id|nct_id|result_group_id|ctgov_group_code|period|reason|count
865493|NCT00496366|1825360|FG000|Overall Study|Death|1
865494|NCT00496470|1825370|FG000|Overall Study|Adverse Event|8
865495|NCT00496470|1825371|FG001|Overall Study|Adverse Event|10
865496|NCT00496470|1825370|FG000|Overall Study|Withdrawal by Subject|5
865497|NCT00496470|1825371|FG001|Overall Study|Withdrawal by Subject|12
865498|NCT00496470|1825370|FG000|Overall Study|Incorrectly enrolled|13
865499|NCT00496470|1825371|FG001|Overall Study|Incorrectly enrolled|5
865500|NCT00496470|1825370|FG000|Overall Study|Other reason|0
865501|NCT00496470|1825371|FG001|Overall Study|Other reason|2
865502|NCT00496483|1825377|FG000|Overall Study|Not dosed|9
865503|NCT00496483|1825377|FG000|Overall Study|Adverse Event|2
865504|NCT00496483|1825377|FG000|Overall Study|Lack of Efficacy|1
865505|NCT00496587|1825384|FG000|Overall Study|Adverse Event|2
865506|NCT00496587|1825384|FG000|Overall Study|Progressive Disease|24
865507|NCT00496587|1825384|FG000|Overall Study|Withdrawal by Subject|2
865508|NCT00496587|1825384|FG000|Overall Study|Death|1
865509|NCT00496587|1825384|FG000|Overall Study|Complications unrelated|2
865510|NCT00496626|1825390|FG000|Overall Study|Lost to Follow-up|0
865511|NCT00496626|1825391|FG001|Overall Study|Lost to Follow-up|1
865512|NCT00496626|1825390|FG000|Overall Study|Protocol Violation|1
865513|NCT00496626|1825391|FG001|Overall Study|Protocol Violation|0
865514|NCT00496626|1825390|FG000|Overall Study|Withdrawal by Subject|5
865515|NCT00496626|1825391|FG001|Overall Study|Withdrawal by Subject|4
865516|NCT00496626|1825390|FG000|Overall Study|Relocated|0
865517|NCT00496626|1825391|FG001|Overall Study|Relocated|1
865518|NCT00496730|1825403|FG000|Overall Study|Lost to Follow-up|4
865519|NCT00496730|1825404|FG001|Overall Study|Lost to Follow-up|3
865520|NCT00496730|1825403|FG000|Overall Study|Withdrawal by Subject|2
865521|NCT00496730|1825404|FG001|Overall Study|Withdrawal by Subject|2
865522|NCT00496769|1825412|FG000|Double Blind|>=1 reason assigned per patient|558
865523|NCT00496769|1825413|FG001|Double Blind|>=1 reason assigned per patient|649
865524|NCT00496769|1825414|FG002|Double Blind|>=1 reason assigned per patient|0
865525|NCT00496769|1825412|FG000|Open Label|>=1 reason assigned per patient|0
865526|NCT00496769|1825413|FG001|Open Label|>=1 reason assigned per patient|0
865527|NCT00496769|1825414|FG002|Open Label|>=1 reason assigned per patient|1011
865528|NCT00496834|1825429|FG000|Overall Study|Withdrawal by Subject|4
865529|NCT00496834|1825430|FG001|Overall Study|Withdrawal by Subject|6
865530|NCT00496834|1825429|FG000|Overall Study|Contraindicated medication administered|0
865531|NCT00496834|1825430|FG001|Overall Study|Contraindicated medication administered|1
865532|NCT00496834|1825429|FG000|Overall Study|Inclusion/exclusion criteria not met|3
865533|NCT00496834|1825430|FG001|Overall Study|Inclusion/exclusion criteria not met|2
865534|NCT00496834|1825429|FG000|Overall Study|Adverse Event|5
865535|NCT00496834|1825430|FG001|Overall Study|Adverse Event|3
865536|NCT00496834|1825429|FG000|Overall Study|IP administration violation|2
865537|NCT00496834|1825430|FG001|Overall Study|IP administration violation|0
865538|NCT00496834|1825429|FG000|Overall Study|Lost to Follow-up|2
865539|NCT00496834|1825430|FG001|Overall Study|Lost to Follow-up|0
865540|NCT00496834|1825429|FG000|Overall Study|Blood Pressure control failure|2
865541|NCT00496834|1825430|FG001|Overall Study|Blood Pressure control failure|1
865542|NCT00496873|1825451|FG000|Overall Study|Ineligible|2
865543|NCT00496873|1825451|FG000|Overall Study|Death|2
865544|NCT00496873|1825451|FG000|Overall Study|Withdrawal by Subject|3
865545|NCT00496964|1825457|FG000|Overall Study|Withdrawal by Subject|0
865546|NCT00496964|1825458|FG001|Overall Study|Withdrawal by Subject|1
865547|NCT00497146|1825486|FG000|Treatment Period|Adverse Event|6
865548|NCT00497146|1825487|FG001|Treatment Period|Adverse Event|2
865549|NCT00497146|1825486|FG000|Treatment Period|Withdrawal by Subject|5
865550|NCT00497146|1825487|FG001|Treatment Period|Withdrawal by Subject|9
865551|NCT00497146|1825486|FG000|Treatment Period|Lost to Follow-up|1
865552|NCT00497146|1825487|FG001|Treatment Period|Lost to Follow-up|3
865553|NCT00497146|1825486|FG000|Treatment Period|Required dialysis|4
865554|NCT00497146|1825487|FG001|Treatment Period|Required dialysis|1
865555|NCT00497146|1825486|FG000|Treatment Period|Change in RAAS inhibitor therapy|5
865556|NCT00497146|1825487|FG001|Treatment Period|Change in RAAS inhibitor therapy|2
865557|NCT00497146|1825486|FG000|Treatment Period|Unable to dose reduce per protocol|4
865558|NCT00497146|1825487|FG001|Treatment Period|Unable to dose reduce per protocol|1
865559|NCT00497146|1825486|FG000|Treatment Period|Other Reason|2
865560|NCT00497146|1825487|FG001|Treatment Period|Other Reason|3
865561|NCT00497146|1825486|FG000|Long-term Follow-up Period|Adverse Event|2
865562|NCT00497146|1825487|FG001|Long-term Follow-up Period|Adverse Event|2
865563|NCT00497146|1825486|FG000|Long-term Follow-up Period|Withdrawal by Subject|8
865564|NCT00497146|1825487|FG001|Long-term Follow-up Period|Withdrawal by Subject|2
865565|NCT00497146|1825486|FG000|Long-term Follow-up Period|Lost to Follow-up|5
865566|NCT00497146|1825487|FG001|Long-term Follow-up Period|Lost to Follow-up|1
865567|NCT00497146|1825486|FG000|Long-term Follow-up Period|Other|0
865568|NCT00497146|1825487|FG001|Long-term Follow-up Period|Other|1
865569|NCT00497198|1825497|FG000|Overall Study|Adverse Event|4
865570|NCT00497198|1825498|FG001|Overall Study|Adverse Event|2
865571|NCT00497198|1825497|FG000|Overall Study|Physician Decision|1
865572|NCT00497198|1825498|FG001|Overall Study|Physician Decision|2
865573|NCT00497198|1825497|FG000|Overall Study|Withdrawal by Subject|0
865574|NCT00497198|1825498|FG001|Overall Study|Withdrawal by Subject|1
865575|NCT00497796|1825535|FG000|Overall Study|Adverse event (not related)|9
865576|NCT00497796|1825536|FG001|Overall Study|Adverse event (not related)|9
865577|NCT00497796|1825535|FG000|Overall Study|Adverse event (related)|5
865578|NCT00497796|1825536|FG001|Overall Study|Adverse event (related)|4
865579|NCT00497796|1825535|FG000|Overall Study|CMV infection or disease treatment|30
865580|NCT00497796|1825536|FG001|Overall Study|CMV infection or disease treatment|4
865581|NCT00497796|1825535|FG000|Overall Study|Consent withdrawn|10
865582|NCT00497796|1825536|FG001|Overall Study|Consent withdrawn|3
865583|NCT00497796|1825535|FG000|Overall Study|Investigator/sponsor discretion|31
865584|NCT00497796|1825536|FG001|Overall Study|Investigator/sponsor discretion|34
865585|NCT00497796|1825535|FG000|Overall Study|Lost to Follow-up|0
865586|NCT00497796|1825536|FG001|Overall Study|Lost to Follow-up|1
865587|NCT00497796|1825535|FG000|Overall Study|Not applicable (randomized not treated)|0
865588|NCT00497796|1825536|FG001|Overall Study|Not applicable (randomized not treated)|4
865589|NCT00497874|1825544|FG000|Overall Study|Withdrawal by Subject|48
865590|NCT00497874|1825545|FG001|Overall Study|Withdrawal by Subject|17
865591|NCT00497874|1825544|FG000|Overall Study|Illness|8
865592|NCT00497874|1825545|FG001|Overall Study|Illness|4
865593|NCT00497874|1825544|FG000|Overall Study|Death|2
865594|NCT00497874|1825545|FG001|Overall Study|Death|4
865595|NCT00497874|1825544|FG000|Overall Study|Unable to contact|52
865596|NCT00497874|1825545|FG001|Overall Study|Unable to contact|67
865597|NCT00497874|1825544|FG000|Overall Study|Unable to schedule|37
865598|NCT00497874|1825545|FG001|Overall Study|Unable to schedule|24
865599|NCT00498173|1825555|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
865600|NCT00498173|1825556|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
865601|NCT00498173|1825557|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
865602|NCT00498186|1825565|FG000|Overall Study|Protocol Violation|10
865603|NCT00498186|1825565|FG000|Overall Study|Lack of Efficacy|31
865604|NCT00498186|1825565|FG000|Overall Study|Adverse Event|89
865605|NCT00498186|1825565|FG000|Overall Study|Unsatisfactory compliance of subject|12
865606|NCT00498186|1825565|FG000|Overall Study|Withdrawal by Subject|18
865607|NCT00498186|1825565|FG000|Overall Study|Lost to Follow-up|3
865608|NCT00498186|1825565|FG000|Overall Study|Other|10
865609|NCT00498355|1825569|FG000|Overall Study|Lost to Follow-up|1
865610|NCT00498368|1825576|FG000|Overall Study|Withdrawal by Subject|3
865611|NCT00498368|1825577|FG001|Overall Study|Withdrawal by Subject|2
865612|NCT00498433|1825586|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
865613|NCT00498433|1825587|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
865614|NCT00498433|1825588|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
865615|NCT00498433|1825586|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
865616|NCT00498433|1825587|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
865617|NCT00498433|1825588|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
865618|NCT00498433|1825586|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
865619|NCT00498433|1825587|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
865620|NCT00498433|1825588|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
865621|NCT00498433|1825586|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
865622|NCT00498433|1825587|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
865623|NCT00498433|1825588|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
865624|NCT00498485|1825607|FG000|Overall Study|Adverse Event|1
865625|NCT00498485|1825608|FG001|Overall Study|Adverse Event|5
865626|NCT00498602|1825632|FG000|Overall Study|Death|0
865627|NCT00498602|1825633|FG001|Overall Study|Death|0
865628|NCT00498602|1825634|FG002|Overall Study|Death|0
865629|NCT00498602|1825635|FG003|Overall Study|Death|0
865630|NCT00498602|1825636|FG004|Overall Study|Death|0
865631|NCT00498602|1825637|FG005|Overall Study|Death|1
865632|NCT00498602|1825638|FG006|Overall Study|Death|0
865633|NCT00498602|1825632|FG000|Overall Study|Lack of Efficacy|1
865634|NCT00498602|1825633|FG001|Overall Study|Lack of Efficacy|0
865635|NCT00498602|1825634|FG002|Overall Study|Lack of Efficacy|0
865636|NCT00498602|1825635|FG003|Overall Study|Lack of Efficacy|0
865637|NCT00498602|1825636|FG004|Overall Study|Lack of Efficacy|0
865638|NCT00498602|1825637|FG005|Overall Study|Lack of Efficacy|0
865639|NCT00498602|1825638|FG006|Overall Study|Lack of Efficacy|0
865640|NCT00498602|1825632|FG000|Overall Study|Lost to Follow-up|0
865641|NCT00498602|1825633|FG001|Overall Study|Lost to Follow-up|2
865642|NCT00498602|1825634|FG002|Overall Study|Lost to Follow-up|0
865643|NCT00498602|1825635|FG003|Overall Study|Lost to Follow-up|2
865644|NCT00498602|1825636|FG004|Overall Study|Lost to Follow-up|0
865645|NCT00498602|1825637|FG005|Overall Study|Lost to Follow-up|0
865646|NCT00498602|1825638|FG006|Overall Study|Lost to Follow-up|0
865647|NCT00498602|1825632|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
865648|NCT00498602|1825633|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
914223|NCT00813709|1891954|FG002|Open Label Period|Lack of Efficacy|0
865649|NCT00498602|1825634|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
865650|NCT00498602|1825635|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
865651|NCT00498602|1825636|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
865652|NCT00498602|1825637|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
865653|NCT00498602|1825638|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
865654|NCT00498602|1825632|FG000|Overall Study|AE not related to Study Drug|1
865655|NCT00498602|1825633|FG001|Overall Study|AE not related to Study Drug|3
865656|NCT00498602|1825634|FG002|Overall Study|AE not related to Study Drug|0
865657|NCT00498602|1825635|FG003|Overall Study|AE not related to Study Drug|0
865658|NCT00498602|1825636|FG004|Overall Study|AE not related to Study Drug|2
865659|NCT00498602|1825637|FG005|Overall Study|AE not related to Study Drug|2
865660|NCT00498602|1825638|FG006|Overall Study|AE not related to Study Drug|1
865661|NCT00498602|1825632|FG000|Overall Study|Caregiver Request|2
865662|NCT00498602|1825633|FG001|Overall Study|Caregiver Request|2
865663|NCT00498602|1825634|FG002|Overall Study|Caregiver Request|2
865664|NCT00498602|1825635|FG003|Overall Study|Caregiver Request|0
865665|NCT00498602|1825636|FG004|Overall Study|Caregiver Request|1
865666|NCT00498602|1825637|FG005|Overall Study|Caregiver Request|2
865667|NCT00498602|1825638|FG006|Overall Study|Caregiver Request|0
865668|NCT00498602|1825632|FG000|Overall Study|Investigator Request|0
865669|NCT00498602|1825633|FG001|Overall Study|Investigator Request|0
865670|NCT00498602|1825634|FG002|Overall Study|Investigator Request|1
865671|NCT00498602|1825635|FG003|Overall Study|Investigator Request|0
865672|NCT00498602|1825636|FG004|Overall Study|Investigator Request|0
865673|NCT00498602|1825637|FG005|Overall Study|Investigator Request|0
865674|NCT00498602|1825638|FG006|Overall Study|Investigator Request|0
865675|NCT00498602|1825632|FG000|Overall Study|Subject Request|3
865676|NCT00498602|1825633|FG001|Overall Study|Subject Request|0
865677|NCT00498602|1825634|FG002|Overall Study|Subject Request|1
865678|NCT00498602|1825635|FG003|Overall Study|Subject Request|1
865679|NCT00498602|1825636|FG004|Overall Study|Subject Request|1
865680|NCT00498602|1825637|FG005|Overall Study|Subject Request|4
865681|NCT00498602|1825638|FG006|Overall Study|Subject Request|1
865682|NCT00498602|1825632|FG000|Overall Study|Other|2
865683|NCT00498602|1825633|FG001|Overall Study|Other|3
865684|NCT00498602|1825634|FG002|Overall Study|Other|1
865685|NCT00498602|1825635|FG003|Overall Study|Other|0
865686|NCT00498602|1825636|FG004|Overall Study|Other|0
865687|NCT00498602|1825637|FG005|Overall Study|Other|3
865688|NCT00498602|1825638|FG006|Overall Study|Other|0
865689|NCT00498797|1825697|FG000|Overall Study|Withdrawal by Subject|4
865690|NCT00498797|1825698|FG001|Overall Study|Withdrawal by Subject|2
865691|NCT00498797|1825697|FG000|Overall Study|Adverse Event|12
865692|NCT00498797|1825698|FG001|Overall Study|Adverse Event|5
865693|NCT00498797|1825697|FG000|Overall Study|Condition under investigation worsened|19
865694|NCT00498797|1825698|FG001|Overall Study|Condition under investigation worsened|21
865695|NCT00498797|1825697|FG000|Overall Study|Other|3
865696|NCT00498797|1825698|FG001|Overall Study|Other|1
865697|NCT00499031|1825717|FG000|Overall Study|Improper pre-protocol treatment|1
865698|NCT00499031|1825717|FG000|Overall Study|Required test not done|1
865699|NCT00499031|1825717|FG000|Overall Study|Never treated|1
865700|NCT00499083|1825721|FG000|Overall Study|Not evaluable|3
865701|NCT00499122|1825748|FG000|Overall Study|Withdrawal by Subject|2
865702|NCT00499174|1825755|FG000|Overall Study|Physician Decision|78
865703|NCT00499174|1825756|FG001|Overall Study|Physician Decision|9
865704|NCT00499252|1825764|FG000|Overall Study|Adverse Event|3
865705|NCT00499252|1825764|FG000|Overall Study|Refused further treatment|2
865706|NCT00499252|1825764|FG000|Overall Study|Ineligible|4
865707|NCT00499252|1825764|FG000|Overall Study|<no further label>|3
865708|NCT00499369|1825786|FG000|Overall Study|Adverse Event|2
865709|NCT00499369|1825787|FG001|Overall Study|Adverse Event|2
865710|NCT00499369|1825788|FG002|Overall Study|Adverse Event|3
865711|NCT00499369|1825789|FG003|Overall Study|Adverse Event|1
865712|NCT00499369|1825790|FG004|Overall Study|Adverse Event|2
865713|NCT00499369|1825786|FG000|Overall Study|Withdrawal by Subject|0
865714|NCT00499369|1825787|FG001|Overall Study|Withdrawal by Subject|1
865715|NCT00499369|1825788|FG002|Overall Study|Withdrawal by Subject|1
865716|NCT00499369|1825789|FG003|Overall Study|Withdrawal by Subject|0
865717|NCT00499369|1825790|FG004|Overall Study|Withdrawal by Subject|0
865718|NCT00499369|1825786|FG000|Overall Study|Progression|10
865719|NCT00499369|1825787|FG001|Overall Study|Progression|12
865720|NCT00499369|1825788|FG002|Overall Study|Progression|9
865721|NCT00499369|1825789|FG003|Overall Study|Progression|6
865722|NCT00499369|1825790|FG004|Overall Study|Progression|10
865723|NCT00499369|1825786|FG000|Overall Study|Death|0
865724|NCT00499369|1825787|FG001|Overall Study|Death|1
865725|NCT00499369|1825788|FG002|Overall Study|Death|0
865726|NCT00499369|1825789|FG003|Overall Study|Death|0
865727|NCT00499369|1825790|FG004|Overall Study|Death|0
865728|NCT00499369|1825786|FG000|Overall Study|Not protocol specified|2
865729|NCT00499369|1825787|FG001|Overall Study|Not protocol specified|0
865730|NCT00499369|1825788|FG002|Overall Study|Not protocol specified|3
865731|NCT00499369|1825789|FG003|Overall Study|Not protocol specified|1
865732|NCT00499369|1825790|FG004|Overall Study|Not protocol specified|0
865733|NCT00499369|1825786|FG000|Overall Study|Ineligible|2
865734|NCT00499369|1825787|FG001|Overall Study|Ineligible|2
865735|NCT00499369|1825788|FG002|Overall Study|Ineligible|1
865736|NCT00499369|1825789|FG003|Overall Study|Ineligible|1
865737|NCT00499369|1825790|FG004|Overall Study|Ineligible|0
865738|NCT00499460|1825812|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1
865739|NCT00499460|1825813|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0
865740|NCT00499460|1825812|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
865741|NCT00499460|1825813|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
865742|NCT00499460|1825812|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0
865743|NCT00499460|1825813|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1
865744|NCT00499486|1825838|FG000|Overall Study|Withdrawal by Subject|16
865745|NCT00499603|1825844|FG000|Overall Study|Adverse Event|0
865746|NCT00499603|1825845|FG001|Overall Study|Adverse Event|1
865747|NCT00499616|1825857|FG000|Overall Study|Death|1
865748|NCT00499616|1825858|FG001|Overall Study|Death|5
865749|NCT00499616|1825859|FG002|Overall Study|Death|3
865750|NCT00499616|1825860|FG003|Overall Study|Death|1
865751|NCT00499616|1825857|FG000|Overall Study|Lack of Efficacy|5
865752|NCT00499616|1825858|FG001|Overall Study|Lack of Efficacy|0
865753|NCT00499616|1825859|FG002|Overall Study|Lack of Efficacy|19
865754|NCT00499616|1825860|FG003|Overall Study|Lack of Efficacy|0
865755|NCT00499616|1825857|FG000|Overall Study|Lost to Follow-up|0
865756|NCT00499616|1825858|FG001|Overall Study|Lost to Follow-up|0
865757|NCT00499616|1825859|FG002|Overall Study|Lost to Follow-up|1
865758|NCT00499616|1825860|FG003|Overall Study|Lost to Follow-up|0
865759|NCT00499616|1825857|FG000|Overall Study|Physician Decision|6
865760|NCT00499616|1825858|FG001|Overall Study|Physician Decision|16
865761|NCT00499616|1825859|FG002|Overall Study|Physician Decision|9
865762|NCT00499616|1825860|FG003|Overall Study|Physician Decision|0
865763|NCT00499616|1825857|FG000|Overall Study|Withdrawal by Subject|1
865764|NCT00499616|1825858|FG001|Overall Study|Withdrawal by Subject|0
865765|NCT00499616|1825859|FG002|Overall Study|Withdrawal by Subject|1
865766|NCT00499616|1825860|FG003|Overall Study|Withdrawal by Subject|0
865767|NCT00499616|1825857|FG000|Overall Study|Ineligible|1
865768|NCT00499616|1825858|FG001|Overall Study|Ineligible|2
865769|NCT00499616|1825859|FG002|Overall Study|Ineligible|0
865770|NCT00499616|1825860|FG003|Overall Study|Ineligible|15
865771|NCT00499616|1825857|FG000|Overall Study|Not evaluable|0
865772|NCT00499616|1825858|FG001|Overall Study|Not evaluable|0
865773|NCT00499616|1825859|FG002|Overall Study|Not evaluable|0
865774|NCT00499616|1825860|FG003|Overall Study|Not evaluable|41
865775|NCT00499616|1825857|FG000|Overall Study|Patient/Parent Refusal|1
865776|NCT00499616|1825858|FG001|Overall Study|Patient/Parent Refusal|5
865777|NCT00499616|1825859|FG002|Overall Study|Patient/Parent Refusal|3
865778|NCT00499616|1825860|FG003|Overall Study|Patient/Parent Refusal|0
865779|NCT00499681|1825885|FG000|Overall Study|toxicity|0
865780|NCT00499681|1825886|FG001|Overall Study|toxicity|1
865781|NCT00499681|1825885|FG000|Overall Study|disease progression|0
865782|NCT00499681|1825886|FG001|Overall Study|disease progression|1
865783|NCT00499694|1825892|FG000|Overall Study|Patient never received treatment.|1
865784|NCT00499746|1825897|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
865785|NCT00499746|1825897|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
865786|NCT00499746|1825897|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1
865787|NCT00499746|1825897|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1
865788|NCT00499863|1825913|FG000|Overall Study|Lack of Efficacy|21
865789|NCT00499863|1825914|FG001|Overall Study|Lack of Efficacy|27
865790|NCT00499863|1825913|FG000|Overall Study|Protocol Violation|12
865791|NCT00499863|1825914|FG001|Overall Study|Protocol Violation|7
865792|NCT00499863|1825913|FG000|Overall Study|Withdrawal by Subject|6
865793|NCT00499863|1825914|FG001|Overall Study|Withdrawal by Subject|4
865794|NCT00499863|1825913|FG000|Overall Study|Adverse Event|8
865795|NCT00499863|1825914|FG001|Overall Study|Adverse Event|2
865796|NCT00499863|1825913|FG000|Overall Study|Sponsor decision|2
865797|NCT00499863|1825914|FG001|Overall Study|Sponsor decision|2
865798|NCT00499863|1825913|FG000|Overall Study|Lost to Follow-up|1
865799|NCT00499863|1825914|FG001|Overall Study|Lost to Follow-up|1
865800|NCT00499889|1825920|FG000|Overall Study|Infection prior to treatment|1
865801|NCT00500071|1825933|FG000|Screening and Washout Phase|Protocol Violation|1
865802|NCT00500071|1825933|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13
865803|NCT00500071|1825933|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2
865804|NCT00500071|1825933|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
865805|NCT00500071|1825933|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
865806|NCT00500071|1825933|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
865807|NCT00500071|1825933|FG000|30-day Safety Follow-up|Lost to Follow-up|17
865808|NCT00500110|1825937|FG000|Overall Study|Withdrawal by Subject|3
865809|NCT00500149|1825941|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
865810|NCT00500149|1825942|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
865811|NCT00500149|1825941|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8
865812|NCT00500149|1825942|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0
865813|NCT00500149|1825941|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1
865814|NCT00500149|1825942|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0
865815|NCT00500149|1825941|FG000|First Intervention (Cross-over Phase)|Adverse Event|0
865816|NCT00500149|1825942|FG001|First Intervention (Cross-over Phase)|Adverse Event|1
865817|NCT00500149|1825941|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
865818|NCT00500149|1825942|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
865819|NCT00500149|1825941|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1
865820|NCT00500149|1825942|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0
865821|NCT00500149|1825941|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
865822|NCT00500149|1825942|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
865823|NCT00500266|1825959|FG000|Overall Study|Death|3
865824|NCT00500266|1825959|FG000|Overall Study|Lost to Follow-up|3
865825|NCT00500266|1825959|FG000|Overall Study|Withdrawal by Subject|3
865826|NCT00500266|1825959|FG000|Overall Study|Assigned, not treated|4
865827|NCT00500292|1825967|FG000|Overall Study|Adverse Event|3
865828|NCT00500292|1825968|FG001|Overall Study|Adverse Event|6
865829|NCT00500292|1825969|FG002|Overall Study|Adverse Event|4
865830|NCT00500292|1825967|FG000|Overall Study|Condition under investigation worsened|21
865831|NCT00500292|1825968|FG001|Overall Study|Condition under investigation worsened|23
865832|NCT00500292|1825969|FG002|Overall Study|Condition under investigation worsened|19
865833|NCT00500292|1825967|FG000|Overall Study|Withdrawal by Subject|0
865834|NCT00500292|1825968|FG001|Overall Study|Withdrawal by Subject|1
865835|NCT00500292|1825969|FG002|Overall Study|Withdrawal by Subject|0
865836|NCT00500292|1825967|FG000|Overall Study|Other|1
865837|NCT00500292|1825968|FG001|Overall Study|Other|1
865838|NCT00500292|1825969|FG002|Overall Study|Other|4
865839|NCT00500318|1825979|FG000|Overall Study|Adverse Event|3
865840|NCT00500318|1825980|FG001|Overall Study|Adverse Event|8
865841|NCT00500318|1825979|FG000|Overall Study|Protocol Violation|1
865842|NCT00500318|1825980|FG001|Overall Study|Protocol Violation|3
865843|NCT00500318|1825979|FG000|Overall Study|Withdrawal by Subject|1
865844|NCT00500318|1825980|FG001|Overall Study|Withdrawal by Subject|2
865845|NCT00500318|1825979|FG000|Overall Study|Lack of Efficacy|0
865846|NCT00500318|1825980|FG001|Overall Study|Lack of Efficacy|3
865847|NCT00500318|1825979|FG000|Overall Study|Other Reason|0
865848|NCT00500318|1825980|FG001|Overall Study|Other Reason|1
865849|NCT00500331|1825993|FG000|Overall Study|Adverse Event|0
865850|NCT00500331|1825994|FG001|Overall Study|Adverse Event|2
865851|NCT00500331|1825995|FG002|Overall Study|Adverse Event|0
865852|NCT00500331|1825996|FG003|Overall Study|Adverse Event|1
865853|NCT00500331|1825997|FG004|Overall Study|Adverse Event|2
865854|NCT00500331|1825998|FG005|Overall Study|Adverse Event|2
865855|NCT00500331|1825999|FG006|Overall Study|Adverse Event|0
865856|NCT00500331|1825993|FG000|Overall Study|Lost to Follow-up|1
865857|NCT00500331|1825994|FG001|Overall Study|Lost to Follow-up|1
865858|NCT00500331|1825995|FG002|Overall Study|Lost to Follow-up|1
865859|NCT00500331|1825996|FG003|Overall Study|Lost to Follow-up|2
865860|NCT00500331|1825997|FG004|Overall Study|Lost to Follow-up|1
865861|NCT00500331|1825998|FG005|Overall Study|Lost to Follow-up|0
865862|NCT00500331|1825999|FG006|Overall Study|Lost to Follow-up|0
865863|NCT00500331|1825993|FG000|Overall Study|Protocol Violation|3
865864|NCT00500331|1825994|FG001|Overall Study|Protocol Violation|1
865865|NCT00500331|1825995|FG002|Overall Study|Protocol Violation|1
865866|NCT00500331|1825996|FG003|Overall Study|Protocol Violation|0
865867|NCT00500331|1825997|FG004|Overall Study|Protocol Violation|1
865868|NCT00500331|1825998|FG005|Overall Study|Protocol Violation|1
865869|NCT00500331|1825999|FG006|Overall Study|Protocol Violation|1
865870|NCT00500331|1825993|FG000|Overall Study|Withdrawal by Subject|4
865871|NCT00500331|1825994|FG001|Overall Study|Withdrawal by Subject|0
865872|NCT00500331|1825995|FG002|Overall Study|Withdrawal by Subject|1
865873|NCT00500331|1825996|FG003|Overall Study|Withdrawal by Subject|5
865874|NCT00500331|1825997|FG004|Overall Study|Withdrawal by Subject|0
865875|NCT00500331|1825998|FG005|Overall Study|Withdrawal by Subject|1
865876|NCT00500331|1825999|FG006|Overall Study|Withdrawal by Subject|1
865877|NCT00500331|1825993|FG000|Overall Study|Lack of Efficacy|3
865878|NCT00500331|1825994|FG001|Overall Study|Lack of Efficacy|1
865879|NCT00500331|1825995|FG002|Overall Study|Lack of Efficacy|0
865880|NCT00500331|1825996|FG003|Overall Study|Lack of Efficacy|0
865881|NCT00500331|1825997|FG004|Overall Study|Lack of Efficacy|0
865882|NCT00500331|1825998|FG005|Overall Study|Lack of Efficacy|0
865883|NCT00500331|1825999|FG006|Overall Study|Lack of Efficacy|0
865884|NCT00500331|1825993|FG000|Overall Study|Liver function test abnormality|0
865885|NCT00500331|1825994|FG001|Overall Study|Liver function test abnormality|0
865886|NCT00500331|1825995|FG002|Overall Study|Liver function test abnormality|1
865887|NCT00500331|1825996|FG003|Overall Study|Liver function test abnormality|0
865888|NCT00500331|1825997|FG004|Overall Study|Liver function test abnormality|0
865889|NCT00500331|1825998|FG005|Overall Study|Liver function test abnormality|0
865890|NCT00500331|1825999|FG006|Overall Study|Liver function test abnormality|0
865891|NCT00500331|1825993|FG000|Overall Study|Increased serum creatinine from Baseline|0
865892|NCT00500331|1825994|FG001|Overall Study|Increased serum creatinine from Baseline|0
865893|NCT00500331|1825995|FG002|Overall Study|Increased serum creatinine from Baseline|0
865894|NCT00500331|1825996|FG003|Overall Study|Increased serum creatinine from Baseline|0
865895|NCT00500331|1825997|FG004|Overall Study|Increased serum creatinine from Baseline|0
865896|NCT00500331|1825998|FG005|Overall Study|Increased serum creatinine from Baseline|1
865897|NCT00500331|1825999|FG006|Overall Study|Increased serum creatinine from Baseline|0
865898|NCT00500331|1825993|FG000|Overall Study|Didn't return for continuation of study|1
865899|NCT00500331|1825994|FG001|Overall Study|Didn't return for continuation of study|0
865900|NCT00500331|1825995|FG002|Overall Study|Didn't return for continuation of study|0
865901|NCT00500331|1825996|FG003|Overall Study|Didn't return for continuation of study|0
865902|NCT00500331|1825997|FG004|Overall Study|Didn't return for continuation of study|0
865903|NCT00500331|1825998|FG005|Overall Study|Didn't return for continuation of study|0
865904|NCT00500331|1825999|FG006|Overall Study|Didn't return for continuation of study|0
865905|NCT00500331|1825993|FG000|Overall Study|Exclusion citeria not met on Visit 4|1
865906|NCT00500331|1825994|FG001|Overall Study|Exclusion citeria not met on Visit 4|0
865907|NCT00500331|1825995|FG002|Overall Study|Exclusion citeria not met on Visit 4|0
865908|NCT00500331|1825996|FG003|Overall Study|Exclusion citeria not met on Visit 4|0
865909|NCT00500331|1825997|FG004|Overall Study|Exclusion citeria not met on Visit 4|0
865910|NCT00500331|1825998|FG005|Overall Study|Exclusion citeria not met on Visit 4|0
865911|NCT00500331|1825999|FG006|Overall Study|Exclusion citeria not met on Visit 4|0
865912|NCT00500331|1825993|FG000|Overall Study|Sponsor decided to withdraw participant|1
865913|NCT00500331|1825994|FG001|Overall Study|Sponsor decided to withdraw participant|0
865914|NCT00500331|1825995|FG002|Overall Study|Sponsor decided to withdraw participant|0
865915|NCT00500331|1825996|FG003|Overall Study|Sponsor decided to withdraw participant|0
865916|NCT00500331|1825997|FG004|Overall Study|Sponsor decided to withdraw participant|0
865917|NCT00500331|1825998|FG005|Overall Study|Sponsor decided to withdraw participant|0
865918|NCT00500331|1825999|FG006|Overall Study|Sponsor decided to withdraw participant|0
865919|NCT00500331|1825993|FG000|Overall Study|Participant was randomized by mistake|1
865920|NCT00500331|1825994|FG001|Overall Study|Participant was randomized by mistake|0
865921|NCT00500331|1825995|FG002|Overall Study|Participant was randomized by mistake|0
865922|NCT00500331|1825996|FG003|Overall Study|Participant was randomized by mistake|0
865923|NCT00500331|1825997|FG004|Overall Study|Participant was randomized by mistake|0
865924|NCT00500331|1825998|FG005|Overall Study|Participant was randomized by mistake|0
865925|NCT00500331|1825999|FG006|Overall Study|Participant was randomized by mistake|0
865926|NCT00500331|1825993|FG000|Overall Study|Diabetologist nurse in the study|0
865927|NCT00500331|1825994|FG001|Overall Study|Diabetologist nurse in the study|0
865928|NCT00500331|1825995|FG002|Overall Study|Diabetologist nurse in the study|1
865929|NCT00500331|1825996|FG003|Overall Study|Diabetologist nurse in the study|0
865930|NCT00500331|1825997|FG004|Overall Study|Diabetologist nurse in the study|0
865931|NCT00500331|1825998|FG005|Overall Study|Diabetologist nurse in the study|0
865932|NCT00500331|1825999|FG006|Overall Study|Diabetologist nurse in the study|0
865933|NCT00500331|1825993|FG000|Overall Study|State ban of biological samples export|0
865934|NCT00500331|1825994|FG001|Overall Study|State ban of biological samples export|0
865935|NCT00500331|1825995|FG002|Overall Study|State ban of biological samples export|0
865936|NCT00500331|1825996|FG003|Overall Study|State ban of biological samples export|1
865937|NCT00500331|1825997|FG004|Overall Study|State ban of biological samples export|0
865938|NCT00500331|1825998|FG005|Overall Study|State ban of biological samples export|0
865939|NCT00500331|1825999|FG006|Overall Study|State ban of biological samples export|0
865940|NCT00500331|1825993|FG000|Overall Study|Protocol violated|0
865941|NCT00500331|1825994|FG001|Overall Study|Protocol violated|0
865942|NCT00500331|1825995|FG002|Overall Study|Protocol violated|0
865943|NCT00500331|1825996|FG003|Overall Study|Protocol violated|1
865944|NCT00500331|1825997|FG004|Overall Study|Protocol violated|0
865945|NCT00500331|1825998|FG005|Overall Study|Protocol violated|0
865946|NCT00500331|1825999|FG006|Overall Study|Protocol violated|0
865947|NCT00500357|1826016|FG000|Overall Study|Death|1
865948|NCT00500370|1826033|FG000|Overall Study|Adverse Event|9
865949|NCT00500370|1826034|FG001|Overall Study|Adverse Event|3
865950|NCT00500370|1826033|FG000|Overall Study|Lost to Follow-up|10
865951|NCT00500370|1826034|FG001|Overall Study|Lost to Follow-up|10
865952|NCT00500370|1826033|FG000|Overall Study|Protocol Violation|2
865953|NCT00500370|1826034|FG001|Overall Study|Protocol Violation|4
865954|NCT00500370|1826033|FG000|Overall Study|Sponsor Decision|2
865955|NCT00500370|1826034|FG001|Overall Study|Sponsor Decision|0
865956|NCT00500370|1826033|FG000|Overall Study|Subject Decision|10
865957|NCT00500370|1826034|FG001|Overall Study|Subject Decision|17
865958|NCT00500539|1826049|FG000|Treatment Period (24 Weeks)|Adverse Event|4
865959|NCT00500539|1826049|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
865960|NCT00500539|1826049|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1
865961|NCT00500539|1826049|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2
865962|NCT00500539|1826049|FG000|Treatment Period (24 Weeks)|Administrative problems|2
865963|NCT00500539|1826049|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5
865964|NCT00500539|1826049|FG000|Follow-up Period (16 Weeks)|Adverse Event|1
865965|NCT00500539|1826049|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2
865966|NCT00500539|1826049|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3
865967|NCT00500539|1826049|FG000|Follow-up Period (16 Weeks)|Administrative problems|1
865968|NCT00500539|1826049|FG000|Follow-up Period (16 Weeks)|Death|1
865969|NCT00500539|1826049|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1
865970|NCT00500539|1826049|FG000|Follow-up Period (16 Weeks)|Missing|3
865971|NCT00500682|1826084|FG000|Overall Study|Adverse Event|37
865972|NCT00500682|1826085|FG001|Overall Study|Adverse Event|29
865973|NCT00500682|1826084|FG000|Overall Study|Death|25
865974|NCT00500682|1826085|FG001|Overall Study|Death|16
865975|NCT00500682|1826084|FG000|Overall Study|Lost to Follow-up|11
865976|NCT00500682|1826085|FG001|Overall Study|Lost to Follow-up|11
865977|NCT00500682|1826084|FG000|Overall Study|Physician Decision|6
865978|NCT00500682|1826085|FG001|Overall Study|Physician Decision|10
865979|NCT00500682|1826084|FG000|Overall Study|Pregnancy|2
865980|NCT00500682|1826085|FG001|Overall Study|Pregnancy|0
865981|NCT00500682|1826084|FG000|Overall Study|Protocol Violation|1
865982|NCT00500682|1826085|FG001|Overall Study|Protocol Violation|3
865983|NCT00500682|1826084|FG000|Overall Study|Withdrawal by Subject|80
865984|NCT00500682|1826085|FG001|Overall Study|Withdrawal by Subject|74
865985|NCT00500682|1826084|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144
865986|NCT00500682|1826085|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144
865987|NCT00500760|1826093|FG000|Overall Study|Death|32
865988|NCT00500760|1826094|FG001|Overall Study|Death|15
865989|NCT00500760|1826093|FG000|Overall Study|Withdrawal by Subject|5
865990|NCT00500760|1826094|FG001|Overall Study|Withdrawal by Subject|7
865991|NCT00500760|1826093|FG000|Overall Study|Administrative decision|2
865992|NCT00500760|1826094|FG001|Overall Study|Administrative decision|0
865993|NCT00500760|1826093|FG000|Overall Study|Lost to Follow-up|3
865994|NCT00500760|1826094|FG001|Overall Study|Lost to Follow-up|0
865995|NCT00500760|1826093|FG000|Overall Study|Other|1
865996|NCT00500760|1826094|FG001|Overall Study|Other|2
865997|NCT00500903|1826103|FG000|Overall Study|Occurrence of Adverse Event(s)|10
865998|NCT00500903|1826104|FG001|Overall Study|Occurrence of Adverse Event(s)|0
865999|NCT00500903|1826105|FG002|Overall Study|Occurrence of Adverse Event(s)|0
866000|NCT00500903|1826103|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
866001|NCT00500903|1826104|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
866002|NCT00500903|1826105|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
866003|NCT00500903|1826103|FG000|Overall Study|Progressive Disease|41
866004|NCT00500903|1826104|FG001|Overall Study|Progressive Disease|2
866005|NCT00500903|1826105|FG002|Overall Study|Progressive Disease|15
866006|NCT00500903|1826103|FG000|Overall Study|Patient Declined Further Treatment|0
866007|NCT00500903|1826104|FG001|Overall Study|Patient Declined Further Treatment|0
866008|NCT00500903|1826105|FG002|Overall Study|Patient Declined Further Treatment|3
866009|NCT00500903|1826103|FG000|Overall Study|Symptomatic Deterioration|2
866010|NCT00500903|1826104|FG001|Overall Study|Symptomatic Deterioration|0
866011|NCT00500903|1826105|FG002|Overall Study|Symptomatic Deterioration|0
866012|NCT00500903|1826103|FG000|Overall Study|Reason Not Specified|10
866013|NCT00500903|1826104|FG001|Overall Study|Reason Not Specified|0
866014|NCT00500903|1826105|FG002|Overall Study|Reason Not Specified|2
866015|NCT00501007|1826143|FG000|Overall Study|Inclusion criteria not met.|29
866016|NCT00501007|1826144|FG001|Overall Study|Inclusion criteria not met.|25
866017|NCT00501046|1826152|FG000|Overall Study|Adverse Event|21
866018|NCT00501046|1826153|FG001|Overall Study|Adverse Event|25
866019|NCT00501046|1826152|FG000|Overall Study|Death|23
866020|NCT00501046|1826153|FG001|Overall Study|Death|30
866021|NCT00501046|1826152|FG000|Overall Study|Lost to Follow-up|14
866022|NCT00501046|1826153|FG001|Overall Study|Lost to Follow-up|13
866023|NCT00501046|1826152|FG000|Overall Study|Physician Decision|7
866024|NCT00501046|1826153|FG001|Overall Study|Physician Decision|2
866025|NCT00501046|1826152|FG000|Overall Study|Pregnancy|0
866026|NCT00501046|1826153|FG001|Overall Study|Pregnancy|3
866027|NCT00501046|1826152|FG000|Overall Study|Protocol Violation|2
866028|NCT00501046|1826153|FG001|Overall Study|Protocol Violation|1
866029|NCT00501046|1826152|FG000|Overall Study|Withdrawal by Subject|84
866030|NCT00501046|1826153|FG001|Overall Study|Withdrawal by Subject|83
866031|NCT00501046|1826152|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119
866032|NCT00501046|1826153|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137
866033|NCT00501059|1826161|FG000|Overall Study|Protocol Violation|80
866034|NCT00501059|1826162|FG001|Overall Study|Protocol Violation|69
866035|NCT00501059|1826161|FG000|Overall Study|Death|140
866036|NCT00501059|1826162|FG001|Overall Study|Death|137
866037|NCT00501059|1826161|FG000|Overall Study|Other|236
866038|NCT00501059|1826162|FG001|Overall Study|Other|239
866039|NCT00501059|1826161|FG000|Overall Study|Missing end-of-study page|91
866040|NCT00501059|1826162|FG001|Overall Study|Missing end-of-study page|92
866041|NCT00501059|1826161|FG000|Overall Study|Clinical endpoint reached|110
866042|NCT00501059|1826162|FG001|Overall Study|Clinical endpoint reached|123
866043|NCT00501059|1826161|FG000|Overall Study|Insufficient therapeutic effect|4
866044|NCT00501059|1826162|FG001|Overall Study|Insufficient therapeutic effect|5
866045|NCT00501059|1826161|FG000|Overall Study|Consent withdrawn by subject|817
866046|NCT00501059|1826162|FG001|Overall Study|Consent withdrawn by subject|873
866047|NCT00501059|1826161|FG000|Overall Study|Non-compliant with study treatment|23
866048|NCT00501059|1826162|FG001|Overall Study|Non-compliant with study treatment|16
866049|NCT00501059|1826161|FG000|Overall Study|Reason not given|3
866050|NCT00501059|1826162|FG001|Overall Study|Reason not given|1
866051|NCT00501059|1826161|FG000|Overall Study|Adverse Event|129
866052|NCT00501059|1826162|FG001|Overall Study|Adverse Event|122
866053|NCT00501059|1826161|FG000|Overall Study|Lost to Follow-up|210
866054|NCT00501059|1826162|FG001|Overall Study|Lost to Follow-up|198
866055|NCT00501059|1826161|FG000|Overall Study|Not treated|25
866056|NCT00501059|1826162|FG001|Overall Study|Not treated|17
866057|NCT00501085|1826170|FG000|Overall Study|Lost to Follow-up|195
866058|NCT00501085|1826170|FG000|Overall Study|Withdrawal by Subject|34
866059|NCT00501085|1826170|FG000|Overall Study|Subject Decision|1
866060|NCT00501085|1826170|FG000|Overall Study|Revision Surgery|7
866061|NCT00501085|1826170|FG000|Overall Study|Explantation Surgery|26
866062|NCT00501085|1826170|FG000|Overall Study|Adverse Event|4
866063|NCT00501085|1826170|FG000|Overall Study|Non-Compliance|24
866064|NCT00501085|1826170|FG000|Overall Study|Study closed by sponsor|109
866065|NCT00501085|1826170|FG000|Overall Study|Other loss to follow-up|32
866066|NCT00501293|1826176|FG000|Optimization Period|Enrolled in error|1
866067|NCT00501293|1826177|FG001|Optimization Period|Enrolled in error|0
866068|NCT00501293|1826176|FG000|Maintenance Period|Withdrawal by Subject|14
866069|NCT00501293|1826177|FG001|Maintenance Period|Withdrawal by Subject|13
866070|NCT00501293|1826176|FG000|Maintenance Period|Lost to Follow-up|12
866071|NCT00501293|1826177|FG001|Maintenance Period|Lost to Follow-up|7
866072|NCT00501293|1826176|FG000|Maintenance Period|Adverse Event|6
866073|NCT00501293|1826177|FG001|Maintenance Period|Adverse Event|6
866074|NCT00501293|1826176|FG000|Maintenance Period|Protocol Violation|2
866075|NCT00501293|1826177|FG001|Maintenance Period|Protocol Violation|1
866076|NCT00501293|1826176|FG000|Maintenance Period|Lack of Efficacy|4
866077|NCT00501293|1826177|FG001|Maintenance Period|Lack of Efficacy|1
866078|NCT00501293|1826176|FG000|Maintenance Period|Noncompliant with study medication|5
866079|NCT00501293|1826177|FG001|Maintenance Period|Noncompliant with study medication|0
866080|NCT00501293|1826176|FG000|Maintenance Period|Went into rehabilitation|1
866081|NCT00501293|1826177|FG001|Maintenance Period|Went into rehabilitation|0
866082|NCT00501293|1826176|FG000|Maintenance Period|Would not wear patch|1
866083|NCT00501293|1826177|FG001|Maintenance Period|Would not wear patch|0
866084|NCT00501293|1826176|FG000|Maintenance Period|Application site reaction|1
866085|NCT00501293|1826177|FG001|Maintenance Period|Application site reaction|0
866086|NCT00501540|1826184|FG000|Overall Study|Death|5
866087|NCT00501644|1826210|FG000|Overall Study|Adverse Event|4
866088|NCT00501644|1826210|FG000|Overall Study|Withdrawal by Subject|1
866089|NCT00501852|1826214|FG000|Overall Study|Adverse Event|3
866090|NCT00501852|1826214|FG000|Overall Study|Withdrawal by Subject|2
866091|NCT00501969|1826244|FG000|Overall Study|Major Protocol Violation|4
866092|NCT00501969|1826244|FG000|Overall Study|Lack of Efficacy|29
866093|NCT00501969|1826244|FG000|Overall Study|Adverse Event|76
866094|NCT00501969|1826244|FG000|Overall Study|Unsatisfactory compliance of subject|7
866095|NCT00501969|1826244|FG000|Overall Study|Subject withdrew consent|51
866096|NCT00501969|1826244|FG000|Overall Study|Lost to Follow-up|4
866097|NCT00501969|1826244|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1
866098|NCT00501969|1826244|FG000|Overall Study|Other: Sponsors Request|10
866099|NCT00501969|1826244|FG000|Overall Study|Other: Sponsor Termination at Site|1
866100|NCT00501969|1826244|FG000|Overall Study|Other: Sponsor Stopped Study|12
866101|NCT00501969|1826244|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1
866102|NCT00501969|1826244|FG000|Overall Study|Other: Patients + Investigator Agreement|1
866103|NCT00501969|1826244|FG000|Overall Study|Other: Patient is Going to Have DBS|1
866104|NCT00501969|1826244|FG000|Overall Study|Other: Pat Pending Surgery for PD|1
866105|NCT00501969|1826244|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
866106|NCT00501969|1826244|FG000|Overall Study|Other: As Required by Local EC|2
866107|NCT00501969|1826244|FG000|Overall Study|Other: Admin Request from the Sponsor|3
866108|NCT00501969|1826244|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1
866109|NCT00502203|1826252|FG000|Overall Study|Inevaluable|1
866110|NCT00502242|1826267|FG000|Overall Study|Lack of Efficacy|1
866111|NCT00502242|1826268|FG001|Overall Study|Lack of Efficacy|11
866112|NCT00502242|1826267|FG000|Overall Study|Adverse Event|31
866113|NCT00502242|1826268|FG001|Overall Study|Adverse Event|20
866114|NCT00502242|1826267|FG000|Overall Study|Physician Decision|2
866115|NCT00502242|1826268|FG001|Overall Study|Physician Decision|3
866116|NCT00502242|1826267|FG000|Overall Study|Other - Unspecified|8
866117|NCT00502242|1826268|FG001|Overall Study|Other - Unspecified|14
866118|NCT00502242|1826267|FG000|Overall Study|Protocol Violation|3
866119|NCT00502242|1826268|FG001|Overall Study|Protocol Violation|1
866120|NCT00502242|1826267|FG000|Overall Study|Withdrawal by Subject|6
866121|NCT00502242|1826268|FG001|Overall Study|Withdrawal by Subject|7
866122|NCT00502307|1826274|FG000|Open Label Period (16 Weeks)|Progressive disease|50
866123|NCT00502307|1826275|FG001|Open Label Period (16 Weeks)|Progressive disease|0
866124|NCT00502307|1826276|FG002|Open Label Period (16 Weeks)|Progressive disease|0
866125|NCT00502307|1826274|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26
866126|NCT00502307|1826275|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
866127|NCT00502307|1826276|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
866128|NCT00502307|1826274|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0
866129|NCT00502307|1826275|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23
866130|NCT00502307|1826276|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2
866131|NCT00502307|1826274|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0
866132|NCT00502307|1826275|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3
866133|NCT00502307|1826276|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7
866134|NCT00502307|1826274|FG000|Maintenance Period|Progressive disease|80
866135|NCT00502307|1826275|FG001|Maintenance Period|Progressive disease|0
866136|NCT00502307|1826276|FG002|Maintenance Period|Progressive disease|0
866137|NCT00502307|1826274|FG000|Maintenance Period|Discontinued due to other reasons|68
866138|NCT00502307|1826275|FG001|Maintenance Period|Discontinued due to other reasons|0
866139|NCT00502307|1826276|FG002|Maintenance Period|Discontinued due to other reasons|0
866140|NCT00502320|1826295|FG000|Overall Study|Lost to Follow-up|1
866141|NCT00502320|1826296|FG001|Overall Study|Lost to Follow-up|1
866142|NCT00502320|1826295|FG000|Overall Study|Withdrew Consent|1
866143|NCT00502320|1826296|FG001|Overall Study|Withdrew Consent|0
866144|NCT00502320|1826295|FG000|Overall Study|No longer met criteria|1
866145|NCT00502320|1826296|FG001|Overall Study|No longer met criteria|0
866146|NCT00502320|1826295|FG000|Overall Study|Screen Failure|0
866147|NCT00502320|1826296|FG001|Overall Study|Screen Failure|1
866148|NCT00502320|1826295|FG000|Overall Study|Adverse Event|3
866149|NCT00502320|1826296|FG001|Overall Study|Adverse Event|5
866150|NCT00502593|1826314|FG000|Overall Study|Withdrawn unspecified reason|1
866151|NCT00502593|1826315|FG001|Overall Study|Withdrawn unspecified reason|1
866152|NCT00502593|1826316|FG002|Overall Study|Withdrawn unspecified reason|3
866153|NCT00502593|1826317|FG003|Overall Study|Withdrawn unspecified reason|1
866154|NCT00502593|1826318|FG004|Overall Study|Withdrawn unspecified reason|2
866155|NCT00502593|1826319|FG005|Overall Study|Withdrawn unspecified reason|0
866156|NCT00502593|1826320|FG006|Overall Study|Withdrawn unspecified reason|2
866157|NCT00502593|1826321|FG007|Overall Study|Withdrawn unspecified reason|0
866158|NCT00502593|1826322|FG008|Overall Study|Withdrawn unspecified reason|0
866159|NCT00502593|1826323|FG009|Overall Study|Withdrawn unspecified reason|0
866160|NCT00502593|1826324|FG010|Overall Study|Withdrawn unspecified reason|0
866161|NCT00502593|1826325|FG011|Overall Study|Withdrawn unspecified reason|0
866162|NCT00502593|1826314|FG000|Overall Study|Withdrawal by Subject|0
866163|NCT00502593|1826315|FG001|Overall Study|Withdrawal by Subject|0
866164|NCT00502593|1826316|FG002|Overall Study|Withdrawal by Subject|6
866165|NCT00502593|1826317|FG003|Overall Study|Withdrawal by Subject|2
866166|NCT00502593|1826318|FG004|Overall Study|Withdrawal by Subject|2
866167|NCT00502593|1826319|FG005|Overall Study|Withdrawal by Subject|0
866168|NCT00502593|1826320|FG006|Overall Study|Withdrawal by Subject|3
866169|NCT00502593|1826321|FG007|Overall Study|Withdrawal by Subject|0
866170|NCT00502593|1826322|FG008|Overall Study|Withdrawal by Subject|3
866171|NCT00502593|1826323|FG009|Overall Study|Withdrawal by Subject|0
866172|NCT00502593|1826324|FG010|Overall Study|Withdrawal by Subject|1
866173|NCT00502593|1826325|FG011|Overall Study|Withdrawal by Subject|0
866174|NCT00502593|1826314|FG000|Overall Study|Lost to Follow-up|2
866175|NCT00502593|1826315|FG001|Overall Study|Lost to Follow-up|1
866176|NCT00502593|1826316|FG002|Overall Study|Lost to Follow-up|1
866177|NCT00502593|1826317|FG003|Overall Study|Lost to Follow-up|1
866178|NCT00502593|1826318|FG004|Overall Study|Lost to Follow-up|0
866179|NCT00502593|1826319|FG005|Overall Study|Lost to Follow-up|0
866180|NCT00502593|1826320|FG006|Overall Study|Lost to Follow-up|0
866181|NCT00502593|1826321|FG007|Overall Study|Lost to Follow-up|0
866182|NCT00502593|1826322|FG008|Overall Study|Lost to Follow-up|3
866183|NCT00502593|1826323|FG009|Overall Study|Lost to Follow-up|0
866184|NCT00502593|1826324|FG010|Overall Study|Lost to Follow-up|1
866185|NCT00502593|1826325|FG011|Overall Study|Lost to Follow-up|0
866186|NCT00502671|1826374|FG000|Overall Study|Disease Progression|13
866187|NCT00502671|1826374|FG000|Overall Study|Personal Reasons|22
866188|NCT00502671|1826374|FG000|Overall Study|Lost to Follow-up|7
866189|NCT00502671|1826374|FG000|Overall Study|Protocol Violation|16
866190|NCT00502671|1826374|FG000|Overall Study|Adverse Event|19
866191|NCT00502697|1826380|FG000|Overall Study|Withdrawal by Subject|3
866192|NCT00502697|1826381|FG001|Overall Study|Withdrawal by Subject|1
866193|NCT00502697|1826380|FG000|Overall Study|disenrolled due to pregnancy loss|3
866194|NCT00502697|1826381|FG001|Overall Study|disenrolled due to pregnancy loss|5
866195|NCT00502697|1826380|FG000|Overall Study|found not to meet eligibility criteria|3
866196|NCT00502697|1826381|FG001|Overall Study|found not to meet eligibility criteria|4
866197|NCT00502697|1826380|FG000|Overall Study|did not meet assignment criteria|4
866198|NCT00502697|1826381|FG001|Overall Study|did not meet assignment criteria|2
866199|NCT00502775|1826390|FG000|Overall Study|Adverse Event|1
866200|NCT00502775|1826391|FG001|Overall Study|Adverse Event|2
866201|NCT00502775|1826392|FG002|Overall Study|Adverse Event|1
866202|NCT00502775|1826390|FG000|Overall Study|Protocol Violation|1
866203|NCT00502775|1826391|FG001|Overall Study|Protocol Violation|5
866204|NCT00502775|1826392|FG002|Overall Study|Protocol Violation|2
866205|NCT00502775|1826390|FG000|Overall Study|Withdrawal by Subject|1
866206|NCT00502775|1826391|FG001|Overall Study|Withdrawal by Subject|1
866207|NCT00502775|1826392|FG002|Overall Study|Withdrawal by Subject|2
866208|NCT00502775|1826390|FG000|Overall Study|Sponsor Terminated Study|1
866209|NCT00502775|1826391|FG001|Overall Study|Sponsor Terminated Study|0
866210|NCT00502775|1826392|FG002|Overall Study|Sponsor Terminated Study|1
866211|NCT00502775|1826390|FG000|Overall Study|Non-compliance with eDiary|4
866212|NCT00502775|1826391|FG001|Overall Study|Non-compliance with eDiary|1
866213|NCT00502775|1826392|FG002|Overall Study|Non-compliance with eDiary|1
866214|NCT00502775|1826390|FG000|Overall Study|Subject unable to swallow capsule|1
866215|NCT00502775|1826391|FG001|Overall Study|Subject unable to swallow capsule|0
866216|NCT00502775|1826392|FG002|Overall Study|Subject unable to swallow capsule|1
866217|NCT00502775|1826390|FG000|Overall Study|Logpad compliance <80%|1
866218|NCT00502775|1826391|FG001|Overall Study|Logpad compliance <80%|0
866219|NCT00502775|1826392|FG002|Overall Study|Logpad compliance <80%|0
866220|NCT00502775|1826390|FG000|Overall Study|Randomized in error|0
866221|NCT00502775|1826391|FG001|Overall Study|Randomized in error|1
866222|NCT00502775|1826392|FG002|Overall Study|Randomized in error|1
866223|NCT00502775|1826390|FG000|Overall Study|Non-compliance|0
866224|NCT00502775|1826391|FG001|Overall Study|Non-compliance|2
866225|NCT00502775|1826392|FG002|Overall Study|Non-compliance|2
866226|NCT00502775|1826390|FG000|Overall Study|Outside pollen area more than 48 hours|0
866227|NCT00502775|1826391|FG001|Overall Study|Outside pollen area more than 48 hours|1
866228|NCT00502775|1826392|FG002|Overall Study|Outside pollen area more than 48 hours|0
866229|NCT00502775|1826390|FG000|Overall Study|Declining pollen counts|0
866230|NCT00502775|1826391|FG001|Overall Study|Declining pollen counts|1
866231|NCT00502775|1826392|FG002|Overall Study|Declining pollen counts|1
866232|NCT00502775|1826390|FG000|Overall Study|Subject in jail|0
866233|NCT00502775|1826391|FG001|Overall Study|Subject in jail|1
866234|NCT00502775|1826392|FG002|Overall Study|Subject in jail|0
866235|NCT00502775|1826390|FG000|Overall Study|Subject took disallowed drug|0
866236|NCT00502775|1826391|FG001|Overall Study|Subject took disallowed drug|0
866237|NCT00502775|1826392|FG002|Overall Study|Subject took disallowed drug|1
866238|NCT00502801|1826400|FG000|Treatment Period|Withdrawal by Subject|3
866239|NCT00502801|1826400|FG000|Treatment Period|Adverse Event|7
866240|NCT00502801|1826400|FG000|Treatment Period|Death|14
866241|NCT00502801|1826400|FG000|Treatment Period|OTHER|30
866242|NCT00502801|1826400|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1
866243|NCT00502801|1826400|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2
866244|NCT00502801|1826400|FG000|End of Therapy to Test of Cure|Death|3
866245|NCT00502801|1826400|FG000|End of Therapy to Test of Cure|OTHER|2
866246|NCT00502840|1826404|FG000|Overall Study|Adverse Event|5
866247|NCT00502840|1826404|FG000|Overall Study|Additional or changed therapy|48
866248|NCT00502840|1826404|FG000|Overall Study|Lack of Efficacy|11
866249|NCT00502840|1826404|FG000|Overall Study|Protocol Violation|4
866250|NCT00502840|1826404|FG000|Overall Study|Withdrawal by Subject|5
866251|NCT00502840|1826404|FG000|Overall Study|Lost to Follow-up|6
866252|NCT00502840|1826404|FG000|Overall Study|Administrative problems|1
866253|NCT00502840|1826404|FG000|Overall Study|Other|20
866254|NCT00502996|1826427|FG000|Overall Study|Lost to Follow-up|9
866255|NCT00502996|1826427|FG000|Overall Study|Protocol Violation|2
866256|NCT00502996|1826427|FG000|Overall Study|Treatment failure|25
866257|NCT00502996|1826427|FG000|Overall Study|Withdrawal Informed Consent|6
866258|NCT00502996|1826427|FG000|Overall Study|Adverse Event|2
866259|NCT00503139|1826444|FG000|Overall Study|Case Report Forms were not collected|4
866260|NCT00503139|1826444|FG000|Overall Study|Protocol Violation|4
866261|NCT00503308|1826450|FG000|Overall Study|Protocol Violation|2
866262|NCT00503308|1826451|FG001|Overall Study|Protocol Violation|1
866263|NCT00503399|1826459|FG000|Overall Study|Death|2
866264|NCT00503399|1826460|FG001|Overall Study|Death|1
866265|NCT00503399|1826459|FG000|Overall Study|Protocol Violation|1
866266|NCT00503399|1826460|FG001|Overall Study|Protocol Violation|0
866267|NCT00503399|1826459|FG000|Overall Study|Withdrawal by Subject|4
866268|NCT00503399|1826460|FG001|Overall Study|Withdrawal by Subject|2
866269|NCT00503399|1826459|FG000|Overall Study|Adverse Event|0
866270|NCT00503399|1826460|FG001|Overall Study|Adverse Event|3
866271|NCT00503399|1826459|FG000|Overall Study|Lost to Follow-up|0
866272|NCT00503399|1826460|FG001|Overall Study|Lost to Follow-up|2
866273|NCT00503425|1826466|FG000|Overall Study|Participant files lost|6
866274|NCT00503425|1826466|FG000|Overall Study|Adverse Event|5
866275|NCT00503425|1826466|FG000|Overall Study|Lack of Efficacy|25
866276|NCT00503425|1826466|FG000|Overall Study|Withdrawal by Subject|8
866277|NCT00503425|1826466|FG000|Overall Study|Lost to Follow-up|3
866278|NCT00503425|1826466|FG000|Overall Study|Death|3
866279|NCT00503425|1826466|FG000|Overall Study|Missing Data/Unknown|4
866280|NCT00503685|1826474|FG000|Overall Study|Adverse Event|0
866281|NCT00503685|1826475|FG001|Overall Study|Adverse Event|0
866282|NCT00503685|1826476|FG002|Overall Study|Adverse Event|2
866283|NCT00503685|1826474|FG000|Overall Study|Withdrawal by Subject|0
866284|NCT00503685|1826475|FG001|Overall Study|Withdrawal by Subject|1
866285|NCT00503685|1826476|FG002|Overall Study|Withdrawal by Subject|0
866286|NCT00503685|1826474|FG000|Overall Study|Protocol Violation|0
866287|NCT00503685|1826475|FG001|Overall Study|Protocol Violation|1
866288|NCT00503685|1826476|FG002|Overall Study|Protocol Violation|0
866289|NCT00503685|1826474|FG000|Overall Study|Eligibility Criteria Not Met|0
866290|NCT00503685|1826475|FG001|Overall Study|Eligibility Criteria Not Met|1
866291|NCT00503685|1826476|FG002|Overall Study|Eligibility Criteria Not Met|0
866292|NCT00503698|1826487|FG000|Overall Study|Protocol Violation|5
866293|NCT00503698|1826488|FG001|Overall Study|Protocol Violation|6
866294|NCT00503698|1826487|FG000|Overall Study|Adverse Event|52
866295|NCT00503698|1826488|FG001|Overall Study|Adverse Event|41
866296|NCT00503698|1826487|FG000|Overall Study|Death|1
866297|NCT00503698|1826488|FG001|Overall Study|Death|0
866298|NCT00503698|1826487|FG000|Overall Study|Lack of Efficacy|3
866299|NCT00503698|1826488|FG001|Overall Study|Lack of Efficacy|4
866300|NCT00503698|1826487|FG000|Overall Study|Trial terminated|216
866301|NCT00503698|1826488|FG001|Overall Study|Trial terminated|253
866302|NCT00503698|1826487|FG000|Overall Study|End hemodialysis due to renal transplant|10
866303|NCT00503698|1826488|FG001|Overall Study|End hemodialysis due to renal transplant|4
866304|NCT00503698|1826487|FG000|Overall Study|Pregnancy/intention to become pregnant|1
866305|NCT00503698|1826488|FG001|Overall Study|Pregnancy/intention to become pregnant|0
866306|NCT00503698|1826487|FG000|Overall Study|Any condition in exclusion criteria|4
866307|NCT00503698|1826488|FG001|Overall Study|Any condition in exclusion criteria|6
866308|NCT00503698|1826487|FG000|Overall Study|Switch to peritoneal or home dialysis|2
866309|NCT00503698|1826488|FG001|Overall Study|Switch to peritoneal or home dialysis|2
866310|NCT00503698|1826487|FG000|Overall Study|Move to nonparticipating dialysis center|2
866311|NCT00503698|1826488|FG001|Overall Study|Move to nonparticipating dialysis center|1
866312|NCT00503698|1826487|FG000|Overall Study|Critically ill|2
866313|NCT00503698|1826488|FG001|Overall Study|Critically ill|0
866314|NCT00503698|1826487|FG000|Overall Study|Unclassified|48
866315|NCT00503698|1826488|FG001|Overall Study|Unclassified|32
866316|NCT00503698|1826487|FG000|Overall Study|Not exposed to trial drug|11
866317|NCT00503698|1826488|FG001|Overall Study|Not exposed to trial drug|6
866318|NCT00503776|1826502|FG000|Overall Study|Withdrawal by Subject|1
866319|NCT00503776|1826503|FG001|Overall Study|Withdrawal by Subject|0
866320|NCT00503776|1826504|FG002|Overall Study|Withdrawal by Subject|1
866321|NCT00503776|1826505|FG003|Overall Study|Withdrawal by Subject|1
866322|NCT00503776|1826502|FG000|Overall Study|Physician Decision|0
866323|NCT00503776|1826503|FG001|Overall Study|Physician Decision|0
866324|NCT00503776|1826504|FG002|Overall Study|Physician Decision|1
866325|NCT00503776|1826505|FG003|Overall Study|Physician Decision|1
866326|NCT00503867|1826520|FG000|Overall Study|Lost to Follow-up|1
866327|NCT00503867|1826520|FG000|Overall Study|Adverse Event|1
866328|NCT00503906|1826524|FG000|Overall Study|Withdrawal by Subject|1
866329|NCT00503984|1826531|FG000|Overall Study|Protocol Violation|0
866330|NCT00503984|1826532|FG001|Overall Study|Protocol Violation|1
866331|NCT00503984|1826533|FG002|Overall Study|Protocol Violation|0
866332|NCT00503984|1826534|FG003|Overall Study|Protocol Violation|0
866333|NCT00503984|1826535|FG004|Overall Study|Protocol Violation|0
866334|NCT00503984|1826536|FG005|Overall Study|Protocol Violation|0
866335|NCT00503984|1826531|FG000|Overall Study|Adverse Event|0
866336|NCT00503984|1826532|FG001|Overall Study|Adverse Event|1
866337|NCT00503984|1826533|FG002|Overall Study|Adverse Event|0
866338|NCT00503984|1826534|FG003|Overall Study|Adverse Event|0
866339|NCT00503984|1826535|FG004|Overall Study|Adverse Event|0
866340|NCT00503984|1826536|FG005|Overall Study|Adverse Event|0
866341|NCT00503984|1826531|FG000|Overall Study|Death|0
866342|NCT00503984|1826532|FG001|Overall Study|Death|0
866343|NCT00503984|1826533|FG002|Overall Study|Death|0
866344|NCT00503984|1826534|FG003|Overall Study|Death|0
866345|NCT00503984|1826535|FG004|Overall Study|Death|1
866346|NCT00503984|1826536|FG005|Overall Study|Death|0
866347|NCT00503997|1826560|FG000|Overall Study|disease progression|1
866348|NCT00503997|1826560|FG000|Overall Study|Adverse Event|5
866349|NCT00503997|1826560|FG000|Overall Study|Death|1
866350|NCT00503997|1826560|FG000|Overall Study|Withdrawal by Subject|1
866351|NCT00504075|1826568|FG000|Overall Study|Adverse Event|1
866352|NCT00504075|1826568|FG000|Overall Study|Lost to Follow-up|5
866353|NCT00504075|1826568|FG000|Overall Study|Withdrawal by Subject|1
866354|NCT00504075|1826568|FG000|Overall Study|Required other therapeutic intervention|1
866355|NCT00504153|1826573|FG000|Overall Study|Withdrawal by Subject|1
866356|NCT00504153|1826573|FG000|Overall Study|Adverse Event|4
866357|NCT00504153|1826573|FG000|Overall Study|Death|1
866358|NCT00504166|1826579|FG000|Overall Study|Adverse Event|1
866359|NCT00504166|1826580|FG001|Overall Study|Adverse Event|4
866360|NCT00504166|1826579|FG000|Overall Study|Withdrawal by Subject|3
866361|NCT00504166|1826580|FG001|Overall Study|Withdrawal by Subject|6
866362|NCT00504166|1826579|FG000|Overall Study|Physician Decision|1
866363|NCT00504166|1826580|FG001|Overall Study|Physician Decision|1
866364|NCT00504166|1826579|FG000|Overall Study|Lost to Follow-up|1
866365|NCT00504166|1826580|FG001|Overall Study|Lost to Follow-up|3
866366|NCT00504231|1826590|FG000|Overall Study|Discrepant chart documentation re route|0
866367|NCT00504231|1826591|FG001|Overall Study|Discrepant chart documentation re route|0
866368|NCT00504231|1826592|FG002|Overall Study|Discrepant chart documentation re route|1
866369|NCT00504231|1826593|FG003|Overall Study|Discrepant chart documentation re route|0
866370|NCT00504257|1826607|FG000|Overall Study|Withdrawal by Subject|2
866371|NCT00504257|1826607|FG000|Overall Study|ineligible histology|2
866372|NCT00504309|1826617|FG000|Overall Study|Death|0
866373|NCT00504309|1826618|FG001|Overall Study|Death|0
866374|NCT00504309|1826619|FG002|Overall Study|Death|0
866375|NCT00504309|1826620|FG003|Overall Study|Death|0
866376|NCT00504309|1826621|FG004|Overall Study|Death|1
866377|NCT00504309|1826622|FG005|Overall Study|Death|0
866378|NCT00504309|1826617|FG000|Overall Study|Withdrawal by Subject|0
866379|NCT00504309|1826618|FG001|Overall Study|Withdrawal by Subject|0
866380|NCT00504309|1826619|FG002|Overall Study|Withdrawal by Subject|1
866381|NCT00504309|1826620|FG003|Overall Study|Withdrawal by Subject|0
866382|NCT00504309|1826621|FG004|Overall Study|Withdrawal by Subject|0
866383|NCT00504309|1826622|FG005|Overall Study|Withdrawal by Subject|0
866384|NCT00504348|1826634|FG000|Overall Study|Adverse Event|3
866385|NCT00504348|1826634|FG000|Overall Study|Lack of Efficacy|4
866386|NCT00504348|1826634|FG000|Overall Study|Physician Decision|1
866387|NCT00504426|1826642|FG000|Overall Study|Adverse Event|0
866388|NCT00504426|1826643|FG001|Overall Study|Adverse Event|0
866389|NCT00504426|1826644|FG002|Overall Study|Adverse Event|2
866390|NCT00504426|1826645|FG003|Overall Study|Adverse Event|0
866391|NCT00504426|1826642|FG000|Overall Study|Protocol Violation|1
866392|NCT00504426|1826643|FG001|Overall Study|Protocol Violation|1
866393|NCT00504426|1826644|FG002|Overall Study|Protocol Violation|2
866394|NCT00504426|1826645|FG003|Overall Study|Protocol Violation|0
866395|NCT00504426|1826642|FG000|Overall Study|Withdrawal by Subject|2
866396|NCT00504426|1826643|FG001|Overall Study|Withdrawal by Subject|0
866397|NCT00504426|1826644|FG002|Overall Study|Withdrawal by Subject|0
866398|NCT00504426|1826645|FG003|Overall Study|Withdrawal by Subject|0
866399|NCT00504556|1826667|FG000|Overall Study|Adverse Event|11
866400|NCT00504556|1826668|FG001|Overall Study|Adverse Event|11
866401|NCT00504556|1826669|FG002|Overall Study|Adverse Event|14
866402|NCT00504556|1826670|FG003|Overall Study|Adverse Event|13
866403|NCT00504556|1826671|FG004|Overall Study|Adverse Event|5
866404|NCT00504556|1826667|FG000|Overall Study|Death|3
866405|NCT00504556|1826668|FG001|Overall Study|Death|3
866406|NCT00504556|1826669|FG002|Overall Study|Death|1
866407|NCT00504556|1826670|FG003|Overall Study|Death|0
866408|NCT00504556|1826671|FG004|Overall Study|Death|2
866409|NCT00504556|1826667|FG000|Overall Study|Protocol Violation|1
866410|NCT00504556|1826668|FG001|Overall Study|Protocol Violation|3
866411|NCT00504556|1826669|FG002|Overall Study|Protocol Violation|2
866412|NCT00504556|1826670|FG003|Overall Study|Protocol Violation|1
866413|NCT00504556|1826671|FG004|Overall Study|Protocol Violation|2
866414|NCT00504556|1826667|FG000|Overall Study|Lost to Follow-up|0
866415|NCT00504556|1826668|FG001|Overall Study|Lost to Follow-up|0
866416|NCT00504556|1826669|FG002|Overall Study|Lost to Follow-up|1
866417|NCT00504556|1826670|FG003|Overall Study|Lost to Follow-up|1
866418|NCT00504556|1826671|FG004|Overall Study|Lost to Follow-up|1
866419|NCT00504556|1826667|FG000|Overall Study|Withdrawal by Subject|16
866420|NCT00504556|1826668|FG001|Overall Study|Withdrawal by Subject|16
866421|NCT00504556|1826669|FG002|Overall Study|Withdrawal by Subject|7
866422|NCT00504556|1826670|FG003|Overall Study|Withdrawal by Subject|8
866423|NCT00504556|1826671|FG004|Overall Study|Withdrawal by Subject|12
866424|NCT00504556|1826667|FG000|Overall Study|administrative reasons|0
866425|NCT00504556|1826668|FG001|Overall Study|administrative reasons|2
866426|NCT00504556|1826669|FG002|Overall Study|administrative reasons|2
866427|NCT00504556|1826670|FG003|Overall Study|administrative reasons|1
866428|NCT00504556|1826671|FG004|Overall Study|administrative reasons|2
866429|NCT00504556|1826667|FG000|Overall Study|did not meet entry criteria|2
866430|NCT00504556|1826668|FG001|Overall Study|did not meet entry criteria|0
866431|NCT00504556|1826669|FG002|Overall Study|did not meet entry criteria|1
866432|NCT00504556|1826670|FG003|Overall Study|did not meet entry criteria|1
866433|NCT00504556|1826671|FG004|Overall Study|did not meet entry criteria|0
866434|NCT00504556|1826667|FG000|Overall Study|data monitor committee decision|0
866435|NCT00504556|1826668|FG001|Overall Study|data monitor committee decision|0
866436|NCT00504556|1826669|FG002|Overall Study|data monitor committee decision|0
866437|NCT00504556|1826670|FG003|Overall Study|data monitor committee decision|100
866438|NCT00504556|1826671|FG004|Overall Study|data monitor committee decision|0
866439|NCT00504556|1826667|FG000|Overall Study|Other|2
866440|NCT00504556|1826668|FG001|Overall Study|Other|2
866441|NCT00504556|1826669|FG002|Overall Study|Other|2
866442|NCT00504556|1826670|FG003|Overall Study|Other|3
866443|NCT00504556|1826671|FG004|Overall Study|Other|0
866444|NCT00504556|1826667|FG000|Overall Study|not in safety analysis set|0
866445|NCT00504556|1826668|FG001|Overall Study|not in safety analysis set|1
866446|NCT00504556|1826669|FG002|Overall Study|not in safety analysis set|1
866447|NCT00504556|1826670|FG003|Overall Study|not in safety analysis set|0
866448|NCT00504556|1826671|FG004|Overall Study|not in safety analysis set|1
866449|NCT00504582|1826686|FG000|Overall Study|Lost to Follow-up|1
866450|NCT00504582|1826687|FG001|Overall Study|Lost to Follow-up|0
866451|NCT00504582|1826688|FG002|Overall Study|Lost to Follow-up|0
866452|NCT00504595|1826700|FG000|Overall Study|Lack of Efficacy|1
866453|NCT00504595|1826701|FG001|Overall Study|Lack of Efficacy|0
866454|NCT00504595|1826702|FG002|Overall Study|Lack of Efficacy|0
866455|NCT00504595|1826703|FG003|Overall Study|Lack of Efficacy|0
866456|NCT00504595|1826700|FG000|Overall Study|Other|0
866457|NCT00504595|1826701|FG001|Overall Study|Other|0
866458|NCT00504595|1826702|FG002|Overall Study|Other|2
866459|NCT00504595|1826703|FG003|Overall Study|Other|0
866460|NCT00504725|1826724|FG000|Overall Study|Protocol Violation|1
866461|NCT00504725|1826725|FG001|Overall Study|Protocol Violation|0
866462|NCT00504777|1826735|FG000|Overall Study|Adverse Event|1
866463|NCT00504829|1826742|FG000|Overall Study|Protocol Violation|6
866464|NCT00504829|1826743|FG001|Overall Study|Protocol Violation|4
866465|NCT00504829|1826744|FG002|Overall Study|Protocol Violation|10
866466|NCT00504881|1826754|FG000|Overall Study|Lack of Efficacy|1
866467|NCT00504881|1826755|FG001|Overall Study|Lack of Efficacy|5
866468|NCT00504881|1826754|FG000|Overall Study|Lost to Follow-up|0
866469|NCT00504881|1826755|FG001|Overall Study|Lost to Follow-up|2
866470|NCT00504881|1826754|FG000|Overall Study|Withdrawal by Subject|1
866471|NCT00504881|1826755|FG001|Overall Study|Withdrawal by Subject|4
866472|NCT00504881|1826754|FG000|Overall Study|Non-Compliance|1
866473|NCT00504881|1826755|FG001|Overall Study|Non-Compliance|0
866474|NCT00504881|1826754|FG000|Overall Study|No Birth Control|0
866475|NCT00504881|1826755|FG001|Overall Study|No Birth Control|1
866476|NCT00504881|1826754|FG000|Overall Study|Safety Visit not performed|0
866477|NCT00504881|1826755|FG001|Overall Study|Safety Visit not performed|1
866478|NCT00504881|1826754|FG000|Overall Study|AE, serious fatal|0
866479|NCT00504881|1826755|FG001|Overall Study|AE, serious fatal|1
866480|NCT00504881|1826754|FG000|Overall Study|SAE, non-fatal|2
866481|NCT00504881|1826755|FG001|Overall Study|SAE, non-fatal|6
866482|NCT00504881|1826754|FG000|Overall Study|AE, non-serious non-fatal|4
866483|NCT00504881|1826755|FG001|Overall Study|AE, non-serious non-fatal|14
866484|NCT00504881|1826754|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
866485|NCT00504881|1826755|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
866486|NCT00504881|1826754|FG000|Overall Study|AE of unknown type|1
866487|NCT00504881|1826755|FG001|Overall Study|AE of unknown type|0
866488|NCT00504894|1826766|FG000|Overall Study|fMRI technical problems|1
866489|NCT00504894|1826767|FG001|Overall Study|fMRI technical problems|1
866490|NCT00504894|1826768|FG002|Overall Study|fMRI technical problems|0
866491|NCT00504894|1826766|FG000|Overall Study|Withdrawal by Subject|0
866492|NCT00504894|1826767|FG001|Overall Study|Withdrawal by Subject|1
866493|NCT00504894|1826768|FG002|Overall Study|Withdrawal by Subject|0
866494|NCT00504894|1826766|FG000|Overall Study|Infusion technical problems|0
866495|NCT00504894|1826767|FG001|Overall Study|Infusion technical problems|1
866496|NCT00504894|1826768|FG002|Overall Study|Infusion technical problems|0
866497|NCT00504894|1826766|FG000|Overall Study|poor subject data|2
866498|NCT00504894|1826767|FG001|Overall Study|poor subject data|0
866499|NCT00504894|1826768|FG002|Overall Study|poor subject data|0
866500|NCT00505076|1826779|FG000|Overall Study|Adverse Event|1
866501|NCT00505076|1826780|FG001|Overall Study|Adverse Event|0
866502|NCT00505076|1826781|FG002|Overall Study|Adverse Event|1
866503|NCT00505076|1826779|FG000|Overall Study|Protocol Violation|2
866504|NCT00505076|1826780|FG001|Overall Study|Protocol Violation|1
866505|NCT00505076|1826781|FG002|Overall Study|Protocol Violation|2
866506|NCT00505076|1826779|FG000|Overall Study|Withdrawal by Subject|0
866507|NCT00505076|1826780|FG001|Overall Study|Withdrawal by Subject|1
866508|NCT00505076|1826781|FG002|Overall Study|Withdrawal by Subject|2
866509|NCT00505284|1826794|FG000|Overall Study|Adverse Event|3
866510|NCT00505284|1826795|FG001|Overall Study|Adverse Event|7
866511|NCT00505284|1826796|FG002|Overall Study|Adverse Event|9
866512|NCT00505284|1826797|FG003|Overall Study|Adverse Event|14
866513|NCT00505284|1826798|FG004|Overall Study|Adverse Event|22
866514|NCT00505284|1826794|FG000|Overall Study|Protocol Violation|0
866515|NCT00505284|1826795|FG001|Overall Study|Protocol Violation|1
866516|NCT00505284|1826796|FG002|Overall Study|Protocol Violation|1
866517|NCT00505284|1826797|FG003|Overall Study|Protocol Violation|0
866518|NCT00505284|1826798|FG004|Overall Study|Protocol Violation|0
866519|NCT00505284|1826794|FG000|Overall Study|Withdrawal by Subject|2
866520|NCT00505284|1826795|FG001|Overall Study|Withdrawal by Subject|6
866521|NCT00505284|1826796|FG002|Overall Study|Withdrawal by Subject|1
866522|NCT00505284|1826797|FG003|Overall Study|Withdrawal by Subject|0
866523|NCT00505284|1826798|FG004|Overall Study|Withdrawal by Subject|6
866524|NCT00505284|1826794|FG000|Overall Study|Lack of Efficacy|0
866525|NCT00505284|1826795|FG001|Overall Study|Lack of Efficacy|1
866526|NCT00505284|1826796|FG002|Overall Study|Lack of Efficacy|1
866527|NCT00505284|1826797|FG003|Overall Study|Lack of Efficacy|1
866528|NCT00505284|1826798|FG004|Overall Study|Lack of Efficacy|1
866529|NCT00505284|1826794|FG000|Overall Study|Physician Decision|0
866530|NCT00505284|1826795|FG001|Overall Study|Physician Decision|1
866531|NCT00505284|1826796|FG002|Overall Study|Physician Decision|0
866532|NCT00505284|1826797|FG003|Overall Study|Physician Decision|0
866533|NCT00505284|1826798|FG004|Overall Study|Physician Decision|0
866534|NCT00505284|1826794|FG000|Overall Study|Other|5
866535|NCT00505284|1826795|FG001|Overall Study|Other|0
866536|NCT00505284|1826796|FG002|Overall Study|Other|0
866537|NCT00505284|1826797|FG003|Overall Study|Other|4
866538|NCT00505284|1826798|FG004|Overall Study|Other|4
866539|NCT00505375|1826821|FG000|Overall Study|Death|1
866540|NCT00505375|1826822|FG001|Overall Study|Death|0
866541|NCT00505375|1826821|FG000|Overall Study|Withdrawal by Subject|2
866542|NCT00505375|1826822|FG001|Overall Study|Withdrawal by Subject|2
866543|NCT00505375|1826821|FG000|Overall Study|Lost to Follow-up|0
866544|NCT00505375|1826822|FG001|Overall Study|Lost to Follow-up|2
866545|NCT00505375|1826821|FG000|Overall Study|Pregnancy|1
866546|NCT00505375|1826822|FG001|Overall Study|Pregnancy|0
866547|NCT00505375|1826821|FG000|Overall Study|Travel issues|0
866548|NCT00505375|1826822|FG001|Overall Study|Travel issues|1
866549|NCT00505414|1826830|FG000|Titration Phase|Adverse Event|0
866550|NCT00505414|1826831|FG001|Titration Phase|Adverse Event|0
866551|NCT00505414|1826832|FG002|Titration Phase|Adverse Event|0
866552|NCT00505414|1826833|FG003|Titration Phase|Adverse Event|8
866553|NCT00505414|1826834|FG004|Titration Phase|Adverse Event|3
866554|NCT00505414|1826830|FG000|Titration Phase|Death|0
866555|NCT00505414|1826831|FG001|Titration Phase|Death|0
866556|NCT00505414|1826832|FG002|Titration Phase|Death|0
866557|NCT00505414|1826833|FG003|Titration Phase|Death|2
866558|NCT00505414|1826834|FG004|Titration Phase|Death|0
866559|NCT00505414|1826830|FG000|Titration Phase|Lack of Efficacy|0
866560|NCT00505414|1826831|FG001|Titration Phase|Lack of Efficacy|0
866561|NCT00505414|1826832|FG002|Titration Phase|Lack of Efficacy|0
866562|NCT00505414|1826833|FG003|Titration Phase|Lack of Efficacy|10
866563|NCT00505414|1826834|FG004|Titration Phase|Lack of Efficacy|1
866564|NCT00505414|1826830|FG000|Titration Phase|Protocol Violation|0
866565|NCT00505414|1826831|FG001|Titration Phase|Protocol Violation|0
866566|NCT00505414|1826832|FG002|Titration Phase|Protocol Violation|0
866567|NCT00505414|1826833|FG003|Titration Phase|Protocol Violation|0
866568|NCT00505414|1826834|FG004|Titration Phase|Protocol Violation|1
866569|NCT00505414|1826830|FG000|Titration Phase|Withdrawal by Subject|0
866570|NCT00505414|1826831|FG001|Titration Phase|Withdrawal by Subject|0
866571|NCT00505414|1826832|FG002|Titration Phase|Withdrawal by Subject|0
866572|NCT00505414|1826833|FG003|Titration Phase|Withdrawal by Subject|3
866573|NCT00505414|1826834|FG004|Titration Phase|Withdrawal by Subject|4
866574|NCT00505414|1826830|FG000|Titration Phase|Underlying disease and therapy required|0
866575|NCT00505414|1826831|FG001|Titration Phase|Underlying disease and therapy required|0
866576|NCT00505414|1826832|FG002|Titration Phase|Underlying disease and therapy required|0
866577|NCT00505414|1826833|FG003|Titration Phase|Underlying disease and therapy required|7
866578|NCT00505414|1826834|FG004|Titration Phase|Underlying disease and therapy required|3
866579|NCT00505414|1826830|FG000|Maintenance Phase|Adverse Event|2
866580|NCT00505414|1826831|FG001|Maintenance Phase|Adverse Event|2
866581|NCT00505414|1826832|FG002|Maintenance Phase|Adverse Event|3
866582|NCT00505414|1826833|FG003|Maintenance Phase|Adverse Event|0
866583|NCT00505414|1826834|FG004|Maintenance Phase|Adverse Event|0
866584|NCT00505414|1826830|FG000|Maintenance Phase|Death|2
866585|NCT00505414|1826831|FG001|Maintenance Phase|Death|0
866586|NCT00505414|1826832|FG002|Maintenance Phase|Death|1
866587|NCT00505414|1826833|FG003|Maintenance Phase|Death|0
866588|NCT00505414|1826834|FG004|Maintenance Phase|Death|0
866589|NCT00505414|1826830|FG000|Maintenance Phase|Lack of Efficacy|2
866590|NCT00505414|1826831|FG001|Maintenance Phase|Lack of Efficacy|1
866591|NCT00505414|1826832|FG002|Maintenance Phase|Lack of Efficacy|1
866592|NCT00505414|1826833|FG003|Maintenance Phase|Lack of Efficacy|0
866593|NCT00505414|1826834|FG004|Maintenance Phase|Lack of Efficacy|0
866594|NCT00505414|1826830|FG000|Maintenance Phase|Withdrawal by Subject|0
866595|NCT00505414|1826831|FG001|Maintenance Phase|Withdrawal by Subject|0
866596|NCT00505414|1826832|FG002|Maintenance Phase|Withdrawal by Subject|1
866597|NCT00505414|1826833|FG003|Maintenance Phase|Withdrawal by Subject|0
866598|NCT00505414|1826834|FG004|Maintenance Phase|Withdrawal by Subject|0
866599|NCT00505414|1826830|FG000|Maintenance Phase|underlying disease and therapy required|0
866600|NCT00505414|1826831|FG001|Maintenance Phase|underlying disease and therapy required|2
866601|NCT00505414|1826832|FG002|Maintenance Phase|underlying disease and therapy required|2
866602|NCT00505414|1826833|FG003|Maintenance Phase|underlying disease and therapy required|0
866603|NCT00505414|1826834|FG004|Maintenance Phase|underlying disease and therapy required|0
866604|NCT00505622|1826853|FG000|Overall Study|Adverse Event|5
866605|NCT00505622|1826854|FG001|Overall Study|Adverse Event|6
866606|NCT00505622|1826855|FG002|Overall Study|Adverse Event|4
866607|NCT00505622|1826853|FG000|Overall Study|Protocol Violation|1
866608|NCT00505622|1826854|FG001|Overall Study|Protocol Violation|1
866609|NCT00505622|1826855|FG002|Overall Study|Protocol Violation|0
866610|NCT00505622|1826853|FG000|Overall Study|Withdrawal by Subject|0
866611|NCT00505622|1826854|FG001|Overall Study|Withdrawal by Subject|3
866612|NCT00505622|1826855|FG002|Overall Study|Withdrawal by Subject|2
866613|NCT00505622|1826853|FG000|Overall Study|Study termination by sponsor|115
866614|NCT00505622|1826854|FG001|Overall Study|Study termination by sponsor|98
866615|NCT00505622|1826855|FG002|Overall Study|Study termination by sponsor|90
866616|NCT00505661|1826867|FG000|Overall Study|Not Eligible|4
866617|NCT00505687|1826871|FG000|Overall Study|Important protocol violation|2
866618|NCT00505687|1826871|FG000|Overall Study|Lack of Efficacy|15
866619|NCT00505687|1826871|FG000|Overall Study|Adverse Event|48
866620|NCT00505687|1826871|FG000|Overall Study|Subject withdrew consent|15
866621|NCT00505687|1826871|FG000|Overall Study|Lost to Follow-up|1
866622|NCT00505687|1826871|FG000|Overall Study|Other: Underwent Implantation Of DBS|1
866623|NCT00505687|1826871|FG000|Overall Study|Other: Scheduled DBS Surgery|1
866624|NCT00505687|1826871|FG000|Overall Study|Other: Prolonged Hospitalization|1
866625|NCT00505687|1826871|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
866626|NCT00505687|1826871|FG000|Overall Study|Other: Neupro Given In Hospital|1
866627|NCT00505687|1826871|FG000|Overall Study|Other: Disease Progression|1
866628|NCT00505687|1826871|FG000|Overall Study|Other: As Per Sponsor|8
866629|NCT00505752|1826879|FG000|Overall Study|Adverse Event|1
866630|NCT00505752|1826880|FG001|Overall Study|Adverse Event|0
866631|NCT00505752|1826881|FG002|Overall Study|Adverse Event|1
866632|NCT00505752|1826882|FG003|Overall Study|Adverse Event|0
866633|NCT00505752|1826879|FG000|Overall Study|Lost to Follow-up|1
866634|NCT00505752|1826880|FG001|Overall Study|Lost to Follow-up|0
866635|NCT00505752|1826881|FG002|Overall Study|Lost to Follow-up|0
866636|NCT00505752|1826882|FG003|Overall Study|Lost to Follow-up|0
866637|NCT00505752|1826879|FG000|Overall Study|Lack of ovarian response|1
866638|NCT00505752|1826880|FG001|Overall Study|Lack of ovarian response|3
866639|NCT00505752|1826881|FG002|Overall Study|Lack of ovarian response|0
866640|NCT00505752|1826882|FG003|Overall Study|Lack of ovarian response|0
866641|NCT00505752|1826879|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1
866642|NCT00505752|1826880|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
866643|NCT00505752|1826881|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3
866644|NCT00505752|1826882|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1
866645|NCT00505752|1826879|FG000|Overall Study|No oocytes retrieved|0
866646|NCT00505752|1826880|FG001|Overall Study|No oocytes retrieved|2
866647|NCT00505752|1826881|FG002|Overall Study|No oocytes retrieved|0
866648|NCT00505752|1826882|FG003|Overall Study|No oocytes retrieved|1
866649|NCT00505752|1826879|FG000|Overall Study|No Fertilization|1
866650|NCT00505752|1826880|FG001|Overall Study|No Fertilization|1
866651|NCT00505752|1826881|FG002|Overall Study|No Fertilization|2
866652|NCT00505752|1826882|FG003|Overall Study|No Fertilization|1
866653|NCT00505752|1826879|FG000|Overall Study|All embryos/blastocysts discarded|0
866654|NCT00505752|1826880|FG001|Overall Study|All embryos/blastocysts discarded|0
866655|NCT00505752|1826881|FG002|Overall Study|All embryos/blastocysts discarded|1
866656|NCT00505752|1826882|FG003|Overall Study|All embryos/blastocysts discarded|1
866657|NCT00505752|1826879|FG000|Overall Study|Other|1
866658|NCT00505752|1826880|FG001|Overall Study|Other|2
866659|NCT00505752|1826881|FG002|Overall Study|Other|1
866660|NCT00505752|1826882|FG003|Overall Study|Other|2
866661|NCT00505765|1826895|FG000|Overall Study|Withdrawal by Subject|1
866662|NCT00505765|1826896|FG001|Overall Study|Withdrawal by Subject|0
866663|NCT00505765|1826897|FG002|Overall Study|Withdrawal by Subject|0
866664|NCT00505765|1826895|FG000|Overall Study|Adverse Event|1
866665|NCT00505765|1826896|FG001|Overall Study|Adverse Event|2
866666|NCT00505765|1826897|FG002|Overall Study|Adverse Event|0
866667|NCT00505765|1826895|FG000|Overall Study|Noncompliance|0
866668|NCT00505765|1826896|FG001|Overall Study|Noncompliance|1
866669|NCT00505765|1826897|FG002|Overall Study|Noncompliance|3
866670|NCT00505778|1826907|FG000|Overall Study|Adverse Event|2
866671|NCT00505778|1826908|FG001|Overall Study|Adverse Event|7
866672|NCT00505778|1826907|FG000|Overall Study|Physician Decision|8
866673|NCT00505778|1826908|FG001|Overall Study|Physician Decision|14
866674|NCT00505778|1826907|FG000|Overall Study|Lost to Follow-up|17
866675|NCT00505778|1826908|FG001|Overall Study|Lost to Follow-up|23
866676|NCT00505778|1826907|FG000|Overall Study|Unable to Meet Protocol Criteria|4
866677|NCT00505778|1826908|FG001|Overall Study|Unable to Meet Protocol Criteria|1
866678|NCT00505778|1826907|FG000|Overall Study|Protocol Violation|7
866679|NCT00505778|1826908|FG001|Overall Study|Protocol Violation|9
866680|NCT00505778|1826907|FG000|Overall Study|Withdrawal by Subject|29
866681|NCT00505778|1826908|FG001|Overall Study|Withdrawal by Subject|14
866682|NCT00505778|1826907|FG000|Overall Study|Relapse|65
866683|NCT00505778|1826908|FG001|Overall Study|Relapse|65
866684|NCT00505778|1826907|FG000|Overall Study|Took No Study Drug|2
866685|NCT00505778|1826908|FG001|Overall Study|Took No Study Drug|2
866686|NCT00505921|1826923|FG000|Overall Study|Ineligible|1
866687|NCT00505921|1826923|FG000|Overall Study|Failed to Mobilize|8
866688|NCT00505934|1826927|FG000|Overall Study|Adverse Event|1
866689|NCT00505934|1826927|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1
866690|NCT00505934|1826927|FG000|Overall Study|Other: IV dose needed to be changed|1
866691|NCT00506077|1826946|FG000|Treatment Period 1|Adverse Event|2
866692|NCT00506077|1826947|FG001|Treatment Period 1|Adverse Event|1
866693|NCT00506077|1826946|FG000|Treatment Period 1|Lost to Follow-up|0
866694|NCT00506077|1826947|FG001|Treatment Period 1|Lost to Follow-up|2
866695|NCT00506077|1826946|FG000|Treatment Period 1|Withdrawal by Subject|2
866696|NCT00506077|1826947|FG001|Treatment Period 1|Withdrawal by Subject|0
866697|NCT00506077|1826946|FG000|Treatment Period 2|Adverse Event|0
866698|NCT00506077|1826947|FG001|Treatment Period 2|Adverse Event|1
866699|NCT00506077|1826946|FG000|Treatment Period 2|Withdrawal by Subject|1
866700|NCT00506077|1826947|FG001|Treatment Period 2|Withdrawal by Subject|0
866701|NCT00506129|1826953|FG000|Overall Study|Disease Progression/Relapse|15
866702|NCT00506129|1826953|FG000|Overall Study|Death|7
866703|NCT00506142|1826959|FG000|Overall Study|Adverse Event|8
866704|NCT00506142|1826960|FG001|Overall Study|Adverse Event|7
866705|NCT00506142|1826959|FG000|Overall Study|Lack of Efficacy|21
866706|NCT00506142|1826960|FG001|Overall Study|Lack of Efficacy|7
866707|NCT00506142|1826959|FG000|Overall Study|Withdrawal by Subject|4
866708|NCT00506142|1826960|FG001|Overall Study|Withdrawal by Subject|5
866709|NCT00506142|1826959|FG000|Overall Study|Physician Decision|1
866710|NCT00506142|1826960|FG001|Overall Study|Physician Decision|0
866711|NCT00506142|1826959|FG000|Overall Study|New health condition|1
866712|NCT00506142|1826960|FG001|Overall Study|New health condition|0
866713|NCT00506285|1826972|FG000|3 Week Screening Phase|Withdrawal by Subject|17
866714|NCT00506285|1826973|FG001|3 Week Screening Phase|Withdrawal by Subject|10
866715|NCT00506285|1826972|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4
866716|NCT00506285|1826973|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3
866717|NCT00506285|1826972|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5
866718|NCT00506285|1826973|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2
866719|NCT00506285|1826972|FG000|6-month Open Label Phase|Lost to Follow-up|1
866720|NCT00506285|1826973|FG001|6-month Open Label Phase|Lost to Follow-up|7
866721|NCT00506285|1826972|FG000|6-month Open Label Phase|Withdrawal by Subject|9
866722|NCT00506285|1826973|FG001|6-month Open Label Phase|Withdrawal by Subject|5
866723|NCT00506350|1826990|FG000|Overall Study|Serious Adverse Event|1
866724|NCT00506350|1826991|FG001|Overall Study|Serious Adverse Event|0
866725|NCT00506350|1826992|FG002|Overall Study|Serious Adverse Event|0
866726|NCT00506350|1826993|FG003|Overall Study|Serious Adverse Event|0
866727|NCT00506350|1826994|FG004|Overall Study|Serious Adverse Event|0
866728|NCT00506350|1826995|FG005|Overall Study|Serious Adverse Event|0
866729|NCT00506350|1826996|FG006|Overall Study|Serious Adverse Event|0
866730|NCT00506350|1826997|FG007|Overall Study|Serious Adverse Event|0
866731|NCT00506350|1826998|FG008|Overall Study|Serious Adverse Event|0
866732|NCT00506350|1826990|FG000|Overall Study|Adverse Event|0
866733|NCT00506350|1826991|FG001|Overall Study|Adverse Event|0
866734|NCT00506350|1826992|FG002|Overall Study|Adverse Event|0
866735|NCT00506350|1826993|FG003|Overall Study|Adverse Event|0
866736|NCT00506350|1826994|FG004|Overall Study|Adverse Event|0
866737|NCT00506350|1826995|FG005|Overall Study|Adverse Event|0
866738|NCT00506350|1826996|FG006|Overall Study|Adverse Event|0
866739|NCT00506350|1826997|FG007|Overall Study|Adverse Event|1
866740|NCT00506350|1826998|FG008|Overall Study|Adverse Event|1
866741|NCT00506350|1826990|FG000|Overall Study|Protocol Violation|0
866742|NCT00506350|1826991|FG001|Overall Study|Protocol Violation|0
866743|NCT00506350|1826992|FG002|Overall Study|Protocol Violation|1
866744|NCT00506350|1826993|FG003|Overall Study|Protocol Violation|0
866745|NCT00506350|1826994|FG004|Overall Study|Protocol Violation|0
866746|NCT00506350|1826995|FG005|Overall Study|Protocol Violation|0
866747|NCT00506350|1826996|FG006|Overall Study|Protocol Violation|1
866748|NCT00506350|1826997|FG007|Overall Study|Protocol Violation|0
866749|NCT00506350|1826998|FG008|Overall Study|Protocol Violation|0
866750|NCT00506350|1826990|FG000|Overall Study|Withdrawal by Subject|0
866751|NCT00506350|1826991|FG001|Overall Study|Withdrawal by Subject|1
866752|NCT00506350|1826992|FG002|Overall Study|Withdrawal by Subject|1
866753|NCT00506350|1826993|FG003|Overall Study|Withdrawal by Subject|1
866754|NCT00506350|1826994|FG004|Overall Study|Withdrawal by Subject|4
866755|NCT00506350|1826995|FG005|Overall Study|Withdrawal by Subject|1
942959|NCT01004614|1932550|FG000|Washout|Withdrawal by Subject|0
866756|NCT00506350|1826996|FG006|Overall Study|Withdrawal by Subject|1
866757|NCT00506350|1826997|FG007|Overall Study|Withdrawal by Subject|2
866758|NCT00506350|1826998|FG008|Overall Study|Withdrawal by Subject|0
866759|NCT00506350|1826990|FG000|Overall Study|Lost to Follow-up|1
866760|NCT00506350|1826991|FG001|Overall Study|Lost to Follow-up|1
866761|NCT00506350|1826992|FG002|Overall Study|Lost to Follow-up|1
866762|NCT00506350|1826993|FG003|Overall Study|Lost to Follow-up|1
866763|NCT00506350|1826994|FG004|Overall Study|Lost to Follow-up|2
866764|NCT00506350|1826995|FG005|Overall Study|Lost to Follow-up|1
866765|NCT00506350|1826996|FG006|Overall Study|Lost to Follow-up|0
866766|NCT00506350|1826997|FG007|Overall Study|Lost to Follow-up|0
866767|NCT00506350|1826998|FG008|Overall Study|Lost to Follow-up|2
866768|NCT00506350|1826990|FG000|Overall Study|Medical Reason|0
866769|NCT00506350|1826991|FG001|Overall Study|Medical Reason|0
866770|NCT00506350|1826992|FG002|Overall Study|Medical Reason|0
866771|NCT00506350|1826993|FG003|Overall Study|Medical Reason|0
866772|NCT00506350|1826994|FG004|Overall Study|Medical Reason|1
866773|NCT00506350|1826995|FG005|Overall Study|Medical Reason|0
866774|NCT00506350|1826996|FG006|Overall Study|Medical Reason|0
866775|NCT00506350|1826997|FG007|Overall Study|Medical Reason|0
866776|NCT00506350|1826998|FG008|Overall Study|Medical Reason|0
866777|NCT00506350|1826990|FG000|Overall Study|Other|1
866778|NCT00506350|1826991|FG001|Overall Study|Other|1
866779|NCT00506350|1826992|FG002|Overall Study|Other|3
866780|NCT00506350|1826993|FG003|Overall Study|Other|0
866781|NCT00506350|1826994|FG004|Overall Study|Other|3
866782|NCT00506350|1826995|FG005|Overall Study|Other|0
866783|NCT00506350|1826996|FG006|Overall Study|Other|0
866784|NCT00506350|1826997|FG007|Overall Study|Other|2
866785|NCT00506350|1826998|FG008|Overall Study|Other|2
866786|NCT00506389|1827028|FG000|In-treatment Period|Other|3
866787|NCT00506389|1827029|FG001|In-treatment Period|Other|3
866788|NCT00506389|1827030|FG002|In-treatment Period|Other|4
866789|NCT00506389|1827028|FG000|In-treatment Period|Lost to Follow-up|0
866790|NCT00506389|1827029|FG001|In-treatment Period|Lost to Follow-up|0
866791|NCT00506389|1827030|FG002|In-treatment Period|Lost to Follow-up|1
866792|NCT00506389|1827028|FG000|In-treatment Period|Lack of compliance|1
866793|NCT00506389|1827029|FG001|In-treatment Period|Lack of compliance|0
866794|NCT00506389|1827030|FG002|In-treatment Period|Lack of compliance|0
866795|NCT00506389|1827028|FG000|In-treatment Period|Reasons not related to trial|4
866796|NCT00506389|1827029|FG001|In-treatment Period|Reasons not related to trial|1
866797|NCT00506389|1827030|FG002|In-treatment Period|Reasons not related to trial|0
866798|NCT00506389|1827028|FG000|In-treatment Period|Withdrawal by Subject|3
866799|NCT00506389|1827029|FG001|In-treatment Period|Withdrawal by Subject|3
866800|NCT00506389|1827030|FG002|In-treatment Period|Withdrawal by Subject|4
866801|NCT00506389|1827028|FG000|In-treatment Period|Lack of Efficacy|0
866802|NCT00506389|1827029|FG001|In-treatment Period|Lack of Efficacy|2
866803|NCT00506389|1827030|FG002|In-treatment Period|Lack of Efficacy|0
866804|NCT00506389|1827028|FG000|In-treatment Period|Adverse Event|11
866805|NCT00506389|1827029|FG001|In-treatment Period|Adverse Event|5
866806|NCT00506389|1827030|FG002|In-treatment Period|Adverse Event|2
866807|NCT00506389|1827028|FG000|In-treatment Period|Randomized but not treated|4
866808|NCT00506389|1827029|FG001|In-treatment Period|Randomized but not treated|1
866809|NCT00506389|1827030|FG002|In-treatment Period|Randomized but not treated|1
866810|NCT00506415|1827041|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
866811|NCT00506415|1827042|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
866812|NCT00506415|1827043|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
866813|NCT00506415|1827044|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
866814|NCT00506415|1827041|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
866815|NCT00506415|1827042|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
866816|NCT00506415|1827043|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
866817|NCT00506415|1827044|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
866818|NCT00506415|1827041|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
866819|NCT00506415|1827042|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
866820|NCT00506415|1827043|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
866821|NCT00506415|1827044|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
866822|NCT00506415|1827041|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
866823|NCT00506415|1827042|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
866824|NCT00506415|1827043|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
866825|NCT00506415|1827044|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
866826|NCT00506415|1827041|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
866827|NCT00506415|1827042|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
866828|NCT00506415|1827043|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
866829|NCT00506415|1827044|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
866830|NCT00506415|1827041|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
866831|NCT00506415|1827042|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
866832|NCT00506415|1827043|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
866833|NCT00506415|1827044|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
866834|NCT00506415|1827041|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
866835|NCT00506415|1827042|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
866836|NCT00506415|1827043|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
866837|NCT00506415|1827044|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
866838|NCT00506415|1827041|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22
866839|NCT00506415|1827042|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0
866840|NCT00506415|1827043|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0
866841|NCT00506415|1827044|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0
866842|NCT00506415|1827041|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
866843|NCT00506415|1827042|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
866844|NCT00506415|1827043|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
866845|NCT00506415|1827044|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
866846|NCT00506415|1827041|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0
866847|NCT00506415|1827042|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33
866848|NCT00506415|1827043|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28
866849|NCT00506415|1827044|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0
866850|NCT00506415|1827041|FG000|Double Blind (Maximum 48 Weeks )|Death|0
866851|NCT00506415|1827042|FG001|Double Blind (Maximum 48 Weeks )|Death|5
866852|NCT00506415|1827043|FG002|Double Blind (Maximum 48 Weeks )|Death|3
866853|NCT00506415|1827044|FG003|Double Blind (Maximum 48 Weeks )|Death|0
866854|NCT00506415|1827041|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
866855|NCT00506415|1827042|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
866856|NCT00506415|1827043|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
866857|NCT00506415|1827044|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
866858|NCT00506415|1827041|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
866859|NCT00506415|1827042|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
866860|NCT00506415|1827043|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
866861|NCT00506415|1827044|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
866862|NCT00506415|1827041|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
866863|NCT00506415|1827042|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
866864|NCT00506415|1827043|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
866865|NCT00506415|1827044|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
866866|NCT00506415|1827041|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
866867|NCT00506415|1827042|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
866868|NCT00506415|1827043|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
866869|NCT00506415|1827044|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
866870|NCT00506415|1827041|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0
866871|NCT00506415|1827042|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3
866872|NCT00506415|1827043|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2
866873|NCT00506415|1827044|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0
866874|NCT00506415|1827041|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
866875|NCT00506415|1827042|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
866876|NCT00506415|1827043|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
866877|NCT00506415|1827044|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
866878|NCT00506415|1827041|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
866879|NCT00506415|1827042|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
866880|NCT00506415|1827043|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
866881|NCT00506415|1827044|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
866882|NCT00506415|1827041|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
866883|NCT00506415|1827042|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
866884|NCT00506415|1827043|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
866885|NCT00506415|1827044|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
866886|NCT00506415|1827041|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
866887|NCT00506415|1827042|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
866888|NCT00506415|1827043|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
866889|NCT00506415|1827044|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
866890|NCT00506415|1827041|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
866891|NCT00506415|1827042|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
866892|NCT00506415|1827043|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
866893|NCT00506415|1827044|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
866894|NCT00506415|1827041|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
866895|NCT00506415|1827042|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
866896|NCT00506415|1827043|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
866897|NCT00506415|1827044|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
866898|NCT00506415|1827041|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
866899|NCT00506415|1827042|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
866900|NCT00506415|1827043|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
866901|NCT00506415|1827044|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
866902|NCT00506415|1827041|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0
866903|NCT00506415|1827042|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0
866904|NCT00506415|1827043|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0
866905|NCT00506415|1827044|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7
866906|NCT00506441|1827057|FG000|Period 1; Open-label Period|Adverse Event|21
866907|NCT00506441|1827058|FG001|Period 1; Open-label Period|Adverse Event|0
866908|NCT00506441|1827057|FG000|Period 1; Open-label Period|Lack of Efficacy|13
866909|NCT00506441|1827058|FG001|Period 1; Open-label Period|Lack of Efficacy|0
866910|NCT00506441|1827057|FG000|Period 1; Open-label Period|Lost to Follow-up|2
866911|NCT00506441|1827058|FG001|Period 1; Open-label Period|Lost to Follow-up|0
866912|NCT00506441|1827057|FG000|Period 1; Open-label Period|Physician Decision|5
866913|NCT00506441|1827058|FG001|Period 1; Open-label Period|Physician Decision|0
866914|NCT00506441|1827057|FG000|Period 1; Open-label Period|Protocol Violation|9
866915|NCT00506441|1827058|FG001|Period 1; Open-label Period|Protocol Violation|0
866916|NCT00506441|1827057|FG000|Period 1; Open-label Period|Withdrawal by Subject|13
866917|NCT00506441|1827058|FG001|Period 1; Open-label Period|Withdrawal by Subject|0
866918|NCT00506441|1827057|FG000|Period 1; Open-label Period|Other Reasons|13
866919|NCT00506441|1827058|FG001|Period 1; Open-label Period|Other Reasons|0
866920|NCT00506441|1827057|FG000|Period 2; Double-blind Period|Adverse Event|0
866921|NCT00506441|1827058|FG001|Period 2; Double-blind Period|Adverse Event|1
866922|NCT00506441|1827057|FG000|Period 2; Double-blind Period|Lack of Efficacy|0
866923|NCT00506441|1827058|FG001|Period 2; Double-blind Period|Lack of Efficacy|2
866924|NCT00506441|1827057|FG000|Period 2; Double-blind Period|Physician Decision|1
866925|NCT00506441|1827058|FG001|Period 2; Double-blind Period|Physician Decision|1
866926|NCT00506441|1827057|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1
866927|NCT00506441|1827058|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0
866928|NCT00506441|1827057|FG000|Period 2; Double-blind Period|Other Reason|1
866929|NCT00506441|1827058|FG001|Period 2; Double-blind Period|Other Reason|1
866930|NCT00506454|1827068|FG000|Overall Study|Withdrawal by Subject|1
866931|NCT00506454|1827069|FG001|Overall Study|Withdrawal by Subject|1
866932|NCT00506493|1827075|FG000|Overall Study|Death|6
866933|NCT00506493|1827075|FG000|Overall Study|Withdrawal by Subject|5
866934|NCT00506519|1827084|FG000|Overall Study|Death|4
866935|NCT00506519|1827085|FG001|Overall Study|Death|6
866936|NCT00506519|1827086|FG002|Overall Study|Death|0
866937|NCT00506519|1827084|FG000|Overall Study|Adverse Event|1
866938|NCT00506519|1827085|FG001|Overall Study|Adverse Event|0
866939|NCT00506519|1827086|FG002|Overall Study|Adverse Event|0
866940|NCT00506662|1827103|FG000|Overall Study|Adverse Event|0
866941|NCT00506662|1827104|FG001|Overall Study|Adverse Event|2
866942|NCT00506662|1827103|FG000|Overall Study|Lack of Efficacy|1
866943|NCT00506662|1827104|FG001|Overall Study|Lack of Efficacy|0
866944|NCT00506662|1827103|FG000|Overall Study|Protocol Violation|2
866945|NCT00506662|1827104|FG001|Overall Study|Protocol Violation|4
866946|NCT00506662|1827103|FG000|Overall Study|Trial terminated|10
866947|NCT00506662|1827104|FG001|Overall Study|Trial terminated|16
866948|NCT00506662|1827103|FG000|Overall Study|Not recorded|4
866949|NCT00506662|1827104|FG001|Overall Study|Not recorded|6
866950|NCT00506753|1827132|FG000|Overall Study|Lost to Follow-up|21
866951|NCT00506753|1827133|FG001|Overall Study|Lost to Follow-up|15
866952|NCT00506779|1827141|FG000|Overall Study|Withdrawal by Subject|1
866953|NCT00506779|1827142|FG001|Overall Study|Withdrawal by Subject|0
866954|NCT00506779|1827143|FG002|Overall Study|Withdrawal by Subject|1
866955|NCT00506779|1827144|FG003|Overall Study|Withdrawal by Subject|0
866956|NCT00506779|1827141|FG000|Overall Study|Adverse Event|0
866957|NCT00506779|1827142|FG001|Overall Study|Adverse Event|1
866958|NCT00506779|1827143|FG002|Overall Study|Adverse Event|1
866959|NCT00506779|1827144|FG003|Overall Study|Adverse Event|1
866960|NCT00506831|1827155|FG000|Overall Study|Death|1
866961|NCT00506831|1827155|FG000|Overall Study|Withdrawal by Subject|1
866962|NCT00506883|1827167|FG000|Overall Study|Lost to Follow-up|1
866963|NCT00506883|1827168|FG001|Overall Study|Lost to Follow-up|1
866964|NCT00506883|1827169|FG002|Overall Study|Lost to Follow-up|1
866965|NCT00506883|1827167|FG000|Overall Study|Withdrawal by Subject|1
866966|NCT00506883|1827168|FG001|Overall Study|Withdrawal by Subject|0
866967|NCT00506883|1827169|FG002|Overall Study|Withdrawal by Subject|1
866968|NCT00506883|1827167|FG000|Overall Study|Lack of Efficacy|0
866969|NCT00506883|1827168|FG001|Overall Study|Lack of Efficacy|1
866970|NCT00506883|1827169|FG002|Overall Study|Lack of Efficacy|1
866971|NCT00506883|1827167|FG000|Overall Study|Other|5
866972|NCT00506883|1827168|FG001|Overall Study|Other|1
866973|NCT00506883|1827169|FG002|Overall Study|Other|1
866974|NCT00506922|1827182|FG000|Overall Study|Physician Decision|0
866975|NCT00506922|1827183|FG001|Overall Study|Physician Decision|0
866976|NCT00506922|1827184|FG002|Overall Study|Physician Decision|0
866977|NCT00506922|1827185|FG003|Overall Study|Physician Decision|2
866978|NCT00506922|1827186|FG004|Overall Study|Physician Decision|0
866979|NCT00506922|1827182|FG000|Overall Study|Withdrawal by Subject|0
866980|NCT00506922|1827183|FG001|Overall Study|Withdrawal by Subject|0
866981|NCT00506922|1827184|FG002|Overall Study|Withdrawal by Subject|0
866982|NCT00506922|1827185|FG003|Overall Study|Withdrawal by Subject|0
866983|NCT00506922|1827186|FG004|Overall Study|Withdrawal by Subject|1
866984|NCT00506948|1827194|FG000|Overall Study|Death|4
866985|NCT00506948|1827194|FG000|Overall Study|Adverse Event|5
866986|NCT00506948|1827194|FG000|Overall Study|Physician Decision|1
866987|NCT00507026|1827201|FG000|Overall Study|Lack of Efficacy|6
866988|NCT00507026|1827202|FG001|Overall Study|Lack of Efficacy|4
866989|NCT00507026|1827203|FG002|Overall Study|Lack of Efficacy|21
866990|NCT00507026|1827201|FG000|Overall Study|Withdrawal by Subject|2
866991|NCT00507026|1827202|FG001|Overall Study|Withdrawal by Subject|0
866992|NCT00507026|1827203|FG002|Overall Study|Withdrawal by Subject|0
866993|NCT00507026|1827201|FG000|Overall Study|Investigator Decision|1
866994|NCT00507026|1827202|FG001|Overall Study|Investigator Decision|0
866995|NCT00507026|1827203|FG002|Overall Study|Investigator Decision|0
866996|NCT00507026|1827201|FG000|Overall Study|Adverse Event|2
866997|NCT00507026|1827202|FG001|Overall Study|Adverse Event|0
866998|NCT00507026|1827203|FG002|Overall Study|Adverse Event|0
866999|NCT00507026|1827201|FG000|Overall Study|Protocol Violation|1
867000|NCT00507026|1827202|FG001|Overall Study|Protocol Violation|0
867001|NCT00507026|1827203|FG002|Overall Study|Protocol Violation|0
867002|NCT00507026|1827201|FG000|Overall Study|Other|1
867003|NCT00507026|1827202|FG001|Overall Study|Other|0
867004|NCT00507026|1827203|FG002|Overall Study|Other|0
867005|NCT00507130|1827215|FG000|Overall Study|Lost to Follow-up|0
867006|NCT00507130|1827216|FG001|Overall Study|Lost to Follow-up|0
867007|NCT00507130|1827217|FG002|Overall Study|Lost to Follow-up|1
867008|NCT00507130|1827218|FG003|Overall Study|Lost to Follow-up|1
867009|NCT00507130|1827215|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
867010|NCT00507130|1827216|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
867011|NCT00507130|1827217|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
867012|NCT00507130|1827218|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
867013|NCT00507416|1827240|FG000|Overall Study|Adverse Event|58
867014|NCT00507416|1827241|FG001|Overall Study|Adverse Event|67
867015|NCT00507416|1827242|FG002|Overall Study|Adverse Event|65
867016|NCT00507416|1827240|FG000|Overall Study|Protocol Violation|1
867017|NCT00507416|1827241|FG001|Overall Study|Protocol Violation|2
867018|NCT00507416|1827242|FG002|Overall Study|Protocol Violation|0
867019|NCT00507416|1827240|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7
867020|NCT00507416|1827241|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7
867021|NCT00507416|1827242|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8
867022|NCT00507416|1827240|FG000|Overall Study|Progressive Disease|20
867023|NCT00507416|1827241|FG001|Overall Study|Progressive Disease|10
867024|NCT00507416|1827242|FG002|Overall Study|Progressive Disease|13
867025|NCT00507416|1827240|FG000|Overall Study|Patient declined further treatment|18
867026|NCT00507416|1827241|FG001|Overall Study|Patient declined further treatment|14
867027|NCT00507416|1827242|FG002|Overall Study|Patient declined further treatment|11
867028|NCT00507416|1827240|FG000|Overall Study|Other|11
867029|NCT00507416|1827241|FG001|Overall Study|Other|16
867030|NCT00507416|1827242|FG002|Overall Study|Other|13
867031|NCT00507416|1827240|FG000|Overall Study|Did not Receive Study Treatment|3
867032|NCT00507416|1827241|FG001|Overall Study|Did not Receive Study Treatment|9
867033|NCT00507416|1827242|FG002|Overall Study|Did not Receive Study Treatment|4
867034|NCT00507429|1827252|FG000|Treatment Phase|Disease Progression|12
867035|NCT00507429|1827253|FG001|Treatment Phase|Disease Progression|5
867036|NCT00507429|1827252|FG000|Treatment Phase|Adverse Event|12
867037|NCT00507429|1827253|FG001|Treatment Phase|Adverse Event|5
867038|NCT00507429|1827252|FG000|Treatment Phase|Withdrawal by Subject|3
867039|NCT00507429|1827253|FG001|Treatment Phase|Withdrawal by Subject|3
867040|NCT00507429|1827252|FG000|Treatment Phase|Physician Decision|4
867041|NCT00507429|1827253|FG001|Treatment Phase|Physician Decision|2
867042|NCT00507429|1827252|FG000|Treatment Phase|Other|6
867043|NCT00507429|1827253|FG001|Treatment Phase|Other|3
867044|NCT00507429|1827252|FG000|Maintenance Phase|Progressive Disease|14
867045|NCT00507429|1827253|FG001|Maintenance Phase|Progressive Disease|0
867046|NCT00507442|1827265|FG000|Overall Study|Adverse Event|8
867047|NCT00507442|1827266|FG001|Overall Study|Adverse Event|11
867048|NCT00507442|1827267|FG002|Overall Study|Adverse Event|4
867049|NCT00507442|1827268|FG003|Overall Study|Adverse Event|1
867050|NCT00507442|1827265|FG000|Overall Study|Protocol Violation|0
867051|NCT00507442|1827266|FG001|Overall Study|Protocol Violation|1
867052|NCT00507442|1827267|FG002|Overall Study|Protocol Violation|0
867053|NCT00507442|1827268|FG003|Overall Study|Protocol Violation|0
867054|NCT00507442|1827265|FG000|Overall Study|Lost to Follow-up|0
867055|NCT00507442|1827266|FG001|Overall Study|Lost to Follow-up|0
867056|NCT00507442|1827267|FG002|Overall Study|Lost to Follow-up|1
867057|NCT00507442|1827268|FG003|Overall Study|Lost to Follow-up|0
867058|NCT00507442|1827265|FG000|Overall Study|Physician Decision|0
867059|NCT00507442|1827266|FG001|Overall Study|Physician Decision|2
867060|NCT00507442|1827267|FG002|Overall Study|Physician Decision|4
867061|NCT00507442|1827268|FG003|Overall Study|Physician Decision|1
867062|NCT00507442|1827265|FG000|Overall Study|Progressive Disease|2
867063|NCT00507442|1827266|FG001|Overall Study|Progressive Disease|4
867064|NCT00507442|1827267|FG002|Overall Study|Progressive Disease|2
867065|NCT00507442|1827268|FG003|Overall Study|Progressive Disease|0
867066|NCT00507442|1827265|FG000|Overall Study|Withdrawal by Subject|4
867067|NCT00507442|1827266|FG001|Overall Study|Withdrawal by Subject|4
867068|NCT00507442|1827267|FG002|Overall Study|Withdrawal by Subject|2
867069|NCT00507442|1827268|FG003|Overall Study|Withdrawal by Subject|1
867070|NCT00507442|1827265|FG000|Overall Study|Other|2
867071|NCT00507442|1827266|FG001|Overall Study|Other|5
867072|NCT00507442|1827267|FG002|Overall Study|Other|2
867073|NCT00507442|1827268|FG003|Overall Study|Other|2
867074|NCT00507455|1827285|FG000|Overall Study|Adverse Event|3
867075|NCT00507455|1827286|FG001|Overall Study|Adverse Event|3
867076|NCT00507455|1827287|FG002|Overall Study|Adverse Event|6
867077|NCT00507455|1827285|FG000|Overall Study|Withdrawal by Subject|2
867078|NCT00507455|1827286|FG001|Overall Study|Withdrawal by Subject|1
867079|NCT00507455|1827287|FG002|Overall Study|Withdrawal by Subject|2
867080|NCT00507455|1827285|FG000|Overall Study|Protocol Violation|4
867081|NCT00507455|1827286|FG001|Overall Study|Protocol Violation|1
867082|NCT00507455|1827287|FG002|Overall Study|Protocol Violation|1
867083|NCT00507455|1827285|FG000|Overall Study|Lost to Follow-up|2
867084|NCT00507455|1827286|FG001|Overall Study|Lost to Follow-up|0
867085|NCT00507455|1827287|FG002|Overall Study|Lost to Follow-up|2
867086|NCT00507455|1827285|FG000|Overall Study|Lack of Efficacy|0
867087|NCT00507455|1827286|FG001|Overall Study|Lack of Efficacy|1
867088|NCT00507455|1827287|FG002|Overall Study|Lack of Efficacy|0
867089|NCT00507455|1827285|FG000|Overall Study|Other - miscellaneous reason|1
867090|NCT00507455|1827286|FG001|Overall Study|Other - miscellaneous reason|0
867091|NCT00507455|1827287|FG002|Overall Study|Other - miscellaneous reason|1
867092|NCT00507507|1827297|FG000|Treatment Period|Lost to Follow-up|0
867093|NCT00507507|1827298|FG001|Treatment Period|Lost to Follow-up|2
867094|NCT00507507|1827297|FG000|Treatment Period|Physician Decision|4
867095|NCT00507507|1827298|FG001|Treatment Period|Physician Decision|1
867096|NCT00507507|1827297|FG000|Treatment Period|Protocol Violation|1
867097|NCT00507507|1827298|FG001|Treatment Period|Protocol Violation|2
867098|NCT00507507|1827297|FG000|Treatment Period|Adverse Event|1
867099|NCT00507507|1827298|FG001|Treatment Period|Adverse Event|1
867100|NCT00507507|1827297|FG000|Treatment Period|Withdrawal by Subject|46
867101|NCT00507507|1827298|FG001|Treatment Period|Withdrawal by Subject|47
867102|NCT00507507|1827297|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1
867103|NCT00507507|1827298|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0
867104|NCT00507507|1827297|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0
867105|NCT00507507|1827298|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1
867106|NCT00507507|1827297|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
867107|NCT00507507|1827298|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
867108|NCT00507546|1827308|FG000|Overall Study|Withdrawal by Subject|1
867109|NCT00507546|1827309|FG001|Overall Study|Withdrawal by Subject|0
867110|NCT00507546|1827308|FG000|Overall Study|Protocol Violation|1
867111|NCT00507546|1827309|FG001|Overall Study|Protocol Violation|0
867112|NCT00507546|1827308|FG000|Overall Study|Physician Decision|0
867113|NCT00507546|1827309|FG001|Overall Study|Physician Decision|1
867114|NCT00507689|1827324|FG000|Pre-Randomization Period|Adverse Event|1
867115|NCT00507689|1827325|FG001|Pre-Randomization Period|Adverse Event|0
867116|NCT00507689|1827324|FG000|Pre-Randomization Period|Physician Decision|1
867117|NCT00507689|1827325|FG001|Pre-Randomization Period|Physician Decision|0
867118|NCT00507689|1827324|FG000|Pre-Randomization Period|Withdrawal by Subject|1
867119|NCT00507689|1827325|FG001|Pre-Randomization Period|Withdrawal by Subject|0
867120|NCT00507689|1827324|FG000|Randomized Period|Adverse Event|1
867121|NCT00507689|1827325|FG001|Randomized Period|Adverse Event|1
867122|NCT00507689|1827324|FG000|Randomized Period|Withdrawal by Subject|0
867123|NCT00507689|1827325|FG001|Randomized Period|Withdrawal by Subject|1
867124|NCT00507728|1827335|FG000|Randomization to Month 3|Lost to Follow-up|15
867125|NCT00507728|1827336|FG001|Randomization to Month 3|Lost to Follow-up|14
867126|NCT00507728|1827337|FG002|Randomization to Month 3|Lost to Follow-up|20
867127|NCT00507728|1827335|FG000|From 3 Months to 6 Months|Lost to Follow-up|6
867128|NCT00507728|1827336|FG001|From 3 Months to 6 Months|Lost to Follow-up|10
867129|NCT00507728|1827337|FG002|From 3 Months to 6 Months|Lost to Follow-up|9
867130|NCT00507819|1827355|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
867131|NCT00507819|1827356|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
867132|NCT00508001|1827365|FG000|Overall Study|Adverse Event|2
867133|NCT00508001|1827366|FG001|Overall Study|Adverse Event|0
867134|NCT00508001|1827367|FG002|Overall Study|Adverse Event|4
867135|NCT00508001|1827365|FG000|Overall Study|condition under investigation worsened|13
867136|NCT00508001|1827366|FG001|Overall Study|condition under investigation worsened|7
867137|NCT00508001|1827367|FG002|Overall Study|condition under investigation worsened|1
867138|NCT00508001|1827365|FG000|Overall Study|Death|0
867139|NCT00508001|1827366|FG001|Overall Study|Death|1
867140|NCT00508001|1827367|FG002|Overall Study|Death|1
867141|NCT00508001|1827365|FG000|Overall Study|Withdrawal by Subject|4
867142|NCT00508001|1827366|FG001|Overall Study|Withdrawal by Subject|4
867143|NCT00508001|1827367|FG002|Overall Study|Withdrawal by Subject|1
867144|NCT00508027|1827375|FG000|Dose Level 1|Lost to Follow-up|4
867145|NCT00508027|1827375|FG000|Dose Level 1|Withdrawal by Subject|2
867146|NCT00508027|1827375|FG000|Dose Level 1|Physician Decision|2
867147|NCT00508027|1827375|FG000|Dose Level 2|Lost to Follow-up|2
867148|NCT00508027|1827375|FG000|Dose Level 2|Withdrawal by Subject|2
867149|NCT00508144|1827408|FG000|Overall Study|Not eligible|6
867150|NCT00508144|1827408|FG000|Overall Study|Death|5
867151|NCT00508157|1827414|FG000|Overall Study|Adverse Event|0
867152|NCT00508157|1827415|FG001|Overall Study|Adverse Event|1
867153|NCT00508157|1827414|FG000|Overall Study|Subject Withdrew Consent|1
867154|NCT00508157|1827415|FG001|Overall Study|Subject Withdrew Consent|0
867155|NCT00508157|1827414|FG000|Overall Study|Lost to Follow-up|1
867156|NCT00508157|1827415|FG001|Overall Study|Lost to Follow-up|0
867157|NCT00508157|1827414|FG000|Overall Study|Subject no longer met study criteria|0
867158|NCT00508157|1827415|FG001|Overall Study|Subject no longer met study criteria|1
867159|NCT00508157|1827414|FG000|Overall Study|Other known cause|0
867160|NCT00508157|1827415|FG001|Overall Study|Other known cause|1
867161|NCT00508261|1827441|FG000|Overall Study|Other|0
867162|NCT00508261|1827442|FG001|Overall Study|Other|1
867163|NCT00508261|1827443|FG002|Overall Study|Other|1
867164|NCT00508261|1827444|FG003|Overall Study|Other|0
867165|NCT00508261|1827441|FG000|Overall Study|Serious Adverse Event|0
867166|NCT00508261|1827442|FG001|Overall Study|Serious Adverse Event|1
867167|NCT00508261|1827443|FG002|Overall Study|Serious Adverse Event|0
867168|NCT00508261|1827444|FG003|Overall Study|Serious Adverse Event|0
867169|NCT00508261|1827441|FG000|Overall Study|Withdrawal by Subject|3
867170|NCT00508261|1827442|FG001|Overall Study|Withdrawal by Subject|4
867171|NCT00508261|1827443|FG002|Overall Study|Withdrawal by Subject|4
867172|NCT00508261|1827444|FG003|Overall Study|Withdrawal by Subject|0
867173|NCT00508261|1827441|FG000|Overall Study|Migrated/ moved from study area|0
867174|NCT00508261|1827442|FG001|Overall Study|Migrated/ moved from study area|1
867175|NCT00508261|1827443|FG002|Overall Study|Migrated/ moved from study area|0
867176|NCT00508261|1827444|FG003|Overall Study|Migrated/ moved from study area|0
867177|NCT00508261|1827441|FG000|Overall Study|Lost to Follow-up|0
867178|NCT00508261|1827442|FG001|Overall Study|Lost to Follow-up|1
867179|NCT00508261|1827443|FG002|Overall Study|Lost to Follow-up|1
867180|NCT00508261|1827444|FG003|Overall Study|Lost to Follow-up|1
867181|NCT00508274|1827458|FG000|Overall Study|Adverse Event|5
867182|NCT00508274|1827458|FG000|Overall Study|Death|7
867183|NCT00508274|1827458|FG000|Overall Study|Disease progression|32
867184|NCT00508274|1827458|FG000|Overall Study|Withdrawal by Subject|1
867185|NCT00508274|1827458|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2
867186|NCT00508274|1827458|FG000|Overall Study|Missing|3
867187|NCT00508391|1827473|FG000|First Treatment|Withdrawal by Subject|6
867188|NCT00508391|1827474|FG001|First Treatment|Withdrawal by Subject|3
867189|NCT00508391|1827473|FG000|Second Treatment|Withdrawal by Subject|2
867190|NCT00508391|1827474|FG001|Second Treatment|Withdrawal by Subject|0
867191|NCT00508404|1827482|FG000|Overall Study|Ongoing at Data Cut-off|12
867192|NCT00508404|1827482|FG000|Overall Study|Adverse Event|2
867193|NCT00508404|1827482|FG000|Overall Study|Death|16
867194|NCT00508404|1827482|FG000|Overall Study|Physician Decision|2
867195|NCT00508404|1827482|FG000|Overall Study|Withdrawal by Subject|3
867196|NCT00508404|1827482|FG000|Overall Study|Protocol-specified Criteria|2
867197|NCT00508404|1827482|FG000|Overall Study|Lost to Follow-up|2
867198|NCT00508404|1827482|FG000|Overall Study|Other - Not Specified|3
867199|NCT00508482|1827499|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9
867200|NCT00508482|1827500|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7
867201|NCT00508482|1827501|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4
867202|NCT00508482|1827499|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12
867203|NCT00508482|1827500|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10
867204|NCT00508482|1827501|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16
867205|NCT00508482|1827499|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20
867206|NCT00508482|1827500|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6
867207|NCT00508482|1827501|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1
867208|NCT00508651|1827516|FG000|Overall Study|Lost to Follow-up|3
867209|NCT00508651|1827517|FG001|Overall Study|Lost to Follow-up|1
867210|NCT00508651|1827516|FG000|Overall Study|Withdrawal by Subject|1
867211|NCT00508651|1827517|FG001|Overall Study|Withdrawal by Subject|1
867212|NCT00508742|1827534|FG000|Period 1: Infant Series|Adverse Event|5
867213|NCT00508742|1827535|FG001|Period 1: Infant Series|Adverse Event|4
867214|NCT00508742|1827534|FG000|Period 1: Infant Series|Protocol Violation|1
867215|NCT00508742|1827535|FG001|Period 1: Infant Series|Protocol Violation|0
867216|NCT00508742|1827534|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31
867217|NCT00508742|1827535|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40
867218|NCT00508742|1827534|FG000|Period 1: Infant Series|Physician Decision|1
867219|NCT00508742|1827535|FG001|Period 1: Infant Series|Physician Decision|0
867220|NCT00508742|1827534|FG000|Period 1: Infant Series|Other|4
867221|NCT00508742|1827535|FG001|Period 1: Infant Series|Other|1
867222|NCT00508742|1827534|FG000|Period 2: After Infant Series|Adverse Event|2
867223|NCT00508742|1827535|FG001|Period 2: After Infant Series|Adverse Event|6
867224|NCT00508742|1827534|FG000|Period 2: After Infant Series|Lost to Follow-up|1
867225|NCT00508742|1827535|FG001|Period 2: After Infant Series|Lost to Follow-up|1
867226|NCT00508742|1827534|FG000|Period 2: After Infant Series|Protocol Violation|1
867227|NCT00508742|1827535|FG001|Period 2: After Infant Series|Protocol Violation|0
867228|NCT00508742|1827534|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0
867229|NCT00508742|1827535|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3
867230|NCT00508742|1827534|FG000|Period 2: After Infant Series|Failed to Return|1
867231|NCT00508742|1827535|FG001|Period 2: After Infant Series|Failed to Return|0
867232|NCT00508742|1827534|FG000|Period 2: After Infant Series|Other|2
867233|NCT00508742|1827535|FG001|Period 2: After Infant Series|Other|1
867234|NCT00508742|1827534|FG000|Period 3: Toddler Dose|Adverse Event|1
867235|NCT00508742|1827535|FG001|Period 3: Toddler Dose|Adverse Event|0
867236|NCT00508742|1827534|FG000|Period 3: Toddler Dose|Lost to Follow-up|2
867237|NCT00508742|1827535|FG001|Period 3: Toddler Dose|Lost to Follow-up|3
867238|NCT00508742|1827534|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
867239|NCT00508742|1827535|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
867240|NCT00508742|1827534|FG000|Period 3: Toddler Dose|Other|5
867241|NCT00508742|1827535|FG001|Period 3: Toddler Dose|Other|4
867242|NCT00508755|1827547|FG000|Overall Study|Withdrawal by Subject|1
867243|NCT00508820|1827555|FG000|Overall Study|Adverse Event|6
867244|NCT00508820|1827556|FG001|Overall Study|Adverse Event|10
867245|NCT00508820|1827555|FG000|Overall Study|Death|6
867246|NCT00508820|1827556|FG001|Overall Study|Death|8
867247|NCT00508820|1827555|FG000|Overall Study|Lost to Follow-up|1
867248|NCT00508820|1827556|FG001|Overall Study|Lost to Follow-up|1
867249|NCT00508820|1827555|FG000|Overall Study|Physician Decision|8
867250|NCT00508820|1827556|FG001|Overall Study|Physician Decision|2
867251|NCT00508820|1827555|FG000|Overall Study|Pregnancy|0
867252|NCT00508820|1827556|FG001|Overall Study|Pregnancy|2
867253|NCT00508820|1827555|FG000|Overall Study|Protocol Violation|2
867254|NCT00508820|1827556|FG001|Overall Study|Protocol Violation|0
867255|NCT00508820|1827555|FG000|Overall Study|Withdrawal by Subject|10
867256|NCT00508820|1827556|FG001|Overall Study|Withdrawal by Subject|12
867257|NCT00508820|1827555|FG000|Overall Study|Other|11
867258|NCT00508820|1827556|FG001|Overall Study|Other|2
867259|NCT00508820|1827555|FG000|Overall Study|Noncompliance|1
867260|NCT00508820|1827556|FG001|Overall Study|Noncompliance|0
867261|NCT00508820|1827555|FG000|Overall Study|Requirement for alternative therapy|7
867262|NCT00508820|1827556|FG001|Overall Study|Requirement for alternative therapy|15
867263|NCT00508820|1827555|FG000|Overall Study|Protocol-specified Criteria|3
867264|NCT00508820|1827556|FG001|Overall Study|Protocol-specified Criteria|12
867265|NCT00508924|1827566|FG000|Overall Study|Protocol Violation|0
867266|NCT00508924|1827567|FG001|Overall Study|Protocol Violation|0
867267|NCT00508924|1827568|FG002|Overall Study|Protocol Violation|1
867268|NCT00508924|1827569|FG003|Overall Study|Protocol Violation|1
867269|NCT00509028|1827585|FG000|Overall Study|Adverse Event|2
867270|NCT00509028|1827586|FG001|Overall Study|Adverse Event|0
867271|NCT00509028|1827585|FG000|Overall Study|Withdrawal by Subject|4
867272|NCT00509028|1827586|FG001|Overall Study|Withdrawal by Subject|3
867273|NCT00509028|1827585|FG000|Overall Study|Lost to Follow-up|0
867274|NCT00509028|1827586|FG001|Overall Study|Lost to Follow-up|1
867275|NCT00509028|1827585|FG000|Overall Study|Protocol Violation|4
867276|NCT00509028|1827586|FG001|Overall Study|Protocol Violation|2
867277|NCT00509028|1827585|FG000|Overall Study|Non-compliance|2
867278|NCT00509028|1827586|FG001|Overall Study|Non-compliance|1
867279|NCT00509067|1827598|FG000|Overall Study|Lost to Follow-up|1
867280|NCT00509067|1827599|FG001|Overall Study|Lost to Follow-up|1
867281|NCT00509067|1827598|FG000|Overall Study|Adverse Event|3
867282|NCT00509067|1827599|FG001|Overall Study|Adverse Event|1
867283|NCT00509067|1827598|FG000|Overall Study|Protocol Violation|0
867284|NCT00509067|1827599|FG001|Overall Study|Protocol Violation|3
867285|NCT00509093|1827609|FG000|Overall Study|Adverse Event|10
867286|NCT00509093|1827609|FG000|Overall Study|Disease Progression|9
867287|NCT00509093|1827609|FG000|Overall Study|Transformed into MDS|1
867288|NCT00509093|1827609|FG000|Overall Study|Withdrawal by Subject|3
867289|NCT00509093|1827609|FG000|Overall Study|Physician Decision|1
867290|NCT00509106|1827615|FG000|Overall Study|Adverse Event|3
867291|NCT00509106|1827616|FG001|Overall Study|Adverse Event|2
867292|NCT00509106|1827615|FG000|Overall Study|Noncompliance|0
867293|NCT00509106|1827616|FG001|Overall Study|Noncompliance|1
867294|NCT00509106|1827615|FG000|Overall Study|At the request of sponsor/investigator|1
867295|NCT00509106|1827616|FG001|Overall Study|At the request of sponsor/investigator|2
867296|NCT00509106|1827615|FG000|Overall Study|Withdrew consent|4
867297|NCT00509106|1827616|FG001|Overall Study|Withdrew consent|8
867298|NCT00509106|1827615|FG000|Overall Study|Lost to Follow-up|16
867299|NCT00509106|1827616|FG001|Overall Study|Lost to Follow-up|10
867300|NCT00509106|1827615|FG000|Overall Study|Other|1
867301|NCT00509106|1827616|FG001|Overall Study|Other|0
867302|NCT00509106|1827615|FG000|Overall Study|Death|6
867303|NCT00509106|1827616|FG001|Overall Study|Death|6
867304|NCT00509145|1827624|FG000|Overall Study|Death|0
867305|NCT00509145|1827625|FG001|Overall Study|Death|2
867306|NCT00509145|1827624|FG000|Overall Study|Adverse Event|42
867307|NCT00509145|1827625|FG001|Overall Study|Adverse Event|28
867308|NCT00509145|1827624|FG000|Overall Study|Withdrawal by Subject|32
867309|NCT00509145|1827625|FG001|Overall Study|Withdrawal by Subject|38
867310|NCT00509145|1827624|FG000|Overall Study|Physician Decision|11
867311|NCT00509145|1827625|FG001|Overall Study|Physician Decision|14
867312|NCT00509145|1827624|FG000|Overall Study|Protocol Violation|1
867313|NCT00509145|1827625|FG001|Overall Study|Protocol Violation|6
867314|NCT00509145|1827624|FG000|Overall Study|Pregnancy|3
867315|NCT00509145|1827625|FG001|Overall Study|Pregnancy|8
867316|NCT00509145|1827624|FG000|Overall Study|Lost to Follow-up|6
867317|NCT00509145|1827625|FG001|Overall Study|Lost to Follow-up|5
867318|NCT00509145|1827624|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12
867319|NCT00509145|1827625|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22
867320|NCT00509145|1827624|FG000|Overall Study|Other|6
867321|NCT00509145|1827625|FG001|Overall Study|Other|6
867322|NCT00509223|1827653|FG000|Overall Study|Lost to Follow-up|1
867323|NCT00509223|1827654|FG001|Overall Study|Lost to Follow-up|1
867324|NCT00509223|1827653|FG000|Overall Study|Adverse Event|1
867325|NCT00509223|1827654|FG001|Overall Study|Adverse Event|1
867326|NCT00509223|1827653|FG000|Overall Study|Withdrawal by Subject|25
867327|NCT00509223|1827654|FG001|Overall Study|Withdrawal by Subject|6
867328|NCT00509223|1827653|FG000|Overall Study|Including: subject change of address|5
867329|NCT00509223|1827654|FG001|Overall Study|Including: subject change of address|2
867330|NCT00509223|1827653|FG000|Overall Study|Did not meet revised inclusion criteria|56
867331|NCT00509223|1827654|FG001|Overall Study|Did not meet revised inclusion criteria|62
867332|NCT00509236|1827662|FG000|Overall Study|Adverse Event|7
867333|NCT00509236|1827663|FG001|Overall Study|Adverse Event|9
867334|NCT00509236|1827662|FG000|Overall Study|Withdrawal by Subject|5
867335|NCT00509236|1827663|FG001|Overall Study|Withdrawal by Subject|10
867336|NCT00509236|1827662|FG000|Overall Study|Protocol Violation|3
867337|NCT00509236|1827663|FG001|Overall Study|Protocol Violation|0
867338|NCT00509236|1827662|FG000|Overall Study|Excluded Medication|1
867339|NCT00509236|1827663|FG001|Overall Study|Excluded Medication|1
867340|NCT00509236|1827662|FG000|Overall Study|Scheduled Kidney Transplant|1
867341|NCT00509236|1827663|FG001|Overall Study|Scheduled Kidney Transplant|0
867342|NCT00509262|1827675|FG000|Overall Study|Adverse Event|16
867343|NCT00509262|1827676|FG001|Overall Study|Adverse Event|18
867344|NCT00509262|1827675|FG000|Overall Study|Other|2
867345|NCT00509262|1827676|FG001|Overall Study|Other|2
867346|NCT00509262|1827675|FG000|Overall Study|Lack of Efficacy|1
867347|NCT00509262|1827676|FG001|Overall Study|Lack of Efficacy|0
867348|NCT00509262|1827675|FG000|Overall Study|Lost to Follow-up|1
867349|NCT00509262|1827676|FG001|Overall Study|Lost to Follow-up|6
867350|NCT00509262|1827675|FG000|Overall Study|Physician Decision|1
867351|NCT00509262|1827676|FG001|Overall Study|Physician Decision|3
867352|NCT00509262|1827675|FG000|Overall Study|Protocol Violation|2
867353|NCT00509262|1827676|FG001|Overall Study|Protocol Violation|2
867354|NCT00509262|1827675|FG000|Overall Study|Withdrawal by Subject|24
867355|NCT00509262|1827676|FG001|Overall Study|Withdrawal by Subject|11
867356|NCT00509366|1827696|FG000|Overall Study|Not Treated (Screen Failure)|1
867357|NCT00509366|1827697|FG001|Overall Study|Not Treated (Screen Failure)|1
867358|NCT00509366|1827698|FG002|Overall Study|Not Treated (Screen Failure)|1
867359|NCT00509366|1827699|FG003|Overall Study|Not Treated (Screen Failure)|0
867360|NCT00509366|1827700|FG004|Overall Study|Not Treated (Screen Failure)|0
867361|NCT00509769|1827737|FG000|Overall Study|Progressive disease|77
867362|NCT00509769|1827737|FG000|Overall Study|Adverse Event|4
867363|NCT00509769|1827737|FG000|Overall Study|Patient's decision|1
867364|NCT00509769|1827737|FG000|Overall Study|Physician Decision|8
867365|NCT00509769|1827737|FG000|Overall Study|Use of prohibited therapies during study|1
867366|NCT00509795|1827745|FG000|Overall Study|Adverse Event|4
867367|NCT00509795|1827746|FG001|Overall Study|Adverse Event|3
867368|NCT00509795|1827747|FG002|Overall Study|Adverse Event|5
867369|NCT00509795|1827748|FG003|Overall Study|Adverse Event|4
867370|NCT00509795|1827745|FG000|Overall Study|Death|3
867371|NCT00509795|1827746|FG001|Overall Study|Death|1
867372|NCT00509795|1827747|FG002|Overall Study|Death|2
867373|NCT00509795|1827748|FG003|Overall Study|Death|7
867374|NCT00509795|1827745|FG000|Overall Study|Lack of Efficacy|0
867375|NCT00509795|1827746|FG001|Overall Study|Lack of Efficacy|0
867376|NCT00509795|1827747|FG002|Overall Study|Lack of Efficacy|2
867377|NCT00509795|1827748|FG003|Overall Study|Lack of Efficacy|2
867378|NCT00509795|1827745|FG000|Overall Study|Lost to Follow-up|1
867379|NCT00509795|1827746|FG001|Overall Study|Lost to Follow-up|2
867380|NCT00509795|1827747|FG002|Overall Study|Lost to Follow-up|4
867381|NCT00509795|1827748|FG003|Overall Study|Lost to Follow-up|4
867382|NCT00509795|1827745|FG000|Overall Study|OTHER|1
867383|NCT00509795|1827746|FG001|Overall Study|OTHER|0
867384|NCT00509795|1827747|FG002|Overall Study|OTHER|4
867385|NCT00509795|1827748|FG003|Overall Study|OTHER|1
867386|NCT00509795|1827745|FG000|Overall Study|Protocol Violation|3
867387|NCT00509795|1827746|FG001|Overall Study|Protocol Violation|0
867388|NCT00509795|1827747|FG002|Overall Study|Protocol Violation|3
867389|NCT00509795|1827748|FG003|Overall Study|Protocol Violation|1
867390|NCT00509795|1827745|FG000|Overall Study|Withdrawal by Subject|10
867391|NCT00509795|1827746|FG001|Overall Study|Withdrawal by Subject|5
867392|NCT00509795|1827747|FG002|Overall Study|Withdrawal by Subject|7
867393|NCT00509795|1827748|FG003|Overall Study|Withdrawal by Subject|8
867394|NCT00509821|1827761|FG000|Study Period 1 (Induction)|Death|0
867395|NCT00509821|1827762|FG001|Study Period 1 (Induction)|Death|1
867396|NCT00509821|1827761|FG000|Study Period 1 (Induction)|Adverse Event|0
867397|NCT00509821|1827762|FG001|Study Period 1 (Induction)|Adverse Event|2
867398|NCT00509821|1827761|FG000|Study Period 1 (Induction)|Progressive Disease|0
867399|NCT00509821|1827762|FG001|Study Period 1 (Induction)|Progressive Disease|1
867400|NCT00509899|1827790|FG000|Overall Study|Progressive disease|1
867401|NCT00509899|1827791|FG001|Overall Study|Progressive disease|3
867402|NCT00509899|1827792|FG002|Overall Study|Progressive disease|5
867403|NCT00509899|1827793|FG003|Overall Study|Progressive disease|1
867404|NCT00509899|1827794|FG004|Overall Study|Progressive disease|0
867405|NCT00509899|1827795|FG005|Overall Study|Progressive disease|1
867406|NCT00509899|1827796|FG006|Overall Study|Progressive disease|0
867407|NCT00509899|1827797|FG007|Overall Study|Progressive disease|0
867408|NCT00509899|1827790|FG000|Overall Study|Unacceptable Toxicity|1
867409|NCT00509899|1827791|FG001|Overall Study|Unacceptable Toxicity|0
867410|NCT00509899|1827792|FG002|Overall Study|Unacceptable Toxicity|0
867411|NCT00509899|1827793|FG003|Overall Study|Unacceptable Toxicity|2
867412|NCT00509899|1827794|FG004|Overall Study|Unacceptable Toxicity|0
867413|NCT00509899|1827795|FG005|Overall Study|Unacceptable Toxicity|0
867414|NCT00509899|1827796|FG006|Overall Study|Unacceptable Toxicity|0
867415|NCT00509899|1827797|FG007|Overall Study|Unacceptable Toxicity|0
867416|NCT00509899|1827790|FG000|Overall Study|Withdrawal by Subject|6
867417|NCT00509899|1827791|FG001|Overall Study|Withdrawal by Subject|2
867418|NCT00509899|1827792|FG002|Overall Study|Withdrawal by Subject|3
867419|NCT00509899|1827793|FG003|Overall Study|Withdrawal by Subject|0
867420|NCT00509899|1827794|FG004|Overall Study|Withdrawal by Subject|3
867421|NCT00509899|1827795|FG005|Overall Study|Withdrawal by Subject|2
867422|NCT00509899|1827796|FG006|Overall Study|Withdrawal by Subject|0
867423|NCT00509899|1827797|FG007|Overall Study|Withdrawal by Subject|0
867424|NCT00509899|1827790|FG000|Overall Study|Physician Decision|4
867425|NCT00509899|1827791|FG001|Overall Study|Physician Decision|2
867426|NCT00509899|1827792|FG002|Overall Study|Physician Decision|7
867427|NCT00509899|1827793|FG003|Overall Study|Physician Decision|0
867428|NCT00509899|1827794|FG004|Overall Study|Physician Decision|1
867429|NCT00509899|1827795|FG005|Overall Study|Physician Decision|4
867430|NCT00509899|1827796|FG006|Overall Study|Physician Decision|0
867431|NCT00509899|1827797|FG007|Overall Study|Physician Decision|0
867432|NCT00509899|1827790|FG000|Overall Study|Intercurrent Illness|1
867433|NCT00509899|1827791|FG001|Overall Study|Intercurrent Illness|0
867434|NCT00509899|1827792|FG002|Overall Study|Intercurrent Illness|0
867435|NCT00509899|1827793|FG003|Overall Study|Intercurrent Illness|1
867436|NCT00509899|1827794|FG004|Overall Study|Intercurrent Illness|0
867437|NCT00509899|1827795|FG005|Overall Study|Intercurrent Illness|1
867438|NCT00509899|1827796|FG006|Overall Study|Intercurrent Illness|0
867439|NCT00509899|1827797|FG007|Overall Study|Intercurrent Illness|0
867440|NCT00509899|1827790|FG000|Overall Study|Death|2
867441|NCT00509899|1827791|FG001|Overall Study|Death|2
867442|NCT00509899|1827792|FG002|Overall Study|Death|3
867443|NCT00509899|1827793|FG003|Overall Study|Death|0
867444|NCT00509899|1827794|FG004|Overall Study|Death|1
867445|NCT00509899|1827795|FG005|Overall Study|Death|1
867446|NCT00509899|1827796|FG006|Overall Study|Death|1
867447|NCT00509899|1827797|FG007|Overall Study|Death|1
867448|NCT00509899|1827790|FG000|Overall Study|Lack of Efficacy|1
867449|NCT00509899|1827791|FG001|Overall Study|Lack of Efficacy|0
867450|NCT00509899|1827792|FG002|Overall Study|Lack of Efficacy|2
867451|NCT00509899|1827793|FG003|Overall Study|Lack of Efficacy|0
867452|NCT00509899|1827794|FG004|Overall Study|Lack of Efficacy|0
867453|NCT00509899|1827795|FG005|Overall Study|Lack of Efficacy|1
867454|NCT00509899|1827796|FG006|Overall Study|Lack of Efficacy|0
867455|NCT00509899|1827797|FG007|Overall Study|Lack of Efficacy|0
867456|NCT00509925|1827811|FG000|Overall Study|Personal reasons|0
867457|NCT00509925|1827812|FG001|Overall Study|Personal reasons|1
867458|NCT00510068|1827822|FG000|Double-blind Period|Disease progression|98
867459|NCT00510068|1827823|FG001|Double-blind Period|Disease progression|169
867460|NCT00510068|1827822|FG000|Double-blind Period|Final primary analysis|52
867461|NCT00510068|1827823|FG001|Double-blind Period|Final primary analysis|18
867462|NCT00510068|1827822|FG000|Double-blind Period|Adverse Event|37
867463|NCT00510068|1827823|FG001|Double-blind Period|Adverse Event|7
867464|NCT00510068|1827822|FG000|Double-blind Period|Withdrawal by Subject|8
867465|NCT00510068|1827823|FG001|Double-blind Period|Withdrawal by Subject|6
867466|NCT00510068|1827822|FG000|Double-blind Period|Death|4
867467|NCT00510068|1827823|FG001|Double-blind Period|Death|3
867468|NCT00510068|1827822|FG000|Double-blind Period|Abnormal test result (s)|1
867469|NCT00510068|1827823|FG001|Double-blind Period|Abnormal test result (s)|0
867470|NCT00510068|1827822|FG000|Double-blind Period|Lost to Follow-up|1
867471|NCT00510068|1827823|FG001|Double-blind Period|Lost to Follow-up|0
867472|NCT00510068|1827822|FG000|Double-blind Period|Protocol Violation|6
867473|NCT00510068|1827823|FG001|Double-blind Period|Protocol Violation|0
867474|NCT00510068|1827822|FG000|Open-label Period|Disease Progression|124
867475|NCT00510068|1827823|FG001|Open-label Period|Disease Progression|0
867476|NCT00510068|1827822|FG000|Open-label Period|Adverse Event|46
867477|NCT00510068|1827823|FG001|Open-label Period|Adverse Event|0
867478|NCT00510068|1827822|FG000|Open-label Period|Withdrawal by Subject|21
867479|NCT00510068|1827823|FG001|Open-label Period|Withdrawal by Subject|0
867480|NCT00510068|1827822|FG000|Open-label Period|Administrative problems|17
867481|NCT00510068|1827823|FG001|Open-label Period|Administrative problems|0
867482|NCT00510068|1827822|FG000|Open-label Period|Death|7
867483|NCT00510068|1827823|FG001|Open-label Period|Death|0
867484|NCT00510068|1827822|FG000|Open-label Period|New cancer therapy|7
867485|NCT00510068|1827823|FG001|Open-label Period|New cancer therapy|0
867486|NCT00510068|1827822|FG000|Open-label Period|Protocol Violation|2
867487|NCT00510068|1827823|FG001|Open-label Period|Protocol Violation|0
867488|NCT00510068|1827822|FG000|Open-label Period|Abnormal laboratory value (s)|1
867489|NCT00510068|1827823|FG001|Open-label Period|Abnormal laboratory value (s)|0
867490|NCT00510146|1827833|FG000|Double-Blind Treatment|Adverse Event|30
867491|NCT00510146|1827834|FG001|Double-Blind Treatment|Adverse Event|13
867492|NCT00510146|1827833|FG000|Double-Blind Treatment|Lack of Efficacy|6
867493|NCT00510146|1827834|FG001|Double-Blind Treatment|Lack of Efficacy|13
867494|NCT00510146|1827833|FG000|Double-Blind Treatment|Lost to Follow-up|3
867495|NCT00510146|1827834|FG001|Double-Blind Treatment|Lost to Follow-up|7
867496|NCT00510146|1827833|FG000|Double-Blind Treatment|Physician Decision|6
867497|NCT00510146|1827834|FG001|Double-Blind Treatment|Physician Decision|0
867498|NCT00510146|1827833|FG000|Double-Blind Treatment|Protocol Violation|1
867499|NCT00510146|1827834|FG001|Double-Blind Treatment|Protocol Violation|2
867500|NCT00510146|1827833|FG000|Double-Blind Treatment|Withdrawal by Subject|27
867501|NCT00510146|1827834|FG001|Double-Blind Treatment|Withdrawal by Subject|13
867502|NCT00510146|1827833|FG000|Double-Blind Treatment|Clinical Relapse|0
867503|NCT00510146|1827834|FG001|Double-Blind Treatment|Clinical Relapse|1
867504|NCT00510146|1827833|FG000|Double-Blind Treatment|Entry Criteria Not Met|3
867505|NCT00510146|1827834|FG001|Double-Blind Treatment|Entry Criteria Not Met|0
867506|NCT00510146|1827833|FG000|Open-Label Treatment|Adverse Event|22
867507|NCT00510146|1827834|FG001|Open-Label Treatment|Adverse Event|8
867508|NCT00510146|1827833|FG000|Open-Label Treatment|Death|1
867509|NCT00510146|1827834|FG001|Open-Label Treatment|Death|1
867510|NCT00510146|1827833|FG000|Open-Label Treatment|Lack of Efficacy|4
867511|NCT00510146|1827834|FG001|Open-Label Treatment|Lack of Efficacy|0
867512|NCT00510146|1827833|FG000|Open-Label Treatment|Lost to Follow-up|10
867513|NCT00510146|1827834|FG001|Open-Label Treatment|Lost to Follow-up|1
867514|NCT00510146|1827833|FG000|Open-Label Treatment|Physician Decision|3
867515|NCT00510146|1827834|FG001|Open-Label Treatment|Physician Decision|1
867516|NCT00510146|1827833|FG000|Open-Label Treatment|Protocol Violation|4
867517|NCT00510146|1827834|FG001|Open-Label Treatment|Protocol Violation|2
867518|NCT00510146|1827833|FG000|Open-Label Treatment|Withdrawal by Subject|24
867519|NCT00510146|1827834|FG001|Open-Label Treatment|Withdrawal by Subject|12
867520|NCT00510146|1827833|FG000|Open-Label Treatment|Clinical Relapse|1
867521|NCT00510146|1827834|FG001|Open-Label Treatment|Clinical Relapse|1
867522|NCT00510146|1827833|FG000|Open-Label Treatment|Sponsor Decision|2
867523|NCT00510146|1827834|FG001|Open-Label Treatment|Sponsor Decision|0
867524|NCT00510198|1827844|FG000|Overall Study|Withdrawal by Subject|5
867525|NCT00510198|1827845|FG001|Overall Study|Withdrawal by Subject|4
867526|NCT00510276|1827859|FG000|Acute Double-Blind Phase|Adverse Event|21
867527|NCT00510276|1827860|FG001|Acute Double-Blind Phase|Adverse Event|6
867528|NCT00510276|1827859|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1
867529|NCT00510276|1827860|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1
867530|NCT00510276|1827859|FG000|Acute Double-Blind Phase|Lack of Efficacy|3
867531|NCT00510276|1827860|FG001|Acute Double-Blind Phase|Lack of Efficacy|4
867532|NCT00510276|1827859|FG000|Acute Double-Blind Phase|Lost to Follow-up|48
867533|NCT00510276|1827860|FG001|Acute Double-Blind Phase|Lost to Follow-up|49
867534|NCT00510276|1827859|FG000|Acute Double-Blind Phase|Physician Decision|0
867535|NCT00510276|1827860|FG001|Acute Double-Blind Phase|Physician Decision|3
867536|NCT00510276|1827859|FG000|Acute Double-Blind Phase|Protocol Violation|4
867537|NCT00510276|1827860|FG001|Acute Double-Blind Phase|Protocol Violation|3
867538|NCT00510276|1827859|FG000|Acute Double-Blind Phase|Sponsor Decision|2
867539|NCT00510276|1827860|FG001|Acute Double-Blind Phase|Sponsor Decision|1
867540|NCT00510276|1827859|FG000|Acute Double-Blind Phase|Subject Decision|26
867541|NCT00510276|1827860|FG001|Acute Double-Blind Phase|Subject Decision|28
867542|NCT00510276|1827859|FG000|Extension Open-Label Phase|Adverse Event|9
867543|NCT00510276|1827860|FG001|Extension Open-Label Phase|Adverse Event|18
867544|NCT00510276|1827859|FG000|Extension Open-Label Phase|Lack of Efficacy|2
867545|NCT00510276|1827860|FG001|Extension Open-Label Phase|Lack of Efficacy|7
867546|NCT00510276|1827859|FG000|Extension Open-Label Phase|Lost to Follow-up|12
867547|NCT00510276|1827860|FG001|Extension Open-Label Phase|Lost to Follow-up|10
867548|NCT00510276|1827859|FG000|Extension Open-Label Phase|Physician Decision|2
867549|NCT00510276|1827860|FG001|Extension Open-Label Phase|Physician Decision|3
867550|NCT00510276|1827859|FG000|Extension Open-Label Phase|Protocol Violation|0
867551|NCT00510276|1827860|FG001|Extension Open-Label Phase|Protocol Violation|1
867552|NCT00510276|1827859|FG000|Extension Open-Label Phase|Sponsor Decision|1
867553|NCT00510276|1827860|FG001|Extension Open-Label Phase|Sponsor Decision|0
867554|NCT00510276|1827859|FG000|Extension Open-Label Phase|Subject Decision|7
867555|NCT00510276|1827860|FG001|Extension Open-Label Phase|Subject Decision|9
867556|NCT00510289|1827873|FG000|Overall Study|Withdrawal by Subject|7
867557|NCT00510289|1827873|FG000|Overall Study|Refused bone marrow biopsy|2
867558|NCT00510289|1827873|FG000|Overall Study|Lost to Follow-up|1
867559|NCT00510289|1827873|FG000|Overall Study|Progressed prior to starting drug|2
867560|NCT00510458|1827878|FG000|Overall Study|5 year not evaluable/missed|21
867561|NCT00510458|1827878|FG000|Overall Study|Death|1
867562|NCT00510458|1827878|FG000|Overall Study|Terminated|14
867563|NCT00510458|1827878|FG000|Overall Study|Lost to Follow-up|6
867564|NCT00510458|1827878|FG000|Overall Study|Withdrawal by Subject|3
867565|NCT00510458|1827878|FG000|Overall Study|Revision|2
867566|NCT00510484|1827885|FG000|Wash-out Period|Adverse Event|0
867567|NCT00510484|1827886|FG001|Wash-out Period|Adverse Event|1
867568|NCT00510510|1827899|FG000|Overall Study|Adverse Event|4
867569|NCT00510510|1827900|FG001|Overall Study|Adverse Event|3
867570|NCT00510510|1827901|FG002|Overall Study|Adverse Event|6
867571|NCT00510510|1827899|FG000|Overall Study|Lack of Efficacy|0
867572|NCT00510510|1827900|FG001|Overall Study|Lack of Efficacy|1
867573|NCT00510510|1827901|FG002|Overall Study|Lack of Efficacy|1
867574|NCT00510510|1827899|FG000|Overall Study|Subjects no longer requires study drug|0
867575|NCT00510510|1827900|FG001|Overall Study|Subjects no longer requires study drug|0
867576|NCT00510510|1827901|FG002|Overall Study|Subjects no longer requires study drug|2
867577|NCT00510510|1827899|FG000|Overall Study|Withdrawal by Subject|1
867578|NCT00510510|1827900|FG001|Overall Study|Withdrawal by Subject|2
867579|NCT00510510|1827901|FG002|Overall Study|Withdrawal by Subject|3
867580|NCT00510510|1827899|FG000|Overall Study|Lost to Follow-up|0
867581|NCT00510510|1827900|FG001|Overall Study|Lost to Follow-up|0
867582|NCT00510510|1827901|FG002|Overall Study|Lost to Follow-up|1
867583|NCT00510510|1827899|FG000|Overall Study|Protocol Violation|0
867584|NCT00510510|1827900|FG001|Overall Study|Protocol Violation|3
867585|NCT00510510|1827901|FG002|Overall Study|Protocol Violation|4
867586|NCT00510653|1827909|FG000|Overall Study|Withdrawal by Subject|8
867587|NCT00510653|1827909|FG000|Overall Study|Monetary|3
867588|NCT00510692|1827915|FG000|Overall Study|Adverse Event|1
867589|NCT00510692|1827916|FG001|Overall Study|Adverse Event|3
867590|NCT00510692|1827915|FG000|Overall Study|Withdrawal by Subject|1
867591|NCT00510692|1827916|FG001|Overall Study|Withdrawal by Subject|0
867592|NCT00510718|1827931|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1
867593|NCT00510718|1827932|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8
867594|NCT00510718|1827931|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
867595|NCT00510718|1827932|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
867596|NCT00510718|1827931|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
867597|NCT00510718|1827932|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
867598|NCT00510718|1827931|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
867599|NCT00510718|1827932|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
867600|NCT00510718|1827931|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
867601|NCT00510718|1827932|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
867602|NCT00510718|1827931|FG000|Multiple Dose Period: 12 Weeks|Other|1
867603|NCT00510718|1827932|FG001|Multiple Dose Period: 12 Weeks|Other|1
867604|NCT00510783|1827957|FG000|Overall Study|Lost to Follow-up|29
867605|NCT00510783|1827958|FG001|Overall Study|Lost to Follow-up|25
867606|NCT00510783|1827957|FG000|Overall Study|Withdrawal by Subject|2
867607|NCT00510783|1827958|FG001|Overall Study|Withdrawal by Subject|3
867608|NCT00510783|1827957|FG000|Overall Study|Protocol Violation|0
867609|NCT00510783|1827958|FG001|Overall Study|Protocol Violation|1
867610|NCT00510835|1827980|FG000|Overall Study|Withdrawal by Subject|6
867611|NCT00510835|1827981|FG001|Overall Study|Withdrawal by Subject|2
867612|NCT00510835|1827982|FG002|Overall Study|Withdrawal by Subject|2
867613|NCT00510874|1827997|FG000|Overall Study|Withdrawal by Subject|1
867614|NCT00510874|1827998|FG001|Overall Study|Withdrawal by Subject|1
867615|NCT00510874|1827999|FG002|Overall Study|Withdrawal by Subject|0
867616|NCT00510874|1828000|FG003|Overall Study|Withdrawal by Subject|0
867617|NCT00510874|1828001|FG004|Overall Study|Withdrawal by Subject|3
867618|NCT00510874|1828002|FG005|Overall Study|Withdrawal by Subject|0
867619|NCT00510874|1828003|FG006|Overall Study|Withdrawal by Subject|0
867620|NCT00510874|1827997|FG000|Overall Study|Lost to Follow-up|2
867621|NCT00510874|1827998|FG001|Overall Study|Lost to Follow-up|3
867622|NCT00510874|1827999|FG002|Overall Study|Lost to Follow-up|1
867623|NCT00510874|1828000|FG003|Overall Study|Lost to Follow-up|3
867624|NCT00510874|1828001|FG004|Overall Study|Lost to Follow-up|4
867625|NCT00510874|1828002|FG005|Overall Study|Lost to Follow-up|0
867626|NCT00510874|1828003|FG006|Overall Study|Lost to Follow-up|1
867627|NCT00510887|1828020|FG000|Overall Study|Lost to Follow-up|1
867628|NCT00510952|1828026|FG000|Overall Study|Adverse Event|1
867629|NCT00510952|1828027|FG001|Overall Study|Adverse Event|0
867630|NCT00510952|1828026|FG000|Overall Study|Entry Criteria Not Met|3
867631|NCT00510952|1828027|FG001|Overall Study|Entry Criteria Not Met|1
867632|NCT00510952|1828026|FG000|Overall Study|Lost to Follow-up|5
867633|NCT00510952|1828027|FG001|Overall Study|Lost to Follow-up|3
867634|NCT00510952|1828026|FG000|Overall Study|Physician Decision|1
867635|NCT00510952|1828027|FG001|Overall Study|Physician Decision|1
867636|NCT00510952|1828026|FG000|Overall Study|Protocol Violation|7
867637|NCT00510952|1828027|FG001|Overall Study|Protocol Violation|4
867638|NCT00510952|1828026|FG000|Overall Study|Sponsor Decision|1
867639|NCT00510952|1828027|FG001|Overall Study|Sponsor Decision|0
867640|NCT00510952|1828026|FG000|Overall Study|Withdrawal by Subject|6
867641|NCT00510952|1828027|FG001|Overall Study|Withdrawal by Subject|7
867642|NCT00510952|1828026|FG000|Overall Study|Did Not Receive Study Drug|2
867643|NCT00510952|1828027|FG001|Overall Study|Did Not Receive Study Drug|0
867644|NCT00511004|1828036|FG000|Overall Study|Lost to Follow-up|0
867645|NCT00511004|1828037|FG001|Overall Study|Lost to Follow-up|0
867646|NCT00511004|1828038|FG002|Overall Study|Lost to Follow-up|4
867647|NCT00511108|1828063|FG000|Overall Study|Adverse Event|2
867648|NCT00511108|1828064|FG001|Overall Study|Adverse Event|0
867649|NCT00511108|1828065|FG002|Overall Study|Adverse Event|1
867650|NCT00511108|1828066|FG003|Overall Study|Adverse Event|2
867651|NCT00511108|1828063|FG000|Overall Study|Lost to Follow-up|0
867652|NCT00511108|1828064|FG001|Overall Study|Lost to Follow-up|2
867653|NCT00511108|1828065|FG002|Overall Study|Lost to Follow-up|1
867654|NCT00511108|1828066|FG003|Overall Study|Lost to Follow-up|0
867655|NCT00511108|1828063|FG000|Overall Study|Physician Decision|0
867656|NCT00511108|1828064|FG001|Overall Study|Physician Decision|0
867657|NCT00511108|1828065|FG002|Overall Study|Physician Decision|0
867658|NCT00511108|1828066|FG003|Overall Study|Physician Decision|1
867659|NCT00511108|1828063|FG000|Overall Study|Withdrawal by Subject|4
867660|NCT00511108|1828064|FG001|Overall Study|Withdrawal by Subject|0
867661|NCT00511108|1828065|FG002|Overall Study|Withdrawal by Subject|3
867662|NCT00511108|1828066|FG003|Overall Study|Withdrawal by Subject|2
867663|NCT00511134|1828078|FG000|Overall Study|Withdrawal by Subject|0
867664|NCT00511134|1828079|FG001|Overall Study|Withdrawal by Subject|2
867665|NCT00511147|1828085|FG000|Overall Study|Withdrawal by Subject|1
867666|NCT00511147|1828085|FG000|Overall Study|Disease progression|5
867667|NCT00511147|1828085|FG000|Overall Study|Required platelet transfusion|1
867668|NCT00511199|1828096|FG000|Overall Study|Unacceptable Vaginal Bleeding|63
867669|NCT00511199|1828097|FG001|Overall Study|Unacceptable Vaginal Bleeding|4
867670|NCT00511199|1828096|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227
867671|NCT00511199|1828097|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52
867672|NCT00511199|1828096|FG000|Overall Study|Withdrawal of Informed Consent|19
867673|NCT00511199|1828097|FG001|Overall Study|Withdrawal of Informed Consent|4
867674|NCT00511199|1828096|FG000|Overall Study|Pregnancy|6
867675|NCT00511199|1828097|FG001|Overall Study|Pregnancy|3
867676|NCT00511199|1828096|FG000|Overall Study|Pregnancy Wish|16
867677|NCT00511199|1828097|FG001|Overall Study|Pregnancy Wish|8
867678|NCT00511199|1828096|FG000|Overall Study|Lost to Follow-up|40
867679|NCT00511199|1828097|FG001|Overall Study|Lost to Follow-up|17
867680|NCT00511199|1828096|FG000|Overall Study|Other Reason|78
867681|NCT00511199|1828097|FG001|Overall Study|Other Reason|37
867682|NCT00511238|1828107|FG000|Overall Study|Adverse Event|13
867683|NCT00511238|1828108|FG001|Overall Study|Adverse Event|33
867684|NCT00511238|1828107|FG000|Overall Study|Withdrawal by Subject|2
867685|NCT00511238|1828108|FG001|Overall Study|Withdrawal by Subject|22
867686|NCT00511238|1828107|FG000|Overall Study|Progressive Disease|23
867687|NCT00511238|1828108|FG001|Overall Study|Progressive Disease|157
867688|NCT00511238|1828107|FG000|Overall Study|various reasons|4
867689|NCT00511238|1828108|FG001|Overall Study|various reasons|14
867690|NCT00511342|1828126|FG000|Overall Study|Unacceptable vaginal bleeding|2
867691|NCT00511342|1828127|FG001|Overall Study|Unacceptable vaginal bleeding|1
867692|NCT00511342|1828126|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8
867693|NCT00511342|1828127|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12
867694|NCT00511342|1828126|FG000|Overall Study|Pregnancy|0
867695|NCT00511342|1828127|FG001|Overall Study|Pregnancy|1
867696|NCT00511342|1828126|FG000|Overall Study|Pregnancy wish|0
867697|NCT00511342|1828127|FG001|Overall Study|Pregnancy wish|1
867698|NCT00511342|1828126|FG000|Overall Study|Lost to Follow-up|1
867699|NCT00511342|1828127|FG001|Overall Study|Lost to Follow-up|5
867700|NCT00511342|1828126|FG000|Overall Study|Other Reason|2
867701|NCT00511342|1828127|FG001|Overall Study|Other Reason|2
867702|NCT00511355|1828135|FG000|Overall Study|Adverse Event|4
867703|NCT00511355|1828136|FG001|Overall Study|Adverse Event|4
867704|NCT00511355|1828135|FG000|Overall Study|Pregnancy Wish|1
867705|NCT00511355|1828136|FG001|Overall Study|Pregnancy Wish|0
867706|NCT00511355|1828135|FG000|Overall Study|Lost to Follow-up|2
867707|NCT00511355|1828136|FG001|Overall Study|Lost to Follow-up|1
867708|NCT00511355|1828135|FG000|Overall Study|Other Reason|0
867709|NCT00511355|1828136|FG001|Overall Study|Other Reason|1
867710|NCT00511355|1828135|FG000|Overall Study|Pre-treatment (serious) adverse event|0
867711|NCT00511355|1828136|FG001|Overall Study|Pre-treatment (serious) adverse event|1
867712|NCT00511355|1828135|FG000|Overall Study|Withdrawal of informed consent|0
867713|NCT00511355|1828136|FG001|Overall Study|Withdrawal of informed consent|1
867714|NCT00511355|1828135|FG000|Overall Study|Other reason pre-treatment|0
867715|NCT00511355|1828136|FG001|Overall Study|Other reason pre-treatment|1
867716|NCT00511433|1828146|FG000|Overall Study|Adverse Event|5
867717|NCT00511433|1828147|FG001|Overall Study|Adverse Event|0
867718|NCT00511433|1828146|FG000|Overall Study|Other Reason|1
867719|NCT00511433|1828147|FG001|Overall Study|Other Reason|1
867720|NCT00511472|1828157|FG000|Overall Study|Clinical Adverse Event|1
867721|NCT00511472|1828158|FG001|Overall Study|Clinical Adverse Event|2
867722|NCT00511472|1828157|FG000|Overall Study|Laboratory Adverse Event|0
867723|NCT00511472|1828158|FG001|Overall Study|Laboratory Adverse Event|2
867724|NCT00511472|1828157|FG000|Overall Study|Not reported|2
867725|NCT00511472|1828158|FG001|Overall Study|Not reported|2
867726|NCT00511667|1828175|FG000|Overall Study|Adverse Event|1
867727|NCT00511667|1828176|FG001|Overall Study|Adverse Event|0
867728|NCT00511667|1828175|FG000|Overall Study|Protocol Violation|1
867729|NCT00511667|1828176|FG001|Overall Study|Protocol Violation|1
867730|NCT00511667|1828175|FG000|Overall Study|Withdrawal by Subject|2
867731|NCT00511667|1828176|FG001|Overall Study|Withdrawal by Subject|0
867732|NCT00511667|1828175|FG000|Overall Study|Site terminated|6
867733|NCT00511667|1828176|FG001|Overall Study|Site terminated|1
867734|NCT00511667|1828175|FG000|Overall Study|Other|2
867735|NCT00511667|1828176|FG001|Overall Study|Other|1
867736|NCT00511797|1828201|FG000|Overall Study|Adverse Event|1
867737|NCT00511797|1828202|FG001|Overall Study|Adverse Event|2
867738|NCT00511797|1828203|FG002|Overall Study|Adverse Event|2
867739|NCT00511797|1828204|FG003|Overall Study|Adverse Event|2
867740|NCT00511797|1828201|FG000|Overall Study|Lost to Follow-up|1
867741|NCT00511797|1828202|FG001|Overall Study|Lost to Follow-up|0
867742|NCT00511797|1828203|FG002|Overall Study|Lost to Follow-up|0
867743|NCT00511797|1828204|FG003|Overall Study|Lost to Follow-up|1
867744|NCT00511797|1828201|FG000|Overall Study|Pregnancy|0
867745|NCT00511797|1828202|FG001|Overall Study|Pregnancy|0
867746|NCT00511797|1828203|FG002|Overall Study|Pregnancy|0
867747|NCT00511797|1828204|FG003|Overall Study|Pregnancy|1
867748|NCT00511797|1828201|FG000|Overall Study|Protocol Violation|0
867749|NCT00511797|1828202|FG001|Overall Study|Protocol Violation|2
867750|NCT00511797|1828203|FG002|Overall Study|Protocol Violation|2
867751|NCT00511797|1828204|FG003|Overall Study|Protocol Violation|3
867752|NCT00511797|1828201|FG000|Overall Study|Withdrawal by Subject|3
867753|NCT00511797|1828202|FG001|Overall Study|Withdrawal by Subject|3
867754|NCT00511797|1828203|FG002|Overall Study|Withdrawal by Subject|4
867755|NCT00511797|1828204|FG003|Overall Study|Withdrawal by Subject|2
867756|NCT00511797|1828201|FG000|Overall Study|Never dispensed|1
867757|NCT00511797|1828202|FG001|Overall Study|Never dispensed|0
867758|NCT00511797|1828203|FG002|Overall Study|Never dispensed|1
867759|NCT00511797|1828204|FG003|Overall Study|Never dispensed|3
867760|NCT00511797|1828201|FG000|Overall Study|Study drug not taken|0
867761|NCT00511797|1828202|FG001|Overall Study|Study drug not taken|1
867762|NCT00511797|1828203|FG002|Overall Study|Study drug not taken|0
867763|NCT00511797|1828204|FG003|Overall Study|Study drug not taken|1
867764|NCT00511797|1828201|FG000|Overall Study|Partially missing diary|0
867765|NCT00511797|1828202|FG001|Overall Study|Partially missing diary|0
867766|NCT00511797|1828203|FG002|Overall Study|Partially missing diary|1
867767|NCT00511797|1828204|FG003|Overall Study|Partially missing diary|0
867768|NCT00511797|1828201|FG000|Overall Study|Other (moving etc)|1
867769|NCT00511797|1828202|FG001|Overall Study|Other (moving etc)|0
867770|NCT00511797|1828203|FG002|Overall Study|Other (moving etc)|1
867771|NCT00511797|1828204|FG003|Overall Study|Other (moving etc)|2
867772|NCT00511810|1828216|FG000|Overall Study|Lost to Follow-up|1
867773|NCT00511810|1828217|FG001|Overall Study|Lost to Follow-up|2
867774|NCT00511810|1828216|FG000|Overall Study|Lack of Efficacy|0
867775|NCT00511810|1828217|FG001|Overall Study|Lack of Efficacy|2
867776|NCT00511810|1828216|FG000|Overall Study|Refused second scn|0
867777|NCT00511810|1828217|FG001|Overall Study|Refused second scn|1
867778|NCT00511836|1828225|FG000|Double-blind Period|Lost to Follow-up|1
867779|NCT00511836|1828226|FG001|Double-blind Period|Lost to Follow-up|0
867780|NCT00511875|1828250|FG000|Overall Study|Lost to Follow-up|4
867781|NCT00511875|1828251|FG001|Overall Study|Lost to Follow-up|0
867782|NCT00511875|1828250|FG000|Overall Study|Missing variables|1
867783|NCT00511875|1828251|FG001|Overall Study|Missing variables|0
867784|NCT00511901|1828259|FG000|Overall Study|Withdrawal by Subject|1
867785|NCT00511901|1828260|FG001|Overall Study|Withdrawal by Subject|3
867786|NCT00512096|1828279|FG000|Overall Study|Adverse Event|2
867787|NCT00512096|1828279|FG000|Overall Study|Withdrawal by Subject|2
867788|NCT00512096|1828279|FG000|Overall Study|Lack of Efficacy|3
867789|NCT00512135|1828283|FG000|Overall Study|Not Treated|5
867790|NCT00512135|1828283|FG000|Overall Study|Lack of Efficacy|2
867791|NCT00512135|1828283|FG000|Overall Study|Adverse Event|6
867792|NCT00512135|1828283|FG000|Overall Study|Withdrawal by Subject|22
867793|NCT00512135|1828283|FG000|Overall Study|Lost to Follow-up|27
867794|NCT00512135|1828283|FG000|Overall Study|Other|22
867795|NCT00512148|1828288|FG000|Primay Study Period|Withdrawal by Subject|1
867796|NCT00512252|1828297|FG000|Overall Study|Lost to Follow-up|0
867797|NCT00512252|1828298|FG001|Overall Study|Lost to Follow-up|0
867798|NCT00512252|1828299|FG002|Overall Study|Lost to Follow-up|1
867799|NCT00512252|1828297|FG000|Overall Study|Protocol Violation|0
867800|NCT00512252|1828298|FG001|Overall Study|Protocol Violation|0
867801|NCT00512252|1828299|FG002|Overall Study|Protocol Violation|1
867802|NCT00512252|1828297|FG000|Overall Study|Death|0
867803|NCT00512252|1828298|FG001|Overall Study|Death|0
867804|NCT00512252|1828299|FG002|Overall Study|Death|1
867805|NCT00512707|1828327|FG000|Overall Study|Lost to Follow-up|5
867806|NCT00512707|1828328|FG001|Overall Study|Lost to Follow-up|11
867807|NCT00512707|1828327|FG000|Overall Study|Developed skin irritation|2
867808|NCT00512707|1828328|FG001|Overall Study|Developed skin irritation|1
867809|NCT00512707|1828327|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2
867810|NCT00512707|1828328|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0
867811|NCT00512707|1828327|FG000|Overall Study|Unable to tolerate the smell of the gel|1
867812|NCT00512707|1828328|FG001|Overall Study|Unable to tolerate the smell of the gel|0
867813|NCT00512798|1828336|FG000|Overall Study|Death|0
867814|NCT00512798|1828337|FG001|Overall Study|Death|3
867815|NCT00512798|1828336|FG000|Overall Study|Adverse Event|2
867816|NCT00512798|1828337|FG001|Overall Study|Adverse Event|4
867817|NCT00512798|1828336|FG000|Overall Study|Progression of disease|14
867818|NCT00512798|1828337|FG001|Overall Study|Progression of disease|20
867819|NCT00512798|1828336|FG000|Overall Study|Withdrawal by Subject|3
867820|NCT00512798|1828337|FG001|Overall Study|Withdrawal by Subject|0
867821|NCT00512902|1828348|FG000|Overall Study|Adverse Event|7
867822|NCT00512902|1828348|FG000|Overall Study|Lost to Follow-up|1
867823|NCT00513019|1828354|FG000|Overall Study|Adverse Event|1
867824|NCT00513019|1828355|FG001|Overall Study|Adverse Event|0
867825|NCT00513019|1828354|FG000|Overall Study|Withdrawal by Subject|4
867826|NCT00513019|1828355|FG001|Overall Study|Withdrawal by Subject|5
867827|NCT00513071|1828361|FG000|Overall Study|Adverse Event|1
867828|NCT00513071|1828361|FG000|Overall Study|Withdrawal by Subject|1
867829|NCT00513071|1828361|FG000|Overall Study|Physician Decision|3
867830|NCT00513240|1828367|FG000|Overall Study|Did not have intended surgery|3
867831|NCT00513240|1828368|FG001|Overall Study|Did not have intended surgery|0
867832|NCT00513240|1828367|FG000|Overall Study|Death|3
867833|NCT00513240|1828368|FG001|Overall Study|Death|3
867834|NCT00513240|1828367|FG000|Overall Study|Withdrawal by Subject|7
867835|NCT00513240|1828368|FG001|Overall Study|Withdrawal by Subject|4
867836|NCT00513305|1828388|FG000|Overall Study|Adverse Event|6
867837|NCT00513305|1828389|FG001|Overall Study|Adverse Event|2
867838|NCT00513305|1828388|FG000|Overall Study|Death (through Consolidation Treatment)|2
867839|NCT00513305|1828389|FG001|Overall Study|Death (through Consolidation Treatment)|2
867840|NCT00513305|1828388|FG000|Overall Study|Lack of Efficacy|8
867841|NCT00513305|1828389|FG001|Overall Study|Lack of Efficacy|13
867842|NCT00513305|1828388|FG000|Overall Study|Withdrawal by Subject|1
867843|NCT00513305|1828389|FG001|Overall Study|Withdrawal by Subject|2
867844|NCT00513305|1828388|FG000|Overall Study|Disease progression|8
867845|NCT00513305|1828389|FG001|Overall Study|Disease progression|5
867846|NCT00513305|1828388|FG000|Overall Study|Eligible for stem cell transplant|1
867847|NCT00513305|1828389|FG001|Overall Study|Eligible for stem cell transplant|0
867848|NCT00513305|1828388|FG000|Overall Study|Hematologic counts did not recover|1
867849|NCT00513305|1828389|FG001|Overall Study|Hematologic counts did not recover|0
867850|NCT00513305|1828388|FG000|Overall Study|Physician Decision|1
867851|NCT00513305|1828389|FG001|Overall Study|Physician Decision|0
867852|NCT00513305|1828388|FG000|Overall Study|Persistent hypocellularity|0
867853|NCT00513305|1828389|FG001|Overall Study|Persistent hypocellularity|1
867854|NCT00513305|1828388|FG000|Overall Study|Sponsor Decision|0
867855|NCT00513305|1828389|FG001|Overall Study|Sponsor Decision|2
867856|NCT00513357|1828405|FG000|Overall Study|did not receive allocated placebo|2
867857|NCT00513357|1828406|FG001|Overall Study|did not receive allocated placebo|3
867858|NCT00513357|1828405|FG000|Overall Study|Adverse Event|4
867859|NCT00513357|1828406|FG001|Overall Study|Adverse Event|2
867860|NCT00513357|1828405|FG000|Overall Study|Death|2
867861|NCT00513357|1828406|FG001|Overall Study|Death|0
867862|NCT00513357|1828405|FG000|Overall Study|Withdrawal by Subject|5
867863|NCT00513357|1828406|FG001|Overall Study|Withdrawal by Subject|4
867864|NCT00513357|1828405|FG000|Overall Study|Disease Progression|2
867865|NCT00513357|1828406|FG001|Overall Study|Disease Progression|1
867866|NCT00513409|1828420|FG000|Overall Study|Adverse Event|0
867867|NCT00513409|1828421|FG001|Overall Study|Adverse Event|1
867868|NCT00513409|1828420|FG000|Overall Study|Withdrawal by Subject|0
867869|NCT00513409|1828421|FG001|Overall Study|Withdrawal by Subject|2
867870|NCT00513409|1828420|FG000|Overall Study|Lost to Follow-up|0
867871|NCT00513409|1828421|FG001|Overall Study|Lost to Follow-up|1
867872|NCT00513409|1828420|FG000|Overall Study|Physician Decision|1
867873|NCT00513409|1828421|FG001|Overall Study|Physician Decision|0
867874|NCT00513409|1828420|FG000|Overall Study|Visit 3 not done|1
867875|NCT00513409|1828421|FG001|Overall Study|Visit 3 not done|2
867876|NCT00513474|1828442|FG000|Overall Study|Death|6
867877|NCT00513474|1828443|FG001|Overall Study|Death|9
867878|NCT00513474|1828442|FG000|Overall Study|Participant Withdrew Consent|1
867879|NCT00513474|1828443|FG001|Overall Study|Participant Withdrew Consent|0
867880|NCT00513500|1828451|FG000|Overall Study|Lost to Follow-up|35
867881|NCT00513500|1828452|FG001|Overall Study|Lost to Follow-up|39
867882|NCT00513500|1828451|FG000|Overall Study|Death|2
867883|NCT00513500|1828452|FG001|Overall Study|Death|1
867884|NCT00513500|1828451|FG000|Overall Study|Hospitalized|4
867885|NCT00513500|1828452|FG001|Overall Study|Hospitalized|14
867886|NCT00513604|1828469|FG000|Overall Study|Not treated|2
867887|NCT00513604|1828470|FG001|Overall Study|Not treated|0
867888|NCT00513604|1828471|FG002|Overall Study|Not treated|1
867889|NCT00513604|1828472|FG003|Overall Study|Not treated|0
867890|NCT00513604|1828473|FG004|Overall Study|Not treated|0
867891|NCT00513604|1828469|FG000|Overall Study|Death during treatment|0
867892|NCT00513604|1828470|FG001|Overall Study|Death during treatment|3
867893|NCT00513604|1828471|FG002|Overall Study|Death during treatment|2
867894|NCT00513604|1828472|FG003|Overall Study|Death during treatment|0
867895|NCT00513604|1828473|FG004|Overall Study|Death during treatment|0
867896|NCT00513682|1828495|FG000|Washout Phase|Adverse Event|2
867897|NCT00513695|1828502|FG000|Overall Study|Discontinued therapy|2
867898|NCT00513695|1828502|FG000|Overall Study|Progression prior to surgery|3
867899|NCT00513708|1828509|FG000|Overall Study|Lost to Follow-up|4
867900|NCT00513708|1828510|FG001|Overall Study|Lost to Follow-up|4
867901|NCT00513708|1828511|FG002|Overall Study|Lost to Follow-up|4
867902|NCT00514020|1828555|FG000|Overall Study|Adverse Event|6
867903|NCT00514020|1828555|FG000|Overall Study|Withdrawal by Subject|3
867904|NCT00514020|1828555|FG000|Overall Study|Physician Decision|1
867905|NCT00514020|1828555|FG000|Overall Study|disease progression|9
867906|NCT00514020|1828555|FG000|Overall Study|other complicating disease|2
867907|NCT00514020|1828555|FG000|Overall Study|patient went to radiation treatment|1
867908|NCT00514020|1828555|FG000|Overall Study|"patients moved to the no tx group"|6
867909|NCT00514046|1828568|FG000|Overall Study|transferred to another protocol|2
867910|NCT00514046|1828569|FG001|Overall Study|transferred to another protocol|1
867911|NCT00514046|1828570|FG002|Overall Study|transferred to another protocol|3
867912|NCT00514046|1828571|FG003|Overall Study|transferred to another protocol|0
867913|NCT00514046|1828572|FG004|Overall Study|transferred to another protocol|1
867914|NCT00514046|1828573|FG005|Overall Study|transferred to another protocol|0
867915|NCT00514046|1828574|FG006|Overall Study|transferred to another protocol|0
867916|NCT00514046|1828575|FG007|Overall Study|transferred to another protocol|0
867917|NCT00514046|1828576|FG008|Overall Study|transferred to another protocol|0
867918|NCT00514046|1828568|FG000|Overall Study|Getting vandetanib via the REMS program|1
867919|NCT00514046|1828569|FG001|Overall Study|Getting vandetanib via the REMS program|0
867920|NCT00514046|1828570|FG002|Overall Study|Getting vandetanib via the REMS program|0
867921|NCT00514046|1828571|FG003|Overall Study|Getting vandetanib via the REMS program|0
867922|NCT00514046|1828572|FG004|Overall Study|Getting vandetanib via the REMS program|0
867923|NCT00514046|1828573|FG005|Overall Study|Getting vandetanib via the REMS program|0
867924|NCT00514046|1828574|FG006|Overall Study|Getting vandetanib via the REMS program|0
867925|NCT00514046|1828575|FG007|Overall Study|Getting vandetanib via the REMS program|1
867926|NCT00514046|1828576|FG008|Overall Study|Getting vandetanib via the REMS program|1
867927|NCT00514046|1828568|FG000|Overall Study|Disease progression on study|0
867928|NCT00514046|1828569|FG001|Overall Study|Disease progression on study|0
867929|NCT00514046|1828570|FG002|Overall Study|Disease progression on study|2
867930|NCT00514046|1828571|FG003|Overall Study|Disease progression on study|0
867931|NCT00514046|1828572|FG004|Overall Study|Disease progression on study|0
867932|NCT00514046|1828573|FG005|Overall Study|Disease progression on study|1
867933|NCT00514046|1828574|FG006|Overall Study|Disease progression on study|0
867934|NCT00514046|1828575|FG007|Overall Study|Disease progression on study|0
867935|NCT00514046|1828576|FG008|Overall Study|Disease progression on study|0
867936|NCT00514449|1828608|FG000|Overall Study|Withdrawal by Subject|1
867937|NCT00514449|1828609|FG001|Overall Study|Withdrawal by Subject|2
867938|NCT00514449|1828608|FG000|Overall Study|Protocol Violation|1
867939|NCT00514449|1828609|FG001|Overall Study|Protocol Violation|2
867940|NCT00514449|1828608|FG000|Overall Study|Lost to Follow-up|1
867941|NCT00514449|1828609|FG001|Overall Study|Lost to Follow-up|0
867942|NCT00514514|1828625|FG000|Pre-phase|Death|10
867943|NCT00514514|1828626|FG001|Pre-phase|Death|0
867944|NCT00514514|1828627|FG002|Pre-phase|Death|0
867945|NCT00514514|1828625|FG000|Pre-phase|administrative problems|2
867946|NCT00514514|1828626|FG001|Pre-phase|administrative problems|0
867947|NCT00514514|1828627|FG002|Pre-phase|administrative problems|0
867948|NCT00514514|1828625|FG000|Pre-phase|Protocol Violation|6
867949|NCT00514514|1828626|FG001|Pre-phase|Protocol Violation|0
867950|NCT00514514|1828627|FG002|Pre-phase|Protocol Violation|0
867951|NCT00514514|1828625|FG000|Pre-phase|condition no longer requires study drug|7
867952|NCT00514514|1828626|FG001|Pre-phase|condition no longer requires study drug|0
867953|NCT00514514|1828627|FG002|Pre-phase|condition no longer requires study drug|0
867954|NCT00514514|1828625|FG000|Pre-phase|abnormal test procedure results|15
867955|NCT00514514|1828626|FG001|Pre-phase|abnormal test procedure results|0
867956|NCT00514514|1828627|FG002|Pre-phase|abnormal test procedure results|0
867957|NCT00514514|1828625|FG000|Pre-phase|Lost to Follow-up|2
867958|NCT00514514|1828626|FG001|Pre-phase|Lost to Follow-up|0
867959|NCT00514514|1828627|FG002|Pre-phase|Lost to Follow-up|0
867960|NCT00514514|1828625|FG000|Pre-phase|abnormal lab values|23
867961|NCT00514514|1828626|FG001|Pre-phase|abnormal lab values|0
867962|NCT00514514|1828627|FG002|Pre-phase|abnormal lab values|0
867963|NCT00514514|1828625|FG000|Pre-phase|Lack of Efficacy|35
867964|NCT00514514|1828626|FG001|Pre-phase|Lack of Efficacy|0
867965|NCT00514514|1828627|FG002|Pre-phase|Lack of Efficacy|0
867966|NCT00514514|1828625|FG000|Pre-phase|Adverse Event|137
867967|NCT00514514|1828626|FG001|Pre-phase|Adverse Event|0
867968|NCT00514514|1828627|FG002|Pre-phase|Adverse Event|0
867969|NCT00514514|1828625|FG000|Pre-phase|Withdrawal by Subject|66
867970|NCT00514514|1828626|FG001|Pre-phase|Withdrawal by Subject|0
867971|NCT00514514|1828627|FG002|Pre-phase|Withdrawal by Subject|0
867972|NCT00514514|1828625|FG000|Randomized - 9 Month|Death|3
867973|NCT00514514|1828626|FG001|Randomized - 9 Month|Death|2
867974|NCT00514514|1828627|FG002|Randomized - 9 Month|Death|2
867975|NCT00514514|1828625|FG000|Randomized - 9 Month|Administrative problems|1
867976|NCT00514514|1828626|FG001|Randomized - 9 Month|Administrative problems|1
867977|NCT00514514|1828627|FG002|Randomized - 9 Month|Administrative problems|2
867978|NCT00514514|1828625|FG000|Randomized - 9 Month|Withdrawal by Subject|7
867979|NCT00514514|1828626|FG001|Randomized - 9 Month|Withdrawal by Subject|7
867980|NCT00514514|1828627|FG002|Randomized - 9 Month|Withdrawal by Subject|5
867981|NCT00514514|1828625|FG000|Randomized - 9 Month|Protocol Violation|1
867982|NCT00514514|1828626|FG001|Randomized - 9 Month|Protocol Violation|1
867983|NCT00514514|1828627|FG002|Randomized - 9 Month|Protocol Violation|0
867984|NCT00514514|1828625|FG000|Randomized - 9 Month|Lack of Efficacy|2
867985|NCT00514514|1828626|FG001|Randomized - 9 Month|Lack of Efficacy|3
867986|NCT00514514|1828627|FG002|Randomized - 9 Month|Lack of Efficacy|1
867987|NCT00514514|1828625|FG000|Randomized - 9 Month|Abnormal laboratory values|0
867988|NCT00514514|1828626|FG001|Randomized - 9 Month|Abnormal laboratory values|3
867989|NCT00514514|1828627|FG002|Randomized - 9 Month|Abnormal laboratory values|1
867990|NCT00514514|1828625|FG000|Randomized - 9 Month|Adverse Event|25
867991|NCT00514514|1828626|FG001|Randomized - 9 Month|Adverse Event|44
867992|NCT00514514|1828627|FG002|Randomized - 9 Month|Adverse Event|27
867993|NCT00514514|1828625|FG000|Extension - 4 Years|Withdrawal by Subject|5
867994|NCT00514514|1828626|FG001|Extension - 4 Years|Withdrawal by Subject|2
867995|NCT00514514|1828627|FG002|Extension - 4 Years|Withdrawal by Subject|2
867996|NCT00514514|1828625|FG000|Extension - 4 Years|Lost to Follow-up|12
867997|NCT00514514|1828626|FG001|Extension - 4 Years|Lost to Follow-up|10
867998|NCT00514514|1828627|FG002|Extension - 4 Years|Lost to Follow-up|9
867999|NCT00514514|1828625|FG000|Extension - 4 Years|Administrative problems|3
868000|NCT00514514|1828626|FG001|Extension - 4 Years|Administrative problems|1
868001|NCT00514514|1828627|FG002|Extension - 4 Years|Administrative problems|1
868002|NCT00514514|1828625|FG000|Extension - 4 Years|Death|8
868003|NCT00514514|1828626|FG001|Extension - 4 Years|Death|3
868004|NCT00514514|1828627|FG002|Extension - 4 Years|Death|6
868005|NCT00514514|1828625|FG000|Extension - 4 Years|Adverse Event|9
868006|NCT00514514|1828626|FG001|Extension - 4 Years|Adverse Event|6
868007|NCT00514514|1828627|FG002|Extension - 4 Years|Adverse Event|3
868008|NCT00514540|1828635|FG000|First-Line Chemo|Withdrawal by Subject|1
868009|NCT00514540|1828635|FG000|First-Line Chemo|Protocol Violation|7
868010|NCT00514540|1828635|FG000|Second-Line|Physician/Patient Decision|31
868011|NCT00514683|1828652|FG000|Overall Study|Not treated|2
868012|NCT00514683|1828653|FG001|Overall Study|Not treated|1
868013|NCT00514683|1828654|FG002|Overall Study|Not treated|0
868014|NCT00514683|1828655|FG003|Overall Study|Not treated|0
868015|NCT00514683|1828656|FG004|Overall Study|Not treated|1
868016|NCT00514683|1828652|FG000|Overall Study|Adverse Event|21
868017|NCT00514683|1828653|FG001|Overall Study|Adverse Event|20
868018|NCT00514683|1828654|FG002|Overall Study|Adverse Event|15
868019|NCT00514683|1828655|FG003|Overall Study|Adverse Event|13
868020|NCT00514683|1828656|FG004|Overall Study|Adverse Event|27
868021|NCT00514683|1828652|FG000|Overall Study|Protocol Violation|1
868022|NCT00514683|1828653|FG001|Overall Study|Protocol Violation|1
868023|NCT00514683|1828654|FG002|Overall Study|Protocol Violation|0
868024|NCT00514683|1828655|FG003|Overall Study|Protocol Violation|1
868025|NCT00514683|1828656|FG004|Overall Study|Protocol Violation|0
868026|NCT00514683|1828652|FG000|Overall Study|Withdrawal by Subject|2
868027|NCT00514683|1828653|FG001|Overall Study|Withdrawal by Subject|2
868028|NCT00514683|1828654|FG002|Overall Study|Withdrawal by Subject|1
868029|NCT00514683|1828655|FG003|Overall Study|Withdrawal by Subject|0
868030|NCT00514683|1828656|FG004|Overall Study|Withdrawal by Subject|4
868031|NCT00514683|1828652|FG000|Overall Study|Reason other than listed above|0
868032|NCT00514683|1828653|FG001|Overall Study|Reason other than listed above|1
868033|NCT00514683|1828654|FG002|Overall Study|Reason other than listed above|2
868034|NCT00514683|1828655|FG003|Overall Study|Reason other than listed above|0
868035|NCT00514683|1828656|FG004|Overall Study|Reason other than listed above|1
868036|NCT00514735|1828685|FG000|Overall Study|Withdrawal by Subject|13
868037|NCT00514735|1828686|FG001|Overall Study|Withdrawal by Subject|5
868038|NCT00514735|1828685|FG000|Overall Study|Death|1
868039|NCT00514735|1828686|FG001|Overall Study|Death|0
868040|NCT00514735|1828685|FG000|Overall Study|Lost to Follow-up|0
868041|NCT00514735|1828686|FG001|Overall Study|Lost to Follow-up|1
868042|NCT00514904|1828705|FG000|Overall Study|Withdrawal by Subject|3
868043|NCT00514904|1828706|FG001|Overall Study|Withdrawal by Subject|2
868044|NCT00514904|1828705|FG000|Overall Study|Lost to Follow-up|21
868045|NCT00514904|1828706|FG001|Overall Study|Lost to Follow-up|3
868046|NCT00514917|1828714|FG000|Overall Study|Death|4
868047|NCT00514917|1828715|FG001|Overall Study|Death|10
868048|NCT00514917|1828714|FG000|Overall Study|Protocol Violation|1
868049|NCT00514917|1828715|FG001|Overall Study|Protocol Violation|0
868050|NCT00514917|1828714|FG000|Overall Study|Lost to Follow-up|4
868051|NCT00514917|1828715|FG001|Overall Study|Lost to Follow-up|3
868052|NCT00514917|1828714|FG000|Overall Study|Withdrawal by Subject|18
868053|NCT00514917|1828715|FG001|Overall Study|Withdrawal by Subject|16
868054|NCT00514917|1828714|FG000|Overall Study|Discontinued due to study closure|88
868055|NCT00514917|1828715|FG001|Overall Study|Discontinued due to study closure|81
868056|NCT00514917|1828714|FG000|Overall Study|Undefined|11
868057|NCT00514917|1828715|FG001|Overall Study|Undefined|5
868058|NCT00514943|1828725|FG000|Stage 1|Progressive disease|4
868059|NCT00514943|1828726|FG001|Stage 1|Progressive disease|8
868060|NCT00514943|1828725|FG000|Stage 1|Other Adverse Event|16
868061|NCT00514943|1828726|FG001|Stage 1|Other Adverse Event|6
868062|NCT00514943|1828725|FG000|Stage 1|Not treated|1
868063|NCT00514943|1828726|FG001|Stage 1|Not treated|2
868064|NCT00514943|1828725|FG000|Stage 1|Patient refused to continue study meds|8
868065|NCT00514943|1828726|FG001|Stage 1|Patient refused to continue study meds|3
868066|NCT00514943|1828725|FG000|Stage 1|Other than stated above|1
868067|NCT00514943|1828726|FG001|Stage 1|Other than stated above|7
868068|NCT00514943|1828725|FG000|Stage 2|Progressive disease|27
868069|NCT00514943|1828726|FG001|Stage 2|Progressive disease|24
868070|NCT00514943|1828725|FG000|Stage 2|Other Adverse Event|3
868071|NCT00514943|1828726|FG001|Stage 2|Other Adverse Event|10
868072|NCT00514943|1828725|FG000|Stage 2|Patient refused to continue study meds|2
868073|NCT00514943|1828726|FG001|Stage 2|Patient refused to continue study meds|0
868074|NCT00514943|1828725|FG000|Stage 2|Other than stated above|0
868075|NCT00514943|1828726|FG001|Stage 2|Other than stated above|2
868076|NCT00515008|1828749|FG000|Overall Study|Lost to Follow-up|1
868077|NCT00515008|1828750|FG001|Overall Study|Lost to Follow-up|0
868078|NCT00515008|1828749|FG000|Overall Study|Declined|0
868079|NCT00515008|1828750|FG001|Overall Study|Declined|3
868080|NCT00515008|1828749|FG000|Overall Study|Left the Boston Area|1
868081|NCT00515008|1828750|FG001|Overall Study|Left the Boston Area|1
868082|NCT00515008|1828749|FG000|Overall Study|Scheduling conflict|1
868083|NCT00515008|1828750|FG001|Overall Study|Scheduling conflict|0
868084|NCT00515034|1828774|FG000|Overall Study|Adverse Event|2
868085|NCT00515034|1828775|FG001|Overall Study|Adverse Event|0
868086|NCT00515034|1828776|FG002|Overall Study|Adverse Event|1
868087|NCT00515034|1828777|FG003|Overall Study|Adverse Event|0
868088|NCT00515034|1828774|FG000|Overall Study|Death|4
868089|NCT00515034|1828775|FG001|Overall Study|Death|2
868090|NCT00515034|1828776|FG002|Overall Study|Death|1
868091|NCT00515034|1828777|FG003|Overall Study|Death|3
868092|NCT00515034|1828774|FG000|Overall Study|Withdrawal by Subject|1
868093|NCT00515034|1828775|FG001|Overall Study|Withdrawal by Subject|0
868094|NCT00515034|1828776|FG002|Overall Study|Withdrawal by Subject|3
868095|NCT00515034|1828777|FG003|Overall Study|Withdrawal by Subject|0
868096|NCT00515034|1828774|FG000|Overall Study|Physician Decision|0
868097|NCT00515034|1828775|FG001|Overall Study|Physician Decision|0
868098|NCT00515034|1828776|FG002|Overall Study|Physician Decision|1
868099|NCT00515034|1828777|FG003|Overall Study|Physician Decision|1
868100|NCT00515034|1828774|FG000|Overall Study|Other|1
868101|NCT00515034|1828775|FG001|Overall Study|Other|0
868102|NCT00515034|1828776|FG002|Overall Study|Other|2
868103|NCT00515034|1828777|FG003|Overall Study|Other|1
868104|NCT00515073|1828787|FG000|Overall Study|Withdrawal by Subject|1
868105|NCT00515073|1828787|FG000|Overall Study|Physician Decision|1
868106|NCT00515086|1828795|FG000|Overall Study|Adverse Event|1
868107|NCT00515086|1828796|FG001|Overall Study|Adverse Event|1
868108|NCT00515086|1828797|FG002|Overall Study|Adverse Event|2
868109|NCT00515086|1828798|FG003|Overall Study|Adverse Event|3
868110|NCT00515086|1828795|FG000|Overall Study|Administrative|1
868111|NCT00515086|1828796|FG001|Overall Study|Administrative|1
868112|NCT00515086|1828797|FG002|Overall Study|Administrative|0
868113|NCT00515086|1828798|FG003|Overall Study|Administrative|0
868114|NCT00515086|1828795|FG000|Overall Study|Withdrawal by Subject|1
868115|NCT00515086|1828796|FG001|Overall Study|Withdrawal by Subject|0
868116|NCT00515086|1828797|FG002|Overall Study|Withdrawal by Subject|0
868117|NCT00515086|1828798|FG003|Overall Study|Withdrawal by Subject|1
868118|NCT00515086|1828795|FG000|Overall Study|Unsatisfactory therapeutic effect|18
868119|NCT00515086|1828796|FG001|Overall Study|Unsatisfactory therapeutic effect|3
868120|NCT00515086|1828797|FG002|Overall Study|Unsatisfactory therapeutic effect|3
868121|NCT00515086|1828798|FG003|Overall Study|Unsatisfactory therapeutic effect|2
868122|NCT00515086|1828795|FG000|Overall Study|Lost to Follow-up|1
868123|NCT00515086|1828796|FG001|Overall Study|Lost to Follow-up|0
868124|NCT00515086|1828797|FG002|Overall Study|Lost to Follow-up|0
868125|NCT00515086|1828798|FG003|Overall Study|Lost to Follow-up|0
868126|NCT00515086|1828795|FG000|Overall Study|Study drug no longer required|0
868127|NCT00515086|1828796|FG001|Overall Study|Study drug no longer required|1
868128|NCT00515086|1828797|FG002|Overall Study|Study drug no longer required|0
868129|NCT00515086|1828798|FG003|Overall Study|Study drug no longer required|0
868130|NCT00515086|1828795|FG000|Overall Study|Death|2
868131|NCT00515086|1828796|FG001|Overall Study|Death|0
868132|NCT00515086|1828797|FG002|Overall Study|Death|0
868133|NCT00515086|1828798|FG003|Overall Study|Death|0
868134|NCT00515099|1828816|FG000|Overall Study|Lost to Follow-up|0
868135|NCT00515099|1828817|FG001|Overall Study|Lost to Follow-up|4
868136|NCT00515099|1828816|FG000|Overall Study|Withdrawal by Subject|2
868137|NCT00515099|1828817|FG001|Overall Study|Withdrawal by Subject|0
868138|NCT00515099|1828816|FG000|Overall Study|IRB Recommendation|1
868139|NCT00515099|1828817|FG001|Overall Study|IRB Recommendation|0
868140|NCT00515216|1828842|FG000|Overall Study|Withdrawal by Subject|1
868141|NCT00515294|1828851|FG000|Overall Study|Lost to Follow-up|3
868142|NCT00515294|1828852|FG001|Overall Study|Lost to Follow-up|2
868143|NCT00515294|1828853|FG002|Overall Study|Lost to Follow-up|3
868144|NCT00515294|1828854|FG003|Overall Study|Lost to Follow-up|1
868145|NCT00515294|1828851|FG000|Overall Study|Driver simulator problems|1
868146|NCT00515294|1828852|FG001|Overall Study|Driver simulator problems|1
868147|NCT00515294|1828853|FG002|Overall Study|Driver simulator problems|1
868148|NCT00515294|1828854|FG003|Overall Study|Driver simulator problems|3
868149|NCT00515294|1828851|FG000|Overall Study|Caffeine amount inaccurate|5
868150|NCT00515294|1828852|FG001|Overall Study|Caffeine amount inaccurate|0
868151|NCT00515294|1828853|FG002|Overall Study|Caffeine amount inaccurate|7
868152|NCT00515294|1828854|FG003|Overall Study|Caffeine amount inaccurate|0
868153|NCT00515463|1828896|FG000|Overall Study|Physician Decision|4
868154|NCT00515463|1828897|FG001|Overall Study|Physician Decision|2
868155|NCT00515463|1828896|FG000|Overall Study|Adverse Event|1
868156|NCT00515463|1828897|FG001|Overall Study|Adverse Event|2
868157|NCT00515463|1828896|FG000|Overall Study|Withdrawal by Subject|3
868158|NCT00515463|1828897|FG001|Overall Study|Withdrawal by Subject|4
868159|NCT00515463|1828896|FG000|Overall Study|Lost to Follow-up|6
868160|NCT00515463|1828897|FG001|Overall Study|Lost to Follow-up|5
868161|NCT00515463|1828896|FG000|Overall Study|Other|0
868162|NCT00515463|1828897|FG001|Overall Study|Other|1
868163|NCT00515502|1828904|FG000|Treatment Period 1|Adverse Event|0
868164|NCT00515502|1828905|FG001|Treatment Period 1|Adverse Event|0
868165|NCT00515502|1828906|FG002|Treatment Period 1|Adverse Event|0
868166|NCT00515502|1828907|FG003|Treatment Period 1|Adverse Event|0
868167|NCT00515502|1828908|FG004|Treatment Period 1|Adverse Event|0
868168|NCT00515502|1828909|FG005|Treatment Period 1|Adverse Event|0
868169|NCT00515502|1828910|FG006|Treatment Period 1|Adverse Event|1
868170|NCT00515502|1828911|FG007|Treatment Period 1|Adverse Event|0
868171|NCT00515502|1828912|FG008|Treatment Period 1|Adverse Event|1
868172|NCT00515502|1828913|FG009|Treatment Period 1|Adverse Event|0
868173|NCT00515502|1828914|FG010|Treatment Period 1|Adverse Event|0
868174|NCT00515502|1828915|FG011|Treatment Period 1|Adverse Event|1
868175|NCT00515502|1828904|FG000|Treatment Period 2|Adverse Event|0
868176|NCT00515502|1828905|FG001|Treatment Period 2|Adverse Event|1
868177|NCT00515502|1828906|FG002|Treatment Period 2|Adverse Event|0
868178|NCT00515502|1828907|FG003|Treatment Period 2|Adverse Event|0
868179|NCT00515502|1828908|FG004|Treatment Period 2|Adverse Event|0
868180|NCT00515502|1828909|FG005|Treatment Period 2|Adverse Event|0
868181|NCT00515502|1828910|FG006|Treatment Period 2|Adverse Event|0
868182|NCT00515502|1828911|FG007|Treatment Period 2|Adverse Event|0
868183|NCT00515502|1828912|FG008|Treatment Period 2|Adverse Event|0
868184|NCT00515502|1828913|FG009|Treatment Period 2|Adverse Event|0
868185|NCT00515502|1828914|FG010|Treatment Period 2|Adverse Event|0
868186|NCT00515502|1828915|FG011|Treatment Period 2|Adverse Event|0
868187|NCT00515541|1828945|FG000|Overall Study|Physician Decision|0
868188|NCT00515541|1828946|FG001|Overall Study|Physician Decision|2
868189|NCT00515541|1828947|FG002|Overall Study|Physician Decision|0
868190|NCT00515541|1828948|FG003|Overall Study|Physician Decision|1
868191|NCT00515541|1828945|FG000|Overall Study|No show for appointments|0
868192|NCT00515541|1828946|FG001|Overall Study|No show for appointments|1
868193|NCT00515541|1828947|FG002|Overall Study|No show for appointments|0
868194|NCT00515541|1828948|FG003|Overall Study|No show for appointments|2
868195|NCT00515541|1828945|FG000|Overall Study|Withdrawal by Subject|0
868196|NCT00515541|1828946|FG001|Overall Study|Withdrawal by Subject|2
868197|NCT00515541|1828947|FG002|Overall Study|Withdrawal by Subject|0
868198|NCT00515541|1828948|FG003|Overall Study|Withdrawal by Subject|2
868199|NCT00515619|1828958|FG000|Overall Study|Adverse Event|34
868200|NCT00515619|1828958|FG000|Overall Study|Lack of Efficacy|92
868201|NCT00515619|1828958|FG000|Overall Study|Withdrawal by Subject|66
868202|NCT00515619|1828958|FG000|Overall Study|Protocol Violation|3
868203|NCT00515619|1828958|FG000|Overall Study|Lost to Follow-up|4
868204|NCT00515619|1828958|FG000|Overall Study|Unsatisfactory compliance|6
868205|NCT00515619|1828958|FG000|Overall Study|Other: Site discontinuing trials|2
868206|NCT00515619|1828958|FG000|Overall Study|Other: Subject cannot attend visits|2
868207|NCT00515619|1828958|FG000|Overall Study|Other: Subject required surgery|1
868208|NCT00515619|1828958|FG000|Overall Study|Other: Subject moved to another country|1
868209|NCT00515619|1828958|FG000|Overall Study|Other: Investigator decision|1
868210|NCT00515619|1828958|FG000|Overall Study|Other: Subject became pregnant|1
868211|NCT00515619|1828958|FG000|Overall Study|Other: Request from sponsor|1
868212|NCT00515619|1828958|FG000|Overall Study|Other: Drug available on license|1
868213|NCT00515619|1828958|FG000|Overall Study|Other: Subject interested in other AED|1
868220|NCT00515827|1828995|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
868221|NCT00515827|1828996|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
868222|NCT00515827|1828995|FG000|Second Intervention (12 Weeks)|Consent withdraw|1
868223|NCT00515827|1828996|FG001|Second Intervention (12 Weeks)|Consent withdraw|0
868224|NCT00516048|1829017|FG000|Overall Study|Death|0
868225|NCT00516048|1829018|FG001|Overall Study|Death|0
868226|NCT00516048|1829019|FG002|Overall Study|Death|1
868227|NCT00516048|1829017|FG000|Overall Study|Subject Decision|0
868228|NCT00516048|1829018|FG001|Overall Study|Subject Decision|2
868229|NCT00516048|1829019|FG002|Overall Study|Subject Decision|0
868230|NCT00516074|1829029|FG000|Overall Study|Adverse Event|0
868231|NCT00516074|1829030|FG001|Overall Study|Adverse Event|1
868232|NCT00516074|1829029|FG000|Overall Study|Subject Decision|4
868233|NCT00516074|1829030|FG001|Overall Study|Subject Decision|2
868234|NCT00516074|1829029|FG000|Overall Study|Loss of Glucose Control|2
868235|NCT00516074|1829030|FG001|Overall Study|Loss of Glucose Control|0
868236|NCT00516139|1829036|FG000|Overall Study|Adverse Event|27
868237|NCT00516139|1829036|FG000|Overall Study|Lost to Follow-up|1
868238|NCT00516139|1829036|FG000|Overall Study|Protocol Violation|1
868239|NCT00516139|1829036|FG000|Overall Study|Withdrawal by Subject|8
868240|NCT00516139|1829036|FG000|Overall Study|Lack of Efficacy|1
868241|NCT00516269|1829054|FG000|Overall Study|Adverse Event|2
868242|NCT00516269|1829055|FG001|Overall Study|Adverse Event|1
868243|NCT00516269|1829054|FG000|Overall Study|Lost to Follow-up|0
868244|NCT00516269|1829055|FG001|Overall Study|Lost to Follow-up|1
868245|NCT00516269|1829054|FG000|Overall Study|Protocol Violation|0
868246|NCT00516269|1829055|FG001|Overall Study|Protocol Violation|1
868247|NCT00516295|1829064|FG000|Overall Study|Lack of Efficacy|2
868248|NCT00516295|1829065|FG001|Overall Study|Lack of Efficacy|0
868249|NCT00516295|1829066|FG002|Overall Study|Lack of Efficacy|0
868250|NCT00516295|1829064|FG000|Overall Study|Ineligible|1
868251|NCT00516295|1829065|FG001|Overall Study|Ineligible|0
868252|NCT00516295|1829066|FG002|Overall Study|Ineligible|0
868253|NCT00516321|1829076|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
868254|NCT00516321|1829077|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
868255|NCT00516321|1829078|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
868256|NCT00516321|1829076|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
868257|NCT00516321|1829077|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
868258|NCT00516321|1829078|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
868259|NCT00516321|1829076|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
868260|NCT00516321|1829077|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
868261|NCT00516321|1829078|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
868262|NCT00516321|1829076|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
868263|NCT00516321|1829077|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
868264|NCT00516321|1829078|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
868265|NCT00516321|1829076|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
868266|NCT00516321|1829077|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
868267|NCT00516321|1829078|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
868268|NCT00516321|1829076|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
868269|NCT00516321|1829077|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
914224|NCT00813709|1891955|FG003|Open Label Period|Lack of Efficacy|3
868270|NCT00516321|1829078|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
868271|NCT00516321|1829076|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
868272|NCT00516321|1829077|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
868273|NCT00516321|1829078|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
868274|NCT00516321|1829076|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
868275|NCT00516321|1829077|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
868276|NCT00516321|1829078|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
868277|NCT00516321|1829076|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0
868278|NCT00516321|1829077|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8
868279|NCT00516321|1829078|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13
868280|NCT00516321|1829076|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
868281|NCT00516321|1829077|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
868282|NCT00516321|1829078|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
868283|NCT00516321|1829076|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0
868284|NCT00516321|1829077|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2
868285|NCT00516321|1829078|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0
868286|NCT00516386|1829086|FG000|Overall Study|not interested in the study|4
868287|NCT00516386|1829086|FG000|Overall Study|Lost to Follow-up|2
868288|NCT00516737|1829101|FG000|Overall Study|Lost to Follow-up|2
868289|NCT00516737|1829102|FG001|Overall Study|Lost to Follow-up|0
868290|NCT00516737|1829101|FG000|Overall Study|Physician Decision|0
868291|NCT00516737|1829102|FG001|Overall Study|Physician Decision|1
868292|NCT00516737|1829101|FG000|Overall Study|Withdrawal by Subject|0
868293|NCT00516737|1829102|FG001|Overall Study|Withdrawal by Subject|1
868294|NCT00516737|1829101|FG000|Overall Study|Lack of Qualifying Event|9
868295|NCT00516737|1829102|FG001|Overall Study|Lack of Qualifying Event|6
868296|NCT00516893|1829108|FG000|Overall Study|Lost to Follow-up|4
868297|NCT00516893|1829108|FG000|Overall Study|Adverse Event|3
868298|NCT00516893|1829108|FG000|Overall Study|Withdrawal by Subject|2
868299|NCT00516893|1829108|FG000|Overall Study|Noncompliance|2
868300|NCT00516893|1829108|FG000|Overall Study|Death|1
868301|NCT00516893|1829108|FG000|Overall Study|Persistent Antibodies per Protocol|6
868302|NCT00516893|1829108|FG000|Overall Study|Relocated|1
868303|NCT00516893|1829108|FG000|Overall Study|Pregnancy|1
868304|NCT00516893|1829108|FG000|Overall Study|Received Medication From Another Study|1
868305|NCT00516906|1829114|FG000|Overall Study|Final Dressing Removal Data not captured|6
868306|NCT00516906|1829115|FG001|Overall Study|Final Dressing Removal Data not captured|2
868307|NCT00517296|1829134|FG000|Overall Study|Withdrawal by Subject|1
868308|NCT00517296|1829135|FG001|Overall Study|Withdrawal by Subject|0
868309|NCT00517413|1829141|FG000|Overall Study|Adverse Event|7
868310|NCT00517413|1829141|FG000|Overall Study|Death|13
868311|NCT00517413|1829141|FG000|Overall Study|Protocol Violation|15
868312|NCT00517413|1829141|FG000|Overall Study|Withdrawal by Subject|2
868313|NCT00517413|1829141|FG000|Overall Study|Failure to return|1
868314|NCT00517413|1829141|FG000|Overall Study|Other-Reasons|23
868315|NCT00517634|1829202|FG000|Second Treatment Period|Withdrawal by Subject|0
868316|NCT00517634|1829203|FG001|Second Treatment Period|Withdrawal by Subject|0
868317|NCT00517634|1829204|FG002|Second Treatment Period|Withdrawal by Subject|0
868318|NCT00517634|1829205|FG003|Second Treatment Period|Withdrawal by Subject|0
868319|NCT00517634|1829206|FG004|Second Treatment Period|Withdrawal by Subject|1
868320|NCT00517634|1829207|FG005|Second Treatment Period|Withdrawal by Subject|0
868321|NCT00517751|1829215|FG000|Overall Study|Death|3
868322|NCT00517751|1829215|FG000|Overall Study|Withdrawal by Subject|37
868323|NCT00517751|1829215|FG000|Overall Study|Lost to Follow-up|4
868324|NCT00517751|1829215|FG000|Overall Study|patient not over due|6
868325|NCT00517751|1829215|FG000|Overall Study|Patient not due for visit|76
868326|NCT00517751|1829215|FG000|Overall Study|Missing|3
868327|NCT00517829|1829221|FG000|Overall Study|Adverse Event|22
868328|NCT00517829|1829222|FG001|Overall Study|Adverse Event|34
868329|NCT00517829|1829221|FG000|Overall Study|Disease Progression|39
868330|NCT00517829|1829222|FG001|Overall Study|Disease Progression|32
868331|NCT00517829|1829221|FG000|Overall Study|Patient Request|6
868332|NCT00517829|1829222|FG001|Overall Study|Patient Request|5
868333|NCT00517829|1829221|FG000|Overall Study|Investigator Request|5
868334|NCT00517829|1829222|FG001|Overall Study|Investigator Request|3
868335|NCT00517829|1829221|FG000|Overall Study|Other|3
868336|NCT00517829|1829222|FG001|Overall Study|Other|1
868337|NCT00517881|1829228|FG000|Overall Study|Protocol Violation|2
868338|NCT00517881|1829228|FG000|Overall Study|Adverse Event|1
868339|NCT00517881|1829228|FG000|Overall Study|Renal transplantation|2
868340|NCT00517933|1829234|FG000|Period 1|Death|2
868341|NCT00517933|1829235|FG001|Period 1|Death|1
868342|NCT00517933|1829234|FG000|Period 1|Adverse Event|4
868343|NCT00517933|1829235|FG001|Period 1|Adverse Event|4
868344|NCT00517933|1829234|FG000|Period 1|Lost to Follow-up|2
868345|NCT00517933|1829235|FG001|Period 1|Lost to Follow-up|0
868346|NCT00517933|1829234|FG000|Period 1|Underwent lung transplant|0
868347|NCT00517933|1829235|FG001|Period 1|Underwent lung transplant|1
868348|NCT00517933|1829234|FG000|Period 2|Death|2
868349|NCT00517933|1829235|FG001|Period 2|Death|4
868350|NCT00517933|1829234|FG000|Period 2|Adverse Event|2
868351|NCT00517933|1829235|FG001|Period 2|Adverse Event|4
868352|NCT00517933|1829234|FG000|Period 2|Physician Decision|1
868353|NCT00517933|1829235|FG001|Period 2|Physician Decision|0
868354|NCT00517933|1829234|FG000|Period 2|Withdrawal by Subject|1
868355|NCT00517933|1829235|FG001|Period 2|Withdrawal by Subject|3
868356|NCT00517933|1829234|FG000|Period 2|Underwent lung transplant|0
868357|NCT00517933|1829235|FG001|Period 2|Underwent lung transplant|2
868358|NCT00518011|1829246|FG000|Overall Study|Death|1
868359|NCT00518011|1829247|FG001|Overall Study|Death|1
868360|NCT00518011|1829246|FG000|Overall Study|Adverse Event|2
868361|NCT00518011|1829247|FG001|Overall Study|Adverse Event|3
868362|NCT00518011|1829246|FG000|Overall Study|Disease Progression|2
868363|NCT00518011|1829247|FG001|Overall Study|Disease Progression|2
868364|NCT00518011|1829246|FG000|Overall Study|Other Reasons|3
868365|NCT00518011|1829247|FG001|Overall Study|Other Reasons|2
868366|NCT00518011|1829246|FG000|Overall Study|Withdrawal by Subject|1
868367|NCT00518011|1829247|FG001|Overall Study|Withdrawal by Subject|0
868368|NCT00518115|1829273|FG000|Overall Study|Adverse Event|6
868369|NCT00518115|1829274|FG001|Overall Study|Adverse Event|1
868370|NCT00518115|1829275|FG002|Overall Study|Adverse Event|5
868371|NCT00518115|1829276|FG003|Overall Study|Adverse Event|6
868372|NCT00518115|1829277|FG004|Overall Study|Adverse Event|5
868373|NCT00518115|1829278|FG005|Overall Study|Adverse Event|5
868374|NCT00518115|1829279|FG006|Overall Study|Adverse Event|5
868375|NCT00518115|1829280|FG007|Overall Study|Adverse Event|10
868376|NCT00518115|1829281|FG008|Overall Study|Adverse Event|2
868377|NCT00518115|1829282|FG009|Overall Study|Adverse Event|9
868378|NCT00518115|1829273|FG000|Overall Study|Lost to Follow-up|0
868379|NCT00518115|1829274|FG001|Overall Study|Lost to Follow-up|0
868380|NCT00518115|1829275|FG002|Overall Study|Lost to Follow-up|2
868381|NCT00518115|1829276|FG003|Overall Study|Lost to Follow-up|3
868382|NCT00518115|1829277|FG004|Overall Study|Lost to Follow-up|1
868383|NCT00518115|1829278|FG005|Overall Study|Lost to Follow-up|3
868384|NCT00518115|1829279|FG006|Overall Study|Lost to Follow-up|0
868385|NCT00518115|1829280|FG007|Overall Study|Lost to Follow-up|1
868386|NCT00518115|1829281|FG008|Overall Study|Lost to Follow-up|1
868387|NCT00518115|1829282|FG009|Overall Study|Lost to Follow-up|1
868388|NCT00518115|1829273|FG000|Overall Study|Protocol Violation|1
868389|NCT00518115|1829274|FG001|Overall Study|Protocol Violation|3
868390|NCT00518115|1829275|FG002|Overall Study|Protocol Violation|1
868391|NCT00518115|1829276|FG003|Overall Study|Protocol Violation|0
868392|NCT00518115|1829277|FG004|Overall Study|Protocol Violation|0
868393|NCT00518115|1829278|FG005|Overall Study|Protocol Violation|0
868394|NCT00518115|1829279|FG006|Overall Study|Protocol Violation|0
868395|NCT00518115|1829280|FG007|Overall Study|Protocol Violation|0
868396|NCT00518115|1829281|FG008|Overall Study|Protocol Violation|0
868397|NCT00518115|1829282|FG009|Overall Study|Protocol Violation|0
868398|NCT00518115|1829273|FG000|Overall Study|Withdrawal by Subject|1
868399|NCT00518115|1829274|FG001|Overall Study|Withdrawal by Subject|1
868400|NCT00518115|1829275|FG002|Overall Study|Withdrawal by Subject|5
868401|NCT00518115|1829276|FG003|Overall Study|Withdrawal by Subject|0
868402|NCT00518115|1829277|FG004|Overall Study|Withdrawal by Subject|2
868403|NCT00518115|1829278|FG005|Overall Study|Withdrawal by Subject|1
868404|NCT00518115|1829279|FG006|Overall Study|Withdrawal by Subject|0
868405|NCT00518115|1829280|FG007|Overall Study|Withdrawal by Subject|2
868406|NCT00518115|1829281|FG008|Overall Study|Withdrawal by Subject|1
868407|NCT00518115|1829282|FG009|Overall Study|Withdrawal by Subject|3
868408|NCT00518115|1829273|FG000|Overall Study|Lack of Efficacy|1
868409|NCT00518115|1829274|FG001|Overall Study|Lack of Efficacy|0
868410|NCT00518115|1829275|FG002|Overall Study|Lack of Efficacy|1
868411|NCT00518115|1829276|FG003|Overall Study|Lack of Efficacy|1
868412|NCT00518115|1829277|FG004|Overall Study|Lack of Efficacy|0
868413|NCT00518115|1829278|FG005|Overall Study|Lack of Efficacy|0
868414|NCT00518115|1829279|FG006|Overall Study|Lack of Efficacy|0
868415|NCT00518115|1829280|FG007|Overall Study|Lack of Efficacy|1
868416|NCT00518115|1829281|FG008|Overall Study|Lack of Efficacy|0
868417|NCT00518115|1829282|FG009|Overall Study|Lack of Efficacy|0
868418|NCT00518115|1829273|FG000|Overall Study|Non-Compliance|1
868419|NCT00518115|1829274|FG001|Overall Study|Non-Compliance|0
868420|NCT00518115|1829275|FG002|Overall Study|Non-Compliance|1
868421|NCT00518115|1829276|FG003|Overall Study|Non-Compliance|0
868422|NCT00518115|1829277|FG004|Overall Study|Non-Compliance|1
868423|NCT00518115|1829278|FG005|Overall Study|Non-Compliance|1
868424|NCT00518115|1829279|FG006|Overall Study|Non-Compliance|1
868425|NCT00518115|1829280|FG007|Overall Study|Non-Compliance|1
868426|NCT00518115|1829281|FG008|Overall Study|Non-Compliance|0
868427|NCT00518115|1829282|FG009|Overall Study|Non-Compliance|1
868428|NCT00518115|1829273|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1
868429|NCT00518115|1829274|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1
868430|NCT00518115|1829275|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0
868431|NCT00518115|1829276|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0
868432|NCT00518115|1829277|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0
868433|NCT00518115|1829278|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4
868434|NCT00518115|1829279|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0
868435|NCT00518115|1829280|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0
868436|NCT00518115|1829281|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0
868437|NCT00518115|1829282|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0
868438|NCT00518115|1829273|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1
868439|NCT00518115|1829274|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0
868440|NCT00518115|1829275|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0
868441|NCT00518115|1829276|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0
868442|NCT00518115|1829277|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0
868443|NCT00518115|1829278|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0
868444|NCT00518115|1829279|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0
868445|NCT00518115|1829280|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0
868446|NCT00518115|1829281|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0
868447|NCT00518115|1829282|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0
868448|NCT00518115|1829273|FG000|Overall Study|Different Monotherapy Diabetic Drug|0
868449|NCT00518115|1829274|FG001|Overall Study|Different Monotherapy Diabetic Drug|0
868450|NCT00518115|1829275|FG002|Overall Study|Different Monotherapy Diabetic Drug|1
868451|NCT00518115|1829276|FG003|Overall Study|Different Monotherapy Diabetic Drug|0
868452|NCT00518115|1829277|FG004|Overall Study|Different Monotherapy Diabetic Drug|0
868453|NCT00518115|1829278|FG005|Overall Study|Different Monotherapy Diabetic Drug|0
868454|NCT00518115|1829279|FG006|Overall Study|Different Monotherapy Diabetic Drug|0
868455|NCT00518115|1829280|FG007|Overall Study|Different Monotherapy Diabetic Drug|0
868456|NCT00518115|1829281|FG008|Overall Study|Different Monotherapy Diabetic Drug|1
868457|NCT00518115|1829282|FG009|Overall Study|Different Monotherapy Diabetic Drug|0
868458|NCT00518115|1829273|FG000|Overall Study|Wrong Monotherapy Administered|0
868459|NCT00518115|1829274|FG001|Overall Study|Wrong Monotherapy Administered|0
868460|NCT00518115|1829275|FG002|Overall Study|Wrong Monotherapy Administered|1
868461|NCT00518115|1829276|FG003|Overall Study|Wrong Monotherapy Administered|0
868462|NCT00518115|1829277|FG004|Overall Study|Wrong Monotherapy Administered|0
868463|NCT00518115|1829278|FG005|Overall Study|Wrong Monotherapy Administered|0
868464|NCT00518115|1829279|FG006|Overall Study|Wrong Monotherapy Administered|1
868465|NCT00518115|1829280|FG007|Overall Study|Wrong Monotherapy Administered|0
868466|NCT00518115|1829281|FG008|Overall Study|Wrong Monotherapy Administered|0
868467|NCT00518115|1829282|FG009|Overall Study|Wrong Monotherapy Administered|0
868468|NCT00518115|1829273|FG000|Overall Study|Violation of Exclusion Criteria|0
868469|NCT00518115|1829274|FG001|Overall Study|Violation of Exclusion Criteria|0
868470|NCT00518115|1829275|FG002|Overall Study|Violation of Exclusion Criteria|0
868471|NCT00518115|1829276|FG003|Overall Study|Violation of Exclusion Criteria|1
868472|NCT00518115|1829277|FG004|Overall Study|Violation of Exclusion Criteria|0
868473|NCT00518115|1829278|FG005|Overall Study|Violation of Exclusion Criteria|0
868474|NCT00518115|1829279|FG006|Overall Study|Violation of Exclusion Criteria|1
868475|NCT00518115|1829280|FG007|Overall Study|Violation of Exclusion Criteria|0
868476|NCT00518115|1829281|FG008|Overall Study|Violation of Exclusion Criteria|0
868477|NCT00518115|1829282|FG009|Overall Study|Violation of Exclusion Criteria|0
868478|NCT00518115|1829273|FG000|Overall Study|Family Emergency; Had to Go to England|0
868479|NCT00518115|1829274|FG001|Overall Study|Family Emergency; Had to Go to England|0
868480|NCT00518115|1829275|FG002|Overall Study|Family Emergency; Had to Go to England|0
868481|NCT00518115|1829276|FG003|Overall Study|Family Emergency; Had to Go to England|0
868482|NCT00518115|1829277|FG004|Overall Study|Family Emergency; Had to Go to England|1
868483|NCT00518115|1829278|FG005|Overall Study|Family Emergency; Had to Go to England|0
868484|NCT00518115|1829279|FG006|Overall Study|Family Emergency; Had to Go to England|0
868485|NCT00518115|1829280|FG007|Overall Study|Family Emergency; Had to Go to England|0
868486|NCT00518115|1829281|FG008|Overall Study|Family Emergency; Had to Go to England|0
868487|NCT00518115|1829282|FG009|Overall Study|Family Emergency; Had to Go to England|0
868488|NCT00518115|1829273|FG000|Overall Study|Withdrew Consent|0
868489|NCT00518115|1829274|FG001|Overall Study|Withdrew Consent|0
868490|NCT00518115|1829275|FG002|Overall Study|Withdrew Consent|0
868491|NCT00518115|1829276|FG003|Overall Study|Withdrew Consent|0
868492|NCT00518115|1829277|FG004|Overall Study|Withdrew Consent|0
868493|NCT00518115|1829278|FG005|Overall Study|Withdrew Consent|1
868494|NCT00518115|1829279|FG006|Overall Study|Withdrew Consent|0
868495|NCT00518115|1829280|FG007|Overall Study|Withdrew Consent|0
868496|NCT00518115|1829281|FG008|Overall Study|Withdrew Consent|0
868497|NCT00518115|1829282|FG009|Overall Study|Withdrew Consent|0
868498|NCT00518115|1829273|FG000|Overall Study|Moved Out of State|0
868499|NCT00518115|1829274|FG001|Overall Study|Moved Out of State|0
868500|NCT00518115|1829275|FG002|Overall Study|Moved Out of State|0
868501|NCT00518115|1829276|FG003|Overall Study|Moved Out of State|0
868502|NCT00518115|1829277|FG004|Overall Study|Moved Out of State|0
868503|NCT00518115|1829278|FG005|Overall Study|Moved Out of State|0
868504|NCT00518115|1829279|FG006|Overall Study|Moved Out of State|0
868505|NCT00518115|1829280|FG007|Overall Study|Moved Out of State|0
868506|NCT00518115|1829281|FG008|Overall Study|Moved Out of State|0
868507|NCT00518115|1829282|FG009|Overall Study|Moved Out of State|1
868508|NCT00518180|1829312|FG000|Overall Study|Withdrawal by Subject|29
868509|NCT00518180|1829313|FG001|Overall Study|Withdrawal by Subject|30
868510|NCT00518180|1829314|FG002|Overall Study|Withdrawal by Subject|42
868511|NCT00518180|1829312|FG000|Overall Study|Lost to Follow-up|30
868512|NCT00518180|1829313|FG001|Overall Study|Lost to Follow-up|28
868513|NCT00518180|1829314|FG002|Overall Study|Lost to Follow-up|34
868514|NCT00518180|1829312|FG000|Overall Study|Administrative reason|0
868515|NCT00518180|1829313|FG001|Overall Study|Administrative reason|2
868516|NCT00518180|1829314|FG002|Overall Study|Administrative reason|2
868517|NCT00518180|1829312|FG000|Overall Study|Protocol Violation|5
868518|NCT00518180|1829313|FG001|Overall Study|Protocol Violation|7
868519|NCT00518180|1829314|FG002|Overall Study|Protocol Violation|4
868520|NCT00518180|1829312|FG000|Overall Study|Unable to classify|0
868521|NCT00518180|1829313|FG001|Overall Study|Unable to classify|2
868522|NCT00518180|1829314|FG002|Overall Study|Unable to classify|0
868523|NCT00518180|1829312|FG000|Overall Study|Adverse Event|1
868524|NCT00518180|1829313|FG001|Overall Study|Adverse Event|0
868525|NCT00518180|1829314|FG002|Overall Study|Adverse Event|0
868526|NCT00518206|1829333|FG000|Overall Study|Disease Progression Requiring Therapy|6
868527|NCT00518206|1829334|FG001|Overall Study|Disease Progression Requiring Therapy|6
868528|NCT00518206|1829333|FG000|Overall Study|Withdrawal by Subject|2
868529|NCT00518206|1829334|FG001|Overall Study|Withdrawal by Subject|0
868530|NCT00518206|1829333|FG000|Overall Study|Drug Supply Issue|1
868531|NCT00518206|1829334|FG001|Overall Study|Drug Supply Issue|0
868532|NCT00518206|1829333|FG000|Overall Study|Reason Unknown|1
868533|NCT00518206|1829334|FG001|Overall Study|Reason Unknown|0
868534|NCT00518206|1829333|FG000|Overall Study|Completion Status Unknown|1
868535|NCT00518206|1829334|FG001|Overall Study|Completion Status Unknown|0
868536|NCT00518284|1829344|FG000|Overall Study|Adverse Event|0
868537|NCT00518284|1829345|FG001|Overall Study|Adverse Event|1
868538|NCT00518284|1829346|FG002|Overall Study|Adverse Event|0
868539|NCT00518284|1829347|FG003|Overall Study|Adverse Event|0
868540|NCT00518284|1829344|FG000|Overall Study|Study Termination|0
868541|NCT00518284|1829345|FG001|Overall Study|Study Termination|2
868542|NCT00518284|1829346|FG002|Overall Study|Study Termination|1
868543|NCT00518284|1829347|FG003|Overall Study|Study Termination|2
868544|NCT00518323|1829361|FG000|Overall Study|Lack of Efficacy|14
868545|NCT00518323|1829362|FG001|Overall Study|Lack of Efficacy|2
868546|NCT00518323|1829363|FG002|Overall Study|Lack of Efficacy|4
868547|NCT00518323|1829364|FG003|Overall Study|Lack of Efficacy|20
868548|NCT00518323|1829361|FG000|Overall Study|Withdrawal by Subject|1
868549|NCT00518323|1829362|FG001|Overall Study|Withdrawal by Subject|2
868550|NCT00518323|1829363|FG002|Overall Study|Withdrawal by Subject|4
868551|NCT00518323|1829364|FG003|Overall Study|Withdrawal by Subject|2
868552|NCT00518323|1829361|FG000|Overall Study|Lost to Follow-up|0
868553|NCT00518323|1829362|FG001|Overall Study|Lost to Follow-up|2
868554|NCT00518323|1829363|FG002|Overall Study|Lost to Follow-up|1
868555|NCT00518323|1829364|FG003|Overall Study|Lost to Follow-up|3
868556|NCT00518323|1829361|FG000|Overall Study|Adverse Event|1
868557|NCT00518323|1829362|FG001|Overall Study|Adverse Event|1
868558|NCT00518323|1829363|FG002|Overall Study|Adverse Event|1
868559|NCT00518323|1829364|FG003|Overall Study|Adverse Event|0
868560|NCT00518323|1829361|FG000|Overall Study|Prohibited medication and others|3
868561|NCT00518323|1829362|FG001|Overall Study|Prohibited medication and others|1
868562|NCT00518323|1829363|FG002|Overall Study|Prohibited medication and others|1
868563|NCT00518323|1829364|FG003|Overall Study|Prohibited medication and others|0
868564|NCT00518336|1829376|FG000|Year 7|Lost to Follow-up|2
868565|NCT00518336|1829377|FG001|Year 7|Lost to Follow-up|0
868566|NCT00518336|1829376|FG000|Year 7|Could not attend in time|0
868567|NCT00518336|1829377|FG001|Year 7|Could not attend in time|3
868568|NCT00518336|1829376|FG000|Year 8|Lost to Follow-up|1
868569|NCT00518336|1829377|FG001|Year 8|Lost to Follow-up|1
868570|NCT00518336|1829376|FG000|Year 8|Could not attend in time|0
868571|NCT00518336|1829377|FG001|Year 8|Could not attend in time|1
868572|NCT00518336|1829376|FG000|Year 9|Migrated/moved from study area|1
868573|NCT00518336|1829377|FG001|Year 9|Migrated/moved from study area|1
868574|NCT00518336|1829376|FG000|Year 9|Lost to Follow-up|3
868575|NCT00518336|1829377|FG001|Year 9|Lost to Follow-up|0
868576|NCT00518336|1829376|FG000|Year 9|Personal reasons|1
868577|NCT00518336|1829377|FG001|Year 9|Personal reasons|0
868578|NCT00518531|1829394|FG000|Treatment Period 1|Adverse Event|5
868579|NCT00518531|1829395|FG001|Treatment Period 1|Adverse Event|0
868580|NCT00518531|1829394|FG000|Treatment Period 1|Lost to Follow-up|5
868581|NCT00518531|1829395|FG001|Treatment Period 1|Lost to Follow-up|3
868582|NCT00518531|1829394|FG000|Treatment Period 1|Physician Decision|1
868583|NCT00518531|1829395|FG001|Treatment Period 1|Physician Decision|0
868584|NCT00518531|1829394|FG000|Treatment Period 1|Protocol Violation|2
868585|NCT00518531|1829395|FG001|Treatment Period 1|Protocol Violation|0
868586|NCT00518531|1829394|FG000|Treatment Period 1|Withdrawal by Subject|4
868587|NCT00518531|1829395|FG001|Treatment Period 1|Withdrawal by Subject|6
868588|NCT00518531|1829394|FG000|Treatment Period 1|Early crossover|1
868589|NCT00518531|1829395|FG001|Treatment Period 1|Early crossover|3
868590|NCT00518531|1829394|FG000|Treatment Period 2|Withdrawal by Subject|0
868591|NCT00518531|1829395|FG001|Treatment Period 2|Withdrawal by Subject|8
868592|NCT00518531|1829394|FG000|Treatment Period 2|Complete out of scheduled visit window|1
868593|NCT00518531|1829395|FG001|Treatment Period 2|Complete out of scheduled visit window|2
868594|NCT00518531|1829394|FG000|Treatment Period 2|Adverse Event|1
868595|NCT00518531|1829395|FG001|Treatment Period 2|Adverse Event|7
868596|NCT00518531|1829394|FG000|Treatment Period 2|Protocol-specified criteria|0
868597|NCT00518531|1829395|FG001|Treatment Period 2|Protocol-specified criteria|1
868598|NCT00518531|1829394|FG000|Treatment Period 2|Non-compliance|1
868599|NCT00518531|1829395|FG001|Treatment Period 2|Non-compliance|2
868600|NCT00518622|1829411|FG000|Overall Study|Lost to Follow-up|0
868601|NCT00518622|1829412|FG001|Overall Study|Lost to Follow-up|0
868602|NCT00518622|1829413|FG002|Overall Study|Lost to Follow-up|1
868603|NCT00518622|1829414|FG003|Overall Study|Lost to Follow-up|0
868604|NCT00518622|1829415|FG004|Overall Study|Lost to Follow-up|0
868605|NCT00518622|1829416|FG005|Overall Study|Lost to Follow-up|0
868606|NCT00518622|1829417|FG006|Overall Study|Lost to Follow-up|0
868607|NCT00518622|1829418|FG007|Overall Study|Lost to Follow-up|0
868608|NCT00518622|1829411|FG000|Overall Study|Study medication taken incorrectly|0
868609|NCT00518622|1829412|FG001|Overall Study|Study medication taken incorrectly|1
868610|NCT00518622|1829413|FG002|Overall Study|Study medication taken incorrectly|0
868611|NCT00518622|1829414|FG003|Overall Study|Study medication taken incorrectly|0
868612|NCT00518622|1829415|FG004|Overall Study|Study medication taken incorrectly|0
868613|NCT00518622|1829416|FG005|Overall Study|Study medication taken incorrectly|0
868614|NCT00518622|1829417|FG006|Overall Study|Study medication taken incorrectly|0
868615|NCT00518622|1829418|FG007|Overall Study|Study medication taken incorrectly|0
868616|NCT00518687|1829438|FG000|Overall Study|Adverse Event|201
868617|NCT00518687|1829439|FG001|Overall Study|Adverse Event|177
868618|NCT00518687|1829438|FG000|Overall Study|Lost to Follow-up|144
868619|NCT00518687|1829439|FG001|Overall Study|Lost to Follow-up|155
868620|NCT00518687|1829438|FG000|Overall Study|Physician Decision|42
868621|NCT00518687|1829439|FG001|Overall Study|Physician Decision|48
868622|NCT00518687|1829438|FG000|Overall Study|Progressive disease|2
868623|NCT00518687|1829439|FG001|Overall Study|Progressive disease|2
868624|NCT00518687|1829438|FG000|Overall Study|Protocol Violation|8
868625|NCT00518687|1829439|FG001|Overall Study|Protocol Violation|10
868626|NCT00518687|1829438|FG000|Overall Study|Study terminated by sponsor|930
868627|NCT00518687|1829439|FG001|Overall Study|Study terminated by sponsor|918
868628|NCT00518687|1829438|FG000|Overall Study|Withdrawal by Subject|110
868629|NCT00518687|1829439|FG001|Overall Study|Withdrawal by Subject|110
868630|NCT00518882|1829464|FG000|Double-Blind, Week 0-26|Adverse Event|23
868631|NCT00518882|1829465|FG001|Double-Blind, Week 0-26|Adverse Event|31
868632|NCT00518882|1829464|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1
868633|NCT00518882|1829465|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0
868634|NCT00518882|1829464|FG000|Double-Blind, Week 0-26|Protocol Violation|4
868635|NCT00518882|1829465|FG001|Double-Blind, Week 0-26|Protocol Violation|3
868636|NCT00518882|1829464|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1
868637|NCT00518882|1829465|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1
868638|NCT00518882|1829464|FG000|Double-Blind, Week 0-26|Lost to follow up|2
868639|NCT00518882|1829465|FG001|Double-Blind, Week 0-26|Lost to follow up|1
868640|NCT00518882|1829464|FG000|Double-Blind, Week 0-26|Subject decision|1
868641|NCT00518882|1829465|FG001|Double-Blind, Week 0-26|Subject decision|1
868642|NCT00518882|1829464|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1
868643|NCT00518882|1829465|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3
868644|NCT00518882|1829464|FG000|Double-Blind, Week 0-26|Loss of trust|0
868645|NCT00518882|1829465|FG001|Double-Blind, Week 0-26|Loss of trust|1
868646|NCT00518882|1829464|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
868647|NCT00518882|1829465|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
868648|NCT00518882|1829464|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0
868649|NCT00518882|1829465|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2
868650|NCT00518882|1829464|FG000|Double-Blind, Week 0-26|Mutual consent|0
868651|NCT00518882|1829465|FG001|Double-Blind, Week 0-26|Mutual consent|1
868652|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Adverse Event|3
868653|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Adverse Event|9
868654|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6
868655|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5
868656|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3
868657|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4
868658|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1
868659|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2
868660|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0
868661|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1
868662|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1
868663|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1
868664|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2
868665|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1
868666|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Change in treatment|1
868667|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Change in treatment|1
868668|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Creatine increased|1
868669|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Creatine increased|0
868670|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1
868671|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0
868672|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2
868673|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0
868674|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Subject decision|2
868675|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Subject decision|0
868676|NCT00518882|1829464|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
868677|NCT00518882|1829465|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
868678|NCT00518973|1829473|FG000|Overall Study|Withdrawal by Subject|3
868679|NCT00518973|1829474|FG001|Overall Study|Withdrawal by Subject|2
868680|NCT00518986|1829482|FG000|Overall Study|Adverse Event|12
868681|NCT00518986|1829483|FG001|Overall Study|Adverse Event|7
868682|NCT00518986|1829482|FG000|Overall Study|Lack of Efficacy|0
868683|NCT00518986|1829483|FG001|Overall Study|Lack of Efficacy|2
868684|NCT00518986|1829482|FG000|Overall Study|Lost to Follow-up|3
868685|NCT00518986|1829483|FG001|Overall Study|Lost to Follow-up|2
868686|NCT00518986|1829482|FG000|Overall Study|Physician Decision|0
868687|NCT00518986|1829483|FG001|Overall Study|Physician Decision|3
868688|NCT00518986|1829482|FG000|Overall Study|Protocol Violation|5
868689|NCT00518986|1829483|FG001|Overall Study|Protocol Violation|7
868690|NCT00518986|1829482|FG000|Overall Study|Withdrawal by Subject|4
868691|NCT00518986|1829483|FG001|Overall Study|Withdrawal by Subject|4
868692|NCT00518986|1829482|FG000|Overall Study|Non-Specific|2
868693|NCT00518986|1829483|FG001|Overall Study|Non-Specific|1
868694|NCT00519077|1829489|FG000|Overall Study|Death|6
868695|NCT00519077|1829489|FG000|Overall Study|Other|2
868696|NCT00519194|1829493|FG000|Overall Study|Withdrawal by Subject|9
868697|NCT00519194|1829493|FG000|Overall Study|Death|9
868698|NCT00519194|1829493|FG000|Overall Study|Lost to Follow-up|3
868699|NCT00519285|1829499|FG000|Overall Study|Adverse Event|127
868700|NCT00519285|1829500|FG001|Overall Study|Adverse Event|266
868701|NCT00519285|1829499|FG000|Overall Study|Disease progression|334
868702|NCT00519285|1829500|FG001|Overall Study|Disease progression|186
868703|NCT00519285|1829499|FG000|Overall Study|Physician Decision|75
868704|NCT00519285|1829500|FG001|Overall Study|Physician Decision|47
868705|NCT00519285|1829499|FG000|Overall Study|Participant's request|53
868706|NCT00519285|1829500|FG001|Overall Study|Participant's request|84
868707|NCT00519285|1829499|FG000|Overall Study|Consent withdrawn|4
868708|NCT00519285|1829500|FG001|Overall Study|Consent withdrawn|5
868709|NCT00519285|1829499|FG000|Overall Study|Poor compliance to protocol|5
868710|NCT00519285|1829500|FG001|Overall Study|Poor compliance to protocol|7
868711|NCT00519285|1829499|FG000|Overall Study|Reason unspecified|5
868712|NCT00519285|1829500|FG001|Overall Study|Reason unspecified|8
868713|NCT00519285|1829499|FG000|Overall Study|Not treated|8
868714|NCT00519285|1829500|FG001|Overall Study|Not treated|7
868715|NCT00519285|1829499|FG000|Overall Study|Treatment ongoing|1
868716|NCT00519285|1829500|FG001|Overall Study|Treatment ongoing|2
868717|NCT00519376|1829506|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
914225|NCT00813709|1891956|FG004|Open Label Period|Lack of Efficacy|1
868718|NCT00519376|1829507|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868719|NCT00519376|1829508|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868720|NCT00519376|1829509|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868721|NCT00519376|1829510|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868722|NCT00519376|1829511|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868723|NCT00519376|1829512|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868724|NCT00519376|1829513|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868725|NCT00519376|1829514|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868726|NCT00519376|1829515|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868727|NCT00519376|1829516|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868728|NCT00519376|1829517|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868729|NCT00519376|1829518|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
868730|NCT00519376|1829519|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868731|NCT00519376|1829520|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868732|NCT00519376|1829521|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
868733|NCT00519376|1829506|FG000|Treatment Period 4|Lost to Follow-up|0
868734|NCT00519376|1829507|FG001|Treatment Period 4|Lost to Follow-up|0
868735|NCT00519376|1829508|FG002|Treatment Period 4|Lost to Follow-up|1
868736|NCT00519376|1829509|FG003|Treatment Period 4|Lost to Follow-up|0
868737|NCT00519376|1829510|FG004|Treatment Period 4|Lost to Follow-up|0
868738|NCT00519376|1829511|FG005|Treatment Period 4|Lost to Follow-up|0
868739|NCT00519376|1829512|FG006|Treatment Period 4|Lost to Follow-up|0
868740|NCT00519376|1829513|FG007|Treatment Period 4|Lost to Follow-up|0
868741|NCT00519376|1829514|FG008|Treatment Period 4|Lost to Follow-up|0
868742|NCT00519376|1829515|FG009|Treatment Period 4|Lost to Follow-up|0
868743|NCT00519376|1829516|FG010|Treatment Period 4|Lost to Follow-up|0
868744|NCT00519376|1829517|FG011|Treatment Period 4|Lost to Follow-up|0
868745|NCT00519376|1829518|FG012|Treatment Period 4|Lost to Follow-up|0
868746|NCT00519376|1829519|FG013|Treatment Period 4|Lost to Follow-up|0
868747|NCT00519376|1829520|FG014|Treatment Period 4|Lost to Follow-up|0
868748|NCT00519376|1829521|FG015|Treatment Period 4|Lost to Follow-up|0
868749|NCT00519428|1829536|FG000|Overall Study|Adverse Event|5
868750|NCT00519428|1829537|FG001|Overall Study|Adverse Event|2
868751|NCT00519428|1829538|FG002|Overall Study|Adverse Event|10
868752|NCT00519428|1829536|FG000|Overall Study|Lost to Follow-up|7
868753|NCT00519428|1829537|FG001|Overall Study|Lost to Follow-up|7
868754|NCT00519428|1829538|FG002|Overall Study|Lost to Follow-up|6
868755|NCT00519428|1829536|FG000|Overall Study|Withdrawal by Subject|8
868756|NCT00519428|1829537|FG001|Overall Study|Withdrawal by Subject|3
868757|NCT00519428|1829538|FG002|Overall Study|Withdrawal by Subject|7
868758|NCT00519428|1829536|FG000|Overall Study|unstated|1
868759|NCT00519428|1829537|FG001|Overall Study|unstated|3
868760|NCT00519428|1829538|FG002|Overall Study|unstated|2
868761|NCT00519532|1829549|FG000|Overall Study|Adverse Event|11
868762|NCT00519532|1829549|FG000|Overall Study|Withdrawal by Subject|5
868763|NCT00519532|1829549|FG000|Overall Study|Lost to Follow-up|2
868764|NCT00519623|1829570|FG000|Overall Study|Adverse Event|1
868765|NCT00519636|1829578|FG000|Treatment Period 1|Adverse Event|1
868766|NCT00519636|1829579|FG001|Treatment Period 1|Adverse Event|0
868767|NCT00519636|1829580|FG002|Treatment Period 1|Adverse Event|1
868768|NCT00519636|1829581|FG003|Treatment Period 1|Adverse Event|0
868769|NCT00519636|1829578|FG000|Treatment Period 1|Sponsor request due to missed visit|1
868770|NCT00519636|1829579|FG001|Treatment Period 1|Sponsor request due to missed visit|0
868771|NCT00519636|1829580|FG002|Treatment Period 1|Sponsor request due to missed visit|0
868772|NCT00519636|1829581|FG003|Treatment Period 1|Sponsor request due to missed visit|0
868773|NCT00519636|1829578|FG000|Washout Period|Adverse Event|2
868774|NCT00519636|1829579|FG001|Washout Period|Adverse Event|1
868775|NCT00519636|1829580|FG002|Washout Period|Adverse Event|1
868776|NCT00519636|1829581|FG003|Washout Period|Adverse Event|0
868777|NCT00519636|1829578|FG000|Washout Period|Lost to Follow-up|1
868778|NCT00519636|1829579|FG001|Washout Period|Lost to Follow-up|0
868779|NCT00519636|1829580|FG002|Washout Period|Lost to Follow-up|0
868780|NCT00519636|1829581|FG003|Washout Period|Lost to Follow-up|0
868781|NCT00519636|1829578|FG000|Washout Period|Protocol Violation|0
868782|NCT00519636|1829579|FG001|Washout Period|Protocol Violation|0
868783|NCT00519636|1829580|FG002|Washout Period|Protocol Violation|1
868784|NCT00519636|1829581|FG003|Washout Period|Protocol Violation|2
868785|NCT00519636|1829578|FG000|Washout Period|Withdrawal by Subject|1
868786|NCT00519636|1829579|FG001|Washout Period|Withdrawal by Subject|0
868787|NCT00519636|1829580|FG002|Washout Period|Withdrawal by Subject|1
868788|NCT00519636|1829581|FG003|Washout Period|Withdrawal by Subject|0
868789|NCT00519636|1829578|FG000|Washout Period|Failed to meet continuation criteria|14
868790|NCT00519636|1829579|FG001|Washout Period|Failed to meet continuation criteria|11
868791|NCT00519636|1829580|FG002|Washout Period|Failed to meet continuation criteria|9
868792|NCT00519636|1829581|FG003|Washout Period|Failed to meet continuation criteria|3
868793|NCT00519636|1829578|FG000|Washout Period|Out of pollen area > 48 hours|1
868794|NCT00519636|1829579|FG001|Washout Period|Out of pollen area > 48 hours|0
868795|NCT00519636|1829580|FG002|Washout Period|Out of pollen area > 48 hours|0
868796|NCT00519636|1829581|FG003|Washout Period|Out of pollen area > 48 hours|0
868797|NCT00519636|1829578|FG000|Washout Period|Participating in study at another site|1
868798|NCT00519636|1829579|FG001|Washout Period|Participating in study at another site|0
868799|NCT00519636|1829580|FG002|Washout Period|Participating in study at another site|0
868800|NCT00519636|1829581|FG003|Washout Period|Participating in study at another site|0
868801|NCT00519636|1829578|FG000|Washout Period|Non-compliant|0
868802|NCT00519636|1829579|FG001|Washout Period|Non-compliant|1
868803|NCT00519636|1829580|FG002|Washout Period|Non-compliant|0
868804|NCT00519636|1829581|FG003|Washout Period|Non-compliant|0
868805|NCT00519636|1829578|FG000|Washout Period|Per doctors request|0
868806|NCT00519636|1829579|FG001|Washout Period|Per doctors request|1
868807|NCT00519636|1829580|FG002|Washout Period|Per doctors request|0
868808|NCT00519636|1829581|FG003|Washout Period|Per doctors request|0
868809|NCT00519636|1829578|FG000|Washout Period|Subject randomized in error|0
868810|NCT00519636|1829579|FG001|Washout Period|Subject randomized in error|0
868811|NCT00519636|1829580|FG002|Washout Period|Subject randomized in error|1
868812|NCT00519636|1829581|FG003|Washout Period|Subject randomized in error|0
868813|NCT00519636|1829578|FG000|Washout Period|Prohibited medications|0
868814|NCT00519636|1829579|FG001|Washout Period|Prohibited medications|0
868815|NCT00519636|1829580|FG002|Washout Period|Prohibited medications|1
868816|NCT00519636|1829581|FG003|Washout Period|Prohibited medications|0
868817|NCT00519636|1829578|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0
868818|NCT00519636|1829579|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0
868819|NCT00519636|1829580|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0
868820|NCT00519636|1829581|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1
868821|NCT00519636|1829578|FG000|Treatment Period 2|Subject randomized in error|0
868822|NCT00519636|1829579|FG001|Treatment Period 2|Subject randomized in error|1
868823|NCT00519636|1829580|FG002|Treatment Period 2|Subject randomized in error|0
868824|NCT00519636|1829581|FG003|Treatment Period 2|Subject randomized in error|0
868825|NCT00519636|1829578|FG000|Treatment Period 2|Per doctors request|0
868826|NCT00519636|1829579|FG001|Treatment Period 2|Per doctors request|0
868827|NCT00519636|1829580|FG002|Treatment Period 2|Per doctors request|1
868828|NCT00519636|1829581|FG003|Treatment Period 2|Per doctors request|0
868829|NCT00519636|1829578|FG000|Treatment Period 2|Subject misrandomized|0
868830|NCT00519636|1829579|FG001|Treatment Period 2|Subject misrandomized|0
868831|NCT00519636|1829580|FG002|Treatment Period 2|Subject misrandomized|0
868832|NCT00519636|1829581|FG003|Treatment Period 2|Subject misrandomized|1
868833|NCT00519636|1829578|FG000|Post Study Period|Subject randomized in error|0
868834|NCT00519636|1829579|FG001|Post Study Period|Subject randomized in error|0
868835|NCT00519636|1829580|FG002|Post Study Period|Subject randomized in error|0
868836|NCT00519636|1829581|FG003|Post Study Period|Subject randomized in error|1
868837|NCT00519649|1829595|FG000|Overall Study|Withdrawal by Subject|1
868838|NCT00519779|1829601|FG000|Overall Study|Withdrawal by Subject|0
868839|NCT00519779|1829602|FG001|Overall Study|Withdrawal by Subject|1
868840|NCT00519831|1829614|FG000|Overall Study|Adverse Event|3
868841|NCT00519896|1829618|FG000|Overall Study|Protocol Violation|1
868842|NCT00519896|1829618|FG000|Overall Study|Adverse Event|1
868843|NCT00520013|1829625|FG000|Overall Study|Withdrawal by Subject|0
868844|NCT00520013|1829626|FG001|Overall Study|Withdrawal by Subject|0
868845|NCT00520013|1829627|FG002|Overall Study|Withdrawal by Subject|1
868846|NCT00520013|1829625|FG000|Overall Study|Adverse Event|2
868847|NCT00520013|1829626|FG001|Overall Study|Adverse Event|10
868848|NCT00520013|1829627|FG002|Overall Study|Adverse Event|7
868849|NCT00520013|1829625|FG000|Overall Study|Progressive Disease|7
868850|NCT00520013|1829626|FG001|Overall Study|Progressive Disease|3
868851|NCT00520013|1829627|FG002|Overall Study|Progressive Disease|0
868852|NCT00520013|1829625|FG000|Overall Study|Clinical Progression|3
868853|NCT00520013|1829626|FG001|Overall Study|Clinical Progression|1
868854|NCT00520013|1829627|FG002|Overall Study|Clinical Progression|0
868855|NCT00520013|1829625|FG000|Overall Study|Death|0
868856|NCT00520013|1829626|FG001|Overall Study|Death|1
868857|NCT00520013|1829627|FG002|Overall Study|Death|0
868858|NCT00520013|1829625|FG000|Overall Study|Physician Decision|0
868859|NCT00520013|1829626|FG001|Overall Study|Physician Decision|0
868860|NCT00520013|1829627|FG002|Overall Study|Physician Decision|3
868861|NCT00520039|1829635|FG000|Overall Study|Exclusion criteria met at first visit|7
868862|NCT00520039|1829636|FG001|Overall Study|Exclusion criteria met at first visit|5
868863|NCT00520130|1829646|FG000|Overall Study|Disease progression on study|4
868864|NCT00520130|1829647|FG001|Overall Study|Disease progression on study|0
868865|NCT00520130|1829646|FG000|Overall Study|Physician Decision|1
868866|NCT00520130|1829647|FG001|Overall Study|Physician Decision|1
868867|NCT00520299|1829679|FG000|Overall Study|Withdrawal by Subject|0
868868|NCT00520299|1829680|FG001|Overall Study|Withdrawal by Subject|0
868869|NCT00520299|1829681|FG002|Overall Study|Withdrawal by Subject|2
868870|NCT00520299|1829679|FG000|Overall Study|Progressive disease|0
868871|NCT00520299|1829680|FG001|Overall Study|Progressive disease|3
868872|NCT00520299|1829681|FG002|Overall Study|Progressive disease|4
868873|NCT00520351|1829691|FG000|First Intervention|Withdrawal by Subject|1
868874|NCT00520351|1829692|FG001|First Intervention|Withdrawal by Subject|1
868875|NCT00520403|1829698|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
868876|NCT00520403|1829698|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4
868877|NCT00520403|1829698|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
868878|NCT00520403|1829698|FG000|Bevacizumab + IFN/Vinblastine|Death|2
868879|NCT00520403|1829698|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
868880|NCT00520403|1829698|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
868881|NCT00520403|1829698|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1
868882|NCT00520403|1829698|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
868883|NCT00520481|1829708|FG000|Overall Study|Adverse Event|4
868884|NCT00520481|1829709|FG001|Overall Study|Adverse Event|1
868885|NCT00520481|1829708|FG000|Overall Study|Withdrawal by Subject|3
868886|NCT00520481|1829709|FG001|Overall Study|Withdrawal by Subject|0
868887|NCT00520494|1829717|FG000|Overall Study|Withdrawal by Subject|1
868888|NCT00520533|1829721|FG000|Overall Study|Death|1
868889|NCT00520533|1829721|FG000|Overall Study|Suspension of the study for safety reasons|1
868890|NCT00520533|1829721|FG000|Overall Study|Withdrawal by Subject|1
868891|NCT00520533|1829721|FG000|Overall Study|Physician Decision|1
868892|NCT00520546|1829726|FG000|Overall Study|Withdrawal by Subject|1
868893|NCT00520546|1829726|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5
868894|NCT00520572|1829741|FG000|Overall Study|Adverse Event|9
868895|NCT00520572|1829742|FG001|Overall Study|Adverse Event|3
868896|NCT00520572|1829743|FG002|Overall Study|Adverse Event|6
868897|NCT00520572|1829744|FG003|Overall Study|Adverse Event|9
868898|NCT00520572|1829745|FG004|Overall Study|Adverse Event|7
868899|NCT00520572|1829746|FG005|Overall Study|Adverse Event|2
868900|NCT00520572|1829741|FG000|Overall Study|Withdrawal by Subject|0
868901|NCT00520572|1829742|FG001|Overall Study|Withdrawal by Subject|9
868902|NCT00520572|1829743|FG002|Overall Study|Withdrawal by Subject|5
868903|NCT00520572|1829744|FG003|Overall Study|Withdrawal by Subject|2
868904|NCT00520572|1829745|FG004|Overall Study|Withdrawal by Subject|2
868905|NCT00520572|1829746|FG005|Overall Study|Withdrawal by Subject|0
868906|NCT00520572|1829741|FG000|Overall Study|Protocol Violation|0
868907|NCT00520572|1829742|FG001|Overall Study|Protocol Violation|0
868908|NCT00520572|1829743|FG002|Overall Study|Protocol Violation|1
868909|NCT00520572|1829744|FG003|Overall Study|Protocol Violation|0
868910|NCT00520572|1829745|FG004|Overall Study|Protocol Violation|0
868911|NCT00520572|1829746|FG005|Overall Study|Protocol Violation|0
868912|NCT00520572|1829741|FG000|Overall Study|Lack of Efficacy|1
868913|NCT00520572|1829742|FG001|Overall Study|Lack of Efficacy|1
868914|NCT00520572|1829743|FG002|Overall Study|Lack of Efficacy|1
868915|NCT00520572|1829744|FG003|Overall Study|Lack of Efficacy|2
868916|NCT00520572|1829745|FG004|Overall Study|Lack of Efficacy|1
868917|NCT00520572|1829746|FG005|Overall Study|Lack of Efficacy|0
868918|NCT00520572|1829741|FG000|Overall Study|Lost to Follow-up|0
868919|NCT00520572|1829742|FG001|Overall Study|Lost to Follow-up|0
868920|NCT00520572|1829743|FG002|Overall Study|Lost to Follow-up|0
868921|NCT00520572|1829744|FG003|Overall Study|Lost to Follow-up|0
868922|NCT00520572|1829745|FG004|Overall Study|Lost to Follow-up|1
868923|NCT00520572|1829746|FG005|Overall Study|Lost to Follow-up|0
868924|NCT00520572|1829741|FG000|Overall Study|Incorrect enrollment|1
868925|NCT00520572|1829742|FG001|Overall Study|Incorrect enrollment|0
868926|NCT00520572|1829743|FG002|Overall Study|Incorrect enrollment|1
868927|NCT00520572|1829744|FG003|Overall Study|Incorrect enrollment|0
868928|NCT00520572|1829745|FG004|Overall Study|Incorrect enrollment|1
868929|NCT00520572|1829746|FG005|Overall Study|Incorrect enrollment|0
868930|NCT00520572|1829741|FG000|Overall Study|Oral corticotherapy for acute urticaria|0
868931|NCT00520572|1829742|FG001|Overall Study|Oral corticotherapy for acute urticaria|1
868932|NCT00520572|1829743|FG002|Overall Study|Oral corticotherapy for acute urticaria|0
868933|NCT00520572|1829744|FG003|Overall Study|Oral corticotherapy for acute urticaria|0
868934|NCT00520572|1829745|FG004|Overall Study|Oral corticotherapy for acute urticaria|0
868935|NCT00520572|1829746|FG005|Overall Study|Oral corticotherapy for acute urticaria|0
868936|NCT00520572|1829741|FG000|Overall Study|Long break in taking Medication|0
868937|NCT00520572|1829742|FG001|Overall Study|Long break in taking Medication|0
868938|NCT00520572|1829743|FG002|Overall Study|Long break in taking Medication|0
868939|NCT00520572|1829744|FG003|Overall Study|Long break in taking Medication|1
868940|NCT00520572|1829745|FG004|Overall Study|Long break in taking Medication|0
868941|NCT00520572|1829746|FG005|Overall Study|Long break in taking Medication|0
868942|NCT00520572|1829741|FG000|Overall Study|Did not receive Treatment|1
868943|NCT00520572|1829742|FG001|Overall Study|Did not receive Treatment|0
868944|NCT00520572|1829743|FG002|Overall Study|Did not receive Treatment|1
868945|NCT00520572|1829744|FG003|Overall Study|Did not receive Treatment|0
868946|NCT00520572|1829745|FG004|Overall Study|Did not receive Treatment|0
868947|NCT00520572|1829746|FG005|Overall Study|Did not receive Treatment|0
868948|NCT00520676|1829762|FG000|Overall Study|Death|84
868949|NCT00520676|1829763|FG001|Overall Study|Death|81
868950|NCT00520676|1829762|FG000|Overall Study|Lost to Follow-up|6
868951|NCT00520676|1829763|FG001|Overall Study|Lost to Follow-up|10
868952|NCT00520676|1829762|FG000|Overall Study|Physician Decision|4
868953|NCT00520676|1829763|FG001|Overall Study|Physician Decision|1
868954|NCT00520676|1829762|FG000|Overall Study|Withdrawal by Subject|7
868955|NCT00520676|1829763|FG001|Overall Study|Withdrawal by Subject|11
868956|NCT00520741|1829771|FG000|Overall Study|Adverse Event|16
868957|NCT00520741|1829772|FG001|Overall Study|Adverse Event|56
868958|NCT00520741|1829771|FG000|Overall Study|Lack of Efficacy|11
868959|NCT00520741|1829772|FG001|Overall Study|Lack of Efficacy|30
868960|NCT00520741|1829771|FG000|Overall Study|Withdrawal by Subject|0
868961|NCT00520741|1829772|FG001|Overall Study|Withdrawal by Subject|11
868962|NCT00520741|1829771|FG000|Overall Study|Protocol Violation|2
868963|NCT00520741|1829772|FG001|Overall Study|Protocol Violation|15
868964|NCT00520741|1829771|FG000|Overall Study|Unsatisfactory compliance of subject|4
868965|NCT00520741|1829772|FG001|Overall Study|Unsatisfactory compliance of subject|3
868966|NCT00520741|1829771|FG000|Overall Study|Lost to Follow-up|4
868967|NCT00520741|1829772|FG001|Overall Study|Lost to Follow-up|4
868968|NCT00520741|1829771|FG000|Overall Study|Other reasons for premature termination|0
868969|NCT00520741|1829772|FG001|Overall Study|Other reasons for premature termination|6
868970|NCT00520767|1829780|FG000|Overall Study|Death|2
868971|NCT00520845|1829784|FG000|Overall Study|Death|3
868972|NCT00520845|1829784|FG000|Overall Study|Adverse Event|4
868973|NCT00520845|1829784|FG000|Overall Study|Disease Progression, relapse|13
868974|NCT00520845|1829784|FG000|Overall Study|Withdrawal by Subject|1
868975|NCT00520845|1829784|FG000|Overall Study|Alternative Therapy|1
868976|NCT00520936|1829817|FG000|Overall Study|Physician Decision|0
868977|NCT00520936|1829818|FG001|Overall Study|Physician Decision|2
868978|NCT00520936|1829819|FG002|Overall Study|Physician Decision|1
868979|NCT00520936|1829820|FG003|Overall Study|Physician Decision|0
868980|NCT00520936|1829821|FG004|Overall Study|Physician Decision|0
868981|NCT00520936|1829822|FG005|Overall Study|Physician Decision|0
868982|NCT00520936|1829823|FG006|Overall Study|Physician Decision|0
868983|NCT00520936|1829824|FG007|Overall Study|Physician Decision|0
868984|NCT00520936|1829817|FG000|Overall Study|Withdrawal by Subject|0
868985|NCT00520936|1829818|FG001|Overall Study|Withdrawal by Subject|0
868986|NCT00520936|1829819|FG002|Overall Study|Withdrawal by Subject|0
868987|NCT00520936|1829820|FG003|Overall Study|Withdrawal by Subject|0
868988|NCT00520936|1829821|FG004|Overall Study|Withdrawal by Subject|0
868989|NCT00520936|1829822|FG005|Overall Study|Withdrawal by Subject|0
868990|NCT00520936|1829823|FG006|Overall Study|Withdrawal by Subject|0
868991|NCT00520936|1829824|FG007|Overall Study|Withdrawal by Subject|1
868992|NCT00520936|1829817|FG000|Overall Study|Toxicity Requiring Removal from Study|0
868993|NCT00520936|1829818|FG001|Overall Study|Toxicity Requiring Removal from Study|1
868994|NCT00520936|1829819|FG002|Overall Study|Toxicity Requiring Removal from Study|0
868995|NCT00520936|1829820|FG003|Overall Study|Toxicity Requiring Removal from Study|0
868996|NCT00520936|1829821|FG004|Overall Study|Toxicity Requiring Removal from Study|0
868997|NCT00520936|1829822|FG005|Overall Study|Toxicity Requiring Removal from Study|0
868998|NCT00520936|1829823|FG006|Overall Study|Toxicity Requiring Removal from Study|2
868999|NCT00520936|1829824|FG007|Overall Study|Toxicity Requiring Removal from Study|0
869000|NCT00520936|1829817|FG000|Overall Study|Death|0
869001|NCT00520936|1829818|FG001|Overall Study|Death|0
869002|NCT00520936|1829819|FG002|Overall Study|Death|0
869003|NCT00520936|1829820|FG003|Overall Study|Death|0
869004|NCT00520936|1829821|FG004|Overall Study|Death|0
869005|NCT00520936|1829822|FG005|Overall Study|Death|0
869006|NCT00520936|1829823|FG006|Overall Study|Death|1
869007|NCT00520936|1829824|FG007|Overall Study|Death|0
869008|NCT00520936|1829817|FG000|Overall Study|Protocol Violation|0
869009|NCT00520936|1829818|FG001|Overall Study|Protocol Violation|1
869010|NCT00520936|1829819|FG002|Overall Study|Protocol Violation|1
869011|NCT00520936|1829820|FG003|Overall Study|Protocol Violation|0
869012|NCT00520936|1829821|FG004|Overall Study|Protocol Violation|1
869013|NCT00520936|1829822|FG005|Overall Study|Protocol Violation|0
869014|NCT00520936|1829823|FG006|Overall Study|Protocol Violation|1
869015|NCT00520936|1829824|FG007|Overall Study|Protocol Violation|0
869016|NCT00520975|1829837|FG000|Overall Study|Disease progression|31
869017|NCT00520975|1829838|FG001|Overall Study|Disease progression|23
869018|NCT00520975|1829837|FG000|Overall Study|Adverse Event|7
869019|NCT00520975|1829838|FG001|Overall Study|Adverse Event|10
869020|NCT00520975|1829837|FG000|Overall Study|Death|0
869021|NCT00520975|1829838|FG001|Overall Study|Death|2
869022|NCT00520975|1829837|FG000|Overall Study|Withdrawal by Subject|3
869023|NCT00520975|1829838|FG001|Overall Study|Withdrawal by Subject|5
869024|NCT00520975|1829837|FG000|Overall Study|Other therapy|2
869025|NCT00520975|1829838|FG001|Overall Study|Other therapy|4
869026|NCT00520975|1829837|FG000|Overall Study|Other reasons|4
869027|NCT00520975|1829838|FG001|Overall Study|Other reasons|2
869028|NCT00520975|1829837|FG000|Overall Study|Not start protocol therapy|1
869029|NCT00520975|1829838|FG001|Overall Study|Not start protocol therapy|2
869030|NCT00521001|1829844|FG000|Overall Study|Ineligible|1
869031|NCT00521014|1829848|FG000|Overall Study|Inevaluable, not treated|1
869032|NCT00521053|1829852|FG000|Observation Phase|Disease Progression|55
869033|NCT00521053|1829852|FG000|Observation Phase|Additional PV-10 via alternate protocol|8
869034|NCT00521053|1829852|FG000|Observation Phase|Death|2
869035|NCT00521053|1829852|FG000|Observation Phase|Adverse Event|1
869036|NCT00521053|1829852|FG000|Observation Phase|Other non-study melanoma treatment|1
869037|NCT00521053|1829852|FG000|Observation Phase|Physician Decision|1
869038|NCT00521079|1829861|FG000|Overall Study|Adverse Event|7
869039|NCT00521079|1829862|FG001|Overall Study|Adverse Event|1
869040|NCT00521079|1829861|FG000|Overall Study|Lost to Follow-up|2
869041|NCT00521079|1829862|FG001|Overall Study|Lost to Follow-up|1
869042|NCT00521079|1829861|FG000|Overall Study|Withdrawal by Subject|5
869043|NCT00521079|1829862|FG001|Overall Study|Withdrawal by Subject|3
869044|NCT00521144|1829873|FG000|Overall Study|Not Treated|0
869045|NCT00521144|1829874|FG001|Overall Study|Not Treated|0
869046|NCT00521144|1829875|FG002|Overall Study|Not Treated|0
869047|NCT00521144|1829876|FG003|Overall Study|Not Treated|1
869048|NCT00521144|1829877|FG004|Overall Study|Not Treated|0
869049|NCT00521144|1829873|FG000|Overall Study|Adverse Event|0
869050|NCT00521144|1829874|FG001|Overall Study|Adverse Event|1
869051|NCT00521144|1829875|FG002|Overall Study|Adverse Event|0
869052|NCT00521144|1829876|FG003|Overall Study|Adverse Event|0
869053|NCT00521144|1829877|FG004|Overall Study|Adverse Event|1
869054|NCT00521144|1829873|FG000|Overall Study|Progressive Disease|4
869055|NCT00521144|1829874|FG001|Overall Study|Progressive Disease|2
869056|NCT00521144|1829875|FG002|Overall Study|Progressive Disease|2
869057|NCT00521144|1829876|FG003|Overall Study|Progressive Disease|0
869058|NCT00521144|1829877|FG004|Overall Study|Progressive Disease|6
869059|NCT00521339|1829889|FG000|Treatment Phase|Adverse Event|2
869060|NCT00521339|1829890|FG001|Treatment Phase|Adverse Event|0
869061|NCT00521339|1829891|FG002|Treatment Phase|Adverse Event|0
869062|NCT00521339|1829889|FG000|Treatment Phase|Intolerability to study drug|2
869063|NCT00521339|1829890|FG001|Treatment Phase|Intolerability to study drug|0
869064|NCT00521339|1829891|FG002|Treatment Phase|Intolerability to study drug|0
869065|NCT00521339|1829889|FG000|Treatment Phase|Lack of Efficacy|3
869066|NCT00521339|1829890|FG001|Treatment Phase|Lack of Efficacy|0
869067|NCT00521339|1829891|FG002|Treatment Phase|Lack of Efficacy|0
869068|NCT00521339|1829889|FG000|Treatment Phase|Withdrawal by Subject|3
869069|NCT00521339|1829890|FG001|Treatment Phase|Withdrawal by Subject|0
869070|NCT00521339|1829891|FG002|Treatment Phase|Withdrawal by Subject|0
869071|NCT00521339|1829889|FG000|Treatment Phase|Lost to Follow-up|1
869072|NCT00521339|1829890|FG001|Treatment Phase|Lost to Follow-up|0
869073|NCT00521339|1829891|FG002|Treatment Phase|Lost to Follow-up|0
869074|NCT00521339|1829889|FG000|Treatment Phase|Protocol Violation|1
869075|NCT00521339|1829890|FG001|Treatment Phase|Protocol Violation|0
869076|NCT00521339|1829891|FG002|Treatment Phase|Protocol Violation|0
869077|NCT00521339|1829889|FG000|Treatment Extension Phase|Withdrawal by Subject|0
869078|NCT00521339|1829890|FG001|Treatment Extension Phase|Withdrawal by Subject|0
869079|NCT00521339|1829891|FG002|Treatment Extension Phase|Withdrawal by Subject|2
869080|NCT00521339|1829889|FG000|Treatment Extension Phase|Death|0
869081|NCT00521339|1829890|FG001|Treatment Extension Phase|Death|0
869082|NCT00521339|1829891|FG002|Treatment Extension Phase|Death|1
869083|NCT00521365|1829921|FG000|Overall Study|Adverse Event|3
869084|NCT00521365|1829921|FG000|Overall Study|Lost to Follow-up|6
869085|NCT00521365|1829921|FG000|Overall Study|Protocol deviation|2
869086|NCT00521365|1829921|FG000|Overall Study|Drug compliance|3
869087|NCT00521365|1829921|FG000|Overall Study|Usage of not allowed drugs|6
869088|NCT00521404|1829925|FG000|Overall Study|Adverse Event|13
869089|NCT00521404|1829925|FG000|Overall Study|Disease Progression|33
869090|NCT00521404|1829925|FG000|Overall Study|Investigator decision|5
869091|NCT00521404|1829925|FG000|Overall Study|Withdrawal of consent|3
869092|NCT00521404|1829925|FG000|Overall Study|Noncompliance or lack of cooperation|1
869093|NCT00521404|1829925|FG000|Overall Study|Other|7
869094|NCT00521586|1829940|FG000|Initial Vaccination (Year 0)|Subject request|8
869095|NCT00521586|1829941|FG001|Initial Vaccination (Year 0)|Subject request|11
869096|NCT00521586|1829940|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5
869097|NCT00521586|1829941|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10
869098|NCT00521586|1829940|FG000|Initial Vaccination (Year 0)|Protocol Violation|2
869099|NCT00521586|1829941|FG001|Initial Vaccination (Year 0)|Protocol Violation|5
869100|NCT00521586|1829940|FG000|Initial Vaccination (Year 0)|Other, unspecified|3
869101|NCT00521586|1829941|FG001|Initial Vaccination (Year 0)|Other, unspecified|1
869102|NCT00521586|1829940|FG000|Initial Vaccination (Year 0)|Investigator request|2
869103|NCT00521586|1829941|FG001|Initial Vaccination (Year 0)|Investigator request|0
869104|NCT00521586|1829940|FG000|Initial Vaccination (Year 0)|Adverse Event|0
869105|NCT00521586|1829941|FG001|Initial Vaccination (Year 0)|Adverse Event|1
869106|NCT00521586|1829940|FG000|Initial Vaccination (Year 0)|Death|1
869107|NCT00521586|1829941|FG001|Initial Vaccination (Year 0)|Death|0
869108|NCT00521586|1829940|FG000|Initial Vaccination (Year 0)|Failed to return|0
869109|NCT00521586|1829941|FG001|Initial Vaccination (Year 0)|Failed to return|1
869110|NCT00521586|1829940|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
869111|NCT00521586|1829941|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
869112|NCT00521586|1829940|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
869113|NCT00521586|1829941|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
869114|NCT00521586|1829940|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
869115|NCT00521586|1829941|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
869116|NCT00521586|1829940|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
869117|NCT00521586|1829941|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
869118|NCT00521586|1829940|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
869119|NCT00521586|1829941|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
869120|NCT00521586|1829940|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
869121|NCT00521586|1829941|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
869122|NCT00521586|1829940|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
869123|NCT00521586|1829941|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
869124|NCT00521586|1829940|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
869125|NCT00521586|1829941|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
869126|NCT00521586|1829940|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0
869127|NCT00521586|1829941|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1
869128|NCT00521586|1829940|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1
869129|NCT00521586|1829941|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4
869130|NCT00521586|1829940|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
869131|NCT00521586|1829941|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
869132|NCT00521599|1829962|FG000|Overall Study|Adverse Event|5
869133|NCT00521599|1829963|FG001|Overall Study|Adverse Event|7
869134|NCT00521599|1829964|FG002|Overall Study|Adverse Event|6
869135|NCT00521599|1829962|FG000|Overall Study|Treatment Failure|8
869136|NCT00521599|1829963|FG001|Overall Study|Treatment Failure|9
869137|NCT00521599|1829964|FG002|Overall Study|Treatment Failure|22
869138|NCT00521599|1829962|FG000|Overall Study|Lost to Follow-up|2
869139|NCT00521599|1829963|FG001|Overall Study|Lost to Follow-up|1
869140|NCT00521599|1829964|FG002|Overall Study|Lost to Follow-up|2
869141|NCT00521599|1829962|FG000|Overall Study|Withdrawal by Subject|3
869142|NCT00521599|1829963|FG001|Overall Study|Withdrawal by Subject|5
869143|NCT00521599|1829964|FG002|Overall Study|Withdrawal by Subject|1
869144|NCT00521599|1829962|FG000|Overall Study|Withdrawal by subject treatment related|3
869145|NCT00521599|1829963|FG001|Overall Study|Withdrawal by subject treatment related|1
869146|NCT00521599|1829964|FG002|Overall Study|Withdrawal by subject treatment related|2
869147|NCT00521599|1829962|FG000|Overall Study|Protocol Violation|2
869148|NCT00521599|1829963|FG001|Overall Study|Protocol Violation|4
869149|NCT00521599|1829964|FG002|Overall Study|Protocol Violation|2
869150|NCT00521599|1829962|FG000|Overall Study|Did not meet protocol eligibility|2
869151|NCT00521599|1829963|FG001|Overall Study|Did not meet protocol eligibility|2
869152|NCT00521599|1829964|FG002|Overall Study|Did not meet protocol eligibility|1
869153|NCT00522041|1830000|FG000|Overall Study|Adverse Event|9
869154|NCT00522041|1830001|FG001|Overall Study|Adverse Event|3
869155|NCT00522041|1830000|FG000|Overall Study|Protocol Violation|2
869156|NCT00522041|1830001|FG001|Overall Study|Protocol Violation|0
869157|NCT00522041|1830000|FG000|Overall Study|Lost to Follow-up|1
869158|NCT00522041|1830001|FG001|Overall Study|Lost to Follow-up|4
869159|NCT00522041|1830000|FG000|Overall Study|Voluntary withdrawal|5
869160|NCT00522041|1830001|FG001|Overall Study|Voluntary withdrawal|4
869161|NCT00522041|1830000|FG000|Overall Study|Did not receive treatment|0
869162|NCT00522041|1830001|FG001|Overall Study|Did not receive treatment|1
869163|NCT00522275|1830017|FG000|Overall Study|Adverse Event|35
869164|NCT00522275|1830017|FG000|Overall Study|Lack of Efficacy|80
869165|NCT00522275|1830017|FG000|Overall Study|Subject withdrew consent|16
869166|NCT00522275|1830017|FG000|Overall Study|Protocol deviation|1
869167|NCT00522275|1830017|FG000|Overall Study|Unsatisfactory compliance|11
869168|NCT00522275|1830017|FG000|Overall Study|Lost to Follow-up|8
869169|NCT00522275|1830017|FG000|Overall Study|Other: Subject wants to become pregnant|2
869170|NCT00522275|1830017|FG000|Overall Study|Other: Subject is pregnant|2
869171|NCT00522275|1830017|FG000|Overall Study|Other: Subject relocated|2
869172|NCT00522275|1830017|FG000|Overall Study|Other: Subject arrested|1
869173|NCT00522275|1830017|FG000|Overall Study|Other: Site / clinic closed|4
869174|NCT00522275|1830017|FG000|Overall Study|Other: Travel to / from site difficulty|3
869175|NCT00522275|1830017|FG000|Overall Study|Other: Sponsor request|2
869176|NCT00522275|1830017|FG000|Overall Study|Other: Subject ran out of medication|1
869177|NCT00522275|1830017|FG000|Overall Study|Other: Subject had surgery for epilepsy|2
869178|NCT00522379|1830026|FG000|Overall Study|Adverse Event|12
869179|NCT00522379|1830027|FG001|Overall Study|Adverse Event|15
869180|NCT00522379|1830028|FG002|Overall Study|Adverse Event|12
869181|NCT00522379|1830029|FG003|Overall Study|Adverse Event|5
869182|NCT00522379|1830030|FG004|Overall Study|Adverse Event|17
869183|NCT00522379|1830026|FG000|Overall Study|Lack of Efficacy|3
869184|NCT00522379|1830027|FG001|Overall Study|Lack of Efficacy|0
869185|NCT00522379|1830028|FG002|Overall Study|Lack of Efficacy|2
869186|NCT00522379|1830029|FG003|Overall Study|Lack of Efficacy|2
869187|NCT00522379|1830030|FG004|Overall Study|Lack of Efficacy|7
869188|NCT00522379|1830026|FG000|Overall Study|Withdrawal by Subject|2
869189|NCT00522379|1830027|FG001|Overall Study|Withdrawal by Subject|3
869190|NCT00522379|1830028|FG002|Overall Study|Withdrawal by Subject|1
869191|NCT00522379|1830029|FG003|Overall Study|Withdrawal by Subject|2
869192|NCT00522379|1830030|FG004|Overall Study|Withdrawal by Subject|0
869193|NCT00522379|1830026|FG000|Overall Study|Protocol Violation|1
869194|NCT00522379|1830027|FG001|Overall Study|Protocol Violation|1
869195|NCT00522379|1830028|FG002|Overall Study|Protocol Violation|2
869196|NCT00522379|1830029|FG003|Overall Study|Protocol Violation|0
869197|NCT00522379|1830030|FG004|Overall Study|Protocol Violation|0
869198|NCT00522379|1830026|FG000|Overall Study|Unsatisfactory Subject Compliance|1
869199|NCT00522379|1830027|FG001|Overall Study|Unsatisfactory Subject Compliance|2
869200|NCT00522379|1830028|FG002|Overall Study|Unsatisfactory Subject Compliance|0
869201|NCT00522379|1830029|FG003|Overall Study|Unsatisfactory Subject Compliance|0
869202|NCT00522379|1830030|FG004|Overall Study|Unsatisfactory Subject Compliance|0
869203|NCT00522379|1830026|FG000|Overall Study|Lost to Follow-up|1
869204|NCT00522379|1830027|FG001|Overall Study|Lost to Follow-up|0
869205|NCT00522379|1830028|FG002|Overall Study|Lost to Follow-up|4
869206|NCT00522379|1830029|FG003|Overall Study|Lost to Follow-up|2
869207|NCT00522379|1830030|FG004|Overall Study|Lost to Follow-up|2
869208|NCT00522379|1830026|FG000|Overall Study|Randomization error|0
869209|NCT00522379|1830027|FG001|Overall Study|Randomization error|0
869210|NCT00522379|1830028|FG002|Overall Study|Randomization error|0
869211|NCT00522379|1830029|FG003|Overall Study|Randomization error|0
869212|NCT00522379|1830030|FG004|Overall Study|Randomization error|1
869213|NCT00522379|1830026|FG000|Overall Study|Dispensing error|1
869214|NCT00522379|1830027|FG001|Overall Study|Dispensing error|0
869215|NCT00522379|1830028|FG002|Overall Study|Dispensing error|0
869216|NCT00522379|1830029|FG003|Overall Study|Dispensing error|1
869217|NCT00522379|1830030|FG004|Overall Study|Dispensing error|0
869218|NCT00522379|1830026|FG000|Overall Study|Subject Moved|1
869219|NCT00522379|1830027|FG001|Overall Study|Subject Moved|1
869220|NCT00522379|1830028|FG002|Overall Study|Subject Moved|0
869221|NCT00522379|1830029|FG003|Overall Study|Subject Moved|0
869222|NCT00522379|1830030|FG004|Overall Study|Subject Moved|0
869223|NCT00522379|1830026|FG000|Overall Study|Sponsor Request|0
869224|NCT00522379|1830027|FG001|Overall Study|Sponsor Request|1
869225|NCT00522379|1830028|FG002|Overall Study|Sponsor Request|0
869226|NCT00522379|1830029|FG003|Overall Study|Sponsor Request|0
869227|NCT00522379|1830030|FG004|Overall Study|Sponsor Request|0
869228|NCT00522379|1830026|FG000|Overall Study|Family Problem|0
869229|NCT00522379|1830027|FG001|Overall Study|Family Problem|0
869230|NCT00522379|1830028|FG002|Overall Study|Family Problem|1
869231|NCT00522379|1830029|FG003|Overall Study|Family Problem|0
869232|NCT00522379|1830030|FG004|Overall Study|Family Problem|0
869233|NCT00522379|1830026|FG000|Overall Study|Site Closed|0
869234|NCT00522379|1830027|FG001|Overall Study|Site Closed|0
869235|NCT00522379|1830028|FG002|Overall Study|Site Closed|0
869236|NCT00522379|1830029|FG003|Overall Study|Site Closed|1
869237|NCT00522379|1830030|FG004|Overall Study|Site Closed|0
869238|NCT00522379|1830026|FG000|Overall Study|Subject Withdrawal|0
869239|NCT00522379|1830027|FG001|Overall Study|Subject Withdrawal|0
869240|NCT00522379|1830028|FG002|Overall Study|Subject Withdrawal|0
869241|NCT00522379|1830029|FG003|Overall Study|Subject Withdrawal|1
869242|NCT00522379|1830030|FG004|Overall Study|Subject Withdrawal|0
869243|NCT00522392|1830044|FG000|Overall Study|Disease progression|0
869244|NCT00522392|1830045|FG001|Overall Study|Disease progression|3
869245|NCT00522392|1830044|FG000|Overall Study|Adverse Event|7
869246|NCT00522392|1830045|FG001|Overall Study|Adverse Event|7
869247|NCT00522392|1830044|FG000|Overall Study|Withdrawal by Subject|1
869248|NCT00522392|1830045|FG001|Overall Study|Withdrawal by Subject|1
869249|NCT00522392|1830044|FG000|Overall Study|Physician Decision|0
869250|NCT00522392|1830045|FG001|Overall Study|Physician Decision|1
869251|NCT00522392|1830044|FG000|Overall Study|Non-compliance|0
869252|NCT00522392|1830045|FG001|Overall Study|Non-compliance|1
869253|NCT00522418|1830053|FG000|Overall Study|Local IRB Consent Violation|5
869254|NCT00522418|1830054|FG001|Overall Study|Local IRB Consent Violation|5
869255|NCT00522418|1830053|FG000|Overall Study|Early Study Termination|46
869256|NCT00522418|1830054|FG001|Overall Study|Early Study Termination|47
869257|NCT00522418|1830053|FG000|Overall Study|Noncompliance|2
869258|NCT00522418|1830054|FG001|Overall Study|Noncompliance|2
869259|NCT00522418|1830053|FG000|Overall Study|Reason Not Specified|3
869260|NCT00522418|1830054|FG001|Overall Study|Reason Not Specified|1
869261|NCT00522418|1830053|FG000|Overall Study|Consent Withdraw|1
869262|NCT00522418|1830054|FG001|Overall Study|Consent Withdraw|2
869263|NCT00522418|1830053|FG000|Overall Study|Lack of Efficacy|0
869264|NCT00522418|1830054|FG001|Overall Study|Lack of Efficacy|1
869265|NCT00522431|1830062|FG000|Overall Study|Adverse Event|5
869266|NCT00522431|1830062|FG000|Overall Study|Protocol Violation|2
869267|NCT00522431|1830062|FG000|Overall Study|Withdrawal by Subject|2
869268|NCT00522431|1830062|FG000|Overall Study|Subject non-compliance|1
869269|NCT00522431|1830062|FG000|Overall Study|Other/unknown|1
869270|NCT00522548|1830068|FG000|Overall Study|Adverse Event|2
869271|NCT00522548|1830069|FG001|Overall Study|Adverse Event|2
869272|NCT00522548|1830068|FG000|Overall Study|Withdrawal by Subject|0
869273|NCT00522548|1830069|FG001|Overall Study|Withdrawal by Subject|2
869274|NCT00522626|1830075|FG000|Overall Study|Lost to Follow-up|7
869275|NCT00522873|1830085|FG000|Overall Study|Adverse Event|41
869276|NCT00522873|1830086|FG001|Overall Study|Adverse Event|26
869277|NCT00522873|1830085|FG000|Overall Study|Withdrawal by Subject|20
869278|NCT00522873|1830086|FG001|Overall Study|Withdrawal by Subject|9
869279|NCT00522873|1830085|FG000|Overall Study|Protocol Violation|14
869280|NCT00522873|1830086|FG001|Overall Study|Protocol Violation|4
869281|NCT00522873|1830085|FG000|Overall Study|Lost to Follow-up|11
869282|NCT00522873|1830086|FG001|Overall Study|Lost to Follow-up|3
869283|NCT00522873|1830085|FG000|Overall Study|Personal Reasons|8
869284|NCT00522873|1830086|FG001|Overall Study|Personal Reasons|1
869285|NCT00522873|1830085|FG000|Overall Study|Medication Errors|1
869286|NCT00522873|1830086|FG001|Overall Study|Medication Errors|1
869287|NCT00522873|1830085|FG000|Overall Study|Never Received Medication|1
869288|NCT00522873|1830086|FG001|Overall Study|Never Received Medication|0
869289|NCT00522951|1830105|FG000|Period 1|body motion|0
869290|NCT00522951|1830106|FG001|Period 1|body motion|1
869291|NCT00522951|1830105|FG000|Washout Period|Adverse Event|0
869292|NCT00522951|1830106|FG001|Washout Period|Adverse Event|1
869293|NCT00522951|1830105|FG000|Washout Period|Death|0
869294|NCT00522951|1830106|FG001|Washout Period|Death|1
869295|NCT00522951|1830105|FG000|Period 2|Withdrawal by Subject|1
869296|NCT00522951|1830106|FG001|Period 2|Withdrawal by Subject|0
869297|NCT00522951|1830105|FG000|Period 2|residual contrast medium|1
869298|NCT00522951|1830106|FG001|Period 2|residual contrast medium|1
869299|NCT00523341|1830131|FG000|Overall Study|Withdrawal by Subject|399
869300|NCT00523341|1830132|FG001|Overall Study|Withdrawal by Subject|427
869301|NCT00523341|1830131|FG000|Overall Study|Other|181
869302|NCT00523341|1830132|FG001|Overall Study|Other|198
869303|NCT00523341|1830131|FG000|Overall Study|Adverse Event|122
869304|NCT00523341|1830132|FG001|Overall Study|Adverse Event|155
869305|NCT00523341|1830131|FG000|Overall Study|Death|101
869306|NCT00523341|1830132|FG001|Overall Study|Death|110
869307|NCT00523341|1830131|FG000|Overall Study|Lost to Follow-up|73
869308|NCT00523341|1830132|FG001|Overall Study|Lost to Follow-up|61
869309|NCT00523341|1830131|FG000|Overall Study|Non-compliance|20
869310|NCT00523341|1830132|FG001|Overall Study|Non-compliance|13
869311|NCT00523341|1830131|FG000|Overall Study|Physician Decision|14
869312|NCT00523341|1830132|FG001|Overall Study|Physician Decision|13
869313|NCT00523341|1830131|FG000|Overall Study|Requirement for Alternative Therapy|4
869314|NCT00523341|1830132|FG001|Overall Study|Requirement for Alternative Therapy|14
869315|NCT00523341|1830131|FG000|Overall Study|Protocol Deviation|6
869316|NCT00523341|1830132|FG001|Overall Study|Protocol Deviation|5
869317|NCT00523341|1830131|FG000|Overall Study|Ineligibility Determined|3
869318|NCT00523341|1830132|FG001|Overall Study|Ineligibility Determined|4
869319|NCT00523341|1830131|FG000|Overall Study|Disease Progression|1
869320|NCT00523341|1830132|FG001|Overall Study|Disease Progression|0
869321|NCT00523367|1830138|FG000|Overall Study|19 screen failures|19
869322|NCT00523367|1830138|FG000|Overall Study|4 Withdrawn by PI|4
869323|NCT00523419|1830142|FG000|Overall Study|Adverse Event|1
869324|NCT00523419|1830142|FG000|Overall Study|Withdrawal by Subject|1
869325|NCT00523419|1830142|FG000|Overall Study|Physician Decision|2
869326|NCT00523419|1830142|FG000|Overall Study|Progressive Disease|22
869327|NCT00523419|1830142|FG000|Overall Study|Death due to Study Disease|4
869328|NCT00523419|1830142|FG000|Overall Study|Death due to Adverse Event|2
869329|NCT00523549|1830148|FG000|Overall Study|Adverse Event|6
869330|NCT00523549|1830149|FG001|Overall Study|Adverse Event|3
869331|NCT00523549|1830148|FG000|Overall Study|Unsatisfactory therapeutic effect|0
914226|NCT00813709|1891957|FG005|Open Label Period|Lack of Efficacy|1
869332|NCT00523549|1830149|FG001|Overall Study|Unsatisfactory therapeutic effect|1
869333|NCT00523549|1830148|FG000|Overall Study|Protocol Deviation|3
869334|NCT00523549|1830149|FG001|Overall Study|Protocol Deviation|1
869335|NCT00523549|1830148|FG000|Overall Study|Patient withdrew consent|7
869336|NCT00523549|1830149|FG001|Overall Study|Patient withdrew consent|6
869337|NCT00523549|1830148|FG000|Overall Study|Lost to Follow-up|3
869338|NCT00523549|1830149|FG001|Overall Study|Lost to Follow-up|5
869339|NCT00523640|1830164|FG000|Overall Study|Death|1
869340|NCT00523705|1830170|FG000|Overall Study|No time for study.|0
869341|NCT00523705|1830171|FG001|Overall Study|No time for study.|1
869342|NCT00523718|1830179|FG000|Overall Study|Withdrawal by Subject|1
869343|NCT00523718|1830180|FG001|Overall Study|Withdrawal by Subject|0
869344|NCT00523718|1830179|FG000|Overall Study|Protocol Violation|2
869345|NCT00523718|1830180|FG001|Overall Study|Protocol Violation|0
869346|NCT00523744|1830186|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
869347|NCT00523744|1830186|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
869348|NCT00523744|1830186|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
869349|NCT00523744|1830186|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
869350|NCT00523744|1830186|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
869351|NCT00523744|1830186|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
869352|NCT00523848|1830193|FG000|Overall Study|Adverse Event|11
869353|NCT00523848|1830193|FG000|Overall Study|Withdrawal by Subject|2
869354|NCT00523848|1830193|FG000|Overall Study|NOT TREATED (Became ineligible)|2
869355|NCT00523848|1830193|FG000|Overall Study|Disease Progression|5
869356|NCT00523848|1830193|FG000|Overall Study|Other, unspecified|4
869357|NCT00523978|1830199|FG000|Overall Study|Withdrawal by Subject|3
869358|NCT00523978|1830200|FG001|Overall Study|Withdrawal by Subject|7
869359|NCT00523978|1830199|FG000|Overall Study|Screen Failures|5
869360|NCT00523978|1830200|FG001|Overall Study|Screen Failures|1
869361|NCT00523978|1830199|FG000|Overall Study|Death|1
869362|NCT00523978|1830200|FG001|Overall Study|Death|0
869363|NCT00523991|1830209|FG000|Overall Study|Adverse Event|6
869364|NCT00523991|1830210|FG001|Overall Study|Adverse Event|5
869365|NCT00523991|1830209|FG000|Overall Study|Protocol Violation|1
869366|NCT00523991|1830210|FG001|Overall Study|Protocol Violation|4
869367|NCT00523991|1830209|FG000|Overall Study|Lost to Follow-up|4
869368|NCT00523991|1830210|FG001|Overall Study|Lost to Follow-up|1
869369|NCT00523991|1830209|FG000|Overall Study|Withdrawal by Subject|7
869370|NCT00523991|1830210|FG001|Overall Study|Withdrawal by Subject|17
869371|NCT00523991|1830209|FG000|Overall Study|Other reason (not specified)|3
869372|NCT00523991|1830210|FG001|Overall Study|Other reason (not specified)|0
869373|NCT00524030|1830227|FG000|Overall Study|Lack of Efficacy|10
869374|NCT00524030|1830228|FG001|Overall Study|Lack of Efficacy|24
869375|NCT00524030|1830227|FG000|Overall Study|Lost to Follow-up|0
869376|NCT00524030|1830228|FG001|Overall Study|Lost to Follow-up|2
869377|NCT00524030|1830227|FG000|Overall Study|Withdrawal by Subject|3
869378|NCT00524030|1830228|FG001|Overall Study|Withdrawal by Subject|8
869379|NCT00524030|1830227|FG000|Overall Study|Noncompliance/Investigator discretion|0
869380|NCT00524030|1830228|FG001|Overall Study|Noncompliance/Investigator discretion|2
869381|NCT00524030|1830227|FG000|Overall Study|Protocol Violation|0
869382|NCT00524030|1830228|FG001|Overall Study|Protocol Violation|1
869383|NCT00524030|1830227|FG000|Overall Study|Pregnancy|1
869384|NCT00524030|1830228|FG001|Overall Study|Pregnancy|0
869385|NCT00524030|1830227|FG000|Overall Study|Adverse Event|3
869386|NCT00524030|1830228|FG001|Overall Study|Adverse Event|21
869387|NCT00524030|1830227|FG000|Overall Study|Death|0
869388|NCT00524030|1830228|FG001|Overall Study|Death|1
869389|NCT00524043|1830238|FG000|Overall Study|Lack of Efficacy|15
869390|NCT00524043|1830239|FG001|Overall Study|Lack of Efficacy|13
869391|NCT00524043|1830240|FG002|Overall Study|Lack of Efficacy|14
869392|NCT00524043|1830238|FG000|Overall Study|Withdrawal by Subject|5
869393|NCT00524043|1830239|FG001|Overall Study|Withdrawal by Subject|7
869394|NCT00524043|1830240|FG002|Overall Study|Withdrawal by Subject|7
869395|NCT00524043|1830238|FG000|Overall Study|Adverse Event|5
869396|NCT00524043|1830239|FG001|Overall Study|Adverse Event|2
869397|NCT00524043|1830240|FG002|Overall Study|Adverse Event|7
869398|NCT00524043|1830238|FG000|Overall Study|Lost to Follow-up|3
869399|NCT00524043|1830239|FG001|Overall Study|Lost to Follow-up|5
869400|NCT00524043|1830240|FG002|Overall Study|Lost to Follow-up|3
869401|NCT00524043|1830238|FG000|Overall Study|Various (eg, incarceration)|2
869402|NCT00524043|1830239|FG001|Overall Study|Various (eg, incarceration)|1
869403|NCT00524043|1830240|FG002|Overall Study|Various (eg, incarceration)|0
869404|NCT00524121|1830248|FG000|Overall Study|Disease progression|6
869405|NCT00524121|1830248|FG000|Overall Study|Adverse Event|4
869406|NCT00524121|1830248|FG000|Overall Study|Patient refused|2
869407|NCT00524121|1830248|FG000|Overall Study|Other|1
869408|NCT00524121|1830248|FG000|Overall Study|Death|1
869409|NCT00524121|1830248|FG000|Overall Study|Not treated (became ineligible)|4
869410|NCT00524121|1830248|FG000|Overall Study|Not treated (changed mind)|1
869411|NCT00524173|1830265|FG000|Overall Study|Lost to Follow-up|0
869412|NCT00524173|1830266|FG001|Overall Study|Lost to Follow-up|1
869413|NCT00524173|1830265|FG000|Overall Study|Death|1
869414|NCT00524173|1830266|FG001|Overall Study|Death|0
869415|NCT00524173|1830265|FG000|Overall Study|Had not reached endpoint at study close|4
869416|NCT00524173|1830266|FG001|Overall Study|Had not reached endpoint at study close|1
869417|NCT00524303|1830289|FG000|Overall Study|Lost to Follow-up|6
869418|NCT00524303|1830290|FG001|Overall Study|Lost to Follow-up|0
869419|NCT00524303|1830291|FG002|Overall Study|Lost to Follow-up|3
869420|NCT00524303|1830289|FG000|Overall Study|Protocol Violation|0
869421|NCT00524303|1830290|FG001|Overall Study|Protocol Violation|1
869422|NCT00524303|1830291|FG002|Overall Study|Protocol Violation|1
869423|NCT00524303|1830289|FG000|Overall Study|Withdrawal by Subject|3
869424|NCT00524303|1830290|FG001|Overall Study|Withdrawal by Subject|0
869425|NCT00524303|1830291|FG002|Overall Study|Withdrawal by Subject|4
869426|NCT00524303|1830289|FG000|Overall Study|Death|0
869427|NCT00524303|1830290|FG001|Overall Study|Death|2
869428|NCT00524303|1830291|FG002|Overall Study|Death|3
869429|NCT00524303|1830289|FG000|Overall Study|Adverse Event|1
869430|NCT00524303|1830290|FG001|Overall Study|Adverse Event|2
869431|NCT00524303|1830291|FG002|Overall Study|Adverse Event|3
869432|NCT00524303|1830289|FG000|Overall Study|Did not Complete Study Dosing|1
869433|NCT00524303|1830290|FG001|Overall Study|Did not Complete Study Dosing|0
869434|NCT00524303|1830291|FG002|Overall Study|Did not Complete Study Dosing|0
869435|NCT00524303|1830289|FG000|Overall Study|Worsening Peripheral Neuropathy|1
869436|NCT00524303|1830290|FG001|Overall Study|Worsening Peripheral Neuropathy|0
869437|NCT00524303|1830291|FG002|Overall Study|Worsening Peripheral Neuropathy|0
869438|NCT00524303|1830289|FG000|Overall Study|Disease Progression|0
869439|NCT00524303|1830290|FG001|Overall Study|Disease Progression|4
869440|NCT00524303|1830291|FG002|Overall Study|Disease Progression|1
869441|NCT00524303|1830289|FG000|Overall Study|Disease Recurrence|0
869442|NCT00524303|1830290|FG001|Overall Study|Disease Recurrence|1
869443|NCT00524303|1830291|FG002|Overall Study|Disease Recurrence|0
869444|NCT00524303|1830289|FG000|Overall Study|Sponsor Request|0
869445|NCT00524303|1830290|FG001|Overall Study|Sponsor Request|0
869446|NCT00524303|1830291|FG002|Overall Study|Sponsor Request|1
869447|NCT00524303|1830289|FG000|Overall Study|Physician Decision|0
869448|NCT00524303|1830290|FG001|Overall Study|Physician Decision|0
869449|NCT00524303|1830291|FG002|Overall Study|Physician Decision|1
869450|NCT00524303|1830289|FG000|Overall Study|Completed 5 years|0
869451|NCT00524303|1830290|FG001|Overall Study|Completed 5 years|0
869452|NCT00524303|1830291|FG002|Overall Study|Completed 5 years|1
869453|NCT00524316|1830302|FG000|Overall Study|Withdrawal by Subject|2
869454|NCT00524316|1830302|FG000|Overall Study|Adverse Event|7
869455|NCT00524316|1830302|FG000|Overall Study|Disease Progression|7
869456|NCT00524368|1830312|FG000|Overall Study|Adverse Event|10
869457|NCT00524368|1830313|FG001|Overall Study|Adverse Event|12
869458|NCT00524368|1830312|FG000|Overall Study|Lost to Follow-up|9
869459|NCT00524368|1830313|FG001|Overall Study|Lost to Follow-up|13
869460|NCT00524368|1830312|FG000|Overall Study|Withdrawal by Subject|4
869461|NCT00524368|1830313|FG001|Overall Study|Withdrawal by Subject|5
869462|NCT00524368|1830312|FG000|Overall Study|Non-compliant|8
869463|NCT00524368|1830313|FG001|Overall Study|Non-compliant|9
869464|NCT00524368|1830312|FG000|Overall Study|Reached a Virologic Endpoint|3
869465|NCT00524368|1830313|FG001|Overall Study|Reached a Virologic Endpoint|2
869466|NCT00524368|1830312|FG000|Overall Study|Sponsor's Decision|2
869467|NCT00524368|1830313|FG001|Overall Study|Sponsor's Decision|0
869468|NCT00524368|1830312|FG000|Overall Study|Ineligible to Continue the study|2
869469|NCT00524368|1830313|FG001|Overall Study|Ineligible to Continue the study|5
869470|NCT00524368|1830312|FG000|Overall Study|Other|3
869471|NCT00524368|1830313|FG001|Overall Study|Other|2
869472|NCT00524420|1830321|FG000|Overall Study|Lack of Efficacy|1
869473|NCT00524420|1830322|FG001|Overall Study|Lack of Efficacy|0
869474|NCT00524589|1830352|FG000|Overall Study|Withdrawal by Subject|2
869475|NCT00524589|1830352|FG000|Overall Study|Disease Progression|16
869476|NCT00524680|1830360|FG000|Overall Study|progression|0
869477|NCT00524680|1830361|FG001|Overall Study|progression|0
869478|NCT00524680|1830362|FG002|Overall Study|progression|0
869479|NCT00524680|1830363|FG003|Overall Study|progression|1
869480|NCT00524680|1830360|FG000|Overall Study|Adverse Event|2
869481|NCT00524680|1830361|FG001|Overall Study|Adverse Event|0
869482|NCT00524680|1830362|FG002|Overall Study|Adverse Event|0
869483|NCT00524680|1830363|FG003|Overall Study|Adverse Event|1
869484|NCT00524680|1830360|FG000|Overall Study|Other|0
869485|NCT00524680|1830361|FG001|Overall Study|Other|1
869486|NCT00524680|1830362|FG002|Overall Study|Other|2
869487|NCT00524680|1830363|FG003|Overall Study|Other|3
869488|NCT00524680|1830360|FG000|Overall Study|Withdrawal by Subject|1
869489|NCT00524680|1830361|FG001|Overall Study|Withdrawal by Subject|0
869490|NCT00524680|1830362|FG002|Overall Study|Withdrawal by Subject|1
869491|NCT00524680|1830363|FG003|Overall Study|Withdrawal by Subject|1
869492|NCT00524745|1830377|FG000|Overall Study|subject withdrawal or lost to follow up|34
869493|NCT00524745|1830378|FG001|Overall Study|subject withdrawal or lost to follow up|13
869494|NCT00524745|1830379|FG002|Overall Study|subject withdrawal or lost to follow up|29
869495|NCT00524745|1830380|FG003|Overall Study|subject withdrawal or lost to follow up|22
869496|NCT00524771|1830392|FG000|Overall Study|Protocol Violation|220
869497|NCT00524771|1830393|FG001|Overall Study|Protocol Violation|585
869498|NCT00525031|1830406|FG000|Overall Study|Disease Progression|1
869499|NCT00525031|1830407|FG001|Overall Study|Disease Progression|1
869500|NCT00525044|1830416|FG000|Overall Study|Lost to Follow-up|0
869501|NCT00525044|1830417|FG001|Overall Study|Lost to Follow-up|1
869502|NCT00525148|1830440|FG000|Overall Study|Other Adverse Event|3
869503|NCT00525148|1830441|FG001|Overall Study|Other Adverse Event|5
869504|NCT00525148|1830442|FG002|Overall Study|Other Adverse Event|1
869505|NCT00525148|1830443|FG003|Overall Study|Other Adverse Event|8
869506|NCT00525148|1830440|FG000|Overall Study|Progressive disease|18
869507|NCT00525148|1830441|FG001|Overall Study|Progressive disease|30
869508|NCT00525148|1830442|FG002|Overall Study|Progressive disease|6
869509|NCT00525148|1830443|FG003|Overall Study|Progressive disease|49
869510|NCT00525148|1830440|FG000|Overall Study|Refused continuation of study medication|0
869511|NCT00525148|1830441|FG001|Overall Study|Refused continuation of study medication|2
869512|NCT00525148|1830442|FG002|Overall Study|Refused continuation of study medication|0
869513|NCT00525148|1830443|FG003|Overall Study|Refused continuation of study medication|1
869514|NCT00525148|1830440|FG000|Overall Study|Other than stated|2
869515|NCT00525148|1830441|FG001|Overall Study|Other than stated|1
869516|NCT00525148|1830442|FG002|Overall Study|Other than stated|0
869517|NCT00525148|1830443|FG003|Overall Study|Other than stated|3
869518|NCT00525161|1830453|FG000|Overall Study|Adverse Event|1
869519|NCT00525265|1830468|FG000|Overall Study|Protocol Violation|1
869520|NCT00525265|1830469|FG001|Overall Study|Protocol Violation|0
869521|NCT00525499|1830488|FG000|Overall Study|Lost to Follow-up|2
869522|NCT00525499|1830489|FG001|Overall Study|Lost to Follow-up|4
869523|NCT00525499|1830490|FG002|Overall Study|Lost to Follow-up|1
869524|NCT00525499|1830491|FG003|Overall Study|Lost to Follow-up|4
869525|NCT00525499|1830488|FG000|Overall Study|Adverse Event|0
869526|NCT00525499|1830489|FG001|Overall Study|Adverse Event|1
869527|NCT00525499|1830490|FG002|Overall Study|Adverse Event|0
869528|NCT00525499|1830491|FG003|Overall Study|Adverse Event|1
869529|NCT00525499|1830488|FG000|Overall Study|Withdrawal by Subject|5
869530|NCT00525499|1830489|FG001|Overall Study|Withdrawal by Subject|1
869531|NCT00525499|1830490|FG002|Overall Study|Withdrawal by Subject|5
869532|NCT00525499|1830491|FG003|Overall Study|Withdrawal by Subject|2
869533|NCT00525499|1830488|FG000|Overall Study|Protocol Violation|0
869534|NCT00525499|1830489|FG001|Overall Study|Protocol Violation|1
869535|NCT00525499|1830490|FG002|Overall Study|Protocol Violation|1
869536|NCT00525499|1830491|FG003|Overall Study|Protocol Violation|0
869537|NCT00525512|1830503|FG000|Double-Blind Phase|Adverse Event|48
869538|NCT00525512|1830504|FG001|Double-Blind Phase|Adverse Event|28
869539|NCT00525512|1830505|FG002|Double-Blind Phase|Adverse Event|0
869540|NCT00525512|1830506|FG003|Double-Blind Phase|Adverse Event|0
869541|NCT00525512|1830503|FG000|Double-Blind Phase|Protocol Violation|3
869542|NCT00525512|1830504|FG001|Double-Blind Phase|Protocol Violation|1
869543|NCT00525512|1830505|FG002|Double-Blind Phase|Protocol Violation|0
869544|NCT00525512|1830506|FG003|Double-Blind Phase|Protocol Violation|0
869545|NCT00525512|1830503|FG000|Double-Blind Phase|Lost to Follow-up|3
869546|NCT00525512|1830504|FG001|Double-Blind Phase|Lost to Follow-up|7
869547|NCT00525512|1830505|FG002|Double-Blind Phase|Lost to Follow-up|0
869548|NCT00525512|1830506|FG003|Double-Blind Phase|Lost to Follow-up|0
869549|NCT00525512|1830503|FG000|Double-Blind Phase|Withdrawal by Subject|17
869550|NCT00525512|1830504|FG001|Double-Blind Phase|Withdrawal by Subject|12
869551|NCT00525512|1830505|FG002|Double-Blind Phase|Withdrawal by Subject|0
869552|NCT00525512|1830506|FG003|Double-Blind Phase|Withdrawal by Subject|0
869553|NCT00525512|1830503|FG000|Double-Blind Phase|Lack of Efficacy|13
869554|NCT00525512|1830504|FG001|Double-Blind Phase|Lack of Efficacy|5
869555|NCT00525512|1830505|FG002|Double-Blind Phase|Lack of Efficacy|0
869556|NCT00525512|1830506|FG003|Double-Blind Phase|Lack of Efficacy|0
869557|NCT00525512|1830503|FG000|Double-Blind Phase|Other reason (not specified)|12
869558|NCT00525512|1830504|FG001|Double-Blind Phase|Other reason (not specified)|13
869559|NCT00525512|1830505|FG002|Double-Blind Phase|Other reason (not specified)|0
869560|NCT00525512|1830506|FG003|Double-Blind Phase|Other reason (not specified)|0
869561|NCT00525512|1830503|FG000|Open-Label Phase|Adverse Event|0
869562|NCT00525512|1830504|FG001|Open-Label Phase|Adverse Event|0
869563|NCT00525512|1830505|FG002|Open-Label Phase|Adverse Event|1
869564|NCT00525512|1830506|FG003|Open-Label Phase|Adverse Event|0
869565|NCT00525512|1830503|FG000|Open-Label Phase|Lost to Follow-up|0
869566|NCT00525512|1830504|FG001|Open-Label Phase|Lost to Follow-up|0
869567|NCT00525512|1830505|FG002|Open-Label Phase|Lost to Follow-up|1
869568|NCT00525512|1830506|FG003|Open-Label Phase|Lost to Follow-up|0
869569|NCT00525512|1830503|FG000|Open-Label Phase|Other reason (not specified)|0
869570|NCT00525512|1830504|FG001|Open-Label Phase|Other reason (not specified)|0
869571|NCT00525512|1830505|FG002|Open-Label Phase|Other reason (not specified)|4
869572|NCT00525512|1830506|FG003|Open-Label Phase|Other reason (not specified)|5
869573|NCT00525590|1830527|FG000|Overall Study|Adverse Event|3
869574|NCT00525590|1830527|FG000|Overall Study|Physician Decision|3
869575|NCT00525590|1830527|FG000|Overall Study|Withdrawal by Subject|16
869576|NCT00525590|1830527|FG000|Overall Study|Lost to Follow-up|1
869577|NCT00525590|1830527|FG000|Overall Study|Death|9
869578|NCT00525590|1830527|FG000|Overall Study|Other|13
869579|NCT00525785|1830551|FG000|Overall Study|Withdrawal by Subject|1
869580|NCT00525785|1830551|FG000|Overall Study|Lack of Efficacy|1
869581|NCT00525785|1830551|FG000|Overall Study|Physician Decision|1
869582|NCT00525824|1830568|FG000|Overall Study|Adverse Event|7
869583|NCT00525824|1830569|FG001|Overall Study|Adverse Event|11
869584|NCT00525824|1830570|FG002|Overall Study|Adverse Event|6
869585|NCT00525824|1830571|FG003|Overall Study|Adverse Event|7
869586|NCT00525824|1830568|FG000|Overall Study|Withdrawal by Subject|5
869587|NCT00525824|1830569|FG001|Overall Study|Withdrawal by Subject|9
869588|NCT00525824|1830570|FG002|Overall Study|Withdrawal by Subject|3
869589|NCT00525824|1830571|FG003|Overall Study|Withdrawal by Subject|4
869590|NCT00525824|1830568|FG000|Overall Study|Lost to Follow-up|4
869591|NCT00525824|1830569|FG001|Overall Study|Lost to Follow-up|2
869592|NCT00525824|1830570|FG002|Overall Study|Lost to Follow-up|4
869593|NCT00525824|1830571|FG003|Overall Study|Lost to Follow-up|0
869594|NCT00525824|1830568|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1
869595|NCT00525824|1830569|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2
869596|NCT00525824|1830570|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1
869597|NCT00525824|1830571|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2
869598|NCT00525824|1830568|FG000|Overall Study|Severe non-compliance|0
869599|NCT00525824|1830569|FG001|Overall Study|Severe non-compliance|1
869600|NCT00525824|1830570|FG002|Overall Study|Severe non-compliance|1
869601|NCT00525824|1830571|FG003|Overall Study|Severe non-compliance|1
869602|NCT00525824|1830568|FG000|Overall Study|Safety reasons|1
869603|NCT00525824|1830569|FG001|Overall Study|Safety reasons|0
869604|NCT00525824|1830570|FG002|Overall Study|Safety reasons|1
869605|NCT00525824|1830571|FG003|Overall Study|Safety reasons|0
869606|NCT00525824|1830568|FG000|Overall Study|Other|1
869607|NCT00525824|1830569|FG001|Overall Study|Other|3
869608|NCT00525824|1830570|FG002|Overall Study|Other|3
869609|NCT00525824|1830571|FG003|Overall Study|Other|1
869610|NCT00525902|1830599|FG000|Overall Study|Lack of Efficacy|1
869611|NCT00525915|1830605|FG000|Overall Study|Non-Compliance|0
869612|NCT00525915|1830606|FG001|Overall Study|Non-Compliance|1
869613|NCT00525915|1830605|FG000|Overall Study|Disease Progression|5
869614|NCT00525915|1830606|FG001|Overall Study|Disease Progression|6
869615|NCT00525915|1830605|FG000|Overall Study|Withdrawal by Subject|1
869616|NCT00525915|1830606|FG001|Overall Study|Withdrawal by Subject|0
869617|NCT00525915|1830605|FG000|Overall Study|Refused Surgery|1
869618|NCT00525915|1830606|FG001|Overall Study|Refused Surgery|2
869619|NCT00525915|1830605|FG000|Overall Study|Unrelated illness|1
869620|NCT00525915|1830606|FG001|Overall Study|Unrelated illness|0
869621|NCT00526071|1830621|FG000|Overall Study|Adverse Event|1
869622|NCT00526071|1830621|FG000|Overall Study|Withdrawal by Subject|1
869623|NCT00526071|1830621|FG000|Overall Study|Lack of Response to Study Drug|4
869624|NCT00526097|1830631|FG000|Overall Study|Adverse Event|6
869625|NCT00526097|1830632|FG001|Overall Study|Adverse Event|44
869626|NCT00526097|1830631|FG000|Overall Study|Protocol Violation|4
869627|NCT00526097|1830632|FG001|Overall Study|Protocol Violation|10
869628|NCT00526097|1830631|FG000|Overall Study|Withdrawal by Subject|3
869629|NCT00526097|1830632|FG001|Overall Study|Withdrawal by Subject|1
869630|NCT00526097|1830631|FG000|Overall Study|Other|2
869631|NCT00526097|1830632|FG001|Overall Study|Other|1
869632|NCT00526110|1830640|FG000|Overall Study|Adverse Event|2
869633|NCT00526110|1830641|FG001|Overall Study|Adverse Event|9
869634|NCT00526110|1830640|FG000|Overall Study|Disease Progression|0
869635|NCT00526110|1830641|FG001|Overall Study|Disease Progression|19
869636|NCT00526110|1830640|FG000|Overall Study|Maximal Response|0
869637|NCT00526110|1830641|FG001|Overall Study|Maximal Response|6
869638|NCT00526110|1830640|FG000|Overall Study|Withdrawal by Subject|0
869639|NCT00526110|1830641|FG001|Overall Study|Withdrawal by Subject|2
869640|NCT00526110|1830640|FG000|Overall Study|Poor Tolerance|0
869641|NCT00526110|1830641|FG001|Overall Study|Poor Tolerance|5
869642|NCT00526162|1830656|FG000|Overall Study|Device not implanted|3
869643|NCT00526227|1830668|FG000|Overall Study|Device not implanted|1
869644|NCT00526227|1830668|FG000|Overall Study|Death|1
869645|NCT00526630|1830697|FG000|First Intervention Period - 12 Weeks|Withdrawn|0
869646|NCT00526630|1830698|FG001|First Intervention Period - 12 Weeks|Withdrawn|3
869647|NCT00526630|1830697|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2
869648|NCT00526630|1830698|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1
869649|NCT00526656|1830706|FG000|Overall Study|Death|1
869650|NCT00526656|1830706|FG000|Overall Study|Refused surgery|1
869651|NCT00526669|1830711|FG000|Combined Treatment Phase|Lost to Follow-up|0
869652|NCT00526669|1830712|FG001|Combined Treatment Phase|Lost to Follow-up|2
869653|NCT00526669|1830711|FG000|Combined Treatment Phase|Withdrawal by Subject|0
869654|NCT00526669|1830712|FG001|Combined Treatment Phase|Withdrawal by Subject|2
869655|NCT00526669|1830711|FG000|Combined Treatment Phase|Sponsor Terminated Study|0
869656|NCT00526669|1830712|FG001|Combined Treatment Phase|Sponsor Terminated Study|2
869657|NCT00526669|1830711|FG000|Combined Treatment Phase|Death|0
869658|NCT00526669|1830712|FG001|Combined Treatment Phase|Death|2
869659|NCT00526799|1830720|FG000|Overall Study|Withdrawal by Subject|1
869660|NCT00526799|1830721|FG001|Overall Study|Withdrawal by Subject|0
869661|NCT00526799|1830720|FG000|Overall Study|Intercurrent Complicating Disease|0
869662|NCT00526799|1830721|FG001|Overall Study|Intercurrent Complicating Disease|1
869663|NCT00526890|1830727|FG000|Overall Study|Adverse Event|2
869664|NCT00526994|1830734|FG000|Overall Study|Lost to Follow-up|98
869665|NCT00526994|1830735|FG001|Overall Study|Lost to Follow-up|108
869666|NCT00526994|1830736|FG002|Overall Study|Lost to Follow-up|96
869667|NCT00526994|1830734|FG000|Overall Study|Death|4
869668|NCT00526994|1830735|FG001|Overall Study|Death|3
869669|NCT00526994|1830736|FG002|Overall Study|Death|3
869670|NCT00526994|1830734|FG000|Overall Study|Withdrawal by Subject|2
869671|NCT00526994|1830735|FG001|Overall Study|Withdrawal by Subject|7
869672|NCT00526994|1830736|FG002|Overall Study|Withdrawal by Subject|5
869673|NCT00526994|1830734|FG000|Overall Study|incarcerated, impaired, incomplete|4
869674|NCT00526994|1830735|FG001|Overall Study|incarcerated, impaired, incomplete|3
869675|NCT00526994|1830736|FG002|Overall Study|incarcerated, impaired, incomplete|3
869676|NCT00527072|1830744|FG000|Overall Study|Adverse Event|13
869677|NCT00527072|1830744|FG000|Overall Study|Lack of Efficacy|11
869678|NCT00527072|1830744|FG000|Overall Study|Lost to Follow-up|3
869679|NCT00527072|1830744|FG000|Overall Study|Protocol Violation|2
869680|NCT00527072|1830744|FG000|Overall Study|Withdrawal by Subject|7
869681|NCT00527111|1830759|FG000|Overall Study|Adverse Event|14
869682|NCT00527111|1830760|FG001|Overall Study|Adverse Event|13
869683|NCT00527111|1830759|FG000|Overall Study|Death|0
869684|NCT00527111|1830760|FG001|Overall Study|Death|1
869685|NCT00527111|1830759|FG000|Overall Study|Investigator Request|2
869686|NCT00527111|1830760|FG001|Overall Study|Investigator Request|1
869687|NCT00527111|1830759|FG000|Overall Study|Patient Request|2
869688|NCT00527111|1830760|FG001|Overall Study|Patient Request|5
869689|NCT00527111|1830759|FG000|Overall Study|Other|2
869690|NCT00527111|1830760|FG001|Overall Study|Other|2
869691|NCT00527319|1830778|FG000|Overall Study|Withdrawal by Subject|5
869692|NCT00527319|1830779|FG001|Overall Study|Withdrawal by Subject|0
869693|NCT00527319|1830780|FG002|Overall Study|Withdrawal by Subject|1
869694|NCT00527319|1830778|FG000|Overall Study|Lost to Follow-up|1
869695|NCT00527319|1830779|FG001|Overall Study|Lost to Follow-up|0
869696|NCT00527319|1830780|FG002|Overall Study|Lost to Follow-up|0
869697|NCT00527319|1830778|FG000|Overall Study|Death|0
869698|NCT00527319|1830779|FG001|Overall Study|Death|3
869699|NCT00527319|1830780|FG002|Overall Study|Death|1
869700|NCT00527319|1830778|FG000|Overall Study|Intercurrent Medical Illness|0
869701|NCT00527319|1830779|FG001|Overall Study|Intercurrent Medical Illness|1
869702|NCT00527319|1830780|FG002|Overall Study|Intercurrent Medical Illness|3
869703|NCT00527319|1830778|FG000|Overall Study|Adverse Event|0
869704|NCT00527319|1830779|FG001|Overall Study|Adverse Event|0
869705|NCT00527319|1830780|FG002|Overall Study|Adverse Event|1
869706|NCT00527332|1830790|FG000|Overall Study|Protocol Violation|4
869707|NCT00527332|1830791|FG001|Overall Study|Protocol Violation|8
869708|NCT00527332|1830790|FG000|Overall Study|Withdrew consent|5
869709|NCT00527332|1830791|FG001|Overall Study|Withdrew consent|1
869710|NCT00527397|1830797|FG000|Overall Study|Adverse Event|3
869711|NCT00527397|1830797|FG000|Overall Study|Lack of Efficacy|1
869712|NCT00527397|1830797|FG000|Overall Study|Protocol Violation|1
869713|NCT00527397|1830797|FG000|Overall Study|Withdrawal by Subject|6
869714|NCT00527397|1830797|FG000|Overall Study|Study terminated by sponsor|13
869715|NCT00527423|1830804|FG000|Overall Study|Protocol Violation|1
869716|NCT00527423|1830804|FG000|Overall Study|Adverse Event|5
869717|NCT00527423|1830804|FG000|Overall Study|Physician Decision|4
869718|NCT00527423|1830804|FG000|Overall Study|Withdrawal by Subject|10
869719|NCT00527423|1830804|FG000|Overall Study|Lost to Follow-up|4
869720|NCT00527423|1830804|FG000|Overall Study|OTHER|4
869721|NCT00527423|1830804|FG000|Overall Study|Death|9
869722|NCT00527488|1830823|FG000|Overall Study|Withdrawn prior to dosing|0
869723|NCT00527488|1830824|FG001|Overall Study|Withdrawn prior to dosing|1
869724|NCT00527488|1830825|FG002|Overall Study|Withdrawn prior to dosing|1
869725|NCT00527488|1830826|FG003|Overall Study|Withdrawn prior to dosing|0
869726|NCT00527514|1830836|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
869727|NCT00527514|1830836|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
869728|NCT00527514|1830836|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
869729|NCT00527514|1830836|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
869730|NCT00527514|1830836|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
869731|NCT00527514|1830836|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
869732|NCT00527514|1830836|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
869733|NCT00527605|1830861|FG000|Overall Study|Adverse Event|3
869734|NCT00527605|1830862|FG001|Overall Study|Adverse Event|0
869735|NCT00527605|1830861|FG000|Overall Study|Withdrawal by Subject|3
869736|NCT00527605|1830862|FG001|Overall Study|Withdrawal by Subject|7
869737|NCT00527605|1830861|FG000|Overall Study|Lost to Follow-up|6
869738|NCT00527605|1830862|FG001|Overall Study|Lost to Follow-up|2
869739|NCT00527605|1830861|FG000|Overall Study|Protocol Violation|1
869740|NCT00527605|1830862|FG001|Overall Study|Protocol Violation|2
869741|NCT00527618|1830868|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3
869742|NCT00527618|1830869|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1
869743|NCT00527618|1830868|FG000|Week 1-12 (First Intervention)|Adverse Event|0
869744|NCT00527618|1830869|FG001|Week 1-12 (First Intervention)|Adverse Event|1
869745|NCT00527618|1830868|FG000|Week 13-14 (Washout)|Lost to Follow-up|1
869746|NCT00527618|1830869|FG001|Week 13-14 (Washout)|Lost to Follow-up|0
869747|NCT00527618|1830868|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0
869748|NCT00527618|1830869|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1
869749|NCT00527618|1830868|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
869750|NCT00527618|1830869|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
869751|NCT00527618|1830868|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
869752|NCT00527618|1830869|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
869753|NCT00527735|1830892|FG000|Overall Study|Disease progression|47
869754|NCT00527735|1830893|FG001|Overall Study|Disease progression|61
869755|NCT00527735|1830894|FG002|Overall Study|Disease progression|53
869756|NCT00527735|1830892|FG000|Overall Study|Death|23
869757|NCT00527735|1830893|FG001|Overall Study|Death|13
869758|NCT00527735|1830894|FG002|Overall Study|Death|15
869759|NCT00527735|1830892|FG000|Overall Study|Completed treatment in treatment phase|14
869760|NCT00527735|1830893|FG001|Overall Study|Completed treatment in treatment phase|13
869761|NCT00527735|1830894|FG002|Overall Study|Completed treatment in treatment phase|18
869762|NCT00527735|1830892|FG000|Overall Study|Adverse Event|10
869763|NCT00527735|1830893|FG001|Overall Study|Adverse Event|6
869764|NCT00527735|1830894|FG002|Overall Study|Adverse Event|7
869765|NCT00527735|1830892|FG000|Overall Study|Not identified|5
869766|NCT00527735|1830893|FG001|Overall Study|Not identified|5
869767|NCT00527735|1830894|FG002|Overall Study|Not identified|5
869768|NCT00527735|1830892|FG000|Overall Study|Withdrawal by Subject|5
869769|NCT00527735|1830893|FG001|Overall Study|Withdrawal by Subject|4
869770|NCT00527735|1830894|FG002|Overall Study|Withdrawal by Subject|3
869771|NCT00527735|1830892|FG000|Overall Study|No longer met study criteria|2
869772|NCT00527735|1830893|FG001|Overall Study|No longer met study criteria|2
869773|NCT00527735|1830894|FG002|Overall Study|No longer met study criteria|1
869774|NCT00527735|1830892|FG000|Overall Study|Lost to Follow-up|0
869775|NCT00527735|1830893|FG001|Overall Study|Lost to Follow-up|0
869776|NCT00527735|1830894|FG002|Overall Study|Lost to Follow-up|3
869777|NCT00527735|1830892|FG000|Overall Study|Poor compliance or noncompliance|0
869778|NCT00527735|1830893|FG001|Overall Study|Poor compliance or noncompliance|1
869779|NCT00527735|1830894|FG002|Overall Study|Poor compliance or noncompliance|1
869780|NCT00527735|1830892|FG000|Overall Study|Completed treatment during maintenance|2
869781|NCT00527735|1830893|FG001|Overall Study|Completed treatment during maintenance|2
869782|NCT00527735|1830894|FG002|Overall Study|Completed treatment during maintenance|1
869783|NCT00527787|1830916|FG000|Overall Study|Adverse Event|14
869784|NCT00527787|1830917|FG001|Overall Study|Adverse Event|24
869785|NCT00527787|1830916|FG000|Overall Study|Withdrawal by Subject|13
869786|NCT00527787|1830917|FG001|Overall Study|Withdrawal by Subject|25
869787|NCT00527787|1830916|FG000|Overall Study|Lost to Follow-up|5
869788|NCT00527787|1830917|FG001|Overall Study|Lost to Follow-up|2
869789|NCT00527787|1830916|FG000|Overall Study|Duodenal Ulcer|1
869790|NCT00527787|1830917|FG001|Overall Study|Duodenal Ulcer|10
869791|NCT00527787|1830916|FG000|Overall Study|misc|5
869792|NCT00527787|1830917|FG001|Overall Study|misc|2
869793|NCT00527826|1830925|FG000|Overall Study|Adverse Event|10
869794|NCT00527826|1830926|FG001|Overall Study|Adverse Event|10
869795|NCT00527826|1830925|FG000|Overall Study|Lost to Follow-up|3
869796|NCT00527826|1830926|FG001|Overall Study|Lost to Follow-up|2
869797|NCT00527826|1830925|FG000|Overall Study|Withdrawal by Subject|5
869798|NCT00527826|1830926|FG001|Overall Study|Withdrawal by Subject|8
869799|NCT00527826|1830925|FG000|Overall Study|Inclusion Criteria Not Met|3
869800|NCT00527826|1830926|FG001|Overall Study|Inclusion Criteria Not Met|3
869801|NCT00527826|1830925|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0
869802|NCT00527826|1830926|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1
869803|NCT00527826|1830925|FG000|Overall Study|Additional Intake of Viani forte|0
869804|NCT00527826|1830926|FG001|Overall Study|Additional Intake of Viani forte|1
869805|NCT00527826|1830925|FG000|Overall Study|Participant moved away|0
869806|NCT00527826|1830926|FG001|Overall Study|Participant moved away|1
869807|NCT00527904|1830942|FG000|Overall Study|Adverse Event|45
869808|NCT00527904|1830942|FG000|Overall Study|Withdrawal by Subject|21
869809|NCT00527904|1830942|FG000|Overall Study|Lost to Follow-up|8
869810|NCT00527904|1830942|FG000|Overall Study|misc|22
869811|NCT00528021|1830959|FG000|Overall Study|Lack of Efficacy|17
869812|NCT00528021|1830960|FG001|Overall Study|Lack of Efficacy|13
869813|NCT00528021|1830961|FG002|Overall Study|Lack of Efficacy|7
869814|NCT00528021|1830962|FG003|Overall Study|Lack of Efficacy|9
869815|NCT00528112|1830974|FG000|Treatment up to 3 Years|Adverse Event|313
869816|NCT00528112|1830975|FG001|Treatment up to 3 Years|Adverse Event|278
869817|NCT00528112|1830974|FG000|Treatment up to 3 Years|Withdrawal by Subject|26
869818|NCT00528112|1830975|FG001|Treatment up to 3 Years|Withdrawal by Subject|31
869819|NCT00528112|1830974|FG000|Treatment up to 3 Years|Protocol Violation|16
869820|NCT00528112|1830975|FG001|Treatment up to 3 Years|Protocol Violation|16
869821|NCT00528112|1830974|FG000|Treatment up to 3 Years|Death|0
869822|NCT00528112|1830975|FG001|Treatment up to 3 Years|Death|1
869823|NCT00528112|1830974|FG000|Treatment up to 3 Years|Lost to Follow-up|63
869824|NCT00528112|1830975|FG001|Treatment up to 3 Years|Lost to Follow-up|61
869825|NCT00528112|1830974|FG000|Treatment up to 3 Years|Pregnancy|9
869826|NCT00528112|1830975|FG001|Treatment up to 3 Years|Pregnancy|10
869827|NCT00528112|1830974|FG000|Treatment up to 3 Years|Other reasons|186
869828|NCT00528112|1830975|FG001|Treatment up to 3 Years|Other reasons|186
869829|NCT00528112|1830974|FG000|Extension Phase|Withdrawal by Subject|0
869830|NCT00528112|1830975|FG001|Extension Phase|Withdrawal by Subject|3
869831|NCT00528112|1830974|FG000|Extension Phase|Other reasons|0
869832|NCT00528112|1830975|FG001|Extension Phase|Other reasons|100
869833|NCT00528112|1830974|FG000|Extension Phase|Pregnancy|0
869834|NCT00528112|1830975|FG001|Extension Phase|Pregnancy|3
869835|NCT00528112|1830974|FG000|Extension Phase|Lost to Follow-up|0
869836|NCT00528112|1830975|FG001|Extension Phase|Lost to Follow-up|12
869837|NCT00528112|1830974|FG000|Extension Phase|Death|0
869838|NCT00528112|1830975|FG001|Extension Phase|Death|1
869839|NCT00528112|1830974|FG000|Extension Phase|Adverse Event|0
869840|NCT00528112|1830975|FG001|Extension Phase|Adverse Event|36
869841|NCT00528112|1830974|FG000|Extension Phase|Protocol Violation|0
869842|NCT00528112|1830975|FG001|Extension Phase|Protocol Violation|2
869843|NCT00528372|1831010|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
869844|NCT00528372|1831011|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
869845|NCT00528372|1831012|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
869846|NCT00528372|1831013|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
869847|NCT00528372|1831014|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
869848|NCT00528372|1831015|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
869849|NCT00528372|1831016|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
869850|NCT00528372|1831017|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
869851|NCT00528372|1831018|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
869852|NCT00528372|1831010|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
869853|NCT00528372|1831011|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
869854|NCT00528372|1831012|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
869855|NCT00528372|1831013|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
869856|NCT00528372|1831014|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
869857|NCT00528372|1831015|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
869858|NCT00528372|1831016|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
942960|NCT01004614|1932551|FG001|Washout|Withdrawal by Subject|1
869859|NCT00528372|1831017|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
869860|NCT00528372|1831018|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
869861|NCT00528372|1831010|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
869862|NCT00528372|1831011|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
869863|NCT00528372|1831012|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
869864|NCT00528372|1831013|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
869865|NCT00528372|1831014|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
869866|NCT00528372|1831015|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
869867|NCT00528372|1831016|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
869868|NCT00528372|1831017|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
869869|NCT00528372|1831018|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
869870|NCT00528372|1831010|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
869871|NCT00528372|1831011|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
869872|NCT00528372|1831012|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
869873|NCT00528372|1831013|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
869874|NCT00528372|1831014|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
869875|NCT00528372|1831015|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
869876|NCT00528372|1831016|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
869877|NCT00528372|1831017|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
869878|NCT00528372|1831018|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
869879|NCT00528372|1831010|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
869880|NCT00528372|1831011|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
869881|NCT00528372|1831012|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
869882|NCT00528372|1831013|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
869883|NCT00528372|1831014|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
869884|NCT00528372|1831015|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
869885|NCT00528372|1831016|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
869886|NCT00528372|1831017|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
869887|NCT00528372|1831018|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
942961|NCT01004614|1932552|FG002|Washout|Withdrawal by Subject|0
869888|NCT00528372|1831010|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
869889|NCT00528372|1831011|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
869890|NCT00528372|1831012|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
869891|NCT00528372|1831013|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
869892|NCT00528372|1831014|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
869893|NCT00528372|1831015|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
869894|NCT00528372|1831016|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
869895|NCT00528372|1831017|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
869896|NCT00528372|1831018|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
869897|NCT00528372|1831010|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3
869898|NCT00528372|1831011|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0
869899|NCT00528372|1831012|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0
869900|NCT00528372|1831013|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1
869901|NCT00528372|1831014|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0
869902|NCT00528372|1831015|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0
869903|NCT00528372|1831016|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0
869904|NCT00528372|1831017|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1
869905|NCT00528372|1831018|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0
869906|NCT00528372|1831010|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
869907|NCT00528372|1831011|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
869908|NCT00528372|1831012|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
869909|NCT00528372|1831013|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
869910|NCT00528372|1831014|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
869911|NCT00528372|1831015|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
869912|NCT00528372|1831016|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
869913|NCT00528372|1831017|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
869914|NCT00528372|1831018|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
869915|NCT00528372|1831010|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
869916|NCT00528372|1831011|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
869917|NCT00528372|1831012|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
869918|NCT00528372|1831013|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
869919|NCT00528372|1831014|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
869920|NCT00528372|1831015|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
869921|NCT00528372|1831016|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
869922|NCT00528372|1831017|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
869923|NCT00528372|1831018|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
869924|NCT00528372|1831010|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
869925|NCT00528372|1831011|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
869926|NCT00528372|1831012|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
869927|NCT00528372|1831013|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
869928|NCT00528372|1831014|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
869929|NCT00528372|1831015|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
869930|NCT00528372|1831016|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
869931|NCT00528372|1831017|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
869932|NCT00528372|1831018|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
869933|NCT00528372|1831010|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
869934|NCT00528372|1831011|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
869935|NCT00528372|1831012|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
869936|NCT00528372|1831013|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
869937|NCT00528372|1831014|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
869938|NCT00528372|1831015|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
869939|NCT00528372|1831016|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
869940|NCT00528372|1831017|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
869941|NCT00528372|1831018|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
869942|NCT00528372|1831010|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
869943|NCT00528372|1831011|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
869944|NCT00528372|1831012|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
869945|NCT00528372|1831013|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
869946|NCT00528372|1831014|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
869947|NCT00528372|1831015|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
869948|NCT00528372|1831016|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
869949|NCT00528372|1831017|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
869950|NCT00528372|1831018|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
869951|NCT00528372|1831010|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
869952|NCT00528372|1831011|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
869953|NCT00528372|1831012|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
869954|NCT00528372|1831013|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
869955|NCT00528372|1831014|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
869956|NCT00528372|1831015|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
869957|NCT00528372|1831016|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
869958|NCT00528372|1831017|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
869959|NCT00528372|1831018|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
869960|NCT00528372|1831010|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
869961|NCT00528372|1831011|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
869962|NCT00528372|1831012|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
869963|NCT00528372|1831013|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
869964|NCT00528372|1831014|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
869965|NCT00528372|1831015|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
869966|NCT00528372|1831016|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
869967|NCT00528372|1831017|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
869968|NCT00528372|1831018|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
869969|NCT00528372|1831010|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2
869970|NCT00528372|1831011|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2
942962|NCT01004614|1932553|FG003|Washout|Withdrawal by Subject|0
869971|NCT00528372|1831012|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1
869972|NCT00528372|1831013|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2
869973|NCT00528372|1831014|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3
869974|NCT00528372|1831015|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0
869975|NCT00528372|1831016|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3
869976|NCT00528372|1831017|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1
869977|NCT00528372|1831018|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0
869978|NCT00528411|1831071|FG000|Overall Study|Adverse Event|4
869979|NCT00528411|1831072|FG001|Overall Study|Adverse Event|0
869980|NCT00528411|1831073|FG002|Overall Study|Adverse Event|1
869981|NCT00528411|1831071|FG000|Overall Study|Incorrect Enrolment|1
869982|NCT00528411|1831072|FG001|Overall Study|Incorrect Enrolment|1
869983|NCT00528411|1831073|FG002|Overall Study|Incorrect Enrolment|0
869984|NCT00528411|1831071|FG000|Overall Study|Severe non-compliance to protocol|0
869985|NCT00528411|1831072|FG001|Overall Study|Severe non-compliance to protocol|1
869986|NCT00528411|1831073|FG002|Overall Study|Severe non-compliance to protocol|0
869987|NCT00528411|1831071|FG000|Overall Study|Prior commitment medication|0
869988|NCT00528411|1831072|FG001|Overall Study|Prior commitment medication|1
869989|NCT00528411|1831073|FG002|Overall Study|Prior commitment medication|0
869990|NCT00528424|1831081|FG000|Overall Study|Lost to Follow-up|13
869991|NCT00528424|1831081|FG000|Overall Study|Withdrew consent|2
869992|NCT00528424|1831081|FG000|Overall Study|Administrative reason|2
869993|NCT00528424|1831081|FG000|Overall Study|Other|12
869994|NCT00528528|1831093|FG000|Overall Study|Lost to Follow-up|0
869995|NCT00528528|1831094|FG001|Overall Study|Lost to Follow-up|0
869996|NCT00528528|1831095|FG002|Overall Study|Lost to Follow-up|1
869997|NCT00528528|1831096|FG003|Overall Study|Lost to Follow-up|1
869998|NCT00528528|1831093|FG000|Overall Study|Ineligible to continue the trial|0
869999|NCT00528528|1831094|FG001|Overall Study|Ineligible to continue the trial|0
870000|NCT00528528|1831095|FG002|Overall Study|Ineligible to continue the trial|0
870001|NCT00528528|1831096|FG003|Overall Study|Ineligible to continue the trial|1
870002|NCT00528528|1831093|FG000|Overall Study|Other|0
870003|NCT00528528|1831094|FG001|Overall Study|Other|1
870004|NCT00528528|1831095|FG002|Overall Study|Other|0
870005|NCT00528528|1831096|FG003|Overall Study|Other|0
870006|NCT00528528|1831093|FG000|Overall Study|Withdrawal by Subject|3
870007|NCT00528528|1831094|FG001|Overall Study|Withdrawal by Subject|2
870008|NCT00528528|1831095|FG002|Overall Study|Withdrawal by Subject|1
870009|NCT00528528|1831096|FG003|Overall Study|Withdrawal by Subject|1
870010|NCT00528528|1831093|FG000|Overall Study|Ongoing participant|0
870011|NCT00528528|1831094|FG001|Overall Study|Ongoing participant|0
870012|NCT00528528|1831095|FG002|Overall Study|Ongoing participant|1
870013|NCT00528528|1831096|FG003|Overall Study|Ongoing participant|0
870014|NCT00528567|1831119|FG000|Overall Study|Death|4
870015|NCT00528567|1831120|FG001|Overall Study|Death|5
870016|NCT00528567|1831119|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30
870017|NCT00528567|1831120|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60
870018|NCT00528567|1831119|FG000|Overall Study|Adverse Event/Intermittent Illness|255
870019|NCT00528567|1831120|FG001|Overall Study|Adverse Event/Intermittent Illness|29
870020|NCT00528567|1831119|FG000|Overall Study|Violation Criteria at Entry|3
870021|NCT00528567|1831120|FG001|Overall Study|Violation Criteria at Entry|17
870022|NCT00528567|1831119|FG000|Overall Study|Withdrew Consent|59
870023|NCT00528567|1831120|FG001|Overall Study|Withdrew Consent|55
870024|NCT00528567|1831119|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52
870025|NCT00528567|1831120|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42
870026|NCT00528567|1831119|FG000|Overall Study|Failure to Return|1
870027|NCT00528567|1831120|FG001|Overall Study|Failure to Return|4
870028|NCT00528567|1831119|FG000|Overall Study|Other Protocol Violation|5
870029|NCT00528567|1831120|FG001|Overall Study|Other Protocol Violation|21
870030|NCT00528567|1831119|FG000|Overall Study|Administrative/Other|22
870031|NCT00528567|1831120|FG001|Overall Study|Administrative/Other|75
870032|NCT00528606|1831144|FG000|Overall Study|Withdrew consent|4
870033|NCT00528606|1831145|FG001|Overall Study|Withdrew consent|3
870034|NCT00528606|1831144|FG000|Overall Study|Lost to Follow-up|4
870035|NCT00528606|1831145|FG001|Overall Study|Lost to Follow-up|1
870036|NCT00528606|1831144|FG000|Overall Study|Adverse Event|3
870037|NCT00528606|1831145|FG001|Overall Study|Adverse Event|0
870038|NCT00528606|1831144|FG000|Overall Study|Other|2
870039|NCT00528606|1831145|FG001|Overall Study|Other|0
870040|NCT00528645|1831151|FG000|Overall Study|Adverse Event|3
870041|NCT00528801|1831162|FG000|Overall Study|Withdrawal by Subject|1
870042|NCT00528801|1831163|FG001|Overall Study|Withdrawal by Subject|1
870043|NCT00528801|1831162|FG000|Overall Study|Protocol Violation|11
870044|NCT00528801|1831163|FG001|Overall Study|Protocol Violation|5
870045|NCT00528801|1831162|FG000|Overall Study|Lost to Follow-up|15
870046|NCT00528801|1831163|FG001|Overall Study|Lost to Follow-up|4
870047|NCT00528801|1831162|FG000|Overall Study|Administrative Reasons|0
870048|NCT00528801|1831163|FG001|Overall Study|Administrative Reasons|1
870049|NCT00528840|1831169|FG000|Overall Study|Lost to Follow-up|10
870050|NCT00528840|1831169|FG000|Overall Study|Adverse Event|1
870051|NCT00528840|1831169|FG000|Overall Study|Withdrawal by Subject|17
870052|NCT00528840|1831169|FG000|Overall Study|Death|2
870053|NCT00528840|1831169|FG000|Overall Study|Administrative Reasons|1
870054|NCT00528840|1831169|FG000|Overall Study|Other|2
870055|NCT00528866|1831173|FG000|Overall Study|Protocol Violation|6
870056|NCT00528879|1831182|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
870057|NCT00528879|1831183|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
870058|NCT00528879|1831184|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
870059|NCT00528879|1831185|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
870060|NCT00528879|1831182|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4
870061|NCT00528879|1831183|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4
870062|NCT00528879|1831184|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2
870063|NCT00528879|1831185|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4
870064|NCT00528879|1831182|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
870065|NCT00528879|1831183|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
870066|NCT00528879|1831184|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
870067|NCT00528879|1831185|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
870068|NCT00528879|1831182|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
870069|NCT00528879|1831183|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
870070|NCT00528879|1831184|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
870071|NCT00528879|1831185|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
870072|NCT00528879|1831182|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
870073|NCT00528879|1831183|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
870074|NCT00528879|1831184|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
870075|NCT00528879|1831185|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
870076|NCT00528879|1831182|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
870077|NCT00528879|1831183|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
870078|NCT00528879|1831184|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
870079|NCT00528879|1831185|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
870080|NCT00528879|1831182|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
870081|NCT00528879|1831183|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
870082|NCT00528879|1831184|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
870083|NCT00528879|1831185|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
870084|NCT00528879|1831182|FG000|Short-term Period (Day 1 to Week 24)|Other|0
870085|NCT00528879|1831183|FG001|Short-term Period (Day 1 to Week 24)|Other|0
870086|NCT00528879|1831184|FG002|Short-term Period (Day 1 to Week 24)|Other|1
870087|NCT00528879|1831185|FG003|Short-term Period (Day 1 to Week 24)|Other|1
870088|NCT00528879|1831182|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
870089|NCT00528879|1831183|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
870090|NCT00528879|1831184|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
870091|NCT00528879|1831185|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
870092|NCT00528879|1831182|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5
870093|NCT00528879|1831183|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4
870094|NCT00528879|1831184|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3
870095|NCT00528879|1831185|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2
870096|NCT00528879|1831182|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
870097|NCT00528879|1831183|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
870098|NCT00528879|1831184|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
870099|NCT00528879|1831185|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
870100|NCT00528879|1831182|FG000|Long-term Period (Weeks 24 to 102)|Death|0
870101|NCT00528879|1831183|FG001|Long-term Period (Weeks 24 to 102)|Death|1
870102|NCT00528879|1831184|FG002|Long-term Period (Weeks 24 to 102)|Death|0
870103|NCT00528879|1831185|FG003|Long-term Period (Weeks 24 to 102)|Death|0
870104|NCT00528879|1831182|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
870105|NCT00528879|1831183|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
870106|NCT00528879|1831184|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
870107|NCT00528879|1831185|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
870108|NCT00528879|1831182|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
870109|NCT00528879|1831183|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
870110|NCT00528879|1831184|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
870111|NCT00528879|1831185|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
870112|NCT00528879|1831182|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1
870113|NCT00528879|1831183|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0
870114|NCT00528879|1831184|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0
870115|NCT00528879|1831185|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0
870116|NCT00528879|1831182|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
870117|NCT00528879|1831183|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
870118|NCT00528879|1831184|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
870119|NCT00528879|1831185|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
870120|NCT00528931|1831195|FG000|Overall Study|Lost to Follow-up|1
870121|NCT00528957|1831202|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
870122|NCT00528957|1831203|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
870123|NCT00528957|1831202|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
870124|NCT00528957|1831203|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
870125|NCT00528957|1831202|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
870126|NCT00528957|1831203|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
870127|NCT00528957|1831202|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
870128|NCT00528957|1831203|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
870129|NCT00528957|1831202|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0
870130|NCT00528957|1831203|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1
870131|NCT00528957|1831202|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
870132|NCT00528957|1831203|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
870133|NCT00528957|1831202|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
870134|NCT00528957|1831203|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
870135|NCT00528957|1831202|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
870136|NCT00528957|1831203|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
870137|NCT00528957|1831202|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
870138|NCT00528957|1831203|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
870139|NCT00528957|1831202|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
870140|NCT00528957|1831203|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
870141|NCT00528957|1831202|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
870142|NCT00528957|1831203|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
870143|NCT00528957|1831202|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
870144|NCT00528957|1831203|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
870145|NCT00528957|1831202|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
870146|NCT00528957|1831203|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
870147|NCT00528957|1831202|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
870148|NCT00528957|1831203|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
870149|NCT00528957|1831202|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
870150|NCT00528957|1831203|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
870151|NCT00528957|1831202|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
870152|NCT00528957|1831203|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
870153|NCT00528970|1831222|FG000|Overall Study|Adverse Event|6
870154|NCT00528970|1831223|FG001|Overall Study|Adverse Event|8
870155|NCT00528970|1831224|FG002|Overall Study|Adverse Event|5
870156|NCT00528970|1831222|FG000|Overall Study|Lost to Follow-up|0
870157|NCT00528970|1831223|FG001|Overall Study|Lost to Follow-up|0
870158|NCT00528970|1831224|FG002|Overall Study|Lost to Follow-up|1
870159|NCT00528970|1831222|FG000|Overall Study|Other than specified|2
870160|NCT00528970|1831223|FG001|Overall Study|Other than specified|3
870161|NCT00528970|1831224|FG002|Overall Study|Other than specified|3
870162|NCT00528970|1831222|FG000|Overall Study|Protocol Violation|2
870163|NCT00528970|1831223|FG001|Overall Study|Protocol Violation|1
870164|NCT00528970|1831224|FG002|Overall Study|Protocol Violation|4
870165|NCT00528970|1831222|FG000|Overall Study|Lack of Efficacy|0
870166|NCT00528970|1831223|FG001|Overall Study|Lack of Efficacy|0
870167|NCT00528970|1831224|FG002|Overall Study|Lack of Efficacy|1
870168|NCT00528970|1831222|FG000|Overall Study|Withdrawal by Subject|4
870169|NCT00528970|1831223|FG001|Overall Study|Withdrawal by Subject|3
870170|NCT00528970|1831224|FG002|Overall Study|Withdrawal by Subject|5
870171|NCT00528970|1831222|FG000|Overall Study|Randomized but not treated|0
870172|NCT00528970|1831223|FG001|Overall Study|Randomized but not treated|0
870173|NCT00528970|1831224|FG002|Overall Study|Randomized but not treated|1
870174|NCT00528996|1831237|FG000|Overall Study|Other reasons than listing|6
870175|NCT00528996|1831238|FG001|Overall Study|Other reasons than listing|7
1166401|NCT03539549|2294077|FG000|Overall Study|Adverse Event|12
1166402|NCT03539549|2294077|FG000|Overall Study|Lost to Follow-up|1
1166403|NCT03539549|2294077|FG000|Overall Study|Death|2
1166404|NCT03539549|2294077|FG000|Overall Study|Progressive Disease|1
1166405|NCT03539549|2294077|FG000|Overall Study|Reason not Specified|1
1166406|NCT03540030|2294083|FG000|Overall Study|Withdrawal by Subject|2
1166407|NCT03540030|2294084|FG001|Overall Study|Withdrawal by Subject|1
1166408|NCT03540030|2294083|FG000|Overall Study|screen fail|7
1166409|NCT03540030|2294084|FG001|Overall Study|screen fail|1
1166410|NCT03540030|2294083|FG000|Overall Study|never had surgery after signing consent|9
1166411|NCT03540030|2294084|FG001|Overall Study|never had surgery after signing consent|1
1166412|NCT03540160|2294106|FG000|Overall Study|Protocol Violation|1
1166413|NCT03540160|2294106|FG000|Overall Study|Physician Decision|8
1166414|NCT03540160|2294106|FG000|Overall Study|Lack of Efficacy|60
1166415|NCT03540160|2294106|FG000|Overall Study|Pregnancy|1
1166416|NCT03540160|2294106|FG000|Overall Study|Adverse Event|20
1166417|NCT03540160|2294106|FG000|Overall Study|Withdrawal by Subject|68
1166418|NCT03540160|2294106|FG000|Overall Study|COVID-19|2
1166419|NCT03540160|2294106|FG000|Overall Study|Study Closure|10
1166420|NCT03540160|2294106|FG000|Overall Study|Lost to Follow-up|18
1166421|NCT03540160|2294106|FG000|Overall Study|Sponsor decision|191
1166422|NCT03541044|2294110|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
1166423|NCT03541044|2294111|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
1166424|NCT03541044|2294110|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
1166425|NCT03541044|2294111|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
1166432|NCT03542266|2294205|FG000|Treatment Phase|Withdrawal by Subject|1
1166433|NCT03542266|2294205|FG000|Treatment Phase|Adverse Event|1
1166434|NCT03542266|2294205|FG000|Treatment Phase|PD|1
1166435|NCT03543137|2294234|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
1166436|NCT03543137|2294235|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
1166437|NCT03543137|2294234|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
1166438|NCT03543137|2294235|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
1166439|NCT03543137|2294234|FG000|Study Period 2: Up to Day 8|Adverse Event|0
1166440|NCT03543137|2294235|FG001|Study Period 2: Up to Day 8|Adverse Event|1
1166441|NCT03544333|2294283|FG000|Overall Study|Withdrawal by Subject|1
1166442|NCT03544333|2294284|FG001|Overall Study|Withdrawal by Subject|0
1166443|NCT03545503|2294311|FG000|Overall Study|Protocol Violation|14
1166444|NCT03545503|2294312|FG001|Overall Study|Protocol Violation|16
1166445|NCT03545984|2294329|FG000|Overall Study|CSF cases not present during rotation|11
1166446|NCT03545984|2294330|FG001|Overall Study|CSF cases not present during rotation|9
1166447|NCT03546621|2294368|FG000|Overall Study|Withdrawal by Subject|0
1166448|NCT03546621|2294369|FG001|Overall Study|Withdrawal by Subject|1
1166449|NCT03546621|2294370|FG002|Overall Study|Withdrawal by Subject|2
1166450|NCT03546621|2294371|FG003|Overall Study|Withdrawal by Subject|1
1166451|NCT03546621|2294368|FG000|Overall Study|Lost to Follow-up|0
1166452|NCT03546621|2294369|FG001|Overall Study|Lost to Follow-up|1
1166453|NCT03546621|2294370|FG002|Overall Study|Lost to Follow-up|0
1166454|NCT03546621|2294371|FG003|Overall Study|Lost to Follow-up|0
1166455|NCT03546621|2294368|FG000|Overall Study|Adverse Event|0
1166456|NCT03546621|2294369|FG001|Overall Study|Adverse Event|1
1166457|NCT03546621|2294370|FG002|Overall Study|Adverse Event|0
1166458|NCT03546621|2294371|FG003|Overall Study|Adverse Event|1
1166459|NCT03546621|2294368|FG000|Overall Study|Progressive disease|0
1166460|NCT03546621|2294369|FG001|Overall Study|Progressive disease|0
1166461|NCT03546621|2294370|FG002|Overall Study|Progressive disease|0
1166462|NCT03546621|2294371|FG003|Overall Study|Progressive disease|1
1166463|NCT03546647|2294381|FG000|Overall Study|Adverse Event|1
1166464|NCT03546647|2294382|FG001|Overall Study|Adverse Event|0
1166465|NCT03546816|2294390|FG000|Overall Study|Adverse Event|5
1166466|NCT03546816|2294391|FG001|Overall Study|Adverse Event|3
1166467|NCT03546816|2294390|FG000|Overall Study|Lack of Efficacy|2
1166468|NCT03546816|2294391|FG001|Overall Study|Lack of Efficacy|4
1166469|NCT03546816|2294390|FG000|Overall Study|Pregnancy|1
1166470|NCT03546816|2294391|FG001|Overall Study|Pregnancy|0
1166471|NCT03546816|2294390|FG000|Overall Study|Physician Decision|2
1166472|NCT03546816|2294391|FG001|Overall Study|Physician Decision|0
1166473|NCT03546816|2294390|FG000|Overall Study|Withdrawal by Subject|8
1166474|NCT03546816|2294391|FG001|Overall Study|Withdrawal by Subject|10
1166475|NCT03546816|2294390|FG000|Overall Study|Lost to Follow-up|3
1166476|NCT03546816|2294391|FG001|Overall Study|Lost to Follow-up|2
1166477|NCT03546842|2294399|FG000|Overall Study|Protocol Violation|1
1166478|NCT03546842|2294399|FG000|Overall Study|Withdrawal by Subject|2
1166479|NCT03547154|2294405|FG000|Overall Study|Disease Progression/Recurrence|6
1166480|NCT03547154|2294406|FG001|Overall Study|Disease Progression/Recurrence|14
1166481|NCT03547154|2294405|FG000|Overall Study|Adverse Event|26
1166482|NCT03547154|2294406|FG001|Overall Study|Adverse Event|31
1166483|NCT03547154|2294405|FG000|Overall Study|Protocol Violation|6
1166484|NCT03547154|2294406|FG001|Overall Study|Protocol Violation|1
1166485|NCT03547154|2294405|FG000|Overall Study|Physician Decision|4
1166486|NCT03547154|2294406|FG001|Overall Study|Physician Decision|3
1166487|NCT03547154|2294405|FG000|Overall Study|Insufficient Therapeutic Response|13
1166488|NCT03547154|2294406|FG001|Overall Study|Insufficient Therapeutic Response|10
1166489|NCT03547154|2294405|FG000|Overall Study|Withdrawal by Subject|10
1166490|NCT03547154|2294406|FG001|Overall Study|Withdrawal by Subject|6
1166491|NCT03547154|2294405|FG000|Overall Study|Not Selected|0
1166492|NCT03547154|2294406|FG001|Overall Study|Not Selected|1
1166493|NCT03547154|2294405|FG000|Overall Study|Continued treatment beyond 12 mo.|58
1166494|NCT03547154|2294406|FG001|Overall Study|Continued treatment beyond 12 mo.|50
1166495|NCT03547167|2294414|FG000|Overall Study|Withdrawal by Subject|34
1166496|NCT03547167|2294415|FG001|Overall Study|Withdrawal by Subject|12
1166497|NCT03547167|2294414|FG000|Overall Study|Screen Failure|0
1166498|NCT03547167|2294415|FG001|Overall Study|Screen Failure|1
1166499|NCT03547167|2294414|FG000|Overall Study|Lost to Follow-up|59
1166500|NCT03547167|2294415|FG001|Overall Study|Lost to Follow-up|15
1166501|NCT03547167|2294414|FG000|Overall Study|Death|4
1166502|NCT03547167|2294415|FG001|Overall Study|Death|2
1166503|NCT03547531|2294427|FG000|Overall Study|not coming in data collection : sick|2
1166504|NCT03547531|2294428|FG001|Overall Study|not coming in data collection : sick|2
1166505|NCT03547531|2294427|FG000|Overall Study|having family occasion|0
1166506|NCT03547531|2294428|FG001|Overall Study|having family occasion|2
1166507|NCT03547583|2294437|FG000|Overall Study|Adverse Event|16
1166508|NCT03547583|2294438|FG001|Overall Study|Adverse Event|11
1166509|NCT03547583|2294439|FG002|Overall Study|Adverse Event|10
1166510|NCT03547583|2294437|FG000|Overall Study|Death|11
1166511|NCT03547583|2294438|FG001|Overall Study|Death|7
1166512|NCT03547583|2294439|FG002|Overall Study|Death|4
1166513|NCT03547583|2294437|FG000|Overall Study|Lost to Follow-up|1
1166514|NCT03547583|2294438|FG001|Overall Study|Lost to Follow-up|0
1166515|NCT03547583|2294439|FG002|Overall Study|Lost to Follow-up|0
1166516|NCT03547583|2294437|FG000|Overall Study|Non-compliance with study drug|0
1166517|NCT03547583|2294438|FG001|Overall Study|Non-compliance with study drug|0
1166518|NCT03547583|2294439|FG002|Overall Study|Non-compliance with study drug|1
1166519|NCT03547583|2294437|FG000|Overall Study|Physician Decision|1
1166520|NCT03547583|2294438|FG001|Overall Study|Physician Decision|0
1166521|NCT03547583|2294439|FG002|Overall Study|Physician Decision|3
1166522|NCT03547583|2294437|FG000|Overall Study|Protocol Violation|2
1166523|NCT03547583|2294438|FG001|Overall Study|Protocol Violation|1
1166524|NCT03547583|2294439|FG002|Overall Study|Protocol Violation|1
1166525|NCT03547583|2294437|FG000|Overall Study|Withdrawal by Subject|12
1166526|NCT03547583|2294438|FG001|Overall Study|Withdrawal by Subject|19
1166527|NCT03547583|2294439|FG002|Overall Study|Withdrawal by Subject|10
1166528|NCT03547583|2294437|FG000|Overall Study|Other|2
1166529|NCT03547583|2294438|FG001|Overall Study|Other|2
1166530|NCT03547583|2294439|FG002|Overall Study|Other|3
1166531|NCT03547635|2294453|FG000|Overall Study|Adverse Event|5
1166532|NCT03547635|2294454|FG001|Overall Study|Adverse Event|2
1166533|NCT03547635|2294455|FG002|Overall Study|Adverse Event|3
1166534|NCT03547635|2294453|FG000|Overall Study|Lost to Follow-up|1
1166535|NCT03547635|2294454|FG001|Overall Study|Lost to Follow-up|3
1166536|NCT03547635|2294455|FG002|Overall Study|Lost to Follow-up|4
1166537|NCT03547635|2294453|FG000|Overall Study|Withdrawal by Subject|1
1166538|NCT03547635|2294454|FG001|Overall Study|Withdrawal by Subject|0
1166539|NCT03547635|2294455|FG002|Overall Study|Withdrawal by Subject|0
1166540|NCT03547635|2294453|FG000|Overall Study|Withdrawal By PI|0
1166541|NCT03547635|2294454|FG001|Overall Study|Withdrawal By PI|1
1166542|NCT03547635|2294455|FG002|Overall Study|Withdrawal By PI|0
1166543|NCT03547635|2294453|FG000|Overall Study|Withdrawal by Sponsor|0
1166544|NCT03547635|2294454|FG001|Overall Study|Withdrawal by Sponsor|0
1166545|NCT03547635|2294455|FG002|Overall Study|Withdrawal by Sponsor|1
1166546|NCT03547635|2294453|FG000|Overall Study|Errant Randomization before Treatment|0
1166547|NCT03547635|2294454|FG001|Overall Study|Errant Randomization before Treatment|1
1166548|NCT03547635|2294455|FG002|Overall Study|Errant Randomization before Treatment|0
1166549|NCT03547635|2294453|FG000|Overall Study|Withdrawal by Subject|1
1166550|NCT03547635|2294454|FG001|Overall Study|Withdrawal by Subject|0
870176|NCT00528996|1831239|FG002|Overall Study|Other reasons than listing|14
870177|NCT00528996|1831240|FG003|Overall Study|Other reasons than listing|11
870178|NCT00528996|1831241|FG004|Overall Study|Other reasons than listing|5
1166551|NCT03547635|2294455|FG002|Overall Study|Withdrawal by Subject|0
1166552|NCT03547687|2294463|FG000|Overall Study|Withdrawal by Subject|1
1166553|NCT03547687|2294463|FG000|Overall Study|Death|1
1166554|NCT03548337|2294469|FG000|Infant Series|Withdrawal by Parent/Guardian|8
1166555|NCT03548337|2294470|FG001|Infant Series|Withdrawal by Parent/Guardian|8
1166556|NCT03548337|2294469|FG000|Infant Series|No Longer Met Eligibility Criteria|1
1166557|NCT03548337|2294470|FG001|Infant Series|No Longer Met Eligibility Criteria|0
1166558|NCT03548337|2294469|FG000|Infant Series|Lost to Follow-up|2
1166559|NCT03548337|2294470|FG001|Infant Series|Lost to Follow-up|1
1166560|NCT03548337|2294469|FG000|Infant Series|Adverse Event|0
1166561|NCT03548337|2294470|FG001|Infant Series|Adverse Event|2
1166562|NCT03548337|2294469|FG000|Infant Series|Randomized but Not Vaccinated|1
1166563|NCT03548337|2294470|FG001|Infant Series|Randomized but Not Vaccinated|0
1166564|NCT03548337|2294469|FG000|Toddler Dose|Withdrawal by parent/guardian|1
1166565|NCT03548337|2294470|FG001|Toddler Dose|Withdrawal by parent/guardian|1
1166566|NCT03548935|2294484|FG000|Overall Study|Withdrawal by Subject|26
1166567|NCT03548935|2294485|FG001|Overall Study|Withdrawal by Subject|17
1166568|NCT03548935|2294484|FG000|Overall Study|Lost to Follow-up|39
1166569|NCT03548935|2294485|FG001|Overall Study|Lost to Follow-up|28
1166570|NCT03548935|2294484|FG000|Overall Study|Death|1
1166571|NCT03548935|2294485|FG001|Overall Study|Death|1
1166600|NCT03549117|2294503|FG000|Overall Study|Withdrawal by Subject|1
1166601|NCT03549117|2294504|FG001|Overall Study|Withdrawal by Subject|0
1166602|NCT03549130|2294512|FG000|Overall Study|Adverse Event|0
1166603|NCT03549130|2294513|FG001|Overall Study|Adverse Event|1
1166604|NCT03549130|2294512|FG000|Overall Study|Lost to Follow-up|0
1166605|NCT03549130|2294513|FG001|Overall Study|Lost to Follow-up|1
1166606|NCT03549338|2294533|FG000|Overall Study|Progressive Disease|1
1166607|NCT03549338|2294534|FG001|Overall Study|Progressive Disease|0
1166608|NCT03549338|2294535|FG002|Overall Study|Progressive Disease|0
1166609|NCT03549338|2294533|FG000|Overall Study|Clinical Progression|0
1166610|NCT03549338|2294534|FG001|Overall Study|Clinical Progression|1
1166611|NCT03549338|2294535|FG002|Overall Study|Clinical Progression|0
1166612|NCT03549429|2294543|FG000|Overall Study|Protocol Violation|5
1166613|NCT03549429|2294544|FG001|Overall Study|Protocol Violation|3
1166614|NCT03550209|2294571|FG000|Overall Study|Lost to Follow-up|1
1166615|NCT03550209|2294572|FG001|Overall Study|Lost to Follow-up|0
1166616|NCT03550209|2294573|FG002|Overall Study|Lost to Follow-up|1
1166617|NCT03550209|2294574|FG003|Overall Study|Lost to Follow-up|0
1166618|NCT03550209|2294571|FG000|Overall Study|Withdrawal by Subject|0
1166619|NCT03550209|2294572|FG001|Overall Study|Withdrawal by Subject|3
1166620|NCT03550209|2294573|FG002|Overall Study|Withdrawal by Subject|1
1166621|NCT03550209|2294574|FG003|Overall Study|Withdrawal by Subject|2
1166622|NCT03550209|2294571|FG000|Overall Study|Excluded due to ineligibility after randomization|0
1166623|NCT03550209|2294572|FG001|Overall Study|Excluded due to ineligibility after randomization|0
1166624|NCT03550209|2294573|FG002|Overall Study|Excluded due to ineligibility after randomization|0
1166625|NCT03550209|2294574|FG003|Overall Study|Excluded due to ineligibility after randomization|2
1166626|NCT03550313|2294587|FG000|Overall Study|Adverse Event|0
1166627|NCT03550313|2294588|FG001|Overall Study|Adverse Event|1
1166628|NCT03550313|2294589|FG002|Overall Study|Adverse Event|0
1166629|NCT03550313|2294587|FG000|Overall Study|Lost to Follow-up|5
1166630|NCT03550313|2294588|FG001|Overall Study|Lost to Follow-up|7
1166631|NCT03550313|2294589|FG002|Overall Study|Lost to Follow-up|12
1166632|NCT03550313|2294587|FG000|Overall Study|Study terminated by sponsor|44
1166633|NCT03550313|2294588|FG001|Overall Study|Study terminated by sponsor|37
1166634|NCT03550313|2294589|FG002|Overall Study|Study terminated by sponsor|48
1166635|NCT03550313|2294587|FG000|Overall Study|No longer met eligibility criteria|3
1166636|NCT03550313|2294588|FG001|Overall Study|No longer met eligibility criteria|5
1166637|NCT03550313|2294589|FG002|Overall Study|No longer met eligibility criteria|6
1166638|NCT03550313|2294587|FG000|Overall Study|Withdrawal by parent/guardian|20
1166639|NCT03550313|2294588|FG001|Overall Study|Withdrawal by parent/guardian|18
1166640|NCT03550313|2294589|FG002|Overall Study|Withdrawal by parent/guardian|26
1166641|NCT03550313|2294587|FG000|Overall Study|Other|4
1166642|NCT03550313|2294588|FG001|Overall Study|Other|2
1166643|NCT03550313|2294589|FG002|Overall Study|Other|2
1166644|NCT03550313|2294587|FG000|Overall Study|Randomized but not vaccinated|3
1166645|NCT03550313|2294588|FG001|Overall Study|Randomized but not vaccinated|23
1166646|NCT03550313|2294589|FG002|Overall Study|Randomized but not vaccinated|2
1166647|NCT03550313|2294587|FG000|Overall Study|Sites terminated due to quality issues|18
1166648|NCT03550313|2294588|FG001|Overall Study|Sites terminated due to quality issues|17
1166649|NCT03550313|2294589|FG002|Overall Study|Sites terminated due to quality issues|18
1166650|NCT03551730|2294633|FG000|Overall Study|Adverse Event|1
1166651|NCT03551730|2294634|FG001|Overall Study|Adverse Event|0
1166652|NCT03551730|2294635|FG002|Overall Study|Adverse Event|0
1166653|NCT03551730|2294636|FG003|Overall Study|Adverse Event|0
1166654|NCT03551743|2294650|FG000|Overall Study|Adverse Event|1
1166655|NCT03551743|2294651|FG001|Overall Study|Adverse Event|0
1166656|NCT03551743|2294652|FG002|Overall Study|Adverse Event|0
1166657|NCT03551743|2294653|FG003|Overall Study|Adverse Event|0
1166658|NCT03551743|2294650|FG000|Overall Study|Withdrawal by Subject|1
1166659|NCT03551743|2294651|FG001|Overall Study|Withdrawal by Subject|0
1166660|NCT03551743|2294652|FG002|Overall Study|Withdrawal by Subject|0
1166661|NCT03551743|2294653|FG003|Overall Study|Withdrawal by Subject|0
1166662|NCT03552198|2294671|FG000|Overall Study|Lost to Follow-up|42
1166663|NCT03552198|2294672|FG001|Overall Study|Lost to Follow-up|48
1166664|NCT03552198|2294673|FG002|Overall Study|Lost to Follow-up|15
1166665|NCT03552198|2294674|FG003|Overall Study|Lost to Follow-up|19
1166666|NCT03552198|2294671|FG000|Overall Study|Incomplete/unmatched questionnaire|6
1166667|NCT03552198|2294672|FG001|Overall Study|Incomplete/unmatched questionnaire|7
1166668|NCT03552198|2294673|FG002|Overall Study|Incomplete/unmatched questionnaire|2
1166669|NCT03552198|2294674|FG003|Overall Study|Incomplete/unmatched questionnaire|2
1166670|NCT03552198|2294671|FG000|Overall Study|Did not receive air alerts|1
1166671|NCT03552198|2294672|FG001|Overall Study|Did not receive air alerts|0
1166672|NCT03552198|2294673|FG002|Overall Study|Did not receive air alerts|0
1166673|NCT03552198|2294674|FG003|Overall Study|Did not receive air alerts|1
1166674|NCT03552523|2294693|FG000|Overall Study|Withdrawal by Subject|1
1166675|NCT03552523|2294694|FG001|Overall Study|Withdrawal by Subject|1
1166676|NCT03552549|2294713|FG000|Overall Study|Disease progression|25
1166677|NCT03552549|2294714|FG001|Overall Study|Disease progression|17
1166678|NCT03552549|2294713|FG000|Overall Study|Adverse event in first 12 months|12
1166679|NCT03552549|2294714|FG001|Overall Study|Adverse event in first 12 months|8
1166680|NCT03552549|2294713|FG000|Overall Study|Withdrawal by Subject|7
1166681|NCT03552549|2294714|FG001|Overall Study|Withdrawal by Subject|7
1166682|NCT03552549|2294713|FG000|Overall Study|Unknown (no reason provided)|4
1166683|NCT03552549|2294714|FG001|Overall Study|Unknown (no reason provided)|2
1166684|NCT03552549|2294713|FG000|Overall Study|Not in participant's best interest|2
1166685|NCT03552549|2294714|FG001|Overall Study|Not in participant's best interest|1
1166686|NCT03552549|2294713|FG000|Overall Study|Did not complete study treatment|2
1166687|NCT03552549|2294714|FG001|Overall Study|Did not complete study treatment|3
1166688|NCT03552549|2294713|FG000|Overall Study|Did not meet eligibility criteria|1
1166689|NCT03552549|2294714|FG001|Overall Study|Did not meet eligibility criteria|0
1166690|NCT03552549|2294713|FG000|Overall Study|Administrative|0
1166691|NCT03552549|2294714|FG001|Overall Study|Administrative|14
1166692|NCT03552757|2294723|FG000|Overall Study|Withdrawal by Subject|10
1166693|NCT03552757|2294724|FG001|Overall Study|Withdrawal by Subject|5
1166694|NCT03552757|2294725|FG002|Overall Study|Withdrawal by Subject|12
1166695|NCT03552757|2294723|FG000|Overall Study|Lost to Follow-up|2
1166696|NCT03552757|2294724|FG001|Overall Study|Lost to Follow-up|7
1166697|NCT03552757|2294725|FG002|Overall Study|Lost to Follow-up|7
1166698|NCT03552757|2294723|FG000|Overall Study|Death|1
1166699|NCT03552757|2294724|FG001|Overall Study|Death|1
1166700|NCT03552757|2294725|FG002|Overall Study|Death|1
1166701|NCT03553758|2294736|FG000|Overall Study|Lost to Follow-up|1
1166702|NCT03553823|2294744|FG000|Overall Study|Physician Decision|0
1166703|NCT03553823|2294745|FG001|Overall Study|Physician Decision|1
1166704|NCT03554005|2294766|FG000|Overall Study|Not in participant's best interest|0
1166705|NCT03554005|2294767|FG001|Overall Study|Not in participant's best interest|0
1166706|NCT03554005|2294768|FG002|Overall Study|Not in participant's best interest|0
1166707|NCT03554005|2294769|FG003|Overall Study|Not in participant's best interest|0
1166708|NCT03554005|2294770|FG004|Overall Study|Not in participant's best interest|0
1166709|NCT03554005|2294771|FG005|Overall Study|Not in participant's best interest|1
1166710|NCT03554005|2294766|FG000|Overall Study|Disease Progression|1
1166711|NCT03554005|2294767|FG001|Overall Study|Disease Progression|1
1166712|NCT03554005|2294768|FG002|Overall Study|Disease Progression|1
1166713|NCT03554005|2294769|FG003|Overall Study|Disease Progression|1
1166714|NCT03554005|2294770|FG004|Overall Study|Disease Progression|5
1166715|NCT03554005|2294771|FG005|Overall Study|Disease Progression|6
1166716|NCT03554005|2294766|FG000|Overall Study|Adverse Event|0
1166717|NCT03554005|2294767|FG001|Overall Study|Adverse Event|0
1166718|NCT03554005|2294768|FG002|Overall Study|Adverse Event|0
1166719|NCT03554005|2294769|FG003|Overall Study|Adverse Event|0
1166720|NCT03554005|2294770|FG004|Overall Study|Adverse Event|0
1166721|NCT03554005|2294771|FG005|Overall Study|Adverse Event|3
1166722|NCT03554005|2294766|FG000|Overall Study|Physician Decision|0
1166723|NCT03554005|2294767|FG001|Overall Study|Physician Decision|0
1166724|NCT03554005|2294768|FG002|Overall Study|Physician Decision|0
1166725|NCT03554005|2294769|FG003|Overall Study|Physician Decision|0
1166726|NCT03554005|2294770|FG004|Overall Study|Physician Decision|1
1166727|NCT03554005|2294771|FG005|Overall Study|Physician Decision|0
1166728|NCT03554005|2294766|FG000|Overall Study|Other|0
1166729|NCT03554005|2294767|FG001|Overall Study|Other|0
1166730|NCT03554005|2294768|FG002|Overall Study|Other|0
1166731|NCT03554005|2294769|FG003|Overall Study|Other|0
1166732|NCT03554005|2294770|FG004|Overall Study|Other|0
1166733|NCT03554005|2294771|FG005|Overall Study|Other|1
1166734|NCT03554018|2294787|FG000|Overall Study|Lost to Follow-up|3
1166735|NCT03554018|2294788|FG001|Overall Study|Lost to Follow-up|7
1166736|NCT03554486|2294796|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1
1166737|NCT03554486|2294797|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0
1166738|NCT03554486|2294798|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0
1166739|NCT03554486|2294796|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2
1166740|NCT03554486|2294797|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0
1166741|NCT03554486|2294798|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0
1166742|NCT03554486|2294796|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0
1166743|NCT03554486|2294797|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
1166744|NCT03554486|2294798|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
1166745|NCT03554629|2294805|FG000|Overall Study|Inadequate data|6
1166746|NCT03554772|2294846|FG000|Overall Study|Lost to Follow-up|0
1166747|NCT03554772|2294847|FG001|Overall Study|Lost to Follow-up|0
1166748|NCT03554772|2294848|FG002|Overall Study|Lost to Follow-up|0
1166749|NCT03554772|2294849|FG003|Overall Study|Lost to Follow-up|2
1166750|NCT03555266|2294869|FG000|Overall Study|Protocol Violation|6
1166751|NCT03555266|2294870|FG001|Overall Study|Protocol Violation|4
1166752|NCT03555305|2294876|FG000|Period 1|Physician Decision|0
1166753|NCT03555305|2294877|FG001|Period 1|Physician Decision|1
1166754|NCT03555305|2294876|FG000|Period 1|Adverse Event|0
1166755|NCT03555305|2294877|FG001|Period 1|Adverse Event|1
1166756|NCT03555435|2294886|FG000|Overall Study|Lost to Follow-up|17
1166757|NCT03555435|2294887|FG001|Overall Study|Lost to Follow-up|19
1166758|NCT03555435|2294888|FG002|Overall Study|Lost to Follow-up|8
1166759|NCT03555565|2294896|FG000|Overall Study|Case Report Forms Uncollected|2
1166760|NCT03555565|2294896|FG000|Overall Study|Protocol Deviation|13
1166761|NCT03555890|2294904|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1166762|NCT03555890|2294905|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1166763|NCT03555890|2294906|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1166764|NCT03555890|2294907|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
1166765|NCT03556891|2294939|FG000|Overall Study|Adverse Event|4
1166766|NCT03556891|2294939|FG000|Overall Study|MRI Need|3
1166767|NCT03556891|2294939|FG000|Overall Study|Device Failure|1
1166768|NCT03556891|2294939|FG000|Overall Study|Death|1
1166769|NCT03556891|2294939|FG000|Overall Study|Lost to Follow-up|1
1166770|NCT03556891|2294939|FG000|Overall Study|Missing at random|1
1166771|NCT03556891|2294939|FG000|Overall Study|Missing due to COVID|1
1166772|NCT03556891|2294939|FG000|Overall Study|Protocol Violation|1
1166773|NCT03557034|2294945|FG000|Overall Study|Withdrawal by Subject|1
1166774|NCT03557034|2294946|FG001|Overall Study|Withdrawal by Subject|0
1166775|NCT03557775|2295003|FG000|Overall Study|Withdrawal by Subject|1
1166776|NCT03557775|2295004|FG001|Overall Study|Withdrawal by Subject|2
1166777|NCT03557775|2295005|FG002|Overall Study|Withdrawal by Subject|4
1166778|NCT03557775|2295003|FG000|Overall Study|Physician Decision|0
1166779|NCT03557775|2295004|FG001|Overall Study|Physician Decision|1
1166780|NCT03557775|2295005|FG002|Overall Study|Physician Decision|0
1166781|NCT03557801|2295016|FG000|Overall Study|Protocol Violation|1
1166782|NCT03557801|2295017|FG001|Overall Study|Protocol Violation|0
1166783|NCT03557801|2295018|FG002|Overall Study|Protocol Violation|0
1166784|NCT03557801|2295016|FG000|Overall Study|Withdrawal by Subject|1
1166785|NCT03557801|2295017|FG001|Overall Study|Withdrawal by Subject|0
1166786|NCT03557801|2295018|FG002|Overall Study|Withdrawal by Subject|3
1166787|NCT03557801|2295016|FG000|Overall Study|Lost to Follow-up|0
1166788|NCT03557801|2295017|FG001|Overall Study|Lost to Follow-up|1
1166789|NCT03557801|2295018|FG002|Overall Study|Lost to Follow-up|0
1166790|NCT03557931|2295029|FG000|Overall Study|Adverse Event|4
1166791|NCT03557931|2295030|FG001|Overall Study|Adverse Event|6
1166792|NCT03557931|2295031|FG002|Overall Study|Adverse Event|1
1166793|NCT03557931|2295029|FG000|Overall Study|Lost to Follow-up|4
1166794|NCT03557931|2295030|FG001|Overall Study|Lost to Follow-up|4
1166795|NCT03557931|2295031|FG002|Overall Study|Lost to Follow-up|1
1166796|NCT03557931|2295029|FG000|Overall Study|Protocol Violation|1
1166797|NCT03557931|2295030|FG001|Overall Study|Protocol Violation|4
1166798|NCT03557931|2295031|FG002|Overall Study|Protocol Violation|1
1166799|NCT03557931|2295029|FG000|Overall Study|Withdrawal by Subject|14
1166800|NCT03557931|2295030|FG001|Overall Study|Withdrawal by Subject|0
1166801|NCT03557931|2295031|FG002|Overall Study|Withdrawal by Subject|7
1166802|NCT03557931|2295029|FG000|Overall Study|Miscellaneous|8
1166803|NCT03557931|2295030|FG001|Overall Study|Miscellaneous|5
1166804|NCT03557931|2295031|FG002|Overall Study|Miscellaneous|3
1166805|NCT03558516|2295061|FG000|Overall Study|Protocol Violation|2
1166806|NCT03558516|2295062|FG001|Overall Study|Protocol Violation|2
1166807|NCT03558555|2295070|FG000|Overall Study|Lost to Follow-up|2
1166808|NCT03558555|2295071|FG001|Overall Study|Lost to Follow-up|1
1166809|NCT03558672|2295077|FG000|Overall Study|Study Early Termination|10
1166810|NCT03558997|2295085|FG000|Overall Study|Adverse Event|0
1166811|NCT03558997|2295086|FG001|Overall Study|Adverse Event|2
1166812|NCT03558997|2295087|FG002|Overall Study|Adverse Event|5
1166813|NCT03558997|2295088|FG003|Overall Study|Adverse Event|1
1166814|NCT03558997|2295085|FG000|Overall Study|Physician Decision|0
1166815|NCT03558997|2295086|FG001|Overall Study|Physician Decision|0
1166816|NCT03558997|2295087|FG002|Overall Study|Physician Decision|1
1166817|NCT03558997|2295088|FG003|Overall Study|Physician Decision|0
1166818|NCT03558997|2295085|FG000|Overall Study|Withdrawal by Subject|1
1166819|NCT03558997|2295086|FG001|Overall Study|Withdrawal by Subject|0
1166820|NCT03558997|2295087|FG002|Overall Study|Withdrawal by Subject|1
1166821|NCT03558997|2295088|FG003|Overall Study|Withdrawal by Subject|1
1166822|NCT03558997|2295085|FG000|Overall Study|Lost to Follow-up|0
1166823|NCT03558997|2295086|FG001|Overall Study|Lost to Follow-up|0
1166824|NCT03558997|2295087|FG002|Overall Study|Lost to Follow-up|1
1166825|NCT03558997|2295088|FG003|Overall Study|Lost to Follow-up|0
1166826|NCT03559062|2295104|FG000|Overall Study|Other|0
1166827|NCT03559062|2295105|FG001|Overall Study|Other|1
1166828|NCT03559062|2295106|FG002|Overall Study|Other|0
1166829|NCT03559218|2295148|FG000|Overall Study|Withdrawal by Subject|1
1166830|NCT03559218|2295149|FG001|Overall Study|Withdrawal by Subject|0
1166831|NCT03559257|2295157|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
1166832|NCT03559257|2295158|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
1166833|NCT03559257|2295157|FG000|Double Blind Treatment Period|Protocol Violation|1
1166834|NCT03559257|2295158|FG001|Double Blind Treatment Period|Protocol Violation|4
1166835|NCT03559257|2295157|FG000|Double Blind Treatment Period|Lack of Efficacy|1
1166836|NCT03559257|2295158|FG001|Double Blind Treatment Period|Lack of Efficacy|1
1166837|NCT03559257|2295157|FG000|Double Blind Treatment Period|Adverse Event|0
1166838|NCT03559257|2295158|FG001|Double Blind Treatment Period|Adverse Event|1
1166839|NCT03559257|2295157|FG000|Double Blind Treatment Period|Screen Failure|0
1166840|NCT03559257|2295158|FG001|Double Blind Treatment Period|Screen Failure|1
1166841|NCT03559257|2295157|FG000|Open-label Treatment Period|Adverse Event|1
1166842|NCT03559257|2295158|FG001|Open-label Treatment Period|Adverse Event|4
1166843|NCT03559257|2295157|FG000|Open-label Treatment Period|Lack of Efficacy|3
1166844|NCT03559257|2295158|FG001|Open-label Treatment Period|Lack of Efficacy|2
1166845|NCT03559257|2295157|FG000|Open-label Treatment Period|Withdrawal by Subject|3
1166846|NCT03559257|2295158|FG001|Open-label Treatment Period|Withdrawal by Subject|0
1166847|NCT03559257|2295157|FG000|Open-label Treatment Period|Protocol Violation|2
1166848|NCT03559257|2295158|FG001|Open-label Treatment Period|Protocol Violation|0
1166849|NCT03559257|2295157|FG000|Open-label Treatment Period|Lost to Follow-up|1
1166850|NCT03559257|2295158|FG001|Open-label Treatment Period|Lost to Follow-up|0
1166851|NCT03559257|2295157|FG000|Open-label Treatment Period|Physician Decision|0
1166852|NCT03559257|2295158|FG001|Open-label Treatment Period|Physician Decision|1
1166853|NCT03559517|2295170|FG000|Overall Study|Withdrawal by Subject|1
1166854|NCT03559517|2295171|FG001|Overall Study|Withdrawal by Subject|0
1166855|NCT03559517|2295172|FG002|Overall Study|Withdrawal by Subject|0
1166856|NCT03559530|2295180|FG000|Overall Study|non-location of medical records|44
1166857|NCT03559530|2295181|FG001|Overall Study|non-location of medical records|0
1166858|NCT03559530|2295180|FG000|Overall Study|culture results not considered for treat|29
1166859|NCT03559530|2295181|FG001|Overall Study|culture results not considered for treat|0
1166860|NCT03559530|2295180|FG000|Overall Study|duplicate cases|8
1166861|NCT03559530|2295181|FG001|Overall Study|duplicate cases|0
1166862|NCT03559530|2295180|FG000|Overall Study|other species of Acinetobacte|7
1166863|NCT03559530|2295181|FG001|Overall Study|other species of Acinetobacte|0
1166864|NCT03559530|2295180|FG000|Overall Study|contamination / colonization|3
1166865|NCT03559530|2295181|FG001|Overall Study|contamination / colonization|0
1166866|NCT03560245|2295221|FG000|Overall Study|Withdrawal by Subject|3
1166867|NCT03560245|2295222|FG001|Overall Study|Withdrawal by Subject|2
1166868|NCT03560245|2295221|FG000|Overall Study|Adverse Event|1
1166869|NCT03560245|2295222|FG001|Overall Study|Adverse Event|1
1166870|NCT03560245|2295221|FG000|Overall Study|Protocol Violation|1
1166871|NCT03560245|2295222|FG001|Overall Study|Protocol Violation|0
1166872|NCT03560245|2295221|FG000|Overall Study|Death|0
1166873|NCT03560245|2295222|FG001|Overall Study|Death|1
1166874|NCT03560245|2295221|FG000|Overall Study|Lost to Follow-up|0
1166875|NCT03560245|2295222|FG001|Overall Study|Lost to Follow-up|1
1166876|NCT03560245|2295221|FG000|Overall Study|Physician Decision|0
1166877|NCT03560245|2295222|FG001|Overall Study|Physician Decision|1
1166878|NCT03560245|2295221|FG000|Overall Study|Other|0
1166879|NCT03560245|2295222|FG001|Overall Study|Other|1
1166880|NCT03560518|2295233|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1
1166881|NCT03560518|2295234|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0
1166882|NCT03560518|2295235|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0
1166883|NCT03560518|2295233|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6
1166884|NCT03560518|2295234|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9
1166885|NCT03560518|2295235|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10
1166886|NCT03560518|2295233|FG000|Double Blind Treatment Period|Protocol Violation|1
1166887|NCT03560518|2295234|FG001|Double Blind Treatment Period|Protocol Violation|2
1166888|NCT03560518|2295235|FG002|Double Blind Treatment Period|Protocol Violation|0
1166889|NCT03560518|2295233|FG000|Double Blind Treatment Period|Pregnancy|0
1166890|NCT03560518|2295234|FG001|Double Blind Treatment Period|Pregnancy|2
1166891|NCT03560518|2295235|FG002|Double Blind Treatment Period|Pregnancy|0
1166892|NCT03560518|2295233|FG000|Double Blind Treatment Period|Lost to Follow-up|5
1166893|NCT03560518|2295234|FG001|Double Blind Treatment Period|Lost to Follow-up|6
1166894|NCT03560518|2295235|FG002|Double Blind Treatment Period|Lost to Follow-up|6
1166895|NCT03560518|2295233|FG000|Double Blind Treatment Period|Withdrawal by Subject|10
1166896|NCT03560518|2295234|FG001|Double Blind Treatment Period|Withdrawal by Subject|6
1166897|NCT03560518|2295235|FG002|Double Blind Treatment Period|Withdrawal by Subject|5
1166898|NCT03560518|2295233|FG000|Double Blind Treatment Period|Lack of Efficacy|2
1166899|NCT03560518|2295234|FG001|Double Blind Treatment Period|Lack of Efficacy|1
1166900|NCT03560518|2295235|FG002|Double Blind Treatment Period|Lack of Efficacy|1
1166901|NCT03560518|2295233|FG000|Double Blind Treatment Period|Adverse Event|0
1166902|NCT03560518|2295234|FG001|Double Blind Treatment Period|Adverse Event|3
1166903|NCT03560518|2295235|FG002|Double Blind Treatment Period|Adverse Event|1
1166904|NCT03560739|2295247|FG000|Overall Study|Adverse Event|0
1166905|NCT03560739|2295248|FG001|Overall Study|Adverse Event|1
1166906|NCT03560739|2295249|FG002|Overall Study|Adverse Event|0
1166907|NCT03560739|2295250|FG003|Overall Study|Adverse Event|0
1166908|NCT03560869|2295260|FG000|Overall Study|Withdrawal by Subject|3
1166909|NCT03560869|2295261|FG001|Overall Study|Withdrawal by Subject|4
1166910|NCT03560869|2295260|FG000|Overall Study|Screening failure|4
1166911|NCT03560869|2295261|FG001|Overall Study|Screening failure|4
1166912|NCT03560869|2295260|FG000|Overall Study|Withdrawal by PI|0
1166913|NCT03560869|2295261|FG001|Overall Study|Withdrawal by PI|1
1166914|NCT03560986|2295269|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
1166915|NCT03560986|2295270|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
1166916|NCT03560986|2295269|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
1166917|NCT03560986|2295270|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
1166918|NCT03560986|2295269|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0
1166919|NCT03560986|2295270|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1
1166920|NCT03560986|2295269|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32
1166921|NCT03560986|2295270|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35
1166922|NCT03560986|2295269|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1
1166923|NCT03560986|2295270|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0
1166924|NCT03560986|2295269|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0
1166925|NCT03560986|2295270|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1
1166926|NCT03560986|2295269|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
1166927|NCT03560986|2295270|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
1166928|NCT03561090|2295284|FG000|Overall Study|Adverse Event|11
1166929|NCT03561090|2295285|FG001|Overall Study|Adverse Event|7
1166930|NCT03561090|2295284|FG000|Overall Study|Non-Compliance With Study Drug|2
1166931|NCT03561090|2295285|FG001|Overall Study|Non-Compliance With Study Drug|0
1166932|NCT03561090|2295284|FG000|Overall Study|Protocol Violation|2
1166933|NCT03561090|2295285|FG001|Overall Study|Protocol Violation|2
1166934|NCT03561090|2295284|FG000|Overall Study|Withdrawal by Subject|7
1166935|NCT03561090|2295285|FG001|Overall Study|Withdrawal by Subject|7
1166936|NCT03561090|2295284|FG000|Overall Study|Lost to Follow-up|7
1166937|NCT03561090|2295285|FG001|Overall Study|Lost to Follow-up|2
1166938|NCT03561090|2295284|FG000|Overall Study|Study Terminated by Sponsor|10
1166939|NCT03561090|2295285|FG001|Overall Study|Study Terminated by Sponsor|15
1166940|NCT03561090|2295284|FG000|Overall Study|Randomized by Mistake|1
1166941|NCT03561090|2295285|FG001|Overall Study|Randomized by Mistake|1
1166942|NCT03561090|2295284|FG000|Overall Study|Other Not Specified|0
1166943|NCT03561090|2295285|FG001|Overall Study|Other Not Specified|2
1166944|NCT03561883|2295295|FG000|Overall Study|Adverse Event|10
1166945|NCT03561883|2295296|FG001|Overall Study|Adverse Event|13
1166946|NCT03561883|2295295|FG000|Overall Study|Non-Compliance With Study Drug|1
1166947|NCT03561883|2295296|FG001|Overall Study|Non-Compliance With Study Drug|2
1166948|NCT03561883|2295295|FG000|Overall Study|Protocol Violation|2
1166949|NCT03561883|2295296|FG001|Overall Study|Protocol Violation|3
1166950|NCT03561883|2295295|FG000|Overall Study|Withdrawal by Subject|14
1166951|NCT03561883|2295296|FG001|Overall Study|Withdrawal by Subject|6
1166952|NCT03561883|2295295|FG000|Overall Study|Lost to Follow-up|2
1166953|NCT03561883|2295296|FG001|Overall Study|Lost to Follow-up|6
1166954|NCT03561883|2295295|FG000|Overall Study|Study Terminated by Sponsor|12
1166955|NCT03561883|2295296|FG001|Overall Study|Study Terminated by Sponsor|11
1166956|NCT03561883|2295295|FG000|Overall Study|Physician Decision|1
1166957|NCT03561883|2295296|FG001|Overall Study|Physician Decision|0
1166958|NCT03561883|2295295|FG000|Overall Study|Randomized by Mistake|1
1166959|NCT03561883|2295296|FG001|Overall Study|Randomized by Mistake|0
1166960|NCT03561883|2295295|FG000|Overall Study|Other, Not Specified|3
1166961|NCT03561883|2295296|FG001|Overall Study|Other, Not Specified|2
1166962|NCT03562117|2295305|FG000|Part 1, Up to 3 Days|Adverse Event|1
1166963|NCT03562117|2295306|FG001|Part 1, Up to 3 Days|Adverse Event|0
1166964|NCT03562117|2295307|FG002|Part 1, Up to 3 Days|Adverse Event|0
1166965|NCT03562481|2295326|FG000|First Intervention|Lost to Follow-up|1
1166966|NCT03562481|2295327|FG001|First Intervention|Lost to Follow-up|0
1166967|NCT03563716|2295416|FG000|Overall Study|Death|20
1166968|NCT03563716|2295417|FG001|Overall Study|Death|14
1166969|NCT03563716|2295416|FG000|Overall Study|Withdrawal by Subject|3
1166970|NCT03563716|2295417|FG001|Overall Study|Withdrawal by Subject|3
1166971|NCT03563716|2295416|FG000|Overall Study|Still on Study|45
1166972|NCT03563716|2295417|FG001|Overall Study|Still on Study|50
1166973|NCT03565068|2295467|FG000|Overall Study|Protocol Violation|0
1166974|NCT03565068|2295468|FG001|Overall Study|Protocol Violation|0
1166975|NCT03565068|2295469|FG002|Overall Study|Protocol Violation|0
1166976|NCT03565068|2295470|FG003|Overall Study|Protocol Violation|0
1166977|NCT03565068|2295471|FG004|Overall Study|Protocol Violation|1
1166978|NCT03565068|2295472|FG005|Overall Study|Protocol Violation|0
1166979|NCT03565068|2295473|FG006|Overall Study|Protocol Violation|0
1166980|NCT03565068|2295474|FG007|Overall Study|Protocol Violation|1
1166981|NCT03565068|2295475|FG008|Overall Study|Protocol Violation|0
1166982|NCT03565068|2295467|FG000|Overall Study|Sponsor decision|0
1166983|NCT03565068|2295468|FG001|Overall Study|Sponsor decision|0
1166984|NCT03565068|2295469|FG002|Overall Study|Sponsor decision|0
1166985|NCT03565068|2295470|FG003|Overall Study|Sponsor decision|0
1166986|NCT03565068|2295471|FG004|Overall Study|Sponsor decision|1
1166987|NCT03565068|2295472|FG005|Overall Study|Sponsor decision|1
1166988|NCT03565068|2295473|FG006|Overall Study|Sponsor decision|0
1166989|NCT03565068|2295474|FG007|Overall Study|Sponsor decision|0
1166990|NCT03565068|2295475|FG008|Overall Study|Sponsor decision|0
1166991|NCT03565068|2295467|FG000|Overall Study|Withdrawal by Subject|0
1166992|NCT03565068|2295468|FG001|Overall Study|Withdrawal by Subject|0
1166993|NCT03565068|2295469|FG002|Overall Study|Withdrawal by Subject|1
1166994|NCT03565068|2295470|FG003|Overall Study|Withdrawal by Subject|0
1166995|NCT03565068|2295471|FG004|Overall Study|Withdrawal by Subject|2
1166996|NCT03565068|2295472|FG005|Overall Study|Withdrawal by Subject|0
1166997|NCT03565068|2295473|FG006|Overall Study|Withdrawal by Subject|1
1166998|NCT03565068|2295474|FG007|Overall Study|Withdrawal by Subject|5
1166999|NCT03565068|2295475|FG008|Overall Study|Withdrawal by Subject|1
1167000|NCT03565068|2295467|FG000|Overall Study|Physician Decision|0
1167001|NCT03565068|2295468|FG001|Overall Study|Physician Decision|0
1167002|NCT03565068|2295469|FG002|Overall Study|Physician Decision|0
1167003|NCT03565068|2295470|FG003|Overall Study|Physician Decision|0
1167004|NCT03565068|2295471|FG004|Overall Study|Physician Decision|0
1167005|NCT03565068|2295472|FG005|Overall Study|Physician Decision|0
1167006|NCT03565068|2295473|FG006|Overall Study|Physician Decision|0
1167007|NCT03565068|2295474|FG007|Overall Study|Physician Decision|1
1167008|NCT03565068|2295475|FG008|Overall Study|Physician Decision|0
1167009|NCT03565068|2295467|FG000|Overall Study|Lost to Follow-up|0
1167010|NCT03565068|2295468|FG001|Overall Study|Lost to Follow-up|0
1167011|NCT03565068|2295469|FG002|Overall Study|Lost to Follow-up|0
1167012|NCT03565068|2295470|FG003|Overall Study|Lost to Follow-up|0
1167013|NCT03565068|2295471|FG004|Overall Study|Lost to Follow-up|0
1167014|NCT03565068|2295472|FG005|Overall Study|Lost to Follow-up|0
1167015|NCT03565068|2295473|FG006|Overall Study|Lost to Follow-up|0
1167016|NCT03565068|2295474|FG007|Overall Study|Lost to Follow-up|1
1167017|NCT03565068|2295475|FG008|Overall Study|Lost to Follow-up|0
1167018|NCT03565211|2295532|FG000|Overall Study|Withdrawal by Subject|2
1167019|NCT03565211|2295532|FG000|Overall Study|Lost to Follow-up|1
1167020|NCT03565211|2295532|FG000|Overall Study|Adverse Event|44
1167021|NCT03565211|2295532|FG000|Overall Study|Personal issues|1
1167022|NCT03565315|2295540|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
1167023|NCT03565315|2295541|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
1167024|NCT03565315|2295542|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
1167025|NCT03565315|2295543|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1
1167026|NCT03565887|2295592|FG000|Overall Study|Adverse Event|1
1167027|NCT03565887|2295593|FG001|Overall Study|Adverse Event|0
1167028|NCT03565887|2295592|FG000|Overall Study|Withdrawal by Subject|0
1167029|NCT03565887|2295593|FG001|Overall Study|Withdrawal by Subject|2
1167030|NCT03566238|2295602|FG000|Overall Study|Adverse Event|0
1167031|NCT03566238|2295603|FG001|Overall Study|Adverse Event|1
1167032|NCT03566238|2295604|FG002|Overall Study|Adverse Event|0
1167033|NCT03566238|2295602|FG000|Overall Study|Lack of Efficacy|4
1167034|NCT03566238|2295603|FG001|Overall Study|Lack of Efficacy|2
1167035|NCT03566238|2295604|FG002|Overall Study|Lack of Efficacy|5
1167036|NCT03566238|2295602|FG000|Overall Study|Other|1
1167037|NCT03566238|2295603|FG001|Overall Study|Other|0
1167038|NCT03566238|2295604|FG002|Overall Study|Other|0
1167039|NCT03566485|2295614|FG000|Overall Study|Disease progression|5
1167040|NCT03566485|2295615|FG001|Overall Study|Disease progression|4
1167041|NCT03566485|2295614|FG000|Overall Study|Clinical progression|0
1167042|NCT03566485|2295615|FG001|Overall Study|Clinical progression|1
1167043|NCT03566485|2295614|FG000|Overall Study|Toxicity|0
1167044|NCT03566485|2295615|FG001|Overall Study|Toxicity|2
1167045|NCT03566550|2295623|FG000|Overall Study|Withdrawal by Subject|0
1167046|NCT03566550|2295624|FG001|Overall Study|Withdrawal by Subject|1
1167047|NCT03566680|2295630|FG000|Overall Study|Pregnancy|1
1167048|NCT03566680|2295630|FG000|Overall Study|Lost to Follow-up|13
1167049|NCT03566680|2295630|FG000|Overall Study|Withdrawal by Subject|3
1167050|NCT03566810|2295642|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
1167051|NCT03566810|2295643|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
1167052|NCT03566810|2295644|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
1167053|NCT03566810|2295645|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
1167054|NCT03566823|2295658|FG000|Overall Study|Lack of Efficacy|0
1167055|NCT03566823|2295659|FG001|Overall Study|Lack of Efficacy|1
1167056|NCT03566823|2295660|FG002|Overall Study|Lack of Efficacy|0
1167057|NCT03566823|2295658|FG000|Overall Study|Withdrawal by Subject|1
1167058|NCT03566823|2295659|FG001|Overall Study|Withdrawal by Subject|2
1167059|NCT03566823|2295660|FG002|Overall Study|Withdrawal by Subject|0
1167060|NCT03566823|2295658|FG000|Overall Study|Adverse Event|1
1167061|NCT03566823|2295659|FG001|Overall Study|Adverse Event|0
1167062|NCT03566823|2295660|FG002|Overall Study|Adverse Event|2
1167063|NCT03566979|2295672|FG000|Overall Study|Withdrawal by Subject|2
1167064|NCT03566979|2295673|FG001|Overall Study|Withdrawal by Subject|0
1167065|NCT03566979|2295674|FG002|Overall Study|Withdrawal by Subject|1
1167066|NCT03566979|2295675|FG003|Overall Study|Withdrawal by Subject|1
1167067|NCT03566979|2295672|FG000|Overall Study|Lost to Follow-up|2
1167068|NCT03566979|2295673|FG001|Overall Study|Lost to Follow-up|7
1167069|NCT03566979|2295674|FG002|Overall Study|Lost to Follow-up|9
1167070|NCT03566979|2295675|FG003|Overall Study|Lost to Follow-up|5
1167071|NCT03566979|2295672|FG000|Overall Study|Adverse Event|1
1167072|NCT03566979|2295673|FG001|Overall Study|Adverse Event|0
1167073|NCT03566979|2295674|FG002|Overall Study|Adverse Event|0
1167074|NCT03566979|2295675|FG003|Overall Study|Adverse Event|0
1167075|NCT03567291|2295701|FG000|Period I|Adverse Event|14
1167076|NCT03567291|2295702|FG001|Period I|Adverse Event|0
1167077|NCT03567291|2295703|FG002|Period I|Adverse Event|0
1167078|NCT03567291|2295704|FG003|Period I|Adverse Event|0
1167079|NCT03567291|2295701|FG000|Period I|Protocol Violation|1
1167080|NCT03567291|2295702|FG001|Period I|Protocol Violation|0
1167081|NCT03567291|2295703|FG002|Period I|Protocol Violation|0
1167082|NCT03567291|2295704|FG003|Period I|Protocol Violation|0
1167083|NCT03567291|2295701|FG000|Period I|Withdrawal by Subject|23
1167084|NCT03567291|2295702|FG001|Period I|Withdrawal by Subject|0
1167085|NCT03567291|2295703|FG002|Period I|Withdrawal by Subject|0
1167086|NCT03567291|2295704|FG003|Period I|Withdrawal by Subject|0
1167087|NCT03567291|2295701|FG000|Period I|Lost to Follow-up|2
1167088|NCT03567291|2295702|FG001|Period I|Lost to Follow-up|0
1167089|NCT03567291|2295703|FG002|Period I|Lost to Follow-up|0
1167090|NCT03567291|2295704|FG003|Period I|Lost to Follow-up|0
1167091|NCT03567291|2295701|FG000|Period I|Terminated by sponsor|44
1167092|NCT03567291|2295702|FG001|Period I|Terminated by sponsor|0
1167093|NCT03567291|2295703|FG002|Period I|Terminated by sponsor|0
1167094|NCT03567291|2295704|FG003|Period I|Terminated by sponsor|0
1167095|NCT03567291|2295701|FG000|Period I|Missing or unknown|7
1167096|NCT03567291|2295702|FG001|Period I|Missing or unknown|0
1167097|NCT03567291|2295703|FG002|Period I|Missing or unknown|0
1167098|NCT03567291|2295704|FG003|Period I|Missing or unknown|0
1167099|NCT03567291|2295701|FG000|Period II|Adverse Event|0
1167100|NCT03567291|2295702|FG001|Period II|Adverse Event|1
1167101|NCT03567291|2295703|FG002|Period II|Adverse Event|0
1167102|NCT03567291|2295704|FG003|Period II|Adverse Event|0
1167103|NCT03567291|2295701|FG000|Period II|Missing or unknown|0
1167104|NCT03567291|2295702|FG001|Period II|Missing or unknown|2
1167105|NCT03567291|2295703|FG002|Period II|Missing or unknown|1
1167106|NCT03567291|2295704|FG003|Period II|Missing or unknown|0
1167107|NCT03567291|2295701|FG000|Period III|Adverse Event|0
1167108|NCT03567291|2295702|FG001|Period III|Adverse Event|0
1167109|NCT03567291|2295703|FG002|Period III|Adverse Event|0
1167110|NCT03567291|2295704|FG003|Period III|Adverse Event|4
1167111|NCT03567291|2295701|FG000|Period III|Withdrawal by Subject|0
1167112|NCT03567291|2295702|FG001|Period III|Withdrawal by Subject|0
1167113|NCT03567291|2295703|FG002|Period III|Withdrawal by Subject|0
1167114|NCT03567291|2295704|FG003|Period III|Withdrawal by Subject|4
1167115|NCT03567291|2295701|FG000|Period III|Lost to Follow-up|0
1167116|NCT03567291|2295702|FG001|Period III|Lost to Follow-up|0
1167117|NCT03567291|2295703|FG002|Period III|Lost to Follow-up|0
1167118|NCT03567291|2295704|FG003|Period III|Lost to Follow-up|1
1167119|NCT03567291|2295701|FG000|Period III|Terminated by sponsor|0
1167120|NCT03567291|2295702|FG001|Period III|Terminated by sponsor|0
1167121|NCT03567291|2295703|FG002|Period III|Terminated by sponsor|0
1167122|NCT03567291|2295704|FG003|Period III|Terminated by sponsor|68
1167123|NCT03567291|2295701|FG000|Period III|Missing or unknown|0
1167124|NCT03567291|2295702|FG001|Period III|Missing or unknown|0
1167125|NCT03567291|2295703|FG002|Period III|Missing or unknown|0
1167126|NCT03567291|2295704|FG003|Period III|Missing or unknown|8
1167127|NCT03567382|2295712|FG000|Overall Study|Lost to Follow-up|1
1167128|NCT03567382|2295713|FG001|Overall Study|Lost to Follow-up|21
1167129|NCT03567382|2295714|FG002|Overall Study|Lost to Follow-up|1
1167130|NCT03567382|2295715|FG003|Overall Study|Lost to Follow-up|21
1167131|NCT03567382|2295712|FG000|Overall Study|Withdrawal by Subject|2
1167132|NCT03567382|2295713|FG001|Overall Study|Withdrawal by Subject|14
1167133|NCT03567382|2295714|FG002|Overall Study|Withdrawal by Subject|1
1167134|NCT03567382|2295715|FG003|Overall Study|Withdrawal by Subject|12
1167135|NCT03567616|2295728|FG000|Overall Study|Disease progression|4
1167136|NCT03567616|2295728|FG000|Overall Study|Withdrawal by Subject|1
1167137|NCT03567616|2295728|FG000|Overall Study|Physician Decision|1
1167138|NCT03567616|2295728|FG000|Overall Study|Death|1
1167139|NCT03567616|2295728|FG000|Overall Study|Adverse Event|1
1167140|NCT03567980|2295735|FG000|Overall Study|Adverse Event|1
1167141|NCT03568500|2295742|FG000|Overall Study|Lost to Follow-up|1
1167142|NCT03568500|2295743|FG001|Overall Study|Lost to Follow-up|1
1167143|NCT03568500|2295744|FG002|Overall Study|Lost to Follow-up|2
1167144|NCT03568500|2295742|FG000|Overall Study|Adverse Event|1
1167145|NCT03568500|2295743|FG001|Overall Study|Adverse Event|1
1167146|NCT03568500|2295744|FG002|Overall Study|Adverse Event|2
1167147|NCT03568500|2295742|FG000|Overall Study|Physician Decision|1
1167148|NCT03568500|2295743|FG001|Overall Study|Physician Decision|0
1167149|NCT03568500|2295744|FG002|Overall Study|Physician Decision|0
1167150|NCT03568500|2295742|FG000|Overall Study|Withdrawal by Subject|4
1167151|NCT03568500|2295743|FG001|Overall Study|Withdrawal by Subject|2
1167152|NCT03568500|2295744|FG002|Overall Study|Withdrawal by Subject|0
1167153|NCT03568500|2295742|FG000|Overall Study|Technical Problems|2
1167154|NCT03568500|2295743|FG001|Overall Study|Technical Problems|1
1167155|NCT03568500|2295744|FG002|Overall Study|Technical Problems|0
1167156|NCT03568500|2295742|FG000|Overall Study|Participant Noncompliance|1
1167157|NCT03568500|2295743|FG001|Overall Study|Participant Noncompliance|1
1167158|NCT03568500|2295744|FG002|Overall Study|Participant Noncompliance|0
1167159|NCT03568942|2295767|FG000|Overall Study|Family emergency|1
1167160|NCT03568942|2295767|FG000|Overall Study|Lost to Follow-up|1
1167161|NCT03569098|2295796|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
1167162|NCT03569098|2295797|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2
1167163|NCT03569098|2295798|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
1167164|NCT03569098|2295796|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0
1167165|NCT03569098|2295797|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6
1167166|NCT03569098|2295798|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3
1167167|NCT03569098|2295796|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
1167168|NCT03569098|2295797|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
1167169|NCT03569098|2295798|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0
1167170|NCT03569098|2295796|FG000|Double-Blind Treatment Cycle 1|Technical problems|0
1167171|NCT03569098|2295797|FG001|Double-Blind Treatment Cycle 1|Technical problems|0
1167172|NCT03569098|2295798|FG002|Double-Blind Treatment Cycle 1|Technical problems|2
1167173|NCT03569098|2295796|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1
1167174|NCT03569098|2295797|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0
1167175|NCT03569098|2295798|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0
1167176|NCT03569098|2295796|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0
1167177|NCT03569098|2295797|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1
1167178|NCT03569098|2295798|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0
1167179|NCT03569098|2295796|FG000|Double-Blind Treatment Cycle 1|Other|1
1167180|NCT03569098|2295797|FG001|Double-Blind Treatment Cycle 1|Other|0
1167181|NCT03569098|2295798|FG002|Double-Blind Treatment Cycle 1|Other|1
1167182|NCT03569098|2295796|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
1167183|NCT03569098|2295797|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21
1167184|NCT03569098|2295798|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
1167185|NCT03569098|2295796|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
1167186|NCT03569098|2295797|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11
1167187|NCT03569098|2295798|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
1167188|NCT03569098|2295796|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0
1167189|NCT03569098|2295797|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3
1167190|NCT03569098|2295798|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0
1167191|NCT03569098|2295796|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
1167192|NCT03569098|2295797|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
1167193|NCT03569098|2295798|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4
1167194|NCT03569098|2295796|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0
1167195|NCT03569098|2295797|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
1167196|NCT03569098|2295798|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
1167197|NCT03569098|2295796|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0
1167198|NCT03569098|2295797|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0
1167199|NCT03569098|2295798|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1
1167200|NCT03569202|2295811|FG000|Part 3|Physician Decision|1
1167201|NCT03569202|2295812|FG001|Part 3|Physician Decision|0
1167202|NCT03569202|2295811|FG000|Part 3|Other|1
1167203|NCT03569202|2295812|FG001|Part 3|Other|1
1167204|NCT03569371|2295818|FG000|Overall Study|Lack of Efficacy|1
1167205|NCT03569371|2295818|FG000|Overall Study|Lost to Follow-up|1
1167206|NCT03569371|2295818|FG000|Overall Study|Adverse Event|1
1167207|NCT03570554|2295889|FG000|Overall Study|Non-compliance with study drug|0
1167208|NCT03570554|2295890|FG001|Overall Study|Non-compliance with study drug|0
1167209|NCT03570554|2295891|FG002|Overall Study|Non-compliance with study drug|1
1167210|NCT03570554|2295892|FG003|Overall Study|Non-compliance with study drug|0
1167211|NCT03570554|2295889|FG000|Overall Study|Adverse Event|0
1167212|NCT03570554|2295890|FG001|Overall Study|Adverse Event|0
1167213|NCT03570554|2295891|FG002|Overall Study|Adverse Event|0
1167214|NCT03570554|2295892|FG003|Overall Study|Adverse Event|1
1167215|NCT03570697|2295935|FG000|Overall Study|Lost to Follow-up|0
1167216|NCT03570697|2295936|FG001|Overall Study|Lost to Follow-up|1
1167217|NCT03570697|2295935|FG000|Overall Study|Death|2
1167218|NCT03570697|2295936|FG001|Overall Study|Death|0
1167219|NCT03570697|2295935|FG000|Overall Study|Withdrawal by Subject|4
1167220|NCT03570697|2295936|FG001|Overall Study|Withdrawal by Subject|2
1167221|NCT03571256|2295945|FG000|Overall Study|Adverse Event|3
1167222|NCT03571256|2295946|FG001|Overall Study|Adverse Event|0
1167223|NCT03571256|2295947|FG002|Overall Study|Adverse Event|1
1167224|NCT03571256|2295945|FG000|Overall Study|Withdrawal by Subject|3
1167225|NCT03571256|2295946|FG001|Overall Study|Withdrawal by Subject|1
1167226|NCT03571256|2295947|FG002|Overall Study|Withdrawal by Subject|1
1167227|NCT03571256|2295945|FG000|Overall Study|Other than specified|0
1167228|NCT03571256|2295946|FG001|Overall Study|Other than specified|1
1167229|NCT03571256|2295947|FG002|Overall Study|Other than specified|1
1167230|NCT03571256|2295945|FG000|Overall Study|Protocol Violation|0
1167231|NCT03571256|2295946|FG001|Overall Study|Protocol Violation|1
1167232|NCT03571256|2295947|FG002|Overall Study|Protocol Violation|1
1167233|NCT03571516|2295959|FG000|Overall Study|Severe diarrhea|1
1167234|NCT03571516|2295960|FG001|Overall Study|Severe diarrhea|0
1167235|NCT03571516|2295959|FG000|Overall Study|Withdrawal by Subject|0
1167236|NCT03571516|2295960|FG001|Overall Study|Withdrawal by Subject|1
1167237|NCT03572062|2296030|FG000|Overall Study|Adverse Event|0
1167238|NCT03572062|2296031|FG001|Overall Study|Adverse Event|0
1167239|NCT03572062|2296032|FG002|Overall Study|Adverse Event|0
1167240|NCT03572062|2296033|FG003|Overall Study|Adverse Event|0
1167241|NCT03572062|2296034|FG004|Overall Study|Adverse Event|0
1167242|NCT03572062|2296035|FG005|Overall Study|Adverse Event|0
1167243|NCT03572062|2296036|FG006|Overall Study|Adverse Event|0
1167244|NCT03572062|2296037|FG007|Overall Study|Adverse Event|0
1167245|NCT03572062|2296038|FG008|Overall Study|Adverse Event|1
1167246|NCT03572062|2296039|FG009|Overall Study|Adverse Event|3
1167247|NCT03572062|2296030|FG000|Overall Study|Death|0
1167248|NCT03572062|2296031|FG001|Overall Study|Death|0
1167249|NCT03572062|2296032|FG002|Overall Study|Death|0
1167250|NCT03572062|2296033|FG003|Overall Study|Death|0
1167251|NCT03572062|2296034|FG004|Overall Study|Death|0
1167252|NCT03572062|2296035|FG005|Overall Study|Death|1
1167253|NCT03572062|2296036|FG006|Overall Study|Death|0
1167254|NCT03572062|2296037|FG007|Overall Study|Death|0
1167255|NCT03572062|2296038|FG008|Overall Study|Death|0
1167256|NCT03572062|2296039|FG009|Overall Study|Death|0
1167257|NCT03572062|2296030|FG000|Overall Study|Lost to Follow-up|0
1167258|NCT03572062|2296031|FG001|Overall Study|Lost to Follow-up|0
1167259|NCT03572062|2296032|FG002|Overall Study|Lost to Follow-up|0
1167260|NCT03572062|2296033|FG003|Overall Study|Lost to Follow-up|0
1167261|NCT03572062|2296034|FG004|Overall Study|Lost to Follow-up|0
1167262|NCT03572062|2296035|FG005|Overall Study|Lost to Follow-up|1
1167263|NCT03572062|2296036|FG006|Overall Study|Lost to Follow-up|1
1167264|NCT03572062|2296037|FG007|Overall Study|Lost to Follow-up|0
1167265|NCT03572062|2296038|FG008|Overall Study|Lost to Follow-up|0
1167266|NCT03572062|2296039|FG009|Overall Study|Lost to Follow-up|0
1167267|NCT03572062|2296030|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
1167268|NCT03572062|2296031|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
1167269|NCT03572062|2296032|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
1167270|NCT03572062|2296033|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
1167271|NCT03572062|2296034|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
1167272|NCT03572062|2296035|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
1167273|NCT03572062|2296036|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
1167274|NCT03572062|2296037|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
1167275|NCT03572062|2296038|FG008|Overall Study|No Longer Meets Eligibility Criteria|1
1167276|NCT03572062|2296039|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
1167277|NCT03572062|2296030|FG000|Overall Study|Study Terminated By Sponsor|0
1167278|NCT03572062|2296031|FG001|Overall Study|Study Terminated By Sponsor|0
1167279|NCT03572062|2296032|FG002|Overall Study|Study Terminated By Sponsor|0
1167280|NCT03572062|2296033|FG003|Overall Study|Study Terminated By Sponsor|0
1167281|NCT03572062|2296034|FG004|Overall Study|Study Terminated By Sponsor|0
1167282|NCT03572062|2296035|FG005|Overall Study|Study Terminated By Sponsor|0
1167283|NCT03572062|2296036|FG006|Overall Study|Study Terminated By Sponsor|0
1167284|NCT03572062|2296037|FG007|Overall Study|Study Terminated By Sponsor|0
1167285|NCT03572062|2296038|FG008|Overall Study|Study Terminated By Sponsor|29
1167286|NCT03572062|2296039|FG009|Overall Study|Study Terminated By Sponsor|27
1167287|NCT03572062|2296030|FG000|Overall Study|Physician Decision|0
1167288|NCT03572062|2296031|FG001|Overall Study|Physician Decision|0
1167289|NCT03572062|2296032|FG002|Overall Study|Physician Decision|0
1167290|NCT03572062|2296033|FG003|Overall Study|Physician Decision|0
1167291|NCT03572062|2296034|FG004|Overall Study|Physician Decision|0
1167292|NCT03572062|2296035|FG005|Overall Study|Physician Decision|0
1167293|NCT03572062|2296036|FG006|Overall Study|Physician Decision|0
1167294|NCT03572062|2296037|FG007|Overall Study|Physician Decision|0
1167295|NCT03572062|2296038|FG008|Overall Study|Physician Decision|1
1167296|NCT03572062|2296039|FG009|Overall Study|Physician Decision|0
1167297|NCT03572062|2296030|FG000|Overall Study|Withdrawal by Subject|0
1167298|NCT03572062|2296031|FG001|Overall Study|Withdrawal by Subject|0
1167299|NCT03572062|2296032|FG002|Overall Study|Withdrawal by Subject|0
1167300|NCT03572062|2296033|FG003|Overall Study|Withdrawal by Subject|0
1167301|NCT03572062|2296034|FG004|Overall Study|Withdrawal by Subject|0
1167302|NCT03572062|2296035|FG005|Overall Study|Withdrawal by Subject|0
1167303|NCT03572062|2296036|FG006|Overall Study|Withdrawal by Subject|0
1167304|NCT03572062|2296037|FG007|Overall Study|Withdrawal by Subject|0
1167305|NCT03572062|2296038|FG008|Overall Study|Withdrawal by Subject|0
1167306|NCT03572062|2296039|FG009|Overall Study|Withdrawal by Subject|1
1167307|NCT03572062|2296030|FG000|Overall Study|Randomized But Not Treated|0
1167308|NCT03572062|2296031|FG001|Overall Study|Randomized But Not Treated|0
1167309|NCT03572062|2296032|FG002|Overall Study|Randomized But Not Treated|0
1167310|NCT03572062|2296033|FG003|Overall Study|Randomized But Not Treated|0
1167311|NCT03572062|2296034|FG004|Overall Study|Randomized But Not Treated|1
1167312|NCT03572062|2296035|FG005|Overall Study|Randomized But Not Treated|2
1167313|NCT03572062|2296036|FG006|Overall Study|Randomized But Not Treated|0
1167314|NCT03572062|2296037|FG007|Overall Study|Randomized But Not Treated|1
1167315|NCT03572062|2296038|FG008|Overall Study|Randomized But Not Treated|0
1167316|NCT03572062|2296039|FG009|Overall Study|Randomized But Not Treated|0
1167317|NCT03572218|2296061|FG000|Overall Study|Lost to Follow-up|3
1167318|NCT03572218|2296062|FG001|Overall Study|Lost to Follow-up|2
1167319|NCT03572218|2296061|FG000|Overall Study|No longer available for study visits|2
1167320|NCT03572218|2296062|FG001|Overall Study|No longer available for study visits|1
1167321|NCT03572218|2296061|FG000|Overall Study|No longer interested|1
1167322|NCT03572218|2296062|FG001|Overall Study|No longer interested|2
1167323|NCT03573323|2296107|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
1167324|NCT03573323|2296108|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
1167325|NCT03573323|2296107|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15
1167326|NCT03573323|2296108|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8
1167327|NCT03573323|2296107|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3
1167328|NCT03573323|2296108|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8
1167329|NCT03573323|2296107|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17
1167330|NCT03573323|2296108|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9
1167331|NCT03573323|2296107|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2
1167332|NCT03573323|2296108|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3
1167333|NCT03573323|2296107|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1
1167334|NCT03573323|2296108|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2
1167335|NCT03573323|2296107|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1
1167336|NCT03573323|2296108|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0
1167337|NCT03573323|2296107|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14
1167338|NCT03573323|2296108|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13
1167339|NCT03573323|2296107|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0
1167340|NCT03573323|2296108|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1
1167341|NCT03573323|2296107|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0
1167342|NCT03573323|2296108|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1
1167343|NCT03573323|2296107|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1
1167344|NCT03573323|2296108|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2
1167345|NCT03573323|2296107|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22
1167346|NCT03573323|2296108|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12
1167347|NCT03573323|2296107|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8
1167348|NCT03573323|2296108|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19
1167349|NCT03573323|2296107|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4
1167350|NCT03573323|2296108|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3
1167351|NCT03573323|2296107|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3
1167352|NCT03573323|2296108|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2
1167353|NCT03573323|2296107|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14
1167354|NCT03573323|2296108|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8
1167355|NCT03573323|2296107|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8
1167356|NCT03573323|2296108|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11
1167357|NCT03573323|2296107|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0
1167358|NCT03573323|2296108|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1
1167359|NCT03573323|2296107|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0
1167360|NCT03573323|2296108|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1
1167364|NCT03573505|2296133|FG000|Overall Study|Adverse Event|1
1167365|NCT03573505|2296134|FG001|Overall Study|Adverse Event|1
1167366|NCT03573505|2296133|FG000|Overall Study|Consent withdrawn|0
1167367|NCT03573505|2296134|FG001|Overall Study|Consent withdrawn|1
1167368|NCT03573505|2296133|FG000|Overall Study|Disease progression|0
1167369|NCT03573505|2296134|FG001|Overall Study|Disease progression|1
1167370|NCT03573505|2296133|FG000|Overall Study|Site Terminated by Sponsor|1
1167371|NCT03573505|2296134|FG001|Overall Study|Site Terminated by Sponsor|1
1167372|NCT03573505|2296133|FG000|Overall Study|Study terminated by sponsor|50
1167373|NCT03573505|2296134|FG001|Overall Study|Study terminated by sponsor|45
1167374|NCT03573505|2296133|FG000|Overall Study|Reason not specified|0
1167375|NCT03573505|2296134|FG001|Overall Study|Reason not specified|1
1167376|NCT03573505|2296133|FG000|Overall Study|Death|0
1167377|NCT03573505|2296134|FG001|Overall Study|Death|4
1167378|NCT03573804|2296141|FG000|Overall Study|claustrophobia or MRI table problems|10
1167379|NCT03573817|2296153|FG000|Overall Study|Adverse Event|0
1167380|NCT03573817|2296154|FG001|Overall Study|Adverse Event|2
1167381|NCT03573817|2296153|FG000|Overall Study|Protocol Violation|0
870179|NCT00528996|1831237|FG000|Overall Study|Refused continue medication|16
870180|NCT00528996|1831238|FG001|Overall Study|Refused continue medication|0
870181|NCT00528996|1831239|FG002|Overall Study|Refused continue medication|3
870182|NCT00528996|1831240|FG003|Overall Study|Refused continue medication|3
870183|NCT00528996|1831241|FG004|Overall Study|Refused continue medication|6
870184|NCT00528996|1831237|FG000|Overall Study|Lost to Follow-up|2
870185|NCT00528996|1831238|FG001|Overall Study|Lost to Follow-up|0
870186|NCT00528996|1831239|FG002|Overall Study|Lost to Follow-up|4
870187|NCT00528996|1831240|FG003|Overall Study|Lost to Follow-up|1
870188|NCT00528996|1831241|FG004|Overall Study|Lost to Follow-up|3
870189|NCT00528996|1831237|FG000|Overall Study|Protocol Violation|1
870190|NCT00528996|1831238|FG001|Overall Study|Protocol Violation|2
870191|NCT00528996|1831239|FG002|Overall Study|Protocol Violation|3
870192|NCT00528996|1831240|FG003|Overall Study|Protocol Violation|3
870193|NCT00528996|1831241|FG004|Overall Study|Protocol Violation|2
870194|NCT00528996|1831237|FG000|Overall Study|Lack of Efficacy|7
870195|NCT00528996|1831238|FG001|Overall Study|Lack of Efficacy|2
870196|NCT00528996|1831239|FG002|Overall Study|Lack of Efficacy|1
870197|NCT00528996|1831240|FG003|Overall Study|Lack of Efficacy|3
870198|NCT00528996|1831241|FG004|Overall Study|Lack of Efficacy|3
870199|NCT00528996|1831237|FG000|Overall Study|Adverse Event|32
870200|NCT00528996|1831238|FG001|Overall Study|Adverse Event|13
870201|NCT00528996|1831239|FG002|Overall Study|Adverse Event|18
870202|NCT00528996|1831240|FG003|Overall Study|Adverse Event|29
870203|NCT00528996|1831241|FG004|Overall Study|Adverse Event|18
870204|NCT00529035|1831256|FG000|Overall Study|Withdrawal by Subject|1
870205|NCT00529087|1831270|FG000|Overall Study|Adverse Event|10
870206|NCT00529087|1831271|FG001|Overall Study|Adverse Event|13
870207|NCT00529087|1831272|FG002|Overall Study|Adverse Event|4
870208|NCT00529087|1831270|FG000|Overall Study|Lost to Follow-up|6
870209|NCT00529087|1831271|FG001|Overall Study|Lost to Follow-up|4
870210|NCT00529087|1831272|FG002|Overall Study|Lost to Follow-up|1
1167382|NCT03573817|2296154|FG001|Overall Study|Protocol Violation|1
1167383|NCT03573817|2296153|FG000|Overall Study|Withdrawal by Subject|1
1167384|NCT03573817|2296154|FG001|Overall Study|Withdrawal by Subject|1
1167385|NCT03573830|2296167|FG000|Overall Study|Dropped without completing treatment|0
1167386|NCT03573830|2296168|FG001|Overall Study|Dropped without completing treatment|7
1167387|NCT03573830|2296167|FG000|Overall Study|Lost to Follow-up|4
1167388|NCT03573830|2296168|FG001|Overall Study|Lost to Follow-up|0
1167389|NCT03573908|2296175|FG000|Treatment Period|Adverse Event|4
1167390|NCT03573908|2296176|FG001|Treatment Period|Adverse Event|9
1167391|NCT03573908|2296177|FG002|Treatment Period|Adverse Event|0
1167392|NCT03573908|2296178|FG003|Treatment Period|Adverse Event|0
1167393|NCT03573908|2296179|FG004|Treatment Period|Adverse Event|0
1167394|NCT03573908|2296175|FG000|Treatment Period|Protocol Violation|1
1167395|NCT03573908|2296176|FG001|Treatment Period|Protocol Violation|0
1167396|NCT03573908|2296177|FG002|Treatment Period|Protocol Violation|0
1167397|NCT03573908|2296178|FG003|Treatment Period|Protocol Violation|0
1167398|NCT03573908|2296179|FG004|Treatment Period|Protocol Violation|0
1167399|NCT03573908|2296175|FG000|Treatment Period|Withdrawal by Subject|7
1167400|NCT03573908|2296176|FG001|Treatment Period|Withdrawal by Subject|5
1167401|NCT03573908|2296177|FG002|Treatment Period|Withdrawal by Subject|0
1167402|NCT03573908|2296178|FG003|Treatment Period|Withdrawal by Subject|0
1167403|NCT03573908|2296179|FG004|Treatment Period|Withdrawal by Subject|0
1167404|NCT03573908|2296175|FG000|Treatment Period|Lost to Follow-up|7
870211|NCT00529087|1831270|FG000|Overall Study|Protocol Violation|8
870212|NCT00529087|1831271|FG001|Overall Study|Protocol Violation|7
870213|NCT00529087|1831272|FG002|Overall Study|Protocol Violation|6
870214|NCT00529087|1831270|FG000|Overall Study|Withdrawal by Subject|3
870215|NCT00529087|1831271|FG001|Overall Study|Withdrawal by Subject|3
870216|NCT00529087|1831272|FG002|Overall Study|Withdrawal by Subject|3
870217|NCT00529087|1831270|FG000|Overall Study|Protocol deviation|1
1167405|NCT03573908|2296176|FG001|Treatment Period|Lost to Follow-up|6
1167406|NCT03573908|2296177|FG002|Treatment Period|Lost to Follow-up|0
1167407|NCT03573908|2296178|FG003|Treatment Period|Lost to Follow-up|0
1167408|NCT03573908|2296179|FG004|Treatment Period|Lost to Follow-up|0
1167409|NCT03573908|2296175|FG000|Treatment Period|Pregnancy|1
1167410|NCT03573908|2296176|FG001|Treatment Period|Pregnancy|0
1167411|NCT03573908|2296177|FG002|Treatment Period|Pregnancy|0
1167412|NCT03573908|2296178|FG003|Treatment Period|Pregnancy|0
1167413|NCT03573908|2296179|FG004|Treatment Period|Pregnancy|0
1167414|NCT03573908|2296175|FG000|Treatment Period|Other, Not Specified|4
1167415|NCT03573908|2296176|FG001|Treatment Period|Other, Not Specified|6
1167416|NCT03573908|2296177|FG002|Treatment Period|Other, Not Specified|0
1167417|NCT03573908|2296178|FG003|Treatment Period|Other, Not Specified|0
1167418|NCT03573908|2296179|FG004|Treatment Period|Other, Not Specified|0
1167419|NCT03573908|2296175|FG000|Randomized Withdrawal Period|Adverse Event|0
1167420|NCT03573908|2296176|FG001|Randomized Withdrawal Period|Adverse Event|0
1167421|NCT03573908|2296177|FG002|Randomized Withdrawal Period|Adverse Event|3
1167422|NCT03573908|2296178|FG003|Randomized Withdrawal Period|Adverse Event|0
1167423|NCT03573908|2296179|FG004|Randomized Withdrawal Period|Adverse Event|0
1167424|NCT03573908|2296175|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
1167425|NCT03573908|2296176|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
1167426|NCT03573908|2296177|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
1167427|NCT03573908|2296178|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
1167428|NCT03573908|2296179|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2
1167429|NCT03573908|2296175|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
1167430|NCT03573908|2296176|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
1167431|NCT03573908|2296177|FG002|Randomized Withdrawal Period|Lost to Follow-up|1
1167432|NCT03573908|2296178|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
1167433|NCT03573908|2296179|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
1167434|NCT03573908|2296175|FG000|Randomized Withdrawal Period|Other, Not Specified|0
1167435|NCT03573908|2296176|FG001|Randomized Withdrawal Period|Other, Not Specified|0
1167436|NCT03573908|2296177|FG002|Randomized Withdrawal Period|Other, Not Specified|4
1167437|NCT03573908|2296178|FG003|Randomized Withdrawal Period|Other, Not Specified|2
1167438|NCT03573908|2296179|FG004|Randomized Withdrawal Period|Other, Not Specified|0
1167439|NCT03574753|2296205|FG000|Overall Study|Adverse Event|3
1167440|NCT03574753|2296205|FG000|Overall Study|Progression/relapse|19
1167441|NCT03574753|2296205|FG000|Overall Study|Death|1
1167442|NCT03575702|2296216|FG000|Overall Study|Withdrawal by Subject|1
1167443|NCT03575702|2296217|FG001|Overall Study|Withdrawal by Subject|1
1167444|NCT03575702|2296216|FG000|Overall Study|Lost to Follow-up|1
1167445|NCT03575702|2296217|FG001|Overall Study|Lost to Follow-up|2
1167446|NCT03575702|2296216|FG000|Overall Study|Protocol Violation|0
1167447|NCT03575702|2296217|FG001|Overall Study|Protocol Violation|1
1167448|NCT03575702|2296216|FG000|Overall Study|Patient non compliance|4
1167449|NCT03575702|2296217|FG001|Overall Study|Patient non compliance|0
1167450|NCT03575806|2296234|FG000|Overall Study|Withdrawal by Subject|0
1167451|NCT03575806|2296235|FG001|Overall Study|Withdrawal by Subject|2
1167452|NCT03575806|2296234|FG000|Overall Study|Protocol Violation|0
1167453|NCT03575806|2296235|FG001|Overall Study|Protocol Violation|2
1167454|NCT03575871|2296244|FG000|Overall Study|Adverse Event|5
1167455|NCT03575871|2296245|FG001|Overall Study|Adverse Event|5
1167456|NCT03575871|2296246|FG002|Overall Study|Adverse Event|8
1167457|NCT03575871|2296244|FG000|Overall Study|Death|1
1167458|NCT03575871|2296245|FG001|Overall Study|Death|0
1167459|NCT03575871|2296246|FG002|Overall Study|Death|0
1167460|NCT03575871|2296244|FG000|Overall Study|Lack of Efficacy|5
1167461|NCT03575871|2296245|FG001|Overall Study|Lack of Efficacy|4
1167462|NCT03575871|2296246|FG002|Overall Study|Lack of Efficacy|7
1167463|NCT03575871|2296244|FG000|Overall Study|Lost to Follow-up|1
1167464|NCT03575871|2296245|FG001|Overall Study|Lost to Follow-up|1
1167465|NCT03575871|2296246|FG002|Overall Study|Lost to Follow-up|1
1167466|NCT03575871|2296244|FG000|Overall Study|Protocol Deviation|1
1167467|NCT03575871|2296245|FG001|Overall Study|Protocol Deviation|1
1167468|NCT03575871|2296246|FG002|Overall Study|Protocol Deviation|1
1167469|NCT03575871|2296244|FG000|Overall Study|Withdrawal by Subject|6
1167470|NCT03575871|2296245|FG001|Overall Study|Withdrawal by Subject|1
1167471|NCT03575871|2296246|FG002|Overall Study|Withdrawal by Subject|9
1167472|NCT03575871|2296244|FG000|Overall Study|Other than specified|2
1167473|NCT03575871|2296245|FG001|Overall Study|Other than specified|2
1167474|NCT03575871|2296246|FG002|Overall Study|Other than specified|0
1167475|NCT03575897|2296256|FG000|Overall Study|Lost to Follow-up|12
1167476|NCT03575897|2296257|FG001|Overall Study|Lost to Follow-up|13
1167477|NCT03575975|2296273|FG000|Overall Study|Lost to Follow-up|1
1167478|NCT03575975|2296274|FG001|Overall Study|Lost to Follow-up|0
1167479|NCT03575975|2296275|FG002|Overall Study|Lost to Follow-up|0
1167480|NCT03576066|2296283|FG000|Overall Study|Noncompliance with study drug|0
1167481|NCT03576066|2296284|FG001|Overall Study|Noncompliance with study drug|1
1167482|NCT03576716|2296314|FG000|Overall Study|Withdrawal by Subject|0
1167483|NCT03576716|2296315|FG001|Overall Study|Withdrawal by Subject|1
1167484|NCT03576768|2296325|FG000|Overall Study|Lost to Follow-up|3
1167485|NCT03576768|2296326|FG001|Overall Study|Lost to Follow-up|3
1167486|NCT03576768|2296327|FG002|Overall Study|Lost to Follow-up|0
1167487|NCT03576768|2296328|FG003|Overall Study|Lost to Follow-up|0
1167488|NCT03577730|2296363|FG000|Overall Study|Physician Decision|3
1167489|NCT03577730|2296364|FG001|Overall Study|Physician Decision|1
1167490|NCT03577730|2296363|FG000|Overall Study|Did not receive allocated intervention|1
1167491|NCT03577730|2296364|FG001|Overall Study|Did not receive allocated intervention|0
1167492|NCT03578146|2296376|FG000|Overall Study|Did Not Receive Treatment|1
1167493|NCT03578146|2296377|FG001|Overall Study|Did Not Receive Treatment|0
1167494|NCT03578146|2296378|FG002|Overall Study|Did Not Receive Treatment|0
1167495|NCT03578146|2296379|FG003|Overall Study|Did Not Receive Treatment|0
1167496|NCT03578146|2296380|FG004|Overall Study|Did Not Receive Treatment|0
1167497|NCT03578146|2296381|FG005|Overall Study|Did Not Receive Treatment|2
1167498|NCT03578146|2296376|FG000|Overall Study|Lost to Follow-up|0
1167499|NCT03578146|2296377|FG001|Overall Study|Lost to Follow-up|1
1167500|NCT03578146|2296378|FG002|Overall Study|Lost to Follow-up|1
1167501|NCT03578146|2296379|FG003|Overall Study|Lost to Follow-up|0
1167502|NCT03578146|2296380|FG004|Overall Study|Lost to Follow-up|0
1167503|NCT03578146|2296381|FG005|Overall Study|Lost to Follow-up|1
1167504|NCT03579290|2296408|FG000|Overall Study|Lost to Follow-up|9
1167505|NCT03579719|2296420|FG000|Overall Study|Protocol deviation, pre-existent disease|1
1167506|NCT03579940|2296435|FG000|Period 2|Withdrawal by Subject|0
1167507|NCT03579940|2296436|FG001|Period 2|Withdrawal by Subject|0
1167508|NCT03579940|2296437|FG002|Period 2|Withdrawal by Subject|1
1167509|NCT03579940|2296438|FG003|Period 2|Withdrawal by Subject|0
1167510|NCT03579940|2296439|FG004|Period 2|Withdrawal by Subject|0
1167511|NCT03579940|2296440|FG005|Period 2|Withdrawal by Subject|0
1167512|NCT03579940|2296441|FG006|Period 2|Withdrawal by Subject|0
1167513|NCT03579940|2296442|FG007|Period 2|Withdrawal by Subject|0
1167514|NCT03579940|2296443|FG008|Period 2|Withdrawal by Subject|0
1167515|NCT03579940|2296444|FG009|Period 2|Withdrawal by Subject|0
1167516|NCT03579940|2296445|FG010|Period 2|Withdrawal by Subject|0
1167517|NCT03581825|2296500|FG000|Period 1|Lens Discomfort|1
1167518|NCT03581825|2296501|FG001|Period 1|Lens Discomfort|0
1167519|NCT03581825|2296500|FG000|Period 2|Unsatisfactory Vision to Test|0
1167520|NCT03581825|2296501|FG001|Period 2|Unsatisfactory Vision to Test|1
1167521|NCT03582215|2296515|FG000|Overall Study|Adverse Event|1
1167522|NCT03582215|2296516|FG001|Overall Study|Adverse Event|0
1167523|NCT03582215|2296517|FG002|Overall Study|Adverse Event|0
1167524|NCT03582215|2296518|FG003|Overall Study|Adverse Event|0
1167525|NCT03582215|2296519|FG004|Overall Study|Adverse Event|0
1167526|NCT03582215|2296520|FG005|Overall Study|Adverse Event|0
1167527|NCT03582215|2296521|FG006|Overall Study|Adverse Event|2
1167528|NCT03582215|2296522|FG007|Overall Study|Adverse Event|2
1167529|NCT03582813|2296582|FG000|Overall Study|Lost to Follow-up|18
1167530|NCT03582813|2296583|FG001|Overall Study|Lost to Follow-up|21
1167531|NCT03582813|2296582|FG000|Overall Study|Withdrawal by Subject|1
1167532|NCT03582813|2296583|FG001|Overall Study|Withdrawal by Subject|0
1167533|NCT03582826|2296591|FG000|Overall Study|Lost to Follow-up|39
1167534|NCT03582826|2296592|FG001|Overall Study|Lost to Follow-up|0
1167535|NCT03582826|2296591|FG000|Overall Study|Withdrawal by Subject|2
1167536|NCT03582826|2296592|FG001|Overall Study|Withdrawal by Subject|0
1167537|NCT03582943|2296609|FG000|Allocated to Groups|Withdrawal by Subject|1
1167538|NCT03582943|2296610|FG001|Allocated to Groups|Withdrawal by Subject|1
1167539|NCT03582943|2296609|FG000|Intervention and Follow up|Withdrawal by Subject|4
1167540|NCT03582943|2296610|FG001|Intervention and Follow up|Withdrawal by Subject|2
1167541|NCT03582943|2296609|FG000|Analyzed|Protocol Violation|4
1167542|NCT03582943|2296610|FG001|Analyzed|Protocol Violation|1
1167543|NCT03583372|2296620|FG000|Overall Study|Withdrawal by Subject|6
1167544|NCT03583372|2296621|FG001|Overall Study|Withdrawal by Subject|11
1167545|NCT03583372|2296622|FG002|Overall Study|Withdrawal by Subject|7
1167546|NCT03583372|2296623|FG003|Overall Study|Withdrawal by Subject|8
1167547|NCT03583372|2296620|FG000|Overall Study|Lost to Follow-up|4
1167548|NCT03583372|2296621|FG001|Overall Study|Lost to Follow-up|6
1167549|NCT03583372|2296622|FG002|Overall Study|Lost to Follow-up|3
1167550|NCT03583372|2296623|FG003|Overall Study|Lost to Follow-up|2
1167551|NCT03583372|2296620|FG000|Overall Study|Adverse Event|1
1167552|NCT03583372|2296621|FG001|Overall Study|Adverse Event|3
1167553|NCT03583372|2296622|FG002|Overall Study|Adverse Event|4
1167554|NCT03583372|2296623|FG003|Overall Study|Adverse Event|4
1167555|NCT03583372|2296620|FG000|Overall Study|Physician Decision|0
1167556|NCT03583372|2296621|FG001|Overall Study|Physician Decision|1
1167557|NCT03583372|2296622|FG002|Overall Study|Physician Decision|1
1167558|NCT03583372|2296623|FG003|Overall Study|Physician Decision|1
1167559|NCT03583372|2296620|FG000|Overall Study|Lack of Efficacy|0
1167560|NCT03583372|2296621|FG001|Overall Study|Lack of Efficacy|1
1167561|NCT03583372|2296622|FG002|Overall Study|Lack of Efficacy|0
1167562|NCT03583372|2296623|FG003|Overall Study|Lack of Efficacy|1
1167563|NCT03583372|2296620|FG000|Overall Study|Death|1
1167564|NCT03583372|2296621|FG001|Overall Study|Death|0
1167565|NCT03583372|2296622|FG002|Overall Study|Death|0
1167566|NCT03583372|2296623|FG003|Overall Study|Death|0
1167567|NCT03583372|2296620|FG000|Overall Study|Protocol Violation|0
1167568|NCT03583372|2296621|FG001|Overall Study|Protocol Violation|1
1167569|NCT03583372|2296622|FG002|Overall Study|Protocol Violation|0
1167570|NCT03583372|2296623|FG003|Overall Study|Protocol Violation|0
1167571|NCT03583372|2296620|FG000|Overall Study|Subject Withdrawn due to Sponsor|0
1167572|NCT03583372|2296621|FG001|Overall Study|Subject Withdrawn due to Sponsor|0
1167573|NCT03583372|2296622|FG002|Overall Study|Subject Withdrawn due to Sponsor|0
1167574|NCT03583372|2296623|FG003|Overall Study|Subject Withdrawn due to Sponsor|1
1167575|NCT03583372|2296620|FG000|Overall Study|Did Not Receive Study Drug|0
1167576|NCT03583372|2296621|FG001|Overall Study|Did Not Receive Study Drug|1
1167577|NCT03583372|2296622|FG002|Overall Study|Did Not Receive Study Drug|0
1167578|NCT03583372|2296623|FG003|Overall Study|Did Not Receive Study Drug|0
1167579|NCT03583372|2296620|FG000|Overall Study|Captured as Other in the Database|1
1167580|NCT03583372|2296621|FG001|Overall Study|Captured as Other in the Database|2
1167581|NCT03583372|2296622|FG002|Overall Study|Captured as Other in the Database|4
1167582|NCT03583372|2296623|FG003|Overall Study|Captured as Other in the Database|1
1167583|NCT03583385|2296633|FG000|Treatment Period 1|Withdrawal by Subject|1
1167584|NCT03583385|2296634|FG001|Treatment Period 1|Withdrawal by Subject|1
1167585|NCT03583385|2296633|FG000|Treatment Period 2|Adverse Event|1
1167586|NCT03583385|2296634|FG001|Treatment Period 2|Adverse Event|0
1167587|NCT03583450|2296642|FG000|Overall Study|hardware malfunction (battery depletion)|1
1167588|NCT03583450|2296643|FG001|Overall Study|hardware malfunction (battery depletion)|0
1167589|NCT03583606|2296654|FG000|Overall Study|Lost to Follow-up|0
1167590|NCT03583606|2296655|FG001|Overall Study|Lost to Follow-up|1
1167591|NCT03583606|2296656|FG002|Overall Study|Lost to Follow-up|0
1167592|NCT03583606|2296654|FG000|Overall Study|Ineligible at baseline|1
1167593|NCT03583606|2296655|FG001|Overall Study|Ineligible at baseline|0
1167594|NCT03583606|2296656|FG002|Overall Study|Ineligible at baseline|0
1167595|NCT03584009|2296667|FG000|Overall Study|Death|18
1167596|NCT03584009|2296668|FG001|Overall Study|Death|9
1167597|NCT03584009|2296667|FG000|Overall Study|Lost to Follow-up|0
1167598|NCT03584009|2296668|FG001|Overall Study|Lost to Follow-up|1
1167599|NCT03584009|2296667|FG000|Overall Study|Physician Decision|1
1167600|NCT03584009|2296668|FG001|Overall Study|Physician Decision|1
1167601|NCT03584009|2296667|FG000|Overall Study|Withdrawal by Subject|3
1167602|NCT03584009|2296668|FG001|Overall Study|Withdrawal by Subject|1
1167603|NCT03584009|2296667|FG000|Overall Study|Ongoing in study|29
1167604|NCT03584009|2296668|FG001|Overall Study|Ongoing in study|40
1167605|NCT03585244|2296681|FG000|Overall Study|Withdrawal by Subject|15
1167606|NCT03585296|2296685|FG000|Overall Study|Adverse Event|1
1167607|NCT03585296|2296685|FG000|Overall Study|Lost to Follow-up|2
1167608|NCT03585296|2296685|FG000|Overall Study|Withdrawal by Subject|2
1167609|NCT03585504|2296691|FG000|Overall Study|Lost to Follow-up|26
1167610|NCT03585504|2296692|FG001|Overall Study|Lost to Follow-up|29
1167611|NCT03585712|2296703|FG000|Treatment Period 1|Protocol Violation|1
1167612|NCT03585712|2296704|FG001|Treatment Period 1|Protocol Violation|0
1167613|NCT03585712|2296705|FG002|Treatment Period 1|Protocol Violation|0
1167614|NCT03585712|2296703|FG000|Treatment Periods 2 and 3|Protocol Violation|0
1167615|NCT03585712|2296704|FG001|Treatment Periods 2 and 3|Protocol Violation|1
1167616|NCT03585712|2296705|FG002|Treatment Periods 2 and 3|Protocol Violation|1
1167617|NCT03585712|2296703|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0
1167618|NCT03585712|2296704|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2
1167619|NCT03585712|2296705|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0
1167620|NCT03585712|2296703|FG000|Treatment Periods 2 and 3|Physician Decision|0
1167621|NCT03585712|2296704|FG001|Treatment Periods 2 and 3|Physician Decision|0
1167622|NCT03585712|2296705|FG002|Treatment Periods 2 and 3|Physician Decision|2
1167623|NCT03585959|2296732|FG000|Overall Study|Physician Decision|1
1167624|NCT03585959|2296732|FG000|Overall Study|Unsuccessful Procedure|2
1167625|NCT03586167|2296744|FG000|Overall Study|Other|1
1167626|NCT03586167|2296745|FG001|Overall Study|Other|0
1167627|NCT03586544|2296753|FG000|First Intervention|Adverse Event|0
1167628|NCT03586544|2296754|FG001|First Intervention|Adverse Event|1
1167629|NCT03586544|2296753|FG000|Second Intervention|Withdrawal by Subject|0
1167630|NCT03586544|2296754|FG001|Second Intervention|Withdrawal by Subject|1
1167631|NCT03586648|2296765|FG000|Period 1|Withdrawal by Subject|0
1167632|NCT03586648|2296766|FG001|Period 1|Withdrawal by Subject|1
1167633|NCT03586648|2296765|FG000|Period 1|Lost to Follow-up|1
1167634|NCT03586648|2296766|FG001|Period 1|Lost to Follow-up|1
1167635|NCT03586648|2296765|FG000|Period 1|Adverse Event|1
1167636|NCT03586648|2296766|FG001|Period 1|Adverse Event|0
1167637|NCT03586648|2296765|FG000|Period 1|Study related symptoms or complaints|2
1167638|NCT03586648|2296766|FG001|Period 1|Study related symptoms or complaints|1
1167639|NCT03586648|2296765|FG000|Period 1|Physician Decision|0
1167640|NCT03586648|2296766|FG001|Period 1|Physician Decision|1
1167641|NCT03586648|2296765|FG000|Period 2|Adverse Event|1
1167642|NCT03586648|2296766|FG001|Period 2|Adverse Event|0
1167643|NCT03586726|2296772|FG000|Overall Study|Withdrawal by Subject|1
1167644|NCT03586830|2296780|FG000|Overall Study|Site terminated by Sponsor|1
1167645|NCT03586830|2296781|FG001|Overall Study|Site terminated by Sponsor|4
1167646|NCT03586830|2296782|FG002|Overall Study|Site terminated by Sponsor|3
1167647|NCT03586830|2296783|FG003|Overall Study|Site terminated by Sponsor|3
1167648|NCT03586830|2296780|FG000|Overall Study|Lost to Follow-up|0
1167649|NCT03586830|2296781|FG001|Overall Study|Lost to Follow-up|2
1167650|NCT03586830|2296782|FG002|Overall Study|Lost to Follow-up|2
1167651|NCT03586830|2296783|FG003|Overall Study|Lost to Follow-up|1
1167652|NCT03586830|2296780|FG000|Overall Study|Withdrawal by Subject|1
1167653|NCT03586830|2296781|FG001|Overall Study|Withdrawal by Subject|0
1167654|NCT03586830|2296782|FG002|Overall Study|Withdrawal by Subject|3
1167655|NCT03586830|2296783|FG003|Overall Study|Withdrawal by Subject|1
1167656|NCT03587974|2296829|FG000|Overall Study|caregiver demented, care recipient died|3
1167657|NCT03587974|2296830|FG001|Overall Study|caregiver demented, care recipient died|3
1167658|NCT03587974|2296829|FG000|Overall Study|Withdrawal by Subject|2
1167659|NCT03587974|2296830|FG001|Overall Study|Withdrawal by Subject|1
1167660|NCT03588572|2296838|FG000|Visitation 1|Lack of Efficacy|1
1167661|NCT03588572|2296839|FG001|Visitation 1|Lack of Efficacy|1
1167662|NCT03588572|2296838|FG000|Visitation 2|Lost to Follow-up|1
1167663|NCT03588572|2296839|FG001|Visitation 2|Lost to Follow-up|1
1167664|NCT03588572|2296838|FG000|Visitation 2|Lack of Efficacy|0
1167665|NCT03588572|2296839|FG001|Visitation 2|Lack of Efficacy|1
1167666|NCT03588572|2296838|FG000|Visitation 2|Withdrawal by Subject|1
1167667|NCT03588572|2296839|FG001|Visitation 2|Withdrawal by Subject|0
1167668|NCT03588572|2296838|FG000|Visitation 3|Lost to Follow-up|1
1167669|NCT03588572|2296839|FG001|Visitation 3|Lost to Follow-up|1
1167670|NCT03588572|2296838|FG000|Visitation 3|Physician Decision|1
1167671|NCT03588572|2296839|FG001|Visitation 3|Physician Decision|1
1167672|NCT03588572|2296838|FG000|Visitation 3|Withdrawal by Subject|1
1167673|NCT03588572|2296839|FG001|Visitation 3|Withdrawal by Subject|0
1167674|NCT03588741|2296845|FG000|Overall Study|Withdrawal by Subject|1
1167675|NCT03588910|2296855|FG000|Overall Study|Withdrawal by Subject|1
1167676|NCT03588910|2296856|FG001|Overall Study|Withdrawal by Subject|0
1167677|NCT03588910|2296855|FG000|Overall Study|Allergy|2
1167678|NCT03588910|2296856|FG001|Overall Study|Allergy|0
1167679|NCT03588910|2296855|FG000|Overall Study|Protocol Violation|0
1167680|NCT03588910|2296856|FG001|Overall Study|Protocol Violation|3
1167681|NCT03588910|2296855|FG000|Overall Study|Did not complete Day 1 Survey|5
1167682|NCT03588910|2296856|FG001|Overall Study|Did not complete Day 1 Survey|10
1167683|NCT03588910|2296855|FG000|Overall Study|Did not complete Day 7 Survey|5
1167684|NCT03588910|2296856|FG001|Overall Study|Did not complete Day 7 Survey|2
1167685|NCT03589807|2296872|FG000|Overall Study|Lost to Follow-up|0
1167686|NCT03589807|2296873|FG001|Overall Study|Lost to Follow-up|2
1167687|NCT03589807|2296874|FG002|Overall Study|Lost to Follow-up|2
1167688|NCT03589807|2296875|FG003|Overall Study|Lost to Follow-up|3
1167689|NCT03589807|2296876|FG004|Overall Study|Lost to Follow-up|1
1167690|NCT03589807|2296877|FG005|Overall Study|Lost to Follow-up|1
1167691|NCT03589807|2296872|FG000|Overall Study|Withdrawal by Subject|0
1167692|NCT03589807|2296873|FG001|Overall Study|Withdrawal by Subject|5
1167693|NCT03589807|2296874|FG002|Overall Study|Withdrawal by Subject|0
1167694|NCT03589807|2296875|FG003|Overall Study|Withdrawal by Subject|0
1167695|NCT03589807|2296876|FG004|Overall Study|Withdrawal by Subject|0
1167696|NCT03589807|2296877|FG005|Overall Study|Withdrawal by Subject|0
1167697|NCT03589807|2296872|FG000|Overall Study|Protocol Violation|0
1167698|NCT03589807|2296873|FG001|Overall Study|Protocol Violation|0
1167699|NCT03589807|2296874|FG002|Overall Study|Protocol Violation|0
1167700|NCT03589807|2296875|FG003|Overall Study|Protocol Violation|1
1167701|NCT03589807|2296876|FG004|Overall Study|Protocol Violation|0
1167702|NCT03589807|2296877|FG005|Overall Study|Protocol Violation|0
1167703|NCT03589807|2296872|FG000|Overall Study|Enrolled but treatment not administered|0
1167704|NCT03589807|2296873|FG001|Overall Study|Enrolled but treatment not administered|0
1167705|NCT03589807|2296874|FG002|Overall Study|Enrolled but treatment not administered|0
1167706|NCT03589807|2296875|FG003|Overall Study|Enrolled but treatment not administered|0
1167707|NCT03589807|2296876|FG004|Overall Study|Enrolled but treatment not administered|1
1167708|NCT03589807|2296877|FG005|Overall Study|Enrolled but treatment not administered|0
1167709|NCT03589885|2296897|FG000|Treatment Period 1-Randomized Set|Adverse Event|0
1167710|NCT03589885|2296898|FG001|Treatment Period 1-Randomized Set|Adverse Event|1
1167711|NCT03589885|2296899|FG002|Treatment Period 1-Randomized Set|Adverse Event|0
870218|NCT00529087|1831271|FG001|Overall Study|Protocol deviation|1
870219|NCT00529087|1831272|FG002|Overall Study|Protocol deviation|2
1167712|NCT03589885|2296900|FG003|Treatment Period 1-Randomized Set|Adverse Event|0
1167713|NCT03589885|2296901|FG004|Treatment Period 1-Randomized Set|Adverse Event|0
1167714|NCT03589885|2296897|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0
1167715|NCT03589885|2296898|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0
1167716|NCT03589885|2296899|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2
1167717|NCT03589885|2296900|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0
1167718|NCT03589885|2296901|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0
1167719|NCT03589885|2296897|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0
1167720|NCT03589885|2296898|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1
1167721|NCT03589885|2296899|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0
1167722|NCT03589885|2296900|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0
1167723|NCT03589885|2296901|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0
1167724|NCT03589885|2296897|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
1167725|NCT03589885|2296898|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
1167726|NCT03589885|2296899|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1
1167727|NCT03589885|2296900|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
1167728|NCT03589885|2296901|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
870220|NCT00529100|1831293|FG000|Overall Study|Adverse Event|0
1167729|NCT03589885|2296897|FG000|Treatment Period 2-Randomized Set|Adverse Event|0
1167730|NCT03589885|2296898|FG001|Treatment Period 2-Randomized Set|Adverse Event|1
1167731|NCT03589885|2296899|FG002|Treatment Period 2-Randomized Set|Adverse Event|0
1167732|NCT03589885|2296900|FG003|Treatment Period 2-Randomized Set|Adverse Event|0
1167733|NCT03589885|2296901|FG004|Treatment Period 2-Randomized Set|Adverse Event|0
1167734|NCT03589885|2296897|FG000|Treatment Period 2-Randomized Set|Pregnancy|1
1167735|NCT03589885|2296898|FG001|Treatment Period 2-Randomized Set|Pregnancy|0
1167736|NCT03589885|2296899|FG002|Treatment Period 2-Randomized Set|Pregnancy|0
1167737|NCT03589885|2296900|FG003|Treatment Period 2-Randomized Set|Pregnancy|0
1167738|NCT03589885|2296901|FG004|Treatment Period 2-Randomized Set|Pregnancy|0
1167739|NCT03589885|2296897|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0
1167740|NCT03589885|2296898|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3
1167741|NCT03589885|2296899|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1
1167742|NCT03589885|2296900|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0
1167743|NCT03589885|2296901|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1
870221|NCT00529100|1831294|FG001|Overall Study|Adverse Event|5
870222|NCT00529100|1831293|FG000|Overall Study|Protocol Violation|0
1167744|NCT03589885|2296897|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
1167745|NCT03589885|2296898|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1
1167746|NCT03589885|2296899|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
1167747|NCT03589885|2296900|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
1167748|NCT03589885|2296901|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
1167749|NCT03591146|2296946|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
1167750|NCT03591146|2296947|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
1167751|NCT03591146|2296948|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
1167752|NCT03591146|2296949|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
1167753|NCT03591146|2296950|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1
1167754|NCT03591146|2296946|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
1167755|NCT03591146|2296947|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1
1167756|NCT03591146|2296948|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
1167757|NCT03591146|2296949|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
1167758|NCT03591146|2296950|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
1167759|NCT03591146|2296946|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
1167760|NCT03591146|2296947|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
1167761|NCT03591146|2296948|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
1167762|NCT03591146|2296949|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
1167763|NCT03591146|2296950|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1
1167764|NCT03591146|2296946|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
1167765|NCT03591146|2296947|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
1167766|NCT03591146|2296948|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
1167767|NCT03591146|2296949|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
1167768|NCT03591146|2296950|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
1167769|NCT03591406|2296964|FG000|Overall Study|Adverse Event|5
1167770|NCT03591406|2296965|FG001|Overall Study|Adverse Event|3
1167771|NCT03591406|2296964|FG000|Overall Study|Protocol Violation|2
1167772|NCT03591406|2296965|FG001|Overall Study|Protocol Violation|1
1167773|NCT03591406|2296964|FG000|Overall Study|Withdrawal by Subject|0
1167774|NCT03591406|2296965|FG001|Overall Study|Withdrawal by Subject|5
1167779|NCT03592745|2296991|FG000|Overall Study|Adverse Event|0
1167780|NCT03592745|2296992|FG001|Overall Study|Adverse Event|2
1167781|NCT03592745|2296991|FG000|Overall Study|Lost to Follow-up|2
1167782|NCT03592745|2296992|FG001|Overall Study|Lost to Follow-up|0
1167783|NCT03592745|2296991|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1
1167784|NCT03592745|2296992|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1
1167785|NCT03593681|2297015|FG000|Overall Study|Inadequate sample collected|12
1167786|NCT03593681|2297015|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11
1167787|NCT03593681|2297015|FG000|Overall Study|Protocol Violation|3
1167788|NCT03593681|2297015|FG000|Overall Study|Withdrawal by Subject|3
1167789|NCT03593681|2297015|FG000|Overall Study|Procedure not attempted|3
1167790|NCT03593681|2297015|FG000|Overall Study|Adverse Event|2
1167791|NCT03593681|2297015|FG000|Overall Study|Physician Decision|1
1167792|NCT03593876|2297036|FG000|Overall Study|Withdrawal by Subject|1
1167793|NCT03593876|2297036|FG000|Overall Study|Discharged home before intervention completion|2
1167794|NCT03594071|2297053|FG000|Overall Study|Re-operation|3
1167795|NCT03594071|2297053|FG000|Overall Study|Missed visit|2
1167796|NCT03594227|2297061|FG000|Overall Study|Adverse Event|2
1167797|NCT03594227|2297062|FG001|Overall Study|Adverse Event|1
1167798|NCT03594227|2297063|FG002|Overall Study|Adverse Event|0
1167799|NCT03594227|2297064|FG003|Overall Study|Adverse Event|2
1167800|NCT03594227|2297061|FG000|Overall Study|Lost to Follow-up|1
1167801|NCT03594227|2297062|FG001|Overall Study|Lost to Follow-up|1
1167802|NCT03594227|2297063|FG002|Overall Study|Lost to Follow-up|1
1167803|NCT03594227|2297064|FG003|Overall Study|Lost to Follow-up|0
1167804|NCT03594227|2297061|FG000|Overall Study|Withdrawal by Subject|1
1167805|NCT03594227|2297062|FG001|Overall Study|Withdrawal by Subject|1
1167806|NCT03594227|2297063|FG002|Overall Study|Withdrawal by Subject|1
1167807|NCT03594227|2297064|FG003|Overall Study|Withdrawal by Subject|1
1167808|NCT03594227|2297061|FG000|Overall Study|Pregnancy|0
1167809|NCT03594227|2297062|FG001|Overall Study|Pregnancy|1
1167810|NCT03594227|2297063|FG002|Overall Study|Pregnancy|0
1167811|NCT03594227|2297064|FG003|Overall Study|Pregnancy|0
1167812|NCT03594227|2297061|FG000|Overall Study|Sponsor Decision|0
1167813|NCT03594227|2297062|FG001|Overall Study|Sponsor Decision|0
1167814|NCT03594227|2297063|FG002|Overall Study|Sponsor Decision|0
1167815|NCT03594227|2297064|FG003|Overall Study|Sponsor Decision|1
1167816|NCT03594227|2297061|FG000|Overall Study|Programmatic Analysis Non-completer|1
1167817|NCT03594227|2297062|FG001|Overall Study|Programmatic Analysis Non-completer|0
1167818|NCT03594227|2297063|FG002|Overall Study|Programmatic Analysis Non-completer|1
1167819|NCT03594227|2297064|FG003|Overall Study|Programmatic Analysis Non-completer|1
1167820|NCT03595176|2297099|FG000|Overall Study|Death|0
1167821|NCT03595176|2297100|FG001|Overall Study|Death|2
1167822|NCT03595176|2297099|FG000|Overall Study|Lost to Follow-up|0
1167823|NCT03595176|2297100|FG001|Overall Study|Lost to Follow-up|1
1167824|NCT03595280|2297112|FG000|Overall Study|Lost to Follow-up|6
1167825|NCT03595280|2297113|FG001|Overall Study|Lost to Follow-up|9
1167826|NCT03595280|2297114|FG002|Overall Study|Lost to Follow-up|15
1167827|NCT03595618|2297144|FG000|Overall Study|Adverse Event|16
1167828|NCT03595618|2297145|FG001|Overall Study|Adverse Event|17
1167829|NCT03595618|2297146|FG002|Overall Study|Adverse Event|20
1167830|NCT03595618|2297147|FG003|Overall Study|Adverse Event|8
1167831|NCT03595618|2297144|FG000|Overall Study|Withdrawal by Subject|12
1167832|NCT03595618|2297145|FG001|Overall Study|Withdrawal by Subject|14
1167833|NCT03595618|2297146|FG002|Overall Study|Withdrawal by Subject|14
1167834|NCT03595618|2297147|FG003|Overall Study|Withdrawal by Subject|10
1167835|NCT03595618|2297144|FG000|Overall Study|Lost to Follow-up|6
1167836|NCT03595618|2297145|FG001|Overall Study|Lost to Follow-up|4
1167837|NCT03595618|2297146|FG002|Overall Study|Lost to Follow-up|5
1167838|NCT03595618|2297147|FG003|Overall Study|Lost to Follow-up|6
1167839|NCT03595618|2297144|FG000|Overall Study|Protocol Violation|2
1167840|NCT03595618|2297145|FG001|Overall Study|Protocol Violation|0
1167841|NCT03595618|2297146|FG002|Overall Study|Protocol Violation|6
1167842|NCT03595618|2297147|FG003|Overall Study|Protocol Violation|2
1167843|NCT03595618|2297144|FG000|Overall Study|Physician Decision|0
1167844|NCT03595618|2297145|FG001|Overall Study|Physician Decision|0
1167845|NCT03595618|2297146|FG002|Overall Study|Physician Decision|1
1167846|NCT03595618|2297147|FG003|Overall Study|Physician Decision|2
1167847|NCT03595618|2297144|FG000|Overall Study|Miscellaneous|7
1167848|NCT03595618|2297145|FG001|Overall Study|Miscellaneous|5
1167849|NCT03595618|2297146|FG002|Overall Study|Miscellaneous|10
1167850|NCT03595618|2297147|FG003|Overall Study|Miscellaneous|6
1167851|NCT03595904|2297159|FG000|Overall Study|Protocol Violation|3
1167852|NCT03595904|2297160|FG001|Overall Study|Protocol Violation|1
1167853|NCT03595904|2297159|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4
1167854|NCT03595904|2297160|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3
1167855|NCT03595904|2297159|FG000|Overall Study|Insurance complications|1
1167856|NCT03595904|2297160|FG001|Overall Study|Insurance complications|0
1167857|NCT03595904|2297159|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2
1167858|NCT03595904|2297160|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1
1167859|NCT03596151|2297166|FG000|Overall Study|Withdrawal by Subject|1
1167860|NCT03596177|2297172|FG000|Single Blind Period|Withdrawal by Subject|1
1167861|NCT03596177|2297173|FG001|Single Blind Period|Withdrawal by Subject|1
1167862|NCT03596177|2297172|FG000|Single Blind Period|Other|1
1167863|NCT03596177|2297173|FG001|Single Blind Period|Other|0
1167864|NCT03596177|2297172|FG000|Double Blind Period|Withdrawal by Subject|0
1167865|NCT03596177|2297173|FG001|Double Blind Period|Withdrawal by Subject|1
1167866|NCT03596177|2297172|FG000|Double Blind Period|Other|0
1167867|NCT03596177|2297173|FG001|Double Blind Period|Other|4
1167868|NCT03596177|2297172|FG000|Double Blind Period|Death during safety follow-up|0
1167869|NCT03596177|2297173|FG001|Double Blind Period|Death during safety follow-up|1
1167870|NCT03597022|2297195|FG000|Overall Study|Premature termination of the study|7
1167871|NCT03597022|2297196|FG001|Overall Study|Premature termination of the study|7
1167872|NCT03597022|2297197|FG002|Overall Study|Premature termination of the study|8
1167873|NCT03597022|2297195|FG000|Overall Study|Serious adverse event|1
1167874|NCT03597022|2297196|FG001|Overall Study|Serious adverse event|1
1167875|NCT03597022|2297197|FG002|Overall Study|Serious adverse event|0
1167876|NCT03597061|2297207|FG000|Overall Study|Lost to Follow-up|1
1167877|NCT03597061|2297208|FG001|Overall Study|Lost to Follow-up|0
1167878|NCT03597061|2297207|FG000|Overall Study|Protocol Violation|0
1167879|NCT03597061|2297208|FG001|Overall Study|Protocol Violation|1
1167880|NCT03597139|2297216|FG000|Overall Study|Adverse Event|3
1167881|NCT03597139|2297217|FG001|Overall Study|Adverse Event|0
1167882|NCT03597139|2297216|FG000|Overall Study|Protocol Non-compliance|1
1167883|NCT03597139|2297217|FG001|Overall Study|Protocol Non-compliance|0
1167887|NCT03597347|2297235|FG000|Overall Study|Withdrawal by Subject|1
1167888|NCT03597347|2297236|FG001|Overall Study|Withdrawal by Subject|1
1167889|NCT03597347|2297237|FG002|Overall Study|Withdrawal by Subject|0
1167890|NCT03597347|2297235|FG000|Overall Study|Withdrawal due to Covid-19|3
1167891|NCT03597347|2297236|FG001|Overall Study|Withdrawal due to Covid-19|0
1167892|NCT03597347|2297237|FG002|Overall Study|Withdrawal due to Covid-19|0
1167893|NCT03597347|2297235|FG000|Overall Study|Sponsor decision to terminate study|3
1167894|NCT03597347|2297236|FG001|Overall Study|Sponsor decision to terminate study|2
1167895|NCT03597347|2297237|FG002|Overall Study|Sponsor decision to terminate study|4
1167896|NCT03597529|2297247|FG000|Overall Study|Lost to Follow-up|10
1167897|NCT03597529|2297248|FG001|Overall Study|Lost to Follow-up|12
1167898|NCT03597529|2297247|FG000|Overall Study|Physician Decision|3
1167899|NCT03597529|2297248|FG001|Overall Study|Physician Decision|1
1167900|NCT03597529|2297247|FG000|Overall Study|Withdrawal by Subject|6
1167901|NCT03597529|2297248|FG001|Overall Study|Withdrawal by Subject|3
1167902|NCT03597529|2297247|FG000|Overall Study|Non-compliant with study activities|1
1167903|NCT03597529|2297248|FG001|Overall Study|Non-compliant with study activities|2
1167904|NCT03599089|2297277|FG000|Overall Study|Lost to Follow-up|1
1167905|NCT03599089|2297278|FG001|Overall Study|Lost to Follow-up|0
1167906|NCT03599089|2297279|FG002|Overall Study|Lost to Follow-up|0
1167907|NCT03599089|2297280|FG003|Overall Study|Lost to Follow-up|0
1167908|NCT03599089|2297277|FG000|Overall Study|Withdrawal by Subject|2
1167909|NCT03599089|2297278|FG001|Overall Study|Withdrawal by Subject|1
1167910|NCT03599089|2297279|FG002|Overall Study|Withdrawal by Subject|0
1167911|NCT03599089|2297280|FG003|Overall Study|Withdrawal by Subject|0
1167912|NCT03599089|2297277|FG000|Overall Study|Lack of Efficacy|0
1167913|NCT03599089|2297278|FG001|Overall Study|Lack of Efficacy|0
1167914|NCT03599089|2297279|FG002|Overall Study|Lack of Efficacy|1
1167915|NCT03599089|2297280|FG003|Overall Study|Lack of Efficacy|2
1167916|NCT03599193|2297292|FG000|Overall Study|Adverse Event|0
1167917|NCT03599193|2297293|FG001|Overall Study|Adverse Event|2
1167918|NCT03599193|2297292|FG000|Overall Study|Withdrawal by Subject|1
1167919|NCT03599193|2297293|FG001|Overall Study|Withdrawal by Subject|0
1167920|NCT03599193|2297292|FG000|Overall Study|Protocol Violation|1
1167921|NCT03599193|2297293|FG001|Overall Study|Protocol Violation|0
1167922|NCT03599193|2297292|FG000|Overall Study|Lost to Follow-up|0
1167923|NCT03599193|2297293|FG001|Overall Study|Lost to Follow-up|1
1167924|NCT03599349|2297311|FG000|Overall Study|Lost to Follow-up|1
1167925|NCT03599362|2297315|FG000|Overall Study|Screen Failure|3
1167926|NCT03600376|2297359|FG000|Overall Study|Adverse Event|1
1167927|NCT03600376|2297360|FG001|Overall Study|Adverse Event|1
1167928|NCT03600376|2297359|FG000|Overall Study|Transferred to other facility|1
1167929|NCT03600376|2297360|FG001|Overall Study|Transferred to other facility|0
1167930|NCT03600376|2297359|FG000|Overall Study|Investigator Decision|0
1167931|NCT03600376|2297360|FG001|Overall Study|Investigator Decision|4
1167932|NCT03600376|2297359|FG000|Overall Study|Determined to be ineligible for study|0
1167933|NCT03600376|2297360|FG001|Overall Study|Determined to be ineligible for study|1
1167934|NCT03600428|2297368|FG000|Overall Study|Not eligible|0
870223|NCT00529100|1831294|FG001|Overall Study|Protocol Violation|1
870224|NCT00529100|1831293|FG000|Overall Study|Progressive Disease|0
870225|NCT00529100|1831294|FG001|Overall Study|Progressive Disease|1
870226|NCT00529100|1831293|FG000|Overall Study|Withdrawal by Subject|0
870227|NCT00529100|1831294|FG001|Overall Study|Withdrawal by Subject|1
870228|NCT00529100|1831293|FG000|Overall Study|Participant Ineligibility|0
870229|NCT00529100|1831294|FG001|Overall Study|Participant Ineligibility|1
870230|NCT00529152|1831321|FG000|Overall Study|Adverse Event|2
870231|NCT00529152|1831321|FG000|Overall Study|Withdrawal by Subject|2
1167935|NCT03600428|2297369|FG001|Overall Study|Not eligible|1
1167936|NCT03600428|2297368|FG000|Overall Study|Lost to Follow-up|5
1167937|NCT03600428|2297369|FG001|Overall Study|Lost to Follow-up|4
1167938|NCT03601052|2297375|FG000|Overall Study|Lost to Follow-up|2
1167939|NCT03601715|2297398|FG000|Second Intervention|Lost to Follow-up|1
1167940|NCT03601715|2297399|FG001|Second Intervention|Lost to Follow-up|1
1167941|NCT03601715|2297400|FG002|Second Intervention|Lost to Follow-up|0
1167942|NCT03602053|2297411|FG000|Overall Study|Withdrawal by Subject|7
1167943|NCT03602053|2297412|FG001|Overall Study|Withdrawal by Subject|9
1167944|NCT03602053|2297413|FG002|Overall Study|Withdrawal by Subject|7
1167945|NCT03602053|2297411|FG000|Overall Study|Lost to Follow-up|5
1167946|NCT03602053|2297412|FG001|Overall Study|Lost to Follow-up|6
1167947|NCT03602053|2297413|FG002|Overall Study|Lost to Follow-up|0
1167948|NCT03602053|2297411|FG000|Overall Study|Protocol Violation|3
1167949|NCT03602053|2297412|FG001|Overall Study|Protocol Violation|0
1167950|NCT03602053|2297413|FG002|Overall Study|Protocol Violation|4
1167951|NCT03602053|2297411|FG000|Overall Study|Physician Decision|1
1167952|NCT03602053|2297412|FG001|Overall Study|Physician Decision|0
1167953|NCT03602053|2297413|FG002|Overall Study|Physician Decision|0
1167954|NCT03602053|2297411|FG000|Overall Study|migration|2
1167955|NCT03602053|2297412|FG001|Overall Study|migration|3
1167956|NCT03602053|2297413|FG002|Overall Study|migration|0
1167957|NCT03602053|2297411|FG000|Overall Study|Other|1
1167958|NCT03602053|2297412|FG001|Overall Study|Other|0
1167959|NCT03602053|2297413|FG002|Overall Study|Other|0
1167960|NCT03602339|2297425|FG000|Overall Study|Withdrawal by Subject|9
1167961|NCT03602339|2297425|FG000|Overall Study|Physician Decision|2
1167962|NCT03602339|2297425|FG000|Overall Study|Other reason|4
1167963|NCT03602482|2297434|FG000|Overall Study|Withdrawal by Subject|6
1167964|NCT03602482|2297435|FG001|Overall Study|Withdrawal by Subject|7
1167965|NCT03602482|2297436|FG002|Overall Study|Withdrawal by Subject|0
1167966|NCT03602482|2297437|FG003|Overall Study|Withdrawal by Subject|0
1167967|NCT03603028|2297450|FG000|Overall Study|Withdrawal by Subject|1
1167968|NCT03603652|2297508|FG000|Overall Study|Death|2
1167969|NCT03604341|2297518|FG000|Overall Study|Withdrawal by Subject|1
1167970|NCT03604341|2297519|FG001|Overall Study|Withdrawal by Subject|1
1167971|NCT03604341|2297518|FG000|Overall Study|Adverse Event|1
1167972|NCT03604341|2297519|FG001|Overall Study|Adverse Event|0
1167973|NCT03604341|2297518|FG000|Overall Study|Protocol Violation|0
1167974|NCT03604341|2297519|FG001|Overall Study|Protocol Violation|1
1167975|NCT03604497|2297525|FG000|Overall Study|Protocol Violation|52
1167976|NCT03604523|2297535|FG000|Overall Study|Physician Decision|1
1167977|NCT03604523|2297536|FG001|Overall Study|Physician Decision|0
1167978|NCT03605212|2297559|FG000|Treatment Period|Adverse Event|1
1167979|NCT03605212|2297560|FG001|Treatment Period|Adverse Event|0
1167980|NCT03605212|2297561|FG002|Treatment Period|Adverse Event|0
1167981|NCT03605212|2297562|FG003|Treatment Period|Adverse Event|0
1167982|NCT03605212|2297563|FG004|Treatment Period|Adverse Event|0
1167983|NCT03605212|2297559|FG000|Treatment Period|Physician Decision|0
1167984|NCT03605212|2297560|FG001|Treatment Period|Physician Decision|0
1167985|NCT03605212|2297561|FG002|Treatment Period|Physician Decision|0
1167986|NCT03605212|2297562|FG003|Treatment Period|Physician Decision|0
1167987|NCT03605212|2297563|FG004|Treatment Period|Physician Decision|1
1167988|NCT03605680|2297580|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6
1167989|NCT03605680|2297581|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0
1167990|NCT03605680|2297582|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0
1167991|NCT03605680|2297583|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0
1167992|NCT03605680|2297580|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1
1167993|NCT03605680|2297581|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
1167994|NCT03605680|2297582|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
1167995|NCT03605680|2297583|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
1167996|NCT03605680|2297580|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9
1167997|NCT03605680|2297581|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
1167998|NCT03605680|2297582|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
1167999|NCT03605680|2297583|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
1168000|NCT03605680|2297580|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3
1168001|NCT03605680|2297581|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
1168002|NCT03605680|2297582|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
1168003|NCT03605680|2297583|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
1168004|NCT03605680|2297580|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13
1168005|NCT03605680|2297581|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
1168006|NCT03605680|2297582|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
1168007|NCT03605680|2297583|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
1168008|NCT03605680|2297580|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12
1168009|NCT03605680|2297581|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
1168010|NCT03605680|2297582|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
1168011|NCT03605680|2297583|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
1168012|NCT03605680|2297580|FG000|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|1
1168013|NCT03605680|2297581|FG001|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|0
1168014|NCT03605680|2297582|FG002|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|0
1168015|NCT03605680|2297583|FG003|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|0
1168016|NCT03605680|2297580|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6
1168017|NCT03605680|2297581|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0
1168018|NCT03605680|2297582|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0
1168019|NCT03605680|2297583|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0
1168020|NCT03605680|2297580|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87
1168021|NCT03605680|2297581|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
1168022|NCT03605680|2297582|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
1168023|NCT03605680|2297583|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
1168024|NCT03605680|2297580|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0
1168025|NCT03605680|2297581|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5
1168026|NCT03605680|2297582|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7
1168027|NCT03605680|2297583|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8
1168028|NCT03605680|2297580|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0
1168029|NCT03605680|2297581|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
1168030|NCT03605680|2297582|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
1168031|NCT03605680|2297583|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3
1168032|NCT03605680|2297580|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
1168033|NCT03605680|2297581|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
1168034|NCT03605680|2297582|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
1168035|NCT03605680|2297583|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
1168036|NCT03605680|2297580|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
1168037|NCT03605680|2297581|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
1168038|NCT03605680|2297582|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4
1168039|NCT03605680|2297583|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
1168040|NCT03605680|2297580|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0
1168041|NCT03605680|2297581|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3
1168042|NCT03605680|2297582|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1
1168043|NCT03605680|2297583|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2
1168044|NCT03605680|2297580|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0
1168045|NCT03605680|2297581|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14
1168046|NCT03605680|2297582|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7
1168047|NCT03605680|2297583|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5
1168048|NCT03605680|2297580|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0
1168049|NCT03605680|2297581|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
1168050|NCT03605680|2297582|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
1168051|NCT03605680|2297583|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7
1168052|NCT03605680|2297580|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
1168053|NCT03605680|2297581|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1
1168054|NCT03605680|2297582|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2
1168055|NCT03605680|2297583|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
1168056|NCT03605680|2297580|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0
1168057|NCT03605680|2297581|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5
1168058|NCT03605680|2297582|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4
1168059|NCT03605680|2297583|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3
1168060|NCT03605680|2297580|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0
1168061|NCT03605680|2297581|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1
1168062|NCT03605680|2297582|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2
1168063|NCT03605680|2297583|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3
1168064|NCT03605693|2297594|FG000|Overall Study|Lost to Follow-up|4
1168065|NCT03605693|2297595|FG001|Overall Study|Lost to Follow-up|0
1168066|NCT03605693|2297594|FG000|Overall Study|Physician Decision|1
1168067|NCT03605693|2297595|FG001|Overall Study|Physician Decision|0
1168068|NCT03605745|2297601|FG000|Overall Study|Study was terminated for business reasons|47
870232|NCT00529152|1831321|FG000|Overall Study|Lost to Follow-up|1
870233|NCT00529217|1831346|FG000|Overall Study|Lack of Efficacy|2
870234|NCT00529217|1831346|FG000|Overall Study|Unable to adhere to study schedule|2
870235|NCT00529243|1831351|FG000|Overall Study|Adverse Event|1
870236|NCT00529243|1831351|FG000|Overall Study|Death|1
870237|NCT00529243|1831351|FG000|Overall Study|Relocated|1
870238|NCT00529308|1831357|FG000|Overall Study|Withdrawal by Subject|1
870239|NCT00529308|1831358|FG001|Overall Study|Withdrawal by Subject|1
870240|NCT00529373|1831366|FG000|Base Study|Adverse Event|525
870241|NCT00529373|1831367|FG001|Base Study|Adverse Event|470
870242|NCT00529373|1831366|FG000|Base Study|Lack of Efficacy|16
870243|NCT00529373|1831367|FG001|Base Study|Lack of Efficacy|75
870244|NCT00529373|1831366|FG000|Base Study|Lost to Follow-up|221
870245|NCT00529373|1831367|FG001|Base Study|Lost to Follow-up|208
870246|NCT00529373|1831366|FG000|Base Study|Other Protocol Specified Criteria|19
1006579|NCT01468701|2025288|FG003|Overall Study|Other reasons than listed|0
1168069|NCT03605836|2297609|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2
1168070|NCT03605836|2297610|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0
1168071|NCT03605836|2297611|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0
1168072|NCT03605836|2297612|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0
1168073|NCT03605836|2297609|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2
1168074|NCT03605836|2297610|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
1168075|NCT03605836|2297611|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
1168076|NCT03605836|2297612|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
1168077|NCT03605836|2297609|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8
1168078|NCT03605836|2297610|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
1168079|NCT03605836|2297611|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
1168080|NCT03605836|2297612|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
1168081|NCT03605836|2297609|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4
1168082|NCT03605836|2297610|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
1168083|NCT03605836|2297611|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
1168084|NCT03605836|2297612|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
1168085|NCT03605836|2297609|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4
1168086|NCT03605836|2297610|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
1168087|NCT03605836|2297611|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
1168088|NCT03605836|2297612|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
1168089|NCT03605836|2297609|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17
1168090|NCT03605836|2297610|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
1168091|NCT03605836|2297611|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
1168092|NCT03605836|2297612|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
1168093|NCT03605836|2297609|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5
1168094|NCT03605836|2297610|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
1168095|NCT03605836|2297611|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
1168096|NCT03605836|2297612|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
1168097|NCT03605836|2297609|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7
1168098|NCT03605836|2297610|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0
1168099|NCT03605836|2297611|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0
1168100|NCT03605836|2297612|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0
1168101|NCT03605836|2297609|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85
1168102|NCT03605836|2297610|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
1168103|NCT03605836|2297611|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
1168104|NCT03605836|2297612|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
1168105|NCT03605836|2297609|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15
1168106|NCT03605836|2297610|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
1168107|NCT03605836|2297611|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
1168108|NCT03605836|2297612|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
1168109|NCT03605836|2297609|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1
1168110|NCT03605836|2297610|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
1168111|NCT03605836|2297611|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
1168112|NCT03605836|2297612|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
1168113|NCT03605836|2297609|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0
1168114|NCT03605836|2297610|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2
1168115|NCT03605836|2297611|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
1168116|NCT03605836|2297612|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
1168117|NCT03605836|2297609|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
1168118|NCT03605836|2297610|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5
1168119|NCT03605836|2297611|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8
1168120|NCT03605836|2297612|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
1168121|NCT03605836|2297609|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
1168122|NCT03605836|2297610|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
1168123|NCT03605836|2297611|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2
1168124|NCT03605836|2297612|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1
1168125|NCT03605836|2297609|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0
1168126|NCT03605836|2297610|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3
1168127|NCT03605836|2297611|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5
1168128|NCT03605836|2297612|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1
1168129|NCT03605836|2297609|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
1168130|NCT03605836|2297610|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1
1168131|NCT03605836|2297611|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
1168132|NCT03605836|2297612|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4
1168133|NCT03605836|2297609|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
1168134|NCT03605836|2297610|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1
1168135|NCT03605836|2297611|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
1168136|NCT03605836|2297612|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
1168137|NCT03605836|2297609|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0
1168138|NCT03605836|2297610|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5
1168139|NCT03605836|2297611|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
1168140|NCT03605836|2297612|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
1168141|NCT03605836|2297609|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0
1168142|NCT03605836|2297610|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10
1168143|NCT03605836|2297611|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6
1168144|NCT03605836|2297612|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4
1168145|NCT03605836|2297609|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
1168146|NCT03605836|2297610|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3
1168147|NCT03605836|2297611|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1
1168148|NCT03605836|2297612|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
1168149|NCT03605836|2297609|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0
1168150|NCT03605836|2297610|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6
1168151|NCT03605836|2297611|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16
1168152|NCT03605836|2297612|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7
1168153|NCT03605836|2297609|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
1168154|NCT03605836|2297610|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
1168155|NCT03605836|2297611|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2
1168156|NCT03605836|2297612|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1
1168157|NCT03606460|2297645|FG000|Overall Study|Lost to Follow-up|1
1168158|NCT03606460|2297646|FG001|Overall Study|Lost to Follow-up|8
1168159|NCT03607487|2297657|FG000|Overall Study|Withdrawal by Subject|2
1168160|NCT03607487|2297658|FG001|Overall Study|Withdrawal by Subject|0
1168161|NCT03607487|2297659|FG002|Overall Study|Withdrawal by Subject|0
1168162|NCT03607487|2297660|FG003|Overall Study|Withdrawal by Subject|1
1168163|NCT03607682|2297681|FG000|Overall Study|Withdrawal by Subject|1
1168164|NCT03607682|2297681|FG000|Overall Study|Disease progression|1
1168165|NCT03607695|2297685|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1
1168166|NCT03607695|2297685|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2
1168167|NCT03607994|2297691|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
1168168|NCT03607994|2297692|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
1168169|NCT03608774|2297717|FG000|Overall Study|Lost to Follow-up|5
1168170|NCT03608774|2297718|FG001|Overall Study|Lost to Follow-up|5
1168171|NCT03608774|2297717|FG000|Overall Study|Withdrawal by Subject|1
1168172|NCT03608774|2297718|FG001|Overall Study|Withdrawal by Subject|0
1168173|NCT03608774|2297717|FG000|Overall Study|Protocol Violation|1
1168174|NCT03608774|2297718|FG001|Overall Study|Protocol Violation|0
1168175|NCT03608774|2297717|FG000|Overall Study|Not eligible at enrollment|0
1168176|NCT03608774|2297718|FG001|Overall Study|Not eligible at enrollment|1
1168177|NCT03608774|2297717|FG000|Overall Study|Health related event|0
1168178|NCT03608774|2297718|FG001|Overall Study|Health related event|1
1168179|NCT03609619|2297739|FG000|Overall Study|Adverse Event|1
1168180|NCT03609619|2297740|FG001|Overall Study|Adverse Event|0
1168181|NCT03609619|2297739|FG000|Overall Study|Lack of Efficacy|1
1168182|NCT03609619|2297740|FG001|Overall Study|Lack of Efficacy|2
1168183|NCT03609619|2297739|FG000|Overall Study|Protocol Violation|5
1168184|NCT03609619|2297740|FG001|Overall Study|Protocol Violation|0
1168185|NCT03609619|2297739|FG000|Overall Study|Withdrawal by Subject|2
1168186|NCT03609619|2297740|FG001|Overall Study|Withdrawal by Subject|3
1168187|NCT03609619|2297739|FG000|Overall Study|Lost to Follow-up|1
1168188|NCT03609619|2297740|FG001|Overall Study|Lost to Follow-up|1
1168189|NCT03610048|2297755|FG000|Overall Study|Study terminated by sponsor|84
1168190|NCT03610048|2297755|FG000|Overall Study|Adverse Event|32
1168191|NCT03610048|2297755|FG000|Overall Study|Withdrawal by Subject|31
1168192|NCT03610048|2297755|FG000|Overall Study|Lost to Follow-up|8
1168193|NCT03610048|2297755|FG000|Overall Study|Other|4
1168194|NCT03610048|2297755|FG000|Overall Study|Physician Decision|1
1168195|NCT03610048|2297755|FG000|Overall Study|Pregnancy|1
1168196|NCT03610165|2297761|FG000|Overall Study|Device didn't work|0
1168197|NCT03610165|2297762|FG001|Overall Study|Device didn't work|1
1168198|NCT03610269|2297768|FG000|Overall Study|Physician Decision|10
1168199|NCT03610269|2297768|FG000|Overall Study|Protocol Violation|1
1168200|NCT03610269|2297768|FG000|Overall Study|Unable to draw blood|1
1168201|NCT03610269|2297768|FG000|Overall Study|Screen fail|4
1168202|NCT03610581|2297792|FG000|Overall Study|Study terminated by sponsor|2
1168203|NCT03610581|2297793|FG001|Overall Study|Study terminated by sponsor|0
1168204|NCT03610581|2297792|FG000|Overall Study|Other|0
1168205|NCT03610581|2297793|FG001|Overall Study|Other|1
1168206|NCT03610581|2297792|FG000|Overall Study|Withdrawal by Subject|1
1168207|NCT03610581|2297793|FG001|Overall Study|Withdrawal by Subject|0
1168208|NCT03611075|2297826|FG000|Overall Study|Physician Decision|0
1168209|NCT03611075|2297827|FG001|Overall Study|Physician Decision|1
1168210|NCT03611075|2297828|FG002|Overall Study|Physician Decision|1
1168211|NCT03611075|2297829|FG003|Overall Study|Physician Decision|0
1168212|NCT03611075|2297830|FG004|Overall Study|Physician Decision|0
1168213|NCT03611075|2297831|FG005|Overall Study|Physician Decision|0
1168214|NCT03611075|2297832|FG006|Overall Study|Physician Decision|0
1168215|NCT03611075|2297833|FG007|Overall Study|Physician Decision|0
1168216|NCT03611075|2297834|FG008|Overall Study|Physician Decision|0
1168217|NCT03611075|2297826|FG000|Overall Study|Lost to Follow-up|1
1168218|NCT03611075|2297827|FG001|Overall Study|Lost to Follow-up|0
1168219|NCT03611075|2297828|FG002|Overall Study|Lost to Follow-up|0
1168220|NCT03611075|2297829|FG003|Overall Study|Lost to Follow-up|2
1168221|NCT03611075|2297830|FG004|Overall Study|Lost to Follow-up|0
1168222|NCT03611075|2297831|FG005|Overall Study|Lost to Follow-up|0
1168223|NCT03611075|2297832|FG006|Overall Study|Lost to Follow-up|0
1168224|NCT03611075|2297833|FG007|Overall Study|Lost to Follow-up|0
1168225|NCT03611075|2297834|FG008|Overall Study|Lost to Follow-up|0
1168226|NCT03611075|2297826|FG000|Overall Study|Withdrawal by Subject|0
1168227|NCT03611075|2297827|FG001|Overall Study|Withdrawal by Subject|1
1168228|NCT03611075|2297828|FG002|Overall Study|Withdrawal by Subject|1
1168229|NCT03611075|2297829|FG003|Overall Study|Withdrawal by Subject|1
1168230|NCT03611075|2297830|FG004|Overall Study|Withdrawal by Subject|0
1168231|NCT03611075|2297831|FG005|Overall Study|Withdrawal by Subject|0
1168232|NCT03611075|2297832|FG006|Overall Study|Withdrawal by Subject|1
1168233|NCT03611075|2297833|FG007|Overall Study|Withdrawal by Subject|0
870247|NCT00529373|1831367|FG001|Base Study|Other Protocol Specified Criteria|20
870248|NCT00529373|1831366|FG000|Base Study|Physician Decision|60
870249|NCT00529373|1831367|FG001|Base Study|Physician Decision|52
870250|NCT00529373|1831366|FG000|Base Study|Protocol Violation|48
870251|NCT00529373|1831367|FG001|Base Study|Protocol Violation|38
870252|NCT00529373|1831366|FG000|Base Study|Withdrawal by Subject|1062
870253|NCT00529373|1831367|FG001|Base Study|Withdrawal by Subject|967
870254|NCT00529373|1831366|FG000|Base Study|Did not continue into Extension|1795
870255|NCT00529373|1831367|FG001|Base Study|Did not continue into Extension|2238
870256|NCT00529373|1831366|FG000|First Extension Study|Adverse Event|162
870257|NCT00529373|1831367|FG001|First Extension Study|Adverse Event|142
870258|NCT00529373|1831366|FG000|First Extension Study|Lack of Efficacy|65
870259|NCT00529373|1831367|FG001|First Extension Study|Lack of Efficacy|427
870260|NCT00529373|1831366|FG000|First Extension Study|Lost to Follow-up|41
870261|NCT00529373|1831367|FG001|First Extension Study|Lost to Follow-up|37
870262|NCT00529373|1831366|FG000|First Extension Study|Other|27
870263|NCT00529373|1831367|FG001|First Extension Study|Other|47
870264|NCT00529373|1831366|FG000|First Extension Study|Physician Decision|50
870265|NCT00529373|1831367|FG001|First Extension Study|Physician Decision|45
870266|NCT00529373|1831366|FG000|First Extension Study|Protocol Violation|16
870267|NCT00529373|1831367|FG001|First Extension Study|Protocol Violation|13
870268|NCT00529373|1831366|FG000|First Extension Study|Withdrawal by Subject|296
870269|NCT00529373|1831367|FG001|First Extension Study|Withdrawal by Subject|287
870270|NCT00529373|1831366|FG000|First Extension Study|Disposition record non-existing|0
870271|NCT00529373|1831367|FG001|First Extension Study|Disposition record non-existing|1
870272|NCT00529373|1831366|FG000|First Extension Study|Discontinued after 5 years completion|208
870273|NCT00529373|1831367|FG001|First Extension Study|Discontinued after 5 years completion|346
1006580|NCT01468701|2025289|FG004|Overall Study|Other reasons than listed|0
1168234|NCT03611075|2297834|FG008|Overall Study|Withdrawal by Subject|0
1168235|NCT03611075|2297826|FG000|Overall Study|Reason unknown|0
1168236|NCT03611075|2297827|FG001|Overall Study|Reason unknown|0
1168237|NCT03611075|2297828|FG002|Overall Study|Reason unknown|0
1168238|NCT03611075|2297829|FG003|Overall Study|Reason unknown|1
1168239|NCT03611075|2297830|FG004|Overall Study|Reason unknown|0
1168240|NCT03611075|2297831|FG005|Overall Study|Reason unknown|0
1168241|NCT03611075|2297832|FG006|Overall Study|Reason unknown|1
1168242|NCT03611075|2297833|FG007|Overall Study|Reason unknown|0
1168243|NCT03611075|2297834|FG008|Overall Study|Reason unknown|0
1168244|NCT03611582|2297879|FG000|Overall Study|Adverse Event|26
1168245|NCT03611582|2297880|FG001|Overall Study|Adverse Event|6
1168246|NCT03611582|2297879|FG000|Overall Study|Protocol Violation|0
1168247|NCT03611582|2297880|FG001|Overall Study|Protocol Violation|1
1168248|NCT03611582|2297879|FG000|Overall Study|Pregnancy|1
1168249|NCT03611582|2297880|FG001|Overall Study|Pregnancy|2
1168250|NCT03611582|2297879|FG000|Overall Study|Lack of Efficacy|0
1168251|NCT03611582|2297880|FG001|Overall Study|Lack of Efficacy|1
1168252|NCT03611582|2297879|FG000|Overall Study|At the discretion of the investigator|1
1168253|NCT03611582|2297880|FG001|Overall Study|At the discretion of the investigator|0
1168254|NCT03611582|2297879|FG000|Overall Study|Safety concern as judged by the investigator|1
1168255|NCT03611582|2297880|FG001|Overall Study|Safety concern as judged by the investigator|2
1168256|NCT03611582|2297879|FG000|Overall Study|Withdrawal by Subject|4
1168257|NCT03611582|2297880|FG001|Overall Study|Withdrawal by Subject|3
1168258|NCT03611582|2297879|FG000|Overall Study|Lost to Follow-up|18
1168259|NCT03611582|2297880|FG001|Overall Study|Lost to Follow-up|7
1168260|NCT03611582|2297879|FG000|Overall Study|other|17
1168261|NCT03611582|2297880|FG001|Overall Study|other|16
1168262|NCT03612856|2297911|FG000|Pre-dose Period|Physician Decision|0
1168263|NCT03612856|2297912|FG001|Pre-dose Period|Physician Decision|1
1168264|NCT03612856|2297913|FG002|Pre-dose Period|Physician Decision|1
1168265|NCT03612856|2297911|FG000|Pre-dose Period|Withdrawal by Subject|0
1168266|NCT03612856|2297912|FG001|Pre-dose Period|Withdrawal by Subject|1
1168267|NCT03612856|2297913|FG002|Pre-dose Period|Withdrawal by Subject|0
1168268|NCT03613129|2297925|FG000|Pre-treatment Assessment|Protocol Violation|2
1168269|NCT03613129|2297926|FG001|Pre-treatment Assessment|Protocol Violation|0
1168270|NCT03613129|2297927|FG002|Pre-treatment Assessment|Protocol Violation|0
1168271|NCT03613129|2297928|FG003|Pre-treatment Assessment|Protocol Violation|0
1168272|NCT03613129|2297929|FG004|Pre-treatment Assessment|Protocol Violation|0
1168273|NCT03613129|2297925|FG000|Pre-treatment Assessment|Withdrawal by Subject|1
1168274|NCT03613129|2297926|FG001|Pre-treatment Assessment|Withdrawal by Subject|0
1168275|NCT03613129|2297927|FG002|Pre-treatment Assessment|Withdrawal by Subject|0
1168276|NCT03613129|2297928|FG003|Pre-treatment Assessment|Withdrawal by Subject|0
1168277|NCT03613129|2297929|FG004|Pre-treatment Assessment|Withdrawal by Subject|0
1168278|NCT03613454|2297943|FG000|Overall Study|Protocol Violation|1
1168279|NCT03613454|2297944|FG001|Overall Study|Protocol Violation|0
1168280|NCT03613454|2297943|FG000|Overall Study|Protocol Violation|0
1168281|NCT03613454|2297944|FG001|Overall Study|Protocol Violation|1
1168282|NCT03613649|2297978|FG000|Second Treatment|Lost to Follow-up|0
1168283|NCT03613649|2297979|FG001|Second Treatment|Lost to Follow-up|0
1168284|NCT03613649|2297980|FG002|Second Treatment|Lost to Follow-up|1
1168285|NCT03613649|2297981|FG003|Second Treatment|Lost to Follow-up|0
1168286|NCT03613649|2297982|FG004|Second Treatment|Lost to Follow-up|0
1168287|NCT03613649|2297983|FG005|Second Treatment|Lost to Follow-up|0
1168288|NCT03613649|2297984|FG006|Second Treatment|Lost to Follow-up|0
1168289|NCT03613649|2297985|FG007|Second Treatment|Lost to Follow-up|0
1168290|NCT03613649|2297986|FG008|Second Treatment|Lost to Follow-up|0
1168291|NCT03613649|2297987|FG009|Second Treatment|Lost to Follow-up|0
1168292|NCT03613649|2297988|FG010|Second Treatment|Lost to Follow-up|0
1168293|NCT03613649|2297989|FG011|Second Treatment|Lost to Follow-up|0
1168294|NCT03613649|2297978|FG000|Second Treatment|Withdrawal by Subject|0
1168295|NCT03613649|2297979|FG001|Second Treatment|Withdrawal by Subject|0
1168296|NCT03613649|2297980|FG002|Second Treatment|Withdrawal by Subject|0
1168297|NCT03613649|2297981|FG003|Second Treatment|Withdrawal by Subject|0
1168298|NCT03613649|2297982|FG004|Second Treatment|Withdrawal by Subject|1
1168299|NCT03613649|2297983|FG005|Second Treatment|Withdrawal by Subject|0
1168300|NCT03613649|2297984|FG006|Second Treatment|Withdrawal by Subject|0
1168301|NCT03613649|2297985|FG007|Second Treatment|Withdrawal by Subject|0
1168302|NCT03613649|2297986|FG008|Second Treatment|Withdrawal by Subject|0
1168303|NCT03613649|2297987|FG009|Second Treatment|Withdrawal by Subject|0
1168304|NCT03613649|2297988|FG010|Second Treatment|Withdrawal by Subject|0
1168305|NCT03613649|2297989|FG011|Second Treatment|Withdrawal by Subject|0
1168306|NCT03613649|2297978|FG000|Third Treatment|Lost to Follow-up|0
1168307|NCT03613649|2297979|FG001|Third Treatment|Lost to Follow-up|0
1168308|NCT03613649|2297980|FG002|Third Treatment|Lost to Follow-up|0
1168309|NCT03613649|2297981|FG003|Third Treatment|Lost to Follow-up|0
1168310|NCT03613649|2297982|FG004|Third Treatment|Lost to Follow-up|1
1168311|NCT03613649|2297983|FG005|Third Treatment|Lost to Follow-up|0
1168312|NCT03613649|2297984|FG006|Third Treatment|Lost to Follow-up|0
1168313|NCT03613649|2297985|FG007|Third Treatment|Lost to Follow-up|0
1168314|NCT03613649|2297986|FG008|Third Treatment|Lost to Follow-up|0
1168315|NCT03613649|2297987|FG009|Third Treatment|Lost to Follow-up|0
1168316|NCT03613649|2297988|FG010|Third Treatment|Lost to Follow-up|0
1168317|NCT03613649|2297989|FG011|Third Treatment|Lost to Follow-up|1
1168318|NCT03613649|2297978|FG000|Third Treatment|Protocol Violation|0
1168319|NCT03613649|2297979|FG001|Third Treatment|Protocol Violation|0
1168320|NCT03613649|2297980|FG002|Third Treatment|Protocol Violation|0
1168321|NCT03613649|2297981|FG003|Third Treatment|Protocol Violation|0
1168322|NCT03613649|2297982|FG004|Third Treatment|Protocol Violation|0
1168323|NCT03613649|2297983|FG005|Third Treatment|Protocol Violation|0
1168324|NCT03613649|2297984|FG006|Third Treatment|Protocol Violation|1
1168325|NCT03613649|2297985|FG007|Third Treatment|Protocol Violation|0
1168326|NCT03613649|2297986|FG008|Third Treatment|Protocol Violation|0
1168327|NCT03613649|2297987|FG009|Third Treatment|Protocol Violation|0
1168328|NCT03613649|2297988|FG010|Third Treatment|Protocol Violation|0
1168329|NCT03613649|2297989|FG011|Third Treatment|Protocol Violation|1
1168330|NCT03613649|2297978|FG000|Fourth Treatment|Protocol Violation|1
1168331|NCT03613649|2297979|FG001|Fourth Treatment|Protocol Violation|0
1168332|NCT03613649|2297980|FG002|Fourth Treatment|Protocol Violation|0
1168333|NCT03613649|2297981|FG003|Fourth Treatment|Protocol Violation|0
1168334|NCT03613649|2297982|FG004|Fourth Treatment|Protocol Violation|1
1168335|NCT03613649|2297983|FG005|Fourth Treatment|Protocol Violation|0
870274|NCT00529373|1831366|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256
1168336|NCT03613649|2297984|FG006|Fourth Treatment|Protocol Violation|0
1168337|NCT03613649|2297985|FG007|Fourth Treatment|Protocol Violation|0
1168338|NCT03613649|2297986|FG008|Fourth Treatment|Protocol Violation|0
1168339|NCT03613649|2297987|FG009|Fourth Treatment|Protocol Violation|0
1168340|NCT03613649|2297988|FG010|Fourth Treatment|Protocol Violation|0
1168341|NCT03613649|2297989|FG011|Fourth Treatment|Protocol Violation|0
1168342|NCT03613649|2297978|FG000|Fourth Treatment|Physician Decision|0
1168343|NCT03613649|2297979|FG001|Fourth Treatment|Physician Decision|0
1168344|NCT03613649|2297980|FG002|Fourth Treatment|Physician Decision|0
1168345|NCT03613649|2297981|FG003|Fourth Treatment|Physician Decision|0
1168346|NCT03613649|2297982|FG004|Fourth Treatment|Physician Decision|0
1168347|NCT03613649|2297983|FG005|Fourth Treatment|Physician Decision|0
1168348|NCT03613649|2297984|FG006|Fourth Treatment|Physician Decision|1
1168349|NCT03613649|2297985|FG007|Fourth Treatment|Physician Decision|0
1168350|NCT03613649|2297986|FG008|Fourth Treatment|Physician Decision|0
1168351|NCT03613649|2297987|FG009|Fourth Treatment|Physician Decision|0
1168352|NCT03613649|2297988|FG010|Fourth Treatment|Physician Decision|0
1168353|NCT03613649|2297989|FG011|Fourth Treatment|Physician Decision|0
1168354|NCT03614078|2298019|FG000|Overall Study|Withdrawal by Subject|2
1168355|NCT03614078|2298020|FG001|Overall Study|Withdrawal by Subject|2
1168356|NCT03614078|2298021|FG002|Overall Study|Withdrawal by Subject|3
1168357|NCT03614078|2298019|FG000|Overall Study|Participant Did Not Return for Visit|0
1168358|NCT03614078|2298020|FG001|Overall Study|Participant Did Not Return for Visit|1
1168359|NCT03614078|2298021|FG002|Overall Study|Participant Did Not Return for Visit|0
1168360|NCT03614078|2298019|FG000|Overall Study|High Neutrophils|0
1168361|NCT03614078|2298020|FG001|Overall Study|High Neutrophils|0
1168362|NCT03614078|2298021|FG002|Overall Study|High Neutrophils|2
1168363|NCT03614078|2298019|FG000|Overall Study|Patient Did Not Meet Eligibility|1
1168364|NCT03614078|2298020|FG001|Overall Study|Patient Did Not Meet Eligibility|0
1168365|NCT03614078|2298021|FG002|Overall Study|Patient Did Not Meet Eligibility|0
1168366|NCT03614078|2298019|FG000|Overall Study|Exacerbation of Psoriasis|0
1168367|NCT03614078|2298020|FG001|Overall Study|Exacerbation of Psoriasis|1
1168368|NCT03614078|2298021|FG002|Overall Study|Exacerbation of Psoriasis|0
1168369|NCT03614078|2298019|FG000|Overall Study|Adverse Event|0
870275|NCT00529373|1831367|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281
870276|NCT00529373|1831366|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
870277|NCT00529373|1831367|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
870278|NCT00529373|1831366|FG000|Second Extension Study|Adverse Event|101
870279|NCT00529373|1831367|FG001|Second Extension Study|Adverse Event|51
870280|NCT00529373|1831366|FG000|Second Extension Study|Lack of Efficacy|7
870281|NCT00529373|1831367|FG001|Second Extension Study|Lack of Efficacy|15
870282|NCT00529373|1831366|FG000|Second Extension Study|Lost to Follow-up|18
870283|NCT00529373|1831367|FG001|Second Extension Study|Lost to Follow-up|12
870284|NCT00529373|1831366|FG000|Second Extension Study|Other|7
870285|NCT00529373|1831367|FG001|Second Extension Study|Other|12
870286|NCT00529373|1831366|FG000|Second Extension Study|Physician Decision|63
1168370|NCT03614078|2298020|FG001|Overall Study|Adverse Event|2
1168371|NCT03614078|2298021|FG002|Overall Study|Adverse Event|0
1168372|NCT03614078|2298019|FG000|Overall Study|Dizziness and Rash|0
1168373|NCT03614078|2298020|FG001|Overall Study|Dizziness and Rash|1
1168374|NCT03614078|2298021|FG002|Overall Study|Dizziness and Rash|0
1168375|NCT03614156|2298043|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6
1168376|NCT03614156|2298044|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0
1168377|NCT03614156|2298045|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0
1168378|NCT03614156|2298046|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0
1168379|NCT03614156|2298043|FG000|Open-Label Treatment Period|Adverse Event|7
1168380|NCT03614156|2298044|FG001|Open-Label Treatment Period|Adverse Event|0
1168381|NCT03614156|2298045|FG002|Open-Label Treatment Period|Adverse Event|0
1168382|NCT03614156|2298046|FG003|Open-Label Treatment Period|Adverse Event|0
1168383|NCT03614156|2298043|FG000|Open-Label Treatment Period|Lack of Efficacy|18
1168384|NCT03614156|2298044|FG001|Open-Label Treatment Period|Lack of Efficacy|0
1168385|NCT03614156|2298045|FG002|Open-Label Treatment Period|Lack of Efficacy|0
1168386|NCT03614156|2298046|FG003|Open-Label Treatment Period|Lack of Efficacy|0
1168387|NCT03614156|2298043|FG000|Open-Label Treatment Period|Withdrawal by Subject|36
1168388|NCT03614156|2298044|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
1168389|NCT03614156|2298045|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
1168390|NCT03614156|2298046|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
1168391|NCT03614156|2298043|FG000|Open-Label Treatment Period|Lost to Follow-up|10
1168392|NCT03614156|2298044|FG001|Open-Label Treatment Period|Lost to Follow-up|0
1168393|NCT03614156|2298045|FG002|Open-Label Treatment Period|Lost to Follow-up|0
1168394|NCT03614156|2298046|FG003|Open-Label Treatment Period|Lost to Follow-up|0
1168395|NCT03614156|2298043|FG000|Open-Label Treatment Period|Protocol Violation|2
1168396|NCT03614156|2298044|FG001|Open-Label Treatment Period|Protocol Violation|0
1168397|NCT03614156|2298045|FG002|Open-Label Treatment Period|Protocol Violation|0
1168398|NCT03614156|2298046|FG003|Open-Label Treatment Period|Protocol Violation|0
1168399|NCT03614156|2298043|FG000|Open-Label Treatment Period|Non-compliance with study drug|1
1168400|NCT03614156|2298044|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
1168401|NCT03614156|2298045|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
1168402|NCT03614156|2298046|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
1168403|NCT03614156|2298043|FG000|Open-Label Treatment Period|Study terminated by sponsor|74
1168404|NCT03614156|2298044|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
1168405|NCT03614156|2298045|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
1168406|NCT03614156|2298046|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
1168407|NCT03614156|2298043|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0
1168408|NCT03614156|2298044|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2
1168409|NCT03614156|2298045|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0
1168410|NCT03614156|2298046|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1
1168411|NCT03614156|2298043|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0
1168412|NCT03614156|2298044|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4
1168413|NCT03614156|2298045|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
1168414|NCT03614156|2298046|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
1168415|NCT03614156|2298043|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
1168416|NCT03614156|2298044|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
1168417|NCT03614156|2298045|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3
1168418|NCT03614156|2298046|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4
1168419|NCT03614156|2298043|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0
1168420|NCT03614156|2298044|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
1168421|NCT03614156|2298045|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
1168422|NCT03614156|2298046|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
1168423|NCT03614156|2298043|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0
1168424|NCT03614156|2298044|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22
1168425|NCT03614156|2298045|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26
1168426|NCT03614156|2298046|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38
1168427|NCT03614156|2298043|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
1168428|NCT03614156|2298044|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1
1168429|NCT03614156|2298045|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
1168430|NCT03614156|2298046|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
1168431|NCT03614156|2298043|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2
1168432|NCT03614156|2298044|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0
1168433|NCT03614156|2298045|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0
1168434|NCT03614156|2298046|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0
1168435|NCT03614156|2298043|FG000|Safety Follow-Up Period|Withdrawal by Subject|0
1168436|NCT03614156|2298044|FG001|Safety Follow-Up Period|Withdrawal by Subject|0
1168437|NCT03614156|2298045|FG002|Safety Follow-Up Period|Withdrawal by Subject|1
1168438|NCT03614156|2298046|FG003|Safety Follow-Up Period|Withdrawal by Subject|0
1168439|NCT03614156|2298043|FG000|Safety Follow-Up Period|Lost to Follow-up|1
1168440|NCT03614156|2298044|FG001|Safety Follow-Up Period|Lost to Follow-up|0
1168441|NCT03614156|2298045|FG002|Safety Follow-Up Period|Lost to Follow-up|0
1168442|NCT03614156|2298046|FG003|Safety Follow-Up Period|Lost to Follow-up|1
1168443|NCT03614975|2298063|FG000|Overall Study|Physician Decision|7
1168444|NCT03614975|2298064|FG001|Overall Study|Physician Decision|5
1168445|NCT03614975|2298063|FG000|Overall Study|Withdrawal by Subject|2
1168446|NCT03614975|2298064|FG001|Overall Study|Withdrawal by Subject|2
1168447|NCT03614975|2298063|FG000|Overall Study|Specimens not in lab batch shipment|1
1168448|NCT03614975|2298064|FG001|Overall Study|Specimens not in lab batch shipment|1
1168449|NCT03615404|2298112|FG000|Overall Study|Death|1
1168450|NCT03615404|2298112|FG000|Overall Study|vaccine did not pass quality assurance|1
1168451|NCT03615482|2298118|FG000|Overall Study|Death|1
1168452|NCT03615482|2298119|FG001|Overall Study|Death|0
1168453|NCT03615482|2298118|FG000|Overall Study|Lost to Follow-up|7
1168454|NCT03615482|2298119|FG001|Overall Study|Lost to Follow-up|7
1168455|NCT03615482|2298118|FG000|Overall Study|Physician Decision|2
1168456|NCT03615482|2298119|FG001|Overall Study|Physician Decision|3
1168457|NCT03615482|2298118|FG000|Overall Study|Withdrawal by Subject|7
1168458|NCT03615482|2298119|FG001|Overall Study|Withdrawal by Subject|7
1168459|NCT03615924|2298164|FG000|Overall Study|Withdrawal by Subject|2
1168460|NCT03615924|2298165|FG001|Overall Study|Withdrawal by Subject|5
1168461|NCT03615924|2298164|FG000|Overall Study|Death|3
1168462|NCT03615924|2298165|FG001|Overall Study|Death|1
1168463|NCT03615924|2298164|FG000|Overall Study|Lost to Follow-up|1
1168464|NCT03615924|2298165|FG001|Overall Study|Lost to Follow-up|0
1168465|NCT03615924|2298164|FG000|Overall Study|Randomized in error|1
1168466|NCT03615924|2298165|FG001|Overall Study|Randomized in error|0
1168467|NCT03615924|2298164|FG000|Overall Study|Study termination by Sponsor|94
1168468|NCT03615924|2298165|FG001|Overall Study|Study termination by Sponsor|86
1168469|NCT03616106|2298173|FG000|Overall Study|Removed by PI|6
1168470|NCT03616106|2298174|FG001|Overall Study|Removed by PI|0
1168471|NCT03616106|2298173|FG000|Overall Study|Withdrawal by Subject|1
1168472|NCT03616106|2298174|FG001|Overall Study|Withdrawal by Subject|1
1168473|NCT03616106|2298173|FG000|Overall Study|Lost to Follow-up|7
1168474|NCT03616106|2298174|FG001|Overall Study|Lost to Follow-up|0
1168475|NCT03616600|2298191|FG000|Overall Study|Withdrawal by Subject|1
1168476|NCT03616600|2298192|FG001|Overall Study|Withdrawal by Subject|0
1168477|NCT03616977|2298208|FG000|Period 1|Physician Decision|0
1168478|NCT03616977|2298209|FG001|Period 1|Physician Decision|1
1168479|NCT03616977|2298208|FG000|Period 3|Adverse Event|1
1168480|NCT03616977|2298209|FG001|Period 3|Adverse Event|1
1168481|NCT03617588|2298248|FG000|Overall Study|Withdrawal by Subject|1
1168482|NCT03617588|2298249|FG001|Overall Study|Withdrawal by Subject|0
1168483|NCT03617770|2298261|FG000|Overall Study|Lost to Follow-up|1
1168484|NCT03617770|2298262|FG001|Overall Study|Lost to Follow-up|0
1168485|NCT03617861|2298270|FG000|Second Intervention (1 Day)|Adverse Event|0
1168486|NCT03617861|2298271|FG001|Second Intervention (1 Day)|Adverse Event|0
1168487|NCT03617861|2298272|FG002|Second Intervention (1 Day)|Adverse Event|1
1168488|NCT03617861|2298273|FG003|Second Intervention (1 Day)|Adverse Event|0
1168489|NCT03618628|2298329|FG000|Overall Study|Death|1
1168490|NCT03618628|2298329|FG000|Overall Study|Lost to Follow-up|1
1168491|NCT03618823|2298339|FG000|Overall Study|Lost to Follow-up|63
1168492|NCT03618823|2298340|FG001|Overall Study|Lost to Follow-up|61
1168493|NCT03619837|2298366|FG000|Screening|received organs from HCV-negative donors|47
1168494|NCT03619837|2298366|FG000|Screening|died on the wait-list|2
1168495|NCT03619837|2298366|FG000|Screening|remained on the wait list|40
1168496|NCT03619837|2298366|FG000|Screening|didn't meet eligibility criteria|3
1168497|NCT03619837|2298366|FG000|Screening|withdrew consent|2
1168498|NCT03619837|2298366|FG000|Screening|never listed for HCV-viremic donor|1
1168499|NCT03619837|2298366|FG000|Screening|developed exclusion criteria|2
1168500|NCT03619837|2298366|FG000|Screening|excluded by the investigator due to non-compliance|1
1168501|NCT03620162|2298384|FG000|Overall Study|Physician Decision|4
1168502|NCT03620162|2298385|FG001|Overall Study|Physician Decision|0
1168503|NCT03620162|2298386|FG002|Overall Study|Physician Decision|1
1168504|NCT03620162|2298387|FG003|Overall Study|Physician Decision|0
1168505|NCT03620162|2298388|FG004|Overall Study|Physician Decision|2
1168506|NCT03620162|2298384|FG000|Overall Study|Lost to Follow-up|2
1168507|NCT03620162|2298385|FG001|Overall Study|Lost to Follow-up|6
1168508|NCT03620162|2298386|FG002|Overall Study|Lost to Follow-up|7
1168509|NCT03620162|2298387|FG003|Overall Study|Lost to Follow-up|3
1168510|NCT03620162|2298388|FG004|Overall Study|Lost to Follow-up|2
1168511|NCT03620162|2298384|FG000|Overall Study|Consent withdrawn by parent/guardian|9
1168512|NCT03620162|2298385|FG001|Overall Study|Consent withdrawn by parent/guardian|8
1168513|NCT03620162|2298386|FG002|Overall Study|Consent withdrawn by parent/guardian|25
1168514|NCT03620162|2298387|FG003|Overall Study|Consent withdrawn by parent/guardian|17
1168515|NCT03620162|2298388|FG004|Overall Study|Consent withdrawn by parent/guardian|9
1168516|NCT03620708|2298414|FG000|Overall Study|Lost to Follow-up|1
1168517|NCT03620708|2298415|FG001|Overall Study|Lost to Follow-up|1
1168518|NCT03620708|2298416|FG002|Overall Study|Lost to Follow-up|2
1168519|NCT03620708|2298414|FG000|Overall Study|Withdrawal by Subject|0
1168520|NCT03620708|2298415|FG001|Overall Study|Withdrawal by Subject|0
1168521|NCT03620708|2298416|FG002|Overall Study|Withdrawal by Subject|1
1168522|NCT03621189|2298442|FG000|Overall Study|Withdrawal by Subject|0
1168523|NCT03621189|2298443|FG001|Overall Study|Withdrawal by Subject|3
1168524|NCT03621189|2298442|FG000|Overall Study|Physician Decision|0
1168525|NCT03621189|2298443|FG001|Overall Study|Physician Decision|2
1168526|NCT03622112|2298478|FG000|Overall Study|Withdrawal by Subject|6
1168527|NCT03622112|2298479|FG001|Overall Study|Withdrawal by Subject|2
1168528|NCT03622112|2298480|FG002|Overall Study|Withdrawal by Subject|4
1168529|NCT03622112|2298481|FG003|Overall Study|Withdrawal by Subject|2
1168530|NCT03622112|2298482|FG004|Overall Study|Withdrawal by Subject|1
1168531|NCT03622112|2298483|FG005|Overall Study|Withdrawal by Subject|2
1168532|NCT03622112|2298484|FG006|Overall Study|Withdrawal by Subject|2
1168533|NCT03622112|2298478|FG000|Overall Study|Death|0
1168534|NCT03622112|2298479|FG001|Overall Study|Death|0
1168535|NCT03622112|2298480|FG002|Overall Study|Death|0
1168536|NCT03622112|2298481|FG003|Overall Study|Death|1
1168537|NCT03622112|2298482|FG004|Overall Study|Death|0
1168538|NCT03622112|2298483|FG005|Overall Study|Death|0
1168539|NCT03622112|2298484|FG006|Overall Study|Death|0
1168540|NCT03622112|2298478|FG000|Overall Study|Lost to Follow-up|1
1168541|NCT03622112|2298479|FG001|Overall Study|Lost to Follow-up|1
1168542|NCT03622112|2298480|FG002|Overall Study|Lost to Follow-up|0
1168543|NCT03622112|2298481|FG003|Overall Study|Lost to Follow-up|0
1168544|NCT03622112|2298482|FG004|Overall Study|Lost to Follow-up|0
1168545|NCT03622112|2298483|FG005|Overall Study|Lost to Follow-up|0
1168546|NCT03622112|2298484|FG006|Overall Study|Lost to Follow-up|0
1168547|NCT03622112|2298478|FG000|Overall Study|Study-specific withdrawal criteria|10
1168548|NCT03622112|2298479|FG001|Overall Study|Study-specific withdrawal criteria|8
1168549|NCT03622112|2298480|FG002|Overall Study|Study-specific withdrawal criteria|7
1168550|NCT03622112|2298481|FG003|Overall Study|Study-specific withdrawal criteria|6
1168551|NCT03622112|2298482|FG004|Overall Study|Study-specific withdrawal criteria|4
1168552|NCT03622112|2298483|FG005|Overall Study|Study-specific withdrawal criteria|18
1168553|NCT03622112|2298484|FG006|Overall Study|Study-specific withdrawal criteria|4
1168554|NCT03622112|2298478|FG000|Overall Study|Protocol Violation|2
1168555|NCT03622112|2298479|FG001|Overall Study|Protocol Violation|0
1168556|NCT03622112|2298480|FG002|Overall Study|Protocol Violation|1
1168557|NCT03622112|2298481|FG003|Overall Study|Protocol Violation|1
1168558|NCT03622112|2298482|FG004|Overall Study|Protocol Violation|0
1168559|NCT03622112|2298483|FG005|Overall Study|Protocol Violation|0
1168560|NCT03622112|2298484|FG006|Overall Study|Protocol Violation|0
1168561|NCT03622112|2298478|FG000|Overall Study|Adverse Event|6
1168562|NCT03622112|2298479|FG001|Overall Study|Adverse Event|8
1168563|NCT03622112|2298480|FG002|Overall Study|Adverse Event|4
1168564|NCT03622112|2298481|FG003|Overall Study|Adverse Event|11
1168565|NCT03622112|2298482|FG004|Overall Study|Adverse Event|4
1168566|NCT03622112|2298483|FG005|Overall Study|Adverse Event|20
1168567|NCT03622112|2298484|FG006|Overall Study|Adverse Event|2
1168568|NCT03622112|2298478|FG000|Overall Study|Reason not specified|0
1168569|NCT03622112|2298479|FG001|Overall Study|Reason not specified|1
1168570|NCT03622112|2298480|FG002|Overall Study|Reason not specified|0
1168571|NCT03622112|2298481|FG003|Overall Study|Reason not specified|1
1168572|NCT03622112|2298482|FG004|Overall Study|Reason not specified|1
1168573|NCT03622112|2298483|FG005|Overall Study|Reason not specified|2
1168574|NCT03622112|2298484|FG006|Overall Study|Reason not specified|1
1168575|NCT03624504|2298550|FG000|Overall Study|Unsuccessful Implant|1
1168576|NCT03624946|2298575|FG000|Overall Study|Lost to Follow-up|0
1168577|NCT03624946|2298576|FG001|Overall Study|Lost to Follow-up|1
1168578|NCT03624972|2298589|FG000|Overall Study|Lost to Follow-up|2
1168579|NCT03624972|2298590|FG001|Overall Study|Lost to Follow-up|0
1168580|NCT03624972|2298591|FG002|Overall Study|Lost to Follow-up|0
1168581|NCT03624972|2298589|FG000|Overall Study|Withdrawal by Subject|0
1168582|NCT03624972|2298590|FG001|Overall Study|Withdrawal by Subject|2
1168583|NCT03624972|2298591|FG002|Overall Study|Withdrawal by Subject|0
1168584|NCT03627065|2298626|FG000|Overall Study|Study Terminated by sponsor|1
1168585|NCT03627065|2298626|FG000|Overall Study|Withdrawal by Subject|2
1168586|NCT03627195|2298636|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1
1168587|NCT03627195|2298637|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0
1168588|NCT03627195|2298638|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0
1168589|NCT03627195|2298639|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0
1168590|NCT03627195|2298640|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0
1168591|NCT03627195|2298641|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0
1168592|NCT03627416|2298661|FG000|Overall Study|Adverse Event|0
1168593|NCT03627416|2298662|FG001|Overall Study|Adverse Event|1
1168594|NCT03627494|2298680|FG000|Part A Washout 2 (7 Days)|Adverse Event|1
1168595|NCT03627494|2298681|FG001|Part A Washout 2 (7 Days)|Adverse Event|0
1168596|NCT03627494|2298682|FG002|Part A Washout 2 (7 Days)|Adverse Event|1
1168597|NCT03627494|2298683|FG003|Part A Washout 2 (7 Days)|Adverse Event|0
1168598|NCT03627494|2298684|FG004|Part A Washout 2 (7 Days)|Adverse Event|0
1168599|NCT03627494|2298685|FG005|Part A Washout 2 (7 Days)|Adverse Event|0
1168600|NCT03627494|2298686|FG006|Part A Washout 2 (7 Days)|Adverse Event|0
1168601|NCT03627494|2298687|FG007|Part A Washout 2 (7 Days)|Adverse Event|0
1168602|NCT03627494|2298688|FG008|Part A Washout 2 (7 Days)|Adverse Event|0
1168603|NCT03627494|2298689|FG009|Part A Washout 2 (7 Days)|Adverse Event|0
1168604|NCT03627494|2298690|FG010|Part A Washout 2 (7 Days)|Adverse Event|0
1168605|NCT03627494|2298691|FG011|Part A Washout 2 (7 Days)|Adverse Event|0
1168606|NCT03627494|2298680|FG000|Part B (Maximum of 34 Days)|Adverse Event|0
1168607|NCT03627494|2298681|FG001|Part B (Maximum of 34 Days)|Adverse Event|0
1168608|NCT03627494|2298682|FG002|Part B (Maximum of 34 Days)|Adverse Event|0
1168609|NCT03627494|2298683|FG003|Part B (Maximum of 34 Days)|Adverse Event|0
1168610|NCT03627494|2298684|FG004|Part B (Maximum of 34 Days)|Adverse Event|0
1168611|NCT03627494|2298685|FG005|Part B (Maximum of 34 Days)|Adverse Event|0
1168612|NCT03627494|2298686|FG006|Part B (Maximum of 34 Days)|Adverse Event|0
1168613|NCT03627494|2298687|FG007|Part B (Maximum of 34 Days)|Adverse Event|0
1168614|NCT03627494|2298688|FG008|Part B (Maximum of 34 Days)|Adverse Event|2
1168615|NCT03627494|2298689|FG009|Part B (Maximum of 34 Days)|Adverse Event|0
1168616|NCT03627494|2298690|FG010|Part B (Maximum of 34 Days)|Adverse Event|0
1168617|NCT03627494|2298691|FG011|Part B (Maximum of 34 Days)|Adverse Event|0
1168618|NCT03627494|2298680|FG000|Part C Washout 1 (7 Days)|Adverse Event|0
1168619|NCT03627494|2298681|FG001|Part C Washout 1 (7 Days)|Adverse Event|0
1168620|NCT03627494|2298682|FG002|Part C Washout 1 (7 Days)|Adverse Event|0
1168621|NCT03627494|2298683|FG003|Part C Washout 1 (7 Days)|Adverse Event|0
1168622|NCT03627494|2298684|FG004|Part C Washout 1 (7 Days)|Adverse Event|0
1168623|NCT03627494|2298685|FG005|Part C Washout 1 (7 Days)|Adverse Event|0
1168624|NCT03627494|2298686|FG006|Part C Washout 1 (7 Days)|Adverse Event|0
1168625|NCT03627494|2298687|FG007|Part C Washout 1 (7 Days)|Adverse Event|0
1168626|NCT03627494|2298688|FG008|Part C Washout 1 (7 Days)|Adverse Event|0
1168627|NCT03627494|2298689|FG009|Part C Washout 1 (7 Days)|Adverse Event|0
1168628|NCT03627494|2298690|FG010|Part C Washout 1 (7 Days)|Adverse Event|1
1168629|NCT03627494|2298691|FG011|Part C Washout 1 (7 Days)|Adverse Event|1
1168630|NCT03627767|2298733|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48
1168631|NCT03627767|2298734|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
1168632|NCT03627767|2298735|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
1168633|NCT03627767|2298736|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
1168634|NCT03627767|2298737|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
1168635|NCT03627767|2298733|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1
1168636|NCT03627767|2298734|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0
1168637|NCT03627767|2298735|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0
1168638|NCT03627767|2298736|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0
1168639|NCT03627767|2298737|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0
1168640|NCT03627767|2298733|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315
1168641|NCT03627767|2298734|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
1168642|NCT03627767|2298735|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
1168643|NCT03627767|2298736|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
1168644|NCT03627767|2298737|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
1168645|NCT03627767|2298733|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13
1168646|NCT03627767|2298734|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
1168647|NCT03627767|2298735|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
1168648|NCT03627767|2298736|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
1168649|NCT03627767|2298737|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
1168650|NCT03627767|2298733|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11
1168651|NCT03627767|2298734|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
1168652|NCT03627767|2298735|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
1168653|NCT03627767|2298736|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
1168654|NCT03627767|2298737|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
1168655|NCT03627767|2298733|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40
1168656|NCT03627767|2298734|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
1168657|NCT03627767|2298735|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
1168658|NCT03627767|2298736|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
1168659|NCT03627767|2298737|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
1168660|NCT03627767|2298733|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1
1168661|NCT03627767|2298734|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
1168662|NCT03627767|2298735|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
1168663|NCT03627767|2298736|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
1168664|NCT03627767|2298737|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
1168665|NCT03627767|2298733|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2
1168666|NCT03627767|2298734|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
1168667|NCT03627767|2298735|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
1168668|NCT03627767|2298736|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
1168669|NCT03627767|2298737|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
1168670|NCT03627767|2298733|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4
1168671|NCT03627767|2298734|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0
1168672|NCT03627767|2298735|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0
1168673|NCT03627767|2298736|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0
1168674|NCT03627767|2298737|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0
1168675|NCT03627767|2298733|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2
1168676|NCT03627767|2298734|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
1168677|NCT03627767|2298735|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
1168678|NCT03627767|2298736|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
1168679|NCT03627767|2298737|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
1168680|NCT03627767|2298733|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
1168681|NCT03627767|2298734|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6
1168682|NCT03627767|2298735|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7
1168683|NCT03627767|2298736|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19
1168684|NCT03627767|2298737|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
1168685|NCT03627767|2298733|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
1168686|NCT03627767|2298734|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
1168687|NCT03627767|2298735|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2
1168688|NCT03627767|2298736|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3
1168689|NCT03627767|2298737|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
1168690|NCT03627767|2298733|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
1168691|NCT03627767|2298734|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1
1168692|NCT03627767|2298735|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5
1168693|NCT03627767|2298736|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2
1168694|NCT03627767|2298737|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
1168695|NCT03627767|2298733|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
1168696|NCT03627767|2298734|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9
1168697|NCT03627767|2298735|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6
1168698|NCT03627767|2298736|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10
1168699|NCT03627767|2298737|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
1168700|NCT03627767|2298733|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
1168701|NCT03627767|2298734|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
1168702|NCT03627767|2298735|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1
1168703|NCT03627767|2298736|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
1168704|NCT03627767|2298737|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
870287|NCT00529373|1831367|FG001|Second Extension Study|Physician Decision|26
870288|NCT00529373|1831366|FG000|Second Extension Study|Protocol Violation|2
870289|NCT00529373|1831367|FG001|Second Extension Study|Protocol Violation|1
870290|NCT00529373|1831366|FG000|Second Extension Study|Withdrawal by Subject|97
870291|NCT00529373|1831367|FG001|Second Extension Study|Withdrawal by Subject|75
870292|NCT00529373|1831366|FG000|Second Extension Study|Status Missing|5
870293|NCT00529373|1831367|FG001|Second Extension Study|Status Missing|5
870294|NCT00529386|1831381|FG000|Overall Study|Lost to Follow-up|1
870295|NCT00529399|1831388|FG000|Overall Study|Lost to Follow-up|1
870296|NCT00529399|1831389|FG001|Overall Study|Lost to Follow-up|0
870297|NCT00529399|1831390|FG002|Overall Study|Lost to Follow-up|1
870298|NCT00529399|1831388|FG000|Overall Study|Withdrawal by Subject|1
870299|NCT00529399|1831389|FG001|Overall Study|Withdrawal by Subject|0
1168705|NCT03627767|2298733|FG000|Double-blind Treatment Period (40 Weeks)|Other|0
1168706|NCT03627767|2298734|FG001|Double-blind Treatment Period (40 Weeks)|Other|0
1168707|NCT03627767|2298735|FG002|Double-blind Treatment Period (40 Weeks)|Other|1
1168708|NCT03627767|2298736|FG003|Double-blind Treatment Period (40 Weeks)|Other|1
1168709|NCT03627767|2298737|FG004|Double-blind Treatment Period (40 Weeks)|Other|0
1168710|NCT03627767|2298733|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0
1168711|NCT03627767|2298734|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0
1168712|NCT03627767|2298735|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0
1168713|NCT03627767|2298736|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0
1168714|NCT03627767|2298737|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9
1168715|NCT03627767|2298733|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
1168716|NCT03627767|2298734|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
1168717|NCT03627767|2298735|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
1168718|NCT03627767|2298736|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
1168719|NCT03627767|2298737|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1
1168720|NCT03627767|2298733|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
1168721|NCT03627767|2298734|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
1168722|NCT03627767|2298735|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
1168723|NCT03627767|2298736|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
1168724|NCT03627767|2298737|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9
1168725|NCT03627767|2298733|FG000|Open-label Rescue Period (12 Weeks)|Other|0
1168726|NCT03627767|2298734|FG001|Open-label Rescue Period (12 Weeks)|Other|0
1168727|NCT03627767|2298735|FG002|Open-label Rescue Period (12 Weeks)|Other|0
1168728|NCT03627767|2298736|FG003|Open-label Rescue Period (12 Weeks)|Other|0
1168729|NCT03627767|2298737|FG004|Open-label Rescue Period (12 Weeks)|Other|1
1168730|NCT03627832|2298750|FG000|Overall Study|Withdrawal by Subject|10
1168731|NCT03627832|2298751|FG001|Overall Study|Withdrawal by Subject|1
1168732|NCT03628417|2298757|FG000|Overall Study|Death|1
1168733|NCT03628417|2298758|FG001|Overall Study|Death|1
1168734|NCT03628508|2298776|FG000|Overall Study|Lost to Follow-up|1
1168735|NCT03628599|2298782|FG000|Overall Study|Adverse Event|0
1168736|NCT03628599|2298783|FG001|Overall Study|Adverse Event|1
1168737|NCT03628898|2298806|FG000|Overall Study|Device deficiency|1
1168738|NCT03628924|2298813|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2
1168739|NCT03628924|2298814|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
1168740|NCT03628924|2298815|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
1168741|NCT03628924|2298816|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
1168742|NCT03628924|2298817|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
1168743|NCT03628924|2298818|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
1168744|NCT03628924|2298819|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
1168745|NCT03628924|2298813|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
1168746|NCT03628924|2298814|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
1168747|NCT03628924|2298815|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
1168748|NCT03628924|2298816|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
1168749|NCT03628924|2298817|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
1168750|NCT03628924|2298818|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
1168751|NCT03628924|2298819|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
1168752|NCT03628924|2298813|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
1168753|NCT03628924|2298814|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2
1168754|NCT03628924|2298815|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
1168755|NCT03628924|2298816|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
1168756|NCT03628924|2298817|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
1168757|NCT03628924|2298818|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
1168758|NCT03628924|2298819|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
1168759|NCT03628924|2298813|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
1168760|NCT03628924|2298814|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
1168761|NCT03628924|2298815|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
1168762|NCT03628924|2298816|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
1168763|NCT03628924|2298817|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
1168764|NCT03628924|2298818|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
1168765|NCT03628924|2298819|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
1168766|NCT03628924|2298813|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3
1168767|NCT03628924|2298814|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
1168768|NCT03628924|2298815|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1
1168769|NCT03628924|2298816|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
1168770|NCT03628924|2298817|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
1168771|NCT03628924|2298818|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
1168772|NCT03628924|2298819|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
1168773|NCT03628924|2298813|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
1168774|NCT03628924|2298814|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
1168775|NCT03628924|2298815|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
1168776|NCT03628924|2298816|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
1168777|NCT03628924|2298817|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
1168778|NCT03628924|2298818|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2
1168779|NCT03628924|2298819|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
1168780|NCT03628924|2298813|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0
1168781|NCT03628924|2298814|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0
1168782|NCT03628924|2298815|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0
1168783|NCT03628924|2298816|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1
1168784|NCT03628924|2298817|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0
1168785|NCT03628924|2298818|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2
1168786|NCT03628924|2298819|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4
1168787|NCT03628924|2298813|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0
1168788|NCT03628924|2298814|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0
1168789|NCT03628924|2298815|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0
1168790|NCT03628924|2298816|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1
1168791|NCT03628924|2298817|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1
1168792|NCT03628924|2298818|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0
1168793|NCT03628924|2298819|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1
1168794|NCT03628924|2298813|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
1168795|NCT03628924|2298814|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
1168796|NCT03628924|2298815|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
1168797|NCT03628924|2298816|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5
1168798|NCT03628924|2298817|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1
1168799|NCT03628924|2298818|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4
1168800|NCT03628924|2298819|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2
1168801|NCT03628924|2298813|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
1168802|NCT03628924|2298814|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
1168803|NCT03628924|2298815|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
1168804|NCT03628924|2298816|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
1168805|NCT03628924|2298817|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1
1168806|NCT03628924|2298818|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5
1168807|NCT03628924|2298819|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3
1168808|NCT03629028|2298833|FG000|Overall Study|Lost to Follow-up|26
1168809|NCT03629028|2298834|FG001|Overall Study|Lost to Follow-up|23
1168810|NCT03629028|2298833|FG000|Overall Study|Pregnancy|4
1168811|NCT03629028|2298834|FG001|Overall Study|Pregnancy|2
1168812|NCT03629028|2298833|FG000|Overall Study|intolerance to examination|2
1168813|NCT03629028|2298834|FG001|Overall Study|intolerance to examination|0
1168814|NCT03629041|2298850|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
1168815|NCT03629041|2298851|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
1168816|NCT03629041|2298852|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
1168817|NCT03629041|2298853|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
1168818|NCT03629054|2298873|FG000|Period 2 (4 Days)|Not treated|0
1168819|NCT03629054|2298874|FG001|Period 2 (4 Days)|Not treated|1
1168820|NCT03629249|2298892|FG000|Overall Study|Study terminated by sponsor|197
1168821|NCT03629249|2298893|FG001|Overall Study|Study terminated by sponsor|197
1168822|NCT03629249|2298894|FG002|Overall Study|Study terminated by sponsor|194
1168823|NCT03629249|2298892|FG000|Overall Study|Protocol deviation|0
1168824|NCT03629249|2298893|FG001|Overall Study|Protocol deviation|2
1168825|NCT03629249|2298894|FG002|Overall Study|Protocol deviation|5
1168826|NCT03629249|2298892|FG000|Overall Study|Subject decision|1
1168827|NCT03629249|2298893|FG001|Overall Study|Subject decision|1
1168828|NCT03629249|2298894|FG002|Overall Study|Subject decision|3
1168829|NCT03629249|2298892|FG000|Overall Study|Adverse Event|1
1168830|NCT03629249|2298893|FG001|Overall Study|Adverse Event|1
1168831|NCT03629249|2298894|FG002|Overall Study|Adverse Event|0
1168832|NCT03629249|2298892|FG000|Overall Study|Death|1
1168833|NCT03629249|2298893|FG001|Overall Study|Death|0
1168834|NCT03629249|2298894|FG002|Overall Study|Death|0
1168835|NCT03629249|2298892|FG000|Overall Study|Physician Decision|1
1168836|NCT03629249|2298893|FG001|Overall Study|Physician Decision|0
1168837|NCT03629249|2298894|FG002|Overall Study|Physician Decision|0
1168838|NCT03629886|2298908|FG000|Overall Study|Migrated / moved from the study area|0
1168839|NCT03629886|2298909|FG001|Overall Study|Migrated / moved from the study area|55
1168840|NCT03629886|2298908|FG000|Overall Study|Consent withdrawal, not due to an AE|0
1168841|NCT03629886|2298909|FG001|Overall Study|Consent withdrawal, not due to an AE|50
1168842|NCT03629886|2298908|FG000|Overall Study|Study vaccine not administrated|0
1168843|NCT03629886|2298909|FG001|Overall Study|Study vaccine not administrated|3
1168844|NCT03629886|2298908|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0
1168845|NCT03629886|2298909|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28
1168846|NCT03629886|2298908|FG000|Overall Study|Refused vaccination step of the study|0
1168847|NCT03629886|2298909|FG001|Overall Study|Refused vaccination step of the study|44
1168848|NCT03630016|2298925|FG000|Overall Study|Poor Sensor Placement|1
1168849|NCT03630302|2298947|FG000|Surgery|hardware issue prevented LFP recordings|1
1168850|NCT03630302|2298947|FG000|3 Month Visit|Adverse Event|2
1168851|NCT03630302|2298947|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2
1168852|NCT03631355|2298962|FG000|Overall Study|Lost to Follow-up|1
1168853|NCT03631355|2298963|FG001|Overall Study|Lost to Follow-up|2
1168854|NCT03631732|2298980|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3
1168855|NCT03631732|2298981|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0
1168856|NCT03631732|2298980|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1
1168857|NCT03631732|2298981|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2
1168858|NCT03631732|2298980|FG000|Randomized Phase Up to Week 24|Adverse Event|2
1168859|NCT03631732|2298981|FG001|Randomized Phase Up to Week 24|Adverse Event|0
1168860|NCT03631732|2298980|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1
1168861|NCT03631732|2298981|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0
1168862|NCT03631732|2298980|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6
1168863|NCT03631732|2298981|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1
1168864|NCT03631732|2298980|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
1168865|NCT03631732|2298981|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
1168866|NCT03631732|2298980|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4
1168867|NCT03631732|2298981|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1
1168868|NCT03631732|2298980|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1
1168869|NCT03631732|2298981|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0
1168870|NCT03631732|2298980|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1
1168871|NCT03631732|2298981|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0
1168872|NCT03631732|2298980|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1
1168873|NCT03631732|2298981|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0
1168874|NCT03633331|2299038|FG000|Overall Study|Withdrawal by Subject|1
1168875|NCT03633825|2299076|FG000|Enrollment|Did not post on network|5066
1168876|NCT03633825|2299077|FG001|Enrollment|Did not post on network|5080
1168877|NCT03633825|2299076|FG000|Enrollment|Post not classified as crisis|13967
1168878|NCT03633825|2299077|FG001|Enrollment|Post not classified as crisis|13757
1168879|NCT03633825|2299076|FG000|Follow up|Lost to Follow-up|478
1168880|NCT03633825|2299077|FG001|Follow up|Lost to Follow-up|450
1168881|NCT03633903|2299085|FG000|Overall Study|Withdrawal by Subject|1
1168882|NCT03633903|2299086|FG001|Overall Study|Withdrawal by Subject|2
1168883|NCT03633903|2299085|FG000|Overall Study|Lost to Follow-up|5
1168884|NCT03633903|2299086|FG001|Overall Study|Lost to Follow-up|5
1168885|NCT03633929|2299092|FG000|Overall Study|Lost to Follow-up|1
1168886|NCT03633929|2299092|FG000|Overall Study|Did not login to software. Did not participate|3
1168887|NCT03634085|2299098|FG000|Overall Study|Adverse Event|1
1168888|NCT03634085|2299099|FG001|Overall Study|Adverse Event|0
1168889|NCT03634085|2299098|FG000|Overall Study|Withdrawal by Subject|0
1168890|NCT03634085|2299099|FG001|Overall Study|Withdrawal by Subject|2
1168891|NCT03634579|2299125|FG000|Overall Study|study termination|9
1168892|NCT03634800|2299129|FG000|Overall Study|Adverse Event|1
1168893|NCT03634800|2299129|FG000|Overall Study|Disease Progression|4
1168894|NCT03634800|2299129|FG000|Overall Study|Withdrawal by Subject|1
1168895|NCT03635086|2299148|FG000|Overall Study|Withdrawal of consent|0
1168896|NCT03635086|2299149|FG001|Overall Study|Withdrawal of consent|0
1168897|NCT03635086|2299150|FG002|Overall Study|Withdrawal of consent|1
1168898|NCT03635086|2299151|FG003|Overall Study|Withdrawal of consent|0
1168899|NCT03635086|2299152|FG004|Overall Study|Withdrawal of consent|0
1168900|NCT03635086|2299148|FG000|Overall Study|Adverse Event|0
1168901|NCT03635086|2299149|FG001|Overall Study|Adverse Event|1
1168902|NCT03635086|2299150|FG002|Overall Study|Adverse Event|0
1168903|NCT03635086|2299151|FG003|Overall Study|Adverse Event|0
870300|NCT00529399|1831390|FG002|Overall Study|Withdrawal by Subject|1
870301|NCT00529399|1831388|FG000|Overall Study|Non-compliant|0
1168904|NCT03635086|2299152|FG004|Overall Study|Adverse Event|0
1168905|NCT03635086|2299148|FG000|Overall Study|Lost to Follow-up|1
1168906|NCT03635086|2299149|FG001|Overall Study|Lost to Follow-up|0
1168907|NCT03635086|2299150|FG002|Overall Study|Lost to Follow-up|0
1168908|NCT03635086|2299151|FG003|Overall Study|Lost to Follow-up|0
1168909|NCT03635086|2299152|FG004|Overall Study|Lost to Follow-up|0
1168910|NCT03635320|2299167|FG000|Overall Study|not implanted the device|1
1168911|NCT03635320|2299168|FG001|Overall Study|not implanted the device|2
1168912|NCT03635320|2299167|FG000|Overall Study|Withdrawal by Subject|11
1168913|NCT03635320|2299168|FG001|Overall Study|Withdrawal by Subject|6
1168914|NCT03635424|2299174|FG000|Overall Study|Adverse Event|1
1168915|NCT03635424|2299174|FG000|Overall Study|Death|1
1168916|NCT03635424|2299174|FG000|Overall Study|Device not implanted|1
1168917|NCT03635775|2299182|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
1168918|NCT03635775|2299183|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
1168919|NCT03635775|2299184|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
1168920|NCT03635775|2299185|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1
1168921|NCT03635957|2299195|FG000|Run-In Period|Lost to Follow-up|1
1168922|NCT03635957|2299195|FG000|Pegloticase + IMM Period|Lack of Efficacy|3
1168923|NCT03636893|2299231|FG000|Overall Study|Death|0
1168924|NCT03636893|2299232|FG001|Overall Study|Death|1
1168925|NCT03636893|2299231|FG000|Overall Study|Protocol Violation|0
1168926|NCT03636893|2299232|FG001|Overall Study|Protocol Violation|3
1168927|NCT03636893|2299231|FG000|Overall Study|Withdrawal by Subject|1
1168928|NCT03636893|2299232|FG001|Overall Study|Withdrawal by Subject|2
1168929|NCT03636893|2299231|FG000|Overall Study|Refusal to surgery|4
1168930|NCT03636893|2299232|FG001|Overall Study|Refusal to surgery|3
1168931|NCT03636893|2299231|FG000|Overall Study|Early surgery (for acute bleeding)|3
1168932|NCT03636893|2299232|FG001|Overall Study|Early surgery (for acute bleeding)|0
1168933|NCT03636893|2299231|FG000|Overall Study|Adverse Event|1
1168934|NCT03636893|2299232|FG001|Overall Study|Adverse Event|1
1168935|NCT03638635|2299308|FG000|Initial Hospitalization|Study terminated prematurely|0
1168936|NCT03638635|2299309|FG001|Initial Hospitalization|Study terminated prematurely|1
1168937|NCT03638635|2299308|FG000|Initial Hospitalization|Withdrawal by study personnel|0
1168938|NCT03638635|2299309|FG001|Initial Hospitalization|Withdrawal by study personnel|1
1168939|NCT03638635|2299308|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
1168940|NCT03638635|2299309|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
1168941|NCT03639311|2299325|FG000|Overall Study|Ongoing at the time of analysis|88
1168942|NCT03639311|2299326|FG001|Overall Study|Ongoing at the time of analysis|0
1168943|NCT03639311|2299325|FG000|Overall Study|Lost to Follow-up|1
1168944|NCT03639311|2299326|FG001|Overall Study|Lost to Follow-up|0
1168945|NCT03639311|2299325|FG000|Overall Study|Adverse Event|1
1168946|NCT03639311|2299326|FG001|Overall Study|Adverse Event|0
1168947|NCT03639675|2299335|FG000|Overall Study|Withdrawal by Subject|1
1168948|NCT03639779|2299345|FG000|Overall Study|Lost to Follow-up|1
1168949|NCT03639987|2299363|FG000|Overall Study|Study terminated by sponsor|26
1168950|NCT03639987|2299364|FG001|Overall Study|Study terminated by sponsor|25
1168951|NCT03639987|2299363|FG000|Overall Study|Lost to Follow-up|0
1168952|NCT03639987|2299364|FG001|Overall Study|Lost to Follow-up|1
1168953|NCT03640052|2299370|FG000|Overall Study|Lost to Follow-up|0
1168954|NCT03640052|2299371|FG001|Overall Study|Lost to Follow-up|1
1168955|NCT03640052|2299372|FG002|Overall Study|Lost to Follow-up|0
1168956|NCT03640052|2299373|FG003|Overall Study|Lost to Follow-up|0
1168957|NCT03640052|2299374|FG004|Overall Study|Lost to Follow-up|0
1168958|NCT03640507|2299389|FG000|Overall Study|Withdrawal by Subject|0
1168959|NCT03640507|2299390|FG001|Overall Study|Withdrawal by Subject|0
1168960|NCT03640507|2299391|FG002|Overall Study|Withdrawal by Subject|1
1168961|NCT03640559|2299401|FG000|Overall Study|Physician Decision|1
1168962|NCT03640559|2299402|FG001|Overall Study|Physician Decision|1
1168963|NCT03640559|2299401|FG000|Overall Study|Withdrawal by Subject|1
1168964|NCT03640559|2299402|FG001|Overall Study|Withdrawal by Subject|0
1168965|NCT03641508|2299419|FG000|First Injection|Lost to Follow-up|2
1168966|NCT03641508|2299420|FG001|First Injection|Lost to Follow-up|0
1168967|NCT03642262|2299430|FG000|Period 1|Withdrawal by Subject|1
1168968|NCT03642262|2299431|FG001|Period 1|Withdrawal by Subject|1
1168969|NCT03642262|2299430|FG000|Period 1|Adverse Event|0
1168970|NCT03642262|2299431|FG001|Period 1|Adverse Event|1
1168971|NCT03642717|2299447|FG000|Overall Study|Lost to Follow-up|2
1168972|NCT03642717|2299447|FG000|Overall Study|Inclusion/exclusion criteria violation|33
1168973|NCT03642717|2299447|FG000|Overall Study|Taken study drug prior to contract date|3
1168974|NCT03642873|2299452|FG000|Third Intervention (1 Day)|Screen failure|0
1168975|NCT03642873|2299453|FG001|Third Intervention (1 Day)|Screen failure|0
1168976|NCT03642873|2299454|FG002|Third Intervention (1 Day)|Screen failure|0
1168977|NCT03642873|2299455|FG003|Third Intervention (1 Day)|Screen failure|0
1168978|NCT03642873|2299456|FG004|Third Intervention (1 Day)|Screen failure|1
1168979|NCT03642873|2299457|FG005|Third Intervention (1 Day)|Screen failure|0
1168980|NCT03643432|2299471|FG000|Overall Study|Lost to Follow-up|1
1168981|NCT03643432|2299472|FG001|Overall Study|Lost to Follow-up|0
1168982|NCT03643575|2299478|FG000|Washout: 7 Days|Withdrew consent due to illness|0
1168983|NCT03643575|2299479|FG001|Washout: 7 Days|Withdrew consent due to illness|0
1168984|NCT03643575|2299480|FG002|Washout: 7 Days|Withdrew consent due to illness|0
1168985|NCT03643575|2299481|FG003|Washout: 7 Days|Withdrew consent due to illness|1
1168986|NCT03643575|2299482|FG004|Washout: 7 Days|Withdrew consent due to illness|0
1168987|NCT03643575|2299483|FG005|Washout: 7 Days|Withdrew consent due to illness|0
1168988|NCT03643575|2299478|FG000|Washout: 7 Days|Adverse Event|1
1168989|NCT03643575|2299479|FG001|Washout: 7 Days|Adverse Event|0
1168990|NCT03643575|2299480|FG002|Washout: 7 Days|Adverse Event|0
1168991|NCT03643575|2299481|FG003|Washout: 7 Days|Adverse Event|0
1168992|NCT03643575|2299482|FG004|Washout: 7 Days|Adverse Event|0
1168993|NCT03643575|2299483|FG005|Washout: 7 Days|Adverse Event|0
1168994|NCT03643575|2299478|FG000|Washout: 7 Days|Non compliance check in|0
1168995|NCT03643575|2299479|FG001|Washout: 7 Days|Non compliance check in|1
1168996|NCT03643575|2299480|FG002|Washout: 7 Days|Non compliance check in|0
1168997|NCT03643575|2299481|FG003|Washout: 7 Days|Non compliance check in|0
1168998|NCT03643575|2299482|FG004|Washout: 7 Days|Non compliance check in|0
1168999|NCT03643575|2299483|FG005|Washout: 7 Days|Non compliance check in|0
1169000|NCT03643952|2299495|FG000|Overall Study|Lack of Efficacy|1
1169003|NCT03644173|2299522|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21
1169004|NCT03644173|2299522|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2
1169005|NCT03644173|2299522|FG000|Participants at the 1-month Follow up|Death|2
1169006|NCT03644173|2299522|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2
1169007|NCT03645421|2299540|FG000|Overall Study|Adverse Event|0
1169008|NCT03645421|2299541|FG001|Overall Study|Adverse Event|0
1169009|NCT03645421|2299542|FG002|Overall Study|Adverse Event|4
1169010|NCT03645421|2299543|FG003|Overall Study|Adverse Event|1
1169011|NCT03645421|2299540|FG000|Overall Study|Withdrawal by patient|0
1169012|NCT03645421|2299541|FG001|Overall Study|Withdrawal by patient|0
1169013|NCT03645421|2299542|FG002|Overall Study|Withdrawal by patient|0
1169014|NCT03645421|2299543|FG003|Overall Study|Withdrawal by patient|3
1169015|NCT03645421|2299540|FG000|Overall Study|Study specific withdrawal criteria|0
1169016|NCT03645421|2299541|FG001|Overall Study|Study specific withdrawal criteria|0
1169017|NCT03645421|2299542|FG002|Overall Study|Study specific withdrawal criteria|1
1169018|NCT03645421|2299543|FG003|Overall Study|Study specific withdrawal criteria|0
1169019|NCT03645434|2299556|FG000|Period 1|Adverse Event|0
1169020|NCT03645434|2299557|FG001|Period 1|Adverse Event|0
1169021|NCT03645434|2299558|FG002|Period 1|Adverse Event|0
1169022|NCT03645434|2299559|FG003|Period 1|Adverse Event|1
1169023|NCT03645434|2299560|FG004|Period 1|Adverse Event|0
1169024|NCT03645434|2299561|FG005|Period 1|Adverse Event|0
1169025|NCT03645434|2299556|FG000|Period 1|COPD exacerbation|0
1169026|NCT03645434|2299557|FG001|Period 1|COPD exacerbation|0
1169027|NCT03645434|2299558|FG002|Period 1|COPD exacerbation|0
1169028|NCT03645434|2299559|FG003|Period 1|COPD exacerbation|0
1169029|NCT03645434|2299560|FG004|Period 1|COPD exacerbation|1
1169030|NCT03645434|2299561|FG005|Period 1|COPD exacerbation|0
1169034|NCT03646305|2299639|FG000|Overall Study|Lost to Follow-up|4
1169035|NCT03646305|2299640|FG001|Overall Study|Lost to Follow-up|2
1169036|NCT03646305|2299641|FG002|Overall Study|Lost to Follow-up|2
1169037|NCT03646305|2299642|FG003|Overall Study|Lost to Follow-up|1
1169038|NCT03646305|2299639|FG000|Overall Study|Withdrawal by Subject|1
1169039|NCT03646305|2299640|FG001|Overall Study|Withdrawal by Subject|0
1169040|NCT03646305|2299641|FG002|Overall Study|Withdrawal by Subject|0
1169041|NCT03646305|2299642|FG003|Overall Study|Withdrawal by Subject|1
1169042|NCT03646656|2299658|FG000|Overall Study|Lost to Follow-up|1
1169043|NCT03646656|2299659|FG001|Overall Study|Lost to Follow-up|0
1169044|NCT03646656|2299658|FG000|Overall Study|Withdrawal by Subject|2
1169045|NCT03646656|2299659|FG001|Overall Study|Withdrawal by Subject|0
1169046|NCT03647267|2299684|FG000|Overall Study|Lost to Follow-up|1
1169047|NCT03647267|2299685|FG001|Overall Study|Lost to Follow-up|0
1169060|NCT03647709|2299708|FG000|Overall Study|Lost to Follow-up|5
1169061|NCT03647709|2299708|FG000|Overall Study|Physician Decision|6
1169062|NCT03647709|2299708|FG000|Overall Study|Withdrawal by Subject|3
1169063|NCT03648879|2299718|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1
1169064|NCT03649412|2299724|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1
1169065|NCT03649412|2299725|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0
1169066|NCT03649412|2299724|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1
1169067|NCT03649412|2299725|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0
1169068|NCT03649412|2299724|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
1169069|NCT03649412|2299725|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
1169070|NCT03649412|2299724|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1
1169071|NCT03649412|2299725|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0
1169072|NCT03649412|2299724|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0
1169073|NCT03649412|2299725|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1
1169074|NCT03649412|2299724|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0
1169075|NCT03649412|2299725|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1
1169076|NCT03649477|2299771|FG000|Overall Study|Adverse Event|2
1169077|NCT03649477|2299772|FG001|Overall Study|Adverse Event|0
1169078|NCT03649477|2299773|FG002|Overall Study|Adverse Event|0
1169079|NCT03650387|2299818|FG000|Overall Study|Withdrawal by Subject|13
1169080|NCT03650387|2299818|FG000|Overall Study|Lost to Follow-up|12
1169081|NCT03650387|2299818|FG000|Overall Study|Adverse Event (Not related)|1
1169082|NCT03650387|2299818|FG000|Overall Study|Due to COVID-19 Pandemic|8
1169083|NCT03650400|2299833|FG000|Overall Study|Study terminated by sponsor|0
1169084|NCT03650400|2299834|FG001|Overall Study|Study terminated by sponsor|5
1169085|NCT03650452|2299842|FG000|Overall Study|Physician Decision|1
1169086|NCT03650452|2299843|FG001|Overall Study|Physician Decision|0
1169087|NCT03650452|2299842|FG000|Overall Study|Withdrawal by Parent/Guardian|3
1169088|NCT03650452|2299843|FG001|Overall Study|Withdrawal by Parent/Guardian|1
1169089|NCT03650452|2299842|FG000|Overall Study|Adverse Event|3
1169090|NCT03650452|2299843|FG001|Overall Study|Adverse Event|4
1169091|NCT03650452|2299842|FG000|Overall Study|Early Withdrawal from Study Treatment|3
1169092|NCT03650452|2299843|FG001|Overall Study|Early Withdrawal from Study Treatment|0
1169093|NCT03652610|2299868|FG000|Overall Study|Lost to Follow-up|1
1169094|NCT03652610|2299869|FG001|Overall Study|Lost to Follow-up|0
1169095|NCT03652610|2299868|FG000|Overall Study|Withdrawal by Subject|3
1169096|NCT03652610|2299869|FG001|Overall Study|Withdrawal by Subject|5
1169097|NCT03652662|2299877|FG000|Overall Study|Withdrawal by Subject|2
1169098|NCT03652662|2299878|FG001|Overall Study|Withdrawal by Subject|1
1169099|NCT03652662|2299877|FG000|Overall Study|Lost to Follow-up|1
1169100|NCT03652662|2299878|FG001|Overall Study|Lost to Follow-up|0
1169101|NCT03652675|2299886|FG000|Overall Study|Lost to Follow-up|4
1169102|NCT03652675|2299887|FG001|Overall Study|Lost to Follow-up|4
1169103|NCT03652818|2299898|FG000|Overall Study|Adverse Event|1
1169104|NCT03652818|2299899|FG001|Overall Study|Adverse Event|0
1169105|NCT03652818|2299900|FG002|Overall Study|Adverse Event|0
1169106|NCT03652818|2299901|FG003|Overall Study|Adverse Event|0
1169107|NCT03652818|2299902|FG004|Overall Study|Adverse Event|0
1169108|NCT03652818|2299898|FG000|Overall Study|Physician Decision|1
1169109|NCT03652818|2299899|FG001|Overall Study|Physician Decision|0
1169110|NCT03652818|2299900|FG002|Overall Study|Physician Decision|0
1169111|NCT03652818|2299901|FG003|Overall Study|Physician Decision|0
1169112|NCT03652818|2299902|FG004|Overall Study|Physician Decision|0
1169113|NCT03652818|2299898|FG000|Overall Study|Lost to Follow-up|0
1169114|NCT03652818|2299899|FG001|Overall Study|Lost to Follow-up|1
1169115|NCT03652818|2299900|FG002|Overall Study|Lost to Follow-up|2
1169116|NCT03652818|2299901|FG003|Overall Study|Lost to Follow-up|1
1169117|NCT03652818|2299902|FG004|Overall Study|Lost to Follow-up|1
1169118|NCT03653026|2299916|FG000|Part 1: Placebo-controlled Period|Adverse Event|5
1169119|NCT03653026|2299917|FG001|Part 1: Placebo-controlled Period|Adverse Event|6
1169120|NCT03653026|2299918|FG002|Part 1: Placebo-controlled Period|Adverse Event|0
1169121|NCT03653026|2299919|FG003|Part 1: Placebo-controlled Period|Adverse Event|0
1169122|NCT03653026|2299916|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6
1169123|NCT03653026|2299917|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4
1169124|NCT03653026|2299918|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
1169125|NCT03653026|2299919|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
1169126|NCT03653026|2299916|FG000|Part 1: Placebo-controlled Period|Other|0
1169127|NCT03653026|2299917|FG001|Part 1: Placebo-controlled Period|Other|3
1169128|NCT03653026|2299918|FG002|Part 1: Placebo-controlled Period|Other|0
1169129|NCT03653026|2299919|FG003|Part 1: Placebo-controlled Period|Other|0
1169130|NCT03653026|2299916|FG000|Part 2: Open-label Extension|Adverse Event|0
1169131|NCT03653026|2299917|FG001|Part 2: Open-label Extension|Adverse Event|0
1169132|NCT03653026|2299918|FG002|Part 2: Open-label Extension|Adverse Event|1
1169133|NCT03653026|2299919|FG003|Part 2: Open-label Extension|Adverse Event|1
1169134|NCT03653026|2299916|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0
1169135|NCT03653026|2299917|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0
1169136|NCT03653026|2299918|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1
1169137|NCT03653026|2299919|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2
1169138|NCT03653026|2299916|FG000|Part 2: Open-label Extension|Other|0
1169139|NCT03653026|2299917|FG001|Part 2: Open-label Extension|Other|0
1169140|NCT03653026|2299918|FG002|Part 2: Open-label Extension|Other|1
1169141|NCT03653026|2299919|FG003|Part 2: Open-label Extension|Other|2
1169142|NCT03653208|2299936|FG000|Overall Study|Withdrawal by Subject|0
1169143|NCT03653208|2299937|FG001|Overall Study|Withdrawal by Subject|0
1169144|NCT03653208|2299938|FG002|Overall Study|Withdrawal by Subject|0
1169145|NCT03653208|2299939|FG003|Overall Study|Withdrawal by Subject|0
1169146|NCT03653208|2299940|FG004|Overall Study|Withdrawal by Subject|1
1169147|NCT03653208|2299941|FG005|Overall Study|Withdrawal by Subject|0
1169148|NCT03653208|2299942|FG006|Overall Study|Withdrawal by Subject|0
1169149|NCT03653208|2299943|FG007|Overall Study|Withdrawal by Subject|1
1169150|NCT03653208|2299944|FG008|Overall Study|Withdrawal by Subject|1
1169151|NCT03653416|2299975|FG000|Overall Study|Protocol Violation|6
1169152|NCT03653416|2299976|FG001|Overall Study|Protocol Violation|1
1169153|NCT03653429|2299984|FG000|Overall Study|Physician Decision|4
1169154|NCT03653429|2299985|FG001|Overall Study|Physician Decision|10
1169155|NCT03654326|2299993|FG000|Overall Study|Withdrawal by Subject|5
1169156|NCT03654326|2299994|FG001|Overall Study|Withdrawal by Subject|3
1169157|NCT03654326|2299993|FG000|Overall Study|Physician Decision|0
1169158|NCT03654326|2299994|FG001|Overall Study|Physician Decision|1
1169159|NCT03654326|2299993|FG000|Overall Study|Unable to adhere to study schedule|0
1169160|NCT03654326|2299994|FG001|Overall Study|Unable to adhere to study schedule|1
1169161|NCT03654326|2299993|FG000|Overall Study|Lost to Follow-up|1
1169162|NCT03654326|2299994|FG001|Overall Study|Lost to Follow-up|1
1169163|NCT03654560|2300011|FG000|Overall Study|Death|3
1169164|NCT03654560|2300012|FG001|Overall Study|Death|1
1169165|NCT03654560|2300011|FG000|Overall Study|Lost to Follow-up|1
1169166|NCT03654560|2300012|FG001|Overall Study|Lost to Follow-up|0
1169167|NCT03655054|2300018|FG000|Overall Study|Lost to Follow-up|1
1169168|NCT03655106|2300028|FG000|Overall Study|Withdrawal by Subject|3
1169169|NCT03655106|2300029|FG001|Overall Study|Withdrawal by Subject|2
1169170|NCT03655106|2300028|FG000|Overall Study|Lost to Follow-up|2
1169171|NCT03655106|2300029|FG001|Overall Study|Lost to Follow-up|1
1169172|NCT03655106|2300028|FG000|Overall Study|Duplicate Enrollment|1
1169173|NCT03655106|2300029|FG001|Overall Study|Duplicate Enrollment|1
1169174|NCT03655106|2300028|FG000|Overall Study|Protocol Violation|3
1169175|NCT03655106|2300029|FG001|Overall Study|Protocol Violation|0
1169176|NCT03655405|2300041|FG000|Overall Study|Death after initial data collection|4
1169177|NCT03655405|2300042|FG001|Overall Study|Death after initial data collection|2
1169178|NCT03655405|2300041|FG000|Overall Study|Died before initial data collection|1
1169179|NCT03655405|2300042|FG001|Overall Study|Died before initial data collection|2
1169180|NCT03655405|2300041|FG000|Overall Study|Protocol Violation|0
1169181|NCT03655405|2300042|FG001|Overall Study|Protocol Violation|1
1169182|NCT03655951|2300059|FG000|Overall Study|Lost to Follow-up|39
1169183|NCT03655951|2300060|FG001|Overall Study|Lost to Follow-up|20
1169184|NCT03655951|2300059|FG000|Overall Study|Withdrawal by Subject|0
1169185|NCT03655951|2300060|FG001|Overall Study|Withdrawal by Subject|1
1169186|NCT03657095|2300074|FG000|Overall Study|Withdrawal by Subject|1
1169187|NCT03657095|2300075|FG001|Overall Study|Withdrawal by Subject|1
1169188|NCT03657095|2300074|FG000|Overall Study|Adverse Event|0
1169189|NCT03657095|2300075|FG001|Overall Study|Adverse Event|3
1169190|NCT03657095|2300074|FG000|Overall Study|Study Terminated by Sponsor|58
1169191|NCT03657095|2300075|FG001|Overall Study|Study Terminated by Sponsor|49
1169192|NCT03657277|2300104|FG000|Overall Study|Physician Decision|2
1169193|NCT03657277|2300104|FG000|Overall Study|Lost to Follow-up|1
1169194|NCT03657277|2300104|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8
1169195|NCT03658811|2300117|FG000|Overall Study|Lost to Follow-up|3
1169196|NCT03658876|2300123|FG000|Overall Study|Protocol Violation|3
1169197|NCT03658876|2300124|FG001|Overall Study|Protocol Violation|2
1169198|NCT03658876|2300123|FG000|Overall Study|Withdrawal by Subject|2
1169199|NCT03658876|2300124|FG001|Overall Study|Withdrawal by Subject|0
1169200|NCT03658876|2300123|FG000|Overall Study|Death|0
1169201|NCT03658876|2300124|FG001|Overall Study|Death|1
1169202|NCT03658876|2300123|FG000|Overall Study|Intercurrent illness|6
1169203|NCT03658876|2300124|FG001|Overall Study|Intercurrent illness|4
1169204|NCT03658876|2300123|FG000|Overall Study|Transplantation/other operation|1
1169205|NCT03658876|2300124|FG001|Overall Study|Transplantation/other operation|5
1169206|NCT03658889|2300132|FG000|Overall Study|Protocol Violation|2
1169207|NCT03658889|2300133|FG001|Overall Study|Protocol Violation|0
1169208|NCT03661983|2300246|FG000|Open Label Stabilization Phase|Adverse Event|5
1169209|NCT03661983|2300247|FG001|Open Label Stabilization Phase|Adverse Event|0
1169210|NCT03661983|2300248|FG002|Open Label Stabilization Phase|Adverse Event|0
1169211|NCT03661983|2300249|FG003|Open Label Stabilization Phase|Adverse Event|0
1169212|NCT03661983|2300246|FG000|Open Label Stabilization Phase|Lack of Efficacy|1
1169213|NCT03661983|2300247|FG001|Open Label Stabilization Phase|Lack of Efficacy|0
1169214|NCT03661983|2300248|FG002|Open Label Stabilization Phase|Lack of Efficacy|0
1169215|NCT03661983|2300249|FG003|Open Label Stabilization Phase|Lack of Efficacy|0
1169216|NCT03661983|2300246|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2
1169217|NCT03661983|2300247|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
1169218|NCT03661983|2300248|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
1169219|NCT03661983|2300249|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
1169220|NCT03661983|2300246|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3
1169221|NCT03661983|2300247|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0
1169222|NCT03661983|2300248|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0
1169223|NCT03661983|2300249|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0
1169224|NCT03661983|2300246|FG000|Double-blind Randomized Phase|Adverse Event|0
1169225|NCT03661983|2300247|FG001|Double-blind Randomized Phase|Adverse Event|1
1169226|NCT03661983|2300248|FG002|Double-blind Randomized Phase|Adverse Event|0
1169227|NCT03661983|2300249|FG003|Double-blind Randomized Phase|Adverse Event|0
1169228|NCT03661983|2300246|FG000|Double-blind Randomized Phase|Disease Relapse|0
1169229|NCT03661983|2300247|FG001|Double-blind Randomized Phase|Disease Relapse|0
1169230|NCT03661983|2300248|FG002|Double-blind Randomized Phase|Disease Relapse|0
1169231|NCT03661983|2300249|FG003|Double-blind Randomized Phase|Disease Relapse|6
1169232|NCT03661983|2300246|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
1169233|NCT03661983|2300247|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
1169234|NCT03661983|2300248|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
1169235|NCT03661983|2300249|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1
1169236|NCT03661983|2300246|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0
1169237|NCT03661983|2300247|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1
1169238|NCT03661983|2300248|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1
1169239|NCT03661983|2300249|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1
1169240|NCT03662334|2300279|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
1169241|NCT03662334|2300280|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
1169242|NCT03662750|2300296|FG000|Overall Study|Withdrawal by Subject|1
1169243|NCT03662789|2300302|FG000|Overall Study|Lost to Follow-up|1
1169244|NCT03662789|2300303|FG001|Overall Study|Lost to Follow-up|2
1169245|NCT03662789|2300302|FG000|Overall Study|Could not perform treadmill test|4
1169246|NCT03662789|2300303|FG001|Overall Study|Could not perform treadmill test|4
1169247|NCT03662789|2300302|FG000|Overall Study|Death|0
1169248|NCT03662789|2300303|FG001|Overall Study|Death|1
1169249|NCT03662997|2300313|FG000|Overall Study|Adverse Event|0
1169250|NCT03662997|2300314|FG001|Overall Study|Adverse Event|2
1169251|NCT03662997|2300315|FG002|Overall Study|Adverse Event|0
1169252|NCT03662997|2300316|FG003|Overall Study|Adverse Event|0
1169253|NCT03663179|2300347|FG000|Overall Study|Withdrawal by Subject|2
1169254|NCT03663179|2300348|FG001|Overall Study|Withdrawal by Subject|0
1169255|NCT03663179|2300347|FG000|Overall Study|Lost to Follow-up|1
1169256|NCT03663179|2300348|FG001|Overall Study|Lost to Follow-up|1
1169257|NCT03663179|2300347|FG000|Overall Study|Revealed exclusionary condition|1
1169258|NCT03663179|2300348|FG001|Overall Study|Revealed exclusionary condition|0
1169259|NCT03663569|2300372|FG000|Overall Study|Discontinuation of study|11
1169260|NCT03663569|2300372|FG000|Overall Study|Never taken Spiolto® Respimat®|1
1169261|NCT03663569|2300372|FG000|Overall Study|Deceased patient|6
1169262|NCT03663569|2300372|FG000|Overall Study|Lost to Follow-up|18
1169263|NCT03663569|2300372|FG000|Overall Study|Withdrawal of consent|5
1169264|NCT03663569|2300372|FG000|Overall Study|Patient's request|11
1169265|NCT03663569|2300372|FG000|Overall Study|Adverse Event|4
1169266|NCT03663569|2300372|FG000|Overall Study|Not come to second visit|3
1169267|NCT03663569|2300372|FG000|Overall Study|Not meet inclusion / exclusion criterion|3
1169268|NCT03663569|2300372|FG000|Overall Study|Serious adverse event|1
1169269|NCT03663582|2300376|FG000|Overall Study|Physician Decision|1
1169270|NCT03666858|2300442|FG000|Cohort 1|Adverse Event|1
1169271|NCT03666858|2300443|FG001|Cohort 1|Adverse Event|0
1169272|NCT03666858|2300442|FG000|Cohort 2|Adverse Event|0
1169273|NCT03666858|2300443|FG001|Cohort 2|Adverse Event|1
1169274|NCT03667053|2300452|FG000|Overall Study|Withdrawal by Subject|1
1169275|NCT03667053|2300453|FG001|Overall Study|Withdrawal by Subject|0
1169276|NCT03667053|2300454|FG002|Overall Study|Withdrawal by Subject|0
1169277|NCT03668600|2300473|FG000|Overall Study|Study Terminated by the Sponsor|157
1169278|NCT03668600|2300473|FG000|Overall Study|Protocol Violation|1
1169279|NCT03668600|2300473|FG000|Overall Study|Pregnancy|1
1169280|NCT03668600|2300473|FG000|Overall Study|Lost to Follow-up|7
1169281|NCT03668600|2300473|FG000|Overall Study|Withdrawal by Subject|56
1169282|NCT03668600|2300473|FG000|Overall Study|Lack of Efficacy|7
1169283|NCT03668600|2300473|FG000|Overall Study|Adverse Event|1
1169284|NCT03668613|2300479|FG000|Overall Study|Adverse Event|0
1169285|NCT03668613|2300480|FG001|Overall Study|Adverse Event|2
1169286|NCT03668613|2300479|FG000|Overall Study|Lack of Efficacy|0
1169287|NCT03668613|2300480|FG001|Overall Study|Lack of Efficacy|1
1169288|NCT03669081|2300489|FG000|Overall Study|Data could not be validated|1
1169289|NCT03669081|2300490|FG001|Overall Study|Data could not be validated|1
1169290|NCT03669549|2300514|FG000|Overall Study|Adverse Event|4
1169291|NCT03669549|2300514|FG000|Overall Study|Withdrawal by Subject|1
1169292|NCT03669549|2300514|FG000|Overall Study|Study terminated by the Sponsor|1
1169293|NCT03669861|2300522|FG000|Overall Study|Disease Flare|5
1169294|NCT03669861|2300522|FG000|Overall Study|Lack of Efficacy|2
1169295|NCT03670537|2300556|FG000|Overall Study|Protocol Violation|1
1169296|NCT03670641|2300560|FG000|Overall Study|Lost to Follow-up|3
1169297|NCT03670810|2300570|FG000|Overall Study|Adverse Event|36
1169298|NCT03670810|2300571|FG001|Overall Study|Adverse Event|38
1169299|NCT03670810|2300572|FG002|Overall Study|Adverse Event|2
1169300|NCT03670810|2300573|FG003|Overall Study|Adverse Event|4
1169301|NCT03670810|2300570|FG000|Overall Study|Lack of Efficacy|8
1169302|NCT03670810|2300571|FG001|Overall Study|Lack of Efficacy|8
1169303|NCT03670810|2300572|FG002|Overall Study|Lack of Efficacy|3
1169304|NCT03670810|2300573|FG003|Overall Study|Lack of Efficacy|4
1169305|NCT03670810|2300570|FG000|Overall Study|Lost to Follow-up|6
1169306|NCT03670810|2300571|FG001|Overall Study|Lost to Follow-up|6
1169307|NCT03670810|2300572|FG002|Overall Study|Lost to Follow-up|4
1169308|NCT03670810|2300573|FG003|Overall Study|Lost to Follow-up|6
1169309|NCT03670810|2300570|FG000|Overall Study|Non-compliance with Study Drug|0
1169310|NCT03670810|2300571|FG001|Overall Study|Non-compliance with Study Drug|2
1169311|NCT03670810|2300572|FG002|Overall Study|Non-compliance with Study Drug|3
1169312|NCT03670810|2300573|FG003|Overall Study|Non-compliance with Study Drug|0
1169313|NCT03670810|2300570|FG000|Overall Study|Missing|1
1169314|NCT03670810|2300571|FG001|Overall Study|Missing|1
1169315|NCT03670810|2300572|FG002|Overall Study|Missing|0
1169316|NCT03670810|2300573|FG003|Overall Study|Missing|1
1169317|NCT03670810|2300570|FG000|Overall Study|Physician Decision|3
1169318|NCT03670810|2300571|FG001|Overall Study|Physician Decision|0
1169319|NCT03670810|2300572|FG002|Overall Study|Physician Decision|1
1169320|NCT03670810|2300573|FG003|Overall Study|Physician Decision|0
1169321|NCT03670810|2300570|FG000|Overall Study|Pregnancy|1
1169322|NCT03670810|2300571|FG001|Overall Study|Pregnancy|1
1169323|NCT03670810|2300572|FG002|Overall Study|Pregnancy|0
1169324|NCT03670810|2300573|FG003|Overall Study|Pregnancy|0
1169325|NCT03670810|2300570|FG000|Overall Study|Protocol Violation|2
1169326|NCT03670810|2300571|FG001|Overall Study|Protocol Violation|12
1169327|NCT03670810|2300572|FG002|Overall Study|Protocol Violation|8
1169328|NCT03670810|2300573|FG003|Overall Study|Protocol Violation|4
1169329|NCT03670810|2300570|FG000|Overall Study|Withdrawal by Subject|20
1169330|NCT03670810|2300571|FG001|Overall Study|Withdrawal by Subject|20
1169331|NCT03670810|2300572|FG002|Overall Study|Withdrawal by Subject|8
1169332|NCT03670810|2300573|FG003|Overall Study|Withdrawal by Subject|9
1169333|NCT03670810|2300570|FG000|Overall Study|Continuing Study|27
1169334|NCT03670810|2300571|FG001|Overall Study|Continuing Study|29
1169335|NCT03670810|2300572|FG002|Overall Study|Continuing Study|12
1169336|NCT03670810|2300573|FG003|Overall Study|Continuing Study|10
1169337|NCT03672006|2300585|FG000|Overall Study|exclusion criteria met|0
1169338|NCT03672006|2300586|FG001|Overall Study|exclusion criteria met|1
1169339|NCT03672097|2300603|FG000|Period 1|Withdrawal by Subject|2
1169340|NCT03672097|2300603|FG000|Period 1|Adverse Event|1
1169341|NCT03672097|2300603|FG000|Period 1|Did not receive treatment|1
1169342|NCT03672097|2300603|FG000|Period 2|Withdrawal by Subject|3
1169343|NCT03672097|2300603|FG000|Period 2|Other|1
1169344|NCT03672396|2300611|FG000|Overall Study|Withdrawal by Subject|4
1169345|NCT03672396|2300611|FG000|Overall Study|Physician Decision|1
1169346|NCT03672396|2300611|FG000|Overall Study|Adverse Event|1
1169347|NCT03673670|2300621|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
1169348|NCT03673670|2300622|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
1169349|NCT03673670|2300623|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
1169350|NCT03673670|2300624|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
1169351|NCT03673670|2300625|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
1169352|NCT03673670|2300626|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
1169353|NCT03673670|2300621|FG000|Treatment Period 1 (3 Days)|Physician Decision|0
1169354|NCT03673670|2300622|FG001|Treatment Period 1 (3 Days)|Physician Decision|0
1169355|NCT03673670|2300623|FG002|Treatment Period 1 (3 Days)|Physician Decision|1
1169356|NCT03673670|2300624|FG003|Treatment Period 1 (3 Days)|Physician Decision|0
1169357|NCT03673670|2300625|FG004|Treatment Period 1 (3 Days)|Physician Decision|0
1169358|NCT03673670|2300626|FG005|Treatment Period 1 (3 Days)|Physician Decision|0
1169359|NCT03673670|2300621|FG000|Treatment Period 1 (3 Days)|Adverse Event|0
1169360|NCT03673670|2300622|FG001|Treatment Period 1 (3 Days)|Adverse Event|0
1169361|NCT03673670|2300623|FG002|Treatment Period 1 (3 Days)|Adverse Event|0
1169362|NCT03673670|2300624|FG003|Treatment Period 1 (3 Days)|Adverse Event|0
1169363|NCT03673670|2300625|FG004|Treatment Period 1 (3 Days)|Adverse Event|0
1169364|NCT03673670|2300626|FG005|Treatment Period 1 (3 Days)|Adverse Event|1
1169365|NCT03673670|2300621|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
1169366|NCT03673670|2300622|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
1169367|NCT03673670|2300623|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
1169368|NCT03673670|2300624|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
1169369|NCT03673670|2300625|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
1169370|NCT03673670|2300626|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
1169371|NCT03673670|2300621|FG000|Treatment Period 2 (3 Days)|Adverse Event|0
1169372|NCT03673670|2300622|FG001|Treatment Period 2 (3 Days)|Adverse Event|0
1169373|NCT03673670|2300623|FG002|Treatment Period 2 (3 Days)|Adverse Event|1
1169374|NCT03673670|2300624|FG003|Treatment Period 2 (3 Days)|Adverse Event|0
1169375|NCT03673670|2300625|FG004|Treatment Period 2 (3 Days)|Adverse Event|1
1169376|NCT03673670|2300626|FG005|Treatment Period 2 (3 Days)|Adverse Event|0
1169377|NCT03673670|2300621|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
1169378|NCT03673670|2300622|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
1169379|NCT03673670|2300623|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
1169380|NCT03673670|2300624|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
1169381|NCT03673670|2300625|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
1169382|NCT03673670|2300626|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
1169383|NCT03673670|2300621|FG000|Treatment Period 3 (3 Days)|Adverse Event|0
1169384|NCT03673670|2300622|FG001|Treatment Period 3 (3 Days)|Adverse Event|0
1169385|NCT03673670|2300623|FG002|Treatment Period 3 (3 Days)|Adverse Event|0
1169386|NCT03673670|2300624|FG003|Treatment Period 3 (3 Days)|Adverse Event|0
1169387|NCT03673670|2300625|FG004|Treatment Period 3 (3 Days)|Adverse Event|1
1169388|NCT03673670|2300626|FG005|Treatment Period 3 (3 Days)|Adverse Event|0
1169389|NCT03674177|2300676|FG000|Overall Study|Lost to Follow-up|2
1169390|NCT03674177|2300677|FG001|Overall Study|Lost to Follow-up|1
1169391|NCT03674177|2300678|FG002|Overall Study|Lost to Follow-up|0
1169392|NCT03674177|2300679|FG003|Overall Study|Lost to Follow-up|2
1169393|NCT03674281|2300692|FG000|Overall Study|screen failure|2
1169394|NCT03674281|2300693|FG001|Overall Study|screen failure|0
1169395|NCT03674281|2300694|FG002|Overall Study|screen failure|0
1169396|NCT03674281|2300692|FG000|Overall Study|Withdrawal by Subject|1
1169397|NCT03674281|2300693|FG001|Overall Study|Withdrawal by Subject|3
1169398|NCT03674281|2300694|FG002|Overall Study|Withdrawal by Subject|3
1169399|NCT03675776|2300753|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5
1169400|NCT03675776|2300754|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6
1169401|NCT03675776|2300755|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8
1169402|NCT03675776|2300753|FG000|Double Blind Treatment Period|Lack of Efficacy|1
1169403|NCT03675776|2300754|FG001|Double Blind Treatment Period|Lack of Efficacy|0
1169404|NCT03675776|2300755|FG002|Double Blind Treatment Period|Lack of Efficacy|0
1169405|NCT03676634|2300767|FG000|Overall Study|Red blood cell loss|1
1169406|NCT03676634|2300767|FG000|Overall Study|Out-of-limit pulse|2
1169407|NCT03677375|2300819|FG000|Overall Study|Incomplete procedure|8
1169408|NCT03677375|2300819|FG000|Overall Study|Adverse Event|3
1169409|NCT03677375|2300819|FG000|Overall Study|Physician Decision|1
1169410|NCT03677401|2300825|FG000|Overall Study|Adverse Event|4
1169411|NCT03677401|2300826|FG001|Overall Study|Adverse Event|14
1169412|NCT03677401|2300825|FG000|Overall Study|Lack of Efficacy|3
1169413|NCT03677401|2300826|FG001|Overall Study|Lack of Efficacy|1
1169414|NCT03677401|2300825|FG000|Overall Study|Withdrawal by Subject|2
1169415|NCT03677401|2300826|FG001|Overall Study|Withdrawal by Subject|2
1169416|NCT03677401|2300825|FG000|Overall Study|Sponsor decision|0
1169417|NCT03677401|2300826|FG001|Overall Study|Sponsor decision|1
1169418|NCT03677401|2300825|FG000|Overall Study|Reason Unspecified|1
1169419|NCT03677401|2300826|FG001|Overall Study|Reason Unspecified|0
1169420|NCT03677869|2300832|FG000|Overall Study|Withdrawal by Subject|1
1169421|NCT03678103|2300836|FG000|Overall Study|Withdrawn prior to completion|4
1169422|NCT03678285|2300840|FG000|Overall Study|Adverse Event|2
1169423|NCT03678285|2300840|FG000|Overall Study|Withdrawal by subject prior to start of workout|1
1169424|NCT03678285|2300840|FG000|Overall Study|Dehydrated prior to start of workout|1
1169425|NCT03678870|2300850|FG000|Overall Study|prescribed non- protocol medications|10
1169426|NCT03678870|2300851|FG001|Overall Study|prescribed non- protocol medications|6
1169427|NCT03678870|2300850|FG000|Overall Study|Lost to Follow-up|3
1169428|NCT03678870|2300851|FG001|Overall Study|Lost to Follow-up|2
1169429|NCT03679741|2300866|FG000|Period 1|No longer meet eligibility criteria|1
1169430|NCT03679741|2300867|FG001|Period 1|No longer meet eligibility criteria|0
1169431|NCT03679741|2300866|FG000|Period 1|Lost to Follow-up|0
1169432|NCT03679741|2300867|FG001|Period 1|Lost to Follow-up|1
1169433|NCT03679741|2300866|FG000|Period 1|Adverse Event|1
1169434|NCT03679741|2300867|FG001|Period 1|Adverse Event|1
1169435|NCT03679741|2300866|FG000|Period 1|Withdrawal by Subject|0
1169436|NCT03679741|2300867|FG001|Period 1|Withdrawal by Subject|1
1169437|NCT03679741|2300866|FG000|Period 2|Adverse Event|2
1169438|NCT03679741|2300867|FG001|Period 2|Adverse Event|1
1169439|NCT03679741|2300866|FG000|Period 2|Withdrawal by Subject|1
1169440|NCT03679741|2300867|FG001|Period 2|Withdrawal by Subject|1
1169441|NCT03680521|2300920|FG000|Overall Study|Ongoing in long-term follow up|7
1169442|NCT03680521|2300921|FG001|Overall Study|Ongoing in long-term follow up|11
1169443|NCT03680742|2300930|FG000|Overall Study|Unsuccessful Implant Attempt|2
1169444|NCT03681093|2300937|FG000|Overall Study|Subject decision|0
1169445|NCT03681093|2300938|FG001|Overall Study|Subject decision|2
1169446|NCT03681093|2300939|FG002|Overall Study|Subject decision|1
1169447|NCT03681119|2300949|FG000|Overall Study|No specific reason|4
1169448|NCT03681119|2300950|FG001|Overall Study|No specific reason|0
1169449|NCT03681119|2300949|FG000|Overall Study|Sickness|2
1169450|NCT03681119|2300950|FG001|Overall Study|Sickness|0
870302|NCT00529399|1831389|FG001|Overall Study|Non-compliant|1
870303|NCT00529399|1831390|FG002|Overall Study|Non-compliant|0
870304|NCT00529451|1831402|FG000|Overall Study|Subject withdrew consent|16
870305|NCT00529451|1831403|FG001|Overall Study|Subject withdrew consent|21
870306|NCT00529451|1831404|FG002|Overall Study|Subject withdrew consent|13
870307|NCT00529451|1831405|FG003|Overall Study|Subject withdrew consent|12
870308|NCT00529451|1831402|FG000|Overall Study|Adverse Event|9
870309|NCT00529451|1831403|FG001|Overall Study|Adverse Event|16
870310|NCT00529451|1831404|FG002|Overall Study|Adverse Event|14
870311|NCT00529451|1831405|FG003|Overall Study|Adverse Event|8
870312|NCT00529451|1831402|FG000|Overall Study|Unsatisfactory therapeutic response|6
870313|NCT00529451|1831403|FG001|Overall Study|Unsatisfactory therapeutic response|2
870314|NCT00529451|1831404|FG002|Overall Study|Unsatisfactory therapeutic response|5
870315|NCT00529451|1831405|FG003|Overall Study|Unsatisfactory therapeutic response|4
870316|NCT00529451|1831402|FG000|Overall Study|Lost to Follow-up|4
870317|NCT00529451|1831403|FG001|Overall Study|Lost to Follow-up|7
870318|NCT00529451|1831404|FG002|Overall Study|Lost to Follow-up|4
870319|NCT00529451|1831405|FG003|Overall Study|Lost to Follow-up|4
870320|NCT00529451|1831402|FG000|Overall Study|Protocol deviation|1
870321|NCT00529451|1831403|FG001|Overall Study|Protocol deviation|1
1169457|NCT03681353|2300963|FG000|Overall Study|Lost to Follow-up|2
1169458|NCT03681353|2300963|FG000|Overall Study|Withdrawal by Subject|3
1169459|NCT03681353|2300963|FG000|Overall Study|withdrawn by PI|2
1169460|NCT03681405|2300969|FG000|Overall Study|Found to be ineligible after randomized|1
1169461|NCT03681405|2300970|FG001|Overall Study|Found to be ineligible after randomized|0
1169462|NCT03681951|2301016|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1
1169463|NCT03681951|2301017|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
1169464|NCT03681951|2301018|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
1169465|NCT03681951|2301019|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
1169466|NCT03681951|2301020|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
1169467|NCT03681951|2301021|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
1169468|NCT03681951|2301022|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
1169469|NCT03681951|2301023|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
1169470|NCT03681951|2301016|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4
1169471|NCT03681951|2301017|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
870322|NCT00529451|1831404|FG002|Overall Study|Protocol deviation|4
870323|NCT00529451|1831405|FG003|Overall Study|Protocol deviation|1
870324|NCT00529451|1831402|FG000|Overall Study|Administrative problems|1
870325|NCT00529451|1831403|FG001|Overall Study|Administrative problems|1
1169472|NCT03681951|2301018|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
1169473|NCT03681951|2301019|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
1169474|NCT03681951|2301020|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
1169475|NCT03681951|2301021|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
1169476|NCT03681951|2301022|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
1169477|NCT03681951|2301023|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
1169478|NCT03681951|2301016|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3
1169479|NCT03681951|2301017|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
1169480|NCT03681951|2301018|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
1169481|NCT03681951|2301019|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
1169482|NCT03681951|2301020|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
1169483|NCT03681951|2301021|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
1169484|NCT03681951|2301022|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
1169485|NCT03681951|2301023|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
1169486|NCT03682107|2301051|FG000|Overall Study|Withdrawal by Subject|0
1169487|NCT03682107|2301052|FG001|Overall Study|Withdrawal by Subject|1
1169488|NCT03682107|2301053|FG002|Overall Study|Withdrawal by Subject|0
1169489|NCT03682107|2301054|FG003|Overall Study|Withdrawal by Subject|0
1169490|NCT03682107|2301055|FG004|Overall Study|Withdrawal by Subject|0
1169491|NCT03682120|2301071|FG000|Overall Study|Lost to Follow-up|11
1169492|NCT03682120|2301072|FG001|Overall Study|Lost to Follow-up|4
1169493|NCT03682120|2301073|FG002|Overall Study|Lost to Follow-up|5
1169494|NCT03682120|2301074|FG003|Overall Study|Lost to Follow-up|2
1169495|NCT03682120|2301071|FG000|Overall Study|Physician Decision|1
1169496|NCT03682120|2301072|FG001|Overall Study|Physician Decision|0
1169497|NCT03682120|2301073|FG002|Overall Study|Physician Decision|0
1169498|NCT03682120|2301074|FG003|Overall Study|Physician Decision|0
1169499|NCT03682120|2301071|FG000|Overall Study|Withdrawal by Subject|1
1169500|NCT03682120|2301072|FG001|Overall Study|Withdrawal by Subject|2
1169501|NCT03682120|2301073|FG002|Overall Study|Withdrawal by Subject|3
1169502|NCT03682120|2301074|FG003|Overall Study|Withdrawal by Subject|0
1169503|NCT03682120|2301071|FG000|Overall Study|Death|0
1169504|NCT03682120|2301072|FG001|Overall Study|Death|1
1169505|NCT03682120|2301073|FG002|Overall Study|Death|0
1169506|NCT03682120|2301074|FG003|Overall Study|Death|0
1169507|NCT03682120|2301071|FG000|Overall Study|Enrolled but Treatment Not Administered|0
1169508|NCT03682120|2301072|FG001|Overall Study|Enrolled but Treatment Not Administered|1
1169509|NCT03682120|2301073|FG002|Overall Study|Enrolled but Treatment Not Administered|0
1169510|NCT03682120|2301074|FG003|Overall Study|Enrolled but Treatment Not Administered|0
1169511|NCT03682302|2301090|FG000|Overall Study|Lost to Follow-up|1
1169512|NCT03682302|2301091|FG001|Overall Study|Lost to Follow-up|2
1169513|NCT03682302|2301092|FG002|Overall Study|Lost to Follow-up|0
1169514|NCT03682302|2301093|FG003|Overall Study|Lost to Follow-up|1
1169515|NCT03682302|2301090|FG000|Overall Study|Study drug was not administered|0
1169516|NCT03682302|2301091|FG001|Overall Study|Study drug was not administered|0
1169517|NCT03682302|2301092|FG002|Overall Study|Study drug was not administered|1
1169518|NCT03682302|2301093|FG003|Overall Study|Study drug was not administered|1
1169519|NCT03682705|2301109|FG000|Overall Study|Adverse Event|1
1169520|NCT03682705|2301110|FG001|Overall Study|Adverse Event|1
1169521|NCT03682705|2301111|FG002|Overall Study|Adverse Event|1
1169522|NCT03682705|2301112|FG003|Overall Study|Adverse Event|0
1169523|NCT03682705|2301113|FG004|Overall Study|Adverse Event|1
1169524|NCT03682705|2301114|FG005|Overall Study|Adverse Event|1
1169525|NCT03682705|2301109|FG000|Overall Study|Withdrawal by Subject|1
1169526|NCT03682705|2301110|FG001|Overall Study|Withdrawal by Subject|3
1169527|NCT03682705|2301111|FG002|Overall Study|Withdrawal by Subject|2
1169528|NCT03682705|2301112|FG003|Overall Study|Withdrawal by Subject|4
1169529|NCT03682705|2301113|FG004|Overall Study|Withdrawal by Subject|0
1169530|NCT03682705|2301114|FG005|Overall Study|Withdrawal by Subject|1
1169531|NCT03682705|2301109|FG000|Overall Study|Other, not specified|0
1169532|NCT03682705|2301110|FG001|Overall Study|Other, not specified|0
1169533|NCT03682705|2301111|FG002|Overall Study|Other, not specified|0
1169534|NCT03682705|2301112|FG003|Overall Study|Other, not specified|1
1169535|NCT03682705|2301113|FG004|Overall Study|Other, not specified|2
1169536|NCT03682705|2301114|FG005|Overall Study|Other, not specified|0
1169537|NCT03682705|2301109|FG000|Overall Study|Lost to Follow-up|0
1169538|NCT03682705|2301110|FG001|Overall Study|Lost to Follow-up|0
1169539|NCT03682705|2301111|FG002|Overall Study|Lost to Follow-up|0
1169540|NCT03682705|2301112|FG003|Overall Study|Lost to Follow-up|0
1169541|NCT03682705|2301113|FG004|Overall Study|Lost to Follow-up|3
1169542|NCT03682705|2301114|FG005|Overall Study|Lost to Follow-up|0
1169543|NCT03683576|2301150|FG000|Overall Study|Withdrawal by Subject|2
1169544|NCT03683576|2301151|FG001|Overall Study|Withdrawal by Subject|0
1169545|NCT03683576|2301152|FG002|Overall Study|Withdrawal by Subject|8
1169546|NCT03683576|2301153|FG003|Overall Study|Withdrawal by Subject|3
1169547|NCT03683576|2301150|FG000|Overall Study|Adverse Event|3
1169548|NCT03683576|2301151|FG001|Overall Study|Adverse Event|0
1169549|NCT03683576|2301152|FG002|Overall Study|Adverse Event|0
1169550|NCT03683576|2301153|FG003|Overall Study|Adverse Event|4
1169551|NCT03683576|2301150|FG000|Overall Study|Lack of Efficacy|1
1169552|NCT03683576|2301151|FG001|Overall Study|Lack of Efficacy|0
1169553|NCT03683576|2301152|FG002|Overall Study|Lack of Efficacy|1
1169554|NCT03683576|2301153|FG003|Overall Study|Lack of Efficacy|1
1169555|NCT03683576|2301150|FG000|Overall Study|Lost to Follow-up|0
1169556|NCT03683576|2301151|FG001|Overall Study|Lost to Follow-up|1
1169557|NCT03683576|2301152|FG002|Overall Study|Lost to Follow-up|2
1169558|NCT03683576|2301153|FG003|Overall Study|Lost to Follow-up|0
1169559|NCT03683576|2301150|FG000|Overall Study|Other, Not Specified|0
1169560|NCT03683576|2301151|FG001|Overall Study|Other, Not Specified|2
1169561|NCT03683576|2301152|FG002|Overall Study|Other, Not Specified|0
1169562|NCT03683576|2301153|FG003|Overall Study|Other, Not Specified|0
870326|NCT00529451|1831404|FG002|Overall Study|Administrative problems|0
870327|NCT00529451|1831405|FG003|Overall Study|Administrative problems|2
870328|NCT00529516|1831421|FG000|Overall Study|Adverse Event|2
1169563|NCT03683576|2301150|FG000|Overall Study|Protocol Violation|0
1169564|NCT03683576|2301151|FG001|Overall Study|Protocol Violation|1
1169565|NCT03683576|2301152|FG002|Overall Study|Protocol Violation|1
1169566|NCT03683576|2301153|FG003|Overall Study|Protocol Violation|0
1169567|NCT03683719|2301168|FG000|Overall Study|Lack of Efficacy|1
1169568|NCT03683719|2301169|FG001|Overall Study|Lack of Efficacy|3
1169569|NCT03683719|2301170|FG002|Overall Study|Lack of Efficacy|4
1169570|NCT03683719|2301171|FG003|Overall Study|Lack of Efficacy|0
1169571|NCT03683719|2301172|FG004|Overall Study|Lack of Efficacy|4
1169572|NCT03683719|2301168|FG000|Overall Study|Adverse Event|6
1169573|NCT03683719|2301169|FG001|Overall Study|Adverse Event|6
1169574|NCT03683719|2301170|FG002|Overall Study|Adverse Event|0
1169575|NCT03683719|2301171|FG003|Overall Study|Adverse Event|1
1169576|NCT03683719|2301172|FG004|Overall Study|Adverse Event|3
1169577|NCT03683719|2301168|FG000|Overall Study|Withdrawal by Subject|4
1169578|NCT03683719|2301169|FG001|Overall Study|Withdrawal by Subject|4
1169579|NCT03683719|2301170|FG002|Overall Study|Withdrawal by Subject|3
1169580|NCT03683719|2301171|FG003|Overall Study|Withdrawal by Subject|5
1169581|NCT03683719|2301172|FG004|Overall Study|Withdrawal by Subject|5
1169582|NCT03683719|2301168|FG000|Overall Study|Lost to Follow-up|1
1169583|NCT03683719|2301169|FG001|Overall Study|Lost to Follow-up|0
1169584|NCT03683719|2301170|FG002|Overall Study|Lost to Follow-up|0
1169585|NCT03683719|2301171|FG003|Overall Study|Lost to Follow-up|1
1169586|NCT03683719|2301172|FG004|Overall Study|Lost to Follow-up|1
870329|NCT00529516|1831422|FG001|Overall Study|Adverse Event|1
870330|NCT00529516|1831423|FG002|Overall Study|Adverse Event|0
870331|NCT00529516|1831421|FG000|Overall Study|Withdrawal by Subject|1
1169587|NCT03683719|2301168|FG000|Overall Study|Other personal reasons|0
1169588|NCT03683719|2301169|FG001|Overall Study|Other personal reasons|0
1169589|NCT03683719|2301170|FG002|Overall Study|Other personal reasons|1
1169590|NCT03683719|2301171|FG003|Overall Study|Other personal reasons|0
1169591|NCT03683719|2301172|FG004|Overall Study|Other personal reasons|1
870332|NCT00529516|1831422|FG001|Overall Study|Withdrawal by Subject|1
870333|NCT00529516|1831423|FG002|Overall Study|Withdrawal by Subject|0
870334|NCT00529516|1831421|FG000|Overall Study|Lost to Follow-up|0
870335|NCT00529516|1831422|FG001|Overall Study|Lost to Follow-up|0
870336|NCT00529516|1831423|FG002|Overall Study|Lost to Follow-up|1
870337|NCT00529529|1831434|FG000|Overall Study|Adverse Event|12
870338|NCT00529529|1831435|FG001|Overall Study|Adverse Event|17
870339|NCT00529529|1831436|FG002|Overall Study|Adverse Event|8
870340|NCT00529529|1831434|FG000|Overall Study|Subject withdrew consent|12
870341|NCT00529529|1831435|FG001|Overall Study|Subject withdrew consent|9
1169592|NCT03683758|2301186|FG000|Overall Study|Non-study commitment conflict|1
1169593|NCT03683758|2301187|FG001|Overall Study|Non-study commitment conflict|3
1169594|NCT03683758|2301186|FG000|Overall Study|Illness preventing participation|1
1169595|NCT03683758|2301187|FG001|Overall Study|Illness preventing participation|0
1169596|NCT03683758|2301186|FG000|Overall Study|Adverse Event|1
1169597|NCT03683758|2301187|FG001|Overall Study|Adverse Event|0
1169598|NCT03684642|2301220|FG000|Overall Study|Adverse Event|6
1169599|NCT03684642|2301221|FG001|Overall Study|Adverse Event|15
1169600|NCT03684642|2301222|FG002|Overall Study|Adverse Event|11
1169601|NCT03684642|2301220|FG000|Overall Study|Withdrawal by Subject|35
1169602|NCT03684642|2301221|FG001|Overall Study|Withdrawal by Subject|53
1169603|NCT03684642|2301222|FG002|Overall Study|Withdrawal by Subject|23
1169604|NCT03684642|2301220|FG000|Overall Study|Lack of Efficacy|0
1169605|NCT03684642|2301221|FG001|Overall Study|Lack of Efficacy|0
1169606|NCT03684642|2301222|FG002|Overall Study|Lack of Efficacy|1
1169607|NCT03684642|2301220|FG000|Overall Study|Poor compliance to protocol|0
1169608|NCT03684642|2301221|FG001|Overall Study|Poor compliance to protocol|4
1169609|NCT03684642|2301222|FG002|Overall Study|Poor compliance to protocol|1
1169610|NCT03684642|2301220|FG000|Overall Study|Other than specified|62
1169611|NCT03684642|2301221|FG001|Overall Study|Other than specified|60
1169612|NCT03684642|2301222|FG002|Overall Study|Other than specified|67
1169613|NCT03684642|2301220|FG000|Overall Study|Randomized and not treated|0
1169614|NCT03684642|2301221|FG001|Overall Study|Randomized and not treated|0
1169615|NCT03684642|2301222|FG002|Overall Study|Randomized and not treated|1
1169616|NCT03684642|2301220|FG000|Overall Study|Missing completion status but alive at last contact|0
1169617|NCT03684642|2301221|FG001|Overall Study|Missing completion status but alive at last contact|1
1169618|NCT03684642|2301222|FG002|Overall Study|Missing completion status but alive at last contact|2
1169619|NCT03684928|2301230|FG000|First Intervention|Lost to Follow-up|0
1169620|NCT03684928|2301231|FG001|First Intervention|Lost to Follow-up|1
1169621|NCT03684928|2301230|FG000|First Intervention|Withdrawal by Subject|0
1169622|NCT03684928|2301231|FG001|First Intervention|Withdrawal by Subject|2
1169623|NCT03684928|2301230|FG000|Second Intervention|Soft Tissue Injury|1
1169624|NCT03684928|2301231|FG001|Second Intervention|Soft Tissue Injury|0
1169625|NCT03685643|2301265|FG000|Overall Study|Lost to Follow-up|14
1169626|NCT03685643|2301266|FG001|Overall Study|Lost to Follow-up|22
1169627|NCT03686033|2301285|FG000|Treatment Period 2 (1 Day)|Adverse Event|0
1169628|NCT03686033|2301286|FG001|Treatment Period 2 (1 Day)|Adverse Event|0
1169629|NCT03686033|2301287|FG002|Treatment Period 2 (1 Day)|Adverse Event|0
1169630|NCT03686033|2301288|FG003|Treatment Period 2 (1 Day)|Adverse Event|0
1169631|NCT03686033|2301289|FG004|Treatment Period 2 (1 Day)|Adverse Event|1
1169632|NCT03686033|2301290|FG005|Treatment Period 2 (1 Day)|Adverse Event|0
1169633|NCT03686176|2301307|FG000|Overall Study|Procedure cancelled|1
1169634|NCT03686176|2301308|FG001|Overall Study|Procedure cancelled|0
1169635|NCT03686176|2301309|FG002|Overall Study|Procedure cancelled|0
1169636|NCT03686176|2301307|FG000|Overall Study|VR Malfunction|1
1169637|NCT03686176|2301308|FG001|Overall Study|VR Malfunction|0
1169638|NCT03686176|2301309|FG002|Overall Study|VR Malfunction|0
870342|NCT00529529|1831436|FG002|Overall Study|Subject withdrew consent|12
870343|NCT00529529|1831434|FG000|Overall Study|Protocol deviation|8
870344|NCT00529529|1831435|FG001|Overall Study|Protocol deviation|12
870345|NCT00529529|1831436|FG002|Overall Study|Protocol deviation|5
870346|NCT00529529|1831434|FG000|Overall Study|Lost to Follow-up|5
870347|NCT00529529|1831435|FG001|Overall Study|Lost to Follow-up|3
870348|NCT00529529|1831436|FG002|Overall Study|Lost to Follow-up|1
870349|NCT00529529|1831434|FG000|Overall Study|Unsatisfactory therapeutic effect|2
870350|NCT00529529|1831435|FG001|Overall Study|Unsatisfactory therapeutic effect|2
870351|NCT00529529|1831436|FG002|Overall Study|Unsatisfactory therapeutic effect|2
870352|NCT00529529|1831434|FG000|Overall Study|Death|2
870353|NCT00529529|1831435|FG001|Overall Study|Death|0
870354|NCT00529529|1831436|FG002|Overall Study|Death|0
870355|NCT00529529|1831434|FG000|Overall Study|Abnormal test procedure result(s)|1
870356|NCT00529529|1831435|FG001|Overall Study|Abnormal test procedure result(s)|0
870357|NCT00529529|1831436|FG002|Overall Study|Abnormal test procedure result(s)|0
870358|NCT00529529|1831434|FG000|Overall Study|Administrative problems|1
870359|NCT00529529|1831435|FG001|Overall Study|Administrative problems|0
870360|NCT00529529|1831436|FG002|Overall Study|Administrative problems|3
870361|NCT00529542|1831446|FG000|Overall Study|Withdrawal by Subject|1
870362|NCT00529542|1831447|FG001|Overall Study|Withdrawal by Subject|0
870363|NCT00529542|1831446|FG000|Overall Study|Lost to Follow-up|0
870364|NCT00529542|1831447|FG001|Overall Study|Lost to Follow-up|1
870365|NCT00529568|1831468|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
870366|NCT00529568|1831469|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
870367|NCT00529568|1831470|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
870368|NCT00529568|1831468|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
870369|NCT00529568|1831469|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
870370|NCT00529568|1831470|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
870371|NCT00529568|1831468|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
870372|NCT00529568|1831469|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
870373|NCT00529568|1831470|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
870374|NCT00529568|1831468|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
870375|NCT00529568|1831469|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
870376|NCT00529568|1831470|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
870377|NCT00529568|1831468|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
870378|NCT00529568|1831469|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
870379|NCT00529568|1831470|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
870380|NCT00529568|1831468|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
870381|NCT00529568|1831469|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
870382|NCT00529568|1831470|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
870383|NCT00529568|1831468|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
870384|NCT00529568|1831469|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
870385|NCT00529568|1831470|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
870386|NCT00529568|1831468|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
870387|NCT00529568|1831469|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
870388|NCT00529568|1831470|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
870389|NCT00529568|1831468|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
870390|NCT00529568|1831469|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
870391|NCT00529568|1831470|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
870392|NCT00529568|1831468|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
870393|NCT00529568|1831469|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
1169639|NCT03687372|2301330|FG000|Overall Study|Lost to Follow-up|12
1169640|NCT03687372|2301331|FG001|Overall Study|Lost to Follow-up|21
1169641|NCT03687372|2301330|FG000|Overall Study|Withdrawal by Subject|4
1169642|NCT03687372|2301331|FG001|Overall Study|Withdrawal by Subject|17
1169643|NCT03687372|2301330|FG000|Overall Study|Investigator Decision|1
1169644|NCT03687372|2301331|FG001|Overall Study|Investigator Decision|1
1169645|NCT03687736|2301395|FG000|Overall Study|Lost to Follow-up|7
1169646|NCT03687736|2301395|FG000|Overall Study|Withdrawal by Subject|3
1169647|NCT03687827|2301401|FG000|Treatment Period 1|Death|0
1169648|NCT03687827|2301402|FG001|Treatment Period 1|Death|1
1169649|NCT03687827|2301401|FG000|Treatment Period 1|Lost to Follow-up|2
1169650|NCT03687827|2301402|FG001|Treatment Period 1|Lost to Follow-up|2
1169651|NCT03687827|2301401|FG000|Treatment Period 1|Physician Decision|5
1169652|NCT03687827|2301402|FG001|Treatment Period 1|Physician Decision|2
1169653|NCT03687827|2301401|FG000|Treatment Period 1|Withdrawal by Subject|7
1169654|NCT03687827|2301402|FG001|Treatment Period 1|Withdrawal by Subject|3
1169655|NCT03687827|2301401|FG000|Treatment Period 2|Physician Decision|4
1169656|NCT03687827|2301402|FG001|Treatment Period 2|Physician Decision|1
1169657|NCT03687827|2301401|FG000|Treatment Period 2|Withdrawal by Subject|1
1169658|NCT03687827|2301402|FG001|Treatment Period 2|Withdrawal by Subject|2
1169659|NCT03687970|2301410|FG000|Overall Study|visit scheduling conflicts|2
1169660|NCT03687970|2301411|FG001|Overall Study|visit scheduling conflicts|0
1169661|NCT03688620|2301437|FG000|Overall Study|Other|0
1169662|NCT03688620|2301438|FG001|Overall Study|Other|0
1169663|NCT03688620|2301439|FG002|Overall Study|Other|1
1169664|NCT03688620|2301437|FG000|Overall Study|Unwilling to attend the scheduled visit|0
1169665|NCT03688620|2301438|FG001|Overall Study|Unwilling to attend the scheduled visit|1
1169666|NCT03688620|2301439|FG002|Overall Study|Unwilling to attend the scheduled visit|0
1169667|NCT03688620|2301437|FG000|Overall Study|Lost to Follow-up|16
1169668|NCT03688620|2301438|FG001|Overall Study|Lost to Follow-up|0
1169669|NCT03688620|2301439|FG002|Overall Study|Lost to Follow-up|1
1169670|NCT03688620|2301437|FG000|Overall Study|Withdrawal by Subject|0
1169671|NCT03688620|2301438|FG001|Overall Study|Withdrawal by Subject|0
1169672|NCT03688620|2301439|FG002|Overall Study|Withdrawal by Subject|6
1169673|NCT03688711|2301455|FG000|Overall Study|Withdrawal by Subject|0
1169674|NCT03688711|2301456|FG001|Overall Study|Withdrawal by Subject|1
1169675|NCT03688880|2301464|FG000|Overall Study|Withdrawal by Subject|0
1169676|NCT03688880|2301465|FG001|Overall Study|Withdrawal by Subject|2
1169677|NCT03688880|2301464|FG000|Overall Study|Use of non-permitted concurrent therapy|0
1169678|NCT03688880|2301465|FG001|Overall Study|Use of non-permitted concurrent therapy|2
1169679|NCT03688880|2301464|FG000|Overall Study|Lost to Follow-up|4
1169680|NCT03688880|2301465|FG001|Overall Study|Lost to Follow-up|7
1169681|NCT03688880|2301464|FG000|Overall Study|Adverse Event|0
1169682|NCT03688880|2301465|FG001|Overall Study|Adverse Event|2
1169683|NCT03688880|2301464|FG000|Overall Study|Device deficiencies|0
1169684|NCT03688880|2301465|FG001|Overall Study|Device deficiencies|2
1169685|NCT03688880|2301464|FG000|Overall Study|Other|10
1169686|NCT03688880|2301465|FG001|Overall Study|Other|16
1169687|NCT03689452|2301473|FG000|Overall Study|Lost to Follow-up|1
1169688|NCT03689452|2301474|FG001|Overall Study|Lost to Follow-up|1
1169689|NCT03691779|2301519|FG000|Part B (24 Weeks)|Adverse Event|0
1169690|NCT03691779|2301520|FG001|Part B (24 Weeks)|Adverse Event|1
1169691|NCT03691779|2301519|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0
1169692|NCT03691779|2301520|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1
1169693|NCT03691831|2301529|FG000|Overall Study|Lost to Follow-up|16
1169694|NCT03691831|2301530|FG001|Overall Study|Lost to Follow-up|12
1169695|NCT03691831|2301529|FG000|Overall Study|Withdrawal by Subject|9
1169696|NCT03691831|2301530|FG001|Overall Study|Withdrawal by Subject|17
1169697|NCT03691831|2301529|FG000|Overall Study|Investigator Decision|2
1169698|NCT03691831|2301530|FG001|Overall Study|Investigator Decision|2
1169699|NCT03691948|2301557|FG000|Overall Study|Lost to Follow-up|1
1169700|NCT03691948|2301558|FG001|Overall Study|Lost to Follow-up|3
1169701|NCT03692676|2301573|FG000|Overall Study|exclude patients with prior use|4424
1169702|NCT03692676|2301574|FG001|Overall Study|exclude patients with prior use|24726
1169703|NCT03692676|2301575|FG002|Overall Study|exclude patients with prior use|0
1169704|NCT03692676|2301576|FG003|Overall Study|exclude patients with prior use|0
1169705|NCT03692676|2301573|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480
1169706|NCT03692676|2301574|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037
1169707|NCT03692676|2301575|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
1169708|NCT03692676|2301576|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
1169709|NCT03692676|2301573|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881
1169710|NCT03692676|2301574|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563
1169711|NCT03692676|2301575|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281
1169712|NCT03692676|2301576|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558
1169713|NCT03692676|2301573|FG000|Overall Study|exclude patients less than 18 years of age on index date|8
1169714|NCT03692676|2301574|FG001|Overall Study|exclude patients less than 18 years of age on index date|613
1169715|NCT03692676|2301575|FG002|Overall Study|exclude patients less than 18 years of age on index date|836
1169716|NCT03692676|2301576|FG003|Overall Study|exclude patients less than 18 years of age on index date|193
1169717|NCT03692676|2301573|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149
1169718|NCT03692676|2301574|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717
1169719|NCT03692676|2301575|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723
1169720|NCT03692676|2301576|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273
1169721|NCT03692676|2301573|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208
1169722|NCT03692676|2301574|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759
1169723|NCT03692676|2301575|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419
1169724|NCT03692676|2301576|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684
1169725|NCT03692676|2301573|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275
1169726|NCT03692676|2301574|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218
1169727|NCT03692676|2301575|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515
1169728|NCT03692676|2301576|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173
1169729|NCT03692676|2301573|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
1169730|NCT03692676|2301574|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
1169731|NCT03692676|2301575|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147
1169732|NCT03692676|2301576|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4
1169733|NCT03692676|2301573|FG000|Overall Study|exclude patients with prior use of same substances and device|0
1169734|NCT03692676|2301574|FG001|Overall Study|exclude patients with prior use of same substances and device|0
1169735|NCT03692676|2301575|FG002|Overall Study|exclude patients with prior use of same substances and device|3700
1169736|NCT03692676|2301576|FG003|Overall Study|exclude patients with prior use of same substances and device|0
1169737|NCT03692676|2301573|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
1169738|NCT03692676|2301574|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
1169739|NCT03692676|2301575|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965
1169740|NCT03692676|2301576|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198
1169741|NCT03692676|2301573|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
1169742|NCT03692676|2301574|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
1169743|NCT03692676|2301575|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
1169744|NCT03692676|2301576|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223
1169745|NCT03692676|2301573|FG000|Overall Study|Other|0
1169746|NCT03692676|2301574|FG001|Overall Study|Other|805
1169747|NCT03692676|2301575|FG002|Overall Study|Other|758
1169748|NCT03692676|2301576|FG003|Overall Study|Other|277
1169749|NCT03692676|2301573|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
1169750|NCT03692676|2301574|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
1169751|NCT03692676|2301575|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
1169752|NCT03692676|2301576|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3
1169753|NCT03693625|2301588|FG000|Overall Study|Adverse Event|2
1169754|NCT03693625|2301589|FG001|Overall Study|Adverse Event|0
1169755|NCT03693625|2301588|FG000|Overall Study|Study Terminated By Sponsor|20
1169756|NCT03693625|2301589|FG001|Overall Study|Study Terminated By Sponsor|7
1169757|NCT03693625|2301588|FG000|Overall Study|Withdrawal by Subject|1
1169758|NCT03693625|2301589|FG001|Overall Study|Withdrawal by Subject|1
1169759|NCT03693950|2301612|FG000|Overall Study|Withdrawal by Subject|1
1169760|NCT03693950|2301613|FG001|Overall Study|Withdrawal by Subject|0
1169761|NCT03693989|2301621|FG000|Overall Study|Protocol Violation|3
1169762|NCT03693989|2301622|FG001|Overall Study|Protocol Violation|4
1169763|NCT03694197|2301628|FG000|Overall Study|Adverse Event|9
1169764|NCT03694197|2301628|FG000|Overall Study|Protocol became inconvenient to participate|1
1169765|NCT03694197|2301628|FG000|Overall Study|Physician Decision|4
1169766|NCT03694197|2301628|FG000|Overall Study|Study terminated by sponsor|1350
1169767|NCT03694197|2301628|FG000|Overall Study|Participant moved|5
1169768|NCT03694197|2301628|FG000|Overall Study|Participant withdrew consent|10
1169769|NCT03694197|2301628|FG000|Overall Study|Related to IMP administration|1
1169770|NCT03694197|2301628|FG000|Overall Study|Not disclosed|5
1169771|NCT03694210|2301632|FG000|Overall Study|Death|1
1169772|NCT03694210|2301632|FG000|Overall Study|Screen Failure|7
1169773|NCT03694275|2301640|FG000|Overall Study|Adverse Event|0
1169774|NCT03694275|2301641|FG001|Overall Study|Adverse Event|1
1169775|NCT03694275|2301640|FG000|Overall Study|Reason not Specified|0
1169776|NCT03694275|2301641|FG001|Overall Study|Reason not Specified|1
1169777|NCT03694548|2301650|FG000|Part A Survey|Protocol Violation|3
1169778|NCT03694548|2301651|FG001|Part A Survey|Protocol Violation|3
1169779|NCT03694548|2301652|FG002|Part A Survey|Protocol Violation|0
1169780|NCT03694548|2301650|FG000|Part B Yoga Program|Protocol Violation|0
1169781|NCT03694548|2301651|FG001|Part B Yoga Program|Protocol Violation|0
1169782|NCT03694548|2301652|FG002|Part B Yoga Program|Protocol Violation|3
1169783|NCT03694548|2301650|FG000|Part B Yoga Program|Did not attend intervention|0
1169784|NCT03694548|2301651|FG001|Part B Yoga Program|Did not attend intervention|0
1169785|NCT03694548|2301652|FG002|Part B Yoga Program|Did not attend intervention|8
1169786|NCT03694925|2301678|FG000|Overall Study|Inadequate laboratory testing|0
1169787|NCT03694925|2301679|FG001|Overall Study|Inadequate laboratory testing|3
1169788|NCT03694925|2301680|FG002|Overall Study|Inadequate laboratory testing|0
1169789|NCT03695094|2301692|FG000|Overall Study|Adverse Event|1
1169790|NCT03695094|2301693|FG001|Overall Study|Adverse Event|1
1169791|NCT03695094|2301692|FG000|Overall Study|Withdrawal by Subject|1
1169792|NCT03695094|2301693|FG001|Overall Study|Withdrawal by Subject|0
1169793|NCT03695367|2301703|FG000|Overall Study|Missed the Day 28 visit.|1
1169794|NCT03695367|2301704|FG001|Overall Study|Missed the Day 28 visit.|0
1169795|NCT03695367|2301703|FG000|Overall Study|Lost to Follow-up|0
1169796|NCT03695367|2301704|FG001|Overall Study|Lost to Follow-up|1
1169797|NCT03695367|2301703|FG000|Overall Study|Withdrawal by Subject|0
1169798|NCT03695367|2301704|FG001|Overall Study|Withdrawal by Subject|1
870394|NCT00529568|1831470|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
870395|NCT00529568|1831468|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
1169799|NCT03695367|2301703|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0
1169800|NCT03695367|2301704|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2
1169801|NCT03695393|2301712|FG000|Overall Study|Death|3
1169802|NCT03695393|2301713|FG001|Overall Study|Death|1
1169803|NCT03695393|2301712|FG000|Overall Study|Lost to Follow-up|0
1169804|NCT03695393|2301713|FG001|Overall Study|Lost to Follow-up|1
1169805|NCT03696108|2301725|FG000|Overall Study|Physician Decision|1
1169806|NCT03696108|2301726|FG001|Overall Study|Physician Decision|0
1169807|NCT03696108|2301725|FG000|Overall Study|Withdrawal by Subject|3
1169808|NCT03696108|2301726|FG001|Overall Study|Withdrawal by Subject|6
1169809|NCT03696342|2301734|FG000|Overall Study|Lost to Follow-up|1
1169810|NCT03696342|2301735|FG001|Overall Study|Lost to Follow-up|0
1169811|NCT03696576|2301743|FG000|Overall Study|Soreness of throat after therapy|1
1169812|NCT03696576|2301744|FG001|Overall Study|Soreness of throat after therapy|1
1169813|NCT03696576|2301743|FG000|Overall Study|Lost to Follow-up|2
1169814|NCT03696576|2301744|FG001|Overall Study|Lost to Follow-up|4
1169815|NCT03697252|2301789|FG000|Overall Study|Adverse Event|3
1169816|NCT03697252|2301790|FG001|Overall Study|Adverse Event|2
1169817|NCT03697252|2301789|FG000|Overall Study|Withdrawal by Subject|14
1169818|NCT03697252|2301790|FG001|Overall Study|Withdrawal by Subject|14
1169819|NCT03697252|2301789|FG000|Overall Study|Lost to Follow-up|0
1169820|NCT03697252|2301790|FG001|Overall Study|Lost to Follow-up|1
1169821|NCT03697252|2301789|FG000|Overall Study|Physician Decision|1
1169822|NCT03697252|2301790|FG001|Overall Study|Physician Decision|1
1169823|NCT03697252|2301789|FG000|Overall Study|Other|0
1169824|NCT03697252|2301790|FG001|Overall Study|Other|1
1169825|NCT03697460|2301796|FG000|Overall Study|Withdrawal by Subject|3
1169826|NCT03697993|2301802|FG000|Overall Study|Became Ineligible after Enrollment|1
1169827|NCT03697993|2301803|FG001|Overall Study|Became Ineligible after Enrollment|3
1169828|NCT03697993|2301802|FG000|Overall Study|Enrolled but Treatment not Administered|2
1169829|NCT03697993|2301803|FG001|Overall Study|Enrolled but Treatment not Administered|1
1169830|NCT03697993|2301802|FG000|Overall Study|Lost to Follow-up|3
1169831|NCT03697993|2301803|FG001|Overall Study|Lost to Follow-up|0
1169832|NCT03697993|2301802|FG000|Overall Study|Physician Decision|4
1169833|NCT03697993|2301803|FG001|Overall Study|Physician Decision|0
1169834|NCT03697993|2301802|FG000|Overall Study|Initial Urine Culture Negative|0
1169835|NCT03697993|2301803|FG001|Overall Study|Initial Urine Culture Negative|1
1169836|NCT03698279|2301816|FG000|Overall Study|Withdrawal by parent/guardian|1
1169837|NCT03698279|2301817|FG001|Overall Study|Withdrawal by parent/guardian|1
1169838|NCT03698279|2301818|FG002|Overall Study|Withdrawal by parent/guardian|1
1169839|NCT03698279|2301819|FG003|Overall Study|Withdrawal by parent/guardian|1
1169840|NCT03698279|2301820|FG004|Overall Study|Withdrawal by parent/guardian|0
1169841|NCT03698279|2301821|FG005|Overall Study|Withdrawal by parent/guardian|0
1169842|NCT03698279|2301816|FG000|Overall Study|Protocol deviation|1
1169843|NCT03698279|2301817|FG001|Overall Study|Protocol deviation|0
1169844|NCT03698279|2301818|FG002|Overall Study|Protocol deviation|1
1169845|NCT03698279|2301819|FG003|Overall Study|Protocol deviation|0
1169846|NCT03698279|2301820|FG004|Overall Study|Protocol deviation|0
1169847|NCT03698279|2301821|FG005|Overall Study|Protocol deviation|0
1169848|NCT03698279|2301816|FG000|Overall Study|Withdrawal by Subject|0
1169849|NCT03698279|2301817|FG001|Overall Study|Withdrawal by Subject|0
1169850|NCT03698279|2301818|FG002|Overall Study|Withdrawal by Subject|1
1169851|NCT03698279|2301819|FG003|Overall Study|Withdrawal by Subject|0
1169852|NCT03698279|2301820|FG004|Overall Study|Withdrawal by Subject|0
1169853|NCT03698279|2301821|FG005|Overall Study|Withdrawal by Subject|0
1169854|NCT03698279|2301816|FG000|Overall Study|Lost to Follow-up|3
1169855|NCT03698279|2301817|FG001|Overall Study|Lost to Follow-up|1
870396|NCT00529568|1831469|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
870397|NCT00529568|1831470|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
870398|NCT00529633|1831481|FG000|Overall Study|Withdrawal by Subject|1
870399|NCT00529633|1831482|FG001|Overall Study|Withdrawal by Subject|1
870400|NCT00529659|1831490|FG000|Overall Study|Adverse Event|8
870401|NCT00529659|1831491|FG001|Overall Study|Adverse Event|7
870402|NCT00529659|1831490|FG000|Overall Study|Lost to Follow-up|0
870403|NCT00529659|1831491|FG001|Overall Study|Lost to Follow-up|2
870404|NCT00529659|1831490|FG000|Overall Study|Physician Decision|0
870405|NCT00529659|1831491|FG001|Overall Study|Physician Decision|2
870406|NCT00529659|1831490|FG000|Overall Study|Protocol Violation|2
870407|NCT00529659|1831491|FG001|Overall Study|Protocol Violation|6
870408|NCT00529659|1831490|FG000|Overall Study|Withdrawal by Subject|1
870409|NCT00529659|1831491|FG001|Overall Study|Withdrawal by Subject|6
1169856|NCT03698279|2301818|FG002|Overall Study|Lost to Follow-up|4
1169857|NCT03698279|2301819|FG003|Overall Study|Lost to Follow-up|5
1169858|NCT03698279|2301820|FG004|Overall Study|Lost to Follow-up|0
1169859|NCT03698279|2301821|FG005|Overall Study|Lost to Follow-up|0
1169860|NCT03698331|2301842|FG000|Overall Study|Adverse Event|2
1169861|NCT03698331|2301843|FG001|Overall Study|Adverse Event|3
1169862|NCT03698331|2301842|FG000|Overall Study|Withdrawal by Subject|1
1169863|NCT03698331|2301843|FG001|Overall Study|Withdrawal by Subject|1
1169864|NCT03698331|2301842|FG000|Overall Study|Lost to Follow-up|0
1169865|NCT03698331|2301843|FG001|Overall Study|Lost to Follow-up|2
1169866|NCT03698331|2301842|FG000|Overall Study|Non-compliance with study drug|1
1169867|NCT03698331|2301843|FG001|Overall Study|Non-compliance with study drug|0
1169868|NCT03698591|2301851|FG000|Overall Study|Withdrawal by Subject|2
1169869|NCT03698591|2301852|FG001|Overall Study|Withdrawal by Subject|2
1169870|NCT03698591|2301851|FG000|Overall Study|Failed drug screen|1
1169871|NCT03698591|2301852|FG001|Overall Study|Failed drug screen|1
1169872|NCT03698591|2301851|FG000|Overall Study|Failed health screen|0
1169873|NCT03698591|2301852|FG001|Overall Study|Failed health screen|1
1169874|NCT03698591|2301851|FG000|Overall Study|Ineligible for financial compensation|1
1169875|NCT03698591|2301852|FG001|Overall Study|Ineligible for financial compensation|0
1169876|NCT03698591|2301851|FG000|Overall Study|Equipment Error|1
1169877|NCT03698591|2301852|FG001|Overall Study|Equipment Error|0
1169878|NCT03698591|2301851|FG000|Overall Study|Could not establish TMS dosage|0
1169879|NCT03698591|2301852|FG001|Overall Study|Could not establish TMS dosage|1
1169880|NCT03699124|2301861|FG000|Overall Study|Adverse Event|6
1169881|NCT03699124|2301862|FG001|Overall Study|Adverse Event|5
1169882|NCT03699124|2301863|FG002|Overall Study|Adverse Event|2
1169883|NCT03699124|2301861|FG000|Overall Study|Death|0
1169884|NCT03699124|2301862|FG001|Overall Study|Death|2
1169885|NCT03699124|2301863|FG002|Overall Study|Death|0
1169886|NCT03699124|2301861|FG000|Overall Study|Lost to Follow-up|20
1169887|NCT03699124|2301862|FG001|Overall Study|Lost to Follow-up|16
1169888|NCT03699124|2301863|FG002|Overall Study|Lost to Follow-up|15
1169889|NCT03699124|2301861|FG000|Overall Study|Protocol Violation|1
1169890|NCT03699124|2301862|FG001|Overall Study|Protocol Violation|0
1169891|NCT03699124|2301863|FG002|Overall Study|Protocol Violation|0
1169892|NCT03699124|2301861|FG000|Overall Study|Withdrawal by Subject|13
1169893|NCT03699124|2301862|FG001|Overall Study|Withdrawal by Subject|14
1169894|NCT03699124|2301863|FG002|Overall Study|Withdrawal by Subject|13
1169895|NCT03699124|2301861|FG000|Overall Study|Other reasons|5
1169896|NCT03699124|2301862|FG001|Overall Study|Other reasons|3
1169897|NCT03699124|2301863|FG002|Overall Study|Other reasons|10
1169898|NCT03700320|2301873|FG000|Overall Study|Adverse Event|5
1169899|NCT03700320|2301874|FG001|Overall Study|Adverse Event|31
1169900|NCT03700320|2301873|FG000|Overall Study|Lack of Efficacy|2
1169901|NCT03700320|2301874|FG001|Overall Study|Lack of Efficacy|5
1169902|NCT03700320|2301873|FG000|Overall Study|Withdrawal by Subject|29
1169903|NCT03700320|2301874|FG001|Overall Study|Withdrawal by Subject|75
1169904|NCT03700320|2301873|FG000|Overall Study|Lost to Follow-up|16
1169905|NCT03700320|2301874|FG001|Overall Study|Lost to Follow-up|23
1169906|NCT03700320|2301873|FG000|Overall Study|Pregnancy|2
1169907|NCT03700320|2301874|FG001|Overall Study|Pregnancy|4
1169908|NCT03700320|2301873|FG000|Overall Study|Protocol Deviation|7
1169909|NCT03700320|2301874|FG001|Overall Study|Protocol Deviation|31
1169910|NCT03700320|2301873|FG000|Overall Study|Non-compliance with Study Drug|1
1169911|NCT03700320|2301874|FG001|Overall Study|Non-compliance with Study Drug|3
1169912|NCT03700320|2301873|FG000|Overall Study|Reason not Specified|0
1169913|NCT03700320|2301874|FG001|Overall Study|Reason not Specified|1
1169914|NCT03700385|2301884|FG000|Overall Study|Lost to Follow-up|1
1169915|NCT03700671|2301890|FG000|Overall Study|Lack of Efficacy|1
1169916|NCT03700671|2301891|FG001|Overall Study|Lack of Efficacy|2
1169917|NCT03700736|2301901|FG000|Overall Study|Pregnancy|1
1169918|NCT03700736|2301902|FG001|Overall Study|Pregnancy|1
1169919|NCT03700736|2301901|FG000|Overall Study|Withdrawal by Subject|2
1169920|NCT03700736|2301902|FG001|Overall Study|Withdrawal by Subject|6
1169921|NCT03700892|2301913|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
1169922|NCT03700892|2301914|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1
1169923|NCT03700892|2301915|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
1169924|NCT03701074|2301935|FG000|Overall Study|Physician Decision|1
1169925|NCT03701074|2301936|FG001|Overall Study|Physician Decision|0
1169926|NCT03702010|2301944|FG000|Follow-up (30days)|Lack of Efficacy|2
1169927|NCT03702010|2301945|FG001|Follow-up (30days)|Lack of Efficacy|2
1169928|NCT03702166|2301957|FG000|Overall Study|Lost to Follow-up|1
1169929|NCT03702166|2301957|FG000|Overall Study|Withdrawal by Subject|1
1169930|NCT03703336|2301968|FG000|Overall Study|Parent withdrew consent|29
1169931|NCT03703336|2301969|FG001|Overall Study|Parent withdrew consent|8
1169932|NCT03703336|2301968|FG000|Overall Study|Migration|3
1169933|NCT03703336|2301969|FG001|Overall Study|Migration|3
1169934|NCT03703336|2301968|FG000|Overall Study|Protocol Violation|3
1169935|NCT03703336|2301969|FG001|Overall Study|Protocol Violation|1
1169936|NCT03703336|2301968|FG000|Overall Study|Physician Decision|2
1169937|NCT03703336|2301969|FG001|Overall Study|Physician Decision|0
1169938|NCT03703336|2301968|FG000|Overall Study|Adverse Event|0
1169939|NCT03703336|2301969|FG001|Overall Study|Adverse Event|2
1169940|NCT03703336|2301968|FG000|Overall Study|Lost to Follow-up|1
1169941|NCT03703336|2301969|FG001|Overall Study|Lost to Follow-up|0
1169942|NCT03703466|2301978|FG000|Overall Study|Death|2
1169943|NCT03703466|2301979|FG001|Overall Study|Death|1
1169944|NCT03703466|2301980|FG002|Overall Study|Death|0
1169945|NCT03703466|2301978|FG000|Overall Study|Protocol Violation|1
1169946|NCT03703466|2301979|FG001|Overall Study|Protocol Violation|0
1169947|NCT03703466|2301980|FG002|Overall Study|Protocol Violation|0
1169948|NCT03703466|2301978|FG000|Overall Study|Withdrawal by Subject|0
1169949|NCT03703466|2301979|FG001|Overall Study|Withdrawal by Subject|3
1169950|NCT03703466|2301980|FG002|Overall Study|Withdrawal by Subject|0
1169951|NCT03703466|2301978|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1
1169952|NCT03703466|2301979|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
1169953|NCT03703466|2301980|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
1169954|NCT03703817|2301991|FG000|Overall Study|Not meeting eligibility criteria|7
1169955|NCT03703817|2301992|FG001|Overall Study|Not meeting eligibility criteria|4
1169956|NCT03704194|2302000|FG000|Overall Study|Withdrawal by Subject|0
1169957|NCT03704194|2302001|FG001|Overall Study|Withdrawal by Subject|1
1169958|NCT03705494|2302040|FG000|Overall Study|Lost to Follow-up|2
1169959|NCT03705494|2302041|FG001|Overall Study|Lost to Follow-up|1
1169960|NCT03705494|2302040|FG000|Overall Study|Withdrawal by Subject|5
1169961|NCT03705494|2302041|FG001|Overall Study|Withdrawal by Subject|2
1169962|NCT03705793|2302049|FG000|Overall Study|Lost to Follow-up|3
1169963|NCT03705793|2302050|FG001|Overall Study|Lost to Follow-up|4
1169964|NCT03705793|2302049|FG000|Overall Study|Withdrawal by Subject|2
1169965|NCT03705793|2302050|FG001|Overall Study|Withdrawal by Subject|1
1169966|NCT03706456|2302090|FG000|Overall Study|Lack of Efficacy|1
1169967|NCT03706456|2302090|FG000|Overall Study|Ongoing|21
1169968|NCT03707522|2302142|FG000|Overall Study|Lost to Follow-up|24
1169969|NCT03707522|2302143|FG001|Overall Study|Lost to Follow-up|27
1169970|NCT03707522|2302144|FG002|Overall Study|Lost to Follow-up|41
1169971|NCT03707522|2302145|FG003|Overall Study|Lost to Follow-up|36
1169972|NCT03707587|2302157|FG000|Overall Study|Death|0
1169973|NCT03707587|2302158|FG001|Overall Study|Death|1
1169974|NCT03707821|2302166|FG000|Overall Study|Protocol Violation|0
1169975|NCT03707821|2302167|FG001|Overall Study|Protocol Violation|1
1169976|NCT03707821|2302166|FG000|Overall Study|Unsatisfactory Visual Response|1
1169977|NCT03707821|2302167|FG001|Overall Study|Unsatisfactory Visual Response|0
1169978|NCT03707821|2302166|FG000|Overall Study|Unsatisfactory Lens Fitting|1
1169979|NCT03707821|2302167|FG001|Overall Study|Unsatisfactory Lens Fitting|0
1169980|NCT03707912|2302175|FG000|Overall Study|Violation of inclusion criteria|1
1169981|NCT03707912|2302176|FG001|Overall Study|Violation of inclusion criteria|0
1169982|NCT03708211|2302184|FG000|Overall Study|Progressive Disease|10
1169983|NCT03708211|2302185|FG001|Overall Study|Progressive Disease|7
1169984|NCT03708211|2302184|FG000|Overall Study|Withdrawal by Subject|0
1169985|NCT03708211|2302185|FG001|Overall Study|Withdrawal by Subject|1
1169986|NCT03708211|2302184|FG000|Overall Study|Other|2
1169987|NCT03708211|2302185|FG001|Overall Study|Other|0
1169988|NCT03708744|2302216|FG000|Overall Study|Withdrawal by Subject|0
1169989|NCT03708744|2302217|FG001|Overall Study|Withdrawal by Subject|0
1169990|NCT03708744|2302218|FG002|Overall Study|Withdrawal by Subject|1
1169991|NCT03708744|2302219|FG003|Overall Study|Withdrawal by Subject|0
1169992|NCT03709654|2302246|FG000|Overall Study|Lost to Follow-up|1
1169993|NCT03709654|2302247|FG001|Overall Study|Lost to Follow-up|1
1169994|NCT03709654|2302246|FG000|Overall Study|Withdrawal by Subject|1
1169995|NCT03709654|2302247|FG001|Overall Study|Withdrawal by Subject|1
1169996|NCT03709654|2302246|FG000|Overall Study|Adverse Event|1
1169997|NCT03709654|2302247|FG001|Overall Study|Adverse Event|0
1169998|NCT03709823|2302266|FG000|Overall Study|Adverse Event|0
1169999|NCT03709823|2302267|FG001|Overall Study|Adverse Event|0
1170000|NCT03709823|2302268|FG002|Overall Study|Adverse Event|1
1170001|NCT03709823|2302269|FG003|Overall Study|Adverse Event|0
1170002|NCT03709823|2302270|FG004|Overall Study|Adverse Event|0
1170003|NCT03709823|2302271|FG005|Overall Study|Adverse Event|0
1170004|NCT03709823|2302266|FG000|Overall Study|Lost to Follow-up|2
1170005|NCT03709823|2302267|FG001|Overall Study|Lost to Follow-up|2
1170006|NCT03709823|2302268|FG002|Overall Study|Lost to Follow-up|2
1170007|NCT03709823|2302269|FG003|Overall Study|Lost to Follow-up|1
1170008|NCT03709823|2302270|FG004|Overall Study|Lost to Follow-up|1
1170009|NCT03709823|2302271|FG005|Overall Study|Lost to Follow-up|0
1170010|NCT03709823|2302266|FG000|Overall Study|Withdrawal by Subject|1
1170011|NCT03709823|2302267|FG001|Overall Study|Withdrawal by Subject|3
1170012|NCT03709823|2302268|FG002|Overall Study|Withdrawal by Subject|0
1170013|NCT03709823|2302269|FG003|Overall Study|Withdrawal by Subject|0
1170014|NCT03709823|2302270|FG004|Overall Study|Withdrawal by Subject|0
1170015|NCT03709823|2302271|FG005|Overall Study|Withdrawal by Subject|0
1170016|NCT03709823|2302266|FG000|Overall Study|Other, Not Specified|0
1170017|NCT03709823|2302267|FG001|Overall Study|Other, Not Specified|0
1170018|NCT03709823|2302268|FG002|Overall Study|Other, Not Specified|0
1170019|NCT03709823|2302269|FG003|Overall Study|Other, Not Specified|1
1170020|NCT03709823|2302270|FG004|Overall Study|Other, Not Specified|0
1170021|NCT03709823|2302271|FG005|Overall Study|Other, Not Specified|0
1170022|NCT03710083|2302288|FG000|Overall Study|Withdrawal by Subject|2
1170023|NCT03710083|2302288|FG000|Overall Study|Unsuccessful Procedure|1
1170024|NCT03710161|2302294|FG000|Overall Study|Study halted due to COVID pandemic|3
1170025|NCT03710161|2302295|FG001|Overall Study|Study halted due to COVID pandemic|2
1170026|NCT03710590|2302321|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10
1170027|NCT03710590|2302322|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8
1170028|NCT03710889|2302328|FG000|Overall Study|Adverse Event|2
1170029|NCT03710889|2302328|FG000|Overall Study|Protocol Deviation|1
1170030|NCT03712280|2302357|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0
1170031|NCT03712280|2302358|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1
1170032|NCT03712280|2302359|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0
1170033|NCT03712280|2302360|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1
1170034|NCT03712280|2302357|FG000|Overall Study|Withdrawal by Participant or Caregiver|1
1170035|NCT03712280|2302358|FG001|Overall Study|Withdrawal by Participant or Caregiver|0
1170036|NCT03712280|2302359|FG002|Overall Study|Withdrawal by Participant or Caregiver|0
1170037|NCT03712280|2302360|FG003|Overall Study|Withdrawal by Participant or Caregiver|0
1170038|NCT03712280|2302357|FG000|Overall Study|Adverse Event|0
1170039|NCT03712280|2302358|FG001|Overall Study|Adverse Event|0
1170040|NCT03712280|2302359|FG002|Overall Study|Adverse Event|1
1170041|NCT03712280|2302360|FG003|Overall Study|Adverse Event|0
1170042|NCT03712449|2302372|FG000|Overall Study|Withdraw Consent|0
1170043|NCT03712449|2302373|FG001|Overall Study|Withdraw Consent|1
1170044|NCT03712917|2302395|FG000|Overall Study|Pregnancy|0
1170045|NCT03712917|2302396|FG001|Overall Study|Pregnancy|0
1170046|NCT03712917|2302397|FG002|Overall Study|Pregnancy|1
1170047|NCT03712917|2302395|FG000|Overall Study|Adverse Event|0
1170048|NCT03712917|2302396|FG001|Overall Study|Adverse Event|4
1170049|NCT03712917|2302397|FG002|Overall Study|Adverse Event|3
1170050|NCT03712917|2302395|FG000|Overall Study|Lost to Follow-up|9
1170051|NCT03712917|2302396|FG001|Overall Study|Lost to Follow-up|4
1170052|NCT03712917|2302397|FG002|Overall Study|Lost to Follow-up|5
1170053|NCT03712930|2302405|FG000|Overall Study|Death|7
1170054|NCT03712930|2302405|FG000|Overall Study|Physician Decision|1
1170055|NCT03712930|2302405|FG000|Overall Study|Study Terminated by Sponsor|3
1170056|NCT03712930|2302405|FG000|Overall Study|Progressive Disease|2
1170057|NCT03714022|2302420|FG000|Overall Study|Adverse Event|1
1170058|NCT03714022|2302421|FG001|Overall Study|Adverse Event|0
1170059|NCT03714022|2302420|FG000|Overall Study|Consent withdrawal|0
1170060|NCT03714022|2302421|FG001|Overall Study|Consent withdrawal|1
1170061|NCT03714022|2302420|FG000|Overall Study|Lost to Follow-up|3
1170062|NCT03714022|2302421|FG001|Overall Study|Lost to Follow-up|2
1170063|NCT03714672|2302444|FG000|Overall Study|Adverse Event|0
1170064|NCT03714672|2302445|FG001|Overall Study|Adverse Event|0
1170065|NCT03714672|2302446|FG002|Overall Study|Adverse Event|3
1170066|NCT03714672|2302447|FG003|Overall Study|Adverse Event|0
1170067|NCT03714672|2302444|FG000|Overall Study|Physician Decision|0
1170068|NCT03714672|2302445|FG001|Overall Study|Physician Decision|1
1170069|NCT03714672|2302446|FG002|Overall Study|Physician Decision|0
1170070|NCT03714672|2302447|FG003|Overall Study|Physician Decision|0
1170071|NCT03714672|2302444|FG000|Overall Study|Other Reason|1
1170072|NCT03714672|2302445|FG001|Overall Study|Other Reason|2
1170073|NCT03714672|2302446|FG002|Overall Study|Other Reason|1
1170074|NCT03714672|2302447|FG003|Overall Study|Other Reason|1
1170075|NCT03714672|2302444|FG000|Overall Study|Lost to Follow-up|1
1170076|NCT03714672|2302445|FG001|Overall Study|Lost to Follow-up|1
1170077|NCT03714672|2302446|FG002|Overall Study|Lost to Follow-up|0
1170078|NCT03714672|2302447|FG003|Overall Study|Lost to Follow-up|0
1170079|NCT03715530|2302478|FG000|Overall Study|Lost to Follow-up|3
1170080|NCT03715530|2302479|FG001|Overall Study|Lost to Follow-up|1
1170081|NCT03715530|2302480|FG002|Overall Study|Lost to Follow-up|2
1170082|NCT03716024|2302499|FG000|Overall Study|Randomized, not Treated|7
1170083|NCT03716024|2302500|FG001|Overall Study|Randomized, not Treated|8
1170084|NCT03716024|2302499|FG000|Overall Study|Adverse Event|1
1170085|NCT03716024|2302500|FG001|Overall Study|Adverse Event|2
1170086|NCT03716024|2302499|FG000|Overall Study|Treatment Failure|1
1170087|NCT03716024|2302500|FG001|Overall Study|Treatment Failure|0
1170088|NCT03716024|2302499|FG000|Overall Study|Lost to Follow-up|2
1170089|NCT03716024|2302500|FG001|Overall Study|Lost to Follow-up|6
1170090|NCT03716024|2302499|FG000|Overall Study|Withdrawal by Subject|0
1170091|NCT03716024|2302500|FG001|Overall Study|Withdrawal by Subject|1
1170092|NCT03716024|2302499|FG000|Overall Study|Missing Reason|0
1170093|NCT03716024|2302500|FG001|Overall Study|Missing Reason|1
1170094|NCT03716050|2302514|FG000|Overall Study|Lost to Follow-up|0
1170095|NCT03716050|2302515|FG001|Overall Study|Lost to Follow-up|0
1170096|NCT03716050|2302516|FG002|Overall Study|Lost to Follow-up|1
1170097|NCT03716050|2302517|FG003|Overall Study|Lost to Follow-up|0
1170098|NCT03716050|2302518|FG004|Overall Study|Lost to Follow-up|0
1170099|NCT03716050|2302519|FG005|Overall Study|Lost to Follow-up|0
1170100|NCT03716050|2302520|FG006|Overall Study|Lost to Follow-up|0
1170101|NCT03716050|2302521|FG007|Overall Study|Lost to Follow-up|0
1170102|NCT03716050|2302514|FG000|Overall Study|Physician Decision|0
1170103|NCT03716050|2302515|FG001|Overall Study|Physician Decision|0
1170104|NCT03716050|2302516|FG002|Overall Study|Physician Decision|0
1170105|NCT03716050|2302517|FG003|Overall Study|Physician Decision|1
1170106|NCT03716050|2302518|FG004|Overall Study|Physician Decision|0
1170107|NCT03716050|2302519|FG005|Overall Study|Physician Decision|0
1170108|NCT03716050|2302520|FG006|Overall Study|Physician Decision|0
1170109|NCT03716050|2302521|FG007|Overall Study|Physician Decision|0
1170110|NCT03716050|2302514|FG000|Overall Study|Protocol Violation|0
1170111|NCT03716050|2302515|FG001|Overall Study|Protocol Violation|0
1170112|NCT03716050|2302516|FG002|Overall Study|Protocol Violation|0
1170113|NCT03716050|2302517|FG003|Overall Study|Protocol Violation|1
1170114|NCT03716050|2302518|FG004|Overall Study|Protocol Violation|0
1170115|NCT03716050|2302519|FG005|Overall Study|Protocol Violation|0
1170116|NCT03716050|2302520|FG006|Overall Study|Protocol Violation|0
1170117|NCT03716050|2302521|FG007|Overall Study|Protocol Violation|2
1170118|NCT03717012|2302549|FG000|Overall Study|Due to trial termination|1
1170119|NCT03717012|2302550|FG001|Overall Study|Due to trial termination|2
1170120|NCT03717012|2302549|FG000|Overall Study|Protocol Violation|0
1170121|NCT03717012|2302550|FG001|Overall Study|Protocol Violation|2
1170122|NCT03717012|2302549|FG000|Overall Study|Adverse Event|0
1170123|NCT03717012|2302550|FG001|Overall Study|Adverse Event|1
1170124|NCT03717012|2302549|FG000|Overall Study|Lung transplant|0
1170125|NCT03717012|2302550|FG001|Overall Study|Lung transplant|1
1170126|NCT03717064|2302565|FG000|Period 2|Adverse Event|1
1170127|NCT03718000|2302588|FG000|Overall Study|Relocation|2
1170128|NCT03718000|2302589|FG001|Overall Study|Relocation|4
1170129|NCT03718000|2302588|FG000|Overall Study|Pregnancy|0
1170130|NCT03718000|2302589|FG001|Overall Study|Pregnancy|1
1170131|NCT03719586|2302623|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8
1170132|NCT03719586|2302624|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7
1170133|NCT03719586|2302625|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4
1170134|NCT03719586|2302626|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0
1170135|NCT03720470|2302660|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5
1170136|NCT03720470|2302661|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0
1170137|NCT03720470|2302662|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0
1170138|NCT03720470|2302663|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5
1170139|NCT03720470|2302664|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8
1170140|NCT03720470|2302665|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6
1170141|NCT03720470|2302660|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
1170142|NCT03720470|2302661|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
1170143|NCT03720470|2302662|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
1170144|NCT03720470|2302663|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
1170145|NCT03720470|2302664|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
1170146|NCT03720470|2302665|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
1170147|NCT03720470|2302660|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
1170148|NCT03720470|2302661|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
1170149|NCT03720470|2302662|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
1170150|NCT03720470|2302663|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
1170151|NCT03720470|2302664|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
1170152|NCT03720470|2302665|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
1170153|NCT03720470|2302660|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0
1170154|NCT03720470|2302661|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0
1170155|NCT03720470|2302662|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0
1170156|NCT03720470|2302663|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0
1170157|NCT03720470|2302664|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1
1170158|NCT03720470|2302665|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1
1170159|NCT03720470|2302660|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2
1170160|NCT03720470|2302661|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0
1170161|NCT03720470|2302662|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0
1170162|NCT03720470|2302663|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2
1170163|NCT03720470|2302664|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2
1170164|NCT03720470|2302665|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1
1170165|NCT03720470|2302660|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5
1170166|NCT03720470|2302661|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
1170167|NCT03720470|2302662|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
1170168|NCT03720470|2302663|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9
1170169|NCT03720470|2302664|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3
1170170|NCT03720470|2302665|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6
1170171|NCT03720470|2302660|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
1170172|NCT03720470|2302661|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
1170173|NCT03720470|2302662|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
1170174|NCT03720470|2302663|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
1170175|NCT03720470|2302664|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
1170176|NCT03720470|2302665|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
1170177|NCT03720470|2302660|FG000|Treatment Period: First Part 16 Weeks|Other|1
1170178|NCT03720470|2302661|FG001|Treatment Period: First Part 16 Weeks|Other|0
1170179|NCT03720470|2302662|FG002|Treatment Period: First Part 16 Weeks|Other|0
1170180|NCT03720470|2302663|FG003|Treatment Period: First Part 16 Weeks|Other|1
1170181|NCT03720470|2302664|FG004|Treatment Period: First Part 16 Weeks|Other|2
1170182|NCT03720470|2302665|FG005|Treatment Period: First Part 16 Weeks|Other|2
1170183|NCT03720470|2302660|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
1170184|NCT03720470|2302661|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
1170185|NCT03720470|2302662|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
1170186|NCT03720470|2302663|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
1170187|NCT03720470|2302664|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
1170188|NCT03720470|2302665|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1
1170189|NCT03720470|2302660|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0
1170190|NCT03720470|2302661|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0
1170191|NCT03720470|2302662|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0
1170192|NCT03720470|2302663|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2
1170193|NCT03720470|2302664|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1
1170194|NCT03720470|2302665|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1
1170195|NCT03720470|2302660|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
1170196|NCT03720470|2302661|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
1170197|NCT03720470|2302662|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1
1170198|NCT03720470|2302663|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
1170199|NCT03720470|2302664|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
1170200|NCT03720470|2302665|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
1170201|NCT03720470|2302660|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
1170202|NCT03720470|2302661|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
1170203|NCT03720470|2302662|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
1170204|NCT03720470|2302663|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
1170205|NCT03720470|2302664|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
1170206|NCT03720470|2302665|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
1170207|NCT03720470|2302660|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0
1170208|NCT03720470|2302661|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0
1170209|NCT03720470|2302662|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0
1170210|NCT03720470|2302663|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0
1170211|NCT03720470|2302664|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0
1170212|NCT03720470|2302665|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1
1170213|NCT03720470|2302660|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0
1170214|NCT03720470|2302661|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0
1170215|NCT03720470|2302662|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1
1170216|NCT03720470|2302663|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0
1170217|NCT03720470|2302664|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0
1170218|NCT03720470|2302665|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0
1170219|NCT03720470|2302660|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
1170220|NCT03720470|2302661|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1
1170221|NCT03720470|2302662|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
1170222|NCT03720470|2302663|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
1170223|NCT03720470|2302664|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
1170224|NCT03720470|2302665|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
1170225|NCT03720470|2302660|FG000|Treatment Period: Final 4 Weeks|Other|0
1170226|NCT03720470|2302661|FG001|Treatment Period: Final 4 Weeks|Other|1
1170227|NCT03720470|2302662|FG002|Treatment Period: Final 4 Weeks|Other|0
1170228|NCT03720470|2302663|FG003|Treatment Period: Final 4 Weeks|Other|2
1170229|NCT03720470|2302664|FG004|Treatment Period: Final 4 Weeks|Other|1
1170230|NCT03720470|2302665|FG005|Treatment Period: Final 4 Weeks|Other|0
1170231|NCT03720652|2302687|FG000|Overall Study|Withdrawal by Subject|2
1170232|NCT03720652|2302688|FG001|Overall Study|Withdrawal by Subject|7
1170233|NCT03720652|2302687|FG000|Overall Study|Lost to Follow-up|0
1170234|NCT03720652|2302688|FG001|Overall Study|Lost to Follow-up|4
1170235|NCT03720847|2302696|FG000|Washout|Physician Decision|1
1170236|NCT03720847|2302697|FG001|Washout|Physician Decision|2
1170237|NCT03721172|2302726|FG000|Placebo-controlled Phase|Adverse Event|7
1170238|NCT03721172|2302727|FG001|Placebo-controlled Phase|Adverse Event|7
1170239|NCT03721172|2302728|FG002|Placebo-controlled Phase|Adverse Event|0
1170240|NCT03721172|2302726|FG000|Placebo-controlled Phase|Lack of Efficacy|4
1170241|NCT03721172|2302727|FG001|Placebo-controlled Phase|Lack of Efficacy|0
1170242|NCT03721172|2302728|FG002|Placebo-controlled Phase|Lack of Efficacy|0
1170243|NCT03721172|2302726|FG000|Placebo-controlled Phase|Non-compliance with study drug|0
1170244|NCT03721172|2302727|FG001|Placebo-controlled Phase|Non-compliance with study drug|1
1170245|NCT03721172|2302728|FG002|Placebo-controlled Phase|Non-compliance with study drug|0
1170246|NCT03721172|2302726|FG000|Placebo-controlled Phase|Lost to Follow-up|15
1170247|NCT03721172|2302727|FG001|Placebo-controlled Phase|Lost to Follow-up|13
1170248|NCT03721172|2302728|FG002|Placebo-controlled Phase|Lost to Follow-up|0
1170249|NCT03721172|2302726|FG000|Placebo-controlled Phase|Withdrawal by Subject|23
1170250|NCT03721172|2302727|FG001|Placebo-controlled Phase|Withdrawal by Subject|18
1170251|NCT03721172|2302728|FG002|Placebo-controlled Phase|Withdrawal by Subject|0
1170252|NCT03721172|2302726|FG000|Placebo-controlled Phase|Other|3
1170253|NCT03721172|2302727|FG001|Placebo-controlled Phase|Other|0
1170254|NCT03721172|2302728|FG002|Placebo-controlled Phase|Other|0
1170255|NCT03721172|2302726|FG000|Apremilast Extension Phase|Adverse Event|0
1170256|NCT03721172|2302727|FG001|Apremilast Extension Phase|Adverse Event|0
1170257|NCT03721172|2302728|FG002|Apremilast Extension Phase|Adverse Event|10
1170258|NCT03721172|2302726|FG000|Apremilast Extension Phase|Lack of Efficacy|0
1170259|NCT03721172|2302727|FG001|Apremilast Extension Phase|Lack of Efficacy|0
1170260|NCT03721172|2302728|FG002|Apremilast Extension Phase|Lack of Efficacy|2
1170261|NCT03721172|2302726|FG000|Apremilast Extension Phase|Non-compliance with study drug|0
1170262|NCT03721172|2302727|FG001|Apremilast Extension Phase|Non-compliance with study drug|0
1170263|NCT03721172|2302728|FG002|Apremilast Extension Phase|Non-compliance with study drug|1
1170264|NCT03721172|2302726|FG000|Apremilast Extension Phase|Lost to Follow-up|0
1170265|NCT03721172|2302727|FG001|Apremilast Extension Phase|Lost to Follow-up|0
1170266|NCT03721172|2302728|FG002|Apremilast Extension Phase|Lost to Follow-up|20
1170267|NCT03721172|2302726|FG000|Apremilast Extension Phase|Protocol Violation|0
1170268|NCT03721172|2302727|FG001|Apremilast Extension Phase|Protocol Violation|0
1170269|NCT03721172|2302728|FG002|Apremilast Extension Phase|Protocol Violation|1
1170270|NCT03721172|2302726|FG000|Apremilast Extension Phase|Physician Decision|0
1170271|NCT03721172|2302727|FG001|Apremilast Extension Phase|Physician Decision|0
1170272|NCT03721172|2302728|FG002|Apremilast Extension Phase|Physician Decision|1
1170273|NCT03721172|2302726|FG000|Apremilast Extension Phase|Withdrawal by Subject|0
1170274|NCT03721172|2302727|FG001|Apremilast Extension Phase|Withdrawal by Subject|0
1170275|NCT03721172|2302728|FG002|Apremilast Extension Phase|Withdrawal by Subject|21
1170276|NCT03721172|2302726|FG000|Apremilast Extension Phase|Other|0
1170277|NCT03721172|2302727|FG001|Apremilast Extension Phase|Other|0
1170278|NCT03721172|2302728|FG002|Apremilast Extension Phase|Other|3
1170279|NCT03721172|2302726|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0
1170280|NCT03721172|2302727|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0
1170281|NCT03721172|2302728|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7
1170286|NCT03722030|2302756|FG000|Overall Study|Withdrawal by Subject|1
1170287|NCT03722030|2302757|FG001|Overall Study|Withdrawal by Subject|0
1170288|NCT03722238|2302766|FG000|Overall Study|Protocol Violation|1
1170289|NCT03722238|2302767|FG001|Overall Study|Protocol Violation|0
1170290|NCT03722238|2302766|FG000|Overall Study|Physician Decision|1
1170291|NCT03722238|2302767|FG001|Overall Study|Physician Decision|0
1170292|NCT03722238|2302766|FG000|Overall Study|Death|1
1170293|NCT03722238|2302767|FG001|Overall Study|Death|0
1170294|NCT03722238|2302766|FG000|Overall Study|Lost to Follow-up|6
1170295|NCT03722238|2302767|FG001|Overall Study|Lost to Follow-up|0
1170296|NCT03722238|2302766|FG000|Overall Study|Partial missing data|44
1170297|NCT03722238|2302767|FG001|Overall Study|Partial missing data|1
1170298|NCT03722238|2302766|FG000|Overall Study|Withdrawal by Subject|2
1170299|NCT03722238|2302767|FG001|Overall Study|Withdrawal by Subject|0
1170300|NCT03722238|2302766|FG000|Overall Study|Other|4
1170301|NCT03722238|2302767|FG001|Overall Study|Other|0
1170302|NCT03722238|2302766|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2
1170303|NCT03722238|2302767|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0
1170304|NCT03722238|2302766|FG000|Overall Study|Did not meet risk classification group criteria|90
1170305|NCT03722238|2302767|FG001|Overall Study|Did not meet risk classification group criteria|0
1170306|NCT03722238|2302766|FG000|Overall Study|Did not sign consent|17
1170307|NCT03722238|2302767|FG001|Overall Study|Did not sign consent|0
1170308|NCT03722238|2302766|FG000|Overall Study|Other eligibility criteria not met pre-consent|22
1170309|NCT03722238|2302767|FG001|Overall Study|Other eligibility criteria not met pre-consent|0
1170310|NCT03722238|2302766|FG000|Overall Study|Not willing to purchase study medication|142
1170311|NCT03722238|2302767|FG001|Overall Study|Not willing to purchase study medication|0
1170312|NCT03722238|2302766|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133
1170313|NCT03722238|2302767|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0
1170314|NCT03722264|2302773|FG000|Overall Study|Physician Decision|3
1170315|NCT03722446|2302781|FG000|Overall Study|Protocol Violation|15
1170316|NCT03722446|2302782|FG001|Overall Study|Protocol Violation|2
1170317|NCT03722524|2302788|FG000|Overall Study|Protocol Violation|86
1170318|NCT03722524|2302788|FG000|Overall Study|Adverse Event|7
1170319|NCT03722524|2302788|FG000|Overall Study|Lost to Follow-up|1
1170320|NCT03722524|2302788|FG000|Overall Study|Reason is not stated|1
1170321|NCT03722524|2302788|FG000|Overall Study|Physician Decision|1
1170322|NCT03722524|2302788|FG000|Overall Study|Patient's decision (refusal to continue participation)|3
1170323|NCT03722576|2302792|FG000|Overall Study|Withdrawal by Subject|3
1170324|NCT03722576|2302792|FG000|Overall Study|Adverse Event|2
1170325|NCT03722576|2302792|FG000|Overall Study|Physician Decision|1
1170326|NCT03722576|2302792|FG000|Overall Study|Lost to Follow-up|1
1170327|NCT03722784|2302798|FG000|Overall Study|Withdrawal by Subject|1
1170328|NCT03722784|2302799|FG001|Overall Study|Withdrawal by Subject|0
1170329|NCT03722784|2302798|FG000|Overall Study|Physician Decision|1
1170330|NCT03722784|2302799|FG001|Overall Study|Physician Decision|1
1170331|NCT03722784|2302798|FG000|Overall Study|Protocol Violation|0
1170332|NCT03722784|2302799|FG001|Overall Study|Protocol Violation|1
1170333|NCT03723915|2302806|FG000|Screening|Failed to meet screening requirements.|2
1170334|NCT03723915|2302806|FG000|On Treatment|Failed to meet treatment requirements|2
1170335|NCT03724812|2302810|FG000|Overall Study|Missed Visit|1
1170336|NCT03724812|2302810|FG000|Overall Study|Death|2
1170337|NCT03724812|2302810|FG000|Overall Study|Withdrawal by Subject|1
1170338|NCT03725982|2302817|FG000|First Intervention|Withdrawal by Subject|0
1170339|NCT03725982|2302818|FG001|First Intervention|Withdrawal by Subject|1
1170340|NCT03725982|2302817|FG000|First Intervention|Physician Decision|1
1170341|NCT03725982|2302818|FG001|First Intervention|Physician Decision|1
1170342|NCT03727841|2302832|FG000|Overall Study|Physician Decision|2
1170343|NCT03727841|2302833|FG001|Overall Study|Physician Decision|1
1170344|NCT03736967|2302843|FG000|Overall Study|Withdrawal by Subject|26
1170345|NCT03736967|2302844|FG001|Overall Study|Withdrawal by Subject|25
1170346|NCT03736967|2302845|FG002|Overall Study|Withdrawal by Subject|23
1170347|NCT03736967|2302846|FG003|Overall Study|Withdrawal by Subject|26
1170348|NCT03736967|2302843|FG000|Overall Study|Lost to Follow-up|3
1170349|NCT03736967|2302844|FG001|Overall Study|Lost to Follow-up|2
1170350|NCT03736967|2302845|FG002|Overall Study|Lost to Follow-up|1
1170351|NCT03736967|2302846|FG003|Overall Study|Lost to Follow-up|1
1170352|NCT03736967|2302843|FG000|Overall Study|Physician Decision|1
1170353|NCT03736967|2302844|FG001|Overall Study|Physician Decision|0
1170354|NCT03736967|2302845|FG002|Overall Study|Physician Decision|0
1170355|NCT03736967|2302846|FG003|Overall Study|Physician Decision|1
1170356|NCT03736967|2302843|FG000|Overall Study|Adverse Event|0
1170357|NCT03736967|2302844|FG001|Overall Study|Adverse Event|1
1170358|NCT03736967|2302845|FG002|Overall Study|Adverse Event|0
1170359|NCT03736967|2302846|FG003|Overall Study|Adverse Event|1
1170360|NCT03736967|2302843|FG000|Overall Study|Death|0
1170361|NCT03736967|2302844|FG001|Overall Study|Death|0
1170362|NCT03736967|2302845|FG002|Overall Study|Death|0
1170363|NCT03736967|2302846|FG003|Overall Study|Death|1
1170364|NCT03736967|2302843|FG000|Overall Study|Randomized but never treated|1
1170365|NCT03736967|2302844|FG001|Overall Study|Randomized but never treated|0
1170366|NCT03736967|2302845|FG002|Overall Study|Randomized but never treated|0
1170367|NCT03736967|2302846|FG003|Overall Study|Randomized but never treated|0
1170368|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Adverse Event|2
1170369|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Adverse Event|6
1170370|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Adverse Event|6
1170371|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Adverse Event|12
1170372|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0
1170373|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
1170374|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
1170375|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3
1170376|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Protocol Violation|0
1170377|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Protocol Violation|0
1170378|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Protocol Violation|1
1170379|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Protocol Violation|0
1170380|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1
1170381|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3
1170382|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1
1170383|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1
1170384|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Program Termination|3
1170385|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Program Termination|0
1170386|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Program Termination|1
1170387|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Program Termination|1
1170388|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1
1170389|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
1170390|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
1170391|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
1170392|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Sponsors Decision|3
1170393|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Sponsors Decision|2
1170394|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Sponsors Decision|1
1170395|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Sponsors Decision|3
1170396|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Promotor Decision|0
1170397|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Promotor Decision|1
1170398|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Promotor Decision|0
1170399|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Promotor Decision|0
1170400|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
1170401|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1
1170402|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
1170403|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
1170404|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Premature Program Termination|0
1170405|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Premature Program Termination|1
1170406|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Premature Program Termination|0
1170407|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Premature Program Termination|0
1170408|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
1170409|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1
1170410|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
1170411|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
1170412|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Study Early Closure|0
1170413|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Study Early Closure|0
1170414|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Study Early Closure|1
1170415|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Study Early Closure|0
1170416|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
1170417|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
1170418|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1
1170419|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
1170420|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0
1170421|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0
1170422|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1
1170423|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0
1170424|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
1170425|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
1170426|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
1170427|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1
1170428|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
1170429|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
1170430|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
1170431|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1
1170432|NCT03739840|2302863|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
1170433|NCT03739840|2302864|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
1170434|NCT03739840|2302865|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
1170435|NCT03739840|2302866|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1
1170436|NCT03739840|2302863|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3
1170437|NCT03739840|2302864|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0
1170438|NCT03739840|2302865|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0
1170439|NCT03739840|2302866|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0
1170440|NCT03739840|2302863|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
1170441|NCT03739840|2302864|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
1170442|NCT03739840|2302865|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
1170443|NCT03739840|2302866|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1
1170444|NCT03739840|2302863|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1
1170445|NCT03739840|2302864|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
1170446|NCT03739840|2302865|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
1170447|NCT03739840|2302866|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
1170448|NCT03739840|2302863|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
1170449|NCT03739840|2302864|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1
1170450|NCT03739840|2302865|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
1170451|NCT03739840|2302866|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
1170452|NCT03739840|2302863|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
1170453|NCT03739840|2302864|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1
1170454|NCT03739840|2302865|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
1170455|NCT03739840|2302866|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
1170456|NCT03739840|2302863|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
1170457|NCT03739840|2302864|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
1170458|NCT03739840|2302865|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1
1170459|NCT03739840|2302866|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
1170460|NCT03739840|2302863|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0
1170461|NCT03739840|2302864|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0
1170462|NCT03739840|2302865|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1
1170463|NCT03739840|2302866|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0
1170464|NCT03739840|2302863|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
1170465|NCT03739840|2302864|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
1170466|NCT03739840|2302865|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1
1170467|NCT03739840|2302866|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
1170468|NCT03753763|2302925|FG000|Overall Study|Adverse Event|2
1170469|NCT03753763|2302926|FG001|Overall Study|Adverse Event|0
1170470|NCT03753763|2302925|FG000|Overall Study|Withdrawal by Subject|3
1170471|NCT03753763|2302926|FG001|Overall Study|Withdrawal by Subject|1
1170472|NCT03753763|2302925|FG000|Overall Study|clinical deterioration|1
1170473|NCT03753763|2302926|FG001|Overall Study|clinical deterioration|0
1170474|NCT03756571|2302934|FG000|Overall Study|Lost to Follow-up|1
1170475|NCT03756571|2302935|FG001|Overall Study|Lost to Follow-up|1
1170476|NCT03763877|2302962|FG000|Overall Study|Withdrawal by Subject|3
1170477|NCT03763877|2302963|FG001|Overall Study|Withdrawal by Subject|1
1170478|NCT03763877|2302964|FG002|Overall Study|Withdrawal by Subject|3
1170479|NCT03763877|2302965|FG003|Overall Study|Withdrawal by Subject|4
1170480|NCT03763877|2302962|FG000|Overall Study|Adverse Event|1
1170481|NCT03763877|2302963|FG001|Overall Study|Adverse Event|1
1170482|NCT03763877|2302964|FG002|Overall Study|Adverse Event|3
1170483|NCT03763877|2302965|FG003|Overall Study|Adverse Event|1
1170484|NCT03763877|2302962|FG000|Overall Study|Protocol Violation|1
1170485|NCT03763877|2302963|FG001|Overall Study|Protocol Violation|1
1170486|NCT03763877|2302964|FG002|Overall Study|Protocol Violation|0
1170487|NCT03763877|2302965|FG003|Overall Study|Protocol Violation|0
1170488|NCT03763877|2302962|FG000|Overall Study|Lost to Follow-up|0
1170489|NCT03763877|2302963|FG001|Overall Study|Lost to Follow-up|1
1170490|NCT03763877|2302964|FG002|Overall Study|Lost to Follow-up|1
1170491|NCT03763877|2302965|FG003|Overall Study|Lost to Follow-up|0
1170492|NCT03772587|2302988|FG000|Overall Study|COVID-19|0
1170493|NCT03772587|2302989|FG001|Overall Study|COVID-19|0
1170494|NCT03772587|2302990|FG002|Overall Study|COVID-19|1
1170495|NCT03772587|2302991|FG003|Overall Study|COVID-19|1
1170496|NCT03772587|2302992|FG004|Overall Study|COVID-19|0
1170497|NCT03772587|2302988|FG000|Overall Study|Withdrawal by Subject|1
1170498|NCT03772587|2302989|FG001|Overall Study|Withdrawal by Subject|0
1170499|NCT03772587|2302990|FG002|Overall Study|Withdrawal by Subject|0
1170500|NCT03772587|2302991|FG003|Overall Study|Withdrawal by Subject|0
1170501|NCT03772587|2302992|FG004|Overall Study|Withdrawal by Subject|0
1170502|NCT03789292|2303016|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7
1170503|NCT03789292|2303017|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8
1170504|NCT03789292|2303018|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0
1170505|NCT03789292|2303016|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2
1170506|NCT03789292|2303017|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
1170507|NCT03789292|2303018|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
1170508|NCT03789292|2303016|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1
1170509|NCT03789292|2303017|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
1170510|NCT03789292|2303018|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
1170511|NCT03789292|2303016|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
1170512|NCT03789292|2303017|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
1170513|NCT03789292|2303018|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0
1170514|NCT03789292|2303016|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9
1170515|NCT03789292|2303017|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8
1170516|NCT03789292|2303018|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0
1170517|NCT03789292|2303016|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1
1170518|NCT03789292|2303017|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
1170519|NCT03789292|2303018|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
1170520|NCT03789292|2303016|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0
1170521|NCT03789292|2303017|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2
1170522|NCT03789292|2303018|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0
1170523|NCT03789292|2303016|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
1170524|NCT03789292|2303017|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
1170525|NCT03789292|2303018|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6
1170526|NCT03789292|2303016|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
1170527|NCT03789292|2303017|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
1170528|NCT03789292|2303018|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1
1170529|NCT03789292|2303016|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1
1170530|NCT03789292|2303017|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
1170531|NCT03789292|2303018|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
1170532|NCT03789292|2303016|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9
1170533|NCT03789292|2303017|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
1170534|NCT03789292|2303018|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
1170535|NCT03789292|2303016|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1
1170536|NCT03789292|2303017|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
1170537|NCT03789292|2303018|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
1170538|NCT03789292|2303016|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2
1170539|NCT03789292|2303017|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1
1170540|NCT03789292|2303018|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0
1170541|NCT03805438|2303045|FG000|Overall Study|Lack of Efficacy|1
1170542|NCT03805438|2303045|FG000|Overall Study|Protocol Violation|1
1170543|NCT03812224|2303059|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
1170544|NCT03812224|2303060|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
1170545|NCT03812224|2303059|FG000|Double-blind Treatment Period|Decision by Sponsor|0
1170546|NCT03812224|2303060|FG001|Double-blind Treatment Period|Decision by Sponsor|1
1170547|NCT03812224|2303059|FG000|Open-label Treatment Period|Withdrawal by Subject|2
1170548|NCT03812224|2303060|FG001|Open-label Treatment Period|Withdrawal by Subject|2
1170549|NCT03812224|2303059|FG000|Open-label Treatment Period|Decision by Sponsor|0
1170550|NCT03812224|2303060|FG001|Open-label Treatment Period|Decision by Sponsor|1
1170551|NCT03817528|2303067|FG000|Overall Study|Withdrawal by Subject|1
1170552|NCT03817528|2303067|FG000|Overall Study|Adverse Event|2
1170553|NCT03817853|2303084|FG000|Induction Phase|Adverse Event|5
1170554|NCT03817853|2303085|FG001|Induction Phase|Adverse Event|0
1170555|NCT03817853|2303086|FG002|Induction Phase|Adverse Event|0
1170556|NCT03817853|2303084|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3
1170557|NCT03817853|2303085|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
1170558|NCT03817853|2303086|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
1170559|NCT03817853|2303084|FG000|Induction Phase|Physician Decision|2
1170560|NCT03817853|2303085|FG001|Induction Phase|Physician Decision|0
1170561|NCT03817853|2303086|FG002|Induction Phase|Physician Decision|0
1170562|NCT03817853|2303084|FG000|Induction Phase|Progressive Disease|4
1170563|NCT03817853|2303085|FG001|Induction Phase|Progressive Disease|0
1170564|NCT03817853|2303086|FG002|Induction Phase|Progressive Disease|0
1170565|NCT03817853|2303084|FG000|Induction Phase|Withdrawal by Subject|3
1170566|NCT03817853|2303085|FG001|Induction Phase|Withdrawal by Subject|0
1170567|NCT03817853|2303086|FG002|Induction Phase|Withdrawal by Subject|0
1170568|NCT03817853|2303084|FG000|Induction Phase|Continuing on Study|34
1170569|NCT03817853|2303085|FG001|Induction Phase|Continuing on Study|0
1170570|NCT03817853|2303086|FG002|Induction Phase|Continuing on Study|0
1170571|NCT03817853|2303084|FG000|Maintenance/ Follow-up Phase|Adverse Event|0
1170572|NCT03817853|2303085|FG001|Maintenance/ Follow-up Phase|Adverse Event|1
1170573|NCT03817853|2303086|FG002|Maintenance/ Follow-up Phase|Adverse Event|0
1170574|NCT03817853|2303084|FG000|Maintenance/ Follow-up Phase|Death|0
1170575|NCT03817853|2303085|FG001|Maintenance/ Follow-up Phase|Death|1
1170576|NCT03817853|2303086|FG002|Maintenance/ Follow-up Phase|Death|1
1170577|NCT03817853|2303084|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0
1170578|NCT03817853|2303085|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1
1170579|NCT03817853|2303086|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3
1170580|NCT03817853|2303084|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
1170581|NCT03817853|2303085|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1
1170582|NCT03817853|2303086|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
1170583|NCT03817853|2303084|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0
1170584|NCT03817853|2303085|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52
1170585|NCT03817853|2303086|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2
1170594|NCT03829228|2303123|FG000|Overall Study|Protocol Violation|1
1170595|NCT03830333|2303142|FG000|Overall Study|Death|0
1170596|NCT03830333|2303143|FG001|Overall Study|Death|1
1170597|NCT03830333|2303142|FG000|Overall Study|Withdrawal by Subject|5
1170598|NCT03830333|2303143|FG001|Overall Study|Withdrawal by Subject|1
1170599|NCT03830333|2303142|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3
1170600|NCT03830333|2303143|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2
1170601|NCT03831880|2303151|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0
1170602|NCT03831880|2303152|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1
1170603|NCT03831880|2303151|FG000|Period 2 (12 Weeks)|Protocol Deviation|0
1170604|NCT03831880|2303152|FG001|Period 2 (12 Weeks)|Protocol Deviation|1
1170605|NCT03831945|2303162|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
1170606|NCT03831945|2303163|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
1170607|NCT03831945|2303162|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
1170608|NCT03831945|2303163|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
1170609|NCT03831945|2303162|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2
1170610|NCT03831945|2303163|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1
1170611|NCT03840174|2303182|FG000|Overall Study|Withdrawal by Subject|1
1170612|NCT03840174|2303183|FG001|Overall Study|Withdrawal by Subject|0
1170613|NCT03840174|2303184|FG002|Overall Study|Withdrawal by Subject|0
1170614|NCT03840174|2303185|FG003|Overall Study|Withdrawal by Subject|0
1170615|NCT03857841|2303214|FG000|Overall Study|Death|1
1170616|NCT03857841|2303215|FG001|Overall Study|Death|0
1170617|NCT03857841|2303216|FG002|Overall Study|Death|0
1170618|NCT03857841|2303217|FG003|Overall Study|Death|0
1170619|NCT03857841|2303214|FG000|Overall Study|Study Terminated by Sponsor|1
1170620|NCT03857841|2303215|FG001|Overall Study|Study Terminated by Sponsor|0
1170621|NCT03857841|2303216|FG002|Overall Study|Study Terminated by Sponsor|0
1170622|NCT03857841|2303217|FG003|Overall Study|Study Terminated by Sponsor|0
1170623|NCT03862625|2303242|FG000|Overall Study|Lost to Follow-up|0
1170624|NCT03862625|2303243|FG001|Overall Study|Lost to Follow-up|1
1170631|NCT03877224|2303280|FG000|Overall Study|Death|3
1170632|NCT03877224|2303281|FG001|Overall Study|Death|2
1170633|NCT03877224|2303280|FG000|Overall Study|Withdrawal by Subject|1
1170634|NCT03877224|2303281|FG001|Overall Study|Withdrawal by Subject|6
1170635|NCT03877224|2303280|FG000|Overall Study|Participant is alive, just unable to come for visits|1
1170636|NCT03877224|2303281|FG001|Overall Study|Participant is alive, just unable to come for visits|0
1170637|NCT03880565|2303289|FG000|Overall Study|Withdrawal by Subject|1
1170638|NCT03880565|2303290|FG001|Overall Study|Withdrawal by Subject|0
1170639|NCT03885596|2303309|FG000|Overall Study|Withdrawal by Subject|2
1170640|NCT03885596|2303310|FG001|Overall Study|Withdrawal by Subject|1
1170641|NCT03885596|2303311|FG002|Overall Study|Withdrawal by Subject|0
1170642|NCT03885596|2303312|FG003|Overall Study|Withdrawal by Subject|0
1170643|NCT03885661|2303327|FG000|Overall Study|Withdrawal by Subject|0
1170644|NCT03885661|2303328|FG001|Overall Study|Withdrawal by Subject|1
1170645|NCT03885661|2303327|FG000|Overall Study|Unwilling to undergo required study procedure|1
1170646|NCT03885661|2303328|FG001|Overall Study|Unwilling to undergo required study procedure|0
1170647|NCT03886493|2303334|FG000|Overall Study|Adverse Event|1
1170648|NCT03888235|2303341|FG000|Overall Study|Lost to Follow-up|1
1170649|NCT03888235|2303342|FG001|Overall Study|Lost to Follow-up|1
1170650|NCT03888235|2303343|FG002|Overall Study|Lost to Follow-up|0
1170681|NCT03900416|2303444|FG000|Six Week Follow-up|Lost to Follow-up|1
1170682|NCT03900416|2303445|FG001|Six Week Follow-up|Lost to Follow-up|0
1170683|NCT03900416|2303444|FG000|Six Week Follow-up|Withdrawal by Subject|1
1170684|NCT03900416|2303445|FG001|Six Week Follow-up|Withdrawal by Subject|0
1170685|NCT03900416|2303444|FG000|Twelve Week Follow-up|Lost to Follow-up|0
1170686|NCT03900416|2303445|FG001|Twelve Week Follow-up|Lost to Follow-up|2
1170687|NCT03900416|2303444|FG000|Twelve Week Follow-up|Withdrawal by Subject|0
1170688|NCT03900416|2303445|FG001|Twelve Week Follow-up|Withdrawal by Subject|1
1170689|NCT03900416|2303444|FG000|Twelve Week Follow-up|Adverse Event|1
1170690|NCT03900416|2303445|FG001|Twelve Week Follow-up|Adverse Event|1
1170691|NCT03900416|2303444|FG000|Six Month Follow-up|Lost to Follow-up|4
1170692|NCT03900416|2303445|FG001|Six Month Follow-up|Lost to Follow-up|3
1170693|NCT03900416|2303444|FG000|Six Month Follow-up|Withdrawal by Subject|1
1170694|NCT03900416|2303445|FG001|Six Month Follow-up|Withdrawal by Subject|1
1170696|NCT03905863|2303457|FG000|Overall Study|Adverse Event|2
1170697|NCT03905863|2303458|FG001|Overall Study|Adverse Event|4
1170698|NCT03905863|2303457|FG000|Overall Study|Withdrawal by Subject|2
1170699|NCT03905863|2303458|FG001|Overall Study|Withdrawal by Subject|2
1170700|NCT03905863|2303457|FG000|Overall Study|Physician Decision|0
1170701|NCT03905863|2303458|FG001|Overall Study|Physician Decision|3
1170702|NCT03905863|2303457|FG000|Overall Study|Lost to Follow-up|1
1170703|NCT03905863|2303458|FG001|Overall Study|Lost to Follow-up|0
1170704|NCT03905863|2303457|FG000|Overall Study|Protocol Violation|0
1170705|NCT03905863|2303458|FG001|Overall Study|Protocol Violation|2
1170706|NCT03905863|2303457|FG000|Overall Study|Death|0
1170707|NCT03905863|2303458|FG001|Overall Study|Death|1
1170708|NCT03909971|2303499|FG000|Overall Study|Other Reasons Not Specified|0
1170709|NCT03909971|2303500|FG001|Overall Study|Other Reasons Not Specified|1
1170710|NCT03909971|2303499|FG000|Overall Study|Global Deterioration of Health Status|2
1170711|NCT03909971|2303500|FG001|Overall Study|Global Deterioration of Health Status|1
1170712|NCT03909971|2303499|FG000|Overall Study|Progressive Disease|6
1170713|NCT03909971|2303500|FG001|Overall Study|Progressive Disease|14
1170714|NCT03909971|2303499|FG000|Overall Study|Death|2
1170715|NCT03909971|2303500|FG001|Overall Study|Death|6
1170716|NCT03920215|2303511|FG000|Overall Study|Lost to Follow-up|1
1170717|NCT03920215|2303512|FG001|Overall Study|Lost to Follow-up|2
1170718|NCT03920215|2303513|FG002|Overall Study|Lost to Follow-up|0
1170719|NCT03920215|2303514|FG003|Overall Study|Lost to Follow-up|0
1170720|NCT03920215|2303511|FG000|Overall Study|Death|0
1170721|NCT03920215|2303512|FG001|Overall Study|Death|0
1170722|NCT03920215|2303513|FG002|Overall Study|Death|0
1170723|NCT03920215|2303514|FG003|Overall Study|Death|1
1170724|NCT03921151|2303526|FG000|Overall Study|Withdrawal by Subject|11
1170725|NCT03921151|2303527|FG001|Overall Study|Withdrawal by Subject|16
1170726|NCT03927911|2303548|FG000|Overall Study|problems with eDiary|0
1170727|NCT03927911|2303549|FG001|Overall Study|problems with eDiary|1
1170728|NCT03927911|2303550|FG002|Overall Study|problems with eDiary|0
1170729|NCT03927911|2303551|FG003|Overall Study|problems with eDiary|1
1170730|NCT03927911|2303552|FG004|Overall Study|problems with eDiary|0
1170731|NCT03927911|2303553|FG005|Overall Study|problems with eDiary|4
1170732|NCT03927911|2303548|FG000|Overall Study|Adverse Event|0
1170733|NCT03927911|2303549|FG001|Overall Study|Adverse Event|0
1170734|NCT03927911|2303550|FG002|Overall Study|Adverse Event|0
1170735|NCT03927911|2303551|FG003|Overall Study|Adverse Event|0
1170736|NCT03927911|2303552|FG004|Overall Study|Adverse Event|0
1170737|NCT03927911|2303553|FG005|Overall Study|Adverse Event|1
1170738|NCT03927911|2303548|FG000|Overall Study|not treated -study terminated by sponsor|0
1170739|NCT03927911|2303549|FG001|Overall Study|not treated -study terminated by sponsor|1
1170740|NCT03927911|2303550|FG002|Overall Study|not treated -study terminated by sponsor|0
1170741|NCT03927911|2303551|FG003|Overall Study|not treated -study terminated by sponsor|0
1170742|NCT03927911|2303552|FG004|Overall Study|not treated -study terminated by sponsor|0
1170743|NCT03927911|2303553|FG005|Overall Study|not treated -study terminated by sponsor|0
1170744|NCT03927911|2303548|FG000|Overall Study|Surgery cancelled|0
1170745|NCT03927911|2303549|FG001|Overall Study|Surgery cancelled|0
1170746|NCT03927911|2303550|FG002|Overall Study|Surgery cancelled|0
1170747|NCT03927911|2303551|FG003|Overall Study|Surgery cancelled|1
1170748|NCT03927911|2303552|FG004|Overall Study|Surgery cancelled|0
1170749|NCT03927911|2303553|FG005|Overall Study|Surgery cancelled|1
1170750|NCT03927911|2303548|FG000|Overall Study|Protocol Violation|0
1170751|NCT03927911|2303549|FG001|Overall Study|Protocol Violation|0
1170752|NCT03927911|2303550|FG002|Overall Study|Protocol Violation|0
1170753|NCT03927911|2303551|FG003|Overall Study|Protocol Violation|0
1170754|NCT03927911|2303552|FG004|Overall Study|Protocol Violation|0
1170755|NCT03927911|2303553|FG005|Overall Study|Protocol Violation|1
1170756|NCT03938857|2303580|FG000|Overall Study|Physician Decision|1
1170757|NCT03938857|2303581|FG001|Overall Study|Physician Decision|0
1170758|NCT03938857|2303582|FG002|Overall Study|Physician Decision|0
1170759|NCT03938857|2303583|FG003|Overall Study|Physician Decision|0
1170760|NCT03945981|2303597|FG000|Overall Study|Lost to Follow-up|12
1170761|NCT03945981|2303597|FG000|Overall Study|Physician Decision|4
1170762|NCT03945981|2303597|FG000|Overall Study|Withdrawal by Subject|6
1170763|NCT03945981|2303597|FG000|Overall Study|Protocol Violation|1
1170764|NCT03950674|2303626|FG000|Overall Study|Death|3
1170765|NCT03950674|2303627|FG001|Overall Study|Death|7
1170766|NCT03950674|2303626|FG000|Overall Study|Ongoing in Study|22
1170767|NCT03950674|2303627|FG001|Overall Study|Ongoing in Study|8
1170768|NCT03954834|2303638|FG000|Overall Study|Adverse Event|1
1170769|NCT03954834|2303639|FG001|Overall Study|Adverse Event|3
1170770|NCT03954834|2303640|FG002|Overall Study|Adverse Event|1
1170771|NCT03954834|2303641|FG003|Overall Study|Adverse Event|1
1170772|NCT03954834|2303638|FG000|Overall Study|Death|0
1170773|NCT03954834|2303639|FG001|Overall Study|Death|0
1170774|NCT03954834|2303640|FG002|Overall Study|Death|0
1170775|NCT03954834|2303641|FG003|Overall Study|Death|1
1170776|NCT03954834|2303638|FG000|Overall Study|Physician Decision|0
1170777|NCT03954834|2303639|FG001|Overall Study|Physician Decision|1
1170778|NCT03954834|2303640|FG002|Overall Study|Physician Decision|0
1170779|NCT03954834|2303641|FG003|Overall Study|Physician Decision|2
1170780|NCT03954834|2303638|FG000|Overall Study|Protocol Violation|1
1170781|NCT03954834|2303639|FG001|Overall Study|Protocol Violation|0
1170782|NCT03954834|2303640|FG002|Overall Study|Protocol Violation|0
1170783|NCT03954834|2303641|FG003|Overall Study|Protocol Violation|1
1170784|NCT03954834|2303638|FG000|Overall Study|Withdrawal by Subject|2
1170785|NCT03954834|2303639|FG001|Overall Study|Withdrawal by Subject|3
1170786|NCT03954834|2303640|FG002|Overall Study|Withdrawal by Subject|13
1170787|NCT03954834|2303641|FG003|Overall Study|Withdrawal by Subject|6
1170788|NCT03954834|2303638|FG000|Overall Study|Participant left the country|0
1170789|NCT03954834|2303639|FG001|Overall Study|Participant left the country|0
1170790|NCT03954834|2303640|FG002|Overall Study|Participant left the country|1
1170791|NCT03954834|2303641|FG003|Overall Study|Participant left the country|0
1170792|NCT03954834|2303638|FG000|Overall Study|Lost to Follow-up|3
1170793|NCT03954834|2303639|FG001|Overall Study|Lost to Follow-up|2
1170794|NCT03954834|2303640|FG002|Overall Study|Lost to Follow-up|3
1170795|NCT03954834|2303641|FG003|Overall Study|Lost to Follow-up|5
1170796|NCT03961529|2303668|FG000|Overall Study|Adverse Event|13
1170797|NCT03961529|2303669|FG001|Overall Study|Adverse Event|5
1170798|NCT03961529|2303670|FG002|Overall Study|Adverse Event|2
1170799|NCT03961529|2303668|FG000|Overall Study|Withdrawal by Subject|17
1170800|NCT03961529|2303669|FG001|Overall Study|Withdrawal by Subject|2
1170801|NCT03961529|2303670|FG002|Overall Study|Withdrawal by Subject|1
1170802|NCT03961529|2303668|FG000|Overall Study|Withdrawal by parent/guardian|0
1170803|NCT03961529|2303669|FG001|Overall Study|Withdrawal by parent/guardian|7
1170804|NCT03961529|2303670|FG002|Overall Study|Withdrawal by parent/guardian|0
1170805|NCT03961529|2303668|FG000|Overall Study|Physician Decision|2
1170806|NCT03961529|2303669|FG001|Overall Study|Physician Decision|1
1170807|NCT03961529|2303670|FG002|Overall Study|Physician Decision|1
1170808|NCT03961529|2303668|FG000|Overall Study|Lost to Follow-up|2
1170809|NCT03961529|2303669|FG001|Overall Study|Lost to Follow-up|1
1170810|NCT03961529|2303670|FG002|Overall Study|Lost to Follow-up|0
1170811|NCT03961529|2303668|FG000|Overall Study|Lack of Efficacy|2
1170812|NCT03961529|2303669|FG001|Overall Study|Lack of Efficacy|0
1170813|NCT03961529|2303670|FG002|Overall Study|Lack of Efficacy|1
1170814|NCT03961529|2303668|FG000|Overall Study|Other|6
1170815|NCT03961529|2303669|FG001|Overall Study|Other|1
1170816|NCT03961529|2303670|FG002|Overall Study|Other|0
1170817|NCT03968159|2303680|FG000|Overall Study|Adverse Event|4
1170818|NCT03968159|2303681|FG001|Overall Study|Adverse Event|4
1170819|NCT03968159|2303680|FG000|Overall Study|Lost to Follow-up|1
1170820|NCT03968159|2303681|FG001|Overall Study|Lost to Follow-up|1
1170821|NCT03968159|2303680|FG000|Overall Study|Use of prohibited medication|0
1170822|NCT03968159|2303681|FG001|Overall Study|Use of prohibited medication|1
1170823|NCT03968159|2303680|FG000|Overall Study|Protocol Violation|2
1170824|NCT03968159|2303681|FG001|Overall Study|Protocol Violation|2
1170825|NCT03968159|2303680|FG000|Overall Study|Withdrawal by Subject|4
1170826|NCT03968159|2303681|FG001|Overall Study|Withdrawal by Subject|6
1170827|NCT03968159|2303680|FG000|Overall Study|Lack of Efficacy|0
1170828|NCT03968159|2303681|FG001|Overall Study|Lack of Efficacy|1
1170829|NCT03968159|2303680|FG000|Overall Study|Not further specified|2
1170830|NCT03968159|2303681|FG001|Overall Study|Not further specified|0
1170831|NCT03970824|2303699|FG000|Overall Study|Withdrawal by Subject|1
1170832|NCT03970824|2303700|FG001|Overall Study|Withdrawal by Subject|1
1170833|NCT03970824|2303701|FG002|Overall Study|Withdrawal by Subject|3
1170834|NCT03970824|2303699|FG000|Overall Study|Lost to Follow-up|0
1170835|NCT03970824|2303700|FG001|Overall Study|Lost to Follow-up|2
1170836|NCT03970824|2303701|FG002|Overall Study|Lost to Follow-up|1
1170837|NCT03970824|2303699|FG000|Overall Study|Adverse Event|1
1170838|NCT03970824|2303700|FG001|Overall Study|Adverse Event|0
1170839|NCT03970824|2303701|FG002|Overall Study|Adverse Event|0
1170840|NCT03982069|2303747|FG000|Overall Study|Lost to Follow-up|5
1170841|NCT03982069|2303748|FG001|Overall Study|Lost to Follow-up|5
1170842|NCT03982069|2303749|FG002|Overall Study|Lost to Follow-up|3
1170843|NCT03982069|2303750|FG003|Overall Study|Lost to Follow-up|5
1170844|NCT03982069|2303747|FG000|Overall Study|Physician Decision|0
1170845|NCT03982069|2303748|FG001|Overall Study|Physician Decision|1
1170846|NCT03982069|2303749|FG002|Overall Study|Physician Decision|0
1170847|NCT03982069|2303750|FG003|Overall Study|Physician Decision|0
1170848|NCT03982069|2303747|FG000|Overall Study|Withdrawal by Subject|2
1170849|NCT03982069|2303748|FG001|Overall Study|Withdrawal by Subject|1
1170850|NCT03982069|2303749|FG002|Overall Study|Withdrawal by Subject|5
1170851|NCT03982069|2303750|FG003|Overall Study|Withdrawal by Subject|2
1170852|NCT03982069|2303747|FG000|Overall Study|Specimen loss|3
1170853|NCT03982069|2303748|FG001|Overall Study|Specimen loss|3
1170854|NCT03982069|2303749|FG002|Overall Study|Specimen loss|1
1170855|NCT03982069|2303750|FG003|Overall Study|Specimen loss|1
1170856|NCT03989232|2303817|FG000|Overall Study|Lost to Follow-up|3
1170857|NCT03989232|2303818|FG001|Overall Study|Lost to Follow-up|10
1170858|NCT03989232|2303817|FG000|Overall Study|Withdrawal by Subject|6
1170859|NCT03989232|2303818|FG001|Overall Study|Withdrawal by Subject|6
1170860|NCT03989232|2303817|FG000|Overall Study|Death|1
1170861|NCT03989232|2303818|FG001|Overall Study|Death|2
1170862|NCT04006171|2303860|FG000|Overall Study|Withdrawal by Subject|8
1170863|NCT04006171|2303861|FG001|Overall Study|Withdrawal by Subject|7
1170864|NCT04006171|2303860|FG000|Overall Study|missing serum samples|2
1170865|NCT04006171|2303861|FG001|Overall Study|missing serum samples|2
1170866|NCT04006171|2303860|FG000|Overall Study|insufficient sample volume|2
1170867|NCT04006171|2303861|FG001|Overall Study|insufficient sample volume|3
1170868|NCT04013529|2303888|FG000|Overall Study|Withdrawal by Subject|1
1170869|NCT04013529|2303889|FG001|Overall Study|Withdrawal by Subject|1
1170870|NCT04018066|2303904|FG000|Overall Study|participants started taking medications during the study period|3
1170871|NCT04018066|2303904|FG000|Overall Study|participant dropped out due to schedule conflicts.|1
1170872|NCT04041440|2303949|FG000|Overall Study|Withdrawal by Subject|0
1170873|NCT04041440|2303950|FG001|Overall Study|Withdrawal by Subject|1
1170874|NCT04041440|2303949|FG000|Overall Study|Lost to Follow-up|0
1170875|NCT04041440|2303950|FG001|Overall Study|Lost to Follow-up|1
1170876|NCT04041570|2303959|FG000|Overall Study|Moved from Area|0
1170877|NCT04041570|2303960|FG001|Overall Study|Moved from Area|2
1170878|NCT04042077|2303969|FG000|Overall Study|Adverse Event|0
1170879|NCT04042077|2303970|FG001|Overall Study|Adverse Event|1
1170880|NCT04042077|2303969|FG000|Overall Study|Death|2
1170881|NCT04042077|2303970|FG001|Overall Study|Death|1
1170882|NCT04042077|2303969|FG000|Overall Study|Physician Decision|2
1170883|NCT04042077|2303970|FG001|Overall Study|Physician Decision|0
1170884|NCT04042077|2303969|FG000|Overall Study|Withdrawal by Subject|3
1170885|NCT04042077|2303970|FG001|Overall Study|Withdrawal by Subject|2
1170886|NCT04042077|2303969|FG000|Overall Study|Lack of Efficacy|0
1170887|NCT04042077|2303970|FG001|Overall Study|Lack of Efficacy|1
1170888|NCT04043143|2303984|FG000|Overall Study|Lost to Follow-up|5
1170889|NCT04043143|2303985|FG001|Overall Study|Lost to Follow-up|5
1170890|NCT04043143|2303984|FG000|Overall Study|screen failure|1
1170891|NCT04043143|2303985|FG001|Overall Study|screen failure|0
1170892|NCT04052204|2304010|FG000|Overall Study|Death|1
1170893|NCT04052204|2304011|FG001|Overall Study|Death|0
1170894|NCT04052204|2304012|FG002|Overall Study|Death|0
1170895|NCT04052204|2304010|FG000|Overall Study|Progressive disease|1
1170896|NCT04052204|2304011|FG001|Overall Study|Progressive disease|0
1170897|NCT04052204|2304012|FG002|Overall Study|Progressive disease|0
1170898|NCT04052204|2304010|FG000|Overall Study|Other|1
1170899|NCT04052204|2304011|FG001|Overall Study|Other|0
1170900|NCT04052204|2304012|FG002|Overall Study|Other|0
1170901|NCT04067011|2304032|FG000|Overall Study|Not Treated|8
1170902|NCT04067011|2304033|FG001|Overall Study|Not Treated|7
1170903|NCT04067011|2304034|FG002|Overall Study|Not Treated|5
1170904|NCT04067011|2304032|FG000|Overall Study|Adverse Event|2
1170905|NCT04067011|2304033|FG001|Overall Study|Adverse Event|1
1170906|NCT04067011|2304034|FG002|Overall Study|Adverse Event|0
1170907|NCT04067011|2304032|FG000|Overall Study|Withdrawal by Subject|6
1170908|NCT04067011|2304033|FG001|Overall Study|Withdrawal by Subject|2
1170909|NCT04067011|2304034|FG002|Overall Study|Withdrawal by Subject|1
1170910|NCT04067011|2304032|FG000|Overall Study|Lost to Follow-up|0
1170911|NCT04067011|2304033|FG001|Overall Study|Lost to Follow-up|0
1170912|NCT04067011|2304034|FG002|Overall Study|Lost to Follow-up|1
1170913|NCT04067011|2304032|FG000|Overall Study|Physician Decision|1
1170914|NCT04067011|2304033|FG001|Overall Study|Physician Decision|1
1170915|NCT04067011|2304034|FG002|Overall Study|Physician Decision|0
1170916|NCT04067011|2304032|FG000|Overall Study|Other Reasons|2
1170917|NCT04067011|2304033|FG001|Overall Study|Other Reasons|0
1170918|NCT04067011|2304034|FG002|Overall Study|Other Reasons|1
1170919|NCT04067011|2304032|FG000|Overall Study|Missing|0
1170920|NCT04067011|2304033|FG001|Overall Study|Missing|2
1170921|NCT04067011|2304034|FG002|Overall Study|Missing|0
1170922|NCT04072159|2304046|FG000|Overall Study|Lost to Follow-up|6
1170923|NCT04072159|2304047|FG001|Overall Study|Lost to Follow-up|6
1170924|NCT04072159|2304046|FG000|Overall Study|Withdrawal by Subject|2
1170925|NCT04072159|2304047|FG001|Overall Study|Withdrawal by Subject|0
1170926|NCT04094870|2304066|FG000|Overall Study|Lost to Follow-up|1
1170927|NCT04094870|2304067|FG001|Overall Study|Lost to Follow-up|1
1170928|NCT04123405|2304108|FG000|Overall Study|Adverse Event|1
1170929|NCT04123405|2304109|FG001|Overall Study|Adverse Event|2
1170930|NCT04123405|2304110|FG002|Overall Study|Adverse Event|3
1170931|NCT04123405|2304111|FG003|Overall Study|Adverse Event|3
1170932|NCT04123405|2304108|FG000|Overall Study|Exclusion criteria met|1
1170933|NCT04123405|2304109|FG001|Overall Study|Exclusion criteria met|2
1170934|NCT04123405|2304110|FG002|Overall Study|Exclusion criteria met|0
1170935|NCT04123405|2304111|FG003|Overall Study|Exclusion criteria met|2
1170936|NCT04123405|2304108|FG000|Overall Study|Withdrawal by Subject|1
1170937|NCT04123405|2304109|FG001|Overall Study|Withdrawal by Subject|3
1170938|NCT04123405|2304110|FG002|Overall Study|Withdrawal by Subject|0
1170939|NCT04123405|2304111|FG003|Overall Study|Withdrawal by Subject|2
1170940|NCT04123405|2304108|FG000|Overall Study|Contact to subject lost|0
1170941|NCT04123405|2304109|FG001|Overall Study|Contact to subject lost|0
1170942|NCT04123405|2304110|FG002|Overall Study|Contact to subject lost|0
1170943|NCT04123405|2304111|FG003|Overall Study|Contact to subject lost|1
1170944|NCT04123405|2304108|FG000|Overall Study|screening failure|1
1170945|NCT04123405|2304109|FG001|Overall Study|screening failure|0
1170946|NCT04123405|2304110|FG002|Overall Study|screening failure|0
1170947|NCT04123405|2304111|FG003|Overall Study|screening failure|0
1170948|NCT04147715|2304158|FG000|Overall Study|Adverse Event|0
1170949|NCT04147715|2304159|FG001|Overall Study|Adverse Event|0
1170950|NCT04147715|2304160|FG002|Overall Study|Adverse Event|0
1170951|NCT04147715|2304161|FG003|Overall Study|Adverse Event|0
1170952|NCT04147715|2304162|FG004|Overall Study|Adverse Event|0
1170953|NCT04147715|2304163|FG005|Overall Study|Adverse Event|0
1170954|NCT04147715|2304164|FG006|Overall Study|Adverse Event|0
1170955|NCT04147715|2304165|FG007|Overall Study|Adverse Event|2
1170956|NCT04147715|2304166|FG008|Overall Study|Adverse Event|1
1170957|NCT04147715|2304167|FG009|Overall Study|Adverse Event|0
1170958|NCT04147715|2304168|FG010|Overall Study|Adverse Event|0
1170959|NCT04147715|2304169|FG011|Overall Study|Adverse Event|0
1170960|NCT04150068|2304244|FG000|Overall Study|Still on study|24
1170961|NCT04150068|2304245|FG001|Overall Study|Still on study|12
1170962|NCT04150068|2304246|FG002|Overall Study|Still on study|16
1170963|NCT04154605|2304255|FG000|Overall Study|Procedure Canceled|1
1170964|NCT04154605|2304256|FG001|Overall Study|Procedure Canceled|1
1170965|NCT04154605|2304255|FG000|Overall Study|Missed follow up|1
1170966|NCT04154605|2304256|FG001|Overall Study|Missed follow up|1
1170967|NCT04154605|2304255|FG000|Overall Study|Withdrawal by Subject|1
1170968|NCT04154605|2304256|FG001|Overall Study|Withdrawal by Subject|0
1170969|NCT04160091|2304266|FG000|Overall Study|Terminated by Sponsor|7
1170970|NCT04160091|2304267|FG001|Overall Study|Terminated by Sponsor|3
1170971|NCT04160091|2304268|FG002|Overall Study|Terminated by Sponsor|5
1170972|NCT04160091|2304269|FG003|Overall Study|Terminated by Sponsor|2
1170973|NCT04160091|2304266|FG000|Overall Study|Noncompliance|0
1170974|NCT04160091|2304267|FG001|Overall Study|Noncompliance|0
1170975|NCT04160091|2304268|FG002|Overall Study|Noncompliance|0
1170976|NCT04160091|2304269|FG003|Overall Study|Noncompliance|1
1170977|NCT04160091|2304266|FG000|Overall Study|Withdrawal by Subject|0
1170978|NCT04160091|2304267|FG001|Overall Study|Withdrawal by Subject|0
1170979|NCT04160091|2304268|FG002|Overall Study|Withdrawal by Subject|0
1170980|NCT04160091|2304269|FG003|Overall Study|Withdrawal by Subject|1
1170981|NCT04164758|2304286|FG000|Overall Study|COVID-19 withdrawal of consent|1
1170982|NCT04164758|2304287|FG001|Overall Study|COVID-19 withdrawal of consent|0
1170983|NCT04164758|2304288|FG002|Overall Study|COVID-19 withdrawal of consent|0
1170984|NCT04164758|2304286|FG000|Overall Study|Adverse Event|0
1170985|NCT04164758|2304287|FG001|Overall Study|Adverse Event|1
1170986|NCT04164758|2304288|FG002|Overall Study|Adverse Event|0
1170987|NCT04165031|2304302|FG000|Overall Study|Adverse Event|1
1170988|NCT04165031|2304303|FG001|Overall Study|Adverse Event|1
1170989|NCT04165031|2304304|FG002|Overall Study|Adverse Event|0
1170990|NCT04165031|2304305|FG003|Overall Study|Adverse Event|0
1170991|NCT04165031|2304306|FG004|Overall Study|Adverse Event|0
1170992|NCT04165031|2304307|FG005|Overall Study|Adverse Event|0
1170993|NCT04165031|2304302|FG000|Overall Study|Withdrawal by Subject|0
1170994|NCT04165031|2304303|FG001|Overall Study|Withdrawal by Subject|0
1170995|NCT04165031|2304304|FG002|Overall Study|Withdrawal by Subject|1
1170996|NCT04165031|2304305|FG003|Overall Study|Withdrawal by Subject|0
1170997|NCT04165031|2304306|FG004|Overall Study|Withdrawal by Subject|0
1170998|NCT04165031|2304307|FG005|Overall Study|Withdrawal by Subject|0
1170999|NCT04171414|2304326|FG000|Overall Study|Death|1
1171000|NCT04171414|2304326|FG000|Overall Study|Withdrawal by Subject|1
1171001|NCT04175808|2304330|FG000|Part A|Miscellaneous|2
1171002|NCT04175808|2304331|FG001|Part A|Miscellaneous|0
1171003|NCT04175808|2304332|FG002|Part A|Miscellaneous|0
1171004|NCT04175808|2304333|FG003|Part A|Miscellaneous|0
1171005|NCT04175808|2304334|FG004|Part A|Miscellaneous|0
1171006|NCT04175808|2304335|FG005|Part A|Miscellaneous|0
1171007|NCT04175808|2304336|FG006|Part A|Miscellaneous|0
1171008|NCT04178720|2304354|FG000|Overall Study|Withdrawal by Subject|2
1171009|NCT04178720|2304355|FG001|Overall Study|Withdrawal by Subject|0
1171010|NCT04178720|2304354|FG000|Overall Study|Relocation|0
1171011|NCT04178720|2304355|FG001|Overall Study|Relocation|1
1171012|NCT04218110|2304398|FG000|Overall Study|Withdrawal by Subject|0
1171013|NCT04218110|2304399|FG001|Overall Study|Withdrawal by Subject|0
1171014|NCT04218110|2304400|FG002|Overall Study|Withdrawal by Subject|0
1171015|NCT04218110|2304401|FG003|Overall Study|Withdrawal by Subject|1
1171016|NCT04222725|2304415|FG000|Overall Study|Adverse Event|0
1171017|NCT04222725|2304416|FG001|Overall Study|Adverse Event|1
1171018|NCT04222725|2304417|FG002|Overall Study|Adverse Event|0
1171019|NCT04222725|2304418|FG003|Overall Study|Adverse Event|0
1171020|NCT04231825|2304490|FG000|Overall Study|Protocol Violation|3
1171021|NCT04231825|2304491|FG001|Overall Study|Protocol Violation|3
1171022|NCT04231825|2304490|FG000|Overall Study|Lost to Follow-up|0
1171023|NCT04231825|2304491|FG001|Overall Study|Lost to Follow-up|1
1171024|NCT04258995|2304522|FG000|Overall Study|Lost to Follow-up|1
1171025|NCT04258995|2304523|FG001|Overall Study|Lost to Follow-up|1
1171026|NCT04317040|2304562|FG000|Overall Study|Lost to Follow-up|2
1171027|NCT04317040|2304563|FG001|Overall Study|Lost to Follow-up|0
1171028|NCT04317040|2304562|FG000|Overall Study|Death|16
1171029|NCT04317040|2304563|FG001|Overall Study|Death|18
1171030|NCT04317040|2304562|FG000|Overall Study|Withdrawal by Subject|0
1171031|NCT04317040|2304563|FG001|Overall Study|Withdrawal by Subject|1
1171032|NCT04317040|2304562|FG000|Overall Study|Incomplete assessments|0
1171033|NCT04317040|2304563|FG001|Overall Study|Incomplete assessments|1
1171034|NCT04319159|2304580|FG000|Overall Study|Screening failure|13
1171035|NCT04319159|2304580|FG000|Overall Study|Re-screening due to COVID-19 implications|2
1171036|NCT04319159|2304580|FG000|Overall Study|Withdrawal by Subject|1
1171037|NCT04331899|2304610|FG000|Trial Period (28 Days)|Withdrawal by Subject|2
1171038|NCT04331899|2304611|FG001|Trial Period (28 Days)|Withdrawal by Subject|2
1171039|NCT04334148|2304619|FG000|Overall Study|positive nasal swab at baseline|0
1171040|NCT04334148|2304620|FG001|Overall Study|positive nasal swab at baseline|1
1171041|NCT04347954|2304640|FG000|Overall Study|Did not present to study site for allocated intervention|3
1171042|NCT04347954|2304641|FG001|Overall Study|Did not present to study site for allocated intervention|0
1171043|NCT04347954|2304642|FG002|Overall Study|Did not present to study site for allocated intervention|3
1171044|NCT04347954|2304640|FG000|Overall Study|Lost to Follow-up|0
1171045|NCT04347954|2304641|FG001|Overall Study|Lost to Follow-up|1
1171046|NCT04347954|2304642|FG002|Overall Study|Lost to Follow-up|0
1171047|NCT04349098|2304652|FG000|Overall Study|Death|16
1171048|NCT04349098|2304653|FG001|Overall Study|Death|8
1171049|NCT04349098|2304652|FG000|Overall Study|Lost to Follow-up|11
1171050|NCT04349098|2304653|FG001|Overall Study|Lost to Follow-up|8
1171051|NCT04349098|2304652|FG000|Overall Study|Withdrawal by Subject|8
1171052|NCT04349098|2304653|FG001|Overall Study|Withdrawal by Subject|5
1171053|NCT04349098|2304652|FG000|Overall Study|Other|3
1171054|NCT04349098|2304653|FG001|Overall Study|Other|5
1171055|NCT04353037|2304663|FG000|Overall Study|Lost to Follow-up|0
1171056|NCT04353037|2304664|FG001|Overall Study|Lost to Follow-up|1
1171057|NCT04353037|2304665|FG002|Overall Study|Lost to Follow-up|2
1171058|NCT04353037|2304666|FG003|Overall Study|Lost to Follow-up|3
1171059|NCT04353037|2304663|FG000|Overall Study|Withdrawal by Subject|0
1171060|NCT04353037|2304664|FG001|Overall Study|Withdrawal by Subject|2
1171061|NCT04353037|2304665|FG002|Overall Study|Withdrawal by Subject|3
1171062|NCT04353037|2304666|FG003|Overall Study|Withdrawal by Subject|5
1171063|NCT04353037|2304663|FG000|Overall Study|Adverse Event|0
1171064|NCT04353037|2304664|FG001|Overall Study|Adverse Event|0
1171065|NCT04353037|2304665|FG002|Overall Study|Adverse Event|2
1171066|NCT04353037|2304666|FG003|Overall Study|Adverse Event|0
1171067|NCT04353037|2304663|FG000|Overall Study|Exposure Change|0
1171068|NCT04353037|2304664|FG001|Overall Study|Exposure Change|0
1171069|NCT04353037|2304665|FG002|Overall Study|Exposure Change|0
1171070|NCT04353037|2304666|FG003|Overall Study|Exposure Change|2
1171071|NCT04355767|2304686|FG000|Overall Study|Withdrawal by Subject|2
1171072|NCT04355767|2304687|FG001|Overall Study|Withdrawal by Subject|2
1171073|NCT04355767|2304686|FG000|Overall Study|Death|5
1171074|NCT04355767|2304687|FG001|Overall Study|Death|1
1171075|NCT04356573|2304695|FG000|Overall Study|Didn't Qualify|1
1171076|NCT04356573|2304696|FG001|Overall Study|Didn't Qualify|0
1171077|NCT04358068|2304708|FG000|Overall Study|Did not initiate study treatment|2
1171078|NCT04358068|2304709|FG001|Overall Study|Did not initiate study treatment|2
1171079|NCT04366349|2304721|FG000|Overall Study|Withdrawal by Subject|1
1171080|NCT04366349|2304722|FG001|Overall Study|Withdrawal by Subject|0
1171081|NCT04366349|2304723|FG002|Overall Study|Withdrawal by Subject|0
1171082|NCT04366349|2304724|FG003|Overall Study|Withdrawal by Subject|0
1171083|NCT04366349|2304725|FG004|Overall Study|Withdrawal by Subject|0
1171084|NCT04366349|2304726|FG005|Overall Study|Withdrawal by Subject|0
1171085|NCT04382053|2304770|FG000|Overall Study|Death|6
1171086|NCT04382053|2304771|FG001|Overall Study|Death|8
870431|NCT00529789|1831517|FG000|Study Period II/III|Parent/Caregiver Decision|9
870432|NCT00529789|1831517|FG000|Study Period II/III|Adverse Event|3
870433|NCT00529789|1831517|FG000|Study Period II/III|Lack of Efficacy|2
870434|NCT00529789|1831517|FG000|Study Period II/III|Withdrawal by Subject|1
870435|NCT00529789|1831517|FG000|Study Period II/III|Protocol Violation|3
870436|NCT00529789|1831517|FG000|Study Period II/III|Physician Decision|3
870437|NCT00529789|1831517|FG000|Study Period II/III|Lost to Follow-up|3
870438|NCT00529789|1831517|FG000|Study Period IV|Parent/Caregiver Decision|1
870439|NCT00529789|1831517|FG000|Study Period IV|Adverse Event|1
870440|NCT00529789|1831517|FG000|Study Period IV|Lack of Efficacy|1
870441|NCT00529789|1831517|FG000|Study Period IV|Lost to Follow-up|3
870442|NCT00529802|1831527|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
1171087|NCT04382053|2304770|FG000|Overall Study|Lost to Follow-up|0
1171088|NCT04382053|2304771|FG001|Overall Study|Lost to Follow-up|2
1171089|NCT04382053|2304770|FG000|Overall Study|Protocol Deviation|1
1171090|NCT04382053|2304771|FG001|Overall Study|Protocol Deviation|2
1171091|NCT04382053|2304770|FG000|Overall Study|Withdrawal by Subject|2
1171092|NCT04382053|2304771|FG001|Overall Study|Withdrawal by Subject|1
1171093|NCT04388826|2304780|FG000|Overall Study|Lost to Follow-up|3
870443|NCT00529802|1831527|FG000|Evaluable for Primary Endpoint|Worsening performance status|2
870444|NCT00529802|1831527|FG000|Evaluable for Primary Endpoint|Adverse Event|2
870445|NCT00529802|1831527|FG000|Evaluable for Primary Endpoint|Death|1
1171094|NCT04388826|2304781|FG001|Overall Study|Lost to Follow-up|2
1171095|NCT04388826|2304780|FG000|Overall Study|Adverse Event|1
1171096|NCT04388826|2304781|FG001|Overall Study|Adverse Event|0
1171097|NCT04398732|2304804|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50
1171098|NCT04401293|2304812|FG000|Overall Study|Withdrawal by Subject|1
1171099|NCT04401293|2304813|FG001|Overall Study|Withdrawal by Subject|3
1171100|NCT04411628|2304823|FG000|Overall Study|Withdrawal by Subject|1
1171101|NCT04411628|2304824|FG001|Overall Study|Withdrawal by Subject|1
1171102|NCT04411628|2304825|FG002|Overall Study|Withdrawal by Subject|2
1171103|NCT04411628|2304826|FG003|Overall Study|Withdrawal by Subject|0
1171104|NCT04411628|2304823|FG000|Overall Study|Lost to Follow-up|0
1171105|NCT04411628|2304824|FG001|Overall Study|Lost to Follow-up|1
1171106|NCT04411628|2304825|FG002|Overall Study|Lost to Follow-up|0
1171107|NCT04411628|2304826|FG003|Overall Study|Lost to Follow-up|0
1171110|NCT04428411|2304888|FG000|Overall Study|Lost to Follow-up|114
1171111|NCT04435184|2304897|FG000|Overall Study|follow-up blood draws missing|3
1171112|NCT04435184|2304898|FG001|Overall Study|follow-up blood draws missing|5
1171113|NCT04476784|2304906|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1
1171114|NCT04476784|2304907|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0
1171115|NCT04492475|2304938|FG000|Overall Study|Enrolled but not treated|8
1171116|NCT04492475|2304939|FG001|Overall Study|Enrolled but not treated|8
1171117|NCT04492475|2304938|FG000|Overall Study|Withdrawal by Subject|4
1171118|NCT04492475|2304939|FG001|Overall Study|Withdrawal by Subject|0
1171119|NCT04492475|2304938|FG000|Overall Study|Became ineligible after enrollment|2
1171120|NCT04492475|2304939|FG001|Overall Study|Became ineligible after enrollment|0
1171121|NCT04495283|2304955|FG000|Overall Study|Physician Decision|0
1171122|NCT04495283|2304956|FG001|Overall Study|Physician Decision|0
1171123|NCT04495283|2304957|FG002|Overall Study|Physician Decision|1
1171124|NCT04495283|2304955|FG000|Overall Study|Withdrawal by Subject|0
1171125|NCT04495283|2304956|FG001|Overall Study|Withdrawal by Subject|1
1171126|NCT04495283|2304957|FG002|Overall Study|Withdrawal by Subject|1
1171127|NCT04495283|2304955|FG000|Overall Study|Other|1
1171128|NCT04495283|2304956|FG001|Overall Study|Other|0
1171129|NCT04495283|2304957|FG002|Overall Study|Other|1
1171130|NCT04497948|2304968|FG000|Overall Study|Death|2
1171131|NCT04501952|2304995|FG000|Overall Study|Adverse Event|0
1171132|NCT04501952|2304996|FG001|Overall Study|Adverse Event|3
1171133|NCT04501952|2304995|FG000|Overall Study|Investigator's Discretion|0
1171134|NCT04501952|2304996|FG001|Overall Study|Investigator's Discretion|1
1171135|NCT04501952|2304995|FG000|Overall Study|Protocol Violation|1
1171136|NCT04501952|2304996|FG001|Overall Study|Protocol Violation|1
1171137|NCT04501952|2304995|FG000|Overall Study|Withdrew Consent|5
1171138|NCT04501952|2304996|FG001|Overall Study|Withdrew Consent|4
1171139|NCT04501952|2304995|FG000|Overall Study|Lost to Follow-up|7
1171140|NCT04501952|2304996|FG001|Overall Study|Lost to Follow-up|2
1171141|NCT04501952|2304995|FG000|Overall Study|Randomized and Never Treated|13
1171142|NCT04501952|2304996|FG001|Overall Study|Randomized and Never Treated|9
1171143|NCT04504032|2305005|FG000|Overall Study|Adverse Event|1
1171144|NCT04504032|2305006|FG001|Overall Study|Adverse Event|2
1171145|NCT04504032|2305005|FG000|Overall Study|Lost to Follow-up|6
1171146|NCT04504032|2305006|FG001|Overall Study|Lost to Follow-up|9
1171147|NCT04504032|2305005|FG000|Overall Study|Protocol Violation|2
1171148|NCT04504032|2305006|FG001|Overall Study|Protocol Violation|0
1171149|NCT04504032|2305005|FG000|Overall Study|Study terminated by sponsor|1
1171150|NCT04504032|2305006|FG001|Overall Study|Study terminated by sponsor|2
1171151|NCT04504032|2305005|FG000|Overall Study|Withdrawal by Subject|9
1171152|NCT04504032|2305006|FG001|Overall Study|Withdrawal by Subject|11
1171153|NCT04504032|2305005|FG000|Overall Study|Disease progression prior to dosing|15
1171154|NCT04504032|2305006|FG001|Overall Study|Disease progression prior to dosing|3
1171155|NCT04504032|2305005|FG000|Overall Study|Drug supply issues|1
1171156|NCT04504032|2305006|FG001|Overall Study|Drug supply issues|1
1171157|NCT04504032|2305005|FG000|Overall Study|Progressed to moderate/severe COVID-19|1
1171158|NCT04504032|2305006|FG001|Overall Study|Progressed to moderate/severe COVID-19|0
1171159|NCT04507763|2305012|FG000|Overall Study|Participants did not meet entrance criteria|201
1171160|NCT04507867|2305021|FG000|Overall Study|Death|7
1171161|NCT04507867|2305022|FG001|Overall Study|Death|1
1171168|NCT04527978|2305076|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1
1171169|NCT04527978|2305077|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0
1171170|NCT04529109|2305098|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0
1171171|NCT04529109|2305099|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1
1171172|NCT04537234|2305118|FG000|Overall Study|Withdrawal by Subject|2
1171173|NCT04537234|2305119|FG001|Overall Study|Withdrawal by Subject|0
1171174|NCT04573972|2305207|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32
1171175|NCT04573972|2305208|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14
1171176|NCT04601103|2305243|FG000|Overall Study|Needed crown & cleaning|0
1171177|NCT04601103|2305244|FG001|Overall Study|Needed crown & cleaning|0
1171178|NCT04601103|2305245|FG002|Overall Study|Needed crown & cleaning|1
1171179|NCT04601103|2305243|FG000|Overall Study|study was terminated|18
1171180|NCT04601103|2305244|FG001|Overall Study|study was terminated|18
1171181|NCT04601103|2305245|FG002|Overall Study|study was terminated|16
1171182|NCT04664855|2305273|FG000|Overall Study|Withdrawal by Subject|0
1171183|NCT04664855|2305274|FG001|Overall Study|Withdrawal by Subject|2
1171184|NCT04701658|2305280|FG000|Overall Study|Lost to Follow-up|6
1171185|NCT04706416|2305286|FG000|Overall Study|Lost to Follow-up|2
1171186|NCT04706416|2305287|FG001|Overall Study|Lost to Follow-up|0
1171187|NCT04727749|2305316|FG000|Overall Study|Lost to Follow-up|10
1171188|NCT04727749|2305317|FG001|Overall Study|Lost to Follow-up|3
1171189|NCT04854707|2305339|FG000|Overall Study|Lack of Efficacy|78
1171190|NCT04854707|2305340|FG001|Overall Study|Lack of Efficacy|59
1171191|NCT04854707|2305341|FG002|Overall Study|Lack of Efficacy|30
1171192|NCT04947436|2305436|FG000|Overall Study|Lost to Follow-up|3
1171193|NCT04947436|2305437|FG001|Overall Study|Lost to Follow-up|7
1171194|NCT04947436|2305438|FG002|Overall Study|Lost to Follow-up|5
1171195|NCT04947436|2305436|FG000|Overall Study|Death|1
1171196|NCT04947436|2305437|FG001|Overall Study|Death|1
1171197|NCT04947436|2305438|FG002|Overall Study|Death|1
1171198|NCT05002972|2305446|FG000|Overall Study|Withdrawal by Subject|2
1171199|NCT05002985|2305450|FG000|Overall Study|Withdrawal by Subject|1
1171200|NCT04512482|2305456|FG000|Second Intervention (1 Day)|Protocol Violation|2
1171201|NCT04512482|2305457|FG001|Second Intervention (1 Day)|Protocol Violation|1
1171202|NCT04523831|2305482|FG000|Overall Study|Lost to Follow-up|15
1171203|NCT04523831|2305483|FG001|Overall Study|Lost to Follow-up|17
1171204|NCT04523831|2305482|FG000|Overall Study|Death|0
1171205|NCT04523831|2305483|FG001|Overall Study|Death|3
1171206|NCT04523831|2305482|FG000|Overall Study|Adverse Event|2
1171207|NCT04523831|2305483|FG001|Overall Study|Adverse Event|0
1171208|NCT04521777|2305492|FG000|Overall Study|Death|2
1171209|NCT04521777|2305492|FG000|Overall Study|Withdrawal by Subject|2
1171210|NCT04507776|2305522|FG000|Overall Study|Participants did not meet the entrance criteria|201
1171211|NCT04502979|2305533|FG000|Overall Study|Lost to Follow-up|1
1171212|NCT04502979|2305534|FG001|Overall Study|Lost to Follow-up|3
1171213|NCT04502979|2305533|FG000|Overall Study|Withdrawal by Subject|2
1171214|NCT04502979|2305534|FG001|Overall Study|Withdrawal by Subject|1
1171215|NCT04498403|2305577|FG000|Overall Study|Adverse Event|1
1171216|NCT04498403|2305578|FG001|Overall Study|Adverse Event|0
1171217|NCT04498403|2305577|FG000|Overall Study|Study Terminated By Sponsor|29
1171218|NCT04498403|2305578|FG001|Overall Study|Study Terminated By Sponsor|10
1171219|NCT04495374|2305586|FG000|Overall Study|Protocol Violation|2
1171220|NCT04495374|2305587|FG001|Overall Study|Protocol Violation|1
1171221|NCT04491994|2305611|FG000|Overall Study|Withdrawal by Subject|10
1171222|NCT04491994|2305612|FG001|Overall Study|Withdrawal by Subject|5
1171223|NCT04491994|2305611|FG000|Overall Study|developed fever > 3 days|4
1171224|NCT04491994|2305612|FG001|Overall Study|developed fever > 3 days|1
1171225|NCT04491994|2305611|FG000|Overall Study|Protocol Violation|11
1171226|NCT04491994|2305612|FG001|Overall Study|Protocol Violation|2
1171227|NCT04491994|2305611|FG000|Overall Study|Lost to Follow-up|4
1171228|NCT04491994|2305612|FG001|Overall Study|Lost to Follow-up|3
1171229|NCT04490499|2305635|FG000|Overall Study|Withdrawal by Subject|2
1171230|NCT04486235|2305645|FG000|Overall Study|Pregnancy|1
1171231|NCT04486235|2305646|FG001|Overall Study|Pregnancy|0
1171232|NCT04486235|2305645|FG000|Overall Study|Lost to Follow-up|1
1171233|NCT04486235|2305646|FG001|Overall Study|Lost to Follow-up|0
1171234|NCT04483011|2305655|FG000|Washout (7 Days)|Withdrawal by Subject|0
1171235|NCT04483011|2305656|FG001|Washout (7 Days)|Withdrawal by Subject|1
1171236|NCT04475588|2305666|FG000|Overall Study|Adverse Event|2
1171237|NCT04475588|2305667|FG001|Overall Study|Adverse Event|0
1171238|NCT04474405|2305693|FG000|Overall Study|Withdrawal by Subject|0
1171239|NCT04474405|2305694|FG001|Overall Study|Withdrawal by Subject|0
1171240|NCT04474405|2305695|FG002|Overall Study|Withdrawal by Subject|1
1171241|NCT04474405|2305696|FG003|Overall Study|Withdrawal by Subject|0
1171242|NCT04474405|2305697|FG004|Overall Study|Withdrawal by Subject|1
1171243|NCT04474405|2305698|FG005|Overall Study|Withdrawal by Subject|0
1171244|NCT04474405|2305693|FG000|Overall Study|Other|0
1171245|NCT04474405|2305694|FG001|Overall Study|Other|0
1171246|NCT04474405|2305695|FG002|Overall Study|Other|0
1171247|NCT04474405|2305696|FG003|Overall Study|Other|0
1171248|NCT04474405|2305697|FG004|Overall Study|Other|3
1171249|NCT04474405|2305698|FG005|Overall Study|Other|0
1171250|NCT04468347|2305720|FG000|Overall Study|Withdrawal by Subject|0
1171251|NCT04468347|2305721|FG001|Overall Study|Withdrawal by Subject|1
1171252|NCT04468347|2305722|FG002|Overall Study|Withdrawal by Subject|3
1171253|NCT04468347|2305723|FG003|Overall Study|Withdrawal by Subject|3
1171254|NCT04468347|2305720|FG000|Overall Study|Lost to Follow-up|0
1171255|NCT04468347|2305721|FG001|Overall Study|Lost to Follow-up|0
1171256|NCT04468347|2305722|FG002|Overall Study|Lost to Follow-up|1
1171257|NCT04468347|2305723|FG003|Overall Study|Lost to Follow-up|1
1171258|NCT04468347|2305720|FG000|Overall Study|Physician Decision|1
1171259|NCT04468347|2305721|FG001|Overall Study|Physician Decision|0
1171260|NCT04468347|2305722|FG002|Overall Study|Physician Decision|2
1171261|NCT04468347|2305723|FG003|Overall Study|Physician Decision|0
1171262|NCT04468347|2305720|FG000|Overall Study|Protocol Violation|1
1171263|NCT04468347|2305721|FG001|Overall Study|Protocol Violation|0
1171264|NCT04468347|2305722|FG002|Overall Study|Protocol Violation|0
1171265|NCT04468347|2305723|FG003|Overall Study|Protocol Violation|0
1171266|NCT04465422|2305748|FG000|Overall Study|Lost to Follow-up|0
1171267|NCT04465422|2305749|FG001|Overall Study|Lost to Follow-up|2
1171268|NCT04463069|2305768|FG000|Overall Study|Withdrawal by Subject|2
1171269|NCT04463069|2305769|FG001|Overall Study|Withdrawal by Subject|10
1171270|NCT04463069|2305768|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0
1171271|NCT04463069|2305769|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13
1171272|NCT04448561|2305777|FG000|Overall Study|Noncompliance|1
1171273|NCT04448561|2305778|FG001|Overall Study|Noncompliance|0
1171274|NCT04450381|2305853|FG000|Overall Study|Protocol Violation|4
1171275|NCT04450381|2305853|FG000|Overall Study|Wrong device setting|2
1171276|NCT04449341|2305859|FG000|Overall Study|Protocol Violation|1
1171277|NCT04449341|2305860|FG001|Overall Study|Protocol Violation|0
1171280|NCT04440449|2305886|FG000|Overall Study|Lost to Follow-up|2
1171281|NCT04440449|2305887|FG001|Overall Study|Lost to Follow-up|0
1171282|NCT04439344|2305894|FG000|Overall Study|Never started threapy|3
1171283|NCT04439344|2305894|FG000|Overall Study|Ineligible|3
1171284|NCT04439344|2305894|FG000|Overall Study|Adverse Event|13
1171285|NCT04439344|2305894|FG000|Overall Study|Death|2
1171286|NCT04439344|2305894|FG000|Overall Study|Disease progression|29
1171287|NCT04439344|2305894|FG000|Overall Study|Withdrawal by Subject|2
1171288|NCT04439344|2305894|FG000|Overall Study|Alternative therapy|1
1171289|NCT04439123|2305898|FG000|Overall Study|Adverse Event|11
1171290|NCT04439123|2305898|FG000|Overall Study|Death|1
1171291|NCT04439123|2305898|FG000|Overall Study|Disease progression|19
1171292|NCT04439123|2305898|FG000|Overall Study|Withdrawal by Subject|2
1171293|NCT04439123|2305898|FG000|Overall Study|Still on treatment|2
1171294|NCT04439214|2305902|FG000|Overall Study|Adverse Event|13
1171295|NCT04439214|2305902|FG000|Overall Study|Disease progression|16
1171296|NCT04439214|2305902|FG000|Overall Study|Death|1
1171297|NCT04439214|2305902|FG000|Overall Study|Withdrawal by Subject|2
1171298|NCT04439214|2305902|FG000|Overall Study|Declining health|1
1171299|NCT04439214|2305902|FG000|Overall Study|Still receiving treatment at the time of the analysis|9
1171300|NCT04439214|2305902|FG000|Overall Study|Ineligible|5
1171301|NCT04439279|2305906|FG000|Overall Study|Adverse Event|7
1171302|NCT04439279|2305906|FG000|Overall Study|Death|4
1171303|NCT04439279|2305906|FG000|Overall Study|Disease progression|17
1171304|NCT04439279|2305906|FG000|Overall Study|Complicating disease|3
1171305|NCT04439279|2305906|FG000|Overall Study|Withdrawal by Subject|2
1171306|NCT04439279|2305906|FG000|Overall Study|Ineligible|1
1171307|NCT04439279|2305906|FG000|Overall Study|Treatment still ongoing|1
1171308|NCT04439240|2305910|FG000|Overall Study|Ineligible|2
1171309|NCT04439240|2305910|FG000|Overall Study|Never started treatment|2
1171310|NCT04439240|2305910|FG000|Overall Study|Adverse Event|12
1171311|NCT04439240|2305910|FG000|Overall Study|Death|2
1171312|NCT04439240|2305910|FG000|Overall Study|Disease progression|25
1171313|NCT04439240|2305910|FG000|Overall Study|Other diseases|2
1171314|NCT04439240|2305910|FG000|Overall Study|Withdrawal by Subject|3
1171315|NCT04439240|2305910|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1
1171316|NCT04439240|2305910|FG000|Overall Study|Symptomatic decline|1
1171317|NCT04439240|2305910|FG000|Overall Study|Pogression of the lymphadenopathy|1
1171318|NCT04439240|2305910|FG000|Overall Study|Clinical progression|1
1171328|NCT04438785|2305920|FG000|Overall Study|change of weight, give up intervention|2
1171329|NCT04438785|2305921|FG001|Overall Study|change of weight, give up intervention|10
1171330|NCT04435808|2305929|FG000|Overall Study|Study stopped by DSMB|0
1171331|NCT04435808|2305930|FG001|Overall Study|Study stopped by DSMB|1
1171332|NCT04428502|2306019|FG000|Overall Study|Did not meet entrance criteria|14
1171333|NCT04428424|2306024|FG000|Overall Study|Does not meet entrance criteria|132
1171334|NCT04428424|2306024|FG000|Overall Study|Lost to Follow-up|115
1171335|NCT04425863|2306068|FG000|Overall Study|Death|0
1171336|NCT04425863|2306069|FG001|Overall Study|Death|0
1171337|NCT04425863|2306070|FG002|Overall Study|Death|1
1171338|NCT04422561|2306103|FG000|Overall Study|Lost to Follow-up|25
1171339|NCT04422561|2306104|FG001|Overall Study|Lost to Follow-up|11
1171340|NCT04419311|2306121|FG000|Overall Study|Lost to Follow-up|1
1171341|NCT04419311|2306122|FG001|Overall Study|Lost to Follow-up|0
1171342|NCT04411667|2306142|FG000|Overall Study|Physician Decision|1
1171343|NCT04411667|2306143|FG001|Overall Study|Physician Decision|0
1171344|NCT04407507|2306155|FG000|Overall Study|Withdrawal by Subject|0
1171345|NCT04407507|2306156|FG001|Overall Study|Withdrawal by Subject|1
1171346|NCT04406194|2306164|FG000|Period 1|Withdrawal by Subject|0
1171347|NCT04406194|2306165|FG001|Period 1|Withdrawal by Subject|1
1171348|NCT04404010|2306185|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1
1171349|NCT04404010|2306186|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0
1171350|NCT04403399|2306196|FG000|Period 2|Physician Decision|0
1171351|NCT04403399|2306197|FG001|Period 2|Physician Decision|1
1171352|NCT04401202|2306227|FG000|Overall Study|Lost to Follow-up|2
1171353|NCT04401202|2306228|FG001|Overall Study|Lost to Follow-up|2
1171354|NCT04401202|2306227|FG000|Overall Study|Adverse Event|0
1171355|NCT04401202|2306228|FG001|Overall Study|Adverse Event|1
1171356|NCT04401202|2306227|FG000|Overall Study|Hospitalized|4
1171357|NCT04401202|2306228|FG001|Overall Study|Hospitalized|1
1171358|NCT04401579|2306237|FG000|Overall Study|Death|23
1171359|NCT04401579|2306238|FG001|Overall Study|Death|36
1171360|NCT04401579|2306237|FG000|Overall Study|Lost to Follow-up|40
1171361|NCT04401579|2306238|FG001|Overall Study|Lost to Follow-up|41
1171362|NCT04401579|2306237|FG000|Overall Study|Withdrawal by Subject|8
1171363|NCT04401579|2306238|FG001|Overall Study|Withdrawal by Subject|16
1171364|NCT04401579|2306237|FG000|Overall Study|Physician Decision|1
1171365|NCT04401579|2306238|FG001|Overall Study|Physician Decision|2
1171366|NCT04401579|2306237|FG000|Overall Study|Became ineligible after enrollment|1
1171367|NCT04401579|2306238|FG001|Overall Study|Became ineligible after enrollment|1
1171368|NCT04401579|2306237|FG000|Overall Study|Enrolled but treatment not administered|7
1171369|NCT04401579|2306238|FG001|Overall Study|Enrolled but treatment not administered|9
1171370|NCT04401579|2306237|FG000|Overall Study|Adverse Event|2
1171371|NCT04401579|2306238|FG001|Overall Study|Adverse Event|1
1171372|NCT04401579|2306237|FG000|Overall Study|Scheduling error|1
1171373|NCT04401579|2306238|FG001|Overall Study|Scheduling error|2
1171374|NCT04401579|2306237|FG000|Overall Study|Transferred to another hospital|1
1171375|NCT04401579|2306238|FG001|Overall Study|Transferred to another hospital|2
1171376|NCT04400682|2306246|FG000|Period 1|Withdrawal by Subject|1
1171377|NCT04400682|2306247|FG001|Period 1|Withdrawal by Subject|4
1171378|NCT04399161|2306256|FG000|Overall Study|Withdrawal by Subject|1
1171379|NCT04399161|2306257|FG001|Overall Study|Withdrawal by Subject|0
1171380|NCT04399161|2306258|FG002|Overall Study|Withdrawal by Subject|2
1171381|NCT04399161|2306256|FG000|Overall Study|Protocol Violation|1
1171382|NCT04399161|2306257|FG001|Overall Study|Protocol Violation|2
1171383|NCT04399161|2306258|FG002|Overall Study|Protocol Violation|0
1171384|NCT04399122|2306277|FG000|Overall Study|Lost to Follow-up|2
1171385|NCT04399122|2306278|FG001|Overall Study|Lost to Follow-up|0
1171386|NCT04399122|2306277|FG000|Overall Study|Withdrawal by Subject|1
1171387|NCT04399122|2306278|FG001|Overall Study|Withdrawal by Subject|0
1171388|NCT04397445|2306284|FG000|Overall Study|Withdrawal by Subject|1
1171389|NCT04397445|2306285|FG001|Overall Study|Withdrawal by Subject|0
1171390|NCT04397445|2306286|FG002|Overall Study|Withdrawal by Subject|0
1171391|NCT04397445|2306287|FG003|Overall Study|Withdrawal by Subject|0
1171392|NCT04396639|2306313|FG000|Overall Study|Withdrawal by Subject|1
1171393|NCT04396639|2306313|FG000|Overall Study|Other|1
1171394|NCT04393493|2306332|FG000|First 4 Days of Intervention|Early improvement|5
1171395|NCT04393493|2306333|FG001|First 4 Days of Intervention|Early improvement|7
1171396|NCT04391842|2306432|FG000|Overall Study|Withdrawal by Subject|2
1171397|NCT04386902|2306445|FG000|Overall Study|Withdrawal by Subject|5
1171398|NCT04386902|2306445|FG000|Overall Study|Technical problems in the recording|5
1171399|NCT04384523|2306464|FG000|Overall Study|Lost to Follow-up|0
1171400|NCT04384523|2306465|FG001|Overall Study|Lost to Follow-up|0
1171401|NCT04384523|2306466|FG002|Overall Study|Lost to Follow-up|0
1171402|NCT04384523|2306467|FG003|Overall Study|Lost to Follow-up|0
1171403|NCT04384523|2306468|FG004|Overall Study|Lost to Follow-up|0
1171404|NCT04384523|2306469|FG005|Overall Study|Lost to Follow-up|1
1171405|NCT04384523|2306464|FG000|Overall Study|Protocol Violation|0
1171406|NCT04384523|2306465|FG001|Overall Study|Protocol Violation|1
1171407|NCT04384523|2306466|FG002|Overall Study|Protocol Violation|0
1171408|NCT04384523|2306467|FG003|Overall Study|Protocol Violation|0
1171409|NCT04384523|2306468|FG004|Overall Study|Protocol Violation|0
1171410|NCT04384523|2306469|FG005|Overall Study|Protocol Violation|0
1171411|NCT04384523|2306464|FG000|Overall Study|Withdrawal by Subject|1
1171412|NCT04384523|2306465|FG001|Overall Study|Withdrawal by Subject|0
1171413|NCT04384523|2306466|FG002|Overall Study|Withdrawal by Subject|0
1171414|NCT04384523|2306467|FG003|Overall Study|Withdrawal by Subject|0
1171415|NCT04384523|2306468|FG004|Overall Study|Withdrawal by Subject|0
1171416|NCT04384523|2306469|FG005|Overall Study|Withdrawal by Subject|0
1171417|NCT04382066|2306514|FG000|Overall Study|Adverse Event|1
1171418|NCT04382066|2306515|FG001|Overall Study|Adverse Event|0
1171419|NCT04382066|2306516|FG002|Overall Study|Adverse Event|0
1171420|NCT04382066|2306514|FG000|Overall Study|Death|1
1171421|NCT04382066|2306515|FG001|Overall Study|Death|0
1171422|NCT04382066|2306516|FG002|Overall Study|Death|1
1171423|NCT04376060|2306584|FG000|Overall Study|Physician Decision|1
1171424|NCT04372186|2306603|FG000|Overall Study|Death|24
1171425|NCT04372186|2306604|FG001|Overall Study|Death|11
1171426|NCT04372186|2306603|FG000|Overall Study|Transferred to a different facility for care|0
1171427|NCT04372186|2306604|FG001|Overall Study|Transferred to a different facility for care|2
1171428|NCT04370028|2306678|FG000|Overall Study|Withdrawal by Subject|695
1171429|NCT04370028|2306678|FG000|Overall Study|Protocol Violation|9
870446|NCT00529802|1831527|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1
870447|NCT00529802|1831527|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1
870448|NCT00529802|1831527|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
870449|NCT00529958|1831536|FG000|2-Year Follow-up|Lost to Follow-up|1
870450|NCT00529958|1831537|FG001|2-Year Follow-up|Lost to Follow-up|2
870451|NCT00529958|1831538|FG002|2-Year Follow-up|Lost to Follow-up|2
870452|NCT00529958|1831536|FG000|2-Year Follow-up|Withdrawal by Subject|3
870453|NCT00529958|1831537|FG001|2-Year Follow-up|Withdrawal by Subject|0
870454|NCT00529958|1831538|FG002|2-Year Follow-up|Withdrawal by Subject|0
870455|NCT00529958|1831536|FG000|5-Year Follow-up|Lost to Follow-up|2
870456|NCT00529958|1831537|FG001|5-Year Follow-up|Lost to Follow-up|3
870457|NCT00529958|1831538|FG002|5-Year Follow-up|Lost to Follow-up|1
870458|NCT00529958|1831536|FG000|5-Year Follow-up|Withdrawal by Subject|1
870459|NCT00529958|1831537|FG001|5-Year Follow-up|Withdrawal by Subject|0
870460|NCT00529958|1831538|FG002|5-Year Follow-up|Withdrawal by Subject|0
1171430|NCT04370028|2306678|FG000|Overall Study|Adverse Event|3
1171431|NCT04368429|2306691|FG000|Overall Study|Adverse Event|1
1171432|NCT04368429|2306692|FG001|Overall Study|Adverse Event|0
1171433|NCT04363736|2306700|FG000|Overall Study|Withdrawal by Subject|1
1171434|NCT04363736|2306701|FG001|Overall Study|Withdrawal by Subject|0
1171435|NCT04363736|2306700|FG000|Overall Study|Lost to Follow-up|10
1171436|NCT04363736|2306701|FG001|Overall Study|Lost to Follow-up|7
1171437|NCT04363736|2306700|FG000|Overall Study|Death|8
1171438|NCT04363736|2306701|FG001|Overall Study|Death|6
1171439|NCT04365699|2306719|FG000|Overall Study|Death|2
1171440|NCT04365699|2306720|FG001|Overall Study|Death|5
1171441|NCT04365699|2306721|FG002|Overall Study|Death|15
1171452|NCT04362137|2306763|FG000|Overall Study|Death|9
1171453|NCT04362137|2306764|FG001|Overall Study|Death|3
1171454|NCT04362137|2306763|FG000|Overall Study|Patient decision|6
1171455|NCT04362137|2306764|FG001|Overall Study|Patient decision|3
1171456|NCT04362137|2306763|FG000|Overall Study|Adverse Event|1
1171457|NCT04362137|2306764|FG001|Overall Study|Adverse Event|0
1171458|NCT04362137|2306763|FG000|Overall Study|Lost to Follow-up|1
1171459|NCT04362137|2306764|FG001|Overall Study|Lost to Follow-up|0
1171460|NCT04362137|2306763|FG000|Overall Study|Protocol deviation|1
1171461|NCT04362137|2306764|FG001|Overall Study|Protocol deviation|0
1171462|NCT04359771|2306772|FG000|Overall Study|Lack of Efficacy|2
1171463|NCT04359771|2306773|FG001|Overall Study|Lack of Efficacy|2
1171464|NCT04358081|2306786|FG000|Treatment Phase of Study|Withdrawal by Subject|0
1171465|NCT04358081|2306787|FG001|Treatment Phase of Study|Withdrawal by Subject|1
1171466|NCT04358081|2306788|FG002|Treatment Phase of Study|Withdrawal by Subject|1
1171467|NCT04358081|2306786|FG000|Treatment Phase of Study|Adverse Event|1
1171468|NCT04358081|2306787|FG001|Treatment Phase of Study|Adverse Event|0
1171469|NCT04358081|2306788|FG002|Treatment Phase of Study|Adverse Event|1
1171470|NCT04358081|2306786|FG000|Treatment Phase of Study|Physician Decision|2
1171471|NCT04358081|2306787|FG001|Treatment Phase of Study|Physician Decision|0
1171472|NCT04358081|2306788|FG002|Treatment Phase of Study|Physician Decision|1
1171473|NCT04358081|2306786|FG000|Treatment Phase of Study|Protocol Violation|1
1171474|NCT04358081|2306787|FG001|Treatment Phase of Study|Protocol Violation|0
1171475|NCT04358081|2306788|FG002|Treatment Phase of Study|Protocol Violation|0
1171476|NCT04358081|2306786|FG000|Study Completion Phase|Death|0
1171477|NCT04358081|2306787|FG001|Study Completion Phase|Death|0
1171478|NCT04358081|2306788|FG002|Study Completion Phase|Death|1
1171479|NCT04358081|2306786|FG000|Study Completion Phase|Lost to Follow-up|1
1171480|NCT04358081|2306787|FG001|Study Completion Phase|Lost to Follow-up|0
1171481|NCT04358081|2306788|FG002|Study Completion Phase|Lost to Follow-up|1
1171482|NCT04356937|2306800|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0
1171483|NCT04356937|2306801|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1
1171484|NCT04355663|2306810|FG000|Overall Study|Physician Decision|2
1171485|NCT04355663|2306811|FG001|Overall Study|Physician Decision|7
1171486|NCT04355663|2306812|FG002|Overall Study|Physician Decision|0
1171487|NCT04355663|2306810|FG000|Overall Study|Adverse Event|0
1171488|NCT04355663|2306811|FG001|Overall Study|Adverse Event|0
1171489|NCT04355663|2306812|FG002|Overall Study|Adverse Event|1
1171490|NCT04355663|2306810|FG000|Overall Study|Withdrawal by Subject|0
1171491|NCT04355663|2306811|FG001|Overall Study|Withdrawal by Subject|8
1171492|NCT04355663|2306812|FG002|Overall Study|Withdrawal by Subject|3
1171493|NCT04354870|2306822|FG000|Overall Study|Lost to Follow-up|32
1171494|NCT04354870|2306823|FG001|Overall Study|Lost to Follow-up|12
1171495|NCT04354870|2306822|FG000|Overall Study|Withdrawal by Subject|10
1171496|NCT04354870|2306823|FG001|Overall Study|Withdrawal by Subject|16
1171497|NCT04354870|2306822|FG000|Overall Study|Did not complete all study visits|6
1171498|NCT04354870|2306823|FG001|Overall Study|Did not complete all study visits|5
1171499|NCT04350788|2306849|FG000|Overall Study|Lost to Follow-up|6
1171500|NCT04350788|2306850|FG001|Overall Study|Lost to Follow-up|2
1171501|NCT04350788|2306849|FG000|Overall Study|Withdrawal by Subject|2
1171502|NCT04350788|2306850|FG001|Overall Study|Withdrawal by Subject|4
1171503|NCT04350788|2306849|FG000|Overall Study|Protocol Violation|4
1171504|NCT04350788|2306850|FG001|Overall Study|Protocol Violation|0
1171505|NCT04349917|2306863|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0
1171506|NCT04349917|2306864|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1
1171507|NCT04349917|2306863|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0
1171508|NCT04349917|2306864|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1
1171509|NCT04348851|2306875|FG000|Post-Test 1|Withdrawal by Subject|0
1171510|NCT04348851|2306876|FG001|Post-Test 1|Withdrawal by Subject|1
1171511|NCT04348851|2306877|FG002|Post-Test 1|Withdrawal by Subject|0
1171512|NCT04348851|2306878|FG003|Post-Test 1|Withdrawal by Subject|0
1171513|NCT04348851|2306875|FG000|Post-Test 1|Lost to Follow-up|0
1171514|NCT04348851|2306876|FG001|Post-Test 1|Lost to Follow-up|1
1171515|NCT04348851|2306877|FG002|Post-Test 1|Lost to Follow-up|0
1171516|NCT04348851|2306878|FG003|Post-Test 1|Lost to Follow-up|0
1171517|NCT04348851|2306875|FG000|Post-Test 2|Stroke survivor death|0
1171518|NCT04348851|2306876|FG001|Post-Test 2|Stroke survivor death|1
1171519|NCT04348851|2306877|FG002|Post-Test 2|Stroke survivor death|0
1171520|NCT04348851|2306878|FG003|Post-Test 2|Stroke survivor death|1
1171521|NCT04345653|2306910|FG000|Overall Study|Withdrawal by Subject|2
1171522|NCT04343261|2306915|FG000|Overall Study|Adverse Event|1
1171523|NCT04343261|2306915|FG000|Overall Study|received inadequate amount of antibodies|7
1171524|NCT04342897|2306947|FG000|Overall Study|Death|7
1171525|NCT04342897|2306948|FG001|Overall Study|Death|4
1171526|NCT04342897|2306947|FG000|Overall Study|Lost to Follow-up|6
1171527|NCT04342897|2306948|FG001|Overall Study|Lost to Follow-up|6
1171528|NCT04342897|2306947|FG000|Overall Study|Withdrawal by Subject|1
1171529|NCT04342897|2306948|FG001|Overall Study|Withdrawal by Subject|2
1171530|NCT04340557|2306960|FG000|Overall Study|Transferred to ICU and/or death|1
1171531|NCT04340557|2306961|FG001|Overall Study|Transferred to ICU and/or death|2
1171532|NCT04339972|2306969|FG000|Overall Study|Scheduling Issues|3
1171533|NCT04339972|2306970|FG001|Overall Study|Scheduling Issues|3
1171534|NCT04339972|2306969|FG000|Overall Study|dropout|1
1171535|NCT04339972|2306970|FG001|Overall Study|dropout|1
1171536|NCT04339972|2306969|FG000|Overall Study|Technical issues|1
1171537|NCT04339972|2306970|FG001|Overall Study|Technical issues|0
1171538|NCT04339972|2306969|FG000|Overall Study|Claustraphobia|0
1171539|NCT04339972|2306970|FG001|Overall Study|Claustraphobia|1
1171540|NCT04339296|2306978|FG000|Overall Study|Refuse to participate after allocation|1
1171541|NCT04339296|2306979|FG001|Overall Study|Refuse to participate after allocation|1
1171542|NCT04339296|2306978|FG000|Overall Study|Withdrew after completion of baseline|2
1171543|NCT04339296|2306979|FG001|Overall Study|Withdrew after completion of baseline|1
1171544|NCT04339296|2306978|FG000|Overall Study|Lost to Follow-up|0
1171545|NCT04339296|2306979|FG001|Overall Study|Lost to Follow-up|4
1171546|NCT04339296|2306978|FG000|Overall Study|Discontinued intervention|5
1171547|NCT04339296|2306979|FG001|Overall Study|Discontinued intervention|3
1171548|NCT04336475|2307009|FG000|Overall Study|pain|1
1171549|NCT04336475|2307010|FG001|Overall Study|pain|0
1171550|NCT04336475|2307009|FG000|Overall Study|upper respiratory infection|1
1171551|NCT04336475|2307010|FG001|Overall Study|upper respiratory infection|0
1171552|NCT04336475|2307009|FG000|Overall Study|Lost to Follow-up|0
1171553|NCT04336475|2307010|FG001|Overall Study|Lost to Follow-up|2
1171554|NCT04335929|2307016|FG000|Overall Study|Lost to Follow-up|10
1171555|NCT04335812|2307022|FG000|Overall Study|Withdrawal by Subject|1
1171556|NCT04335812|2307023|FG001|Overall Study|Withdrawal by Subject|3
1171557|NCT04335812|2307022|FG000|Overall Study|Lost to Follow-up|12
1171558|NCT04335812|2307023|FG001|Overall Study|Lost to Follow-up|12
1171559|NCT04335812|2307022|FG000|Overall Study|Did not engage in the intervention|22
1171560|NCT04335812|2307023|FG001|Overall Study|Did not engage in the intervention|18
1171561|NCT04335136|2307031|FG000|Overall Study|Death|8
1171562|NCT04335136|2307032|FG001|Overall Study|Death|4
1171563|NCT04335136|2307031|FG000|Overall Study|Lost to Follow-up|2
1171564|NCT04335136|2307032|FG001|Overall Study|Lost to Follow-up|0
1171565|NCT04335136|2307031|FG000|Overall Study|Protocol Violation|1
1171566|NCT04335136|2307032|FG001|Overall Study|Protocol Violation|0
1171567|NCT04335136|2307031|FG000|Overall Study|Withdrawal by Subject|1
1171568|NCT04335136|2307032|FG001|Overall Study|Withdrawal by Subject|1
1171569|NCT04335136|2307031|FG000|Overall Study|Health-threatening condition|0
1171570|NCT04335136|2307032|FG001|Overall Study|Health-threatening condition|1
1171571|NCT04335136|2307031|FG000|Overall Study|Adverse Event|0
1171572|NCT04335136|2307032|FG001|Overall Study|Adverse Event|1
1171573|NCT04335136|2307031|FG000|Overall Study|Erroneously randomized|2
1171574|NCT04335136|2307032|FG001|Overall Study|Erroneously randomized|0
1171575|NCT04333199|2307082|FG000|Evaluated Patients|Lost to Follow-up|0
1171576|NCT04333199|2307083|FG001|Evaluated Patients|Lost to Follow-up|1
1171577|NCT04333199|2307084|FG002|Evaluated Patients|Lost to Follow-up|2
1171578|NCT04332419|2307145|FG000|Overall Study|Withdrawal by Subject|1
1171579|NCT04332107|2307160|FG000|Day 3|Lost to Follow-up|23
1171580|NCT04332107|2307161|FG001|Day 3|Lost to Follow-up|14
1171581|NCT04332107|2307160|FG000|Day 3|Missing outcome data|3
1171582|NCT04332107|2307161|FG001|Day 3|Missing outcome data|6
1171583|NCT04332107|2307160|FG000|Day 14|Lost to Follow-up|13
1171584|NCT04332107|2307161|FG001|Day 14|Lost to Follow-up|4
1171585|NCT04332107|2307160|FG000|Day 14|Missing outcome data|4
1171586|NCT04332107|2307161|FG001|Day 14|Missing outcome data|4
1171587|NCT04332107|2307160|FG000|Day 21|Lost to Follow-up|10
1171588|NCT04332107|2307161|FG001|Day 21|Lost to Follow-up|2
1171589|NCT04329923|2307199|FG000|Overall Study|Withdrawal by Subject|1
1171590|NCT04329923|2307200|FG001|Overall Study|Withdrawal by Subject|4
1171591|NCT04329923|2307201|FG002|Overall Study|Withdrawal by Subject|1
1171592|NCT04329923|2307202|FG003|Overall Study|Withdrawal by Subject|1
1171593|NCT04329923|2307203|FG004|Overall Study|Withdrawal by Subject|1
1171594|NCT04329923|2307204|FG005|Overall Study|Withdrawal by Subject|1
1171595|NCT04329923|2307199|FG000|Overall Study|early termination of study|0
1171596|NCT04329923|2307200|FG001|Overall Study|early termination of study|0
1171597|NCT04329923|2307201|FG002|Overall Study|early termination of study|0
1171598|NCT04329923|2307202|FG003|Overall Study|early termination of study|0
1171599|NCT04329923|2307203|FG004|Overall Study|early termination of study|1
1171600|NCT04329923|2307204|FG005|Overall Study|early termination of study|2
1171601|NCT04329923|2307199|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0
1171602|NCT04329923|2307200|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0
1171603|NCT04329923|2307201|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0
1171604|NCT04329923|2307202|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0
1171605|NCT04329923|2307203|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0
1171606|NCT04329923|2307204|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2
1171607|NCT04328467|2307221|FG000|Overall Study|Did not meet inclusion criteria after randomization|4
1171608|NCT04328467|2307222|FG001|Overall Study|Did not meet inclusion criteria after randomization|2
1171609|NCT04328467|2307223|FG002|Overall Study|Did not meet inclusion criteria after randomization|1
1171610|NCT04327388|2307234|FG000|Overall Study|Adverse Event|17
1171611|NCT04327388|2307235|FG001|Overall Study|Adverse Event|18
1171612|NCT04327388|2307236|FG002|Overall Study|Adverse Event|9
1171613|NCT04327388|2307234|FG000|Overall Study|Other|1
1171614|NCT04327388|2307235|FG001|Overall Study|Other|2
1171615|NCT04327388|2307236|FG002|Overall Study|Other|0
1171616|NCT04327388|2307234|FG000|Overall Study|Randomized and not treated|2
1171617|NCT04327388|2307235|FG001|Overall Study|Randomized and not treated|0
1171618|NCT04327388|2307236|FG002|Overall Study|Randomized and not treated|2
1171619|NCT04322526|2307246|FG000|First Intervention (1 Day)|Withdrawal by Subject|1
1171620|NCT04322526|2307247|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
1171621|NCT04322526|2307246|FG000|Washout (1 Week)|Lost to Follow-up|1
1171622|NCT04322526|2307247|FG001|Washout (1 Week)|Lost to Follow-up|2
1171623|NCT04322682|2307264|FG000|Overall Study|Withdrawal by Subject|33
1171624|NCT04322682|2307265|FG001|Overall Study|Withdrawal by Subject|47
1171625|NCT04322682|2307264|FG000|Overall Study|Death|5
1171626|NCT04322682|2307265|FG001|Overall Study|Death|9
1171627|NCT04322682|2307264|FG000|Overall Study|Lost to Follow-up|4
1171628|NCT04322682|2307265|FG001|Overall Study|Lost to Follow-up|8
1171629|NCT04322682|2307264|FG000|Overall Study|Admitted to Hospital and Intubated|1
1171630|NCT04322682|2307265|FG001|Overall Study|Admitted to Hospital and Intubated|0
1171631|NCT04320615|2307316|FG000|Overall Study|Withdrawal by Subject|4
1171632|NCT04320615|2307317|FG001|Overall Study|Withdrawal by Subject|10
1171633|NCT04320615|2307316|FG000|Overall Study|Physician Decision|2
1171634|NCT04320615|2307317|FG001|Overall Study|Physician Decision|0
1171635|NCT04320615|2307316|FG000|Overall Study|Other|2
1171636|NCT04320615|2307317|FG001|Overall Study|Other|0
1171637|NCT04320615|2307316|FG000|Overall Study|Lost to Follow-up|5
1171638|NCT04320615|2307317|FG001|Overall Study|Lost to Follow-up|23
1171639|NCT04320615|2307316|FG000|Overall Study|Death|35
1171640|NCT04320615|2307317|FG001|Overall Study|Death|71
1171641|NCT04318535|2307327|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
1171642|NCT04318535|2307328|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1
1171643|NCT04318535|2307329|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
1171644|NCT04314037|2307350|FG000|Treatment Period 2|Adverse Event|1
1171645|NCT04314037|2307351|FG001|Treatment Period 2|Adverse Event|0
1171646|NCT04314037|2307350|FG000|Treatment Period 3|Protocol Violation|1
1171647|NCT04314037|2307351|FG001|Treatment Period 3|Protocol Violation|0
1171648|NCT04314037|2307350|FG000|Treatment Period 3|Adverse Event|0
1171649|NCT04314037|2307351|FG001|Treatment Period 3|Adverse Event|1
1171650|NCT04315298|2307382|FG000|Overall Study|Withdrawal by Subject|0
1171651|NCT04315298|2307383|FG001|Overall Study|Withdrawal by Subject|0
1171652|NCT04315298|2307384|FG002|Overall Study|Withdrawal by Subject|0
1171653|NCT04315298|2307385|FG003|Overall Study|Withdrawal by Subject|2
1171654|NCT04315298|2307386|FG004|Overall Study|Withdrawal by Subject|2
1171655|NCT04315298|2307387|FG005|Overall Study|Withdrawal by Subject|2
1171656|NCT04315298|2307388|FG006|Overall Study|Withdrawal by Subject|0
1171657|NCT04315298|2307389|FG007|Overall Study|Withdrawal by Subject|1
1171658|NCT04315298|2307390|FG008|Overall Study|Withdrawal by Subject|1
1171659|NCT04315298|2307391|FG009|Overall Study|Withdrawal by Subject|1
1171660|NCT04315298|2307392|FG010|Overall Study|Withdrawal by Subject|0
1171661|NCT04315298|2307393|FG011|Overall Study|Withdrawal by Subject|0
1171662|NCT04315298|2307394|FG012|Overall Study|Withdrawal by Subject|0
1171663|NCT04315298|2307395|FG013|Overall Study|Withdrawal by Subject|0
1171664|NCT04315298|2307396|FG014|Overall Study|Withdrawal by Subject|0
1171665|NCT04315298|2307397|FG015|Overall Study|Withdrawal by Subject|0
1171666|NCT04315298|2307398|FG016|Overall Study|Withdrawal by Subject|0
1171667|NCT04315298|2307399|FG017|Overall Study|Withdrawal by Subject|0
1171668|NCT04315298|2307400|FG018|Overall Study|Withdrawal by Subject|0
1171669|NCT04315298|2307382|FG000|Overall Study|Physician Decision|0
1171670|NCT04315298|2307383|FG001|Overall Study|Physician Decision|0
1171671|NCT04315298|2307384|FG002|Overall Study|Physician Decision|0
1171672|NCT04315298|2307385|FG003|Overall Study|Physician Decision|0
1171673|NCT04315298|2307386|FG004|Overall Study|Physician Decision|1
1171674|NCT04315298|2307387|FG005|Overall Study|Physician Decision|0
1171675|NCT04315298|2307388|FG006|Overall Study|Physician Decision|0
1171676|NCT04315298|2307389|FG007|Overall Study|Physician Decision|0
1171677|NCT04315298|2307390|FG008|Overall Study|Physician Decision|0
1171678|NCT04315298|2307391|FG009|Overall Study|Physician Decision|0
1171679|NCT04315298|2307392|FG010|Overall Study|Physician Decision|0
1171680|NCT04315298|2307393|FG011|Overall Study|Physician Decision|0
1171681|NCT04315298|2307394|FG012|Overall Study|Physician Decision|0
1171682|NCT04315298|2307395|FG013|Overall Study|Physician Decision|0
1171683|NCT04315298|2307396|FG014|Overall Study|Physician Decision|0
1171684|NCT04315298|2307397|FG015|Overall Study|Physician Decision|0
1171685|NCT04315298|2307398|FG016|Overall Study|Physician Decision|0
1171686|NCT04315298|2307399|FG017|Overall Study|Physician Decision|0
1171687|NCT04315298|2307400|FG018|Overall Study|Physician Decision|0
1171688|NCT04315298|2307382|FG000|Overall Study|Lost to Follow-up|5
1171689|NCT04315298|2307383|FG001|Overall Study|Lost to Follow-up|10
1171690|NCT04315298|2307384|FG002|Overall Study|Lost to Follow-up|6
1171691|NCT04315298|2307385|FG003|Overall Study|Lost to Follow-up|8
1171692|NCT04315298|2307386|FG004|Overall Study|Lost to Follow-up|12
1171693|NCT04315298|2307387|FG005|Overall Study|Lost to Follow-up|13
1171694|NCT04315298|2307388|FG006|Overall Study|Lost to Follow-up|9
1171695|NCT04315298|2307389|FG007|Overall Study|Lost to Follow-up|16
1171696|NCT04315298|2307390|FG008|Overall Study|Lost to Follow-up|14
1171697|NCT04315298|2307391|FG009|Overall Study|Lost to Follow-up|0
1171698|NCT04315298|2307392|FG010|Overall Study|Lost to Follow-up|2
1171699|NCT04315298|2307393|FG011|Overall Study|Lost to Follow-up|1
1171700|NCT04315298|2307394|FG012|Overall Study|Lost to Follow-up|0
1171701|NCT04315298|2307395|FG013|Overall Study|Lost to Follow-up|0
1171702|NCT04315298|2307396|FG014|Overall Study|Lost to Follow-up|0
1171703|NCT04315298|2307397|FG015|Overall Study|Lost to Follow-up|2
1171704|NCT04315298|2307398|FG016|Overall Study|Lost to Follow-up|0
1171705|NCT04315298|2307399|FG017|Overall Study|Lost to Follow-up|0
1171706|NCT04315298|2307400|FG018|Overall Study|Lost to Follow-up|0
1171707|NCT04315298|2307382|FG000|Overall Study|Death|24
1171708|NCT04315298|2307383|FG001|Overall Study|Death|60
1171709|NCT04315298|2307384|FG002|Overall Study|Death|49
1171710|NCT04315298|2307385|FG003|Overall Study|Death|59
1171711|NCT04315298|2307386|FG004|Overall Study|Death|70
1171712|NCT04315298|2307387|FG005|Overall Study|Death|114
1171713|NCT04315298|2307388|FG006|Overall Study|Death|9
1171714|NCT04315298|2307389|FG007|Overall Study|Death|12
1171715|NCT04315298|2307390|FG008|Overall Study|Death|21
1171716|NCT04315298|2307391|FG009|Overall Study|Death|16
1171717|NCT04315298|2307392|FG010|Overall Study|Death|40
1171718|NCT04315298|2307393|FG011|Overall Study|Death|40
1171719|NCT04315298|2307394|FG012|Overall Study|Death|3
1171720|NCT04315298|2307395|FG013|Overall Study|Death|4
1171721|NCT04315298|2307396|FG014|Overall Study|Death|6
1171722|NCT04315298|2307397|FG015|Overall Study|Death|4
1171723|NCT04315298|2307398|FG016|Overall Study|Death|3
1171724|NCT04315298|2307399|FG017|Overall Study|Death|1
1171725|NCT04315298|2307400|FG018|Overall Study|Death|0
1171726|NCT04308239|2307510|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
1171727|NCT04308239|2307511|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
1171728|NCT04308239|2307510|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
1171729|NCT04308239|2307511|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
1171730|NCT04308239|2307510|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
1171731|NCT04308239|2307511|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
1171732|NCT04308239|2307510|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
1171733|NCT04308239|2307511|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
1171734|NCT04308668|2307523|FG000|Overall Study|Lost to Follow-up|32
1171735|NCT04308668|2307524|FG001|Overall Study|Lost to Follow-up|38
1171736|NCT04308668|2307523|FG000|Overall Study|Withdrawal by Subject|4
1171737|NCT04308668|2307524|FG001|Overall Study|Withdrawal by Subject|4
1171738|NCT04307940|2307533|FG000|Overall Study|Adverse Event|1
1171739|NCT04307940|2307534|FG001|Overall Study|Adverse Event|0
1171740|NCT04307940|2307535|FG002|Overall Study|Adverse Event|0
1171741|NCT04307940|2307533|FG000|Overall Study|Withdrawal by Subject|2
1171742|NCT04307940|2307534|FG001|Overall Study|Withdrawal by Subject|3
1171743|NCT04307940|2307535|FG002|Overall Study|Withdrawal by Subject|1
1171744|NCT04307940|2307533|FG000|Overall Study|Lost to Follow-up|2
1171745|NCT04307940|2307534|FG001|Overall Study|Lost to Follow-up|0
1171746|NCT04307940|2307535|FG002|Overall Study|Lost to Follow-up|1
1171747|NCT04302545|2307545|FG000|Overall Study|Lost to Follow-up|3
1171748|NCT04302545|2307546|FG001|Overall Study|Lost to Follow-up|4
1171749|NCT04297241|2307568|FG000|Overall Study|Withdrawal by Subject|1
1171750|NCT04297241|2307568|FG000|Overall Study|Adverse Event|1
1171751|NCT04297241|2307568|FG000|Overall Study|Physician Decision|3
1171752|NCT04295356|2307597|FG000|Overall Study|Physician Decision|1
1171753|NCT04295356|2307598|FG001|Overall Study|Physician Decision|0
1171754|NCT04295356|2307597|FG000|Overall Study|Lost to Follow-up|0
1171755|NCT04295356|2307598|FG001|Overall Study|Lost to Follow-up|3
1171756|NCT04295356|2307597|FG000|Overall Study|Protocol Violation|0
1171757|NCT04295356|2307598|FG001|Overall Study|Protocol Violation|1
1171758|NCT04292535|2307622|FG000|Overall Study|Withdrawal by Subject|0
1171759|NCT04292535|2307623|FG001|Overall Study|Withdrawal by Subject|0
1171760|NCT04292535|2307624|FG002|Overall Study|Withdrawal by Subject|0
1171761|NCT04292535|2307625|FG003|Overall Study|Withdrawal by Subject|0
1171762|NCT04292535|2307626|FG004|Overall Study|Withdrawal by Subject|0
1171763|NCT04292535|2307627|FG005|Overall Study|Withdrawal by Subject|0
1171764|NCT04292535|2307628|FG006|Overall Study|Withdrawal by Subject|0
1171765|NCT04292535|2307629|FG007|Overall Study|Withdrawal by Subject|1
1171766|NCT04292535|2307630|FG008|Overall Study|Withdrawal by Subject|0
1171767|NCT04292535|2307631|FG009|Overall Study|Withdrawal by Subject|0
1171768|NCT04292535|2307632|FG010|Overall Study|Withdrawal by Subject|0
1171769|NCT04292535|2307633|FG011|Overall Study|Withdrawal by Subject|0
1171770|NCT04292535|2307634|FG012|Overall Study|Withdrawal by Subject|0
1171771|NCT04292535|2307635|FG013|Overall Study|Withdrawal by Subject|0
1171772|NCT04292535|2307622|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
1171773|NCT04292535|2307623|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
1171774|NCT04292535|2307624|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
1171775|NCT04292535|2307625|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
1171776|NCT04292535|2307626|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
1171777|NCT04292535|2307627|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
1171778|NCT04292535|2307628|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
1171779|NCT04292535|2307629|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
1171780|NCT04292535|2307630|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
1171781|NCT04292535|2307631|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
1171782|NCT04292535|2307632|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
1171783|NCT04292535|2307633|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
1171784|NCT04292535|2307634|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
1171785|NCT04292535|2307635|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
1171786|NCT04292535|2307622|FG000|Overall Study|Report of Dizziness|0
1171787|NCT04292535|2307623|FG001|Overall Study|Report of Dizziness|0
1171788|NCT04292535|2307624|FG002|Overall Study|Report of Dizziness|0
1171789|NCT04292535|2307625|FG003|Overall Study|Report of Dizziness|0
1171790|NCT04292535|2307626|FG004|Overall Study|Report of Dizziness|0
1171791|NCT04292535|2307627|FG005|Overall Study|Report of Dizziness|0
1171792|NCT04292535|2307628|FG006|Overall Study|Report of Dizziness|0
1171793|NCT04292535|2307629|FG007|Overall Study|Report of Dizziness|0
1171794|NCT04292535|2307630|FG008|Overall Study|Report of Dizziness|0
1171795|NCT04292535|2307631|FG009|Overall Study|Report of Dizziness|0
1171796|NCT04292535|2307632|FG010|Overall Study|Report of Dizziness|0
1171797|NCT04292535|2307633|FG011|Overall Study|Report of Dizziness|0
1171798|NCT04292535|2307634|FG012|Overall Study|Report of Dizziness|0
1171799|NCT04292535|2307635|FG013|Overall Study|Report of Dizziness|1
1171800|NCT04292535|2307622|FG000|Overall Study|Equipment Failure|0
1171801|NCT04292535|2307623|FG001|Overall Study|Equipment Failure|0
1171802|NCT04292535|2307624|FG002|Overall Study|Equipment Failure|0
1171803|NCT04292535|2307625|FG003|Overall Study|Equipment Failure|0
1171804|NCT04292535|2307626|FG004|Overall Study|Equipment Failure|0
1171805|NCT04292535|2307627|FG005|Overall Study|Equipment Failure|0
1171806|NCT04292535|2307628|FG006|Overall Study|Equipment Failure|0
1171807|NCT04292535|2307629|FG007|Overall Study|Equipment Failure|0
1171808|NCT04292535|2307630|FG008|Overall Study|Equipment Failure|0
1171809|NCT04292535|2307631|FG009|Overall Study|Equipment Failure|0
1171810|NCT04292535|2307632|FG010|Overall Study|Equipment Failure|0
1171811|NCT04292535|2307633|FG011|Overall Study|Equipment Failure|1
1171812|NCT04292535|2307634|FG012|Overall Study|Equipment Failure|0
1171813|NCT04292535|2307635|FG013|Overall Study|Equipment Failure|0
1171814|NCT04292171|2307667|FG000|Overall Study|Pharmacy error|2
1171815|NCT04292171|2307668|FG001|Overall Study|Pharmacy error|0
1171816|NCT04292171|2307667|FG000|Overall Study|Delivered prior to procedure|0
1171817|NCT04292171|2307668|FG001|Overall Study|Delivered prior to procedure|1
1171818|NCT04292899|2307678|FG000|Overall Study|Death|21
1171819|NCT04292899|2307679|FG001|Overall Study|Death|28
1171820|NCT04292899|2307680|FG002|Overall Study|Death|188
1171821|NCT04292899|2307681|FG003|Overall Study|Death|371
1171822|NCT04292899|2307678|FG000|Overall Study|Lost to Follow-up|8
1171823|NCT04292899|2307679|FG001|Overall Study|Lost to Follow-up|4
1171824|NCT04292899|2307680|FG002|Overall Study|Lost to Follow-up|22
1171825|NCT04292899|2307681|FG003|Overall Study|Lost to Follow-up|235
1171826|NCT04292899|2307678|FG000|Overall Study|Withdrew consent|1
1171827|NCT04292899|2307679|FG001|Overall Study|Withdrew consent|0
1171828|NCT04292899|2307680|FG002|Overall Study|Withdrew consent|11
1171829|NCT04292899|2307681|FG003|Overall Study|Withdrew consent|32
1171830|NCT04292899|2307678|FG000|Overall Study|Adverse Event|2
1171831|NCT04292899|2307679|FG001|Overall Study|Adverse Event|1
1171832|NCT04292899|2307680|FG002|Overall Study|Adverse Event|2
1171833|NCT04292899|2307681|FG003|Overall Study|Adverse Event|2
1171834|NCT04292899|2307678|FG000|Overall Study|Investigator's Discretion|0
1171835|NCT04292899|2307679|FG001|Overall Study|Investigator's Discretion|0
1171836|NCT04292899|2307680|FG002|Overall Study|Investigator's Discretion|0
1171837|NCT04292899|2307681|FG003|Overall Study|Investigator's Discretion|3
1171838|NCT04292899|2307678|FG000|Overall Study|Non-compliance With Study Drug|0
1171839|NCT04292899|2307679|FG001|Overall Study|Non-compliance With Study Drug|0
1171840|NCT04292899|2307680|FG002|Overall Study|Non-compliance With Study Drug|0
1171841|NCT04292899|2307681|FG003|Overall Study|Non-compliance With Study Drug|1
1171842|NCT04292899|2307678|FG000|Overall Study|Protocol Violation|0
1171843|NCT04292899|2307679|FG001|Overall Study|Protocol Violation|0
1171844|NCT04292899|2307680|FG002|Overall Study|Protocol Violation|0
1171845|NCT04292899|2307681|FG003|Overall Study|Protocol Violation|1
1171846|NCT04292730|2307693|FG000|Overall Study|Lost to Follow-up|8
1171847|NCT04292730|2307694|FG001|Overall Study|Lost to Follow-up|12
1171848|NCT04292730|2307695|FG002|Overall Study|Lost to Follow-up|12
1171849|NCT04292730|2307696|FG003|Overall Study|Lost to Follow-up|48
1171850|NCT04292730|2307693|FG000|Overall Study|Death|2
1171851|NCT04292730|2307694|FG001|Overall Study|Death|2
1171852|NCT04292730|2307695|FG002|Overall Study|Death|4
1171853|NCT04292730|2307696|FG003|Overall Study|Death|12
1171854|NCT04292730|2307693|FG000|Overall Study|Withdrew Consent|2
1171855|NCT04292730|2307694|FG001|Overall Study|Withdrew Consent|2
1171856|NCT04292730|2307695|FG002|Overall Study|Withdrew Consent|5
1171857|NCT04292730|2307696|FG003|Overall Study|Withdrew Consent|6
1171858|NCT04292730|2307693|FG000|Overall Study|Non-Compliance with Study Drug|0
1171859|NCT04292730|2307694|FG001|Overall Study|Non-Compliance with Study Drug|1
1171860|NCT04292730|2307695|FG002|Overall Study|Non-Compliance with Study Drug|0
1171861|NCT04292730|2307696|FG003|Overall Study|Non-Compliance with Study Drug|0
1171862|NCT04292730|2307693|FG000|Overall Study|Protocol Violation|0
1171863|NCT04292730|2307694|FG001|Overall Study|Protocol Violation|0
1171864|NCT04292730|2307695|FG002|Overall Study|Protocol Violation|1
1171865|NCT04292730|2307696|FG003|Overall Study|Protocol Violation|0
1171866|NCT04292730|2307693|FG000|Overall Study|Randomized but not Treated|8
1171867|NCT04292730|2307694|FG001|Overall Study|Randomized but not Treated|4
1171868|NCT04292730|2307695|FG002|Overall Study|Randomized but not Treated|0
1171869|NCT04292730|2307696|FG003|Overall Study|Randomized but not Treated|14
1171870|NCT04289623|2307729|FG000|Wave 1 Emails|Email was not delivered|268
1171871|NCT04289623|2307730|FG001|Wave 1 Emails|Email was not delivered|257
1171872|NCT04289623|2307731|FG002|Wave 1 Emails|Email was not delivered|0
1171873|NCT04289623|2307732|FG003|Wave 1 Emails|Email was not delivered|0
1171874|NCT04289623|2307733|FG004|Wave 1 Emails|Email was not delivered|0
1171875|NCT04289623|2307734|FG005|Wave 1 Emails|Email was not delivered|0
1171876|NCT04276207|2307748|FG000|Period 1|Withdrawal by Subject|0
1171877|NCT04276207|2307749|FG001|Period 1|Withdrawal by Subject|1
1171878|NCT04280705|2307779|FG000|Overall Study|Enrolled but not treated|4
1171879|NCT04280705|2307780|FG001|Overall Study|Enrolled but not treated|10
1171880|NCT04280705|2307779|FG000|Overall Study|Physician Decision|1
1171881|NCT04280705|2307780|FG001|Overall Study|Physician Decision|0
1171882|NCT04280705|2307779|FG000|Overall Study|Withdrawal by Subject|7
1171883|NCT04280705|2307780|FG001|Overall Study|Withdrawal by Subject|9
1171884|NCT04280705|2307779|FG000|Overall Study|Adverse Event|0
1171885|NCT04280705|2307780|FG001|Overall Study|Adverse Event|4
1171886|NCT04280705|2307779|FG000|Overall Study|Transferred to another hospital|1
1171887|NCT04280705|2307780|FG001|Overall Study|Transferred to another hospital|1
1171888|NCT04287517|2307788|FG000|Overall Study|Withdrawal by Subject|1
1171889|NCT04287517|2307789|FG001|Overall Study|Withdrawal by Subject|1
1171890|NCT04275336|2307859|FG000|Overall Study|First venipuncture failed|4
1171891|NCT04275336|2307860|FG001|Overall Study|First venipuncture failed|6
1171892|NCT04275336|2307861|FG002|Overall Study|First venipuncture failed|5
1171893|NCT04275336|2307859|FG000|Overall Study|Unscheduled venipuncture|9
1171894|NCT04275336|2307860|FG001|Overall Study|Unscheduled venipuncture|13
1171895|NCT04275336|2307861|FG002|Overall Study|Unscheduled venipuncture|7
1171896|NCT04275336|2307859|FG000|Overall Study|Failed specimen of saliva|4
1171897|NCT04275336|2307860|FG001|Overall Study|Failed specimen of saliva|3
1171898|NCT04275336|2307861|FG002|Overall Study|Failed specimen of saliva|4
1171899|NCT04272775|2307874|FG000|Overall Study|Study Terminated by Sponsor|1
1171900|NCT04272775|2307875|FG001|Overall Study|Study Terminated by Sponsor|0
1171901|NCT04272775|2307874|FG000|Overall Study|Protocol Violation|0
1171902|NCT04272775|2307875|FG001|Overall Study|Protocol Violation|1
1171903|NCT04272775|2307874|FG000|Overall Study|Symptomatic Deterioration|1
1171904|NCT04272775|2307875|FG001|Overall Study|Symptomatic Deterioration|1
1171905|NCT04272775|2307874|FG000|Overall Study|Withdrawal by Subject|1
1171906|NCT04272775|2307875|FG001|Overall Study|Withdrawal by Subject|2
1171907|NCT04272775|2307874|FG000|Overall Study|Adverse Event|1
1171908|NCT04272775|2307875|FG001|Overall Study|Adverse Event|2
1171909|NCT04272775|2307874|FG000|Overall Study|Progressive Disease|3
1171910|NCT04272775|2307875|FG001|Overall Study|Progressive Disease|1
1171911|NCT04271605|2307907|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5
1171912|NCT04268316|2307918|FG000|Overall Study|Withdrawal by Subject|2
1171913|NCT04268316|2307919|FG001|Overall Study|Withdrawal by Subject|1
1171914|NCT04268316|2307920|FG002|Overall Study|Withdrawal by Subject|0
1171915|NCT04263142|2307963|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0
1171916|NCT04263142|2307964|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0
1171917|NCT04263142|2307965|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0
1171918|NCT04263142|2307966|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0
1171919|NCT04263142|2307967|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1
1171920|NCT04263142|2307963|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0
1171921|NCT04263142|2307964|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0
1171922|NCT04263142|2307965|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0
1171923|NCT04263142|2307966|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0
1171924|NCT04263142|2307967|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1
1171925|NCT04256785|2307982|FG000|Overall Study|Adverse Event|8
1171926|NCT04256785|2307983|FG001|Overall Study|Adverse Event|6
1171927|NCT04256785|2307982|FG000|Overall Study|Lack of Efficacy|3
1171928|NCT04256785|2307983|FG001|Overall Study|Lack of Efficacy|4
1171929|NCT04256785|2307982|FG000|Overall Study|Lost to Follow-up|7
1171930|NCT04256785|2307983|FG001|Overall Study|Lost to Follow-up|7
1171931|NCT04256785|2307982|FG000|Overall Study|Protocol Violation|1
1171932|NCT04256785|2307983|FG001|Overall Study|Protocol Violation|0
1171933|NCT04256785|2307982|FG000|Overall Study|Withdrawal by Subject|4
1171934|NCT04256785|2307983|FG001|Overall Study|Withdrawal by Subject|1
1171935|NCT04256785|2307982|FG000|Overall Study|Surgery or quarantined due to Covid-19|5
1171936|NCT04256785|2307983|FG001|Overall Study|Surgery or quarantined due to Covid-19|7
1171937|NCT04249336|2308018|FG000|Overall Study|Lost to Follow-up|3
1171938|NCT04249336|2308019|FG001|Overall Study|Lost to Follow-up|3
1171939|NCT04249336|2308020|FG002|Overall Study|Lost to Follow-up|3
1171940|NCT04249336|2308021|FG003|Overall Study|Lost to Follow-up|3
1171941|NCT04247061|2308049|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6
1171942|NCT04247061|2308049|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2
1171943|NCT04247061|2308049|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1
1171944|NCT04245202|2308055|FG000|Overall Study|Lack of Efficacy|10
1171945|NCT04245202|2308056|FG001|Overall Study|Lack of Efficacy|1
1171946|NCT04238650|2308087|FG000|Overall Study|Withdrawal by Subject|0
1171947|NCT04238650|2308088|FG001|Overall Study|Withdrawal by Subject|1
1171948|NCT04238663|2308097|FG000|Overall Study|Lost to Follow-up|0
1171949|NCT04238663|2308098|FG001|Overall Study|Lost to Follow-up|1
1171950|NCT04238663|2308099|FG002|Overall Study|Lost to Follow-up|0
1171951|NCT04222699|2308182|FG000|Overall Study|Lost to Follow-up|2
1171952|NCT04206293|2308205|FG000|Overall Study|Consent withdrawal|1
1171953|NCT04228302|2308216|FG000|Overall Study|Adverse Event|0
1171954|NCT04228302|2308217|FG001|Overall Study|Adverse Event|0
1171955|NCT04228302|2308218|FG002|Overall Study|Adverse Event|0
1171956|NCT04228302|2308219|FG003|Overall Study|Adverse Event|0
1171957|NCT04228302|2308220|FG004|Overall Study|Adverse Event|1
1171958|NCT04228302|2308221|FG005|Overall Study|Adverse Event|0
1171959|NCT04223687|2308259|FG000|Overall Study|Missing primary outcome|1
1171960|NCT04223687|2308260|FG001|Overall Study|Missing primary outcome|0
1171961|NCT04223232|2308266|FG000|Overall Study|Withdrawal by Subject|1
1171962|NCT04189224|2308270|FG000|Period 2|Adverse Event|0
1171963|NCT04189224|2308271|FG001|Period 2|Adverse Event|1
1171964|NCT04214600|2308279|FG000|Overall Study|Lost to Follow-up|9
1171965|NCT04214600|2308280|FG001|Overall Study|Lost to Follow-up|14
1171966|NCT04202497|2308287|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1
1171967|NCT04202497|2308288|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
1171968|NCT04202497|2308289|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
1171969|NCT04202497|2308290|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
1171970|NCT04209530|2308317|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4
1171971|NCT04209530|2308318|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2
1171972|NCT04209530|2308317|FG000|Overall Study|Withdrawal by Subject|0
1171973|NCT04209530|2308318|FG001|Overall Study|Withdrawal by Subject|1
1171974|NCT04207840|2308338|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
1171975|NCT04207840|2308339|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
1171976|NCT04207840|2308340|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1
1171977|NCT04207840|2308338|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
1171978|NCT04207840|2308339|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
1171979|NCT04207840|2308340|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1
1171980|NCT04206384|2308375|FG000|Overall Study|Withdrawal by Subject|8
1171981|NCT04206384|2308375|FG000|Overall Study|Adverse Event|2
1171982|NCT04195893|2308396|FG000|Second Intervention|Withdrawal by Subject|1
1171983|NCT04195893|2308397|FG001|Second Intervention|Withdrawal by Subject|0
1171984|NCT04195581|2308412|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4
1171985|NCT04195581|2308412|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5
1171986|NCT04195581|2308412|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1
1171987|NCT04195581|2308412|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1
1171988|NCT04195581|2308412|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3
1171989|NCT04195581|2308412|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2
1171990|NCT04194151|2308436|FG000|Overall Study|Physician Decision|1
1171991|NCT04194151|2308437|FG001|Overall Study|Physician Decision|1
1171992|NCT04194151|2308438|FG002|Overall Study|Physician Decision|1
1171993|NCT04194151|2308439|FG003|Overall Study|Physician Decision|1
1171994|NCT04194151|2308440|FG004|Overall Study|Physician Decision|0
1171995|NCT04194151|2308441|FG005|Overall Study|Physician Decision|1
1171996|NCT04194151|2308436|FG000|Overall Study|Monitorization problem|0
1171997|NCT04194151|2308437|FG001|Overall Study|Monitorization problem|1
1171998|NCT04194151|2308438|FG002|Overall Study|Monitorization problem|0
1171999|NCT04194151|2308439|FG003|Overall Study|Monitorization problem|0
1172000|NCT04194151|2308440|FG004|Overall Study|Monitorization problem|0
1172001|NCT04194151|2308441|FG005|Overall Study|Monitorization problem|0
1172002|NCT04194008|2308455|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19
1172003|NCT04194008|2308455|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6
1172004|NCT04194008|2308455|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2
1172005|NCT04194008|2308455|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3
1172006|NCT04194008|2308455|FG000|Treatment Phase With Nerivio|Missing data|4
1172007|NCT04194008|2308455|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1
1172008|NCT04189081|2308466|FG000|Overall Study|Lost to Follow-up|1
1172009|NCT04189081|2308467|FG001|Overall Study|Lost to Follow-up|0
1172010|NCT04189081|2308468|FG002|Overall Study|Lost to Follow-up|0
1172011|NCT04189081|2308466|FG000|Overall Study|Withdrawal by Subject|0
1172012|NCT04189081|2308467|FG001|Overall Study|Withdrawal by Subject|0
1172013|NCT04189081|2308468|FG002|Overall Study|Withdrawal by Subject|1
1172014|NCT04186806|2308489|FG000|Period 1: 7 Days|Adverse Event|1
1172015|NCT04186806|2308490|FG001|Period 1: 7 Days|Adverse Event|0
1172016|NCT04179838|2308524|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
1172017|NCT04179838|2308525|FG001|First Intervention (1 Day)|Withdrawal by Subject|3
1172018|NCT04179838|2308524|FG000|Second Intervention (1 Day)|Protocol Violation|0
1172019|NCT04179838|2308525|FG001|Second Intervention (1 Day)|Protocol Violation|1
1172020|NCT04179461|2308531|FG000|Overall Study|Lost to Follow-up|4
1172021|NCT04178590|2308559|FG000|Overall Study|Pregnancy|1
1172022|NCT04178590|2308559|FG000|Overall Study|Lost to Follow-up|1
1172023|NCT04177862|2308587|FG000|Overall Study|Protocol Violation|2
1172024|NCT04177862|2308588|FG001|Overall Study|Protocol Violation|7
1172025|NCT04173741|2308672|FG000|Overall Study|IVC measurement cannot be done|1
1172026|NCT04173741|2308673|FG001|Overall Study|IVC measurement cannot be done|1
1172027|NCT04169061|2308679|FG000|Overall Study|Adverse Event|2
1172028|NCT04169061|2308679|FG000|Overall Study|Death|1
1172029|NCT04169061|2308679|FG000|Overall Study|Withdrawal by Subject|1
1172030|NCT04169061|2308679|FG000|Overall Study|Protocol Violation|1
1172031|NCT04157738|2308685|FG000|Overall Study|Moved out of state|0
1172032|NCT04157738|2308686|FG001|Overall Study|Moved out of state|2
1172033|NCT04157738|2308685|FG000|Overall Study|Did not show up to the Follow-up appointment|1
1172034|NCT04157738|2308686|FG001|Overall Study|Did not show up to the Follow-up appointment|0
1172035|NCT04156646|2308694|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0
1172036|NCT04156646|2308695|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1
1172037|NCT04170686|2308706|FG000|Screening|Physician Decision|12
1172038|NCT04170686|2308707|FG001|Screening|Physician Decision|13
1172039|NCT04170686|2308706|FG000|Randomization and Treatment|Lost to Follow-up|26
1172040|NCT04170686|2308707|FG001|Randomization and Treatment|Lost to Follow-up|15
1172041|NCT04162795|2308767|FG000|Overall Study|Other|16
1172042|NCT04162795|2308767|FG000|Overall Study|Screen failures|10
1172043|NCT04161807|2308771|FG000|Overall Study|Withdrawal by Subject|2
1172044|NCT04161807|2308771|FG000|Overall Study|Performed only 1 treatment|2
1172045|NCT04161144|2308777|FG000|Overall Study|Withdrawal by Subject|0
1172046|NCT04161144|2308778|FG001|Overall Study|Withdrawal by Subject|1
1172047|NCT04161144|2308777|FG000|Overall Study|Protocol Violation|1
1172048|NCT04161144|2308778|FG001|Overall Study|Protocol Violation|0
1172049|NCT04161131|2308784|FG000|Overall Study|Ineligible|2
1172050|NCT04161131|2308784|FG000|Overall Study|Lost to Follow-up|4
1172051|NCT04161079|2308788|FG000|Clinical Investigation 2010-040|Adverse Event|1
1172052|NCT04152083|2308807|FG000|Overall Study|Lost to Follow-up|2
1172053|NCT04152083|2308808|FG001|Overall Study|Lost to Follow-up|1
1172054|NCT04152083|2308807|FG000|Overall Study|Adverse Event|1
1172055|NCT04152083|2308808|FG001|Overall Study|Adverse Event|0
1172056|NCT04152083|2308807|FG000|Overall Study|Randomized but not treated|3
1172057|NCT04152083|2308808|FG001|Overall Study|Randomized but not treated|2
1172058|NCT04155047|2308820|FG000|Overall Study|Adverse Event|1
1172059|NCT04155047|2308821|FG001|Overall Study|Adverse Event|0
1172060|NCT04155047|2308820|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1
1172061|NCT04155047|2308821|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0
1172062|NCT04150250|2308850|FG000|Overall Study|Lost to Follow-up|0
1172063|NCT04150250|2308851|FG001|Overall Study|Lost to Follow-up|2
1172064|NCT04149353|2308936|FG000|Overall Study|Study terminated|1
1172065|NCT04148651|2308941|FG000|Overall Study|Lost to Follow-up|2
1172066|NCT04136444|2308961|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0
1172067|NCT04136444|2308962|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1
1172068|NCT04147611|2308996|FG000|Overall Study|Physician Decision|0
1172069|NCT04147611|2308997|FG001|Overall Study|Physician Decision|1
1172070|NCT04142216|2309066|FG000|Overall Study|Hospitalization|0
1172071|NCT04142216|2309067|FG001|Overall Study|Hospitalization|2
1172072|NCT04142216|2309066|FG000|Overall Study|Death|3
1172073|NCT04142216|2309067|FG001|Overall Study|Death|1
1172074|NCT04142216|2309066|FG000|Overall Study|Referral to another hemodialysis unit|3
1172075|NCT04142216|2309067|FG001|Overall Study|Referral to another hemodialysis unit|2
1172076|NCT04142216|2309066|FG000|Overall Study|Use of clove|0
1172077|NCT04142216|2309067|FG001|Overall Study|Use of clove|1
1172078|NCT04142450|2309078|FG000|Overall Study|Screen Failure|1
1172079|NCT04142450|2309078|FG000|Overall Study|Lost to Follow-up|1
1172080|NCT04142242|2309088|FG000|Overall Study|Non-compliance with the protocol|1
1172081|NCT04142242|2309089|FG001|Overall Study|Non-compliance with the protocol|0
1172082|NCT04142242|2309090|FG002|Overall Study|Non-compliance with the protocol|0
1172083|NCT04142242|2309091|FG003|Overall Study|Non-compliance with the protocol|0
1172084|NCT04142242|2309092|FG004|Overall Study|Non-compliance with the protocol|0
1172085|NCT04142242|2309093|FG005|Overall Study|Non-compliance with the protocol|1
1172086|NCT04142242|2309088|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
1172087|NCT04142242|2309089|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1
1172088|NCT04142242|2309090|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
1172089|NCT04142242|2309091|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
1172090|NCT04142242|2309092|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
1172091|NCT04142242|2309093|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
1172092|NCT04142242|2309088|FG000|Overall Study|Ongoing|0
1172093|NCT04142242|2309089|FG001|Overall Study|Ongoing|0
1172094|NCT04142242|2309090|FG002|Overall Study|Ongoing|31
1172095|NCT04142242|2309091|FG003|Overall Study|Ongoing|39
1172096|NCT04142242|2309092|FG004|Overall Study|Ongoing|0
1172097|NCT04142242|2309093|FG005|Overall Study|Ongoing|0
1172098|NCT04140890|2309108|FG000|Overall Study|Withdrawal by Subject|0
1172099|NCT04140890|2309109|FG001|Overall Study|Withdrawal by Subject|1
1172100|NCT04139018|2309120|FG000|Overall Study|Screen fail|1
1172101|NCT04139018|2309121|FG001|Overall Study|Screen fail|0
1172102|NCT04139018|2309120|FG000|Overall Study|Withdrawal by Subject|2
1172103|NCT04139018|2309121|FG001|Overall Study|Withdrawal by Subject|0
1172104|NCT04139018|2309120|FG000|Overall Study|Lost to Follow-up|0
1172105|NCT04139018|2309121|FG001|Overall Study|Lost to Follow-up|1
1172106|NCT04138810|2309129|FG000|Overall Study|Withdrawal by Subject|0
1172107|NCT04138810|2309130|FG001|Overall Study|Withdrawal by Subject|1
1172108|NCT04138810|2309129|FG000|Overall Study|Subject cancelled surgery|1
1172109|NCT04138810|2309130|FG001|Overall Study|Subject cancelled surgery|0
1172110|NCT04131556|2309136|FG000|Overall Study|Adverse Event|1
1172111|NCT04131556|2309136|FG000|Overall Study|Withdrawal by Subject|1
1172112|NCT04126174|2309143|FG000|Overall Study|Lost to Follow-up|3
1172113|NCT04126174|2309144|FG001|Overall Study|Lost to Follow-up|3
1172114|NCT04138043|2309188|FG000|Overall Study|Withdrawal by Subject|0
1172115|NCT04138043|2309189|FG001|Overall Study|Withdrawal by Subject|1
1172116|NCT04132336|2309222|FG000|Overall Study|Investigator Decision|0
1172117|NCT04132336|2309223|FG001|Overall Study|Investigator Decision|1
1172118|NCT04132336|2309224|FG002|Overall Study|Investigator Decision|0
1172119|NCT04132336|2309225|FG003|Overall Study|Investigator Decision|0
1172120|NCT04132336|2309226|FG004|Overall Study|Investigator Decision|0
1172121|NCT04132336|2309227|FG005|Overall Study|Investigator Decision|0
1172122|NCT04132336|2309228|FG006|Overall Study|Investigator Decision|0
1172123|NCT04128293|2309268|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
1172124|NCT04128293|2309269|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
1172125|NCT04128293|2309270|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
1172126|NCT04128293|2309271|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
1172127|NCT04126343|2309292|FG000|Overall Study|Adverse Event|0
1172128|NCT04126343|2309293|FG001|Overall Study|Adverse Event|0
1172129|NCT04126343|2309294|FG002|Overall Study|Adverse Event|0
1172130|NCT04126343|2309295|FG003|Overall Study|Adverse Event|0
1172131|NCT04126343|2309296|FG004|Overall Study|Adverse Event|0
1172132|NCT04126343|2309297|FG005|Overall Study|Adverse Event|1
1172133|NCT04126343|2309292|FG000|Overall Study|Withdrawal by Subject|0
1172134|NCT04126343|2309293|FG001|Overall Study|Withdrawal by Subject|0
1172135|NCT04126343|2309294|FG002|Overall Study|Withdrawal by Subject|0
1172136|NCT04126343|2309295|FG003|Overall Study|Withdrawal by Subject|1
1172137|NCT04126343|2309296|FG004|Overall Study|Withdrawal by Subject|0
1172138|NCT04126343|2309297|FG005|Overall Study|Withdrawal by Subject|0
1172139|NCT04126343|2309292|FG000|Overall Study|Related to COVID-19 pandemic|3
1172140|NCT04126343|2309293|FG001|Overall Study|Related to COVID-19 pandemic|4
1172141|NCT04126343|2309294|FG002|Overall Study|Related to COVID-19 pandemic|3
1172142|NCT04126343|2309295|FG003|Overall Study|Related to COVID-19 pandemic|3
1172143|NCT04126343|2309296|FG004|Overall Study|Related to COVID-19 pandemic|3
1172144|NCT04126343|2309297|FG005|Overall Study|Related to COVID-19 pandemic|3
1172145|NCT04124952|2309316|FG000|Overall Study|Lost to Follow-up|1
1172146|NCT04123665|2309322|FG000|Overall Study|Withdrawal by Subject|7
1172147|NCT04123665|2309323|FG001|Overall Study|Withdrawal by Subject|0
1172148|NCT04123665|2309322|FG000|Overall Study|Lost to Follow-up|1
1172149|NCT04123665|2309323|FG001|Overall Study|Lost to Follow-up|0
1172150|NCT04122534|2309329|FG000|Overall Study|Lost to Follow-up|4
1172151|NCT04096365|2309383|FG000|Overall Study|Adverse Event|1
1172152|NCT04080297|2309389|FG000|Overall Study|Adverse Event|1
1172153|NCT04080297|2309390|FG001|Overall Study|Adverse Event|3
1172154|NCT04080297|2309389|FG000|Overall Study|concurrent illness|1
1172155|NCT04080297|2309390|FG001|Overall Study|concurrent illness|0
1172156|NCT04115358|2309399|FG000|Overall Study|exfoliation|0
1172157|NCT04115358|2309400|FG001|Overall Study|exfoliation|0
1172158|NCT04115358|2309401|FG002|Overall Study|exfoliation|1
1172159|NCT04113694|2309425|FG000|Overall Study|Adverse Event|2
1172160|NCT04113694|2309425|FG000|Overall Study|Lost to Follow-up|2
1172161|NCT04113694|2309425|FG000|Overall Study|Withdrawal by Subject|6
1172162|NCT04113694|2309425|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1
1172163|NCT04109222|2309474|FG000|Overall Study|Adverse Event|1
1172164|NCT04109222|2309475|FG001|Overall Study|Adverse Event|0
1172165|NCT04109222|2309476|FG002|Overall Study|Adverse Event|0
1172166|NCT04106817|2309494|FG000|Overall Study|Lost to Follow-up|1
1172167|NCT04106817|2309495|FG001|Overall Study|Lost to Follow-up|0
1172168|NCT04106817|2309496|FG002|Overall Study|Lost to Follow-up|0
1172169|NCT04105972|2309506|FG000|Overall Study|Adverse Event|2
1172170|NCT04105972|2309507|FG001|Overall Study|Adverse Event|1
1172171|NCT04105218|2309515|FG000|Overall Study|Withdrawal by Subject|3
1172172|NCT04105218|2309516|FG001|Overall Study|Withdrawal by Subject|2
1172173|NCT04105218|2309515|FG000|Overall Study|Study was terminated; unable to complete study visits|1
1172174|NCT04105218|2309516|FG001|Overall Study|Study was terminated; unable to complete study visits|3
1172175|NCT04105218|2309515|FG000|Overall Study|Failed screening tests|2
1172176|NCT04105218|2309516|FG001|Overall Study|Failed screening tests|1
1172177|NCT04102540|2309531|FG000|Overall Study|Withdrawn by PI|2
1172178|NCT04102540|2309531|FG000|Overall Study|Lost to Follow-up|6
1172179|NCT04102345|2309537|FG000|Overall Study|Withdrawal by Subject|1
1172180|NCT04102345|2309538|FG001|Overall Study|Withdrawal by Subject|0
1172181|NCT04099277|2309587|FG000|Overall Study|Physician Decision|1
1172182|NCT04099277|2309587|FG000|Overall Study|Withdrawal by Subject|1
1172183|NCT04098809|2309593|FG000|Overall Study|Withdrawal by Subject|1
1172184|NCT04098809|2309594|FG001|Overall Study|Withdrawal by Subject|3
1172185|NCT04098809|2309593|FG000|Overall Study|Physician Decision|2
1172186|NCT04098809|2309594|FG001|Overall Study|Physician Decision|1
1172187|NCT04098458|2309613|FG000|Overall Study|Death|1
1172188|NCT04098458|2309613|FG000|Overall Study|did not meet study inclusion criteria|3
1172189|NCT04095286|2309624|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
1172190|NCT04095286|2309625|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1
1172191|NCT04095286|2309626|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
1172192|NCT04095286|2309627|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
1172193|NCT04095286|2309628|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
1172194|NCT04095286|2309629|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
1172195|NCT04095286|2309624|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1
1172196|NCT04095286|2309625|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
1172197|NCT04095286|2309626|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
1172198|NCT04095286|2309627|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
1172199|NCT04095286|2309628|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
1172200|NCT04095286|2309629|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
1172201|NCT04095286|2309624|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
1172202|NCT04095286|2309625|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
1172203|NCT04095286|2309626|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1
1172204|NCT04095286|2309627|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
1172205|NCT04095286|2309628|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
1172206|NCT04095286|2309629|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
1172207|NCT04095286|2309624|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
1172208|NCT04095286|2309625|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
1172209|NCT04095286|2309626|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2
1172210|NCT04095286|2309627|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
1172211|NCT04095286|2309628|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
1172212|NCT04095286|2309629|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
1172213|NCT04095286|2309624|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
1172214|NCT04095286|2309625|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
1172215|NCT04095286|2309626|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
1172216|NCT04095286|2309627|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
1172217|NCT04095286|2309628|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1
1172218|NCT04095286|2309629|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
1172219|NCT04094883|2309637|FG000|Overall Study|Withdrawal by Subject|1
1172220|NCT04091659|2309643|FG000|Overall Study|Protocol Violation|3
1172221|NCT04091659|2309644|FG001|Overall Study|Protocol Violation|0
1172222|NCT04091659|2309643|FG000|Overall Study|Lost to Follow-up|0
1172223|NCT04091659|2309644|FG001|Overall Study|Lost to Follow-up|1
1172224|NCT04090242|2309669|FG000|Overall Study|Withdrawal by Subject|1
1172225|NCT04090242|2309670|FG001|Overall Study|Withdrawal by Subject|0
1172226|NCT04089761|2309677|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14
870461|NCT00530023|1831548|FG000|Overall Study|Withdrawal by Subject|0
870462|NCT00530023|1831549|FG001|Overall Study|Withdrawal by Subject|1
870463|NCT00530075|1831555|FG000|Overall Study|Adverse Event|1
870464|NCT00530075|1831555|FG000|Overall Study|Death|1
870465|NCT00530075|1831555|FG000|Overall Study|Lack of Efficacy|3
870466|NCT00530075|1831555|FG000|Overall Study|Protocol Violation|1
870467|NCT00530075|1831555|FG000|Overall Study|Withdrawal by Subject|1
870468|NCT00530088|1831559|FG000|Overall Study|Disease Progression|4
870469|NCT00530088|1831559|FG000|Overall Study|Physician Decision|4
870470|NCT00530088|1831559|FG000|Overall Study|Other Not Specified|2
870471|NCT00530218|1831563|FG000|Overall Study|CMV Not Detected|13
870472|NCT00530218|1831563|FG000|Overall Study|Death|12
870473|NCT00530257|1831570|FG000|Overall Study|Lost to Follow-up|1
870474|NCT00530270|1831579|FG000|Overall Study|Protocol Violation|1
870475|NCT00530270|1831580|FG001|Overall Study|Protocol Violation|0
1172227|NCT04089761|2309677|FG000|"Run In Phase"|Lost to Follow-up|1
1172228|NCT04089761|2309677|FG000|"Treatment Phase"|No evaluable data|5
1172229|NCT04089761|2309677|FG000|"Treatment Phase"|Lost to Follow-up|1
1172230|NCT04079803|2309684|FG000|Overall Study|Withdrawal by Subject|0
1172231|NCT04079803|2309685|FG001|Overall Study|Withdrawal by Subject|0
1172232|NCT04079803|2309686|FG002|Overall Study|Withdrawal by Subject|1
1172233|NCT04084769|2309725|FG000|Overall Study|Protocol Violation|1
1172234|NCT04084769|2309726|FG001|Overall Study|Protocol Violation|3
1172235|NCT04084769|2309727|FG002|Overall Study|Protocol Violation|0
1172236|NCT04084769|2309728|FG003|Overall Study|Protocol Violation|1
1172237|NCT04084769|2309725|FG000|Overall Study|Withdrawal by Subject|0
1172238|NCT04084769|2309726|FG001|Overall Study|Withdrawal by Subject|1
1172239|NCT04084769|2309727|FG002|Overall Study|Withdrawal by Subject|0
1172240|NCT04084769|2309728|FG003|Overall Study|Withdrawal by Subject|0
1172241|NCT04084769|2309725|FG000|Overall Study|Withdrawal by parent/guardian|1
1172242|NCT04084769|2309726|FG001|Overall Study|Withdrawal by parent/guardian|0
1172243|NCT04084769|2309727|FG002|Overall Study|Withdrawal by parent/guardian|0
1172244|NCT04084769|2309728|FG003|Overall Study|Withdrawal by parent/guardian|1
1172245|NCT04084769|2309725|FG000|Overall Study|Lost to Follow-up|2
1172246|NCT04084769|2309726|FG001|Overall Study|Lost to Follow-up|0
1172247|NCT04084769|2309727|FG002|Overall Study|Lost to Follow-up|0
1172248|NCT04084769|2309728|FG003|Overall Study|Lost to Follow-up|0
1172249|NCT04086641|2309764|FG000|Foot 1 (Two Week Utilization)|COVID-19|1
1172250|NCT04086641|2309765|FG001|Foot 1 (Two Week Utilization)|COVID-19|2
1172251|NCT04086472|2309785|FG000|Overall Study|Lost to Follow-up|1
1172252|NCT04086472|2309786|FG001|Overall Study|Lost to Follow-up|0
1172253|NCT04086472|2309787|FG002|Overall Study|Lost to Follow-up|0
1172254|NCT04086472|2309788|FG003|Overall Study|Lost to Follow-up|0
1172255|NCT04086472|2309789|FG004|Overall Study|Lost to Follow-up|1
1172256|NCT04086472|2309785|FG000|Overall Study|Physician Decision|0
1172257|NCT04086472|2309786|FG001|Overall Study|Physician Decision|1
1172258|NCT04086472|2309787|FG002|Overall Study|Physician Decision|1
1172259|NCT04086472|2309788|FG003|Overall Study|Physician Decision|0
1172260|NCT04086472|2309789|FG004|Overall Study|Physician Decision|0
1172261|NCT04086472|2309785|FG000|Overall Study|Withdrawal by Subject|1
1172262|NCT04086472|2309786|FG001|Overall Study|Withdrawal by Subject|1
1172263|NCT04086472|2309787|FG002|Overall Study|Withdrawal by Subject|1
1172264|NCT04086472|2309788|FG003|Overall Study|Withdrawal by Subject|0
1172265|NCT04086472|2309789|FG004|Overall Study|Withdrawal by Subject|0
1172266|NCT04086472|2309785|FG000|Overall Study|Various reasons|2
1172267|NCT04086472|2309786|FG001|Overall Study|Various reasons|0
1172268|NCT04086472|2309787|FG002|Overall Study|Various reasons|0
1172269|NCT04086472|2309788|FG003|Overall Study|Various reasons|3
1172270|NCT04086472|2309789|FG004|Overall Study|Various reasons|1
1172271|NCT04085289|2309804|FG000|Overall Study|Withdrawal by Subject|0
1172272|NCT04085289|2309805|FG001|Overall Study|Withdrawal by Subject|0
1172273|NCT04085289|2309806|FG002|Overall Study|Withdrawal by Subject|1
1172274|NCT04082663|2309817|FG000|Overall Study|Adverse Event|6
1172275|NCT04082663|2309817|FG000|Overall Study|Lost to Follow-up|1
1172276|NCT04079790|2309898|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1
1172277|NCT04079790|2309899|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
1172278|NCT04079790|2309900|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
1172279|NCT04079790|2309901|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
1172280|NCT04079790|2309898|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
1172281|NCT04079790|2309899|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
1172282|NCT04079790|2309900|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1
1172283|NCT04079790|2309901|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
1172284|NCT04079790|2309898|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
1172285|NCT04079790|2309899|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
1172286|NCT04079790|2309900|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2
1172287|NCT04079790|2309901|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
1172288|NCT04073407|2309992|FG000|Part 1|Withdrawal by Subject|1
1172289|NCT04073407|2309993|FG001|Part 1|Withdrawal by Subject|0
1172290|NCT04073407|2309992|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4
1172291|NCT04073407|2309993|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1
1172292|NCT04073407|2309992|FG000|Part 2|Withdrawal by Subject|0
1172293|NCT04073407|2309993|FG001|Part 2|Withdrawal by Subject|1
1172294|NCT04073368|2310003|FG000|Overall Study|Adverse Event|2
1172295|NCT04073368|2310004|FG001|Overall Study|Adverse Event|0
1172296|NCT04073368|2310005|FG002|Overall Study|Adverse Event|1
1172297|NCT04073368|2310006|FG003|Overall Study|Adverse Event|1
1172298|NCT04073368|2310003|FG000|Overall Study|Withdrawal by Subject|2
1172299|NCT04073368|2310004|FG001|Overall Study|Withdrawal by Subject|2
1172300|NCT04073368|2310005|FG002|Overall Study|Withdrawal by Subject|1
1172301|NCT04073368|2310006|FG003|Overall Study|Withdrawal by Subject|1
1172302|NCT04073368|2310003|FG000|Overall Study|Lost to Follow-up|1
1172303|NCT04073368|2310004|FG001|Overall Study|Lost to Follow-up|1
1172304|NCT04073368|2310005|FG002|Overall Study|Lost to Follow-up|1
1172305|NCT04073368|2310006|FG003|Overall Study|Lost to Follow-up|0
1172306|NCT04073368|2310003|FG000|Overall Study|Protocol Violation|0
1172307|NCT04073368|2310004|FG001|Overall Study|Protocol Violation|1
1172308|NCT04073368|2310005|FG002|Overall Study|Protocol Violation|0
1172309|NCT04073368|2310006|FG003|Overall Study|Protocol Violation|0
1172310|NCT04073368|2310003|FG000|Overall Study|Subject noncompliance|7
1172311|NCT04073368|2310004|FG001|Overall Study|Subject noncompliance|4
1172312|NCT04073368|2310005|FG002|Overall Study|Subject noncompliance|0
1172313|NCT04073368|2310006|FG003|Overall Study|Subject noncompliance|0
1172314|NCT04073186|2310016|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1
1172315|NCT04073186|2310016|FG000|First Wearing Cycle|Withdrawal by Subject|1
1172316|NCT04073186|2310016|FG000|First Wearing Cycle|Protocol Violation|1
1172317|NCT04073186|2310016|FG000|First Wearing Cycle|Lens Discomfort|2
1172318|NCT04073186|2310016|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1
1172319|NCT04073186|2310016|FG000|Second Wearing Cycle|Adverse Event|1
1172320|NCT04071301|2310097|FG000|Overall Study|Withdrawal by Subject|6
1172321|NCT04071301|2310097|FG000|Overall Study|Death|1
1172322|NCT04071158|2310106|FG000|Overall Study|Lost to Follow-up|1
1172323|NCT04071158|2310107|FG001|Overall Study|Lost to Follow-up|2
1172324|NCT04071158|2310108|FG002|Overall Study|Lost to Follow-up|3
1172325|NCT04071158|2310109|FG003|Overall Study|Lost to Follow-up|3
1172326|NCT04071158|2310110|FG004|Overall Study|Lost to Follow-up|5
1172327|NCT04071158|2310106|FG000|Overall Study|Randomized but not treated|2
1172328|NCT04071158|2310107|FG001|Overall Study|Randomized but not treated|2
1172329|NCT04071158|2310108|FG002|Overall Study|Randomized but not treated|0
1172330|NCT04071158|2310109|FG003|Overall Study|Randomized but not treated|0
1172331|NCT04071158|2310110|FG004|Overall Study|Randomized but not treated|0
1172332|NCT04069715|2310157|FG000|Overall Study|Lost to Follow-up|1
1172333|NCT04069715|2310158|FG001|Overall Study|Lost to Follow-up|1
1172334|NCT04069715|2310157|FG000|Overall Study|Physician Decision|1
1172335|NCT04069715|2310158|FG001|Overall Study|Physician Decision|1
1172336|NCT04069715|2310157|FG000|Overall Study|Withdrawal by Subject|3
1172337|NCT04069715|2310158|FG001|Overall Study|Withdrawal by Subject|3
1172338|NCT04050722|2310166|FG000|Overall Study|Withdrawal by Subject|1
1172339|NCT04050722|2310167|FG001|Overall Study|Withdrawal by Subject|0
1172340|NCT04067141|2310188|FG000|First Intervention|Withdrawal by Subject|0
1172341|NCT04067141|2310189|FG001|First Intervention|Withdrawal by Subject|1
1172342|NCT04067141|2310188|FG000|Second Intervention|Adverse Event|0
1172343|NCT04067141|2310189|FG001|Second Intervention|Adverse Event|2
1172346|NCT04049578|2310199|FG000|Overall Study|Physician Decision|1
1172347|NCT04067401|2310205|FG000|Overall Study|Withdrawal by Subject|7
1172348|NCT04067401|2310206|FG001|Overall Study|Withdrawal by Subject|0
1172349|NCT04067401|2310205|FG000|Overall Study|no data provided|1
1172350|NCT04067401|2310206|FG001|Overall Study|no data provided|0
1172351|NCT04067050|2310214|FG000|One Month|Lost to Follow-up|4
1172352|NCT04067050|2310215|FG001|One Month|Lost to Follow-up|0
1172353|NCT04067050|2310214|FG000|Two Month|Lost to Follow-up|1
1172354|NCT04067050|2310215|FG001|Two Month|Lost to Follow-up|0
1172355|NCT04067050|2310214|FG000|Two Month|Adverse Event|1
1172356|NCT04067050|2310215|FG001|Two Month|Adverse Event|0
1172357|NCT04060654|2310251|FG000|Overall Study|Withdrawal by Subject|1
1172358|NCT04060654|2310251|FG000|Overall Study|Lost to Follow-up|5
1172359|NCT04058353|2310264|FG000|Overall Study|Adverse Event|2
1172360|NCT04058353|2310265|FG001|Overall Study|Adverse Event|1
1172361|NCT04058353|2310264|FG000|Overall Study|Physician Decision|1
1172362|NCT04058353|2310265|FG001|Overall Study|Physician Decision|0
1172363|NCT04058353|2310264|FG000|Overall Study|Other|1
1172364|NCT04058353|2310265|FG001|Overall Study|Other|0
1172365|NCT04054765|2310297|FG000|Baseline|Withdrawal by Subject|5
1172366|NCT04054765|2310298|FG001|Baseline|Withdrawal by Subject|3
1172367|NCT04054765|2310297|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8
1172368|NCT04054765|2310298|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3
1172369|NCT04054765|2310297|FG000|3-month Follow up|Withdrawal by Subject|0
1172370|NCT04054765|2310298|FG001|3-month Follow up|Withdrawal by Subject|3
1172371|NCT04054765|2310297|FG000|6-month Follow up|Lost to Follow-up|32
1172372|NCT04054765|2310298|FG001|6-month Follow up|Lost to Follow-up|32
1172373|NCT04054011|2310304|FG000|Overall Study|COVID|3
1172374|NCT04059094|2310315|FG000|Overall Study|Adverse Event|0
1172375|NCT04059094|2310316|FG001|Overall Study|Adverse Event|0
1172376|NCT04059094|2310317|FG002|Overall Study|Adverse Event|0
1172377|NCT04059094|2310318|FG003|Overall Study|Adverse Event|0
1172378|NCT04059094|2310319|FG004|Overall Study|Adverse Event|1
1172379|NCT04059094|2310315|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0
1172380|NCT04059094|2310316|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2
1172381|NCT04059094|2310317|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0
1172382|NCT04059094|2310318|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0
1172383|NCT04059094|2310319|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0
1172384|NCT04046341|2310344|FG000|Overall Study|Lost to Follow-up|2
1172385|NCT04046341|2310344|FG000|Overall Study|Withdrawal by Subject|1
1172386|NCT04043416|2310359|FG000|Washout|Change in health condition|0
1172387|NCT04043416|2310360|FG001|Washout|Change in health condition|1
1172388|NCT04054193|2310426|FG000|Cycle 1|Physician Decision|1
1172389|NCT04054193|2310426|FG000|Cycle 1|Consent withdrawn by parent/guardian|1
1172390|NCT04054193|2310426|FG000|Cycle 1|Allocated but not treated|3
1172391|NCT04054193|2310426|FG000|Cycles 2-3|Physician Decision|2
1172392|NCT04054193|2310426|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2
1172393|NCT04054193|2310426|FG000|Cycles 2-3|Various reasons|17
1172394|NCT04050618|2310433|FG000|First Intervention|Withdrawal by Subject|2
1172395|NCT04050618|2310434|FG001|First Intervention|Withdrawal by Subject|0
1172396|NCT04050618|2310433|FG000|Second Intervention|Withdrawal by Subject|1
1172397|NCT04050618|2310434|FG001|Second Intervention|Withdrawal by Subject|0
1172398|NCT04053465|2310447|FG000|Overall Study|Withdrawal by Subject|4
1172399|NCT04053465|2310448|FG001|Overall Study|Withdrawal by Subject|4
1172400|NCT04049552|2310467|FG000|Overall Study|Lost to Follow-up|1
1172401|NCT04053023|2310475|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1
1172402|NCT04053023|2310476|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0
1172403|NCT04050865|2310501|FG000|Overall Study|Adverse Event|1
1172404|NCT04050865|2310502|FG001|Overall Study|Adverse Event|0
1172405|NCT04050865|2310501|FG000|Overall Study|no insert|1
1172406|NCT04050865|2310502|FG001|Overall Study|no insert|0
1172407|NCT04050865|2310501|FG000|Overall Study|Only 1 insert|2
1172408|NCT04050865|2310502|FG001|Overall Study|Only 1 insert|3
1172409|NCT04050865|2310501|FG000|Overall Study|Physician Decision|0
1172410|NCT04050865|2310502|FG001|Overall Study|Physician Decision|1
1172411|NCT04050865|2310501|FG000|Overall Study|Withdrawal by Subject|0
1172412|NCT04050865|2310502|FG001|Overall Study|Withdrawal by Subject|1
1172413|NCT04050371|2310520|FG000|Overall Study|Withdrawal by Subject|1
1172414|NCT04050371|2310521|FG001|Overall Study|Withdrawal by Subject|0
1172415|NCT04048681|2310531|FG000|Overall Study|family emergency|0
1172416|NCT04048681|2310532|FG001|Overall Study|family emergency|0
1172417|NCT04048681|2310533|FG002|Overall Study|family emergency|0
1172418|NCT04048681|2310534|FG003|Overall Study|family emergency|1
1172419|NCT04048681|2310535|FG004|Overall Study|family emergency|0
1172420|NCT04046250|2310545|FG000|Overall Study|Death|0
1172421|NCT04046250|2310546|FG001|Overall Study|Death|1
1172422|NCT04046250|2310545|FG000|Overall Study|Withdrawal by Subject|3
1172423|NCT04046250|2310546|FG001|Overall Study|Withdrawal by Subject|3
1172424|NCT04044352|2310561|FG000|Overall Study|Lost to Follow-up|9
1172425|NCT04044352|2310561|FG000|Overall Study|Withdrawal by Subject|2
1172426|NCT04043728|2310569|FG000|Overall Study|Lost to Follow-up|1
1172427|NCT04043728|2310570|FG001|Overall Study|Lost to Follow-up|2
1172428|NCT04043728|2310571|FG002|Overall Study|Lost to Follow-up|0
1172429|NCT04041414|2310600|FG000|Overall Study|Lost to Follow-up|1
1172430|NCT04041414|2310601|FG001|Overall Study|Lost to Follow-up|2
1172431|NCT04041700|2310614|FG000|Overall Study|Pregnancy|1
1172432|NCT04041700|2310614|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1
1172433|NCT04040933|2310618|FG000|Overall Study|Protocol Violation|1
1172434|NCT04040933|2310618|FG000|Overall Study|Withdrawal by Subject|2
1172435|NCT04029519|2310659|FG000|Overall Study|Protocol Violation|1
1172436|NCT04029519|2310659|FG000|Overall Study|Withdrawal by Subject|3
1172437|NCT04029519|2310659|FG000|Overall Study|Lost to Follow-up|1
1172438|NCT04024228|2310665|FG000|Overall Study|Adverse Event|1
1172439|NCT04024228|2310666|FG001|Overall Study|Adverse Event|0
1172440|NCT04024228|2310665|FG000|Overall Study|Protocol Deviation|0
1172441|NCT04024228|2310666|FG001|Overall Study|Protocol Deviation|2
1172442|NCT04024228|2310665|FG000|Overall Study|Withdrawal by Subject|3
1172443|NCT04024228|2310666|FG001|Overall Study|Withdrawal by Subject|4
1172444|NCT04039919|2310679|FG000|Treatment Period 1|Withdrawal by Subject|1
1172445|NCT04039919|2310680|FG001|Treatment Period 1|Withdrawal by Subject|0
1172446|NCT04039919|2310681|FG002|Treatment Period 1|Withdrawal by Subject|0
1172447|NCT04039919|2310682|FG003|Treatment Period 1|Withdrawal by Subject|0
1172448|NCT04039919|2310683|FG004|Treatment Period 1|Withdrawal by Subject|0
1172449|NCT04039919|2310679|FG000|Treatment Period 1|Sponsor's decision|0
1172450|NCT04039919|2310680|FG001|Treatment Period 1|Sponsor's decision|0
1172451|NCT04039919|2310681|FG002|Treatment Period 1|Sponsor's decision|0
1172452|NCT04039919|2310682|FG003|Treatment Period 1|Sponsor's decision|0
1172453|NCT04039919|2310683|FG004|Treatment Period 1|Sponsor's decision|16
1172454|NCT04039919|2310679|FG000|Treatment Period 5|Withdrawal by Subject|1
1172455|NCT04039919|2310680|FG001|Treatment Period 5|Withdrawal by Subject|0
1172456|NCT04039919|2310681|FG002|Treatment Period 5|Withdrawal by Subject|0
1172457|NCT04039919|2310682|FG003|Treatment Period 5|Withdrawal by Subject|0
1172458|NCT04039919|2310683|FG004|Treatment Period 5|Withdrawal by Subject|0
1172459|NCT04037748|2310732|FG000|Treatment Period 1|Withdrawal by Subject|3
1172460|NCT04037748|2310733|FG001|Treatment Period 1|Withdrawal by Subject|0
1172461|NCT04037748|2310732|FG000|Treatment Period 1|Adverse Event|1
1172462|NCT04037748|2310733|FG001|Treatment Period 1|Adverse Event|1
1172463|NCT04037748|2310732|FG000|Treatment Period 1|Protocol Violation|4
1172464|NCT04037748|2310733|FG001|Treatment Period 1|Protocol Violation|5
1172465|NCT04037748|2310732|FG000|Treatment Period 2|Adverse Event|0
1172466|NCT04037748|2310733|FG001|Treatment Period 2|Adverse Event|1
1172467|NCT04037748|2310732|FG000|Treatment Period 2|Protocol Violation|2
1172468|NCT04037748|2310733|FG001|Treatment Period 2|Protocol Violation|0
1172469|NCT04027686|2310750|FG000|Overall Study|Lost to Follow-up|2
1172470|NCT04027686|2310751|FG001|Overall Study|Lost to Follow-up|0
1172471|NCT04027686|2310750|FG000|Overall Study|Withdrawal by Subject|0
1172472|NCT04027686|2310751|FG001|Overall Study|Withdrawal by Subject|1
1172473|NCT04036110|2310781|FG000|Overall Study|Lost to Follow-up|3
1172474|NCT04036110|2310782|FG001|Overall Study|Lost to Follow-up|2
1172475|NCT04036110|2310783|FG002|Overall Study|Lost to Follow-up|1
1172476|NCT04036110|2310781|FG000|Overall Study|Study Suspended|4
1172477|NCT04036110|2310782|FG001|Overall Study|Study Suspended|5
1172478|NCT04036110|2310783|FG002|Overall Study|Study Suspended|1
1172479|NCT04035577|2310800|FG000|Overall Study|Lost to Follow-up|1
1172480|NCT04035577|2310800|FG000|Overall Study|Withdrawal by Subject|1
1172481|NCT04035564|2310808|FG000|Overall Study|Protocol Violation|1
1172482|NCT04035564|2310809|FG001|Overall Study|Protocol Violation|2
1172483|NCT04035564|2310808|FG000|Overall Study|No laboratory available|2
1172484|NCT04035564|2310809|FG001|Overall Study|No laboratory available|2
1172485|NCT04035564|2310808|FG000|Overall Study|Guardian declined consent|1
1172486|NCT04035564|2310809|FG001|Overall Study|Guardian declined consent|2
1172487|NCT04032977|2310817|FG000|Overall Study|Withdrawal by Subject|6
1172488|NCT04032977|2310818|FG001|Overall Study|Withdrawal by Subject|1
1172489|NCT04032977|2310817|FG000|Overall Study|Lost to Follow-up|2
1172490|NCT04032977|2310818|FG001|Overall Study|Lost to Follow-up|7
1172491|NCT04032977|2310817|FG000|Overall Study|Pregnancy|1
1172492|NCT04032977|2310818|FG001|Overall Study|Pregnancy|0
1172493|NCT04032652|2310826|FG000|Overall Study|The study was terminated and the PI has|1
1172494|NCT04032652|2310827|FG001|Overall Study|The study was terminated and the PI has|1
1172495|NCT04032613|2310847|FG000|Overall Study|Did not complete post-program assessment|5
1172496|NCT04032613|2310848|FG001|Overall Study|Did not complete post-program assessment|2
1172497|NCT04032171|2310856|FG000|Overall Study|Study Termination|1
1172498|NCT04032171|2310857|FG001|Overall Study|Study Termination|0
1172499|NCT04032158|2310865|FG000|Overall Study|Study Termination|2
1172500|NCT04032158|2310866|FG001|Overall Study|Study Termination|1
1172501|NCT04031404|2310872|FG000|Baseline|Lost to Follow-up|0
1172502|NCT04031404|2310873|FG001|Baseline|Lost to Follow-up|1
870476|NCT00530335|1831586|FG000|Overall Study|Adverse Event|3
870477|NCT00530335|1831586|FG000|Overall Study|Protocol Violation|1
870478|NCT00530335|1831586|FG000|Overall Study|Withdrawal by Subject|1
870479|NCT00530335|1831586|FG000|Overall Study|Physician Decision|1
870480|NCT00530348|1831592|FG000|Overall Study|Adverse Event|5
870481|NCT00530348|1831593|FG001|Overall Study|Adverse Event|1
870482|NCT00530348|1831592|FG000|Overall Study|Death|0
870483|NCT00530348|1831593|FG001|Overall Study|Death|1
870484|NCT00530348|1831592|FG000|Overall Study|Lack of Efficacy|2
870485|NCT00530348|1831593|FG001|Overall Study|Lack of Efficacy|0
870486|NCT00530348|1831592|FG000|Overall Study|Lost to Follow-up|0
870487|NCT00530348|1831593|FG001|Overall Study|Lost to Follow-up|2
870488|NCT00530348|1831592|FG000|Overall Study|Physician Decision|1
870489|NCT00530348|1831593|FG001|Overall Study|Physician Decision|2
870490|NCT00530348|1831592|FG000|Overall Study|Pregnancy|1
870491|NCT00530348|1831593|FG001|Overall Study|Pregnancy|0
870492|NCT00530348|1831592|FG000|Overall Study|Withdrawal by Subject|12
870493|NCT00530348|1831593|FG001|Overall Study|Withdrawal by Subject|12
870494|NCT00530348|1831592|FG000|Overall Study|Randomised in error|1
870495|NCT00530348|1831593|FG001|Overall Study|Randomised in error|0
870496|NCT00530348|1831592|FG000|Overall Study|Noncompliance with inclusion criterion 3|0
870497|NCT00530348|1831593|FG001|Overall Study|Noncompliance with inclusion criterion 3|1
870498|NCT00530439|1831601|FG000|Overall Study|GDM|9
870499|NCT00530439|1831602|FG001|Overall Study|GDM|3
870500|NCT00530439|1831601|FG000|Overall Study|Withdraw|18
870501|NCT00530439|1831602|FG001|Overall Study|Withdraw|14
870502|NCT00530439|1831601|FG000|Overall Study|Missed abortion|1
870503|NCT00530439|1831602|FG001|Overall Study|Missed abortion|4
870504|NCT00530439|1831601|FG000|Overall Study|Misclassification|2
870505|NCT00530439|1831602|FG001|Overall Study|Misclassification|0
870506|NCT00530439|1831601|FG000|Overall Study|Twin pregnancy|0
870507|NCT00530439|1831602|FG001|Overall Study|Twin pregnancy|2
870508|NCT00530439|1831601|FG000|Overall Study|Severe malformation/abortion|0
870509|NCT00530439|1831602|FG001|Overall Study|Severe malformation/abortion|3
870510|NCT00530504|1831608|FG000|Overall Study|Death|54
870511|NCT00530504|1831608|FG000|Overall Study|Lost to Follow-up|26
870512|NCT00530504|1831608|FG000|Overall Study|Withdrawal by Subject|39
870513|NCT00530504|1831608|FG000|Overall Study|Exited study due to other reasons|33
870514|NCT00530621|1831614|FG000|Overall Study|Adverse Event|11
870515|NCT00530621|1831615|FG001|Overall Study|Adverse Event|8
870516|NCT00530621|1831614|FG000|Overall Study|Physician Decision|2
870517|NCT00530621|1831615|FG001|Overall Study|Physician Decision|4
870518|NCT00530621|1831614|FG000|Overall Study|Progressive Disease (PD)|47
870519|NCT00530621|1831615|FG001|Overall Study|Progressive Disease (PD)|40
870520|NCT00530621|1831614|FG000|Overall Study|Sponsor Decision|12
870521|NCT00530621|1831615|FG001|Overall Study|Sponsor Decision|15
870522|NCT00530621|1831614|FG000|Overall Study|Subject Decision|4
870523|NCT00530621|1831615|FG001|Overall Study|Subject Decision|7
870524|NCT00530621|1831614|FG000|Overall Study|Death|3
870525|NCT00530621|1831615|FG001|Overall Study|Death|6
870526|NCT00530621|1831614|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1
870527|NCT00530621|1831615|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0
870528|NCT00530712|1831629|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2
870529|NCT00530712|1831629|FG000|30 Day Follow-up Visit|Missed Visit|5
870530|NCT00530712|1831629|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4
870531|NCT00530712|1831629|FG000|6 Month Follow-up Visit|Missed Visit|3
870532|NCT00530712|1831629|FG000|6 Month Follow-up Visit|Lost to Follow-up|3
870533|NCT00530712|1831629|FG000|6 Month Follow-up Visit|Death|2
870534|NCT00530712|1831629|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5
870535|NCT00530712|1831629|FG000|12 Month Follow-up Visit|Missed Visit|3
870536|NCT00530712|1831629|FG000|12 Month Follow-up Visit|Lost to Follow-up|7
870537|NCT00530712|1831629|FG000|12 Month Follow-up Visit|Death|9
870538|NCT00530777|1831656|FG000|Overall Study|Lost to Follow-up|0
870539|NCT00530777|1831657|FG001|Overall Study|Lost to Follow-up|1
870540|NCT00530777|1831656|FG000|Overall Study|Death|1
870541|NCT00530777|1831657|FG001|Overall Study|Death|2
870542|NCT00530777|1831656|FG000|Overall Study|Physician Decision|1
870543|NCT00530777|1831657|FG001|Overall Study|Physician Decision|0
870544|NCT00530777|1831656|FG000|Overall Study|Withdrawal by Subject|0
870545|NCT00530777|1831657|FG001|Overall Study|Withdrawal by Subject|1
870546|NCT00530777|1831656|FG000|Overall Study|Unable to adhere to visit schedule|5
870547|NCT00530777|1831657|FG001|Overall Study|Unable to adhere to visit schedule|1
870548|NCT00530790|1831663|FG000|Overall Study|Adverse Event|2
870549|NCT00530790|1831663|FG000|Overall Study|Withdrawal by Subject|2
870550|NCT00530790|1831663|FG000|Overall Study|Physician Decision|1
1172503|NCT04031404|2310872|FG000|Baseline|Did not meet full inclusion/exclusion.|2
1172504|NCT04031404|2310873|FG001|Baseline|Did not meet full inclusion/exclusion.|4
1172505|NCT04031404|2310872|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1
1172506|NCT04031404|2310873|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3
1172507|NCT04031404|2310872|FG000|Pre-randomization|Disqualified by TMS safety screening|1
1172508|NCT04031404|2310873|FG001|Pre-randomization|Disqualified by TMS safety screening|0
1172509|NCT04031404|2310872|FG000|Washout (5 Day Min)|Lost to Follow-up|1
1172510|NCT04031404|2310873|FG001|Washout (5 Day Min)|Lost to Follow-up|0
1172511|NCT04029961|2310918|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1
1172512|NCT04029961|2310919|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0
1172513|NCT04029961|2310918|FG000|Overall Study|Change in Treatment Course|0
1172514|NCT04029961|2310919|FG001|Overall Study|Change in Treatment Course|1
1172515|NCT04025684|2310929|FG000|Overall Study|Withdrawal by Subject|1
1172516|NCT04025684|2310930|FG001|Overall Study|Withdrawal by Subject|1
1172517|NCT04025684|2310931|FG002|Overall Study|Withdrawal by Subject|0
1172518|NCT04025684|2310932|FG003|Overall Study|Withdrawal by Subject|0
870551|NCT00530816|1831679|FG000|Overall Study|Progressive Disease|16
870552|NCT00530816|1831680|FG001|Overall Study|Progressive Disease|24
870553|NCT00530816|1831681|FG002|Overall Study|Progressive Disease|24
870554|NCT00530816|1831679|FG000|Overall Study|Adverse Event|6
870555|NCT00530816|1831680|FG001|Overall Study|Adverse Event|13
870556|NCT00530816|1831681|FG002|Overall Study|Adverse Event|7
870557|NCT00530816|1831679|FG000|Overall Study|Other|3
870558|NCT00530816|1831680|FG001|Overall Study|Other|3
870559|NCT00530816|1831681|FG002|Overall Study|Other|4
870560|NCT00530816|1831679|FG000|Overall Study|Withdrawal by Subject|1
870561|NCT00530816|1831680|FG001|Overall Study|Withdrawal by Subject|2
870562|NCT00530816|1831681|FG002|Overall Study|Withdrawal by Subject|6
870563|NCT00530842|1831691|FG000|Overall Study|Adverse Event|10
870564|NCT00530842|1831692|FG001|Overall Study|Adverse Event|6
870565|NCT00530842|1831691|FG000|Overall Study|Lack of Efficacy|2
870566|NCT00530842|1831692|FG001|Overall Study|Lack of Efficacy|1
870567|NCT00530842|1831691|FG000|Overall Study|Lost to Follow-up|0
870568|NCT00530842|1831692|FG001|Overall Study|Lost to Follow-up|4
870569|NCT00530842|1831691|FG000|Overall Study|Protocol Violation|3
870570|NCT00530842|1831692|FG001|Overall Study|Protocol Violation|2
870571|NCT00530842|1831691|FG000|Overall Study|Withdrawal by Subject|4
870572|NCT00530842|1831692|FG001|Overall Study|Withdrawal by Subject|5
870573|NCT00530842|1831691|FG000|Overall Study|Individual different reasons|4
870574|NCT00530842|1831692|FG001|Overall Study|Individual different reasons|3
870575|NCT00530842|1831691|FG000|Period 1|Adverse Event|7
870576|NCT00530842|1831692|FG001|Period 1|Adverse Event|3
870577|NCT00530842|1831691|FG000|Period 1|Lack of Efficacy|1
870578|NCT00530842|1831692|FG001|Period 1|Lack of Efficacy|1
870579|NCT00530842|1831691|FG000|Period 1|Protocol Violation|2
870580|NCT00530842|1831692|FG001|Period 1|Protocol Violation|1
870581|NCT00530842|1831691|FG000|Period 1|Withdrawal by Subject|2
870582|NCT00530842|1831692|FG001|Period 1|Withdrawal by Subject|3
870583|NCT00530842|1831691|FG000|Period 1|Individual different reasons|2
870584|NCT00530842|1831692|FG001|Period 1|Individual different reasons|3
870585|NCT00530842|1831691|FG000|Period 2|Adverse Event|3
870586|NCT00530842|1831692|FG001|Period 2|Adverse Event|3
870587|NCT00530842|1831691|FG000|Period 2|Lack of Efficacy|1
870588|NCT00530842|1831692|FG001|Period 2|Lack of Efficacy|0
870589|NCT00530842|1831691|FG000|Period 2|Lost to Follow-up|0
870590|NCT00530842|1831692|FG001|Period 2|Lost to Follow-up|4
870591|NCT00530842|1831691|FG000|Period 2|Protocol Violation|1
870592|NCT00530842|1831692|FG001|Period 2|Protocol Violation|0
870593|NCT00530842|1831691|FG000|Period 2|Withdrawal by Subject|1
870594|NCT00530842|1831692|FG001|Period 2|Withdrawal by Subject|2
870595|NCT00530842|1831691|FG000|Period 2|Individual different reasons|2
870596|NCT00530842|1831692|FG001|Period 2|Individual different reasons|0
870597|NCT00530855|1831700|FG000|Overall Study|Lack of Efficacy|20
870598|NCT00530855|1831700|FG000|Overall Study|Withdrawal by Subject|30
870599|NCT00530855|1831700|FG000|Overall Study|Fatal Serious AE|3
870600|NCT00530855|1831700|FG000|Overall Study|Non Fatal Serious AE|7
870601|NCT00530855|1831700|FG000|Overall Study|Non Fatal Non Serious AE|12
870602|NCT00530855|1831700|FG000|Overall Study|Protocol Violation|3
870603|NCT00530855|1831700|FG000|Overall Study|Unsatisfactory compliance of subject|11
870604|NCT00530855|1831700|FG000|Overall Study|Lost to Follow-up|9
870605|NCT00530855|1831700|FG000|Overall Study|Other reason for premature termination|17
870606|NCT00530894|1831708|FG000|Overall Study|Death|84
870607|NCT00530894|1831709|FG001|Overall Study|Death|89
870608|NCT00530894|1831710|FG002|Overall Study|Death|55
870609|NCT00530894|1831711|FG003|Overall Study|Death|89
870610|NCT00530894|1831708|FG000|Overall Study|Lost to Follow-up|1
870611|NCT00530894|1831709|FG001|Overall Study|Lost to Follow-up|3
870612|NCT00530894|1831710|FG002|Overall Study|Lost to Follow-up|0
870613|NCT00530894|1831711|FG003|Overall Study|Lost to Follow-up|0
870614|NCT00530894|1831708|FG000|Overall Study|Withdrawal by Subject|1
870615|NCT00530894|1831709|FG001|Overall Study|Withdrawal by Subject|23
870616|NCT00530894|1831710|FG002|Overall Study|Withdrawal by Subject|0
870617|NCT00530894|1831711|FG003|Overall Study|Withdrawal by Subject|5
870618|NCT00530894|1831708|FG000|Overall Study|Alive and censored prior to 1 year|2
870619|NCT00530894|1831709|FG001|Overall Study|Alive and censored prior to 1 year|0
870620|NCT00530894|1831710|FG002|Overall Study|Alive and censored prior to 1 year|0
870621|NCT00530894|1831711|FG003|Overall Study|Alive and censored prior to 1 year|0
870622|NCT00530920|1831726|FG000|Overall Study|Randomized but not treated|0
870623|NCT00530920|1831727|FG001|Overall Study|Randomized but not treated|2
870624|NCT00530920|1831728|FG002|Overall Study|Randomized but not treated|0
870625|NCT00530920|1831726|FG000|Overall Study|Adverse Event|0
870626|NCT00530920|1831727|FG001|Overall Study|Adverse Event|0
870627|NCT00530920|1831728|FG002|Overall Study|Adverse Event|3
870628|NCT00530920|1831726|FG000|Overall Study|Withdrawal by Subject|0
870629|NCT00530920|1831727|FG001|Overall Study|Withdrawal by Subject|0
870630|NCT00530920|1831728|FG002|Overall Study|Withdrawal by Subject|1
870631|NCT00530946|1831741|FG000|Overall Study|Adverse Event|1
870632|NCT00530946|1831742|FG001|Overall Study|Adverse Event|2
870633|NCT00530946|1831743|FG002|Overall Study|Adverse Event|1
870634|NCT00530946|1831744|FG003|Overall Study|Adverse Event|1
870635|NCT00530946|1831741|FG000|Overall Study|Protocol Violation|0
870636|NCT00530946|1831742|FG001|Overall Study|Protocol Violation|0
870637|NCT00530946|1831743|FG002|Overall Study|Protocol Violation|0
870638|NCT00530946|1831744|FG003|Overall Study|Protocol Violation|1
870639|NCT00530946|1831741|FG000|Overall Study|Noncompliance|1
870640|NCT00530946|1831742|FG001|Overall Study|Noncompliance|0
870641|NCT00530946|1831743|FG002|Overall Study|Noncompliance|0
870642|NCT00530946|1831744|FG003|Overall Study|Noncompliance|0
870643|NCT00531011|1831756|FG000|Overall Study|Withdrawal by Subject|2
870644|NCT00531011|1831757|FG001|Overall Study|Withdrawal by Subject|4
870645|NCT00531011|1831756|FG000|Overall Study|Death|1
870646|NCT00531011|1831757|FG001|Overall Study|Death|0
870647|NCT00531011|1831756|FG000|Overall Study|Lost to Follow-up|1
870648|NCT00531011|1831757|FG001|Overall Study|Lost to Follow-up|0
870649|NCT00531011|1831756|FG000|Overall Study|Physician Decision|0
870650|NCT00531011|1831757|FG001|Overall Study|Physician Decision|3
870651|NCT00531050|1831769|FG000|Part 1: Period 1|Adverse Event|0
870652|NCT00531050|1831770|FG001|Part 1: Period 1|Adverse Event|1
870653|NCT00531050|1831771|FG002|Part 1: Period 1|Adverse Event|0
870654|NCT00531050|1831772|FG003|Part 1: Period 1|Adverse Event|0
870655|NCT00531050|1831773|FG004|Part 1: Period 1|Adverse Event|0
870656|NCT00531050|1831774|FG005|Part 1: Period 1|Adverse Event|0
870657|NCT00531050|1831769|FG000|Part 1: Period 1|Protocol Deviation|0
870658|NCT00531050|1831770|FG001|Part 1: Period 1|Protocol Deviation|0
870659|NCT00531050|1831771|FG002|Part 1: Period 1|Protocol Deviation|0
870660|NCT00531050|1831772|FG003|Part 1: Period 1|Protocol Deviation|1
870661|NCT00531050|1831773|FG004|Part 1: Period 1|Protocol Deviation|0
870662|NCT00531050|1831774|FG005|Part 1: Period 1|Protocol Deviation|0
870663|NCT00531050|1831769|FG000|Part 1: Period 3|Adverse Event|1
870664|NCT00531050|1831770|FG001|Part 1: Period 3|Adverse Event|0
870665|NCT00531050|1831771|FG002|Part 1: Period 3|Adverse Event|0
870666|NCT00531050|1831772|FG003|Part 1: Period 3|Adverse Event|0
870667|NCT00531050|1831773|FG004|Part 1: Period 3|Adverse Event|0
870668|NCT00531050|1831774|FG005|Part 1: Period 3|Adverse Event|0
870669|NCT00531050|1831769|FG000|Part 2: Period 1|Adverse Event|0
870670|NCT00531050|1831770|FG001|Part 2: Period 1|Adverse Event|0
870671|NCT00531050|1831771|FG002|Part 2: Period 1|Adverse Event|0
870672|NCT00531050|1831772|FG003|Part 2: Period 1|Adverse Event|0
870673|NCT00531050|1831773|FG004|Part 2: Period 1|Adverse Event|0
870674|NCT00531050|1831774|FG005|Part 2: Period 1|Adverse Event|1
870675|NCT00531050|1831769|FG000|Part 2: Period 3|Abnormal test procedure|1
870676|NCT00531050|1831770|FG001|Part 2: Period 3|Abnormal test procedure|0
870677|NCT00531050|1831771|FG002|Part 2: Period 3|Abnormal test procedure|0
870678|NCT00531050|1831772|FG003|Part 2: Period 3|Abnormal test procedure|0
870679|NCT00531050|1831773|FG004|Part 2: Period 3|Abnormal test procedure|0
870680|NCT00531050|1831774|FG005|Part 2: Period 3|Abnormal test procedure|1
870681|NCT00531206|1831791|FG000|Overall Study|Adverse Event related|5
870682|NCT00531206|1831791|FG000|Overall Study|Lack of Efficacy|2
870683|NCT00531206|1831791|FG000|Overall Study|Lost to Follow-up|5
870684|NCT00531206|1831791|FG000|Overall Study|including non-related adverse events|8
870685|NCT00531232|1831798|FG000|Overall Study|Investigator decision|0
870686|NCT00531232|1831799|FG001|Overall Study|Investigator decision|0
870687|NCT00531232|1831800|FG002|Overall Study|Investigator decision|4
870688|NCT00531232|1831798|FG000|Overall Study|Participants refused further treatment|0
870689|NCT00531232|1831799|FG001|Overall Study|Participants refused further treatment|1
870690|NCT00531232|1831800|FG002|Overall Study|Participants refused further treatment|2
870691|NCT00531232|1831798|FG000|Overall Study|Adverse events (AEs)|1
870692|NCT00531232|1831799|FG001|Overall Study|Adverse events (AEs)|2
870693|NCT00531232|1831800|FG002|Overall Study|Adverse events (AEs)|2
870694|NCT00531232|1831798|FG000|Overall Study|Treatment failure|1
870695|NCT00531232|1831799|FG001|Overall Study|Treatment failure|3
870696|NCT00531232|1831800|FG002|Overall Study|Treatment failure|7
870697|NCT00531232|1831798|FG000|Overall Study|Disease recurrence|0
870698|NCT00531232|1831799|FG001|Overall Study|Disease recurrence|0
870699|NCT00531232|1831800|FG002|Overall Study|Disease recurrence|1
870700|NCT00531232|1831798|FG000|Overall Study|Deceased|2
870701|NCT00531232|1831799|FG001|Overall Study|Deceased|2
870702|NCT00531232|1831800|FG002|Overall Study|Deceased|2
870703|NCT00531232|1831798|FG000|Overall Study|Withdrawal by Subject|0
870704|NCT00531232|1831799|FG001|Overall Study|Withdrawal by Subject|1
870705|NCT00531232|1831800|FG002|Overall Study|Withdrawal by Subject|2
870706|NCT00531232|1831798|FG000|Overall Study|Other|0
870707|NCT00531232|1831799|FG001|Overall Study|Other|0
870708|NCT00531232|1831800|FG002|Overall Study|Other|5
870709|NCT00531284|1831828|FG000|Overall Study|Progressive Disease|1
870710|NCT00531284|1831829|FG001|Overall Study|Progressive Disease|3
870711|NCT00531284|1831830|FG002|Overall Study|Progressive Disease|5
870712|NCT00531284|1831831|FG003|Overall Study|Progressive Disease|42
870713|NCT00531284|1831832|FG004|Overall Study|Progressive Disease|4
870714|NCT00531284|1831833|FG005|Overall Study|Progressive Disease|4
870715|NCT00531284|1831834|FG006|Overall Study|Progressive Disease|3
870716|NCT00531284|1831835|FG007|Overall Study|Progressive Disease|8
870717|NCT00531284|1831836|FG008|Overall Study|Progressive Disease|6
870718|NCT00531284|1831837|FG009|Overall Study|Progressive Disease|3
870719|NCT00531284|1831838|FG010|Overall Study|Progressive Disease|3
870720|NCT00531284|1831839|FG011|Overall Study|Progressive Disease|14
870721|NCT00531284|1831840|FG012|Overall Study|Progressive Disease|2
870722|NCT00531284|1831841|FG013|Overall Study|Progressive Disease|1
870723|NCT00531284|1831842|FG014|Overall Study|Progressive Disease|2
870724|NCT00531284|1831843|FG015|Overall Study|Progressive Disease|11
870725|NCT00531284|1831844|FG016|Overall Study|Progressive Disease|5
870726|NCT00531284|1831828|FG000|Overall Study|Adverse Event|0
870727|NCT00531284|1831829|FG001|Overall Study|Adverse Event|1
870728|NCT00531284|1831830|FG002|Overall Study|Adverse Event|1
870729|NCT00531284|1831831|FG003|Overall Study|Adverse Event|7
870730|NCT00531284|1831832|FG004|Overall Study|Adverse Event|0
870731|NCT00531284|1831833|FG005|Overall Study|Adverse Event|2
870732|NCT00531284|1831834|FG006|Overall Study|Adverse Event|3
870733|NCT00531284|1831835|FG007|Overall Study|Adverse Event|2
870734|NCT00531284|1831836|FG008|Overall Study|Adverse Event|3
870735|NCT00531284|1831837|FG009|Overall Study|Adverse Event|0
870736|NCT00531284|1831838|FG010|Overall Study|Adverse Event|0
870737|NCT00531284|1831839|FG011|Overall Study|Adverse Event|5
870738|NCT00531284|1831840|FG012|Overall Study|Adverse Event|0
870739|NCT00531284|1831841|FG013|Overall Study|Adverse Event|1
870740|NCT00531284|1831842|FG014|Overall Study|Adverse Event|1
870741|NCT00531284|1831843|FG015|Overall Study|Adverse Event|0
870742|NCT00531284|1831844|FG016|Overall Study|Adverse Event|2
870743|NCT00531284|1831828|FG000|Overall Study|Withdrawal by Subject|1
870744|NCT00531284|1831829|FG001|Overall Study|Withdrawal by Subject|0
870745|NCT00531284|1831830|FG002|Overall Study|Withdrawal by Subject|0
870746|NCT00531284|1831831|FG003|Overall Study|Withdrawal by Subject|4
870747|NCT00531284|1831832|FG004|Overall Study|Withdrawal by Subject|0
870748|NCT00531284|1831833|FG005|Overall Study|Withdrawal by Subject|0
870749|NCT00531284|1831834|FG006|Overall Study|Withdrawal by Subject|0
870750|NCT00531284|1831835|FG007|Overall Study|Withdrawal by Subject|0
870751|NCT00531284|1831836|FG008|Overall Study|Withdrawal by Subject|0
870752|NCT00531284|1831837|FG009|Overall Study|Withdrawal by Subject|0
870753|NCT00531284|1831838|FG010|Overall Study|Withdrawal by Subject|0
870754|NCT00531284|1831839|FG011|Overall Study|Withdrawal by Subject|3
870755|NCT00531284|1831840|FG012|Overall Study|Withdrawal by Subject|0
870756|NCT00531284|1831841|FG013|Overall Study|Withdrawal by Subject|1
870757|NCT00531284|1831842|FG014|Overall Study|Withdrawal by Subject|0
870758|NCT00531284|1831843|FG015|Overall Study|Withdrawal by Subject|1
870759|NCT00531284|1831844|FG016|Overall Study|Withdrawal by Subject|1
870760|NCT00531284|1831828|FG000|Overall Study|Other|1
870761|NCT00531284|1831829|FG001|Overall Study|Other|0
870762|NCT00531284|1831830|FG002|Overall Study|Other|0
870763|NCT00531284|1831831|FG003|Overall Study|Other|10
870764|NCT00531284|1831832|FG004|Overall Study|Other|2
870765|NCT00531284|1831833|FG005|Overall Study|Other|1
870766|NCT00531284|1831834|FG006|Overall Study|Other|0
870767|NCT00531284|1831835|FG007|Overall Study|Other|0
870768|NCT00531284|1831836|FG008|Overall Study|Other|2
870769|NCT00531284|1831837|FG009|Overall Study|Other|1
870770|NCT00531284|1831838|FG010|Overall Study|Other|0
870771|NCT00531284|1831839|FG011|Overall Study|Other|2
870772|NCT00531284|1831840|FG012|Overall Study|Other|0
870773|NCT00531284|1831841|FG013|Overall Study|Other|0
870774|NCT00531284|1831842|FG014|Overall Study|Other|1
870775|NCT00531284|1831843|FG015|Overall Study|Other|0
870776|NCT00531284|1831844|FG016|Overall Study|Other|0
870777|NCT00531427|1831902|FG000|Overall Study|Withdrawal by Subject|7
870778|NCT00531427|1831903|FG001|Overall Study|Withdrawal by Subject|13
870779|NCT00531427|1831902|FG000|Overall Study|Adverse Event|44
870780|NCT00531427|1831903|FG001|Overall Study|Adverse Event|30
870781|NCT00531427|1831902|FG000|Overall Study|Lost to Follow-up|4
870782|NCT00531427|1831903|FG001|Overall Study|Lost to Follow-up|3
870783|NCT00531427|1831902|FG000|Overall Study|Lack of Efficacy|14
870784|NCT00531427|1831903|FG001|Overall Study|Lack of Efficacy|39
870785|NCT00531427|1831902|FG000|Overall Study|Administrative|4
870786|NCT00531427|1831903|FG001|Overall Study|Administrative|9
870787|NCT00531479|1831921|FG000|Overall Study|Death|68
870788|NCT00531479|1831922|FG001|Overall Study|Death|71
870789|NCT00531479|1831921|FG000|Overall Study|Lost to Follow-up|0
870790|NCT00531479|1831922|FG001|Overall Study|Lost to Follow-up|2
870791|NCT00531479|1831921|FG000|Overall Study|Other|0
870792|NCT00531479|1831922|FG001|Overall Study|Other|1
870793|NCT00531479|1831921|FG000|Overall Study|Withdrawal by Subject|6
1172519|NCT04025684|2310929|FG000|Overall Study|Multiple reasons|1
1172520|NCT04025684|2310930|FG001|Overall Study|Multiple reasons|3
1172521|NCT04025684|2310931|FG002|Overall Study|Multiple reasons|0
1172522|NCT04025684|2310932|FG003|Overall Study|Multiple reasons|1
1172523|NCT04019054|2310944|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0
1172524|NCT04019054|2310945|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1
1172525|NCT04019054|2310944|FG000|Overall Study|Withdrawal by Subject|3
1172526|NCT04019054|2310945|FG001|Overall Study|Withdrawal by Subject|1
1172527|NCT04016311|2311078|FG000|Overall Study|Withdrawal by Subject|1
1172528|NCT04016311|2311079|FG001|Overall Study|Withdrawal by Subject|0
1172529|NCT04023682|2311172|FG000|Overall Study|Clinical schedules did not allow continued participation|6
1172530|NCT04023994|2311219|FG000|Overall Study|Lost to Follow-up|0
1172531|NCT04023994|2311220|FG001|Overall Study|Lost to Follow-up|1
1172532|NCT04023994|2311221|FG002|Overall Study|Lost to Follow-up|2
1172533|NCT04023994|2311222|FG003|Overall Study|Lost to Follow-up|0
1172534|NCT04023994|2311223|FG004|Overall Study|Lost to Follow-up|0
1172535|NCT04023994|2311224|FG005|Overall Study|Lost to Follow-up|0
1172536|NCT04023994|2311219|FG000|Overall Study|Withdrawal by Subject|0
1172537|NCT04023994|2311220|FG001|Overall Study|Withdrawal by Subject|0
1172538|NCT04023994|2311221|FG002|Overall Study|Withdrawal by Subject|0
870794|NCT00531479|1831922|FG001|Overall Study|Withdrawal by Subject|6
870795|NCT00531479|1831921|FG000|Overall Study|Did not receive treatment|2
870796|NCT00531479|1831922|FG001|Overall Study|Did not receive treatment|3
870797|NCT00531752|1831953|FG000|First Double-blind Intervention Period|Adverse Event|2
1172539|NCT04023994|2311222|FG003|Overall Study|Withdrawal by Subject|1
1172540|NCT04023994|2311223|FG004|Overall Study|Withdrawal by Subject|0
1172541|NCT04023994|2311224|FG005|Overall Study|Withdrawal by Subject|0
1172542|NCT04017611|2311267|FG000|Overall Study|Withdrawn prior to completion|1
1172543|NCT04015232|2311273|FG000|Overall Study|Withdrawal by Subject|7
1172544|NCT04015232|2311274|FG001|Overall Study|Withdrawal by Subject|4
1172545|NCT04015232|2311273|FG000|Overall Study|Protocol Violation|1
1172546|NCT04015232|2311274|FG001|Overall Study|Protocol Violation|0
1172547|NCT04015232|2311273|FG000|Overall Study|Medical Grounds|3
1172548|NCT04015232|2311274|FG001|Overall Study|Medical Grounds|3
1172549|NCT04014062|2311314|FG000|Period I: Dosing|Medical Grounds|4
1172550|NCT04014062|2311315|FG001|Period I: Dosing|Medical Grounds|5
1172551|NCT04014062|2311314|FG000|Period I: Dosing|Withdrawal by Subject|3
1172552|NCT04014062|2311315|FG001|Period I: Dosing|Withdrawal by Subject|1
1172553|NCT04013191|2311352|FG000|Overall Study|Adverse Event|1
1172554|NCT04013191|2311353|FG001|Overall Study|Adverse Event|0
1172555|NCT04011735|2311370|FG000|Overall Study|Withdrawal by Subject|1
1172556|NCT04011735|2311371|FG001|Overall Study|Withdrawal by Subject|0
1172557|NCT04011735|2311372|FG002|Overall Study|Withdrawal by Subject|1
1172558|NCT04011735|2311370|FG000|Overall Study|Met exclusion criteria after study entry|0
1172559|NCT04011735|2311371|FG001|Overall Study|Met exclusion criteria after study entry|1
1172560|NCT04011735|2311372|FG002|Overall Study|Met exclusion criteria after study entry|0
1172561|NCT04009577|2311391|FG000|Core Study|Adverse Event|1
1172562|NCT04009577|2311392|FG001|Core Study|Adverse Event|0
1172563|NCT04009577|2311393|FG002|Core Study|Adverse Event|2
1172564|NCT04009577|2311394|FG003|Core Study|Adverse Event|4
1172565|NCT04009577|2311391|FG000|Core Study|Withdrawal by Subject|0
1172566|NCT04009577|2311392|FG001|Core Study|Withdrawal by Subject|0
1172567|NCT04009577|2311393|FG002|Core Study|Withdrawal by Subject|2
1172568|NCT04009577|2311394|FG003|Core Study|Withdrawal by Subject|0
1172569|NCT04009577|2311391|FG000|Core Study|Other|0
1172570|NCT04009577|2311392|FG001|Core Study|Other|0
1172571|NCT04009577|2311393|FG002|Core Study|Other|0
1172572|NCT04009577|2311394|FG003|Core Study|Other|1
1172573|NCT04009577|2311391|FG000|Extension Phase|Adverse Event|0
1172574|NCT04009577|2311392|FG001|Extension Phase|Adverse Event|0
1172575|NCT04009577|2311393|FG002|Extension Phase|Adverse Event|0
1172576|NCT04009577|2311394|FG003|Extension Phase|Adverse Event|1
1172577|NCT04009577|2311391|FG000|Extension Phase|Inadequate therapeutic effect|0
1172578|NCT04009577|2311392|FG001|Extension Phase|Inadequate therapeutic effect|0
1172579|NCT04009577|2311393|FG002|Extension Phase|Inadequate therapeutic effect|1
1172580|NCT04009577|2311394|FG003|Extension Phase|Inadequate therapeutic effect|0
1172581|NCT04009577|2311391|FG000|Extension Phase|Withdrawal by Subject|0
1172582|NCT04009577|2311392|FG001|Extension Phase|Withdrawal by Subject|0
1172583|NCT04009577|2311393|FG002|Extension Phase|Withdrawal by Subject|1
1172584|NCT04009577|2311394|FG003|Extension Phase|Withdrawal by Subject|0
1172585|NCT04009577|2311391|FG000|Extension Phase|Not Treated|0
1172586|NCT04009577|2311392|FG001|Extension Phase|Not Treated|0
1172587|NCT04009577|2311393|FG002|Extension Phase|Not Treated|2
1172588|NCT04009577|2311394|FG003|Extension Phase|Not Treated|0
1172589|NCT04007159|2311420|FG000|Induction Phase|(missed study visits)|16
1172590|NCT04007159|2311420|FG000|Induction Phase|Withdrawal by Subject|4
1172591|NCT04007159|2311420|FG000|Induction Phase|Adverse Event|2
1172592|NCT04007159|2311420|FG000|Challenge Phase|missed study visits|3
1172593|NCT04007107|2311431|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
1172594|NCT04007107|2311432|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1
1172595|NCT04007107|2311433|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
1172596|NCT04007107|2311434|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
1172597|NCT04005885|2311450|FG000|First Intervention|Withdrawal by Subject|1
1172598|NCT04005885|2311451|FG001|First Intervention|Withdrawal by Subject|1
1172599|NCT04005885|2311450|FG000|Second Intervention|Withdrawal by Subject|0
1172600|NCT04005885|2311451|FG001|Second Intervention|Withdrawal by Subject|2
1172601|NCT04000815|2311465|FG000|Overall Study|Lost to Follow-up|9
1172602|NCT04000815|2311466|FG001|Overall Study|Lost to Follow-up|2
1172603|NCT04000815|2311467|FG002|Overall Study|Lost to Follow-up|3
1172604|NCT04000815|2311465|FG000|Overall Study|Withdrawal by Subject|4
1172605|NCT04000815|2311466|FG001|Overall Study|Withdrawal by Subject|3
1172606|NCT04000815|2311467|FG002|Overall Study|Withdrawal by Subject|2
1172607|NCT04000815|2311465|FG000|Overall Study|Right ovarian cyst occured|1
1172608|NCT04000815|2311466|FG001|Overall Study|Right ovarian cyst occured|0
1172609|NCT04000815|2311467|FG002|Overall Study|Right ovarian cyst occured|0
1172610|NCT04000815|2311465|FG000|Overall Study|Hypertension occured on follow up|0
1172611|NCT04000815|2311466|FG001|Overall Study|Hypertension occured on follow up|0
1172612|NCT04000815|2311467|FG002|Overall Study|Hypertension occured on follow up|2
1172613|NCT04006366|2311492|FG000|Overall Study|Withdrawal by Subject|1
1172614|NCT04006145|2311498|FG000|Overall Study|Lost to Follow-up|0
1172615|NCT04006145|2311499|FG001|Overall Study|Lost to Follow-up|1
1172616|NCT04006145|2311498|FG000|Overall Study|Other|1
1172617|NCT04006145|2311499|FG001|Overall Study|Other|2
1172618|NCT04005755|2311505|FG000|Overall Study|Adverse Event|6
1172619|NCT04005755|2311505|FG000|Overall Study|Physician Decision|3
1172620|NCT04005755|2311505|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4
1172621|NCT04005755|2311505|FG000|Overall Study|Withdrawal by Subject|3
1172622|NCT04005755|2311505|FG000|Overall Study|Lost to Follow-up|1
1172623|NCT03993288|2311528|FG000|Overall Study|Lost to Follow-up|2
1172624|NCT03993288|2311529|FG001|Overall Study|Lost to Follow-up|1
1172625|NCT03993288|2311528|FG000|Overall Study|non-compliance to the inclusion criteria|0
1172626|NCT03993288|2311529|FG001|Overall Study|non-compliance to the inclusion criteria|1
1172627|NCT03993288|2311528|FG000|Overall Study|wrong randomization|0
1172628|NCT03993288|2311529|FG001|Overall Study|wrong randomization|1
1172629|NCT03993288|2311528|FG000|Overall Study|improper enrollment|0
1172630|NCT03993288|2311529|FG001|Overall Study|improper enrollment|1
1172631|NCT03993288|2311528|FG000|Overall Study|prescribed with prohibited concomitant therapy|1
1172632|NCT03993288|2311529|FG001|Overall Study|prescribed with prohibited concomitant therapy|0
1172633|NCT03993288|2311528|FG000|Overall Study|developed SAE|2
1172634|NCT03993288|2311529|FG001|Overall Study|developed SAE|0
1172635|NCT03993288|2311528|FG000|Overall Study|consent withdrawal|1
1172636|NCT03993288|2311529|FG001|Overall Study|consent withdrawal|0
1172637|NCT03993288|2311528|FG000|Overall Study|did not follow the treatment schedule|1
1172638|NCT03993288|2311529|FG001|Overall Study|did not follow the treatment schedule|0
1172639|NCT03993288|2311528|FG000|Overall Study|did not follow the treatment regimen|1
1172640|NCT03993288|2311529|FG001|Overall Study|did not follow the treatment regimen|0
1172641|NCT03993288|2311528|FG000|Overall Study|Adverse Event|1
1172642|NCT03993288|2311529|FG001|Overall Study|Adverse Event|0
1172643|NCT03993288|2311528|FG000|Overall Study|Withdrawal by Subject|1
1172644|NCT03993288|2311529|FG001|Overall Study|Withdrawal by Subject|1
1172645|NCT03978832|2311560|FG000|Overall Study|Adverse Event|1
1172646|NCT03978832|2311560|FG000|Overall Study|Lost to Follow-up|1
1172647|NCT03978832|2311560|FG000|Overall Study|Withdrawal by Subject|6
1172648|NCT03978832|2311560|FG000|Overall Study|Physician Decision|2
1172649|NCT03978832|2311560|FG000|Overall Study|did not pass screening criteria|44
1172650|NCT04004260|2311601|FG000|Overall Study|Withdrawal by Subject|7
1172651|NCT04004260|2311602|FG001|Overall Study|Withdrawal by Subject|3
1172652|NCT04004260|2311601|FG000|Overall Study|Lost to Follow-up|22
1172653|NCT04004260|2311602|FG001|Overall Study|Lost to Follow-up|12
1172654|NCT04004260|2311601|FG000|Overall Study|Did not engage in intervention|13
1172655|NCT04004260|2311602|FG001|Overall Study|Did not engage in intervention|17
1172656|NCT04002960|2311635|FG000|Overall Study|Withdrawn prior to Completion|2
1172657|NCT04002648|2311645|FG000|Overall Study|Lost to Follow-up|2
1172658|NCT04002648|2311646|FG001|Overall Study|Lost to Follow-up|0
1172659|NCT03990649|2311675|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
1172660|NCT03990649|2311676|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1
1172661|NCT03990649|2311677|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
1172662|NCT03990649|2311675|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
1172663|NCT03990649|2311676|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1
1172664|NCT03990649|2311677|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
1172665|NCT03990649|2311675|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2
1172666|NCT03990649|2311676|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
1172667|NCT03990649|2311677|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
1172668|NCT03990649|2311675|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
1172669|NCT03990649|2311676|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
1172670|NCT03990649|2311677|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0
1172671|NCT03990649|2311675|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
1172672|NCT03990649|2311676|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
1172673|NCT03990649|2311677|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1
1172674|NCT03990649|2311675|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
1172675|NCT03990649|2311676|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
1172676|NCT03990649|2311677|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2
1172677|NCT03990649|2311675|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
1172678|NCT03990649|2311676|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
1172679|NCT03990649|2311677|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1
1172680|NCT04000581|2311695|FG000|Overall Study|Withdrawal by Subject|0
1172681|NCT04000581|2311696|FG001|Overall Study|Withdrawal by Subject|1
1172682|NCT03996694|2311702|FG000|First Washout (7 Days)|positive urine drug screen|0
1172683|NCT03996694|2311703|FG001|First Washout (7 Days)|positive urine drug screen|0
1172684|NCT03996694|2311704|FG002|First Washout (7 Days)|positive urine drug screen|1
1172685|NCT03996694|2311705|FG003|First Washout (7 Days)|positive urine drug screen|0
1172686|NCT03996694|2311706|FG004|First Washout (7 Days)|positive urine drug screen|0
1172687|NCT03996694|2311707|FG005|First Washout (7 Days)|positive urine drug screen|0
1172688|NCT03996694|2311702|FG000|First Washout (7 Days)|Adverse Event|0
1172689|NCT03996694|2311703|FG001|First Washout (7 Days)|Adverse Event|1
1172690|NCT03996694|2311704|FG002|First Washout (7 Days)|Adverse Event|0
1172691|NCT03996694|2311705|FG003|First Washout (7 Days)|Adverse Event|0
1172692|NCT03996694|2311706|FG004|First Washout (7 Days)|Adverse Event|0
1172693|NCT03996694|2311707|FG005|First Washout (7 Days)|Adverse Event|0
1172694|NCT03996694|2311702|FG000|First Washout (7 Days)|Lost to Follow-up|0
1172695|NCT03996694|2311703|FG001|First Washout (7 Days)|Lost to Follow-up|0
1172696|NCT03996694|2311704|FG002|First Washout (7 Days)|Lost to Follow-up|1
1172697|NCT03996694|2311705|FG003|First Washout (7 Days)|Lost to Follow-up|0
1172698|NCT03996694|2311706|FG004|First Washout (7 Days)|Lost to Follow-up|0
1172699|NCT03996694|2311707|FG005|First Washout (7 Days)|Lost to Follow-up|0
1172700|NCT03996694|2311702|FG000|Third Washout (7 Days)|Withdrawal by Subject|0
1172701|NCT03996694|2311703|FG001|Third Washout (7 Days)|Withdrawal by Subject|0
1172702|NCT03996694|2311704|FG002|Third Washout (7 Days)|Withdrawal by Subject|0
1172703|NCT03996694|2311705|FG003|Third Washout (7 Days)|Withdrawal by Subject|0
1172704|NCT03996694|2311706|FG004|Third Washout (7 Days)|Withdrawal by Subject|1
1172705|NCT03996694|2311707|FG005|Third Washout (7 Days)|Withdrawal by Subject|0
1172706|NCT03988907|2311723|FG000|Overall Study|Unable to complete visit|0
1172707|NCT03988907|2311724|FG001|Overall Study|Unable to complete visit|1
1172708|NCT03988088|2311738|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0
1172709|NCT03988088|2311739|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1
1172710|NCT03988088|2311740|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0
1172711|NCT03988088|2311741|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0
1172712|NCT03988088|2311738|FG000|Open-Label Addendum|Lost to Follow-up|0
1172713|NCT03988088|2311739|FG001|Open-Label Addendum|Lost to Follow-up|0
1172714|NCT03988088|2311740|FG002|Open-Label Addendum|Lost to Follow-up|1
1172715|NCT03988088|2311741|FG003|Open-Label Addendum|Lost to Follow-up|0
1172716|NCT03980522|2311754|FG000|Treatment Period|Adverse Event|1
1172717|NCT03980522|2311755|FG001|Treatment Period|Adverse Event|0
1172718|NCT03980522|2311756|FG002|Treatment Period|Adverse Event|0
1172719|NCT03980522|2311757|FG003|Treatment Period|Adverse Event|0
1172720|NCT03980522|2311758|FG004|Treatment Period|Adverse Event|0
1172721|NCT03995784|2311774|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1
1172722|NCT03993392|2311785|FG000|Overall Study|Withdrawal by Subject|3
1172723|NCT03993392|2311785|FG000|Overall Study|Lost to Follow-up|2
1172724|NCT03993392|2311785|FG000|Overall Study|Did not meet Day 1 check-in criteria|1
1172725|NCT03981822|2311808|FG000|Overall Study|Lost to Follow-up|0
1172726|NCT03981822|2311809|FG001|Overall Study|Lost to Follow-up|1
1172727|NCT03981822|2311810|FG002|Overall Study|Lost to Follow-up|1
1172728|NCT03981822|2311811|FG003|Overall Study|Lost to Follow-up|0
1172729|NCT03981822|2311812|FG004|Overall Study|Lost to Follow-up|6
1172730|NCT03981822|2311813|FG005|Overall Study|Lost to Follow-up|4
1172731|NCT03981822|2311814|FG006|Overall Study|Lost to Follow-up|4
1172732|NCT03981822|2311815|FG007|Overall Study|Lost to Follow-up|2
1172733|NCT03981822|2311808|FG000|Overall Study|Withdrawal by Subject|0
1172734|NCT03981822|2311809|FG001|Overall Study|Withdrawal by Subject|1
1172735|NCT03981822|2311810|FG002|Overall Study|Withdrawal by Subject|0
1172736|NCT03981822|2311811|FG003|Overall Study|Withdrawal by Subject|0
1172737|NCT03981822|2311812|FG004|Overall Study|Withdrawal by Subject|0
1172738|NCT03981822|2311813|FG005|Overall Study|Withdrawal by Subject|1
1172739|NCT03981822|2311814|FG006|Overall Study|Withdrawal by Subject|0
1172740|NCT03981822|2311815|FG007|Overall Study|Withdrawal by Subject|2
1172741|NCT03981822|2311808|FG000|Overall Study|COVID-19 Related|0
1172742|NCT03981822|2311809|FG001|Overall Study|COVID-19 Related|0
1172743|NCT03981822|2311810|FG002|Overall Study|COVID-19 Related|0
1172744|NCT03981822|2311811|FG003|Overall Study|COVID-19 Related|0
1172745|NCT03981822|2311812|FG004|Overall Study|COVID-19 Related|2
1172746|NCT03981822|2311813|FG005|Overall Study|COVID-19 Related|1
1172747|NCT03981822|2311814|FG006|Overall Study|COVID-19 Related|2
1172748|NCT03981822|2311815|FG007|Overall Study|COVID-19 Related|1
1172749|NCT03991494|2311868|FG000|Overall Study|Progressive Disease|4
1172750|NCT03988803|2311887|FG000|Period 2|Prematurely discontinued from medication|2
1172751|NCT03988803|2311887|FG000|Period 2|Adverse Event|1
1172752|NCT03987932|2311898|FG000|Overall Study|Lost to Follow-up|2
1172753|NCT03987932|2311899|FG001|Overall Study|Lost to Follow-up|1
1172754|NCT03987932|2311900|FG002|Overall Study|Lost to Follow-up|1
1172755|NCT03987932|2311898|FG000|Overall Study|Non-study related elective surgery|0
1172756|NCT03987932|2311899|FG001|Overall Study|Non-study related elective surgery|0
1172757|NCT03987932|2311900|FG002|Overall Study|Non-study related elective surgery|1
1172758|NCT03987191|2311910|FG000|Overall Study|COVID-19 related research disruption|0
1172759|NCT03987191|2311911|FG001|Overall Study|COVID-19 related research disruption|2
1172760|NCT03988842|2311917|FG000|Overall Study|Death|1
1172761|NCT03981861|2311922|FG000|Overall Study|Withdrawal by Subject|3
1172762|NCT03974334|2311926|FG000|Overall Study|Lost to Follow-up|1
1172763|NCT03987074|2311954|FG000|Overall Study|Withdrew Consent|1
1172764|NCT03987074|2311955|FG001|Overall Study|Withdrew Consent|1
1172765|NCT03987074|2311956|FG002|Overall Study|Withdrew Consent|0
1172766|NCT03987074|2311957|FG003|Overall Study|Withdrew Consent|2
1172767|NCT03987074|2311958|FG004|Overall Study|Withdrew Consent|1
1172768|NCT03987074|2311954|FG000|Overall Study|Adverse Event|2
1172769|NCT03987074|2311955|FG001|Overall Study|Adverse Event|1
1172770|NCT03987074|2311956|FG002|Overall Study|Adverse Event|0
1172771|NCT03987074|2311957|FG003|Overall Study|Adverse Event|0
1172772|NCT03987074|2311958|FG004|Overall Study|Adverse Event|1
1172773|NCT03987074|2311954|FG000|Overall Study|Lost to Follow-up|0
1172774|NCT03987074|2311955|FG001|Overall Study|Lost to Follow-up|0
1172775|NCT03987074|2311956|FG002|Overall Study|Lost to Follow-up|1
1172776|NCT03987074|2311957|FG003|Overall Study|Lost to Follow-up|1
1172777|NCT03987074|2311958|FG004|Overall Study|Lost to Follow-up|0
1172778|NCT03987074|2311954|FG000|Overall Study|Investigator's Discretion|0
1172779|NCT03987074|2311955|FG001|Overall Study|Investigator's Discretion|0
1172780|NCT03987074|2311956|FG002|Overall Study|Investigator's Discretion|0
1172781|NCT03987074|2311957|FG003|Overall Study|Investigator's Discretion|1
1172782|NCT03987074|2311958|FG004|Overall Study|Investigator's Discretion|0
1172783|NCT03979820|2311992|FG000|Overall Study|Protocol Violation|1
1172784|NCT03979820|2311993|FG001|Overall Study|Protocol Violation|0
1172785|NCT03979820|2311994|FG002|Overall Study|Protocol Violation|0
1172786|NCT03979820|2311995|FG003|Overall Study|Protocol Violation|0
1172787|NCT03979820|2311992|FG000|Overall Study|Withdrawal by Subject|0
1172788|NCT03979820|2311993|FG001|Overall Study|Withdrawal by Subject|0
1172789|NCT03979820|2311994|FG002|Overall Study|Withdrawal by Subject|1
1172790|NCT03979820|2311995|FG003|Overall Study|Withdrawal by Subject|0
1172791|NCT03979820|2311992|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5
1172792|NCT03979820|2311993|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
1172793|NCT03979820|2311994|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
1172794|NCT03979820|2311995|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10
1172795|NCT03972137|2312009|FG000|Overall Study|Lost to Follow-up|2
1172796|NCT03972137|2312009|FG000|Overall Study|Withdrawal by Subject|4
1172797|NCT03970395|2312027|FG000|Overall Study|Withdrawal by Subject|3
1172798|NCT03970395|2312028|FG001|Overall Study|Withdrawal by Subject|4
1172799|NCT03970395|2312027|FG000|Overall Study|Lost to Follow-up|4
1172800|NCT03970395|2312028|FG001|Overall Study|Lost to Follow-up|8
1172801|NCT03987620|2312040|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43
1172802|NCT03987620|2312041|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41
1172803|NCT03987620|2312040|FG000|Overall Study|Adverse Event|3
1172804|NCT03987620|2312041|FG001|Overall Study|Adverse Event|0
1172805|NCT03987620|2312040|FG000|Overall Study|Lost to Follow-up|1
1172806|NCT03987620|2312041|FG001|Overall Study|Lost to Follow-up|2
1172807|NCT03987620|2312040|FG000|Overall Study|Physician Decision|0
1172808|NCT03987620|2312041|FG001|Overall Study|Physician Decision|1
1172809|NCT03987620|2312040|FG000|Overall Study|Pregnancy|1
1172810|NCT03987620|2312041|FG001|Overall Study|Pregnancy|0
1172811|NCT03987620|2312040|FG000|Overall Study|Withdrawal by Subject|7
1172812|NCT03987620|2312041|FG001|Overall Study|Withdrawal by Subject|1
1172813|NCT03987620|2312040|FG000|Overall Study|Other|2
1172814|NCT03987620|2312041|FG001|Overall Study|Other|5
1172815|NCT03983317|2312047|FG000|Overall Study|Physician Decision|5
1172816|NCT03984825|2312110|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2
1172817|NCT03984825|2312110|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1
1172818|NCT03984825|2312110|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3
1172819|NCT03982433|2312123|FG000|Overall Study|Lost to Follow-up|1
1172820|NCT03976466|2312133|FG000|Overall Study|Lost to Follow-up|1
1172821|NCT03976466|2312134|FG001|Overall Study|Lost to Follow-up|3
1172822|NCT03979638|2312144|FG000|Period 1|Physician Decision|1
1172823|NCT03979638|2312145|FG001|Period 1|Physician Decision|1
1172824|NCT03979638|2312144|FG000|Period 1|Withdrawal by Subject|4
1172825|NCT03979638|2312145|FG001|Period 1|Withdrawal by Subject|3
1172826|NCT03979638|2312144|FG000|Period 1|Study terminated by Sponsor|1
1172827|NCT03979638|2312145|FG001|Period 1|Study terminated by Sponsor|3
1172828|NCT03979638|2312144|FG000|Period 1|Protocol Violation|1
1172829|NCT03979638|2312145|FG001|Period 1|Protocol Violation|0
1172830|NCT03979638|2312144|FG000|Period 2|Study terminated by Sponsor|1
1172831|NCT03979638|2312145|FG001|Period 2|Study terminated by Sponsor|1
1172832|NCT03979274|2312160|FG000|Treatment Period 2|Withdrawal by Subject|0
1172833|NCT03979274|2312161|FG001|Treatment Period 2|Withdrawal by Subject|1
1172834|NCT03977727|2312178|FG000|Second Treatment|Lost to Follow-up|0
1172835|NCT03977727|2312179|FG001|Second Treatment|Lost to Follow-up|3
1172836|NCT03977155|2312188|FG000|Overall Study|Adverse Event|3
1172837|NCT03977155|2312189|FG001|Overall Study|Adverse Event|0
1172838|NCT03977155|2312190|FG002|Overall Study|Adverse Event|0
1172839|NCT03977155|2312188|FG000|Overall Study|Lost to Follow-up|0
1172840|NCT03977155|2312189|FG001|Overall Study|Lost to Follow-up|1
1172841|NCT03977155|2312190|FG002|Overall Study|Lost to Follow-up|0
1172842|NCT03977155|2312188|FG000|Overall Study|Withdrawal by Subject|1
1172843|NCT03977155|2312189|FG001|Overall Study|Withdrawal by Subject|1
1172844|NCT03977155|2312190|FG002|Overall Study|Withdrawal by Subject|2
1172845|NCT03977155|2312188|FG000|Overall Study|Participant was unable to come in for the Visit|1
1172846|NCT03977155|2312189|FG001|Overall Study|Participant was unable to come in for the Visit|0
1172847|NCT03977155|2312190|FG002|Overall Study|Participant was unable to come in for the Visit|0
1172848|NCT03970733|2312285|FG000|Overall Study|Withdrawal by Subject|0
1172849|NCT03970733|2312286|FG001|Overall Study|Withdrawal by Subject|5
1172850|NCT03970733|2312287|FG002|Overall Study|Withdrawal by Subject|1
1172851|NCT03970733|2312285|FG000|Overall Study|e.g.: moved from study area|1
1172852|NCT03970733|2312286|FG001|Overall Study|e.g.: moved from study area|0
1172853|NCT03970733|2312287|FG002|Overall Study|e.g.: moved from study area|0
1172854|NCT03970733|2312285|FG000|Overall Study|Lost to Follow-up|2
1172855|NCT03970733|2312286|FG001|Overall Study|Lost to Follow-up|1
1172856|NCT03970733|2312287|FG002|Overall Study|Lost to Follow-up|1
1172857|NCT03970733|2312285|FG000|Overall Study|Other|1
1172858|NCT03970733|2312286|FG001|Overall Study|Other|0
1172859|NCT03970733|2312287|FG002|Overall Study|Other|0
1172860|NCT03968978|2312297|FG000|Overall Study|Adverse Event|1
1172861|NCT03968978|2312298|FG001|Overall Study|Adverse Event|0
1172862|NCT03967444|2312315|FG000|Overall Study|Lost to Follow-up|1
1172863|NCT03967444|2312316|FG001|Overall Study|Lost to Follow-up|2
1172864|NCT03966911|2312328|FG000|Overall Study|Adverse Event|1
1172865|NCT03966911|2312329|FG001|Overall Study|Adverse Event|1
1172866|NCT03966911|2312328|FG000|Overall Study|Withdrawal by Subject|8
1172867|NCT03966911|2312329|FG001|Overall Study|Withdrawal by Subject|2
1172868|NCT03966911|2312328|FG000|Overall Study|Unable to complete study visits due to COVID-19|0
1172869|NCT03966911|2312329|FG001|Overall Study|Unable to complete study visits due to COVID-19|13
1172870|NCT03966365|2312339|FG000|Overall Study|Protocol Violation|1
1172871|NCT03966365|2312340|FG001|Overall Study|Protocol Violation|0
1172872|NCT03965403|2312346|FG000|Overall Study|Subject not meeting eligibility criteria|1
1172873|NCT03965351|2312403|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
1172874|NCT03965351|2312404|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
1172875|NCT03965351|2312403|FG000|Second Intervention (4 Weeks)|Adverse Event|0
1172876|NCT03965351|2312404|FG001|Second Intervention (4 Weeks)|Adverse Event|1
1172877|NCT03958955|2312419|FG000|Overall Study|Adverse Event|1
1172878|NCT03965052|2312427|FG000|Overall Study|Protocol Violation|1
1172879|NCT03965052|2312428|FG001|Overall Study|Protocol Violation|0
1172880|NCT03963401|2312457|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1
1172881|NCT03963401|2312458|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2
1172882|NCT03963401|2312459|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0
1172883|NCT03963401|2312460|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0
1172884|NCT03963401|2312461|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1
1172885|NCT03963401|2312462|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2
1172886|NCT03963401|2312457|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
1172887|NCT03963401|2312458|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
1172888|NCT03963401|2312459|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
1172889|NCT03963401|2312460|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
1172890|NCT03963401|2312461|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
1172891|NCT03963401|2312462|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
1172892|NCT03963401|2312457|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
1172893|NCT03963401|2312458|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
1172894|NCT03963401|2312459|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
1172895|NCT03963401|2312460|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
1172896|NCT03963401|2312461|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
1172897|NCT03963401|2312462|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0
1172898|NCT03963401|2312457|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
1172899|NCT03963401|2312458|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1
1172900|NCT03963401|2312459|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
1172901|NCT03963401|2312460|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
1172902|NCT03963401|2312461|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
1172903|NCT03963401|2312462|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
1172904|NCT03963401|2312457|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6
1172905|NCT03963401|2312458|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3
1172906|NCT03963401|2312459|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2
1172907|NCT03963401|2312460|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0
1172908|NCT03963401|2312461|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4
1172909|NCT03963401|2312462|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3
1172910|NCT03963401|2312457|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
1172911|NCT03963401|2312458|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
1172912|NCT03963401|2312459|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
1172913|NCT03963401|2312460|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
1172914|NCT03963401|2312461|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
1172915|NCT03963401|2312462|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
1172916|NCT03963401|2312457|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
1172917|NCT03963401|2312458|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
1172918|NCT03963401|2312459|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1
1172919|NCT03963401|2312460|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
1172920|NCT03963401|2312461|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
1172921|NCT03963401|2312462|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
1172922|NCT03963401|2312457|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1
1172923|NCT03963401|2312458|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
1172924|NCT03963401|2312459|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
1172925|NCT03963401|2312460|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
1172926|NCT03963401|2312461|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
1172927|NCT03963401|2312462|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
1172928|NCT03963401|2312457|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4
1172929|NCT03963401|2312458|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
1172930|NCT03963401|2312459|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
1172931|NCT03963401|2312460|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
1172932|NCT03963401|2312461|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
1172933|NCT03963401|2312462|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
1172934|NCT03963401|2312457|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1
1172935|NCT03963401|2312458|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
1172936|NCT03963401|2312459|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
1172937|NCT03963401|2312460|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
1172938|NCT03963401|2312461|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
1172939|NCT03963401|2312462|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
1172940|NCT03963401|2312457|FG000|Extension Period (Week 17 - Week 52)|Other|1
1172941|NCT03963401|2312458|FG001|Extension Period (Week 17 - Week 52)|Other|1
1172942|NCT03963401|2312459|FG002|Extension Period (Week 17 - Week 52)|Other|0
1172943|NCT03963401|2312460|FG003|Extension Period (Week 17 - Week 52)|Other|1
1172944|NCT03963401|2312461|FG004|Extension Period (Week 17 - Week 52)|Other|1
1172945|NCT03963401|2312462|FG005|Extension Period (Week 17 - Week 52)|Other|1
1172946|NCT03962790|2312489|FG000|Period 1|Adverse Event|0
1172947|NCT03962790|2312490|FG001|Period 1|Adverse Event|1
1172948|NCT03962790|2312489|FG000|Period 1|Failed to meet all eligibility criteria|1
1172949|NCT03962790|2312490|FG001|Period 1|Failed to meet all eligibility criteria|1
1172950|NCT03962790|2312489|FG000|Period 1|No Longer Meets Eligibility Criteria|1
1172951|NCT03962790|2312490|FG001|Period 1|No Longer Meets Eligibility Criteria|0
1172952|NCT03962790|2312489|FG000|Period 1|Withdrawal by Subject|1
1172953|NCT03962790|2312490|FG001|Period 1|Withdrawal by Subject|0
1172954|NCT03956225|2312498|FG000|Overall Study|Lack of Efficacy|1
1172955|NCT03956225|2312499|FG001|Overall Study|Lack of Efficacy|1
1172956|NCT03956225|2312498|FG000|Overall Study|Lost to Follow-up|0
1172957|NCT03956225|2312499|FG001|Overall Study|Lost to Follow-up|1
1172958|NCT03956225|2312498|FG000|Overall Study|Withdrawal by Subject|2
1172959|NCT03956225|2312499|FG001|Overall Study|Withdrawal by Subject|1
1172960|NCT03956225|2312498|FG000|Overall Study|Other Reasons|2
1172961|NCT03956225|2312499|FG001|Overall Study|Other Reasons|1
1172962|NCT03958149|2312517|FG000|Overall Study|Withdrawal by Subject|0
1172963|NCT03958149|2312518|FG001|Overall Study|Withdrawal by Subject|1
1172964|NCT03953183|2312530|FG000|Overall Study|Physician Decision|0
1172965|NCT03953183|2312531|FG001|Overall Study|Physician Decision|1
1172966|NCT03953183|2312530|FG000|Overall Study|Withdrawal by Subject|0
1172967|NCT03953183|2312531|FG001|Overall Study|Withdrawal by Subject|1
1172968|NCT03962738|2312552|FG000|Overall Study|Protocol Deviation|3
1172969|NCT03962738|2312553|FG001|Overall Study|Protocol Deviation|0
1172970|NCT03962738|2312554|FG002|Overall Study|Protocol Deviation|1
1172971|NCT03962738|2312555|FG003|Overall Study|Protocol Deviation|1
1172972|NCT03962738|2312552|FG000|Overall Study|Withdrawal by Subject|4
1172973|NCT03962738|2312553|FG001|Overall Study|Withdrawal by Subject|0
1172974|NCT03962738|2312554|FG002|Overall Study|Withdrawal by Subject|0
1172975|NCT03962738|2312555|FG003|Overall Study|Withdrawal by Subject|0
1172976|NCT03962738|2312552|FG000|Overall Study|Lost to Follow-up|0
1172977|NCT03962738|2312553|FG001|Overall Study|Lost to Follow-up|0
1172978|NCT03962738|2312554|FG002|Overall Study|Lost to Follow-up|1
1172979|NCT03962738|2312555|FG003|Overall Study|Lost to Follow-up|0
1172980|NCT03962101|2312573|FG000|Overall Study|Adverse Event|1
1172981|NCT03962101|2312573|FG000|Overall Study|Physician Decision|2
1172982|NCT03962101|2312573|FG000|Overall Study|Not related to medical events|1
1172983|NCT03959137|2312578|FG000|Overall Study|Protocol Violation|6
1172984|NCT03946124|2312582|FG000|Overall Study|Withdrawal by Subject|19
1172985|NCT03961308|2312588|FG000|Overall Study|Withdrawal by Subject|1
1172986|NCT03961308|2312589|FG001|Overall Study|Withdrawal by Subject|0
1172987|NCT03961308|2312588|FG000|Overall Study|Other|1
1172988|NCT03961308|2312589|FG001|Overall Study|Other|0
1172989|NCT03961308|2312588|FG000|Overall Study|Lost to Follow-up|0
1172990|NCT03961308|2312589|FG001|Overall Study|Lost to Follow-up|1
1172991|NCT03961308|2312588|FG000|Overall Study|Adverse Event|0
1172992|NCT03961308|2312589|FG001|Overall Study|Adverse Event|1
1172993|NCT03956862|2312615|FG000|Overall Study|Lost to Follow-up|1
1172994|NCT03956862|2312616|FG001|Overall Study|Lost to Follow-up|1
1172995|NCT03956862|2312615|FG000|Overall Study|Withdrawal by Subject|1
1172996|NCT03956862|2312616|FG001|Overall Study|Withdrawal by Subject|1
1172997|NCT03954444|2312625|FG000|Overall Study|Withdrawal by Subject|5
1172998|NCT03954444|2312626|FG001|Overall Study|Withdrawal by Subject|5
1172999|NCT03954444|2312627|FG002|Overall Study|Withdrawal by Subject|5
1173000|NCT03954444|2312625|FG000|Overall Study|Adverse Event|1
1173001|NCT03954444|2312626|FG001|Overall Study|Adverse Event|3
1173002|NCT03954444|2312627|FG002|Overall Study|Adverse Event|2
1173003|NCT03954444|2312625|FG000|Overall Study|Protocol Violation|0
1173004|NCT03954444|2312626|FG001|Overall Study|Protocol Violation|3
1173005|NCT03954444|2312627|FG002|Overall Study|Protocol Violation|5
1173006|NCT03954444|2312625|FG000|Overall Study|Use of prohibited therapy|1
1173007|NCT03954444|2312626|FG001|Overall Study|Use of prohibited therapy|1
1173008|NCT03954444|2312627|FG002|Overall Study|Use of prohibited therapy|2
1173009|NCT03954444|2312625|FG000|Overall Study|Lost to Follow-up|1
1173010|NCT03954444|2312626|FG001|Overall Study|Lost to Follow-up|0
1173011|NCT03954444|2312627|FG002|Overall Study|Lost to Follow-up|1
1173012|NCT03954444|2312625|FG000|Overall Study|Non-compliant with study drug application|2
1173013|NCT03954444|2312626|FG001|Overall Study|Non-compliant with study drug application|2
1173014|NCT03954444|2312627|FG002|Overall Study|Non-compliant with study drug application|0
1173015|NCT03954444|2312625|FG000|Overall Study|Administrative reasons|0
1173016|NCT03954444|2312626|FG001|Overall Study|Administrative reasons|0
1173017|NCT03954444|2312627|FG002|Overall Study|Administrative reasons|1
1173018|NCT03954444|2312625|FG000|Overall Study|Miscellaneous|3
1173019|NCT03954444|2312626|FG001|Overall Study|Miscellaneous|2
1173020|NCT03954444|2312627|FG002|Overall Study|Miscellaneous|1
1173021|NCT03953820|2312635|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1
1173022|NCT03953820|2312636|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0
1173023|NCT03953820|2312637|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0
1173024|NCT03953820|2312635|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1
1173025|NCT03953820|2312636|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0
1173026|NCT03953820|2312637|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0
1173027|NCT03951766|2312650|FG000|Treatment Phase|Lost to Follow-up|1
1173028|NCT03951766|2312650|FG000|Follow-up Phase|Lost to Follow-up|10
1173029|NCT03950856|2312680|FG000|Overall Study|Death|1
1173030|NCT03950856|2312681|FG001|Overall Study|Death|2
1173031|NCT03950856|2312682|FG002|Overall Study|Death|0
1173032|NCT03950856|2312683|FG003|Overall Study|Death|0
1173033|NCT03950856|2312680|FG000|Overall Study|Lost to Follow-up|5
1173034|NCT03950856|2312681|FG001|Overall Study|Lost to Follow-up|6
1173035|NCT03950856|2312682|FG002|Overall Study|Lost to Follow-up|8
1173036|NCT03950856|2312683|FG003|Overall Study|Lost to Follow-up|2
1173037|NCT03950856|2312680|FG000|Overall Study|Protocol Violation|2
1173038|NCT03950856|2312681|FG001|Overall Study|Protocol Violation|0
1173039|NCT03950856|2312682|FG002|Overall Study|Protocol Violation|0
1173040|NCT03950856|2312683|FG003|Overall Study|Protocol Violation|1
1173041|NCT03950856|2312680|FG000|Overall Study|Withdrawal by Subject|4
1173042|NCT03950856|2312681|FG001|Overall Study|Withdrawal by Subject|1
1173043|NCT03950856|2312682|FG002|Overall Study|Withdrawal by Subject|3
1173044|NCT03950856|2312683|FG003|Overall Study|Withdrawal by Subject|1
1173045|NCT03950856|2312680|FG000|Overall Study|Unable to phone|7
1173046|NCT03950856|2312681|FG001|Overall Study|Unable to phone|6
1173047|NCT03950856|2312682|FG002|Overall Study|Unable to phone|7
1173048|NCT03950856|2312683|FG003|Overall Study|Unable to phone|2
1173049|NCT03956550|2312736|FG000|Overall Study|Sponsor decision|65
1173050|NCT03956550|2312737|FG001|Overall Study|Sponsor decision|66
1173051|NCT03956550|2312738|FG002|Overall Study|Sponsor decision|64
1173052|NCT03956550|2312736|FG000|Overall Study|Adverse Event|0
1173053|NCT03956550|2312737|FG001|Overall Study|Adverse Event|1
1173054|NCT03956550|2312738|FG002|Overall Study|Adverse Event|0
1173055|NCT03956550|2312736|FG000|Overall Study|Withdrawal by Subject|5
1173056|NCT03956550|2312737|FG001|Overall Study|Withdrawal by Subject|5
1173057|NCT03956550|2312738|FG002|Overall Study|Withdrawal by Subject|6
1173058|NCT03958656|2312790|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0
1173059|NCT03958656|2312791|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1
1173060|NCT03958656|2312792|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0
1173061|NCT03958656|2312793|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0
1173062|NCT03958656|2312790|FG000|Overall Study|No longer meets eligibility criteria|0
870798|NCT00531752|1831954|FG001|First Double-blind Intervention Period|Adverse Event|0
870799|NCT00531752|1831955|FG002|First Double-blind Intervention Period|Adverse Event|1
870800|NCT00531752|1831956|FG003|First Double-blind Intervention Period|Adverse Event|1
870801|NCT00531752|1831953|FG000|First Double-blind Intervention Period|Other|1
870802|NCT00531752|1831954|FG001|First Double-blind Intervention Period|Other|4
870803|NCT00531752|1831955|FG002|First Double-blind Intervention Period|Other|4
870804|NCT00531752|1831956|FG003|First Double-blind Intervention Period|Other|0
870805|NCT00531752|1831953|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2
870806|NCT00531752|1831954|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0
870807|NCT00531752|1831955|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1
870808|NCT00531752|1831956|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1
870809|NCT00531752|1831953|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
1173063|NCT03958656|2312791|FG001|Overall Study|No longer meets eligibility criteria|0
1173064|NCT03958656|2312792|FG002|Overall Study|No longer meets eligibility criteria|1
1173065|NCT03958656|2312793|FG003|Overall Study|No longer meets eligibility criteria|0
1173066|NCT03958656|2312790|FG000|Overall Study|Started anti-cancer treatment|0
1173067|NCT03958656|2312791|FG001|Overall Study|Started anti-cancer treatment|0
1173068|NCT03958656|2312792|FG002|Overall Study|Started anti-cancer treatment|1
1173069|NCT03958656|2312793|FG003|Overall Study|Started anti-cancer treatment|0
1173070|NCT03954743|2312814|FG000|Overall Study|Adverse Event|1
1173071|NCT03954743|2312815|FG001|Overall Study|Adverse Event|0
1173072|NCT03954743|2312814|FG000|Overall Study|Lost to Follow-up|6
1173073|NCT03954743|2312815|FG001|Overall Study|Lost to Follow-up|4
1173074|NCT03954743|2312814|FG000|Overall Study|Protocol Violation|1
1173075|NCT03954743|2312815|FG001|Overall Study|Protocol Violation|0
1173076|NCT03954743|2312814|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13
1173077|NCT03954743|2312815|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12
1173078|NCT03954743|2312814|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
1173079|NCT03954743|2312815|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
1173080|NCT03951805|2312825|FG000|Overall Study|Adverse Event|1
1173081|NCT03951805|2312826|FG001|Overall Study|Adverse Event|0
1173082|NCT03951805|2312827|FG002|Overall Study|Adverse Event|0
1173083|NCT03951805|2312828|FG003|Overall Study|Adverse Event|0
1173084|NCT03950622|2312853|FG000|Overall Study|Withdrawal by Subject|1
1173085|NCT03950622|2312854|FG001|Overall Study|Withdrawal by Subject|0
1173086|NCT03950622|2312853|FG000|Overall Study|Protocol Deviation|0
1173087|NCT03950622|2312854|FG001|Overall Study|Protocol Deviation|1
1173088|NCT03950622|2312853|FG000|Overall Study|Physician Decision|1
1173089|NCT03950622|2312854|FG001|Overall Study|Physician Decision|0
1173090|NCT03950622|2312853|FG000|Overall Study|Lost to Follow-up|5
1173091|NCT03950622|2312854|FG001|Overall Study|Lost to Follow-up|5
1173092|NCT03950622|2312853|FG000|Overall Study|Death|1
1173093|NCT03950622|2312854|FG001|Overall Study|Death|1
1173094|NCT03948581|2312884|FG000|Overall Study|Lost to Follow-up|0
1173095|NCT03948581|2312885|FG001|Overall Study|Lost to Follow-up|1
1173096|NCT03948334|2312906|FG000|Overall Study|Adverse Event|1
1173097|NCT03948334|2312907|FG001|Overall Study|Adverse Event|4
1173098|NCT03948334|2312906|FG000|Overall Study|Lack of Efficacy|2
1173099|NCT03948334|2312907|FG001|Overall Study|Lack of Efficacy|0
1173100|NCT03948334|2312906|FG000|Overall Study|Lost to Follow-up|1
1173101|NCT03948334|2312907|FG001|Overall Study|Lost to Follow-up|0
1173102|NCT03948334|2312906|FG000|Overall Study|Physician Decision|1
1173103|NCT03948334|2312907|FG001|Overall Study|Physician Decision|0
1173104|NCT03948334|2312906|FG000|Overall Study|Pregnancy|0
1173105|NCT03948334|2312907|FG001|Overall Study|Pregnancy|1
1173106|NCT03948334|2312906|FG000|Overall Study|Protocol Deviation|1
1173107|NCT03948334|2312907|FG001|Overall Study|Protocol Deviation|0
1173108|NCT03948334|2312906|FG000|Overall Study|Study terminated by Sponsor|50
1173109|NCT03948334|2312907|FG001|Overall Study|Study terminated by Sponsor|51
1173110|NCT03948334|2312906|FG000|Overall Study|Subject Decision /Guardian Decision|4
1173111|NCT03948334|2312907|FG001|Overall Study|Subject Decision /Guardian Decision|7
1173112|NCT03944707|2312934|FG000|Overall Study|Adverse Event|0
1173113|NCT03944707|2312935|FG001|Overall Study|Adverse Event|2
1173114|NCT03944707|2312934|FG000|Overall Study|Study terminated by sponsor|12
1173115|NCT03944707|2312935|FG001|Overall Study|Study terminated by sponsor|7
1173116|NCT03944707|2312934|FG000|Overall Study|Subject decision|0
1173117|NCT03944707|2312935|FG001|Overall Study|Subject decision|1
1173118|NCT03943095|2312952|FG000|Overall Study|Incorrectly dispensed wrong box kit|0
1173119|NCT03943095|2312953|FG001|Overall Study|Incorrectly dispensed wrong box kit|1
1173120|NCT03943095|2312952|FG000|Overall Study|Withdrawal by Subject|1
1173121|NCT03943095|2312953|FG001|Overall Study|Withdrawal by Subject|0
1173122|NCT03943290|2312969|FG000|Overall Study|Sponsor Terminated Study|6
1173123|NCT03943290|2312970|FG001|Overall Study|Sponsor Terminated Study|1
1173124|NCT03943290|2312971|FG002|Overall Study|Sponsor Terminated Study|11
1173125|NCT03943290|2312972|FG003|Overall Study|Sponsor Terminated Study|6
1173126|NCT03943290|2312973|FG004|Overall Study|Sponsor Terminated Study|7
1173127|NCT03943290|2312974|FG005|Overall Study|Sponsor Terminated Study|6
1173128|NCT03943290|2312975|FG006|Overall Study|Sponsor Terminated Study|6
1173129|NCT03943290|2312976|FG007|Overall Study|Sponsor Terminated Study|7
1173130|NCT03943290|2312977|FG008|Overall Study|Sponsor Terminated Study|8
1173131|NCT03943290|2312969|FG000|Overall Study|Lost to Follow-up|1
1173132|NCT03943290|2312970|FG001|Overall Study|Lost to Follow-up|0
1173133|NCT03943290|2312971|FG002|Overall Study|Lost to Follow-up|1
1173134|NCT03943290|2312972|FG003|Overall Study|Lost to Follow-up|0
1173135|NCT03943290|2312973|FG004|Overall Study|Lost to Follow-up|0
1173136|NCT03943290|2312974|FG005|Overall Study|Lost to Follow-up|0
1173137|NCT03943290|2312975|FG006|Overall Study|Lost to Follow-up|0
1173138|NCT03943290|2312976|FG007|Overall Study|Lost to Follow-up|1
1173139|NCT03943290|2312977|FG008|Overall Study|Lost to Follow-up|0
1173140|NCT03943290|2312969|FG000|Overall Study|Withdrawal by Subject|0
1173141|NCT03943290|2312970|FG001|Overall Study|Withdrawal by Subject|0
1173142|NCT03943290|2312971|FG002|Overall Study|Withdrawal by Subject|1
1173143|NCT03943290|2312972|FG003|Overall Study|Withdrawal by Subject|0
1173144|NCT03943290|2312973|FG004|Overall Study|Withdrawal by Subject|0
1173145|NCT03943290|2312974|FG005|Overall Study|Withdrawal by Subject|0
1173146|NCT03943290|2312975|FG006|Overall Study|Withdrawal by Subject|0
1173147|NCT03943290|2312976|FG007|Overall Study|Withdrawal by Subject|0
1173148|NCT03943290|2312977|FG008|Overall Study|Withdrawal by Subject|0
1173149|NCT03942042|2313012|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0
1173150|NCT03942042|2313013|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1
1173151|NCT03942042|2313012|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1
1173152|NCT03942042|2313013|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0
1173153|NCT03923530|2313032|FG000|Overall Study|Withdrawal by Subject|1
1173154|NCT03923530|2313032|FG000|Overall Study|screen failure|3
1173155|NCT03914417|2313036|FG000|Overall Study|Withdrawal by Subject|2
1173156|NCT03913377|2313042|FG000|Period 1|Test Article no longer available|0
1173157|NCT03913377|2313043|FG001|Period 1|Test Article no longer available|1
1173158|NCT03913377|2313044|FG002|Period 1|Test Article no longer available|0
1173159|NCT03913377|2313042|FG000|Period 1|No Longer Meets Eligibility Criteria|0
1173160|NCT03913377|2313043|FG001|Period 1|No Longer Meets Eligibility Criteria|0
1173161|NCT03913377|2313044|FG002|Period 1|No Longer Meets Eligibility Criteria|1
1173162|NCT03937778|2313055|FG000|Overall Study|Withdrawal by Subject|1
1173163|NCT03937778|2313055|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1
1173164|NCT03937479|2313064|FG000|Overall Study|Adverse Event|2
1173165|NCT03937479|2313065|FG001|Overall Study|Adverse Event|3
1173166|NCT03937479|2313066|FG002|Overall Study|Adverse Event|0
1173167|NCT03937479|2313067|FG003|Overall Study|Adverse Event|0
1173168|NCT03937479|2313068|FG004|Overall Study|Adverse Event|1
1173169|NCT03937479|2313064|FG000|Overall Study|Withdrawal by Subject|3
1173170|NCT03937479|2313065|FG001|Overall Study|Withdrawal by Subject|5
1173171|NCT03937479|2313066|FG002|Overall Study|Withdrawal by Subject|2
1173172|NCT03937479|2313067|FG003|Overall Study|Withdrawal by Subject|2
1173173|NCT03937479|2313068|FG004|Overall Study|Withdrawal by Subject|1
1173174|NCT03937479|2313064|FG000|Overall Study|Protocol Violation|5
1173175|NCT03937479|2313065|FG001|Overall Study|Protocol Violation|6
1173176|NCT03937479|2313066|FG002|Overall Study|Protocol Violation|4
1173177|NCT03937479|2313067|FG003|Overall Study|Protocol Violation|3
1173178|NCT03937479|2313068|FG004|Overall Study|Protocol Violation|2
1173179|NCT03937479|2313064|FG000|Overall Study|Lost to Follow-up|0
1173180|NCT03937479|2313065|FG001|Overall Study|Lost to Follow-up|1
1173181|NCT03937479|2313066|FG002|Overall Study|Lost to Follow-up|0
1173182|NCT03937479|2313067|FG003|Overall Study|Lost to Follow-up|1
1173183|NCT03937479|2313068|FG004|Overall Study|Lost to Follow-up|0
1173184|NCT03937479|2313064|FG000|Overall Study|Physician Decision|0
1173185|NCT03937479|2313065|FG001|Overall Study|Physician Decision|0
1173186|NCT03937479|2313066|FG002|Overall Study|Physician Decision|1
1173187|NCT03937479|2313067|FG003|Overall Study|Physician Decision|0
1173188|NCT03937479|2313068|FG004|Overall Study|Physician Decision|1
1173189|NCT03936244|2313104|FG000|Overall Study|Lost to Follow-up|5
1173190|NCT03936244|2313105|FG001|Overall Study|Lost to Follow-up|1
1173191|NCT03936244|2313104|FG000|Overall Study|Physician Decision|7
1173192|NCT03936244|2313105|FG001|Overall Study|Physician Decision|3
1173193|NCT03935126|2313112|FG000|Overall Study|Study termination by sponsor|3
1173200|NCT03933462|2313140|FG000|Overall Study|Adverse Event|2
1173201|NCT03933462|2313141|FG001|Overall Study|Adverse Event|0
1173202|NCT03931330|2313156|FG000|Overall Study|Physician Decision|1
1173203|NCT03912259|2313172|FG000|Overall Study|Adverse Event (AE)|2
1173204|NCT03912259|2313173|FG001|Overall Study|Adverse Event (AE)|4
1173205|NCT03912259|2313172|FG000|Overall Study|Lack of Efficacy|4
1173206|NCT03912259|2313173|FG001|Overall Study|Lack of Efficacy|1
1173207|NCT03912259|2313172|FG000|Overall Study|Withdrawal by Subject|11
1173208|NCT03912259|2313173|FG001|Overall Study|Withdrawal by Subject|1
1173209|NCT03931785|2313209|FG000|Overall Study|Lost to Follow-up|4
1173210|NCT03931785|2313210|FG001|Overall Study|Lost to Follow-up|1
1173211|NCT03931785|2313211|FG002|Overall Study|Lost to Follow-up|4
1173212|NCT03931785|2313212|FG003|Overall Study|Lost to Follow-up|3
1173213|NCT03931785|2313209|FG000|Overall Study|Adverse Event|1
1173214|NCT03931785|2313210|FG001|Overall Study|Adverse Event|0
1173215|NCT03931785|2313211|FG002|Overall Study|Adverse Event|3
1173216|NCT03931785|2313212|FG003|Overall Study|Adverse Event|4
1173217|NCT03931785|2313209|FG000|Overall Study|Protocol Violation|0
1173218|NCT03931785|2313210|FG001|Overall Study|Protocol Violation|1
1173219|NCT03931785|2313211|FG002|Overall Study|Protocol Violation|0
1173220|NCT03931785|2313212|FG003|Overall Study|Protocol Violation|0
1173221|NCT03931785|2313209|FG000|Overall Study|Noncompliance With Study drug|0
1173222|NCT03931785|2313210|FG001|Overall Study|Noncompliance With Study drug|1
1173223|NCT03931785|2313211|FG002|Overall Study|Noncompliance With Study drug|0
1173224|NCT03931785|2313212|FG003|Overall Study|Noncompliance With Study drug|0
1173225|NCT03931785|2313209|FG000|Overall Study|Other Not specified|0
1173226|NCT03931785|2313210|FG001|Overall Study|Other Not specified|2
1173227|NCT03931785|2313211|FG002|Overall Study|Other Not specified|2
1173228|NCT03931785|2313212|FG003|Overall Study|Other Not specified|2
1173229|NCT03931785|2313209|FG000|Overall Study|Withdrawal by Subject|0
1173230|NCT03931785|2313210|FG001|Overall Study|Withdrawal by Subject|2
1173231|NCT03931785|2313211|FG002|Overall Study|Withdrawal by Subject|4
1173232|NCT03931785|2313212|FG003|Overall Study|Withdrawal by Subject|1
1173233|NCT03931785|2313209|FG000|Overall Study|Pregnancy|0
1173234|NCT03931785|2313210|FG001|Overall Study|Pregnancy|0
1173235|NCT03931785|2313211|FG002|Overall Study|Pregnancy|0
1173236|NCT03931785|2313212|FG003|Overall Study|Pregnancy|1
1173237|NCT03927846|2313228|FG000|Overall Study|Lost to Follow-up|10
1173238|NCT03927846|2313229|FG001|Overall Study|Lost to Follow-up|11
1173239|NCT03927105|2313235|FG000|Overall Study|Death|1
1173240|NCT03927105|2313235|FG000|Overall Study|In observation for potential re-treatment|2
1173241|NCT03927105|2313235|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1
1173242|NCT03923933|2313241|FG000|Overall Study|Lost to Follow-up|1
1173243|NCT03923933|2313242|FG001|Overall Study|Lost to Follow-up|0
1173244|NCT03923933|2313241|FG000|Overall Study|Withdrawal by Subject|0
1173245|NCT03923933|2313242|FG001|Overall Study|Withdrawal by Subject|1
1173246|NCT03909295|2313248|FG000|Overall Study|Adverse Event|2
1173247|NCT03909295|2313248|FG000|Overall Study|Study terminated by sponsor|50
1173248|NCT03908970|2313254|FG000|Overall Study|Adverse Event|7
1173249|NCT03908970|2313255|FG001|Overall Study|Adverse Event|21
1173250|NCT03908970|2313254|FG000|Overall Study|Physician Decision|1
1173251|NCT03908970|2313255|FG001|Overall Study|Physician Decision|4
1173252|NCT03908970|2313254|FG000|Overall Study|Withdrawal by Subject|9
1173253|NCT03908970|2313255|FG001|Overall Study|Withdrawal by Subject|22
1173254|NCT03897179|2313261|FG000|Overall Study|Withdrawal by Subject|1
1173255|NCT03927950|2313325|FG000|Overall Study|Adverse Event|9
1173256|NCT03920670|2313347|FG000|Overall Study|Protocol Violation|2
1173257|NCT03920670|2313348|FG001|Overall Study|Protocol Violation|2
1173258|NCT03920670|2313347|FG000|Overall Study|Adverse Event|1
1173259|NCT03920670|2313348|FG001|Overall Study|Adverse Event|0
1173260|NCT03898063|2313378|FG000|Overall Study|Withdrawal by Subject|10
1173261|NCT03898063|2313379|FG001|Overall Study|Withdrawal by Subject|8
1173268|NCT03909100|2313438|FG000|Overall Study|Protocol Deviation|2
1173269|NCT03909100|2313438|FG000|Overall Study|Technical Problems|4
1173270|NCT03909100|2313438|FG000|Overall Study|Withdrawal by Subject|4
1173271|NCT03909100|2313438|FG000|Overall Study|Lost to Follow-up|1
1173272|NCT03909100|2313438|FG000|Overall Study|Reason not Specified|4
1173273|NCT03905642|2313445|FG000|Overall Study|Withdrawal by Subject|3
1173274|NCT03905642|2313445|FG000|Overall Study|Pregnancy|1
1173275|NCT03905642|2313445|FG000|Overall Study|Adverse Event|1
1173276|NCT03905642|2313445|FG000|Overall Study|Lack of Efficacy|1
1173277|NCT03905642|2313445|FG000|Overall Study|Completed study but not 24 of 28 days|2
1173278|NCT03892889|2313449|FG000|Overall Study|Adverse Event|17
1173279|NCT03892889|2313449|FG000|Overall Study|Lack of Efficacy|1
1173280|NCT03892889|2313449|FG000|Overall Study|Lost to Follow-up|46
1173281|NCT03892889|2313449|FG000|Overall Study|Non-compliance with study drug|22
1173282|NCT03892889|2313449|FG000|Overall Study|Pregnancy|1
1173283|NCT03892889|2313449|FG000|Overall Study|Protocol Deviation|3
1173284|NCT03892889|2313449|FG000|Overall Study|Withdrawal by Subject|50
1173285|NCT03892889|2313449|FG000|Overall Study|Withdrawal by Caregiver|1
1173286|NCT03892889|2313449|FG000|Overall Study|Study Terminated by Sponsor|50
1173287|NCT03892889|2313449|FG000|Overall Study|Physician Decision|8
1173288|NCT03892889|2313449|FG000|Overall Study|Reason not Specified|5
1173289|NCT03921723|2313453|FG000|Period 2 (4 Days)|Withdrawal by Subject|3
1173290|NCT03921723|2313453|FG000|Period 3 (4 Days)|Withdrawal by Subject|1
1173291|NCT03918239|2313497|FG000|Overall Study|Lost to Follow-up|3
1173292|NCT03918239|2313498|FG001|Overall Study|Lost to Follow-up|1
1173293|NCT03918239|2313497|FG000|Overall Study|Pregnancy|0
1173294|NCT03918239|2313498|FG001|Overall Study|Pregnancy|2
1173295|NCT03918239|2313497|FG000|Overall Study|Withdrawal by Subject|3
1173296|NCT03918239|2313498|FG001|Overall Study|Withdrawal by Subject|3
1173297|NCT03918239|2313497|FG000|Overall Study|positive urine drug screening results|4
1173298|NCT03918239|2313498|FG001|Overall Study|positive urine drug screening results|1
1173299|NCT03917823|2313506|FG000|Overall Study|Lost to Follow-up|1
1173300|NCT03917823|2313507|FG001|Overall Study|Lost to Follow-up|1
1173301|NCT03917823|2313506|FG000|Overall Study|Withdrawal by Subject|0
1173302|NCT03917823|2313507|FG001|Overall Study|Withdrawal by Subject|1
1173303|NCT03902613|2313528|FG000|Overall Study|Physician Decision|1
1173304|NCT03902574|2313535|FG000|Overall Study|Urinary drug test was positive on Day 20|0
1173305|NCT03902574|2313536|FG001|Overall Study|Urinary drug test was positive on Day 20|0
1173306|NCT03902574|2313537|FG002|Overall Study|Urinary drug test was positive on Day 20|1
1173307|NCT03914950|2313545|FG000|Overall Study|Physician Decision|54
1173308|NCT03911843|2313557|FG000|Overall Study|Adverse Event|2
1173309|NCT03911843|2313558|FG001|Overall Study|Adverse Event|0
1173310|NCT03911843|2313557|FG000|Overall Study|Protocol Violation|2
1173311|NCT03911843|2313558|FG001|Overall Study|Protocol Violation|0
1173312|NCT03911843|2313557|FG000|Overall Study|Lost to Follow-up|0
1173313|NCT03911843|2313558|FG001|Overall Study|Lost to Follow-up|1
1173314|NCT03894813|2313575|FG000|Overall Study|Adverse Event|1
1173315|NCT03894813|2313576|FG001|Overall Study|Adverse Event|1
1173316|NCT03894813|2313575|FG000|Overall Study|Lack of Efficacy|3
1173317|NCT03894813|2313576|FG001|Overall Study|Lack of Efficacy|3
1173318|NCT03894813|2313575|FG000|Overall Study|Lost to Follow-up|1
1173319|NCT03894813|2313576|FG001|Overall Study|Lost to Follow-up|0
1173320|NCT03894813|2313575|FG000|Overall Study|Pregnancy|2
1173321|NCT03894813|2313576|FG001|Overall Study|Pregnancy|1
1173322|NCT03894813|2313575|FG000|Overall Study|Protocol Violation|3
1173323|NCT03894813|2313576|FG001|Overall Study|Protocol Violation|7
1173324|NCT03894813|2313575|FG000|Overall Study|Withdrawal by Subject|1
1173325|NCT03894813|2313576|FG001|Overall Study|Withdrawal by Subject|3
1173326|NCT03894813|2313575|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0
1173327|NCT03894813|2313576|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1
1173328|NCT03911960|2313584|FG000|Overall Study|Lost to Follow-up|5
1173329|NCT03911960|2313585|FG001|Overall Study|Lost to Follow-up|3
1173330|NCT03907072|2313595|FG000|Overall Study|Study Terminated by Sponsor|2
1173331|NCT03907072|2313596|FG001|Overall Study|Study Terminated by Sponsor|2
1173332|NCT03907072|2313597|FG002|Overall Study|Study Terminated by Sponsor|2
1173333|NCT03911401|2313617|FG000|Overall Study|Adverse Event|1
1173334|NCT03911401|2313618|FG001|Overall Study|Adverse Event|2
1173335|NCT03911401|2313619|FG002|Overall Study|Adverse Event|5
1173336|NCT03911401|2313617|FG000|Overall Study|Lack of Efficacy|1
1173337|NCT03911401|2313618|FG001|Overall Study|Lack of Efficacy|1
1173338|NCT03911401|2313619|FG002|Overall Study|Lack of Efficacy|8
1173339|NCT03911401|2313617|FG000|Overall Study|Physician Decision|0
1173340|NCT03911401|2313618|FG001|Overall Study|Physician Decision|0
1173341|NCT03911401|2313619|FG002|Overall Study|Physician Decision|1
1173342|NCT03911401|2313617|FG000|Overall Study|Withdrawal by Subject|1
1173343|NCT03911401|2313618|FG001|Overall Study|Withdrawal by Subject|2
1173344|NCT03911401|2313619|FG002|Overall Study|Withdrawal by Subject|0
1173345|NCT03911401|2313617|FG000|Overall Study|Withdrawal by parent/guardian|4
1173346|NCT03911401|2313618|FG001|Overall Study|Withdrawal by parent/guardian|4
1173347|NCT03911401|2313619|FG002|Overall Study|Withdrawal by parent/guardian|11
1173348|NCT03904420|2313646|FG000|Overall Study|Study terminated|2
1173349|NCT03904420|2313647|FG001|Overall Study|Study terminated|2
1173350|NCT03903822|2313661|FG000|Treatment Phase (6 Weeks)|Adverse Event|3
1173351|NCT03903822|2313662|FG001|Treatment Phase (6 Weeks)|Adverse Event|3
1173352|NCT03903822|2313663|FG002|Treatment Phase (6 Weeks)|Adverse Event|1
1173353|NCT03903822|2313664|FG003|Treatment Phase (6 Weeks)|Adverse Event|1
1173354|NCT03903822|2313665|FG004|Treatment Phase (6 Weeks)|Adverse Event|1
1173355|NCT03903822|2313666|FG005|Treatment Phase (6 Weeks)|Adverse Event|6
1173356|NCT03903822|2313667|FG006|Treatment Phase (6 Weeks)|Adverse Event|1
1173357|NCT03903822|2313668|FG007|Treatment Phase (6 Weeks)|Adverse Event|0
1173358|NCT03903822|2313661|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0
1173359|NCT03903822|2313662|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0
1173360|NCT03903822|2313663|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0
1173361|NCT03903822|2313664|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0
1173362|NCT03903822|2313665|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1
1173363|NCT03903822|2313666|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1
1173364|NCT03903822|2313667|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0
1173365|NCT03903822|2313668|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0
1173366|NCT03903822|2313661|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0
1173367|NCT03903822|2313662|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0
1173368|NCT03903822|2313663|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0
1173369|NCT03903822|2313664|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0
1173370|NCT03903822|2313665|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0
1173371|NCT03903822|2313666|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0
1173372|NCT03903822|2313667|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1
1173373|NCT03903822|2313668|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1
1173374|NCT03903822|2313661|FG000|Treatment Phase (6 Weeks)|Physician Decision|0
1173375|NCT03903822|2313662|FG001|Treatment Phase (6 Weeks)|Physician Decision|2
1173376|NCT03903822|2313663|FG002|Treatment Phase (6 Weeks)|Physician Decision|0
1173377|NCT03903822|2313664|FG003|Treatment Phase (6 Weeks)|Physician Decision|0
1173378|NCT03903822|2313665|FG004|Treatment Phase (6 Weeks)|Physician Decision|0
1173379|NCT03903822|2313666|FG005|Treatment Phase (6 Weeks)|Physician Decision|0
1173380|NCT03903822|2313667|FG006|Treatment Phase (6 Weeks)|Physician Decision|0
1173381|NCT03903822|2313668|FG007|Treatment Phase (6 Weeks)|Physician Decision|0
1173382|NCT03903822|2313661|FG000|Treatment Phase (6 Weeks)|Pregnancy|0
1173383|NCT03903822|2313662|FG001|Treatment Phase (6 Weeks)|Pregnancy|0
1173384|NCT03903822|2313663|FG002|Treatment Phase (6 Weeks)|Pregnancy|0
1173385|NCT03903822|2313664|FG003|Treatment Phase (6 Weeks)|Pregnancy|1
1173386|NCT03903822|2313665|FG004|Treatment Phase (6 Weeks)|Pregnancy|1
1173387|NCT03903822|2313666|FG005|Treatment Phase (6 Weeks)|Pregnancy|0
1173388|NCT03903822|2313667|FG006|Treatment Phase (6 Weeks)|Pregnancy|0
1173389|NCT03903822|2313668|FG007|Treatment Phase (6 Weeks)|Pregnancy|0
1173390|NCT03903822|2313661|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0
1173391|NCT03903822|2313662|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0
1173392|NCT03903822|2313663|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0
1173393|NCT03903822|2313664|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1
1173394|NCT03903822|2313665|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0
1173395|NCT03903822|2313666|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0
1173396|NCT03903822|2313667|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0
1173397|NCT03903822|2313668|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0
1173398|NCT03903822|2313661|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
1173399|NCT03903822|2313662|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4
1173400|NCT03903822|2313663|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
1173401|NCT03903822|2313664|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
1173402|NCT03903822|2313665|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1
1173403|NCT03903822|2313666|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
1173404|NCT03903822|2313667|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
1173405|NCT03903822|2313668|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
1173406|NCT03903822|2313661|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2
1173407|NCT03903822|2313662|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0
1173408|NCT03903822|2313663|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0
1173409|NCT03903822|2313664|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0
1173410|NCT03903822|2313665|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0
1173411|NCT03903822|2313666|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1
1173412|NCT03903822|2313667|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0
1173413|NCT03903822|2313668|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0
1173414|NCT03903822|2313661|FG000|Treatment Phase (6 Weeks)|Other|2
1173415|NCT03903822|2313662|FG001|Treatment Phase (6 Weeks)|Other|1
1173416|NCT03903822|2313663|FG002|Treatment Phase (6 Weeks)|Other|0
1173417|NCT03903822|2313664|FG003|Treatment Phase (6 Weeks)|Other|0
1173418|NCT03903822|2313665|FG004|Treatment Phase (6 Weeks)|Other|1
1173419|NCT03903822|2313666|FG005|Treatment Phase (6 Weeks)|Other|1
1173420|NCT03903822|2313667|FG006|Treatment Phase (6 Weeks)|Other|0
870810|NCT00531752|1831954|FG001|First Double-blind Intervention Period|Lost to Follow-up|0
870811|NCT00531752|1831955|FG002|First Double-blind Intervention Period|Lost to Follow-up|1
870812|NCT00531752|1831956|FG003|First Double-blind Intervention Period|Lost to Follow-up|1
870813|NCT00531752|1831953|FG000|First Double-blind Intervention Period|Randomized but not treated|1
870814|NCT00531752|1831954|FG001|First Double-blind Intervention Period|Randomized but not treated|0
870815|NCT00531752|1831955|FG002|First Double-blind Intervention Period|Randomized but not treated|0
870816|NCT00531752|1831956|FG003|First Double-blind Intervention Period|Randomized but not treated|0
870817|NCT00531752|1831953|FG000|Second Double-blind Intervention Period|Adverse Event|1
870818|NCT00531752|1831954|FG001|Second Double-blind Intervention Period|Adverse Event|1
870819|NCT00531752|1831955|FG002|Second Double-blind Intervention Period|Adverse Event|0
870820|NCT00531752|1831956|FG003|Second Double-blind Intervention Period|Adverse Event|0
870821|NCT00531752|1831953|FG000|Second Double-blind Intervention Period|Other|1
870822|NCT00531752|1831954|FG001|Second Double-blind Intervention Period|Other|1
870823|NCT00531752|1831955|FG002|Second Double-blind Intervention Period|Other|0
870824|NCT00531752|1831956|FG003|Second Double-blind Intervention Period|Other|0
870825|NCT00531752|1831953|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
1173421|NCT03903822|2313668|FG007|Treatment Phase (6 Weeks)|Other|0
1173422|NCT03903822|2313661|FG000|Follow up Phase (4 Weeks)|Adverse Event|3
1173423|NCT03903822|2313662|FG001|Follow up Phase (4 Weeks)|Adverse Event|2
1173424|NCT03903822|2313663|FG002|Follow up Phase (4 Weeks)|Adverse Event|1
1173425|NCT03903822|2313664|FG003|Follow up Phase (4 Weeks)|Adverse Event|1
1173426|NCT03903822|2313665|FG004|Follow up Phase (4 Weeks)|Adverse Event|0
1173427|NCT03903822|2313666|FG005|Follow up Phase (4 Weeks)|Adverse Event|5
1173428|NCT03903822|2313667|FG006|Follow up Phase (4 Weeks)|Adverse Event|1
1173429|NCT03903822|2313668|FG007|Follow up Phase (4 Weeks)|Adverse Event|0
1173430|NCT03903822|2313661|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0
1173431|NCT03903822|2313662|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0
1173432|NCT03903822|2313663|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0
1173433|NCT03903822|2313664|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0
1173434|NCT03903822|2313665|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1
1173435|NCT03903822|2313666|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0
1173436|NCT03903822|2313667|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0
1173437|NCT03903822|2313668|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0
1173438|NCT03903822|2313661|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2
1173439|NCT03903822|2313662|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0
1173440|NCT03903822|2313663|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0
1173441|NCT03903822|2313664|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0
1173442|NCT03903822|2313665|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0
1173443|NCT03903822|2313666|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0
1173444|NCT03903822|2313667|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1
1173445|NCT03903822|2313668|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3
1173446|NCT03903822|2313661|FG000|Follow up Phase (4 Weeks)|Pregnancy|0
1173447|NCT03903822|2313662|FG001|Follow up Phase (4 Weeks)|Pregnancy|0
1173448|NCT03903822|2313663|FG002|Follow up Phase (4 Weeks)|Pregnancy|0
1173449|NCT03903822|2313664|FG003|Follow up Phase (4 Weeks)|Pregnancy|1
1173450|NCT03903822|2313665|FG004|Follow up Phase (4 Weeks)|Pregnancy|1
1173451|NCT03903822|2313666|FG005|Follow up Phase (4 Weeks)|Pregnancy|0
1173452|NCT03903822|2313667|FG006|Follow up Phase (4 Weeks)|Pregnancy|0
1173453|NCT03903822|2313668|FG007|Follow up Phase (4 Weeks)|Pregnancy|0
1173454|NCT03903822|2313661|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
1173455|NCT03903822|2313662|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5
1173456|NCT03903822|2313663|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
1173457|NCT03903822|2313664|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
1173458|NCT03903822|2313665|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
1173459|NCT03903822|2313666|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
1173460|NCT03903822|2313667|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
1173461|NCT03903822|2313668|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
1173462|NCT03903822|2313661|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
1173463|NCT03903822|2313662|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
1173464|NCT03903822|2313663|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
1173465|NCT03903822|2313664|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
1173466|NCT03903822|2313665|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
1173467|NCT03903822|2313666|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1
1173468|NCT03903822|2313667|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
1173469|NCT03903822|2313668|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
1173470|NCT03903822|2313661|FG000|Follow up Phase (4 Weeks)|Other|1
1173471|NCT03903822|2313662|FG001|Follow up Phase (4 Weeks)|Other|1
1173472|NCT03903822|2313663|FG002|Follow up Phase (4 Weeks)|Other|0
1173473|NCT03903822|2313664|FG003|Follow up Phase (4 Weeks)|Other|0
1173474|NCT03903822|2313665|FG004|Follow up Phase (4 Weeks)|Other|0
1173475|NCT03903822|2313666|FG005|Follow up Phase (4 Weeks)|Other|0
1173476|NCT03903822|2313667|FG006|Follow up Phase (4 Weeks)|Other|0
1173477|NCT03903822|2313668|FG007|Follow up Phase (4 Weeks)|Other|0
1173478|NCT03905096|2313688|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1
1173479|NCT03905096|2313689|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0
1173480|NCT03899064|2313702|FG000|Overall Study|Lost to Follow-up|1
1173481|NCT03899064|2313702|FG000|Overall Study|Protocol Violation|2
1173482|NCT03899064|2313702|FG000|Overall Study|Withdrawal by Subject|2
1173483|NCT03899064|2313702|FG000|Overall Study|Other|2
1173484|NCT03894969|2313711|FG000|Overall Study|Adverse Event|0
1173485|NCT03894969|2313712|FG001|Overall Study|Adverse Event|2
1173486|NCT03894969|2313713|FG002|Overall Study|Adverse Event|0
1173487|NCT03894969|2313714|FG003|Overall Study|Adverse Event|3
1173488|NCT03894969|2313715|FG004|Overall Study|Adverse Event|3
1173489|NCT03894969|2313711|FG000|Overall Study|Lost to Follow-up|1
1173490|NCT03894969|2313712|FG001|Overall Study|Lost to Follow-up|0
1173491|NCT03894969|2313713|FG002|Overall Study|Lost to Follow-up|1
1173492|NCT03894969|2313714|FG003|Overall Study|Lost to Follow-up|0
1173493|NCT03894969|2313715|FG004|Overall Study|Lost to Follow-up|0
1173494|NCT03894969|2313711|FG000|Overall Study|Withdrawal by Subject|1
1173495|NCT03894969|2313712|FG001|Overall Study|Withdrawal by Subject|1
1173496|NCT03894969|2313713|FG002|Overall Study|Withdrawal by Subject|1
1173497|NCT03894969|2313714|FG003|Overall Study|Withdrawal by Subject|3
1173498|NCT03894969|2313715|FG004|Overall Study|Withdrawal by Subject|8
1173499|NCT03894969|2313711|FG000|Overall Study|Other|0
1173500|NCT03894969|2313712|FG001|Overall Study|Other|0
1173501|NCT03894969|2313713|FG002|Overall Study|Other|0
1173502|NCT03894969|2313714|FG003|Overall Study|Other|0
1173503|NCT03894969|2313715|FG004|Overall Study|Other|3
1173504|NCT03903159|2313728|FG000|Overall Study|Discharged with Staff Approval|2
1173505|NCT03903159|2313728|FG000|Overall Study|Discharged at Staff Request|2
1173506|NCT03903159|2313728|FG000|Overall Study|Discharged Against Staff Advice|1
1173507|NCT03902392|2313734|FG000|Overall Study|Lost to Follow-up|7
1173508|NCT03902392|2313735|FG001|Overall Study|Lost to Follow-up|7
1173509|NCT03895034|2313788|FG000|Overall Study|Lost to Follow-up|2
1173510|NCT03900728|2313795|FG000|Overall Study|No text responses|0
1173511|NCT03900728|2313796|FG001|Overall Study|No text responses|0
1173512|NCT03900728|2313797|FG002|Overall Study|No text responses|4
1173513|NCT03895372|2313836|FG000|Investigational Treatment Period|Adverse Event|1
1173514|NCT03895372|2313837|FG001|Investigational Treatment Period|Adverse Event|0
1173515|NCT03895372|2313838|FG002|Investigational Treatment Period|Adverse Event|0
1173516|NCT03895372|2313839|FG003|Investigational Treatment Period|Adverse Event|0
1173517|NCT03895372|2313840|FG004|Investigational Treatment Period|Adverse Event|0
1173518|NCT03895372|2313841|FG005|Investigational Treatment Period|Adverse Event|0
1173519|NCT03895372|2313842|FG006|Investigational Treatment Period|Adverse Event|4
1173520|NCT03895372|2313843|FG007|Investigational Treatment Period|Adverse Event|3
1173521|NCT03895372|2313836|FG000|Investigational Treatment Period|Lack of Efficacy|1
1173522|NCT03895372|2313837|FG001|Investigational Treatment Period|Lack of Efficacy|0
1173523|NCT03895372|2313838|FG002|Investigational Treatment Period|Lack of Efficacy|0
1173524|NCT03895372|2313839|FG003|Investigational Treatment Period|Lack of Efficacy|0
1173525|NCT03895372|2313840|FG004|Investigational Treatment Period|Lack of Efficacy|0
1173526|NCT03895372|2313841|FG005|Investigational Treatment Period|Lack of Efficacy|0
1173527|NCT03895372|2313842|FG006|Investigational Treatment Period|Lack of Efficacy|0
1173528|NCT03895372|2313843|FG007|Investigational Treatment Period|Lack of Efficacy|0
1173529|NCT03895372|2313836|FG000|Investigational Treatment Period|Lost to Follow-up|0
1173530|NCT03895372|2313837|FG001|Investigational Treatment Period|Lost to Follow-up|0
1173531|NCT03895372|2313838|FG002|Investigational Treatment Period|Lost to Follow-up|0
1173532|NCT03895372|2313839|FG003|Investigational Treatment Period|Lost to Follow-up|0
1173533|NCT03895372|2313840|FG004|Investigational Treatment Period|Lost to Follow-up|0
1173534|NCT03895372|2313841|FG005|Investigational Treatment Period|Lost to Follow-up|0
1173535|NCT03895372|2313842|FG006|Investigational Treatment Period|Lost to Follow-up|1
1173536|NCT03895372|2313843|FG007|Investigational Treatment Period|Lost to Follow-up|0
870826|NCT00531752|1831954|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0
1173537|NCT03895372|2313836|FG000|Investigational Treatment Period|Other|0
1173538|NCT03895372|2313837|FG001|Investigational Treatment Period|Other|0
1173539|NCT03895372|2313838|FG002|Investigational Treatment Period|Other|0
1173540|NCT03895372|2313839|FG003|Investigational Treatment Period|Other|0
1173541|NCT03895372|2313840|FG004|Investigational Treatment Period|Other|0
1173542|NCT03895372|2313841|FG005|Investigational Treatment Period|Other|1
1173543|NCT03895372|2313842|FG006|Investigational Treatment Period|Other|0
1173544|NCT03895372|2313843|FG007|Investigational Treatment Period|Other|2
1173545|NCT03895372|2313836|FG000|Investigational Treatment Period|Protocol Violation|0
1173546|NCT03895372|2313837|FG001|Investigational Treatment Period|Protocol Violation|0
1173547|NCT03895372|2313838|FG002|Investigational Treatment Period|Protocol Violation|0
1173548|NCT03895372|2313839|FG003|Investigational Treatment Period|Protocol Violation|1
1173549|NCT03895372|2313840|FG004|Investigational Treatment Period|Protocol Violation|0
1173550|NCT03895372|2313841|FG005|Investigational Treatment Period|Protocol Violation|0
1173551|NCT03895372|2313842|FG006|Investigational Treatment Period|Protocol Violation|0
870827|NCT00531752|1831955|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0
870828|NCT00531752|1831956|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1
870829|NCT00531752|1831953|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
870830|NCT00531752|1831954|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0
870831|NCT00531752|1831955|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0
870832|NCT00531752|1831956|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1
870833|NCT00531934|1831998|FG000|Overall Study|Adverse Event|4
1173552|NCT03895372|2313843|FG007|Investigational Treatment Period|Protocol Violation|0
1173553|NCT03895372|2313836|FG000|Investigational Treatment Period|Withdrawal by Subject|2
1173554|NCT03895372|2313837|FG001|Investigational Treatment Period|Withdrawal by Subject|3
1173555|NCT03895372|2313838|FG002|Investigational Treatment Period|Withdrawal by Subject|1
1173556|NCT03895372|2313839|FG003|Investigational Treatment Period|Withdrawal by Subject|1
1173557|NCT03895372|2313840|FG004|Investigational Treatment Period|Withdrawal by Subject|0
1173558|NCT03895372|2313841|FG005|Investigational Treatment Period|Withdrawal by Subject|1
1173559|NCT03895372|2313842|FG006|Investigational Treatment Period|Withdrawal by Subject|3
1173560|NCT03895372|2313843|FG007|Investigational Treatment Period|Withdrawal by Subject|0
1173561|NCT03895372|2313836|FG000|Extension Treatment Period|Adverse Event|0
1173562|NCT03895372|2313837|FG001|Extension Treatment Period|Adverse Event|1
1173563|NCT03895372|2313838|FG002|Extension Treatment Period|Adverse Event|0
1173564|NCT03895372|2313839|FG003|Extension Treatment Period|Adverse Event|1
1173565|NCT03895372|2313840|FG004|Extension Treatment Period|Adverse Event|0
1173566|NCT03895372|2313841|FG005|Extension Treatment Period|Adverse Event|0
1173567|NCT03895372|2313842|FG006|Extension Treatment Period|Adverse Event|3
1173568|NCT03895372|2313843|FG007|Extension Treatment Period|Adverse Event|3
1173569|NCT03895372|2313836|FG000|Extension Treatment Period|Other|1
1173570|NCT03895372|2313837|FG001|Extension Treatment Period|Other|3
1173571|NCT03895372|2313838|FG002|Extension Treatment Period|Other|0
1173572|NCT03895372|2313839|FG003|Extension Treatment Period|Other|0
1173573|NCT03895372|2313840|FG004|Extension Treatment Period|Other|1
1173574|NCT03895372|2313841|FG005|Extension Treatment Period|Other|0
1173575|NCT03895372|2313842|FG006|Extension Treatment Period|Other|0
1173576|NCT03895372|2313843|FG007|Extension Treatment Period|Other|2
1173577|NCT03895372|2313836|FG000|Extension Treatment Period|Pregnancy|0
1173578|NCT03895372|2313837|FG001|Extension Treatment Period|Pregnancy|0
1173579|NCT03895372|2313838|FG002|Extension Treatment Period|Pregnancy|0
1173580|NCT03895372|2313839|FG003|Extension Treatment Period|Pregnancy|0
1173581|NCT03895372|2313840|FG004|Extension Treatment Period|Pregnancy|1
1173582|NCT03895372|2313841|FG005|Extension Treatment Period|Pregnancy|0
1173583|NCT03895372|2313842|FG006|Extension Treatment Period|Pregnancy|0
1173584|NCT03895372|2313843|FG007|Extension Treatment Period|Pregnancy|0
1173585|NCT03895372|2313836|FG000|Extension Treatment Period|Withdrawal by Subject|2
1173586|NCT03895372|2313837|FG001|Extension Treatment Period|Withdrawal by Subject|1
1173587|NCT03895372|2313838|FG002|Extension Treatment Period|Withdrawal by Subject|0
1173588|NCT03895372|2313839|FG003|Extension Treatment Period|Withdrawal by Subject|0
1173589|NCT03895372|2313840|FG004|Extension Treatment Period|Withdrawal by Subject|1
1173590|NCT03895372|2313841|FG005|Extension Treatment Period|Withdrawal by Subject|1
1173591|NCT03895372|2313842|FG006|Extension Treatment Period|Withdrawal by Subject|1
1173592|NCT03895372|2313843|FG007|Extension Treatment Period|Withdrawal by Subject|1
1173593|NCT03896022|2313869|FG000|Overall Study|Withdrawal by Subject|1
1173594|NCT03896022|2313870|FG001|Overall Study|Withdrawal by Subject|0
1173595|NCT03896022|2313871|FG002|Overall Study|Withdrawal by Subject|0
1173596|NCT03896022|2313869|FG000|Overall Study|Did not have procedure|3
1173597|NCT03896022|2313870|FG001|Overall Study|Did not have procedure|0
1173598|NCT03896022|2313871|FG002|Overall Study|Did not have procedure|0
1173599|NCT03891862|2313883|FG000|Open-label Period|Adverse Event|2
1173600|NCT03891862|2313884|FG001|Open-label Period|Adverse Event|0
1173601|NCT03891862|2313885|FG002|Open-label Period|Adverse Event|0
1173602|NCT03891862|2313883|FG000|Open-label Period|Protocol Violation|5
1173603|NCT03891862|2313884|FG001|Open-label Period|Protocol Violation|0
1173604|NCT03891862|2313885|FG002|Open-label Period|Protocol Violation|0
1173605|NCT03891862|2313883|FG000|Open-label Period|Withdrawal by Subject|6
1173606|NCT03891862|2313884|FG001|Open-label Period|Withdrawal by Subject|0
1173607|NCT03891862|2313885|FG002|Open-label Period|Withdrawal by Subject|0
1173608|NCT03891862|2313883|FG000|Open-label Period|Death|1
1173609|NCT03891862|2313884|FG001|Open-label Period|Death|0
1173610|NCT03891862|2313885|FG002|Open-label Period|Death|0
1173611|NCT03891862|2313883|FG000|Open-label Period|Lost to Follow-up|2
1173612|NCT03891862|2313884|FG001|Open-label Period|Lost to Follow-up|0
1173613|NCT03891862|2313885|FG002|Open-label Period|Lost to Follow-up|0
1173614|NCT03891862|2313883|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0
1173615|NCT03891862|2313884|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1
1173616|NCT03891862|2313885|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1
1173617|NCT03891862|2313883|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0
1173618|NCT03891862|2313884|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2
1173619|NCT03891862|2313885|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1
1173620|NCT03891862|2313883|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0
1173621|NCT03891862|2313884|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1
1173622|NCT03891862|2313885|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2
1173623|NCT03891862|2313883|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
1173624|NCT03891862|2313884|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2
1173625|NCT03891862|2313885|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
1173626|NCT03892564|2313913|FG000|Overall Study|Withdrawal by Subject|2
1173627|NCT03892707|2313920|FG000|Overall Study|Screen failure|6
1173628|NCT03892707|2313921|FG001|Overall Study|Screen failure|0
1173629|NCT03892707|2313920|FG000|Overall Study|Pain resolution|0
1173630|NCT03892707|2313921|FG001|Overall Study|Pain resolution|4
1173631|NCT03892707|2313920|FG000|Overall Study|Withdrawal by Subject|0
1173632|NCT03892707|2313921|FG001|Overall Study|Withdrawal by Subject|1
1173633|NCT03892707|2313920|FG000|Overall Study|Other (long business trip)|0
1173634|NCT03892707|2313921|FG001|Overall Study|Other (long business trip)|1
1173635|NCT03891641|2313940|FG000|Overall Study|Study Stoppage Due to COVID-19|2
1173636|NCT03891641|2313941|FG001|Overall Study|Study Stoppage Due to COVID-19|2
1173637|NCT03890367|2313950|FG000|Overall Study|Withdrawal by parent/guardian|1
1173638|NCT03890367|2313951|FG001|Overall Study|Withdrawal by parent/guardian|3
1173639|NCT03890367|2313952|FG002|Overall Study|Withdrawal by parent/guardian|0
1173640|NCT03890367|2313950|FG000|Overall Study|Protocol deviation|2
1173641|NCT03890367|2313951|FG001|Overall Study|Protocol deviation|2
1173642|NCT03890367|2313952|FG002|Overall Study|Protocol deviation|1
1173643|NCT03890367|2313950|FG000|Overall Study|Lost to Follow-up|1
1173644|NCT03890367|2313951|FG001|Overall Study|Lost to Follow-up|1
1173645|NCT03890367|2313952|FG002|Overall Study|Lost to Follow-up|0
1173646|NCT03889704|2313960|FG000|Overall Study|Study terminated due to pandemic|1
1173647|NCT03888391|2313974|FG000|Overall Study|Lost to Follow-up|15
1173648|NCT03888482|2313980|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0
1173649|NCT03888482|2313981|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1
1173650|NCT03888482|2313980|FG000|Second Wear (8 -1/+2 Days)|Other|1
1173651|NCT03888482|2313981|FG001|Second Wear (8 -1/+2 Days)|Other|0
1173652|NCT03887442|2314016|FG000|Overall Study|Adverse Event|1
1173653|NCT03887442|2314017|FG001|Overall Study|Adverse Event|0
1173654|NCT03878602|2314041|FG000|Overall Study|cord blood donation|7
1173655|NCT03878602|2314042|FG001|Overall Study|cord blood donation|1
1173656|NCT03878602|2314041|FG000|Overall Study|incomplete data collection|2
1173657|NCT03878602|2314042|FG001|Overall Study|incomplete data collection|0
1173658|NCT03875118|2314052|FG000|Overall Study|Withdrawal by Subject|4
1173659|NCT03875118|2314053|FG001|Overall Study|Withdrawal by Subject|4
1173660|NCT03873987|2314061|FG000|Overall Study|Adverse Event|1
1173661|NCT03873987|2314062|FG001|Overall Study|Adverse Event|0
1173662|NCT03873987|2314061|FG000|Overall Study|staff was unable to start a new IV line|1
1173663|NCT03873987|2314062|FG001|Overall Study|staff was unable to start a new IV line|0
1173664|NCT03873987|2314061|FG000|Overall Study|Lost to Follow-up|0
1173665|NCT03873987|2314062|FG001|Overall Study|Lost to Follow-up|1
1173666|NCT03878758|2314088|FG000|Overall Study|Withdrawal by Subject|1
1173667|NCT03878758|2314088|FG000|Overall Study|Protocol defined|2
1173668|NCT03878758|2314088|FG000|Overall Study|Improper consent documentation|1
1173669|NCT03849300|2314105|FG000|Overall Study|move out to different area|1
1173670|NCT03849300|2314106|FG001|Overall Study|move out to different area|3
1173671|NCT03849300|2314107|FG002|Overall Study|move out to different area|1
1173672|NCT03849300|2314108|FG003|Overall Study|move out to different area|4
1173673|NCT03849300|2314105|FG000|Overall Study|scheduling/transportation conflict|4
1173674|NCT03849300|2314106|FG001|Overall Study|scheduling/transportation conflict|4
1173675|NCT03849300|2314107|FG002|Overall Study|scheduling/transportation conflict|3
1173676|NCT03849300|2314108|FG003|Overall Study|scheduling/transportation conflict|2
1173677|NCT03883113|2314150|FG000|Overall Study|Physician Decision|4
1173678|NCT03883113|2314151|FG001|Overall Study|Physician Decision|2
1173679|NCT03883113|2314150|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9
1173680|NCT03883113|2314151|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7
1173681|NCT03883113|2314150|FG000|Overall Study|Pregnancy|1
1173682|NCT03883113|2314151|FG001|Overall Study|Pregnancy|0
1173683|NCT03883113|2314150|FG000|Overall Study|Adverse Event|0
1173684|NCT03883113|2314151|FG001|Overall Study|Adverse Event|1
1173685|NCT03883113|2314150|FG000|Overall Study|Withdrawal by Subject|1
1173686|NCT03883113|2314151|FG001|Overall Study|Withdrawal by Subject|2
1173687|NCT03883113|2314150|FG000|Overall Study|Lost to Follow-up|1
1173688|NCT03883113|2314151|FG001|Overall Study|Lost to Follow-up|0
1173689|NCT03880227|2314173|FG000|First Visit|Withdrawal by Subject|1
1173690|NCT03880227|2314174|FG001|First Visit|Withdrawal by Subject|0
1173691|NCT03880227|2314175|FG002|First Visit|Withdrawal by Subject|0
1173692|NCT03880227|2314176|FG003|First Visit|Withdrawal by Subject|0
1173693|NCT03880227|2314173|FG000|1 Week Washout/ Delay|Lost to Follow-up|0
1173694|NCT03880227|2314174|FG001|1 Week Washout/ Delay|Lost to Follow-up|1
1173695|NCT03880227|2314175|FG002|1 Week Washout/ Delay|Lost to Follow-up|0
1173696|NCT03880227|2314176|FG003|1 Week Washout/ Delay|Lost to Follow-up|0
1173697|NCT03880227|2314173|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0
1173698|NCT03880227|2314174|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0
1173699|NCT03880227|2314175|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2
1173700|NCT03880227|2314176|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0
1173701|NCT03880227|2314173|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
1173702|NCT03880227|2314174|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
1173703|NCT03880227|2314175|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1
1173704|NCT03880227|2314176|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
1173705|NCT03876743|2314190|FG000|Overall Study|Lost to Follow-up|6
1173706|NCT03876743|2314191|FG001|Overall Study|Lost to Follow-up|4
1173707|NCT03876743|2314192|FG002|Overall Study|Lost to Follow-up|4
1173708|NCT03876743|2314193|FG003|Overall Study|Lost to Follow-up|7
1173709|NCT03885934|2314213|FG000|Overall Study|Withdrawn by Parent/Guardian|1
1173710|NCT03885934|2314214|FG001|Overall Study|Withdrawn by Parent/Guardian|0
1173711|NCT03885934|2314215|FG002|Overall Study|Withdrawn by Parent/Guardian|0
1173712|NCT03885934|2314216|FG003|Overall Study|Withdrawn by Parent/Guardian|0
1173713|NCT03885934|2314217|FG004|Overall Study|Withdrawn by Parent/Guardian|0
1173714|NCT03885934|2314218|FG005|Overall Study|Withdrawn by Parent/Guardian|0
1173715|NCT03885726|2314232|FG000|Overall Study|Staffing issues/lost interest|1
1173716|NCT03885726|2314232|FG000|Overall Study|Early discharge from hospital|3
1173717|NCT03883386|2314257|FG000|First Assignment|Lost to Follow-up|1
1173718|NCT03883386|2314258|FG001|First Assignment|Lost to Follow-up|0
1173719|NCT03883386|2314257|FG000|First Assignment|Withdrawal by Subject|1
1173720|NCT03883386|2314258|FG001|First Assignment|Withdrawal by Subject|1
1173721|NCT03882801|2314270|FG000|Period 1|Adverse Event|0
1173722|NCT03882801|2314271|FG001|Period 1|Adverse Event|1
1173723|NCT03882801|2314270|FG000|Period 1|Non-compliance with study drug|1
1173724|NCT03882801|2314271|FG001|Period 1|Non-compliance with study drug|1
1173725|NCT03882801|2314270|FG000|Period 1|Never treated with study drug|1
1173726|NCT03882801|2314271|FG001|Period 1|Never treated with study drug|0
1173727|NCT03882801|2314270|FG000|Washout Period|Physician Decision|0
1173728|NCT03882801|2314271|FG001|Washout Period|Physician Decision|1
1173729|NCT03882801|2314270|FG000|Period 2|Non-compliance with study drug|0
1173730|NCT03882801|2314271|FG001|Period 2|Non-compliance with study drug|1
1173731|NCT03882424|2314282|FG000|Overall Study|Lost to Follow-up|3
1173732|NCT03882424|2314283|FG001|Overall Study|Lost to Follow-up|0
1173733|NCT03882424|2314284|FG002|Overall Study|Lost to Follow-up|0
1173734|NCT03882424|2314282|FG000|Overall Study|schedule conflict|1
1173735|NCT03882424|2314283|FG001|Overall Study|schedule conflict|0
1173736|NCT03882424|2314284|FG002|Overall Study|schedule conflict|0
1173737|NCT03882047|2314295|FG000|Overall Study|Adverse Event|0
1173738|NCT03882047|2314296|FG001|Overall Study|Adverse Event|2
1173739|NCT03882047|2314297|FG002|Overall Study|Adverse Event|2
1173740|NCT03882047|2314295|FG000|Overall Study|Treatment Failure|3
1173741|NCT03882047|2314296|FG001|Overall Study|Treatment Failure|3
1173742|NCT03882047|2314297|FG002|Overall Study|Treatment Failure|12
1173743|NCT03882047|2314295|FG000|Overall Study|Lost to Follow-up|0
1173744|NCT03882047|2314296|FG001|Overall Study|Lost to Follow-up|1
1173745|NCT03882047|2314297|FG002|Overall Study|Lost to Follow-up|0
1173746|NCT03882047|2314295|FG000|Overall Study|Did Not Wish to Continue|1
870834|NCT00531934|1831999|FG001|Overall Study|Adverse Event|8
870835|NCT00531934|1831998|FG000|Overall Study|Progression|52
870836|NCT00531934|1831999|FG001|Overall Study|Progression|42
870837|NCT00531934|1831998|FG000|Overall Study|Death|7
870838|NCT00531934|1831999|FG001|Overall Study|Death|10
870839|NCT00531934|1831998|FG000|Overall Study|Withdrawal by Subject|1
870840|NCT00531934|1831999|FG001|Overall Study|Withdrawal by Subject|1
870841|NCT00531934|1831998|FG000|Overall Study|Other|2
870842|NCT00531934|1831999|FG001|Overall Study|Other|2
870843|NCT00531947|1832007|FG000|Overall Study|Adverse Event|5
870844|NCT00531947|1832008|FG001|Overall Study|Adverse Event|10
870845|NCT00531947|1832007|FG000|Overall Study|Lost to Follow-up|12
870846|NCT00531947|1832008|FG001|Overall Study|Lost to Follow-up|9
870847|NCT00531947|1832007|FG000|Overall Study|Withdrawal by Subject|14
870848|NCT00531947|1832008|FG001|Overall Study|Withdrawal by Subject|19
870849|NCT00531947|1832007|FG000|Overall Study|Protocol Violation|2
870850|NCT00531947|1832008|FG001|Overall Study|Protocol Violation|1
870851|NCT00531947|1832007|FG000|Overall Study|Non-Compliance|4
870852|NCT00531947|1832008|FG001|Overall Study|Non-Compliance|7
870853|NCT00531947|1832007|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5
870854|NCT00531947|1832008|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5
870855|NCT00531960|1832016|FG000|Overall Study|Adverse Event|5
870856|NCT00531960|1832017|FG001|Overall Study|Adverse Event|4
870857|NCT00531960|1832016|FG000|Overall Study|Death|3
870858|NCT00531960|1832017|FG001|Overall Study|Death|2
870859|NCT00531960|1832016|FG000|Overall Study|Lack of Efficacy|42
870860|NCT00531960|1832017|FG001|Overall Study|Lack of Efficacy|41
870861|NCT00531960|1832016|FG000|Overall Study|Violation of Selection Criteria|2
870862|NCT00531960|1832017|FG001|Overall Study|Violation of Selection Criteria|0
870863|NCT00531960|1832016|FG000|Overall Study|Refused Treatment|5
870864|NCT00531960|1832017|FG001|Overall Study|Refused Treatment|6
870865|NCT00531960|1832016|FG000|Overall Study|Other|4
870866|NCT00531960|1832017|FG001|Overall Study|Other|10
870867|NCT00532129|1832023|FG000|Treatment Period|Adverse event/Serious adverse event|25
870868|NCT00532129|1832023|FG000|Treatment Period|Physician Decision|15
870869|NCT00532129|1832023|FG000|Treatment Period|Disease progression|3
870870|NCT00532129|1832023|FG000|Treatment Period|Protocol Violation|1
870871|NCT00532129|1832023|FG000|Treatment Period|Other|5
870872|NCT00532129|1832023|FG000|Follow-up Period|Adverse event/Serious adverse event|1
870873|NCT00532129|1832023|FG000|Follow-up Period|Disease progression|57
870874|NCT00532129|1832023|FG000|Follow-up Period|Lost to Follow-up|1
870875|NCT00532129|1832023|FG000|Follow-up Period|Other|6
870876|NCT00532155|1832029|FG000|Overall Study|Adverse Event|66
870877|NCT00532155|1832030|FG001|Overall Study|Adverse Event|123
870878|NCT00532155|1832029|FG000|Overall Study|Lack of Efficacy|332
870879|NCT00532155|1832030|FG001|Overall Study|Lack of Efficacy|255
870880|NCT00532155|1832029|FG000|Overall Study|Protocol Violation|1
870881|NCT00532155|1832030|FG001|Overall Study|Protocol Violation|3
870882|NCT00532155|1832029|FG000|Overall Study|Lost to Follow-up|2
1173747|NCT03882047|2314296|FG001|Overall Study|Did Not Wish to Continue|4
1173748|NCT03882047|2314297|FG002|Overall Study|Did Not Wish to Continue|1
1173749|NCT03882047|2314295|FG000|Overall Study|Noncompliance With Protocol|2
1173750|NCT03882047|2314296|FG001|Overall Study|Noncompliance With Protocol|0
1173751|NCT03882047|2314297|FG002|Overall Study|Noncompliance With Protocol|0
1173752|NCT03882047|2314295|FG000|Overall Study|Did Not Meet Eligibility|0
1173753|NCT03882047|2314296|FG001|Overall Study|Did Not Meet Eligibility|0
1173754|NCT03882047|2314297|FG002|Overall Study|Did Not Meet Eligibility|1
1173755|NCT03881059|2314314|FG000|Overall Study|Adverse Event|1
1173756|NCT03881059|2314315|FG001|Overall Study|Adverse Event|3
1173757|NCT03881059|2314316|FG002|Overall Study|Adverse Event|4
1173758|NCT03881059|2314314|FG000|Overall Study|Randomized by mistake with study treatment|0
1173759|NCT03881059|2314315|FG001|Overall Study|Randomized by mistake with study treatment|1
1173760|NCT03881059|2314316|FG002|Overall Study|Randomized by mistake with study treatment|1
1173761|NCT03881059|2314314|FG000|Overall Study|Withdrawal by Subject|5
1173762|NCT03881059|2314315|FG001|Overall Study|Withdrawal by Subject|2
1173763|NCT03881059|2314316|FG002|Overall Study|Withdrawal by Subject|3
1173764|NCT03881059|2314314|FG000|Overall Study|Other|2
1173765|NCT03881059|2314315|FG001|Overall Study|Other|1
1173766|NCT03881059|2314316|FG002|Overall Study|Other|0
1173767|NCT03880266|2314343|FG000|Overall Study|Withdrawal by Subject|0
1173768|NCT03880266|2314344|FG001|Overall Study|Withdrawal by Subject|1
1173769|NCT03880266|2314345|FG002|Overall Study|Withdrawal by Subject|1
1173770|NCT03880266|2314346|FG003|Overall Study|Withdrawal by Subject|0
1173771|NCT03880266|2314347|FG004|Overall Study|Withdrawal by Subject|0
1173772|NCT03880266|2314348|FG005|Overall Study|Withdrawal by Subject|0
1173773|NCT03880266|2314349|FG006|Overall Study|Withdrawal by Subject|0
1173774|NCT03880266|2314350|FG007|Overall Study|Withdrawal by Subject|0
1173775|NCT03878160|2314402|FG000|Overall Study|Lost to Follow-up|1
1173776|NCT03878160|2314403|FG001|Overall Study|Lost to Follow-up|1
1173777|NCT03878160|2314404|FG002|Overall Study|Lost to Follow-up|1
1173778|NCT03878160|2314402|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1
1173779|NCT03878160|2314403|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
1173780|NCT03878160|2314404|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
1173781|NCT03864627|2314414|FG000|Overall Study|Adverse Event|0
1173782|NCT03864627|2314415|FG001|Overall Study|Adverse Event|1
1173783|NCT03864627|2314414|FG000|Overall Study|Lack of Efficacy|0
1173784|NCT03864627|2314415|FG001|Overall Study|Lack of Efficacy|1
1173785|NCT03864627|2314414|FG000|Overall Study|Lost to Follow-up|0
1173786|NCT03864627|2314415|FG001|Overall Study|Lost to Follow-up|1
1173787|NCT03864627|2314414|FG000|Overall Study|Withdrawal by Subject|4
1173788|NCT03864627|2314415|FG001|Overall Study|Withdrawal by Subject|8
1173789|NCT03864627|2314414|FG000|Overall Study|Study terminated by sponsor|0
1173790|NCT03864627|2314415|FG001|Overall Study|Study terminated by sponsor|1
1173791|NCT03848403|2314430|FG000|Period 2 (Day 8)|Adverse Event|1
1173792|NCT03848403|2314431|FG001|Period 2 (Day 8)|Adverse Event|2
870883|NCT00532155|1832030|FG001|Overall Study|Lost to Follow-up|0
870884|NCT00532155|1832029|FG000|Overall Study|Physician Decision|16
870885|NCT00532155|1832030|FG001|Overall Study|Physician Decision|15
870886|NCT00532155|1832029|FG000|Overall Study|Withdrawal by Subject|23
870887|NCT00532155|1832030|FG001|Overall Study|Withdrawal by Subject|44
870888|NCT00532155|1832029|FG000|Overall Study|Consent withdrawn|5
870889|NCT00532155|1832030|FG001|Overall Study|Consent withdrawn|7
870890|NCT00532155|1832029|FG000|Overall Study|Moved|1
870891|NCT00532155|1832030|FG001|Overall Study|Moved|0
870892|NCT00532155|1832029|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1
870893|NCT00532155|1832030|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0
870894|NCT00532155|1832029|FG000|Overall Study|Occurence of a second cancer|0
870895|NCT00532155|1832030|FG001|Overall Study|Occurence of a second cancer|1
870896|NCT00532155|1832029|FG000|Overall Study|Occurence of a secondary cancer|0
870897|NCT00532155|1832030|FG001|Overall Study|Occurence of a secondary cancer|1
870898|NCT00532155|1832029|FG000|Overall Study|Promotor ended study|1
870899|NCT00532155|1832030|FG001|Overall Study|Promotor ended study|0
870900|NCT00532155|1832029|FG000|Overall Study|Progressive disease (by incorrect scan)|0
870901|NCT00532155|1832030|FG001|Overall Study|Progressive disease (by incorrect scan)|1
870902|NCT00532155|1832029|FG000|Overall Study|Had brain metastasis, was mis-randomized|1
870903|NCT00532155|1832030|FG001|Overall Study|Had brain metastasis, was mis-randomized|0
870904|NCT00532155|1832029|FG000|Overall Study|Study stopped|1
870905|NCT00532155|1832030|FG001|Overall Study|Study stopped|0
870906|NCT00532155|1832029|FG000|Overall Study|Study terminated by sponsor|1
870907|NCT00532155|1832030|FG001|Overall Study|Study terminated by sponsor|0
870908|NCT00532155|1832029|FG000|Overall Study|Study termination stop further treatment|4
870909|NCT00532155|1832030|FG001|Overall Study|Study termination stop further treatment|0
870910|NCT00532155|1832029|FG000|Overall Study|Did not receive study medication|2
870911|NCT00532155|1832030|FG001|Overall Study|Did not receive study medication|6
870912|NCT00532259|1832036|FG000|Overall Study|Withdrawal by Subject|2
870913|NCT00532259|1832036|FG000|Overall Study|Adverse Event|1
870914|NCT00532259|1832036|FG000|Overall Study|Death|1
870915|NCT00532259|1832036|FG000|Overall Study|Lack of Efficacy|21
870916|NCT00532259|1832036|FG000|Overall Study|Lost to Follow-up|3
870917|NCT00532259|1832036|FG000|Overall Study|Physician Decision|3
870918|NCT00532259|1832036|FG000|Overall Study|Protocol Violation|1
870919|NCT00532298|1832047|FG000|Overall Study|Adverse Event|1
1173793|NCT03848403|2314432|FG002|Period 2 (Day 8)|Adverse Event|2
1173794|NCT03848403|2314430|FG000|Period 2 (Day 8)|Physician Decision|0
1173795|NCT03848403|2314431|FG001|Period 2 (Day 8)|Physician Decision|1
1173796|NCT03848403|2314432|FG002|Period 2 (Day 8)|Physician Decision|0
1173797|NCT03848403|2314430|FG000|Period 2 (Day 8)|Sponsor Decision|8
1173798|NCT03848403|2314431|FG001|Period 2 (Day 8)|Sponsor Decision|6
1173799|NCT03848403|2314432|FG002|Period 2 (Day 8)|Sponsor Decision|5
1173800|NCT03879772|2314477|FG000|Overall Study|Adverse Event|2
1173801|NCT03879772|2314478|FG001|Overall Study|Adverse Event|2
1173802|NCT03879772|2314479|FG002|Overall Study|Adverse Event|3
1173803|NCT03879772|2314480|FG003|Overall Study|Adverse Event|4
1173804|NCT03879772|2314481|FG004|Overall Study|Adverse Event|3
1173805|NCT03879772|2314477|FG000|Overall Study|Treatment Failure|1
1173806|NCT03879772|2314478|FG001|Overall Study|Treatment Failure|0
1173807|NCT03879772|2314479|FG002|Overall Study|Treatment Failure|0
1173808|NCT03879772|2314480|FG003|Overall Study|Treatment Failure|2
1173809|NCT03879772|2314481|FG004|Overall Study|Treatment Failure|1
1173810|NCT03879772|2314477|FG000|Overall Study|Lost to Follow-up|0
1173811|NCT03879772|2314478|FG001|Overall Study|Lost to Follow-up|0
1173812|NCT03879772|2314479|FG002|Overall Study|Lost to Follow-up|0
1173813|NCT03879772|2314480|FG003|Overall Study|Lost to Follow-up|0
1173814|NCT03879772|2314481|FG004|Overall Study|Lost to Follow-up|1
1173815|NCT03879772|2314477|FG000|Overall Study|Withdrawal by Subject|0
1173816|NCT03879772|2314478|FG001|Overall Study|Withdrawal by Subject|1
1173817|NCT03879772|2314479|FG002|Overall Study|Withdrawal by Subject|3
1173818|NCT03879772|2314480|FG003|Overall Study|Withdrawal by Subject|1
1173819|NCT03879772|2314481|FG004|Overall Study|Withdrawal by Subject|1
1173820|NCT03879772|2314477|FG000|Overall Study|Protocol Violation|0
1173821|NCT03879772|2314478|FG001|Overall Study|Protocol Violation|0
1173822|NCT03879772|2314479|FG002|Overall Study|Protocol Violation|3
1173823|NCT03879772|2314480|FG003|Overall Study|Protocol Violation|1
1173824|NCT03879772|2314481|FG004|Overall Study|Protocol Violation|2
1173825|NCT03879772|2314477|FG000|Overall Study|Did Not Meet Entry Requirements|1
1173826|NCT03879772|2314478|FG001|Overall Study|Did Not Meet Entry Requirements|0
1173827|NCT03879772|2314479|FG002|Overall Study|Did Not Meet Entry Requirements|1
1173828|NCT03879772|2314480|FG003|Overall Study|Did Not Meet Entry Requirements|0
1173829|NCT03879772|2314481|FG004|Overall Study|Did Not Meet Entry Requirements|0
1173830|NCT03878108|2314524|FG000|Overall Study|Adverse Event|1
1173831|NCT03878108|2314525|FG001|Overall Study|Adverse Event|0
1173832|NCT03877237|2314541|FG000|Overall Study|Adverse Event|1
1173833|NCT03877237|2314542|FG001|Overall Study|Adverse Event|2
1173834|NCT03877237|2314541|FG000|Overall Study|Death|3
1173835|NCT03877237|2314542|FG001|Overall Study|Death|2
1173836|NCT03877237|2314541|FG000|Overall Study|Physician Decision|1
1173837|NCT03877237|2314542|FG001|Overall Study|Physician Decision|0
1173838|NCT03877237|2314541|FG000|Overall Study|Withdrawal by Subject|0
1173839|NCT03877237|2314542|FG001|Overall Study|Withdrawal by Subject|2
1173840|NCT03859323|2314571|FG000|Overall Study|Lost to Follow-up|0
1173841|NCT03859323|2314572|FG001|Overall Study|Lost to Follow-up|0
1173842|NCT03859323|2314573|FG002|Overall Study|Lost to Follow-up|0
1173843|NCT03859323|2314574|FG003|Overall Study|Lost to Follow-up|0
1173844|NCT03859323|2314575|FG004|Overall Study|Lost to Follow-up|0
1173845|NCT03859323|2314576|FG005|Overall Study|Lost to Follow-up|0
1173846|NCT03859323|2314577|FG006|Overall Study|Lost to Follow-up|1
1173847|NCT03859323|2314578|FG007|Overall Study|Lost to Follow-up|0
1173848|NCT03859323|2314579|FG008|Overall Study|Lost to Follow-up|0
1173849|NCT03859323|2314580|FG009|Overall Study|Lost to Follow-up|0
1173850|NCT03859323|2314581|FG010|Overall Study|Lost to Follow-up|0
1173851|NCT03859323|2314582|FG011|Overall Study|Lost to Follow-up|0
1173852|NCT03859323|2314583|FG012|Overall Study|Lost to Follow-up|0
1173853|NCT03859323|2314571|FG000|Overall Study|Withdrawal by Subject|0
1173854|NCT03859323|2314572|FG001|Overall Study|Withdrawal by Subject|0
1173855|NCT03859323|2314573|FG002|Overall Study|Withdrawal by Subject|1
1173856|NCT03859323|2314574|FG003|Overall Study|Withdrawal by Subject|0
1173857|NCT03859323|2314575|FG004|Overall Study|Withdrawal by Subject|0
1173858|NCT03859323|2314576|FG005|Overall Study|Withdrawal by Subject|1
1173859|NCT03859323|2314577|FG006|Overall Study|Withdrawal by Subject|0
1173860|NCT03859323|2314578|FG007|Overall Study|Withdrawal by Subject|0
1173861|NCT03859323|2314579|FG008|Overall Study|Withdrawal by Subject|0
1173862|NCT03859323|2314580|FG009|Overall Study|Withdrawal by Subject|1
1173863|NCT03859323|2314581|FG010|Overall Study|Withdrawal by Subject|1
1173864|NCT03859323|2314582|FG011|Overall Study|Withdrawal by Subject|2
1173865|NCT03859323|2314583|FG012|Overall Study|Withdrawal by Subject|1
1173866|NCT03859323|2314571|FG000|Overall Study|Pregnancy|0
1173867|NCT03859323|2314572|FG001|Overall Study|Pregnancy|0
1173868|NCT03859323|2314573|FG002|Overall Study|Pregnancy|0
1173869|NCT03859323|2314574|FG003|Overall Study|Pregnancy|0
1173870|NCT03859323|2314575|FG004|Overall Study|Pregnancy|0
1173871|NCT03859323|2314576|FG005|Overall Study|Pregnancy|0
1173872|NCT03859323|2314577|FG006|Overall Study|Pregnancy|0
1173873|NCT03859323|2314578|FG007|Overall Study|Pregnancy|0
1173874|NCT03859323|2314579|FG008|Overall Study|Pregnancy|0
1173875|NCT03859323|2314580|FG009|Overall Study|Pregnancy|1
1173876|NCT03859323|2314581|FG010|Overall Study|Pregnancy|0
1173877|NCT03859323|2314582|FG011|Overall Study|Pregnancy|0
1173878|NCT03859323|2314583|FG012|Overall Study|Pregnancy|0
1173879|NCT03875508|2314648|FG000|Overall Study|Adverse Event|1
1173880|NCT03875508|2314648|FG000|Overall Study|Lost to Follow-up|8
1173881|NCT03875508|2314648|FG000|Overall Study|Lack of Efficacy|1
1173882|NCT03875508|2314648|FG000|Overall Study|Other, not specified|2
1173883|NCT03869333|2314656|FG000|Overall Study|Lost to Follow-up|1
1173884|NCT03869333|2314657|FG001|Overall Study|Lost to Follow-up|0
1173885|NCT03869333|2314658|FG002|Overall Study|Lost to Follow-up|0
1173886|NCT03869333|2314659|FG003|Overall Study|Lost to Follow-up|0
1173887|NCT03869333|2314656|FG000|Overall Study|Pregnancy|1
1173888|NCT03869333|2314657|FG001|Overall Study|Pregnancy|0
1173889|NCT03869333|2314658|FG002|Overall Study|Pregnancy|0
1173890|NCT03869333|2314659|FG003|Overall Study|Pregnancy|0
1173891|NCT03869333|2314656|FG000|Overall Study|Physician Decision|0
1173892|NCT03869333|2314657|FG001|Overall Study|Physician Decision|1
1173893|NCT03869333|2314658|FG002|Overall Study|Physician Decision|0
1173894|NCT03869333|2314659|FG003|Overall Study|Physician Decision|0
1173895|NCT03864900|2314671|FG000|Overall Study|Withdrawal by Subject|1
1173896|NCT03864900|2314672|FG001|Overall Study|Withdrawal by Subject|1
1173897|NCT03864900|2314671|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2
1173898|NCT03864900|2314672|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5
1173899|NCT03875482|2314697|FG000|Overall Study|Adverse Event|0
1173900|NCT03875482|2314698|FG001|Overall Study|Adverse Event|1
1173901|NCT03875482|2314697|FG000|Overall Study|Withdrew consent|5
1173902|NCT03875482|2314698|FG001|Overall Study|Withdrew consent|6
1173903|NCT03875482|2314697|FG000|Overall Study|Lost to Follow-up|8
1173904|NCT03875482|2314698|FG001|Overall Study|Lost to Follow-up|2
1173905|NCT03875482|2314697|FG000|Overall Study|Lack of Efficacy|0
1173906|NCT03875482|2314698|FG001|Overall Study|Lack of Efficacy|11
1173907|NCT03874013|2314716|FG000|Overall Study|Adverse Event|0
1173908|NCT03874013|2314717|FG001|Overall Study|Adverse Event|1
1173909|NCT03873116|2314726|FG000|Overall Study|Study drug discontinuation due to rash|0
1173910|NCT03873116|2314727|FG001|Overall Study|Study drug discontinuation due to rash|0
1173911|NCT03873116|2314728|FG002|Overall Study|Study drug discontinuation due to rash|1
1173912|NCT03872843|2314738|FG000|Overall Study|Lost to Follow-up|5
870920|NCT00532298|1832048|FG001|Overall Study|Adverse Event|0
870921|NCT00532298|1832049|FG002|Overall Study|Adverse Event|0
870922|NCT00532298|1832050|FG003|Overall Study|Adverse Event|0
870923|NCT00532298|1832051|FG004|Overall Study|Adverse Event|1
870924|NCT00532298|1832052|FG005|Overall Study|Adverse Event|1
870925|NCT00532298|1832047|FG000|Overall Study|Lost to Follow-up|1
870926|NCT00532298|1832048|FG001|Overall Study|Lost to Follow-up|1
870927|NCT00532298|1832049|FG002|Overall Study|Lost to Follow-up|1
870928|NCT00532298|1832050|FG003|Overall Study|Lost to Follow-up|0
870929|NCT00532298|1832051|FG004|Overall Study|Lost to Follow-up|0
870930|NCT00532298|1832052|FG005|Overall Study|Lost to Follow-up|1
870931|NCT00532441|1832066|FG000|Overall Study|Death|1
870932|NCT00532441|1832067|FG001|Overall Study|Death|0
870933|NCT00532493|1832082|FG000|Overall Study|Death|1
870934|NCT00532493|1832083|FG001|Overall Study|Death|1
870935|NCT00532493|1832082|FG000|Overall Study|Lost to Follow-up|10
870936|NCT00532493|1832083|FG001|Overall Study|Lost to Follow-up|7
870937|NCT00532493|1832082|FG000|Overall Study|Withdrawal by Subject|7
870938|NCT00532493|1832083|FG001|Overall Study|Withdrawal by Subject|9
870939|NCT00532493|1832082|FG000|Overall Study|Physician Decision|1
870940|NCT00532493|1832083|FG001|Overall Study|Physician Decision|6
870941|NCT00532493|1832082|FG000|Overall Study|Adverse Event|6
870942|NCT00532493|1832083|FG001|Overall Study|Adverse Event|5
870943|NCT00532493|1832082|FG000|Overall Study|Protocol Deviation|1
870944|NCT00532493|1832083|FG001|Overall Study|Protocol Deviation|0
870945|NCT00532493|1832082|FG000|Overall Study|Subject Moved Away|3
870946|NCT00532493|1832083|FG001|Overall Study|Subject Moved Away|1
870947|NCT00532493|1832082|FG000|Overall Study|Contraindicative Medication|1
870948|NCT00532493|1832083|FG001|Overall Study|Contraindicative Medication|0
870949|NCT00532779|1832094|FG000|Overall Study|Adverse Event|122
870950|NCT00532779|1832095|FG001|Overall Study|Adverse Event|112
870951|NCT00532779|1832096|FG002|Overall Study|Adverse Event|56
870952|NCT00532779|1832094|FG000|Overall Study|Lost to Follow-up|76
870953|NCT00532779|1832095|FG001|Overall Study|Lost to Follow-up|65
870954|NCT00532779|1832096|FG002|Overall Study|Lost to Follow-up|66
870955|NCT00532779|1832094|FG000|Overall Study|Withdrawal by Subject|63
870956|NCT00532779|1832095|FG001|Overall Study|Withdrawal by Subject|60
870957|NCT00532779|1832096|FG002|Overall Study|Withdrawal by Subject|90
870958|NCT00532779|1832094|FG000|Overall Study|Lack of Efficacy|12
870959|NCT00532779|1832095|FG001|Overall Study|Lack of Efficacy|12
870960|NCT00532779|1832096|FG002|Overall Study|Lack of Efficacy|40
870961|NCT00532779|1832094|FG000|Overall Study|Protocol Violation|5
870962|NCT00532779|1832095|FG001|Overall Study|Protocol Violation|9
870963|NCT00532779|1832096|FG002|Overall Study|Protocol Violation|7
870964|NCT00532779|1832094|FG000|Overall Study|Pregnancy|2
870965|NCT00532779|1832095|FG001|Overall Study|Pregnancy|5
870966|NCT00532779|1832096|FG002|Overall Study|Pregnancy|3
870967|NCT00532779|1832094|FG000|Overall Study|Death|0
870968|NCT00532779|1832095|FG001|Overall Study|Death|1
870969|NCT00532779|1832096|FG002|Overall Study|Death|0
870970|NCT00532779|1832094|FG000|Overall Study|Drug noncompliance, moved, other|14
870971|NCT00532779|1832095|FG001|Overall Study|Drug noncompliance, moved, other|23
870972|NCT00532779|1832096|FG002|Overall Study|Drug noncompliance, moved, other|29
1173913|NCT03872843|2314739|FG001|Overall Study|Lost to Follow-up|7
1173914|NCT03870997|2314751|FG000|Overall Study|Did not complete mid-study/final survey|10544
1173915|NCT03870997|2314752|FG001|Overall Study|Did not complete mid-study/final survey|10431
1173916|NCT03870997|2314753|FG002|Overall Study|Did not complete mid-study/final survey|10978
1173917|NCT03870997|2314754|FG003|Overall Study|Did not complete mid-study/final survey|10947
870973|NCT00532844|1832106|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0
870974|NCT00532844|1832107|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1
870975|NCT00532844|1832106|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1
870976|NCT00532844|1832107|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0
870977|NCT00532844|1832106|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1
870978|NCT00532844|1832107|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0
870979|NCT00532844|1832106|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1
870980|NCT00532844|1832107|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0
870981|NCT00532844|1832106|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1
870982|NCT00532844|1832107|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0
870983|NCT00532883|1832130|FG000|Overall Study|Adverse Event|1
870984|NCT00532883|1832131|FG001|Overall Study|Adverse Event|0
870985|NCT00532883|1832132|FG002|Overall Study|Adverse Event|0
870986|NCT00532883|1832133|FG003|Overall Study|Adverse Event|1
870987|NCT00532883|1832130|FG000|Overall Study|Lost to Follow-up|1
870988|NCT00532883|1832131|FG001|Overall Study|Lost to Follow-up|1
870989|NCT00532883|1832132|FG002|Overall Study|Lost to Follow-up|1
870990|NCT00532883|1832133|FG003|Overall Study|Lost to Follow-up|0
870991|NCT00532883|1832130|FG000|Overall Study|Withdrawal by Subject|0
870992|NCT00532883|1832131|FG001|Overall Study|Withdrawal by Subject|1
870993|NCT00532883|1832132|FG002|Overall Study|Withdrawal by Subject|1
870994|NCT00532883|1832133|FG003|Overall Study|Withdrawal by Subject|0
870995|NCT00532883|1832130|FG000|Overall Study|Subject was Nonadherent|0
870996|NCT00532883|1832131|FG001|Overall Study|Subject was Nonadherent|1
870997|NCT00532883|1832132|FG002|Overall Study|Subject was Nonadherent|1
870998|NCT00532883|1832133|FG003|Overall Study|Subject was Nonadherent|0
870999|NCT00532883|1832130|FG000|Overall Study|Early Study Termination|4
871000|NCT00532883|1832131|FG001|Overall Study|Early Study Termination|4
871001|NCT00532883|1832132|FG002|Overall Study|Early Study Termination|1
871002|NCT00532883|1832133|FG003|Overall Study|Early Study Termination|4
871003|NCT00532935|1832145|FG000|Overall Study|Adverse Event|11
871004|NCT00532935|1832146|FG001|Overall Study|Adverse Event|12
871005|NCT00532935|1832145|FG000|Overall Study|Lack of Efficacy|0
871006|NCT00532935|1832146|FG001|Overall Study|Lack of Efficacy|3
871007|NCT00532935|1832145|FG000|Overall Study|Lost to Follow-up|10
871008|NCT00532935|1832146|FG001|Overall Study|Lost to Follow-up|6
871009|NCT00532935|1832145|FG000|Overall Study|Physician Decision|4
871010|NCT00532935|1832146|FG001|Overall Study|Physician Decision|5
871011|NCT00532935|1832145|FG000|Overall Study|Pregnancy|1
871012|NCT00532935|1832146|FG001|Overall Study|Pregnancy|0
871013|NCT00532935|1832145|FG000|Overall Study|Protocol Violation|4
871014|NCT00532935|1832146|FG001|Overall Study|Protocol Violation|2
871015|NCT00532935|1832145|FG000|Overall Study|Withdrawal by Subject|10
871016|NCT00532935|1832146|FG001|Overall Study|Withdrawal by Subject|9
871017|NCT00532935|1832145|FG000|Overall Study|Protocol Specific Criteria|11
871018|NCT00532935|1832146|FG001|Overall Study|Protocol Specific Criteria|15
871019|NCT00532948|1832155|FG000|Overall Study|Protocol Violation|1
871020|NCT00532948|1832156|FG001|Overall Study|Protocol Violation|0
871021|NCT00532948|1832157|FG002|Overall Study|Protocol Violation|0
871022|NCT00532948|1832155|FG000|Overall Study|Death|3
871023|NCT00532948|1832156|FG001|Overall Study|Death|3
871024|NCT00532948|1832157|FG002|Overall Study|Death|4
871025|NCT00532948|1832155|FG000|Overall Study|Violation of selection criteria at entry|0
871026|NCT00532948|1832156|FG001|Overall Study|Violation of selection criteria at entry|1
871027|NCT00532948|1832157|FG002|Overall Study|Violation of selection criteria at entry|0
871028|NCT00532948|1832155|FG000|Overall Study|Failure to return|0
871029|NCT00532948|1832156|FG001|Overall Study|Failure to return|1
871030|NCT00532948|1832157|FG002|Overall Study|Failure to return|0
871031|NCT00533273|1832188|FG000|Double-blind|Withdrew consent|0
871032|NCT00533273|1832189|FG001|Double-blind|Withdrew consent|2
871033|NCT00533273|1832188|FG000|Open-label|Withdrawal by Subject|6
871034|NCT00533273|1832189|FG001|Open-label|Withdrawal by Subject|0
871035|NCT00533429|1832197|FG000|Overall Study|Adverse Event|3
871036|NCT00533429|1832198|FG001|Overall Study|Adverse Event|1
871037|NCT00533429|1832197|FG000|Overall Study|Death|1
871038|NCT00533429|1832198|FG001|Overall Study|Death|0
871039|NCT00533429|1832197|FG000|Overall Study|Withdrawal by Subject|2
871040|NCT00533429|1832198|FG001|Overall Study|Withdrawal by Subject|0
871041|NCT00533429|1832197|FG000|Overall Study|Progressive Disease|12
871042|NCT00533429|1832198|FG001|Overall Study|Progressive Disease|13
871043|NCT00533429|1832197|FG000|Overall Study|Symptomatic deterioration|1
871044|NCT00533429|1832198|FG001|Overall Study|Symptomatic deterioration|2
871045|NCT00533507|1832217|FG000|Overall Study|Withdrawal by Subject|1
871046|NCT00533702|1832228|FG000|Overall Study|Withdrawal by Subject|3
871047|NCT00533702|1832229|FG001|Overall Study|Withdrawal by Subject|1
871048|NCT00533702|1832228|FG000|Overall Study|Found ineligible after randomization|2
871049|NCT00533702|1832229|FG001|Overall Study|Found ineligible after randomization|1
1173918|NCT03870997|2314755|FG004|Overall Study|Did not complete mid-study/final survey|10588
1173919|NCT03870997|2314756|FG005|Overall Study|Did not complete mid-study/final survey|10531
1173920|NCT03869684|2314768|FG000|Overall Study|Adverse Event|0
1173921|NCT03869684|2314769|FG001|Overall Study|Adverse Event|3
1173922|NCT03869684|2314770|FG002|Overall Study|Adverse Event|1
1173923|NCT03869684|2314768|FG000|Overall Study|Withdrawal by Subject|1
1173924|NCT03869684|2314769|FG001|Overall Study|Withdrawal by Subject|0
1173925|NCT03869684|2314770|FG002|Overall Study|Withdrawal by Subject|0
1173926|NCT03869684|2314768|FG000|Overall Study|Lost to Follow-up|1
1173927|NCT03869684|2314769|FG001|Overall Study|Lost to Follow-up|0
1173928|NCT03869684|2314770|FG002|Overall Study|Lost to Follow-up|0
1173929|NCT03869684|2314768|FG000|Overall Study|Study prematurely terminated by sponsor|0
1173930|NCT03869684|2314769|FG001|Overall Study|Study prematurely terminated by sponsor|0
1173931|NCT03869684|2314770|FG002|Overall Study|Study prematurely terminated by sponsor|2
1173932|NCT03848416|2314824|FG000|Overall Study|Withdrawal by Subject|1
1173933|NCT03848416|2314825|FG001|Overall Study|Withdrawal by Subject|0
1173934|NCT03848416|2314826|FG002|Overall Study|Withdrawal by Subject|0
1173935|NCT03848416|2314824|FG000|Overall Study|Death|0
1173936|NCT03848416|2314825|FG001|Overall Study|Death|0
1173937|NCT03848416|2314826|FG002|Overall Study|Death|1
1173938|NCT03847987|2314836|FG000|Overall Study|Lost to Follow-up|1
1173939|NCT03847987|2314837|FG001|Overall Study|Lost to Follow-up|0
1173940|NCT03847987|2314836|FG000|Overall Study|Adverse Event|2
1173941|NCT03847987|2314837|FG001|Overall Study|Adverse Event|0
1173942|NCT03853551|2314899|FG000|Overall Study|Death|2
1173943|NCT03853551|2314899|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7
1173944|NCT03870555|2314906|FG000|Period 3 (2 Days)|Adverse Event|1
1173945|NCT03870555|2314907|FG001|Period 3 (2 Days)|Adverse Event|0
1173946|NCT03870555|2314908|FG002|Period 3 (2 Days)|Adverse Event|0
1173947|NCT03851094|2314934|FG000|Overall Study|Withdrawal by Subject|0
1173948|NCT03851094|2314935|FG001|Overall Study|Withdrawal by Subject|1
1173949|NCT03851094|2314934|FG000|Overall Study|Participant lost device|0
1173950|NCT03851094|2314935|FG001|Overall Study|Participant lost device|1
1173951|NCT03851094|2314934|FG000|Overall Study|Participant returned device|0
1173952|NCT03851094|2314935|FG001|Overall Study|Participant returned device|2
871050|NCT00533845|1832237|FG000|Overall Study|Physician Decision|1
871051|NCT00533845|1832238|FG001|Overall Study|Physician Decision|0
871052|NCT00533897|1832247|FG000|Lead-in (LI) Period 1|Adverse Event|1
871053|NCT00533897|1832248|FG001|Lead-in (LI) Period 1|Adverse Event|0
871054|NCT00533897|1832249|FG002|Lead-in (LI) Period 1|Adverse Event|0
871055|NCT00533897|1832250|FG003|Lead-in (LI) Period 1|Adverse Event|0
871056|NCT00533897|1832251|FG004|Lead-in (LI) Period 1|Adverse Event|0
871057|NCT00533897|1832252|FG005|Lead-in (LI) Period 1|Adverse Event|0
871058|NCT00533897|1832253|FG006|Lead-in (LI) Period 1|Adverse Event|0
871059|NCT00533897|1832254|FG007|Lead-in (LI) Period 1|Adverse Event|0
871060|NCT00533897|1832247|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2
871061|NCT00533897|1832248|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0
871062|NCT00533897|1832249|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0
871063|NCT00533897|1832250|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0
871064|NCT00533897|1832251|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0
871065|NCT00533897|1832252|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0
871066|NCT00533897|1832253|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0
871067|NCT00533897|1832254|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0
871068|NCT00533897|1832247|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1
871069|NCT00533897|1832248|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0
871070|NCT00533897|1832249|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0
871071|NCT00533897|1832250|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0
871072|NCT00533897|1832251|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0
871073|NCT00533897|1832252|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0
871074|NCT00533897|1832253|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0
871075|NCT00533897|1832254|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0
871076|NCT00533897|1832247|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
871077|NCT00533897|1832248|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
871078|NCT00533897|1832249|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
871079|NCT00533897|1832250|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
871080|NCT00533897|1832251|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
871081|NCT00533897|1832252|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
871082|NCT00533897|1832253|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
871083|NCT00533897|1832254|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
871084|NCT00533897|1832247|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3
871085|NCT00533897|1832248|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0
871086|NCT00533897|1832249|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0
871087|NCT00533897|1832250|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0
871088|NCT00533897|1832251|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0
1173953|NCT03868631|2314958|FG000|Baseline to Week 6|Adverse Event|0
1173954|NCT03868631|2314959|FG001|Baseline to Week 6|Adverse Event|3
1173955|NCT03868631|2314958|FG000|Baseline to Week 6|Protocol Violation|1
1173956|NCT03868631|2314959|FG001|Baseline to Week 6|Protocol Violation|1
1173957|NCT03868631|2314958|FG000|Baseline to Week 6|Withdrawal by Subject|3
1173958|NCT03868631|2314959|FG001|Baseline to Week 6|Withdrawal by Subject|0
1173959|NCT03868631|2314958|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2
1173960|NCT03868631|2314959|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0
1173961|NCT03868631|2314958|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
1173962|NCT03868631|2314959|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
1173963|NCT03868631|2314958|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
1173964|NCT03868631|2314959|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
1173965|NCT03865953|2314967|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2
1173966|NCT03865953|2314968|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
1173967|NCT03865953|2314967|FG000|First Intervention (4 Weeks)|Protocol Violation|0
1173968|NCT03865953|2314968|FG001|First Intervention (4 Weeks)|Protocol Violation|1
1173969|NCT03865953|2314967|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0
1173970|NCT03865953|2314968|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2
1173971|NCT03865381|2314974|FG000|Overall Study|Protocol Violation/Non-Compliance|3
1173972|NCT03865381|2314974|FG000|Overall Study|Withdrawal by Subject|2
1173973|NCT03868059|2315002|FG000|Overall Study|Adverse Event|3
1173974|NCT03868059|2315002|FG000|Overall Study|Lost to Follow-up|3
871089|NCT00533897|1832252|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0
871090|NCT00533897|1832253|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0
871091|NCT00533897|1832254|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0
871092|NCT00533897|1832247|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
871093|NCT00533897|1832248|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
871094|NCT00533897|1832249|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
871095|NCT00533897|1832250|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
871096|NCT00533897|1832251|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
871097|NCT00533897|1832252|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
871098|NCT00533897|1832253|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
871099|NCT00533897|1832254|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
871100|NCT00533897|1832247|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
871101|NCT00533897|1832248|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
871102|NCT00533897|1832249|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
871103|NCT00533897|1832250|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
871104|NCT00533897|1832251|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
871105|NCT00533897|1832252|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
871106|NCT00533897|1832253|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
871107|NCT00533897|1832254|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
871108|NCT00533897|1832247|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
871109|NCT00533897|1832248|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
871110|NCT00533897|1832249|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
871111|NCT00533897|1832250|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
871112|NCT00533897|1832251|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
871113|NCT00533897|1832252|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
871114|NCT00533897|1832253|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
871115|NCT00533897|1832254|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
871116|NCT00533897|1832247|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
871117|NCT00533897|1832248|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
871118|NCT00533897|1832249|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
871119|NCT00533897|1832250|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
871120|NCT00533897|1832251|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
871121|NCT00533897|1832252|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
871122|NCT00533897|1832253|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
871123|NCT00533897|1832254|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
871124|NCT00533897|1832247|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
871125|NCT00533897|1832248|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
871126|NCT00533897|1832249|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
871127|NCT00533897|1832250|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
871128|NCT00533897|1832251|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
871129|NCT00533897|1832252|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
871130|NCT00533897|1832253|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
871131|NCT00533897|1832254|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
871132|NCT00533897|1832247|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0
871133|NCT00533897|1832248|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0
871134|NCT00533897|1832249|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0
871135|NCT00533897|1832250|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0
871136|NCT00533897|1832251|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0
871137|NCT00533897|1832252|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0
871138|NCT00533897|1832253|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2
871139|NCT00533897|1832254|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5
871140|NCT00533897|1832247|FG000|Long Term Extension (LTE)|Death|0
1173975|NCT03868059|2315002|FG000|Overall Study|Withdrawal by Subject|6
1173976|NCT03850444|2315008|FG000|Overall Study|Adverse Event|12
1173977|NCT03850444|2315009|FG001|Overall Study|Adverse Event|9
1173978|NCT03850444|2315008|FG000|Overall Study|Death|38
1173979|NCT03850444|2315009|FG001|Overall Study|Death|64
1173980|NCT03850444|2315008|FG000|Overall Study|Lost to Follow-up|0
1173981|NCT03850444|2315009|FG001|Overall Study|Lost to Follow-up|1
1173982|NCT03850444|2315008|FG000|Overall Study|Withdrawal by Subject|0
1173983|NCT03850444|2315009|FG001|Overall Study|Withdrawal by Subject|1
1173984|NCT03850444|2315008|FG000|Overall Study|Ongoing in Study|78
1173985|NCT03850444|2315009|FG001|Overall Study|Ongoing in Study|59
1173986|NCT03865407|2315026|FG000|Overall Study|Adverse Event|1
1173987|NCT03865407|2315027|FG001|Overall Study|Adverse Event|0
1173988|NCT03865407|2315026|FG000|Overall Study|Withdrawal by Subject|1
1173989|NCT03865407|2315027|FG001|Overall Study|Withdrawal by Subject|0
1173990|NCT03865407|2315026|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1
1173991|NCT03865407|2315027|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0
1173992|NCT03855189|2315045|FG000|Overall Study|Adverse Event|5
1173993|NCT03855189|2315046|FG001|Overall Study|Adverse Event|2
1173994|NCT03855189|2315047|FG002|Overall Study|Adverse Event|4
1173995|NCT03855189|2315045|FG000|Overall Study|Treatment Failure|1
1173996|NCT03855189|2315046|FG001|Overall Study|Treatment Failure|1
1173997|NCT03855189|2315047|FG002|Overall Study|Treatment Failure|2
1173998|NCT03855189|2315045|FG000|Overall Study|Noncompliance with Protocol|0
1173999|NCT03855189|2315046|FG001|Overall Study|Noncompliance with Protocol|1
1174000|NCT03855189|2315047|FG002|Overall Study|Noncompliance with Protocol|0
1174001|NCT03855189|2315045|FG000|Overall Study|Did Not Return|4
1174002|NCT03855189|2315046|FG001|Overall Study|Did Not Return|3
1174003|NCT03855189|2315047|FG002|Overall Study|Did Not Return|0
1174004|NCT03864653|2315059|FG000|Overall Study|Withdrawal by Subject|1
1174005|NCT03853213|2315076|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1
871141|NCT00533897|1832248|FG001|Long Term Extension (LTE)|Death|0
871142|NCT00533897|1832249|FG002|Long Term Extension (LTE)|Death|0
871143|NCT00533897|1832250|FG003|Long Term Extension (LTE)|Death|0
871144|NCT00533897|1832251|FG004|Long Term Extension (LTE)|Death|0
871145|NCT00533897|1832252|FG005|Long Term Extension (LTE)|Death|0
871146|NCT00533897|1832253|FG006|Long Term Extension (LTE)|Death|1
871147|NCT00533897|1832254|FG007|Long Term Extension (LTE)|Death|3
871148|NCT00533897|1832247|FG000|Long Term Extension (LTE)|Lack of Efficacy|0
871149|NCT00533897|1832248|FG001|Long Term Extension (LTE)|Lack of Efficacy|0
871150|NCT00533897|1832249|FG002|Long Term Extension (LTE)|Lack of Efficacy|0
871151|NCT00533897|1832250|FG003|Long Term Extension (LTE)|Lack of Efficacy|0
871152|NCT00533897|1832251|FG004|Long Term Extension (LTE)|Lack of Efficacy|0
871153|NCT00533897|1832252|FG005|Long Term Extension (LTE)|Lack of Efficacy|0
871154|NCT00533897|1832253|FG006|Long Term Extension (LTE)|Lack of Efficacy|5
871155|NCT00533897|1832254|FG007|Long Term Extension (LTE)|Lack of Efficacy|3
871156|NCT00533897|1832247|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0
871157|NCT00533897|1832248|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0
871158|NCT00533897|1832249|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0
871159|NCT00533897|1832250|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0
871160|NCT00533897|1832251|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0
871161|NCT00533897|1832252|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0
871162|NCT00533897|1832253|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1
871163|NCT00533897|1832254|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0
871164|NCT00533897|1832247|FG000|Long Term Extension (LTE)|Adverse Event|0
871165|NCT00533897|1832248|FG001|Long Term Extension (LTE)|Adverse Event|0
871166|NCT00533897|1832249|FG002|Long Term Extension (LTE)|Adverse Event|0
871167|NCT00533897|1832250|FG003|Long Term Extension (LTE)|Adverse Event|0
871168|NCT00533897|1832251|FG004|Long Term Extension (LTE)|Adverse Event|0
871169|NCT00533897|1832252|FG005|Long Term Extension (LTE)|Adverse Event|0
871170|NCT00533897|1832253|FG006|Long Term Extension (LTE)|Adverse Event|2
871171|NCT00533897|1832254|FG007|Long Term Extension (LTE)|Adverse Event|5
871172|NCT00533897|1832247|FG000|Long Term Extension (LTE)|Pregnancy|0
871173|NCT00533897|1832248|FG001|Long Term Extension (LTE)|Pregnancy|0
871174|NCT00533897|1832249|FG002|Long Term Extension (LTE)|Pregnancy|0
871175|NCT00533897|1832250|FG003|Long Term Extension (LTE)|Pregnancy|0
871176|NCT00533897|1832251|FG004|Long Term Extension (LTE)|Pregnancy|0
871177|NCT00533897|1832252|FG005|Long Term Extension (LTE)|Pregnancy|0
871178|NCT00533897|1832253|FG006|Long Term Extension (LTE)|Pregnancy|0
871179|NCT00533897|1832254|FG007|Long Term Extension (LTE)|Pregnancy|2
871180|NCT00533897|1832247|FG000|Long Term Extension (LTE)|Lost to Follow-up|0
871181|NCT00533897|1832248|FG001|Long Term Extension (LTE)|Lost to Follow-up|0
871182|NCT00533897|1832249|FG002|Long Term Extension (LTE)|Lost to Follow-up|0
871183|NCT00533897|1832250|FG003|Long Term Extension (LTE)|Lost to Follow-up|0
871184|NCT00533897|1832251|FG004|Long Term Extension (LTE)|Lost to Follow-up|0
871185|NCT00533897|1832252|FG005|Long Term Extension (LTE)|Lost to Follow-up|0
871186|NCT00533897|1832253|FG006|Long Term Extension (LTE)|Lost to Follow-up|1
871187|NCT00533897|1832254|FG007|Long Term Extension (LTE)|Lost to Follow-up|1
871188|NCT00533897|1832247|FG000|Long Term Extension (LTE)|Other|0
871189|NCT00533897|1832248|FG001|Long Term Extension (LTE)|Other|0
1174006|NCT03853213|2315077|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0
1174007|NCT03853213|2315076|FG000|Overall Study|Other (e.g., too busy)|0
1174008|NCT03853213|2315077|FG001|Overall Study|Other (e.g., too busy)|2
1174009|NCT03847610|2315083|FG000|Overall Study|Withdrawal by Subject|1
1174010|NCT03850093|2315090|FG000|Overall Study|Withdrawal by Subject|1
1174011|NCT03850093|2315091|FG001|Overall Study|Withdrawal by Subject|0
1174012|NCT03850093|2315092|FG002|Overall Study|Withdrawal by Subject|2
1174013|NCT03855228|2315174|FG000|Overall Study|Adverse Event|2
1174014|NCT03855228|2315175|FG001|Overall Study|Adverse Event|4
1174015|NCT03855228|2315176|FG002|Overall Study|Adverse Event|4
1174016|NCT03855228|2315177|FG003|Overall Study|Adverse Event|8
1174017|NCT03855228|2315174|FG000|Overall Study|Treatment Failure|1
1174018|NCT03855228|2315175|FG001|Overall Study|Treatment Failure|2
1174019|NCT03855228|2315176|FG002|Overall Study|Treatment Failure|1
1174020|NCT03855228|2315177|FG003|Overall Study|Treatment Failure|8
1174021|NCT03855228|2315174|FG000|Overall Study|Lost to Follow-up|0
1174022|NCT03855228|2315175|FG001|Overall Study|Lost to Follow-up|0
1174023|NCT03855228|2315176|FG002|Overall Study|Lost to Follow-up|0
1174024|NCT03855228|2315177|FG003|Overall Study|Lost to Follow-up|1
1174025|NCT03855228|2315174|FG000|Overall Study|Protocol Violation|0
1174026|NCT03855228|2315175|FG001|Overall Study|Protocol Violation|1
1174027|NCT03855228|2315176|FG002|Overall Study|Protocol Violation|2
1174028|NCT03855228|2315177|FG003|Overall Study|Protocol Violation|1
1174029|NCT03855228|2315174|FG000|Overall Study|Did Not Meet Entry Requirements|0
1174030|NCT03855228|2315175|FG001|Overall Study|Did Not Meet Entry Requirements|2
1174031|NCT03855228|2315176|FG002|Overall Study|Did Not Meet Entry Requirements|1
1174032|NCT03855228|2315177|FG003|Overall Study|Did Not Meet Entry Requirements|1
1174033|NCT03861936|2315190|FG000|Overall Study|Withdrawal by Subject|4
1174034|NCT03861936|2315191|FG001|Overall Study|Withdrawal by Subject|1
1174035|NCT03861936|2315192|FG002|Overall Study|Withdrawal by Subject|3
1174036|NCT03861936|2315190|FG000|Overall Study|Lost to Follow-up|5
1174037|NCT03861936|2315191|FG001|Overall Study|Lost to Follow-up|3
1174038|NCT03861936|2315192|FG002|Overall Study|Lost to Follow-up|3
1174039|NCT03861936|2315190|FG000|Overall Study|Physician Decision|0
1174040|NCT03861936|2315191|FG001|Overall Study|Physician Decision|1
1174041|NCT03861936|2315192|FG002|Overall Study|Physician Decision|0
1174042|NCT03861936|2315190|FG000|Overall Study|Protocol Deviation|0
1174043|NCT03861936|2315191|FG001|Overall Study|Protocol Deviation|0
1174044|NCT03861936|2315192|FG002|Overall Study|Protocol Deviation|1
1174045|NCT03861936|2315190|FG000|Overall Study|Reason not Specified|5
1174046|NCT03861936|2315191|FG001|Overall Study|Reason not Specified|5
1174047|NCT03861936|2315192|FG002|Overall Study|Reason not Specified|3
1174048|NCT03850509|2315232|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2
1174049|NCT03850509|2315233|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1
1174050|NCT03861559|2315241|FG000|Overall Study|Adverse Event|0
1174051|NCT03861559|2315242|FG001|Overall Study|Adverse Event|2
1174052|NCT03861559|2315241|FG000|Overall Study|Treatment failure|0
1174053|NCT03861559|2315242|FG001|Overall Study|Treatment failure|2
1174054|NCT03861559|2315241|FG000|Overall Study|Noncompliance|1
1174055|NCT03861559|2315242|FG001|Overall Study|Noncompliance|1
1174056|NCT03861559|2315241|FG000|Overall Study|Did not meet eligibility requirements|1
1174057|NCT03861559|2315242|FG001|Overall Study|Did not meet eligibility requirements|0
1174058|NCT03851016|2315327|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
1174059|NCT03851016|2315328|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2
1174060|NCT03850496|2315337|FG000|Overall Study|Withdrawal by Subject|1
1174061|NCT03850496|2315338|FG001|Overall Study|Withdrawal by Subject|0
1174062|NCT03850496|2315339|FG002|Overall Study|Withdrawal by Subject|0
1174063|NCT03850496|2315337|FG000|Overall Study|Lost to Follow-up|0
1174064|NCT03850496|2315338|FG001|Overall Study|Lost to Follow-up|1
1174065|NCT03850496|2315339|FG002|Overall Study|Lost to Follow-up|4
1174066|NCT03848949|2315349|FG000|Overall Study|Lost to Follow-up|5
1174067|NCT03848949|2315350|FG001|Overall Study|Lost to Follow-up|7
1174068|NCT03846219|2315368|FG000|Overall Study|Withdrawal by Subject|3
1174069|NCT03846219|2315369|FG001|Overall Study|Withdrawal by Subject|2
1174070|NCT03846219|2315370|FG002|Overall Study|Withdrawal by Subject|2
1174071|NCT03846219|2315368|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0
1174072|NCT03846219|2315369|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2
1174073|NCT03846219|2315370|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1
1174074|NCT03846219|2315368|FG000|Overall Study|Physician Decision|0
1174075|NCT03846219|2315369|FG001|Overall Study|Physician Decision|0
1174076|NCT03846219|2315370|FG002|Overall Study|Physician Decision|2
1174077|NCT03844945|2315399|FG000|Overall Study|Adverse Event|1
1174078|NCT03844945|2315400|FG001|Overall Study|Adverse Event|1
1174079|NCT03844945|2315401|FG002|Overall Study|Adverse Event|4
1174080|NCT03844945|2315402|FG003|Overall Study|Adverse Event|0
1174081|NCT03844945|2315399|FG000|Overall Study|Withdrawal by Subject|0
1174082|NCT03844945|2315400|FG001|Overall Study|Withdrawal by Subject|0
1174083|NCT03844945|2315401|FG002|Overall Study|Withdrawal by Subject|1
1174084|NCT03844945|2315402|FG003|Overall Study|Withdrawal by Subject|0
1174085|NCT03844945|2315399|FG000|Overall Study|Lack of Efficacy|0
1174086|NCT03844945|2315400|FG001|Overall Study|Lack of Efficacy|0
1174087|NCT03844945|2315401|FG002|Overall Study|Lack of Efficacy|0
1174088|NCT03844945|2315402|FG003|Overall Study|Lack of Efficacy|1
1174089|NCT03843632|2315425|FG000|Overall Study|Withdrawal by Subject|1
1174090|NCT03843632|2315426|FG001|Overall Study|Withdrawal by Subject|0
1174091|NCT03843632|2315427|FG002|Overall Study|Withdrawal by Subject|0
1174092|NCT03843632|2315428|FG003|Overall Study|Withdrawal by Subject|0
1174093|NCT03840811|2315441|FG000|Overall Study|Lost to Follow-up|0
1174094|NCT03840811|2315442|FG001|Overall Study|Lost to Follow-up|0
1174095|NCT03840811|2315443|FG002|Overall Study|Lost to Follow-up|1
1174096|NCT03837028|2315455|FG000|Overall Study|Lost to Follow-up|4
1174097|NCT03837028|2315456|FG001|Overall Study|Lost to Follow-up|0
1174098|NCT03837028|2315457|FG002|Overall Study|Lost to Follow-up|2
1174099|NCT03837028|2315458|FG003|Overall Study|Lost to Follow-up|0
1174100|NCT03837028|2315455|FG000|Overall Study|Withdrawal by Subject|12
1174101|NCT03837028|2315456|FG001|Overall Study|Withdrawal by Subject|11
871190|NCT00533897|1832249|FG002|Long Term Extension (LTE)|Other|0
871191|NCT00533897|1832250|FG003|Long Term Extension (LTE)|Other|0
871192|NCT00533897|1832251|FG004|Long Term Extension (LTE)|Other|0
871193|NCT00533897|1832252|FG005|Long Term Extension (LTE)|Other|0
871194|NCT00533897|1832253|FG006|Long Term Extension (LTE)|Other|1
871195|NCT00533897|1832254|FG007|Long Term Extension (LTE)|Other|6
871196|NCT00533949|1832298|FG000|Overall Study|Protocol Violation|12
871197|NCT00533949|1832299|FG001|Overall Study|Protocol Violation|12
871198|NCT00533949|1832300|FG002|Overall Study|Protocol Violation|9
871199|NCT00533949|1832301|FG003|Overall Study|Protocol Violation|9
871200|NCT00533949|1832298|FG000|Overall Study|Withdrawal by Subject|3
871201|NCT00533949|1832299|FG001|Overall Study|Withdrawal by Subject|2
871202|NCT00533949|1832300|FG002|Overall Study|Withdrawal by Subject|1
871203|NCT00533949|1832301|FG003|Overall Study|Withdrawal by Subject|1
871204|NCT00534092|1832330|FG000|Overall Study|Lost to Follow-up|1
871205|NCT00534092|1832331|FG001|Overall Study|Lost to Follow-up|0
871206|NCT00534092|1832330|FG000|Overall Study|personal reasons/family concerns|1
871207|NCT00534092|1832331|FG001|Overall Study|personal reasons/family concerns|0
871208|NCT00534105|1832341|FG000|Overall Study|Lost to Follow-up|23
871209|NCT00534105|1832342|FG001|Overall Study|Lost to Follow-up|39
871210|NCT00534248|1832377|FG000|Overall Study|Adverse Event|19
871211|NCT00534248|1832378|FG001|Overall Study|Adverse Event|29
871212|NCT00534248|1832377|FG000|Overall Study|Lost to Follow-up|353
871213|NCT00534248|1832378|FG001|Overall Study|Lost to Follow-up|375
871214|NCT00534248|1832377|FG000|Overall Study|Other protocol specified criteria|13
871215|NCT00534248|1832378|FG001|Overall Study|Other protocol specified criteria|3
871216|NCT00534248|1832377|FG000|Overall Study|Physician Decision|10
871217|NCT00534248|1832378|FG001|Overall Study|Physician Decision|7
871218|NCT00534248|1832377|FG000|Overall Study|Protocol Violation|3
871219|NCT00534248|1832378|FG001|Overall Study|Protocol Violation|4
871220|NCT00534248|1832377|FG000|Overall Study|Withdrawal by Subject|263
871221|NCT00534248|1832378|FG001|Overall Study|Withdrawal by Subject|255
871222|NCT00534313|1832388|FG000|Short-term Period|Adverse Event|1
871223|NCT00534313|1832389|FG001|Short-term Period|Adverse Event|2
871224|NCT00534313|1832390|FG002|Short-term Period|Adverse Event|1
871225|NCT00534313|1832391|FG003|Short-term Period|Adverse Event|3
871226|NCT00534313|1832388|FG000|Short-term Period|Lack of Efficacy|3
871227|NCT00534313|1832389|FG001|Short-term Period|Lack of Efficacy|4
871228|NCT00534313|1832390|FG002|Short-term Period|Lack of Efficacy|0
871229|NCT00534313|1832391|FG003|Short-term Period|Lack of Efficacy|3
871230|NCT00534313|1832388|FG000|Short-term Period|Participant not meeting study criteria|0
871231|NCT00534313|1832389|FG001|Short-term Period|Participant not meeting study criteria|0
871232|NCT00534313|1832390|FG002|Short-term Period|Participant not meeting study criteria|0
871233|NCT00534313|1832391|FG003|Short-term Period|Participant not meeting study criteria|1
871234|NCT00534313|1832388|FG000|Short-term Period|Participant withdrew consent|2
871235|NCT00534313|1832389|FG001|Short-term Period|Participant withdrew consent|0
871236|NCT00534313|1832390|FG002|Short-term Period|Participant withdrew consent|0
871237|NCT00534313|1832391|FG003|Short-term Period|Participant withdrew consent|2
871238|NCT00534313|1832388|FG000|Short-term Period|Pregnancy|0
871239|NCT00534313|1832389|FG001|Short-term Period|Pregnancy|0
871240|NCT00534313|1832390|FG002|Short-term Period|Pregnancy|1
871241|NCT00534313|1832391|FG003|Short-term Period|Pregnancy|0
871242|NCT00534313|1832388|FG000|Long-term Period|Adverse Event|2
871243|NCT00534313|1832389|FG001|Long-term Period|Adverse Event|1
871244|NCT00534313|1832390|FG002|Long-term Period|Adverse Event|0
871245|NCT00534313|1832391|FG003|Long-term Period|Adverse Event|1
871246|NCT00534313|1832388|FG000|Long-term Period|Lack of Efficacy|14
871247|NCT00534313|1832389|FG001|Long-term Period|Lack of Efficacy|10
871248|NCT00534313|1832390|FG002|Long-term Period|Lack of Efficacy|14
871249|NCT00534313|1832391|FG003|Long-term Period|Lack of Efficacy|12
871250|NCT00534313|1832388|FG000|Long-term Period|Lost to Follow-up|1
871251|NCT00534313|1832389|FG001|Long-term Period|Lost to Follow-up|2
871252|NCT00534313|1832390|FG002|Long-term Period|Lost to Follow-up|0
871253|NCT00534313|1832391|FG003|Long-term Period|Lost to Follow-up|0
871254|NCT00534313|1832388|FG000|Long-term Period|Withdrawal by Subject|2
871255|NCT00534313|1832389|FG001|Long-term Period|Withdrawal by Subject|2
871256|NCT00534313|1832390|FG002|Long-term Period|Withdrawal by Subject|0
871257|NCT00534313|1832391|FG003|Long-term Period|Withdrawal by Subject|0
871258|NCT00534313|1832388|FG000|Long-term Period|No longer meets study criteria|0
1174102|NCT03837028|2315457|FG002|Overall Study|Withdrawal by Subject|11
1174103|NCT03837028|2315458|FG003|Overall Study|Withdrawal by Subject|7
1174104|NCT03841331|2315501|FG000|Overall Study|Withdrawal by Subject|4
1174105|NCT03841331|2315502|FG001|Overall Study|Withdrawal by Subject|9
1174106|NCT03841331|2315501|FG000|Overall Study|Lost to Follow-up|5
1174107|NCT03841331|2315502|FG001|Overall Study|Lost to Follow-up|1
1174108|NCT03840135|2315517|FG000|Overall Study|Protocol Violation|6
1174109|NCT03840135|2315518|FG001|Overall Study|Protocol Violation|1
1174110|NCT03840135|2315517|FG000|Overall Study|Withdrawal by Subject|1
1174111|NCT03840135|2315518|FG001|Overall Study|Withdrawal by Subject|0
1174112|NCT03839641|2315530|FG000|Overall Study|Withdrawal by Subject|1
1174113|NCT03839641|2315531|FG001|Overall Study|Withdrawal by Subject|1
1174114|NCT03839212|2315539|FG000|Overall Study|COVID-19 related suspension of research activities.|4
871259|NCT00534313|1832389|FG001|Long-term Period|No longer meets study criteria|1
871260|NCT00534313|1832390|FG002|Long-term Period|No longer meets study criteria|0
871261|NCT00534313|1832391|FG003|Long-term Period|No longer meets study criteria|0
871262|NCT00534313|1832388|FG000|Long-term Period|Poor compliance/noncompliance|0
871263|NCT00534313|1832389|FG001|Long-term Period|Poor compliance/noncompliance|1
871264|NCT00534313|1832390|FG002|Long-term Period|Poor compliance/noncompliance|1
871265|NCT00534313|1832391|FG003|Long-term Period|Poor compliance/noncompliance|0
871266|NCT00534313|1832388|FG000|Long-term Period|Administrative reason by sponsor|17
871267|NCT00534313|1832389|FG001|Long-term Period|Administrative reason by sponsor|15
871268|NCT00534313|1832390|FG002|Long-term Period|Administrative reason by sponsor|26
871269|NCT00534313|1832391|FG003|Long-term Period|Administrative reason by sponsor|18
871270|NCT00534313|1832388|FG000|Long-term Period|Other|1
871271|NCT00534313|1832389|FG001|Long-term Period|Other|2
871272|NCT00534313|1832390|FG002|Long-term Period|Other|2
871273|NCT00534313|1832391|FG003|Long-term Period|Other|2
871274|NCT00534352|1832436|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
871275|NCT00534352|1832436|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
871276|NCT00534352|1832436|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
871277|NCT00534352|1832436|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
871278|NCT00534352|1832436|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
871279|NCT00534352|1832436|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
871280|NCT00534404|1832463|FG000|Overall Study|Death|0
871281|NCT00534404|1832464|FG001|Overall Study|Death|0
871282|NCT00534404|1832465|FG002|Overall Study|Death|2
871283|NCT00534404|1832463|FG000|Overall Study|Withdrawal by Subject|8
871284|NCT00534404|1832464|FG001|Overall Study|Withdrawal by Subject|2
871285|NCT00534404|1832465|FG002|Overall Study|Withdrawal by Subject|38
871286|NCT00534404|1832463|FG000|Overall Study|Removed by study staff|2
871287|NCT00534404|1832464|FG001|Overall Study|Removed by study staff|3
871288|NCT00534404|1832465|FG002|Overall Study|Removed by study staff|1
871289|NCT00534404|1832463|FG000|Overall Study|Lost to Follow-up|170
871290|NCT00534404|1832464|FG001|Overall Study|Lost to Follow-up|138
871291|NCT00534404|1832465|FG002|Overall Study|Lost to Follow-up|201
871292|NCT00534495|1832479|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0
871293|NCT00534495|1832480|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1
871294|NCT00534495|1832481|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0
871295|NCT00534495|1832479|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1
871296|NCT00534495|1832480|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0
871297|NCT00534495|1832481|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0
871298|NCT00534495|1832479|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
871299|NCT00534495|1832480|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
871300|NCT00534495|1832481|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
871301|NCT00534495|1832479|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
871302|NCT00534495|1832480|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
871303|NCT00534495|1832481|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
871304|NCT00534495|1832479|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
871305|NCT00534495|1832480|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
871306|NCT00534495|1832481|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
871307|NCT00534495|1832479|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
871308|NCT00534495|1832480|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
871309|NCT00534495|1832481|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
871310|NCT00534495|1832479|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
871311|NCT00534495|1832480|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
871312|NCT00534495|1832481|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
871313|NCT00534495|1832479|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
871314|NCT00534495|1832480|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
871315|NCT00534495|1832481|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
871316|NCT00534495|1832479|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0
871317|NCT00534495|1832480|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0
871318|NCT00534495|1832481|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2
871319|NCT00534599|1832494|FG000|Overall Study|Adverse Event|25
871320|NCT00534599|1832495|FG001|Overall Study|Adverse Event|4
871321|NCT00534599|1832494|FG000|Overall Study|Incorrect enrollment|2
1174115|NCT03839355|2315545|FG000|Overall Study|Withdrawal by Subject|1
1174116|NCT03839355|2315546|FG001|Overall Study|Withdrawal by Subject|0
871322|NCT00534599|1832495|FG001|Overall Study|Incorrect enrollment|1
871323|NCT00534599|1832494|FG000|Overall Study|Mis-randomization|2
871324|NCT00534599|1832495|FG001|Overall Study|Mis-randomization|2
871325|NCT00534599|1832494|FG000|Overall Study|Developed study-specific d/c criteria|5
871326|NCT00534599|1832495|FG001|Overall Study|Developed study-specific d/c criteria|0
871327|NCT00534599|1832494|FG000|Overall Study|Lack of Efficacy|0
871328|NCT00534599|1832495|FG001|Overall Study|Lack of Efficacy|1
871329|NCT00534599|1832494|FG000|Overall Study|Generalized anxiety disorder worsened|0
871330|NCT00534599|1832495|FG001|Overall Study|Generalized anxiety disorder worsened|1
871331|NCT00534599|1832494|FG000|Overall Study|Protocol Violation|1
871332|NCT00534599|1832495|FG001|Overall Study|Protocol Violation|3
871333|NCT00534599|1832494|FG000|Overall Study|Lost to Follow-up|11
871334|NCT00534599|1832495|FG001|Overall Study|Lost to Follow-up|14
871335|NCT00534599|1832494|FG000|Overall Study|Withdrawal by Subject|4
871336|NCT00534599|1832495|FG001|Overall Study|Withdrawal by Subject|6
871337|NCT00534599|1832494|FG000|Overall Study|Other|7
871338|NCT00534599|1832495|FG001|Overall Study|Other|0
871339|NCT00534638|1832503|FG000|Overall Study|Withdrawal by Subject|3
871340|NCT00534638|1832504|FG001|Overall Study|Withdrawal by Subject|4
871341|NCT00534638|1832503|FG000|Overall Study|Migrated/moved from study area|13
871342|NCT00534638|1832504|FG001|Overall Study|Migrated/moved from study area|11
871343|NCT00534638|1832503|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83
871344|NCT00534638|1832504|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117
871345|NCT00534638|1832503|FG000|Overall Study|Lost to follow-up, complete vaccination|4707
871346|NCT00534638|1832504|FG001|Overall Study|Lost to follow-up, complete vaccination|10757
871347|NCT00534638|1832503|FG000|Overall Study|Other|1685
871348|NCT00534638|1832504|FG001|Overall Study|Other|902
871349|NCT00534976|1832559|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
871350|NCT00534976|1832560|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
871351|NCT00534976|1832559|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
871352|NCT00534976|1832560|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
871353|NCT00534976|1832559|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
871354|NCT00534976|1832560|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
871355|NCT00535132|1832597|FG000|Safety Analysis Set|Did Not Receive Study Medication|2
871356|NCT00535132|1832598|FG001|Safety Analysis Set|Did Not Receive Study Medication|2
871357|NCT00535132|1832597|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
871358|NCT00535132|1832598|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
871359|NCT00535145|1832606|FG000|Phase I|Adverse Event|3
871360|NCT00535145|1832606|FG000|Phase I|Lost to Follow-up|7
871361|NCT00535145|1832606|FG000|Phase I|Withdrawal by Subject|6
871362|NCT00535145|1832606|FG000|Phase I|(eligibility)|8
871363|NCT00535145|1832606|FG000|Phase I|(protocol violation)|1
871364|NCT00535145|1832606|FG000|Phase I|(PI decision)|1
871365|NCT00535145|1832606|FG000|Phase I|(diagnosis)|3
871366|NCT00535145|1832606|FG000|Phase II|Adverse Event|2
871367|NCT00535145|1832606|FG000|Phase II|Lack of Efficacy|1
871368|NCT00535145|1832606|FG000|Phase II|Lost to Follow-up|5
871369|NCT00535145|1832606|FG000|Phase II|Withdrawal by Subject|5
871370|NCT00535145|1832606|FG000|Phase II|Subject non-compliance|2
871371|NCT00535223|1832616|FG000|Overall Study|Withdrawal by Subject|4
871372|NCT00535223|1832617|FG001|Overall Study|Withdrawal by Subject|1
871373|NCT00535236|1832633|FG000|Overall Study|Adverse Event|1
871374|NCT00535236|1832634|FG001|Overall Study|Adverse Event|0
871375|NCT00535236|1832635|FG002|Overall Study|Adverse Event|9
871376|NCT00535236|1832636|FG003|Overall Study|Adverse Event|3
871377|NCT00535236|1832637|FG004|Overall Study|Adverse Event|3
871378|NCT00535236|1832638|FG005|Overall Study|Adverse Event|0
871379|NCT00535236|1832639|FG006|Overall Study|Adverse Event|5
871380|NCT00535236|1832640|FG007|Overall Study|Adverse Event|1
871381|NCT00535236|1832641|FG008|Overall Study|Adverse Event|2
871382|NCT00535236|1832642|FG009|Overall Study|Adverse Event|1
871383|NCT00535236|1832633|FG000|Overall Study|Lost to Follow-up|1
871384|NCT00535236|1832634|FG001|Overall Study|Lost to Follow-up|2
871385|NCT00535236|1832635|FG002|Overall Study|Lost to Follow-up|0
871386|NCT00535236|1832636|FG003|Overall Study|Lost to Follow-up|0
871387|NCT00535236|1832637|FG004|Overall Study|Lost to Follow-up|2
871388|NCT00535236|1832638|FG005|Overall Study|Lost to Follow-up|0
871389|NCT00535236|1832639|FG006|Overall Study|Lost to Follow-up|0
871390|NCT00535236|1832640|FG007|Overall Study|Lost to Follow-up|0
871391|NCT00535236|1832641|FG008|Overall Study|Lost to Follow-up|6
871392|NCT00535236|1832642|FG009|Overall Study|Lost to Follow-up|1
871393|NCT00535236|1832633|FG000|Overall Study|Physician Decision|0
871394|NCT00535236|1832634|FG001|Overall Study|Physician Decision|0
871395|NCT00535236|1832635|FG002|Overall Study|Physician Decision|0
871396|NCT00535236|1832636|FG003|Overall Study|Physician Decision|0
871397|NCT00535236|1832637|FG004|Overall Study|Physician Decision|1
871398|NCT00535236|1832638|FG005|Overall Study|Physician Decision|0
871399|NCT00535236|1832639|FG006|Overall Study|Physician Decision|1
871400|NCT00535236|1832640|FG007|Overall Study|Physician Decision|0
871401|NCT00535236|1832641|FG008|Overall Study|Physician Decision|0
871402|NCT00535236|1832642|FG009|Overall Study|Physician Decision|0
1174117|NCT03838731|2315563|FG000|Overall Study|Pregnancy|0
1174118|NCT03838731|2315564|FG001|Overall Study|Pregnancy|1
1174119|NCT03838731|2315563|FG000|Overall Study|Withdrawal of consent|1
871403|NCT00535236|1832633|FG000|Overall Study|Protocol Violation|2
871404|NCT00535236|1832634|FG001|Overall Study|Protocol Violation|0
871405|NCT00535236|1832635|FG002|Overall Study|Protocol Violation|1
871406|NCT00535236|1832636|FG003|Overall Study|Protocol Violation|0
871407|NCT00535236|1832637|FG004|Overall Study|Protocol Violation|0
871408|NCT00535236|1832638|FG005|Overall Study|Protocol Violation|0
871409|NCT00535236|1832639|FG006|Overall Study|Protocol Violation|0
871410|NCT00535236|1832640|FG007|Overall Study|Protocol Violation|0
871411|NCT00535236|1832641|FG008|Overall Study|Protocol Violation|1
871412|NCT00535236|1832642|FG009|Overall Study|Protocol Violation|0
871413|NCT00535236|1832633|FG000|Overall Study|Withdrawal by Subject|3
871414|NCT00535236|1832634|FG001|Overall Study|Withdrawal by Subject|0
871415|NCT00535236|1832635|FG002|Overall Study|Withdrawal by Subject|2
871416|NCT00535236|1832636|FG003|Overall Study|Withdrawal by Subject|1
871417|NCT00535236|1832637|FG004|Overall Study|Withdrawal by Subject|6
871418|NCT00535236|1832638|FG005|Overall Study|Withdrawal by Subject|1
871419|NCT00535236|1832639|FG006|Overall Study|Withdrawal by Subject|5
871420|NCT00535236|1832640|FG007|Overall Study|Withdrawal by Subject|0
871421|NCT00535236|1832641|FG008|Overall Study|Withdrawal by Subject|4
871422|NCT00535236|1832642|FG009|Overall Study|Withdrawal by Subject|2
871423|NCT00535288|1832672|FG000|Overall Study|Adverse Event|20
871424|NCT00535288|1832673|FG001|Overall Study|Adverse Event|19
871425|NCT00535288|1832674|FG002|Overall Study|Adverse Event|25
871426|NCT00535288|1832675|FG003|Overall Study|Adverse Event|20
871427|NCT00535288|1832676|FG004|Overall Study|Adverse Event|30
871428|NCT00535288|1832672|FG000|Overall Study|Lost to Follow-up|0
871429|NCT00535288|1832673|FG001|Overall Study|Lost to Follow-up|3
871430|NCT00535288|1832674|FG002|Overall Study|Lost to Follow-up|0
871431|NCT00535288|1832675|FG003|Overall Study|Lost to Follow-up|0
871432|NCT00535288|1832676|FG004|Overall Study|Lost to Follow-up|0
871433|NCT00535288|1832672|FG000|Overall Study|Lack of Efficacy|26
871434|NCT00535288|1832673|FG001|Overall Study|Lack of Efficacy|3
871435|NCT00535288|1832674|FG002|Overall Study|Lack of Efficacy|4
871436|NCT00535288|1832675|FG003|Overall Study|Lack of Efficacy|4
871437|NCT00535288|1832676|FG004|Overall Study|Lack of Efficacy|7
871438|NCT00535288|1832672|FG000|Overall Study|Unwilling to cooperate|6
871439|NCT00535288|1832673|FG001|Overall Study|Unwilling to cooperate|6
871440|NCT00535288|1832674|FG002|Overall Study|Unwilling to cooperate|3
871441|NCT00535288|1832675|FG003|Overall Study|Unwilling to cooperate|3
871442|NCT00535288|1832676|FG004|Overall Study|Unwilling to cooperate|4
871443|NCT00535288|1832672|FG000|Overall Study|Other|2
871444|NCT00535288|1832673|FG001|Overall Study|Other|1
871445|NCT00535288|1832674|FG002|Overall Study|Other|1
871446|NCT00535288|1832675|FG003|Overall Study|Other|2
871447|NCT00535288|1832676|FG004|Overall Study|Other|1
871448|NCT00535405|1832713|FG000|Overall Study|Adverse Event|6
871449|NCT00535405|1832714|FG001|Overall Study|Adverse Event|8
871450|NCT00535405|1832715|FG002|Overall Study|Adverse Event|3
871451|NCT00535405|1832716|FG003|Overall Study|Adverse Event|8
871452|NCT00535405|1832717|FG004|Overall Study|Adverse Event|6
871453|NCT00535405|1832713|FG000|Overall Study|Lost to Follow-up|1
871454|NCT00535405|1832714|FG001|Overall Study|Lost to Follow-up|3
871455|NCT00535405|1832715|FG002|Overall Study|Lost to Follow-up|3
871456|NCT00535405|1832716|FG003|Overall Study|Lost to Follow-up|2
871457|NCT00535405|1832717|FG004|Overall Study|Lost to Follow-up|1
871458|NCT00535405|1832713|FG000|Overall Study|Physician Decision|3
871459|NCT00535405|1832714|FG001|Overall Study|Physician Decision|2
871460|NCT00535405|1832715|FG002|Overall Study|Physician Decision|0
871461|NCT00535405|1832716|FG003|Overall Study|Physician Decision|1
871462|NCT00535405|1832717|FG004|Overall Study|Physician Decision|1
871463|NCT00535405|1832713|FG000|Overall Study|Protocol Violation|2
871464|NCT00535405|1832714|FG001|Overall Study|Protocol Violation|2
871465|NCT00535405|1832715|FG002|Overall Study|Protocol Violation|2
871466|NCT00535405|1832716|FG003|Overall Study|Protocol Violation|1
871467|NCT00535405|1832717|FG004|Overall Study|Protocol Violation|0
871468|NCT00535405|1832713|FG000|Overall Study|Withdrawal by Subject|5
871469|NCT00535405|1832714|FG001|Overall Study|Withdrawal by Subject|11
871470|NCT00535405|1832715|FG002|Overall Study|Withdrawal by Subject|10
871471|NCT00535405|1832716|FG003|Overall Study|Withdrawal by Subject|10
871472|NCT00535405|1832717|FG004|Overall Study|Withdrawal by Subject|8
871473|NCT00535496|1832731|FG000|Overall Study|Lost to Follow-up|0
871474|NCT00535496|1832732|FG001|Overall Study|Lost to Follow-up|1
871475|NCT00535496|1832733|FG002|Overall Study|Lost to Follow-up|0
871476|NCT00535496|1832734|FG003|Overall Study|Lost to Follow-up|0
871477|NCT00535496|1832731|FG000|Overall Study|Not treated with sugammadex|0
871478|NCT00535496|1832732|FG001|Overall Study|Not treated with sugammadex|1
871479|NCT00535496|1832733|FG002|Overall Study|Not treated with sugammadex|0
1174120|NCT03838731|2315564|FG001|Overall Study|Withdrawal of consent|0
1174121|NCT03838198|2315572|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
1174122|NCT03838198|2315573|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
1174123|NCT03838198|2315574|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1
1174124|NCT03838198|2315575|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
1174125|NCT03838198|2315572|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
1174126|NCT03838198|2315573|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
1174127|NCT03838198|2315574|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
1174128|NCT03838198|2315575|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
1174129|NCT03836677|2315694|FG000|Period 1|Adverse Event|0
1174130|NCT03836677|2315695|FG001|Period 1|Adverse Event|1
1174131|NCT03836677|2315694|FG000|Period 2|Severe non-compliance to protocol|1
1174132|NCT03836677|2315695|FG001|Period 2|Severe non-compliance to protocol|0
1174133|NCT03827564|2315715|FG000|Overall Study|Discontinued due to Study Termination|1
1174134|NCT03827564|2315716|FG001|Overall Study|Discontinued due to Study Termination|0
1174135|NCT03824236|2315725|FG000|Overall Study|Lost to Follow-up|0
1174136|NCT03824236|2315726|FG001|Overall Study|Lost to Follow-up|0
1174137|NCT03824236|2315727|FG002|Overall Study|Lost to Follow-up|1
1174138|NCT03810235|2315748|FG000|Overall Study|Withdrawal by Subject|2
1174139|NCT03810235|2315749|FG001|Overall Study|Withdrawal by Subject|0
1174140|NCT03836664|2315768|FG000|Overall Study|Didn't complete forms and lost drug|3
1174141|NCT03836664|2315769|FG001|Overall Study|Didn't complete forms and lost drug|3
1174142|NCT03832738|2315782|FG000|Overall Study|Withdrawal by Subject|6
1174143|NCT03832738|2315783|FG001|Overall Study|Withdrawal by Subject|7
1174144|NCT03832738|2315784|FG002|Overall Study|Withdrawal by Subject|16
1174145|NCT03832738|2315782|FG000|Overall Study|Physician Decision|0
1174146|NCT03832738|2315783|FG001|Overall Study|Physician Decision|1
1174147|NCT03832738|2315784|FG002|Overall Study|Physician Decision|2
1174148|NCT03832738|2315782|FG000|Overall Study|Adverse Event|2
1174149|NCT03832738|2315783|FG001|Overall Study|Adverse Event|3
1174150|NCT03832738|2315784|FG002|Overall Study|Adverse Event|1
1174151|NCT03832738|2315782|FG000|Overall Study|Pregnancy|0
1174152|NCT03832738|2315783|FG001|Overall Study|Pregnancy|1
1174153|NCT03832738|2315784|FG002|Overall Study|Pregnancy|0
1174154|NCT03823391|2315794|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1
1174155|NCT03823391|2315795|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1
1174156|NCT03823391|2315794|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1
1174157|NCT03823391|2315795|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0
1174158|NCT03808298|2315817|FG000|Overall Study|Adverse Event|3
1174159|NCT03808298|2315817|FG000|Overall Study|Physician Decision|1
1174160|NCT03808298|2315817|FG000|Overall Study|Withdrawal by Subject|1
1174161|NCT03808298|2315817|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3
1174162|NCT03836729|2315846|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1
1174163|NCT03835975|2315859|FG000|Overall Study|Lost to Follow-up|1
1174164|NCT03835975|2315860|FG001|Overall Study|Lost to Follow-up|1
1174165|NCT03835975|2315861|FG002|Overall Study|Lost to Follow-up|0
1174166|NCT03835975|2315862|FG003|Overall Study|Lost to Follow-up|0
871480|NCT00535496|1832734|FG003|Overall Study|Not treated with sugammadex|0
871481|NCT00535626|1832765|FG000|Overall Study|Death|15
871482|NCT00535626|1832765|FG000|Overall Study|Lost to Follow-up|29
871483|NCT00535626|1832765|FG000|Overall Study|Withdrawal by Subject|20
871484|NCT00535626|1832765|FG000|Overall Study|Removal/revision of study component|8
871485|NCT00535626|1832765|FG000|Overall Study|Subject terminated|31
871486|NCT00535626|1832765|FG000|Overall Study|Unable to return|2
871487|NCT00535730|1832776|FG000|Overall Study|Adverse Event|1
871488|NCT00535730|1832777|FG001|Overall Study|Adverse Event|1
871489|NCT00535730|1832776|FG000|Overall Study|Lost to Follow-up|0
871490|NCT00535730|1832777|FG001|Overall Study|Lost to Follow-up|1
871491|NCT00535730|1832776|FG000|Overall Study|Physician Decision|0
871492|NCT00535730|1832777|FG001|Overall Study|Physician Decision|1
871493|NCT00535730|1832776|FG000|Overall Study|Protocol Violation|1
871494|NCT00535730|1832777|FG001|Overall Study|Protocol Violation|0
871495|NCT00535730|1832776|FG000|Overall Study|Withdrawal by Subject|0
871496|NCT00535730|1832777|FG001|Overall Study|Withdrawal by Subject|4
871497|NCT00535847|1832914|FG000|Overall Study|Adverse Event|5
871498|NCT00535847|1832915|FG001|Overall Study|Adverse Event|3
871499|NCT00535847|1832916|FG002|Overall Study|Adverse Event|2
871500|NCT00535847|1832914|FG000|Overall Study|Non compliance|1
871501|NCT00535847|1832915|FG001|Overall Study|Non compliance|1
871502|NCT00535847|1832916|FG002|Overall Study|Non compliance|0
871503|NCT00535847|1832914|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16
871504|NCT00535847|1832915|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10
871505|NCT00535847|1832916|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0
871506|NCT00536107|1832954|FG000|Overall Study|Death|5
871507|NCT00536107|1832955|FG001|Overall Study|Death|1
871508|NCT00536107|1832954|FG000|Overall Study|Incorrect enrolment|1
871509|NCT00536107|1832955|FG001|Overall Study|Incorrect enrolment|0
871510|NCT00536107|1832954|FG000|Overall Study|Withdrawal by Subject|0
871511|NCT00536107|1832955|FG001|Overall Study|Withdrawal by Subject|1
871512|NCT00536107|1832954|FG000|Overall Study|Study Termination|2
871513|NCT00536107|1832955|FG001|Overall Study|Study Termination|4
871514|NCT00536120|1832963|FG000|Overall Study|Lost to Follow-up|1
871515|NCT00536120|1832964|FG001|Overall Study|Lost to Follow-up|0
871516|NCT00536120|1832963|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3
871517|NCT00536120|1832964|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0
871518|NCT00536120|1832963|FG000|Overall Study|Non-compliance|1
871519|NCT00536120|1832964|FG001|Overall Study|Non-compliance|0
871520|NCT00536120|1832963|FG000|Overall Study|Sponsor Decision Due to Lab Values|1
871521|NCT00536120|1832964|FG001|Overall Study|Sponsor Decision Due to Lab Values|0
871522|NCT00536120|1832963|FG000|Overall Study|Steroid Use|0
871523|NCT00536120|1832964|FG001|Overall Study|Steroid Use|2
1174167|NCT03835975|2315863|FG004|Overall Study|Lost to Follow-up|0
1174168|NCT03835975|2315859|FG000|Overall Study|No longer met eligibility criteria|0
1174169|NCT03835975|2315860|FG001|Overall Study|No longer met eligibility criteria|1
1174170|NCT03835975|2315861|FG002|Overall Study|No longer met eligibility criteria|0
1174171|NCT03835975|2315862|FG003|Overall Study|No longer met eligibility criteria|0
1174172|NCT03835975|2315863|FG004|Overall Study|No longer met eligibility criteria|0
1174173|NCT03835975|2315859|FG000|Overall Study|Protocol Violation|1
1174174|NCT03835975|2315860|FG001|Overall Study|Protocol Violation|1
1174175|NCT03835975|2315861|FG002|Overall Study|Protocol Violation|2
1174176|NCT03835975|2315862|FG003|Overall Study|Protocol Violation|0
1174177|NCT03835975|2315863|FG004|Overall Study|Protocol Violation|0
1174178|NCT03835975|2315859|FG000|Overall Study|Withdrawal by Subject|1
1174179|NCT03835975|2315860|FG001|Overall Study|Withdrawal by Subject|0
1174180|NCT03835975|2315861|FG002|Overall Study|Withdrawal by Subject|1
1174181|NCT03835975|2315862|FG003|Overall Study|Withdrawal by Subject|1
1174182|NCT03835975|2315863|FG004|Overall Study|Withdrawal by Subject|0
1174183|NCT03835221|2315918|FG000|Methafilcon A|Withdrawal by Subject|1
1174184|NCT03819634|2315924|FG000|Overall Study|Physician Decision|2
1174185|NCT03812679|2315928|FG000|Overall Study|Adverse Event|2
1174186|NCT03812679|2315928|FG000|Overall Study|Missed >4 consecutive therapy days|1
1174187|NCT03812679|2315928|FG000|Overall Study|Renal transplant|1
1174188|NCT03812679|2315928|FG000|Overall Study|Withdrawal by Subject|1
871524|NCT00536120|1832963|FG000|Overall Study|Missed Study Visit|0
871525|NCT00536120|1832964|FG001|Overall Study|Missed Study Visit|1
871526|NCT00536198|1832981|FG000|Overall Study|Lost to Follow-up|15
871527|NCT00536198|1832982|FG001|Overall Study|Lost to Follow-up|14
871528|NCT00536198|1832981|FG000|Overall Study|Withdrawal by Subject|16
871529|NCT00536198|1832982|FG001|Overall Study|Withdrawal by Subject|12
871530|NCT00536198|1832981|FG000|Overall Study|Adverse Event|2
871531|NCT00536198|1832982|FG001|Overall Study|Adverse Event|2
871532|NCT00536198|1832981|FG000|Overall Study|Rescue|3
871533|NCT00536198|1832982|FG001|Overall Study|Rescue|9
871534|NCT00536198|1832981|FG000|Overall Study|Pregnancy|1
871535|NCT00536198|1832982|FG001|Overall Study|Pregnancy|1
871536|NCT00536198|1832981|FG000|Overall Study|Protocol Violation|0
871537|NCT00536198|1832982|FG001|Overall Study|Protocol Violation|1
871538|NCT00536263|1832993|FG000|Overall Study|Adverse Event|5
871539|NCT00536263|1832994|FG001|Overall Study|Adverse Event|5
871540|NCT00536263|1832995|FG002|Overall Study|Adverse Event|7
871541|NCT00536263|1832993|FG000|Overall Study|Lost to Follow-up|3
871542|NCT00536263|1832994|FG001|Overall Study|Lost to Follow-up|4
871543|NCT00536263|1832995|FG002|Overall Study|Lost to Follow-up|4
871544|NCT00536263|1832993|FG000|Overall Study|Subject withdrew - not treatment related|2
871545|NCT00536263|1832994|FG001|Overall Study|Subject withdrew - not treatment related|0
871546|NCT00536263|1832995|FG002|Overall Study|Subject withdrew - not treatment related|5
871547|NCT00536263|1832993|FG000|Overall Study|Subject withdrew - treatment related|0
871548|NCT00536263|1832994|FG001|Overall Study|Subject withdrew - treatment related|3
871549|NCT00536263|1832995|FG002|Overall Study|Subject withdrew - treatment related|2
871550|NCT00536263|1832993|FG000|Overall Study|Noncompliance with protocol|0
871551|NCT00536263|1832994|FG001|Overall Study|Noncompliance with protocol|0
871552|NCT00536263|1832995|FG002|Overall Study|Noncompliance with protocol|1
871553|NCT00536263|1832993|FG000|Overall Study|Did not meet protocol eligibility|1
871554|NCT00536263|1832994|FG001|Overall Study|Did not meet protocol eligibility|2
871555|NCT00536263|1832995|FG002|Overall Study|Did not meet protocol eligibility|2
871556|NCT00536380|1833016|FG000|Overall Study|Adverse Event|0
871557|NCT00536380|1833017|FG001|Overall Study|Adverse Event|2
871558|NCT00536380|1833018|FG002|Overall Study|Adverse Event|2
871559|NCT00536380|1833016|FG000|Overall Study|Lost to Follow-up|0
871560|NCT00536380|1833017|FG001|Overall Study|Lost to Follow-up|0
871561|NCT00536380|1833018|FG002|Overall Study|Lost to Follow-up|1
871562|NCT00536380|1833016|FG000|Overall Study|Withdrawal unrelated to study drug|2
871563|NCT00536380|1833017|FG001|Overall Study|Withdrawal unrelated to study drug|0
871564|NCT00536380|1833018|FG002|Overall Study|Withdrawal unrelated to study drug|1
871565|NCT00536380|1833016|FG000|Overall Study|Withdrawal related to study drug|7
871566|NCT00536380|1833017|FG001|Overall Study|Withdrawal related to study drug|5
871567|NCT00536380|1833018|FG002|Overall Study|Withdrawal related to study drug|2
871568|NCT00536380|1833016|FG000|Overall Study|Noncompliance with protocol|3
871569|NCT00536380|1833017|FG001|Overall Study|Noncompliance with protocol|2
871570|NCT00536380|1833018|FG002|Overall Study|Noncompliance with protocol|2
871571|NCT00536380|1833016|FG000|Overall Study|Did not meet protocol eligibility|0
1174189|NCT03812679|2315928|FG000|Overall Study|Termination of study|2
1174190|NCT03812679|2315928|FG000|Overall Study|Water device replacement|1
1174221|NCT03801148|2316004|FG000|Period 1 (2 Days)|Adverse Event|1
1174222|NCT03801148|2316005|FG001|Period 1 (2 Days)|Adverse Event|1
1174223|NCT03801148|2316006|FG002|Period 1 (2 Days)|Adverse Event|0
1174224|NCT03801148|2316007|FG003|Period 1 (2 Days)|Adverse Event|0
1174225|NCT03801148|2316004|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
1174226|NCT03801148|2316005|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0
1174227|NCT03801148|2316006|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0
1174228|NCT03801148|2316007|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1
1174229|NCT03801148|2316004|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1174230|NCT03801148|2316005|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1174231|NCT03801148|2316006|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
1174232|NCT03801148|2316007|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1174233|NCT03801148|2316004|FG000|Follow-Up (12 Days)|Lost to Follow-up|0
1174234|NCT03801148|2316005|FG001|Follow-Up (12 Days)|Lost to Follow-up|1
1174235|NCT03801148|2316006|FG002|Follow-Up (12 Days)|Lost to Follow-up|1
1174236|NCT03801148|2316007|FG003|Follow-Up (12 Days)|Lost to Follow-up|0
1174237|NCT03832322|2316023|FG000|Overall Study|Failed cecal intubation in 2nd exam|3
1174238|NCT03832322|2316024|FG001|Overall Study|Failed cecal intubation in 2nd exam|1
1174239|NCT03832387|2316034|FG000|Overall Study|Protocol Violation|2
1174240|NCT03832387|2316035|FG001|Overall Study|Protocol Violation|6
1174241|NCT03832387|2316034|FG000|Overall Study|EXCLUSION CRITERIA|3
1174242|NCT03832387|2316035|FG001|Overall Study|EXCLUSION CRITERIA|1
1174243|NCT03807739|2316058|FG000|Overall Study|Adverse Event|1
1174244|NCT03807739|2316059|FG001|Overall Study|Adverse Event|0
1174245|NCT03807739|2316060|FG002|Overall Study|Adverse Event|0
1174246|NCT03807739|2316061|FG003|Overall Study|Adverse Event|0
1174247|NCT03807739|2316058|FG000|Overall Study|Withdrawal by Subject|1
1174248|NCT03807739|2316059|FG001|Overall Study|Withdrawal by Subject|0
1174249|NCT03807739|2316060|FG002|Overall Study|Withdrawal by Subject|0
1174250|NCT03807739|2316061|FG003|Overall Study|Withdrawal by Subject|0
1174251|NCT03831282|2316071|FG000|Overall Study|Could not place sensor|1
871572|NCT00536380|1833017|FG001|Overall Study|Did not meet protocol eligibility|0
871573|NCT00536380|1833018|FG002|Overall Study|Did not meet protocol eligibility|1
871574|NCT00536380|1833016|FG000|Overall Study|Administrative|0
871575|NCT00536380|1833017|FG001|Overall Study|Administrative|0
871576|NCT00536380|1833018|FG002|Overall Study|Administrative|1
871577|NCT00536471|1833030|FG000|Overall Study|Lost to Follow-up|48
871578|NCT00536471|1833031|FG001|Overall Study|Lost to Follow-up|23
871579|NCT00536471|1833032|FG002|Overall Study|Lost to Follow-up|48
871580|NCT00536471|1833033|FG003|Overall Study|Lost to Follow-up|22
871581|NCT00536471|1833030|FG000|Overall Study|Adverse Event|32
871582|NCT00536471|1833031|FG001|Overall Study|Adverse Event|16
871583|NCT00536471|1833032|FG002|Overall Study|Adverse Event|28
871584|NCT00536471|1833033|FG003|Overall Study|Adverse Event|13
1174252|NCT03824912|2316078|FG000|Overall Study|Lost to Follow-up|18
1174253|NCT03824912|2316079|FG001|Overall Study|Lost to Follow-up|15
1174254|NCT03824912|2316080|FG002|Overall Study|Lost to Follow-up|8
1174255|NCT03824912|2316078|FG000|Overall Study|Negative Baseline Culture Result|118
1174256|NCT03824912|2316079|FG001|Overall Study|Negative Baseline Culture Result|112
1174257|NCT03824912|2316080|FG002|Overall Study|Negative Baseline Culture Result|57
1174258|NCT03824912|2316078|FG000|Overall Study|Non-Compliance with Study Drug|0
1174259|NCT03824912|2316079|FG001|Overall Study|Non-Compliance with Study Drug|0
1174260|NCT03824912|2316080|FG002|Overall Study|Non-Compliance with Study Drug|1
1174261|NCT03824912|2316078|FG000|Overall Study|Protocol Violation|1
1174262|NCT03824912|2316079|FG001|Overall Study|Protocol Violation|4
1174263|NCT03824912|2316080|FG002|Overall Study|Protocol Violation|1
1174264|NCT03824912|2316078|FG000|Overall Study|Withdrawal by Subject|3
1174265|NCT03824912|2316079|FG001|Overall Study|Withdrawal by Subject|2
1174266|NCT03824912|2316080|FG002|Overall Study|Withdrawal by Subject|1
1174267|NCT03824912|2316078|FG000|Overall Study|Participation in another study|0
1174268|NCT03824912|2316079|FG001|Overall Study|Participation in another study|1
1174269|NCT03824912|2316080|FG002|Overall Study|Participation in another study|0
1174270|NCT03822884|2316094|FG000|Overall Study|Withdrawal by Subject|0
1174271|NCT03822884|2316095|FG001|Overall Study|Withdrawal by Subject|0
1174272|NCT03822884|2316096|FG002|Overall Study|Withdrawal by Subject|0
1174273|NCT03822884|2316097|FG003|Overall Study|Withdrawal by Subject|0
1174274|NCT03822884|2316098|FG004|Overall Study|Withdrawal by Subject|1
1174275|NCT03822884|2316099|FG005|Overall Study|Withdrawal by Subject|0
1174276|NCT03810014|2316115|FG000|Overall Study|Pregnancy|2
1174277|NCT03810014|2316116|FG001|Overall Study|Pregnancy|2
1174278|NCT03810014|2316117|FG002|Overall Study|Pregnancy|0
1174279|NCT03810014|2316118|FG003|Overall Study|Pregnancy|2
1174280|NCT03830892|2316143|FG000|Overall Study|Physician Decision|2
1174281|NCT03830892|2316144|FG001|Overall Study|Physician Decision|3
1174282|NCT03830892|2316143|FG000|Overall Study|Study terminated due to COVID|4
1174283|NCT03830892|2316144|FG001|Overall Study|Study terminated due to COVID|0
1174284|NCT03830892|2316143|FG000|Overall Study|Protocol Violation|0
1174285|NCT03830892|2316144|FG001|Overall Study|Protocol Violation|1
1174286|NCT03830892|2316143|FG000|Overall Study|Withdrawal by Subject|0
1174287|NCT03830892|2316144|FG001|Overall Study|Withdrawal by Subject|2
1174288|NCT03825042|2316156|FG000|Overall Study|Adverse Event|1
1174289|NCT03825042|2316157|FG001|Overall Study|Adverse Event|0
1174290|NCT03825042|2316156|FG000|Overall Study|Withdrawal by Subject|1
1174291|NCT03825042|2316157|FG001|Overall Study|Withdrawal by Subject|0
1174292|NCT03823378|2316169|FG000|Overall Study|Adverse Event|2
1174293|NCT03823378|2316170|FG001|Overall Study|Adverse Event|2
1174294|NCT03823378|2316171|FG002|Overall Study|Adverse Event|0
1174295|NCT03823378|2316172|FG003|Overall Study|Adverse Event|0
1174296|NCT03823378|2316173|FG004|Overall Study|Adverse Event|0
1174297|NCT03823378|2316174|FG005|Overall Study|Adverse Event|0
1174298|NCT03823378|2316169|FG000|Overall Study|Lost to Follow-up|0
1174299|NCT03823378|2316170|FG001|Overall Study|Lost to Follow-up|1
1174300|NCT03823378|2316171|FG002|Overall Study|Lost to Follow-up|0
1174301|NCT03823378|2316172|FG003|Overall Study|Lost to Follow-up|0
1174302|NCT03823378|2316173|FG004|Overall Study|Lost to Follow-up|1
1174303|NCT03823378|2316174|FG005|Overall Study|Lost to Follow-up|0
1174304|NCT03823378|2316169|FG000|Overall Study|Withdrawal by Subject|0
1174305|NCT03823378|2316170|FG001|Overall Study|Withdrawal by Subject|1
1174306|NCT03823378|2316171|FG002|Overall Study|Withdrawal by Subject|4
1174307|NCT03823378|2316172|FG003|Overall Study|Withdrawal by Subject|2
1174308|NCT03823378|2316173|FG004|Overall Study|Withdrawal by Subject|0
1174309|NCT03823378|2316174|FG005|Overall Study|Withdrawal by Subject|1
1174310|NCT03823378|2316169|FG000|Overall Study|Other, not specified|19
1174311|NCT03823378|2316170|FG001|Overall Study|Other, not specified|12
1174312|NCT03823378|2316171|FG002|Overall Study|Other, not specified|6
1174313|NCT03823378|2316172|FG003|Overall Study|Other, not specified|8
1174314|NCT03823378|2316173|FG004|Overall Study|Other, not specified|17
1174315|NCT03823378|2316174|FG005|Overall Study|Other, not specified|7
1174316|NCT03831191|2316192|FG000|Induction Period (16 Weeks)|Adverse Event|2
1174317|NCT03831191|2316193|FG001|Induction Period (16 Weeks)|Adverse Event|1
1174318|NCT03831191|2316194|FG002|Induction Period (16 Weeks)|Adverse Event|3
1174319|NCT03831191|2316195|FG003|Induction Period (16 Weeks)|Adverse Event|4
1174320|NCT03831191|2316196|FG004|Induction Period (16 Weeks)|Adverse Event|0
1174321|NCT03831191|2316197|FG005|Induction Period (16 Weeks)|Adverse Event|0
1174322|NCT03831191|2316198|FG006|Induction Period (16 Weeks)|Adverse Event|0
1174323|NCT03831191|2316199|FG007|Induction Period (16 Weeks)|Adverse Event|0
1174324|NCT03831191|2316200|FG008|Induction Period (16 Weeks)|Adverse Event|0
1174325|NCT03831191|2316201|FG009|Induction Period (16 Weeks)|Adverse Event|0
1174326|NCT03831191|2316202|FG010|Induction Period (16 Weeks)|Adverse Event|0
1174327|NCT03831191|2316203|FG011|Induction Period (16 Weeks)|Adverse Event|0
1174328|NCT03831191|2316204|FG012|Induction Period (16 Weeks)|Adverse Event|0
1174329|NCT03831191|2316205|FG013|Induction Period (16 Weeks)|Adverse Event|0
1174330|NCT03831191|2316206|FG014|Induction Period (16 Weeks)|Adverse Event|0
1174331|NCT03831191|2316192|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2
1174332|NCT03831191|2316193|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3
1174333|NCT03831191|2316194|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
1174334|NCT03831191|2316195|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
1174335|NCT03831191|2316196|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
1174336|NCT03831191|2316197|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
1174337|NCT03831191|2316198|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
1174338|NCT03831191|2316199|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
1174339|NCT03831191|2316200|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0
1174340|NCT03831191|2316201|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0
1174341|NCT03831191|2316202|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0
1174342|NCT03831191|2316203|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0
1174343|NCT03831191|2316204|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0
1174344|NCT03831191|2316205|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0
1174345|NCT03831191|2316206|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0
1174346|NCT03831191|2316192|FG000|Induction Period (16 Weeks)|Pregnancy|0
1174347|NCT03831191|2316193|FG001|Induction Period (16 Weeks)|Pregnancy|0
1174348|NCT03831191|2316194|FG002|Induction Period (16 Weeks)|Pregnancy|1
1174349|NCT03831191|2316195|FG003|Induction Period (16 Weeks)|Pregnancy|0
1174350|NCT03831191|2316196|FG004|Induction Period (16 Weeks)|Pregnancy|0
1174351|NCT03831191|2316197|FG005|Induction Period (16 Weeks)|Pregnancy|0
1174352|NCT03831191|2316198|FG006|Induction Period (16 Weeks)|Pregnancy|0
1174353|NCT03831191|2316199|FG007|Induction Period (16 Weeks)|Pregnancy|0
1174354|NCT03831191|2316200|FG008|Induction Period (16 Weeks)|Pregnancy|0
1174355|NCT03831191|2316201|FG009|Induction Period (16 Weeks)|Pregnancy|0
1174356|NCT03831191|2316202|FG010|Induction Period (16 Weeks)|Pregnancy|0
1174357|NCT03831191|2316203|FG011|Induction Period (16 Weeks)|Pregnancy|0
1174358|NCT03831191|2316204|FG012|Induction Period (16 Weeks)|Pregnancy|0
1174359|NCT03831191|2316205|FG013|Induction Period (16 Weeks)|Pregnancy|0
1174360|NCT03831191|2316206|FG014|Induction Period (16 Weeks)|Pregnancy|0
1174361|NCT03831191|2316192|FG000|Induction Period (16 Weeks)|Protocol Violation|0
1174362|NCT03831191|2316193|FG001|Induction Period (16 Weeks)|Protocol Violation|0
1174363|NCT03831191|2316194|FG002|Induction Period (16 Weeks)|Protocol Violation|0
1174364|NCT03831191|2316195|FG003|Induction Period (16 Weeks)|Protocol Violation|2
1174365|NCT03831191|2316196|FG004|Induction Period (16 Weeks)|Protocol Violation|0
1174366|NCT03831191|2316197|FG005|Induction Period (16 Weeks)|Protocol Violation|0
1174367|NCT03831191|2316198|FG006|Induction Period (16 Weeks)|Protocol Violation|0
1174368|NCT03831191|2316199|FG007|Induction Period (16 Weeks)|Protocol Violation|0
1174369|NCT03831191|2316200|FG008|Induction Period (16 Weeks)|Protocol Violation|0
1174370|NCT03831191|2316201|FG009|Induction Period (16 Weeks)|Protocol Violation|0
1174371|NCT03831191|2316202|FG010|Induction Period (16 Weeks)|Protocol Violation|0
1174372|NCT03831191|2316203|FG011|Induction Period (16 Weeks)|Protocol Violation|0
1174373|NCT03831191|2316204|FG012|Induction Period (16 Weeks)|Protocol Violation|0
1174374|NCT03831191|2316205|FG013|Induction Period (16 Weeks)|Protocol Violation|0
1174375|NCT03831191|2316206|FG014|Induction Period (16 Weeks)|Protocol Violation|0
1174376|NCT03831191|2316192|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7
1174377|NCT03831191|2316193|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2
871585|NCT00536471|1833030|FG000|Overall Study|Withdrawal by Subject|40
871586|NCT00536471|1833031|FG001|Overall Study|Withdrawal by Subject|24
871587|NCT00536471|1833032|FG002|Overall Study|Withdrawal by Subject|43
871588|NCT00536471|1833033|FG003|Overall Study|Withdrawal by Subject|21
871589|NCT00536471|1833030|FG000|Overall Study|Lack of Efficacy|17
871590|NCT00536471|1833031|FG001|Overall Study|Lack of Efficacy|18
871591|NCT00536471|1833032|FG002|Overall Study|Lack of Efficacy|11
871592|NCT00536471|1833033|FG003|Overall Study|Lack of Efficacy|9
871593|NCT00536471|1833030|FG000|Overall Study|Protocol Violation|8
871594|NCT00536471|1833031|FG001|Overall Study|Protocol Violation|1
871595|NCT00536471|1833032|FG002|Overall Study|Protocol Violation|2
871596|NCT00536471|1833033|FG003|Overall Study|Protocol Violation|3
871597|NCT00536471|1833030|FG000|Overall Study|Physician Decision|11
871598|NCT00536471|1833031|FG001|Overall Study|Physician Decision|1
871599|NCT00536471|1833032|FG002|Overall Study|Physician Decision|3
871600|NCT00536471|1833033|FG003|Overall Study|Physician Decision|2
871601|NCT00536471|1833030|FG000|Overall Study|Death|0
871602|NCT00536471|1833031|FG001|Overall Study|Death|0
871603|NCT00536471|1833032|FG002|Overall Study|Death|1
871604|NCT00536471|1833033|FG003|Overall Study|Death|2
871605|NCT00536471|1833030|FG000|Overall Study|Sponsor Decision|0
871606|NCT00536471|1833031|FG001|Overall Study|Sponsor Decision|1
871607|NCT00536471|1833032|FG002|Overall Study|Sponsor Decision|3
871608|NCT00536471|1833033|FG003|Overall Study|Sponsor Decision|2
871609|NCT00536484|1833052|FG000|Overall Study|Adverse Event|21
871610|NCT00536484|1833053|FG001|Overall Study|Adverse Event|34
871611|NCT00536484|1833052|FG000|Overall Study|Withdrawal by Subject|11
871612|NCT00536484|1833053|FG001|Overall Study|Withdrawal by Subject|11
871613|NCT00536484|1833052|FG000|Overall Study|Lost to Follow-up|8
871614|NCT00536484|1833053|FG001|Overall Study|Lost to Follow-up|6
871615|NCT00536484|1833052|FG000|Overall Study|Lack of Efficacy|16
871616|NCT00536484|1833053|FG001|Overall Study|Lack of Efficacy|5
871617|NCT00536484|1833052|FG000|Overall Study|Other|4
871618|NCT00536484|1833053|FG001|Overall Study|Other|0
871619|NCT00536510|1833061|FG000|Overall Study|Adverse Event|27
871620|NCT00536510|1833062|FG001|Overall Study|Adverse Event|4
871621|NCT00536510|1833061|FG000|Overall Study|Lost to Follow-up|11
871622|NCT00536510|1833062|FG001|Overall Study|Lost to Follow-up|8
871623|NCT00536510|1833061|FG000|Overall Study|Protocol Violation|4
871624|NCT00536510|1833062|FG001|Overall Study|Protocol Violation|5
871625|NCT00536510|1833061|FG000|Overall Study|Withdrawal by Subject|16
871626|NCT00536510|1833062|FG001|Overall Study|Withdrawal by Subject|9
871627|NCT00536510|1833061|FG000|Overall Study|Flushing with Product|20
871628|NCT00536510|1833062|FG001|Overall Study|Flushing with Product|0
871629|NCT00536510|1833061|FG000|Overall Study|Laboratory Adverse Event|2
871630|NCT00536510|1833062|FG001|Overall Study|Laboratory Adverse Event|1
1174378|NCT03831191|2316194|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1
1174379|NCT03831191|2316195|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3
1174380|NCT03831191|2316196|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
1174381|NCT03831191|2316197|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
1174382|NCT03831191|2316198|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
1174383|NCT03831191|2316199|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
1174384|NCT03831191|2316200|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
1174385|NCT03831191|2316201|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
1174386|NCT03831191|2316202|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
1174387|NCT03831191|2316203|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0
1174388|NCT03831191|2316204|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0
1174389|NCT03831191|2316205|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0
1174390|NCT03831191|2316206|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0
1174391|NCT03831191|2316192|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12
1174392|NCT03831191|2316193|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15
1174393|NCT03831191|2316194|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16
1174394|NCT03831191|2316195|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13
1174395|NCT03831191|2316196|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
1174396|NCT03831191|2316197|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
1174397|NCT03831191|2316198|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
1174398|NCT03831191|2316199|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
1174399|NCT03831191|2316200|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
1174400|NCT03831191|2316201|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
1174401|NCT03831191|2316202|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
1174402|NCT03831191|2316203|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
1174403|NCT03831191|2316204|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
1174404|NCT03831191|2316205|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
1174405|NCT03831191|2316206|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
1174406|NCT03831191|2316192|FG000|Induction Period (16 Weeks)|Sponsor Decision|0
1174407|NCT03831191|2316193|FG001|Induction Period (16 Weeks)|Sponsor Decision|0
1174408|NCT03831191|2316194|FG002|Induction Period (16 Weeks)|Sponsor Decision|0
1174409|NCT03831191|2316195|FG003|Induction Period (16 Weeks)|Sponsor Decision|1
1174410|NCT03831191|2316196|FG004|Induction Period (16 Weeks)|Sponsor Decision|0
1174411|NCT03831191|2316197|FG005|Induction Period (16 Weeks)|Sponsor Decision|0
1174412|NCT03831191|2316198|FG006|Induction Period (16 Weeks)|Sponsor Decision|0
1174413|NCT03831191|2316199|FG007|Induction Period (16 Weeks)|Sponsor Decision|0
1174414|NCT03831191|2316200|FG008|Induction Period (16 Weeks)|Sponsor Decision|0
1174415|NCT03831191|2316201|FG009|Induction Period (16 Weeks)|Sponsor Decision|0
1174416|NCT03831191|2316202|FG010|Induction Period (16 Weeks)|Sponsor Decision|0
1174417|NCT03831191|2316203|FG011|Induction Period (16 Weeks)|Sponsor Decision|0
1174418|NCT03831191|2316204|FG012|Induction Period (16 Weeks)|Sponsor Decision|0
1174419|NCT03831191|2316205|FG013|Induction Period (16 Weeks)|Sponsor Decision|0
1174420|NCT03831191|2316206|FG014|Induction Period (16 Weeks)|Sponsor Decision|0
1174421|NCT03831191|2316192|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
1174422|NCT03831191|2316193|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
1174423|NCT03831191|2316194|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
1174424|NCT03831191|2316195|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
1174425|NCT03831191|2316196|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
1174426|NCT03831191|2316197|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5
1174427|NCT03831191|2316198|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2
1174428|NCT03831191|2316199|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
1174429|NCT03831191|2316200|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8
1174430|NCT03831191|2316201|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
1174431|NCT03831191|2316202|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
1174432|NCT03831191|2316203|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7
1174433|NCT03831191|2316204|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
1174434|NCT03831191|2316205|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
1174435|NCT03831191|2316206|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6
1174436|NCT03831191|2316192|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174437|NCT03831191|2316193|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174438|NCT03831191|2316194|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174439|NCT03831191|2316195|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174440|NCT03831191|2316196|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174441|NCT03831191|2316197|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174442|NCT03831191|2316198|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174443|NCT03831191|2316199|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174444|NCT03831191|2316200|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174445|NCT03831191|2316201|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174446|NCT03831191|2316202|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174447|NCT03831191|2316203|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174448|NCT03831191|2316204|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174449|NCT03831191|2316205|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1174450|NCT03831191|2316206|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
1174451|NCT03831191|2316192|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174452|NCT03831191|2316193|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174453|NCT03831191|2316194|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174454|NCT03831191|2316195|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174455|NCT03831191|2316196|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174456|NCT03831191|2316197|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174457|NCT03831191|2316198|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174458|NCT03831191|2316199|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174459|NCT03831191|2316200|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174460|NCT03831191|2316201|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174461|NCT03831191|2316202|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174462|NCT03831191|2316203|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174463|NCT03831191|2316204|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174464|NCT03831191|2316205|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1174465|NCT03831191|2316206|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1
1174466|NCT03830281|2316241|FG000|Lead-in Period (2 Weeks)|Adverse Event|2
1174467|NCT03830281|2316242|FG001|Lead-in Period (2 Weeks)|Adverse Event|0
1174468|NCT03830281|2316241|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6
1174469|NCT03830281|2316242|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0
1174470|NCT03830281|2316241|FG000|Lead-in Period (2 Weeks)|Physician Decision|2
1174471|NCT03830281|2316242|FG001|Lead-in Period (2 Weeks)|Physician Decision|0
1174472|NCT03830281|2316241|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29
1174473|NCT03830281|2316242|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0
1174474|NCT03830281|2316241|FG000|Treatment Period (16 Weeks)|Adverse Event|1
1174475|NCT03830281|2316242|FG001|Treatment Period (16 Weeks)|Adverse Event|7
1174476|NCT03830281|2316241|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4
1174477|NCT03830281|2316242|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3
1174478|NCT03830281|2316241|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1
1174479|NCT03830281|2316242|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1
1174480|NCT03830281|2316241|FG000|Treatment Period (16 Weeks)|Physician Decision|1
1174481|NCT03830281|2316242|FG001|Treatment Period (16 Weeks)|Physician Decision|0
1174482|NCT03830281|2316241|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5
1174483|NCT03830281|2316242|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6
1174484|NCT03827395|2316258|FG000|Overall Study|Lost to Follow-up|1
1174485|NCT03827395|2316259|FG001|Overall Study|Lost to Follow-up|0
1174486|NCT03827395|2316258|FG000|Overall Study|Protocol Violation|1
1174487|NCT03827395|2316259|FG001|Overall Study|Protocol Violation|0
1174488|NCT03827395|2316258|FG000|Overall Study|Became ineligible after enrollment|1
1174489|NCT03827395|2316259|FG001|Overall Study|Became ineligible after enrollment|2
1174490|NCT03819218|2316265|FG000|Overall Study|Protocol Violation|1
1174491|NCT03828487|2316278|FG000|Overall Study|Physician Decision|1
1174492|NCT03828617|2316286|FG000|Overall Study|Lost to Follow-up|22
1174493|NCT03828617|2316287|FG001|Overall Study|Lost to Follow-up|12
1174494|NCT03828617|2316288|FG002|Overall Study|Lost to Follow-up|23
1174495|NCT03828617|2316289|FG003|Overall Study|Lost to Follow-up|7
1174496|NCT03828617|2316286|FG000|Overall Study|No longer met eligibility criteria|0
1174497|NCT03828617|2316287|FG001|Overall Study|No longer met eligibility criteria|1
1174498|NCT03828617|2316288|FG002|Overall Study|No longer met eligibility criteria|1
1174499|NCT03828617|2316289|FG003|Overall Study|No longer met eligibility criteria|3
1174500|NCT03828617|2316286|FG000|Overall Study|Protocol Violation|0
1174501|NCT03828617|2316287|FG001|Overall Study|Protocol Violation|2
1174502|NCT03828617|2316288|FG002|Overall Study|Protocol Violation|0
1174503|NCT03828617|2316289|FG003|Overall Study|Protocol Violation|0
1174504|NCT03828617|2316286|FG000|Overall Study|Withdrawal by Subject|2
1174505|NCT03828617|2316287|FG001|Overall Study|Withdrawal by Subject|0
1174506|NCT03828617|2316288|FG002|Overall Study|Withdrawal by Subject|2
1174507|NCT03828617|2316289|FG003|Overall Study|Withdrawal by Subject|0
1174508|NCT03828539|2316300|FG000|Overall Study|Adverse Event|3
1174509|NCT03828539|2316301|FG001|Overall Study|Adverse Event|12
1174510|NCT03828539|2316300|FG000|Overall Study|Patient's/guardian's decision|3
1174511|NCT03828539|2316301|FG001|Overall Study|Patient's/guardian's decision|5
1174512|NCT03828539|2316300|FG000|Overall Study|Lost to Follow-up|4
1174513|NCT03828539|2316301|FG001|Overall Study|Lost to Follow-up|2
1174514|NCT03828539|2316300|FG000|Overall Study|Protocol Violation|3
1174515|NCT03828539|2316301|FG001|Overall Study|Protocol Violation|2
1174516|NCT03828539|2316300|FG000|Overall Study|Withdrawal of informed consent|2
1174517|NCT03828539|2316301|FG001|Overall Study|Withdrawal of informed consent|1
1174518|NCT03828539|2316300|FG000|Overall Study|New therapy for study indication|1
1174519|NCT03828539|2316301|FG001|Overall Study|New therapy for study indication|0
1174520|NCT03824704|2316307|FG000|Overall Study|Study Terminated by Sponsor|1
1174521|NCT03817879|2316322|FG000|Overall Study|Drop out|5
1174522|NCT03817879|2316323|FG001|Overall Study|Drop out|12
1174523|NCT03817879|2316322|FG000|Overall Study|Withdrawal by Subject|0
1174524|NCT03817879|2316323|FG001|Overall Study|Withdrawal by Subject|1
1174525|NCT03806127|2316344|FG000|Overall Study|Withdrawal by Subject|4
1174526|NCT03806127|2316345|FG001|Overall Study|Withdrawal by Subject|5
1174527|NCT03806127|2316344|FG000|Overall Study|Protocol Violation|3
1174528|NCT03806127|2316345|FG001|Overall Study|Protocol Violation|1
1174529|NCT03806127|2316344|FG000|Overall Study|Adverse Event|3
1174530|NCT03806127|2316345|FG001|Overall Study|Adverse Event|0
1174531|NCT03806127|2316344|FG000|Overall Study|Unable to Complete Procedures|0
1174532|NCT03806127|2316345|FG001|Overall Study|Unable to Complete Procedures|1
1174533|NCT03806127|2316344|FG000|Overall Study|Pregnancy|0
1174534|NCT03806127|2316345|FG001|Overall Study|Pregnancy|1
1174535|NCT03806127|2316344|FG000|Overall Study|Lost to Follow-up|5
1174536|NCT03806127|2316345|FG001|Overall Study|Lost to Follow-up|1
1174537|NCT03806127|2316344|FG000|Overall Study|Physician Decision|1
1174538|NCT03806127|2316345|FG001|Overall Study|Physician Decision|1
1174539|NCT03806127|2316344|FG000|Overall Study|Could Not Come Due to Covid|1
1174540|NCT03806127|2316345|FG001|Overall Study|Could Not Come Due to Covid|0
1174541|NCT03806127|2316344|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1
1174542|NCT03806127|2316345|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0
1174543|NCT03806127|2316344|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1
1174544|NCT03806127|2316345|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0
1174545|NCT03806127|2316344|FG000|Overall Study|Covid 19 Restrictions|2
871631|NCT00536510|1833061|FG000|Overall Study|Patient Discontinued for Other Reasons|2
871632|NCT00536510|1833062|FG001|Overall Study|Patient Discontinued for Other Reasons|2
871633|NCT00536575|1833068|FG000|Overall Study|Withdrawal by Subject|1
871634|NCT00536575|1833068|FG000|Overall Study|Death|1
871635|NCT00536731|1833096|FG000|Overall Study|Adverse Event|3
871636|NCT00536731|1833097|FG001|Overall Study|Adverse Event|2
871637|NCT00536731|1833098|FG002|Overall Study|Adverse Event|3
871638|NCT00536731|1833096|FG000|Overall Study|Withdrawal by Subject|0
871639|NCT00536731|1833097|FG001|Overall Study|Withdrawal by Subject|2
871640|NCT00536731|1833098|FG002|Overall Study|Withdrawal by Subject|0
871641|NCT00536731|1833096|FG000|Overall Study|Intake of prohibited conc. medication|0
871642|NCT00536731|1833097|FG001|Overall Study|Intake of prohibited conc. medication|0
871643|NCT00536731|1833098|FG002|Overall Study|Intake of prohibited conc. medication|1
871644|NCT00536731|1833096|FG000|Overall Study|Safety reasons|0
871645|NCT00536731|1833097|FG001|Overall Study|Safety reasons|0
871646|NCT00536731|1833098|FG002|Overall Study|Safety reasons|1
871647|NCT00536731|1833096|FG000|Overall Study|Other|1
871648|NCT00536731|1833097|FG001|Overall Study|Other|1
871649|NCT00536731|1833098|FG002|Overall Study|Other|0
871650|NCT00536744|1833108|FG000|Overall Study|Adverse Event|13
871651|NCT00536744|1833109|FG001|Overall Study|Adverse Event|10
871652|NCT00536744|1833108|FG000|Overall Study|Death|2
871653|NCT00536744|1833109|FG001|Overall Study|Death|1
871654|NCT00536744|1833108|FG000|Overall Study|Physician Decision|3
871655|NCT00536744|1833109|FG001|Overall Study|Physician Decision|1
871656|NCT00536744|1833108|FG000|Overall Study|Lost to Follow-up|3
871657|NCT00536744|1833109|FG001|Overall Study|Lost to Follow-up|5
871658|NCT00536744|1833108|FG000|Overall Study|Withdrawal by Subject|7
871659|NCT00536744|1833109|FG001|Overall Study|Withdrawal by Subject|8
871660|NCT00536744|1833108|FG000|Overall Study|PI tried alternative treatment|1
871661|NCT00536744|1833109|FG001|Overall Study|PI tried alternative treatment|3
871662|NCT00536809|1833115|FG000|Phase II|Adverse Event|1
871663|NCT00536809|1833115|FG000|Phase II|Referred for surgical resection|1
871664|NCT00536874|1833119|FG000|Overall Study|Adverse Event|1
871665|NCT00536874|1833119|FG000|Overall Study|Death|2
871666|NCT00536874|1833119|FG000|Overall Study|Withdrawal by Subject|1
871667|NCT00536939|1833132|FG000|Overall Study|Withdrawal by Subject|1
871668|NCT00536939|1833133|FG001|Overall Study|Withdrawal by Subject|0
871669|NCT00536939|1833132|FG000|Overall Study|Other Complicating Disease|1
871670|NCT00536939|1833133|FG001|Overall Study|Other Complicating Disease|0
871671|NCT00536991|1833138|FG000|Overall Study|Withdrawal by Subject|10
871672|NCT00536991|1833138|FG000|Overall Study|Physician Decision|1
871673|NCT00536991|1833138|FG000|Overall Study|patient ineligible|2
871674|NCT00537017|1833143|FG000|Treatment Phase|Adverse Event|19
871675|NCT00537017|1833143|FG000|Treatment Phase|Withdrawal by Subject|13
871676|NCT00537017|1833143|FG000|Treatment Phase|Protocol Violation|2
871677|NCT00537017|1833143|FG000|Follow-up Phase|Withdrawal by Subject|9
871678|NCT00537030|1833147|FG000|Overall Study|Physician Decision|2
871679|NCT00537030|1833147|FG000|Overall Study|Withdrawal by Subject|2
871680|NCT00537030|1833147|FG000|Overall Study|≥ Grade 2 allergy|7
871681|NCT00537030|1833147|FG000|Overall Study|Disease progression/ relapse during Tx|1
871682|NCT00537030|1833147|FG000|Overall Study|Ineligible|2
871683|NCT00537030|1833147|FG000|Overall Study|Inevaluable|2
871684|NCT00537056|1833151|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5
871685|NCT00537082|1833160|FG000|Overall Study|Adverse Event|6
871686|NCT00537082|1833161|FG001|Overall Study|Adverse Event|6
871687|NCT00537082|1833162|FG002|Overall Study|Adverse Event|3
871688|NCT00537082|1833160|FG000|Overall Study|Protocol Violation|0
871689|NCT00537082|1833161|FG001|Overall Study|Protocol Violation|2
871690|NCT00537082|1833162|FG002|Overall Study|Protocol Violation|1
871691|NCT00537082|1833160|FG000|Overall Study|Lack of Efficacy|0
871692|NCT00537082|1833161|FG001|Overall Study|Lack of Efficacy|0
871693|NCT00537082|1833162|FG002|Overall Study|Lack of Efficacy|2
871694|NCT00537082|1833160|FG000|Overall Study|Withdrawal by Subject|0
871695|NCT00537082|1833161|FG001|Overall Study|Withdrawal by Subject|1
1174546|NCT03806127|2316345|FG001|Overall Study|Covid 19 Restrictions|0
1174547|NCT03806127|2316344|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0
1174548|NCT03806127|2316345|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1
1174549|NCT03806127|2316344|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0
1174550|NCT03806127|2316345|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1
1174551|NCT03827473|2316353|FG000|Overall Study|Withdrawal by Subject|1
1174552|NCT03827473|2316354|FG001|Overall Study|Withdrawal by Subject|0
1174553|NCT03826914|2316362|FG000|Overall Study|Withdrawal by Subject|1
1174554|NCT03826914|2316363|FG001|Overall Study|Withdrawal by Subject|1
1174555|NCT03808688|2316386|FG000|Overall Study|Adverse Event|13
1174556|NCT03808688|2316387|FG001|Overall Study|Adverse Event|17
1174557|NCT03808688|2316386|FG000|Overall Study|Lack of Efficacy|2
1174558|NCT03808688|2316387|FG001|Overall Study|Lack of Efficacy|0
1174559|NCT03808688|2316386|FG000|Overall Study|Lost to Follow-up|0
1174560|NCT03808688|2316387|FG001|Overall Study|Lost to Follow-up|2
1174561|NCT03808688|2316386|FG000|Overall Study|Withdrawal by Subject|1
1174562|NCT03808688|2316387|FG001|Overall Study|Withdrawal by Subject|0
1174563|NCT03808688|2316386|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1
1174564|NCT03808688|2316387|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0
1174565|NCT03808688|2316386|FG000|Overall Study|IOP Too High|1
1174566|NCT03808688|2316387|FG001|Overall Study|IOP Too High|1
1174567|NCT03808688|2316386|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0
1174568|NCT03808688|2316387|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1
1174569|NCT03808688|2316386|FG000|Overall Study|Visit Out of Window|0
1174570|NCT03808688|2316387|FG001|Overall Study|Visit Out of Window|1
1174571|NCT03808688|2316386|FG000|Overall Study|Medication Non-Compliance|0
1174572|NCT03808688|2316387|FG001|Overall Study|Medication Non-Compliance|1
1174573|NCT03811093|2316397|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
1174574|NCT03811093|2316398|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
1174575|NCT03811093|2316397|FG000|Overall Study|Unable to measure body fat percentage|2
1174576|NCT03811093|2316398|FG001|Overall Study|Unable to measure body fat percentage|0
1174577|NCT03822182|2316410|FG000|Overall Study|Protocol Violation|0
1174578|NCT03822182|2316411|FG001|Overall Study|Protocol Violation|1
1174579|NCT03822182|2316412|FG002|Overall Study|Protocol Violation|1
1174580|NCT03822416|2316423|FG000|Overall Study|Lost to Follow-up|1
1174581|NCT03822416|2316424|FG001|Overall Study|Lost to Follow-up|0
1174582|NCT03822416|2316423|FG000|Overall Study|Withdrawal by Subject|0
1174583|NCT03822416|2316424|FG001|Overall Study|Withdrawal by Subject|1
1174584|NCT03809104|2316430|FG000|Overall Study|Withdrawal by Subject|3
1174585|NCT03806231|2316445|FG000|Overall Study|Physician Decision|1
1174586|NCT03806231|2316446|FG001|Overall Study|Physician Decision|0
1174587|NCT03806231|2316445|FG000|Overall Study|Withdrawal by Subject|1
1174588|NCT03806231|2316446|FG001|Overall Study|Withdrawal by Subject|0
1174589|NCT03804710|2316454|FG000|Overall Study|Adverse Event|0
1174590|NCT03804710|2316455|FG001|Overall Study|Adverse Event|3
1174591|NCT03804710|2316454|FG000|Overall Study|Withdrawal by Subject|2
1174592|NCT03804710|2316455|FG001|Overall Study|Withdrawal by Subject|1
1174593|NCT03804710|2316454|FG000|Overall Study|Other|0
1174594|NCT03804710|2316455|FG001|Overall Study|Other|1
1174595|NCT03821064|2316499|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1
1174596|NCT03820024|2316514|FG000|Overall Study|Physician Decision|1
1174597|NCT03820024|2316515|FG001|Overall Study|Physician Decision|2
1174598|NCT03816761|2316540|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0
1174599|NCT03816761|2316541|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0
1174600|NCT03816761|2316542|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0
1174601|NCT03816761|2316543|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0
1174602|NCT03816761|2316544|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0
1174603|NCT03816761|2316545|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1
1174604|NCT03816761|2316540|FG000|Second Treatment Period (7 Days)|Unclassified|0
1174605|NCT03816761|2316541|FG001|Second Treatment Period (7 Days)|Unclassified|0
1174606|NCT03816761|2316542|FG002|Second Treatment Period (7 Days)|Unclassified|0
1174607|NCT03816761|2316543|FG003|Second Treatment Period (7 Days)|Unclassified|1
1174608|NCT03816761|2316544|FG004|Second Treatment Period (7 Days)|Unclassified|0
1174609|NCT03816761|2316545|FG005|Second Treatment Period (7 Days)|Unclassified|0
1174610|NCT03812510|2316610|FG000|Overall Study|Lost to Follow-up|39
1174611|NCT03812510|2316610|FG000|Overall Study|Withdrawal by Subject|42
1174612|NCT03812510|2316610|FG000|Overall Study|Physician Decision|2
1174613|NCT03812510|2316610|FG000|Overall Study|Study Terminated by Sponsor|9
1174614|NCT03812510|2316610|FG000|Overall Study|Did Not Start Study Medication|55
1174615|NCT03812510|2316610|FG000|Overall Study|Adverse Event|5
1174616|NCT03802994|2316620|FG000|Overall Study|Lost to Follow-up|0
1174617|NCT03802994|2316621|FG001|Overall Study|Lost to Follow-up|2
1174618|NCT03802994|2316622|FG002|Overall Study|Lost to Follow-up|3
1174619|NCT03802994|2316623|FG003|Overall Study|Lost to Follow-up|2
1174620|NCT03802994|2316624|FG004|Overall Study|Lost to Follow-up|2
1174621|NCT03810183|2316649|FG000|Overall Study|Study terminated by Sponsor|2
1174622|NCT03810183|2316650|FG001|Overall Study|Study terminated by Sponsor|1
1174623|NCT03809611|2316679|FG000|Overall Study|Withdrawal by Subject|1
1174624|NCT03809611|2316680|FG001|Overall Study|Withdrawal by Subject|1
1174625|NCT03805971|2316700|FG000|Overall Study|Withdrawal by Subject|1
1174626|NCT03805971|2316700|FG000|Overall Study|Protocol Violation|2
1174627|NCT03802916|2316707|FG000|Overall Study|Adverse Event|0
1174628|NCT03802916|2316708|FG001|Overall Study|Adverse Event|1
1174629|NCT03802916|2316707|FG000|Overall Study|Withdrawal by Subject|0
1174630|NCT03802916|2316708|FG001|Overall Study|Withdrawal by Subject|1
1174631|NCT03809039|2316725|FG000|Part 1|Withdrawal by Subject|1
1174632|NCT03809039|2316726|FG001|Part 1|Withdrawal by Subject|0
1174633|NCT03809039|2316727|FG002|Part 1|Withdrawal by Subject|0
1174634|NCT03809039|2316728|FG003|Part 1|Withdrawal by Subject|1
1174635|NCT03809039|2316729|FG004|Part 1|Withdrawal by Subject|0
1174636|NCT03809039|2316730|FG005|Part 1|Withdrawal by Subject|0
1174637|NCT03809039|2316731|FG006|Part 1|Withdrawal by Subject|0
1174638|NCT03809039|2316732|FG007|Part 1|Withdrawal by Subject|0
1174639|NCT03809039|2316733|FG008|Part 1|Withdrawal by Subject|0
1174640|NCT03809039|2316725|FG000|Part 3|Withdrawn by study termination|0
1174641|NCT03809039|2316726|FG001|Part 3|Withdrawn by study termination|0
1174642|NCT03809039|2316727|FG002|Part 3|Withdrawn by study termination|0
1174643|NCT03809039|2316728|FG003|Part 3|Withdrawn by study termination|0
1174644|NCT03809039|2316729|FG004|Part 3|Withdrawn by study termination|0
1174645|NCT03809039|2316730|FG005|Part 3|Withdrawn by study termination|0
1174646|NCT03809039|2316731|FG006|Part 3|Withdrawn by study termination|0
1174647|NCT03809039|2316732|FG007|Part 3|Withdrawn by study termination|2
1174648|NCT03809039|2316733|FG008|Part 3|Withdrawn by study termination|6
1174649|NCT03807700|2316768|FG000|Overall Study|Withdrawal by Subject|2
1174650|NCT03807700|2316769|FG001|Overall Study|Withdrawal by Subject|1
1174651|NCT03804918|2316776|FG000|Overall Study|Participant did not use the app|1
1174652|NCT03803475|2316792|FG000|Overall Study|Physician Decision|1
1174653|NCT03801928|2316845|FG000|Overall Study|Adverse Event|1
1174654|NCT03801928|2316846|FG001|Overall Study|Adverse Event|0
1174655|NCT03801928|2316847|FG002|Overall Study|Adverse Event|1
1174656|NCT03801928|2316848|FG003|Overall Study|Adverse Event|2
1174657|NCT03801928|2316849|FG004|Overall Study|Adverse Event|0
1174658|NCT03801928|2316850|FG005|Overall Study|Adverse Event|2
871696|NCT00537082|1833162|FG002|Overall Study|Withdrawal by Subject|0
871697|NCT00537082|1833160|FG000|Overall Study|Discontinued before initiating treatment|3
871698|NCT00537082|1833161|FG001|Overall Study|Discontinued before initiating treatment|0
871699|NCT00537082|1833162|FG002|Overall Study|Discontinued before initiating treatment|0
871700|NCT00537095|1833172|FG000|Overall Study|surgery|1
871701|NCT00537095|1833173|FG001|Overall Study|surgery|0
871702|NCT00537095|1833172|FG000|Overall Study|Adverse Event|24
871703|NCT00537095|1833173|FG001|Overall Study|Adverse Event|4
871704|NCT00537095|1833172|FG000|Overall Study|disease progression|21
871705|NCT00537095|1833173|FG001|Overall Study|disease progression|48
871706|NCT00537095|1833172|FG000|Overall Study|Death|3
871707|NCT00537095|1833173|FG001|Overall Study|Death|1
871708|NCT00537095|1833172|FG000|Overall Study|Withdrawal by Subject|2
871709|NCT00537095|1833173|FG001|Overall Study|Withdrawal by Subject|2
871710|NCT00537095|1833172|FG000|Overall Study|subjective disease progression|0
871711|NCT00537095|1833173|FG001|Overall Study|subjective disease progression|1
871712|NCT00537095|1833172|FG000|Overall Study|Incorrect enrolment|0
871713|NCT00537095|1833173|FG001|Overall Study|Incorrect enrolment|1
871714|NCT00537238|1833181|FG000|Overall Study|Death|1
871715|NCT00537238|1833182|FG001|Overall Study|Death|2
871716|NCT00537238|1833181|FG000|Overall Study|Adverse Event|31
871717|NCT00537238|1833182|FG001|Overall Study|Adverse Event|22
871718|NCT00537238|1833181|FG000|Overall Study|Lack of Efficacy|20
871719|NCT00537238|1833182|FG001|Overall Study|Lack of Efficacy|21
871720|NCT00537238|1833181|FG000|Overall Study|Lost to Follow-up|12
871721|NCT00537238|1833182|FG001|Overall Study|Lost to Follow-up|8
871722|NCT00537238|1833181|FG000|Overall Study|Withdrawal by Subject|51
871723|NCT00537238|1833182|FG001|Overall Study|Withdrawal by Subject|47
871724|NCT00537238|1833181|FG000|Overall Study|Protocol Violation|15
871725|NCT00537238|1833182|FG001|Overall Study|Protocol Violation|19
871726|NCT00537238|1833181|FG000|Overall Study|Does not meet entrance criteria|0
871727|NCT00537238|1833182|FG001|Overall Study|Does not meet entrance criteria|2
871728|NCT00537238|1833181|FG000|Overall Study|Other|44
871729|NCT00537238|1833182|FG001|Overall Study|Other|52
871730|NCT00537277|1833188|FG000|Overall Study|Adverse Event|1
871731|NCT00537277|1833188|FG000|Overall Study|Lack of Efficacy|2
871732|NCT00537277|1833188|FG000|Overall Study|Lost to Follow-up|12
871733|NCT00537277|1833188|FG000|Overall Study|Protocol Violation|11
871734|NCT00537277|1833188|FG000|Overall Study|Unclassified|4
871735|NCT00537277|1833188|FG000|Overall Study|Inability to tolerate trial medication|4
871736|NCT00537277|1833188|FG000|Overall Study|Non-compliance with trial procedures|15
871737|NCT00537303|1833198|FG000|Overall Study|Adverse Event|1
871738|NCT00537303|1833199|FG001|Overall Study|Adverse Event|4
871739|NCT00537303|1833198|FG000|Overall Study|Lack of Efficacy|6
871740|NCT00537303|1833199|FG001|Overall Study|Lack of Efficacy|7
871741|NCT00537303|1833198|FG000|Overall Study|Protocol Violation|8
871742|NCT00537303|1833199|FG001|Overall Study|Protocol Violation|4
871743|NCT00537303|1833198|FG000|Overall Study|Withdrawal criteria|3
871744|NCT00537303|1833199|FG001|Overall Study|Withdrawal criteria|3
871745|NCT00537303|1833198|FG000|Overall Study|Unclassified|8
871746|NCT00537303|1833199|FG001|Overall Study|Unclassified|7
1174659|NCT03801928|2316845|FG000|Overall Study|Lack of Efficacy|0
1174660|NCT03801928|2316846|FG001|Overall Study|Lack of Efficacy|0
1174661|NCT03801928|2316847|FG002|Overall Study|Lack of Efficacy|1
1174662|NCT03801928|2316848|FG003|Overall Study|Lack of Efficacy|0
1174663|NCT03801928|2316849|FG004|Overall Study|Lack of Efficacy|0
1174664|NCT03801928|2316850|FG005|Overall Study|Lack of Efficacy|0
1174665|NCT03801928|2316845|FG000|Overall Study|Lost to Follow-up|5
1174666|NCT03801928|2316846|FG001|Overall Study|Lost to Follow-up|1
1174667|NCT03801928|2316847|FG002|Overall Study|Lost to Follow-up|1
1174668|NCT03801928|2316848|FG003|Overall Study|Lost to Follow-up|4
1174669|NCT03801928|2316849|FG004|Overall Study|Lost to Follow-up|4
1174670|NCT03801928|2316850|FG005|Overall Study|Lost to Follow-up|2
1174671|NCT03801928|2316845|FG000|Overall Study|Withdrawal by Subject|0
1174672|NCT03801928|2316846|FG001|Overall Study|Withdrawal by Subject|0
1174673|NCT03801928|2316847|FG002|Overall Study|Withdrawal by Subject|2
1174674|NCT03801928|2316848|FG003|Overall Study|Withdrawal by Subject|1
1174675|NCT03801928|2316849|FG004|Overall Study|Withdrawal by Subject|0
1174676|NCT03801928|2316850|FG005|Overall Study|Withdrawal by Subject|0
1174677|NCT03801928|2316845|FG000|Overall Study|Other|0
1174678|NCT03801928|2316846|FG001|Overall Study|Other|2
1174679|NCT03801928|2316847|FG002|Overall Study|Other|0
1174680|NCT03801928|2316848|FG003|Overall Study|Other|1
1174681|NCT03801928|2316849|FG004|Overall Study|Other|0
1174682|NCT03801928|2316850|FG005|Overall Study|Other|1
871747|NCT00537316|1833211|FG000|Part 1|Adverse Event|7
871748|NCT00537316|1833212|FG001|Part 1|Adverse Event|11
871749|NCT00537316|1833213|FG002|Part 1|Adverse Event|8
871750|NCT00537316|1833214|FG003|Part 1|Adverse Event|0
871751|NCT00537316|1833215|FG004|Part 1|Adverse Event|0
871752|NCT00537316|1833216|FG005|Part 1|Adverse Event|0
871753|NCT00537316|1833217|FG006|Part 1|Adverse Event|0
871754|NCT00537316|1833211|FG000|Part 1|Protocol defined clinical event|1
871755|NCT00537316|1833212|FG001|Part 1|Protocol defined clinical event|0
871756|NCT00537316|1833213|FG002|Part 1|Protocol defined clinical event|0
871757|NCT00537316|1833214|FG003|Part 1|Protocol defined clinical event|0
871758|NCT00537316|1833215|FG004|Part 1|Protocol defined clinical event|0
871759|NCT00537316|1833216|FG005|Part 1|Protocol defined clinical event|0
871760|NCT00537316|1833217|FG006|Part 1|Protocol defined clinical event|0
871761|NCT00537316|1833211|FG000|Part 1|Lost to Follow-up|1
871762|NCT00537316|1833212|FG001|Part 1|Lost to Follow-up|0
871763|NCT00537316|1833213|FG002|Part 1|Lost to Follow-up|0
871764|NCT00537316|1833214|FG003|Part 1|Lost to Follow-up|0
871765|NCT00537316|1833215|FG004|Part 1|Lost to Follow-up|0
871766|NCT00537316|1833216|FG005|Part 1|Lost to Follow-up|0
871767|NCT00537316|1833217|FG006|Part 1|Lost to Follow-up|0
871768|NCT00537316|1833211|FG000|Part 1|Withdrawal by Subject|3
871769|NCT00537316|1833212|FG001|Part 1|Withdrawal by Subject|8
871770|NCT00537316|1833213|FG002|Part 1|Withdrawal by Subject|4
871771|NCT00537316|1833214|FG003|Part 1|Withdrawal by Subject|0
871772|NCT00537316|1833215|FG004|Part 1|Withdrawal by Subject|0
871773|NCT00537316|1833216|FG005|Part 1|Withdrawal by Subject|0
871774|NCT00537316|1833217|FG006|Part 1|Withdrawal by Subject|0
871775|NCT00537316|1833211|FG000|Part 1|Protocol Violation|1
871776|NCT00537316|1833212|FG001|Part 1|Protocol Violation|5
871777|NCT00537316|1833213|FG002|Part 1|Protocol Violation|1
871778|NCT00537316|1833214|FG003|Part 1|Protocol Violation|0
871779|NCT00537316|1833215|FG004|Part 1|Protocol Violation|0
871780|NCT00537316|1833216|FG005|Part 1|Protocol Violation|0
1174683|NCT03800173|2316872|FG000|Overall Study|Lost to Follow-up|0
1174684|NCT03800173|2316873|FG001|Overall Study|Lost to Follow-up|0
1174685|NCT03800173|2316874|FG002|Overall Study|Lost to Follow-up|0
1174686|NCT03800173|2316875|FG003|Overall Study|Lost to Follow-up|0
1174687|NCT03800173|2316876|FG004|Overall Study|Lost to Follow-up|1
1174688|NCT03799211|2316911|FG000|Overall Study|Lost to Follow-up|2
1174689|NCT03799211|2316912|FG001|Overall Study|Lost to Follow-up|13
1174690|NCT03799211|2316911|FG000|Overall Study|Withdrawal by Subject|2
1174691|NCT03799211|2316912|FG001|Overall Study|Withdrawal by Subject|0
1174692|NCT03798717|2316926|FG000|Overall Study|Failed Screening|0
1174693|NCT03798717|2316927|FG001|Overall Study|Failed Screening|0
1174694|NCT03798717|2316928|FG002|Overall Study|Failed Screening|0
1174695|NCT03798717|2316929|FG003|Overall Study|Failed Screening|0
1174696|NCT03798717|2316930|FG004|Overall Study|Failed Screening|0
1174697|NCT03798717|2316931|FG005|Overall Study|Failed Screening|1
1174698|NCT03798717|2316926|FG000|Overall Study|Physician Decision|1
1174699|NCT03798717|2316927|FG001|Overall Study|Physician Decision|0
1174700|NCT03798717|2316928|FG002|Overall Study|Physician Decision|1
1174701|NCT03798717|2316929|FG003|Overall Study|Physician Decision|0
1174702|NCT03798717|2316930|FG004|Overall Study|Physician Decision|0
1174703|NCT03798717|2316931|FG005|Overall Study|Physician Decision|0
1174704|NCT03798717|2316926|FG000|Overall Study|Withdrawal by Subject|0
1174705|NCT03798717|2316927|FG001|Overall Study|Withdrawal by Subject|0
1174706|NCT03798717|2316928|FG002|Overall Study|Withdrawal by Subject|0
1174707|NCT03798717|2316929|FG003|Overall Study|Withdrawal by Subject|1
1174708|NCT03798717|2316930|FG004|Overall Study|Withdrawal by Subject|0
1174709|NCT03798717|2316931|FG005|Overall Study|Withdrawal by Subject|0
1174710|NCT03798717|2316926|FG000|Overall Study|Lost to Follow-up|1
1174711|NCT03798717|2316927|FG001|Overall Study|Lost to Follow-up|0
1174712|NCT03798717|2316928|FG002|Overall Study|Lost to Follow-up|0
1174713|NCT03798717|2316929|FG003|Overall Study|Lost to Follow-up|1
1174714|NCT03798717|2316930|FG004|Overall Study|Lost to Follow-up|0
1174715|NCT03798717|2316931|FG005|Overall Study|Lost to Follow-up|0
1174716|NCT03798717|2316926|FG000|Overall Study|Adverse Event|0
1174717|NCT03798717|2316927|FG001|Overall Study|Adverse Event|1
1174718|NCT03798717|2316928|FG002|Overall Study|Adverse Event|0
1174719|NCT03798717|2316929|FG003|Overall Study|Adverse Event|0
1174720|NCT03798717|2316930|FG004|Overall Study|Adverse Event|0
1174721|NCT03798717|2316931|FG005|Overall Study|Adverse Event|0
1174722|NCT03798717|2316926|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
1174723|NCT03798717|2316927|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
1174724|NCT03798717|2316928|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
1174725|NCT03798717|2316929|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
1174726|NCT03798717|2316930|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1
1174727|NCT03798717|2316931|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
1174728|NCT03798483|2316940|FG000|Overall Study|Lost to Follow-up|2
1174729|NCT03798366|2316950|FG000|Overall Study|Lost to Follow-up|0
1174730|NCT03798366|2316951|FG001|Overall Study|Lost to Follow-up|1
1174731|NCT03799952|2316959|FG000|Overall Study|Program was too easy, discontinued|1
1174732|NCT03799952|2316960|FG001|Overall Study|Program was too easy, discontinued|0
1174733|NCT03799952|2316959|FG000|Overall Study|Lost to Follow-up|0
1174734|NCT03799952|2316960|FG001|Overall Study|Lost to Follow-up|2
1174735|NCT03796728|2316994|FG000|Overall Study|Lost to Follow-up|8
1174736|NCT03796728|2316994|FG000|Overall Study|Reason not Specified|16
1174737|NCT03797144|2317000|FG000|Enrollment|Protocol Violation|4
1174738|NCT03797144|2317001|FG001|Enrollment|Protocol Violation|1
1174739|NCT03797144|2317000|FG000|Surgery|Protocol Violation|1
1174740|NCT03797144|2317001|FG001|Surgery|Protocol Violation|0
1174741|NCT03797144|2317000|FG000|3 Month|Early termination cut-off date|2
1174742|NCT03797144|2317001|FG001|3 Month|Early termination cut-off date|0
1174743|NCT03797144|2317000|FG000|12 Month|Early termination cut-off date|8
1174744|NCT03797144|2317001|FG001|12 Month|Early termination cut-off date|9
1174745|NCT03797144|2317000|FG000|24 Month|Early termination cut-off date|1
1174746|NCT03797144|2317001|FG001|24 Month|Early termination cut-off date|1
1174747|NCT03782571|2317008|FG000|Period 1|Withdrawal by Subject|1
1174748|NCT03782571|2317009|FG001|Period 1|Withdrawal by Subject|0
1174749|NCT03782571|2317010|FG002|Period 1|Withdrawal by Subject|0
1174750|NCT03782571|2317011|FG003|Period 1|Withdrawal by Subject|0
1174751|NCT03782571|2317008|FG000|Period 3|Subject Unable to Attend V5|1
1174752|NCT03782571|2317009|FG001|Period 3|Subject Unable to Attend V5|0
1174753|NCT03782571|2317010|FG002|Period 3|Subject Unable to Attend V5|0
1174754|NCT03782571|2317011|FG003|Period 3|Subject Unable to Attend V5|0
1174755|NCT03782571|2317008|FG000|Period 3|Adverse Event|1
1174756|NCT03782571|2317009|FG001|Period 3|Adverse Event|0
1174757|NCT03782571|2317010|FG002|Period 3|Adverse Event|0
1174758|NCT03782571|2317011|FG003|Period 3|Adverse Event|0
1174759|NCT03796039|2317034|FG000|Overall Study|Death|2
1174760|NCT03796039|2317035|FG001|Overall Study|Death|1
1174761|NCT03796039|2317034|FG000|Overall Study|Withdrawal by Subject|7
1174762|NCT03796039|2317035|FG001|Overall Study|Withdrawal by Subject|4
1174763|NCT03783780|2317041|FG000|Overall Study|Withdrawn prior to completion|1
1174764|NCT03780959|2317049|FG000|Part 1|Adverse Event|1
1174765|NCT03780959|2317050|FG001|Part 1|Adverse Event|0
1174766|NCT03780959|2317051|FG002|Part 1|Adverse Event|0
1174767|NCT03780959|2317049|FG000|Part 1|Withdrawal by Subject|1
1174768|NCT03780959|2317050|FG001|Part 1|Withdrawal by Subject|0
1174769|NCT03780959|2317051|FG002|Part 1|Withdrawal by Subject|0
1174770|NCT03780959|2317049|FG000|Part 1|Withdrawal by Parent/Guardian|1
1174771|NCT03780959|2317050|FG001|Part 1|Withdrawal by Parent/Guardian|0
1174772|NCT03780959|2317051|FG002|Part 1|Withdrawal by Parent/Guardian|0
1174773|NCT03780959|2317049|FG000|Part 1|Response Status|2
1174774|NCT03780959|2317050|FG001|Part 1|Response Status|0
1174775|NCT03780959|2317051|FG002|Part 1|Response Status|0
1174776|NCT03780959|2317049|FG000|Part 2|Withdrawal by Parent/Guardian|0
1174777|NCT03780959|2317050|FG001|Part 2|Withdrawal by Parent/Guardian|1
1174778|NCT03780959|2317051|FG002|Part 2|Withdrawal by Parent/Guardian|0
1174779|NCT03780959|2317049|FG000|Part 2|Response Status|0
1174780|NCT03780959|2317050|FG001|Part 2|Response Status|18
1174781|NCT03780959|2317051|FG002|Part 2|Response Status|6
1174782|NCT03796676|2317080|FG000|Overall Study|Adverse Event|2
1174783|NCT03796676|2317081|FG001|Overall Study|Adverse Event|1
1174784|NCT03796676|2317082|FG002|Overall Study|Adverse Event|2
1174785|NCT03796676|2317080|FG000|Overall Study|Lost to Follow-up|2
1174786|NCT03796676|2317081|FG001|Overall Study|Lost to Follow-up|1
1174787|NCT03796676|2317082|FG002|Overall Study|Lost to Follow-up|0
1174788|NCT03796676|2317080|FG000|Overall Study|Protocol Violation|0
1174789|NCT03796676|2317081|FG001|Overall Study|Protocol Violation|0
1174790|NCT03796676|2317082|FG002|Overall Study|Protocol Violation|1
1174791|NCT03796676|2317080|FG000|Overall Study|Withdrawal by Subject|1
1174792|NCT03796676|2317081|FG001|Overall Study|Withdrawal by Subject|1
1174793|NCT03796676|2317082|FG002|Overall Study|Withdrawal by Subject|0
1174794|NCT03796676|2317080|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1
1174795|NCT03796676|2317081|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
1174796|NCT03796676|2317082|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
1174797|NCT03792477|2317107|FG000|Overall Study|Adverse Event|0
1174798|NCT03792477|2317108|FG001|Overall Study|Adverse Event|0
1174799|NCT03792477|2317109|FG002|Overall Study|Adverse Event|0
1174800|NCT03792477|2317110|FG003|Overall Study|Adverse Event|1
1174801|NCT03792477|2317111|FG004|Overall Study|Adverse Event|0
1174802|NCT03792477|2317107|FG000|Overall Study|Lost to Follow-up|0
1174803|NCT03792477|2317108|FG001|Overall Study|Lost to Follow-up|0
1174804|NCT03792477|2317109|FG002|Overall Study|Lost to Follow-up|2
1174805|NCT03792477|2317110|FG003|Overall Study|Lost to Follow-up|0
1174806|NCT03792477|2317111|FG004|Overall Study|Lost to Follow-up|0
1174807|NCT03792477|2317107|FG000|Overall Study|Other|0
1174808|NCT03792477|2317108|FG001|Overall Study|Other|0
1174809|NCT03792477|2317109|FG002|Overall Study|Other|0
1174810|NCT03792477|2317110|FG003|Overall Study|Other|0
1174811|NCT03792477|2317111|FG004|Overall Study|Other|1
1174812|NCT03783962|2317119|FG000|Overall Study|Lost to Follow-up|3
1174813|NCT03783962|2317120|FG001|Overall Study|Lost to Follow-up|6
1174814|NCT03783962|2317119|FG000|Overall Study|Protocol Violation|0
1174815|NCT03783962|2317120|FG001|Overall Study|Protocol Violation|1
1174816|NCT03793556|2317184|FG000|Overall Study|Withdrawal by Subject|12
1174817|NCT03793556|2317185|FG001|Overall Study|Withdrawal by Subject|1
1174818|NCT03793556|2317184|FG000|Overall Study|Lost to Follow-up|1
1174819|NCT03793556|2317185|FG001|Overall Study|Lost to Follow-up|1
1174820|NCT03785548|2317196|FG000|Overall Study|age > 80|1
1174821|NCT03785548|2317197|FG001|Overall Study|age > 80|0
1174822|NCT03785548|2317196|FG000|Overall Study|no Postop queries|1
1174823|NCT03785548|2317197|FG001|Overall Study|no Postop queries|0
1174836|NCT03773133|2317218|FG000|Overall Study|Screen Failure|8
1174837|NCT03792672|2317236|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1
1174838|NCT03792672|2317237|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0
1174839|NCT03792672|2317238|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0
1174840|NCT03792672|2317239|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2
1174841|NCT03792672|2317240|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0
1174842|NCT03792672|2317241|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0
1174843|NCT03792672|2317236|FG000|Washout Period 3 (10 Days)|Physician Decision|0
1174844|NCT03792672|2317237|FG001|Washout Period 3 (10 Days)|Physician Decision|0
1174845|NCT03792672|2317238|FG002|Washout Period 3 (10 Days)|Physician Decision|1
1174846|NCT03792672|2317239|FG003|Washout Period 3 (10 Days)|Physician Decision|0
871781|NCT00537316|1833217|FG006|Part 1|Protocol Violation|0
871782|NCT00537316|1833211|FG000|Part 1|Did not meet protocol eligibility|1
871783|NCT00537316|1833212|FG001|Part 1|Did not meet protocol eligibility|3
871784|NCT00537316|1833213|FG002|Part 1|Did not meet protocol eligibility|2
871785|NCT00537316|1833214|FG003|Part 1|Did not meet protocol eligibility|0
871786|NCT00537316|1833215|FG004|Part 1|Did not meet protocol eligibility|0
871787|NCT00537316|1833216|FG005|Part 1|Did not meet protocol eligibility|0
871788|NCT00537316|1833217|FG006|Part 1|Did not meet protocol eligibility|0
871789|NCT00537316|1833211|FG000|Part 1|Administrative|0
871790|NCT00537316|1833212|FG001|Part 1|Administrative|0
871791|NCT00537316|1833213|FG002|Part 1|Administrative|2
871792|NCT00537316|1833214|FG003|Part 1|Administrative|0
871793|NCT00537316|1833215|FG004|Part 1|Administrative|0
871794|NCT00537316|1833216|FG005|Part 1|Administrative|0
871795|NCT00537316|1833217|FG006|Part 1|Administrative|0
1174847|NCT03792672|2317240|FG004|Washout Period 3 (10 Days)|Physician Decision|0
1174848|NCT03792672|2317241|FG005|Washout Period 3 (10 Days)|Physician Decision|0
1174849|NCT03792672|2317236|FG000|Treatment Period 4 (2 Days)|Other|1
1174850|NCT03792672|2317237|FG001|Treatment Period 4 (2 Days)|Other|0
1174851|NCT03792672|2317238|FG002|Treatment Period 4 (2 Days)|Other|0
1174852|NCT03792672|2317239|FG003|Treatment Period 4 (2 Days)|Other|0
1174853|NCT03792672|2317240|FG004|Treatment Period 4 (2 Days)|Other|0
1174854|NCT03792672|2317241|FG005|Treatment Period 4 (2 Days)|Other|0
1174855|NCT03787615|2317350|FG000|Overall Study|Withdrawal by Subject|2
1174856|NCT03787615|2317350|FG000|Overall Study|Lost to Follow-up|2
1174857|NCT03786718|2317355|FG000|Overall Study|Lost to Follow-up|3
1174858|NCT03786718|2317355|FG000|Overall Study|Withdrawal by Subject|1
1174859|NCT03786718|2317355|FG000|Overall Study|Did not use the intervention|2
1174860|NCT03786718|2317355|FG000|Overall Study|diagnosis changed from type 2 to type 1|1
871796|NCT00537316|1833211|FG000|Part 2|Never entered follow-up|0
871797|NCT00537316|1833212|FG001|Part 2|Never entered follow-up|0
871798|NCT00537316|1833213|FG002|Part 2|Never entered follow-up|0
1174861|NCT03784963|2317364|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12
1174862|NCT03784963|2317365|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10
1174863|NCT03784963|2317366|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1
1174864|NCT03784963|2317367|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0
1174865|NCT03787212|2317388|FG000|Period 1|Study Termination|2
1174866|NCT03787212|2317389|FG001|Period 1|Study Termination|2
1174867|NCT03783702|2317414|FG000|Overall Study|Lost to Follow-up|6
1174868|NCT03783702|2317415|FG001|Overall Study|Lost to Follow-up|8
1174869|NCT03783702|2317414|FG000|Overall Study|Protocol Violation|1
1174870|NCT03783702|2317415|FG001|Overall Study|Protocol Violation|3
1174871|NCT03783039|2317473|FG000|Overall Study|Death|2
1174872|NCT03783039|2317474|FG001|Overall Study|Death|1
1174873|NCT03776175|2317502|FG000|Treatment Period (42 Days)|Adverse Event|0
1174874|NCT03776175|2317503|FG001|Treatment Period (42 Days)|Adverse Event|1
1174875|NCT03776175|2317504|FG002|Treatment Period (42 Days)|Adverse Event|1
1174876|NCT03776175|2317505|FG003|Treatment Period (42 Days)|Adverse Event|0
1174877|NCT03776175|2317502|FG000|Treatment Period (42 Days)|Lost to Follow-up|0
1174878|NCT03776175|2317503|FG001|Treatment Period (42 Days)|Lost to Follow-up|0
1174879|NCT03776175|2317504|FG002|Treatment Period (42 Days)|Lost to Follow-up|0
1174880|NCT03776175|2317505|FG003|Treatment Period (42 Days)|Lost to Follow-up|2
1174881|NCT03776175|2317502|FG000|Treatment Period (42 Days)|Participants screened at other site|0
1174882|NCT03776175|2317503|FG001|Treatment Period (42 Days)|Participants screened at other site|2
1174883|NCT03776175|2317504|FG002|Treatment Period (42 Days)|Participants screened at other site|0
1174884|NCT03776175|2317505|FG003|Treatment Period (42 Days)|Participants screened at other site|0
1174885|NCT03776175|2317502|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1
1174886|NCT03776175|2317503|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2
1174887|NCT03776175|2317504|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3
1174888|NCT03776175|2317505|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0
1174889|NCT03776175|2317502|FG000|Treatment Period (42 Days)|Unable to attend study visits|0
1174890|NCT03776175|2317503|FG001|Treatment Period (42 Days)|Unable to attend study visits|2
1174891|NCT03776175|2317504|FG002|Treatment Period (42 Days)|Unable to attend study visits|0
1174892|NCT03776175|2317505|FG003|Treatment Period (42 Days)|Unable to attend study visits|0
1174893|NCT03776175|2317502|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0
1174894|NCT03776175|2317503|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0
1174895|NCT03776175|2317504|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0
1174896|NCT03776175|2317505|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2
1174897|NCT03771963|2317515|FG000|Overall Study|Lost to Follow-up|22
1174898|NCT03771963|2317515|FG000|Overall Study|Withdrawal of Consent|10
1174899|NCT03771352|2317519|FG000|Overall Study|Screen failure|2
1174900|NCT03771352|2317519|FG000|Overall Study|Withdrawal by Subject|2
1174901|NCT03773796|2317523|FG000|Overall Study|Adverse Event|1
1174902|NCT03773796|2317523|FG000|Overall Study|Withdrawal by Subject|1
1174903|NCT03773796|2317523|FG000|Overall Study|Lack of Efficacy|1
1174904|NCT03781375|2317544|FG000|Double-blind Phase|Adverse Event|0
1174905|NCT03781375|2317545|FG001|Double-blind Phase|Adverse Event|1
1174906|NCT03781375|2317544|FG000|Double-blind Phase|Lack of Response|6
1174907|NCT03781375|2317545|FG001|Double-blind Phase|Lack of Response|2
1174908|NCT03781375|2317544|FG000|Double-blind Phase|Other|1
1174909|NCT03781375|2317545|FG001|Double-blind Phase|Other|3
1174910|NCT03781375|2317544|FG000|Open-label Phase|Protocol Issues|0
1174911|NCT03781375|2317545|FG001|Open-label Phase|Protocol Issues|1
1174912|NCT03781375|2317544|FG000|Open-label Phase|Suboptimal Clinical Response|1
1174913|NCT03781375|2317545|FG001|Open-label Phase|Suboptimal Clinical Response|0
1174914|NCT03781375|2317544|FG000|Open-label Phase|Other|2
1174915|NCT03781375|2317545|FG001|Open-label Phase|Other|2
1174916|NCT03781336|2317554|FG000|Overall Study|Withdrawal by Subject|2
1174917|NCT03781336|2317555|FG001|Overall Study|Withdrawal by Subject|2
1174918|NCT03780400|2317561|FG000|Overall Study|Lost to Follow-up|5
1174919|NCT03780400|2317561|FG000|Overall Study|Withdrawal by Subject|2
1174920|NCT03779503|2317574|FG000|First Intervention|Adverse Event|0
1174921|NCT03779503|2317575|FG001|First Intervention|Adverse Event|1
1174922|NCT03779503|2317574|FG000|First Intervention|Withdrawal by Subject|1
1174923|NCT03779503|2317575|FG001|First Intervention|Withdrawal by Subject|0
1174924|NCT03777059|2317609|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6
1174925|NCT03777059|2317610|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9
1174926|NCT03777059|2317611|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4
1174927|NCT03777059|2317612|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6
1174928|NCT03777059|2317609|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
1174929|NCT03777059|2317610|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
1174930|NCT03777059|2317611|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
1174931|NCT03777059|2317612|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
1174932|NCT03777059|2317609|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
1174933|NCT03777059|2317610|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9
1174934|NCT03777059|2317611|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
1174935|NCT03777059|2317612|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10
1174936|NCT03777059|2317609|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
1174937|NCT03777059|2317610|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
1174938|NCT03777059|2317611|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4
1174939|NCT03777059|2317612|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5
1174940|NCT03777059|2317609|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0
1174941|NCT03777059|2317610|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1
1174942|NCT03777059|2317611|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0
1174943|NCT03777059|2317612|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0
1174944|NCT03777059|2317609|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4
1174945|NCT03777059|2317610|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5
1174946|NCT03777059|2317611|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7
1174947|NCT03777059|2317612|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8
1174948|NCT03777059|2317609|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
1174949|NCT03777059|2317610|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2
1174950|NCT03777059|2317611|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
1174951|NCT03777059|2317612|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1
1174952|NCT03777059|2317609|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
1174953|NCT03777059|2317610|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3
1174954|NCT03777059|2317611|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4
1174955|NCT03777059|2317612|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
871799|NCT00537316|1833214|FG003|Part 2|Never entered follow-up|0
871800|NCT00537316|1833215|FG004|Part 2|Never entered follow-up|0
871801|NCT00537316|1833216|FG005|Part 2|Never entered follow-up|0
871802|NCT00537316|1833217|FG006|Part 2|Never entered follow-up|1
871803|NCT00537316|1833211|FG000|Part 2|Adverse Event|4
871804|NCT00537316|1833212|FG001|Part 2|Adverse Event|0
871805|NCT00537316|1833213|FG002|Part 2|Adverse Event|2
871806|NCT00537316|1833214|FG003|Part 2|Adverse Event|0
871807|NCT00537316|1833215|FG004|Part 2|Adverse Event|0
871808|NCT00537316|1833216|FG005|Part 2|Adverse Event|0
871809|NCT00537316|1833217|FG006|Part 2|Adverse Event|0
871810|NCT00537316|1833211|FG000|Part 2|Lost to Follow-up|1
871811|NCT00537316|1833212|FG001|Part 2|Lost to Follow-up|0
871812|NCT00537316|1833213|FG002|Part 2|Lost to Follow-up|2
871813|NCT00537316|1833214|FG003|Part 2|Lost to Follow-up|0
871814|NCT00537316|1833215|FG004|Part 2|Lost to Follow-up|0
871815|NCT00537316|1833216|FG005|Part 2|Lost to Follow-up|0
871816|NCT00537316|1833217|FG006|Part 2|Lost to Follow-up|0
871817|NCT00537316|1833211|FG000|Part 2|Withdrawal by Subject|5
871818|NCT00537316|1833212|FG001|Part 2|Withdrawal by Subject|1
871819|NCT00537316|1833213|FG002|Part 2|Withdrawal by Subject|4
871820|NCT00537316|1833214|FG003|Part 2|Withdrawal by Subject|0
871821|NCT00537316|1833215|FG004|Part 2|Withdrawal by Subject|0
871822|NCT00537316|1833216|FG005|Part 2|Withdrawal by Subject|0
871823|NCT00537316|1833217|FG006|Part 2|Withdrawal by Subject|0
871824|NCT00537316|1833211|FG000|Part 2|Administrative|16
871825|NCT00537316|1833212|FG001|Part 2|Administrative|8
871826|NCT00537316|1833213|FG002|Part 2|Administrative|24
871827|NCT00537316|1833214|FG003|Part 2|Administrative|3
871828|NCT00537316|1833215|FG004|Part 2|Administrative|1
871829|NCT00537316|1833216|FG005|Part 2|Administrative|4
871830|NCT00537316|1833217|FG006|Part 2|Administrative|1
871831|NCT00537329|1833236|FG000|Overall Study|Death|10
871832|NCT00537329|1833236|FG000|Overall Study|Adverse Event|3
871833|NCT00537329|1833236|FG000|Overall Study|Lack of Efficacy|2
871834|NCT00537329|1833236|FG000|Overall Study|Lost to Follow-up|6
871835|NCT00537329|1833236|FG000|Overall Study|Withdrawal by Subject|4
871836|NCT00537329|1833236|FG000|Overall Study|Other|1
871837|NCT00537381|1833242|FG000|Overall Study|Adverse Event|13
871838|NCT00537381|1833243|FG001|Overall Study|Adverse Event|9
871839|NCT00537381|1833242|FG000|Overall Study|Death|3
871840|NCT00537381|1833243|FG001|Overall Study|Death|3
871841|NCT00537381|1833242|FG000|Overall Study|Withdrawal by Subject|5
871842|NCT00537381|1833243|FG001|Overall Study|Withdrawal by Subject|14
871843|NCT00537381|1833242|FG000|Overall Study|Physician Decision|7
871844|NCT00537381|1833243|FG001|Overall Study|Physician Decision|6
871845|NCT00537381|1833242|FG000|Overall Study|Disease Progression|9
871846|NCT00537381|1833243|FG001|Overall Study|Disease Progression|18
871847|NCT00537381|1833242|FG000|Overall Study|Sponsor decision|14
871848|NCT00537381|1833243|FG001|Overall Study|Sponsor decision|9
871849|NCT00537381|1833242|FG000|Overall Study|Other|5
871850|NCT00537381|1833243|FG001|Overall Study|Other|3
871851|NCT00537394|1833254|FG000|First Year of Follow-up|Death|7
871852|NCT00537394|1833255|FG001|First Year of Follow-up|Death|0
871853|NCT00537394|1833256|FG002|First Year of Follow-up|Death|0
871854|NCT00537394|1833254|FG000|First Year of Follow-up|Severe debilitation|1
871855|NCT00537394|1833255|FG001|First Year of Follow-up|Severe debilitation|0
871856|NCT00537394|1833256|FG002|First Year of Follow-up|Severe debilitation|1
871857|NCT00537394|1833254|FG000|First Year of Follow-up|Withdrawal by Subject|3
871858|NCT00537394|1833255|FG001|First Year of Follow-up|Withdrawal by Subject|6
871859|NCT00537394|1833256|FG002|First Year of Follow-up|Withdrawal by Subject|1
871860|NCT00537394|1833254|FG000|First Year of Follow-up|Lost to Follow-up|1
871861|NCT00537394|1833255|FG001|First Year of Follow-up|Lost to Follow-up|5
871862|NCT00537394|1833256|FG002|First Year of Follow-up|Lost to Follow-up|1
871863|NCT00537394|1833254|FG000|2nd Year of Follow-up|Death|4
1174956|NCT03777059|2317609|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
1174957|NCT03777059|2317610|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1
1174958|NCT03777059|2317611|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
1174959|NCT03777059|2317612|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3
1174960|NCT03777059|2317609|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
1174961|NCT03777059|2317610|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
1174962|NCT03777059|2317611|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
1174963|NCT03777059|2317612|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
1174964|NCT03777059|2317609|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
1174965|NCT03777059|2317610|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
1174966|NCT03777059|2317611|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
1174967|NCT03777059|2317612|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
1174968|NCT03772522|2317624|FG000|Pre-intervention|Withdrawal by Subject|3
1174969|NCT03772522|2317625|FG001|Pre-intervention|Withdrawal by Subject|4
1174970|NCT03772522|2317624|FG000|Intervention|Withdrawal by Subject|1
1174971|NCT03772522|2317625|FG001|Intervention|Withdrawal by Subject|0
1174972|NCT03772522|2317624|FG000|Post-intervention Follow-up|Lost to Follow-up|1
1174973|NCT03772522|2317625|FG001|Post-intervention Follow-up|Lost to Follow-up|0
1174974|NCT03772327|2317637|FG000|Overall Study|Lost to Follow-up|3
1174975|NCT03772327|2317638|FG001|Overall Study|Lost to Follow-up|4
1174976|NCT03772327|2317637|FG000|Overall Study|Withdrawal by Subject|2
1174977|NCT03772327|2317638|FG001|Overall Study|Withdrawal by Subject|3
1174978|NCT03774576|2317648|FG000|Period 2|Adverse Event|1
1174979|NCT03772041|2317676|FG000|Overall Study|Adverse Event|8
1174980|NCT03772041|2317677|FG001|Overall Study|Adverse Event|3
1174981|NCT03772041|2317676|FG000|Overall Study|Withdrawal by Subject|0
1174982|NCT03772041|2317677|FG001|Overall Study|Withdrawal by Subject|2
1174983|NCT03772041|2317676|FG000|Overall Study|Protocol Violation|4
1174984|NCT03772041|2317677|FG001|Overall Study|Protocol Violation|2
1174985|NCT03772041|2317676|FG000|Overall Study|Physician Decision|2
1174986|NCT03772041|2317677|FG001|Overall Study|Physician Decision|3
1174987|NCT03775681|2317683|FG000|Overall Study|Physician Decision|3
1174988|NCT03774823|2317689|FG000|Overall Study|Withdrawal by Subject|1
1174989|NCT03774823|2317690|FG001|Overall Study|Withdrawal by Subject|1
1174990|NCT03774433|2317705|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14
1174991|NCT03769896|2317728|FG000|Open-label Phase|Lack of Efficacy|5
1174992|NCT03769896|2317729|FG001|Open-label Phase|Lack of Efficacy|0
1174993|NCT03769896|2317728|FG000|Open-label Phase|Adverse Event|3
1174994|NCT03769896|2317729|FG001|Open-label Phase|Adverse Event|0
1174995|NCT03769896|2317728|FG000|Open-label Phase|Withdrawal by Subject|1
1174996|NCT03769896|2317729|FG001|Open-label Phase|Withdrawal by Subject|0
1174997|NCT03769649|2317736|FG000|Overall Study|Lost to Follow-up|4
1175014|NCT03768726|2317767|FG000|Treatment Phase|Adverse Event|2
1175015|NCT03768726|2317768|FG001|Treatment Phase|Adverse Event|2
871864|NCT00537394|1833255|FG001|2nd Year of Follow-up|Death|1
871865|NCT00537394|1833256|FG002|2nd Year of Follow-up|Death|2
871866|NCT00537394|1833254|FG000|2nd Year of Follow-up|Withdrawal by Subject|0
871867|NCT00537394|1833255|FG001|2nd Year of Follow-up|Withdrawal by Subject|1
871868|NCT00537394|1833256|FG002|2nd Year of Follow-up|Withdrawal by Subject|2
871869|NCT00537394|1833254|FG000|2nd Year of Follow-up|Lost to Follow-up|6
871870|NCT00537394|1833255|FG001|2nd Year of Follow-up|Lost to Follow-up|7
871871|NCT00537394|1833256|FG002|2nd Year of Follow-up|Lost to Follow-up|2
871872|NCT00537394|1833254|FG000|2nd Year of Follow-up|Clinic site closure|1
871873|NCT00537394|1833255|FG001|2nd Year of Follow-up|Clinic site closure|0
871874|NCT00537394|1833256|FG002|2nd Year of Follow-up|Clinic site closure|0
871875|NCT00537485|1833289|FG000|Overall Study|Adverse Event|10
871876|NCT00537485|1833290|FG001|Overall Study|Adverse Event|5
871877|NCT00537485|1833289|FG000|Overall Study|Withdrawal by Subject|3
1175016|NCT03768726|2317767|FG000|Treatment Phase|Lost to Follow-up|1
1175017|NCT03768726|2317768|FG001|Treatment Phase|Lost to Follow-up|0
1175018|NCT03768726|2317767|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2
1175019|NCT03768726|2317768|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0
1175020|NCT03768726|2317767|FG000|Treatment Phase|Withdrawal by Subject|3
1175021|NCT03768726|2317768|FG001|Treatment Phase|Withdrawal by Subject|1
1175022|NCT03768726|2317767|FG000|Follow-Up|Adverse Event|2
1175023|NCT03768726|2317768|FG001|Follow-Up|Adverse Event|2
1175024|NCT03768726|2317767|FG000|Follow-Up|Withdrawal By Parent/Guardian|1
1175025|NCT03768726|2317768|FG001|Follow-Up|Withdrawal By Parent/Guardian|1
1175026|NCT03768726|2317767|FG000|Follow-Up|Withdrawal by Subject|2
1175027|NCT03768726|2317768|FG001|Follow-Up|Withdrawal by Subject|0
1175028|NCT03768726|2317767|FG000|Follow-Up|Other|1
1175029|NCT03768726|2317768|FG001|Follow-Up|Other|0
1175030|NCT03768206|2317776|FG000|Overall Study|Lost to Follow-up|2
1175031|NCT03768206|2317777|FG001|Overall Study|Lost to Follow-up|1
1175032|NCT03768206|2317776|FG000|Overall Study|Withdrawal by Subject|0
1175033|NCT03768206|2317777|FG001|Overall Study|Withdrawal by Subject|1
1175034|NCT03767894|2317784|FG000|Overall Study|Withdrawal by Subject|1
1175035|NCT03766646|2317817|FG000|Overall Study|Withdrawal by Subject|1
1175036|NCT03766646|2317818|FG001|Overall Study|Withdrawal by Subject|0
1175037|NCT03766646|2317817|FG000|Overall Study|Protocol Violation|0
1175038|NCT03766646|2317818|FG001|Overall Study|Protocol Violation|3
1175039|NCT03765164|2317890|FG000|Pre-intervention|Withdrawal by Subject|5
1175040|NCT03765164|2317891|FG001|Pre-intervention|Withdrawal by Subject|6
1175041|NCT03765138|2317897|FG000|Overall Study|Lost to Follow-up|1
1175042|NCT03762681|2317965|FG000|Part 1|Withdrawal by Subject|0
1175043|NCT03762681|2317966|FG001|Part 1|Withdrawal by Subject|0
1175044|NCT03762681|2317967|FG002|Part 1|Withdrawal by Subject|0
1175045|NCT03762681|2317968|FG003|Part 1|Withdrawal by Subject|1
1175046|NCT03762681|2317969|FG004|Part 1|Withdrawal by Subject|0
1175047|NCT03762681|2317970|FG005|Part 1|Withdrawal by Subject|0
1175048|NCT03762681|2317971|FG006|Part 1|Withdrawal by Subject|0
1175049|NCT03762681|2317972|FG007|Part 1|Withdrawal by Subject|0
1175050|NCT03762681|2317965|FG000|Part 2a|Pandemic Travel Restrictions|0
871878|NCT00537485|1833290|FG001|Overall Study|Withdrawal by Subject|2
871879|NCT00537485|1833289|FG000|Overall Study|Withdrawal by Subject|1
871880|NCT00537485|1833290|FG001|Overall Study|Withdrawal by Subject|3
871881|NCT00537485|1833289|FG000|Overall Study|Physician Decision|1
871882|NCT00537485|1833290|FG001|Overall Study|Physician Decision|0
871883|NCT00537745|1833351|FG000|Overall Study|Did not meet eligibility criteria|2
871884|NCT00537745|1833351|FG000|Overall Study|Withdrawal by Subject|2
871885|NCT00537745|1833351|FG000|Overall Study|Subject unable to provide Interlock info|1
871886|NCT00537771|1833358|FG000|Overall Study|Withdrawal by Subject|6
871887|NCT00537771|1833359|FG001|Overall Study|Withdrawal by Subject|23
871888|NCT00537771|1833358|FG000|Overall Study|Adverse Event|8
871889|NCT00537771|1833359|FG001|Overall Study|Adverse Event|15
871890|NCT00537771|1833358|FG000|Overall Study|Lost to Follow-up|9
871891|NCT00537771|1833359|FG001|Overall Study|Lost to Follow-up|15
871892|NCT00537771|1833358|FG000|Overall Study|Protocol Violation|2
871893|NCT00537771|1833359|FG001|Overall Study|Protocol Violation|6
871894|NCT00537771|1833358|FG000|Overall Study|Severe Non-Compliance to Protocol|4
871895|NCT00537771|1833359|FG001|Overall Study|Severe Non-Compliance to Protocol|2
871896|NCT00537810|1833369|FG000|Overall Study|Withdrawal by Subject|4
871897|NCT00537810|1833370|FG001|Overall Study|Withdrawal by Subject|11
871898|NCT00537810|1833371|FG002|Overall Study|Withdrawal by Subject|4
871899|NCT00537810|1833372|FG003|Overall Study|Withdrawal by Subject|3
871900|NCT00537810|1833369|FG000|Overall Study|Medically withdrawn|2
871901|NCT00537810|1833370|FG001|Overall Study|Medically withdrawn|2
871902|NCT00537810|1833371|FG002|Overall Study|Medically withdrawn|0
871903|NCT00537810|1833372|FG003|Overall Study|Medically withdrawn|1
871904|NCT00537823|1833384|FG000|Overall Study|Adverse Event|2
871905|NCT00537823|1833385|FG001|Overall Study|Adverse Event|0
871906|NCT00537940|1833394|FG000|Overall Study|Adverse Event|20
871907|NCT00537940|1833395|FG001|Overall Study|Adverse Event|19
871908|NCT00537940|1833394|FG000|Overall Study|Lack of Efficacy|8
871909|NCT00537940|1833395|FG001|Overall Study|Lack of Efficacy|16
871910|NCT00537940|1833394|FG000|Overall Study|Lost to Follow-up|23
871911|NCT00537940|1833395|FG001|Overall Study|Lost to Follow-up|29
871912|NCT00537940|1833394|FG000|Overall Study|Withdrawal by Subject|113
871913|NCT00537940|1833395|FG001|Overall Study|Withdrawal by Subject|95
871914|NCT00537940|1833394|FG000|Overall Study|Protocol Violation|6
871915|NCT00537940|1833395|FG001|Overall Study|Protocol Violation|4
871916|NCT00537940|1833394|FG000|Overall Study|Pregnancy|1
871917|NCT00537940|1833395|FG001|Overall Study|Pregnancy|1
871918|NCT00537940|1833394|FG000|Overall Study|Study terminated by sponsor|2
871919|NCT00537940|1833395|FG001|Overall Study|Study terminated by sponsor|3
871920|NCT00537940|1833394|FG000|Overall Study|Other|10
871921|NCT00537940|1833395|FG001|Overall Study|Other|12
871922|NCT00537979|1833403|FG000|Overall Study|Adverse Event|2
871923|NCT00537979|1833404|FG001|Overall Study|Adverse Event|2
871924|NCT00537979|1833403|FG000|Overall Study|Withdrawal by Subject|1
871925|NCT00537979|1833404|FG001|Overall Study|Withdrawal by Subject|4
871926|NCT00537979|1833403|FG000|Overall Study|Lost to Follow-up|1
871927|NCT00537979|1833404|FG001|Overall Study|Lost to Follow-up|4
871928|NCT00537979|1833403|FG000|Overall Study|Lack of Efficacy|0
871929|NCT00537979|1833404|FG001|Overall Study|Lack of Efficacy|1
871930|NCT00537979|1833403|FG000|Overall Study|Non-compliance with treatment/procedure|2
871931|NCT00537979|1833404|FG001|Overall Study|Non-compliance with treatment/procedure|2
871932|NCT00537979|1833403|FG000|Overall Study|Death|0
871933|NCT00537979|1833404|FG001|Overall Study|Death|3
1175051|NCT03762681|2317966|FG001|Part 2a|Pandemic Travel Restrictions|0
1175052|NCT03762681|2317967|FG002|Part 2a|Pandemic Travel Restrictions|0
1175053|NCT03762681|2317968|FG003|Part 2a|Pandemic Travel Restrictions|0
1175054|NCT03762681|2317969|FG004|Part 2a|Pandemic Travel Restrictions|0
1175055|NCT03762681|2317970|FG005|Part 2a|Pandemic Travel Restrictions|0
1175056|NCT03762681|2317971|FG006|Part 2a|Pandemic Travel Restrictions|0
1175057|NCT03762681|2317972|FG007|Part 2a|Pandemic Travel Restrictions|1
1175058|NCT03762668|2318001|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0
1175059|NCT03762668|2318002|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1
1175060|NCT03762616|2318008|FG000|Overall Study|Protocol Violation|2
1175061|NCT03762200|2318023|FG000|Overall Study|Death|2
1175062|NCT03761147|2318038|FG000|Overall Study|Withdrawal by Subject|6
1175063|NCT03761147|2318039|FG001|Overall Study|Withdrawal by Subject|1
1175064|NCT03761147|2318038|FG000|Overall Study|Adverse Event|1
1175065|NCT03761147|2318039|FG001|Overall Study|Adverse Event|3
1175066|NCT03760510|2318153|FG000|Overall Study|Not ventilated for 24 hours|105
1175067|NCT03760510|2318154|FG001|Overall Study|Not ventilated for 24 hours|97
1175068|NCT03760250|2318160|FG000|Overall Study|Withdrawal by Subject|1
1175069|NCT03760250|2318160|FG000|Overall Study|Physician Decision|1
1175070|NCT03760068|2318166|FG000|Overall Study|Withdrawal by Subject|7
1175071|NCT03760068|2318167|FG001|Overall Study|Withdrawal by Subject|8
1175072|NCT03760068|2318166|FG000|Overall Study|Adverse Event|1
1175073|NCT03760068|2318167|FG001|Overall Study|Adverse Event|2
1175074|NCT03760068|2318166|FG000|Overall Study|Administrative Decision by Sponsor|0
1175075|NCT03760068|2318167|FG001|Overall Study|Administrative Decision by Sponsor|2
1175076|NCT03760068|2318166|FG000|Overall Study|Physician Decision|1
1175077|NCT03760068|2318167|FG001|Overall Study|Physician Decision|2
1175078|NCT03760068|2318166|FG000|Overall Study|Lost to Follow-up|4
1175079|NCT03760068|2318167|FG001|Overall Study|Lost to Follow-up|9
1175080|NCT03760068|2318166|FG000|Overall Study|Subject Moved Out of State|1
1175081|NCT03760068|2318167|FG001|Overall Study|Subject Moved Out of State|0
1175082|NCT03759600|2318174|FG000|Overall Study|Ongoing at Data Cut-off|16
1175083|NCT03759600|2318174|FG000|Overall Study|Adverse Event|1
1175084|NCT03759600|2318174|FG000|Overall Study|Progressive Disease|3
1175085|NCT03759587|2318178|FG000|Overall Study|Ongoing|19
1175086|NCT03759340|2318182|FG000|Overall Study|Adverse Event|2
1175087|NCT03759340|2318182|FG000|Overall Study|Lost to Follow-up|1
1175088|NCT03759340|2318182|FG000|Overall Study|Withdrawal by Subject|15
1175089|NCT03759340|2318182|FG000|Overall Study|Study Terminated by Sponsor|38
1175090|NCT03757988|2318205|FG000|Overall Study|Withdrawal by Subject|1
1175091|NCT03757234|2318226|FG000|Overall Study|Adverse Event|0
1175092|NCT03757234|2318227|FG001|Overall Study|Adverse Event|0
1175093|NCT03757234|2318228|FG002|Overall Study|Adverse Event|0
1175094|NCT03757234|2318229|FG003|Overall Study|Adverse Event|0
1175095|NCT03757234|2318230|FG004|Overall Study|Adverse Event|1
1175096|NCT03757234|2318226|FG000|Overall Study|Lost to Follow-up|1
1175097|NCT03757234|2318227|FG001|Overall Study|Lost to Follow-up|0
1175098|NCT03757234|2318228|FG002|Overall Study|Lost to Follow-up|0
1175099|NCT03757234|2318229|FG003|Overall Study|Lost to Follow-up|0
1175100|NCT03757234|2318230|FG004|Overall Study|Lost to Follow-up|1
1175101|NCT03757234|2318226|FG000|Overall Study|Withdrawal by Subject|1
1175102|NCT03757234|2318227|FG001|Overall Study|Withdrawal by Subject|1
1175103|NCT03757234|2318228|FG002|Overall Study|Withdrawal by Subject|0
1175104|NCT03757234|2318229|FG003|Overall Study|Withdrawal by Subject|1
1175105|NCT03757234|2318230|FG004|Overall Study|Withdrawal by Subject|2
1175106|NCT03757234|2318226|FG000|Overall Study|Other|1
1175107|NCT03757234|2318227|FG001|Overall Study|Other|1
1175108|NCT03757234|2318228|FG002|Overall Study|Other|0
1175109|NCT03757234|2318229|FG003|Overall Study|Other|0
1175110|NCT03757234|2318230|FG004|Overall Study|Other|0
1175111|NCT03756883|2318258|FG000|Overall Study|Adverse Event|2
1175112|NCT03756883|2318259|FG001|Overall Study|Adverse Event|2
1175113|NCT03756883|2318260|FG002|Overall Study|Adverse Event|2
1175114|NCT03756883|2318258|FG000|Overall Study|Lack of Efficacy|0
1175115|NCT03756883|2318259|FG001|Overall Study|Lack of Efficacy|1
1175116|NCT03756883|2318260|FG002|Overall Study|Lack of Efficacy|2
1175117|NCT03756883|2318258|FG000|Overall Study|Lost to Follow-up|3
1175118|NCT03756883|2318259|FG001|Overall Study|Lost to Follow-up|3
1175119|NCT03756883|2318260|FG002|Overall Study|Lost to Follow-up|0
1175120|NCT03756883|2318258|FG000|Overall Study|Protocol Violation|2
1175121|NCT03756883|2318259|FG001|Overall Study|Protocol Violation|0
1175122|NCT03756883|2318260|FG002|Overall Study|Protocol Violation|1
1175123|NCT03756883|2318258|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0
1175124|NCT03756883|2318259|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0
1175125|NCT03756883|2318260|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2
1175126|NCT03756883|2318258|FG000|Overall Study|Withdrawal by Subject|4
1175127|NCT03756883|2318259|FG001|Overall Study|Withdrawal by Subject|1
1175128|NCT03756883|2318260|FG002|Overall Study|Withdrawal by Subject|0
1175129|NCT03756883|2318258|FG000|Overall Study|Other Reasons|2
1175130|NCT03756883|2318259|FG001|Overall Study|Other Reasons|4
1175131|NCT03756883|2318260|FG002|Overall Study|Other Reasons|0
1175132|NCT03756285|2318279|FG000|Overall Study|Lost to Follow-up|0
1175133|NCT03756285|2318280|FG001|Overall Study|Lost to Follow-up|1
1175134|NCT03756285|2318279|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0
1175135|NCT03756285|2318280|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1
1175136|NCT03756285|2318279|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
1175137|NCT03756285|2318280|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
1175138|NCT03756129|2318293|FG000|Overall Study|Adverse Event|1
1175139|NCT03756129|2318294|FG001|Overall Study|Adverse Event|1
1175140|NCT03756129|2318295|FG002|Overall Study|Adverse Event|0
1175141|NCT03756129|2318296|FG003|Overall Study|Adverse Event|2
1175142|NCT03756129|2318297|FG004|Overall Study|Adverse Event|0
1175143|NCT03756129|2318298|FG005|Overall Study|Adverse Event|0
1175144|NCT03756129|2318293|FG000|Overall Study|Withdrawal by Subject|2
1175145|NCT03756129|2318294|FG001|Overall Study|Withdrawal by Subject|1
1175146|NCT03756129|2318295|FG002|Overall Study|Withdrawal by Subject|3
1175147|NCT03756129|2318296|FG003|Overall Study|Withdrawal by Subject|1
1175148|NCT03756129|2318297|FG004|Overall Study|Withdrawal by Subject|1
1175149|NCT03756129|2318298|FG005|Overall Study|Withdrawal by Subject|3
1175150|NCT03756129|2318293|FG000|Overall Study|Lost to Follow-up|0
1175151|NCT03756129|2318294|FG001|Overall Study|Lost to Follow-up|0
1175152|NCT03756129|2318295|FG002|Overall Study|Lost to Follow-up|0
1175153|NCT03756129|2318296|FG003|Overall Study|Lost to Follow-up|0
1175154|NCT03756129|2318297|FG004|Overall Study|Lost to Follow-up|0
1175155|NCT03756129|2318298|FG005|Overall Study|Lost to Follow-up|1
1175156|NCT03756129|2318293|FG000|Overall Study|Physician Decision|0
1175157|NCT03756129|2318294|FG001|Overall Study|Physician Decision|0
1175158|NCT03756129|2318295|FG002|Overall Study|Physician Decision|0
1175159|NCT03756129|2318296|FG003|Overall Study|Physician Decision|0
1175160|NCT03756129|2318297|FG004|Overall Study|Physician Decision|0
1175161|NCT03756129|2318298|FG005|Overall Study|Physician Decision|1
1175162|NCT03755882|2318334|FG000|Period 1|Protocol Violation|1
1175163|NCT03755882|2318335|FG001|Period 1|Protocol Violation|0
1175164|NCT03755882|2318334|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3
1175165|NCT03755882|2318335|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0
1175166|NCT03755661|2318343|FG000|Overall Study|Lost to Follow-up|1
1175167|NCT03755661|2318344|FG001|Overall Study|Lost to Follow-up|0
1175168|NCT03754582|2318350|FG000|Treatment Phase|Adverse Event|0
1175169|NCT03754582|2318351|FG001|Treatment Phase|Adverse Event|1
1175170|NCT03754582|2318352|FG002|Treatment Phase|Adverse Event|0
1175171|NCT03754582|2318350|FG000|Follow-up Phase|Other|0
1175172|NCT03754582|2318351|FG001|Follow-up Phase|Other|0
1175173|NCT03754582|2318352|FG002|Follow-up Phase|Other|1
1175174|NCT03752528|2318385|FG000|Part A|Lost to Follow-up|1
1175175|NCT03752528|2318385|FG000|Part A|Protocol Violation|1
1175176|NCT03752528|2318385|FG000|Part B|Protocol Violation|1
1175177|NCT03752528|2318385|FG000|Part B|Study terminated by sponsor|3
1175178|NCT03752151|2318392|FG000|Overall Study|Withdrawal by Subject|1
1175179|NCT03752151|2318392|FG000|Overall Study|Protocol Violation|1
1175180|NCT03751657|2318399|FG000|Overall Study|Physician Decision|0
1175181|NCT03751657|2318400|FG001|Overall Study|Physician Decision|1
1175182|NCT03751657|2318399|FG000|Overall Study|Withdrawal by Subject|1
1175183|NCT03751657|2318400|FG001|Overall Study|Withdrawal by Subject|1
1175184|NCT03751657|2318399|FG000|Overall Study|Lost to Follow-up|2
1175185|NCT03751657|2318400|FG001|Overall Study|Lost to Follow-up|1
1175186|NCT03751280|2318408|FG000|Overall Study|Adverse Event|0
1175187|NCT03751280|2318409|FG001|Overall Study|Adverse Event|1
1175188|NCT03751280|2318408|FG000|Overall Study|Lost to Follow-up|3
1175189|NCT03751280|2318409|FG001|Overall Study|Lost to Follow-up|5
1175190|NCT03751280|2318408|FG000|Overall Study|Physician Decision|0
1175191|NCT03751280|2318409|FG001|Overall Study|Physician Decision|2
1175192|NCT03751280|2318408|FG000|Overall Study|Protocol Violation|0
1175193|NCT03751280|2318409|FG001|Overall Study|Protocol Violation|2
1175194|NCT03751280|2318408|FG000|Overall Study|Withdrawal by Subject|5
1175195|NCT03751280|2318409|FG001|Overall Study|Withdrawal by Subject|2
1175196|NCT03751020|2318419|FG000|Overall Study|Withdrawal by Subject|2
1175197|NCT03751020|2318420|FG001|Overall Study|Withdrawal by Subject|0
1175198|NCT03751020|2318421|FG002|Overall Study|Withdrawal by Subject|0
1175199|NCT03751020|2318419|FG000|Overall Study|Lost to Follow-up|7
1175200|NCT03751020|2318420|FG001|Overall Study|Lost to Follow-up|4
1175201|NCT03751020|2318421|FG002|Overall Study|Lost to Follow-up|10
1175202|NCT03750955|2318431|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
1175203|NCT03750955|2318432|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
1175204|NCT03750955|2318431|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
1175205|NCT03750955|2318432|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
1175206|NCT03750695|2318440|FG000|Overall Study|Lost to Follow-up|0
1175207|NCT03750695|2318441|FG001|Overall Study|Lost to Follow-up|1
1175208|NCT03748706|2318549|FG000|Overall Study|Lost to Follow-up|1
1175209|NCT03746405|2318577|FG000|Overall Study|Withdrawal by Subject|3
1175210|NCT03746405|2318578|FG001|Overall Study|Withdrawal by Subject|0
1175211|NCT03746405|2318577|FG000|Overall Study|technical difficulties|0
1175212|NCT03746405|2318578|FG001|Overall Study|technical difficulties|2
1175213|NCT03745222|2318605|FG000|Overall Study|Withdrawal by Subject|0
1175214|NCT03745222|2318606|FG001|Overall Study|Withdrawal by Subject|1
1175215|NCT03745222|2318607|FG002|Overall Study|Withdrawal by Subject|0
1175216|NCT03743038|2318642|FG000|Overall Study|Physician Decision|1
1175217|NCT03742271|2318665|FG000|Overall Study|Unsatisfactory Visual Response|1
1175218|NCT03742271|2318665|FG000|Overall Study|Withdrawal by Subject|3
1175219|NCT03742271|2318665|FG000|Overall Study|Lost to Follow-up|4
1175220|NCT03742271|2318665|FG000|Overall Study|Failed Insertion & removal|3
1175221|NCT03742271|2318665|FG000|Overall Study|Protocol Violation|1
1175222|NCT03741062|2318700|FG000|Overall Study|Protocol Violation|1
1175223|NCT03741062|2318701|FG001|Overall Study|Protocol Violation|0
1175224|NCT03739866|2318732|FG000|Overall Study|Lost to Follow-up|0
1175225|NCT03739866|2318733|FG001|Overall Study|Lost to Follow-up|0
1175226|NCT03739866|2318734|FG002|Overall Study|Lost to Follow-up|0
1175227|NCT03739866|2318735|FG003|Overall Study|Lost to Follow-up|1
1175228|NCT03739866|2318736|FG004|Overall Study|Lost to Follow-up|0
1175229|NCT03739866|2318737|FG005|Overall Study|Lost to Follow-up|0
1175230|NCT03739866|2318738|FG006|Overall Study|Lost to Follow-up|0
1175231|NCT03739866|2318739|FG007|Overall Study|Lost to Follow-up|0
1175232|NCT03739866|2318732|FG000|Overall Study|Enrolled but not treated|0
1175233|NCT03739866|2318733|FG001|Overall Study|Enrolled but not treated|0
1175234|NCT03739866|2318734|FG002|Overall Study|Enrolled but not treated|1
1175235|NCT03739866|2318735|FG003|Overall Study|Enrolled but not treated|0
1175236|NCT03739866|2318736|FG004|Overall Study|Enrolled but not treated|1
1175237|NCT03739866|2318737|FG005|Overall Study|Enrolled but not treated|0
1175238|NCT03739866|2318738|FG006|Overall Study|Enrolled but not treated|0
1175239|NCT03739866|2318739|FG007|Overall Study|Enrolled but not treated|0
1175240|NCT03739528|2318780|FG000|Overall Study|Not treated|8
1175241|NCT03739528|2318781|FG001|Overall Study|Not treated|12
1175242|NCT03739528|2318780|FG000|Overall Study|Treatment and study discontinued|6
1175243|NCT03739528|2318781|FG001|Overall Study|Treatment and study discontinued|2
1175244|NCT03739528|2318780|FG000|Overall Study|Treatment discontinued + study completed|1
1175245|NCT03739528|2318781|FG001|Overall Study|Treatment discontinued + study completed|3
1175246|NCT03739242|2318792|FG000|Overall Study|Withdrawal by Subject|1
1175247|NCT03739242|2318793|FG001|Overall Study|Withdrawal by Subject|1
1175248|NCT03739242|2318792|FG000|Overall Study|Protocol Violation|0
1175249|NCT03739242|2318793|FG001|Overall Study|Protocol Violation|1
1175250|NCT03738865|2318801|FG000|Overall Study|Withdrawal by Subject|3
1175251|NCT03738865|2318802|FG001|Overall Study|Withdrawal by Subject|3
1175252|NCT03738865|2318801|FG000|Overall Study|Adverse Event|2
1175253|NCT03738865|2318802|FG001|Overall Study|Adverse Event|0
1175254|NCT03738865|2318801|FG000|Overall Study|Physician Decision|0
1175255|NCT03738865|2318802|FG001|Overall Study|Physician Decision|1
1175256|NCT03738475|2318819|FG000|Overall Study|Participant Non-Compliance|1
1175257|NCT03738475|2318820|FG001|Overall Study|Participant Non-Compliance|0
1175258|NCT03738241|2318836|FG000|Overall Study|Withdrawal by Subject|0
1175259|NCT03738241|2318837|FG001|Overall Study|Withdrawal by Subject|0
1175260|NCT03738241|2318838|FG002|Overall Study|Withdrawal by Subject|0
1175261|NCT03738241|2318839|FG003|Overall Study|Withdrawal by Subject|0
1175262|NCT03738241|2318840|FG004|Overall Study|Withdrawal by Subject|0
1175263|NCT03738241|2318841|FG005|Overall Study|Withdrawal by Subject|0
1175264|NCT03738241|2318842|FG006|Overall Study|Withdrawal by Subject|0
1175265|NCT03738241|2318843|FG007|Overall Study|Withdrawal by Subject|0
1175266|NCT03738241|2318844|FG008|Overall Study|Withdrawal by Subject|0
1175267|NCT03738241|2318845|FG009|Overall Study|Withdrawal by Subject|1
1175268|NCT03738241|2318836|FG000|Overall Study|Physician Decision|0
1175269|NCT03738241|2318837|FG001|Overall Study|Physician Decision|0
1175270|NCT03738241|2318838|FG002|Overall Study|Physician Decision|0
1175271|NCT03738241|2318839|FG003|Overall Study|Physician Decision|0
1175272|NCT03738241|2318840|FG004|Overall Study|Physician Decision|0
871934|NCT00537979|1833403|FG000|Overall Study|Kidney transplant|0
871935|NCT00537979|1833404|FG001|Overall Study|Kidney transplant|3
871936|NCT00537979|1833403|FG000|Overall Study|Heart failure|0
871937|NCT00537979|1833404|FG001|Overall Study|Heart failure|1
871938|NCT00538291|1833425|FG000|Overall Study|Adverse Event|2
871939|NCT00538291|1833425|FG000|Overall Study|Withdrawal by Subject|1
871940|NCT00538473|1833458|FG000|Overall Study|Adverse Event|1
871941|NCT00538473|1833459|FG001|Overall Study|Adverse Event|0
871942|NCT00538590|1833480|FG000|Overall Study|Death|1
871943|NCT00538590|1833481|FG001|Overall Study|Death|0
871944|NCT00538629|1833496|FG000|Overall Study|At subject's request|1
871945|NCT00538629|1833496|FG000|Overall Study|Adverse Event|2
871946|NCT00538629|1833496|FG000|Overall Study|Lack of Efficacy|12
871947|NCT00538629|1833496|FG000|Overall Study|Lost to Follow-up|6
871948|NCT00538629|1833496|FG000|Overall Study|Subject's untimely distrust of medicine|1
871949|NCT00538681|1833514|FG000|Overall Study|Progressive Disease|7
871950|NCT00538681|1833515|FG001|Overall Study|Progressive Disease|0
871951|NCT00538681|1833516|FG002|Overall Study|Progressive Disease|1
871952|NCT00538681|1833517|FG003|Overall Study|Progressive Disease|0
871953|NCT00538681|1833514|FG000|Overall Study|Sponsor Decision|1
871954|NCT00538681|1833515|FG001|Overall Study|Sponsor Decision|3
871955|NCT00538681|1833516|FG002|Overall Study|Sponsor Decision|8
871956|NCT00538681|1833517|FG003|Overall Study|Sponsor Decision|9
871957|NCT00538681|1833514|FG000|Overall Study|Adverse Event|1
871958|NCT00538681|1833515|FG001|Overall Study|Adverse Event|1
871959|NCT00538681|1833516|FG002|Overall Study|Adverse Event|1
1175273|NCT03738241|2318841|FG005|Overall Study|Physician Decision|0
1175274|NCT03738241|2318842|FG006|Overall Study|Physician Decision|0
1175275|NCT03738241|2318843|FG007|Overall Study|Physician Decision|0
1175276|NCT03738241|2318844|FG008|Overall Study|Physician Decision|1
1175277|NCT03738241|2318845|FG009|Overall Study|Physician Decision|0
1175278|NCT03738241|2318836|FG000|Overall Study|Adverse Event|1
1175279|NCT03738241|2318837|FG001|Overall Study|Adverse Event|0
1175280|NCT03738241|2318838|FG002|Overall Study|Adverse Event|0
1175281|NCT03738241|2318839|FG003|Overall Study|Adverse Event|0
1175282|NCT03738241|2318840|FG004|Overall Study|Adverse Event|0
1175283|NCT03738241|2318841|FG005|Overall Study|Adverse Event|0
1175284|NCT03738241|2318842|FG006|Overall Study|Adverse Event|0
1175285|NCT03738241|2318843|FG007|Overall Study|Adverse Event|0
1175286|NCT03738241|2318844|FG008|Overall Study|Adverse Event|0
1175287|NCT03738241|2318845|FG009|Overall Study|Adverse Event|0
1175288|NCT03736785|2318902|FG000|Overall Study|Adverse Event|1
1175289|NCT03736785|2318903|FG001|Overall Study|Adverse Event|1
1175290|NCT03736785|2318904|FG002|Overall Study|Adverse Event|1
1175291|NCT03736785|2318902|FG000|Overall Study|Death|1
1175292|NCT03736785|2318903|FG001|Overall Study|Death|0
1175293|NCT03736785|2318904|FG002|Overall Study|Death|1
1175294|NCT03736785|2318902|FG000|Overall Study|Lost to Follow-up|0
1175295|NCT03736785|2318903|FG001|Overall Study|Lost to Follow-up|2
1175296|NCT03736785|2318904|FG002|Overall Study|Lost to Follow-up|3
1175297|NCT03736785|2318902|FG000|Overall Study|Non compliance with study drug|1
1175298|NCT03736785|2318903|FG001|Overall Study|Non compliance with study drug|1
1175299|NCT03736785|2318904|FG002|Overall Study|Non compliance with study drug|0
1175300|NCT03736785|2318902|FG000|Overall Study|Physician Decision|0
1175301|NCT03736785|2318903|FG001|Overall Study|Physician Decision|1
1175302|NCT03736785|2318904|FG002|Overall Study|Physician Decision|1
1175303|NCT03736785|2318902|FG000|Overall Study|Protocol Violation|1
1175304|NCT03736785|2318903|FG001|Overall Study|Protocol Violation|4
1175305|NCT03736785|2318904|FG002|Overall Study|Protocol Violation|3
1175306|NCT03736785|2318902|FG000|Overall Study|Sponsor Decision|1
1175307|NCT03736785|2318903|FG001|Overall Study|Sponsor Decision|0
1175308|NCT03736785|2318904|FG002|Overall Study|Sponsor Decision|0
1175309|NCT03736785|2318902|FG000|Overall Study|Unknown/Missing data|3
1175310|NCT03736785|2318903|FG001|Overall Study|Unknown/Missing data|2
1175311|NCT03736785|2318904|FG002|Overall Study|Unknown/Missing data|1
1175312|NCT03736785|2318902|FG000|Overall Study|Withdrawal by Subject|9
1175313|NCT03736785|2318903|FG001|Overall Study|Withdrawal by Subject|6
1175314|NCT03736785|2318904|FG002|Overall Study|Withdrawal by Subject|4
1175315|NCT03736031|2318915|FG000|Overall Study|Death|2
1175316|NCT03736031|2318916|FG001|Overall Study|Death|4
1175317|NCT03736031|2318915|FG000|Overall Study|Lost to Follow-up|21
1175318|NCT03736031|2318916|FG001|Overall Study|Lost to Follow-up|2
1175319|NCT03736031|2318915|FG000|Overall Study|Withdrawal by Subject|9
1175320|NCT03736031|2318916|FG001|Overall Study|Withdrawal by Subject|0
1175321|NCT03734991|2318928|FG000|Overall Study|Adverse Event|4
1175322|NCT03734991|2318929|FG001|Overall Study|Adverse Event|0
1175323|NCT03734991|2318928|FG000|Overall Study|Lost to Follow-up|4
1175324|NCT03734991|2318929|FG001|Overall Study|Lost to Follow-up|0
1175325|NCT03734991|2318928|FG000|Overall Study|Physician Decision|0
1175326|NCT03734991|2318929|FG001|Overall Study|Physician Decision|1
1175327|NCT03734991|2318928|FG000|Overall Study|Pregnancy|1
1175328|NCT03734991|2318929|FG001|Overall Study|Pregnancy|0
1175329|NCT03734991|2318928|FG000|Overall Study|Withdrawal by Subject|6
1175330|NCT03734991|2318929|FG001|Overall Study|Withdrawal by Subject|3
1175331|NCT03734991|2318928|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49
1175332|NCT03734991|2318929|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41
1175333|NCT03734991|2318928|FG000|Overall Study|Other|2
1175334|NCT03734991|2318929|FG001|Overall Study|Other|2
1175335|NCT03733899|2318943|FG000|Period 1|Protocol Violation|0
1175336|NCT03733899|2318944|FG001|Period 1|Protocol Violation|0
1175337|NCT03733899|2318945|FG002|Period 1|Protocol Violation|0
1175338|NCT03733899|2318946|FG003|Period 1|Protocol Violation|0
1175339|NCT03733899|2318947|FG004|Period 1|Protocol Violation|0
1175340|NCT03733899|2318948|FG005|Period 1|Protocol Violation|1
871960|NCT00538681|1833517|FG003|Overall Study|Adverse Event|0
871961|NCT00538681|1833514|FG000|Overall Study|Death|0
871962|NCT00538681|1833515|FG001|Overall Study|Death|0
871963|NCT00538681|1833516|FG002|Overall Study|Death|1
871964|NCT00538681|1833517|FG003|Overall Study|Death|1
871965|NCT00538681|1833514|FG000|Overall Study|Investigator Decision|0
871966|NCT00538681|1833515|FG001|Overall Study|Investigator Decision|0
871967|NCT00538681|1833516|FG002|Overall Study|Investigator Decision|0
871968|NCT00538681|1833517|FG003|Overall Study|Investigator Decision|1
871969|NCT00538733|1833528|FG000|Overall Study|Adverse Event|8
871970|NCT00538733|1833528|FG000|Overall Study|Death|1
871971|NCT00538733|1833528|FG000|Overall Study|declined to participate|2
871972|NCT00538733|1833528|FG000|Overall Study|still on therapy|1
871973|NCT00538785|1833546|FG000|Overall Study|Death|9
871974|NCT00538785|1833547|FG001|Overall Study|Death|10
871975|NCT00538785|1833546|FG000|Overall Study|Withdrawal of consent|9
871976|NCT00538785|1833547|FG001|Overall Study|Withdrawal of consent|7
871977|NCT00538785|1833546|FG000|Overall Study|Lost to Follow-up|1
871978|NCT00538785|1833547|FG001|Overall Study|Lost to Follow-up|0
871979|NCT00538902|1833574|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
1175341|NCT03733899|2318943|FG000|Period 2|Unscuccessful Treatment|0
1175342|NCT03733899|2318944|FG001|Period 2|Unscuccessful Treatment|1
1175343|NCT03733899|2318945|FG002|Period 2|Unscuccessful Treatment|0
1175344|NCT03733899|2318946|FG003|Period 2|Unscuccessful Treatment|0
1175345|NCT03733899|2318947|FG004|Period 2|Unscuccessful Treatment|0
1175346|NCT03733899|2318948|FG005|Period 2|Unscuccessful Treatment|0
1175347|NCT03733899|2318943|FG000|Period 3|Withdrawal by Subject|1
1175348|NCT03733899|2318944|FG001|Period 3|Withdrawal by Subject|0
1175349|NCT03733899|2318945|FG002|Period 3|Withdrawal by Subject|0
1175350|NCT03733899|2318946|FG003|Period 3|Withdrawal by Subject|0
1175351|NCT03733899|2318947|FG004|Period 3|Withdrawal by Subject|0
1175352|NCT03733899|2318948|FG005|Period 3|Withdrawal by Subject|0
1175353|NCT03733470|2318967|FG000|Overall Study|PI Decision|1
871980|NCT00538902|1833575|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
871981|NCT00538902|1833576|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
871982|NCT00538902|1833574|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
871983|NCT00538902|1833575|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
871984|NCT00538902|1833576|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
871985|NCT00538902|1833574|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
871986|NCT00538902|1833575|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
871987|NCT00538902|1833576|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
871988|NCT00538902|1833574|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
871989|NCT00538902|1833575|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
871990|NCT00538902|1833576|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
871991|NCT00538902|1833574|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
871992|NCT00538902|1833575|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
871993|NCT00538902|1833576|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
871994|NCT00538902|1833574|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
871995|NCT00538902|1833575|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
871996|NCT00538902|1833576|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
871997|NCT00538902|1833574|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
871998|NCT00538902|1833575|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
871999|NCT00538902|1833576|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
872000|NCT00538902|1833574|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18
872001|NCT00538902|1833575|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25
872002|NCT00538902|1833576|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22
872003|NCT00539006|1833594|FG000|Pre-treatment|Other|0
872004|NCT00539006|1833595|FG001|Pre-treatment|Other|1
872005|NCT00539006|1833596|FG002|Pre-treatment|Other|0
872006|NCT00539006|1833597|FG003|Pre-treatment|Other|0
872007|NCT00539006|1833594|FG000|Treatment Period 1|Lost to Follow-up|0
872008|NCT00539006|1833595|FG001|Treatment Period 1|Lost to Follow-up|0
872009|NCT00539006|1833596|FG002|Treatment Period 1|Lost to Follow-up|1
872010|NCT00539006|1833597|FG003|Treatment Period 1|Lost to Follow-up|0
872011|NCT00539006|1833594|FG000|Treatment Period 1|Protocol Violation|0
872012|NCT00539006|1833595|FG001|Treatment Period 1|Protocol Violation|0
872013|NCT00539006|1833596|FG002|Treatment Period 1|Protocol Violation|1
872014|NCT00539006|1833597|FG003|Treatment Period 1|Protocol Violation|0
872015|NCT00539006|1833594|FG000|Treatment Period 1|Lack of Efficacy|0
872016|NCT00539006|1833595|FG001|Treatment Period 1|Lack of Efficacy|0
872017|NCT00539006|1833596|FG002|Treatment Period 1|Lack of Efficacy|0
872018|NCT00539006|1833597|FG003|Treatment Period 1|Lack of Efficacy|1
872019|NCT00539006|1833594|FG000|Washout|Adverse Event|2
872020|NCT00539006|1833595|FG001|Washout|Adverse Event|1
872021|NCT00539006|1833596|FG002|Washout|Adverse Event|0
872022|NCT00539006|1833597|FG003|Washout|Adverse Event|0
872023|NCT00539006|1833594|FG000|Washout|Protocol Violation|1
872024|NCT00539006|1833595|FG001|Washout|Protocol Violation|1
872025|NCT00539006|1833596|FG002|Washout|Protocol Violation|0
872026|NCT00539006|1833597|FG003|Washout|Protocol Violation|0
872027|NCT00539006|1833594|FG000|Washout|Withdrawal by Subject|0
872028|NCT00539006|1833595|FG001|Washout|Withdrawal by Subject|2
872029|NCT00539006|1833596|FG002|Washout|Withdrawal by Subject|0
872030|NCT00539006|1833597|FG003|Washout|Withdrawal by Subject|0
872031|NCT00539006|1833594|FG000|Washout|Failed to meet continuation criteria|16
872032|NCT00539006|1833595|FG001|Washout|Failed to meet continuation criteria|5
872033|NCT00539006|1833596|FG002|Washout|Failed to meet continuation criteria|14
872034|NCT00539006|1833597|FG003|Washout|Failed to meet continuation criteria|6
872035|NCT00539006|1833594|FG000|Washout|Other|1
872036|NCT00539006|1833595|FG001|Washout|Other|1
872037|NCT00539006|1833596|FG002|Washout|Other|2
872038|NCT00539006|1833597|FG003|Washout|Other|3
872039|NCT00539006|1833594|FG000|Treatment Period 2|Protocol Violation|1
872040|NCT00539006|1833595|FG001|Treatment Period 2|Protocol Violation|0
872041|NCT00539006|1833596|FG002|Treatment Period 2|Protocol Violation|0
872042|NCT00539006|1833597|FG003|Treatment Period 2|Protocol Violation|0
872043|NCT00539006|1833594|FG000|Treatment Period 2|Other|0
872044|NCT00539006|1833595|FG001|Treatment Period 2|Other|1
872045|NCT00539006|1833596|FG002|Treatment Period 2|Other|0
872046|NCT00539006|1833597|FG003|Treatment Period 2|Other|0
872047|NCT00539032|1833615|FG000|Overall Study|Withdrawal by Subject|2
872048|NCT00539032|1833616|FG001|Overall Study|Withdrawal by Subject|1
1175354|NCT03733470|2318968|FG001|Overall Study|PI Decision|1
872049|NCT00539188|1833633|FG000|Overall Study|Withdrawal by Subject|1
872050|NCT00539188|1833634|FG001|Overall Study|Withdrawal by Subject|0
872051|NCT00539188|1833633|FG000|Overall Study|Lost to Follow-up|2
872052|NCT00539188|1833634|FG001|Overall Study|Lost to Follow-up|1
1175355|NCT03733301|2318977|FG000|Overall Study|Screen Fail|1
1175356|NCT03733301|2318978|FG001|Overall Study|Screen Fail|0
1175357|NCT03733301|2318979|FG002|Overall Study|Screen Fail|0
1175358|NCT03733301|2318977|FG000|Overall Study|Non-compliance|1
1175359|NCT03733301|2318978|FG001|Overall Study|Non-compliance|0
1175360|NCT03733301|2318979|FG002|Overall Study|Non-compliance|0
1175361|NCT03733301|2318977|FG000|Overall Study|Lack of Efficacy|2
1175362|NCT03733301|2318978|FG001|Overall Study|Lack of Efficacy|3
1175363|NCT03733301|2318979|FG002|Overall Study|Lack of Efficacy|0
1175364|NCT03733301|2318977|FG000|Overall Study|Adverse Event|0
1175365|NCT03733301|2318978|FG001|Overall Study|Adverse Event|1
1175366|NCT03733301|2318979|FG002|Overall Study|Adverse Event|3
1175367|NCT03733301|2318977|FG000|Overall Study|Withdrawal by Subject|3
1175368|NCT03733301|2318978|FG001|Overall Study|Withdrawal by Subject|5
1175369|NCT03733301|2318979|FG002|Overall Study|Withdrawal by Subject|1
1175370|NCT03732638|2318990|FG000|Overall Study|Adverse Event|5
1175371|NCT03732638|2318991|FG001|Overall Study|Adverse Event|2
1175372|NCT03732638|2318990|FG000|Overall Study|Eligibility failure due to baseline laboratory values|8
1175373|NCT03732638|2318991|FG001|Overall Study|Eligibility failure due to baseline laboratory values|13
1175374|NCT03732638|2318990|FG000|Overall Study|Lack of Efficacy|1
1175375|NCT03732638|2318991|FG001|Overall Study|Lack of Efficacy|1
1175376|NCT03732638|2318990|FG000|Overall Study|Lost to Follow-up|19
1175377|NCT03732638|2318991|FG001|Overall Study|Lost to Follow-up|12
1175378|NCT03732638|2318990|FG000|Overall Study|Non-compliance|6
1175379|NCT03732638|2318991|FG001|Overall Study|Non-compliance|5
1175380|NCT03732638|2318990|FG000|Overall Study|Physician Decision|0
1175381|NCT03732638|2318991|FG001|Overall Study|Physician Decision|1
1175382|NCT03732638|2318990|FG000|Overall Study|Protocol deviation|4
1175383|NCT03732638|2318991|FG001|Overall Study|Protocol deviation|5
1175384|NCT03732638|2318990|FG000|Overall Study|Withdrawal by Subject|11
1175385|NCT03732638|2318991|FG001|Overall Study|Withdrawal by Subject|22
1175386|NCT03732248|2319000|FG000|Overall Study|Withdrawal by Subject|1
1175387|NCT03732248|2319001|FG001|Overall Study|Withdrawal by Subject|0
1175388|NCT03731182|2319009|FG000|Overall Study|Lost to Follow-up|2
1175389|NCT03731182|2319010|FG001|Overall Study|Lost to Follow-up|0
1175390|NCT03731182|2319009|FG000|Overall Study|Physician Decision|1
1175391|NCT03731182|2319010|FG001|Overall Study|Physician Decision|0
1175392|NCT03731182|2319009|FG000|Overall Study|Withdrawal By Parent/Guardian|2
1175393|NCT03731182|2319010|FG001|Overall Study|Withdrawal By Parent/Guardian|0
1175394|NCT03730961|2319019|FG000|Overall Study|Adverse Event|0
1175395|NCT03730961|2319020|FG001|Overall Study|Adverse Event|1
1175396|NCT03730103|2319036|FG000|Overall Study|Did not meet inclusion criteria|0
1175397|NCT03730103|2319037|FG001|Overall Study|Did not meet inclusion criteria|5
1175398|NCT03728140|2319067|FG000|Overall Study|Abnormal embryo transfer operation|10
1175399|NCT03728140|2319068|FG001|Overall Study|Abnormal embryo transfer operation|7
1175400|NCT03727347|2319087|FG000|Overall Study|Withdrawal by Subject|2
1175401|NCT03727347|2319087|FG000|Overall Study|Lost to Follow-up|1
1175402|NCT03726996|2319100|FG000|Overall Study|Parent's decision|2
1175403|NCT03726996|2319100|FG000|Overall Study|Study early termination|2
1175404|NCT03725852|2319115|FG000|Overall Study|Death|1
1175405|NCT03725852|2319116|FG001|Overall Study|Death|0
1175406|NCT03725852|2319115|FG000|Overall Study|Withdrawal by Subject|1
1175407|NCT03725852|2319116|FG001|Overall Study|Withdrawal by Subject|0
872053|NCT00539240|1833643|FG000|Overall Study|Withdrawal by Subject|0
872054|NCT00539240|1833644|FG001|Overall Study|Withdrawal by Subject|2
872055|NCT00539240|1833645|FG002|Overall Study|Withdrawal by Subject|0
872056|NCT00539240|1833643|FG000|Overall Study|Protocol Violation|1
872057|NCT00539240|1833644|FG001|Overall Study|Protocol Violation|1
872058|NCT00539240|1833645|FG002|Overall Study|Protocol Violation|4
872059|NCT00539240|1833643|FG000|Overall Study|Lost to Follow-up|2
872060|NCT00539240|1833644|FG001|Overall Study|Lost to Follow-up|3
872061|NCT00539240|1833645|FG002|Overall Study|Lost to Follow-up|1
872062|NCT00539240|1833643|FG000|Overall Study|Adverse Event|3
872063|NCT00539240|1833644|FG001|Overall Study|Adverse Event|1
872064|NCT00539240|1833645|FG002|Overall Study|Adverse Event|10
872065|NCT00539279|1833659|FG000|Treatment|Withdrawal by Subject|10
872066|NCT00539279|1833660|FG001|Treatment|Withdrawal by Subject|8
872067|NCT00539279|1833659|FG000|Treatment|Death|1
872068|NCT00539279|1833660|FG001|Treatment|Death|0
872069|NCT00539279|1833659|FG000|Post-Treatment Assessment|Lost to Follow-up|12
872070|NCT00539279|1833660|FG001|Post-Treatment Assessment|Lost to Follow-up|9
872071|NCT00539279|1833659|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1
872072|NCT00539279|1833660|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7
872073|NCT00539305|1833668|FG000|Overall Study|Adverse Event|1
872074|NCT00539305|1833669|FG001|Overall Study|Adverse Event|0
872075|NCT00539305|1833668|FG000|Overall Study|Substance Use|0
872076|NCT00539305|1833669|FG001|Overall Study|Substance Use|1
872077|NCT00539305|1833668|FG000|Overall Study|Withdrawal by Subject|0
872078|NCT00539305|1833669|FG001|Overall Study|Withdrawal by Subject|1
1175408|NCT03725852|2319115|FG000|Overall Study|Travel restrictions due to COVID-19|2
1175409|NCT03725852|2319116|FG001|Overall Study|Travel restrictions due to COVID-19|0
1175410|NCT03725722|2319127|FG000|Overall Study|Lack of Efficacy|2
1175411|NCT03725722|2319128|FG001|Overall Study|Lack of Efficacy|1
1175412|NCT03725722|2319129|FG002|Overall Study|Lack of Efficacy|2
1175413|NCT03725722|2319130|FG003|Overall Study|Lack of Efficacy|0
1175414|NCT03725722|2319131|FG004|Overall Study|Lack of Efficacy|2
1175415|NCT03725722|2319127|FG000|Overall Study|Adverse Event|2
1175416|NCT03725722|2319128|FG001|Overall Study|Adverse Event|2
1175417|NCT03725722|2319129|FG002|Overall Study|Adverse Event|1
1175418|NCT03725722|2319130|FG003|Overall Study|Adverse Event|0
1175419|NCT03725722|2319131|FG004|Overall Study|Adverse Event|6
1175420|NCT03725722|2319127|FG000|Overall Study|Withdrawal by Subject|4
1175421|NCT03725722|2319128|FG001|Overall Study|Withdrawal by Subject|1
1175422|NCT03725722|2319129|FG002|Overall Study|Withdrawal by Subject|0
1175423|NCT03725722|2319130|FG003|Overall Study|Withdrawal by Subject|4
1175424|NCT03725722|2319131|FG004|Overall Study|Withdrawal by Subject|4
1175425|NCT03725722|2319127|FG000|Overall Study|Lost to Follow-up|3
1175426|NCT03725722|2319128|FG001|Overall Study|Lost to Follow-up|1
1175427|NCT03725722|2319129|FG002|Overall Study|Lost to Follow-up|2
1175428|NCT03725722|2319130|FG003|Overall Study|Lost to Follow-up|2
1175429|NCT03725722|2319131|FG004|Overall Study|Lost to Follow-up|1
1175430|NCT03725722|2319127|FG000|Overall Study|Personal reasons|0
1175431|NCT03725722|2319128|FG001|Overall Study|Personal reasons|0
1175432|NCT03725722|2319129|FG002|Overall Study|Personal reasons|1
1175433|NCT03725722|2319130|FG003|Overall Study|Personal reasons|0
1175434|NCT03725722|2319131|FG004|Overall Study|Personal reasons|1
1175435|NCT03725722|2319127|FG000|Overall Study|COVID-19 situation|0
1175436|NCT03725722|2319128|FG001|Overall Study|COVID-19 situation|1
1175437|NCT03725722|2319129|FG002|Overall Study|COVID-19 situation|0
872079|NCT00539500|1833675|FG000|Overall Study|Disease Progression|1
872080|NCT00539500|1833675|FG000|Overall Study|Lost to Follow-up|2
872081|NCT00539513|1833681|FG000|Overall Study|Withdrawal by Subject|2
872082|NCT00539513|1833682|FG001|Overall Study|Withdrawal by Subject|1
872083|NCT00539513|1833681|FG000|Overall Study|Lost to Follow-up|0
872084|NCT00539513|1833682|FG001|Overall Study|Lost to Follow-up|1
872085|NCT00539591|1833713|FG000|Overall Study|Toxicity|3
872086|NCT00539591|1833714|FG001|Overall Study|Toxicity|0
872087|NCT00539591|1833715|FG002|Overall Study|Toxicity|0
872088|NCT00539591|1833713|FG000|Overall Study|Disease progression|2
872089|NCT00539591|1833714|FG001|Overall Study|Disease progression|2
872090|NCT00539591|1833715|FG002|Overall Study|Disease progression|3
872091|NCT00539734|1833759|FG000|Overall Study|Protocol Violation|1
872092|NCT00539864|1833765|FG000|Overall Study|Lost to Follow-up|0
872093|NCT00539864|1833766|FG001|Overall Study|Lost to Follow-up|1
872094|NCT00539864|1833765|FG000|Overall Study|Withdrawal by Subject|1
872095|NCT00539864|1833766|FG001|Overall Study|Withdrawal by Subject|1
872096|NCT00539981|1833783|FG000|Overall Study|Adverse events (AE)|3
872097|NCT00539981|1833784|FG001|Overall Study|Adverse events (AE)|3
872098|NCT00539981|1833783|FG000|Overall Study|Lost to Follow-up|260
872099|NCT00539981|1833784|FG001|Overall Study|Lost to Follow-up|251
872100|NCT00539981|1833783|FG000|Overall Study|Withdrew consent|22
872101|NCT00539981|1833784|FG001|Overall Study|Withdrew consent|14
872102|NCT00539981|1833783|FG000|Overall Study|Death|1
872103|NCT00539981|1833784|FG001|Overall Study|Death|1
872104|NCT00539981|1833783|FG000|Overall Study|Other reason-unspecified|9
872105|NCT00539981|1833784|FG001|Overall Study|Other reason-unspecified|13
872106|NCT00539994|1833796|FG000|Overall Study|Lost to Follow-up|2
872107|NCT00539994|1833797|FG001|Overall Study|Lost to Follow-up|1
872108|NCT00539994|1833798|FG002|Overall Study|Lost to Follow-up|0
872109|NCT00539994|1833796|FG000|Overall Study|Withdrawal by Subject|1
872110|NCT00539994|1833797|FG001|Overall Study|Withdrawal by Subject|0
872111|NCT00539994|1833798|FG002|Overall Study|Withdrawal by Subject|1
872112|NCT00539994|1833796|FG000|Overall Study|Physician Decision|0
872113|NCT00539994|1833797|FG001|Overall Study|Physician Decision|0
872114|NCT00539994|1833798|FG002|Overall Study|Physician Decision|1
872115|NCT00540046|1833825|FG000|Overall Study|Lost to Follow-up|33
872116|NCT00540046|1833826|FG001|Overall Study|Lost to Follow-up|23
872117|NCT00540124|1833837|FG000|Overall Study|Adverse Event|0
872118|NCT00540124|1833838|FG001|Overall Study|Adverse Event|2
872119|NCT00540124|1833839|FG002|Overall Study|Adverse Event|1
872120|NCT00540124|1833837|FG000|Overall Study|Entry Criteria Not Met|2
872121|NCT00540124|1833838|FG001|Overall Study|Entry Criteria Not Met|0
872122|NCT00540124|1833839|FG002|Overall Study|Entry Criteria Not Met|0
872123|NCT00540124|1833837|FG000|Overall Study|Lack of Efficacy|1
872124|NCT00540124|1833838|FG001|Overall Study|Lack of Efficacy|0
872125|NCT00540124|1833839|FG002|Overall Study|Lack of Efficacy|0
872126|NCT00540124|1833837|FG000|Overall Study|Withdrawal by Subject|1
872127|NCT00540124|1833838|FG001|Overall Study|Withdrawal by Subject|1
872128|NCT00540124|1833839|FG002|Overall Study|Withdrawal by Subject|0
872129|NCT00540228|1833852|FG000|Overall Study|Adverse Event|2
872130|NCT00540228|1833853|FG001|Overall Study|Adverse Event|0
872131|NCT00540228|1833854|FG002|Overall Study|Adverse Event|0
872132|NCT00540228|1833855|FG003|Overall Study|Adverse Event|0
872133|NCT00540228|1833856|FG004|Overall Study|Adverse Event|0
1175438|NCT03725722|2319130|FG003|Overall Study|COVID-19 situation|0
1175439|NCT03725722|2319131|FG004|Overall Study|COVID-19 situation|0
1175440|NCT03725085|2319152|FG000|Overall Study|Lost to Follow-up|2
1175441|NCT03724981|2319168|FG000|First Device|Protocol Violation|1
1175442|NCT03724981|2319169|FG001|First Device|Protocol Violation|1
1175443|NCT03724968|2319179|FG000|Overall Study|Insurance issues|0
1175444|NCT03724968|2319180|FG001|Overall Study|Insurance issues|1
1175445|NCT03724968|2319179|FG000|Overall Study|Study closed|0
1175446|NCT03724968|2319180|FG001|Overall Study|Study closed|1
1175447|NCT03723070|2319244|FG000|Overall Study|Lost to Follow-up|2
1175448|NCT03723070|2319244|FG000|Overall Study|Physician Decision|1
1175449|NCT03723070|2319244|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6
1175450|NCT03720210|2319248|FG000|Overall Study|Lost to Follow-up|1
1175451|NCT03718143|2319256|FG000|Overall Study|Death|1
1175452|NCT03718143|2319257|FG001|Overall Study|Death|0
1175453|NCT03718143|2319258|FG002|Overall Study|Death|0
1175454|NCT03718143|2319256|FG000|Overall Study|Progression of Disease|1
1175455|NCT03718143|2319257|FG001|Overall Study|Progression of Disease|0
1175456|NCT03718143|2319258|FG002|Overall Study|Progression of Disease|0
1175457|NCT03718143|2319256|FG000|Overall Study|Withdrawal of Informed Consent|1
1175458|NCT03718143|2319257|FG001|Overall Study|Withdrawal of Informed Consent|2
1175459|NCT03718143|2319258|FG002|Overall Study|Withdrawal of Informed Consent|1
1175460|NCT03709576|2319266|FG000|Overall Study|progression prior to enrollment|1
1175461|NCT03704636|2319271|FG000|Overall Study|Inadequate Venous Flow|3
1175462|NCT03694821|2319295|FG000|Overall Study|Study terminated|4
1175463|NCT03694821|2319296|FG001|Overall Study|Study terminated|8
1175464|NCT03694821|2319297|FG002|Overall Study|Study terminated|4
1175465|NCT03686969|2319307|FG000|Overall Study|Study terminated|1
1175466|NCT03686969|2319308|FG001|Overall Study|Study terminated|0
1175467|NCT03682367|2319316|FG000|Overall Study|Protocol Violation|2
1175468|NCT03682367|2319317|FG001|Overall Study|Protocol Violation|1
1175469|NCT03682367|2319316|FG000|Overall Study|Closed Study Early|0
1175470|NCT03682367|2319317|FG001|Overall Study|Closed Study Early|3
1175471|NCT03680911|2319325|FG000|At Home Treatment|Study Termination|3
1175472|NCT03680911|2319326|FG001|At Home Treatment|Study Termination|0
1175473|NCT03680911|2319325|FG000|At Home Treatment|Lost to Follow-up|0
1175474|NCT03680911|2319326|FG001|At Home Treatment|Lost to Follow-up|1
1175475|NCT03680911|2319325|FG000|At Home Treatment|Withdrawal by Subject|0
1175476|NCT03680911|2319326|FG001|At Home Treatment|Withdrawal by Subject|2
1175477|NCT03680911|2319325|FG000|Visit 3 (4 Month Follow up)|Study Termination|0
1175478|NCT03680911|2319326|FG001|Visit 3 (4 Month Follow up)|Study Termination|1
1175479|NCT03656692|2319332|FG000|Overall Study|Worsening of disease activity|2
1175480|NCT03656692|2319332|FG000|Overall Study|Physician Decision|1
1175481|NCT03648983|2319336|FG000|Overall Study|Study was terminated due to PI departure|95
1175482|NCT03643159|2319343|FG000|Overall Study|Adverse Event|1
1175483|NCT03643159|2319343|FG000|Overall Study|Withdrawal by Subject|1
1175484|NCT03630120|2319361|FG000|Overall Study|Disease progression|0
1175485|NCT03630120|2319362|FG001|Overall Study|Disease progression|1
1175486|NCT03630120|2319363|FG002|Overall Study|Disease progression|1
1175487|NCT03630120|2319364|FG003|Overall Study|Disease progression|1
1175488|NCT03615144|2319395|FG000|Overall Study|Participant no longer eligible for this protocol|1
1175489|NCT03615144|2319396|FG001|Overall Study|Participant no longer eligible for this protocol|0
1175490|NCT03605303|2319402|FG000|Period 1|Study Terminated|2
1175491|NCT03605303|2319403|FG001|Period 1|Study Terminated|1
1175492|NCT03600740|2319409|FG000|Overall Study|Surgical plan was altered-subject not eligible|1
1175493|NCT03598140|2319415|FG000|Overall Study|enrolled but didn't start|1
1175494|NCT03598140|2319416|FG001|Overall Study|enrolled but didn't start|0
1175495|NCT03598036|2319424|FG000|Overall Study|Withdrawal by Subject|1
1175496|NCT03598036|2319425|FG001|Overall Study|Withdrawal by Subject|0
1175497|NCT03590743|2319444|FG000|Overall Study|Withdrawal by Subject|0
1175498|NCT03590743|2319445|FG001|Overall Study|Withdrawal by Subject|1
1175499|NCT03580382|2319453|FG000|Overall Study|Early Termination of Study|0
1175500|NCT03580382|2319454|FG001|Overall Study|Early Termination of Study|3
1175501|NCT03571646|2319471|FG000|Overall Study|Adverse Event|1
1175502|NCT03571646|2319472|FG001|Overall Study|Adverse Event|0
1175503|NCT03571646|2319471|FG000|Overall Study|Withdrawal by Subject|1
1175504|NCT03571646|2319472|FG001|Overall Study|Withdrawal by Subject|1
1175505|NCT03543358|2319495|FG000|Overall Study|Death|1
1175506|NCT03543358|2319496|FG001|Overall Study|Death|0
1175507|NCT03543358|2319495|FG000|Overall Study|Disease Progression|1
1175508|NCT03543358|2319496|FG001|Overall Study|Disease Progression|0
1175509|NCT03543358|2319495|FG000|Overall Study|Parent Study Closure|1
1175510|NCT03543358|2319496|FG001|Overall Study|Parent Study Closure|0
1175511|NCT03509207|2319524|FG000|Overall Study|Death|2
1175512|NCT03500341|2319541|FG000|Overall Study|Withdrawn prior to Completion|2
1175513|NCT03500159|2319547|FG000|Overall Study|Study Terminated|2
1175514|NCT03500159|2319548|FG001|Overall Study|Study Terminated|1
1175515|NCT03477903|2319574|FG000|Overall Study|Study Terminated by Sponsor|1
1175516|NCT03469258|2319578|FG000|Overall Study|Upon surgery, did not meet criteria|4
1175517|NCT03466658|2319582|FG000|Overall Study|Withdrawal by Subject|3
1175518|NCT03465891|2319590|FG000|Overall Study|Withdrawal by Subject|0
1175519|NCT03465891|2319591|FG001|Overall Study|Withdrawal by Subject|1
1175520|NCT03465891|2319590|FG000|Overall Study|Disease progression|1
1175521|NCT03465891|2319591|FG001|Overall Study|Disease progression|0
1175522|NCT03387059|2319669|FG000|Overall Study|Study termination|5
1175523|NCT03387059|2319670|FG001|Overall Study|Study termination|4
1175524|NCT03379233|2319687|FG000|Overall Study|Technical issues with Concept 2 inhalers|1
1175525|NCT03379233|2319688|FG001|Overall Study|Technical issues with Concept 2 inhalers|6
1175526|NCT03361228|2319704|FG000|Overall Study|Other|1
1175527|NCT03361228|2319705|FG001|Overall Study|Other|1
1175528|NCT03361228|2319704|FG000|Overall Study|Death|3
1175529|NCT03361228|2319705|FG001|Overall Study|Death|0
1175530|NCT03359174|2319720|FG000|Overall Study|Adverse Event|1
1175531|NCT03348904|2319731|FG000|Overall Study|Administrative reason by the sponsor|0
1175532|NCT03348904|2319732|FG001|Overall Study|Administrative reason by the sponsor|1
1175533|NCT03348904|2319733|FG002|Overall Study|Administrative reason by the sponsor|0
1175534|NCT03345901|2319741|FG000|Overall Study|The study was terminated|18
1175535|NCT03344562|2319748|FG000|Overall Study|Withdrawal by Subject|2
1175536|NCT03344562|2319749|FG001|Overall Study|Withdrawal by Subject|0
1175537|NCT03342638|2319757|FG000|Overall Study|Withdrawal by Subject|1
1175538|NCT03342638|2319758|FG001|Overall Study|Withdrawal by Subject|0
1175539|NCT03342638|2319757|FG000|Overall Study|Physician Decision|0
1175540|NCT03342638|2319758|FG001|Overall Study|Physician Decision|1
1175541|NCT03339401|2319775|FG000|Overall Study|Death|2
1175542|NCT03339401|2319776|FG001|Overall Study|Death|1
1175543|NCT03339401|2319775|FG000|Overall Study|Withdrawal by Subject|2
1175544|NCT03339401|2319776|FG001|Overall Study|Withdrawal by Subject|0
1175545|NCT03339401|2319775|FG000|Overall Study|Study terminated|4
1175546|NCT03339401|2319776|FG001|Overall Study|Study terminated|3
1175547|NCT03339401|2319775|FG000|Overall Study|Investigator Decision|1
1175548|NCT03339401|2319776|FG001|Overall Study|Investigator Decision|0
1175549|NCT03339245|2319784|FG000|Overall Study|Adverse Event|1
1175550|NCT03339245|2319785|FG001|Overall Study|Adverse Event|1
1175551|NCT03339245|2319784|FG000|Overall Study|Withdrawal by Subject|1
1175552|NCT03339245|2319785|FG001|Overall Study|Withdrawal by Subject|0
1175553|NCT03329404|2319797|FG000|Overall Study|The study was suspended.|1
1175554|NCT03329404|2319798|FG001|Overall Study|The study was suspended.|4
1175555|NCT03326869|2319806|FG000|Overall Study|Study data has been lost to natural disa|1
1175556|NCT03326869|2319807|FG001|Overall Study|Study data has been lost to natural disa|1
1175557|NCT03305055|2319832|FG000|Overall Study|Withdrawal by Subject|0
1175558|NCT03305055|2319833|FG001|Overall Study|Withdrawal by Subject|1
1175559|NCT03305055|2319832|FG000|Overall Study|Adverse Event|1
1175560|NCT03305055|2319833|FG001|Overall Study|Adverse Event|1
1175561|NCT03303469|2319839|FG000|Overall Study|Lost to Follow-up|2
1175562|NCT03302247|2319843|FG000|Overall Study|the study has closed prematurely|2
1175563|NCT03302247|2319843|FG000|Overall Study|Death|1
1175564|NCT03300024|2319849|FG000|Overall Study|Physician Decision|4
1175565|NCT03300024|2319850|FG001|Overall Study|Physician Decision|6
1175566|NCT03283709|2319860|FG000|Overall Study|trial terminated|0
1175567|NCT03283709|2319861|FG001|Overall Study|trial terminated|1
1175568|NCT03263806|2319896|FG000|Overall Study|Elevated Troponin (failed screen)|1
1175569|NCT03263806|2319897|FG001|Overall Study|Elevated Troponin (failed screen)|0
1175570|NCT03263806|2319896|FG000|Overall Study|Withdrawal by Subject|0
1175571|NCT03263806|2319897|FG001|Overall Study|Withdrawal by Subject|1
1175572|NCT03263806|2319896|FG000|Overall Study|Study Termination|5
1175573|NCT03263806|2319897|FG001|Overall Study|Study Termination|6
1175574|NCT03261531|2319903|FG000|Overall Study|Withdrawal by Subject|4
1175575|NCT03219372|2319922|FG000|Overall Study|Withdrawal by Subject|1
1175576|NCT03219372|2319923|FG001|Overall Study|Withdrawal by Subject|0
1175577|NCT03217175|2319929|FG000|Overall Study|Physician Decision|4
1175578|NCT03217175|2319930|FG001|Overall Study|Physician Decision|1
1175579|NCT03223662|2319957|FG000|Overall Study|Physician Decision|1
1175580|NCT03223662|2319957|FG000|Overall Study|Study closure|1
1175581|NCT03212144|2319963|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1
1175582|NCT03212144|2319964|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0
1175583|NCT03212144|2319963|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1
1175584|NCT03212144|2319964|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1
1175585|NCT03204539|2319980|FG000|Overall Study|Loss of funding|0
1175586|NCT03204539|2319981|FG001|Overall Study|Loss of funding|1
1175587|NCT03206216|2319989|FG000|Overall Study|Withdrawal by Subject|0
872134|NCT00540228|1833852|FG000|Overall Study|Lost to Follow-up|1
872135|NCT00540228|1833853|FG001|Overall Study|Lost to Follow-up|1
872136|NCT00540228|1833854|FG002|Overall Study|Lost to Follow-up|0
872137|NCT00540228|1833855|FG003|Overall Study|Lost to Follow-up|0
872138|NCT00540228|1833856|FG004|Overall Study|Lost to Follow-up|0
872139|NCT00540293|1833868|FG000|Overall Study|Adverse event related to study drug|10
872140|NCT00540293|1833868|FG000|Overall Study|Adverse event not related to study drug|7
872141|NCT00540293|1833868|FG000|Overall Study|Withdrawal by Subject|6
872142|NCT00540293|1833868|FG000|Overall Study|Protocol violation, & subject schedule|12
872143|NCT00540423|1833880|FG000|Double-Blind Treatment Period|Adverse Event|0
872144|NCT00540423|1833881|FG001|Double-Blind Treatment Period|Adverse Event|1
872145|NCT00540423|1833882|FG002|Double-Blind Treatment Period|Adverse Event|0
872146|NCT00540423|1833880|FG000|Open-Label Treatment Period|Lack of Efficacy|0
872147|NCT00540423|1833881|FG001|Open-Label Treatment Period|Lack of Efficacy|0
872148|NCT00540423|1833882|FG002|Open-Label Treatment Period|Lack of Efficacy|2
872149|NCT00540436|1833900|FG000|First 12-Week Treatment Period|Adverse Event|1
872150|NCT00540436|1833900|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1
1175588|NCT03206216|2319990|FG001|Overall Study|Withdrawal by Subject|1
1175589|NCT03195660|2319996|FG000|Overall Study|The study was terminated|2
1175590|NCT03166618|2320006|FG000|Overall Study|Study was Terminated|0
1175591|NCT03166618|2320007|FG001|Overall Study|Study was Terminated|1
1175592|NCT03169530|2320015|FG000|Overall Study|Study ended by NIH|15
1175593|NCT03169530|2320016|FG001|Overall Study|Study ended by NIH|17
1175594|NCT03151226|2320031|FG000|Overall Study|Withdrawal by Subject|2
1175595|NCT03151226|2320031|FG000|Overall Study|not wear device correctly|1
1175596|NCT03168906|2320046|FG000|Overall Study|Lack of Efficacy|6
1175597|NCT03168906|2320047|FG001|Overall Study|Lack of Efficacy|6
1175598|NCT03178201|2320054|FG000|Overall Study|Off study|5
1175599|NCT03172026|2320060|FG000|Overall Study|Withdrawal by Subject|1
1175600|NCT03172026|2320061|FG001|Overall Study|Withdrawal by Subject|0
1175601|NCT03172026|2320060|FG000|Overall Study|COVID restrictions|1
1175602|NCT03172026|2320061|FG001|Overall Study|COVID restrictions|0
1175603|NCT03152526|2320070|FG000|Overall Study|Withdrawal by Subject|0
1175604|NCT03152526|2320071|FG001|Overall Study|Withdrawal by Subject|1
1175605|NCT03123393|2320106|FG000|Overall Study|Study Terminated by Sponsor|6
1175606|NCT03123393|2320107|FG001|Overall Study|Study Terminated by Sponsor|9
1175607|NCT03123393|2320106|FG000|Overall Study|Withdrawal by Subject|2
1175608|NCT03123393|2320107|FG001|Overall Study|Withdrawal by Subject|1
1175609|NCT03123393|2320106|FG000|Overall Study|Reason not Specified|13
1175610|NCT03123393|2320107|FG001|Overall Study|Reason not Specified|13
1175611|NCT03119662|2320119|FG000|Overall Study|Withdrawal by Subject|0
1175612|NCT03119662|2320120|FG001|Overall Study|Withdrawal by Subject|1
1175613|NCT03120676|2320135|FG000|Overall Study|Not treated|1
1175614|NCT03113071|2320195|FG000|Overall Study|Withdrawal by Subject|1
1175615|NCT03113071|2320196|FG001|Overall Study|Withdrawal by Subject|0
1175616|NCT03110900|2320204|FG000|Overall Study|Sponsor withdrew|1
1175617|NCT03110900|2320205|FG001|Overall Study|Sponsor withdrew|1
1175618|NCT03078868|2320211|FG000|Overall Study|Physician Decision|3
1175619|NCT03065933|2320224|FG000|Overall Study|study terminated|5
1175620|NCT03070002|2320228|FG000|Follow up for 2 Years|Death|1
1175621|NCT03058705|2320232|FG000|Overall Study|Withdrawal by Subject|2
1175622|NCT03058705|2320232|FG000|Overall Study|Physician Decision|2
1175623|NCT03053518|2320254|FG000|Overall Study|Withdrawal by Subject|3
1175624|NCT03053518|2320254|FG000|Overall Study|Lost to Follow-up|2
872151|NCT00540436|1833900|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1
872152|NCT00540436|1833900|FG000|Second 12-Week Treatment Period|Adverse Event|1
872153|NCT00540449|1833906|FG000|Overall Study|Adverse Event|12
872154|NCT00540449|1833907|FG001|Overall Study|Adverse Event|32
872155|NCT00540449|1833906|FG000|Overall Study|Sponsor's Decision|1
872156|NCT00540449|1833907|FG001|Overall Study|Sponsor's Decision|1
872157|NCT00540449|1833906|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
872158|NCT00540449|1833907|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
872159|NCT00540449|1833906|FG000|Overall Study|Lost to Follow-up|19
872160|NCT00540449|1833907|FG001|Overall Study|Lost to Follow-up|17
872161|NCT00540449|1833906|FG000|Overall Study|Subject Non-Compliant|7
872162|NCT00540449|1833907|FG001|Overall Study|Subject Non-Compliant|5
872163|NCT00540449|1833906|FG000|Overall Study|Subject Reached A Virologic Endpoint|32
872164|NCT00540449|1833907|FG001|Overall Study|Subject Reached A Virologic Endpoint|8
872165|NCT00540449|1833906|FG000|Overall Study|Withdrawal by Subject|10
872166|NCT00540449|1833907|FG001|Overall Study|Withdrawal by Subject|10
872167|NCT00540449|1833906|FG000|Overall Study|Other|1
872168|NCT00540449|1833907|FG001|Overall Study|Other|4
872169|NCT00540514|1833915|FG000|Overall Study|Still on treatment|3
872170|NCT00540514|1833916|FG001|Overall Study|Still on treatment|0
872171|NCT00540514|1833915|FG000|Overall Study|Unacceptable Toxicity|61
872172|NCT00540514|1833916|FG001|Overall Study|Unacceptable Toxicity|62
872173|NCT00540514|1833915|FG000|Overall Study|Adverse Event|20
872174|NCT00540514|1833916|FG001|Overall Study|Adverse Event|24
872175|NCT00540514|1833915|FG000|Overall Study|Physician Decision|86
872176|NCT00540514|1833916|FG001|Overall Study|Physician Decision|99
872177|NCT00540514|1833915|FG000|Overall Study|Protocol Deviation|3
872178|NCT00540514|1833916|FG001|Overall Study|Protocol Deviation|4
872179|NCT00540514|1833915|FG000|Overall Study|Lost to Follow-up|1
872180|NCT00540514|1833916|FG001|Overall Study|Lost to Follow-up|1
872181|NCT00540514|1833915|FG000|Overall Study|Withdrawal by Subject|65
872182|NCT00540514|1833916|FG001|Overall Study|Withdrawal by Subject|67
872183|NCT00540514|1833915|FG000|Overall Study|Excluded prior to treatment|7
872184|NCT00540514|1833916|FG001|Overall Study|Excluded prior to treatment|7
872185|NCT00540514|1833915|FG000|Overall Study|Paclitaxel not available|0
872186|NCT00540514|1833916|FG001|Overall Study|Paclitaxel not available|2
872187|NCT00540592|1833937|FG000|Overall Study|Adverse Event|0
872188|NCT00540592|1833938|FG001|Overall Study|Adverse Event|1
872189|NCT00540592|1833939|FG002|Overall Study|Adverse Event|0
872190|NCT00540592|1833940|FG003|Overall Study|Adverse Event|0
872191|NCT00540592|1833941|FG004|Overall Study|Adverse Event|1
872192|NCT00540592|1833942|FG005|Overall Study|Adverse Event|0
872193|NCT00540592|1833943|FG006|Overall Study|Adverse Event|0
872194|NCT00540592|1833944|FG007|Overall Study|Adverse Event|1
872195|NCT00540592|1833945|FG008|Overall Study|Adverse Event|1
1175625|NCT03053518|2320254|FG000|Overall Study|Ineligible|5
1175626|NCT03050398|2320258|FG000|Overall Study|Study terminated by sponsor|8
1175627|NCT03029832|2320276|FG000|Overall Study|Safety Follow-Up Completed|2
1175628|NCT03029832|2320277|FG001|Overall Study|Safety Follow-Up Completed|0
1175629|NCT03029832|2320276|FG000|Overall Study|Death due to Disease Progression|1
1175630|NCT03029832|2320277|FG001|Overall Study|Death due to Disease Progression|0
1175631|NCT03029832|2320276|FG000|Overall Study|Study Terminated By Sponsor|1
1175632|NCT03029832|2320277|FG001|Overall Study|Study Terminated By Sponsor|1
1175633|NCT03010423|2320312|FG000|Overall Study|Study termination|8
1175634|NCT02991430|2320328|FG000|Treatment Period 1|Adverse Event|1
1175635|NCT02991430|2320329|FG001|Treatment Period 1|Adverse Event|0
1175636|NCT02991430|2320330|FG002|Treatment Period 1|Adverse Event|2
1175637|NCT02991430|2320328|FG000|Treatment Period 1|Withdrawal by Subject|0
1175638|NCT02991430|2320329|FG001|Treatment Period 1|Withdrawal by Subject|4
1175639|NCT02991430|2320330|FG002|Treatment Period 1|Withdrawal by Subject|0
1175640|NCT02991430|2320328|FG000|Treatment Period 2|Study Termination|6
1175641|NCT02991430|2320329|FG001|Treatment Period 2|Study Termination|3
1175642|NCT02991430|2320330|FG002|Treatment Period 2|Study Termination|3
1175643|NCT02991430|2320328|FG000|Treatment Period 2|Lost to Follow-up|0
1175644|NCT02991430|2320329|FG001|Treatment Period 2|Lost to Follow-up|0
1175645|NCT02991430|2320330|FG002|Treatment Period 2|Lost to Follow-up|1
1175646|NCT02991430|2320328|FG000|Post-treatment Observation Period|Study Termination|3
1175647|NCT02991430|2320329|FG001|Post-treatment Observation Period|Study Termination|6
1175648|NCT02991430|2320330|FG002|Post-treatment Observation Period|Study Termination|5
1175649|NCT02978833|2320363|FG000|Overall Study|Study terminated|1
1175650|NCT02978833|2320364|FG001|Overall Study|Study terminated|1
1175651|NCT02982720|2320401|FG000|Overall Study|Adverse Event|3
1175652|NCT02982720|2320401|FG000|Overall Study|Death|1
1175653|NCT02966223|2320405|FG000|Overall Study|Physician Decision|3
1175654|NCT02966223|2320405|FG000|Overall Study|Withdrawal by Subject|11
1175655|NCT02966223|2320405|FG000|Overall Study|Lost to Follow-up|1
1175656|NCT02965846|2320412|FG000|Overall Study|Lost to Follow-up|1
1175657|NCT02965846|2320413|FG001|Overall Study|Lost to Follow-up|0
1175658|NCT02965846|2320414|FG002|Overall Study|Lost to Follow-up|0
1175659|NCT02965846|2320412|FG000|Overall Study|Withdrawal by Subject|0
1175660|NCT02965846|2320413|FG001|Overall Study|Withdrawal by Subject|1
1175661|NCT02965846|2320414|FG002|Overall Study|Withdrawal by Subject|0
1175662|NCT02965846|2320412|FG000|Overall Study|Study Terminated By Sponsor|4
1175663|NCT02965846|2320413|FG001|Overall Study|Study Terminated By Sponsor|4
1175664|NCT02965846|2320414|FG002|Overall Study|Study Terminated By Sponsor|0
1175665|NCT02965846|2320412|FG000|Overall Study|Participants not randomized|0
1175666|NCT02965846|2320413|FG001|Overall Study|Participants not randomized|0
1175667|NCT02965846|2320414|FG002|Overall Study|Participants not randomized|33
1175668|NCT02956005|2320435|FG000|Overall Study|Not eligible|1
1175669|NCT02956005|2320435|FG000|Overall Study|Withdrawal by Subject|3
1175670|NCT02956005|2320435|FG000|Overall Study|Physician Decision|12
1175671|NCT02940223|2320450|FG000|Overall Study|Failed Requirement|2
1175672|NCT02940223|2320451|FG001|Overall Study|Failed Requirement|0
1175673|NCT02954159|2320459|FG000|Overall Study|Study ended prematurely due to low enrol|1
1175674|NCT02954159|2320460|FG001|Overall Study|Study ended prematurely due to low enrol|0
1175675|NCT02954159|2320459|FG000|Overall Study|Withdrawal by Subject|0
1175676|NCT02954159|2320460|FG001|Overall Study|Withdrawal by Subject|1
1175677|NCT02954952|2320469|FG000|Overall Study|Withdrawal by Subject|1
1175678|NCT02954952|2320470|FG001|Overall Study|Withdrawal by Subject|0
1175679|NCT02954952|2320471|FG002|Overall Study|Withdrawal by Subject|0
1175680|NCT02954952|2320469|FG000|Overall Study|No data collected|0
1175681|NCT02954952|2320470|FG001|Overall Study|No data collected|1
1175682|NCT02954952|2320471|FG002|Overall Study|No data collected|0
1175683|NCT02947022|2320483|FG000|Overall Study|Study Stopped|1
1175684|NCT02950480|2320498|FG000|Overall Study|Withdrawal by Subject|1
1175685|NCT02950480|2320499|FG001|Overall Study|Withdrawal by Subject|0
1175686|NCT02949947|2320507|FG000|Overall Study|Non Compliance|0
1175687|NCT02949947|2320508|FG001|Overall Study|Non Compliance|1
1175688|NCT02949947|2320507|FG000|Overall Study|Insurance change|1
1175689|NCT02949947|2320508|FG001|Overall Study|Insurance change|0
1175690|NCT02947100|2320514|FG000|Overall Study|study terminated early|3
1175691|NCT02947100|2320514|FG000|Overall Study|did not meet inclusion criteria|1
1175692|NCT02908516|2320535|FG000|Overall Study|Study Terminated|3
1175693|NCT02908516|2320536|FG001|Overall Study|Study Terminated|3
1175694|NCT02923830|2320544|FG000|Overall Study|Physician Decision|13
1175695|NCT02923830|2320545|FG001|Overall Study|Physician Decision|15
1175696|NCT02920450|2320551|FG000|Overall Study|Death|1
1175697|NCT02920450|2320552|FG001|Overall Study|Death|0
1175698|NCT02920450|2320553|FG002|Overall Study|Death|0
1175699|NCT02920450|2320554|FG003|Overall Study|Death|0
1175700|NCT02920450|2320551|FG000|Overall Study|Withdrawal by Subject|1
1175701|NCT02920450|2320552|FG001|Overall Study|Withdrawal by Subject|0
1175702|NCT02920450|2320553|FG002|Overall Study|Withdrawal by Subject|0
1175703|NCT02920450|2320554|FG003|Overall Study|Withdrawal by Subject|0
1175704|NCT02920177|2320563|FG000|Overall Study|Withdrawal by Subject|1
1175705|NCT02920177|2320564|FG001|Overall Study|Withdrawal by Subject|1
1175706|NCT02920177|2320563|FG000|Overall Study|Physician Decision|1
1175707|NCT02920177|2320564|FG001|Overall Study|Physician Decision|0
1175708|NCT02920177|2320563|FG000|Overall Study|Lost to Follow-up|0
1175709|NCT02920177|2320564|FG001|Overall Study|Lost to Follow-up|1
1175710|NCT02926638|2320572|FG000|Overall Study|Progression|2
1175711|NCT02926638|2320573|FG001|Overall Study|Progression|5
1175712|NCT02926638|2320572|FG000|Overall Study|Ineligible|1
1175713|NCT02926638|2320573|FG001|Overall Study|Ineligible|0
1175714|NCT02926638|2320572|FG000|Overall Study|Not protocol specified|1
1175715|NCT02926638|2320573|FG001|Overall Study|Not protocol specified|0
1175716|NCT02920242|2320582|FG000|Overall Study|Withdrawal by Subject|1
1175717|NCT02920242|2320583|FG001|Overall Study|Withdrawal by Subject|0
1175718|NCT02920242|2320584|FG002|Overall Study|Withdrawal by Subject|1
1175719|NCT02920242|2320582|FG000|Overall Study|Did not meet inc./exc. criteria|1
1175720|NCT02920242|2320583|FG001|Overall Study|Did not meet inc./exc. criteria|0
1175721|NCT02920242|2320584|FG002|Overall Study|Did not meet inc./exc. criteria|0
1175722|NCT02899728|2320616|FG000|Overall Study|Withdrawal by Subject|1
1175723|NCT02899728|2320617|FG001|Overall Study|Withdrawal by Subject|1
1175724|NCT02875067|2320623|FG000|Overall Study|Withdrawal by Subject|1
1175725|NCT02875067|2320623|FG000|Overall Study|Withdrawal by Termination of Study|5
1175726|NCT02860169|2320638|FG000|Part A|Withdrawal by Subject|1
1175727|NCT02860169|2320638|FG000|Part A|Other (Screening failure)|6
1175728|NCT02860169|2320638|FG000|Part A|Other (Survey not completed)|3
1175729|NCT02860169|2320638|FG000|Part A|Other (did not completed consent)|1
1175730|NCT02860169|2320638|FG000|Part B|Other (Screening failure)|10
1175731|NCT02860169|2320638|FG000|Part B|Withdrawal by Subject|1
872196|NCT00540592|1833946|FG009|Overall Study|Adverse Event|2
872197|NCT00540592|1833937|FG000|Overall Study|Lost to Follow-up|2
872198|NCT00540592|1833938|FG001|Overall Study|Lost to Follow-up|0
872199|NCT00540592|1833939|FG002|Overall Study|Lost to Follow-up|0
872200|NCT00540592|1833940|FG003|Overall Study|Lost to Follow-up|0
872201|NCT00540592|1833941|FG004|Overall Study|Lost to Follow-up|0
872202|NCT00540592|1833942|FG005|Overall Study|Lost to Follow-up|0
872203|NCT00540592|1833943|FG006|Overall Study|Lost to Follow-up|0
1175732|NCT02860169|2320638|FG000|Part C|Other (Screening failure)|1
1175733|NCT02865395|2320647|FG000|Overall Study|Physician Decision|6
1175734|NCT02865395|2320648|FG001|Overall Study|Physician Decision|10
1175735|NCT02865395|2320649|FG002|Overall Study|Physician Decision|7
872204|NCT00540592|1833944|FG007|Overall Study|Lost to Follow-up|0
872205|NCT00540592|1833945|FG008|Overall Study|Lost to Follow-up|0
872206|NCT00540592|1833946|FG009|Overall Study|Lost to Follow-up|0
872207|NCT00540592|1833937|FG000|Overall Study|Withdrawal by Subject|0
872208|NCT00540592|1833938|FG001|Overall Study|Withdrawal by Subject|0
872209|NCT00540592|1833939|FG002|Overall Study|Withdrawal by Subject|1
872210|NCT00540592|1833940|FG003|Overall Study|Withdrawal by Subject|1
872211|NCT00540592|1833941|FG004|Overall Study|Withdrawal by Subject|0
872212|NCT00540592|1833942|FG005|Overall Study|Withdrawal by Subject|0
872213|NCT00540592|1833943|FG006|Overall Study|Withdrawal by Subject|0
872214|NCT00540592|1833944|FG007|Overall Study|Withdrawal by Subject|0
872215|NCT00540592|1833945|FG008|Overall Study|Withdrawal by Subject|0
872216|NCT00540592|1833946|FG009|Overall Study|Withdrawal by Subject|0
872217|NCT00540644|1833970|FG000|Overall Study|Adverse Event|3
872218|NCT00540644|1833971|FG001|Overall Study|Adverse Event|1
872219|NCT00540644|1833970|FG000|Overall Study|Disease Progression|3
872220|NCT00540644|1833971|FG001|Overall Study|Disease Progression|1
872221|NCT00540644|1833970|FG000|Overall Study|Physician Decision|0
872222|NCT00540644|1833971|FG001|Overall Study|Physician Decision|5
872223|NCT00540644|1833970|FG000|Overall Study|Withdrawal by Subject|2
872224|NCT00540644|1833971|FG001|Overall Study|Withdrawal by Subject|2
872225|NCT00540644|1833970|FG000|Overall Study|Noncomplilance|1
872226|NCT00540644|1833971|FG001|Overall Study|Noncomplilance|0
872227|NCT00541034|1834012|FG000|Overall Study|Non-Compliance|3
872228|NCT00541099|1834016|FG000|Overall Study|Ineligible|3
872229|NCT00541229|1834037|FG000|Treatment Period I (Week 1)|Physician Decision|0
872230|NCT00541229|1834038|FG001|Treatment Period I (Week 1)|Physician Decision|0
872231|NCT00541229|1834039|FG002|Treatment Period I (Week 1)|Physician Decision|1
872232|NCT00541229|1834040|FG003|Treatment Period I (Week 1)|Physician Decision|0
872233|NCT00541229|1834041|FG004|Treatment Period I (Week 1)|Physician Decision|0
872234|NCT00541229|1834042|FG005|Treatment Period I (Week 1)|Physician Decision|0
872235|NCT00541229|1834037|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0
872236|NCT00541229|1834038|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0
872237|NCT00541229|1834039|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0
872238|NCT00541229|1834040|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0
872239|NCT00541229|1834041|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0
872240|NCT00541229|1834042|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1
872241|NCT00541229|1834037|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0
872242|NCT00541229|1834038|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0
872243|NCT00541229|1834039|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0
872244|NCT00541229|1834040|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0
872245|NCT00541229|1834041|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0
872246|NCT00541229|1834042|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1
872247|NCT00541229|1834037|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
872248|NCT00541229|1834038|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
872249|NCT00541229|1834039|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
1175736|NCT02868892|2320657|FG000|Overall Study|Investigator left site and no follow-up|6
1175737|NCT02865083|2320663|FG000|Overall Study|Early Termination|3
1175738|NCT02865083|2320664|FG001|Overall Study|Early Termination|1
1175739|NCT02865122|2320673|FG000|Overall Study|Adverse Event|1
1175740|NCT02865122|2320674|FG001|Overall Study|Adverse Event|0
1175741|NCT02865122|2320675|FG002|Overall Study|Adverse Event|0
1175742|NCT02865915|2320685|FG000|Overall Study|Pregnancy|1
1175743|NCT02865915|2320686|FG001|Overall Study|Pregnancy|0
1175744|NCT02865915|2320685|FG000|Overall Study|Withdrawal by Subject|1
1175745|NCT02865915|2320686|FG001|Overall Study|Withdrawal by Subject|1
1175746|NCT02865915|2320685|FG000|Overall Study|Adverse Event|0
1175747|NCT02865915|2320686|FG001|Overall Study|Adverse Event|4
1175748|NCT02865915|2320685|FG000|Overall Study|Lost to Follow-up|0
1175749|NCT02865915|2320686|FG001|Overall Study|Lost to Follow-up|1
1175750|NCT02865915|2320685|FG000|Overall Study|Protocol Violation|0
1175751|NCT02865915|2320686|FG001|Overall Study|Protocol Violation|1
1175752|NCT02865915|2320685|FG000|Overall Study|Study terminated by sponsor|23
1175753|NCT02865915|2320686|FG001|Overall Study|Study terminated by sponsor|18
1175754|NCT02865915|2320685|FG000|Overall Study|Dosing group discontinued|0
1175755|NCT02865915|2320686|FG001|Overall Study|Dosing group discontinued|5
1175756|NCT02855411|2320692|FG000|Overall Study|Study terminated by sponsor|21
1175757|NCT02855411|2320692|FG000|Overall Study|Does not meet entrance criteria|14
1175758|NCT02828124|2320708|FG000|Overall Study|Disease Progression|1
1175759|NCT02828124|2320709|FG001|Overall Study|Disease Progression|2
1175760|NCT02828124|2320710|FG002|Overall Study|Disease Progression|1
1175761|NCT02828124|2320711|FG003|Overall Study|Disease Progression|4
1175762|NCT02828124|2320708|FG000|Overall Study|AE Unrelated to Study Drug|0
1175763|NCT02828124|2320709|FG001|Overall Study|AE Unrelated to Study Drug|0
1175764|NCT02828124|2320710|FG002|Overall Study|AE Unrelated to Study Drug|0
1175765|NCT02828124|2320711|FG003|Overall Study|AE Unrelated to Study Drug|1
1175766|NCT02828124|2320708|FG000|Overall Study|Subject Withdrew Consent|0
1175767|NCT02828124|2320709|FG001|Overall Study|Subject Withdrew Consent|0
1175768|NCT02828124|2320710|FG002|Overall Study|Subject Withdrew Consent|0
1175769|NCT02828124|2320711|FG003|Overall Study|Subject Withdrew Consent|1
1175770|NCT02825043|2320730|FG000|Overall Study|Lost to Follow-up|4
1175771|NCT02819804|2320734|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
1175772|NCT02809118|2320741|FG000|Overall Study|Withdrawal by Subject|0
1175773|NCT02809118|2320742|FG001|Overall Study|Withdrawal by Subject|1
1175774|NCT02809118|2320743|FG002|Overall Study|Withdrawal by Subject|1
1175775|NCT02806960|2320779|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3
1175776|NCT02806960|2320780|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3
1175777|NCT02806960|2320781|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3
1175778|NCT02806960|2320782|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3
1175779|NCT02815397|2320792|FG000|Overall Study|Physician Decision|2
872250|NCT00541229|1834040|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
872251|NCT00541229|1834041|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
872252|NCT00541229|1834042|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
872253|NCT00541229|1834037|FG000|Washout Period I (Week 2-5)|Adverse Event|1
872254|NCT00541229|1834038|FG001|Washout Period I (Week 2-5)|Adverse Event|0
872255|NCT00541229|1834039|FG002|Washout Period I (Week 2-5)|Adverse Event|1
872256|NCT00541229|1834040|FG003|Washout Period I (Week 2-5)|Adverse Event|0
872257|NCT00541229|1834041|FG004|Washout Period I (Week 2-5)|Adverse Event|0
872258|NCT00541229|1834042|FG005|Washout Period I (Week 2-5)|Adverse Event|0
872259|NCT00541229|1834037|FG000|Washout Period I (Week 2-5)|Physician Decision|0
872260|NCT00541229|1834038|FG001|Washout Period I (Week 2-5)|Physician Decision|0
872261|NCT00541229|1834039|FG002|Washout Period I (Week 2-5)|Physician Decision|0
872262|NCT00541229|1834040|FG003|Washout Period I (Week 2-5)|Physician Decision|1
872263|NCT00541229|1834041|FG004|Washout Period I (Week 2-5)|Physician Decision|0
872264|NCT00541229|1834042|FG005|Washout Period I (Week 2-5)|Physician Decision|0
872265|NCT00541229|1834037|FG000|Washout Period I (Week 2-5)|Protocol Violation|0
872266|NCT00541229|1834038|FG001|Washout Period I (Week 2-5)|Protocol Violation|0
872267|NCT00541229|1834039|FG002|Washout Period I (Week 2-5)|Protocol Violation|0
872268|NCT00541229|1834040|FG003|Washout Period I (Week 2-5)|Protocol Violation|0
872269|NCT00541229|1834041|FG004|Washout Period I (Week 2-5)|Protocol Violation|0
872270|NCT00541229|1834042|FG005|Washout Period I (Week 2-5)|Protocol Violation|1
872271|NCT00541229|1834037|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
872272|NCT00541229|1834038|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
872273|NCT00541229|1834039|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
872274|NCT00541229|1834040|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
872275|NCT00541229|1834041|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
872276|NCT00541229|1834042|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
872277|NCT00541229|1834037|FG000|Treatment Period II (Week 6)|Protocol Violation|0
872278|NCT00541229|1834038|FG001|Treatment Period II (Week 6)|Protocol Violation|0
872279|NCT00541229|1834039|FG002|Treatment Period II (Week 6)|Protocol Violation|0
872280|NCT00541229|1834040|FG003|Treatment Period II (Week 6)|Protocol Violation|0
872281|NCT00541229|1834041|FG004|Treatment Period II (Week 6)|Protocol Violation|1
872282|NCT00541229|1834042|FG005|Treatment Period II (Week 6)|Protocol Violation|1
872283|NCT00541229|1834037|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
872284|NCT00541229|1834038|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1175780|NCT02802592|2320796|FG000|Overall Study|Study terminated due to loss of funding|4
1175781|NCT02730793|2320821|FG000|Overall Study|Physician Decision|0
1175782|NCT02730793|2320822|FG001|Overall Study|Physician Decision|1
1175783|NCT02730793|2320821|FG000|Overall Study|Withdrawal by Subject|0
1175784|NCT02730793|2320822|FG001|Overall Study|Withdrawal by Subject|1
1175785|NCT02760602|2320839|FG000|Overall Study|Withdrawal by Subject|1
1175786|NCT02760602|2320840|FG001|Overall Study|Withdrawal by Subject|0
1175787|NCT02760602|2320839|FG000|Overall Study|Terminated by sponsor|12
1175788|NCT02760602|2320840|FG001|Overall Study|Terminated by sponsor|13
1175789|NCT02757521|2320848|FG000|Overall Study|Adverse Event|1
872285|NCT00541229|1834039|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
872286|NCT00541229|1834040|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
872287|NCT00541229|1834041|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
872288|NCT00541229|1834042|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
872289|NCT00541229|1834037|FG000|Washout Period II (Week 7-10)|Protocol Violation|1
872290|NCT00541229|1834038|FG001|Washout Period II (Week 7-10)|Protocol Violation|0
872291|NCT00541229|1834039|FG002|Washout Period II (Week 7-10)|Protocol Violation|0
872292|NCT00541229|1834040|FG003|Washout Period II (Week 7-10)|Protocol Violation|0
872293|NCT00541229|1834041|FG004|Washout Period II (Week 7-10)|Protocol Violation|0
872294|NCT00541229|1834042|FG005|Washout Period II (Week 7-10)|Protocol Violation|0
872295|NCT00541229|1834037|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0
872296|NCT00541229|1834038|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0
872297|NCT00541229|1834039|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0
872298|NCT00541229|1834040|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0
872299|NCT00541229|1834041|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1
872300|NCT00541229|1834042|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0
872301|NCT00541229|1834037|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
872302|NCT00541229|1834038|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
872303|NCT00541229|1834039|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
872304|NCT00541229|1834040|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
872305|NCT00541229|1834041|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
872306|NCT00541229|1834042|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
872307|NCT00541229|1834037|FG000|Treatment Period III (Week 11)|Adverse Event|0
872308|NCT00541229|1834038|FG001|Treatment Period III (Week 11)|Adverse Event|0
872309|NCT00541229|1834039|FG002|Treatment Period III (Week 11)|Adverse Event|0
872310|NCT00541229|1834040|FG003|Treatment Period III (Week 11)|Adverse Event|0
872311|NCT00541229|1834041|FG004|Treatment Period III (Week 11)|Adverse Event|1
872312|NCT00541229|1834042|FG005|Treatment Period III (Week 11)|Adverse Event|0
872313|NCT00541229|1834037|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0
872314|NCT00541229|1834038|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0
872315|NCT00541229|1834039|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0
872316|NCT00541229|1834040|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0
872317|NCT00541229|1834041|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0
872318|NCT00541229|1834042|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1
872319|NCT00541229|1834037|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
872320|NCT00541229|1834038|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
872321|NCT00541229|1834039|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
872322|NCT00541229|1834040|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
872323|NCT00541229|1834041|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
872324|NCT00541229|1834042|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
872325|NCT00541307|1834059|FG000|Overall Study|Death|5
872326|NCT00541307|1834059|FG000|Overall Study|Physician Decision|3
872327|NCT00541307|1834059|FG000|Overall Study|Withdrawal by Subject|6
872328|NCT00541307|1834059|FG000|Overall Study|Lost to Follow-up|4
872329|NCT00541307|1834059|FG000|Overall Study|Subject returned early (outside window)|1
872330|NCT00541307|1834059|FG000|Overall Study|Surgical Bypass|5
872331|NCT00541346|1834063|FG000|Follow-up|Adverse Event|1
872332|NCT00541385|1834069|FG000|Overall Study|Adverse Event|6
872333|NCT00541385|1834070|FG001|Overall Study|Adverse Event|3
872334|NCT00541385|1834069|FG000|Overall Study|Withdrawal by Subject|2
872335|NCT00541385|1834070|FG001|Overall Study|Withdrawal by Subject|2
872336|NCT00541385|1834069|FG000|Overall Study|Lost to Follow-up|6
872337|NCT00541385|1834070|FG001|Overall Study|Lost to Follow-up|1
872338|NCT00541385|1834069|FG000|Overall Study|Parasite reappearance/malaria|67
872339|NCT00541385|1834070|FG001|Overall Study|Parasite reappearance/malaria|32
872340|NCT00541450|1834078|FG000|Phase A|Adverse Event|3
872341|NCT00541450|1834079|FG001|Phase A|Adverse Event|0
872342|NCT00541450|1834078|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0
872343|NCT00541450|1834079|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2
872344|NCT00541450|1834078|FG000|Phase A|Hyperglycemia|0
872345|NCT00541450|1834079|FG001|Phase A|Hyperglycemia|1
872346|NCT00541450|1834078|FG000|Phase A|Lost to Follow-up|6
872347|NCT00541450|1834079|FG001|Phase A|Lost to Follow-up|4
872348|NCT00541450|1834078|FG000|Phase A|Physician Decision|2
872349|NCT00541450|1834079|FG001|Phase A|Physician Decision|0
872350|NCT00541450|1834078|FG000|Phase A|Protocol Violation|2
1175790|NCT02757521|2320849|FG001|Overall Study|Adverse Event|0
1175791|NCT02725671|2320902|FG000|Overall Study|Lost to Follow-up|1
1175792|NCT02732327|2320923|FG000|Overall Study|Protocol Violation|0
1175793|NCT02732327|2320924|FG001|Overall Study|Protocol Violation|1
1175794|NCT02726399|2320930|FG000|Overall Study|Participant Non-Compliance|1
1175795|NCT02726399|2320930|FG000|Overall Study|Adverse Event|2
1175796|NCT02726399|2320930|FG000|Overall Study|Progression of disease|4
1175797|NCT02720510|2320936|FG000|Overall Study|Study Terminated by the sponsor|2
1175798|NCT02720510|2320937|FG001|Overall Study|Study Terminated by the sponsor|0
1175799|NCT02720510|2320936|FG000|Overall Study|Adverse Event|0
1175800|NCT02720510|2320937|FG001|Overall Study|Adverse Event|1
1175801|NCT02720510|2320936|FG000|Overall Study|Physician Decision|1
1175802|NCT02720510|2320937|FG001|Overall Study|Physician Decision|2
1175803|NCT02715765|2320946|FG000|Overall Study|Study Termination|3
1175804|NCT02715765|2320947|FG001|Overall Study|Study Termination|0
1175805|NCT02715765|2320948|FG002|Overall Study|Study Termination|0
1175806|NCT02717130|2320967|FG000|Overall Study|Withdrawal by Subject|1
1175807|NCT02717130|2320967|FG000|Overall Study|Adverse Event|1
1175808|NCT02717130|2320967|FG000|Overall Study|Physician Decision|1
1175809|NCT02717130|2320967|FG000|Overall Study|Study Closure|4
1175810|NCT02685202|2320971|FG000|Overall Study|Lost to Follow-up|9
1175811|NCT02709083|2320975|FG000|Overall Study|Original PI left institution|7
1175812|NCT02693171|2320979|FG000|Overall Study|Adverse Event|1
1175813|NCT02693171|2320979|FG000|Overall Study|Discontinuation of Study by Sponsor|8
1175814|NCT02696226|2320987|FG000|Overall Study|Study terminated - lack of enrollment|1
1175815|NCT02696226|2320988|FG001|Overall Study|Study terminated - lack of enrollment|0
1175816|NCT02696226|2320989|FG002|Overall Study|Study terminated - lack of enrollment|2
1175817|NCT02696226|2320990|FG003|Overall Study|Study terminated - lack of enrollment|0
1175818|NCT02693743|2321002|FG000|Overall Study|Physician Decision|1
1175819|NCT02693743|2321003|FG001|Overall Study|Physician Decision|0
1175820|NCT02706691|2321009|FG000|Overall Study|Adverse Event|1
1175821|NCT02694757|2321027|FG000|Overall Study|Lack of Efficacy|3
1175822|NCT02693002|2321033|FG000|Overall Study|Withdrawal by Subject|1
1175823|NCT02693002|2321034|FG001|Overall Study|Withdrawal by Subject|0
1175824|NCT02689518|2321040|FG000|Overall Study|Withdrawal by Subject|3
1175825|NCT02673684|2321071|FG000|Overall Study|Study not completed d/t loss of funding|9
1175826|NCT02673684|2321072|FG001|Overall Study|Study not completed d/t loss of funding|8
1175827|NCT02674204|2321082|FG000|Overall Study|Adverse Event|1
1175828|NCT02674204|2321083|FG001|Overall Study|Adverse Event|0
1175829|NCT02671461|2321105|FG000|Treatment|Adverse Event|0
1175830|NCT02671461|2321106|FG001|Treatment|Adverse Event|0
1175831|NCT02671461|2321107|FG002|Treatment|Adverse Event|1
1175832|NCT02671461|2321105|FG000|Treatment|Administrative Reason by Sponsor|1
1175833|NCT02671461|2321106|FG001|Treatment|Administrative Reason by Sponsor|3
1175834|NCT02671461|2321107|FG002|Treatment|Administrative Reason by Sponsor|4
1175835|NCT02671461|2321105|FG000|Treatment|Randomized, not treated|1
1175836|NCT02671461|2321106|FG001|Treatment|Randomized, not treated|0
1175837|NCT02671461|2321107|FG002|Treatment|Randomized, not treated|0
872351|NCT00541450|1834079|FG001|Phase A|Protocol Violation|3
872352|NCT00541450|1834078|FG000|Phase A|Withdrawal by Subject|7
872353|NCT00541450|1834079|FG001|Phase A|Withdrawal by Subject|7
872354|NCT00541450|1834078|FG000|Phase B|Adverse Event|6
872355|NCT00541450|1834079|FG001|Phase B|Adverse Event|6
872356|NCT00541450|1834078|FG000|Phase B|Hyperglycemia|10
872357|NCT00541450|1834079|FG001|Phase B|Hyperglycemia|9
872358|NCT00541450|1834078|FG000|Phase B|Lost to Follow-up|6
872359|NCT00541450|1834079|FG001|Phase B|Lost to Follow-up|4
872360|NCT00541450|1834078|FG000|Phase B|Physician Decision|4
872361|NCT00541450|1834079|FG001|Phase B|Physician Decision|2
872362|NCT00541450|1834078|FG000|Phase B|Pregnancy|0
872363|NCT00541450|1834079|FG001|Phase B|Pregnancy|1
872364|NCT00541450|1834078|FG000|Phase B|Protocol Violation|3
872365|NCT00541450|1834079|FG001|Phase B|Protocol Violation|3
872366|NCT00541450|1834078|FG000|Phase B|Withdrawal by Subject|8
872367|NCT00541450|1834079|FG001|Phase B|Withdrawal by Subject|6
872368|NCT00541658|1834096|FG000|Overall Study|Adverse Event|28
872369|NCT00541658|1834097|FG001|Overall Study|Adverse Event|37
872370|NCT00541658|1834098|FG002|Overall Study|Adverse Event|25
872371|NCT00541658|1834096|FG000|Overall Study|Physician Decision|0
872372|NCT00541658|1834097|FG001|Overall Study|Physician Decision|0
872373|NCT00541658|1834098|FG002|Overall Study|Physician Decision|4
872374|NCT00541658|1834096|FG000|Overall Study|Lost to Follow-up|3
872375|NCT00541658|1834097|FG001|Overall Study|Lost to Follow-up|3
872376|NCT00541658|1834098|FG002|Overall Study|Lost to Follow-up|6
872377|NCT00541658|1834096|FG000|Overall Study|Protocol Violation|0
872378|NCT00541658|1834097|FG001|Overall Study|Protocol Violation|1
872379|NCT00541658|1834098|FG002|Overall Study|Protocol Violation|1
872380|NCT00541658|1834096|FG000|Overall Study|Withdrawal by Subject|28
872381|NCT00541658|1834097|FG001|Overall Study|Withdrawal by Subject|32
872382|NCT00541658|1834098|FG002|Overall Study|Withdrawal by Subject|32
872383|NCT00541658|1834096|FG000|Overall Study|Took No Study Drug|1
1175838|NCT02671461|2321105|FG000|Follow-up|Withdrawal by Subject|1
1175839|NCT02671461|2321106|FG001|Follow-up|Withdrawal by Subject|0
1175840|NCT02671461|2321107|FG002|Follow-up|Withdrawal by Subject|0
1175841|NCT02671461|2321105|FG000|Follow-up|Lost to Follow-up|0
1175842|NCT02671461|2321106|FG001|Follow-up|Lost to Follow-up|0
1175843|NCT02671461|2321107|FG002|Follow-up|Lost to Follow-up|1
872384|NCT00541658|1834097|FG001|Overall Study|Took No Study Drug|0
872385|NCT00541658|1834098|FG002|Overall Study|Took No Study Drug|0
872386|NCT00541775|1834120|FG000|Overall Study|Adverse Event|3
872387|NCT00541775|1834121|FG001|Overall Study|Adverse Event|2
872388|NCT00541775|1834122|FG002|Overall Study|Adverse Event|1
872389|NCT00541775|1834120|FG000|Overall Study|Lack of Efficacy|0
872390|NCT00541775|1834121|FG001|Overall Study|Lack of Efficacy|0
872391|NCT00541775|1834122|FG002|Overall Study|Lack of Efficacy|3
872392|NCT00541775|1834120|FG000|Overall Study|Lost to Follow-up|0
872393|NCT00541775|1834121|FG001|Overall Study|Lost to Follow-up|0
872394|NCT00541775|1834122|FG002|Overall Study|Lost to Follow-up|2
872395|NCT00541775|1834120|FG000|Overall Study|Protocol Violation|1
872396|NCT00541775|1834121|FG001|Overall Study|Protocol Violation|0
872397|NCT00541775|1834122|FG002|Overall Study|Protocol Violation|0
872398|NCT00541775|1834120|FG000|Overall Study|Withdrawal by Subject and Other|5
872399|NCT00541775|1834121|FG001|Overall Study|Withdrawal by Subject and Other|0
872400|NCT00541775|1834122|FG002|Overall Study|Withdrawal by Subject and Other|2
872401|NCT00541866|1834135|FG000|Overall Study|Adverse Event|3
872402|NCT00541866|1834136|FG001|Overall Study|Adverse Event|0
872403|NCT00541866|1834137|FG002|Overall Study|Adverse Event|0
872404|NCT00541866|1834138|FG003|Overall Study|Adverse Event|0
872405|NCT00541866|1834139|FG004|Overall Study|Adverse Event|0
872406|NCT00541866|1834135|FG000|Overall Study|Death|1
872407|NCT00541866|1834136|FG001|Overall Study|Death|0
872408|NCT00541866|1834137|FG002|Overall Study|Death|0
872409|NCT00541866|1834138|FG003|Overall Study|Death|0
872410|NCT00541866|1834139|FG004|Overall Study|Death|0
872411|NCT00541866|1834135|FG000|Overall Study|Lack of Efficacy|19
872412|NCT00541866|1834136|FG001|Overall Study|Lack of Efficacy|15
872413|NCT00541866|1834137|FG002|Overall Study|Lack of Efficacy|10
872414|NCT00541866|1834138|FG003|Overall Study|Lack of Efficacy|12
872415|NCT00541866|1834139|FG004|Overall Study|Lack of Efficacy|14
872416|NCT00541866|1834135|FG000|Overall Study|Not Reported or Other|11
872417|NCT00541866|1834136|FG001|Overall Study|Not Reported or Other|3
872418|NCT00541866|1834137|FG002|Overall Study|Not Reported or Other|3
872419|NCT00541866|1834138|FG003|Overall Study|Not Reported or Other|3
872420|NCT00541866|1834139|FG004|Overall Study|Not Reported or Other|1
872421|NCT00541866|1834135|FG000|Overall Study|Physician Decision|0
872422|NCT00541866|1834136|FG001|Overall Study|Physician Decision|0
872423|NCT00541866|1834137|FG002|Overall Study|Physician Decision|2
872424|NCT00541866|1834138|FG003|Overall Study|Physician Decision|1
872425|NCT00541866|1834139|FG004|Overall Study|Physician Decision|0
872426|NCT00541931|1834169|FG000|Overall Study|Adverse Event|1
872427|NCT00541931|1834170|FG001|Overall Study|Adverse Event|0
872428|NCT00541931|1834169|FG000|Overall Study|Lost to Follow-up|3
872429|NCT00541931|1834170|FG001|Overall Study|Lost to Follow-up|3
872430|NCT00541931|1834169|FG000|Overall Study|Withdrawal by Subject|1
872431|NCT00541931|1834170|FG001|Overall Study|Withdrawal by Subject|0
872432|NCT00541931|1834169|FG000|Overall Study|Transportation Issue|0
872433|NCT00541931|1834170|FG001|Overall Study|Transportation Issue|1
872434|NCT00541970|1834182|FG000|Month 7|Protocol Violation|9
872435|NCT00541970|1834183|FG001|Month 7|Protocol Violation|13
872436|NCT00541970|1834184|FG002|Month 7|Protocol Violation|11
872437|NCT00541970|1834185|FG003|Month 7|Protocol Violation|5
872438|NCT00541970|1834182|FG000|Month 12|Adverse Event|0
872439|NCT00541970|1834183|FG001|Month 12|Adverse Event|1
872440|NCT00541970|1834184|FG002|Month 12|Adverse Event|1
872441|NCT00541970|1834185|FG003|Month 12|Adverse Event|1
872442|NCT00541970|1834182|FG000|Month 12|Protocol Violation|12
872443|NCT00541970|1834183|FG001|Month 12|Protocol Violation|21
872444|NCT00541970|1834184|FG002|Month 12|Protocol Violation|20
872445|NCT00541970|1834185|FG003|Month 12|Protocol Violation|15
872446|NCT00541970|1834182|FG000|Month 18|Adverse Event|0
872447|NCT00541970|1834183|FG001|Month 18|Adverse Event|1
872448|NCT00541970|1834184|FG002|Month 18|Adverse Event|1
872449|NCT00541970|1834185|FG003|Month 18|Adverse Event|1
872450|NCT00541970|1834182|FG000|Month 18|Protocol Violation|14
872451|NCT00541970|1834183|FG001|Month 18|Protocol Violation|23
872452|NCT00541970|1834184|FG002|Month 18|Protocol Violation|24
872453|NCT00541970|1834185|FG003|Month 18|Protocol Violation|16
872454|NCT00541970|1834182|FG000|Month 24|Adverse Event|0
872455|NCT00541970|1834183|FG001|Month 24|Adverse Event|1
872456|NCT00541970|1834184|FG002|Month 24|Adverse Event|1
872457|NCT00541970|1834185|FG003|Month 24|Adverse Event|1
872458|NCT00541970|1834182|FG000|Month 24|Protocol Violation|29
872459|NCT00541970|1834183|FG001|Month 24|Protocol Violation|31
872460|NCT00541970|1834184|FG002|Month 24|Protocol Violation|31
872461|NCT00541970|1834185|FG003|Month 24|Protocol Violation|21
872462|NCT00541970|1834182|FG000|Month 36|Protocol Violation|61
872463|NCT00541970|1834183|FG001|Month 36|Protocol Violation|66
872464|NCT00541970|1834184|FG002|Month 36|Protocol Violation|66
872465|NCT00541970|1834185|FG003|Month 36|Protocol Violation|60
1175844|NCT02671461|2321105|FG000|Follow-up|Administrative Reason by Sponsor|0
1175845|NCT02671461|2321106|FG001|Follow-up|Administrative Reason by Sponsor|1
1175846|NCT02671461|2321107|FG002|Follow-up|Administrative Reason by Sponsor|0
1175847|NCT02653495|2321178|FG000|Overall Study|Lost to Follow-up|2
1175848|NCT02653495|2321179|FG001|Overall Study|Lost to Follow-up|0
1175849|NCT02653495|2321178|FG000|Overall Study|Screening Failure|10
1175850|NCT02653495|2321179|FG001|Overall Study|Screening Failure|0
1175851|NCT02639390|2321191|FG000|Overall Study|Subject unable to comply with treatment schedule.|0
1175852|NCT02639390|2321192|FG001|Overall Study|Subject unable to comply with treatment schedule.|2
1175853|NCT02634606|2321198|FG000|Overall Study|unable to obtain the drug at start|13
1175854|NCT02636283|2321212|FG000|Overall Study|Adverse Event|2
1175855|NCT02636283|2321213|FG001|Overall Study|Adverse Event|0
1175856|NCT02636283|2321212|FG000|Overall Study|Trial Terminated Prematurely|0
1175857|NCT02636283|2321213|FG001|Overall Study|Trial Terminated Prematurely|3
1175858|NCT02638129|2321221|FG000|Overall Study|Study terminated|28
1175859|NCT02638129|2321222|FG001|Overall Study|Study terminated|30
1175860|NCT02615990|2321230|FG000|Overall Study|study terminated|1
1175861|NCT02615990|2321231|FG001|Overall Study|study terminated|1
1175862|NCT02640677|2321237|FG000|Overall Study|Lost to Follow-up|1
1175863|NCT02640677|2321237|FG000|Overall Study|Withdrawal by Subject|1
1175864|NCT02623959|2321247|FG000|Overall Study|Progression|0
1175865|NCT02623959|2321248|FG001|Overall Study|Progression|1
1175866|NCT02631148|2321258|FG000|Overall Study|8 were ineligible|8
1175867|NCT02631148|2321259|FG001|Overall Study|8 were ineligible|0
1175868|NCT02631148|2321258|FG000|Overall Study|Withdrawal by Subject|1
872466|NCT00541970|1834182|FG000|Month 48|Withdrawal by Subject|2
872467|NCT00541970|1834183|FG001|Month 48|Withdrawal by Subject|4
872468|NCT00541970|1834184|FG002|Month 48|Withdrawal by Subject|4
872469|NCT00541970|1834185|FG003|Month 48|Withdrawal by Subject|2
872470|NCT00541970|1834182|FG000|Month 48|Other|3
872471|NCT00541970|1834183|FG001|Month 48|Other|1
872472|NCT00541970|1834184|FG002|Month 48|Other|1
872473|NCT00541970|1834185|FG003|Month 48|Other|0
872474|NCT00541970|1834182|FG000|Month 48|Lost to Follow-up|66
872475|NCT00541970|1834183|FG001|Month 48|Lost to Follow-up|68
872476|NCT00541970|1834184|FG002|Month 48|Lost to Follow-up|68
872477|NCT00541970|1834185|FG003|Month 48|Lost to Follow-up|73
872478|NCT00541970|1834182|FG000|Month 60|Protocol Violation|78
872479|NCT00541970|1834183|FG001|Month 60|Protocol Violation|77
872480|NCT00541970|1834184|FG002|Month 60|Protocol Violation|82
872481|NCT00541970|1834185|FG003|Month 60|Protocol Violation|72
872482|NCT00542178|1834201|FG000|Overall Study|did not complete year 4 follow-up|75
872483|NCT00542178|1834202|FG001|Overall Study|did not complete year 4 follow-up|80
872484|NCT00542178|1834203|FG002|Overall Study|did not complete year 4 follow-up|74
872485|NCT00542178|1834204|FG003|Overall Study|did not complete year 4 follow-up|62
872486|NCT00542178|1834205|FG004|Overall Study|did not complete year 4 follow-up|64
872487|NCT00542178|1834206|FG005|Overall Study|did not complete year 4 follow-up|89
872488|NCT00542178|1834207|FG006|Overall Study|did not complete year 4 follow-up|87
872489|NCT00542178|1834208|FG007|Overall Study|did not complete year 4 follow-up|85
872490|NCT00542191|1834222|FG000|Overall Study|Death|3
872491|NCT00542269|1834229|FG000|Overall Study|Adverse Event|10
872492|NCT00542269|1834230|FG001|Overall Study|Adverse Event|4
872493|NCT00542269|1834231|FG002|Overall Study|Adverse Event|5
872494|NCT00542269|1834229|FG000|Overall Study|Protocol Violation|1
872495|NCT00542269|1834230|FG001|Overall Study|Protocol Violation|1
872496|NCT00542269|1834231|FG002|Overall Study|Protocol Violation|0
872497|NCT00542269|1834229|FG000|Overall Study|Withdrawal by Subject|1
872498|NCT00542269|1834230|FG001|Overall Study|Withdrawal by Subject|0
872499|NCT00542269|1834231|FG002|Overall Study|Withdrawal by Subject|0
872500|NCT00542269|1834229|FG000|Overall Study|Administrative problems|1
872501|NCT00542269|1834230|FG001|Overall Study|Administrative problems|1
872502|NCT00542269|1834231|FG002|Overall Study|Administrative problems|1
872503|NCT00542321|1834247|FG000|Overall Study|Death|0
872504|NCT00542321|1834248|FG001|Overall Study|Death|1
872505|NCT00542386|1834260|FG000|Overall Study|Adverse Event|1
872506|NCT00542386|1834261|FG001|Overall Study|Adverse Event|7
872507|NCT00542386|1834262|FG002|Overall Study|Adverse Event|7
872508|NCT00542386|1834263|FG003|Overall Study|Adverse Event|8
872509|NCT00542386|1834264|FG004|Overall Study|Adverse Event|13
872510|NCT00542386|1834265|FG005|Overall Study|Adverse Event|4
872511|NCT00542386|1834260|FG000|Overall Study|Death|0
872512|NCT00542386|1834261|FG001|Overall Study|Death|0
872513|NCT00542386|1834262|FG002|Overall Study|Death|1
872514|NCT00542386|1834263|FG003|Overall Study|Death|2
872515|NCT00542386|1834264|FG004|Overall Study|Death|1
872516|NCT00542386|1834265|FG005|Overall Study|Death|2
872517|NCT00542386|1834260|FG000|Overall Study|Lack of Efficacy|32
872518|NCT00542386|1834261|FG001|Overall Study|Lack of Efficacy|12
872519|NCT00542386|1834262|FG002|Overall Study|Lack of Efficacy|10
872520|NCT00542386|1834263|FG003|Overall Study|Lack of Efficacy|13
872521|NCT00542386|1834264|FG004|Overall Study|Lack of Efficacy|7
872522|NCT00542386|1834265|FG005|Overall Study|Lack of Efficacy|31
872523|NCT00542386|1834260|FG000|Overall Study|Physician Decision|1
872524|NCT00542386|1834261|FG001|Overall Study|Physician Decision|0
872525|NCT00542386|1834262|FG002|Overall Study|Physician Decision|0
872526|NCT00542386|1834263|FG003|Overall Study|Physician Decision|1
1175869|NCT02631148|2321259|FG001|Overall Study|Withdrawal by Subject|0
1175870|NCT02631148|2321258|FG000|Overall Study|PAH not available to study participant|1
1175871|NCT02631148|2321259|FG001|Overall Study|PAH not available to study participant|0
1175872|NCT02630472|2321267|FG000|Overall Study|Physician Decision|10
872527|NCT00542386|1834264|FG004|Overall Study|Physician Decision|0
872528|NCT00542386|1834265|FG005|Overall Study|Physician Decision|0
872529|NCT00542386|1834260|FG000|Overall Study|Protocol Violation|0
872530|NCT00542386|1834261|FG001|Overall Study|Protocol Violation|0
872531|NCT00542386|1834262|FG002|Overall Study|Protocol Violation|1
872532|NCT00542386|1834263|FG003|Overall Study|Protocol Violation|0
872533|NCT00542386|1834264|FG004|Overall Study|Protocol Violation|0
872534|NCT00542386|1834265|FG005|Overall Study|Protocol Violation|4
872535|NCT00542386|1834260|FG000|Overall Study|Withdrawal by Subject|5
872536|NCT00542386|1834261|FG001|Overall Study|Withdrawal by Subject|8
872537|NCT00542386|1834262|FG002|Overall Study|Withdrawal by Subject|10
872538|NCT00542386|1834263|FG003|Overall Study|Withdrawal by Subject|11
872539|NCT00542386|1834264|FG004|Overall Study|Withdrawal by Subject|15
872540|NCT00542386|1834265|FG005|Overall Study|Withdrawal by Subject|7
872541|NCT00542386|1834260|FG000|Overall Study|Other Reasons|4
872542|NCT00542386|1834261|FG001|Overall Study|Other Reasons|1
872543|NCT00542386|1834262|FG002|Overall Study|Other Reasons|4
872544|NCT00542386|1834263|FG003|Overall Study|Other Reasons|3
872545|NCT00542386|1834264|FG004|Overall Study|Other Reasons|4
872546|NCT00542386|1834265|FG005|Overall Study|Other Reasons|2
872547|NCT00542425|1834284|FG000|Initial 24 Weeks|Administrative reasons|0
872548|NCT00542425|1834285|FG001|Initial 24 Weeks|Administrative reasons|0
872549|NCT00542425|1834286|FG002|Initial 24 Weeks|Administrative reasons|1
872550|NCT00542425|1834287|FG003|Initial 24 Weeks|Administrative reasons|1
872551|NCT00542425|1834288|FG004|Initial 24 Weeks|Administrative reasons|0
872552|NCT00542425|1834284|FG000|Initial 24 Weeks|Adverse Event|0
872553|NCT00542425|1834285|FG001|Initial 24 Weeks|Adverse Event|1
872554|NCT00542425|1834286|FG002|Initial 24 Weeks|Adverse Event|1
872555|NCT00542425|1834287|FG003|Initial 24 Weeks|Adverse Event|3
872556|NCT00542425|1834288|FG004|Initial 24 Weeks|Adverse Event|2
872557|NCT00542425|1834284|FG000|Initial 24 Weeks|Inability to complete procedures|0
872558|NCT00542425|1834285|FG001|Initial 24 Weeks|Inability to complete procedures|3
872559|NCT00542425|1834286|FG002|Initial 24 Weeks|Inability to complete procedures|2
872560|NCT00542425|1834287|FG003|Initial 24 Weeks|Inability to complete procedures|1
872561|NCT00542425|1834288|FG004|Initial 24 Weeks|Inability to complete procedures|2
872562|NCT00542425|1834284|FG000|Initial 24 Weeks|Lost to Follow-up|2
872563|NCT00542425|1834285|FG001|Initial 24 Weeks|Lost to Follow-up|2
872564|NCT00542425|1834286|FG002|Initial 24 Weeks|Lost to Follow-up|1
872565|NCT00542425|1834287|FG003|Initial 24 Weeks|Lost to Follow-up|0
872566|NCT00542425|1834288|FG004|Initial 24 Weeks|Lost to Follow-up|0
872567|NCT00542425|1834284|FG000|Initial 24 Weeks|Non-compliance|0
872568|NCT00542425|1834285|FG001|Initial 24 Weeks|Non-compliance|0
872569|NCT00542425|1834286|FG002|Initial 24 Weeks|Non-compliance|0
872570|NCT00542425|1834287|FG003|Initial 24 Weeks|Non-compliance|1
872571|NCT00542425|1834288|FG004|Initial 24 Weeks|Non-compliance|1
872572|NCT00542425|1834284|FG000|Initial 24 Weeks|Protocol Violation|0
872573|NCT00542425|1834285|FG001|Initial 24 Weeks|Protocol Violation|0
872574|NCT00542425|1834286|FG002|Initial 24 Weeks|Protocol Violation|0
872575|NCT00542425|1834287|FG003|Initial 24 Weeks|Protocol Violation|1
872576|NCT00542425|1834288|FG004|Initial 24 Weeks|Protocol Violation|0
872577|NCT00542425|1834284|FG000|Initial 24 Weeks|Refusal of treatment|2
872578|NCT00542425|1834285|FG001|Initial 24 Weeks|Refusal of treatment|2
872579|NCT00542425|1834286|FG002|Initial 24 Weeks|Refusal of treatment|1
872580|NCT00542425|1834287|FG003|Initial 24 Weeks|Refusal of treatment|4
872581|NCT00542425|1834288|FG004|Initial 24 Weeks|Refusal of treatment|1
872582|NCT00542425|1834284|FG000|Initial 24 Weeks|Other|0
872583|NCT00542425|1834285|FG001|Initial 24 Weeks|Other|2
872584|NCT00542425|1834286|FG002|Initial 24 Weeks|Other|1
872585|NCT00542425|1834287|FG003|Initial 24 Weeks|Other|0
872586|NCT00542425|1834288|FG004|Initial 24 Weeks|Other|0
872587|NCT00542425|1834284|FG000|Extended 24 Weeks of Treatment|Adverse Event|0
872588|NCT00542425|1834285|FG001|Extended 24 Weeks of Treatment|Adverse Event|0
872589|NCT00542425|1834286|FG002|Extended 24 Weeks of Treatment|Adverse Event|1
872590|NCT00542425|1834287|FG003|Extended 24 Weeks of Treatment|Adverse Event|1
872591|NCT00542425|1834288|FG004|Extended 24 Weeks of Treatment|Adverse Event|0
872592|NCT00542425|1834284|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0
872593|NCT00542425|1834285|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0
872594|NCT00542425|1834286|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1
872595|NCT00542425|1834287|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0
872596|NCT00542425|1834288|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0
872597|NCT00542425|1834284|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0
872598|NCT00542425|1834285|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1
872599|NCT00542425|1834286|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0
872600|NCT00542425|1834287|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0
872601|NCT00542425|1834288|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0
872602|NCT00542425|1834284|FG000|Extended 24 Weeks of Treatment|Other|1
872603|NCT00542425|1834285|FG001|Extended 24 Weeks of Treatment|Other|1
872604|NCT00542425|1834286|FG002|Extended 24 Weeks of Treatment|Other|0
1175873|NCT02630472|2321268|FG001|Overall Study|Physician Decision|0
1175874|NCT02626520|2321277|FG000|Overall Study|Physician Decision|1
1175875|NCT02626520|2321278|FG001|Overall Study|Physician Decision|1
1175876|NCT02626520|2321277|FG000|Overall Study|Adverse Event|0
1175877|NCT02626520|2321278|FG001|Overall Study|Adverse Event|4
1175878|NCT02626520|2321277|FG000|Overall Study|Lack of Efficacy|0
1175879|NCT02626520|2321278|FG001|Overall Study|Lack of Efficacy|2
1175880|NCT02626520|2321277|FG000|Overall Study|Did not start protocol therapy|0
1175881|NCT02626520|2321278|FG001|Overall Study|Did not start protocol therapy|2
1175882|NCT02626520|2321277|FG000|Overall Study|Study terminated|0
1175883|NCT02626520|2321278|FG001|Overall Study|Study terminated|1
1175884|NCT02614898|2321286|FG000|Overall Study|Participated until study termination|10
1175885|NCT02614898|2321287|FG001|Overall Study|Participated until study termination|26
1175886|NCT02614898|2321286|FG000|Overall Study|Lost to Follow-up|0
1175887|NCT02614898|2321287|FG001|Overall Study|Lost to Follow-up|2
1175888|NCT02614898|2321286|FG000|Overall Study|Physician Decision|1
1175889|NCT02614898|2321287|FG001|Overall Study|Physician Decision|8
1175890|NCT02614898|2321286|FG000|Overall Study|Study Terminated by Sponsor|3
1175891|NCT02614898|2321287|FG001|Overall Study|Study Terminated by Sponsor|0
1175892|NCT02614898|2321286|FG000|Overall Study|Withdrawal by Subject|0
1175893|NCT02614898|2321287|FG001|Overall Study|Withdrawal by Subject|2
1175894|NCT02614898|2321286|FG000|Overall Study|Withdrawal by Parent/Guardian|1
1175895|NCT02614898|2321287|FG001|Overall Study|Withdrawal by Parent/Guardian|1
1175896|NCT02614898|2321286|FG000|Overall Study|Other-Additional Information Unavailable|0
1175897|NCT02614898|2321287|FG001|Overall Study|Other-Additional Information Unavailable|11
1175898|NCT02614898|2321286|FG000|Overall Study|Missing|0
1175899|NCT02614898|2321287|FG001|Overall Study|Missing|1
1175900|NCT02622828|2321294|FG000|Overall Study|participant withdrew|3
1175901|NCT02619812|2321320|FG000|Overall Study|Withdrawal by Subject|0
1175902|NCT02619812|2321321|FG001|Overall Study|Withdrawal by Subject|0
1175903|NCT02619812|2321322|FG002|Overall Study|Withdrawal by Subject|1
1175904|NCT02619812|2321323|FG003|Overall Study|Withdrawal by Subject|2
1175905|NCT02612285|2321333|FG000|Overall Study|Withdrawal by Subject|1
1175906|NCT02606279|2321343|FG000|Overall Study|Lost to Follow-up|0
1175907|NCT02606279|2321344|FG001|Overall Study|Lost to Follow-up|1
1175908|NCT02605824|2321352|FG000|Overall Study|Physician Decision|1
1175909|NCT02605824|2321353|FG001|Overall Study|Physician Decision|0
1175910|NCT02598622|2321361|FG000|Overall Study|Withdrawal by Subject|3
1175911|NCT02598622|2321362|FG001|Overall Study|Withdrawal by Subject|0
1175912|NCT02598622|2321361|FG000|Overall Study|Physician Decision|3
1175913|NCT02598622|2321362|FG001|Overall Study|Physician Decision|0
1175914|NCT02582749|2321383|FG000|Overall Study|Study terminated by funder|5
1175915|NCT02582749|2321384|FG001|Overall Study|Study terminated by funder|10
1175916|NCT02582749|2321383|FG000|Overall Study|Withdrawal by Subject|0
1175917|NCT02582749|2321384|FG001|Overall Study|Withdrawal by Subject|1
1175918|NCT02569957|2321417|FG000|Overall Study|Withdrawal by Subject|0
1175919|NCT02569957|2321418|FG001|Overall Study|Withdrawal by Subject|1
1175920|NCT02575365|2321437|FG000|Overall Study|Lost to Follow-up|4
1175921|NCT02547129|2321447|FG000|Overall Study|Difficulty with ongoing infection|1
1175922|NCT02547129|2321448|FG001|Overall Study|Difficulty with ongoing infection|0
1175923|NCT02533531|2321487|FG000|Overall Study|Device did not turn on|1
1175924|NCT02520726|2321503|FG000|Overall Study|Lost to Follow-up|3
872605|NCT00542425|1834287|FG003|Extended 24 Weeks of Treatment|Other|0
872606|NCT00542425|1834288|FG004|Extended 24 Weeks of Treatment|Other|1
872607|NCT00542789|1834319|FG000|Overall Study|Adverse Event|18
872608|NCT00542789|1834320|FG001|Overall Study|Adverse Event|17
872609|NCT00542789|1834319|FG000|Overall Study|Withdrawal by Subject|7
872610|NCT00542789|1834320|FG001|Overall Study|Withdrawal by Subject|3
872611|NCT00542789|1834319|FG000|Overall Study|Protocol Violation|8
872612|NCT00542789|1834320|FG001|Overall Study|Protocol Violation|1
872613|NCT00542789|1834319|FG000|Overall Study|Recurrence of Gastric Ulcer|8
872614|NCT00542789|1834320|FG001|Overall Study|Recurrence of Gastric Ulcer|57
872615|NCT00542815|1834329|FG000|Overall Study|Adverse Event|19
872616|NCT00542815|1834330|FG001|Overall Study|Adverse Event|6
872617|NCT00542815|1834331|FG002|Overall Study|Adverse Event|9
872618|NCT00542815|1834329|FG000|Overall Study|Death|10
872619|NCT00542815|1834330|FG001|Overall Study|Death|7
872620|NCT00542815|1834331|FG002|Overall Study|Death|3
872621|NCT00542815|1834329|FG000|Overall Study|Lack of Efficacy|9
872622|NCT00542815|1834330|FG001|Overall Study|Lack of Efficacy|2
872623|NCT00542815|1834331|FG002|Overall Study|Lack of Efficacy|0
872624|NCT00542815|1834329|FG000|Overall Study|Physician Decision|2
872625|NCT00542815|1834330|FG001|Overall Study|Physician Decision|1
872626|NCT00542815|1834331|FG002|Overall Study|Physician Decision|0
872627|NCT00542815|1834329|FG000|Overall Study|Protocol Violation|1
872628|NCT00542815|1834330|FG001|Overall Study|Protocol Violation|1
872629|NCT00542815|1834331|FG002|Overall Study|Protocol Violation|2
872630|NCT00542815|1834329|FG000|Overall Study|Withdrawal by Subject|41
1175925|NCT02520726|2321504|FG001|Overall Study|Lost to Follow-up|2
1175926|NCT02519712|2321514|FG000|Overall Study|Disease Relapse|1
1175927|NCT02519712|2321514|FG000|Overall Study|Disease Progression|1
1175928|NCT02519712|2321514|FG000|Overall Study|Accruals are donors|2
1175929|NCT02516228|2321522|FG000|Overall Study|Lost to Follow-up|1
1175930|NCT02516228|2321522|FG000|Overall Study|Withdrawal by Subject|1
1175931|NCT02516228|2321522|FG000|Overall Study|Physician Decision|1
872631|NCT00542815|1834330|FG001|Overall Study|Withdrawal by Subject|5
872632|NCT00542815|1834331|FG002|Overall Study|Withdrawal by Subject|8
1175932|NCT02506101|2321562|FG000|Overall Study|Transportation issues|1
1175933|NCT02506101|2321563|FG001|Overall Study|Transportation issues|0
1175934|NCT02506101|2321562|FG000|Overall Study|No enrollment and staff unavailability|1
1175935|NCT02506101|2321563|FG001|Overall Study|No enrollment and staff unavailability|0
1175937|NCT02500901|2321588|FG000|Overall Study|Disease ProgressionDD|2
1175938|NCT02483533|2321594|FG000|Overall Study|Lack of Efficacy|50
1175939|NCT02483533|2321595|FG001|Overall Study|Lack of Efficacy|50
1175940|NCT02496039|2321601|FG000|Overall Study|Adverse Event|3
1175941|NCT02496039|2321601|FG000|Overall Study|Protocol Violation|1
1175942|NCT02494206|2321610|FG000|Overall Study|Adverse Event|1
1175943|NCT02494206|2321610|FG000|Overall Study|Disease Progression|1
1175944|NCT02473445|2321614|FG000|Overall Study|Withdrawal by Subject|2
1175945|NCT02473445|2321614|FG000|Overall Study|Sponsor Decision|20
1175946|NCT02491411|2321618|FG000|Overall Study|Physician Decision|4
1175947|NCT02476994|2321624|FG000|Overall Study|Based on feedback from FDA|1
1175948|NCT02476994|2321625|FG001|Overall Study|Based on feedback from FDA|0
1175949|NCT02473523|2321631|FG000|Overall Study|Death|1
1175950|NCT02473523|2321631|FG000|Overall Study|Lost to Follow-up|1
1175951|NCT02472639|2321650|FG000|Overall Study|Physician Decision|4
1175952|NCT02472639|2321651|FG001|Overall Study|Physician Decision|3
1175953|NCT02469415|2321657|FG000|Overall Study|Withdrawal by Subject|1
1175954|NCT02469415|2321657|FG000|Overall Study|Investigational agent placed on hold|2
1175955|NCT02452359|2321669|FG000|Overall Study|Adverse Event|1
1175956|NCT02452359|2321669|FG000|Overall Study|Lost to Follow-up|15
1175957|NCT02452359|2321669|FG000|Overall Study|Pregnancy|1
1175958|NCT02452359|2321669|FG000|Overall Study|Withdrawal by Subject|4
1175959|NCT02452398|2321677|FG000|Overall Study|Adverse Event|1
1175960|NCT02452398|2321677|FG000|Overall Study|Lost to Follow-up|28
1175961|NCT02452398|2321677|FG000|Overall Study|Physician Decision|2
1175962|NCT02452398|2321677|FG000|Overall Study|Withdrawal by Subject|6
1175963|NCT02452398|2321677|FG000|Overall Study|Moved away|4
1175964|NCT02447887|2321681|FG000|Overall Study|Study was terminated|3
1175965|NCT02439970|2321702|FG000|Overall Study|Study Terminated|2
1175966|NCT02439970|2321703|FG001|Overall Study|Study Terminated|3
1175967|NCT02439957|2321711|FG000|Overall Study|Study Terminated|3
1175968|NCT02439957|2321712|FG001|Overall Study|Study Terminated|3
1175969|NCT02441036|2321723|FG000|Overall Study|No tissue resected|0
1175970|NCT02441036|2321724|FG001|Overall Study|No tissue resected|1
1175971|NCT02441036|2321725|FG002|Overall Study|No tissue resected|0
1175972|NCT02441036|2321726|FG003|Overall Study|No tissue resected|1
1175973|NCT02441036|2321727|FG004|Overall Study|No tissue resected|0
1175974|NCT02430532|2321764|FG000|Overall Study|Sponsor Decision to Stop Study Early|30
1175975|NCT02430532|2321765|FG001|Overall Study|Sponsor Decision to Stop Study Early|25
1175976|NCT02430532|2321764|FG000|Overall Study|Consent Withdrawn|0
872633|NCT00542815|1834329|FG000|Overall Study|Other reasons|24
872634|NCT00542815|1834330|FG001|Overall Study|Other reasons|10
872635|NCT00542815|1834331|FG002|Overall Study|Other reasons|10
872636|NCT00542828|1834339|FG000|Overall Study|Physician Decision|1
872637|NCT00542828|1834339|FG000|Overall Study|Need for Prohibited Treatment|3
872638|NCT00542828|1834339|FG000|Overall Study|Study Prematurely Discontinued|7
872639|NCT00542828|1834339|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2
872640|NCT00542880|1834345|FG000|Period 1|Eligibility criteria not fulfilled|2
872641|NCT00542880|1834346|FG001|Period 1|Eligibility criteria not fulfilled|6
872642|NCT00542880|1834345|FG000|Period 1|Adverse Event|2
872643|NCT00542880|1834346|FG001|Period 1|Adverse Event|2
872644|NCT00542880|1834345|FG000|Period 1|Development of study-specific criteria|1
872645|NCT00542880|1834346|FG001|Period 1|Development of study-specific criteria|2
872646|NCT00542880|1834345|FG000|Period 1|Withdrawal by Subject|1
872647|NCT00542880|1834346|FG001|Period 1|Withdrawal by Subject|1
872648|NCT00542880|1834345|FG000|Period 1|Protocol Violation|0
872649|NCT00542880|1834346|FG001|Period 1|Protocol Violation|1
872650|NCT00542880|1834345|FG000|Period 2|Adverse Event|5
872651|NCT00542880|1834346|FG001|Period 2|Adverse Event|7
872652|NCT00542880|1834345|FG000|Period 2|Eligibility not fulfilled|0
872653|NCT00542880|1834346|FG001|Period 2|Eligibility not fulfilled|1
872654|NCT00542880|1834345|FG000|Period 2|Discontinuation criteria|2
872655|NCT00542880|1834346|FG001|Period 2|Discontinuation criteria|0
872656|NCT00542880|1834345|FG000|Period 2|Severe non-compliance|0
872657|NCT00542880|1834346|FG001|Period 2|Severe non-compliance|1
872658|NCT00542880|1834345|FG000|Period 2|Other|0
872659|NCT00542880|1834346|FG001|Period 2|Other|1
872660|NCT00542880|1834345|FG000|Period 3|Adverse Event|0
872661|NCT00542880|1834346|FG001|Period 3|Adverse Event|2
872662|NCT00542919|1834356|FG000|Overall Study|Adverse Event|1
872663|NCT00542919|1834357|FG001|Overall Study|Adverse Event|5
872664|NCT00542919|1834358|FG002|Overall Study|Adverse Event|1
872665|NCT00542919|1834356|FG000|Overall Study|Withdrawal by Subject|1
872666|NCT00542919|1834357|FG001|Overall Study|Withdrawal by Subject|0
872667|NCT00542919|1834358|FG002|Overall Study|Withdrawal by Subject|3
1175977|NCT02430532|2321765|FG001|Overall Study|Consent Withdrawn|2
1175978|NCT02430532|2321764|FG000|Overall Study|Adverse Event|0
1175979|NCT02430532|2321765|FG001|Overall Study|Adverse Event|1
1175980|NCT02428231|2321775|FG000|Overall Study|Other|10
1175981|NCT02428231|2321776|FG001|Overall Study|Other|16
1175982|NCT02428231|2321775|FG000|Overall Study|Required Symptomatic Therapy|0
1175983|NCT02428231|2321776|FG001|Overall Study|Required Symptomatic Therapy|1
1175984|NCT02428231|2321775|FG000|Overall Study|Adverse Event|3
1175985|NCT02428231|2321776|FG001|Overall Study|Adverse Event|0
1175986|NCT02424565|2321782|FG000|Period 1 (D0)|Protocol Violation|0
1175987|NCT02424565|2321783|FG001|Period 1 (D0)|Protocol Violation|1
1175988|NCT02422303|2321804|FG000|Overall Study|Lost to Follow-up|1
1175989|NCT02422303|2321805|FG001|Overall Study|Lost to Follow-up|1
1175990|NCT02414152|2321828|FG000|Overall Study|Withdrawal by Subject|1
1175991|NCT02414152|2321828|FG000|Overall Study|Lack of Efficacy|1
1175992|NCT02410551|2321832|FG000|Overall Study|Adverse Event|1
1175993|NCT02410551|2321832|FG000|Overall Study|Withdrawal by Subject|1
1175994|NCT02410551|2321832|FG000|Overall Study|FDA Clinical hold-patients taken off|2
1175995|NCT02410954|2321843|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6
1175996|NCT02410954|2321844|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0
1175997|NCT02410954|2321843|FG000|Overall Study|Instrument malfunction generated unusable data|8
1175998|NCT02410954|2321844|FG001|Overall Study|Instrument malfunction generated unusable data|0
1175999|NCT02409355|2321856|FG000|Overall Study|Withdrawal by Subject|1
1176000|NCT02409355|2321857|FG001|Overall Study|Withdrawal by Subject|0
1176001|NCT02409355|2321856|FG000|Overall Study|Death|1
1176002|NCT02409355|2321857|FG001|Overall Study|Death|1
1176003|NCT02409355|2321856|FG000|Overall Study|Study terminated by Sponsor|2
1176004|NCT02409355|2321857|FG001|Overall Study|Study terminated by Sponsor|3
1176005|NCT02404545|2321882|FG000|Overall Study|Sponsor Termination|6
1176006|NCT02404545|2321883|FG001|Overall Study|Sponsor Termination|6
1176007|NCT02392377|2321892|FG000|Overall Study|Withdrawal by Subject|0
1176008|NCT02392377|2321893|FG001|Overall Study|Withdrawal by Subject|1
1176009|NCT02394665|2321927|FG000|Overall Study|Physician Decision|1
1176010|NCT02394665|2321928|FG001|Overall Study|Physician Decision|0
1176011|NCT02394665|2321929|FG002|Overall Study|Physician Decision|0
1176012|NCT02390362|2321948|FG000|Overall Study|Withdrawal by Subject|0
1176013|NCT02390362|2321949|FG001|Overall Study|Withdrawal by Subject|1
1176014|NCT02388776|2321955|FG000|Overall Study|Death|1
1176015|NCT02388776|2321955|FG000|Overall Study|Lost to Follow-up|1
1176016|NCT02383433|2321960|FG000|Overall Study|Disease progression|2
1176017|NCT02379390|2321988|FG000|Overall Study|Adverse Event|1
1176018|NCT02379390|2321989|FG001|Overall Study|Adverse Event|1
1176019|NCT02379390|2321988|FG000|Overall Study|Investigator's decision|1
1176020|NCT02379390|2321989|FG001|Overall Study|Investigator's decision|0
1176021|NCT02379390|2321988|FG000|Overall Study|Study Termination|0
1176022|NCT02379390|2321989|FG001|Overall Study|Study Termination|1
1176023|NCT02361580|2322013|FG000|Overall Study|Lost to Follow-up|6
1176024|NCT02361580|2322014|FG001|Overall Study|Lost to Follow-up|3
1176025|NCT02370888|2322045|FG000|Overall Study|disease progression|2
1176026|NCT02370888|2322045|FG000|Overall Study|did not meet chimerism criteria|6
1176027|NCT02365233|2322069|FG000|Overall Study|IRB withheld the data|1
1176028|NCT02365233|2322070|FG001|Overall Study|IRB withheld the data|2
1176029|NCT02365233|2322071|FG002|Overall Study|IRB withheld the data|2
1176030|NCT02347943|2322082|FG000|Overall Study|Study was cancelled|140
1176031|NCT02347943|2322083|FG001|Overall Study|Study was cancelled|67
1176032|NCT02347943|2322084|FG002|Overall Study|Study was cancelled|45
1176033|NCT02365207|2322092|FG000|Overall Study|Withdrawal by Subject|1
1176034|NCT02365207|2322092|FG000|Overall Study|Physician Decision|1
1176035|NCT02360111|2322096|FG000|Overall Study|Death|2
1176036|NCT02353468|2322100|FG000|Overall Study|Study terminated|3
1176037|NCT02346877|2322128|FG000|Overall Study|Adverse Event|1
1176038|NCT02346877|2322129|FG001|Overall Study|Adverse Event|0
1176039|NCT02346877|2322128|FG000|Overall Study|Administrative Decision|1
1176040|NCT02346877|2322129|FG001|Overall Study|Administrative Decision|0
1176041|NCT02346877|2322128|FG000|Overall Study|Sponsor Decision|12
1176042|NCT02346877|2322129|FG001|Overall Study|Sponsor Decision|0
1176043|NCT02346877|2322128|FG000|Overall Study|Missing|5
1176044|NCT02346877|2322129|FG001|Overall Study|Missing|0
1176045|NCT02353572|2322152|FG000|Overall Study|Withdrawal by Subject|1
1176046|NCT02353572|2322152|FG000|Overall Study|Study terminated|2
1176047|NCT02343263|2322168|FG000|Overall Study|Physician Decision|5
1176048|NCT02343263|2322169|FG001|Overall Study|Physician Decision|3
1176049|NCT02343263|2322170|FG002|Overall Study|Physician Decision|1
1176050|NCT02343159|2322185|FG000|Overall Study|Early Study Termination|16
1176051|NCT02343159|2322186|FG001|Overall Study|Early Study Termination|19
1176052|NCT02343159|2322187|FG002|Overall Study|Early Study Termination|23
1176053|NCT02343159|2322185|FG000|Overall Study|Physician Decision|2
1176054|NCT02343159|2322186|FG001|Overall Study|Physician Decision|0
1176055|NCT02343159|2322187|FG002|Overall Study|Physician Decision|1
1176056|NCT02343159|2322185|FG000|Overall Study|Withdrawal by Subject|3
1176057|NCT02343159|2322186|FG001|Overall Study|Withdrawal by Subject|0
1176058|NCT02343159|2322187|FG002|Overall Study|Withdrawal by Subject|2
1176059|NCT02343159|2322185|FG000|Overall Study|Lost to Follow-up|0
1176060|NCT02343159|2322186|FG001|Overall Study|Lost to Follow-up|2
1176061|NCT02343159|2322187|FG002|Overall Study|Lost to Follow-up|2
1176062|NCT02343159|2322185|FG000|Overall Study|Adverse Event|4
1176063|NCT02343159|2322186|FG001|Overall Study|Adverse Event|4
1176064|NCT02343159|2322187|FG002|Overall Study|Adverse Event|2
1176065|NCT02343159|2322185|FG000|Overall Study|Sponsor Decision|0
1176066|NCT02343159|2322186|FG001|Overall Study|Sponsor Decision|1
1176067|NCT02343159|2322187|FG002|Overall Study|Sponsor Decision|0
1176068|NCT02343159|2322185|FG000|Overall Study|Enrollment Error|1
1176069|NCT02343159|2322186|FG001|Overall Study|Enrollment Error|0
1176070|NCT02343159|2322187|FG002|Overall Study|Enrollment Error|0
1176071|NCT02336425|2322204|FG000|Overall Study|Study terminated.|2
1176072|NCT02336425|2322205|FG001|Overall Study|Study terminated.|2
1176073|NCT02336425|2322206|FG002|Overall Study|Study terminated.|3
1176074|NCT02336425|2322207|FG003|Overall Study|Study terminated.|3
1176075|NCT02308735|2322268|FG000|Overall Study|Physician Decision|2
1176076|NCT02308735|2322269|FG001|Overall Study|Physician Decision|0
1176077|NCT02308735|2322270|FG002|Overall Study|Physician Decision|0
1176078|NCT02308735|2322271|FG003|Overall Study|Physician Decision|2
1176079|NCT02299206|2322281|FG000|Overall Study|Lost to Follow-up|1
1176080|NCT02299206|2322281|FG000|Overall Study|Withdrawal by Subject|1
1176081|NCT02302859|2322287|FG000|Overall Study|Lost Phone|1
1176082|NCT02302859|2322288|FG001|Overall Study|Lost Phone|1
1176083|NCT02302859|2322287|FG000|Overall Study|Withdrawal by Subject|0
1176084|NCT02302859|2322288|FG001|Overall Study|Withdrawal by Subject|1
1176085|NCT02299934|2322294|FG000|Overall Study|Termination of study|13
1176086|NCT02294981|2322321|FG000|Overall Study|Lost to Follow-up|1
1176087|NCT02284906|2322328|FG000|Overall Study|Pretreatment Event/Adverse Event|0
1176088|NCT02284906|2322329|FG001|Overall Study|Pretreatment Event/Adverse Event|1
1176089|NCT02284906|2322330|FG002|Overall Study|Pretreatment Event/Adverse Event|0
1176090|NCT02284906|2322328|FG000|Overall Study|Major Protocol Deviation|0
1176091|NCT02284906|2322329|FG001|Overall Study|Major Protocol Deviation|1
1176092|NCT02284906|2322330|FG002|Overall Study|Major Protocol Deviation|0
1176093|NCT02284906|2322328|FG000|Overall Study|Voluntary Withdrawal|2
1176094|NCT02284906|2322329|FG001|Overall Study|Voluntary Withdrawal|4
1176095|NCT02284906|2322330|FG002|Overall Study|Voluntary Withdrawal|5
1176096|NCT02284906|2322328|FG000|Overall Study|Study Termination|0
872668|NCT00542919|1834356|FG000|Overall Study|Physician Decision|2
872669|NCT00542919|1834357|FG001|Overall Study|Physician Decision|2
872670|NCT00542919|1834358|FG002|Overall Study|Physician Decision|1
872671|NCT00542919|1834356|FG000|Overall Study|Sponsor Decision|1
872672|NCT00542919|1834357|FG001|Overall Study|Sponsor Decision|0
872673|NCT00542919|1834358|FG002|Overall Study|Sponsor Decision|0
872674|NCT00542919|1834356|FG000|Overall Study|Lost to Follow-up|2
872675|NCT00542919|1834357|FG001|Overall Study|Lost to Follow-up|0
872676|NCT00542919|1834358|FG002|Overall Study|Lost to Follow-up|1
872677|NCT00542997|1834385|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2
872678|NCT00542997|1834385|FG000|Wash in / Wash Out Period|Adverse Event|3
872679|NCT00542997|1834385|FG000|Efficacy Period|Adverse Event|3
872680|NCT00543062|1834392|FG000|Overall Study|Withdrawal by Subject|1
872681|NCT00543062|1834393|FG001|Overall Study|Withdrawal by Subject|0
872682|NCT00543062|1834394|FG002|Overall Study|Withdrawal by Subject|2
872683|NCT00543062|1834395|FG003|Overall Study|Withdrawal by Subject|0
872684|NCT00543062|1834392|FG000|Overall Study|Adverse Event|0
872685|NCT00543062|1834393|FG001|Overall Study|Adverse Event|1
872686|NCT00543062|1834394|FG002|Overall Study|Adverse Event|1
872687|NCT00543062|1834395|FG003|Overall Study|Adverse Event|1
872688|NCT00543062|1834392|FG000|Overall Study|Protocol Violation|1
872689|NCT00543062|1834393|FG001|Overall Study|Protocol Violation|0
872690|NCT00543062|1834394|FG002|Overall Study|Protocol Violation|0
872691|NCT00543062|1834395|FG003|Overall Study|Protocol Violation|0
872692|NCT00543140|1834432|FG000|Overall Study|Lost to Follow-up|33
872693|NCT00543140|1834432|FG000|Overall Study|Withdrawal by Subject|13
872694|NCT00543140|1834432|FG000|Overall Study|Protocol Violation|10
872695|NCT00543140|1834432|FG000|Overall Study|Insufficient weight loss|10
872696|NCT00543140|1834432|FG000|Overall Study|SAE leading to explant of SAGB|3
872697|NCT00543140|1834432|FG000|Overall Study|Death|1
872698|NCT00543140|1834432|FG000|Overall Study|Subject moved|1
872699|NCT00543140|1834432|FG000|Overall Study|Conversion to different procedure|1
872700|NCT00543296|1834436|FG000|Overall Study|Physician Decision|7
872701|NCT00543309|1834443|FG000|Overall Study|Physician Decision|0
872702|NCT00543309|1834444|FG001|Overall Study|Physician Decision|1
872703|NCT00543309|1834445|FG002|Overall Study|Physician Decision|0
872704|NCT00543387|1834463|FG000|Panel 1 + Panel 2|Adverse Event|0
872705|NCT00543387|1834464|FG001|Panel 1 + Panel 2|Adverse Event|1
872706|NCT00543387|1834465|FG002|Panel 1 + Panel 2|Adverse Event|0
872707|NCT00543387|1834466|FG003|Panel 1 + Panel 2|Adverse Event|0
872708|NCT00543387|1834467|FG004|Panel 1 + Panel 2|Adverse Event|0
872709|NCT00543387|1834468|FG005|Panel 1 + Panel 2|Adverse Event|0
872710|NCT00543387|1834469|FG006|Panel 1 + Panel 2|Adverse Event|0
872711|NCT00543387|1834470|FG007|Panel 1 + Panel 2|Adverse Event|1
872712|NCT00543387|1834471|FG008|Panel 1 + Panel 2|Adverse Event|1
872713|NCT00543387|1834472|FG009|Panel 1 + Panel 2|Adverse Event|0
872714|NCT00543387|1834473|FG010|Panel 1 + Panel 2|Adverse Event|0
872715|NCT00543387|1834463|FG000|Panel 1 + Panel 2|Physician Decision|0
872716|NCT00543387|1834464|FG001|Panel 1 + Panel 2|Physician Decision|0
872717|NCT00543387|1834465|FG002|Panel 1 + Panel 2|Physician Decision|1
1176097|NCT02284906|2322329|FG001|Overall Study|Study Termination|11
1176098|NCT02284906|2322330|FG002|Overall Study|Study Termination|14
1176099|NCT02284906|2322328|FG000|Overall Study|Reason not Specified|1
1176100|NCT02284906|2322329|FG001|Overall Study|Reason not Specified|1
1176101|NCT02284906|2322330|FG002|Overall Study|Reason not Specified|0
1176102|NCT02287025|2322340|FG000|Overall Study|Not treated|2
1176103|NCT02287025|2322341|FG001|Overall Study|Not treated|0
1176104|NCT02287025|2322340|FG000|Overall Study|Progression of disease|3
1176105|NCT02287025|2322341|FG001|Overall Study|Progression of disease|2
1176106|NCT02287025|2322340|FG000|Overall Study|Adverse Event|2
1176107|NCT02287025|2322341|FG001|Overall Study|Adverse Event|4
1176108|NCT02287025|2322340|FG000|Overall Study|Withdrawal by Subject|2
1176109|NCT02287025|2322341|FG001|Overall Study|Withdrawal by Subject|2
1176110|NCT02287025|2322340|FG000|Overall Study|Screening failed|1
1176111|NCT02287025|2322341|FG001|Overall Study|Screening failed|1
1176112|NCT02276560|2322356|FG000|Overall Study|Adverse Event|1
1176113|NCT02276560|2322357|FG001|Overall Study|Adverse Event|0
1176114|NCT02276560|2322358|FG002|Overall Study|Adverse Event|0
1176115|NCT02284373|2322373|FG000|Overall Study|Withdrawal by Subject|0
1176116|NCT02284373|2322374|FG001|Overall Study|Withdrawal by Subject|1
1176117|NCT02284373|2322375|FG002|Overall Study|Withdrawal by Subject|0
1176118|NCT02284373|2322373|FG000|Overall Study|Other|0
1176119|NCT02284373|2322374|FG001|Overall Study|Other|1
1176120|NCT02284373|2322375|FG002|Overall Study|Other|0
1176121|NCT02284373|2322373|FG000|Overall Study|Lost to Follow-up|0
1176122|NCT02284373|2322374|FG001|Overall Study|Lost to Follow-up|1
1176123|NCT02284373|2322375|FG002|Overall Study|Lost to Follow-up|0
1176124|NCT02285270|2322383|FG000|Overall Study|Lost to Follow-up|1
1176125|NCT02285270|2322383|FG000|Overall Study|Physician Decision|3
1176126|NCT02285270|2322383|FG000|Overall Study|Determined to be ineligible|1
1176127|NCT02275481|2322389|FG000|Overall Study|Death|2
1176128|NCT02275481|2322390|FG001|Overall Study|Death|1
1176129|NCT02275481|2322389|FG000|Overall Study|Lost to Follow-up|2
1176130|NCT02275481|2322390|FG001|Overall Study|Lost to Follow-up|0
1176131|NCT02275481|2322389|FG000|Overall Study|Withdrawal by Subject|3
1176132|NCT02275481|2322390|FG001|Overall Study|Withdrawal by Subject|0
1176133|NCT02275481|2322389|FG000|Overall Study|all other reasons combined|2
1176134|NCT02275481|2322390|FG001|Overall Study|all other reasons combined|1
1176135|NCT02275481|2322389|FG000|Overall Study|Physician Decision|0
1176136|NCT02275481|2322390|FG001|Overall Study|Physician Decision|1
1176137|NCT02273752|2322400|FG000|Overall Study|Trial was terminated early|2
1176138|NCT02270684|2322406|FG000|Overall Study|Lost to Follow-up|0
1176139|NCT02270684|2322407|FG001|Overall Study|Lost to Follow-up|3
1176140|NCT02270684|2322406|FG000|Overall Study|Study terminated|1
1176141|NCT02270684|2322407|FG001|Overall Study|Study terminated|0
1176142|NCT02271594|2322424|FG000|Overall Study|Study closed; recruiting failure|19
872718|NCT00543387|1834466|FG003|Panel 1 + Panel 2|Physician Decision|0
872719|NCT00543387|1834467|FG004|Panel 1 + Panel 2|Physician Decision|0
872720|NCT00543387|1834468|FG005|Panel 1 + Panel 2|Physician Decision|0
872721|NCT00543387|1834469|FG006|Panel 1 + Panel 2|Physician Decision|0
872722|NCT00543387|1834470|FG007|Panel 1 + Panel 2|Physician Decision|1
872723|NCT00543387|1834471|FG008|Panel 1 + Panel 2|Physician Decision|0
872724|NCT00543387|1834472|FG009|Panel 1 + Panel 2|Physician Decision|0
872725|NCT00543387|1834473|FG010|Panel 1 + Panel 2|Physician Decision|0
872726|NCT00543387|1834463|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3
872727|NCT00543387|1834464|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2
872728|NCT00543387|1834465|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2
872729|NCT00543387|1834466|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3
872730|NCT00543387|1834467|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3
872731|NCT00543387|1834468|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3
872732|NCT00543387|1834469|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5
872733|NCT00543387|1834470|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4
872734|NCT00543387|1834471|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4
872735|NCT00543387|1834472|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0
872736|NCT00543387|1834473|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0
872737|NCT00543387|1834463|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0
872738|NCT00543387|1834464|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0
872739|NCT00543387|1834465|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0
872740|NCT00543387|1834466|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0
872741|NCT00543387|1834467|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0
872742|NCT00543387|1834468|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0
872743|NCT00543387|1834469|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1
872744|NCT00543387|1834470|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0
872745|NCT00543387|1834471|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0
872746|NCT00543387|1834472|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0
872747|NCT00543387|1834473|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0
872748|NCT00543387|1834463|FG000|Crossover Participants|Progressive Disease|0
872749|NCT00543387|1834464|FG001|Crossover Participants|Progressive Disease|0
872750|NCT00543387|1834465|FG002|Crossover Participants|Progressive Disease|0
872751|NCT00543387|1834466|FG003|Crossover Participants|Progressive Disease|0
872752|NCT00543387|1834467|FG004|Crossover Participants|Progressive Disease|0
1176143|NCT02271594|2322425|FG001|Overall Study|Study closed; recruiting failure|12
1176144|NCT02263365|2322435|FG000|Overall Study|Physician Decision|22
1176145|NCT02263365|2322436|FG001|Overall Study|Physician Decision|18
1176146|NCT02241551|2322470|FG000|Overall Study|Adverse Event|1
1176147|NCT02241551|2322471|FG001|Overall Study|Adverse Event|0
1176148|NCT02246114|2322481|FG000|Overall Study|miscarriage|1
872753|NCT00543387|1834468|FG005|Crossover Participants|Progressive Disease|0
872754|NCT00543387|1834469|FG006|Crossover Participants|Progressive Disease|0
872755|NCT00543387|1834470|FG007|Crossover Participants|Progressive Disease|0
872756|NCT00543387|1834471|FG008|Crossover Participants|Progressive Disease|0
872757|NCT00543387|1834472|FG009|Crossover Participants|Progressive Disease|1
872758|NCT00543387|1834473|FG010|Crossover Participants|Progressive Disease|2
872759|NCT00543387|1834463|FG000|Crossover Participants|Study Terminated by Sponsor|0
872760|NCT00543387|1834464|FG001|Crossover Participants|Study Terminated by Sponsor|0
872761|NCT00543387|1834465|FG002|Crossover Participants|Study Terminated by Sponsor|0
872762|NCT00543387|1834466|FG003|Crossover Participants|Study Terminated by Sponsor|0
872763|NCT00543387|1834467|FG004|Crossover Participants|Study Terminated by Sponsor|0
872764|NCT00543387|1834468|FG005|Crossover Participants|Study Terminated by Sponsor|0
872765|NCT00543387|1834469|FG006|Crossover Participants|Study Terminated by Sponsor|0
872766|NCT00543387|1834470|FG007|Crossover Participants|Study Terminated by Sponsor|0
872767|NCT00543387|1834471|FG008|Crossover Participants|Study Terminated by Sponsor|0
872768|NCT00543387|1834472|FG009|Crossover Participants|Study Terminated by Sponsor|0
872769|NCT00543387|1834473|FG010|Crossover Participants|Study Terminated by Sponsor|1
872770|NCT00543439|1834517|FG000|Period 1|Adverse Event|0
872771|NCT00543439|1834518|FG001|Period 1|Adverse Event|2
872772|NCT00543439|1834519|FG002|Period 1|Adverse Event|1
872773|NCT00543439|1834517|FG000|Period 1|Withdrawal by Subject|1
872774|NCT00543439|1834518|FG001|Period 1|Withdrawal by Subject|1
872775|NCT00543439|1834519|FG002|Period 1|Withdrawal by Subject|0
872776|NCT00543439|1834517|FG000|Period 1|Physician Decision|0
872777|NCT00543439|1834518|FG001|Period 1|Physician Decision|0
872778|NCT00543439|1834519|FG002|Period 1|Physician Decision|1
872779|NCT00543439|1834517|FG000|Period 2|Protocol Violation|1
872780|NCT00543439|1834518|FG001|Period 2|Protocol Violation|0
872781|NCT00543439|1834519|FG002|Period 2|Protocol Violation|1
872782|NCT00543439|1834517|FG000|Period 2|Adverse Event|0
872783|NCT00543439|1834518|FG001|Period 2|Adverse Event|1
872784|NCT00543439|1834519|FG002|Period 2|Adverse Event|1
872785|NCT00543543|1834540|FG000|Base Study|Adverse Event|1
872786|NCT00543543|1834541|FG001|Base Study|Adverse Event|11
872787|NCT00543543|1834542|FG002|Base Study|Adverse Event|0
872788|NCT00543543|1834543|FG003|Base Study|Adverse Event|5
872789|NCT00543543|1834540|FG000|Base Study|Lost to Follow-up|12
872790|NCT00543543|1834541|FG001|Base Study|Lost to Follow-up|749
872791|NCT00543543|1834542|FG002|Base Study|Lost to Follow-up|9
872792|NCT00543543|1834543|FG003|Base Study|Lost to Follow-up|701
872793|NCT00543543|1834540|FG000|Base Study|Physician Decision|0
872794|NCT00543543|1834541|FG001|Base Study|Physician Decision|4
872795|NCT00543543|1834542|FG002|Base Study|Physician Decision|0
872796|NCT00543543|1834543|FG003|Base Study|Physician Decision|7
872797|NCT00543543|1834540|FG000|Base Study|Protocol Violation|0
872798|NCT00543543|1834541|FG001|Base Study|Protocol Violation|6
872799|NCT00543543|1834542|FG002|Base Study|Protocol Violation|0
872800|NCT00543543|1834543|FG003|Base Study|Protocol Violation|6
872801|NCT00543543|1834540|FG000|Base Study|Withdrawal by Subject|7
872802|NCT00543543|1834541|FG001|Base Study|Withdrawal by Subject|482
872803|NCT00543543|1834542|FG002|Base Study|Withdrawal by Subject|5
872804|NCT00543543|1834543|FG003|Base Study|Withdrawal by Subject|503
872805|NCT00543543|1834540|FG000|Extension Study|Adverse Event|0
872806|NCT00543543|1834541|FG001|Extension Study|Adverse Event|0
872807|NCT00543543|1834542|FG002|Extension Study|Adverse Event|0
872808|NCT00543543|1834543|FG003|Extension Study|Adverse Event|5
872809|NCT00543543|1834540|FG000|Extension Study|Lost to Follow-up|0
872810|NCT00543543|1834541|FG001|Extension Study|Lost to Follow-up|0
872811|NCT00543543|1834542|FG002|Extension Study|Lost to Follow-up|0
872812|NCT00543543|1834543|FG003|Extension Study|Lost to Follow-up|77
872813|NCT00543543|1834540|FG000|Extension Study|Physician Decision|0
872814|NCT00543543|1834541|FG001|Extension Study|Physician Decision|0
872815|NCT00543543|1834542|FG002|Extension Study|Physician Decision|0
872816|NCT00543543|1834543|FG003|Extension Study|Physician Decision|7
872817|NCT00543543|1834540|FG000|Extension Study|Pregnancy|0
872818|NCT00543543|1834541|FG001|Extension Study|Pregnancy|0
872819|NCT00543543|1834542|FG002|Extension Study|Pregnancy|0
872820|NCT00543543|1834543|FG003|Extension Study|Pregnancy|6
872821|NCT00543543|1834540|FG000|Extension Study|Protocol Violation|0
872822|NCT00543543|1834541|FG001|Extension Study|Protocol Violation|0
872823|NCT00543543|1834542|FG002|Extension Study|Protocol Violation|0
872824|NCT00543543|1834543|FG003|Extension Study|Protocol Violation|11
872825|NCT00543543|1834540|FG000|Extension Study|Withdrawal by Subject|0
872826|NCT00543543|1834541|FG001|Extension Study|Withdrawal by Subject|0
872827|NCT00543543|1834542|FG002|Extension Study|Withdrawal by Subject|0
872828|NCT00543543|1834543|FG003|Extension Study|Withdrawal by Subject|120
872829|NCT00543569|1834562|FG000|Overall Study|Death|2
872830|NCT00543569|1834563|FG001|Overall Study|Death|2
872831|NCT00543569|1834564|FG002|Overall Study|Death|3
872832|NCT00543569|1834565|FG003|Overall Study|Death|1
872833|NCT00543569|1834562|FG000|Overall Study|Lost to Follow-up|0
1176149|NCT02246114|2322482|FG001|Overall Study|miscarriage|0
1176150|NCT02232880|2322488|FG000|Overall Study|study stopped prior to randomization|1
1176151|NCT02244944|2322510|FG000|Overall Study|Withdrawal by Subject|1
1176152|NCT02244944|2322510|FG000|Overall Study|Study Terminated|1
1176153|NCT02241187|2322514|FG000|Overall Study|Protocol closed due to lack of accrual.|2
1176154|NCT02239926|2322520|FG000|Overall Study|Withdrawal by Subject|0
1176155|NCT02239926|2322521|FG001|Overall Study|Withdrawal by Subject|1
1176156|NCT02231892|2322530|FG000|Overall Study|Lost to Follow-up|1
1176157|NCT02231892|2322531|FG001|Overall Study|Lost to Follow-up|0
1176158|NCT02231892|2322532|FG002|Overall Study|Lost to Follow-up|3
1176159|NCT02231892|2322530|FG000|Overall Study|Withdrawal by Subject|4
1176160|NCT02231892|2322531|FG001|Overall Study|Withdrawal by Subject|3
1176161|NCT02231892|2322532|FG002|Overall Study|Withdrawal by Subject|15
1176162|NCT02231892|2322530|FG000|Overall Study|Physician Decision|0
1176163|NCT02231892|2322531|FG001|Overall Study|Physician Decision|2
1176164|NCT02231892|2322532|FG002|Overall Study|Physician Decision|4
1176165|NCT02231892|2322530|FG000|Overall Study|Motor activity when stimulating ante ACC|4
1176166|NCT02231892|2322531|FG001|Overall Study|Motor activity when stimulating ante ACC|7
1176167|NCT02231892|2322532|FG002|Overall Study|Motor activity when stimulating ante ACC|12
1176168|NCT02231892|2322530|FG000|Overall Study|Participant motor threshold was >83%|0
1176169|NCT02231892|2322531|FG001|Overall Study|Participant motor threshold was >83%|0
1176170|NCT02231892|2322532|FG002|Overall Study|Participant motor threshold was >83%|9
1176171|NCT02231892|2322530|FG000|Overall Study|Could not find motor threshold|2
1176172|NCT02231892|2322531|FG001|Overall Study|Could not find motor threshold|0
1176173|NCT02231892|2322532|FG002|Overall Study|Could not find motor threshold|1
1176174|NCT02231892|2322530|FG000|Overall Study|Could not find reliable motor hotspot|0
1176175|NCT02231892|2322531|FG001|Overall Study|Could not find reliable motor hotspot|0
1176176|NCT02231892|2322532|FG002|Overall Study|Could not find reliable motor hotspot|1
1176177|NCT02241343|2322546|FG000|Overall Study|Adverse Event|1
1176178|NCT02224599|2322581|FG000|Overall Study|Physician Decision|1
1176179|NCT02224599|2322581|FG000|Overall Study|Progression of Disease|1
1176180|NCT02201472|2322585|FG000|Overall Study|Lack of Efficacy|2
1176181|NCT02200042|2322608|FG000|Overall Study|Withdrawal by Subject|0
1176182|NCT02200042|2322609|FG001|Overall Study|Withdrawal by Subject|1
1176183|NCT02181790|2322617|FG000|Overall Study|study terminated|2
1176184|NCT02181790|2322618|FG001|Overall Study|study terminated|0
1176185|NCT02177266|2322646|FG000|Overall Study|Adverse Event|0
1176186|NCT02177266|2322647|FG001|Overall Study|Adverse Event|1
1176187|NCT02177266|2322646|FG000|Overall Study|Withdrawal by Subject|1
1176188|NCT02177266|2322647|FG001|Overall Study|Withdrawal by Subject|0
1176189|NCT02170298|2322664|FG000|Overall Study|Withdrawal by Subject|0
1176190|NCT02170298|2322665|FG001|Overall Study|Withdrawal by Subject|1
1176191|NCT02170298|2322664|FG000|Overall Study|unblinded, rerandomized to intervention|1
1176192|NCT02170298|2322665|FG001|Overall Study|unblinded, rerandomized to intervention|0
1176193|NCT02169830|2322687|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0
1176194|NCT02169830|2322688|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0
1176195|NCT02169830|2322689|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1
1176196|NCT02169830|2322687|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1
1176197|NCT02169830|2322688|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0
1176198|NCT02169830|2322689|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0
1176199|NCT02169830|2322687|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
1176200|NCT02169830|2322688|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5
1176201|NCT02169830|2322689|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0
1176202|NCT02169830|2322687|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0
1176203|NCT02169830|2322688|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1
1176204|NCT02169830|2322689|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0
1176205|NCT02169830|2322687|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0
1176206|NCT02169830|2322688|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1
1176207|NCT02169830|2322689|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0
1176208|NCT02163187|2322699|FG000|Overall Study|Device removed|1
1176209|NCT02163187|2322700|FG001|Overall Study|Device removed|0
1176210|NCT02163187|2322699|FG000|Overall Study|Progressive disease|1
872834|NCT00543569|1834563|FG001|Overall Study|Lost to Follow-up|0
872835|NCT00543569|1834564|FG002|Overall Study|Lost to Follow-up|1
872836|NCT00543569|1834565|FG003|Overall Study|Lost to Follow-up|1
872837|NCT00543569|1834562|FG000|Overall Study|Miscellaneous Reasons|7
872838|NCT00543569|1834563|FG001|Overall Study|Miscellaneous Reasons|3
872839|NCT00543569|1834564|FG002|Overall Study|Miscellaneous Reasons|11
872840|NCT00543569|1834565|FG003|Overall Study|Miscellaneous Reasons|4
872841|NCT00543569|1834562|FG000|Overall Study|Randomized but never received study drug|3
872842|NCT00543569|1834563|FG001|Overall Study|Randomized but never received study drug|3
872843|NCT00543569|1834564|FG002|Overall Study|Randomized but never received study drug|5
872844|NCT00543569|1834565|FG003|Overall Study|Randomized but never received study drug|3
872845|NCT00543725|1834577|FG000|Overall Study|Adverse Event|18
872846|NCT00543725|1834578|FG001|Overall Study|Adverse Event|27
872847|NCT00543725|1834577|FG000|Overall Study|Sponsor's Decision|0
872848|NCT00543725|1834578|FG001|Overall Study|Sponsor's Decision|1
872849|NCT00543725|1834577|FG000|Overall Study|Subject Non-Compliant|4
1176211|NCT02163187|2322700|FG001|Overall Study|Progressive disease|0
1176212|NCT02161016|2322706|FG000|Overall Study|withdrawn by IRB|1
1176213|NCT02159040|2322710|FG000|Overall Study|Death|1
1176214|NCT02168270|2322714|FG000|Overall Study|Lack of Efficacy|4
1176215|NCT02157116|2322718|FG000|Overall Study|Withdrawal by Subject|4
1176216|NCT02157116|2322718|FG000|Overall Study|Physician Decision|3
1176217|NCT02157116|2322718|FG000|Overall Study|Failed Screening|2
1176218|NCT02154087|2322722|FG000|Overall Study|Study Termination|1
1176219|NCT02152566|2322730|FG000|Overall Study|Lost to Follow-up|1
1176220|NCT02152566|2322730|FG000|Overall Study|Withdrawal by Subject|2
1176221|NCT02145390|2322747|FG000|Overall Study|Withdrawal by Subject|1
1176222|NCT02150863|2322780|FG000|Overall Study|Lost to Follow-up|0
1176223|NCT02150863|2322781|FG001|Overall Study|Lost to Follow-up|1
1176224|NCT02150863|2322782|FG002|Overall Study|Lost to Follow-up|0
1176225|NCT02131155|2322818|FG000|Overall Study|Adverse Event|1
1176226|NCT02131155|2322819|FG001|Overall Study|Adverse Event|0
1176227|NCT02131155|2322818|FG000|Overall Study|Treatment completed|1
1176228|NCT02131155|2322819|FG001|Overall Study|Treatment completed|0
1176229|NCT02131155|2322818|FG000|Overall Study|Primary tumour recurrence|2
1176230|NCT02131155|2322819|FG001|Overall Study|Primary tumour recurrence|1
1176231|NCT02131155|2322818|FG000|Overall Study|Refused to continue study medication|1
1176232|NCT02131155|2322819|FG001|Overall Study|Refused to continue study medication|0
1176233|NCT02131155|2322818|FG000|Overall Study|Study early termination|20
1176234|NCT02131155|2322819|FG001|Overall Study|Study early termination|10
1176235|NCT02117050|2322825|FG000|Overall Study|Subject Enrolled but not Dosed|1
1176236|NCT02105116|2322847|FG000|Overall Study|not eligible for step 2 of trial|5
1176237|NCT02105116|2322847|FG000|Overall Study|Death|1
1176238|NCT02099344|2322864|FG000|Overall Study|Physician Decision|1
1176239|NCT02099344|2322865|FG001|Overall Study|Physician Decision|0
1176240|NCT02096042|2322882|FG000|Overall Study|Disease Progression|1
1176241|NCT02096042|2322883|FG001|Overall Study|Disease Progression|0
1176242|NCT02096042|2322884|FG002|Overall Study|Disease Progression|0
1176243|NCT02088957|2322891|FG000|Overall Study|Lack of Efficacy|1
1176244|NCT02088957|2322892|FG001|Overall Study|Lack of Efficacy|0
1176245|NCT02093689|2322901|FG000|Overall Study|Physician Decision|4
1176246|NCT02093689|2322902|FG001|Overall Study|Physician Decision|0
1176247|NCT02093689|2322903|FG002|Overall Study|Physician Decision|0
1176248|NCT02091752|2322909|FG000|Overall Study|Study terminated by Sponsor|2
1176249|NCT02091752|2322909|FG000|Overall Study|Adverse Event|1
1176250|NCT02068547|2322915|FG000|Overall Study|Lost to Follow-up|3
1176251|NCT02068547|2322916|FG001|Overall Study|Lost to Follow-up|3
1176252|NCT02068547|2322915|FG000|Overall Study|Physician Decision|1
1176253|NCT02068547|2322916|FG001|Overall Study|Physician Decision|0
1176254|NCT02081183|2322954|FG000|Overall Study|Lost to Follow-up|0
1176255|NCT02081183|2322955|FG001|Overall Study|Lost to Follow-up|1
1176256|NCT02081183|2322954|FG000|Overall Study|Protocol Violation|1
1176257|NCT02081183|2322955|FG001|Overall Study|Protocol Violation|0
1176258|NCT02081183|2322954|FG000|Overall Study|Other|3
1176259|NCT02081183|2322955|FG001|Overall Study|Other|3
1176260|NCT02067104|2322975|FG000|Overall Study|Study termination due to low accrual|4
1176261|NCT02067104|2322976|FG001|Overall Study|Study termination due to low accrual|5
1176262|NCT02057874|2322986|FG000|Overall Study|participant did not return for scan|1
1176263|NCT02058537|2323000|FG000|Overall Study|Withdrawal by Subject|1
1176264|NCT02038153|2323013|FG000|Overall Study|Withdrawal by Subject|1
1176265|NCT02054910|2323019|FG000|Overall Study|Lost to Follow-up|4
1176266|NCT02054910|2323020|FG001|Overall Study|Lost to Follow-up|1
1176267|NCT02044302|2323030|FG000|Overall Study|study terminated|2
1176268|NCT02044302|2323031|FG001|Overall Study|study terminated|0
1176269|NCT02046226|2323035|FG000|Overall Study|Lost to Follow-up|7
1176270|NCT02044848|2323042|FG000|Overall Study|Administrative Problems|2
872850|NCT00543725|1834578|FG001|Overall Study|Subject Non-Compliant|4
872851|NCT00543725|1834577|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
872852|NCT00543725|1834578|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
872853|NCT00543725|1834577|FG000|Overall Study|Subject Reached A Virologic Endpoint|22
872854|NCT00543725|1834578|FG001|Overall Study|Subject Reached A Virologic Endpoint|14
872855|NCT00543725|1834577|FG000|Overall Study|Protocol Violation|0
872856|NCT00543725|1834578|FG001|Overall Study|Protocol Violation|1
872857|NCT00543725|1834577|FG000|Overall Study|Withdrawal by Subject|4
872858|NCT00543725|1834578|FG001|Overall Study|Withdrawal by Subject|13
1176271|NCT02044848|2323043|FG001|Overall Study|Administrative Problems|3
1176272|NCT02042950|2323049|FG000|Overall Study|Progressive Disease|4
1176273|NCT02048904|2323053|FG000|Overall Study|Withdrawal by Subject|7
1176274|NCT02048904|2323053|FG000|Overall Study|Physician Decision|70
1176275|NCT02044822|2323057|FG000|Overall Study|Study Terminated by Sponsor|77
1176276|NCT02044822|2323057|FG000|Overall Study|Investigator's Discretion|10
1176277|NCT02044822|2323057|FG000|Overall Study|Withdrew Consent|3
1176278|NCT02044822|2323057|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2
1176279|NCT02044822|2323057|FG000|Overall Study|Lost to Follow-up|1
1176280|NCT02042924|2323061|FG000|Overall Study|Early Death|1
1176281|NCT02017522|2323069|FG000|Overall Study|Withdrawal by Subject|1
1176282|NCT02030015|2323074|FG000|Overall Study|Withdrawal by Subject|3
1176283|NCT02030015|2323074|FG000|Overall Study|Death|13
1176284|NCT02015663|2323080|FG000|Overall Study|unsatisfactory therapeutic effect|1
1176285|NCT02015663|2323081|FG001|Overall Study|unsatisfactory therapeutic effect|0
1176286|NCT02015663|2323080|FG000|Overall Study|Withdrawal by Subject|1
1176287|NCT02015663|2323081|FG001|Overall Study|Withdrawal by Subject|0
1176288|NCT02015663|2323080|FG000|Overall Study|Protocol Violation|0
1176289|NCT02015663|2323081|FG001|Overall Study|Protocol Violation|1
1176290|NCT02015663|2323080|FG000|Overall Study|Adverse Event|3
1176291|NCT02015663|2323081|FG001|Overall Study|Adverse Event|0
1176292|NCT02015663|2323080|FG000|Overall Study|Administrative problems|10
1176293|NCT02015663|2323081|FG001|Overall Study|Administrative problems|11
1176294|NCT02029846|2323090|FG000|Overall Study|n=1 each arm|1
1176295|NCT02029846|2323091|FG001|Overall Study|n=1 each arm|1
1176296|NCT02011542|2323128|FG000|Overall Study|Physician Decision|1
1176297|NCT02008370|2323132|FG000|Overall Study|Lost to Follow-up|7
1176298|NCT02005445|2323153|FG000|Overall Study|Dual study enrollment|0
1176299|NCT02005445|2323154|FG001|Overall Study|Dual study enrollment|1
1176300|NCT02006927|2323173|FG000|Overall Study|Adverse Event|2
1176301|NCT02006927|2323173|FG000|Overall Study|Withdrawal by Subject|1
1176302|NCT01996982|2323177|FG000|Overall Study|PI/team left institution|7
1176303|NCT01986751|2323187|FG000|Overall Study|improperly consented|10
1176304|NCT01986751|2323188|FG001|Overall Study|improperly consented|2
1176305|NCT01977729|2323247|FG000|Overall Study|Study terminated|1
1176306|NCT01982253|2323260|FG000|Overall Study|Withdrawal by Subject|1
1176307|NCT01982253|2323261|FG001|Overall Study|Withdrawal by Subject|0
1176308|NCT01982253|2323262|FG002|Overall Study|Withdrawal by Subject|0
1176309|NCT01982253|2323260|FG000|Overall Study|Study terminated by sponsor|1
1176310|NCT01982253|2323261|FG001|Overall Study|Study terminated by sponsor|4
1176311|NCT01982253|2323262|FG002|Overall Study|Study terminated by sponsor|4
1176312|NCT01984268|2323270|FG000|Overall Study|Study Terminated|15
1176313|NCT01980875|2323290|FG000|Overall Study|Withdrew Consent|1
1176314|NCT01980875|2323291|FG001|Overall Study|Withdrew Consent|1
1176315|NCT01980875|2323292|FG002|Overall Study|Withdrew Consent|1
1176316|NCT01980875|2323290|FG000|Overall Study|Study Terminated by Sponsor|7
1176317|NCT01980875|2323291|FG001|Overall Study|Study Terminated by Sponsor|24
1176318|NCT01980875|2323292|FG002|Overall Study|Study Terminated by Sponsor|22
1176319|NCT01980875|2323290|FG000|Overall Study|Lost to Follow-up|0
1176320|NCT01980875|2323291|FG001|Overall Study|Lost to Follow-up|0
1176321|NCT01980875|2323292|FG002|Overall Study|Lost to Follow-up|1
1176322|NCT01970462|2323338|FG000|Overall Study|Lost to Follow-up|0
1176323|NCT01970462|2323339|FG001|Overall Study|Lost to Follow-up|2
1176324|NCT01969565|2323345|FG000|Overall Study|Withdrawal by Subject|1
1176325|NCT01968226|2323350|FG000|Overall Study|[F-18] RDG-K5 was not available|2
1176326|NCT01962974|2323369|FG000|Overall Study|Study termination|7
1176327|NCT01951378|2323386|FG000|Overall Study|Study Terminated-Not completed|23
1176328|NCT01951378|2323387|FG001|Overall Study|Study Terminated-Not completed|17
1176329|NCT01944059|2323410|FG000|Overall Study|Lost to Follow-up|1
1176330|NCT01944059|2323410|FG000|Overall Study|Physician Decision|3
1176331|NCT01944059|2323410|FG000|Overall Study|Withdrawal by Subject|1
1176332|NCT01944059|2323410|FG000|Overall Study|Adverse Event|2
1176333|NCT01935947|2323418|FG000|Overall Study|Adverse Event|0
1176334|NCT01935947|2323419|FG001|Overall Study|Adverse Event|2
1176335|NCT01935947|2323420|FG002|Overall Study|Adverse Event|0
1176336|NCT01935947|2323418|FG000|Overall Study|Diease Progression|2
1176337|NCT01935947|2323419|FG001|Overall Study|Diease Progression|2
1176338|NCT01935947|2323420|FG002|Overall Study|Diease Progression|2
1176339|NCT01935947|2323418|FG000|Overall Study|Death|1
1176340|NCT01935947|2323419|FG001|Overall Study|Death|0
1176341|NCT01935947|2323420|FG002|Overall Study|Death|0
1176342|NCT01939223|2323433|FG000|Overall Study|AE not assoc. with disease recurrence|1
1176343|NCT01939223|2323434|FG001|Overall Study|AE not assoc. with disease recurrence|1
1176344|NCT01939223|2323433|FG000|Overall Study|Disease recurrence (radiological)|1
1176345|NCT01939223|2323434|FG001|Overall Study|Disease recurrence (radiological)|3
1176346|NCT01939223|2323433|FG000|Overall Study|Study stopped by Sponsor|5
1176347|NCT01939223|2323434|FG001|Overall Study|Study stopped by Sponsor|7
1176348|NCT01939223|2323433|FG000|Overall Study|Withdrawal by Subject|6
1176349|NCT01939223|2323434|FG001|Overall Study|Withdrawal by Subject|0
1176350|NCT01938716|2323440|FG000|Overall Study|Physician Decision|2
1176351|NCT01938716|2323440|FG000|Overall Study|Withdrawal by Subject|2
1176352|NCT01936974|2323446|FG000|Overall Study|Physician Decision|2
1176353|NCT01936974|2323447|FG001|Overall Study|Physician Decision|5
1176354|NCT01934504|2323474|FG000|Overall Study|Protocol Deviation|0
1176355|NCT01934504|2323475|FG001|Overall Study|Protocol Deviation|0
1176356|NCT01934504|2323476|FG002|Overall Study|Protocol Deviation|0
1176357|NCT01934504|2323477|FG003|Overall Study|Protocol Deviation|2
1176358|NCT01934504|2323474|FG000|Overall Study|Study Terminated by Sponsor|1
1176359|NCT01934504|2323475|FG001|Overall Study|Study Terminated by Sponsor|0
1176360|NCT01934504|2323476|FG002|Overall Study|Study Terminated by Sponsor|5
1176361|NCT01934504|2323477|FG003|Overall Study|Study Terminated by Sponsor|5
1176362|NCT01928082|2323487|FG000|Overall Study|Study terminated.|1
1176363|NCT01928615|2323491|FG000|Overall Study|Study Terminated by Sponsor|2
1176364|NCT01911793|2323498|FG000|Overall Study|Physician Decision|1
1176365|NCT01911793|2323499|FG001|Overall Study|Physician Decision|5
1176366|NCT01912404|2323507|FG000|Overall Study|Due to personal reasons|1
1176367|NCT01912404|2323508|FG001|Overall Study|Due to personal reasons|0
1176368|NCT01910389|2323516|FG000|Overall Study|Withdrawal by Subject|2
1176369|NCT01910389|2323517|FG001|Overall Study|Withdrawal by Subject|0
1176370|NCT01910389|2323516|FG000|Overall Study|Study Closed|13
1176371|NCT01910389|2323517|FG001|Overall Study|Study Closed|8
1176372|NCT01913327|2323543|FG000|Overall Study|Withdrawal by Subject|0
872859|NCT00543725|1834577|FG000|Overall Study|Lost to Follow-up|15
872860|NCT00543725|1834578|FG001|Overall Study|Lost to Follow-up|11
872861|NCT00543725|1834577|FG000|Overall Study|Other|3
872862|NCT00543725|1834578|FG001|Overall Study|Other|3
872863|NCT00543803|1834597|FG000|Overall Study|Adverse Event|14
872864|NCT00543803|1834597|FG000|Overall Study|Lack of Efficacy|22
872865|NCT00543803|1834597|FG000|Overall Study|Lost to Follow-up|20
872866|NCT00543803|1834597|FG000|Overall Study|Other|86
872867|NCT00543855|1834607|FG000|Overall Study|Adverse Event|3
872868|NCT00543855|1834608|FG001|Overall Study|Adverse Event|1
872869|NCT00543855|1834609|FG002|Overall Study|Adverse Event|3
872870|NCT00543855|1834610|FG003|Overall Study|Adverse Event|4
872871|NCT00543855|1834607|FG000|Overall Study|Lost to Follow-up|0
872872|NCT00543855|1834608|FG001|Overall Study|Lost to Follow-up|0
872873|NCT00543855|1834609|FG002|Overall Study|Lost to Follow-up|1
872874|NCT00543855|1834610|FG003|Overall Study|Lost to Follow-up|0
872875|NCT00543855|1834607|FG000|Overall Study|Withdrawal by Subject|0
872876|NCT00543855|1834608|FG001|Overall Study|Withdrawal by Subject|1
872877|NCT00543855|1834609|FG002|Overall Study|Withdrawal by Subject|2
872878|NCT00543855|1834610|FG003|Overall Study|Withdrawal by Subject|0
872879|NCT00543855|1834607|FG000|Overall Study|Protocol Violation|1
872880|NCT00543855|1834608|FG001|Overall Study|Protocol Violation|0
872881|NCT00543855|1834609|FG002|Overall Study|Protocol Violation|0
872882|NCT00543855|1834610|FG003|Overall Study|Protocol Violation|0
872883|NCT00543985|1834620|FG000|Overall Study|Withdrawal by Subject|4
872884|NCT00544167|1834641|FG000|Overall Study|Adverse Event|21
872885|NCT00544167|1834641|FG000|Overall Study|Physician Decision|8
872886|NCT00544440|1834645|FG000|Overall Study|Other|1
872887|NCT00544440|1834645|FG000|Overall Study|Adverse Event|1
872888|NCT00544440|1834645|FG000|Overall Study|Withdrawal by Subject|2
872889|NCT00544440|1834645|FG000|Overall Study|Subject Non-compliance|1
872890|NCT00544440|1834645|FG000|Overall Study|Progressive Disease|47
872891|NCT00544440|1834645|FG000|Overall Study|Other|5
872892|NCT00544544|1834649|FG000|Overall Study|Withdrawal by Subject|1
872893|NCT00544544|1834649|FG000|Overall Study|Adverse Event|1
872894|NCT00544544|1834649|FG000|Overall Study|Lost to Follow-up|1
872895|NCT00544557|1834653|FG000|Overall Study|Adverse Event|140
872896|NCT00544557|1834653|FG000|Overall Study|Lack of Efficacy|196
872897|NCT00544557|1834653|FG000|Overall Study|Other|98
872898|NCT00544648|1834659|FG000|Overall Study|Withdrawal by Subject|1
872899|NCT00544648|1834660|FG001|Overall Study|Withdrawal by Subject|0
872900|NCT00544648|1834659|FG000|Overall Study|Adverse Event|1
1176373|NCT01913327|2323544|FG001|Overall Study|Withdrawal by Subject|1
1176374|NCT01902888|2323550|FG000|Overall Study|Study Terminated|3
1176375|NCT01901224|2323554|FG000|Overall Study|study was not funded and terminated|2
1176376|NCT01910441|2323560|FG000|Overall Study|Sponsor decision|0
1176377|NCT01910441|2323561|FG001|Overall Study|Sponsor decision|2
1176378|NCT01910441|2323560|FG000|Overall Study|Lost to Follow-up|6
1176379|NCT01910441|2323561|FG001|Overall Study|Lost to Follow-up|5
1176380|NCT01910441|2323560|FG000|Overall Study|Withdrawal by Subject|0
1176381|NCT01910441|2323561|FG001|Overall Study|Withdrawal by Subject|1
1176382|NCT01910441|2323560|FG000|Overall Study|Non-compliance|0
1176383|NCT01910441|2323561|FG001|Overall Study|Non-compliance|1
1176384|NCT01910441|2323560|FG000|Overall Study|Adverse Event|1
1176385|NCT01910441|2323561|FG001|Overall Study|Adverse Event|0
1176386|NCT01910441|2323560|FG000|Overall Study|Physician Decision|0
1176387|NCT01910441|2323561|FG001|Overall Study|Physician Decision|1
1176388|NCT01902966|2323567|FG000|Overall Study|Death|1
1176389|NCT01902966|2323567|FG000|Overall Study|Physician Decision|1
1176390|NCT01902966|2323567|FG000|Overall Study|Withdrawal by Subject|1
1176391|NCT01900730|2323582|FG000|Overall Study|Withdrawal by Subject|1
1176392|NCT01900730|2323583|FG001|Overall Study|Withdrawal by Subject|0
1176393|NCT01900730|2323582|FG000|Overall Study|Screen Failure|1
1176394|NCT01900730|2323583|FG001|Overall Study|Screen Failure|0
1176395|NCT01900626|2323611|FG000|Overall Study|study was closed due to low enrollment|1
1176396|NCT01900626|2323612|FG001|Overall Study|study was closed due to low enrollment|1
1176397|NCT01884077|2323634|FG000|Overall Study|screen fail|0
1176398|NCT01884077|2323635|FG001|Overall Study|screen fail|2
1176399|NCT01884077|2323634|FG000|Overall Study|canceled surgery|2
1176400|NCT01884077|2323635|FG001|Overall Study|canceled surgery|0
1176401|NCT01884077|2323634|FG000|Overall Study|Lost to Follow-up|0
1176402|NCT01884077|2323635|FG001|Overall Study|Lost to Follow-up|4
1176403|NCT01884077|2323634|FG000|Overall Study|study closed|6
1176404|NCT01884077|2323635|FG001|Overall Study|study closed|4
1176405|NCT01887288|2323667|FG000|Overall Study|The study was terminated and the PI has|16
1176406|NCT01861717|2323715|FG000|Overall Study|Lost to Follow-up|1
1176407|NCT01861717|2323715|FG000|Overall Study|Withdrawal by Subject|1
1176408|NCT01866709|2323722|FG000|Overall Study|Adverse Event|1
1176409|NCT01866709|2323723|FG001|Overall Study|Adverse Event|0
1176410|NCT01860040|2323731|FG000|Overall Study|Withdrawal by Subject|1
1176411|NCT01860040|2323732|FG001|Overall Study|Withdrawal by Subject|0
1176412|NCT01856322|2323777|FG000|Overall Study|off study due to lack of accrual|0
1176413|NCT01856322|2323778|FG001|Overall Study|off study due to lack of accrual|0
1176414|NCT01856322|2323779|FG002|Overall Study|off study due to lack of accrual|3
1176415|NCT01853176|2323788|FG000|Overall Study|Study terminated|4
1176416|NCT01853176|2323789|FG001|Overall Study|Study terminated|0
1176417|NCT01857271|2323795|FG000|Overall Study|Lost to Follow-up|1
1176418|NCT01853982|2323810|FG000|Overall Study|Withdrawal by Subject|1
1176419|NCT01853982|2323811|FG001|Overall Study|Withdrawal by Subject|0
1176420|NCT01853982|2323810|FG000|Overall Study|Death|1
1176421|NCT01853982|2323811|FG001|Overall Study|Death|0
1176422|NCT01853982|2323810|FG000|Overall Study|Lost to Follow-up|0
1176423|NCT01853982|2323811|FG001|Overall Study|Lost to Follow-up|1
1176424|NCT01831596|2323842|FG000|Overall Study|Other|8
1176425|NCT01821963|2323855|FG000|Overall Study|Adverse Event|1
1176426|NCT01821898|2323861|FG000|Overall Study|Withdrawal by Subject|2
1176427|NCT01821898|2323862|FG001|Overall Study|Withdrawal by Subject|1
1176428|NCT01829477|2323893|FG000|Overall Study|Study Terminated by Sponsor|15
1176429|NCT01829477|2323894|FG001|Overall Study|Study Terminated by Sponsor|15
1176430|NCT01829477|2323893|FG000|Overall Study|Withdrawal by Subject|1
1176431|NCT01829477|2323894|FG001|Overall Study|Withdrawal by Subject|0
1176432|NCT01803711|2323902|FG000|Overall Study|Adverse Event|1
1176433|NCT01803711|2323903|FG001|Overall Study|Adverse Event|1
1176434|NCT01806051|2323931|FG000|Overall Study|Withdrawal by Subject|6
1176435|NCT01810302|2323958|FG000|Overall Study|Death|1
1176436|NCT01810302|2323959|FG001|Overall Study|Death|0
1176437|NCT01810302|2323958|FG000|Overall Study|Physician Decision|0
1176438|NCT01810302|2323959|FG001|Overall Study|Physician Decision|1
1176439|NCT01806961|2323965|FG000|Overall Study|sponsor decision|16
1176440|NCT01783015|2323975|FG000|Blinded Treatment|Adverse Event|0
1176441|NCT01783015|2323976|FG001|Blinded Treatment|Adverse Event|1
1176442|NCT01783015|2323977|FG002|Blinded Treatment|Adverse Event|0
1176443|NCT01783015|2323975|FG000|Blinded Treatment|Protocol Violation|0
1176444|NCT01783015|2323976|FG001|Blinded Treatment|Protocol Violation|1
1176445|NCT01783015|2323977|FG002|Blinded Treatment|Protocol Violation|0
872901|NCT00544648|1834660|FG001|Overall Study|Adverse Event|1
872902|NCT00544648|1834659|FG000|Overall Study|progression of disease|1
872903|NCT00544648|1834660|FG001|Overall Study|progression of disease|0
872904|NCT00544817|1834685|FG000|Combined Modality|Lack of Efficacy|2
872905|NCT00544817|1834685|FG000|Combined Modality|Worsening Neurologic Symptoms|2
872906|NCT00544817|1834685|FG000|Combined Modality|Adverse Event|2
872907|NCT00544817|1834685|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1
872908|NCT00544817|1834685|FG000|No Treatment Interval|Lack of Efficacy|8
872909|NCT00544817|1834685|FG000|No Treatment Interval|Physician Decision|3
872910|NCT00544817|1834685|FG000|No Treatment Interval|Adverse Event|1
872911|NCT00544817|1834685|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15
872912|NCT00544817|1834685|FG000|Follow-up Systemic Therapy|Physician Decision|3
872913|NCT00544817|1834685|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
872914|NCT00544869|1834692|FG000|Overall Study|Rsolution of congenitive symptoms|3
872915|NCT00544869|1834693|FG001|Overall Study|Rsolution of congenitive symptoms|0
872916|NCT00544869|1834694|FG002|Overall Study|Rsolution of congenitive symptoms|0
872917|NCT00544869|1834692|FG000|Overall Study|Adverse Event|6
872918|NCT00544869|1834693|FG001|Overall Study|Adverse Event|1
872919|NCT00544869|1834694|FG002|Overall Study|Adverse Event|0
872920|NCT00544869|1834692|FG000|Overall Study|Lack of Efficacy|1
872921|NCT00544869|1834693|FG001|Overall Study|Lack of Efficacy|1
872922|NCT00544869|1834694|FG002|Overall Study|Lack of Efficacy|0
872923|NCT00544869|1834692|FG000|Overall Study|Physician Decision|2
872924|NCT00544869|1834693|FG001|Overall Study|Physician Decision|0
872925|NCT00544869|1834694|FG002|Overall Study|Physician Decision|0
872926|NCT00544882|1834704|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
872927|NCT00544882|1834705|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
872928|NCT00544882|1834706|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
872929|NCT00544882|1834704|FG000|Cycle 1: Run-in Cycle|Adverse Event|1
872930|NCT00544882|1834705|FG001|Cycle 1: Run-in Cycle|Adverse Event|0
872931|NCT00544882|1834706|FG002|Cycle 1: Run-in Cycle|Adverse Event|0
872932|NCT00544882|1834704|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
872933|NCT00544882|1834705|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
872934|NCT00544882|1834706|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
872935|NCT00544882|1834704|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
872936|NCT00544882|1834705|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
872937|NCT00544882|1834706|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
872938|NCT00544882|1834704|FG000|Cycle 3: Follow-up|Noncompliance|0
872939|NCT00544882|1834705|FG001|Cycle 3: Follow-up|Noncompliance|1
872940|NCT00544882|1834706|FG002|Cycle 3: Follow-up|Noncompliance|0
872941|NCT00544882|1834704|FG000|Cycle 3: Follow-up|Pregnancy|0
872942|NCT00544882|1834705|FG001|Cycle 3: Follow-up|Pregnancy|1
872943|NCT00544882|1834706|FG002|Cycle 3: Follow-up|Pregnancy|0
872944|NCT00545051|1834727|FG000|Overall Study|Adverse Event|7
872945|NCT00545051|1834728|FG001|Overall Study|Adverse Event|3
872946|NCT00545051|1834727|FG000|Overall Study|Death|1
872947|NCT00545051|1834728|FG001|Overall Study|Death|0
872948|NCT00545051|1834727|FG000|Overall Study|Violation of inclusion/exclusion|0
872949|NCT00545051|1834728|FG001|Overall Study|Violation of inclusion/exclusion|2
1176446|NCT01783015|2323975|FG000|Blinded Treatment|Withdrawal by Subject|0
1176447|NCT01783015|2323976|FG001|Blinded Treatment|Withdrawal by Subject|1
1176448|NCT01783015|2323977|FG002|Blinded Treatment|Withdrawal by Subject|0
1176449|NCT01783015|2323975|FG000|Blinded Treatment|Study Terminated by Sponsor|2
1176450|NCT01783015|2323976|FG001|Blinded Treatment|Study Terminated by Sponsor|0
1176451|NCT01783015|2323977|FG002|Blinded Treatment|Study Terminated by Sponsor|0
1176452|NCT01783015|2323975|FG000|Open Label Treatment|Study Terminated by Sponsor|0
1176453|NCT01783015|2323976|FG001|Open Label Treatment|Study Terminated by Sponsor|0
1176454|NCT01783015|2323977|FG002|Open Label Treatment|Study Terminated by Sponsor|6
1176455|NCT01781026|2324011|FG000|Overall Study|Lack of Efficacy|2
1176456|NCT01777854|2324037|FG000|Overall Study|Physician Decision|3
1176457|NCT01777854|2324038|FG001|Overall Study|Physician Decision|3
1176458|NCT01772719|2324046|FG000|Overall Study|Withdrawal by Subject|3
1176459|NCT01772719|2324046|FG000|Overall Study|Adverse Event|2
1176460|NCT01772719|2324046|FG000|Overall Study|Protocol Violation|1
1176461|NCT01772719|2324046|FG000|Overall Study|Lost to Follow-up|1
1176462|NCT01764997|2324058|FG000|Run-in Period|Adverse Event|15
1176463|NCT01764997|2324059|FG001|Run-in Period|Adverse Event|0
1176464|NCT01764997|2324060|FG002|Run-in Period|Adverse Event|0
1176465|NCT01764997|2324061|FG003|Run-in Period|Adverse Event|0
1176466|NCT01764997|2324062|FG004|Run-in Period|Adverse Event|0
1176467|NCT01764997|2324058|FG000|Run-in Period|Lack of Efficacy|5
1176468|NCT01764997|2324059|FG001|Run-in Period|Lack of Efficacy|0
1176469|NCT01764997|2324060|FG002|Run-in Period|Lack of Efficacy|0
1176470|NCT01764997|2324061|FG003|Run-in Period|Lack of Efficacy|0
1176471|NCT01764997|2324062|FG004|Run-in Period|Lack of Efficacy|0
1176472|NCT01764997|2324058|FG000|Run-in Period|Poor compliance to protocol|1
1176473|NCT01764997|2324059|FG001|Run-in Period|Poor compliance to protocol|0
1176474|NCT01764997|2324060|FG002|Run-in Period|Poor compliance to protocol|0
1176475|NCT01764997|2324061|FG003|Run-in Period|Poor compliance to protocol|0
1176476|NCT01764997|2324062|FG004|Run-in Period|Poor compliance to protocol|0
1176477|NCT01764997|2324058|FG000|Run-in Period|Other than specified above|17
1176478|NCT01764997|2324059|FG001|Run-in Period|Other than specified above|0
1176479|NCT01764997|2324060|FG002|Run-in Period|Other than specified above|0
1176480|NCT01764997|2324061|FG003|Run-in Period|Other than specified above|0
1176481|NCT01764997|2324062|FG004|Run-in Period|Other than specified above|0
1176482|NCT01764997|2324058|FG000|Study Drug Treatment Period|Adverse Event|0
1176483|NCT01764997|2324059|FG001|Study Drug Treatment Period|Adverse Event|1
1176484|NCT01764997|2324060|FG002|Study Drug Treatment Period|Adverse Event|0
1176485|NCT01764997|2324061|FG003|Study Drug Treatment Period|Adverse Event|0
1176486|NCT01764997|2324062|FG004|Study Drug Treatment Period|Adverse Event|24
1176487|NCT01764997|2324058|FG000|Study Drug Treatment Period|Lack of Efficacy|0
1176488|NCT01764997|2324059|FG001|Study Drug Treatment Period|Lack of Efficacy|0
1176489|NCT01764997|2324060|FG002|Study Drug Treatment Period|Lack of Efficacy|0
1176490|NCT01764997|2324061|FG003|Study Drug Treatment Period|Lack of Efficacy|0
1176491|NCT01764997|2324062|FG004|Study Drug Treatment Period|Lack of Efficacy|2
1176492|NCT01764997|2324058|FG000|Study Drug Treatment Period|Other than specified above|0
1176493|NCT01764997|2324059|FG001|Study Drug Treatment Period|Other than specified above|0
1176494|NCT01764997|2324060|FG002|Study Drug Treatment Period|Other than specified above|0
1176495|NCT01764997|2324061|FG003|Study Drug Treatment Period|Other than specified above|0
1176496|NCT01764997|2324062|FG004|Study Drug Treatment Period|Other than specified above|10
1176497|NCT01769443|2324078|FG000|Overall Study|Study closure|1
1176498|NCT01769443|2324079|FG001|Overall Study|Study closure|0
1176499|NCT01749826|2324101|FG000|Overall Study|Study Terminated|20
1176500|NCT01749826|2324102|FG001|Overall Study|Study Terminated|0
1176501|NCT01752023|2324163|FG000|Overall Study|Physician Decision|2
1176502|NCT01752023|2324164|FG001|Overall Study|Physician Decision|1
1176503|NCT01740154|2324174|FG000|Overall Study|Adverse Event|1
1176504|NCT01748890|2324178|FG000|Overall Study|Insufficient recruitment for analysis|4
1176505|NCT01748162|2324184|FG000|Overall Study|no additional croup episodes to evaluate|2
1176506|NCT01748162|2324185|FG001|Overall Study|no additional croup episodes to evaluate|2
1176507|NCT01748162|2324184|FG000|Overall Study|participant consented but did not begin|0
1176508|NCT01748162|2324185|FG001|Overall Study|participant consented but did not begin|1
1176509|NCT01748162|2324184|FG000|Overall Study|reasons not available|3
1176510|NCT01748162|2324185|FG001|Overall Study|reasons not available|2
1176511|NCT01732926|2324210|FG000|Overall Study|Study Terminated by Sponsor|168
1176512|NCT01732926|2324211|FG001|Overall Study|Study Terminated by Sponsor|80
1176513|NCT01732926|2324210|FG000|Overall Study|Withdrawal by Subject|46
1176514|NCT01732926|2324211|FG001|Overall Study|Withdrawal by Subject|8
1176515|NCT01732926|2324210|FG000|Overall Study|Physician Decision|24
1176516|NCT01732926|2324211|FG001|Overall Study|Physician Decision|11
1176517|NCT01732926|2324210|FG000|Overall Study|Other Reason|21
1176518|NCT01732926|2324211|FG001|Overall Study|Other Reason|4
1176519|NCT01732926|2324210|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7
1176520|NCT01732926|2324211|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6
1176521|NCT01732926|2324210|FG000|Overall Study|Blind Broken by Subject or Study Site|1
1176522|NCT01732926|2324211|FG001|Overall Study|Blind Broken by Subject or Study Site|1
1176523|NCT01732913|2324228|FG000|Overall Study|Study Terminated by Sponsor|105
1176524|NCT01732913|2324229|FG001|Overall Study|Study Terminated by Sponsor|55
1176525|NCT01732913|2324228|FG000|Overall Study|Withdrawal by Subject|27
1176526|NCT01732913|2324229|FG001|Overall Study|Withdrawal by Subject|4
1176527|NCT01732913|2324228|FG000|Overall Study|Physician Decision|14
1176528|NCT01732913|2324229|FG001|Overall Study|Physician Decision|7
1176529|NCT01732913|2324228|FG000|Overall Study|Other|7
1176530|NCT01732913|2324229|FG001|Overall Study|Other|1
1176531|NCT01732913|2324228|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3
1176532|NCT01732913|2324229|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2
1176533|NCT01716052|2324241|FG000|Overall Study|Withdrawal of funding|1
1176534|NCT01716052|2324242|FG001|Overall Study|Withdrawal of funding|1
1176535|NCT01712854|2324257|FG000|Overall Study|Physician Decision|1
1176536|NCT01708057|2324284|FG000|Overall Study|Withdrawal due to study termination.|1
1176537|NCT01708057|2324285|FG001|Overall Study|Withdrawal due to study termination.|1
1176538|NCT01708057|2324286|FG002|Overall Study|Withdrawal due to study termination.|1
1176539|NCT01693367|2324306|FG000|Overall Study|Withdrawal by Subject|1
1176540|NCT01693367|2324307|FG001|Overall Study|Withdrawal by Subject|1
1176541|NCT01693367|2324306|FG000|Overall Study|Physician Decision|0
1176542|NCT01693367|2324307|FG001|Overall Study|Physician Decision|1
1176543|NCT01697800|2324328|FG000|Overall Study|Death|0
1176544|NCT01697800|2324329|FG001|Overall Study|Death|1
1176545|NCT01700348|2324335|FG000|Overall Study|Withdrawal by Subject|22
1176546|NCT01700348|2324335|FG000|Overall Study|Lost to Follow-up|1
1176547|NCT01689974|2324380|FG000|Overall Study|Termination of Study|5
1176548|NCT01689974|2324381|FG001|Overall Study|Termination of Study|5
1176549|NCT01676961|2324387|FG000|Overall Study|Death|3
1176550|NCT01676961|2324387|FG000|Overall Study|Lost to Follow-up|1
1176551|NCT01676961|2324387|FG000|Overall Study|Withdrawal by Subject|1
1176552|NCT01675011|2324455|FG000|Overall Study|Trial terminated by Sponsor|3
1176553|NCT01675011|2324456|FG001|Overall Study|Trial terminated by Sponsor|1
1176554|NCT01668147|2324484|FG000|Overall Study|Withdrawal by Subject|6
1176555|NCT01676701|2324494|FG000|Overall Study|Protocol Violation|1
1176556|NCT01676701|2324495|FG001|Overall Study|Protocol Violation|0
1176557|NCT01676701|2324494|FG000|Overall Study|Sponsor Decision|3
1176558|NCT01676701|2324495|FG001|Overall Study|Sponsor Decision|4
1176559|NCT01662102|2324510|FG000|Overall Study|Sponsor's decision|1
1176560|NCT01662102|2324511|FG001|Overall Study|Sponsor's decision|0
1176561|NCT01659554|2324518|FG000|Overall Study|Study Termination|4
1176562|NCT01658813|2324522|FG000|Overall Study|Disease progression|3
1176563|NCT01642732|2324550|FG000|Overall Study|Withdrawal by Subject|1
1176564|NCT01648270|2324563|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12
1176565|NCT01641601|2324579|FG000|Overall Study|Study discontinued.|3
1176566|NCT01641601|2324580|FG001|Overall Study|Study discontinued.|5
1176567|NCT01627899|2324608|FG000|Overall Study|Study terminated early by sponsor.|5
1176568|NCT01632020|2324614|FG000|Overall Study|Withdrawal by Subject|1
1176569|NCT01632020|2324615|FG001|Overall Study|Withdrawal by Subject|0
1176570|NCT01632020|2324614|FG000|Overall Study|Adverse Event|1
1176571|NCT01632020|2324615|FG001|Overall Study|Adverse Event|0
1176572|NCT01619800|2324627|FG000|Overall Study|study terminated|2
1176573|NCT01619800|2324628|FG001|Overall Study|study terminated|0
1176574|NCT01614067|2324645|FG000|Overall Study|Pregnancy|1
1176575|NCT01614067|2324646|FG001|Overall Study|Pregnancy|0
1176576|NCT01614067|2324645|FG000|Overall Study|Physician Decision|6
1176577|NCT01614067|2324646|FG001|Overall Study|Physician Decision|5
1176578|NCT01614067|2324645|FG000|Overall Study|Withdrawal by Subject|0
1176579|NCT01614067|2324646|FG001|Overall Study|Withdrawal by Subject|1
1176580|NCT01614067|2324645|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8
1176581|NCT01614067|2324646|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9
1176582|NCT01605019|2324659|FG000|Overall Study|pt did not meet transplant endpoint|3
1176583|NCT01605019|2324660|FG001|Overall Study|pt did not meet transplant endpoint|0
1176584|NCT01609231|2324668|FG000|Overall Study|Adverse Event|1
1176585|NCT01609231|2324669|FG001|Overall Study|Adverse Event|3
872950|NCT00545051|1834727|FG000|Overall Study|Protocol Violation|1
872951|NCT00545051|1834728|FG001|Overall Study|Protocol Violation|0
872952|NCT00545051|1834727|FG000|Overall Study|Withdrawal by Subject|0
872953|NCT00545051|1834728|FG001|Overall Study|Withdrawal by Subject|1
872954|NCT00545051|1834727|FG000|Overall Study|Administrative reasons|0
872955|NCT00545051|1834728|FG001|Overall Study|Administrative reasons|1
872956|NCT00545064|1834734|FG000|Overall Study|Lost to Follow-up|3
872957|NCT00545064|1834734|FG000|Overall Study|Withdrawal by Subject|2
872958|NCT00545064|1834734|FG000|Overall Study|did not complete course of treatment|1
872959|NCT00545064|1834734|FG000|Overall Study|cancel all appointments, no rebooking|1
872960|NCT00545064|1834734|FG000|Overall Study|inclement weather|1
872961|NCT00545077|1834742|FG000|Overall Study|Treatment not received|5
872962|NCT00545077|1834743|FG001|Overall Study|Treatment not received|1
872963|NCT00545077|1834742|FG000|Overall Study|Disease Progression|131
872964|NCT00545077|1834743|FG001|Overall Study|Disease Progression|98
872965|NCT00545077|1834742|FG000|Overall Study|Withdrawal by Subject|3
872966|NCT00545077|1834743|FG001|Overall Study|Withdrawal by Subject|14
872967|NCT00545077|1834742|FG000|Overall Study|Physician Decision|6
872968|NCT00545077|1834743|FG001|Overall Study|Physician Decision|3
872969|NCT00545077|1834742|FG000|Overall Study|Lost to Follow-up|2
1176586|NCT01609231|2324668|FG000|Overall Study|Physician Decision|1
1176587|NCT01609231|2324669|FG001|Overall Study|Physician Decision|0
1176588|NCT01609231|2324668|FG000|Overall Study|Withdrawal by Subject|1
1176589|NCT01609231|2324669|FG001|Overall Study|Withdrawal by Subject|0
1176590|NCT01603043|2324695|FG000|Overall Study|Study Futility|7
1176591|NCT01603043|2324696|FG001|Overall Study|Study Futility|3
1176592|NCT01605370|2324704|FG000|Overall Study|Adverse Event|1
1176593|NCT01605370|2324705|FG001|Overall Study|Adverse Event|0
1176594|NCT01605617|2324713|FG000|First Intervention|Adverse Event|0
1176595|NCT01605617|2324714|FG001|First Intervention|Adverse Event|1
1176596|NCT01605617|2324713|FG000|Washout Period of 4 Weeks|Study Terminated|2
872970|NCT00545077|1834743|FG001|Overall Study|Lost to Follow-up|0
872971|NCT00545077|1834742|FG000|Overall Study|Protocol Violation|1
872972|NCT00545077|1834743|FG001|Overall Study|Protocol Violation|0
872973|NCT00545077|1834742|FG000|Overall Study|Adverse Event|0
872974|NCT00545077|1834743|FG001|Overall Study|Adverse Event|31
872975|NCT00545077|1834742|FG000|Overall Study|Death|0
872976|NCT00545077|1834743|FG001|Overall Study|Death|8
872977|NCT00545103|1834753|FG000|Overall Study|Lack of Efficacy|48
872978|NCT00545103|1834754|FG001|Overall Study|Lack of Efficacy|45
872979|NCT00545103|1834755|FG002|Overall Study|Lack of Efficacy|31
872980|NCT00545103|1834756|FG003|Overall Study|Lack of Efficacy|27
872981|NCT00545103|1834753|FG000|Overall Study|Withdrawal by Subject|6
872982|NCT00545103|1834754|FG001|Overall Study|Withdrawal by Subject|10
872983|NCT00545103|1834755|FG002|Overall Study|Withdrawal by Subject|18
1176597|NCT01605617|2324714|FG001|Washout Period of 4 Weeks|Study Terminated|1
1176598|NCT01603121|2324731|FG000|Second Intervention, 10 Hours|Adverse Event|1
1176599|NCT01603121|2324732|FG001|Second Intervention, 10 Hours|Adverse Event|0
1176600|NCT01603394|2324745|FG000|Overall Study|Adverse Event|1
1176601|NCT01592383|2324749|FG000|Overall Study|Adverse Event|1
1176602|NCT01591096|2324771|FG000|Overall Study|Adverse Event|1
1176603|NCT01576575|2324788|FG000|Buprenorphine Control|Withdrawal by Subject|3
1176604|NCT01576575|2324788|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3
1176605|NCT01576575|2324788|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1
1176606|NCT01582100|2324812|FG000|Overall Study|Adverse Event|1
1176607|NCT01582100|2324812|FG000|Overall Study|Withdrawal by Subject|1
1176608|NCT01575028|2324825|FG000|Overall Study|Physician Decision|0
1176609|NCT01575028|2324826|FG001|Overall Study|Physician Decision|1
1176610|NCT01578785|2324834|FG000|Overall Study|Withdrawal by Subject|0
1176611|NCT01578785|2324835|FG001|Overall Study|Withdrawal by Subject|1
1176612|NCT01578785|2324834|FG000|Overall Study|Study terminated by sponsor|59
1176613|NCT01578785|2324835|FG001|Overall Study|Study terminated by sponsor|118
1176614|NCT01576549|2324841|FG000|Overall Study|Sponsor Decision|2
1176615|NCT01561989|2324861|FG000|Overall Study|accural target not met.|5
1176616|NCT01561989|2324862|FG001|Overall Study|accural target not met.|6
1176617|NCT01564732|2324870|FG000|Overall Study|Early termination by the study sponsor|6
872984|NCT00545103|1834756|FG003|Overall Study|Withdrawal by Subject|22
872985|NCT00545103|1834753|FG000|Overall Study|Adverse Event|11
872986|NCT00545103|1834754|FG001|Overall Study|Adverse Event|12
872987|NCT00545103|1834755|FG002|Overall Study|Adverse Event|17
872988|NCT00545103|1834756|FG003|Overall Study|Adverse Event|10
872989|NCT00545103|1834753|FG000|Overall Study|Lost to Follow-up|4
872990|NCT00545103|1834754|FG001|Overall Study|Lost to Follow-up|6
872991|NCT00545103|1834755|FG002|Overall Study|Lost to Follow-up|3
872992|NCT00545103|1834756|FG003|Overall Study|Lost to Follow-up|4
872993|NCT00545103|1834753|FG000|Overall Study|Protocol Violation|1
872994|NCT00545103|1834754|FG001|Overall Study|Protocol Violation|2
872995|NCT00545103|1834755|FG002|Overall Study|Protocol Violation|3
872996|NCT00545103|1834756|FG003|Overall Study|Protocol Violation|0
872997|NCT00545103|1834753|FG000|Overall Study|Suspected recurrence of diverticulitis|1
872998|NCT00545103|1834754|FG001|Overall Study|Suspected recurrence of diverticulitis|0
872999|NCT00545103|1834755|FG002|Overall Study|Suspected recurrence of diverticulitis|0
873000|NCT00545103|1834756|FG003|Overall Study|Suspected recurrence of diverticulitis|3
873001|NCT00545103|1834753|FG000|Overall Study|Difficult to open package|0
873002|NCT00545103|1834754|FG001|Overall Study|Difficult to open package|0
873003|NCT00545103|1834755|FG002|Overall Study|Difficult to open package|0
873004|NCT00545103|1834756|FG003|Overall Study|Difficult to open package|1
873005|NCT00545103|1834753|FG000|Overall Study|Investigational product not taken|1
873006|NCT00545103|1834754|FG001|Overall Study|Investigational product not taken|0
873007|NCT00545103|1834755|FG002|Overall Study|Investigational product not taken|0
873008|NCT00545103|1834756|FG003|Overall Study|Investigational product not taken|1
873009|NCT00545103|1834753|FG000|Overall Study|Wish to start a family|0
873010|NCT00545103|1834754|FG001|Overall Study|Wish to start a family|0
873011|NCT00545103|1834755|FG002|Overall Study|Wish to start a family|0
873012|NCT00545103|1834756|FG003|Overall Study|Wish to start a family|1
873013|NCT00545103|1834753|FG000|Overall Study|Diverticulitis crisis|0
873014|NCT00545103|1834754|FG001|Overall Study|Diverticulitis crisis|0
873015|NCT00545103|1834755|FG002|Overall Study|Diverticulitis crisis|0
873016|NCT00545103|1834756|FG003|Overall Study|Diverticulitis crisis|1
873017|NCT00545103|1834753|FG000|Overall Study|Personal reasons|1
873018|NCT00545103|1834754|FG001|Overall Study|Personal reasons|0
873019|NCT00545103|1834755|FG002|Overall Study|Personal reasons|0
873020|NCT00545103|1834756|FG003|Overall Study|Personal reasons|0
1176618|NCT01564732|2324871|FG001|Overall Study|Early termination by the study sponsor|5
1176619|NCT01560507|2324880|FG000|Overall Study|Lost to Follow-up|3
1176620|NCT01560507|2324881|FG001|Overall Study|Lost to Follow-up|1
1176621|NCT01560507|2324882|FG002|Overall Study|Lost to Follow-up|2
1176622|NCT01560507|2324880|FG000|Overall Study|Withdrawal by Subject|1
1176623|NCT01560507|2324881|FG001|Overall Study|Withdrawal by Subject|1
1176624|NCT01560507|2324882|FG002|Overall Study|Withdrawal by Subject|0
1176625|NCT01555073|2324926|FG000|Overall Study|Lost to Follow-up|1
1176626|NCT01555073|2324927|FG001|Overall Study|Lost to Follow-up|2
1176627|NCT01555073|2324928|FG002|Overall Study|Lost to Follow-up|0
1176628|NCT01555073|2324929|FG003|Overall Study|Lost to Follow-up|5
1176629|NCT01541397|2324964|FG000|Overall Study|Study ended prior to data collection|4
1176630|NCT01541397|2324965|FG001|Overall Study|Study ended prior to data collection|2
1176631|NCT01546207|2324971|FG000|Overall Study|Death|1
1176632|NCT01547728|2324979|FG000|Overall Study|Change in procedure and equipment|1
1176633|NCT01547728|2324979|FG000|Overall Study|Drug not ready for subject|1
1176634|NCT01547728|2324979|FG000|Overall Study|Screen failure|39
1176635|NCT01546883|2324996|FG000|Overall Study|Withdrawal by Subject|3
1176636|NCT01546883|2324996|FG000|Overall Study|Adverse Event|4
1176637|NCT01546883|2324996|FG000|Overall Study|Lost to Follow-up|2
1176638|NCT01546883|2324996|FG000|Overall Study|early closure of study|2
1176639|NCT01546883|2324996|FG000|Overall Study|other unrelated illness|1
873021|NCT00545103|1834753|FG000|Overall Study|Subject's decision|1
873022|NCT00545103|1834754|FG001|Overall Study|Subject's decision|0
873023|NCT00545103|1834755|FG002|Overall Study|Subject's decision|0
873024|NCT00545103|1834756|FG003|Overall Study|Subject's decision|0
873025|NCT00545103|1834753|FG000|Overall Study|Noncompliance|0
873026|NCT00545103|1834754|FG001|Overall Study|Noncompliance|1
873027|NCT00545103|1834755|FG002|Overall Study|Noncompliance|0
873028|NCT00545103|1834756|FG003|Overall Study|Noncompliance|0
873029|NCT00545103|1834753|FG000|Overall Study|Investigator decision|0
873030|NCT00545103|1834754|FG001|Overall Study|Investigator decision|0
873031|NCT00545103|1834755|FG002|Overall Study|Investigator decision|1
873032|NCT00545103|1834756|FG003|Overall Study|Investigator decision|0
873033|NCT00545103|1834753|FG000|Overall Study|Subject moved|0
873034|NCT00545103|1834754|FG001|Overall Study|Subject moved|1
873035|NCT00545103|1834755|FG002|Overall Study|Subject moved|0
873036|NCT00545103|1834756|FG003|Overall Study|Subject moved|0
873037|NCT00545103|1834753|FG000|Overall Study|Use of prohibited medication|0
873038|NCT00545103|1834754|FG001|Overall Study|Use of prohibited medication|0
873039|NCT00545103|1834755|FG002|Overall Study|Use of prohibited medication|1
873040|NCT00545103|1834756|FG003|Overall Study|Use of prohibited medication|0
873041|NCT00545103|1834753|FG000|Overall Study|Does not want to take study drug anymore|1
873042|NCT00545103|1834754|FG001|Overall Study|Does not want to take study drug anymore|0
873043|NCT00545103|1834755|FG002|Overall Study|Does not want to take study drug anymore|1
873044|NCT00545103|1834756|FG003|Overall Study|Does not want to take study drug anymore|0
873045|NCT00545103|1834753|FG000|Overall Study|Subject met endpoint under protocol v. 1|0
873046|NCT00545103|1834754|FG001|Overall Study|Subject met endpoint under protocol v. 1|0
873047|NCT00545103|1834755|FG002|Overall Study|Subject met endpoint under protocol v. 1|1
873048|NCT00545103|1834756|FG003|Overall Study|Subject met endpoint under protocol v. 1|0
873049|NCT00545103|1834753|FG000|Overall Study|Death|0
873050|NCT00545103|1834754|FG001|Overall Study|Death|1
873051|NCT00545103|1834755|FG002|Overall Study|Death|0
873052|NCT00545103|1834756|FG003|Overall Study|Death|0
873053|NCT00545168|1834782|FG000|Overall Study|Lost to Follow-up|5
873054|NCT00545168|1834783|FG001|Overall Study|Lost to Follow-up|5
873055|NCT00545168|1834784|FG002|Overall Study|Lost to Follow-up|5
873056|NCT00545168|1834782|FG000|Overall Study|Withdrawal by Subject|9
873057|NCT00545168|1834783|FG001|Overall Study|Withdrawal by Subject|0
873058|NCT00545168|1834784|FG002|Overall Study|Withdrawal by Subject|13
873059|NCT00545168|1834782|FG000|Overall Study|Protocol Violation|1
873060|NCT00545168|1834783|FG001|Overall Study|Protocol Violation|0
873061|NCT00545168|1834784|FG002|Overall Study|Protocol Violation|1
873062|NCT00545168|1834782|FG000|Overall Study|Visit for Day 21 was not done in error|1
873063|NCT00545168|1834783|FG001|Overall Study|Visit for Day 21 was not done in error|0
873064|NCT00545168|1834784|FG002|Overall Study|Visit for Day 21 was not done in error|2
873065|NCT00545233|1834804|FG000|Overall Study|Adverse Event|10
873066|NCT00545233|1834805|FG001|Overall Study|Adverse Event|5
873067|NCT00545233|1834804|FG000|Overall Study|Violation of Selection Criteria at Entry|5
873068|NCT00545233|1834805|FG001|Overall Study|Violation of Selection Criteria at Entry|1
873069|NCT00545233|1834804|FG000|Overall Study|Protocol Violation|2
873070|NCT00545233|1834805|FG001|Overall Study|Protocol Violation|0
873071|NCT00545233|1834804|FG000|Overall Study|Refused Treatment|9
873072|NCT00545233|1834805|FG001|Overall Study|Refused Treatment|7
873073|NCT00545233|1834804|FG000|Overall Study|Failure to Return|4
873074|NCT00545233|1834805|FG001|Overall Study|Failure to Return|6
873075|NCT00545233|1834804|FG000|Overall Study|Insufficient response|14
873076|NCT00545233|1834805|FG001|Overall Study|Insufficient response|15
873077|NCT00545233|1834804|FG000|Overall Study|Physician Decision|2
873078|NCT00545233|1834805|FG001|Overall Study|Physician Decision|1
873079|NCT00545272|1834818|FG000|Overall Study|Protocol deviation|0
873080|NCT00545272|1834819|FG001|Overall Study|Protocol deviation|1
873081|NCT00545272|1834820|FG002|Overall Study|Protocol deviation|0
873082|NCT00545272|1834821|FG003|Overall Study|Protocol deviation|1
873083|NCT00545272|1834822|FG004|Overall Study|Protocol deviation|0
1176640|NCT01536015|2325006|FG000|Overall Study|Adverse Event|1
1176641|NCT01536015|2325007|FG001|Overall Study|Adverse Event|4
1176642|NCT01536015|2325006|FG000|Overall Study|Lost to Follow-up|0
1176643|NCT01536015|2325007|FG001|Overall Study|Lost to Follow-up|1
1176644|NCT01536015|2325006|FG000|Overall Study|Inclusion Criterion not met|2
1176645|NCT01536015|2325007|FG001|Overall Study|Inclusion Criterion not met|0
1176646|NCT01536015|2325006|FG000|Overall Study|Study closure|5
1176647|NCT01536015|2325007|FG001|Overall Study|Study closure|5
873084|NCT00545272|1834823|FG005|Overall Study|Protocol deviation|1
873085|NCT00545272|1834818|FG000|Overall Study|Adverse Event|0
873086|NCT00545272|1834819|FG001|Overall Study|Adverse Event|0
873087|NCT00545272|1834820|FG002|Overall Study|Adverse Event|1
873088|NCT00545272|1834821|FG003|Overall Study|Adverse Event|0
873089|NCT00545272|1834822|FG004|Overall Study|Adverse Event|0
873090|NCT00545272|1834823|FG005|Overall Study|Adverse Event|1
873091|NCT00545272|1834818|FG000|Overall Study|Abnormal laboratory value(s)|0
873092|NCT00545272|1834819|FG001|Overall Study|Abnormal laboratory value(s)|0
873093|NCT00545272|1834820|FG002|Overall Study|Abnormal laboratory value(s)|0
873094|NCT00545272|1834821|FG003|Overall Study|Abnormal laboratory value(s)|0
873095|NCT00545272|1834822|FG004|Overall Study|Abnormal laboratory value(s)|0
873096|NCT00545272|1834823|FG005|Overall Study|Abnormal laboratory value(s)|1
873097|NCT00545272|1834818|FG000|Overall Study|Abnormal test procedure result(s)|0
873098|NCT00545272|1834819|FG001|Overall Study|Abnormal test procedure result(s)|0
873099|NCT00545272|1834820|FG002|Overall Study|Abnormal test procedure result(s)|0
873100|NCT00545272|1834821|FG003|Overall Study|Abnormal test procedure result(s)|0
873101|NCT00545272|1834822|FG004|Overall Study|Abnormal test procedure result(s)|1
873102|NCT00545272|1834823|FG005|Overall Study|Abnormal test procedure result(s)|0
873103|NCT00545272|1834818|FG000|Overall Study|Lost to Follow-up|0
873104|NCT00545272|1834819|FG001|Overall Study|Lost to Follow-up|0
873105|NCT00545272|1834820|FG002|Overall Study|Lost to Follow-up|0
873106|NCT00545272|1834821|FG003|Overall Study|Lost to Follow-up|0
873107|NCT00545272|1834822|FG004|Overall Study|Lost to Follow-up|1
873108|NCT00545272|1834823|FG005|Overall Study|Lost to Follow-up|0
873109|NCT00545298|1834840|FG000|Overall Study|Issues with Standard of Care|2
873110|NCT00545298|1834841|FG001|Overall Study|Issues with Standard of Care|0
873111|NCT00545298|1834842|FG002|Overall Study|Issues with Standard of Care|1
873112|NCT00545363|1834855|FG000|Overall Study|Adverse Event|6
873113|NCT00545363|1834856|FG001|Overall Study|Adverse Event|7
873114|NCT00545363|1834855|FG000|Overall Study|Withdrawal by Subject|6
873115|NCT00545363|1834856|FG001|Overall Study|Withdrawal by Subject|5
873116|NCT00545363|1834855|FG000|Overall Study|Non-compliance|3
873117|NCT00545363|1834856|FG001|Overall Study|Non-compliance|1
873118|NCT00545363|1834855|FG000|Overall Study|Did not meet entry criteria|1
873119|NCT00545363|1834856|FG001|Overall Study|Did not meet entry criteria|1
873120|NCT00545363|1834855|FG000|Overall Study|Lost to Follow-up|2
873121|NCT00545363|1834856|FG001|Overall Study|Lost to Follow-up|0
873122|NCT00545363|1834855|FG000|Overall Study|Other|1
873123|NCT00545363|1834856|FG001|Overall Study|Other|1
873124|NCT00545402|1834864|FG000|Overall Study|Discontinuation of treatment|17
873125|NCT00545402|1834865|FG001|Overall Study|Discontinuation of treatment|9
873126|NCT00545402|1834864|FG000|Overall Study|Use of unauthorized immunosuppressant|8
873127|NCT00545402|1834865|FG001|Overall Study|Use of unauthorized immunosuppressant|7
873128|NCT00545402|1834864|FG000|Overall Study|Death|5
873129|NCT00545402|1834865|FG001|Overall Study|Death|7
873130|NCT00545402|1834864|FG000|Overall Study|Graft loss|2
873131|NCT00545402|1834865|FG001|Overall Study|Graft loss|4
873132|NCT00545402|1834864|FG000|Overall Study|Withdrawal by Subject|0
873133|NCT00545402|1834865|FG001|Overall Study|Withdrawal by Subject|1
873134|NCT00545402|1834864|FG000|Overall Study|Protocol Violation|1
873135|NCT00545402|1834865|FG001|Overall Study|Protocol Violation|0
873136|NCT00545402|1834864|FG000|Overall Study|Reason not specified|1
873137|NCT00545402|1834865|FG001|Overall Study|Reason not specified|1
873138|NCT00545441|1834873|FG000|Overall Study|Fistula draining at 6 months|2
873139|NCT00545441|1834874|FG001|Overall Study|Fistula draining at 6 months|4
873140|NCT00545441|1834873|FG000|Overall Study|Lost to Follow-up|9
873141|NCT00545441|1834874|FG001|Overall Study|Lost to Follow-up|5
873142|NCT00545441|1834873|FG000|Overall Study|Technical failure|0
873143|NCT00545441|1834874|FG001|Overall Study|Technical failure|1
873144|NCT00545441|1834873|FG000|Overall Study|Withdrawal by Subject|1
873145|NCT00545441|1834874|FG001|Overall Study|Withdrawal by Subject|1
873146|NCT00545441|1834873|FG000|Overall Study|Persistence or recurrence of fistula|5
873147|NCT00545441|1834874|FG001|Overall Study|Persistence or recurrence of fistula|2
873148|NCT00545441|1834873|FG000|Overall Study|Patients were not treated|1
873149|NCT00545441|1834874|FG001|Overall Study|Patients were not treated|3
873150|NCT00545532|1834882|FG000|Overall Study|Withdrawal by Subject|1
873151|NCT00545532|1834883|FG001|Overall Study|Withdrawal by Subject|3
873152|NCT00545532|1834882|FG000|Overall Study|Lost to Follow-up|5
873153|NCT00545532|1834883|FG001|Overall Study|Lost to Follow-up|6
873154|NCT00545532|1834882|FG000|Overall Study|Death|0
873155|NCT00545532|1834883|FG001|Overall Study|Death|1
1176648|NCT01534676|2325033|FG000|Overall Study|Study closed due to poor enrollment|2
1176649|NCT01534676|2325034|FG001|Overall Study|Study closed due to poor enrollment|1
1176650|NCT01530087|2325058|FG000|Overall Study|Physician Decision|2
1176651|NCT01531387|2325095|FG000|Overall Study|Early termination of study|11
1176652|NCT01531387|2325096|FG001|Overall Study|Early termination of study|11
1176653|NCT01527292|2325115|FG000|Overall Study|Physician Decision|0
1176654|NCT01527292|2325116|FG001|Overall Study|Physician Decision|3
1176655|NCT01528696|2325135|FG000|Overall Study|See detailed description|18
1176656|NCT01528696|2325136|FG001|Overall Study|See detailed description|19
1176657|NCT01520714|2325170|FG000|Overall Study|Protocol Violation|0
1176658|NCT01520714|2325171|FG001|Overall Study|Protocol Violation|3
1176659|NCT01520714|2325170|FG000|Overall Study|Adverse Event|0
1176660|NCT01520714|2325171|FG001|Overall Study|Adverse Event|2
1176661|NCT01520714|2325170|FG000|Overall Study|Lack of Efficacy|0
1176662|NCT01520714|2325171|FG001|Overall Study|Lack of Efficacy|1
1176663|NCT01516034|2325186|FG000|Overall Study|Physician Decision|1
1176664|NCT01516034|2325186|FG000|Overall Study|Lack of Efficacy|7
1176665|NCT01510756|2325211|FG000|Overall Study|Death|1
1176666|NCT01510756|2325211|FG000|Overall Study|Lack of Efficacy|2
1176667|NCT01510756|2325211|FG000|Overall Study|Physician Decision|1
1176668|NCT01509053|2325237|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
1176669|NCT01509053|2325237|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
1176670|NCT01509053|2325237|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
1176671|NCT01509053|2325237|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
1176672|NCT01509053|2325237|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
1176673|NCT01509053|2325237|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
1176674|NCT01478113|2325286|FG000|Overall Study|Withdrawal by Subject|0
1176675|NCT01478113|2325287|FG001|Overall Study|Withdrawal by Subject|1
1176676|NCT01478113|2325286|FG000|Overall Study|Physician Decision|1
1176677|NCT01478113|2325287|FG001|Overall Study|Physician Decision|0
1176678|NCT01482598|2325305|FG000|Overall Study|Death|7
1176679|NCT01482598|2325306|FG001|Overall Study|Death|10
1176680|NCT01482598|2325305|FG000|Overall Study|Physician Decision|0
1176681|NCT01482598|2325306|FG001|Overall Study|Physician Decision|3
1176682|NCT01482598|2325305|FG000|Overall Study|Withdrawal by Subject|4
1176683|NCT01482598|2325306|FG001|Overall Study|Withdrawal by Subject|5
1176684|NCT01482598|2325305|FG000|Overall Study|Lost to Follow-up|5
1176685|NCT01482598|2325306|FG001|Overall Study|Lost to Follow-up|4
1176686|NCT01473732|2325326|FG000|Overall Study|Adverse Event|1
1176687|NCT01473732|2325327|FG001|Overall Study|Adverse Event|0
1176688|NCT01473732|2325326|FG000|Overall Study|Death|1
1176689|NCT01473732|2325327|FG001|Overall Study|Death|0
1176690|NCT01465230|2325342|FG000|Overall Study|Withdrawal by Subject|2
1176691|NCT01463293|2325364|FG000|Overall Study|Lost to Follow-up|1
1176692|NCT01463293|2325365|FG001|Overall Study|Lost to Follow-up|4
1176693|NCT01463293|2325366|FG002|Overall Study|Lost to Follow-up|5
1176694|NCT01463293|2325364|FG000|Overall Study|Adverse Event|1
1176695|NCT01463293|2325365|FG001|Overall Study|Adverse Event|2
1176696|NCT01463293|2325366|FG002|Overall Study|Adverse Event|0
1176697|NCT01463293|2325364|FG000|Overall Study|Withdrawal by Subject|4
1176698|NCT01463293|2325365|FG001|Overall Study|Withdrawal by Subject|10
1176699|NCT01463293|2325366|FG002|Overall Study|Withdrawal by Subject|5
1176700|NCT01463293|2325364|FG000|Overall Study|Other|0
1176701|NCT01463293|2325365|FG001|Overall Study|Other|0
1176702|NCT01463293|2325366|FG002|Overall Study|Other|2
1176703|NCT01457053|2325374|FG000|Overall Study|Unable to undergo selected treatment|1
1176704|NCT01457053|2325375|FG001|Overall Study|Unable to undergo selected treatment|1
1176705|NCT01451723|2325383|FG000|Overall Study|study halted|6
1176706|NCT01451723|2325384|FG001|Overall Study|study halted|5
1176707|NCT01440517|2325394|FG000|Overall Study|Subject withdrawn prior to dosing|1
1176708|NCT01440595|2325400|FG000|Overall Study|Lost to Follow-up|0
1176709|NCT01440595|2325401|FG001|Overall Study|Lost to Follow-up|1
1176710|NCT01440595|2325402|FG002|Overall Study|Lost to Follow-up|0
1176711|NCT01440595|2325400|FG000|Overall Study|Study terminated by sponsor.|1
1176712|NCT01440595|2325401|FG001|Overall Study|Study terminated by sponsor.|2
1176713|NCT01440595|2325402|FG002|Overall Study|Study terminated by sponsor.|1
1176714|NCT01446796|2325408|FG000|Overall Study|Withdrawal by Subject|1
1176715|NCT01446796|2325409|FG001|Overall Study|Withdrawal by Subject|0
1176716|NCT01443923|2325419|FG000|Overall Study|Adverse Event|1
1176717|NCT01443923|2325420|FG001|Overall Study|Adverse Event|0
1176718|NCT01439347|2325428|FG000|Overall Study|Death|10
1176719|NCT01439347|2325429|FG001|Overall Study|Death|9
873156|NCT00545571|1834891|FG000|Overall Study|Administrative Reasons|1
873157|NCT00545571|1834891|FG000|Overall Study|Adverse Event|2
873158|NCT00545571|1834891|FG000|Overall Study|Death|5
873159|NCT00545571|1834891|FG000|Overall Study|Lack of Efficacy|1
873160|NCT00545571|1834891|FG000|Overall Study|Protocol Violation|2
873161|NCT00545571|1834891|FG000|Overall Study|Refused Treatment|1
873162|NCT00545571|1834891|FG000|Overall Study|Screen Failure|16
873163|NCT00545571|1834891|FG000|Overall Study|Transfusion|12
873164|NCT00545571|1834891|FG000|Overall Study|Early Termination of Study|24
873165|NCT00545571|1834891|FG000|Overall Study|Kidney Transplantation|3
873166|NCT00545584|1834898|FG000|Overall Study|Only one reason for discontinuation|62
1006581|NCT01468701|2025290|FG005|Overall Study|Other reasons than listed|0
1176720|NCT01439347|2325428|FG000|Overall Study|Withdrawal by Subject|0
1176721|NCT01439347|2325429|FG001|Overall Study|Withdrawal by Subject|1
1176722|NCT01439347|2325428|FG000|Overall Study|Physician Decision|1
1176723|NCT01439347|2325429|FG001|Overall Study|Physician Decision|0
1176724|NCT01439347|2325428|FG000|Overall Study|Sponsor Terminated Study|2
1176725|NCT01439347|2325429|FG001|Overall Study|Sponsor Terminated Study|3
1176726|NCT01433471|2325454|FG000|Overall Study|Withdrawal by Subject|0
1176727|NCT01433471|2325455|FG001|Overall Study|Withdrawal by Subject|1
1176728|NCT01436084|2325463|FG000|Overall Study|Disease Progression|2
1176729|NCT01436084|2325463|FG000|Overall Study|Withdrawal by Subject|1
1176730|NCT01436084|2325463|FG000|Overall Study|Early Closure of Study|1
1176731|NCT01415986|2325491|FG000|Overall Study|Lost to Follow-up|1
1176732|NCT01410799|2325496|FG000|Overall Study|PI decision|13
1176733|NCT01426113|2325502|FG000|Overall Study|Study Discontinued|1
1176734|NCT01426113|2325503|FG001|Overall Study|Study Discontinued|1
1176735|NCT01426113|2325502|FG000|Overall Study|Adverse Event|0
1176736|NCT01426113|2325503|FG001|Overall Study|Adverse Event|1
1176737|NCT01420965|2325521|FG000|Overall Study|Withdrawal by Subject|1
1176738|NCT01420965|2325522|FG001|Overall Study|Withdrawal by Subject|0
1176739|NCT01420965|2325523|FG002|Overall Study|Withdrawal by Subject|0
1176740|NCT01420965|2325521|FG000|Overall Study|Adverse Event|0
873167|NCT00545584|1834899|FG001|Overall Study|Only one reason for discontinuation|61
873168|NCT00545584|1834900|FG002|Overall Study|Only one reason for discontinuation|48
873169|NCT00545584|1834898|FG000|Overall Study|Two or more reasons for discontinuation|17
873170|NCT00545584|1834899|FG001|Overall Study|Two or more reasons for discontinuation|19
873171|NCT00545584|1834900|FG002|Overall Study|Two or more reasons for discontinuation|8
873172|NCT00545688|1834938|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1
873173|NCT00545688|1834939|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2
873174|NCT00545688|1834940|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1
873175|NCT00545688|1834941|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1
873176|NCT00545688|1834938|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1
873177|NCT00545688|1834939|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1
1176741|NCT01420965|2325522|FG001|Overall Study|Adverse Event|1
1176742|NCT01420965|2325523|FG002|Overall Study|Adverse Event|0
1176743|NCT01417377|2325531|FG000|Overall Study|Lost to Follow-up|12
1176744|NCT01417377|2325531|FG000|Overall Study|Enrolled, but not treated|1
1176745|NCT01416272|2325535|FG000|Overall Study|Unacceptable distance visual acuity|2
1176746|NCT01416272|2325535|FG000|Overall Study|Lost to Follow-up|1
1176747|NCT01416272|2325535|FG000|Overall Study|Study related complaints|1
1176748|NCT01414166|2325541|FG000|Overall Study|Adverse Event|10
1176749|NCT01414166|2325542|FG001|Overall Study|Adverse Event|2
1176750|NCT01414166|2325541|FG000|Overall Study|Lost to Follow-up|4
1176751|NCT01414166|2325542|FG001|Overall Study|Lost to Follow-up|1
1176752|NCT01414166|2325541|FG000|Overall Study|Non-compliance with study drug|2
1176753|NCT01414166|2325542|FG001|Overall Study|Non-compliance with study drug|0
1176754|NCT01414166|2325541|FG000|Overall Study|Physician Decision|2
1176755|NCT01414166|2325542|FG001|Overall Study|Physician Decision|0
1176756|NCT01414166|2325541|FG000|Overall Study|Protocol Violation|2
1176757|NCT01414166|2325542|FG001|Overall Study|Protocol Violation|0
1176758|NCT01414166|2325541|FG000|Overall Study|Study terminated by Sponsor|68
1176759|NCT01414166|2325542|FG001|Overall Study|Study terminated by Sponsor|75
1176760|NCT01414166|2325541|FG000|Overall Study|Withdrawal by Subject|3
1176761|NCT01414166|2325542|FG001|Overall Study|Withdrawal by Subject|5
1176762|NCT01408641|2325569|FG000|Overall Study|Physician Decision|1
1176763|NCT01408641|2325570|FG001|Overall Study|Physician Decision|0
1176764|NCT01409031|2325578|FG000|Overall Study|transferred to other hosp|1
1176765|NCT01409031|2325579|FG001|Overall Study|transferred to other hosp|0
1176766|NCT01403194|2325602|FG000|Overall Study|Screen Failure|2
1176767|NCT01403194|2325602|FG000|Overall Study|Lost to Follow-up|8
1176768|NCT01397552|2325612|FG000|Overall Study|Adverse Event|1
1176769|NCT01397552|2325613|FG001|Overall Study|Adverse Event|0
1176770|NCT01397552|2325612|FG000|Overall Study|Withdrawal by Subject|2
1176771|NCT01397552|2325613|FG001|Overall Study|Withdrawal by Subject|1
1176772|NCT01392170|2325619|FG000|Overall Study|Withdrawal by Subject|1
1176773|NCT01392170|2325619|FG000|Overall Study|Ineligible|1
1176774|NCT01389817|2325625|FG000|Overall Study|Physician Decision|1
1176775|NCT01389817|2325626|FG001|Overall Study|Physician Decision|0
1176776|NCT01389817|2325625|FG000|Overall Study|Lost to Follow-up|1
1176777|NCT01389817|2325626|FG001|Overall Study|Lost to Follow-up|0
1176778|NCT01389817|2325625|FG000|Overall Study|Withdrawal by Subject|2
1176779|NCT01389817|2325626|FG001|Overall Study|Withdrawal by Subject|0
1176780|NCT01390181|2325645|FG000|Overall Study|Lost to Follow-up|1
1176781|NCT01390181|2325645|FG000|Overall Study|Study Terminated due to Low Accrual|3
1176782|NCT01372618|2325693|FG000|Overall Study|PI Died. Study Terminated|9
1176783|NCT01379274|2325701|FG000|Overall Study|funding withdrawn|1
1176784|NCT01369641|2325714|FG000|Overall Study|Withdrawal by Subject|1
1176785|NCT01359254|2325729|FG000|Overall Study|Death|1
1176786|NCT01359254|2325730|FG001|Overall Study|Death|0
1176787|NCT01352416|2325767|FG000|Overall Study|Physician Decision|1
1176788|NCT01352416|2325768|FG001|Overall Study|Physician Decision|2
1176789|NCT01352416|2325769|FG002|Overall Study|Physician Decision|2
1176790|NCT01352416|2325770|FG003|Overall Study|Physician Decision|1
1176791|NCT01349595|2325786|FG000|Overall Study|Lack of funding|2
873178|NCT00545688|1834940|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4
873179|NCT00545688|1834941|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1
873180|NCT00545688|1834938|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
873181|NCT00545688|1834939|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
873182|NCT00545688|1834940|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
873183|NCT00545688|1834941|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
873184|NCT00545688|1834938|FG000|Neo-Adjuvant Treatment Period|Death|0
873185|NCT00545688|1834939|FG001|Neo-Adjuvant Treatment Period|Death|1
873186|NCT00545688|1834940|FG002|Neo-Adjuvant Treatment Period|Death|0
873187|NCT00545688|1834941|FG003|Neo-Adjuvant Treatment Period|Death|0
873188|NCT00545688|1834938|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0
873189|NCT00545688|1834939|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1
873190|NCT00545688|1834940|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7
873191|NCT00545688|1834941|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2
873192|NCT00545688|1834938|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1
873193|NCT00545688|1834939|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0
873194|NCT00545688|1834940|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0
873195|NCT00545688|1834941|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0
873196|NCT00545688|1834938|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0
873197|NCT00545688|1834939|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0
873198|NCT00545688|1834940|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2
873199|NCT00545688|1834941|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2
873200|NCT00545688|1834938|FG000|Adjuvant Treatment Period|Disease Progression|3
873201|NCT00545688|1834939|FG001|Adjuvant Treatment Period|Disease Progression|3
873202|NCT00545688|1834940|FG002|Adjuvant Treatment Period|Disease Progression|0
873203|NCT00545688|1834941|FG003|Adjuvant Treatment Period|Disease Progression|7
873204|NCT00545688|1834938|FG000|Adjuvant Treatment Period|Refused Treatment|1
873205|NCT00545688|1834939|FG001|Adjuvant Treatment Period|Refused Treatment|1
873206|NCT00545688|1834940|FG002|Adjuvant Treatment Period|Refused Treatment|1
873207|NCT00545688|1834941|FG003|Adjuvant Treatment Period|Refused Treatment|5
873208|NCT00545688|1834938|FG000|Adjuvant Treatment Period|Lost to Follow-up|1
873209|NCT00545688|1834939|FG001|Adjuvant Treatment Period|Lost to Follow-up|0
873210|NCT00545688|1834940|FG002|Adjuvant Treatment Period|Lost to Follow-up|1
873211|NCT00545688|1834941|FG003|Adjuvant Treatment Period|Lost to Follow-up|0
873212|NCT00545688|1834938|FG000|Adjuvant Treatment Period|Adverse Event|0
873213|NCT00545688|1834939|FG001|Adjuvant Treatment Period|Adverse Event|3
873214|NCT00545688|1834940|FG002|Adjuvant Treatment Period|Adverse Event|2
873215|NCT00545688|1834941|FG003|Adjuvant Treatment Period|Adverse Event|2
873216|NCT00545688|1834938|FG000|Adjuvant Treatment Period|Unknown Reason|0
873217|NCT00545688|1834939|FG001|Adjuvant Treatment Period|Unknown Reason|1
873218|NCT00545688|1834940|FG002|Adjuvant Treatment Period|Unknown Reason|0
873219|NCT00545688|1834941|FG003|Adjuvant Treatment Period|Unknown Reason|0
873220|NCT00545688|1834938|FG000|Follow-Up Period|Death|4
873221|NCT00545688|1834939|FG001|Follow-Up Period|Death|2
873222|NCT00545688|1834940|FG002|Follow-Up Period|Death|2
873223|NCT00545688|1834941|FG003|Follow-Up Period|Death|6
873224|NCT00545688|1834938|FG000|Follow-Up Period|Disease Progression|6
873225|NCT00545688|1834939|FG001|Follow-Up Period|Disease Progression|5
1176792|NCT01349595|2325787|FG001|Overall Study|Lack of funding|2
1176793|NCT01347840|2325806|FG000|Overall Study|Withdrawal by Subject|1
1176794|NCT01335997|2325817|FG000|Period I and II|Adverse Event|63
1176795|NCT01335997|2325818|FG001|Period I and II|Adverse Event|43
1176796|NCT01335997|2325817|FG000|Period I and II|Noncompliance with Study Drug|1
1176797|NCT01335997|2325818|FG001|Period I and II|Noncompliance with Study Drug|1
1176798|NCT01335997|2325817|FG000|Period I and II|Lost to Follow-up|3
1176799|NCT01335997|2325818|FG001|Period I and II|Lost to Follow-up|5
1176800|NCT01335997|2325817|FG000|Period I and II|Withdrawal by Subject|9
1176801|NCT01335997|2325818|FG001|Period I and II|Withdrawal by Subject|4
1176802|NCT01335997|2325817|FG000|Period I and II|Study Terminated by Sponsor|406
1176803|NCT01335997|2325818|FG001|Period I and II|Study Terminated by Sponsor|415
1176804|NCT01335997|2325817|FG000|Period I and II|Protocol Violation|9
1176805|NCT01335997|2325818|FG001|Period I and II|Protocol Violation|10
1176806|NCT01335997|2325817|FG000|Period I and II|Physician Decision|2
1176807|NCT01335997|2325818|FG001|Period I and II|Physician Decision|1
1176808|NCT01335997|2325817|FG000|Period III|Adverse Event|0
1176809|NCT01335997|2325818|FG001|Period III|Adverse Event|2
1176810|NCT01335997|2325817|FG000|Period III|Study Terminated by Sponsor|77
1176811|NCT01335997|2325818|FG001|Period III|Study Terminated by Sponsor|76
1176812|NCT01335997|2325817|FG000|Period III|Protocol Violation|0
1176813|NCT01335997|2325818|FG001|Period III|Protocol Violation|1
1176814|NCT01335997|2325817|FG000|Period III|Lost to Follow-up|1
1176815|NCT01335997|2325818|FG001|Period III|Lost to Follow-up|0
1176816|NCT01341587|2325841|FG000|Overall Study|Lost to Follow-up|2
1176817|NCT01341587|2325842|FG001|Overall Study|Lost to Follow-up|0
1176818|NCT01341587|2325841|FG000|Overall Study|stopped using the meters|2
1176819|NCT01341587|2325842|FG001|Overall Study|stopped using the meters|10
1176820|NCT01334606|2325848|FG000|Overall Study|Study Terminated due to slow enrolment|18
873226|NCT00545688|1834940|FG002|Follow-Up Period|Disease Progression|9
873227|NCT00545688|1834941|FG003|Follow-Up Period|Disease Progression|9
1176821|NCT01332799|2325860|FG000|Overall Study|Insufficient funding|10
1176822|NCT01332799|2325861|FG001|Overall Study|Insufficient funding|10
1176823|NCT01329549|2325867|FG000|Overall Study|Withdrawal by Subject|1
1176824|NCT01329549|2325867|FG000|Overall Study|Adverse Event|1
1176825|NCT01326845|2325873|FG000|Overall Study|Administrative Problems|5
1176826|NCT01326845|2325874|FG001|Overall Study|Administrative Problems|2
1176827|NCT01326845|2325873|FG000|Overall Study|Adverse Event|1
1176828|NCT01326845|2325874|FG001|Overall Study|Adverse Event|0
1176829|NCT01326845|2325873|FG000|Overall Study|Misisng|1
1176830|NCT01326845|2325874|FG001|Overall Study|Misisng|3
1176831|NCT01329341|2325880|FG000|Overall Study|Withdrawal by Subject|44
1176832|NCT01320683|2325902|FG000|Overall Study|Positive antibody response|1
1176833|NCT01313273|2325908|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
1176834|NCT01313273|2325909|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
1176835|NCT01313273|2325908|FG000|Overall Study|Withdrawal by Subject|1
1176836|NCT01313273|2325909|FG001|Overall Study|Withdrawal by Subject|0
1176837|NCT01313273|2325908|FG000|Overall Study|Screening Chromogranin A-in normal range|0
1176838|NCT01313273|2325909|FG001|Overall Study|Screening Chromogranin A-in normal range|1
1176839|NCT01321008|2325915|FG000|Overall Study|Early Study Termination|1
1176840|NCT01310803|2325921|FG000|Overall Study|Subject terminated by Sponsor|1
1176841|NCT01310803|2325922|FG001|Overall Study|Subject terminated by Sponsor|0
1176842|NCT01313923|2325941|FG000|Overall Study|Physician Decision|3
1176843|NCT01321697|2325945|FG000|Overall Study|Study Terminated|7
1176844|NCT01312428|2325951|FG000|Overall Study|Study Termination|3
1176845|NCT01312428|2325952|FG001|Overall Study|Study Termination|4
1176846|NCT01290822|2326010|FG000|Overall Study|Withdrawal by Subject|1
1176847|NCT01290822|2326010|FG000|Overall Study|Physician Decision|10
1176848|NCT01290718|2326014|FG000|Overall Study|Early termination of the study|4
1176849|NCT01293123|2326020|FG000|Overall Study|Lost to Follow-up|0
1176850|NCT01293123|2326021|FG001|Overall Study|Lost to Follow-up|1
1176851|NCT01294046|2326027|FG000|Overall Study|Infection and surgical explant|1
873228|NCT00545688|1834938|FG000|Follow-Up Period|Refused Treatment|6
873229|NCT00545688|1834939|FG001|Follow-Up Period|Refused Treatment|2
873230|NCT00545688|1834940|FG002|Follow-Up Period|Refused Treatment|0
873231|NCT00545688|1834941|FG003|Follow-Up Period|Refused Treatment|2
873232|NCT00545688|1834938|FG000|Follow-Up Period|Lost to Follow-up|3
873233|NCT00545688|1834939|FG001|Follow-Up Period|Lost to Follow-up|3
873234|NCT00545688|1834940|FG002|Follow-Up Period|Lost to Follow-up|3
873235|NCT00545688|1834941|FG003|Follow-Up Period|Lost to Follow-up|1
873236|NCT00545688|1834938|FG000|Follow-Up Period|Unspecified Reason|2
873237|NCT00545688|1834939|FG001|Follow-Up Period|Unspecified Reason|5
873238|NCT00545688|1834940|FG002|Follow-Up Period|Unspecified Reason|6
873239|NCT00545688|1834941|FG003|Follow-Up Period|Unspecified Reason|8
873240|NCT00545688|1834938|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0
873241|NCT00545688|1834939|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2
873242|NCT00545688|1834940|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0
873243|NCT00545688|1834941|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1
873244|NCT00545714|1834954|FG000|Induction Phase (6 Months)|Physician Decision|3
873245|NCT00545714|1834954|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6
873246|NCT00545714|1834954|FG000|Induction Phase (6 Months)|Disease Progression|1
873247|NCT00545714|1834954|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2
873248|NCT00545714|1834954|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
873249|NCT00545714|1834954|FG000|Maintenance Phase (36 Months)|Disease Progression|9
873250|NCT00545714|1834954|FG000|Maintenance Phase (36 Months)|Physician Decision|1
873251|NCT00545714|1834954|FG000|Maintenance Phase (36 Months)|Protocol Violation|1
873252|NCT00545714|1834954|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3
873253|NCT00545714|1834954|FG000|Maintenance Phase (36 Months)|Death|2
873254|NCT00545740|1834962|FG000|Overall Study|Lack of Efficacy|34
873255|NCT00545740|1834963|FG001|Overall Study|Lack of Efficacy|35
873256|NCT00545740|1834964|FG002|Overall Study|Lack of Efficacy|47
873257|NCT00545740|1834965|FG003|Overall Study|Lack of Efficacy|36
873258|NCT00545740|1834962|FG000|Overall Study|Withdrawal by Subject|17
873259|NCT00545740|1834963|FG001|Overall Study|Withdrawal by Subject|15
873260|NCT00545740|1834964|FG002|Overall Study|Withdrawal by Subject|16
873261|NCT00545740|1834965|FG003|Overall Study|Withdrawal by Subject|18
873262|NCT00545740|1834962|FG000|Overall Study|Adverse Event|10
873263|NCT00545740|1834963|FG001|Overall Study|Adverse Event|18
873264|NCT00545740|1834964|FG002|Overall Study|Adverse Event|19
873265|NCT00545740|1834965|FG003|Overall Study|Adverse Event|9
873266|NCT00545740|1834962|FG000|Overall Study|Lost to Follow-up|7
873267|NCT00545740|1834963|FG001|Overall Study|Lost to Follow-up|5
873268|NCT00545740|1834964|FG002|Overall Study|Lost to Follow-up|5
873269|NCT00545740|1834965|FG003|Overall Study|Lost to Follow-up|6
873270|NCT00545740|1834962|FG000|Overall Study|Protocol Violation|1
873271|NCT00545740|1834963|FG001|Overall Study|Protocol Violation|3
873272|NCT00545740|1834964|FG002|Overall Study|Protocol Violation|1
873273|NCT00545740|1834965|FG003|Overall Study|Protocol Violation|0
873274|NCT00545740|1834962|FG000|Overall Study|Non-compliance|0
873275|NCT00545740|1834963|FG001|Overall Study|Non-compliance|2
873276|NCT00545740|1834964|FG002|Overall Study|Non-compliance|1
873277|NCT00545740|1834965|FG003|Overall Study|Non-compliance|0
873278|NCT00545740|1834962|FG000|Overall Study|Moved|2
1176852|NCT01294046|2326027|FG000|Overall Study|Eligibility criteria expanded|1
1176853|NCT01294046|2326027|FG000|Overall Study|Stimulation response inadqequate|1
1176854|NCT01281124|2326071|FG000|Overall Study|Death|1
1176855|NCT01282216|2326083|FG000|Overall Study|Graft failure|0
1176856|NCT01282216|2326084|FG001|Overall Study|Graft failure|0
1176857|NCT01282216|2326085|FG002|Overall Study|Graft failure|3
1176858|NCT01282216|2326086|FG003|Overall Study|Graft failure|2
1176859|NCT01282216|2326083|FG000|Overall Study|Physician Decision|0
1176860|NCT01282216|2326084|FG001|Overall Study|Physician Decision|0
1176861|NCT01282216|2326085|FG002|Overall Study|Physician Decision|11
1176862|NCT01282216|2326086|FG003|Overall Study|Physician Decision|0
1176863|NCT01282216|2326083|FG000|Overall Study|Relapse|0
1176864|NCT01282216|2326084|FG001|Overall Study|Relapse|0
1176865|NCT01282216|2326085|FG002|Overall Study|Relapse|17
1176866|NCT01282216|2326086|FG003|Overall Study|Relapse|6
1176867|NCT01282216|2326083|FG000|Overall Study|Death|0
1176868|NCT01282216|2326084|FG001|Overall Study|Death|0
1176869|NCT01282216|2326085|FG002|Overall Study|Death|2
1176870|NCT01282216|2326086|FG003|Overall Study|Death|0
1176871|NCT01284491|2326092|FG000|Overall Study|Study termination|13
1176872|NCT01274533|2326124|FG000|Overall Study|Withdrawal by Subject|1
1176873|NCT01274533|2326124|FG000|Overall Study|Non-compliance|1
1176874|NCT01274533|2326124|FG000|Overall Study|Disease progression|2
1176875|NCT01279616|2326128|FG000|Overall Study|donor could not be located|5
1176876|NCT01279616|2326128|FG000|Overall Study|no signs of sickle cell disease|2
1176877|NCT01276054|2326134|FG000|Overall Study|No one to oversee trial after P.I. left|2
1176878|NCT01276054|2326135|FG001|Overall Study|No one to oversee trial after P.I. left|2
1176879|NCT01264965|2326141|FG000|Overall Study|Withdrawal by Subject|10
1176880|NCT01266824|2326147|FG000|Overall Study|Study terminated prior to completion|2
1176881|NCT01266824|2326148|FG001|Overall Study|Study terminated prior to completion|3
1176882|NCT01264835|2326154|FG000|Overall Study|Lost to Follow-up|1
1176883|NCT01274429|2326158|FG000|Overall Study|Study closed do to lack of funding|5
1176884|NCT01273064|2326167|FG000|Overall Study|Adverse Event|5
1176885|NCT01273064|2326168|FG001|Overall Study|Adverse Event|1
1176886|NCT01273064|2326169|FG002|Overall Study|Adverse Event|3
1176887|NCT01273064|2326170|FG003|Overall Study|Adverse Event|2
1176888|NCT01273064|2326171|FG004|Overall Study|Adverse Event|1
1176889|NCT01273064|2326167|FG000|Overall Study|Withdrawal by Subject|4
1176890|NCT01273064|2326168|FG001|Overall Study|Withdrawal by Subject|2
1176891|NCT01273064|2326169|FG002|Overall Study|Withdrawal by Subject|2
1176892|NCT01273064|2326170|FG003|Overall Study|Withdrawal by Subject|2
1176893|NCT01273064|2326171|FG004|Overall Study|Withdrawal by Subject|0
1176894|NCT01273064|2326167|FG000|Overall Study|Study Termination|13
1176895|NCT01273064|2326168|FG001|Overall Study|Study Termination|27
1176896|NCT01273064|2326169|FG002|Overall Study|Study Termination|26
1176897|NCT01273064|2326170|FG003|Overall Study|Study Termination|16
1176898|NCT01273064|2326171|FG004|Overall Study|Study Termination|8
1176899|NCT01273064|2326167|FG000|Overall Study|Lost to Follow-up|1
1176900|NCT01273064|2326168|FG001|Overall Study|Lost to Follow-up|0
1176901|NCT01273064|2326169|FG002|Overall Study|Lost to Follow-up|0
1176902|NCT01273064|2326170|FG003|Overall Study|Lost to Follow-up|0
1176903|NCT01273064|2326171|FG004|Overall Study|Lost to Follow-up|0
1176904|NCT01273064|2326167|FG000|Overall Study|Physician Decision|0
1176905|NCT01273064|2326168|FG001|Overall Study|Physician Decision|0
1176906|NCT01273064|2326169|FG002|Overall Study|Physician Decision|0
1176907|NCT01273064|2326170|FG003|Overall Study|Physician Decision|0
1176908|NCT01273064|2326171|FG004|Overall Study|Physician Decision|1
1176909|NCT01274559|2326185|FG000|Overall Study|Adverse Event|57
1176910|NCT01274559|2326186|FG001|Overall Study|Adverse Event|13
1176911|NCT01274559|2326185|FG000|Overall Study|Death|1
1176912|NCT01274559|2326186|FG001|Overall Study|Death|1
1176913|NCT01274559|2326185|FG000|Overall Study|Lost to Follow-up|3
1176914|NCT01274559|2326186|FG001|Overall Study|Lost to Follow-up|3
1176915|NCT01274559|2326185|FG000|Overall Study|Non-compliance with Study Drug|2
1176916|NCT01274559|2326186|FG001|Overall Study|Non-compliance with Study Drug|4
1176917|NCT01274559|2326185|FG000|Overall Study|Physician Decision|2
1176918|NCT01274559|2326186|FG001|Overall Study|Physician Decision|1
1176919|NCT01274559|2326185|FG000|Overall Study|Protocol Violation|28
1176920|NCT01274559|2326186|FG001|Overall Study|Protocol Violation|23
1176921|NCT01274559|2326185|FG000|Overall Study|Study Terminated by Sponsor|79
1176922|NCT01274559|2326186|FG001|Overall Study|Study Terminated by Sponsor|87
1176923|NCT01274559|2326185|FG000|Overall Study|Withdrawal by Subject|25
1176924|NCT01274559|2326186|FG001|Overall Study|Withdrawal by Subject|13
1176925|NCT01267825|2326220|FG000|Overall Study|study terminated. no data collected.|1
1176926|NCT01267825|2326221|FG001|Overall Study|study terminated. no data collected.|0
1176927|NCT01264679|2326227|FG000|Overall Study|Participation in Another Clinical Trial|1
1176928|NCT01264679|2326227|FG000|Overall Study|Physician Decision|1
1176929|NCT01264679|2326227|FG000|Overall Study|Sponsor's Suspension of Dosing|2
1176930|NCT01264679|2326227|FG000|Overall Study|Withdrawal by Subject|1
1176931|NCT01259284|2326235|FG000|Overall Study|Study Termination|2
1176932|NCT01259284|2326236|FG001|Overall Study|Study Termination|0
1176933|NCT01259284|2326237|FG002|Overall Study|Study Termination|0
1176934|NCT01249157|2326245|FG000|Overall Study|Withdrawal by Subject|1
1176935|NCT01263028|2326249|FG000|Overall Study|Withdrawal by Subject|1
1176936|NCT01263028|2326249|FG000|Overall Study|Adverse Event|1
1176937|NCT01263028|2326249|FG000|Overall Study|Study terminated due to low enrollment.|4
1176938|NCT01259024|2326261|FG000|Overall Study|Physician Decision|1
1176939|NCT01251952|2326265|FG000|Overall Study|Adverse Event|1
1176940|NCT01251120|2326271|FG000|Overall Study|Lack of Efficacy|0
1176941|NCT01251120|2326272|FG001|Overall Study|Lack of Efficacy|1
1176942|NCT01248130|2326280|FG000|Overall Study|Protocol Violation|1
1176943|NCT01248130|2326281|FG001|Overall Study|Protocol Violation|0
1176944|NCT01248130|2326280|FG000|Overall Study|Ineligible|1
1176945|NCT01248130|2326281|FG001|Overall Study|Ineligible|0
1176946|NCT01243892|2326289|FG000|Overall Study|Did not meet eligibility criteria|2
1176947|NCT01243892|2326290|FG001|Overall Study|Did not meet eligibility criteria|0
1176948|NCT01246011|2326299|FG000|Overall Study|If needed warfarin clinically, withdrawn|0
1176949|NCT01246011|2326300|FG001|Overall Study|If needed warfarin clinically, withdrawn|0
1176950|NCT01246011|2326301|FG002|Overall Study|If needed warfarin clinically, withdrawn|3
1176951|NCT01246011|2326299|FG000|Overall Study|Withdrawal by Subject|0
1176952|NCT01246011|2326300|FG001|Overall Study|Withdrawal by Subject|0
1176953|NCT01246011|2326301|FG002|Overall Study|Withdrawal by Subject|1
1176954|NCT01242020|2326312|FG000|Overall Study|Withdrawal by Subject|2
1176955|NCT01242020|2326313|FG001|Overall Study|Withdrawal by Subject|0
1176956|NCT01242020|2326312|FG000|Overall Study|Failed screening|1
1176957|NCT01242020|2326313|FG001|Overall Study|Failed screening|0
1176958|NCT01244620|2326319|FG000|Overall Study|Study terminated|4
1176959|NCT01244620|2326320|FG001|Overall Study|Study terminated|4
1176960|NCT01244620|2326321|FG002|Overall Study|Study terminated|4
1176961|NCT01244620|2326322|FG003|Overall Study|Study terminated|4
1176962|NCT01241279|2326338|FG000|Overall Study|Lost to Follow-up|0
1176963|NCT01241279|2326339|FG001|Overall Study|Lost to Follow-up|1
1176964|NCT01230788|2326345|FG000|Overall Study|Prescribed exclusion drug|1
1176965|NCT01239680|2326351|FG000|Overall Study|Withdrawal by Subject|2
1176966|NCT01239680|2326352|FG001|Overall Study|Withdrawal by Subject|0
1176967|NCT01230307|2326383|FG000|Overall Study|LVAD Placement|0
1176968|NCT01230307|2326384|FG001|Overall Study|LVAD Placement|2
873279|NCT00545740|1834963|FG001|Overall Study|Moved|0
873280|NCT00545740|1834964|FG002|Overall Study|Moved|1
873281|NCT00545740|1834965|FG003|Overall Study|Moved|0
873282|NCT00545740|1834962|FG000|Overall Study|Diverticulitis attack|0
873283|NCT00545740|1834963|FG001|Overall Study|Diverticulitis attack|0
873284|NCT00545740|1834964|FG002|Overall Study|Diverticulitis attack|1
873285|NCT00545740|1834965|FG003|Overall Study|Diverticulitis attack|1
873286|NCT00545740|1834962|FG000|Overall Study|Suspected Diverticulitis Recurrence|1
873287|NCT00545740|1834963|FG001|Overall Study|Suspected Diverticulitis Recurrence|1
873288|NCT00545740|1834964|FG002|Overall Study|Suspected Diverticulitis Recurrence|1
873289|NCT00545740|1834965|FG003|Overall Study|Suspected Diverticulitis Recurrence|1
1176969|NCT01230489|2326390|FG000|Overall Study|Death|2
1176970|NCT01230489|2326390|FG000|Overall Study|Adverse Event|2
1176971|NCT01230489|2326390|FG000|Overall Study|Treatment modality changed|1
1176972|NCT01217060|2326446|FG000|Overall Study|Withdrawal by Subject|1
1176973|NCT01217047|2326454|FG000|Overall Study|Lost to Follow-up|0
1176974|NCT01217047|2326455|FG001|Overall Study|Lost to Follow-up|1
1176975|NCT01217047|2326456|FG002|Overall Study|Lost to Follow-up|0
1176976|NCT01206101|2326467|FG000|Overall Study|Adverse Event|1
1176977|NCT01206101|2326468|FG001|Overall Study|Adverse Event|0
1176978|NCT01206101|2326467|FG000|Overall Study|Physician Decision|0
1176979|NCT01206101|2326468|FG001|Overall Study|Physician Decision|1
1176980|NCT01206101|2326467|FG000|Overall Study|Unclassified|1
1176981|NCT01206101|2326468|FG001|Overall Study|Unclassified|0
1176982|NCT01209520|2326491|FG000|Overall Study|Withdrawal by Subject|3
1176983|NCT01207102|2326512|FG000|Overall Study|Withdrawal by Subject|5
1176984|NCT01207102|2326512|FG000|Overall Study|Adverse Event|2
1176985|NCT01207102|2326512|FG000|Overall Study|progression|2
1176986|NCT01207102|2326512|FG000|Overall Study|Withdrawal by Treating Physician|1
1176987|NCT01206439|2326530|FG000|Overall Study|subject did not meet inclusion criteria|1
1176988|NCT01198548|2326552|FG000|Overall Study|Disease Progression|9
1176989|NCT01198548|2326552|FG000|Overall Study|Administrative Decision|1
1176990|NCT01193556|2326575|FG000|Overall Study|Study termination|26
1176991|NCT01193556|2326576|FG001|Overall Study|Study termination|25
1176992|NCT01189435|2326582|FG000|Overall Study|Withdrawal by Subject|1
1176993|NCT01189435|2326582|FG000|Overall Study|Physician Decision|1
1176994|NCT01193530|2326588|FG000|Overall Study|Withdrawal by Subject|2
1176995|NCT01193530|2326589|FG001|Overall Study|Withdrawal by Subject|2
1176996|NCT01193530|2326588|FG000|Overall Study|Began Contraindicated Therapy|1
1176997|NCT01193530|2326589|FG001|Overall Study|Began Contraindicated Therapy|0
1176998|NCT01193530|2326588|FG000|Overall Study|Lost Light Box|0
1176999|NCT01193530|2326589|FG001|Overall Study|Lost Light Box|1
1177000|NCT01193530|2326588|FG000|Overall Study|Returned home - out of state|0
1177001|NCT01193530|2326589|FG001|Overall Study|Returned home - out of state|1
1177002|NCT01193530|2326588|FG000|Overall Study|Non-Compliance|0
1177003|NCT01193530|2326589|FG001|Overall Study|Non-Compliance|1
1177004|NCT01183221|2326623|FG000|3 Weeks Wash Out|Lost to Follow-up|1
1177005|NCT01183221|2326624|FG001|3 Weeks Wash Out|Lost to Follow-up|1
1177006|NCT01189227|2326632|FG000|Overall Study|Study terminated due to low accrual|6
1177007|NCT01189227|2326633|FG001|Overall Study|Study terminated due to low accrual|3
1177008|NCT01179737|2326652|FG000|Cohort 1 & Cohort 2|Adverse Event|3
1177009|NCT01179737|2326653|FG001|Cohort 1 & Cohort 2|Adverse Event|1
1177010|NCT01179737|2326654|FG002|Cohort 1 & Cohort 2|Adverse Event|1
1177011|NCT01179737|2326655|FG003|Cohort 1 & Cohort 2|Adverse Event|0
1177012|NCT01179737|2326652|FG000|Cohort 1 & Cohort 2|Withdrew consent|2
1177013|NCT01179737|2326653|FG001|Cohort 1 & Cohort 2|Withdrew consent|0
1177014|NCT01179737|2326654|FG002|Cohort 1 & Cohort 2|Withdrew consent|0
1177015|NCT01179737|2326655|FG003|Cohort 1 & Cohort 2|Withdrew consent|0
1177016|NCT01179737|2326652|FG000|Cohort 1 & Cohort 2|Administrative problems|0
1177017|NCT01179737|2326653|FG001|Cohort 1 & Cohort 2|Administrative problems|0
1177018|NCT01179737|2326654|FG002|Cohort 1 & Cohort 2|Administrative problems|2
1177019|NCT01179737|2326655|FG003|Cohort 1 & Cohort 2|Administrative problems|4
1177020|NCT01179737|2326652|FG000|Cohort 1 & Cohort 2|Death|0
1177021|NCT01179737|2326653|FG001|Cohort 1 & Cohort 2|Death|0
1177022|NCT01179737|2326654|FG002|Cohort 1 & Cohort 2|Death|1
1177023|NCT01179737|2326655|FG003|Cohort 1 & Cohort 2|Death|0
1177024|NCT01179737|2326652|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1177025|NCT01179737|2326653|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
1177026|NCT01179737|2326654|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1177027|NCT01179737|2326655|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1177028|NCT01179737|2326652|FG000|Cohort 1 & Cohort 2 Expansion|Death|1
1177029|NCT01179737|2326653|FG001|Cohort 1 & Cohort 2 Expansion|Death|0
1177030|NCT01179737|2326654|FG002|Cohort 1 & Cohort 2 Expansion|Death|0
1177031|NCT01179737|2326655|FG003|Cohort 1 & Cohort 2 Expansion|Death|0
1177032|NCT01179737|2326652|FG000|Extension|The study was terminated|3
1177033|NCT01179737|2326653|FG001|Extension|The study was terminated|0
1177034|NCT01179737|2326654|FG002|Extension|The study was terminated|0
1177035|NCT01179737|2326655|FG003|Extension|The study was terminated|0
1177036|NCT01183468|2326668|FG000|Overall Study|Lost to Follow-up|2
1177037|NCT01183468|2326669|FG001|Overall Study|Lost to Follow-up|1
1177038|NCT01183468|2326670|FG002|Overall Study|Lost to Follow-up|0
1177039|NCT01183468|2326671|FG003|Overall Study|Lost to Follow-up|0
1177040|NCT01183468|2326668|FG000|Overall Study|Physician Decision|1
1177041|NCT01183468|2326669|FG001|Overall Study|Physician Decision|0
1177042|NCT01183468|2326670|FG002|Overall Study|Physician Decision|0
1177043|NCT01183468|2326671|FG003|Overall Study|Physician Decision|0
1177044|NCT01183468|2326668|FG000|Overall Study|Withdrawal by Subject|0
1177045|NCT01183468|2326669|FG001|Overall Study|Withdrawal by Subject|1
1177046|NCT01183468|2326670|FG002|Overall Study|Withdrawal by Subject|0
1177047|NCT01183468|2326671|FG003|Overall Study|Withdrawal by Subject|0
1177048|NCT01181921|2326679|FG000|Overall Study|Lost to Follow-up|1
1177049|NCT01188798|2326685|FG000|Overall Study|Death|0
1177050|NCT01188798|2326686|FG001|Overall Study|Death|1
1177051|NCT01188798|2326685|FG000|Overall Study|Required additional transplant|1
1177052|NCT01188798|2326686|FG001|Overall Study|Required additional transplant|1
1177053|NCT01188798|2326685|FG000|Overall Study|Protocol closure|1
1177054|NCT01188798|2326686|FG001|Overall Study|Protocol closure|1
1177055|NCT01174368|2326693|FG000|Overall Study|Withdrawal by Subject|1
1177056|NCT01183884|2326701|FG000|Overall Study|Progressive Disease|26
1177057|NCT01183884|2326701|FG000|Overall Study|Adverse Event|3
1177058|NCT01183884|2326701|FG000|Overall Study|Withdrawal by Subject|1
1177059|NCT01183884|2326701|FG000|Overall Study|Other Complicating Disease|3
1177060|NCT01183884|2326701|FG000|Overall Study|Not Treated|1
1177061|NCT01183884|2326701|FG000|Overall Study|Other|4
1177062|NCT01166178|2326711|FG000|Overall Study|Withdrawal by Subject|1
1177063|NCT01166178|2326712|FG001|Overall Study|Withdrawal by Subject|0
1177064|NCT01166178|2326711|FG000|Overall Study|Study was terminated|20
1177065|NCT01166178|2326712|FG001|Overall Study|Study was terminated|8
1177066|NCT01176513|2326718|FG000|Overall Study|Withdrew subjects prior to dosing|3
1177067|NCT01179399|2326726|FG000|Overall Study|Adverse Event|1
1177068|NCT01179399|2326726|FG000|Overall Study|Lack of Efficacy|30
1177069|NCT01179399|2326726|FG000|Overall Study|Withdrawal by Subject|1
1177070|NCT01171534|2326741|FG000|Overall Study|Lost to Follow-up|0
1177071|NCT01171534|2326742|FG001|Overall Study|Lost to Follow-up|2
1177072|NCT01171534|2326741|FG000|Overall Study|screen failure|0
1177073|NCT01171534|2326742|FG001|Overall Study|screen failure|1
1177074|NCT01155388|2326754|FG000|Overall Study|Adverse Event|1
1177075|NCT01155388|2326755|FG001|Overall Study|Adverse Event|0
1177076|NCT01155375|2326782|FG000|Overall Study|Adverse Event|1
1177077|NCT01155375|2326783|FG001|Overall Study|Adverse Event|0
1177078|NCT01162304|2326798|FG000|Overall Study|Beck scale to high|11
1177079|NCT01147393|2326850|FG000|Dose Level 1|Dose limiting Toxicity|2
1177080|NCT01147393|2326850|FG000|Dose Level -1|Dose Limited Toxicity|1
1177081|NCT01147536|2326863|FG000|Overall Study|Administrative study close|2
1177082|NCT01147536|2326863|FG000|Overall Study|Death|1
1177083|NCT01133288|2326876|FG000|Eligibility Assessment|met exclusion criteria|5
1177084|NCT01133288|2326876|FG000|Intervention Allocation|study terminated|2
1177085|NCT01142128|2326884|FG000|Overall Study|Physician Decision|1
1177086|NCT01142128|2326884|FG000|Overall Study|Lost to Follow-up|1
1177087|NCT01142128|2326884|FG000|Overall Study|Withdrawal by Subject|2
1177088|NCT01128114|2326903|FG000|Overall Study|Treatment Withdrawn|6
1177089|NCT01128114|2326903|FG000|Overall Study|Screening Failed|2
1177090|NCT01126879|2326909|FG000|Overall Study|Progressive Disease|3
1177091|NCT01126879|2326910|FG001|Overall Study|Progressive Disease|1
1177092|NCT01126879|2326909|FG000|Overall Study|Withdrawal by Subject|1
1177093|NCT01126879|2326910|FG001|Overall Study|Withdrawal by Subject|0
1177094|NCT01126879|2326909|FG000|Overall Study|Adverse Event|0
1177095|NCT01126879|2326910|FG001|Overall Study|Adverse Event|1
1177096|NCT01126879|2326909|FG000|Overall Study|Physician Decision|1
1177097|NCT01126879|2326910|FG001|Overall Study|Physician Decision|0
1177098|NCT01136811|2326916|FG000|Overall Study|Physician Decision|11
1177099|NCT01139125|2326929|FG000|Overall Study|Withdrawal by Subject|1
1177100|NCT01131455|2326953|FG000|Overall Study|Death of PI|6
1177101|NCT01131455|2326954|FG001|Overall Study|Death of PI|4
1177102|NCT01131455|2326955|FG002|Overall Study|Death of PI|0
1177103|NCT01123850|2326972|FG000|Overall Study|Slow enrollment|45
1177104|NCT01122381|2327005|FG000|Overall Study|study terminated early|0
1177105|NCT01122381|2327006|FG001|Overall Study|study terminated early|1
1177106|NCT01116232|2327012|FG000|Overall Study|Progressive diease|4
1177107|NCT01108523|2327040|FG000|Overall Study|Protocol Violation|4
1177108|NCT01106534|2327048|FG000|Overall Study|Withdrawal by Subject|18
1177109|NCT01106534|2327048|FG000|Overall Study|Lost to Follow-up|2
1177110|NCT01106534|2327048|FG000|Overall Study|Death|16
1177111|NCT01106534|2327048|FG000|Overall Study|Physician Decision|1
1177112|NCT01100658|2327057|FG000|Overall Study|Withdrawal by Subject|1
1177113|NCT01103180|2327063|FG000|Overall Study|Withdrawal by Subject|8
1177114|NCT01103180|2327064|FG001|Overall Study|Withdrawal by Subject|13
1177115|NCT01103180|2327063|FG000|Overall Study|Lost to Follow-up|13
1177116|NCT01103180|2327064|FG001|Overall Study|Lost to Follow-up|7
1177117|NCT01103180|2327063|FG000|Overall Study|Physician Decision|1
1177118|NCT01103180|2327064|FG001|Overall Study|Physician Decision|0
1177119|NCT01103180|2327063|FG000|Overall Study|Protocol Violation|0
1177120|NCT01103180|2327064|FG001|Overall Study|Protocol Violation|1
1177121|NCT01102140|2327081|FG000|Overall Study|Lost to Follow-up|1
1177122|NCT01102140|2327082|FG001|Overall Study|Lost to Follow-up|0
1177123|NCT01102140|2327081|FG000|Overall Study|Investigator terminated study|2
1177124|NCT01102140|2327082|FG001|Overall Study|Investigator terminated study|2
1177125|NCT01095250|2327094|FG000|Overall Study|administrative reasons|8
1177126|NCT01095250|2327095|FG001|Overall Study|administrative reasons|10
1177127|NCT01095250|2327096|FG002|Overall Study|administrative reasons|7
1177128|NCT01095250|2327097|FG003|Overall Study|administrative reasons|5
1177129|NCT01095250|2327094|FG000|Overall Study|Withdrawal by Subject|0
1177130|NCT01095250|2327095|FG001|Overall Study|Withdrawal by Subject|0
1177131|NCT01095250|2327096|FG002|Overall Study|Withdrawal by Subject|1
1177132|NCT01095250|2327097|FG003|Overall Study|Withdrawal by Subject|0
1177133|NCT01093846|2327114|FG000|Overall Study|Adverse Event|0
1177134|NCT01093846|2327115|FG001|Overall Study|Adverse Event|0
1177135|NCT01093846|2327116|FG002|Overall Study|Adverse Event|1
1177136|NCT01093846|2327114|FG000|Overall Study|Lack of Efficacy|0
1177137|NCT01093846|2327115|FG001|Overall Study|Lack of Efficacy|0
1177138|NCT01093846|2327116|FG002|Overall Study|Lack of Efficacy|4
1177139|NCT01093846|2327114|FG000|Overall Study|Condition no longer required study drug|1
1177140|NCT01093846|2327115|FG001|Overall Study|Condition no longer required study drug|1
1177141|NCT01093846|2327116|FG002|Overall Study|Condition no longer required study drug|1
1177142|NCT01093846|2327114|FG000|Overall Study|Administrative Problems|18
1177143|NCT01093846|2327115|FG001|Overall Study|Administrative Problems|17
1177144|NCT01093846|2327116|FG002|Overall Study|Administrative Problems|15
1177145|NCT01081886|2327129|FG000|Overall Study|Study termination|11
1177146|NCT01081886|2327130|FG001|Overall Study|Study termination|13
1177147|NCT01080768|2327151|FG000|Overall Study|Protocol Deviation|2
1177148|NCT01080768|2327152|FG001|Overall Study|Protocol Deviation|1
1177149|NCT01074502|2327162|FG000|Overall Study|Withdrawal by Subject|1
1177150|NCT01069861|2327175|FG000|Overall Study|Death|1
1177151|NCT01069861|2327175|FG000|Overall Study|Adverse Event|1
1177152|NCT01069861|2327175|FG000|Overall Study|Did not meet entrance criteria|1
1177153|NCT01069120|2327208|FG000|Overall Study|Study prematurely terminated|27
1177154|NCT01058642|2327227|FG000|Treatment Period 1|Adverse Event|0
1177155|NCT01058642|2327228|FG001|Treatment Period 1|Adverse Event|1
1177156|NCT01058642|2327229|FG002|Treatment Period 1|Adverse Event|1
1177157|NCT01058642|2327230|FG003|Treatment Period 1|Adverse Event|0
1177158|NCT01058642|2327227|FG000|Treatment Period 1|Physician Decision|0
1177159|NCT01058642|2327228|FG001|Treatment Period 1|Physician Decision|0
1177160|NCT01058642|2327229|FG002|Treatment Period 1|Physician Decision|1
1177161|NCT01058642|2327230|FG003|Treatment Period 1|Physician Decision|0
1177162|NCT01058642|2327227|FG000|Treatment Period 1|Withdrawal by Subject|1
1177163|NCT01058642|2327228|FG001|Treatment Period 1|Withdrawal by Subject|0
1177164|NCT01058642|2327229|FG002|Treatment Period 1|Withdrawal by Subject|0
1177165|NCT01058642|2327230|FG003|Treatment Period 1|Withdrawal by Subject|0
1177166|NCT01058642|2327227|FG000|Treatment Period 1|Lack of Efficacy|0
1177167|NCT01058642|2327228|FG001|Treatment Period 1|Lack of Efficacy|0
1177168|NCT01058642|2327229|FG002|Treatment Period 1|Lack of Efficacy|0
1177169|NCT01058642|2327230|FG003|Treatment Period 1|Lack of Efficacy|1
1177170|NCT01058642|2327227|FG000|Treatment Period 1|Protocol Violation|0
1177171|NCT01058642|2327228|FG001|Treatment Period 1|Protocol Violation|0
1177172|NCT01058642|2327229|FG002|Treatment Period 1|Protocol Violation|0
1177173|NCT01058642|2327230|FG003|Treatment Period 1|Protocol Violation|1
1177174|NCT01058642|2327227|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1
1177175|NCT01058642|2327228|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0
1177176|NCT01058642|2327229|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0
1177177|NCT01058642|2327230|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0
1177178|NCT01065818|2327238|FG000|Overall Study|Withdrawal by Subject|1
1177179|NCT01065818|2327238|FG000|Overall Study|Not a candidate for surgery|1
1177180|NCT01051921|2327242|FG000|Overall Study|Physician Decision|9
1177181|NCT01051921|2327242|FG000|Overall Study|Adverse Event|8
1177182|NCT01051921|2327242|FG000|Overall Study|Withdrawal by Subject|7
1177183|NCT01051921|2327242|FG000|Overall Study|Lost to Follow-up|4
1177184|NCT01051921|2327242|FG000|Overall Study|virological failure|1
1177185|NCT01051921|2327242|FG000|Overall Study|patient moved|1
1177186|NCT01058369|2327264|FG000|Overall Study|Adverse Event|1
1177187|NCT01058369|2327264|FG000|Overall Study|Early termination study|1
1177188|NCT01053221|2327274|FG000|Overall Study|The study was closed prematurely|5
1177189|NCT01053221|2327275|FG001|Overall Study|The study was closed prematurely|9
1177190|NCT01038752|2327283|FG000|Overall Study|Tumor Progression|2
1177191|NCT01038752|2327284|FG001|Overall Study|Tumor Progression|2
1177192|NCT01038752|2327283|FG000|Overall Study|Lost to Follow-up|3
1177193|NCT01038752|2327284|FG001|Overall Study|Lost to Follow-up|3
1177194|NCT01050218|2327290|FG000|Overall Study|Adverse Event|37
1177195|NCT01050218|2327290|FG000|Overall Study|Lack of Efficacy|8
1177196|NCT01050218|2327290|FG000|Overall Study|Protocol Violation|3
1177197|NCT01050218|2327290|FG000|Overall Study|Withdrawal by Subject|18
1177198|NCT01050218|2327290|FG000|Overall Study|Discontinued by sponsor|18
1177199|NCT01050218|2327290|FG000|Overall Study|Compliance|2
1177200|NCT01050218|2327290|FG000|Overall Study|Failed to return|7
1177201|NCT01050218|2327290|FG000|Overall Study|Serious Adverse Event|1
1177202|NCT01050218|2327290|FG000|Overall Study|Family emergency|1
1177203|NCT01045694|2327294|FG000|Overall Study|Withdrawal by Subject|2
1177204|NCT01031628|2327319|FG000|Overall Study|Study terminated early|0
1177205|NCT01031628|2327320|FG001|Overall Study|Study terminated early|1
1177206|NCT01031628|2327321|FG002|Overall Study|Study terminated early|3
1177207|NCT01031628|2327322|FG003|Overall Study|Study terminated early|0
1177208|NCT01030198|2327353|FG000|Overall Study|Could not measure efficacy accurately|0
1177209|NCT01030198|2327354|FG001|Overall Study|Could not measure efficacy accurately|7
1177210|NCT01028300|2327360|FG000|Overall Study|Study Terminated|4
1177211|NCT01022398|2327371|FG000|Overall Study|Study terminated|2
1177212|NCT01022398|2327372|FG001|Overall Study|Study terminated|2
1177213|NCT01019980|2327379|FG000|Overall Study|Drug not available.|2
1177214|NCT01019980|2327380|FG001|Overall Study|Drug not available.|0
1177215|NCT01017263|2327390|FG000|Overall Study|not eligible|12
1177216|NCT01018810|2327417|FG000|Overall Study|Withdrawal by Subject|0
1177217|NCT01018810|2327418|FG001|Overall Study|Withdrawal by Subject|1
1177218|NCT01018810|2327419|FG002|Overall Study|Withdrawal by Subject|0
1177219|NCT01018810|2327420|FG003|Overall Study|Withdrawal by Subject|0
1177220|NCT01018810|2327421|FG004|Overall Study|Withdrawal by Subject|0
1177221|NCT01018810|2327417|FG000|Overall Study|Sponsor Decision|2
1177222|NCT01018810|2327418|FG001|Overall Study|Sponsor Decision|0
1177223|NCT01018810|2327419|FG002|Overall Study|Sponsor Decision|1
1177224|NCT01018810|2327420|FG003|Overall Study|Sponsor Decision|1
1177225|NCT01018810|2327421|FG004|Overall Study|Sponsor Decision|1
1177226|NCT01014767|2327450|FG000|Overall Study|PI left institution, data unavailable|12
1177227|NCT01014767|2327451|FG001|Overall Study|PI left institution, data unavailable|1
1177228|NCT01014767|2327452|FG002|Overall Study|PI left institution, data unavailable|4
1177229|NCT01014767|2327453|FG003|Overall Study|PI left institution, data unavailable|1
1177230|NCT01013701|2327463|FG000|Overall Study|study prematurely terminated|7
1177231|NCT01012414|2327468|FG000|Overall Study|Withdrawal by Subject|2
1177232|NCT01012414|2327468|FG000|Overall Study|Lost to Follow-up|1
1177233|NCT01012414|2327468|FG000|Overall Study|Trial was stopped before completed|7
1177234|NCT01001390|2327487|FG000|Overall Study|Failure to wear AFO device|2
1177235|NCT01001390|2327488|FG001|Overall Study|Failure to wear AFO device|0
1177236|NCT01004510|2327506|FG000|Overall Study|Adverse Event|1
1177237|NCT01005914|2327510|FG000|Overall Study|Adverse Event|4
1177238|NCT01005914|2327510|FG000|Overall Study|Death|4
1177239|NCT01005914|2327510|FG000|Overall Study|Lack of Efficacy|1
1177240|NCT01005914|2327510|FG000|Overall Study|Withdrawal by Subject|1
1177241|NCT00996333|2327514|FG000|Overall Study|Screen failure|1
1177242|NCT00996333|2327514|FG000|Overall Study|Withdrawal by Subject|1
1177243|NCT00996333|2327514|FG000|Overall Study|Death|4
1177244|NCT00996333|2327514|FG000|Overall Study|Adverse Event|1
1177245|NCT00996333|2327514|FG000|Overall Study|Physician Decision|1
1177246|NCT00996333|2327514|FG000|Overall Study|Other|5
1177247|NCT00998738|2327518|FG000|Overall Study|Uknown|1
1177248|NCT00997386|2327526|FG000|Overall Study|Death|7
1177249|NCT00985738|2327532|FG000|Overall Study|Study closed prematurely|8
1177250|NCT00985738|2327533|FG001|Overall Study|Study closed prematurely|8
1177251|NCT00975611|2327626|FG000|Overall Study|Screen Fail|16
1177252|NCT00975611|2327626|FG000|Overall Study|Physician Decision|1
1177253|NCT00974922|2327651|FG000|Overall Study|study terminated|24
1177254|NCT00965146|2327666|FG000|Overall Study|Death|7
1177255|NCT00965146|2327666|FG000|Overall Study|Lost to Follow-up|22
1177256|NCT00965146|2327666|FG000|Overall Study|Withdrawal by Subject|17
1177257|NCT00965146|2327666|FG000|Overall Study|Unable to return|1
1177258|NCT00965146|2327666|FG000|Overall Study|Unwilling to return|11
1177259|NCT00965146|2327666|FG000|Overall Study|Intercurrent illness|1
1177260|NCT00965146|2327666|FG000|Overall Study|Revision / Removal of Study Implant|6
1177261|NCT00965146|2327666|FG000|Overall Study|Overall Study Termination|145
1177262|NCT00972023|2327670|FG000|Overall Study|Withdrawal by Subject|1
1177263|NCT00953329|2327689|FG000|Overall Study|Lack of Efficacy|1
1177264|NCT00958893|2327706|FG000|Overall Study|Study prematurely terminated|4
1177265|NCT00966654|2327710|FG000|Overall Study|Study was terminated,PI left institution|12
1177266|NCT00960154|2327718|FG000|Overall Study|Study termination|25
1177267|NCT00960154|2327719|FG001|Overall Study|Study termination|25
1177268|NCT00960752|2327728|FG000|Overall Study|Adverse Event|0
1177269|NCT00960752|2327729|FG001|Overall Study|Adverse Event|0
1177270|NCT00960752|2327730|FG002|Overall Study|Adverse Event|1
1177271|NCT00960752|2327728|FG000|Overall Study|Progression|0
1177272|NCT00960752|2327729|FG001|Overall Study|Progression|0
1177273|NCT00960752|2327730|FG002|Overall Study|Progression|1
1177274|NCT00958347|2327738|FG000|Overall Study|Death|43
1177275|NCT00958347|2327738|FG000|Overall Study|Withdrawal by Subject|23
1177276|NCT00958347|2327738|FG000|Overall Study|Lost to Follow-up|15
1177277|NCT00958347|2327738|FG000|Overall Study|revision/removal|10
1177278|NCT00958347|2327738|FG000|Overall Study|study termination|135
1177282|NCT00953615|2327755|FG000|Overall Study|Adverse Event|1
1177283|NCT00957034|2327767|FG000|Overall Study|Adverse Event|0
1177284|NCT00957034|2327768|FG001|Overall Study|Adverse Event|1
1177285|NCT00957034|2327769|FG002|Overall Study|Adverse Event|1
1177286|NCT00957034|2327767|FG000|Overall Study|Sponsor Terminated Study|6
1177287|NCT00957034|2327768|FG001|Overall Study|Sponsor Terminated Study|1
1177288|NCT00957034|2327769|FG002|Overall Study|Sponsor Terminated Study|5
1177289|NCT00957034|2327767|FG000|Overall Study|Withdrawal by Subject|0
1177290|NCT00957034|2327768|FG001|Overall Study|Withdrawal by Subject|2
1177291|NCT00957034|2327769|FG002|Overall Study|Withdrawal by Subject|0
1177292|NCT00949988|2327777|FG000|Overall Study|Withdrawal by Subject|3
1177293|NCT00948194|2327783|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1
1177294|NCT00948194|2327784|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0
1177295|NCT00946985|2327790|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4
1177296|NCT00946985|2327790|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
1177297|NCT00946985|2327790|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
1177298|NCT00946985|2327790|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
1177299|NCT00946985|2327790|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
1177300|NCT00946985|2327790|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
1177301|NCT00946985|2327790|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
1177302|NCT00946985|2327790|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2
1177303|NCT00946985|2327790|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
1177304|NCT00950690|2327798|FG000|Overall Study|Death|4
1177305|NCT00950690|2327798|FG000|Overall Study|Adverse Event|15
1177306|NCT00950690|2327798|FG000|Overall Study|Lack of Efficacy|22
1177307|NCT00950690|2327798|FG000|Overall Study|Lost to Follow-up|40
1177308|NCT00950690|2327798|FG000|Overall Study|Other|163
1177309|NCT00944229|2327802|FG000|Overall Study|Withdrawal by Subject|11
1177310|NCT00944229|2327802|FG000|Overall Study|Physician Decision|14
1177311|NCT00941928|2327806|FG000|Overall Study|Withdrawal by Subject|1
1177312|NCT00941928|2327806|FG000|Overall Study|Disease Progression|1
1177313|NCT00947011|2327823|FG000|Overall Study|Study was terminated,PI left institution|12
1177314|NCT00943605|2327831|FG000|Overall Study|Study termination|30
1177315|NCT00943605|2327832|FG001|Overall Study|Study termination|30
1177316|NCT00942409|2327838|FG000|Overall Study|Lack of Efficacy|1
1177317|NCT00942409|2327838|FG000|Overall Study|study drug unavailable|2
1177318|NCT00936598|2327848|FG000|Overall Study|Withdrawal by Subject|1
1177319|NCT00936598|2327849|FG001|Overall Study|Withdrawal by Subject|0
1177320|NCT00936598|2327848|FG000|Overall Study|Ineligible after consent|1
1177321|NCT00936598|2327849|FG001|Overall Study|Ineligible after consent|0
1177322|NCT00934791|2327873|FG000|Overall Study|Withdrawal by Subject|1
1177323|NCT00934791|2327874|FG001|Overall Study|Withdrawal by Subject|0
1177324|NCT00925548|2327922|FG000|Overall Study|Discontinuation of trial by sponsor|10
1177325|NCT00925548|2327923|FG001|Overall Study|Discontinuation of trial by sponsor|5
1177326|NCT00926575|2327932|FG000|Overall Study|Adverse Event|1
1177327|NCT00926575|2327933|FG001|Overall Study|Adverse Event|1
1177328|NCT00926575|2327932|FG000|Overall Study|Death|4
1177329|NCT00926575|2327933|FG001|Overall Study|Death|4
1177330|NCT00926575|2327932|FG000|Overall Study|Lost to Follow-up|1
1177331|NCT00926575|2327933|FG001|Overall Study|Lost to Follow-up|1
1177332|NCT00926575|2327932|FG000|Overall Study|Physician Decision|1
1177333|NCT00926575|2327933|FG001|Overall Study|Physician Decision|2
1177334|NCT00926575|2327932|FG000|Overall Study|Protocol Violation|1
1177335|NCT00926575|2327933|FG001|Overall Study|Protocol Violation|0
1177336|NCT00926575|2327932|FG000|Overall Study|Withdrawal by Subject|8
1177337|NCT00926575|2327933|FG001|Overall Study|Withdrawal by Subject|9
1177338|NCT00918463|2327960|FG000|Overall Study|Death|1
1177339|NCT00918463|2327960|FG000|Overall Study|Lack of Efficacy|1
1177340|NCT00913692|2327964|FG000|Screening (4 Months)|Physician Decision|3
1177341|NCT00913692|2327964|FG000|Screening (4 Months)|Not eligible after screening phase.|6
1177342|NCT00913692|2327964|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1
1177343|NCT00918645|2327971|FG000|Overall Study|Withdrawal by Subject|1
1177344|NCT00906035|2328004|FG000|Overall Study|Withdrawal by Subject|2
1177345|NCT00906035|2328005|FG001|Overall Study|Withdrawal by Subject|3
1177346|NCT00906035|2328006|FG002|Overall Study|Withdrawal by Subject|0
1177347|NCT00894790|2328037|FG000|Overall Study|Protocol Violation|0
873290|NCT00545740|1834962|FG000|Overall Study|Site closure|1
873291|NCT00545740|1834963|FG001|Overall Study|Site closure|0
873292|NCT00545740|1834964|FG002|Overall Study|Site closure|0
873293|NCT00545740|1834965|FG003|Overall Study|Site closure|0
873294|NCT00545740|1834962|FG000|Overall Study|Missed visit|1
873295|NCT00545740|1834963|FG001|Overall Study|Missed visit|0
873296|NCT00545740|1834964|FG002|Overall Study|Missed visit|0
873297|NCT00545740|1834965|FG003|Overall Study|Missed visit|0
873298|NCT00545740|1834962|FG000|Overall Study|Physician Decision|0
873299|NCT00545740|1834963|FG001|Overall Study|Physician Decision|0
873300|NCT00545740|1834964|FG002|Overall Study|Physician Decision|3
873301|NCT00545740|1834965|FG003|Overall Study|Physician Decision|0
873302|NCT00545740|1834962|FG000|Overall Study|Accepted only monthly telephone calls|1
873303|NCT00545740|1834963|FG001|Overall Study|Accepted only monthly telephone calls|0
1177348|NCT00894790|2328038|FG001|Overall Study|Protocol Violation|1
1177349|NCT00894790|2328037|FG000|Overall Study|Lost to Follow-up|0
1177350|NCT00894790|2328038|FG001|Overall Study|Lost to Follow-up|1
1177351|NCT00894790|2328037|FG000|Overall Study|Did not meet entrance criteria|1
1177352|NCT00894790|2328038|FG001|Overall Study|Did not meet entrance criteria|0
1177353|NCT00902668|2328044|FG000|Overall Study|Protocol stopped due to slow accrual.|3
1177354|NCT00881205|2328050|FG000|Overall Study|Adverse Event|8
1177355|NCT00881205|2328051|FG001|Overall Study|Adverse Event|3
1177356|NCT00881205|2328050|FG000|Overall Study|Withdrawal by Subject|1
1177357|NCT00881205|2328051|FG001|Overall Study|Withdrawal by Subject|2
1177358|NCT00881205|2328050|FG000|Overall Study|Lost to Follow-up|0
1177359|NCT00881205|2328051|FG001|Overall Study|Lost to Follow-up|1
1177360|NCT00881205|2328050|FG000|Overall Study|Administrative problems|1
1177361|NCT00881205|2328051|FG001|Overall Study|Administrative problems|1
1177362|NCT00881205|2328050|FG000|Overall Study|Condition no longer requires drug|1
1177363|NCT00881205|2328051|FG001|Overall Study|Condition no longer requires drug|0
1177364|NCT00903006|2328068|FG000|Overall Study|Withdrawal by Subject|2
1177365|NCT00903006|2328069|FG001|Overall Study|Withdrawal by Subject|0
873304|NCT00545740|1834964|FG002|Overall Study|Accepted only monthly telephone calls|0
873305|NCT00545740|1834965|FG003|Overall Study|Accepted only monthly telephone calls|0
873306|NCT00545740|1834962|FG000|Overall Study|Sponsor decision|0
873307|NCT00545740|1834963|FG001|Overall Study|Sponsor decision|1
873308|NCT00545740|1834964|FG002|Overall Study|Sponsor decision|0
873309|NCT00545740|1834965|FG003|Overall Study|Sponsor decision|0
873310|NCT00545740|1834962|FG000|Overall Study|Lack of time|0
873311|NCT00545740|1834963|FG001|Overall Study|Lack of time|1
873312|NCT00545740|1834964|FG002|Overall Study|Lack of time|0
873313|NCT00545740|1834965|FG003|Overall Study|Lack of time|0
873314|NCT00545740|1834962|FG000|Overall Study|Non-adherence to visits|0
873315|NCT00545740|1834963|FG001|Overall Study|Non-adherence to visits|1
873316|NCT00545740|1834964|FG002|Overall Study|Non-adherence to visits|0
873317|NCT00545740|1834965|FG003|Overall Study|Non-adherence to visits|0
873318|NCT00545740|1834962|FG000|Overall Study|Patient difficulties|0
873319|NCT00545740|1834963|FG001|Overall Study|Patient difficulties|1
873320|NCT00545740|1834964|FG002|Overall Study|Patient difficulties|0
873321|NCT00545740|1834965|FG003|Overall Study|Patient difficulties|0
873322|NCT00545740|1834962|FG000|Overall Study|Husband against study|0
873323|NCT00545740|1834963|FG001|Overall Study|Husband against study|0
873324|NCT00545740|1834964|FG002|Overall Study|Husband against study|1
873325|NCT00545740|1834965|FG003|Overall Study|Husband against study|0
873326|NCT00545753|1834978|FG000|Overall Study|Withdrawal by Subject|0
873327|NCT00545753|1834979|FG001|Overall Study|Withdrawal by Subject|1
873328|NCT00545753|1834980|FG002|Overall Study|Withdrawal by Subject|10
873329|NCT00545753|1834978|FG000|Overall Study|Lost to Follow-up|13
873330|NCT00545753|1834979|FG001|Overall Study|Lost to Follow-up|3
873331|NCT00545753|1834980|FG002|Overall Study|Lost to Follow-up|12
873332|NCT00545753|1834978|FG000|Overall Study|Protocol Violation|3
873333|NCT00545753|1834979|FG001|Overall Study|Protocol Violation|1
873334|NCT00545753|1834980|FG002|Overall Study|Protocol Violation|4
873335|NCT00545779|1834993|FG000|Overall Study|Violation of selection criteria at entry|8
873336|NCT00545779|1834993|FG000|Overall Study|Other protocol violation|1
873337|NCT00545779|1834993|FG000|Overall Study|Did not cooperate|7
873338|NCT00545779|1834993|FG000|Overall Study|Withdrawal by Subject|20
873339|NCT00545779|1834993|FG000|Overall Study|Adverse Event/intercurrent illness|5
873340|NCT00545779|1834993|FG000|Overall Study|Failure to return|3
873341|NCT00545792|1834997|FG000|Overall Study|Withdrawal by Subject|1
873342|NCT00545818|1835003|FG000|Overall Study|Protocol Violation|1
873343|NCT00545818|1835004|FG001|Overall Study|Protocol Violation|0
873344|NCT00545818|1835003|FG000|Overall Study|Adverse Event|1
1177366|NCT00903006|2328070|FG002|Overall Study|Withdrawal by Subject|0
1177367|NCT00903006|2328071|FG003|Overall Study|Withdrawal by Subject|0
1177368|NCT00903006|2328068|FG000|Overall Study|Progressive Disease|0
1177369|NCT00903006|2328069|FG001|Overall Study|Progressive Disease|3
1177370|NCT00903006|2328070|FG002|Overall Study|Progressive Disease|1
1177371|NCT00903006|2328071|FG003|Overall Study|Progressive Disease|0
1177372|NCT00887315|2328088|FG000|Overall Study|Study termination|7
1177373|NCT00887315|2328089|FG001|Overall Study|Study termination|4
1177374|NCT00891904|2328095|FG000|Overall Study|Death|1
1177375|NCT00891904|2328095|FG000|Overall Study|Adverse Event|1
1177376|NCT00881608|2328104|FG000|Overall Study|Study prematurely terminated|11
1177377|NCT00889421|2328116|FG000|Overall Study|Lack of Efficacy|3
1177378|NCT00882310|2328133|FG000|Overall Study|Screen Failure|10
1177379|NCT00882310|2328133|FG000|Overall Study|Never received treatment|1
1177380|NCT00882310|2328133|FG000|Overall Study|Death|6
1177381|NCT00882310|2328133|FG000|Overall Study|Progression of disease|4
1177382|NCT00882310|2328133|FG000|Overall Study|Adverse Event|1
1177383|NCT00880542|2328137|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
1177384|NCT00880542|2328137|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
1177385|NCT00880542|2328137|FG000|REP: Surgical Resection|progressive disease|1
1177386|NCT00874939|2328145|FG000|Overall Study|Study terminated|4
1177387|NCT00877071|2328172|FG000|Overall Study|disease progression|2
873345|NCT00545818|1835004|FG001|Overall Study|Adverse Event|1
873346|NCT00545818|1835003|FG000|Overall Study|Lost to Follow-up|1
873347|NCT00545818|1835004|FG001|Overall Study|Lost to Follow-up|6
873348|NCT00545844|1835010|FG000|Overall Study|Lost to Follow-up|9
873349|NCT00545844|1835010|FG000|Overall Study|Protocol Violation|1
873350|NCT00545844|1835010|FG000|Overall Study|Withdrawal by Subject|2
873351|NCT00545948|1835019|FG000|Overall Study|Not Treated|1
873352|NCT00545948|1835020|FG001|Overall Study|Not Treated|1
873353|NCT00545948|1835021|FG002|Overall Study|Not Treated|7
873354|NCT00546000|1835039|FG000|Overall Study|Adverse Event|1
873355|NCT00546000|1835039|FG000|Overall Study|Lost to Follow-up|1
873356|NCT00546000|1835039|FG000|Overall Study|Baseline HPA Axis Supression|2
873357|NCT00546052|1835043|FG000|Overall Study|Adverse Event|47
873358|NCT00546052|1835043|FG000|Overall Study|Lost to Follow-up|144
873359|NCT00546052|1835043|FG000|Overall Study|Protocol Violation|9
873360|NCT00546052|1835043|FG000|Overall Study|Withdrawal by Subject|20
873361|NCT00546052|1835043|FG000|Overall Study|Non Compliance|7
873362|NCT00546078|1835052|FG000|Overall Study|Lost to Follow-up|1
873363|NCT00546078|1835053|FG001|Overall Study|Lost to Follow-up|3
873364|NCT00546078|1835052|FG000|Overall Study|Withdrawal by Subject|2
873365|NCT00546078|1835053|FG001|Overall Study|Withdrawal by Subject|3
873366|NCT00546078|1835052|FG000|Overall Study|Other reason|1
873367|NCT00546078|1835053|FG001|Overall Study|Other reason|1
873368|NCT00546117|1835065|FG000|Overall Study|Withdrawal by Subject|3
873369|NCT00546117|1835066|FG001|Overall Study|Withdrawal by Subject|0
873370|NCT00546117|1835065|FG000|Overall Study|Inability to schedule follow-up visit|1
873371|NCT00546117|1835066|FG001|Overall Study|Inability to schedule follow-up visit|0
873372|NCT00546260|1835084|FG000|Overall Study|Drug not given pre diagnostic angiogr|8
873373|NCT00546260|1835085|FG001|Overall Study|Drug not given pre diagnostic angiogr|2
873374|NCT00546351|1835107|FG000|Overall Study|Adverse Event|76
873375|NCT00546351|1835107|FG000|Overall Study|Lack of Efficacy|15
873376|NCT00546351|1835107|FG000|Overall Study|Withdrawal by Subject|109
873377|NCT00546351|1835107|FG000|Overall Study|Lost to Follow-up|9
873378|NCT00546351|1835107|FG000|Overall Study|Protocol Deviation|1
873379|NCT00546351|1835107|FG000|Overall Study|Unsatisfactory compliance|9
873380|NCT00546351|1835107|FG000|Overall Study|Other reasons for premature termination|17
873381|NCT00546364|1835114|FG000|Overall Study|Disease progression|5
873382|NCT00546364|1835115|FG001|Overall Study|Disease progression|11
873383|NCT00546364|1835116|FG002|Overall Study|Disease progression|8
873384|NCT00546364|1835114|FG000|Overall Study|Completed and off treatment|1
873385|NCT00546364|1835115|FG001|Overall Study|Completed and off treatment|0
873386|NCT00546364|1835116|FG002|Overall Study|Completed and off treatment|2
873387|NCT00546364|1835114|FG000|Overall Study|Administrative reason by sponsor|1
873388|NCT00546364|1835115|FG001|Overall Study|Administrative reason by sponsor|0
873389|NCT00546364|1835116|FG002|Overall Study|Administrative reason by sponsor|0
873390|NCT00546364|1835114|FG000|Overall Study|Poor compliance/noncompliance|0
873391|NCT00546364|1835115|FG001|Overall Study|Poor compliance/noncompliance|0
873392|NCT00546364|1835116|FG002|Overall Study|Poor compliance/noncompliance|1
873393|NCT00546364|1835114|FG000|Overall Study|No longer meets study criteria|1
873394|NCT00546364|1835115|FG001|Overall Study|No longer meets study criteria|1
873395|NCT00546364|1835116|FG002|Overall Study|No longer meets study criteria|0
873396|NCT00546364|1835114|FG000|Overall Study|Withdrawal by Subject|5
873397|NCT00546364|1835115|FG001|Overall Study|Withdrawal by Subject|6
873398|NCT00546364|1835116|FG002|Overall Study|Withdrawal by Subject|3
873399|NCT00546364|1835114|FG000|Overall Study|Prior taxotere|1
873400|NCT00546364|1835115|FG001|Overall Study|Prior taxotere|0
873401|NCT00546364|1835116|FG002|Overall Study|Prior taxotere|0
873402|NCT00546364|1835114|FG000|Overall Study|Mixed response|1
873403|NCT00546364|1835115|FG001|Overall Study|Mixed response|0
873404|NCT00546364|1835116|FG002|Overall Study|Mixed response|0
873405|NCT00546364|1835114|FG000|Overall Study|Palliative treatment|1
1177388|NCT00878969|2328179|FG000|Overall Study|Physician Decision|5
1177389|NCT00878969|2328180|FG001|Overall Study|Physician Decision|3
1177390|NCT00878969|2328181|FG002|Overall Study|Physician Decision|2
1177391|NCT00878969|2328179|FG000|Overall Study|Withdrawal by Subject|1
1177392|NCT00878969|2328180|FG001|Overall Study|Withdrawal by Subject|6
1177393|NCT00878969|2328181|FG002|Overall Study|Withdrawal by Subject|3
1177394|NCT00878969|2328179|FG000|Overall Study|kidney transplant|2
1177395|NCT00878969|2328180|FG001|Overall Study|kidney transplant|3
1177396|NCT00878969|2328181|FG002|Overall Study|kidney transplant|2
1177397|NCT00878969|2328179|FG000|Overall Study|Adverse Event|3
1177398|NCT00878969|2328180|FG001|Overall Study|Adverse Event|1
1177399|NCT00878969|2328181|FG002|Overall Study|Adverse Event|2
1177400|NCT00878969|2328179|FG000|Overall Study|Lost to Follow-up|2
1177401|NCT00878969|2328180|FG001|Overall Study|Lost to Follow-up|1
1177402|NCT00878969|2328181|FG002|Overall Study|Lost to Follow-up|0
1177403|NCT00878969|2328179|FG000|Overall Study|Protocol Violation|2
1177404|NCT00878969|2328180|FG001|Overall Study|Protocol Violation|0
1177405|NCT00878969|2328181|FG002|Overall Study|Protocol Violation|0
1177406|NCT00878969|2328179|FG000|Overall Study|Death|0
1177407|NCT00878969|2328180|FG001|Overall Study|Death|0
1177408|NCT00878969|2328181|FG002|Overall Study|Death|2
1177409|NCT00878969|2328179|FG000|Overall Study|Pregnancy|0
1177410|NCT00878969|2328180|FG001|Overall Study|Pregnancy|1
1177411|NCT00878969|2328181|FG002|Overall Study|Pregnancy|0
1177412|NCT00865514|2328189|FG000|Overall Study|Infusion cost exceeded funding|2
1177413|NCT00863512|2328206|FG000|Overall Study|Adverse Event|2
1177414|NCT00863512|2328207|FG001|Overall Study|Adverse Event|0
1177415|NCT00863512|2328206|FG000|Overall Study|Withdrawal by Subject|11
1177416|NCT00863512|2328207|FG001|Overall Study|Withdrawal by Subject|0
1177417|NCT00863512|2328206|FG000|Overall Study|Physician Decision|1
1177418|NCT00863512|2328207|FG001|Overall Study|Physician Decision|0
1177419|NCT00868998|2328213|FG000|Overall Study|Screen Failure|1
1177420|NCT00868998|2328213|FG000|Overall Study|Withdrawal by Subject|1
1177421|NCT00868998|2328213|FG000|Overall Study|Progression of disease|2
1177422|NCT00868998|2328213|FG000|Overall Study|Death|1
1177423|NCT00869258|2328217|FG000|Overall Study|Physician Decision|1
1177424|NCT00863330|2328221|FG000|Overall Study|study terminated early due to administra|6
1177425|NCT00853229|2328227|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
1177426|NCT00853229|2328228|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
1177427|NCT00860249|2328239|FG000|Overall Study|trial was terminated prior to completion|21
1177428|NCT00860249|2328240|FG001|Overall Study|trial was terminated prior to completion|18
1177429|NCT00860249|2328241|FG002|Overall Study|trial was terminated prior to completion|21
1177430|NCT00860158|2328249|FG000|Overall Study|Study Terminated|1
1177431|NCT00853567|2328256|FG000|Overall Study|Study prematurely terminated|71
1177432|NCT00849524|2328264|FG000|Overall Study|Lack of Efficacy|3
1177433|NCT00851682|2328279|FG000|Overall Study|screen failure|5
1177434|NCT00851682|2328280|FG001|Overall Study|screen failure|0
1177435|NCT00851747|2328302|FG000|Overall Study|Physician Decision|6
1177436|NCT00851747|2328303|FG001|Overall Study|Physician Decision|6
1177437|NCT00851747|2328304|FG002|Overall Study|Physician Decision|6
1177438|NCT00852241|2328311|FG000|Overall Study|Physician Decision|18
1177439|NCT00851552|2328315|FG000|Overall Study|Death|2
1177440|NCT00851552|2328315|FG000|Overall Study|Adverse Event|1
1177441|NCT00851552|2328315|FG000|Overall Study|Disease Progression|4
1177442|NCT00845845|2328325|FG000|Overall Study|Lost to Follow-up|0
1177443|NCT00845845|2328326|FG001|Overall Study|Lost to Follow-up|4
1177444|NCT00851591|2328334|FG000|Overall Study|Withdrawal by Subject|2
1177445|NCT00851591|2328335|FG001|Overall Study|Withdrawal by Subject|0
1177446|NCT00835679|2328372|FG000|Overall Study|Withdrawal by Subject|1
1177447|NCT00835679|2328373|FG001|Overall Study|Withdrawal by Subject|0
1177448|NCT00835679|2328374|FG002|Overall Study|Withdrawal by Subject|0
1177449|NCT00835679|2328375|FG003|Overall Study|Withdrawal by Subject|0
1177450|NCT00841035|2328389|FG000|Phase 1 Overall Study|Physician Decision|13
1177451|NCT00840827|2328407|FG000|Overall Study|Adverse Event|1
1177452|NCT00840827|2328407|FG000|Overall Study|Lack of Efficacy|4
1177453|NCT00840827|2328407|FG000|Overall Study|Physician Decision|1
1177454|NCT00832624|2328441|FG000|Overall Study|Study Terminated|10
1177455|NCT00827567|2328484|FG000|Overall Study|Progression of Disease/Screen Failure|4
873406|NCT00546364|1835115|FG001|Overall Study|Palliative treatment|0
873407|NCT00546364|1835116|FG002|Overall Study|Palliative treatment|1
873408|NCT00546364|1835114|FG000|Overall Study|Target lesions resected|1
873409|NCT00546364|1835115|FG001|Overall Study|Target lesions resected|0
873410|NCT00546364|1835116|FG002|Overall Study|Target lesions resected|0
873411|NCT00546364|1835114|FG000|Overall Study|Physician Decision|0
873412|NCT00546364|1835115|FG001|Overall Study|Physician Decision|0
873413|NCT00546364|1835116|FG002|Overall Study|Physician Decision|1
873414|NCT00546364|1835114|FG000|Overall Study|Sponsor decision|0
873415|NCT00546364|1835115|FG001|Overall Study|Sponsor decision|0
873416|NCT00546364|1835116|FG002|Overall Study|Sponsor decision|1
1177456|NCT00815633|2328488|FG000|Overall Study|study terminated|1
1177457|NCT00814983|2328494|FG000|Overall Study|Screen failure|1
1177458|NCT00814983|2328495|FG001|Overall Study|Screen failure|0
1177459|NCT00814983|2328494|FG000|Overall Study|Withdrawal by Subject|1
1177460|NCT00814983|2328495|FG001|Overall Study|Withdrawal by Subject|0
1177461|NCT00814983|2328494|FG000|Overall Study|Graft failure|1
1177462|NCT00814983|2328495|FG001|Overall Study|Graft failure|0
1177463|NCT00819832|2328518|FG000|Overall Study|Sponsor Termination of Study|3
1177464|NCT00819832|2328519|FG001|Overall Study|Sponsor Termination of Study|0
1177465|NCT00819832|2328520|FG002|Overall Study|Sponsor Termination of Study|0
1177466|NCT00819832|2328521|FG003|Overall Study|Sponsor Termination of Study|0
1177467|NCT00819832|2328522|FG004|Overall Study|Sponsor Termination of Study|0
1177468|NCT00819832|2328523|FG005|Overall Study|Sponsor Termination of Study|0
1177469|NCT00814892|2328546|FG000|Overall Study|Disease Progression|1
1177470|NCT00814892|2328546|FG000|Overall Study|Study Termination|1
1177471|NCT00802659|2328563|FG000|Overall Study|Physician Decision|0
1177472|NCT00802659|2328564|FG001|Overall Study|Physician Decision|1
1177473|NCT00802659|2328565|FG002|Overall Study|Physician Decision|0
1177474|NCT00802659|2328566|FG003|Overall Study|Physician Decision|0
873417|NCT00546377|1835124|FG000|Overall Study|Deemed ineligible|1
873418|NCT00546377|1835124|FG000|Overall Study|Adverse Event|6
873419|NCT00546481|1835144|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
873420|NCT00546481|1835145|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
873421|NCT00546481|1835146|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
873422|NCT00546481|1835144|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
873423|NCT00546481|1835145|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
873424|NCT00546481|1835146|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
873425|NCT00546481|1835144|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
873426|NCT00546481|1835145|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
873427|NCT00546481|1835146|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
873428|NCT00546481|1835144|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
873429|NCT00546481|1835145|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
873430|NCT00546481|1835146|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
873431|NCT00546481|1835144|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
873432|NCT00546481|1835145|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
873433|NCT00546481|1835146|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
873434|NCT00546481|1835144|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
873435|NCT00546481|1835145|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
873436|NCT00546481|1835146|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
873437|NCT00546481|1835144|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0
873438|NCT00546481|1835145|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0
873439|NCT00546481|1835146|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2
873440|NCT00546481|1835144|FG000|Maintenance Phase (CERA)|Kidney transplantation|0
873441|NCT00546481|1835145|FG001|Maintenance Phase (CERA)|Kidney transplantation|0
873442|NCT00546481|1835146|FG002|Maintenance Phase (CERA)|Kidney transplantation|1
873443|NCT00546481|1835144|FG000|Maintenance Phase (CERA)|Other Reason|0
873444|NCT00546481|1835145|FG001|Maintenance Phase (CERA)|Other Reason|0
873445|NCT00546481|1835146|FG002|Maintenance Phase (CERA)|Other Reason|1
873446|NCT00546572|1835156|FG000|Vax 1 / Year 0|Randomized, not treated|1
873447|NCT00546572|1835157|FG001|Vax 1 / Year 0|Randomized, not treated|1
873448|NCT00546572|1835156|FG000|Vax 1 / Year 0|Withdrawal by Subject|3
873449|NCT00546572|1835157|FG001|Vax 1 / Year 0|Withdrawal by Subject|2
873450|NCT00546572|1835156|FG000|Vax 1 / Year 0|Protocol Violation|3
873451|NCT00546572|1835157|FG001|Vax 1 / Year 0|Protocol Violation|4
873452|NCT00546572|1835156|FG000|Vax 1 / Year 0|Death|2
873453|NCT00546572|1835157|FG001|Vax 1 / Year 0|Death|2
873454|NCT00546572|1835156|FG000|Vax 1 / Year 0|Adverse Event|0
873455|NCT00546572|1835157|FG001|Vax 1 / Year 0|Adverse Event|1
873456|NCT00546572|1835156|FG000|Vax 1 / Year 0|Lost to Follow-up|0
873457|NCT00546572|1835157|FG001|Vax 1 / Year 0|Lost to Follow-up|1
873458|NCT00546572|1835156|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
873459|NCT00546572|1835157|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
873460|NCT00546572|1835156|FG000|Vax 2 / Year 1|Other|1
873461|NCT00546572|1835157|FG001|Vax 2 / Year 1|Other|1
873462|NCT00546572|1835156|FG000|Vax 2 / Year 1|Adverse Event|1
873463|NCT00546572|1835157|FG001|Vax 2 / Year 1|Adverse Event|0
873464|NCT00546572|1835156|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
873465|NCT00546572|1835157|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
873466|NCT00546637|1835176|FG000|Overall Study|Adverse Event|46
873467|NCT00546637|1835177|FG001|Overall Study|Adverse Event|20
873468|NCT00546637|1835176|FG000|Overall Study|Lack of Efficacy|5
873469|NCT00546637|1835177|FG001|Overall Study|Lack of Efficacy|5
873470|NCT00546637|1835176|FG000|Overall Study|Lost to Follow-up|2
873471|NCT00546637|1835177|FG001|Overall Study|Lost to Follow-up|2
873472|NCT00546637|1835176|FG000|Overall Study|Other|10
873473|NCT00546637|1835177|FG001|Overall Study|Other|12
873474|NCT00546637|1835176|FG000|Overall Study|Withdrawal by Subject|7
873475|NCT00546637|1835177|FG001|Overall Study|Withdrawal by Subject|9
873476|NCT00546637|1835176|FG000|Overall Study|Randomized, but not treated|3
873477|NCT00546637|1835177|FG001|Overall Study|Randomized, but not treated|1
873478|NCT00546715|1835187|FG000|Overall Study|Withdrawal by Subject|0
873479|NCT00546715|1835188|FG001|Overall Study|Withdrawal by Subject|1
873480|NCT00546715|1835189|FG002|Overall Study|Withdrawal by Subject|0
873481|NCT00546715|1835190|FG003|Overall Study|Withdrawal by Subject|0
873482|NCT00546754|1835211|FG000|Overall Study|Serious Adverse Event|1
1177475|NCT00807365|2328576|FG000|Overall Study|Study Terminated|5
1177476|NCT00814333|2328582|FG000|Enrollment|Lost to Follow-up|1
1177477|NCT00814333|2328583|FG001|Enrollment|Lost to Follow-up|0
1177478|NCT00808080|2328589|FG000|Overall Study|Patients Became Ineligible for infusion|6
1177479|NCT00802893|2328594|FG000|Overall Study|study terminated|3
1177480|NCT00809341|2328600|FG000|Overall Study|Physician Decision|0
1177481|NCT00809341|2328601|FG001|Overall Study|Physician Decision|1
1177482|NCT00808899|2328629|FG000|Overall Study|Death|1
1177483|NCT00808899|2328629|FG000|Overall Study|Physician Decision|3
1177484|NCT00803179|2328640|FG000|Overall Study|Lost to Follow-up|3
1177485|NCT00790452|2328688|FG000|Overall Study|Drug supply issue|1
1177486|NCT00790452|2328689|FG001|Overall Study|Drug supply issue|0
1177487|NCT00787917|2328701|FG000|Blinded Treatment|Adverse Event|1
1177488|NCT00787917|2328702|FG001|Blinded Treatment|Adverse Event|0
1177489|NCT00787917|2328701|FG000|Blinded Treatment|Lack of Efficacy|1
1177490|NCT00787917|2328702|FG001|Blinded Treatment|Lack of Efficacy|0
1177491|NCT00787917|2328701|FG000|Blinded Treatment|Administrative problems|3
1177492|NCT00787917|2328702|FG001|Blinded Treatment|Administrative problems|2
1177493|NCT00787917|2328701|FG000|Open Label|Unsatisfactory therapeutic effect|1
1177494|NCT00787917|2328702|FG001|Open Label|Unsatisfactory therapeutic effect|0
1177495|NCT00787917|2328701|FG000|Open Label|Administrative problems|3
1177496|NCT00787917|2328702|FG001|Open Label|Administrative problems|0
1177497|NCT00798590|2328712|FG000|Overall Study|P.I, Left institution. Study terminated|11
1177498|NCT00798590|2328713|FG001|Overall Study|P.I, Left institution. Study terminated|8
1177499|NCT00796510|2328721|FG000|Overall Study|Death|1
1177500|NCT00796510|2328722|FG001|Overall Study|Death|0
1177501|NCT00796510|2328721|FG000|Overall Study|Study Terminated|2
1177502|NCT00796510|2328722|FG001|Overall Study|Study Terminated|0
1177503|NCT00796861|2328728|FG000|Overall Study|Withdrawal by Subject|2
1177504|NCT00796861|2328728|FG000|Overall Study|Death|2
1177505|NCT00791076|2328732|FG000|Overall Study|Study was terminated,PI left institution|8
1177506|NCT00796107|2328747|FG000|Overall Study|Lack of Efficacy|1
1177507|NCT00796107|2328747|FG000|Overall Study|Progressive Disease|5
1177508|NCT00785356|2328771|FG000|Overall Study|Study prematurely terminated|8
1177509|NCT00782483|2328779|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6
1177510|NCT00784043|2328789|FG000|Overall Study|Withdrawal by Subject|8
1177511|NCT00784043|2328790|FG001|Overall Study|Withdrawal by Subject|5
1177512|NCT00784043|2328789|FG000|Overall Study|Protocol Terminated|23
1177513|NCT00784043|2328790|FG001|Overall Study|Protocol Terminated|1
1177514|NCT00774306|2328813|FG000|Overall Study|Adverse Event|3
1177515|NCT00774306|2328814|FG001|Overall Study|Adverse Event|0
1177516|NCT00774306|2328815|FG002|Overall Study|Adverse Event|0
1177517|NCT00774306|2328816|FG003|Overall Study|Adverse Event|0
1177518|NCT00774306|2328813|FG000|Overall Study|Protocol Violation|2
1177519|NCT00774306|2328814|FG001|Overall Study|Protocol Violation|0
1177520|NCT00774306|2328815|FG002|Overall Study|Protocol Violation|3
1177521|NCT00774306|2328816|FG003|Overall Study|Protocol Violation|0
1177522|NCT00774306|2328813|FG000|Overall Study|Withdrawal by Subject|6
1177523|NCT00774306|2328814|FG001|Overall Study|Withdrawal by Subject|1
1177524|NCT00774306|2328815|FG002|Overall Study|Withdrawal by Subject|1
1177525|NCT00774306|2328816|FG003|Overall Study|Withdrawal by Subject|0
1177526|NCT00774306|2328813|FG000|Overall Study|Lost to Follow-up|6
1177527|NCT00774306|2328814|FG001|Overall Study|Lost to Follow-up|0
1177528|NCT00774306|2328815|FG002|Overall Study|Lost to Follow-up|4
1177529|NCT00774306|2328816|FG003|Overall Study|Lost to Follow-up|5
1177530|NCT00774306|2328813|FG000|Overall Study|Death|1
1177531|NCT00774306|2328814|FG001|Overall Study|Death|1
1177532|NCT00774306|2328815|FG002|Overall Study|Death|0
1177533|NCT00774306|2328816|FG003|Overall Study|Death|0
1177534|NCT00779038|2328839|FG000|Overall Study|Study Prematurely Terminated|13
1177535|NCT00776100|2328854|FG000|Overall Study|Disease Progression|1
1177536|NCT00776100|2328855|FG001|Overall Study|Disease Progression|0
1177537|NCT00771316|2328863|FG000|Overall Study|Adverse Event|0
1177538|NCT00771316|2328864|FG001|Overall Study|Adverse Event|1
1177539|NCT00771316|2328863|FG000|Overall Study|Patient withdrew consent|1
1177540|NCT00771316|2328864|FG001|Overall Study|Patient withdrew consent|0
1177541|NCT00771316|2328863|FG000|Overall Study|Discontinued due to early termination|1
1177542|NCT00771316|2328864|FG001|Overall Study|Discontinued due to early termination|0
1177543|NCT00768040|2328885|FG000|Overall Study|Adverse Event|3
1177544|NCT00768040|2328886|FG001|Overall Study|Adverse Event|2
1177545|NCT00768040|2328885|FG000|Overall Study|Abnormal laboratory value|1
1177546|NCT00768040|2328886|FG001|Overall Study|Abnormal laboratory value|1
1177547|NCT00776555|2328894|FG000|Overall Study|Study terminated|3
1177548|NCT00776555|2328895|FG001|Overall Study|Study terminated|0
1177549|NCT00775190|2328903|FG000|Overall Study|Lost to Follow-up|2
1177550|NCT00775190|2328904|FG001|Overall Study|Lost to Follow-up|3
1177551|NCT00775190|2328903|FG000|Overall Study|Withdrawal by Subject|1
1177552|NCT00775190|2328904|FG001|Overall Study|Withdrawal by Subject|2
1177553|NCT00775190|2328903|FG000|Overall Study|Protocol Violation|1
1177554|NCT00775190|2328904|FG001|Overall Study|Protocol Violation|0
1177555|NCT00762723|2328917|FG000|Overall Study|Study Terminated slow enrollement|5
1177556|NCT00762723|2328918|FG001|Overall Study|Study Terminated slow enrollement|5
1177557|NCT00762723|2328919|FG002|Overall Study|Study Terminated slow enrollement|3
1177558|NCT00770965|2328931|FG000|Safety Set|Withdrawal by Subject|0
1177559|NCT00770965|2328932|FG001|Safety Set|Withdrawal by Subject|0
1177560|NCT00770965|2328933|FG002|Safety Set|Withdrawal by Subject|0
1177561|NCT00770965|2328934|FG003|Safety Set|Withdrawal by Subject|1
1177562|NCT00770965|2328931|FG000|Safety Set|Protocol deviation|0
1177563|NCT00770965|2328932|FG001|Safety Set|Protocol deviation|0
1177564|NCT00770965|2328933|FG002|Safety Set|Protocol deviation|1
1177565|NCT00770965|2328934|FG003|Safety Set|Protocol deviation|0
1177566|NCT00770965|2328931|FG000|Excluded Set|Administrative problems|14
1177567|NCT00770965|2328932|FG001|Excluded Set|Administrative problems|12
1177568|NCT00770965|2328933|FG002|Excluded Set|Administrative problems|12
1177569|NCT00770965|2328934|FG003|Excluded Set|Administrative problems|10
1177570|NCT00770965|2328931|FG000|Excluded Set|Withdrawal by Subject|1
1177571|NCT00770965|2328932|FG001|Excluded Set|Withdrawal by Subject|1
1177572|NCT00770965|2328933|FG002|Excluded Set|Withdrawal by Subject|2
1177573|NCT00770965|2328934|FG003|Excluded Set|Withdrawal by Subject|3
1177574|NCT00769002|2328948|FG000|Overall Study|Study was not completed, no data|9
1177575|NCT00769002|2328949|FG001|Overall Study|Study was not completed, no data|9
1177576|NCT00766636|2328956|FG000|Overall Study|Withdrawal by Subject|1
1177577|NCT00766636|2328957|FG001|Overall Study|Withdrawal by Subject|1
1177578|NCT00766636|2328956|FG000|Overall Study|Incomplete Treatment|0
1177579|NCT00766636|2328957|FG001|Overall Study|Incomplete Treatment|1
1177580|NCT00766636|2328956|FG000|Overall Study|Adverse Event|1
873483|NCT00546754|1835212|FG001|Overall Study|Serious Adverse Event|1
873484|NCT00546754|1835211|FG000|Overall Study|Adverse Event|11
873485|NCT00546754|1835212|FG001|Overall Study|Adverse Event|16
873486|NCT00546754|1835211|FG000|Overall Study|Lack of Efficacy|1
873487|NCT00546754|1835212|FG001|Overall Study|Lack of Efficacy|1
873488|NCT00546754|1835211|FG000|Overall Study|Lost to Follow-up|9
873489|NCT00546754|1835212|FG001|Overall Study|Lost to Follow-up|15
873490|NCT00546754|1835211|FG000|Overall Study|Protocol Violation|3
873491|NCT00546754|1835212|FG001|Overall Study|Protocol Violation|0
873492|NCT00546754|1835211|FG000|Overall Study|Withdrawal by Subject|6
873493|NCT00546754|1835212|FG001|Overall Study|Withdrawal by Subject|7
873494|NCT00546754|1835211|FG000|Overall Study|Dyspnea|1
873495|NCT00546754|1835212|FG001|Overall Study|Dyspnea|0
873496|NCT00546754|1835211|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
873497|NCT00546754|1835212|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
873498|NCT00546754|1835211|FG000|Overall Study|Hip Replacement|1
873499|NCT00546754|1835212|FG001|Overall Study|Hip Replacement|0
873500|NCT00546754|1835211|FG000|Overall Study|Suicide|1
873501|NCT00546754|1835212|FG001|Overall Study|Suicide|0
873502|NCT00546754|1835211|FG000|Overall Study|Missing Cooperation|1
873503|NCT00546754|1835212|FG001|Overall Study|Missing Cooperation|0
873504|NCT00546754|1835211|FG000|Overall Study|Elevated Creatinine and Potassium levels|0
873505|NCT00546754|1835212|FG001|Overall Study|Elevated Creatinine and Potassium levels|1
873506|NCT00546754|1835211|FG000|Overall Study|Patient's Decision|0
873507|NCT00546754|1835212|FG001|Overall Study|Patient's Decision|1
873508|NCT00546754|1835211|FG000|Overall Study|Missing|14
873509|NCT00546754|1835212|FG001|Overall Study|Missing|7
873510|NCT00546819|1835220|FG000|Overall Study|Adverse Event|2
873511|NCT00546819|1835221|FG001|Overall Study|Adverse Event|3
873512|NCT00546819|1835220|FG000|Overall Study|Lost to Follow-up|2
873513|NCT00546819|1835221|FG001|Overall Study|Lost to Follow-up|1
873514|NCT00546819|1835220|FG000|Overall Study|Withdrawal by Subject|4
873515|NCT00546819|1835221|FG001|Overall Study|Withdrawal by Subject|2
873516|NCT00546871|1835227|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
873517|NCT00546871|1835228|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
873518|NCT00546871|1835227|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
873519|NCT00546871|1835228|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
873520|NCT00546871|1835227|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
873521|NCT00546871|1835228|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
873522|NCT00546871|1835227|FG000|Study Extension Period|Protocol Violation|1
873523|NCT00546871|1835228|FG001|Study Extension Period|Protocol Violation|0
873524|NCT00546871|1835227|FG000|Study Extension Period|Withdrawal by Subject|0
873525|NCT00546871|1835228|FG001|Study Extension Period|Withdrawal by Subject|1
873526|NCT00546910|1835277|FG000|Overall Study|Adverse Event|2
873527|NCT00546910|1835278|FG001|Overall Study|Adverse Event|3
873528|NCT00546910|1835277|FG000|Overall Study|Lack of Efficacy|5
873529|NCT00546910|1835278|FG001|Overall Study|Lack of Efficacy|7
873530|NCT00546910|1835277|FG000|Overall Study|Physician Decision|0
873531|NCT00546910|1835278|FG001|Overall Study|Physician Decision|1
873532|NCT00546910|1835277|FG000|Overall Study|Withdrawal by Subject|2
873533|NCT00546910|1835278|FG001|Overall Study|Withdrawal by Subject|0
873534|NCT00547118|1835290|FG000|Overall Study|Did not qualify prior to starting drug|1
873535|NCT00547118|1835291|FG001|Overall Study|Did not qualify prior to starting drug|1
873536|NCT00547118|1835290|FG000|Overall Study|Study suspended|7
873537|NCT00547118|1835291|FG001|Overall Study|Study suspended|8
873538|NCT00547157|1835301|FG000|Overall Study|Other|1
873539|NCT00547157|1835302|FG001|Overall Study|Other|0
873540|NCT00547157|1835301|FG000|Overall Study|Death|38
873541|NCT00547157|1835302|FG001|Overall Study|Death|18
1177581|NCT00766636|2328957|FG001|Overall Study|Adverse Event|0
1177582|NCT00766636|2328956|FG000|Overall Study|Disease Progression|1
1177583|NCT00766636|2328957|FG001|Overall Study|Disease Progression|0
1177584|NCT00768248|2328965|FG000|Overall Study|Research coordinator didn't collect data|1
873542|NCT00547157|1835301|FG000|Overall Study|Withdrawal by Subject|3
873543|NCT00547157|1835302|FG001|Overall Study|Withdrawal by Subject|1
873544|NCT00547157|1835301|FG000|Overall Study|Administrative decision|3
873545|NCT00547157|1835302|FG001|Overall Study|Administrative decision|2
873546|NCT00547157|1835301|FG000|Overall Study|Lost to Follow-up|4
873547|NCT00547157|1835302|FG001|Overall Study|Lost to Follow-up|2
873548|NCT00547248|1835312|FG000|Overall Study|Protocol Violation|0
873549|NCT00547248|1835313|FG001|Overall Study|Protocol Violation|0
873550|NCT00547248|1835314|FG002|Overall Study|Protocol Violation|1
1177585|NCT00768248|2328966|FG001|Overall Study|Research coordinator didn't collect data|1
1177586|NCT00764699|2328976|FG000|Overall Study|PI left and study terminated|3
1177587|NCT00763009|2328984|FG000|Overall Study|Coronary Anatomy unsuitable|1
1177588|NCT00761176|2328991|FG000|Overall Study|Death|1
1177589|NCT00761176|2328992|FG001|Overall Study|Death|0
1177590|NCT00761176|2328991|FG000|Overall Study|Withdrawal by Subject|1
1177591|NCT00761176|2328992|FG001|Overall Study|Withdrawal by Subject|1
1177592|NCT00754793|2329017|FG000|Overall Study|voluntary withdrawn from study|0
1177593|NCT00754793|2329018|FG001|Overall Study|voluntary withdrawn from study|1
1177594|NCT00754052|2329026|FG000|Overall Study|Study terminated by Sponsor|5
1177595|NCT00754052|2329027|FG001|Overall Study|Study terminated by Sponsor|3
1177596|NCT00750204|2329049|FG000|Overall Study|study halted prematurely|1
1177597|NCT00750204|2329050|FG001|Overall Study|study halted prematurely|1
1177598|NCT00752986|2329072|FG000|Overall Study|Withdrawal by Subject|2
1177599|NCT00752986|2329073|FG001|Overall Study|Withdrawal by Subject|1
1177600|NCT00752986|2329074|FG002|Overall Study|Withdrawal by Subject|2
1177601|NCT00752986|2329072|FG000|Overall Study|Protocol Violation|3
1177602|NCT00752986|2329073|FG001|Overall Study|Protocol Violation|0
1177603|NCT00752986|2329074|FG002|Overall Study|Protocol Violation|0
1177604|NCT00754013|2329097|FG000|Overall Study|Lost to Follow-up|1
1177605|NCT00754013|2329098|FG001|Overall Study|Lost to Follow-up|1
1177606|NCT00754013|2329097|FG000|Overall Study|didn't return after study termed|3
1177607|NCT00754013|2329098|FG001|Overall Study|didn't return after study termed|4
1177608|NCT00735553|2329107|FG000|Overall Study|Study prematurely terminated|77
1177609|NCT00751933|2329115|FG000|Overall Study|Withdrawal by Subject|0
1177610|NCT00751933|2329116|FG001|Overall Study|Withdrawal by Subject|1
1177611|NCT00751933|2329117|FG002|Overall Study|Withdrawal by Subject|0
1177612|NCT00751933|2329118|FG003|Overall Study|Withdrawal by Subject|0
1177613|NCT00751933|2329115|FG000|Overall Study|Physician Decision|0
1177614|NCT00751933|2329116|FG001|Overall Study|Physician Decision|0
1177615|NCT00751933|2329117|FG002|Overall Study|Physician Decision|1
1177616|NCT00751933|2329118|FG003|Overall Study|Physician Decision|1
1177617|NCT00747461|2329135|FG000|Overall Study|study terminated by sponsor|5
1177618|NCT00736385|2329157|FG000|Overall Study|Withdrawal by Subject|2
1177619|NCT00736385|2329158|FG001|Overall Study|Withdrawal by Subject|2
1177620|NCT00736385|2329157|FG000|Overall Study|Adverse Event|0
1177621|NCT00736385|2329158|FG001|Overall Study|Adverse Event|1
1177622|NCT00743197|2329183|FG000|Overall Study|Study terminated due to departure of PI.|1
1177623|NCT00743197|2329184|FG001|Overall Study|Study terminated due to departure of PI.|2
1177624|NCT00739063|2329190|FG000|Overall Study|Screen failures|8
1177625|NCT00740597|2329194|FG000|Overall Study|insurance would not cover treatment|1
1177626|NCT00737282|2329213|FG000|Overall Study|Study prematurely terminated|175
1177627|NCT00739882|2329221|FG000|Double-blind Period|Adverse Event|1
1177628|NCT00739882|2329222|FG001|Double-blind Period|Adverse Event|2
1177629|NCT00739882|2329221|FG000|Double-blind Period|Protocol Violation|1
1177630|NCT00739882|2329222|FG001|Double-blind Period|Protocol Violation|0
1177631|NCT00739882|2329221|FG000|Double-blind Period|Lack of Efficacy|1
1177632|NCT00739882|2329222|FG001|Double-blind Period|Lack of Efficacy|1
1177633|NCT00739882|2329221|FG000|Double-blind Period|Other|16
1177634|NCT00739882|2329222|FG001|Double-blind Period|Other|8
1177635|NCT00739882|2329221|FG000|Open-label Period|Adverse Event|1
1177636|NCT00739882|2329222|FG001|Open-label Period|Adverse Event|0
1177637|NCT00739882|2329221|FG000|Open-label Period|Other|9
1177638|NCT00739882|2329222|FG001|Open-label Period|Other|5
1177639|NCT00735254|2329254|FG000|Overall Study|Protocol Violation|1
1177640|NCT00735254|2329255|FG001|Overall Study|Protocol Violation|1
1177641|NCT00735254|2329256|FG002|Overall Study|Protocol Violation|1
1177642|NCT00735254|2329257|FG003|Overall Study|Protocol Violation|0
1177643|NCT00729365|2329270|FG000|Overall Study|Physician Decision|33
1177644|NCT00729365|2329271|FG001|Overall Study|Physician Decision|6
1177645|NCT00729365|2329272|FG002|Overall Study|Physician Decision|7
1177646|NCT00724282|2329290|FG000|Overall Study|Withdrawal by Subject|3
1177647|NCT00724282|2329290|FG000|Overall Study|Physician Decision|1
1177648|NCT00730886|2329296|FG000|Overall Study|Lost to Follow-up|1
1177649|NCT00730886|2329297|FG001|Overall Study|Lost to Follow-up|0
1177650|NCT00730886|2329296|FG000|Overall Study|Physician Decision|1
1177651|NCT00730886|2329297|FG001|Overall Study|Physician Decision|0
1177652|NCT00729560|2329325|FG000|Overall Study|Withdrawal by Subject|3
1177653|NCT00714948|2329346|FG000|Overall Study|Adverse Event|2
1177654|NCT00720343|2329350|FG000|Overall Study|Physician Decision|3
1177655|NCT00720343|2329350|FG000|Overall Study|No data|3
1177656|NCT00718640|2329365|FG000|Overall Study|Adverse Event|4
1177657|NCT00718640|2329365|FG000|Overall Study|Death|1
1177658|NCT00718640|2329365|FG000|Overall Study|Unresolved toxicity after 2 weeks|2
1177659|NCT00720083|2329371|FG000|Overall Study|Ineligible|1
1177660|NCT00720083|2329372|FG001|Overall Study|Ineligible|2
1177661|NCT00717275|2329378|FG000|Overall Study|Premature study termination.|3
1177662|NCT00708734|2329382|FG000|Overall Study|scheduling conflict|2
1177663|NCT00708734|2329382|FG000|Overall Study|moved|1
1177664|NCT00708734|2329382|FG000|Overall Study|leg injury|1
1177665|NCT00708734|2329382|FG000|Overall Study|knee replacement|1
1177666|NCT00708734|2329382|FG000|Overall Study|vertigo|1
1177667|NCT00708734|2329382|FG000|Overall Study|leg fracture|1
1177668|NCT00711087|2329388|FG000|Overall Study|Lost to Follow-up|1
1177669|NCT00711087|2329389|FG001|Overall Study|Lost to Follow-up|0
1177670|NCT00706797|2329397|FG000|Overall Study|Lack of Efficacy|3
1177671|NCT00706797|2329398|FG001|Overall Study|Lack of Efficacy|0
1177672|NCT00706797|2329397|FG000|Overall Study|Adverse Event|0
1177673|NCT00706797|2329398|FG001|Overall Study|Adverse Event|3
1177674|NCT00706797|2329397|FG000|Overall Study|Withdrawal by Subject|8
1177675|NCT00706797|2329398|FG001|Overall Study|Withdrawal by Subject|1
1177676|NCT00706797|2329397|FG000|Overall Study|Death|1
1177677|NCT00706797|2329398|FG001|Overall Study|Death|0
1177678|NCT00706797|2329397|FG000|Overall Study|Discontinuation of study by sponsor|52
1177679|NCT00706797|2329398|FG001|Overall Study|Discontinuation of study by sponsor|63
1177680|NCT00706797|2329397|FG000|Overall Study|Protocol Violation|3
1177681|NCT00706797|2329398|FG001|Overall Study|Protocol Violation|2
1177682|NCT00706797|2329397|FG000|Overall Study|Lost to Follow-up|1
1177683|NCT00706797|2329398|FG001|Overall Study|Lost to Follow-up|2
1177684|NCT00706797|2329397|FG000|Overall Study|Other|1
1177685|NCT00706797|2329398|FG001|Overall Study|Other|0
1177686|NCT00713596|2329407|FG000|Overall Study|Study was terminated|2
1177687|NCT00713596|2329408|FG001|Overall Study|Study was terminated|3
1177688|NCT00713596|2329409|FG002|Overall Study|Study was terminated|2
1177689|NCT00703092|2329422|FG000|Overall Study|Withdrawal by Subject|2
1177690|NCT00713258|2329428|FG000|Overall Study|Adverse Event|2
1177691|NCT00713258|2329429|FG001|Overall Study|Adverse Event|4
1177692|NCT00713258|2329428|FG000|Overall Study|Non-Compliance|2
1177693|NCT00713258|2329429|FG001|Overall Study|Non-Compliance|1
1177694|NCT00713258|2329428|FG000|Overall Study|Other|1
1177695|NCT00713258|2329429|FG001|Overall Study|Other|1
1177696|NCT00707434|2329439|FG000|Overall Study|Adverse Event|1
1177697|NCT00707161|2329443|FG000|Overall Study|Physician Decision|6
1177698|NCT00708916|2329456|FG000|Overall Study|Subject Noncompliance|2
1177699|NCT00708916|2329456|FG000|Overall Study|Adverse Event|2
1177700|NCT00700778|2329461|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2
1177701|NCT00699842|2329468|FG000|Overall Study|Death|0
1177702|NCT00699842|2329469|FG001|Overall Study|Death|1
1177703|NCT00699842|2329470|FG002|Overall Study|Death|0
1177704|NCT00702962|2329480|FG000|Overall Study|Progressive disease|0
1177705|NCT00702962|2329481|FG001|Overall Study|Progressive disease|1
1177706|NCT00702962|2329480|FG000|Overall Study|Hospitalized for other health disorder|1
1177707|NCT00702962|2329481|FG001|Overall Study|Hospitalized for other health disorder|0
1177708|NCT00703534|2329491|FG000|Overall Study|Adverse Event|14
1177709|NCT00703534|2329492|FG001|Overall Study|Adverse Event|3
1177710|NCT00703534|2329491|FG000|Overall Study|Withdrawal by Subject|8
1177711|NCT00703534|2329492|FG001|Overall Study|Withdrawal by Subject|7
1177712|NCT00703534|2329491|FG000|Overall Study|Incorrect Enrollment|6
1177713|NCT00703534|2329492|FG001|Overall Study|Incorrect Enrollment|6
1177714|NCT00703534|2329491|FG000|Overall Study|Lost to Follow-up|1
1177715|NCT00703534|2329492|FG001|Overall Study|Lost to Follow-up|4
1177716|NCT00703534|2329491|FG000|Overall Study|Severe Non Compliance|1
1177717|NCT00703534|2329492|FG001|Overall Study|Severe Non Compliance|5
1177718|NCT00698009|2329498|FG000|Overall Study|Withdrawal by Subject|1
1177719|NCT00702702|2329522|FG000|Overall Study|Study prematurely terminated|56
1177720|NCT00699413|2329541|FG000|Overall Study|Withdrawal by Subject|0
1177721|NCT00699413|2329542|FG001|Overall Study|Withdrawal by Subject|2
1177722|NCT00699413|2329541|FG000|Overall Study|Study terminated by sponsor|4
1177723|NCT00699413|2329542|FG001|Overall Study|Study terminated by sponsor|2
1177724|NCT00686972|2329552|FG000|Overall Study|P.I, Left institution. Study terminated|51
1177725|NCT00693017|2329558|FG000|Overall Study|Sponsor Decision|2
1177726|NCT00693017|2329559|FG001|Overall Study|Sponsor Decision|1
1177727|NCT00693017|2329558|FG000|Overall Study|Death|0
1177728|NCT00693017|2329559|FG001|Overall Study|Death|1
1177729|NCT00692003|2329598|FG000|Overall Study|Sponsor Decision|5
1177730|NCT00692003|2329599|FG001|Overall Study|Sponsor Decision|1
1177731|NCT00678288|2329607|FG000|Overall Study|Adverse Event|0
1177732|NCT00678288|2329608|FG001|Overall Study|Adverse Event|2
1177733|NCT00678288|2329607|FG000|Overall Study|Withdrawal by Subject|1
1177734|NCT00678288|2329608|FG001|Overall Study|Withdrawal by Subject|1
1177735|NCT00678288|2329607|FG000|Overall Study|Study terminated by the sponsor|2
1177736|NCT00678288|2329608|FG001|Overall Study|Study terminated by the sponsor|0
1177737|NCT00678288|2329607|FG000|Overall Study|Not compliant with study medication|0
1177738|NCT00678288|2329608|FG001|Overall Study|Not compliant with study medication|1
1177739|NCT00678288|2329607|FG000|Overall Study|Switch to commercial drug|0
1177740|NCT00678288|2329608|FG001|Overall Study|Switch to commercial drug|1
1177741|NCT00678288|2329607|FG000|Overall Study|Reason not reported|1
1177742|NCT00678288|2329608|FG001|Overall Study|Reason not reported|0
1177743|NCT00678288|2329607|FG000|Overall Study|Disease progression/recurrence/relapse|6
1177744|NCT00678288|2329608|FG001|Overall Study|Disease progression/recurrence/relapse|1
1177745|NCT00689052|2329620|FG000|Overall Study|Adverse Event|4
1177746|NCT00689052|2329621|FG001|Overall Study|Adverse Event|6
1177747|NCT00689052|2329620|FG000|Overall Study|Protocol Violation|1
1177748|NCT00689052|2329621|FG001|Overall Study|Protocol Violation|0
1177749|NCT00689052|2329620|FG000|Overall Study|Lost to Follow-up|2
1177750|NCT00689052|2329621|FG001|Overall Study|Lost to Follow-up|0
1177751|NCT00689052|2329620|FG000|Overall Study|Withdrawal by Subject|2
1177752|NCT00689052|2329621|FG001|Overall Study|Withdrawal by Subject|0
1177753|NCT00689052|2329620|FG000|Overall Study|Early termination of the trial|22
1177754|NCT00689052|2329621|FG001|Overall Study|Early termination of the trial|24
1177755|NCT00683917|2329641|FG000|Overall Study|Study prematurely terminated|10
1177756|NCT00686036|2329664|FG000|Overall Study|Adverse Event|3
1177757|NCT00686036|2329665|FG001|Overall Study|Adverse Event|0
1177758|NCT00686036|2329664|FG000|Overall Study|Withdrawal by Subject|3
1177759|NCT00686036|2329665|FG001|Overall Study|Withdrawal by Subject|1
873551|NCT00547248|1835315|FG003|Overall Study|Protocol Violation|1
873552|NCT00547248|1835312|FG000|Overall Study|Migrated/moved from study area|0
873553|NCT00547248|1835313|FG001|Overall Study|Migrated/moved from study area|0
873554|NCT00547248|1835314|FG002|Overall Study|Migrated/moved from study area|2
873555|NCT00547248|1835315|FG003|Overall Study|Migrated/moved from study area|0
873556|NCT00547248|1835312|FG000|Overall Study|Withdrawal by Subject|0
873557|NCT00547248|1835313|FG001|Overall Study|Withdrawal by Subject|0
873558|NCT00547248|1835314|FG002|Overall Study|Withdrawal by Subject|7
873559|NCT00547248|1835315|FG003|Overall Study|Withdrawal by Subject|1
873560|NCT00547365|1835328|FG000|Overall Study|Physician Decision|1
873561|NCT00547365|1835328|FG000|Overall Study|Lost to Follow-up|1
873562|NCT00547365|1835328|FG000|Overall Study|Protocol Violation|2
873563|NCT00547365|1835328|FG000|Overall Study|death (not related to study)|4
873564|NCT00547378|1835336|FG000|Randomized Cohort|Withdrawal by Subject|7
873565|NCT00547378|1835337|FG001|Randomized Cohort|Withdrawal by Subject|5
873566|NCT00547378|1835338|FG002|Randomized Cohort|Withdrawal by Subject|0
873567|NCT00547378|1835336|FG000|Randomized Cohort|Death|0
873568|NCT00547378|1835337|FG001|Randomized Cohort|Death|1
873569|NCT00547378|1835338|FG002|Randomized Cohort|Death|0
873570|NCT00547378|1835336|FG000|Randomized Cohort|Lost to Follow-up|1
873571|NCT00547378|1835337|FG001|Randomized Cohort|Lost to Follow-up|0
873572|NCT00547378|1835338|FG002|Randomized Cohort|Lost to Follow-up|0
873573|NCT00547378|1835336|FG000|Randomized Cohort|Adverse Event|1
873574|NCT00547378|1835337|FG001|Randomized Cohort|Adverse Event|0
873575|NCT00547378|1835338|FG002|Randomized Cohort|Adverse Event|0
873576|NCT00547378|1835336|FG000|Randomized Cohort|Other reasons|2
873577|NCT00547378|1835337|FG001|Randomized Cohort|Other reasons|0
873578|NCT00547378|1835338|FG002|Randomized Cohort|Other reasons|0
873579|NCT00547378|1835336|FG000|All Implanted Cohort|Withdrawal by Subject|5
873580|NCT00547378|1835337|FG001|All Implanted Cohort|Withdrawal by Subject|4
873581|NCT00547378|1835338|FG002|All Implanted Cohort|Withdrawal by Subject|27
873582|NCT00547378|1835336|FG000|All Implanted Cohort|Adverse Event|4
873583|NCT00547378|1835337|FG001|All Implanted Cohort|Adverse Event|10
873584|NCT00547378|1835338|FG002|All Implanted Cohort|Adverse Event|17
873585|NCT00547378|1835336|FG000|All Implanted Cohort|Lost to Follow-up|0
873586|NCT00547378|1835337|FG001|All Implanted Cohort|Lost to Follow-up|1
873587|NCT00547378|1835338|FG002|All Implanted Cohort|Lost to Follow-up|14
873588|NCT00547378|1835336|FG000|All Implanted Cohort|Death|3
873589|NCT00547378|1835337|FG001|All Implanted Cohort|Death|1
873590|NCT00547378|1835338|FG002|All Implanted Cohort|Death|4
873591|NCT00547378|1835336|FG000|All Implanted Cohort|Physician Decision|0
873592|NCT00547378|1835337|FG001|All Implanted Cohort|Physician Decision|2
873593|NCT00547378|1835338|FG002|All Implanted Cohort|Physician Decision|6
873594|NCT00547378|1835336|FG000|All Implanted Cohort|Site closure|2
873595|NCT00547378|1835337|FG001|All Implanted Cohort|Site closure|0
873596|NCT00547378|1835338|FG002|All Implanted Cohort|Site closure|1
873597|NCT00547378|1835336|FG000|All Implanted Cohort|Other reasons|1
873598|NCT00547378|1835337|FG001|All Implanted Cohort|Other reasons|0
873599|NCT00547378|1835338|FG002|All Implanted Cohort|Other reasons|1
873600|NCT00547521|1835348|FG000|Short Term Study (4 Months)|Adverse Event|1
873601|NCT00547521|1835349|FG001|Short Term Study (4 Months)|Adverse Event|0
873602|NCT00547521|1835348|FG000|Short Term Study (4 Months)|Lack of Efficacy|0
873603|NCT00547521|1835349|FG001|Short Term Study (4 Months)|Lack of Efficacy|2
873604|NCT00547521|1835348|FG000|Short Term Study (4 Months)|Withdrawal of consent|0
873605|NCT00547521|1835349|FG001|Short Term Study (4 Months)|Withdrawal of consent|1
873606|NCT00547521|1835348|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
873607|NCT00547521|1835349|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
873608|NCT00547521|1835348|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0
873609|NCT00547521|1835349|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14
873610|NCT00547521|1835348|FG000|Long Term Extension (LTE) Study|Adverse Event|0
873611|NCT00547521|1835349|FG001|Long Term Extension (LTE) Study|Adverse Event|9
873612|NCT00547521|1835348|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0
1177760|NCT00686036|2329664|FG000|Overall Study|Study terminated by AstraZeneca|2
873613|NCT00547521|1835349|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3
873614|NCT00547521|1835348|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0
873615|NCT00547521|1835349|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2
873616|NCT00547521|1835348|FG000|Long Term Extension (LTE) Study|Other|0
873617|NCT00547521|1835349|FG001|Long Term Extension (LTE) Study|Other|2
873618|NCT00547521|1835348|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
873619|NCT00547521|1835349|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
873620|NCT00547534|1835362|FG000|Overall Study|Adverse Event|7
873621|NCT00547534|1835362|FG000|Overall Study|Disease Progression|4
873622|NCT00547703|1835399|FG000|Overall Study|Lost to Follow-up|1
873623|NCT00547703|1835400|FG001|Overall Study|Lost to Follow-up|0
873624|NCT00547911|1835433|FG000|Overall Study|Adverse Event|0
873625|NCT00547911|1835434|FG001|Overall Study|Adverse Event|0
873626|NCT00547911|1835435|FG002|Overall Study|Adverse Event|0
873627|NCT00547911|1835436|FG003|Overall Study|Adverse Event|1
873628|NCT00547911|1835437|FG004|Overall Study|Adverse Event|0
873629|NCT00547911|1835438|FG005|Overall Study|Adverse Event|0
873630|NCT00548145|1835480|FG000|Overall Study|Death|0
873631|NCT00548145|1835481|FG001|Overall Study|Death|1
873632|NCT00548145|1835480|FG000|Overall Study|Withdrawal by Subject|0
873633|NCT00548145|1835481|FG001|Overall Study|Withdrawal by Subject|2
873634|NCT00548145|1835480|FG000|Overall Study|Physician Decision|1
873635|NCT00548145|1835481|FG001|Overall Study|Physician Decision|1
873636|NCT00548184|1835496|FG000|Overall Study|Adverse Event|3
873637|NCT00548184|1835496|FG000|Overall Study|took other drug|1
873638|NCT00548184|1835496|FG000|Overall Study|Found Her2 negative|1
873639|NCT00548249|1835516|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
873640|NCT00548249|1835517|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
873641|NCT00548249|1835518|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
873642|NCT00548249|1835519|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
873643|NCT00548249|1835520|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
873644|NCT00548249|1835516|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5
873645|NCT00548249|1835517|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1
873646|NCT00548249|1835518|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3
873647|NCT00548249|1835519|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1
873648|NCT00548249|1835520|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2
873649|NCT00548249|1835516|FG000|Overall Study|Protocol Violation|1
873650|NCT00548249|1835517|FG001|Overall Study|Protocol Violation|1
873651|NCT00548249|1835518|FG002|Overall Study|Protocol Violation|4
873652|NCT00548249|1835519|FG003|Overall Study|Protocol Violation|0
873653|NCT00548249|1835520|FG004|Overall Study|Protocol Violation|3
873654|NCT00548249|1835516|FG000|Overall Study|Miscellaneous|2
873655|NCT00548249|1835517|FG001|Overall Study|Miscellaneous|3
873656|NCT00548249|1835518|FG002|Overall Study|Miscellaneous|2
873657|NCT00548249|1835519|FG003|Overall Study|Miscellaneous|0
873658|NCT00548249|1835520|FG004|Overall Study|Miscellaneous|2
873659|NCT00548249|1835516|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
873660|NCT00548249|1835517|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
873661|NCT00548249|1835518|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
873662|NCT00548249|1835519|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
873663|NCT00548249|1835520|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
873664|NCT00548249|1835516|FG000|Overall Study|Adverse Event|2
873665|NCT00548249|1835517|FG001|Overall Study|Adverse Event|2
873666|NCT00548249|1835518|FG002|Overall Study|Adverse Event|0
873667|NCT00548249|1835519|FG003|Overall Study|Adverse Event|1
873668|NCT00548249|1835520|FG004|Overall Study|Adverse Event|1
873669|NCT00548249|1835516|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0
873670|NCT00548249|1835517|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0
873671|NCT00548249|1835518|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1
873672|NCT00548249|1835519|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3
873673|NCT00548249|1835520|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2
873674|NCT00548249|1835516|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0
873675|NCT00548249|1835517|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0
873676|NCT00548249|1835518|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1
873677|NCT00548249|1835519|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2
873678|NCT00548249|1835520|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2
873679|NCT00548249|1835516|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
873680|NCT00548249|1835517|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
873681|NCT00548249|1835518|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
873682|NCT00548249|1835519|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
873683|NCT00548249|1835520|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
873684|NCT00548249|1835516|FG000|Overall Study|Prolonged hospitalization|0
873685|NCT00548249|1835517|FG001|Overall Study|Prolonged hospitalization|0
873686|NCT00548249|1835518|FG002|Overall Study|Prolonged hospitalization|2
873687|NCT00548249|1835519|FG003|Overall Study|Prolonged hospitalization|1
873688|NCT00548249|1835520|FG004|Overall Study|Prolonged hospitalization|0
873689|NCT00548249|1835516|FG000|Overall Study|Withdrawal by Subject|2
873690|NCT00548249|1835517|FG001|Overall Study|Withdrawal by Subject|0
873691|NCT00548249|1835518|FG002|Overall Study|Withdrawal by Subject|0
1177761|NCT00686036|2329665|FG001|Overall Study|Study terminated by AstraZeneca|1
1177762|NCT00686036|2329664|FG000|Overall Study|PSA ≥ 10ng/mL|1
1177763|NCT00686036|2329665|FG001|Overall Study|PSA ≥ 10ng/mL|0
1177764|NCT00686036|2329664|FG000|Overall Study|Other reasons not identified|0
1177765|NCT00686036|2329665|FG001|Overall Study|Other reasons not identified|4
1177766|NCT00683787|2329687|FG000|Overall Study|Progression|3
1177767|NCT00683787|2329688|FG001|Overall Study|Progression|3
1177768|NCT00683787|2329689|FG002|Overall Study|Progression|0
1177769|NCT00683787|2329687|FG000|Overall Study|Adverse Event|0
1177770|NCT00683787|2329688|FG001|Overall Study|Adverse Event|0
1177771|NCT00683787|2329689|FG002|Overall Study|Adverse Event|2
1177772|NCT00678041|2329704|FG000|Overall Study|Physician Decision|5
1177773|NCT00678041|2329705|FG001|Overall Study|Physician Decision|5
1177774|NCT00681629|2329723|FG000|Overall Study|Study termination|4
1177775|NCT00681629|2329724|FG001|Overall Study|Study termination|2
1177776|NCT00681629|2329723|FG000|Overall Study|Adverse Event|1
1177777|NCT00681629|2329724|FG001|Overall Study|Adverse Event|0
1177778|NCT00673361|2329784|FG000|Overall Study|Screen Failure|2
1177779|NCT00673179|2329801|FG000|Overall Study|Toxicity/Complications|3
1177780|NCT00673179|2329802|FG001|Overall Study|Toxicity/Complications|0
1177781|NCT00660348|2329821|FG000|Overall Study|Withdrawal by Subject|1
1177782|NCT00660348|2329822|FG001|Overall Study|Withdrawal by Subject|0
1177783|NCT00664066|2329828|FG000|Overall Study|Study terminated|3
1177784|NCT00667017|2329832|FG000|Overall Study|Withdrawal by Subject|1
873692|NCT00548249|1835519|FG003|Overall Study|Withdrawal by Subject|0
873693|NCT00548249|1835520|FG004|Overall Study|Withdrawal by Subject|0
873694|NCT00548249|1835516|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
873695|NCT00548249|1835517|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
873696|NCT00548249|1835518|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
873697|NCT00548249|1835519|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
873698|NCT00548249|1835520|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
873699|NCT00548249|1835516|FG000|Overall Study|Sponsor's request|0
873700|NCT00548249|1835517|FG001|Overall Study|Sponsor's request|0
873701|NCT00548249|1835518|FG002|Overall Study|Sponsor's request|0
873702|NCT00548249|1835519|FG003|Overall Study|Sponsor's request|1
873703|NCT00548249|1835520|FG004|Overall Study|Sponsor's request|0
873704|NCT00548262|1835532|FG000|Overall Study|Death|21
873705|NCT00548262|1835532|FG000|Overall Study|Adverse Event|2
873706|NCT00548262|1835532|FG000|Overall Study|Lack of Efficacy|4
873707|NCT00548262|1835532|FG000|Overall Study|Lost to Follow-up|1
873708|NCT00548262|1835532|FG000|Overall Study|Other|3
873709|NCT00548262|1835532|FG000|Overall Study|Withdrawal by Subject|1
873710|NCT00548340|1835539|FG000|Overall Study|Protocol Violation|2
873711|NCT00548340|1835540|FG001|Overall Study|Protocol Violation|3
873712|NCT00548340|1835541|FG002|Overall Study|Protocol Violation|3
873713|NCT00548340|1835539|FG000|Overall Study|Adverse Event|2
873714|NCT00548340|1835540|FG001|Overall Study|Adverse Event|2
873715|NCT00548340|1835541|FG002|Overall Study|Adverse Event|2
873716|NCT00548340|1835539|FG000|Overall Study|Lost to Follow-up|1
873717|NCT00548340|1835540|FG001|Overall Study|Lost to Follow-up|1
873718|NCT00548340|1835541|FG002|Overall Study|Lost to Follow-up|0
873719|NCT00548340|1835539|FG000|Overall Study|Withdrawal by Subject|2
873720|NCT00548340|1835540|FG001|Overall Study|Withdrawal by Subject|4
873721|NCT00548340|1835541|FG002|Overall Study|Withdrawal by Subject|3
873722|NCT00548340|1835539|FG000|Overall Study|Other|1
873723|NCT00548340|1835540|FG001|Overall Study|Other|1
873724|NCT00548340|1835541|FG002|Overall Study|Other|1
873725|NCT00548405|1835552|FG000|Overall Study|Adverse Event|6
873726|NCT00548405|1835553|FG001|Overall Study|Adverse Event|2
873727|NCT00548405|1835554|FG002|Overall Study|Adverse Event|0
873728|NCT00548405|1835552|FG000|Overall Study|Lack of Efficacy|6
873729|NCT00548405|1835553|FG001|Overall Study|Lack of Efficacy|0
873730|NCT00548405|1835554|FG002|Overall Study|Lack of Efficacy|0
873731|NCT00548405|1835552|FG000|Overall Study|Physician Decision|3
873732|NCT00548405|1835553|FG001|Overall Study|Physician Decision|4
873733|NCT00548405|1835554|FG002|Overall Study|Physician Decision|1
873734|NCT00548405|1835552|FG000|Overall Study|Pregnancy|1
873735|NCT00548405|1835553|FG001|Overall Study|Pregnancy|0
873736|NCT00548405|1835554|FG002|Overall Study|Pregnancy|0
873737|NCT00548405|1835552|FG000|Overall Study|Protocol Violation|1
873738|NCT00548405|1835553|FG001|Overall Study|Protocol Violation|0
873739|NCT00548405|1835554|FG002|Overall Study|Protocol Violation|0
873740|NCT00548405|1835552|FG000|Overall Study|Withdrawal by Subject|36
873741|NCT00548405|1835553|FG001|Overall Study|Withdrawal by Subject|12
873742|NCT00548405|1835554|FG002|Overall Study|Withdrawal by Subject|5
873743|NCT00548405|1835552|FG000|Overall Study|Lost to Follow-up|1
873744|NCT00548405|1835553|FG001|Overall Study|Lost to Follow-up|1
873745|NCT00548405|1835554|FG002|Overall Study|Lost to Follow-up|2
873746|NCT00548405|1835552|FG000|Overall Study|Death|0
873747|NCT00548405|1835553|FG001|Overall Study|Death|1
873748|NCT00548405|1835554|FG002|Overall Study|Death|1
873749|NCT00548405|1835552|FG000|Overall Study|Sponsor decision|1
873750|NCT00548405|1835553|FG001|Overall Study|Sponsor decision|0
873751|NCT00548405|1835554|FG002|Overall Study|Sponsor decision|0
1177785|NCT00665444|2329836|FG000|Overall Study|Physician Decision|1
1177786|NCT00665444|2329836|FG000|Overall Study|Study Terminated by Study Sponsor|1
1177787|NCT00660595|2329851|FG000|Overall Study|Lost to Follow-up|0
1177788|NCT00660595|2329852|FG001|Overall Study|Lost to Follow-up|1
1177789|NCT00660595|2329851|FG000|Overall Study|Did not consent to participate in study|12
1177790|NCT00660595|2329852|FG001|Overall Study|Did not consent to participate in study|8
1177791|NCT00660595|2329851|FG000|Overall Study|Participant left hospital|1
1177792|NCT00660595|2329852|FG001|Overall Study|Participant left hospital|0
1177793|NCT00660595|2329851|FG000|Overall Study|Non Specified reasons|5
1177794|NCT00660595|2329852|FG001|Overall Study|Non Specified reasons|0
1177795|NCT00646282|2329869|FG000|Overall Study|Protocol terminated|4
1177796|NCT00646282|2329870|FG001|Overall Study|Protocol terminated|4
873752|NCT00548405|1835552|FG000|Overall Study|Randomized but not treated|1
873753|NCT00548405|1835553|FG001|Overall Study|Randomized but not treated|0
873754|NCT00548405|1835554|FG002|Overall Study|Randomized but not treated|0
873755|NCT00548548|1835577|FG000|Overall Study|Death|345
873756|NCT00548548|1835578|FG001|Overall Study|Death|348
873757|NCT00548548|1835577|FG000|Overall Study|Lost to Follow-up|17
873758|NCT00548548|1835578|FG001|Overall Study|Lost to Follow-up|18
873759|NCT00548717|1835608|FG000|Overall Study|Death|5
873760|NCT00548717|1835609|FG001|Overall Study|Death|2
873761|NCT00548717|1835608|FG000|Overall Study|Relapse|3
873762|NCT00548717|1835609|FG001|Overall Study|Relapse|0
873763|NCT00548717|1835608|FG000|Overall Study|Alternative treatment for GVHD|1
873764|NCT00548717|1835609|FG001|Overall Study|Alternative treatment for GVHD|0
873765|NCT00548808|1835620|FG000|Overall Study|Lost to Follow-up|9
873766|NCT00548808|1835621|FG001|Overall Study|Lost to Follow-up|3
873767|NCT00548808|1835620|FG000|Overall Study|Protocol Violation|8
873768|NCT00548808|1835621|FG001|Overall Study|Protocol Violation|8
873769|NCT00548808|1835620|FG000|Overall Study|Withdrawal by Subject|8
873770|NCT00548808|1835621|FG001|Overall Study|Withdrawal by Subject|4
873771|NCT00548808|1835620|FG000|Overall Study|Physician Decision|6
873772|NCT00548808|1835621|FG001|Overall Study|Physician Decision|3
873773|NCT00548808|1835620|FG000|Overall Study|Adverse Event|4
873774|NCT00548808|1835621|FG001|Overall Study|Adverse Event|5
873775|NCT00548808|1835620|FG000|Overall Study|Death|2
873776|NCT00548808|1835621|FG001|Overall Study|Death|0
873777|NCT00548808|1835620|FG000|Overall Study|Entry Criteria Not Met|2
873778|NCT00548808|1835621|FG001|Overall Study|Entry Criteria Not Met|2
873779|NCT00548808|1835620|FG000|Overall Study|Lack of Efficacy|2
873780|NCT00548808|1835621|FG001|Overall Study|Lack of Efficacy|0
873781|NCT00548808|1835620|FG000|Overall Study|Sponsor Decision|1
873782|NCT00548808|1835621|FG001|Overall Study|Sponsor Decision|1
873783|NCT00548847|1835627|FG000|Overall Study|Disease progression|7
873784|NCT00549055|1835650|FG000|Overall Study|Adverse Event|4
873785|NCT00549055|1835650|FG000|Overall Study|Lack of Efficacy|18
873786|NCT00549055|1835650|FG000|Overall Study|Stabilization|5
873787|NCT00549055|1835650|FG000|Overall Study|Progression to fibrosis|2
873788|NCT00549055|1835650|FG000|Overall Study|Decrease of size|1
873789|NCT00549055|1835650|FG000|Overall Study|Active choroidal neovascula increased|1
873790|NCT00549055|1835650|FG000|Overall Study|Vitreous hemorrhage|1
873791|NCT00549055|1835650|FG000|Overall Study|Growth choroidal neovascularisation|1
873792|NCT00549055|1835650|FG000|Overall Study|Choroidal neovascularization|1
873793|NCT00549055|1835650|FG000|Overall Study|Very low visual acuity (VA)|1
873794|NCT00549198|1835665|FG000|Overall Study|Adverse Event|28
873795|NCT00549198|1835666|FG001|Overall Study|Adverse Event|26
873796|NCT00549198|1835665|FG000|Overall Study|Insufficient Viral Load Response|4
873797|NCT00549198|1835666|FG001|Overall Study|Insufficient Viral Load Response|2
873798|NCT00549198|1835665|FG000|Overall Study|Protocol-defined Virological Failure|7
873799|NCT00549198|1835666|FG001|Overall Study|Protocol-defined Virological Failure|0
873800|NCT00549198|1835665|FG000|Overall Study|Non-compliance|2
873801|NCT00549198|1835666|FG001|Overall Study|Non-compliance|4
873802|NCT00549198|1835665|FG000|Overall Study|Lost to Follow-up|7
873803|NCT00549198|1835666|FG001|Overall Study|Lost to Follow-up|8
873804|NCT00549198|1835665|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3
873805|NCT00549198|1835666|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0
873806|NCT00549198|1835665|FG000|Overall Study|Protocol Violation|7
873807|NCT00549198|1835666|FG001|Overall Study|Protocol Violation|2
873808|NCT00549198|1835665|FG000|Overall Study|Investigator Decision|4
873809|NCT00549198|1835666|FG001|Overall Study|Investigator Decision|3
873810|NCT00549198|1835665|FG000|Overall Study|Withdrawal by Subject|7
873811|NCT00549198|1835666|FG001|Overall Study|Withdrawal by Subject|7
873812|NCT00549198|1835665|FG000|Overall Study|Disease Progression|1
873813|NCT00549198|1835666|FG001|Overall Study|Disease Progression|0
873814|NCT00549198|1835665|FG000|Overall Study|Participant Moved|2
873815|NCT00549198|1835666|FG001|Overall Study|Participant Moved|0
873816|NCT00549198|1835665|FG000|Overall Study|Participant not able to perform Week 96|1
873817|NCT00549198|1835666|FG001|Overall Study|Participant not able to perform Week 96|0
873818|NCT00549198|1835665|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1
873819|NCT00549198|1835666|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0
873820|NCT00549198|1835665|FG000|Overall Study|Prohibited Medication|1
1177797|NCT00657553|2329878|FG000|Overall Study|low accrual, no analysis run|5
1177798|NCT00657553|2329879|FG001|Overall Study|low accrual, no analysis run|5
1177799|NCT00648895|2329900|FG000|Overall Study|Lack of Efficacy|0
1177800|NCT00648895|2329901|FG001|Overall Study|Lack of Efficacy|1
1177801|NCT00647426|2329907|FG000|Overall Study|Withdrawal by Subject|2
1177802|NCT00645567|2329912|FG000|Overall Study|Adverse Event|1
1177803|NCT00637806|2329923|FG000|Double-blind Phase|Study Discontinued|2
1177804|NCT00637806|2329924|FG001|Double-blind Phase|Study Discontinued|0
1177805|NCT00637806|2329925|FG002|Double-blind Phase|Study Discontinued|1
1177806|NCT00637806|2329926|FG003|Double-blind Phase|Study Discontinued|0
1177807|NCT00637806|2329923|FG000|Extension Phase|Study Discontinued|0
1177808|NCT00637806|2329924|FG001|Extension Phase|Study Discontinued|0
1177809|NCT00637806|2329925|FG002|Extension Phase|Study Discontinued|0
1177810|NCT00637806|2329926|FG003|Extension Phase|Study Discontinued|1
1177811|NCT00629798|2329951|FG000|Overall Study|Not Treated|4
1177812|NCT00637728|2329961|FG000|Double-blind Phase|Adverse Event|1
1177813|NCT00637728|2329962|FG001|Double-blind Phase|Adverse Event|0
1177814|NCT00637728|2329963|FG002|Double-blind Phase|Adverse Event|0
1177815|NCT00637728|2329961|FG000|Double-blind Phase|Non-compliance|2
1177816|NCT00637728|2329962|FG001|Double-blind Phase|Non-compliance|0
1177817|NCT00637728|2329963|FG002|Double-blind Phase|Non-compliance|0
1177818|NCT00637728|2329961|FG000|Double-blind Phase|Study Discontinued|1
1177819|NCT00637728|2329962|FG001|Double-blind Phase|Study Discontinued|1
1177820|NCT00637728|2329963|FG002|Double-blind Phase|Study Discontinued|0
1177821|NCT00637416|2329998|FG000|Overall Study|Lost to Follow-up|1
1177822|NCT00637416|2329999|FG001|Overall Study|Lost to Follow-up|1
873821|NCT00549198|1835666|FG001|Overall Study|Prohibited Medication|2
873822|NCT00549198|1835665|FG000|Overall Study|Participant planning pregnancy|1
873823|NCT00549198|1835666|FG001|Overall Study|Participant planning pregnancy|0
873824|NCT00549198|1835665|FG000|Overall Study|Participant overweight, no scan possible|1
873825|NCT00549198|1835666|FG001|Overall Study|Participant overweight, no scan possible|0
873826|NCT00549198|1835665|FG000|Overall Study|No scan facilities|0
873827|NCT00549198|1835666|FG001|Overall Study|No scan facilities|2
873828|NCT00549198|1835665|FG000|Overall Study|Pregnancy|0
873829|NCT00549198|1835666|FG001|Overall Study|Pregnancy|3
873830|NCT00549198|1835665|FG000|Overall Study|Not Exposed to Study Drug|3
873831|NCT00549198|1835666|FG001|Overall Study|Not Exposed to Study Drug|4
873832|NCT00549302|1835674|FG000|Double-Blind|Death|2
873833|NCT00549302|1835675|FG001|Double-Blind|Death|9
873834|NCT00549302|1835676|FG002|Double-Blind|Death|0
873835|NCT00549302|1835674|FG000|Double-Blind|Adverse Event|3
873836|NCT00549302|1835675|FG001|Double-Blind|Adverse Event|16
873837|NCT00549302|1835676|FG002|Double-Blind|Adverse Event|0
873838|NCT00549302|1835674|FG000|Double-Blind|Withdrawal by Subject|3
873839|NCT00549302|1835675|FG001|Double-Blind|Withdrawal by Subject|8
873840|NCT00549302|1835676|FG002|Double-Blind|Withdrawal by Subject|0
873841|NCT00549302|1835674|FG000|Double-Blind|Investigator Decision|1
873842|NCT00549302|1835675|FG001|Double-Blind|Investigator Decision|5
873843|NCT00549302|1835676|FG002|Double-Blind|Investigator Decision|0
873844|NCT00549302|1835674|FG000|Double-Blind|Sponsor Decision|0
873845|NCT00549302|1835675|FG001|Double-Blind|Sponsor Decision|1
873846|NCT00549302|1835676|FG002|Double-Blind|Sponsor Decision|0
873847|NCT00549302|1835674|FG000|Double-Blind|Lost to Follow-up|1
873848|NCT00549302|1835675|FG001|Double-Blind|Lost to Follow-up|2
873849|NCT00549302|1835676|FG002|Double-Blind|Lost to Follow-up|0
873850|NCT00549302|1835674|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
873851|NCT00549302|1835675|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
873852|NCT00549302|1835676|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
873853|NCT00549302|1835674|FG000|Double-Blind|New condition or starts new therapy|0
873854|NCT00549302|1835675|FG001|Double-Blind|New condition or starts new therapy|2
873855|NCT00549302|1835676|FG002|Double-Blind|New condition or starts new therapy|0
873856|NCT00549302|1835674|FG000|Open-Label|Adverse Event|0
873857|NCT00549302|1835675|FG001|Open-Label|Adverse Event|0
873858|NCT00549302|1835676|FG002|Open-Label|Adverse Event|11
873859|NCT00549302|1835674|FG000|Open-Label|Death|0
873860|NCT00549302|1835675|FG001|Open-Label|Death|0
873861|NCT00549302|1835676|FG002|Open-Label|Death|40
873862|NCT00549302|1835674|FG000|Open-Label|Investigator Decision|0
873863|NCT00549302|1835675|FG001|Open-Label|Investigator Decision|0
873864|NCT00549302|1835676|FG002|Open-Label|Investigator Decision|5
873865|NCT00549302|1835674|FG000|Open-Label|Lost to Follow-up|0
873866|NCT00549302|1835675|FG001|Open-Label|Lost to Follow-up|0
873867|NCT00549302|1835676|FG002|Open-Label|Lost to Follow-up|2
873868|NCT00549302|1835674|FG000|Open-Label|Other|0
873869|NCT00549302|1835675|FG001|Open-Label|Other|0
873870|NCT00549302|1835676|FG002|Open-Label|Other|3
873871|NCT00549302|1835674|FG000|Open-Label|New drug pulmonary atrial hypertension|0
873872|NCT00549302|1835675|FG001|Open-Label|New drug pulmonary atrial hypertension|0
873873|NCT00549302|1835676|FG002|Open-Label|New drug pulmonary atrial hypertension|2
873874|NCT00549302|1835674|FG000|Open-Label|Withdrawal by Subject|0
873875|NCT00549302|1835675|FG001|Open-Label|Withdrawal by Subject|0
873876|NCT00549302|1835676|FG002|Open-Label|Withdrawal by Subject|6
873877|NCT00549445|1835697|FG000|Overall Study|Sputum & Blood Samples Not Available|15
873878|NCT00549445|1835698|FG001|Overall Study|Sputum & Blood Samples Not Available|17
873879|NCT00549549|1835708|FG000|Overall Study|Adverse Event|5
1177823|NCT00637416|2329998|FG000|Overall Study|Unable to take study drug|0
1177824|NCT00637416|2329999|FG001|Overall Study|Unable to take study drug|1
1177825|NCT00631137|2330049|FG000|Overall Study|Withdrawal by Subject|1
1177826|NCT00631137|2330050|FG001|Overall Study|Withdrawal by Subject|0
1177827|NCT00633061|2330067|FG000|Overall Study|Study closed|86
1177828|NCT00633061|2330068|FG001|Overall Study|Study closed|0
1177829|NCT00630292|2330080|FG000|Overall Study|Withdrawal by Subject|1
1177830|NCT00634010|2330086|FG000|Overall Study|Adverse Event|2
873880|NCT00549549|1835709|FG001|Overall Study|Adverse Event|3
873881|NCT00549549|1835710|FG002|Overall Study|Adverse Event|1
873882|NCT00549549|1835711|FG003|Overall Study|Adverse Event|9
873883|NCT00549549|1835708|FG000|Overall Study|Lack of Efficacy|9
873884|NCT00549549|1835709|FG001|Overall Study|Lack of Efficacy|6
873885|NCT00549549|1835710|FG002|Overall Study|Lack of Efficacy|4
873886|NCT00549549|1835711|FG003|Overall Study|Lack of Efficacy|2
873887|NCT00549549|1835708|FG000|Overall Study|Lost to Follow-up|1
873888|NCT00549549|1835709|FG001|Overall Study|Lost to Follow-up|0
873889|NCT00549549|1835710|FG002|Overall Study|Lost to Follow-up|1
873890|NCT00549549|1835711|FG003|Overall Study|Lost to Follow-up|2
873891|NCT00549549|1835708|FG000|Overall Study|Withdrawal by Subject|0
873892|NCT00549549|1835709|FG001|Overall Study|Withdrawal by Subject|4
873893|NCT00549549|1835710|FG002|Overall Study|Withdrawal by Subject|1
873894|NCT00549549|1835711|FG003|Overall Study|Withdrawal by Subject|0
873895|NCT00549549|1835708|FG000|Overall Study|Other|9
873896|NCT00549549|1835709|FG001|Overall Study|Other|9
873897|NCT00549549|1835710|FG002|Overall Study|Other|9
873898|NCT00549549|1835711|FG003|Overall Study|Other|11
873899|NCT00549549|1835708|FG000|Overall Study|Randomized but not treated|0
873900|NCT00549549|1835709|FG001|Overall Study|Randomized but not treated|0
873901|NCT00549549|1835710|FG002|Overall Study|Randomized but not treated|1
873902|NCT00549549|1835711|FG003|Overall Study|Randomized but not treated|1
873903|NCT00549562|1835721|FG000|Overall Study|Adverse Event|1
873904|NCT00549562|1835721|FG000|Overall Study|Lack of Efficacy|1
873905|NCT00549601|1835728|FG000|Randomized|Protocol Violation|0
873906|NCT00549601|1835729|FG001|Randomized|Protocol Violation|0
873907|NCT00549601|1835730|FG002|Randomized|Protocol Violation|1
873908|NCT00549601|1835728|FG000|Randomized|Withdrawal by Subject|0
873909|NCT00549601|1835729|FG001|Randomized|Withdrawal by Subject|1
873910|NCT00549601|1835730|FG002|Randomized|Withdrawal by Subject|1
873911|NCT00549601|1835728|FG000|Received Study Drug|Adverse Event|2
873912|NCT00549601|1835729|FG001|Received Study Drug|Adverse Event|5
873913|NCT00549601|1835730|FG002|Received Study Drug|Adverse Event|1
873914|NCT00549601|1835728|FG000|Received Study Drug|Death|0
873915|NCT00549601|1835729|FG001|Received Study Drug|Death|1
873916|NCT00549601|1835730|FG002|Received Study Drug|Death|0
873917|NCT00549601|1835728|FG000|Received Study Drug|Lost to Follow-up|0
873918|NCT00549601|1835729|FG001|Received Study Drug|Lost to Follow-up|1
873919|NCT00549601|1835730|FG002|Received Study Drug|Lost to Follow-up|1
873920|NCT00549601|1835728|FG000|Received Study Drug|Protocol Violation|3
873921|NCT00549601|1835729|FG001|Received Study Drug|Protocol Violation|4
873922|NCT00549601|1835730|FG002|Received Study Drug|Protocol Violation|1
873923|NCT00549601|1835728|FG000|Received Study Drug|Withdrawal by Subject|2
873924|NCT00549601|1835729|FG001|Received Study Drug|Withdrawal by Subject|0
873925|NCT00549601|1835730|FG002|Received Study Drug|Withdrawal by Subject|1
873926|NCT00549640|1835742|FG000|Overall Study|Withdrawal by Subject|6
873927|NCT00549640|1835743|FG001|Overall Study|Withdrawal by Subject|12
873928|NCT00549640|1835742|FG000|Overall Study|Adverse Event|5
873929|NCT00549640|1835743|FG001|Overall Study|Adverse Event|0
873930|NCT00549640|1835742|FG000|Overall Study|Lost to Follow-up|7
873931|NCT00549640|1835743|FG001|Overall Study|Lost to Follow-up|4
873932|NCT00549718|1835753|FG000|Overall Study|Insufficient clinical response|20
873933|NCT00549718|1835754|FG001|Overall Study|Insufficient clinical response|7
873934|NCT00549718|1835755|FG002|Overall Study|Insufficient clinical response|18
873935|NCT00549718|1835756|FG003|Overall Study|Insufficient clinical response|32
873936|NCT00549718|1835753|FG000|Overall Study|Adverse Event|6
873937|NCT00549718|1835754|FG001|Overall Study|Adverse Event|8
873938|NCT00549718|1835755|FG002|Overall Study|Adverse Event|7
873939|NCT00549718|1835756|FG003|Overall Study|Adverse Event|3
873940|NCT00549718|1835753|FG000|Overall Study|Lost to Follow-up|4
873941|NCT00549718|1835754|FG001|Overall Study|Lost to Follow-up|2
873942|NCT00549718|1835755|FG002|Overall Study|Lost to Follow-up|0
873943|NCT00549718|1835756|FG003|Overall Study|Lost to Follow-up|6
873944|NCT00549718|1835753|FG000|Overall Study|Withdrawal by Subject|9
873945|NCT00549718|1835754|FG001|Overall Study|Withdrawal by Subject|18
873946|NCT00549718|1835755|FG002|Overall Study|Withdrawal by Subject|12
873947|NCT00549718|1835756|FG003|Overall Study|Withdrawal by Subject|13
873948|NCT00549718|1835753|FG000|Overall Study|Administrative|2
873949|NCT00549718|1835754|FG001|Overall Study|Administrative|2
873950|NCT00549718|1835755|FG002|Overall Study|Administrative|2
873951|NCT00549718|1835756|FG003|Overall Study|Administrative|1
873952|NCT00549757|1835768|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590
873953|NCT00549757|1835769|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462
873954|NCT00549757|1835768|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
873955|NCT00549757|1835769|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
1177831|NCT00634010|2330087|FG001|Overall Study|Adverse Event|5
1177832|NCT00634010|2330086|FG000|Overall Study|Withdrawal by Subject|5
1177833|NCT00634010|2330087|FG001|Overall Study|Withdrawal by Subject|6
1177834|NCT00634010|2330086|FG000|Overall Study|Physician Decision|1
1177835|NCT00634010|2330087|FG001|Overall Study|Physician Decision|1
1177836|NCT00634010|2330086|FG000|Overall Study|Disease Progression|1
1177837|NCT00634010|2330087|FG001|Overall Study|Disease Progression|1
1177838|NCT00634010|2330086|FG000|Overall Study|Non-Compliant|1
1177839|NCT00634010|2330087|FG001|Overall Study|Non-Compliant|1
1177840|NCT00626561|2330137|FG000|Overall Study|Withdrawal by Subject|2
1177841|NCT00626561|2330137|FG000|Overall Study|Disease Progression|2
1177842|NCT00613730|2330141|FG000|Overall Study|Disease progression|2
1177843|NCT00613730|2330141|FG000|Overall Study|Administrative decision|1
1177844|NCT00625586|2330145|FG000|Overall Study|Adverse Event|1
1177845|NCT00625742|2330153|FG000|Overall Study|Disease Progression|2
1177846|NCT00625742|2330153|FG000|Overall Study|Withdrawal by Subject|1
1177847|NCT00625742|2330153|FG000|Overall Study|Adverse Event|4
1177848|NCT00625742|2330153|FG000|Overall Study|Lost to Follow-up|4
1177849|NCT00625742|2330153|FG000|Overall Study|Ineligible|1
1177850|NCT00619151|2330163|FG000|Overall Study|Study terminated prior to followup|1
1177851|NCT00619151|2330164|FG001|Overall Study|Study terminated prior to followup|0
1177852|NCT00622167|2330170|FG000|Overall Study|Did not meet angiographic criteria|20
1177853|NCT00616759|2330189|FG000|Overall Study|Physician Decision|2
1177854|NCT00616759|2330190|FG001|Overall Study|Physician Decision|0
1177855|NCT00616759|2330189|FG000|Overall Study|Withdrawal by Subject|1
1177856|NCT00616759|2330190|FG001|Overall Study|Withdrawal by Subject|2
1177857|NCT00616642|2330198|FG000|Overall Study|Withdrawal by Subject|0
1177858|NCT00616642|2330199|FG001|Overall Study|Withdrawal by Subject|1
1177859|NCT00619515|2330205|FG000|Overall Study|Study Termination by IRB|73
1177860|NCT00612677|2330213|FG000|Overall Study|study closed before treatment started|1
1177861|NCT00616603|2330220|FG000|Overall Study|Physician Decision|2
1177862|NCT00616603|2330221|FG001|Overall Study|Physician Decision|0
1177863|NCT00616603|2330222|FG002|Overall Study|Physician Decision|2
1177864|NCT00609765|2330263|FG000|Overall Study|Study ended prior to 12 months|1
1177865|NCT00595920|2330288|FG000|Overall Study|The OLTERMS study was discontinued by th|116
1177866|NCT00596947|2330294|FG000|Overall Study|study halted due to low enrollment|5
1177867|NCT00596947|2330295|FG001|Overall Study|study halted due to low enrollment|3
1177868|NCT00596947|2330294|FG000|Overall Study|Lost to Follow-up|1
1177869|NCT00596947|2330295|FG001|Overall Study|Lost to Follow-up|0
1177870|NCT00584012|2330301|FG000|Overall Study|Withdrawal by Subject|1
1177871|NCT00577772|2330337|FG000|Overall Study|Lost to Follow-up|0
1177872|NCT00577772|2330338|FG001|Overall Study|Lost to Follow-up|1
1177873|NCT00592007|2330344|FG000|Overall Study|Withdrawal by Subject|1
1177874|NCT00592007|2330344|FG000|Overall Study|patient ineligible (out of lab range)|1
1177875|NCT00595582|2330348|FG000|Overall Study|Pilot study that PI terminated|2
1177876|NCT00595582|2330348|FG000|Overall Study|Lost to Follow-up|1
1177877|NCT00595582|2330348|FG000|Overall Study|Adverse Event|2
1177878|NCT00595582|2330348|FG000|Overall Study|Physician Decision|5
1177879|NCT00588146|2330352|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4
1177880|NCT00588146|2330353|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3
1177881|NCT00590538|2330368|FG000|Overall Study|Study terminated before completed|2
1177882|NCT00583115|2330372|FG000|Overall Study|Death|1
1177883|NCT00582712|2330376|FG000|Overall Study|Adverse Event|1
1177884|NCT00582712|2330376|FG000|Overall Study|Lack of Efficacy|1
1177885|NCT00582712|2330376|FG000|Overall Study|Withdrawal by Subject|1
1177886|NCT00582712|2330376|FG000|Overall Study|Complicating disease requiring treatment|1
1177887|NCT00587795|2330407|FG000|Overall Study|Withdrawal by Subject|1
1177888|NCT00587795|2330408|FG001|Overall Study|Withdrawal by Subject|0
1177889|NCT00590135|2330414|FG000|Overall Study|Primary endpoint measure not obtainable|59
1177890|NCT00582036|2330421|FG000|Overall Study|Withdrawal by Subject|0
1177891|NCT00582036|2330422|FG001|Overall Study|Withdrawal by Subject|1
873956|NCT00549757|1835768|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
873957|NCT00549757|1835769|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
873958|NCT00549757|1835768|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
873959|NCT00549757|1835769|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
873960|NCT00549757|1835768|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
873961|NCT00549757|1835769|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
873962|NCT00549757|1835768|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
873963|NCT00549757|1835769|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
873964|NCT00549757|1835768|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
873965|NCT00549757|1835769|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
873966|NCT00549757|1835768|FG000|Active Treatment Phase: Max. 50 Months|Death|188
873967|NCT00549757|1835769|FG001|Active Treatment Phase: Max. 50 Months|Death|200
873968|NCT00549757|1835768|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353
873969|NCT00549757|1835769|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380
873970|NCT00549757|1835768|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
873971|NCT00549757|1835769|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
873972|NCT00549757|1835768|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8
1177892|NCT00585585|2330428|FG000|Overall Study|Adverse Event|1
1177893|NCT00585221|2330432|FG000|Overall Study|Protocol Violation|8
1177894|NCT00581113|2330438|FG000|Overall Study|Withdrawal by Subject|0
1177895|NCT00581113|2330439|FG001|Overall Study|Withdrawal by Subject|1
1177896|NCT00579254|2330445|FG000|Overall Study|Lost to Follow-up|39
1177897|NCT00579254|2330445|FG000|Overall Study|Discontinued when study terminated|73
1177898|NCT00587223|2330449|FG000|Overall Study|Adverse Event|1
1177899|NCT00577395|2330480|FG000|Overall Study|Study was terminated early by Sponsor|7
1177900|NCT00577395|2330481|FG001|Overall Study|Study was terminated early by Sponsor|6
1177901|NCT00573391|2330489|FG000|Overall Study|study stopped|2
1177902|NCT00573391|2330490|FG001|Overall Study|study stopped|2
1177903|NCT00573391|2330489|FG000|Overall Study|Death|1
1177904|NCT00573391|2330490|FG001|Overall Study|Death|0
1177905|NCT00574080|2330534|FG000|Overall Study|Death|10
1177906|NCT00574080|2330535|FG001|Overall Study|Death|10
1177907|NCT00558558|2330541|FG000|Overall Study|Unable to swallow|1
1177908|NCT00558558|2330541|FG000|Overall Study|Withdrawal by Subject|1
1177909|NCT00558558|2330541|FG000|Overall Study|Lack of Efficacy|4
1177910|NCT00573937|2330551|FG000|Overall Study|Study Terminated|0
1177911|NCT00573937|2330552|FG001|Overall Study|Study Terminated|1
1177912|NCT00577317|2330560|FG000|Overall Study|Study Terminated|0
1177913|NCT00577317|2330561|FG001|Overall Study|Study Terminated|2
1177914|NCT00571922|2330569|FG000|Overall Study|Completion unknown|36
1177915|NCT00571922|2330570|FG001|Overall Study|Completion unknown|36
1177916|NCT00573157|2330582|FG000|Overall Study|Adverse Event|3
1177917|NCT00573157|2330583|FG001|Overall Study|Adverse Event|1
1177918|NCT00573157|2330582|FG000|Overall Study|Other|1
1177919|NCT00573157|2330583|FG001|Overall Study|Other|1
1177920|NCT00561912|2330602|FG000|Overall Study|ineligible|1
1177921|NCT00561795|2330608|FG000|Overall Study|Adverse Event|3
1177922|NCT00561795|2330609|FG001|Overall Study|Adverse Event|3
1177923|NCT00561795|2330610|FG002|Overall Study|Adverse Event|0
1177924|NCT00561795|2330611|FG003|Overall Study|Adverse Event|0
1177925|NCT00561795|2330608|FG000|Overall Study|Study Closed/Terminated|0
873973|NCT00549757|1835769|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9
873974|NCT00549757|1835768|FG000|Extension Period (in Average 9 Months)|Death|143
873975|NCT00549757|1835769|FG001|Extension Period (in Average 9 Months)|Death|136
873976|NCT00549757|1835768|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52
873977|NCT00549757|1835769|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47
873978|NCT00549757|1835768|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
873979|NCT00549757|1835769|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
873980|NCT00549757|1835768|FG000|Extension Period (in Average 9 Months)|Patient's request|421
873981|NCT00549757|1835769|FG001|Extension Period (in Average 9 Months)|Patient's request|436
873982|NCT00549770|1835789|FG000|Overall Study|Protocol deviation|1
873983|NCT00549770|1835790|FG001|Overall Study|Protocol deviation|1
873984|NCT00549770|1835791|FG002|Overall Study|Protocol deviation|1
873985|NCT00549770|1835792|FG003|Overall Study|Protocol deviation|2
873986|NCT00549770|1835793|FG004|Overall Study|Protocol deviation|2
873987|NCT00549770|1835794|FG005|Overall Study|Protocol deviation|2
873988|NCT00549770|1835795|FG006|Overall Study|Protocol deviation|1
873989|NCT00549770|1835796|FG007|Overall Study|Protocol deviation|2
873990|NCT00549770|1835789|FG000|Overall Study|Administrative problems|0
873991|NCT00549770|1835790|FG001|Overall Study|Administrative problems|1
873992|NCT00549770|1835791|FG002|Overall Study|Administrative problems|0
873993|NCT00549770|1835792|FG003|Overall Study|Administrative problems|0
873994|NCT00549770|1835793|FG004|Overall Study|Administrative problems|0
873995|NCT00549770|1835794|FG005|Overall Study|Administrative problems|0
873996|NCT00549770|1835795|FG006|Overall Study|Administrative problems|0
873997|NCT00549770|1835796|FG007|Overall Study|Administrative problems|1
873998|NCT00549770|1835789|FG000|Overall Study|Lost to Follow-up|0
873999|NCT00549770|1835790|FG001|Overall Study|Lost to Follow-up|0
874000|NCT00549770|1835791|FG002|Overall Study|Lost to Follow-up|2
874001|NCT00549770|1835792|FG003|Overall Study|Lost to Follow-up|2
874002|NCT00549770|1835793|FG004|Overall Study|Lost to Follow-up|3
874003|NCT00549770|1835794|FG005|Overall Study|Lost to Follow-up|2
874004|NCT00549770|1835795|FG006|Overall Study|Lost to Follow-up|0
874005|NCT00549770|1835796|FG007|Overall Study|Lost to Follow-up|0
874006|NCT00549770|1835789|FG000|Overall Study|Withdrawal by Subject|4
874007|NCT00549770|1835790|FG001|Overall Study|Withdrawal by Subject|6
874008|NCT00549770|1835791|FG002|Overall Study|Withdrawal by Subject|4
874009|NCT00549770|1835792|FG003|Overall Study|Withdrawal by Subject|5
874010|NCT00549770|1835793|FG004|Overall Study|Withdrawal by Subject|6
874011|NCT00549770|1835794|FG005|Overall Study|Withdrawal by Subject|6
874012|NCT00549770|1835795|FG006|Overall Study|Withdrawal by Subject|4
874013|NCT00549770|1835796|FG007|Overall Study|Withdrawal by Subject|9
874014|NCT00549770|1835789|FG000|Overall Study|Lack of Efficacy|1
874015|NCT00549770|1835790|FG001|Overall Study|Lack of Efficacy|0
874016|NCT00549770|1835791|FG002|Overall Study|Lack of Efficacy|2
874017|NCT00549770|1835792|FG003|Overall Study|Lack of Efficacy|3
1177926|NCT00561795|2330609|FG001|Overall Study|Study Closed/Terminated|3
1177927|NCT00561795|2330610|FG002|Overall Study|Study Closed/Terminated|0
1177928|NCT00561795|2330611|FG003|Overall Study|Study Closed/Terminated|0
1177929|NCT00561795|2330608|FG000|Overall Study|Physician Decision|1
1177930|NCT00561795|2330609|FG001|Overall Study|Physician Decision|0
1177931|NCT00561795|2330610|FG002|Overall Study|Physician Decision|0
1177932|NCT00561795|2330611|FG003|Overall Study|Physician Decision|0
1177933|NCT00556075|2330647|FG000|Overall Study|Lost to Follow-up|3
1177934|NCT00556075|2330648|FG001|Overall Study|Lost to Follow-up|0
1177935|NCT00556075|2330649|FG002|Overall Study|Lost to Follow-up|3
1177936|NCT00556075|2330647|FG000|Overall Study|Withdrawal by Subject|3
1177937|NCT00556075|2330648|FG001|Overall Study|Withdrawal by Subject|3
1177938|NCT00556075|2330649|FG002|Overall Study|Withdrawal by Subject|0
1177939|NCT00556075|2330647|FG000|Overall Study|Protocol Violation|1
1177940|NCT00556075|2330648|FG001|Overall Study|Protocol Violation|1
1177941|NCT00556075|2330649|FG002|Overall Study|Protocol Violation|3
1177942|NCT00556075|2330647|FG000|Overall Study|Not eligible|1
1177943|NCT00556075|2330648|FG001|Overall Study|Not eligible|1
1177944|NCT00556075|2330649|FG002|Overall Study|Not eligible|2
1177945|NCT00556075|2330647|FG000|Overall Study|Adverse Event|1
1177946|NCT00556075|2330648|FG001|Overall Study|Adverse Event|2
1177947|NCT00556075|2330649|FG002|Overall Study|Adverse Event|0
1177948|NCT00556075|2330647|FG000|Overall Study|Personal issues|4
1177949|NCT00556075|2330648|FG001|Overall Study|Personal issues|1
1177950|NCT00556075|2330649|FG002|Overall Study|Personal issues|0
1177951|NCT00556075|2330647|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0
1177952|NCT00556075|2330648|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1
1177953|NCT00556075|2330649|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0
1177954|NCT00556166|2330661|FG000|Overall Study|Withdrawal by Subject|1
1177955|NCT00539838|2330685|FG000|Overall Study|Fail to return|2
1177956|NCT00539838|2330686|FG001|Overall Study|Fail to return|0
1177957|NCT00539838|2330687|FG002|Overall Study|Fail to return|0
1177958|NCT00539838|2330685|FG000|Overall Study|Withdrawal by Subject|0
1177959|NCT00539838|2330686|FG001|Overall Study|Withdrawal by Subject|4
1177960|NCT00539838|2330687|FG002|Overall Study|Withdrawal by Subject|0
1177961|NCT00539838|2330685|FG000|Overall Study|Death|0
1177962|NCT00539838|2330686|FG001|Overall Study|Death|2
1177963|NCT00539838|2330687|FG002|Overall Study|Death|0
1177964|NCT00539838|2330685|FG000|Overall Study|Did not cooperate|1
1177965|NCT00539838|2330686|FG001|Overall Study|Did not cooperate|0
1177966|NCT00539838|2330687|FG002|Overall Study|Did not cooperate|1
1177967|NCT00539838|2330685|FG000|Overall Study|Administrative|4
1177968|NCT00539838|2330686|FG001|Overall Study|Administrative|0
1177969|NCT00539838|2330687|FG002|Overall Study|Administrative|8
1177970|NCT00549328|2330697|FG000|Overall Study|Adverse Event|2
1177971|NCT00549328|2330697|FG000|Overall Study|Disease Progression|10
1177972|NCT00549328|2330697|FG000|Overall Study|Death|1
1177973|NCT00549328|2330697|FG000|Overall Study|Use of Prohibited Medication|1
1177974|NCT00548327|2330703|FG000|Overall Study|Adverse Event|0
1177975|NCT00548327|2330704|FG001|Overall Study|Adverse Event|1
1177976|NCT00547300|2330735|FG000|Overall Study|Study was Administratively Terminated|25
874018|NCT00549770|1835793|FG004|Overall Study|Lack of Efficacy|5
874019|NCT00549770|1835794|FG005|Overall Study|Lack of Efficacy|1
874020|NCT00549770|1835795|FG006|Overall Study|Lack of Efficacy|3
874021|NCT00549770|1835796|FG007|Overall Study|Lack of Efficacy|8
874022|NCT00549770|1835789|FG000|Overall Study|Abnormal test procedure results|0
874023|NCT00549770|1835790|FG001|Overall Study|Abnormal test procedure results|0
874024|NCT00549770|1835791|FG002|Overall Study|Abnormal test procedure results|0
874025|NCT00549770|1835792|FG003|Overall Study|Abnormal test procedure results|2
874026|NCT00549770|1835793|FG004|Overall Study|Abnormal test procedure results|0
874027|NCT00549770|1835794|FG005|Overall Study|Abnormal test procedure results|1
874028|NCT00549770|1835795|FG006|Overall Study|Abnormal test procedure results|1
874029|NCT00549770|1835796|FG007|Overall Study|Abnormal test procedure results|1
874030|NCT00549770|1835789|FG000|Overall Study|Abnormal laboratory values|0
874031|NCT00549770|1835790|FG001|Overall Study|Abnormal laboratory values|0
874032|NCT00549770|1835791|FG002|Overall Study|Abnormal laboratory values|0
874033|NCT00549770|1835792|FG003|Overall Study|Abnormal laboratory values|0
874034|NCT00549770|1835793|FG004|Overall Study|Abnormal laboratory values|0
874035|NCT00549770|1835794|FG005|Overall Study|Abnormal laboratory values|1
874036|NCT00549770|1835795|FG006|Overall Study|Abnormal laboratory values|0
874037|NCT00549770|1835796|FG007|Overall Study|Abnormal laboratory values|0
874038|NCT00549770|1835789|FG000|Overall Study|Adverse Event|1
874039|NCT00549770|1835790|FG001|Overall Study|Adverse Event|3
874040|NCT00549770|1835791|FG002|Overall Study|Adverse Event|1
874041|NCT00549770|1835792|FG003|Overall Study|Adverse Event|2
874042|NCT00549770|1835793|FG004|Overall Study|Adverse Event|1
874043|NCT00549770|1835794|FG005|Overall Study|Adverse Event|0
874044|NCT00549770|1835795|FG006|Overall Study|Adverse Event|5
874045|NCT00549770|1835796|FG007|Overall Study|Adverse Event|4
874046|NCT00549900|1835827|FG000|Overall Study|Adverse Event|1
874047|NCT00549939|1835834|FG000|12-week Double Blind Treatment Period|Adverse Event|1
874048|NCT00549939|1835835|FG001|12-week Double Blind Treatment Period|Adverse Event|1
1006582|NCT01468701|2025291|FG006|Overall Study|Other reasons than listed|0
1177977|NCT00547300|2330736|FG001|Overall Study|Study was Administratively Terminated|24
1177978|NCT00547300|2330735|FG000|Overall Study|Did not Meet Entry Criteria|0
1177979|NCT00547300|2330736|FG001|Overall Study|Did not Meet Entry Criteria|2
1177980|NCT00535262|2330768|FG000|Overall Study|No funding|3
1177981|NCT00537199|2330785|FG000|Overall Study|Study Terminated|1
1177982|NCT00536978|2330795|FG000|Overall Study|Not eligible for Adback Infusion|22
1177983|NCT00524485|2330799|FG000|Overall Study|Withdrawal by Subject|5
1177984|NCT00524134|2330821|FG000|Overall Study|Withdrawal by Subject|1
1177985|NCT00524134|2330821|FG000|Overall Study|Physician Decision|1
1177986|NCT00527748|2330825|FG000|Overall Study|Other|3
1177987|NCT00517699|2330829|FG000|Overall Study|Withdrawal by Subject|1
1177988|NCT00517699|2330829|FG000|Overall Study|Lack of Efficacy|1
1177989|NCT00517699|2330829|FG000|Overall Study|Administrative error|1
1177990|NCT00517699|2330829|FG000|Overall Study|Study terminated by Sponsor|2
1177991|NCT00528775|2330833|FG000|Overall Study|Other not specified|1
1177992|NCT00527982|2330869|FG000|Overall Study|Physician Decision|1
1177993|NCT00527982|2330870|FG001|Overall Study|Physician Decision|0
1177994|NCT00524459|2330876|FG000|Overall Study|Withdrawal by Subject|1
1177995|NCT00524459|2330876|FG000|Overall Study|Other|1
1177996|NCT00517361|2330880|FG000|Overall Study|Death|6
1177997|NCT00517361|2330880|FG000|Overall Study|The study was terminated|5
1177998|NCT00522457|2330892|FG000|Overall Study|Due to disease progression|16
1177999|NCT00522457|2330892|FG000|Overall Study|Adverse Event|2
1178000|NCT00526331|2330896|FG000|Overall Study|Sponsor Termination|55
1178001|NCT00522301|2330917|FG000|Overall Study|Withdrawal by Subject|1
1178002|NCT00522301|2330917|FG000|Overall Study|Adverse Event|5
1178003|NCT00517192|2330923|FG000|Overall Study|Adverse Event|1
1178004|NCT00517192|2330924|FG001|Overall Study|Adverse Event|1
1178005|NCT00517192|2330923|FG000|Overall Study|Lost to Follow-up|1
1178006|NCT00517192|2330924|FG001|Overall Study|Lost to Follow-up|1
1178007|NCT00517192|2330923|FG000|Overall Study|Withdrawal by Subject|1
1178008|NCT00517192|2330924|FG001|Overall Study|Withdrawal by Subject|0
1178009|NCT00517192|2330923|FG000|Overall Study|Early termination of the trial|16
874049|NCT00549939|1835836|FG002|12-week Double Blind Treatment Period|Adverse Event|2
874050|NCT00549939|1835834|FG000|12-week Double Blind Treatment Period|Too many blood draws|0
874051|NCT00549939|1835835|FG001|12-week Double Blind Treatment Period|Too many blood draws|1
874052|NCT00549939|1835836|FG002|12-week Double Blind Treatment Period|Too many blood draws|0
874053|NCT00549939|1835834|FG000|40-week Open Label Treatment Period|Adverse Event|0
874054|NCT00549939|1835835|FG001|40-week Open Label Treatment Period|Adverse Event|2
874055|NCT00549939|1835836|FG002|40-week Open Label Treatment Period|Adverse Event|1
874056|NCT00549939|1835834|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0
874057|NCT00549939|1835835|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1
874058|NCT00549939|1835836|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0
874059|NCT00549939|1835834|FG000|40-week Open Label Treatment Period|Protocol Violation|0
874060|NCT00549939|1835835|FG001|40-week Open Label Treatment Period|Protocol Violation|1
874061|NCT00549939|1835836|FG002|40-week Open Label Treatment Period|Protocol Violation|0
874062|NCT00549939|1835834|FG000|40-week Open Label Treatment Period|Other|0
874063|NCT00549939|1835835|FG001|40-week Open Label Treatment Period|Other|1
874064|NCT00549939|1835836|FG002|40-week Open Label Treatment Period|Other|4
874065|NCT00550043|1835851|FG000|Overall Study|Adverse Event|0
874066|NCT00550043|1835852|FG001|Overall Study|Adverse Event|0
874067|NCT00550043|1835853|FG002|Overall Study|Adverse Event|0
874068|NCT00550043|1835854|FG003|Overall Study|Adverse Event|1
874069|NCT00550043|1835855|FG004|Overall Study|Adverse Event|1
874070|NCT00550043|1835851|FG000|Overall Study|Subject Withdrew Consent|0
874071|NCT00550043|1835852|FG001|Overall Study|Subject Withdrew Consent|2
874072|NCT00550043|1835853|FG002|Overall Study|Subject Withdrew Consent|1
874073|NCT00550043|1835854|FG003|Overall Study|Subject Withdrew Consent|0
874074|NCT00550043|1835855|FG004|Overall Study|Subject Withdrew Consent|0
874075|NCT00550043|1835851|FG000|Overall Study|Other Reasons- Unspecified|0
874076|NCT00550043|1835852|FG001|Overall Study|Other Reasons- Unspecified|1
874077|NCT00550043|1835853|FG002|Overall Study|Other Reasons- Unspecified|0
874078|NCT00550043|1835854|FG003|Overall Study|Other Reasons- Unspecified|1
874079|NCT00550043|1835855|FG004|Overall Study|Other Reasons- Unspecified|0
874080|NCT00550147|1835867|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
874081|NCT00550147|1835867|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
874082|NCT00550147|1835867|FG000|Quetiapine Addition Treatment Period|Adverse Event|3
874083|NCT00550147|1835867|FG000|Quetiapine Addition Treatment Period|Noncompliance|2
874084|NCT00550147|1835867|FG000|Quetiapine Addition Treatment Period|Moved out of state|1
874085|NCT00550173|1835883|FG000|Overall Study|Death|45
874086|NCT00550173|1835884|FG001|Overall Study|Death|38
874087|NCT00550173|1835885|FG002|Overall Study|Death|50
874088|NCT00550173|1835883|FG000|Overall Study|Physician Decision|1
874089|NCT00550173|1835884|FG001|Overall Study|Physician Decision|2
874090|NCT00550173|1835885|FG002|Overall Study|Physician Decision|2
874091|NCT00550173|1835883|FG000|Overall Study|Withdrawal by Subject|9
874092|NCT00550173|1835884|FG001|Overall Study|Withdrawal by Subject|12
874093|NCT00550173|1835885|FG002|Overall Study|Withdrawal by Subject|17
874094|NCT00550173|1835883|FG000|Overall Study|Sponsor Decision|13
874095|NCT00550173|1835884|FG001|Overall Study|Sponsor Decision|7
874096|NCT00550173|1835885|FG002|Overall Study|Sponsor Decision|1
874097|NCT00550173|1835883|FG000|Overall Study|Lost to Follow-up|4
874098|NCT00550173|1835884|FG001|Overall Study|Lost to Follow-up|4
874099|NCT00550173|1835885|FG002|Overall Study|Lost to Follow-up|3
1178010|NCT00517192|2330924|FG001|Overall Study|Early termination of the trial|18
1178011|NCT00503581|2330937|FG000|Overall Study|Study closed|3
1178012|NCT00503581|2330938|FG001|Overall Study|Study closed|4
1178013|NCT00503581|2330939|FG002|Overall Study|Study closed|2
1178014|NCT00509600|2330947|FG000|Overall Study|Adverse Event|1
1178015|NCT00515112|2330953|FG000|Overall Study|Death|0
1178016|NCT00515112|2330954|FG001|Overall Study|Death|1
1178017|NCT00515112|2330953|FG000|Overall Study|The study was terminated|3
1178018|NCT00515112|2330954|FG001|Overall Study|The study was terminated|2
1178019|NCT00508872|2330960|FG000|Overall Study|Lost to Follow-up|1
1178020|NCT00508872|2330960|FG000|Overall Study|Physician Decision|1
1178021|NCT00514813|2330968|FG000|Overall Study|Study terminated|14
1178022|NCT00514813|2330969|FG001|Overall Study|Study terminated|74
1178023|NCT00514813|2330970|FG002|Overall Study|Study terminated|40
1178024|NCT00514813|2330971|FG003|Overall Study|Study terminated|2
1178025|NCT00514813|2330968|FG000|Overall Study|Adverse Event|0
1178026|NCT00514813|2330969|FG001|Overall Study|Adverse Event|2
1178027|NCT00514813|2330970|FG002|Overall Study|Adverse Event|2
1178028|NCT00514813|2330971|FG003|Overall Study|Adverse Event|0
1178029|NCT00514813|2330968|FG000|Overall Study|Protocol Violation|1
1178030|NCT00514813|2330969|FG001|Overall Study|Protocol Violation|0
874100|NCT00550238|1835894|FG000|Overall Study|Adverse Event|88
874101|NCT00550238|1835894|FG000|Overall Study|Death|34
874102|NCT00550238|1835894|FG000|Overall Study|Disease progression|46
874103|NCT00550238|1835894|FG000|Overall Study|Withdrawal by Subject|167
874104|NCT00550238|1835894|FG000|Overall Study|Physician Decision|31
874105|NCT00550238|1835894|FG000|Overall Study|Patient noncompliance|25
874106|NCT00550238|1835894|FG000|Overall Study|Lost to Follow-up|13
874107|NCT00550238|1835894|FG000|Overall Study|Sponsor decision|55
874108|NCT00550407|1835933|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
874109|NCT00550407|1835934|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
874110|NCT00550407|1835935|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
874111|NCT00550407|1835933|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
874112|NCT00550407|1835934|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
874113|NCT00550407|1835935|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
874114|NCT00550407|1835933|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
874115|NCT00550407|1835934|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
874116|NCT00550407|1835935|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
874117|NCT00550407|1835933|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
874118|NCT00550407|1835934|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
874119|NCT00550407|1835935|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
874120|NCT00550407|1835933|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
874121|NCT00550407|1835934|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
874122|NCT00550407|1835935|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
874123|NCT00550407|1835933|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
874124|NCT00550407|1835934|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
874125|NCT00550407|1835935|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
874126|NCT00550407|1835933|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
874127|NCT00550407|1835934|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
874128|NCT00550407|1835935|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
874129|NCT00550407|1835933|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
874130|NCT00550407|1835934|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
874131|NCT00550407|1835935|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
874132|NCT00550407|1835933|FG000|26-Week Randomized Phase|Adverse Event|0
874133|NCT00550407|1835934|FG001|26-Week Randomized Phase|Adverse Event|5
874134|NCT00550407|1835935|FG002|26-Week Randomized Phase|Adverse Event|2
874135|NCT00550407|1835933|FG000|26-Week Randomized Phase|Lack of Efficacy|0
874136|NCT00550407|1835934|FG001|26-Week Randomized Phase|Lack of Efficacy|36
874137|NCT00550407|1835935|FG002|26-Week Randomized Phase|Lack of Efficacy|19
874138|NCT00550407|1835933|FG000|26-Week Randomized Phase|Investigator Discretion|0
874139|NCT00550407|1835934|FG001|26-Week Randomized Phase|Investigator Discretion|1
874140|NCT00550407|1835935|FG002|26-Week Randomized Phase|Investigator Discretion|0
874141|NCT00550407|1835933|FG000|26-Week Randomized Phase|Withdrawal by Subject|0
874142|NCT00550407|1835934|FG001|26-Week Randomized Phase|Withdrawal by Subject|1
874143|NCT00550407|1835935|FG002|26-Week Randomized Phase|Withdrawal by Subject|3
874144|NCT00550420|1835943|FG000|Overall Study|Adverse Event|28
874145|NCT00550420|1835943|FG000|Overall Study|Lost to Follow-up|8
874146|NCT00550420|1835943|FG000|Overall Study|Protocol Violation|11
874147|NCT00550420|1835943|FG000|Overall Study|Withdrawal by Subject|30
874148|NCT00550420|1835943|FG000|Overall Study|Still in study at termination|206
874149|NCT00550420|1835943|FG000|Overall Study|Missing|2
874150|NCT00550420|1835943|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12
874151|NCT00550420|1835943|FG000|Overall Study|Investigators opinion|1
874152|NCT00550420|1835943|FG000|Overall Study|Lack of curative effect|1
874153|NCT00550420|1835943|FG000|Overall Study|Unethical stop of enrollment|2
874154|NCT00550420|1835943|FG000|Overall Study|Caregiver's decision to withdraw|1
874155|NCT00550420|1835943|FG000|Overall Study|Out of Electrocardiogram criteria|1
874156|NCT00550420|1835943|FG000|Overall Study|Exclusion criteria|1
874157|NCT00550420|1835943|FG000|Overall Study|Prohibited medicine|1
874158|NCT00550446|1835956|FG000|Up To Week 12|Adverse Event|2
874159|NCT00550446|1835957|FG001|Up To Week 12|Adverse Event|2
874160|NCT00550446|1835958|FG002|Up To Week 12|Adverse Event|0
874161|NCT00550446|1835959|FG003|Up To Week 12|Adverse Event|0
874162|NCT00550446|1835960|FG004|Up To Week 12|Adverse Event|2
874163|NCT00550446|1835961|FG005|Up To Week 12|Adverse Event|2
874164|NCT00550446|1835962|FG006|Up To Week 12|Adverse Event|1
874165|NCT00550446|1835963|FG007|Up To Week 12|Adverse Event|0
874166|NCT00550446|1835964|FG008|Up To Week 12|Adverse Event|0
874167|NCT00550446|1835965|FG009|Up To Week 12|Adverse Event|0
874168|NCT00550446|1835966|FG010|Up To Week 12|Adverse Event|0
874169|NCT00550446|1835956|FG000|Up To Week 12|Lack of Efficacy|3
874170|NCT00550446|1835957|FG001|Up To Week 12|Lack of Efficacy|1
874171|NCT00550446|1835958|FG002|Up To Week 12|Lack of Efficacy|0
874172|NCT00550446|1835959|FG003|Up To Week 12|Lack of Efficacy|1
874173|NCT00550446|1835960|FG004|Up To Week 12|Lack of Efficacy|0
874174|NCT00550446|1835961|FG005|Up To Week 12|Lack of Efficacy|3
874175|NCT00550446|1835962|FG006|Up To Week 12|Lack of Efficacy|3
874176|NCT00550446|1835963|FG007|Up To Week 12|Lack of Efficacy|0
874177|NCT00550446|1835964|FG008|Up To Week 12|Lack of Efficacy|0
874178|NCT00550446|1835965|FG009|Up To Week 12|Lack of Efficacy|0
874179|NCT00550446|1835966|FG010|Up To Week 12|Lack of Efficacy|0
874180|NCT00550446|1835956|FG000|Up To Week 12|Lost to Follow-up|0
874181|NCT00550446|1835957|FG001|Up To Week 12|Lost to Follow-up|1
874182|NCT00550446|1835958|FG002|Up To Week 12|Lost to Follow-up|0
874183|NCT00550446|1835959|FG003|Up To Week 12|Lost to Follow-up|0
874184|NCT00550446|1835960|FG004|Up To Week 12|Lost to Follow-up|1
874185|NCT00550446|1835961|FG005|Up To Week 12|Lost to Follow-up|1
874186|NCT00550446|1835962|FG006|Up To Week 12|Lost to Follow-up|2
874187|NCT00550446|1835963|FG007|Up To Week 12|Lost to Follow-up|0
874188|NCT00550446|1835964|FG008|Up To Week 12|Lost to Follow-up|0
874189|NCT00550446|1835965|FG009|Up To Week 12|Lost to Follow-up|0
874190|NCT00550446|1835966|FG010|Up To Week 12|Lost to Follow-up|0
874191|NCT00550446|1835956|FG000|Up To Week 12|Withdrawal by Subject|2
874192|NCT00550446|1835957|FG001|Up To Week 12|Withdrawal by Subject|0
874193|NCT00550446|1835958|FG002|Up To Week 12|Withdrawal by Subject|3
874194|NCT00550446|1835959|FG003|Up To Week 12|Withdrawal by Subject|2
874195|NCT00550446|1835960|FG004|Up To Week 12|Withdrawal by Subject|0
874196|NCT00550446|1835961|FG005|Up To Week 12|Withdrawal by Subject|1
874197|NCT00550446|1835962|FG006|Up To Week 12|Withdrawal by Subject|3
874198|NCT00550446|1835963|FG007|Up To Week 12|Withdrawal by Subject|0
874199|NCT00550446|1835964|FG008|Up To Week 12|Withdrawal by Subject|0
874200|NCT00550446|1835965|FG009|Up To Week 12|Withdrawal by Subject|0
874201|NCT00550446|1835966|FG010|Up To Week 12|Withdrawal by Subject|0
874202|NCT00550446|1835956|FG000|Up To Week 12|Other|3
874203|NCT00550446|1835957|FG001|Up To Week 12|Other|0
874204|NCT00550446|1835958|FG002|Up To Week 12|Other|0
874205|NCT00550446|1835959|FG003|Up To Week 12|Other|0
874206|NCT00550446|1835960|FG004|Up To Week 12|Other|0
874207|NCT00550446|1835961|FG005|Up To Week 12|Other|1
874208|NCT00550446|1835962|FG006|Up To Week 12|Other|4
874209|NCT00550446|1835963|FG007|Up To Week 12|Other|0
874210|NCT00550446|1835964|FG008|Up To Week 12|Other|0
874211|NCT00550446|1835965|FG009|Up To Week 12|Other|0
874212|NCT00550446|1835966|FG010|Up To Week 12|Other|0
874213|NCT00550446|1835956|FG000|Up To Week 12|Randomized not treated|0
874214|NCT00550446|1835957|FG001|Up To Week 12|Randomized not treated|1
874215|NCT00550446|1835958|FG002|Up To Week 12|Randomized not treated|1
874216|NCT00550446|1835959|FG003|Up To Week 12|Randomized not treated|0
874217|NCT00550446|1835960|FG004|Up To Week 12|Randomized not treated|0
874218|NCT00550446|1835961|FG005|Up To Week 12|Randomized not treated|0
874219|NCT00550446|1835962|FG006|Up To Week 12|Randomized not treated|0
874220|NCT00550446|1835963|FG007|Up To Week 12|Randomized not treated|0
874221|NCT00550446|1835964|FG008|Up To Week 12|Randomized not treated|0
874222|NCT00550446|1835965|FG009|Up To Week 12|Randomized not treated|0
874223|NCT00550446|1835966|FG010|Up To Week 12|Randomized not treated|0
874224|NCT00550446|1835956|FG000|Post Week 12|Adverse Event|2
874225|NCT00550446|1835957|FG001|Post Week 12|Adverse Event|1
874226|NCT00550446|1835958|FG002|Post Week 12|Adverse Event|1
874227|NCT00550446|1835959|FG003|Post Week 12|Adverse Event|1
874228|NCT00550446|1835960|FG004|Post Week 12|Adverse Event|1
874229|NCT00550446|1835961|FG005|Post Week 12|Adverse Event|1
874230|NCT00550446|1835962|FG006|Post Week 12|Adverse Event|0
874231|NCT00550446|1835963|FG007|Post Week 12|Adverse Event|0
874232|NCT00550446|1835964|FG008|Post Week 12|Adverse Event|0
874233|NCT00550446|1835965|FG009|Post Week 12|Adverse Event|4
874234|NCT00550446|1835966|FG010|Post Week 12|Adverse Event|0
874235|NCT00550446|1835956|FG000|Post Week 12|Lack of Efficacy|0
874236|NCT00550446|1835957|FG001|Post Week 12|Lack of Efficacy|0
874237|NCT00550446|1835958|FG002|Post Week 12|Lack of Efficacy|1
874238|NCT00550446|1835959|FG003|Post Week 12|Lack of Efficacy|0
874239|NCT00550446|1835960|FG004|Post Week 12|Lack of Efficacy|0
874240|NCT00550446|1835961|FG005|Post Week 12|Lack of Efficacy|0
874241|NCT00550446|1835962|FG006|Post Week 12|Lack of Efficacy|0
874242|NCT00550446|1835963|FG007|Post Week 12|Lack of Efficacy|1
874243|NCT00550446|1835964|FG008|Post Week 12|Lack of Efficacy|1
874244|NCT00550446|1835965|FG009|Post Week 12|Lack of Efficacy|2
874245|NCT00550446|1835966|FG010|Post Week 12|Lack of Efficacy|1
1178031|NCT00514813|2330970|FG002|Overall Study|Protocol Violation|0
1178032|NCT00514813|2330971|FG003|Overall Study|Protocol Violation|0
1178033|NCT00514813|2330968|FG000|Overall Study|Withdrawal by Subject|0
1178034|NCT00514813|2330969|FG001|Overall Study|Withdrawal by Subject|1
1178035|NCT00514813|2330970|FG002|Overall Study|Withdrawal by Subject|0
874246|NCT00550446|1835956|FG000|Post Week 12|Lost to Follow-up|0
874247|NCT00550446|1835957|FG001|Post Week 12|Lost to Follow-up|0
874248|NCT00550446|1835958|FG002|Post Week 12|Lost to Follow-up|1
874249|NCT00550446|1835959|FG003|Post Week 12|Lost to Follow-up|1
874250|NCT00550446|1835960|FG004|Post Week 12|Lost to Follow-up|0
874251|NCT00550446|1835961|FG005|Post Week 12|Lost to Follow-up|0
874252|NCT00550446|1835962|FG006|Post Week 12|Lost to Follow-up|1
874253|NCT00550446|1835963|FG007|Post Week 12|Lost to Follow-up|0
874254|NCT00550446|1835964|FG008|Post Week 12|Lost to Follow-up|0
874255|NCT00550446|1835965|FG009|Post Week 12|Lost to Follow-up|0
874256|NCT00550446|1835966|FG010|Post Week 12|Lost to Follow-up|0
874257|NCT00550446|1835956|FG000|Post Week 12|Withdrawal by Subject|0
874258|NCT00550446|1835957|FG001|Post Week 12|Withdrawal by Subject|0
874259|NCT00550446|1835958|FG002|Post Week 12|Withdrawal by Subject|0
874260|NCT00550446|1835959|FG003|Post Week 12|Withdrawal by Subject|0
874261|NCT00550446|1835960|FG004|Post Week 12|Withdrawal by Subject|1
874262|NCT00550446|1835961|FG005|Post Week 12|Withdrawal by Subject|0
874263|NCT00550446|1835962|FG006|Post Week 12|Withdrawal by Subject|0
874264|NCT00550446|1835963|FG007|Post Week 12|Withdrawal by Subject|0
874265|NCT00550446|1835964|FG008|Post Week 12|Withdrawal by Subject|0
874266|NCT00550446|1835965|FG009|Post Week 12|Withdrawal by Subject|0
874267|NCT00550446|1835966|FG010|Post Week 12|Withdrawal by Subject|0
874268|NCT00550446|1835956|FG000|Post Week 12|Other|1
874269|NCT00550446|1835957|FG001|Post Week 12|Other|1
874270|NCT00550446|1835958|FG002|Post Week 12|Other|0
874271|NCT00550446|1835959|FG003|Post Week 12|Other|1
874272|NCT00550446|1835960|FG004|Post Week 12|Other|0
874273|NCT00550446|1835961|FG005|Post Week 12|Other|0
874274|NCT00550446|1835962|FG006|Post Week 12|Other|1
874275|NCT00550446|1835963|FG007|Post Week 12|Other|0
874276|NCT00550446|1835964|FG008|Post Week 12|Other|1
874277|NCT00550446|1835965|FG009|Post Week 12|Other|1
874278|NCT00550446|1835966|FG010|Post Week 12|Other|0
874279|NCT00550459|1836006|FG000|Overall Study|Adverse Event|0
874280|NCT00550459|1836007|FG001|Overall Study|Adverse Event|2
874281|NCT00550459|1836006|FG000|Overall Study|Withdrawal by Subject|1
874282|NCT00550459|1836007|FG001|Overall Study|Withdrawal by Subject|1
874283|NCT00550537|1836013|FG000|Overall Study|Death|18
874284|NCT00550537|1836013|FG000|Overall Study|Adverse Event|20
874285|NCT00550537|1836013|FG000|Overall Study|Disease progression before|46
874286|NCT00550537|1836013|FG000|Overall Study|Withdrawal by Subject|7
874287|NCT00550537|1836013|FG000|Overall Study|Change in treatment plan|4
874288|NCT00550537|1836013|FG000|Overall Study|Other complicating ilness|3
874289|NCT00550537|1836013|FG000|Overall Study|Declining performance status|2
874290|NCT00550537|1836013|FG000|Overall Study|Treated closer to home|4
874291|NCT00550550|1836024|FG000|Overall Study|Adverse Event|13
874292|NCT00550550|1836025|FG001|Overall Study|Adverse Event|5
874293|NCT00550550|1836024|FG000|Overall Study|Treatment Failure|0
874294|NCT00550550|1836025|FG001|Overall Study|Treatment Failure|1
874295|NCT00550550|1836024|FG000|Overall Study|Lost to Follow-up|4
874296|NCT00550550|1836025|FG001|Overall Study|Lost to Follow-up|0
874297|NCT00550550|1836024|FG000|Overall Study|Withdrawal by Subject|10
874298|NCT00550550|1836025|FG001|Overall Study|Withdrawal by Subject|8
874299|NCT00550550|1836024|FG000|Overall Study|Protocol Violation|5
874300|NCT00550550|1836025|FG001|Overall Study|Protocol Violation|14
874301|NCT00550550|1836024|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
874302|NCT00550550|1836025|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
874303|NCT00550550|1836024|FG000|Overall Study|Randomized But Not Treated|1
874304|NCT00550550|1836025|FG001|Overall Study|Randomized But Not Treated|0
874305|NCT00550615|1836039|FG000|Overall Study|Withdrawal by Subject|0
874306|NCT00550615|1836040|FG001|Overall Study|Withdrawal by Subject|0
874307|NCT00550615|1836041|FG002|Overall Study|Withdrawal by Subject|2
874308|NCT00550615|1836042|FG003|Overall Study|Withdrawal by Subject|3
874309|NCT00550615|1836039|FG000|Overall Study|Not evaluable|0
874310|NCT00550615|1836040|FG001|Overall Study|Not evaluable|0
874311|NCT00550615|1836041|FG002|Overall Study|Not evaluable|2
874312|NCT00550615|1836042|FG003|Overall Study|Not evaluable|7
874313|NCT00550680|1836052|FG000|Overall Study|Administrative Reasons|1
874314|NCT00550680|1836052|FG000|Overall Study|Adverse Event|5
874315|NCT00550680|1836052|FG000|Overall Study|Death|3
874316|NCT00550680|1836052|FG000|Overall Study|Early Improvement|1
874317|NCT00550680|1836052|FG000|Overall Study|Lost to Follow-up|3
874318|NCT00550680|1836052|FG000|Overall Study|Lack of Efficacy|1
874319|NCT00550680|1836052|FG000|Overall Study|Other|10
874320|NCT00550680|1836052|FG000|Overall Study|Protocol Violation|7
874321|NCT00550680|1836052|FG000|Overall Study|Refused Treatment|19
874322|NCT00550680|1836052|FG000|Overall Study|Screen Failure|6
874323|NCT00550732|1836056|FG000|Overall Study|Death|4
874324|NCT00550732|1836056|FG000|Overall Study|Withdrawal by Subject|2
1178036|NCT00514813|2330971|FG003|Overall Study|Withdrawal by Subject|0
1178037|NCT00514813|2330968|FG000|Overall Study|Lack of Efficacy|0
1178038|NCT00514813|2330969|FG001|Overall Study|Lack of Efficacy|1
1178039|NCT00514813|2330970|FG002|Overall Study|Lack of Efficacy|0
1178040|NCT00514813|2330971|FG003|Overall Study|Lack of Efficacy|0
1178041|NCT00514813|2330968|FG000|Overall Study|Kidney transplant|0
1178042|NCT00514813|2330969|FG001|Overall Study|Kidney transplant|6
1178043|NCT00514813|2330970|FG002|Overall Study|Kidney transplant|2
874325|NCT00550732|1836056|FG000|Overall Study|Physician Decision|2
874326|NCT00550732|1836056|FG000|Overall Study|Lost to Follow-up|1
874327|NCT00550732|1836056|FG000|Overall Study|Palliative care|1
874328|NCT00550732|1836056|FG000|Overall Study|Adverse Event|1
874329|NCT00550745|1836063|FG000|Overall Study|Death|20
874330|NCT00550745|1836064|FG001|Overall Study|Death|16
874331|NCT00550745|1836063|FG000|Overall Study|Lost to Follow-up|45
874332|NCT00550745|1836064|FG001|Overall Study|Lost to Follow-up|30
874333|NCT00550745|1836063|FG000|Overall Study|Physician Decision|0
874334|NCT00550745|1836064|FG001|Overall Study|Physician Decision|2
874335|NCT00550745|1836063|FG000|Overall Study|Protocol Violation|4
874336|NCT00550745|1836064|FG001|Overall Study|Protocol Violation|2
874337|NCT00550745|1836063|FG000|Overall Study|Withdrawal by Subject|17
874338|NCT00550745|1836064|FG001|Overall Study|Withdrawal by Subject|10
874339|NCT00550745|1836063|FG000|Overall Study|Screen failure|1
874340|NCT00550745|1836064|FG001|Overall Study|Screen failure|0
874341|NCT00550771|1836072|FG000|Overall Study|Adverse Event|11
874342|NCT00550771|1836073|FG001|Overall Study|Adverse Event|3
874343|NCT00550771|1836072|FG000|Overall Study|Discontinued for study-related reasons|0
874344|NCT00550771|1836073|FG001|Overall Study|Discontinued for study-related reasons|1
874345|NCT00550771|1836072|FG000|Overall Study|Physician Decision|2
874346|NCT00550771|1836073|FG001|Overall Study|Physician Decision|0
874347|NCT00550771|1836072|FG000|Overall Study|Withdrawal by Subject|0
874348|NCT00550771|1836073|FG001|Overall Study|Withdrawal by Subject|1
874349|NCT00550771|1836072|FG000|Overall Study|Protocol Violation|4
874350|NCT00550771|1836073|FG001|Overall Study|Protocol Violation|5
874351|NCT00550836|1836081|FG000|Overall Study|Withdrawal by Subject|3
874352|NCT00550836|1836082|FG001|Overall Study|Withdrawal by Subject|9
874353|NCT00550953|1836107|FG000|Overall Study|Adverse Event|4
874354|NCT00550953|1836108|FG001|Overall Study|Adverse Event|3
874355|NCT00550953|1836107|FG000|Overall Study|Not able to visit the site|2
874356|NCT00550953|1836108|FG001|Overall Study|Not able to visit the site|3
874357|NCT00551031|1836119|FG000|Overall Study|Adverse Event|0
874358|NCT00551031|1836120|FG001|Overall Study|Adverse Event|1
874359|NCT00551031|1836121|FG002|Overall Study|Adverse Event|0
874360|NCT00551031|1836122|FG003|Overall Study|Adverse Event|0
874361|NCT00551031|1836123|FG004|Overall Study|Adverse Event|0
874362|NCT00551031|1836119|FG000|Overall Study|Protocol Violation|1
874363|NCT00551031|1836120|FG001|Overall Study|Protocol Violation|1
874364|NCT00551031|1836121|FG002|Overall Study|Protocol Violation|0
874365|NCT00551031|1836122|FG003|Overall Study|Protocol Violation|0
874366|NCT00551031|1836123|FG004|Overall Study|Protocol Violation|0
874367|NCT00551031|1836119|FG000|Overall Study|Lost to Follow-up|0
874368|NCT00551031|1836120|FG001|Overall Study|Lost to Follow-up|1
874369|NCT00551031|1836121|FG002|Overall Study|Lost to Follow-up|0
874370|NCT00551031|1836122|FG003|Overall Study|Lost to Follow-up|1
874371|NCT00551031|1836123|FG004|Overall Study|Lost to Follow-up|1
874372|NCT00551031|1836119|FG000|Overall Study|Withdrawal by Subject|0
874373|NCT00551031|1836120|FG001|Overall Study|Withdrawal by Subject|4
874374|NCT00551031|1836121|FG002|Overall Study|Withdrawal by Subject|1
874375|NCT00551031|1836122|FG003|Overall Study|Withdrawal by Subject|2
874376|NCT00551031|1836123|FG004|Overall Study|Withdrawal by Subject|0
874377|NCT00551031|1836119|FG000|Overall Study|Serious Adverse Event|0
874378|NCT00551031|1836120|FG001|Overall Study|Serious Adverse Event|2
874379|NCT00551031|1836121|FG002|Overall Study|Serious Adverse Event|1
874380|NCT00551031|1836122|FG003|Overall Study|Serious Adverse Event|0
874381|NCT00551031|1836123|FG004|Overall Study|Serious Adverse Event|0
874382|NCT00551031|1836119|FG000|Overall Study|Did not receive vaccine|1
874383|NCT00551031|1836120|FG001|Overall Study|Did not receive vaccine|2
874384|NCT00551031|1836121|FG002|Overall Study|Did not receive vaccine|0
874385|NCT00551031|1836122|FG003|Overall Study|Did not receive vaccine|0
874386|NCT00551031|1836123|FG004|Overall Study|Did not receive vaccine|0
874387|NCT00551135|1836143|FG000|Overall Study|Adverse Event|1
874388|NCT00551135|1836144|FG001|Overall Study|Adverse Event|0
874389|NCT00551135|1836145|FG002|Overall Study|Adverse Event|1
874390|NCT00551135|1836146|FG003|Overall Study|Adverse Event|1
874391|NCT00551135|1836143|FG000|Overall Study|Lost to Follow-up|0
874392|NCT00551135|1836144|FG001|Overall Study|Lost to Follow-up|0
874393|NCT00551135|1836145|FG002|Overall Study|Lost to Follow-up|0
874394|NCT00551135|1836146|FG003|Overall Study|Lost to Follow-up|1
874395|NCT00551135|1836143|FG000|Overall Study|Other|3
874396|NCT00551135|1836144|FG001|Overall Study|Other|2
874397|NCT00551135|1836145|FG002|Overall Study|Other|1
874398|NCT00551135|1836146|FG003|Overall Study|Other|2
874399|NCT00551135|1836143|FG000|Overall Study|Withdrawal by Subject|1
874400|NCT00551135|1836144|FG001|Overall Study|Withdrawal by Subject|0
874401|NCT00551135|1836145|FG002|Overall Study|Withdrawal by Subject|3
874402|NCT00551135|1836146|FG003|Overall Study|Withdrawal by Subject|1
874403|NCT00551161|1836156|FG000|Overall Study|Withdrawal by Subject|1
874404|NCT00551213|1836181|FG000|Overall Study|Adverse Event|6
1178044|NCT00514813|2330971|FG003|Overall Study|Kidney transplant|0
1178045|NCT00514813|2330968|FG000|Overall Study|Death|0
1178046|NCT00514813|2330969|FG001|Overall Study|Death|2
1178047|NCT00514813|2330970|FG002|Overall Study|Death|3
1178048|NCT00514813|2330971|FG003|Overall Study|Death|2
874405|NCT00551213|1836182|FG001|Overall Study|Adverse Event|3
874406|NCT00551213|1836181|FG000|Overall Study|Progressive Disease|41
874407|NCT00551213|1836182|FG001|Overall Study|Progressive Disease|12
874408|NCT00551213|1836181|FG000|Overall Study|Withdrawal by Subject|2
874409|NCT00551213|1836182|FG001|Overall Study|Withdrawal by Subject|0
874410|NCT00551213|1836181|FG000|Overall Study|Not Treated|1
874411|NCT00551213|1836182|FG001|Overall Study|Not Treated|2
874412|NCT00551291|1836188|FG000|Overall Study|Physician Decision|1
874413|NCT00551369|1836192|FG000|Overall Study|Protocol Violation|5
874414|NCT00551369|1836192|FG000|Overall Study|Withdrawal by Subject|1
874415|NCT00551369|1836192|FG000|Overall Study|Not treated per protocol and re|1
874416|NCT00551421|1836196|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
874417|NCT00551460|1836201|FG000|Overall Study|Adverse Event|1
874418|NCT00551460|1836201|FG000|Overall Study|Withdrawal by Subject|1
874419|NCT00551460|1836201|FG000|Overall Study|Physician Decision|1
874420|NCT00551460|1836201|FG000|Overall Study|Death|7
874421|NCT00551460|1836201|FG000|Overall Study|Ineligible|4
874422|NCT00551460|1836201|FG000|Overall Study|Not analyzable (did not start treatment)|4
874423|NCT00551525|1836205|FG000|Overall Study|Protocol Violation|5
874424|NCT00551642|1836211|FG000|Treatment Period|Protocol Deviation|6
874425|NCT00551642|1836212|FG001|Treatment Period|Protocol Deviation|11
874426|NCT00551642|1836211|FG000|Treatment Period|Delivery device failure|1
874427|NCT00551642|1836212|FG001|Treatment Period|Delivery device failure|3
874428|NCT00551642|1836211|FG000|Treatment Period|Physician Decision|0
874429|NCT00551642|1836212|FG001|Treatment Period|Physician Decision|1
874430|NCT00551642|1836211|FG000|Treatment Period|Death|33
874431|NCT00551642|1836212|FG001|Treatment Period|Death|31
874432|NCT00551642|1836211|FG000|Treatment Period|Inclusion/Exclusion criteria|4
874433|NCT00551642|1836212|FG001|Treatment Period|Inclusion/Exclusion criteria|4
874434|NCT00551642|1836211|FG000|Treatment Period|Adverse Event|15
874435|NCT00551642|1836212|FG001|Treatment Period|Adverse Event|12
874436|NCT00551642|1836211|FG000|Treatment Period|Withdrawal by Subject|2
874437|NCT00551642|1836212|FG001|Treatment Period|Withdrawal by Subject|1
874438|NCT00551759|1836250|FG000|Overall Study|Adverse Event|7
874439|NCT00551759|1836250|FG000|Overall Study|Death|5
874440|NCT00551759|1836250|FG000|Overall Study|Ineligible|1
874441|NCT00552032|1836256|FG000|Overall Study|Withdrawal by Subject|2
874442|NCT00552032|1836257|FG001|Overall Study|Withdrawal by Subject|2
874443|NCT00552032|1836256|FG000|Overall Study|Protocol Violation|7
874444|NCT00552032|1836257|FG001|Overall Study|Protocol Violation|12
874445|NCT00552032|1836256|FG000|Overall Study|Lost to Follow-up|8
874446|NCT00552032|1836257|FG001|Overall Study|Lost to Follow-up|5
874447|NCT00552058|1836265|FG000|Overall Study|Adverse Event|8
874448|NCT00552058|1836266|FG001|Overall Study|Adverse Event|7
874449|NCT00552058|1836265|FG000|Overall Study|Lack of Efficacy|1
874450|NCT00552058|1836266|FG001|Overall Study|Lack of Efficacy|5
874451|NCT00552058|1836265|FG000|Overall Study|Lost to Follow-up|1
874452|NCT00552058|1836266|FG001|Overall Study|Lost to Follow-up|0
874453|NCT00552058|1836265|FG000|Overall Study|Withdrawal by Subject|4
874454|NCT00552058|1836266|FG001|Overall Study|Withdrawal by Subject|4
874455|NCT00552058|1836265|FG000|Overall Study|Other: Protocol Violation|0
874456|NCT00552058|1836266|FG001|Overall Study|Other: Protocol Violation|1
874457|NCT00552058|1836265|FG000|Overall Study|Other: Non Compliance|1
874458|NCT00552058|1836266|FG001|Overall Study|Other: Non Compliance|2
874459|NCT00552058|1836265|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0
874460|NCT00552058|1836266|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1
874461|NCT00552058|1836265|FG000|Overall Study|Other: Low CDAI score, entry violation|0
874462|NCT00552058|1836266|FG001|Overall Study|Other: Low CDAI score, entry violation|1
874463|NCT00552058|1836265|FG000|Overall Study|Other: Positive Stool Result|0
874464|NCT00552058|1836266|FG001|Overall Study|Other: Positive Stool Result|1
874465|NCT00552058|1836265|FG000|Overall Study|Other: Randomized in error|0
874466|NCT00552058|1836266|FG001|Overall Study|Other: Randomized in error|1
874467|NCT00552058|1836265|FG000|Overall Study|Other: Sponsors Decision|0
874468|NCT00552058|1836266|FG001|Overall Study|Other: Sponsors Decision|1
874469|NCT00552058|1836265|FG000|Overall Study|Other: Early Roll Over|1
874470|NCT00552058|1836266|FG001|Overall Study|Other: Early Roll Over|0
874471|NCT00552071|1836274|FG000|Overall Study|Adverse Event|1
874472|NCT00552071|1836275|FG001|Overall Study|Adverse Event|0
874473|NCT00552071|1836274|FG000|Overall Study|Lack of Efficacy|1
874474|NCT00552071|1836275|FG001|Overall Study|Lack of Efficacy|0
874475|NCT00552071|1836274|FG000|Overall Study|Physician Decision|1
874476|NCT00552071|1836275|FG001|Overall Study|Physician Decision|0
874477|NCT00552071|1836274|FG000|Overall Study|Pregnancy|1
874478|NCT00552071|1836275|FG001|Overall Study|Pregnancy|0
874479|NCT00552071|1836274|FG000|Overall Study|Death|0
874480|NCT00552071|1836275|FG001|Overall Study|Death|1
874481|NCT00552071|1836274|FG000|Overall Study|Withdrawal by Subject|0
874482|NCT00552071|1836275|FG001|Overall Study|Withdrawal by Subject|1
874483|NCT00552084|1836285|FG000|Overall Study|Adverse Event|2
1178049|NCT00501228|2331004|FG000|Overall Study|Withdrawal by Subject|1
1178050|NCT00496782|2331010|FG000|Overall Study|Protocol Violation|1
1178051|NCT00496782|2331011|FG001|Overall Study|Protocol Violation|2
1178052|NCT00487578|2331023|FG000|Overall Study|Adverse Event|1
1178053|NCT00487578|2331024|FG001|Overall Study|Adverse Event|2
1178054|NCT00487578|2331023|FG000|Overall Study|Lack of Efficacy|0
1178055|NCT00487578|2331024|FG001|Overall Study|Lack of Efficacy|1
1178056|NCT00487578|2331023|FG000|Overall Study|Lost to Follow-up|0
1178057|NCT00487578|2331024|FG001|Overall Study|Lost to Follow-up|1
1178058|NCT00503009|2331033|FG000|Overall Study|Protocol Violation|1
1178059|NCT00503009|2331034|FG001|Overall Study|Protocol Violation|0
1178060|NCT00503009|2331035|FG002|Overall Study|Protocol Violation|1
1178061|NCT00503009|2331033|FG000|Overall Study|Withdrawal by Subject|0
1178062|NCT00503009|2331034|FG001|Overall Study|Withdrawal by Subject|1
1178063|NCT00503009|2331035|FG002|Overall Study|Withdrawal by Subject|1
1178064|NCT00503009|2331033|FG000|Overall Study|Physician Decision|0
1178065|NCT00503009|2331034|FG001|Overall Study|Physician Decision|1
1178066|NCT00503009|2331035|FG002|Overall Study|Physician Decision|1
1178067|NCT00499590|2331050|FG000|Overall Study|Study Terminated|112
1178068|NCT00499590|2331051|FG001|Overall Study|Study Terminated|112
1178069|NCT00499590|2331052|FG002|Overall Study|Study Terminated|112
1178070|NCT00499590|2331050|FG000|Overall Study|Not treated|1
1178071|NCT00499590|2331051|FG001|Overall Study|Not treated|0
1178072|NCT00499590|2331052|FG002|Overall Study|Not treated|1
1178073|NCT00503841|2331087|FG000|Overall Study|All screen failures|44
1178074|NCT00493025|2331093|FG000|Overall Study|Physician Decision|19
1178075|NCT00491400|2331100|FG000|Overall Study|Withdrawal by Subject|5
1178076|NCT00491400|2331101|FG001|Overall Study|Withdrawal by Subject|4
1178077|NCT00490776|2331109|FG000|Overall Study|Withdrawal by Subject|1
1178078|NCT00490776|2331109|FG000|Overall Study|Administrative Problems|1
1178079|NCT00490776|2331109|FG000|Overall Study|Death|1
1178080|NCT00490776|2331109|FG000|Overall Study|New Cancer Therapy|1
1178081|NCT00490776|2331109|FG000|Overall Study|Disease Progression|5
1178082|NCT00487162|2331115|FG000|Overall Study|Adverse Event|0
1178083|NCT00487162|2331116|FG001|Overall Study|Adverse Event|1
1178084|NCT00487162|2331115|FG000|Overall Study|Physician Decision|0
1178085|NCT00487162|2331116|FG001|Overall Study|Physician Decision|1
1178086|NCT00487162|2331115|FG000|Overall Study|Withdrawal by Subject|2
1178087|NCT00487162|2331116|FG001|Overall Study|Withdrawal by Subject|3
1178088|NCT00487981|2331122|FG000|Overall Study|Hypothyroidism diagnosis|1
1178089|NCT00491387|2331126|FG000|Overall Study|study terminated|20
1178090|NCT00483119|2331137|FG000|Overall Study|Adverse Event|0
1178091|NCT00483119|2331138|FG001|Overall Study|Adverse Event|1
1178092|NCT00483119|2331137|FG000|Overall Study|Physician Decision|1
1178093|NCT00483119|2331138|FG001|Overall Study|Physician Decision|0
1178094|NCT00474188|2331170|FG000|Overall Study|Withdrawal by Subject|1
1178095|NCT00474188|2331170|FG000|Overall Study|Study discontinued by sponsor|5
1178096|NCT00470067|2331189|FG000|Overall Study|Death|1
1178097|NCT00470067|2331189|FG000|Overall Study|Disease Progression|6
1178098|NCT00475657|2331216|FG000|Overall Study|Death|1
1178099|NCT00475657|2331216|FG000|Overall Study|Sponsor's Decision|3
1178100|NCT00472082|2331220|FG000|Overall Study|Study prematurely terminated|5
1178101|NCT00467753|2331234|FG000|Overall Study|Lost to Follow-up|1
1178102|NCT00467753|2331235|FG001|Overall Study|Lost to Follow-up|2
1178103|NCT00467753|2331234|FG000|Overall Study|Adverse Event|2
1178104|NCT00467753|2331235|FG001|Overall Study|Adverse Event|0
1178105|NCT00456612|2331245|FG000|Overall Study|Withdrawal by Subject|3
1178106|NCT00469612|2331252|FG000|Overall Study|Study terminated before data collected|2
1178107|NCT00469612|2331253|FG001|Overall Study|Study terminated before data collected|0
1178108|NCT00461812|2331259|FG000|Overall Study|study terminated|10
1178109|NCT00461682|2331269|FG000|Overall Study|Protocol Violation|1
1178110|NCT00462904|2331275|FG000|Overall Study|Lost to Follow-up|1
1178111|NCT00450333|2331283|FG000|Overall Study|Study terminated|47
1178112|NCT00450333|2331284|FG001|Overall Study|Study terminated|54
1178113|NCT00450333|2331285|FG002|Overall Study|Study terminated|16
1178114|NCT00450333|2331286|FG003|Overall Study|Study terminated|21
1178115|NCT00450333|2331283|FG000|Overall Study|Adverse Event|1
1178116|NCT00450333|2331284|FG001|Overall Study|Adverse Event|7
1178117|NCT00450333|2331285|FG002|Overall Study|Adverse Event|2
1178118|NCT00450333|2331286|FG003|Overall Study|Adverse Event|2
1178119|NCT00450333|2331283|FG000|Overall Study|Protocol Violation|1
1178120|NCT00450333|2331284|FG001|Overall Study|Protocol Violation|0
1178121|NCT00450333|2331285|FG002|Overall Study|Protocol Violation|1
1178122|NCT00450333|2331286|FG003|Overall Study|Protocol Violation|0
1178123|NCT00450333|2331283|FG000|Overall Study|Withdrawal by Subject|1
1178124|NCT00450333|2331284|FG001|Overall Study|Withdrawal by Subject|0
1178125|NCT00450333|2331285|FG002|Overall Study|Withdrawal by Subject|3
1178126|NCT00450333|2331286|FG003|Overall Study|Withdrawal by Subject|0
1178127|NCT00450333|2331283|FG000|Overall Study|Kidney transplant|1
1178128|NCT00450333|2331284|FG001|Overall Study|Kidney transplant|0
1178129|NCT00450333|2331285|FG002|Overall Study|Kidney transplant|1
1178130|NCT00450333|2331286|FG003|Overall Study|Kidney transplant|3
1178131|NCT00450333|2331283|FG000|Overall Study|Death|3
1178132|NCT00450333|2331284|FG001|Overall Study|Death|2
1178133|NCT00450333|2331285|FG002|Overall Study|Death|2
1178134|NCT00450333|2331286|FG003|Overall Study|Death|2
1178135|NCT00455143|2331296|FG000|Overall Study|Physician Decision|1
1178136|NCT00455143|2331296|FG000|Overall Study|Withdrawal by Subject|1
1178137|NCT00455143|2331296|FG000|Overall Study|Staff was not avail to follow patient|2
1178138|NCT00455143|2331296|FG000|Overall Study|No longer met Inclusion Criteria|1
1178139|NCT00455143|2331296|FG000|Overall Study|Surgical time, staff not available|1
1178140|NCT00454571|2331312|FG000|Overall Study|Adverse Event|2
1178141|NCT00454571|2331313|FG001|Overall Study|Adverse Event|0
1178142|NCT00454571|2331312|FG000|Overall Study|Physician Decision|0
1178143|NCT00454571|2331313|FG001|Overall Study|Physician Decision|1
1178144|NCT00454571|2331312|FG000|Overall Study|Protocol Violation|1
1178145|NCT00454571|2331313|FG001|Overall Study|Protocol Violation|0
1178146|NCT00454571|2331312|FG000|Overall Study|Withdrawal by Subject|10
1178147|NCT00454571|2331313|FG001|Overall Study|Withdrawal by Subject|5
1178148|NCT00452361|2331321|FG000|Overall Study|Adverse Event|8
1178149|NCT00452361|2331322|FG001|Overall Study|Adverse Event|0
1178150|NCT00452361|2331321|FG000|Overall Study|Withdrawal by Subject|0
1178151|NCT00452361|2331322|FG001|Overall Study|Withdrawal by Subject|1
1178152|NCT00452361|2331321|FG000|Overall Study|Premature termination|13
1178153|NCT00452361|2331322|FG001|Overall Study|Premature termination|9
1178154|NCT00443040|2331331|FG000|Overall Study|Withdrawal by Subject|1
1178155|NCT00443040|2331332|FG001|Overall Study|Withdrawal by Subject|0
1178156|NCT00443040|2331333|FG002|Overall Study|Withdrawal by Subject|0
1178157|NCT00443040|2331331|FG000|Overall Study|Converted to an open laparotomy|3
1178158|NCT00443040|2331332|FG001|Overall Study|Converted to an open laparotomy|0
1178159|NCT00443040|2331333|FG002|Overall Study|Converted to an open laparotomy|1
1178160|NCT00447603|2331341|FG000|Screening|Withdrawal by Subject|1
1178161|NCT00447603|2331342|FG001|Screening|Withdrawal by Subject|0
1178162|NCT00447603|2331343|FG002|Screening|Withdrawal by Subject|0
1178163|NCT00447603|2331341|FG000|Screening|Protocol Violation|1
1178164|NCT00447603|2331342|FG001|Screening|Protocol Violation|0
1178165|NCT00447603|2331343|FG002|Screening|Protocol Violation|0
1178166|NCT00447603|2331341|FG000|Screening|Screen Failure|4
1178167|NCT00447603|2331342|FG001|Screening|Screen Failure|0
1178168|NCT00447603|2331343|FG002|Screening|Screen Failure|0
1178169|NCT00447603|2331341|FG000|Screening|Study Terminated by Sponsor|15
1178170|NCT00447603|2331342|FG001|Screening|Study Terminated by Sponsor|0
1178171|NCT00447603|2331343|FG002|Screening|Study Terminated by Sponsor|0
1178172|NCT00447603|2331341|FG000|Filter Period|Adverse Event|0
1178173|NCT00447603|2331342|FG001|Filter Period|Adverse Event|0
1178174|NCT00447603|2331343|FG002|Filter Period|Adverse Event|1
1178175|NCT00447603|2331341|FG000|Filter Period|Screen Failure|0
1178176|NCT00447603|2331342|FG001|Filter Period|Screen Failure|3
1178177|NCT00447603|2331343|FG002|Filter Period|Screen Failure|4
1178178|NCT00447603|2331341|FG000|Filter Period|Study terminated by Sponsor|0
1178179|NCT00447603|2331342|FG001|Filter Period|Study terminated by Sponsor|1
1178180|NCT00447603|2331343|FG002|Filter Period|Study terminated by Sponsor|10
1178181|NCT00447421|2331351|FG000|Overall Study|Lack of Efficacy|1
1178182|NCT00447421|2331351|FG000|Overall Study|Adverse Event|3
1178183|NCT00447421|2331351|FG000|Overall Study|Sponsor Decision|2
1178184|NCT00441272|2331357|FG000|Overall Study|Study terminated prior to enrollment|25
1178185|NCT00441272|2331358|FG001|Overall Study|Study terminated prior to enrollment|25
1178186|NCT00440271|2331370|FG000|Overall Study|Protocol Violation|1
1178187|NCT00440271|2331371|FG001|Overall Study|Protocol Violation|1
1178188|NCT00440271|2331370|FG000|Overall Study|Adverse Event|0
1178189|NCT00440271|2331371|FG001|Overall Study|Adverse Event|1
1178190|NCT00440271|2331370|FG000|Overall Study|Lost to Follow-up|1
1178191|NCT00440271|2331371|FG001|Overall Study|Lost to Follow-up|0
1178192|NCT00440271|2331370|FG000|Overall Study|Withdrawal by Subject|0
1178193|NCT00440271|2331371|FG001|Overall Study|Withdrawal by Subject|2
1178194|NCT00440271|2331370|FG000|Overall Study|Lack of Efficacy|0
1178195|NCT00440271|2331371|FG001|Overall Study|Lack of Efficacy|1
1178196|NCT00440271|2331370|FG000|Overall Study|Due to closure of trial|8
1178197|NCT00440271|2331371|FG001|Overall Study|Due to closure of trial|10
1178198|NCT00440271|2331370|FG000|Overall Study|Other|2
1178199|NCT00440271|2331371|FG001|Overall Study|Other|0
1178200|NCT00442351|2331383|FG000|Overall Study|Administrative|6
1178201|NCT00442351|2331384|FG001|Overall Study|Administrative|5
1178202|NCT00442351|2331383|FG000|Overall Study|Did not meet protocol eligibility|1
1178203|NCT00442351|2331384|FG001|Overall Study|Did not meet protocol eligibility|0
1178204|NCT00442351|2331383|FG000|Overall Study|Other|0
1178205|NCT00442351|2331384|FG001|Overall Study|Other|1
1178206|NCT00429026|2331390|FG000|Overall Study|Inevaluable for response.|40
1178207|NCT00439569|2331401|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
1178208|NCT00439569|2331401|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
1178209|NCT00439569|2331401|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
1178210|NCT00422669|2331408|FG000|Overall Study|The study was terminated early.|98
1178211|NCT00422669|2331409|FG001|Overall Study|The study was terminated early.|100
1178212|NCT00422669|2331410|FG002|Overall Study|The study was terminated early.|7
1178213|NCT00434590|2331422|FG000|Overall Study|Administrative problems|5
1178214|NCT00434590|2331423|FG001|Overall Study|Administrative problems|5
1178215|NCT00424645|2331431|FG000|Overall Study|Death|1
1178216|NCT00424645|2331432|FG001|Overall Study|Death|0
1178217|NCT00430027|2331438|FG000|Overall Study|Study terminated|8
1178218|NCT00429858|2331442|FG000|Overall Study|Withdrawal by Subject|1
1178219|NCT00429858|2331442|FG000|Overall Study|Study Termination|1
1178220|NCT00425438|2331449|FG000|Overall Study|Termination by Sponsor|25
1178221|NCT00425438|2331450|FG001|Overall Study|Termination by Sponsor|27
1178222|NCT00422942|2331460|FG000|Overall Study|Study terminated by Sponsor|3
1178223|NCT00409344|2331466|FG000|Overall Study|no enrollment|0
1178224|NCT00409344|2331467|FG001|Overall Study|no enrollment|0
1178225|NCT00414453|2331473|FG000|Overall Study|Abnormal lab work|16
1178226|NCT00417248|2331483|FG000|Overall Study|Study Terminated|6
1178227|NCT00417248|2331483|FG000|Overall Study|Death|1
1178228|NCT00417248|2331483|FG000|Overall Study|Lack of Efficacy|1
1178229|NCT00418145|2331488|FG000|Overall Study|study terminated|6
1178230|NCT00409331|2331498|FG000|Overall Study|Physician Decision|1
1178231|NCT00391430|2331515|FG000|Overall Study|Withdrawal by Subject|3
1178232|NCT00391430|2331516|FG001|Overall Study|Withdrawal by Subject|0
1178233|NCT00391430|2331517|FG002|Overall Study|Withdrawal by Subject|12
1178234|NCT00384293|2331550|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
1178235|NCT00384293|2331551|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
1178236|NCT00384293|2331552|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
1178237|NCT00384293|2331550|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
1178238|NCT00384293|2331551|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
1178239|NCT00384293|2331552|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
1178240|NCT00384293|2331550|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
1178241|NCT00384293|2331551|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
1178242|NCT00384293|2331552|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
1178243|NCT00384293|2331550|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
1178244|NCT00384293|2331551|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
1178245|NCT00384293|2331552|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
1178246|NCT00384293|2331550|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
1178247|NCT00384293|2331551|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
1178248|NCT00384293|2331552|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
1178249|NCT00384293|2331550|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
1178250|NCT00384293|2331551|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
1178251|NCT00384293|2331552|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
1178252|NCT00384293|2331550|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
1178253|NCT00384293|2331551|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
1178254|NCT00384293|2331552|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
1178255|NCT00384293|2331550|FG000|Post-randomization Period|Adverse Event|0
1178256|NCT00384293|2331551|FG001|Post-randomization Period|Adverse Event|23
1178257|NCT00384293|2331552|FG002|Post-randomization Period|Adverse Event|7
1178258|NCT00384293|2331550|FG000|Post-randomization Period|Lost to Follow-up|0
1178259|NCT00384293|2331551|FG001|Post-randomization Period|Lost to Follow-up|2
1178260|NCT00384293|2331552|FG002|Post-randomization Period|Lost to Follow-up|1
1178261|NCT00384293|2331550|FG000|Post-randomization Period|Protocol Violation|0
1178262|NCT00384293|2331551|FG001|Post-randomization Period|Protocol Violation|1
1178263|NCT00384293|2331552|FG002|Post-randomization Period|Protocol Violation|0
1178264|NCT00384293|2331550|FG000|Post-randomization Period|Withdrawal by Subject|0
1178265|NCT00384293|2331551|FG001|Post-randomization Period|Withdrawal by Subject|8
1178266|NCT00384293|2331552|FG002|Post-randomization Period|Withdrawal by Subject|6
1178267|NCT00384293|2331550|FG000|Post-randomization Period|Trial Termination|0
1178268|NCT00384293|2331551|FG001|Post-randomization Period|Trial Termination|180
1178269|NCT00384293|2331552|FG002|Post-randomization Period|Trial Termination|204
1178270|NCT00384293|2331550|FG000|Post-randomization Period|Patient Randomized in Error|0
1178271|NCT00384293|2331551|FG001|Post-randomization Period|Patient Randomized in Error|0
1178272|NCT00384293|2331552|FG002|Post-randomization Period|Patient Randomized in Error|1
1178273|NCT00377455|2331573|FG000|Overall Study|Withdrawal by Subject|1
1178274|NCT00371462|2331579|FG000|Overall Study|Withdrawal by Subject|1
1178275|NCT00371462|2331580|FG001|Overall Study|Withdrawal by Subject|0
1178276|NCT00371462|2331579|FG000|Overall Study|Other|7
1178277|NCT00371462|2331580|FG001|Overall Study|Other|8
1178278|NCT00369265|2331588|FG000|Overall Study|Study terminated|4
1178279|NCT00369265|2331589|FG001|Overall Study|Study terminated|7
1178280|NCT00364689|2331602|FG000|Overall Study|Lost to Follow-up|1
1178281|NCT00352118|2331608|FG000|Overall Study|Physician Decision|4
1178282|NCT00356421|2331631|FG000|Overall Study|Lack of Efficacy|3
1178283|NCT00356421|2331632|FG001|Overall Study|Lack of Efficacy|0
1178284|NCT00356421|2331631|FG000|Overall Study|Withdrawal by Subject|9
1178285|NCT00356421|2331632|FG001|Overall Study|Withdrawal by Subject|2
1178286|NCT00356421|2331631|FG000|Overall Study|Related to study drug|15
1178287|NCT00356421|2331632|FG001|Overall Study|Related to study drug|12
1178288|NCT00356421|2331631|FG000|Overall Study|Not related to study drug|5
1178289|NCT00356421|2331632|FG001|Overall Study|Not related to study drug|3
1178290|NCT00350623|2331641|FG000|Overall Study|Lost to Follow-up|8
1178291|NCT00350623|2331642|FG001|Overall Study|Lost to Follow-up|3
1178292|NCT00350623|2331643|FG002|Overall Study|Lost to Follow-up|4
1178293|NCT00350623|2331641|FG000|Overall Study|Withdrawal by Subject|0
1178294|NCT00350623|2331642|FG001|Overall Study|Withdrawal by Subject|1
1178295|NCT00350623|2331643|FG002|Overall Study|Withdrawal by Subject|1
1178296|NCT00350623|2331641|FG000|Overall Study|patient traveling outside the country|0
1178297|NCT00350623|2331642|FG001|Overall Study|patient traveling outside the country|0
1178298|NCT00350623|2331643|FG002|Overall Study|patient traveling outside the country|1
1178299|NCT00350844|2331671|FG000|Overall Study|Lost to Follow-up|1
1178300|NCT00348556|2331675|FG000|Overall Study|Adverse Event|1
1178301|NCT00319839|2331679|FG000|Overall Study|Adverse Event|5
1178302|NCT00319839|2331679|FG000|Overall Study|Withdrawal by Subject|1
1178303|NCT00344019|2331686|FG000|Overall Study|did not meet final inclusion criteria|0
1178304|NCT00344019|2331687|FG001|Overall Study|did not meet final inclusion criteria|0
1178305|NCT00344019|2331688|FG002|Overall Study|did not meet final inclusion criteria|74
1178306|NCT00338455|2331701|FG000|Overall Study|Death|2
1178307|NCT00338455|2331702|FG001|Overall Study|Death|1
1178308|NCT00338455|2331701|FG000|Overall Study|Physician Decision|1
1178309|NCT00338455|2331702|FG001|Overall Study|Physician Decision|0
1178310|NCT00329108|2331710|FG000|Overall Study|Adverse Event|2
1178311|NCT00329108|2331711|FG001|Overall Study|Adverse Event|2
1178312|NCT00329108|2331710|FG000|Overall Study|Lack of Efficacy|3
1178313|NCT00329108|2331711|FG001|Overall Study|Lack of Efficacy|3
1178314|NCT00329108|2331710|FG000|Overall Study|Withdrawal by Subject|0
1178315|NCT00329108|2331711|FG001|Overall Study|Withdrawal by Subject|2
1178316|NCT00329108|2331710|FG000|Overall Study|symptomatic deterioration|1
1178317|NCT00329108|2331711|FG001|Overall Study|symptomatic deterioration|1
1178318|NCT00329108|2331710|FG000|Overall Study|Subject no longer willing to participate|2
1178319|NCT00329108|2331711|FG001|Overall Study|Subject no longer willing to participate|2
1178320|NCT00329108|2331710|FG000|Overall Study|study terminated by sponsor|1
1178321|NCT00329108|2331711|FG001|Overall Study|study terminated by sponsor|0
1178322|NCT00329108|2331710|FG000|Overall Study|withdrew patient after SAE resolved|1
1178323|NCT00329108|2331711|FG001|Overall Study|withdrew patient after SAE resolved|0
1178324|NCT00329108|2331710|FG000|Overall Study|Protocol Violation|0
1178325|NCT00329108|2331711|FG001|Overall Study|Protocol Violation|2
1178326|NCT00333229|2331732|FG000|Overall Study|Lack of Efficacy|0
1178327|NCT00333229|2331733|FG001|Overall Study|Lack of Efficacy|1
1178328|NCT00314327|2331779|FG000|Overall Study|Withdrawal by Subject|1
1178329|NCT00308113|2331787|FG000|Overall Study|Protocol closure|0
1178330|NCT00308113|2331788|FG001|Overall Study|Protocol closure|0
1178331|NCT00308113|2331789|FG002|Overall Study|Protocol closure|0
1178332|NCT00308113|2331790|FG003|Overall Study|Protocol closure|1
1178333|NCT00298740|2331810|FG000|Overall Study|Lack of Efficacy|6
1178334|NCT00298740|2331810|FG000|Overall Study|Withdrawal by Subject|3
1178335|NCT00301080|2331814|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1
1178336|NCT00301080|2331815|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1178337|NCT00301080|2331816|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1178338|NCT00301080|2331817|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1178339|NCT00301080|2331818|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1178340|NCT00290407|2331836|FG000|Overall Study|Physician Decision|2
1178341|NCT00295490|2331844|FG000|Overall Study|Protocol Violation|0
1178342|NCT00295490|2331845|FG001|Overall Study|Protocol Violation|0
1178343|NCT00295490|2331846|FG002|Overall Study|Protocol Violation|3
1178344|NCT00295490|2331847|FG003|Overall Study|Protocol Violation|3
1178345|NCT00295490|2331844|FG000|Overall Study|Withdrawal by Subject|0
1178346|NCT00295490|2331845|FG001|Overall Study|Withdrawal by Subject|2
1178347|NCT00295490|2331846|FG002|Overall Study|Withdrawal by Subject|0
1178348|NCT00295490|2331847|FG003|Overall Study|Withdrawal by Subject|1
1178349|NCT00295490|2331844|FG000|Overall Study|Lost to Follow-up|0
1178350|NCT00295490|2331845|FG001|Overall Study|Lost to Follow-up|0
1178351|NCT00295490|2331846|FG002|Overall Study|Lost to Follow-up|1
1178352|NCT00295490|2331847|FG003|Overall Study|Lost to Follow-up|0
1178353|NCT00295490|2331844|FG000|Overall Study|Adverse Event|1
1178354|NCT00295490|2331845|FG001|Overall Study|Adverse Event|0
1178355|NCT00295490|2331846|FG002|Overall Study|Adverse Event|0
1178356|NCT00295490|2331847|FG003|Overall Study|Adverse Event|0
1178357|NCT00295490|2331844|FG000|Overall Study|Other|0
1178358|NCT00295490|2331845|FG001|Overall Study|Other|2
1178359|NCT00295490|2331846|FG002|Overall Study|Other|0
1178360|NCT00295490|2331847|FG003|Overall Study|Other|1
1178361|NCT00268463|2331859|FG000|Overall Study|study terminated due to low accrual|10
1178362|NCT00268463|2331860|FG001|Overall Study|study terminated due to low accrual|12
1178363|NCT00276419|2331877|FG000|First Intervention|Adverse Event|1
874484|NCT00552084|1836286|FG001|Overall Study|Adverse Event|3
874485|NCT00552084|1836285|FG000|Overall Study|Withdrawal by Subject|4
874486|NCT00552084|1836286|FG001|Overall Study|Withdrawal by Subject|5
874487|NCT00552084|1836285|FG000|Overall Study|Protocol Violation|1
874488|NCT00552084|1836286|FG001|Overall Study|Protocol Violation|0
874489|NCT00552084|1836285|FG000|Overall Study|change in anti-arrythmic drug|1
874490|NCT00552084|1836286|FG001|Overall Study|change in anti-arrythmic drug|1
874491|NCT00552110|1836297|FG000|Overall Study|Serious or Life-Threatening AE|0
874492|NCT00552110|1836298|FG001|Overall Study|Serious or Life-Threatening AE|0
874493|NCT00552110|1836299|FG002|Overall Study|Serious or Life-Threatening AE|1
874494|NCT00552110|1836300|FG003|Overall Study|Serious or Life-Threatening AE|0
874495|NCT00552110|1836301|FG004|Overall Study|Serious or Life-Threatening AE|0
874496|NCT00552110|1836297|FG000|Overall Study|Lack of Efficacy|1
874497|NCT00552110|1836298|FG001|Overall Study|Lack of Efficacy|0
1178364|NCT00276419|2331878|FG001|First Intervention|Adverse Event|0
1178365|NCT00276419|2331877|FG000|First Intervention|Withdrawal by Subject|0
1178366|NCT00276419|2331878|FG001|First Intervention|Withdrawal by Subject|2
1178367|NCT00271947|2331926|FG000|Overall Study|Lost to Follow-up|1
1178368|NCT00252174|2331946|FG000|Overall Study|Withdrawal by Subject|0
1178369|NCT00252174|2331947|FG001|Overall Study|Withdrawal by Subject|1
1178370|NCT00252174|2331948|FG002|Overall Study|Withdrawal by Subject|0
1178371|NCT00256295|2331956|FG000|Overall Study|Withdrawal by Subject|3
1178372|NCT00256295|2331956|FG000|Overall Study|Death|1
1178373|NCT00239720|2331970|FG000|Overall Study|Adverse Event|1
1178374|NCT00239720|2331971|FG001|Overall Study|Adverse Event|0
1178375|NCT00239720|2331970|FG000|Overall Study|Lost to Follow-up|0
1178376|NCT00239720|2331971|FG001|Overall Study|Lost to Follow-up|1
1178377|NCT00250718|2331977|FG000|Overall Study|Death|1
1178378|NCT00250718|2331977|FG000|Overall Study|Adverse Event|1
1178379|NCT00250718|2331977|FG000|Overall Study|Withdrawal by Subject|1
1178380|NCT00206375|2332025|FG000|Overall Study|Lost to Follow-up|1
1178381|NCT00206375|2332026|FG001|Overall Study|Lost to Follow-up|0
1178382|NCT00206375|2332027|FG002|Overall Study|Lost to Follow-up|0
1178383|NCT00206375|2332025|FG000|Overall Study|Withdrawal by Subject|2
1178384|NCT00206375|2332026|FG001|Overall Study|Withdrawal by Subject|1
1178385|NCT00206375|2332027|FG002|Overall Study|Withdrawal by Subject|3
1178386|NCT00206375|2332025|FG000|Overall Study|Study terminated due to lack of funds|0
1178387|NCT00206375|2332026|FG001|Overall Study|Study terminated due to lack of funds|1
1178388|NCT00206375|2332027|FG002|Overall Study|Study terminated due to lack of funds|1
1178389|NCT00229931|2332037|FG000|Overall Study|Death|1
1178390|NCT00229931|2332038|FG001|Overall Study|Death|0
1178391|NCT00229931|2332037|FG000|Overall Study|Lost to Follow-up|3
1178392|NCT00229931|2332038|FG001|Overall Study|Lost to Follow-up|2
1178393|NCT00209131|2332046|FG000|Overall Study|Lack of personnel due to turnovers.|15
1178394|NCT00209131|2332047|FG001|Overall Study|Lack of personnel due to turnovers.|11
1178395|NCT00209027|2332077|FG000|Overall Study|study terminated|10
1178396|NCT00209027|2332078|FG001|Overall Study|study terminated|0
1178397|NCT00182637|2332084|FG000|Overall Study|Adverse Event|2
1178398|NCT00182637|2332084|FG000|Overall Study|Disease Progression|1
1178399|NCT00176488|2332089|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1
1178400|NCT00162773|2332126|FG000|Overall Study|P.I, Left institution. Study terminated|22
1178401|NCT00147238|2332156|FG000|Overall Study|Inevaluable|8
1178402|NCT00165503|2332160|FG000|Overall Study|Death|1
1178403|NCT00165503|2332160|FG000|Overall Study|Lost to Follow-up|12
1178404|NCT00165503|2332160|FG000|Overall Study|Unresectable|3
1178405|NCT00160563|2332167|FG000|Overall Study|Adverse Event|1
1178406|NCT00160563|2332168|FG001|Overall Study|Adverse Event|1
1178407|NCT00160563|2332169|FG002|Overall Study|Adverse Event|1
1178408|NCT00160563|2332167|FG000|Overall Study|Lost to Follow-up|1
1178409|NCT00160563|2332168|FG001|Overall Study|Lost to Follow-up|1
1178410|NCT00160563|2332169|FG002|Overall Study|Lost to Follow-up|2
1178411|NCT00160563|2332167|FG000|Overall Study|Protocol Violation|0
1178412|NCT00160563|2332168|FG001|Overall Study|Protocol Violation|0
1178413|NCT00160563|2332169|FG002|Overall Study|Protocol Violation|3
1178414|NCT00160563|2332167|FG000|Overall Study|Withdrawal by Subject|1
1178415|NCT00160563|2332168|FG001|Overall Study|Withdrawal by Subject|2
1178416|NCT00160563|2332169|FG002|Overall Study|Withdrawal by Subject|3
1178417|NCT00160563|2332167|FG000|Overall Study|Other (listed in the study report)|48
1178418|NCT00160563|2332168|FG001|Overall Study|Other (listed in the study report)|40
1178419|NCT00160563|2332169|FG002|Overall Study|Other (listed in the study report)|81
1178420|NCT00160563|2332167|FG000|Overall Study|Missing reason|0
1178421|NCT00160563|2332168|FG001|Overall Study|Missing reason|1
1178422|NCT00160563|2332169|FG002|Overall Study|Missing reason|0
1178423|NCT00142519|2332180|FG000|Overall Study|Not Treated|7
1178424|NCT00142519|2332181|FG001|Overall Study|Not Treated|9
1178425|NCT00142519|2332180|FG000|Overall Study|Protocol Violation|1
1178426|NCT00142519|2332181|FG001|Overall Study|Protocol Violation|0
1178427|NCT00142519|2332180|FG000|Overall Study|Withdrawal by Subject|10
1178428|NCT00142519|2332181|FG001|Overall Study|Withdrawal by Subject|7
1178429|NCT00138073|2332196|FG000|Overall Study|lack of resources|55
1178430|NCT00113386|2332202|FG000|Overall Study|Withdrawal by Subject|1
1178431|NCT00113386|2332203|FG001|Overall Study|Withdrawal by Subject|0
1178432|NCT00113386|2332202|FG000|Overall Study|Physician Decision|0
1178433|NCT00113386|2332203|FG001|Overall Study|Physician Decision|1
1178434|NCT00113386|2332202|FG000|Overall Study|Toxicity|3
1178435|NCT00113386|2332203|FG001|Overall Study|Toxicity|0
1178436|NCT00113386|2332202|FG000|Overall Study|Ineligible|1
1178437|NCT00113386|2332203|FG001|Overall Study|Ineligible|2
1178438|NCT00113386|2332202|FG000|Overall Study|Unknown - Lost to Follow-Up|2
1178439|NCT00113386|2332203|FG001|Overall Study|Unknown - Lost to Follow-Up|1
1178440|NCT00138151|2332209|FG000|Overall Study|Withdrawal by Subject|3
1178441|NCT00138151|2332209|FG000|Overall Study|Physician Decision|1
1178442|NCT00129974|2332213|FG000|Overall Study|Other|1
1178443|NCT00126659|2332220|FG000|Overall Study|Adverse Event|0
1178444|NCT00126659|2332221|FG001|Overall Study|Adverse Event|0
1178445|NCT00126659|2332222|FG002|Overall Study|Adverse Event|2
1178446|NCT00125268|2332239|FG000|Overall Study|Withdrawal by Subject|1
1178447|NCT00125268|2332240|FG001|Overall Study|Withdrawal by Subject|1
1178448|NCT00113399|2332248|FG000|Overall Study|Death|1
1178449|NCT00113399|2332249|FG001|Overall Study|Death|1
1178450|NCT00113399|2332248|FG000|Overall Study|Withdrawal by Subject|1
1178451|NCT00113399|2332249|FG001|Overall Study|Withdrawal by Subject|2
1178452|NCT00113399|2332248|FG000|Overall Study|Complete Response|0
1178453|NCT00113399|2332249|FG001|Overall Study|Complete Response|1
1178454|NCT00113399|2332248|FG000|Overall Study|Other|0
1178455|NCT00113399|2332249|FG001|Overall Study|Other|1
1178456|NCT00107614|2332259|FG000|Overall Study|Physician Decision|10
1178457|NCT00107614|2332259|FG000|Overall Study|Death|2
1178458|NCT00107315|2332263|FG000|Overall Study|Disease Progression|9
1178459|NCT00107315|2332263|FG000|Overall Study|Adverse Event|4
1178460|NCT00107315|2332263|FG000|Overall Study|Withdrawal by Subject|2
1178461|NCT00108433|2332269|FG000|Overall Study|Lack of Efficacy|1
1178462|NCT00108433|2332270|FG001|Overall Study|Lack of Efficacy|2
1178463|NCT00108433|2332269|FG000|Overall Study|Death|3
1178464|NCT00108433|2332270|FG001|Overall Study|Death|0
1178465|NCT00108433|2332269|FG000|Overall Study|Adverse Event|3
1178466|NCT00108433|2332270|FG001|Overall Study|Adverse Event|1
1178467|NCT00108433|2332269|FG000|Overall Study|Other|14
1178468|NCT00108433|2332270|FG001|Overall Study|Other|14
1178469|NCT00113919|2332276|FG000|Overall Study|Physician Decision|8
1178470|NCT00113919|2332276|FG000|Overall Study|Death|6
1178471|NCT00100828|2332289|FG000|Overall Study|Physician Decision|6
1178472|NCT00104728|2332293|FG000|Overall Study|screen failures|19
1178473|NCT00083915|2332312|FG000|Overall Study|Death|6
1178474|NCT00083915|2332313|FG001|Overall Study|Death|3
1178475|NCT00083915|2332312|FG000|Overall Study|Physician Decision|11
1178476|NCT00083915|2332313|FG001|Overall Study|Physician Decision|6
1178477|NCT00083915|2332312|FG000|Overall Study|Withdrawal by Subject|8
1178478|NCT00083915|2332313|FG001|Overall Study|Withdrawal by Subject|3
1178479|NCT00083915|2332312|FG000|Overall Study|disease progression|18
1178480|NCT00083915|2332313|FG001|Overall Study|disease progression|23
1178481|NCT00083915|2332312|FG000|Overall Study|Failure to collect|3
1178482|NCT00083915|2332313|FG001|Overall Study|Failure to collect|0
874498|NCT00552110|1836299|FG002|Overall Study|Lack of Efficacy|0
874499|NCT00552110|1836300|FG003|Overall Study|Lack of Efficacy|1
874500|NCT00552110|1836301|FG004|Overall Study|Lack of Efficacy|4
874501|NCT00552110|1836297|FG000|Overall Study|Withdrawal by Subject|0
874502|NCT00552110|1836298|FG001|Overall Study|Withdrawal by Subject|2
874503|NCT00552110|1836299|FG002|Overall Study|Withdrawal by Subject|0
874504|NCT00552110|1836300|FG003|Overall Study|Withdrawal by Subject|3
874505|NCT00552110|1836301|FG004|Overall Study|Withdrawal by Subject|2
874506|NCT00552110|1836297|FG000|Overall Study|Lost to Follow-up|0
874507|NCT00552110|1836298|FG001|Overall Study|Lost to Follow-up|0
874508|NCT00552110|1836299|FG002|Overall Study|Lost to Follow-up|0
874509|NCT00552110|1836300|FG003|Overall Study|Lost to Follow-up|1
874510|NCT00552110|1836301|FG004|Overall Study|Lost to Follow-up|1
874511|NCT00552110|1836297|FG000|Overall Study|Failed to Comply With Study Requirements|1
874512|NCT00552110|1836298|FG001|Overall Study|Failed to Comply With Study Requirements|1
874513|NCT00552110|1836299|FG002|Overall Study|Failed to Comply With Study Requirements|1
874514|NCT00552110|1836300|FG003|Overall Study|Failed to Comply With Study Requirements|0
874515|NCT00552110|1836301|FG004|Overall Study|Failed to Comply With Study Requirements|1
874516|NCT00552110|1836297|FG000|Overall Study|Withdrawn per Sponsor|0
874517|NCT00552110|1836298|FG001|Overall Study|Withdrawn per Sponsor|1
874518|NCT00552110|1836299|FG002|Overall Study|Withdrawn per Sponsor|0
874519|NCT00552110|1836300|FG003|Overall Study|Withdrawn per Sponsor|0
874520|NCT00552110|1836301|FG004|Overall Study|Withdrawn per Sponsor|1
874521|NCT00552110|1836297|FG000|Overall Study|Use of Prohibited Medication|1
874522|NCT00552110|1836298|FG001|Overall Study|Use of Prohibited Medication|1
874523|NCT00552110|1836299|FG002|Overall Study|Use of Prohibited Medication|0
874524|NCT00552110|1836300|FG003|Overall Study|Use of Prohibited Medication|0
874525|NCT00552110|1836301|FG004|Overall Study|Use of Prohibited Medication|0
874526|NCT00552110|1836297|FG000|Overall Study|Delay of Study due to Relabeling|0
874527|NCT00552110|1836298|FG001|Overall Study|Delay of Study due to Relabeling|0
874528|NCT00552110|1836299|FG002|Overall Study|Delay of Study due to Relabeling|0
874529|NCT00552110|1836300|FG003|Overall Study|Delay of Study due to Relabeling|1
874530|NCT00552110|1836301|FG004|Overall Study|Delay of Study due to Relabeling|0
874531|NCT00552110|1836297|FG000|Overall Study|Increased Blood Pressure at Visit 2|0
874532|NCT00552110|1836298|FG001|Overall Study|Increased Blood Pressure at Visit 2|0
874533|NCT00552110|1836299|FG002|Overall Study|Increased Blood Pressure at Visit 2|0
874534|NCT00552110|1836300|FG003|Overall Study|Increased Blood Pressure at Visit 2|1
874535|NCT00552110|1836301|FG004|Overall Study|Increased Blood Pressure at Visit 2|0
874536|NCT00552110|1836297|FG000|Overall Study|Nonserious Adverse Event (AE)|1
874537|NCT00552110|1836298|FG001|Overall Study|Nonserious Adverse Event (AE)|0
874538|NCT00552110|1836299|FG002|Overall Study|Nonserious Adverse Event (AE)|0
874539|NCT00552110|1836300|FG003|Overall Study|Nonserious Adverse Event (AE)|1
874540|NCT00552110|1836301|FG004|Overall Study|Nonserious Adverse Event (AE)|0
874541|NCT00552175|1836316|FG000|Overall Study|Lack of Efficacy|2
874542|NCT00552175|1836317|FG001|Overall Study|Lack of Efficacy|0
874543|NCT00552175|1836318|FG002|Overall Study|Lack of Efficacy|1
1178483|NCT00083915|2332312|FG000|Overall Study|No response|3
1178484|NCT00083915|2332313|FG001|Overall Study|No response|1
1178485|NCT00083915|2332312|FG000|Overall Study|Insurance issues|1
1178486|NCT00083915|2332313|FG001|Overall Study|Insurance issues|1
1178487|NCT00088829|2332332|FG000|Overall Study|PI left institution and study was close|22
1178488|NCT00085631|2332355|FG000|Overall Study|Missing Data|4
1178489|NCT00085631|2332356|FG001|Overall Study|Missing Data|11
1178490|NCT00085631|2332357|FG002|Overall Study|Missing Data|7
1178491|NCT00062751|2332369|FG000|Overall Study|Disease progression|24
1178492|NCT00062751|2332370|FG001|Overall Study|Disease progression|17
1178493|NCT00062751|2332371|FG002|Overall Study|Disease progression|24
1178494|NCT00062751|2332372|FG003|Overall Study|Disease progression|2
874544|NCT00552175|1836316|FG000|Overall Study|Adverse Event|9
874545|NCT00552175|1836317|FG001|Overall Study|Adverse Event|9
1178495|NCT00062751|2332373|FG004|Overall Study|Disease progression|2
1178496|NCT00062751|2332369|FG000|Overall Study|Adverse Event|4
1178497|NCT00062751|2332370|FG001|Overall Study|Adverse Event|7
1178498|NCT00062751|2332371|FG002|Overall Study|Adverse Event|2
1178499|NCT00062751|2332372|FG003|Overall Study|Adverse Event|2
1178500|NCT00062751|2332373|FG004|Overall Study|Adverse Event|2
874546|NCT00552175|1836318|FG002|Overall Study|Adverse Event|10
874547|NCT00552175|1836316|FG000|Overall Study|Withdrawal by Subject|2
874548|NCT00552175|1836317|FG001|Overall Study|Withdrawal by Subject|2
874549|NCT00552175|1836318|FG002|Overall Study|Withdrawal by Subject|1
874550|NCT00552175|1836316|FG000|Overall Study|Lost to Follow-up|0
874551|NCT00552175|1836317|FG001|Overall Study|Lost to Follow-up|0
874552|NCT00552175|1836318|FG002|Overall Study|Lost to Follow-up|1
874553|NCT00552175|1836316|FG000|Overall Study|Entry Criteria Not Met|1
874554|NCT00552175|1836317|FG001|Overall Study|Entry Criteria Not Met|1
874555|NCT00552175|1836318|FG002|Overall Study|Entry Criteria Not Met|0
874556|NCT00552175|1836316|FG000|Overall Study|Reason Not Specified|3
874557|NCT00552175|1836317|FG001|Overall Study|Reason Not Specified|1
874558|NCT00552175|1836318|FG002|Overall Study|Reason Not Specified|1
874559|NCT00552188|1836329|FG000|Overall Study|Adverse Event|0
874560|NCT00552188|1836330|FG001|Overall Study|Adverse Event|2
874561|NCT00552188|1836329|FG000|Overall Study|Lost to Follow-up|2
874562|NCT00552188|1836330|FG001|Overall Study|Lost to Follow-up|1
874563|NCT00552188|1836329|FG000|Overall Study|Withdrawal of consent|0
874564|NCT00552188|1836330|FG001|Overall Study|Withdrawal of consent|1
874565|NCT00552188|1836329|FG000|Overall Study|Subject returned to home country|0
874566|NCT00552188|1836330|FG001|Overall Study|Subject returned to home country|1
874567|NCT00552240|1836338|FG000|Overall Study|Adverse Event|9
874568|NCT00552240|1836339|FG001|Overall Study|Adverse Event|9
874569|NCT00552240|1836338|FG000|Overall Study|Protocol Violation|1
874570|NCT00552240|1836339|FG001|Overall Study|Protocol Violation|1
874571|NCT00552240|1836338|FG000|Overall Study|Lost to Follow-up|5
874572|NCT00552240|1836339|FG001|Overall Study|Lost to Follow-up|6
874573|NCT00552240|1836338|FG000|Overall Study|Withdrawal by Subject|2
874574|NCT00552240|1836339|FG001|Overall Study|Withdrawal by Subject|2
874575|NCT00552240|1836338|FG000|Overall Study|Lack of Efficacy|6
874576|NCT00552240|1836339|FG001|Overall Study|Lack of Efficacy|0
874577|NCT00552240|1836338|FG000|Overall Study|Other|1
874578|NCT00552240|1836339|FG001|Overall Study|Other|0
874579|NCT00552279|1836347|FG000|Overall Study|Adverse Event|0
874580|NCT00552279|1836348|FG001|Overall Study|Adverse Event|1
874581|NCT00552279|1836347|FG000|Overall Study|Withdrawal by Subject|12
874582|NCT00552279|1836348|FG001|Overall Study|Withdrawal by Subject|1
874583|NCT00552279|1836347|FG000|Overall Study|Lost to Follow-up|1
874584|NCT00552279|1836348|FG001|Overall Study|Lost to Follow-up|0
874585|NCT00552279|1836347|FG000|Overall Study|Other|1
874586|NCT00552279|1836348|FG001|Overall Study|Other|1
874587|NCT00552305|1836354|FG000|Overall Study|Adverse Event|43
874588|NCT00552305|1836354|FG000|Overall Study|Lack of Efficacy|120
874589|NCT00552305|1836354|FG000|Overall Study|Lost to Follow-up|4
874590|NCT00552305|1836354|FG000|Overall Study|Protocol Violation|3
874591|NCT00552305|1836354|FG000|Overall Study|Withdrawal by Subject|44
874592|NCT00552305|1836354|FG000|Overall Study|Lack of efficacy/withdrew consent|1
874593|NCT00552305|1836354|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3
874594|NCT00552305|1836354|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
874595|NCT00552305|1836354|FG000|Overall Study|Unsatisfactory compliance|11
874596|NCT00552305|1836354|FG000|Overall Study|Poor compliance/lost to follow-up|1
874597|NCT00552305|1836354|FG000|Overall Study|AE/Other: prohibited drug required|1
874598|NCT00552305|1836354|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1
874599|NCT00552305|1836354|FG000|Overall Study|Other: Site closed|4
874600|NCT00552305|1836354|FG000|Overall Study|Other: Personal problems|1
874601|NCT00552305|1836354|FG000|Overall Study|Other: Unable to attend visits|1
874602|NCT00552305|1836354|FG000|Overall Study|Other: Subject underwent surgery|4
874603|NCT00552305|1836354|FG000|Overall Study|Other: Subject became pregnant|1
874604|NCT00552305|1836354|FG000|Overall Study|Other: Health problems, not drug related|1
874605|NCT00552305|1836354|FG000|Overall Study|Other: Subject moved from area|2
874606|NCT00552305|1836354|FG000|Overall Study|Other: Subject incarcerated|1
874607|NCT00552305|1836354|FG000|Overall Study|Other: Subject went to rehab|1
874608|NCT00552344|1836358|FG000|Overall Study|Lack of Efficacy|55
874609|NCT00552344|1836358|FG000|Overall Study|Loss of efficacy|75
874610|NCT00552344|1836358|FG000|Overall Study|Lost to Follow-up|8
874611|NCT00552344|1836358|FG000|Overall Study|Withdrawal by Subject|48
1178501|NCT00062751|2332369|FG000|Overall Study|Other|2
1178502|NCT00062751|2332370|FG001|Overall Study|Other|3
1178503|NCT00062751|2332371|FG002|Overall Study|Other|1
1178504|NCT00062751|2332372|FG003|Overall Study|Other|0
1178505|NCT00062751|2332373|FG004|Overall Study|Other|1
1178506|NCT00062751|2332369|FG000|Overall Study|Withdrawal by Subject|1
1178507|NCT00062751|2332370|FG001|Overall Study|Withdrawal by Subject|2
1178508|NCT00062751|2332371|FG002|Overall Study|Withdrawal by Subject|2
1178509|NCT00062751|2332372|FG003|Overall Study|Withdrawal by Subject|1
1178510|NCT00062751|2332373|FG004|Overall Study|Withdrawal by Subject|0
1178511|NCT00062751|2332369|FG000|Overall Study|Symptomatic deterioration|1
1178512|NCT00062751|2332370|FG001|Overall Study|Symptomatic deterioration|1
1178513|NCT00062751|2332371|FG002|Overall Study|Symptomatic deterioration|0
1178514|NCT00062751|2332372|FG003|Overall Study|Symptomatic deterioration|0
1178515|NCT00062751|2332373|FG004|Overall Study|Symptomatic deterioration|1
1178516|NCT00062751|2332369|FG000|Overall Study|Death|1
1178517|NCT00062751|2332370|FG001|Overall Study|Death|0
1178518|NCT00062751|2332371|FG002|Overall Study|Death|1
1178519|NCT00062751|2332372|FG003|Overall Study|Death|0
1178520|NCT00062751|2332373|FG004|Overall Study|Death|0
1178521|NCT00066807|2332388|FG000|Overall Study|Study was terminated early|14
1178522|NCT00066807|2332389|FG001|Overall Study|Study was terminated early|15
1178523|NCT00038142|2332410|FG000|Overall Study|Ineligible|1
1178524|NCT00038142|2332411|FG001|Overall Study|Ineligible|0
1178525|NCT00038142|2332410|FG000|Overall Study|Progressive Disease|11
874612|NCT00552344|1836358|FG000|Overall Study|SAE, non-fatal|6
874613|NCT00552344|1836358|FG000|Overall Study|AE, non-serious non-fatal|38
874614|NCT00552344|1836358|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
874615|NCT00552344|1836358|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
874616|NCT00552344|1836358|FG000|Overall Study|Other Reason|22
874617|NCT00552396|1836370|FG000|Overall Study|protocol withdrawal criteria|3
874618|NCT00552396|1836371|FG001|Overall Study|protocol withdrawal criteria|3
874619|NCT00552396|1836372|FG002|Overall Study|protocol withdrawal criteria|3
874620|NCT00552396|1836373|FG003|Overall Study|protocol withdrawal criteria|6
874621|NCT00552396|1836374|FG004|Overall Study|protocol withdrawal criteria|3
874622|NCT00552396|1836375|FG005|Overall Study|protocol withdrawal criteria|3
874623|NCT00552396|1836376|FG006|Overall Study|protocol withdrawal criteria|9
1178526|NCT00038142|2332411|FG001|Overall Study|Progressive Disease|7
1178527|NCT00038142|2332410|FG000|Overall Study|Death|1
1178528|NCT00038142|2332411|FG001|Overall Study|Death|0
1178529|NCT00038142|2332410|FG000|Overall Study|Adverse Event|1
1178530|NCT00038142|2332411|FG001|Overall Study|Adverse Event|0
1178531|NCT00038142|2332410|FG000|Overall Study|Unknown Reason|8
1178532|NCT00038142|2332411|FG001|Overall Study|Unknown Reason|0
1178533|NCT00006478|2332426|FG000|Overall Study|Vaccine could not be produced|1
1178534|NCT00006478|2332426|FG000|Overall Study|Physician Decision|6
1178535|NCT00006916|2332439|FG000|Overall Study|Device not inserted|4
1178536|NCT00006916|2332439|FG000|Overall Study|Complication of device insertion|1
1178537|NCT02009384|2332513|FG000|Overall Study|Death|2
874624|NCT00552513|1836434|FG000|Overall Study|Lost to Follow-up|5
874625|NCT00552513|1836435|FG001|Overall Study|Lost to Follow-up|1
874626|NCT00552578|1836445|FG000|Overall Study|Lost to Follow-up|1
874627|NCT00552578|1836446|FG001|Overall Study|Lost to Follow-up|1
874628|NCT00552617|1836462|FG000|Overall Study|Not Treated|0
874629|NCT00552617|1836463|FG001|Overall Study|Not Treated|0
874630|NCT00552617|1836464|FG002|Overall Study|Not Treated|1
874631|NCT00552617|1836465|FG003|Overall Study|Not Treated|0
1178538|NCT04558125|2332517|FG000|Overall Study|Death|1
1178539|NCT02401308|2332523|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0
1178540|NCT02401308|2332524|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1
1178541|NCT04381988|2332532|FG000|Overall Study|The study was terminated|4
1178542|NCT04381988|2332533|FG001|Overall Study|The study was terminated|0
1178544|NCT00479167|2332567|FG000|Overall Study|Withdrawal by Subject|1
1178545|NCT03998189|2332574|FG000|Overall Study|Lack of Efficacy|0
1178546|NCT03998189|2332575|FG001|Overall Study|Lack of Efficacy|1
1178547|NCT02934503|2332689|FG000|Overall Study|progression of disease|3
1178548|NCT02934503|2332689|FG000|Overall Study|Withdrawal by Subject|1
1178549|NCT02137252|2332695|FG000|Overall Study|trial terminated early|2
1178550|NCT02137252|2332696|FG001|Overall Study|trial terminated early|1
1178551|NCT01294670|2332711|FG000|Overall Study|Not treated|1
1178552|NCT01294670|2332712|FG001|Overall Study|Not treated|0
1178553|NCT01294670|2332713|FG002|Overall Study|Not treated|0
1178554|NCT01294670|2332714|FG003|Overall Study|Not treated|0
1178555|NCT01294670|2332715|FG004|Overall Study|Not treated|0
1178556|NCT03095287|2332727|FG000|Overall Study|Treatment Failure|1
874632|NCT00552617|1836466|FG004|Overall Study|Not Treated|0
874633|NCT00552617|1836467|FG005|Overall Study|Not Treated|0
874634|NCT00552617|1836468|FG006|Overall Study|Not Treated|0
874635|NCT00552617|1836469|FG007|Overall Study|Not Treated|0
874636|NCT00552617|1836470|FG008|Overall Study|Not Treated|0
874637|NCT00552617|1836471|FG009|Overall Study|Not Treated|1
874638|NCT00552617|1836462|FG000|Overall Study|Lost to Follow-up|0
874639|NCT00552617|1836463|FG001|Overall Study|Lost to Follow-up|0
874640|NCT00552617|1836464|FG002|Overall Study|Lost to Follow-up|0
874641|NCT00552617|1836465|FG003|Overall Study|Lost to Follow-up|1
1178557|NCT03095287|2332727|FG000|Overall Study|Adverse Event|1
1178558|NCT02930122|2332737|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
1178559|NCT02930122|2332738|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
1178560|NCT04144166|2332765|FG000|Overall Study|Discharged before study start|1
1178561|NCT04144166|2332765|FG000|Overall Study|Pregnancy|1
1178562|NCT04144166|2332765|FG000|Overall Study|Nail polish could not be removed from finger|1
1178563|NCT04090164|2332776|FG000|Overall Study|incomplete data on file|245
1178564|NCT04090164|2332777|FG001|Overall Study|incomplete data on file|0
1178565|NCT03997825|2332870|FG000|Overall Study|Death|3
1178566|NCT03997825|2332870|FG000|Overall Study|Lost to Follow-up|10
1178567|NCT03997825|2332870|FG000|Overall Study|Withdrawal by Subject|3
1178568|NCT03997825|2332870|FG000|Overall Study|Refused participation|1
1178569|NCT03764813|2332907|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
1178570|NCT03764813|2332908|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
1178571|NCT03764813|2332909|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
1178572|NCT03764813|2332910|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
1178573|NCT01545050|2334150|FG000|Overall Study|Lack of Efficacy|0
1178574|NCT01545050|2334151|FG001|Overall Study|Lack of Efficacy|0
1178575|NCT01545050|2334152|FG002|Overall Study|Lack of Efficacy|0
1178576|NCT01545050|2334153|FG003|Overall Study|Lack of Efficacy|3
1178577|NCT01545050|2334154|FG004|Overall Study|Lack of Efficacy|2
1178578|NCT01545050|2334150|FG000|Overall Study|Adverse Event|1
1178579|NCT01545050|2334151|FG001|Overall Study|Adverse Event|1
1178580|NCT01545050|2334152|FG002|Overall Study|Adverse Event|2
1178581|NCT01545050|2334153|FG003|Overall Study|Adverse Event|2
1178582|NCT01545050|2334154|FG004|Overall Study|Adverse Event|0
1178583|NCT01545050|2334150|FG000|Overall Study|Discontinued study treatment|1
1178584|NCT01545050|2334151|FG001|Overall Study|Discontinued study treatment|0
1178585|NCT01545050|2334152|FG002|Overall Study|Discontinued study treatment|0
1178586|NCT01545050|2334153|FG003|Overall Study|Discontinued study treatment|0
1178587|NCT01545050|2334154|FG004|Overall Study|Discontinued study treatment|0
1178588|NCT01545050|2334150|FG000|Overall Study|Withdrawal by Subject|1
1178589|NCT01545050|2334151|FG001|Overall Study|Withdrawal by Subject|0
1178590|NCT01545050|2334152|FG002|Overall Study|Withdrawal by Subject|0
1178591|NCT01545050|2334153|FG003|Overall Study|Withdrawal by Subject|2
1178592|NCT01545050|2334154|FG004|Overall Study|Withdrawal by Subject|1
1178593|NCT01545050|2334150|FG000|Overall Study|Participant no longer meets study criteria|0
1178594|NCT01545050|2334151|FG001|Overall Study|Participant no longer meets study criteria|2
1178595|NCT01545050|2334152|FG002|Overall Study|Participant no longer meets study criteria|0
1178596|NCT01545050|2334153|FG003|Overall Study|Participant no longer meets study criteria|0
1178597|NCT01545050|2334154|FG004|Overall Study|Participant no longer meets study criteria|1
1178598|NCT01545050|2334150|FG000|Overall Study|Administrative reason by sponsor|4
1178599|NCT01545050|2334151|FG001|Overall Study|Administrative reason by sponsor|2
1178600|NCT01545050|2334152|FG002|Overall Study|Administrative reason by sponsor|3
1178601|NCT01545050|2334153|FG003|Overall Study|Administrative reason by sponsor|5
1178602|NCT01545050|2334154|FG004|Overall Study|Administrative reason by sponsor|5
1178603|NCT02087189|2335183|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2
1178604|NCT04524507|2335533|FG000|Overall Study|Lost to Follow-up|2
1178605|NCT04524507|2335534|FG001|Overall Study|Lost to Follow-up|4
1178606|NCT04524507|2335533|FG000|Overall Study|Withdrawal by Subject|2
1178607|NCT04524507|2335534|FG001|Overall Study|Withdrawal by Subject|9
1178608|NCT04524507|2335533|FG000|Overall Study|Death|2
1178609|NCT04524507|2335534|FG001|Overall Study|Death|10
1178610|NCT04382924|2335547|FG000|Overall Study|Death|2
1178611|NCT04382924|2335548|FG001|Overall Study|Death|5
1178612|NCT04382924|2335549|FG002|Overall Study|Death|4
1178613|NCT04382924|2335547|FG000|Overall Study|Protocol Violation|0
1178614|NCT04382924|2335548|FG001|Overall Study|Protocol Violation|1
1178615|NCT04382924|2335549|FG002|Overall Study|Protocol Violation|1
1178616|NCT04382924|2335547|FG000|Overall Study|Transferred to other hospital/declined in person visits|0
1178617|NCT04382924|2335548|FG001|Overall Study|Transferred to other hospital/declined in person visits|1
1178618|NCT04382924|2335549|FG002|Overall Study|Transferred to other hospital/declined in person visits|1
1178619|NCT04382924|2335547|FG000|Overall Study|Withdrawal by Subject|6
1178620|NCT04382924|2335548|FG001|Overall Study|Withdrawal by Subject|3
1178621|NCT04382924|2335549|FG002|Overall Study|Withdrawal by Subject|6
1178624|NCT03842436|2335589|FG000|Overall Study|Lost to Follow-up|1
1178641|NCT03462030|2335619|FG000|Overall Study|Withdrawal by Subject|1
1178642|NCT03462030|2335620|FG001|Overall Study|Withdrawal by Subject|1
1178643|NCT03446768|2335628|FG000|Overall Study|Withdrawal by Subject|0
1178644|NCT03446768|2335629|FG001|Overall Study|Withdrawal by Subject|1
1178655|NCT03253393|2335706|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6
1178656|NCT03253393|2335707|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7
1178657|NCT03253393|2335708|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0
1178670|NCT03188822|2335734|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6
1178671|NCT03188822|2335734|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1
1178720|NCT03128671|2335758|FG000|Allocation|ICU discharge prior to intervention initiation|4
1178721|NCT03128671|2335759|FG001|Allocation|ICU discharge prior to intervention initiation|0
874642|NCT00552617|1836466|FG004|Overall Study|Lost to Follow-up|0
874643|NCT00552617|1836467|FG005|Overall Study|Lost to Follow-up|2
874644|NCT00552617|1836468|FG006|Overall Study|Lost to Follow-up|0
874645|NCT00552617|1836469|FG007|Overall Study|Lost to Follow-up|0
874646|NCT00552617|1836470|FG008|Overall Study|Lost to Follow-up|2
874647|NCT00552617|1836471|FG009|Overall Study|Lost to Follow-up|0
874648|NCT00552669|1836495|FG000|Overall Study|Death|3
874649|NCT00552669|1836496|FG001|Overall Study|Death|7
874650|NCT00552760|1836513|FG000|Overall Study|Adverse Event|3
874651|NCT00552760|1836514|FG001|Overall Study|Adverse Event|5
874652|NCT00552760|1836513|FG000|Overall Study|Relapsed- Depressed Event|10
874653|NCT00552760|1836514|FG001|Overall Study|Relapsed- Depressed Event|16
874654|NCT00552760|1836513|FG000|Overall Study|Relapse- Manic Event|3
874655|NCT00552760|1836514|FG001|Overall Study|Relapse- Manic Event|3
874656|NCT00552760|1836513|FG000|Overall Study|Relapsed- Mixed Event|3
874657|NCT00552760|1836514|FG001|Overall Study|Relapsed- Mixed Event|5
874658|NCT00552760|1836513|FG000|Overall Study|Protocol Violation|0
874659|NCT00552760|1836514|FG001|Overall Study|Protocol Violation|1
874660|NCT00552760|1836513|FG000|Overall Study|Lost to Follow-up|1
874661|NCT00552760|1836514|FG001|Overall Study|Lost to Follow-up|1
874662|NCT00552760|1836513|FG000|Overall Study|Non-compliance|1
874663|NCT00552760|1836514|FG001|Overall Study|Non-compliance|1
874664|NCT00552760|1836513|FG000|Overall Study|Medical Condition|1
874665|NCT00552760|1836514|FG001|Overall Study|Medical Condition|1
874666|NCT00552760|1836513|FG000|Overall Study|Withdrawal by Subject|3
874667|NCT00552760|1836514|FG001|Overall Study|Withdrawal by Subject|0
874668|NCT00552760|1836513|FG000|Overall Study|Medication Change|1
874669|NCT00552760|1836514|FG001|Overall Study|Medication Change|0
874670|NCT00552929|1836543|FG000|Overall Study|Lost to Follow-up|0
874671|NCT00552929|1836544|FG001|Overall Study|Lost to Follow-up|0
874672|NCT00552929|1836545|FG002|Overall Study|Lost to Follow-up|0
1178722|NCT03128671|2335758|FG000|Allocation|Death|1
1178723|NCT03128671|2335759|FG001|Allocation|Death|0
1178724|NCT03128671|2335758|FG000|Allocation|Withdrawal by Subject|4
1178725|NCT03128671|2335759|FG001|Allocation|Withdrawal by Subject|0
1178726|NCT03128671|2335758|FG000|Intervention|Withdrawal by Subject|11
1178727|NCT03128671|2335759|FG001|Intervention|Withdrawal by Subject|10
1178728|NCT03128671|2335758|FG000|Intervention|Palliative/hospice care initiated|9
1178729|NCT03128671|2335759|FG001|Intervention|Palliative/hospice care initiated|10
1178730|NCT03128671|2335758|FG000|Intervention|Death|13
1178731|NCT03128671|2335759|FG001|Intervention|Death|11
1178732|NCT03128671|2335758|FG000|Intervention|Interrupted by hurricane|1
1178733|NCT03128671|2335759|FG001|Intervention|Interrupted by hurricane|0
1178734|NCT03128671|2335758|FG000|Intervention|Physician Decision|2
1178735|NCT03128671|2335759|FG001|Intervention|Physician Decision|3
1178736|NCT03111732|2335765|FG000|Overall Study|Enrolled in different study|1
1178737|NCT03111732|2335765|FG000|Overall Study|Progressive disease|3
1178738|NCT03111732|2335765|FG000|Overall Study|Withdrawal by Subject|1
1178743|NCT03065244|2335786|FG000|Overall Study|Lost to Follow-up|1
1178744|NCT03065244|2335787|FG001|Overall Study|Lost to Follow-up|1
1178745|NCT03065244|2335786|FG000|Overall Study|Diagnosed with a different disease|1
1178746|NCT03065244|2335787|FG001|Overall Study|Diagnosed with a different disease|1
1178747|NCT03065244|2335786|FG000|Overall Study|Protocol Violation|0
1178748|NCT03065244|2335787|FG001|Overall Study|Protocol Violation|1
1178749|NCT03065244|2335786|FG000|Overall Study|Withdrawal by Subject|1
1178750|NCT03065244|2335787|FG001|Overall Study|Withdrawal by Subject|1
1178751|NCT02879305|2335795|FG000|Overall Study|Investigator Site Closed|55
1178752|NCT02879305|2335796|FG001|Overall Study|Investigator Site Closed|57
1178753|NCT02879305|2335795|FG000|Overall Study|Withdrawal by Subject|44
1178754|NCT02879305|2335796|FG001|Overall Study|Withdrawal by Subject|42
1178755|NCT02879305|2335795|FG000|Overall Study|Lost to Follow-up|17
1178756|NCT02879305|2335796|FG001|Overall Study|Lost to Follow-up|12
1178757|NCT02879305|2335795|FG000|Overall Study|Other|1
1178758|NCT02879305|2335796|FG001|Overall Study|Other|0
1178774|NCT02787850|2335826|FG000|Overall Study|Withdrawal by Subject|0
874673|NCT00552929|1836546|FG003|Overall Study|Lost to Follow-up|0
1178775|NCT02787850|2335827|FG001|Overall Study|Withdrawal by Subject|1
1178776|NCT02676284|2335846|FG000|Overall Study|Withdrawal by Subject|1
1178777|NCT02632409|2335852|FG000|Randomized|AE unrelated to study Drug|0
1178778|NCT02632409|2335853|FG001|Randomized|AE unrelated to study Drug|1
1178779|NCT02632409|2335852|FG000|Randomized|Participant withdrew consent|2
1178780|NCT02632409|2335853|FG001|Randomized|Participant withdrew consent|1
1178781|NCT02632409|2335852|FG000|Randomized|No Longer meets study criteria|5
1178782|NCT02632409|2335853|FG001|Randomized|No Longer meets study criteria|0
1178783|NCT02632409|2335852|FG000|Randomized|other reasons|1
1178784|NCT02632409|2335853|FG001|Randomized|other reasons|0
1178785|NCT02632409|2335852|FG000|Treatment Period|Ongoing Treatment|20
1178786|NCT02632409|2335853|FG001|Treatment Period|Ongoing Treatment|21
1178787|NCT02632409|2335852|FG000|Treatment Period|Disease Recurrence|147
1178788|NCT02632409|2335853|FG001|Treatment Period|Disease Recurrence|90
1178789|NCT02632409|2335852|FG000|Treatment Period|Study Drug Toxicity|8
1178790|NCT02632409|2335853|FG001|Treatment Period|Study Drug Toxicity|49
1178791|NCT02632409|2335852|FG000|Treatment Period|Death|1
1178792|NCT02632409|2335853|FG001|Treatment Period|Death|0
1178793|NCT02632409|2335852|FG000|Treatment Period|AE unrelated to study drug|15
1178794|NCT02632409|2335853|FG001|Treatment Period|AE unrelated to study drug|16
1178795|NCT02632409|2335852|FG000|Treatment Period|Request to discontinue treatment|4
1178796|NCT02632409|2335853|FG001|Treatment Period|Request to discontinue treatment|19
1178797|NCT02632409|2335852|FG000|Treatment Period|Participant withdrew consent|7
1178798|NCT02632409|2335853|FG001|Treatment Period|Participant withdrew consent|5
1178799|NCT02632409|2335852|FG000|Treatment Period|Lost to Follow-up|0
1178800|NCT02632409|2335853|FG001|Treatment Period|Lost to Follow-up|1
1178801|NCT02632409|2335852|FG000|Treatment Period|Maximum clinical benefit|1
1178802|NCT02632409|2335853|FG001|Treatment Period|Maximum clinical benefit|0
1178803|NCT02632409|2335852|FG000|Treatment Period|No longer meets study criteria|3
1178804|NCT02632409|2335853|FG001|Treatment Period|No longer meets study criteria|0
1178805|NCT02632409|2335852|FG000|Treatment Period|Administrative Reason by sponsor|0
1178806|NCT02632409|2335853|FG001|Treatment Period|Administrative Reason by sponsor|1
1178807|NCT02632409|2335852|FG000|Treatment Period|Other Reasons|10
1178808|NCT02632409|2335853|FG001|Treatment Period|Other Reasons|6
1178809|NCT02516241|2335862|FG000|Overall Study|Death|255
1178810|NCT02516241|2335863|FG001|Overall Study|Death|262
1178811|NCT02516241|2335864|FG002|Overall Study|Death|270
1178812|NCT02516241|2335862|FG000|Overall Study|Lost to Follow-up|1
1178813|NCT02516241|2335863|FG001|Overall Study|Lost to Follow-up|1
1178814|NCT02516241|2335864|FG002|Overall Study|Lost to Follow-up|3
1178815|NCT02516241|2335862|FG000|Overall Study|Withdrawal by Subject|2
1178816|NCT02516241|2335863|FG001|Overall Study|Withdrawal by Subject|7
1178817|NCT02516241|2335864|FG002|Overall Study|Withdrawal by Subject|12
1178818|NCT02516241|2335862|FG000|Overall Study|participants ongoing at data cut-off|84
1178819|NCT02516241|2335863|FG001|Overall Study|participants ongoing at data cut-off|76
874674|NCT00552929|1836547|FG004|Overall Study|Lost to Follow-up|0
874675|NCT00552929|1836548|FG005|Overall Study|Lost to Follow-up|0
874676|NCT00552929|1836549|FG006|Overall Study|Lost to Follow-up|0
874677|NCT00552929|1836550|FG007|Overall Study|Lost to Follow-up|0
874678|NCT00552929|1836551|FG008|Overall Study|Lost to Follow-up|1
874679|NCT00552929|1836552|FG009|Overall Study|Lost to Follow-up|0
874680|NCT00552929|1836543|FG000|Overall Study|Not Eligible|0
874681|NCT00552929|1836544|FG001|Overall Study|Not Eligible|0
874682|NCT00552929|1836545|FG002|Overall Study|Not Eligible|0
874683|NCT00552929|1836546|FG003|Overall Study|Not Eligible|0
874684|NCT00552929|1836547|FG004|Overall Study|Not Eligible|0
874685|NCT00552929|1836548|FG005|Overall Study|Not Eligible|1
874686|NCT00552929|1836549|FG006|Overall Study|Not Eligible|0
874687|NCT00552929|1836550|FG007|Overall Study|Not Eligible|0
874688|NCT00552929|1836551|FG008|Overall Study|Not Eligible|0
874689|NCT00552929|1836552|FG009|Overall Study|Not Eligible|0
874690|NCT00553059|1836576|FG000|Overall Study|Deemed ineligible|1
874691|NCT00553059|1836577|FG001|Overall Study|Deemed ineligible|1
874692|NCT00553059|1836576|FG000|Overall Study|Drug supply not available|0
874693|NCT00553059|1836577|FG001|Overall Study|Drug supply not available|1
874694|NCT00553150|1836593|FG000|Overall Study|Withdrawal by Subject|0
874695|NCT00553150|1836594|FG001|Overall Study|Withdrawal by Subject|0
874696|NCT00553150|1836595|FG002|Overall Study|Withdrawal by Subject|0
874697|NCT00553150|1836596|FG003|Overall Study|Withdrawal by Subject|2
874698|NCT00553150|1836593|FG000|Overall Study|Protocol Violation|0
874699|NCT00553150|1836594|FG001|Overall Study|Protocol Violation|0
874700|NCT00553150|1836595|FG002|Overall Study|Protocol Violation|0
874701|NCT00553150|1836596|FG003|Overall Study|Protocol Violation|1
874702|NCT00553150|1836593|FG000|Overall Study|Ineligible|0
874703|NCT00553150|1836594|FG001|Overall Study|Ineligible|0
874704|NCT00553150|1836595|FG002|Overall Study|Ineligible|0
874705|NCT00553150|1836596|FG003|Overall Study|Ineligible|1
874706|NCT00553202|1836618|FG000|Overall Study|Death|16
874707|NCT00553202|1836618|FG000|Overall Study|Lost to Follow-up|1
874708|NCT00553202|1836618|FG000|Overall Study|Physician Decision|28
874709|NCT00553202|1836618|FG000|Overall Study|Withdrawal by Subject|1
874710|NCT00553202|1836618|FG000|Overall Study|No donor identified|16
874711|NCT00553202|1836618|FG000|Overall Study|Fails to meet organ function|6
874712|NCT00553254|1836625|FG000|Overall Study|Death|3
874713|NCT00553254|1836626|FG001|Overall Study|Death|6
874714|NCT00553254|1836627|FG002|Overall Study|Death|25
874715|NCT00553254|1836625|FG000|Overall Study|Lost to Follow-up|0
874716|NCT00553254|1836626|FG001|Overall Study|Lost to Follow-up|0
874717|NCT00553254|1836627|FG002|Overall Study|Lost to Follow-up|2
874718|NCT00553254|1836625|FG000|Overall Study|Withdrawal by Subject|2
874719|NCT00553254|1836626|FG001|Overall Study|Withdrawal by Subject|0
874720|NCT00553254|1836627|FG002|Overall Study|Withdrawal by Subject|2
1178820|NCT02516241|2335864|FG002|Overall Study|participants ongoing at data cut-off|59
1178821|NCT02431702|2335877|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7
1178822|NCT02431702|2335878|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
1178823|NCT02431702|2335879|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
1178824|NCT02431702|2335880|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
1178825|NCT02431702|2335881|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
1178826|NCT02431702|2335882|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
1178827|NCT02431702|2335883|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
1178828|NCT02431702|2335877|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11
1178829|NCT02431702|2335878|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
1178830|NCT02431702|2335879|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
1178831|NCT02431702|2335880|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
1178832|NCT02431702|2335881|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
1178833|NCT02431702|2335882|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
1178834|NCT02431702|2335883|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23
1178835|NCT02431702|2335877|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9
1178836|NCT02431702|2335878|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
1178837|NCT02431702|2335879|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
1178838|NCT02431702|2335880|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
1178839|NCT02431702|2335881|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
1178840|NCT02431702|2335882|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
1178841|NCT02431702|2335883|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6
1178842|NCT02431702|2335877|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5
1178843|NCT02431702|2335878|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0
1178844|NCT02431702|2335879|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0
1178845|NCT02431702|2335880|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0
1178846|NCT02431702|2335881|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0
1178847|NCT02431702|2335882|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0
1178848|NCT02431702|2335883|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3
1178849|NCT02431702|2335877|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2
1178850|NCT02431702|2335878|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
1178851|NCT02431702|2335879|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
1178852|NCT02431702|2335880|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
1178853|NCT02431702|2335881|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
1178854|NCT02431702|2335882|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
1178855|NCT02431702|2335883|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
1178856|NCT02431702|2335877|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0
1178857|NCT02431702|2335878|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5
1178858|NCT02431702|2335879|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1
1178859|NCT02431702|2335880|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0
1178860|NCT02431702|2335881|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0
1178861|NCT02431702|2335882|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0
1178862|NCT02431702|2335883|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0
1178863|NCT02431702|2335877|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
1178864|NCT02431702|2335878|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6
1178865|NCT02431702|2335879|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13
1178866|NCT02431702|2335880|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
1178867|NCT02431702|2335881|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
1178868|NCT02431702|2335882|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
1178869|NCT02431702|2335883|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
1178870|NCT02431702|2335877|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
1178871|NCT02431702|2335878|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11
1178872|NCT02431702|2335879|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8
1178873|NCT02431702|2335880|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
1178874|NCT02431702|2335881|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
1178875|NCT02431702|2335882|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
1178876|NCT02431702|2335883|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
1178877|NCT02431702|2335877|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
1178878|NCT02431702|2335878|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2
1178879|NCT02431702|2335879|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
1178880|NCT02431702|2335880|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
1178881|NCT02431702|2335881|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
1178882|NCT02431702|2335882|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
1178883|NCT02431702|2335883|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
1178884|NCT02431702|2335877|FG000|Part 2: 9Month Disease Progression Phase|Other|0
1178885|NCT02431702|2335878|FG001|Part 2: 9Month Disease Progression Phase|Other|2
1178886|NCT02431702|2335879|FG002|Part 2: 9Month Disease Progression Phase|Other|2
1178887|NCT02431702|2335880|FG003|Part 2: 9Month Disease Progression Phase|Other|0
1178888|NCT02431702|2335881|FG004|Part 2: 9Month Disease Progression Phase|Other|0
1178889|NCT02431702|2335882|FG005|Part 2: 9Month Disease Progression Phase|Other|0
1178890|NCT02431702|2335883|FG006|Part 2: 9Month Disease Progression Phase|Other|0
1178891|NCT02431702|2335877|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
1178892|NCT02431702|2335878|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
1178893|NCT02431702|2335879|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5
1178894|NCT02431702|2335880|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
1178895|NCT02431702|2335881|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
1178896|NCT02431702|2335882|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
1178897|NCT02431702|2335883|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
1178898|NCT02431702|2335877|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0
1178899|NCT02431702|2335878|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0
1178900|NCT02431702|2335879|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0
1178901|NCT02431702|2335880|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2
1178902|NCT02431702|2335881|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3
1178903|NCT02431702|2335882|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0
1178904|NCT02431702|2335883|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0
1178905|NCT02431702|2335877|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
1178906|NCT02431702|2335878|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
1178907|NCT02431702|2335879|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
1178908|NCT02431702|2335880|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1
1178909|NCT02431702|2335881|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
1178910|NCT02431702|2335882|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5
1178911|NCT02431702|2335883|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
1178912|NCT02431702|2335877|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
1178913|NCT02431702|2335878|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
1178914|NCT02431702|2335879|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
1178915|NCT02431702|2335880|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5
1178916|NCT02431702|2335881|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
1178917|NCT02431702|2335882|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
1178918|NCT02431702|2335883|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
1178919|NCT02431702|2335877|FG000|Part 3: 9 Month of Additional Treatment|Other|0
1178920|NCT02431702|2335878|FG001|Part 3: 9 Month of Additional Treatment|Other|0
1178921|NCT02431702|2335879|FG002|Part 3: 9 Month of Additional Treatment|Other|0
1178922|NCT02431702|2335880|FG003|Part 3: 9 Month of Additional Treatment|Other|1
1178923|NCT02431702|2335881|FG004|Part 3: 9 Month of Additional Treatment|Other|1
1178924|NCT02431702|2335882|FG005|Part 3: 9 Month of Additional Treatment|Other|6
1178925|NCT02431702|2335883|FG006|Part 3: 9 Month of Additional Treatment|Other|0
1178951|NCT02200770|2335958|FG000|Randomized-controlled Period (RCP)|Adverse Event|0
1178952|NCT02200770|2335959|FG001|Randomized-controlled Period (RCP)|Adverse Event|2
1178953|NCT02200770|2335958|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
1178954|NCT02200770|2335959|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
1178955|NCT02200770|2335958|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0
1178956|NCT02200770|2335959|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1
1178957|NCT02200770|2335958|FG000|Randomized-controlled Period (RCP)|Other|1
1178958|NCT02200770|2335959|FG001|Randomized-controlled Period (RCP)|Other|2
1178959|NCT02200770|2335958|FG000|Open-label Period (OLP)|Adverse Event|1
1178960|NCT02200770|2335959|FG001|Open-label Period (OLP)|Adverse Event|2
1178961|NCT02200770|2335958|FG000|Open-label Period (OLP)|Death|1
1178962|NCT02200770|2335959|FG001|Open-label Period (OLP)|Death|2
1178963|NCT02200770|2335958|FG000|Open-label Period (OLP)|Lost to Follow-up|0
1178964|NCT02200770|2335959|FG001|Open-label Period (OLP)|Lost to Follow-up|1
1178965|NCT02200770|2335958|FG000|Open-label Period (OLP)|Withdrawal by Subject|0
1178966|NCT02200770|2335959|FG001|Open-label Period (OLP)|Withdrawal by Subject|14
1178967|NCT02200770|2335958|FG000|Open-label Period (OLP)|Other|6
1178968|NCT02200770|2335959|FG001|Open-label Period (OLP)|Other|15
874721|NCT00553254|1836625|FG000|Overall Study|Study terminated by Sponsor|0
874722|NCT00553254|1836626|FG001|Overall Study|Study terminated by Sponsor|0
874723|NCT00553254|1836627|FG002|Overall Study|Study terminated by Sponsor|1
874724|NCT00553254|1836625|FG000|Overall Study|Other|1
874725|NCT00553254|1836626|FG001|Overall Study|Other|0
874726|NCT00553254|1836627|FG002|Overall Study|Other|13
874727|NCT00553267|1836642|FG000|Overall Study|Adverse Event|8
874728|NCT00553267|1836643|FG001|Overall Study|Adverse Event|10
874729|NCT00553267|1836644|FG002|Overall Study|Adverse Event|5
874730|NCT00553267|1836642|FG000|Overall Study|Non compliant with protocol|3
874731|NCT00553267|1836643|FG001|Overall Study|Non compliant with protocol|3
874732|NCT00553267|1836644|FG002|Overall Study|Non compliant with protocol|2
874733|NCT00553267|1836642|FG000|Overall Study|Lost to Follow-up|0
874734|NCT00553267|1836643|FG001|Overall Study|Lost to Follow-up|0
874735|NCT00553267|1836644|FG002|Overall Study|Lost to Follow-up|1
874736|NCT00553267|1836642|FG000|Overall Study|Consent withdrawn|2
874737|NCT00553267|1836643|FG001|Overall Study|Consent withdrawn|3
874738|NCT00553267|1836644|FG002|Overall Study|Consent withdrawn|1
874739|NCT00553267|1836642|FG000|Overall Study|Specified category|1
874740|NCT00553267|1836643|FG001|Overall Study|Specified category|2
874741|NCT00553267|1836644|FG002|Overall Study|Specified category|1
874742|NCT00553280|1836652|FG000|Overall Study|Adverse Event|19
874743|NCT00553280|1836652|FG000|Overall Study|Lack of Efficacy|3
874744|NCT00553280|1836652|FG000|Overall Study|Withdrawal by Subject|3
874745|NCT00553280|1836652|FG000|Overall Study|Physician Decision|1
874746|NCT00553319|1836659|FG000|Overall Study|Lost to Follow-up|10
874747|NCT00553319|1836660|FG001|Overall Study|Lost to Follow-up|9
874748|NCT00553319|1836661|FG002|Overall Study|Lost to Follow-up|5
874749|NCT00553319|1836659|FG000|Overall Study|wanted treatment elsewhere|2
874750|NCT00553319|1836660|FG001|Overall Study|wanted treatment elsewhere|1
874751|NCT00553319|1836661|FG002|Overall Study|wanted treatment elsewhere|1
874752|NCT00553319|1836659|FG000|Overall Study|non-compliance|0
874753|NCT00553319|1836660|FG001|Overall Study|non-compliance|0
874754|NCT00553319|1836661|FG002|Overall Study|non-compliance|2
874755|NCT00553319|1836659|FG000|Overall Study|incarceration|1
874756|NCT00553319|1836660|FG001|Overall Study|incarceration|0
874757|NCT00553319|1836661|FG002|Overall Study|incarceration|0
874758|NCT00553319|1836659|FG000|Overall Study|moved|1
874759|NCT00553319|1836660|FG001|Overall Study|moved|0
874760|NCT00553319|1836661|FG002|Overall Study|moved|1
874761|NCT00553332|1836669|FG000|Overall Study|ineligible, incorrect diagnosis|1
874762|NCT00553358|1836676|FG000|Overall Study|Randomized but did not receive treatment|3
874763|NCT00553358|1836677|FG001|Overall Study|Randomized but did not receive treatment|3
874764|NCT00553358|1836678|FG002|Overall Study|Randomized but did not receive treatment|1
874765|NCT00553358|1836676|FG000|Overall Study|Lost to Follow-up|22
874766|NCT00553358|1836677|FG001|Overall Study|Lost to Follow-up|26
874767|NCT00553358|1836678|FG002|Overall Study|Lost to Follow-up|18
874768|NCT00553358|1836676|FG000|Overall Study|Withdrew completely|23
874769|NCT00553358|1836677|FG001|Overall Study|Withdrew completely|33
874770|NCT00553358|1836678|FG002|Overall Study|Withdrew completely|34
874771|NCT00553358|1836676|FG000|Overall Study|Died during clinical follow-up|25
874772|NCT00553358|1836677|FG001|Overall Study|Died during clinical follow-up|29
874773|NCT00553358|1836678|FG002|Overall Study|Died during clinical follow-up|32
874774|NCT00553358|1836676|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4
1178991|NCT02136069|2335987|FG000|Overall Study|UC flare-up|1
1178992|NCT02136069|2335988|FG001|Overall Study|UC flare-up|0
1178993|NCT02136069|2335987|FG000|Overall Study|Adverse Event|6
1178994|NCT02136069|2335988|FG001|Overall Study|Adverse Event|8
1178995|NCT02136069|2335987|FG000|Overall Study|Death|0
1178996|NCT02136069|2335988|FG001|Overall Study|Death|1
1178997|NCT02136069|2335987|FG000|Overall Study|Lack of Efficacy|10
1178998|NCT02136069|2335988|FG001|Overall Study|Lack of Efficacy|4
1178999|NCT02136069|2335987|FG000|Overall Study|Lost to Follow-up|1
1179000|NCT02136069|2335988|FG001|Overall Study|Lost to Follow-up|0
1179001|NCT02136069|2335987|FG000|Overall Study|Non-Compliance|1
1179002|NCT02136069|2335988|FG001|Overall Study|Non-Compliance|0
1179003|NCT02136069|2335987|FG000|Overall Study|Physician Decision|5
1179004|NCT02136069|2335988|FG001|Overall Study|Physician Decision|4
1179005|NCT02136069|2335987|FG000|Overall Study|Withdrawal by Subject|10
1179006|NCT02136069|2335988|FG001|Overall Study|Withdrawal by Subject|11
1179007|NCT02086552|2335994|FG000|Overall Study|Withdrawal by Subject|1
1179068|NCT01209767|2336060|FG000|Overall Study|Withdrawal by Subject|1
1179069|NCT01209767|2336060|FG000|Overall Study|Lost to Follow-up|3
1179072|NCT01186848|2336079|FG000|Overall Study|Lost to Follow-up|4
1179073|NCT01186848|2336079|FG000|Overall Study|Withdrawal by Subject|2
1179074|NCT01186848|2336079|FG000|Overall Study|Adverse Event|2
1179099|NCT01024608|2336116|FG000|Overall Study|Adverse Event|1
1179100|NCT01024608|2336117|FG001|Overall Study|Adverse Event|0
1179101|NCT01024608|2336116|FG000|Overall Study|Withdrawal by Subject|1
1179102|NCT01024608|2336117|FG001|Overall Study|Withdrawal by Subject|0
1179103|NCT01024608|2336116|FG000|Overall Study|Lost to Follow-up|0
1179104|NCT01024608|2336117|FG001|Overall Study|Lost to Follow-up|1
1179105|NCT01024608|2336116|FG000|Overall Study|Protocol Violation|0
1179106|NCT01024608|2336117|FG001|Overall Study|Protocol Violation|3
1179107|NCT01024608|2336116|FG000|Overall Study|Never received study treatment|2
1179108|NCT01024608|2336117|FG001|Overall Study|Never received study treatment|0
1179109|NCT00988247|2336125|FG000|Overall Study|Adverse Event|17
1179110|NCT00988247|2336126|FG001|Overall Study|Adverse Event|3
1179111|NCT00988247|2336125|FG000|Overall Study|Withdrawal by Subject|44
1179112|NCT00988247|2336126|FG001|Overall Study|Withdrawal by Subject|13
1179113|NCT00988247|2336125|FG000|Overall Study|Pregnancy|1
1179114|NCT00988247|2336126|FG001|Overall Study|Pregnancy|2
1179115|NCT00988247|2336125|FG000|Overall Study|Lost to Follow-up|11
1179116|NCT00988247|2336126|FG001|Overall Study|Lost to Follow-up|2
1179117|NCT00988247|2336125|FG000|Overall Study|Protocol Violation|4
1179118|NCT00988247|2336126|FG001|Overall Study|Protocol Violation|5
1179119|NCT00988247|2336125|FG000|Overall Study|Sponsor requested withdrawal|3
1179120|NCT00988247|2336126|FG001|Overall Study|Sponsor requested withdrawal|1
1179121|NCT00988247|2336125|FG000|Overall Study|Other|3
1179122|NCT00988247|2336126|FG001|Overall Study|Other|0
1179123|NCT00730639|2336158|FG000|Overall Study|Adverse Event|3
1179124|NCT00730639|2336159|FG001|Overall Study|Adverse Event|0
1179125|NCT00730639|2336160|FG002|Overall Study|Adverse Event|9
1179126|NCT00730639|2336161|FG003|Overall Study|Adverse Event|8
1179127|NCT00730639|2336162|FG004|Overall Study|Adverse Event|23
1179128|NCT00730639|2336158|FG000|Overall Study|Complete Response|0
1179129|NCT00730639|2336159|FG001|Overall Study|Complete Response|0
1179130|NCT00730639|2336160|FG002|Overall Study|Complete Response|2
1179131|NCT00730639|2336161|FG003|Overall Study|Complete Response|2
1179132|NCT00730639|2336162|FG004|Overall Study|Complete Response|1
1179133|NCT00730639|2336158|FG000|Overall Study|Completed Maximum Cycles|0
1179134|NCT00730639|2336159|FG001|Overall Study|Completed Maximum Cycles|0
1179135|NCT00730639|2336160|FG002|Overall Study|Completed Maximum Cycles|11
1179136|NCT00730639|2336161|FG003|Overall Study|Completed Maximum Cycles|3
1179137|NCT00730639|2336162|FG004|Overall Study|Completed Maximum Cycles|6
1179138|NCT00730639|2336158|FG000|Overall Study|Death|0
1179139|NCT00730639|2336159|FG001|Overall Study|Death|0
1179140|NCT00730639|2336160|FG002|Overall Study|Death|0
1179141|NCT00730639|2336161|FG003|Overall Study|Death|0
1179142|NCT00730639|2336162|FG004|Overall Study|Death|2
1179143|NCT00730639|2336158|FG000|Overall Study|Disease Progression|12
1179144|NCT00730639|2336159|FG001|Overall Study|Disease Progression|13
1179145|NCT00730639|2336160|FG002|Overall Study|Disease Progression|48
1179146|NCT00730639|2336161|FG003|Overall Study|Disease Progression|32
1179147|NCT00730639|2336162|FG004|Overall Study|Disease Progression|88
1179148|NCT00730639|2336158|FG000|Overall Study|non-specified|0
1179149|NCT00730639|2336159|FG001|Overall Study|non-specified|0
1179150|NCT00730639|2336160|FG002|Overall Study|non-specified|4
1179151|NCT00730639|2336161|FG003|Overall Study|non-specified|2
1179152|NCT00730639|2336162|FG004|Overall Study|non-specified|3
1179153|NCT00730639|2336158|FG000|Overall Study|Protocol Violation|0
1179154|NCT00730639|2336159|FG001|Overall Study|Protocol Violation|0
1179155|NCT00730639|2336160|FG002|Overall Study|Protocol Violation|1
1179156|NCT00730639|2336161|FG003|Overall Study|Protocol Violation|0
1179157|NCT00730639|2336162|FG004|Overall Study|Protocol Violation|0
1179158|NCT00730639|2336158|FG000|Overall Study|Withdrawal by Subject|0
1179159|NCT00730639|2336159|FG001|Overall Study|Withdrawal by Subject|0
1179160|NCT00730639|2336160|FG002|Overall Study|Withdrawal by Subject|6
1179161|NCT00730639|2336161|FG003|Overall Study|Withdrawal by Subject|3
874775|NCT00553358|1836677|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
1179162|NCT00730639|2336162|FG004|Overall Study|Withdrawal by Subject|4
1179163|NCT00730639|2336158|FG000|Overall Study|Treatment on-going|2
874776|NCT00553358|1836678|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
874777|NCT00553358|1836676|FG000|Overall Study|Died after clinical follow-up ended|1
874778|NCT00553358|1836677|FG001|Overall Study|Died after clinical follow-up ended|2
874779|NCT00553358|1836678|FG002|Overall Study|Died after clinical follow-up ended|0
874780|NCT00553358|1836676|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
874781|NCT00553358|1836677|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
874782|NCT00553358|1836678|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
874783|NCT00553436|1836701|FG000|Overall Study|Conversion to another procedure|1
874784|NCT00553462|1836705|FG000|Overall Study|Adverse Event|4
874785|NCT00553462|1836705|FG000|Overall Study|Progression|4
874786|NCT00553462|1836705|FG000|Overall Study|Withdrawal by Subject|5
874787|NCT00553462|1836705|FG000|Overall Study|Physician Decision|1
874788|NCT00553475|1836712|FG000|Overall Study|Adverse Event|7
874789|NCT00553475|1836713|FG001|Overall Study|Adverse Event|17
874790|NCT00553475|1836714|FG002|Overall Study|Adverse Event|13
874791|NCT00553475|1836712|FG000|Overall Study|Lack of Efficacy|7
874792|NCT00553475|1836713|FG001|Overall Study|Lack of Efficacy|1
874793|NCT00553475|1836714|FG002|Overall Study|Lack of Efficacy|0
874794|NCT00553475|1836712|FG000|Overall Study|Withdrawal by Subject|1
874795|NCT00553475|1836713|FG001|Overall Study|Withdrawal by Subject|1
874796|NCT00553475|1836714|FG002|Overall Study|Withdrawal by Subject|0
874797|NCT00553475|1836712|FG000|Overall Study|Physician Decision|1
874798|NCT00553475|1836713|FG001|Overall Study|Physician Decision|0
874799|NCT00553475|1836714|FG002|Overall Study|Physician Decision|0
874800|NCT00553475|1836712|FG000|Overall Study|Due to moving|0
874801|NCT00553475|1836713|FG001|Overall Study|Due to moving|1
874802|NCT00553475|1836714|FG002|Overall Study|Due to moving|0
874803|NCT00553501|1836724|FG000|Overall Study|Adverse Event|2
874804|NCT00553501|1836724|FG000|Overall Study|Death|1
874805|NCT00553501|1836724|FG000|Overall Study|Progression|1
874806|NCT00553514|1836733|FG000|Overall Study|Protocol deviation|0
874807|NCT00553514|1836734|FG001|Overall Study|Protocol deviation|0
874808|NCT00553514|1836735|FG002|Overall Study|Protocol deviation|0
874809|NCT00553514|1836736|FG003|Overall Study|Protocol deviation|1
874810|NCT00553514|1836737|FG004|Overall Study|Protocol deviation|0
874811|NCT00553514|1836733|FG000|Overall Study|Lack of ovarian response|4
874812|NCT00553514|1836734|FG001|Overall Study|Lack of ovarian response|5
874813|NCT00553514|1836735|FG002|Overall Study|Lack of ovarian response|5
874814|NCT00553514|1836736|FG003|Overall Study|Lack of ovarian response|5
874815|NCT00553514|1836737|FG004|Overall Study|Lack of ovarian response|6
874816|NCT00553514|1836733|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3
874817|NCT00553514|1836734|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0
874818|NCT00553514|1836735|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1
874819|NCT00553514|1836736|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0
874820|NCT00553514|1836737|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0
874821|NCT00553514|1836733|FG000|Overall Study|Risk of multiple pregnancy|0
874822|NCT00553514|1836734|FG001|Overall Study|Risk of multiple pregnancy|2
874823|NCT00553514|1836735|FG002|Overall Study|Risk of multiple pregnancy|0
874824|NCT00553514|1836736|FG003|Overall Study|Risk of multiple pregnancy|1
874825|NCT00553514|1836737|FG004|Overall Study|Risk of multiple pregnancy|0
874826|NCT00553514|1836733|FG000|Overall Study|Other|1
874827|NCT00553514|1836734|FG001|Overall Study|Other|1
874828|NCT00553514|1836735|FG002|Overall Study|Other|0
874829|NCT00553514|1836736|FG003|Overall Study|Other|0
874830|NCT00553514|1836737|FG004|Overall Study|Other|1
874831|NCT00553540|1836751|FG000|Overall Study|discharged after first visit|2
874832|NCT00553540|1836752|FG001|Overall Study|discharged after first visit|5
874833|NCT00553605|1836760|FG000|Overall Study|Did not meet entrance criteria|1
874834|NCT00553605|1836761|FG001|Overall Study|Did not meet entrance criteria|3
874835|NCT00553605|1836760|FG000|Overall Study|Did not receive full dose|1
874836|NCT00553605|1836761|FG001|Overall Study|Did not receive full dose|0
874837|NCT00553605|1836760|FG000|Overall Study|Randomized but not treated|2
874838|NCT00553605|1836761|FG001|Overall Study|Randomized but not treated|0
874839|NCT00553631|1836769|FG000|Overall Study|Withdrawal by Subject|0
874840|NCT00553631|1836770|FG001|Overall Study|Withdrawal by Subject|1
874841|NCT00553631|1836769|FG000|Overall Study|Lost to Follow-up|1
874842|NCT00553631|1836770|FG001|Overall Study|Lost to Follow-up|0
874843|NCT00553644|1836776|FG000|Overall Study|Adverse Event|17
874844|NCT00553644|1836776|FG000|Overall Study|Withdrawal by Subject|4
874845|NCT00553644|1836776|FG000|Overall Study|Physician Decision|1
874846|NCT00553644|1836776|FG000|Overall Study|Alternative therapy|6
874847|NCT00553696|1836784|FG000|Overall Study|Adverse Event|2
874848|NCT00553696|1836785|FG001|Overall Study|Adverse Event|4
874849|NCT00553696|1836786|FG002|Overall Study|Adverse Event|0
874850|NCT00553696|1836787|FG003|Overall Study|Adverse Event|1
874851|NCT00553696|1836784|FG000|Overall Study|Global deterioration of health status|0
874852|NCT00553696|1836785|FG001|Overall Study|Global deterioration of health status|2
874853|NCT00553696|1836786|FG002|Overall Study|Global deterioration of health status|0
1179164|NCT00730639|2336159|FG001|Overall Study|Treatment on-going|5
874854|NCT00553696|1836787|FG003|Overall Study|Global deterioration of health status|0
874855|NCT00553696|1836784|FG000|Overall Study|Objective progression or relapse|2
874856|NCT00553696|1836785|FG001|Overall Study|Objective progression or relapse|9
874857|NCT00553696|1836786|FG002|Overall Study|Objective progression or relapse|6
874858|NCT00553696|1836787|FG003|Overall Study|Objective progression or relapse|0
874859|NCT00553696|1836784|FG000|Overall Study|Withdrawal by Subject|0
874860|NCT00553696|1836785|FG001|Overall Study|Withdrawal by Subject|1
874861|NCT00553696|1836786|FG002|Overall Study|Withdrawal by Subject|0
874862|NCT00553696|1836787|FG003|Overall Study|Withdrawal by Subject|0
874863|NCT00553787|1836810|FG000|Overall Study|Adverse Event|34
874864|NCT00553787|1836811|FG001|Overall Study|Adverse Event|21
874865|NCT00553787|1836812|FG002|Overall Study|Adverse Event|67
874866|NCT00553787|1836810|FG000|Overall Study|Lost to Follow-up|132
874867|NCT00553787|1836811|FG001|Overall Study|Lost to Follow-up|44
874868|NCT00553787|1836812|FG002|Overall Study|Lost to Follow-up|78
874869|NCT00553787|1836810|FG000|Overall Study|Withdrawal by Subject|151
874870|NCT00553787|1836811|FG001|Overall Study|Withdrawal by Subject|40
874871|NCT00553787|1836812|FG002|Overall Study|Withdrawal by Subject|83
874872|NCT00553787|1836810|FG000|Overall Study|Lack of Efficacy|31
874873|NCT00553787|1836811|FG001|Overall Study|Lack of Efficacy|1
874874|NCT00553787|1836812|FG002|Overall Study|Lack of Efficacy|3
874875|NCT00553787|1836810|FG000|Overall Study|Pregnancy|0
874876|NCT00553787|1836811|FG001|Overall Study|Pregnancy|1
874877|NCT00553787|1836812|FG002|Overall Study|Pregnancy|2
874878|NCT00553787|1836810|FG000|Overall Study|non compliance|4
874879|NCT00553787|1836811|FG001|Overall Study|non compliance|0
1179165|NCT00730639|2336160|FG002|Overall Study|Treatment on-going|5
1179166|NCT00730639|2336161|FG003|Overall Study|Treatment on-going|4
1179167|NCT00730639|2336162|FG004|Overall Study|Treatment on-going|4
1179168|NCT04834362|2336200|FG000|Overall Study|Death|1
1179169|NCT04834362|2336201|FG001|Overall Study|Death|2
1179170|NCT04611789|2336227|FG000|Overall Study|Lost to Follow-up|1
1179171|NCT04611789|2336228|FG001|Overall Study|Lost to Follow-up|0
1179172|NCT04611789|2336229|FG002|Overall Study|Lost to Follow-up|0
1179173|NCT04254809|2336303|FG000|Overall Study|Lost to Follow-up|5
1179174|NCT04254809|2336304|FG001|Overall Study|Lost to Follow-up|10
1179175|NCT04230122|2336312|FG000|Overall Study|Lost to Follow-up|1
1179176|NCT04230122|2336313|FG001|Overall Study|Lost to Follow-up|0
1179177|NCT04033068|2336342|FG000|Overall Study|Withdrawal by Subject|0
1179178|NCT04033068|2336343|FG001|Overall Study|Withdrawal by Subject|0
1179179|NCT04033068|2336344|FG002|Overall Study|Withdrawal by Subject|1
1179180|NCT04033068|2336345|FG003|Overall Study|Withdrawal by Subject|0
1179181|NCT04033068|2336342|FG000|Overall Study|Lost to Follow-up|0
1179182|NCT04033068|2336343|FG001|Overall Study|Lost to Follow-up|1
1179183|NCT04033068|2336344|FG002|Overall Study|Lost to Follow-up|0
1179184|NCT04033068|2336345|FG003|Overall Study|Lost to Follow-up|0
1179185|NCT04033068|2336342|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0
1179186|NCT04033068|2336343|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0
1179187|NCT04033068|2336344|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0
1179188|NCT04033068|2336345|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1
1179189|NCT03561597|2336355|FG000|Overall Study|Lost to Follow-up|20
1179190|NCT03350984|2336382|FG000|Overall Study|Death|1
1179191|NCT03350984|2336383|FG001|Overall Study|Death|0
1179192|NCT03350984|2336382|FG000|Overall Study|Lost to Follow-up|5
1179193|NCT03350984|2336383|FG001|Overall Study|Lost to Follow-up|6
1179194|NCT03350984|2336382|FG000|Overall Study|Protocol Violation|1
1179195|NCT03350984|2336383|FG001|Overall Study|Protocol Violation|2
1179196|NCT03350984|2336382|FG000|Overall Study|Physician Decision|1
1179197|NCT03350984|2336383|FG001|Overall Study|Physician Decision|0
1179198|NCT03298867|2336391|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1
1179199|NCT03298867|2336392|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1
1179200|NCT03298867|2336391|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
874880|NCT00553787|1836812|FG002|Overall Study|non compliance|11
874881|NCT00553787|1836810|FG000|Overall Study|Requirement for restricted medication|8
874882|NCT00553787|1836811|FG001|Overall Study|Requirement for restricted medication|7
874883|NCT00553787|1836812|FG002|Overall Study|Requirement for restricted medication|5
874884|NCT00553787|1836810|FG000|Overall Study|Other|18
874885|NCT00553787|1836811|FG001|Overall Study|Other|10
874886|NCT00553787|1836812|FG002|Overall Study|Other|13
874887|NCT00554099|1836844|FG000|Treatment Period (12 Weeks)|Adverse Event|3
874888|NCT00554099|1836845|FG001|Treatment Period (12 Weeks)|Adverse Event|5
874889|NCT00554099|1836846|FG002|Treatment Period (12 Weeks)|Adverse Event|1
874890|NCT00554099|1836844|FG000|Treatment Period (12 Weeks)|Physician Decision|3
874891|NCT00554099|1836845|FG001|Treatment Period (12 Weeks)|Physician Decision|0
874892|NCT00554099|1836846|FG002|Treatment Period (12 Weeks)|Physician Decision|0
874893|NCT00554099|1836844|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1
874894|NCT00554099|1836845|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0
874895|NCT00554099|1836846|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2
874896|NCT00554099|1836844|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
874897|NCT00554099|1836845|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
874898|NCT00554099|1836846|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
874899|NCT00554099|1836844|FG000|Treatment Period (12 Weeks)|Protocol Violation|0
874900|NCT00554099|1836845|FG001|Treatment Period (12 Weeks)|Protocol Violation|0
874901|NCT00554099|1836846|FG002|Treatment Period (12 Weeks)|Protocol Violation|2
874902|NCT00554099|1836844|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4
874903|NCT00554099|1836845|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1
874904|NCT00554099|1836846|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4
874905|NCT00554099|1836844|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
874906|NCT00554099|1836845|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
874907|NCT00554099|1836846|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
874908|NCT00554099|1836844|FG000|Non-Treatment Phase (9 Months)|Relapse|2
874909|NCT00554099|1836845|FG001|Non-Treatment Phase (9 Months)|Relapse|1
874910|NCT00554099|1836846|FG002|Non-Treatment Phase (9 Months)|Relapse|1
874911|NCT00554099|1836844|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
874912|NCT00554099|1836845|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
874913|NCT00554099|1836846|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
874914|NCT00554190|1836854|FG000|Overall Study|Termination forms not completed|10
874915|NCT00554216|1836861|FG000|Overall Study|Lost to Follow-up|92
874916|NCT00554216|1836862|FG001|Overall Study|Lost to Follow-up|31
874917|NCT00554216|1836863|FG002|Overall Study|Lost to Follow-up|63
874918|NCT00554216|1836861|FG000|Overall Study|Adverse Event|16
874919|NCT00554216|1836862|FG001|Overall Study|Adverse Event|16
874920|NCT00554216|1836863|FG002|Overall Study|Adverse Event|36
874921|NCT00554216|1836861|FG000|Overall Study|Withdrawal by Subject|92
874922|NCT00554216|1836862|FG001|Overall Study|Withdrawal by Subject|31
874923|NCT00554216|1836863|FG002|Overall Study|Withdrawal by Subject|43
874924|NCT00554216|1836861|FG000|Overall Study|Non compliance|10
874925|NCT00554216|1836862|FG001|Overall Study|Non compliance|4
874926|NCT00554216|1836863|FG002|Overall Study|Non compliance|5
1179201|NCT03298867|2336392|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
1179202|NCT03298867|2336391|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1
1179203|NCT03298867|2336392|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9
1179204|NCT03298867|2336391|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0
1179205|NCT03298867|2336392|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1
1179206|NCT03298867|2336391|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0
1179207|NCT03298867|2336392|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1
1179208|NCT03298867|2336391|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0
1179209|NCT03298867|2336392|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2
1179210|NCT03298867|2336391|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0
1179211|NCT03298867|2336392|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1
1179212|NCT03298867|2336391|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0
1179213|NCT03298867|2336392|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2
1179214|NCT03298867|2336391|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0
1179215|NCT03298867|2336392|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1
1179216|NCT03277261|2336400|FG000|Overall Study|Adverse Event|17
1179217|NCT03277261|2336401|FG001|Overall Study|Adverse Event|1
1179218|NCT03277261|2336400|FG000|Overall Study|Participant Withdrawal of Consent|6
1179219|NCT03277261|2336401|FG001|Overall Study|Participant Withdrawal of Consent|15
1179220|NCT03277261|2336400|FG000|Overall Study|Investigator / Sponsor Decision|4
1179221|NCT03277261|2336401|FG001|Overall Study|Investigator / Sponsor Decision|2
1179222|NCT03277261|2336400|FG000|Overall Study|Pregnancy|2
1179223|NCT03277261|2336401|FG001|Overall Study|Pregnancy|0
1179224|NCT03277261|2336400|FG000|Overall Study|Lost to Follow-up|2
1179225|NCT03277261|2336401|FG001|Overall Study|Lost to Follow-up|2
1179226|NCT03277261|2336400|FG000|Overall Study|Lack of Efficacy|2
874927|NCT00554216|1836861|FG000|Overall Study|Pregnancy|2
874928|NCT00554216|1836862|FG001|Overall Study|Pregnancy|1
874929|NCT00554216|1836863|FG002|Overall Study|Pregnancy|14
874930|NCT00554216|1836861|FG000|Overall Study|Restricted med|3
874931|NCT00554216|1836862|FG001|Overall Study|Restricted med|1
874932|NCT00554216|1836863|FG002|Overall Study|Restricted med|1
874933|NCT00554216|1836861|FG000|Overall Study|Other|12
874934|NCT00554216|1836862|FG001|Overall Study|Other|7
874935|NCT00554216|1836863|FG002|Overall Study|Other|10
874936|NCT00554216|1836861|FG000|Overall Study|Lack of Efficacy|15
874937|NCT00554216|1836862|FG001|Overall Study|Lack of Efficacy|3
874938|NCT00554216|1836863|FG002|Overall Study|Lack of Efficacy|0
874939|NCT00554229|1836873|FG000|Overall Study|Lost to Follow-up|3
874940|NCT00554229|1836874|FG001|Overall Study|Lost to Follow-up|6
874941|NCT00554229|1836873|FG000|Overall Study|Withdrawal by Subject|29
874942|NCT00554229|1836874|FG001|Overall Study|Withdrawal by Subject|37
874943|NCT00554229|1836873|FG000|Overall Study|Adverse Event|71
874944|NCT00554229|1836874|FG001|Overall Study|Adverse Event|39
874945|NCT00554229|1836873|FG000|Overall Study|Protocol Violation|3
874946|NCT00554229|1836874|FG001|Overall Study|Protocol Violation|3
874947|NCT00554229|1836873|FG000|Overall Study|Reason not otherwise captured, eg; death|119
874948|NCT00554229|1836874|FG001|Overall Study|Reason not otherwise captured, eg; death|140
874949|NCT00554229|1836873|FG000|Overall Study|Randomised but no treatment received|1
874950|NCT00554229|1836874|FG001|Overall Study|Randomised but no treatment received|0
874951|NCT00554515|1836902|FG000|Overall Study|Withdrawal by Subject|3
874952|NCT00554515|1836902|FG000|Overall Study|Disease progression|52
874953|NCT00554515|1836902|FG000|Overall Study|Physician Decision|18
874954|NCT00554515|1836902|FG000|Overall Study|Withdrawal by Subject|11
874955|NCT00554515|1836902|FG000|Overall Study|Adverse Event|9
874956|NCT00554515|1836902|FG000|Overall Study|Death|2
874957|NCT00554515|1836902|FG000|Overall Study|Achieved Stable Disease|7
874958|NCT00554515|1836902|FG000|Overall Study|Other|1
874959|NCT00554515|1836902|FG000|Overall Study|Misc|15
874960|NCT00554619|1836933|FG000|Overall Study|Adverse Event|1
874961|NCT00554619|1836933|FG000|Overall Study|Physician Decision|1
874962|NCT00554619|1836933|FG000|Overall Study|Liver Function Test Abnormality|1
874963|NCT00554788|1836954|FG000|Overall Study|Adverse Event|0
874964|NCT00554788|1836955|FG001|Overall Study|Adverse Event|1
874965|NCT00554788|1836956|FG002|Overall Study|Adverse Event|2
874966|NCT00554788|1836954|FG000|Overall Study|Lost to Follow-up|4
874967|NCT00554788|1836955|FG001|Overall Study|Lost to Follow-up|3
874968|NCT00554788|1836956|FG002|Overall Study|Lost to Follow-up|3
874969|NCT00554788|1836954|FG000|Overall Study|Physician Decision|1
874970|NCT00554788|1836955|FG001|Overall Study|Physician Decision|1
874971|NCT00554788|1836956|FG002|Overall Study|Physician Decision|3
874972|NCT00554788|1836954|FG000|Overall Study|Withdrawal by Subject|0
874973|NCT00554788|1836955|FG001|Overall Study|Withdrawal by Subject|0
874974|NCT00554788|1836956|FG002|Overall Study|Withdrawal by Subject|1
874975|NCT00554788|1836954|FG000|Overall Study|Refusal of further protocol therapy|0
874976|NCT00554788|1836955|FG001|Overall Study|Refusal of further protocol therapy|1
874977|NCT00554788|1836956|FG002|Overall Study|Refusal of further protocol therapy|1
874978|NCT00554788|1836954|FG000|Overall Study|Progressive disease|0
874979|NCT00554788|1836955|FG001|Overall Study|Progressive disease|0
874980|NCT00554788|1836956|FG002|Overall Study|Progressive disease|3
1179227|NCT03277261|2336401|FG001|Overall Study|Lack of Efficacy|2
1179228|NCT03277261|2336400|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
1179229|NCT03277261|2336401|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
1179230|NCT03277248|2336410|FG000|Overall Study|Adverse Event|3
1179231|NCT03277248|2336411|FG001|Overall Study|Adverse Event|1
1179232|NCT03277248|2336410|FG000|Overall Study|Subject Withdrawal of Consent|6
1179233|NCT03277248|2336411|FG001|Overall Study|Subject Withdrawal of Consent|23
1179234|NCT03277248|2336410|FG000|Overall Study|Investigator/Sponsor Decision|2
1179235|NCT03277248|2336411|FG001|Overall Study|Investigator/Sponsor Decision|2
1179236|NCT03277248|2336410|FG000|Overall Study|Pregnancy|4
1179237|NCT03277248|2336411|FG001|Overall Study|Pregnancy|1
1179238|NCT03277248|2336410|FG000|Overall Study|Lost to Follow-up|0
1179239|NCT03277248|2336411|FG001|Overall Study|Lost to Follow-up|2
1179240|NCT03277248|2336410|FG000|Overall Study|Lack of Efficacy|0
1179241|NCT03277248|2336411|FG001|Overall Study|Lack of Efficacy|2
1179242|NCT03277248|2336410|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
1179243|NCT03277248|2336411|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
1179244|NCT03179462|2336429|FG000|Overall Study|screening failure|1
1179245|NCT03179462|2336430|FG001|Overall Study|screening failure|2
1179246|NCT03179462|2336431|FG002|Overall Study|screening failure|0
1179247|NCT03099707|2336441|FG000|Overall Study|Withdrawal by Subject|0
1179248|NCT03099707|2336442|FG001|Overall Study|Withdrawal by Subject|3
1179249|NCT03099707|2336441|FG000|Overall Study|Lost to Follow-up|0
1179250|NCT03099707|2336442|FG001|Overall Study|Lost to Follow-up|1
1179251|NCT03064763|2336448|FG000|Overall Study|Ongoing in study|10
1179252|NCT03064763|2336448|FG000|Overall Study|Death|8
1179253|NCT02928224|2336464|FG000|Overall Study|Randomized, Not Treated|0
1179254|NCT02928224|2336465|FG001|Overall Study|Randomized, Not Treated|2
1179255|NCT02928224|2336466|FG002|Overall Study|Randomized, Not Treated|4
1179256|NCT02928224|2336467|FG003|Overall Study|Randomized, Not Treated|28
1179257|NCT02928224|2336464|FG000|Overall Study|Treatment Ongoing|6
1179258|NCT02928224|2336465|FG001|Overall Study|Treatment Ongoing|78
1179259|NCT02928224|2336466|FG002|Overall Study|Treatment Ongoing|78
1179260|NCT02928224|2336467|FG003|Overall Study|Treatment Ongoing|37
874981|NCT00554788|1836954|FG000|Overall Study|Ineligible|2
874982|NCT00554788|1836955|FG001|Overall Study|Ineligible|0
874983|NCT00554788|1836956|FG002|Overall Study|Ineligible|1
874984|NCT00554801|1836967|FG000|Overall Study|left area before completion|5
874985|NCT00554801|1836968|FG001|Overall Study|left area before completion|0
874986|NCT00554801|1836967|FG000|Overall Study|Withdrawal by Subject|14
874987|NCT00554801|1836968|FG001|Overall Study|Withdrawal by Subject|0
874988|NCT00554840|1836978|FG000|Overall Study|Physician Decision|0
874989|NCT00554840|1836979|FG001|Overall Study|Physician Decision|1
874990|NCT00555061|1837036|FG000|Overall Study|Adverse Event|3
874991|NCT00555061|1837036|FG000|Overall Study|Protocol Violation|1
874992|NCT00555061|1837036|FG000|Overall Study|Lost to Follow-up|2
874993|NCT00555061|1837036|FG000|Overall Study|Withdrawal by Subject|2
874994|NCT00555061|1837036|FG000|Overall Study|Participant enrolled, but never treated|1
874995|NCT00555217|1837059|FG000|Overall Study|Withdrawal by Subject|35
874996|NCT00555217|1837060|FG001|Overall Study|Withdrawal by Subject|31
874997|NCT00555217|1837059|FG000|Overall Study|Lost to Follow-up|19
874998|NCT00555217|1837060|FG001|Overall Study|Lost to Follow-up|20
874999|NCT00555217|1837059|FG000|Overall Study|close out sites|21
875000|NCT00555217|1837060|FG001|Overall Study|close out sites|17
875001|NCT00555321|1837071|FG000|Treatment Phase up to 12-months|Adverse Event|6
875002|NCT00555321|1837072|FG001|Treatment Phase up to 12-months|Adverse Event|7
875003|NCT00555321|1837073|FG002|Treatment Phase up to 12-months|Adverse Event|11
875004|NCT00555321|1837074|FG003|Treatment Phase up to 12-months|Adverse Event|7
875005|NCT00555321|1837075|FG004|Treatment Phase up to 12-months|Adverse Event|18
875006|NCT00555321|1837071|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1
875007|NCT00555321|1837072|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0
875008|NCT00555321|1837073|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1
875009|NCT00555321|1837074|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0
875010|NCT00555321|1837075|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0
875011|NCT00555321|1837071|FG000|Treatment Phase up to 12-months|Death|2
875012|NCT00555321|1837072|FG001|Treatment Phase up to 12-months|Death|1
875013|NCT00555321|1837073|FG002|Treatment Phase up to 12-months|Death|4
875014|NCT00555321|1837074|FG003|Treatment Phase up to 12-months|Death|0
875015|NCT00555321|1837075|FG004|Treatment Phase up to 12-months|Death|0
875016|NCT00555321|1837071|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9
875017|NCT00555321|1837072|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8
875018|NCT00555321|1837073|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5
875019|NCT00555321|1837074|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0
875020|NCT00555321|1837075|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0
875021|NCT00555321|1837071|FG000|Treatment Phase up to 12-months|Other Reason|1
875022|NCT00555321|1837072|FG001|Treatment Phase up to 12-months|Other Reason|3
875023|NCT00555321|1837073|FG002|Treatment Phase up to 12-months|Other Reason|2
875024|NCT00555321|1837074|FG003|Treatment Phase up to 12-months|Other Reason|0
875025|NCT00555321|1837075|FG004|Treatment Phase up to 12-months|Other Reason|0
875026|NCT00555321|1837071|FG000|Treatment Phase up to 12-months|Never treated|2
1179261|NCT02928224|2336464|FG000|Overall Study|Progressive Disease|23
1179262|NCT02928224|2336465|FG001|Overall Study|Progressive Disease|104
1179263|NCT02928224|2336466|FG002|Overall Study|Progressive Disease|101
1179264|NCT02928224|2336467|FG003|Overall Study|Progressive Disease|103
1179265|NCT02928224|2336464|FG000|Overall Study|Adverse Event|2
1179266|NCT02928224|2336465|FG001|Overall Study|Adverse Event|11
1179267|NCT02928224|2336466|FG002|Overall Study|Adverse Event|11
1179268|NCT02928224|2336467|FG003|Overall Study|Adverse Event|10
1179269|NCT02928224|2336464|FG000|Overall Study|Changes in Patient's Condition|3
1179270|NCT02928224|2336465|FG001|Overall Study|Changes in Patient's Condition|9
1179271|NCT02928224|2336466|FG002|Overall Study|Changes in Patient's Condition|9
1179272|NCT02928224|2336467|FG003|Overall Study|Changes in Patient's Condition|13
1179273|NCT02928224|2336464|FG000|Overall Study|Death|1
1179274|NCT02928224|2336465|FG001|Overall Study|Death|7
1179275|NCT02928224|2336466|FG002|Overall Study|Death|5
1179276|NCT02928224|2336467|FG003|Overall Study|Death|11
1179277|NCT02928224|2336464|FG000|Overall Study|Withdrawal by Subject|1
1179278|NCT02928224|2336465|FG001|Overall Study|Withdrawal by Subject|4
1179279|NCT02928224|2336466|FG002|Overall Study|Withdrawal by Subject|3
1179280|NCT02928224|2336467|FG003|Overall Study|Withdrawal by Subject|9
1179281|NCT02928224|2336464|FG000|Overall Study|Dose Interruptions>28|1
1179282|NCT02928224|2336465|FG001|Overall Study|Dose Interruptions>28|2
1179283|NCT02928224|2336466|FG002|Overall Study|Dose Interruptions>28|2
1179284|NCT02928224|2336467|FG003|Overall Study|Dose Interruptions>28|4
1179285|NCT02928224|2336464|FG000|Overall Study|Patient Decision to Discontinue Drug|0
1179286|NCT02928224|2336465|FG001|Overall Study|Patient Decision to Discontinue Drug|2
1179287|NCT02928224|2336466|FG002|Overall Study|Patient Decision to Discontinue Drug|2
1179288|NCT02928224|2336467|FG003|Overall Study|Patient Decision to Discontinue Drug|4
1179289|NCT02928224|2336464|FG000|Overall Study|Physician Decision|0
1179290|NCT02928224|2336465|FG001|Overall Study|Physician Decision|2
1179291|NCT02928224|2336466|FG002|Overall Study|Physician Decision|4
1179292|NCT02928224|2336467|FG003|Overall Study|Physician Decision|2
1179293|NCT02928224|2336464|FG000|Overall Study|not listed|0
1179294|NCT02928224|2336465|FG001|Overall Study|not listed|3
1179295|NCT02928224|2336466|FG002|Overall Study|not listed|1
1179296|NCT02928224|2336467|FG003|Overall Study|not listed|0
1179297|NCT02906033|2336505|FG000|Baseline|Protocol Violation|37
1179298|NCT02906033|2336506|FG001|Baseline|Protocol Violation|33
1179299|NCT02906033|2336505|FG000|Follow-up|Lost to Follow-up|46
1179300|NCT02906033|2336506|FG001|Follow-up|Lost to Follow-up|62
1179301|NCT02837783|2336514|FG000|Overall Study|Adverse Event|1
1179302|NCT02837783|2336515|FG001|Overall Study|Adverse Event|0
1179303|NCT02837783|2336514|FG000|Overall Study|Other, Not Specified|1
1179304|NCT02837783|2336515|FG001|Overall Study|Other, Not Specified|2
1179305|NCT02831673|2336523|FG000|Overall Study|Adverse Event|6
1179306|NCT02831673|2336524|FG001|Overall Study|Adverse Event|4
1179307|NCT02831673|2336523|FG000|Overall Study|Lack of Efficacy|3
1179308|NCT02831673|2336524|FG001|Overall Study|Lack of Efficacy|1
1179309|NCT02831673|2336523|FG000|Overall Study|Protocol Violation|5
1179310|NCT02831673|2336524|FG001|Overall Study|Protocol Violation|4
1179311|NCT02831673|2336523|FG000|Overall Study|Protocol Withdrawal Criterion Met|1
1179312|NCT02831673|2336524|FG001|Overall Study|Protocol Withdrawal Criterion Met|6
1179313|NCT02831673|2336523|FG000|Overall Study|Lost to Follow-up|9
1179314|NCT02831673|2336524|FG001|Overall Study|Lost to Follow-up|6
1179315|NCT02831673|2336523|FG000|Overall Study|Physician Decision|6
1179316|NCT02831673|2336524|FG001|Overall Study|Physician Decision|3
1179317|NCT02831673|2336523|FG000|Overall Study|Withdrawal by Subject|6
1179318|NCT02831673|2336524|FG001|Overall Study|Withdrawal by Subject|4
1179319|NCT02831673|2336523|FG000|Overall Study|Ongoing at Week 48 primary analysis.|320
1179320|NCT02831673|2336524|FG001|Overall Study|Ongoing at Week 48 primary analysis.|330
1179321|NCT02786537|2336536|FG000|As Randomized|Adverse Event|0
1179322|NCT02786537|2336537|FG001|As Randomized|Adverse Event|11
1179323|NCT02786537|2336538|FG002|As Randomized|Adverse Event|0
1179324|NCT02786537|2336539|FG003|As Randomized|Adverse Event|4
1179325|NCT02786537|2336540|FG004|As Randomized|Adverse Event|6
1179326|NCT02786537|2336541|FG005|As Randomized|Adverse Event|2
1179327|NCT02786537|2336536|FG000|As Randomized|Lack of Efficacy|0
1179328|NCT02786537|2336537|FG001|As Randomized|Lack of Efficacy|0
1179329|NCT02786537|2336538|FG002|As Randomized|Lack of Efficacy|0
1179330|NCT02786537|2336539|FG003|As Randomized|Lack of Efficacy|1
1179331|NCT02786537|2336540|FG004|As Randomized|Lack of Efficacy|0
1179332|NCT02786537|2336541|FG005|As Randomized|Lack of Efficacy|0
1179333|NCT02786537|2336536|FG000|As Randomized|Withdrawal by Subject|1
1179334|NCT02786537|2336537|FG001|As Randomized|Withdrawal by Subject|2
1179335|NCT02786537|2336538|FG002|As Randomized|Withdrawal by Subject|0
1179336|NCT02786537|2336539|FG003|As Randomized|Withdrawal by Subject|1
1179337|NCT02786537|2336540|FG004|As Randomized|Withdrawal by Subject|1
1179338|NCT02786537|2336541|FG005|As Randomized|Withdrawal by Subject|0
1179339|NCT02786537|2336536|FG000|As Randomized|Death|0
1179340|NCT02786537|2336537|FG001|As Randomized|Death|2
1179341|NCT02786537|2336538|FG002|As Randomized|Death|0
1179342|NCT02786537|2336539|FG003|As Randomized|Death|3
1179343|NCT02786537|2336540|FG004|As Randomized|Death|1
1179344|NCT02786537|2336541|FG005|As Randomized|Death|0
1179345|NCT02786537|2336536|FG000|As Randomized|Non-compliance with study drug|1
1179346|NCT02786537|2336537|FG001|As Randomized|Non-compliance with study drug|11
1179347|NCT02786537|2336538|FG002|As Randomized|Non-compliance with study drug|0
1179348|NCT02786537|2336539|FG003|As Randomized|Non-compliance with study drug|1
1179349|NCT02786537|2336540|FG004|As Randomized|Non-compliance with study drug|0
1179350|NCT02786537|2336541|FG005|As Randomized|Non-compliance with study drug|1
1179351|NCT02786537|2336536|FG000|As Randomized|Lost to treatment follow-up|4
1179352|NCT02786537|2336537|FG001|As Randomized|Lost to treatment follow-up|32
1179353|NCT02786537|2336538|FG002|As Randomized|Lost to treatment follow-up|0
1179354|NCT02786537|2336539|FG003|As Randomized|Lost to treatment follow-up|24
1179355|NCT02786537|2336540|FG004|As Randomized|Lost to treatment follow-up|4
1179356|NCT02786537|2336541|FG005|As Randomized|Lost to treatment follow-up|4
1179357|NCT02786537|2336536|FG000|As Randomized|Incarceration|0
1179358|NCT02786537|2336537|FG001|As Randomized|Incarceration|1
1179359|NCT02786537|2336538|FG002|As Randomized|Incarceration|0
1179360|NCT02786537|2336539|FG003|As Randomized|Incarceration|0
1179361|NCT02786537|2336540|FG004|As Randomized|Incarceration|0
1179362|NCT02786537|2336541|FG005|As Randomized|Incarceration|0
1179363|NCT02786537|2336536|FG000|As Randomized|Opiate Dependency Relapse|0
1179364|NCT02786537|2336537|FG001|As Randomized|Opiate Dependency Relapse|1
1179365|NCT02786537|2336538|FG002|As Randomized|Opiate Dependency Relapse|0
1179366|NCT02786537|2336539|FG003|As Randomized|Opiate Dependency Relapse|0
1179367|NCT02786537|2336540|FG004|As Randomized|Opiate Dependency Relapse|0
1179368|NCT02786537|2336541|FG005|As Randomized|Opiate Dependency Relapse|0
1179369|NCT02786537|2336536|FG000|As Randomized|HCV drugs stolen from pt|0
1179370|NCT02786537|2336537|FG001|As Randomized|HCV drugs stolen from pt|1
1179371|NCT02786537|2336538|FG002|As Randomized|HCV drugs stolen from pt|0
1179372|NCT02786537|2336539|FG003|As Randomized|HCV drugs stolen from pt|0
1179373|NCT02786537|2336540|FG004|As Randomized|HCV drugs stolen from pt|0
1179374|NCT02786537|2336541|FG005|As Randomized|HCV drugs stolen from pt|0
1179375|NCT02786537|2336536|FG000|As Randomized|Advised to stop after lapse in dosing|0
1179376|NCT02786537|2336537|FG001|As Randomized|Advised to stop after lapse in dosing|1
1179377|NCT02786537|2336538|FG002|As Randomized|Advised to stop after lapse in dosing|0
1179378|NCT02786537|2336539|FG003|As Randomized|Advised to stop after lapse in dosing|0
1179379|NCT02786537|2336540|FG004|As Randomized|Advised to stop after lapse in dosing|0
1179380|NCT02786537|2336541|FG005|As Randomized|Advised to stop after lapse in dosing|0
1179381|NCT02786537|2336536|FG000|As Randomized|Subject lost insurance|0
1179382|NCT02786537|2336537|FG001|As Randomized|Subject lost insurance|0
1179383|NCT02786537|2336538|FG002|As Randomized|Subject lost insurance|0
1179384|NCT02786537|2336539|FG003|As Randomized|Subject lost insurance|1
1179385|NCT02786537|2336540|FG004|As Randomized|Subject lost insurance|0
1179386|NCT02786537|2336541|FG005|As Randomized|Subject lost insurance|0
1179387|NCT02786537|2336536|FG000|As Treated|Adverse Event|0
1179388|NCT02786537|2336537|FG001|As Treated|Adverse Event|11
1179389|NCT02786537|2336538|FG002|As Treated|Adverse Event|0
1179390|NCT02786537|2336539|FG003|As Treated|Adverse Event|4
1179391|NCT02786537|2336540|FG004|As Treated|Adverse Event|6
1179392|NCT02786537|2336541|FG005|As Treated|Adverse Event|2
1179393|NCT02786537|2336536|FG000|As Treated|Death|0
1179394|NCT02786537|2336537|FG001|As Treated|Death|2
1179395|NCT02786537|2336538|FG002|As Treated|Death|0
1179396|NCT02786537|2336539|FG003|As Treated|Death|3
1179397|NCT02786537|2336540|FG004|As Treated|Death|1
1179398|NCT02786537|2336541|FG005|As Treated|Death|0
1179399|NCT02786537|2336536|FG000|As Treated|Lack of Efficacy|0
1179400|NCT02786537|2336537|FG001|As Treated|Lack of Efficacy|0
1179401|NCT02786537|2336538|FG002|As Treated|Lack of Efficacy|0
1179402|NCT02786537|2336539|FG003|As Treated|Lack of Efficacy|1
1179403|NCT02786537|2336540|FG004|As Treated|Lack of Efficacy|0
1179404|NCT02786537|2336541|FG005|As Treated|Lack of Efficacy|0
1179405|NCT02786537|2336536|FG000|As Treated|Lost to Follow-up|4
1179406|NCT02786537|2336537|FG001|As Treated|Lost to Follow-up|32
1179407|NCT02786537|2336538|FG002|As Treated|Lost to Follow-up|0
1179408|NCT02786537|2336539|FG003|As Treated|Lost to Follow-up|25
1179409|NCT02786537|2336540|FG004|As Treated|Lost to Follow-up|4
1179410|NCT02786537|2336541|FG005|As Treated|Lost to Follow-up|4
1179411|NCT02786537|2336536|FG000|As Treated|Non-compliance with study drug|1
1179412|NCT02786537|2336537|FG001|As Treated|Non-compliance with study drug|11
1179413|NCT02786537|2336538|FG002|As Treated|Non-compliance with study drug|0
1179414|NCT02786537|2336539|FG003|As Treated|Non-compliance with study drug|1
1179415|NCT02786537|2336540|FG004|As Treated|Non-compliance with study drug|0
1179416|NCT02786537|2336541|FG005|As Treated|Non-compliance with study drug|1
1179417|NCT02786537|2336536|FG000|As Treated|Lost insurance|0
1179418|NCT02786537|2336537|FG001|As Treated|Lost insurance|0
1179419|NCT02786537|2336538|FG002|As Treated|Lost insurance|0
1179420|NCT02786537|2336539|FG003|As Treated|Lost insurance|1
1179421|NCT02786537|2336540|FG004|As Treated|Lost insurance|0
1179422|NCT02786537|2336541|FG005|As Treated|Lost insurance|0
1179423|NCT02786537|2336536|FG000|As Treated|Withdrawal by Subject|1
1179424|NCT02786537|2336537|FG001|As Treated|Withdrawal by Subject|2
1179425|NCT02786537|2336538|FG002|As Treated|Withdrawal by Subject|0
1179426|NCT02786537|2336539|FG003|As Treated|Withdrawal by Subject|0
1179427|NCT02786537|2336540|FG004|As Treated|Withdrawal by Subject|1
1179428|NCT02786537|2336541|FG005|As Treated|Withdrawal by Subject|0
1179429|NCT02786537|2336536|FG000|As Treated|Incarceration|0
1179430|NCT02786537|2336537|FG001|As Treated|Incarceration|1
1179431|NCT02786537|2336538|FG002|As Treated|Incarceration|0
1179432|NCT02786537|2336539|FG003|As Treated|Incarceration|0
1179433|NCT02786537|2336540|FG004|As Treated|Incarceration|0
1179434|NCT02786537|2336541|FG005|As Treated|Incarceration|0
1179435|NCT02786537|2336536|FG000|As Treated|Opiate dependency relapse|0
1179436|NCT02786537|2336537|FG001|As Treated|Opiate dependency relapse|1
1179437|NCT02786537|2336538|FG002|As Treated|Opiate dependency relapse|0
1179438|NCT02786537|2336539|FG003|As Treated|Opiate dependency relapse|0
1179439|NCT02786537|2336540|FG004|As Treated|Opiate dependency relapse|0
1179440|NCT02786537|2336541|FG005|As Treated|Opiate dependency relapse|0
1179441|NCT02786537|2336536|FG000|As Treated|Drugs stolen from patient|0
1179442|NCT02786537|2336537|FG001|As Treated|Drugs stolen from patient|1
1179443|NCT02786537|2336538|FG002|As Treated|Drugs stolen from patient|0
1179444|NCT02786537|2336539|FG003|As Treated|Drugs stolen from patient|0
1179445|NCT02786537|2336540|FG004|As Treated|Drugs stolen from patient|0
1179446|NCT02786537|2336541|FG005|As Treated|Drugs stolen from patient|0
1179447|NCT02786537|2336536|FG000|As Treated|Advised to stop tx after loss of meds|0
1179448|NCT02786537|2336537|FG001|As Treated|Advised to stop tx after loss of meds|1
1179449|NCT02786537|2336538|FG002|As Treated|Advised to stop tx after loss of meds|0
1179450|NCT02786537|2336539|FG003|As Treated|Advised to stop tx after loss of meds|0
1179451|NCT02786537|2336540|FG004|As Treated|Advised to stop tx after loss of meds|0
1179452|NCT02786537|2336541|FG005|As Treated|Advised to stop tx after loss of meds|0
1179453|NCT02740231|2336651|FG000|Overall Study|Withdrawal by Subject|1
1179454|NCT02740231|2336652|FG001|Overall Study|Withdrawal by Subject|1
1179455|NCT02740231|2336653|FG002|Overall Study|Withdrawal by Subject|1
1179456|NCT02740231|2336654|FG003|Overall Study|Withdrawal by Subject|0
1179457|NCT02740231|2336651|FG000|Overall Study|Lack of Efficacy|0
1179458|NCT02740231|2336652|FG001|Overall Study|Lack of Efficacy|1
1179459|NCT02740231|2336653|FG002|Overall Study|Lack of Efficacy|0
1179460|NCT02740231|2336654|FG003|Overall Study|Lack of Efficacy|4
1179461|NCT02740231|2336651|FG000|Overall Study|Lost to Follow-up|1
1179462|NCT02740231|2336652|FG001|Overall Study|Lost to Follow-up|3
1179463|NCT02740231|2336653|FG002|Overall Study|Lost to Follow-up|0
1179464|NCT02740231|2336654|FG003|Overall Study|Lost to Follow-up|3
1179465|NCT02740231|2336651|FG000|Overall Study|Adverse Event|0
1179466|NCT02740231|2336652|FG001|Overall Study|Adverse Event|1
875027|NCT00555321|1837072|FG001|Treatment Phase up to 12-months|Never treated|3
875028|NCT00555321|1837073|FG002|Treatment Phase up to 12-months|Never treated|1
875029|NCT00555321|1837074|FG003|Treatment Phase up to 12-months|Never treated|0
875030|NCT00555321|1837075|FG004|Treatment Phase up to 12-months|Never treated|4
875031|NCT00555321|1837071|FG000|Long-term Extension Phase|Adverse Event|2
875032|NCT00555321|1837072|FG001|Long-term Extension Phase|Adverse Event|5
875033|NCT00555321|1837073|FG002|Long-term Extension Phase|Adverse Event|2
875034|NCT00555321|1837074|FG003|Long-term Extension Phase|Adverse Event|1
875035|NCT00555321|1837075|FG004|Long-term Extension Phase|Adverse Event|0
875036|NCT00555321|1837071|FG000|Long-term Extension Phase|Withdrawal by Subject|2
875037|NCT00555321|1837072|FG001|Long-term Extension Phase|Withdrawal by Subject|1
875038|NCT00555321|1837073|FG002|Long-term Extension Phase|Withdrawal by Subject|2
875039|NCT00555321|1837074|FG003|Long-term Extension Phase|Withdrawal by Subject|3
875040|NCT00555321|1837075|FG004|Long-term Extension Phase|Withdrawal by Subject|2
875041|NCT00555321|1837071|FG000|Long-term Extension Phase|Administrative reason by sponsor|23
875042|NCT00555321|1837072|FG001|Long-term Extension Phase|Administrative reason by sponsor|21
875043|NCT00555321|1837073|FG002|Long-term Extension Phase|Administrative reason by sponsor|18
875044|NCT00555321|1837074|FG003|Long-term Extension Phase|Administrative reason by sponsor|31
875045|NCT00555321|1837075|FG004|Long-term Extension Phase|Administrative reason by sponsor|23
875046|NCT00555321|1837071|FG000|Long-term Extension Phase|Death|2
875047|NCT00555321|1837072|FG001|Long-term Extension Phase|Death|0
875048|NCT00555321|1837073|FG002|Long-term Extension Phase|Death|0
875049|NCT00555321|1837074|FG003|Long-term Extension Phase|Death|3
875050|NCT00555321|1837075|FG004|Long-term Extension Phase|Death|0
875051|NCT00555321|1837071|FG000|Long-term Extension Phase|Participant did not meet study criteria|0
875052|NCT00555321|1837072|FG001|Long-term Extension Phase|Participant did not meet study criteria|0
875053|NCT00555321|1837073|FG002|Long-term Extension Phase|Participant did not meet study criteria|0
875054|NCT00555321|1837074|FG003|Long-term Extension Phase|Participant did not meet study criteria|0
875055|NCT00555321|1837075|FG004|Long-term Extension Phase|Participant did not meet study criteria|1
875056|NCT00555321|1837071|FG000|Long-term Extension Phase|Other Reason|1
875057|NCT00555321|1837072|FG001|Long-term Extension Phase|Other Reason|0
875058|NCT00555321|1837073|FG002|Long-term Extension Phase|Other Reason|2
875059|NCT00555321|1837074|FG003|Long-term Extension Phase|Other Reason|0
875060|NCT00555321|1837075|FG004|Long-term Extension Phase|Other Reason|0
875061|NCT00555425|1837104|FG000|Overall Study|Missed Medication > 1 wk|34
875062|NCT00555425|1837105|FG001|Overall Study|Missed Medication > 1 wk|15
875063|NCT00555425|1837104|FG000|Overall Study|Missed 3 physician management visits|1
875064|NCT00555425|1837105|FG001|Overall Study|Missed 3 physician management visits|0
875065|NCT00555425|1837104|FG000|Overall Study|Met criteria for protective transfer|16
875066|NCT00555425|1837105|FG001|Overall Study|Met criteria for protective transfer|3
875067|NCT00555425|1837104|FG000|Overall Study|Became pregnant and transferred care|0
875068|NCT00555425|1837105|FG001|Overall Study|Became pregnant and transferred care|1
1179467|NCT02740231|2336653|FG002|Overall Study|Adverse Event|0
1179468|NCT02740231|2336654|FG003|Overall Study|Adverse Event|1
1179469|NCT02710084|2336666|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3
1179470|NCT02710084|2336667|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1
1179471|NCT02660034|2336688|FG000|Overall Study|Progressive Disease (Radiographic)|3
1179472|NCT02660034|2336689|FG001|Overall Study|Progressive Disease (Radiographic)|1
1179473|NCT02660034|2336690|FG002|Overall Study|Progressive Disease (Radiographic)|0
1179474|NCT02660034|2336691|FG003|Overall Study|Progressive Disease (Radiographic)|1
1179475|NCT02660034|2336692|FG004|Overall Study|Progressive Disease (Radiographic)|0
1179476|NCT02660034|2336693|FG005|Overall Study|Progressive Disease (Radiographic)|0
1179477|NCT02660034|2336694|FG006|Overall Study|Progressive Disease (Radiographic)|0
1179478|NCT02660034|2336695|FG007|Overall Study|Progressive Disease (Radiographic)|0
1179479|NCT02660034|2336696|FG008|Overall Study|Progressive Disease (Radiographic)|0
1179480|NCT02660034|2336697|FG009|Overall Study|Progressive Disease (Radiographic)|0
1179481|NCT02660034|2336698|FG010|Overall Study|Progressive Disease (Radiographic)|0
1179482|NCT02660034|2336699|FG011|Overall Study|Progressive Disease (Radiographic)|0
1179483|NCT02660034|2336700|FG012|Overall Study|Progressive Disease (Radiographic)|0
875069|NCT00555438|1837111|FG000|10 Days Post-operative|Death|4
875070|NCT00555438|1837111|FG000|Between 10 Days and 30 Days Postoperativ|Death|5
875071|NCT00555477|1837126|FG000|Overall Study|Adverse Event|0
875072|NCT00555477|1837127|FG001|Overall Study|Adverse Event|9
875073|NCT00555477|1837126|FG000|Overall Study|Withdrawal by Subject|1
875074|NCT00555477|1837127|FG001|Overall Study|Withdrawal by Subject|2
875075|NCT00555477|1837126|FG000|Overall Study|Physician Decision|1
875076|NCT00555477|1837127|FG001|Overall Study|Physician Decision|2
875077|NCT00555568|1837135|FG000|Overall Study|Lost to Follow-up|26
875078|NCT00555568|1837136|FG001|Overall Study|Lost to Follow-up|16
875079|NCT00555568|1837137|FG002|Overall Study|Lost to Follow-up|16
875080|NCT00555620|1837155|FG000|Overall Study|Death|0
875081|NCT00555620|1837156|FG001|Overall Study|Death|1
875082|NCT00555620|1837157|FG002|Overall Study|Death|0
875083|NCT00555620|1837158|FG003|Overall Study|Death|0
875084|NCT00555620|1837159|FG004|Overall Study|Death|0
875085|NCT00555620|1837160|FG005|Overall Study|Death|1
875086|NCT00555620|1837155|FG000|Overall Study|Study terminated by sponsor|0
875087|NCT00555620|1837156|FG001|Overall Study|Study terminated by sponsor|0
875088|NCT00555620|1837157|FG002|Overall Study|Study terminated by sponsor|1
875089|NCT00555620|1837158|FG003|Overall Study|Study terminated by sponsor|0
875090|NCT00555620|1837159|FG004|Overall Study|Study terminated by sponsor|0
875091|NCT00555620|1837160|FG005|Overall Study|Study terminated by sponsor|0
875092|NCT00555620|1837155|FG000|Overall Study|Adverse Event|0
875093|NCT00555620|1837156|FG001|Overall Study|Adverse Event|0
875094|NCT00555620|1837157|FG002|Overall Study|Adverse Event|1
875095|NCT00555620|1837158|FG003|Overall Study|Adverse Event|5
875096|NCT00555620|1837159|FG004|Overall Study|Adverse Event|0
875097|NCT00555620|1837160|FG005|Overall Study|Adverse Event|1
875098|NCT00555620|1837155|FG000|Overall Study|Objective progression or relapse|6
875099|NCT00555620|1837156|FG001|Overall Study|Objective progression or relapse|5
875100|NCT00555620|1837157|FG002|Overall Study|Objective progression or relapse|12
875101|NCT00555620|1837158|FG003|Overall Study|Objective progression or relapse|17
875102|NCT00555620|1837159|FG004|Overall Study|Objective progression or relapse|3
875103|NCT00555620|1837160|FG005|Overall Study|Objective progression or relapse|16
875104|NCT00555620|1837155|FG000|Overall Study|Participant refused treatment|0
875105|NCT00555620|1837156|FG001|Overall Study|Participant refused treatment|1
875106|NCT00555620|1837157|FG002|Overall Study|Participant refused treatment|1
875107|NCT00555620|1837158|FG003|Overall Study|Participant refused treatment|0
875108|NCT00555620|1837159|FG004|Overall Study|Participant refused treatment|0
875109|NCT00555620|1837160|FG005|Overall Study|Participant refused treatment|1
875110|NCT00555620|1837155|FG000|Overall Study|Other|0
875111|NCT00555620|1837156|FG001|Overall Study|Other|0
875112|NCT00555620|1837157|FG002|Overall Study|Other|0
875113|NCT00555620|1837158|FG003|Overall Study|Other|1
875114|NCT00555620|1837159|FG004|Overall Study|Other|0
875115|NCT00555620|1837160|FG005|Overall Study|Other|3
875116|NCT00555672|1837180|FG000|Overall Study|Death|0
875117|NCT00555672|1837181|FG001|Overall Study|Death|2
875118|NCT00555672|1837180|FG000|Overall Study|Adverse Event|8
875119|NCT00555672|1837181|FG001|Overall Study|Adverse Event|2
875120|NCT00555672|1837180|FG000|Overall Study|Objective progression or relapse|11
875121|NCT00555672|1837181|FG001|Overall Study|Objective progression or relapse|5
875122|NCT00555672|1837180|FG000|Overall Study|Other|3
875123|NCT00555672|1837181|FG001|Overall Study|Other|1
875124|NCT00555672|1837180|FG000|Overall Study|Participant refused|2
875125|NCT00555672|1837181|FG001|Overall Study|Participant refused|0
875126|NCT00555906|1837218|FG000|Phase 1|Objective Progression or Relapse|3
875127|NCT00555906|1837219|FG001|Phase 1|Objective Progression or Relapse|5
875128|NCT00555906|1837220|FG002|Phase 1|Objective Progression or Relapse|3
875129|NCT00555906|1837221|FG003|Phase 1|Objective Progression or Relapse|1
875130|NCT00555906|1837222|FG004|Phase 1|Objective Progression or Relapse|0
875131|NCT00555906|1837218|FG000|Phase 1|Global Deterioration of Health Status|0
875132|NCT00555906|1837219|FG001|Phase 1|Global Deterioration of Health Status|1
875133|NCT00555906|1837220|FG002|Phase 1|Global Deterioration of Health Status|1
875134|NCT00555906|1837221|FG003|Phase 1|Global Deterioration of Health Status|1
1179484|NCT02660034|2336701|FG013|Overall Study|Progressive Disease (Radiographic)|0
1179485|NCT02660034|2336688|FG000|Overall Study|Progressive Disease (Clinical)|7
1179486|NCT02660034|2336689|FG001|Overall Study|Progressive Disease (Clinical)|8
875135|NCT00555906|1837222|FG004|Phase 1|Global Deterioration of Health Status|0
875136|NCT00555906|1837218|FG000|Phase 1|Adverse Event|0
875137|NCT00555906|1837219|FG001|Phase 1|Adverse Event|0
875138|NCT00555906|1837220|FG002|Phase 1|Adverse Event|3
875139|NCT00555906|1837221|FG003|Phase 1|Adverse Event|2
875140|NCT00555906|1837222|FG004|Phase 1|Adverse Event|0
875141|NCT00555906|1837218|FG000|Phase 1|Withdrawal by Subject|0
875142|NCT00555906|1837219|FG001|Phase 1|Withdrawal by Subject|0
875143|NCT00555906|1837220|FG002|Phase 1|Withdrawal by Subject|0
875144|NCT00555906|1837221|FG003|Phase 1|Withdrawal by Subject|1
875145|NCT00555906|1837222|FG004|Phase 1|Withdrawal by Subject|0
875146|NCT00555906|1837218|FG000|Phase 2|Adverse Event|0
875147|NCT00555906|1837219|FG001|Phase 2|Adverse Event|0
875148|NCT00555906|1837220|FG002|Phase 2|Adverse Event|0
875149|NCT00555906|1837221|FG003|Phase 2|Adverse Event|0
875150|NCT00555906|1837222|FG004|Phase 2|Adverse Event|4
875151|NCT00555906|1837218|FG000|Phase 2|Global Deterioration of Health Status|0
875152|NCT00555906|1837219|FG001|Phase 2|Global Deterioration of Health Status|0
875153|NCT00555906|1837220|FG002|Phase 2|Global Deterioration of Health Status|0
875154|NCT00555906|1837221|FG003|Phase 2|Global Deterioration of Health Status|0
875155|NCT00555906|1837222|FG004|Phase 2|Global Deterioration of Health Status|2
875156|NCT00555906|1837218|FG000|Phase 2|Objective Progression or Relapse|0
875157|NCT00555906|1837219|FG001|Phase 2|Objective Progression or Relapse|0
875158|NCT00555906|1837220|FG002|Phase 2|Objective Progression or Relapse|0
875159|NCT00555906|1837221|FG003|Phase 2|Objective Progression or Relapse|0
875160|NCT00555906|1837222|FG004|Phase 2|Objective Progression or Relapse|16
875161|NCT00555906|1837218|FG000|Phase 2|Withdrawal by Subject|0
875162|NCT00555906|1837219|FG001|Phase 2|Withdrawal by Subject|0
875163|NCT00555906|1837220|FG002|Phase 2|Withdrawal by Subject|0
875164|NCT00555906|1837221|FG003|Phase 2|Withdrawal by Subject|0
875165|NCT00555906|1837222|FG004|Phase 2|Withdrawal by Subject|2
875166|NCT00555906|1837218|FG000|Phase 2|Other|0
875167|NCT00555906|1837219|FG001|Phase 2|Other|0
875168|NCT00555906|1837220|FG002|Phase 2|Other|0
875169|NCT00555906|1837221|FG003|Phase 2|Other|0
875170|NCT00555906|1837222|FG004|Phase 2|Other|6
875171|NCT00555906|1837218|FG000|Phase 2|Randomized but not Treated|0
875172|NCT00555906|1837219|FG001|Phase 2|Randomized but not Treated|0
875173|NCT00555906|1837220|FG002|Phase 2|Randomized but not Treated|0
875174|NCT00555906|1837221|FG003|Phase 2|Randomized but not Treated|0
875175|NCT00555906|1837222|FG004|Phase 2|Randomized but not Treated|2
875176|NCT00555971|1837239|FG000|Overall Study|Adverse Event|1
875177|NCT00555971|1837240|FG001|Overall Study|Adverse Event|1
875178|NCT00556322|1837274|FG000|Overall Study|Insufficient therapeutic response|158
875179|NCT00556322|1837275|FG001|Overall Study|Insufficient therapeutic response|168
875180|NCT00556322|1837274|FG000|Overall Study|Adverse Event|7
875181|NCT00556322|1837275|FG001|Overall Study|Adverse Event|4
875182|NCT00556322|1837274|FG000|Overall Study|Other|4
875183|NCT00556322|1837275|FG001|Overall Study|Other|1
875184|NCT00556322|1837274|FG000|Overall Study|Lost to Follow-up|5
875185|NCT00556322|1837275|FG001|Overall Study|Lost to Follow-up|3
875186|NCT00556322|1837274|FG000|Overall Study|Withdrawal by Subject|19
875187|NCT00556322|1837275|FG001|Overall Study|Withdrawal by Subject|7
875188|NCT00556322|1837274|FG000|Overall Study|Protocol Violation|5
875189|NCT00556322|1837275|FG001|Overall Study|Protocol Violation|1
875190|NCT00556322|1837274|FG000|Overall Study|Ongoing at data cutoff|3
875191|NCT00556322|1837275|FG001|Overall Study|Ongoing at data cutoff|5
875192|NCT00556322|1837274|FG000|Overall Study|Death|20
875193|NCT00556322|1837275|FG001|Overall Study|Death|14
875194|NCT00556374|1837286|FG000|Overall Study|Withdrawal by Subject|190
875195|NCT00556374|1837287|FG001|Overall Study|Withdrawal by Subject|172
875196|NCT00556374|1837286|FG000|Overall Study|Death|50
875197|NCT00556374|1837287|FG001|Overall Study|Death|43
875198|NCT00556374|1837286|FG000|Overall Study|Lost to Follow-up|7
875199|NCT00556374|1837287|FG001|Overall Study|Lost to Follow-up|5
875200|NCT00556426|1837293|FG000|Overall Study|Withdrawal by Subject|3
875201|NCT00556426|1837293|FG000|Overall Study|Death|6
875202|NCT00556439|1837302|FG000|Study Entry to Week 12|Lack of Efficacy|5
875203|NCT00556439|1837303|FG001|Study Entry to Week 12|Lack of Efficacy|0
875204|NCT00556439|1837304|FG002|Study Entry to Week 12|Lack of Efficacy|6
875205|NCT00556439|1837305|FG003|Study Entry to Week 12|Lack of Efficacy|0
875206|NCT00556439|1837302|FG000|Study Entry to Week 12|Physician Decision|1
875207|NCT00556439|1837303|FG001|Study Entry to Week 12|Physician Decision|0
875208|NCT00556439|1837304|FG002|Study Entry to Week 12|Physician Decision|0
875209|NCT00556439|1837305|FG003|Study Entry to Week 12|Physician Decision|0
875210|NCT00556439|1837302|FG000|Study Entry to Week 12|Withdrawal by Subject|1
875211|NCT00556439|1837303|FG001|Study Entry to Week 12|Withdrawal by Subject|0
875212|NCT00556439|1837304|FG002|Study Entry to Week 12|Withdrawal by Subject|1
875213|NCT00556439|1837305|FG003|Study Entry to Week 12|Withdrawal by Subject|0
875214|NCT00556439|1837302|FG000|Study Entry to Week 12|Recurrent infection|1
875215|NCT00556439|1837303|FG001|Study Entry to Week 12|Recurrent infection|0
1179487|NCT02660034|2336690|FG002|Overall Study|Progressive Disease (Clinical)|3
1179488|NCT02660034|2336691|FG003|Overall Study|Progressive Disease (Clinical)|9
1179489|NCT02660034|2336692|FG004|Overall Study|Progressive Disease (Clinical)|3
1179490|NCT02660034|2336693|FG005|Overall Study|Progressive Disease (Clinical)|0
1179491|NCT02660034|2336694|FG006|Overall Study|Progressive Disease (Clinical)|0
1179492|NCT02660034|2336695|FG007|Overall Study|Progressive Disease (Clinical)|0
1179493|NCT02660034|2336696|FG008|Overall Study|Progressive Disease (Clinical)|0
1179494|NCT02660034|2336697|FG009|Overall Study|Progressive Disease (Clinical)|0
1179495|NCT02660034|2336698|FG010|Overall Study|Progressive Disease (Clinical)|0
1179496|NCT02660034|2336699|FG011|Overall Study|Progressive Disease (Clinical)|0
1179497|NCT02660034|2336700|FG012|Overall Study|Progressive Disease (Clinical)|0
1179498|NCT02660034|2336701|FG013|Overall Study|Progressive Disease (Clinical)|0
1179499|NCT02660034|2336688|FG000|Overall Study|Lost to Follow-up|0
1179500|NCT02660034|2336689|FG001|Overall Study|Lost to Follow-up|0
1179501|NCT02660034|2336690|FG002|Overall Study|Lost to Follow-up|1
1179502|NCT02660034|2336691|FG003|Overall Study|Lost to Follow-up|1
1179503|NCT02660034|2336692|FG004|Overall Study|Lost to Follow-up|0
1179504|NCT02660034|2336693|FG005|Overall Study|Lost to Follow-up|0
1179505|NCT02660034|2336694|FG006|Overall Study|Lost to Follow-up|0
1179506|NCT02660034|2336695|FG007|Overall Study|Lost to Follow-up|0
1179507|NCT02660034|2336696|FG008|Overall Study|Lost to Follow-up|0
1179508|NCT02660034|2336697|FG009|Overall Study|Lost to Follow-up|1
1179509|NCT02660034|2336698|FG010|Overall Study|Lost to Follow-up|1
1179510|NCT02660034|2336699|FG011|Overall Study|Lost to Follow-up|1
1179511|NCT02660034|2336700|FG012|Overall Study|Lost to Follow-up|0
1179512|NCT02660034|2336701|FG013|Overall Study|Lost to Follow-up|0
1179513|NCT02660034|2336688|FG000|Overall Study|Participant moved into special access scheme|1
1179514|NCT02660034|2336689|FG001|Overall Study|Participant moved into special access scheme|2
1179515|NCT02660034|2336690|FG002|Overall Study|Participant moved into special access scheme|0
1179516|NCT02660034|2336691|FG003|Overall Study|Participant moved into special access scheme|0
1179517|NCT02660034|2336692|FG004|Overall Study|Participant moved into special access scheme|0
1179518|NCT02660034|2336693|FG005|Overall Study|Participant moved into special access scheme|0
1179519|NCT02660034|2336694|FG006|Overall Study|Participant moved into special access scheme|0
1179520|NCT02660034|2336695|FG007|Overall Study|Participant moved into special access scheme|0
1179521|NCT02660034|2336696|FG008|Overall Study|Participant moved into special access scheme|0
1179522|NCT02660034|2336697|FG009|Overall Study|Participant moved into special access scheme|0
1179523|NCT02660034|2336698|FG010|Overall Study|Participant moved into special access scheme|0
1179524|NCT02660034|2336699|FG011|Overall Study|Participant moved into special access scheme|0
1179525|NCT02660034|2336700|FG012|Overall Study|Participant moved into special access scheme|0
1179526|NCT02660034|2336701|FG013|Overall Study|Participant moved into special access scheme|0
1179527|NCT02660034|2336688|FG000|Overall Study|Adverse Event|1
1179528|NCT02660034|2336689|FG001|Overall Study|Adverse Event|0
1179529|NCT02660034|2336690|FG002|Overall Study|Adverse Event|0
1179530|NCT02660034|2336691|FG003|Overall Study|Adverse Event|0
1179531|NCT02660034|2336692|FG004|Overall Study|Adverse Event|0
1179532|NCT02660034|2336693|FG005|Overall Study|Adverse Event|0
1179533|NCT02660034|2336694|FG006|Overall Study|Adverse Event|0
1179534|NCT02660034|2336695|FG007|Overall Study|Adverse Event|0
1179535|NCT02660034|2336696|FG008|Overall Study|Adverse Event|0
1179536|NCT02660034|2336697|FG009|Overall Study|Adverse Event|0
1179537|NCT02660034|2336698|FG010|Overall Study|Adverse Event|0
1179538|NCT02660034|2336699|FG011|Overall Study|Adverse Event|0
1179539|NCT02660034|2336700|FG012|Overall Study|Adverse Event|0
1179540|NCT02660034|2336701|FG013|Overall Study|Adverse Event|0
1179541|NCT02660034|2336688|FG000|Overall Study|Sponsor Decision|0
1179542|NCT02660034|2336689|FG001|Overall Study|Sponsor Decision|1
1179543|NCT02660034|2336690|FG002|Overall Study|Sponsor Decision|2
1179544|NCT02660034|2336691|FG003|Overall Study|Sponsor Decision|2
1179545|NCT02660034|2336692|FG004|Overall Study|Sponsor Decision|3
1179546|NCT02660034|2336693|FG005|Overall Study|Sponsor Decision|0
1179547|NCT02660034|2336694|FG006|Overall Study|Sponsor Decision|0
1179548|NCT02660034|2336695|FG007|Overall Study|Sponsor Decision|0
1179549|NCT02660034|2336696|FG008|Overall Study|Sponsor Decision|0
1179550|NCT02660034|2336697|FG009|Overall Study|Sponsor Decision|0
1179551|NCT02660034|2336698|FG010|Overall Study|Sponsor Decision|0
1179552|NCT02660034|2336699|FG011|Overall Study|Sponsor Decision|0
1179553|NCT02660034|2336700|FG012|Overall Study|Sponsor Decision|0
1179554|NCT02660034|2336701|FG013|Overall Study|Sponsor Decision|1
1179555|NCT02660034|2336688|FG000|Overall Study|Withdrawal by Subject|0
1179556|NCT02660034|2336689|FG001|Overall Study|Withdrawal by Subject|0
1179557|NCT02660034|2336690|FG002|Overall Study|Withdrawal by Subject|0
1179558|NCT02660034|2336691|FG003|Overall Study|Withdrawal by Subject|0
1179559|NCT02660034|2336692|FG004|Overall Study|Withdrawal by Subject|0
1179560|NCT02660034|2336693|FG005|Overall Study|Withdrawal by Subject|0
1179561|NCT02660034|2336694|FG006|Overall Study|Withdrawal by Subject|1
1179562|NCT02660034|2336695|FG007|Overall Study|Withdrawal by Subject|1
1179563|NCT02660034|2336696|FG008|Overall Study|Withdrawal by Subject|1
1179564|NCT02660034|2336697|FG009|Overall Study|Withdrawal by Subject|0
1179565|NCT02660034|2336698|FG010|Overall Study|Withdrawal by Subject|0
1179566|NCT02660034|2336699|FG011|Overall Study|Withdrawal by Subject|1
1179567|NCT02660034|2336700|FG012|Overall Study|Withdrawal by Subject|2
1179568|NCT02660034|2336701|FG013|Overall Study|Withdrawal by Subject|0
1179569|NCT02660034|2336688|FG000|Overall Study|Death|0
1179570|NCT02660034|2336689|FG001|Overall Study|Death|0
1179571|NCT02660034|2336690|FG002|Overall Study|Death|0
1179572|NCT02660034|2336691|FG003|Overall Study|Death|0
1179573|NCT02660034|2336692|FG004|Overall Study|Death|0
1179574|NCT02660034|2336693|FG005|Overall Study|Death|13
1179575|NCT02660034|2336694|FG006|Overall Study|Death|14
1179576|NCT02660034|2336695|FG007|Overall Study|Death|10
1179577|NCT02660034|2336696|FG008|Overall Study|Death|9
1179578|NCT02660034|2336697|FG009|Overall Study|Death|21
1179579|NCT02660034|2336698|FG010|Overall Study|Death|17
1179580|NCT02660034|2336699|FG011|Overall Study|Death|15
1179581|NCT02660034|2336700|FG012|Overall Study|Death|18
1179582|NCT02660034|2336701|FG013|Overall Study|Death|7
1179583|NCT02660034|2336688|FG000|Overall Study|Physician Decision|0
1179584|NCT02660034|2336689|FG001|Overall Study|Physician Decision|0
1179585|NCT02660034|2336690|FG002|Overall Study|Physician Decision|0
1179586|NCT02660034|2336691|FG003|Overall Study|Physician Decision|0
1179587|NCT02660034|2336692|FG004|Overall Study|Physician Decision|0
1179588|NCT02660034|2336693|FG005|Overall Study|Physician Decision|0
1179589|NCT02660034|2336694|FG006|Overall Study|Physician Decision|0
1179590|NCT02660034|2336695|FG007|Overall Study|Physician Decision|0
1179591|NCT02660034|2336696|FG008|Overall Study|Physician Decision|0
1179592|NCT02660034|2336697|FG009|Overall Study|Physician Decision|0
1179593|NCT02660034|2336698|FG010|Overall Study|Physician Decision|0
1179594|NCT02660034|2336699|FG011|Overall Study|Physician Decision|0
1179595|NCT02660034|2336700|FG012|Overall Study|Physician Decision|0
1179596|NCT02660034|2336701|FG013|Overall Study|Physician Decision|1
1179597|NCT02660034|2336688|FG000|Overall Study|Participants transferred to LTE|0
1179598|NCT02660034|2336689|FG001|Overall Study|Participants transferred to LTE|0
1179599|NCT02660034|2336690|FG002|Overall Study|Participants transferred to LTE|0
1179600|NCT02660034|2336691|FG003|Overall Study|Participants transferred to LTE|0
1179601|NCT02660034|2336692|FG004|Overall Study|Participants transferred to LTE|0
1179602|NCT02660034|2336693|FG005|Overall Study|Participants transferred to LTE|10
1179603|NCT02660034|2336694|FG006|Overall Study|Participants transferred to LTE|8
1179604|NCT02660034|2336695|FG007|Overall Study|Participants transferred to LTE|8
1179605|NCT02660034|2336696|FG008|Overall Study|Participants transferred to LTE|10
1179606|NCT02660034|2336697|FG009|Overall Study|Participants transferred to LTE|1
1179607|NCT02660034|2336698|FG010|Overall Study|Participants transferred to LTE|2
1179608|NCT02660034|2336699|FG011|Overall Study|Participants transferred to LTE|4
1179609|NCT02660034|2336700|FG012|Overall Study|Participants transferred to LTE|1
875216|NCT00556439|1837304|FG002|Study Entry to Week 12|Recurrent infection|0
875217|NCT00556439|1837305|FG003|Study Entry to Week 12|Recurrent infection|0
875218|NCT00556439|1837302|FG000|Study Entry to Week 12|Malignancy|0
875219|NCT00556439|1837303|FG001|Study Entry to Week 12|Malignancy|0
875220|NCT00556439|1837304|FG002|Study Entry to Week 12|Malignancy|1
875221|NCT00556439|1837305|FG003|Study Entry to Week 12|Malignancy|0
875222|NCT00556439|1837302|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
875223|NCT00556439|1837303|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
875224|NCT00556439|1837304|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
875225|NCT00556439|1837305|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
875226|NCT00556439|1837302|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1
875227|NCT00556439|1837303|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0
875228|NCT00556439|1837304|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0
875229|NCT00556439|1837305|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0
875230|NCT00556439|1837302|FG000|After Week 12 (Randomized Study Period)|Malignancy|0
875231|NCT00556439|1837303|FG001|After Week 12 (Randomized Study Period)|Malignancy|1
875232|NCT00556439|1837304|FG002|After Week 12 (Randomized Study Period)|Malignancy|0
875233|NCT00556439|1837305|FG003|After Week 12 (Randomized Study Period)|Malignancy|1
875234|NCT00556439|1837302|FG000|After Week 12 (Randomized Study Period)|Severe infection|1
875235|NCT00556439|1837303|FG001|After Week 12 (Randomized Study Period)|Severe infection|0
875236|NCT00556439|1837304|FG002|After Week 12 (Randomized Study Period)|Severe infection|0
875237|NCT00556439|1837305|FG003|After Week 12 (Randomized Study Period)|Severe infection|0
875238|NCT00556673|1837374|FG000|Overall Study|Protocol deviation|3
875239|NCT00556673|1837375|FG001|Overall Study|Protocol deviation|2
875240|NCT00556712|1837385|FG000|Overall Study|Adverse Event|7
875241|NCT00556712|1837386|FG001|Overall Study|Adverse Event|19
875242|NCT00556712|1837385|FG000|Overall Study|Death|5
875243|NCT00556712|1837386|FG001|Overall Study|Death|10
875244|NCT00556712|1837385|FG000|Overall Study|Progressive Disease|383
875245|NCT00556712|1837386|FG001|Overall Study|Progressive Disease|320
875246|NCT00556712|1837385|FG000|Overall Study|Protocol Violation|3
875247|NCT00556712|1837386|FG001|Overall Study|Protocol Violation|2
875248|NCT00556712|1837385|FG000|Overall Study|Refused Treatment|17
875249|NCT00556712|1837386|FG001|Overall Study|Refused Treatment|16
875250|NCT00556712|1837385|FG000|Overall Study|Failure to Return|2
875251|NCT00556712|1837386|FG001|Overall Study|Failure to Return|3
875252|NCT00556712|1837385|FG000|Overall Study|Other|2
875253|NCT00556712|1837386|FG001|Overall Study|Other|2
875254|NCT00556712|1837385|FG000|Overall Study|Ongoing at Data Cutoff|32
1179610|NCT02660034|2336701|FG013|Overall Study|Participants transferred to LTE|1
1179611|NCT02640625|2336735|FG000|Overall Study|Adverse Event|1
1179612|NCT02561962|2336749|FG000|Overall Study|Ongoing in study|1
1179613|NCT02561962|2336750|FG001|Overall Study|Ongoing in study|0
1179614|NCT02561962|2336751|FG002|Overall Study|Ongoing in study|0
1179615|NCT02561962|2336752|FG003|Overall Study|Ongoing in study|1
1179616|NCT02561962|2336753|FG004|Overall Study|Ongoing in study|0
1179617|NCT02561962|2336754|FG005|Overall Study|Ongoing in study|1
1179618|NCT02561962|2336755|FG006|Overall Study|Ongoing in study|0
1179619|NCT02561962|2336756|FG007|Overall Study|Ongoing in study|4
1179620|NCT02561962|2336757|FG008|Overall Study|Ongoing in study|1
1179621|NCT02561962|2336749|FG000|Overall Study|Withdrawal by Subject|1
1179622|NCT02561962|2336750|FG001|Overall Study|Withdrawal by Subject|0
1179623|NCT02561962|2336751|FG002|Overall Study|Withdrawal by Subject|0
1179624|NCT02561962|2336752|FG003|Overall Study|Withdrawal by Subject|0
1179625|NCT02561962|2336753|FG004|Overall Study|Withdrawal by Subject|1
1179626|NCT02561962|2336754|FG005|Overall Study|Withdrawal by Subject|1
1179627|NCT02561962|2336755|FG006|Overall Study|Withdrawal by Subject|2
1179628|NCT02561962|2336756|FG007|Overall Study|Withdrawal by Subject|1
1179629|NCT02561962|2336757|FG008|Overall Study|Withdrawal by Subject|0
1179630|NCT02561962|2336749|FG000|Overall Study|Decision by sponsor|0
1179631|NCT02561962|2336750|FG001|Overall Study|Decision by sponsor|0
1179632|NCT02561962|2336751|FG002|Overall Study|Decision by sponsor|0
1179633|NCT02561962|2336752|FG003|Overall Study|Decision by sponsor|0
1179634|NCT02561962|2336753|FG004|Overall Study|Decision by sponsor|1
1179635|NCT02561962|2336754|FG005|Overall Study|Decision by sponsor|1
1179636|NCT02561962|2336755|FG006|Overall Study|Decision by sponsor|0
1179637|NCT02561962|2336756|FG007|Overall Study|Decision by sponsor|3
1179638|NCT02561962|2336757|FG008|Overall Study|Decision by sponsor|0
1179639|NCT02561962|2336749|FG000|Overall Study|Lost to Follow-up|0
1179640|NCT02561962|2336750|FG001|Overall Study|Lost to Follow-up|0
1179641|NCT02561962|2336751|FG002|Overall Study|Lost to Follow-up|0
1179642|NCT02561962|2336752|FG003|Overall Study|Lost to Follow-up|0
1179643|NCT02561962|2336753|FG004|Overall Study|Lost to Follow-up|0
1179644|NCT02561962|2336754|FG005|Overall Study|Lost to Follow-up|1
1179645|NCT02561962|2336755|FG006|Overall Study|Lost to Follow-up|0
1179646|NCT02561962|2336756|FG007|Overall Study|Lost to Follow-up|0
1179647|NCT02561962|2336757|FG008|Overall Study|Lost to Follow-up|0
1179648|NCT02519348|2336786|FG000|Overall Study|Death|31
1179649|NCT02519348|2336787|FG001|Overall Study|Death|74
1179650|NCT02519348|2336788|FG002|Overall Study|Death|47
1179651|NCT02519348|2336789|FG003|Overall Study|Death|54
1179652|NCT02519348|2336790|FG004|Overall Study|Death|63
1179653|NCT02519348|2336791|FG005|Overall Study|Death|18
1179654|NCT02519348|2336792|FG006|Overall Study|Death|2
1179655|NCT02519348|2336793|FG007|Overall Study|Death|5
1179656|NCT02519348|2336794|FG008|Overall Study|Death|5
1179657|NCT02519348|2336786|FG000|Overall Study|Withdrawal by Subject|4
1179658|NCT02519348|2336787|FG001|Overall Study|Withdrawal by Subject|7
1179659|NCT02519348|2336788|FG002|Overall Study|Withdrawal by Subject|4
1179660|NCT02519348|2336789|FG003|Overall Study|Withdrawal by Subject|3
1179661|NCT02519348|2336790|FG004|Overall Study|Withdrawal by Subject|3
1179662|NCT02519348|2336791|FG005|Overall Study|Withdrawal by Subject|2
1179663|NCT02519348|2336792|FG006|Overall Study|Withdrawal by Subject|0
1179664|NCT02519348|2336793|FG007|Overall Study|Withdrawal by Subject|0
1179665|NCT02519348|2336794|FG008|Overall Study|Withdrawal by Subject|1
1179666|NCT02519348|2336786|FG000|Overall Study|Lost to Follow-up|0
1179667|NCT02519348|2336787|FG001|Overall Study|Lost to Follow-up|0
1179668|NCT02519348|2336788|FG002|Overall Study|Lost to Follow-up|1
1179669|NCT02519348|2336789|FG003|Overall Study|Lost to Follow-up|0
1179670|NCT02519348|2336790|FG004|Overall Study|Lost to Follow-up|2
1179671|NCT02519348|2336791|FG005|Overall Study|Lost to Follow-up|1
1179672|NCT02519348|2336792|FG006|Overall Study|Lost to Follow-up|1
1179673|NCT02519348|2336793|FG007|Overall Study|Lost to Follow-up|0
1179674|NCT02519348|2336794|FG008|Overall Study|Lost to Follow-up|0
1179675|NCT02519348|2336786|FG000|Overall Study|Other|0
1179676|NCT02519348|2336787|FG001|Overall Study|Other|3
1179677|NCT02519348|2336788|FG002|Overall Study|Other|0
1179678|NCT02519348|2336789|FG003|Overall Study|Other|0
1179679|NCT02519348|2336790|FG004|Overall Study|Other|1
1179680|NCT02519348|2336791|FG005|Overall Study|Other|0
1179681|NCT02519348|2336792|FG006|Overall Study|Other|0
1179682|NCT02519348|2336793|FG007|Overall Study|Other|0
1179683|NCT02519348|2336794|FG008|Overall Study|Other|0
1179684|NCT02519348|2336786|FG000|Overall Study|Ongoing at the time of data cut-off date|5
1179685|NCT02519348|2336787|FG001|Overall Study|Ongoing at the time of data cut-off date|20
1179686|NCT02519348|2336788|FG002|Overall Study|Ongoing at the time of data cut-off date|23
1179687|NCT02519348|2336789|FG003|Overall Study|Ongoing at the time of data cut-off date|12
1179688|NCT02519348|2336790|FG004|Overall Study|Ongoing at the time of data cut-off date|15
1179689|NCT02519348|2336791|FG005|Overall Study|Ongoing at the time of data cut-off date|26
1179690|NCT02519348|2336792|FG006|Overall Study|Ongoing at the time of data cut-off date|0
1179691|NCT02519348|2336793|FG007|Overall Study|Ongoing at the time of data cut-off date|0
1179692|NCT02519348|2336794|FG008|Overall Study|Ongoing at the time of data cut-off date|0
1179693|NCT02500589|2336817|FG000|Overall Study|Withdrawal by Subject|11
1179694|NCT02500589|2336818|FG001|Overall Study|Withdrawal by Subject|14
1179695|NCT02500589|2336817|FG000|Overall Study|Lost to Follow-up|10
1179696|NCT02500589|2336818|FG001|Overall Study|Lost to Follow-up|12
1179697|NCT02500589|2336817|FG000|Overall Study|Excluded post rand: cognitive impairment|0
1179698|NCT02500589|2336818|FG001|Overall Study|Excluded post rand: cognitive impairment|1
1179699|NCT02500589|2336817|FG000|Overall Study|Death|7
1179700|NCT02500589|2336818|FG001|Overall Study|Death|5
1179701|NCT02474329|2336828|FG000|Overall Study|Withdraw or did not contribute data.|13
1179702|NCT02471339|2336835|FG000|Overall Study|Did not provide follow-up data|2
1179703|NCT02471339|2336836|FG001|Overall Study|Did not provide follow-up data|0
1179704|NCT02384993|2336844|FG000|Overall Study|Adverse Event|0
1179705|NCT02384993|2336845|FG001|Overall Study|Adverse Event|1
1179706|NCT01388491|2336877|FG000|Overall Study|Adverse Event|10
1179707|NCT01388491|2336878|FG001|Overall Study|Adverse Event|9
1179708|NCT01388491|2336877|FG000|Overall Study|Sponsor Request|9
1179709|NCT01388491|2336878|FG001|Overall Study|Sponsor Request|7
1179710|NCT01388491|2336877|FG000|Overall Study|Withdrawal by Subject|6
1179711|NCT01388491|2336878|FG001|Overall Study|Withdrawal by Subject|10
1179712|NCT01388491|2336877|FG000|Overall Study|Lost to Follow-up|4
1179713|NCT01388491|2336878|FG001|Overall Study|Lost to Follow-up|3
1179714|NCT01388491|2336877|FG000|Overall Study|Protocol Violation|2
1179715|NCT01388491|2336878|FG001|Overall Study|Protocol Violation|0
1179716|NCT01388491|2336877|FG000|Overall Study|Noncompliance|2
1179717|NCT01388491|2336878|FG001|Overall Study|Noncompliance|0
1179718|NCT01388491|2336877|FG000|Overall Study|Pregnancy|1
1179719|NCT01388491|2336878|FG001|Overall Study|Pregnancy|0
1179720|NCT01373151|2336891|FG000|Period 1|Lack of Efficacy|3
1179721|NCT01373151|2336892|FG001|Period 1|Lack of Efficacy|0
1179722|NCT01373151|2336893|FG002|Period 1|Lack of Efficacy|0
1179723|NCT01373151|2336894|FG003|Period 1|Lack of Efficacy|0
1179724|NCT01373151|2336895|FG004|Period 1|Lack of Efficacy|1
1179725|NCT01373151|2336896|FG005|Period 1|Lack of Efficacy|0
1179726|NCT01373151|2336897|FG006|Period 1|Lack of Efficacy|0
875255|NCT00556712|1837386|FG001|Overall Study|Ongoing at Data Cutoff|66
875256|NCT00556894|1837412|FG000|Overall Study|Adverse Event|2
875257|NCT00556894|1837413|FG001|Overall Study|Adverse Event|3
875258|NCT00556894|1837414|FG002|Overall Study|Adverse Event|3
875259|NCT00556894|1837412|FG000|Overall Study|Death|1
875260|NCT00556894|1837413|FG001|Overall Study|Death|0
875261|NCT00556894|1837414|FG002|Overall Study|Death|0
875262|NCT00556894|1837412|FG000|Overall Study|regulatory decision in Bulgaria|10
875263|NCT00556894|1837413|FG001|Overall Study|regulatory decision in Bulgaria|14
875264|NCT00556894|1837414|FG002|Overall Study|regulatory decision in Bulgaria|13
875265|NCT00556894|1837412|FG000|Overall Study|Change in therapy|2
875266|NCT00556894|1837413|FG001|Overall Study|Change in therapy|1
875267|NCT00556894|1837414|FG002|Overall Study|Change in therapy|2
875268|NCT00556894|1837412|FG000|Overall Study|Withdrawal by Subject|1
875269|NCT00556894|1837413|FG001|Overall Study|Withdrawal by Subject|1
875270|NCT00556894|1837414|FG002|Overall Study|Withdrawal by Subject|1
875271|NCT00556933|1837426|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2
875272|NCT00556933|1837427|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3
875273|NCT00556933|1837428|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3
875274|NCT00556933|1837429|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0
875275|NCT00556933|1837426|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
875276|NCT00556933|1837427|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
875277|NCT00556933|1837428|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
875278|NCT00556933|1837429|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
875279|NCT00556933|1837426|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
875280|NCT00556933|1837427|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
875281|NCT00556933|1837428|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
875282|NCT00556933|1837429|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
875283|NCT00556933|1837426|FG000|Single vs. Divided-dose rATG Induction|Death|0
875284|NCT00556933|1837427|FG001|Single vs. Divided-dose rATG Induction|Death|1
875285|NCT00556933|1837428|FG002|Single vs. Divided-dose rATG Induction|Death|0
875286|NCT00556933|1837429|FG003|Single vs. Divided-dose rATG Induction|Death|0
875287|NCT00556933|1837426|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
875288|NCT00556933|1837427|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
875289|NCT00556933|1837428|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
875290|NCT00556933|1837429|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
875291|NCT00556933|1837426|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
875292|NCT00556933|1837427|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
875293|NCT00556933|1837428|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
875294|NCT00556933|1837429|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
875295|NCT00556933|1837426|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
875296|NCT00556933|1837427|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
875297|NCT00556933|1837428|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
875298|NCT00556933|1837429|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
875299|NCT00556933|1837426|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
875300|NCT00556933|1837427|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
875301|NCT00556933|1837428|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
875302|NCT00556933|1837429|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
1179727|NCT01373151|2336891|FG000|Period 1|Adverse Event|0
1179728|NCT01373151|2336892|FG001|Period 1|Adverse Event|0
1179729|NCT01373151|2336893|FG002|Period 1|Adverse Event|1
1179730|NCT01373151|2336894|FG003|Period 1|Adverse Event|0
1179731|NCT01373151|2336895|FG004|Period 1|Adverse Event|4
1179732|NCT01373151|2336896|FG005|Period 1|Adverse Event|3
1179733|NCT01373151|2336897|FG006|Period 1|Adverse Event|0
1179734|NCT01373151|2336891|FG000|Period 1|Withdrawal by Subject|2
875303|NCT00556933|1837426|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
875304|NCT00556933|1837427|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
875305|NCT00556933|1837428|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
875306|NCT00556933|1837429|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
875307|NCT00556933|1837426|FG000|CNI Withdrawal vs. Minimization|Graft loss|0
875308|NCT00556933|1837427|FG001|CNI Withdrawal vs. Minimization|Graft loss|1
875309|NCT00556933|1837428|FG002|CNI Withdrawal vs. Minimization|Graft loss|2
875310|NCT00556933|1837429|FG003|CNI Withdrawal vs. Minimization|Graft loss|0
875311|NCT00556933|1837426|FG000|CNI Withdrawal vs. Minimization|Death|0
875312|NCT00556933|1837427|FG001|CNI Withdrawal vs. Minimization|Death|0
875313|NCT00556933|1837428|FG002|CNI Withdrawal vs. Minimization|Death|0
875314|NCT00556933|1837429|FG003|CNI Withdrawal vs. Minimization|Death|1
875315|NCT00556998|1837456|FG000|Voriconazole Intravenous (IV)|Adverse Event|1
875316|NCT00556998|1837456|FG000|Voriconazole Intravenous (IV)|Other|4
875317|NCT00556998|1837456|FG000|Voriconazole Oral|Adverse Event|1
875318|NCT00556998|1837456|FG000|Voriconazole Oral|Intolerant of oral treatment|1
875319|NCT00557076|1837466|FG000|Overall Study|Unblinding|0
875320|NCT00557076|1837467|FG001|Overall Study|Unblinding|1
875321|NCT00557193|1837473|FG000|Induction|Adverse Event|2
875322|NCT00557193|1837474|FG001|Induction|Adverse Event|0
875323|NCT00557193|1837475|FG002|Induction|Adverse Event|0
875324|NCT00557193|1837476|FG003|Induction|Adverse Event|0
875325|NCT00557193|1837477|FG004|Induction|Adverse Event|0
875326|NCT00557193|1837478|FG005|Induction|Adverse Event|0
875327|NCT00557193|1837473|FG000|Induction|Death|6
875328|NCT00557193|1837474|FG001|Induction|Death|0
875329|NCT00557193|1837475|FG002|Induction|Death|0
875330|NCT00557193|1837476|FG003|Induction|Death|0
875331|NCT00557193|1837477|FG004|Induction|Death|0
875332|NCT00557193|1837478|FG005|Induction|Death|0
875333|NCT00557193|1837473|FG000|Induction|Physician Decision|3
875334|NCT00557193|1837474|FG001|Induction|Physician Decision|0
875335|NCT00557193|1837475|FG002|Induction|Physician Decision|0
875336|NCT00557193|1837476|FG003|Induction|Physician Decision|0
875337|NCT00557193|1837477|FG004|Induction|Physician Decision|0
875338|NCT00557193|1837478|FG005|Induction|Physician Decision|0
875339|NCT00557193|1837473|FG000|Induction|Withdrawal by Subject|1
875340|NCT00557193|1837474|FG001|Induction|Withdrawal by Subject|0
875341|NCT00557193|1837475|FG002|Induction|Withdrawal by Subject|0
875342|NCT00557193|1837476|FG003|Induction|Withdrawal by Subject|0
875343|NCT00557193|1837477|FG004|Induction|Withdrawal by Subject|0
875344|NCT00557193|1837478|FG005|Induction|Withdrawal by Subject|0
875345|NCT00557193|1837473|FG000|Induction|Refusal of Further Protocol Therapy|2
875346|NCT00557193|1837474|FG001|Induction|Refusal of Further Protocol Therapy|0
875347|NCT00557193|1837475|FG002|Induction|Refusal of Further Protocol Therapy|0
875348|NCT00557193|1837476|FG003|Induction|Refusal of Further Protocol Therapy|0
875349|NCT00557193|1837477|FG004|Induction|Refusal of Further Protocol Therapy|0
875350|NCT00557193|1837478|FG005|Induction|Refusal of Further Protocol Therapy|0
875351|NCT00557193|1837473|FG000|Induction|Ineligible|8
875352|NCT00557193|1837474|FG001|Induction|Ineligible|0
875353|NCT00557193|1837475|FG002|Induction|Ineligible|0
875354|NCT00557193|1837476|FG003|Induction|Ineligible|0
875355|NCT00557193|1837477|FG004|Induction|Ineligible|0
875356|NCT00557193|1837478|FG005|Induction|Ineligible|0
875357|NCT00557193|1837473|FG000|Induction|Inevaluable for post Induction|2
875358|NCT00557193|1837474|FG001|Induction|Inevaluable for post Induction|0
875359|NCT00557193|1837475|FG002|Induction|Inevaluable for post Induction|0
875360|NCT00557193|1837476|FG003|Induction|Inevaluable for post Induction|0
875361|NCT00557193|1837477|FG004|Induction|Inevaluable for post Induction|0
875362|NCT00557193|1837478|FG005|Induction|Inevaluable for post Induction|0
875363|NCT00557193|1837473|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2
875364|NCT00557193|1837474|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0
875365|NCT00557193|1837475|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0
875366|NCT00557193|1837476|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0
875367|NCT00557193|1837477|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0
875368|NCT00557193|1837478|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0
875369|NCT00557193|1837473|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
875370|NCT00557193|1837474|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1
875371|NCT00557193|1837475|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2
875372|NCT00557193|1837476|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1
875373|NCT00557193|1837477|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0
875374|NCT00557193|1837478|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3
875375|NCT00557193|1837473|FG000|Post Induction Therapy by Tx Assignment|Death|0
875376|NCT00557193|1837474|FG001|Post Induction Therapy by Tx Assignment|Death|0
875377|NCT00557193|1837475|FG002|Post Induction Therapy by Tx Assignment|Death|2
1179735|NCT01373151|2336892|FG001|Period 1|Withdrawal by Subject|0
1179736|NCT01373151|2336893|FG002|Period 1|Withdrawal by Subject|3
1179737|NCT01373151|2336894|FG003|Period 1|Withdrawal by Subject|1
1179738|NCT01373151|2336895|FG004|Period 1|Withdrawal by Subject|0
1179739|NCT01373151|2336896|FG005|Period 1|Withdrawal by Subject|1
1179740|NCT01373151|2336897|FG006|Period 1|Withdrawal by Subject|0
1179741|NCT01373151|2336891|FG000|Period 2|Lack of Efficacy|9
1179742|NCT01373151|2336892|FG001|Period 2|Lack of Efficacy|0
1179743|NCT01373151|2336893|FG002|Period 2|Lack of Efficacy|0
1179744|NCT01373151|2336894|FG003|Period 2|Lack of Efficacy|1
1179745|NCT01373151|2336895|FG004|Period 2|Lack of Efficacy|2
1179746|NCT01373151|2336896|FG005|Period 2|Lack of Efficacy|0
1179747|NCT01373151|2336897|FG006|Period 2|Lack of Efficacy|3
1179748|NCT01373151|2336891|FG000|Period 2|Adverse Event|0
1179749|NCT01373151|2336892|FG001|Period 2|Adverse Event|0
1179750|NCT01373151|2336893|FG002|Period 2|Adverse Event|3
1179751|NCT01373151|2336894|FG003|Period 2|Adverse Event|3
1179752|NCT01373151|2336895|FG004|Period 2|Adverse Event|0
1179753|NCT01373151|2336896|FG005|Period 2|Adverse Event|0
875378|NCT00557193|1837476|FG003|Post Induction Therapy by Tx Assignment|Death|0
875379|NCT00557193|1837477|FG004|Post Induction Therapy by Tx Assignment|Death|2
875380|NCT00557193|1837478|FG005|Post Induction Therapy by Tx Assignment|Death|2
875381|NCT00557193|1837473|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
875382|NCT00557193|1837474|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3
875383|NCT00557193|1837475|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5
875384|NCT00557193|1837476|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1
875385|NCT00557193|1837477|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2
875386|NCT00557193|1837478|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2
875387|NCT00557193|1837473|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
875388|NCT00557193|1837474|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
875389|NCT00557193|1837475|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
875390|NCT00557193|1837476|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
875391|NCT00557193|1837477|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
875392|NCT00557193|1837478|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
875393|NCT00557193|1837473|FG000|Post Induction Therapy by Tx Assignment|Relapse|0
875394|NCT00557193|1837474|FG001|Post Induction Therapy by Tx Assignment|Relapse|5
875395|NCT00557193|1837475|FG002|Post Induction Therapy by Tx Assignment|Relapse|16
875396|NCT00557193|1837476|FG003|Post Induction Therapy by Tx Assignment|Relapse|3
875397|NCT00557193|1837477|FG004|Post Induction Therapy by Tx Assignment|Relapse|1
875398|NCT00557193|1837478|FG005|Post Induction Therapy by Tx Assignment|Relapse|20
875399|NCT00557193|1837473|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
875400|NCT00557193|1837474|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
875401|NCT00557193|1837475|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
875402|NCT00557193|1837476|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
875403|NCT00557193|1837477|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
875404|NCT00557193|1837478|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
875405|NCT00557193|1837473|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
875406|NCT00557193|1837474|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
875407|NCT00557193|1837475|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
875408|NCT00557193|1837476|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
875409|NCT00557193|1837477|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
875410|NCT00557193|1837478|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
875411|NCT00557193|1837473|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0
875412|NCT00557193|1837474|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0
875413|NCT00557193|1837475|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4
875414|NCT00557193|1837476|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0
875415|NCT00557193|1837477|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0
875416|NCT00557193|1837478|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5
875417|NCT00557245|1837506|FG000|Overall Study|Lost to Follow-up|7
875418|NCT00557245|1837507|FG001|Overall Study|Lost to Follow-up|8
875419|NCT00557245|1837508|FG002|Overall Study|Lost to Follow-up|10
875420|NCT00557245|1837506|FG000|Overall Study|Ineligible|5
875421|NCT00557245|1837507|FG001|Overall Study|Ineligible|4
875422|NCT00557245|1837508|FG002|Overall Study|Ineligible|2
875423|NCT00557310|1837528|FG000|Main Study (0 - 18 Months)|Adverse Event|4
875424|NCT00557310|1837528|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1
875425|NCT00557310|1837528|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1
875426|NCT00557310|1837528|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
875427|NCT00557310|1837528|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2
875428|NCT00557310|1837528|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1
875429|NCT00557323|1837532|FG000|Overall Study|Death|3
875430|NCT00557323|1837532|FG000|Overall Study|Withdrawal by Subject|2
875431|NCT00557323|1837532|FG000|Overall Study|Administrative change|2
875432|NCT00557440|1837568|FG000|Treatment Period 1|Adverse Event|0
1179754|NCT01373151|2336897|FG006|Period 2|Adverse Event|1
1179755|NCT01373151|2336891|FG000|Period 2|subject request to discontinue|0
1179756|NCT01373151|2336892|FG001|Period 2|subject request to discontinue|1
1179757|NCT01373151|2336893|FG002|Period 2|subject request to discontinue|0
1179758|NCT01373151|2336894|FG003|Period 2|subject request to discontinue|0
1179759|NCT01373151|2336895|FG004|Period 2|subject request to discontinue|0
1179760|NCT01373151|2336896|FG005|Period 2|subject request to discontinue|0
1179761|NCT01373151|2336897|FG006|Period 2|subject request to discontinue|0
1179762|NCT01373151|2336891|FG000|Period 2|Withdrawal by Subject|0
1179763|NCT01373151|2336892|FG001|Period 2|Withdrawal by Subject|0
1179764|NCT01373151|2336893|FG002|Period 2|Withdrawal by Subject|0
1179765|NCT01373151|2336894|FG003|Period 2|Withdrawal by Subject|1
1179766|NCT01373151|2336895|FG004|Period 2|Withdrawal by Subject|0
1179767|NCT01373151|2336896|FG005|Period 2|Withdrawal by Subject|0
1179768|NCT01373151|2336897|FG006|Period 2|Withdrawal by Subject|0
1179769|NCT01373151|2336891|FG000|Period 2|Other|0
1179770|NCT01373151|2336892|FG001|Period 2|Other|0
1179771|NCT01373151|2336893|FG002|Period 2|Other|1
1179772|NCT01373151|2336894|FG003|Period 2|Other|0
1179773|NCT01373151|2336895|FG004|Period 2|Other|0
1179774|NCT01373151|2336896|FG005|Period 2|Other|0
1179775|NCT01373151|2336897|FG006|Period 2|Other|1
1179776|NCT01281644|2336926|FG000|Overall Study|Lost to Follow-up|3
1179777|NCT01281644|2336926|FG000|Overall Study|Withdrawal by Subject|2
1179780|NCT00960297|2336949|FG000|Overall Study|Physician Decision|1
1179781|NCT00960297|2336949|FG000|Overall Study|Venous port infection|1
1179782|NCT00960297|2336949|FG000|Overall Study|Disease progression|1
1179783|NCT00910650|2336953|FG000|Overall Study|Death|2
1179784|NCT00703326|2336963|FG000|Overall Study|Lost to Follow-up|47
1179785|NCT00703326|2336964|FG001|Overall Study|Lost to Follow-up|18
1179786|NCT00703326|2336963|FG000|Overall Study|Withdrawal by Subject|54
1179787|NCT00703326|2336964|FG001|Overall Study|Withdrawal by Subject|20
1179788|NCT00703326|2336963|FG000|Overall Study|Adverse Event|1
1179789|NCT00703326|2336964|FG001|Overall Study|Adverse Event|0
1179790|NCT00602667|2336974|FG000|Overall Study|Still on Therapy|0
1179791|NCT00602667|2336975|FG001|Overall Study|Still on Therapy|2
1179792|NCT00602667|2336976|FG002|Overall Study|Still on Therapy|2
1179793|NCT00602667|2336974|FG000|Overall Study|Death|0
1179794|NCT00602667|2336975|FG001|Overall Study|Death|1
1179795|NCT00602667|2336976|FG002|Overall Study|Death|1
1179796|NCT00602667|2336974|FG000|Overall Study|Family request|3
1179797|NCT00602667|2336975|FG001|Overall Study|Family request|25
1179798|NCT00602667|2336976|FG002|Overall Study|Family request|6
1179799|NCT00602667|2336974|FG000|Overall Study|Excessive toxicity|1
1179800|NCT00602667|2336975|FG001|Overall Study|Excessive toxicity|1
1179801|NCT00602667|2336976|FG002|Overall Study|Excessive toxicity|0
1179802|NCT00602667|2336974|FG000|Overall Study|Second malignancy|0
1179803|NCT00602667|2336975|FG001|Overall Study|Second malignancy|1
1179804|NCT00602667|2336976|FG002|Overall Study|Second malignancy|0
1179805|NCT00602667|2336974|FG000|Overall Study|Physician Decision|2
1179806|NCT00602667|2336975|FG001|Overall Study|Physician Decision|3
1179807|NCT00602667|2336976|FG002|Overall Study|Physician Decision|8
1179808|NCT00602667|2336974|FG000|Overall Study|Progressive disease|13
1179809|NCT00602667|2336975|FG001|Overall Study|Progressive disease|48
1179810|NCT00602667|2336976|FG002|Overall Study|Progressive disease|45
1179811|NCT00602667|2336974|FG000|Overall Study|Progressive disease prior to therapy|0
1179812|NCT00602667|2336975|FG001|Overall Study|Progressive disease prior to therapy|0
1179813|NCT00602667|2336976|FG002|Overall Study|Progressive disease prior to therapy|1
1179814|NCT00472186|2337017|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1
1179815|NCT00472186|2337018|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0
1179819|NCT03996876|2337061|FG000|Overall Study|Incomplete Data|2
1179820|NCT03996876|2337062|FG001|Overall Study|Incomplete Data|4
1179821|NCT03589976|2337071|FG000|Overall Study|Death|5
1179822|NCT03589976|2337072|FG001|Overall Study|Death|1
1179823|NCT03589976|2337071|FG000|Overall Study|Adverse Event|5
1179824|NCT03589976|2337072|FG001|Overall Study|Adverse Event|1
1179825|NCT03589976|2337071|FG000|Overall Study|Withdrawal by Subject|4
1179826|NCT03589976|2337072|FG001|Overall Study|Withdrawal by Subject|1
1179827|NCT03589976|2337071|FG000|Overall Study|Lost to Follow-up|1
1179828|NCT03589976|2337072|FG001|Overall Study|Lost to Follow-up|0
1179829|NCT03589976|2337071|FG000|Overall Study|Other|4
1179830|NCT03589976|2337072|FG001|Overall Study|Other|3
1179831|NCT03517449|2337080|FG000|Overall Study|Death|184
1179832|NCT03517449|2337081|FG001|Overall Study|Death|236
1179833|NCT03517449|2337080|FG000|Overall Study|Lost to Follow-up|0
1179834|NCT03517449|2337081|FG001|Overall Study|Lost to Follow-up|2
1179835|NCT03517449|2337080|FG000|Overall Study|Withdrawal by Subject|7
1179836|NCT03517449|2337081|FG001|Overall Study|Withdrawal by Subject|26
1179837|NCT03517449|2337080|FG000|Overall Study|Participants Ongoing|220
1179838|NCT03517449|2337081|FG001|Overall Study|Participants Ongoing|152
1179839|NCT03135262|2337128|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1
875433|NCT00557440|1837569|FG001|Treatment Period 1|Adverse Event|0
875434|NCT00557440|1837570|FG002|Treatment Period 1|Adverse Event|1
875435|NCT00557466|1837584|FG000|Overall Study|Adverse Event|3
875436|NCT00557466|1837585|FG001|Overall Study|Adverse Event|1
875437|NCT00557466|1837586|FG002|Overall Study|Adverse Event|4
875438|NCT00557466|1837587|FG003|Overall Study|Adverse Event|1
875439|NCT00557466|1837588|FG004|Overall Study|Adverse Event|2
875440|NCT00557466|1837589|FG005|Overall Study|Adverse Event|4
875441|NCT00557466|1837584|FG000|Overall Study|Abnormal laboratory value(s)|1
875442|NCT00557466|1837585|FG001|Overall Study|Abnormal laboratory value(s)|2
875443|NCT00557466|1837586|FG002|Overall Study|Abnormal laboratory value(s)|0
875444|NCT00557466|1837587|FG003|Overall Study|Abnormal laboratory value(s)|0
875445|NCT00557466|1837588|FG004|Overall Study|Abnormal laboratory value(s)|0
875446|NCT00557466|1837589|FG005|Overall Study|Abnormal laboratory value(s)|0
875447|NCT00557466|1837584|FG000|Overall Study|Protocol deviation|0
875448|NCT00557466|1837585|FG001|Overall Study|Protocol deviation|1
875449|NCT00557466|1837586|FG002|Overall Study|Protocol deviation|0
875450|NCT00557466|1837587|FG003|Overall Study|Protocol deviation|2
875451|NCT00557466|1837588|FG004|Overall Study|Protocol deviation|0
875452|NCT00557466|1837589|FG005|Overall Study|Protocol deviation|0
875453|NCT00557466|1837584|FG000|Overall Study|Subject withdrew consent|0
875454|NCT00557466|1837585|FG001|Overall Study|Subject withdrew consent|0
875455|NCT00557466|1837586|FG002|Overall Study|Subject withdrew consent|0
875456|NCT00557466|1837587|FG003|Overall Study|Subject withdrew consent|0
875457|NCT00557466|1837588|FG004|Overall Study|Subject withdrew consent|1
875458|NCT00557466|1837589|FG005|Overall Study|Subject withdrew consent|2
875459|NCT00557466|1837584|FG000|Overall Study|Administrative problems|0
875460|NCT00557466|1837585|FG001|Overall Study|Administrative problems|1
875461|NCT00557466|1837586|FG002|Overall Study|Administrative problems|1
875462|NCT00557466|1837587|FG003|Overall Study|Administrative problems|0
875463|NCT00557466|1837588|FG004|Overall Study|Administrative problems|0
875464|NCT00557466|1837589|FG005|Overall Study|Administrative problems|0
875465|NCT00557466|1837584|FG000|Overall Study|Abnormal test procedure results|0
875466|NCT00557466|1837585|FG001|Overall Study|Abnormal test procedure results|0
875467|NCT00557466|1837586|FG002|Overall Study|Abnormal test procedure results|1
875468|NCT00557466|1837587|FG003|Overall Study|Abnormal test procedure results|0
875469|NCT00557466|1837588|FG004|Overall Study|Abnormal test procedure results|0
875470|NCT00557466|1837589|FG005|Overall Study|Abnormal test procedure results|0
875471|NCT00557466|1837584|FG000|Overall Study|Lost to Follow-up|0
875472|NCT00557466|1837585|FG001|Overall Study|Lost to Follow-up|0
875473|NCT00557466|1837586|FG002|Overall Study|Lost to Follow-up|0
875474|NCT00557466|1837587|FG003|Overall Study|Lost to Follow-up|1
875475|NCT00557466|1837588|FG004|Overall Study|Lost to Follow-up|0
875476|NCT00557466|1837589|FG005|Overall Study|Lost to Follow-up|0
875477|NCT00557492|1837603|FG000|Overall Study|Change in health insurance|1
875478|NCT00557505|1837616|FG000|Overall Study|Death|0
875479|NCT00557505|1837617|FG001|Overall Study|Death|0
875480|NCT00557505|1837618|FG002|Overall Study|Death|0
875481|NCT00557505|1837619|FG003|Overall Study|Death|0
875482|NCT00557505|1837620|FG004|Overall Study|Death|0
875483|NCT00557505|1837621|FG005|Overall Study|Death|0
875484|NCT00557505|1837622|FG006|Overall Study|Death|0
875485|NCT00557505|1837623|FG007|Overall Study|Death|0
875486|NCT00557505|1837624|FG008|Overall Study|Death|1
875487|NCT00557505|1837616|FG000|Overall Study|Adverse Event|0
875488|NCT00557505|1837617|FG001|Overall Study|Adverse Event|0
875489|NCT00557505|1837618|FG002|Overall Study|Adverse Event|1
875490|NCT00557505|1837619|FG003|Overall Study|Adverse Event|0
875491|NCT00557505|1837620|FG004|Overall Study|Adverse Event|0
1179840|NCT03135262|2337129|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0
1179841|NCT03135262|2337130|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0
1179842|NCT03135262|2337131|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0
1179843|NCT03135262|2337132|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0
1179844|NCT03135262|2337128|FG000|Overall Study|Progression of disease|0
1179845|NCT03135262|2337129|FG001|Overall Study|Progression of disease|0
1179846|NCT03135262|2337130|FG002|Overall Study|Progression of disease|0
1179847|NCT03135262|2337131|FG003|Overall Study|Progression of disease|1
1179848|NCT03135262|2337132|FG004|Overall Study|Progression of disease|0
1179849|NCT03135262|2337128|FG000|Overall Study|Death|6
1179850|NCT03135262|2337129|FG001|Overall Study|Death|2
1179851|NCT03135262|2337130|FG002|Overall Study|Death|2
1179852|NCT03135262|2337131|FG003|Overall Study|Death|2
1179853|NCT03135262|2337132|FG004|Overall Study|Death|0
1179854|NCT03135262|2337128|FG000|Overall Study|Withdrawal by Subject|0
875492|NCT00557505|1837621|FG005|Overall Study|Adverse Event|0
875493|NCT00557505|1837622|FG006|Overall Study|Adverse Event|1
875494|NCT00557505|1837623|FG007|Overall Study|Adverse Event|0
875495|NCT00557505|1837624|FG008|Overall Study|Adverse Event|0
875496|NCT00557505|1837616|FG000|Overall Study|Global deterioration of health|1
875497|NCT00557505|1837617|FG001|Overall Study|Global deterioration of health|0
875498|NCT00557505|1837618|FG002|Overall Study|Global deterioration of health|0
875499|NCT00557505|1837619|FG003|Overall Study|Global deterioration of health|0
875500|NCT00557505|1837620|FG004|Overall Study|Global deterioration of health|0
875501|NCT00557505|1837621|FG005|Overall Study|Global deterioration of health|0
875502|NCT00557505|1837622|FG006|Overall Study|Global deterioration of health|0
875503|NCT00557505|1837623|FG007|Overall Study|Global deterioration of health|0
875504|NCT00557505|1837624|FG008|Overall Study|Global deterioration of health|0
875505|NCT00557505|1837616|FG000|Overall Study|Objective progression or relapse|2
875506|NCT00557505|1837617|FG001|Overall Study|Objective progression or relapse|3
875507|NCT00557505|1837618|FG002|Overall Study|Objective progression or relapse|3
875508|NCT00557505|1837619|FG003|Overall Study|Objective progression or relapse|2
875509|NCT00557505|1837620|FG004|Overall Study|Objective progression or relapse|2
875510|NCT00557505|1837621|FG005|Overall Study|Objective progression or relapse|3
875511|NCT00557505|1837622|FG006|Overall Study|Objective progression or relapse|2
875512|NCT00557505|1837623|FG007|Overall Study|Objective progression or relapse|5
875513|NCT00557505|1837624|FG008|Overall Study|Objective progression or relapse|15
875514|NCT00557505|1837616|FG000|Overall Study|Withdrawal by Subject|0
875515|NCT00557505|1837617|FG001|Overall Study|Withdrawal by Subject|0
875516|NCT00557505|1837618|FG002|Overall Study|Withdrawal by Subject|0
875517|NCT00557505|1837619|FG003|Overall Study|Withdrawal by Subject|1
875518|NCT00557505|1837620|FG004|Overall Study|Withdrawal by Subject|0
875519|NCT00557505|1837621|FG005|Overall Study|Withdrawal by Subject|0
875520|NCT00557505|1837622|FG006|Overall Study|Withdrawal by Subject|0
875521|NCT00557505|1837623|FG007|Overall Study|Withdrawal by Subject|0
875522|NCT00557505|1837624|FG008|Overall Study|Withdrawal by Subject|1
875523|NCT00557622|1837649|FG000|4-Week Run-in Phase|Withdrawal by Subject|1
875524|NCT00557622|1837650|FG001|4-Week Run-in Phase|Withdrawal by Subject|0
875525|NCT00557622|1837649|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1
875526|NCT00557622|1837650|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0
875527|NCT00557622|1837649|FG000|12-Week Treatment Phase|Lost to Follow-up|0
875528|NCT00557622|1837650|FG001|12-Week Treatment Phase|Lost to Follow-up|1
875529|NCT00557830|1837659|FG000|Screening Treatment Phase|Withdrawal by Subject|1
875530|NCT00557830|1837660|FG001|Screening Treatment Phase|Withdrawal by Subject|0
875531|NCT00557830|1837661|FG002|Screening Treatment Phase|Withdrawal by Subject|0
875532|NCT00557830|1837659|FG000|Screening Treatment Phase|Adverse Event|2
875533|NCT00557830|1837660|FG001|Screening Treatment Phase|Adverse Event|0
875534|NCT00557830|1837661|FG002|Screening Treatment Phase|Adverse Event|0
875535|NCT00557830|1837659|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3
875536|NCT00557830|1837660|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0
875537|NCT00557830|1837661|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0
875538|NCT00557856|1837669|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3
875539|NCT00557856|1837670|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5
875540|NCT00557856|1837671|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3
875541|NCT00557856|1837672|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1
875542|NCT00557856|1837673|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3
875543|NCT00557856|1837674|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2
875544|NCT00557856|1837675|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5
875545|NCT00557856|1837676|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3
875546|NCT00557856|1837677|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0
875547|NCT00557856|1837669|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
875548|NCT00557856|1837670|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
875549|NCT00557856|1837671|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
875550|NCT00557856|1837672|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
875551|NCT00557856|1837673|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1179855|NCT03135262|2337129|FG001|Overall Study|Withdrawal by Subject|0
1179856|NCT03135262|2337130|FG002|Overall Study|Withdrawal by Subject|1
1179857|NCT03135262|2337131|FG003|Overall Study|Withdrawal by Subject|0
875552|NCT00557856|1837674|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
875553|NCT00557856|1837675|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
875554|NCT00557856|1837676|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
875555|NCT00557856|1837677|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
875556|NCT00557856|1837669|FG000|Part 1: Dose Escalation Phase|Adverse Event|1
875557|NCT00557856|1837670|FG001|Part 1: Dose Escalation Phase|Adverse Event|0
875558|NCT00557856|1837671|FG002|Part 1: Dose Escalation Phase|Adverse Event|1
875559|NCT00557856|1837672|FG003|Part 1: Dose Escalation Phase|Adverse Event|1
875560|NCT00557856|1837673|FG004|Part 1: Dose Escalation Phase|Adverse Event|1
875561|NCT00557856|1837674|FG005|Part 1: Dose Escalation Phase|Adverse Event|3
875562|NCT00557856|1837675|FG006|Part 1: Dose Escalation Phase|Adverse Event|1
875563|NCT00557856|1837676|FG007|Part 1: Dose Escalation Phase|Adverse Event|2
875564|NCT00557856|1837677|FG008|Part 1: Dose Escalation Phase|Adverse Event|0
875565|NCT00557856|1837669|FG000|Part 1: Dose Escalation Phase|Other|0
875566|NCT00557856|1837670|FG001|Part 1: Dose Escalation Phase|Other|0
875567|NCT00557856|1837671|FG002|Part 1: Dose Escalation Phase|Other|1
875568|NCT00557856|1837672|FG003|Part 1: Dose Escalation Phase|Other|1
875569|NCT00557856|1837673|FG004|Part 1: Dose Escalation Phase|Other|0
875570|NCT00557856|1837674|FG005|Part 1: Dose Escalation Phase|Other|0
875571|NCT00557856|1837675|FG006|Part 1: Dose Escalation Phase|Other|0
875572|NCT00557856|1837676|FG007|Part 1: Dose Escalation Phase|Other|1
875573|NCT00557856|1837677|FG008|Part 1: Dose Escalation Phase|Other|0
875574|NCT00557856|1837669|FG000|Part 1: Dose Escalation Phase|Death|0
875575|NCT00557856|1837670|FG001|Part 1: Dose Escalation Phase|Death|0
875576|NCT00557856|1837671|FG002|Part 1: Dose Escalation Phase|Death|0
875577|NCT00557856|1837672|FG003|Part 1: Dose Escalation Phase|Death|0
875578|NCT00557856|1837673|FG004|Part 1: Dose Escalation Phase|Death|0
875579|NCT00557856|1837674|FG005|Part 1: Dose Escalation Phase|Death|1
875580|NCT00557856|1837675|FG006|Part 1: Dose Escalation Phase|Death|0
875581|NCT00557856|1837676|FG007|Part 1: Dose Escalation Phase|Death|0
875582|NCT00557856|1837677|FG008|Part 1: Dose Escalation Phase|Death|0
875583|NCT00557856|1837669|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0
875584|NCT00557856|1837670|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0
875585|NCT00557856|1837671|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0
875586|NCT00557856|1837672|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0
875587|NCT00557856|1837673|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0
875588|NCT00557856|1837674|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2
875589|NCT00557856|1837675|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1
875590|NCT00557856|1837676|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0
875591|NCT00557856|1837677|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0
875592|NCT00557856|1837669|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2
875593|NCT00557856|1837670|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0
875594|NCT00557856|1837671|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0
875595|NCT00557856|1837672|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0
875596|NCT00557856|1837673|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0
875597|NCT00557856|1837674|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0
875598|NCT00557856|1837675|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0
875599|NCT00557856|1837676|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0
875600|NCT00557856|1837677|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0
875601|NCT00557856|1837669|FG000|Part 2: Exploratory Phase|objective progression or relapse|0
875602|NCT00557856|1837670|FG001|Part 2: Exploratory Phase|objective progression or relapse|0
875603|NCT00557856|1837671|FG002|Part 2: Exploratory Phase|objective progression or relapse|0
875604|NCT00557856|1837672|FG003|Part 2: Exploratory Phase|objective progression or relapse|0
875605|NCT00557856|1837673|FG004|Part 2: Exploratory Phase|objective progression or relapse|0
875606|NCT00557856|1837674|FG005|Part 2: Exploratory Phase|objective progression or relapse|0
875607|NCT00557856|1837675|FG006|Part 2: Exploratory Phase|objective progression or relapse|0
875608|NCT00557856|1837676|FG007|Part 2: Exploratory Phase|objective progression or relapse|0
875609|NCT00557856|1837677|FG008|Part 2: Exploratory Phase|objective progression or relapse|15
875610|NCT00557856|1837669|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0
875611|NCT00557856|1837670|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0
875612|NCT00557856|1837671|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0
875613|NCT00557856|1837672|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0
875614|NCT00557856|1837673|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0
875615|NCT00557856|1837674|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0
875616|NCT00557856|1837675|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0
875617|NCT00557856|1837676|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0
875618|NCT00557856|1837677|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1
875619|NCT00557856|1837669|FG000|Part 2: Exploratory Phase|Adverse Event|0
875620|NCT00557856|1837670|FG001|Part 2: Exploratory Phase|Adverse Event|0
875621|NCT00557856|1837671|FG002|Part 2: Exploratory Phase|Adverse Event|0
1179858|NCT03135262|2337132|FG004|Overall Study|Withdrawal by Subject|1
1179859|NCT03135262|2337128|FG000|Overall Study|Study terminated by sponsor|2
1179860|NCT03135262|2337129|FG001|Overall Study|Study terminated by sponsor|4
1179861|NCT03135262|2337130|FG002|Overall Study|Study terminated by sponsor|4
875622|NCT00557856|1837672|FG003|Part 2: Exploratory Phase|Adverse Event|0
875623|NCT00557856|1837673|FG004|Part 2: Exploratory Phase|Adverse Event|0
875624|NCT00557856|1837674|FG005|Part 2: Exploratory Phase|Adverse Event|0
875625|NCT00557856|1837675|FG006|Part 2: Exploratory Phase|Adverse Event|0
875626|NCT00557856|1837676|FG007|Part 2: Exploratory Phase|Adverse Event|0
875627|NCT00557856|1837677|FG008|Part 2: Exploratory Phase|Adverse Event|4
875628|NCT00557856|1837669|FG000|Part 2: Exploratory Phase|Other|0
875629|NCT00557856|1837670|FG001|Part 2: Exploratory Phase|Other|0
875630|NCT00557856|1837671|FG002|Part 2: Exploratory Phase|Other|0
875631|NCT00557856|1837672|FG003|Part 2: Exploratory Phase|Other|0
875632|NCT00557856|1837673|FG004|Part 2: Exploratory Phase|Other|0
875633|NCT00557856|1837674|FG005|Part 2: Exploratory Phase|Other|0
875634|NCT00557856|1837675|FG006|Part 2: Exploratory Phase|Other|0
875635|NCT00557856|1837676|FG007|Part 2: Exploratory Phase|Other|0
875636|NCT00557856|1837677|FG008|Part 2: Exploratory Phase|Other|1
875637|NCT00557856|1837669|FG000|Part 2: Exploratory Phase|Death|0
875638|NCT00557856|1837670|FG001|Part 2: Exploratory Phase|Death|0
875639|NCT00557856|1837671|FG002|Part 2: Exploratory Phase|Death|0
875640|NCT00557856|1837672|FG003|Part 2: Exploratory Phase|Death|0
875641|NCT00557856|1837673|FG004|Part 2: Exploratory Phase|Death|0
875642|NCT00557856|1837674|FG005|Part 2: Exploratory Phase|Death|0
875643|NCT00557856|1837675|FG006|Part 2: Exploratory Phase|Death|0
875644|NCT00557856|1837676|FG007|Part 2: Exploratory Phase|Death|0
875645|NCT00557856|1837677|FG008|Part 2: Exploratory Phase|Death|2
875646|NCT00557856|1837669|FG000|Part 2: Exploratory Phase|global deterioration of health status|0
875647|NCT00557856|1837670|FG001|Part 2: Exploratory Phase|global deterioration of health status|0
875648|NCT00557856|1837671|FG002|Part 2: Exploratory Phase|global deterioration of health status|0
875649|NCT00557856|1837672|FG003|Part 2: Exploratory Phase|global deterioration of health status|0
875650|NCT00557856|1837673|FG004|Part 2: Exploratory Phase|global deterioration of health status|0
875651|NCT00557856|1837674|FG005|Part 2: Exploratory Phase|global deterioration of health status|0
875652|NCT00557856|1837675|FG006|Part 2: Exploratory Phase|global deterioration of health status|0
875653|NCT00557856|1837676|FG007|Part 2: Exploratory Phase|global deterioration of health status|0
875654|NCT00557856|1837677|FG008|Part 2: Exploratory Phase|global deterioration of health status|1
875655|NCT00558025|1837720|FG000|Overall Study|Adverse Event|1
875656|NCT00558025|1837721|FG001|Overall Study|Adverse Event|1
875657|NCT00558025|1837720|FG000|Overall Study|Withdrawal by Subject|2
875658|NCT00558025|1837721|FG001|Overall Study|Withdrawal by Subject|2
875659|NCT00558025|1837720|FG000|Overall Study|Protocol Violation|1
875660|NCT00558025|1837721|FG001|Overall Study|Protocol Violation|0
875661|NCT00558064|1837729|FG000|Overall Study|Adverse Event|3
875662|NCT00558064|1837730|FG001|Overall Study|Adverse Event|2
875663|NCT00558064|1837729|FG000|Overall Study|Lack of Efficacy|0
875664|NCT00558064|1837730|FG001|Overall Study|Lack of Efficacy|1
875665|NCT00558064|1837729|FG000|Overall Study|Protocol Violation|1
875666|NCT00558064|1837730|FG001|Overall Study|Protocol Violation|0
875667|NCT00558064|1837729|FG000|Overall Study|Lost to Follow-up|0
875668|NCT00558064|1837730|FG001|Overall Study|Lost to Follow-up|1
875669|NCT00558064|1837729|FG000|Overall Study|Withdrawal by Subject|0
875670|NCT00558064|1837730|FG001|Overall Study|Withdrawal by Subject|1
875671|NCT00558064|1837729|FG000|Overall Study|No visit within allowance period|1
875672|NCT00558064|1837730|FG001|Overall Study|No visit within allowance period|0
875673|NCT00558103|1837741|FG000|Randomized Treatment Phase|Lost to Follow-up|2
875674|NCT00558103|1837742|FG001|Randomized Treatment Phase|Lost to Follow-up|2
875675|NCT00558103|1837743|FG002|Randomized Treatment Phase|Lost to Follow-up|2
875676|NCT00558103|1837744|FG003|Randomized Treatment Phase|Lost to Follow-up|1
875677|NCT00558103|1837745|FG004|Randomized Treatment Phase|Lost to Follow-up|3
875678|NCT00558103|1837746|FG005|Randomized Treatment Phase|Lost to Follow-up|0
875679|NCT00558103|1837741|FG000|Randomized Treatment Phase|Withdrawal by Subject|2
875680|NCT00558103|1837742|FG001|Randomized Treatment Phase|Withdrawal by Subject|2
875681|NCT00558103|1837743|FG002|Randomized Treatment Phase|Withdrawal by Subject|0
875682|NCT00558103|1837744|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
875683|NCT00558103|1837745|FG004|Randomized Treatment Phase|Withdrawal by Subject|1
875684|NCT00558103|1837746|FG005|Randomized Treatment Phase|Withdrawal by Subject|0
875685|NCT00558103|1837741|FG000|Randomized Treatment Phase|Disease Progression|1
875686|NCT00558103|1837742|FG001|Randomized Treatment Phase|Disease Progression|0
875687|NCT00558103|1837743|FG002|Randomized Treatment Phase|Disease Progression|1
875688|NCT00558103|1837744|FG003|Randomized Treatment Phase|Disease Progression|0
875689|NCT00558103|1837745|FG004|Randomized Treatment Phase|Disease Progression|0
875690|NCT00558103|1837746|FG005|Randomized Treatment Phase|Disease Progression|0
875691|NCT00558103|1837741|FG000|Randomized Treatment Phase|Adverse Event|0
875692|NCT00558103|1837742|FG001|Randomized Treatment Phase|Adverse Event|0
875693|NCT00558103|1837743|FG002|Randomized Treatment Phase|Adverse Event|0
875694|NCT00558103|1837744|FG003|Randomized Treatment Phase|Adverse Event|1
875695|NCT00558103|1837745|FG004|Randomized Treatment Phase|Adverse Event|1
875696|NCT00558103|1837746|FG005|Randomized Treatment Phase|Adverse Event|0
875697|NCT00558103|1837741|FG000|Monotherapy Extension Phase|Protocol Violation|0
875698|NCT00558103|1837742|FG001|Monotherapy Extension Phase|Protocol Violation|0
875699|NCT00558103|1837743|FG002|Monotherapy Extension Phase|Protocol Violation|0
875700|NCT00558103|1837744|FG003|Monotherapy Extension Phase|Protocol Violation|0
875701|NCT00558103|1837745|FG004|Monotherapy Extension Phase|Protocol Violation|0
875702|NCT00558103|1837746|FG005|Monotherapy Extension Phase|Protocol Violation|1
875703|NCT00558103|1837741|FG000|Monotherapy Extension Phase|Disease Progression|0
875704|NCT00558103|1837742|FG001|Monotherapy Extension Phase|Disease Progression|0
875705|NCT00558103|1837743|FG002|Monotherapy Extension Phase|Disease Progression|0
875706|NCT00558103|1837744|FG003|Monotherapy Extension Phase|Disease Progression|0
875707|NCT00558103|1837745|FG004|Monotherapy Extension Phase|Disease Progression|0
875708|NCT00558103|1837746|FG005|Monotherapy Extension Phase|Disease Progression|8
875709|NCT00558259|1837768|FG000|Overall Study|Adverse Event|50
875710|NCT00558259|1837769|FG001|Overall Study|Adverse Event|81
875711|NCT00558259|1837768|FG000|Overall Study|Protocol Violation|9
875712|NCT00558259|1837769|FG001|Overall Study|Protocol Violation|5
875713|NCT00558259|1837768|FG000|Overall Study|Withdrawal by Subject|12
875714|NCT00558259|1837769|FG001|Overall Study|Withdrawal by Subject|13
875715|NCT00558272|1837777|FG000|Overall Study|Adverse Event|10
875716|NCT00558272|1837778|FG001|Overall Study|Adverse Event|0
875717|NCT00558272|1837777|FG000|Overall Study|Death|1
875718|NCT00558272|1837778|FG001|Overall Study|Death|0
875719|NCT00558272|1837777|FG000|Overall Study|Dev. of study specific discon. criteria|1
875720|NCT00558272|1837778|FG001|Overall Study|Dev. of study specific discon. criteria|0
875721|NCT00558272|1837777|FG000|Overall Study|AZ study team decision|0
875722|NCT00558272|1837778|FG001|Overall Study|AZ study team decision|1
875723|NCT00558272|1837777|FG000|Overall Study|Incorrectly enrolled|1
875724|NCT00558272|1837778|FG001|Overall Study|Incorrectly enrolled|0
875725|NCT00558272|1837777|FG000|Overall Study|Withdrawal by Subject|0
875726|NCT00558272|1837778|FG001|Overall Study|Withdrawal by Subject|1
875727|NCT00558285|1837789|FG000|Overall Study|Adverse Event|1
875728|NCT00558285|1837790|FG001|Overall Study|Adverse Event|1
875729|NCT00558285|1837791|FG002|Overall Study|Adverse Event|4
875730|NCT00558285|1837792|FG003|Overall Study|Adverse Event|1
875731|NCT00558285|1837793|FG004|Overall Study|Adverse Event|2
875732|NCT00558285|1837789|FG000|Overall Study|Abnormal test procedure result(s)|1
875733|NCT00558285|1837790|FG001|Overall Study|Abnormal test procedure result(s)|0
875734|NCT00558285|1837791|FG002|Overall Study|Abnormal test procedure result(s)|0
875735|NCT00558285|1837792|FG003|Overall Study|Abnormal test procedure result(s)|0
875736|NCT00558285|1837793|FG004|Overall Study|Abnormal test procedure result(s)|0
875737|NCT00558285|1837789|FG000|Overall Study|Subject withdrew consent|2
875738|NCT00558285|1837790|FG001|Overall Study|Subject withdrew consent|0
875739|NCT00558285|1837791|FG002|Overall Study|Subject withdrew consent|1
875740|NCT00558285|1837792|FG003|Overall Study|Subject withdrew consent|1
875741|NCT00558285|1837793|FG004|Overall Study|Subject withdrew consent|1
875742|NCT00558285|1837789|FG000|Overall Study|Lost to Follow-up|1
875743|NCT00558285|1837790|FG001|Overall Study|Lost to Follow-up|1
875744|NCT00558285|1837791|FG002|Overall Study|Lost to Follow-up|0
875745|NCT00558285|1837792|FG003|Overall Study|Lost to Follow-up|0
875746|NCT00558285|1837793|FG004|Overall Study|Lost to Follow-up|0
875747|NCT00558285|1837789|FG000|Overall Study|Administrative problems|0
875748|NCT00558285|1837790|FG001|Overall Study|Administrative problems|0
875749|NCT00558285|1837791|FG002|Overall Study|Administrative problems|0
875750|NCT00558285|1837792|FG003|Overall Study|Administrative problems|1
875751|NCT00558285|1837793|FG004|Overall Study|Administrative problems|1
875752|NCT00558285|1837789|FG000|Overall Study|Protocol deviation|1
875753|NCT00558285|1837790|FG001|Overall Study|Protocol deviation|1
875754|NCT00558285|1837791|FG002|Overall Study|Protocol deviation|0
875755|NCT00558285|1837792|FG003|Overall Study|Protocol deviation|1
875756|NCT00558285|1837793|FG004|Overall Study|Protocol deviation|0
875757|NCT00558363|1837807|FG000|Overall Study|Physician Decision|18
875758|NCT00558363|1837808|FG001|Overall Study|Physician Decision|4
875759|NCT00558363|1837807|FG000|Overall Study|Withdrawal by Subject|11
875760|NCT00558363|1837808|FG001|Overall Study|Withdrawal by Subject|4
875761|NCT00558363|1837807|FG000|Overall Study|Adverse Event|5
875762|NCT00558363|1837808|FG001|Overall Study|Adverse Event|5
875763|NCT00558363|1837807|FG000|Overall Study|Lack of Efficacy|2
875764|NCT00558363|1837808|FG001|Overall Study|Lack of Efficacy|2
875765|NCT00558363|1837807|FG000|Overall Study|Protocol Violation|2
875766|NCT00558363|1837808|FG001|Overall Study|Protocol Violation|1
875767|NCT00558363|1837807|FG000|Overall Study|Lost to Follow-up|0
875768|NCT00558363|1837808|FG001|Overall Study|Lost to Follow-up|1
875769|NCT00558363|1837807|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32
875770|NCT00558363|1837808|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16
875771|NCT00558363|1837807|FG000|Overall Study|Randomized in Error|1
875772|NCT00558363|1837808|FG001|Overall Study|Randomized in Error|2
875773|NCT00558363|1837807|FG000|Overall Study|Hospitalized; Unable to Continue|0
875774|NCT00558363|1837808|FG001|Overall Study|Hospitalized; Unable to Continue|1
875775|NCT00558428|1837818|FG000|Overall Study|Adverse Event|6
875776|NCT00558428|1837819|FG001|Overall Study|Adverse Event|22
875777|NCT00558428|1837820|FG002|Overall Study|Adverse Event|3
875778|NCT00558428|1837821|FG003|Overall Study|Adverse Event|4
875779|NCT00558428|1837818|FG000|Overall Study|Lost to Follow-up|0
875780|NCT00558428|1837819|FG001|Overall Study|Lost to Follow-up|1
1179862|NCT03135262|2337131|FG003|Overall Study|Study terminated by sponsor|3
1179863|NCT03135262|2337132|FG004|Overall Study|Study terminated by sponsor|0
1179864|NCT03104075|2337164|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1
1179865|NCT03104075|2337165|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0
875781|NCT00558428|1837820|FG002|Overall Study|Lost to Follow-up|0
875782|NCT00558428|1837821|FG003|Overall Study|Lost to Follow-up|0
875783|NCT00558428|1837818|FG000|Overall Study|Lack of Efficacy|0
875784|NCT00558428|1837819|FG001|Overall Study|Lack of Efficacy|0
875785|NCT00558428|1837820|FG002|Overall Study|Lack of Efficacy|1
875786|NCT00558428|1837821|FG003|Overall Study|Lack of Efficacy|2
875787|NCT00558428|1837818|FG000|Overall Study|Non compliant with protocol|1
875788|NCT00558428|1837819|FG001|Overall Study|Non compliant with protocol|0
875789|NCT00558428|1837820|FG002|Overall Study|Non compliant with protocol|0
875790|NCT00558428|1837821|FG003|Overall Study|Non compliant with protocol|3
875791|NCT00558428|1837818|FG000|Overall Study|Consent withdrawn|2
875792|NCT00558428|1837819|FG001|Overall Study|Consent withdrawn|1
875793|NCT00558428|1837820|FG002|Overall Study|Consent withdrawn|0
875794|NCT00558428|1837821|FG003|Overall Study|Consent withdrawn|1
875795|NCT00558428|1837818|FG000|Overall Study|Other|3
875796|NCT00558428|1837819|FG001|Overall Study|Other|0
875797|NCT00558428|1837820|FG002|Overall Study|Other|0
875798|NCT00558428|1837821|FG003|Overall Study|Other|1
875799|NCT00558467|1837833|FG000|Overall Study|Adverse Event|1
875800|NCT00558467|1837834|FG001|Overall Study|Adverse Event|2
875801|NCT00558467|1837833|FG000|Overall Study|Lack of Efficacy|0
875802|NCT00558467|1837834|FG001|Overall Study|Lack of Efficacy|1
875803|NCT00558467|1837833|FG000|Overall Study|Patient moving out of state|0
875804|NCT00558467|1837834|FG001|Overall Study|Patient moving out of state|1
875805|NCT00558519|1837840|FG000|Overall Study|Ph+|20
875806|NCT00558519|1837840|FG000|Overall Study|Ineligible|1
875807|NCT00558519|1837840|FG000|Overall Study|Insufficient data|1
875808|NCT00558519|1837840|FG000|Overall Study|Never received treatment|1
875809|NCT00558636|1837874|FG000|Treatment|Adverse Event|9
875810|NCT00558636|1837875|FG001|Treatment|Adverse Event|2
875811|NCT00558636|1837874|FG000|Treatment|Withdrawal by Subject|2
875812|NCT00558636|1837875|FG001|Treatment|Withdrawal by Subject|0
875813|NCT00558636|1837874|FG000|Treatment|Premature termination of the study|35
875814|NCT00558636|1837875|FG001|Treatment|Premature termination of the study|37
875815|NCT00558636|1837874|FG000|Treatment|Disease progression|1
875816|NCT00558636|1837875|FG001|Treatment|Disease progression|5
875817|NCT00558636|1837874|FG000|Follow-up|Premature termination of the study|12
875818|NCT00558636|1837875|FG001|Follow-up|Premature termination of the study|7
875819|NCT00558701|1837883|FG000|Overall Study|Protocol Deviations|1
875820|NCT00558701|1837884|FG001|Overall Study|Protocol Deviations|4
875821|NCT00558753|1837892|FG000|Overall Study|Lost to Follow-up|5
875822|NCT00558753|1837893|FG001|Overall Study|Lost to Follow-up|7
875823|NCT00558831|1837915|FG000|Overall Study|Lost to Follow-up|1
875824|NCT00558896|1837950|FG000|Overall Study|Adverse Event|1
875825|NCT00558896|1837951|FG001|Overall Study|Adverse Event|1
875826|NCT00558896|1837952|FG002|Overall Study|Adverse Event|1
875827|NCT00558896|1837953|FG003|Overall Study|Adverse Event|3
875828|NCT00558896|1837954|FG004|Overall Study|Adverse Event|4
875829|NCT00558896|1837955|FG005|Overall Study|Adverse Event|10
875830|NCT00558896|1837956|FG006|Overall Study|Adverse Event|3
875831|NCT00558896|1837950|FG000|Overall Study|Death|3
875832|NCT00558896|1837951|FG001|Overall Study|Death|0
875833|NCT00558896|1837952|FG002|Overall Study|Death|2
875834|NCT00558896|1837953|FG003|Overall Study|Death|3
875835|NCT00558896|1837954|FG004|Overall Study|Death|2
875836|NCT00558896|1837955|FG005|Overall Study|Death|2
875837|NCT00558896|1837956|FG006|Overall Study|Death|6
875838|NCT00558896|1837950|FG000|Overall Study|Withdrawal by Subject|2
875839|NCT00558896|1837951|FG001|Overall Study|Withdrawal by Subject|1
875840|NCT00558896|1837952|FG002|Overall Study|Withdrawal by Subject|1
875841|NCT00558896|1837953|FG003|Overall Study|Withdrawal by Subject|1
875842|NCT00558896|1837954|FG004|Overall Study|Withdrawal by Subject|1
875843|NCT00558896|1837955|FG005|Overall Study|Withdrawal by Subject|5
875844|NCT00558896|1837956|FG006|Overall Study|Withdrawal by Subject|5
875845|NCT00558896|1837950|FG000|Overall Study|Alternative Treatment|2
875846|NCT00558896|1837951|FG001|Overall Study|Alternative Treatment|2
875847|NCT00558896|1837952|FG002|Overall Study|Alternative Treatment|0
875848|NCT00558896|1837953|FG003|Overall Study|Alternative Treatment|2
875849|NCT00558896|1837954|FG004|Overall Study|Alternative Treatment|6
875850|NCT00558896|1837955|FG005|Overall Study|Alternative Treatment|7
875851|NCT00558896|1837956|FG006|Overall Study|Alternative Treatment|1
875852|NCT00558896|1837950|FG000|Overall Study|Physician discretion|3
1179886|NCT03038087|2337190|FG000|Overall Study|lost data|1
1179887|NCT02662985|2337230|FG000|Treatment Period 1|Adverse Event|0
1179888|NCT02662985|2337231|FG001|Treatment Period 1|Adverse Event|2
1179889|NCT02662985|2337230|FG000|Treatment Period 1|Protocol Violation|0
1179890|NCT02662985|2337231|FG001|Treatment Period 1|Protocol Violation|1
1179891|NCT02662985|2337230|FG000|Treatment Period 1|Physician Decision|1
1179892|NCT02662985|2337231|FG001|Treatment Period 1|Physician Decision|0
1179893|NCT02662985|2337230|FG000|Treatment Period 1|Withdrawal by Subject|0
1179894|NCT02662985|2337231|FG001|Treatment Period 1|Withdrawal by Subject|1
1179895|NCT02662985|2337230|FG000|Treatment Period 2|Lack of Efficacy|0
1179896|NCT02662985|2337231|FG001|Treatment Period 2|Lack of Efficacy|1
1179897|NCT02662985|2337230|FG000|Treatment Period 2|Lost to Follow-up|1
1179898|NCT02662985|2337231|FG001|Treatment Period 2|Lost to Follow-up|0
1179899|NCT02662985|2337230|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
1179900|NCT02662985|2337231|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
1179901|NCT02662985|2337230|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1
875853|NCT00558896|1837951|FG001|Overall Study|Physician discretion|2
875854|NCT00558896|1837952|FG002|Overall Study|Physician discretion|1
875855|NCT00558896|1837953|FG003|Overall Study|Physician discretion|2
875856|NCT00558896|1837954|FG004|Overall Study|Physician discretion|1
875857|NCT00558896|1837955|FG005|Overall Study|Physician discretion|3
875858|NCT00558896|1837956|FG006|Overall Study|Physician discretion|3
875859|NCT00558896|1837950|FG000|Overall Study|Continues on treatment|10
875860|NCT00558896|1837951|FG001|Overall Study|Continues on treatment|1
875861|NCT00558896|1837952|FG002|Overall Study|Continues on treatment|0
875862|NCT00558896|1837953|FG003|Overall Study|Continues on treatment|1
875863|NCT00558896|1837954|FG004|Overall Study|Continues on treatment|9
875864|NCT00558896|1837955|FG005|Overall Study|Continues on treatment|25
875865|NCT00558896|1837956|FG006|Overall Study|Continues on treatment|6
875866|NCT00559104|1837978|FG000|Overall Study|Lack of Efficacy|9
875867|NCT00559104|1837979|FG001|Overall Study|Lack of Efficacy|0
875868|NCT00559273|1837987|FG000|Correction Period (20 Weeks)|Death|3
875869|NCT00559273|1837988|FG001|Correction Period (20 Weeks)|Death|4
875870|NCT00559273|1837987|FG000|Correction Period (20 Weeks)|Adverse Event|2
875871|NCT00559273|1837988|FG001|Correction Period (20 Weeks)|Adverse Event|1
875872|NCT00559273|1837987|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2
875873|NCT00559273|1837988|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6
875874|NCT00559273|1837987|FG000|Correction Period (20 Weeks)|Participant treated by another center|0
875875|NCT00559273|1837988|FG001|Correction Period (20 Weeks)|Participant treated by another center|1
875876|NCT00559273|1837987|FG000|Correction Period (20 Weeks)|Did not received study treatment|2
875877|NCT00559273|1837988|FG001|Correction Period (20 Weeks)|Did not received study treatment|0
875878|NCT00559273|1837987|FG000|Evaluation Period (8 Weeks)|Death|1
875879|NCT00559273|1837988|FG001|Evaluation Period (8 Weeks)|Death|3
875880|NCT00559273|1837987|FG000|Evaluation Period (8 Weeks)|Adverse Event|0
875881|NCT00559273|1837988|FG001|Evaluation Period (8 Weeks)|Adverse Event|1
875882|NCT00559273|1837987|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
875883|NCT00559273|1837988|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
875884|NCT00559273|1837987|FG000|Evaluation Period (8 Weeks)|Physician Decision|0
875885|NCT00559273|1837988|FG001|Evaluation Period (8 Weeks)|Physician Decision|1
875886|NCT00559364|1837996|FG000|Overall Study|Inclusion/exclusion criteria failure|1
875887|NCT00559364|1837997|FG001|Overall Study|Inclusion/exclusion criteria failure|0
875888|NCT00559377|1838003|FG000|Overall Study|Withdrawal by Subject|9
875889|NCT00559507|1838019|FG000|Overall Study|Not treated, patient ineligible|3
875890|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Adverse Event|17
875891|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Adverse Event|25
875892|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11
875893|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5
875894|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0
875895|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6
875896|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
875897|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
875898|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Death|1
875899|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Death|1
875900|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
875901|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
1179902|NCT02662985|2337231|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1
1179903|NCT02662985|2337230|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0
1179904|NCT02662985|2337231|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1
1179905|NCT02662985|2337230|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1
1179906|NCT02662985|2337231|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2
1179907|NCT02662985|2337230|FG000|Treatment Period 3 (Extension Period)|Death|0
1179908|NCT02662985|2337231|FG001|Treatment Period 3 (Extension Period)|Death|1
1179909|NCT02606461|2337241|FG000|Overall Study|Withdrawal by Subject|3
1179910|NCT02606461|2337242|FG001|Overall Study|Withdrawal by Subject|2
1179911|NCT02606461|2337243|FG002|Overall Study|Withdrawal by Subject|14
1179912|NCT02606461|2337244|FG003|Overall Study|Withdrawal by Subject|11
1179913|NCT02606461|2337241|FG000|Overall Study|Death|16
1179914|NCT02606461|2337242|FG001|Overall Study|Death|25
1179915|NCT02606461|2337243|FG002|Overall Study|Death|105
1179916|NCT02606461|2337244|FG003|Overall Study|Death|58
1179917|NCT02606461|2337241|FG000|Overall Study|Lost to Follow-up|2
1179918|NCT02606461|2337242|FG001|Overall Study|Lost to Follow-up|2
1179919|NCT02606461|2337243|FG002|Overall Study|Lost to Follow-up|4
1179920|NCT02606461|2337244|FG003|Overall Study|Lost to Follow-up|1
1179921|NCT02606461|2337241|FG000|Overall Study|Physician Decision|0
1179922|NCT02606461|2337242|FG001|Overall Study|Physician Decision|0
1179923|NCT02606461|2337243|FG002|Overall Study|Physician Decision|1
1179924|NCT02606461|2337244|FG003|Overall Study|Physician Decision|1
875902|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6
875903|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1
875904|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3
875905|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0
875906|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Missed Doses|0
875907|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Missed Doses|1
875908|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0
875909|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1
875910|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
875911|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
875912|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Early Discontinuation|0
875913|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Early Discontinuation|1
875914|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1
875915|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0
875916|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
875917|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
875918|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Investigator Decision|0
875919|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Investigator Decision|1
875920|NCT00559585|1838025|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1
875921|NCT00559585|1838026|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0
875922|NCT00559585|1838025|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
875923|NCT00559585|1838026|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
875924|NCT00559585|1838025|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100
875925|NCT00559585|1838026|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0
875926|NCT00559585|1838025|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
875927|NCT00559585|1838026|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
875928|NCT00559585|1838025|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16
875929|NCT00559585|1838026|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0
875930|NCT00559585|1838025|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
875931|NCT00559585|1838026|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
875932|NCT00559585|1838025|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
875933|NCT00559585|1838026|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
875934|NCT00559585|1838025|FG000|Open Label LT Period Main + Sub-Study|Death|20
875935|NCT00559585|1838026|FG001|Open Label LT Period Main + Sub-Study|Death|0
875936|NCT00559585|1838025|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1
875937|NCT00559585|1838026|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0
875938|NCT00559585|1838025|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
875939|NCT00559585|1838026|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
875940|NCT00559585|1838025|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
875941|NCT00559585|1838026|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
875942|NCT00559585|1838025|FG000|Open Label LT Period Main + Sub-Study|non-specified|71
875943|NCT00559585|1838026|FG001|Open Label LT Period Main + Sub-Study|non-specified|0
875944|NCT00559585|1838025|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1
875945|NCT00559585|1838026|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0
875946|NCT00559637|1838043|FG000|Overall Study|Adverse Event|22
875947|NCT00559637|1838043|FG000|Overall Study|Withdrawal by Subject|4
875948|NCT00559637|1838043|FG000|Overall Study|Protocol Violation|6
875949|NCT00559637|1838043|FG000|Overall Study|Withdrawal criteria fulfilled|4
875950|NCT00559637|1838043|FG000|Overall Study|Failure to return|6
875951|NCT00559637|1838043|FG000|Overall Study|Insufficient response|3
875952|NCT00559637|1838043|FG000|Overall Study|Started requiring dialysis after month 7|2
875953|NCT00559637|1838043|FG000|Overall Study|Suspected lung cancer|1
1179925|NCT02606461|2337241|FG000|Overall Study|Disease Progression|1
1179926|NCT02606461|2337242|FG001|Overall Study|Disease Progression|0
1179927|NCT02606461|2337243|FG002|Overall Study|Disease Progression|0
1179928|NCT02606461|2337244|FG003|Overall Study|Disease Progression|0
1179929|NCT02606461|2337241|FG000|Overall Study|No treatment|0
1179930|NCT02606461|2337242|FG001|Overall Study|No treatment|0
1179931|NCT02606461|2337243|FG002|Overall Study|No treatment|1
1179932|NCT02606461|2337244|FG003|Overall Study|No treatment|0
1179933|NCT02606461|2337241|FG000|Overall Study|Ongoing|5
1179934|NCT02606461|2337242|FG001|Overall Study|Ongoing|1
1179935|NCT02606461|2337243|FG002|Overall Study|Ongoing|63
1179936|NCT02606461|2337244|FG003|Overall Study|Ongoing|26
1179937|NCT02536339|2337257|FG000|Overall Study|Death|20
1179938|NCT02536339|2337257|FG000|Overall Study|Withdrawal by Subject|3
1179939|NCT02536339|2337257|FG000|Overall Study|Lost to Follow-up|2
1179940|NCT02536339|2337257|FG000|Overall Study|Treatment discontinued|2
1179941|NCT02536339|2337257|FG000|Overall Study|Physician Decision|1
1179942|NCT02514083|2337261|FG000|Overall Study|Adverse Event|1
875954|NCT00559637|1838043|FG000|Overall Study|Participation in another study|1
875955|NCT00559637|1838043|FG000|Overall Study|Delayed administration of C.E.R.A|1
875956|NCT00559637|1838043|FG000|Overall Study|Change of center|1
875957|NCT00559637|1838043|FG000|Overall Study|Change of home|1
875958|NCT00559637|1838043|FG000|Overall Study|Inclusion or exclusion criteria violated|2
875959|NCT00559754|1838047|FG000|Overall Study|Disease progression|1
875960|NCT00559754|1838047|FG000|Overall Study|Adverse Event|5
875961|NCT00559754|1838047|FG000|Overall Study|Protocol Violation|1
875962|NCT00559754|1838047|FG000|Overall Study|Investigator criteria|2
875963|NCT00559754|1838047|FG000|Overall Study|Withdrawal by Subject|2
875964|NCT00559845|1838051|FG000|Overall Study|Withdrew Consent|1
875965|NCT00559845|1838051|FG000|Overall Study|Disease Progression|1
875966|NCT00559845|1838051|FG000|Overall Study|Adverse Event|3
875967|NCT00559845|1838051|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
875968|NCT00559845|1838051|FG000|Overall Study|Premature Surgery-Investigator Decision|1
875969|NCT00559949|1838059|FG000|Overall Study|Progressive Disease during cycle 1|1
875970|NCT00559949|1838059|FG000|Overall Study|Adverse Event|1
875971|NCT00559949|1838059|FG000|Overall Study|Withdrawal by Subject|4
875972|NCT00559949|1838059|FG000|Overall Study|No disease evaluation per protocol|1
875973|NCT00559962|1838071|FG000|Overall Study|Adverse Event|1
875974|NCT00559962|1838072|FG001|Overall Study|Adverse Event|7
875975|NCT00559962|1838073|FG002|Overall Study|Adverse Event|8
875976|NCT00559962|1838074|FG003|Overall Study|Adverse Event|5
875977|NCT00559962|1838075|FG004|Overall Study|Adverse Event|11
875978|NCT00559962|1838076|FG005|Overall Study|Adverse Event|4
875979|NCT00559962|1838077|FG006|Overall Study|Adverse Event|4
875980|NCT00559962|1838078|FG007|Overall Study|Adverse Event|2
875981|NCT00559962|1838071|FG000|Overall Study|Lost to Follow-up|0
875982|NCT00559962|1838072|FG001|Overall Study|Lost to Follow-up|1
875983|NCT00559962|1838073|FG002|Overall Study|Lost to Follow-up|0
875984|NCT00559962|1838074|FG003|Overall Study|Lost to Follow-up|0
875985|NCT00559962|1838075|FG004|Overall Study|Lost to Follow-up|0
875986|NCT00559962|1838076|FG005|Overall Study|Lost to Follow-up|0
875987|NCT00559962|1838077|FG006|Overall Study|Lost to Follow-up|0
875988|NCT00559962|1838078|FG007|Overall Study|Lost to Follow-up|0
875989|NCT00559962|1838071|FG000|Overall Study|Withdrawal by Subject|1
875990|NCT00559962|1838072|FG001|Overall Study|Withdrawal by Subject|1
875991|NCT00559962|1838073|FG002|Overall Study|Withdrawal by Subject|2
875992|NCT00559962|1838074|FG003|Overall Study|Withdrawal by Subject|0
875993|NCT00559962|1838075|FG004|Overall Study|Withdrawal by Subject|3
875994|NCT00559962|1838076|FG005|Overall Study|Withdrawal by Subject|1
875995|NCT00559962|1838077|FG006|Overall Study|Withdrawal by Subject|0
875996|NCT00559962|1838078|FG007|Overall Study|Withdrawal by Subject|2
875997|NCT00559962|1838071|FG000|Overall Study|Inclusion/exclusion criteria not met|0
875998|NCT00559962|1838072|FG001|Overall Study|Inclusion/exclusion criteria not met|0
875999|NCT00559962|1838073|FG002|Overall Study|Inclusion/exclusion criteria not met|0
876000|NCT00559962|1838074|FG003|Overall Study|Inclusion/exclusion criteria not met|0
876001|NCT00559962|1838075|FG004|Overall Study|Inclusion/exclusion criteria not met|0
876002|NCT00559962|1838076|FG005|Overall Study|Inclusion/exclusion criteria not met|0
876003|NCT00559962|1838077|FG006|Overall Study|Inclusion/exclusion criteria not met|1
876004|NCT00559962|1838078|FG007|Overall Study|Inclusion/exclusion criteria not met|0
876005|NCT00559988|1838099|FG000|Overall Study|Death|147
876006|NCT00559988|1838100|FG001|Overall Study|Death|140
876007|NCT00559988|1838099|FG000|Overall Study|Withdrawal by Subject|152
876008|NCT00559988|1838100|FG001|Overall Study|Withdrawal by Subject|139
876009|NCT00559988|1838099|FG000|Overall Study|Lost to Follow-up|42
876010|NCT00559988|1838100|FG001|Overall Study|Lost to Follow-up|56
876011|NCT00559988|1838099|FG000|Overall Study|ICD device explanted|10
876012|NCT00559988|1838100|FG001|Overall Study|ICD device explanted|17
876013|NCT00560066|1838108|FG000|Overall Study|Death|2
876014|NCT00560066|1838109|FG001|Overall Study|Death|1
876015|NCT00560066|1838108|FG000|Overall Study|Withdrawal by Subject|0
876016|NCT00560066|1838109|FG001|Overall Study|Withdrawal by Subject|3
876017|NCT00560066|1838108|FG000|Overall Study|Lost to Follow-up|4
876018|NCT00560066|1838109|FG001|Overall Study|Lost to Follow-up|10
876019|NCT00560066|1838108|FG000|Overall Study|Protocol Violation|0
876020|NCT00560066|1838109|FG001|Overall Study|Protocol Violation|1
876021|NCT00560066|1838108|FG000|Overall Study|Administrative reason|0
876022|NCT00560066|1838109|FG001|Overall Study|Administrative reason|5
876023|NCT00560066|1838108|FG000|Overall Study|Missing primary reason|0
876024|NCT00560066|1838109|FG001|Overall Study|Missing primary reason|2
876025|NCT00560105|1838122|FG000|Overall Study|musculoskeletal chest discomfort with us|1
876026|NCT00560105|1838123|FG001|Overall Study|musculoskeletal chest discomfort with us|2
876027|NCT00560235|1838132|FG000|Phase 1|Discontinued|8
876028|NCT00560235|1838133|FG001|Phase 1|Discontinued|0
876029|NCT00560235|1838134|FG002|Phase 1|Discontinued|0
876030|NCT00560235|1838132|FG000|Phase 1B|Discontinued|0
876031|NCT00560235|1838133|FG001|Phase 1B|Discontinued|19
876032|NCT00560235|1838134|FG002|Phase 1B|Discontinued|0
876033|NCT00560235|1838132|FG000|Phase 2|Discontinued|0
876034|NCT00560235|1838133|FG001|Phase 2|Discontinued|0
876035|NCT00560235|1838134|FG002|Phase 2|Discontinued|96
876036|NCT00560235|1838132|FG000|Phase 2|Ongoing at Date of Cut-Off|0
876037|NCT00560235|1838133|FG001|Phase 2|Ongoing at Date of Cut-Off|0
876038|NCT00560235|1838134|FG002|Phase 2|Ongoing at Date of Cut-Off|1
876039|NCT00560313|1838152|FG000|Overall Study|Adverse Events or Death|2
876040|NCT00560313|1838152|FG000|Overall Study|Withdrawal by Subject|2
876041|NCT00560313|1838152|FG000|Overall Study|Lost to Follow-up|1
876042|NCT00560313|1838152|FG000|Overall Study|Protocol Violation|1
876043|NCT00560352|1838174|FG000|Overall Study|Adverse event unrelated to study drug|2
876044|NCT00560352|1838175|FG001|Overall Study|Adverse event unrelated to study drug|1
876045|NCT00560352|1838176|FG002|Overall Study|Adverse event unrelated to study drug|1
876046|NCT00560352|1838174|FG000|Overall Study|Study drug toxicity|3
876047|NCT00560352|1838175|FG001|Overall Study|Study drug toxicity|0
876048|NCT00560352|1838176|FG002|Overall Study|Study drug toxicity|1
876049|NCT00560352|1838174|FG000|Overall Study|Disease progression|0
876050|NCT00560352|1838175|FG001|Overall Study|Disease progression|1
876051|NCT00560352|1838176|FG002|Overall Study|Disease progression|1
876052|NCT00560352|1838174|FG000|Overall Study|Withdrawal by Subject|1
876053|NCT00560352|1838175|FG001|Overall Study|Withdrawal by Subject|1
876054|NCT00560352|1838176|FG002|Overall Study|Withdrawal by Subject|1
876055|NCT00560352|1838174|FG000|Overall Study|Maximum clinical benefit|1
876056|NCT00560352|1838175|FG001|Overall Study|Maximum clinical benefit|0
876057|NCT00560352|1838176|FG002|Overall Study|Maximum clinical benefit|0
876058|NCT00560391|1838193|FG000|Overall Study|Still on treatment|0
876059|NCT00560391|1838194|FG001|Overall Study|Still on treatment|0
876060|NCT00560391|1838195|FG002|Overall Study|Still on treatment|0
876061|NCT00560391|1838196|FG003|Overall Study|Still on treatment|1
876062|NCT00560391|1838197|FG004|Overall Study|Still on treatment|2
876063|NCT00560404|1838212|FG000|Overall Study|Adverse Event|2
876064|NCT00560404|1838213|FG001|Overall Study|Adverse Event|3
876065|NCT00560404|1838212|FG000|Overall Study|Death|3
876066|NCT00560404|1838213|FG001|Overall Study|Death|3
876067|NCT00560404|1838212|FG000|Overall Study|Protocol Violation|12
876068|NCT00560404|1838213|FG001|Overall Study|Protocol Violation|7
876069|NCT00560404|1838212|FG000|Overall Study|Administrative Reasons|1
876070|NCT00560404|1838213|FG001|Overall Study|Administrative Reasons|1
876071|NCT00560404|1838212|FG000|Overall Study|Withdrew Consent|4
876072|NCT00560404|1838213|FG001|Overall Study|Withdrew Consent|0
876073|NCT00560404|1838212|FG000|Overall Study|Failure to return|1
876074|NCT00560404|1838213|FG001|Overall Study|Failure to return|2
876075|NCT00560404|1838212|FG000|Overall Study|Other withdrawal reason|13
876076|NCT00560404|1838213|FG001|Overall Study|Other withdrawal reason|5
876077|NCT00560417|1838221|FG000|Overall Study|Adverse Event|3
876078|NCT00560417|1838222|FG001|Overall Study|Adverse Event|2
876079|NCT00560417|1838221|FG000|Overall Study|Entry Criteria Not Met|1
876080|NCT00560417|1838222|FG001|Overall Study|Entry Criteria Not Met|0
876081|NCT00560417|1838221|FG000|Overall Study|Lost to Follow-up|0
876082|NCT00560417|1838222|FG001|Overall Study|Lost to Follow-up|1
876083|NCT00560417|1838221|FG000|Overall Study|Physician Decision|2
876084|NCT00560417|1838222|FG001|Overall Study|Physician Decision|6
876085|NCT00560417|1838221|FG000|Overall Study|Protocol Violation|6
876086|NCT00560417|1838222|FG001|Overall Study|Protocol Violation|5
876087|NCT00560417|1838221|FG000|Overall Study|Sponsor Decision|2
876088|NCT00560417|1838222|FG001|Overall Study|Sponsor Decision|0
876089|NCT00560417|1838221|FG000|Overall Study|Withdrawal by Subject|3
876090|NCT00560417|1838222|FG001|Overall Study|Withdrawal by Subject|3
876091|NCT00560508|1838230|FG000|12 Week Double-blind Period|Adverse Event|3
876092|NCT00560508|1838231|FG001|12 Week Double-blind Period|Adverse Event|2
876093|NCT00560508|1838230|FG000|12 Week Double-blind Period|Protocol Violation|1
876094|NCT00560508|1838231|FG001|12 Week Double-blind Period|Protocol Violation|0
876095|NCT00560508|1838230|FG000|12 Week Double-blind Period|Withdrawal by Subject|1
876096|NCT00560508|1838231|FG001|12 Week Double-blind Period|Withdrawal by Subject|1
876097|NCT00560508|1838230|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6
876098|NCT00560508|1838231|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6
876099|NCT00560508|1838230|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
876100|NCT00560508|1838231|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
876101|NCT00560508|1838230|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
1179962|NCT02180724|2337289|FG000|Overall Study|Death|12
1179963|NCT02180724|2337290|FG001|Overall Study|Death|1
1179964|NCT02180724|2337289|FG000|Overall Study|Lost to Follow-up|1
1179965|NCT02180724|2337290|FG001|Overall Study|Lost to Follow-up|0
1179966|NCT02180724|2337289|FG000|Overall Study|Withdrawal by Subject|1
1179967|NCT02180724|2337290|FG001|Overall Study|Withdrawal by Subject|2
1179968|NCT02180724|2337289|FG000|Overall Study|Ongoing Study|78
1179969|NCT02180724|2337290|FG001|Overall Study|Ongoing Study|11
1179970|NCT02108964|2337304|FG000|Overall Study|Progressive disease|12
1179971|NCT02108964|2337305|FG001|Overall Study|Progressive disease|25
1179972|NCT02108964|2337306|FG002|Overall Study|Progressive disease|50
1179973|NCT02108964|2337307|FG003|Overall Study|Progressive disease|6
1179974|NCT02108964|2337308|FG004|Overall Study|Progressive disease|18
1179975|NCT02108964|2337309|FG005|Overall Study|Progressive disease|5
1179976|NCT02108964|2337310|FG006|Overall Study|Progressive disease|7
1179977|NCT02108964|2337311|FG007|Overall Study|Progressive disease|9
1179978|NCT02108964|2337304|FG000|Overall Study|Physician Decision|1
1179979|NCT02108964|2337305|FG001|Overall Study|Physician Decision|5
1179980|NCT02108964|2337306|FG002|Overall Study|Physician Decision|6
1179981|NCT02108964|2337307|FG003|Overall Study|Physician Decision|0
1179982|NCT02108964|2337308|FG004|Overall Study|Physician Decision|1
1179983|NCT02108964|2337309|FG005|Overall Study|Physician Decision|0
1179984|NCT02108964|2337310|FG006|Overall Study|Physician Decision|0
1179985|NCT02108964|2337311|FG007|Overall Study|Physician Decision|0
1179986|NCT02108964|2337304|FG000|Overall Study|Adverse Event|0
1179987|NCT02108964|2337305|FG001|Overall Study|Adverse Event|0
1179988|NCT02108964|2337306|FG002|Overall Study|Adverse Event|4
1179989|NCT02108964|2337307|FG003|Overall Study|Adverse Event|0
1179990|NCT02108964|2337308|FG004|Overall Study|Adverse Event|1
1179991|NCT02108964|2337309|FG005|Overall Study|Adverse Event|0
1179992|NCT02108964|2337310|FG006|Overall Study|Adverse Event|3
1179993|NCT02108964|2337311|FG007|Overall Study|Adverse Event|1
1179994|NCT02108964|2337304|FG000|Overall Study|Death|1
1179995|NCT02108964|2337305|FG001|Overall Study|Death|1
1179996|NCT02108964|2337306|FG002|Overall Study|Death|2
1179997|NCT02108964|2337307|FG003|Overall Study|Death|0
1179998|NCT02108964|2337308|FG004|Overall Study|Death|3
1179999|NCT02108964|2337309|FG005|Overall Study|Death|0
1180000|NCT02108964|2337310|FG006|Overall Study|Death|0
1180001|NCT02108964|2337311|FG007|Overall Study|Death|1
1180002|NCT02108964|2337304|FG000|Overall Study|Subject/Guardian decision|0
1180003|NCT02108964|2337305|FG001|Overall Study|Subject/Guardian decision|1
1180004|NCT02108964|2337306|FG002|Overall Study|Subject/Guardian decision|3
1180005|NCT02108964|2337307|FG003|Overall Study|Subject/Guardian decision|0
1180006|NCT02108964|2337308|FG004|Overall Study|Subject/Guardian decision|2
1180007|NCT02108964|2337309|FG005|Overall Study|Subject/Guardian decision|0
1180008|NCT02108964|2337310|FG006|Overall Study|Subject/Guardian decision|1
1180009|NCT02108964|2337311|FG007|Overall Study|Subject/Guardian decision|1
1180010|NCT02036970|2337354|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0
1180011|NCT02036970|2337355|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0
1180012|NCT02036970|2337356|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3
1180013|NCT02036970|2337357|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2
1180014|NCT02036970|2337358|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0
1180015|NCT02036970|2337359|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1
1180016|NCT02036970|2337360|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0
1180017|NCT02036970|2337361|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1
1180018|NCT02036970|2337362|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3
1180019|NCT02036970|2337363|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1
1180020|NCT02036970|2337354|FG000|Part 1: Day 1 Through Week 16|Death|0
1180021|NCT02036970|2337355|FG001|Part 1: Day 1 Through Week 16|Death|0
1180022|NCT02036970|2337356|FG002|Part 1: Day 1 Through Week 16|Death|0
1180023|NCT02036970|2337357|FG003|Part 1: Day 1 Through Week 16|Death|0
1180024|NCT02036970|2337358|FG004|Part 1: Day 1 Through Week 16|Death|0
1180025|NCT02036970|2337359|FG005|Part 1: Day 1 Through Week 16|Death|0
1180026|NCT02036970|2337360|FG006|Part 1: Day 1 Through Week 16|Death|0
1180027|NCT02036970|2337361|FG007|Part 1: Day 1 Through Week 16|Death|0
1180028|NCT02036970|2337362|FG008|Part 1: Day 1 Through Week 16|Death|1
1180029|NCT02036970|2337363|FG009|Part 1: Day 1 Through Week 16|Death|0
1180030|NCT02036970|2337354|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1
1180031|NCT02036970|2337355|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0
1180032|NCT02036970|2337356|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1
1180033|NCT02036970|2337357|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0
1180034|NCT02036970|2337358|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0
1180035|NCT02036970|2337359|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0
1180036|NCT02036970|2337360|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0
1180037|NCT02036970|2337361|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0
1180038|NCT02036970|2337362|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2
1180039|NCT02036970|2337363|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0
1180040|NCT02036970|2337354|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
1180041|NCT02036970|2337355|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
1180042|NCT02036970|2337356|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
1180043|NCT02036970|2337357|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
1180044|NCT02036970|2337358|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1
1180045|NCT02036970|2337359|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
1180046|NCT02036970|2337360|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
1180047|NCT02036970|2337361|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
1180048|NCT02036970|2337362|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2
1180049|NCT02036970|2337363|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4
1180050|NCT02036970|2337354|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0
1180051|NCT02036970|2337355|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0
1180052|NCT02036970|2337356|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0
1180053|NCT02036970|2337357|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1
1180054|NCT02036970|2337358|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0
1180055|NCT02036970|2337359|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0
1180056|NCT02036970|2337360|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0
1180057|NCT02036970|2337361|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0
1180058|NCT02036970|2337362|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0
1180059|NCT02036970|2337363|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0
1180060|NCT02036970|2337354|FG000|Part 2: Week 16 Onwards|Adverse Event|0
1180061|NCT02036970|2337355|FG001|Part 2: Week 16 Onwards|Adverse Event|2
1180062|NCT02036970|2337356|FG002|Part 2: Week 16 Onwards|Adverse Event|1
1180063|NCT02036970|2337357|FG003|Part 2: Week 16 Onwards|Adverse Event|1
1180064|NCT02036970|2337358|FG004|Part 2: Week 16 Onwards|Adverse Event|1
1180065|NCT02036970|2337359|FG005|Part 2: Week 16 Onwards|Adverse Event|0
1180066|NCT02036970|2337360|FG006|Part 2: Week 16 Onwards|Adverse Event|1
1180067|NCT02036970|2337361|FG007|Part 2: Week 16 Onwards|Adverse Event|0
1180068|NCT02036970|2337362|FG008|Part 2: Week 16 Onwards|Adverse Event|6
1180069|NCT02036970|2337363|FG009|Part 2: Week 16 Onwards|Adverse Event|3
1180070|NCT02036970|2337354|FG000|Part 2: Week 16 Onwards|Protocol Violation|0
1180071|NCT02036970|2337355|FG001|Part 2: Week 16 Onwards|Protocol Violation|0
1180072|NCT02036970|2337356|FG002|Part 2: Week 16 Onwards|Protocol Violation|0
1180073|NCT02036970|2337357|FG003|Part 2: Week 16 Onwards|Protocol Violation|0
1180074|NCT02036970|2337358|FG004|Part 2: Week 16 Onwards|Protocol Violation|0
1180075|NCT02036970|2337359|FG005|Part 2: Week 16 Onwards|Protocol Violation|0
1180076|NCT02036970|2337360|FG006|Part 2: Week 16 Onwards|Protocol Violation|0
1180077|NCT02036970|2337361|FG007|Part 2: Week 16 Onwards|Protocol Violation|1
1180078|NCT02036970|2337362|FG008|Part 2: Week 16 Onwards|Protocol Violation|0
1180079|NCT02036970|2337363|FG009|Part 2: Week 16 Onwards|Protocol Violation|0
1180080|NCT02036970|2337354|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0
1180081|NCT02036970|2337355|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1
1180082|NCT02036970|2337356|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1
1180083|NCT02036970|2337357|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0
1180084|NCT02036970|2337358|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0
1180085|NCT02036970|2337359|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0
1180086|NCT02036970|2337360|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0
1180087|NCT02036970|2337361|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0
1180088|NCT02036970|2337362|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3
1180089|NCT02036970|2337363|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0
1180090|NCT02036970|2337354|FG000|Part 2: Week 16 Onwards|Progressive Disease|0
1180091|NCT02036970|2337355|FG001|Part 2: Week 16 Onwards|Progressive Disease|2
1180092|NCT02036970|2337356|FG002|Part 2: Week 16 Onwards|Progressive Disease|1
1180093|NCT02036970|2337357|FG003|Part 2: Week 16 Onwards|Progressive Disease|1
1180094|NCT02036970|2337358|FG004|Part 2: Week 16 Onwards|Progressive Disease|0
1180095|NCT02036970|2337359|FG005|Part 2: Week 16 Onwards|Progressive Disease|0
1180096|NCT02036970|2337360|FG006|Part 2: Week 16 Onwards|Progressive Disease|0
1180097|NCT02036970|2337361|FG007|Part 2: Week 16 Onwards|Progressive Disease|0
1180098|NCT02036970|2337362|FG008|Part 2: Week 16 Onwards|Progressive Disease|0
1180099|NCT02036970|2337363|FG009|Part 2: Week 16 Onwards|Progressive Disease|2
1180109|NCT01958021|2337411|FG000|Overall Study|Progressive disease|87
1180110|NCT01958021|2337412|FG001|Overall Study|Progressive disease|146
1180111|NCT01958021|2337411|FG000|Overall Study|Adverse Event|25
1180112|NCT01958021|2337412|FG001|Overall Study|Adverse Event|7
1180113|NCT01958021|2337411|FG000|Overall Study|Subject/guardian decision|12
1180114|NCT01958021|2337412|FG001|Overall Study|Subject/guardian decision|13
1180115|NCT01958021|2337411|FG000|Overall Study|Physician Decision|10
1180116|NCT01958021|2337412|FG001|Overall Study|Physician Decision|13
1180117|NCT01958021|2337411|FG000|Overall Study|Protocol Violation|3
1180118|NCT01958021|2337412|FG001|Overall Study|Protocol Violation|1
1180119|NCT01958021|2337411|FG000|Overall Study|Death|2
1180120|NCT01958021|2337412|FG001|Overall Study|Death|0
1180121|NCT01941719|2337420|FG000|Overall Study|Lost to Follow-up|20
1180122|NCT01941719|2337421|FG001|Overall Study|Lost to Follow-up|19
1180123|NCT01828099|2337430|FG000|Overall Study|Adverse Event|15
1180124|NCT01828099|2337431|FG001|Overall Study|Adverse Event|18
1180125|NCT01828099|2337430|FG000|Overall Study|Death|9
1180126|NCT01828099|2337431|FG001|Overall Study|Death|11
1180127|NCT01828099|2337430|FG000|Overall Study|Lost to Follow-up|2
1180128|NCT01828099|2337431|FG001|Overall Study|Lost to Follow-up|0
1180129|NCT01828099|2337430|FG000|Overall Study|Non-compliance with study treatment|2
1180130|NCT01828099|2337431|FG001|Overall Study|Non-compliance with study treatment|0
1180131|NCT01828099|2337430|FG000|Overall Study|Physician Decision|7
1180132|NCT01828099|2337431|FG001|Overall Study|Physician Decision|11
1180133|NCT01828099|2337430|FG000|Overall Study|Progressive disease|51
1180134|NCT01828099|2337431|FG001|Overall Study|Progressive disease|94
1180135|NCT01828099|2337430|FG000|Overall Study|Protocol Violation|1
1180136|NCT01828099|2337431|FG001|Overall Study|Protocol Violation|0
1180137|NCT01828099|2337430|FG000|Overall Study|Subject/guardian decision|7
1180138|NCT01828099|2337431|FG001|Overall Study|Subject/guardian decision|23
1180139|NCT01593254|2337439|FG000|Treatment Period|Treatment Failure|1
1180140|NCT01593254|2337440|FG001|Treatment Period|Treatment Failure|2
1180141|NCT01593254|2337439|FG000|Treatment Period|Pregnancy|0
1180142|NCT01593254|2337440|FG001|Treatment Period|Pregnancy|1
1180143|NCT01593254|2337439|FG000|Treatment Period|Poor/Non-Compliance|2
1180144|NCT01593254|2337440|FG001|Treatment Period|Poor/Non-Compliance|1
1180145|NCT01593254|2337439|FG000|Treatment Period|Maximum clinical benefit|1
1180146|NCT01593254|2337440|FG001|Treatment Period|Maximum clinical benefit|0
1180147|NCT01593254|2337439|FG000|Treatment Period|Subject withdrew consent|0
1180148|NCT01593254|2337440|FG001|Treatment Period|Subject withdrew consent|5
1180149|NCT01593254|2337439|FG000|Treatment Period|Subject Request to Discontinue|1
1180150|NCT01593254|2337440|FG001|Treatment Period|Subject Request to Discontinue|1
1180151|NCT01593254|2337439|FG000|Treatment Period|AE unrelated to Study Drug|0
1180152|NCT01593254|2337440|FG001|Treatment Period|AE unrelated to Study Drug|1
1180153|NCT01593254|2337439|FG000|Treatment Period|Death|2
1180154|NCT01593254|2337440|FG001|Treatment Period|Death|1
1180155|NCT01593254|2337439|FG000|Treatment Period|Study Drug Toxicity|3
1180156|NCT01593254|2337440|FG001|Treatment Period|Study Drug Toxicity|9
1180157|NCT01593254|2337439|FG000|Treatment Period|Disease Progression|1
1180158|NCT01593254|2337440|FG001|Treatment Period|Disease Progression|6
1180159|NCT01593254|2337439|FG000|Treatment Period|Did Not Achieve RCC|0
1180160|NCT01593254|2337440|FG001|Treatment Period|Did Not Achieve RCC|1
1180161|NCT01593254|2337439|FG000|Treatment Period|Patient Refused to Return|0
1180162|NCT01593254|2337440|FG001|Treatment Period|Patient Refused to Return|1
1180163|NCT01593254|2337439|FG000|Treatment Period|No Response|1
1180164|NCT01593254|2337440|FG001|Treatment Period|No Response|0
1180165|NCT01593254|2337439|FG000|Treatment Period|T315I MUTATION|0
1180166|NCT01593254|2337440|FG001|Treatment Period|T315I MUTATION|1
1180167|NCT01593254|2337439|FG000|Treatment Period|Investigator Decision|2
1180168|NCT01593254|2337440|FG001|Treatment Period|Investigator Decision|1
1180169|NCT01593254|2337439|FG000|Follow-Up Period|Withdrawal by Subject|0
1180170|NCT01593254|2337440|FG001|Follow-Up Period|Withdrawal by Subject|2
1180171|NCT01593254|2337439|FG000|Follow-Up Period|Non-Compliance|1
1180172|NCT01593254|2337440|FG001|Follow-Up Period|Non-Compliance|0
1180173|NCT01593254|2337439|FG000|Follow-Up Period|Death|2
1180174|NCT01593254|2337440|FG001|Follow-Up Period|Death|2
1180175|NCT01593254|2337439|FG000|Follow-Up Period|Subject request to Discontinue|0
1180176|NCT01593254|2337440|FG001|Follow-Up Period|Subject request to Discontinue|1
1180177|NCT01593254|2337439|FG000|Follow-Up Period|Pregnancy|0
1180178|NCT01593254|2337440|FG001|Follow-Up Period|Pregnancy|1
1180179|NCT01593254|2337439|FG000|Follow-Up Period|Study Drug Toxicity|0
1180180|NCT01593254|2337440|FG001|Follow-Up Period|Study Drug Toxicity|1
1180181|NCT01593254|2337439|FG000|Follow-Up Period|Patient refused to return|0
1180182|NCT01593254|2337440|FG001|Follow-Up Period|Patient refused to return|1
1180183|NCT01593254|2337439|FG000|Follow-Up Period|Fundus Hemorrhage|0
1180184|NCT01593254|2337440|FG001|Follow-Up Period|Fundus Hemorrhage|1
1180185|NCT01593254|2337439|FG000|Follow-Up Period|Disease Progression|0
1180186|NCT01593254|2337440|FG001|Follow-Up Period|Disease Progression|1
1180187|NCT01593254|2337439|FG000|Follow-Up Period|Study Drug Side Effects|0
1180188|NCT01593254|2337440|FG001|Follow-Up Period|Study Drug Side Effects|1
1180189|NCT00943618|2337466|FG000|Overall Study|Lost to Follow-up|38
1180190|NCT00943618|2337467|FG001|Overall Study|Lost to Follow-up|48
1180191|NCT00943618|2337468|FG002|Overall Study|Lost to Follow-up|20
1180192|NCT00943618|2337466|FG000|Overall Study|Discontinued Medication|17
1180193|NCT00943618|2337467|FG001|Overall Study|Discontinued Medication|29
1180194|NCT00943618|2337468|FG002|Overall Study|Discontinued Medication|11
1180195|NCT00529763|2337479|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1
1180196|NCT00529763|2337480|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
1180197|NCT00529763|2337481|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1
1180198|NCT00529763|2337479|FG000|Overall Study|Death|0
1180199|NCT00529763|2337480|FG001|Overall Study|Death|1
1180200|NCT00529763|2337481|FG002|Overall Study|Death|1
1180201|NCT00529763|2337479|FG000|Overall Study|Disease Progression|6
1180202|NCT00529763|2337480|FG001|Overall Study|Disease Progression|16
1180203|NCT00529763|2337481|FG002|Overall Study|Disease Progression|1
1180204|NCT00529763|2337479|FG000|Overall Study|Lost to Follow-up|0
1180205|NCT00529763|2337480|FG001|Overall Study|Lost to Follow-up|1
1180206|NCT00529763|2337481|FG002|Overall Study|Lost to Follow-up|1
1180207|NCT00529763|2337479|FG000|Overall Study|Stem Cell Transplant|0
1180208|NCT00529763|2337480|FG001|Overall Study|Stem Cell Transplant|3
1180209|NCT00529763|2337481|FG002|Overall Study|Stem Cell Transplant|0
1180210|NCT00529763|2337479|FG000|Overall Study|Study Drug Toxicity|1
1180211|NCT00529763|2337480|FG001|Overall Study|Study Drug Toxicity|6
1180212|NCT00529763|2337481|FG002|Overall Study|Study Drug Toxicity|1
1180213|NCT00529763|2337479|FG000|Overall Study|Patient Withdrew Consent|2
1180214|NCT00529763|2337480|FG001|Overall Study|Patient Withdrew Consent|3
1180215|NCT00529763|2337481|FG002|Overall Study|Patient Withdrew Consent|2
1180217|NCT03938272|2337510|FG000|Overall Study|Withdrawal by Subject|1
1180218|NCT03938272|2337511|FG001|Overall Study|Withdrawal by Subject|0
1180219|NCT03938272|2337510|FG000|Overall Study|Physician Decision|0
1180220|NCT03938272|2337511|FG001|Overall Study|Physician Decision|2
1180221|NCT03938272|2337510|FG000|Overall Study|Study termination by sponsor|10
1180222|NCT03938272|2337511|FG001|Overall Study|Study termination by sponsor|8
1180223|NCT03641339|2337523|FG000|Overall Study|Physician Decision|1
1180224|NCT03641339|2337524|FG001|Overall Study|Physician Decision|0
1180225|NCT03641339|2337525|FG002|Overall Study|Physician Decision|0
1180226|NCT03641339|2337526|FG003|Overall Study|Physician Decision|0
1180227|NCT03641339|2337527|FG004|Overall Study|Physician Decision|0
1180228|NCT03641339|2337528|FG005|Overall Study|Physician Decision|0
1180229|NCT03641339|2337523|FG000|Overall Study|Withdrawal by Subject|0
1180230|NCT03641339|2337524|FG001|Overall Study|Withdrawal by Subject|2
1180231|NCT03641339|2337525|FG002|Overall Study|Withdrawal by Subject|0
1180232|NCT03641339|2337526|FG003|Overall Study|Withdrawal by Subject|2
1180233|NCT03641339|2337527|FG004|Overall Study|Withdrawal by Subject|0
1180234|NCT03641339|2337528|FG005|Overall Study|Withdrawal by Subject|1
1180235|NCT03625466|2337544|FG000|Overall Study|Adverse Event|0
1180236|NCT03625466|2337545|FG001|Overall Study|Adverse Event|1
1180237|NCT03625466|2337544|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
1180238|NCT03625466|2337545|FG001|Overall Study|Withdrawal of Consent (not due to AE)|1
1180239|NCT03476239|2337551|FG000|Overall Study|Continuing study|43
1180240|NCT03476239|2337551|FG000|Overall Study|Withdrawal by Subject|6
1180241|NCT03476239|2337551|FG000|Overall Study|Death|39
1180242|NCT03476239|2337551|FG000|Overall Study|Lost to Follow-up|2
1180243|NCT03476239|2337551|FG000|Overall Study|Data Not Available|15
1180244|NCT03476239|2337551|FG000|Overall Study|Did not receive study drug|1
1180245|NCT03317795|2337566|FG000|Overall Study|IUD Expulsion|1
1180246|NCT03317795|2337567|FG001|Overall Study|IUD Expulsion|0
1180247|NCT03317795|2337566|FG000|Overall Study|Lost to Follow-up|1
1180248|NCT03317795|2337567|FG001|Overall Study|Lost to Follow-up|3
1180249|NCT03317795|2337566|FG000|Overall Study|Treatment change|0
1180250|NCT03317795|2337567|FG001|Overall Study|Treatment change|3
1180251|NCT03317795|2337566|FG000|Overall Study|Intolerance of medication|0
1180252|NCT03317795|2337567|FG001|Overall Study|Intolerance of medication|1
1180253|NCT03287245|2337577|FG000|Overall Study|Study terminated by sponsor|3
1180254|NCT03287245|2337578|FG001|Overall Study|Study terminated by sponsor|0
1180255|NCT03287245|2337579|FG002|Overall Study|Study terminated by sponsor|3
1180256|NCT03287245|2337580|FG003|Overall Study|Study terminated by sponsor|1
1180257|NCT03287245|2337577|FG000|Overall Study|Adverse Event|1
1180258|NCT03287245|2337578|FG001|Overall Study|Adverse Event|0
1180259|NCT03287245|2337579|FG002|Overall Study|Adverse Event|0
1180260|NCT03287245|2337580|FG003|Overall Study|Adverse Event|0
1180261|NCT03287245|2337577|FG000|Overall Study|Withdrawal by Subject|8
1180262|NCT03287245|2337578|FG001|Overall Study|Withdrawal by Subject|3
1180263|NCT03287245|2337579|FG002|Overall Study|Withdrawal by Subject|3
1180264|NCT03287245|2337580|FG003|Overall Study|Withdrawal by Subject|0
1180265|NCT03287245|2337577|FG000|Overall Study|Physician Decision|3
1180266|NCT03287245|2337578|FG001|Overall Study|Physician Decision|2
1180267|NCT03287245|2337579|FG002|Overall Study|Physician Decision|0
1180268|NCT03287245|2337580|FG003|Overall Study|Physician Decision|0
1180279|NCT03092219|2337630|FG000|Overall Study|Protocol Violation|7
1180280|NCT03092219|2337631|FG001|Overall Study|Protocol Violation|4
1180281|NCT03033069|2337644|FG000|Overall Study|Adverse Event|6
1180282|NCT03033069|2337645|FG001|Overall Study|Adverse Event|7
1180283|NCT03033069|2337646|FG002|Overall Study|Adverse Event|4
1180284|NCT03033069|2337647|FG003|Overall Study|Adverse Event|6
1180285|NCT03033069|2337644|FG000|Overall Study|Lack of Efficacy|0
1180286|NCT03033069|2337645|FG001|Overall Study|Lack of Efficacy|0
1180287|NCT03033069|2337646|FG002|Overall Study|Lack of Efficacy|1
1180288|NCT03033069|2337647|FG003|Overall Study|Lack of Efficacy|0
1180289|NCT03033069|2337644|FG000|Overall Study|Lost to Follow-up|6
1180290|NCT03033069|2337645|FG001|Overall Study|Lost to Follow-up|5
1180291|NCT03033069|2337646|FG002|Overall Study|Lost to Follow-up|5
1180292|NCT03033069|2337647|FG003|Overall Study|Lost to Follow-up|6
1180293|NCT03033069|2337644|FG000|Overall Study|Non-Compliance With Study Drug|1
1180294|NCT03033069|2337645|FG001|Overall Study|Non-Compliance With Study Drug|1
1180295|NCT03033069|2337646|FG002|Overall Study|Non-Compliance With Study Drug|1
1180296|NCT03033069|2337647|FG003|Overall Study|Non-Compliance With Study Drug|0
1180297|NCT03033069|2337644|FG000|Overall Study|Protocol Deviation|0
1180298|NCT03033069|2337645|FG001|Overall Study|Protocol Deviation|1
1180299|NCT03033069|2337646|FG002|Overall Study|Protocol Deviation|0
1180300|NCT03033069|2337647|FG003|Overall Study|Protocol Deviation|0
1180301|NCT03033069|2337644|FG000|Overall Study|Withdrawal by Subject|10
1180302|NCT03033069|2337645|FG001|Overall Study|Withdrawal by Subject|10
1180303|NCT03033069|2337646|FG002|Overall Study|Withdrawal by Subject|11
1180304|NCT03033069|2337647|FG003|Overall Study|Withdrawal by Subject|6
1180305|NCT03033069|2337644|FG000|Overall Study|Withdrawal By Caregiver|1
1180306|NCT03033069|2337645|FG001|Overall Study|Withdrawal By Caregiver|0
1180307|NCT03033069|2337646|FG002|Overall Study|Withdrawal By Caregiver|0
1180308|NCT03033069|2337647|FG003|Overall Study|Withdrawal By Caregiver|0
1180309|NCT03033069|2337644|FG000|Overall Study|Reason not Specified|0
1180310|NCT03033069|2337645|FG001|Overall Study|Reason not Specified|1
1180311|NCT03033069|2337646|FG002|Overall Study|Reason not Specified|0
1180312|NCT03033069|2337647|FG003|Overall Study|Reason not Specified|1
1180313|NCT02663622|2337676|FG000|Overall Study|Ongoing in study|0
1180314|NCT02663622|2337677|FG001|Overall Study|Ongoing in study|0
1180315|NCT02663622|2337678|FG002|Overall Study|Ongoing in study|0
1180316|NCT02663622|2337679|FG003|Overall Study|Ongoing in study|6
1180317|NCT02663622|2337676|FG000|Overall Study|Death|3
1180318|NCT02663622|2337677|FG001|Overall Study|Death|1
1180319|NCT02663622|2337678|FG002|Overall Study|Death|1
1180320|NCT02663622|2337679|FG003|Overall Study|Death|8
1180321|NCT02663622|2337676|FG000|Overall Study|Protocol Violation|0
1180322|NCT02663622|2337677|FG001|Overall Study|Protocol Violation|0
1180323|NCT02663622|2337678|FG002|Overall Study|Protocol Violation|0
1180324|NCT02663622|2337679|FG003|Overall Study|Protocol Violation|1
1180325|NCT02609503|2337690|FG000|Overall Study|Adverse Event|1
1180326|NCT02609503|2337690|FG000|Overall Study|Death|1
1180327|NCT02609503|2337690|FG000|Overall Study|Withdrawal by Subject|1
1180328|NCT02609503|2337690|FG000|Overall Study|Disease progression|1
1180329|NCT02587598|2337708|FG000|Overall Study|Death|4
1180330|NCT02587598|2337709|FG001|Overall Study|Death|8
1180331|NCT02587598|2337710|FG002|Overall Study|Death|4
1180332|NCT02587598|2337711|FG003|Overall Study|Death|16
1180333|NCT02587598|2337712|FG004|Overall Study|Death|9
1180334|NCT02587598|2337713|FG005|Overall Study|Death|4
1180335|NCT02587598|2337714|FG006|Overall Study|Death|6
1180336|NCT02587598|2337715|FG007|Overall Study|Death|7
1180337|NCT02587598|2337716|FG008|Overall Study|Death|9
1180338|NCT02587598|2337717|FG009|Overall Study|Death|1
1180339|NCT02587598|2337718|FG010|Overall Study|Death|3
1180340|NCT02587598|2337708|FG000|Overall Study|Study Terminated by the Sponsor|0
1180341|NCT02587598|2337709|FG001|Overall Study|Study Terminated by the Sponsor|1
1180342|NCT02587598|2337710|FG002|Overall Study|Study Terminated by the Sponsor|0
876102|NCT00560508|1838231|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
876103|NCT00560508|1838230|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
876104|NCT00560508|1838231|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
876105|NCT00560573|1838251|FG000|Overall Study|Death|4
876106|NCT00560573|1838252|FG001|Overall Study|Death|1
876107|NCT00560573|1838253|FG002|Overall Study|Death|4
876108|NCT00560573|1838254|FG003|Overall Study|Death|5
876109|NCT00560573|1838255|FG004|Overall Study|Death|1
876110|NCT00560573|1838256|FG005|Overall Study|Death|10
876111|NCT00560573|1838251|FG000|Overall Study|Lost to Follow-up|0
876112|NCT00560573|1838252|FG001|Overall Study|Lost to Follow-up|0
876113|NCT00560573|1838253|FG002|Overall Study|Lost to Follow-up|0
876114|NCT00560573|1838254|FG003|Overall Study|Lost to Follow-up|1
876115|NCT00560573|1838255|FG004|Overall Study|Lost to Follow-up|1
876116|NCT00560573|1838256|FG005|Overall Study|Lost to Follow-up|0
876117|NCT00560573|1838251|FG000|Overall Study|Withdrawal by Subject|0
876118|NCT00560573|1838252|FG001|Overall Study|Withdrawal by Subject|0
1180343|NCT02587598|2337711|FG003|Overall Study|Study Terminated by the Sponsor|3
1180344|NCT02587598|2337712|FG004|Overall Study|Study Terminated by the Sponsor|0
1180345|NCT02587598|2337713|FG005|Overall Study|Study Terminated by the Sponsor|1
1180346|NCT02587598|2337714|FG006|Overall Study|Study Terminated by the Sponsor|0
1180347|NCT02587598|2337715|FG007|Overall Study|Study Terminated by the Sponsor|0
1180348|NCT02587598|2337716|FG008|Overall Study|Study Terminated by the Sponsor|0
1180349|NCT02587598|2337717|FG009|Overall Study|Study Terminated by the Sponsor|1
1180350|NCT02587598|2337718|FG010|Overall Study|Study Terminated by the Sponsor|6
1180351|NCT02587598|2337708|FG000|Overall Study|Reason for study withdrawal not specified|0
1180352|NCT02587598|2337709|FG001|Overall Study|Reason for study withdrawal not specified|1
1180353|NCT02587598|2337710|FG002|Overall Study|Reason for study withdrawal not specified|0
1180354|NCT02587598|2337711|FG003|Overall Study|Reason for study withdrawal not specified|0
1180355|NCT02587598|2337712|FG004|Overall Study|Reason for study withdrawal not specified|0
1180356|NCT02587598|2337713|FG005|Overall Study|Reason for study withdrawal not specified|0
1180357|NCT02587598|2337714|FG006|Overall Study|Reason for study withdrawal not specified|0
1180358|NCT02587598|2337715|FG007|Overall Study|Reason for study withdrawal not specified|0
1180359|NCT02587598|2337716|FG008|Overall Study|Reason for study withdrawal not specified|0
1180360|NCT02587598|2337717|FG009|Overall Study|Reason for study withdrawal not specified|0
1180361|NCT02587598|2337718|FG010|Overall Study|Reason for study withdrawal not specified|0
1180362|NCT02587598|2337708|FG000|Overall Study|Withdrawal by Subject|0
1180363|NCT02587598|2337709|FG001|Overall Study|Withdrawal by Subject|1
1180364|NCT02587598|2337710|FG002|Overall Study|Withdrawal by Subject|0
1180365|NCT02587598|2337711|FG003|Overall Study|Withdrawal by Subject|2
1180366|NCT02587598|2337712|FG004|Overall Study|Withdrawal by Subject|3
1180367|NCT02587598|2337713|FG005|Overall Study|Withdrawal by Subject|1
1180368|NCT02587598|2337714|FG006|Overall Study|Withdrawal by Subject|0
1180369|NCT02587598|2337715|FG007|Overall Study|Withdrawal by Subject|0
1180370|NCT02587598|2337716|FG008|Overall Study|Withdrawal by Subject|0
1180371|NCT02587598|2337717|FG009|Overall Study|Withdrawal by Subject|1
1180372|NCT02587598|2337718|FG010|Overall Study|Withdrawal by Subject|2
1180373|NCT02587598|2337708|FG000|Overall Study|Physician Decision|0
1180374|NCT02587598|2337709|FG001|Overall Study|Physician Decision|0
1180375|NCT02587598|2337710|FG002|Overall Study|Physician Decision|0
1180376|NCT02587598|2337711|FG003|Overall Study|Physician Decision|0
1180377|NCT02587598|2337712|FG004|Overall Study|Physician Decision|0
1180378|NCT02587598|2337713|FG005|Overall Study|Physician Decision|0
1180379|NCT02587598|2337714|FG006|Overall Study|Physician Decision|0
1180380|NCT02587598|2337715|FG007|Overall Study|Physician Decision|0
1180381|NCT02587598|2337716|FG008|Overall Study|Physician Decision|0
1180382|NCT02587598|2337717|FG009|Overall Study|Physician Decision|0
1180383|NCT02587598|2337718|FG010|Overall Study|Physician Decision|3
1180384|NCT02485574|2337754|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4
1180385|NCT02481310|2337766|FG000|Follow up|Still in follow up|0
1180386|NCT02481310|2337767|FG001|Follow up|Still in follow up|3
1180387|NCT02481310|2337768|FG002|Follow up|Still in follow up|0
1180388|NCT02214160|2337775|FG000|Overall Study|Withdrawal by Subject|1
1180389|NCT02214160|2337776|FG001|Overall Study|Withdrawal by Subject|0
1180390|NCT02214160|2337777|FG002|Overall Study|Withdrawal by Subject|6
1180391|NCT02214160|2337775|FG000|Overall Study|Death|2
1180392|NCT02214160|2337776|FG001|Overall Study|Death|2
1180393|NCT02214160|2337777|FG002|Overall Study|Death|1
1180394|NCT02214160|2337775|FG000|Overall Study|Subject Non-Compliance|0
1180395|NCT02214160|2337776|FG001|Overall Study|Subject Non-Compliance|3
1180396|NCT02214160|2337777|FG002|Overall Study|Subject Non-Compliance|1
1180397|NCT02214160|2337775|FG000|Overall Study|Adverse Event|0
1180398|NCT02214160|2337776|FG001|Overall Study|Adverse Event|1
1180399|NCT02214160|2337777|FG002|Overall Study|Adverse Event|1
1180400|NCT02214160|2337775|FG000|Overall Study|Sponsor Decision|0
1180401|NCT02214160|2337776|FG001|Overall Study|Sponsor Decision|2
1180402|NCT02214160|2337777|FG002|Overall Study|Sponsor Decision|0
1180403|NCT02214160|2337775|FG000|Overall Study|Protocol Violation|1
1180404|NCT02214160|2337776|FG001|Overall Study|Protocol Violation|0
1180405|NCT02214160|2337777|FG002|Overall Study|Protocol Violation|0
1180406|NCT02214160|2337775|FG000|Overall Study|Physician Decision|0
1180407|NCT02214160|2337776|FG001|Overall Study|Physician Decision|0
1180408|NCT02214160|2337777|FG002|Overall Study|Physician Decision|1
1180409|NCT02032823|2337791|FG000|Overall Study|Death|59
1180410|NCT02032823|2337792|FG001|Overall Study|Death|86
1180411|NCT02032823|2337791|FG000|Overall Study|Lost to Follow-up|12
1180412|NCT02032823|2337792|FG001|Overall Study|Lost to Follow-up|15
1180413|NCT02032823|2337791|FG000|Overall Study|Withdrawal by Subject|65
1180414|NCT02032823|2337792|FG001|Overall Study|Withdrawal by Subject|49
1180415|NCT02032823|2337791|FG000|Overall Study|Ongoing study at data cut-off|782
1180416|NCT02032823|2337792|FG001|Overall Study|Ongoing study at data cut-off|760
1180417|NCT02032823|2337791|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3
1180418|NCT02032823|2337792|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5
876119|NCT00560573|1838253|FG002|Overall Study|Withdrawal by Subject|0
876120|NCT00560573|1838254|FG003|Overall Study|Withdrawal by Subject|1
876121|NCT00560573|1838255|FG004|Overall Study|Withdrawal by Subject|1
876122|NCT00560573|1838256|FG005|Overall Study|Withdrawal by Subject|0
876123|NCT00560573|1838251|FG000|Overall Study|Other|2
876124|NCT00560573|1838252|FG001|Overall Study|Other|2
876125|NCT00560573|1838253|FG002|Overall Study|Other|2
876126|NCT00560573|1838254|FG003|Overall Study|Other|3
1180467|NCT01547117|2337828|FG000|Overall Study|Physician Decision|0
1180468|NCT01547117|2337829|FG001|Overall Study|Physician Decision|1
1180469|NCT01547117|2337830|FG002|Overall Study|Physician Decision|1
1180470|NCT01547117|2337831|FG003|Overall Study|Physician Decision|3
1180471|NCT01547117|2337828|FG000|Overall Study|Withdrawal by Subject|1
1180472|NCT01547117|2337829|FG001|Overall Study|Withdrawal by Subject|2
1180473|NCT01547117|2337830|FG002|Overall Study|Withdrawal by Subject|1
1180474|NCT01547117|2337831|FG003|Overall Study|Withdrawal by Subject|2
1180475|NCT01460160|2337857|FG000|Treatment Phase|Lack of Efficacy|3
1180476|NCT01460160|2337857|FG000|Treatment Phase|Study Drug Toxicity|2
1180477|NCT01460160|2337857|FG000|Treatment Phase|Adverse Event|8
1180478|NCT01460160|2337857|FG000|Treatment Phase|Withdrawal by Subject|4
1180479|NCT01460160|2337857|FG000|Treatment Phase|Death|2
1180480|NCT01460160|2337857|FG000|Treatment Phase|Other reasons|9
1180481|NCT01460160|2337857|FG000|Follow-up Phase|Withdrawal by Subject|4
1180482|NCT01460160|2337857|FG000|Follow-up Phase|Death|14
1180483|NCT01460160|2337857|FG000|Follow-up Phase|Lost to Follow-up|7
1180484|NCT01460160|2337857|FG000|Follow-up Phase|Follow-up no longer required per protocol|70
1180485|NCT01460160|2337857|FG000|Follow-up Phase|Other and not reported reasons|5
1180486|NCT01170702|2337874|FG000|Overall Study|Exclusion criteria met after consent|1
1180487|NCT01170702|2337875|FG001|Overall Study|Exclusion criteria met after consent|2
1180488|NCT01170702|2337876|FG002|Overall Study|Exclusion criteria met after consent|0
1180489|NCT01170702|2337877|FG003|Overall Study|Exclusion criteria met after consent|2
876127|NCT00560573|1838255|FG004|Overall Study|Other|3
876128|NCT00560573|1838256|FG005|Overall Study|Other|3
876129|NCT00560573|1838251|FG000|Overall Study|Enrolled, not treated|0
876130|NCT00560573|1838252|FG001|Overall Study|Enrolled, not treated|0
876131|NCT00560573|1838253|FG002|Overall Study|Enrolled, not treated|0
876132|NCT00560573|1838254|FG003|Overall Study|Enrolled, not treated|0
876133|NCT00560573|1838255|FG004|Overall Study|Enrolled, not treated|1
876134|NCT00560573|1838256|FG005|Overall Study|Enrolled, not treated|0
876135|NCT00560703|1838297|FG000|Overall Study|Adverse Event|0
876136|NCT00560703|1838298|FG001|Overall Study|Adverse Event|2
876137|NCT00560703|1838297|FG000|Overall Study|Protocol Violation|0
876138|NCT00560703|1838298|FG001|Overall Study|Protocol Violation|2
876139|NCT00560703|1838297|FG000|Overall Study|Withdrawal by Subject|0
876140|NCT00560703|1838298|FG001|Overall Study|Withdrawal by Subject|1
1180538|NCT01018563|2337904|FG000|Overall Study|Termination of the study by Sponsor|2
1180539|NCT01018563|2337905|FG001|Overall Study|Termination of the study by Sponsor|1
1180540|NCT00805961|2337925|FG000|Modality Therapy|Withdrawal by Subject|1
1180541|NCT00805961|2337925|FG000|Modality Therapy|Adverse Event|1
1180542|NCT00805961|2337925|FG000|Modality Therapy|Disease Progression|2
1180543|NCT00805961|2337925|FG000|Treatment-Free Interval|Adverse Event|3
1180544|NCT00805961|2337925|FG000|Treatment-Free Interval|Intercurrent Illness|2
1180545|NCT00805961|2337925|FG000|Treatment-Free Interval|Physician Decision|1
1180546|NCT00805961|2337925|FG000|Treatment-Free Interval|Lack of Efficacy|1
1180547|NCT00805961|2337925|FG000|Maintenance Treatment|Lack of Efficacy|13
1180548|NCT00805961|2337925|FG000|Maintenance Treatment|Intercurrent Illness|7
1180549|NCT00805961|2337925|FG000|Maintenance Treatment|Adverse Event|6
1180550|NCT00805961|2337925|FG000|Maintenance Treatment|Withdrawal by Subject|5
1180551|NCT00805961|2337925|FG000|Maintenance Treatment|Symptomatic Deterioration|2
1180552|NCT00805961|2337925|FG000|Maintenance Treatment|Withdrawn Consent|1
876141|NCT00560703|1838297|FG000|Overall Study|non-compliance|0
876142|NCT00560703|1838298|FG001|Overall Study|non-compliance|1
876143|NCT00560755|1838304|FG000|Overall Study|Protocol Violation|15
876144|NCT00560755|1838304|FG000|Overall Study|Withdrawal by Subject|26
876145|NCT00560755|1838304|FG000|Overall Study|Lost to Follow-up|9
876146|NCT00560755|1838304|FG000|Overall Study|Adverse Event|8
876147|NCT00560755|1838304|FG000|Overall Study|Physician Decision|2
876148|NCT00560794|1838309|FG000|Overall Study|Adverse Event|2
876149|NCT00560794|1838309|FG000|Overall Study|Patient was not Compliant|1
876150|NCT00560794|1838309|FG000|Overall Study|Minimal Residual Disease Relapse|1
876151|NCT00560794|1838309|FG000|Overall Study|Hematological Relapse|1
876152|NCT00560794|1838309|FG000|Overall Study|Received Bone Marrow Transplant|6
876153|NCT00560833|1838320|FG000|Overall Study|Adverse Event|16
876154|NCT00560833|1838321|FG001|Overall Study|Adverse Event|10
876155|NCT00560833|1838322|FG002|Overall Study|Adverse Event|25
876156|NCT00560833|1838323|FG003|Overall Study|Adverse Event|23
876157|NCT00560833|1838324|FG004|Overall Study|Adverse Event|35
876158|NCT00560833|1838320|FG000|Overall Study|Lost to Follow-up|0
876159|NCT00560833|1838321|FG001|Overall Study|Lost to Follow-up|0
876160|NCT00560833|1838322|FG002|Overall Study|Lost to Follow-up|1
876161|NCT00560833|1838323|FG003|Overall Study|Lost to Follow-up|0
876162|NCT00560833|1838324|FG004|Overall Study|Lost to Follow-up|0
876163|NCT00560833|1838320|FG000|Overall Study|Lack of Efficacy|22
876164|NCT00560833|1838321|FG001|Overall Study|Lack of Efficacy|9
876165|NCT00560833|1838322|FG002|Overall Study|Lack of Efficacy|6
876166|NCT00560833|1838323|FG003|Overall Study|Lack of Efficacy|4
876167|NCT00560833|1838324|FG004|Overall Study|Lack of Efficacy|4
876168|NCT00560833|1838320|FG000|Overall Study|Participant uncooperative|5
876169|NCT00560833|1838321|FG001|Overall Study|Participant uncooperative|5
876170|NCT00560833|1838322|FG002|Overall Study|Participant uncooperative|4
876171|NCT00560833|1838323|FG003|Overall Study|Participant uncooperative|4
876172|NCT00560833|1838324|FG004|Overall Study|Participant uncooperative|2
876173|NCT00560833|1838320|FG000|Overall Study|Other|1
876174|NCT00560833|1838321|FG001|Overall Study|Other|1
876175|NCT00560833|1838322|FG002|Overall Study|Other|3
876176|NCT00560833|1838323|FG003|Overall Study|Other|0
876177|NCT00560833|1838324|FG004|Overall Study|Other|0
876178|NCT00560833|1838320|FG000|Overall Study|Never received drug|0
876179|NCT00560833|1838321|FG001|Overall Study|Never received drug|1
876180|NCT00560833|1838322|FG002|Overall Study|Never received drug|0
876181|NCT00560833|1838323|FG003|Overall Study|Never received drug|0
876182|NCT00560833|1838324|FG004|Overall Study|Never received drug|1
876183|NCT00560885|1838346|FG000|Overall Study|Death|7
876184|NCT00560885|1838346|FG000|Overall Study|Withdrawal by Subject|1
876185|NCT00560937|1838352|FG000|Overall Study|Withdrawal by Subject|0
876186|NCT00560937|1838353|FG001|Overall Study|Withdrawal by Subject|1
876187|NCT00560937|1838352|FG000|Overall Study|Physician Decision|1
876188|NCT00560937|1838353|FG001|Overall Study|Physician Decision|1
876189|NCT00560950|1838361|FG000|Overall Study|Lost to Follow-up|1
1180553|NCT03921424|2337946|FG000|Overall Study|Lost to Follow-up|0
1180554|NCT03921424|2337947|FG001|Overall Study|Lost to Follow-up|1
1180555|NCT03921424|2337946|FG000|Overall Study|Withdrawal By Parent/Guardian|0
1180556|NCT03921424|2337947|FG001|Overall Study|Withdrawal By Parent/Guardian|2
1180557|NCT03598777|2337974|FG000|Overall Study|Study Terminated by Sponsor|3
1180558|NCT03598777|2337975|FG001|Overall Study|Study Terminated by Sponsor|0
1180559|NCT03598777|2337976|FG002|Overall Study|Study Terminated by Sponsor|0
1180560|NCT03598777|2337977|FG003|Overall Study|Study Terminated by Sponsor|0
1180561|NCT03598777|2337978|FG004|Overall Study|Study Terminated by Sponsor|15
1180562|NCT03598777|2337974|FG000|Overall Study|Withdrawal by Subject|1
1180563|NCT03598777|2337975|FG001|Overall Study|Withdrawal by Subject|1
1180564|NCT03598777|2337976|FG002|Overall Study|Withdrawal by Subject|0
1180565|NCT03598777|2337977|FG003|Overall Study|Withdrawal by Subject|0
1180566|NCT03598777|2337978|FG004|Overall Study|Withdrawal by Subject|0
876190|NCT00560950|1838362|FG001|Overall Study|Lost to Follow-up|0
1180567|NCT03598777|2337974|FG000|Overall Study|Adverse Event|1
1180568|NCT03598777|2337975|FG001|Overall Study|Adverse Event|0
1180569|NCT03598777|2337976|FG002|Overall Study|Adverse Event|0
1180570|NCT03598777|2337977|FG003|Overall Study|Adverse Event|0
1180571|NCT03598777|2337978|FG004|Overall Study|Adverse Event|0
1180572|NCT03598777|2337974|FG000|Overall Study|Lost to Follow-up|1
1180573|NCT03598777|2337975|FG001|Overall Study|Lost to Follow-up|0
1180574|NCT03598777|2337976|FG002|Overall Study|Lost to Follow-up|0
1180575|NCT03598777|2337977|FG003|Overall Study|Lost to Follow-up|0
1180576|NCT03598777|2337978|FG004|Overall Study|Lost to Follow-up|0
876191|NCT00561015|1838385|FG000|Overall Study|Adverse Event|0
876192|NCT00561015|1838386|FG001|Overall Study|Adverse Event|0
876193|NCT00561015|1838387|FG002|Overall Study|Adverse Event|0
876194|NCT00561015|1838388|FG003|Overall Study|Adverse Event|0
876195|NCT00561015|1838389|FG004|Overall Study|Adverse Event|1
876196|NCT00561015|1838390|FG005|Overall Study|Adverse Event|0
876197|NCT00561015|1838385|FG000|Overall Study|Lost to Follow-up|2
876198|NCT00561015|1838386|FG001|Overall Study|Lost to Follow-up|0
876199|NCT00561015|1838387|FG002|Overall Study|Lost to Follow-up|0
876200|NCT00561015|1838388|FG003|Overall Study|Lost to Follow-up|1
876201|NCT00561015|1838389|FG004|Overall Study|Lost to Follow-up|0
876202|NCT00561015|1838390|FG005|Overall Study|Lost to Follow-up|3
876203|NCT00561015|1838385|FG000|Overall Study|Participant non-compliance|2
876204|NCT00561015|1838386|FG001|Overall Study|Participant non-compliance|0
876205|NCT00561015|1838387|FG002|Overall Study|Participant non-compliance|0
876206|NCT00561015|1838388|FG003|Overall Study|Participant non-compliance|0
876207|NCT00561015|1838389|FG004|Overall Study|Participant non-compliance|0
876208|NCT00561015|1838390|FG005|Overall Study|Participant non-compliance|0
876209|NCT00561080|1838411|FG000|Vaccination Period (up to Month 4)|Adverse Event|0
876210|NCT00561080|1838412|FG001|Vaccination Period (up to Month 4)|Adverse Event|4
876211|NCT00561080|1838413|FG002|Vaccination Period (up to Month 4)|Adverse Event|6
876212|NCT00561080|1838411|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
876213|NCT00561080|1838412|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
876214|NCT00561080|1838413|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
876215|NCT00561080|1838411|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0
876216|NCT00561080|1838412|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1
876217|NCT00561080|1838413|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3
876218|NCT00561080|1838411|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
876219|NCT00561080|1838412|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
876220|NCT00561080|1838413|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
876221|NCT00561080|1838411|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0
876222|NCT00561080|1838412|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1
876223|NCT00561080|1838413|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0
876224|NCT00561080|1838411|FG000|Vaccination Period (up to Month 4)|Other|0
876225|NCT00561080|1838412|FG001|Vaccination Period (up to Month 4)|Other|2
876226|NCT00561080|1838413|FG002|Vaccination Period (up to Month 4)|Other|1
876227|NCT00561080|1838411|FG000|12-month Post Last Dose Follow-up|Adverse Event|3
876228|NCT00561080|1838412|FG001|12-month Post Last Dose Follow-up|Adverse Event|3
876229|NCT00561080|1838413|FG002|12-month Post Last Dose Follow-up|Adverse Event|1
876230|NCT00561080|1838411|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0
876231|NCT00561080|1838412|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0
876232|NCT00561080|1838413|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4
876233|NCT00561080|1838411|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
1180595|NCT03406078|2338017|FG000|Overall Study|Death|1
1180596|NCT03406078|2338018|FG001|Overall Study|Death|0
1180597|NCT03406078|2338017|FG000|Overall Study|Lost to Follow-up|0
1180598|NCT03406078|2338018|FG001|Overall Study|Lost to Follow-up|1
1180599|NCT03406078|2338017|FG000|Overall Study|Withdrawal by Subject|5
1180600|NCT03406078|2338018|FG001|Overall Study|Withdrawal by Subject|2
1180601|NCT03345342|2338040|FG000|Open-Label Phase|Adverse Event|30
1180602|NCT03345342|2338041|FG001|Open-Label Phase|Adverse Event|0
1180603|NCT03345342|2338042|FG002|Open-Label Phase|Adverse Event|0
1180604|NCT03345342|2338043|FG003|Open-Label Phase|Adverse Event|0
1180605|NCT03345342|2338044|FG004|Open-Label Phase|Adverse Event|0
1180606|NCT03345342|2338040|FG000|Open-Label Phase|Death|1
1180607|NCT03345342|2338041|FG001|Open-Label Phase|Death|0
1180608|NCT03345342|2338042|FG002|Open-Label Phase|Death|0
1180609|NCT03345342|2338043|FG003|Open-Label Phase|Death|0
1180610|NCT03345342|2338044|FG004|Open-Label Phase|Death|0
1180611|NCT03345342|2338040|FG000|Open-Label Phase|Initiated Prohibited Medication|2
1180612|NCT03345342|2338041|FG001|Open-Label Phase|Initiated Prohibited Medication|0
1180613|NCT03345342|2338042|FG002|Open-Label Phase|Initiated Prohibited Medication|0
1180614|NCT03345342|2338043|FG003|Open-Label Phase|Initiated Prohibited Medication|0
1180615|NCT03345342|2338044|FG004|Open-Label Phase|Initiated Prohibited Medication|0
1180616|NCT03345342|2338040|FG000|Open-Label Phase|Lack of Efficacy|6
1180617|NCT03345342|2338041|FG001|Open-Label Phase|Lack of Efficacy|0
1180618|NCT03345342|2338042|FG002|Open-Label Phase|Lack of Efficacy|0
1180619|NCT03345342|2338043|FG003|Open-Label Phase|Lack of Efficacy|0
1180620|NCT03345342|2338044|FG004|Open-Label Phase|Lack of Efficacy|0
1180621|NCT03345342|2338040|FG000|Open-Label Phase|Lost to Follow-up|9
1180622|NCT03345342|2338041|FG001|Open-Label Phase|Lost to Follow-up|0
1180623|NCT03345342|2338042|FG002|Open-Label Phase|Lost to Follow-up|0
1180624|NCT03345342|2338043|FG003|Open-Label Phase|Lost to Follow-up|0
1180625|NCT03345342|2338044|FG004|Open-Label Phase|Lost to Follow-up|0
1180626|NCT03345342|2338040|FG000|Open-Label Phase|Non-Compliance with Study Drug|4
1180627|NCT03345342|2338041|FG001|Open-Label Phase|Non-Compliance with Study Drug|0
1180628|NCT03345342|2338042|FG002|Open-Label Phase|Non-Compliance with Study Drug|0
1180629|NCT03345342|2338043|FG003|Open-Label Phase|Non-Compliance with Study Drug|0
1180630|NCT03345342|2338044|FG004|Open-Label Phase|Non-Compliance with Study Drug|0
1180631|NCT03345342|2338040|FG000|Open-Label Phase|Physician Decision|4
1180632|NCT03345342|2338041|FG001|Open-Label Phase|Physician Decision|0
1180633|NCT03345342|2338042|FG002|Open-Label Phase|Physician Decision|0
1180634|NCT03345342|2338043|FG003|Open-Label Phase|Physician Decision|0
1180635|NCT03345342|2338044|FG004|Open-Label Phase|Physician Decision|0
876234|NCT00561080|1838412|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
876235|NCT00561080|1838413|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
876236|NCT00561080|1838411|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2
876237|NCT00561080|1838412|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0
876238|NCT00561080|1838413|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0
876239|NCT00561340|1838434|FG000|Overall Study|refused to drink pediasure|6
876240|NCT00561340|1838435|FG001|Overall Study|refused to drink pediasure|0
876241|NCT00561353|1838451|FG000|Overall Study|Subject reached a virologic endpoint|2
876242|NCT00561353|1838452|FG001|Overall Study|Subject reached a virologic endpoint|1
876243|NCT00561353|1838453|FG002|Overall Study|Subject reached a virologic endpoint|1
876244|NCT00561353|1838454|FG003|Overall Study|Subject reached a virologic endpoint|4
876245|NCT00561353|1838455|FG004|Overall Study|Subject reached a virologic endpoint|1
876246|NCT00561353|1838456|FG005|Overall Study|Subject reached a virologic endpoint|3
876247|NCT00561353|1838457|FG006|Overall Study|Subject reached a virologic endpoint|4
876248|NCT00561353|1838458|FG007|Overall Study|Subject reached a virologic endpoint|4
876249|NCT00561353|1838459|FG008|Overall Study|Subject reached a virologic endpoint|5
876250|NCT00561353|1838460|FG009|Overall Study|Subject reached a virologic endpoint|0
876251|NCT00561353|1838451|FG000|Overall Study|Subject ineligible to continue the trial|0
876252|NCT00561353|1838452|FG001|Overall Study|Subject ineligible to continue the trial|0
876253|NCT00561353|1838453|FG002|Overall Study|Subject ineligible to continue the trial|0
876254|NCT00561353|1838454|FG003|Overall Study|Subject ineligible to continue the trial|0
876255|NCT00561353|1838455|FG004|Overall Study|Subject ineligible to continue the trial|0
876256|NCT00561353|1838456|FG005|Overall Study|Subject ineligible to continue the trial|1
876257|NCT00561353|1838457|FG006|Overall Study|Subject ineligible to continue the trial|1
1180636|NCT03345342|2338040|FG000|Open-Label Phase|Protocol Violation|8
1180637|NCT03345342|2338041|FG001|Open-Label Phase|Protocol Violation|0
1180638|NCT03345342|2338042|FG002|Open-Label Phase|Protocol Violation|0
1180639|NCT03345342|2338043|FG003|Open-Label Phase|Protocol Violation|0
1180640|NCT03345342|2338044|FG004|Open-Label Phase|Protocol Violation|0
1180641|NCT03345342|2338040|FG000|Open-Label Phase|Withdrawal by Subject|57
1180642|NCT03345342|2338041|FG001|Open-Label Phase|Withdrawal by Subject|0
1180643|NCT03345342|2338042|FG002|Open-Label Phase|Withdrawal by Subject|0
1180644|NCT03345342|2338043|FG003|Open-Label Phase|Withdrawal by Subject|0
1180645|NCT03345342|2338044|FG004|Open-Label Phase|Withdrawal by Subject|0
1180646|NCT03345342|2338040|FG000|Open-Label Phase|Other|15
876258|NCT00561353|1838458|FG007|Overall Study|Subject ineligible to continue the trial|0
876259|NCT00561353|1838459|FG008|Overall Study|Subject ineligible to continue the trial|2
876260|NCT00561353|1838460|FG009|Overall Study|Subject ineligible to continue the trial|1
876261|NCT00561353|1838451|FG000|Overall Study|Other|1
876262|NCT00561353|1838452|FG001|Overall Study|Other|0
876263|NCT00561353|1838453|FG002|Overall Study|Other|1
876264|NCT00561353|1838454|FG003|Overall Study|Other|0
876265|NCT00561353|1838455|FG004|Overall Study|Other|0
876266|NCT00561353|1838456|FG005|Overall Study|Other|2
876267|NCT00561353|1838457|FG006|Overall Study|Other|0
876268|NCT00561353|1838458|FG007|Overall Study|Other|0
876269|NCT00561353|1838459|FG008|Overall Study|Other|0
1180647|NCT03345342|2338041|FG001|Open-Label Phase|Other|0
1180648|NCT03345342|2338042|FG002|Open-Label Phase|Other|0
1180649|NCT03345342|2338043|FG003|Open-Label Phase|Other|0
1180650|NCT03345342|2338044|FG004|Open-Label Phase|Other|0
1180651|NCT03345342|2338040|FG000|Double-Blind Phase|Adverse Event|0
1180652|NCT03345342|2338041|FG001|Double-Blind Phase|Adverse Event|1
1180653|NCT03345342|2338042|FG002|Double-Blind Phase|Adverse Event|6
1180654|NCT03345342|2338043|FG003|Double-Blind Phase|Adverse Event|0
1180655|NCT03345342|2338044|FG004|Double-Blind Phase|Adverse Event|0
1180656|NCT03345342|2338040|FG000|Double-Blind Phase|Death|0
1180657|NCT03345342|2338041|FG001|Double-Blind Phase|Death|2
1180658|NCT03345342|2338042|FG002|Double-Blind Phase|Death|1
1180659|NCT03345342|2338043|FG003|Double-Blind Phase|Death|0
1180660|NCT03345342|2338044|FG004|Double-Blind Phase|Death|0
1180661|NCT03345342|2338040|FG000|Double-Blind Phase|Initiated Prohibited Medication|0
1180662|NCT03345342|2338041|FG001|Double-Blind Phase|Initiated Prohibited Medication|0
1180663|NCT03345342|2338042|FG002|Double-Blind Phase|Initiated Prohibited Medication|2
1180664|NCT03345342|2338043|FG003|Double-Blind Phase|Initiated Prohibited Medication|0
1180665|NCT03345342|2338044|FG004|Double-Blind Phase|Initiated Prohibited Medication|0
1180666|NCT03345342|2338040|FG000|Double-Blind Phase|Lost to Follow-up|0
1180667|NCT03345342|2338041|FG001|Double-Blind Phase|Lost to Follow-up|1
1180668|NCT03345342|2338042|FG002|Double-Blind Phase|Lost to Follow-up|7
1180669|NCT03345342|2338043|FG003|Double-Blind Phase|Lost to Follow-up|0
1180670|NCT03345342|2338044|FG004|Double-Blind Phase|Lost to Follow-up|0
1180671|NCT03345342|2338040|FG000|Double-Blind Phase|Physician Decision|0
1180672|NCT03345342|2338041|FG001|Double-Blind Phase|Physician Decision|1
1180673|NCT03345342|2338042|FG002|Double-Blind Phase|Physician Decision|4
1180674|NCT03345342|2338043|FG003|Double-Blind Phase|Physician Decision|0
1180675|NCT03345342|2338044|FG004|Double-Blind Phase|Physician Decision|0
1180676|NCT03345342|2338040|FG000|Double-Blind Phase|Protocol Violation|0
1180677|NCT03345342|2338041|FG001|Double-Blind Phase|Protocol Violation|0
1180678|NCT03345342|2338042|FG002|Double-Blind Phase|Protocol Violation|1
1180679|NCT03345342|2338043|FG003|Double-Blind Phase|Protocol Violation|0
1180680|NCT03345342|2338044|FG004|Double-Blind Phase|Protocol Violation|0
1180681|NCT03345342|2338040|FG000|Double-Blind Phase|Withdrawal by Subject|0
1180682|NCT03345342|2338041|FG001|Double-Blind Phase|Withdrawal by Subject|16
1180683|NCT03345342|2338042|FG002|Double-Blind Phase|Withdrawal by Subject|38
1180684|NCT03345342|2338043|FG003|Double-Blind Phase|Withdrawal by Subject|0
1180685|NCT03345342|2338044|FG004|Double-Blind Phase|Withdrawal by Subject|0
1180686|NCT03345342|2338040|FG000|Double-Blind Phase|Other|0
1180687|NCT03345342|2338041|FG001|Double-Blind Phase|Other|1
1180688|NCT03345342|2338042|FG002|Double-Blind Phase|Other|3
1180689|NCT03345342|2338043|FG003|Double-Blind Phase|Other|0
1180690|NCT03345342|2338044|FG004|Double-Blind Phase|Other|0
1180691|NCT03345342|2338040|FG000|Follow-Up Phase|Adverse Event|0
1180692|NCT03345342|2338041|FG001|Follow-Up Phase|Adverse Event|0
1180693|NCT03345342|2338042|FG002|Follow-Up Phase|Adverse Event|0
1180694|NCT03345342|2338043|FG003|Follow-Up Phase|Adverse Event|0
1180695|NCT03345342|2338044|FG004|Follow-Up Phase|Adverse Event|4
1180696|NCT03345342|2338040|FG000|Follow-Up Phase|Lost to Follow-up|0
1180697|NCT03345342|2338041|FG001|Follow-Up Phase|Lost to Follow-up|0
1180698|NCT03345342|2338042|FG002|Follow-Up Phase|Lost to Follow-up|0
1180699|NCT03345342|2338043|FG003|Follow-Up Phase|Lost to Follow-up|0
1180700|NCT03345342|2338044|FG004|Follow-Up Phase|Lost to Follow-up|6
1180701|NCT03345342|2338040|FG000|Follow-Up Phase|Physician Decision|0
1180702|NCT03345342|2338041|FG001|Follow-Up Phase|Physician Decision|0
1180703|NCT03345342|2338042|FG002|Follow-Up Phase|Physician Decision|0
1180704|NCT03345342|2338043|FG003|Follow-Up Phase|Physician Decision|0
1180705|NCT03345342|2338044|FG004|Follow-Up Phase|Physician Decision|5
1180706|NCT03345342|2338040|FG000|Follow-Up Phase|Withdrawal by Subject|0
1180707|NCT03345342|2338041|FG001|Follow-Up Phase|Withdrawal by Subject|0
876270|NCT00561353|1838460|FG009|Overall Study|Other|0
1180708|NCT03345342|2338042|FG002|Follow-Up Phase|Withdrawal by Subject|0
1180709|NCT03345342|2338043|FG003|Follow-Up Phase|Withdrawal by Subject|5
1180710|NCT03345342|2338044|FG004|Follow-Up Phase|Withdrawal by Subject|15
1180711|NCT03345342|2338040|FG000|Follow-Up Phase|Other|0
1180712|NCT03345342|2338041|FG001|Follow-Up Phase|Other|0
1180713|NCT03345342|2338042|FG002|Follow-Up Phase|Other|0
1180714|NCT03345342|2338043|FG003|Follow-Up Phase|Other|3
1180715|NCT03345342|2338044|FG004|Follow-Up Phase|Other|1
1180716|NCT03265145|2338058|FG000|Overall Study|Protocol Violation|2
1180717|NCT03265145|2338059|FG001|Overall Study|Protocol Violation|0
1180718|NCT03265145|2338058|FG000|Overall Study|Adverse Event|1
1180719|NCT03265145|2338059|FG001|Overall Study|Adverse Event|0
1180720|NCT03265145|2338058|FG000|Overall Study|Withdrawal by Subject|23
1180721|NCT03265145|2338059|FG001|Overall Study|Withdrawal by Subject|19
1180722|NCT03265145|2338058|FG000|Overall Study|Death|12
1180723|NCT03265145|2338059|FG001|Overall Study|Death|12
1180724|NCT03265145|2338058|FG000|Overall Study|Lost to Follow-up|13
1180725|NCT03265145|2338059|FG001|Overall Study|Lost to Follow-up|9
1180726|NCT03265145|2338058|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0
1180727|NCT03265145|2338059|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1
1180728|NCT03265145|2338058|FG000|Overall Study|Switched back to previous medication|1
1180729|NCT03265145|2338059|FG001|Overall Study|Switched back to previous medication|0
1180730|NCT03265145|2338058|FG000|Overall Study|Did not want to take medication|1
1180731|NCT03265145|2338059|FG001|Overall Study|Did not want to take medication|0
1180732|NCT03265145|2338058|FG000|Overall Study|Subject could not afford medication|0
1180733|NCT03265145|2338059|FG001|Overall Study|Subject could not afford medication|1
1180734|NCT03265145|2338058|FG000|Overall Study|Site closed|2
1180735|NCT03265145|2338059|FG001|Overall Study|Site closed|3
1180736|NCT03265145|2338058|FG000|Overall Study|Incorrectly randomized|16
1180737|NCT03265145|2338059|FG001|Overall Study|Incorrectly randomized|6
1180738|NCT03265145|2338058|FG000|Overall Study|Entered into Electronic Data Capture in error|0
1180739|NCT03265145|2338059|FG001|Overall Study|Entered into Electronic Data Capture in error|1
1180740|NCT03265145|2338058|FG000|Overall Study|Physician Decision|0
1180741|NCT03265145|2338059|FG001|Overall Study|Physician Decision|3
1180742|NCT03265145|2338058|FG000|Overall Study|Subject transferred to another facility|0
1180743|NCT03265145|2338059|FG001|Overall Study|Subject transferred to another facility|1
1180744|NCT03197935|2338074|FG000|Overall Study|Death due to any cause|9
1180745|NCT03197935|2338075|FG001|Overall Study|Death due to any cause|7
1180746|NCT03197935|2338074|FG000|Overall Study|Lost to Follow-up|0
1180747|NCT03197935|2338075|FG001|Overall Study|Lost to Follow-up|3
1180748|NCT03197935|2338074|FG000|Overall Study|Physician Decision|0
1180749|NCT03197935|2338075|FG001|Overall Study|Physician Decision|1
1180750|NCT03197935|2338074|FG000|Overall Study|Withdrawal by Subject|11
1180751|NCT03197935|2338075|FG001|Overall Study|Withdrawal by Subject|7
1180752|NCT03197935|2338074|FG000|Overall Study|On-Going in Study|147
1180753|NCT03197935|2338075|FG001|Overall Study|On-Going in Study|146
1180754|NCT03197935|2338074|FG000|Overall Study|Did not receive any study treatment|1
1180755|NCT03197935|2338075|FG001|Overall Study|Did not receive any study treatment|1
1180761|NCT02880241|2338117|FG000|Overall Study|Lack of Efficacy|1
1180762|NCT02880241|2338118|FG001|Overall Study|Lack of Efficacy|0
1180763|NCT02880241|2338119|FG002|Overall Study|Lack of Efficacy|0
1180764|NCT02880241|2338120|FG003|Overall Study|Lack of Efficacy|0
1180765|NCT02880241|2338121|FG004|Overall Study|Lack of Efficacy|0
1180766|NCT02880241|2338122|FG005|Overall Study|Lack of Efficacy|0
1180767|NCT02832687|2338140|FG000|Overall Study|Adverse Event|0
1180768|NCT02832687|2338141|FG001|Overall Study|Adverse Event|2
1180769|NCT02499900|2338153|FG000|Core Study Period|Other|1
1180770|NCT02499900|2338154|FG001|Core Study Period|Other|4
1180771|NCT02499900|2338153|FG000|Core Study Period|Lost to Follow-up|1
1180772|NCT02499900|2338154|FG001|Core Study Period|Lost to Follow-up|2
1180773|NCT02499900|2338153|FG000|Core Study Period|Per sponsor request|0
1180774|NCT02499900|2338154|FG001|Core Study Period|Per sponsor request|1
1180775|NCT02499900|2338153|FG000|Core Study Period|Pregnancy|1
1180776|NCT02499900|2338154|FG001|Core Study Period|Pregnancy|0
1180777|NCT02499900|2338153|FG000|Core Study Period|Protocol Violation|3
1180778|NCT02499900|2338154|FG001|Core Study Period|Protocol Violation|0
1180779|NCT02499900|2338153|FG000|Core Study Period|Withdrawal by Subject|11
1180780|NCT02499900|2338154|FG001|Core Study Period|Withdrawal by Subject|10
1180781|NCT02499900|2338153|FG000|Core Study Period|Adverse Event|18
1180782|NCT02499900|2338154|FG001|Core Study Period|Adverse Event|14
1180783|NCT02499900|2338153|FG000|Core Study Period|Death|0
1180784|NCT02499900|2338154|FG001|Core Study Period|Death|1
1180785|NCT02499900|2338153|FG000|Completed Core, Continued Into Extension|Physician Decision|1
1180786|NCT02499900|2338154|FG001|Completed Core, Continued Into Extension|Physician Decision|0
1180787|NCT02499900|2338153|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0
1180788|NCT02499900|2338154|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2
1180789|NCT02499900|2338153|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
1180790|NCT02499900|2338154|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
1180791|NCT02499900|2338153|FG000|Completed Core, Continued Into Extension|Personal motivation|1
1180792|NCT02499900|2338154|FG001|Completed Core, Continued Into Extension|Personal motivation|0
1180793|NCT02499900|2338153|FG000|Extension Study Period|Adverse Event|2
1180794|NCT02499900|2338154|FG001|Extension Study Period|Adverse Event|4
1180795|NCT02499900|2338153|FG000|Extension Study Period|Withdrawal by Subject|5
1180796|NCT02499900|2338154|FG001|Extension Study Period|Withdrawal by Subject|2
1180797|NCT02499900|2338153|FG000|Extension Study Period|Physician Decision|2
1180798|NCT02499900|2338154|FG001|Extension Study Period|Physician Decision|5
1180799|NCT02499900|2338153|FG000|Extension Study Period|Pregnancy|1
1180800|NCT02499900|2338154|FG001|Extension Study Period|Pregnancy|2
1180801|NCT02499900|2338153|FG000|Extension Study Period|Lost to Follow-up|2
1180802|NCT02499900|2338154|FG001|Extension Study Period|Lost to Follow-up|5
1180803|NCT02499900|2338153|FG000|Extension Study Period|Other|0
1180804|NCT02499900|2338154|FG001|Extension Study Period|Other|2
1180805|NCT02269917|2338181|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25
1180806|NCT02269917|2338182|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7
1180807|NCT02269917|2338183|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0
1180808|NCT02269917|2338181|FG000|BL to EOE-Test and BL to Switch-Control|Other|19
1180809|NCT02269917|2338182|FG001|BL to EOE-Test and BL to Switch-Control|Other|4
1180810|NCT02269917|2338183|FG002|BL to EOE-Test and BL to Switch-Control|Other|0
1180811|NCT02269917|2338181|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32
1180812|NCT02269917|2338182|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10
1180813|NCT02269917|2338183|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0
1180814|NCT02269917|2338181|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24
1180815|NCT02269917|2338182|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4
1180816|NCT02269917|2338183|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0
1180817|NCT02269917|2338181|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4
1180818|NCT02269917|2338182|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
1180819|NCT02269917|2338183|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
1180820|NCT02269917|2338181|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4
1180821|NCT02269917|2338182|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
1180822|NCT02269917|2338183|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
1180823|NCT02269917|2338181|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2
1180824|NCT02269917|2338182|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1
1180825|NCT02269917|2338183|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0
1180826|NCT02269917|2338181|FG000|BL to EOE-Test and BL to Switch-Control|Death|4
1180827|NCT02269917|2338182|FG001|BL to EOE-Test and BL to Switch-Control|Death|0
1180828|NCT02269917|2338183|FG002|BL to EOE-Test and BL to Switch-Control|Death|0
1180829|NCT02269917|2338181|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3
1180830|NCT02269917|2338182|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5
1180831|NCT02269917|2338183|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0
1180832|NCT02269917|2338181|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
1180833|NCT02269917|2338182|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
1180834|NCT02269917|2338183|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
1180835|NCT02269917|2338181|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
1180836|NCT02269917|2338182|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
1180837|NCT02269917|2338183|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10
1180838|NCT02269917|2338181|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
1180839|NCT02269917|2338182|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
1180840|NCT02269917|2338183|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11
1180841|NCT02269917|2338181|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
1180842|NCT02269917|2338182|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
1180843|NCT02269917|2338183|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
1180844|NCT02269917|2338181|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
1180845|NCT02269917|2338182|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
1180846|NCT02269917|2338183|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2
1180847|NCT02269917|2338181|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
1180848|NCT02269917|2338182|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
1180849|NCT02269917|2338183|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5
1180850|NCT02269917|2338181|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
1180851|NCT02269917|2338182|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
1180852|NCT02269917|2338183|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8
1180853|NCT02225366|2338194|FG000|Overall Study|Lack of Efficacy|1
1180854|NCT02225366|2338195|FG001|Overall Study|Lack of Efficacy|0
1180859|NCT02021773|2338208|FG000|Overall Study|Adverse Event|1
1180860|NCT02021773|2338209|FG001|Overall Study|Adverse Event|4
1180861|NCT02021773|2338210|FG002|Overall Study|Adverse Event|3
1180862|NCT02021773|2338208|FG000|Overall Study|Lack of Efficacy|2
1180863|NCT02021773|2338209|FG001|Overall Study|Lack of Efficacy|2
1180864|NCT02021773|2338210|FG002|Overall Study|Lack of Efficacy|2
1180865|NCT02021773|2338208|FG000|Overall Study|Protocol Violation|2
1180866|NCT02021773|2338209|FG001|Overall Study|Protocol Violation|3
1180867|NCT02021773|2338210|FG002|Overall Study|Protocol Violation|1
1180868|NCT02021773|2338208|FG000|Overall Study|Withdrawal by Subject|3
1180869|NCT02021773|2338209|FG001|Overall Study|Withdrawal by Subject|4
1180870|NCT02021773|2338210|FG002|Overall Study|Withdrawal by Subject|5
1180871|NCT02021773|2338208|FG000|Overall Study|Lost to Follow-up|1
1180872|NCT02021773|2338209|FG001|Overall Study|Lost to Follow-up|3
1180873|NCT02021773|2338210|FG002|Overall Study|Lost to Follow-up|0
1180874|NCT02021773|2338208|FG000|Overall Study|Reason not specified|3
1180875|NCT02021773|2338209|FG001|Overall Study|Reason not specified|0
1180876|NCT02021773|2338210|FG002|Overall Study|Reason not specified|0
1180905|NCT01530997|2338231|FG000|Overall Study|Physician Decision|1
1180906|NCT01530997|2338231|FG000|Overall Study|Withdrawal by Subject|1
1180907|NCT01067521|2338257|FG000|Double-Blind Placebo-Controlled Period|Death|0
1180908|NCT01067521|2338258|FG001|Double-Blind Placebo-Controlled Period|Death|1
876271|NCT00561353|1838451|FG000|Overall Study|Adverse Event|0
876272|NCT00561353|1838452|FG001|Overall Study|Adverse Event|0
876273|NCT00561353|1838453|FG002|Overall Study|Adverse Event|0
876274|NCT00561353|1838454|FG003|Overall Study|Adverse Event|2
876275|NCT00561353|1838455|FG004|Overall Study|Adverse Event|0
876276|NCT00561353|1838456|FG005|Overall Study|Adverse Event|0
876277|NCT00561353|1838457|FG006|Overall Study|Adverse Event|1
876278|NCT00561353|1838458|FG007|Overall Study|Adverse Event|0
876279|NCT00561353|1838459|FG008|Overall Study|Adverse Event|0
876280|NCT00561353|1838460|FG009|Overall Study|Adverse Event|1
876281|NCT00561353|1838451|FG000|Overall Study|Lost to Follow-up|2
876282|NCT00561353|1838452|FG001|Overall Study|Lost to Follow-up|0
876283|NCT00561353|1838453|FG002|Overall Study|Lost to Follow-up|1
876284|NCT00561353|1838454|FG003|Overall Study|Lost to Follow-up|0
876285|NCT00561353|1838455|FG004|Overall Study|Lost to Follow-up|0
876286|NCT00561353|1838456|FG005|Overall Study|Lost to Follow-up|0
876287|NCT00561353|1838457|FG006|Overall Study|Lost to Follow-up|0
876288|NCT00561353|1838458|FG007|Overall Study|Lost to Follow-up|0
876289|NCT00561353|1838459|FG008|Overall Study|Lost to Follow-up|0
876290|NCT00561353|1838460|FG009|Overall Study|Lost to Follow-up|0
876291|NCT00561353|1838451|FG000|Overall Study|Withdrawal by Subject|0
876292|NCT00561353|1838452|FG001|Overall Study|Withdrawal by Subject|2
876293|NCT00561353|1838453|FG002|Overall Study|Withdrawal by Subject|0
876294|NCT00561353|1838454|FG003|Overall Study|Withdrawal by Subject|0
876295|NCT00561353|1838455|FG004|Overall Study|Withdrawal by Subject|0
876296|NCT00561353|1838456|FG005|Overall Study|Withdrawal by Subject|0
876297|NCT00561353|1838457|FG006|Overall Study|Withdrawal by Subject|0
876298|NCT00561353|1838458|FG007|Overall Study|Withdrawal by Subject|0
876299|NCT00561353|1838459|FG008|Overall Study|Withdrawal by Subject|0
876300|NCT00561353|1838460|FG009|Overall Study|Withdrawal by Subject|0
876301|NCT00561392|1838522|FG000|Overall Study|Adverse Event|38
876302|NCT00561392|1838522|FG000|Overall Study|Lack of Efficacy|2
876303|NCT00561392|1838522|FG000|Overall Study|Protocol Violation|1
876304|NCT00561392|1838522|FG000|Overall Study|Withdrawal by Subject|8
876305|NCT00561392|1838522|FG000|Overall Study|Administrative problems|4
876306|NCT00561470|1838545|FG000|Overall Study|Adverse Event|74
876307|NCT00561470|1838546|FG001|Overall Study|Adverse Event|163
1180909|NCT01067521|2338257|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29
1180910|NCT01067521|2338258|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6
1180911|NCT01067521|2338257|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
1180912|NCT01067521|2338258|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
1180913|NCT01067521|2338257|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1
1180914|NCT01067521|2338258|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1
1180915|NCT01067521|2338257|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
1180916|NCT01067521|2338258|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
1180917|NCT01067521|2338257|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
1180918|NCT01067521|2338258|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
1180919|NCT01067521|2338257|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2
1180920|NCT01067521|2338258|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
1180921|NCT01067521|2338257|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7
1180922|NCT01067521|2338258|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4
1180923|NCT01067521|2338257|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
1180924|NCT01067521|2338258|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
1180925|NCT01067521|2338257|FG000|Open-Label Period|Death|3
1180926|NCT01067521|2338258|FG001|Open-Label Period|Death|1
1180927|NCT01067521|2338257|FG000|Open-Label Period|Adverse Event|30
1180928|NCT01067521|2338258|FG001|Open-Label Period|Adverse Event|28
1180929|NCT01067521|2338257|FG000|Open-Label Period|Withdrawal by Subject|160
1180930|NCT01067521|2338258|FG001|Open-Label Period|Withdrawal by Subject|88
1180931|NCT01067521|2338257|FG000|Open-Label Period|Physician Decision|13
1180932|NCT01067521|2338258|FG001|Open-Label Period|Physician Decision|11
1180933|NCT01067521|2338257|FG000|Open-Label Period|Non-compliance with study drug|5
1180934|NCT01067521|2338258|FG001|Open-Label Period|Non-compliance with study drug|0
1180935|NCT01067521|2338257|FG000|Open-Label Period|Protocol Violation|3
1180936|NCT01067521|2338258|FG001|Open-Label Period|Protocol Violation|0
1180937|NCT01067521|2338257|FG000|Open-Label Period|Pregnancy|14
1180938|NCT01067521|2338258|FG001|Open-Label Period|Pregnancy|8
1180939|NCT01067521|2338257|FG000|Open-Label Period|Teva requested subject to be withdrawn|5
1180940|NCT01067521|2338258|FG001|Open-Label Period|Teva requested subject to be withdrawn|2
1180941|NCT01067521|2338257|FG000|Open-Label Period|Lost to Follow-up|21
1180942|NCT01067521|2338258|FG001|Open-Label Period|Lost to Follow-up|20
1180943|NCT01047319|2338272|FG000|Overall Study|Teva requested participant withdrawal|3
1180944|NCT01047319|2338273|FG001|Overall Study|Teva requested participant withdrawal|0
1180945|NCT01047319|2338274|FG002|Overall Study|Teva requested participant withdrawal|1
1180946|NCT01047319|2338272|FG000|Overall Study|Protocol Violation|3
1180947|NCT01047319|2338273|FG001|Overall Study|Protocol Violation|2
1180948|NCT01047319|2338274|FG002|Overall Study|Protocol Violation|4
1180949|NCT01047319|2338272|FG000|Overall Study|Lack of Efficacy|4
1180950|NCT01047319|2338273|FG001|Overall Study|Lack of Efficacy|3
1180951|NCT01047319|2338274|FG002|Overall Study|Lack of Efficacy|3
1180952|NCT01047319|2338272|FG000|Overall Study|Death|5
1180953|NCT01047319|2338273|FG001|Overall Study|Death|1
1180954|NCT01047319|2338274|FG002|Overall Study|Death|5
1180955|NCT01047319|2338272|FG000|Overall Study|Pregnancy|13
876308|NCT00561470|1838545|FG000|Overall Study|Disease progression|437
876309|NCT00561470|1838546|FG001|Overall Study|Disease progression|305
876310|NCT00561470|1838545|FG000|Overall Study|poor compliance to protocol|4
876311|NCT00561470|1838546|FG001|Overall Study|poor compliance to protocol|4
876312|NCT00561470|1838545|FG000|Overall Study|Lost to Follow-up|2
876313|NCT00561470|1838546|FG001|Overall Study|Lost to Follow-up|0
876314|NCT00561470|1838545|FG000|Overall Study|Physician Decision|21
876315|NCT00561470|1838546|FG001|Overall Study|Physician Decision|20
876316|NCT00561470|1838545|FG000|Overall Study|Consent Withdrawn|2
876317|NCT00561470|1838546|FG001|Overall Study|Consent Withdrawn|6
876318|NCT00561470|1838545|FG000|Overall Study|Subject request|43
876319|NCT00561470|1838546|FG001|Overall Study|Subject request|77
876320|NCT00561470|1838545|FG000|Overall Study|Metastatic surgery|10
876321|NCT00561470|1838546|FG001|Overall Study|Metastatic surgery|12
876322|NCT00561470|1838545|FG000|Overall Study|Unauthorized procedure|3
876323|NCT00561470|1838546|FG001|Overall Study|Unauthorized procedure|1
876324|NCT00561470|1838545|FG000|Overall Study|Randomized but not treated|5
876325|NCT00561470|1838546|FG001|Overall Study|Randomized but not treated|5
876326|NCT00561470|1838545|FG000|Overall Study|Missed visit window|1
876327|NCT00561470|1838546|FG001|Overall Study|Missed visit window|4
876328|NCT00561470|1838545|FG000|Overall Study|Planning surgery|1
876329|NCT00561470|1838546|FG001|Overall Study|Planning surgery|1
876330|NCT00561470|1838545|FG000|Overall Study|Ongoing Treatment|11
876331|NCT00561470|1838546|FG001|Overall Study|Ongoing Treatment|14
876332|NCT00561574|1838556|FG000|Overall Study|Adverse Event|21
876333|NCT00561574|1838557|FG001|Overall Study|Adverse Event|24
876334|NCT00561574|1838556|FG000|Overall Study|Lack of Efficacy|11
876335|NCT00561574|1838557|FG001|Overall Study|Lack of Efficacy|21
876336|NCT00561574|1838556|FG000|Overall Study|Withdrawal by Subject|4
876337|NCT00561574|1838557|FG001|Overall Study|Withdrawal by Subject|4
1180956|NCT01047319|2338273|FG001|Overall Study|Pregnancy|8
1180957|NCT01047319|2338274|FG002|Overall Study|Pregnancy|8
1180958|NCT01047319|2338272|FG000|Overall Study|Physician Decision|12
1180959|NCT01047319|2338273|FG001|Overall Study|Physician Decision|9
1180960|NCT01047319|2338274|FG002|Overall Study|Physician Decision|10
1180961|NCT01047319|2338272|FG000|Overall Study|Lost to Follow-up|14
1180962|NCT01047319|2338273|FG001|Overall Study|Lost to Follow-up|10
1180963|NCT01047319|2338274|FG002|Overall Study|Lost to Follow-up|10
1180964|NCT01047319|2338272|FG000|Overall Study|Adverse Event|16
1180965|NCT01047319|2338273|FG001|Overall Study|Adverse Event|27
1180966|NCT01047319|2338274|FG002|Overall Study|Adverse Event|21
1180967|NCT01047319|2338272|FG000|Overall Study|Withdrawal by Subject|77
1180968|NCT01047319|2338273|FG001|Overall Study|Withdrawal by Subject|75
1180969|NCT01047319|2338274|FG002|Overall Study|Withdrawal by Subject|87
1180970|NCT01047319|2338272|FG000|Overall Study|Study terminated by Sponsor|198
1180971|NCT01047319|2338273|FG001|Overall Study|Study terminated by Sponsor|215
1180972|NCT01047319|2338274|FG002|Overall Study|Study terminated by Sponsor|203
1180973|NCT00988052|2338284|FG000|Overall Study|Missing|1
1180974|NCT00988052|2338285|FG001|Overall Study|Missing|0
1180975|NCT00988052|2338284|FG000|Overall Study|Teva requested subject withdrawal|3
1180976|NCT00988052|2338285|FG001|Overall Study|Teva requested subject withdrawal|1
1180977|NCT00988052|2338284|FG000|Overall Study|Death|1
1180978|NCT00988052|2338285|FG001|Overall Study|Death|3
1180979|NCT00988052|2338284|FG000|Overall Study|Protocol Violation|6
1180980|NCT00988052|2338285|FG001|Overall Study|Protocol Violation|5
1180981|NCT00988052|2338284|FG000|Overall Study|Pregnancy|6
1180982|NCT00988052|2338285|FG001|Overall Study|Pregnancy|6
1180983|NCT00988052|2338284|FG000|Overall Study|Lack of Efficacy|8
1180984|NCT00988052|2338285|FG001|Overall Study|Lack of Efficacy|7
1180985|NCT00988052|2338284|FG000|Overall Study|Lost to Follow-up|6
1180986|NCT00988052|2338285|FG001|Overall Study|Lost to Follow-up|11
1180987|NCT00988052|2338284|FG000|Overall Study|Physician Decision|27
1180988|NCT00988052|2338285|FG001|Overall Study|Physician Decision|28
1180989|NCT00988052|2338284|FG000|Overall Study|Adverse Event|35
1180990|NCT00988052|2338285|FG001|Overall Study|Adverse Event|28
1180991|NCT00988052|2338284|FG000|Overall Study|Withdrawal by Subject|90
1180992|NCT00988052|2338285|FG001|Overall Study|Withdrawal by Subject|91
1180993|NCT00988052|2338284|FG000|Overall Study|Study terminated by sponsor|240
1180994|NCT00988052|2338285|FG001|Overall Study|Study terminated by sponsor|236
1180995|NCT00861705|2338295|FG000|Overall Study|Never Began Treatment|7
876338|NCT00561574|1838556|FG000|Overall Study|Reason Unrelated to Trial|6
876339|NCT00561574|1838557|FG001|Overall Study|Reason Unrelated to Trial|2
876340|NCT00561574|1838556|FG000|Overall Study|Lost to Follow-up|1
876341|NCT00561574|1838557|FG001|Overall Study|Lost to Follow-up|0
876342|NCT00561574|1838556|FG000|Overall Study|Other|5
876343|NCT00561574|1838557|FG001|Overall Study|Other|7
876344|NCT00561652|1838576|FG000|Overall Study|Withdrawal by Subject|0
876345|NCT00561652|1838577|FG001|Overall Study|Withdrawal by Subject|1
876346|NCT00561678|1838585|FG000|Overall Study|Withdrawal by Subject|4
876347|NCT00561678|1838586|FG001|Overall Study|Withdrawal by Subject|3
876348|NCT00561678|1838585|FG000|Overall Study|surgery cancelled|1
876349|NCT00561678|1838586|FG001|Overall Study|surgery cancelled|1
876350|NCT00561678|1838585|FG000|Overall Study|surgery rescheduled to different site|2
876351|NCT00561678|1838586|FG001|Overall Study|surgery rescheduled to different site|2
876352|NCT00561678|1838585|FG000|Overall Study|anesthesia provider refusal|1
876353|NCT00561678|1838586|FG001|Overall Study|anesthesia provider refusal|0
876354|NCT00561730|1838592|FG000|Overall Study|Adverse Event|2
876355|NCT00561730|1838592|FG000|Overall Study|Handling of the drug|1
876356|NCT00561730|1838592|FG000|Overall Study|Lost to Follow-up|5
876357|NCT00561730|1838592|FG000|Overall Study|Not specified reasons|1
876358|NCT00561821|1838602|FG000|Overall Study|Not treated|0
876359|NCT00561821|1838603|FG001|Overall Study|Not treated|0
876360|NCT00561821|1838604|FG002|Overall Study|Not treated|1
876361|NCT00561821|1838605|FG003|Overall Study|Not treated|0
876362|NCT00561821|1838602|FG000|Overall Study|Withdrawal by Subject|0
876363|NCT00561821|1838603|FG001|Overall Study|Withdrawal by Subject|1
876364|NCT00561821|1838604|FG002|Overall Study|Withdrawal by Subject|0
876365|NCT00561821|1838605|FG003|Overall Study|Withdrawal by Subject|2
876366|NCT00561821|1838602|FG000|Overall Study|Reasons not related to trial|2
876367|NCT00561821|1838603|FG001|Overall Study|Reasons not related to trial|1
876368|NCT00561821|1838604|FG002|Overall Study|Reasons not related to trial|0
876369|NCT00561821|1838605|FG003|Overall Study|Reasons not related to trial|0
876370|NCT00561821|1838602|FG000|Overall Study|Other (reason not specified)|1
876371|NCT00561821|1838603|FG001|Overall Study|Other (reason not specified)|1
876372|NCT00561821|1838604|FG002|Overall Study|Other (reason not specified)|0
876373|NCT00561821|1838605|FG003|Overall Study|Other (reason not specified)|0
876374|NCT00561821|1838602|FG000|Overall Study|Adverse Event|2
876375|NCT00561821|1838603|FG001|Overall Study|Adverse Event|3
876376|NCT00561821|1838604|FG002|Overall Study|Adverse Event|1
876377|NCT00561821|1838605|FG003|Overall Study|Adverse Event|1
876378|NCT00561925|1838622|FG000|14 Day Lead-In Period|Adverse Event|38
876379|NCT00561925|1838623|FG001|14 Day Lead-In Period|Adverse Event|0
876380|NCT00561925|1838624|FG002|14 Day Lead-In Period|Adverse Event|0
876381|NCT00561925|1838625|FG003|14 Day Lead-In Period|Adverse Event|0
1180996|NCT00861705|2338296|FG001|Overall Study|Never Began Treatment|3
1180997|NCT00861705|2338297|FG002|Overall Study|Never Began Treatment|0
1180998|NCT00861705|2338298|FG003|Overall Study|Never Began Treatment|1
1180999|NCT04446429|2338318|FG000|Overall Study|Lost to Follow-up|6
1181000|NCT04446429|2338319|FG001|Overall Study|Lost to Follow-up|0
1181001|NCT04194528|2338351|FG000|Overall Study|Adverse Event|1
1181004|NCT03116685|2338400|FG000|Overall Study|Physician Decision|0
1181005|NCT03116685|2338401|FG001|Overall Study|Physician Decision|1
1181006|NCT03099304|2338412|FG000|DB Period Day 1 to Week 24|Adverse Event|1
1181007|NCT03099304|2338413|FG001|DB Period Day 1 to Week 24|Adverse Event|1
1181008|NCT03099304|2338414|FG002|DB Period Day 1 to Week 24|Adverse Event|0
1181009|NCT03099304|2338415|FG003|DB Period Day 1 to Week 24|Adverse Event|0
1181010|NCT03099304|2338416|FG004|DB Period Day 1 to Week 24|Adverse Event|1
1181011|NCT03099304|2338412|FG000|DB Period Day 1 to Week 24|Lost to Follow-up|1
1181012|NCT03099304|2338413|FG001|DB Period Day 1 to Week 24|Lost to Follow-up|1
1181013|NCT03099304|2338414|FG002|DB Period Day 1 to Week 24|Lost to Follow-up|0
1181014|NCT03099304|2338415|FG003|DB Period Day 1 to Week 24|Lost to Follow-up|0
1181015|NCT03099304|2338416|FG004|DB Period Day 1 to Week 24|Lost to Follow-up|0
1181016|NCT03099304|2338412|FG000|DB Period Day 1 to Week 24|Reason not specified|0
1181017|NCT03099304|2338413|FG001|DB Period Day 1 to Week 24|Reason not specified|0
1181018|NCT03099304|2338414|FG002|DB Period Day 1 to Week 24|Reason not specified|0
1181019|NCT03099304|2338415|FG003|DB Period Day 1 to Week 24|Reason not specified|1
1181020|NCT03099304|2338416|FG004|DB Period Day 1 to Week 24|Reason not specified|0
1181021|NCT03099304|2338412|FG000|DB Period Day 1 to Week 24|Withdrawal by Subject|3
1181022|NCT03099304|2338413|FG001|DB Period Day 1 to Week 24|Withdrawal by Subject|3
1181023|NCT03099304|2338414|FG002|DB Period Day 1 to Week 24|Withdrawal by Subject|0
1181024|NCT03099304|2338415|FG003|DB Period Day 1 to Week 24|Withdrawal by Subject|2
1181025|NCT03099304|2338416|FG004|DB Period Day 1 to Week 24|Withdrawal by Subject|2
1181026|NCT03099304|2338412|FG000|DB Period Day 1 to Week 24|Protocol Violation|0
1181027|NCT03099304|2338413|FG001|DB Period Day 1 to Week 24|Protocol Violation|0
1181028|NCT03099304|2338414|FG002|DB Period Day 1 to Week 24|Protocol Violation|1
1181029|NCT03099304|2338415|FG003|DB Period Day 1 to Week 24|Protocol Violation|1
1181030|NCT03099304|2338416|FG004|DB Period Day 1 to Week 24|Protocol Violation|0
1181031|NCT03099304|2338412|FG000|DB Period Weeks 24 to 52|Protocol Violation|0
1181032|NCT03099304|2338413|FG001|DB Period Weeks 24 to 52|Protocol Violation|0
1181033|NCT03099304|2338414|FG002|DB Period Weeks 24 to 52|Protocol Violation|1
1181034|NCT03099304|2338415|FG003|DB Period Weeks 24 to 52|Protocol Violation|0
1181035|NCT03099304|2338416|FG004|DB Period Weeks 24 to 52|Protocol Violation|0
1181036|NCT03099304|2338412|FG000|DB Period Weeks 24 to 52|Lost to Follow-up|0
1181037|NCT03099304|2338413|FG001|DB Period Weeks 24 to 52|Lost to Follow-up|1
1181038|NCT03099304|2338414|FG002|DB Period Weeks 24 to 52|Lost to Follow-up|1
1181039|NCT03099304|2338415|FG003|DB Period Weeks 24 to 52|Lost to Follow-up|1
1181040|NCT03099304|2338416|FG004|DB Period Weeks 24 to 52|Lost to Follow-up|0
1181041|NCT03099304|2338412|FG000|DB Period Weeks 24 to 52|Adverse Event|0
1181042|NCT03099304|2338413|FG001|DB Period Weeks 24 to 52|Adverse Event|0
1181043|NCT03099304|2338414|FG002|DB Period Weeks 24 to 52|Adverse Event|0
1181044|NCT03099304|2338415|FG003|DB Period Weeks 24 to 52|Adverse Event|1
1181045|NCT03099304|2338416|FG004|DB Period Weeks 24 to 52|Adverse Event|1
1181046|NCT03099304|2338412|FG000|DB Period Weeks 24 to 52|Withdrawal by Subject|0
1181047|NCT03099304|2338413|FG001|DB Period Weeks 24 to 52|Withdrawal by Subject|0
1181048|NCT03099304|2338414|FG002|DB Period Weeks 24 to 52|Withdrawal by Subject|0
1181049|NCT03099304|2338415|FG003|DB Period Weeks 24 to 52|Withdrawal by Subject|4
1181050|NCT03099304|2338416|FG004|DB Period Weeks 24 to 52|Withdrawal by Subject|1
1181051|NCT03099304|2338412|FG000|DB Period Weeks 24 to 52|Reason not specified|0
1181052|NCT03099304|2338413|FG001|DB Period Weeks 24 to 52|Reason not specified|0
1181053|NCT03099304|2338414|FG002|DB Period Weeks 24 to 52|Reason not specified|0
1181054|NCT03099304|2338415|FG003|DB Period Weeks 24 to 52|Reason not specified|1
1181055|NCT03099304|2338416|FG004|DB Period Weeks 24 to 52|Reason not specified|0
1181056|NCT02682901|2338462|FG000|Overall Study|Adverse Event|10
1181057|NCT02682901|2338463|FG001|Overall Study|Adverse Event|3
1181058|NCT02682901|2338462|FG000|Overall Study|Lack of Efficacy|0
1181059|NCT02682901|2338463|FG001|Overall Study|Lack of Efficacy|1
876382|NCT00561925|1838626|FG004|14 Day Lead-In Period|Adverse Event|0
876383|NCT00561925|1838622|FG000|14 Day Lead-In Period|In/Exclusion criteria|4
1181076|NCT02567825|2338480|FG000|Overall Study|No follow-up post-randomization|5
1181077|NCT02567825|2338481|FG001|Overall Study|No follow-up post-randomization|1
1181078|NCT02567825|2338480|FG000|Overall Study|Follow-up less than 23 months|16
1181079|NCT02567825|2338481|FG001|Overall Study|Follow-up less than 23 months|20
1181081|NCT02555657|2338498|FG000|Overall Study|Death|274
1181082|NCT02555657|2338499|FG001|Overall Study|Death|262
1181083|NCT02555657|2338498|FG000|Overall Study|Physician Decision|0
1181084|NCT02555657|2338499|FG001|Overall Study|Physician Decision|1
1181085|NCT02555657|2338498|FG000|Overall Study|Sponsor Decision|27
1181086|NCT02555657|2338499|FG001|Overall Study|Sponsor Decision|15
1181087|NCT02555657|2338498|FG000|Overall Study|Withdrawal by Subject|11
1181088|NCT02555657|2338499|FG001|Overall Study|Withdrawal by Subject|32
1181089|NCT02328014|2338510|FG000|Overall Study|Adverse Event|1
1181090|NCT02328014|2338511|FG001|Overall Study|Adverse Event|0
1181091|NCT02328014|2338512|FG002|Overall Study|Adverse Event|0
1181092|NCT02328014|2338513|FG003|Overall Study|Adverse Event|1
1181093|NCT02328014|2338510|FG000|Overall Study|Death|0
1181094|NCT02328014|2338511|FG001|Overall Study|Death|0
1181095|NCT02328014|2338512|FG002|Overall Study|Death|0
1181096|NCT02328014|2338513|FG003|Overall Study|Death|4
1181097|NCT02328014|2338510|FG000|Overall Study|Physician Decision|0
1181098|NCT02328014|2338511|FG001|Overall Study|Physician Decision|0
1181099|NCT02328014|2338512|FG002|Overall Study|Physician Decision|0
1181100|NCT02328014|2338513|FG003|Overall Study|Physician Decision|1
1181101|NCT02328014|2338510|FG000|Overall Study|Disease Progression|1
1181102|NCT02328014|2338511|FG001|Overall Study|Disease Progression|0
1181103|NCT02328014|2338512|FG002|Overall Study|Disease Progression|1
1181104|NCT02328014|2338513|FG003|Overall Study|Disease Progression|3
1181105|NCT02328014|2338510|FG000|Overall Study|Study Terminated by Sponsor|4
1181106|NCT02328014|2338511|FG001|Overall Study|Study Terminated by Sponsor|1
1181107|NCT02328014|2338512|FG002|Overall Study|Study Terminated by Sponsor|1
1181108|NCT02328014|2338513|FG003|Overall Study|Study Terminated by Sponsor|0
1181109|NCT02328014|2338510|FG000|Overall Study|Subject Started Another Cancer Therapy|0
1181110|NCT02328014|2338511|FG001|Overall Study|Subject Started Another Cancer Therapy|5
1181111|NCT02328014|2338512|FG002|Overall Study|Subject Started Another Cancer Therapy|4
1181112|NCT02328014|2338513|FG003|Overall Study|Subject Started Another Cancer Therapy|12
1181113|NCT02328014|2338510|FG000|Overall Study|Withdrawal by Subject|0
1181114|NCT02328014|2338511|FG001|Overall Study|Withdrawal by Subject|0
1181115|NCT02328014|2338512|FG002|Overall Study|Withdrawal by Subject|0
1181116|NCT02328014|2338513|FG003|Overall Study|Withdrawal by Subject|1
1181117|NCT02190721|2338526|FG000|Overall Study|Patient was out of the city|0
1181118|NCT02190721|2338527|FG001|Overall Study|Patient was out of the city|1
1181119|NCT02190721|2338528|FG002|Overall Study|Patient was out of the city|0
1181120|NCT00739401|2338565|FG000|Overall Study|patients were not due for the 2 year follow-up|34
1181121|NCT00739401|2338565|FG000|Overall Study|Death|3
1181122|NCT00739401|2338565|FG000|Overall Study|Withdrawal by Subject|4
1181123|NCT00651742|2338569|FG000|Overall Study|Objective Disease Progression|22
1181124|NCT00651742|2338569|FG000|Overall Study|Toxicity|3
1181125|NCT00651742|2338569|FG000|Overall Study|Investigator Judgment|1
1181126|NCT00651742|2338569|FG000|Overall Study|Withdrawal of Consent|1
1181127|NCT00651742|2338569|FG000|Overall Study|Enrolled but not treated|1
1181128|NCT04930263|2338599|FG000|Overall Study|Withdrawal by Subject|3
1181129|NCT04930263|2338600|FG001|Overall Study|Withdrawal by Subject|5
1181130|NCT04876274|2338608|FG000|Overall Study|Lost to Follow-up|9
1181131|NCT04876274|2338609|FG001|Overall Study|Lost to Follow-up|8
1181132|NCT04524598|2338619|FG000|Phase I - Feasibility|Lost to Follow-up|2
1181133|NCT04524598|2338620|FG001|Phase I - Feasibility|Lost to Follow-up|4
1181134|NCT04524598|2338621|FG002|Phase I - Feasibility|Lost to Follow-up|0
1181135|NCT04524598|2338622|FG003|Phase I - Feasibility|Lost to Follow-up|0
1181136|NCT04524598|2338623|FG004|Phase I - Feasibility|Lost to Follow-up|0
1181137|NCT04524598|2338619|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2
1181138|NCT04524598|2338620|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1
1181139|NCT04524598|2338621|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
1181140|NCT04524598|2338622|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
1181141|NCT04524598|2338623|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
1181142|NCT04524598|2338619|FG000|Phase II - Outcomes|Lost to Follow-up|0
1181143|NCT04524598|2338620|FG001|Phase II - Outcomes|Lost to Follow-up|0
1181144|NCT04524598|2338621|FG002|Phase II - Outcomes|Lost to Follow-up|16
1181145|NCT04524598|2338622|FG003|Phase II - Outcomes|Lost to Follow-up|8
1181146|NCT04524598|2338623|FG004|Phase II - Outcomes|Lost to Follow-up|0
1181147|NCT04524598|2338619|FG000|Phase II - Outcomes|Withdrawal by Subject|0
1181148|NCT04524598|2338620|FG001|Phase II - Outcomes|Withdrawal by Subject|0
1181149|NCT04524598|2338621|FG002|Phase II - Outcomes|Withdrawal by Subject|2
1181150|NCT04524598|2338622|FG003|Phase II - Outcomes|Withdrawal by Subject|0
1181151|NCT04524598|2338623|FG004|Phase II - Outcomes|Withdrawal by Subject|0
876384|NCT00561925|1838623|FG001|14 Day Lead-In Period|In/Exclusion criteria|0
876385|NCT00561925|1838624|FG002|14 Day Lead-In Period|In/Exclusion criteria|0
876386|NCT00561925|1838625|FG003|14 Day Lead-In Period|In/Exclusion criteria|0
876387|NCT00561925|1838626|FG004|14 Day Lead-In Period|In/Exclusion criteria|0
876388|NCT00561925|1838622|FG000|14 Day Lead-In Period|Lost to Follow-up|4
876389|NCT00561925|1838623|FG001|14 Day Lead-In Period|Lost to Follow-up|0
876390|NCT00561925|1838624|FG002|14 Day Lead-In Period|Lost to Follow-up|0
876391|NCT00561925|1838625|FG003|14 Day Lead-In Period|Lost to Follow-up|0
876392|NCT00561925|1838626|FG004|14 Day Lead-In Period|Lost to Follow-up|0
876393|NCT00561925|1838622|FG000|14 Day Lead-In Period|Withdrawal by Subject|4
876394|NCT00561925|1838623|FG001|14 Day Lead-In Period|Withdrawal by Subject|0
876395|NCT00561925|1838624|FG002|14 Day Lead-In Period|Withdrawal by Subject|0
876396|NCT00561925|1838625|FG003|14 Day Lead-In Period|Withdrawal by Subject|0
876397|NCT00561925|1838626|FG004|14 Day Lead-In Period|Withdrawal by Subject|0
876398|NCT00561925|1838622|FG000|14 Day Lead-In Period|Other|5
876399|NCT00561925|1838623|FG001|14 Day Lead-In Period|Other|0
876400|NCT00561925|1838624|FG002|14 Day Lead-In Period|Other|0
876401|NCT00561925|1838625|FG003|14 Day Lead-In Period|Other|0
876402|NCT00561925|1838626|FG004|14 Day Lead-In Period|Other|0
876403|NCT00561925|1838622|FG000|144-week Double-blind, Double-dummy|Adverse Event|0
876404|NCT00561925|1838623|FG001|144-week Double-blind, Double-dummy|Adverse Event|48
876405|NCT00561925|1838624|FG002|144-week Double-blind, Double-dummy|Adverse Event|43
876406|NCT00561925|1838625|FG003|144-week Double-blind, Double-dummy|Adverse Event|0
876407|NCT00561925|1838626|FG004|144-week Double-blind, Double-dummy|Adverse Event|0
876408|NCT00561925|1838622|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0
876409|NCT00561925|1838623|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15
876410|NCT00561925|1838624|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9
876411|NCT00561925|1838625|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0
876412|NCT00561925|1838626|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0
876413|NCT00561925|1838622|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0
876414|NCT00561925|1838623|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15
876415|NCT00561925|1838624|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12
876416|NCT00561925|1838625|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0
876417|NCT00561925|1838626|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0
876418|NCT00561925|1838622|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
876419|NCT00561925|1838623|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
876420|NCT00561925|1838624|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
876421|NCT00561925|1838625|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
876422|NCT00561925|1838626|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
876423|NCT00561925|1838622|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0
876424|NCT00561925|1838623|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36
876425|NCT00561925|1838624|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33
876426|NCT00561925|1838625|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0
876427|NCT00561925|1838626|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0
876428|NCT00561925|1838622|FG000|144-week Double-blind, Double-dummy|Pregnancy|0
876429|NCT00561925|1838623|FG001|144-week Double-blind, Double-dummy|Pregnancy|1
876430|NCT00561925|1838624|FG002|144-week Double-blind, Double-dummy|Pregnancy|9
876431|NCT00561925|1838625|FG003|144-week Double-blind, Double-dummy|Pregnancy|0
876432|NCT00561925|1838626|FG004|144-week Double-blind, Double-dummy|Pregnancy|0
876433|NCT00561925|1838622|FG000|144-week Double-blind, Double-dummy|Death|0
1181152|NCT04524598|2338619|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
1181153|NCT04524598|2338620|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
1181154|NCT04524598|2338621|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8
1181155|NCT04524598|2338622|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5
1181156|NCT04524598|2338623|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
1181157|NCT04524598|2338619|FG000|Phase II - Control Extension|Lost to Follow-up|0
1181158|NCT04524598|2338620|FG001|Phase II - Control Extension|Lost to Follow-up|0
1181159|NCT04524598|2338621|FG002|Phase II - Control Extension|Lost to Follow-up|0
1181160|NCT04524598|2338622|FG003|Phase II - Control Extension|Lost to Follow-up|0
1181161|NCT04524598|2338623|FG004|Phase II - Control Extension|Lost to Follow-up|6
1181162|NCT04524598|2338619|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
1181163|NCT04524598|2338620|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
1181164|NCT04524598|2338621|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
1181165|NCT04524598|2338622|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
1181166|NCT04524598|2338623|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6
1181167|NCT04321252|2338646|FG000|Overall Study|Withdrawal by Subject|0
1181168|NCT04321252|2338647|FG001|Overall Study|Withdrawal by Subject|0
1181169|NCT04321252|2338648|FG002|Overall Study|Withdrawal by Subject|0
1181170|NCT04321252|2338649|FG003|Overall Study|Withdrawal by Subject|0
1181171|NCT04321252|2338650|FG004|Overall Study|Withdrawal by Subject|0
1181172|NCT04321252|2338651|FG005|Overall Study|Withdrawal by Subject|1
1181173|NCT04321252|2338652|FG006|Overall Study|Withdrawal by Subject|0
1181174|NCT04321252|2338653|FG007|Overall Study|Withdrawal by Subject|0
1181175|NCT04321252|2338654|FG008|Overall Study|Withdrawal by Subject|0
1181176|NCT04176445|2338684|FG000|Overall Study|Adverse Event|0
1181177|NCT04176445|2338685|FG001|Overall Study|Adverse Event|1
1181178|NCT04176445|2338684|FG000|Overall Study|change plans weaning after first intervention|0
1181179|NCT04176445|2338685|FG001|Overall Study|change plans weaning after first intervention|1
1181180|NCT04126213|2338697|FG000|Overall Study|Lost to Follow-up|9
1181181|NCT04126213|2338698|FG001|Overall Study|Lost to Follow-up|1
1181182|NCT04126213|2338699|FG002|Overall Study|Lost to Follow-up|5
1181183|NCT04126213|2338700|FG003|Overall Study|Lost to Follow-up|10
1181184|NCT04126213|2338701|FG004|Overall Study|Lost to Follow-up|4
1181185|NCT04126213|2338702|FG005|Overall Study|Lost to Follow-up|7
1181186|NCT04126213|2338697|FG000|Overall Study|Withdrawal by Subject|3
1181187|NCT04126213|2338698|FG001|Overall Study|Withdrawal by Subject|2
1181188|NCT04126213|2338699|FG002|Overall Study|Withdrawal by Subject|1
1181189|NCT04126213|2338700|FG003|Overall Study|Withdrawal by Subject|1
1181190|NCT04126213|2338701|FG004|Overall Study|Withdrawal by Subject|1
1181191|NCT04126213|2338702|FG005|Overall Study|Withdrawal by Subject|1
1181192|NCT04126213|2338697|FG000|Overall Study|Other|0
1181193|NCT04126213|2338698|FG001|Overall Study|Other|0
1181194|NCT04126213|2338699|FG002|Overall Study|Other|2
1181195|NCT04126213|2338700|FG003|Overall Study|Other|2
1181196|NCT04126213|2338701|FG004|Overall Study|Other|0
1181197|NCT04126213|2338702|FG005|Overall Study|Other|1
1181198|NCT04126213|2338697|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1181199|NCT04126213|2338698|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
1181200|NCT04126213|2338699|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
1181201|NCT04126213|2338700|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1181202|NCT04126213|2338701|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
1181203|NCT04126213|2338702|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
1181204|NCT03672188|2338738|FG000|Overall Study|Withdrawal by Subject|0
1181205|NCT03672188|2338739|FG001|Overall Study|Withdrawal by Subject|0
1181206|NCT03672188|2338740|FG002|Overall Study|Withdrawal by Subject|0
1181207|NCT03672188|2338741|FG003|Overall Study|Withdrawal by Subject|3
1181208|NCT03672188|2338742|FG004|Overall Study|Withdrawal by Subject|0
1181209|NCT03672188|2338743|FG005|Overall Study|Withdrawal by Subject|0
1181210|NCT03672188|2338744|FG006|Overall Study|Withdrawal by Subject|0
1181211|NCT03672188|2338745|FG007|Overall Study|Withdrawal by Subject|0
1181212|NCT03672188|2338746|FG008|Overall Study|Withdrawal by Subject|0
1181213|NCT03672188|2338747|FG009|Overall Study|Withdrawal by Subject|0
1181214|NCT03672188|2338748|FG010|Overall Study|Withdrawal by Subject|0
1181215|NCT03672188|2338749|FG011|Overall Study|Withdrawal by Subject|0
1181216|NCT03672188|2338750|FG012|Overall Study|Withdrawal by Subject|0
1181217|NCT03672188|2338751|FG013|Overall Study|Withdrawal by Subject|0
1181218|NCT03672188|2338752|FG014|Overall Study|Withdrawal by Subject|0
1181219|NCT03672188|2338738|FG000|Overall Study|Death|0
1181220|NCT03672188|2338739|FG001|Overall Study|Death|0
1181221|NCT03672188|2338740|FG002|Overall Study|Death|0
1181222|NCT03672188|2338741|FG003|Overall Study|Death|0
1181223|NCT03672188|2338742|FG004|Overall Study|Death|0
1181224|NCT03672188|2338743|FG005|Overall Study|Death|0
1181225|NCT03672188|2338744|FG006|Overall Study|Death|0
1181226|NCT03672188|2338745|FG007|Overall Study|Death|0
1181227|NCT03672188|2338746|FG008|Overall Study|Death|0
1181228|NCT03672188|2338747|FG009|Overall Study|Death|0
1181229|NCT03672188|2338748|FG010|Overall Study|Death|0
1181230|NCT03672188|2338749|FG011|Overall Study|Death|0
1181231|NCT03672188|2338750|FG012|Overall Study|Death|1
1181232|NCT03672188|2338751|FG013|Overall Study|Death|0
1181233|NCT03672188|2338752|FG014|Overall Study|Death|0
1181234|NCT03672188|2338738|FG000|Overall Study|Lost to Follow-up|0
1181235|NCT03672188|2338739|FG001|Overall Study|Lost to Follow-up|0
1181236|NCT03672188|2338740|FG002|Overall Study|Lost to Follow-up|1
1181237|NCT03672188|2338741|FG003|Overall Study|Lost to Follow-up|0
1181238|NCT03672188|2338742|FG004|Overall Study|Lost to Follow-up|0
1181239|NCT03672188|2338743|FG005|Overall Study|Lost to Follow-up|0
1181240|NCT03672188|2338744|FG006|Overall Study|Lost to Follow-up|0
1181241|NCT03672188|2338745|FG007|Overall Study|Lost to Follow-up|0
1181242|NCT03672188|2338746|FG008|Overall Study|Lost to Follow-up|0
1181243|NCT03672188|2338747|FG009|Overall Study|Lost to Follow-up|0
1181244|NCT03672188|2338748|FG010|Overall Study|Lost to Follow-up|0
1181245|NCT03672188|2338749|FG011|Overall Study|Lost to Follow-up|0
1181246|NCT03672188|2338750|FG012|Overall Study|Lost to Follow-up|0
1181247|NCT03672188|2338751|FG013|Overall Study|Lost to Follow-up|0
1181248|NCT03672188|2338752|FG014|Overall Study|Lost to Follow-up|0
1181249|NCT03573336|2338825|FG000|Overall Study|Study terminated|2
1181250|NCT03573336|2338826|FG001|Overall Study|Study terminated|4
1181251|NCT03573336|2338827|FG002|Overall Study|Study terminated|2
1181252|NCT03230916|2338846|FG000|Overall Study|Withdrawal by Subject|0
1181253|NCT03230916|2338847|FG001|Overall Study|Withdrawal by Subject|0
1181254|NCT03230916|2338848|FG002|Overall Study|Withdrawal by Subject|0
1181255|NCT03230916|2338849|FG003|Overall Study|Withdrawal by Subject|0
1181256|NCT03230916|2338850|FG004|Overall Study|Withdrawal by Subject|0
1181257|NCT03230916|2338851|FG005|Overall Study|Withdrawal by Subject|1
1181258|NCT03230916|2338852|FG006|Overall Study|Withdrawal by Subject|0
1181259|NCT03230916|2338853|FG007|Overall Study|Withdrawal by Subject|0
1181260|NCT03230916|2338854|FG008|Overall Study|Withdrawal by Subject|0
1181261|NCT03230916|2338855|FG009|Overall Study|Withdrawal by Subject|0
1181262|NCT03230916|2338856|FG010|Overall Study|Withdrawal by Subject|0
1181263|NCT03195894|2338899|FG000|Overall Study|"An example is Started other treatment."|4
1181264|NCT03195894|2338900|FG001|Overall Study|"An example is Started other treatment."|5
1181265|NCT03195894|2338899|FG000|Overall Study|Withdrawal by Subject|15
1181266|NCT03195894|2338900|FG001|Overall Study|Withdrawal by Subject|4
1181267|NCT03195894|2338899|FG000|Overall Study|Lost to Follow-up|14
1181268|NCT03195894|2338900|FG001|Overall Study|Lost to Follow-up|19
1181269|NCT03032705|2338911|FG000|Overall Study|Lost to Follow-up|16
1181270|NCT03032705|2338912|FG001|Overall Study|Lost to Follow-up|17
1181271|NCT03032705|2338911|FG000|Overall Study|did not quality|6
1181272|NCT03032705|2338912|FG001|Overall Study|did not quality|6
1181273|NCT02573259|2338954|FG000|Overall Study|Death|1
1181274|NCT02573259|2338955|FG001|Overall Study|Death|6
1181275|NCT02573259|2338956|FG002|Overall Study|Death|5
1181276|NCT02573259|2338957|FG003|Overall Study|Death|6
1181277|NCT02573259|2338958|FG004|Overall Study|Death|9
1181278|NCT02573259|2338959|FG005|Overall Study|Death|32
1181279|NCT02573259|2338960|FG006|Overall Study|Death|21
1181280|NCT02573259|2338954|FG000|Overall Study|Lost to Follow-up|0
1181281|NCT02573259|2338955|FG001|Overall Study|Lost to Follow-up|0
1181282|NCT02573259|2338956|FG002|Overall Study|Lost to Follow-up|0
1181283|NCT02573259|2338957|FG003|Overall Study|Lost to Follow-up|0
1181284|NCT02573259|2338958|FG004|Overall Study|Lost to Follow-up|0
1181285|NCT02573259|2338959|FG005|Overall Study|Lost to Follow-up|2
1181286|NCT02573259|2338960|FG006|Overall Study|Lost to Follow-up|1
1181287|NCT02573259|2338954|FG000|Overall Study|Participant refused further follow-up|0
1181288|NCT02573259|2338955|FG001|Overall Study|Participant refused further follow-up|2
1181289|NCT02573259|2338956|FG002|Overall Study|Participant refused further follow-up|1
1181290|NCT02573259|2338957|FG003|Overall Study|Participant refused further follow-up|0
1181291|NCT02573259|2338958|FG004|Overall Study|Participant refused further follow-up|3
1181292|NCT02573259|2338959|FG005|Overall Study|Participant refused further follow-up|20
1181293|NCT02573259|2338960|FG006|Overall Study|Participant refused further follow-up|7
1181294|NCT02573259|2338954|FG000|Overall Study|Other|0
1181295|NCT02573259|2338955|FG001|Overall Study|Other|0
1181296|NCT02573259|2338956|FG002|Overall Study|Other|0
1181297|NCT02573259|2338957|FG003|Overall Study|Other|0
1181298|NCT02573259|2338958|FG004|Overall Study|Other|1
1181299|NCT02573259|2338959|FG005|Overall Study|Other|4
1181300|NCT02573259|2338960|FG006|Overall Study|Other|5
1181301|NCT02318329|2339002|FG000|Overall Study|Progressive Disease|2
1181302|NCT02318329|2339003|FG001|Overall Study|Progressive Disease|3
1181303|NCT02318329|2339004|FG002|Overall Study|Progressive Disease|2
1181304|NCT02318329|2339005|FG003|Overall Study|Progressive Disease|3
1181305|NCT02318329|2339006|FG004|Overall Study|Progressive Disease|3
1181306|NCT02318329|2339007|FG005|Overall Study|Progressive Disease|3
1181307|NCT02318329|2339008|FG006|Overall Study|Progressive Disease|1
1181308|NCT02318329|2339009|FG007|Overall Study|Progressive Disease|1
1181309|NCT02318329|2339010|FG008|Overall Study|Progressive Disease|5
1181310|NCT02318329|2339011|FG009|Overall Study|Progressive Disease|39
1181311|NCT02318329|2339002|FG000|Overall Study|Death|0
1181312|NCT02318329|2339003|FG001|Overall Study|Death|0
1181313|NCT02318329|2339004|FG002|Overall Study|Death|0
1181314|NCT02318329|2339005|FG003|Overall Study|Death|0
1181315|NCT02318329|2339006|FG004|Overall Study|Death|0
1181316|NCT02318329|2339007|FG005|Overall Study|Death|0
1181317|NCT02318329|2339008|FG006|Overall Study|Death|0
1181318|NCT02318329|2339009|FG007|Overall Study|Death|0
1181319|NCT02318329|2339010|FG008|Overall Study|Death|0
1181320|NCT02318329|2339011|FG009|Overall Study|Death|5
1181321|NCT02318329|2339002|FG000|Overall Study|Lost to Follow-up|0
1181322|NCT02318329|2339003|FG001|Overall Study|Lost to Follow-up|0
1181323|NCT02318329|2339004|FG002|Overall Study|Lost to Follow-up|0
1181324|NCT02318329|2339005|FG003|Overall Study|Lost to Follow-up|0
1181325|NCT02318329|2339006|FG004|Overall Study|Lost to Follow-up|0
1181326|NCT02318329|2339007|FG005|Overall Study|Lost to Follow-up|0
1181327|NCT02318329|2339008|FG006|Overall Study|Lost to Follow-up|0
1181328|NCT02318329|2339009|FG007|Overall Study|Lost to Follow-up|0
1181329|NCT02318329|2339010|FG008|Overall Study|Lost to Follow-up|0
1181330|NCT02318329|2339011|FG009|Overall Study|Lost to Follow-up|1
1181331|NCT02318329|2339002|FG000|Overall Study|Withdrawal by Subject|0
1181332|NCT02318329|2339003|FG001|Overall Study|Withdrawal by Subject|0
1181333|NCT02318329|2339004|FG002|Overall Study|Withdrawal by Subject|0
1181334|NCT02318329|2339005|FG003|Overall Study|Withdrawal by Subject|0
1181335|NCT02318329|2339006|FG004|Overall Study|Withdrawal by Subject|0
1181336|NCT02318329|2339007|FG005|Overall Study|Withdrawal by Subject|0
1181337|NCT02318329|2339008|FG006|Overall Study|Withdrawal by Subject|0
1181338|NCT02318329|2339009|FG007|Overall Study|Withdrawal by Subject|0
1181339|NCT02318329|2339010|FG008|Overall Study|Withdrawal by Subject|0
1181340|NCT02318329|2339011|FG009|Overall Study|Withdrawal by Subject|6
1181341|NCT02318329|2339002|FG000|Overall Study|Other|1
1181342|NCT02318329|2339003|FG001|Overall Study|Other|1
1181343|NCT02318329|2339004|FG002|Overall Study|Other|1
1181344|NCT02318329|2339005|FG003|Overall Study|Other|0
1181345|NCT02318329|2339006|FG004|Overall Study|Other|0
1181346|NCT02318329|2339007|FG005|Overall Study|Other|0
1181347|NCT02318329|2339008|FG006|Overall Study|Other|0
1181348|NCT02318329|2339009|FG007|Overall Study|Other|0
1181349|NCT02318329|2339010|FG008|Overall Study|Other|1
1181350|NCT02318329|2339011|FG009|Overall Study|Other|1
1181351|NCT02097420|2339052|FG000|Overall Study|Death|4
1181352|NCT02097420|2339052|FG000|Overall Study|Device explanted|3
1181353|NCT02097420|2339052|FG000|Overall Study|Not reached 12-month visit|7
1181354|NCT01602666|2339058|FG000|Induction Chemotherapy|Death|2
1181355|NCT01602666|2339059|FG001|Induction Chemotherapy|Death|1
1181356|NCT01602666|2339058|FG000|Induction Chemotherapy|Lack of Efficacy|16
1181357|NCT01602666|2339059|FG001|Induction Chemotherapy|Lack of Efficacy|7
1181358|NCT01602666|2339058|FG000|Induction Chemotherapy|Physician Decision|12
1181359|NCT01602666|2339059|FG001|Induction Chemotherapy|Physician Decision|5
1181360|NCT01602666|2339058|FG000|Induction Chemotherapy|Withdrawal by Subject|0
1181361|NCT01602666|2339059|FG001|Induction Chemotherapy|Withdrawal by Subject|2
1181362|NCT01602666|2339058|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5
1181363|NCT01602666|2339059|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6
1181364|NCT01602666|2339058|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2
1181365|NCT01602666|2339059|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3
1181366|NCT01602666|2339058|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4
1181367|NCT01602666|2339059|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5
1181368|NCT01602666|2339058|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2
1181369|NCT01602666|2339059|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3
1181370|NCT01602666|2339058|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4
1181371|NCT01602666|2339059|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0
1181372|NCT01602666|2339058|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0
1181373|NCT01602666|2339059|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14
1181374|NCT01602666|2339058|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0
1181375|NCT01602666|2339059|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9
1181376|NCT01375959|2339069|FG000|First Intervention (6 Weeks)|Adverse Event|2
1181377|NCT01375959|2339070|FG001|First Intervention (6 Weeks)|Adverse Event|3
1181378|NCT01375959|2339069|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0
1181379|NCT01375959|2339070|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1
1181380|NCT01375959|2339069|FG000|Second Intervention (6 Weeks)|Adverse Event|0
1181381|NCT01375959|2339070|FG001|Second Intervention (6 Weeks)|Adverse Event|2
1181382|NCT01224106|2339081|FG000|Double-Blind Treatment Phase|Death|3
1181383|NCT01224106|2339082|FG001|Double-Blind Treatment Phase|Death|0
1181384|NCT01224106|2339083|FG002|Double-Blind Treatment Phase|Death|0
1181385|NCT01224106|2339084|FG003|Double-Blind Treatment Phase|Death|0
1181386|NCT01224106|2339085|FG004|Double-Blind Treatment Phase|Death|0
1181387|NCT01224106|2339081|FG000|Double-Blind Treatment Phase|Physician Decision|6
1181388|NCT01224106|2339082|FG001|Double-Blind Treatment Phase|Physician Decision|5
1181389|NCT01224106|2339083|FG002|Double-Blind Treatment Phase|Physician Decision|4
1181390|NCT01224106|2339084|FG003|Double-Blind Treatment Phase|Physician Decision|0
1181391|NCT01224106|2339085|FG004|Double-Blind Treatment Phase|Physician Decision|0
1181392|NCT01224106|2339081|FG000|Double-Blind Treatment Phase|Adverse Event|0
1181393|NCT01224106|2339082|FG001|Double-Blind Treatment Phase|Adverse Event|5
1181394|NCT01224106|2339083|FG002|Double-Blind Treatment Phase|Adverse Event|3
1181395|NCT01224106|2339084|FG003|Double-Blind Treatment Phase|Adverse Event|0
1181396|NCT01224106|2339085|FG004|Double-Blind Treatment Phase|Adverse Event|0
1181397|NCT01224106|2339081|FG000|Double-Blind Treatment Phase|Other|0
1181398|NCT01224106|2339082|FG001|Double-Blind Treatment Phase|Other|0
1181399|NCT01224106|2339083|FG002|Double-Blind Treatment Phase|Other|1
1181400|NCT01224106|2339084|FG003|Double-Blind Treatment Phase|Other|0
1181401|NCT01224106|2339085|FG004|Double-Blind Treatment Phase|Other|0
1181402|NCT01224106|2339081|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7
1181403|NCT01224106|2339082|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8
1181404|NCT01224106|2339083|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8
1181405|NCT01224106|2339084|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0
1181406|NCT01224106|2339085|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0
1181407|NCT01224106|2339081|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62
1181408|NCT01224106|2339082|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68
1181409|NCT01224106|2339083|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63
1181410|NCT01224106|2339084|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
1181411|NCT01224106|2339085|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
1181412|NCT01224106|2339081|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1
1181413|NCT01224106|2339082|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
1181414|NCT01224106|2339083|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
1181415|NCT01224106|2339084|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
1181416|NCT01224106|2339085|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0
1181417|NCT01224106|2339081|FG000|Open-Label Extension (OLE) Phase|Death|0
1181418|NCT01224106|2339082|FG001|Open-Label Extension (OLE) Phase|Death|0
1181419|NCT01224106|2339083|FG002|Open-Label Extension (OLE) Phase|Death|0
1181420|NCT01224106|2339084|FG003|Open-Label Extension (OLE) Phase|Death|1
1181421|NCT01224106|2339085|FG004|Open-Label Extension (OLE) Phase|Death|3
1181422|NCT01224106|2339081|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0
1181423|NCT01224106|2339082|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
1181424|NCT01224106|2339083|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0
1181425|NCT01224106|2339084|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2
1181426|NCT01224106|2339085|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6
1181427|NCT01224106|2339081|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0
1181428|NCT01224106|2339082|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0
1181429|NCT01224106|2339083|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0
1181430|NCT01224106|2339084|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2
1181431|NCT01224106|2339085|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7
1181432|NCT01224106|2339081|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
1181433|NCT01224106|2339082|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
1181434|NCT01224106|2339083|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
1181435|NCT01224106|2339084|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6
1181436|NCT01224106|2339085|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15
1181437|NCT01224106|2339081|FG000|Open-Label Extension (OLE) Phase|Other|0
1181438|NCT01224106|2339082|FG001|Open-Label Extension (OLE) Phase|Other|0
1181439|NCT01224106|2339083|FG002|Open-Label Extension (OLE) Phase|Other|0
1181440|NCT01224106|2339084|FG003|Open-Label Extension (OLE) Phase|Other|5
1181441|NCT01224106|2339085|FG004|Open-Label Extension (OLE) Phase|Other|3
1181442|NCT00567567|2339115|FG000|Overall Study|Adverse Event|0
1181443|NCT00567567|2339116|FG001|Overall Study|Adverse Event|2
1181444|NCT00567567|2339117|FG002|Overall Study|Adverse Event|5
1181445|NCT00567567|2339115|FG000|Overall Study|Death|8
1181446|NCT00567567|2339116|FG001|Overall Study|Death|1
1181447|NCT00567567|2339117|FG002|Overall Study|Death|5
1181448|NCT00567567|2339115|FG000|Overall Study|Lack of Efficacy|16
1181449|NCT00567567|2339116|FG001|Overall Study|Lack of Efficacy|17
1181450|NCT00567567|2339117|FG002|Overall Study|Lack of Efficacy|48
1181451|NCT00567567|2339115|FG000|Overall Study|Lost to Follow-up|0
1181452|NCT00567567|2339116|FG001|Overall Study|Lost to Follow-up|0
1181453|NCT00567567|2339117|FG002|Overall Study|Lost to Follow-up|1
1181454|NCT00567567|2339115|FG000|Overall Study|Physician Decision|16
1181455|NCT00567567|2339116|FG001|Overall Study|Physician Decision|18
1181456|NCT00567567|2339117|FG002|Overall Study|Physician Decision|84
1181457|NCT00567567|2339115|FG000|Overall Study|Withdrawal by Subject|0
1181458|NCT00567567|2339116|FG001|Overall Study|Withdrawal by Subject|0
1181459|NCT00567567|2339117|FG002|Overall Study|Withdrawal by Subject|2
1181460|NCT00567567|2339115|FG000|Overall Study|Ineligible|4
1181461|NCT00567567|2339116|FG001|Overall Study|Ineligible|0
1181462|NCT00567567|2339117|FG002|Overall Study|Ineligible|9
1181463|NCT00567567|2339115|FG000|Overall Study|Refusal by patient/parent/guardian|9
1181464|NCT00567567|2339116|FG001|Overall Study|Refusal by patient/parent/guardian|16
1181465|NCT00567567|2339117|FG002|Overall Study|Refusal by patient/parent/guardian|122
1181466|NCT00567567|2339115|FG000|Overall Study|Enrolled another COG therapeutic study|99
1181467|NCT00567567|2339116|FG001|Overall Study|Enrolled another COG therapeutic study|80
1181468|NCT00567567|2339117|FG002|Overall Study|Enrolled another COG therapeutic study|0
1181469|NCT00567567|2339115|FG000|Overall Study|Unable adequate stem cell for transplant|0
1181470|NCT00567567|2339116|FG001|Overall Study|Unable adequate stem cell for transplant|0
1181471|NCT00567567|2339117|FG002|Overall Study|Unable adequate stem cell for transplant|2
1181472|NCT00354835|2339129|FG000|Overall Study|Death|1
1181473|NCT00354835|2339130|FG001|Overall Study|Death|1
1181474|NCT00354835|2339129|FG000|Overall Study|Physician Decision|8
1181475|NCT00354835|2339130|FG001|Overall Study|Physician Decision|13
1181476|NCT00354835|2339129|FG000|Overall Study|Withdrawal by Subject|2
1181477|NCT00354835|2339130|FG001|Overall Study|Withdrawal by Subject|1
1181478|NCT00354835|2339129|FG000|Overall Study|Ineligible|17
1181479|NCT00354835|2339130|FG001|Overall Study|Ineligible|16
1181480|NCT00354835|2339129|FG000|Overall Study|Disease progression or relapse|15
1181481|NCT00354835|2339130|FG001|Overall Study|Disease progression or relapse|22
1181482|NCT00354835|2339129|FG000|Overall Study|Adverse Event|6
1181483|NCT00354835|2339130|FG001|Overall Study|Adverse Event|0
1181484|NCT00354835|2339129|FG000|Overall Study|Refusal of further therapy|3
1181485|NCT00354835|2339130|FG001|Overall Study|Refusal of further therapy|8
1181486|NCT04531241|2339151|FG000|Period 1|Withdrawal by Subject|2
1181487|NCT04531241|2339152|FG001|Period 1|Withdrawal by Subject|0
1181488|NCT04531241|2339151|FG000|Period 1|Dispesed incorrect lens power|1
1181489|NCT04531241|2339152|FG001|Period 1|Dispesed incorrect lens power|0
1181490|NCT04531241|2339151|FG000|Period 1|Protocol Violation|1
1181491|NCT04531241|2339152|FG001|Period 1|Protocol Violation|0
1181492|NCT04531241|2339151|FG000|Period 1|No longer eligible|0
1181493|NCT04531241|2339152|FG001|Period 1|No longer eligible|1
1181494|NCT04531241|2339151|FG000|Period 1|Lens Discomfort|0
1181495|NCT04531241|2339152|FG001|Period 1|Lens Discomfort|1
1181496|NCT04531241|2339151|FG000|Period 2|Covid-19 Related|1
1181497|NCT04531241|2339152|FG001|Period 2|Covid-19 Related|1
1181498|NCT04185220|2339197|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0
1181499|NCT04185220|2339198|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1
1181500|NCT04185220|2339197|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0
1181501|NCT04185220|2339198|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1
1181515|NCT03815175|2339219|FG000|Overall Study|Subject Lost to Follow-up|6
1181516|NCT03815175|2339219|FG000|Overall Study|Subject Withdrew Consent|48
1181517|NCT03815175|2339219|FG000|Overall Study|Subject Withdrawn by Physician/Site|10
1181518|NCT03815175|2339219|FG000|Overall Study|Death|86
1181519|NCT03815175|2339219|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1
1181520|NCT03815175|2339219|FG000|Overall Study|Subject Discontinued by Sponsor|2
1181521|NCT03815175|2339219|FG000|Overall Study|Other Status Change Reason|1
1181522|NCT03815175|2339219|FG000|Overall Study|Missed Visit|12
1181525|NCT03600714|2339232|FG000|Overall Study|Out of country and could not return for post-treatment visits|1
1181526|NCT03470441|2339253|FG000|Overall Study|Death|0
1181527|NCT03470441|2339254|FG001|Overall Study|Death|1
1181528|NCT03470441|2339255|FG002|Overall Study|Death|1
1181529|NCT03470441|2339256|FG003|Overall Study|Death|0
1181530|NCT03470441|2339253|FG000|Overall Study|Adverse Event|0
1181531|NCT03470441|2339254|FG001|Overall Study|Adverse Event|0
1181532|NCT03470441|2339255|FG002|Overall Study|Adverse Event|0
1181533|NCT03470441|2339256|FG003|Overall Study|Adverse Event|1
1181534|NCT03470441|2339253|FG000|Overall Study|Withdrawal by Subject|1
1181535|NCT03470441|2339254|FG001|Overall Study|Withdrawal by Subject|4
1181536|NCT03470441|2339255|FG002|Overall Study|Withdrawal by Subject|1
1181537|NCT03470441|2339256|FG003|Overall Study|Withdrawal by Subject|3
1181538|NCT03452397|2339270|FG000|Overall Study|Adverse Event|1
1181539|NCT03452397|2339271|FG001|Overall Study|Adverse Event|0
1181540|NCT03452397|2339272|FG002|Overall Study|Adverse Event|0
1181541|NCT03452397|2339273|FG003|Overall Study|Adverse Event|0
1181542|NCT03452397|2339270|FG000|Overall Study|Administrative reason|0
1181543|NCT03452397|2339271|FG001|Overall Study|Administrative reason|0
1181544|NCT03452397|2339272|FG002|Overall Study|Administrative reason|1
1181545|NCT03452397|2339273|FG003|Overall Study|Administrative reason|1
1181546|NCT03452397|2339270|FG000|Overall Study|Withdrawal by Subject|0
1181547|NCT03452397|2339271|FG001|Overall Study|Withdrawal by Subject|0
1181548|NCT03452397|2339272|FG002|Overall Study|Withdrawal by Subject|1
1181549|NCT03452397|2339273|FG003|Overall Study|Withdrawal by Subject|0
1181550|NCT03448939|2339287|FG000|Overall Study|Adverse Event|5
1181551|NCT03448939|2339288|FG001|Overall Study|Adverse Event|1
1181552|NCT03448939|2339287|FG000|Overall Study|Lost to Follow-up|6
1181553|NCT03448939|2339288|FG001|Overall Study|Lost to Follow-up|6
1181554|NCT03448939|2339287|FG000|Overall Study|Pregnancy|1
1181555|NCT03448939|2339288|FG001|Overall Study|Pregnancy|1
1181556|NCT03448939|2339287|FG000|Overall Study|Withdrawal by Subject|9
1181557|NCT03448939|2339288|FG001|Overall Study|Withdrawal by Subject|3
1181558|NCT03410108|2339294|FG000|Overall Study|Ongoing|41
1181559|NCT03410108|2339294|FG000|Overall Study|Adverse Event|4
1181560|NCT03410108|2339294|FG000|Overall Study|Progressive Disease|58
1181561|NCT03410108|2339294|FG000|Overall Study|Withdrawal by Subject|1
1181572|NCT03283371|2339321|FG000|Placebo-controlled|Adverse Event|1
1181573|NCT03283371|2339322|FG001|Placebo-controlled|Adverse Event|1
1181574|NCT03283371|2339323|FG002|Placebo-controlled|Adverse Event|0
1181575|NCT03283371|2339324|FG003|Placebo-controlled|Adverse Event|0
1181576|NCT03283371|2339321|FG000|Placebo-controlled|Lack of Efficacy|1
1181577|NCT03283371|2339322|FG001|Placebo-controlled|Lack of Efficacy|0
1181578|NCT03283371|2339323|FG002|Placebo-controlled|Lack of Efficacy|0
1181579|NCT03283371|2339324|FG003|Placebo-controlled|Lack of Efficacy|0
1181580|NCT03283371|2339321|FG000|Placebo-controlled|Withdrawal by Subject|1
1181581|NCT03283371|2339322|FG001|Placebo-controlled|Withdrawal by Subject|1
1181582|NCT03283371|2339323|FG002|Placebo-controlled|Withdrawal by Subject|0
1181583|NCT03283371|2339324|FG003|Placebo-controlled|Withdrawal by Subject|0
1181584|NCT03283371|2339321|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0
1181585|NCT03283371|2339322|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1
1181586|NCT03283371|2339323|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0
1181587|NCT03283371|2339324|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0
1181588|NCT03283371|2339321|FG000|Open-label Phase|Adverse Event|0
1181589|NCT03283371|2339322|FG001|Open-label Phase|Adverse Event|0
1181590|NCT03283371|2339323|FG002|Open-label Phase|Adverse Event|2
1181591|NCT03283371|2339324|FG003|Open-label Phase|Adverse Event|0
1181592|NCT03283371|2339321|FG000|Open-label Phase|Withdrawal by Subject|0
1181593|NCT03283371|2339322|FG001|Open-label Phase|Withdrawal by Subject|0
1181594|NCT03283371|2339323|FG002|Open-label Phase|Withdrawal by Subject|1
1181595|NCT03283371|2339324|FG003|Open-label Phase|Withdrawal by Subject|0
1181596|NCT03283371|2339321|FG000|Open-label Phase|Other|0
876434|NCT00561925|1838623|FG001|144-week Double-blind, Double-dummy|Death|6
876435|NCT00561925|1838624|FG002|144-week Double-blind, Double-dummy|Death|3
876436|NCT00561925|1838625|FG003|144-week Double-blind, Double-dummy|Death|0
876437|NCT00561925|1838626|FG004|144-week Double-blind, Double-dummy|Death|0
876438|NCT00561925|1838622|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0
876439|NCT00561925|1838623|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2
876440|NCT00561925|1838624|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0
876441|NCT00561925|1838625|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0
876442|NCT00561925|1838626|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0
876443|NCT00561925|1838622|FG000|144-week Double-blind, Double-dummy|Other|0
876444|NCT00561925|1838623|FG001|144-week Double-blind, Double-dummy|Other|8
876445|NCT00561925|1838624|FG002|144-week Double-blind, Double-dummy|Other|11
876446|NCT00561925|1838625|FG003|144-week Double-blind, Double-dummy|Other|0
876447|NCT00561925|1838626|FG004|144-week Double-blind, Double-dummy|Other|0
876448|NCT00561925|1838622|FG000|Open-Label Extension Period|Declined entry into extension period|0
876449|NCT00561925|1838623|FG001|Open-Label Extension Period|Declined entry into extension period|0
876450|NCT00561925|1838624|FG002|Open-Label Extension Period|Declined entry into extension period|0
876451|NCT00561925|1838625|FG003|Open-Label Extension Period|Declined entry into extension period|43
876452|NCT00561925|1838626|FG004|Open-Label Extension Period|Declined entry into extension period|50
876453|NCT00561951|1838647|FG000|Overall Study|Adverse Event|11
876454|NCT00561951|1838648|FG001|Overall Study|Adverse Event|14
876455|NCT00561951|1838649|FG002|Overall Study|Adverse Event|14
876456|NCT00561951|1838647|FG000|Overall Study|Lack of Efficacy|5
876457|NCT00561951|1838648|FG001|Overall Study|Lack of Efficacy|3
876458|NCT00561951|1838649|FG002|Overall Study|Lack of Efficacy|2
876459|NCT00561951|1838647|FG000|Overall Study|Lost to Follow-up|1
876460|NCT00561951|1838648|FG001|Overall Study|Lost to Follow-up|1
876461|NCT00561951|1838649|FG002|Overall Study|Lost to Follow-up|0
876462|NCT00561951|1838647|FG000|Overall Study|Withdrawal by Subject|10
876463|NCT00561951|1838648|FG001|Overall Study|Withdrawal by Subject|9
876464|NCT00561951|1838649|FG002|Overall Study|Withdrawal by Subject|10
876465|NCT00561951|1838647|FG000|Overall Study|Protocol Violation|4
876466|NCT00561951|1838648|FG001|Overall Study|Protocol Violation|3
876467|NCT00561951|1838649|FG002|Overall Study|Protocol Violation|4
876468|NCT00561951|1838647|FG000|Overall Study|Physician Decision|1
876469|NCT00561951|1838648|FG001|Overall Study|Physician Decision|0
876470|NCT00561951|1838649|FG002|Overall Study|Physician Decision|0
876471|NCT00561951|1838647|FG000|Overall Study|Pregnancy|0
876472|NCT00561951|1838648|FG001|Overall Study|Pregnancy|1
876473|NCT00561951|1838649|FG002|Overall Study|Pregnancy|0
876474|NCT00561951|1838647|FG000|Overall Study|Meet Withdrawal Criterion|0
876475|NCT00561951|1838648|FG001|Overall Study|Meet Withdrawal Criterion|1
876476|NCT00561951|1838649|FG002|Overall Study|Meet Withdrawal Criterion|1
876477|NCT00561951|1838647|FG000|Overall Study|Adverse Event Occured Before Treatment|1
876478|NCT00561951|1838648|FG001|Overall Study|Adverse Event Occured Before Treatment|2
876479|NCT00561951|1838649|FG002|Overall Study|Adverse Event Occured Before Treatment|1
876480|NCT00561977|1838660|FG000|Overall Study|Withdrawal by Subject|0
876481|NCT00561977|1838661|FG001|Overall Study|Withdrawal by Subject|2
876482|NCT00561977|1838662|FG002|Overall Study|Withdrawal by Subject|1
876483|NCT00561977|1838660|FG000|Overall Study|Pregnancy|0
1181597|NCT03283371|2339322|FG001|Open-label Phase|Other|0
1181598|NCT03283371|2339323|FG002|Open-label Phase|Other|1
1181599|NCT03283371|2339324|FG003|Open-label Phase|Other|1
1181600|NCT03257254|2339334|FG000|Overall Study|Withdrawal by Subject|7
1181601|NCT03257254|2339334|FG000|Overall Study|Lost to Follow-up|9
1181602|NCT03257254|2339334|FG000|Overall Study|Study discontinued by sponsor|5
1181603|NCT03084718|2339343|FG000|Overall Study|Withdrawal by Subject|4
1181604|NCT03084718|2339344|FG001|Overall Study|Withdrawal by Subject|3
1181605|NCT03084718|2339345|FG002|Overall Study|Withdrawal by Subject|4
1181606|NCT03084718|2339346|FG003|Overall Study|Withdrawal by Subject|0
1181607|NCT03084718|2339347|FG004|Overall Study|Withdrawal by Subject|0
1181608|NCT03084718|2339343|FG000|Overall Study|Physician Decision|1
1181609|NCT03084718|2339344|FG001|Overall Study|Physician Decision|0
1181610|NCT03084718|2339345|FG002|Overall Study|Physician Decision|0
1181611|NCT03084718|2339346|FG003|Overall Study|Physician Decision|0
1181612|NCT03084718|2339347|FG004|Overall Study|Physician Decision|0
1181613|NCT03084718|2339343|FG000|Overall Study|Adverse Event|3
1181614|NCT03084718|2339344|FG001|Overall Study|Adverse Event|5
1181615|NCT03084718|2339345|FG002|Overall Study|Adverse Event|5
1181616|NCT03084718|2339346|FG003|Overall Study|Adverse Event|8
1181617|NCT03084718|2339347|FG004|Overall Study|Adverse Event|2
1181618|NCT03084718|2339343|FG000|Overall Study|Lack of Efficacy|2
1181619|NCT03084718|2339344|FG001|Overall Study|Lack of Efficacy|0
1181620|NCT03084718|2339345|FG002|Overall Study|Lack of Efficacy|1
1181621|NCT03084718|2339346|FG003|Overall Study|Lack of Efficacy|4
1181622|NCT03084718|2339347|FG004|Overall Study|Lack of Efficacy|0
1181623|NCT03084718|2339343|FG000|Overall Study|Lost to Follow-up|0
1181624|NCT03084718|2339344|FG001|Overall Study|Lost to Follow-up|1
1181625|NCT03084718|2339345|FG002|Overall Study|Lost to Follow-up|0
1181626|NCT03084718|2339346|FG003|Overall Study|Lost to Follow-up|0
1181627|NCT03084718|2339347|FG004|Overall Study|Lost to Follow-up|2
1181628|NCT03084718|2339343|FG000|Overall Study|Protocol Violation|0
1181629|NCT03084718|2339344|FG001|Overall Study|Protocol Violation|0
1181630|NCT03084718|2339345|FG002|Overall Study|Protocol Violation|1
1181631|NCT03084718|2339346|FG003|Overall Study|Protocol Violation|0
1181632|NCT03084718|2339347|FG004|Overall Study|Protocol Violation|0
1181633|NCT03084718|2339343|FG000|Overall Study|Death|0
1181634|NCT03084718|2339344|FG001|Overall Study|Death|1
1181635|NCT03084718|2339345|FG002|Overall Study|Death|0
1181636|NCT03084718|2339346|FG003|Overall Study|Death|0
1181637|NCT03084718|2339347|FG004|Overall Study|Death|0
1181638|NCT03084718|2339343|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
1181639|NCT03084718|2339344|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
1181640|NCT03084718|2339345|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
1181641|NCT03084718|2339346|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2
1181642|NCT03084718|2339347|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
1181643|NCT03069417|2339364|FG000|Overall Study|Lost to Follow-up|2
1181644|NCT03069417|2339365|FG001|Overall Study|Lost to Follow-up|0
1181645|NCT03069417|2339364|FG000|Overall Study|Reason Unknown|4
1181646|NCT03069417|2339365|FG001|Overall Study|Reason Unknown|7
1181647|NCT02936323|2339394|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1181648|NCT02936323|2339395|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
1181649|NCT02936323|2339396|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1181650|NCT02936323|2339397|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
1181651|NCT02936323|2339398|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
1181652|NCT02936323|2339399|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
1181653|NCT02936323|2339400|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1181654|NCT02936323|2339401|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1181655|NCT02936323|2339402|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1181656|NCT02936323|2339403|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1181657|NCT02936323|2339394|FG000|Phase 1 Dose Escalation|Death|2
1181658|NCT02936323|2339395|FG001|Phase 1 Dose Escalation|Death|1
1181659|NCT02936323|2339396|FG002|Phase 1 Dose Escalation|Death|3
1181660|NCT02936323|2339397|FG003|Phase 1 Dose Escalation|Death|1
1181661|NCT02936323|2339398|FG004|Phase 1 Dose Escalation|Death|2
1181662|NCT02936323|2339399|FG005|Phase 1 Dose Escalation|Death|3
1181663|NCT02936323|2339400|FG006|Phase 1 Dose Escalation|Death|3
1181664|NCT02936323|2339401|FG007|Phase 1 Dose Escalation|Death|0
876484|NCT00561977|1838661|FG001|Overall Study|Pregnancy|1
876485|NCT00561977|1838662|FG002|Overall Study|Pregnancy|1
876486|NCT00562094|1838670|FG000|Overall Study|Lost to Follow-up|62
876487|NCT00562120|1838678|FG000|First Intervention Period|Adverse Event|1
876488|NCT00562120|1838679|FG001|First Intervention Period|Adverse Event|0
1181665|NCT02936323|2339402|FG008|Phase 1 Dose Escalation|Death|0
1181666|NCT02936323|2339403|FG009|Phase 1 Dose Escalation|Death|0
1181667|NCT02936323|2339394|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0
1181668|NCT02936323|2339395|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0
1181669|NCT02936323|2339396|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0
1181670|NCT02936323|2339397|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0
1181671|NCT02936323|2339398|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0
1181672|NCT02936323|2339399|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1
876489|NCT00562120|1838680|FG002|First Intervention Period|Adverse Event|0
876490|NCT00562120|1838681|FG003|First Intervention Period|Adverse Event|0
876491|NCT00562120|1838678|FG000|First Intervention Period|Randomized but not Treated|1
876492|NCT00562120|1838679|FG001|First Intervention Period|Randomized but not Treated|0
876493|NCT00562120|1838680|FG002|First Intervention Period|Randomized but not Treated|0
876494|NCT00562120|1838681|FG003|First Intervention Period|Randomized but not Treated|0
876495|NCT00562159|1838693|FG000|Overall Study|Adverse Event|11
876496|NCT00562159|1838694|FG001|Overall Study|Adverse Event|8
876497|NCT00562159|1838693|FG000|Overall Study|Lost to Follow-up|5
876498|NCT00562159|1838694|FG001|Overall Study|Lost to Follow-up|4
876499|NCT00562159|1838693|FG000|Overall Study|Withdrawal by Subject|9
876500|NCT00562159|1838694|FG001|Overall Study|Withdrawal by Subject|8
876501|NCT00562159|1838693|FG000|Overall Study|Protocol Violation|12
876502|NCT00562159|1838694|FG001|Overall Study|Protocol Violation|12
876503|NCT00562159|1838693|FG000|Overall Study|Did not meet protocol eligibility|1
876504|NCT00562159|1838694|FG001|Overall Study|Did not meet protocol eligibility|1
876505|NCT00562302|1838703|FG000|Overall Study|Lost to Follow-up|3
876506|NCT00562302|1838704|FG001|Overall Study|Lost to Follow-up|3
876507|NCT00562302|1838703|FG000|Overall Study|Adverse Event|0
876508|NCT00562302|1838704|FG001|Overall Study|Adverse Event|6
876509|NCT00562302|1838703|FG000|Overall Study|Non-compliance|1
876510|NCT00562302|1838704|FG001|Overall Study|Non-compliance|2
876511|NCT00562302|1838703|FG000|Overall Study|Withdrawal by Subject|7
876512|NCT00562302|1838704|FG001|Overall Study|Withdrawal by Subject|8
876513|NCT00562302|1838703|FG000|Overall Study|Death|1
876514|NCT00562302|1838704|FG001|Overall Study|Death|2
876515|NCT00562302|1838703|FG000|Overall Study|Lung resection prior to study completion|7
876516|NCT00562302|1838704|FG001|Overall Study|Lung resection prior to study completion|7
876517|NCT00562302|1838703|FG000|Overall Study|Not stated|1
876518|NCT00562302|1838704|FG001|Overall Study|Not stated|4
876519|NCT00562354|1838722|FG000|Overall Study|Physician Decision|0
876520|NCT00562354|1838723|FG001|Overall Study|Physician Decision|1
1181673|NCT02936323|2339400|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0
1181674|NCT02936323|2339401|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0
1181675|NCT02936323|2339402|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0
1181676|NCT02936323|2339403|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0
1181677|NCT02936323|2339394|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1181678|NCT02936323|2339395|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1181679|NCT02936323|2339396|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1181680|NCT02936323|2339397|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1181681|NCT02936323|2339398|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1181682|NCT02936323|2339399|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
876521|NCT00562354|1838722|FG000|Overall Study|Lost to Follow-up|0
876522|NCT00562354|1838723|FG001|Overall Study|Lost to Follow-up|1
876523|NCT00562484|1838733|FG000|Overall Study|Adverse Event|6
876524|NCT00562484|1838734|FG001|Overall Study|Adverse Event|1
876525|NCT00562484|1838733|FG000|Overall Study|Protocol Violation|11
876526|NCT00562484|1838734|FG001|Overall Study|Protocol Violation|2
876527|NCT00562484|1838733|FG000|Overall Study|Withdrawal by Subject|12
876528|NCT00562484|1838734|FG001|Overall Study|Withdrawal by Subject|9
876529|NCT00562484|1838733|FG000|Overall Study|Moved away from the study area|20
876530|NCT00562484|1838734|FG001|Overall Study|Moved away from the study area|9
876531|NCT00562484|1838733|FG000|Overall Study|Lost to Follow-up|132
876532|NCT00562484|1838734|FG001|Overall Study|Lost to Follow-up|71
876533|NCT00562484|1838733|FG000|Overall Study|Reason not provided or not specified|25
876534|NCT00562484|1838734|FG001|Overall Study|Reason not provided or not specified|12
876535|NCT00562588|1838742|FG000|Overall Study|Adverse Event|40
876536|NCT00562588|1838743|FG001|Overall Study|Adverse Event|58
876537|NCT00562588|1838742|FG000|Overall Study|Protocol Violation|30
876538|NCT00562588|1838743|FG001|Overall Study|Protocol Violation|26
876539|NCT00562588|1838742|FG000|Overall Study|Lost to Follow-up|12
876540|NCT00562588|1838743|FG001|Overall Study|Lost to Follow-up|4
876541|NCT00562588|1838742|FG000|Overall Study|Withdrawal by Subject|10
876542|NCT00562588|1838743|FG001|Overall Study|Withdrawal by Subject|9
876543|NCT00562588|1838742|FG000|Overall Study|Other|0
876544|NCT00562588|1838743|FG001|Overall Study|Other|2
876545|NCT00562627|1838752|FG000|Overall Study|Protocol Violation|1
876546|NCT00562627|1838753|FG001|Overall Study|Protocol Violation|1
876547|NCT00562627|1838754|FG002|Overall Study|Protocol Violation|1
876548|NCT00562718|1838762|FG000|Overall Study|Death|1
876549|NCT00562718|1838762|FG000|Overall Study|Withdrawal by Subject|3
876550|NCT00562718|1838762|FG000|Overall Study|Adverse Event|4
876551|NCT00562718|1838762|FG000|Overall Study|Lack of Efficacy|2
876552|NCT00562718|1838762|FG000|Overall Study|not stated|1
876553|NCT00562861|1838768|FG000|Overall Study|Adverse Event|1
876554|NCT00562861|1838769|FG001|Overall Study|Adverse Event|1
876555|NCT00562861|1838768|FG000|Overall Study|Lack of Efficacy|5
876556|NCT00562861|1838769|FG001|Overall Study|Lack of Efficacy|5
876557|NCT00562861|1838768|FG000|Overall Study|noncompliance, moved|7
876558|NCT00562861|1838769|FG001|Overall Study|noncompliance, moved|2
876559|NCT00562861|1838768|FG000|Overall Study|Lost to Follow-up|7
876560|NCT00562861|1838769|FG001|Overall Study|Lost to Follow-up|3
1181683|NCT02936323|2339400|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1181684|NCT02936323|2339401|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11
1181685|NCT02936323|2339402|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4
1181686|NCT02936323|2339403|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2
1181687|NCT02936323|2339394|FG000|Phase 2a Dose Expansion|Physician Decision|0
1181688|NCT02936323|2339395|FG001|Phase 2a Dose Expansion|Physician Decision|0
1181689|NCT02936323|2339396|FG002|Phase 2a Dose Expansion|Physician Decision|0
1181690|NCT02936323|2339397|FG003|Phase 2a Dose Expansion|Physician Decision|0
1181691|NCT02936323|2339398|FG004|Phase 2a Dose Expansion|Physician Decision|0
1181692|NCT02936323|2339399|FG005|Phase 2a Dose Expansion|Physician Decision|0
1181693|NCT02936323|2339400|FG006|Phase 2a Dose Expansion|Physician Decision|0
1181694|NCT02936323|2339401|FG007|Phase 2a Dose Expansion|Physician Decision|0
1181695|NCT02936323|2339402|FG008|Phase 2a Dose Expansion|Physician Decision|0
1181696|NCT02936323|2339403|FG009|Phase 2a Dose Expansion|Physician Decision|1
1181697|NCT02936323|2339394|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0
1181698|NCT02936323|2339395|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0
1181699|NCT02936323|2339396|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0
1181700|NCT02936323|2339397|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0
1181701|NCT02936323|2339398|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0
1181702|NCT02936323|2339399|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0
1181703|NCT02936323|2339400|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0
1181704|NCT02936323|2339401|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2
1181705|NCT02936323|2339402|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1
1181706|NCT02936323|2339403|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0
1181707|NCT02936323|2339394|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1181708|NCT02936323|2339395|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1181709|NCT02936323|2339396|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1181710|NCT02936323|2339397|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1181711|NCT02936323|2339398|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1181712|NCT02936323|2339399|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1181713|NCT02936323|2339400|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1181714|NCT02936323|2339401|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1181715|NCT02936323|2339402|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0
876561|NCT00562965|1838777|FG000|Overall Study|Withdrawal by Subject|0
876562|NCT00562965|1838778|FG001|Overall Study|Withdrawal by Subject|1
876563|NCT00562965|1838777|FG000|Overall Study|Death|2
876564|NCT00562965|1838778|FG001|Overall Study|Death|4
876565|NCT00562965|1838777|FG000|Overall Study|Lost to Follow-up|1
876566|NCT00562965|1838778|FG001|Overall Study|Lost to Follow-up|0
876567|NCT00562965|1838777|FG000|Overall Study|Other|0
876568|NCT00562965|1838778|FG001|Overall Study|Other|1
876569|NCT00562978|1838786|FG000|Overall Study|Patient had imaging dose only|1
876570|NCT00562978|1838787|FG001|Overall Study|Patient had imaging dose only|11
876571|NCT00563186|1838795|FG000|Overall Study|LOS<48 hours|97
876572|NCT00563186|1838796|FG001|Overall Study|LOS<48 hours|74
876573|NCT00563186|1838795|FG000|Overall Study|Incomplete data|1
876574|NCT00563186|1838796|FG001|Overall Study|Incomplete data|1
876575|NCT00563316|1838816|FG000|Overall Study|Adverse Event|2
876576|NCT00563316|1838816|FG000|Overall Study|Physician Decision|1
876577|NCT00563316|1838816|FG000|Overall Study|Lost to Follow-up|2
876578|NCT00563316|1838816|FG000|Overall Study|Death|1
876579|NCT00563316|1838816|FG000|Overall Study|On-going in study as of 16 July 2009.|5
876580|NCT00563316|1838816|FG000|Overall Study|Other|1
876581|NCT00563368|1838831|FG000|Overall Study|Lost to Follow-up|14
876582|NCT00563368|1838832|FG001|Overall Study|Lost to Follow-up|14
876583|NCT00563368|1838833|FG002|Overall Study|Lost to Follow-up|12
876584|NCT00563368|1838834|FG003|Overall Study|Lost to Follow-up|6
876585|NCT00563368|1838835|FG004|Overall Study|Lost to Follow-up|9
876586|NCT00563368|1838836|FG005|Overall Study|Lost to Follow-up|8
876587|NCT00563368|1838837|FG006|Overall Study|Lost to Follow-up|9
876588|NCT00563368|1838831|FG000|Overall Study|Adverse Event|3
876589|NCT00563368|1838832|FG001|Overall Study|Adverse Event|4
876590|NCT00563368|1838833|FG002|Overall Study|Adverse Event|5
876591|NCT00563368|1838834|FG003|Overall Study|Adverse Event|9
876592|NCT00563368|1838835|FG004|Overall Study|Adverse Event|6
876593|NCT00563368|1838836|FG005|Overall Study|Adverse Event|10
876594|NCT00563368|1838837|FG006|Overall Study|Adverse Event|17
876595|NCT00563368|1838831|FG000|Overall Study|Withdrawal by Subject|11
876596|NCT00563368|1838832|FG001|Overall Study|Withdrawal by Subject|6
876597|NCT00563368|1838833|FG002|Overall Study|Withdrawal by Subject|5
876598|NCT00563368|1838834|FG003|Overall Study|Withdrawal by Subject|7
876599|NCT00563368|1838835|FG004|Overall Study|Withdrawal by Subject|8
876600|NCT00563368|1838836|FG005|Overall Study|Withdrawal by Subject|5
876601|NCT00563368|1838837|FG006|Overall Study|Withdrawal by Subject|4
876602|NCT00563368|1838831|FG000|Overall Study|protocol non-compliance|1
876603|NCT00563368|1838832|FG001|Overall Study|protocol non-compliance|1
876604|NCT00563368|1838833|FG002|Overall Study|protocol non-compliance|2
876605|NCT00563368|1838834|FG003|Overall Study|protocol non-compliance|1
1181716|NCT02936323|2339403|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1
1181717|NCT02936323|2339394|FG000|Phase 2a Dose Expansion|Death|0
1181718|NCT02936323|2339395|FG001|Phase 2a Dose Expansion|Death|0
1181719|NCT02936323|2339396|FG002|Phase 2a Dose Expansion|Death|0
1181720|NCT02936323|2339397|FG003|Phase 2a Dose Expansion|Death|0
1181721|NCT02936323|2339398|FG004|Phase 2a Dose Expansion|Death|0
1181722|NCT02936323|2339399|FG005|Phase 2a Dose Expansion|Death|0
1181723|NCT02936323|2339400|FG006|Phase 2a Dose Expansion|Death|0
1181724|NCT02936323|2339401|FG007|Phase 2a Dose Expansion|Death|4
1181725|NCT02936323|2339402|FG008|Phase 2a Dose Expansion|Death|8
1181726|NCT02936323|2339403|FG009|Phase 2a Dose Expansion|Death|10
1181727|NCT02437318|2339446|FG000|Overall Study|Progressive disease|173
1181728|NCT02437318|2339447|FG001|Overall Study|Progressive disease|208
1181729|NCT02437318|2339446|FG000|Overall Study|Subject/guardian decision|22
1181730|NCT02437318|2339447|FG001|Overall Study|Subject/guardian decision|10
1181731|NCT02437318|2339446|FG000|Overall Study|Physician Decision|11
1181732|NCT02437318|2339447|FG001|Overall Study|Physician Decision|10
1181733|NCT02437318|2339446|FG000|Overall Study|Adverse Event|14
1181734|NCT02437318|2339447|FG001|Overall Study|Adverse Event|3
1181735|NCT02437318|2339446|FG000|Overall Study|Death|4
1181736|NCT02437318|2339447|FG001|Overall Study|Death|4
1181737|NCT02437318|2339446|FG000|Overall Study|Protocol Violation|5
1181738|NCT02437318|2339447|FG001|Overall Study|Protocol Violation|6
1181739|NCT02437318|2339446|FG000|Overall Study|Untreated|0
1181740|NCT02437318|2339447|FG001|Overall Study|Untreated|1
1181741|NCT02429791|2339455|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6
1181742|NCT02429791|2339456|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2
1181743|NCT02429791|2339455|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
876606|NCT00563368|1838835|FG004|Overall Study|protocol non-compliance|0
876607|NCT00563368|1838836|FG005|Overall Study|protocol non-compliance|1
876608|NCT00563368|1838837|FG006|Overall Study|protocol non-compliance|3
876609|NCT00563368|1838831|FG000|Overall Study|Pregnancy|1
876610|NCT00563368|1838832|FG001|Overall Study|Pregnancy|0
876611|NCT00563368|1838833|FG002|Overall Study|Pregnancy|1
876612|NCT00563368|1838834|FG003|Overall Study|Pregnancy|2
876613|NCT00563368|1838835|FG004|Overall Study|Pregnancy|1
876614|NCT00563368|1838836|FG005|Overall Study|Pregnancy|2
876615|NCT00563368|1838837|FG006|Overall Study|Pregnancy|0
876616|NCT00563368|1838831|FG000|Overall Study|requirement for restricted medication|0
876617|NCT00563368|1838832|FG001|Overall Study|requirement for restricted medication|0
876618|NCT00563368|1838833|FG002|Overall Study|requirement for restricted medication|2
876619|NCT00563368|1838834|FG003|Overall Study|requirement for restricted medication|0
876620|NCT00563368|1838835|FG004|Overall Study|requirement for restricted medication|0
876621|NCT00563368|1838836|FG005|Overall Study|requirement for restricted medication|0
876622|NCT00563368|1838837|FG006|Overall Study|requirement for restricted medication|0
876623|NCT00563368|1838831|FG000|Overall Study|Other|5
876624|NCT00563368|1838832|FG001|Overall Study|Other|5
876625|NCT00563368|1838833|FG002|Overall Study|Other|3
876626|NCT00563368|1838834|FG003|Overall Study|Other|4
876627|NCT00563368|1838835|FG004|Overall Study|Other|4
876628|NCT00563368|1838836|FG005|Overall Study|Other|4
876629|NCT00563368|1838837|FG006|Overall Study|Other|0
876630|NCT00563381|1838855|FG000|Overall Study|Adverse Event|264
876631|NCT00563381|1838856|FG001|Overall Study|Adverse Event|292
876632|NCT00563381|1838855|FG000|Overall Study|Protocol Violation|66
876633|NCT00563381|1838856|FG001|Overall Study|Protocol Violation|74
876634|NCT00563381|1838855|FG000|Overall Study|Lost to Follow-up|7
876635|NCT00563381|1838856|FG001|Overall Study|Lost to Follow-up|15
876636|NCT00563381|1838855|FG000|Overall Study|Withdrawal by Subject|192
876637|NCT00563381|1838856|FG001|Overall Study|Withdrawal by Subject|209
876638|NCT00563381|1838855|FG000|Overall Study|Lack of Efficacy|32
876639|NCT00563381|1838856|FG001|Overall Study|Lack of Efficacy|24
876640|NCT00563381|1838855|FG000|Overall Study|Individual different reasons|24
876641|NCT00563381|1838856|FG001|Overall Study|Individual different reasons|34
876642|NCT00563706|1838880|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
876643|NCT00563706|1838881|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
876644|NCT00563706|1838882|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
876645|NCT00563706|1838883|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
876646|NCT00563706|1838884|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
876647|NCT00563706|1838885|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
876648|NCT00563706|1838886|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
876649|NCT00563706|1838887|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
876650|NCT00563706|1838888|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
876651|NCT00563706|1838880|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
876652|NCT00563706|1838881|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
876653|NCT00563706|1838882|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
876654|NCT00563706|1838883|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
876655|NCT00563706|1838884|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
876656|NCT00563706|1838885|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
876657|NCT00563706|1838886|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
876658|NCT00563706|1838887|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
876659|NCT00563706|1838888|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
876660|NCT00563706|1838880|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
876661|NCT00563706|1838881|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
1181744|NCT02429791|2339456|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2
1181745|NCT02429791|2339455|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
1181746|NCT02429791|2339456|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
1181747|NCT02429791|2339455|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
1181748|NCT02429791|2339456|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
1181749|NCT02429791|2339455|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1
1181750|NCT02429791|2339456|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4
1181751|NCT02429791|2339455|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
1181752|NCT02429791|2339456|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
1181753|NCT02429791|2339455|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
1181754|NCT02429791|2339456|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
1181755|NCT02429791|2339455|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
1181756|NCT02429791|2339456|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
1181757|NCT02429791|2339455|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
1181758|NCT02429791|2339456|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
1181759|NCT02429791|2339455|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
1181760|NCT02429791|2339456|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
1181761|NCT02429791|2339455|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
1181762|NCT02429791|2339456|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
1181763|NCT02429791|2339455|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
1181764|NCT02429791|2339456|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
1181765|NCT02422797|2339471|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11
1181766|NCT02422797|2339472|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1
1181767|NCT02422797|2339471|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
1181768|NCT02422797|2339472|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1
1181769|NCT02422797|2339471|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
1181770|NCT02422797|2339472|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
1181771|NCT02422797|2339471|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
1181772|NCT02422797|2339472|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
1181773|NCT02422797|2339471|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0
1181774|NCT02422797|2339472|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3
1181775|NCT02422797|2339471|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
1181776|NCT02422797|2339472|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
1181777|NCT02422797|2339471|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
1181778|NCT02422797|2339472|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
1181779|NCT02422797|2339471|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
1181780|NCT02422797|2339472|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
1181781|NCT02422797|2339471|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
1181782|NCT02422797|2339472|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
1181783|NCT02422797|2339471|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
1181784|NCT02422797|2339472|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
1181785|NCT02422797|2339471|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
1181786|NCT02422797|2339472|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
1181787|NCT02422797|2339471|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
1181788|NCT02422797|2339472|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
1181789|NCT02422797|2339471|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
1181790|NCT02422797|2339472|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
1181791|NCT02422797|2339471|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
1181792|NCT02422797|2339472|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
1181793|NCT02422615|2339490|FG000|Overall Study|Progressive disease|193
1181794|NCT02422615|2339491|FG001|Overall Study|Progressive disease|142
1181795|NCT02422615|2339490|FG000|Overall Study|Adverse Event|41
1181796|NCT02422615|2339491|FG001|Overall Study|Adverse Event|10
1181797|NCT02422615|2339490|FG000|Overall Study|Physician Decision|22
1181798|NCT02422615|2339491|FG001|Overall Study|Physician Decision|7
1181799|NCT02422615|2339490|FG000|Overall Study|Subject/guardian decision|21
1181800|NCT02422615|2339491|FG001|Overall Study|Subject/guardian decision|5
1181801|NCT02422615|2339490|FG000|Overall Study|Death|2
1181802|NCT02422615|2339491|FG001|Overall Study|Death|0
1181803|NCT02422615|2339490|FG000|Overall Study|Protocol Violation|1
1181804|NCT02422615|2339491|FG001|Overall Study|Protocol Violation|1
1181805|NCT02422615|2339490|FG000|Overall Study|Technical problems|0
1181806|NCT02422615|2339491|FG001|Overall Study|Technical problems|1
1181807|NCT02132611|2339510|FG000|Overall Study|Death|2
1181808|NCT01910402|2339516|FG000|Randomized Phase|Adverse Event|10
1181809|NCT01910402|2339517|FG001|Randomized Phase|Adverse Event|18
1181810|NCT01910402|2339516|FG000|Randomized Phase|Physician Decision|1
1181811|NCT01910402|2339517|FG001|Randomized Phase|Physician Decision|0
1181812|NCT01910402|2339516|FG000|Randomized Phase|Lack of Efficacy|5
1181813|NCT01910402|2339517|FG001|Randomized Phase|Lack of Efficacy|4
1181814|NCT01910402|2339516|FG000|Randomized Phase|Lost to Follow-up|11
1181815|NCT01910402|2339517|FG001|Randomized Phase|Lost to Follow-up|13
1181816|NCT01910402|2339516|FG000|Randomized Phase|Protocol Violation|10
1181817|NCT01910402|2339517|FG001|Randomized Phase|Protocol Violation|13
1181818|NCT01910402|2339516|FG000|Randomized Phase|Withdrawal by Subject|5
1181819|NCT01910402|2339517|FG001|Randomized Phase|Withdrawal by Subject|7
1181820|NCT01910402|2339516|FG000|Continuation Phase|Ongoing|84
1181821|NCT01910402|2339517|FG001|Continuation Phase|Ongoing|0
1181822|NCT01910402|2339516|FG000|Continuation Phase|Adverse Event|1
1181823|NCT01910402|2339517|FG001|Continuation Phase|Adverse Event|0
1181824|NCT01910402|2339516|FG000|Continuation Phase|Protocol Violation|3
1181825|NCT01910402|2339517|FG001|Continuation Phase|Protocol Violation|0
1181826|NCT01910402|2339516|FG000|Continuation Phase|Withdrawal by Subject|2
1181827|NCT01910402|2339517|FG001|Continuation Phase|Withdrawal by Subject|0
1181828|NCT01796197|2339525|FG000|Overall Study|Lost to Follow-up|1
1181829|NCT01796197|2339525|FG000|Overall Study|Lack of Efficacy|1
1181830|NCT01147822|2339531|FG000|Overall Study|Death|66
876662|NCT00563706|1838882|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
876663|NCT00563706|1838883|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
876664|NCT00563706|1838884|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
876665|NCT00563706|1838885|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
876666|NCT00563706|1838886|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
876667|NCT00563706|1838887|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
876668|NCT00563706|1838888|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
876669|NCT00563706|1838880|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
876670|NCT00563706|1838881|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
876671|NCT00563706|1838882|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
876672|NCT00563706|1838883|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
876673|NCT00563706|1838884|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
876674|NCT00563706|1838885|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
876675|NCT00563706|1838886|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
876676|NCT00563706|1838887|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
876677|NCT00563706|1838888|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
876678|NCT00563706|1838880|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0
876679|NCT00563706|1838881|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0
876680|NCT00563706|1838882|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0
876681|NCT00563706|1838883|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0
876682|NCT00563706|1838884|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0
876683|NCT00563706|1838885|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0
876684|NCT00563706|1838886|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0
876685|NCT00563706|1838887|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1
876686|NCT00563706|1838888|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2
876687|NCT00563784|1838908|FG000|Overall Study|Withdrawal by Subject|2
876688|NCT00563784|1838908|FG000|Overall Study|Screen Failures|20
876689|NCT00563797|1838914|FG000|Overall Study|Lost to Follow-up|7
876690|NCT00563797|1838915|FG001|Overall Study|Lost to Follow-up|2
876691|NCT00564018|1838926|FG000|Overall Study|Withdrawal by Subject|2
876692|NCT00564018|1838927|FG001|Overall Study|Withdrawal by Subject|3
876693|NCT00564018|1838928|FG002|Overall Study|Withdrawal by Subject|1
876694|NCT00564070|1838938|FG000|Overall Study|Lost to Follow-up|9
876695|NCT00564070|1838939|FG001|Overall Study|Lost to Follow-up|7
876696|NCT00564070|1838938|FG000|Overall Study|Worsening depression, referred to care|3
876697|NCT00564070|1838939|FG001|Overall Study|Worsening depression, referred to care|0
876698|NCT00564278|1838951|FG000|Overall Study|Lost to Follow-up|35
876699|NCT00564278|1838952|FG001|Overall Study|Lost to Follow-up|33
876700|NCT00564278|1838951|FG000|Overall Study|Physician Decision|1
876701|NCT00564278|1838952|FG001|Overall Study|Physician Decision|2
876702|NCT00564278|1838951|FG000|Overall Study|Withdrawal by Subject|11
876703|NCT00564278|1838952|FG001|Overall Study|Withdrawal by Subject|7
876704|NCT00564395|1838958|FG000|First Intervention (10 Days)|Withdrawal by Subject|1
876705|NCT00564395|1838959|FG001|First Intervention (10 Days)|Withdrawal by Subject|0
876706|NCT00564395|1838958|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1
876707|NCT00564395|1838959|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2
876708|NCT00564486|1839001|FG000|Overall Study|Adverse Event|0
876709|NCT00564486|1839002|FG001|Overall Study|Adverse Event|1
876710|NCT00564486|1839003|FG002|Overall Study|Adverse Event|0
876711|NCT00564486|1839004|FG003|Overall Study|Adverse Event|0
876712|NCT00564486|1839001|FG000|Overall Study|Withdrawal by Subject|4
876713|NCT00564486|1839002|FG001|Overall Study|Withdrawal by Subject|0
876714|NCT00564486|1839003|FG002|Overall Study|Withdrawal by Subject|0
876715|NCT00564486|1839004|FG003|Overall Study|Withdrawal by Subject|5
876716|NCT00564486|1839001|FG000|Overall Study|Subject refused to have blood drawn|0
876717|NCT00564486|1839002|FG001|Overall Study|Subject refused to have blood drawn|0
876718|NCT00564486|1839003|FG002|Overall Study|Subject refused to have blood drawn|1
876719|NCT00564486|1839004|FG003|Overall Study|Subject refused to have blood drawn|0
876720|NCT00564486|1839001|FG000|Overall Study|Lost to Follow-up|3
876721|NCT00564486|1839002|FG001|Overall Study|Lost to Follow-up|0
876722|NCT00564486|1839003|FG002|Overall Study|Lost to Follow-up|2
876723|NCT00564486|1839004|FG003|Overall Study|Lost to Follow-up|2
876724|NCT00564629|1839020|FG000|Overall Study|Vomited within 2 hours of receiving drug|15
1181831|NCT01147822|2339532|FG001|Overall Study|Death|59
1181832|NCT01147822|2339531|FG000|Overall Study|Protocol Violation|0
1181833|NCT01147822|2339532|FG001|Overall Study|Protocol Violation|1
1181834|NCT01147822|2339531|FG000|Overall Study|Lost to Follow-up|3
1181835|NCT01147822|2339532|FG001|Overall Study|Lost to Follow-up|2
1181836|NCT01147822|2339531|FG000|Overall Study|Physician Decision|0
1181837|NCT01147822|2339532|FG001|Overall Study|Physician Decision|2
1181838|NCT01147822|2339531|FG000|Overall Study|Withdrawal by Subject|8
1181839|NCT01147822|2339532|FG001|Overall Study|Withdrawal by Subject|13
1181840|NCT01147822|2339531|FG000|Overall Study|Not Completed/Ongoing|111
1181841|NCT01147822|2339532|FG001|Overall Study|Not Completed/Ongoing|102
876725|NCT00564629|1839021|FG001|Overall Study|Vomited within 2 hours of receiving drug|9
876726|NCT00564733|1839043|FG000|Overall Study|Withdrawal by Subject|4
876727|NCT00564733|1839043|FG000|Overall Study|Ineligible|5
876728|NCT00564850|1839047|FG000|Overall Study|Protocol Violation|2
876729|NCT00564889|1839051|FG000|Overall Study|Death|7
876730|NCT00564889|1839051|FG000|Overall Study|Adverse Event|12
876731|NCT00564889|1839051|FG000|Overall Study|Alternative treatment|3
876732|NCT00564889|1839051|FG000|Overall Study|Disease progression|3
876733|NCT00564889|1839051|FG000|Overall Study|Other, not specified|4
876734|NCT00564902|1839058|FG000|Overall Study|Withdrawal by Subject|0
876735|NCT00564902|1839059|FG001|Overall Study|Withdrawal by Subject|3
876736|NCT00564902|1839060|FG002|Overall Study|Withdrawal by Subject|4
876737|NCT00564902|1839058|FG000|Overall Study|Death|1
876738|NCT00564902|1839059|FG001|Overall Study|Death|1
876739|NCT00564902|1839060|FG002|Overall Study|Death|0
876740|NCT00565058|1839088|FG000|Overall Study|Adverse Event|1
876741|NCT00565058|1839089|FG001|Overall Study|Adverse Event|0
876742|NCT00565136|1839114|FG000|Overall Study|Lost to Follow-up|1
876743|NCT00565136|1839114|FG000|Overall Study|Withdrawal by Subject|1
876744|NCT00565136|1839114|FG000|Overall Study|Protocol Violation|1
876745|NCT00565409|1839130|FG000|Period 1 Open Label|Adverse Event|17
876746|NCT00565409|1839131|FG001|Period 1 Open Label|Adverse Event|0
876747|NCT00565409|1839132|FG002|Period 1 Open Label|Adverse Event|0
876748|NCT00565409|1839133|FG003|Period 1 Open Label|Adverse Event|0
876749|NCT00565409|1839130|FG000|Period 1 Open Label|Death|2
1181842|NCT04476251|2339553|FG000|Overall Study|Not treated|1
1181843|NCT04439110|2339557|FG000|Overall Study|Ineligible|2
1181844|NCT04439110|2339557|FG000|Overall Study|Adverse Event|4
1181845|NCT04439110|2339557|FG000|Overall Study|Death|2
1181846|NCT04439110|2339557|FG000|Overall Study|Disease proression|25
1181847|NCT04439110|2339557|FG000|Overall Study|Withdrawal by Subject|1
1181848|NCT04439110|2339557|FG000|Overall Study|Alternative therapy|1
1181849|NCT04439110|2339557|FG000|Overall Study|Other complicating disease|1
1181850|NCT04439110|2339557|FG000|Overall Study|Personal reasons|1
1181851|NCT04439110|2339557|FG000|Overall Study|Still on treatment|1
1181852|NCT03915860|2339573|FG000|Overall Study|Adverse Event|3
1181853|NCT03915860|2339573|FG000|Overall Study|Withdrawal by Subject|6
1181854|NCT03915860|2339573|FG000|Overall Study|Lost to Follow-up|2
1181855|NCT03915860|2339573|FG000|Overall Study|Other than specified|3
876750|NCT00565409|1839131|FG001|Period 1 Open Label|Death|0
876751|NCT00565409|1839132|FG002|Period 1 Open Label|Death|0
876752|NCT00565409|1839133|FG003|Period 1 Open Label|Death|0
876753|NCT00565409|1839130|FG000|Period 1 Open Label|Lost to Follow-up|1
876754|NCT00565409|1839131|FG001|Period 1 Open Label|Lost to Follow-up|0
876755|NCT00565409|1839132|FG002|Period 1 Open Label|Lost to Follow-up|0
876756|NCT00565409|1839133|FG003|Period 1 Open Label|Lost to Follow-up|0
876757|NCT00565409|1839130|FG000|Period 1 Open Label|Other|21
876758|NCT00565409|1839131|FG001|Period 1 Open Label|Other|0
876759|NCT00565409|1839132|FG002|Period 1 Open Label|Other|0
876760|NCT00565409|1839133|FG003|Period 1 Open Label|Other|0
876761|NCT00565409|1839130|FG000|Period 1 Open Label|Protocol Violation|14
876762|NCT00565409|1839131|FG001|Period 1 Open Label|Protocol Violation|0
876763|NCT00565409|1839132|FG002|Period 1 Open Label|Protocol Violation|0
876764|NCT00565409|1839133|FG003|Period 1 Open Label|Protocol Violation|0
876765|NCT00565409|1839130|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
876766|NCT00565409|1839131|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
876767|NCT00565409|1839132|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
876768|NCT00565409|1839133|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
876769|NCT00565409|1839130|FG000|Period 1 Open Label|no conclusion of participation record|1
876770|NCT00565409|1839131|FG001|Period 1 Open Label|no conclusion of participation record|0
876771|NCT00565409|1839132|FG002|Period 1 Open Label|no conclusion of participation record|0
876772|NCT00565409|1839133|FG003|Period 1 Open Label|no conclusion of participation record|0
876773|NCT00565409|1839130|FG000|After Period 1, Prior to Period 2|did not meet criteria|152
876774|NCT00565409|1839131|FG001|After Period 1, Prior to Period 2|did not meet criteria|0
876775|NCT00565409|1839132|FG002|After Period 1, Prior to Period 2|did not meet criteria|0
876776|NCT00565409|1839133|FG003|After Period 1, Prior to Period 2|did not meet criteria|0
876777|NCT00565409|1839130|FG000|Period 2 Double-Blind|Adverse Event|0
876778|NCT00565409|1839131|FG001|Period 2 Double-Blind|Adverse Event|7
876779|NCT00565409|1839132|FG002|Period 2 Double-Blind|Adverse Event|4
876780|NCT00565409|1839133|FG003|Period 2 Double-Blind|Adverse Event|5
876781|NCT00565409|1839130|FG000|Period 2 Double-Blind|Death|0
876782|NCT00565409|1839131|FG001|Period 2 Double-Blind|Death|2
876783|NCT00565409|1839132|FG002|Period 2 Double-Blind|Death|0
876784|NCT00565409|1839133|FG003|Period 2 Double-Blind|Death|0
876785|NCT00565409|1839130|FG000|Period 2 Double-Blind|Protocol Violation|0
876786|NCT00565409|1839131|FG001|Period 2 Double-Blind|Protocol Violation|4
876787|NCT00565409|1839132|FG002|Period 2 Double-Blind|Protocol Violation|6
876788|NCT00565409|1839133|FG003|Period 2 Double-Blind|Protocol Violation|2
876789|NCT00565409|1839130|FG000|Period 2 Double-Blind|Lost to Follow-up|0
876790|NCT00565409|1839131|FG001|Period 2 Double-Blind|Lost to Follow-up|0
876791|NCT00565409|1839132|FG002|Period 2 Double-Blind|Lost to Follow-up|1
876792|NCT00565409|1839133|FG003|Period 2 Double-Blind|Lost to Follow-up|0
876793|NCT00565409|1839130|FG000|Period 2 Double-Blind|Other|0
876794|NCT00565409|1839131|FG001|Period 2 Double-Blind|Other|4
876795|NCT00565409|1839132|FG002|Period 2 Double-Blind|Other|5
876796|NCT00565409|1839133|FG003|Period 2 Double-Blind|Other|9
876797|NCT00565409|1839130|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
876798|NCT00565409|1839131|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
876799|NCT00565409|1839132|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
876800|NCT00565409|1839133|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
876801|NCT00565448|1839145|FG000|Overall Study|Adverse Event|1
876802|NCT00565448|1839146|FG001|Overall Study|Adverse Event|2
876803|NCT00565448|1839145|FG000|Overall Study|Disease progression|1
876804|NCT00565448|1839146|FG001|Overall Study|Disease progression|0
876805|NCT00565448|1839145|FG000|Overall Study|Withdrawal by Subject|1
876806|NCT00565448|1839146|FG001|Overall Study|Withdrawal by Subject|0
876807|NCT00565604|1839178|FG000|Overall Study|Failure to treat|2
876808|NCT00565604|1839178|FG000|Overall Study|Lost to Follow-up|2
876809|NCT00565617|1839182|FG000|Overall Study|Withdrawal by Subject|1
876810|NCT00565721|1839205|FG000|Overall Study|Screen Failure|2
876811|NCT00565721|1839205|FG000|Overall Study|Lost to Follow-up|6
876812|NCT00565721|1839205|FG000|Overall Study|Technical Problems|1
876813|NCT00565721|1839205|FG000|Overall Study|Physician Decision|2
876814|NCT00565721|1839205|FG000|Overall Study|Other reasons|6
876815|NCT00565747|1839226|FG000|Overall Study|No embryo transfer|67
876816|NCT00565747|1839227|FG001|Overall Study|No embryo transfer|73
876817|NCT00565773|1839233|FG000|Overall Study|Withdrawal by Subject|1
1181857|NCT03795233|2339596|FG000|Overall Study|Withdrawal by Subject|2
1181858|NCT03795233|2339597|FG001|Overall Study|Withdrawal by Subject|1
1181859|NCT03795233|2339596|FG000|Overall Study|Lost to Follow-up|1
876818|NCT00565773|1839233|FG000|Overall Study|Physician Decision|1
876819|NCT00565812|1839240|FG000|Overall Study|Death|2
876820|NCT00565812|1839241|FG001|Overall Study|Death|1
876821|NCT00565812|1839242|FG002|Overall Study|Death|3
876822|NCT00565812|1839240|FG000|Overall Study|Did not Meet Entrance Criteria|1
876823|NCT00565812|1839241|FG001|Overall Study|Did not Meet Entrance Criteria|0
876824|NCT00565812|1839242|FG002|Overall Study|Did not Meet Entrance Criteria|1
876825|NCT00565812|1839240|FG000|Overall Study|Lost to Follow-up|10
876826|NCT00565812|1839241|FG001|Overall Study|Lost to Follow-up|8
876827|NCT00565812|1839242|FG002|Overall Study|Lost to Follow-up|8
876828|NCT00565812|1839240|FG000|Overall Study|Withdrawal by Subject|58
876829|NCT00565812|1839241|FG001|Overall Study|Withdrawal by Subject|47
876830|NCT00565812|1839242|FG002|Overall Study|Withdrawal by Subject|48
876831|NCT00565812|1839240|FG000|Overall Study|Work Schedule|5
876832|NCT00565812|1839241|FG001|Overall Study|Work Schedule|3
876833|NCT00565812|1839242|FG002|Overall Study|Work Schedule|1
876834|NCT00565812|1839240|FG000|Overall Study|Protocol Violation|2
876835|NCT00565812|1839241|FG001|Overall Study|Protocol Violation|6
876836|NCT00565812|1839242|FG002|Overall Study|Protocol Violation|4
876837|NCT00565812|1839240|FG000|Overall Study|Adverse Event|41
876838|NCT00565812|1839241|FG001|Overall Study|Adverse Event|54
876839|NCT00565812|1839242|FG002|Overall Study|Adverse Event|40
876840|NCT00565812|1839240|FG000|Overall Study|Jury Duty|1
876841|NCT00565812|1839241|FG001|Overall Study|Jury Duty|0
876842|NCT00565812|1839242|FG002|Overall Study|Jury Duty|0
876843|NCT00565812|1839240|FG000|Overall Study|Relocated Out of Area|5
876844|NCT00565812|1839241|FG001|Overall Study|Relocated Out of Area|8
876845|NCT00565812|1839242|FG002|Overall Study|Relocated Out of Area|9
876846|NCT00565812|1839240|FG000|Overall Study|Sponsor Decision|1
876847|NCT00565812|1839241|FG001|Overall Study|Sponsor Decision|5
876848|NCT00565812|1839242|FG002|Overall Study|Sponsor Decision|1
876849|NCT00565812|1839240|FG000|Overall Study|Domestic Reasons|7
876850|NCT00565812|1839241|FG001|Overall Study|Domestic Reasons|1
876851|NCT00565812|1839242|FG002|Overall Study|Domestic Reasons|3
876852|NCT00565812|1839240|FG000|Overall Study|Research Site Closure|6
876853|NCT00565812|1839241|FG001|Overall Study|Research Site Closure|1
876854|NCT00565812|1839242|FG002|Overall Study|Research Site Closure|8
876855|NCT00565812|1839240|FG000|Overall Study|Surgical Intervention|0
876856|NCT00565812|1839241|FG001|Overall Study|Surgical Intervention|1
876857|NCT00565812|1839242|FG002|Overall Study|Surgical Intervention|2
876858|NCT00565812|1839240|FG000|Overall Study|Low Compliance|1
876859|NCT00565812|1839241|FG001|Overall Study|Low Compliance|0
876860|NCT00565812|1839242|FG002|Overall Study|Low Compliance|1
876861|NCT00565812|1839240|FG000|Overall Study|Follow-up Visit Not Completed|2
876862|NCT00565812|1839241|FG001|Overall Study|Follow-up Visit Not Completed|0
876863|NCT00565812|1839242|FG002|Overall Study|Follow-up Visit Not Completed|1
876864|NCT00565812|1839240|FG000|Overall Study|Physician Decision|2
876865|NCT00565812|1839241|FG001|Overall Study|Physician Decision|0
876866|NCT00565812|1839242|FG002|Overall Study|Physician Decision|0
876883|NCT00566020|1839311|FG000|6-week Dosage Adjustment Phase|Adverse Event|5
876884|NCT00566020|1839312|FG001|6-week Dosage Adjustment Phase|Adverse Event|0
876885|NCT00566020|1839311|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2
876886|NCT00566020|1839312|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0
876887|NCT00566020|1839311|FG000|46-week Long-term Administration Phase|Adverse Event|0
876888|NCT00566020|1839312|FG001|46-week Long-term Administration Phase|Adverse Event|7
876889|NCT00566020|1839311|FG000|46-week Long-term Administration Phase|Physician Decision|0
876890|NCT00566020|1839312|FG001|46-week Long-term Administration Phase|Physician Decision|7
876891|NCT00566020|1839311|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0
876892|NCT00566020|1839312|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2
876893|NCT00566020|1839311|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
1181860|NCT03795233|2339597|FG001|Overall Study|Lost to Follow-up|0
1181861|NCT03795233|2339596|FG000|Overall Study|Death|1
1181862|NCT03795233|2339597|FG001|Overall Study|Death|0
1181863|NCT03786380|2339608|FG000|Overall Study|Adverse Event|1
1181864|NCT03786380|2339609|FG001|Overall Study|Adverse Event|0
1181865|NCT03786380|2339610|FG002|Overall Study|Adverse Event|0
1181866|NCT03786380|2339611|FG003|Overall Study|Adverse Event|3
1181867|NCT03786380|2339612|FG004|Overall Study|Adverse Event|1
1181868|NCT03786380|2339608|FG000|Overall Study|Lack of Efficacy|0
1181869|NCT03786380|2339609|FG001|Overall Study|Lack of Efficacy|0
1181870|NCT03786380|2339610|FG002|Overall Study|Lack of Efficacy|0
1181871|NCT03786380|2339611|FG003|Overall Study|Lack of Efficacy|0
1181872|NCT03786380|2339612|FG004|Overall Study|Lack of Efficacy|1
1181873|NCT03786380|2339608|FG000|Overall Study|Withdrawal by Subject|1
1181874|NCT03786380|2339609|FG001|Overall Study|Withdrawal by Subject|2
1181875|NCT03786380|2339610|FG002|Overall Study|Withdrawal by Subject|2
1181876|NCT03786380|2339611|FG003|Overall Study|Withdrawal by Subject|1
1181877|NCT03786380|2339612|FG004|Overall Study|Withdrawal by Subject|2
1181878|NCT03786380|2339608|FG000|Overall Study|Lost to Follow-up|3
1181879|NCT03786380|2339609|FG001|Overall Study|Lost to Follow-up|0
1181880|NCT03786380|2339610|FG002|Overall Study|Lost to Follow-up|1
1181881|NCT03786380|2339611|FG003|Overall Study|Lost to Follow-up|2
1181882|NCT03786380|2339612|FG004|Overall Study|Lost to Follow-up|0
1181883|NCT03786380|2339608|FG000|Overall Study|Physician Decision|0
1181884|NCT03786380|2339609|FG001|Overall Study|Physician Decision|0
1181885|NCT03786380|2339610|FG002|Overall Study|Physician Decision|1
1181886|NCT03786380|2339611|FG003|Overall Study|Physician Decision|0
1181887|NCT03786380|2339612|FG004|Overall Study|Physician Decision|0
1181888|NCT03786380|2339608|FG000|Overall Study|Study Terminated by the Sponsor|30
1181889|NCT03786380|2339609|FG001|Overall Study|Study Terminated by the Sponsor|20
1181890|NCT03786380|2339610|FG002|Overall Study|Study Terminated by the Sponsor|50
1181891|NCT03786380|2339611|FG003|Overall Study|Study Terminated by the Sponsor|57
1181892|NCT03786380|2339612|FG004|Overall Study|Study Terminated by the Sponsor|23
1181893|NCT03786380|2339608|FG000|Overall Study|Reason Not Specified|0
1181894|NCT03786380|2339609|FG001|Overall Study|Reason Not Specified|0
1181895|NCT03786380|2339610|FG002|Overall Study|Reason Not Specified|0
1181896|NCT03786380|2339611|FG003|Overall Study|Reason Not Specified|0
1181897|NCT03786380|2339612|FG004|Overall Study|Reason Not Specified|1
1181907|NCT03685708|2339649|FG000|Overall Study|Withdrawal by Subject|0
1181908|NCT03685708|2339650|FG001|Overall Study|Withdrawal by Subject|0
1181909|NCT03685708|2339651|FG002|Overall Study|Withdrawal by Subject|1
1181910|NCT03685708|2339649|FG000|Overall Study|Screen Fail|0
1181911|NCT03685708|2339650|FG001|Overall Study|Screen Fail|1
1181912|NCT03685708|2339651|FG002|Overall Study|Screen Fail|1
1181913|NCT03685708|2339649|FG000|Overall Study|COVID 19 Pandemic|1
1181914|NCT03685708|2339650|FG001|Overall Study|COVID 19 Pandemic|1
1181915|NCT03685708|2339651|FG002|Overall Study|COVID 19 Pandemic|6
1181916|NCT03685708|2339649|FG000|Overall Study|Disease Progression|0
1181917|NCT03685708|2339650|FG001|Overall Study|Disease Progression|0
1181918|NCT03685708|2339651|FG002|Overall Study|Disease Progression|1
1181925|NCT03645863|2339671|FG000|Overall Study|Withdrawal by Subject|1
1181926|NCT03645863|2339672|FG001|Overall Study|Withdrawal by Subject|0
1181927|NCT03645863|2339673|FG002|Overall Study|Withdrawal by Subject|0
1181928|NCT03564145|2339681|FG000|Overall Study|Adverse Event|4
1181929|NCT03564145|2339681|FG000|Overall Study|Lost to Follow-up|21
1181930|NCT03564145|2339681|FG000|Overall Study|Protocol Violation|2
1181931|NCT03564145|2339681|FG000|Overall Study|Withdrawal by Subject|48
1181932|NCT03564145|2339681|FG000|Overall Study|Study Terminated by Sponsor|146
1181933|NCT03564145|2339681|FG000|Overall Study|Physician Decision|1
1181934|NCT03564145|2339681|FG000|Overall Study|Other Than Specified|1
876894|NCT00566020|1839312|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
876895|NCT00566098|1839317|FG000|Collection of MILs|Withdrawal by Subject|1
876896|NCT00566098|1839317|FG000|Collection of MILs|Relapsed|1
876897|NCT00566098|1839317|FG000|Generation of MILs Product|Relapsed|1
876898|NCT00566098|1839317|FG000|Administration of ASCT+MILs|Death|10
876899|NCT00566098|1839317|FG000|Administration of ASCT+MILs|Lack of Efficacy|8
876900|NCT00566111|1839324|FG000|Overall Study|Adverse Event|0
1181935|NCT03564145|2339681|FG000|Overall Study|Pregnancy|1
1181936|NCT03564119|2339687|FG000|Overall Study|Adverse Event|4
1181937|NCT03564119|2339688|FG001|Overall Study|Adverse Event|0
1181938|NCT03564119|2339687|FG000|Overall Study|Lost to Follow-up|1
1181939|NCT03564119|2339688|FG001|Overall Study|Lost to Follow-up|4
1181940|NCT03564119|2339687|FG000|Overall Study|Protocol Violation|1
1181941|NCT03564119|2339688|FG001|Overall Study|Protocol Violation|0
1181942|NCT03564119|2339687|FG000|Overall Study|Withdrawal by Subject|9
1181943|NCT03564119|2339688|FG001|Overall Study|Withdrawal by Subject|4
1181944|NCT03564119|2339687|FG000|Overall Study|Other Than Specified|0
1181945|NCT03564119|2339688|FG001|Overall Study|Other Than Specified|1
1181946|NCT03181529|2339743|FG000|Overall Study|Withdrawal by Subject|1
1181947|NCT03181529|2339744|FG001|Overall Study|Withdrawal by Subject|1
1181948|NCT03181529|2339743|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1
1181949|NCT03181529|2339744|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0
1181950|NCT02946931|2339813|FG000|Overall Study|Did not require collection of CRFs|573
1181951|NCT02946931|2339813|FG000|Overall Study|Other than listed|38
1181952|NCT02946931|2339813|FG000|Overall Study|Discharge from hospital|117
1181953|NCT02946931|2339813|FG000|Overall Study|Adverse Event|81
1181954|NCT02946931|2339813|FG000|Overall Study|CRFs not fixed|2
1181955|NCT02946931|2339813|FG000|Overall Study|CRFs not valid|1
1181956|NCT02946931|2339813|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6
1181957|NCT02779556|2339819|FG000|Baseline|Partial baseline interview completed|1
1181958|NCT02779556|2339820|FG001|Baseline|Partial baseline interview completed|0
1181959|NCT02779556|2339819|FG000|3 Months|Lost to Follow-up|40
1181960|NCT02779556|2339820|FG001|3 Months|Lost to Follow-up|29
1181961|NCT02779556|2339819|FG000|3 Months|Missed 3 month clinic visit|27
1181962|NCT02779556|2339820|FG001|3 Months|Missed 3 month clinic visit|19
1181963|NCT02779556|2339819|FG000|6 Month|Lost to Follow-up|33
1181964|NCT02779556|2339820|FG001|6 Month|Lost to Follow-up|39
1181965|NCT02779556|2339819|FG000|6 Month HbA1c|No value collected during window|69
1181966|NCT02779556|2339820|FG001|6 Month HbA1c|No value collected during window|50
1181967|NCT02779556|2339819|FG000|12 Month HbA1c|No value collected during window|138
1181968|NCT02779556|2339820|FG001|12 Month HbA1c|No value collected during window|102
1181969|NCT02675751|2339844|FG000|Overall Study|Lost to Follow-up|16
1181970|NCT02621424|2339859|FG000|Overall Study|Withdrawal by Subject|1
1181971|NCT02621424|2339860|FG001|Overall Study|Withdrawal by Subject|2
876901|NCT00566111|1839325|FG001|Overall Study|Adverse Event|2
876902|NCT00566228|1839342|FG000|Overall Study|Withdrawal by Subject|1
876903|NCT00566228|1839343|FG001|Overall Study|Withdrawal by Subject|0
876904|NCT00566228|1839342|FG000|Overall Study|Attempt to mobilize stem cells failed|2
876905|NCT00566228|1839343|FG001|Overall Study|Attempt to mobilize stem cells failed|2
876906|NCT00566228|1839342|FG000|Overall Study|Unable to collect sufficient CD34 cells|3
876907|NCT00566228|1839343|FG001|Overall Study|Unable to collect sufficient CD34 cells|2
876908|NCT00566228|1839342|FG000|Overall Study|progressed before infusion could occur|0
876909|NCT00566228|1839343|FG001|Overall Study|progressed before infusion could occur|1
876910|NCT00566254|1839351|FG000|Overall Study|Adverse Event|3
876911|NCT00566254|1839352|FG001|Overall Study|Adverse Event|1
876912|NCT00566254|1839351|FG000|Overall Study|Protocol Violation|1
876913|NCT00566254|1839352|FG001|Overall Study|Protocol Violation|3
876914|NCT00566254|1839351|FG000|Overall Study|Withdrawal by Subject|1
876915|NCT00566254|1839352|FG001|Overall Study|Withdrawal by Subject|2
876916|NCT00566254|1839351|FG000|Overall Study|Lack of Efficacy|5
876917|NCT00566254|1839352|FG001|Overall Study|Lack of Efficacy|6
876918|NCT00566254|1839351|FG000|Overall Study|Other|0
876919|NCT00566254|1839352|FG001|Overall Study|Other|2
876920|NCT00566501|1839360|FG000|Overall Study|Adverse Event|68
876921|NCT00566501|1839361|FG001|Overall Study|Adverse Event|59
876922|NCT00566501|1839360|FG000|Overall Study|Medication Non-compliance|5
876923|NCT00566501|1839361|FG001|Overall Study|Medication Non-compliance|0
876924|NCT00566501|1839360|FG000|Overall Study|Protocol Violation|2
876925|NCT00566501|1839361|FG001|Overall Study|Protocol Violation|2
876926|NCT00566501|1839360|FG000|Overall Study|Request of Investigator or Sponsor|6
876927|NCT00566501|1839361|FG001|Overall Study|Request of Investigator or Sponsor|7
876928|NCT00566501|1839360|FG000|Overall Study|Withdrawal by Subject|33
876929|NCT00566501|1839361|FG001|Overall Study|Withdrawal by Subject|30
876930|NCT00566501|1839360|FG000|Overall Study|Lack of Efficacy|8
876931|NCT00566501|1839361|FG001|Overall Study|Lack of Efficacy|3
876932|NCT00566501|1839360|FG000|Overall Study|Other|25
876933|NCT00566501|1839361|FG001|Overall Study|Other|21
876934|NCT00566527|1839370|FG000|Overall Study|Reason not provided|3
876935|NCT00566527|1839371|FG001|Overall Study|Reason not provided|11
876936|NCT00566527|1839372|FG002|Overall Study|Reason not provided|10
876937|NCT00566527|1839370|FG000|Overall Study|Adverse Event|2
876938|NCT00566527|1839371|FG001|Overall Study|Adverse Event|0
876939|NCT00566527|1839372|FG002|Overall Study|Adverse Event|1
876940|NCT00566527|1839370|FG000|Overall Study|Physician Decision|3
1181972|NCT02611960|2339868|FG000|Overall Study|COVID-19 Association Unspecified Adverse Event|7
1181973|NCT02611960|2339869|FG001|Overall Study|COVID-19 Association Unspecified Adverse Event|8
1181974|NCT02611960|2339868|FG000|Overall Study|Death|87
1181975|NCT02611960|2339869|FG001|Overall Study|Death|85
1181976|NCT02611960|2339868|FG000|Overall Study|Withdrawal by Subject|0
1181977|NCT02611960|2339869|FG001|Overall Study|Withdrawal by Subject|1
1181978|NCT02611960|2339868|FG000|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|1
1181979|NCT02611960|2339869|FG001|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|4
1181980|NCT02611960|2339868|FG000|Overall Study|Participants Ongoing|22
1181981|NCT02611960|2339869|FG001|Overall Study|Participants Ongoing|18
1181982|NCT02595372|2339876|FG000|Overall Study|Adverse Event|6
1181983|NCT02595372|2339876|FG000|Overall Study|Physician Decision|2
1181984|NCT02595372|2339876|FG000|Overall Study|Disease Progression|1
1181985|NCT02434354|2339886|FG000|Overall Study|screen fail|3
1181986|NCT02334722|2339892|FG000|Overall Study|Lost to Follow-up|4
1181987|NCT02334722|2339893|FG001|Overall Study|Lost to Follow-up|0
1181988|NCT02334722|2339892|FG000|Overall Study|6 week questionnaire not completed|2
1181989|NCT02334722|2339893|FG001|Overall Study|6 week questionnaire not completed|0
876941|NCT00566527|1839371|FG001|Overall Study|Physician Decision|8
876942|NCT00566527|1839372|FG002|Overall Study|Physician Decision|20
876943|NCT00566527|1839370|FG000|Overall Study|Lost to Follow-up|3
876944|NCT00566527|1839371|FG001|Overall Study|Lost to Follow-up|4
876945|NCT00566527|1839372|FG002|Overall Study|Lost to Follow-up|4
876946|NCT00566527|1839370|FG000|Overall Study|Withdrawal by Subject|6
876947|NCT00566527|1839371|FG001|Overall Study|Withdrawal by Subject|43
876948|NCT00566527|1839372|FG002|Overall Study|Withdrawal by Subject|43
876949|NCT00566631|1839395|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18
876950|NCT00566631|1839395|FG000|Part 1: Core Treatment Phase|Physician Decision|1
876951|NCT00566631|1839395|FG000|Part 1: Core Treatment Phase|Adverse Event|9
876952|NCT00566631|1839395|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4
876953|NCT00566631|1839395|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26
876954|NCT00566631|1839395|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
876955|NCT00566631|1839395|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1
876956|NCT00566631|1839395|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95
876957|NCT00566631|1839395|FG000|Part 2: Extension Phase|Lack of Efficacy|25
876958|NCT00566631|1839395|FG000|Part 2: Extension Phase|Withdrawal by Subject|34
876959|NCT00566631|1839395|FG000|Part 2: Extension Phase|Adverse Event|11
876960|NCT00566631|1839395|FG000|Part 2: Extension Phase|Lost to Follow-up|6
876961|NCT00566631|1839395|FG000|Part 2: Extension Phase|Death|1
876962|NCT00566631|1839395|FG000|Part 2: Extension Phase|Other|5
876963|NCT00566696|1839399|FG000|Overall Study|Met Exclusion Criteria|2
876964|NCT00566696|1839399|FG000|Overall Study|Muromonab not available|1
876965|NCT00566696|1839399|FG000|Overall Study|Health Status Change|1
876966|NCT00566696|1839399|FG000|Overall Study|Physician Decision|1
876967|NCT00566696|1839399|FG000|Overall Study|Non-Patient Donors|37
876968|NCT00566709|1839405|FG000|Overall Study|Protocol Violation|5
876969|NCT00566709|1839406|FG001|Overall Study|Protocol Violation|0
876970|NCT00566722|1839415|FG000|Overall Study|Adverse Event|0
876971|NCT00566722|1839416|FG001|Overall Study|Adverse Event|1
876972|NCT00566722|1839417|FG002|Overall Study|Adverse Event|0
876973|NCT00566722|1839415|FG000|Overall Study|Withdrawal by Subject|0
876974|NCT00566722|1839416|FG001|Overall Study|Withdrawal by Subject|0
876975|NCT00566722|1839417|FG002|Overall Study|Withdrawal by Subject|1
876976|NCT00566722|1839415|FG000|Overall Study|Lost to Follow-up|1
876977|NCT00566722|1839416|FG001|Overall Study|Lost to Follow-up|1
876978|NCT00566722|1839417|FG002|Overall Study|Lost to Follow-up|1
876979|NCT00566722|1839415|FG000|Overall Study|Lack of Efficacy|1
876980|NCT00566722|1839416|FG001|Overall Study|Lack of Efficacy|2
876981|NCT00566722|1839417|FG002|Overall Study|Lack of Efficacy|4
876982|NCT00566722|1839415|FG000|Overall Study|Did not meet exclusion criteria|0
876983|NCT00566722|1839416|FG001|Overall Study|Did not meet exclusion criteria|0
876984|NCT00566722|1839417|FG002|Overall Study|Did not meet exclusion criteria|2
876985|NCT00566722|1839415|FG000|Overall Study|Serious adverse event|0
876986|NCT00566722|1839416|FG001|Overall Study|Serious adverse event|1
876987|NCT00566722|1839417|FG002|Overall Study|Serious adverse event|0
876988|NCT00566722|1839415|FG000|Overall Study|Noncompliant with drug administration|0
876989|NCT00566722|1839416|FG001|Overall Study|Noncompliant with drug administration|0
876990|NCT00566722|1839417|FG002|Overall Study|Noncompliant with drug administration|1
876991|NCT00566735|1839430|FG000|Overall Study|Withdrawal by Subject|0
876992|NCT00566735|1839431|FG001|Overall Study|Withdrawal by Subject|1
876993|NCT00566735|1839430|FG000|Overall Study|Refused neuropsychological testing|2
876994|NCT00566735|1839431|FG001|Overall Study|Refused neuropsychological testing|5
876995|NCT00566735|1839430|FG000|Overall Study|Switched into a manic episode|0
876996|NCT00566735|1839431|FG001|Overall Study|Switched into a manic episode|1
876997|NCT00566852|1839448|FG000|Overall Study|Protocol Violation|22
876998|NCT00566852|1839449|FG001|Overall Study|Protocol Violation|24
876999|NCT00566852|1839448|FG000|Overall Study|Death|95
877000|NCT00566852|1839449|FG001|Overall Study|Death|78
877001|NCT00566852|1839448|FG000|Overall Study|Withdrawal by Subject|30
877002|NCT00566852|1839449|FG001|Overall Study|Withdrawal by Subject|25
877003|NCT00566852|1839448|FG000|Overall Study|Patient refusal|37
877004|NCT00566852|1839449|FG001|Overall Study|Patient refusal|37
877005|NCT00566852|1839448|FG000|Overall Study|Not tested due to disability|6
877006|NCT00566852|1839449|FG001|Overall Study|Not tested due to disability|12
877007|NCT00566852|1839448|FG000|Overall Study|Missing reason not specified|1
1181990|NCT02334722|2339892|FG000|Overall Study|Unable to obtain medication|1
1181991|NCT02334722|2339893|FG001|Overall Study|Unable to obtain medication|1
1181992|NCT02334722|2339892|FG000|Overall Study|Withdrawal by Subject|0
1181993|NCT02334722|2339893|FG001|Overall Study|Withdrawal by Subject|3
1181994|NCT02334722|2339892|FG000|Overall Study|Adverse Event|0
1181995|NCT02334722|2339893|FG001|Overall Study|Adverse Event|2
1181996|NCT02334722|2339892|FG000|Overall Study|Physician Decision|0
1181997|NCT02334722|2339893|FG001|Overall Study|Physician Decision|1
877008|NCT00566852|1839449|FG001|Overall Study|Missing reason not specified|2
877009|NCT00566852|1839448|FG000|Overall Study|Missing reason not reported|16
877010|NCT00566852|1839449|FG001|Overall Study|Missing reason not reported|20
877011|NCT00566982|1839498|FG000|Overall Study|Adverse Event|6
877012|NCT00566982|1839499|FG001|Overall Study|Adverse Event|48
877013|NCT00566982|1839498|FG000|Overall Study|Withdrawal by Subject|1
877014|NCT00566982|1839499|FG001|Overall Study|Withdrawal by Subject|14
877015|NCT00566982|1839498|FG000|Overall Study|Protocol Violation|1
877016|NCT00566982|1839499|FG001|Overall Study|Protocol Violation|4
877017|NCT00566982|1839498|FG000|Overall Study|Lost to Follow-up|0
877018|NCT00566982|1839499|FG001|Overall Study|Lost to Follow-up|1
877019|NCT00566982|1839498|FG000|Overall Study|Other-family problems & doctor's request|0
877020|NCT00566982|1839499|FG001|Overall Study|Other-family problems & doctor's request|2
877021|NCT00567112|1839521|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0
877022|NCT00567112|1839522|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1
877023|NCT00567112|1839523|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0
877024|NCT00567112|1839521|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2
877025|NCT00567112|1839522|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0
877026|NCT00567112|1839523|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0
877027|NCT00567112|1839521|FG000|Washout Period 3 (3 Days)|Protocol Violation|1
877028|NCT00567112|1839522|FG001|Washout Period 3 (3 Days)|Protocol Violation|0
877029|NCT00567112|1839523|FG002|Washout Period 3 (3 Days)|Protocol Violation|0
877030|NCT00567164|1839535|FG000|Overall Study|Withdrawal by Subject|171
877031|NCT00567164|1839536|FG001|Overall Study|Withdrawal by Subject|21
877032|NCT00567164|1839537|FG002|Overall Study|Withdrawal by Subject|17
877033|NCT00567164|1839535|FG000|Overall Study|Protocol Violation|23
877034|NCT00567164|1839536|FG001|Overall Study|Protocol Violation|4
877035|NCT00567164|1839537|FG002|Overall Study|Protocol Violation|2
877036|NCT00567164|1839535|FG000|Overall Study|Adverse Event|92
877037|NCT00567164|1839536|FG001|Overall Study|Adverse Event|13
877038|NCT00567164|1839537|FG002|Overall Study|Adverse Event|9
877039|NCT00567164|1839535|FG000|Overall Study|Death|0
877040|NCT00567164|1839536|FG001|Overall Study|Death|0
877041|NCT00567164|1839537|FG002|Overall Study|Death|1
877042|NCT00567164|1839535|FG000|Overall Study|Lost to Follow-up|202
877043|NCT00567164|1839536|FG001|Overall Study|Lost to Follow-up|23
877044|NCT00567164|1839537|FG002|Overall Study|Lost to Follow-up|21
877045|NCT00567164|1839535|FG000|Overall Study|Pregnancy|20
877046|NCT00567164|1839536|FG001|Overall Study|Pregnancy|4
877047|NCT00567164|1839537|FG002|Overall Study|Pregnancy|6
877048|NCT00567164|1839535|FG000|Overall Study|Primary Reason coded as 'Other'|37
877049|NCT00567164|1839536|FG001|Overall Study|Primary Reason coded as 'Other'|8
877050|NCT00567164|1839537|FG002|Overall Study|Primary Reason coded as 'Other'|16
877051|NCT00567164|1839535|FG000|Overall Study|Missing|1
877052|NCT00567164|1839536|FG001|Overall Study|Missing|0
877053|NCT00567164|1839537|FG002|Overall Study|Missing|0
877054|NCT00567190|1839551|FG000|Overall Study|Death|235
877055|NCT00567190|1839552|FG001|Overall Study|Death|280
877056|NCT00567190|1839551|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48
877057|NCT00567190|1839552|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53
877058|NCT00567255|1839578|FG000|Overall Study|Adverse Event|241
877059|NCT00567255|1839579|FG001|Overall Study|Adverse Event|68
877060|NCT00567255|1839578|FG000|Overall Study|Lost to Follow-up|77
877061|NCT00567255|1839579|FG001|Overall Study|Lost to Follow-up|48
877062|NCT00567255|1839578|FG000|Overall Study|Withdrawal by Subject|75
877063|NCT00567255|1839579|FG001|Overall Study|Withdrawal by Subject|56
1182028|NCT01966731|2339912|FG000|Overall Study|Death|2
1182029|NCT01966731|2339912|FG000|Overall Study|Lost to Follow-up|1
1182030|NCT01966731|2339912|FG000|Overall Study|Physician Decision|2
1182031|NCT01966731|2339912|FG000|Overall Study|Follow up is not complete|600
1182032|NCT01966731|2339912|FG000|Overall Study|Screening Failure|29
1182033|NCT01966731|2339912|FG000|Overall Study|Found to be ineligible|1
1182034|NCT01844518|2339936|FG000|Overall Study|Adverse Event|7
877064|NCT00567255|1839578|FG000|Overall Study|Lack of Efficacy|19
877065|NCT00567255|1839579|FG001|Overall Study|Lack of Efficacy|33
877066|NCT00567255|1839578|FG000|Overall Study|Protocol Violation|20
877067|NCT00567255|1839579|FG001|Overall Study|Protocol Violation|8
877068|NCT00567255|1839578|FG000|Overall Study|Pregnancy|6
877069|NCT00567255|1839579|FG001|Overall Study|Pregnancy|0
877070|NCT00567255|1839578|FG000|Overall Study|Drug noncompliance,moved,other|25
877071|NCT00567255|1839579|FG001|Overall Study|Drug noncompliance,moved,other|15
877072|NCT00567268|1839585|FG000|Overall Study|Protocol Violation|7
877073|NCT00567268|1839585|FG000|Overall Study|Lost to Follow-up|36
877074|NCT00567268|1839585|FG000|Overall Study|No Visit After First Day of Treatment|2
877075|NCT00567268|1839585|FG000|Overall Study|No Drug Administration|4
877076|NCT00567268|1839585|FG000|Overall Study|"Safety Evaluation Not Assessable"|1
877077|NCT00567359|1839642|FG000|Overall Study|Withdrawal by Subject|1
877078|NCT00567398|1839648|FG000|Overall Study|Adverse Event|6
877079|NCT00567398|1839649|FG001|Overall Study|Adverse Event|14
877080|NCT00567398|1839648|FG000|Overall Study|Physician Decision|0
877081|NCT00567398|1839649|FG001|Overall Study|Physician Decision|4
877082|NCT00567398|1839648|FG000|Overall Study|Withdrawal by Subject|0
877083|NCT00567398|1839649|FG001|Overall Study|Withdrawal by Subject|2
877084|NCT00567398|1839648|FG000|Overall Study|Renal Transplantation|0
877085|NCT00567398|1839649|FG001|Overall Study|Renal Transplantation|3
877086|NCT00567398|1839648|FG000|Overall Study|Other|1
877087|NCT00567398|1839649|FG001|Overall Study|Other|0
877088|NCT00567476|1839657|FG000|Overall Study|Adverse Event|2
877089|NCT00567476|1839658|FG001|Overall Study|Adverse Event|0
877090|NCT00567476|1839657|FG000|Overall Study|Pregnancy|1
877091|NCT00567476|1839658|FG001|Overall Study|Pregnancy|0
877092|NCT00567476|1839657|FG000|Overall Study|Protocol Violation|4
877093|NCT00567476|1839658|FG001|Overall Study|Protocol Violation|1
877094|NCT00567476|1839657|FG000|Overall Study|Lost to Follow-up|0
877095|NCT00567476|1839658|FG001|Overall Study|Lost to Follow-up|1
877096|NCT00567476|1839657|FG000|Overall Study|Administrative issues|1
877097|NCT00567476|1839658|FG001|Overall Study|Administrative issues|0
877098|NCT00567476|1839657|FG000|Overall Study|Medical Decision|0
877099|NCT00567476|1839658|FG001|Overall Study|Medical Decision|1
877100|NCT00567476|1839657|FG000|Overall Study|Non-adherence to protocol|0
877101|NCT00567476|1839658|FG001|Overall Study|Non-adherence to protocol|1
877102|NCT00567489|1839666|FG000|Overall Study|Adverse Event|6
877103|NCT00567489|1839667|FG001|Overall Study|Adverse Event|14
877104|NCT00567489|1839666|FG000|Overall Study|Physician Decision|0
877105|NCT00567489|1839667|FG001|Overall Study|Physician Decision|4
877106|NCT00567489|1839666|FG000|Overall Study|Withdrawal by Subject|0
877107|NCT00567489|1839667|FG001|Overall Study|Withdrawal by Subject|2
877108|NCT00567489|1839666|FG000|Overall Study|Renal Transplantation|0
877109|NCT00567489|1839667|FG001|Overall Study|Renal Transplantation|3
877110|NCT00567489|1839666|FG000|Overall Study|Other|1
877111|NCT00567489|1839667|FG001|Overall Study|Other|0
877112|NCT00567502|1839677|FG000|Overall Study|Lost to Follow-up|91
877113|NCT00567502|1839678|FG001|Overall Study|Lost to Follow-up|14
877114|NCT00567502|1839679|FG002|Overall Study|Lost to Follow-up|351
877115|NCT00567502|1839680|FG003|Overall Study|Lost to Follow-up|2
877116|NCT00567502|1839677|FG000|Overall Study|Death|65
877117|NCT00567502|1839678|FG001|Overall Study|Death|16
877118|NCT00567502|1839679|FG002|Overall Study|Death|360
877119|NCT00567502|1839680|FG003|Overall Study|Death|5
877120|NCT00567502|1839677|FG000|Overall Study|Other|64
877121|NCT00567502|1839678|FG001|Overall Study|Other|2
877122|NCT00567502|1839679|FG002|Overall Study|Other|134
877123|NCT00567502|1839680|FG003|Overall Study|Other|6
877124|NCT00567502|1839677|FG000|Overall Study|Participant request|12
877125|NCT00567502|1839678|FG001|Overall Study|Participant request|1
1182035|NCT01844518|2339937|FG001|Overall Study|Adverse Event|1
1182036|NCT01844518|2339936|FG000|Overall Study|Lack of Efficacy|17
1182037|NCT01844518|2339937|FG001|Overall Study|Lack of Efficacy|5
1182038|NCT01844518|2339936|FG000|Overall Study|Participant's request to discontinue|4
1182039|NCT01844518|2339937|FG001|Overall Study|Participant's request to discontinue|1
1182040|NCT01844518|2339936|FG000|Overall Study|Poor/Non-compliance|1
1182041|NCT01844518|2339937|FG001|Overall Study|Poor/Non-compliance|0
1182042|NCT01844518|2339936|FG000|Overall Study|No Longer Met Study Criteria|2
1182043|NCT01844518|2339937|FG001|Overall Study|No Longer Met Study Criteria|0
1182044|NCT01844518|2339936|FG000|Overall Study|Withdrawal by Subject|9
877126|NCT00567502|1839679|FG002|Overall Study|Participant request|33
877127|NCT00567502|1839680|FG003|Overall Study|Participant request|1
877128|NCT00567502|1839677|FG000|Overall Study|Sponsor request|9
877129|NCT00567502|1839678|FG001|Overall Study|Sponsor request|0
877130|NCT00567502|1839679|FG002|Overall Study|Sponsor request|30
877131|NCT00567502|1839680|FG003|Overall Study|Sponsor request|1
877132|NCT00567502|1839677|FG000|Overall Study|Never Initiated Treatment|0
877133|NCT00567502|1839678|FG001|Overall Study|Never Initiated Treatment|0
877134|NCT00567502|1839679|FG002|Overall Study|Never Initiated Treatment|0
877135|NCT00567502|1839680|FG003|Overall Study|Never Initiated Treatment|72
877136|NCT00567541|1839703|FG000|Overall Study|Adverse Event|0
877137|NCT00567541|1839704|FG001|Overall Study|Adverse Event|1
877171|NCT00567593|1839741|FG000|Overall Study|Adverse Event|1
877172|NCT00567593|1839741|FG000|Overall Study|Physician Decision|1
877173|NCT00567879|1839772|FG000|Overall Study|Adverse Event|2
877174|NCT00567879|1839773|FG001|Overall Study|Adverse Event|0
877175|NCT00567879|1839774|FG002|Overall Study|Adverse Event|1
877176|NCT00567879|1839775|FG003|Overall Study|Adverse Event|0
877177|NCT00567879|1839776|FG004|Overall Study|Adverse Event|1
877178|NCT00567879|1839777|FG005|Overall Study|Adverse Event|0
877179|NCT00567879|1839772|FG000|Overall Study|Abnormal test procedure(s)|0
877180|NCT00567879|1839773|FG001|Overall Study|Abnormal test procedure(s)|0
877181|NCT00567879|1839774|FG002|Overall Study|Abnormal test procedure(s)|1
877182|NCT00567879|1839775|FG003|Overall Study|Abnormal test procedure(s)|0
877183|NCT00567879|1839776|FG004|Overall Study|Abnormal test procedure(s)|0
877184|NCT00567879|1839777|FG005|Overall Study|Abnormal test procedure(s)|0
877185|NCT00567879|1839772|FG000|Overall Study|Withdrawal by Subject|0
877186|NCT00567879|1839773|FG001|Overall Study|Withdrawal by Subject|0
877187|NCT00567879|1839774|FG002|Overall Study|Withdrawal by Subject|3
877188|NCT00567879|1839775|FG003|Overall Study|Withdrawal by Subject|1
877189|NCT00567879|1839776|FG004|Overall Study|Withdrawal by Subject|0
877190|NCT00567879|1839777|FG005|Overall Study|Withdrawal by Subject|0
877191|NCT00567879|1839772|FG000|Overall Study|New cancer therapy|0
877192|NCT00567879|1839773|FG001|Overall Study|New cancer therapy|0
877193|NCT00567879|1839774|FG002|Overall Study|New cancer therapy|1
877194|NCT00567879|1839775|FG003|Overall Study|New cancer therapy|0
877195|NCT00567879|1839776|FG004|Overall Study|New cancer therapy|0
877196|NCT00567879|1839777|FG005|Overall Study|New cancer therapy|0
877197|NCT00567879|1839772|FG000|Overall Study|Disease progression|5
877198|NCT00567879|1839773|FG001|Overall Study|Disease progression|7
877199|NCT00567879|1839774|FG002|Overall Study|Disease progression|15
877200|NCT00567879|1839775|FG003|Overall Study|Disease progression|5
877201|NCT00567879|1839776|FG004|Overall Study|Disease progression|11
877202|NCT00567879|1839777|FG005|Overall Study|Disease progression|3
877203|NCT00567892|1839797|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
877204|NCT00567892|1839798|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
877205|NCT00567892|1839799|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
877206|NCT00567892|1839800|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
877207|NCT00567892|1839797|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
877208|NCT00567892|1839798|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
877209|NCT00567892|1839799|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1182045|NCT01844518|2339937|FG001|Overall Study|Withdrawal by Subject|0
1182046|NCT01844518|2339936|FG000|Overall Study|Pregnancy|1
1182047|NCT01844518|2339937|FG001|Overall Study|Pregnancy|0
1182048|NCT01675479|2339946|FG000|Overall Study|Lost to Follow-up|11
1182049|NCT01349959|2339959|FG000|Overall Study|Adverse Event|7
877210|NCT00567892|1839800|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
877211|NCT00567996|1839815|FG000|Overall Study|Adverse Event|18
877212|NCT00567996|1839816|FG001|Overall Study|Adverse Event|16
877213|NCT00567996|1839817|FG002|Overall Study|Adverse Event|13
877214|NCT00567996|1839815|FG000|Overall Study|Protocol Deviation|9
877215|NCT00567996|1839816|FG001|Overall Study|Protocol Deviation|11
877216|NCT00567996|1839817|FG002|Overall Study|Protocol Deviation|13
877217|NCT00567996|1839815|FG000|Overall Study|Withdrawal by Subject|8
877218|NCT00567996|1839816|FG001|Overall Study|Withdrawal by Subject|12
877219|NCT00567996|1839817|FG002|Overall Study|Withdrawal by Subject|22
877220|NCT00567996|1839815|FG000|Overall Study|Abnormal Lab value(s)|2
877221|NCT00567996|1839816|FG001|Overall Study|Abnormal Lab value(s)|1
877222|NCT00567996|1839817|FG002|Overall Study|Abnormal Lab value(s)|2
877223|NCT00567996|1839815|FG000|Overall Study|Abnormal test procedure result(s)|2
877224|NCT00567996|1839816|FG001|Overall Study|Abnormal test procedure result(s)|1
877225|NCT00567996|1839817|FG002|Overall Study|Abnormal test procedure result(s)|1
877226|NCT00567996|1839815|FG000|Overall Study|Lost to Follow-up|2
877227|NCT00567996|1839816|FG001|Overall Study|Lost to Follow-up|5
877228|NCT00567996|1839817|FG002|Overall Study|Lost to Follow-up|2
877229|NCT00567996|1839815|FG000|Overall Study|Unsatisfactory therapeutic effect|1
877230|NCT00567996|1839816|FG001|Overall Study|Unsatisfactory therapeutic effect|2
877231|NCT00567996|1839817|FG002|Overall Study|Unsatisfactory therapeutic effect|15
877232|NCT00567996|1839815|FG000|Overall Study|Administrative problems|1
877233|NCT00567996|1839816|FG001|Overall Study|Administrative problems|1
877234|NCT00567996|1839817|FG002|Overall Study|Administrative problems|0
877235|NCT00567996|1839815|FG000|Overall Study|Death|1
877236|NCT00567996|1839816|FG001|Overall Study|Death|0
877237|NCT00567996|1839817|FG002|Overall Study|Death|2
877238|NCT00567996|1839815|FG000|Overall Study|Patient's inability to use the device|0
877239|NCT00567996|1839816|FG001|Overall Study|Patient's inability to use the device|1
877240|NCT00567996|1839817|FG002|Overall Study|Patient's inability to use the device|0
877241|NCT00568061|1839841|FG000|Overall Study|Inclusion / exclusion criteria|5
877242|NCT00568061|1839842|FG001|Overall Study|Inclusion / exclusion criteria|1
877243|NCT00568061|1839841|FG000|Overall Study|Adverse Event|0
877244|NCT00568061|1839842|FG001|Overall Study|Adverse Event|1
877245|NCT00568126|1839860|FG000|Overall Study|Adverse Event|3
877246|NCT00568126|1839861|FG001|Overall Study|Adverse Event|0
877247|NCT00568126|1839860|FG000|Overall Study|Withdrawal by Subject|2
877248|NCT00568126|1839861|FG001|Overall Study|Withdrawal by Subject|3
877249|NCT00568126|1839860|FG000|Overall Study|Lost to Follow-up|4
877250|NCT00568126|1839861|FG001|Overall Study|Lost to Follow-up|3
877251|NCT00568126|1839860|FG000|Overall Study|Lack of Efficacy|0
877252|NCT00568126|1839861|FG001|Overall Study|Lack of Efficacy|1
877253|NCT00568126|1839860|FG000|Overall Study|Physician Decision|2
877254|NCT00568126|1839861|FG001|Overall Study|Physician Decision|2
877255|NCT00568178|1839869|FG000|Double Blind Base Study|Adverse Event|0
877256|NCT00568178|1839870|FG001|Double Blind Base Study|Adverse Event|2
877257|NCT00568178|1839871|FG002|Double Blind Base Study|Adverse Event|1
877258|NCT00568178|1839872|FG003|Double Blind Base Study|Adverse Event|2
877259|NCT00568178|1839873|FG004|Double Blind Base Study|Adverse Event|0
877260|NCT00568178|1839874|FG005|Double Blind Base Study|Adverse Event|0
877261|NCT00568178|1839869|FG000|Double Blind Base Study|Lost to Follow-up|1
877262|NCT00568178|1839870|FG001|Double Blind Base Study|Lost to Follow-up|0
877263|NCT00568178|1839871|FG002|Double Blind Base Study|Lost to Follow-up|0
877264|NCT00568178|1839872|FG003|Double Blind Base Study|Lost to Follow-up|1
877265|NCT00568178|1839873|FG004|Double Blind Base Study|Lost to Follow-up|0
877266|NCT00568178|1839874|FG005|Double Blind Base Study|Lost to Follow-up|0
877267|NCT00568178|1839869|FG000|Double Blind Base Study|Physician Decision|1
877268|NCT00568178|1839870|FG001|Double Blind Base Study|Physician Decision|1
877269|NCT00568178|1839871|FG002|Double Blind Base Study|Physician Decision|0
877270|NCT00568178|1839872|FG003|Double Blind Base Study|Physician Decision|1
1006583|NCT01468701|2025292|FG007|Overall Study|Other reasons than listed|0
1182056|NCT01193842|2339977|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1182057|NCT01193842|2339978|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
1182058|NCT01193842|2339979|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1182059|NCT01193842|2339980|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1182060|NCT01193842|2339981|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1182061|NCT01193842|2339977|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
1182062|NCT01193842|2339978|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1182063|NCT01193842|2339979|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1182064|NCT01193842|2339980|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1182065|NCT01193842|2339981|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1182066|NCT01193842|2339977|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1182067|NCT01193842|2339978|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1182068|NCT01193842|2339979|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
1182069|NCT01193842|2339980|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1182070|NCT01193842|2339981|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1182071|NCT01193842|2339977|FG000|Phase II: Randomized Groups|Death|0
1182072|NCT01193842|2339978|FG001|Phase II: Randomized Groups|Death|0
1182073|NCT01193842|2339979|FG002|Phase II: Randomized Groups|Death|0
1182074|NCT01193842|2339980|FG003|Phase II: Randomized Groups|Death|1
1182075|NCT01193842|2339981|FG004|Phase II: Randomized Groups|Death|1
1182076|NCT01193842|2339977|FG000|Phase II: Randomized Groups|Adverse Event|0
1182077|NCT01193842|2339978|FG001|Phase II: Randomized Groups|Adverse Event|0
1182078|NCT01193842|2339979|FG002|Phase II: Randomized Groups|Adverse Event|0
877271|NCT00568178|1839873|FG004|Double Blind Base Study|Physician Decision|0
877272|NCT00568178|1839874|FG005|Double Blind Base Study|Physician Decision|0
877273|NCT00568178|1839869|FG000|Double Blind Base Study|Protocol Violation|3
877274|NCT00568178|1839870|FG001|Double Blind Base Study|Protocol Violation|2
877275|NCT00568178|1839871|FG002|Double Blind Base Study|Protocol Violation|0
877276|NCT00568178|1839872|FG003|Double Blind Base Study|Protocol Violation|0
877277|NCT00568178|1839873|FG004|Double Blind Base Study|Protocol Violation|0
877278|NCT00568178|1839874|FG005|Double Blind Base Study|Protocol Violation|0
877279|NCT00568178|1839869|FG000|Double Blind Base Study|Withdrawal by Subject|1
877280|NCT00568178|1839870|FG001|Double Blind Base Study|Withdrawal by Subject|1
877281|NCT00568178|1839871|FG002|Double Blind Base Study|Withdrawal by Subject|0
877282|NCT00568178|1839872|FG003|Double Blind Base Study|Withdrawal by Subject|0
877283|NCT00568178|1839873|FG004|Double Blind Base Study|Withdrawal by Subject|0
877284|NCT00568178|1839874|FG005|Double Blind Base Study|Withdrawal by Subject|0
877285|NCT00568178|1839869|FG000|Double Blind Base Study|Progressive Disease|0
877286|NCT00568178|1839870|FG001|Double Blind Base Study|Progressive Disease|0
877287|NCT00568178|1839871|FG002|Double Blind Base Study|Progressive Disease|0
877288|NCT00568178|1839872|FG003|Double Blind Base Study|Progressive Disease|1
877289|NCT00568178|1839873|FG004|Double Blind Base Study|Progressive Disease|0
877290|NCT00568178|1839874|FG005|Double Blind Base Study|Progressive Disease|0
877291|NCT00568178|1839869|FG000|Open Label Extension|Adverse Event|0
877292|NCT00568178|1839870|FG001|Open Label Extension|Adverse Event|0
877293|NCT00568178|1839871|FG002|Open Label Extension|Adverse Event|0
877294|NCT00568178|1839872|FG003|Open Label Extension|Adverse Event|0
877295|NCT00568178|1839873|FG004|Open Label Extension|Adverse Event|11
877296|NCT00568178|1839874|FG005|Open Label Extension|Adverse Event|8
877297|NCT00568178|1839869|FG000|Open Label Extension|Protocol Violation|0
877298|NCT00568178|1839870|FG001|Open Label Extension|Protocol Violation|0
877299|NCT00568178|1839871|FG002|Open Label Extension|Protocol Violation|0
877300|NCT00568178|1839872|FG003|Open Label Extension|Protocol Violation|0
877301|NCT00568178|1839873|FG004|Open Label Extension|Protocol Violation|1
877302|NCT00568178|1839874|FG005|Open Label Extension|Protocol Violation|0
877303|NCT00568178|1839869|FG000|Open Label Extension|Lost to Follow-up|0
877304|NCT00568178|1839870|FG001|Open Label Extension|Lost to Follow-up|0
877305|NCT00568178|1839871|FG002|Open Label Extension|Lost to Follow-up|0
877306|NCT00568178|1839872|FG003|Open Label Extension|Lost to Follow-up|0
877307|NCT00568178|1839873|FG004|Open Label Extension|Lost to Follow-up|6
877308|NCT00568178|1839874|FG005|Open Label Extension|Lost to Follow-up|11
877309|NCT00568178|1839869|FG000|Open Label Extension|Physician Decision|0
877310|NCT00568178|1839870|FG001|Open Label Extension|Physician Decision|0
877311|NCT00568178|1839871|FG002|Open Label Extension|Physician Decision|0
877312|NCT00568178|1839872|FG003|Open Label Extension|Physician Decision|0
877313|NCT00568178|1839873|FG004|Open Label Extension|Physician Decision|9
877314|NCT00568178|1839874|FG005|Open Label Extension|Physician Decision|8
877315|NCT00568178|1839869|FG000|Open Label Extension|Pregnancy|0
877316|NCT00568178|1839870|FG001|Open Label Extension|Pregnancy|0
877317|NCT00568178|1839871|FG002|Open Label Extension|Pregnancy|0
877318|NCT00568178|1839872|FG003|Open Label Extension|Pregnancy|0
877319|NCT00568178|1839873|FG004|Open Label Extension|Pregnancy|0
877320|NCT00568178|1839874|FG005|Open Label Extension|Pregnancy|1
877321|NCT00568178|1839869|FG000|Open Label Extension|Progressive Disease|0
877322|NCT00568178|1839870|FG001|Open Label Extension|Progressive Disease|0
877323|NCT00568178|1839871|FG002|Open Label Extension|Progressive Disease|0
1182079|NCT01193842|2339980|FG003|Phase II: Randomized Groups|Adverse Event|5
1182080|NCT01193842|2339981|FG004|Phase II: Randomized Groups|Adverse Event|3
1182081|NCT01193842|2339977|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0
1182082|NCT01193842|2339978|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0
1182083|NCT01193842|2339979|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0
1182084|NCT01193842|2339980|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1
1182085|NCT01193842|2339981|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2
1182086|NCT01193842|2339977|FG000|Phase II: Randomized Groups|Ineligible|0
1182087|NCT01193842|2339978|FG001|Phase II: Randomized Groups|Ineligible|0
1182088|NCT01193842|2339979|FG002|Phase II: Randomized Groups|Ineligible|0
1182089|NCT01193842|2339980|FG003|Phase II: Randomized Groups|Ineligible|0
1182090|NCT01193842|2339981|FG004|Phase II: Randomized Groups|Ineligible|1
1182091|NCT01193842|2339977|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1182092|NCT01193842|2339978|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
877324|NCT00568178|1839872|FG003|Open Label Extension|Progressive Disease|0
877325|NCT00568178|1839873|FG004|Open Label Extension|Progressive Disease|3
877326|NCT00568178|1839874|FG005|Open Label Extension|Progressive Disease|1
877327|NCT00568178|1839869|FG000|Open Label Extension|Termination of Trial|0
877328|NCT00568178|1839870|FG001|Open Label Extension|Termination of Trial|0
877329|NCT00568178|1839871|FG002|Open Label Extension|Termination of Trial|0
877330|NCT00568178|1839872|FG003|Open Label Extension|Termination of Trial|0
877331|NCT00568178|1839873|FG004|Open Label Extension|Termination of Trial|45
877332|NCT00568178|1839874|FG005|Open Label Extension|Termination of Trial|47
877333|NCT00568178|1839869|FG000|Open Label Extension|Withdrawal by Subject|0
877334|NCT00568178|1839870|FG001|Open Label Extension|Withdrawal by Subject|0
877335|NCT00568178|1839871|FG002|Open Label Extension|Withdrawal by Subject|0
877336|NCT00568178|1839872|FG003|Open Label Extension|Withdrawal by Subject|0
877337|NCT00568178|1839873|FG004|Open Label Extension|Withdrawal by Subject|4
877338|NCT00568178|1839874|FG005|Open Label Extension|Withdrawal by Subject|4
877339|NCT00568321|1839891|FG000|Overall Study|Adverse Event|1
877340|NCT00568321|1839892|FG001|Overall Study|Adverse Event|0
877341|NCT00568321|1839893|FG002|Overall Study|Adverse Event|0
877342|NCT00568321|1839891|FG000|Overall Study|Lack of Efficacy|8
877343|NCT00568321|1839892|FG001|Overall Study|Lack of Efficacy|5
877344|NCT00568321|1839893|FG002|Overall Study|Lack of Efficacy|6
877345|NCT00568321|1839891|FG000|Overall Study|Lost to Follow-up|0
877346|NCT00568321|1839892|FG001|Overall Study|Lost to Follow-up|0
877347|NCT00568321|1839893|FG002|Overall Study|Lost to Follow-up|1
877348|NCT00568321|1839891|FG000|Overall Study|Withdrawal by Subject|2
877349|NCT00568321|1839892|FG001|Overall Study|Withdrawal by Subject|0
877350|NCT00568321|1839893|FG002|Overall Study|Withdrawal by Subject|0
877351|NCT00568321|1839891|FG000|Overall Study|Protocol Violation|0
877352|NCT00568321|1839892|FG001|Overall Study|Protocol Violation|0
877353|NCT00568321|1839893|FG002|Overall Study|Protocol Violation|1
877354|NCT00568321|1839891|FG000|Overall Study|Randomized, not treated|2
877355|NCT00568321|1839892|FG001|Overall Study|Randomized, not treated|0
877356|NCT00568321|1839893|FG002|Overall Study|Randomized, not treated|1
877357|NCT00568334|1839905|FG000|Overall Study|Withdrawal by Subject|0
877358|NCT00568334|1839906|FG001|Overall Study|Withdrawal by Subject|1
877359|NCT00568334|1839905|FG000|Overall Study|Lost to Follow-up|1
877360|NCT00568334|1839906|FG001|Overall Study|Lost to Follow-up|0
877361|NCT00568399|1839921|FG000|Overall Study|Death|2
877362|NCT00568399|1839921|FG000|Overall Study|Adverse Event|5
877363|NCT00568399|1839921|FG000|Overall Study|Withdrawal by Subject|8
877364|NCT00568451|1839929|FG000|Overall Study|Disease Progression|0
877365|NCT00568451|1839930|FG001|Overall Study|Disease Progression|0
877366|NCT00568451|1839931|FG002|Overall Study|Disease Progression|2
877367|NCT00568451|1839932|FG003|Overall Study|Disease Progression|7
877368|NCT00568555|1839945|FG000|Overall Study|Withdrawal by Subject|1
877369|NCT00568555|1839946|FG001|Overall Study|Withdrawal by Subject|1
877370|NCT00568685|1839966|FG000|Overall Study|Adverse Event|2
877371|NCT00568685|1839967|FG001|Overall Study|Adverse Event|3
877372|NCT00568685|1839968|FG002|Overall Study|Adverse Event|3
877373|NCT00568685|1839966|FG000|Overall Study|Withdrawal by Subject|7
877374|NCT00568685|1839967|FG001|Overall Study|Withdrawal by Subject|2
877375|NCT00568685|1839968|FG002|Overall Study|Withdrawal by Subject|2
877376|NCT00568685|1839966|FG000|Overall Study|Protocol Violation|1
877377|NCT00568685|1839967|FG001|Overall Study|Protocol Violation|0
877378|NCT00568685|1839968|FG002|Overall Study|Protocol Violation|0
877379|NCT00568776|1839984|FG000|Overall Study|Adverse Event|8
877380|NCT00568776|1839985|FG001|Overall Study|Adverse Event|8
877381|NCT00568776|1839986|FG002|Overall Study|Adverse Event|10
877382|NCT00568776|1839987|FG003|Overall Study|Adverse Event|8
877383|NCT00568776|1839984|FG000|Overall Study|Death|0
877384|NCT00568776|1839985|FG001|Overall Study|Death|1
877385|NCT00568776|1839986|FG002|Overall Study|Death|4
877386|NCT00568776|1839987|FG003|Overall Study|Death|3
877387|NCT00568776|1839984|FG000|Overall Study|Physician Decision|0
877388|NCT00568776|1839985|FG001|Overall Study|Physician Decision|2
877389|NCT00568776|1839986|FG002|Overall Study|Physician Decision|0
877390|NCT00568776|1839987|FG003|Overall Study|Physician Decision|0
877391|NCT00568776|1839984|FG000|Overall Study|Lack of Efficacy|2
1182093|NCT01193842|2339979|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1182094|NCT01193842|2339980|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
1182095|NCT01193842|2339981|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
1182096|NCT01168219|2339998|FG000|Overall Study|off study before starting treatment|2
1182097|NCT01168219|2339998|FG000|Overall Study|withdrew before transplant|1
1182098|NCT01168219|2339998|FG000|Overall Study|ineligible due to CML|2
1182099|NCT01062425|2340021|FG000|Overall Study|Protocol Violation|3
1182100|NCT01062425|2340022|FG001|Overall Study|Protocol Violation|6
877392|NCT00568776|1839985|FG001|Overall Study|Lack of Efficacy|2
877393|NCT00568776|1839986|FG002|Overall Study|Lack of Efficacy|2
877394|NCT00568776|1839987|FG003|Overall Study|Lack of Efficacy|4
877395|NCT00568776|1839984|FG000|Overall Study|Lost to Follow-up|1
877396|NCT00568776|1839985|FG001|Overall Study|Lost to Follow-up|1
877397|NCT00568776|1839986|FG002|Overall Study|Lost to Follow-up|1
877398|NCT00568776|1839987|FG003|Overall Study|Lost to Follow-up|1
877399|NCT00568776|1839984|FG000|Overall Study|Protocol Violation|1
877400|NCT00568776|1839985|FG001|Overall Study|Protocol Violation|0
877401|NCT00568776|1839986|FG002|Overall Study|Protocol Violation|1
877402|NCT00568776|1839987|FG003|Overall Study|Protocol Violation|1
877403|NCT00568776|1839984|FG000|Overall Study|Withdrawal by Subject|13
877404|NCT00568776|1839985|FG001|Overall Study|Withdrawal by Subject|15
877405|NCT00568776|1839986|FG002|Overall Study|Withdrawal by Subject|13
877406|NCT00568776|1839987|FG003|Overall Study|Withdrawal by Subject|7
877407|NCT00568776|1839984|FG000|Overall Study|Loss of Caregiver|0
877408|NCT00568776|1839985|FG001|Overall Study|Loss of Caregiver|2
877409|NCT00568776|1839986|FG002|Overall Study|Loss of Caregiver|1
877410|NCT00568776|1839987|FG003|Overall Study|Loss of Caregiver|2
877411|NCT00568776|1839984|FG000|Overall Study|Sponsor Decision|2
877412|NCT00568776|1839985|FG001|Overall Study|Sponsor Decision|2
877413|NCT00568776|1839986|FG002|Overall Study|Sponsor Decision|41
877414|NCT00568776|1839987|FG003|Overall Study|Sponsor Decision|42
877415|NCT00568776|1839984|FG000|Overall Study|Miscellaeneous|3
877416|NCT00568776|1839985|FG001|Overall Study|Miscellaeneous|3
877417|NCT00568776|1839986|FG002|Overall Study|Miscellaeneous|1
877418|NCT00568776|1839987|FG003|Overall Study|Miscellaeneous|4
877419|NCT00568958|1840008|FG000|Allocation|Withdrawal by Subject|7
877420|NCT00568958|1840009|FG001|Allocation|Withdrawal by Subject|3
877421|NCT00568958|1840008|FG000|Allocation|Physician Decision|2
877422|NCT00568958|1840009|FG001|Allocation|Physician Decision|0
877423|NCT00568958|1840008|FG000|Follow-Up|Withdrawal by Subject|6
877424|NCT00568958|1840009|FG001|Follow-Up|Withdrawal by Subject|6
877425|NCT00568958|1840008|FG000|Follow-Up|Physician Decision|1
877426|NCT00568958|1840009|FG001|Follow-Up|Physician Decision|1
877427|NCT00568958|1840008|FG000|Follow-Up|Family Emergency|1
877428|NCT00568958|1840009|FG001|Follow-Up|Family Emergency|0
877429|NCT00568958|1840008|FG000|Follow-Up|Adverse Event|1
877430|NCT00568958|1840009|FG001|Follow-Up|Adverse Event|0
877431|NCT00569127|1840034|FG000|Overall Study|Adverse Event|57
877432|NCT00569127|1840035|FG001|Overall Study|Adverse Event|47
877433|NCT00569127|1840034|FG000|Overall Study|Withdrawal by Subject|13
877434|NCT00569127|1840035|FG001|Overall Study|Withdrawal by Subject|27
877435|NCT00569127|1840034|FG000|Overall Study|Progression|99
877436|NCT00569127|1840035|FG001|Overall Study|Progression|100
877437|NCT00569127|1840034|FG000|Overall Study|Death|4
877438|NCT00569127|1840035|FG001|Overall Study|Death|3
877439|NCT00569127|1840034|FG000|Overall Study|Other|20
877440|NCT00569127|1840035|FG001|Overall Study|Other|19
877441|NCT00569127|1840034|FG000|Overall Study|Lost to Follow-up|0
877442|NCT00569127|1840035|FG001|Overall Study|Lost to Follow-up|3
877443|NCT00569127|1840034|FG000|Overall Study|Not Eligible|14
877444|NCT00569127|1840035|FG001|Overall Study|Not Eligible|11
877445|NCT00569127|1840034|FG000|Overall Study|Still on Treatment|7
877446|NCT00569127|1840035|FG001|Overall Study|Still on Treatment|3
877447|NCT00569166|1840044|FG000|Overall Study|Withdrawal by Subject|7
877448|NCT00569166|1840045|FG001|Overall Study|Withdrawal by Subject|5
877449|NCT00569166|1840046|FG002|Overall Study|Withdrawal by Subject|3
877450|NCT00569166|1840044|FG000|Overall Study|Lost to Follow-up|2
877451|NCT00569166|1840045|FG001|Overall Study|Lost to Follow-up|1
877452|NCT00569166|1840046|FG002|Overall Study|Lost to Follow-up|1
877453|NCT00569231|1840067|FG000|Overall Study|Study unrelated surgery|1
877454|NCT00569231|1840067|FG000|Overall Study|Airfare expense|2
877455|NCT00569231|1840067|FG000|Overall Study|Withdrawal by Subject|1
877456|NCT00569231|1840067|FG000|Overall Study|Car accident injury|1
877457|NCT00569231|1840067|FG000|Overall Study|Non-compliance|2
877458|NCT00569270|1840071|FG000|Period: First Intervention|Protocol Violation|0
877459|NCT00569270|1840072|FG001|Period: First Intervention|Protocol Violation|1
877460|NCT00569374|1840091|FG000|Overall Study|Withdrawal by Subject|4
877461|NCT00569582|1840104|FG000|Overall Study|Withdrawal by Subject|5
877462|NCT00569582|1840104|FG000|Overall Study|Death|2
877463|NCT00569582|1840104|FG000|Overall Study|Adverse Event|7
877464|NCT00569582|1840104|FG000|Overall Study|Subject was too ill to travel.|1
877465|NCT00569582|1840104|FG000|Overall Study|Subject was non-compliant.|1
877466|NCT00569777|1840118|FG000|Overall Study|Withdrawal by Subject|4
877467|NCT00569777|1840119|FG001|Overall Study|Withdrawal by Subject|0
877468|NCT00569777|1840118|FG000|Overall Study|Adverse Event|3
1182117|NCT00812708|2340042|FG000|Overall Study|Device could not be implanted|2
1182118|NCT00812708|2340042|FG000|Overall Study|Lack of medical insurance|1
1182119|NCT00812708|2340042|FG000|Overall Study|Switched to another study|1
1182120|NCT00812708|2340042|FG000|Overall Study|Surgery cancelled due to uveitis|1
1182121|NCT00812708|2340042|FG000|Overall Study|Signed consent but later withdrew|3
1182122|NCT00792259|2340050|FG000|Overall Study|Poor Quality Scans|1
1182123|NCT00792259|2340051|FG001|Overall Study|Poor Quality Scans|0
1182124|NCT00792259|2340052|FG002|Overall Study|Poor Quality Scans|0
1182125|NCT00741988|2340062|FG000|Overall Study|Adverse Event|2
1182126|NCT00741988|2340063|FG001|Overall Study|Adverse Event|4
1182127|NCT00741988|2340062|FG000|Overall Study|Lack of Efficacy|2
1182128|NCT00741988|2340063|FG001|Overall Study|Lack of Efficacy|0
1182129|NCT00515671|2340080|FG000|Overall Study|Lost to Follow-up|13
1182130|NCT00515671|2340081|FG001|Overall Study|Lost to Follow-up|10
1182131|NCT00515671|2340080|FG000|Overall Study|Withdrawal by Subject|3
1182132|NCT00515671|2340081|FG001|Overall Study|Withdrawal by Subject|5
1182133|NCT00515671|2340080|FG000|Overall Study|incarcerated|1
1182134|NCT00515671|2340081|FG001|Overall Study|incarcerated|2
1182135|NCT00455403|2340089|FG000|Overall Study|Lost to Follow-up|2
1182136|NCT00455403|2340090|FG001|Overall Study|Lost to Follow-up|1
1182137|NCT00455403|2340089|FG000|Overall Study|Withdrawal by Subject|1
1182138|NCT00455403|2340090|FG001|Overall Study|Withdrawal by Subject|3
1182139|NCT00455403|2340089|FG000|Overall Study|Protocol Violation|0
1182140|NCT00455403|2340090|FG001|Overall Study|Protocol Violation|2
1182141|NCT00238420|2340098|FG000|Overall Study|Protocol Violation|1
1182142|NCT00238420|2340099|FG001|Overall Study|Protocol Violation|1
1182143|NCT04128319|2340118|FG000|Overall Study|Death|3
1182144|NCT03761810|2340124|FG000|Overall Study|Adverse Event|12
1182145|NCT03761810|2340125|FG001|Overall Study|Adverse Event|0
1182146|NCT03761810|2340124|FG000|Overall Study|Lost to Follow-up|15
1182147|NCT03761810|2340125|FG001|Overall Study|Lost to Follow-up|7
1182148|NCT03761810|2340124|FG000|Overall Study|Pregnancy|1
1182149|NCT03761810|2340125|FG001|Overall Study|Pregnancy|0
1182150|NCT03761810|2340124|FG000|Overall Study|Withdrawal by Subject|14
1182151|NCT03761810|2340125|FG001|Overall Study|Withdrawal by Subject|5
1182152|NCT03761810|2340124|FG000|Overall Study|Physician Decision|1
1182153|NCT03761810|2340125|FG001|Overall Study|Physician Decision|0
1182154|NCT03761810|2340124|FG000|Overall Study|Withdrawal by Parent/Guardian|4
1182155|NCT03761810|2340125|FG001|Overall Study|Withdrawal by Parent/Guardian|0
1182156|NCT03761810|2340124|FG000|Overall Study|Other Than Specified|1
1182157|NCT03761810|2340125|FG001|Overall Study|Other Than Specified|0
1182158|NCT03761784|2340133|FG000|Overall Study|Adverse Event|4
1182159|NCT03761784|2340134|FG001|Overall Study|Adverse Event|0
1182160|NCT03761784|2340133|FG000|Overall Study|Lost to Follow-up|10
1182161|NCT03761784|2340134|FG001|Overall Study|Lost to Follow-up|7
1182162|NCT03761784|2340133|FG000|Overall Study|Pregnancy|1
1182163|NCT03761784|2340134|FG001|Overall Study|Pregnancy|0
1182164|NCT03761784|2340133|FG000|Overall Study|Protocol Violation|2
1182165|NCT03761784|2340134|FG001|Overall Study|Protocol Violation|0
1182166|NCT03761784|2340133|FG000|Overall Study|Withdrawal by Parent or Guardian|4
1182167|NCT03761784|2340134|FG001|Overall Study|Withdrawal by Parent or Guardian|1
1182168|NCT03761784|2340133|FG000|Overall Study|Withdrawal by Subject|9
1182169|NCT03761784|2340134|FG001|Overall Study|Withdrawal by Subject|4
1182170|NCT03761784|2340133|FG000|Overall Study|Physician Decision|1
1182171|NCT03761784|2340134|FG001|Overall Study|Physician Decision|0
1182172|NCT03761784|2340133|FG000|Overall Study|Other Than Specified|1
1182173|NCT03761784|2340134|FG001|Overall Study|Other Than Specified|0
1182174|NCT03541317|2340142|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1
1182175|NCT03541317|2340143|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0
1182176|NCT03541317|2340144|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0
1182177|NCT03541317|2340145|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0
1182178|NCT03541317|2340146|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0
1182179|NCT03541317|2340147|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0
1182252|NCT03361865|2340206|FG000|Overall Study|Death|17
1182253|NCT03361865|2340207|FG001|Overall Study|Death|18
1182254|NCT03361865|2340206|FG000|Overall Study|Physician Decision|1
1182255|NCT03361865|2340207|FG001|Overall Study|Physician Decision|9
1182256|NCT03361865|2340206|FG000|Overall Study|Withdrawal by Subject|1
1182257|NCT03361865|2340207|FG001|Overall Study|Withdrawal by Subject|0
1182278|NCT02929056|2340257|FG000|Overall Study|Lost to Follow-up|0
1182279|NCT02929056|2340258|FG001|Overall Study|Lost to Follow-up|1
1182280|NCT02896855|2340266|FG000|Overall Study|Death|50
1182281|NCT02896855|2340267|FG001|Overall Study|Death|40
1182282|NCT02896855|2340266|FG000|Overall Study|Lost to Follow-up|15
1182283|NCT02896855|2340267|FG001|Overall Study|Lost to Follow-up|9
1182284|NCT02896855|2340266|FG000|Overall Study|Withdrawal by Subject|7
1182285|NCT02896855|2340267|FG001|Overall Study|Withdrawal by Subject|4
1182286|NCT02871778|2340280|FG000|Part A: Treatment Period 1|Adverse Event|1
1182287|NCT02871778|2340281|FG001|Part A: Treatment Period 1|Adverse Event|1
1182288|NCT02871778|2340282|FG002|Part A: Treatment Period 1|Adverse Event|1
1182289|NCT02871778|2340283|FG003|Part A: Treatment Period 1|Adverse Event|0
1182290|NCT02871778|2340284|FG004|Part A: Treatment Period 1|Adverse Event|0
1182291|NCT02871778|2340285|FG005|Part A: Treatment Period 1|Adverse Event|0
1182292|NCT02871778|2340286|FG006|Part A: Treatment Period 1|Adverse Event|0
1182293|NCT02871778|2340287|FG007|Part A: Treatment Period 1|Adverse Event|0
1182294|NCT02871778|2340280|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
1182295|NCT02871778|2340281|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
1182296|NCT02871778|2340282|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
1182297|NCT02871778|2340283|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
1182298|NCT02871778|2340284|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
1182299|NCT02871778|2340285|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
1182300|NCT02871778|2340286|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
1182301|NCT02871778|2340287|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
1182302|NCT02871778|2340280|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0
1182303|NCT02871778|2340281|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0
1182304|NCT02871778|2340282|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1
1182305|NCT02871778|2340283|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0
1182306|NCT02871778|2340284|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0
1182307|NCT02871778|2340285|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0
1182308|NCT02871778|2340286|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0
1182309|NCT02871778|2340287|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0
1182310|NCT02871778|2340280|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0
1182311|NCT02871778|2340281|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0
1182312|NCT02871778|2340282|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1
1182313|NCT02871778|2340283|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0
1182314|NCT02871778|2340284|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0
1182315|NCT02871778|2340285|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0
1182316|NCT02871778|2340286|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0
1182317|NCT02871778|2340287|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0
1182318|NCT02871778|2340280|FG000|Part A: Treatment Period 1|Wrong drug shipment|0
1182319|NCT02871778|2340281|FG001|Part A: Treatment Period 1|Wrong drug shipment|1
1182320|NCT02871778|2340282|FG002|Part A: Treatment Period 1|Wrong drug shipment|0
1182321|NCT02871778|2340283|FG003|Part A: Treatment Period 1|Wrong drug shipment|0
1182322|NCT02871778|2340284|FG004|Part A: Treatment Period 1|Wrong drug shipment|0
1182323|NCT02871778|2340285|FG005|Part A: Treatment Period 1|Wrong drug shipment|0
1182324|NCT02871778|2340286|FG006|Part A: Treatment Period 1|Wrong drug shipment|0
1182325|NCT02871778|2340287|FG007|Part A: Treatment Period 1|Wrong drug shipment|0
1182326|NCT02871778|2340280|FG000|Part A: Treatment Period 2|Adverse Event|2
1182327|NCT02871778|2340281|FG001|Part A: Treatment Period 2|Adverse Event|2
1182328|NCT02871778|2340282|FG002|Part A: Treatment Period 2|Adverse Event|0
1182329|NCT02871778|2340283|FG003|Part A: Treatment Period 2|Adverse Event|0
1182330|NCT02871778|2340284|FG004|Part A: Treatment Period 2|Adverse Event|0
1182331|NCT02871778|2340285|FG005|Part A: Treatment Period 2|Adverse Event|0
1182332|NCT02871778|2340286|FG006|Part A: Treatment Period 2|Adverse Event|0
1182333|NCT02871778|2340287|FG007|Part A: Treatment Period 2|Adverse Event|0
1182334|NCT02871778|2340280|FG000|Part A: Treatment Period 2|Lost to Follow-up|0
1182335|NCT02871778|2340281|FG001|Part A: Treatment Period 2|Lost to Follow-up|0
1182336|NCT02871778|2340282|FG002|Part A: Treatment Period 2|Lost to Follow-up|0
1182337|NCT02871778|2340283|FG003|Part A: Treatment Period 2|Lost to Follow-up|1
1182338|NCT02871778|2340284|FG004|Part A: Treatment Period 2|Lost to Follow-up|0
1182339|NCT02871778|2340285|FG005|Part A: Treatment Period 2|Lost to Follow-up|0
1182340|NCT02871778|2340286|FG006|Part A: Treatment Period 2|Lost to Follow-up|0
1182341|NCT02871778|2340287|FG007|Part A: Treatment Period 2|Lost to Follow-up|0
1182342|NCT02871778|2340280|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
1182343|NCT02871778|2340281|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1182344|NCT02871778|2340282|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
1182345|NCT02871778|2340283|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1182346|NCT02871778|2340284|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1182347|NCT02871778|2340285|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1182348|NCT02871778|2340286|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1182349|NCT02871778|2340287|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1182350|NCT02871778|2340280|FG000|Part B: Treatment Period 3|Adverse Event|0
1182351|NCT02871778|2340281|FG001|Part B: Treatment Period 3|Adverse Event|0
1182352|NCT02871778|2340282|FG002|Part B: Treatment Period 3|Adverse Event|0
1182353|NCT02871778|2340283|FG003|Part B: Treatment Period 3|Adverse Event|0
1182354|NCT02871778|2340284|FG004|Part B: Treatment Period 3|Adverse Event|1
1182355|NCT02871778|2340285|FG005|Part B: Treatment Period 3|Adverse Event|1
1182356|NCT02871778|2340286|FG006|Part B: Treatment Period 3|Adverse Event|1
1182357|NCT02871778|2340287|FG007|Part B: Treatment Period 3|Adverse Event|0
1182358|NCT02756208|2340320|FG000|Overall Study|Withdrawal by Subject|1
1182359|NCT02756208|2340321|FG001|Overall Study|Withdrawal by Subject|0
1182360|NCT02756208|2340322|FG002|Overall Study|Withdrawal by Subject|1
1182361|NCT02756208|2340323|FG003|Overall Study|Withdrawal by Subject|3
1182362|NCT02756208|2340320|FG000|Overall Study|Lost to Follow-up|3
1182363|NCT02756208|2340321|FG001|Overall Study|Lost to Follow-up|1
1182364|NCT02756208|2340322|FG002|Overall Study|Lost to Follow-up|1
1182365|NCT02756208|2340323|FG003|Overall Study|Lost to Follow-up|1
1182366|NCT02756208|2340320|FG000|Overall Study|Physician Decision|1
1182367|NCT02756208|2340321|FG001|Overall Study|Physician Decision|0
1182368|NCT02756208|2340322|FG002|Overall Study|Physician Decision|0
1182369|NCT02756208|2340323|FG003|Overall Study|Physician Decision|0
1182370|NCT02756208|2340320|FG000|Overall Study|Protocol Violation|0
1182371|NCT02756208|2340321|FG001|Overall Study|Protocol Violation|1
1182372|NCT02756208|2340322|FG002|Overall Study|Protocol Violation|0
1182373|NCT02756208|2340323|FG003|Overall Study|Protocol Violation|0
1182374|NCT02714218|2340336|FG000|Overall Study|Disease Progression|56
1182375|NCT02714218|2340337|FG001|Overall Study|Disease Progression|51
1182376|NCT02714218|2340338|FG002|Overall Study|Disease Progression|14
1182377|NCT02714218|2340336|FG000|Overall Study|Adverse Event Unrelated to Study Drug|10
1182378|NCT02714218|2340337|FG001|Overall Study|Adverse Event Unrelated to Study Drug|6
1182379|NCT02714218|2340338|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0
1182380|NCT02714218|2340336|FG000|Overall Study|Study Drug Toxicity|46
1182381|NCT02714218|2340337|FG001|Overall Study|Study Drug Toxicity|69
1182382|NCT02714218|2340338|FG002|Overall Study|Study Drug Toxicity|4
1182383|NCT02714218|2340336|FG000|Overall Study|Request to Discontinue Treatment|1
1182384|NCT02714218|2340337|FG001|Overall Study|Request to Discontinue Treatment|5
1182385|NCT02714218|2340338|FG002|Overall Study|Request to Discontinue Treatment|1
1182386|NCT02714218|2340336|FG000|Overall Study|Participant Withdrew Consent|2
1182387|NCT02714218|2340337|FG001|Overall Study|Participant Withdrew Consent|3
1182388|NCT02714218|2340338|FG002|Overall Study|Participant Withdrew Consent|0
1182389|NCT02714218|2340336|FG000|Overall Study|Maximum Clinical Benefit|2
1182390|NCT02714218|2340337|FG001|Overall Study|Maximum Clinical Benefit|2
1182391|NCT02714218|2340338|FG002|Overall Study|Maximum Clinical Benefit|0
1182392|NCT02714218|2340336|FG000|Overall Study|Medical Decision|0
1182393|NCT02714218|2340337|FG001|Overall Study|Medical Decision|1
1182394|NCT02714218|2340338|FG002|Overall Study|Medical Decision|0
877469|NCT00569777|1840119|FG001|Overall Study|Adverse Event|0
877470|NCT00569777|1840118|FG000|Overall Study|Lost to Follow-up|1
877471|NCT00569777|1840119|FG001|Overall Study|Lost to Follow-up|0
877472|NCT00569777|1840118|FG000|Overall Study|scheduled eye surgery|0
877473|NCT00569777|1840119|FG001|Overall Study|scheduled eye surgery|1
877474|NCT00569777|1840118|FG000|Overall Study|did not meet exclusion criteria|1
877475|NCT00569777|1840119|FG001|Overall Study|did not meet exclusion criteria|2
877476|NCT00569777|1840118|FG000|Overall Study|pregnant|1
877477|NCT00569777|1840119|FG001|Overall Study|pregnant|0
877478|NCT00569803|1840133|FG000|Overall Study|Lost to Follow-up|1
877479|NCT00569803|1840134|FG001|Overall Study|Lost to Follow-up|0
877480|NCT00569803|1840135|FG002|Overall Study|Lost to Follow-up|0
877481|NCT00569803|1840136|FG003|Overall Study|Lost to Follow-up|0
877482|NCT00569803|1840137|FG004|Overall Study|Lost to Follow-up|0
877483|NCT00569803|1840138|FG005|Overall Study|Lost to Follow-up|0
877484|NCT00569803|1840139|FG006|Overall Study|Lost to Follow-up|0
877485|NCT00569803|1840140|FG007|Overall Study|Lost to Follow-up|0
877486|NCT00569803|1840133|FG000|Overall Study|injection syringe leaked during dosing|0
877487|NCT00569803|1840134|FG001|Overall Study|injection syringe leaked during dosing|0
877488|NCT00569803|1840135|FG002|Overall Study|injection syringe leaked during dosing|0
877489|NCT00569803|1840136|FG003|Overall Study|injection syringe leaked during dosing|1
877490|NCT00569803|1840137|FG004|Overall Study|injection syringe leaked during dosing|0
877491|NCT00569803|1840138|FG005|Overall Study|injection syringe leaked during dosing|0
877492|NCT00569803|1840139|FG006|Overall Study|injection syringe leaked during dosing|0
877493|NCT00569803|1840140|FG007|Overall Study|injection syringe leaked during dosing|0
877494|NCT00569803|1840133|FG000|Overall Study|Withdrawal by Subject|0
877495|NCT00569803|1840134|FG001|Overall Study|Withdrawal by Subject|0
877496|NCT00569803|1840135|FG002|Overall Study|Withdrawal by Subject|0
877497|NCT00569803|1840136|FG003|Overall Study|Withdrawal by Subject|0
877498|NCT00569803|1840137|FG004|Overall Study|Withdrawal by Subject|0
877499|NCT00569803|1840138|FG005|Overall Study|Withdrawal by Subject|0
877500|NCT00569803|1840139|FG006|Overall Study|Withdrawal by Subject|0
877501|NCT00569803|1840140|FG007|Overall Study|Withdrawal by Subject|1
877502|NCT00569946|1840166|FG000|Overall Study|Adverse Event|16
877503|NCT00569946|1840166|FG000|Overall Study|Objective Progression or Relapse|42
877504|NCT00569946|1840166|FG000|Overall Study|Global Deterioration of Health Status|1
877505|NCT00570037|1840172|FG000|Overall Study|Could not reach for 6-8 week contact|44
877506|NCT00570037|1840173|FG001|Overall Study|Could not reach for 6-8 week contact|69
877507|NCT00570063|1840181|FG000|Overall Study|Adverse Event|4
877508|NCT00570063|1840182|FG001|Overall Study|Adverse Event|1
877509|NCT00570063|1840181|FG000|Overall Study|Lack of Efficacy|0
877510|NCT00570063|1840182|FG001|Overall Study|Lack of Efficacy|1
877511|NCT00570063|1840181|FG000|Overall Study|Withdrawal by Subject|4
877512|NCT00570063|1840182|FG001|Overall Study|Withdrawal by Subject|3
877513|NCT00570063|1840181|FG000|Overall Study|Sponsor's Decision|7
877514|NCT00570063|1840182|FG001|Overall Study|Sponsor's Decision|3
877515|NCT00570128|1840199|FG000|Overall Study|Adverse Event|1
877516|NCT00570128|1840200|FG001|Overall Study|Adverse Event|0
877517|NCT00570128|1840199|FG000|Overall Study|Lost to Follow-up|1
877518|NCT00570128|1840200|FG001|Overall Study|Lost to Follow-up|0
877519|NCT00570128|1840199|FG000|Overall Study|Withdrawal by Subject|2
877520|NCT00570128|1840200|FG001|Overall Study|Withdrawal by Subject|0
877521|NCT00570141|1840206|FG000|Overall Study|Adverse Event|1
877522|NCT00570141|1840206|FG000|Overall Study|Missed visits|1
877523|NCT00570141|1840206|FG000|Overall Study|Lost to Follow-up|1
877524|NCT00570232|1840210|FG000|Overall Study|Adverse Event|10
877525|NCT00570232|1840210|FG000|Overall Study|discontinued due to medical condition|3
877526|NCT00570232|1840210|FG000|Overall Study|discontinued due to recurrence|8
877527|NCT00570232|1840210|FG000|Overall Study|discontinued due to noncompliance|2
877528|NCT00570310|1840216|FG000|Overall Study|Adverse Event|1
877529|NCT00570310|1840217|FG001|Overall Study|Adverse Event|2
877530|NCT00570310|1840216|FG000|Overall Study|Lack of Efficacy|1
877531|NCT00570310|1840217|FG001|Overall Study|Lack of Efficacy|4
877532|NCT00570323|1840225|FG000|Started Treatment After Randomization|Withdrawal by Subject|0
877533|NCT00570323|1840226|FG001|Started Treatment After Randomization|Withdrawal by Subject|1
877534|NCT00570323|1840225|FG000|Started Treatment After Randomization|Protocol Violation|1
877535|NCT00570323|1840226|FG001|Started Treatment After Randomization|Protocol Violation|0
1182395|NCT02714218|2340336|FG000|Overall Study|Not Reported|9
1182396|NCT02714218|2340337|FG001|Overall Study|Not Reported|5
1182397|NCT02714218|2340338|FG002|Overall Study|Not Reported|0
1182398|NCT02714218|2340336|FG000|Overall Study|Completed|2
1182399|NCT02714218|2340337|FG001|Overall Study|Completed|0
1182400|NCT02714218|2340338|FG002|Overall Study|Completed|0
1182401|NCT02714218|2340336|FG000|Overall Study|Dose Delayed > 6 weeks|1
1182402|NCT02714218|2340337|FG001|Overall Study|Dose Delayed > 6 weeks|0
1182403|NCT02714218|2340338|FG002|Overall Study|Dose Delayed > 6 weeks|0
1182404|NCT02714218|2340336|FG000|Overall Study|Complete Response|1
1182405|NCT02714218|2340337|FG001|Overall Study|Complete Response|0
1182406|NCT02714218|2340338|FG002|Overall Study|Complete Response|0
1182407|NCT02714218|2340336|FG000|Overall Study|Stop treatment, but will do follow up|0
1182408|NCT02714218|2340337|FG001|Overall Study|Stop treatment, but will do follow up|1
1182409|NCT02714218|2340338|FG002|Overall Study|Stop treatment, but will do follow up|0
1182428|NCT02564263|2340376|FG000|Overall Study|Adverse Event|31
1182429|NCT02564263|2340377|FG001|Overall Study|Adverse Event|29
1182430|NCT02564263|2340376|FG000|Overall Study|Death|236
1182431|NCT02564263|2340377|FG001|Overall Study|Death|242
1182432|NCT02564263|2340376|FG000|Overall Study|Withdrawal by Subject|5
1182433|NCT02564263|2340377|FG001|Overall Study|Withdrawal by Subject|18
1182434|NCT02564263|2340376|FG000|Overall Study|Ongoing in Study|42
1182435|NCT02564263|2340377|FG001|Overall Study|Ongoing in Study|25
1182436|NCT02450331|2340385|FG000|Overall Study|Death|120
1182437|NCT02450331|2340386|FG001|Overall Study|Death|114
1182438|NCT02450331|2340385|FG000|Overall Study|Lost to Follow-up|9
1182439|NCT02450331|2340386|FG001|Overall Study|Lost to Follow-up|7
1182440|NCT02450331|2340385|FG000|Overall Study|Withdrawal by Subject|50
1182441|NCT02450331|2340386|FG001|Overall Study|Withdrawal by Subject|39
1182442|NCT02450331|2340385|FG000|Overall Study|On-Study Status: In Disease recurrence follow-up|179
1182443|NCT02450331|2340386|FG001|Overall Study|On-Study Status: In Disease recurrence follow-up|208
1182444|NCT02450331|2340385|FG000|Overall Study|On-Study Status: In Survival follow-up|45
1182445|NCT02450331|2340386|FG001|Overall Study|On-Study Status: In Survival follow-up|38
1182464|NCT02149121|2340428|FG000|Main Study Period|Lack of Efficacy|2
1182465|NCT02149121|2340429|FG001|Main Study Period|Lack of Efficacy|2
1182466|NCT02149121|2340430|FG002|Main Study Period|Lack of Efficacy|1
1182467|NCT02149121|2340431|FG003|Main Study Period|Lack of Efficacy|0
1182468|NCT02149121|2340432|FG004|Main Study Period|Lack of Efficacy|0
1182469|NCT02149121|2340433|FG005|Main Study Period|Lack of Efficacy|0
1182470|NCT02149121|2340434|FG006|Main Study Period|Lack of Efficacy|0
1182471|NCT02149121|2340428|FG000|Main Study Period|Withdrawal by Subject|9
1182472|NCT02149121|2340429|FG001|Main Study Period|Withdrawal by Subject|5
1182473|NCT02149121|2340430|FG002|Main Study Period|Withdrawal by Subject|1
1182474|NCT02149121|2340431|FG003|Main Study Period|Withdrawal by Subject|0
1182475|NCT02149121|2340432|FG004|Main Study Period|Withdrawal by Subject|0
1182476|NCT02149121|2340433|FG005|Main Study Period|Withdrawal by Subject|0
1182477|NCT02149121|2340434|FG006|Main Study Period|Withdrawal by Subject|0
1182478|NCT02149121|2340428|FG000|Main Study Period|Adverse Event|2
1182479|NCT02149121|2340429|FG001|Main Study Period|Adverse Event|5
1182480|NCT02149121|2340430|FG002|Main Study Period|Adverse Event|1
1182481|NCT02149121|2340431|FG003|Main Study Period|Adverse Event|0
1182482|NCT02149121|2340432|FG004|Main Study Period|Adverse Event|0
1182483|NCT02149121|2340433|FG005|Main Study Period|Adverse Event|0
1182484|NCT02149121|2340434|FG006|Main Study Period|Adverse Event|0
1182485|NCT02149121|2340428|FG000|Main Study Period|Protocol Violation|2
1182486|NCT02149121|2340429|FG001|Main Study Period|Protocol Violation|0
1182487|NCT02149121|2340430|FG002|Main Study Period|Protocol Violation|0
1182488|NCT02149121|2340431|FG003|Main Study Period|Protocol Violation|0
1182489|NCT02149121|2340432|FG004|Main Study Period|Protocol Violation|0
1182490|NCT02149121|2340433|FG005|Main Study Period|Protocol Violation|0
1182491|NCT02149121|2340434|FG006|Main Study Period|Protocol Violation|0
1182492|NCT02149121|2340428|FG000|Main Study Period|Lost to Follow-up|2
1182493|NCT02149121|2340429|FG001|Main Study Period|Lost to Follow-up|1
1182494|NCT02149121|2340430|FG002|Main Study Period|Lost to Follow-up|0
1182495|NCT02149121|2340431|FG003|Main Study Period|Lost to Follow-up|0
1182496|NCT02149121|2340432|FG004|Main Study Period|Lost to Follow-up|0
1182497|NCT02149121|2340433|FG005|Main Study Period|Lost to Follow-up|0
1182498|NCT02149121|2340434|FG006|Main Study Period|Lost to Follow-up|0
1182499|NCT02149121|2340428|FG000|Main Study Period|Death|1
1182500|NCT02149121|2340429|FG001|Main Study Period|Death|0
1182501|NCT02149121|2340430|FG002|Main Study Period|Death|0
1182502|NCT02149121|2340431|FG003|Main Study Period|Death|0
1182503|NCT02149121|2340432|FG004|Main Study Period|Death|0
1182504|NCT02149121|2340433|FG005|Main Study Period|Death|0
1182505|NCT02149121|2340434|FG006|Main Study Period|Death|0
1182506|NCT02149121|2340428|FG000|Main Study Period|Physician Decision|1
1182507|NCT02149121|2340429|FG001|Main Study Period|Physician Decision|0
1182508|NCT02149121|2340430|FG002|Main Study Period|Physician Decision|0
1182509|NCT02149121|2340431|FG003|Main Study Period|Physician Decision|0
1182510|NCT02149121|2340432|FG004|Main Study Period|Physician Decision|0
1182511|NCT02149121|2340433|FG005|Main Study Period|Physician Decision|0
1182512|NCT02149121|2340434|FG006|Main Study Period|Physician Decision|0
1182513|NCT02149121|2340428|FG000|Main Study Period|Developed any malignancy|0
1182514|NCT02149121|2340429|FG001|Main Study Period|Developed any malignancy|1
1182515|NCT02149121|2340430|FG002|Main Study Period|Developed any malignancy|1
1182516|NCT02149121|2340431|FG003|Main Study Period|Developed any malignancy|0
1182517|NCT02149121|2340432|FG004|Main Study Period|Developed any malignancy|0
1182518|NCT02149121|2340433|FG005|Main Study Period|Developed any malignancy|0
1182519|NCT02149121|2340434|FG006|Main Study Period|Developed any malignancy|0
1182520|NCT02149121|2340428|FG000|Main Study Period|Unmet predefined eligibility criteria|2
1182521|NCT02149121|2340429|FG001|Main Study Period|Unmet predefined eligibility criteria|2
1182522|NCT02149121|2340430|FG002|Main Study Period|Unmet predefined eligibility criteria|0
1182523|NCT02149121|2340431|FG003|Main Study Period|Unmet predefined eligibility criteria|0
1182524|NCT02149121|2340432|FG004|Main Study Period|Unmet predefined eligibility criteria|0
1182525|NCT02149121|2340433|FG005|Main Study Period|Unmet predefined eligibility criteria|0
1182526|NCT02149121|2340434|FG006|Main Study Period|Unmet predefined eligibility criteria|0
877536|NCT00570323|1840225|FG000|Started Treatment After Randomization|Physician Decision|1
877537|NCT00570323|1840226|FG001|Started Treatment After Randomization|Physician Decision|0
877538|NCT00570323|1840225|FG000|Complete Study After Start|Lost to Follow-up|0
877539|NCT00570323|1840226|FG001|Complete Study After Start|Lost to Follow-up|1
877540|NCT00570323|1840225|FG000|Complete Study After Start|Withdrawal by Subject|2
877541|NCT00570323|1840226|FG001|Complete Study After Start|Withdrawal by Subject|0
877542|NCT00570323|1840225|FG000|Complete Study After Start|Physician Decision|1
877543|NCT00570323|1840226|FG001|Complete Study After Start|Physician Decision|0
877544|NCT00570401|1840256|FG000|Overall Study|Adverse Event|2
877545|NCT00570492|1840262|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
877546|NCT00570492|1840263|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
877547|NCT00570492|1840264|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
877548|NCT00570492|1840262|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
877549|NCT00570492|1840263|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
877550|NCT00570492|1840264|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
877551|NCT00570492|1840262|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56
877552|NCT00570492|1840263|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0
877553|NCT00570492|1840264|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0
877554|NCT00570492|1840262|FG000|16-week Single-blind Baseline Period|Protocol Violation|15
877555|NCT00570492|1840263|FG001|16-week Single-blind Baseline Period|Protocol Violation|0
877556|NCT00570492|1840264|FG002|16-week Single-blind Baseline Period|Protocol Violation|0
1182527|NCT02149121|2340428|FG000|Main Study Period|Disease progression|0
1182528|NCT02149121|2340429|FG001|Main Study Period|Disease progression|1
1182529|NCT02149121|2340430|FG002|Main Study Period|Disease progression|0
1182530|NCT02149121|2340431|FG003|Main Study Period|Disease progression|0
1182531|NCT02149121|2340432|FG004|Main Study Period|Disease progression|0
1182532|NCT02149121|2340433|FG005|Main Study Period|Disease progression|0
1182533|NCT02149121|2340434|FG006|Main Study Period|Disease progression|0
1182534|NCT02149121|2340428|FG000|Extension Study Period|Withdrawal by Subject|0
1182535|NCT02149121|2340429|FG001|Extension Study Period|Withdrawal by Subject|0
1182536|NCT02149121|2340430|FG002|Extension Study Period|Withdrawal by Subject|0
1182537|NCT02149121|2340431|FG003|Extension Study Period|Withdrawal by Subject|1
1182538|NCT02149121|2340432|FG004|Extension Study Period|Withdrawal by Subject|0
1182539|NCT02149121|2340433|FG005|Extension Study Period|Withdrawal by Subject|2
1182540|NCT02149121|2340434|FG006|Extension Study Period|Withdrawal by Subject|0
1182541|NCT02066181|2340457|FG000|Overall Study|Withdrawal by Subject|1
1182542|NCT02066181|2340458|FG001|Overall Study|Withdrawal by Subject|1
1182543|NCT01933932|2340469|FG000|Overall Study|Death|173
1182544|NCT01933932|2340470|FG001|Overall Study|Death|163
1182545|NCT01933932|2340469|FG000|Overall Study|Withdrawal by Subject|11
1182546|NCT01933932|2340470|FG001|Overall Study|Withdrawal by Subject|14
1182547|NCT01933932|2340469|FG000|Overall Study|Eligibility criteria not fulfilled|0
1182548|NCT01933932|2340470|FG001|Overall Study|Eligibility criteria not fulfilled|1
1182549|NCT01927419|2340478|FG000|Overall Study|Disease progression|15
1182550|NCT01927419|2340479|FG001|Overall Study|Disease progression|17
1182551|NCT01927419|2340478|FG000|Overall Study|Study drug toxicity|43
1182552|NCT01927419|2340479|FG001|Overall Study|Study drug toxicity|7
1182553|NCT01927419|2340478|FG000|Overall Study|Death|0
1182554|NCT01927419|2340479|FG001|Overall Study|Death|1
1182555|NCT01927419|2340478|FG000|Overall Study|Adverse event unrelated to study drug|6
1182556|NCT01927419|2340479|FG001|Overall Study|Adverse event unrelated to study drug|1
1182557|NCT01927419|2340478|FG000|Overall Study|Withdrawal by Subject|3
1182558|NCT01927419|2340479|FG001|Overall Study|Withdrawal by Subject|1
1182559|NCT01927419|2340478|FG000|Overall Study|Other|2
1182560|NCT01927419|2340479|FG001|Overall Study|Other|1
1182561|NCT01927419|2340478|FG000|Overall Study|Not reported|1
1182562|NCT01927419|2340479|FG001|Overall Study|Not reported|0
1182563|NCT01889186|2340489|FG000|Overall Study|Adverse event- not related to progression|18
1182564|NCT01889186|2340490|FG001|Overall Study|Adverse event- not related to progression|5
1182565|NCT01889186|2340489|FG000|Overall Study|Adverse event- related to progression|7
1182566|NCT01889186|2340490|FG001|Overall Study|Adverse event- related to progression|2
1182567|NCT01889186|2340489|FG000|Overall Study|COVID-19 logistical restrictions|1
1182568|NCT01889186|2340490|FG001|Overall Study|COVID-19 logistical restrictions|0
1182569|NCT01889186|2340489|FG000|Overall Study|Investigator request|1
1182570|NCT01889186|2340490|FG001|Overall Study|Investigator request|1
1182571|NCT01889186|2340489|FG000|Overall Study|Progressive disease- Richter's|12
1182572|NCT01889186|2340490|FG001|Overall Study|Progressive disease- Richter's|7
1182573|NCT01889186|2340489|FG000|Overall Study|Progressive disease per protocol|46
1182574|NCT01889186|2340490|FG001|Overall Study|Progressive disease per protocol|17
1182575|NCT01889186|2340489|FG000|Overall Study|Stem cell transplant|2
1182576|NCT01889186|2340490|FG001|Overall Study|Stem cell transplant|1
1182577|NCT01889186|2340489|FG000|Overall Study|Withdrew consent|2
1182578|NCT01889186|2340490|FG001|Overall Study|Withdrew consent|3
1182579|NCT01889186|2340489|FG000|Overall Study|Other, not specified|18
1182580|NCT01889186|2340490|FG001|Overall Study|Other, not specified|15
1182581|NCT01850004|2340498|FG000|Overall Study|Subject Moved|1
1182582|NCT01850004|2340498|FG000|Overall Study|Poor/Non-compliance|1
1182583|NCT01850004|2340498|FG000|Overall Study|Subject Withdrew Consent|4
1182584|NCT01850004|2340498|FG000|Overall Study|Subject Request to Discontinue Treatment|1
1182585|NCT01850004|2340498|FG000|Overall Study|AE Unrelated to Study Drug|1
1182586|NCT01844505|2340510|FG000|Overall Study|Disease progression|170
1182587|NCT01844505|2340511|FG001|Overall Study|Disease progression|88
1182588|NCT01844505|2340512|FG002|Overall Study|Disease progression|224
1182589|NCT01844505|2340510|FG000|Overall Study|Study drug toxicity|40
1182590|NCT01844505|2340511|FG001|Overall Study|Study drug toxicity|131
1182591|NCT01844505|2340512|FG002|Overall Study|Study drug toxicity|50
1182592|NCT01844505|2340510|FG000|Overall Study|Death|1
1182593|NCT01844505|2340511|FG001|Overall Study|Death|3
1182594|NCT01844505|2340512|FG002|Overall Study|Death|1
1182595|NCT01844505|2340510|FG000|Overall Study|Adverse event unrelated to study drug|7
1182596|NCT01844505|2340511|FG001|Overall Study|Adverse event unrelated to study drug|15
1182597|NCT01844505|2340512|FG002|Overall Study|Adverse event unrelated to study drug|6
1182598|NCT01844505|2340510|FG000|Overall Study|Subject request discontinue treatment|17
1182599|NCT01844505|2340511|FG001|Overall Study|Subject request discontinue treatment|14
1182600|NCT01844505|2340512|FG002|Overall Study|Subject request discontinue treatment|8
1182601|NCT01844505|2340510|FG000|Overall Study|Withdrawal by Subject|0
1182602|NCT01844505|2340511|FG001|Overall Study|Withdrawal by Subject|3
1182603|NCT01844505|2340512|FG002|Overall Study|Withdrawal by Subject|0
1182604|NCT01844505|2340510|FG000|Overall Study|Lost to Follow-up|1
1182605|NCT01844505|2340511|FG001|Overall Study|Lost to Follow-up|0
1182606|NCT01844505|2340512|FG002|Overall Study|Lost to Follow-up|0
1182607|NCT01844505|2340510|FG000|Overall Study|Maximum clinical benefit|8
1182608|NCT01844505|2340511|FG001|Overall Study|Maximum clinical benefit|11
1182609|NCT01844505|2340512|FG002|Overall Study|Maximum clinical benefit|2
1182610|NCT01844505|2340510|FG000|Overall Study|Poor/non-compliance|1
1182611|NCT01844505|2340511|FG001|Overall Study|Poor/non-compliance|1
1182612|NCT01844505|2340512|FG002|Overall Study|Poor/non-compliance|1
1182613|NCT01844505|2340510|FG000|Overall Study|Subject no longer meets criteria|0
1182614|NCT01844505|2340511|FG001|Overall Study|Subject no longer meets criteria|1
1182615|NCT01844505|2340512|FG002|Overall Study|Subject no longer meets criteria|0
1182616|NCT01844505|2340510|FG000|Overall Study|Other Reasons|4
1182617|NCT01844505|2340511|FG001|Overall Study|Other Reasons|2
1182618|NCT01844505|2340512|FG002|Overall Study|Other Reasons|2
1182619|NCT01844505|2340510|FG000|Overall Study|Not Reported|0
1182620|NCT01844505|2340511|FG001|Overall Study|Not Reported|0
1182621|NCT01844505|2340512|FG002|Overall Study|Not Reported|1
1182622|NCT01757535|2340522|FG000|Overall Study|Disease Relapse|143
1182623|NCT01757535|2340523|FG001|Overall Study|Disease Relapse|180
1182624|NCT01757535|2340522|FG000|Overall Study|Adverse Event|29
1182625|NCT01757535|2340523|FG001|Overall Study|Adverse Event|11
1182626|NCT01757535|2340522|FG000|Overall Study|Withdrawal by Subject|9
1182627|NCT01757535|2340523|FG001|Overall Study|Withdrawal by Subject|13
1182628|NCT01757535|2340522|FG000|Overall Study|Miscellaneous|5
1182629|NCT01757535|2340523|FG001|Overall Study|Miscellaneous|2
1182630|NCT01757535|2340522|FG000|Overall Study|Physician Decision|6
1182631|NCT01757535|2340523|FG001|Overall Study|Physician Decision|0
1182632|NCT01757535|2340522|FG000|Overall Study|Death|1
1182633|NCT01757535|2340523|FG001|Overall Study|Death|2
1182634|NCT01750281|2340532|FG000|Overall Study|Discontinued Selumetinib/Placebo|37
1182635|NCT01750281|2340533|FG001|Overall Study|Discontinued Selumetinib/Placebo|77
1182636|NCT01750281|2340534|FG002|Overall Study|Discontinued Selumetinib/Placebo|75
1182637|NCT01750281|2340532|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
1182638|NCT01750281|2340533|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
1182639|NCT01750281|2340534|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
1182640|NCT01750281|2340532|FG000|Overall Study|Did not receive treatment|0
1182641|NCT01750281|2340533|FG001|Overall Study|Did not receive treatment|1
1182642|NCT01750281|2340534|FG002|Overall Study|Did not receive treatment|0
1182667|NCT01510184|2340558|FG000|Overall Study|Sponsor discretion|28
1182668|NCT01510184|2340559|FG001|Overall Study|Sponsor discretion|28
1182669|NCT01510184|2340558|FG000|Overall Study|Death|1
1182670|NCT01510184|2340559|FG001|Overall Study|Death|2
1182671|NCT01510184|2340558|FG000|Overall Study|Withdrawal by Subject|1
1182672|NCT01510184|2340559|FG001|Overall Study|Withdrawal by Subject|4
1182673|NCT01510184|2340558|FG000|Overall Study|Other|0
1182674|NCT01510184|2340559|FG001|Overall Study|Other|1
1182675|NCT01471444|2340567|FG000|Overall Study|Physician Decision|3
1182676|NCT01471444|2340568|FG001|Overall Study|Physician Decision|2
1182677|NCT01471444|2340567|FG000|Overall Study|Withdrawal by Subject|0
1182678|NCT01471444|2340568|FG001|Overall Study|Withdrawal by Subject|1
1006584|NCT01468701|2025293|FG008|Overall Study|Other reasons than listed|318
1182863|NCT01238211|2340592|FG000|Overall Study|Continues active treatment|31
1182864|NCT01238211|2340592|FG000|Overall Study|Adverse Event|7
1182865|NCT01238211|2340592|FG000|Overall Study|Death|4
1182866|NCT01238211|2340592|FG000|Overall Study|Relapse/Progression|2
1182867|NCT01238211|2340592|FG000|Overall Study|Withdrawal by Subject|7
1182868|NCT01238211|2340592|FG000|Overall Study|Non-protocol treatment|4
1182869|NCT01238211|2340592|FG000|Overall Study|Investigator/Patient Decision|3
877557|NCT00570492|1840262|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2
877558|NCT00570492|1840263|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0
877559|NCT00570492|1840264|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0
877560|NCT00570492|1840262|FG000|16-week Single-blind Baseline Period|Adverse Event|1
877561|NCT00570492|1840263|FG001|16-week Single-blind Baseline Period|Adverse Event|0
877562|NCT00570492|1840264|FG002|16-week Single-blind Baseline Period|Adverse Event|0
877563|NCT00570492|1840262|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
877564|NCT00570492|1840263|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
877565|NCT00570492|1840264|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
1182870|NCT03745651|2340640|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
1182871|NCT03745651|2340641|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
1182872|NCT03745651|2340642|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1182873|NCT03745651|2340643|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1182874|NCT03745651|2340644|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1182875|NCT03745651|2340645|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1182876|NCT03745651|2340646|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1182877|NCT03745651|2340640|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3
1182878|NCT03745651|2340641|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13
1182879|NCT03745651|2340642|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4
1182880|NCT03745651|2340643|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1182881|NCT03745651|2340644|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1182882|NCT03745651|2340645|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1182883|NCT03745651|2340646|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1182884|NCT03745651|2340640|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3
1182885|NCT03745651|2340641|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1182886|NCT03745651|2340642|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
1182887|NCT03745651|2340643|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1182888|NCT03745651|2340644|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1182889|NCT03745651|2340645|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1182890|NCT03745651|2340646|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1182891|NCT03745651|2340640|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1182892|NCT03745651|2340641|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2
1182893|NCT03745651|2340642|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1182894|NCT03745651|2340643|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1182895|NCT03745651|2340644|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1182896|NCT03745651|2340645|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1182897|NCT03745651|2340646|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1182898|NCT03745651|2340640|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
1182899|NCT03745651|2340641|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21
1182900|NCT03745651|2340642|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15
1182901|NCT03745651|2340643|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1182902|NCT03745651|2340644|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1182903|NCT03745651|2340645|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1182904|NCT03745651|2340646|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1182905|NCT03745651|2340640|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1
1182906|NCT03745651|2340641|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
1182907|NCT03745651|2340642|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
1182908|NCT03745651|2340643|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
1182909|NCT03745651|2340644|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
1182910|NCT03745651|2340645|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
1182911|NCT03745651|2340646|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
1182912|NCT03745651|2340640|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1182913|NCT03745651|2340641|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1182914|NCT03745651|2340642|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1182915|NCT03745651|2340643|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1182916|NCT03745651|2340644|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1182917|NCT03745651|2340645|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4
1182918|NCT03745651|2340646|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1182919|NCT03745651|2340640|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1182920|NCT03745651|2340641|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1182921|NCT03745651|2340642|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1182922|NCT03745651|2340643|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
1182923|NCT03745651|2340644|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1182924|NCT03745651|2340645|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
1182925|NCT03745651|2340646|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
1182926|NCT03745651|2340640|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1182927|NCT03745651|2340641|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1182928|NCT03745651|2340642|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1182929|NCT03745651|2340643|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4
1182930|NCT03745651|2340644|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2
1182931|NCT03745651|2340645|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
1182932|NCT03745651|2340646|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10
1182933|NCT03745651|2340640|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1182934|NCT03745651|2340641|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1182935|NCT03745651|2340642|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1182936|NCT03745651|2340643|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
1182937|NCT03745651|2340644|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1182938|NCT03745651|2340645|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4
1182939|NCT03745651|2340646|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2
1182940|NCT03745651|2340640|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
1182941|NCT03745651|2340641|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
1182942|NCT03745651|2340642|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
1182943|NCT03745651|2340643|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
1182944|NCT03745651|2340644|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
1182945|NCT03745651|2340645|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
1182946|NCT03745651|2340646|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
1182947|NCT03745651|2340640|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1182948|NCT03745651|2340641|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1182949|NCT03745651|2340642|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1182950|NCT03745651|2340643|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1182951|NCT03745651|2340644|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1182952|NCT03745651|2340645|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
1182953|NCT03745651|2340646|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1182954|NCT03745651|2340640|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1182955|NCT03745651|2340641|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1182956|NCT03745651|2340642|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1182957|NCT03745651|2340643|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12
1182958|NCT03745651|2340644|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8
1182959|NCT03745651|2340645|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26
1182960|NCT03745651|2340646|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34
1182961|NCT03745651|2340640|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
1182962|NCT03745651|2340641|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
1182963|NCT03745651|2340642|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
1182964|NCT03745651|2340643|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
1182965|NCT03745651|2340644|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
1182966|NCT03745651|2340645|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
1182967|NCT03745651|2340646|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
1182968|NCT03745638|2340665|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4
1182969|NCT03745638|2340666|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2
1182970|NCT03745638|2340667|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
1182971|NCT03745638|2340668|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1182972|NCT03745638|2340669|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1182973|NCT03745638|2340670|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1182974|NCT03745638|2340671|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1182975|NCT03745638|2340665|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1
1182976|NCT03745638|2340666|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1182977|NCT03745638|2340667|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1182978|NCT03745638|2340668|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1182979|NCT03745638|2340669|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1182980|NCT03745638|2340670|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1182981|NCT03745638|2340671|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1182982|NCT03745638|2340665|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5
1182983|NCT03745638|2340666|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12
1182984|NCT03745638|2340667|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8
1182985|NCT03745638|2340668|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1182986|NCT03745638|2340669|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1182987|NCT03745638|2340670|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1182988|NCT03745638|2340671|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1182989|NCT03745638|2340665|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
1182990|NCT03745638|2340666|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
1182991|NCT03745638|2340667|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1182992|NCT03745638|2340668|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1182993|NCT03745638|2340669|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1182994|NCT03745638|2340670|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
877566|NCT00570492|1840262|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
1182995|NCT03745638|2340671|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1182996|NCT03745638|2340665|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1
1182997|NCT03745638|2340666|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
1182998|NCT03745638|2340667|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
1182999|NCT03745638|2340668|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
877567|NCT00570492|1840263|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20
877568|NCT00570492|1840264|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20
1183000|NCT03745638|2340669|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
1183001|NCT03745638|2340670|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
1183002|NCT03745638|2340671|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
1183003|NCT03745638|2340665|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1183004|NCT03745638|2340666|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3
1183005|NCT03745638|2340667|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1183006|NCT03745638|2340668|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1183007|NCT03745638|2340669|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1183008|NCT03745638|2340670|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1183009|NCT03745638|2340671|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1183010|NCT03745638|2340665|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17
1183011|NCT03745638|2340666|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
1183012|NCT03745638|2340667|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19
1183013|NCT03745638|2340668|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1183014|NCT03745638|2340669|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1183015|NCT03745638|2340670|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1183016|NCT03745638|2340671|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1183017|NCT03745638|2340665|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2
1183018|NCT03745638|2340666|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1
1183019|NCT03745638|2340667|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
1183020|NCT03745638|2340668|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
1183021|NCT03745638|2340669|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
1183022|NCT03745638|2340670|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
1183023|NCT03745638|2340671|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
1183024|NCT03745638|2340665|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1183025|NCT03745638|2340666|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1183026|NCT03745638|2340667|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1183027|NCT03745638|2340668|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1183028|NCT03745638|2340669|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1183029|NCT03745638|2340670|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6
1183030|NCT03745638|2340671|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1
1183031|NCT03745638|2340665|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1183032|NCT03745638|2340666|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1183033|NCT03745638|2340667|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1183034|NCT03745638|2340668|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
1183035|NCT03745638|2340669|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1183036|NCT03745638|2340670|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
1183037|NCT03745638|2340671|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
1183038|NCT03745638|2340665|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1183039|NCT03745638|2340666|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1183040|NCT03745638|2340667|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1183041|NCT03745638|2340668|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3
1183042|NCT03745638|2340669|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5
1183043|NCT03745638|2340670|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
1183044|NCT03745638|2340671|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24
1183045|NCT03745638|2340665|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1183046|NCT03745638|2340666|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1183047|NCT03745638|2340667|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1183048|NCT03745638|2340668|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1183049|NCT03745638|2340669|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
1183050|NCT03745638|2340670|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3
1183051|NCT03745638|2340671|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1183052|NCT03745638|2340665|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1183053|NCT03745638|2340666|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1183054|NCT03745638|2340667|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1183055|NCT03745638|2340668|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1183056|NCT03745638|2340669|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1183057|NCT03745638|2340670|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
1183058|NCT03745638|2340671|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1183059|NCT03745638|2340665|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1183060|NCT03745638|2340666|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1183061|NCT03745638|2340667|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1183062|NCT03745638|2340668|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7
1183063|NCT03745638|2340669|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3
1183064|NCT03745638|2340670|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17
1183065|NCT03745638|2340671|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21
1183066|NCT03745638|2340665|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
1183067|NCT03745638|2340666|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
1183068|NCT03745638|2340667|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
1183069|NCT03745638|2340668|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
1183070|NCT03745638|2340669|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
1183071|NCT03745638|2340670|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4
1183072|NCT03745638|2340671|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3
1183073|NCT03715764|2340690|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2
1183074|NCT03715764|2340691|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3
1183075|NCT03715764|2340690|FG000|3 Month Follow-up|Lost to Follow-up|2
1183076|NCT03715764|2340691|FG001|3 Month Follow-up|Lost to Follow-up|2
1183077|NCT03715764|2340690|FG000|3 Month Follow-up|Withdrawal by Subject|1
1183078|NCT03715764|2340691|FG001|3 Month Follow-up|Withdrawal by Subject|1
1183079|NCT03715764|2340690|FG000|6 Month Follow-up|Lost to Follow-up|3
1183080|NCT03715764|2340691|FG001|6 Month Follow-up|Lost to Follow-up|0
1183081|NCT03715764|2340690|FG000|12 Month Follow-up|Lost to Follow-up|2
1183082|NCT03715764|2340691|FG001|12 Month Follow-up|Lost to Follow-up|3
1183083|NCT03715764|2340690|FG000|12 Month Follow-up|Pregnancy|0
1183084|NCT03715764|2340691|FG001|12 Month Follow-up|Pregnancy|1
1183085|NCT03715764|2340690|FG000|12 Month Follow-up|Surgery|2
1183086|NCT03715764|2340691|FG001|12 Month Follow-up|Surgery|0
1183087|NCT03715764|2340690|FG000|12 Month Follow-up|Wrong address|1
1183088|NCT03715764|2340691|FG001|12 Month Follow-up|Wrong address|0
1183089|NCT03715764|2340690|FG000|12 Month Follow-up|No symptoms|1
1183090|NCT03715764|2340691|FG001|12 Month Follow-up|No symptoms|0
1183091|NCT03715764|2340690|FG000|12 Month Follow-up|Changed primary care centre|0
1183092|NCT03715764|2340691|FG001|12 Month Follow-up|Changed primary care centre|1
1183093|NCT03654729|2340704|FG000|Overall Study|Death|9
1183094|NCT03654729|2340705|FG001|Overall Study|Death|9
1183095|NCT03654729|2340706|FG002|Overall Study|Death|16
1183096|NCT03654729|2340704|FG000|Overall Study|Withdrawal by Subject|8
1183097|NCT03654729|2340705|FG001|Overall Study|Withdrawal by Subject|6
1183098|NCT03654729|2340706|FG002|Overall Study|Withdrawal by Subject|4
1183099|NCT03654729|2340704|FG000|Overall Study|Study terminated by Sponsor|3
1183100|NCT03654729|2340705|FG001|Overall Study|Study terminated by Sponsor|5
1183101|NCT03654729|2340706|FG002|Overall Study|Study terminated by Sponsor|4
1183102|NCT03654729|2340704|FG000|Overall Study|Not reported|2
1183103|NCT03654729|2340705|FG001|Overall Study|Not reported|4
1183104|NCT03654729|2340706|FG002|Overall Study|Not reported|5
1183105|NCT03654729|2340704|FG000|Overall Study|Progressive disease|3
1183106|NCT03654729|2340705|FG001|Overall Study|Progressive disease|0
1183107|NCT03654729|2340706|FG002|Overall Study|Progressive disease|0
1183108|NCT03654729|2340704|FG000|Overall Study|Lost to Follow-up|2
1183109|NCT03654729|2340705|FG001|Overall Study|Lost to Follow-up|0
1183110|NCT03654729|2340706|FG002|Overall Study|Lost to Follow-up|0
1183111|NCT03654729|2340704|FG000|Overall Study|Physician Decision|2
1183112|NCT03654729|2340705|FG001|Overall Study|Physician Decision|0
1183113|NCT03654729|2340706|FG002|Overall Study|Physician Decision|0
1183114|NCT03654729|2340704|FG000|Overall Study|Protocol Violation|1
1183115|NCT03654729|2340705|FG001|Overall Study|Protocol Violation|1
1183116|NCT03654729|2340706|FG002|Overall Study|Protocol Violation|0
1183117|NCT03654729|2340704|FG000|Overall Study|Non-compliance with study drug|0
1183118|NCT03654729|2340705|FG001|Overall Study|Non-compliance with study drug|1
1183119|NCT03654729|2340706|FG002|Overall Study|Non-compliance with study drug|0
1183120|NCT03654729|2340704|FG000|Overall Study|Site terminated by Sponsor|1
1183121|NCT03654729|2340705|FG001|Overall Study|Site terminated by Sponsor|0
1183122|NCT03654729|2340706|FG002|Overall Study|Site terminated by Sponsor|0
1183131|NCT02976038|2340771|FG000|Overall Study|Physician Decision|22
1183132|NCT02976038|2340771|FG000|Overall Study|Withdrawal by Subject|3
1183133|NCT02976038|2340771|FG000|Overall Study|Lost to Follow-up|2
1183134|NCT02976038|2340771|FG000|Overall Study|Adverse Event|1
1183135|NCT02951767|2340785|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54
1183136|NCT02951767|2340785|FG000|Overall Study|Withdrawal by Subject|5
1183137|NCT02951767|2340785|FG000|Overall Study|Death|59
1183138|NCT02951767|2340785|FG000|Overall Study|Lost to Follow-up|1
1183139|NCT02657434|2340791|FG000|Overall Study|On-Going in Study|77
1183140|NCT02657434|2340792|FG001|Overall Study|On-Going in Study|91
1183141|NCT02657434|2340791|FG000|Overall Study|Death|177
1183142|NCT02657434|2340792|FG001|Overall Study|Death|183
1183143|NCT02657434|2340791|FG000|Overall Study|Lost to Follow-up|2
1183144|NCT02657434|2340792|FG001|Overall Study|Lost to Follow-up|2
1183145|NCT02657434|2340791|FG000|Overall Study|Randomization by Error|2
1183146|NCT02657434|2340792|FG001|Overall Study|Randomization by Error|0
1183147|NCT02657434|2340791|FG000|Overall Study|Withdrawal by Subject|27
1183148|NCT02657434|2340792|FG001|Overall Study|Withdrawal by Subject|16
1183149|NCT02657434|2340791|FG000|Overall Study|Protocol Violation|1
1183150|NCT02657434|2340792|FG001|Overall Study|Protocol Violation|0
1183151|NCT02631070|2340801|FG000|Overall Study|Withdrawal by Subject|35
877569|NCT00570492|1840262|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
877570|NCT00570492|1840263|FG001|52-week Double-blind Treatment Period|Protocol Violation|12
877571|NCT00570492|1840264|FG002|52-week Double-blind Treatment Period|Protocol Violation|15
877572|NCT00570492|1840262|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
1183152|NCT02631070|2340802|FG001|Overall Study|Withdrawal by Subject|13
1183153|NCT02631070|2340801|FG000|Overall Study|Death|45
1183154|NCT02631070|2340802|FG001|Overall Study|Death|24
1183155|NCT02631070|2340801|FG000|Overall Study|Lost to Follow-up|5
1183156|NCT02631070|2340802|FG001|Overall Study|Lost to Follow-up|1
1183157|NCT02631070|2340801|FG000|Overall Study|Transition to rollover protocol|52
1183158|NCT02631070|2340802|FG001|Overall Study|Transition to rollover protocol|21
1183159|NCT02631070|2340801|FG000|Overall Study|Other reasons|12
1183160|NCT02631070|2340802|FG001|Overall Study|Other reasons|5
1183161|NCT02557139|2340811|FG000|Overall Study|Significant liver elevation|1
1183162|NCT02557139|2340812|FG001|Overall Study|Significant liver elevation|0
1183163|NCT02557139|2340813|FG002|Overall Study|Significant liver elevation|1
1183164|NCT02557139|2340811|FG000|Overall Study|Withdrawal by Subject|1
1183165|NCT02557139|2340812|FG001|Overall Study|Withdrawal by Subject|0
1183166|NCT02557139|2340813|FG002|Overall Study|Withdrawal by Subject|0
1183167|NCT02557139|2340811|FG000|Overall Study|Illness of prohibited medication|0
1183168|NCT02557139|2340812|FG001|Overall Study|Illness of prohibited medication|0
1183169|NCT02557139|2340813|FG002|Overall Study|Illness of prohibited medication|1
1183170|NCT02513667|2340832|FG000|Overall Study|Withdrawal by Subject|0
1183171|NCT02513667|2340833|FG001|Overall Study|Withdrawal by Subject|1
1183172|NCT02281955|2340839|FG000|Overall Study|Death|1
1183173|NCT02202434|2340847|FG000|Overall Study|Death|70
1183174|NCT02202434|2340848|FG001|Overall Study|Death|39
1183175|NCT02202434|2340849|FG002|Overall Study|Death|13
1183176|NCT02202434|2340850|FG003|Overall Study|Death|27
1183177|NCT02202434|2340847|FG000|Overall Study|Lost to Follow-up|1
1183178|NCT02202434|2340848|FG001|Overall Study|Lost to Follow-up|1
1183179|NCT02202434|2340849|FG002|Overall Study|Lost to Follow-up|1
1183180|NCT02202434|2340850|FG003|Overall Study|Lost to Follow-up|0
1183181|NCT02202434|2340847|FG000|Overall Study|Physician Decision|2
1183182|NCT02202434|2340848|FG001|Overall Study|Physician Decision|3
1183183|NCT02202434|2340849|FG002|Overall Study|Physician Decision|0
1183184|NCT02202434|2340850|FG003|Overall Study|Physician Decision|0
1183185|NCT02202434|2340847|FG000|Overall Study|Withdrawal by Subject|13
1183186|NCT02202434|2340848|FG001|Overall Study|Withdrawal by Subject|14
877573|NCT00570492|1840263|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5
877574|NCT00570492|1840264|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7
877575|NCT00570492|1840262|FG000|52-week Double-blind Treatment Period|Adverse Event|0
877576|NCT00570492|1840263|FG001|52-week Double-blind Treatment Period|Adverse Event|5
877577|NCT00570492|1840264|FG002|52-week Double-blind Treatment Period|Adverse Event|5
877578|NCT00570492|1840262|FG000|52-week Double-blind Treatment Period|Physician Decision|0
877579|NCT00570492|1840263|FG001|52-week Double-blind Treatment Period|Physician Decision|2
877580|NCT00570492|1840264|FG002|52-week Double-blind Treatment Period|Physician Decision|4
877581|NCT00570492|1840262|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
877582|NCT00570492|1840263|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3
877583|NCT00570492|1840264|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0
877584|NCT00570492|1840262|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
877585|NCT00570492|1840263|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
877586|NCT00570492|1840264|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
877587|NCT00570505|1840270|FG000|Overall Study|Adverse Event|7
877588|NCT00570505|1840270|FG000|Overall Study|Withdrawal by Subject|7
877589|NCT00570505|1840270|FG000|Overall Study|Lost to Follow-up|23
877590|NCT00570505|1840270|FG000|Overall Study|Other loss to follow-up|4
877591|NCT00570661|1840274|FG000|Overall Study|Disease worsening|5
877592|NCT00570661|1840274|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1
877593|NCT00570661|1840274|FG000|Overall Study|Adverse Event|1
877594|NCT00570674|1840279|FG000|Overall Study|Withdrawal by Subject|0
877595|NCT00570674|1840280|FG001|Overall Study|Withdrawal by Subject|0
877596|NCT00570674|1840281|FG002|Overall Study|Withdrawal by Subject|1
877597|NCT00570674|1840282|FG003|Overall Study|Withdrawal by Subject|0
877598|NCT00570674|1840283|FG004|Overall Study|Withdrawal by Subject|0
877599|NCT00570674|1840284|FG005|Overall Study|Withdrawal by Subject|0
877600|NCT00570674|1840285|FG006|Overall Study|Withdrawal by Subject|0
877601|NCT00570687|1840298|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1183187|NCT02202434|2340849|FG002|Overall Study|Withdrawal by Subject|1
1183188|NCT02202434|2340850|FG003|Overall Study|Withdrawal by Subject|4
1183189|NCT02202434|2340847|FG000|Overall Study|Completed Study|1
1183190|NCT02202434|2340848|FG001|Overall Study|Completed Study|0
1183191|NCT02202434|2340849|FG002|Overall Study|Completed Study|0
1183192|NCT02202434|2340850|FG003|Overall Study|Completed Study|0
1183193|NCT02202434|2340847|FG000|Overall Study|Visit Missed|21
1183194|NCT02202434|2340848|FG001|Overall Study|Visit Missed|12
1183195|NCT02202434|2340849|FG002|Overall Study|Visit Missed|0
1183196|NCT02202434|2340850|FG003|Overall Study|Visit Missed|5
1183197|NCT02202434|2340847|FG000|Overall Study|Other|1
1183198|NCT02202434|2340848|FG001|Overall Study|Other|0
1183199|NCT02202434|2340849|FG002|Overall Study|Other|0
1183200|NCT02202434|2340850|FG003|Overall Study|Other|1
1183201|NCT02108652|2340860|FG000|Overall Study|Death|226
1183202|NCT02108652|2340860|FG000|Overall Study|Lost to Follow-up|2
1183203|NCT02108652|2340860|FG000|Overall Study|Withdrawal by Subject|8
1183204|NCT02108652|2340860|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74
1183205|NCT02097134|2340864|FG000|Overall Study|Physician Decision|4
1183206|NCT02097134|2340864|FG000|Overall Study|Non-Protocol Therapy|1
1183207|NCT02097134|2340864|FG000|Overall Study|Progressive Disease|3
1183208|NCT02097134|2340864|FG000|Overall Study|Refusal of Further Protocol Therapy|1
1183209|NCT02028884|2340871|FG000|Double-blind Period|Adverse Event|5
1183210|NCT02028884|2340872|FG001|Double-blind Period|Adverse Event|3
1183211|NCT02028884|2340871|FG000|Double-blind Period|Eligibility Violation|1
1183212|NCT02028884|2340872|FG001|Double-blind Period|Eligibility Violation|0
1183213|NCT02028884|2340871|FG000|Double-blind Period|Non-Compliance With Study Drug|2
1183214|NCT02028884|2340872|FG001|Double-blind Period|Non-Compliance With Study Drug|0
1183215|NCT02028884|2340871|FG000|Double-blind Period|Withdrawal by Subject|2
1183216|NCT02028884|2340872|FG001|Double-blind Period|Withdrawal by Subject|0
1183217|NCT02028884|2340871|FG000|Double-blind Period|On-going in Study|8
1183218|NCT02028884|2340872|FG001|Double-blind Period|On-going in Study|20
1183219|NCT02028884|2340871|FG000|Open-label Extension Period|Adverse Event|2
1183220|NCT02028884|2340872|FG001|Open-label Extension Period|Adverse Event|1
1183221|NCT02028884|2340871|FG000|Open-label Extension Period|Lack of Efficacy|3
1183222|NCT02028884|2340872|FG001|Open-label Extension Period|Lack of Efficacy|0
1183223|NCT02028884|2340871|FG000|Open-label Extension Period|Non-Compliance With Study Drug|0
1183224|NCT02028884|2340872|FG001|Open-label Extension Period|Non-Compliance With Study Drug|1
1183225|NCT02028884|2340871|FG000|Open-label Extension Period|Withdrawal by Subject|0
1183226|NCT02028884|2340872|FG001|Open-label Extension Period|Withdrawal by Subject|2
1183227|NCT02028884|2340871|FG000|Open-label Extension Period|On-going in Study|19
1183228|NCT02028884|2340872|FG001|Open-label Extension Period|On-going in Study|14
877602|NCT00570687|1840299|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1006585|NCT01468701|2025294|FG009|Overall Study|Other reasons than listed|658
1183262|NCT01564537|2340898|FG000|Overall Study|Withdrawal by Participant|4
1183263|NCT01564537|2340899|FG001|Overall Study|Withdrawal by Participant|4
1183264|NCT01564537|2340898|FG000|Overall Study|Lost to Follow-up|1
1183265|NCT01564537|2340899|FG001|Overall Study|Lost to Follow-up|0
1183266|NCT01564537|2340898|FG000|Overall Study|Other Miscellaneous Reasons|1
1183267|NCT01564537|2340899|FG001|Overall Study|Other Miscellaneous Reasons|2
1183268|NCT01230242|2340906|FG000|Overall Study|Physician Decision|2
1183269|NCT01230242|2340906|FG000|Overall Study|Withdrawal by Subject|1
1183285|NCT00983437|2340964|FG000|Overall Study|Adverse Event|9
1183286|NCT00983437|2340964|FG000|Overall Study|Lack of Efficacy|1
1183287|NCT00983437|2340964|FG000|Overall Study|Withdrawal by Subject|8
1183288|NCT00983437|2340964|FG000|Overall Study|Noncompliance to Study Procedures|1
1183289|NCT00983437|2340964|FG000|Overall Study|Lost to Follow-up|2
1183290|NCT00983437|2340964|FG000|Overall Study|Other Reason|26
1183291|NCT00965757|2340970|FG000|Double-blind Phase|Progression of concomitant disease|1
1183292|NCT00965757|2340971|FG001|Double-blind Phase|Progression of concomitant disease|2
1183293|NCT00965757|2340972|FG002|Double-blind Phase|Progression of concomitant disease|0
1183294|NCT00965757|2340973|FG003|Double-blind Phase|Progression of concomitant disease|0
1183295|NCT00965757|2340970|FG000|Double-blind Phase|Adverse drug reaction|2
1183296|NCT00965757|2340971|FG001|Double-blind Phase|Adverse drug reaction|1
1183297|NCT00965757|2340972|FG002|Double-blind Phase|Adverse drug reaction|0
1183298|NCT00965757|2340973|FG003|Double-blind Phase|Adverse drug reaction|0
1183299|NCT00965757|2340970|FG000|Double-blind Phase|Abnormal Laboratory Value|2
1183300|NCT00965757|2340971|FG001|Double-blind Phase|Abnormal Laboratory Value|0
1183301|NCT00965757|2340972|FG002|Double-blind Phase|Abnormal Laboratory Value|0
1183302|NCT00965757|2340973|FG003|Double-blind Phase|Abnormal Laboratory Value|0
1183303|NCT00965757|2340970|FG000|Double-blind Phase|Lack of Efficacy|7
1183304|NCT00965757|2340971|FG001|Double-blind Phase|Lack of Efficacy|11
1183305|NCT00965757|2340972|FG002|Double-blind Phase|Lack of Efficacy|0
1183306|NCT00965757|2340973|FG003|Double-blind Phase|Lack of Efficacy|0
1183307|NCT00965757|2340970|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2
1183308|NCT00965757|2340971|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1183309|NCT00965757|2340972|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1183310|NCT00965757|2340973|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1183311|NCT00965757|2340970|FG000|Double-blind Phase|Lost to Follow-up|0
1183312|NCT00965757|2340971|FG001|Double-blind Phase|Lost to Follow-up|1
1183313|NCT00965757|2340972|FG002|Double-blind Phase|Lost to Follow-up|0
1183314|NCT00965757|2340973|FG003|Double-blind Phase|Lost to Follow-up|0
1183315|NCT00965757|2340970|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2
1183316|NCT00965757|2340971|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3
1183317|NCT00965757|2340972|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0
1183318|NCT00965757|2340973|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0
1183319|NCT00965757|2340970|FG000|Double-blind Phase|Other|1
1183320|NCT00965757|2340971|FG001|Double-blind Phase|Other|0
1183321|NCT00965757|2340972|FG002|Double-blind Phase|Other|0
1183322|NCT00965757|2340973|FG003|Double-blind Phase|Other|0
1183323|NCT00965757|2340970|FG000|Extension Phase|Progression of concomitant disease|0
1183324|NCT00965757|2340971|FG001|Extension Phase|Progression of concomitant disease|0
1183325|NCT00965757|2340972|FG002|Extension Phase|Progression of concomitant disease|4
1183326|NCT00965757|2340973|FG003|Extension Phase|Progression of concomitant disease|2
1183327|NCT00965757|2340970|FG000|Extension Phase|Adverse drug reaction|0
1183328|NCT00965757|2340971|FG001|Extension Phase|Adverse drug reaction|0
1183329|NCT00965757|2340972|FG002|Extension Phase|Adverse drug reaction|6
1183330|NCT00965757|2340973|FG003|Extension Phase|Adverse drug reaction|3
1183331|NCT00965757|2340970|FG000|Extension Phase|Abnormal Laboratory Value|0
1183332|NCT00965757|2340971|FG001|Extension Phase|Abnormal Laboratory Value|0
1183333|NCT00965757|2340972|FG002|Extension Phase|Abnormal Laboratory Value|6
1183334|NCT00965757|2340973|FG003|Extension Phase|Abnormal Laboratory Value|1
1183335|NCT00965757|2340970|FG000|Extension Phase|Lack of Efficacy|0
1183336|NCT00965757|2340971|FG001|Extension Phase|Lack of Efficacy|0
1183337|NCT00965757|2340972|FG002|Extension Phase|Lack of Efficacy|8
1183338|NCT00965757|2340973|FG003|Extension Phase|Lack of Efficacy|12
1183339|NCT00965757|2340970|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0
1183340|NCT00965757|2340971|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0
1183341|NCT00965757|2340972|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4
1183342|NCT00965757|2340973|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0
1183343|NCT00965757|2340970|FG000|Extension Phase|Lost to Follow-up|0
1183344|NCT00965757|2340971|FG001|Extension Phase|Lost to Follow-up|0
1183345|NCT00965757|2340972|FG002|Extension Phase|Lost to Follow-up|0
1183346|NCT00965757|2340973|FG003|Extension Phase|Lost to Follow-up|1
1183347|NCT00965757|2340970|FG000|Extension Phase|Ineligible after Taking Study Drug|0
1183348|NCT00965757|2340971|FG001|Extension Phase|Ineligible after Taking Study Drug|0
1183349|NCT00965757|2340972|FG002|Extension Phase|Ineligible after Taking Study Drug|3
1183350|NCT00965757|2340973|FG003|Extension Phase|Ineligible after Taking Study Drug|3
1183351|NCT00965757|2340970|FG000|Extension Phase|Protocol Violation|0
1183352|NCT00965757|2340971|FG001|Extension Phase|Protocol Violation|0
1183353|NCT00965757|2340972|FG002|Extension Phase|Protocol Violation|0
1183354|NCT00965757|2340973|FG003|Extension Phase|Protocol Violation|1
1183355|NCT00965757|2340970|FG000|Extension Phase|Other|0
1183356|NCT00965757|2340971|FG001|Extension Phase|Other|0
1183357|NCT00965757|2340972|FG002|Extension Phase|Other|2
1183358|NCT00965757|2340973|FG003|Extension Phase|Other|1
1183359|NCT00928447|2340981|FG000|Overall Study|Withdrawal by Subject|1
1183360|NCT00928447|2340981|FG000|Overall Study|Investigator's decision|1
1183361|NCT00893789|2340989|FG000|Overall Study|Withdrawal by Subject|3
1183362|NCT00893789|2340990|FG001|Overall Study|Withdrawal by Subject|1
1183363|NCT00893789|2340991|FG002|Overall Study|Withdrawal by Subject|3
1183364|NCT00893789|2340992|FG003|Overall Study|Withdrawal by Subject|1
1183365|NCT00893789|2340989|FG000|Overall Study|Noncompliance With Study Drug|1
1183366|NCT00893789|2340990|FG001|Overall Study|Noncompliance With Study Drug|0
1183367|NCT00893789|2340991|FG002|Overall Study|Noncompliance With Study Drug|1
1183368|NCT00893789|2340992|FG003|Overall Study|Noncompliance With Study Drug|2
1183369|NCT00893789|2340989|FG000|Overall Study|Noncompliance With Study Procedures|1
1183370|NCT00893789|2340990|FG001|Overall Study|Noncompliance With Study Procedures|0
1183371|NCT00893789|2340991|FG002|Overall Study|Noncompliance With Study Procedures|0
1183372|NCT00893789|2340992|FG003|Overall Study|Noncompliance With Study Procedures|0
1183373|NCT00893789|2340989|FG000|Overall Study|Taking Excluded Concomitant Medication|1
1183374|NCT00893789|2340990|FG001|Overall Study|Taking Excluded Concomitant Medication|0
1183375|NCT00893789|2340991|FG002|Overall Study|Taking Excluded Concomitant Medication|1
1183376|NCT00893789|2340992|FG003|Overall Study|Taking Excluded Concomitant Medication|0
1183377|NCT00893789|2340989|FG000|Overall Study|Adverse Event|0
1183378|NCT00893789|2340990|FG001|Overall Study|Adverse Event|2
1183379|NCT00893789|2340991|FG002|Overall Study|Adverse Event|1
1183380|NCT00893789|2340992|FG003|Overall Study|Adverse Event|5
1183381|NCT00893789|2340989|FG000|Overall Study|Protocol Violation|0
1183382|NCT00893789|2340990|FG001|Overall Study|Protocol Violation|1
1183383|NCT00893789|2340991|FG002|Overall Study|Protocol Violation|1
1183384|NCT00893789|2340992|FG003|Overall Study|Protocol Violation|4
1183385|NCT00893789|2340989|FG000|Overall Study|Lost to Follow-up|0
1183386|NCT00893789|2340990|FG001|Overall Study|Lost to Follow-up|0
1183387|NCT00893789|2340991|FG002|Overall Study|Lost to Follow-up|0
1183388|NCT00893789|2340992|FG003|Overall Study|Lost to Follow-up|1
877603|NCT00570687|1840300|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877604|NCT00570687|1840301|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877605|NCT00570687|1840302|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
877606|NCT00570687|1840303|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
877607|NCT00570687|1840304|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
877608|NCT00570687|1840305|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1183389|NCT03933449|2341012|FG000|Overall Study|Adverse Event|6
1183390|NCT03933449|2341013|FG001|Overall Study|Adverse Event|4
1183391|NCT03933449|2341012|FG000|Overall Study|Death|36
1183392|NCT03933449|2341013|FG001|Overall Study|Death|51
1183393|NCT03933449|2341012|FG000|Overall Study|Ongoing in Study|20
1183394|NCT03933449|2341013|FG001|Overall Study|Ongoing in Study|6
1183395|NCT03901144|2341019|FG000|Overall Study|Lost to Follow-up|1
1183396|NCT03901144|2341020|FG001|Overall Study|Lost to Follow-up|1
877609|NCT00570687|1840306|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
877610|NCT00570687|1840307|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
877611|NCT00570687|1840298|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877612|NCT00570687|1840299|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877613|NCT00570687|1840300|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877614|NCT00570687|1840301|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877615|NCT00570687|1840302|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877616|NCT00570687|1840303|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877617|NCT00570687|1840304|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877618|NCT00570687|1840305|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877619|NCT00570687|1840306|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
877620|NCT00570687|1840307|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877621|NCT00570687|1840298|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877622|NCT00570687|1840299|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877623|NCT00570687|1840300|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877624|NCT00570687|1840301|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877625|NCT00570687|1840302|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877626|NCT00570687|1840303|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877627|NCT00570687|1840304|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
877628|NCT00570687|1840305|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877629|NCT00570687|1840306|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877630|NCT00570687|1840307|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
877631|NCT00570713|1840327|FG000|Overall Study|Adverse Event|16
877632|NCT00570713|1840328|FG001|Overall Study|Adverse Event|9
877633|NCT00570713|1840327|FG000|Overall Study|Death|7
877634|NCT00570713|1840328|FG001|Overall Study|Death|7
877635|NCT00570713|1840327|FG000|Overall Study|Lack of Efficacy|40
877636|NCT00570713|1840328|FG001|Overall Study|Lack of Efficacy|49
877637|NCT00570713|1840327|FG000|Overall Study|Physician Decision|2
877638|NCT00570713|1840328|FG001|Overall Study|Physician Decision|2
877639|NCT00570713|1840327|FG000|Overall Study|Withdrawal by Subject|3
877640|NCT00570713|1840328|FG001|Overall Study|Withdrawal by Subject|3
877641|NCT00570713|1840327|FG000|Overall Study|Discontinuation of Study by the Sponsor|10
877642|NCT00570713|1840328|FG001|Overall Study|Discontinuation of Study by the Sponsor|7
877643|NCT00570739|1840338|FG000|Overall Study|Adverse Event|8
877644|NCT00570739|1840339|FG001|Overall Study|Adverse Event|6
877645|NCT00570739|1840340|FG002|Overall Study|Adverse Event|2
877646|NCT00570739|1840341|FG003|Overall Study|Adverse Event|2
877647|NCT00570739|1840338|FG000|Overall Study|Lost to Follow-up|4
877648|NCT00570739|1840339|FG001|Overall Study|Lost to Follow-up|5
877649|NCT00570739|1840340|FG002|Overall Study|Lost to Follow-up|4
877650|NCT00570739|1840341|FG003|Overall Study|Lost to Follow-up|1
877651|NCT00570739|1840338|FG000|Overall Study|Physician Decision|1
877652|NCT00570739|1840339|FG001|Overall Study|Physician Decision|1
877653|NCT00570739|1840340|FG002|Overall Study|Physician Decision|0
877654|NCT00570739|1840341|FG003|Overall Study|Physician Decision|0
877655|NCT00570739|1840338|FG000|Overall Study|Withdrawal by Subject|7
877656|NCT00570739|1840339|FG001|Overall Study|Withdrawal by Subject|7
877657|NCT00570739|1840340|FG002|Overall Study|Withdrawal by Subject|3
877658|NCT00570739|1840341|FG003|Overall Study|Withdrawal by Subject|5
877659|NCT00570739|1840338|FG000|Overall Study|Required restricted medication|0
877660|NCT00570739|1840339|FG001|Overall Study|Required restricted medication|0
877661|NCT00570739|1840340|FG002|Overall Study|Required restricted medication|1
877662|NCT00570739|1840341|FG003|Overall Study|Required restricted medication|0
877663|NCT00570739|1840338|FG000|Overall Study|Met discontinuation criteria|1
877664|NCT00570739|1840339|FG001|Overall Study|Met discontinuation criteria|0
877665|NCT00570739|1840340|FG002|Overall Study|Met discontinuation criteria|1
877666|NCT00570739|1840341|FG003|Overall Study|Met discontinuation criteria|1
877667|NCT00570739|1840338|FG000|Overall Study|Other|0
877668|NCT00570739|1840339|FG001|Overall Study|Other|2
877669|NCT00570739|1840340|FG002|Overall Study|Other|5
877670|NCT00570739|1840341|FG003|Overall Study|Other|3
877671|NCT00570765|1840374|FG000|DB Phase|Withdrawal by Subject|1
877672|NCT00570765|1840375|FG001|DB Phase|Withdrawal by Subject|0
1183397|NCT03901144|2341021|FG002|Overall Study|Lost to Follow-up|1
1183398|NCT03901144|2341022|FG003|Overall Study|Lost to Follow-up|1
1183399|NCT03461211|2341047|FG000|Overall Study|Adverse Event|1
1183400|NCT03461211|2341048|FG001|Overall Study|Adverse Event|1
1183401|NCT03461211|2341047|FG000|Overall Study|Lack of Efficacy|0
1183402|NCT03461211|2341048|FG001|Overall Study|Lack of Efficacy|1
1183403|NCT03282123|2341056|FG000|Overall Study|Withdrawal by Subject|5
1183404|NCT03276780|2341063|FG000|Overall Study|Withdrawal by Subject|5
1183405|NCT03276780|2341064|FG001|Overall Study|Withdrawal by Subject|3
1183406|NCT03276780|2341063|FG000|Overall Study|Lost to Follow-up|3
1183407|NCT03276780|2341064|FG001|Overall Study|Lost to Follow-up|5
1183408|NCT03276780|2341063|FG000|Overall Study|Moved out of state|1
1183409|NCT03276780|2341064|FG001|Overall Study|Moved out of state|1
1183410|NCT03276780|2341063|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1
1183411|NCT03276780|2341064|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0
1183412|NCT03276780|2341063|FG000|Overall Study|No show to appointments after baseline through Week 5|8
1183413|NCT03276780|2341064|FG001|Overall Study|No show to appointments after baseline through Week 5|1
1183414|NCT03219333|2341074|FG000|Overall Study|Withdrawal by Subject|8
1183415|NCT03219333|2341075|FG001|Overall Study|Withdrawal by Subject|3
1183416|NCT03219333|2341074|FG000|Overall Study|Lost to Follow-up|1
1183417|NCT03219333|2341075|FG001|Overall Study|Lost to Follow-up|0
1183418|NCT03219333|2341074|FG000|Overall Study|Death|94
877673|NCT00570765|1840376|FG002|DB Phase|Withdrawal by Subject|0
877674|NCT00570765|1840377|FG003|DB Phase|Withdrawal by Subject|0
877675|NCT00570765|1840374|FG000|DB Phase|Protocol Violation|0
877676|NCT00570765|1840375|FG001|DB Phase|Protocol Violation|1
877677|NCT00570765|1840376|FG002|DB Phase|Protocol Violation|0
877678|NCT00570765|1840377|FG003|DB Phase|Protocol Violation|0
877679|NCT00570765|1840374|FG000|DB Phase|Adverse Event|3
877680|NCT00570765|1840375|FG001|DB Phase|Adverse Event|6
877681|NCT00570765|1840376|FG002|DB Phase|Adverse Event|0
877682|NCT00570765|1840377|FG003|DB Phase|Adverse Event|0
877683|NCT00570765|1840374|FG000|DB Phase|Did Not Receive Study Drug|0
877684|NCT00570765|1840375|FG001|DB Phase|Did Not Receive Study Drug|0
877685|NCT00570765|1840376|FG002|DB Phase|Did Not Receive Study Drug|1
877686|NCT00570765|1840377|FG003|DB Phase|Did Not Receive Study Drug|0
877687|NCT00570765|1840374|FG000|LTSE Phase|Withdrawal by Subject|0
877688|NCT00570765|1840375|FG001|LTSE Phase|Withdrawal by Subject|0
877689|NCT00570765|1840376|FG002|LTSE Phase|Withdrawal by Subject|0
877690|NCT00570765|1840377|FG003|LTSE Phase|Withdrawal by Subject|1
877691|NCT00570765|1840374|FG000|LTSE Phase|Adverse Event|0
877692|NCT00570765|1840375|FG001|LTSE Phase|Adverse Event|0
877693|NCT00570765|1840376|FG002|LTSE Phase|Adverse Event|0
877694|NCT00570765|1840377|FG003|LTSE Phase|Adverse Event|7
877695|NCT00570765|1840374|FG000|LTSE Phase|Physician Decision|0
877696|NCT00570765|1840375|FG001|LTSE Phase|Physician Decision|0
877697|NCT00570765|1840376|FG002|LTSE Phase|Physician Decision|0
877698|NCT00570765|1840377|FG003|LTSE Phase|Physician Decision|4
877699|NCT00570778|1840388|FG000|Overall Study|Protocol deviation|2
877700|NCT00570778|1840389|FG001|Overall Study|Protocol deviation|1
877701|NCT00570778|1840390|FG002|Overall Study|Protocol deviation|2
877702|NCT00570778|1840391|FG003|Overall Study|Protocol deviation|2
877703|NCT00570778|1840388|FG000|Overall Study|Adverse Event|0
877704|NCT00570778|1840389|FG001|Overall Study|Adverse Event|1
877705|NCT00570778|1840390|FG002|Overall Study|Adverse Event|4
877706|NCT00570778|1840391|FG003|Overall Study|Adverse Event|1
877707|NCT00570778|1840388|FG000|Overall Study|Subject withdrew consent|0
877708|NCT00570778|1840389|FG001|Overall Study|Subject withdrew consent|1
877709|NCT00570778|1840390|FG002|Overall Study|Subject withdrew consent|0
877710|NCT00570778|1840391|FG003|Overall Study|Subject withdrew consent|1
877711|NCT00570778|1840388|FG000|Overall Study|Abnormal test procedure|1
877712|NCT00570778|1840389|FG001|Overall Study|Abnormal test procedure|0
877713|NCT00570778|1840390|FG002|Overall Study|Abnormal test procedure|0
877714|NCT00570778|1840391|FG003|Overall Study|Abnormal test procedure|0
877715|NCT00570778|1840388|FG000|Overall Study|Unsatisfactory therapeutic effect|1
877716|NCT00570778|1840389|FG001|Overall Study|Unsatisfactory therapeutic effect|0
877717|NCT00570778|1840390|FG002|Overall Study|Unsatisfactory therapeutic effect|0
877718|NCT00570778|1840391|FG003|Overall Study|Unsatisfactory therapeutic effect|0
877719|NCT00570778|1840388|FG000|Overall Study|Lost to Follow-up|0
877720|NCT00570778|1840389|FG001|Overall Study|Lost to Follow-up|0
877721|NCT00570778|1840390|FG002|Overall Study|Lost to Follow-up|1
877722|NCT00570778|1840391|FG003|Overall Study|Lost to Follow-up|0
877723|NCT00570778|1840388|FG000|Overall Study|Subject no longer requires study drug|0
877724|NCT00570778|1840389|FG001|Overall Study|Subject no longer requires study drug|1
877725|NCT00570778|1840390|FG002|Overall Study|Subject no longer requires study drug|0
877726|NCT00570778|1840391|FG003|Overall Study|Subject no longer requires study drug|0
877727|NCT00570908|1840401|FG000|Overall Study|Adverse Event|5
877728|NCT00570908|1840401|FG000|Overall Study|Withdrawal by Subject|2
877729|NCT00570921|1840405|FG000|Overall Study|Protocol Violation|1
877730|NCT00570921|1840405|FG000|Overall Study|Physician Decision|1
877731|NCT00571038|1840420|FG000|Overall Study|Lost to Follow-up|1
877732|NCT00571038|1840421|FG001|Overall Study|Lost to Follow-up|4
877733|NCT00571038|1840420|FG000|Overall Study|Death|7
877734|NCT00571038|1840421|FG001|Overall Study|Death|5
877735|NCT00571038|1840420|FG000|Overall Study|Withdrawal by Subject|1
1183419|NCT03219333|2341075|FG001|Overall Study|Death|44
1183420|NCT03219333|2341074|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
1183421|NCT03219333|2341075|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
1183422|NCT03100149|2341097|FG000|Overall Study|Adverse Event|0
1183423|NCT03100149|2341098|FG001|Overall Study|Adverse Event|1
1183424|NCT03100149|2341099|FG002|Overall Study|Adverse Event|0
1183425|NCT03100149|2341097|FG000|Overall Study|Participant Moved out of Country|0
1183426|NCT03100149|2341098|FG001|Overall Study|Participant Moved out of Country|0
1183427|NCT03100149|2341099|FG002|Overall Study|Participant Moved out of Country|1
1183428|NCT03100149|2341097|FG000|Overall Study|Withdrawal by Subject|0
1183429|NCT03100149|2341098|FG001|Overall Study|Withdrawal by Subject|3
1183430|NCT03100149|2341099|FG002|Overall Study|Withdrawal by Subject|1
1183431|NCT03050814|2341110|FG000|Overall Study|Screen failures|0
1183432|NCT03050814|2341111|FG001|Overall Study|Screen failures|0
1183433|NCT03050814|2341112|FG002|Overall Study|Screen failures|4
1183434|NCT02797262|2341129|FG000|Overall Study|Withdrawal by Subject|5
1183435|NCT02797262|2341130|FG001|Overall Study|Withdrawal by Subject|1
1183436|NCT02797262|2341129|FG000|Overall Study|Lost to Follow-up|10
1183437|NCT02797262|2341130|FG001|Overall Study|Lost to Follow-up|7
1183438|NCT02797262|2341129|FG000|Overall Study|Death|1
1183439|NCT02797262|2341130|FG001|Overall Study|Death|2
1183440|NCT02797262|2341129|FG000|Overall Study|Adverse Event|1
1183441|NCT02797262|2341130|FG001|Overall Study|Adverse Event|0
1183442|NCT02797262|2341129|FG000|Overall Study|COVID-19|2
1183443|NCT02797262|2341130|FG001|Overall Study|COVID-19|1
1183444|NCT02797262|2341129|FG000|Overall Study|Out-of-country|1
1183445|NCT02797262|2341130|FG001|Overall Study|Out-of-country|0
1183460|NCT02409368|2341168|FG000|Overall Study|Adverse event unrelated to study drug|16
1183461|NCT02409368|2341169|FG001|Overall Study|Adverse event unrelated to study drug|42
1183462|NCT02409368|2341170|FG002|Overall Study|Adverse event unrelated to study drug|10
1183463|NCT02409368|2341168|FG000|Overall Study|Death|5
1183464|NCT02409368|2341169|FG001|Overall Study|Death|17
1183465|NCT02409368|2341170|FG002|Overall Study|Death|5
1183466|NCT02409368|2341168|FG000|Overall Study|Disease Progression|101
1183467|NCT02409368|2341169|FG001|Overall Study|Disease Progression|346
1183468|NCT02409368|2341170|FG002|Overall Study|Disease Progression|63
1183469|NCT02409368|2341168|FG000|Overall Study|Lost to Follow-up|1
1183470|NCT02409368|2341169|FG001|Overall Study|Lost to Follow-up|5
1183471|NCT02409368|2341170|FG002|Overall Study|Lost to Follow-up|0
1183472|NCT02409368|2341168|FG000|Overall Study|maximum clinical benefit|3
1183473|NCT02409368|2341169|FG001|Overall Study|maximum clinical benefit|8
1183474|NCT02409368|2341170|FG002|Overall Study|maximum clinical benefit|1
1183475|NCT02409368|2341168|FG000|Overall Study|poor/non compliant|0
1183476|NCT02409368|2341169|FG001|Overall Study|poor/non compliant|2
1183477|NCT02409368|2341170|FG002|Overall Study|poor/non compliant|2
1183478|NCT02409368|2341168|FG000|Overall Study|study drug toxicity|12
1183479|NCT02409368|2341169|FG001|Overall Study|study drug toxicity|35
1183480|NCT02409368|2341170|FG002|Overall Study|study drug toxicity|6
1183481|NCT02409368|2341168|FG000|Overall Study|no longer meets study criteria|3
1183482|NCT02409368|2341169|FG001|Overall Study|no longer meets study criteria|9
1183483|NCT02409368|2341170|FG002|Overall Study|no longer meets study criteria|3
1183484|NCT02409368|2341168|FG000|Overall Study|Participant request to discontinue|3
1183485|NCT02409368|2341169|FG001|Overall Study|Participant request to discontinue|3
1183486|NCT02409368|2341170|FG002|Overall Study|Participant request to discontinue|3
1183487|NCT02409368|2341168|FG000|Overall Study|Participant withdrew consent|2
1183488|NCT02409368|2341169|FG001|Overall Study|Participant withdrew consent|4
1183489|NCT02409368|2341170|FG002|Overall Study|Participant withdrew consent|3
1183490|NCT02409368|2341168|FG000|Overall Study|Other Reasons|2
877736|NCT00571038|1840421|FG001|Overall Study|Withdrawal by Subject|3
877737|NCT00571038|1840420|FG000|Overall Study|Moved out of state|2
877738|NCT00571038|1840421|FG001|Overall Study|Moved out of state|2
1183491|NCT02409368|2341169|FG001|Overall Study|Other Reasons|17
1183492|NCT02409368|2341170|FG002|Overall Study|Other Reasons|3
1183493|NCT02409368|2341168|FG000|Overall Study|Not Reported|0
1183494|NCT02409368|2341169|FG001|Overall Study|Not Reported|1
1183495|NCT02409368|2341170|FG002|Overall Study|Not Reported|0
1183496|NCT02277119|2341191|FG000|Overall Study|Lack of Efficacy|1
1183497|NCT02277119|2341192|FG001|Overall Study|Lack of Efficacy|1
1183498|NCT02277119|2341193|FG002|Overall Study|Lack of Efficacy|1
1183499|NCT02277119|2341191|FG000|Overall Study|Protocol Violation|2
1183500|NCT02277119|2341192|FG001|Overall Study|Protocol Violation|3
1183501|NCT02277119|2341193|FG002|Overall Study|Protocol Violation|7
1183502|NCT02220894|2341203|FG000|Overall Study|Adverse Event|118
1183503|NCT02220894|2341204|FG001|Overall Study|Adverse Event|70
1183504|NCT02220894|2341203|FG000|Overall Study|Death|252
1183505|NCT02220894|2341204|FG001|Overall Study|Death|368
1183506|NCT02220894|2341203|FG000|Overall Study|Lost to Follow-up|0
1183507|NCT02220894|2341204|FG001|Overall Study|Lost to Follow-up|2
1183508|NCT02220894|2341203|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1183509|NCT02220894|2341204|FG001|Overall Study|Withdrawal by Parent/Guardian|1
1183510|NCT02220894|2341203|FG000|Overall Study|Withdrawal by Subject|2
1183511|NCT02220894|2341204|FG001|Overall Study|Withdrawal by Subject|13
1183512|NCT02220894|2341203|FG000|Overall Study|Ongoing in Study|265
1183513|NCT02220894|2341204|FG001|Overall Study|Ongoing in Study|183
877739|NCT00571064|1840427|FG000|Overall Study|Adverse Event|13
877740|NCT00571064|1840427|FG000|Overall Study|Protocol Violation|4
877741|NCT00571064|1840427|FG000|Overall Study|Withdrawal by Subject|2
877742|NCT00571064|1840427|FG000|Overall Study|Other|2
877743|NCT00571103|1840432|FG000|Overall Study|Withdrawal by Subject|1
877744|NCT00571103|1840432|FG000|Overall Study|Lost to Follow-up|1
877745|NCT00571519|1840484|FG000|Overall Study|Subject withdrew consent|0
877746|NCT00571519|1840485|FG001|Overall Study|Subject withdrew consent|1
877747|NCT00571519|1840486|FG002|Overall Study|Subject withdrew consent|0
1183534|NCT01721759|2341368|FG000|Overall Study|Disease progression|78
1183535|NCT01721759|2341368|FG000|Overall Study|Study drug toxicity|14
1183536|NCT01721759|2341368|FG000|Overall Study|Adverse event unrelated to study drug|9
1183537|NCT01721759|2341368|FG000|Overall Study|Withdrawal by Subject|1
1183538|NCT01285102|2341381|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4
1183539|NCT01026220|2341385|FG000|Induction|Death|1
1183540|NCT01026220|2341386|FG001|Induction|Death|0
1183541|NCT01026220|2341387|FG002|Induction|Death|0
1183542|NCT01026220|2341385|FG000|Induction|Lack of Efficacy|2
1183543|NCT01026220|2341386|FG001|Induction|Lack of Efficacy|0
1183544|NCT01026220|2341387|FG002|Induction|Lack of Efficacy|0
1183545|NCT01026220|2341385|FG000|Induction|Physician Decision|12
1183546|NCT01026220|2341386|FG001|Induction|Physician Decision|0
1183547|NCT01026220|2341387|FG002|Induction|Physician Decision|0
1183548|NCT01026220|2341385|FG000|Induction|Withdrawal by Subject|9
1183549|NCT01026220|2341386|FG001|Induction|Withdrawal by Subject|0
1183550|NCT01026220|2341387|FG002|Induction|Withdrawal by Subject|0
1183551|NCT01026220|2341385|FG000|Induction|Ineligible|1
1183552|NCT01026220|2341386|FG001|Induction|Ineligible|0
1183553|NCT01026220|2341387|FG002|Induction|Ineligible|0
1183554|NCT01026220|2341385|FG000|Consolidation Maintenance|Death|0
1183555|NCT01026220|2341386|FG001|Consolidation Maintenance|Death|1
1183556|NCT01026220|2341387|FG002|Consolidation Maintenance|Death|0
1183557|NCT01026220|2341385|FG000|Consolidation Maintenance|Lack of Efficacy|0
1183558|NCT01026220|2341386|FG001|Consolidation Maintenance|Lack of Efficacy|1
1183559|NCT01026220|2341387|FG002|Consolidation Maintenance|Lack of Efficacy|1
1183560|NCT01026220|2341385|FG000|Consolidation Maintenance|Physician Decision|0
1183561|NCT01026220|2341386|FG001|Consolidation Maintenance|Physician Decision|2
1183562|NCT01026220|2341387|FG002|Consolidation Maintenance|Physician Decision|7
1183563|NCT01026220|2341385|FG000|Consolidation Maintenance|Withdrawal by Subject|0
1183564|NCT01026220|2341386|FG001|Consolidation Maintenance|Withdrawal by Subject|2
1183565|NCT01026220|2341387|FG002|Consolidation Maintenance|Withdrawal by Subject|6
1183566|NCT03877926|2341487|FG000|Overall Study|Adverse Event|1
1183567|NCT03877926|2341488|FG001|Overall Study|Adverse Event|0
1183568|NCT03877926|2341489|FG002|Overall Study|Adverse Event|0
1183569|NCT03877926|2341490|FG003|Overall Study|Adverse Event|0
1183570|NCT03877926|2341487|FG000|Overall Study|Death|2
1183571|NCT03877926|2341488|FG001|Overall Study|Death|2
1183572|NCT03877926|2341489|FG002|Overall Study|Death|2
1183573|NCT03877926|2341490|FG003|Overall Study|Death|0
1183574|NCT03877926|2341487|FG000|Overall Study|Lost to Follow-up|41
1183575|NCT03877926|2341488|FG001|Overall Study|Lost to Follow-up|52
1183576|NCT03877926|2341489|FG002|Overall Study|Lost to Follow-up|45
1183577|NCT03877926|2341490|FG003|Overall Study|Lost to Follow-up|17
1183578|NCT03877926|2341487|FG000|Overall Study|Physician Decision|2
1183579|NCT03877926|2341488|FG001|Overall Study|Physician Decision|0
1183580|NCT03877926|2341489|FG002|Overall Study|Physician Decision|2
1183581|NCT03877926|2341490|FG003|Overall Study|Physician Decision|0
1183582|NCT03877926|2341487|FG000|Overall Study|Withdrawal by Subject|18
1183583|NCT03877926|2341488|FG001|Overall Study|Withdrawal by Subject|21
1183584|NCT03877926|2341489|FG002|Overall Study|Withdrawal by Subject|12
1183585|NCT03877926|2341490|FG003|Overall Study|Withdrawal by Subject|4
1183586|NCT03877926|2341487|FG000|Overall Study|Other - Various|4
1183587|NCT03877926|2341488|FG001|Overall Study|Other - Various|1
1183588|NCT03877926|2341489|FG002|Overall Study|Other - Various|1
1183589|NCT03877926|2341490|FG003|Overall Study|Other - Various|0
1183590|NCT03877926|2341487|FG000|Overall Study|Not Treated|3
1183591|NCT03877926|2341488|FG001|Overall Study|Not Treated|1
1183592|NCT03877926|2341489|FG002|Overall Study|Not Treated|1
1183593|NCT03877926|2341490|FG003|Overall Study|Not Treated|0
1183594|NCT03862807|2341513|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1
1183595|NCT03857867|2341517|FG000|Overall Study|Physician Decision|1
1183596|NCT03691571|2341524|FG000|Overall Study|Withdrawal by Subject|9
1183597|NCT03691571|2341525|FG001|Overall Study|Withdrawal by Subject|2
1183598|NCT03436199|2341535|FG000|Overall Study|Adverse Event|15
1183599|NCT03436199|2341536|FG001|Overall Study|Adverse Event|40
1183600|NCT03436199|2341537|FG002|Overall Study|Adverse Event|7
1183601|NCT03436199|2341535|FG000|Overall Study|Withdrawal by Subject|4
1183602|NCT03436199|2341536|FG001|Overall Study|Withdrawal by Subject|10
1183603|NCT03436199|2341537|FG002|Overall Study|Withdrawal by Subject|3
1183604|NCT03436199|2341535|FG000|Overall Study|Lost to Follow-up|1
1183605|NCT03436199|2341536|FG001|Overall Study|Lost to Follow-up|0
1183606|NCT03436199|2341537|FG002|Overall Study|Lost to Follow-up|2
1183607|NCT03436199|2341535|FG000|Overall Study|Protocol Violation|1
1183608|NCT03436199|2341536|FG001|Overall Study|Protocol Violation|1
1183609|NCT03436199|2341537|FG002|Overall Study|Protocol Violation|0
1183610|NCT03436199|2341535|FG000|Overall Study|Physician Decision|0
1183611|NCT03436199|2341536|FG001|Overall Study|Physician Decision|1
1183612|NCT03436199|2341537|FG002|Overall Study|Physician Decision|0
1183613|NCT03436199|2341535|FG000|Overall Study|Could not return to clinic|1
1183614|NCT03436199|2341536|FG001|Overall Study|Could not return to clinic|0
1183615|NCT03436199|2341537|FG002|Overall Study|Could not return to clinic|0
1183616|NCT03436199|2341535|FG000|Overall Study|Withdrawn per physician|0
1183617|NCT03436199|2341536|FG001|Overall Study|Withdrawn per physician|1
1183618|NCT03436199|2341537|FG002|Overall Study|Withdrawn per physician|0
1183619|NCT03417102|2341547|FG000|Overall Study|Adverse Event|0
1183620|NCT03417102|2341548|FG001|Overall Study|Adverse Event|1
1183621|NCT03417102|2341547|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0
1183622|NCT03417102|2341548|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3
1183623|NCT03417102|2341547|FG000|Overall Study|Other|0
1183624|NCT03417102|2341548|FG001|Overall Study|Other|1
1183625|NCT03250273|2341569|FG000|Overall Study|Disease Progression|2
1183626|NCT03250273|2341570|FG001|Overall Study|Disease Progression|9
1183627|NCT03250273|2341569|FG000|Overall Study|Adverse Event|0
1183628|NCT03250273|2341570|FG001|Overall Study|Adverse Event|1
1183629|NCT03250273|2341569|FG000|Overall Study|Death|0
1183630|NCT03250273|2341570|FG001|Overall Study|Death|1
877748|NCT00571519|1840487|FG003|Overall Study|Subject withdrew consent|2
877749|NCT00571519|1840488|FG004|Overall Study|Subject withdrew consent|1
877750|NCT00571519|1840489|FG005|Overall Study|Subject withdrew consent|1
877751|NCT00571519|1840490|FG006|Overall Study|Subject withdrew consent|2
877752|NCT00571519|1840484|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1
877753|NCT00571519|1840485|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0
877754|NCT00571519|1840486|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1
877755|NCT00571519|1840487|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1
877756|NCT00571519|1840488|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0
877757|NCT00571519|1840489|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0
877758|NCT00571519|1840490|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0
1006586|NCT01468701|2025295|FG010|Overall Study|Other reasons than listed|433
1183631|NCT03250273|2341569|FG000|Overall Study|Failed to Maintain Eligibility|0
1183632|NCT03250273|2341570|FG001|Overall Study|Failed to Maintain Eligibility|1
1183633|NCT03217136|2341578|FG000|Overall Study|Lost to Follow-up|2
1183634|NCT03217136|2341579|FG001|Overall Study|Lost to Follow-up|1
1183635|NCT03217136|2341578|FG000|Overall Study|Site Randomized Participant in Error|0
1183636|NCT03217136|2341579|FG001|Overall Study|Site Randomized Participant in Error|1
1183637|NCT03217136|2341578|FG000|Overall Study|Did Not Meet Criteria after Randomization|0
1183638|NCT03217136|2341579|FG001|Overall Study|Did Not Meet Criteria after Randomization|1
1183639|NCT03217136|2341578|FG000|Overall Study|Dispensing Error|1
1183640|NCT03217136|2341579|FG001|Overall Study|Dispensing Error|0
1183641|NCT03217136|2341578|FG000|Overall Study|Withdrawal by Parent/Guardian|1
1183642|NCT03217136|2341579|FG001|Overall Study|Withdrawal by Parent/Guardian|0
1183643|NCT03181542|2341587|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1
1183644|NCT03181542|2341588|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0
1183645|NCT02983617|2341596|FG000|Overall Study|Adverse Event|0
1183646|NCT02983617|2341597|FG001|Overall Study|Adverse Event|7
1183647|NCT02983617|2341596|FG000|Overall Study|Death|0
1183648|NCT02983617|2341597|FG001|Overall Study|Death|1
1183649|NCT02983617|2341596|FG000|Overall Study|Investigator's Discretion|0
1183650|NCT02983617|2341597|FG001|Overall Study|Investigator's Discretion|1
1183651|NCT02649946|2341631|FG000|Overall Study|Withdrawal by Subject|1
1183652|NCT02649946|2341632|FG001|Overall Study|Withdrawal by Subject|1
1183653|NCT02649946|2341631|FG000|Overall Study|Death|7
1183654|NCT02649946|2341632|FG001|Overall Study|Death|9
1183655|NCT02649946|2341631|FG000|Overall Study|Physician Decision|1
1183656|NCT02649946|2341632|FG001|Overall Study|Physician Decision|0
1183657|NCT02649946|2341631|FG000|Overall Study|Lost to Follow-up|2
1183658|NCT02649946|2341632|FG001|Overall Study|Lost to Follow-up|1
1183659|NCT02649946|2341631|FG000|Overall Study|Erroneously enrolled|1
1183660|NCT02649946|2341632|FG001|Overall Study|Erroneously enrolled|0
1183661|NCT02649946|2341631|FG000|Overall Study|Missed 6-month follow-up visit|0
1183662|NCT02649946|2341632|FG001|Overall Study|Missed 6-month follow-up visit|4
1183683|NCT02431247|2341660|FG000|BL to EOE-Test and BL to Switch- Control|Other|11
1183684|NCT02431247|2341661|FG001|BL to EOE-Test and BL to Switch- Control|Other|2
1183685|NCT02431247|2341662|FG002|BL to EOE-Test and BL to Switch- Control|Other|0
1183686|NCT02431247|2341660|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17
1183687|NCT02431247|2341661|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8
1183688|NCT02431247|2341662|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0
1183689|NCT02431247|2341660|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9
1183690|NCT02431247|2341661|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4
1183691|NCT02431247|2341662|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0
1183692|NCT02431247|2341660|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
1183693|NCT02431247|2341661|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
1183694|NCT02431247|2341662|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0
1183695|NCT02431247|2341660|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12
1183696|NCT02431247|2341661|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16
1183697|NCT02431247|2341662|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0
1183698|NCT02431247|2341660|FG000|BL to EOE-Test and BL to Switch- Control|Death|0
1183699|NCT02431247|2341661|FG001|BL to EOE-Test and BL to Switch- Control|Death|1
1183700|NCT02431247|2341662|FG002|BL to EOE-Test and BL to Switch- Control|Death|0
1183701|NCT02431247|2341660|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14
1183702|NCT02431247|2341661|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9
1183703|NCT02431247|2341662|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0
1183704|NCT02431247|2341660|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2
1183705|NCT02431247|2341661|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
1183706|NCT02431247|2341662|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
1183707|NCT02431247|2341660|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
1183708|NCT02431247|2341661|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
1183709|NCT02431247|2341662|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4
1183710|NCT02431247|2341660|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
1183711|NCT02431247|2341661|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
1183712|NCT02431247|2341662|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12
1183713|NCT02431247|2341660|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
1183714|NCT02431247|2341661|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
1183715|NCT02431247|2341662|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
1183716|NCT02431247|2341660|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
1183717|NCT02431247|2341661|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
1183718|NCT02431247|2341662|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5
1183719|NCT02431247|2341660|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
1183720|NCT02431247|2341661|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
1183721|NCT02431247|2341662|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
1183722|NCT02431247|2341660|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
1183723|NCT02431247|2341661|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
1183724|NCT02431247|2341662|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10
1183725|NCT02395666|2341676|FG000|Overall Study|Physician Decision|3
1183726|NCT02395666|2341677|FG001|Overall Study|Physician Decision|0
1183727|NCT02395666|2341676|FG000|Overall Study|Lost to Follow-up|1
1183728|NCT02395666|2341677|FG001|Overall Study|Lost to Follow-up|0
1183729|NCT02395666|2341676|FG000|Overall Study|Withdrawal by Subject|2
1183730|NCT02395666|2341677|FG001|Overall Study|Withdrawal by Subject|1
1183731|NCT02345850|2341690|FG000|Overall Study|Not transplanted|10
1183732|NCT02345850|2341691|FG001|Overall Study|Not transplanted|5
1183733|NCT02345850|2341692|FG002|Overall Study|Not transplanted|4
1183734|NCT02345850|2341690|FG000|Overall Study|Lost to Follow-up|2
1183735|NCT02345850|2341691|FG001|Overall Study|Lost to Follow-up|3
1183736|NCT02345850|2341692|FG002|Overall Study|Lost to Follow-up|2
1183737|NCT02345850|2341690|FG000|Overall Study|Withdrawal by Subject|1
1183738|NCT02345850|2341691|FG001|Overall Study|Withdrawal by Subject|0
1183739|NCT02345850|2341692|FG002|Overall Study|Withdrawal by Subject|0
1183740|NCT02343302|2341702|FG000|Overall Study|Physician Decision|1
1183741|NCT02343302|2341703|FG001|Overall Study|Physician Decision|1
1183742|NCT02281084|2341713|FG000|Overall Study|Adverse Event|1
1183743|NCT02281084|2341714|FG001|Overall Study|Adverse Event|0
1183744|NCT02281084|2341715|FG002|Overall Study|Adverse Event|0
1183745|NCT02281084|2341716|FG003|Overall Study|Adverse Event|0
1183746|NCT02281084|2341713|FG000|Overall Study|Withdrawal by Subject|1
1183747|NCT02281084|2341714|FG001|Overall Study|Withdrawal by Subject|2
1183748|NCT02281084|2341715|FG002|Overall Study|Withdrawal by Subject|0
1183749|NCT02281084|2341716|FG003|Overall Study|Withdrawal by Subject|0
1183750|NCT02281084|2341713|FG000|Overall Study|Death|20
1183751|NCT02281084|2341714|FG001|Overall Study|Death|16
1183752|NCT02281084|2341715|FG002|Overall Study|Death|3
1183753|NCT02281084|2341716|FG003|Overall Study|Death|5
1183754|NCT02281084|2341713|FG000|Overall Study|Physician Decision|0
1183755|NCT02281084|2341714|FG001|Overall Study|Physician Decision|0
1183756|NCT02281084|2341715|FG002|Overall Study|Physician Decision|1
1183757|NCT02281084|2341716|FG003|Overall Study|Physician Decision|0
1183758|NCT01464164|2341762|FG000|Overall Study|Screen failure|0
877759|NCT00571519|1840484|FG000|Overall Study|Therapeutic failure/lack of efficacy|0
877760|NCT00571519|1840485|FG001|Overall Study|Therapeutic failure/lack of efficacy|1
877761|NCT00571519|1840486|FG002|Overall Study|Therapeutic failure/lack of efficacy|0
877762|NCT00571519|1840487|FG003|Overall Study|Therapeutic failure/lack of efficacy|0
877763|NCT00571519|1840488|FG004|Overall Study|Therapeutic failure/lack of efficacy|0
877764|NCT00571519|1840489|FG005|Overall Study|Therapeutic failure/lack of efficacy|0
877765|NCT00571519|1840490|FG006|Overall Study|Therapeutic failure/lack of efficacy|0
877766|NCT00571519|1840484|FG000|Overall Study|Termination of study by Sponsor|2
877767|NCT00571519|1840485|FG001|Overall Study|Termination of study by Sponsor|7
877768|NCT00571519|1840486|FG002|Overall Study|Termination of study by Sponsor|10
877769|NCT00571519|1840487|FG003|Overall Study|Termination of study by Sponsor|24
877770|NCT00571519|1840488|FG004|Overall Study|Termination of study by Sponsor|8
877771|NCT00571519|1840489|FG005|Overall Study|Termination of study by Sponsor|9
877772|NCT00571519|1840490|FG006|Overall Study|Termination of study by Sponsor|22
877773|NCT00571519|1840484|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
877774|NCT00571519|1840485|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
877775|NCT00571519|1840486|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1
877776|NCT00571519|1840487|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
877777|NCT00571519|1840488|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
877778|NCT00571519|1840489|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
877779|NCT00571519|1840490|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
877780|NCT00571649|1840508|FG000|Treatment Period|Adverse Event|438
877781|NCT00571649|1840509|FG001|Treatment Period|Adverse Event|385
877782|NCT00571649|1840508|FG000|Treatment Period|Clinical endpoint reached|50
877783|NCT00571649|1840509|FG001|Treatment Period|Clinical endpoint reached|56
877784|NCT00571649|1840508|FG000|Treatment Period|Withdrawal by Subject|285
877785|NCT00571649|1840509|FG001|Treatment Period|Withdrawal by Subject|255
877786|NCT00571649|1840508|FG000|Treatment Period|Death|76
877787|NCT00571649|1840509|FG001|Treatment Period|Death|59
877788|NCT00571649|1840508|FG000|Treatment Period|Physician Decision|8
877789|NCT00571649|1840509|FG001|Treatment Period|Physician Decision|9
877790|NCT00571649|1840508|FG000|Treatment Period|Lost to Follow-up|43
877791|NCT00571649|1840509|FG001|Treatment Period|Lost to Follow-up|41
877792|NCT00571649|1840508|FG000|Treatment Period|Non-compliant with study medication|88
1183759|NCT01464164|2341763|FG001|Overall Study|Screen failure|1
1183760|NCT01464164|2341764|FG002|Overall Study|Screen failure|2
1183761|NCT01464164|2341765|FG003|Overall Study|Screen failure|0
1183762|NCT01464164|2341766|FG004|Overall Study|Screen failure|0
1183763|NCT01464164|2341767|FG005|Overall Study|Screen failure|0
1183764|NCT01464164|2341768|FG006|Overall Study|Screen failure|0
1183765|NCT01464164|2341762|FG000|Overall Study|Physician Decision|0
1183766|NCT01464164|2341763|FG001|Overall Study|Physician Decision|0
1183767|NCT01464164|2341764|FG002|Overall Study|Physician Decision|0
1183768|NCT01464164|2341765|FG003|Overall Study|Physician Decision|0
1183769|NCT01464164|2341766|FG004|Overall Study|Physician Decision|0
1183770|NCT01464164|2341767|FG005|Overall Study|Physician Decision|0
877793|NCT00571649|1840509|FG001|Treatment Period|Non-compliant with study medication|89
877794|NCT00571649|1840508|FG000|Treatment Period|Patient convenience|11
877795|NCT00571649|1840509|FG001|Treatment Period|Patient convenience|13
877796|NCT00571649|1840508|FG000|Treatment Period|Protocol Violation|90
877797|NCT00571649|1840509|FG001|Treatment Period|Protocol Violation|92
877798|NCT00571649|1840508|FG000|Treatment Period|Technical problems|3
877799|NCT00571649|1840509|FG001|Treatment Period|Technical problems|5
877800|NCT00571649|1840508|FG000|Follow-up Period|Adverse Event|46
877801|NCT00571649|1840509|FG001|Follow-up Period|Adverse Event|40
877802|NCT00571649|1840508|FG000|Follow-up Period|Clinical endpoint reached|5
1183771|NCT01464164|2341768|FG006|Overall Study|Physician Decision|2
1183772|NCT01111565|2341798|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3
1183773|NCT01111565|2341799|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
1183774|NCT01111565|2341800|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
1183775|NCT01111565|2341801|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
1183776|NCT01111565|2341802|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
1183777|NCT01111565|2341798|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1
1183778|NCT01111565|2341799|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0
1183779|NCT01111565|2341800|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0
1183780|NCT01111565|2341801|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0
1183781|NCT01111565|2341802|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0
1183782|NCT01111565|2341798|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58
1183783|NCT01111565|2341799|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
1183784|NCT01111565|2341800|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
1183785|NCT01111565|2341801|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
877803|NCT00571649|1840509|FG001|Follow-up Period|Clinical endpoint reached|2
877804|NCT00571649|1840508|FG000|Follow-up Period|Withdrawal by Subject|119
877805|NCT00571649|1840509|FG001|Follow-up Period|Withdrawal by Subject|115
877806|NCT00571649|1840508|FG000|Follow-up Period|Death|132
877807|NCT00571649|1840509|FG001|Follow-up Period|Death|133
877808|NCT00571649|1840508|FG000|Follow-up Period|Physician Decision|7
877809|NCT00571649|1840509|FG001|Follow-up Period|Physician Decision|13
877810|NCT00571649|1840508|FG000|Follow-up Period|Lost to Follow-up|95
877811|NCT00571649|1840509|FG001|Follow-up Period|Lost to Follow-up|92
877812|NCT00571649|1840508|FG000|Follow-up Period|Patient convenience|136
877813|NCT00571649|1840509|FG001|Follow-up Period|Patient convenience|121
877814|NCT00571649|1840508|FG000|Follow-up Period|Protocol Violation|5
877815|NCT00571649|1840509|FG001|Follow-up Period|Protocol Violation|12
877816|NCT00571662|1840515|FG000|Overall Study|Withdrawal by Subject|2
877817|NCT00571662|1840515|FG000|Overall Study|psychiatric instability|1
877818|NCT00571662|1840515|FG000|Overall Study|Adverse Event|5
877819|NCT00571688|1840523|FG000|Overall Study|Lost to Follow-up|3
877820|NCT00571688|1840524|FG001|Overall Study|Lost to Follow-up|6
877821|NCT00571688|1840523|FG000|Overall Study|subject did not tolerate Consta|1
877822|NCT00571688|1840524|FG001|Overall Study|subject did not tolerate Consta|0
877823|NCT00571688|1840523|FG000|Overall Study|subject moved out of the area|1
877824|NCT00571688|1840524|FG001|Overall Study|subject moved out of the area|0
877825|NCT00571701|1840532|FG000|First Intervention 12 Months|Withdrawal by Subject|2
877826|NCT00571701|1840533|FG001|First Intervention 12 Months|Withdrawal by Subject|1
877827|NCT00571701|1840532|FG000|First Intervention 12 Months|Death|1
877828|NCT00571701|1840533|FG001|First Intervention 12 Months|Death|0
877829|NCT00571701|1840532|FG000|Second Intervention 12 Months|Adverse Event|0
877830|NCT00571701|1840533|FG001|Second Intervention 12 Months|Adverse Event|1
877831|NCT00571701|1840532|FG000|Second Intervention 12 Months|Withdrawal by Subject|3
877832|NCT00571701|1840533|FG001|Second Intervention 12 Months|Withdrawal by Subject|0
877833|NCT00571948|1840559|FG000|Overall Study|Lost to Follow-up|2
877834|NCT00571948|1840560|FG001|Overall Study|Lost to Follow-up|0
877835|NCT00571948|1840559|FG000|Overall Study|Withdrawal by Subject|1
877836|NCT00571948|1840560|FG001|Overall Study|Withdrawal by Subject|2
877837|NCT00571948|1840559|FG000|Overall Study|Protocol Violation|3
877838|NCT00571948|1840560|FG001|Overall Study|Protocol Violation|3
877839|NCT00571948|1840559|FG000|Overall Study|infant refused study meal|3
877840|NCT00571948|1840560|FG001|Overall Study|infant refused study meal|4
877841|NCT00571948|1840559|FG000|Overall Study|Parent were afraid of blood colection|2
877842|NCT00571948|1840560|FG001|Overall Study|Parent were afraid of blood colection|5
877843|NCT00572039|1840586|FG000|Overall Study|Withdrawal by Subject|9
877844|NCT00572039|1840587|FG001|Overall Study|Withdrawal by Subject|6
877845|NCT00572039|1840586|FG000|Overall Study|Death|2
877846|NCT00572039|1840587|FG001|Overall Study|Death|3
1183786|NCT01111565|2341802|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
1183787|NCT01111565|2341798|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1
1183788|NCT01111565|2341799|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
1183789|NCT01111565|2341800|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
1183790|NCT01111565|2341801|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
1183791|NCT01111565|2341802|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
1183792|NCT01111565|2341798|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1
1183793|NCT01111565|2341799|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
1183794|NCT01111565|2341800|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
1183795|NCT01111565|2341801|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
1183796|NCT01111565|2341802|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
1183797|NCT01111565|2341798|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1
1183798|NCT01111565|2341799|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0
1183799|NCT01111565|2341800|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0
1183800|NCT01111565|2341801|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0
1183801|NCT01111565|2341802|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0
1183802|NCT01111565|2341798|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1
1183803|NCT01111565|2341799|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
1183804|NCT01111565|2341800|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
1183805|NCT01111565|2341801|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
877847|NCT00572039|1840586|FG000|Overall Study|Ill|5
877848|NCT00572039|1840587|FG001|Overall Study|Ill|1
877849|NCT00572156|1840610|FG000|Overall Study|Adverse Event|3
877850|NCT00572156|1840611|FG001|Overall Study|Adverse Event|1
877851|NCT00572156|1840612|FG002|Overall Study|Adverse Event|5
877852|NCT00572156|1840613|FG003|Overall Study|Adverse Event|1
877853|NCT00572156|1840610|FG000|Overall Study|Lost to Follow-up|1
877854|NCT00572156|1840611|FG001|Overall Study|Lost to Follow-up|1
877855|NCT00572156|1840612|FG002|Overall Study|Lost to Follow-up|1
877856|NCT00572156|1840613|FG003|Overall Study|Lost to Follow-up|0
877857|NCT00572156|1840610|FG000|Overall Study|Protocol Violation|1
877858|NCT00572156|1840611|FG001|Overall Study|Protocol Violation|2
877859|NCT00572156|1840612|FG002|Overall Study|Protocol Violation|0
877860|NCT00572156|1840613|FG003|Overall Study|Protocol Violation|2
877861|NCT00572156|1840610|FG000|Overall Study|Patient/Parent Decision|1
877862|NCT00572156|1840611|FG001|Overall Study|Patient/Parent Decision|6
877863|NCT00572156|1840612|FG002|Overall Study|Patient/Parent Decision|4
877864|NCT00572156|1840613|FG003|Overall Study|Patient/Parent Decision|3
877865|NCT00572156|1840610|FG000|Overall Study|Sponsor Decision|20
877866|NCT00572156|1840611|FG001|Overall Study|Sponsor Decision|16
877867|NCT00572156|1840612|FG002|Overall Study|Sponsor Decision|17
877868|NCT00572156|1840613|FG003|Overall Study|Sponsor Decision|19
877869|NCT00572195|1840623|FG000|Overall Study|Withdrawal by Subject|50
877870|NCT00572195|1840623|FG000|Overall Study|Death|9
877871|NCT00572195|1840623|FG000|Overall Study|Adverse Event|4
877872|NCT00572195|1840623|FG000|Overall Study|Lost to Follow-up|5
877873|NCT00572455|1840650|FG000|Stage I (14 Days)|Adverse Event|0
877874|NCT00572455|1840651|FG001|Stage I (14 Days)|Adverse Event|0
877875|NCT00572455|1840652|FG002|Stage I (14 Days)|Adverse Event|0
877876|NCT00572455|1840653|FG003|Stage I (14 Days)|Adverse Event|0
877877|NCT00572455|1840654|FG004|Stage I (14 Days)|Adverse Event|0
877878|NCT00572455|1840655|FG005|Stage I (14 Days)|Adverse Event|3
877879|NCT00572455|1840656|FG006|Stage I (14 Days)|Adverse Event|0
877880|NCT00572455|1840657|FG007|Stage I (14 Days)|Adverse Event|0
877881|NCT00572455|1840658|FG008|Stage I (14 Days)|Adverse Event|0
877882|NCT00572455|1840659|FG009|Stage I (14 Days)|Adverse Event|0
877883|NCT00572455|1840660|FG010|Stage I (14 Days)|Adverse Event|0
877884|NCT00572455|1840661|FG011|Stage I (14 Days)|Adverse Event|0
877885|NCT00572455|1840662|FG012|Stage I (14 Days)|Adverse Event|0
877886|NCT00572455|1840663|FG013|Stage I (14 Days)|Adverse Event|0
877887|NCT00572455|1840650|FG000|Stage I (14 Days)|Other|0
877888|NCT00572455|1840651|FG001|Stage I (14 Days)|Other|0
877889|NCT00572455|1840652|FG002|Stage I (14 Days)|Other|0
877890|NCT00572455|1840653|FG003|Stage I (14 Days)|Other|0
877891|NCT00572455|1840654|FG004|Stage I (14 Days)|Other|1
877892|NCT00572455|1840655|FG005|Stage I (14 Days)|Other|0
877893|NCT00572455|1840656|FG006|Stage I (14 Days)|Other|0
877894|NCT00572455|1840657|FG007|Stage I (14 Days)|Other|0
877895|NCT00572455|1840658|FG008|Stage I (14 Days)|Other|0
877896|NCT00572455|1840659|FG009|Stage I (14 Days)|Other|0
877897|NCT00572455|1840660|FG010|Stage I (14 Days)|Other|0
877898|NCT00572455|1840661|FG011|Stage I (14 Days)|Other|0
877899|NCT00572455|1840662|FG012|Stage I (14 Days)|Other|0
877900|NCT00572455|1840663|FG013|Stage I (14 Days)|Other|0
877901|NCT00572455|1840650|FG000|Stage II (28 Days)|Adverse Event|0
877902|NCT00572455|1840651|FG001|Stage II (28 Days)|Adverse Event|0
877903|NCT00572455|1840652|FG002|Stage II (28 Days)|Adverse Event|0
877904|NCT00572455|1840653|FG003|Stage II (28 Days)|Adverse Event|0
877905|NCT00572455|1840654|FG004|Stage II (28 Days)|Adverse Event|0
877906|NCT00572455|1840655|FG005|Stage II (28 Days)|Adverse Event|0
877907|NCT00572455|1840656|FG006|Stage II (28 Days)|Adverse Event|0
877908|NCT00572455|1840657|FG007|Stage II (28 Days)|Adverse Event|0
877909|NCT00572455|1840658|FG008|Stage II (28 Days)|Adverse Event|1
877910|NCT00572455|1840659|FG009|Stage II (28 Days)|Adverse Event|3
877911|NCT00572455|1840660|FG010|Stage II (28 Days)|Adverse Event|3
1183806|NCT01111565|2341802|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
1183807|NCT01111565|2341798|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
1183808|NCT01111565|2341799|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
1183809|NCT01111565|2341800|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
1183810|NCT01111565|2341801|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
1183811|NCT01111565|2341802|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
877912|NCT00572455|1840661|FG011|Stage II (28 Days)|Adverse Event|4
877913|NCT00572455|1840662|FG012|Stage II (28 Days)|Adverse Event|5
877914|NCT00572455|1840663|FG013|Stage II (28 Days)|Adverse Event|1
877915|NCT00572455|1840650|FG000|Stage II (28 Days)|Death|0
877916|NCT00572455|1840651|FG001|Stage II (28 Days)|Death|0
877917|NCT00572455|1840652|FG002|Stage II (28 Days)|Death|0
877918|NCT00572455|1840653|FG003|Stage II (28 Days)|Death|0
877919|NCT00572455|1840654|FG004|Stage II (28 Days)|Death|0
877920|NCT00572455|1840655|FG005|Stage II (28 Days)|Death|0
877921|NCT00572455|1840656|FG006|Stage II (28 Days)|Death|0
877922|NCT00572455|1840657|FG007|Stage II (28 Days)|Death|0
877923|NCT00572455|1840658|FG008|Stage II (28 Days)|Death|1
877924|NCT00572455|1840659|FG009|Stage II (28 Days)|Death|0
877925|NCT00572455|1840660|FG010|Stage II (28 Days)|Death|0
877926|NCT00572455|1840661|FG011|Stage II (28 Days)|Death|0
877927|NCT00572455|1840662|FG012|Stage II (28 Days)|Death|0
877928|NCT00572455|1840663|FG013|Stage II (28 Days)|Death|0
877929|NCT00572455|1840650|FG000|Stage II (28 Days)|Withdrawal by Subject|0
877930|NCT00572455|1840651|FG001|Stage II (28 Days)|Withdrawal by Subject|0
877931|NCT00572455|1840652|FG002|Stage II (28 Days)|Withdrawal by Subject|0
877932|NCT00572455|1840653|FG003|Stage II (28 Days)|Withdrawal by Subject|0
877933|NCT00572455|1840654|FG004|Stage II (28 Days)|Withdrawal by Subject|0
877934|NCT00572455|1840655|FG005|Stage II (28 Days)|Withdrawal by Subject|0
877935|NCT00572455|1840656|FG006|Stage II (28 Days)|Withdrawal by Subject|0
877936|NCT00572455|1840657|FG007|Stage II (28 Days)|Withdrawal by Subject|1
877937|NCT00572455|1840658|FG008|Stage II (28 Days)|Withdrawal by Subject|0
877938|NCT00572455|1840659|FG009|Stage II (28 Days)|Withdrawal by Subject|0
877939|NCT00572455|1840660|FG010|Stage II (28 Days)|Withdrawal by Subject|2
877940|NCT00572455|1840661|FG011|Stage II (28 Days)|Withdrawal by Subject|0
877941|NCT00572455|1840662|FG012|Stage II (28 Days)|Withdrawal by Subject|0
877942|NCT00572455|1840663|FG013|Stage II (28 Days)|Withdrawal by Subject|0
877943|NCT00572455|1840650|FG000|Stage II (28 Days)|Other|0
877944|NCT00572455|1840651|FG001|Stage II (28 Days)|Other|0
877945|NCT00572455|1840652|FG002|Stage II (28 Days)|Other|0
877946|NCT00572455|1840653|FG003|Stage II (28 Days)|Other|0
877947|NCT00572455|1840654|FG004|Stage II (28 Days)|Other|0
877948|NCT00572455|1840655|FG005|Stage II (28 Days)|Other|0
877949|NCT00572455|1840656|FG006|Stage II (28 Days)|Other|0
877950|NCT00572455|1840657|FG007|Stage II (28 Days)|Other|0
877951|NCT00572455|1840658|FG008|Stage II (28 Days)|Other|1
877952|NCT00572455|1840659|FG009|Stage II (28 Days)|Other|0
877953|NCT00572455|1840660|FG010|Stage II (28 Days)|Other|0
877954|NCT00572455|1840661|FG011|Stage II (28 Days)|Other|0
877955|NCT00572455|1840662|FG012|Stage II (28 Days)|Other|0
877956|NCT00572455|1840663|FG013|Stage II (28 Days)|Other|0
877957|NCT00572455|1840650|FG000|Stage II (28 Days)|Randomized, but not treated|0
877958|NCT00572455|1840651|FG001|Stage II (28 Days)|Randomized, but not treated|0
877959|NCT00572455|1840652|FG002|Stage II (28 Days)|Randomized, but not treated|0
877960|NCT00572455|1840653|FG003|Stage II (28 Days)|Randomized, but not treated|0
877961|NCT00572455|1840654|FG004|Stage II (28 Days)|Randomized, but not treated|0
877962|NCT00572455|1840655|FG005|Stage II (28 Days)|Randomized, but not treated|0
877963|NCT00572455|1840656|FG006|Stage II (28 Days)|Randomized, but not treated|0
877964|NCT00572455|1840657|FG007|Stage II (28 Days)|Randomized, but not treated|0
877965|NCT00572455|1840658|FG008|Stage II (28 Days)|Randomized, but not treated|0
877966|NCT00572455|1840659|FG009|Stage II (28 Days)|Randomized, but not treated|0
877967|NCT00572455|1840660|FG010|Stage II (28 Days)|Randomized, but not treated|0
877968|NCT00572455|1840661|FG011|Stage II (28 Days)|Randomized, but not treated|0
877969|NCT00572455|1840662|FG012|Stage II (28 Days)|Randomized, but not treated|0
877970|NCT00572455|1840663|FG013|Stage II (28 Days)|Randomized, but not treated|1
877971|NCT00572533|1840704|FG000|Overall Study|Death|4
877972|NCT00572533|1840705|FG001|Overall Study|Death|1
877973|NCT00572533|1840704|FG000|Overall Study|Received Kidney Transplant|2
877974|NCT00572533|1840705|FG001|Overall Study|Received Kidney Transplant|1
877975|NCT00572533|1840704|FG000|Overall Study|Social Issues|1
877976|NCT00572533|1840705|FG001|Overall Study|Social Issues|0
877977|NCT00572533|1840704|FG000|Overall Study|Transfer out of Facility|0
877978|NCT00572533|1840705|FG001|Overall Study|Transfer out of Facility|1
877979|NCT00572572|1840713|FG000|Overall Study|Withdrawal by Subject|3
877980|NCT00572572|1840714|FG001|Overall Study|Withdrawal by Subject|6
877981|NCT00572624|1840722|FG000|Overall Study|Lost to Follow-up|10
877982|NCT00572624|1840723|FG001|Overall Study|Lost to Follow-up|4
877983|NCT00572624|1840722|FG000|Overall Study|Wanted to do a different diet program|1
877984|NCT00572624|1840723|FG001|Overall Study|Wanted to do a different diet program|0
877985|NCT00572624|1840722|FG000|Overall Study|Medication change|1
877986|NCT00572624|1840723|FG001|Overall Study|Medication change|0
877987|NCT00572624|1840722|FG000|Overall Study|Started a new job-- no time for study|1
877988|NCT00572624|1840723|FG001|Overall Study|Started a new job-- no time for study|0
877989|NCT00572624|1840722|FG000|Overall Study|Admitted to being a smoker|1
1183812|NCT01111565|2341798|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
1183813|NCT01111565|2341799|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
1183814|NCT01111565|2341800|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2
1183815|NCT01111565|2341801|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
1183816|NCT01111565|2341802|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
1183817|NCT01111565|2341798|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
1183818|NCT01111565|2341799|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
1183819|NCT01111565|2341800|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
1183820|NCT01111565|2341801|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2
1183821|NCT01111565|2341802|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
1183822|NCT01111565|2341798|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
1183823|NCT01111565|2341799|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
1183824|NCT01111565|2341800|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
1183825|NCT01111565|2341801|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1
1183826|NCT01111565|2341802|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
1183827|NCT01111565|2341798|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
1183828|NCT01111565|2341799|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
1183829|NCT01111565|2341800|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
1183830|NCT01111565|2341801|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
1183831|NCT01111565|2341802|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1
1183832|NCT01092117|2341812|FG000|Index Procedure to 1 Month|Death|1
1183833|NCT01092117|2341812|FG000|1 Month|Death|1
1183834|NCT01092117|2341812|FG000|1 Month|Withdrawal by Subject|1
1183835|NCT01092117|2341812|FG000|1 Month|Lost to Follow-up|1
1183836|NCT01092117|2341812|FG000|6 Months|Death|2
1183837|NCT01092117|2341812|FG000|6 Months|Withdrawal by Subject|3
1183838|NCT01092117|2341812|FG000|12 Month|Death|11
1183839|NCT01092117|2341812|FG000|12 Month|Withdrawal by Subject|2
1183840|NCT01092117|2341812|FG000|12 Month|Lost to Follow-up|1
1183841|NCT01092117|2341812|FG000|Year 2|Death|5
1183842|NCT01092117|2341812|FG000|Year 2|Withdrawal by Subject|4
1183843|NCT01092117|2341812|FG000|Year 2|Lost to Follow-up|1
1183844|NCT01092117|2341812|FG000|Year 3|Death|7
1183845|NCT01092117|2341812|FG000|Year 3|Withdrawal by Subject|9
1183846|NCT01092117|2341812|FG000|Year 3|Lost to Follow-up|3
1183847|NCT01092117|2341812|FG000|Year 4|Death|8
1183848|NCT01092117|2341812|FG000|Year 4|Withdrawal by Subject|4
1183849|NCT01092117|2341812|FG000|Year 4|Lost to Follow-up|4
1183860|NCT00950989|2341824|FG000|Overall Study|Death|0
1183861|NCT00950989|2341825|FG001|Overall Study|Death|0
1183862|NCT00950989|2341826|FG002|Overall Study|Death|1
1183863|NCT00950989|2341827|FG003|Overall Study|Death|0
1183864|NCT00950989|2341824|FG000|Overall Study|Administrative Decision|0
1183865|NCT00950989|2341825|FG001|Overall Study|Administrative Decision|1
1183866|NCT00950989|2341826|FG002|Overall Study|Administrative Decision|0
1183867|NCT00950989|2341827|FG003|Overall Study|Administrative Decision|0
1183868|NCT00950989|2341824|FG000|Overall Study|Disease Progression|0
1183869|NCT00950989|2341825|FG001|Overall Study|Disease Progression|0
1183870|NCT00950989|2341826|FG002|Overall Study|Disease Progression|1
1183871|NCT00950989|2341827|FG003|Overall Study|Disease Progression|0
1183872|NCT00950989|2341824|FG000|Overall Study|Withdrawal by Subject|2
1183873|NCT00950989|2341825|FG001|Overall Study|Withdrawal by Subject|1
1183874|NCT00950989|2341826|FG002|Overall Study|Withdrawal by Subject|0
1183875|NCT00950989|2341827|FG003|Overall Study|Withdrawal by Subject|0
1183876|NCT00950989|2341824|FG000|Overall Study|Adverse Event|2
1183877|NCT00950989|2341825|FG001|Overall Study|Adverse Event|1
1183878|NCT00950989|2341826|FG002|Overall Study|Adverse Event|1
1183879|NCT00950989|2341827|FG003|Overall Study|Adverse Event|0
1183880|NCT00601900|2341842|FG000|Overall Study|Withdrawal by Subject|0
1183881|NCT00601900|2341843|FG001|Overall Study|Withdrawal by Subject|3
1183882|NCT00489307|2341851|FG000|Overall Study|Death|1
1183883|NCT00489307|2341852|FG001|Overall Study|Death|1
1183884|NCT00489307|2341851|FG000|Overall Study|Lost to Follow-up|2
1183885|NCT00489307|2341852|FG001|Overall Study|Lost to Follow-up|2
1183886|NCT00489307|2341851|FG000|Overall Study|Physician Decision|1
1183887|NCT00489307|2341852|FG001|Overall Study|Physician Decision|0
1183888|NCT00489307|2341851|FG000|Overall Study|Withdrawal by Subject|2
1183889|NCT00489307|2341852|FG001|Overall Study|Withdrawal by Subject|4
1183890|NCT00489307|2341851|FG000|Overall Study|Hospitalization unrelated to treatment|10
1183891|NCT00489307|2341852|FG001|Overall Study|Hospitalization unrelated to treatment|7
877990|NCT00572624|1840723|FG001|Overall Study|Admitted to being a smoker|0
877991|NCT00572624|1840722|FG000|Overall Study|Refused to do the stress test|1
877992|NCT00572624|1840723|FG001|Overall Study|Refused to do the stress test|0
877993|NCT00572624|1840722|FG000|Overall Study|Problem with vascular access|1
877994|NCT00572624|1840723|FG001|Overall Study|Problem with vascular access|0
877995|NCT00572624|1840722|FG000|Overall Study|Health issues unrelated to the study|1
877996|NCT00572624|1840723|FG001|Overall Study|Health issues unrelated to the study|0
877997|NCT00572728|1840729|FG000|Overall Study|Withdrawal by Subject|10
877998|NCT00572728|1840729|FG000|Overall Study|Ineligible|3
877999|NCT00572728|1840729|FG000|Overall Study|Enrolled under Amendment 4|5
878000|NCT00572728|1840729|FG000|Overall Study|Offstudy due to complicating disease|1
878001|NCT00572728|1840729|FG000|Overall Study|FLT1 not completed|4
878002|NCT00572728|1840729|FG000|Overall Study|First Chemotherapy not initiated|2
878003|NCT00572728|1840729|FG000|Overall Study|FLT2 not completed|5
878004|NCT00572728|1840729|FG000|Overall Study|Second chemotherapy not initiated|1
878005|NCT00572728|1840729|FG000|Overall Study|FLT2 after second chemotherapy initiated|7
878006|NCT00572728|1840729|FG000|Overall Study|Pathology missing|1
878007|NCT00572832|1840737|FG000|Overall Study|Lost to Follow-up|0
878008|NCT00572832|1840738|FG001|Overall Study|Lost to Follow-up|11
878009|NCT00572832|1840737|FG000|Overall Study|Pregnancy|0
878010|NCT00572832|1840738|FG001|Overall Study|Pregnancy|1
878011|NCT00572910|1840759|FG000|Overall Study|Adverse Event|1
878012|NCT00572910|1840760|FG001|Overall Study|Adverse Event|2
878013|NCT00572910|1840761|FG002|Overall Study|Adverse Event|0
878014|NCT00572910|1840762|FG003|Overall Study|Adverse Event|2
878015|NCT00572910|1840763|FG004|Overall Study|Adverse Event|0
878016|NCT00572910|1840764|FG005|Overall Study|Adverse Event|0
878017|NCT00572910|1840765|FG006|Overall Study|Adverse Event|4
878018|NCT00572910|1840766|FG007|Overall Study|Adverse Event|2
878019|NCT00572910|1840767|FG008|Overall Study|Adverse Event|1
878020|NCT00572910|1840768|FG009|Overall Study|Adverse Event|3
878021|NCT00572910|1840769|FG010|Overall Study|Adverse Event|2
878022|NCT00572910|1840759|FG000|Overall Study|Lost to Follow-up|0
878023|NCT00572910|1840760|FG001|Overall Study|Lost to Follow-up|1
878024|NCT00572910|1840761|FG002|Overall Study|Lost to Follow-up|1
878025|NCT00572910|1840762|FG003|Overall Study|Lost to Follow-up|2
878026|NCT00572910|1840763|FG004|Overall Study|Lost to Follow-up|1
878027|NCT00572910|1840764|FG005|Overall Study|Lost to Follow-up|0
878028|NCT00572910|1840765|FG006|Overall Study|Lost to Follow-up|0
878029|NCT00572910|1840766|FG007|Overall Study|Lost to Follow-up|0
878030|NCT00572910|1840767|FG008|Overall Study|Lost to Follow-up|0
878031|NCT00572910|1840768|FG009|Overall Study|Lost to Follow-up|1
878032|NCT00572910|1840769|FG010|Overall Study|Lost to Follow-up|0
878033|NCT00572910|1840759|FG000|Overall Study|Withdrawal by Subject|3
878034|NCT00572910|1840760|FG001|Overall Study|Withdrawal by Subject|0
878035|NCT00572910|1840761|FG002|Overall Study|Withdrawal by Subject|1
878036|NCT00572910|1840762|FG003|Overall Study|Withdrawal by Subject|0
878037|NCT00572910|1840763|FG004|Overall Study|Withdrawal by Subject|1
878038|NCT00572910|1840764|FG005|Overall Study|Withdrawal by Subject|3
878039|NCT00572910|1840765|FG006|Overall Study|Withdrawal by Subject|0
878040|NCT00572910|1840766|FG007|Overall Study|Withdrawal by Subject|2
878041|NCT00572910|1840767|FG008|Overall Study|Withdrawal by Subject|2
878042|NCT00572910|1840768|FG009|Overall Study|Withdrawal by Subject|2
878043|NCT00572910|1840769|FG010|Overall Study|Withdrawal by Subject|1
878044|NCT00573066|1840817|FG000|Overall Study|Exclusion criteria|18
878045|NCT00573066|1840817|FG000|Overall Study|IV malfunction|1
878046|NCT00573066|1840817|FG000|Overall Study|Postoperative bleeding|1
878047|NCT00573131|1840823|FG000|Overall Study|Withdrawal by Subject|10
878048|NCT00573131|1840824|FG001|Overall Study|Withdrawal by Subject|8
878049|NCT00573144|1840832|FG000|Overall Study|Withdrawal by Subject|2
878050|NCT00573144|1840833|FG001|Overall Study|Withdrawal by Subject|3
878051|NCT00573170|1840839|FG000|First Treatment Period|Did Not Treat Attack 1|0
878052|NCT00573170|1840840|FG001|First Treatment Period|Did Not Treat Attack 1|0
878053|NCT00573170|1840841|FG002|First Treatment Period|Did Not Treat Attack 1|0
878054|NCT00573170|1840842|FG003|First Treatment Period|Did Not Treat Attack 1|0
878055|NCT00573170|1840843|FG004|First Treatment Period|Did Not Treat Attack 1|1
878056|NCT00573170|1840844|FG005|First Treatment Period|Did Not Treat Attack 1|0
878057|NCT00573170|1840839|FG000|First Washout Period|Adverse Event|1
878058|NCT00573170|1840840|FG001|First Washout Period|Adverse Event|1
878059|NCT00573170|1840841|FG002|First Washout Period|Adverse Event|0
878060|NCT00573170|1840842|FG003|First Washout Period|Adverse Event|0
878061|NCT00573170|1840843|FG004|First Washout Period|Adverse Event|0
878062|NCT00573170|1840844|FG005|First Washout Period|Adverse Event|1
878063|NCT00573170|1840839|FG000|First Washout Period|Lack of Efficacy|0
878064|NCT00573170|1840840|FG001|First Washout Period|Lack of Efficacy|0
878065|NCT00573170|1840841|FG002|First Washout Period|Lack of Efficacy|0
878066|NCT00573170|1840842|FG003|First Washout Period|Lack of Efficacy|0
878067|NCT00573170|1840843|FG004|First Washout Period|Lack of Efficacy|0
878068|NCT00573170|1840844|FG005|First Washout Period|Lack of Efficacy|1
878069|NCT00573170|1840839|FG000|First Washout Period|Lost to Follow-up|1
878070|NCT00573170|1840840|FG001|First Washout Period|Lost to Follow-up|1
1183892|NCT00489307|2341851|FG000|Overall Study|Surgery after assignment|1
1183893|NCT00489307|2341852|FG001|Overall Study|Surgery after assignment|0
1183894|NCT00489307|2341851|FG000|Overall Study|Did not fill up the forms|2
1183895|NCT00489307|2341852|FG001|Overall Study|Did not fill up the forms|1
1183896|NCT00489307|2341851|FG000|Overall Study|Patient or family refusal|5
1183897|NCT00489307|2341852|FG001|Overall Study|Patient or family refusal|9
1183898|NCT00072410|2341860|FG000|Overall Study|Progressive disease|0
1183899|NCT00072410|2341861|FG001|Overall Study|Progressive disease|3
1183900|NCT04498247|2341908|FG000|Overall Study|Lost to Follow-up|0
1183901|NCT04498247|2341909|FG001|Overall Study|Lost to Follow-up|0
1183902|NCT04498247|2341910|FG002|Overall Study|Lost to Follow-up|0
1183903|NCT04498247|2341911|FG003|Overall Study|Lost to Follow-up|1
1183904|NCT04498247|2341912|FG004|Overall Study|Lost to Follow-up|0
1183905|NCT04498247|2341913|FG005|Overall Study|Lost to Follow-up|0
1183906|NCT04498247|2341914|FG006|Overall Study|Lost to Follow-up|0
1183907|NCT04498247|2341915|FG007|Overall Study|Lost to Follow-up|0
1183908|NCT04498247|2341908|FG000|Overall Study|Mistakenly Randomized; Not Treated|1
1183909|NCT04498247|2341909|FG001|Overall Study|Mistakenly Randomized; Not Treated|0
1183910|NCT04498247|2341910|FG002|Overall Study|Mistakenly Randomized; Not Treated|0
1183911|NCT04498247|2341911|FG003|Overall Study|Mistakenly Randomized; Not Treated|0
1183912|NCT04498247|2341912|FG004|Overall Study|Mistakenly Randomized; Not Treated|0
1183913|NCT04498247|2341913|FG005|Overall Study|Mistakenly Randomized; Not Treated|0
1183914|NCT04498247|2341914|FG006|Overall Study|Mistakenly Randomized; Not Treated|0
1183915|NCT04498247|2341915|FG007|Overall Study|Mistakenly Randomized; Not Treated|0
1183916|NCT04498247|2341908|FG000|Overall Study|Withdrawal by Subject|0
1183917|NCT04498247|2341909|FG001|Overall Study|Withdrawal by Subject|8
1183918|NCT04498247|2341910|FG002|Overall Study|Withdrawal by Subject|0
1183919|NCT04498247|2341911|FG003|Overall Study|Withdrawal by Subject|7
1183920|NCT04498247|2341912|FG004|Overall Study|Withdrawal by Subject|0
1183921|NCT04498247|2341913|FG005|Overall Study|Withdrawal by Subject|0
1183922|NCT04498247|2341914|FG006|Overall Study|Withdrawal by Subject|1
1183923|NCT04498247|2341915|FG007|Overall Study|Withdrawal by Subject|0
1183924|NCT04498247|2341908|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0
1183925|NCT04498247|2341909|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4
1183926|NCT04498247|2341910|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0
1183927|NCT04498247|2341911|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3
1183928|NCT04498247|2341912|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0
1183929|NCT04498247|2341913|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0
1183930|NCT04498247|2341914|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7
1183931|NCT04498247|2341915|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0
1183932|NCT04472650|2341932|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1
1183933|NCT04472650|2341933|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0
1183934|NCT04151290|2341950|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286
1183935|NCT04046939|2341958|FG000|Primary Assessment Period|Adverse Event|1
1183936|NCT04046939|2341959|FG001|Primary Assessment Period|Adverse Event|0
1183937|NCT04046939|2341960|FG002|Primary Assessment Period|Adverse Event|0
1183938|NCT04046939|2341961|FG003|Primary Assessment Period|Adverse Event|0
878071|NCT00573170|1840841|FG002|First Washout Period|Lost to Follow-up|0
878072|NCT00573170|1840842|FG003|First Washout Period|Lost to Follow-up|2
878073|NCT00573170|1840843|FG004|First Washout Period|Lost to Follow-up|0
878074|NCT00573170|1840844|FG005|First Washout Period|Lost to Follow-up|2
878075|NCT00573170|1840839|FG000|First Washout Period|Withdrawal by Subject|2
878076|NCT00573170|1840840|FG001|First Washout Period|Withdrawal by Subject|0
878077|NCT00573170|1840841|FG002|First Washout Period|Withdrawal by Subject|0
878078|NCT00573170|1840842|FG003|First Washout Period|Withdrawal by Subject|2
878079|NCT00573170|1840843|FG004|First Washout Period|Withdrawal by Subject|3
878080|NCT00573170|1840844|FG005|First Washout Period|Withdrawal by Subject|3
878081|NCT00573170|1840839|FG000|First Washout Period|Other|4
878082|NCT00573170|1840840|FG001|First Washout Period|Other|0
878083|NCT00573170|1840841|FG002|First Washout Period|Other|1
878084|NCT00573170|1840842|FG003|First Washout Period|Other|1
878085|NCT00573170|1840843|FG004|First Washout Period|Other|0
878086|NCT00573170|1840844|FG005|First Washout Period|Other|0
878087|NCT00573170|1840839|FG000|Second Washout Period|Adverse Event|1
878088|NCT00573170|1840840|FG001|Second Washout Period|Adverse Event|0
878089|NCT00573170|1840841|FG002|Second Washout Period|Adverse Event|0
878090|NCT00573170|1840842|FG003|Second Washout Period|Adverse Event|0
878091|NCT00573170|1840843|FG004|Second Washout Period|Adverse Event|1
878092|NCT00573170|1840844|FG005|Second Washout Period|Adverse Event|0
878093|NCT00573170|1840839|FG000|Second Washout Period|Protocol Violation|2
878094|NCT00573170|1840840|FG001|Second Washout Period|Protocol Violation|1
878095|NCT00573170|1840841|FG002|Second Washout Period|Protocol Violation|1
878096|NCT00573170|1840842|FG003|Second Washout Period|Protocol Violation|0
878097|NCT00573170|1840843|FG004|Second Washout Period|Protocol Violation|0
878098|NCT00573170|1840844|FG005|Second Washout Period|Protocol Violation|0
878099|NCT00573170|1840839|FG000|Second Washout Period|Withdrawal by Subject|1
878100|NCT00573170|1840840|FG001|Second Washout Period|Withdrawal by Subject|1
878101|NCT00573170|1840841|FG002|Second Washout Period|Withdrawal by Subject|2
878102|NCT00573170|1840842|FG003|Second Washout Period|Withdrawal by Subject|0
878103|NCT00573170|1840843|FG004|Second Washout Period|Withdrawal by Subject|1
878104|NCT00573170|1840844|FG005|Second Washout Period|Withdrawal by Subject|0
878105|NCT00573170|1840839|FG000|Second Washout Period|Lost to Follow-up|0
878106|NCT00573170|1840840|FG001|Second Washout Period|Lost to Follow-up|0
878107|NCT00573170|1840841|FG002|Second Washout Period|Lost to Follow-up|0
878108|NCT00573170|1840842|FG003|Second Washout Period|Lost to Follow-up|1
878109|NCT00573170|1840843|FG004|Second Washout Period|Lost to Follow-up|0
878110|NCT00573170|1840844|FG005|Second Washout Period|Lost to Follow-up|0
1183939|NCT04046939|2341958|FG000|Primary Assessment Period|Withdrawal by Subject|1
1183940|NCT04046939|2341959|FG001|Primary Assessment Period|Withdrawal by Subject|0
1183941|NCT04046939|2341960|FG002|Primary Assessment Period|Withdrawal by Subject|1
1183942|NCT04046939|2341961|FG003|Primary Assessment Period|Withdrawal by Subject|0
1183943|NCT04046939|2341958|FG000|Primary Assessment Period|Physician Decision|0
1183944|NCT04046939|2341959|FG001|Primary Assessment Period|Physician Decision|0
1183945|NCT04046939|2341960|FG002|Primary Assessment Period|Physician Decision|1
1183946|NCT04046939|2341961|FG003|Primary Assessment Period|Physician Decision|0
1183947|NCT04046939|2341958|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1
1183948|NCT04046939|2341959|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0
1183949|NCT04046939|2341960|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0
1183950|NCT04046939|2341961|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1
1183951|NCT04038385|2341979|FG000|Overall Study|Completed baseline assessment only|7
1183952|NCT04038385|2341980|FG001|Overall Study|Completed baseline assessment only|4
1183953|NCT04038385|2341979|FG000|Overall Study|Moved out of area|4
1183954|NCT04038385|2341980|FG001|Overall Study|Moved out of area|2
1183955|NCT04038385|2341979|FG000|Overall Study|Discontinued study involvement|6
1183956|NCT04038385|2341980|FG001|Overall Study|Discontinued study involvement|1
1183957|NCT03978091|2341992|FG000|Overall Study|Lost to Follow-up|0
1183958|NCT03978091|2341993|FG001|Overall Study|Lost to Follow-up|0
1183959|NCT03978091|2341994|FG002|Overall Study|Lost to Follow-up|1
1183960|NCT03978091|2341995|FG003|Overall Study|Lost to Follow-up|0
1183961|NCT03978091|2341996|FG004|Overall Study|Lost to Follow-up|0
1183962|NCT03978091|2341997|FG005|Overall Study|Lost to Follow-up|0
1183963|NCT03978091|2341992|FG000|Overall Study|Withdrawal by Subject|0
1183964|NCT03978091|2341993|FG001|Overall Study|Withdrawal by Subject|0
1183965|NCT03978091|2341994|FG002|Overall Study|Withdrawal by Subject|0
1183966|NCT03978091|2341995|FG003|Overall Study|Withdrawal by Subject|1
1183967|NCT03978091|2341996|FG004|Overall Study|Withdrawal by Subject|1
1183968|NCT03978091|2341997|FG005|Overall Study|Withdrawal by Subject|0
1183969|NCT03923738|2342011|FG000|Period 1|Adverse Event|1
1183970|NCT03923738|2342011|FG000|Period 1|Withdrawal by Subject|1
1183971|NCT03887117|2342021|FG000|Overall Study|Discontinued prematurely|0
1183972|NCT03887117|2342022|FG001|Overall Study|Discontinued prematurely|1
1183973|NCT03887117|2342023|FG002|Overall Study|Discontinued prematurely|1
1183974|NCT03887117|2342024|FG003|Overall Study|Discontinued prematurely|2
1183975|NCT03858634|2342045|FG000|Overall Study|Withdrawal by Subject|1
1183976|NCT03858634|2342046|FG001|Overall Study|Withdrawal by Subject|0
1183977|NCT03858634|2342045|FG000|Overall Study|Adverse Event|1
1183978|NCT03858634|2342046|FG001|Overall Study|Adverse Event|0
1183979|NCT03858634|2342045|FG000|Overall Study|Lost to Follow-up|0
1183980|NCT03858634|2342046|FG001|Overall Study|Lost to Follow-up|1
1183981|NCT03858634|2342045|FG000|Overall Study|Other, Not Specified|1
1183982|NCT03858634|2342046|FG001|Overall Study|Other, Not Specified|1
1183983|NCT03819114|2342064|FG000|Overall Study|Protocol Violation|0
1183984|NCT03819114|2342065|FG001|Overall Study|Protocol Violation|1
1183985|NCT03819114|2342066|FG002|Overall Study|Protocol Violation|1
1183986|NCT03819114|2342067|FG003|Overall Study|Protocol Violation|0
1183987|NCT03819114|2342064|FG000|Overall Study|Lost to Follow-up|0
1183988|NCT03819114|2342065|FG001|Overall Study|Lost to Follow-up|0
1183989|NCT03819114|2342066|FG002|Overall Study|Lost to Follow-up|1
1183990|NCT03819114|2342067|FG003|Overall Study|Lost to Follow-up|0
1183991|NCT03804268|2342081|FG000|Overall Study|Adverse Event|2
1183992|NCT03804268|2342082|FG001|Overall Study|Adverse Event|2
1183993|NCT03804268|2342081|FG000|Overall Study|Withdrawal by Subject|2
1183994|NCT03804268|2342082|FG001|Overall Study|Withdrawal by Subject|0
1183995|NCT03804268|2342081|FG000|Overall Study|Lost to Follow-up|1
1183996|NCT03804268|2342082|FG001|Overall Study|Lost to Follow-up|0
1183997|NCT03804268|2342081|FG000|Overall Study|Physician Decision|2
1183998|NCT03804268|2342082|FG001|Overall Study|Physician Decision|0
1183999|NCT03420781|2342118|FG000|Treatment Period (40 Weeks)|Adverse Event|1
1184000|NCT03420781|2342119|FG001|Treatment Period (40 Weeks)|Adverse Event|6
1184001|NCT03420781|2342120|FG002|Treatment Period (40 Weeks)|Adverse Event|0
1184002|NCT03420781|2342121|FG003|Treatment Period (40 Weeks)|Adverse Event|0
1184003|NCT03420781|2342122|FG004|Treatment Period (40 Weeks)|Adverse Event|0
1184004|NCT03420781|2342118|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1
1184005|NCT03420781|2342119|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1
1184006|NCT03420781|2342120|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0
1184007|NCT03420781|2342121|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0
1184008|NCT03420781|2342122|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0
1184009|NCT03420781|2342118|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22
1184010|NCT03420781|2342119|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16
1184011|NCT03420781|2342120|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0
1184012|NCT03420781|2342121|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0
1184013|NCT03420781|2342122|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0
1184014|NCT03420781|2342118|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10
1184015|NCT03420781|2342119|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6
1184016|NCT03420781|2342120|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0
1184017|NCT03420781|2342121|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0
1184018|NCT03420781|2342122|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0
1184019|NCT03420781|2342118|FG000|Treatment Period (40 Weeks)|Death|2
1184020|NCT03420781|2342119|FG001|Treatment Period (40 Weeks)|Death|2
1184021|NCT03420781|2342120|FG002|Treatment Period (40 Weeks)|Death|0
1184022|NCT03420781|2342121|FG003|Treatment Period (40 Weeks)|Death|0
1184023|NCT03420781|2342122|FG004|Treatment Period (40 Weeks)|Death|0
1184024|NCT03420781|2342118|FG000|Treatment Period (40 Weeks)|Physician Decision|3
1184025|NCT03420781|2342119|FG001|Treatment Period (40 Weeks)|Physician Decision|4
1184026|NCT03420781|2342120|FG002|Treatment Period (40 Weeks)|Physician Decision|0
1184027|NCT03420781|2342121|FG003|Treatment Period (40 Weeks)|Physician Decision|0
1184028|NCT03420781|2342122|FG004|Treatment Period (40 Weeks)|Physician Decision|0
1184029|NCT03420781|2342118|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0
1184030|NCT03420781|2342119|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2
1184031|NCT03420781|2342120|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0
1184032|NCT03420781|2342121|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0
1184033|NCT03420781|2342122|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0
1184034|NCT03420781|2342118|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101
878111|NCT00573170|1840839|FG000|Second Washout Period|Other|1
878112|NCT00573170|1840840|FG001|Second Washout Period|Other|2
878113|NCT00573170|1840841|FG002|Second Washout Period|Other|1
878114|NCT00573170|1840842|FG003|Second Washout Period|Other|4
878115|NCT00573170|1840843|FG004|Second Washout Period|Other|6
878116|NCT00573170|1840844|FG005|Second Washout Period|Other|2
878117|NCT00573170|1840839|FG000|Third Treatment Period|Withdrawal by Subject|1
878118|NCT00573170|1840840|FG001|Third Treatment Period|Withdrawal by Subject|0
878119|NCT00573170|1840841|FG002|Third Treatment Period|Withdrawal by Subject|0
878120|NCT00573170|1840842|FG003|Third Treatment Period|Withdrawal by Subject|0
878121|NCT00573170|1840843|FG004|Third Treatment Period|Withdrawal by Subject|0
878122|NCT00573170|1840844|FG005|Third Treatment Period|Withdrawal by Subject|0
878123|NCT00573170|1840839|FG000|Third Treatment Period|Lost to Follow-up|0
878124|NCT00573170|1840840|FG001|Third Treatment Period|Lost to Follow-up|0
878125|NCT00573170|1840841|FG002|Third Treatment Period|Lost to Follow-up|0
878126|NCT00573170|1840842|FG003|Third Treatment Period|Lost to Follow-up|0
878127|NCT00573170|1840843|FG004|Third Treatment Period|Lost to Follow-up|0
878128|NCT00573170|1840844|FG005|Third Treatment Period|Lost to Follow-up|2
878129|NCT00573183|1840863|FG000|Overall Study|Lost to Follow-up|52
878130|NCT00573183|1840864|FG001|Overall Study|Lost to Follow-up|50
878131|NCT00573183|1840863|FG000|Overall Study|Withdrawal by Subject|8
878132|NCT00573183|1840864|FG001|Overall Study|Withdrawal by Subject|2
878133|NCT00573183|1840863|FG000|Overall Study|Death|0
878134|NCT00573183|1840864|FG001|Overall Study|Death|1
878135|NCT00573183|1840863|FG000|Overall Study|Adverse Event|2
878136|NCT00573183|1840864|FG001|Overall Study|Adverse Event|0
878137|NCT00573183|1840863|FG000|Overall Study|Incarceration|5
878138|NCT00573183|1840864|FG001|Overall Study|Incarceration|8
878139|NCT00573183|1840863|FG000|Overall Study|Other|5
878140|NCT00573183|1840864|FG001|Overall Study|Other|2
878141|NCT00573248|1840874|FG000|Overall Study|scheduling conflicts|15
878142|NCT00573248|1840875|FG001|Overall Study|scheduling conflicts|11
878143|NCT00573313|1840905|FG000|Overall Study|Protocol Violation|5
878144|NCT00573313|1840906|FG001|Overall Study|Protocol Violation|0
878145|NCT00573313|1840907|FG002|Overall Study|Protocol Violation|6
878146|NCT00573313|1840908|FG003|Overall Study|Protocol Violation|0
878147|NCT00573430|1840918|FG000|Overall Study|Incorrect enrollment of randomization|0
878148|NCT00573430|1840919|FG001|Overall Study|Incorrect enrollment of randomization|4
878149|NCT00573430|1840920|FG002|Overall Study|Incorrect enrollment of randomization|3
878150|NCT00573430|1840918|FG000|Overall Study|Adverse Event|0
878151|NCT00573430|1840919|FG001|Overall Study|Adverse Event|0
878152|NCT00573430|1840920|FG002|Overall Study|Adverse Event|2
878153|NCT00573430|1840918|FG000|Overall Study|Withdrawal by Subject|1
878154|NCT00573430|1840919|FG001|Overall Study|Withdrawal by Subject|0
878155|NCT00573430|1840920|FG002|Overall Study|Withdrawal by Subject|1
878156|NCT00573430|1840918|FG000|Overall Study|Protocol Violation|0
878157|NCT00573430|1840919|FG001|Overall Study|Protocol Violation|1
878158|NCT00573430|1840920|FG002|Overall Study|Protocol Violation|1
878159|NCT00573430|1840918|FG000|Overall Study|Eligibility criteria not fulfilled|0
878160|NCT00573430|1840919|FG001|Overall Study|Eligibility criteria not fulfilled|0
878161|NCT00573430|1840920|FG002|Overall Study|Eligibility criteria not fulfilled|3
878162|NCT00573443|1840931|FG000|Double-Blind Phase|Lost to Follow-up|1
878163|NCT00573443|1840932|FG001|Double-Blind Phase|Lost to Follow-up|3
878164|NCT00573443|1840933|FG002|Double-Blind Phase|Lost to Follow-up|2
878165|NCT00573443|1840931|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1
878166|NCT00573443|1840932|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0
878167|NCT00573443|1840933|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1
878168|NCT00573443|1840931|FG000|Double-Blind Phase|Adverse Event|1
878169|NCT00573443|1840932|FG001|Double-Blind Phase|Adverse Event|5
878170|NCT00573443|1840933|FG002|Double-Blind Phase|Adverse Event|0
878171|NCT00573443|1840931|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2
878172|NCT00573443|1840932|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3
878173|NCT00573443|1840933|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1
878174|NCT00573443|1840931|FG000|Double-Blind Phase|Medication refusal due to AE|2
878175|NCT00573443|1840932|FG001|Double-Blind Phase|Medication refusal due to AE|2
878176|NCT00573443|1840933|FG002|Double-Blind Phase|Medication refusal due to AE|0
1184035|NCT03420781|2342119|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89
1184036|NCT03420781|2342120|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
1184037|NCT03420781|2342121|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
1184038|NCT03420781|2342122|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
1184039|NCT03420781|2342118|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1
1184040|NCT03420781|2342119|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
1184041|NCT03420781|2342120|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
1184042|NCT03420781|2342121|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
1184043|NCT03420781|2342122|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
1184044|NCT03420781|2342118|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3
1184045|NCT03420781|2342119|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0
1184046|NCT03420781|2342120|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0
1184047|NCT03420781|2342121|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0
1184048|NCT03420781|2342122|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0
1184049|NCT03420781|2342118|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
1184050|NCT03420781|2342119|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
1184051|NCT03420781|2342120|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
1184052|NCT03420781|2342121|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2
1184053|NCT03420781|2342122|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
1184054|NCT03420781|2342118|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
1184055|NCT03420781|2342119|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
1184056|NCT03420781|2342120|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
1184057|NCT03420781|2342121|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
1184058|NCT03420781|2342122|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2
1184059|NCT03420781|2342118|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
1184060|NCT03420781|2342119|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
1184061|NCT03420781|2342120|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6
1184062|NCT03420781|2342121|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
1184063|NCT03420781|2342122|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
878177|NCT00573443|1840931|FG000|Double-Blind Phase|Withdrawal by Subject|2
878178|NCT00573443|1840932|FG001|Double-Blind Phase|Withdrawal by Subject|2
878179|NCT00573443|1840933|FG002|Double-Blind Phase|Withdrawal by Subject|7
878180|NCT00573443|1840931|FG000|Double-Blind Phase|Protocol Violation|0
878181|NCT00573443|1840932|FG001|Double-Blind Phase|Protocol Violation|2
878182|NCT00573443|1840933|FG002|Double-Blind Phase|Protocol Violation|1
878183|NCT00573443|1840931|FG000|Double-Blind Phase|Other|0
878184|NCT00573443|1840932|FG001|Double-Blind Phase|Other|2
878185|NCT00573443|1840933|FG002|Double-Blind Phase|Other|3
878186|NCT00573443|1840931|FG000|Open-Label Extension Phase|Lost to Follow-up|1
878187|NCT00573443|1840932|FG001|Open-Label Extension Phase|Lost to Follow-up|0
878188|NCT00573443|1840933|FG002|Open-Label Extension Phase|Lost to Follow-up|0
878189|NCT00573443|1840931|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2
878190|NCT00573443|1840932|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0
878191|NCT00573443|1840933|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0
878192|NCT00573443|1840931|FG000|Open-Label Extension Phase|Adverse Event|3
878193|NCT00573443|1840932|FG001|Open-Label Extension Phase|Adverse Event|0
878194|NCT00573443|1840933|FG002|Open-Label Extension Phase|Adverse Event|0
878195|NCT00573443|1840931|FG000|Open-Label Extension Phase|Serious Adverse Event|5
878196|NCT00573443|1840932|FG001|Open-Label Extension Phase|Serious Adverse Event|0
878197|NCT00573443|1840933|FG002|Open-Label Extension Phase|Serious Adverse Event|0
878198|NCT00573443|1840931|FG000|Open-Label Extension Phase|Withdrawal by Subject|3
878199|NCT00573443|1840932|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
878200|NCT00573443|1840933|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
878201|NCT00573443|1840931|FG000|Open-Label Extension Phase|Protocol Violation|2
878202|NCT00573443|1840932|FG001|Open-Label Extension Phase|Protocol Violation|0
878203|NCT00573443|1840933|FG002|Open-Label Extension Phase|Protocol Violation|0
878204|NCT00573443|1840931|FG000|Open-Label Extension Phase|Other|2
878205|NCT00573443|1840932|FG001|Open-Label Extension Phase|Other|0
878206|NCT00573443|1840933|FG002|Open-Label Extension Phase|Other|0
878207|NCT00573469|1840945|FG000|Overall Study|Adverse Event|1
878208|NCT00573469|1840946|FG001|Overall Study|Adverse Event|1
878209|NCT00573469|1840947|FG002|Overall Study|Adverse Event|1
878210|NCT00573469|1840945|FG000|Overall Study|Withdrawal by Subject|0
878211|NCT00573469|1840946|FG001|Overall Study|Withdrawal by Subject|2
878212|NCT00573469|1840947|FG002|Overall Study|Withdrawal by Subject|0
878213|NCT00573469|1840945|FG000|Overall Study|Other|5
878214|NCT00573469|1840946|FG001|Overall Study|Other|1
878215|NCT00573469|1840947|FG002|Overall Study|Other|3
878216|NCT00573534|1840964|FG000|Overall Study|oppositional behavior|3
878217|NCT00573755|1840971|FG000|Overall Study|Still receiving treatment|1
878218|NCT00573755|1840972|FG001|Overall Study|Still receiving treatment|0
878219|NCT00573768|1840981|FG000|Overall Study|Adverse Event|1
878220|NCT00573768|1840982|FG001|Overall Study|Adverse Event|1
878221|NCT00573768|1840983|FG002|Overall Study|Adverse Event|2
878222|NCT00573768|1840981|FG000|Overall Study|Protocol Violation|1
1184064|NCT03316586|2342138|FG000|Overall Study|Adverse Event|2
1184065|NCT03316586|2342138|FG000|Overall Study|Physician Decision|3
1184066|NCT03316586|2342138|FG000|Overall Study|Lack of Efficacy|10
1184067|NCT03316586|2342138|FG000|Overall Study|still on treatment|1
1184068|NCT03316586|2342138|FG000|Overall Study|Patient needed radiation therapy|1
1184069|NCT03316586|2342138|FG000|Overall Study|Physician Decision to send patient for breast surgery|1
1184070|NCT03269695|2342157|FG000|Overall Study|Adverse Event|2
1184071|NCT03269695|2342158|FG001|Overall Study|Adverse Event|1
1184072|NCT03269695|2342157|FG000|Overall Study|Lack of Efficacy|0
1184073|NCT03269695|2342158|FG001|Overall Study|Lack of Efficacy|1
1184074|NCT03269695|2342157|FG000|Overall Study|Withdrawal by Subject|0
1184075|NCT03269695|2342158|FG001|Overall Study|Withdrawal by Subject|1
1184076|NCT03227757|2342165|FG000|Overall Study|Death|7
1184077|NCT03227757|2342165|FG000|Overall Study|Withdrawal|5
1184078|NCT03227757|2342165|FG000|Overall Study|Missed visits|4
878223|NCT00573768|1840982|FG001|Overall Study|Protocol Violation|0
878224|NCT00573768|1840983|FG002|Overall Study|Protocol Violation|1
878225|NCT00573768|1840981|FG000|Overall Study|Withdrawal by Subject|0
878226|NCT00573768|1840982|FG001|Overall Study|Withdrawal by Subject|1
878227|NCT00573768|1840983|FG002|Overall Study|Withdrawal by Subject|0
878228|NCT00573768|1840981|FG000|Overall Study|Lost to Follow-up|0
878229|NCT00573768|1840982|FG001|Overall Study|Lost to Follow-up|0
878230|NCT00573768|1840983|FG002|Overall Study|Lost to Follow-up|1
878231|NCT00573794|1840991|FG000|Overall Study|Adverse Event|81
878232|NCT00573794|1840991|FG000|Overall Study|Withdrew Consent|90
878233|NCT00573794|1840991|FG000|Overall Study|Lost to Follow-up|13
878234|NCT00573794|1840991|FG000|Overall Study|Protocol Violation|6
878235|NCT00573794|1840991|FG000|Overall Study|Lack of Efficacy|94
878236|NCT00573794|1840991|FG000|Overall Study|Other|46
878237|NCT00573833|1840995|FG000|Overall Study|Not Treated|2
878238|NCT00573859|1840999|FG000|Medication Versus Placebo|Scheduling conflicts|12
878239|NCT00573859|1840999|FG000|Smoking Versus Abstinence|Scheduling conflicts|12
878240|NCT00574119|1841038|FG000|Overall Study|Adverse Event|1
878241|NCT00574119|1841038|FG000|Overall Study|Protocol Violation|1
878242|NCT00574119|1841038|FG000|Overall Study|Withdrawal by Subject|1
878243|NCT00574119|1841038|FG000|Overall Study|Physician Decision|1
878244|NCT00574145|1841044|FG000|Overall Study|Withdrawal by Subject|2
878245|NCT00574145|1841045|FG001|Overall Study|Withdrawal by Subject|1
878246|NCT00574249|1841065|FG000|Overall Study|Adverse Event|6
878247|NCT00574249|1841066|FG001|Overall Study|Adverse Event|18
878248|NCT00574249|1841065|FG000|Overall Study|Lack of Efficacy|5
878249|NCT00574249|1841066|FG001|Overall Study|Lack of Efficacy|3
878250|NCT00574249|1841065|FG000|Overall Study|Lost to Follow-up|4
878251|NCT00574249|1841066|FG001|Overall Study|Lost to Follow-up|3
878252|NCT00574249|1841065|FG000|Overall Study|Protocol Violation|5
878253|NCT00574249|1841066|FG001|Overall Study|Protocol Violation|2
878254|NCT00574249|1841065|FG000|Overall Study|History of carcinoma|1
878255|NCT00574249|1841066|FG001|Overall Study|History of carcinoma|0
878256|NCT00574249|1841065|FG000|Overall Study|Withdrawal by Subject|3
878257|NCT00574249|1841066|FG001|Overall Study|Withdrawal by Subject|0
878258|NCT00574249|1841065|FG000|Overall Study|Physician Decision|1
878259|NCT00574249|1841066|FG001|Overall Study|Physician Decision|0
878260|NCT00574249|1841065|FG000|Overall Study|Pregnancy|1
878261|NCT00574249|1841066|FG001|Overall Study|Pregnancy|0
878262|NCT00574249|1841065|FG000|Overall Study|Excluded by company|0
878263|NCT00574249|1841066|FG001|Overall Study|Excluded by company|1
878264|NCT00574249|1841065|FG000|Overall Study|PPD test taken twice|0
878265|NCT00574249|1841066|FG001|Overall Study|PPD test taken twice|1
878266|NCT00574275|1841074|FG000|Overall Study|Randomized but not treated|2
878267|NCT00574275|1841075|FG001|Overall Study|Randomized but not treated|3
878268|NCT00574275|1841074|FG000|Overall Study|Adverse Event|32
878269|NCT00574275|1841075|FG001|Overall Study|Adverse Event|76
878270|NCT00574275|1841074|FG000|Overall Study|Disease progression|160
878271|NCT00574275|1841075|FG001|Overall Study|Disease progression|146
878272|NCT00574275|1841074|FG000|Overall Study|Lost to Follow-up|2
878273|NCT00574275|1841075|FG001|Overall Study|Lost to Follow-up|1
878274|NCT00574275|1841074|FG000|Overall Study|Study stopped based on DMC decision|62
878275|NCT00574275|1841075|FG001|Overall Study|Study stopped based on DMC decision|23
878276|NCT00574275|1841074|FG000|Overall Study|Withdrawal by Subject|15
878277|NCT00574275|1841075|FG001|Overall Study|Withdrawal by Subject|17
878278|NCT00574275|1841074|FG000|Overall Study|Error calculating tumor measurement|1
878279|NCT00574275|1841075|FG001|Overall Study|Error calculating tumor measurement|0
878280|NCT00574275|1841074|FG000|Overall Study|Physician Decision|1
1184127|NCT03142334|2342197|FG000|Overall Study|Death|18
1184128|NCT03142334|2342198|FG001|Overall Study|Death|33
1184129|NCT03142334|2342197|FG000|Overall Study|Withdrawal by Subject|15
1184130|NCT03142334|2342198|FG001|Overall Study|Withdrawal by Subject|11
1184131|NCT03142334|2342197|FG000|Overall Study|Ongoing on trial follow up|463
1184132|NCT03142334|2342198|FG001|Overall Study|Ongoing on trial follow up|454
1184133|NCT02908685|2342288|FG000|Part 1 Exploratory|Withdrawal by Subject|0
1184134|NCT02908685|2342289|FG001|Part 1 Exploratory|Withdrawal by Subject|1
878281|NCT00574275|1841075|FG001|Overall Study|Physician Decision|1
878282|NCT00574275|1841074|FG000|Overall Study|Protocol Violation|0
878283|NCT00574275|1841075|FG001|Overall Study|Protocol Violation|1
878284|NCT00574275|1841074|FG000|Overall Study|Patient and Investigator decision|0
878285|NCT00574275|1841075|FG001|Overall Study|Patient and Investigator decision|1
878286|NCT00574275|1841074|FG000|Overall Study|Insurance change|0
878287|NCT00574275|1841075|FG001|Overall Study|Insurance change|1
878288|NCT00574275|1841074|FG000|Overall Study|Operation for curative intent|0
878289|NCT00574275|1841075|FG001|Overall Study|Operation for curative intent|1
878290|NCT00574288|1841088|FG000|Overall Study|Adverse Event|2
878291|NCT00574288|1841089|FG001|Overall Study|Adverse Event|0
878292|NCT00574288|1841090|FG002|Overall Study|Adverse Event|0
878293|NCT00574288|1841091|FG003|Overall Study|Adverse Event|0
878294|NCT00574288|1841092|FG004|Overall Study|Adverse Event|1
878295|NCT00574288|1841093|FG005|Overall Study|Adverse Event|0
878296|NCT00574288|1841094|FG006|Overall Study|Adverse Event|0
878297|NCT00574288|1841088|FG000|Overall Study|Death|0
878298|NCT00574288|1841089|FG001|Overall Study|Death|0
878299|NCT00574288|1841090|FG002|Overall Study|Death|0
878300|NCT00574288|1841091|FG003|Overall Study|Death|0
878301|NCT00574288|1841092|FG004|Overall Study|Death|0
878302|NCT00574288|1841093|FG005|Overall Study|Death|25
878303|NCT00574288|1841094|FG006|Overall Study|Death|21
878304|NCT00574288|1841088|FG000|Overall Study|Lost to Follow-up|0
878305|NCT00574288|1841089|FG001|Overall Study|Lost to Follow-up|0
878306|NCT00574288|1841090|FG002|Overall Study|Lost to Follow-up|0
878307|NCT00574288|1841091|FG003|Overall Study|Lost to Follow-up|0
878308|NCT00574288|1841092|FG004|Overall Study|Lost to Follow-up|0
878309|NCT00574288|1841093|FG005|Overall Study|Lost to Follow-up|1
878310|NCT00574288|1841094|FG006|Overall Study|Lost to Follow-up|2
878311|NCT00574288|1841088|FG000|Overall Study|Study Terminated By Sponsor|0
878312|NCT00574288|1841089|FG001|Overall Study|Study Terminated By Sponsor|0
878313|NCT00574288|1841090|FG002|Overall Study|Study Terminated By Sponsor|0
878314|NCT00574288|1841091|FG003|Overall Study|Study Terminated By Sponsor|0
878315|NCT00574288|1841092|FG004|Overall Study|Study Terminated By Sponsor|0
878316|NCT00574288|1841093|FG005|Overall Study|Study Terminated By Sponsor|0
878317|NCT00574288|1841094|FG006|Overall Study|Study Terminated By Sponsor|5
878318|NCT00574288|1841088|FG000|Overall Study|Progressive Disease|17
878319|NCT00574288|1841089|FG001|Overall Study|Progressive Disease|2
878320|NCT00574288|1841090|FG002|Overall Study|Progressive Disease|3
878321|NCT00574288|1841091|FG003|Overall Study|Progressive Disease|2
878322|NCT00574288|1841092|FG004|Overall Study|Progressive Disease|1
1184135|NCT02908685|2342290|FG002|Part 1 Exploratory|Withdrawal by Subject|0
1184136|NCT02908685|2342291|FG003|Part 1 Exploratory|Withdrawal by Subject|0
1184137|NCT02908685|2342292|FG004|Part 1 Exploratory|Withdrawal by Subject|0
1184138|NCT02908685|2342293|FG005|Part 1 Exploratory|Withdrawal by Subject|0
1184139|NCT02908685|2342294|FG006|Part 1 Exploratory|Withdrawal by Subject|0
1184140|NCT02908685|2342295|FG007|Part 1 Exploratory|Withdrawal by Subject|0
1184141|NCT02908685|2342296|FG008|Part 1 Exploratory|Withdrawal by Subject|0
1184142|NCT02908685|2342297|FG009|Part 1 Exploratory|Withdrawal by Subject|0
1184143|NCT02908685|2342298|FG010|Part 1 Exploratory|Withdrawal by Subject|0
1184144|NCT02908685|2342299|FG011|Part 1 Exploratory|Withdrawal by Subject|0
1184145|NCT02908685|2342288|FG000|Part 2 Confirmatory|Changed to Spinraza|0
1184146|NCT02908685|2342289|FG001|Part 2 Confirmatory|Changed to Spinraza|0
1184147|NCT02908685|2342290|FG002|Part 2 Confirmatory|Changed to Spinraza|0
1184148|NCT02908685|2342291|FG003|Part 2 Confirmatory|Changed to Spinraza|0
1184149|NCT02908685|2342292|FG004|Part 2 Confirmatory|Changed to Spinraza|0
1184150|NCT02908685|2342293|FG005|Part 2 Confirmatory|Changed to Spinraza|0
1184151|NCT02908685|2342294|FG006|Part 2 Confirmatory|Changed to Spinraza|0
1184152|NCT02908685|2342295|FG007|Part 2 Confirmatory|Changed to Spinraza|0
1184153|NCT02908685|2342296|FG008|Part 2 Confirmatory|Changed to Spinraza|0
1184154|NCT02908685|2342297|FG009|Part 2 Confirmatory|Changed to Spinraza|0
1184155|NCT02908685|2342298|FG010|Part 2 Confirmatory|Changed to Spinraza|2
1184156|NCT02908685|2342299|FG011|Part 2 Confirmatory|Changed to Spinraza|1
1184157|NCT02908685|2342288|FG000|Part 2 Confirmatory|Changed to other treatment|0
1184158|NCT02908685|2342289|FG001|Part 2 Confirmatory|Changed to other treatment|0
1184159|NCT02908685|2342290|FG002|Part 2 Confirmatory|Changed to other treatment|0
1184160|NCT02908685|2342291|FG003|Part 2 Confirmatory|Changed to other treatment|0
1184161|NCT02908685|2342292|FG004|Part 2 Confirmatory|Changed to other treatment|0
1184162|NCT02908685|2342293|FG005|Part 2 Confirmatory|Changed to other treatment|0
1184163|NCT02908685|2342294|FG006|Part 2 Confirmatory|Changed to other treatment|0
1184164|NCT02908685|2342295|FG007|Part 2 Confirmatory|Changed to other treatment|0
1184165|NCT02908685|2342296|FG008|Part 2 Confirmatory|Changed to other treatment|0
1184166|NCT02908685|2342297|FG009|Part 2 Confirmatory|Changed to other treatment|0
1184167|NCT02908685|2342298|FG010|Part 2 Confirmatory|Changed to other treatment|1
1184168|NCT02908685|2342299|FG011|Part 2 Confirmatory|Changed to other treatment|0
1184177|NCT02857426|2342329|FG000|Overall Study|Disease progression|34
1184178|NCT02857426|2342330|FG001|Overall Study|Disease progression|13
1184179|NCT02857426|2342329|FG000|Overall Study|Study drug toxicity|4
1184180|NCT02857426|2342330|FG001|Overall Study|Study drug toxicity|1
1184181|NCT02857426|2342329|FG000|Overall Study|Death|1
1184182|NCT02857426|2342330|FG001|Overall Study|Death|0
1184183|NCT02857426|2342329|FG000|Overall Study|Adverse event unrelated to study drug|6
1184184|NCT02857426|2342330|FG001|Overall Study|Adverse event unrelated to study drug|2
1184185|NCT02857426|2342329|FG000|Overall Study|Participant withdrew consent|1
1184186|NCT02857426|2342330|FG001|Overall Study|Participant withdrew consent|1
1184187|NCT02857426|2342329|FG000|Overall Study|Maximum clinical benefit|1
1184188|NCT02857426|2342330|FG001|Overall Study|Maximum clinical benefit|0
1184189|NCT02857426|2342329|FG000|Overall Study|Completed treatment|0
1184190|NCT02857426|2342330|FG001|Overall Study|Completed treatment|2
1184191|NCT02855125|2342338|FG000|Overall Study|Withdrawal by Subject|2
1184192|NCT02855125|2342339|FG001|Overall Study|Withdrawal by Subject|2
1184193|NCT02855125|2342338|FG000|Overall Study|Clinical Disease Progression|5
1184194|NCT02855125|2342339|FG001|Overall Study|Clinical Disease Progression|4
1184195|NCT02855125|2342338|FG000|Overall Study|Radiologic Disease Progression|36
1184196|NCT02855125|2342339|FG001|Overall Study|Radiologic Disease Progression|39
1184197|NCT02855125|2342338|FG000|Overall Study|Adverse Event|11
1184198|NCT02855125|2342339|FG001|Overall Study|Adverse Event|7
1184199|NCT02855125|2342338|FG000|Overall Study|Physician Decision|1
1184200|NCT02855125|2342339|FG001|Overall Study|Physician Decision|0
1184201|NCT02855125|2342338|FG000|Overall Study|On Treatment|9
878323|NCT00574288|1841093|FG005|Overall Study|Progressive Disease|0
878324|NCT00574288|1841094|FG006|Overall Study|Progressive Disease|0
878325|NCT00574288|1841088|FG000|Overall Study|Other|1
878326|NCT00574288|1841089|FG001|Overall Study|Other|1
878327|NCT00574288|1841090|FG002|Overall Study|Other|0
878328|NCT00574288|1841091|FG003|Overall Study|Other|0
878329|NCT00574288|1841092|FG004|Overall Study|Other|0
878330|NCT00574288|1841093|FG005|Overall Study|Other|0
878331|NCT00574288|1841094|FG006|Overall Study|Other|0
878332|NCT00574405|1841129|FG000|Overall Study|Withdrawal by Subject|3
878333|NCT00574405|1841130|FG001|Overall Study|Withdrawal by Subject|2
878334|NCT00574795|1841198|FG000|Infant Series|Withdrawal by Subject|2
878335|NCT00574795|1841198|FG000|Infant Series|Protocol Violation|2
878336|NCT00574795|1841198|FG000|Infant Series|Adverse Event|1
878337|NCT00574795|1841198|FG000|After Infant Series|Withdrawal by Subject|1
1184202|NCT02855125|2342339|FG001|Overall Study|On Treatment|11
1184203|NCT02855125|2342338|FG000|Overall Study|Randomized but not treated|0
1184204|NCT02855125|2342339|FG001|Overall Study|Randomized but not treated|1
1184205|NCT02836236|2342347|FG000|Overall Study|Randomized but Never Treated|1
1184206|NCT02836236|2342348|FG001|Overall Study|Randomized but Never Treated|0
1184207|NCT02836236|2342347|FG000|Overall Study|Withdrew Consent|2
1184208|NCT02836236|2342348|FG001|Overall Study|Withdrew Consent|0
1184209|NCT02836236|2342347|FG000|Overall Study|Adverse Event|0
1184210|NCT02836236|2342348|FG001|Overall Study|Adverse Event|1
1184211|NCT02836236|2342347|FG000|Overall Study|Investigator's Discretion|1
1184212|NCT02836236|2342348|FG001|Overall Study|Investigator's Discretion|0
1184213|NCT02836236|2342347|FG000|Overall Study|Still on Study|101
1184214|NCT02836236|2342348|FG001|Overall Study|Still on Study|49
1184215|NCT02831764|2342356|FG000|Overall Study|Protocol specific withdrawal criteria|0
1184216|NCT02831764|2342357|FG001|Overall Study|Protocol specific withdrawal criteria|2
1184217|NCT02831764|2342356|FG000|Overall Study|Withdrawal by Subject|7
1184218|NCT02831764|2342357|FG001|Overall Study|Withdrawal by Subject|6
1184219|NCT02831764|2342356|FG000|Overall Study|Physician Decision|2
1184220|NCT02831764|2342357|FG001|Overall Study|Physician Decision|2
1184221|NCT02831764|2342356|FG000|Overall Study|Lost to Follow-up|6
1184222|NCT02831764|2342357|FG001|Overall Study|Lost to Follow-up|5
1184223|NCT02831764|2342356|FG000|Overall Study|Adverse Event|8
1184224|NCT02831764|2342357|FG001|Overall Study|Adverse Event|5
1184225|NCT02831764|2342356|FG000|Overall Study|Lack of Efficacy|2
1184226|NCT02831764|2342357|FG001|Overall Study|Lack of Efficacy|2
1184227|NCT02831764|2342356|FG000|Overall Study|Protocol Violation|5
1184228|NCT02831764|2342357|FG001|Overall Study|Protocol Violation|2
1184229|NCT02831764|2342356|FG000|Overall Study|Ongoing at the time of the analysis|330
1184230|NCT02831764|2342357|FG001|Overall Study|Ongoing at the time of the analysis|335
1184231|NCT02680587|2342375|FG000|Overall Study|Withdrawal by Subject|1
1184232|NCT02680587|2342376|FG001|Overall Study|Withdrawal by Subject|0
1184233|NCT02652949|2342397|FG000|30-Day Follow-up for Primary Endpoint|Death|1
1184234|NCT02652949|2342397|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
878338|NCT00574795|1841198|FG000|After Infant Series|Adverse Event|2
878339|NCT00574795|1841198|FG000|Toddler Dose|Withdrawal by Subject|1
878340|NCT00574847|1841228|FG000|Overall Study|Adverse Event|2
878341|NCT00574847|1841229|FG001|Overall Study|Adverse Event|0
878342|NCT00574847|1841228|FG000|Overall Study|Death|1
878343|NCT00574847|1841229|FG001|Overall Study|Death|0
878344|NCT00574847|1841228|FG000|Overall Study|Withdrawal by Subject|2
878345|NCT00574847|1841229|FG001|Overall Study|Withdrawal by Subject|2
878346|NCT00574847|1841228|FG000|Overall Study|Physician Decision|1
878347|NCT00574847|1841229|FG001|Overall Study|Physician Decision|0
878348|NCT00574847|1841228|FG000|Overall Study|Did not receive medication (declined)|2
878349|NCT00574847|1841229|FG001|Overall Study|Did not receive medication (declined)|5
878350|NCT00574873|1841237|FG000|Overall Study|Withdrawal by Subject|18
878351|NCT00574873|1841238|FG001|Overall Study|Withdrawal by Subject|19
878352|NCT00574873|1841237|FG000|Overall Study|Investigator request|18
878353|NCT00574873|1841238|FG001|Overall Study|Investigator request|8
878354|NCT00574873|1841237|FG000|Overall Study|Death|15
878355|NCT00574873|1841238|FG001|Overall Study|Death|14
878356|NCT00574873|1841237|FG000|Overall Study|Lost to Follow-up|14
878357|NCT00574873|1841238|FG001|Overall Study|Lost to Follow-up|5
878358|NCT00574873|1841237|FG000|Overall Study|Other|40
878359|NCT00574873|1841238|FG001|Overall Study|Other|4
878360|NCT00574873|1841237|FG000|Overall Study|Discontinuation of study by sponsor|5
878361|NCT00574873|1841238|FG001|Overall Study|Discontinuation of study by sponsor|199
878362|NCT00574873|1841237|FG000|Overall Study|Blank, site closed per local regulations|2
878363|NCT00574873|1841238|FG001|Overall Study|Blank, site closed per local regulations|2
878364|NCT00574873|1841237|FG000|Overall Study|Extension Study|126
878365|NCT00574873|1841238|FG001|Overall Study|Extension Study|0
878366|NCT00574912|1841244|FG000|Overall Study|Could not place IV lines.|3
878367|NCT00574912|1841244|FG000|Overall Study|scheduling conflicts|3
878368|NCT00574912|1841244|FG000|Overall Study|Physician Decision|2
878369|NCT00574951|1841256|FG000|Overall Study|Ineligible - improper prior treatment|1
878370|NCT00575042|1841297|FG000|Overall Study|Adverse Event|2
878371|NCT00575042|1841297|FG000|Overall Study|Lost to Follow-up|1
878372|NCT00575094|1841302|FG000|Overall Study|Adverse Event|2
1184235|NCT02652949|2342397|FG000|6-Month Follow-up Secondary Endpoint|Death|5
1184236|NCT02652949|2342397|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
1184237|NCT02652949|2342397|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
1184238|NCT02652949|2342397|FG000|12-Month Follow-up Secondary Endpoint|Death|4
1184239|NCT02652949|2342397|FG000|24-Month Follow-up Secondary Endpoint|Death|2
1184240|NCT02652949|2342397|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
1184241|NCT02652949|2342397|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
1184242|NCT02652949|2342397|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28
1184243|NCT02574455|2342409|FG000|Overall Study|Death|197
1184244|NCT02574455|2342410|FG001|Overall Study|Death|210
1184245|NCT02574455|2342409|FG000|Overall Study|Withdrawal of Consent|11
1184246|NCT02574455|2342410|FG001|Overall Study|Withdrawal of Consent|28
1184247|NCT02574455|2342409|FG000|Overall Study|Lost to Follow-up|4
1184248|NCT02574455|2342410|FG001|Overall Study|Lost to Follow-up|4
1184249|NCT02574455|2342409|FG000|Overall Study|Sponsor's Decision|55
1184250|NCT02574455|2342410|FG001|Overall Study|Sponsor's Decision|20
1184251|NCT02527798|2342426|FG000|Overall Study|Physician Decision|1
1184252|NCT02527798|2342427|FG001|Overall Study|Physician Decision|0
1184253|NCT02527798|2342428|FG002|Overall Study|Physician Decision|1
1184254|NCT02527798|2342429|FG003|Overall Study|Physician Decision|1
1184255|NCT02527798|2342430|FG004|Overall Study|Physician Decision|0
1184256|NCT02527798|2342431|FG005|Overall Study|Physician Decision|0
1184257|NCT02527798|2342426|FG000|Overall Study|Death|0
1184258|NCT02527798|2342427|FG001|Overall Study|Death|0
1184259|NCT02527798|2342428|FG002|Overall Study|Death|1
1184260|NCT02527798|2342429|FG003|Overall Study|Death|0
1184261|NCT02527798|2342430|FG004|Overall Study|Death|0
1184262|NCT02527798|2342431|FG005|Overall Study|Death|0
1184263|NCT02527798|2342426|FG000|Overall Study|Withdrawal by Subject|0
1184264|NCT02527798|2342427|FG001|Overall Study|Withdrawal by Subject|1
1184265|NCT02527798|2342428|FG002|Overall Study|Withdrawal by Subject|2
1184266|NCT02527798|2342429|FG003|Overall Study|Withdrawal by Subject|0
1184267|NCT02527798|2342430|FG004|Overall Study|Withdrawal by Subject|0
1184268|NCT02527798|2342431|FG005|Overall Study|Withdrawal by Subject|0
1184269|NCT02527798|2342426|FG000|Overall Study|Reason undisclosed|1
1184270|NCT02527798|2342427|FG001|Overall Study|Reason undisclosed|0
1184271|NCT02527798|2342428|FG002|Overall Study|Reason undisclosed|1
1184272|NCT02527798|2342429|FG003|Overall Study|Reason undisclosed|0
1184273|NCT02527798|2342430|FG004|Overall Study|Reason undisclosed|0
1184274|NCT02527798|2342431|FG005|Overall Study|Reason undisclosed|0
1184275|NCT02527798|2342426|FG000|Overall Study|Did not receive intervention|1
1184276|NCT02527798|2342427|FG001|Overall Study|Did not receive intervention|1
1184277|NCT02527798|2342428|FG002|Overall Study|Did not receive intervention|0
1184278|NCT02527798|2342429|FG003|Overall Study|Did not receive intervention|0
1184279|NCT02527798|2342430|FG004|Overall Study|Did not receive intervention|0
1184280|NCT02527798|2342431|FG005|Overall Study|Did not receive intervention|0
1184281|NCT02279745|2342482|FG000|Overall Study|Adverse Event|7
878373|NCT00575094|1841302|FG000|Overall Study|Withdrawal by Subject|1
878374|NCT00575328|1841339|FG000|Overall Study|Adverse Event|1
878375|NCT00575328|1841340|FG001|Overall Study|Adverse Event|1
878376|NCT00575328|1841339|FG000|Overall Study|Lost to Follow-up|2
878377|NCT00575328|1841340|FG001|Overall Study|Lost to Follow-up|1
878378|NCT00575380|1841357|FG000|Overall Study|Withdrawal by Subject|1
878379|NCT00575380|1841358|FG001|Overall Study|Withdrawal by Subject|0
878380|NCT00575380|1841357|FG000|Overall Study|Adverse Event|0
878381|NCT00575380|1841358|FG001|Overall Study|Adverse Event|1
878382|NCT00575380|1841357|FG000|Overall Study|Various|0
878383|NCT00575380|1841358|FG001|Overall Study|Various|2
878384|NCT00575510|1841367|FG000|Overall Study|Lost to Follow-up|4
878385|NCT00575510|1841368|FG001|Overall Study|Lost to Follow-up|6
878386|NCT00575510|1841369|FG002|Overall Study|Lost to Follow-up|9
878387|NCT00575510|1841367|FG000|Overall Study|Withdrawal by Subject|1
878388|NCT00575510|1841368|FG001|Overall Study|Withdrawal by Subject|0
878389|NCT00575510|1841369|FG002|Overall Study|Withdrawal by Subject|0
878390|NCT00575510|1841367|FG000|Overall Study|Clinic Called Patient|7
878391|NCT00575510|1841368|FG001|Overall Study|Clinic Called Patient|7
878392|NCT00575510|1841369|FG002|Overall Study|Clinic Called Patient|7
878393|NCT00575510|1841367|FG000|Overall Study|Pregnancy|0
878394|NCT00575510|1841368|FG001|Overall Study|Pregnancy|0
878395|NCT00575510|1841369|FG002|Overall Study|Pregnancy|1
878396|NCT00575588|1841380|FG000|Overall Study|Adverse Event|11
878397|NCT00575588|1841381|FG001|Overall Study|Adverse Event|13
878398|NCT00575588|1841380|FG000|Overall Study|Withdrawal by Subject|27
878399|NCT00575588|1841381|FG001|Overall Study|Withdrawal by Subject|31
878400|NCT00575588|1841380|FG000|Overall Study|Lost to Follow-up|1
878401|NCT00575588|1841381|FG001|Overall Study|Lost to Follow-up|3
878402|NCT00575588|1841380|FG000|Overall Study|Death|4
878403|NCT00575588|1841381|FG001|Overall Study|Death|2
878404|NCT00575588|1841380|FG000|Overall Study|Incorrect enrollment|8
878405|NCT00575588|1841381|FG001|Overall Study|Incorrect enrollment|4
878406|NCT00575588|1841380|FG000|Overall Study|Study specific discontinuation criteria|203
878407|NCT00575588|1841381|FG001|Overall Study|Study specific discontinuation criteria|218
878408|NCT00575588|1841380|FG000|Overall Study|Severe non-compliance to protocol|5
1184282|NCT02279745|2342482|FG000|Overall Study|Death|6
1184283|NCT02279745|2342482|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2
1184284|NCT02279745|2342482|FG000|Overall Study|Withdrawal by Subject|2
878409|NCT00575588|1841381|FG001|Overall Study|Severe non-compliance to protocol|7
878410|NCT00575588|1841380|FG000|Overall Study|Safety reasons|2
878411|NCT00575588|1841381|FG001|Overall Study|Safety reasons|1
878412|NCT00575588|1841380|FG000|Overall Study|Elevated triglyceride|1
878413|NCT00575588|1841381|FG001|Overall Study|Elevated triglyceride|0
878414|NCT00575588|1841380|FG000|Overall Study|Patient moved|1
878415|NCT00575588|1841381|FG001|Overall Study|Patient moved|3
878416|NCT00575588|1841380|FG000|Overall Study|Impossible to determine HbA1c|0
878417|NCT00575588|1841381|FG001|Overall Study|Impossible to determine HbA1c|1
878418|NCT00575666|1841389|FG000|Overall Study|Withdrawal by Subject|3
878419|NCT00575666|1841390|FG001|Overall Study|Withdrawal by Subject|2
878420|NCT00575666|1841389|FG000|Overall Study|Physician Decision|1
878421|NCT00575666|1841390|FG001|Overall Study|Physician Decision|1
878422|NCT00576056|1841404|FG000|Overall Study|Adverse Event|1
878423|NCT00576056|1841404|FG000|Overall Study|Death|1
878424|NCT00576056|1841404|FG000|Overall Study|Lack of Efficacy|1
878425|NCT00576056|1841404|FG000|Overall Study|Withdrawal by Subject|2
878426|NCT00576056|1841404|FG000|Overall Study|did not meet eligibility criteria|8
878427|NCT00576056|1841404|FG000|Overall Study|Physician Decision|1
878428|NCT00576199|1841412|FG000|Overall Study|Adverse Event|12
878429|NCT00576199|1841412|FG000|Overall Study|Insufficient Therapeutic Response|14
878430|NCT00576199|1841412|FG000|Overall Study|Refused Treatment|2
878431|NCT00576199|1841412|FG000|Overall Study|Reason Unspecified|2
878432|NCT00576303|1841425|FG000|Dose Titration Period|Early withdrawal|17
878433|NCT00576303|1841425|FG000|Efficacy Evaluation Period|Early withdrawal|5
878434|NCT00576303|1841425|FG000|Long Term Safety Period|Early withdrawal|16
878435|NCT00576316|1841429|FG000|Overall Study|Adverse Event|9
878436|NCT00576316|1841429|FG000|Overall Study|Withdrawal by Subject|2
878437|NCT00576316|1841429|FG000|Overall Study|Protocol Violation|9
878438|NCT00576381|1841433|FG000|Overall Study|Reoperation|3
878439|NCT00576381|1841433|FG000|Overall Study|Adverse Event|4
878440|NCT00576407|1841437|FG000|Overall Study|Death|7
878441|NCT00576407|1841437|FG000|Overall Study|Physician Decision|1
878442|NCT00576420|1841445|FG000|Overall Study|Death|0
878443|NCT00576420|1841446|FG001|Overall Study|Death|0
878444|NCT00576420|1841447|FG002|Overall Study|Death|1
878445|NCT00576472|1841511|FG000|MPH In-Lab Phase|Declined participation in medication pha|0
878446|NCT00576472|1841512|FG001|MPH In-Lab Phase|Declined participation in medication pha|0
878447|NCT00576472|1841513|FG002|MPH In-Lab Phase|Declined participation in medication pha|0
878448|NCT00576472|1841514|FG003|MPH In-Lab Phase|Declined participation in medication pha|75
878449|NCT00576472|1841515|FG004|MPH In-Lab Phase|Declined participation in medication pha|0
878450|NCT00576472|1841516|FG005|MPH In-Lab Phase|Declined participation in medication pha|0
878451|NCT00576472|1841517|FG006|MPH In-Lab Phase|Declined participation in medication pha|0
878452|NCT00576472|1841518|FG007|MPH In-Lab Phase|Declined participation in medication pha|0
878453|NCT00576472|1841519|FG008|MPH In-Lab Phase|Declined participation in medication pha|0
878454|NCT00576472|1841520|FG009|MPH In-Lab Phase|Declined participation in medication pha|0
878455|NCT00576472|1841521|FG010|MPH In-Lab Phase|Declined participation in medication pha|0
878456|NCT00576472|1841522|FG011|MPH In-Lab Phase|Declined participation in medication pha|0
878457|NCT00576472|1841523|FG012|MPH In-Lab Phase|Declined participation in medication pha|0
878458|NCT00576472|1841524|FG013|MPH In-Lab Phase|Declined participation in medication pha|0
878459|NCT00576472|1841525|FG014|MPH In-Lab Phase|Declined participation in medication pha|0
878460|NCT00576472|1841511|FG000|MPH In-Lab Phase|Lost to Follow-up|0
878461|NCT00576472|1841512|FG001|MPH In-Lab Phase|Lost to Follow-up|0
878462|NCT00576472|1841513|FG002|MPH In-Lab Phase|Lost to Follow-up|0
878463|NCT00576472|1841514|FG003|MPH In-Lab Phase|Lost to Follow-up|1
878464|NCT00576472|1841515|FG004|MPH In-Lab Phase|Lost to Follow-up|0
878465|NCT00576472|1841516|FG005|MPH In-Lab Phase|Lost to Follow-up|0
878466|NCT00576472|1841517|FG006|MPH In-Lab Phase|Lost to Follow-up|0
878467|NCT00576472|1841518|FG007|MPH In-Lab Phase|Lost to Follow-up|0
878468|NCT00576472|1841519|FG008|MPH In-Lab Phase|Lost to Follow-up|0
878469|NCT00576472|1841520|FG009|MPH In-Lab Phase|Lost to Follow-up|0
878470|NCT00576472|1841521|FG010|MPH In-Lab Phase|Lost to Follow-up|0
878471|NCT00576472|1841522|FG011|MPH In-Lab Phase|Lost to Follow-up|0
878472|NCT00576472|1841523|FG012|MPH In-Lab Phase|Lost to Follow-up|0
878473|NCT00576472|1841524|FG013|MPH In-Lab Phase|Lost to Follow-up|0
878474|NCT00576472|1841525|FG014|MPH In-Lab Phase|Lost to Follow-up|0
878475|NCT00576472|1841511|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878476|NCT00576472|1841512|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878477|NCT00576472|1841513|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878478|NCT00576472|1841514|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
878479|NCT00576472|1841515|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878480|NCT00576472|1841516|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878481|NCT00576472|1841517|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878482|NCT00576472|1841518|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878483|NCT00576472|1841519|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878484|NCT00576472|1841520|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1184285|NCT02279745|2342482|FG000|Overall Study|Pregnancy|1
1184286|NCT02279745|2342482|FG000|Overall Study|Study Non-compliance|1
1184287|NCT02279745|2342482|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1
1184288|NCT02030938|2342514|FG000|Overall Study|Lost to Follow-up|4
1184289|NCT02030938|2342514|FG000|Overall Study|Withdrawal by Subject|1
1184290|NCT02006147|2342526|FG000|Overall Study|Protocol Violation|1
1184291|NCT02006147|2342527|FG001|Overall Study|Protocol Violation|1
1184292|NCT02006147|2342528|FG002|Overall Study|Protocol Violation|0
1184293|NCT02006147|2342529|FG003|Overall Study|Protocol Violation|0
1184294|NCT02006147|2342526|FG000|Overall Study|Withdrawal by Subject|0
1184295|NCT02006147|2342527|FG001|Overall Study|Withdrawal by Subject|1
1184296|NCT02006147|2342528|FG002|Overall Study|Withdrawal by Subject|0
1184297|NCT02006147|2342529|FG003|Overall Study|Withdrawal by Subject|0
1184298|NCT02006147|2342526|FG000|Overall Study|Withdrawal by Sponsor|1
1184299|NCT02006147|2342527|FG001|Overall Study|Withdrawal by Sponsor|0
1184300|NCT02006147|2342528|FG002|Overall Study|Withdrawal by Sponsor|0
1184301|NCT02006147|2342529|FG003|Overall Study|Withdrawal by Sponsor|0
1184302|NCT01999179|2342535|FG000|Overall Study|Adverse Event|1
1184303|NCT01999179|2342535|FG000|Overall Study|Lost to Follow-up|1
1184304|NCT01999179|2342535|FG000|Overall Study|Change in Therapy|3
1184305|NCT01999179|2342535|FG000|Overall Study|New catheter|2
1184306|NCT01940341|2342541|FG000|Double-Blind Phase|Randomized but Never Treated|0
1184307|NCT01940341|2342542|FG001|Double-Blind Phase|Randomized but Never Treated|1
1184308|NCT01940341|2342541|FG000|Double-Blind Phase|Adverse Event|3
1184309|NCT01940341|2342542|FG001|Double-Blind Phase|Adverse Event|2
1184310|NCT01940341|2342541|FG000|Double-Blind Phase|Withdrew Consent|3
1184311|NCT01940341|2342542|FG001|Double-Blind Phase|Withdrew Consent|2
1184312|NCT01940341|2342541|FG000|Double-Blind Phase|Lost to Follow-up|4
1184313|NCT01940341|2342542|FG001|Double-Blind Phase|Lost to Follow-up|1
1184314|NCT01940341|2342541|FG000|Double-Blind Phase|Pregnancy|0
1184315|NCT01940341|2342542|FG001|Double-Blind Phase|Pregnancy|1
1184316|NCT01940341|2342541|FG000|Double-Blind Phase|Investigator's Discretion|1
1184317|NCT01940341|2342542|FG001|Double-Blind Phase|Investigator's Discretion|0
878485|NCT00576472|1841521|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878486|NCT00576472|1841522|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878487|NCT00576472|1841523|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878488|NCT00576472|1841524|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878489|NCT00576472|1841525|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
878490|NCT00576472|1841511|FG000|MPH In-Lab Phase|No attention/academic problems|0
878491|NCT00576472|1841512|FG001|MPH In-Lab Phase|No attention/academic problems|0
878492|NCT00576472|1841513|FG002|MPH In-Lab Phase|No attention/academic problems|0
878493|NCT00576472|1841514|FG003|MPH In-Lab Phase|No attention/academic problems|245
878494|NCT00576472|1841515|FG004|MPH In-Lab Phase|No attention/academic problems|0
878495|NCT00576472|1841516|FG005|MPH In-Lab Phase|No attention/academic problems|0
878496|NCT00576472|1841517|FG006|MPH In-Lab Phase|No attention/academic problems|0
878497|NCT00576472|1841518|FG007|MPH In-Lab Phase|No attention/academic problems|0
878498|NCT00576472|1841519|FG008|MPH In-Lab Phase|No attention/academic problems|0
878499|NCT00576472|1841520|FG009|MPH In-Lab Phase|No attention/academic problems|0
878500|NCT00576472|1841521|FG010|MPH In-Lab Phase|No attention/academic problems|0
878501|NCT00576472|1841522|FG011|MPH In-Lab Phase|No attention/academic problems|0
878502|NCT00576472|1841523|FG012|MPH In-Lab Phase|No attention/academic problems|0
878503|NCT00576472|1841524|FG013|MPH In-Lab Phase|No attention/academic problems|0
878504|NCT00576472|1841525|FG014|MPH In-Lab Phase|No attention/academic problems|0
878505|NCT00576472|1841511|FG000|MPH In-Lab Phase|Psychiatric exclusion|0
878506|NCT00576472|1841512|FG001|MPH In-Lab Phase|Psychiatric exclusion|0
878507|NCT00576472|1841513|FG002|MPH In-Lab Phase|Psychiatric exclusion|0
878508|NCT00576472|1841514|FG003|MPH In-Lab Phase|Psychiatric exclusion|10
878509|NCT00576472|1841515|FG004|MPH In-Lab Phase|Psychiatric exclusion|0
878510|NCT00576472|1841516|FG005|MPH In-Lab Phase|Psychiatric exclusion|0
878511|NCT00576472|1841517|FG006|MPH In-Lab Phase|Psychiatric exclusion|0
878512|NCT00576472|1841518|FG007|MPH In-Lab Phase|Psychiatric exclusion|0
878513|NCT00576472|1841519|FG008|MPH In-Lab Phase|Psychiatric exclusion|0
878514|NCT00576472|1841520|FG009|MPH In-Lab Phase|Psychiatric exclusion|0
878515|NCT00576472|1841521|FG010|MPH In-Lab Phase|Psychiatric exclusion|0
878516|NCT00576472|1841522|FG011|MPH In-Lab Phase|Psychiatric exclusion|0
878517|NCT00576472|1841523|FG012|MPH In-Lab Phase|Psychiatric exclusion|0
878518|NCT00576472|1841524|FG013|MPH In-Lab Phase|Psychiatric exclusion|0
878519|NCT00576472|1841525|FG014|MPH In-Lab Phase|Psychiatric exclusion|0
878520|NCT00576472|1841511|FG000|MPH Cross Over Phase|Withdrawal by Subject|0
878521|NCT00576472|1841512|FG001|MPH Cross Over Phase|Withdrawal by Subject|0
878522|NCT00576472|1841513|FG002|MPH Cross Over Phase|Withdrawal by Subject|0
878523|NCT00576472|1841514|FG003|MPH Cross Over Phase|Withdrawal by Subject|0
878524|NCT00576472|1841515|FG004|MPH Cross Over Phase|Withdrawal by Subject|0
878525|NCT00576472|1841516|FG005|MPH Cross Over Phase|Withdrawal by Subject|0
878526|NCT00576472|1841517|FG006|MPH Cross Over Phase|Withdrawal by Subject|6
878527|NCT00576472|1841518|FG007|MPH Cross Over Phase|Withdrawal by Subject|0
878528|NCT00576472|1841519|FG008|MPH Cross Over Phase|Withdrawal by Subject|0
878529|NCT00576472|1841520|FG009|MPH Cross Over Phase|Withdrawal by Subject|0
878530|NCT00576472|1841521|FG010|MPH Cross Over Phase|Withdrawal by Subject|0
1184318|NCT01940341|2342541|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0
1184319|NCT01940341|2342542|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
1184320|NCT01940341|2342541|FG000|Double-Blind Phase|Protocol Specified Criteria|1
1184321|NCT01940341|2342542|FG001|Double-Blind Phase|Protocol Specified Criteria|0
1184322|NCT01940341|2342541|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269
1184323|NCT01940341|2342542|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132
1184324|NCT01940341|2342541|FG000|Open-label Extension Phase|Still on Study|4
1184325|NCT01940341|2342542|FG001|Open-label Extension Phase|Still on Study|1
1184326|NCT01925794|2342550|FG000|180 Days|Death|2
1184327|NCT01925794|2342550|FG000|180 Days|Withdrawal by Subject|2
1184328|NCT01925794|2342550|FG000|270 Days|Death|2
1184329|NCT01925794|2342550|FG000|270 Days|Protocol Violation|3
1184330|NCT01886872|2342570|FG000|Overall Study|Ineligible|7
1184331|NCT01886872|2342571|FG001|Overall Study|Ineligible|4
878531|NCT00576472|1841522|FG011|MPH Cross Over Phase|Withdrawal by Subject|0
878532|NCT00576472|1841523|FG012|MPH Cross Over Phase|Withdrawal by Subject|0
878533|NCT00576472|1841524|FG013|MPH Cross Over Phase|Withdrawal by Subject|0
878534|NCT00576472|1841525|FG014|MPH Cross Over Phase|Withdrawal by Subject|0
878535|NCT00576472|1841511|FG000|MPH Cross Over Phase|Ineligible due to disease|0
878536|NCT00576472|1841512|FG001|MPH Cross Over Phase|Ineligible due to disease|0
878537|NCT00576472|1841513|FG002|MPH Cross Over Phase|Ineligible due to disease|0
878538|NCT00576472|1841514|FG003|MPH Cross Over Phase|Ineligible due to disease|0
878539|NCT00576472|1841515|FG004|MPH Cross Over Phase|Ineligible due to disease|0
878540|NCT00576472|1841516|FG005|MPH Cross Over Phase|Ineligible due to disease|0
878541|NCT00576472|1841517|FG006|MPH Cross Over Phase|Ineligible due to disease|2
878542|NCT00576472|1841518|FG007|MPH Cross Over Phase|Ineligible due to disease|0
878543|NCT00576472|1841519|FG008|MPH Cross Over Phase|Ineligible due to disease|0
878544|NCT00576472|1841520|FG009|MPH Cross Over Phase|Ineligible due to disease|0
878545|NCT00576472|1841521|FG010|MPH Cross Over Phase|Ineligible due to disease|0
878546|NCT00576472|1841522|FG011|MPH Cross Over Phase|Ineligible due to disease|0
878547|NCT00576472|1841523|FG012|MPH Cross Over Phase|Ineligible due to disease|0
878548|NCT00576472|1841524|FG013|MPH Cross Over Phase|Ineligible due to disease|0
878549|NCT00576472|1841525|FG014|MPH Cross Over Phase|Ineligible due to disease|0
878550|NCT00576472|1841511|FG000|MPH Cross Over Phase|Physician Decision|0
878551|NCT00576472|1841512|FG001|MPH Cross Over Phase|Physician Decision|0
878552|NCT00576472|1841513|FG002|MPH Cross Over Phase|Physician Decision|0
878553|NCT00576472|1841514|FG003|MPH Cross Over Phase|Physician Decision|0
878554|NCT00576472|1841515|FG004|MPH Cross Over Phase|Physician Decision|0
878555|NCT00576472|1841516|FG005|MPH Cross Over Phase|Physician Decision|0
878556|NCT00576472|1841517|FG006|MPH Cross Over Phase|Physician Decision|4
878557|NCT00576472|1841518|FG007|MPH Cross Over Phase|Physician Decision|0
878558|NCT00576472|1841519|FG008|MPH Cross Over Phase|Physician Decision|0
878559|NCT00576472|1841520|FG009|MPH Cross Over Phase|Physician Decision|0
878560|NCT00576472|1841521|FG010|MPH Cross Over Phase|Physician Decision|0
878561|NCT00576472|1841522|FG011|MPH Cross Over Phase|Physician Decision|0
878562|NCT00576472|1841523|FG012|MPH Cross Over Phase|Physician Decision|0
878563|NCT00576472|1841524|FG013|MPH Cross Over Phase|Physician Decision|0
878564|NCT00576472|1841525|FG014|MPH Cross Over Phase|Physician Decision|0
878565|NCT00576472|1841511|FG000|MPH Cross Over Phase|Did not complete cross over phase|0
878566|NCT00576472|1841512|FG001|MPH Cross Over Phase|Did not complete cross over phase|0
878567|NCT00576472|1841513|FG002|MPH Cross Over Phase|Did not complete cross over phase|0
878568|NCT00576472|1841514|FG003|MPH Cross Over Phase|Did not complete cross over phase|0
878569|NCT00576472|1841515|FG004|MPH Cross Over Phase|Did not complete cross over phase|0
878570|NCT00576472|1841516|FG005|MPH Cross Over Phase|Did not complete cross over phase|0
878571|NCT00576472|1841517|FG006|MPH Cross Over Phase|Did not complete cross over phase|0
878572|NCT00576472|1841518|FG007|MPH Cross Over Phase|Did not complete cross over phase|0
878573|NCT00576472|1841519|FG008|MPH Cross Over Phase|Did not complete cross over phase|2
878574|NCT00576472|1841520|FG009|MPH Cross Over Phase|Did not complete cross over phase|0
878575|NCT00576472|1841521|FG010|MPH Cross Over Phase|Did not complete cross over phase|1
878576|NCT00576472|1841522|FG011|MPH Cross Over Phase|Did not complete cross over phase|1
878577|NCT00576472|1841523|FG012|MPH Cross Over Phase|Did not complete cross over phase|0
878578|NCT00576472|1841524|FG013|MPH Cross Over Phase|Did not complete cross over phase|0
878579|NCT00576472|1841525|FG014|MPH Cross Over Phase|Did not complete cross over phase|0
878580|NCT00576472|1841511|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0
878581|NCT00576472|1841512|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0
878582|NCT00576472|1841513|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0
878583|NCT00576472|1841514|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0
878584|NCT00576472|1841515|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0
878585|NCT00576472|1841516|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0
878586|NCT00576472|1841517|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0
878587|NCT00576472|1841518|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0
878588|NCT00576472|1841519|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0
878589|NCT00576472|1841520|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0
878590|NCT00576472|1841521|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0
878591|NCT00576472|1841522|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0
1006587|NCT01468701|2025296|FG011|Overall Study|Other reasons than listed|504
1184332|NCT01886872|2342572|FG002|Overall Study|Ineligible|12
878592|NCT00576472|1841523|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0
878593|NCT00576472|1841524|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16
878594|NCT00576472|1841525|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0
878595|NCT00576472|1841511|FG000|MPH Home Maintenance Phase|Declined to participate|0
878596|NCT00576472|1841512|FG001|MPH Home Maintenance Phase|Declined to participate|0
878597|NCT00576472|1841513|FG002|MPH Home Maintenance Phase|Declined to participate|0
878598|NCT00576472|1841514|FG003|MPH Home Maintenance Phase|Declined to participate|0
878599|NCT00576472|1841515|FG004|MPH Home Maintenance Phase|Declined to participate|0
878600|NCT00576472|1841516|FG005|MPH Home Maintenance Phase|Declined to participate|0
878601|NCT00576472|1841517|FG006|MPH Home Maintenance Phase|Declined to participate|0
878602|NCT00576472|1841518|FG007|MPH Home Maintenance Phase|Declined to participate|0
878603|NCT00576472|1841519|FG008|MPH Home Maintenance Phase|Declined to participate|0
878604|NCT00576472|1841520|FG009|MPH Home Maintenance Phase|Declined to participate|0
878605|NCT00576472|1841521|FG010|MPH Home Maintenance Phase|Declined to participate|0
878606|NCT00576472|1841522|FG011|MPH Home Maintenance Phase|Declined to participate|0
878607|NCT00576472|1841523|FG012|MPH Home Maintenance Phase|Declined to participate|0
878608|NCT00576472|1841524|FG013|MPH Home Maintenance Phase|Declined to participate|7
878609|NCT00576472|1841525|FG014|MPH Home Maintenance Phase|Declined to participate|0
878610|NCT00576472|1841511|FG000|MPH Home Maintenance Phase|Insufficient data|0
878611|NCT00576472|1841512|FG001|MPH Home Maintenance Phase|Insufficient data|0
878612|NCT00576472|1841513|FG002|MPH Home Maintenance Phase|Insufficient data|0
878613|NCT00576472|1841514|FG003|MPH Home Maintenance Phase|Insufficient data|0
878614|NCT00576472|1841515|FG004|MPH Home Maintenance Phase|Insufficient data|0
878615|NCT00576472|1841516|FG005|MPH Home Maintenance Phase|Insufficient data|0
878616|NCT00576472|1841517|FG006|MPH Home Maintenance Phase|Insufficient data|0
878617|NCT00576472|1841518|FG007|MPH Home Maintenance Phase|Insufficient data|0
878618|NCT00576472|1841519|FG008|MPH Home Maintenance Phase|Insufficient data|0
878619|NCT00576472|1841520|FG009|MPH Home Maintenance Phase|Insufficient data|0
878620|NCT00576472|1841521|FG010|MPH Home Maintenance Phase|Insufficient data|0
878621|NCT00576472|1841522|FG011|MPH Home Maintenance Phase|Insufficient data|0
878622|NCT00576472|1841523|FG012|MPH Home Maintenance Phase|Insufficient data|0
878623|NCT00576472|1841524|FG013|MPH Home Maintenance Phase|Insufficient data|4
878624|NCT00576472|1841525|FG014|MPH Home Maintenance Phase|Insufficient data|0
878625|NCT00576472|1841511|FG000|MPH Home Maintenance Phase|Side effects|0
878626|NCT00576472|1841512|FG001|MPH Home Maintenance Phase|Side effects|0
878627|NCT00576472|1841513|FG002|MPH Home Maintenance Phase|Side effects|0
878628|NCT00576472|1841514|FG003|MPH Home Maintenance Phase|Side effects|0
878629|NCT00576472|1841515|FG004|MPH Home Maintenance Phase|Side effects|0
878630|NCT00576472|1841516|FG005|MPH Home Maintenance Phase|Side effects|0
878631|NCT00576472|1841517|FG006|MPH Home Maintenance Phase|Side effects|0
878632|NCT00576472|1841518|FG007|MPH Home Maintenance Phase|Side effects|0
878633|NCT00576472|1841519|FG008|MPH Home Maintenance Phase|Side effects|0
878634|NCT00576472|1841520|FG009|MPH Home Maintenance Phase|Side effects|0
878635|NCT00576472|1841521|FG010|MPH Home Maintenance Phase|Side effects|0
878636|NCT00576472|1841522|FG011|MPH Home Maintenance Phase|Side effects|0
878637|NCT00576472|1841523|FG012|MPH Home Maintenance Phase|Side effects|0
878638|NCT00576472|1841524|FG013|MPH Home Maintenance Phase|Side effects|0
878639|NCT00576472|1841525|FG014|MPH Home Maintenance Phase|Side effects|8
878640|NCT00576472|1841511|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0
878641|NCT00576472|1841512|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0
878642|NCT00576472|1841513|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0
878643|NCT00576472|1841514|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0
878644|NCT00576472|1841515|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0
878645|NCT00576472|1841516|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0
878646|NCT00576472|1841517|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0
878647|NCT00576472|1841518|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0
878648|NCT00576472|1841519|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0
878649|NCT00576472|1841520|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0
878650|NCT00576472|1841521|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0
878651|NCT00576472|1841522|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0
878652|NCT00576472|1841523|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0
878653|NCT00576472|1841524|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0
878654|NCT00576472|1841525|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6
878655|NCT00576472|1841511|FG000|MPH Home Maintenance Phase|Medical reasons|0
878656|NCT00576472|1841512|FG001|MPH Home Maintenance Phase|Medical reasons|0
878657|NCT00576472|1841513|FG002|MPH Home Maintenance Phase|Medical reasons|0
878658|NCT00576472|1841514|FG003|MPH Home Maintenance Phase|Medical reasons|0
878659|NCT00576472|1841515|FG004|MPH Home Maintenance Phase|Medical reasons|0
878660|NCT00576472|1841516|FG005|MPH Home Maintenance Phase|Medical reasons|0
878661|NCT00576472|1841517|FG006|MPH Home Maintenance Phase|Medical reasons|0
878662|NCT00576472|1841518|FG007|MPH Home Maintenance Phase|Medical reasons|0
878663|NCT00576472|1841519|FG008|MPH Home Maintenance Phase|Medical reasons|0
878664|NCT00576472|1841520|FG009|MPH Home Maintenance Phase|Medical reasons|0
878665|NCT00576472|1841521|FG010|MPH Home Maintenance Phase|Medical reasons|0
878666|NCT00576472|1841522|FG011|MPH Home Maintenance Phase|Medical reasons|0
878667|NCT00576472|1841523|FG012|MPH Home Maintenance Phase|Medical reasons|0
878668|NCT00576472|1841524|FG013|MPH Home Maintenance Phase|Medical reasons|0
878669|NCT00576472|1841525|FG014|MPH Home Maintenance Phase|Medical reasons|6
878670|NCT00576472|1841511|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0
878671|NCT00576472|1841512|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0
878672|NCT00576472|1841513|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0
878673|NCT00576472|1841514|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0
878674|NCT00576472|1841515|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0
878675|NCT00576472|1841516|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0
878676|NCT00576472|1841517|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0
878677|NCT00576472|1841518|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0
878678|NCT00576472|1841519|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0
878679|NCT00576472|1841520|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0
878680|NCT00576472|1841521|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0
878681|NCT00576472|1841522|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0
878682|NCT00576472|1841523|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0
878683|NCT00576472|1841524|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0
878684|NCT00576472|1841525|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3
878685|NCT00576576|1841556|FG000|Overall Study|Lost to Follow-up|6
878686|NCT00576576|1841556|FG000|Overall Study|Protocol Violation|1
878687|NCT00576628|1841560|FG000|Overall Study|Adverse Event|11
878688|NCT00576628|1841560|FG000|Overall Study|Death|2
878689|NCT00576628|1841560|FG000|Overall Study|Failure to return|1
878690|NCT00576628|1841560|FG000|Overall Study|Refused Treatment|8
878691|NCT00576628|1841560|FG000|Overall Study|Pregnancy|1
878692|NCT00576628|1841560|FG000|Overall Study|RBC transfusion|1
878693|NCT00576628|1841560|FG000|Overall Study|Progression of Kidney Disease|1
878694|NCT00576628|1841560|FG000|Overall Study|Progression of Renal Failure|1
878695|NCT00576628|1841560|FG000|Overall Study|The patient move into other town|1
878696|NCT00576628|1841560|FG000|Overall Study|Transplantation|1
878697|NCT00576628|1841560|FG000|Overall Study|Dialysis|15
878698|NCT00576693|1841571|FG000|Overall Study|Lost to Follow-up|7
878699|NCT00576693|1841572|FG001|Overall Study|Lost to Follow-up|11
878700|NCT00576693|1841571|FG000|Overall Study|Withdrawal by Subject|3
878701|NCT00576693|1841572|FG001|Overall Study|Withdrawal by Subject|13
878702|NCT00576732|1841581|FG000|DOUBLE BLIND|Adverse Event|0
878703|NCT00576732|1841582|FG001|DOUBLE BLIND|Adverse Event|0
878704|NCT00576732|1841583|FG002|DOUBLE BLIND|Adverse Event|1
878705|NCT00576732|1841584|FG003|DOUBLE BLIND|Adverse Event|0
878706|NCT00576732|1841585|FG004|DOUBLE BLIND|Adverse Event|0
878707|NCT00576732|1841586|FG005|DOUBLE BLIND|Adverse Event|0
878708|NCT00576732|1841581|FG000|DOUBLE BLIND|Lost to Follow-up|0
878709|NCT00576732|1841582|FG001|DOUBLE BLIND|Lost to Follow-up|1
878710|NCT00576732|1841583|FG002|DOUBLE BLIND|Lost to Follow-up|1
878711|NCT00576732|1841584|FG003|DOUBLE BLIND|Lost to Follow-up|0
878712|NCT00576732|1841585|FG004|DOUBLE BLIND|Lost to Follow-up|0
878713|NCT00576732|1841586|FG005|DOUBLE BLIND|Lost to Follow-up|0
878714|NCT00576732|1841581|FG000|DOUBLE BLIND|Withdrawal by Subject|1
878715|NCT00576732|1841582|FG001|DOUBLE BLIND|Withdrawal by Subject|1
878716|NCT00576732|1841583|FG002|DOUBLE BLIND|Withdrawal by Subject|3
878717|NCT00576732|1841584|FG003|DOUBLE BLIND|Withdrawal by Subject|0
878718|NCT00576732|1841585|FG004|DOUBLE BLIND|Withdrawal by Subject|0
878719|NCT00576732|1841586|FG005|DOUBLE BLIND|Withdrawal by Subject|0
878720|NCT00576732|1841581|FG000|DOUBLE BLIND|OTHER|0
878721|NCT00576732|1841582|FG001|DOUBLE BLIND|OTHER|2
878722|NCT00576732|1841583|FG002|DOUBLE BLIND|OTHER|1
878723|NCT00576732|1841584|FG003|DOUBLE BLIND|OTHER|0
878724|NCT00576732|1841585|FG004|DOUBLE BLIND|OTHER|0
878725|NCT00576732|1841586|FG005|DOUBLE BLIND|OTHER|0
878726|NCT00576732|1841581|FG000|DOUBLE BLIND|Lack of Efficacy|6
878727|NCT00576732|1841582|FG001|DOUBLE BLIND|Lack of Efficacy|1
878728|NCT00576732|1841583|FG002|DOUBLE BLIND|Lack of Efficacy|0
878729|NCT00576732|1841584|FG003|DOUBLE BLIND|Lack of Efficacy|0
878730|NCT00576732|1841585|FG004|DOUBLE BLIND|Lack of Efficacy|0
878731|NCT00576732|1841586|FG005|DOUBLE BLIND|Lack of Efficacy|0
878732|NCT00576732|1841581|FG000|DOUBLE BLIND|Protocol Violation|1
878733|NCT00576732|1841582|FG001|DOUBLE BLIND|Protocol Violation|0
878734|NCT00576732|1841583|FG002|DOUBLE BLIND|Protocol Violation|0
878735|NCT00576732|1841584|FG003|DOUBLE BLIND|Protocol Violation|0
878736|NCT00576732|1841585|FG004|DOUBLE BLIND|Protocol Violation|0
878737|NCT00576732|1841586|FG005|DOUBLE BLIND|Protocol Violation|0
878738|NCT00576732|1841581|FG000|OPEN LABEL|Adverse Event|0
878739|NCT00576732|1841582|FG001|OPEN LABEL|Adverse Event|0
878740|NCT00576732|1841583|FG002|OPEN LABEL|Adverse Event|0
878741|NCT00576732|1841584|FG003|OPEN LABEL|Adverse Event|4
878742|NCT00576732|1841585|FG004|OPEN LABEL|Adverse Event|0
878743|NCT00576732|1841586|FG005|OPEN LABEL|Adverse Event|1
878744|NCT00576732|1841581|FG000|OPEN LABEL|Lost to Follow-up|0
878745|NCT00576732|1841582|FG001|OPEN LABEL|Lost to Follow-up|0
1184343|NCT01849250|2342596|FG000|Overall Study|Withdrawal by Subject|1
1184344|NCT01849250|2342597|FG001|Overall Study|Withdrawal by Subject|0
1184345|NCT01849250|2342596|FG000|Overall Study|Not Evaluable|5
1184346|NCT01849250|2342597|FG001|Overall Study|Not Evaluable|3
1184347|NCT01849250|2342596|FG000|Overall Study|Screen Failure|1
1184348|NCT01849250|2342597|FG001|Overall Study|Screen Failure|0
878746|NCT00576732|1841583|FG002|OPEN LABEL|Lost to Follow-up|0
878747|NCT00576732|1841584|FG003|OPEN LABEL|Lost to Follow-up|2
878748|NCT00576732|1841585|FG004|OPEN LABEL|Lost to Follow-up|1
878749|NCT00576732|1841586|FG005|OPEN LABEL|Lost to Follow-up|1
878750|NCT00576732|1841581|FG000|OPEN LABEL|Withdrawal by Subject|0
878751|NCT00576732|1841582|FG001|OPEN LABEL|Withdrawal by Subject|0
878752|NCT00576732|1841583|FG002|OPEN LABEL|Withdrawal by Subject|0
878753|NCT00576732|1841584|FG003|OPEN LABEL|Withdrawal by Subject|1
878754|NCT00576732|1841585|FG004|OPEN LABEL|Withdrawal by Subject|0
878755|NCT00576732|1841586|FG005|OPEN LABEL|Withdrawal by Subject|1
878756|NCT00576732|1841581|FG000|OPEN LABEL|OTHER|0
878757|NCT00576732|1841582|FG001|OPEN LABEL|OTHER|0
878758|NCT00576732|1841583|FG002|OPEN LABEL|OTHER|0
878759|NCT00576732|1841584|FG003|OPEN LABEL|OTHER|0
878760|NCT00576732|1841585|FG004|OPEN LABEL|OTHER|0
878761|NCT00576732|1841586|FG005|OPEN LABEL|OTHER|2
878762|NCT00576732|1841581|FG000|OPEN LABEL|Lack of Efficacy|0
878763|NCT00576732|1841582|FG001|OPEN LABEL|Lack of Efficacy|0
878764|NCT00576732|1841583|FG002|OPEN LABEL|Lack of Efficacy|0
878765|NCT00576732|1841584|FG003|OPEN LABEL|Lack of Efficacy|2
878766|NCT00576732|1841585|FG004|OPEN LABEL|Lack of Efficacy|2
878767|NCT00576732|1841586|FG005|OPEN LABEL|Lack of Efficacy|3
878768|NCT00576732|1841581|FG000|OPEN LABEL|Protocol Violation|0
878769|NCT00576732|1841582|FG001|OPEN LABEL|Protocol Violation|0
878770|NCT00576732|1841583|FG002|OPEN LABEL|Protocol Violation|0
878771|NCT00576732|1841584|FG003|OPEN LABEL|Protocol Violation|2
878772|NCT00576732|1841585|FG004|OPEN LABEL|Protocol Violation|1
878773|NCT00576732|1841586|FG005|OPEN LABEL|Protocol Violation|0
878774|NCT00576758|1841600|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3
878775|NCT00576758|1841601|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3
878776|NCT00576758|1841600|FG000|Induction Treatment Period|Insufficient therapeutic response|2
878777|NCT00576758|1841601|FG001|Induction Treatment Period|Insufficient therapeutic response|0
878778|NCT00576758|1841600|FG000|Induction Treatment Period|Violation of selection criteria at entry|1
878779|NCT00576758|1841601|FG001|Induction Treatment Period|Violation of selection criteria at entry|1
878780|NCT00576758|1841600|FG000|Induction Treatment Period|Death|1
878781|NCT00576758|1841601|FG001|Induction Treatment Period|Death|0
878782|NCT00576758|1841600|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
878783|NCT00576758|1841601|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
878784|NCT00576758|1841600|FG000|Induction Treatment Period|Withdrew consent|1
878785|NCT00576758|1841601|FG001|Induction Treatment Period|Withdrew consent|0
878786|NCT00576758|1841600|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6
878787|NCT00576758|1841601|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7
878788|NCT00576758|1841600|FG000|Extension Treatment Period|Death|1
878789|NCT00576758|1841601|FG001|Extension Treatment Period|Death|1
878790|NCT00576758|1841600|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2
878791|NCT00576758|1841601|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1
878792|NCT00576758|1841600|FG000|Extension Treatment Period|Insufficient therapeutic response|30
878793|NCT00576758|1841601|FG001|Extension Treatment Period|Insufficient therapeutic response|33
878794|NCT00576758|1841600|FG000|Extension Treatment Period|Administrative/Other|3
878795|NCT00576758|1841601|FG001|Extension Treatment Period|Administrative/Other|1
878796|NCT00576758|1841600|FG000|Follow-up Period|Administrative/Other|6
878797|NCT00576758|1841601|FG001|Follow-up Period|Administrative/Other|8
878798|NCT00576758|1841600|FG000|Follow-up Period|Death|3
878799|NCT00576758|1841601|FG001|Follow-up Period|Death|3
878800|NCT00576758|1841600|FG000|Follow-up Period|Insufficient therapeutic response|16
878801|NCT00576758|1841601|FG001|Follow-up Period|Insufficient therapeutic response|5
878802|NCT00576758|1841600|FG000|Follow-up Period|Withdrew consent|2
878803|NCT00576758|1841601|FG001|Follow-up Period|Withdrew consent|1
878804|NCT00576823|1841611|FG000|12-week Efficacy Phase|Parent's schedule issue|1
878805|NCT00576823|1841612|FG001|12-week Efficacy Phase|Parent's schedule issue|0
878806|NCT00576823|1841613|FG002|12-week Efficacy Phase|Parent's schedule issue|0
878807|NCT00576823|1841611|FG000|40-week Safety Extension Phase|Lack of Efficacy|1
878808|NCT00576823|1841612|FG001|40-week Safety Extension Phase|Lack of Efficacy|0
1184371|NCT01609790|2342616|FG000|Overall Study|Protocol Violation|1
1184372|NCT01609790|2342617|FG001|Overall Study|Protocol Violation|7
1184373|NCT01609790|2342618|FG002|Overall Study|Protocol Violation|8
1184374|NCT01441115|2342630|FG000|Overall Study|Taken off study - Principal Investigator discretion|1
1184375|NCT01295944|2342637|FG000|Overall Study|Switched to alternative treatment|1
1184376|NCT01295944|2342637|FG000|Overall Study|Ineligible|9
1184377|NCT01295944|2342637|FG000|Overall Study|Withdrawal by Subject|4
1184378|NCT01295944|2342637|FG000|Overall Study|Participant chose to be treated in Peru|1
1184379|NCT01295944|2342637|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1
1184380|NCT01295944|2342637|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1
1184381|NCT01295944|2342637|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1
878809|NCT00576823|1841613|FG002|40-week Safety Extension Phase|Lack of Efficacy|0
878810|NCT00576836|1841624|FG000|Overall Study|Death|0
878811|NCT00576836|1841625|FG001|Overall Study|Death|1
878812|NCT00576836|1841624|FG000|Overall Study|Physician Decision|0
878813|NCT00576836|1841625|FG001|Overall Study|Physician Decision|1
878814|NCT00576901|1841629|FG000|Overall Study|Withdrawal by Subject|1
878815|NCT00576901|1841629|FG000|Overall Study|Disease course|1
878816|NCT00576901|1841629|FG000|Overall Study|Protocol Violation|1
878817|NCT00576927|1841635|FG000|Clinical Assessment|Lack of Efficacy|24
878818|NCT00576927|1841635|FG000|Clinical Assessment|Death|1
878819|NCT00576927|1841635|FG000|Clinical Assessment|Withdrawal by Subject|10
878820|NCT00576927|1841635|FG000|Clinical Assessment|Physician Decision|1
878821|NCT00576927|1841635|FG000|Baseline|Physician Decision|9
878822|NCT00576927|1841635|FG000|Baseline|Medication Change by PCP of subject|1
878823|NCT00576927|1841635|FG000|Baseline|Withdrawal by Subject|3
878824|NCT00576927|1841635|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
878825|NCT00576927|1841635|FG000|Sleep Hygiene Behavioral Intervention|Death|1
878826|NCT00576927|1841635|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
878827|NCT00576927|1841635|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
878828|NCT00576927|1841635|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
878829|NCT00577005|1841643|FG000|Overall Study|Lost to Follow-up|3
878830|NCT00577005|1841644|FG001|Overall Study|Lost to Follow-up|2
878831|NCT00577005|1841643|FG000|Overall Study|Withdrawal by Subject|2
878832|NCT00577005|1841644|FG001|Overall Study|Withdrawal by Subject|1
878833|NCT00577031|1841653|FG000|Overall Study|Adverse Event|52
878834|NCT00577031|1841653|FG000|Overall Study|Progression of disease|93
878835|NCT00577031|1841653|FG000|Overall Study|Protocol Violation|5
878836|NCT00577031|1841653|FG000|Overall Study|Participant withdrew consent|13
878837|NCT00577031|1841653|FG000|Overall Study|Participant non-compliance|5
878838|NCT00577031|1841653|FG000|Overall Study|Need for surgery|17
878839|NCT00577031|1841653|FG000|Overall Study|Medical decision|14
878840|NCT00577031|1841653|FG000|Overall Study|Death|6
878841|NCT00577096|1841677|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3
878842|NCT00577096|1841678|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2
878843|NCT00577096|1841677|FG000|Short Term Participation|Withdrawal by Subject|3
878844|NCT00577096|1841678|FG001|Short Term Participation|Withdrawal by Subject|5
878845|NCT00577096|1841677|FG000|Short Term Participation|Death|1
878846|NCT00577096|1841678|FG001|Short Term Participation|Death|1
878847|NCT00577122|1841686|FG000|Overall Study|Adverse Event|0
878848|NCT00577122|1841687|FG001|Overall Study|Adverse Event|2
878849|NCT00577122|1841686|FG000|Overall Study|Progression, relapse during active trt|6
878850|NCT00577122|1841687|FG001|Overall Study|Progression, relapse during active trt|8
878851|NCT00577122|1841686|FG000|Overall Study|Prog, refract disease during active trt|8
878852|NCT00577122|1841687|FG001|Overall Study|Prog, refract disease during active trt|5
878853|NCT00577122|1841686|FG000|Overall Study|Alternative Therapy|0
878854|NCT00577122|1841687|FG001|Overall Study|Alternative Therapy|1
878855|NCT00577382|1841713|FG000|Overall Study|Adverse Event|0
878856|NCT00577382|1841714|FG001|Overall Study|Adverse Event|6
878857|NCT00577382|1841713|FG000|Overall Study|Withdrawal by Subject|0
878858|NCT00577382|1841714|FG001|Overall Study|Withdrawal by Subject|1
878859|NCT00577382|1841713|FG000|Overall Study|Progressive Disease|17
1184388|NCT01199302|2342654|FG000|Overall Study|Adverse Event|1
1184389|NCT01199302|2342655|FG001|Overall Study|Adverse Event|1
1184390|NCT01199302|2342656|FG002|Overall Study|Adverse Event|2
1184391|NCT01199302|2342657|FG003|Overall Study|Adverse Event|0
1184392|NCT01199302|2342654|FG000|Overall Study|Withdrawal by Subject|2
1184393|NCT01199302|2342655|FG001|Overall Study|Withdrawal by Subject|2
1184394|NCT01199302|2342656|FG002|Overall Study|Withdrawal by Subject|3
1184395|NCT01199302|2342657|FG003|Overall Study|Withdrawal by Subject|0
1184396|NCT01199302|2342654|FG000|Overall Study|Disease Progression|3
1184397|NCT01199302|2342655|FG001|Overall Study|Disease Progression|4
1184398|NCT01199302|2342656|FG002|Overall Study|Disease Progression|4
1184399|NCT01199302|2342657|FG003|Overall Study|Disease Progression|2
1184400|NCT01199302|2342654|FG000|Overall Study|Study Termination|13
1184401|NCT01199302|2342655|FG001|Overall Study|Study Termination|8
1184402|NCT01199302|2342656|FG002|Overall Study|Study Termination|11
1184403|NCT01199302|2342657|FG003|Overall Study|Study Termination|9
1184404|NCT01199302|2342654|FG000|Overall Study|Lost to Follow-up|0
1184405|NCT01199302|2342655|FG001|Overall Study|Lost to Follow-up|1
1184406|NCT01199302|2342656|FG002|Overall Study|Lost to Follow-up|0
1184407|NCT01199302|2342657|FG003|Overall Study|Lost to Follow-up|0
1184408|NCT01199302|2342654|FG000|Overall Study|Other|1
1184409|NCT01199302|2342655|FG001|Overall Study|Other|0
1184410|NCT01199302|2342656|FG002|Overall Study|Other|0
1184411|NCT01199302|2342657|FG003|Overall Study|Other|0
1184412|NCT01123707|2342668|FG000|Overall Study|Lost to Follow-up|3
1184413|NCT01123707|2342669|FG001|Overall Study|Lost to Follow-up|1
1184414|NCT01123707|2342670|FG002|Overall Study|Lost to Follow-up|3
1184415|NCT01123707|2342671|FG003|Overall Study|Lost to Follow-up|2
1184416|NCT01123707|2342668|FG000|Overall Study|Adverse Event|5
1184417|NCT01123707|2342669|FG001|Overall Study|Adverse Event|7
1184418|NCT01123707|2342670|FG002|Overall Study|Adverse Event|5
1184419|NCT01123707|2342671|FG003|Overall Study|Adverse Event|3
1184420|NCT01123707|2342668|FG000|Overall Study|Sponsor Discontinued Study|30
1184421|NCT01123707|2342669|FG001|Overall Study|Sponsor Discontinued Study|24
1184422|NCT01123707|2342670|FG002|Overall Study|Sponsor Discontinued Study|25
1184423|NCT01123707|2342671|FG003|Overall Study|Sponsor Discontinued Study|40
1184424|NCT01123707|2342668|FG000|Overall Study|Participant Met Withdrawal Criteria|1
1184425|NCT01123707|2342669|FG001|Overall Study|Participant Met Withdrawal Criteria|1
878860|NCT00577382|1841714|FG001|Overall Study|Progressive Disease|19
878861|NCT00577382|1841713|FG000|Overall Study|Intercurrent Illness|1
878862|NCT00577382|1841714|FG001|Overall Study|Intercurrent Illness|2
878863|NCT00577382|1841713|FG000|Overall Study|Death|1
878864|NCT00577382|1841714|FG001|Overall Study|Death|1
878865|NCT00577382|1841713|FG000|Overall Study|Lost to Follow-up|2
878866|NCT00577382|1841714|FG001|Overall Study|Lost to Follow-up|2
878867|NCT00577408|1841722|FG000|Overall Study|Stopped attending study visits|9
878868|NCT00577408|1841723|FG001|Overall Study|Stopped attending study visits|11
878869|NCT00577408|1841722|FG000|Overall Study|Continued opioid use|3
878870|NCT00577408|1841723|FG001|Overall Study|Continued opioid use|2
878871|NCT00577408|1841722|FG000|Overall Study|Non-compliance with study meds|0
878872|NCT00577408|1841723|FG001|Overall Study|Non-compliance with study meds|3
878873|NCT00577408|1841722|FG000|Overall Study|Refused Oral Naltrexone|0
878874|NCT00577408|1841723|FG001|Overall Study|Refused Oral Naltrexone|1
878875|NCT00577408|1841722|FG000|Overall Study|Moved out of state|0
878876|NCT00577408|1841723|FG001|Overall Study|Moved out of state|1
878877|NCT00577408|1841722|FG000|Overall Study|Scheduling Issues|0
878878|NCT00577408|1841723|FG001|Overall Study|Scheduling Issues|3
878879|NCT00577408|1841722|FG000|Overall Study|Death|0
878880|NCT00577408|1841723|FG001|Overall Study|Death|1
878881|NCT00577408|1841722|FG000|Overall Study|Psychiatric hospitalization|0
878882|NCT00577408|1841723|FG001|Overall Study|Psychiatric hospitalization|1
878883|NCT00577460|1841732|FG000|Overall Study|Adverse Event|11
878884|NCT00577460|1841733|FG001|Overall Study|Adverse Event|7
878885|NCT00577460|1841734|FG002|Overall Study|Adverse Event|14
878886|NCT00577460|1841732|FG000|Overall Study|Protocol Violation|0
878887|NCT00577460|1841733|FG001|Overall Study|Protocol Violation|1
878888|NCT00577460|1841734|FG002|Overall Study|Protocol Violation|1
878889|NCT00577460|1841732|FG000|Overall Study|Lost to Follow-up|0
878890|NCT00577460|1841733|FG001|Overall Study|Lost to Follow-up|3
878891|NCT00577460|1841734|FG002|Overall Study|Lost to Follow-up|4
878892|NCT00577460|1841732|FG000|Overall Study|Withdrawal by Subject|5
878893|NCT00577460|1841733|FG001|Overall Study|Withdrawal by Subject|5
878894|NCT00577460|1841734|FG002|Overall Study|Withdrawal by Subject|6
878895|NCT00577460|1841732|FG000|Overall Study|Other|0
878896|NCT00577460|1841733|FG001|Overall Study|Other|3
878897|NCT00577460|1841734|FG002|Overall Study|Other|2
878898|NCT00577473|1841751|FG000|Overall Study|Protocol Violation|1
1184426|NCT01123707|2342670|FG002|Overall Study|Participant Met Withdrawal Criteria|0
1184427|NCT01123707|2342671|FG003|Overall Study|Participant Met Withdrawal Criteria|1
1184428|NCT01123707|2342668|FG000|Overall Study|Investigator Withdrew Participant|0
1184429|NCT01123707|2342669|FG001|Overall Study|Investigator Withdrew Participant|1
1184430|NCT01123707|2342670|FG002|Overall Study|Investigator Withdrew Participant|1
1184431|NCT01123707|2342671|FG003|Overall Study|Investigator Withdrew Participant|1
878899|NCT00577473|1841752|FG001|Overall Study|Protocol Violation|4
878900|NCT00577473|1841751|FG000|Overall Study|Adverse Event|8
878901|NCT00577473|1841752|FG001|Overall Study|Adverse Event|5
878902|NCT00577473|1841751|FG000|Overall Study|Withdrawal by Subject|2
878903|NCT00577473|1841752|FG001|Overall Study|Withdrawal by Subject|6
878904|NCT00577473|1841751|FG000|Overall Study|Physician Decision|2
878905|NCT00577473|1841752|FG001|Overall Study|Physician Decision|2
878906|NCT00577473|1841751|FG000|Overall Study|Lack of Efficacy|8
878907|NCT00577473|1841752|FG001|Overall Study|Lack of Efficacy|7
878908|NCT00577629|1841775|FG000|Treatment Period|Death|1
878909|NCT00577629|1841775|FG000|Long Term Follow-Up|Death|15
878910|NCT00577629|1841775|FG000|Long Term Follow-Up|Lost to Follow-up|5
878911|NCT00577629|1841775|FG000|Long Term Follow-Up|Withdrawal by Subject|4
878912|NCT00577629|1841775|FG000|Long Term Follow-Up|Physician Decision|1
878913|NCT00577642|1841781|FG000|Overall Study|Clinical Disease Progression|1
878914|NCT00577655|1841787|FG000|Overall Study|Patient Request|0
878915|NCT00577655|1841788|FG001|Overall Study|Patient Request|2
878916|NCT00577655|1841787|FG000|Overall Study|Protocol Violation|0
878917|NCT00577655|1841788|FG001|Overall Study|Protocol Violation|1
878918|NCT00577655|1841787|FG000|Overall Study|Lost to Follow-up|1
878919|NCT00577655|1841788|FG001|Overall Study|Lost to Follow-up|1
878920|NCT00577707|1841795|FG000|Overall Study|Withdrawal by Subject|3
878921|NCT00577720|1841803|FG000|Overall Study|Adverse Event|2
878922|NCT00577720|1841804|FG001|Overall Study|Adverse Event|1
878923|NCT00577720|1841805|FG002|Overall Study|Adverse Event|0
878924|NCT00577720|1841806|FG003|Overall Study|Adverse Event|4
878925|NCT00577720|1841803|FG000|Overall Study|Lost to Follow-up|0
878926|NCT00577720|1841804|FG001|Overall Study|Lost to Follow-up|0
878927|NCT00577720|1841805|FG002|Overall Study|Lost to Follow-up|1
878928|NCT00577720|1841806|FG003|Overall Study|Lost to Follow-up|0
878929|NCT00577720|1841803|FG000|Overall Study|Protocol Violation|0
878930|NCT00577720|1841804|FG001|Overall Study|Protocol Violation|0
878931|NCT00577720|1841805|FG002|Overall Study|Protocol Violation|0
878932|NCT00577720|1841806|FG003|Overall Study|Protocol Violation|1
878933|NCT00577720|1841803|FG000|Overall Study|Withdrawal by Subject|2
878934|NCT00577720|1841804|FG001|Overall Study|Withdrawal by Subject|0
878935|NCT00577720|1841805|FG002|Overall Study|Withdrawal by Subject|0
878936|NCT00577720|1841806|FG003|Overall Study|Withdrawal by Subject|2
878937|NCT00577824|1841819|FG000|Overall Study|Adverse Event|6
878938|NCT00577824|1841820|FG001|Overall Study|Adverse Event|18
878939|NCT00577824|1841821|FG002|Overall Study|Adverse Event|1
878940|NCT00577824|1841819|FG000|Overall Study|Patient decision|0
878941|NCT00577824|1841820|FG001|Overall Study|Patient decision|1
878942|NCT00577824|1841821|FG002|Overall Study|Patient decision|1
878943|NCT00577824|1841819|FG000|Overall Study|Protocol Violation|1
878944|NCT00577824|1841820|FG001|Overall Study|Protocol Violation|1
878945|NCT00577824|1841821|FG002|Overall Study|Protocol Violation|0
878946|NCT00577863|1841831|FG000|Overall Study|Adverse Event|4
878947|NCT00577863|1841832|FG001|Overall Study|Adverse Event|2
878948|NCT00577863|1841831|FG000|Overall Study|Death|1
878949|NCT00577863|1841832|FG001|Overall Study|Death|0
878950|NCT00577863|1841831|FG000|Overall Study|Lost to Follow-up|2
878951|NCT00577863|1841832|FG001|Overall Study|Lost to Follow-up|2
878952|NCT00577863|1841831|FG000|Overall Study|Entry Criteria Exclusion|1
878953|NCT00577863|1841832|FG001|Overall Study|Entry Criteria Exclusion|0
878954|NCT00577863|1841831|FG000|Overall Study|Withdrawal by Subject|0
878955|NCT00577863|1841832|FG001|Overall Study|Withdrawal by Subject|2
878956|NCT00577863|1841831|FG000|Overall Study|Sponsor Decision|2
878957|NCT00577863|1841832|FG001|Overall Study|Sponsor Decision|7
878958|NCT00577863|1841831|FG000|Overall Study|Did Not Receive at Least One Injection|0
878959|NCT00577863|1841832|FG001|Overall Study|Did Not Receive at Least One Injection|1
878960|NCT00577889|1841841|FG000|Overall Study|Withdrawal by Subject|1
878961|NCT00577889|1841842|FG001|Overall Study|Withdrawal by Subject|0
878962|NCT00577889|1841843|FG002|Overall Study|Withdrawal by Subject|0
878963|NCT00577993|1841854|FG000|Overall Study|Adverse Event|1
878964|NCT00577993|1841855|FG001|Overall Study|Adverse Event|0
878965|NCT00577993|1841856|FG002|Overall Study|Adverse Event|0
878966|NCT00577993|1841854|FG000|Overall Study|Death|0
878967|NCT00577993|1841855|FG001|Overall Study|Death|1
878968|NCT00577993|1841856|FG002|Overall Study|Death|1
878969|NCT00577993|1841854|FG000|Overall Study|Lack of Efficacy|0
878970|NCT00577993|1841855|FG001|Overall Study|Lack of Efficacy|1
878971|NCT00577993|1841856|FG002|Overall Study|Lack of Efficacy|0
878972|NCT00577993|1841854|FG000|Overall Study|Protocol Violation|2
878973|NCT00577993|1841855|FG001|Overall Study|Protocol Violation|3
878974|NCT00577993|1841856|FG002|Overall Study|Protocol Violation|0
878975|NCT00577993|1841854|FG000|Overall Study|Withdrawal by Subject|1
878976|NCT00577993|1841855|FG001|Overall Study|Withdrawal by Subject|0
878977|NCT00577993|1841856|FG002|Overall Study|Withdrawal by Subject|2
878978|NCT00577993|1841854|FG000|Overall Study|Conversion|2
878979|NCT00577993|1841855|FG001|Overall Study|Conversion|5
878980|NCT00577993|1841856|FG002|Overall Study|Conversion|0
878981|NCT00577993|1841854|FG000|Overall Study|Uninsured|1
878982|NCT00577993|1841855|FG001|Overall Study|Uninsured|0
878983|NCT00577993|1841856|FG002|Overall Study|Uninsured|0
878984|NCT00578136|1841869|FG000|Overall Study|Not given intervention|1
878985|NCT00578136|1841870|FG001|Overall Study|Not given intervention|1
1184432|NCT01123707|2342668|FG000|Overall Study|Subject Withdrew Consent|4
1184433|NCT01123707|2342669|FG001|Overall Study|Subject Withdrew Consent|5
1184434|NCT01123707|2342670|FG002|Overall Study|Subject Withdrew Consent|1
1184435|NCT01123707|2342671|FG003|Overall Study|Subject Withdrew Consent|2
1184436|NCT01123707|2342668|FG000|Overall Study|Lack of Efficacy|1
1184437|NCT01123707|2342669|FG001|Overall Study|Lack of Efficacy|2
1184438|NCT01123707|2342670|FG002|Overall Study|Lack of Efficacy|1
1184439|NCT01123707|2342671|FG003|Overall Study|Lack of Efficacy|0
1184440|NCT01123707|2342668|FG000|Overall Study|Subject Met Exclusion Criteria|0
1184441|NCT01123707|2342669|FG001|Overall Study|Subject Met Exclusion Criteria|0
1184442|NCT01123707|2342670|FG002|Overall Study|Subject Met Exclusion Criteria|2
1184443|NCT01123707|2342671|FG003|Overall Study|Subject Met Exclusion Criteria|1
878986|NCT00578175|1841879|FG000|Overall Study|Adverse Event|0
878987|NCT00578175|1841880|FG001|Overall Study|Adverse Event|1
878988|NCT00578175|1841881|FG002|Overall Study|Adverse Event|1
878989|NCT00578175|1841879|FG000|Overall Study|Other reasons|70
878990|NCT00578175|1841880|FG001|Overall Study|Other reasons|42
878991|NCT00578175|1841881|FG002|Overall Study|Other reasons|23
878992|NCT00578227|1841907|FG000|Overall Study|Lost to Follow-up|0
878993|NCT00578227|1841908|FG001|Overall Study|Lost to Follow-up|1
878994|NCT00578227|1841909|FG002|Overall Study|Lost to Follow-up|1
878995|NCT00578227|1841907|FG000|Overall Study|Withdrawal by Subject|5
878996|NCT00578227|1841908|FG001|Overall Study|Withdrawal by Subject|1
878997|NCT00578227|1841909|FG002|Overall Study|Withdrawal by Subject|3
878998|NCT00578292|1841928|FG000|Overall Study|Death|1
878999|NCT00578292|1841928|FG000|Overall Study|Graft failure|2
879000|NCT00578318|1841953|FG000|Overall Study|Lost to Follow-up|2
879001|NCT00578318|1841954|FG001|Overall Study|Lost to Follow-up|0
879002|NCT00578318|1841953|FG000|Overall Study|Physician Decision|1
879003|NCT00578318|1841954|FG001|Overall Study|Physician Decision|0
879004|NCT00578344|1841969|FG000|Overall Study|Insurance problems|1
879005|NCT00578344|1841969|FG000|Overall Study|Graft failure|1
879006|NCT00578448|1841994|FG000|Day 1 up to 3 Years of Planned Study|Death|1
879007|NCT00578448|1841994|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1
879008|NCT00578448|1841994|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
879009|NCT00578448|1841994|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1
879010|NCT00578565|1842021|FG000|Overall Study|Adverse Event|3
879011|NCT00578643|1842035|FG000|Overall Study|Death|1
879012|NCT00578643|1842035|FG000|Overall Study|Lost to Follow-up|1
879013|NCT00578786|1842060|FG000|Overall Study|Adverse Event|27
879014|NCT00578786|1842061|FG001|Overall Study|Adverse Event|37
879015|NCT00578786|1842062|FG002|Overall Study|Adverse Event|17
879016|NCT00578786|1842060|FG000|Overall Study|Lack of Efficacy|2
879017|NCT00578786|1842061|FG001|Overall Study|Lack of Efficacy|5
879018|NCT00578786|1842062|FG002|Overall Study|Lack of Efficacy|2
879019|NCT00578786|1842060|FG000|Overall Study|Early Escape from Prior Study|2
879020|NCT00578786|1842061|FG001|Overall Study|Early Escape from Prior Study|1
879021|NCT00578786|1842062|FG002|Overall Study|Early Escape from Prior Study|2
879022|NCT00578786|1842060|FG000|Overall Study|Withdrawal by Subject|7
879023|NCT00578786|1842061|FG001|Overall Study|Withdrawal by Subject|8
879024|NCT00578786|1842062|FG002|Overall Study|Withdrawal by Subject|5
879025|NCT00578786|1842060|FG000|Overall Study|Protocol Violation|0
879026|NCT00578786|1842061|FG001|Overall Study|Protocol Violation|3
879027|NCT00578786|1842062|FG002|Overall Study|Protocol Violation|1
879028|NCT00578786|1842060|FG000|Overall Study|Physician Decision|1
879029|NCT00578786|1842061|FG001|Overall Study|Physician Decision|0
879030|NCT00578786|1842062|FG002|Overall Study|Physician Decision|1
879031|NCT00578786|1842060|FG000|Overall Study|Sponsor Decision|0
879032|NCT00578786|1842061|FG001|Overall Study|Sponsor Decision|0
879033|NCT00578786|1842062|FG002|Overall Study|Sponsor Decision|1
879034|NCT00578786|1842060|FG000|Overall Study|Lost to Follow-up|0
879035|NCT00578786|1842061|FG001|Overall Study|Lost to Follow-up|4
879036|NCT00578786|1842062|FG002|Overall Study|Lost to Follow-up|0
879037|NCT00578786|1842060|FG000|Overall Study|Pregnancy|0
879038|NCT00578786|1842061|FG001|Overall Study|Pregnancy|1
879039|NCT00578786|1842062|FG002|Overall Study|Pregnancy|0
879040|NCT00578786|1842060|FG000|Overall Study|Not Otherwise Specified|0
879041|NCT00578786|1842061|FG001|Overall Study|Not Otherwise Specified|4
879042|NCT00578786|1842062|FG002|Overall Study|Not Otherwise Specified|1
879043|NCT00578786|1842060|FG000|Overall Study|Qualified but Not Enrolled in Extension|0
879044|NCT00578786|1842061|FG001|Overall Study|Qualified but Not Enrolled in Extension|3
879045|NCT00578786|1842062|FG002|Overall Study|Qualified but Not Enrolled in Extension|0
879046|NCT00578812|1842082|FG000|Overall Study|Not treated|6
879047|NCT00578812|1842083|FG001|Overall Study|Not treated|7
879048|NCT00578864|1842092|FG000|Overall Study|Death|1
879049|NCT00578864|1842093|FG001|Overall Study|Death|0
879050|NCT00578877|1842101|FG000|Overall Study|Lost to Follow-up|8
879051|NCT00578877|1842102|FG001|Overall Study|Lost to Follow-up|10
879052|NCT00578877|1842101|FG000|Overall Study|early discontinue|61
879053|NCT00578877|1842102|FG001|Overall Study|early discontinue|101
879054|NCT00578877|1842101|FG000|Overall Study|did not provide follow-up data|12
879055|NCT00578877|1842102|FG001|Overall Study|did not provide follow-up data|17
879056|NCT00578942|1842130|FG000|Overall Study|Lost to Follow-up|1
879057|NCT00579059|1842150|FG000|Overall Study|Study Canceled at 1 Year|21
879058|NCT00579059|1842151|FG001|Overall Study|Study Canceled at 1 Year|10
879059|NCT00579098|1842159|FG000|Overall Study|Lost to Follow-up|2
879060|NCT00579098|1842160|FG001|Overall Study|Lost to Follow-up|0
879061|NCT00579098|1842159|FG000|Overall Study|Adverse Event|2
879062|NCT00579098|1842160|FG001|Overall Study|Adverse Event|3
879063|NCT00579098|1842159|FG000|Overall Study|Withdrawal by Subject|2
879064|NCT00579098|1842160|FG001|Overall Study|Withdrawal by Subject|3
879065|NCT00579098|1842159|FG000|Overall Study|AF returned after ablation|3
879066|NCT00579098|1842160|FG001|Overall Study|AF returned after ablation|2
879067|NCT00579345|1842200|FG000|Overall Study|Withdrawal by Subject|2
879068|NCT00579345|1842201|FG001|Overall Study|Withdrawal by Subject|0
879069|NCT00579345|1842202|FG002|Overall Study|Withdrawal by Subject|0
879070|NCT00579345|1842203|FG003|Overall Study|Withdrawal by Subject|0
879071|NCT00579345|1842204|FG004|Overall Study|Withdrawal by Subject|0
879072|NCT00579345|1842205|FG005|Overall Study|Withdrawal by Subject|0
879073|NCT00579345|1842206|FG006|Overall Study|Withdrawal by Subject|0
879074|NCT00579345|1842207|FG007|Overall Study|Withdrawal by Subject|1
879075|NCT00579345|1842200|FG000|Overall Study|Lost to Follow-up|1
879076|NCT00579345|1842201|FG001|Overall Study|Lost to Follow-up|0
879077|NCT00579345|1842202|FG002|Overall Study|Lost to Follow-up|0
879078|NCT00579345|1842203|FG003|Overall Study|Lost to Follow-up|0
879079|NCT00579345|1842204|FG004|Overall Study|Lost to Follow-up|0
879080|NCT00579345|1842205|FG005|Overall Study|Lost to Follow-up|0
879081|NCT00579345|1842206|FG006|Overall Study|Lost to Follow-up|0
879082|NCT00579345|1842207|FG007|Overall Study|Lost to Follow-up|0
879083|NCT00579345|1842200|FG000|Overall Study|Adverse Event|0
879084|NCT00579345|1842201|FG001|Overall Study|Adverse Event|0
879085|NCT00579345|1842202|FG002|Overall Study|Adverse Event|1
879086|NCT00579345|1842203|FG003|Overall Study|Adverse Event|0
879087|NCT00579345|1842204|FG004|Overall Study|Adverse Event|0
879088|NCT00579345|1842205|FG005|Overall Study|Adverse Event|0
879089|NCT00579345|1842206|FG006|Overall Study|Adverse Event|0
879090|NCT00579345|1842207|FG007|Overall Study|Adverse Event|0
879091|NCT00579345|1842200|FG000|Overall Study|Protocol Violation|1
879092|NCT00579345|1842201|FG001|Overall Study|Protocol Violation|0
879093|NCT00579345|1842202|FG002|Overall Study|Protocol Violation|0
879094|NCT00579345|1842203|FG003|Overall Study|Protocol Violation|0
879095|NCT00579345|1842204|FG004|Overall Study|Protocol Violation|0
879096|NCT00579345|1842205|FG005|Overall Study|Protocol Violation|0
879097|NCT00579345|1842206|FG006|Overall Study|Protocol Violation|0
879098|NCT00579345|1842207|FG007|Overall Study|Protocol Violation|1
879099|NCT00579345|1842200|FG000|Overall Study|Death|1
879100|NCT00579345|1842201|FG001|Overall Study|Death|1
879101|NCT00579345|1842202|FG002|Overall Study|Death|1
879102|NCT00579345|1842203|FG003|Overall Study|Death|1
879103|NCT00579345|1842204|FG004|Overall Study|Death|0
879104|NCT00579345|1842205|FG005|Overall Study|Death|0
879105|NCT00579345|1842206|FG006|Overall Study|Death|0
879106|NCT00579345|1842207|FG007|Overall Study|Death|0
879107|NCT00579501|1842244|FG000|Overall Study|Death|1
879108|NCT00579501|1842244|FG000|Overall Study|End of neoadjuvant therapy|25
879109|NCT00579501|1842244|FG000|Overall Study|toxicity|1
879110|NCT00579501|1842244|FG000|Overall Study|Secondary lesion|1
879111|NCT00579501|1842244|FG000|Overall Study|Radiation therapy before surgery|1
879112|NCT00579527|1842248|FG000|Overall Study|Death|4
879113|NCT00579553|1842255|FG000|Overall Study|Lost to Follow-up|16
879114|NCT00579553|1842256|FG001|Overall Study|Lost to Follow-up|13
879115|NCT00579670|1842267|FG000|Overall Study|Death|1
879116|NCT00579670|1842268|FG001|Overall Study|Death|0
879117|NCT00579670|1842269|FG002|Overall Study|Death|0
879118|NCT00579670|1842270|FG003|Overall Study|Death|0
879119|NCT00579670|1842271|FG004|Overall Study|Death|0
879120|NCT00579670|1842267|FG000|Overall Study|Adverse Event|1
879121|NCT00579670|1842268|FG001|Overall Study|Adverse Event|0
879122|NCT00579670|1842269|FG002|Overall Study|Adverse Event|1
879123|NCT00579670|1842270|FG003|Overall Study|Adverse Event|2
879124|NCT00579670|1842271|FG004|Overall Study|Adverse Event|0
879125|NCT00579670|1842267|FG000|Overall Study|Lack of Efficacy|0
879126|NCT00579670|1842268|FG001|Overall Study|Lack of Efficacy|0
879127|NCT00579670|1842269|FG002|Overall Study|Lack of Efficacy|1
879128|NCT00579670|1842270|FG003|Overall Study|Lack of Efficacy|14
879129|NCT00579670|1842271|FG004|Overall Study|Lack of Efficacy|0
879130|NCT00579670|1842267|FG000|Overall Study|Lost to Follow-up|0
879131|NCT00579670|1842268|FG001|Overall Study|Lost to Follow-up|1
879132|NCT00579670|1842269|FG002|Overall Study|Lost to Follow-up|0
879133|NCT00579670|1842270|FG003|Overall Study|Lost to Follow-up|4
879134|NCT00579670|1842271|FG004|Overall Study|Lost to Follow-up|0
879135|NCT00579670|1842267|FG000|Overall Study|Other|0
879136|NCT00579670|1842268|FG001|Overall Study|Other|0
879137|NCT00579670|1842269|FG002|Overall Study|Other|1
879138|NCT00579670|1842270|FG003|Overall Study|Other|2
879139|NCT00579670|1842271|FG004|Overall Study|Other|0
879140|NCT00579670|1842267|FG000|Overall Study|Withdrawal by Subject|0
879141|NCT00579670|1842268|FG001|Overall Study|Withdrawal by Subject|0
1184515|NCT00462943|2342757|FG000|Overall Study|Failure to achieve a response|5
1184516|NCT00462943|2342758|FG001|Overall Study|Failure to achieve a response|5
1184517|NCT00462943|2342759|FG002|Overall Study|Failure to achieve a response|1
1184518|NCT00462943|2342757|FG000|Overall Study|Adverse Event|6
1184519|NCT00462943|2342758|FG001|Overall Study|Adverse Event|4
1184520|NCT00462943|2342759|FG002|Overall Study|Adverse Event|1
879142|NCT00579670|1842269|FG002|Overall Study|Withdrawal by Subject|1
879143|NCT00579670|1842270|FG003|Overall Study|Withdrawal by Subject|0
879144|NCT00579670|1842271|FG004|Overall Study|Withdrawal by Subject|0
879147|NCT00579982|1842327|FG000|Overall Study|Adverse Event|4
1184521|NCT00462943|2342757|FG000|Overall Study|Protocol Violation|1
1184522|NCT00462943|2342758|FG001|Overall Study|Protocol Violation|0
1184523|NCT00462943|2342759|FG002|Overall Study|Protocol Violation|0
1184524|NCT00462943|2342757|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8
1184525|NCT00462943|2342758|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2
1184526|NCT00462943|2342759|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4
1184527|NCT00462943|2342757|FG000|Overall Study|Disease Progression|15
1184528|NCT00462943|2342758|FG001|Overall Study|Disease Progression|15
1184529|NCT00462943|2342759|FG002|Overall Study|Disease Progression|9
1184530|NCT00462943|2342757|FG000|Overall Study|Death|5
1184531|NCT00462943|2342758|FG001|Overall Study|Death|2
1184532|NCT00462943|2342759|FG002|Overall Study|Death|7
1184533|NCT00462943|2342757|FG000|Overall Study|Stem Cell Transplant|1
1184534|NCT00462943|2342758|FG001|Overall Study|Stem Cell Transplant|1
1184535|NCT00462943|2342759|FG002|Overall Study|Stem Cell Transplant|0
1184536|NCT00462943|2342757|FG000|Overall Study|Bone Marrow Transplant|1
1184537|NCT00462943|2342758|FG001|Overall Study|Bone Marrow Transplant|0
1184538|NCT00462943|2342759|FG002|Overall Study|Bone Marrow Transplant|0
1184539|NCT00462943|2342757|FG000|Overall Study|Required Lymphocyte Infusion|1
1184540|NCT00462943|2342758|FG001|Overall Study|Required Lymphocyte Infusion|0
1184541|NCT00462943|2342759|FG002|Overall Study|Required Lymphocyte Infusion|0
1184542|NCT00462943|2342757|FG000|Overall Study|Transplant - not specified|1
1184543|NCT00462943|2342758|FG001|Overall Study|Transplant - not specified|0
1184544|NCT00462943|2342759|FG002|Overall Study|Transplant - not specified|1
1184545|NCT00462943|2342757|FG000|Overall Study|Physician Decision|1
1184546|NCT00462943|2342758|FG001|Overall Study|Physician Decision|0
1184547|NCT00462943|2342759|FG002|Overall Study|Physician Decision|0
1184548|NCT00462943|2342757|FG000|Overall Study|Withdrawal by Subject|0
1184549|NCT00462943|2342758|FG001|Overall Study|Withdrawal by Subject|1
1184550|NCT00462943|2342759|FG002|Overall Study|Withdrawal by Subject|0
1184551|NCT00248287|2342786|FG000|Overall Study|Adverse Event|11
1184552|NCT00248287|2342787|FG001|Overall Study|Adverse Event|10
1184553|NCT00248287|2342786|FG000|Overall Study|Death|1
1184554|NCT00248287|2342787|FG001|Overall Study|Death|0
1184555|NCT00248287|2342786|FG000|Overall Study|Lost to Follow-up|0
1184556|NCT00248287|2342787|FG001|Overall Study|Lost to Follow-up|1
1184557|NCT00248287|2342786|FG000|Overall Study|Investigator Request|4
1184558|NCT00248287|2342787|FG001|Overall Study|Investigator Request|3
1184559|NCT00248287|2342786|FG000|Overall Study|Patient Request|5
1184560|NCT00248287|2342787|FG001|Overall Study|Patient Request|3
1184561|NCT00248287|2342786|FG000|Overall Study|Other|3
1184562|NCT00248287|2342787|FG001|Overall Study|Other|2
1184563|NCT00105560|2342797|FG000|Overall Study|Lost to Follow-up|1
1184564|NCT04569786|2342831|FG000|Overall Study|Lost to Follow-up|1
1184565|NCT04569786|2342832|FG001|Overall Study|Lost to Follow-up|0
1184566|NCT04569786|2342833|FG002|Overall Study|Lost to Follow-up|4
1184567|NCT04569786|2342834|FG003|Overall Study|Lost to Follow-up|1
1184568|NCT04569786|2342835|FG004|Overall Study|Lost to Follow-up|0
1184569|NCT04569786|2342831|FG000|Overall Study|Withdrawal by Subject|0
1184570|NCT04569786|2342832|FG001|Overall Study|Withdrawal by Subject|0
1184571|NCT04569786|2342833|FG002|Overall Study|Withdrawal by Subject|0
1184572|NCT04569786|2342834|FG003|Overall Study|Withdrawal by Subject|5
1184573|NCT04569786|2342835|FG004|Overall Study|Withdrawal by Subject|1
1184574|NCT04569786|2342831|FG000|Overall Study|Physician Decision|0
1184575|NCT04569786|2342832|FG001|Overall Study|Physician Decision|0
1184576|NCT04569786|2342833|FG002|Overall Study|Physician Decision|0
1184577|NCT04569786|2342834|FG003|Overall Study|Physician Decision|1
1184578|NCT04569786|2342835|FG004|Overall Study|Physician Decision|0
1184581|NCT04129944|2342865|FG000|Overall Study|Death|0
1184582|NCT04129944|2342866|FG001|Overall Study|Death|0
1184583|NCT04129944|2342867|FG002|Overall Study|Death|0
1184584|NCT04129944|2342868|FG003|Overall Study|Death|1
1184585|NCT04129944|2342865|FG000|Overall Study|Lost to Follow-up|1
1184586|NCT04129944|2342866|FG001|Overall Study|Lost to Follow-up|0
1184587|NCT04129944|2342867|FG002|Overall Study|Lost to Follow-up|0
1184588|NCT04129944|2342868|FG003|Overall Study|Lost to Follow-up|0
1184589|NCT04129944|2342865|FG000|Overall Study|Withdrawal by Subject|1
1184590|NCT04129944|2342866|FG001|Overall Study|Withdrawal by Subject|0
1184591|NCT04129944|2342867|FG002|Overall Study|Withdrawal by Subject|1
1184592|NCT04129944|2342868|FG003|Overall Study|Withdrawal by Subject|2
1184593|NCT03857542|2342889|FG000|Overall Study|Adverse Event|1
1184594|NCT03857542|2342890|FG001|Overall Study|Adverse Event|3
1184595|NCT03857542|2342889|FG000|Overall Study|Withdrawal by Subject|2
1184596|NCT03857542|2342890|FG001|Overall Study|Withdrawal by Subject|1
1184597|NCT03857542|2342889|FG000|Overall Study|Lost to Follow-up|2
1184598|NCT03857542|2342890|FG001|Overall Study|Lost to Follow-up|1
1184599|NCT03857542|2342889|FG000|Overall Study|Reason not Specified|1
1184600|NCT03857542|2342890|FG001|Overall Study|Reason not Specified|0
1184601|NCT03848832|2342900|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0
1184602|NCT03848832|2342901|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0
1184603|NCT03848832|2342902|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1
1184604|NCT03848832|2342900|FG000|Overall Study|Withdrawal by Subject|0
1184605|NCT03848832|2342901|FG001|Overall Study|Withdrawal by Subject|0
1184606|NCT03848832|2342902|FG002|Overall Study|Withdrawal by Subject|1
1184607|NCT03848832|2342900|FG000|Overall Study|Withdrawal (Covid-19)|0
1184608|NCT03848832|2342901|FG001|Overall Study|Withdrawal (Covid-19)|2
1184609|NCT03848832|2342902|FG002|Overall Study|Withdrawal (Covid-19)|0
1184610|NCT03848832|2342900|FG000|Overall Study|Physician Decision|2
1184611|NCT03848832|2342901|FG001|Overall Study|Physician Decision|1
1184612|NCT03848832|2342902|FG002|Overall Study|Physician Decision|3
1184613|NCT03848832|2342900|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0
1184614|NCT03848832|2342901|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0
1184615|NCT03848832|2342902|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1
1184616|NCT03848832|2342900|FG000|Overall Study|Adverse Event|1
1184617|NCT03848832|2342901|FG001|Overall Study|Adverse Event|0
1184618|NCT03848832|2342902|FG002|Overall Study|Adverse Event|0
1184619|NCT03656744|2342924|FG000|Overall Study|Adverse Event|1
1184620|NCT03656744|2342925|FG001|Overall Study|Adverse Event|4
1184621|NCT03656744|2342926|FG002|Overall Study|Adverse Event|1
1184622|NCT03656744|2342924|FG000|Overall Study|Protocol Violation|1
1184623|NCT03656744|2342925|FG001|Overall Study|Protocol Violation|0
1184624|NCT03656744|2342926|FG002|Overall Study|Protocol Violation|0
1184625|NCT03656744|2342924|FG000|Overall Study|Lost to Follow-up|2
1184626|NCT03656744|2342925|FG001|Overall Study|Lost to Follow-up|2
1184627|NCT03656744|2342926|FG002|Overall Study|Lost to Follow-up|0
1184628|NCT03656744|2342924|FG000|Overall Study|Withdrawal by Subject|0
1184629|NCT03656744|2342925|FG001|Overall Study|Withdrawal by Subject|1
1184630|NCT03656744|2342926|FG002|Overall Study|Withdrawal by Subject|0
1184631|NCT03656744|2342924|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1
1184632|NCT03656744|2342925|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
1184633|NCT03656744|2342926|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
1184634|NCT03510598|2342942|FG000|Overall Study|Withdrawal by Subject|1
1184635|NCT03487796|2342950|FG000|Overall Study|Lost to Follow-up|18
1184636|NCT03487796|2342951|FG001|Overall Study|Lost to Follow-up|6
1184637|NCT03446612|2342965|FG000|Overall Study|Protocol defined stopping criteria|0
1184638|NCT03446612|2342966|FG001|Overall Study|Protocol defined stopping criteria|1
1184639|NCT03434379|2342989|FG000|Global Period|Lost to Follow-up|3
1184640|NCT03434379|2342990|FG001|Global Period|Lost to Follow-up|1
1184641|NCT03434379|2342991|FG002|Global Period|Lost to Follow-up|0
1184642|NCT03434379|2342992|FG003|Global Period|Lost to Follow-up|0
1184643|NCT03434379|2342989|FG000|Global Period|Death|99
879148|NCT00579982|1842327|FG000|Overall Study|Protocol Violation|4
879149|NCT00580034|1842331|FG000|Overall Study|Toxicity|10
879150|NCT00580034|1842332|FG001|Overall Study|Toxicity|0
879151|NCT00580047|1842339|FG000|Overall Study|Lost to Follow-up|1
879152|NCT00580047|1842340|FG001|Overall Study|Lost to Follow-up|1
879153|NCT00580047|1842341|FG002|Overall Study|Lost to Follow-up|0
879154|NCT00580047|1842339|FG000|Overall Study|Withdrawal by Subject|1
879155|NCT00580047|1842340|FG001|Overall Study|Withdrawal by Subject|1
879156|NCT00580047|1842341|FG002|Overall Study|Withdrawal by Subject|2
879157|NCT00580047|1842339|FG000|Overall Study|Withdrawal by Subject|1
879158|NCT00580047|1842340|FG001|Overall Study|Withdrawal by Subject|0
879159|NCT00580047|1842341|FG002|Overall Study|Withdrawal by Subject|0
879160|NCT00580606|1842401|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
879161|NCT00580606|1842402|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
879162|NCT00580606|1842401|FG000|Open Label (OL)|Withdrawal by Subject|4
879163|NCT00580606|1842402|FG001|Open Label (OL)|Withdrawal by Subject|6
879164|NCT00580606|1842401|FG000|Open Label (OL)|Dosing Symptoms|0
879165|NCT00580606|1842402|FG001|Open Label (OL)|Dosing Symptoms|1
879166|NCT00580606|1842401|FG000|Open Label (OL)|Lost to Follow-up|0
879167|NCT00580606|1842402|FG001|Open Label (OL)|Lost to Follow-up|1
879168|NCT00580606|1842401|FG000|Open Label (OL)|Pregnancy|0
879169|NCT00580606|1842402|FG001|Open Label (OL)|Pregnancy|1
879170|NCT00580606|1842401|FG000|Open Label (OL)|Non-compliance|2
879171|NCT00580606|1842402|FG001|Open Label (OL)|Non-compliance|0
879172|NCT00580606|1842401|FG000|Open Label (OL)|Physician Decision|1
879173|NCT00580606|1842402|FG001|Open Label (OL)|Physician Decision|1
879174|NCT00580606|1842401|FG000|Open Label (OL)|Needed Prohibited Medication|0
879175|NCT00580606|1842402|FG001|Open Label (OL)|Needed Prohibited Medication|1
879176|NCT00580723|1842442|FG000|Overall Study|Did not want to participate in extension|3
879177|NCT00580723|1842442|FG000|Overall Study|Lost to Follow-up|5
879178|NCT00580788|1842450|FG000|Overall Study|Adverse Event|0
879179|NCT00580788|1842451|FG001|Overall Study|Adverse Event|0
879180|NCT00580788|1842452|FG002|Overall Study|Adverse Event|0
879181|NCT00580788|1842453|FG003|Overall Study|Adverse Event|1
879182|NCT00580801|1842473|FG000|Overall Study|Physician Decision|1
879183|NCT00580801|1842474|FG001|Overall Study|Physician Decision|0
879184|NCT00580801|1842475|FG002|Overall Study|Physician Decision|0
879185|NCT00580801|1842473|FG000|Overall Study|Adverse Event|2
879186|NCT00580801|1842474|FG001|Overall Study|Adverse Event|0
879187|NCT00580801|1842475|FG002|Overall Study|Adverse Event|0
879188|NCT00580801|1842473|FG000|Overall Study|Lost to Follow-up|2
879189|NCT00580801|1842474|FG001|Overall Study|Lost to Follow-up|0
879190|NCT00580801|1842475|FG002|Overall Study|Lost to Follow-up|0
879191|NCT00580801|1842473|FG000|Overall Study|Reached a virologic endpoint|0
879192|NCT00580801|1842474|FG001|Overall Study|Reached a virologic endpoint|1
879193|NCT00580801|1842475|FG002|Overall Study|Reached a virologic endpoint|2
879194|NCT00580801|1842473|FG000|Overall Study|Participant non-compliant|0
879195|NCT00580801|1842474|FG001|Overall Study|Participant non-compliant|0
879196|NCT00580801|1842475|FG002|Overall Study|Participant non-compliant|1
879197|NCT00580801|1842473|FG000|Overall Study|Travel|1
879198|NCT00580801|1842474|FG001|Overall Study|Travel|0
879199|NCT00580801|1842475|FG002|Overall Study|Travel|0
879200|NCT00580840|1842483|FG000|Run-in|Adverse Event|17
879201|NCT00580840|1842484|FG001|Run-in|Adverse Event|0
879202|NCT00580840|1842485|FG002|Run-in|Adverse Event|0
1184644|NCT03434379|2342990|FG001|Global Period|Death|179
1184645|NCT03434379|2342991|FG002|Global Period|Death|0
1184646|NCT03434379|2342992|FG003|Global Period|Death|0
1184647|NCT03434379|2342989|FG000|Global Period|Withdrawal by Subject|20
1184648|NCT03434379|2342990|FG001|Global Period|Withdrawal by Subject|20
1184649|NCT03434379|2342991|FG002|Global Period|Withdrawal by Subject|0
1184650|NCT03434379|2342992|FG003|Global Period|Withdrawal by Subject|0
1184651|NCT03434379|2342989|FG000|Global Period|On Study|43
1184652|NCT03434379|2342990|FG001|Global Period|On Study|136
1184653|NCT03434379|2342991|FG002|Global Period|On Study|0
1184654|NCT03434379|2342992|FG003|Global Period|On Study|0
1184655|NCT03434379|2342989|FG000|China Extension Period|Lost to Follow-up|0
1184656|NCT03434379|2342990|FG001|China Extension Period|Lost to Follow-up|0
1184657|NCT03434379|2342991|FG002|China Extension Period|Lost to Follow-up|1
1184658|NCT03434379|2342992|FG003|China Extension Period|Lost to Follow-up|0
1184659|NCT03434379|2342989|FG000|China Extension Period|Death|0
1184660|NCT03434379|2342990|FG001|China Extension Period|Death|0
1184661|NCT03434379|2342991|FG002|China Extension Period|Death|38
1184662|NCT03434379|2342992|FG003|China Extension Period|Death|61
1184663|NCT03434379|2342989|FG000|China Extension Period|Withdrawal by Subject|0
1184664|NCT03434379|2342990|FG001|China Extension Period|Withdrawal by Subject|0
1184665|NCT03434379|2342991|FG002|China Extension Period|Withdrawal by Subject|7
1184666|NCT03434379|2342992|FG003|China Extension Period|Withdrawal by Subject|6
1184667|NCT03434379|2342989|FG000|China Extension Period|On Study|0
1184668|NCT03434379|2342990|FG001|China Extension Period|On Study|0
879203|NCT00580840|1842486|FG003|Run-in|Adverse Event|0
879204|NCT00580840|1842483|FG000|Run-in|Lack of Efficacy|93
1184669|NCT03434379|2342991|FG002|China Extension Period|On Study|15
1184670|NCT03434379|2342992|FG003|China Extension Period|On Study|66
1184671|NCT03410693|2343006|FG000|Overall Study|Disc trt: Withdrawal by participant|6
1184672|NCT03410693|2343007|FG001|Overall Study|Disc trt: Withdrawal by participant|4
1184673|NCT03410693|2343006|FG000|Overall Study|Disc trt: Lost to follow up|0
1184674|NCT03410693|2343007|FG001|Overall Study|Disc trt: Lost to follow up|1
1184675|NCT03410693|2343006|FG000|Overall Study|Disc trt: radiological progression|58
1184676|NCT03410693|2343007|FG001|Overall Study|Disc trt: radiological progression|50
1184677|NCT03410693|2343006|FG000|Overall Study|Disc trt: Other|1
1184678|NCT03410693|2343007|FG001|Overall Study|Disc trt: Other|0
1184679|NCT03410693|2343006|FG000|Overall Study|Study drug never administered|1
1184680|NCT03410693|2343007|FG001|Overall Study|Study drug never administered|6
1184681|NCT03410693|2343006|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6
1184682|NCT03410693|2343007|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4
1184683|NCT03410693|2343006|FG000|Overall Study|Disc trt: Adverse Event (AE)|13
1184684|NCT03410693|2343007|FG001|Overall Study|Disc trt: Adverse Event (AE)|9
1184685|NCT03410693|2343006|FG000|Overall Study|Disc trt: Physician decision|0
1184686|NCT03410693|2343007|FG001|Overall Study|Disc trt: Physician decision|5
1184687|NCT03410693|2343006|FG000|Overall Study|Disc trt: clinical progression|1
1184688|NCT03410693|2343007|FG001|Overall Study|Disc trt: clinical progression|5
1184689|NCT03410693|2343006|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1
1184690|NCT03410693|2343007|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4
1184691|NCT03370120|2343019|FG000|Overall Study|Adverse event, non-fatal|24
1184692|NCT03370120|2343019|FG000|Overall Study|Withdrawal by Subject|6
1184693|NCT03370120|2343019|FG000|Overall Study|Lost to Follow-up|1
1184694|NCT03370120|2343019|FG000|Overall Study|Lack of Efficacy|37
1184695|NCT03370120|2343019|FG000|Overall Study|Per sponsor's instructions|1
1184696|NCT03370120|2343019|FG000|Overall Study|Study was terminated by parent company UCB|2
1184697|NCT03370120|2343019|FG000|Overall Study|The study was ended by the promoter|3
1184698|NCT03370120|2343019|FG000|Overall Study|Discontinuation of drug development|3
1184699|NCT03370120|2343019|FG000|Overall Study|End of project|2
1184700|NCT03370120|2343019|FG000|Overall Study|Premature study closure|2
1184701|NCT03370120|2343019|FG000|Overall Study|Premature program termination|1
1184702|NCT03370120|2343019|FG000|Overall Study|Premature study termination|7
1184703|NCT03370120|2343019|FG000|Overall Study|Trial terminated by sponsor|2
1184704|NCT03370120|2343019|FG000|Overall Study|Trial discontinued by sponsor|2
1184705|NCT03370120|2343019|FG000|Overall Study|Study ended|15
1184706|NCT03370120|2343019|FG000|Overall Study|Clinical trial has been cancelled|1
1184707|NCT03370120|2343019|FG000|Overall Study|End of study per sponsor decision|2
1184708|NCT03370120|2343019|FG000|Overall Study|Promoter's decision|2
1184709|NCT03370120|2343019|FG000|Overall Study|The trial has been suspended|3
1184710|NCT03370120|2343019|FG000|Overall Study|Sponsor stopped PSL development based on data|3
1184711|NCT03370120|2343019|FG000|Overall Study|Early termination by order of sponsor|2
1184712|NCT03370120|2343019|FG000|Overall Study|Discontinuation of the study|5
1184713|NCT03370120|2343019|FG000|Overall Study|End of clinical trial discontinuation|1
1184714|NCT03370120|2343019|FG000|Overall Study|Because the clinical trial ended halfway|4
1184715|NCT03370120|2343019|FG000|Overall Study|Development discontinued|5
1184716|NCT03370120|2343019|FG000|Overall Study|Padsenovil program closed|3
1184717|NCT03370120|2343019|FG000|Overall Study|End of project|2
1184718|NCT03370120|2343019|FG000|Overall Study|Termination of project|1
1184719|NCT03370120|2343019|FG000|Overall Study|The study was interrupted by sponsor|4
1184720|NCT03370120|2343019|FG000|Overall Study|The protocol was interrupted by sponsor|1
1184721|NCT03370120|2343019|FG000|Overall Study|End of sponsor decision|1
1184722|NCT03370120|2343019|FG000|Overall Study|The study was terminated prematurely by study lead|1
1184723|NCT03370120|2343019|FG000|Overall Study|Early termination of studies|5
1184724|NCT03370120|2343019|FG000|Overall Study|This study is ended early|1
1184725|NCT03370120|2343019|FG000|Overall Study|End of padsevonil program|2
1184726|NCT03370120|2343019|FG000|Overall Study|Decision of sponsor|6
1184727|NCT03370120|2343019|FG000|Overall Study|Asked by the sponsor|3
1184728|NCT03370120|2343019|FG000|Overall Study|Sponsor decision to stop the protocol|1
1184729|NCT03370120|2343019|FG000|Overall Study|PI decision poor compliance from participant|1
1184730|NCT03370120|2343019|FG000|Overall Study|Promoter ended the study|3
1184731|NCT03370120|2343019|FG000|Overall Study|Premature study close by sponsor's decision|4
1184732|NCT03370120|2343019|FG000|Overall Study|Study terminated by sponsor|33
1184733|NCT03370120|2343019|FG000|Overall Study|Sponsor prematurely terminated this study|2
1184734|NCT03370120|2343019|FG000|Overall Study|Sponsor decision to terminate study|63
1184735|NCT03370120|2343019|FG000|Overall Study|Program closure|3
1184736|NCT03370120|2343019|FG000|Overall Study|Study ended prematurely|1
1184737|NCT03370120|2343019|FG000|Overall Study|Study stopped by sponsor|2
1184738|NCT03370120|2343019|FG000|Overall Study|Program termination|55
1184739|NCT03370120|2343019|FG000|Overall Study|Sponsor decision|62
1184740|NCT03370120|2343019|FG000|Overall Study|Sponsor study closure|10
1184741|NCT03332498|2343043|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0
1184742|NCT03332498|2343044|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0
1184743|NCT03332498|2343045|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2
1184747|NCT03143829|2343058|FG000|Overall Study|Withdrawal by Subject|2
879205|NCT00580840|1842484|FG001|Run-in|Lack of Efficacy|0
879206|NCT00580840|1842485|FG002|Run-in|Lack of Efficacy|0
879207|NCT00580840|1842486|FG003|Run-in|Lack of Efficacy|0
879208|NCT00580840|1842483|FG000|Run-in|Loss of Efficacy|1
879209|NCT00580840|1842484|FG001|Run-in|Loss of Efficacy|0
879210|NCT00580840|1842485|FG002|Run-in|Loss of Efficacy|0
879211|NCT00580840|1842486|FG003|Run-in|Loss of Efficacy|0
879212|NCT00580840|1842483|FG000|Run-in|Lost to Follow-up|4
879213|NCT00580840|1842484|FG001|Run-in|Lost to Follow-up|0
879214|NCT00580840|1842485|FG002|Run-in|Lost to Follow-up|0
879215|NCT00580840|1842486|FG003|Run-in|Lost to Follow-up|0
879216|NCT00580840|1842483|FG000|Run-in|Withdrawal by Subject|5
879217|NCT00580840|1842484|FG001|Run-in|Withdrawal by Subject|0
879218|NCT00580840|1842485|FG002|Run-in|Withdrawal by Subject|0
879219|NCT00580840|1842486|FG003|Run-in|Withdrawal by Subject|0
879220|NCT00580840|1842483|FG000|Run-in|Other: Per Sponsor Request|2
879221|NCT00580840|1842484|FG001|Run-in|Other: Per Sponsor Request|0
879222|NCT00580840|1842485|FG002|Run-in|Other: Per Sponsor Request|0
879223|NCT00580840|1842486|FG003|Run-in|Other: Per Sponsor Request|0
879224|NCT00580840|1842483|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1
1184748|NCT03143829|2343059|FG001|Overall Study|Withdrawal by Subject|5
1184749|NCT03143829|2343058|FG000|Overall Study|Lost to Follow-up|0
1184750|NCT03143829|2343059|FG001|Overall Study|Lost to Follow-up|2
1184751|NCT03143829|2343058|FG000|Overall Study|Death|1
1184752|NCT03143829|2343059|FG001|Overall Study|Death|1
1184753|NCT03143829|2343058|FG000|Overall Study|changed treatment, no longer eligible|2
1184754|NCT03143829|2343059|FG001|Overall Study|changed treatment, no longer eligible|2
1184755|NCT02963610|2343074|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3
1184756|NCT02766335|2343081|FG000|Initial Registration|Adverse Event|6
1184757|NCT02766335|2343082|FG001|Initial Registration|Adverse Event|3
1184758|NCT02766335|2343083|FG002|Initial Registration|Adverse Event|0
1184759|NCT02766335|2343081|FG000|Initial Registration|Refusal unrelated to adverse event|1
1184760|NCT02766335|2343082|FG001|Initial Registration|Refusal unrelated to adverse event|0
1184761|NCT02766335|2343083|FG002|Initial Registration|Refusal unrelated to adverse event|0
1184762|NCT02766335|2343081|FG000|Initial Registration|Progression/relapse|49
1184763|NCT02766335|2343082|FG001|Initial Registration|Progression/relapse|15
1184764|NCT02766335|2343083|FG002|Initial Registration|Progression/relapse|0
1184765|NCT02766335|2343081|FG000|Initial Registration|Death|1
1184766|NCT02766335|2343082|FG001|Initial Registration|Death|3
1184767|NCT02766335|2343083|FG002|Initial Registration|Death|0
1184768|NCT02766335|2343081|FG000|Initial Registration|not protocol specified|1
1184769|NCT02766335|2343082|FG001|Initial Registration|not protocol specified|9
1184770|NCT02766335|2343083|FG002|Initial Registration|not protocol specified|0
1184771|NCT02766335|2343081|FG000|Re-registration of Arm I to MEDI4738|Death|0
1184772|NCT02766335|2343082|FG001|Re-registration of Arm I to MEDI4738|Death|0
1184773|NCT02766335|2343083|FG002|Re-registration of Arm I to MEDI4738|Death|1
1184774|NCT02766335|2343081|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0
1184775|NCT02766335|2343082|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0
1184776|NCT02766335|2343083|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1
1184777|NCT02606136|2343089|FG000|Overall Study|Participant/Legal Guardian Decision|5
1184778|NCT02606136|2343089|FG000|Overall Study|Withdrawal by Subject|1
1184779|NCT02228382|2343098|FG000|Overall Study|Death|5
1184780|NCT02228382|2343099|FG001|Overall Study|Death|7
1184781|NCT02228382|2343100|FG002|Overall Study|Death|5
1184782|NCT02228382|2343101|FG003|Overall Study|Death|0
1184783|NCT02228382|2343102|FG004|Overall Study|Death|2
1184784|NCT02228382|2343098|FG000|Overall Study|Participant refused further follow-up|0
1184785|NCT02228382|2343099|FG001|Overall Study|Participant refused further follow-up|0
1184786|NCT02228382|2343100|FG002|Overall Study|Participant refused further follow-up|1
1184787|NCT02228382|2343101|FG003|Overall Study|Participant refused further follow-up|0
1184788|NCT02228382|2343102|FG004|Overall Study|Participant refused further follow-up|0
1184789|NCT02228382|2343098|FG000|Overall Study|Study terminated by sponsor|3
1184790|NCT02228382|2343099|FG001|Overall Study|Study terminated by sponsor|5
1184791|NCT02228382|2343100|FG002|Overall Study|Study terminated by sponsor|7
1184792|NCT02228382|2343101|FG003|Overall Study|Study terminated by sponsor|0
1184793|NCT02228382|2343102|FG004|Overall Study|Study terminated by sponsor|0
1184794|NCT02228382|2343098|FG000|Overall Study|Lost to Follow-up|0
1184795|NCT02228382|2343099|FG001|Overall Study|Lost to Follow-up|0
1184796|NCT02228382|2343100|FG002|Overall Study|Lost to Follow-up|3
1184797|NCT02228382|2343101|FG003|Overall Study|Lost to Follow-up|1
1184798|NCT02228382|2343102|FG004|Overall Study|Lost to Follow-up|0
1184799|NCT02228382|2343098|FG000|Overall Study|Withdrawal by Subject|0
1184800|NCT02228382|2343099|FG001|Overall Study|Withdrawal by Subject|3
1184801|NCT02228382|2343100|FG002|Overall Study|Withdrawal by Subject|2
1184802|NCT02228382|2343101|FG003|Overall Study|Withdrawal by Subject|1
1184803|NCT02228382|2343102|FG004|Overall Study|Withdrawal by Subject|0
1184804|NCT02228382|2343098|FG000|Overall Study|Other|2
1184805|NCT02228382|2343099|FG001|Overall Study|Other|3
1184806|NCT02228382|2343100|FG002|Overall Study|Other|3
1184807|NCT02228382|2343101|FG003|Overall Study|Other|0
1184808|NCT02228382|2343102|FG004|Overall Study|Other|0
1184809|NCT02208024|2343119|FG000|Overall Study|Withdrawal by Subject|1
879225|NCT00580840|1842484|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0
1184810|NCT02001623|2343165|FG000|Overall Study|Disease Progression|2
1184811|NCT02001623|2343166|FG001|Overall Study|Disease Progression|2
1184812|NCT02001623|2343167|FG002|Overall Study|Disease Progression|3
1184813|NCT02001623|2343168|FG003|Overall Study|Disease Progression|2
1184814|NCT02001623|2343169|FG004|Overall Study|Disease Progression|3
1184815|NCT02001623|2343170|FG005|Overall Study|Disease Progression|2
1184816|NCT02001623|2343171|FG006|Overall Study|Disease Progression|3
1184817|NCT02001623|2343172|FG007|Overall Study|Disease Progression|3
1184818|NCT02001623|2343173|FG008|Overall Study|Disease Progression|7
1184819|NCT02001623|2343174|FG009|Overall Study|Disease Progression|40
1184820|NCT02001623|2343175|FG010|Overall Study|Disease Progression|5
1184821|NCT02001623|2343176|FG011|Overall Study|Disease Progression|9
1184822|NCT02001623|2343177|FG012|Overall Study|Disease Progression|9
1184823|NCT02001623|2343178|FG013|Overall Study|Disease Progression|20
1184824|NCT02001623|2343179|FG014|Overall Study|Disease Progression|9
1184825|NCT02001623|2343165|FG000|Overall Study|Physician Decision|0
1184826|NCT02001623|2343166|FG001|Overall Study|Physician Decision|0
1184827|NCT02001623|2343167|FG002|Overall Study|Physician Decision|0
1184828|NCT02001623|2343168|FG003|Overall Study|Physician Decision|0
1184829|NCT02001623|2343169|FG004|Overall Study|Physician Decision|0
1184830|NCT02001623|2343170|FG005|Overall Study|Physician Decision|0
1184831|NCT02001623|2343171|FG006|Overall Study|Physician Decision|0
1184832|NCT02001623|2343172|FG007|Overall Study|Physician Decision|0
1184833|NCT02001623|2343173|FG008|Overall Study|Physician Decision|3
1184834|NCT02001623|2343174|FG009|Overall Study|Physician Decision|2
1184835|NCT02001623|2343175|FG010|Overall Study|Physician Decision|3
1184836|NCT02001623|2343176|FG011|Overall Study|Physician Decision|3
1184837|NCT02001623|2343177|FG012|Overall Study|Physician Decision|1
1184838|NCT02001623|2343178|FG013|Overall Study|Physician Decision|2
1184839|NCT02001623|2343179|FG014|Overall Study|Physician Decision|1
1184840|NCT02001623|2343165|FG000|Overall Study|Death|0
1184841|NCT02001623|2343166|FG001|Overall Study|Death|1
1184842|NCT02001623|2343167|FG002|Overall Study|Death|0
1184843|NCT02001623|2343168|FG003|Overall Study|Death|0
1184844|NCT02001623|2343169|FG004|Overall Study|Death|0
1184845|NCT02001623|2343170|FG005|Overall Study|Death|0
1184846|NCT02001623|2343171|FG006|Overall Study|Death|0
1184847|NCT02001623|2343172|FG007|Overall Study|Death|0
1184848|NCT02001623|2343173|FG008|Overall Study|Death|0
1184849|NCT02001623|2343174|FG009|Overall Study|Death|0
1184850|NCT02001623|2343175|FG010|Overall Study|Death|0
1184851|NCT02001623|2343176|FG011|Overall Study|Death|0
1184852|NCT02001623|2343177|FG012|Overall Study|Death|0
1184853|NCT02001623|2343178|FG013|Overall Study|Death|0
1184854|NCT02001623|2343179|FG014|Overall Study|Death|0
1184855|NCT02001623|2343165|FG000|Overall Study|Adverse Event|0
1184856|NCT02001623|2343166|FG001|Overall Study|Adverse Event|0
1184857|NCT02001623|2343167|FG002|Overall Study|Adverse Event|0
1184858|NCT02001623|2343168|FG003|Overall Study|Adverse Event|0
1184859|NCT02001623|2343169|FG004|Overall Study|Adverse Event|0
1184860|NCT02001623|2343170|FG005|Overall Study|Adverse Event|1
1184861|NCT02001623|2343171|FG006|Overall Study|Adverse Event|0
1184862|NCT02001623|2343172|FG007|Overall Study|Adverse Event|3
1184863|NCT02001623|2343173|FG008|Overall Study|Adverse Event|4
1184864|NCT02001623|2343174|FG009|Overall Study|Adverse Event|6
1184865|NCT02001623|2343175|FG010|Overall Study|Adverse Event|4
1184866|NCT02001623|2343176|FG011|Overall Study|Adverse Event|0
1184867|NCT02001623|2343177|FG012|Overall Study|Adverse Event|3
1184868|NCT02001623|2343178|FG013|Overall Study|Adverse Event|5
1184869|NCT02001623|2343179|FG014|Overall Study|Adverse Event|6
1184870|NCT02001623|2343165|FG000|Overall Study|Other - Miscellaneous|0
1184871|NCT02001623|2343166|FG001|Overall Study|Other - Miscellaneous|0
1184872|NCT02001623|2343167|FG002|Overall Study|Other - Miscellaneous|0
1184873|NCT02001623|2343168|FG003|Overall Study|Other - Miscellaneous|0
1184874|NCT02001623|2343169|FG004|Overall Study|Other - Miscellaneous|0
1184875|NCT02001623|2343170|FG005|Overall Study|Other - Miscellaneous|0
1184876|NCT02001623|2343171|FG006|Overall Study|Other - Miscellaneous|0
1184877|NCT02001623|2343172|FG007|Overall Study|Other - Miscellaneous|0
1184878|NCT02001623|2343173|FG008|Overall Study|Other - Miscellaneous|0
1184879|NCT02001623|2343174|FG009|Overall Study|Other - Miscellaneous|1
1184880|NCT02001623|2343175|FG010|Overall Study|Other - Miscellaneous|0
1184881|NCT02001623|2343176|FG011|Overall Study|Other - Miscellaneous|0
1184882|NCT02001623|2343177|FG012|Overall Study|Other - Miscellaneous|0
1184883|NCT02001623|2343178|FG013|Overall Study|Other - Miscellaneous|1
1184884|NCT02001623|2343179|FG014|Overall Study|Other - Miscellaneous|0
1184885|NCT02001623|2343165|FG000|Overall Study|Withdrawal by Subject|1
1184886|NCT02001623|2343166|FG001|Overall Study|Withdrawal by Subject|0
1184887|NCT02001623|2343167|FG002|Overall Study|Withdrawal by Subject|0
1184888|NCT02001623|2343168|FG003|Overall Study|Withdrawal by Subject|0
1184889|NCT02001623|2343169|FG004|Overall Study|Withdrawal by Subject|0
1184890|NCT02001623|2343170|FG005|Overall Study|Withdrawal by Subject|0
1184891|NCT02001623|2343171|FG006|Overall Study|Withdrawal by Subject|0
1184892|NCT02001623|2343172|FG007|Overall Study|Withdrawal by Subject|0
1184893|NCT02001623|2343173|FG008|Overall Study|Withdrawal by Subject|1
1184894|NCT02001623|2343174|FG009|Overall Study|Withdrawal by Subject|3
1184895|NCT02001623|2343175|FG010|Overall Study|Withdrawal by Subject|2
1184896|NCT02001623|2343176|FG011|Overall Study|Withdrawal by Subject|2
1184897|NCT02001623|2343177|FG012|Overall Study|Withdrawal by Subject|1
1184898|NCT02001623|2343178|FG013|Overall Study|Withdrawal by Subject|5
1184899|NCT02001623|2343179|FG014|Overall Study|Withdrawal by Subject|2
1184900|NCT02001623|2343165|FG000|Overall Study|Lost to Follow-up|0
1184901|NCT02001623|2343166|FG001|Overall Study|Lost to Follow-up|0
1184902|NCT02001623|2343167|FG002|Overall Study|Lost to Follow-up|0
1184903|NCT02001623|2343168|FG003|Overall Study|Lost to Follow-up|0
1184904|NCT02001623|2343169|FG004|Overall Study|Lost to Follow-up|0
1184905|NCT02001623|2343170|FG005|Overall Study|Lost to Follow-up|0
1184906|NCT02001623|2343171|FG006|Overall Study|Lost to Follow-up|0
1184907|NCT02001623|2343172|FG007|Overall Study|Lost to Follow-up|0
1184908|NCT02001623|2343173|FG008|Overall Study|Lost to Follow-up|0
1184909|NCT02001623|2343174|FG009|Overall Study|Lost to Follow-up|1
1184910|NCT02001623|2343175|FG010|Overall Study|Lost to Follow-up|0
1184911|NCT02001623|2343176|FG011|Overall Study|Lost to Follow-up|0
1184912|NCT02001623|2343177|FG012|Overall Study|Lost to Follow-up|0
1184913|NCT02001623|2343178|FG013|Overall Study|Lost to Follow-up|0
1184914|NCT02001623|2343179|FG014|Overall Study|Lost to Follow-up|0
1184915|NCT02001623|2343165|FG000|Overall Study|Start of New Anti-cancer Treatment|0
1184916|NCT02001623|2343166|FG001|Overall Study|Start of New Anti-cancer Treatment|0
1184917|NCT02001623|2343167|FG002|Overall Study|Start of New Anti-cancer Treatment|0
1184918|NCT02001623|2343168|FG003|Overall Study|Start of New Anti-cancer Treatment|0
1184919|NCT02001623|2343169|FG004|Overall Study|Start of New Anti-cancer Treatment|0
1184920|NCT02001623|2343170|FG005|Overall Study|Start of New Anti-cancer Treatment|0
1184921|NCT02001623|2343171|FG006|Overall Study|Start of New Anti-cancer Treatment|0
1184922|NCT02001623|2343172|FG007|Overall Study|Start of New Anti-cancer Treatment|0
1184923|NCT02001623|2343173|FG008|Overall Study|Start of New Anti-cancer Treatment|0
1184924|NCT02001623|2343174|FG009|Overall Study|Start of New Anti-cancer Treatment|0
1184925|NCT02001623|2343175|FG010|Overall Study|Start of New Anti-cancer Treatment|0
1184926|NCT02001623|2343176|FG011|Overall Study|Start of New Anti-cancer Treatment|1
1184927|NCT02001623|2343177|FG012|Overall Study|Start of New Anti-cancer Treatment|0
1184928|NCT02001623|2343178|FG013|Overall Study|Start of New Anti-cancer Treatment|1
1184929|NCT02001623|2343179|FG014|Overall Study|Start of New Anti-cancer Treatment|0
1184930|NCT02001623|2343165|FG000|Overall Study|Dose Delay Due to Toxicity|0
1184931|NCT02001623|2343166|FG001|Overall Study|Dose Delay Due to Toxicity|0
1184932|NCT02001623|2343167|FG002|Overall Study|Dose Delay Due to Toxicity|0
1184933|NCT02001623|2343168|FG003|Overall Study|Dose Delay Due to Toxicity|0
1184934|NCT02001623|2343169|FG004|Overall Study|Dose Delay Due to Toxicity|0
1184935|NCT02001623|2343170|FG005|Overall Study|Dose Delay Due to Toxicity|0
1184936|NCT02001623|2343171|FG006|Overall Study|Dose Delay Due to Toxicity|0
1184937|NCT02001623|2343172|FG007|Overall Study|Dose Delay Due to Toxicity|0
1184938|NCT02001623|2343173|FG008|Overall Study|Dose Delay Due to Toxicity|0
1184939|NCT02001623|2343174|FG009|Overall Study|Dose Delay Due to Toxicity|0
1184940|NCT02001623|2343175|FG010|Overall Study|Dose Delay Due to Toxicity|0
1184941|NCT02001623|2343176|FG011|Overall Study|Dose Delay Due to Toxicity|0
1184942|NCT02001623|2343177|FG012|Overall Study|Dose Delay Due to Toxicity|0
1184943|NCT02001623|2343178|FG013|Overall Study|Dose Delay Due to Toxicity|1
1184944|NCT02001623|2343179|FG014|Overall Study|Dose Delay Due to Toxicity|0
1184945|NCT01900002|2343228|FG000|Overall Study|Withdrawal by Subject|2
1184946|NCT01900002|2343228|FG000|Overall Study|ineligible for Y-90|4
1184947|NCT01595061|2343232|FG000|Overall Study|Never Treated|3
1184948|NCT01595061|2343232|FG000|Overall Study|Inadequate Pathology|1
1184970|NCT04598152|2343304|FG000|Overall Study|Lost to Follow-up|0
1184971|NCT04598152|2343305|FG001|Overall Study|Lost to Follow-up|1
1184972|NCT03945825|2343360|FG000|Overall Study|Enrolled but treatment not administered|0
1184973|NCT03945825|2343361|FG001|Overall Study|Enrolled but treatment not administered|0
1184974|NCT03945825|2343362|FG002|Overall Study|Enrolled but treatment not administered|0
1184975|NCT03945825|2343363|FG003|Overall Study|Enrolled but treatment not administered|0
1184976|NCT03945825|2343364|FG004|Overall Study|Enrolled but treatment not administered|1
1184977|NCT03945825|2343365|FG005|Overall Study|Enrolled but treatment not administered|0
879226|NCT00580840|1842485|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0
879227|NCT00580840|1842486|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0
879228|NCT00580840|1842483|FG000|Run-in|Other: Exclusionary Lab Value|1
879229|NCT00580840|1842484|FG001|Run-in|Other: Exclusionary Lab Value|0
879230|NCT00580840|1842485|FG002|Run-in|Other: Exclusionary Lab Value|0
879231|NCT00580840|1842486|FG003|Run-in|Other: Exclusionary Lab Value|0
879232|NCT00580840|1842483|FG000|Double-Blind|Adverse Event|0
879233|NCT00580840|1842484|FG001|Double-Blind|Adverse Event|3
879234|NCT00580840|1842485|FG002|Double-Blind|Adverse Event|4
879235|NCT00580840|1842486|FG003|Double-Blind|Adverse Event|1
879236|NCT00580840|1842483|FG000|Double-Blind|Loss of Efficacy|0
879237|NCT00580840|1842484|FG001|Double-Blind|Loss of Efficacy|1
879238|NCT00580840|1842485|FG002|Double-Blind|Loss of Efficacy|2
879239|NCT00580840|1842486|FG003|Double-Blind|Loss of Efficacy|10
879240|NCT00580840|1842483|FG000|Double-Blind|Lost to Follow-up|0
879241|NCT00580840|1842484|FG001|Double-Blind|Lost to Follow-up|1
879242|NCT00580840|1842485|FG002|Double-Blind|Lost to Follow-up|0
879243|NCT00580840|1842486|FG003|Double-Blind|Lost to Follow-up|2
879244|NCT00580840|1842483|FG000|Double-Blind|Withdrawal by Subject|0
879245|NCT00580840|1842484|FG001|Double-Blind|Withdrawal by Subject|1
879246|NCT00580840|1842485|FG002|Double-Blind|Withdrawal by Subject|2
879247|NCT00580840|1842486|FG003|Double-Blind|Withdrawal by Subject|2
879248|NCT00580840|1842483|FG000|Double-Blind|Other: Discontinued Methotrexate|0
879249|NCT00580840|1842484|FG001|Double-Blind|Other: Discontinued Methotrexate|1
879250|NCT00580840|1842485|FG002|Double-Blind|Other: Discontinued Methotrexate|0
879251|NCT00580840|1842486|FG003|Double-Blind|Other: Discontinued Methotrexate|0
879252|NCT00580840|1842483|FG000|Double-Blind|Other: Forbidden Medication|0
879253|NCT00580840|1842484|FG001|Double-Blind|Other: Forbidden Medication|0
879254|NCT00580840|1842485|FG002|Double-Blind|Other: Forbidden Medication|1
879255|NCT00580840|1842486|FG003|Double-Blind|Other: Forbidden Medication|0
879256|NCT00580866|1842511|FG000|Overall Study|Lost to Follow-up|2
879257|NCT00580866|1842512|FG001|Overall Study|Lost to Follow-up|2
879258|NCT00580970|1842529|FG000|Pre-treatment|Non-compliance|1
879259|NCT00580970|1842529|FG000|Treatment (Lovastatin)|Non-compliance|6
879260|NCT00580970|1842529|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7
879261|NCT00580970|1842529|FG000|Treatment (Lovastatin)|Physician Decision|4
879262|NCT00580970|1842529|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1
879263|NCT00580970|1842529|FG000|Treatment (Lovastatin)|Death|1
879264|NCT00580983|1842533|FG000|Overall Study|Did not complete 12 mon post RT studies|7
879265|NCT00581100|1842550|FG000|Overall Study|Death|1
879266|NCT00581100|1842551|FG001|Overall Study|Death|0
879267|NCT00581100|1842550|FG000|Overall Study|Adverse Event|2
879268|NCT00581100|1842551|FG001|Overall Study|Adverse Event|1
879269|NCT00581100|1842550|FG000|Overall Study|Withdrawal by Subject|1
879270|NCT00581100|1842551|FG001|Overall Study|Withdrawal by Subject|4
879271|NCT00581100|1842550|FG000|Overall Study|Other|3
879272|NCT00581100|1842551|FG001|Overall Study|Other|0
879273|NCT00581308|1842573|FG000|Pre Discharge|Lost to Follow-up|1
879274|NCT00581308|1842573|FG000|Pre Discharge|Device Removed|1
879275|NCT00581308|1842573|FG000|Month 1|Lost to Follow-up|3
879276|NCT00581308|1842573|FG000|Month 1|Withdrawal by Subject|2
879277|NCT00581308|1842573|FG000|Month 1|Device Removed|2
879278|NCT00581308|1842573|FG000|Month 1|Uknown|1
879279|NCT00581308|1842573|FG000|Month 6|Lost to Follow-up|1
879280|NCT00581308|1842573|FG000|Month 6|Withdrawal by Subject|2
879281|NCT00581308|1842573|FG000|Month 12|Death|1
1184978|NCT03945825|2343360|FG000|Overall Study|Lost to Follow-up|1
1184979|NCT03945825|2343361|FG001|Overall Study|Lost to Follow-up|5
1184980|NCT03945825|2343362|FG002|Overall Study|Lost to Follow-up|0
1184981|NCT03945825|2343363|FG003|Overall Study|Lost to Follow-up|1
1184982|NCT03945825|2343364|FG004|Overall Study|Lost to Follow-up|2
1184983|NCT03945825|2343365|FG005|Overall Study|Lost to Follow-up|2
1184984|NCT03945825|2343360|FG000|Overall Study|Withdrawal by Subject|1
1184985|NCT03945825|2343361|FG001|Overall Study|Withdrawal by Subject|0
1184986|NCT03945825|2343362|FG002|Overall Study|Withdrawal by Subject|1
1184987|NCT03945825|2343363|FG003|Overall Study|Withdrawal by Subject|1
1184988|NCT03945825|2343364|FG004|Overall Study|Withdrawal by Subject|0
1184989|NCT03945825|2343365|FG005|Overall Study|Withdrawal by Subject|1
1184990|NCT03562767|2343412|FG000|Overall Study|Physician Decision|2
1184991|NCT03562767|2343413|FG001|Overall Study|Physician Decision|0
1184992|NCT03562767|2343414|FG002|Overall Study|Physician Decision|0
1184993|NCT03562767|2343412|FG000|Overall Study|Logistic Reason|1
1184994|NCT03562767|2343413|FG001|Overall Study|Logistic Reason|3
1184995|NCT03562767|2343414|FG002|Overall Study|Logistic Reason|0
1184996|NCT03559699|2343426|FG000|Overall Study|Withdrawal by Subject|6
1184997|NCT03559699|2343426|FG000|Overall Study|Lost to Follow-up|1
1184998|NCT03305016|2343452|FG000|Overall Study|Withdrawal by Subject|2
1184999|NCT03291067|2343469|FG000|Overall Study|Adverse Event|0
1185000|NCT03291067|2343470|FG001|Overall Study|Adverse Event|2
1185001|NCT03291067|2343471|FG002|Overall Study|Adverse Event|17
1185002|NCT03291067|2343472|FG003|Overall Study|Adverse Event|3
1185003|NCT03291067|2343469|FG000|Overall Study|Lost to Follow-up|2
879282|NCT00581308|1842573|FG000|Month 12|Lost to Follow-up|14
1185004|NCT03291067|2343470|FG001|Overall Study|Lost to Follow-up|1
1185005|NCT03291067|2343471|FG002|Overall Study|Lost to Follow-up|0
1185006|NCT03291067|2343472|FG003|Overall Study|Lost to Follow-up|1
1185007|NCT03291067|2343469|FG000|Overall Study|Physician Decision|0
1185008|NCT03291067|2343470|FG001|Overall Study|Physician Decision|0
1185009|NCT03291067|2343471|FG002|Overall Study|Physician Decision|1
1185010|NCT03291067|2343472|FG003|Overall Study|Physician Decision|0
1185011|NCT03291067|2343469|FG000|Overall Study|Protocol Violation|5
1185012|NCT03291067|2343470|FG001|Overall Study|Protocol Violation|3
1185013|NCT03291067|2343471|FG002|Overall Study|Protocol Violation|4
1185014|NCT03291067|2343472|FG003|Overall Study|Protocol Violation|2
1185015|NCT03291067|2343469|FG000|Overall Study|Withdrawal by Subject|3
1185016|NCT03291067|2343470|FG001|Overall Study|Withdrawal by Subject|4
1185017|NCT03291067|2343471|FG002|Overall Study|Withdrawal by Subject|7
1185018|NCT03291067|2343472|FG003|Overall Study|Withdrawal by Subject|5
1185019|NCT03291067|2343469|FG000|Overall Study|Other|0
1185020|NCT03291067|2343470|FG001|Overall Study|Other|4
1185021|NCT03291067|2343471|FG002|Overall Study|Other|4
1185022|NCT03291067|2343472|FG003|Overall Study|Other|6
879283|NCT00581308|1842573|FG000|Month 12|Withdrawal by Subject|3
879284|NCT00581308|1842573|FG000|Month 12|Device Removed|1
879285|NCT00581308|1842573|FG000|Month 12|Other|1
879286|NCT00581360|1842589|FG000|Overall Study|Withdrawal by Subject|1
879287|NCT00581542|1842621|FG000|Overall Study|they met an exclusion criteria|2
879288|NCT00581542|1842622|FG001|Overall Study|they met an exclusion criteria|2
879289|NCT00581542|1842621|FG000|Overall Study|Lost to Follow-up|9
879290|NCT00581542|1842622|FG001|Overall Study|Lost to Follow-up|21
879291|NCT00581555|1842632|FG000|Overall Study|Adverse Event|4
879292|NCT00581555|1842633|FG001|Overall Study|Adverse Event|3
879293|NCT00581555|1842632|FG000|Overall Study|Physician Decision|3
879294|NCT00581555|1842633|FG001|Overall Study|Physician Decision|2
879295|NCT00581555|1842632|FG000|Overall Study|Withdrawal by Subject|18
879296|NCT00581555|1842633|FG001|Overall Study|Withdrawal by Subject|9
879297|NCT00581555|1842632|FG000|Overall Study|Lost to Follow-up|2
879298|NCT00581555|1842633|FG001|Overall Study|Lost to Follow-up|2
879299|NCT00581555|1842632|FG000|Overall Study|Other reasons|16
879300|NCT00581555|1842633|FG001|Overall Study|Other reasons|4
879301|NCT00581776|1842648|FG000|Overall Study|Disease progression or no response|3
879302|NCT00581828|1842652|FG000|Overall Study|Protocol Violation|1
879303|NCT00581893|1842667|FG000|Second Intervention (1 Month)|Lost to Follow-up|3
879304|NCT00581893|1842668|FG001|Second Intervention (1 Month)|Lost to Follow-up|2
879305|NCT00581919|1842674|FG000|Overall Study|Adverse Event|8
879306|NCT00581919|1842674|FG000|Overall Study|Death|1
879307|NCT00581919|1842674|FG000|Overall Study|Disease Progression|10
879308|NCT00581919|1842674|FG000|Overall Study|Physician Decision|1
879309|NCT00581919|1842674|FG000|Overall Study|Other Complicating Disease|1
879310|NCT00581919|1842674|FG000|Overall Study|Started Non-Protocol Therapy|2
879311|NCT00581919|1842674|FG000|Overall Study|Withdrawal by Subject|1
879312|NCT00581945|1842681|FG000|Overall Study|Adverse Event|4
879313|NCT00581945|1842682|FG001|Overall Study|Adverse Event|4
879314|NCT00581945|1842681|FG000|Overall Study|Unsatisfactory therapeutic effect|2
879315|NCT00581945|1842682|FG001|Overall Study|Unsatisfactory therapeutic effect|0
879316|NCT00581945|1842681|FG000|Overall Study|Withdrawal by Subject|2
1185033|NCT03271047|2343495|FG000|Phase 1b: Dose Finding Period|Death|8
1185034|NCT03271047|2343496|FG001|Phase 1b: Dose Finding Period|Death|8
1185035|NCT03271047|2343497|FG002|Phase 1b: Dose Finding Period|Death|0
1185036|NCT03271047|2343498|FG003|Phase 1b: Dose Finding Period|Death|0
1185037|NCT03271047|2343495|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1
1185038|NCT03271047|2343496|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0
1185039|NCT03271047|2343497|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0
1185040|NCT03271047|2343498|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0
1185041|NCT03271047|2343495|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
1185042|NCT03271047|2343496|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2
1185043|NCT03271047|2343497|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
1185044|NCT03271047|2343498|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
1185045|NCT03271047|2343495|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
1185046|NCT03271047|2343496|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
1185047|NCT03271047|2343497|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
1185048|NCT03271047|2343498|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
1185049|NCT03271047|2343495|FG000|Randomized Phase 2 Period|Other|0
1185050|NCT03271047|2343496|FG001|Randomized Phase 2 Period|Other|0
1185051|NCT03271047|2343497|FG002|Randomized Phase 2 Period|Other|0
1185052|NCT03271047|2343498|FG003|Randomized Phase 2 Period|Other|1
1185053|NCT03271047|2343495|FG000|Randomized Phase 2 Period|Death|0
1185054|NCT03271047|2343496|FG001|Randomized Phase 2 Period|Death|0
1185055|NCT03271047|2343497|FG002|Randomized Phase 2 Period|Death|20
1185056|NCT03271047|2343498|FG003|Randomized Phase 2 Period|Death|21
1185057|NCT03271047|2343495|FG000|Randomized Phase 2 Period|Lost to Follow-up|0
1185058|NCT03271047|2343496|FG001|Randomized Phase 2 Period|Lost to Follow-up|0
1185059|NCT03271047|2343497|FG002|Randomized Phase 2 Period|Lost to Follow-up|2
1185060|NCT03271047|2343498|FG003|Randomized Phase 2 Period|Lost to Follow-up|1
1185061|NCT03271047|2343495|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0
1185062|NCT03271047|2343496|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0
1185063|NCT03271047|2343497|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5
1185064|NCT03271047|2343498|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0
1185065|NCT03271047|2343495|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0
1185066|NCT03271047|2343496|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0
1185067|NCT03271047|2343497|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0
879317|NCT00581945|1842682|FG001|Overall Study|Withdrawal by Subject|6
879318|NCT00581945|1842681|FG000|Overall Study|Death|1
879319|NCT00581945|1842682|FG001|Overall Study|Death|0
879320|NCT00582010|1842695|FG000|Overall Study|Death|0
879321|NCT00582010|1842696|FG001|Overall Study|Death|1
1185068|NCT03271047|2343498|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4
1185069|NCT03257436|2343510|FG000|Overall Study|Withdrawal by Subject|76
1185070|NCT03257436|2343510|FG000|Overall Study|Death|19
1185071|NCT03158285|2343527|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4
1185072|NCT03158285|2343528|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2
1185073|NCT03158285|2343529|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6
1185074|NCT03158285|2343527|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0
1185075|NCT03158285|2343528|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
1185076|NCT03158285|2343529|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
1185077|NCT03158285|2343527|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
1185078|NCT03158285|2343528|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
1185079|NCT03158285|2343529|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0
1185080|NCT03158285|2343527|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
1185081|NCT03158285|2343528|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1
1185082|NCT03158285|2343529|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
1185083|NCT03158285|2343527|FG000|Placebo-controlled Period: Week 0 - 24|Other|1
1185084|NCT03158285|2343528|FG001|Placebo-controlled Period: Week 0 - 24|Other|1
1185085|NCT03158285|2343529|FG002|Placebo-controlled Period: Week 0 - 24|Other|0
1185086|NCT03158285|2343527|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
1185087|NCT03158285|2343528|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0
1185088|NCT03158285|2343529|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1
1185089|NCT03158285|2343527|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5
1185090|NCT03158285|2343528|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
1185091|NCT03158285|2343529|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
1185092|NCT03158285|2343527|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
1185093|NCT03158285|2343528|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
1185094|NCT03158285|2343529|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
1185095|NCT03158285|2343527|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0
1185096|NCT03158285|2343528|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0
1185097|NCT03158285|2343529|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1
1185098|NCT03158285|2343527|FG000|Active Treatment Period: Week 24 - 52|Other|1
1185099|NCT03158285|2343528|FG001|Active Treatment Period: Week 24 - 52|Other|1
879322|NCT00582114|1842708|FG000|Overall Study|Death|4
879323|NCT00582114|1842709|FG001|Overall Study|Death|4
879324|NCT00582114|1842708|FG000|Overall Study|Kidney Transplant|3
879325|NCT00582114|1842709|FG001|Overall Study|Kidney Transplant|1
879326|NCT00582114|1842708|FG000|Overall Study|Lost to Follow-up|7
879327|NCT00582114|1842709|FG001|Overall Study|Lost to Follow-up|6
879328|NCT00582114|1842708|FG000|Overall Study|Withdrawal by Subject|8
879329|NCT00582114|1842709|FG001|Overall Study|Withdrawal by Subject|16
879330|NCT00582114|1842708|FG000|Overall Study|Adverse Event|1
879331|NCT00582114|1842709|FG001|Overall Study|Adverse Event|1
879332|NCT00582114|1842708|FG000|Overall Study|Physician Decision|0
879333|NCT00582114|1842709|FG001|Overall Study|Physician Decision|6
1185100|NCT03158285|2343529|FG002|Active Treatment Period: Week 24 - 52|Other|0
1185101|NCT03158285|2343527|FG000|Active Treatment Period: Week 52-100|Adverse Event|7
1185102|NCT03158285|2343528|FG001|Active Treatment Period: Week 52-100|Adverse Event|5
1185103|NCT03158285|2343529|FG002|Active Treatment Period: Week 52-100|Adverse Event|3
1185104|NCT03158285|2343527|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1
1185105|NCT03158285|2343528|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1
1185106|NCT03158285|2343529|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3
1185107|NCT03158285|2343527|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5
1185108|NCT03158285|2343528|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2
1185109|NCT03158285|2343529|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1
1185110|NCT03158285|2343527|FG000|Active Treatment Period: Week 52-100|Pregnancy|0
1185111|NCT03158285|2343528|FG001|Active Treatment Period: Week 52-100|Pregnancy|0
1185112|NCT03158285|2343529|FG002|Active Treatment Period: Week 52-100|Pregnancy|1
1185113|NCT03158285|2343527|FG000|Active Treatment Period: Week 52-100|Death|1
1185114|NCT03158285|2343528|FG001|Active Treatment Period: Week 52-100|Death|0
1185115|NCT03158285|2343529|FG002|Active Treatment Period: Week 52-100|Death|0
1185116|NCT03158285|2343527|FG000|Active Treatment Period: Week 52-100|Other|4
1185117|NCT03158285|2343528|FG001|Active Treatment Period: Week 52-100|Other|1
1185118|NCT03158285|2343529|FG002|Active Treatment Period: Week 52-100|Other|0
1185119|NCT03051217|2343545|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2
1185120|NCT03051217|2343546|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
1185121|NCT03051217|2343547|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
1185122|NCT03051217|2343548|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
1185123|NCT03051217|2343549|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
879334|NCT00582114|1842708|FG000|Overall Study|Stopped by data safety monitoring board|19
879335|NCT00582114|1842709|FG001|Overall Study|Stopped by data safety monitoring board|20
879336|NCT00582166|1842715|FG000|Overall Study|Death|1
879337|NCT00582166|1842715|FG000|Overall Study|Ineligible pathology|1
879338|NCT00582309|1842726|FG000|Overall Study|Protocol Violation|0
879339|NCT00582309|1842727|FG001|Overall Study|Protocol Violation|0
879340|NCT00582309|1842728|FG002|Overall Study|Protocol Violation|2
879341|NCT00582426|1842751|FG000|Overall Study|Lost to Follow-up|0
879342|NCT00582426|1842752|FG001|Overall Study|Lost to Follow-up|2
879343|NCT00582426|1842751|FG000|Overall Study|Adverse Event|4
879344|NCT00582426|1842752|FG001|Overall Study|Adverse Event|2
879345|NCT00582426|1842751|FG000|Overall Study|Protocol Violation|6
879346|NCT00582426|1842752|FG001|Overall Study|Protocol Violation|2
879347|NCT00582426|1842751|FG000|Overall Study|Death|4
879348|NCT00582426|1842752|FG001|Overall Study|Death|3
879349|NCT00582426|1842751|FG000|Overall Study|Withdrawal by Subject|3
879350|NCT00582426|1842752|FG001|Overall Study|Withdrawal by Subject|2
879351|NCT00582426|1842751|FG000|Overall Study|Disease Progression|2
879352|NCT00582426|1842752|FG001|Overall Study|Disease Progression|2
879353|NCT00582426|1842751|FG000|Overall Study|Use of illicit drugs|1
879354|NCT00582426|1842752|FG001|Overall Study|Use of illicit drugs|0
879355|NCT00582491|1842760|FG000|Overall Study|Withdrawal by Subject|1
879356|NCT00582491|1842761|FG001|Overall Study|Withdrawal by Subject|0
879357|NCT00582556|1842779|FG000|Overall Study|Withdrawal by Subject|0
879358|NCT00582556|1842780|FG001|Overall Study|Withdrawal by Subject|1
879359|NCT00582556|1842781|FG002|Overall Study|Withdrawal by Subject|1
879360|NCT00582556|1842779|FG000|Overall Study|Physician Decision|0
879361|NCT00582556|1842780|FG001|Overall Study|Physician Decision|0
879362|NCT00582556|1842781|FG002|Overall Study|Physician Decision|1
879363|NCT00582608|1842790|FG000|Overall Study|Not Treated|7
879364|NCT00582608|1842790|FG000|Overall Study|Patient Ineligible|1
879365|NCT00582608|1842790|FG000|Overall Study|Lack of accrual|4
879366|NCT00582738|1842805|FG000|Overall Study|Administrative Problems|7
879367|NCT00582738|1842806|FG001|Overall Study|Administrative Problems|8
879368|NCT00582738|1842805|FG000|Overall Study|Adverse Event|0
879369|NCT00582738|1842806|FG001|Overall Study|Adverse Event|5
879370|NCT00582738|1842805|FG000|Overall Study|Graft Lost|0
879371|NCT00582738|1842806|FG001|Overall Study|Graft Lost|1
879372|NCT00582738|1842805|FG000|Overall Study|Other|1
879373|NCT00582738|1842806|FG001|Overall Study|Other|0
879374|NCT00582738|1842805|FG000|Overall Study|Protocol Violation|1
879375|NCT00582738|1842806|FG001|Overall Study|Protocol Violation|1
879376|NCT00582738|1842805|FG000|Overall Study|Withdrawal by Subject|0
879377|NCT00582738|1842806|FG001|Overall Study|Withdrawal by Subject|3
879378|NCT00582790|1842818|FG000|Overall Study|Rapid progression of disease|1
1185124|NCT03051217|2343550|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
1185125|NCT03051217|2343551|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
1185126|NCT03051217|2343545|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1185127|NCT03051217|2343546|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1
1185128|NCT03051217|2343547|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1185129|NCT03051217|2343548|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1185130|NCT03051217|2343549|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1185131|NCT03051217|2343550|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1185132|NCT03051217|2343551|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1185133|NCT03051217|2343545|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1185134|NCT03051217|2343546|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1185135|NCT03051217|2343547|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1185136|NCT03051217|2343548|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1185137|NCT03051217|2343549|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1185138|NCT03051217|2343550|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1185139|NCT03051217|2343551|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1185140|NCT03051217|2343545|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
1185141|NCT03051217|2343546|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
1185142|NCT03051217|2343547|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
1185143|NCT03051217|2343548|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
1185144|NCT03051217|2343549|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
1185145|NCT03051217|2343550|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
1185146|NCT03051217|2343551|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
1185147|NCT03051217|2343545|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1185148|NCT03051217|2343546|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1185149|NCT03051217|2343547|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1185150|NCT03051217|2343548|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
1185151|NCT03051217|2343549|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1185152|NCT03051217|2343550|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1185153|NCT03051217|2343551|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1185154|NCT03051217|2343545|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1185155|NCT03051217|2343546|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1185156|NCT03051217|2343547|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1185157|NCT03051217|2343548|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
1185158|NCT03051217|2343549|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1185159|NCT03051217|2343550|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1185160|NCT03051217|2343551|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1185161|NCT03051217|2343545|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1185162|NCT03051217|2343546|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1185163|NCT03051217|2343547|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1185164|NCT03051217|2343548|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1185165|NCT03051217|2343549|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
1185166|NCT03051217|2343550|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1185167|NCT03051217|2343551|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1185168|NCT03051217|2343545|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1185169|NCT03051217|2343546|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1185170|NCT03051217|2343547|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1185171|NCT03051217|2343548|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1185172|NCT03051217|2343549|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1185173|NCT03051217|2343550|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
1185174|NCT03051217|2343551|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1185175|NCT03025542|2343578|FG000|Overall Study|Adverse Event|0
1185176|NCT03025542|2343579|FG001|Overall Study|Adverse Event|2
1185177|NCT03025542|2343578|FG000|Overall Study|Lost to Follow-up|1
1185178|NCT03025542|2343579|FG001|Overall Study|Lost to Follow-up|0
1185179|NCT03025542|2343578|FG000|Overall Study|Withdrawal by Subject|1
1185180|NCT03025542|2343579|FG001|Overall Study|Withdrawal by Subject|0
1185181|NCT02889809|2343615|FG000|Overall Study|Withdrawal by Subject|30
1185182|NCT02889809|2343616|FG001|Overall Study|Withdrawal by Subject|21
1185183|NCT02889809|2343615|FG000|Overall Study|Lost to Follow-up|1
1185184|NCT02889809|2343616|FG001|Overall Study|Lost to Follow-up|1
1185185|NCT02889809|2343615|FG000|Overall Study|Site Closed|12
1185186|NCT02889809|2343616|FG001|Overall Study|Site Closed|11
1185187|NCT02859558|2343625|FG000|Step 1|Lost to Follow-up|1
1185188|NCT02859558|2343626|FG001|Step 1|Lost to Follow-up|3
1185189|NCT02859558|2343627|FG002|Step 1|Lost to Follow-up|3
1185190|NCT02859558|2343625|FG000|Step 1|Did Not Return to Clinic|2
1185191|NCT02859558|2343626|FG001|Step 1|Did Not Return to Clinic|3
1185192|NCT02859558|2343627|FG002|Step 1|Did Not Return to Clinic|4
1185193|NCT02859558|2343625|FG000|Step 1|Moved|0
1185194|NCT02859558|2343626|FG001|Step 1|Moved|1
1185195|NCT02859558|2343627|FG002|Step 1|Moved|1
1185196|NCT02859558|2343625|FG000|Step 1|Withdrawal By Participant|1
1185197|NCT02859558|2343626|FG001|Step 1|Withdrawal By Participant|2
1185198|NCT02859558|2343627|FG002|Step 1|Withdrawal By Participant|1
1185199|NCT02859558|2343625|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1
1185200|NCT02859558|2343626|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0
1185201|NCT02859558|2343627|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0
1185202|NCT02859558|2343625|FG000|Step 1|Incarceration|0
1185203|NCT02859558|2343626|FG001|Step 1|Incarceration|1
1185204|NCT02859558|2343627|FG002|Step 1|Incarceration|0
1185205|NCT02859558|2343625|FG000|Step 1|Non-Adherence to Study Drug|2
1185206|NCT02859558|2343626|FG001|Step 1|Non-Adherence to Study Drug|0
1185207|NCT02859558|2343627|FG002|Step 1|Non-Adherence to Study Drug|1
1185208|NCT02859558|2343625|FG000|Step 1|Non-Adherence to Study Requirements|3
1185209|NCT02859558|2343626|FG001|Step 1|Non-Adherence to Study Requirements|1
1185210|NCT02859558|2343627|FG002|Step 1|Non-Adherence to Study Requirements|0
1185211|NCT02859558|2343625|FG000|Step 1|Virologic Failure|2
1185212|NCT02859558|2343626|FG001|Step 1|Virologic Failure|1
1185213|NCT02859558|2343627|FG002|Step 1|Virologic Failure|1
1185214|NCT02859558|2343625|FG000|Step 2|Lost to Follow-up|2
1185215|NCT02859558|2343626|FG001|Step 2|Lost to Follow-up|0
1185216|NCT02859558|2343627|FG002|Step 2|Lost to Follow-up|0
1185217|NCT02859558|2343625|FG000|Step 2|Active On Study|22
1185218|NCT02859558|2343626|FG001|Step 2|Active On Study|36
1185219|NCT02859558|2343627|FG002|Step 2|Active On Study|18
1185220|NCT02849587|2343638|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
1185221|NCT02849587|2343639|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3
1185222|NCT02849587|2343640|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
1185223|NCT02849587|2343638|FG000|Overall Study|Withdrawal by Subject|0
1185224|NCT02849587|2343639|FG001|Overall Study|Withdrawal by Subject|1
1185225|NCT02849587|2343640|FG002|Overall Study|Withdrawal by Subject|0
1185226|NCT02815540|2343652|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2
1185227|NCT02781727|2343687|FG000|Pre-dosing Period|Withdrawal by Subject|1
1185228|NCT02781727|2343688|FG001|Pre-dosing Period|Withdrawal by Subject|0
1185229|NCT02781727|2343687|FG000|Treatment Period|Withdrawal by Subject|1
1185230|NCT02781727|2343688|FG001|Treatment Period|Withdrawal by Subject|0
1185231|NCT02781727|2343687|FG000|Treatment Period|Lost to Follow-up|0
1185232|NCT02781727|2343688|FG001|Treatment Period|Lost to Follow-up|1
1185233|NCT02778204|2343698|FG000|Overall Study|Adverse Event|1
1185234|NCT02778204|2343699|FG001|Overall Study|Adverse Event|0
1185235|NCT02778204|2343700|FG002|Overall Study|Adverse Event|0
1185236|NCT02778204|2343701|FG003|Overall Study|Adverse Event|0
1185237|NCT02778204|2343698|FG000|Overall Study|Withdrawal by Subject|0
1185238|NCT02778204|2343699|FG001|Overall Study|Withdrawal by Subject|0
1185239|NCT02778204|2343700|FG002|Overall Study|Withdrawal by Subject|1
1185240|NCT02778204|2343701|FG003|Overall Study|Withdrawal by Subject|2
1185241|NCT02778204|2343698|FG000|Overall Study|Lost to Follow-up|1
1185242|NCT02778204|2343699|FG001|Overall Study|Lost to Follow-up|0
1185243|NCT02778204|2343700|FG002|Overall Study|Lost to Follow-up|2
1185244|NCT02778204|2343701|FG003|Overall Study|Lost to Follow-up|1
1185245|NCT02778204|2343698|FG000|Overall Study|Protocol Violation|0
1185246|NCT02778204|2343699|FG001|Overall Study|Protocol Violation|0
1185247|NCT02778204|2343700|FG002|Overall Study|Protocol Violation|1
1185248|NCT02778204|2343701|FG003|Overall Study|Protocol Violation|0
1185249|NCT02778204|2343698|FG000|Overall Study|Eligibility Violation|0
1185250|NCT02778204|2343699|FG001|Overall Study|Eligibility Violation|0
1185251|NCT02778204|2343700|FG002|Overall Study|Eligibility Violation|0
1185252|NCT02778204|2343701|FG003|Overall Study|Eligibility Violation|1
1185269|NCT02496611|2343733|FG000|Overall Study|Lost to Follow-up|2
1185270|NCT02496611|2343734|FG001|Overall Study|Lost to Follow-up|1
1185271|NCT02496611|2343733|FG000|Overall Study|Withdrawal by Subject|5
1185272|NCT02496611|2343734|FG001|Overall Study|Withdrawal by Subject|2
879379|NCT00582816|1842823|FG000|Overall Study|Engraftment Failure|3
879380|NCT00582907|1842831|FG000|1st Course|Withdrawal by Subject|1
879381|NCT00582907|1842832|FG001|1st Course|Withdrawal by Subject|0
879382|NCT00582907|1842833|FG002|1st Course|Withdrawal by Subject|0
879383|NCT00582907|1842834|FG003|1st Course|Withdrawal by Subject|0
879384|NCT00582907|1842831|FG000|1st Course|Lost to Follow-up|0
879385|NCT00582907|1842832|FG001|1st Course|Lost to Follow-up|0
879386|NCT00582907|1842833|FG002|1st Course|Lost to Follow-up|0
879387|NCT00582907|1842834|FG003|1st Course|Lost to Follow-up|1
879388|NCT00582907|1842831|FG000|2nd Course|Lack of Efficacy|1
879389|NCT00582907|1842832|FG001|2nd Course|Lack of Efficacy|0
879390|NCT00582907|1842833|FG002|2nd Course|Lack of Efficacy|0
1185309|NCT02227199|2343762|FG000|Overall Study|Physician Decision|0
1185310|NCT02227199|2343763|FG001|Overall Study|Physician Decision|0
1185311|NCT02227199|2343764|FG002|Overall Study|Physician Decision|1
1185312|NCT02227199|2343762|FG000|Overall Study|Adverse Event|0
1185313|NCT02227199|2343763|FG001|Overall Study|Adverse Event|0
1185314|NCT02227199|2343764|FG002|Overall Study|Adverse Event|3
1185315|NCT02198794|2343776|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79
1185316|NCT02198794|2343777|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
1185317|NCT02198794|2343778|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
1185318|NCT02198794|2343779|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
1185319|NCT02198794|2343776|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33
1185320|NCT02198794|2343777|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0
1185321|NCT02198794|2343778|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0
1185322|NCT02198794|2343779|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0
1185323|NCT02198794|2343776|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24
1185324|NCT02198794|2343777|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
1185325|NCT02198794|2343778|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
1185326|NCT02198794|2343779|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
1185327|NCT02198794|2343776|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9
1185328|NCT02198794|2343777|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
1185329|NCT02198794|2343778|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
1185330|NCT02198794|2343779|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
1185331|NCT02198794|2343776|FG000|Part A: Open-Label (158 Weeks)|Death|8
1185332|NCT02198794|2343777|FG001|Part A: Open-Label (158 Weeks)|Death|0
1185333|NCT02198794|2343778|FG002|Part A: Open-Label (158 Weeks)|Death|0
1185334|NCT02198794|2343779|FG003|Part A: Open-Label (158 Weeks)|Death|0
1185335|NCT02198794|2343776|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3
1185336|NCT02198794|2343777|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
1185337|NCT02198794|2343778|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
1185338|NCT02198794|2343779|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
1185339|NCT02198794|2343776|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5
1185340|NCT02198794|2343777|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0
1185341|NCT02198794|2343778|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0
879391|NCT00582907|1842834|FG003|2nd Course|Lack of Efficacy|0
879392|NCT00582933|1842840|FG000|Overall Study|Physician Decision|3
1185342|NCT02198794|2343779|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0
1185343|NCT02198794|2343776|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1
1185344|NCT02198794|2343777|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0
1185345|NCT02198794|2343778|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0
1185346|NCT02198794|2343779|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0
1185347|NCT02198794|2343776|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1
1185348|NCT02198794|2343777|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0
1185349|NCT02198794|2343778|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0
1185350|NCT02198794|2343779|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0
1185351|NCT02198794|2343776|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142
1185352|NCT02198794|2343777|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
1185353|NCT02198794|2343778|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
1185354|NCT02198794|2343779|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
1185355|NCT02198794|2343776|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
1185356|NCT02198794|2343777|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3
1185357|NCT02198794|2343778|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1
1185358|NCT02198794|2343779|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
1185359|NCT02198794|2343776|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
1185360|NCT02198794|2343777|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
1185361|NCT02198794|2343778|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
1185362|NCT02198794|2343779|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
1185363|NCT02198794|2343776|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
1185364|NCT02198794|2343777|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
1185365|NCT02198794|2343778|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
1185366|NCT02198794|2343779|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3
1185367|NCT02198794|2343776|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
1185368|NCT02198794|2343777|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
1185369|NCT02198794|2343778|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
1185370|NCT02198794|2343779|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2
1185371|NCT02198794|2343776|FG000|Part C: Safety Assessment (52 Weeks)|Death|0
1185372|NCT02198794|2343777|FG001|Part C: Safety Assessment (52 Weeks)|Death|0
1185373|NCT02198794|2343778|FG002|Part C: Safety Assessment (52 Weeks)|Death|0
1185374|NCT02198794|2343779|FG003|Part C: Safety Assessment (52 Weeks)|Death|2
1185375|NCT02177695|2343790|FG000|ITT Analysis|Ineligible|5
1185376|NCT02177695|2343791|FG001|ITT Analysis|Ineligible|5
1185377|NCT02177695|2343790|FG000|Primary COXEN Analysis|inadequate tissue submitted|5
1185378|NCT02177695|2343791|FG001|Primary COXEN Analysis|inadequate tissue submitted|6
1185379|NCT02177695|2343790|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15
1185380|NCT02177695|2343791|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8
1185381|NCT02177695|2343790|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13
1185382|NCT02177695|2343791|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13
1185383|NCT02105636|2343821|FG000|Overall Study|Disease Progression|162
1185384|NCT02105636|2343822|FG001|Overall Study|Disease Progression|83
1185385|NCT02105636|2343821|FG000|Overall Study|Study Drug Toxicity|9
1185386|NCT02105636|2343822|FG001|Overall Study|Study Drug Toxicity|11
1185387|NCT02105636|2343821|FG000|Overall Study|Adverse Event Unrelated to Study Drug|12
1185388|NCT02105636|2343822|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
1185389|NCT02105636|2343821|FG000|Overall Study|Subject Request to Discontinue Treatment|4
1185390|NCT02105636|2343822|FG001|Overall Study|Subject Request to Discontinue Treatment|6
1185391|NCT02105636|2343821|FG000|Overall Study|Subject Withdrew Consent|4
1185392|NCT02105636|2343822|FG001|Overall Study|Subject Withdrew Consent|1
1185393|NCT02105636|2343821|FG000|Overall Study|Maximum Clinical Benefit|1
1185394|NCT02105636|2343822|FG001|Overall Study|Maximum Clinical Benefit|1
1185395|NCT02105636|2343821|FG000|Overall Study|Poor/Non-compliance|0
1185396|NCT02105636|2343822|FG001|Overall Study|Poor/Non-compliance|1
1185397|NCT02105636|2343821|FG000|Overall Study|Reason Not Specified|0
1185398|NCT02105636|2343822|FG001|Overall Study|Reason Not Specified|2
1185399|NCT02105636|2343821|FG000|Overall Study|Not Reported|3
1185400|NCT02105636|2343822|FG001|Overall Study|Not Reported|0
1185413|NCT02038946|2343838|FG000|Overall Study|Death|5
1185414|NCT02038946|2343838|FG000|Overall Study|Withdrawal by Subject|3
1185415|NCT02038946|2343838|FG000|Overall Study|Lost to Follow-up|2
1185416|NCT02038946|2343838|FG000|Overall Study|Other reasons|2
1185417|NCT01988571|2343844|FG000|Overall Study|Death|3
1185418|NCT01988571|2343845|FG001|Overall Study|Death|1
1185419|NCT01988571|2343844|FG000|Overall Study|Physician Decision|2
1185420|NCT01988571|2343845|FG001|Overall Study|Physician Decision|1
1185421|NCT01988571|2343844|FG000|Overall Study|Lost to Follow-up|3
1185422|NCT01988571|2343845|FG001|Overall Study|Lost to Follow-up|0
1185423|NCT01988571|2343844|FG000|Overall Study|Withdrawal by Subject|31
1185424|NCT01988571|2343845|FG001|Overall Study|Withdrawal by Subject|33
1185425|NCT01974206|2343853|FG000|Overall Study|Did Not Take Study Drug|0
1185426|NCT01974206|2343854|FG001|Overall Study|Did Not Take Study Drug|1
1185427|NCT01974206|2343853|FG000|Overall Study|Physician Decision|1
1185428|NCT01974206|2343854|FG001|Overall Study|Physician Decision|0
1185429|NCT01974206|2343853|FG000|Overall Study|Withdrawal by Subject|3
1185430|NCT01974206|2343854|FG001|Overall Study|Withdrawal by Subject|0
1185431|NCT01974206|2343853|FG000|Overall Study|Lost to Follow-up|1
1185432|NCT01974206|2343854|FG001|Overall Study|Lost to Follow-up|0
1185433|NCT01974206|2343853|FG000|Overall Study|Death|1
1185434|NCT01974206|2343854|FG001|Overall Study|Death|0
1185435|NCT01715285|2343872|FG000|Treatment Period|Adverse Event|60
1185436|NCT01715285|2343873|FG001|Treatment Period|Adverse Event|33
879393|NCT00582972|1842848|FG000|Overall Study|Protocol Violation|2
879394|NCT00583102|1842876|FG000|Overall Study|Adverse Event|3
1185437|NCT01715285|2343874|FG002|Treatment Period|Adverse Event|0
1185438|NCT01715285|2343872|FG000|Treatment Period|Lost to Follow-up|3
1185439|NCT01715285|2343873|FG001|Treatment Period|Lost to Follow-up|2
1185440|NCT01715285|2343874|FG002|Treatment Period|Lost to Follow-up|0
1185441|NCT01715285|2343872|FG000|Treatment Period|Death|36
1185442|NCT01715285|2343873|FG001|Treatment Period|Death|23
1185443|NCT01715285|2343874|FG002|Treatment Period|Death|0
1185444|NCT01715285|2343872|FG000|Treatment Period|Noncompliance With Study Drug|4
1185445|NCT01715285|2343873|FG001|Treatment Period|Noncompliance With Study Drug|2
1185446|NCT01715285|2343874|FG002|Treatment Period|Noncompliance With Study Drug|0
1185447|NCT01715285|2343872|FG000|Treatment Period|Progressive Disease|254
1185448|NCT01715285|2343873|FG001|Treatment Period|Progressive Disease|388
1185449|NCT01715285|2343874|FG002|Treatment Period|Progressive Disease|0
1185450|NCT01715285|2343872|FG000|Treatment Period|Withdrawal Of Consent|52
1185451|NCT01715285|2343873|FG001|Treatment Period|Withdrawal Of Consent|47
1185452|NCT01715285|2343874|FG002|Treatment Period|Withdrawal Of Consent|0
1185453|NCT01715285|2343872|FG000|Treatment Period|Physician Decision|21
1185454|NCT01715285|2343873|FG001|Treatment Period|Physician Decision|23
1185455|NCT01715285|2343874|FG002|Treatment Period|Physician Decision|0
1185456|NCT01715285|2343872|FG000|Treatment Period|Ongoing|157
1185457|NCT01715285|2343873|FG001|Treatment Period|Ongoing|0
1185458|NCT01715285|2343874|FG002|Treatment Period|Ongoing|0
1185459|NCT01715285|2343872|FG000|Treatment Period|Other|10
1185460|NCT01715285|2343873|FG001|Treatment Period|Other|12
1185461|NCT01715285|2343874|FG002|Treatment Period|Other|0
1185462|NCT01715285|2343872|FG000|Treatment Period|Placebo Cross-over|0
1185463|NCT01715285|2343873|FG001|Treatment Period|Placebo Cross-over|72
1185464|NCT01715285|2343874|FG002|Treatment Period|Placebo Cross-over|0
1185465|NCT01715285|2343872|FG000|Open-label (OL) Extension Phase|Ongoing|157
1185466|NCT01715285|2343873|FG001|Open-label (OL) Extension Phase|Ongoing|0
1185467|NCT01715285|2343874|FG002|Open-label (OL) Extension Phase|Ongoing|72
879395|NCT00583219|1842880|FG000|Phase 2|Withdrawal by Subject|1
879396|NCT00583362|1842884|FG000|Overall Study|Adverse Event|44
879397|NCT00583362|1842884|FG000|Overall Study|Lack of Efficacy|22
879398|NCT00583362|1842884|FG000|Overall Study|Lost to Follow-up|4
879399|NCT00583362|1842884|FG000|Overall Study|Non-compliance with study drug|28
879400|NCT00583362|1842884|FG000|Overall Study|Pregnancy|7
879401|NCT00583362|1842884|FG000|Overall Study|Miscommunication of visit window|5
879402|NCT00583362|1842884|FG000|Overall Study|Current site closed|7
879403|NCT00583362|1842884|FG000|Overall Study|Subject not dosed in LBSL99|1
879404|NCT00583362|1842884|FG000|Overall Study|Subject moved out of the country/state|2
879405|NCT00583362|1842884|FG000|Overall Study|Missed visits due to staff changes|1
879406|NCT00583362|1842884|FG000|Overall Study|Misunderstanding of protocol|1
879407|NCT00583362|1842884|FG000|Overall Study|Behavioral problems and non-compliance|1
879408|NCT00583362|1842884|FG000|Overall Study|Sponsor request due to missed doses|1
879409|NCT00583362|1842884|FG000|Overall Study|Physician Decision|19
879410|NCT00583362|1842884|FG000|Overall Study|Protocol Violation|2
879411|NCT00583362|1842884|FG000|Overall Study|Withdrawal by Subject|57
879412|NCT00583453|1842903|FG000|Overall Study|discontinued intervention|0
879413|NCT00583453|1842904|FG001|Overall Study|discontinued intervention|2
879414|NCT00583557|1842921|FG000|Overall Study|Withdrawal by Subject|18
879415|NCT00583557|1842921|FG000|Overall Study|Adverse Event|9
879416|NCT00583557|1842921|FG000|Overall Study|Lack of Efficacy|31
879417|NCT00583557|1842921|FG000|Overall Study|Lack of Compliance|5
879418|NCT00583557|1842921|FG000|Overall Study|Other|5
879419|NCT00583557|1842921|FG000|Overall Study|Did not receive belimumab in LBRA99|2
879420|NCT00583596|1842925|FG000|Overall Study|Lost to Follow-up|110
879421|NCT00583596|1842925|FG000|Overall Study|Excluded due to Hurricane Katrina|30
879422|NCT00583596|1842925|FG000|Overall Study|Death|2
879423|NCT00583596|1842925|FG000|Overall Study|Withdrawal by Subject|6
879424|NCT00583596|1842925|FG000|Overall Study|Lost to Follow-up|94
879425|NCT00583596|1842925|FG000|Overall Study|Data not complete|1
1185468|NCT01332266|2343890|FG000|Phase 1b|Death|3
1185469|NCT01332266|2343891|FG001|Phase 1b|Death|3
1185470|NCT01332266|2343892|FG002|Phase 1b|Death|2
1185471|NCT01332266|2343893|FG003|Phase 1b|Death|0
1185472|NCT01332266|2343894|FG004|Phase 1b|Death|0
1185473|NCT01332266|2343890|FG000|Phase 1b|Lost to Follow-up|0
1185474|NCT01332266|2343891|FG001|Phase 1b|Lost to Follow-up|1
1185475|NCT01332266|2343892|FG002|Phase 1b|Lost to Follow-up|0
1185476|NCT01332266|2343893|FG003|Phase 1b|Lost to Follow-up|0
1185477|NCT01332266|2343894|FG004|Phase 1b|Lost to Follow-up|0
1185478|NCT01332266|2343890|FG000|Phase 1b|Withdrawal by Subject|1
1185479|NCT01332266|2343891|FG001|Phase 1b|Withdrawal by Subject|1
1185480|NCT01332266|2343892|FG002|Phase 1b|Withdrawal by Subject|1
1185481|NCT01332266|2343893|FG003|Phase 1b|Withdrawal by Subject|0
1185482|NCT01332266|2343894|FG004|Phase 1b|Withdrawal by Subject|0
1185483|NCT01332266|2343890|FG000|Phase 2|Death|0
1185484|NCT01332266|2343891|FG001|Phase 2|Death|0
1185485|NCT01332266|2343892|FG002|Phase 2|Death|0
1185486|NCT01332266|2343893|FG003|Phase 2|Death|33
1185487|NCT01332266|2343894|FG004|Phase 2|Death|36
1185488|NCT01332266|2343890|FG000|Phase 2|Lost to Follow-up|0
1185489|NCT01332266|2343891|FG001|Phase 2|Lost to Follow-up|0
1185490|NCT01332266|2343892|FG002|Phase 2|Lost to Follow-up|0
1185491|NCT01332266|2343893|FG003|Phase 2|Lost to Follow-up|2
1185492|NCT01332266|2343894|FG004|Phase 2|Lost to Follow-up|0
1185493|NCT01332266|2343890|FG000|Phase 2|Physician Decision|0
1185494|NCT01332266|2343891|FG001|Phase 2|Physician Decision|0
1185495|NCT01332266|2343892|FG002|Phase 2|Physician Decision|0
1185496|NCT01332266|2343893|FG003|Phase 2|Physician Decision|3
1185497|NCT01332266|2343894|FG004|Phase 2|Physician Decision|1
1185498|NCT01332266|2343890|FG000|Phase 2|Symptomatic deterioration|0
1185499|NCT01332266|2343891|FG001|Phase 2|Symptomatic deterioration|0
1185500|NCT01332266|2343892|FG002|Phase 2|Symptomatic deterioration|0
1185501|NCT01332266|2343893|FG003|Phase 2|Symptomatic deterioration|0
1185502|NCT01332266|2343894|FG004|Phase 2|Symptomatic deterioration|1
1185503|NCT01332266|2343890|FG000|Phase 2|Progression Disease|0
1185504|NCT01332266|2343891|FG001|Phase 2|Progression Disease|0
1185505|NCT01332266|2343892|FG002|Phase 2|Progression Disease|0
1185506|NCT01332266|2343893|FG003|Phase 2|Progression Disease|2
1185507|NCT01332266|2343894|FG004|Phase 2|Progression Disease|1
1185508|NCT01332266|2343890|FG000|Phase 2|Withdrawal by Subject|0
1185509|NCT01332266|2343891|FG001|Phase 2|Withdrawal by Subject|0
1185510|NCT01332266|2343892|FG002|Phase 2|Withdrawal by Subject|0
1185511|NCT01332266|2343893|FG003|Phase 2|Withdrawal by Subject|2
1185512|NCT01332266|2343894|FG004|Phase 2|Withdrawal by Subject|2
1185513|NCT01150890|2343911|FG000|Overall Study|Other|0
1185514|NCT01150890|2343912|FG001|Overall Study|Other|1
1185515|NCT01150890|2343913|FG002|Overall Study|Other|0
1185516|NCT01150890|2343914|FG003|Overall Study|Other|2
1185517|NCT01150890|2343911|FG000|Overall Study|Pregnancy|0
1185518|NCT01150890|2343912|FG001|Overall Study|Pregnancy|0
1185519|NCT01150890|2343913|FG002|Overall Study|Pregnancy|0
1185520|NCT01150890|2343914|FG003|Overall Study|Pregnancy|1
1185521|NCT01150890|2343911|FG000|Overall Study|Administrative Decision|4
1185522|NCT01150890|2343912|FG001|Overall Study|Administrative Decision|4
1185523|NCT01150890|2343913|FG002|Overall Study|Administrative Decision|5
1185524|NCT01150890|2343914|FG003|Overall Study|Administrative Decision|6
1185525|NCT01150890|2343911|FG000|Overall Study|Ineligibility determined|0
1185526|NCT01150890|2343912|FG001|Overall Study|Ineligibility determined|1
1185527|NCT01150890|2343913|FG002|Overall Study|Ineligibility determined|0
1185528|NCT01150890|2343914|FG003|Overall Study|Ineligibility determined|0
1185529|NCT01150890|2343911|FG000|Overall Study|Adverse Event|0
1185530|NCT01150890|2343912|FG001|Overall Study|Adverse Event|0
1185531|NCT01150890|2343913|FG002|Overall Study|Adverse Event|2
1185532|NCT01150890|2343914|FG003|Overall Study|Adverse Event|0
1185533|NCT01150890|2343911|FG000|Overall Study|Withdrawal by Subject|0
1185534|NCT01150890|2343912|FG001|Overall Study|Withdrawal by Subject|0
1185535|NCT01150890|2343913|FG002|Overall Study|Withdrawal by Subject|2
1185536|NCT01150890|2343914|FG003|Overall Study|Withdrawal by Subject|1
1185537|NCT01150890|2343911|FG000|Overall Study|Disease progression|0
1185538|NCT01150890|2343912|FG001|Overall Study|Disease progression|7
1185539|NCT01150890|2343913|FG002|Overall Study|Disease progression|3
1185540|NCT01150890|2343914|FG003|Overall Study|Disease progression|7
1185541|NCT01140867|2343927|FG000|Overall Study|Adverse Event|22
1185542|NCT01140867|2343927|FG000|Overall Study|Lack of Efficacy|3
1185543|NCT01140867|2343927|FG000|Overall Study|Lost to Follow-up|2
1185544|NCT01140867|2343927|FG000|Overall Study|Withdrawal by Subject|1
1185545|NCT01140867|2343927|FG000|Overall Study|Protocol Violation|1
1185546|NCT01140867|2343927|FG000|Overall Study|Uncooperative patient|2
1185547|NCT01140867|2343927|FG000|Overall Study|Medication Noncompliance|2
1185548|NCT01137773|2343933|FG000|Overall Study|Death|3
1185549|NCT01137773|2343934|FG001|Overall Study|Death|3
1185550|NCT01137773|2343933|FG000|Overall Study|Lost to Follow-up|6
1185551|NCT01137773|2343934|FG001|Overall Study|Lost to Follow-up|0
1185552|NCT01127256|2343944|FG000|Overall Study|Adverse Event|13
1185553|NCT01127256|2343945|FG001|Overall Study|Adverse Event|13
1185554|NCT01127256|2343944|FG000|Overall Study|Lack of Efficacy|4
1185555|NCT01127256|2343945|FG001|Overall Study|Lack of Efficacy|0
1185556|NCT01127256|2343944|FG000|Overall Study|Lost to Follow-up|16
1185557|NCT01127256|2343945|FG001|Overall Study|Lost to Follow-up|17
1185558|NCT01127256|2343944|FG000|Overall Study|Withdrawal by Subject|5
1185559|NCT01127256|2343945|FG001|Overall Study|Withdrawal by Subject|9
1185560|NCT01127256|2343944|FG000|Overall Study|Protocol Violation|1
1185561|NCT01127256|2343945|FG001|Overall Study|Protocol Violation|0
1185562|NCT01004861|2343964|FG000|Overall Study|Disease progression|3
1185563|NCT01004861|2343965|FG001|Overall Study|Disease progression|4
1185564|NCT01004861|2343966|FG002|Overall Study|Disease progression|5
1185565|NCT01004861|2343967|FG003|Overall Study|Disease progression|4
1185566|NCT01004861|2343968|FG004|Overall Study|Disease progression|4
1185567|NCT01004861|2343969|FG005|Overall Study|Disease progression|4
1185568|NCT01004861|2343970|FG006|Overall Study|Disease progression|5
1185569|NCT01004861|2343971|FG007|Overall Study|Disease progression|1
1185570|NCT01004861|2343972|FG008|Overall Study|Disease progression|4
1185571|NCT01004861|2343973|FG009|Overall Study|Disease progression|7
1185572|NCT01004861|2343974|FG010|Overall Study|Disease progression|6
1185573|NCT01004861|2343975|FG011|Overall Study|Disease progression|3
1185574|NCT01004861|2343976|FG012|Overall Study|Disease progression|8
1185575|NCT01004861|2343964|FG000|Overall Study|Physician Decision|0
1185576|NCT01004861|2343965|FG001|Overall Study|Physician Decision|2
1185577|NCT01004861|2343966|FG002|Overall Study|Physician Decision|1
1185578|NCT01004861|2343967|FG003|Overall Study|Physician Decision|1
1185579|NCT01004861|2343968|FG004|Overall Study|Physician Decision|1
1185580|NCT01004861|2343969|FG005|Overall Study|Physician Decision|0
1185581|NCT01004861|2343970|FG006|Overall Study|Physician Decision|0
1185582|NCT01004861|2343971|FG007|Overall Study|Physician Decision|1
1185583|NCT01004861|2343972|FG008|Overall Study|Physician Decision|0
1185584|NCT01004861|2343973|FG009|Overall Study|Physician Decision|0
1185585|NCT01004861|2343974|FG010|Overall Study|Physician Decision|0
1185586|NCT01004861|2343975|FG011|Overall Study|Physician Decision|0
1185587|NCT01004861|2343976|FG012|Overall Study|Physician Decision|3
1185588|NCT01004861|2343964|FG000|Overall Study|Adverse Event|0
1185589|NCT01004861|2343965|FG001|Overall Study|Adverse Event|0
1185590|NCT01004861|2343966|FG002|Overall Study|Adverse Event|0
1185591|NCT01004861|2343967|FG003|Overall Study|Adverse Event|1
1185592|NCT01004861|2343968|FG004|Overall Study|Adverse Event|0
1185593|NCT01004861|2343969|FG005|Overall Study|Adverse Event|2
1185594|NCT01004861|2343970|FG006|Overall Study|Adverse Event|1
1185595|NCT01004861|2343971|FG007|Overall Study|Adverse Event|1
1185596|NCT01004861|2343972|FG008|Overall Study|Adverse Event|13
1185597|NCT01004861|2343973|FG009|Overall Study|Adverse Event|1
1185598|NCT01004861|2343974|FG010|Overall Study|Adverse Event|1
1185599|NCT01004861|2343975|FG011|Overall Study|Adverse Event|0
1185600|NCT01004861|2343976|FG012|Overall Study|Adverse Event|2
1185601|NCT01004861|2343964|FG000|Overall Study|Protocol Violation|0
1185602|NCT01004861|2343965|FG001|Overall Study|Protocol Violation|0
1185603|NCT01004861|2343966|FG002|Overall Study|Protocol Violation|0
1185604|NCT01004861|2343967|FG003|Overall Study|Protocol Violation|0
1185605|NCT01004861|2343968|FG004|Overall Study|Protocol Violation|1
1185606|NCT01004861|2343969|FG005|Overall Study|Protocol Violation|0
1185607|NCT01004861|2343970|FG006|Overall Study|Protocol Violation|0
1185608|NCT01004861|2343971|FG007|Overall Study|Protocol Violation|0
1185609|NCT01004861|2343972|FG008|Overall Study|Protocol Violation|0
1185610|NCT01004861|2343973|FG009|Overall Study|Protocol Violation|0
1185611|NCT01004861|2343974|FG010|Overall Study|Protocol Violation|0
1185612|NCT01004861|2343975|FG011|Overall Study|Protocol Violation|0
1185613|NCT01004861|2343976|FG012|Overall Study|Protocol Violation|0
1185614|NCT01004861|2343964|FG000|Overall Study|Lost to Follow-up|0
1185615|NCT01004861|2343965|FG001|Overall Study|Lost to Follow-up|0
1185616|NCT01004861|2343966|FG002|Overall Study|Lost to Follow-up|0
1185617|NCT01004861|2343967|FG003|Overall Study|Lost to Follow-up|0
1185618|NCT01004861|2343968|FG004|Overall Study|Lost to Follow-up|0
1185619|NCT01004861|2343969|FG005|Overall Study|Lost to Follow-up|0
1185620|NCT01004861|2343970|FG006|Overall Study|Lost to Follow-up|0
1185621|NCT01004861|2343971|FG007|Overall Study|Lost to Follow-up|1
1185622|NCT01004861|2343972|FG008|Overall Study|Lost to Follow-up|3
1185623|NCT01004861|2343973|FG009|Overall Study|Lost to Follow-up|0
1185624|NCT01004861|2343974|FG010|Overall Study|Lost to Follow-up|0
1185625|NCT01004861|2343975|FG011|Overall Study|Lost to Follow-up|1
1185626|NCT01004861|2343976|FG012|Overall Study|Lost to Follow-up|0
1185627|NCT01004861|2343964|FG000|Overall Study|Non-compliance|0
1185628|NCT01004861|2343965|FG001|Overall Study|Non-compliance|0
1185629|NCT01004861|2343966|FG002|Overall Study|Non-compliance|0
1185630|NCT01004861|2343967|FG003|Overall Study|Non-compliance|0
1185631|NCT01004861|2343968|FG004|Overall Study|Non-compliance|0
1185632|NCT01004861|2343969|FG005|Overall Study|Non-compliance|0
1185633|NCT01004861|2343970|FG006|Overall Study|Non-compliance|0
1185634|NCT01004861|2343971|FG007|Overall Study|Non-compliance|0
1185635|NCT01004861|2343972|FG008|Overall Study|Non-compliance|5
1185636|NCT01004861|2343973|FG009|Overall Study|Non-compliance|0
1185637|NCT01004861|2343974|FG010|Overall Study|Non-compliance|0
1185638|NCT01004861|2343975|FG011|Overall Study|Non-compliance|0
1185639|NCT01004861|2343976|FG012|Overall Study|Non-compliance|1
1185640|NCT01004861|2343964|FG000|Overall Study|Other|0
1185641|NCT01004861|2343965|FG001|Overall Study|Other|0
1185642|NCT01004861|2343966|FG002|Overall Study|Other|0
1185643|NCT01004861|2343967|FG003|Overall Study|Other|0
1185644|NCT01004861|2343968|FG004|Overall Study|Other|0
1185645|NCT01004861|2343969|FG005|Overall Study|Other|0
1185646|NCT01004861|2343970|FG006|Overall Study|Other|0
1185647|NCT01004861|2343971|FG007|Overall Study|Other|0
1185648|NCT01004861|2343972|FG008|Overall Study|Other|0
1185649|NCT01004861|2343973|FG009|Overall Study|Other|2
1185650|NCT01004861|2343974|FG010|Overall Study|Other|1
1185651|NCT01004861|2343975|FG011|Overall Study|Other|2
1185652|NCT01004861|2343976|FG012|Overall Study|Other|3
1185653|NCT01004861|2343964|FG000|Overall Study|Patient decision|0
1185654|NCT01004861|2343965|FG001|Overall Study|Patient decision|0
1185655|NCT01004861|2343966|FG002|Overall Study|Patient decision|0
1185656|NCT01004861|2343967|FG003|Overall Study|Patient decision|0
1185657|NCT01004861|2343968|FG004|Overall Study|Patient decision|1
1185658|NCT01004861|2343969|FG005|Overall Study|Patient decision|0
1185659|NCT01004861|2343970|FG006|Overall Study|Patient decision|1
1185660|NCT01004861|2343971|FG007|Overall Study|Patient decision|0
1185661|NCT01004861|2343972|FG008|Overall Study|Patient decision|7
1185662|NCT01004861|2343973|FG009|Overall Study|Patient decision|1
1185663|NCT01004861|2343974|FG010|Overall Study|Patient decision|1
1185664|NCT01004861|2343975|FG011|Overall Study|Patient decision|2
1185665|NCT01004861|2343976|FG012|Overall Study|Patient decision|3
1185666|NCT01004861|2343964|FG000|Overall Study|Transitioned to Phase 4 study|0
1185667|NCT01004861|2343965|FG001|Overall Study|Transitioned to Phase 4 study|0
1185668|NCT01004861|2343966|FG002|Overall Study|Transitioned to Phase 4 study|0
1185669|NCT01004861|2343967|FG003|Overall Study|Transitioned to Phase 4 study|0
1185670|NCT01004861|2343968|FG004|Overall Study|Transitioned to Phase 4 study|0
1185671|NCT01004861|2343969|FG005|Overall Study|Transitioned to Phase 4 study|0
1185672|NCT01004861|2343970|FG006|Overall Study|Transitioned to Phase 4 study|0
1185673|NCT01004861|2343971|FG007|Overall Study|Transitioned to Phase 4 study|0
1185674|NCT01004861|2343972|FG008|Overall Study|Transitioned to Phase 4 study|2
1185675|NCT01004861|2343973|FG009|Overall Study|Transitioned to Phase 4 study|0
1185676|NCT01004861|2343974|FG010|Overall Study|Transitioned to Phase 4 study|0
1185677|NCT01004861|2343975|FG011|Overall Study|Transitioned to Phase 4 study|0
1185678|NCT01004861|2343976|FG012|Overall Study|Transitioned to Phase 4 study|0
1185679|NCT01004861|2343964|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185680|NCT01004861|2343965|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185681|NCT01004861|2343966|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185682|NCT01004861|2343967|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185683|NCT01004861|2343968|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185684|NCT01004861|2343969|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185685|NCT01004861|2343970|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185686|NCT01004861|2343971|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185687|NCT01004861|2343972|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1
1185688|NCT01004861|2343973|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185689|NCT01004861|2343974|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185690|NCT01004861|2343975|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185691|NCT01004861|2343976|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1185692|NCT01004861|2343964|FG000|Overall Study|Patient withdrew|0
1185693|NCT01004861|2343965|FG001|Overall Study|Patient withdrew|0
1185694|NCT01004861|2343966|FG002|Overall Study|Patient withdrew|0
1185695|NCT01004861|2343967|FG003|Overall Study|Patient withdrew|0
1185696|NCT01004861|2343968|FG004|Overall Study|Patient withdrew|0
879426|NCT00583596|1842925|FG000|Overall Study|Not consented|15
879427|NCT00583596|1842925|FG000|Overall Study|Outside f-up window|26
879428|NCT00583791|1842961|FG000|Overall Study|Other|67
879429|NCT00583791|1842961|FG000|Overall Study|Death|6
1185697|NCT01004861|2343969|FG005|Overall Study|Patient withdrew|0
1185698|NCT01004861|2343970|FG006|Overall Study|Patient withdrew|0
1185699|NCT01004861|2343971|FG007|Overall Study|Patient withdrew|0
1185700|NCT01004861|2343972|FG008|Overall Study|Patient withdrew|1
1185701|NCT01004861|2343973|FG009|Overall Study|Patient withdrew|0
1185702|NCT01004861|2343974|FG010|Overall Study|Patient withdrew|0
1185703|NCT01004861|2343975|FG011|Overall Study|Patient withdrew|0
1185704|NCT01004861|2343976|FG012|Overall Study|Patient withdrew|0
1185705|NCT01004861|2343964|FG000|Overall Study|Surgical resection|0
1185706|NCT01004861|2343965|FG001|Overall Study|Surgical resection|0
1185707|NCT01004861|2343966|FG002|Overall Study|Surgical resection|0
1185708|NCT01004861|2343967|FG003|Overall Study|Surgical resection|0
1185709|NCT01004861|2343968|FG004|Overall Study|Surgical resection|0
1185710|NCT01004861|2343969|FG005|Overall Study|Surgical resection|0
1185711|NCT01004861|2343970|FG006|Overall Study|Surgical resection|0
1185712|NCT01004861|2343971|FG007|Overall Study|Surgical resection|0
1185713|NCT01004861|2343972|FG008|Overall Study|Surgical resection|1
1185714|NCT01004861|2343973|FG009|Overall Study|Surgical resection|0
879430|NCT00583947|1843002|FG000|Cross-over Period|Adverse Event|2
879431|NCT00583947|1843003|FG001|Cross-over Period|Adverse Event|0
879432|NCT00583947|1843002|FG000|Cross-over Period|Withdrawal by Subject|2
879433|NCT00583947|1843003|FG001|Cross-over Period|Withdrawal by Subject|0
879434|NCT00583947|1843002|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0
1185715|NCT01004861|2343974|FG010|Overall Study|Surgical resection|0
1185716|NCT01004861|2343975|FG011|Overall Study|Surgical resection|0
1185717|NCT01004861|2343976|FG012|Overall Study|Surgical resection|0
1185718|NCT01004861|2343964|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185719|NCT01004861|2343965|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185720|NCT01004861|2343966|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185721|NCT01004861|2343967|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185722|NCT01004861|2343968|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185723|NCT01004861|2343969|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185724|NCT01004861|2343970|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185725|NCT01004861|2343971|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185726|NCT01004861|2343972|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1
1185727|NCT01004861|2343973|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185728|NCT01004861|2343974|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185729|NCT01004861|2343975|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185730|NCT01004861|2343976|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0
1185731|NCT01004861|2343964|FG000|Overall Study|Study termination by Sponsor|0
1185732|NCT01004861|2343965|FG001|Overall Study|Study termination by Sponsor|0
1185733|NCT01004861|2343966|FG002|Overall Study|Study termination by Sponsor|0
1185734|NCT01004861|2343967|FG003|Overall Study|Study termination by Sponsor|0
1185735|NCT01004861|2343968|FG004|Overall Study|Study termination by Sponsor|0
1185736|NCT01004861|2343969|FG005|Overall Study|Study termination by Sponsor|0
1185737|NCT01004861|2343970|FG006|Overall Study|Study termination by Sponsor|0
1185738|NCT01004861|2343971|FG007|Overall Study|Study termination by Sponsor|0
1185739|NCT01004861|2343972|FG008|Overall Study|Study termination by Sponsor|1
1185740|NCT01004861|2343973|FG009|Overall Study|Study termination by Sponsor|0
1185741|NCT01004861|2343974|FG010|Overall Study|Study termination by Sponsor|0
1185742|NCT01004861|2343975|FG011|Overall Study|Study termination by Sponsor|0
1185743|NCT01004861|2343976|FG012|Overall Study|Study termination by Sponsor|0
1185744|NCT00912223|2344008|FG000|Overall Study|Withdrawal by Subject|1
1185745|NCT00912223|2344008|FG000|Overall Study|Not transplanted|1
1185746|NCT00912223|2344008|FG000|Overall Study|Transformed disease|1
1185747|NCT00381381|2344012|FG000|Overall Study|Adverse Event|3
1185748|NCT00381381|2344012|FG000|Overall Study|Lost to Follow-up|52
1185749|NCT00381381|2344012|FG000|Overall Study|Withdrawal by Subject|9
879435|NCT00583947|1843003|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1
879436|NCT00583947|1843002|FG000|Cross-over Period|Other|1
879437|NCT00583947|1843003|FG001|Cross-over Period|Other|1
879438|NCT00584194|1843016|FG000|Overall Study|Other|135
879439|NCT00584415|1843035|FG000|Overall Study|Adverse Event|7
879440|NCT00584454|1843040|FG000|Overall Study|Adverse Event|1
879441|NCT00584454|1843040|FG000|Overall Study|Relocation|1
879442|NCT00584454|1843040|FG000|Overall Study|Clinical Hold|2
879443|NCT00584727|1843058|FG000|First Intervention|Discontinuation|0
879444|NCT00584727|1843059|FG001|First Intervention|Discontinuation|0
879445|NCT00584727|1843060|FG002|First Intervention|Discontinuation|1
879446|NCT00584727|1843061|FG003|First Intervention|Discontinuation|0
879447|NCT00584727|1843062|FG004|First Intervention|Discontinuation|0
879448|NCT00584727|1843063|FG005|First Intervention|Discontinuation|0
879449|NCT00584727|1843058|FG000|Third Intervention|Protocol Violation|0
879450|NCT00584727|1843059|FG001|Third Intervention|Protocol Violation|0
879451|NCT00584727|1843060|FG002|Third Intervention|Protocol Violation|1
1185750|NCT04706403|2344036|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
1185751|NCT04706403|2344037|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
1185752|NCT04706403|2344038|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
1185753|NCT04706403|2344039|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
1185754|NCT04706403|2344040|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2
1185756|NCT03712124|2344069|FG000|Overall Study|Protocol Violation|1
1185757|NCT03712124|2344070|FG001|Overall Study|Protocol Violation|0
1185758|NCT03535740|2344082|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55
1185759|NCT03535740|2344082|FG000|Overall Study|Death|34
1185760|NCT03535740|2344082|FG000|Overall Study|Lost to Follow-up|1
1185761|NCT03535740|2344082|FG000|Overall Study|Withdrawal by Subject|13
1185762|NCT03503318|2344090|FG000|Overall Study|Death|1
1185763|NCT03503318|2344091|FG001|Overall Study|Death|0
1185764|NCT03503318|2344092|FG002|Overall Study|Death|4
1185765|NCT03503318|2344090|FG000|Overall Study|Adverse Event|3
1185766|NCT03503318|2344091|FG001|Overall Study|Adverse Event|4
1185767|NCT03503318|2344092|FG002|Overall Study|Adverse Event|2
1185768|NCT03503318|2344090|FG000|Overall Study|Withdrawal by Subject|12
1185769|NCT03503318|2344091|FG001|Overall Study|Withdrawal by Subject|17
1185770|NCT03503318|2344092|FG002|Overall Study|Withdrawal by Subject|16
1185771|NCT03503318|2344090|FG000|Overall Study|Protocol Violation|5
1185772|NCT03503318|2344091|FG001|Overall Study|Protocol Violation|0
1185773|NCT03503318|2344092|FG002|Overall Study|Protocol Violation|3
1185774|NCT03503318|2344090|FG000|Overall Study|Lost to Follow-up|17
1185775|NCT03503318|2344091|FG001|Overall Study|Lost to Follow-up|15
1185776|NCT03503318|2344092|FG002|Overall Study|Lost to Follow-up|12
1185777|NCT03503318|2344090|FG000|Overall Study|Other than specified|1
1185778|NCT03503318|2344091|FG001|Overall Study|Other than specified|3
1185779|NCT03503318|2344092|FG002|Overall Study|Other than specified|3
1185780|NCT02921789|2344120|FG000|Overall Study|Adverse Event|0
1185781|NCT02921789|2344121|FG001|Overall Study|Adverse Event|1
1185782|NCT02921789|2344120|FG000|Overall Study|Lost to Follow-up|1
1185783|NCT02921789|2344121|FG001|Overall Study|Lost to Follow-up|0
1185784|NCT02921789|2344120|FG000|Overall Study|Protocol Deviation|2
1185785|NCT02921789|2344121|FG001|Overall Study|Protocol Deviation|0
1185786|NCT02921789|2344120|FG000|Overall Study|Withdrawal by Subject|2
1185787|NCT02921789|2344121|FG001|Overall Study|Withdrawal by Subject|1
1185788|NCT02921789|2344120|FG000|Overall Study|Miscellaneous|3
1185789|NCT02921789|2344121|FG001|Overall Study|Miscellaneous|2
879452|NCT00584727|1843061|FG003|Third Intervention|Protocol Violation|0
879453|NCT00584727|1843062|FG004|Third Intervention|Protocol Violation|4
879454|NCT00584727|1843063|FG005|Third Intervention|Protocol Violation|2
879455|NCT00584740|1843076|FG000|Overall Study|Adverse Event|1
879456|NCT00584740|1843077|FG001|Overall Study|Adverse Event|1
879457|NCT00584740|1843076|FG000|Overall Study|Lack of Efficacy|8
879458|NCT00584740|1843077|FG001|Overall Study|Lack of Efficacy|2
879459|NCT00584740|1843076|FG000|Overall Study|Withdrawal by Subject|3
879460|NCT00584740|1843077|FG001|Overall Study|Withdrawal by Subject|2
879461|NCT00584740|1843076|FG000|Overall Study|Lost to Follow-up|0
879462|NCT00584740|1843077|FG001|Overall Study|Lost to Follow-up|1
879463|NCT00584805|1843083|FG000|Overall Study|No longer at risk of exposure|39
879464|NCT00584805|1843083|FG000|Overall Study|Relocation|36
879465|NCT00584805|1843083|FG000|Overall Study|Withdrawal by Subject|18
879466|NCT00584805|1843083|FG000|Overall Study|Non-compliance|1
879467|NCT00584805|1843083|FG000|Overall Study|Lost to follow up|3
879468|NCT00584805|1843083|FG000|Overall Study|Screen failures|2
879469|NCT00584844|1843117|FG000|Overall Study|Withdrawal by Subject|59
879470|NCT00584844|1843117|FG000|Overall Study|Screen Failure|20
914227|NCT00813709|1891952|FG000|Open Label Period|Randomized but not treated|0
914228|NCT00813709|1891953|FG001|Open Label Period|Randomized but not treated|0
914229|NCT00813709|1891954|FG002|Open Label Period|Randomized but not treated|0
914230|NCT00813709|1891955|FG003|Open Label Period|Randomized but not treated|1
914231|NCT00813709|1891956|FG004|Open Label Period|Randomized but not treated|0
914232|NCT00813709|1891957|FG005|Open Label Period|Randomized but not treated|1
914233|NCT00813709|1891952|FG000|Open Label Period|Other|0
914234|NCT00813709|1891953|FG001|Open Label Period|Other|0
914235|NCT00813709|1891954|FG002|Open Label Period|Other|0
914236|NCT00813709|1891955|FG003|Open Label Period|Other|11
914237|NCT00813709|1891956|FG004|Open Label Period|Other|5
914238|NCT00813709|1891957|FG005|Open Label Period|Other|6
914239|NCT00813748|1891988|FG000|Skin Test Substudy|Physician Decision|0
914240|NCT00813748|1891989|FG001|Skin Test Substudy|Physician Decision|1
914241|NCT00813761|1891999|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
914242|NCT00813761|1892000|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
914243|NCT00813761|1892001|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
914244|NCT00813761|1892002|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
914245|NCT00813761|1891999|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
914246|NCT00813761|1892000|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
914247|NCT00813761|1892001|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
914248|NCT00813761|1892002|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
1185790|NCT02896257|2344141|FG000|Providers|Without eligible patients|21
1185791|NCT02896257|2344142|FG001|Providers|Without eligible patients|28
1185792|NCT02896257|2344141|FG000|Patients|PFT entry criteria not met|43
1185793|NCT02896257|2344142|FG001|Patients|PFT entry criteria not met|50
1185794|NCT02896257|2344141|FG000|Patients|No capacity to review|8
1185795|NCT02896257|2344142|FG001|Patients|No capacity to review|11
1185796|NCT02896257|2344141|FG000|Patients|Appointment rescheduled/cancelled|5
1185797|NCT02896257|2344142|FG001|Patients|Appointment rescheduled/cancelled|7
1185798|NCT02896257|2344141|FG000|Patients|PCP not assigned a clinic|4
1185799|NCT02896257|2344142|FG001|Patients|PCP not assigned a clinic|0
1185800|NCT02896257|2344141|FG000|Patients|No history of COPD|0
1185801|NCT02896257|2344142|FG001|Patients|No history of COPD|1
1185802|NCT02896257|2344141|FG000|Patients|Deceased between review and index date|0
1185803|NCT02896257|2344142|FG001|Patients|Deceased between review and index date|1
1185804|NCT02896257|2344141|FG000|Patients|No ICS Rx upon review|1
1185805|NCT02896257|2344142|FG001|Patients|No ICS Rx upon review|1
1185806|NCT02896257|2344141|FG000|Patients|Protocol Violation|2
1185807|NCT02896257|2344142|FG001|Patients|Protocol Violation|1
1185808|NCT02896257|2344141|FG000|Patients|Hospice care|0
1185809|NCT02896257|2344142|FG001|Patients|Hospice care|1
1185810|NCT02736617|2344158|FG000|Treatment|Adverse Event|1
1185811|NCT02736617|2344158|FG000|Treatment|Lack of Efficacy|1
1185812|NCT02736617|2344158|FG000|Treatment|Withdrawal by Subject|1
1185813|NCT02736617|2344158|FG000|Maintenance|Lack of Efficacy|4
1185814|NCT02736617|2344158|FG000|Maintenance|Physician Decision|1
1185815|NCT02579265|2344169|FG000|Overall Study|Weaned off earlier than 28 days|44
1185816|NCT02579265|2344170|FG001|Overall Study|Weaned off earlier than 28 days|43
1185817|NCT02579265|2344169|FG000|Overall Study|Adverse Event|2
1185818|NCT02579265|2344170|FG001|Overall Study|Adverse Event|0
1185819|NCT02579265|2344169|FG000|Overall Study|Any other reason not specified|0
1185820|NCT02579265|2344170|FG001|Overall Study|Any other reason not specified|2
1185821|NCT02579265|2344169|FG000|Overall Study|Withdrawal by Subject|2
1185822|NCT02579265|2344170|FG001|Overall Study|Withdrawal by Subject|0
1185823|NCT02579265|2344169|FG000|Overall Study|Physician Decision|1
1185824|NCT02579265|2344170|FG001|Overall Study|Physician Decision|0
1185825|NCT02579265|2344169|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1
1185826|NCT02579265|2344170|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0
1185827|NCT02013167|2344188|FG000|Overall Study|Withdrawal by Subject|15
1185828|NCT02013167|2344189|FG001|Overall Study|Withdrawal by Subject|14
1185829|NCT02013167|2344188|FG000|Overall Study|Sponsor Decision|1
1185830|NCT02013167|2344189|FG001|Overall Study|Sponsor Decision|3
1185831|NCT02013167|2344188|FG000|Overall Study|Lost to Follow-up|0
1185832|NCT02013167|2344189|FG001|Overall Study|Lost to Follow-up|1
1185833|NCT02013167|2344188|FG000|Overall Study|Death|85
1185834|NCT02013167|2344189|FG001|Overall Study|Death|160
1185835|NCT02004522|2344198|FG000|Overall Study|Adverse Event|55
1185836|NCT02004522|2344199|FG001|Overall Study|Adverse Event|6
1185837|NCT02004522|2344198|FG000|Overall Study|Withdrawal by Subject|13
1185838|NCT02004522|2344199|FG001|Overall Study|Withdrawal by Subject|7
1185839|NCT02004522|2344198|FG000|Overall Study|Death|12
1185840|NCT02004522|2344199|FG001|Overall Study|Death|3
1185841|NCT02004522|2344198|FG000|Overall Study|Physician Decision|3
1185842|NCT02004522|2344199|FG001|Overall Study|Physician Decision|4
1185843|NCT02004522|2344198|FG000|Overall Study|Protocol Violation|1
1185844|NCT02004522|2344199|FG001|Overall Study|Protocol Violation|0
1185845|NCT02004522|2344198|FG000|Overall Study|Other is reason listed by PI.|4
1185846|NCT02004522|2344199|FG001|Overall Study|Other is reason listed by PI.|1
1185847|NCT02004522|2344198|FG000|Overall Study|Never Dosed|2
1185848|NCT02004522|2344199|FG001|Overall Study|Never Dosed|4
1185849|NCT02004522|2344198|FG000|Overall Study|Disease Progression|35
1185850|NCT02004522|2344199|FG001|Overall Study|Disease Progression|31
1185851|NCT02004522|2344198|FG000|Overall Study|Completed Treatrment Cycles Per Protocol|1
1185852|NCT02004522|2344199|FG001|Overall Study|Completed Treatrment Cycles Per Protocol|103
1185853|NCT02000427|2344205|FG000|Overall Study|Death|22
1185854|NCT01981850|2344216|FG000|Main Phase Stage 1|Death|2
1185855|NCT01981850|2344217|FG001|Main Phase Stage 1|Death|0
1185856|NCT01981850|2344218|FG002|Main Phase Stage 1|Death|0
1185857|NCT01981850|2344219|FG003|Main Phase Stage 1|Death|0
1185858|NCT01981850|2344220|FG004|Main Phase Stage 1|Death|0
1185859|NCT01981850|2344221|FG005|Main Phase Stage 1|Death|0
1185860|NCT01981850|2344222|FG006|Main Phase Stage 1|Death|0
1185861|NCT01981850|2344223|FG007|Main Phase Stage 1|Death|0
1185862|NCT01981850|2344224|FG008|Main Phase Stage 1|Death|0
1185863|NCT01981850|2344225|FG009|Main Phase Stage 1|Death|0
1185864|NCT01981850|2344216|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1
1185865|NCT01981850|2344217|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0
1185866|NCT01981850|2344218|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0
1185867|NCT01981850|2344219|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0
1185868|NCT01981850|2344220|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0
1185869|NCT01981850|2344221|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0
1185870|NCT01981850|2344222|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0
1185871|NCT01981850|2344223|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0
1185872|NCT01981850|2344224|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0
879471|NCT00584870|1843132|FG000|Overall Study|Adverse Event|4
1185873|NCT01981850|2344225|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0
1185874|NCT01981850|2344216|FG000|Main Phase Stage 1|Lack of Efficacy|0
1185875|NCT01981850|2344217|FG001|Main Phase Stage 1|Lack of Efficacy|2
1185876|NCT01981850|2344218|FG002|Main Phase Stage 1|Lack of Efficacy|0
1185877|NCT01981850|2344219|FG003|Main Phase Stage 1|Lack of Efficacy|0
1185878|NCT01981850|2344220|FG004|Main Phase Stage 1|Lack of Efficacy|0
1185879|NCT01981850|2344221|FG005|Main Phase Stage 1|Lack of Efficacy|0
1185880|NCT01981850|2344222|FG006|Main Phase Stage 1|Lack of Efficacy|0
1185881|NCT01981850|2344223|FG007|Main Phase Stage 1|Lack of Efficacy|0
1185882|NCT01981850|2344224|FG008|Main Phase Stage 1|Lack of Efficacy|0
1185883|NCT01981850|2344225|FG009|Main Phase Stage 1|Lack of Efficacy|0
1185884|NCT01981850|2344216|FG000|Main Phase Stage 1|Various reasons|0
1185885|NCT01981850|2344217|FG001|Main Phase Stage 1|Various reasons|0
1185886|NCT01981850|2344218|FG002|Main Phase Stage 1|Various reasons|2
1185887|NCT01981850|2344219|FG003|Main Phase Stage 1|Various reasons|0
1185888|NCT01981850|2344220|FG004|Main Phase Stage 1|Various reasons|0
1185889|NCT01981850|2344221|FG005|Main Phase Stage 1|Various reasons|0
1185890|NCT01981850|2344222|FG006|Main Phase Stage 1|Various reasons|0
1185891|NCT01981850|2344223|FG007|Main Phase Stage 1|Various reasons|0
1185892|NCT01981850|2344224|FG008|Main Phase Stage 1|Various reasons|0
1185893|NCT01981850|2344225|FG009|Main Phase Stage 1|Various reasons|0
1185894|NCT01981850|2344216|FG000|Main Phase Stage 2|Adverse Event|0
1185895|NCT01981850|2344217|FG001|Main Phase Stage 2|Adverse Event|0
1185896|NCT01981850|2344218|FG002|Main Phase Stage 2|Adverse Event|0
879472|NCT00584870|1843133|FG001|Overall Study|Adverse Event|3
879473|NCT00584870|1843134|FG002|Overall Study|Adverse Event|2
879474|NCT00584870|1843132|FG000|Overall Study|Lost to Follow-up|4
879475|NCT00584870|1843133|FG001|Overall Study|Lost to Follow-up|1
879476|NCT00584870|1843134|FG002|Overall Study|Lost to Follow-up|1
1185897|NCT01981850|2344219|FG003|Main Phase Stage 2|Adverse Event|0
1185898|NCT01981850|2344220|FG004|Main Phase Stage 2|Adverse Event|6
1185899|NCT01981850|2344221|FG005|Main Phase Stage 2|Adverse Event|5
1185900|NCT01981850|2344222|FG006|Main Phase Stage 2|Adverse Event|7
1185901|NCT01981850|2344223|FG007|Main Phase Stage 2|Adverse Event|0
1185902|NCT01981850|2344224|FG008|Main Phase Stage 2|Adverse Event|0
1185903|NCT01981850|2344225|FG009|Main Phase Stage 2|Adverse Event|0
1185904|NCT01981850|2344216|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0
1185905|NCT01981850|2344217|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0
1185906|NCT01981850|2344218|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0
1185907|NCT01981850|2344219|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0
1185908|NCT01981850|2344220|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4
1185909|NCT01981850|2344221|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3
1185910|NCT01981850|2344222|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3
1185911|NCT01981850|2344223|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0
1185912|NCT01981850|2344224|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0
1185913|NCT01981850|2344225|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0
1185914|NCT01981850|2344216|FG000|Main Phase Stage 2|Lack of Efficacy|0
1185915|NCT01981850|2344217|FG001|Main Phase Stage 2|Lack of Efficacy|0
1185916|NCT01981850|2344218|FG002|Main Phase Stage 2|Lack of Efficacy|0
1185917|NCT01981850|2344219|FG003|Main Phase Stage 2|Lack of Efficacy|0
1185918|NCT01981850|2344220|FG004|Main Phase Stage 2|Lack of Efficacy|1
1185919|NCT01981850|2344221|FG005|Main Phase Stage 2|Lack of Efficacy|2
1185920|NCT01981850|2344222|FG006|Main Phase Stage 2|Lack of Efficacy|0
1185921|NCT01981850|2344223|FG007|Main Phase Stage 2|Lack of Efficacy|0
1185922|NCT01981850|2344224|FG008|Main Phase Stage 2|Lack of Efficacy|0
1185923|NCT01981850|2344225|FG009|Main Phase Stage 2|Lack of Efficacy|0
1185924|NCT01981850|2344216|FG000|Main Phase Stage 2|Various reasons|0
1185925|NCT01981850|2344217|FG001|Main Phase Stage 2|Various reasons|0
1185926|NCT01981850|2344218|FG002|Main Phase Stage 2|Various reasons|0
1185927|NCT01981850|2344219|FG003|Main Phase Stage 2|Various reasons|0
1185928|NCT01981850|2344220|FG004|Main Phase Stage 2|Various reasons|2
1185929|NCT01981850|2344221|FG005|Main Phase Stage 2|Various reasons|0
1185930|NCT01981850|2344222|FG006|Main Phase Stage 2|Various reasons|1
1185931|NCT01981850|2344223|FG007|Main Phase Stage 2|Various reasons|0
1185932|NCT01981850|2344224|FG008|Main Phase Stage 2|Various reasons|0
1185933|NCT01981850|2344225|FG009|Main Phase Stage 2|Various reasons|0
1185934|NCT01981850|2344216|FG000|Main Phase Stage 2|Progressive Disease|0
1185935|NCT01981850|2344217|FG001|Main Phase Stage 2|Progressive Disease|0
1185936|NCT01981850|2344218|FG002|Main Phase Stage 2|Progressive Disease|0
1185937|NCT01981850|2344219|FG003|Main Phase Stage 2|Progressive Disease|0
1185938|NCT01981850|2344220|FG004|Main Phase Stage 2|Progressive Disease|0
1185939|NCT01981850|2344221|FG005|Main Phase Stage 2|Progressive Disease|6
1185940|NCT01981850|2344222|FG006|Main Phase Stage 2|Progressive Disease|6
1185941|NCT01981850|2344223|FG007|Main Phase Stage 2|Progressive Disease|0
1185942|NCT01981850|2344224|FG008|Main Phase Stage 2|Progressive Disease|0
1185943|NCT01981850|2344225|FG009|Main Phase Stage 2|Progressive Disease|0
1185944|NCT01981850|2344216|FG000|Open Label Extension (OLE)|Adverse Event|0
1185945|NCT01981850|2344217|FG001|Open Label Extension (OLE)|Adverse Event|0
1185946|NCT01981850|2344218|FG002|Open Label Extension (OLE)|Adverse Event|0
1185947|NCT01981850|2344219|FG003|Open Label Extension (OLE)|Adverse Event|0
1185948|NCT01981850|2344220|FG004|Open Label Extension (OLE)|Adverse Event|0
1185949|NCT01981850|2344221|FG005|Open Label Extension (OLE)|Adverse Event|0
1185950|NCT01981850|2344222|FG006|Open Label Extension (OLE)|Adverse Event|0
1185951|NCT01981850|2344223|FG007|Open Label Extension (OLE)|Adverse Event|2
1185952|NCT01981850|2344224|FG008|Open Label Extension (OLE)|Adverse Event|1
1185953|NCT01981850|2344225|FG009|Open Label Extension (OLE)|Adverse Event|8
1185954|NCT01981850|2344216|FG000|Open Label Extension (OLE)|Lack of Efficacy|0
1185955|NCT01981850|2344217|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
1185956|NCT01981850|2344218|FG002|Open Label Extension (OLE)|Lack of Efficacy|0
1185957|NCT01981850|2344219|FG003|Open Label Extension (OLE)|Lack of Efficacy|0
1185958|NCT01981850|2344220|FG004|Open Label Extension (OLE)|Lack of Efficacy|0
1185959|NCT01981850|2344221|FG005|Open Label Extension (OLE)|Lack of Efficacy|0
1185960|NCT01981850|2344222|FG006|Open Label Extension (OLE)|Lack of Efficacy|0
1185961|NCT01981850|2344223|FG007|Open Label Extension (OLE)|Lack of Efficacy|4
1185962|NCT01981850|2344224|FG008|Open Label Extension (OLE)|Lack of Efficacy|1
1185963|NCT01981850|2344225|FG009|Open Label Extension (OLE)|Lack of Efficacy|19
1185964|NCT01981850|2344216|FG000|Open Label Extension (OLE)|Various reasons|0
1185965|NCT01981850|2344217|FG001|Open Label Extension (OLE)|Various reasons|0
1185966|NCT01981850|2344218|FG002|Open Label Extension (OLE)|Various reasons|0
1185967|NCT01981850|2344219|FG003|Open Label Extension (OLE)|Various reasons|0
1185968|NCT01981850|2344220|FG004|Open Label Extension (OLE)|Various reasons|0
1185969|NCT01981850|2344221|FG005|Open Label Extension (OLE)|Various reasons|0
1185970|NCT01981850|2344222|FG006|Open Label Extension (OLE)|Various reasons|0
1185971|NCT01981850|2344223|FG007|Open Label Extension (OLE)|Various reasons|3
1185972|NCT01981850|2344224|FG008|Open Label Extension (OLE)|Various reasons|1
1185973|NCT01981850|2344225|FG009|Open Label Extension (OLE)|Various reasons|3
1185974|NCT01981850|2344216|FG000|Open Label Extension (OLE)|Progressive Disease|0
1185975|NCT01981850|2344217|FG001|Open Label Extension (OLE)|Progressive Disease|0
1185976|NCT01981850|2344218|FG002|Open Label Extension (OLE)|Progressive Disease|0
1185977|NCT01981850|2344219|FG003|Open Label Extension (OLE)|Progressive Disease|0
1185978|NCT01981850|2344220|FG004|Open Label Extension (OLE)|Progressive Disease|0
1185979|NCT01981850|2344221|FG005|Open Label Extension (OLE)|Progressive Disease|0
1185980|NCT01981850|2344222|FG006|Open Label Extension (OLE)|Progressive Disease|0
1185981|NCT01981850|2344223|FG007|Open Label Extension (OLE)|Progressive Disease|3
1185982|NCT01981850|2344224|FG008|Open Label Extension (OLE)|Progressive Disease|2
1185983|NCT01981850|2344225|FG009|Open Label Extension (OLE)|Progressive Disease|9
1185984|NCT01981850|2344216|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1185985|NCT01981850|2344217|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1185986|NCT01981850|2344218|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1185987|NCT01981850|2344219|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1185988|NCT01981850|2344220|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1185989|NCT01981850|2344221|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0
879477|NCT00584870|1843132|FG000|Overall Study|Lack of Efficacy|7
879478|NCT00584870|1843133|FG001|Overall Study|Lack of Efficacy|14
879479|NCT00584870|1843134|FG002|Overall Study|Lack of Efficacy|8
879480|NCT00584870|1843132|FG000|Overall Study|Withdrawal by Subject|10
879481|NCT00584870|1843133|FG001|Overall Study|Withdrawal by Subject|5
879482|NCT00584870|1843134|FG002|Overall Study|Withdrawal by Subject|3
879483|NCT00584870|1843132|FG000|Overall Study|Protocol Violation|1
879484|NCT00584870|1843133|FG001|Overall Study|Protocol Violation|1
879485|NCT00584870|1843134|FG002|Overall Study|Protocol Violation|2
879486|NCT00584870|1843132|FG000|Overall Study|Did not met entrance criteria|1
879487|NCT00584870|1843133|FG001|Overall Study|Did not met entrance criteria|0
879488|NCT00584870|1843134|FG002|Overall Study|Did not met entrance criteria|0
879489|NCT00584870|1843132|FG000|Overall Study|Other|2
879490|NCT00584870|1843133|FG001|Overall Study|Other|0
879491|NCT00584870|1843134|FG002|Overall Study|Other|0
879492|NCT00584870|1843132|FG000|Overall Study|Randomized but not treated|0
879493|NCT00584870|1843133|FG001|Overall Study|Randomized but not treated|1
879494|NCT00584870|1843134|FG002|Overall Study|Randomized but not treated|2
879495|NCT00584909|1843142|FG000|Overall Study|Adverse Event|4
879496|NCT00584987|1843163|FG000|Overall Study|Protocol Violation|1
879497|NCT00584987|1843164|FG001|Overall Study|Protocol Violation|1
879498|NCT00584987|1843165|FG002|Overall Study|Protocol Violation|1
879499|NCT00584987|1843166|FG003|Overall Study|Protocol Violation|0
879500|NCT00584987|1843163|FG000|Overall Study|Adverse Event|0
879501|NCT00584987|1843164|FG001|Overall Study|Adverse Event|0
879502|NCT00584987|1843165|FG002|Overall Study|Adverse Event|0
879503|NCT00584987|1843166|FG003|Overall Study|Adverse Event|1
879504|NCT00585039|1843189|FG000|Overall Study|medication spilled|2
879505|NCT00585039|1843190|FG001|Overall Study|medication spilled|0
879506|NCT00585052|1843198|FG000|Overall Study|Withdrawal by Subject|1
879507|NCT00585078|1843202|FG000|Overall Study|Withdrawal by Subject|4
879508|NCT00585078|1843202|FG000|Overall Study|Poor performance status|1
879509|NCT00585078|1843202|FG000|Overall Study|Disease Progression|24
879510|NCT00585078|1843202|FG000|Overall Study|Adverse Event|10
879511|NCT00585078|1843202|FG000|Overall Study|Death|1
879512|NCT00585169|1843210|FG000|Overall Study|Withdrawal by Subject|1
879513|NCT00585195|1843241|FG000|Overall Study|Adverse Event|0
879514|NCT00585195|1843242|FG001|Overall Study|Adverse Event|0
879515|NCT00585195|1843243|FG002|Overall Study|Adverse Event|0
879516|NCT00585195|1843244|FG003|Overall Study|Adverse Event|0
1185990|NCT01981850|2344222|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1185991|NCT01981850|2344223|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1185992|NCT01981850|2344224|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1185993|NCT01981850|2344225|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8
1185994|NCT01981850|2344216|FG000|Open Label Extension (OLE)|Lost to Follow-up|0
1185995|NCT01981850|2344217|FG001|Open Label Extension (OLE)|Lost to Follow-up|0
1185996|NCT01981850|2344218|FG002|Open Label Extension (OLE)|Lost to Follow-up|0
1185997|NCT01981850|2344219|FG003|Open Label Extension (OLE)|Lost to Follow-up|0
1185998|NCT01981850|2344220|FG004|Open Label Extension (OLE)|Lost to Follow-up|0
1185999|NCT01981850|2344221|FG005|Open Label Extension (OLE)|Lost to Follow-up|0
1186000|NCT01981850|2344222|FG006|Open Label Extension (OLE)|Lost to Follow-up|0
1186001|NCT01981850|2344223|FG007|Open Label Extension (OLE)|Lost to Follow-up|0
1186002|NCT01981850|2344224|FG008|Open Label Extension (OLE)|Lost to Follow-up|0
1186003|NCT01981850|2344225|FG009|Open Label Extension (OLE)|Lost to Follow-up|1
1186004|NCT01804816|2344257|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
1186005|NCT01804816|2344257|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1
1186028|NCT01519960|2344300|FG000|Overall Study|Ongoing in Follow-Up|101
1186029|NCT01519960|2344301|FG001|Overall Study|Ongoing in Follow-Up|11
1186030|NCT01519960|2344302|FG002|Overall Study|Ongoing in Follow-Up|10
1186031|NCT01519960|2344300|FG000|Overall Study|Ongoing/Switched to PEG-IFN|0
1186032|NCT01519960|2344301|FG001|Overall Study|Ongoing/Switched to PEG-IFN|33
1186033|NCT01519960|2344302|FG002|Overall Study|Ongoing/Switched to PEG-IFN|0
1186034|NCT01519960|2344300|FG000|Overall Study|Adverse Event|0
1186035|NCT01519960|2344301|FG001|Overall Study|Adverse Event|1
1186036|NCT01519960|2344302|FG002|Overall Study|Adverse Event|0
1186037|NCT01519960|2344300|FG000|Overall Study|Withdrawal by Subject|0
1186038|NCT01519960|2344301|FG001|Overall Study|Withdrawal by Subject|4
1186039|NCT01519960|2344302|FG002|Overall Study|Withdrawal by Subject|0
1186040|NCT01519960|2344300|FG000|Overall Study|Lost to Follow-up|0
1186041|NCT01519960|2344301|FG001|Overall Study|Lost to Follow-up|1
1186042|NCT01519960|2344302|FG002|Overall Study|Lost to Follow-up|0
1186043|NCT00688376|2344315|FG000|Double-Blind Phase|Adverse Event|4
1186044|NCT00688376|2344316|FG001|Double-Blind Phase|Adverse Event|4
1186045|NCT00688376|2344315|FG000|Double-Blind Phase|Protocol Violation|1
1186046|NCT00688376|2344316|FG001|Double-Blind Phase|Protocol Violation|2
1186047|NCT00688376|2344315|FG000|Double-Blind Phase|Withdrawal by Subject|1
1186048|NCT00688376|2344316|FG001|Double-Blind Phase|Withdrawal by Subject|0
1186049|NCT00688376|2344315|FG000|Double-Blind Phase|Not treated|0
1186050|NCT00688376|2344316|FG001|Double-Blind Phase|Not treated|1
1186051|NCT00688376|2344315|FG000|Blinded Extension Phase|Adverse Event|3
1186052|NCT00688376|2344316|FG001|Blinded Extension Phase|Adverse Event|4
1186053|NCT00688376|2344315|FG000|Blinded Extension Phase|Withdrawal by Subject|0
1186054|NCT00688376|2344316|FG001|Blinded Extension Phase|Withdrawal by Subject|1
1186055|NCT00688376|2344315|FG000|Blinded Extension Phase|Physician Decision|1
1186056|NCT00688376|2344316|FG001|Blinded Extension Phase|Physician Decision|0
1186057|NCT00688376|2344315|FG000|Blinded Extension Phase|Other|1
1186058|NCT00688376|2344316|FG001|Blinded Extension Phase|Other|0
1186059|NCT00121108|2344343|FG000|Overall Study|Lost to Follow-up|10
1186060|NCT00121108|2344344|FG001|Overall Study|Lost to Follow-up|22
1186061|NCT00121108|2344343|FG000|Overall Study|Withdrawal by Subject|106
1186062|NCT00121108|2344344|FG001|Overall Study|Withdrawal by Subject|195
1186063|NCT00121108|2344343|FG000|Overall Study|Death|5
1186064|NCT00121108|2344344|FG001|Overall Study|Death|8
1186065|NCT00003102|2344354|FG000|Overall Study|Physician Decision|1
1186066|NCT00003102|2344355|FG001|Overall Study|Physician Decision|1
1186067|NCT00003102|2344356|FG002|Overall Study|Physician Decision|0
1186068|NCT00003102|2344354|FG000|Overall Study|Progressive Disease|0
1186069|NCT00003102|2344355|FG001|Overall Study|Progressive Disease|1
1186070|NCT00003102|2344356|FG002|Overall Study|Progressive Disease|0
1186071|NCT00003102|2344354|FG000|Overall Study|Adverse Event|0
1186072|NCT00003102|2344355|FG001|Overall Study|Adverse Event|1
1186073|NCT00003102|2344356|FG002|Overall Study|Adverse Event|1
1186074|NCT00003102|2344354|FG000|Overall Study|Death|0
1186075|NCT00003102|2344355|FG001|Overall Study|Death|0
1186076|NCT00003102|2344356|FG002|Overall Study|Death|1
1186077|NCT04633837|2344366|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5
1186078|NCT04633837|2344367|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0
1186079|NCT04057937|2344384|FG000|Placebo-controlled Phase|Adverse Event|3
1186080|NCT04057937|2344385|FG001|Placebo-controlled Phase|Adverse Event|0
1186081|NCT04057937|2344384|FG000|Active-treatment Phase|Withdrawal by Subject|1
1186082|NCT04057937|2344385|FG001|Active-treatment Phase|Withdrawal by Subject|0
1186083|NCT04057937|2344384|FG000|Active-treatment Phase|Pregnancy|0
1186084|NCT04057937|2344385|FG001|Active-treatment Phase|Pregnancy|1
1186085|NCT04057937|2344384|FG000|Active-treatment Phase|Physician Decision|0
1186086|NCT04057937|2344385|FG001|Active-treatment Phase|Physician Decision|1
1186088|NCT03674112|2344402|FG000|Overall Study|Adverse Event|1
1186089|NCT03674112|2344403|FG001|Overall Study|Adverse Event|0
1186090|NCT03674112|2344402|FG000|Overall Study|Ongoing in the Study|79
1186091|NCT03674112|2344403|FG001|Overall Study|Ongoing in the Study|80
1186114|NCT03032510|2344444|FG000|Overall Study|Adverse Event|5
1186115|NCT03032510|2344445|FG001|Overall Study|Adverse Event|2
1186116|NCT03032510|2344444|FG000|Overall Study|Lost to Follow-up|8
1186117|NCT03032510|2344445|FG001|Overall Study|Lost to Follow-up|7
1186118|NCT03032510|2344444|FG000|Overall Study|Withdrawal by Subject|8
1186119|NCT03032510|2344445|FG001|Overall Study|Withdrawal by Subject|7
1186120|NCT03032510|2344444|FG000|Overall Study|Subject noncompliance|4
1186121|NCT03032510|2344445|FG001|Overall Study|Subject noncompliance|2
1186122|NCT03032510|2344444|FG000|Overall Study|Physician Decision|2
1186123|NCT03032510|2344445|FG001|Overall Study|Physician Decision|0
1186124|NCT02946047|2344476|FG000|Overall Study|Adverse Event|1
1186125|NCT02946047|2344477|FG001|Overall Study|Adverse Event|0
1186126|NCT02946047|2344478|FG002|Overall Study|Adverse Event|0
1186127|NCT02946047|2344479|FG003|Overall Study|Adverse Event|0
1186128|NCT02784704|2344497|FG000|Overall Study|Adverse Event|4
1186129|NCT02784704|2344498|FG001|Overall Study|Adverse Event|2
1186130|NCT02784704|2344497|FG000|Overall Study|Lost to Follow-up|6
1186131|NCT02784704|2344498|FG001|Overall Study|Lost to Follow-up|4
1186132|NCT02784704|2344497|FG000|Overall Study|Withdrawal by Subject|1
1186133|NCT02784704|2344498|FG001|Overall Study|Withdrawal by Subject|3
1186134|NCT02784704|2344497|FG000|Overall Study|Subject Non Compliance|2
1186135|NCT02784704|2344498|FG001|Overall Study|Subject Non Compliance|0
1186136|NCT02614066|2344510|FG000|Overall Study|Initiated KTE-X19 and Died|5
1186137|NCT02614066|2344511|FG001|Overall Study|Initiated KTE-X19 and Died|12
1186138|NCT02614066|2344512|FG002|Overall Study|Initiated KTE-X19 and Died|11
1186139|NCT02614066|2344513|FG003|Overall Study|Initiated KTE-X19 and Died|20
1186140|NCT02614066|2344510|FG000|Overall Study|Full Consent Withdrawn|0
1186141|NCT02614066|2344511|FG001|Overall Study|Full Consent Withdrawn|1
1186142|NCT02614066|2344512|FG002|Overall Study|Full Consent Withdrawn|0
1186143|NCT02614066|2344513|FG003|Overall Study|Full Consent Withdrawn|3
879517|NCT00585195|1843245|FG004|Overall Study|Adverse Event|2
879518|NCT00585195|1843246|FG005|Overall Study|Adverse Event|1
879519|NCT00585195|1843247|FG006|Overall Study|Adverse Event|0
879520|NCT00585195|1843248|FG007|Overall Study|Adverse Event|1
879521|NCT00585195|1843249|FG008|Overall Study|Adverse Event|0
879522|NCT00585195|1843250|FG009|Overall Study|Adverse Event|0
879523|NCT00585195|1843251|FG010|Overall Study|Adverse Event|3
879524|NCT00585195|1843252|FG011|Overall Study|Adverse Event|0
879525|NCT00585195|1843253|FG012|Overall Study|Adverse Event|8
879526|NCT00585195|1843254|FG013|Overall Study|Adverse Event|6
879527|NCT00585195|1843255|FG014|Overall Study|Adverse Event|4
879528|NCT00585195|1843256|FG015|Overall Study|Adverse Event|1
879529|NCT00585195|1843257|FG016|Overall Study|Adverse Event|14
879530|NCT00585195|1843258|FG017|Overall Study|Adverse Event|9
1186144|NCT02614066|2344510|FG000|Overall Study|Lost to Follow-up|0
1186145|NCT02614066|2344511|FG001|Overall Study|Lost to Follow-up|1
1186146|NCT02614066|2344512|FG002|Overall Study|Lost to Follow-up|0
1186147|NCT02614066|2344513|FG003|Overall Study|Lost to Follow-up|0
1186148|NCT02614066|2344510|FG000|Overall Study|Still on-study|1
1186149|NCT02614066|2344511|FG001|Overall Study|Still on-study|9
1186150|NCT02614066|2344512|FG002|Overall Study|Still on-study|5
1186151|NCT02614066|2344513|FG003|Overall Study|Still on-study|32
879531|NCT00585195|1843259|FG018|Overall Study|Adverse Event|2
879532|NCT00585195|1843260|FG019|Overall Study|Adverse Event|3
879533|NCT00585195|1843261|FG020|Overall Study|Adverse Event|1
879534|NCT00585195|1843241|FG000|Overall Study|Progressive Disease|2
879535|NCT00585195|1843242|FG001|Overall Study|Progressive Disease|2
879536|NCT00585195|1843243|FG002|Overall Study|Progressive Disease|5
879537|NCT00585195|1843244|FG003|Overall Study|Progressive Disease|4
879538|NCT00585195|1843245|FG004|Overall Study|Progressive Disease|6
879539|NCT00585195|1843246|FG005|Overall Study|Progressive Disease|4
879540|NCT00585195|1843247|FG006|Overall Study|Progressive Disease|6
879541|NCT00585195|1843248|FG007|Overall Study|Progressive Disease|3
879542|NCT00585195|1843249|FG008|Overall Study|Progressive Disease|0
879543|NCT00585195|1843250|FG009|Overall Study|Progressive Disease|5
879544|NCT00585195|1843251|FG010|Overall Study|Progressive Disease|2
879545|NCT00585195|1843252|FG011|Overall Study|Progressive Disease|25
879546|NCT00585195|1843253|FG012|Overall Study|Progressive Disease|29
879547|NCT00585195|1843254|FG013|Overall Study|Progressive Disease|26
879548|NCT00585195|1843255|FG014|Overall Study|Progressive Disease|21
879549|NCT00585195|1843256|FG015|Overall Study|Progressive Disease|12
879550|NCT00585195|1843257|FG016|Overall Study|Progressive Disease|94
879551|NCT00585195|1843258|FG017|Overall Study|Progressive Disease|42
879552|NCT00585195|1843259|FG018|Overall Study|Progressive Disease|4
879553|NCT00585195|1843260|FG019|Overall Study|Progressive Disease|9
879554|NCT00585195|1843261|FG020|Overall Study|Progressive Disease|8
1186152|NCT02614066|2344510|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0
1186153|NCT02614066|2344511|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5
1186154|NCT02614066|2344512|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4
1186155|NCT02614066|2344513|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16
1186156|NCT02577354|2344523|FG000|Overall Study|Lack of Efficacy|4
1186157|NCT02577354|2344524|FG001|Overall Study|Lack of Efficacy|4
1186158|NCT02577354|2344523|FG000|Overall Study|Lost to Follow-up|3
1186159|NCT02577354|2344524|FG001|Overall Study|Lost to Follow-up|1
1186160|NCT02577354|2344523|FG000|Overall Study|Missed Visit|4
1186161|NCT02577354|2344524|FG001|Overall Study|Missed Visit|3
1186162|NCT02577354|2344523|FG000|Overall Study|Adverse Event|4
1186163|NCT02577354|2344524|FG001|Overall Study|Adverse Event|5
1186164|NCT02471807|2344544|FG000|Overall Study|Death|14
1186165|NCT02471807|2344544|FG000|Overall Study|Withdrawal by Subject|1
1186166|NCT02471807|2344544|FG000|Overall Study|Explant|5
1186167|NCT02471807|2344544|FG000|Overall Study|Visits not yet due|2
1186168|NCT02471807|2344544|FG000|Overall Study|Missed Visit|1
1186169|NCT02343952|2344548|FG000|Study Treatment|Disease Progression|23
1186170|NCT02343952|2344548|FG000|Study Treatment|Death|3
1186171|NCT02343952|2344548|FG000|Study Treatment|Adverse Event|19
1186172|NCT02343952|2344548|FG000|Study Treatment|Withdrawal by Subject|7
1186173|NCT02343952|2344548|FG000|Study Treatment|other complicating Diseases|1
1186174|NCT02343952|2344548|FG000|Follow up|Withdrawal by Subject|3
1186175|NCT02343952|2344548|FG000|Follow up|Death|33
1186176|NCT02343952|2344548|FG000|Follow up|Patient does not meet eligibility for study.|1
1186177|NCT02343952|2344548|FG000|Follow up|Research department closed by the practice.|5
1186178|NCT02343952|2344548|FG000|Follow up|Patient went home to Russia|1
1186179|NCT02343952|2344548|FG000|Follow up|Disease Progression|1
1186180|NCT02343952|2344548|FG000|Follow up|study terminated|1
1186181|NCT02321514|2344552|FG000|Overall Study|Death|15
1186182|NCT02321514|2344552|FG000|Overall Study|Missed Visit|7
1186183|NCT02321514|2344552|FG000|Overall Study|Study Exit|3
1186184|NCT01966471|2344567|FG000|Overall Study|Death|33
1186185|NCT01966471|2344568|FG001|Overall Study|Death|44
1186186|NCT01966471|2344567|FG000|Overall Study|Lost to Follow-up|14
1186187|NCT01966471|2344568|FG001|Overall Study|Lost to Follow-up|16
1186188|NCT01966471|2344567|FG000|Overall Study|Other|3
1186189|NCT01966471|2344568|FG001|Overall Study|Other|5
1186190|NCT01966471|2344567|FG000|Overall Study|Physician Decision|5
1186191|NCT01966471|2344568|FG001|Overall Study|Physician Decision|5
1186192|NCT01966471|2344567|FG000|Overall Study|Withdrawal by Subject|48
1186193|NCT01966471|2344568|FG001|Overall Study|Withdrawal by Subject|43
1186194|NCT01453946|2344583|FG000|Overall Study|Did not receive drug for the taper phase|1
1186195|NCT01453946|2344583|FG000|Overall Study|Protocol Violation|2
1186196|NCT01453946|2344583|FG000|Overall Study|Lack of Efficacy|3
1186197|NCT01453946|2344583|FG000|Overall Study|Adverse Event|3
1186198|NCT01444092|2344587|FG000|Overall Study|Adverse Event|8
1186199|NCT01444092|2344587|FG000|Overall Study|Protocol Violation|1
1186200|NCT01444092|2344587|FG000|Overall Study|Withdrawal by Subject|1
1186201|NCT01444092|2344587|FG000|Overall Study|Other Eligibility criteria|7
1186202|NCT01332968|2344593|FG000|Induction Period|Withdrawal by Subject|3
1186203|NCT01332968|2344594|FG001|Induction Period|Withdrawal by Subject|5
1186204|NCT01332968|2344595|FG002|Induction Period|Withdrawal by Subject|0
1186205|NCT01332968|2344596|FG003|Induction Period|Withdrawal by Subject|0
1186206|NCT01332968|2344597|FG004|Induction Period|Withdrawal by Subject|0
1186207|NCT01332968|2344598|FG005|Induction Period|Withdrawal by Subject|0
1186208|NCT01332968|2344599|FG006|Induction Period|Withdrawal by Subject|0
1186209|NCT01332968|2344600|FG007|Induction Period|Withdrawal by Subject|0
1186210|NCT01332968|2344593|FG000|Induction Period|Protocol Violation|3
1186211|NCT01332968|2344594|FG001|Induction Period|Protocol Violation|4
1186212|NCT01332968|2344595|FG002|Induction Period|Protocol Violation|0
1186213|NCT01332968|2344596|FG003|Induction Period|Protocol Violation|0
1186214|NCT01332968|2344597|FG004|Induction Period|Protocol Violation|0
1186215|NCT01332968|2344598|FG005|Induction Period|Protocol Violation|0
1186216|NCT01332968|2344599|FG006|Induction Period|Protocol Violation|0
1186217|NCT01332968|2344600|FG007|Induction Period|Protocol Violation|0
1186218|NCT01332968|2344593|FG000|Induction Period|Progressive disease|15
1186219|NCT01332968|2344594|FG001|Induction Period|Progressive disease|7
1186220|NCT01332968|2344595|FG002|Induction Period|Progressive disease|0
1186221|NCT01332968|2344596|FG003|Induction Period|Progressive disease|0
1186222|NCT01332968|2344597|FG004|Induction Period|Progressive disease|0
1186223|NCT01332968|2344598|FG005|Induction Period|Progressive disease|0
1186224|NCT01332968|2344599|FG006|Induction Period|Progressive disease|0
1186225|NCT01332968|2344600|FG007|Induction Period|Progressive disease|0
1186226|NCT01332968|2344593|FG000|Induction Period|Physician Decision|6
1186227|NCT01332968|2344594|FG001|Induction Period|Physician Decision|1
1186228|NCT01332968|2344595|FG002|Induction Period|Physician Decision|0
1186229|NCT01332968|2344596|FG003|Induction Period|Physician Decision|0
1186230|NCT01332968|2344597|FG004|Induction Period|Physician Decision|0
1186231|NCT01332968|2344598|FG005|Induction Period|Physician Decision|0
1186232|NCT01332968|2344599|FG006|Induction Period|Physician Decision|0
1186233|NCT01332968|2344600|FG007|Induction Period|Physician Decision|0
1186234|NCT01332968|2344593|FG000|Induction Period|Other|2
1186235|NCT01332968|2344594|FG001|Induction Period|Other|2
1186236|NCT01332968|2344595|FG002|Induction Period|Other|0
1186237|NCT01332968|2344596|FG003|Induction Period|Other|0
1186238|NCT01332968|2344597|FG004|Induction Period|Other|0
1186239|NCT01332968|2344598|FG005|Induction Period|Other|0
1186240|NCT01332968|2344599|FG006|Induction Period|Other|0
1186241|NCT01332968|2344600|FG007|Induction Period|Other|0
1186242|NCT01332968|2344593|FG000|Induction Period|Non-compliance|1
1186243|NCT01332968|2344594|FG001|Induction Period|Non-compliance|0
1186244|NCT01332968|2344595|FG002|Induction Period|Non-compliance|0
1186245|NCT01332968|2344596|FG003|Induction Period|Non-compliance|0
1186246|NCT01332968|2344597|FG004|Induction Period|Non-compliance|0
1186247|NCT01332968|2344598|FG005|Induction Period|Non-compliance|0
1186248|NCT01332968|2344599|FG006|Induction Period|Non-compliance|0
1186249|NCT01332968|2344600|FG007|Induction Period|Non-compliance|0
1186250|NCT01332968|2344593|FG000|Induction Period|Death|1
1186251|NCT01332968|2344594|FG001|Induction Period|Death|4
1186252|NCT01332968|2344595|FG002|Induction Period|Death|0
1186253|NCT01332968|2344596|FG003|Induction Period|Death|0
1186254|NCT01332968|2344597|FG004|Induction Period|Death|0
1186255|NCT01332968|2344598|FG005|Induction Period|Death|0
1186256|NCT01332968|2344599|FG006|Induction Period|Death|0
1186257|NCT01332968|2344600|FG007|Induction Period|Death|0
1186258|NCT01332968|2344593|FG000|Induction Period|Adverse Event|23
1186259|NCT01332968|2344594|FG001|Induction Period|Adverse Event|26
1186260|NCT01332968|2344595|FG002|Induction Period|Adverse Event|0
1186261|NCT01332968|2344596|FG003|Induction Period|Adverse Event|0
1186262|NCT01332968|2344597|FG004|Induction Period|Adverse Event|0
1186263|NCT01332968|2344598|FG005|Induction Period|Adverse Event|0
1186264|NCT01332968|2344599|FG006|Induction Period|Adverse Event|0
1186265|NCT01332968|2344600|FG007|Induction Period|Adverse Event|0
1186266|NCT01332968|2344593|FG000|Induction Period|Randomized, but not treated|4
1186267|NCT01332968|2344594|FG001|Induction Period|Randomized, but not treated|7
1186268|NCT01332968|2344595|FG002|Induction Period|Randomized, but not treated|0
1186269|NCT01332968|2344596|FG003|Induction Period|Randomized, but not treated|0
1186270|NCT01332968|2344597|FG004|Induction Period|Randomized, but not treated|0
1186271|NCT01332968|2344598|FG005|Induction Period|Randomized, but not treated|0
1186272|NCT01332968|2344599|FG006|Induction Period|Randomized, but not treated|0
1186273|NCT01332968|2344600|FG007|Induction Period|Randomized, but not treated|0
1186274|NCT01332968|2344593|FG000|Maintenance/Observation Period|Withdrawal by Subject|0
1186275|NCT01332968|2344594|FG001|Maintenance/Observation Period|Withdrawal by Subject|0
1186276|NCT01332968|2344595|FG002|Maintenance/Observation Period|Withdrawal by Subject|10
1186277|NCT01332968|2344596|FG003|Maintenance/Observation Period|Withdrawal by Subject|5
1186278|NCT01332968|2344597|FG004|Maintenance/Observation Period|Withdrawal by Subject|0
1186279|NCT01332968|2344598|FG005|Maintenance/Observation Period|Withdrawal by Subject|0
1186280|NCT01332968|2344599|FG006|Maintenance/Observation Period|Withdrawal by Subject|0
1186281|NCT01332968|2344600|FG007|Maintenance/Observation Period|Withdrawal by Subject|0
1186282|NCT01332968|2344593|FG000|Maintenance/Observation Period|Protocol Violation|0
1186283|NCT01332968|2344594|FG001|Maintenance/Observation Period|Protocol Violation|0
1186284|NCT01332968|2344595|FG002|Maintenance/Observation Period|Protocol Violation|1
1186285|NCT01332968|2344596|FG003|Maintenance/Observation Period|Protocol Violation|1
1186286|NCT01332968|2344597|FG004|Maintenance/Observation Period|Protocol Violation|0
1186287|NCT01332968|2344598|FG005|Maintenance/Observation Period|Protocol Violation|0
1186288|NCT01332968|2344599|FG006|Maintenance/Observation Period|Protocol Violation|0
1186289|NCT01332968|2344600|FG007|Maintenance/Observation Period|Protocol Violation|0
1186290|NCT01332968|2344593|FG000|Maintenance/Observation Period|Progressive disease|0
1186291|NCT01332968|2344594|FG001|Maintenance/Observation Period|Progressive disease|0
1186292|NCT01332968|2344595|FG002|Maintenance/Observation Period|Progressive disease|72
1186293|NCT01332968|2344596|FG003|Maintenance/Observation Period|Progressive disease|39
1186294|NCT01332968|2344597|FG004|Maintenance/Observation Period|Progressive disease|0
1186295|NCT01332968|2344598|FG005|Maintenance/Observation Period|Progressive disease|0
1186296|NCT01332968|2344599|FG006|Maintenance/Observation Period|Progressive disease|0
1186297|NCT01332968|2344600|FG007|Maintenance/Observation Period|Progressive disease|0
1186298|NCT01332968|2344593|FG000|Maintenance/Observation Period|Physician Decision|0
1186299|NCT01332968|2344594|FG001|Maintenance/Observation Period|Physician Decision|0
1186300|NCT01332968|2344595|FG002|Maintenance/Observation Period|Physician Decision|14
1186301|NCT01332968|2344596|FG003|Maintenance/Observation Period|Physician Decision|19
1186302|NCT01332968|2344597|FG004|Maintenance/Observation Period|Physician Decision|0
1186303|NCT01332968|2344598|FG005|Maintenance/Observation Period|Physician Decision|0
1186304|NCT01332968|2344599|FG006|Maintenance/Observation Period|Physician Decision|0
1186305|NCT01332968|2344600|FG007|Maintenance/Observation Period|Physician Decision|0
1186306|NCT01332968|2344593|FG000|Maintenance/Observation Period|Other|0
1186307|NCT01332968|2344594|FG001|Maintenance/Observation Period|Other|0
1186308|NCT01332968|2344595|FG002|Maintenance/Observation Period|Other|4
1186309|NCT01332968|2344596|FG003|Maintenance/Observation Period|Other|5
1186310|NCT01332968|2344597|FG004|Maintenance/Observation Period|Other|0
1186311|NCT01332968|2344598|FG005|Maintenance/Observation Period|Other|0
1186312|NCT01332968|2344599|FG006|Maintenance/Observation Period|Other|0
1186313|NCT01332968|2344600|FG007|Maintenance/Observation Period|Other|0
1186314|NCT01332968|2344593|FG000|Maintenance/Observation Period|Non-compliance|0
1186315|NCT01332968|2344594|FG001|Maintenance/Observation Period|Non-compliance|0
1186316|NCT01332968|2344595|FG002|Maintenance/Observation Period|Non-compliance|2
1186317|NCT01332968|2344596|FG003|Maintenance/Observation Period|Non-compliance|3
1186318|NCT01332968|2344597|FG004|Maintenance/Observation Period|Non-compliance|0
1186319|NCT01332968|2344598|FG005|Maintenance/Observation Period|Non-compliance|1
1186320|NCT01332968|2344599|FG006|Maintenance/Observation Period|Non-compliance|0
1186321|NCT01332968|2344600|FG007|Maintenance/Observation Period|Non-compliance|0
1186322|NCT01332968|2344593|FG000|Maintenance/Observation Period|Lost to Follow-up|0
1186323|NCT01332968|2344594|FG001|Maintenance/Observation Period|Lost to Follow-up|0
1186324|NCT01332968|2344595|FG002|Maintenance/Observation Period|Lost to Follow-up|1
1186325|NCT01332968|2344596|FG003|Maintenance/Observation Period|Lost to Follow-up|2
1186326|NCT01332968|2344597|FG004|Maintenance/Observation Period|Lost to Follow-up|0
1186327|NCT01332968|2344598|FG005|Maintenance/Observation Period|Lost to Follow-up|0
1186328|NCT01332968|2344599|FG006|Maintenance/Observation Period|Lost to Follow-up|0
1186329|NCT01332968|2344600|FG007|Maintenance/Observation Period|Lost to Follow-up|0
1186330|NCT01332968|2344593|FG000|Maintenance/Observation Period|Death|0
1186331|NCT01332968|2344594|FG001|Maintenance/Observation Period|Death|0
1186332|NCT01332968|2344595|FG002|Maintenance/Observation Period|Death|5
1186333|NCT01332968|2344596|FG003|Maintenance/Observation Period|Death|6
1186334|NCT01332968|2344597|FG004|Maintenance/Observation Period|Death|0
1186335|NCT01332968|2344598|FG005|Maintenance/Observation Period|Death|0
1186336|NCT01332968|2344599|FG006|Maintenance/Observation Period|Death|0
1186337|NCT01332968|2344600|FG007|Maintenance/Observation Period|Death|0
1186338|NCT01332968|2344593|FG000|Maintenance/Observation Period|Adverse Event|0
1186339|NCT01332968|2344594|FG001|Maintenance/Observation Period|Adverse Event|0
1186340|NCT01332968|2344595|FG002|Maintenance/Observation Period|Adverse Event|50
1186341|NCT01332968|2344596|FG003|Maintenance/Observation Period|Adverse Event|65
1186342|NCT01332968|2344597|FG004|Maintenance/Observation Period|Adverse Event|0
1186343|NCT01332968|2344598|FG005|Maintenance/Observation Period|Adverse Event|0
1186344|NCT01332968|2344599|FG006|Maintenance/Observation Period|Adverse Event|0
1186345|NCT01332968|2344600|FG007|Maintenance/Observation Period|Adverse Event|0
1186346|NCT01332968|2344593|FG000|Maintenance/Observation Period|Treatment ongoing|0
1186347|NCT01332968|2344594|FG001|Maintenance/Observation Period|Treatment ongoing|0
1186348|NCT01332968|2344595|FG002|Maintenance/Observation Period|Treatment ongoing|54
1186349|NCT01332968|2344596|FG003|Maintenance/Observation Period|Treatment ongoing|62
1186350|NCT01332968|2344597|FG004|Maintenance/Observation Period|Treatment ongoing|10
1186351|NCT01332968|2344598|FG005|Maintenance/Observation Period|Treatment ongoing|8
1186352|NCT01332968|2344599|FG006|Maintenance/Observation Period|Treatment ongoing|0
1186353|NCT01332968|2344600|FG007|Maintenance/Observation Period|Treatment ongoing|0
1186354|NCT01332968|2344593|FG000|Follow-Up Period|Death|0
1186355|NCT01332968|2344594|FG001|Follow-Up Period|Death|0
1186356|NCT01332968|2344595|FG002|Follow-Up Period|Death|0
1186357|NCT01332968|2344596|FG003|Follow-Up Period|Death|0
1186358|NCT01332968|2344597|FG004|Follow-Up Period|Death|0
1186359|NCT01332968|2344598|FG005|Follow-Up Period|Death|0
1186360|NCT01332968|2344599|FG006|Follow-Up Period|Death|38
1186361|NCT01332968|2344600|FG007|Follow-Up Period|Death|22
1186362|NCT01332968|2344593|FG000|Follow-Up Period|Follow-up ongoing|0
1186363|NCT01332968|2344594|FG001|Follow-Up Period|Follow-up ongoing|0
1186364|NCT01332968|2344595|FG002|Follow-Up Period|Follow-up ongoing|0
1186365|NCT01332968|2344596|FG003|Follow-Up Period|Follow-up ongoing|0
1186366|NCT01332968|2344597|FG004|Follow-Up Period|Follow-up ongoing|0
1186367|NCT01332968|2344598|FG005|Follow-Up Period|Follow-up ongoing|0
1186368|NCT01332968|2344599|FG006|Follow-Up Period|Follow-up ongoing|502
1186369|NCT01332968|2344600|FG007|Follow-Up Period|Follow-up ongoing|505
1186370|NCT01332968|2344593|FG000|Follow-Up Period|Withdrawal by Subject|0
1186371|NCT01332968|2344594|FG001|Follow-Up Period|Withdrawal by Subject|0
1186372|NCT01332968|2344595|FG002|Follow-Up Period|Withdrawal by Subject|0
1186373|NCT01332968|2344596|FG003|Follow-Up Period|Withdrawal by Subject|0
1186374|NCT01332968|2344597|FG004|Follow-Up Period|Withdrawal by Subject|0
1186375|NCT01332968|2344598|FG005|Follow-Up Period|Withdrawal by Subject|0
1186376|NCT01332968|2344599|FG006|Follow-Up Period|Withdrawal by Subject|1
1186377|NCT01332968|2344600|FG007|Follow-Up Period|Withdrawal by Subject|2
1186378|NCT01332968|2344593|FG000|Follow-Up Period|Lost to Follow-up|0
1186379|NCT01332968|2344594|FG001|Follow-Up Period|Lost to Follow-up|0
1186380|NCT01332968|2344595|FG002|Follow-Up Period|Lost to Follow-up|0
1186381|NCT01332968|2344596|FG003|Follow-Up Period|Lost to Follow-up|0
1186382|NCT01332968|2344597|FG004|Follow-Up Period|Lost to Follow-up|0
1186383|NCT01332968|2344598|FG005|Follow-Up Period|Lost to Follow-up|0
1186384|NCT01332968|2344599|FG006|Follow-Up Period|Lost to Follow-up|1
1186385|NCT01332968|2344600|FG007|Follow-Up Period|Lost to Follow-up|2
1186386|NCT01265784|2344611|FG000|Overall Study|Lost to Follow-up|5
1186387|NCT01265784|2344612|FG001|Overall Study|Lost to Follow-up|3
1186388|NCT01265784|2344613|FG002|Overall Study|Lost to Follow-up|2
1186389|NCT01265784|2344611|FG000|Overall Study|Withdrawal by Subject|0
1186390|NCT01265784|2344612|FG001|Overall Study|Withdrawal by Subject|5
1186391|NCT01265784|2344613|FG002|Overall Study|Withdrawal by Subject|0
1186392|NCT01265784|2344611|FG000|Overall Study|Physician Decision|1
1186393|NCT01265784|2344612|FG001|Overall Study|Physician Decision|0
1186394|NCT01265784|2344613|FG002|Overall Study|Physician Decision|1
1186395|NCT01265784|2344611|FG000|Overall Study|Adverse Event|1
1186396|NCT01265784|2344612|FG001|Overall Study|Adverse Event|0
1186397|NCT01265784|2344613|FG002|Overall Study|Adverse Event|0
1186398|NCT01265784|2344611|FG000|Overall Study|Death|3
1186399|NCT01265784|2344612|FG001|Overall Study|Death|0
1186400|NCT01265784|2344613|FG002|Overall Study|Death|0
1186401|NCT01265784|2344611|FG000|Overall Study|Protocol Violation|2
1186402|NCT01265784|2344612|FG001|Overall Study|Protocol Violation|0
1186403|NCT01265784|2344613|FG002|Overall Study|Protocol Violation|0
1186404|NCT01265784|2344611|FG000|Overall Study|Incorrectly Randomized|0
1186405|NCT01265784|2344612|FG001|Overall Study|Incorrectly Randomized|0
1186406|NCT01265784|2344613|FG002|Overall Study|Incorrectly Randomized|1
1186407|NCT00577577|2344623|FG000|Overall Study|Adverse Event|3
1186408|NCT00577577|2344624|FG001|Overall Study|Adverse Event|2
1186409|NCT00577577|2344623|FG000|Overall Study|Lost to Follow-up|1
879555|NCT00585195|1843241|FG000|Overall Study|Withdrawal by Subject|1
879556|NCT00585195|1843242|FG001|Overall Study|Withdrawal by Subject|1
879557|NCT00585195|1843243|FG002|Overall Study|Withdrawal by Subject|2
879558|NCT00585195|1843244|FG003|Overall Study|Withdrawal by Subject|2
879559|NCT00585195|1843245|FG004|Overall Study|Withdrawal by Subject|0
879560|NCT00585195|1843246|FG005|Overall Study|Withdrawal by Subject|0
879561|NCT00585195|1843247|FG006|Overall Study|Withdrawal by Subject|0
879562|NCT00585195|1843248|FG007|Overall Study|Withdrawal by Subject|1
879563|NCT00585195|1843249|FG008|Overall Study|Withdrawal by Subject|0
879564|NCT00585195|1843250|FG009|Overall Study|Withdrawal by Subject|0
879565|NCT00585195|1843251|FG010|Overall Study|Withdrawal by Subject|3
879566|NCT00585195|1843252|FG011|Overall Study|Withdrawal by Subject|8
879567|NCT00585195|1843253|FG012|Overall Study|Withdrawal by Subject|15
879568|NCT00585195|1843254|FG013|Overall Study|Withdrawal by Subject|0
879569|NCT00585195|1843255|FG014|Overall Study|Withdrawal by Subject|3
879570|NCT00585195|1843256|FG015|Overall Study|Withdrawal by Subject|0
879571|NCT00585195|1843257|FG016|Overall Study|Withdrawal by Subject|7
879572|NCT00585195|1843258|FG017|Overall Study|Withdrawal by Subject|1
879573|NCT00585195|1843259|FG018|Overall Study|Withdrawal by Subject|2
879574|NCT00585195|1843260|FG019|Overall Study|Withdrawal by Subject|2
879575|NCT00585195|1843261|FG020|Overall Study|Withdrawal by Subject|0
879576|NCT00585195|1843241|FG000|Overall Study|Other|0
879577|NCT00585195|1843242|FG001|Overall Study|Other|1
879578|NCT00585195|1843243|FG002|Overall Study|Other|1
879579|NCT00585195|1843244|FG003|Overall Study|Other|1
879580|NCT00585195|1843245|FG004|Overall Study|Other|0
879581|NCT00585195|1843246|FG005|Overall Study|Other|1
1186410|NCT00577577|2344624|FG001|Overall Study|Lost to Follow-up|0
1186411|NCT00577577|2344623|FG000|Overall Study|Protocol Violation|0
1186412|NCT00577577|2344624|FG001|Overall Study|Protocol Violation|3
1186413|NCT00577577|2344623|FG000|Overall Study|Transportation|1
1186414|NCT00577577|2344624|FG001|Overall Study|Transportation|0
1186415|NCT00392327|2344638|FG000|Overall Study|Death|1
1186416|NCT00392327|2344639|FG001|Overall Study|Death|0
1186417|NCT00392327|2344640|FG002|Overall Study|Death|1
1186418|NCT00392327|2344641|FG003|Overall Study|Death|0
1186419|NCT00392327|2344642|FG004|Overall Study|Death|0
1186420|NCT00392327|2344643|FG005|Overall Study|Death|0
1186421|NCT00392327|2344644|FG006|Overall Study|Death|0
1186422|NCT00392327|2344645|FG007|Overall Study|Death|0
1186423|NCT00392327|2344638|FG000|Overall Study|Lack of Efficacy|8
1186424|NCT00392327|2344639|FG001|Overall Study|Lack of Efficacy|8
1186425|NCT00392327|2344640|FG002|Overall Study|Lack of Efficacy|9
1186426|NCT00392327|2344641|FG003|Overall Study|Lack of Efficacy|6
1186427|NCT00392327|2344642|FG004|Overall Study|Lack of Efficacy|3
1186428|NCT00392327|2344643|FG005|Overall Study|Lack of Efficacy|3
1186429|NCT00392327|2344644|FG006|Overall Study|Lack of Efficacy|3
1186430|NCT00392327|2344645|FG007|Overall Study|Lack of Efficacy|3
1186431|NCT00392327|2344638|FG000|Overall Study|Physician Decision|3
1186432|NCT00392327|2344639|FG001|Overall Study|Physician Decision|5
1186433|NCT00392327|2344640|FG002|Overall Study|Physician Decision|2
1186434|NCT00392327|2344641|FG003|Overall Study|Physician Decision|2
1186435|NCT00392327|2344642|FG004|Overall Study|Physician Decision|0
1186436|NCT00392327|2344643|FG005|Overall Study|Physician Decision|1
1186437|NCT00392327|2344644|FG006|Overall Study|Physician Decision|5
1186438|NCT00392327|2344645|FG007|Overall Study|Physician Decision|3
1186439|NCT00392327|2344638|FG000|Overall Study|Protocol Violation|0
1186440|NCT00392327|2344639|FG001|Overall Study|Protocol Violation|0
1186441|NCT00392327|2344640|FG002|Overall Study|Protocol Violation|1
1186442|NCT00392327|2344641|FG003|Overall Study|Protocol Violation|0
1186443|NCT00392327|2344642|FG004|Overall Study|Protocol Violation|0
1186444|NCT00392327|2344643|FG005|Overall Study|Protocol Violation|0
1186445|NCT00392327|2344644|FG006|Overall Study|Protocol Violation|0
1186446|NCT00392327|2344645|FG007|Overall Study|Protocol Violation|0
1186447|NCT00392327|2344638|FG000|Overall Study|Withdrawal by Subject|3
1186448|NCT00392327|2344639|FG001|Overall Study|Withdrawal by Subject|2
1186449|NCT00392327|2344640|FG002|Overall Study|Withdrawal by Subject|4
1186450|NCT00392327|2344641|FG003|Overall Study|Withdrawal by Subject|6
1186451|NCT00392327|2344642|FG004|Overall Study|Withdrawal by Subject|0
1186452|NCT00392327|2344643|FG005|Overall Study|Withdrawal by Subject|1
1186453|NCT00392327|2344644|FG006|Overall Study|Withdrawal by Subject|1
1186454|NCT00392327|2344645|FG007|Overall Study|Withdrawal by Subject|5
1186455|NCT00392327|2344638|FG000|Overall Study|Ineligible|0
1186456|NCT00392327|2344639|FG001|Overall Study|Ineligible|4
1186457|NCT00392327|2344640|FG002|Overall Study|Ineligible|3
1186458|NCT00392327|2344641|FG003|Overall Study|Ineligible|2
1186459|NCT00392327|2344642|FG004|Overall Study|Ineligible|0
1186460|NCT00392327|2344643|FG005|Overall Study|Ineligible|0
1186461|NCT00392327|2344644|FG006|Overall Study|Ineligible|0
1186462|NCT00392327|2344645|FG007|Overall Study|Ineligible|0
1186463|NCT00085202|2344665|FG000|Overall Study|Still on therapy|2
1186464|NCT00085202|2344666|FG001|Overall Study|Still on therapy|0
1186465|NCT00085202|2344665|FG000|Overall Study|Bone involvement confirmed by bone scan|0
1186466|NCT00085202|2344666|FG001|Overall Study|Bone involvement confirmed by bone scan|1
1186467|NCT00085202|2344665|FG000|Overall Study|Excessive toxicity|6
1186468|NCT00085202|2344666|FG001|Overall Study|Excessive toxicity|5
1186469|NCT00085202|2344665|FG000|Overall Study|Non-specified|3
1186470|NCT00085202|2344666|FG001|Overall Study|Non-specified|5
1186471|NCT00085202|2344665|FG000|Overall Study|Withdrawal by Subject|2
1186472|NCT00085202|2344666|FG001|Overall Study|Withdrawal by Subject|1
1186473|NCT00085202|2344665|FG000|Overall Study|Physician Decision|4
1186474|NCT00085202|2344666|FG001|Overall Study|Physician Decision|1
1186475|NCT00085202|2344665|FG000|Overall Study|Progressive disease|1
1186476|NCT00085202|2344666|FG001|Overall Study|Progressive disease|11
1186483|NCT04386616|2344785|FG000|Overall Study|Death|22
1186484|NCT04386616|2344786|FG001|Overall Study|Death|22
1186485|NCT04386616|2344787|FG002|Overall Study|Death|21
1186486|NCT04386616|2344785|FG000|Overall Study|Lost to Follow-up|5
1186487|NCT04386616|2344786|FG001|Overall Study|Lost to Follow-up|8
1186488|NCT04386616|2344787|FG002|Overall Study|Lost to Follow-up|6
1186489|NCT04386616|2344785|FG000|Overall Study|Withdrawal by Subject|2
879582|NCT00585195|1843247|FG006|Overall Study|Other|0
879583|NCT00585195|1843248|FG007|Overall Study|Other|0
879584|NCT00585195|1843249|FG008|Overall Study|Other|2
879585|NCT00585195|1843250|FG009|Overall Study|Other|1
879586|NCT00585195|1843251|FG010|Overall Study|Other|0
879587|NCT00585195|1843252|FG011|Overall Study|Other|19
879588|NCT00585195|1843253|FG012|Overall Study|Other|23
879589|NCT00585195|1843254|FG013|Overall Study|Other|7
879590|NCT00585195|1843255|FG014|Overall Study|Other|11
879591|NCT00585195|1843256|FG015|Overall Study|Other|3
879592|NCT00585195|1843257|FG016|Overall Study|Other|28
879593|NCT00585195|1843258|FG017|Overall Study|Other|12
879594|NCT00585195|1843259|FG018|Overall Study|Other|10
879595|NCT00585195|1843260|FG019|Overall Study|Other|4
879596|NCT00585195|1843261|FG020|Overall Study|Other|2
879597|NCT00585195|1843241|FG000|Overall Study|Randomized not treated|0
879598|NCT00585195|1843242|FG001|Overall Study|Randomized not treated|0
879599|NCT00585195|1843243|FG002|Overall Study|Randomized not treated|1
879600|NCT00585195|1843244|FG003|Overall Study|Randomized not treated|0
879601|NCT00585195|1843245|FG004|Overall Study|Randomized not treated|1
879602|NCT00585195|1843246|FG005|Overall Study|Randomized not treated|0
879603|NCT00585195|1843247|FG006|Overall Study|Randomized not treated|1
879604|NCT00585195|1843248|FG007|Overall Study|Randomized not treated|0
879605|NCT00585195|1843249|FG008|Overall Study|Randomized not treated|0
879606|NCT00585195|1843250|FG009|Overall Study|Randomized not treated|0
879607|NCT00585195|1843251|FG010|Overall Study|Randomized not treated|2
879608|NCT00585195|1843252|FG011|Overall Study|Randomized not treated|0
879609|NCT00585195|1843253|FG012|Overall Study|Randomized not treated|0
879610|NCT00585195|1843254|FG013|Overall Study|Randomized not treated|0
879611|NCT00585195|1843255|FG014|Overall Study|Randomized not treated|0
879612|NCT00585195|1843256|FG015|Overall Study|Randomized not treated|1
879613|NCT00585195|1843257|FG016|Overall Study|Randomized not treated|0
879614|NCT00585195|1843258|FG017|Overall Study|Randomized not treated|1
879615|NCT00585195|1843259|FG018|Overall Study|Randomized not treated|3
879616|NCT00585195|1843260|FG019|Overall Study|Randomized not treated|0
879617|NCT00585195|1843261|FG020|Overall Study|Randomized not treated|2
879618|NCT00585195|1843241|FG000|Overall Study|Death|0
879619|NCT00585195|1843242|FG001|Overall Study|Death|0
879620|NCT00585195|1843243|FG002|Overall Study|Death|0
879621|NCT00585195|1843244|FG003|Overall Study|Death|0
879622|NCT00585195|1843245|FG004|Overall Study|Death|0
879623|NCT00585195|1843246|FG005|Overall Study|Death|0
879624|NCT00585195|1843247|FG006|Overall Study|Death|0
879625|NCT00585195|1843248|FG007|Overall Study|Death|0
879626|NCT00585195|1843249|FG008|Overall Study|Death|1
879627|NCT00585195|1843250|FG009|Overall Study|Death|0
879628|NCT00585195|1843251|FG010|Overall Study|Death|1
879629|NCT00585195|1843252|FG011|Overall Study|Death|1
879630|NCT00585195|1843253|FG012|Overall Study|Death|7
879631|NCT00585195|1843254|FG013|Overall Study|Death|2
879632|NCT00585195|1843255|FG014|Overall Study|Death|8
879633|NCT00585195|1843256|FG015|Overall Study|Death|2
879634|NCT00585195|1843257|FG016|Overall Study|Death|11
879635|NCT00585195|1843258|FG017|Overall Study|Death|0
879636|NCT00585195|1843259|FG018|Overall Study|Death|0
879637|NCT00585195|1843260|FG019|Overall Study|Death|0
879638|NCT00585195|1843261|FG020|Overall Study|Death|1
879639|NCT00585195|1843241|FG000|Overall Study|Lost to Follow-up|0
879640|NCT00585195|1843242|FG001|Overall Study|Lost to Follow-up|0
879641|NCT00585195|1843243|FG002|Overall Study|Lost to Follow-up|0
879642|NCT00585195|1843244|FG003|Overall Study|Lost to Follow-up|0
879643|NCT00585195|1843245|FG004|Overall Study|Lost to Follow-up|0
879644|NCT00585195|1843246|FG005|Overall Study|Lost to Follow-up|0
879645|NCT00585195|1843247|FG006|Overall Study|Lost to Follow-up|0
879646|NCT00585195|1843248|FG007|Overall Study|Lost to Follow-up|0
879647|NCT00585195|1843249|FG008|Overall Study|Lost to Follow-up|0
879648|NCT00585195|1843250|FG009|Overall Study|Lost to Follow-up|0
879649|NCT00585195|1843251|FG010|Overall Study|Lost to Follow-up|0
879650|NCT00585195|1843252|FG011|Overall Study|Lost to Follow-up|0
879651|NCT00585195|1843253|FG012|Overall Study|Lost to Follow-up|1
879652|NCT00585195|1843254|FG013|Overall Study|Lost to Follow-up|0
879653|NCT00585195|1843255|FG014|Overall Study|Lost to Follow-up|0
879654|NCT00585195|1843256|FG015|Overall Study|Lost to Follow-up|0
879655|NCT00585195|1843257|FG016|Overall Study|Lost to Follow-up|0
879656|NCT00585195|1843258|FG017|Overall Study|Lost to Follow-up|2
879657|NCT00585195|1843259|FG018|Overall Study|Lost to Follow-up|0
879658|NCT00585195|1843260|FG019|Overall Study|Lost to Follow-up|0
879659|NCT00585195|1843261|FG020|Overall Study|Lost to Follow-up|0
879660|NCT00585195|1843241|FG000|Overall Study|Ongoing|0
879661|NCT00585195|1843242|FG001|Overall Study|Ongoing|0
879662|NCT00585195|1843243|FG002|Overall Study|Ongoing|0
879663|NCT00585195|1843244|FG003|Overall Study|Ongoing|0
1186490|NCT04386616|2344786|FG001|Overall Study|Withdrawal by Subject|4
1186491|NCT04386616|2344787|FG002|Overall Study|Withdrawal by Subject|1
1186492|NCT04386616|2344785|FG000|Overall Study|Adverse Event|1
1186493|NCT04386616|2344786|FG001|Overall Study|Adverse Event|1
1186494|NCT04386616|2344787|FG002|Overall Study|Adverse Event|0
1186495|NCT04296942|2344820|FG000|Overall Study|Study closure by sponsor|1
1186496|NCT04296942|2344821|FG001|Overall Study|Study closure by sponsor|0
1186497|NCT04296942|2344822|FG002|Overall Study|Study closure by sponsor|0
1186498|NCT04278872|2344834|FG000|Overall Study|Adverse Event|1
1186499|NCT04278872|2344835|FG001|Overall Study|Adverse Event|0
1186500|NCT04278872|2344834|FG000|Overall Study|Protocol Violation|0
1186501|NCT04278872|2344835|FG001|Overall Study|Protocol Violation|1
1186502|NCT04278872|2344834|FG000|Overall Study|Study Termination|2
1186503|NCT04278872|2344835|FG001|Overall Study|Study Termination|0
1186504|NCT04213807|2344844|FG000|Overall Study|Physician Decision|0
1186505|NCT04213807|2344845|FG001|Overall Study|Physician Decision|0
1186506|NCT04213807|2344846|FG002|Overall Study|Physician Decision|1
1186507|NCT04001803|2344875|FG000|Overall Study|Ongoing at the time of analysis|103
1186508|NCT04001803|2344875|FG000|Overall Study|Adverse Event|2
1186509|NCT04001803|2344875|FG000|Overall Study|Protocol Violation|2
1186510|NCT04001803|2344875|FG000|Overall Study|Lost to Follow-up|2
1186511|NCT04001803|2344875|FG000|Overall Study|Physician Decision|1
1186512|NCT04001803|2344875|FG000|Overall Study|Withdrawal by Subject|4
1186528|NCT03833661|2344936|FG000|Overall Study|Treatment ongoing|9
1186529|NCT03721107|2344959|FG000|Overall Study|Adverse Event|1
1186530|NCT03721107|2344960|FG001|Overall Study|Adverse Event|1
1186531|NCT03721107|2344961|FG002|Overall Study|Adverse Event|6
1186532|NCT03721107|2344962|FG003|Overall Study|Adverse Event|5
1186533|NCT03721107|2344959|FG000|Overall Study|Lost to Follow-up|2
1186534|NCT03721107|2344960|FG001|Overall Study|Lost to Follow-up|0
1186535|NCT03721107|2344961|FG002|Overall Study|Lost to Follow-up|3
1186536|NCT03721107|2344962|FG003|Overall Study|Lost to Follow-up|0
1186537|NCT03721107|2344959|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0
1186538|NCT03721107|2344960|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0
879664|NCT00585195|1843245|FG004|Overall Study|Ongoing|0
879665|NCT00585195|1843246|FG005|Overall Study|Ongoing|0
879666|NCT00585195|1843247|FG006|Overall Study|Ongoing|0
879667|NCT00585195|1843248|FG007|Overall Study|Ongoing|0
879668|NCT00585195|1843249|FG008|Overall Study|Ongoing|0
879669|NCT00585195|1843250|FG009|Overall Study|Ongoing|0
879670|NCT00585195|1843251|FG010|Overall Study|Ongoing|0
879671|NCT00585195|1843252|FG011|Overall Study|Ongoing|0
879672|NCT00585195|1843253|FG012|Overall Study|Ongoing|2
879673|NCT00585195|1843254|FG013|Overall Study|Ongoing|0
879674|NCT00585195|1843255|FG014|Overall Study|Ongoing|0
879675|NCT00585195|1843256|FG015|Overall Study|Ongoing|0
879676|NCT00585195|1843257|FG016|Overall Study|Ongoing|0
879677|NCT00585195|1843258|FG017|Overall Study|Ongoing|0
879678|NCT00585195|1843259|FG018|Overall Study|Ongoing|0
879679|NCT00585195|1843260|FG019|Overall Study|Ongoing|0
879680|NCT00585195|1843261|FG020|Overall Study|Ongoing|0
879681|NCT00585195|1843241|FG000|Overall Study|Withdrawn Due to Pregnancy|0
879682|NCT00585195|1843242|FG001|Overall Study|Withdrawn Due to Pregnancy|0
879683|NCT00585195|1843243|FG002|Overall Study|Withdrawn Due to Pregnancy|0
879684|NCT00585195|1843244|FG003|Overall Study|Withdrawn Due to Pregnancy|0
879685|NCT00585195|1843245|FG004|Overall Study|Withdrawn Due to Pregnancy|0
879686|NCT00585195|1843246|FG005|Overall Study|Withdrawn Due to Pregnancy|0
879687|NCT00585195|1843247|FG006|Overall Study|Withdrawn Due to Pregnancy|0
879688|NCT00585195|1843248|FG007|Overall Study|Withdrawn Due to Pregnancy|0
879689|NCT00585195|1843249|FG008|Overall Study|Withdrawn Due to Pregnancy|0
879690|NCT00585195|1843250|FG009|Overall Study|Withdrawn Due to Pregnancy|0
879691|NCT00585195|1843251|FG010|Overall Study|Withdrawn Due to Pregnancy|0
879692|NCT00585195|1843252|FG011|Overall Study|Withdrawn Due to Pregnancy|0
879693|NCT00585195|1843253|FG012|Overall Study|Withdrawn Due to Pregnancy|0
879694|NCT00585195|1843254|FG013|Overall Study|Withdrawn Due to Pregnancy|0
879695|NCT00585195|1843255|FG014|Overall Study|Withdrawn Due to Pregnancy|1
1186539|NCT03721107|2344961|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0
1186540|NCT03721107|2344962|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1
1186541|NCT03721107|2344959|FG000|Overall Study|Physician Decision|0
1186542|NCT03721107|2344960|FG001|Overall Study|Physician Decision|1
1186543|NCT03721107|2344961|FG002|Overall Study|Physician Decision|0
1186544|NCT03721107|2344962|FG003|Overall Study|Physician Decision|0
1186545|NCT03721107|2344959|FG000|Overall Study|Pregnancy|0
1186546|NCT03721107|2344960|FG001|Overall Study|Pregnancy|0
1186547|NCT03721107|2344961|FG002|Overall Study|Pregnancy|1
1186548|NCT03721107|2344962|FG003|Overall Study|Pregnancy|0
1186549|NCT03721107|2344959|FG000|Overall Study|Withdrawal by Subject|1
1186550|NCT03721107|2344960|FG001|Overall Study|Withdrawal by Subject|1
1186551|NCT03721107|2344961|FG002|Overall Study|Withdrawal by Subject|5
1186552|NCT03721107|2344962|FG003|Overall Study|Withdrawal by Subject|5
1186553|NCT03721107|2344959|FG000|Overall Study|Other|1
1186554|NCT03721107|2344960|FG001|Overall Study|Other|0
1186555|NCT03721107|2344961|FG002|Overall Study|Other|0
1186556|NCT03721107|2344962|FG003|Overall Study|Other|1
1186557|NCT03644849|2345002|FG000|Overall Study|Lost to Follow-up|1
1186558|NCT03644849|2345003|FG001|Overall Study|Lost to Follow-up|3
1186559|NCT03604159|2345020|FG000|Overall Study|Lost to Follow-up|6
1186560|NCT03604159|2345021|FG001|Overall Study|Lost to Follow-up|7
1186561|NCT03602885|2345029|FG000|Overall Study|Lost to Follow-up|3
1186562|NCT03602885|2345030|FG001|Overall Study|Lost to Follow-up|0
1186563|NCT03539601|2345040|FG000|Overall Study|Withdraw by parent/guardian|1
1186564|NCT03539601|2345041|FG001|Overall Study|Withdraw by parent/guardian|0
1186565|NCT03539601|2345042|FG002|Overall Study|Withdraw by parent/guardian|1
1186566|NCT03539601|2345043|FG003|Overall Study|Withdraw by parent/guardian|0
1186567|NCT03539601|2345040|FG000|Overall Study|Adverse Event|0
1186568|NCT03539601|2345041|FG001|Overall Study|Adverse Event|2
1186569|NCT03539601|2345042|FG002|Overall Study|Adverse Event|0
1186570|NCT03539601|2345043|FG003|Overall Study|Adverse Event|0
1186571|NCT03539601|2345040|FG000|Overall Study|Lost to Follow-up|2
1186572|NCT03539601|2345041|FG001|Overall Study|Lost to Follow-up|4
1186573|NCT03539601|2345042|FG002|Overall Study|Lost to Follow-up|5
1186574|NCT03539601|2345043|FG003|Overall Study|Lost to Follow-up|0
1186575|NCT03539601|2345040|FG000|Overall Study|Withdrawal by Subject|2
1186576|NCT03539601|2345041|FG001|Overall Study|Withdrawal by Subject|0
1186577|NCT03539601|2345042|FG002|Overall Study|Withdrawal by Subject|0
1186578|NCT03539601|2345043|FG003|Overall Study|Withdrawal by Subject|1
1186579|NCT03539601|2345040|FG000|Overall Study|Randomized but not treated|1
1186580|NCT03539601|2345041|FG001|Overall Study|Randomized but not treated|1
1186581|NCT03539601|2345042|FG002|Overall Study|Randomized but not treated|0
1186582|NCT03539601|2345043|FG003|Overall Study|Randomized but not treated|0
1186583|NCT03539458|2345061|FG000|Overall Study|Death|1
1186584|NCT03532451|2345067|FG000|Overall Study|Withdrawal by Subject|0
1186585|NCT03532451|2345068|FG001|Overall Study|Withdrawal by Subject|1
1186586|NCT03532451|2345067|FG000|Overall Study|Progression prior to the surgery|1
1186587|NCT03532451|2345068|FG001|Overall Study|Progression prior to the surgery|0
1186588|NCT03478956|2345085|FG000|Overall Study|Adverse Event|1
1186589|NCT03478956|2345086|FG001|Overall Study|Adverse Event|0
1186590|NCT03478956|2345085|FG000|Overall Study|Withdrawal by Subject|0
1186591|NCT03478956|2345086|FG001|Overall Study|Withdrawal by Subject|1
1186592|NCT03478956|2345085|FG000|Overall Study|Ongoing in the Study|11
1186593|NCT03478956|2345086|FG001|Overall Study|Ongoing in the Study|11
1186594|NCT03464136|2345094|FG000|Overall Study|Lost to Follow-up|5
1186595|NCT03464136|2345095|FG001|Overall Study|Lost to Follow-up|8
1186596|NCT03464136|2345094|FG000|Overall Study|Withdrawal by Subject|16
1186597|NCT03464136|2345095|FG001|Overall Study|Withdrawal by Subject|13
1186598|NCT03464136|2345094|FG000|Overall Study|Death|1
1186599|NCT03464136|2345095|FG001|Overall Study|Death|0
1186600|NCT03464136|2345094|FG000|Overall Study|Other|8
1186601|NCT03464136|2345095|FG001|Overall Study|Other|4
1186602|NCT03439657|2345103|FG000|Overall Study|Adverse Event|2
1186603|NCT03439657|2345104|FG001|Overall Study|Adverse Event|3
1186604|NCT03439657|2345103|FG000|Overall Study|Lost to Follow-up|1
1186605|NCT03439657|2345104|FG001|Overall Study|Lost to Follow-up|0
1186606|NCT03439657|2345103|FG000|Overall Study|Protocol Violation|1
1186607|NCT03439657|2345104|FG001|Overall Study|Protocol Violation|1
1186608|NCT03439657|2345103|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3
1186609|NCT03439657|2345104|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0
1186610|NCT03400943|2345116|FG000|Treatment Period 1|Adverse Event|0
1186611|NCT03400943|2345117|FG001|Treatment Period 1|Adverse Event|0
1186612|NCT03400943|2345118|FG002|Treatment Period 1|Adverse Event|0
1186613|NCT03400943|2345119|FG003|Treatment Period 1|Adverse Event|1
1186614|NCT03400943|2345116|FG000|Treatment Period 1|Lost to Follow-up|1
1186615|NCT03400943|2345117|FG001|Treatment Period 1|Lost to Follow-up|0
1186616|NCT03400943|2345118|FG002|Treatment Period 1|Lost to Follow-up|0
1186617|NCT03400943|2345119|FG003|Treatment Period 1|Lost to Follow-up|0
1186618|NCT03400943|2345116|FG000|Treatment Period 1|Protocol Violation|0
1186619|NCT03400943|2345117|FG001|Treatment Period 1|Protocol Violation|1
1186620|NCT03400943|2345118|FG002|Treatment Period 1|Protocol Violation|1
1186621|NCT03400943|2345119|FG003|Treatment Period 1|Protocol Violation|0
1186622|NCT03400943|2345116|FG000|Treatment Period 1|Study terminated by sponsor|2
1186623|NCT03400943|2345117|FG001|Treatment Period 1|Study terminated by sponsor|0
1186624|NCT03400943|2345118|FG002|Treatment Period 1|Study terminated by sponsor|0
1186625|NCT03400943|2345119|FG003|Treatment Period 1|Study terminated by sponsor|1
1186626|NCT03400943|2345116|FG000|Treatment Period 1|Withdrawal by Subject|0
1186627|NCT03400943|2345117|FG001|Treatment Period 1|Withdrawal by Subject|0
1186628|NCT03400943|2345118|FG002|Treatment Period 1|Withdrawal by Subject|3
1186629|NCT03400943|2345119|FG003|Treatment Period 1|Withdrawal by Subject|1
1186630|NCT03400943|2345116|FG000|Treatment Period 1|Other|2
1186631|NCT03400943|2345117|FG001|Treatment Period 1|Other|1
1186632|NCT03400943|2345118|FG002|Treatment Period 1|Other|2
1186633|NCT03400943|2345119|FG003|Treatment Period 1|Other|2
1186634|NCT03400943|2345116|FG000|Post-treatment Period 1|Adverse Event|2
1186635|NCT03400943|2345117|FG001|Post-treatment Period 1|Adverse Event|0
1186636|NCT03400943|2345118|FG002|Post-treatment Period 1|Adverse Event|0
1186637|NCT03400943|2345119|FG003|Post-treatment Period 1|Adverse Event|0
1186638|NCT03400943|2345116|FG000|Post-treatment Period 1|Protocol Violation|1
1186639|NCT03400943|2345117|FG001|Post-treatment Period 1|Protocol Violation|0
1186640|NCT03400943|2345118|FG002|Post-treatment Period 1|Protocol Violation|0
1186641|NCT03400943|2345119|FG003|Post-treatment Period 1|Protocol Violation|0
1186642|NCT03400943|2345116|FG000|Post-treatment Period 1|Study terminated by sponsor|5
1186643|NCT03400943|2345117|FG001|Post-treatment Period 1|Study terminated by sponsor|0
1186644|NCT03400943|2345118|FG002|Post-treatment Period 1|Study terminated by sponsor|5
1186645|NCT03400943|2345119|FG003|Post-treatment Period 1|Study terminated by sponsor|6
1186646|NCT03400943|2345116|FG000|Post-treatment Period 1|Withdrawal by Subject|1
1186647|NCT03400943|2345117|FG001|Post-treatment Period 1|Withdrawal by Subject|0
1186648|NCT03400943|2345118|FG002|Post-treatment Period 1|Withdrawal by Subject|2
1186649|NCT03400943|2345119|FG003|Post-treatment Period 1|Withdrawal by Subject|2
1186650|NCT03400943|2345116|FG000|Post-treatment Period 1|Other|2
1186651|NCT03400943|2345117|FG001|Post-treatment Period 1|Other|0
1186652|NCT03400943|2345118|FG002|Post-treatment Period 1|Other|4
1186653|NCT03400943|2345119|FG003|Post-treatment Period 1|Other|5
1186654|NCT03400943|2345116|FG000|Treatment Period 2|Study terminated by sponsor|0
1186655|NCT03400943|2345117|FG001|Treatment Period 2|Study terminated by sponsor|1
1186656|NCT03400943|2345118|FG002|Treatment Period 2|Study terminated by sponsor|0
1186657|NCT03400943|2345119|FG003|Treatment Period 2|Study terminated by sponsor|0
1186658|NCT03400943|2345116|FG000|Treatment Period 2|Withdrawal by Subject|0
1186659|NCT03400943|2345117|FG001|Treatment Period 2|Withdrawal by Subject|1
1186660|NCT03400943|2345118|FG002|Treatment Period 2|Withdrawal by Subject|0
1186661|NCT03400943|2345119|FG003|Treatment Period 2|Withdrawal by Subject|0
1186662|NCT03400943|2345116|FG000|Treatment Period 2|Other|1
1186663|NCT03400943|2345117|FG001|Treatment Period 2|Other|6
1186664|NCT03400943|2345118|FG002|Treatment Period 2|Other|0
1186665|NCT03400943|2345119|FG003|Treatment Period 2|Other|0
1186666|NCT03400943|2345116|FG000|Follow-up Period|Withdrawal by Subject|1
1186667|NCT03400943|2345117|FG001|Follow-up Period|Withdrawal by Subject|0
1186668|NCT03400943|2345118|FG002|Follow-up Period|Withdrawal by Subject|0
1186669|NCT03400943|2345119|FG003|Follow-up Period|Withdrawal by Subject|0
1186670|NCT03377790|2345133|FG000|Overall Study|Withdrawal by Subject|1
1186671|NCT03377790|2345134|FG001|Overall Study|Withdrawal by Subject|0
1186672|NCT03377790|2345133|FG000|Overall Study|Adverse Event|1
1186673|NCT03377790|2345134|FG001|Overall Study|Adverse Event|0
1186674|NCT03377790|2345133|FG000|Overall Study|Lost to Follow-up|0
1186675|NCT03377790|2345134|FG001|Overall Study|Lost to Follow-up|2
1186676|NCT03377790|2345133|FG000|Overall Study|Randomized but not treated|1
1186677|NCT03377790|2345134|FG001|Overall Study|Randomized but not treated|0
1186678|NCT03377790|2345133|FG000|Overall Study|Withdrawn by Parent/Guardian|7
1186679|NCT03377790|2345134|FG001|Overall Study|Withdrawn by Parent/Guardian|4
1186680|NCT03353675|2345140|FG000|Overall Study|Adverse Event|4
1186681|NCT03294109|2345146|FG000|Overall Study|Withdrawal by Subject|6
1186682|NCT03294109|2345147|FG001|Overall Study|Withdrawal by Subject|5
1186683|NCT03268005|2345156|FG000|Overall Study|Death|2
1186684|NCT03268005|2345157|FG001|Overall Study|Death|1
1186685|NCT03268005|2345156|FG000|Overall Study|Lost to Follow-up|2
1186686|NCT03268005|2345157|FG001|Overall Study|Lost to Follow-up|2
1186687|NCT03268005|2345156|FG000|Overall Study|Withdrawal by Subject|11
879696|NCT00585195|1843256|FG015|Overall Study|Withdrawn Due to Pregnancy|0
879697|NCT00585195|1843257|FG016|Overall Study|Withdrawn Due to Pregnancy|0
879698|NCT00585195|1843258|FG017|Overall Study|Withdrawn Due to Pregnancy|0
879699|NCT00585195|1843259|FG018|Overall Study|Withdrawn Due to Pregnancy|0
879700|NCT00585195|1843260|FG019|Overall Study|Withdrawn Due to Pregnancy|0
879701|NCT00585195|1843261|FG020|Overall Study|Withdrawn Due to Pregnancy|0
879702|NCT00585286|1843353|FG000|Overall Study|Lost to Follow-up|1
879703|NCT00585312|1843359|FG000|Overall Study|Adverse Event|3
879704|NCT00585312|1843360|FG001|Overall Study|Adverse Event|0
879705|NCT00585312|1843359|FG000|Overall Study|Lack of Efficacy|6
879706|NCT00585312|1843360|FG001|Overall Study|Lack of Efficacy|11
879707|NCT00585312|1843359|FG000|Overall Study|Lost to Follow-up|1
879708|NCT00585312|1843360|FG001|Overall Study|Lost to Follow-up|1
879709|NCT00585312|1843359|FG000|Overall Study|Reason not specified|2
879710|NCT00585312|1843360|FG001|Overall Study|Reason not specified|0
879711|NCT00585312|1843359|FG000|Overall Study|Withdrawal by Subject|5
879712|NCT00585312|1843360|FG001|Overall Study|Withdrawal by Subject|1
879713|NCT00585312|1843359|FG000|Overall Study|Study terminated by the sponsor|34
1186688|NCT03268005|2345157|FG001|Overall Study|Withdrawal by Subject|11
1186705|NCT03225170|2345183|FG000|Overall Study|Lost to Follow-up|4
1186706|NCT03225170|2345184|FG001|Overall Study|Lost to Follow-up|4
1186707|NCT03225170|2345185|FG002|Overall Study|Lost to Follow-up|0
1186708|NCT03225170|2345183|FG000|Overall Study|Did not complete intervention/control writing exercise|0
1186709|NCT03225170|2345184|FG001|Overall Study|Did not complete intervention/control writing exercise|1
1186710|NCT03225170|2345185|FG002|Overall Study|Did not complete intervention/control writing exercise|0
1186711|NCT03219034|2345209|FG000|Overall Study|Lost to Follow-up|9
879714|NCT00585312|1843360|FG001|Overall Study|Study terminated by the sponsor|31
879715|NCT00585325|1843368|FG000|Overall Study|Withdrawal by Subject|1
879716|NCT00585325|1843369|FG001|Overall Study|Withdrawal by Subject|1
879717|NCT00585351|1843381|FG000|Notification Period (Informed Consent)|Physician Decision|0
879718|NCT00585351|1843382|FG001|Notification Period (Informed Consent)|Physician Decision|2
879719|NCT00585351|1843383|FG002|Notification Period (Informed Consent)|Physician Decision|0
879720|NCT00585351|1843384|FG003|Notification Period (Informed Consent)|Physician Decision|0
1186712|NCT03219034|2345210|FG001|Overall Study|Lost to Follow-up|13
1186713|NCT03219034|2345209|FG000|Overall Study|Additional dental work needed|1
1186714|NCT03219034|2345210|FG001|Overall Study|Additional dental work needed|0
1186715|NCT03219034|2345209|FG000|Overall Study|UPPP Surgery|1
1186716|NCT03219034|2345210|FG001|Overall Study|UPPP Surgery|0
1186717|NCT03219034|2345209|FG000|Overall Study|Dental sensitivity|0
1186718|NCT03219034|2345210|FG001|Overall Study|Dental sensitivity|1
1186719|NCT03219034|2345209|FG000|Overall Study|Death in family|0
1186720|NCT03219034|2345210|FG001|Overall Study|Death in family|1
1186721|NCT03181789|2345222|FG000|Overall Study|Withdrawal by Subject|0
1186722|NCT03181789|2345223|FG001|Overall Study|Withdrawal by Subject|1
1186723|NCT03181789|2345224|FG002|Overall Study|Withdrawal by Subject|1
1186724|NCT03181789|2345225|FG003|Overall Study|Withdrawal by Subject|0
1186725|NCT03181789|2345222|FG000|Overall Study|Lost to Follow-up|7
1186726|NCT03181789|2345223|FG001|Overall Study|Lost to Follow-up|1
1186727|NCT03181789|2345224|FG002|Overall Study|Lost to Follow-up|0
1186728|NCT03181789|2345225|FG003|Overall Study|Lost to Follow-up|0
1186729|NCT03181789|2345222|FG000|Overall Study|Participant unable to adhere to visit|0
1186730|NCT03181789|2345223|FG001|Overall Study|Participant unable to adhere to visit|1
1186731|NCT03181789|2345224|FG002|Overall Study|Participant unable to adhere to visit|0
1186732|NCT03181789|2345225|FG003|Overall Study|Participant unable to adhere to visit|0
1186733|NCT03168438|2345237|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0
1186734|NCT03168438|2345238|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1
1186735|NCT03110380|2345247|FG000|Double-Blind Treatment Phase|Withdrew Consent|10
1186736|NCT03110380|2345248|FG001|Double-Blind Treatment Phase|Withdrew Consent|16
1186737|NCT03110380|2345249|FG002|Double-Blind Treatment Phase|Withdrew Consent|0
1186738|NCT03110380|2345250|FG003|Double-Blind Treatment Phase|Withdrew Consent|0
1186739|NCT03110380|2345247|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
1186740|NCT03110380|2345248|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3
1186741|NCT03110380|2345249|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0
1186742|NCT03110380|2345250|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
879721|NCT00585351|1843385|FG004|Notification Period (Informed Consent)|Physician Decision|0
879722|NCT00585351|1843386|FG005|Notification Period (Informed Consent)|Physician Decision|0
879723|NCT00585351|1843387|FG006|Notification Period (Informed Consent)|Physician Decision|0
879724|NCT00585351|1843388|FG007|Notification Period (Informed Consent)|Physician Decision|0
879725|NCT00585351|1843381|FG000|Notification Period (Informed Consent)|Flight aborted|2
879726|NCT00585351|1843382|FG001|Notification Period (Informed Consent)|Flight aborted|1
879727|NCT00585351|1843383|FG002|Notification Period (Informed Consent)|Flight aborted|0
879728|NCT00585351|1843384|FG003|Notification Period (Informed Consent)|Flight aborted|0
879729|NCT00585351|1843385|FG004|Notification Period (Informed Consent)|Flight aborted|0
879730|NCT00585351|1843386|FG005|Notification Period (Informed Consent)|Flight aborted|0
879731|NCT00585351|1843387|FG006|Notification Period (Informed Consent)|Flight aborted|0
879732|NCT00585351|1843388|FG007|Notification Period (Informed Consent)|Flight aborted|0
879733|NCT00585351|1843381|FG000|Notification Period (Informed Consent)|No study medication on flight|0
1186743|NCT03110380|2345247|FG000|Double-Blind Treatment Phase|Adverse Event|3
1186744|NCT03110380|2345248|FG001|Double-Blind Treatment Phase|Adverse Event|3
1186745|NCT03110380|2345249|FG002|Double-Blind Treatment Phase|Adverse Event|0
1186746|NCT03110380|2345250|FG003|Double-Blind Treatment Phase|Adverse Event|0
1186747|NCT03110380|2345247|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1
1186748|NCT03110380|2345248|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3
1186749|NCT03110380|2345249|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0
1186750|NCT03110380|2345250|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0
1186751|NCT03110380|2345247|FG000|Double-Blind Treatment Phase|Death|2
1186752|NCT03110380|2345248|FG001|Double-Blind Treatment Phase|Death|1
1186753|NCT03110380|2345249|FG002|Double-Blind Treatment Phase|Death|0
1186754|NCT03110380|2345250|FG003|Double-Blind Treatment Phase|Death|0
1186755|NCT03110380|2345247|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
1186756|NCT03110380|2345248|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
1186757|NCT03110380|2345249|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
1186758|NCT03110380|2345250|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
1186759|NCT03110380|2345247|FG000|Double-Blind Treatment Phase|Protocol Violation|0
1186760|NCT03110380|2345248|FG001|Double-Blind Treatment Phase|Protocol Violation|1
1186761|NCT03110380|2345249|FG002|Double-Blind Treatment Phase|Protocol Violation|0
1186762|NCT03110380|2345250|FG003|Double-Blind Treatment Phase|Protocol Violation|0
1186763|NCT03110380|2345247|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0
1186764|NCT03110380|2345248|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2
1186765|NCT03110380|2345249|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0
1186766|NCT03110380|2345250|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0
1186767|NCT03110380|2345247|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
1186768|NCT03110380|2345248|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
1186769|NCT03110380|2345249|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3
1186770|NCT03110380|2345250|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1
1186771|NCT03110380|2345247|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
1186772|NCT03110380|2345248|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
1186773|NCT03110380|2345249|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
1186774|NCT03110380|2345250|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
1186775|NCT03110380|2345247|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0
1186776|NCT03110380|2345248|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0
1186777|NCT03110380|2345249|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0
1186778|NCT03110380|2345250|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1
879734|NCT00585351|1843382|FG001|Notification Period (Informed Consent)|No study medication on flight|1
879735|NCT00585351|1843383|FG002|Notification Period (Informed Consent)|No study medication on flight|0
879736|NCT00585351|1843384|FG003|Notification Period (Informed Consent)|No study medication on flight|0
879737|NCT00585351|1843385|FG004|Notification Period (Informed Consent)|No study medication on flight|0
1186809|NCT03078478|2345289|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
1186810|NCT03078478|2345290|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
1186811|NCT03078478|2345289|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
1186812|NCT03078478|2345290|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
1186813|NCT03078478|2345289|FG000|Maintenance Period 1 (36 Weeks)|Death|3
1186814|NCT03078478|2345290|FG001|Maintenance Period 1 (36 Weeks)|Death|3
1186815|NCT03078478|2345289|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
1186816|NCT03078478|2345290|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
1186817|NCT03078478|2345289|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
1186818|NCT03078478|2345290|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
879738|NCT00585351|1843386|FG005|Notification Period (Informed Consent)|No study medication on flight|0
879739|NCT00585351|1843387|FG006|Notification Period (Informed Consent)|No study medication on flight|0
879740|NCT00585351|1843388|FG007|Notification Period (Informed Consent)|No study medication on flight|0
879741|NCT00585351|1843381|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
879742|NCT00585351|1843382|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
879743|NCT00585351|1843383|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
879744|NCT00585351|1843384|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
879745|NCT00585351|1843385|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
879746|NCT00585351|1843386|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
879747|NCT00585351|1843387|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
879748|NCT00585351|1843388|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
879749|NCT00585351|1843381|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0
879750|NCT00585351|1843382|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0
879751|NCT00585351|1843383|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0
879752|NCT00585351|1843384|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0
879753|NCT00585351|1843385|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0
879754|NCT00585351|1843386|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0
879755|NCT00585351|1843387|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1
879756|NCT00585351|1843388|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1
879757|NCT00585351|1843381|FG000|Enrollment Period (Intervention)|Death|0
879758|NCT00585351|1843382|FG001|Enrollment Period (Intervention)|Death|0
879759|NCT00585351|1843383|FG002|Enrollment Period (Intervention)|Death|0
879760|NCT00585351|1843384|FG003|Enrollment Period (Intervention)|Death|0
879761|NCT00585351|1843385|FG004|Enrollment Period (Intervention)|Death|1
879762|NCT00585351|1843386|FG005|Enrollment Period (Intervention)|Death|0
879763|NCT00585351|1843387|FG006|Enrollment Period (Intervention)|Death|1
879764|NCT00585351|1843388|FG007|Enrollment Period (Intervention)|Death|0
879765|NCT00585351|1843381|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0
879766|NCT00585351|1843382|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0
879767|NCT00585351|1843383|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0
879768|NCT00585351|1843384|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0
879769|NCT00585351|1843385|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1
879770|NCT00585351|1843386|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2
879771|NCT00585351|1843387|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0
879772|NCT00585351|1843388|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0
879773|NCT00585468|1843406|FG000|First Intervention|Withdrawal by Subject|1
879774|NCT00585468|1843407|FG001|First Intervention|Withdrawal by Subject|1
879775|NCT00585533|1843419|FG000|Overall Study|objective or symptomatic progression|9
879776|NCT00585546|1843423|FG000|Clenbuterol Treatment - up to 12 Months|Death|1
879777|NCT00585546|1843423|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
879778|NCT00585689|1843453|FG000|Overall Study|Received different ABI-007 schedule|3
879779|NCT00585689|1843453|FG000|Overall Study|Adverse Event|1
879780|NCT00585689|1843453|FG000|Overall Study|Patient Declined Surgery|1
879781|NCT00585689|1843453|FG000|Overall Study|Patient had unresectable disease|1
879782|NCT00585689|1843453|FG000|Overall Study|Death|1
879783|NCT00585923|1843494|FG000|Overall Study|Physician decided not to continue|31
879784|NCT00585923|1843495|FG001|Overall Study|Physician decided not to continue|33
879785|NCT00585975|1843503|FG000|Overall Study|Withdrawal by Subject|3
879786|NCT00585975|1843504|FG001|Overall Study|Withdrawal by Subject|3
879787|NCT00585975|1843503|FG000|Overall Study|Lost to Follow-up|2
879788|NCT00585975|1843504|FG001|Overall Study|Lost to Follow-up|1
879789|NCT00585975|1843503|FG000|Overall Study|Enrollment met/over-enrolled|10
879790|NCT00585975|1843504|FG001|Overall Study|Enrollment met/over-enrolled|9
879791|NCT00586066|1843522|FG000|Overall Study|Lost to Follow-up|6
879792|NCT00586066|1843523|FG001|Overall Study|Lost to Follow-up|3
879793|NCT00586066|1843522|FG000|Overall Study|Lack of Efficacy|5
879794|NCT00586066|1843523|FG001|Overall Study|Lack of Efficacy|3
879795|NCT00586066|1843522|FG000|Overall Study|Adverse Event|2
879796|NCT00586066|1843523|FG001|Overall Study|Adverse Event|2
879797|NCT00586066|1843522|FG000|Overall Study|Physician Decision|1
879798|NCT00586066|1843523|FG001|Overall Study|Physician Decision|0
879799|NCT00586066|1843522|FG000|Overall Study|Withdrawal of consent|4
879800|NCT00586066|1843523|FG001|Overall Study|Withdrawal of consent|2
879801|NCT00586105|1843529|FG000|Overall Study|Adverse Event|4
1186819|NCT03078478|2345289|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
1186820|NCT03078478|2345290|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
1186821|NCT03078478|2345289|FG000|Maintencance Period 2 (36 Weeks)|Death|4
1186822|NCT03078478|2345290|FG001|Maintencance Period 2 (36 Weeks)|Death|6
1186823|NCT03078478|2345289|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
1186824|NCT03078478|2345290|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
1186825|NCT02993263|2345305|FG000|Overall Study|Equipment Software failed and results were lost.|323
1186826|NCT02985684|2345309|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
1186827|NCT02985684|2345309|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
1186828|NCT02985684|2345309|FG000|6-Month Closure Success Evaluation|Device Removal|3
1186829|NCT02951052|2345324|FG000|Overall Study|Adverse Event|13
1186830|NCT02951052|2345325|FG001|Overall Study|Adverse Event|5
1186831|NCT02951052|2345324|FG000|Overall Study|Withdrawal by Subject|1
1186832|NCT02951052|2345325|FG001|Overall Study|Withdrawal by Subject|5
1186833|NCT02951052|2345324|FG000|Overall Study|Physician Decision|2
1186834|NCT02951052|2345325|FG001|Overall Study|Physician Decision|0
1186835|NCT02951052|2345324|FG000|Overall Study|Lost to Follow-up|1
1186836|NCT02951052|2345325|FG001|Overall Study|Lost to Follow-up|1
1186837|NCT02951052|2345324|FG000|Overall Study|Protocol-specified withdrawal criterion|1
1186838|NCT02951052|2345325|FG001|Overall Study|Protocol-specified withdrawal criterion|0
1186839|NCT02951052|2345324|FG000|Overall Study|Protocol Violation|5
1186840|NCT02951052|2345325|FG001|Overall Study|Protocol Violation|3
1186841|NCT02951052|2345324|FG000|Overall Study|Lack of Efficacy|3
1186842|NCT02951052|2345325|FG001|Overall Study|Lack of Efficacy|4
1186843|NCT02951052|2345324|FG000|Overall Study|Ongoing|1
1186844|NCT02951052|2345325|FG001|Overall Study|Ongoing|0
1186845|NCT02903914|2345343|FG000|Overall Study|Adverse Event|0
1186846|NCT02903914|2345344|FG001|Overall Study|Adverse Event|0
1186847|NCT02903914|2345345|FG002|Overall Study|Adverse Event|1
1186848|NCT02903914|2345346|FG003|Overall Study|Adverse Event|0
1186849|NCT02903914|2345347|FG004|Overall Study|Adverse Event|0
1186850|NCT02903914|2345348|FG005|Overall Study|Adverse Event|1
1186851|NCT02903914|2345349|FG006|Overall Study|Adverse Event|2
1186852|NCT02903914|2345350|FG007|Overall Study|Adverse Event|1
1186853|NCT02903914|2345343|FG000|Overall Study|Withdrawal by Subject|3
1186854|NCT02903914|2345344|FG001|Overall Study|Withdrawal by Subject|1
1186855|NCT02903914|2345345|FG002|Overall Study|Withdrawal by Subject|28
1186856|NCT02903914|2345346|FG003|Overall Study|Withdrawal by Subject|0
1186857|NCT02903914|2345347|FG004|Overall Study|Withdrawal by Subject|1
1186858|NCT02903914|2345348|FG005|Overall Study|Withdrawal by Subject|1
1186859|NCT02903914|2345349|FG006|Overall Study|Withdrawal by Subject|12
1186860|NCT02903914|2345350|FG007|Overall Study|Withdrawal by Subject|0
1186861|NCT02903914|2345343|FG000|Overall Study|Progressive Disease|1
1186862|NCT02903914|2345344|FG001|Overall Study|Progressive Disease|0
1186863|NCT02903914|2345345|FG002|Overall Study|Progressive Disease|4
1186864|NCT02903914|2345346|FG003|Overall Study|Progressive Disease|0
1186865|NCT02903914|2345347|FG004|Overall Study|Progressive Disease|0
1186866|NCT02903914|2345348|FG005|Overall Study|Progressive Disease|0
879802|NCT00586105|1843529|FG000|Overall Study|Death|2
879803|NCT00586105|1843529|FG000|Overall Study|Protocol Violation|1
879804|NCT00586105|1843529|FG000|Overall Study|Withdrawal by Subject|3
879805|NCT00586105|1843529|FG000|Overall Study|Disease progression|19
879806|NCT00586105|1843529|FG000|Overall Study|Switched to commercial drug|9
879807|NCT00586105|1843529|FG000|Overall Study|Reason not reported|1
879808|NCT00586157|1843533|FG000|First Intervention|Worsening behavior|1
879809|NCT00586157|1843534|FG001|First Intervention|Worsening behavior|0
879810|NCT00586157|1843533|FG000|Second Intervention|Withdrawal by Subject|1
879811|NCT00586157|1843534|FG001|Second Intervention|Withdrawal by Subject|0
879812|NCT00586157|1843533|FG000|Second Intervention|Worsening behavior|1
879813|NCT00586157|1843534|FG001|Second Intervention|Worsening behavior|0
879814|NCT00586157|1843533|FG000|Second Intervention|Adverse Event|0
879815|NCT00586157|1843534|FG001|Second Intervention|Adverse Event|1
879816|NCT00586313|1843567|FG000|Overall Study|Lack of Efficacy|2
879817|NCT00586326|1843571|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6
879818|NCT00586326|1843571|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
879819|NCT00586326|1843571|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2
879820|NCT00586326|1843571|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1
879821|NCT00586326|1843571|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
879822|NCT00586326|1843571|FG000|Enrollment to Device Placement-Enrolled|Other|1
879823|NCT00586326|1843571|FG000|Device Placed toTreatment-ITT|Skin Distance|7
879824|NCT00586326|1843571|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6
879825|NCT00586326|1843571|FG000|Device Placed toTreatment-ITT|Microinvasion|1
879826|NCT00586326|1843571|FG000|Device Placed toTreatment-ITT|Positive Margins|3
879827|NCT00586326|1843571|FG000|Device Placed toTreatment-ITT|Physician Decision|1
879828|NCT00586326|1843571|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
1186867|NCT02903914|2345349|FG006|Overall Study|Progressive Disease|2
1186868|NCT02903914|2345350|FG007|Overall Study|Progressive Disease|4
1186869|NCT02903914|2345343|FG000|Overall Study|Death|0
1186870|NCT02903914|2345344|FG001|Overall Study|Death|0
1186871|NCT02903914|2345345|FG002|Overall Study|Death|9
1186872|NCT02903914|2345346|FG003|Overall Study|Death|0
1186873|NCT02903914|2345347|FG004|Overall Study|Death|1
1186874|NCT02903914|2345348|FG005|Overall Study|Death|3
1186875|NCT02903914|2345349|FG006|Overall Study|Death|24
1186876|NCT02903914|2345350|FG007|Overall Study|Death|0
1186877|NCT02903914|2345343|FG000|Overall Study|Lost to Follow-up|0
1186878|NCT02903914|2345344|FG001|Overall Study|Lost to Follow-up|1
1186879|NCT02903914|2345345|FG002|Overall Study|Lost to Follow-up|0
1186880|NCT02903914|2345346|FG003|Overall Study|Lost to Follow-up|0
1186881|NCT02903914|2345347|FG004|Overall Study|Lost to Follow-up|2
1186882|NCT02903914|2345348|FG005|Overall Study|Lost to Follow-up|0
1186883|NCT02903914|2345349|FG006|Overall Study|Lost to Follow-up|1
1186884|NCT02903914|2345350|FG007|Overall Study|Lost to Follow-up|0
1186885|NCT02903914|2345343|FG000|Overall Study|Physician Decision|0
1186886|NCT02903914|2345344|FG001|Overall Study|Physician Decision|0
1186887|NCT02903914|2345345|FG002|Overall Study|Physician Decision|1
1186888|NCT02903914|2345346|FG003|Overall Study|Physician Decision|0
1186889|NCT02903914|2345347|FG004|Overall Study|Physician Decision|0
1186890|NCT02903914|2345348|FG005|Overall Study|Physician Decision|0
1186891|NCT02903914|2345349|FG006|Overall Study|Physician Decision|1
1186892|NCT02903914|2345350|FG007|Overall Study|Physician Decision|0
1186893|NCT02903914|2345343|FG000|Overall Study|Symptomatic Deterioration|0
1186894|NCT02903914|2345344|FG001|Overall Study|Symptomatic Deterioration|0
1186895|NCT02903914|2345345|FG002|Overall Study|Symptomatic Deterioration|1
1186896|NCT02903914|2345346|FG003|Overall Study|Symptomatic Deterioration|0
1186897|NCT02903914|2345347|FG004|Overall Study|Symptomatic Deterioration|0
1186898|NCT02903914|2345348|FG005|Overall Study|Symptomatic Deterioration|0
1186899|NCT02903914|2345349|FG006|Overall Study|Symptomatic Deterioration|0
1186900|NCT02903914|2345350|FG007|Overall Study|Symptomatic Deterioration|0
1186901|NCT02903914|2345343|FG000|Overall Study|New Cancer Therapy|2
1186902|NCT02903914|2345344|FG001|Overall Study|New Cancer Therapy|2
1186903|NCT02903914|2345345|FG002|Overall Study|New Cancer Therapy|21
1186904|NCT02903914|2345346|FG003|Overall Study|New Cancer Therapy|4
1186905|NCT02903914|2345347|FG004|Overall Study|New Cancer Therapy|3
1186906|NCT02903914|2345348|FG005|Overall Study|New Cancer Therapy|6
1186907|NCT02903914|2345349|FG006|Overall Study|New Cancer Therapy|55
1186908|NCT02903914|2345350|FG007|Overall Study|New Cancer Therapy|0
1186909|NCT02903914|2345343|FG000|Overall Study|Reasoning not specified|2
1186910|NCT02903914|2345344|FG001|Overall Study|Reasoning not specified|3
1186911|NCT02903914|2345345|FG002|Overall Study|Reasoning not specified|20
1186912|NCT02903914|2345346|FG003|Overall Study|Reasoning not specified|3
1186913|NCT02903914|2345347|FG004|Overall Study|Reasoning not specified|3
1186914|NCT02903914|2345348|FG005|Overall Study|Reasoning not specified|3
1186915|NCT02903914|2345349|FG006|Overall Study|Reasoning not specified|20
1186916|NCT02903914|2345350|FG007|Overall Study|Reasoning not specified|0
1186917|NCT02879448|2345372|FG000|Overall Study|No implant attempt|17
1186918|NCT02879448|2345373|FG001|Overall Study|No implant attempt|28
1186919|NCT02879448|2345372|FG000|Overall Study|Withdrawal by Subject|20
1186920|NCT02879448|2345373|FG001|Overall Study|Withdrawal by Subject|46
1186921|NCT02879448|2345372|FG000|Overall Study|Death|63
1186922|NCT02879448|2345373|FG001|Overall Study|Death|85
1186923|NCT02879448|2345372|FG000|Overall Study|Lost to Follow-up|3
1186924|NCT02879448|2345373|FG001|Overall Study|Lost to Follow-up|4
1186925|NCT02879448|2345372|FG000|Overall Study|Missing visit|34
1186926|NCT02879448|2345373|FG001|Overall Study|Missing visit|39
1186927|NCT02879448|2345372|FG000|Overall Study|Pending evaluation|1
1186928|NCT02879448|2345373|FG001|Overall Study|Pending evaluation|0
879829|NCT00586326|1843571|FG000|Treated Through 5-yr Follow Up-Treated|Death|2
879830|NCT00586326|1843571|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
879831|NCT00586326|1843571|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
879832|NCT00586326|1843571|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
879833|NCT00586326|1843571|FG000|Treated Through 5-yr Follow Up-Treated|Other|2
879834|NCT00586339|1843582|FG000|Overall Study|Withdrawal by Subject|1
879835|NCT00586339|1843583|FG001|Overall Study|Withdrawal by Subject|3
879836|NCT00586339|1843584|FG002|Overall Study|Withdrawal by Subject|1
879837|NCT00586339|1843582|FG000|Overall Study|Migrated/moved from study area|3
879838|NCT00586339|1843583|FG001|Overall Study|Migrated/moved from study area|2
879839|NCT00586339|1843584|FG002|Overall Study|Migrated/moved from study area|4
879840|NCT00586339|1843582|FG000|Overall Study|Lost to Follow-up|3
879841|NCT00586339|1843583|FG001|Overall Study|Lost to Follow-up|2
879842|NCT00586339|1843584|FG002|Overall Study|Lost to Follow-up|1
879843|NCT00586469|1843594|FG000|Overall Study|Adverse Event|0
879844|NCT00586469|1843595|FG001|Overall Study|Adverse Event|1
879845|NCT00586495|1843610|FG000|Treatment Period|Adverse Event|11
1186929|NCT02873195|2345381|FG000|Overall Study|Ineligible|5
1186930|NCT02873195|2345382|FG001|Overall Study|Ineligible|0
1186952|NCT02821000|2345424|FG000|Overall Study|Death|44
879846|NCT00586495|1843610|FG000|Treatment Period|Death|1
879847|NCT00586495|1843610|FG000|Treatment Period|Protocol Violation|1
879848|NCT00586495|1843610|FG000|Treatment Period|Withdrawal by Subject|1
879849|NCT00586495|1843610|FG000|Treatment Period|Disease progression, recurrence/relapse|71
879850|NCT00586495|1843610|FG000|Treatment Period|Switch to commercial drug|10
879851|NCT00586495|1843610|FG000|Follow-up|Death|40
879852|NCT00586495|1843610|FG000|Follow-up|Lost to Follow-up|1
879853|NCT00586495|1843610|FG000|Follow-up|Withdrawal by Subject|4
879854|NCT00586495|1843610|FG000|Follow-up|Protocol driven decision point|37
879855|NCT00586495|1843610|FG000|Follow-up|Switch to commercial drug|10
879856|NCT00586508|1843616|FG000|Overall Study|Progressive disease|52
879857|NCT00586508|1843617|FG001|Overall Study|Progressive disease|8
879858|NCT00586508|1843616|FG000|Overall Study|Death|0
879859|NCT00586508|1843617|FG001|Overall Study|Death|1
879860|NCT00586508|1843616|FG000|Overall Study|Adverse Event|12
879861|NCT00586508|1843617|FG001|Overall Study|Adverse Event|4
879862|NCT00586508|1843616|FG000|Overall Study|Withdrawal by Subject|4
879863|NCT00586508|1843617|FG001|Overall Study|Withdrawal by Subject|0
879864|NCT00586521|1843623|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
879865|NCT00586612|1843633|FG000|Primary Phase|Protocol Violation|1
879866|NCT00586612|1843634|FG001|Primary Phase|Protocol Violation|0
879867|NCT00586612|1843633|FG000|Primary Phase|Lost to Follow-up|0
879868|NCT00586612|1843634|FG001|Primary Phase|Lost to Follow-up|1
879869|NCT00586612|1843633|FG000|Primary Phase|Withdrawal by Subject|0
879870|NCT00586612|1843634|FG001|Primary Phase|Withdrawal by Subject|2
879871|NCT00586612|1843633|FG000|Booster Phase|Lost to Follow-up|3
879872|NCT00586612|1843634|FG001|Booster Phase|Lost to Follow-up|1
879873|NCT00586625|1843642|FG000|Overall Study|Adverse Event|6
879874|NCT00586625|1843643|FG001|Overall Study|Adverse Event|6
879875|NCT00586625|1843642|FG000|Overall Study|Protocol Violation|3
879876|NCT00586625|1843643|FG001|Overall Study|Protocol Violation|0
879877|NCT00586625|1843642|FG000|Overall Study|Withdrawal by Subject|32
879878|NCT00586625|1843643|FG001|Overall Study|Withdrawal by Subject|10
879879|NCT00586625|1843642|FG000|Overall Study|Subject non-compliance|0
879880|NCT00586625|1843643|FG001|Overall Study|Subject non-compliance|1
879881|NCT00586625|1843642|FG000|Overall Study|Subject unable to return for visit|2
879882|NCT00586625|1843643|FG001|Overall Study|Subject unable to return for visit|0
879883|NCT00586664|1843652|FG000|Overall Study|Withdrawal by Subject|3
879884|NCT00586664|1843653|FG001|Overall Study|Withdrawal by Subject|7
879885|NCT00586664|1843654|FG002|Overall Study|Withdrawal by Subject|1
879886|NCT00586664|1843652|FG000|Overall Study|Exclusion criteria met|2
879887|NCT00586664|1843653|FG001|Overall Study|Exclusion criteria met|0
879888|NCT00586664|1843654|FG002|Overall Study|Exclusion criteria met|0
879889|NCT00586690|1843664|FG000|Overall Study|Death|2
879890|NCT00586690|1843665|FG001|Overall Study|Death|0
879891|NCT00586690|1843664|FG000|Overall Study|Disease Progression|10
879892|NCT00586690|1843665|FG001|Overall Study|Disease Progression|0
879893|NCT00586690|1843664|FG000|Overall Study|Adverse Event|1
879894|NCT00586690|1843665|FG001|Overall Study|Adverse Event|0
879895|NCT00586690|1843664|FG000|Overall Study|Lack of Efficacy|2
879896|NCT00586690|1843665|FG001|Overall Study|Lack of Efficacy|0
879897|NCT00586690|1843664|FG000|Overall Study|Lab can't accommodate|1
879898|NCT00586690|1843665|FG001|Overall Study|Lab can't accommodate|0
879899|NCT00586703|1843670|FG000|Overall Study|Death|12
879900|NCT00586820|1843685|FG000|Overall Study|Unsuccessful PCI|1
879901|NCT00586820|1843686|FG001|Overall Study|Unsuccessful PCI|0
879902|NCT00586846|1843692|FG000|Overall Study|Physician Decision|1
879903|NCT00586846|1843692|FG000|Overall Study|Death|1
879904|NCT00586846|1843692|FG000|Overall Study|Evaluable for Toxicity Only|4
879905|NCT00586898|1843696|FG000|Overall Study|Adverse Event|1
879906|NCT00586898|1843696|FG000|Overall Study|Patiemt Non-compliance|1
879907|NCT00586898|1843696|FG000|Overall Study|Evaluable for Toxicity Only|5
879908|NCT00587054|1843738|FG000|Overall Study|Patient not treated|9
879909|NCT00587158|1843765|FG000|Overall Study|Did not want to do 24 hr urine collect.|4
879910|NCT00587158|1843766|FG001|Overall Study|Did not want to do 24 hr urine collect.|3
879911|NCT00587158|1843765|FG000|Overall Study|Physician Decision|0
879912|NCT00587158|1843766|FG001|Overall Study|Physician Decision|1
879913|NCT00587158|1843765|FG000|Overall Study|Lost to Follow-up|1
1186953|NCT02821000|2345424|FG000|Overall Study|Withdrawal by Subject|1
1186954|NCT02821000|2345424|FG000|Overall Study|Ongoing in Study|58
1186955|NCT02785952|2345430|FG000|Overall Study|Adverse Event|31
1186956|NCT02785952|2345431|FG001|Overall Study|Adverse Event|19
1186957|NCT02785952|2345430|FG000|Overall Study|Refusal unrelated to adverse events|10
1186958|NCT02785952|2345431|FG001|Overall Study|Refusal unrelated to adverse events|5
1186959|NCT02785952|2345430|FG000|Overall Study|Disease progression/relapse|61
1186960|NCT02785952|2345431|FG001|Overall Study|Disease progression/relapse|89
1186961|NCT02785952|2345430|FG000|Overall Study|Death|11
1186962|NCT02785952|2345431|FG001|Overall Study|Death|7
1186963|NCT02785952|2345430|FG000|Overall Study|Other- not protocol specified|6
1186964|NCT02785952|2345431|FG001|Overall Study|Other- not protocol specified|4
1186965|NCT02785952|2345430|FG000|Overall Study|On protocol treatment|6
1186966|NCT02785952|2345431|FG001|Overall Study|On protocol treatment|3
1186967|NCT02748616|2345443|FG000|Overall Study|Lost to Follow-up|1
1186968|NCT02748616|2345443|FG000|Overall Study|Withdrawal by Subject|2
1186969|NCT02748616|2345443|FG000|Overall Study|Physician Decision|2
1186970|NCT02748616|2345443|FG000|Overall Study|Did Not Complete Ursodial Course|2
1186971|NCT02723864|2345454|FG000|Overall Study|Refused further treatment|1
1186972|NCT02723864|2345455|FG001|Overall Study|Refused further treatment|0
1186973|NCT02723864|2345456|FG002|Overall Study|Refused further treatment|0
1186974|NCT02723864|2345457|FG003|Overall Study|Refused further treatment|0
1186975|NCT02723864|2345458|FG004|Overall Study|Refused further treatment|1
879914|NCT00587158|1843766|FG001|Overall Study|Lost to Follow-up|2
879915|NCT00587158|1843765|FG000|Overall Study|Death|0
879916|NCT00587158|1843766|FG001|Overall Study|Death|1
879917|NCT00587158|1843765|FG000|Overall Study|Subject did not want to take study med|0
879918|NCT00587158|1843766|FG001|Overall Study|Subject did not want to take study med|1
879919|NCT00587171|1843774|FG000|Overall Study|Lost to Follow-up|1
879920|NCT00587171|1843775|FG001|Overall Study|Lost to Follow-up|1
879921|NCT00587288|1843783|FG000|Overall Study|Adverse Event|0
879922|NCT00587288|1843784|FG001|Overall Study|Adverse Event|1
879923|NCT00587288|1843783|FG000|Overall Study|Lack of Efficacy|2
879924|NCT00587288|1843784|FG001|Overall Study|Lack of Efficacy|8
879925|NCT00587288|1843783|FG000|Overall Study|Protocol Violation|1
879926|NCT00587288|1843784|FG001|Overall Study|Protocol Violation|0
879927|NCT00587431|1843794|FG000|Overall Study|Adverse Event|1
879928|NCT00587431|1843795|FG001|Overall Study|Adverse Event|0
879929|NCT00587431|1843794|FG000|Overall Study|Withdrawal by Subject|0
879930|NCT00587431|1843795|FG001|Overall Study|Withdrawal by Subject|1
879931|NCT00587457|1843807|FG000|Overall Study|Adverse Event|1
879932|NCT00587457|1843808|FG001|Overall Study|Adverse Event|2
879933|NCT00587457|1843809|FG002|Overall Study|Adverse Event|1
879934|NCT00587457|1843807|FG000|Overall Study|Disease progression|2
879935|NCT00587457|1843808|FG001|Overall Study|Disease progression|0
879936|NCT00587457|1843809|FG002|Overall Study|Disease progression|2
879937|NCT00587457|1843807|FG000|Overall Study|Initiation of alternative therapy|0
879938|NCT00587457|1843808|FG001|Overall Study|Initiation of alternative therapy|1
879939|NCT00587457|1843809|FG002|Overall Study|Initiation of alternative therapy|0
879940|NCT00587457|1843807|FG000|Overall Study|Undefined|0
879941|NCT00587457|1843808|FG001|Overall Study|Undefined|0
879942|NCT00587457|1843809|FG002|Overall Study|Undefined|1
879943|NCT00587457|1843807|FG000|Overall Study|Development of neutralizing Abs|0
879944|NCT00587457|1843808|FG001|Overall Study|Development of neutralizing Abs|0
879945|NCT00587457|1843809|FG002|Overall Study|Development of neutralizing Abs|1
879946|NCT00587587|1843832|FG000|Overall Study|Lost to Follow-up|6
879947|NCT00587587|1843833|FG001|Overall Study|Lost to Follow-up|1
879948|NCT00587639|1843841|FG000|Overall Study|Withdrawal by Subject|1
879949|NCT00587847|1843877|FG000|Overall Study|Lack of Efficacy|5
879950|NCT00587847|1843877|FG000|Overall Study|Adverse Event|2
879951|NCT00587860|1843884|FG000|Overall Study|Lost to Follow-up|2
879952|NCT00587860|1843885|FG001|Overall Study|Lost to Follow-up|2
879953|NCT00587860|1843884|FG000|Overall Study|Withdrawal by Subject|3
879954|NCT00587860|1843885|FG001|Overall Study|Withdrawal by Subject|3
879955|NCT00587964|1843891|FG000|Overall Study|Withdrawal by Subject|1
879956|NCT00587964|1843891|FG000|Overall Study|Lost to Follow-up|1
879957|NCT00587964|1843891|FG000|Overall Study|Patient found to be ineligible|1
879958|NCT00587964|1843891|FG000|Overall Study|Patient did not receive intervention|5
879959|NCT00587964|1843891|FG000|Overall Study|Progression of Disease|4
879960|NCT00587990|1843898|FG000|Overall Study|Death|0
879961|NCT00587990|1843899|FG001|Overall Study|Death|0
879962|NCT00587990|1843900|FG002|Overall Study|Death|1
879963|NCT00588094|1843908|FG000|Overall Study|Adverse Event|3
879964|NCT00588094|1843908|FG000|Overall Study|Progression of Disease|2
879965|NCT00588237|1843921|FG000|Overall Study|Evaluable for toxicity only|3
879966|NCT00588237|1843921|FG000|Overall Study|Patien not treated|1
879967|NCT00588341|1843925|FG000|Overall Study|Withdrawal by Subject|3
879968|NCT00588341|1843925|FG000|Overall Study|Not treated due to metastatic disease|1
879969|NCT00588341|1843925|FG000|Overall Study|Patient ineligible|1
879970|NCT00588354|1843931|FG000|Baseline to 2 Weeks|Adverse Event|1
879971|NCT00588354|1843932|FG001|Baseline to 2 Weeks|Adverse Event|0
879972|NCT00588354|1843931|FG000|Baseline to 2 Weeks|Lack of Efficacy|1
879973|NCT00588354|1843932|FG001|Baseline to 2 Weeks|Lack of Efficacy|0
879974|NCT00588354|1843931|FG000|Baseline to 4 Weeks|Lost to Follow-up|0
1186976|NCT02723864|2345459|FG005|Overall Study|Refused further treatment|2
1186977|NCT02723864|2345460|FG006|Overall Study|Refused further treatment|0
1186978|NCT02723864|2345454|FG000|Overall Study|Exceed treatment hold time|0
1186979|NCT02723864|2345455|FG001|Overall Study|Exceed treatment hold time|1
1186980|NCT02723864|2345456|FG002|Overall Study|Exceed treatment hold time|0
1186981|NCT02723864|2345457|FG003|Overall Study|Exceed treatment hold time|0
1186982|NCT02723864|2345458|FG004|Overall Study|Exceed treatment hold time|0
1186983|NCT02723864|2345459|FG005|Overall Study|Exceed treatment hold time|0
1186984|NCT02723864|2345460|FG006|Overall Study|Exceed treatment hold time|0
1186985|NCT02723864|2345454|FG000|Overall Study|Clinical progression|0
1186986|NCT02723864|2345455|FG001|Overall Study|Clinical progression|0
1186987|NCT02723864|2345456|FG002|Overall Study|Clinical progression|1
1186988|NCT02723864|2345457|FG003|Overall Study|Clinical progression|0
1186989|NCT02723864|2345458|FG004|Overall Study|Clinical progression|0
1186990|NCT02723864|2345459|FG005|Overall Study|Clinical progression|3
1186991|NCT02723864|2345460|FG006|Overall Study|Clinical progression|1
1186992|NCT02723864|2345454|FG000|Overall Study|Physician Decision|0
1186993|NCT02723864|2345455|FG001|Overall Study|Physician Decision|0
1186994|NCT02723864|2345456|FG002|Overall Study|Physician Decision|0
1186995|NCT02723864|2345457|FG003|Overall Study|Physician Decision|0
1186996|NCT02723864|2345458|FG004|Overall Study|Physician Decision|0
1186997|NCT02723864|2345459|FG005|Overall Study|Physician Decision|0
1186998|NCT02723864|2345460|FG006|Overall Study|Physician Decision|1
1186999|NCT02723864|2345454|FG000|Overall Study|Changes in patient condition|0
1187000|NCT02723864|2345455|FG001|Overall Study|Changes in patient condition|0
1187001|NCT02723864|2345456|FG002|Overall Study|Changes in patient condition|0
1187002|NCT02723864|2345457|FG003|Overall Study|Changes in patient condition|0
1187003|NCT02723864|2345458|FG004|Overall Study|Changes in patient condition|0
1187004|NCT02723864|2345459|FG005|Overall Study|Changes in patient condition|1
1187005|NCT02723864|2345460|FG006|Overall Study|Changes in patient condition|0
1187006|NCT02723864|2345454|FG000|Overall Study|Patient choice|0
1187007|NCT02723864|2345455|FG001|Overall Study|Patient choice|0
879975|NCT00588354|1843932|FG001|Baseline to 4 Weeks|Lost to Follow-up|1
879976|NCT00588445|1843953|FG000|Overall Study|Protocol Violation|1
879977|NCT00588445|1843953|FG000|Overall Study|Withdrawal by Subject|3
879978|NCT00588445|1843953|FG000|Overall Study|Disease Progression|1
879979|NCT00588445|1843953|FG000|Overall Study|Not Treated|10
879980|NCT00588640|1843963|FG000|Overall Study|Physician Decision|1
879981|NCT00588640|1843963|FG000|Overall Study|Ineligible Patient|1
879982|NCT00588666|1843967|FG000|Overall Study|Adverse Event|4
879983|NCT00588692|1843973|FG000|Overall Study|Withdrawal by Subject|4
879984|NCT00588692|1843974|FG001|Overall Study|Withdrawal by Subject|2
879985|NCT00588692|1843973|FG000|Overall Study|Hip Surgery|0
879986|NCT00588692|1843974|FG001|Overall Study|Hip Surgery|1
879987|NCT00588692|1843973|FG000|Overall Study|Severe Peptic Ulcer Disease|1
879988|NCT00588692|1843974|FG001|Overall Study|Severe Peptic Ulcer Disease|0
879989|NCT00588692|1843973|FG000|Overall Study|Cancer|1
879990|NCT00588692|1843974|FG001|Overall Study|Cancer|0
879991|NCT00588692|1843973|FG000|Overall Study|Death|1
879992|NCT00588692|1843974|FG001|Overall Study|Death|0
879993|NCT00588731|1843984|FG000|Overall Study|Withdrawal by Subject|3
879994|NCT00588731|1843985|FG001|Overall Study|Withdrawal by Subject|2
880015|NCT00588822|1844004|FG000|Overall Study|progression of disease|8
880016|NCT00588848|1844010|FG000|Overall Study|Physician Decision|0
880017|NCT00588848|1844011|FG001|Overall Study|Physician Decision|3
880018|NCT00588952|1844034|FG000|Overall Study|Adverse Event|0
880019|NCT00588952|1844035|FG001|Overall Study|Adverse Event|2
880020|NCT00588952|1844034|FG000|Overall Study|Withdrawal by Subject|3
880021|NCT00588952|1844035|FG001|Overall Study|Withdrawal by Subject|5
880022|NCT00589108|1844054|FG000|Overall Study|Lost to Follow-up|1
880023|NCT00589108|1844055|FG001|Overall Study|Lost to Follow-up|1
1187008|NCT02723864|2345456|FG002|Overall Study|Patient choice|0
1187009|NCT02723864|2345457|FG003|Overall Study|Patient choice|0
1187010|NCT02723864|2345458|FG004|Overall Study|Patient choice|0
1187011|NCT02723864|2345459|FG005|Overall Study|Patient choice|1
1187012|NCT02723864|2345460|FG006|Overall Study|Patient choice|0
1187013|NCT02723864|2345454|FG000|Overall Study|Adverse Event|0
1187014|NCT02723864|2345455|FG001|Overall Study|Adverse Event|0
1187015|NCT02723864|2345456|FG002|Overall Study|Adverse Event|0
1187016|NCT02723864|2345457|FG003|Overall Study|Adverse Event|0
1187017|NCT02723864|2345458|FG004|Overall Study|Adverse Event|0
1187018|NCT02723864|2345459|FG005|Overall Study|Adverse Event|1
1187019|NCT02723864|2345460|FG006|Overall Study|Adverse Event|0
1187020|NCT02723864|2345454|FG000|Overall Study|Started new treatment|0
1187021|NCT02723864|2345455|FG001|Overall Study|Started new treatment|0
1187022|NCT02723864|2345456|FG002|Overall Study|Started new treatment|0
1187023|NCT02723864|2345457|FG003|Overall Study|Started new treatment|0
1187024|NCT02723864|2345458|FG004|Overall Study|Started new treatment|0
1187025|NCT02723864|2345459|FG005|Overall Study|Started new treatment|1
1187026|NCT02723864|2345460|FG006|Overall Study|Started new treatment|0
1187027|NCT02723864|2345454|FG000|Overall Study|Switched to alternative treatment|0
1187028|NCT02723864|2345455|FG001|Overall Study|Switched to alternative treatment|0
1187029|NCT02723864|2345456|FG002|Overall Study|Switched to alternative treatment|0
1187030|NCT02723864|2345457|FG003|Overall Study|Switched to alternative treatment|0
1187031|NCT02723864|2345458|FG004|Overall Study|Switched to alternative treatment|0
1187032|NCT02723864|2345459|FG005|Overall Study|Switched to alternative treatment|1
1187033|NCT02723864|2345460|FG006|Overall Study|Switched to alternative treatment|0
1187034|NCT02723864|2345454|FG000|Overall Study|Late determination of ineligibility|0
1187035|NCT02723864|2345455|FG001|Overall Study|Late determination of ineligibility|0
1187036|NCT02723864|2345456|FG002|Overall Study|Late determination of ineligibility|0
1187037|NCT02723864|2345457|FG003|Overall Study|Late determination of ineligibility|0
1187038|NCT02723864|2345458|FG004|Overall Study|Late determination of ineligibility|0
1187039|NCT02723864|2345459|FG005|Overall Study|Late determination of ineligibility|1
1187040|NCT02723864|2345460|FG006|Overall Study|Late determination of ineligibility|0
1187041|NCT02719522|2345497|FG000|Overall Study|Implant Failure|4
1187042|NCT02719522|2345497|FG000|Overall Study|Death|2
1187043|NCT02719522|2345497|FG000|Overall Study|Lost to Follow-up|5
1187044|NCT02586025|2345518|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1
1187045|NCT02586025|2345519|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0
1187046|NCT02586025|2345518|FG000|Neoadjuvant Treatment|Death|1
1187047|NCT02586025|2345519|FG001|Neoadjuvant Treatment|Death|0
1187048|NCT02586025|2345518|FG000|Neoadjuvant Treatment|Adverse Event|1
1187049|NCT02586025|2345519|FG001|Neoadjuvant Treatment|Adverse Event|0
1187050|NCT02586025|2345518|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4
1187051|NCT02586025|2345519|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3
1187052|NCT02586025|2345518|FG000|Neoadjuvant Treatment|Physician Decision|2
1187053|NCT02586025|2345519|FG001|Neoadjuvant Treatment|Physician Decision|1
1187054|NCT02586025|2345518|FG000|Neoadjuvant Treatment|Progressive Disease|2
1187055|NCT02586025|2345519|FG001|Neoadjuvant Treatment|Progressive Disease|3
1187056|NCT02586025|2345518|FG000|Adjuvant Treatment|Remain in Adjuvant Treatment|133
1187057|NCT02586025|2345519|FG001|Adjuvant Treatment|Remain in Adjuvant Treatment|61
1187058|NCT02586025|2345518|FG000|Adjuvant Treatment|Withdrawal by Subject|5
1187059|NCT02586025|2345519|FG001|Adjuvant Treatment|Withdrawal by Subject|3
1187060|NCT02586025|2345518|FG000|Adjuvant Treatment|Physician Decision|0
1187061|NCT02586025|2345519|FG001|Adjuvant Treatment|Physician Decision|1
1187062|NCT02586025|2345518|FG000|Adjuvant Treatment|Recurrent Disease|1
1187063|NCT02586025|2345519|FG001|Adjuvant Treatment|Recurrent Disease|4
1187064|NCT02586025|2345518|FG000|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
1187065|NCT02586025|2345519|FG001|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
1187066|NCT02585232|2345527|FG000|Overall Study|Lost to Follow-up|8
1187067|NCT02585232|2345528|FG001|Overall Study|Lost to Follow-up|8
1187068|NCT02585232|2345527|FG000|Overall Study|Withdrawal by Subject|4
1187069|NCT02585232|2345528|FG001|Overall Study|Withdrawal by Subject|8
1187070|NCT02583269|2345539|FG000|Overall Study|Patient hospitalized prior to start|1
1187071|NCT02583269|2345540|FG001|Overall Study|Patient hospitalized prior to start|0
1187072|NCT02583269|2345541|FG002|Overall Study|Patient hospitalized prior to start|0
1187073|NCT02583269|2345542|FG003|Overall Study|Patient hospitalized prior to start|0
1187074|NCT02583269|2345543|FG004|Overall Study|Patient hospitalized prior to start|0
1187075|NCT02579096|2345558|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10
1187076|NCT02579096|2345559|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6
1187077|NCT02579096|2345558|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2
1187078|NCT02579096|2345559|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1
1187079|NCT02579096|2345558|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32
1187080|NCT02579096|2345559|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36
1187081|NCT02579096|2345558|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9
1187082|NCT02579096|2345559|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4
1187083|NCT02579096|2345558|FG000|Phase 1, Weeks 0 - 24|Other reasons|4
1187084|NCT02579096|2345559|FG001|Phase 1, Weeks 0 - 24|Other reasons|3
1187085|NCT02579096|2345558|FG000|Phase 2, Weeks 25 - 48|Death|2
1187086|NCT02579096|2345559|FG001|Phase 2, Weeks 25 - 48|Death|4
1187087|NCT02579096|2345558|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3
1187088|NCT02579096|2345559|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1
1187089|NCT02579096|2345558|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4
1187090|NCT02579096|2345559|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0
1187091|NCT02579096|2345558|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9
1187092|NCT02579096|2345559|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12
1187093|NCT02579096|2345558|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4
1187094|NCT02579096|2345559|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9
1187095|NCT02579096|2345558|FG000|Phase 2, Weeks 25 - 48|Other reasons|0
1187096|NCT02579096|2345559|FG001|Phase 2, Weeks 25 - 48|Other reasons|5
1187097|NCT02579096|2345558|FG000|Phase 3, Weeks 49 - 72|Death|3
1187098|NCT02579096|2345559|FG001|Phase 3, Weeks 49 - 72|Death|2
1187099|NCT02579096|2345558|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0
1187100|NCT02579096|2345559|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1
1187101|NCT02579096|2345558|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0
1187102|NCT02579096|2345559|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5
1187103|NCT02579096|2345558|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6
1187104|NCT02579096|2345559|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4
1187105|NCT02579096|2345558|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10
1187106|NCT02579096|2345559|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5
1187107|NCT02579096|2345558|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0
1187108|NCT02579096|2345559|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1
1187109|NCT02579096|2345558|FG000|Phase 3, Weeks 49 - 72|Other reasons|3
1187110|NCT02579096|2345559|FG001|Phase 3, Weeks 49 - 72|Other reasons|0
1187111|NCT02562235|2345565|FG000|Overall Study|Adverse Event|3
1187112|NCT02545283|2345597|FG000|Overall Study|Lost to Follow-up|2
1187113|NCT02545283|2345598|FG001|Overall Study|Lost to Follow-up|4
1187114|NCT02545283|2345597|FG000|Overall Study|Withdrawal by Subject|5
1187115|NCT02545283|2345598|FG001|Overall Study|Withdrawal by Subject|9
1187116|NCT02545283|2345597|FG000|Overall Study|Death|109
1187117|NCT02545283|2345598|FG001|Overall Study|Death|211
1187118|NCT02545283|2345597|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0
1187119|NCT02545283|2345598|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3
1187120|NCT02545283|2345597|FG000|Overall Study|Study Terminated By Sponsor|33
1187121|NCT02545283|2345598|FG001|Overall Study|Study Terminated By Sponsor|71
1187122|NCT02524171|2345621|FG000|6-month Follow-up|Lost to Follow-up|53
1187123|NCT02524171|2345622|FG001|6-month Follow-up|Lost to Follow-up|45
1187124|NCT02524171|2345621|FG000|12-month Follow-up Interview|Lost to Follow-up|45
1187125|NCT02524171|2345622|FG001|12-month Follow-up Interview|Lost to Follow-up|41
1187126|NCT02476968|2345662|FG000|Overall Study|Other|0
1187127|NCT02476968|2345663|FG001|Overall Study|Other|2
1187128|NCT02476968|2345664|FG002|Overall Study|Other|0
1187129|NCT02476968|2345662|FG000|Overall Study|Lost to Follow-up|10
1187130|NCT02476968|2345663|FG001|Overall Study|Lost to Follow-up|0
1187131|NCT02476968|2345664|FG002|Overall Study|Lost to Follow-up|1
1187132|NCT02476968|2345662|FG000|Overall Study|Death|34
1187133|NCT02476968|2345663|FG001|Overall Study|Death|6
1187134|NCT02476968|2345664|FG002|Overall Study|Death|0
1187135|NCT02476968|2345662|FG000|Overall Study|Eligibility criteria not fulfilled|0
1187136|NCT02476968|2345663|FG001|Overall Study|Eligibility criteria not fulfilled|0
1187137|NCT02476968|2345664|FG002|Overall Study|Eligibility criteria not fulfilled|1
880024|NCT00589108|1844056|FG002|Overall Study|Lost to Follow-up|1
880025|NCT00589108|1844054|FG000|Overall Study|Death|3
880026|NCT00589108|1844055|FG001|Overall Study|Death|3
880027|NCT00589108|1844056|FG002|Overall Study|Death|4
880028|NCT00589121|1844066|FG000|Overall Study|Protocol Violation|2
880029|NCT00589121|1844067|FG001|Overall Study|Protocol Violation|6
880030|NCT00589121|1844066|FG000|Overall Study|No protocol treatment received|0
880031|NCT00589121|1844067|FG001|Overall Study|No protocol treatment received|1
880032|NCT00589290|1844085|FG000|Overall Study|Withdrawal by Subject|1
880033|NCT00589303|1844093|FG000|Overall Study|Withdrawal by Subject|2
880034|NCT00589303|1844094|FG001|Overall Study|Withdrawal by Subject|1
880035|NCT00589472|1844110|FG000|Overall Study|Adverse Event|1
880036|NCT00589602|1844118|FG000|Overall Study|Did not collect enough CD34+ cells|1
880037|NCT00589628|1844126|FG000|Overall Study|Lost to Follow-up|0
880038|NCT00589628|1844127|FG001|Overall Study|Lost to Follow-up|1
880039|NCT00589667|1844133|FG000|Overall Study|Adverse Event|2
880040|NCT00589667|1844133|FG000|Overall Study|Withdrawal by Subject|1
880041|NCT00589693|1844139|FG000|Overall Study|randomized in error|12
880042|NCT00589693|1844140|FG001|Overall Study|randomized in error|6
880043|NCT00589693|1844139|FG000|Overall Study|Adverse Event|4
880044|NCT00589693|1844140|FG001|Overall Study|Adverse Event|4
880045|NCT00589693|1844139|FG000|Overall Study|Death|26
880046|NCT00589693|1844140|FG001|Overall Study|Death|16
880047|NCT00589693|1844139|FG000|Overall Study|Lack of Efficacy|0
880048|NCT00589693|1844140|FG001|Overall Study|Lack of Efficacy|1
880049|NCT00589693|1844139|FG000|Overall Study|Lost to Follow-up|1
880050|NCT00589693|1844140|FG001|Overall Study|Lost to Follow-up|0
880051|NCT00589693|1844139|FG000|Overall Study|Physician Decision|0
1187138|NCT02476968|2345662|FG000|Overall Study|Patient decision|30
1187139|NCT02476968|2345663|FG001|Overall Study|Patient decision|7
1187140|NCT02476968|2345664|FG002|Overall Study|Patient decision|0
1187141|NCT02367040|2345676|FG000|Overall Study|Lost to Follow-up|1
1187142|NCT02367040|2345677|FG001|Overall Study|Lost to Follow-up|1
1187143|NCT02367040|2345676|FG000|Overall Study|Lack of Efficacy|1
1187144|NCT02367040|2345677|FG001|Overall Study|Lack of Efficacy|0
1187145|NCT02367040|2345676|FG000|Overall Study|Additional primary malignancy|0
1187146|NCT02367040|2345677|FG001|Overall Study|Additional primary malignancy|1
1187147|NCT02367040|2345676|FG000|Overall Study|AE not associated with clinical disease progression|104
1187148|NCT02367040|2345677|FG001|Overall Study|AE not associated with clinical disease progression|9
1187149|NCT02367040|2345676|FG000|Overall Study|AE associated with clinical disease progression|1
1187150|NCT02367040|2345677|FG001|Overall Study|AE associated with clinical disease progression|3
880052|NCT00589693|1844140|FG001|Overall Study|Physician Decision|1
880053|NCT00589693|1844139|FG000|Overall Study|Protocol Violation|1
880054|NCT00589693|1844140|FG001|Overall Study|Protocol Violation|1
880055|NCT00589784|1844148|FG000|Overall Study|Withdrawal by Subject|0
880056|NCT00589784|1844149|FG001|Overall Study|Withdrawal by Subject|6
880057|NCT00589784|1844148|FG000|Overall Study|Patient inevaluable|1
880058|NCT00589784|1844149|FG001|Overall Study|Patient inevaluable|0
880059|NCT00589784|1844148|FG000|Overall Study|Adverse Event|0
880060|NCT00589784|1844149|FG001|Overall Study|Adverse Event|4
880061|NCT00589797|1844156|FG000|Overall Study|Death|1
880062|NCT00589797|1844157|FG001|Overall Study|Death|0
880063|NCT00589797|1844156|FG000|Overall Study|Lost to Follow-up|12
880064|NCT00589797|1844157|FG001|Overall Study|Lost to Follow-up|9
880065|NCT00589797|1844156|FG000|Overall Study|Physician Decision|8
880066|NCT00589797|1844157|FG001|Overall Study|Physician Decision|3
880067|NCT00589797|1844156|FG000|Overall Study|Withdrawal by Subject|6
880068|NCT00589797|1844157|FG001|Overall Study|Withdrawal by Subject|5
880069|NCT00589797|1844156|FG000|Overall Study|Non-Randomized Training Subjects|46
880070|NCT00589797|1844157|FG001|Overall Study|Non-Randomized Training Subjects|6
880071|NCT00589914|1844194|FG000|Overall Study|Adverse Event|19
880072|NCT00589914|1844195|FG001|Overall Study|Adverse Event|10
880073|NCT00589914|1844194|FG000|Overall Study|Death|2
880074|NCT00589914|1844195|FG001|Overall Study|Death|0
880075|NCT00589914|1844194|FG000|Overall Study|Lack of Efficacy|40
880076|NCT00589914|1844195|FG001|Overall Study|Lack of Efficacy|43
880077|NCT00589914|1844194|FG000|Overall Study|Lost to Follow-up|11
880078|NCT00589914|1844195|FG001|Overall Study|Lost to Follow-up|18
880079|NCT00589914|1844194|FG000|Overall Study|Pregnancy|1
880080|NCT00589914|1844195|FG001|Overall Study|Pregnancy|0
880081|NCT00589914|1844194|FG000|Overall Study|Withdrawal by Subject|55
880082|NCT00589914|1844195|FG001|Overall Study|Withdrawal by Subject|49
880083|NCT00589914|1844194|FG000|Overall Study|Other|22
880084|NCT00589914|1844195|FG001|Overall Study|Other|17
880085|NCT00589979|1844203|FG000|Run-In Period|Adverse Event|5
880086|NCT00589979|1844204|FG001|Run-In Period|Adverse Event|0
880087|NCT00589979|1844205|FG002|Run-In Period|Adverse Event|0
880088|NCT00589979|1844203|FG000|Run-In Period|Protocol Violation|3
880089|NCT00589979|1844204|FG001|Run-In Period|Protocol Violation|0
880090|NCT00589979|1844205|FG002|Run-In Period|Protocol Violation|0
880091|NCT00589979|1844203|FG000|Run-In Period|Did not qualify for randomization|54
880092|NCT00589979|1844204|FG001|Run-In Period|Did not qualify for randomization|0
880093|NCT00589979|1844205|FG002|Run-In Period|Did not qualify for randomization|0
880094|NCT00589979|1844203|FG000|Run-In Period|Withdrawal by Subject|10
880095|NCT00589979|1844204|FG001|Run-In Period|Withdrawal by Subject|0
880096|NCT00589979|1844205|FG002|Run-In Period|Withdrawal by Subject|0
880097|NCT00589979|1844203|FG000|Run-In Period|Informed Consent Withdrawn|4
880098|NCT00589979|1844204|FG001|Run-In Period|Informed Consent Withdrawn|0
880099|NCT00589979|1844205|FG002|Run-In Period|Informed Consent Withdrawn|0
880100|NCT00589979|1844203|FG000|Double-Blind Treatment Period 1|Adverse Event|0
880101|NCT00589979|1844204|FG001|Double-Blind Treatment Period 1|Adverse Event|1
880102|NCT00589979|1844205|FG002|Double-Blind Treatment Period 1|Adverse Event|0
880103|NCT00589979|1844203|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
880104|NCT00589979|1844204|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
880105|NCT00589979|1844205|FG002|Double-Blind Treatment Period 1|Protocol Violation|1
880106|NCT00589979|1844203|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
880107|NCT00589979|1844204|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0
880108|NCT00589979|1844205|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1
880109|NCT00589979|1844203|FG000|Double-Blind Treatment Period 2|Adverse Event|0
880110|NCT00589979|1844204|FG001|Double-Blind Treatment Period 2|Adverse Event|1
880111|NCT00589979|1844205|FG002|Double-Blind Treatment Period 2|Adverse Event|0
880112|NCT00589979|1844203|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
880113|NCT00589979|1844204|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0
880114|NCT00589979|1844205|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1
880115|NCT00589979|1844203|FG000|Double-Blind Treatment Period 2|Other|0
880116|NCT00589979|1844204|FG001|Double-Blind Treatment Period 2|Other|0
880117|NCT00589979|1844205|FG002|Double-Blind Treatment Period 2|Other|1
880118|NCT00589979|1844203|FG000|Double-Blind Treatment Period 3|Protocol Violation|0
880119|NCT00589979|1844204|FG001|Double-Blind Treatment Period 3|Protocol Violation|1
880120|NCT00589979|1844205|FG002|Double-Blind Treatment Period 3|Protocol Violation|0
880121|NCT00589979|1844203|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0
880122|NCT00589979|1844204|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0
1187151|NCT02367040|2345676|FG000|Overall Study|Physician Decision|2
1187152|NCT02367040|2345677|FG001|Overall Study|Physician Decision|8
1187153|NCT02367040|2345676|FG000|Overall Study|Non-compliance with study drug|1
1187154|NCT02367040|2345677|FG001|Overall Study|Non-compliance with study drug|0
1187155|NCT02367040|2345676|FG000|Overall Study|Failure to meet continuation criteria|1
1187156|NCT02367040|2345677|FG001|Overall Study|Failure to meet continuation criteria|0
1187157|NCT02367040|2345676|FG000|Overall Study|Switching to other therapy|2
1187158|NCT02367040|2345677|FG001|Overall Study|Switching to other therapy|0
1187159|NCT02367040|2345676|FG000|Overall Study|Withdrawal by Subject|41
1187160|NCT02367040|2345677|FG001|Overall Study|Withdrawal by Subject|14
1187161|NCT02367040|2345676|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1
1187162|NCT02367040|2345677|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0
1187163|NCT02367040|2345676|FG000|Overall Study|Patient decision|35
1187164|NCT02367040|2345677|FG001|Overall Study|Patient decision|11
1187165|NCT02367040|2345676|FG000|Overall Study|Required procedure failed|1
1187166|NCT02367040|2345677|FG001|Overall Study|Required procedure failed|0
1187167|NCT02367040|2345676|FG000|Overall Study|Randomized by mistake with study treatment|1
1187168|NCT02367040|2345677|FG001|Overall Study|Randomized by mistake with study treatment|0
1187169|NCT02367040|2345676|FG000|Overall Study|Protocol Violation|1
1187170|NCT02367040|2345677|FG001|Overall Study|Protocol Violation|0
1187171|NCT02367040|2345676|FG000|Overall Study|Progressive disease - radiological progression|39
1187172|NCT02367040|2345677|FG001|Overall Study|Progressive disease - radiological progression|67
880123|NCT00589979|1844205|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1
880124|NCT00590031|1844233|FG000|Overall Study|Adverse Event|3
880125|NCT00590031|1844233|FG000|Overall Study|Withdrawal by Subject|1
880126|NCT00590031|1844233|FG000|Overall Study|Metastatic Disease|1
880127|NCT00590031|1844233|FG000|Overall Study|Admin Hold|1
880128|NCT00590044|1844239|FG000|Overall Study|Withdrawal by Subject|2
880129|NCT00590044|1844240|FG001|Overall Study|Withdrawal by Subject|2
880130|NCT00590044|1844239|FG000|Overall Study|wrong insulin arm assigned|1
880131|NCT00590044|1844240|FG001|Overall Study|wrong insulin arm assigned|0
880132|NCT00590044|1844239|FG000|Overall Study|Protocol Violation|1
880133|NCT00590044|1844240|FG001|Overall Study|Protocol Violation|0
880134|NCT00590317|1844269|FG000|Overall Study|Lack of Efficacy|1
880135|NCT00590317|1844270|FG001|Overall Study|Lack of Efficacy|5
880136|NCT00590564|1844298|FG000|Overall Study|Withdrawal by Subject|4
880137|NCT00590564|1844298|FG000|Overall Study|Lost to Follow-up|6
880138|NCT00590564|1844298|FG000|Overall Study|Protocol Violation|1
880139|NCT00590564|1844298|FG000|Overall Study|Patient Found to be Ineligible|1
880140|NCT00590564|1844298|FG000|Overall Study|Patient Non-compliance|6
880141|NCT00590577|1844306|FG000|Overall Study|Lack of Efficacy|31
880142|NCT00590577|1844307|FG001|Overall Study|Lack of Efficacy|28
880143|NCT00590577|1844308|FG002|Overall Study|Lack of Efficacy|23
880144|NCT00590577|1844309|FG003|Overall Study|Lack of Efficacy|45
880145|NCT00590577|1844306|FG000|Overall Study|Withdrawal by Subject|23
880146|NCT00590577|1844307|FG001|Overall Study|Withdrawal by Subject|28
880147|NCT00590577|1844308|FG002|Overall Study|Withdrawal by Subject|30
880148|NCT00590577|1844309|FG003|Overall Study|Withdrawal by Subject|26
880149|NCT00590577|1844306|FG000|Overall Study|Adverse Event|10
880150|NCT00590577|1844307|FG001|Overall Study|Adverse Event|10
880151|NCT00590577|1844308|FG002|Overall Study|Adverse Event|13
880152|NCT00590577|1844309|FG003|Overall Study|Adverse Event|11
880153|NCT00590577|1844306|FG000|Overall Study|Lost to Follow-up|12
880154|NCT00590577|1844307|FG001|Overall Study|Lost to Follow-up|6
880155|NCT00590577|1844308|FG002|Overall Study|Lost to Follow-up|6
880156|NCT00590577|1844309|FG003|Overall Study|Lost to Follow-up|9
880157|NCT00590577|1844306|FG000|Overall Study|Pregnancy|0
880158|NCT00590577|1844307|FG001|Overall Study|Pregnancy|1
880159|NCT00590577|1844308|FG002|Overall Study|Pregnancy|0
880160|NCT00590577|1844309|FG003|Overall Study|Pregnancy|0
880161|NCT00590577|1844306|FG000|Overall Study|Various reasons|1
880162|NCT00590577|1844307|FG001|Overall Study|Various reasons|3
880163|NCT00590577|1844308|FG002|Overall Study|Various reasons|1
880164|NCT00590577|1844309|FG003|Overall Study|Various reasons|2
880165|NCT00590590|1844322|FG000|Overall Study|Lack of Efficacy|1
880166|NCT00590590|1844323|FG001|Overall Study|Lack of Efficacy|2
880167|NCT00590590|1844324|FG002|Overall Study|Lack of Efficacy|0
880168|NCT00590590|1844322|FG000|Overall Study|Adverse Event|1
880169|NCT00590590|1844323|FG001|Overall Study|Adverse Event|0
880170|NCT00590590|1844324|FG002|Overall Study|Adverse Event|0
880171|NCT00590590|1844322|FG000|Overall Study|Protocol Violation|0
880172|NCT00590590|1844323|FG001|Overall Study|Protocol Violation|0
880173|NCT00590590|1844324|FG002|Overall Study|Protocol Violation|2
880174|NCT00590590|1844322|FG000|Overall Study|Lost to Follow-up|4
880175|NCT00590590|1844323|FG001|Overall Study|Lost to Follow-up|1
880176|NCT00590590|1844324|FG002|Overall Study|Lost to Follow-up|2
880177|NCT00590590|1844322|FG000|Overall Study|Withdrawal by Subject|0
880178|NCT00590590|1844323|FG001|Overall Study|Withdrawal by Subject|1
880179|NCT00590590|1844324|FG002|Overall Study|Withdrawal by Subject|1
880180|NCT00590590|1844322|FG000|Overall Study|Did not complete due to study closure|1
880181|NCT00590590|1844323|FG001|Overall Study|Did not complete due to study closure|1
880182|NCT00590590|1844324|FG002|Overall Study|Did not complete due to study closure|1
880183|NCT00590590|1844322|FG000|Overall Study|Did not complete study|0
1187173|NCT02367040|2345676|FG000|Overall Study|Progressive disease - clinical progression|2
1187174|NCT02367040|2345677|FG001|Overall Study|Progressive disease - clinical progression|6
1187175|NCT02367040|2345676|FG000|Overall Study|Drug not administered|3
1187176|NCT02367040|2345677|FG001|Overall Study|Drug not administered|2
880184|NCT00590590|1844323|FG001|Overall Study|Did not complete study|1
880185|NCT00590590|1844324|FG002|Overall Study|Did not complete study|0
880186|NCT00590681|1844332|FG000|Overall Study|Withdrawal by Subject|7
880187|NCT00590681|1844332|FG000|Overall Study|Adverse Event|8
880188|NCT00590681|1844332|FG000|Overall Study|Death|3
880189|NCT00590681|1844332|FG000|Overall Study|Lost to Follow-up|1
880190|NCT00590681|1844332|FG000|Overall Study|disease progression|1
880191|NCT00590720|1844347|FG000|Overall Study|Lost to Follow-up|1
880192|NCT00590720|1844348|FG001|Overall Study|Lost to Follow-up|0
880193|NCT00590720|1844347|FG000|Overall Study|Withdrawal by Subject|0
880194|NCT00590720|1844348|FG001|Overall Study|Withdrawal by Subject|1
880195|NCT00590759|1844354|FG000|Overall Study|Death|52
880196|NCT00590759|1844354|FG000|Overall Study|Lost to Follow-up|28
880197|NCT00590824|1844368|FG000|Overall Study|Disease could not be resected|0
880198|NCT00590824|1844369|FG001|Overall Study|Disease could not be resected|2
880199|NCT00590824|1844370|FG002|Overall Study|Disease could not be resected|1
880200|NCT00590824|1844371|FG003|Overall Study|Disease could not be resected|0
880201|NCT00590824|1844368|FG000|Overall Study|Adverse Event|0
880202|NCT00590824|1844369|FG001|Overall Study|Adverse Event|0
880203|NCT00590824|1844370|FG002|Overall Study|Adverse Event|0
880204|NCT00590824|1844371|FG003|Overall Study|Adverse Event|1
880205|NCT00590902|1844404|FG000|Overall Study|Death|1
880206|NCT00590954|1844408|FG000|Overall Study|Inevaluable|2
880207|NCT00590967|1844416|FG000|Overall Study|Withdrawal by Subject|1
880208|NCT00590967|1844417|FG001|Overall Study|Withdrawal by Subject|1
880209|NCT00590967|1844416|FG000|Overall Study|Ineligible|1
880210|NCT00590967|1844417|FG001|Overall Study|Ineligible|0
880211|NCT00590967|1844416|FG000|Overall Study|Poor performance status|0
880212|NCT00590967|1844417|FG001|Overall Study|Poor performance status|1
880213|NCT00590967|1844416|FG000|Overall Study|Non-compliant|0
880214|NCT00590967|1844417|FG001|Overall Study|Non-compliant|2
880215|NCT00590967|1844416|FG000|Overall Study|Did not sign consent form|0
880216|NCT00590967|1844417|FG001|Overall Study|Did not sign consent form|1
880217|NCT00590967|1844416|FG000|Overall Study|Did not receive chemo per protocol|1
880218|NCT00590967|1844417|FG001|Overall Study|Did not receive chemo per protocol|0
880219|NCT00590980|1844423|FG000|Overall Study|Did not meet all inclusion criteria|10
880220|NCT00591006|1844427|FG000|Overall Study|Withdrawal by Subject|0
880221|NCT00591006|1844428|FG001|Overall Study|Withdrawal by Subject|0
880222|NCT00591006|1844429|FG002|Overall Study|Withdrawal by Subject|0
880223|NCT00591006|1844430|FG003|Overall Study|Withdrawal by Subject|0
880224|NCT00591006|1844431|FG004|Overall Study|Withdrawal by Subject|0
880225|NCT00591006|1844432|FG005|Overall Study|Withdrawal by Subject|0
880226|NCT00591006|1844433|FG006|Overall Study|Withdrawal by Subject|0
880227|NCT00591006|1844434|FG007|Overall Study|Withdrawal by Subject|0
880228|NCT00591006|1844435|FG008|Overall Study|Withdrawal by Subject|0
880229|NCT00591006|1844436|FG009|Overall Study|Withdrawal by Subject|0
880230|NCT00591006|1844437|FG010|Overall Study|Withdrawal by Subject|0
880231|NCT00591006|1844438|FG011|Overall Study|Withdrawal by Subject|0
880232|NCT00591006|1844439|FG012|Overall Study|Withdrawal by Subject|0
880233|NCT00591006|1844440|FG013|Overall Study|Withdrawal by Subject|0
880234|NCT00591006|1844441|FG014|Overall Study|Withdrawal by Subject|0
880235|NCT00591006|1844442|FG015|Overall Study|Withdrawal by Subject|1
880236|NCT00591006|1844443|FG016|Overall Study|Withdrawal by Subject|0
880237|NCT00591006|1844444|FG017|Overall Study|Withdrawal by Subject|0
880238|NCT00591006|1844445|FG018|Overall Study|Withdrawal by Subject|0
880239|NCT00591006|1844446|FG019|Overall Study|Withdrawal by Subject|0
880240|NCT00591006|1844447|FG020|Overall Study|Withdrawal by Subject|0
880241|NCT00591006|1844448|FG021|Overall Study|Withdrawal by Subject|0
880242|NCT00591006|1844449|FG022|Overall Study|Withdrawal by Subject|0
880243|NCT00591006|1844450|FG023|Overall Study|Withdrawal by Subject|1
880244|NCT00591006|1844427|FG000|Overall Study|Adverse Event|0
880245|NCT00591006|1844428|FG001|Overall Study|Adverse Event|0
880246|NCT00591006|1844429|FG002|Overall Study|Adverse Event|0
880247|NCT00591006|1844430|FG003|Overall Study|Adverse Event|0
880248|NCT00591006|1844431|FG004|Overall Study|Adverse Event|0
880249|NCT00591006|1844432|FG005|Overall Study|Adverse Event|0
880250|NCT00591006|1844433|FG006|Overall Study|Adverse Event|0
880251|NCT00591006|1844434|FG007|Overall Study|Adverse Event|0
880252|NCT00591006|1844435|FG008|Overall Study|Adverse Event|0
880253|NCT00591006|1844436|FG009|Overall Study|Adverse Event|0
880254|NCT00591006|1844437|FG010|Overall Study|Adverse Event|0
880255|NCT00591006|1844438|FG011|Overall Study|Adverse Event|0
880256|NCT00591006|1844439|FG012|Overall Study|Adverse Event|0
880257|NCT00591006|1844440|FG013|Overall Study|Adverse Event|0
880258|NCT00591006|1844441|FG014|Overall Study|Adverse Event|0
880259|NCT00591006|1844442|FG015|Overall Study|Adverse Event|0
880260|NCT00591006|1844443|FG016|Overall Study|Adverse Event|0
880261|NCT00591006|1844444|FG017|Overall Study|Adverse Event|0
880262|NCT00591006|1844445|FG018|Overall Study|Adverse Event|0
880263|NCT00591006|1844446|FG019|Overall Study|Adverse Event|0
880264|NCT00591006|1844447|FG020|Overall Study|Adverse Event|0
880265|NCT00591006|1844448|FG021|Overall Study|Adverse Event|0
880266|NCT00591006|1844449|FG022|Overall Study|Adverse Event|1
880267|NCT00591006|1844450|FG023|Overall Study|Adverse Event|0
880268|NCT00591149|1844480|FG000|Overall Study|Adverse Event|4
880269|NCT00591149|1844480|FG000|Overall Study|Withdrawal by Subject|1
880270|NCT00591214|1844484|FG000|Overall Study|Physician Decision|7
880271|NCT00591214|1844484|FG000|Overall Study|Withdrawal by Subject|1
880272|NCT00591253|1844509|FG000|Overall Study|Adverse Event|3
880273|NCT00591253|1844510|FG001|Overall Study|Adverse Event|3
880274|NCT00591253|1844511|FG002|Overall Study|Adverse Event|1
880275|NCT00591253|1844509|FG000|Overall Study|Protocol Violation|2
880276|NCT00591253|1844510|FG001|Overall Study|Protocol Violation|2
880277|NCT00591253|1844511|FG002|Overall Study|Protocol Violation|2
880278|NCT00591253|1844509|FG000|Overall Study|Lost to Follow-up|2
880279|NCT00591253|1844510|FG001|Overall Study|Lost to Follow-up|4
880280|NCT00591253|1844511|FG002|Overall Study|Lost to Follow-up|0
880281|NCT00591253|1844509|FG000|Overall Study|Withdrawal by Subject|1
880282|NCT00591253|1844510|FG001|Overall Study|Withdrawal by Subject|7
880283|NCT00591253|1844511|FG002|Overall Study|Withdrawal by Subject|6
880284|NCT00591253|1844509|FG000|Overall Study|Lack of Efficacy|1
880285|NCT00591253|1844510|FG001|Overall Study|Lack of Efficacy|0
880286|NCT00591253|1844511|FG002|Overall Study|Lack of Efficacy|3
880287|NCT00591253|1844509|FG000|Overall Study|Other|5
880288|NCT00591253|1844510|FG001|Overall Study|Other|5
880289|NCT00591253|1844511|FG002|Overall Study|Other|3
880290|NCT00591266|1844522|FG000|Overall Study|Adverse Event|2
880291|NCT00591266|1844523|FG001|Overall Study|Adverse Event|2
880292|NCT00591266|1844524|FG002|Overall Study|Adverse Event|3
880293|NCT00591266|1844522|FG000|Overall Study|Lost to Follow-up|0
880294|NCT00591266|1844523|FG001|Overall Study|Lost to Follow-up|1
880295|NCT00591266|1844524|FG002|Overall Study|Lost to Follow-up|0
880296|NCT00591266|1844522|FG000|Overall Study|Protocol Violation|0
880297|NCT00591266|1844523|FG001|Overall Study|Protocol Violation|0
880298|NCT00591266|1844524|FG002|Overall Study|Protocol Violation|1
880299|NCT00591266|1844522|FG000|Overall Study|Withdrawal by Subject|6
880300|NCT00591266|1844523|FG001|Overall Study|Withdrawal by Subject|2
880301|NCT00591266|1844524|FG002|Overall Study|Withdrawal by Subject|5
880302|NCT00591266|1844522|FG000|Overall Study|Lack of Efficacy|0
880303|NCT00591266|1844523|FG001|Overall Study|Lack of Efficacy|2
880304|NCT00591266|1844524|FG002|Overall Study|Lack of Efficacy|0
880305|NCT00591266|1844522|FG000|Overall Study|Other|1
880306|NCT00591266|1844523|FG001|Overall Study|Other|4
880307|NCT00591266|1844524|FG002|Overall Study|Other|5
880308|NCT00591344|1844544|FG000|Overall Study|Transportation issues|1
880309|NCT00591344|1844545|FG001|Overall Study|Transportation issues|0
880310|NCT00591344|1844544|FG000|Overall Study|Moved out of state|1
880311|NCT00591344|1844545|FG001|Overall Study|Moved out of state|0
880312|NCT00591344|1844544|FG000|Overall Study|Medical complications|1
880313|NCT00591344|1844545|FG001|Overall Study|Medical complications|3
880314|NCT00591344|1844544|FG000|Overall Study|Underwent DBS|2
880315|NCT00591344|1844545|FG001|Overall Study|Underwent DBS|2
880316|NCT00591344|1844544|FG000|Overall Study|Death|0
880317|NCT00591344|1844545|FG001|Overall Study|Death|1
880318|NCT00591344|1844544|FG000|Overall Study|Lost to Follow-up|0
880319|NCT00591344|1844545|FG001|Overall Study|Lost to Follow-up|1
880320|NCT00591344|1844544|FG000|Overall Study|Did not want to come off medication|0
880321|NCT00591344|1844545|FG001|Overall Study|Did not want to come off medication|1
880322|NCT00591370|1844555|FG000|Overall Study|Not Treated|2
880323|NCT00591409|1844569|FG000|Overall Study|Not Treated|0
880324|NCT00591409|1844570|FG001|Overall Study|Not Treated|0
880325|NCT00591409|1844571|FG002|Overall Study|Not Treated|0
880326|NCT00591409|1844572|FG003|Overall Study|Not Treated|0
880327|NCT00591409|1844573|FG004|Overall Study|Not Treated|1
880328|NCT00591409|1844574|FG005|Overall Study|Not Treated|0
880329|NCT00591409|1844575|FG006|Overall Study|Not Treated|0
880330|NCT00591409|1844576|FG007|Overall Study|Not Treated|0
880331|NCT00591409|1844577|FG008|Overall Study|Not Treated|0
880332|NCT00591409|1844578|FG009|Overall Study|Not Treated|1
880333|NCT00591565|1844600|FG000|Overall Study|lost follow up, withdrawn|5
880334|NCT00591578|1844607|FG000|Double-Blind Treatment Phase|Adverse Event|20
880335|NCT00591578|1844608|FG001|Double-Blind Treatment Phase|Adverse Event|26
880336|NCT00591578|1844609|FG002|Double-Blind Treatment Phase|Adverse Event|19
880337|NCT00591578|1844607|FG000|Double-Blind Treatment Phase|Protocol Violation|3
880338|NCT00591578|1844608|FG001|Double-Blind Treatment Phase|Protocol Violation|2
880339|NCT00591578|1844609|FG002|Double-Blind Treatment Phase|Protocol Violation|3
880340|NCT00591578|1844607|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12
880341|NCT00591578|1844608|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12
880342|NCT00591578|1844609|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11
880343|NCT00591578|1844607|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22
880344|NCT00591578|1844608|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22
880345|NCT00591578|1844609|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22
880346|NCT00591578|1844607|FG000|Double-Blind Treatment Phase|Pregnancy|1
880347|NCT00591578|1844608|FG001|Double-Blind Treatment Phase|Pregnancy|0
880348|NCT00591578|1844609|FG002|Double-Blind Treatment Phase|Pregnancy|0
880349|NCT00591578|1844607|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16
880350|NCT00591578|1844608|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9
880351|NCT00591578|1844609|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25
880352|NCT00591578|1844607|FG000|Double-Blind Treatment Phase|Other|4
880353|NCT00591578|1844608|FG001|Double-Blind Treatment Phase|Other|9
880354|NCT00591578|1844609|FG002|Double-Blind Treatment Phase|Other|4
880355|NCT00591578|1844607|FG000|Open-Label Extension Phase|Adverse Event|3
880356|NCT00591578|1844608|FG001|Open-Label Extension Phase|Adverse Event|5
880357|NCT00591578|1844609|FG002|Open-Label Extension Phase|Adverse Event|0
880358|NCT00591578|1844607|FG000|Open-Label Extension Phase|Lost to Follow-up|1
880359|NCT00591578|1844608|FG001|Open-Label Extension Phase|Lost to Follow-up|4
880360|NCT00591578|1844609|FG002|Open-Label Extension Phase|Lost to Follow-up|0
880361|NCT00591578|1844607|FG000|Open-Label Extension Phase|Withdrawal by Subject|1
880362|NCT00591578|1844608|FG001|Open-Label Extension Phase|Withdrawal by Subject|1
880363|NCT00591578|1844609|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
880364|NCT00591578|1844607|FG000|Open-Label Extension Phase|Other|1
880365|NCT00591578|1844608|FG001|Open-Label Extension Phase|Other|0
880366|NCT00591578|1844609|FG002|Open-Label Extension Phase|Other|0
880367|NCT00591591|1844620|FG000|Overall Study|Withdrawal by Subject|1
880368|NCT00591591|1844621|FG001|Overall Study|Withdrawal by Subject|37
880369|NCT00591591|1844620|FG000|Overall Study|Lack of Efficacy|10
880370|NCT00591591|1844621|FG001|Overall Study|Lack of Efficacy|2
880371|NCT00591630|1844631|FG000|Overall Study|Death|0
880372|NCT00591630|1844632|FG001|Overall Study|Death|0
880373|NCT00591630|1844633|FG002|Overall Study|Death|1
880374|NCT00591630|1844634|FG003|Overall Study|Death|0
880375|NCT00591721|1844646|FG000|Overall Study|Withdrawal by Subject|10
880376|NCT00591721|1844647|FG001|Overall Study|Withdrawal by Subject|10
880377|NCT00591721|1844646|FG000|Overall Study|Lost to Follow-up|1
880378|NCT00591721|1844647|FG001|Overall Study|Lost to Follow-up|4
880379|NCT00591721|1844646|FG000|Overall Study|Intervention not received|10
880380|NCT00591721|1844647|FG001|Overall Study|Intervention not received|8
880381|NCT00591734|1844653|FG000|Overall Study|Lack of Efficacy|35
880382|NCT00591734|1844653|FG000|Overall Study|Adverse Event|5
880383|NCT00591734|1844653|FG000|Overall Study|Physician Decision|5
880384|NCT00591734|1844653|FG000|Overall Study|Intercurrent Illness|8
880385|NCT00591773|1844669|FG000|Overall Study|Adverse Event|9
880386|NCT00591773|1844670|FG001|Overall Study|Adverse Event|9
880387|NCT00591773|1844671|FG002|Overall Study|Adverse Event|6
880388|NCT00591773|1844669|FG000|Overall Study|Protocol Violation|2
880389|NCT00591773|1844670|FG001|Overall Study|Protocol Violation|3
880390|NCT00591773|1844671|FG002|Overall Study|Protocol Violation|0
880391|NCT00591773|1844669|FG000|Overall Study|Lost to Follow-up|1
880392|NCT00591773|1844670|FG001|Overall Study|Lost to Follow-up|4
880393|NCT00591773|1844671|FG002|Overall Study|Lost to Follow-up|1
880394|NCT00591773|1844669|FG000|Overall Study|Withdrawal by Subject|2
880395|NCT00591773|1844670|FG001|Overall Study|Withdrawal by Subject|5
880396|NCT00591773|1844671|FG002|Overall Study|Withdrawal by Subject|3
880397|NCT00591773|1844669|FG000|Overall Study|Lack of Efficacy|1
880398|NCT00591773|1844670|FG001|Overall Study|Lack of Efficacy|2
880399|NCT00591773|1844671|FG002|Overall Study|Lack of Efficacy|2
880400|NCT00591773|1844669|FG000|Overall Study|Other|1
1187225|NCT02306122|2345723|FG000|Initial Physician Randomization|Physician Decision|0
1187226|NCT02306122|2345724|FG001|Initial Physician Randomization|Physician Decision|0
1187227|NCT02306122|2345725|FG002|Initial Physician Randomization|Physician Decision|0
1187228|NCT02306122|2345726|FG003|Initial Physician Randomization|Physician Decision|0
1187229|NCT02306122|2345727|FG004|Initial Physician Randomization|Physician Decision|0
1187230|NCT02306122|2345728|FG005|Initial Physician Randomization|Physician Decision|0
1187231|NCT02306122|2345729|FG006|Initial Physician Randomization|Physician Decision|0
1187232|NCT02306122|2345730|FG007|Initial Physician Randomization|Physician Decision|0
1187233|NCT02306122|2345731|FG008|Initial Physician Randomization|Physician Decision|1
1187234|NCT02306122|2345732|FG009|Initial Physician Randomization|Physician Decision|0
1187235|NCT02306122|2345733|FG010|Initial Physician Randomization|Physician Decision|0
1187236|NCT02278120|2345762|FG000|Overall Study|Progressive disease|122
1187237|NCT02278120|2345763|FG001|Overall Study|Progressive disease|174
1187238|NCT02278120|2345762|FG000|Overall Study|Patient/guardian decision|14
1187239|NCT02278120|2345763|FG001|Overall Study|Patient/guardian decision|8
1187240|NCT02278120|2345762|FG000|Overall Study|Adverse Event|12
1187241|NCT02278120|2345763|FG001|Overall Study|Adverse Event|10
1187242|NCT02278120|2345762|FG000|Overall Study|Physician Decision|8
1187243|NCT02278120|2345763|FG001|Overall Study|Physician Decision|19
1187244|NCT02278120|2345762|FG000|Overall Study|Death|3
1187245|NCT02278120|2345763|FG001|Overall Study|Death|3
1187246|NCT02278120|2345762|FG000|Overall Study|Lost to Follow-up|2
1187247|NCT02278120|2345763|FG001|Overall Study|Lost to Follow-up|0
1187248|NCT02278120|2345762|FG000|Overall Study|Protocol Violation|0
1187249|NCT02278120|2345763|FG001|Overall Study|Protocol Violation|2
1187268|NCT02178709|2345787|FG000|Overall Study|Adverse Event|5
1187269|NCT02178709|2345787|FG000|Overall Study|Death|2
1187270|NCT02178709|2345787|FG000|Overall Study|Withdrawal by Subject|2
1187271|NCT02178709|2345787|FG000|Overall Study|Physician Decision|2
1187272|NCT02178709|2345787|FG000|Overall Study|Disease Progression|5
1187273|NCT02147184|2345793|FG000|Overall Study|Lost to Follow-up|28
1187274|NCT02147184|2345794|FG001|Overall Study|Lost to Follow-up|15
1187275|NCT02147184|2345793|FG000|Overall Study|Study Burden|11
1187276|NCT02147184|2345794|FG001|Overall Study|Study Burden|7
1187277|NCT02147184|2345793|FG000|Overall Study|Pregnancy|6
1187278|NCT02147184|2345794|FG001|Overall Study|Pregnancy|0
1187279|NCT02147184|2345793|FG000|Overall Study|Moved out of state|3
1187280|NCT02147184|2345794|FG001|Overall Study|Moved out of state|3
1187281|NCT02147184|2345793|FG000|Overall Study|Physician Decision|0
1187282|NCT02147184|2345794|FG001|Overall Study|Physician Decision|2
1187283|NCT02147184|2345793|FG000|Overall Study|Other|1
1187284|NCT02147184|2345794|FG001|Overall Study|Other|0
1187285|NCT02075840|2345812|FG000|Overall Study|Withdrawal by Subject|13
1187286|NCT02075840|2345813|FG001|Overall Study|Withdrawal by Subject|22
1187287|NCT02075840|2345812|FG000|Overall Study|Reason not specified|1
1187288|NCT02075840|2345813|FG001|Overall Study|Reason not specified|0
1187289|NCT02075840|2345812|FG000|Overall Study|Adverse Event|0
1187290|NCT02075840|2345813|FG001|Overall Study|Adverse Event|2
1187291|NCT02075840|2345812|FG000|Overall Study|Death|35
1187292|NCT02075840|2345813|FG001|Overall Study|Death|40
1187293|NCT02075840|2345812|FG000|Overall Study|Lost to Follow-up|3
1187294|NCT02075840|2345813|FG001|Overall Study|Lost to Follow-up|2
1187295|NCT02075840|2345812|FG000|Overall Study|Physician Decision|1
1187296|NCT02075840|2345813|FG001|Overall Study|Physician Decision|3
1187297|NCT02075840|2345812|FG000|Overall Study|Ongoing at CCOD|99
1187298|NCT02075840|2345813|FG001|Overall Study|Ongoing at CCOD|82
1187307|NCT02043678|2345841|FG000|Overall Study|Never treated|11
1187308|NCT02043678|2345842|FG001|Overall Study|Never treated|9
1187309|NCT02043678|2345841|FG000|Overall Study|AE with clinical progressive disease(PD)|18
1187310|NCT02043678|2345842|FG001|Overall Study|AE with clinical progressive disease(PD)|18
1187311|NCT02043678|2345841|FG000|Overall Study|AE without clinical PD|51
1187312|NCT02043678|2345842|FG001|Overall Study|AE without clinical PD|34
1187313|NCT02043678|2345841|FG000|Overall Study|Lost to Follow-up|1
1187314|NCT02043678|2345842|FG001|Overall Study|Lost to Follow-up|1
1187315|NCT02043678|2345841|FG000|Overall Study|Other|19
1187316|NCT02043678|2345842|FG001|Overall Study|Other|16
1187317|NCT02043678|2345841|FG000|Overall Study|Clinical PD|108
1187318|NCT02043678|2345842|FG001|Overall Study|Clinical PD|138
1187319|NCT02043678|2345841|FG000|Overall Study|Radiological PD|91
1187320|NCT02043678|2345842|FG001|Overall Study|Radiological PD|80
1187321|NCT02043678|2345841|FG000|Overall Study|Protocol-driven decision point|56
1187322|NCT02043678|2345842|FG001|Overall Study|Protocol-driven decision point|56
1187323|NCT02043678|2345841|FG000|Overall Study|Withdrawal by Subject|12
1187324|NCT02043678|2345842|FG001|Overall Study|Withdrawal by Subject|15
1187325|NCT02043678|2345841|FG000|Overall Study|Ongoing with treatment|34
1187326|NCT02043678|2345842|FG001|Overall Study|Ongoing with treatment|38
1187327|NCT02000219|2345848|FG000|14-Week Study Period|Physician Decision|1
1187328|NCT02000219|2345848|FG000|14-Week Study Period|Adverse Event|1
1187329|NCT02000219|2345848|FG000|14-Week Study Period|Underwent transplantation|1
1187330|NCT02000219|2345848|FG000|Continuation Period|Withdrawal by Subject|1
1187331|NCT02000219|2345848|FG000|Continuation Period|Had liver transplant|2
1187332|NCT02000219|2345848|FG000|Continuation Period|Non-compliance with study drug|2
1187333|NCT01978938|2345854|FG000|Overall Study|Lost to Follow-up|12
1187334|NCT01978938|2345855|FG001|Overall Study|Lost to Follow-up|6
1187335|NCT01978938|2345854|FG000|Overall Study|Withdrawal by Subject|8
1187336|NCT01978938|2345855|FG001|Overall Study|Withdrawal by Subject|4
1187337|NCT01978938|2345854|FG000|Overall Study|Adverse Event, non-fatal|2
1187338|NCT01978938|2345855|FG001|Overall Study|Adverse Event, non-fatal|1
1187339|NCT01978938|2345854|FG000|Overall Study|Participant noncompliance|1
1187340|NCT01978938|2345855|FG001|Overall Study|Participant noncompliance|1
1187341|NCT01978938|2345854|FG000|Overall Study|Did not meet inclusion criteria|0
1187342|NCT01978938|2345855|FG001|Overall Study|Did not meet inclusion criteria|1
1187343|NCT01978938|2345854|FG000|Overall Study|Previously scheduled procedure|0
1187344|NCT01978938|2345855|FG001|Overall Study|Previously scheduled procedure|1
1187345|NCT01854385|2345861|FG000|Pre-Treatment|Withdrawal by Subject|4
1187346|NCT01854385|2345861|FG000|Pre-Treatment|Did not meet criteria based on headache number|15
1187347|NCT01854385|2345861|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3
1187348|NCT01854385|2345861|FG000|Pre-Treatment|Unable to come for study visits|1
1187349|NCT01854385|2345861|FG000|Treatment|Lost to Follow-up|1
1187350|NCT01844856|2345867|FG000|Overall Study|Lost to Follow-up|15
1187351|NCT01844856|2345868|FG001|Overall Study|Lost to Follow-up|3
1187352|NCT01844856|2345867|FG000|Overall Study|Adverse Event|3
1187353|NCT01844856|2345868|FG001|Overall Study|Adverse Event|6
1187354|NCT01844856|2345867|FG000|Overall Study|Withdrawal by Subject|3
1187355|NCT01844856|2345868|FG001|Overall Study|Withdrawal by Subject|2
1187356|NCT01844856|2345867|FG000|Overall Study|Noncompliance|2
1187357|NCT01844856|2345868|FG001|Overall Study|Noncompliance|3
1187358|NCT01844856|2345867|FG000|Overall Study|Enterococcus Resistant|0
1187359|NCT01844856|2345868|FG001|Overall Study|Enterococcus Resistant|1
1187360|NCT01844856|2345867|FG000|Overall Study|Inadvertently Not Scheduled|1
1187361|NCT01844856|2345868|FG001|Overall Study|Inadvertently Not Scheduled|0
1187362|NCT01844856|2345867|FG000|Overall Study|Randomized but was a Screen Failure|0
1187363|NCT01844856|2345868|FG001|Overall Study|Randomized but was a Screen Failure|1
1187364|NCT01712789|2345932|FG000|Overall Study|Lack of Efficacy|2
1187365|NCT01712789|2345932|FG000|Overall Study|Lost to Follow-up|1
1187366|NCT01712789|2345932|FG000|Overall Study|Progressive Disease|504
1187367|NCT01712789|2345932|FG000|Overall Study|Death|57
1187368|NCT01712789|2345932|FG000|Overall Study|Adverse Event|52
1187369|NCT01712789|2345932|FG000|Overall Study|Miscellaneous|31
1187370|NCT01712789|2345932|FG000|Overall Study|Withdrawal by Subject|21
1187371|NCT01712789|2345932|FG000|Overall Study|Transition to Commercial Treatment|8
1187372|NCT01712789|2345932|FG000|Overall Study|Participants Did Not Receive Study Drug|6
1187373|NCT01660451|2345939|FG000|Overall Study|Protocol Violation|0
1187374|NCT01660451|2345940|FG001|Overall Study|Protocol Violation|1
1187375|NCT01660451|2345941|FG002|Overall Study|Protocol Violation|1
1187376|NCT01660451|2345939|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11
1187377|NCT01660451|2345940|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8
1187378|NCT01660451|2345941|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26
1187379|NCT01660451|2345939|FG000|Overall Study|AE with Clinical PD|1
1187380|NCT01660451|2345940|FG001|Overall Study|AE with Clinical PD|3
1187381|NCT01660451|2345941|FG002|Overall Study|AE with Clinical PD|9
1187382|NCT01660451|2345939|FG000|Overall Study|Sponsor Decision|0
1187383|NCT01660451|2345940|FG001|Overall Study|Sponsor Decision|0
1187384|NCT01660451|2345941|FG002|Overall Study|Sponsor Decision|1
1187385|NCT01660451|2345939|FG000|Overall Study|Protocol Deviation|0
1187386|NCT01660451|2345940|FG001|Overall Study|Protocol Deviation|0
1187387|NCT01660451|2345941|FG002|Overall Study|Protocol Deviation|1
1187388|NCT01660451|2345939|FG000|Overall Study|Physician Decision|1
1187389|NCT01660451|2345940|FG001|Overall Study|Physician Decision|2
1187390|NCT01660451|2345941|FG002|Overall Study|Physician Decision|5
1187391|NCT01660451|2345939|FG000|Overall Study|Withdrawal by Subject|1
1187392|NCT01660451|2345940|FG001|Overall Study|Withdrawal by Subject|0
1187393|NCT01660451|2345941|FG002|Overall Study|Withdrawal by Subject|16
1187394|NCT01660451|2345939|FG000|Overall Study|Ongoing with treatment|3
1187395|NCT01660451|2345940|FG001|Overall Study|Ongoing with treatment|3
1187396|NCT01660451|2345941|FG002|Overall Study|Ongoing with treatment|46
1187397|NCT01651403|2345952|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
1187398|NCT01651403|2345953|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
1187399|NCT01651403|2345952|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
1187400|NCT01651403|2345953|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
1187401|NCT01651403|2345952|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0
1187402|NCT01651403|2345953|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1
1187403|NCT01651403|2345952|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13
1187404|NCT01651403|2345953|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9
1187405|NCT01651403|2345952|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2
1187406|NCT01651403|2345953|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1
1187407|NCT01651403|2345952|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6
1187408|NCT01651403|2345953|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4
1187409|NCT01542736|2345968|FG000|Overall Study|Death|1
1187410|NCT01535807|2345974|FG000|Overall Study|Withdrawal by Subject|1
1187411|NCT01535807|2345975|FG001|Overall Study|Withdrawal by Subject|1
1187412|NCT01535807|2345974|FG000|Overall Study|Data collection error|1
1187413|NCT01535807|2345975|FG001|Overall Study|Data collection error|1
1187414|NCT01147666|2345996|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1
880401|NCT00591773|1844670|FG001|Overall Study|Other|1
880402|NCT00591773|1844671|FG002|Overall Study|Other|4
880403|NCT00591786|1844689|FG000|Overall Study|Withdrawal of Informed Consent|0
880404|NCT00591786|1844690|FG001|Overall Study|Withdrawal of Informed Consent|0
880405|NCT00591786|1844691|FG002|Overall Study|Withdrawal of Informed Consent|1
1187415|NCT01147666|2345997|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1
1187416|NCT01147666|2345998|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1
1187417|NCT01147666|2345999|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1187418|NCT01147666|2346000|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1187419|NCT01147666|2346001|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1187420|NCT01147666|2346002|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1187421|NCT01147666|2346003|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1187422|NCT01147666|2346004|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1187423|NCT01147666|2346005|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1187424|NCT01147666|2346006|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1187425|NCT01147666|2346007|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1187426|NCT01147666|2346008|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1
1187427|NCT01147666|2346009|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1187428|NCT01147666|2346010|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1187429|NCT01147666|2345996|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1187430|NCT01147666|2345997|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
1187431|NCT01147666|2345998|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1187432|NCT01147666|2345999|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1187433|NCT01147666|2346000|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
1187434|NCT01147666|2346001|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
1187435|NCT01147666|2346002|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
1187436|NCT01147666|2346003|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
1187437|NCT01147666|2346004|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1187438|NCT01147666|2346005|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
1187439|NCT01147666|2346006|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1187440|NCT01147666|2346007|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1187441|NCT01147666|2346008|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
1187442|NCT01147666|2346009|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1187443|NCT01147666|2346010|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
1187444|NCT01147666|2345996|FG000|Dosing Period 1: 6-Week Treatment|Death|0
1187445|NCT01147666|2345997|FG001|Dosing Period 1: 6-Week Treatment|Death|0
1187446|NCT01147666|2345998|FG002|Dosing Period 1: 6-Week Treatment|Death|0
1187447|NCT01147666|2345999|FG003|Dosing Period 1: 6-Week Treatment|Death|0
1187448|NCT01147666|2346000|FG004|Dosing Period 1: 6-Week Treatment|Death|1
1187449|NCT01147666|2346001|FG005|Dosing Period 1: 6-Week Treatment|Death|1
1187450|NCT01147666|2346002|FG006|Dosing Period 1: 6-Week Treatment|Death|1
1187451|NCT01147666|2346003|FG007|Dosing Period 1: 6-Week Treatment|Death|0
1187452|NCT01147666|2346004|FG008|Dosing Period 1: 6-Week Treatment|Death|0
1187453|NCT01147666|2346005|FG009|Dosing Period 1: 6-Week Treatment|Death|0
1187454|NCT01147666|2346006|FG010|Dosing Period 1: 6-Week Treatment|Death|0
1187455|NCT01147666|2346007|FG011|Dosing Period 1: 6-Week Treatment|Death|0
1187456|NCT01147666|2346008|FG012|Dosing Period 1: 6-Week Treatment|Death|1
1187457|NCT01147666|2346009|FG013|Dosing Period 1: 6-Week Treatment|Death|0
1187458|NCT01147666|2346010|FG014|Dosing Period 1: 6-Week Treatment|Death|0
1187459|NCT01147666|2345996|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
1187460|NCT01147666|2345997|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187461|NCT01147666|2345998|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187462|NCT01147666|2345999|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
1187463|NCT01147666|2346000|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187464|NCT01147666|2346001|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187465|NCT01147666|2346002|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187466|NCT01147666|2346003|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187467|NCT01147666|2346004|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187468|NCT01147666|2346005|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187469|NCT01147666|2346006|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
1187470|NCT01147666|2346007|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187471|NCT01147666|2346008|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187472|NCT01147666|2346009|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187473|NCT01147666|2346010|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1187474|NCT01147666|2345996|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1187475|NCT01147666|2345997|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1187476|NCT01147666|2345998|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1187477|NCT01147666|2345999|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1187478|NCT01147666|2346000|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1187479|NCT01147666|2346001|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1187480|NCT01147666|2346002|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1187481|NCT01147666|2346003|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1187482|NCT01147666|2346004|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1187483|NCT01147666|2346005|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1187484|NCT01147666|2346006|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1187485|NCT01147666|2346007|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1187486|NCT01147666|2346008|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1187487|NCT01147666|2346009|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1187488|NCT01147666|2346010|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1187489|NCT01147666|2345996|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187490|NCT01147666|2345997|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187491|NCT01147666|2345998|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187492|NCT01147666|2345999|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1
1187493|NCT01147666|2346000|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187494|NCT01147666|2346001|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187495|NCT01147666|2346002|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187496|NCT01147666|2346003|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187497|NCT01147666|2346004|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187498|NCT01147666|2346005|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187499|NCT01147666|2346006|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2
1187500|NCT01147666|2346007|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187501|NCT01147666|2346008|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187502|NCT01147666|2346009|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187503|NCT01147666|2346010|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0
1187504|NCT01147666|2345996|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187505|NCT01147666|2345997|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187506|NCT01147666|2345998|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187507|NCT01147666|2345999|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187508|NCT01147666|2346000|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187509|NCT01147666|2346001|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187510|NCT01147666|2346002|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187511|NCT01147666|2346003|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187512|NCT01147666|2346004|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187513|NCT01147666|2346005|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187514|NCT01147666|2346006|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187515|NCT01147666|2346007|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
1187516|NCT01147666|2346008|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
1187517|NCT01147666|2346009|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1187518|NCT01147666|2346010|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
1187519|NCT01147666|2345996|FG000|Dosing Period 2: 19-Week Treatment|Death|0
1187520|NCT01147666|2345997|FG001|Dosing Period 2: 19-Week Treatment|Death|0
1187521|NCT01147666|2345998|FG002|Dosing Period 2: 19-Week Treatment|Death|0
1187522|NCT01147666|2345999|FG003|Dosing Period 2: 19-Week Treatment|Death|0
1187523|NCT01147666|2346000|FG004|Dosing Period 2: 19-Week Treatment|Death|1
1187524|NCT01147666|2346001|FG005|Dosing Period 2: 19-Week Treatment|Death|1
1187525|NCT01147666|2346002|FG006|Dosing Period 2: 19-Week Treatment|Death|1
1187526|NCT01147666|2346003|FG007|Dosing Period 2: 19-Week Treatment|Death|0
1187527|NCT01147666|2346004|FG008|Dosing Period 2: 19-Week Treatment|Death|0
1187528|NCT01147666|2346005|FG009|Dosing Period 2: 19-Week Treatment|Death|0
1187529|NCT01147666|2346006|FG010|Dosing Period 2: 19-Week Treatment|Death|0
1187530|NCT01147666|2346007|FG011|Dosing Period 2: 19-Week Treatment|Death|0
1187531|NCT01147666|2346008|FG012|Dosing Period 2: 19-Week Treatment|Death|1
1187532|NCT01147666|2346009|FG013|Dosing Period 2: 19-Week Treatment|Death|0
1187533|NCT01147666|2346010|FG014|Dosing Period 2: 19-Week Treatment|Death|0
1187534|NCT01147666|2345996|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1187535|NCT01147666|2345997|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1187536|NCT01147666|2345998|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1187537|NCT01147666|2345999|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1187538|NCT01147666|2346000|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3
1187539|NCT01147666|2346001|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
1187540|NCT01147666|2346002|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
1187541|NCT01147666|2346003|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
1187542|NCT01147666|2346004|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1187543|NCT01147666|2346005|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
1187544|NCT01147666|2346006|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1187545|NCT01147666|2346007|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1187546|NCT01147666|2346008|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
1187547|NCT01147666|2346009|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1187548|NCT01147666|2346010|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
1187549|NCT01147666|2345996|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187550|NCT01147666|2345997|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187551|NCT01147666|2345998|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187552|NCT01147666|2345999|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1
1187553|NCT01147666|2346000|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187554|NCT01147666|2346001|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187555|NCT01147666|2346002|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187556|NCT01147666|2346003|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187557|NCT01147666|2346004|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187558|NCT01147666|2346005|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187559|NCT01147666|2346006|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187560|NCT01147666|2346007|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187561|NCT01147666|2346008|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187562|NCT01147666|2346009|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
880406|NCT00591786|1844692|FG003|Overall Study|Withdrawal of Informed Consent|0
880407|NCT00591786|1844693|FG004|Overall Study|Withdrawal of Informed Consent|0
880408|NCT00591786|1844694|FG005|Overall Study|Withdrawal of Informed Consent|0
880409|NCT00591786|1844695|FG006|Overall Study|Withdrawal of Informed Consent|0
880410|NCT00591786|1844696|FG007|Overall Study|Withdrawal of Informed Consent|0
880411|NCT00591786|1844697|FG008|Overall Study|Withdrawal of Informed Consent|0
880412|NCT00591786|1844698|FG009|Overall Study|Withdrawal of Informed Consent|0
880413|NCT00591838|1844752|FG000|Overall Study|Withdrawal by Subject|0
880414|NCT00591838|1844753|FG001|Overall Study|Withdrawal by Subject|0
880415|NCT00591838|1844754|FG002|Overall Study|Withdrawal by Subject|0
880416|NCT00591838|1844755|FG003|Overall Study|Withdrawal by Subject|1
880417|NCT00591838|1844756|FG004|Overall Study|Withdrawal by Subject|0
880418|NCT00591851|1844769|FG000|Overall Study|Withdrawal by Subject|3
880419|NCT00591851|1844769|FG000|Overall Study|Adverse Event|2
880420|NCT00591851|1844769|FG000|Overall Study|Progressive Disease|1
880421|NCT00591864|1844773|FG000|Overall Study|Incomplete Imaging|5
880422|NCT00592072|1844785|FG000|Wash Out Period|Lost to Follow-up|1
880423|NCT00592072|1844786|FG001|Wash Out Period|Lost to Follow-up|1
880424|NCT00592319|1844819|FG000|Overall Study|Lost to Follow-up|0
880425|NCT00592319|1844820|FG001|Overall Study|Lost to Follow-up|3
880426|NCT00592358|1844828|FG000|Overall Study|Withdrawal by Subject|2
880427|NCT00592358|1844828|FG000|Overall Study|Adverse Event|1
880428|NCT00592358|1844828|FG000|Overall Study|Lack of Efficacy|2
880429|NCT00592358|1844828|FG000|Overall Study|Inability to swallow pills|1
1187563|NCT01147666|2346010|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1187564|NCT01147666|2345996|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1187565|NCT01147666|2345997|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1187566|NCT01147666|2345998|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1187567|NCT01147666|2345999|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1187568|NCT01147666|2346000|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
1187569|NCT01147666|2346001|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
880430|NCT00592384|1844834|FG000|Overall Study|Withdrawal by Subject|5
1187570|NCT01147666|2346002|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1187571|NCT01147666|2346003|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
1187572|NCT01147666|2346004|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1187573|NCT01147666|2346005|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
1187574|NCT01147666|2346006|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1187575|NCT01147666|2346007|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1187576|NCT01147666|2346008|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1187577|NCT01147666|2346009|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
1187578|NCT01147666|2346010|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1187579|NCT01147666|2345996|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187580|NCT01147666|2345997|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187581|NCT01147666|2345998|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187582|NCT01147666|2345999|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1
1187583|NCT01147666|2346000|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187584|NCT01147666|2346001|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187585|NCT01147666|2346002|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187586|NCT01147666|2346003|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187587|NCT01147666|2346004|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187588|NCT01147666|2346005|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187589|NCT01147666|2346006|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2
1187590|NCT01147666|2346007|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187591|NCT01147666|2346008|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187592|NCT01147666|2346009|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187593|NCT01147666|2346010|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0
1187594|NCT01147666|2345996|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187595|NCT01147666|2345997|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187596|NCT01147666|2345998|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187597|NCT01147666|2345999|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187598|NCT01147666|2346000|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187599|NCT01147666|2346001|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187600|NCT01147666|2346002|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187601|NCT01147666|2346003|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187602|NCT01147666|2346004|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187603|NCT01147666|2346005|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187604|NCT01147666|2346006|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187605|NCT01147666|2346007|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187606|NCT01147666|2346008|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1
1187607|NCT01147666|2346009|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187608|NCT01147666|2346010|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1187609|NCT01147666|2345996|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187610|NCT01147666|2345997|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187611|NCT01147666|2345998|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187612|NCT01147666|2345999|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187613|NCT01147666|2346000|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187614|NCT01147666|2346001|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187615|NCT01147666|2346002|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187616|NCT01147666|2346003|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187617|NCT01147666|2346004|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187618|NCT01147666|2346005|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187619|NCT01147666|2346006|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187620|NCT01147666|2346007|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187621|NCT01147666|2346008|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
1187622|NCT01147666|2346009|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1187623|NCT01147666|2346010|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
1187624|NCT01065454|2346076|FG000|Treatment|Adverse Event|7
1187625|NCT01065454|2346077|FG001|Treatment|Adverse Event|4
1187626|NCT01065454|2346078|FG002|Treatment|Adverse Event|3
1187627|NCT01065454|2346079|FG003|Treatment|Adverse Event|6
1187628|NCT01065454|2346076|FG000|Treatment|Death|1
1187629|NCT01065454|2346077|FG001|Treatment|Death|0
1187630|NCT01065454|2346078|FG002|Treatment|Death|0
1187631|NCT01065454|2346079|FG003|Treatment|Death|0
1187632|NCT01065454|2346076|FG000|Treatment|Non-compliance|1
1187633|NCT01065454|2346077|FG001|Treatment|Non-compliance|0
1187634|NCT01065454|2346078|FG002|Treatment|Non-compliance|0
1187635|NCT01065454|2346079|FG003|Treatment|Non-compliance|1
1187636|NCT01065454|2346076|FG000|Treatment|Protocol Decision|0
1187637|NCT01065454|2346077|FG001|Treatment|Protocol Decision|0
1187638|NCT01065454|2346078|FG002|Treatment|Protocol Decision|3
1187639|NCT01065454|2346079|FG003|Treatment|Protocol Decision|2
1187640|NCT01065454|2346076|FG000|Treatment|Protocol Violation|1
1187641|NCT01065454|2346077|FG001|Treatment|Protocol Violation|0
1187642|NCT01065454|2346078|FG002|Treatment|Protocol Violation|1
1187643|NCT01065454|2346079|FG003|Treatment|Protocol Violation|0
1187644|NCT01065454|2346076|FG000|Treatment|Withdrawal by Subject|3
1187645|NCT01065454|2346077|FG001|Treatment|Withdrawal by Subject|1
1187646|NCT01065454|2346078|FG002|Treatment|Withdrawal by Subject|2
1187647|NCT01065454|2346079|FG003|Treatment|Withdrawal by Subject|3
1187648|NCT01065454|2346076|FG000|Follow up|Adverse Event|1
1187649|NCT01065454|2346077|FG001|Follow up|Adverse Event|0
1187650|NCT01065454|2346078|FG002|Follow up|Adverse Event|0
1187651|NCT01065454|2346079|FG003|Follow up|Adverse Event|1
1187652|NCT01065454|2346076|FG000|Follow up|Death|0
1187653|NCT01065454|2346077|FG001|Follow up|Death|1
1187654|NCT01065454|2346078|FG002|Follow up|Death|1
1187655|NCT01065454|2346079|FG003|Follow up|Death|0
1187656|NCT01065454|2346076|FG000|Follow up|Lost to Follow-up|0
1187657|NCT01065454|2346077|FG001|Follow up|Lost to Follow-up|0
1187658|NCT01065454|2346078|FG002|Follow up|Lost to Follow-up|0
1187659|NCT01065454|2346079|FG003|Follow up|Lost to Follow-up|1
1187660|NCT01065454|2346076|FG000|Follow up|Progressive disease|0
1187661|NCT01065454|2346077|FG001|Follow up|Progressive disease|0
1187662|NCT01065454|2346078|FG002|Follow up|Progressive disease|0
1187663|NCT01065454|2346079|FG003|Follow up|Progressive disease|1
1187664|NCT01065454|2346076|FG000|Follow up|Withdrawal by Subject|1
1187665|NCT01065454|2346077|FG001|Follow up|Withdrawal by Subject|1
1187666|NCT01065454|2346078|FG002|Follow up|Withdrawal by Subject|1
1187667|NCT01065454|2346079|FG003|Follow up|Withdrawal by Subject|0
1187668|NCT01065454|2346076|FG000|Follow up|study ongoing|37
1187669|NCT01065454|2346077|FG001|Follow up|study ongoing|22
1187670|NCT01065454|2346078|FG002|Follow up|study ongoing|15
1187671|NCT01065454|2346079|FG003|Follow up|study ongoing|41
1187672|NCT00982111|2346091|FG000|Overall Study|Adverse Event|1
1187673|NCT00982111|2346092|FG001|Overall Study|Adverse Event|1
1187674|NCT00982111|2346091|FG000|Overall Study|Progressive Disease|46
1187675|NCT00982111|2346092|FG001|Overall Study|Progressive Disease|39
1187676|NCT00982111|2346091|FG000|Overall Study|Lost to Follow-up|9
1187677|NCT00982111|2346092|FG001|Overall Study|Lost to Follow-up|6
1187678|NCT00982111|2346091|FG000|Overall Study|New Anti-Cancer Therapy|5
1187679|NCT00982111|2346092|FG001|Overall Study|New Anti-Cancer Therapy|5
1187680|NCT00982111|2346091|FG000|Overall Study|Medical Decision|1
1187681|NCT00982111|2346092|FG001|Overall Study|Medical Decision|0
1187682|NCT00982111|2346091|FG000|Overall Study|Withdrawal by Subject|17
1187683|NCT00982111|2346092|FG001|Overall Study|Withdrawal by Subject|19
1187684|NCT00982111|2346091|FG000|Overall Study|Global Study End|0
1187685|NCT00982111|2346092|FG001|Overall Study|Global Study End|1
1187686|NCT00982111|2346091|FG000|Overall Study|Sponsor's Decision|0
1187687|NCT00982111|2346092|FG001|Overall Study|Sponsor's Decision|1
1187688|NCT00291486|2346104|FG000|Overall Study|Adverse Event|0
1187689|NCT00291486|2346105|FG001|Overall Study|Adverse Event|3
1187690|NCT00291486|2346106|FG002|Overall Study|Adverse Event|0
1187691|NCT00291486|2346107|FG003|Overall Study|Adverse Event|1
1187692|NCT00291486|2346108|FG004|Overall Study|Adverse Event|0
1187693|NCT00291486|2346104|FG000|Overall Study|Withdrawal by Subject|0
1187694|NCT00291486|2346105|FG001|Overall Study|Withdrawal by Subject|0
1187695|NCT00291486|2346106|FG002|Overall Study|Withdrawal by Subject|0
1187696|NCT00291486|2346107|FG003|Overall Study|Withdrawal by Subject|0
1187697|NCT00291486|2346108|FG004|Overall Study|Withdrawal by Subject|1
1187698|NCT00291486|2346104|FG000|Overall Study|Disease progression|1
1187699|NCT00291486|2346105|FG001|Overall Study|Disease progression|0
1187700|NCT00291486|2346106|FG002|Overall Study|Disease progression|1
1187701|NCT00291486|2346107|FG003|Overall Study|Disease progression|0
1187702|NCT00291486|2346108|FG004|Overall Study|Disease progression|0
1187703|NCT00116142|2346136|FG000|Overall Study|Adverse Event|8
1187704|NCT00116142|2346137|FG001|Overall Study|Adverse Event|7
1187705|NCT00116142|2346136|FG000|Overall Study|Protocol Violation|2
1187706|NCT00116142|2346137|FG001|Overall Study|Protocol Violation|1
1187707|NCT00116142|2346136|FG000|Overall Study|Withdrawal by Subject|5
1187708|NCT00116142|2346137|FG001|Overall Study|Withdrawal by Subject|5
1187709|NCT00116142|2346136|FG000|Overall Study|Physician Decision|3
1187710|NCT00116142|2346137|FG001|Overall Study|Physician Decision|1
1187711|NCT00116142|2346136|FG000|Overall Study|Delayed Radiation Therapy|1
1187712|NCT00116142|2346137|FG001|Overall Study|Delayed Radiation Therapy|0
1187713|NCT00116142|2346136|FG000|Overall Study|Patient could not tolerate docetaxel|0
1187714|NCT00116142|2346137|FG001|Overall Study|Patient could not tolerate docetaxel|2
1187715|NCT00116142|2346136|FG000|Overall Study|Patient stopped due to depression|0
1187716|NCT00116142|2346137|FG001|Overall Study|Patient stopped due to depression|1
1187717|NCT00116142|2346136|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0
1187718|NCT00116142|2346137|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1
1187719|NCT00116142|2346136|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0
1187720|NCT00116142|2346137|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1
1187721|NCT00116142|2346136|FG000|Overall Study|Patient didn't start due to low platelet counts|0
1187722|NCT00116142|2346137|FG001|Overall Study|Patient didn't start due to low platelet counts|1
1187723|NCT00070018|2346146|FG000|Overall Study|Adverse Event|2
1187724|NCT00070018|2346146|FG000|Overall Study|Lack of Efficacy|1
1187725|NCT00070018|2346146|FG000|Overall Study|Withdrawal by Subject|1
1187730|NCT04447287|2346168|FG000|Period 1: Run-in Period|Adverse Event|3
1187731|NCT04447287|2346169|FG001|Period 1: Run-in Period|Adverse Event|0
1187732|NCT04447287|2346170|FG002|Period 1: Run-in Period|Adverse Event|0
1187733|NCT04447287|2346168|FG000|Period 1: Run-in Period|Withdrawal by Subject|1
1187734|NCT04447287|2346169|FG001|Period 1: Run-in Period|Withdrawal by Subject|0
1187735|NCT04447287|2346170|FG002|Period 1: Run-in Period|Withdrawal by Subject|0
1187736|NCT04447287|2346168|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1
1187737|NCT04447287|2346169|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
1187738|NCT04447287|2346170|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
1187739|NCT04039503|2346226|FG000|Overall Study|Adverse Event|3
1187740|NCT04039503|2346227|FG001|Overall Study|Adverse Event|0
1187741|NCT04039503|2346228|FG002|Overall Study|Adverse Event|2
1187742|NCT04039503|2346229|FG003|Overall Study|Adverse Event|0
1187743|NCT04039503|2346226|FG000|Overall Study|Lost to Follow-up|0
1187744|NCT04039503|2346227|FG001|Overall Study|Lost to Follow-up|0
1187745|NCT04039503|2346228|FG002|Overall Study|Lost to Follow-up|1
1187746|NCT04039503|2346229|FG003|Overall Study|Lost to Follow-up|0
1187747|NCT04039503|2346226|FG000|Overall Study|Protocol Violation|0
1187748|NCT04039503|2346227|FG001|Overall Study|Protocol Violation|1
1187749|NCT04039503|2346228|FG002|Overall Study|Protocol Violation|2
1187750|NCT04039503|2346229|FG003|Overall Study|Protocol Violation|1
1187751|NCT04039503|2346226|FG000|Overall Study|Withdrawal by Subject|4
1187752|NCT04039503|2346227|FG001|Overall Study|Withdrawal by Subject|3
1187753|NCT04039503|2346228|FG002|Overall Study|Withdrawal by Subject|5
1187754|NCT04039503|2346229|FG003|Overall Study|Withdrawal by Subject|2
1187763|NCT03695172|2346251|FG000|Overall Study|Withdrawal by Subject|1
1187764|NCT03695172|2346252|FG001|Overall Study|Withdrawal by Subject|1
1187765|NCT03695172|2346253|FG002|Overall Study|Withdrawal by Subject|0
1187786|NCT03394027|2346307|FG000|Overall Study|Ineligible|3
1187787|NCT03394027|2346308|FG001|Overall Study|Ineligible|1
1187788|NCT03394027|2346309|FG002|Overall Study|Ineligible|3
1187789|NCT03394027|2346307|FG000|Overall Study|Participant declined to participate before treatment started|0
1187790|NCT03394027|2346308|FG001|Overall Study|Participant declined to participate before treatment started|0
1187791|NCT03394027|2346309|FG002|Overall Study|Participant declined to participate before treatment started|1
1187792|NCT03357952|2346337|FG000|Overall Study|Withdrawal by Subject|0
1187793|NCT03357952|2346338|FG001|Overall Study|Withdrawal by Subject|1
1187794|NCT03357952|2346337|FG000|Overall Study|Sponsor Decision|9
1187795|NCT03357952|2346338|FG001|Overall Study|Sponsor Decision|0
1187808|NCT03170869|2346369|FG000|Overall Study|Protocol Violation|5
1187809|NCT03170869|2346369|FG000|Overall Study|Early study termination|3
1187819|NCT03066622|2346402|FG000|Overall Study|Lost to Follow-up|24
1187820|NCT03066622|2346403|FG001|Overall Study|Lost to Follow-up|25
1187821|NCT03066622|2346402|FG000|Overall Study|Withdrawal by Subject|2
1187822|NCT03066622|2346403|FG001|Overall Study|Withdrawal by Subject|1
1187823|NCT03052920|2346409|FG000|Overall Study|Withdrawal by Subject|1
1187824|NCT03016312|2346428|FG000|Overall Study|Death|194
1187825|NCT03016312|2346429|FG001|Overall Study|Death|164
1187826|NCT03016312|2346428|FG000|Overall Study|Lost to Follow-up|11
1187827|NCT03016312|2346429|FG001|Overall Study|Lost to Follow-up|12
1187828|NCT03016312|2346428|FG000|Overall Study|Started new therapy, loss of contact|2
1187829|NCT03016312|2346429|FG001|Overall Study|Started new therapy, loss of contact|1
1187830|NCT03016312|2346428|FG000|Overall Study|Physician Decision|0
1187831|NCT03016312|2346429|FG001|Overall Study|Physician Decision|2
1187832|NCT03016312|2346428|FG000|Overall Study|Withdrawal by Subject|34
1187833|NCT03016312|2346429|FG001|Overall Study|Withdrawal by Subject|39
1187834|NCT02722434|2346447|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1
1187835|NCT02722434|2346448|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0
1187836|NCT02722434|2346447|FG000|Overall Study|Withdrawal After Beginning Treatment|0
1187837|NCT02722434|2346448|FG001|Overall Study|Withdrawal After Beginning Treatment|3
1187838|NCT02604511|2346462|FG000|Overall Study|Adverse Event|3
1187839|NCT02604511|2346462|FG000|Overall Study|Disease Progression|4
1187840|NCT02604511|2346462|FG000|Overall Study|Withdrawal by Subject|3
1187841|NCT02604511|2346462|FG000|Overall Study|Participant ineligible|1
1187842|NCT02604511|2346462|FG000|Overall Study|Intercurrent illness|1
1187843|NCT02549092|2346468|FG000|Treatment Period|Adverse Event|2
1187844|NCT02549092|2346469|FG001|Treatment Period|Adverse Event|2
1187845|NCT02549092|2346468|FG000|Treatment Period|Withdrawal by Subject|1
1187846|NCT02549092|2346469|FG001|Treatment Period|Withdrawal by Subject|3
1187847|NCT02549092|2346468|FG000|Treatment Period|Lack of Efficacy|0
1187848|NCT02549092|2346469|FG001|Treatment Period|Lack of Efficacy|2
1187849|NCT02549092|2346468|FG000|Extension/Transition Period|Still in Extension/Transition Period|4
1187850|NCT02549092|2346469|FG001|Extension/Transition Period|Still in Extension/Transition Period|8
1187851|NCT02549092|2346468|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
1187852|NCT02549092|2346469|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
1187853|NCT01963728|2346531|FG000|Overall Study|Study terminated early|0
1187854|NCT01963728|2346532|FG001|Overall Study|Study terminated early|1
1187855|NCT01248247|2346542|FG000|Overall Study|Adverse Event|2
1187856|NCT01248247|2346543|FG001|Overall Study|Adverse Event|4
1187857|NCT01248247|2346544|FG002|Overall Study|Adverse Event|4
1187858|NCT01248247|2346545|FG003|Overall Study|Adverse Event|2
1187859|NCT01248247|2346542|FG000|Overall Study|Death|0
1187860|NCT01248247|2346543|FG001|Overall Study|Death|1
1187861|NCT01248247|2346544|FG002|Overall Study|Death|4
1187862|NCT01248247|2346545|FG003|Overall Study|Death|7
1187863|NCT01248247|2346542|FG000|Overall Study|Lost to Follow-up|0
1187864|NCT01248247|2346543|FG001|Overall Study|Lost to Follow-up|1
1187865|NCT01248247|2346544|FG002|Overall Study|Lost to Follow-up|1
1187866|NCT01248247|2346545|FG003|Overall Study|Lost to Follow-up|0
1187867|NCT01248247|2346542|FG000|Overall Study|Alternative treatment|0
1187868|NCT01248247|2346543|FG001|Overall Study|Alternative treatment|1
1187869|NCT01248247|2346544|FG002|Overall Study|Alternative treatment|0
1187870|NCT01248247|2346545|FG003|Overall Study|Alternative treatment|0
1187871|NCT01248247|2346542|FG000|Overall Study|Other|2
1187872|NCT01248247|2346543|FG001|Overall Study|Other|8
1187873|NCT01248247|2346544|FG002|Overall Study|Other|8
1187874|NCT01248247|2346545|FG003|Overall Study|Other|5
1187875|NCT01248247|2346542|FG000|Overall Study|Progression|18
1187876|NCT01248247|2346543|FG001|Overall Study|Progression|27
1187877|NCT01248247|2346544|FG002|Overall Study|Progression|56
1187878|NCT01248247|2346545|FG003|Overall Study|Progression|44
1187879|NCT01248247|2346542|FG000|Overall Study|Refuse further treatment|0
1187880|NCT01248247|2346543|FG001|Overall Study|Refuse further treatment|0
1187881|NCT01248247|2346544|FG002|Overall Study|Refuse further treatment|1
1187882|NCT01248247|2346545|FG003|Overall Study|Refuse further treatment|2
1187883|NCT01248247|2346542|FG000|Overall Study|Complicating disease|0
1187884|NCT01248247|2346543|FG001|Overall Study|Complicating disease|0
1187885|NCT01248247|2346544|FG002|Overall Study|Complicating disease|1
1187886|NCT01248247|2346545|FG003|Overall Study|Complicating disease|1
1187887|NCT01164228|2346557|FG000|Overall Study|Progression|24
1187888|NCT01164228|2346558|FG001|Overall Study|Progression|25
1187889|NCT01164228|2346557|FG000|Overall Study|Adverse Event|13
1187890|NCT01164228|2346558|FG001|Overall Study|Adverse Event|7
1187891|NCT01164228|2346557|FG000|Overall Study|Death|1
880431|NCT00592384|1844835|FG001|Overall Study|Withdrawal by Subject|6
880432|NCT00592501|1844865|FG000|Overall Study|Withdrawal by Subject|1
880433|NCT00592501|1844865|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1
880434|NCT00592553|1844872|FG000|Overall Study|Protocol Noncompliance|1
880435|NCT00592553|1844873|FG001|Overall Study|Protocol Noncompliance|0
880436|NCT00592553|1844874|FG002|Overall Study|Protocol Noncompliance|0
880437|NCT00592631|1844884|FG000|Overall Study|Lost to Follow-up|0
880438|NCT00592631|1844885|FG001|Overall Study|Lost to Follow-up|2
1187892|NCT01164228|2346558|FG001|Overall Study|Death|1
1187893|NCT01164228|2346557|FG000|Overall Study|Withdrawal by Subject|2
1187894|NCT01164228|2346558|FG001|Overall Study|Withdrawal by Subject|0
1187895|NCT01164228|2346557|FG000|Overall Study|Physician Decision|1
1187896|NCT01164228|2346558|FG001|Overall Study|Physician Decision|2
1187897|NCT01164228|2346557|FG000|Overall Study|Symptomatic deterioration|1
1187898|NCT01164228|2346558|FG001|Overall Study|Symptomatic deterioration|0
1187899|NCT01164228|2346557|FG000|Overall Study|Never started treatment|1
1187900|NCT01164228|2346558|FG001|Overall Study|Never started treatment|3
1187901|NCT01164228|2346557|FG000|Overall Study|Ineligible|1
1187902|NCT01164228|2346558|FG001|Overall Study|Ineligible|0
880439|NCT00592683|1844893|FG000|Overall Study|Found ineligible|0
880440|NCT00592683|1844894|FG001|Overall Study|Found ineligible|1
880441|NCT00592683|1844893|FG000|Overall Study|Withdrawal by Subject|1
880442|NCT00592683|1844894|FG001|Overall Study|Withdrawal by Subject|0
880443|NCT00592683|1844893|FG000|Overall Study|Adverse Event|0
880444|NCT00592683|1844894|FG001|Overall Study|Adverse Event|2
880445|NCT00592683|1844893|FG000|Overall Study|Protocol Violation|1
880446|NCT00592683|1844894|FG001|Overall Study|Protocol Violation|0
880447|NCT00592683|1844893|FG000|Overall Study|Study drug expired|1
880448|NCT00592683|1844894|FG001|Overall Study|Study drug expired|0
880449|NCT00592683|1844893|FG000|Overall Study|Other|1
880450|NCT00592683|1844894|FG001|Overall Study|Other|0
880451|NCT00592683|1844893|FG000|Overall Study|Lost to Follow-up|0
880452|NCT00592683|1844894|FG001|Overall Study|Lost to Follow-up|1
880453|NCT00592774|1844912|FG000|Overall Study|Adverse Event|5
880454|NCT00592774|1844913|FG001|Overall Study|Adverse Event|19
880455|NCT00592774|1844914|FG002|Overall Study|Adverse Event|2
880456|NCT00592774|1844915|FG003|Overall Study|Adverse Event|14
880457|NCT00592774|1844916|FG004|Overall Study|Adverse Event|8
880458|NCT00592774|1844912|FG000|Overall Study|Protocol Violation|0
880459|NCT00592774|1844913|FG001|Overall Study|Protocol Violation|1
1187948|NCT00591318|2346653|FG000|Overall Study|Lack of Efficacy|2
1187949|NCT00591318|2346654|FG001|Overall Study|Lack of Efficacy|0
880460|NCT00592774|1844914|FG002|Overall Study|Protocol Violation|0
880461|NCT00592774|1844915|FG003|Overall Study|Protocol Violation|0
880462|NCT00592774|1844916|FG004|Overall Study|Protocol Violation|1
880463|NCT00592774|1844912|FG000|Overall Study|Withdrawal by Subject|3
880464|NCT00592774|1844913|FG001|Overall Study|Withdrawal by Subject|7
880465|NCT00592774|1844914|FG002|Overall Study|Withdrawal by Subject|0
880466|NCT00592774|1844915|FG003|Overall Study|Withdrawal by Subject|0
880467|NCT00592774|1844916|FG004|Overall Study|Withdrawal by Subject|0
880468|NCT00592774|1844912|FG000|Overall Study|Lack of Efficacy|3
880469|NCT00592774|1844913|FG001|Overall Study|Lack of Efficacy|3
880470|NCT00592774|1844914|FG002|Overall Study|Lack of Efficacy|0
880471|NCT00592774|1844915|FG003|Overall Study|Lack of Efficacy|0
880472|NCT00592774|1844916|FG004|Overall Study|Lack of Efficacy|2
880473|NCT00592774|1844912|FG000|Overall Study|Physician Decision|0
1187950|NCT00591318|2346653|FG000|Overall Study|Adverse Event|2
1187951|NCT00591318|2346654|FG001|Overall Study|Adverse Event|0
1187952|NCT00210249|2346673|FG000|Overall Study|Lost to Follow-up|5
1187953|NCT00210249|2346673|FG000|Overall Study|Protocol Violation|11
1187954|NCT04534517|2346679|FG000|Overall Study|Adverse Event|1
1187955|NCT04534517|2346679|FG000|Overall Study|Withdrawal by Subject|1
1187956|NCT04534517|2346679|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1
1187957|NCT04534517|2346679|FG000|Overall Study|COVID-19 Related|1
1187958|NCT04494646|2346685|FG000|Overall Study|Adverse Event|0
1187959|NCT04494646|2346686|FG001|Overall Study|Adverse Event|1
1187960|NCT04494646|2346685|FG000|Overall Study|Withdrawal by Subject|0
1187961|NCT04494646|2346686|FG001|Overall Study|Withdrawal by Subject|1
1187962|NCT04258020|2346694|FG000|Overall Study|Withdrawal by Subject|1
1187963|NCT04258020|2346695|FG001|Overall Study|Withdrawal by Subject|0
1187964|NCT04234464|2346703|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1
1187965|NCT04234464|2346704|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0
1187966|NCT04126733|2346710|FG000|Treatment Period|Other Reason|1
1187967|NCT04126733|2346710|FG000|Treatment Period|Death|1
1187968|NCT04126733|2346710|FG000|Treatment Period|Physician Decision|3
1187969|NCT04126733|2346710|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7
1187970|NCT04126733|2346710|FG000|Treatment Period|Adverse Event|7
1187971|NCT04126733|2346710|FG000|Treatment Period|Progressive Disease - Radiological Progression|44
1187972|NCT04126733|2346710|FG000|Treatment Period|Ongoing with Study Treatment|7
1187973|NCT04126733|2346710|FG000|Active Follow-up Period|Death|13
1187974|NCT04126733|2346710|FG000|Active Follow-up Period|Other Reason|1
1187975|NCT04126733|2346710|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4
1187976|NCT04126733|2346710|FG000|Active Follow-up Period|Withdrawal by Subject|2
1187977|NCT04126733|2346710|FG000|Long-term Follow-up Period|Withdrawal by Subject|1
1187978|NCT04126733|2346710|FG000|Long-term Follow-up Period|Death|5
1187979|NCT03905694|2346714|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18
1187980|NCT03860259|2346720|FG000|Overall Study|Lost to Follow-up|5
1187981|NCT03860259|2346721|FG001|Overall Study|Lost to Follow-up|5
1187982|NCT03860259|2346720|FG000|Overall Study|Protocol Violation|1
1187983|NCT03860259|2346721|FG001|Overall Study|Protocol Violation|0
1187984|NCT03852316|2346727|FG000|Overall Study|Protocol Violation|1
1187985|NCT03852316|2346727|FG000|Overall Study|Withdrawal by Subject|2
1187986|NCT03852316|2346727|FG000|Overall Study|Enrolled but Device not Utilized|1
1187987|NCT03789318|2346736|FG000|Overall Study|Adverse Event|0
1187988|NCT03789318|2346737|FG001|Overall Study|Adverse Event|0
1187989|NCT03789318|2346738|FG002|Overall Study|Adverse Event|1
1187990|NCT03789318|2346739|FG003|Overall Study|Adverse Event|1
1187991|NCT03789318|2346740|FG004|Overall Study|Adverse Event|0
1187992|NCT03789318|2346736|FG000|Overall Study|Lost to Follow-up|0
1187993|NCT03789318|2346737|FG001|Overall Study|Lost to Follow-up|0
1187994|NCT03789318|2346738|FG002|Overall Study|Lost to Follow-up|1
1187995|NCT03789318|2346739|FG003|Overall Study|Lost to Follow-up|0
1187996|NCT03789318|2346740|FG004|Overall Study|Lost to Follow-up|0
1187997|NCT03789318|2346736|FG000|Overall Study|Withdrawal by Subject|0
1187998|NCT03789318|2346737|FG001|Overall Study|Withdrawal by Subject|0
1187999|NCT03789318|2346738|FG002|Overall Study|Withdrawal by Subject|1
1188000|NCT03789318|2346739|FG003|Overall Study|Withdrawal by Subject|0
1188001|NCT03789318|2346740|FG004|Overall Study|Withdrawal by Subject|0
1188002|NCT03774875|2346754|FG000|Overall Study|Adverse Event|8
1188003|NCT03774875|2346755|FG001|Overall Study|Adverse Event|16
1188004|NCT03774875|2346754|FG000|Overall Study|Lack of Efficacy|2
1188005|NCT03774875|2346755|FG001|Overall Study|Lack of Efficacy|4
1188006|NCT03774875|2346754|FG000|Overall Study|Withdrawal by Subject|12
1188007|NCT03774875|2346755|FG001|Overall Study|Withdrawal by Subject|10
1188008|NCT03774875|2346754|FG000|Overall Study|Lost to Follow-up|0
1188009|NCT03774875|2346755|FG001|Overall Study|Lost to Follow-up|2
1188010|NCT03774875|2346754|FG000|Overall Study|Protocol Deviation|0
1188011|NCT03774875|2346755|FG001|Overall Study|Protocol Deviation|1
1188012|NCT03774875|2346754|FG000|Overall Study|Reason Unknown|1
1188013|NCT03774875|2346755|FG001|Overall Study|Reason Unknown|0
1188014|NCT03681184|2346763|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0
1188015|NCT03681184|2346764|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1
1188016|NCT03681184|2346763|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12
1188017|NCT03681184|2346764|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23
1188018|NCT03681184|2346763|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
1188019|NCT03681184|2346764|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
1188020|NCT03158688|2346802|FG000|Overall Study|Continuing in study|107
1188021|NCT03158688|2346803|FG001|Overall Study|Continuing in study|233
1188022|NCT03158688|2346802|FG000|Overall Study|Death|36
1188023|NCT03158688|2346803|FG001|Overall Study|Death|59
1188024|NCT03158688|2346802|FG000|Overall Study|Withdrawal by Subject|9
1188025|NCT03158688|2346803|FG001|Overall Study|Withdrawal by Subject|14
1188026|NCT03158688|2346802|FG000|Overall Study|Decision by sponsor|2
1188027|NCT03158688|2346803|FG001|Overall Study|Decision by sponsor|3
1188028|NCT03158688|2346802|FG000|Overall Study|Lost to Follow-up|0
1188029|NCT03158688|2346803|FG001|Overall Study|Lost to Follow-up|3
1188030|NCT03103321|2346813|FG000|Overall Study|Protocol Violation|1
1188031|NCT03103321|2346814|FG001|Overall Study|Protocol Violation|1
1188032|NCT03103321|2346815|FG002|Overall Study|Protocol Violation|1
1188033|NCT03103321|2346816|FG003|Overall Study|Protocol Violation|0
1188034|NCT03079869|2346828|FG000|Overall Study|Adverse Event|6
1188035|NCT03079869|2346829|FG001|Overall Study|Adverse Event|8
1188036|NCT03079869|2346828|FG000|Overall Study|Withdrawal by Subject|4
1188037|NCT03079869|2346829|FG001|Overall Study|Withdrawal by Subject|1
1188038|NCT03079869|2346828|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3
1188039|NCT03079869|2346829|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2
1188040|NCT03033875|2346838|FG000|Overall Study|Withdrawal by Subject|5
1188041|NCT03033875|2346839|FG001|Overall Study|Withdrawal by Subject|9
1188042|NCT03033875|2346840|FG002|Overall Study|Withdrawal by Subject|4
1188043|NCT03033875|2346838|FG000|Overall Study|Other|14
1188044|NCT03033875|2346839|FG001|Overall Study|Other|15
1188045|NCT03033875|2346840|FG002|Overall Study|Other|8
1188046|NCT02887248|2346852|FG000|Overall Study|Withdrawal by Subject|1
1188047|NCT02887248|2346852|FG000|Overall Study|Adverse Event|1
1188048|NCT02887248|2346852|FG000|Overall Study|Progressive Disease|1
1188049|NCT02849990|2346856|FG000|Overall Study|Adverse Event|1
1188050|NCT02849990|2346856|FG000|Overall Study|Withdrawal by Subject|1
1188054|NCT02467270|2346912|FG000|Overall Study|Participants Never Treated|0
1188055|NCT02467270|2346913|FG001|Overall Study|Participants Never Treated|1
1188056|NCT02467270|2346914|FG002|Overall Study|Participants Never Treated|0
1188057|NCT02467270|2346912|FG000|Overall Study|Ongoing|50
1188058|NCT02467270|2346913|FG001|Overall Study|Ongoing|41
1188059|NCT02467270|2346914|FG002|Overall Study|Ongoing|43
1188060|NCT02467270|2346912|FG000|Overall Study|Adverse Event|16
1188061|NCT02467270|2346913|FG001|Overall Study|Adverse Event|15
1188062|NCT02467270|2346914|FG002|Overall Study|Adverse Event|14
1188063|NCT02467270|2346912|FG000|Overall Study|Progressive Disease|7
1188064|NCT02467270|2346913|FG001|Overall Study|Progressive Disease|7
1188065|NCT02467270|2346914|FG002|Overall Study|Progressive Disease|4
1188066|NCT02467270|2346912|FG000|Overall Study|Death|2
1188067|NCT02467270|2346913|FG001|Overall Study|Death|0
1188068|NCT02467270|2346914|FG002|Overall Study|Death|2
1188069|NCT02467270|2346912|FG000|Overall Study|Lack of Efficacy|12
1188070|NCT02467270|2346913|FG001|Overall Study|Lack of Efficacy|18
1188071|NCT02467270|2346914|FG002|Overall Study|Lack of Efficacy|23
1188072|NCT02467270|2346912|FG000|Overall Study|Non-compliance With Study Drug|0
1188073|NCT02467270|2346913|FG001|Overall Study|Non-compliance With Study Drug|2
1188074|NCT02467270|2346914|FG002|Overall Study|Non-compliance With Study Drug|1
1188075|NCT02467270|2346912|FG000|Overall Study|Lost to Follow-up|2
1188076|NCT02467270|2346913|FG001|Overall Study|Lost to Follow-up|1
1188077|NCT02467270|2346914|FG002|Overall Study|Lost to Follow-up|0
1188078|NCT02467270|2346912|FG000|Overall Study|Pregnancy|0
1188079|NCT02467270|2346913|FG001|Overall Study|Pregnancy|1
1188080|NCT02467270|2346914|FG002|Overall Study|Pregnancy|0
1188081|NCT02467270|2346912|FG000|Overall Study|Physician Decision|0
1188082|NCT02467270|2346913|FG001|Overall Study|Physician Decision|4
1188083|NCT02467270|2346914|FG002|Overall Study|Physician Decision|1
1188084|NCT02467270|2346912|FG000|Overall Study|Withdrawal by Subject|4
1188085|NCT02467270|2346913|FG001|Overall Study|Withdrawal by Subject|3
1188086|NCT02467270|2346914|FG002|Overall Study|Withdrawal by Subject|5
1188087|NCT02467270|2346912|FG000|Overall Study|Reason not Specified|1
1188088|NCT02467270|2346913|FG001|Overall Study|Reason not Specified|2
1188089|NCT02467270|2346914|FG002|Overall Study|Reason not Specified|1
1188090|NCT02452554|2346928|FG000|Overall Study|Death|2
1188091|NCT02452554|2346929|FG001|Overall Study|Death|1
1188092|NCT02452554|2346930|FG002|Overall Study|Death|0
1188093|NCT02452554|2346931|FG003|Overall Study|Death|0
1188094|NCT02452554|2346932|FG004|Overall Study|Death|0
1188095|NCT02452554|2346933|FG005|Overall Study|Death|0
1188096|NCT02452554|2346928|FG000|Overall Study|Lack of Efficacy|13
1188097|NCT02452554|2346929|FG001|Overall Study|Lack of Efficacy|14
1188098|NCT02452554|2346930|FG002|Overall Study|Lack of Efficacy|9
1188099|NCT02452554|2346931|FG003|Overall Study|Lack of Efficacy|1
1188100|NCT02452554|2346932|FG004|Overall Study|Lack of Efficacy|5
1188101|NCT02452554|2346933|FG005|Overall Study|Lack of Efficacy|8
1188102|NCT02452554|2346928|FG000|Overall Study|Physician Decision|0
1188103|NCT02452554|2346929|FG001|Overall Study|Physician Decision|1
1188104|NCT02452554|2346930|FG002|Overall Study|Physician Decision|0
1188105|NCT02452554|2346931|FG003|Overall Study|Physician Decision|0
1188106|NCT02452554|2346932|FG004|Overall Study|Physician Decision|0
1188107|NCT02452554|2346933|FG005|Overall Study|Physician Decision|0
1188108|NCT02452554|2346928|FG000|Overall Study|Withdrawal by Subject|1
1188109|NCT02452554|2346929|FG001|Overall Study|Withdrawal by Subject|0
1188110|NCT02452554|2346930|FG002|Overall Study|Withdrawal by Subject|2
1188111|NCT02452554|2346931|FG003|Overall Study|Withdrawal by Subject|0
1188112|NCT02452554|2346932|FG004|Overall Study|Withdrawal by Subject|0
1188113|NCT02452554|2346933|FG005|Overall Study|Withdrawal by Subject|1
1188114|NCT02452554|2346928|FG000|Overall Study|Ineligible|0
1188115|NCT02452554|2346929|FG001|Overall Study|Ineligible|1
1188116|NCT02452554|2346930|FG002|Overall Study|Ineligible|0
1188117|NCT02452554|2346931|FG003|Overall Study|Ineligible|0
1188118|NCT02452554|2346932|FG004|Overall Study|Ineligible|0
1188119|NCT02452554|2346933|FG005|Overall Study|Ineligible|0
1188120|NCT02452554|2346928|FG000|Overall Study|Never Received Treatment|1
1188121|NCT02452554|2346929|FG001|Overall Study|Never Received Treatment|0
1188122|NCT02452554|2346930|FG002|Overall Study|Never Received Treatment|0
1188123|NCT02452554|2346931|FG003|Overall Study|Never Received Treatment|0
1188124|NCT02452554|2346932|FG004|Overall Study|Never Received Treatment|0
1188125|NCT02452554|2346933|FG005|Overall Study|Never Received Treatment|0
1188126|NCT02335424|2346961|FG000|Overall Study|Withdrawal by Subject|12
1188127|NCT02335424|2346961|FG000|Overall Study|Ongoing In Study|89
1188128|NCT02335424|2346961|FG000|Overall Study|Adverse Event|25
1188129|NCT02335424|2346961|FG000|Overall Study|Death|239
1188130|NCT02335424|2346961|FG000|Overall Study|Lost to Follow-up|2
1188131|NCT02335424|2346961|FG000|Overall Study|Physician Decision|3
1188132|NCT02335424|2346961|FG000|Overall Study|Not treated|4
1188133|NCT02318277|2346973|FG000|Overall Study|Physician Decision|0
1188134|NCT02318277|2346974|FG001|Overall Study|Physician Decision|0
1188135|NCT02318277|2346975|FG002|Overall Study|Physician Decision|0
1188136|NCT02318277|2346976|FG003|Overall Study|Physician Decision|0
1188137|NCT02318277|2346977|FG004|Overall Study|Physician Decision|0
1188138|NCT02318277|2346978|FG005|Overall Study|Physician Decision|0
1188139|NCT02318277|2346979|FG006|Overall Study|Physician Decision|0
1188140|NCT02318277|2346980|FG007|Overall Study|Physician Decision|1
1188141|NCT02318277|2346973|FG000|Overall Study|Other|0
1188142|NCT02318277|2346974|FG001|Overall Study|Other|0
1188143|NCT02318277|2346975|FG002|Overall Study|Other|0
1188144|NCT02318277|2346976|FG003|Overall Study|Other|0
1188145|NCT02318277|2346977|FG004|Overall Study|Other|0
1188146|NCT02318277|2346978|FG005|Overall Study|Other|0
1188147|NCT02318277|2346979|FG006|Overall Study|Other|1
1188148|NCT02318277|2346980|FG007|Overall Study|Other|0
1188149|NCT02318277|2346973|FG000|Overall Study|Withdrawal by Subject|0
1188150|NCT02318277|2346974|FG001|Overall Study|Withdrawal by Subject|0
1188151|NCT02318277|2346975|FG002|Overall Study|Withdrawal by Subject|1
1188152|NCT02318277|2346976|FG003|Overall Study|Withdrawal by Subject|0
1188153|NCT02318277|2346977|FG004|Overall Study|Withdrawal by Subject|1
1188154|NCT02318277|2346978|FG005|Overall Study|Withdrawal by Subject|1
1188155|NCT02318277|2346979|FG006|Overall Study|Withdrawal by Subject|6
880474|NCT00592774|1844913|FG001|Overall Study|Physician Decision|1
880475|NCT00592774|1844914|FG002|Overall Study|Physician Decision|1
880476|NCT00592774|1844915|FG003|Overall Study|Physician Decision|0
880477|NCT00592774|1844916|FG004|Overall Study|Physician Decision|1
880478|NCT00592774|1844912|FG000|Overall Study|Other|0
880479|NCT00592774|1844913|FG001|Overall Study|Other|1
880480|NCT00592774|1844914|FG002|Overall Study|Other|1
880481|NCT00592774|1844915|FG003|Overall Study|Other|0
880482|NCT00592774|1844916|FG004|Overall Study|Other|2
880483|NCT00592839|1844931|FG000|Overall Study|Withdrawal by Subject|1
880484|NCT00592839|1844932|FG001|Overall Study|Withdrawal by Subject|1
880485|NCT00592839|1844933|FG002|Overall Study|Withdrawal by Subject|3
880486|NCT00592839|1844931|FG000|Overall Study|Protocol Violation|1
880487|NCT00592839|1844932|FG001|Overall Study|Protocol Violation|1
880488|NCT00592839|1844933|FG002|Overall Study|Protocol Violation|2
880489|NCT00592839|1844931|FG000|Overall Study|Adverse Event|0
880490|NCT00592839|1844932|FG001|Overall Study|Adverse Event|1
880491|NCT00592839|1844933|FG002|Overall Study|Adverse Event|0
880492|NCT00592839|1844931|FG000|Overall Study|Lost to Follow-up|0
880493|NCT00592839|1844932|FG001|Overall Study|Lost to Follow-up|1
880494|NCT00592839|1844933|FG002|Overall Study|Lost to Follow-up|1
880495|NCT00592852|1844941|FG000|Overall Study|Non-compliance|1
880496|NCT00592852|1844941|FG000|Overall Study|Adverse Event|3
880497|NCT00592852|1844941|FG000|Overall Study|Found ineligible|1
880498|NCT00592852|1844941|FG000|Overall Study|Withdrawal by Subject|1
880499|NCT00592904|1844949|FG000|Overall Study|Adverse Event|15
880500|NCT00592904|1844950|FG001|Overall Study|Adverse Event|25
880501|NCT00592904|1844951|FG002|Overall Study|Adverse Event|13
880502|NCT00592904|1844952|FG003|Overall Study|Adverse Event|5
880503|NCT00592904|1844949|FG000|Overall Study|Protocol Violation|1
880504|NCT00592904|1844950|FG001|Overall Study|Protocol Violation|1
880505|NCT00592904|1844951|FG002|Overall Study|Protocol Violation|0
880506|NCT00592904|1844952|FG003|Overall Study|Protocol Violation|1
880507|NCT00592904|1844949|FG000|Overall Study|Withdrawal by Subject|4
880508|NCT00592904|1844950|FG001|Overall Study|Withdrawal by Subject|16
880509|NCT00592904|1844951|FG002|Overall Study|Withdrawal by Subject|1
880510|NCT00592904|1844952|FG003|Overall Study|Withdrawal by Subject|2
880511|NCT00592904|1844949|FG000|Overall Study|Lack of Efficacy|2
880512|NCT00592904|1844950|FG001|Overall Study|Lack of Efficacy|7
880513|NCT00592904|1844951|FG002|Overall Study|Lack of Efficacy|2
1188156|NCT02318277|2346980|FG007|Overall Study|Withdrawal by Subject|14
1188157|NCT02318277|2346973|FG000|Overall Study|Participant trial terminated by sponsor|0
880514|NCT00592904|1844952|FG003|Overall Study|Lack of Efficacy|3
880515|NCT00592904|1844949|FG000|Overall Study|Physician Decision|0
880516|NCT00592904|1844950|FG001|Overall Study|Physician Decision|3
880517|NCT00592904|1844951|FG002|Overall Study|Physician Decision|1
880518|NCT00592904|1844952|FG003|Overall Study|Physician Decision|0
880519|NCT00592904|1844949|FG000|Overall Study|Other|3
880520|NCT00592904|1844950|FG001|Overall Study|Other|3
880521|NCT00592904|1844951|FG002|Overall Study|Other|0
880522|NCT00592904|1844952|FG003|Overall Study|Other|0
880523|NCT00593112|1844973|FG000|Overall Study|Scan Anxiety|3
880524|NCT00593112|1844974|FG001|Overall Study|Scan Anxiety|0
880525|NCT00593112|1844973|FG000|Overall Study|Abnormal Scan|1
880526|NCT00593112|1844974|FG001|Overall Study|Abnormal Scan|0
880527|NCT00593112|1844973|FG000|Overall Study|Unreadable Scan|1
880528|NCT00593112|1844974|FG001|Overall Study|Unreadable Scan|0
880529|NCT00593112|1844973|FG000|Overall Study|Withdrawal by Subject|5
880530|NCT00593112|1844974|FG001|Overall Study|Withdrawal by Subject|0
880531|NCT00593333|1844982|FG000|Overall Study|Lost to Follow-up|10
880532|NCT00593333|1844983|FG001|Overall Study|Lost to Follow-up|11
880533|NCT00593385|1845003|FG000|Overall Study|Death|14
880534|NCT00593385|1845003|FG000|Overall Study|Lost to Follow-up|17
880535|NCT00593385|1845003|FG000|Overall Study|Withdrawal by Subject|9
880536|NCT00593489|1845028|FG000|Allocation|did not attend workshop; allocation not|2
880537|NCT00593489|1845029|FG001|Allocation|did not attend workshop; allocation not|1
880538|NCT00593554|1845039|FG000|Overall Study|Death|1
880539|NCT00593554|1845040|FG001|Overall Study|Death|2
880540|NCT00593554|1845039|FG000|Overall Study|Physician Decision|0
880541|NCT00593554|1845040|FG001|Overall Study|Physician Decision|1
880542|NCT00593554|1845039|FG000|Overall Study|Withdrawal by Subject|1
880543|NCT00593554|1845040|FG001|Overall Study|Withdrawal by Subject|0
880544|NCT00593554|1845039|FG000|Overall Study|Disease Progression|1
880545|NCT00593554|1845040|FG001|Overall Study|Disease Progression|2
880546|NCT00593606|1845046|FG000|Overall Study|Adverse Event|13
880547|NCT00593606|1845046|FG000|Overall Study|Withdrawal by Subject|1
880548|NCT00593606|1845046|FG000|Overall Study|Protocol Violation|3
880549|NCT00593606|1845046|FG000|Overall Study|Lost to Follow-up|2
880550|NCT00593606|1845046|FG000|Overall Study|Run-In Failure|5
880551|NCT00593606|1845046|FG000|Overall Study|Screen Failure|3
880552|NCT00593684|1845056|FG000|Overall Study|Death|2
880553|NCT00593684|1845057|FG001|Overall Study|Death|1
880554|NCT00593736|1845067|FG000|Screening Period and Placebo Run-in|Adverse Event|0
880555|NCT00593736|1845068|FG001|Screening Period and Placebo Run-in|Adverse Event|0
880556|NCT00593736|1845069|FG002|Screening Period and Placebo Run-in|Adverse Event|0
880557|NCT00593736|1845070|FG003|Screening Period and Placebo Run-in|Adverse Event|3
1188158|NCT02318277|2346974|FG001|Overall Study|Participant trial terminated by sponsor|0
1188159|NCT02318277|2346975|FG002|Overall Study|Participant trial terminated by sponsor|1
1188160|NCT02318277|2346976|FG003|Overall Study|Participant trial terminated by sponsor|0
1188161|NCT02318277|2346977|FG004|Overall Study|Participant trial terminated by sponsor|1
1188162|NCT02318277|2346978|FG005|Overall Study|Participant trial terminated by sponsor|2
1188163|NCT02318277|2346979|FG006|Overall Study|Participant trial terminated by sponsor|5
1188164|NCT02318277|2346980|FG007|Overall Study|Participant trial terminated by sponsor|16
1188165|NCT02318277|2346973|FG000|Overall Study|Lost to Follow-up|1
1188166|NCT02318277|2346974|FG001|Overall Study|Lost to Follow-up|0
1188167|NCT02318277|2346975|FG002|Overall Study|Lost to Follow-up|1
1188168|NCT02318277|2346976|FG003|Overall Study|Lost to Follow-up|0
1188169|NCT02318277|2346977|FG004|Overall Study|Lost to Follow-up|0
1188170|NCT02318277|2346978|FG005|Overall Study|Lost to Follow-up|0
1188171|NCT02318277|2346979|FG006|Overall Study|Lost to Follow-up|3
1188172|NCT02318277|2346980|FG007|Overall Study|Lost to Follow-up|4
1188173|NCT02318277|2346973|FG000|Overall Study|Death|5
1188174|NCT02318277|2346974|FG001|Overall Study|Death|3
1188175|NCT02318277|2346975|FG002|Overall Study|Death|1
1188176|NCT02318277|2346976|FG003|Overall Study|Death|4
1188177|NCT02318277|2346977|FG004|Overall Study|Death|6
1188178|NCT02318277|2346978|FG005|Overall Study|Death|5
1188179|NCT02318277|2346979|FG006|Overall Study|Death|34
1188180|NCT02318277|2346980|FG007|Overall Study|Death|58
1188181|NCT02318277|2346973|FG000|Overall Study|Transitioned to Hospice|0
1188182|NCT02318277|2346974|FG001|Overall Study|Transitioned to Hospice|0
1188183|NCT02318277|2346975|FG002|Overall Study|Transitioned to Hospice|0
1188184|NCT02318277|2346976|FG003|Overall Study|Transitioned to Hospice|0
1188185|NCT02318277|2346977|FG004|Overall Study|Transitioned to Hospice|0
1188186|NCT02318277|2346978|FG005|Overall Study|Transitioned to Hospice|1
1188187|NCT02318277|2346979|FG006|Overall Study|Transitioned to Hospice|0
880558|NCT00593736|1845067|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0
880559|NCT00593736|1845068|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0
880560|NCT00593736|1845069|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0
880561|NCT00593736|1845070|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9
880562|NCT00593736|1845067|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0
880563|NCT00593736|1845068|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0
880564|NCT00593736|1845069|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0
880565|NCT00593736|1845070|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43
1188188|NCT02318277|2346980|FG007|Overall Study|Transitioned to Hospice|0
1188219|NCT02143063|2347045|FG000|Overall Study|Lost to Follow-up|16
1188220|NCT02143063|2347046|FG001|Overall Study|Lost to Follow-up|28
1188221|NCT02143063|2347047|FG002|Overall Study|Lost to Follow-up|29
1188222|NCT02143063|2347045|FG000|Overall Study|Withdrawal by Subject|0
1188223|NCT02143063|2347046|FG001|Overall Study|Withdrawal by Subject|1
1188224|NCT02143063|2347047|FG002|Overall Study|Withdrawal by Subject|0
1188225|NCT02143063|2347045|FG000|Overall Study|Death|0
1188226|NCT02143063|2347046|FG001|Overall Study|Death|1
1188227|NCT02143063|2347047|FG002|Overall Study|Death|1
1188228|NCT02017964|2347055|FG000|Overall Study|Patient deemed ineligible|1
1188229|NCT01968785|2347061|FG000|Overall Study|Withdrawal by Subject|1
1188230|NCT01968785|2347062|FG001|Overall Study|Withdrawal by Subject|0
1188231|NCT01956110|2347070|FG000|Overall Study|Protocol Violation|25
1188232|NCT01956110|2347071|FG001|Overall Study|Protocol Violation|11
1188233|NCT01956110|2347070|FG000|Overall Study|Adverse Event|9
1188234|NCT01956110|2347071|FG001|Overall Study|Adverse Event|10
1188235|NCT01956110|2347070|FG000|Overall Study|Personal reasons|1
1188236|NCT01956110|2347071|FG001|Overall Study|Personal reasons|1
1188237|NCT01648023|2347080|FG000|Overall Study|Screen Fail Post Randomization|1
1188238|NCT01648023|2347081|FG001|Overall Study|Screen Fail Post Randomization|2
1188239|NCT01083433|2347104|FG000|Overall Study|Lost to Follow-up|2
1188240|NCT01083433|2347105|FG001|Overall Study|Lost to Follow-up|1
1188241|NCT01083433|2347106|FG002|Overall Study|Lost to Follow-up|1
1188242|NCT01083433|2347104|FG000|Overall Study|Withdrawal by Subject|0
1188243|NCT01083433|2347105|FG001|Overall Study|Withdrawal by Subject|5
1188244|NCT01083433|2347106|FG002|Overall Study|Withdrawal by Subject|3
1188245|NCT01083433|2347104|FG000|Overall Study|Pregnancy|0
1188246|NCT01083433|2347105|FG001|Overall Study|Pregnancy|0
1188247|NCT01083433|2347106|FG002|Overall Study|Pregnancy|1
1188248|NCT00787176|2347132|FG000|Overall Study|Low quality fetal heart rate tracing|7
1188249|NCT00787176|2347133|FG001|Overall Study|Low quality fetal heart rate tracing|3
1188250|NCT00787176|2347134|FG002|Overall Study|Low quality fetal heart rate tracing|6
1188251|NCT00787176|2347135|FG003|Overall Study|Low quality fetal heart rate tracing|5
1188252|NCT00352534|2347148|FG000|Initial Staging|Ineligible|8
1188253|NCT00352534|2347149|FG001|Initial Staging|Ineligible|9
1188254|NCT00352534|2347150|FG002|Initial Staging|Ineligible|0
1188255|NCT00352534|2347151|FG003|Initial Staging|Ineligible|0
1188256|NCT00352534|2347152|FG004|Initial Staging|Ineligible|0
1188257|NCT00352534|2347153|FG005|Initial Staging|Ineligible|0
1188258|NCT00352534|2347154|FG006|Initial Staging|Ineligible|0
1188259|NCT00352534|2347148|FG000|Final Risk Group Assignment|Lack of Efficacy|0
1188260|NCT00352534|2347149|FG001|Final Risk Group Assignment|Lack of Efficacy|0
1188261|NCT00352534|2347150|FG002|Final Risk Group Assignment|Lack of Efficacy|0
1188262|NCT00352534|2347151|FG003|Final Risk Group Assignment|Lack of Efficacy|2
1188263|NCT00352534|2347152|FG004|Final Risk Group Assignment|Lack of Efficacy|1
1188264|NCT00352534|2347153|FG005|Final Risk Group Assignment|Lack of Efficacy|19
1188265|NCT00352534|2347154|FG006|Final Risk Group Assignment|Lack of Efficacy|0
1188266|NCT00352534|2347148|FG000|Final Risk Group Assignment|Physician Decision|0
1188267|NCT00352534|2347149|FG001|Final Risk Group Assignment|Physician Decision|0
1188268|NCT00352534|2347150|FG002|Final Risk Group Assignment|Physician Decision|0
1188269|NCT00352534|2347151|FG003|Final Risk Group Assignment|Physician Decision|0
1188270|NCT00352534|2347152|FG004|Final Risk Group Assignment|Physician Decision|0
1188271|NCT00352534|2347153|FG005|Final Risk Group Assignment|Physician Decision|8
1188272|NCT00352534|2347154|FG006|Final Risk Group Assignment|Physician Decision|0
1188273|NCT00352534|2347148|FG000|Final Risk Group Assignment|Withdrawal by Subject|0
1188274|NCT00352534|2347149|FG001|Final Risk Group Assignment|Withdrawal by Subject|0
1188275|NCT00352534|2347150|FG002|Final Risk Group Assignment|Withdrawal by Subject|0
1188276|NCT00352534|2347151|FG003|Final Risk Group Assignment|Withdrawal by Subject|0
1188277|NCT00352534|2347152|FG004|Final Risk Group Assignment|Withdrawal by Subject|0
1188278|NCT00352534|2347153|FG005|Final Risk Group Assignment|Withdrawal by Subject|3
1188279|NCT00352534|2347154|FG006|Final Risk Group Assignment|Withdrawal by Subject|0
1188280|NCT00352534|2347148|FG000|Final Risk Group Assignment|Ineligible|0
1188281|NCT00352534|2347149|FG001|Final Risk Group Assignment|Ineligible|0
1188282|NCT00352534|2347150|FG002|Final Risk Group Assignment|Ineligible|3
1188283|NCT00352534|2347151|FG003|Final Risk Group Assignment|Ineligible|1
1188284|NCT00352534|2347152|FG004|Final Risk Group Assignment|Ineligible|0
1188285|NCT00352534|2347153|FG005|Final Risk Group Assignment|Ineligible|13
1188286|NCT00352534|2347154|FG006|Final Risk Group Assignment|Ineligible|0
1188287|NCT00352534|2347148|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0
1188288|NCT00352534|2347149|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0
1188289|NCT00352534|2347150|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0
1188290|NCT00352534|2347151|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0
1188291|NCT00352534|2347152|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0
1188292|NCT00352534|2347153|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0
1188293|NCT00352534|2347154|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28
1188294|NCT00352534|2347148|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1188295|NCT00352534|2347149|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1188296|NCT00352534|2347150|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1188297|NCT00352534|2347151|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1188298|NCT00352534|2347152|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1188299|NCT00352534|2347153|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1188300|NCT00352534|2347154|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
1188301|NCT00352534|2347148|FG000|Final Risk Group Assignment|Death|0
1188302|NCT00352534|2347149|FG001|Final Risk Group Assignment|Death|0
1188303|NCT00352534|2347150|FG002|Final Risk Group Assignment|Death|0
1188304|NCT00352534|2347151|FG003|Final Risk Group Assignment|Death|0
1188305|NCT00352534|2347152|FG004|Final Risk Group Assignment|Death|0
1188306|NCT00352534|2347153|FG005|Final Risk Group Assignment|Death|2
1188307|NCT00352534|2347154|FG006|Final Risk Group Assignment|Death|0
1188308|NCT00033293|2347166|FG000|Overall Study|Death|0
1188309|NCT00033293|2347167|FG001|Overall Study|Death|1
1188310|NCT00033293|2347166|FG000|Overall Study|Lack of Efficacy|5
1188311|NCT00033293|2347167|FG001|Overall Study|Lack of Efficacy|8
1188312|NCT00033293|2347166|FG000|Overall Study|Lost to Follow-up|0
1188313|NCT00033293|2347167|FG001|Overall Study|Lost to Follow-up|1
1188314|NCT00033293|2347166|FG000|Overall Study|Physician Decision|3
1188315|NCT00033293|2347167|FG001|Overall Study|Physician Decision|1
1188316|NCT00033293|2347166|FG000|Overall Study|Withdrawal by Subject|1
1188317|NCT00033293|2347167|FG001|Overall Study|Withdrawal by Subject|0
1188318|NCT00033293|2347166|FG000|Overall Study|Could not be weaned from steroid therapy|1
1188319|NCT00033293|2347167|FG001|Overall Study|Could not be weaned from steroid therapy|1
1188320|NCT00033293|2347166|FG000|Overall Study|Treatment refused|0
1188321|NCT00033293|2347167|FG001|Overall Study|Treatment refused|6
1188322|NCT04497415|2347177|FG000|Overall Study|Lost to Follow-up|43
1188323|NCT04497415|2347178|FG001|Overall Study|Lost to Follow-up|27
1188324|NCT03894540|2347212|FG000|Overall Study|Adverse Event|0
1188325|NCT03894540|2347213|FG001|Overall Study|Adverse Event|0
1188326|NCT03894540|2347214|FG002|Overall Study|Adverse Event|0
1188327|NCT03894540|2347215|FG003|Overall Study|Adverse Event|0
1188328|NCT03894540|2347216|FG004|Overall Study|Adverse Event|1
1188329|NCT03894540|2347217|FG005|Overall Study|Adverse Event|0
1188330|NCT03894540|2347212|FG000|Overall Study|Withdrawal by Subject|0
1188331|NCT03894540|2347213|FG001|Overall Study|Withdrawal by Subject|0
1188332|NCT03894540|2347214|FG002|Overall Study|Withdrawal by Subject|0
1188333|NCT03894540|2347215|FG003|Overall Study|Withdrawal by Subject|0
1188334|NCT03894540|2347216|FG004|Overall Study|Withdrawal by Subject|1
1188335|NCT03894540|2347217|FG005|Overall Study|Withdrawal by Subject|0
1188336|NCT03894540|2347212|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
1188337|NCT03894540|2347213|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
1188338|NCT03894540|2347214|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1
1188339|NCT03894540|2347215|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
1188340|NCT03894540|2347216|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2
1188341|NCT03894540|2347217|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
1188342|NCT03894540|2347212|FG000|Overall Study|Progressive Disease Clinical|1
880566|NCT00593736|1845067|FG000|Screening Period and Placebo Run-in|Study Termination|0
880567|NCT00593736|1845068|FG001|Screening Period and Placebo Run-in|Study Termination|0
880568|NCT00593736|1845069|FG002|Screening Period and Placebo Run-in|Study Termination|0
880569|NCT00593736|1845070|FG003|Screening Period and Placebo Run-in|Study Termination|15
880570|NCT00593736|1845067|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
880571|NCT00593736|1845068|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
880572|NCT00593736|1845069|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
880573|NCT00593736|1845070|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
880574|NCT00593736|1845067|FG000|Screening Period and Placebo Run-in|Various|0
880575|NCT00593736|1845068|FG001|Screening Period and Placebo Run-in|Various|0
880576|NCT00593736|1845069|FG002|Screening Period and Placebo Run-in|Various|0
880577|NCT00593736|1845070|FG003|Screening Period and Placebo Run-in|Various|25
880578|NCT00593736|1845067|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2
880579|NCT00593736|1845068|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1
880580|NCT00593736|1845069|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2
880581|NCT00593736|1845070|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0
880582|NCT00593736|1845067|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0
880583|NCT00593736|1845068|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0
880584|NCT00593736|1845069|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1
880585|NCT00593736|1845070|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1
880586|NCT00593736|1845067|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
880587|NCT00593736|1845068|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
880588|NCT00593736|1845069|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
880589|NCT00593736|1845070|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
880590|NCT00593736|1845067|FG000|Treatment Period and Placebo Run-out|Various|1
880591|NCT00593736|1845068|FG001|Treatment Period and Placebo Run-out|Various|1
880592|NCT00593736|1845069|FG002|Treatment Period and Placebo Run-out|Various|1
880593|NCT00593736|1845070|FG003|Treatment Period and Placebo Run-out|Various|0
880594|NCT00593814|1845082|FG000|Overall Study|Death|7
880595|NCT00593814|1845083|FG001|Overall Study|Death|0
880596|NCT00593814|1845082|FG000|Overall Study|Withdrawal by Subject|7
880597|NCT00593814|1845083|FG001|Overall Study|Withdrawal by Subject|0
880598|NCT00593814|1845082|FG000|Overall Study|Lost to Follow-up|7
880599|NCT00593814|1845083|FG001|Overall Study|Lost to Follow-up|0
880600|NCT00593814|1845082|FG000|Overall Study|Physician Decision|3
880601|NCT00593814|1845083|FG001|Overall Study|Physician Decision|0
880602|NCT00593827|1845091|FG000|Overall Study|On Active Treatment/Pending|0
880603|NCT00593827|1845092|FG001|Overall Study|On Active Treatment/Pending|2
880604|NCT00593840|1845098|FG000|Overall Study|Withdrawal by Subject|1
880605|NCT00593918|1845108|FG000|Overall Study|Withdrawal by Subject|5
880606|NCT00593918|1845109|FG001|Overall Study|Withdrawal by Subject|24
880607|NCT00593957|1845118|FG000|Overall Study|Physician Decision|0
880608|NCT00593957|1845119|FG001|Overall Study|Physician Decision|1
880609|NCT00593957|1845120|FG002|Overall Study|Physician Decision|2
880610|NCT00594035|1845157|FG000|Overall Study|Lost to Follow-up|1
880611|NCT00594035|1845158|FG001|Overall Study|Lost to Follow-up|1
880612|NCT00594035|1845157|FG000|Overall Study|Withdrawal by Subject|1
880613|NCT00594035|1845158|FG001|Overall Study|Withdrawal by Subject|0
880614|NCT00594035|1845157|FG000|Overall Study|Subject transferred to nursing home|0
1188343|NCT03894540|2347213|FG001|Overall Study|Progressive Disease Clinical|1
1188344|NCT03894540|2347214|FG002|Overall Study|Progressive Disease Clinical|0
1188345|NCT03894540|2347215|FG003|Overall Study|Progressive Disease Clinical|1
1188346|NCT03894540|2347216|FG004|Overall Study|Progressive Disease Clinical|5
1188347|NCT03894540|2347217|FG005|Overall Study|Progressive Disease Clinical|1
1188348|NCT03894540|2347212|FG000|Overall Study|Study termination by sponsor|0
1188349|NCT03894540|2347213|FG001|Overall Study|Study termination by sponsor|0
1188350|NCT03894540|2347214|FG002|Overall Study|Study termination by sponsor|0
1188351|NCT03894540|2347215|FG003|Overall Study|Study termination by sponsor|0
1188352|NCT03894540|2347216|FG004|Overall Study|Study termination by sponsor|2
1188353|NCT03894540|2347217|FG005|Overall Study|Study termination by sponsor|0
1188354|NCT03725293|2347250|FG000|Overall Study|Physician Decision|9
1188355|NCT03725293|2347251|FG001|Overall Study|Physician Decision|6
1188356|NCT03725293|2347250|FG000|Overall Study|alternative vascular access needs|1
1188357|NCT03725293|2347251|FG001|Overall Study|alternative vascular access needs|2
1188358|NCT03725293|2347250|FG000|Overall Study|venous anatomy screen failures|2
1188359|NCT03725293|2347251|FG001|Overall Study|venous anatomy screen failures|1
1188360|NCT03702231|2347260|FG000|Overall Study|Withdrawal by Subject|1
1188361|NCT03702231|2347261|FG001|Overall Study|Withdrawal by Subject|0
1188362|NCT03702231|2347262|FG002|Overall Study|Withdrawal by Subject|0
1188363|NCT03702231|2347260|FG000|Overall Study|Protocol Violation|0
1188364|NCT03702231|2347261|FG001|Overall Study|Protocol Violation|0
1188365|NCT03702231|2347262|FG002|Overall Study|Protocol Violation|1
1188366|NCT03702231|2347260|FG000|Overall Study|COVID Pandemic|3
1188367|NCT03702231|2347261|FG001|Overall Study|COVID Pandemic|4
1188368|NCT03702231|2347262|FG002|Overall Study|COVID Pandemic|1
1188369|NCT03600805|2347295|FG000|Overall Study|Adverse Event|2
1188370|NCT03600805|2347296|FG001|Overall Study|Adverse Event|1
1188371|NCT03600805|2347297|FG002|Overall Study|Adverse Event|1
1188372|NCT03600805|2347298|FG003|Overall Study|Adverse Event|7
880615|NCT00594035|1845158|FG001|Overall Study|Subject transferred to nursing home|1
880616|NCT00594035|1845157|FG000|Overall Study|Subject couldn't return due to job|0
880617|NCT00594035|1845158|FG001|Overall Study|Subject couldn't return due to job|1
880618|NCT00594100|1845168|FG000|Procedure|Technical Failure|9
880619|NCT00594100|1845168|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
880620|NCT00594100|1845168|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
880621|NCT00594100|1845168|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
880622|NCT00594165|1845172|FG000|Overall Study|Major protocol violation|1
880623|NCT00594165|1845172|FG000|Overall Study|Lack of Efficacy|12
880624|NCT00594165|1845172|FG000|Overall Study|Adverse Event|52
880625|NCT00594165|1845172|FG000|Overall Study|Unsatisfactory compliance of subject|6
880626|NCT00594165|1845172|FG000|Overall Study|Subject withdrew consent|27
880627|NCT00594165|1845172|FG000|Overall Study|Study ended per sponsor|102
880628|NCT00594165|1845172|FG000|Overall Study|Lost to Follow-up|4
880629|NCT00594165|1845172|FG000|Overall Study|Other: PI discretion|5
880630|NCT00594165|1845172|FG000|Overall Study|Other: Subject moving|3
880631|NCT00594165|1845172|FG000|Overall Study|Other: Brain surgery controlled symptoms|1
880632|NCT00594165|1845172|FG000|Overall Study|Other: House bound; can't get to clinic|1
880633|NCT00594165|1845172|FG000|Overall Study|Other: Subject enrolled in other trial|1
880634|NCT00594165|1845172|FG000|Overall Study|Other: Site terminated participation|2
880635|NCT00594178|1845176|FG000|Overall Study|Physician Decision|5
880636|NCT00594204|1845182|FG000|Overall Study|Adverse Event|15
880637|NCT00594204|1845183|FG001|Overall Study|Adverse Event|3
880638|NCT00594204|1845182|FG000|Overall Study|Lost to Follow-up|9
880639|NCT00594204|1845183|FG001|Overall Study|Lost to Follow-up|5
880640|NCT00594204|1845182|FG000|Overall Study|Withdrawal by Subject|23
880641|NCT00594204|1845183|FG001|Overall Study|Withdrawal by Subject|29
880642|NCT00594204|1845182|FG000|Overall Study|Other|4
880643|NCT00594204|1845183|FG001|Overall Study|Other|3
880644|NCT00594204|1845182|FG000|Overall Study|Lack of Efficacy|3
880645|NCT00594204|1845183|FG001|Overall Study|Lack of Efficacy|4
880646|NCT00594204|1845182|FG000|Overall Study|Randomized but not treated|4
880647|NCT00594204|1845183|FG001|Overall Study|Randomized but not treated|1
880648|NCT00594386|1845207|FG000|Overall Study|Major protocol violation|2
880649|NCT00594386|1845207|FG000|Overall Study|Lack of Efficacy|12
880650|NCT00594386|1845207|FG000|Overall Study|Adverse Event|68
880651|NCT00594386|1845207|FG000|Overall Study|Unsatisfactory compliance of subject|11
880652|NCT00594386|1845207|FG000|Overall Study|Subject withdrew consent|35
880653|NCT00594386|1845207|FG000|Overall Study|Study ended per sponsor|115
880654|NCT00594386|1845207|FG000|Overall Study|Lost to Follow-up|6
880655|NCT00594386|1845207|FG000|Overall Study|Other: Patient went off patch (hospital)|1
880656|NCT00594386|1845207|FG000|Overall Study|Other: Subject moved to Seattle|1
880657|NCT00594386|1845207|FG000|Overall Study|Other: Subject admitted to nursing home|1
880658|NCT00594386|1845207|FG000|Overall Study|Other: Study terminated per investigator|2
880659|NCT00594386|1845207|FG000|Overall Study|Other: Sponsor closure of study|1
880660|NCT00594386|1845207|FG000|Overall Study|Other: Site terminated participation|1
880661|NCT00594386|1845207|FG000|Overall Study|Other: Patient wants prescription Neupro|1
880662|NCT00594386|1845207|FG000|Overall Study|Other: Loss of drivers license|1
880663|NCT00594399|1845213|FG000|Initial 3 Month Counseling|Not ready to exercise|1
1188373|NCT03600805|2347295|FG000|Overall Study|Lack of Efficacy|2
1188374|NCT03600805|2347296|FG001|Overall Study|Lack of Efficacy|1
880664|NCT00594399|1845214|FG001|Initial 3 Month Counseling|Not ready to exercise|0
880665|NCT00594399|1845215|FG002|Initial 3 Month Counseling|Not ready to exercise|0
880666|NCT00594399|1845213|FG000|Initial 3 Month Counseling|Lack of Interest|3
880667|NCT00594399|1845214|FG001|Initial 3 Month Counseling|Lack of Interest|3
880668|NCT00594399|1845215|FG002|Initial 3 Month Counseling|Lack of Interest|0
880669|NCT00594399|1845213|FG000|Initial 3 Month Counseling|Personal issues|2
1188375|NCT03600805|2347297|FG002|Overall Study|Lack of Efficacy|0
1188376|NCT03600805|2347298|FG003|Overall Study|Lack of Efficacy|0
1188377|NCT03600805|2347295|FG000|Overall Study|Withdrawal by Subject|1
1188378|NCT03600805|2347296|FG001|Overall Study|Withdrawal by Subject|0
1188379|NCT03600805|2347297|FG002|Overall Study|Withdrawal by Subject|0
1188380|NCT03600805|2347298|FG003|Overall Study|Withdrawal by Subject|1
880670|NCT00594399|1845214|FG001|Initial 3 Month Counseling|Personal issues|0
880671|NCT00594399|1845215|FG002|Initial 3 Month Counseling|Personal issues|0
880672|NCT00594399|1845213|FG000|Initial 3 Month Counseling|Too busy|7
880673|NCT00594399|1845214|FG001|Initial 3 Month Counseling|Too busy|1
880674|NCT00594399|1845215|FG002|Initial 3 Month Counseling|Too busy|0
880675|NCT00594399|1845213|FG000|Initial 3 Month Counseling|Pain|2
880676|NCT00594399|1845214|FG001|Initial 3 Month Counseling|Pain|0
880677|NCT00594399|1845215|FG002|Initial 3 Month Counseling|Pain|0
880678|NCT00594399|1845213|FG000|Initial 3 Month Counseling|Moved|1
880679|NCT00594399|1845214|FG001|Initial 3 Month Counseling|Moved|0
880680|NCT00594399|1845215|FG002|Initial 3 Month Counseling|Moved|0
880681|NCT00594399|1845213|FG000|Initial 3 Month Counseling|Family illness|1
880682|NCT00594399|1845214|FG001|Initial 3 Month Counseling|Family illness|0
880683|NCT00594399|1845215|FG002|Initial 3 Month Counseling|Family illness|0
880684|NCT00594399|1845213|FG000|Rerandomization Arm 1 Only|Death|2
880685|NCT00594399|1845214|FG001|Rerandomization Arm 1 Only|Death|1
880686|NCT00594399|1845215|FG002|Rerandomization Arm 1 Only|Death|0
880687|NCT00594399|1845213|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0
880688|NCT00594399|1845214|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3
880689|NCT00594399|1845215|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0
880690|NCT00594464|1845234|FG000|Overall Study|Withdrawal by Subject|1
880691|NCT00594464|1845234|FG000|Overall Study|Delay in operation|2
880692|NCT00594516|1845244|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
880693|NCT00594516|1845245|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
880694|NCT00594516|1845246|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
880695|NCT00594516|1845244|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
880696|NCT00594516|1845245|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
880697|NCT00594516|1845246|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
880698|NCT00594516|1845244|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16
880699|NCT00594516|1845245|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0
880700|NCT00594516|1845246|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0
880701|NCT00594516|1845244|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
880702|NCT00594516|1845245|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
880703|NCT00594516|1845246|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
880704|NCT00594516|1845244|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
880705|NCT00594516|1845245|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
1188381|NCT03600805|2347295|FG000|Overall Study|Other unspecified|14
1188382|NCT03600805|2347296|FG001|Overall Study|Other unspecified|6
1188383|NCT03600805|2347297|FG002|Overall Study|Other unspecified|7
1188384|NCT03600805|2347298|FG003|Overall Study|Other unspecified|11
1188385|NCT03556358|2347312|FG000|Overall Study|Subjects Randomized that did not Treat|3
1188386|NCT03556358|2347313|FG001|Overall Study|Subjects Randomized that did not Treat|0
1188387|NCT03556358|2347312|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7
1188388|NCT03556358|2347313|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5
1188389|NCT03556358|2347312|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0
1188390|NCT03556358|2347313|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1
1188391|NCT03556358|2347312|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0
1188392|NCT03556358|2347313|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1
1188393|NCT03556358|2347312|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0
1188394|NCT03556358|2347313|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2
1188395|NCT03556358|2347312|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0
1188396|NCT03556358|2347313|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1
880706|NCT00594516|1845246|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
880707|NCT00594516|1845244|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
880708|NCT00594516|1845245|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
880709|NCT00594516|1845246|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
1188397|NCT03556358|2347312|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1
1188398|NCT03556358|2347313|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2
1188399|NCT03290781|2347326|FG000|Overall Study|Adverse Event|5
1188400|NCT03290781|2347327|FG001|Overall Study|Adverse Event|7
1188401|NCT03290781|2347328|FG002|Overall Study|Adverse Event|4
1188402|NCT03290781|2347329|FG003|Overall Study|Adverse Event|1
1188403|NCT03290781|2347330|FG004|Overall Study|Adverse Event|0
1188404|NCT03290781|2347331|FG005|Overall Study|Adverse Event|0
1188405|NCT03290781|2347332|FG006|Overall Study|Adverse Event|0
1188406|NCT03290781|2347326|FG000|Overall Study|Death|0
1188407|NCT03290781|2347327|FG001|Overall Study|Death|0
1188408|NCT03290781|2347328|FG002|Overall Study|Death|1
1188409|NCT03290781|2347329|FG003|Overall Study|Death|0
1188410|NCT03290781|2347330|FG004|Overall Study|Death|1
1188411|NCT03290781|2347331|FG005|Overall Study|Death|0
1188412|NCT03290781|2347332|FG006|Overall Study|Death|0
1188413|NCT03290781|2347326|FG000|Overall Study|Withdrawal by Subject|6
1188414|NCT03290781|2347327|FG001|Overall Study|Withdrawal by Subject|5
1188415|NCT03290781|2347328|FG002|Overall Study|Withdrawal by Subject|9
1188416|NCT03290781|2347329|FG003|Overall Study|Withdrawal by Subject|10
1188417|NCT03290781|2347330|FG004|Overall Study|Withdrawal by Subject|1
1188418|NCT03290781|2347331|FG005|Overall Study|Withdrawal by Subject|2
1188419|NCT03290781|2347332|FG006|Overall Study|Withdrawal by Subject|0
1188420|NCT03290781|2347326|FG000|Overall Study|Physician Decision|0
1188421|NCT03290781|2347327|FG001|Overall Study|Physician Decision|1
1188422|NCT03290781|2347328|FG002|Overall Study|Physician Decision|0
1188423|NCT03290781|2347329|FG003|Overall Study|Physician Decision|0
1188424|NCT03290781|2347330|FG004|Overall Study|Physician Decision|0
1188425|NCT03290781|2347331|FG005|Overall Study|Physician Decision|0
1188426|NCT03290781|2347332|FG006|Overall Study|Physician Decision|0
1188427|NCT03290781|2347326|FG000|Overall Study|Site Terminated by Sponsor|1
1188428|NCT03290781|2347327|FG001|Overall Study|Site Terminated by Sponsor|0
1188429|NCT03290781|2347328|FG002|Overall Study|Site Terminated by Sponsor|2
1188430|NCT03290781|2347329|FG003|Overall Study|Site Terminated by Sponsor|1
1188431|NCT03290781|2347330|FG004|Overall Study|Site Terminated by Sponsor|0
1188432|NCT03290781|2347331|FG005|Overall Study|Site Terminated by Sponsor|0
1188433|NCT03290781|2347332|FG006|Overall Study|Site Terminated by Sponsor|0
1188434|NCT03290781|2347326|FG000|Overall Study|Lost to Follow-up|0
1188435|NCT03290781|2347327|FG001|Overall Study|Lost to Follow-up|0
1188436|NCT03290781|2347328|FG002|Overall Study|Lost to Follow-up|0
1188437|NCT03290781|2347329|FG003|Overall Study|Lost to Follow-up|1
1188438|NCT03290781|2347330|FG004|Overall Study|Lost to Follow-up|0
1188439|NCT03290781|2347331|FG005|Overall Study|Lost to Follow-up|0
1188440|NCT03290781|2347332|FG006|Overall Study|Lost to Follow-up|0
1188441|NCT03290781|2347326|FG000|Overall Study|Protocol Deviation|2
1188442|NCT03290781|2347327|FG001|Overall Study|Protocol Deviation|0
1188443|NCT03290781|2347328|FG002|Overall Study|Protocol Deviation|0
1188444|NCT03290781|2347329|FG003|Overall Study|Protocol Deviation|1
1188445|NCT03290781|2347330|FG004|Overall Study|Protocol Deviation|0
1188446|NCT03290781|2347331|FG005|Overall Study|Protocol Deviation|0
1188447|NCT03290781|2347332|FG006|Overall Study|Protocol Deviation|0
1188448|NCT03290781|2347326|FG000|Overall Study|Disease Relapse|32
1188449|NCT03290781|2347327|FG001|Overall Study|Disease Relapse|5
1188450|NCT03290781|2347328|FG002|Overall Study|Disease Relapse|38
1188451|NCT03290781|2347329|FG003|Overall Study|Disease Relapse|7
1188452|NCT03290781|2347330|FG004|Overall Study|Disease Relapse|3
1188453|NCT03290781|2347331|FG005|Overall Study|Disease Relapse|1
1188454|NCT03290781|2347332|FG006|Overall Study|Disease Relapse|4
1188455|NCT03290781|2347326|FG000|Overall Study|Other|3
1188456|NCT03290781|2347327|FG001|Overall Study|Other|0
1188457|NCT03290781|2347328|FG002|Overall Study|Other|2
1188458|NCT03290781|2347329|FG003|Overall Study|Other|2
1188459|NCT03290781|2347330|FG004|Overall Study|Other|0
1188460|NCT03290781|2347331|FG005|Overall Study|Other|0
1188461|NCT03290781|2347332|FG006|Overall Study|Other|0
1188462|NCT03228680|2347391|FG000|Overall Study|Adverse Event|13
1188463|NCT03228680|2347392|FG001|Overall Study|Adverse Event|18
1188464|NCT03228680|2347391|FG000|Overall Study|Randomization failure|0
1188465|NCT03228680|2347392|FG001|Overall Study|Randomization failure|1
1188466|NCT03228680|2347391|FG000|Overall Study|Withdrawal by Subject|1
1188467|NCT03228680|2347392|FG001|Overall Study|Withdrawal by Subject|0
1188468|NCT03228680|2347391|FG000|Overall Study|Other|9
1188469|NCT03228680|2347392|FG001|Overall Study|Other|16
1188470|NCT03170882|2347414|FG000|Overall Study|Ongoing|10
1188471|NCT03170882|2347415|FG001|Overall Study|Ongoing|14
1188472|NCT03170882|2347414|FG000|Overall Study|Death|15
1006588|NCT01468701|2025297|FG012|Overall Study|Other reasons than listed|28
1188473|NCT03170882|2347415|FG001|Overall Study|Death|29
1188474|NCT03170882|2347414|FG000|Overall Study|Lost to Follow-up|0
1188475|NCT03170882|2347415|FG001|Overall Study|Lost to Follow-up|1
1188476|NCT03170882|2347414|FG000|Overall Study|Withdrawal by Subject|4
1188477|NCT03170882|2347415|FG001|Overall Study|Withdrawal by Subject|6
1188478|NCT03170882|2347414|FG000|Overall Study|Reason not Specified|0
1188479|NCT03170882|2347415|FG001|Overall Study|Reason not Specified|1
1188480|NCT03064126|2347430|FG000|Overall Study|Death|6
1188481|NCT03064126|2347431|FG001|Overall Study|Death|2
1188482|NCT03064126|2347432|FG002|Overall Study|Death|2
1188483|NCT03064126|2347433|FG003|Overall Study|Death|1
1188484|NCT03064126|2347430|FG000|Overall Study|Investigator Discretion|1
1188485|NCT03064126|2347431|FG001|Overall Study|Investigator Discretion|0
1188486|NCT03064126|2347432|FG002|Overall Study|Investigator Discretion|0
1188487|NCT03064126|2347433|FG003|Overall Study|Investigator Discretion|0
1188488|NCT03064126|2347430|FG000|Overall Study|Withdrawal by Subject|7
1188489|NCT03064126|2347431|FG001|Overall Study|Withdrawal by Subject|4
1188490|NCT03064126|2347432|FG002|Overall Study|Withdrawal by Subject|0
1188491|NCT03064126|2347433|FG003|Overall Study|Withdrawal by Subject|0
1188492|NCT03064126|2347430|FG000|Overall Study|Subject moved|1
1188493|NCT03064126|2347431|FG001|Overall Study|Subject moved|0
1188494|NCT03064126|2347432|FG002|Overall Study|Subject moved|0
1188495|NCT03064126|2347433|FG003|Overall Study|Subject moved|0
1188496|NCT03064126|2347430|FG000|Overall Study|Protocol Violation|11
1188497|NCT03064126|2347431|FG001|Overall Study|Protocol Violation|1
1188498|NCT03064126|2347432|FG002|Overall Study|Protocol Violation|1
1188499|NCT03064126|2347433|FG003|Overall Study|Protocol Violation|0
1188500|NCT02679781|2347476|FG000|Overall Study|Lost to Follow-up|1
1188501|NCT02679781|2347477|FG001|Overall Study|Lost to Follow-up|2
1188502|NCT02679781|2347476|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6
1188503|NCT02679781|2347477|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1
1188504|NCT02624869|2347486|FG000|Overall Study|Lost to Follow-up|0
1188505|NCT02624869|2347487|FG001|Overall Study|Lost to Follow-up|0
1188506|NCT02624869|2347488|FG002|Overall Study|Lost to Follow-up|1
1188507|NCT02624869|2347486|FG000|Overall Study|Withdrawal by Subject|1
1188508|NCT02624869|2347487|FG001|Overall Study|Withdrawal by Subject|3
1188509|NCT02624869|2347488|FG002|Overall Study|Withdrawal by Subject|1
1188510|NCT02569242|2347512|FG000|Overall Study|Death|1
1188511|NCT02569242|2347513|FG001|Overall Study|Death|0
1188512|NCT02569242|2347512|FG000|Overall Study|Withdrawal by Subject|0
1188513|NCT02569242|2347513|FG001|Overall Study|Withdrawal by Subject|1
1188514|NCT02435433|2347536|FG000|Overall Study|On Treatment|11
1188515|NCT02435433|2347537|FG001|Overall Study|On Treatment|0
1188516|NCT02435433|2347538|FG002|Overall Study|On Treatment|0
1188517|NCT02435433|2347539|FG003|Overall Study|On Treatment|0
1188518|NCT02435433|2347540|FG004|Overall Study|On Treatment|0
1188519|NCT02435433|2347536|FG000|Overall Study|Withdrawal by Subject|2
1188520|NCT02435433|2347537|FG001|Overall Study|Withdrawal by Subject|3
1188521|NCT02435433|2347538|FG002|Overall Study|Withdrawal by Subject|0
1188522|NCT02435433|2347539|FG003|Overall Study|Withdrawal by Subject|0
1188523|NCT02435433|2347540|FG004|Overall Study|Withdrawal by Subject|0
1188524|NCT02435433|2347536|FG000|Overall Study|Lost to Follow-up|2
1188525|NCT02435433|2347537|FG001|Overall Study|Lost to Follow-up|2
1188526|NCT02435433|2347538|FG002|Overall Study|Lost to Follow-up|0
1188527|NCT02435433|2347539|FG003|Overall Study|Lost to Follow-up|0
1188528|NCT02435433|2347540|FG004|Overall Study|Lost to Follow-up|0
1188529|NCT02426125|2347550|FG000|Overall Study|Lost to Follow-up|12
1188530|NCT02426125|2347551|FG001|Overall Study|Lost to Follow-up|10
1188531|NCT02426125|2347550|FG000|Overall Study|Protocol Violation|1
1188532|NCT02426125|2347551|FG001|Overall Study|Protocol Violation|0
1188533|NCT02426125|2347550|FG000|Overall Study|Withdrawal by Subject|16
1188534|NCT02426125|2347551|FG001|Overall Study|Withdrawal by Subject|16
1188535|NCT02368886|2347572|FG000|Overall Study|Cancel|1
1188536|NCT02368886|2347573|FG001|Overall Study|Cancel|1
1188537|NCT02368886|2347574|FG002|Overall Study|Cancel|1
1188538|NCT02368886|2347575|FG003|Overall Study|Cancel|3
1188539|NCT02368886|2347572|FG000|Overall Study|Ineligible|0
1188540|NCT02368886|2347573|FG001|Overall Study|Ineligible|0
1188541|NCT02368886|2347574|FG002|Overall Study|Ineligible|0
1188542|NCT02368886|2347575|FG003|Overall Study|Ineligible|1
1188543|NCT02354703|2347587|FG000|Overall Study|Withdrawal by Subject|1
1188544|NCT02354703|2347588|FG001|Overall Study|Withdrawal by Subject|1
1188545|NCT02354703|2347589|FG002|Overall Study|Withdrawal by Subject|1
1188546|NCT02354703|2347590|FG003|Overall Study|Withdrawal by Subject|1
1188547|NCT02354703|2347587|FG000|Overall Study|Lost to Follow-up|2
1188548|NCT02354703|2347588|FG001|Overall Study|Lost to Follow-up|7
1188549|NCT02354703|2347589|FG002|Overall Study|Lost to Follow-up|9
1188550|NCT02354703|2347590|FG003|Overall Study|Lost to Follow-up|2
1188551|NCT02354703|2347587|FG000|Overall Study|Adverse Event|0
1188552|NCT02354703|2347588|FG001|Overall Study|Adverse Event|0
1188553|NCT02354703|2347589|FG002|Overall Study|Adverse Event|1
1188554|NCT02354703|2347590|FG003|Overall Study|Adverse Event|0
1188555|NCT02312258|2347604|FG000|Overall Study|Adverse Event|15
1188556|NCT02312258|2347605|FG001|Overall Study|Adverse Event|47
1188557|NCT02312258|2347604|FG000|Overall Study|Lost to Follow-up|0
1188558|NCT02312258|2347605|FG001|Overall Study|Lost to Follow-up|1
1188559|NCT02312258|2347604|FG000|Overall Study|Progressive Disease|174
1188560|NCT02312258|2347605|FG001|Overall Study|Progressive Disease|188
1188561|NCT02312258|2347604|FG000|Overall Study|Withdrawal by Subject|8
1188562|NCT02312258|2347605|FG001|Overall Study|Withdrawal by Subject|9
1188563|NCT02312258|2347604|FG000|Overall Study|Reason not Specified|11
1188564|NCT02312258|2347605|FG001|Overall Study|Reason not Specified|31
1188565|NCT02312258|2347604|FG000|Overall Study|Participants Ongoing Treatment|43
1188566|NCT02312258|2347605|FG001|Overall Study|Participants Ongoing Treatment|83
1188567|NCT01981551|2347611|FG000|Overall Study|Refused further treatment|8
1188568|NCT01981551|2347611|FG000|Overall Study|Adverse Event|1
1188569|NCT01772472|2347617|FG000|Overall Study|Death|56
1188570|NCT01772472|2347618|FG001|Overall Study|Death|42
1188571|NCT01772472|2347617|FG000|Overall Study|Physician Decision|1
1188572|NCT01772472|2347618|FG001|Overall Study|Physician Decision|3
1188573|NCT01772472|2347617|FG000|Overall Study|Other|5
1188574|NCT01772472|2347618|FG001|Overall Study|Other|5
1188575|NCT01772472|2347617|FG000|Overall Study|Lost to Follow-up|12
1188576|NCT01772472|2347618|FG001|Overall Study|Lost to Follow-up|8
1188577|NCT01772472|2347617|FG000|Overall Study|Withdrawal by Subject|72
1188578|NCT01772472|2347618|FG001|Overall Study|Withdrawal by Subject|50
1188579|NCT01772472|2347617|FG000|Overall Study|Ongoing|597
1188580|NCT01772472|2347618|FG001|Overall Study|Ongoing|635
1188581|NCT00468130|2347630|FG000|Overall Study|Adverse Event|2
1188582|NCT00468130|2347631|FG001|Overall Study|Adverse Event|1
1188583|NCT00468130|2347630|FG000|Overall Study|Withdrawal by Subject|0
1188584|NCT00468130|2347631|FG001|Overall Study|Withdrawal by Subject|1
1188585|NCT00384111|2347639|FG000|Overall Study|Disease Progression|3
1188586|NCT00384111|2347639|FG000|Overall Study|Adverse Event|1
1188587|NCT00384111|2347639|FG000|Overall Study|Investigator Decision|3
1188588|NCT00384111|2347639|FG000|Overall Study|Study Terminated by the Sponsor|19
880710|NCT00594516|1845244|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
880711|NCT00594516|1845245|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
880712|NCT00594516|1845246|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
880713|NCT00594516|1845244|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
880714|NCT00594516|1845245|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
880715|NCT00594516|1845246|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
880716|NCT00594516|1845244|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
880717|NCT00594516|1845245|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
880718|NCT00594516|1845246|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
880719|NCT00594568|1845253|FG000|Initial Treatment|Adverse Event|51
880720|NCT00594568|1845254|FG001|Initial Treatment|Adverse Event|121
880721|NCT00594568|1845255|FG002|Initial Treatment|Adverse Event|144
880722|NCT00594568|1845253|FG000|Initial Treatment|Death|6
880723|NCT00594568|1845254|FG001|Initial Treatment|Death|11
880724|NCT00594568|1845255|FG002|Initial Treatment|Death|15
1188589|NCT04854642|2347643|FG000|Overall Study|Adverse Event|1
1188590|NCT04854642|2347644|FG001|Overall Study|Adverse Event|2
1188591|NCT04854642|2347643|FG000|Overall Study|Withdrawal by Subject|0
1188592|NCT04854642|2347644|FG001|Overall Study|Withdrawal by Subject|1
1188593|NCT04608344|2347667|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0
1188594|NCT04608344|2347668|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1
1188595|NCT04608344|2347667|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1
1188596|NCT04608344|2347668|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0
1188597|NCT04388787|2347708|FG000|Blinded Period|Patient could not follow instructions|1
1188598|NCT04388787|2347708|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9
1188599|NCT04377620|2347732|FG000|Overall Study|Death|42
1188600|NCT04377620|2347733|FG001|Overall Study|Death|48
1188601|NCT04377620|2347734|FG002|Overall Study|Death|36
1188602|NCT04377620|2347732|FG000|Overall Study|Withdrawal by Subject|0
1188603|NCT04377620|2347733|FG001|Overall Study|Withdrawal by Subject|2
1188604|NCT04377620|2347734|FG002|Overall Study|Withdrawal by Subject|0
1188605|NCT04310566|2347765|FG000|Period 1|Study Termination due to COVID-19|15
1188606|NCT04310566|2347766|FG001|Period 1|Study Termination due to COVID-19|17
1188607|NCT04310566|2347765|FG000|Period 1|Protocol Violation|0
1188608|NCT04310566|2347766|FG001|Period 1|Protocol Violation|1
1188609|NCT04310566|2347765|FG000|Period 1|Subject no longer meets eligbility criteria|0
1188610|NCT04310566|2347766|FG001|Period 1|Subject no longer meets eligbility criteria|1
1188611|NCT04310566|2347765|FG000|Period 1|Lost to Follow-up|1
1188612|NCT04310566|2347766|FG001|Period 1|Lost to Follow-up|0
1188613|NCT04310566|2347765|FG000|Period 1|Withdrawal by Subject|0
1188614|NCT04310566|2347766|FG001|Period 1|Withdrawal by Subject|1
1188615|NCT04310566|2347765|FG000|Period 2|Study Termination|7
1188616|NCT04310566|2347766|FG001|Period 2|Study Termination|5
1188617|NCT04206020|2347774|FG000|Overall Study|Adverse Event|1
1188618|NCT04206020|2347775|FG001|Overall Study|Adverse Event|4
1188619|NCT04206020|2347774|FG000|Overall Study|Protocol Violation|2
1188620|NCT04206020|2347775|FG001|Overall Study|Protocol Violation|0
1188621|NCT04206020|2347774|FG000|Overall Study|Withdrawal by Subject|2
1188622|NCT04206020|2347775|FG001|Overall Study|Withdrawal by Subject|0
1188623|NCT04206020|2347774|FG000|Overall Study|Lost to Follow-up|2
1188624|NCT04206020|2347775|FG001|Overall Study|Lost to Follow-up|0
1188625|NCT04206020|2347774|FG000|Overall Study|Pregnancy|0
1188626|NCT04206020|2347775|FG001|Overall Study|Pregnancy|1
1188627|NCT04206020|2347774|FG000|Overall Study|Unable to attend visits|1
1188628|NCT04206020|2347775|FG001|Overall Study|Unable to attend visits|2
1188629|NCT04097301|2347781|FG000|Overall Study|Death|1
1188630|NCT04097301|2347781|FG000|Overall Study|Withdrawal by Subject|1
1188631|NCT04097301|2347781|FG000|Overall Study|Screening Failure|5
1188632|NCT03953079|2347794|FG000|Core Study|Withdrawal by Subject|1
1188633|NCT03953079|2347795|FG001|Core Study|Withdrawal by Subject|2
1188634|NCT03953079|2347796|FG002|Core Study|Withdrawal by Subject|1
1188635|NCT03953079|2347794|FG000|Core Study|COVID-19|0
1188636|NCT03953079|2347795|FG001|Core Study|COVID-19|1
1188637|NCT03953079|2347796|FG002|Core Study|COVID-19|0
1188638|NCT03953079|2347794|FG000|Core Study|Difficulties leaving the house|0
1188639|NCT03953079|2347795|FG001|Core Study|Difficulties leaving the house|1
1188640|NCT03953079|2347796|FG002|Core Study|Difficulties leaving the house|0
1188641|NCT03953079|2347794|FG000|Extension Study|Withdrawal by Subject|1
1188642|NCT03953079|2347795|FG001|Extension Study|Withdrawal by Subject|0
1188643|NCT03953079|2347796|FG002|Extension Study|Withdrawal by Subject|0
1188644|NCT03953079|2347794|FG000|Extension Study|Received Rescue Treatment|5
1188645|NCT03953079|2347795|FG001|Extension Study|Received Rescue Treatment|6
1188646|NCT03953079|2347796|FG002|Extension Study|Received Rescue Treatment|5
1188647|NCT03922750|2347808|FG000|Overall Study|Unclassified|0
1188648|NCT03922750|2347809|FG001|Overall Study|Unclassified|0
1188649|NCT03922750|2347810|FG002|Overall Study|Unclassified|1
1188650|NCT03922750|2347808|FG000|Overall Study|Adverse Event|0
1188651|NCT03922750|2347809|FG001|Overall Study|Adverse Event|1
1188652|NCT03922750|2347810|FG002|Overall Study|Adverse Event|0
1188653|NCT03910673|2347823|FG000|Overall Study|Adverse Event|0
1188654|NCT03910673|2347824|FG001|Overall Study|Adverse Event|0
1188655|NCT03910673|2347825|FG002|Overall Study|Adverse Event|0
1188656|NCT03910673|2347826|FG003|Overall Study|Adverse Event|2
1188657|NCT03910673|2347827|FG004|Overall Study|Adverse Event|0
1188658|NCT03885999|2347831|FG000|Overall Study|Adverse Event|1
1188659|NCT03882970|2347839|FG000|Overall Study|Adverse Event|5
1188660|NCT03882970|2347840|FG001|Overall Study|Adverse Event|7
1188661|NCT03882970|2347841|FG002|Overall Study|Adverse Event|3
1188662|NCT03882970|2347842|FG003|Overall Study|Adverse Event|1
1188663|NCT03882970|2347839|FG000|Overall Study|Death|1
1188664|NCT03882970|2347840|FG001|Overall Study|Death|2
1188665|NCT03882970|2347841|FG002|Overall Study|Death|1
1188666|NCT03882970|2347842|FG003|Overall Study|Death|1
1188667|NCT03882970|2347839|FG000|Overall Study|Lost to Follow-up|8
1188668|NCT03882970|2347840|FG001|Overall Study|Lost to Follow-up|9
1188669|NCT03882970|2347841|FG002|Overall Study|Lost to Follow-up|5
1188670|NCT03882970|2347842|FG003|Overall Study|Lost to Follow-up|5
1188671|NCT03882970|2347839|FG000|Overall Study|Physician Decision|0
1188672|NCT03882970|2347840|FG001|Overall Study|Physician Decision|2
1188673|NCT03882970|2347841|FG002|Overall Study|Physician Decision|2
1188674|NCT03882970|2347842|FG003|Overall Study|Physician Decision|2
1188675|NCT03882970|2347839|FG000|Overall Study|Protocol Violation|2
1188676|NCT03882970|2347840|FG001|Overall Study|Protocol Violation|0
1188677|NCT03882970|2347841|FG002|Overall Study|Protocol Violation|0
1188678|NCT03882970|2347842|FG003|Overall Study|Protocol Violation|0
1188679|NCT03882970|2347839|FG000|Overall Study|Withdrawal by Subject|8
1188680|NCT03882970|2347840|FG001|Overall Study|Withdrawal by Subject|17
1188681|NCT03882970|2347841|FG002|Overall Study|Withdrawal by Subject|7
1188682|NCT03882970|2347842|FG003|Overall Study|Withdrawal by Subject|22
1188683|NCT03882970|2347839|FG000|Overall Study|Personal Reason|2
1188684|NCT03882970|2347840|FG001|Overall Study|Personal Reason|3
1188685|NCT03882970|2347841|FG002|Overall Study|Personal Reason|1
1188686|NCT03882970|2347842|FG003|Overall Study|Personal Reason|3
1188687|NCT03867734|2347866|FG000|Overall Study|Lost to Follow-up|2
1188688|NCT03781778|2347886|FG000|Overall Study|Withdrawal by Subject|2
1188689|NCT03781778|2347887|FG001|Overall Study|Withdrawal by Subject|2
880725|NCT00594568|1845253|FG000|Initial Treatment|Lost to Follow-up|4
880726|NCT00594568|1845254|FG001|Initial Treatment|Lost to Follow-up|1
880727|NCT00594568|1845255|FG002|Initial Treatment|Lost to Follow-up|4
880728|NCT00594568|1845253|FG000|Initial Treatment|Physician Decision|3
880729|NCT00594568|1845254|FG001|Initial Treatment|Physician Decision|2
880730|NCT00594568|1845255|FG002|Initial Treatment|Physician Decision|4
880731|NCT00594568|1845253|FG000|Initial Treatment|Protocol Violation|2
880732|NCT00594568|1845254|FG001|Initial Treatment|Protocol Violation|2
1188690|NCT03730480|2347910|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1
1188691|NCT03713034|2347923|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5
1188692|NCT03713034|2347924|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4
1188693|NCT03654404|2347932|FG000|Overall Study|Death|1
1188694|NCT03654404|2347932|FG000|Overall Study|Lost to Follow-up|2
1188695|NCT03654404|2347932|FG000|Overall Study|Withdrawal by Subject|5
1188696|NCT03567057|2347939|FG000|Overall Study|Adverse Event|56
1188697|NCT03567057|2347940|FG001|Overall Study|Adverse Event|53
1188698|NCT03567057|2347941|FG002|Overall Study|Adverse Event|28
1188699|NCT03567057|2347939|FG000|Overall Study|Withdrawal by Subject|22
1188700|NCT03567057|2347940|FG001|Overall Study|Withdrawal by Subject|24
1188701|NCT03567057|2347941|FG002|Overall Study|Withdrawal by Subject|13
1188702|NCT03567057|2347939|FG000|Overall Study|Lost to Follow-up|3
1188703|NCT03567057|2347940|FG001|Overall Study|Lost to Follow-up|5
1188704|NCT03567057|2347941|FG002|Overall Study|Lost to Follow-up|2
1188705|NCT03567057|2347939|FG000|Overall Study|COVID-19 pandemic|4
1188706|NCT03567057|2347940|FG001|Overall Study|COVID-19 pandemic|3
1188707|NCT03567057|2347941|FG002|Overall Study|COVID-19 pandemic|0
1188708|NCT03567057|2347939|FG000|Overall Study|Non-compliance with study drug|4
1188709|NCT03567057|2347940|FG001|Overall Study|Non-compliance with study drug|2
1188710|NCT03567057|2347941|FG002|Overall Study|Non-compliance with study drug|0
1188711|NCT03567057|2347939|FG000|Overall Study|Lack of Efficacy|3
1188712|NCT03567057|2347940|FG001|Overall Study|Lack of Efficacy|0
1188713|NCT03567057|2347941|FG002|Overall Study|Lack of Efficacy|1
1188714|NCT03567057|2347939|FG000|Overall Study|Death|1
1188715|NCT03567057|2347940|FG001|Overall Study|Death|0
1188716|NCT03567057|2347941|FG002|Overall Study|Death|0
1188717|NCT03567057|2347939|FG000|Overall Study|Physician Decision|1
1188718|NCT03567057|2347940|FG001|Overall Study|Physician Decision|0
1188719|NCT03567057|2347941|FG002|Overall Study|Physician Decision|0
1188720|NCT03567057|2347939|FG000|Overall Study|Unstable medical condition|1
1188721|NCT03567057|2347940|FG001|Overall Study|Unstable medical condition|0
1188722|NCT03567057|2347941|FG002|Overall Study|Unstable medical condition|0
1188723|NCT03567057|2347939|FG000|Overall Study|Medical history event|0
880733|NCT00594568|1845255|FG002|Initial Treatment|Protocol Violation|5
880734|NCT00594568|1845253|FG000|Initial Treatment|Withdrawal by Subject|25
880735|NCT00594568|1845254|FG001|Initial Treatment|Withdrawal by Subject|31
880736|NCT00594568|1845255|FG002|Initial Treatment|Withdrawal by Subject|46
880737|NCT00594568|1845253|FG000|Initial Treatment|Sponsor decision|193
880738|NCT00594568|1845254|FG001|Initial Treatment|Sponsor decision|142
880739|NCT00594568|1845255|FG002|Initial Treatment|Sponsor decision|147
880740|NCT00594568|1845253|FG000|Initial Treatment|Caregiver decision|21
880741|NCT00594568|1845254|FG001|Initial Treatment|Caregiver decision|36
1188724|NCT03567057|2347940|FG001|Overall Study|Medical history event|0
1188725|NCT03567057|2347941|FG002|Overall Study|Medical history event|1
1188726|NCT03567057|2347939|FG000|Overall Study|Other|0
1188727|NCT03567057|2347940|FG001|Overall Study|Other|0
1188728|NCT03567057|2347941|FG002|Overall Study|Other|1
1188729|NCT03548987|2347951|FG000|Run-in Period (Week 0 to Week 20)|Other|9
1188730|NCT03548987|2347952|FG001|Run-in Period (Week 0 to Week 20)|Other|0
1188731|NCT03548987|2347951|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8
1188732|NCT03548987|2347952|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0
1188733|NCT03548987|2347951|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11
1188734|NCT03548987|2347952|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0
1188735|NCT03548987|2347951|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2
1188736|NCT03548987|2347952|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0
1188737|NCT03548987|2347951|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19
1188738|NCT03548987|2347952|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0
1188739|NCT03548987|2347951|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1
1188740|NCT03548987|2347952|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0
1188741|NCT03548987|2347951|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1
1188742|NCT03548987|2347952|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0
1188743|NCT03548987|2347951|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48
1188744|NCT03548987|2347952|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0
1188745|NCT03548987|2347951|FG000|Maintenance Period (Week 20 to Week 68)|other|12
1188746|NCT03548987|2347952|FG001|Maintenance Period (Week 20 to Week 68)|other|23
1188747|NCT03548987|2347951|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2
1188748|NCT03548987|2347952|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1
1188749|NCT03548987|2347951|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
1188750|NCT03548987|2347952|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
1188751|NCT03548987|2347951|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2
1188752|NCT03548987|2347952|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0
1188753|NCT03548987|2347951|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1
1188754|NCT03548987|2347952|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0
1188755|NCT03548987|2347951|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13
1188756|NCT03548987|2347952|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6
1188757|NCT03548064|2347967|FG000|Overall Study|Withdrawal by Subject|0
1188758|NCT03548064|2347968|FG001|Overall Study|Withdrawal by Subject|0
1188759|NCT03548064|2347969|FG002|Overall Study|Withdrawal by Subject|0
1188760|NCT03548064|2347970|FG003|Overall Study|Withdrawal by Subject|1
1188761|NCT03548064|2347971|FG004|Overall Study|Withdrawal by Subject|0
1188762|NCT03548064|2347972|FG005|Overall Study|Withdrawal by Subject|0
1188763|NCT03548064|2347973|FG006|Overall Study|Withdrawal by Subject|0
1188764|NCT03548064|2347974|FG007|Overall Study|Withdrawal by Subject|0
1188765|NCT03548064|2347967|FG000|Overall Study|Lost to Follow-up|0
1188766|NCT03548064|2347968|FG001|Overall Study|Lost to Follow-up|0
1188767|NCT03548064|2347969|FG002|Overall Study|Lost to Follow-up|0
1188768|NCT03548064|2347970|FG003|Overall Study|Lost to Follow-up|0
1188769|NCT03548064|2347971|FG004|Overall Study|Lost to Follow-up|2
1188770|NCT03548064|2347972|FG005|Overall Study|Lost to Follow-up|0
1188771|NCT03548064|2347973|FG006|Overall Study|Lost to Follow-up|0
1188772|NCT03548064|2347974|FG007|Overall Study|Lost to Follow-up|0
1188773|NCT03548064|2347967|FG000|Overall Study|Covid-19 Pandemic|0
1188774|NCT03548064|2347968|FG001|Overall Study|Covid-19 Pandemic|0
1188775|NCT03548064|2347969|FG002|Overall Study|Covid-19 Pandemic|0
1188776|NCT03548064|2347970|FG003|Overall Study|Covid-19 Pandemic|0
1188777|NCT03548064|2347971|FG004|Overall Study|Covid-19 Pandemic|10
1188778|NCT03548064|2347972|FG005|Overall Study|Covid-19 Pandemic|3
1188779|NCT03548064|2347973|FG006|Overall Study|Covid-19 Pandemic|0
1188780|NCT03548064|2347974|FG007|Overall Study|Covid-19 Pandemic|0
1188781|NCT03474107|2348000|FG000|Overall Study|Adverse Event|42
1188782|NCT03474107|2348001|FG001|Overall Study|Adverse Event|46
1188783|NCT03474107|2348000|FG000|Overall Study|Death|2
1188784|NCT03474107|2348001|FG001|Overall Study|Death|2
1188785|NCT03474107|2348000|FG000|Overall Study|Lost to Follow-up|0
1188786|NCT03474107|2348001|FG001|Overall Study|Lost to Follow-up|1
1188787|NCT03474107|2348000|FG000|Overall Study|Progressive Disease|177
1188788|NCT03474107|2348001|FG001|Overall Study|Progressive Disease|180
1188789|NCT03474107|2348000|FG000|Overall Study|Protocol Violation|1
1188790|NCT03474107|2348001|FG001|Overall Study|Protocol Violation|1
1188791|NCT03474107|2348000|FG000|Overall Study|Withdrawal by Subject|15
1188792|NCT03474107|2348001|FG001|Overall Study|Withdrawal by Subject|27
1188793|NCT03474107|2348000|FG000|Overall Study|Physician Decision|7
1188794|NCT03474107|2348001|FG001|Overall Study|Physician Decision|22
1188795|NCT03474107|2348000|FG000|Overall Study|Miscellaneous|1
1188796|NCT03474107|2348001|FG001|Overall Study|Miscellaneous|6
1188797|NCT03446456|2348009|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
1188798|NCT03446456|2348010|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
1188799|NCT03446456|2348009|FG000|Overall Study|Lost to Follow-up|1
1188800|NCT03446456|2348010|FG001|Overall Study|Lost to Follow-up|3
1188801|NCT03446456|2348009|FG000|Overall Study|Participant failed the toxicology test|1
1188802|NCT03446456|2348010|FG001|Overall Study|Participant failed the toxicology test|0
1188803|NCT03446456|2348009|FG000|Overall Study|Break down of the experimental equipment|1
1188804|NCT03446456|2348010|FG001|Overall Study|Break down of the experimental equipment|0
1188805|NCT03382834|2348018|FG000|Overall Study|Lost to Follow-up|1
1188806|NCT03382834|2348019|FG001|Overall Study|Lost to Follow-up|0
1188807|NCT03382834|2348018|FG000|Overall Study|Withdrawal by Subject|0
1188808|NCT03382834|2348019|FG001|Overall Study|Withdrawal by Subject|1
1188809|NCT03371823|2348027|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1
1188810|NCT03371823|2348028|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0
1188811|NCT03366337|2348038|FG000|Overall Study|Lost to Follow-up|1
1188812|NCT03366337|2348039|FG001|Overall Study|Lost to Follow-up|0
1188813|NCT03366337|2348040|FG002|Overall Study|Lost to Follow-up|1
1188814|NCT03366337|2348041|FG003|Overall Study|Lost to Follow-up|0
1188815|NCT03366337|2348038|FG000|Overall Study|Withdrawal by Subject|2
1188816|NCT03366337|2348039|FG001|Overall Study|Withdrawal by Subject|0
1188817|NCT03366337|2348040|FG002|Overall Study|Withdrawal by Subject|1
1188818|NCT03366337|2348041|FG003|Overall Study|Withdrawal by Subject|1
1188819|NCT03353350|2348055|FG000|30-week Core Treatment Period|Protocol Violation|1
1188820|NCT03353350|2348056|FG001|30-week Core Treatment Period|Protocol Violation|1
1188821|NCT03353350|2348057|FG002|30-week Core Treatment Period|Protocol Violation|1
1188822|NCT03353350|2348058|FG003|30-week Core Treatment Period|Protocol Violation|0
1188823|NCT03353350|2348055|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2
1188824|NCT03353350|2348056|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2
1188825|NCT03353350|2348057|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2
1188826|NCT03353350|2348058|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0
1188827|NCT03353350|2348055|FG000|30-week Core Treatment Period|Adverse Event|0
1188828|NCT03353350|2348056|FG001|30-week Core Treatment Period|Adverse Event|4
1188829|NCT03353350|2348057|FG002|30-week Core Treatment Period|Adverse Event|2
1188830|NCT03353350|2348058|FG003|30-week Core Treatment Period|Adverse Event|3
1188831|NCT03353350|2348055|FG000|30-week Core Treatment Period|Withdrawal by Subject|19
1188832|NCT03353350|2348056|FG001|30-week Core Treatment Period|Withdrawal by Subject|12
1188833|NCT03353350|2348057|FG002|30-week Core Treatment Period|Withdrawal by Subject|19
1188834|NCT03353350|2348058|FG003|30-week Core Treatment Period|Withdrawal by Subject|19
1188835|NCT03353350|2348055|FG000|26-week Treatment Extension Period|Protocol Violation|2
1188836|NCT03353350|2348056|FG001|26-week Treatment Extension Period|Protocol Violation|0
1188837|NCT03353350|2348057|FG002|26-week Treatment Extension Period|Protocol Violation|0
1188838|NCT03353350|2348058|FG003|26-week Treatment Extension Period|Protocol Violation|0
1188839|NCT03353350|2348055|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0
1188840|NCT03353350|2348056|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0
1188841|NCT03353350|2348057|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1
1188842|NCT03353350|2348058|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1
1188843|NCT03353350|2348055|FG000|26-week Treatment Extension Period|Adverse Event|1
1188844|NCT03353350|2348056|FG001|26-week Treatment Extension Period|Adverse Event|0
1188845|NCT03353350|2348057|FG002|26-week Treatment Extension Period|Adverse Event|0
1188846|NCT03353350|2348058|FG003|26-week Treatment Extension Period|Adverse Event|1
1188847|NCT03353350|2348055|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2
1188848|NCT03353350|2348056|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3
1188849|NCT03353350|2348057|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3
1188850|NCT03353350|2348058|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12
1188851|NCT03350503|2348068|FG000|Overall Study|Adverse Event|1
1188852|NCT03350503|2348068|FG000|Overall Study|Hospital Transfer or Removal|2
1188853|NCT03350503|2348068|FG000|Overall Study|Subject Wishes|2
1188854|NCT03326193|2348072|FG000|Overall Study|Treatment ongoing at the time of analysis|26
1188855|NCT03326193|2348072|FG000|Overall Study|Death|19
1188856|NCT03326193|2348072|FG000|Overall Study|Withdrawal by Subject|8
1188873|NCT03282565|2348097|FG000|Overall Study|COVID-19 Research Shutdown|0
1188874|NCT03282565|2348098|FG001|Overall Study|COVID-19 Research Shutdown|2
1188875|NCT03282565|2348099|FG002|Overall Study|COVID-19 Research Shutdown|2
1188876|NCT03276936|2348109|FG000|Overall Study|Adverse Event|4
1188877|NCT03276936|2348110|FG001|Overall Study|Adverse Event|2
1188878|NCT03276936|2348109|FG000|Overall Study|Lost to Follow-up|16
1188879|NCT03276936|2348110|FG001|Overall Study|Lost to Follow-up|13
1188880|NCT03276936|2348109|FG000|Overall Study|Withdrawal by Subject|30
1188881|NCT03276936|2348110|FG001|Overall Study|Withdrawal by Subject|20
1188882|NCT03276936|2348109|FG000|Overall Study|Not mentioned|6
1188883|NCT03276936|2348110|FG001|Overall Study|Not mentioned|3
1188884|NCT03271021|2348118|FG000|Overall Study|Adverse Event|3
1188885|NCT03271021|2348119|FG001|Overall Study|Adverse Event|2
1188886|NCT03271021|2348118|FG000|Overall Study|Withdrawal by Subject|36
1188887|NCT03271021|2348119|FG001|Overall Study|Withdrawal by Subject|53
1188888|NCT03271021|2348118|FG000|Overall Study|Lost to Follow-up|34
1188889|NCT03271021|2348119|FG001|Overall Study|Lost to Follow-up|39
1188890|NCT03271021|2348118|FG000|Overall Study|Protocol Violation|6
1188891|NCT03271021|2348119|FG001|Overall Study|Protocol Violation|4
1188892|NCT03271021|2348118|FG000|Overall Study|Abnormal Lab Results|1
1188893|NCT03271021|2348119|FG001|Overall Study|Abnormal Lab Results|0
1188894|NCT03271021|2348118|FG000|Overall Study|Miscellaneous|9
1188895|NCT03271021|2348119|FG001|Overall Study|Miscellaneous|8
1188896|NCT03255083|2348129|FG000|Overall Study|Clinical progression|1
1188897|NCT03255083|2348130|FG001|Overall Study|Clinical progression|0
1188898|NCT03255083|2348131|FG002|Overall Study|Clinical progression|0
1188899|NCT03255083|2348132|FG003|Overall Study|Clinical progression|0
1188900|NCT03255083|2348129|FG000|Overall Study|Adverse Event|0
1188901|NCT03255083|2348130|FG001|Overall Study|Adverse Event|1
1188902|NCT03255083|2348131|FG002|Overall Study|Adverse Event|0
1188903|NCT03255083|2348132|FG003|Overall Study|Adverse Event|0
1188904|NCT03255083|2348129|FG000|Overall Study|Progressive disease by RECIST version 1.1|4
1188905|NCT03255083|2348130|FG001|Overall Study|Progressive disease by RECIST version 1.1|1
1188906|NCT03255083|2348131|FG002|Overall Study|Progressive disease by RECIST version 1.1|2
1188907|NCT03255083|2348132|FG003|Overall Study|Progressive disease by RECIST version 1.1|1
1188908|NCT03255083|2348129|FG000|Overall Study|Withdrawal by Subject|1
1188909|NCT03255083|2348130|FG001|Overall Study|Withdrawal by Subject|1
1188910|NCT03255083|2348131|FG002|Overall Study|Withdrawal by Subject|1
1188911|NCT03255083|2348132|FG003|Overall Study|Withdrawal by Subject|0
1188912|NCT03227471|2348157|FG000|Overall Study|Withdrawal by Subject|0
1188913|NCT03227471|2348158|FG001|Overall Study|Withdrawal by Subject|0
1188914|NCT03227471|2348159|FG002|Overall Study|Withdrawal by Subject|0
1188915|NCT03227471|2348160|FG003|Overall Study|Withdrawal by Subject|0
1188916|NCT03227471|2348161|FG004|Overall Study|Withdrawal by Subject|1
1188917|NCT03227471|2348162|FG005|Overall Study|Withdrawal by Subject|0
1188918|NCT03227471|2348163|FG006|Overall Study|Withdrawal by Subject|0
1188919|NCT03227471|2348164|FG007|Overall Study|Withdrawal by Subject|0
1188920|NCT03227471|2348165|FG008|Overall Study|Withdrawal by Subject|0
1188921|NCT03227471|2348166|FG009|Overall Study|Withdrawal by Subject|0
1188922|NCT03227471|2348167|FG010|Overall Study|Withdrawal by Subject|0
1188923|NCT03227471|2348168|FG011|Overall Study|Withdrawal by Subject|0
1188924|NCT03227471|2348169|FG012|Overall Study|Withdrawal by Subject|1
1188925|NCT03227471|2348170|FG013|Overall Study|Withdrawal by Subject|0
1188926|NCT03227471|2348171|FG014|Overall Study|Withdrawal by Subject|0
1188927|NCT03227471|2348157|FG000|Overall Study|Randomized, Never Dosed|0
1188928|NCT03227471|2348158|FG001|Overall Study|Randomized, Never Dosed|0
1188929|NCT03227471|2348159|FG002|Overall Study|Randomized, Never Dosed|0
1188930|NCT03227471|2348160|FG003|Overall Study|Randomized, Never Dosed|0
1188931|NCT03227471|2348161|FG004|Overall Study|Randomized, Never Dosed|0
1188932|NCT03227471|2348162|FG005|Overall Study|Randomized, Never Dosed|0
1188933|NCT03227471|2348163|FG006|Overall Study|Randomized, Never Dosed|0
1188934|NCT03227471|2348164|FG007|Overall Study|Randomized, Never Dosed|0
1188935|NCT03227471|2348165|FG008|Overall Study|Randomized, Never Dosed|0
1188936|NCT03227471|2348166|FG009|Overall Study|Randomized, Never Dosed|0
1188937|NCT03227471|2348167|FG010|Overall Study|Randomized, Never Dosed|0
1188938|NCT03227471|2348168|FG011|Overall Study|Randomized, Never Dosed|0
1188939|NCT03227471|2348169|FG012|Overall Study|Randomized, Never Dosed|0
1188940|NCT03227471|2348170|FG013|Overall Study|Randomized, Never Dosed|0
1188941|NCT03227471|2348171|FG014|Overall Study|Randomized, Never Dosed|1
1188942|NCT03227029|2348235|FG000|Overall Study|Child Wheezed (no treatment)|0
1188943|NCT03227029|2348236|FG001|Overall Study|Child Wheezed (no treatment)|1
1188944|NCT03227029|2348237|FG002|Overall Study|Child Wheezed (no treatment)|0
1188945|NCT03227029|2348235|FG000|Overall Study|No post RSV season visit due to COVID|3
1188946|NCT03227029|2348236|FG001|Overall Study|No post RSV season visit due to COVID|3
1188947|NCT03227029|2348237|FG002|Overall Study|No post RSV season visit due to COVID|2
1188948|NCT03227029|2348235|FG000|Overall Study|Not able to get to clinic|0
1188949|NCT03227029|2348236|FG001|Overall Study|Not able to get to clinic|0
1188950|NCT03227029|2348237|FG002|Overall Study|Not able to get to clinic|1
1188951|NCT03227029|2348235|FG000|Overall Study|Withdrawal by Subject|1
1188952|NCT03227029|2348236|FG001|Overall Study|Withdrawal by Subject|0
1188953|NCT03227029|2348237|FG002|Overall Study|Withdrawal by Subject|0
1188954|NCT03227029|2348235|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0
1188955|NCT03227029|2348236|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0
1188956|NCT03227029|2348237|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1
1188957|NCT03221842|2348245|FG000|Period 1 (Open-label)|Adverse Event|4
1188958|NCT03221842|2348246|FG001|Period 1 (Open-label)|Adverse Event|0
1188959|NCT03221842|2348245|FG000|Period 1 (Open-label)|Physician Decision|2
1188960|NCT03221842|2348246|FG001|Period 1 (Open-label)|Physician Decision|0
1188961|NCT03221842|2348245|FG000|Period 1 (Open-label)|Lost to Follow-up|1
1188962|NCT03221842|2348246|FG001|Period 1 (Open-label)|Lost to Follow-up|0
1188963|NCT03221842|2348245|FG000|Period 1 (Open-label)|Terminated by sponsor|1
1188964|NCT03221842|2348246|FG001|Period 1 (Open-label)|Terminated by sponsor|0
1188965|NCT03221842|2348245|FG000|Period 1 (Open-label)|Other|2
1188966|NCT03221842|2348246|FG001|Period 1 (Open-label)|Other|0
1188967|NCT03221842|2348245|FG000|Period 2 (Randomized, Blinded)|Death|0
1188968|NCT03221842|2348246|FG001|Period 2 (Randomized, Blinded)|Death|1
1188969|NCT03221842|2348245|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1
1188970|NCT03221842|2348246|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0
1188971|NCT03194321|2348256|FG000|Overall Study|Withdrawal by Subject|1
1188972|NCT03194321|2348256|FG000|Overall Study|Lost to Follow-up|1
1188973|NCT03194321|2348256|FG000|Overall Study|Travel for Follow-up|1
1188974|NCT03165721|2348263|FG000|Overall Study|Refused further treatment|3
1188975|NCT03165721|2348264|FG001|Overall Study|Refused further treatment|0
1188976|NCT03165721|2348265|FG002|Overall Study|Refused further treatment|0
1188977|NCT03165721|2348263|FG000|Overall Study|Physician Decision|1
1188978|NCT03165721|2348264|FG001|Overall Study|Physician Decision|0
1188979|NCT03165721|2348265|FG002|Overall Study|Physician Decision|0
1188980|NCT03085095|2348275|FG000|Overall Study|Adverse Event|23
1188981|NCT03085095|2348276|FG001|Overall Study|Adverse Event|8
1188982|NCT03085095|2348275|FG000|Overall Study|Protocol Violation|0
1188983|NCT03085095|2348276|FG001|Overall Study|Protocol Violation|1
1188984|NCT03085095|2348275|FG000|Overall Study|Lost to Follow-up|2
1188985|NCT03085095|2348276|FG001|Overall Study|Lost to Follow-up|1
1188986|NCT03085095|2348275|FG000|Overall Study|Withdrawal by Subject|17
1188987|NCT03085095|2348276|FG001|Overall Study|Withdrawal by Subject|6
1188988|NCT03085095|2348275|FG000|Overall Study|Physician Decision|9
1188989|NCT03085095|2348276|FG001|Overall Study|Physician Decision|3
1188990|NCT03085095|2348275|FG000|Overall Study|Testosterone Suppression Level Not Met|7
1188991|NCT03085095|2348276|FG001|Overall Study|Testosterone Suppression Level Not Met|13
1188992|NCT03085095|2348275|FG000|Overall Study|Did not Receive Study Drug|2
1188993|NCT03085095|2348276|FG001|Overall Study|Did not Receive Study Drug|2
1188994|NCT03085095|2348275|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1
1188995|NCT03085095|2348276|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0
1188996|NCT03048422|2348288|FG000|Overall Study|Death|1
1188997|NCT03048422|2348289|FG001|Overall Study|Death|0
1188998|NCT03048422|2348290|FG002|Overall Study|Death|0
1188999|NCT03048422|2348288|FG000|Overall Study|Lost to Follow-up|5
1189000|NCT03048422|2348289|FG001|Overall Study|Lost to Follow-up|0
1189001|NCT03048422|2348290|FG002|Overall Study|Lost to Follow-up|1
1189002|NCT03048422|2348288|FG000|Overall Study|Withdrawal by Subject|5
1189003|NCT03048422|2348289|FG001|Overall Study|Withdrawal by Subject|7
1189004|NCT03048422|2348290|FG002|Overall Study|Withdrawal by Subject|4
1189005|NCT03048422|2348288|FG000|Overall Study|Moved|3
1189006|NCT03048422|2348289|FG001|Overall Study|Moved|2
1189007|NCT03048422|2348290|FG002|Overall Study|Moved|2
1189008|NCT03048422|2348288|FG000|Overall Study|Noncompliant with Study Requirements|2
1189009|NCT03048422|2348289|FG001|Overall Study|Noncompliant with Study Requirements|1
1189010|NCT03048422|2348290|FG002|Overall Study|Noncompliant with Study Requirements|2
1189011|NCT03048422|2348288|FG000|Overall Study|Not Able to Get to Clinic|1
1189012|NCT03048422|2348289|FG001|Overall Study|Not Able to Get to Clinic|0
1189013|NCT03048422|2348290|FG002|Overall Study|Not Able to Get to Clinic|0
1189019|NCT03032068|2348312|FG000|Overall Study|Adverse Event|1
1189020|NCT02908672|2348331|FG000|Overall Study|Death|112
1189021|NCT02908672|2348332|FG001|Overall Study|Death|93
1189022|NCT02908672|2348331|FG000|Overall Study|Lost to Follow-up|3
1189023|NCT02908672|2348332|FG001|Overall Study|Lost to Follow-up|3
1189024|NCT02908672|2348331|FG000|Overall Study|Other|2
1189025|NCT02908672|2348332|FG001|Overall Study|Other|0
1189026|NCT02908672|2348331|FG000|Overall Study|Protocol Violation|1
1189027|NCT02908672|2348332|FG001|Overall Study|Protocol Violation|1
880742|NCT00594568|1845255|FG002|Initial Treatment|Caregiver decision|36
880743|NCT00594568|1845253|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
880744|NCT00594568|1845254|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
880745|NCT00594568|1845255|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
880746|NCT00594568|1845253|FG000|Initial Treatment|Entry criteria exclusion|0
880747|NCT00594568|1845254|FG001|Initial Treatment|Entry criteria exclusion|1
880748|NCT00594568|1845255|FG002|Initial Treatment|Entry criteria exclusion|1
880749|NCT00594568|1845253|FG000|Delayed Start|Death|0
1189028|NCT02908672|2348331|FG000|Overall Study|Withdrawal by Subject|13
1189029|NCT02908672|2348332|FG001|Overall Study|Withdrawal by Subject|18
1189030|NCT02908672|2348331|FG000|Overall Study|Study is ongoing|124
1189031|NCT02908672|2348332|FG001|Overall Study|Study is ongoing|141
1189032|NCT02908672|2348331|FG000|Overall Study|Discontinued the study during run-in|3
1189033|NCT02908672|2348332|FG001|Overall Study|Discontinued the study during run-in|0
1189034|NCT02864407|2348338|FG000|Overall Study|Protocol Violation|3
1189035|NCT02864407|2348338|FG000|Overall Study|Lost to Follow-up|115
1189036|NCT02864407|2348338|FG000|Overall Study|Not treated with Vahelva® Respimat®|1
1189037|NCT02864407|2348338|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3
1189038|NCT02864407|2348338|FG000|Overall Study|Consent prior to the contract date|1
1189039|NCT02835690|2348345|FG000|Overall Study|Death|4
1189040|NCT02835690|2348346|FG001|Overall Study|Death|6
1189041|NCT02835690|2348347|FG002|Overall Study|Death|6
1189042|NCT02835690|2348345|FG000|Overall Study|Ongoing in Study (Follow-up)|10
1189043|NCT02835690|2348346|FG001|Overall Study|Ongoing in Study (Follow-up)|7
1189044|NCT02835690|2348347|FG002|Overall Study|Ongoing in Study (Follow-up)|9
1189045|NCT02835690|2348345|FG000|Overall Study|Not Treated|0
1189046|NCT02835690|2348346|FG001|Overall Study|Not Treated|2
1189047|NCT02835690|2348347|FG002|Overall Study|Not Treated|0
1189048|NCT02828982|2348355|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
1189049|NCT02828982|2348356|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
1189050|NCT02815280|2348370|FG000|Double-Blind Phase|Adverse Event|1
1189051|NCT02815280|2348371|FG001|Double-Blind Phase|Adverse Event|1
1189052|NCT02815280|2348370|FG000|Double-Blind Phase|Lost to Follow-up|10
1189053|NCT02815280|2348371|FG001|Double-Blind Phase|Lost to Follow-up|9
1189054|NCT02815280|2348370|FG000|Double-Blind Phase|Withdrawal by Subject|20
1189055|NCT02815280|2348371|FG001|Double-Blind Phase|Withdrawal by Subject|11
1189056|NCT02815280|2348370|FG000|Double-Blind Phase|Protocol Violation|2
1189057|NCT02815280|2348371|FG001|Double-Blind Phase|Protocol Violation|2
1189058|NCT02815280|2348370|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3
1189059|NCT02815280|2348371|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2
1189060|NCT02815280|2348370|FG000|Open-Label Phase|Adverse Event|2
1189061|NCT02815280|2348371|FG001|Open-Label Phase|Adverse Event|3
1189062|NCT02815280|2348370|FG000|Open-Label Phase|Lost to Follow-up|18
1189063|NCT02815280|2348371|FG001|Open-Label Phase|Lost to Follow-up|9
1189064|NCT02815280|2348370|FG000|Open-Label Phase|Withdrawal by Subject|33
1189065|NCT02815280|2348371|FG001|Open-Label Phase|Withdrawal by Subject|18
1189066|NCT02815280|2348370|FG000|Open-Label Phase|Protocol Violation|3
1189067|NCT02815280|2348371|FG001|Open-Label Phase|Protocol Violation|0
1189068|NCT02815280|2348370|FG000|Open-Label Phase|Administrative|26
1189069|NCT02815280|2348371|FG001|Open-Label Phase|Administrative|12
1189070|NCT02815280|2348370|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5
1189071|NCT02815280|2348371|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2
1189072|NCT02815267|2348383|FG000|Double-Blind Phase|Adverse Event|0
1189073|NCT02815267|2348384|FG001|Double-Blind Phase|Adverse Event|3
1189074|NCT02815267|2348383|FG000|Double-Blind Phase|Lost to Follow-up|17
1189075|NCT02815267|2348384|FG001|Double-Blind Phase|Lost to Follow-up|9
1189076|NCT02815267|2348383|FG000|Double-Blind Phase|Withdrawal by Subject|11
1189077|NCT02815267|2348384|FG001|Double-Blind Phase|Withdrawal by Subject|10
1189078|NCT02815267|2348383|FG000|Double-Blind Phase|Protocol Violation|3
1189079|NCT02815267|2348384|FG001|Double-Blind Phase|Protocol Violation|2
1189080|NCT02815267|2348383|FG000|Double-Blind Phase|Site withdrawal|1
1189081|NCT02815267|2348384|FG001|Double-Blind Phase|Site withdrawal|6
1189082|NCT02815267|2348383|FG000|Double-Blind Phase|Received a disallowed medication|1
1189083|NCT02815267|2348384|FG001|Double-Blind Phase|Received a disallowed medication|1
1189084|NCT02815267|2348383|FG000|Open-Label Phase|Adverse Event|1
1189085|NCT02815267|2348384|FG001|Open-Label Phase|Adverse Event|1
1189086|NCT02815267|2348383|FG000|Open-Label Phase|Lost to Follow-up|23
1189087|NCT02815267|2348384|FG001|Open-Label Phase|Lost to Follow-up|9
1189088|NCT02815267|2348383|FG000|Open-Label Phase|Withdrawal by Subject|24
1189089|NCT02815267|2348384|FG001|Open-Label Phase|Withdrawal by Subject|13
1189090|NCT02815267|2348383|FG000|Open-Label Phase|Protocol Violation|0
1189091|NCT02815267|2348384|FG001|Open-Label Phase|Protocol Violation|1
1189092|NCT02815267|2348383|FG000|Open-Label Phase|Administrative|21
1189093|NCT02815267|2348384|FG001|Open-Label Phase|Administrative|12
1189094|NCT02815267|2348383|FG000|Open-Label Phase|Other|2
1189095|NCT02815267|2348384|FG001|Open-Label Phase|Other|5
1189096|NCT02802228|2348396|FG000|Overall Study|Withdrawal by Subject|2
1189097|NCT02802228|2348397|FG001|Overall Study|Withdrawal by Subject|0
1189098|NCT02802228|2348396|FG000|Overall Study|Lost to Follow-up|1
1189099|NCT02802228|2348397|FG001|Overall Study|Lost to Follow-up|0
1189100|NCT02802228|2348396|FG000|Overall Study|Adverse Event|1
1189101|NCT02802228|2348397|FG001|Overall Study|Adverse Event|0
1189102|NCT02802228|2348396|FG000|Overall Study|Physician Decision|1
1189103|NCT02802228|2348397|FG001|Overall Study|Physician Decision|0
1189104|NCT02701283|2348429|FG000|Overall Study|Death|25
1189105|NCT02701283|2348430|FG001|Overall Study|Death|29
1189106|NCT02701283|2348431|FG002|Overall Study|Death|19
1189107|NCT02701283|2348429|FG000|Overall Study|Lost to Follow-up|3
1189108|NCT02701283|2348430|FG001|Overall Study|Lost to Follow-up|8
1189109|NCT02701283|2348431|FG002|Overall Study|Lost to Follow-up|1
1189110|NCT02701283|2348429|FG000|Overall Study|Withdrawal by Subject|12
1189111|NCT02701283|2348430|FG001|Overall Study|Withdrawal by Subject|41
1189112|NCT02701283|2348431|FG002|Overall Study|Withdrawal by Subject|1
1189113|NCT02701283|2348429|FG000|Overall Study|Missed 2-year visit|22
1189114|NCT02701283|2348430|FG001|Overall Study|Missed 2-year visit|27
1189115|NCT02701283|2348431|FG002|Overall Study|Missed 2-year visit|0
1189116|NCT02701283|2348429|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7
1189117|NCT02701283|2348430|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57
1189118|NCT02701283|2348431|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0
1189119|NCT02674516|2348444|FG000|Overall Study|Lost to Follow-up|3
1189120|NCT02674516|2348445|FG001|Overall Study|Lost to Follow-up|0
1189121|NCT02674516|2348444|FG000|Overall Study|Protocol Violation|0
1189122|NCT02674516|2348445|FG001|Overall Study|Protocol Violation|4
1189123|NCT02674516|2348444|FG000|Overall Study|Knowledge of study hypothesis|1
1189124|NCT02674516|2348445|FG001|Overall Study|Knowledge of study hypothesis|0
1189125|NCT02655016|2348453|FG000|Overall Study|Disease progression|6
1189126|NCT02655016|2348454|FG001|Overall Study|Disease progression|4
1189127|NCT02655016|2348453|FG000|Overall Study|Site closed|0
1189128|NCT02655016|2348454|FG001|Overall Study|Site closed|1
1189129|NCT02655016|2348453|FG000|Overall Study|Death|30
1189130|NCT02655016|2348454|FG001|Overall Study|Death|48
1189131|NCT02655016|2348453|FG000|Overall Study|Lost to Follow-up|1
1189132|NCT02655016|2348454|FG001|Overall Study|Lost to Follow-up|1
880750|NCT00594568|1845254|FG001|Delayed Start|Death|0
880751|NCT00594568|1845255|FG002|Delayed Start|Death|1
880752|NCT00594568|1845253|FG000|Delayed Start|Adverse Event|12
880753|NCT00594568|1845254|FG001|Delayed Start|Adverse Event|2
880754|NCT00594568|1845255|FG002|Delayed Start|Adverse Event|2
880755|NCT00594568|1845253|FG000|Delayed Start|Withdrawal by Subject|4
880756|NCT00594568|1845254|FG001|Delayed Start|Withdrawal by Subject|3
880757|NCT00594568|1845255|FG002|Delayed Start|Withdrawal by Subject|0
880758|NCT00594568|1845253|FG000|Delayed Start|Physician Decision|0
880759|NCT00594568|1845254|FG001|Delayed Start|Physician Decision|0
880760|NCT00594568|1845255|FG002|Delayed Start|Physician Decision|1
880761|NCT00594568|1845253|FG000|Delayed Start|Lost to Follow-up|0
880762|NCT00594568|1845254|FG001|Delayed Start|Lost to Follow-up|0
880763|NCT00594568|1845255|FG002|Delayed Start|Lost to Follow-up|1
880764|NCT00594568|1845253|FG000|Delayed Start|Caregiver Decision|5
880765|NCT00594568|1845254|FG001|Delayed Start|Caregiver Decision|6
880766|NCT00594568|1845255|FG002|Delayed Start|Caregiver Decision|2
880767|NCT00594568|1845253|FG000|Delayed Start|Sponsor Decision|77
880768|NCT00594568|1845254|FG001|Delayed Start|Sponsor Decision|66
880769|NCT00594568|1845255|FG002|Delayed Start|Sponsor Decision|59
880770|NCT00594568|1845253|FG000|Safety Follow Up (SFU)-Optional|Death|0
880771|NCT00594568|1845254|FG001|Safety Follow Up (SFU)-Optional|Death|1
880772|NCT00594568|1845255|FG002|Safety Follow Up (SFU)-Optional|Death|0
880773|NCT00594568|1845253|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5
880774|NCT00594568|1845254|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0
880775|NCT00594568|1845255|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0
880776|NCT00594568|1845253|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
880777|NCT00594568|1845254|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
880778|NCT00594568|1845255|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
880779|NCT00594568|1845253|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
880780|NCT00594568|1845254|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
880781|NCT00594568|1845255|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
880782|NCT00594568|1845253|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
880783|NCT00594568|1845254|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
880784|NCT00594568|1845255|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
880785|NCT00594568|1845253|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
880786|NCT00594568|1845254|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
880787|NCT00594568|1845255|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
880788|NCT00594646|1845271|FG000|Overall Study|Withdrawal by Subject|1
880789|NCT00594646|1845271|FG000|Overall Study|Lost to Follow-up|15
880790|NCT00594659|1845279|FG000|Overall Study|Lost to Follow-up|13
880791|NCT00594659|1845280|FG001|Overall Study|Lost to Follow-up|9
880792|NCT00594659|1845281|FG002|Overall Study|Lost to Follow-up|7
880793|NCT00594815|1845293|FG000|Overall Study|Never Treated|3
880794|NCT00594815|1845293|FG000|Overall Study|Withdrawal by Subject|2
880795|NCT00594815|1845293|FG000|Overall Study|Toxicity|4
880796|NCT00594854|1845299|FG000|Overall Study|Study terminated|7
880797|NCT00594854|1845300|FG001|Overall Study|Study terminated|10
880798|NCT00594880|1845308|FG000|Overall Study|Withdrawal by Subject|1
880799|NCT00594880|1845309|FG001|Overall Study|Withdrawal by Subject|1
880800|NCT00594880|1845308|FG000|Overall Study|Lost to Follow-up|1
880801|NCT00594880|1845309|FG001|Overall Study|Lost to Follow-up|0
880802|NCT00594906|1845321|FG000|Overall Study|Physician Decision|1
880803|NCT00594906|1845322|FG001|Overall Study|Physician Decision|0
880804|NCT00594906|1845321|FG000|Overall Study|Physician Decision|0
880805|NCT00594906|1845322|FG001|Overall Study|Physician Decision|1
880806|NCT00594906|1845321|FG000|Overall Study|Death|0
880807|NCT00594906|1845322|FG001|Overall Study|Death|1
880808|NCT00594932|1845330|FG000|First 3 Months|Withdrawal by Subject|1
880809|NCT00594932|1845331|FG001|First 3 Months|Withdrawal by Subject|3
880810|NCT00594932|1845330|FG000|Final 3 Months|Withdrawal by Subject|4
880811|NCT00594932|1845331|FG001|Final 3 Months|Withdrawal by Subject|3
880812|NCT00594958|1845351|FG000|Overall Study|Withdrawal by Subject|1
880813|NCT00594958|1845352|FG001|Overall Study|Withdrawal by Subject|0
1189133|NCT02655016|2348453|FG000|Overall Study|Withdrawal by Subject|18
1189134|NCT02655016|2348454|FG001|Overall Study|Withdrawal by Subject|36
1189135|NCT02545868|2348486|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
1189136|NCT02545868|2348487|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
1189137|NCT02545868|2348488|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
1189138|NCT02505425|2348505|FG000|Overall Study|Lost to Follow-up|41
1189139|NCT02505425|2348506|FG001|Overall Study|Lost to Follow-up|61
1189140|NCT02505425|2348507|FG002|Overall Study|Lost to Follow-up|31
1189141|NCT02505425|2348508|FG003|Overall Study|Lost to Follow-up|19
1189142|NCT02505425|2348505|FG000|Overall Study|Withdrawal by Subject|39
1189143|NCT02505425|2348506|FG001|Overall Study|Withdrawal by Subject|9
1189144|NCT02505425|2348507|FG002|Overall Study|Withdrawal by Subject|19
1189145|NCT02505425|2348508|FG003|Overall Study|Withdrawal by Subject|7
1189146|NCT02505425|2348505|FG000|Overall Study|Death|8
1189147|NCT02505425|2348506|FG001|Overall Study|Death|12
1189148|NCT02505425|2348507|FG002|Overall Study|Death|0
1189149|NCT02505425|2348508|FG003|Overall Study|Death|0
1189168|NCT02487979|2348528|FG000|Overall Study|Physician Decision|2
1189169|NCT02487979|2348528|FG000|Overall Study|Withdrawal by Subject|2
1189170|NCT02487979|2348528|FG000|Overall Study|Progressive Disease|17
1189171|NCT02463448|2348532|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3
1189172|NCT02463448|2348532|FG000|6 Months Through 12 Months|Lost to Follow-up|1
1189173|NCT02463448|2348532|FG000|6 Months Through 12 Months|Withdrawal by Subject|1
1189174|NCT02463448|2348532|FG000|12 Months Through End of Study|Lost to Follow-up|1
1189190|NCT02276547|2348558|FG000|Overall Study|Death|2
1189191|NCT02276547|2348558|FG000|Overall Study|Explant|2
1189192|NCT02263885|2348562|FG000|Overall Study|Withdrawal by Subject|7
1189193|NCT02263885|2348562|FG000|Overall Study|Alternative Treatment|3
1189194|NCT02257736|2348569|FG000|Overall Study|Progressive disease|365
1189195|NCT02257736|2348570|FG001|Overall Study|Progressive disease|327
1189196|NCT02257736|2348569|FG000|Overall Study|Adverse Event|45
1189197|NCT02257736|2348570|FG001|Overall Study|Adverse Event|56
1189198|NCT02257736|2348569|FG000|Overall Study|Withdrawal by Subject|21
1189199|NCT02257736|2348570|FG001|Overall Study|Withdrawal by Subject|38
1189200|NCT02257736|2348569|FG000|Overall Study|Death|11
1189201|NCT02257736|2348570|FG001|Overall Study|Death|6
1189202|NCT02257736|2348569|FG000|Overall Study|Physician Decision|5
1189203|NCT02257736|2348570|FG001|Overall Study|Physician Decision|9
1189204|NCT02257736|2348569|FG000|Overall Study|Non-Compliance with study drug|1
1189205|NCT02257736|2348570|FG001|Overall Study|Non-Compliance with study drug|2
1189206|NCT02257736|2348569|FG000|Overall Study|Protocol Violation|1
1189207|NCT02257736|2348570|FG001|Overall Study|Protocol Violation|0
1189208|NCT02257736|2348569|FG000|Overall Study|Other|1
1189209|NCT02257736|2348570|FG001|Overall Study|Other|7
1189210|NCT02257736|2348569|FG000|Overall Study|Randomized, not treated|1
1189211|NCT02257736|2348570|FG001|Overall Study|Randomized, not treated|2
1189212|NCT02213926|2348576|FG000|Overall Study|Death|59
1189213|NCT02213926|2348576|FG000|Overall Study|Withdrawal by Subject|10
1189214|NCT02213926|2348576|FG000|Overall Study|study terminated by sponsor|51
1189215|NCT02213926|2348576|FG000|Overall Study|Lost to Follow-up|3
1189216|NCT02213926|2348576|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1
1189217|NCT02091960|2348580|FG000|Overall Study|Death|7
1189218|NCT02091960|2348580|FG000|Overall Study|Withdrawal by Subject|1
1189219|NCT02091960|2348580|FG000|Overall Study|Miscellaneous Reasons|31
1189220|NCT02091960|2348580|FG000|Overall Study|On Study at Data Cut-off|12
1189221|NCT02073279|2348586|FG000|Double-blind Period|Adverse Event|1
1189222|NCT02073279|2348587|FG001|Double-blind Period|Adverse Event|1
1189223|NCT02073279|2348586|FG000|Double-blind Period|Protocol Deviation|0
1189224|NCT02073279|2348587|FG001|Double-blind Period|Protocol Deviation|1
1189225|NCT02073279|2348586|FG000|Double-blind Period|Withdrawal by Subject|2
1189226|NCT02073279|2348587|FG001|Double-blind Period|Withdrawal by Subject|2
1189227|NCT02073279|2348586|FG000|Double-blind Period|Reason Not Specified|1
1189228|NCT02073279|2348587|FG001|Double-blind Period|Reason Not Specified|2
1189229|NCT02073279|2348586|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0
1189230|NCT02073279|2348587|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1
1189231|NCT02073279|2348586|FG000|Double-blind Period|On-going in Study|11
1189232|NCT02073279|2348587|FG001|Double-blind Period|On-going in Study|40
1189233|NCT02073279|2348586|FG000|Open-label Extension Period|Lack of Efficacy|1
1189234|NCT02073279|2348587|FG001|Open-label Extension Period|Lack of Efficacy|0
1189235|NCT02073279|2348586|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0
1189236|NCT02073279|2348587|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1
1189237|NCT02073279|2348586|FG000|Open-label Extension Period|Withdrawal by Subject|1
1189238|NCT02073279|2348587|FG001|Open-label Extension Period|Withdrawal by Subject|1
1189239|NCT02073279|2348586|FG000|Open-label Extension Period|Reason Not Specified|1
1189240|NCT02073279|2348587|FG001|Open-label Extension Period|Reason Not Specified|1
1189241|NCT02073279|2348586|FG000|Open-label Extension Period|On-going in Study|14
1189242|NCT02073279|2348587|FG001|Open-label Extension Period|On-going in Study|13
1189243|NCT02008396|2348598|FG000|Overall Study|Protocol Violation|0
1189244|NCT02008396|2348599|FG001|Overall Study|Protocol Violation|1
1189245|NCT01995175|2348606|FG000|Overall Study|Withdrawal by Subject|35
1189246|NCT01995175|2348606|FG000|Overall Study|Lost to Follow-up|102
1189247|NCT01995175|2348606|FG000|Overall Study|Other|67
1189248|NCT01995175|2348606|FG000|Overall Study|Migrated / moved from the study area|49
1189249|NCT01877655|2348626|FG000|Overall Study|Death|57
1189250|NCT01877655|2348627|FG001|Overall Study|Death|52
1189251|NCT01877655|2348626|FG000|Overall Study|Withdrawal by Subject|18
1189252|NCT01877655|2348627|FG001|Overall Study|Withdrawal by Subject|26
1189253|NCT01877655|2348626|FG000|Overall Study|Physician Decision|11
1189254|NCT01877655|2348627|FG001|Overall Study|Physician Decision|10
1189255|NCT01877655|2348626|FG000|Overall Study|Miscellaneous|4
1189256|NCT01877655|2348627|FG001|Overall Study|Miscellaneous|4
1189257|NCT01877655|2348626|FG000|Overall Study|Randomized but Never Received Drug|8
1189258|NCT01877655|2348627|FG001|Overall Study|Randomized but Never Received Drug|5
1189269|NCT01804270|2348657|FG000|Overall Study|Withdrawal by Subject|1
1189270|NCT01804270|2348658|FG001|Overall Study|Withdrawal by Subject|1
1189274|NCT01781390|2348684|FG000|Overall Study|Withdrawal of Consent|0
1189275|NCT01781390|2348685|FG001|Overall Study|Withdrawal of Consent|3
1189276|NCT01781390|2348686|FG002|Overall Study|Withdrawal of Consent|1
1189277|NCT01781390|2348684|FG000|Overall Study|Lost to Follow-up|1
1189278|NCT01781390|2348685|FG001|Overall Study|Lost to Follow-up|1
1189279|NCT01781390|2348686|FG002|Overall Study|Lost to Follow-up|1
1189280|NCT01781390|2348684|FG000|Overall Study|Adverse Event|1
1189281|NCT01781390|2348685|FG001|Overall Study|Adverse Event|2
1189282|NCT01781390|2348686|FG002|Overall Study|Adverse Event|1
1189283|NCT01781390|2348684|FG000|Overall Study|Participants who were Randomized and Not Treated|1
1189284|NCT01781390|2348685|FG001|Overall Study|Participants who were Randomized and Not Treated|1
1189285|NCT01781390|2348686|FG002|Overall Study|Participants who were Randomized and Not Treated|1
1189286|NCT01566695|2348696|FG000|Overall Study|Lack of Efficacy|18
1189287|NCT01566695|2348697|FG001|Overall Study|Lack of Efficacy|45
1189288|NCT01566695|2348696|FG000|Overall Study|Adverse Event|28
1189289|NCT01566695|2348697|FG001|Overall Study|Adverse Event|27
1189290|NCT01566695|2348696|FG000|Overall Study|Death|20
1189291|NCT01566695|2348697|FG001|Overall Study|Death|8
1189292|NCT01566695|2348696|FG000|Overall Study|Withdrawal by Subject|14
1189293|NCT01566695|2348697|FG001|Overall Study|Withdrawal by Subject|7
1189294|NCT01566695|2348696|FG000|Overall Study|Progressive Disease|11
1189295|NCT01566695|2348697|FG001|Overall Study|Progressive Disease|6
1189296|NCT01566695|2348696|FG000|Overall Study|Miscellaneous|4
1189297|NCT01566695|2348697|FG001|Overall Study|Miscellaneous|6
1189298|NCT01412333|2348705|FG000|Overall Study|Death|1
1189299|NCT01412333|2348706|FG001|Overall Study|Death|1
1189300|NCT01412333|2348705|FG000|Overall Study|Physician Decision|0
1189301|NCT01412333|2348706|FG001|Overall Study|Physician Decision|1
1189302|NCT01412333|2348705|FG000|Overall Study|Reason not specified|16
1189303|NCT01412333|2348706|FG001|Overall Study|Reason not specified|10
1189304|NCT01412333|2348705|FG000|Overall Study|Non-compliance with study drug|1
1189305|NCT01412333|2348706|FG001|Overall Study|Non-compliance with study drug|1
1189306|NCT01412333|2348705|FG000|Overall Study|Protocol Violation|1
1189307|NCT01412333|2348706|FG001|Overall Study|Protocol Violation|1
1189308|NCT01412333|2348705|FG000|Overall Study|Non-compliance|1
1189309|NCT01412333|2348706|FG001|Overall Study|Non-compliance|3
1189310|NCT01412333|2348705|FG000|Overall Study|Lack of Efficacy|15
1189311|NCT01412333|2348706|FG001|Overall Study|Lack of Efficacy|6
1189312|NCT01412333|2348705|FG000|Overall Study|Pregnancy|3
1189313|NCT01412333|2348706|FG001|Overall Study|Pregnancy|0
1189314|NCT01412333|2348705|FG000|Overall Study|Consent withdrawn by participant|25
1189315|NCT01412333|2348706|FG001|Overall Study|Consent withdrawn by participant|12
1189316|NCT01412333|2348705|FG000|Overall Study|Adverse Event|25
1189317|NCT01412333|2348706|FG001|Overall Study|Adverse Event|16
1189318|NCT01412333|2348705|FG000|Overall Study|Lost to Follow-up|10
1189319|NCT01412333|2348706|FG001|Overall Study|Lost to Follow-up|6
1189320|NCT01338636|2348713|FG000|Overall Study|Withdrawn due to lack of improvement|8
1189321|NCT01253161|2348717|FG000|Overall Study|Adverse Event|1
1189322|NCT01247324|2348723|FG000|Overall Study|Death|1
1189323|NCT01247324|2348724|FG001|Overall Study|Death|0
1189324|NCT01247324|2348723|FG000|Overall Study|Physician Decision|0
1189325|NCT01247324|2348724|FG001|Overall Study|Physician Decision|1
1189326|NCT01247324|2348723|FG000|Overall Study|Non-compliance with study drug|3
1189327|NCT01247324|2348724|FG001|Overall Study|Non-compliance with study drug|0
1189328|NCT01247324|2348723|FG000|Overall Study|Lack of Efficacy|12
1189329|NCT01247324|2348724|FG001|Overall Study|Lack of Efficacy|8
1189330|NCT01247324|2348723|FG000|Overall Study|Non-compliance|2
1189331|NCT01247324|2348724|FG001|Overall Study|Non-compliance|0
1189332|NCT01247324|2348723|FG000|Overall Study|Pregnancy|2
1189333|NCT01247324|2348724|FG001|Overall Study|Pregnancy|3
1189334|NCT01247324|2348723|FG000|Overall Study|Protocol Violation|1
1189335|NCT01247324|2348724|FG001|Overall Study|Protocol Violation|2
1189336|NCT01247324|2348723|FG000|Overall Study|Reason not specified|11
1189337|NCT01247324|2348724|FG001|Overall Study|Reason not specified|8
1189338|NCT01247324|2348723|FG000|Overall Study|Consent withdrawn by participant|13
1189339|NCT01247324|2348724|FG001|Overall Study|Consent withdrawn by participant|8
1189340|NCT01247324|2348723|FG000|Overall Study|Adverse Event|25
1189341|NCT01247324|2348724|FG001|Overall Study|Adverse Event|13
1189342|NCT01247324|2348723|FG000|Overall Study|Lost to Follow-up|1
1189343|NCT01247324|2348724|FG001|Overall Study|Lost to Follow-up|1
1189344|NCT01208974|2348731|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1
1189345|NCT01208974|2348732|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
1189346|NCT01208974|2348733|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
1189347|NCT01208974|2348734|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
1189348|NCT01208974|2348731|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1
1189349|NCT01208974|2348732|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
1189350|NCT01208974|2348733|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
1189351|NCT01208974|2348734|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
1189352|NCT01208974|2348731|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1
1189353|NCT01208974|2348732|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
1189354|NCT01208974|2348733|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
1189355|NCT01208974|2348734|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
1189356|NCT01063517|2348743|FG000|Overall Study|Consent withdrawal|1
1189357|NCT01063517|2348744|FG001|Overall Study|Consent withdrawal|0
1189358|NCT01063517|2348743|FG000|Overall Study|Study reached data cut-off|19
1189359|NCT01063517|2348744|FG001|Overall Study|Study reached data cut-off|7
1189360|NCT01063517|2348743|FG000|Overall Study|Lost to Follow-up|4
1189361|NCT01063517|2348744|FG001|Overall Study|Lost to Follow-up|3
1189362|NCT01063517|2348743|FG000|Overall Study|Withdrawal by Subject|1
1189363|NCT01063517|2348744|FG001|Overall Study|Withdrawal by Subject|2
1189364|NCT01063517|2348743|FG000|Overall Study|Death|33
1189365|NCT01063517|2348744|FG001|Overall Study|Death|48
1189366|NCT00938912|2348750|FG000|Overall Study|Withdrawal by Subject|28
1189367|NCT00938912|2348750|FG000|Overall Study|Lost to Follow-up|4
1189368|NCT00938912|2348750|FG000|Overall Study|Lack of Efficacy|43
1189369|NCT00938912|2348750|FG000|Overall Study|Adverse event, non-fatal|24
1189370|NCT00938912|2348750|FG000|Overall Study|Adverse event, fatal|1
1189371|NCT00938912|2348750|FG000|Overall Study|Participant self adjusted antiepileptic medication|1
1189372|NCT00938912|2348750|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1
1189373|NCT00938912|2348750|FG000|Overall Study|Participant needed prohibit medication|1
1189374|NCT00938912|2348750|FG000|Overall Study|Participant was scheduled for lobal resection|1
1189375|NCT00938912|2348750|FG000|Overall Study|Did not meet Eligibility criteria|1
1189376|NCT00938912|2348750|FG000|Overall Study|Participant relocated not related to AE|1
1189377|NCT00938912|2348750|FG000|Overall Study|Participant moved to another city|1
1189378|NCT00938912|2348750|FG000|Overall Study|Participant experienced break through seizures|1
1189379|NCT00938912|2348750|FG000|Overall Study|No longer wished to participate in the study|1
1189380|NCT00938912|2348750|FG000|Overall Study|Protocol Deviation|2
1189381|NCT00885495|2348784|FG000|Overall Study|Adverse Event|1
1189382|NCT00885495|2348785|FG001|Overall Study|Adverse Event|2
1189383|NCT00885495|2348784|FG000|Overall Study|Protocol Violation|0
1189384|NCT00885495|2348785|FG001|Overall Study|Protocol Violation|1
1189385|NCT00885495|2348784|FG000|Overall Study|Withdrawal by Subject|1
1189386|NCT00885495|2348785|FG001|Overall Study|Withdrawal by Subject|0
1189387|NCT00792948|2348792|FG000|Overall Study|Adverse Event|6
1189388|NCT00792948|2348792|FG000|Overall Study|Death|4
1189389|NCT00792948|2348792|FG000|Overall Study|Withdrawal by Subject|3
1189390|NCT00792948|2348792|FG000|Overall Study|Ineligible|2
1189391|NCT00792948|2348792|FG000|Overall Study|Insurance denial - not treated|1
1189392|NCT00792948|2348792|FG000|Overall Study|Physician Decision|11
1189393|NCT00792948|2348792|FG000|Overall Study|Protocol Violation|1
1189394|NCT00676715|2348803|FG000|Overall Study|Withdrawal by Subject|7
1189395|NCT00676715|2348804|FG001|Overall Study|Withdrawal by Subject|9
1189396|NCT00676715|2348805|FG002|Overall Study|Withdrawal by Subject|10
1189397|NCT00676715|2348806|FG003|Overall Study|Withdrawal by Subject|10
1189398|NCT00676715|2348803|FG000|Overall Study|Other|2
1189399|NCT00676715|2348804|FG001|Overall Study|Other|6
1189400|NCT00676715|2348805|FG002|Overall Study|Other|4
1189401|NCT00676715|2348806|FG003|Overall Study|Other|3
1189402|NCT00676715|2348803|FG000|Overall Study|Lost to Follow-up|1
1189403|NCT00676715|2348804|FG001|Overall Study|Lost to Follow-up|1
1189404|NCT00676715|2348805|FG002|Overall Study|Lost to Follow-up|7
1189405|NCT00676715|2348806|FG003|Overall Study|Lost to Follow-up|3
1189406|NCT00676715|2348803|FG000|Overall Study|Death|1
1189407|NCT00676715|2348804|FG001|Overall Study|Death|1
1189408|NCT00676715|2348805|FG002|Overall Study|Death|1
1189409|NCT00676715|2348806|FG003|Overall Study|Death|0
1189410|NCT00676715|2348803|FG000|Overall Study|Adverse Event|0
1189411|NCT00676715|2348804|FG001|Overall Study|Adverse Event|1
1189412|NCT00676715|2348805|FG002|Overall Study|Adverse Event|2
1189413|NCT00676715|2348806|FG003|Overall Study|Adverse Event|0
1189414|NCT00676715|2348803|FG000|Overall Study|Participants Ongoing|29
1189415|NCT00676715|2348804|FG001|Overall Study|Participants Ongoing|29
1189416|NCT00676715|2348805|FG002|Overall Study|Participants Ongoing|17
1189417|NCT00676715|2348806|FG003|Overall Study|Participants Ongoing|24
1189418|NCT00579826|2348818|FG000|Overall Study|Withdrawal by Subject|5
1189419|NCT00579826|2348819|FG001|Overall Study|Withdrawal by Subject|3
1189420|NCT00322218|2348827|FG000|Overall Study|Death|3
1189421|NCT00322218|2348828|FG001|Overall Study|Death|6
1189422|NCT00186888|2348837|FG000|Overall Study|Toxicity|0
1189423|NCT00186888|2348838|FG001|Overall Study|Toxicity|1
1189424|NCT00186888|2348839|FG002|Overall Study|Toxicity|0
1189425|NCT00186888|2348837|FG000|Overall Study|Relapse or progression of disease|4
1189426|NCT00186888|2348838|FG001|Overall Study|Relapse or progression of disease|2
1189427|NCT00186888|2348839|FG002|Overall Study|Relapse or progression of disease|0
1189428|NCT04311463|2348928|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
1189429|NCT04311463|2348929|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0
1189430|NCT04311463|2348928|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1
1189431|NCT04311463|2348929|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1
1189432|NCT04311463|2348928|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2
1189433|NCT04311463|2348929|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
1189434|NCT03930186|2348945|FG000|Weeks 0 to 16|Adverse Event|6
1189435|NCT03930186|2348945|FG000|Weeks 0 to 16|Withdrawal by Subject|6
1189436|NCT03930186|2348945|FG000|Weeks 16 to 32|Adverse Event|1
1189437|NCT03930186|2348945|FG000|Weeks 16 to 32|Withdrawal by Subject|3
1189438|NCT03740100|2348949|FG000|Overall Study|Adverse Event|1
1189439|NCT03740100|2348949|FG000|Overall Study|Death|1
1189440|NCT03597295|2348953|FG000|Overall Study|Death|37
1189441|NCT03597295|2348953|FG000|Overall Study|Lost to Follow-up|3
1189442|NCT03597295|2348953|FG000|Overall Study|Participants ongoing in the study|54
1189443|NCT03086369|2348982|FG000|Overall Study|Adverse Event|0
1189444|NCT03086369|2348983|FG001|Overall Study|Adverse Event|0
1189445|NCT03086369|2348984|FG002|Overall Study|Adverse Event|0
1189446|NCT03086369|2348985|FG003|Overall Study|Adverse Event|3
1189447|NCT03086369|2348986|FG004|Overall Study|Adverse Event|4
1189448|NCT03086369|2348982|FG000|Overall Study|Lost to Follow-up|1
1189449|NCT03086369|2348983|FG001|Overall Study|Lost to Follow-up|0
1189450|NCT03086369|2348984|FG002|Overall Study|Lost to Follow-up|0
1189451|NCT03086369|2348985|FG003|Overall Study|Lost to Follow-up|2
1189452|NCT03086369|2348986|FG004|Overall Study|Lost to Follow-up|1
1189453|NCT03086369|2348982|FG000|Overall Study|Physician Decision|0
1189454|NCT03086369|2348983|FG001|Overall Study|Physician Decision|0
1189455|NCT03086369|2348984|FG002|Overall Study|Physician Decision|0
1189456|NCT03086369|2348985|FG003|Overall Study|Physician Decision|2
1189457|NCT03086369|2348986|FG004|Overall Study|Physician Decision|5
1189458|NCT03086369|2348982|FG000|Overall Study|Withdrawal by Subject|0
1189459|NCT03086369|2348983|FG001|Overall Study|Withdrawal by Subject|0
1189460|NCT03086369|2348984|FG002|Overall Study|Withdrawal by Subject|0
1189461|NCT03086369|2348985|FG003|Overall Study|Withdrawal by Subject|5
1189462|NCT03086369|2348986|FG004|Overall Study|Withdrawal by Subject|5
1189463|NCT03086369|2348982|FG000|Overall Study|Progressive Disease|0
1189464|NCT03086369|2348983|FG001|Overall Study|Progressive Disease|0
1189465|NCT03086369|2348984|FG002|Overall Study|Progressive Disease|0
1189466|NCT03086369|2348985|FG003|Overall Study|Progressive Disease|14
1189467|NCT03086369|2348986|FG004|Overall Study|Progressive Disease|4
1189468|NCT03086369|2348982|FG000|Overall Study|On Treatment|0
1189469|NCT03086369|2348983|FG001|Overall Study|On Treatment|0
1189470|NCT03086369|2348984|FG002|Overall Study|On Treatment|0
1189471|NCT03086369|2348985|FG003|Overall Study|On Treatment|1
1189472|NCT03086369|2348986|FG004|Overall Study|On Treatment|2
1189473|NCT02849626|2349012|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11
1189474|NCT02849626|2349013|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3
1189475|NCT02849626|2349012|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
1189476|NCT02849626|2349013|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
1189477|NCT02849626|2349012|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
1189478|NCT02849626|2349013|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
1189479|NCT02849626|2349012|FG000|Core Phase (up to 23 Weeks)|Non-specified|3
1189480|NCT02849626|2349013|FG001|Core Phase (up to 23 Weeks)|Non-specified|0
1189481|NCT02849626|2349012|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3
1189482|NCT02849626|2349013|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2
880814|NCT00594958|1845353|FG002|Overall Study|Withdrawal by Subject|1
880815|NCT00594958|1845351|FG000|Overall Study|Adverse Event|4
880816|NCT00594958|1845352|FG001|Overall Study|Adverse Event|1
880817|NCT00594958|1845353|FG002|Overall Study|Adverse Event|2
880818|NCT00594958|1845351|FG000|Overall Study|Pregnancy|0
880819|NCT00594958|1845352|FG001|Overall Study|Pregnancy|2
880820|NCT00594958|1845353|FG002|Overall Study|Pregnancy|0
880821|NCT00594958|1845351|FG000|Overall Study|Protocol Violation|1
880822|NCT00594958|1845352|FG001|Overall Study|Protocol Violation|0
880823|NCT00594958|1845353|FG002|Overall Study|Protocol Violation|2
880824|NCT00594958|1845351|FG000|Overall Study|Lost to Follow-up|5
880825|NCT00594958|1845352|FG001|Overall Study|Lost to Follow-up|0
880826|NCT00594958|1845353|FG002|Overall Study|Lost to Follow-up|3
880827|NCT00594958|1845351|FG000|Overall Study|administrative|3
880828|NCT00594958|1845352|FG001|Overall Study|administrative|0
880829|NCT00594958|1845353|FG002|Overall Study|administrative|2
880830|NCT00595075|1845374|FG000|Overall Study|Withdrawal by Subject|1
880831|NCT00595075|1845375|FG001|Overall Study|Withdrawal by Subject|0
880832|NCT00595127|1845411|FG000|Overall Study|Death|6
880833|NCT00595127|1845411|FG000|Overall Study|Relapsed|3
880834|NCT00595127|1845411|FG000|Overall Study|joined another trial|1
880835|NCT00595309|1845450|FG000|Overall Study|Lost to Follow-up|1
880836|NCT00595309|1845450|FG000|Overall Study|planned vaccination against yellow fever|1
880837|NCT00595309|1845450|FG000|Overall Study|acute infection after V0|1
880838|NCT00595309|1845450|FG000|Overall Study|personal reason|1
880839|NCT00595335|1845456|FG000|Baseline to Six Months|Withdrawal by Subject|0
880840|NCT00595335|1845457|FG001|Baseline to Six Months|Withdrawal by Subject|1
1006589|NCT01468701|2025298|FG013|Overall Study|Other reasons than listed|239
1189483|NCT02849626|2349012|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
1189484|NCT02849626|2349013|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
1189485|NCT02849626|2349012|FG000|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
1189486|NCT02849626|2349013|FG001|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
1189487|NCT02849626|2349012|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1
1189488|NCT02849626|2349013|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0
880841|NCT00595335|1845456|FG000|Baseline to Six Months|Disease Progression|1
880842|NCT00595335|1845457|FG001|Baseline to Six Months|Disease Progression|1
880843|NCT00595335|1845456|FG000|Baseline to Six Months|Adverse Event|1
880844|NCT00595335|1845457|FG001|Baseline to Six Months|Adverse Event|0
880845|NCT00595335|1845456|FG000|Six Months to Twelve Months|Withdrawal by Subject|0
880846|NCT00595335|1845457|FG001|Six Months to Twelve Months|Withdrawal by Subject|1
880847|NCT00595335|1845456|FG000|Six Months to Twelve Months|Disease Progression|1
880848|NCT00595335|1845457|FG001|Six Months to Twelve Months|Disease Progression|0
880849|NCT00595413|1845480|FG000|Overall Study|Adverse Event|0
880850|NCT00595413|1845481|FG001|Overall Study|Adverse Event|2
880851|NCT00595413|1845482|FG002|Overall Study|Adverse Event|1
880852|NCT00595413|1845483|FG003|Overall Study|Adverse Event|1
880853|NCT00595413|1845480|FG000|Overall Study|Lost to Follow-up|2
880854|NCT00595413|1845481|FG001|Overall Study|Lost to Follow-up|2
880855|NCT00595413|1845482|FG002|Overall Study|Lost to Follow-up|1
880856|NCT00595413|1845483|FG003|Overall Study|Lost to Follow-up|3
880857|NCT00595413|1845480|FG000|Overall Study|Death|0
880858|NCT00595413|1845481|FG001|Overall Study|Death|0
880859|NCT00595413|1845482|FG002|Overall Study|Death|1
880860|NCT00595413|1845483|FG003|Overall Study|Death|0
880861|NCT00595413|1845480|FG000|Overall Study|Other|5
880862|NCT00595413|1845481|FG001|Overall Study|Other|1
880863|NCT00595413|1845482|FG002|Overall Study|Other|5
880864|NCT00595413|1845483|FG003|Overall Study|Other|0
880865|NCT00595465|1845496|FG000|Overall Study|Adverse Event|4
880866|NCT00595465|1845497|FG001|Overall Study|Adverse Event|3
880867|NCT00595465|1845498|FG002|Overall Study|Adverse Event|3
880868|NCT00595465|1845496|FG000|Overall Study|Pregnancy|0
880869|NCT00595465|1845497|FG001|Overall Study|Pregnancy|0
880870|NCT00595465|1845498|FG002|Overall Study|Pregnancy|1
880871|NCT00595465|1845496|FG000|Overall Study|Protocol Violation|2
880872|NCT00595465|1845497|FG001|Overall Study|Protocol Violation|1
880873|NCT00595465|1845498|FG002|Overall Study|Protocol Violation|0
880874|NCT00595465|1845496|FG000|Overall Study|Lost to Follow-up|0
880875|NCT00595465|1845497|FG001|Overall Study|Lost to Follow-up|0
880876|NCT00595465|1845498|FG002|Overall Study|Lost to Follow-up|2
880877|NCT00595465|1845496|FG000|Overall Study|administrative reason|0
880878|NCT00595465|1845497|FG001|Overall Study|administrative reason|0
880879|NCT00595465|1845498|FG002|Overall Study|administrative reason|1
880880|NCT00595478|1845508|FG000|36-week Follow-up Period|Lost to Follow-up|5
880881|NCT00595478|1845509|FG001|36-week Follow-up Period|Lost to Follow-up|4
880882|NCT00595478|1845508|FG000|36-week Follow-up Period|Withdrawal by Subject|4
880883|NCT00595478|1845509|FG001|36-week Follow-up Period|Withdrawal by Subject|4
880884|NCT00595504|1845517|FG000|Overall Study|Withdrawal by Subject|1
880885|NCT00595504|1845518|FG001|Overall Study|Withdrawal by Subject|3
880886|NCT00595504|1845517|FG000|Overall Study|Physician Decision|1
880887|NCT00595504|1845518|FG001|Overall Study|Physician Decision|0
880888|NCT00595517|1845524|FG000|Overall Study|Adverse Event|6
880889|NCT00595517|1845524|FG000|Overall Study|Withdrawal by Subject|4
880890|NCT00595517|1845524|FG000|Overall Study|Protocol Violation|2
880891|NCT00595517|1845524|FG000|Overall Study|Recurrence of ulcer|5
880892|NCT00595517|1845524|FG000|Overall Study|usage of prohibited treatment|1
880893|NCT00595517|1845524|FG000|Overall Study|No intention to attend regularly|1
880894|NCT00595621|1845544|FG000|Open Label Run in|Adverse Event|1
880895|NCT00595621|1845545|FG001|Open Label Run in|Adverse Event|0
880896|NCT00595621|1845544|FG000|Open Label Run in|Physician Decision|1
880897|NCT00595621|1845545|FG001|Open Label Run in|Physician Decision|0
880898|NCT00595621|1845544|FG000|Open Label Run in|Withdrawal by Subject|1
880899|NCT00595621|1845545|FG001|Open Label Run in|Withdrawal by Subject|0
880900|NCT00595621|1845544|FG000|Randomization and Study|Adverse Event|2
880901|NCT00595621|1845545|FG001|Randomization and Study|Adverse Event|0
880902|NCT00595621|1845544|FG000|Randomization and Study|Withdrawal by Subject|0
880903|NCT00595621|1845545|FG001|Randomization and Study|Withdrawal by Subject|1
880904|NCT00595764|1845554|FG000|Overall Study|Protocol Violation|24
880905|NCT00595764|1845555|FG001|Overall Study|Protocol Violation|19
880906|NCT00595764|1845554|FG000|Overall Study|Missed Medication >1 week|10
880907|NCT00595764|1845555|FG001|Overall Study|Missed Medication >1 week|17
880908|NCT00595764|1845554|FG000|Overall Study|Missed 3 PM visits|1
880909|NCT00595764|1845555|FG001|Overall Study|Missed 3 PM visits|7
880910|NCT00595764|1845554|FG000|Overall Study|Withdrawal by Subject|4
880911|NCT00595764|1845555|FG001|Overall Study|Withdrawal by Subject|0
880912|NCT00595868|1845576|FG000|Overall Study|Lost to Follow-up|45
880913|NCT00595868|1845577|FG001|Overall Study|Lost to Follow-up|50
880914|NCT00595959|1845597|FG000|Overall Study|Withdrawal by Subject|1
880915|NCT00595959|1845597|FG000|Overall Study|Lost to Follow-up|1
880916|NCT00596011|1845603|FG000|Overall Study|Withdrawal by Subject|2
880917|NCT00596011|1845604|FG001|Overall Study|Withdrawal by Subject|3
1189489|NCT02810418|2349036|FG000|Arm A Dose Escalation|Adverse Event|2
1189490|NCT02810418|2349037|FG001|Arm A Dose Escalation|Adverse Event|1
1189491|NCT02810418|2349038|FG002|Arm A Dose Escalation|Adverse Event|0
880918|NCT00596011|1845603|FG000|Overall Study|Adverse Event|11
1189492|NCT02810418|2349039|FG003|Arm A Dose Escalation|Adverse Event|0
1189493|NCT02810418|2349040|FG004|Arm A Dose Escalation|Adverse Event|0
1189494|NCT02810418|2349041|FG005|Arm A Dose Escalation|Adverse Event|0
1189495|NCT02810418|2349042|FG006|Arm A Dose Escalation|Adverse Event|0
1189496|NCT02810418|2349036|FG000|Dose Expansion|Adverse Event|0
1189497|NCT02810418|2349037|FG001|Dose Expansion|Adverse Event|1
1189498|NCT02810418|2349038|FG002|Dose Expansion|Adverse Event|1
1189499|NCT02810418|2349039|FG003|Dose Expansion|Adverse Event|0
1189500|NCT02810418|2349040|FG004|Dose Expansion|Adverse Event|0
1189501|NCT02810418|2349041|FG005|Dose Expansion|Adverse Event|0
1189502|NCT02810418|2349042|FG006|Dose Expansion|Adverse Event|0
1189503|NCT02810418|2349036|FG000|Dose Expansion|Physician Decision|0
1189504|NCT02810418|2349037|FG001|Dose Expansion|Physician Decision|0
880919|NCT00596011|1845604|FG001|Overall Study|Adverse Event|7
880920|NCT00596362|1845640|FG000|Overall Study|Progressive Disease|1
880921|NCT00596427|1845646|FG000|Overall Study|Withdrawal by Subject|2
880922|NCT00596427|1845647|FG001|Overall Study|Withdrawal by Subject|2
880923|NCT00596427|1845646|FG000|Overall Study|Increased Fasting Triacylglycerol level|1
880924|NCT00596427|1845647|FG001|Overall Study|Increased Fasting Triacylglycerol level|0
880925|NCT00596427|1845646|FG000|Overall Study|Protocol Violation|1
880926|NCT00596427|1845647|FG001|Overall Study|Protocol Violation|0
880927|NCT00596466|1845672|FG000|Overall Study|Lack of Efficacy|5
880928|NCT00596466|1845672|FG000|Overall Study|Adverse Event|4
880929|NCT00596466|1845672|FG000|Overall Study|Withdrawal by Subject|2
880930|NCT00596466|1845672|FG000|Overall Study|Protocol Violation|2
880931|NCT00596466|1845672|FG000|Overall Study|Unpecified|2
880932|NCT00596466|1845672|FG000|Overall Study|Enrolled, not treated|2
880933|NCT00596635|1845691|FG000|Overall Study|Lost to Follow-up|0
880934|NCT00596635|1845692|FG001|Overall Study|Lost to Follow-up|2
880935|NCT00596635|1845693|FG002|Overall Study|Lost to Follow-up|0
880936|NCT00596635|1845691|FG000|Overall Study|Treatment for symptomatic UTI|4
880937|NCT00596635|1845692|FG001|Overall Study|Treatment for symptomatic UTI|6
880938|NCT00596635|1845693|FG002|Overall Study|Treatment for symptomatic UTI|3
880939|NCT00596635|1845691|FG000|Overall Study|Hip fracture|2
880940|NCT00596635|1845692|FG001|Overall Study|Hip fracture|3
880941|NCT00596635|1845693|FG002|Overall Study|Hip fracture|3
880942|NCT00596635|1845691|FG000|Overall Study|Could not provide urine specimen|1
880943|NCT00596635|1845692|FG001|Overall Study|Could not provide urine specimen|2
880944|NCT00596635|1845693|FG002|Overall Study|Could not provide urine specimen|2
880945|NCT00596687|1845703|FG000|Overall Study|< 24 hours of insulin treatment|8
880946|NCT00596687|1845704|FG001|Overall Study|< 24 hours of insulin treatment|6
880947|NCT00596687|1845703|FG000|Overall Study|continuous insulin infusion during TPN|2
880948|NCT00596687|1845704|FG001|Overall Study|continuous insulin infusion during TPN|1
880949|NCT00596687|1845703|FG000|Overall Study|Withdrawal by Subject|3
880950|NCT00596687|1845704|FG001|Overall Study|Withdrawal by Subject|1
880951|NCT00596687|1845703|FG000|Overall Study|cancelled surgery|1
880952|NCT00596687|1845704|FG001|Overall Study|cancelled surgery|1
880953|NCT00596752|1845712|FG000|Overall Study|Other Reason|44
880954|NCT00596752|1845713|FG001|Overall Study|Other Reason|49
880955|NCT00596752|1845712|FG000|Overall Study|Adverse Event|34
880956|NCT00596752|1845713|FG001|Overall Study|Adverse Event|34
880957|NCT00596752|1845712|FG000|Overall Study|Lost to Follow-up|22
880958|NCT00596752|1845713|FG001|Overall Study|Lost to Follow-up|38
880959|NCT00596752|1845712|FG000|Overall Study|Withdrawal by Subject|12
880960|NCT00596752|1845713|FG001|Overall Study|Withdrawal by Subject|9
880961|NCT00596752|1845712|FG000|Overall Study|Unsatisfactory Compliance|9
880962|NCT00596752|1845713|FG001|Overall Study|Unsatisfactory Compliance|6
880963|NCT00596752|1845712|FG000|Overall Study|Lack of Efficacy|4
880964|NCT00596752|1845713|FG001|Overall Study|Lack of Efficacy|7
880965|NCT00596752|1845712|FG000|Overall Study|Protocol Violation|1
880966|NCT00596752|1845713|FG001|Overall Study|Protocol Violation|0
880967|NCT00596817|1845722|FG000|Open-label Period|Adverse Event|0
880968|NCT00596817|1845723|FG001|Open-label Period|Adverse Event|49
880969|NCT00596817|1845722|FG000|Open-label Period|Lack of Efficacy|0
880970|NCT00596817|1845723|FG001|Open-label Period|Lack of Efficacy|33
880971|NCT00596817|1845722|FG000|Open-label Period|Other Reasons|0
880972|NCT00596817|1845723|FG001|Open-label Period|Other Reasons|65
880973|NCT00596817|1845722|FG000|Open-label Period to Double-blind Period|Adverse Event|0
880974|NCT00596817|1845723|FG001|Open-label Period to Double-blind Period|Adverse Event|5
880975|NCT00596817|1845722|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0
880976|NCT00596817|1845723|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24
880977|NCT00596817|1845722|FG000|Open-label Period to Double-blind Period|Not Eligible|0
880978|NCT00596817|1845723|FG001|Open-label Period to Double-blind Period|Not Eligible|49
880979|NCT00596817|1845722|FG000|Open-label Period to Double-blind Period|Other Reasons|0
880980|NCT00596817|1845723|FG001|Open-label Period to Double-blind Period|Other Reasons|14
880981|NCT00596817|1845722|FG000|Double-blind Period|Adverse Event|5
880982|NCT00596817|1845723|FG001|Double-blind Period|Adverse Event|16
880983|NCT00596817|1845722|FG000|Double-blind Period|Lack of Efficacy|52
880984|NCT00596817|1845723|FG001|Double-blind Period|Lack of Efficacy|28
880985|NCT00596817|1845722|FG000|Double-blind Period|Non-compliance With Study Product|3
880986|NCT00596817|1845723|FG001|Double-blind Period|Non-compliance With Study Product|4
880987|NCT00596817|1845722|FG000|Double-blind Period|Protocol Violation|11
880988|NCT00596817|1845723|FG001|Double-blind Period|Protocol Violation|8
880989|NCT00596817|1845722|FG000|Double-blind Period|Withdrawal of Consent|7
880990|NCT00596817|1845723|FG001|Double-blind Period|Withdrawal of Consent|3
880991|NCT00596817|1845722|FG000|Double-blind Period|Lost to Follow-up|0
880992|NCT00596817|1845723|FG001|Double-blind Period|Lost to Follow-up|2
880993|NCT00596817|1845722|FG000|Double-blind Period|Other Reasons|10
880994|NCT00596817|1845723|FG001|Double-blind Period|Other Reasons|18
880995|NCT00596830|1845732|FG000|Overall Study|Death|258
880996|NCT00596830|1845733|FG001|Overall Study|Death|247
880997|NCT00596830|1845732|FG000|Overall Study|Lost to Follow-up|7
880998|NCT00596830|1845733|FG001|Overall Study|Lost to Follow-up|11
880999|NCT00596830|1845732|FG000|Overall Study|Withdrawal by Subject|22
881000|NCT00596830|1845733|FG001|Overall Study|Withdrawal by Subject|12
881001|NCT00596830|1845732|FG000|Overall Study|Study terminated by sponsor|51
881002|NCT00596830|1845733|FG001|Overall Study|Study terminated by sponsor|62
881003|NCT00596830|1845732|FG000|Overall Study|Follow-up was discontinued|1
881004|NCT00596830|1845733|FG001|Overall Study|Follow-up was discontinued|0
881005|NCT00596830|1845732|FG000|Overall Study|Randomized but not treated|3
881006|NCT00596830|1845733|FG001|Overall Study|Randomized but not treated|7
881007|NCT00596934|1845739|FG000|Overall Study|Protocol Violation|1
881008|NCT00596934|1845739|FG000|Overall Study|Withdrawal by Subject|1
881009|NCT00596960|1845747|FG000|Overall Study|Death|1
881010|NCT00596960|1845748|FG001|Overall Study|Death|2
881011|NCT00596960|1845747|FG000|Overall Study|Lost to Follow-up|6
881012|NCT00596960|1845748|FG001|Overall Study|Lost to Follow-up|5
881013|NCT00596960|1845747|FG000|Overall Study|Withdrawal by Subject|1
881014|NCT00596960|1845748|FG001|Overall Study|Withdrawal by Subject|0
881015|NCT00596960|1845747|FG000|Overall Study|Incarcerated|2
881016|NCT00596960|1845748|FG001|Overall Study|Incarcerated|0
881017|NCT00596960|1845747|FG000|Overall Study|Physician Decision|1
881018|NCT00596960|1845748|FG001|Overall Study|Physician Decision|0
881019|NCT00596960|1845747|FG000|Overall Study|Protocol Violation|0
881020|NCT00596960|1845748|FG001|Overall Study|Protocol Violation|1
881021|NCT00596960|1845747|FG000|Overall Study|No alcohol use data|0
881022|NCT00596960|1845748|FG001|Overall Study|No alcohol use data|1
881023|NCT00597012|1845756|FG000|Overall Study|Death|1
881024|NCT00597012|1845757|FG001|Overall Study|Death|1
881025|NCT00597012|1845756|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3
881026|NCT00597012|1845757|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1
881027|NCT00597012|1845756|FG000|Overall Study|Withdrawal by Subject|7
881028|NCT00597012|1845757|FG001|Overall Study|Withdrawal by Subject|4
881029|NCT00597012|1845756|FG000|Overall Study|Ineligible|2
881030|NCT00597012|1845757|FG001|Overall Study|Ineligible|0
881031|NCT00597012|1845756|FG000|Overall Study|Lost to Follow-up|0
881032|NCT00597012|1845757|FG001|Overall Study|Lost to Follow-up|2
881033|NCT00597116|1845778|FG000|Overall Study|Adverse Event|2
881034|NCT00597116|1845779|FG001|Overall Study|Adverse Event|1
881035|NCT00597116|1845778|FG000|Overall Study|Withdrawal by Subject|0
881036|NCT00597116|1845779|FG001|Overall Study|Withdrawal by Subject|2
881037|NCT00597116|1845778|FG000|Overall Study|Physician Decision|0
881038|NCT00597116|1845779|FG001|Overall Study|Physician Decision|1
881039|NCT00597116|1845778|FG000|Overall Study|Death|0
1189505|NCT02810418|2349038|FG002|Dose Expansion|Physician Decision|2
1189506|NCT02810418|2349039|FG003|Dose Expansion|Physician Decision|0
1189507|NCT02810418|2349040|FG004|Dose Expansion|Physician Decision|0
1189508|NCT02810418|2349041|FG005|Dose Expansion|Physician Decision|0
1189509|NCT02810418|2349042|FG006|Dose Expansion|Physician Decision|0
1189510|NCT02810418|2349036|FG000|Arm B Dose Escalation|Adverse Event|0
1189511|NCT02810418|2349037|FG001|Arm B Dose Escalation|Adverse Event|0
1189512|NCT02810418|2349038|FG002|Arm B Dose Escalation|Adverse Event|0
1189513|NCT02810418|2349039|FG003|Arm B Dose Escalation|Adverse Event|0
1189514|NCT02810418|2349040|FG004|Arm B Dose Escalation|Adverse Event|1
1189515|NCT02810418|2349041|FG005|Arm B Dose Escalation|Adverse Event|2
1189516|NCT02810418|2349042|FG006|Arm B Dose Escalation|Adverse Event|0
1189517|NCT02779855|2349108|FG000|Overall Study|Withdrawal by patient prior to treatment|1
1189518|NCT02779855|2349109|FG001|Overall Study|Withdrawal by patient prior to treatment|0
1189519|NCT02779855|2349110|FG002|Overall Study|Withdrawal by patient prior to treatment|0
1189520|NCT02654132|2349121|FG000|Overall Study|Disease Progression|26
1189521|NCT02654132|2349122|FG001|Overall Study|Disease Progression|31
1189522|NCT02654132|2349121|FG000|Overall Study|Adverse Event Unrelated to Study Drug|5
1189523|NCT02654132|2349122|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5
1189524|NCT02654132|2349121|FG000|Overall Study|Switched to another tx|0
1189525|NCT02654132|2349122|FG001|Overall Study|Switched to another tx|1
1189526|NCT02654132|2349121|FG000|Overall Study|Study Drug Toxicity|1
1189527|NCT02654132|2349122|FG001|Overall Study|Study Drug Toxicity|2
1189528|NCT02654132|2349121|FG000|Overall Study|Maximum Clinical Benefit|0
1189529|NCT02654132|2349122|FG001|Overall Study|Maximum Clinical Benefit|2
1189530|NCT02654132|2349121|FG000|Overall Study|Subj Request to Discontinue Treatment|1
1189531|NCT02654132|2349122|FG001|Overall Study|Subj Request to Discontinue Treatment|0
1189532|NCT02654132|2349121|FG000|Overall Study|Not Reported|0
1189533|NCT02654132|2349122|FG001|Overall Study|Not Reported|1
1189534|NCT02654132|2349121|FG000|Overall Study|Subject Withdrew Consent|2
1189535|NCT02654132|2349122|FG001|Overall Study|Subject Withdrew Consent|1
1189536|NCT02654132|2349121|FG000|Overall Study|Inadequate response to therapy|1
1189537|NCT02654132|2349122|FG001|Overall Study|Inadequate response to therapy|0
1189538|NCT02654132|2349121|FG000|Overall Study|Clinical Progression (not protocol)|0
1189539|NCT02654132|2349122|FG001|Overall Study|Clinical Progression (not protocol)|1
1189540|NCT02654132|2349121|FG000|Overall Study|Never treated|0
1189541|NCT02654132|2349122|FG001|Overall Study|Never treated|2
1189542|NCT02603432|2349131|FG000|Overall Study|Ongoing|184
1189543|NCT02603432|2349132|FG001|Overall Study|Ongoing|144
1189544|NCT02603432|2349131|FG000|Overall Study|Adverse Event|1
1189545|NCT02603432|2349132|FG001|Overall Study|Adverse Event|0
1189546|NCT02603432|2349131|FG000|Overall Study|Death|144
1189547|NCT02603432|2349132|FG001|Overall Study|Death|177
1189548|NCT02603432|2349131|FG000|Overall Study|Lost to Follow-up|4
1189549|NCT02603432|2349132|FG001|Overall Study|Lost to Follow-up|6
1189550|NCT02603432|2349131|FG000|Overall Study|Progressive Disease|5
1189551|NCT02603432|2349132|FG001|Overall Study|Progressive Disease|5
1189552|NCT02603432|2349131|FG000|Overall Study|Withdrawal by Subject|9
1189553|NCT02603432|2349132|FG001|Overall Study|Withdrawal by Subject|17
1189554|NCT02603432|2349131|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
1189555|NCT02603432|2349132|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
1189556|NCT02603432|2349131|FG000|Overall Study|Other|0
1189557|NCT02603432|2349132|FG001|Overall Study|Other|1
881040|NCT00597116|1845779|FG001|Overall Study|Death|1
881041|NCT00597116|1845778|FG000|Overall Study|Lost to Follow-up|1
881042|NCT00597116|1845779|FG001|Overall Study|Lost to Follow-up|0
881043|NCT00597116|1845778|FG000|Overall Study|Progressive disease|11
881044|NCT00597116|1845779|FG001|Overall Study|Progressive disease|6
881045|NCT00597207|1845787|FG000|Overall Study|Lost to Follow-up|5
881046|NCT00597207|1845788|FG001|Overall Study|Lost to Follow-up|7
881047|NCT00597376|1845829|FG000|Overall Study|Withdrawal by Subject|4
881048|NCT00597376|1845830|FG001|Overall Study|Withdrawal by Subject|3
881049|NCT00597376|1845829|FG000|Overall Study|Adverse Event|4
881050|NCT00597376|1845830|FG001|Overall Study|Adverse Event|1
881051|NCT00597506|1845857|FG000|Overall Study|Subject is being followed for survival|1
881052|NCT00597519|1845861|FG000|Overall Study|Death|1
881053|NCT00597584|1845880|FG000|Overall Study|Adverse Event|4
881054|NCT00597584|1845881|FG001|Overall Study|Adverse Event|2
881055|NCT00597584|1845880|FG000|Overall Study|Death|53
881056|NCT00597584|1845881|FG001|Overall Study|Death|30
881057|NCT00597584|1845880|FG000|Overall Study|Lack of Efficacy|1
881058|NCT00597584|1845881|FG001|Overall Study|Lack of Efficacy|0
881059|NCT00597584|1845880|FG000|Overall Study|Lost to Follow-up|2
881060|NCT00597584|1845881|FG001|Overall Study|Lost to Follow-up|4
881061|NCT00597584|1845880|FG000|Overall Study|Physician Decision|3
881062|NCT00597584|1845881|FG001|Overall Study|Physician Decision|0
881063|NCT00597584|1845880|FG000|Overall Study|Pregnancy|2
881064|NCT00597584|1845881|FG001|Overall Study|Pregnancy|0
881065|NCT00597584|1845880|FG000|Overall Study|Withdrawal by Subject|44
881066|NCT00597584|1845881|FG001|Overall Study|Withdrawal by Subject|12
881067|NCT00597584|1845880|FG000|Overall Study|Discontinued Dialysis|0
881068|NCT00597584|1845881|FG001|Overall Study|Discontinued Dialysis|1
881069|NCT00597584|1845880|FG000|Overall Study|Lost ability to consent|1
881070|NCT00597584|1845881|FG001|Overall Study|Lost ability to consent|1
881071|NCT00597584|1845880|FG000|Overall Study|Never dosed|1
881072|NCT00597584|1845881|FG001|Overall Study|Never dosed|0
881073|NCT00597584|1845880|FG000|Overall Study|Relocation|8
881074|NCT00597584|1845881|FG001|Overall Study|Relocation|6
881075|NCT00597584|1845880|FG000|Overall Study|Renal transplant|9
881076|NCT00597584|1845881|FG001|Overall Study|Renal transplant|7
881077|NCT00597701|1845900|FG000|Overall Study|Withdrawal by Subject|5
881078|NCT00597701|1845901|FG001|Overall Study|Withdrawal by Subject|5
881079|NCT00597701|1845900|FG000|Overall Study|Death|0
881080|NCT00597701|1845901|FG001|Overall Study|Death|1
881081|NCT00597701|1845900|FG000|Overall Study|Physician Decision|2
881082|NCT00597701|1845901|FG001|Overall Study|Physician Decision|0
881083|NCT00597701|1845900|FG000|Overall Study|Did not start intervention (pharmacy er)|0
881084|NCT00597701|1845901|FG001|Overall Study|Did not start intervention (pharmacy er)|2
881085|NCT00597714|1845909|FG000|Overall Study|Death|56
881086|NCT00597714|1845910|FG001|Overall Study|Death|46
881087|NCT00597714|1845911|FG002|Overall Study|Death|0
881088|NCT00597714|1845909|FG000|Overall Study|Recipient death|0
881089|NCT00597714|1845910|FG001|Overall Study|Recipient death|0
881090|NCT00597714|1845911|FG002|Overall Study|Recipient death|10
881091|NCT00597753|1845944|FG000|Overall Study|Adverse Event|6
881092|NCT00597753|1845945|FG001|Overall Study|Adverse Event|2
881093|NCT00597753|1845944|FG000|Overall Study|Death|55
881094|NCT00597753|1845945|FG001|Overall Study|Death|29
881095|NCT00597753|1845944|FG000|Overall Study|Lack of Efficacy|2
881096|NCT00597753|1845945|FG001|Overall Study|Lack of Efficacy|0
881097|NCT00597753|1845944|FG000|Overall Study|Lost to Follow-up|10
881098|NCT00597753|1845945|FG001|Overall Study|Lost to Follow-up|3
1189558|NCT02600923|2349138|FG000|Overall Study|Death|10
1189559|NCT02600923|2349138|FG000|Overall Study|Adverse Event|3
1189560|NCT02600923|2349138|FG000|Overall Study|Global deterioration of health status|2
1189561|NCT02600923|2349138|FG000|Overall Study|Insufficient clinical response|6
1189562|NCT02600923|2349138|FG000|Overall Study|Lost to Follow-up|1
1189563|NCT02600923|2349138|FG000|Overall Study|Withdrawal by Subject|5
881099|NCT00597753|1845944|FG000|Overall Study|Physician Decision|5
881100|NCT00597753|1845945|FG001|Overall Study|Physician Decision|1
881101|NCT00597753|1845944|FG000|Overall Study|Pregnancy|1
881102|NCT00597753|1845945|FG001|Overall Study|Pregnancy|0
881103|NCT00597753|1845944|FG000|Overall Study|Withdrawal by Subject|35
881104|NCT00597753|1845945|FG001|Overall Study|Withdrawal by Subject|12
881105|NCT00597753|1845944|FG000|Overall Study|Discontinued Dialysis|0
881106|NCT00597753|1845945|FG001|Overall Study|Discontinued Dialysis|1
881107|NCT00597753|1845944|FG000|Overall Study|Never dosed|2
881108|NCT00597753|1845945|FG001|Overall Study|Never dosed|0
881109|NCT00597753|1845944|FG000|Overall Study|Noncompliance|2
881110|NCT00597753|1845945|FG001|Overall Study|Noncompliance|1
881111|NCT00597753|1845944|FG000|Overall Study|Relocation|17
881112|NCT00597753|1845945|FG001|Overall Study|Relocation|6
881113|NCT00597753|1845944|FG000|Overall Study|Renal transplant|10
881114|NCT00597753|1845945|FG001|Overall Study|Renal transplant|3
881115|NCT00597753|1845944|FG000|Overall Study|Site closed by sponsor|19
881116|NCT00597753|1845945|FG001|Overall Study|Site closed by sponsor|7
881117|NCT00597753|1845944|FG000|Overall Study|Site elected to close|2
881118|NCT00597753|1845945|FG001|Overall Study|Site elected to close|4
881119|NCT00597766|1845954|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1
881120|NCT00597766|1845955|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0
881121|NCT00597766|1845956|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0
881122|NCT00597766|1845954|FG000|Follow-up 2, Week 8|Lost to Follow-up|0
881123|NCT00597766|1845955|FG001|Follow-up 2, Week 8|Lost to Follow-up|0
881124|NCT00597766|1845956|FG002|Follow-up 2, Week 8|Lost to Follow-up|1
881125|NCT00598078|1846008|FG000|Period 2 (Day 2)|Adverse Event|1
881126|NCT00598078|1846009|FG001|Period 2 (Day 2)|Adverse Event|0
881127|NCT00598273|1846020|FG000|Overall Study|Adverse Event|4
881128|NCT00598273|1846021|FG001|Overall Study|Adverse Event|5
881129|NCT00598273|1846022|FG002|Overall Study|Adverse Event|2
881130|NCT00598273|1846020|FG000|Overall Study|Death|6
881131|NCT00598273|1846021|FG001|Overall Study|Death|12
881132|NCT00598273|1846022|FG002|Overall Study|Death|8
881133|NCT00598273|1846020|FG000|Overall Study|Lost to Follow-up|8
881134|NCT00598273|1846021|FG001|Overall Study|Lost to Follow-up|3
881135|NCT00598273|1846022|FG002|Overall Study|Lost to Follow-up|5
881136|NCT00598273|1846020|FG000|Overall Study|Physician Decision|0
881137|NCT00598273|1846021|FG001|Overall Study|Physician Decision|0
881138|NCT00598273|1846022|FG002|Overall Study|Physician Decision|1
881139|NCT00598273|1846020|FG000|Overall Study|Withdrawal by Subject|12
881140|NCT00598273|1846021|FG001|Overall Study|Withdrawal by Subject|10
881141|NCT00598273|1846022|FG002|Overall Study|Withdrawal by Subject|10
881142|NCT00598273|1846020|FG000|Overall Study|Noncompliance|3
881143|NCT00598273|1846021|FG001|Overall Study|Noncompliance|2
881144|NCT00598273|1846022|FG002|Overall Study|Noncompliance|3
881145|NCT00598273|1846020|FG000|Overall Study|Relocation|0
881146|NCT00598273|1846021|FG001|Overall Study|Relocation|2
881147|NCT00598273|1846022|FG002|Overall Study|Relocation|4
881148|NCT00598273|1846020|FG000|Overall Study|Renal transplant|1
881149|NCT00598273|1846021|FG001|Overall Study|Renal transplant|0
881150|NCT00598273|1846022|FG002|Overall Study|Renal transplant|1
881151|NCT00598273|1846020|FG000|Overall Study|Site elected to close|1
881152|NCT00598273|1846021|FG001|Overall Study|Site elected to close|0
881153|NCT00598273|1846022|FG002|Overall Study|Site elected to close|0
881154|NCT00598273|1846020|FG000|Overall Study|Started dialysis|6
881155|NCT00598273|1846021|FG001|Overall Study|Started dialysis|4
881156|NCT00598273|1846022|FG002|Overall Study|Started dialysis|5
881157|NCT00598442|1846033|FG000|Overall Study|Adverse Event|3
881158|NCT00598442|1846034|FG001|Overall Study|Adverse Event|0
881159|NCT00598442|1846035|FG002|Overall Study|Adverse Event|0
881160|NCT00598442|1846033|FG000|Overall Study|Death|19
881161|NCT00598442|1846034|FG001|Overall Study|Death|11
881162|NCT00598442|1846035|FG002|Overall Study|Death|11
881163|NCT00598442|1846033|FG000|Overall Study|Lost to Follow-up|4
881164|NCT00598442|1846034|FG001|Overall Study|Lost to Follow-up|3
881165|NCT00598442|1846035|FG002|Overall Study|Lost to Follow-up|3
881166|NCT00598442|1846033|FG000|Overall Study|Physician Decision|2
881167|NCT00598442|1846034|FG001|Overall Study|Physician Decision|1
881168|NCT00598442|1846035|FG002|Overall Study|Physician Decision|1
881169|NCT00598442|1846033|FG000|Overall Study|Withdrawal by Subject|8
881170|NCT00598442|1846034|FG001|Overall Study|Withdrawal by Subject|16
881171|NCT00598442|1846035|FG002|Overall Study|Withdrawal by Subject|6
881172|NCT00598442|1846033|FG000|Overall Study|Noncompliance|0
881173|NCT00598442|1846034|FG001|Overall Study|Noncompliance|2
881174|NCT00598442|1846035|FG002|Overall Study|Noncompliance|1
881175|NCT00598442|1846033|FG000|Overall Study|Relocation|1
881176|NCT00598442|1846034|FG001|Overall Study|Relocation|4
881177|NCT00598442|1846035|FG002|Overall Study|Relocation|0
881178|NCT00598442|1846033|FG000|Overall Study|Renal transplant|0
881179|NCT00598442|1846034|FG001|Overall Study|Renal transplant|0
1189564|NCT02600923|2349138|FG000|Overall Study|Objective progression or relapse|50
1189565|NCT02600923|2349138|FG000|Overall Study|Study terminated by Sponsor|53
1189566|NCT02600923|2349138|FG000|Overall Study|Not treated|1
1189567|NCT02412735|2349163|FG000|Overall Study|Adverse Event|0
1189568|NCT02412735|2349164|FG001|Overall Study|Adverse Event|1
1189569|NCT02412735|2349165|FG002|Overall Study|Adverse Event|2
1189570|NCT02412735|2349163|FG000|Overall Study|Withdrawal by Subject|23
1189571|NCT02412735|2349164|FG001|Overall Study|Withdrawal by Subject|27
1189572|NCT02412735|2349165|FG002|Overall Study|Withdrawal by Subject|22
1189573|NCT02412735|2349163|FG000|Overall Study|Investigator Decision|3
1189574|NCT02412735|2349164|FG001|Overall Study|Investigator Decision|3
1189575|NCT02412735|2349165|FG002|Overall Study|Investigator Decision|2
1189576|NCT02412735|2349163|FG000|Overall Study|Lost to Follow-up|17
1189577|NCT02412735|2349164|FG001|Overall Study|Lost to Follow-up|11
1189578|NCT02412735|2349165|FG002|Overall Study|Lost to Follow-up|18
1189579|NCT02412735|2349163|FG000|Overall Study|Reason not Specified|3
1189580|NCT02412735|2349164|FG001|Overall Study|Reason not Specified|2
1189581|NCT02412735|2349165|FG002|Overall Study|Reason not Specified|2
1189582|NCT02371889|2349175|FG000|Overall Study|Adverse medication effect|11
1189583|NCT02371889|2349176|FG001|Overall Study|Adverse medication effect|2
1189584|NCT02371889|2349175|FG000|Overall Study|Lost to Follow-up|6
1189585|NCT02371889|2349176|FG001|Overall Study|Lost to Follow-up|5
1189586|NCT02371889|2349175|FG000|Overall Study|Personal time constraints|2
1189587|NCT02371889|2349176|FG001|Overall Study|Personal time constraints|4
1189588|NCT02371889|2349175|FG000|Overall Study|Lack of Efficacy|0
1189589|NCT02371889|2349176|FG001|Overall Study|Lack of Efficacy|2
1189590|NCT02371889|2349175|FG000|Overall Study|Relapse|0
1189591|NCT02371889|2349176|FG001|Overall Study|Relapse|1
1189592|NCT02337829|2349190|FG000|Overall Study|Death|0
1189593|NCT02337829|2349191|FG001|Overall Study|Death|1
1189594|NCT02337829|2349192|FG002|Overall Study|Death|0
1189595|NCT02337829|2349193|FG003|Overall Study|Death|0
1189596|NCT02337829|2349190|FG000|Overall Study|Study terminated by sponsor|12
1189597|NCT02337829|2349191|FG001|Overall Study|Study terminated by sponsor|10
1189598|NCT02337829|2349192|FG002|Overall Study|Study terminated by sponsor|5
1189599|NCT02337829|2349193|FG003|Overall Study|Study terminated by sponsor|6
1189600|NCT02337829|2349190|FG000|Overall Study|discontinued for other reasons|6
1189601|NCT02337829|2349191|FG001|Overall Study|discontinued for other reasons|3
1189602|NCT02337829|2349192|FG002|Overall Study|discontinued for other reasons|1
1189603|NCT02337829|2349193|FG003|Overall Study|discontinued for other reasons|4
1189604|NCT02315703|2349213|FG000|Overall Study|Adverse Event|0
1189605|NCT02315703|2349214|FG001|Overall Study|Adverse Event|0
1189606|NCT02315703|2349215|FG002|Overall Study|Adverse Event|0
1189607|NCT02315703|2349216|FG003|Overall Study|Adverse Event|1
1189608|NCT02315703|2349217|FG004|Overall Study|Adverse Event|1
1189609|NCT02315703|2349218|FG005|Overall Study|Adverse Event|0
1189610|NCT02315703|2349219|FG006|Overall Study|Adverse Event|1
1189611|NCT02315703|2349220|FG007|Overall Study|Adverse Event|0
1189612|NCT02315703|2349213|FG000|Overall Study|Lost to Follow-up|1
1189613|NCT02315703|2349214|FG001|Overall Study|Lost to Follow-up|5
1189614|NCT02315703|2349215|FG002|Overall Study|Lost to Follow-up|3
1189615|NCT02315703|2349216|FG003|Overall Study|Lost to Follow-up|3
1189616|NCT02315703|2349217|FG004|Overall Study|Lost to Follow-up|2
1189617|NCT02315703|2349218|FG005|Overall Study|Lost to Follow-up|1
1189618|NCT02315703|2349219|FG006|Overall Study|Lost to Follow-up|2
1189619|NCT02315703|2349220|FG007|Overall Study|Lost to Follow-up|2
1189620|NCT02315703|2349213|FG000|Overall Study|Pregnancy|0
1189621|NCT02315703|2349214|FG001|Overall Study|Pregnancy|0
1189622|NCT02315703|2349215|FG002|Overall Study|Pregnancy|0
1189623|NCT02315703|2349216|FG003|Overall Study|Pregnancy|0
1189624|NCT02315703|2349217|FG004|Overall Study|Pregnancy|0
1189625|NCT02315703|2349218|FG005|Overall Study|Pregnancy|0
1189626|NCT02315703|2349219|FG006|Overall Study|Pregnancy|0
1189627|NCT02315703|2349220|FG007|Overall Study|Pregnancy|1
1189628|NCT02315703|2349213|FG000|Overall Study|Withdrawal by Subject|1
1189629|NCT02315703|2349214|FG001|Overall Study|Withdrawal by Subject|3
1189630|NCT02315703|2349215|FG002|Overall Study|Withdrawal by Subject|0
1189631|NCT02315703|2349216|FG003|Overall Study|Withdrawal by Subject|3
1189632|NCT02315703|2349217|FG004|Overall Study|Withdrawal by Subject|4
1189633|NCT02315703|2349218|FG005|Overall Study|Withdrawal by Subject|1
1189634|NCT02315703|2349219|FG006|Overall Study|Withdrawal by Subject|1
1189635|NCT02315703|2349220|FG007|Overall Study|Withdrawal by Subject|2
1189636|NCT02315703|2349213|FG000|Overall Study|Physician Decision|0
1189637|NCT02315703|2349214|FG001|Overall Study|Physician Decision|0
1189638|NCT02315703|2349215|FG002|Overall Study|Physician Decision|0
1189639|NCT02315703|2349216|FG003|Overall Study|Physician Decision|0
1189640|NCT02315703|2349217|FG004|Overall Study|Physician Decision|0
1189641|NCT02315703|2349218|FG005|Overall Study|Physician Decision|2
1189642|NCT02315703|2349219|FG006|Overall Study|Physician Decision|1
1189643|NCT02315703|2349220|FG007|Overall Study|Physician Decision|0
1189644|NCT02315703|2349213|FG000|Overall Study|Other|4
1189645|NCT02315703|2349214|FG001|Overall Study|Other|2
1189646|NCT02315703|2349215|FG002|Overall Study|Other|2
1189647|NCT02315703|2349216|FG003|Overall Study|Other|2
1189648|NCT02315703|2349217|FG004|Overall Study|Other|1
1189649|NCT02315703|2349218|FG005|Overall Study|Other|2
1189650|NCT02315703|2349219|FG006|Overall Study|Other|8
1189651|NCT02315703|2349220|FG007|Overall Study|Other|2
1189652|NCT02272803|2349240|FG000|Overall Study|Disease progression|4
1189653|NCT02272803|2349241|FG001|Overall Study|Disease progression|2
1189654|NCT02272803|2349240|FG000|Overall Study|Adverse Event unrelated to study drug|1
1189655|NCT02272803|2349241|FG001|Overall Study|Adverse Event unrelated to study drug|4
1189656|NCT02272803|2349240|FG000|Overall Study|Study drug toxicity|1
1189657|NCT02272803|2349241|FG001|Overall Study|Study drug toxicity|4
1189658|NCT02272803|2349240|FG000|Overall Study|Subj request to discontinue study trt|1
1189659|NCT02272803|2349241|FG001|Overall Study|Subj request to discontinue study trt|4
1189660|NCT02272803|2349240|FG000|Overall Study|Maximum clinical benefit|1
1189661|NCT02272803|2349241|FG001|Overall Study|Maximum clinical benefit|1
1189662|NCT02272803|2349240|FG000|Overall Study|Subject moved to care facility|0
1189663|NCT02272803|2349241|FG001|Overall Study|Subject moved to care facility|1
1189664|NCT02272803|2349240|FG000|Overall Study|Poor/non-compliance|0
1189665|NCT02272803|2349241|FG001|Overall Study|Poor/non-compliance|1
1189666|NCT02272803|2349240|FG000|Overall Study|Withdrawal by Subject|1
1189667|NCT02272803|2349241|FG001|Overall Study|Withdrawal by Subject|0
1189668|NCT02186834|2349247|FG000|Dose Escalation|Death|0
1189669|NCT02186834|2349248|FG001|Dose Escalation|Death|0
1189670|NCT02186834|2349249|FG002|Dose Escalation|Death|0
1189671|NCT02186834|2349250|FG003|Dose Escalation|Death|1
1189672|NCT02186834|2349251|FG004|Dose Escalation|Death|0
1189673|NCT02186834|2349252|FG005|Dose Escalation|Death|0
1189674|NCT02186834|2349247|FG000|Treatment at RP2D|Died prior to treatment|0
1189675|NCT02186834|2349248|FG001|Treatment at RP2D|Died prior to treatment|0
1189676|NCT02186834|2349249|FG002|Treatment at RP2D|Died prior to treatment|0
1189677|NCT02186834|2349250|FG003|Treatment at RP2D|Died prior to treatment|0
1189678|NCT02186834|2349251|FG004|Treatment at RP2D|Died prior to treatment|0
1189679|NCT02186834|2349252|FG005|Treatment at RP2D|Died prior to treatment|1
1189680|NCT02100722|2349272|FG000|Overall Study|Withdrawal pre-procedure|4
1189681|NCT02100722|2349273|FG001|Overall Study|Withdrawal pre-procedure|9
1189682|NCT02100722|2349272|FG000|Overall Study|Withdrawal post-procedure|0
1189683|NCT02100722|2349273|FG001|Overall Study|Withdrawal post-procedure|3
1189684|NCT02100722|2349272|FG000|Overall Study|Lost to Follow-up|2
1189685|NCT02100722|2349273|FG001|Overall Study|Lost to Follow-up|2
1189686|NCT02100722|2349272|FG000|Overall Study|Continuing on study|751
1189687|NCT02100722|2349273|FG001|Overall Study|Continuing on study|729
1189688|NCT02059265|2349280|FG000|Overall Study|Ineligible|4
1189689|NCT02046096|2349286|FG000|Overall Study|Death|28
1189690|NCT02046096|2349287|FG001|Overall Study|Death|45
1189691|NCT02046096|2349286|FG000|Overall Study|Lost to Follow-up|9
1189692|NCT02046096|2349287|FG001|Overall Study|Lost to Follow-up|20
1189693|NCT02046096|2349286|FG000|Overall Study|Withdrawal by Subject|5
1189694|NCT02046096|2349287|FG001|Overall Study|Withdrawal by Subject|17
1189695|NCT02046096|2349286|FG000|Overall Study|Other endpoint|2
1189696|NCT02046096|2349287|FG001|Overall Study|Other endpoint|19
1189697|NCT01945775|2349297|FG000|Overall Study|Death|214
1189698|NCT01945775|2349298|FG001|Overall Study|Death|98
1189699|NCT01945775|2349297|FG000|Overall Study|Lost to Follow-up|12
1189700|NCT01945775|2349298|FG001|Overall Study|Lost to Follow-up|7
1189701|NCT01945775|2349297|FG000|Overall Study|Withdrawal by Subject|11
1189702|NCT01945775|2349298|FG001|Overall Study|Withdrawal by Subject|21
1189703|NCT01945775|2349297|FG000|Overall Study|Other|50
1189704|NCT01945775|2349298|FG001|Overall Study|Other|18
1189705|NCT01781637|2349306|FG000|Overall Study|Adverse Event|1
1189706|NCT01781637|2349307|FG001|Overall Study|Adverse Event|0
1189707|NCT01781637|2349306|FG000|Overall Study|Lack of Efficacy|2
1189708|NCT01781637|2349307|FG001|Overall Study|Lack of Efficacy|6
1189709|NCT01781637|2349306|FG000|Overall Study|Withdrawal by Subject|1
1189710|NCT01781637|2349307|FG001|Overall Study|Withdrawal by Subject|0
1189711|NCT01711541|2349318|FG000|Overall Study|Cancel prior to treatment|0
1189712|NCT01711541|2349319|FG001|Overall Study|Cancel prior to treatment|0
1189713|NCT01711541|2349320|FG002|Overall Study|Cancel prior to treatment|0
1189714|NCT01711541|2349321|FG003|Overall Study|Cancel prior to treatment|1
1189715|NCT01711541|2349322|FG004|Overall Study|Cancel prior to treatment|0
1189716|NCT01711541|2349318|FG000|Overall Study|Ineligible|0
1189717|NCT01711541|2349319|FG001|Overall Study|Ineligible|1
1189718|NCT01711541|2349320|FG002|Overall Study|Ineligible|0
1189719|NCT01711541|2349321|FG003|Overall Study|Ineligible|0
1189720|NCT01711541|2349322|FG004|Overall Study|Ineligible|0
1189721|NCT01670539|2349339|FG000|Overall Study|Death|3
1189722|NCT01670539|2349340|FG001|Overall Study|Death|5
1189723|NCT01670539|2349339|FG000|Overall Study|Withdrawal by Subject|3
1189724|NCT01670539|2349340|FG001|Overall Study|Withdrawal by Subject|0
1189725|NCT01622868|2349349|FG000|Overall Study|Protocol Violation|7
1189726|NCT01622868|2349350|FG001|Overall Study|Protocol Violation|0
1189727|NCT01371981|2349362|FG000|Overall Study|Adverse Event|12
1189728|NCT01371981|2349363|FG001|Overall Study|Adverse Event|17
1189729|NCT01371981|2349364|FG002|Overall Study|Adverse Event|0
1189730|NCT01371981|2349365|FG003|Overall Study|Adverse Event|4
1189731|NCT01371981|2349366|FG004|Overall Study|Adverse Event|1
1189732|NCT01371981|2349367|FG005|Overall Study|Adverse Event|0
1189733|NCT01371981|2349362|FG000|Overall Study|Death|22
1189734|NCT01371981|2349363|FG001|Overall Study|Death|16
1189735|NCT01371981|2349364|FG002|Overall Study|Death|0
1189736|NCT01371981|2349365|FG003|Overall Study|Death|0
1189737|NCT01371981|2349366|FG004|Overall Study|Death|2
1189738|NCT01371981|2349367|FG005|Overall Study|Death|2
1189739|NCT01371981|2349362|FG000|Overall Study|Lack of Efficacy|69
1189740|NCT01371981|2349363|FG001|Overall Study|Lack of Efficacy|61
1189741|NCT01371981|2349364|FG002|Overall Study|Lack of Efficacy|4
1189742|NCT01371981|2349365|FG003|Overall Study|Lack of Efficacy|8
1189743|NCT01371981|2349366|FG004|Overall Study|Lack of Efficacy|5
1189744|NCT01371981|2349367|FG005|Overall Study|Lack of Efficacy|0
1189745|NCT01371981|2349362|FG000|Overall Study|Physician Decision|48
1189746|NCT01371981|2349363|FG001|Overall Study|Physician Decision|63
1189747|NCT01371981|2349364|FG002|Overall Study|Physician Decision|1
1189748|NCT01371981|2349365|FG003|Overall Study|Physician Decision|7
1189749|NCT01371981|2349366|FG004|Overall Study|Physician Decision|14
1189750|NCT01371981|2349367|FG005|Overall Study|Physician Decision|3
1189751|NCT01371981|2349362|FG000|Overall Study|Withdrawal by Subject|12
1189752|NCT01371981|2349363|FG001|Overall Study|Withdrawal by Subject|19
1189753|NCT01371981|2349364|FG002|Overall Study|Withdrawal by Subject|1
1189754|NCT01371981|2349365|FG003|Overall Study|Withdrawal by Subject|2
1189755|NCT01371981|2349366|FG004|Overall Study|Withdrawal by Subject|10
1189756|NCT01371981|2349367|FG005|Overall Study|Withdrawal by Subject|3
1189757|NCT01371981|2349362|FG000|Overall Study|Ineligible|19
1189758|NCT01371981|2349363|FG001|Overall Study|Ineligible|13
1189759|NCT01371981|2349364|FG002|Overall Study|Ineligible|0
1189760|NCT01371981|2349365|FG003|Overall Study|Ineligible|0
1189761|NCT01371981|2349366|FG004|Overall Study|Ineligible|0
1189762|NCT01371981|2349367|FG005|Overall Study|Ineligible|4
1189763|NCT01371981|2349362|FG000|Overall Study|Did not start treatment|2
1189764|NCT01371981|2349363|FG001|Overall Study|Did not start treatment|3
1189765|NCT01371981|2349364|FG002|Overall Study|Did not start treatment|0
1189766|NCT01371981|2349365|FG003|Overall Study|Did not start treatment|0
1189767|NCT01371981|2349366|FG004|Overall Study|Did not start treatment|0
1189768|NCT01371981|2349367|FG005|Overall Study|Did not start treatment|2
1189769|NCT01196390|2349388|FG000|Overall Study|Protocol Violation|4
1189770|NCT01196390|2349389|FG001|Overall Study|Protocol Violation|5
1189771|NCT00980538|2349397|FG000|Overall Study|Lost to Follow-up|20
1189772|NCT00980538|2349397|FG000|Overall Study|Sponsor's Decision|4
1189773|NCT00980538|2349397|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34
1189774|NCT00980538|2349397|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12
1189775|NCT00980538|2349397|FG000|Overall Study|Switch to Commercially Available Medication|25
1189776|NCT00980538|2349397|FG000|Overall Study|Participant Non-Compliant|9
1189777|NCT00980538|2349397|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9
1189778|NCT00980538|2349397|FG000|Overall Study|Participant Ineligible to Continue the Trial|6
1189779|NCT00980538|2349397|FG000|Overall Study|Other|60
1189780|NCT00980538|2349397|FG000|Overall Study|Other|1
1189781|NCT00980460|2349406|FG000|Overall Study|Death|0
1189782|NCT00980460|2349407|FG001|Overall Study|Death|0
1189783|NCT00980460|2349408|FG002|Overall Study|Death|1
1189784|NCT00980460|2349409|FG003|Overall Study|Death|2
1189785|NCT00980460|2349410|FG004|Overall Study|Death|1
1189786|NCT00980460|2349406|FG000|Overall Study|Lack of Efficacy|0
1189787|NCT00980460|2349407|FG001|Overall Study|Lack of Efficacy|0
1189788|NCT00980460|2349408|FG002|Overall Study|Lack of Efficacy|10
1189789|NCT00980460|2349409|FG003|Overall Study|Lack of Efficacy|6
1189790|NCT00980460|2349410|FG004|Overall Study|Lack of Efficacy|8
1189791|NCT00980460|2349406|FG000|Overall Study|Lost to Follow-up|0
1189792|NCT00980460|2349407|FG001|Overall Study|Lost to Follow-up|0
1189793|NCT00980460|2349408|FG002|Overall Study|Lost to Follow-up|0
1189794|NCT00980460|2349409|FG003|Overall Study|Lost to Follow-up|1
1189795|NCT00980460|2349410|FG004|Overall Study|Lost to Follow-up|0
1189796|NCT00980460|2349406|FG000|Overall Study|Physician Decision|0
881180|NCT00598442|1846035|FG002|Overall Study|Renal transplant|1
881181|NCT00598442|1846033|FG000|Overall Study|Site closed by sponsor|5
881182|NCT00598442|1846034|FG001|Overall Study|Site closed by sponsor|2
881183|NCT00598442|1846035|FG002|Overall Study|Site closed by sponsor|1
881184|NCT00598442|1846033|FG000|Overall Study|Started dialysis|1
881185|NCT00598442|1846034|FG001|Overall Study|Started dialysis|0
881186|NCT00598442|1846035|FG002|Overall Study|Started dialysis|0
881187|NCT00598481|1846043|FG000|Treatment|Physician Decision|1
881188|NCT00598559|1846057|FG000|Overall Study|Adverse Event|11
881189|NCT00598559|1846058|FG001|Overall Study|Adverse Event|7
881190|NCT00598559|1846059|FG002|Overall Study|Adverse Event|0
881191|NCT00598559|1846057|FG000|Overall Study|Withdrawal by Subject|2
881192|NCT00598559|1846058|FG001|Overall Study|Withdrawal by Subject|2
881193|NCT00598559|1846059|FG002|Overall Study|Withdrawal by Subject|0
881194|NCT00598559|1846057|FG000|Overall Study|Protocol Non-compliance|1
881195|NCT00598559|1846058|FG001|Overall Study|Protocol Non-compliance|0
881196|NCT00598559|1846059|FG002|Overall Study|Protocol Non-compliance|0
881197|NCT00598559|1846057|FG000|Overall Study|Early discharge from hospital|9
881198|NCT00598559|1846058|FG001|Overall Study|Early discharge from hospital|12
881199|NCT00598559|1846059|FG002|Overall Study|Early discharge from hospital|3
881200|NCT00598559|1846057|FG000|Overall Study|Subject unable/unwilling to attend visit|4
881201|NCT00598559|1846058|FG001|Overall Study|Subject unable/unwilling to attend visit|7
881202|NCT00598559|1846059|FG002|Overall Study|Subject unable/unwilling to attend visit|0
881203|NCT00598585|1846069|FG000|Overall Study|Lost to Follow-up|1
881204|NCT00598585|1846070|FG001|Overall Study|Lost to Follow-up|0
1189797|NCT00980460|2349407|FG001|Overall Study|Physician Decision|0
1189798|NCT00980460|2349408|FG002|Overall Study|Physician Decision|11
1189799|NCT00980460|2349409|FG003|Overall Study|Physician Decision|5
1189800|NCT00980460|2349410|FG004|Overall Study|Physician Decision|3
1189801|NCT00980460|2349406|FG000|Overall Study|Withdrawal by Subject|0
1189802|NCT00980460|2349407|FG001|Overall Study|Withdrawal by Subject|0
881205|NCT00598650|1846076|FG000|Overall Study|Withdrawal by Subject|3
881206|NCT00598650|1846076|FG000|Overall Study|Adverse Event|18
881207|NCT00598650|1846076|FG000|Overall Study|No treatment for 3 weeks|1
881208|NCT00598650|1846076|FG000|Overall Study|Not eligible|1
881209|NCT00598650|1846076|FG000|Overall Study|Prohibited Concomitant Medication|2
881210|NCT00598650|1846076|FG000|Overall Study|Physician Decision|2
881211|NCT00598702|1846110|FG000|Overall Study|Other|0
881212|NCT00598702|1846111|FG001|Overall Study|Other|2
881213|NCT00598702|1846112|FG002|Overall Study|Other|0
881214|NCT00598702|1846113|FG003|Overall Study|Other|0
881215|NCT00598702|1846114|FG004|Overall Study|Other|0
881216|NCT00598702|1846115|FG005|Overall Study|Other|1
881217|NCT00598702|1846116|FG006|Overall Study|Other|0
881218|NCT00598702|1846117|FG007|Overall Study|Other|0
881219|NCT00598702|1846110|FG000|Overall Study|Early discharge from hospital|0
881220|NCT00598702|1846111|FG001|Overall Study|Early discharge from hospital|0
881221|NCT00598702|1846112|FG002|Overall Study|Early discharge from hospital|2
881222|NCT00598702|1846113|FG003|Overall Study|Early discharge from hospital|5
881223|NCT00598702|1846114|FG004|Overall Study|Early discharge from hospital|0
881224|NCT00598702|1846115|FG005|Overall Study|Early discharge from hospital|10
881225|NCT00598702|1846116|FG006|Overall Study|Early discharge from hospital|1
881226|NCT00598702|1846117|FG007|Overall Study|Early discharge from hospital|0
881227|NCT00598702|1846110|FG000|Overall Study|Adverse Event|0
881228|NCT00598702|1846111|FG001|Overall Study|Adverse Event|0
881229|NCT00598702|1846112|FG002|Overall Study|Adverse Event|0
881230|NCT00598702|1846113|FG003|Overall Study|Adverse Event|1
881231|NCT00598702|1846114|FG004|Overall Study|Adverse Event|0
881232|NCT00598702|1846115|FG005|Overall Study|Adverse Event|0
881233|NCT00598702|1846116|FG006|Overall Study|Adverse Event|0
881234|NCT00598702|1846117|FG007|Overall Study|Adverse Event|0
881235|NCT00598702|1846110|FG000|Overall Study|Withdrawal by Subject|0
881236|NCT00598702|1846111|FG001|Overall Study|Withdrawal by Subject|0
881237|NCT00598702|1846112|FG002|Overall Study|Withdrawal by Subject|0
881238|NCT00598702|1846113|FG003|Overall Study|Withdrawal by Subject|1
881239|NCT00598702|1846114|FG004|Overall Study|Withdrawal by Subject|1
881240|NCT00598702|1846115|FG005|Overall Study|Withdrawal by Subject|0
881241|NCT00598702|1846116|FG006|Overall Study|Withdrawal by Subject|0
881242|NCT00598702|1846117|FG007|Overall Study|Withdrawal by Subject|0
881243|NCT00598702|1846110|FG000|Overall Study|Physician Decision|0
881244|NCT00598702|1846111|FG001|Overall Study|Physician Decision|0
881245|NCT00598702|1846112|FG002|Overall Study|Physician Decision|0
881246|NCT00598702|1846113|FG003|Overall Study|Physician Decision|0
881247|NCT00598702|1846114|FG004|Overall Study|Physician Decision|1
881248|NCT00598702|1846115|FG005|Overall Study|Physician Decision|0
881249|NCT00598702|1846116|FG006|Overall Study|Physician Decision|0
881250|NCT00598702|1846117|FG007|Overall Study|Physician Decision|0
881251|NCT00598702|1846110|FG000|Overall Study|Dose limiting toxicity|0
881252|NCT00598702|1846111|FG001|Overall Study|Dose limiting toxicity|0
881253|NCT00598702|1846112|FG002|Overall Study|Dose limiting toxicity|0
881254|NCT00598702|1846113|FG003|Overall Study|Dose limiting toxicity|1
881255|NCT00598702|1846114|FG004|Overall Study|Dose limiting toxicity|1
881256|NCT00598702|1846115|FG005|Overall Study|Dose limiting toxicity|1
881257|NCT00598702|1846116|FG006|Overall Study|Dose limiting toxicity|0
881258|NCT00598702|1846117|FG007|Overall Study|Dose limiting toxicity|0
881259|NCT00598832|1846150|FG000|Overall Study|Lack of Efficacy|3
881260|NCT00598832|1846151|FG001|Overall Study|Lack of Efficacy|7
881261|NCT00598832|1846150|FG000|Overall Study|Adverse Event|6
881262|NCT00598832|1846151|FG001|Overall Study|Adverse Event|2
881263|NCT00598832|1846150|FG000|Overall Study|Withdrawal by Subject|25
881264|NCT00598832|1846151|FG001|Overall Study|Withdrawal by Subject|36
881265|NCT00598832|1846150|FG000|Overall Study|Protocol Violation|0
881266|NCT00598832|1846151|FG001|Overall Study|Protocol Violation|2
881267|NCT00598832|1846150|FG000|Overall Study|Lost to Follow-up|24
881268|NCT00598832|1846151|FG001|Overall Study|Lost to Follow-up|29
881269|NCT00598832|1846150|FG000|Overall Study|Pregnancy|2
881270|NCT00598832|1846151|FG001|Overall Study|Pregnancy|2
881271|NCT00598832|1846150|FG000|Overall Study|Physician Decision|1
881272|NCT00598832|1846151|FG001|Overall Study|Physician Decision|4
881273|NCT00598832|1846150|FG000|Overall Study|Non compliance|1
881274|NCT00598832|1846151|FG001|Overall Study|Non compliance|0
881275|NCT00598871|1846159|FG000|Overall Study|Adverse Event|0
881276|NCT00598871|1846160|FG001|Overall Study|Adverse Event|1
881277|NCT00598975|1846168|FG000|Overall Study|Adverse Event|1
881278|NCT00598975|1846169|FG001|Overall Study|Adverse Event|1
881279|NCT00598975|1846168|FG000|Overall Study|Brain metastases|1
881280|NCT00598975|1846169|FG001|Overall Study|Brain metastases|0
881281|NCT00598975|1846168|FG000|Overall Study|Withdrawal by Subject|1
881282|NCT00598975|1846169|FG001|Overall Study|Withdrawal by Subject|1
881283|NCT00598975|1846168|FG000|Overall Study|Withdrawal of consent|0
1189803|NCT00980460|2349408|FG002|Overall Study|Withdrawal by Subject|1
1189804|NCT00980460|2349409|FG003|Overall Study|Withdrawal by Subject|0
1189805|NCT00980460|2349410|FG004|Overall Study|Withdrawal by Subject|0
1189806|NCT00980460|2349406|FG000|Overall Study|Ineligible|0
1189807|NCT00980460|2349407|FG001|Overall Study|Ineligible|2
1189808|NCT00980460|2349408|FG002|Overall Study|Ineligible|3
1189809|NCT00980460|2349409|FG003|Overall Study|Ineligible|1
1189810|NCT00980460|2349410|FG004|Overall Study|Ineligible|4
1189811|NCT00980460|2349406|FG000|Overall Study|Refusal of further therapy|0
1189812|NCT00980460|2349407|FG001|Overall Study|Refusal of further therapy|2
1189813|NCT00980460|2349408|FG002|Overall Study|Refusal of further therapy|3
1189814|NCT00980460|2349409|FG003|Overall Study|Refusal of further therapy|2
1189815|NCT00980460|2349410|FG004|Overall Study|Refusal of further therapy|0
1189816|NCT00980460|2349406|FG000|Overall Study|No therapy within 42 days of resection|0
1189817|NCT00980460|2349407|FG001|Overall Study|No therapy within 42 days of resection|0
1189818|NCT00980460|2349408|FG002|Overall Study|No therapy within 42 days of resection|3
1189819|NCT00980460|2349409|FG003|Overall Study|No therapy within 42 days of resection|1
1189820|NCT00980460|2349410|FG004|Overall Study|No therapy within 42 days of resection|0
1189821|NCT00980460|2349406|FG000|Overall Study|No transplant by protocol timepoints|0
1189822|NCT00980460|2349407|FG001|Overall Study|No transplant by protocol timepoints|0
1189823|NCT00980460|2349408|FG002|Overall Study|No transplant by protocol timepoints|3
1189824|NCT00980460|2349409|FG003|Overall Study|No transplant by protocol timepoints|0
1189825|NCT00980460|2349410|FG004|Overall Study|No transplant by protocol timepoints|0
881284|NCT00598975|1846169|FG001|Overall Study|Withdrawal of consent|1
881285|NCT00598975|1846168|FG000|Overall Study|Disease progression|8
881286|NCT00598975|1846169|FG001|Overall Study|Disease progression|3
881287|NCT00598975|1846168|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1
881288|NCT00598975|1846169|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0
881289|NCT00599027|1846183|FG000|Overall Study|Withdrawal by Subject|1
881290|NCT00599027|1846184|FG001|Overall Study|Withdrawal by Subject|1
881291|NCT00599027|1846183|FG000|Overall Study|Adverse Event|0
881292|NCT00599027|1846184|FG001|Overall Study|Adverse Event|1
881293|NCT00599027|1846183|FG000|Overall Study|Treatment Failure|0
881294|NCT00599027|1846184|FG001|Overall Study|Treatment Failure|1
881295|NCT00599196|1846199|FG000|Overall Study|Lack of Efficacy|22
881296|NCT00599196|1846199|FG000|Overall Study|Adverse Event|93
881297|NCT00599196|1846199|FG000|Overall Study|Unsatisfactory compliance of subject|3
881298|NCT00599196|1846199|FG000|Overall Study|Subject withdrew consent|43
881299|NCT00599196|1846199|FG000|Overall Study|Study ended per sponsor|197
881300|NCT00599196|1846199|FG000|Overall Study|Lost to Follow-up|17
881301|NCT00599196|1846199|FG000|Overall Study|Other: Patient Leaving For Israel|1
881302|NCT00599196|1846199|FG000|Overall Study|Other: Spouse Withdrew Consent|1
881303|NCT00599196|1846199|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
881304|NCT00599196|1846199|FG000|Overall Study|Other: Pt Moved To Australia|1
881305|NCT00599196|1846199|FG000|Overall Study|Other: Patient Stopped Due To Moving|1
881306|NCT00599196|1846199|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1
881307|NCT00599313|1846217|FG000|Overall Study|Adverse Event|19
881308|NCT00599313|1846217|FG000|Overall Study|Disease Progression|12
881309|NCT00599313|1846217|FG000|Overall Study|Patient Request|4
881310|NCT00599313|1846217|FG000|Overall Study|Ineligible|1
881311|NCT00599326|1846221|FG000|Overall Study|Lost to Follow-up|1
881312|NCT00599326|1846221|FG000|Overall Study|Noncompliant|1
881313|NCT00599339|1846225|FG000|Overall Study|Adverse Event|79
881314|NCT00599339|1846225|FG000|Overall Study|Withdrawal by Subject|137
881315|NCT00599339|1846225|FG000|Overall Study|Other Reason|179
881316|NCT00599339|1846225|FG000|Overall Study|Lost to Follow-up|221
881317|NCT00599339|1846225|FG000|Overall Study|No valid data consent|36
881318|NCT00599339|1846225|FG000|Overall Study|Study Termination Status Unknown|12
881319|NCT00599521|1846249|FG000|Overall Study|Lack of Efficacy|4
881320|NCT00599521|1846250|FG001|Overall Study|Lack of Efficacy|8
881321|NCT00599521|1846249|FG000|Overall Study|Adverse Event|4
881322|NCT00599521|1846250|FG001|Overall Study|Adverse Event|1
881323|NCT00599521|1846249|FG000|Overall Study|Withdrawal by Subject|28
881324|NCT00599521|1846250|FG001|Overall Study|Withdrawal by Subject|34
881325|NCT00599521|1846249|FG000|Overall Study|Protocol Violation|1
881326|NCT00599521|1846250|FG001|Overall Study|Protocol Violation|1
881327|NCT00599521|1846249|FG000|Overall Study|Lost to Follow-up|23
881328|NCT00599521|1846250|FG001|Overall Study|Lost to Follow-up|23
881329|NCT00599521|1846249|FG000|Overall Study|Pregnancy|0
881330|NCT00599521|1846250|FG001|Overall Study|Pregnancy|2
881331|NCT00599638|1846260|FG000|First Intervention Period (2 Weeks)|Adverse Event|1
881332|NCT00599638|1846261|FG001|First Intervention Period (2 Weeks)|Adverse Event|0
881333|NCT00599638|1846262|FG002|First Intervention Period (2 Weeks)|Adverse Event|3
881334|NCT00599638|1846263|FG003|First Intervention Period (2 Weeks)|Adverse Event|2
881335|NCT00599638|1846260|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
881336|NCT00599638|1846261|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
881337|NCT00599638|1846262|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
881338|NCT00599638|1846263|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
881339|NCT00599638|1846260|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0
881340|NCT00599638|1846261|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1
881341|NCT00599638|1846262|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0
881342|NCT00599638|1846263|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1
881343|NCT00599638|1846260|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0
881344|NCT00599638|1846261|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1
881345|NCT00599638|1846262|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0
881346|NCT00599638|1846263|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1
881347|NCT00599638|1846260|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
881348|NCT00599638|1846261|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0
881349|NCT00599638|1846262|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0
881350|NCT00599638|1846263|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1
881351|NCT00599638|1846260|FG000|Washout Period (2 Weeks)|Adverse Event|0
881352|NCT00599638|1846261|FG001|Washout Period (2 Weeks)|Adverse Event|0
881353|NCT00599638|1846262|FG002|Washout Period (2 Weeks)|Adverse Event|0
881354|NCT00599638|1846263|FG003|Washout Period (2 Weeks)|Adverse Event|1
881355|NCT00599638|1846260|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0
881356|NCT00599638|1846261|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0
881357|NCT00599638|1846262|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0
881358|NCT00599638|1846263|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1
881359|NCT00599638|1846260|FG000|Washout Period (2 Weeks)|Protocol Violation|0
881360|NCT00599638|1846261|FG001|Washout Period (2 Weeks)|Protocol Violation|1
881361|NCT00599638|1846262|FG002|Washout Period (2 Weeks)|Protocol Violation|0
881362|NCT00599638|1846263|FG003|Washout Period (2 Weeks)|Protocol Violation|0
881363|NCT00599638|1846260|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1
881364|NCT00599638|1846261|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0
881365|NCT00599638|1846262|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0
881366|NCT00599638|1846263|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0
881367|NCT00599755|1846271|FG000|Overall Study|Adverse Event|11
881368|NCT00599755|1846271|FG000|Overall Study|Withdrawal by Subject|2
881369|NCT00599755|1846271|FG000|Overall Study|Progression of Disease|3
881370|NCT00599755|1846271|FG000|Overall Study|Other Reason|2
881371|NCT00599755|1846271|FG000|Overall Study|No data available|1
881372|NCT00599924|1846295|FG000|Overall Study|Lack of Efficacy|3
1189880|NCT00602641|2349449|FG000|Overall Study|Never started protocol therapy|6
1189881|NCT00602641|2349450|FG001|Overall Study|Never started protocol therapy|2
1189882|NCT00602641|2349449|FG000|Overall Study|Still on treatment at time of analysis|8
1189883|NCT00602641|2349450|FG001|Overall Study|Still on treatment at time of analysis|15
1189884|NCT00602641|2349449|FG000|Overall Study|Adverse Event|62
1189885|NCT00602641|2349450|FG001|Overall Study|Adverse Event|53
1189886|NCT00602641|2349449|FG000|Overall Study|Disease progression|38
1189887|NCT00602641|2349450|FG001|Overall Study|Disease progression|55
1189888|NCT00602641|2349449|FG000|Overall Study|Death|6
1189889|NCT00602641|2349450|FG001|Overall Study|Death|5
1189890|NCT00602641|2349449|FG000|Overall Study|Withdrawal by Subject|15
1189891|NCT00602641|2349450|FG001|Overall Study|Withdrawal by Subject|12
1189892|NCT00602641|2349449|FG000|Overall Study|Alternative therapy|5
1189893|NCT00602641|2349450|FG001|Overall Study|Alternative therapy|2
1189894|NCT00602641|2349449|FG000|Overall Study|Other Complicating Disease|5
1189895|NCT00602641|2349450|FG001|Overall Study|Other Complicating Disease|2
1189896|NCT00602641|2349449|FG000|Overall Study|Physician Decision|5
1189897|NCT00602641|2349450|FG001|Overall Study|Physician Decision|4
1189898|NCT00602641|2349449|FG000|Overall Study|Administrative Closure|1
1189899|NCT00602641|2349450|FG001|Overall Study|Administrative Closure|1
1189900|NCT00602641|2349449|FG000|Overall Study|Other|3
1189901|NCT00602641|2349450|FG001|Overall Study|Other|1
881373|NCT00599924|1846296|FG001|Overall Study|Lack of Efficacy|5
881374|NCT00599924|1846297|FG002|Overall Study|Lack of Efficacy|1
881375|NCT00599924|1846298|FG003|Overall Study|Lack of Efficacy|2
881376|NCT00599924|1846299|FG004|Overall Study|Lack of Efficacy|3
881377|NCT00599924|1846300|FG005|Overall Study|Lack of Efficacy|2
881378|NCT00599924|1846301|FG006|Overall Study|Lack of Efficacy|0
881379|NCT00599924|1846295|FG000|Overall Study|Adverse Event|0
881380|NCT00599924|1846296|FG001|Overall Study|Adverse Event|0
881381|NCT00599924|1846297|FG002|Overall Study|Adverse Event|0
881382|NCT00599924|1846298|FG003|Overall Study|Adverse Event|2
881383|NCT00599924|1846299|FG004|Overall Study|Adverse Event|0
881384|NCT00599924|1846300|FG005|Overall Study|Adverse Event|0
881385|NCT00599924|1846301|FG006|Overall Study|Adverse Event|2
881386|NCT00599924|1846295|FG000|Overall Study|Death|0
881387|NCT00599924|1846296|FG001|Overall Study|Death|0
881388|NCT00599924|1846297|FG002|Overall Study|Death|0
881389|NCT00599924|1846298|FG003|Overall Study|Death|2
881390|NCT00599924|1846299|FG004|Overall Study|Death|0
881391|NCT00599924|1846300|FG005|Overall Study|Death|2
881392|NCT00599924|1846301|FG006|Overall Study|Death|1
881393|NCT00599924|1846295|FG000|Overall Study|Protocol Violation|0
881394|NCT00599924|1846296|FG001|Overall Study|Protocol Violation|0
881395|NCT00599924|1846297|FG002|Overall Study|Protocol Violation|0
881396|NCT00599924|1846298|FG003|Overall Study|Protocol Violation|1
881397|NCT00599924|1846299|FG004|Overall Study|Protocol Violation|0
881398|NCT00599924|1846300|FG005|Overall Study|Protocol Violation|0
881399|NCT00599924|1846301|FG006|Overall Study|Protocol Violation|0
881400|NCT00599924|1846295|FG000|Overall Study|Withdrawal by Subject|0
881401|NCT00599924|1846296|FG001|Overall Study|Withdrawal by Subject|0
881402|NCT00599924|1846297|FG002|Overall Study|Withdrawal by Subject|1
881403|NCT00599924|1846298|FG003|Overall Study|Withdrawal by Subject|0
881404|NCT00599924|1846299|FG004|Overall Study|Withdrawal by Subject|1
881405|NCT00599924|1846300|FG005|Overall Study|Withdrawal by Subject|0
881406|NCT00599924|1846301|FG006|Overall Study|Withdrawal by Subject|0
881407|NCT00599924|1846295|FG000|Overall Study|Other|0
881408|NCT00599924|1846296|FG001|Overall Study|Other|0
881409|NCT00599924|1846297|FG002|Overall Study|Other|0
881410|NCT00599924|1846298|FG003|Overall Study|Other|1
881411|NCT00599924|1846299|FG004|Overall Study|Other|2
881412|NCT00599924|1846300|FG005|Overall Study|Other|0
881413|NCT00599924|1846301|FG006|Overall Study|Other|2
881414|NCT00600028|1846332|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
881415|NCT00600028|1846333|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
881416|NCT00600028|1846332|FG000|First Intervention (12 Weeks)|Adverse Event|0
881417|NCT00600028|1846333|FG001|First Intervention (12 Weeks)|Adverse Event|1
881418|NCT00600028|1846332|FG000|Second Intervention (12 Weeks)|Adverse Event|0
881419|NCT00600028|1846333|FG001|Second Intervention (12 Weeks)|Adverse Event|2
881420|NCT00600067|1846344|FG000|Overall Study|Adverse Event|0
881421|NCT00600067|1846345|FG001|Overall Study|Adverse Event|1
881422|NCT00600067|1846344|FG000|Overall Study|Lost to Follow-up|2
881423|NCT00600067|1846345|FG001|Overall Study|Lost to Follow-up|3
881424|NCT00600067|1846344|FG000|Overall Study|protocol non-compliance|0
1189922|NCT00407602|2349465|FG000|Overall Study|Death - unrelated to device|1
1189923|NCT00407602|2349465|FG000|Overall Study|Device explanted|5
1189924|NCT00407602|2349465|FG000|Overall Study|Withdrawal by Subject|1
881425|NCT00600067|1846345|FG001|Overall Study|protocol non-compliance|3
881426|NCT00600067|1846344|FG000|Overall Study|Lack of Efficacy|1
881427|NCT00600067|1846345|FG001|Overall Study|Lack of Efficacy|0
881428|NCT00600106|1846361|FG000|Overall Study|Withdrawal by Subject|1
881429|NCT00600106|1846362|FG001|Overall Study|Withdrawal by Subject|1
881430|NCT00600119|1846374|FG000|Single-blind Placebo run-in Period|Other - Not specified|1
881431|NCT00600119|1846375|FG001|Single-blind Placebo run-in Period|Other - Not specified|0
881432|NCT00600119|1846376|FG002|Single-blind Placebo run-in Period|Other - Not specified|0
881433|NCT00600119|1846377|FG003|Single-blind Placebo run-in Period|Other - Not specified|0
881434|NCT00600119|1846378|FG004|Single-blind Placebo run-in Period|Other - Not specified|1
881435|NCT00600119|1846379|FG005|Single-blind Placebo run-in Period|Other - Not specified|1
881436|NCT00600119|1846374|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
881437|NCT00600119|1846375|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
881438|NCT00600119|1846376|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
881439|NCT00600119|1846377|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
881440|NCT00600119|1846378|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
881441|NCT00600119|1846379|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
881442|NCT00600119|1846374|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0
881443|NCT00600119|1846375|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0
881444|NCT00600119|1846376|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1
881445|NCT00600119|1846377|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0
881446|NCT00600119|1846378|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1
881447|NCT00600119|1846379|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0
881448|NCT00600119|1846374|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1
881449|NCT00600119|1846375|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0
881450|NCT00600119|1846376|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0
881451|NCT00600119|1846377|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0
881452|NCT00600119|1846378|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0
881453|NCT00600119|1846379|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0
881454|NCT00600119|1846374|FG000|Single-blind Placebo run-in Period|Adverse Event|0
881455|NCT00600119|1846375|FG001|Single-blind Placebo run-in Period|Adverse Event|0
881456|NCT00600119|1846376|FG002|Single-blind Placebo run-in Period|Adverse Event|0
881457|NCT00600119|1846377|FG003|Single-blind Placebo run-in Period|Adverse Event|1
881458|NCT00600119|1846378|FG004|Single-blind Placebo run-in Period|Adverse Event|0
881459|NCT00600119|1846379|FG005|Single-blind Placebo run-in Period|Adverse Event|1
881460|NCT00600119|1846374|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2
881461|NCT00600119|1846375|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1
881462|NCT00600119|1846376|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0
881463|NCT00600119|1846377|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0
881464|NCT00600119|1846378|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0
881465|NCT00600119|1846379|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0
881466|NCT00600119|1846374|FG000|Double-blind Treatment Period|Withdrawal by Subject|2
881467|NCT00600119|1846375|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
1189925|NCT04567186|2349489|FG000|Period 1|COVID-19 related|1
1189926|NCT04567186|2349490|FG001|Period 1|COVID-19 related|0
1189927|NCT04567186|2349489|FG000|Period 1|Protocol Violation|0
1189928|NCT04567186|2349490|FG001|Period 1|Protocol Violation|1
1189929|NCT04567186|2349489|FG000|Period 1|Adverse Event|0
1189930|NCT04567186|2349490|FG001|Period 1|Adverse Event|2
1189931|NCT04567186|2349489|FG000|Period 2|COVID-19 Related|0
1189932|NCT04567186|2349490|FG001|Period 2|COVID-19 Related|1
1189933|NCT04567186|2349489|FG000|Period 2|Protocol Violation|0
1189934|NCT04567186|2349490|FG001|Period 2|Protocol Violation|1
1189935|NCT04567186|2349489|FG000|Period 2|Lost to Follow-up|0
1189936|NCT04567186|2349490|FG001|Period 2|Lost to Follow-up|1
1189937|NCT04567186|2349489|FG000|Period 3|Subject no longer meets eligibilty criteria|1
1189938|NCT04567186|2349490|FG001|Period 3|Subject no longer meets eligibilty criteria|0
1189939|NCT04065074|2349513|FG000|Overall Study|Adverse Event|1
1189940|NCT04065074|2349513|FG000|Overall Study|Protocol Non-Compliance after injection|1
1189941|NCT03980730|2349519|FG000|Overall Study|Study Terminated by Sponsor|0
1189942|NCT03980730|2349520|FG001|Overall Study|Study Terminated by Sponsor|3
1189943|NCT03980730|2349519|FG000|Overall Study|Adverse Event|2
1189944|NCT03980730|2349520|FG001|Overall Study|Adverse Event|0
1189945|NCT03980730|2349519|FG000|Overall Study|Sponsor Request|0
1189946|NCT03980730|2349520|FG001|Overall Study|Sponsor Request|1
1189947|NCT03793010|2349528|FG000|Overall Study|Withdrawal by Subject|5
1189948|NCT03793010|2349529|FG001|Overall Study|Withdrawal by Subject|7
1189949|NCT03793010|2349528|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19
1189950|NCT03793010|2349529|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18
1189951|NCT03793010|2349528|FG000|Overall Study|Lost to Follow-up|1
1189952|NCT03793010|2349529|FG001|Overall Study|Lost to Follow-up|2
1189953|NCT03793010|2349528|FG000|Overall Study|Patient couldn't sit still for injection|1
1189954|NCT03793010|2349529|FG001|Overall Study|Patient couldn't sit still for injection|0
1189955|NCT03793010|2349528|FG000|Overall Study|Withdrew to pursue other treatment|1
1189956|NCT03793010|2349529|FG001|Overall Study|Withdrew to pursue other treatment|0
1189957|NCT03793010|2349528|FG000|Overall Study|Did not meet eligibility criteria|1
1189958|NCT03793010|2349529|FG001|Overall Study|Did not meet eligibility criteria|0
1189959|NCT03644017|2349535|FG000|Overall Study|Access Abandonment|5
1189960|NCT03644017|2349535|FG000|Overall Study|Kidney Transplant|2
1189961|NCT03592186|2349541|FG000|Overall Study|Withdrawal by Subject|1
1189962|NCT03592186|2349542|FG001|Overall Study|Withdrawal by Subject|0
1189963|NCT03592186|2349541|FG000|Overall Study|Lost to Follow-up|16
1189964|NCT03592186|2349542|FG001|Overall Study|Lost to Follow-up|11
1189965|NCT03529942|2349548|FG000|Overall Study|Withdrawal by Subject|13
1189966|NCT03529942|2349548|FG000|Overall Study|Physician Decision|1
1189967|NCT03529942|2349548|FG000|Overall Study|Lost to Follow-up|7
1189968|NCT03529942|2349548|FG000|Overall Study|Needle inserted but no drug administered|1
1189969|NCT03529942|2349548|FG000|Overall Study|Personal reasons|1
881468|NCT00600119|1846376|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
881469|NCT00600119|1846377|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
881470|NCT00600119|1846378|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
881471|NCT00600119|1846379|FG005|Double-blind Treatment Period|Withdrawal by Subject|3
881472|NCT00600119|1846374|FG000|Double-blind Treatment Period|Other|0
881473|NCT00600119|1846375|FG001|Double-blind Treatment Period|Other|0
881474|NCT00600119|1846376|FG002|Double-blind Treatment Period|Other|0
881475|NCT00600119|1846377|FG003|Double-blind Treatment Period|Other|0
881476|NCT00600119|1846378|FG004|Double-blind Treatment Period|Other|2
881477|NCT00600119|1846379|FG005|Double-blind Treatment Period|Other|1
881478|NCT00600119|1846374|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
881479|NCT00600119|1846375|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
881480|NCT00600119|1846376|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
881481|NCT00600119|1846377|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
881482|NCT00600119|1846378|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
881483|NCT00600119|1846379|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
881484|NCT00600119|1846374|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
881485|NCT00600119|1846375|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
881486|NCT00600119|1846376|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
881487|NCT00600119|1846377|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
881488|NCT00600119|1846378|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
881489|NCT00600119|1846379|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
881490|NCT00600119|1846374|FG000|Double-blind Treatment Period|Sponsor Decision|0
881491|NCT00600119|1846375|FG001|Double-blind Treatment Period|Sponsor Decision|1
881492|NCT00600119|1846376|FG002|Double-blind Treatment Period|Sponsor Decision|0
881493|NCT00600119|1846377|FG003|Double-blind Treatment Period|Sponsor Decision|0
881494|NCT00600119|1846378|FG004|Double-blind Treatment Period|Sponsor Decision|1
881495|NCT00600119|1846379|FG005|Double-blind Treatment Period|Sponsor Decision|0
881496|NCT00600119|1846374|FG000|Double-blind Treatment Period|Physician Decision|2
881497|NCT00600119|1846375|FG001|Double-blind Treatment Period|Physician Decision|0
881498|NCT00600119|1846376|FG002|Double-blind Treatment Period|Physician Decision|0
881499|NCT00600119|1846377|FG003|Double-blind Treatment Period|Physician Decision|0
1189970|NCT03373760|2349557|FG000|Overall Study|Adverse Event|8
1189971|NCT03373760|2349557|FG000|Overall Study|Disease Progression|46
1189972|NCT03373760|2349557|FG000|Overall Study|Death|4
1189973|NCT03349775|2349566|FG000|Overall Study|Side Effects|1
1189974|NCT03349775|2349567|FG001|Overall Study|Side Effects|2
1189975|NCT03349775|2349566|FG000|Overall Study|Withdrawal by Subject|1
1189976|NCT03349775|2349567|FG001|Overall Study|Withdrawal by Subject|1
1189977|NCT03349775|2349566|FG000|Overall Study|No primary outcome measurements|0
1189978|NCT03349775|2349567|FG001|Overall Study|No primary outcome measurements|1
1189979|NCT03256344|2349584|FG000|Overall Study|Ongoing on study|3
1189980|NCT03256344|2349585|FG001|Overall Study|Ongoing on study|3
1189981|NCT03256344|2349584|FG000|Overall Study|Death|5
1189982|NCT03256344|2349585|FG001|Overall Study|Death|19
1189983|NCT03256344|2349584|FG000|Overall Study|Withdrawal by Subject|3
1189984|NCT03256344|2349585|FG001|Overall Study|Withdrawal by Subject|3
1189985|NCT03207815|2349593|FG000|Overall Study|Protocol Violation|3
1189986|NCT03207815|2349594|FG001|Overall Study|Protocol Violation|1
1189987|NCT03207815|2349593|FG000|Overall Study|Adverse Event|1
881500|NCT00600119|1846378|FG004|Double-blind Treatment Period|Physician Decision|0
881501|NCT00600119|1846379|FG005|Double-blind Treatment Period|Physician Decision|0
881502|NCT00600119|1846374|FG000|Double-blind Treatment Period|Lost to Follow-up|0
881503|NCT00600119|1846375|FG001|Double-blind Treatment Period|Lost to Follow-up|1
881504|NCT00600119|1846376|FG002|Double-blind Treatment Period|Lost to Follow-up|0
881505|NCT00600119|1846377|FG003|Double-blind Treatment Period|Lost to Follow-up|0
881506|NCT00600119|1846378|FG004|Double-blind Treatment Period|Lost to Follow-up|0
881507|NCT00600119|1846379|FG005|Double-blind Treatment Period|Lost to Follow-up|0
881508|NCT00600119|1846374|FG000|Double-blind Treatment Period|Adverse Event|1
881509|NCT00600119|1846375|FG001|Double-blind Treatment Period|Adverse Event|1
881510|NCT00600119|1846376|FG002|Double-blind Treatment Period|Adverse Event|0
881511|NCT00600119|1846377|FG003|Double-blind Treatment Period|Adverse Event|1
881512|NCT00600119|1846378|FG004|Double-blind Treatment Period|Adverse Event|2
881513|NCT00600119|1846379|FG005|Double-blind Treatment Period|Adverse Event|10
881514|NCT00600119|1846374|FG000|Follow-up Period|Adverse Event|0
881515|NCT00600119|1846375|FG001|Follow-up Period|Adverse Event|0
881516|NCT00600119|1846376|FG002|Follow-up Period|Adverse Event|0
881517|NCT00600119|1846377|FG003|Follow-up Period|Adverse Event|0
881518|NCT00600119|1846378|FG004|Follow-up Period|Adverse Event|0
881519|NCT00600119|1846379|FG005|Follow-up Period|Adverse Event|1
881520|NCT00600119|1846374|FG000|Follow-up Period|Other|1
881521|NCT00600119|1846375|FG001|Follow-up Period|Other|0
881522|NCT00600119|1846376|FG002|Follow-up Period|Other|0
881523|NCT00600119|1846377|FG003|Follow-up Period|Other|0
881524|NCT00600119|1846378|FG004|Follow-up Period|Other|0
881525|NCT00600119|1846379|FG005|Follow-up Period|Other|0
881526|NCT00600171|1846399|FG000|Overall Study|Adverse Event|0
881527|NCT00600171|1846400|FG001|Overall Study|Adverse Event|1
881528|NCT00600171|1846401|FG002|Overall Study|Adverse Event|0
881529|NCT00600171|1846402|FG003|Overall Study|Adverse Event|0
881530|NCT00600171|1846403|FG004|Overall Study|Adverse Event|1
881531|NCT00600171|1846404|FG005|Overall Study|Adverse Event|0
881532|NCT00600171|1846399|FG000|Overall Study|Lack of Efficacy|9
881533|NCT00600171|1846400|FG001|Overall Study|Lack of Efficacy|12
881534|NCT00600171|1846401|FG002|Overall Study|Lack of Efficacy|3
881535|NCT00600171|1846402|FG003|Overall Study|Lack of Efficacy|5
881536|NCT00600171|1846403|FG004|Overall Study|Lack of Efficacy|4
881537|NCT00600171|1846404|FG005|Overall Study|Lack of Efficacy|0
881538|NCT00600171|1846399|FG000|Overall Study|Protocol Violation|1
881539|NCT00600171|1846400|FG001|Overall Study|Protocol Violation|2
881540|NCT00600171|1846401|FG002|Overall Study|Protocol Violation|0
881541|NCT00600171|1846402|FG003|Overall Study|Protocol Violation|1
881542|NCT00600171|1846403|FG004|Overall Study|Protocol Violation|0
881543|NCT00600171|1846404|FG005|Overall Study|Protocol Violation|0
881544|NCT00600171|1846399|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
881545|NCT00600171|1846400|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
881546|NCT00600171|1846401|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7
881547|NCT00600171|1846402|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3
881548|NCT00600171|1846403|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2
881549|NCT00600171|1846404|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2
881550|NCT00600171|1846399|FG000|Overall Study|Withdrawal by Subject|3
881551|NCT00600171|1846400|FG001|Overall Study|Withdrawal by Subject|0
881552|NCT00600171|1846401|FG002|Overall Study|Withdrawal by Subject|0
881553|NCT00600171|1846402|FG003|Overall Study|Withdrawal by Subject|1
881554|NCT00600171|1846403|FG004|Overall Study|Withdrawal by Subject|1
881555|NCT00600171|1846404|FG005|Overall Study|Withdrawal by Subject|1
881556|NCT00600171|1846399|FG000|Overall Study|Physician Decision|0
881557|NCT00600171|1846400|FG001|Overall Study|Physician Decision|1
881558|NCT00600171|1846401|FG002|Overall Study|Physician Decision|0
881559|NCT00600171|1846402|FG003|Overall Study|Physician Decision|1
881560|NCT00600171|1846403|FG004|Overall Study|Physician Decision|0
881561|NCT00600171|1846404|FG005|Overall Study|Physician Decision|2
881562|NCT00600171|1846399|FG000|Overall Study|Lost to Follow-up|0
881563|NCT00600171|1846400|FG001|Overall Study|Lost to Follow-up|0
881564|NCT00600171|1846401|FG002|Overall Study|Lost to Follow-up|0
881565|NCT00600171|1846402|FG003|Overall Study|Lost to Follow-up|1
1189988|NCT03207815|2349594|FG001|Overall Study|Adverse Event|2
1189989|NCT03207815|2349593|FG000|Overall Study|Lost to Follow-up|1
1189990|NCT03207815|2349594|FG001|Overall Study|Lost to Follow-up|2
1189991|NCT03207815|2349593|FG000|Overall Study|Investigator's Discretion|1
1189992|NCT03207815|2349594|FG001|Overall Study|Investigator's Discretion|1
1189993|NCT03207815|2349593|FG000|Overall Study|Lack of Efficacy|0
1189994|NCT03207815|2349594|FG001|Overall Study|Lack of Efficacy|1
1189995|NCT03207815|2349593|FG000|Overall Study|Pregnancy/Partner Pregnancy|1
1189996|NCT03207815|2349594|FG001|Overall Study|Pregnancy/Partner Pregnancy|0
1189997|NCT03207815|2349593|FG000|Overall Study|Withdrew Consent|1
1189998|NCT03207815|2349594|FG001|Overall Study|Withdrew Consent|0
1189999|NCT03073733|2349612|FG000|Overall Study|Lost to Follow-up|1
1190000|NCT03073733|2349613|FG001|Overall Study|Lost to Follow-up|0
1190001|NCT03073733|2349614|FG002|Overall Study|Lost to Follow-up|0
1190002|NCT03073733|2349612|FG000|Overall Study|Physician Decision|0
1190003|NCT03073733|2349613|FG001|Overall Study|Physician Decision|1
1190004|NCT03073733|2349614|FG002|Overall Study|Physician Decision|0
1190005|NCT03073733|2349612|FG000|Overall Study|Withdrawal by Subject|0
1190006|NCT03073733|2349613|FG001|Overall Study|Withdrawal by Subject|0
1190007|NCT03073733|2349614|FG002|Overall Study|Withdrawal by Subject|1
1190008|NCT02968563|2349633|FG000|Overall Study|Adverse Event|0
1190009|NCT02968563|2349634|FG001|Overall Study|Adverse Event|6
1190010|NCT02968563|2349633|FG000|Overall Study|Death|1
1190011|NCT02968563|2349634|FG001|Overall Study|Death|1
1190012|NCT02968563|2349633|FG000|Overall Study|Lost to Follow-up|0
1190013|NCT02968563|2349634|FG001|Overall Study|Lost to Follow-up|1
1190014|NCT02915783|2349640|FG000|Overall Study|Ongoing: Receiving Treatment|6
1190015|NCT02915783|2349640|FG000|Overall Study|Ongoing: In Survival Follow Up|8
1190016|NCT02913482|2349647|FG000|Overall Study|Death|0
1190017|NCT02913482|2349648|FG001|Overall Study|Death|2
1190018|NCT02913482|2349649|FG002|Overall Study|Death|2
1190019|NCT02913482|2349647|FG000|Overall Study|Progressive Disease|1
881566|NCT00600171|1846403|FG004|Overall Study|Lost to Follow-up|0
881567|NCT00600171|1846404|FG005|Overall Study|Lost to Follow-up|0
881568|NCT00600353|1846431|FG000|Overall Study|history of malignancy within 5 years|1
881569|NCT00600353|1846432|FG001|Overall Study|history of malignancy within 5 years|0
881570|NCT00600353|1846431|FG000|Overall Study|History of prepartive regimen|0
881571|NCT00600353|1846432|FG001|Overall Study|History of prepartive regimen|1
881572|NCT00600613|1846438|FG000|Overall Study|Protocol Deviation|1
881573|NCT00600756|1846479|FG000|Analysis After 6 Months|Adverse Event|43
881574|NCT00600756|1846480|FG001|Analysis After 6 Months|Adverse Event|33
881575|NCT00600756|1846479|FG000|Analysis After 6 Months|Withdrawal by Subject|38
881576|NCT00600756|1846480|FG001|Analysis After 6 Months|Withdrawal by Subject|30
881577|NCT00600756|1846479|FG000|Analysis After 6 Months|Incorrect Enrollment|12
881578|NCT00600756|1846480|FG001|Analysis After 6 Months|Incorrect Enrollment|21
881579|NCT00600756|1846479|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11
881580|NCT00600756|1846480|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14
881581|NCT00600756|1846479|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11
881582|NCT00600756|1846480|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11
881583|NCT00600756|1846479|FG000|Analysis After 6 Months|Lost to Follow-up|10
881584|NCT00600756|1846480|FG001|Analysis After 6 Months|Lost to Follow-up|8
881585|NCT00600756|1846479|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6
881586|NCT00600756|1846480|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3
881587|NCT00600756|1846479|FG000|Overall Study Analysis After 12 Months|Adverse Event|53
881588|NCT00600756|1846480|FG001|Overall Study Analysis After 12 Months|Adverse Event|44
881589|NCT00600756|1846479|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
881590|NCT00600756|1846480|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
881591|NCT00600756|1846479|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21
881592|NCT00600756|1846480|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29
881593|NCT00600756|1846479|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
881594|NCT00600756|1846480|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
881595|NCT00600756|1846479|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
881596|NCT00600756|1846480|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
881597|NCT00600756|1846479|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16
881598|NCT00600756|1846480|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13
881599|NCT00600756|1846479|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
881600|NCT00600756|1846480|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
881601|NCT00600821|1846488|FG000|Overall Study|Death|45
881602|NCT00600821|1846489|FG001|Overall Study|Death|46
881603|NCT00600821|1846488|FG000|Overall Study|Lost to Follow-up|2
881604|NCT00600821|1846489|FG001|Overall Study|Lost to Follow-up|2
881605|NCT00600821|1846488|FG000|Overall Study|Withdrawal by Subject|1
881606|NCT00600821|1846489|FG001|Overall Study|Withdrawal by Subject|1
881607|NCT00600821|1846488|FG000|Overall Study|Terminated by sponsor|8
881608|NCT00600821|1846489|FG001|Overall Study|Terminated by sponsor|6
1190020|NCT02913482|2349648|FG001|Overall Study|Progressive Disease|1
1190021|NCT02913482|2349649|FG002|Overall Study|Progressive Disease|1
1190022|NCT02787044|2349661|FG000|Overall Study|Lost to Follow-up|15
1190023|NCT02787044|2349662|FG001|Overall Study|Lost to Follow-up|19
1190024|NCT02698163|2349674|FG000|Overall Study|Lost to Follow-up|0
1190025|NCT02698163|2349675|FG001|Overall Study|Lost to Follow-up|1
881609|NCT00600821|1846488|FG000|Overall Study|Objective progression or relapse|0
881610|NCT00600821|1846489|FG001|Overall Study|Objective progression or relapse|1
881611|NCT00600821|1846488|FG000|Overall Study|Randomized but not treated|0
881612|NCT00600821|1846489|FG001|Overall Study|Randomized but not treated|1
881613|NCT00600821|1846488|FG000|Overall Study|Other|2
881614|NCT00600821|1846489|FG001|Overall Study|Other|3
881615|NCT00600886|1846499|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
881616|NCT00600886|1846500|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
881617|NCT00600886|1846499|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
881618|NCT00600886|1846500|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
881619|NCT00600886|1846499|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
881620|NCT00600886|1846500|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
881621|NCT00600886|1846499|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
881622|NCT00600886|1846500|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
881623|NCT00600886|1846499|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
881624|NCT00600886|1846500|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
881625|NCT00600886|1846499|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
881626|NCT00600886|1846500|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
881627|NCT00600886|1846499|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
881628|NCT00600886|1846500|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
881629|NCT00600886|1846499|FG000|Core Phase - Full Analysis Set (FAS)|Death|0
881630|NCT00600886|1846500|FG001|Core Phase - Full Analysis Set (FAS)|Death|1
881631|NCT00600886|1846499|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
881632|NCT00600886|1846500|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
881633|NCT00600886|1846499|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3
881634|NCT00600886|1846500|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3
881635|NCT00600886|1846499|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9
881636|NCT00600886|1846500|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3
881637|NCT00600886|1846499|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3
881638|NCT00600886|1846500|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1
881639|NCT00600886|1846499|FG000|Extension - Same Treatment (FAS)|Adverse Event|4
881640|NCT00600886|1846500|FG001|Extension - Same Treatment (FAS)|Adverse Event|1
881641|NCT00600886|1846499|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
881642|NCT00600886|1846500|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
881643|NCT00600886|1846499|FG000|Extension - Same Treatment (FAS)|Death|1
881644|NCT00600886|1846500|FG001|Extension - Same Treatment (FAS)|Death|1
881645|NCT00600886|1846499|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
881646|NCT00600886|1846500|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
881647|NCT00600886|1846499|FG000|Extension - After Crossover (CAS)|Adverse Event|19
881648|NCT00600886|1846500|FG001|Extension - After Crossover (CAS)|Adverse Event|1
881649|NCT00600886|1846499|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19
881650|NCT00600886|1846500|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4
881651|NCT00600886|1846499|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13
881652|NCT00600886|1846500|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4
881653|NCT00600886|1846499|FG000|Extension - After Crossover (CAS)|Administrative Problems|4
881654|NCT00600886|1846500|FG001|Extension - After Crossover (CAS)|Administrative Problems|4
881655|NCT00600886|1846499|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
881656|NCT00600886|1846500|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
881657|NCT00600886|1846499|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
881658|NCT00600886|1846500|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
881659|NCT00600886|1846499|FG000|Extension - After Crossover (CAS)|Death|1
881660|NCT00600886|1846500|FG001|Extension - After Crossover (CAS)|Death|0
881661|NCT00600938|1846531|FG000|Core Study|Abnormal test procedure result(s)|3
881662|NCT00600938|1846532|FG001|Core Study|Abnormal test procedure result(s)|2
881663|NCT00600938|1846533|FG002|Core Study|Abnormal test procedure result(s)|0
881664|NCT00600938|1846534|FG003|Core Study|Abnormal test procedure result(s)|0
881665|NCT00600938|1846531|FG000|Core Study|Unsatisfactory therapeutic effect|1
881666|NCT00600938|1846532|FG001|Core Study|Unsatisfactory therapeutic effect|2
881667|NCT00600938|1846533|FG002|Core Study|Unsatisfactory therapeutic effect|0
881668|NCT00600938|1846534|FG003|Core Study|Unsatisfactory therapeutic effect|0
881669|NCT00600938|1846531|FG000|Core Study|Patient withdrew consent|7
881670|NCT00600938|1846532|FG001|Core Study|Patient withdrew consent|12
881671|NCT00600938|1846533|FG002|Core Study|Patient withdrew consent|0
881672|NCT00600938|1846534|FG003|Core Study|Patient withdrew consent|0
881673|NCT00600938|1846531|FG000|Core Study|Lost to Follow-up|3
881674|NCT00600938|1846532|FG001|Core Study|Lost to Follow-up|2
881675|NCT00600938|1846533|FG002|Core Study|Lost to Follow-up|0
881676|NCT00600938|1846534|FG003|Core Study|Lost to Follow-up|0
881677|NCT00600938|1846531|FG000|Core Study|Death|1
881678|NCT00600938|1846532|FG001|Core Study|Death|1
881679|NCT00600938|1846533|FG002|Core Study|Death|0
881680|NCT00600938|1846534|FG003|Core Study|Death|0
881681|NCT00600938|1846531|FG000|Core Study|Protocol Violation|1
881682|NCT00600938|1846532|FG001|Core Study|Protocol Violation|2
881683|NCT00600938|1846533|FG002|Core Study|Protocol Violation|0
881684|NCT00600938|1846534|FG003|Core Study|Protocol Violation|0
881685|NCT00600938|1846531|FG000|Extension Study|Adverse Event|1
881686|NCT00600938|1846532|FG001|Extension Study|Adverse Event|0
881687|NCT00600938|1846533|FG002|Extension Study|Adverse Event|2
881688|NCT00600938|1846534|FG003|Extension Study|Adverse Event|0
881689|NCT00600938|1846531|FG000|Extension Study|Abnormal test procedure results|0
881690|NCT00600938|1846532|FG001|Extension Study|Abnormal test procedure results|1
881691|NCT00600938|1846533|FG002|Extension Study|Abnormal test procedure results|1
881692|NCT00600938|1846534|FG003|Extension Study|Abnormal test procedure results|1
881693|NCT00600938|1846531|FG000|Extension Study|Unsatisfactory therapeutic effect|4
881694|NCT00600938|1846532|FG001|Extension Study|Unsatisfactory therapeutic effect|1
881695|NCT00600938|1846533|FG002|Extension Study|Unsatisfactory therapeutic effect|1
881696|NCT00600938|1846534|FG003|Extension Study|Unsatisfactory therapeutic effect|0
881697|NCT00600938|1846531|FG000|Extension Study|Withdrawal by Subject|2
881698|NCT00600938|1846532|FG001|Extension Study|Withdrawal by Subject|2
881699|NCT00600938|1846533|FG002|Extension Study|Withdrawal by Subject|3
881700|NCT00600938|1846534|FG003|Extension Study|Withdrawal by Subject|0
881701|NCT00600938|1846531|FG000|Extension Study|Lost to Follow-up|1
881702|NCT00600938|1846532|FG001|Extension Study|Lost to Follow-up|1
881703|NCT00600938|1846533|FG002|Extension Study|Lost to Follow-up|2
881704|NCT00600938|1846534|FG003|Extension Study|Lost to Follow-up|0
881705|NCT00600938|1846531|FG000|Extension Study|Death|1
881706|NCT00600938|1846532|FG001|Extension Study|Death|0
881707|NCT00600938|1846533|FG002|Extension Study|Death|0
881708|NCT00600938|1846534|FG003|Extension Study|Death|0
881709|NCT00601107|1846563|FG000|Overall Study|Adverse Event|0
881710|NCT00601107|1846564|FG001|Overall Study|Adverse Event|1
881711|NCT00601107|1846565|FG002|Overall Study|Adverse Event|3
881712|NCT00601107|1846566|FG003|Overall Study|Adverse Event|0
881713|NCT00601107|1846563|FG000|Overall Study|Withdrawal by Subject|5
881714|NCT00601107|1846564|FG001|Overall Study|Withdrawal by Subject|4
881715|NCT00601107|1846565|FG002|Overall Study|Withdrawal by Subject|7
881716|NCT00601107|1846566|FG003|Overall Study|Withdrawal by Subject|4
881717|NCT00601107|1846563|FG000|Overall Study|Lost to Follow-up|3
881718|NCT00601107|1846564|FG001|Overall Study|Lost to Follow-up|3
881719|NCT00601107|1846565|FG002|Overall Study|Lost to Follow-up|0
881720|NCT00601107|1846566|FG003|Overall Study|Lost to Follow-up|3
881721|NCT00601107|1846563|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
881722|NCT00601107|1846564|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
881723|NCT00601107|1846565|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
881724|NCT00601107|1846566|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
881725|NCT00601107|1846563|FG000|Overall Study|Worsening of Psoriasis|4
881726|NCT00601107|1846564|FG001|Overall Study|Worsening of Psoriasis|1
881727|NCT00601107|1846565|FG002|Overall Study|Worsening of Psoriasis|1
881728|NCT00601107|1846566|FG003|Overall Study|Worsening of Psoriasis|4
881729|NCT00601107|1846563|FG000|Overall Study|Undefined|1
881730|NCT00601107|1846564|FG001|Overall Study|Undefined|0
881731|NCT00601107|1846565|FG002|Overall Study|Undefined|1
881732|NCT00601107|1846566|FG003|Overall Study|Undefined|0
881733|NCT00601172|1846582|FG000|Overall Study|Adverse Event|43
881734|NCT00601172|1846583|FG001|Overall Study|Adverse Event|32
881735|NCT00601172|1846582|FG000|Overall Study|Lack of Efficacy|11
881736|NCT00601172|1846583|FG001|Overall Study|Lack of Efficacy|12
881737|NCT00601172|1846582|FG000|Overall Study|Protocol Violation|2
881738|NCT00601172|1846583|FG001|Overall Study|Protocol Violation|5
881739|NCT00601172|1846582|FG000|Overall Study|Lost to Follow-up|4
881740|NCT00601172|1846583|FG001|Overall Study|Lost to Follow-up|3
881741|NCT00601172|1846582|FG000|Overall Study|Physician Decision|27
881742|NCT00601172|1846583|FG001|Overall Study|Physician Decision|28
881743|NCT00601172|1846582|FG000|Overall Study|Withdrawal by Subject|35
881744|NCT00601172|1846583|FG001|Overall Study|Withdrawal by Subject|27
881745|NCT00601172|1846582|FG000|Overall Study|Did not meet continuation criteria|19
881746|NCT00601172|1846583|FG001|Overall Study|Did not meet continuation criteria|20
881747|NCT00601250|1846592|FG000|Overall Study|Adverse Event|3
881748|NCT00601250|1846593|FG001|Overall Study|Adverse Event|9
881749|NCT00601250|1846592|FG000|Overall Study|Protocol Violation|3
881750|NCT00601250|1846593|FG001|Overall Study|Protocol Violation|2
881751|NCT00601250|1846592|FG000|Overall Study|Lost to Follow-up|2
881752|NCT00601250|1846593|FG001|Overall Study|Lost to Follow-up|6
881753|NCT00601250|1846592|FG000|Overall Study|Withdrawal by Subject|4
881754|NCT00601250|1846593|FG001|Overall Study|Withdrawal by Subject|13
881755|NCT00601250|1846592|FG000|Overall Study|Other incl. lack of efficacy|2
1190036|NCT02352948|2349748|FG000|Overall Study|Death|47
1190037|NCT02352948|2349749|FG001|Overall Study|Death|48
1190038|NCT02352948|2349750|FG002|Overall Study|Death|114
1190039|NCT02352948|2349751|FG003|Overall Study|Death|74
1190040|NCT02352948|2349752|FG004|Overall Study|Death|77
1190041|NCT02352948|2349753|FG005|Overall Study|Death|44
1190042|NCT02352948|2349748|FG000|Overall Study|Lost to Follow-up|1
881756|NCT00601250|1846593|FG001|Overall Study|Other incl. lack of efficacy|9
881757|NCT00601354|1846601|FG000|Overall Study|Lost to Follow-up|4
881758|NCT00601354|1846602|FG001|Overall Study|Lost to Follow-up|5
881759|NCT00601419|1846612|FG000|Overall Study|Lost to Follow-up|3
881760|NCT00601419|1846612|FG000|Overall Study|Missed Visits|1
881761|NCT00601458|1846635|FG000|Overall Study|Dosing Error|1
881762|NCT00601458|1846636|FG001|Overall Study|Dosing Error|0
881763|NCT00601458|1846637|FG002|Overall Study|Dosing Error|0
881764|NCT00601458|1846635|FG000|Overall Study|Incomplete Data|0
881765|NCT00601458|1846636|FG001|Overall Study|Incomplete Data|2
881766|NCT00601458|1846637|FG002|Overall Study|Incomplete Data|0
881767|NCT00601458|1846635|FG000|Overall Study|Protocol Violation|3
881768|NCT00601458|1846636|FG001|Overall Study|Protocol Violation|2
881769|NCT00601458|1846637|FG002|Overall Study|Protocol Violation|1
881770|NCT00601458|1846635|FG000|Overall Study|Early Termination|0
881771|NCT00601458|1846636|FG001|Overall Study|Early Termination|1
881772|NCT00601458|1846637|FG002|Overall Study|Early Termination|1
881773|NCT00601484|1846647|FG000|Overall Study|Adverse Event|0
881774|NCT00601484|1846648|FG001|Overall Study|Adverse Event|1
881775|NCT00601484|1846647|FG000|Overall Study|Lost to Follow-up|4
881776|NCT00601484|1846648|FG001|Overall Study|Lost to Follow-up|3
881777|NCT00601484|1846647|FG000|Overall Study|Lack of Efficacy|0
881778|NCT00601484|1846648|FG001|Overall Study|Lack of Efficacy|2
881779|NCT00601484|1846647|FG000|Overall Study|Withdrawal by Subject|1
881780|NCT00601484|1846648|FG001|Overall Study|Withdrawal by Subject|1
881781|NCT00601484|1846647|FG000|Overall Study|Randomized, but not treated|0
881782|NCT00601484|1846648|FG001|Overall Study|Randomized, but not treated|1
881783|NCT00601523|1846656|FG000|Overall Study|Adverse Event|42
881784|NCT00601523|1846657|FG001|Overall Study|Adverse Event|14
881785|NCT00601523|1846656|FG000|Overall Study|Lack of Efficacy|3
881786|NCT00601523|1846657|FG001|Overall Study|Lack of Efficacy|0
881787|NCT00601523|1846656|FG000|Overall Study|Protocol Violation|5
881788|NCT00601523|1846657|FG001|Overall Study|Protocol Violation|1
881789|NCT00601523|1846656|FG000|Overall Study|Lost to Follow-up|0
881790|NCT00601523|1846657|FG001|Overall Study|Lost to Follow-up|1
881791|NCT00601523|1846656|FG000|Overall Study|Withdrawal by Subject|18
881792|NCT00601523|1846657|FG001|Overall Study|Withdrawal by Subject|9
881793|NCT00601523|1846656|FG000|Overall Study|Other|9
881794|NCT00601523|1846657|FG001|Overall Study|Other|1
881795|NCT00601640|1846670|FG000|Overall Study|Withdrawal by Subject|3
881796|NCT00601640|1846671|FG001|Overall Study|Withdrawal by Subject|0
881797|NCT00601640|1846672|FG002|Overall Study|Withdrawal by Subject|7
881798|NCT00601640|1846670|FG000|Overall Study|Death|1
881799|NCT00601640|1846671|FG001|Overall Study|Death|0
881800|NCT00601640|1846672|FG002|Overall Study|Death|0
881801|NCT00601640|1846670|FG000|Overall Study|Adverse Event|0
881802|NCT00601640|1846671|FG001|Overall Study|Adverse Event|4
881803|NCT00601640|1846672|FG002|Overall Study|Adverse Event|2
881804|NCT00601640|1846670|FG000|Overall Study|intercurrent illness|1
881805|NCT00601640|1846671|FG001|Overall Study|intercurrent illness|0
881806|NCT00601640|1846672|FG002|Overall Study|intercurrent illness|0
881807|NCT00601640|1846670|FG000|Overall Study|change in eligibility status|0
881808|NCT00601640|1846671|FG001|Overall Study|change in eligibility status|1
881809|NCT00601640|1846672|FG002|Overall Study|change in eligibility status|1
881810|NCT00601705|1846682|FG000|Overall Study|Withdrawal by Subject|1
881811|NCT00601835|1846738|FG000|Overall Study|Withdrawal by Subject|9
881812|NCT00601835|1846739|FG001|Overall Study|Withdrawal by Subject|6
881813|NCT00601835|1846738|FG000|Overall Study|Physician Decision|1
881814|NCT00601835|1846739|FG001|Overall Study|Physician Decision|0
881815|NCT00601835|1846738|FG000|Overall Study|Lost to Follow-up|37
881816|NCT00601835|1846739|FG001|Overall Study|Lost to Follow-up|5
881817|NCT00601835|1846738|FG000|Overall Study|Adverse Event|1
881818|NCT00601835|1846739|FG001|Overall Study|Adverse Event|1
881819|NCT00601835|1846738|FG000|Overall Study|Relocate|12
881820|NCT00601835|1846739|FG001|Overall Study|Relocate|2
881823|NCT00602420|1846824|FG000|Overall Study|Death|1
881824|NCT00602420|1846825|FG001|Overall Study|Death|4
881825|NCT00602420|1846824|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
881826|NCT00602420|1846825|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
881827|NCT00602420|1846824|FG000|Overall Study|Withdrawal by Subject|18
881828|NCT00602420|1846825|FG001|Overall Study|Withdrawal by Subject|17
881829|NCT00602420|1846824|FG000|Overall Study|Adverse Event|1
881830|NCT00602420|1846825|FG001|Overall Study|Adverse Event|0
881831|NCT00602472|1846860|FG000|Overall Study|Adverse Event|5
881832|NCT00602472|1846861|FG001|Overall Study|Adverse Event|23
881833|NCT00602472|1846860|FG000|Overall Study|Protocol Violation|4
1190043|NCT02352948|2349749|FG001|Overall Study|Lost to Follow-up|0
1190044|NCT02352948|2349750|FG002|Overall Study|Lost to Follow-up|2
1190045|NCT02352948|2349751|FG003|Overall Study|Lost to Follow-up|1
1190046|NCT02352948|2349752|FG004|Overall Study|Lost to Follow-up|2
1190047|NCT02352948|2349753|FG005|Overall Study|Lost to Follow-up|1
1190048|NCT02352948|2349748|FG000|Overall Study|Withdrawal by Subject|1
1190049|NCT02352948|2349749|FG001|Overall Study|Withdrawal by Subject|10
1190050|NCT02352948|2349750|FG002|Overall Study|Withdrawal by Subject|11
1190051|NCT02352948|2349751|FG003|Overall Study|Withdrawal by Subject|23
1190052|NCT02352948|2349752|FG004|Overall Study|Withdrawal by Subject|9
881834|NCT00602472|1846861|FG001|Overall Study|Protocol Violation|19
881835|NCT00602472|1846860|FG000|Overall Study|Withdrawal by Subject|8
881836|NCT00602472|1846861|FG001|Overall Study|Withdrawal by Subject|14
881837|NCT00602472|1846860|FG000|Overall Study|Other incl. lack of efficacy|4
881838|NCT00602472|1846861|FG001|Overall Study|Other incl. lack of efficacy|2
881839|NCT00602537|1846869|FG000|12 Week Double Blind Comparison|Adverse Event|2
881840|NCT00602537|1846870|FG001|12 Week Double Blind Comparison|Adverse Event|5
881841|NCT00602537|1846869|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13
881842|NCT00602537|1846870|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23
881843|NCT00602537|1846869|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5
881844|NCT00602537|1846870|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6
881845|NCT00602537|1846869|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3
881846|NCT00602537|1846870|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13
881847|NCT00602537|1846869|FG000|Follow Up Study Comparison|Adverse Event|1
881848|NCT00602537|1846870|FG001|Follow Up Study Comparison|Adverse Event|0
881849|NCT00602537|1846869|FG000|Follow Up Study Comparison|Lost to Follow-up|8
881850|NCT00602537|1846870|FG001|Follow Up Study Comparison|Lost to Follow-up|1
881851|NCT00602537|1846869|FG000|Follow Up Study Comparison|Withdrawal by Subject|2
881852|NCT00602537|1846870|FG001|Follow Up Study Comparison|Withdrawal by Subject|2
881899|NCT00602797|1846934|FG000|Overall Study|Adverse Event|1
881900|NCT00602927|1846945|FG000|Period 1: 13 Days|Protocol Violation|2
881901|NCT00602927|1846946|FG001|Period 1: 13 Days|Protocol Violation|4
881902|NCT00602927|1846945|FG000|Period 1: 13 Days|MRI scanner technical issue|1
881903|NCT00602927|1846946|FG001|Period 1: 13 Days|MRI scanner technical issue|0
881904|NCT00602927|1846945|FG000|Period 1: 13 Days|Time|1
881905|NCT00602927|1846946|FG001|Period 1: 13 Days|Time|0
881906|NCT00602927|1846945|FG000|Period 1: 13 Days|Claustrophobia|0
881907|NCT00602927|1846946|FG001|Period 1: 13 Days|Claustrophobia|1
1190053|NCT02352948|2349753|FG005|Overall Study|Withdrawal by Subject|4
1190054|NCT02352948|2349748|FG000|Overall Study|Eligibility criteria not fulfilled|0
1190055|NCT02352948|2349749|FG001|Overall Study|Eligibility criteria not fulfilled|1
1190056|NCT02352948|2349750|FG002|Overall Study|Eligibility criteria not fulfilled|0
1190057|NCT02352948|2349751|FG003|Overall Study|Eligibility criteria not fulfilled|1
1190058|NCT02352948|2349752|FG004|Overall Study|Eligibility criteria not fulfilled|0
1190059|NCT02352948|2349753|FG005|Overall Study|Eligibility criteria not fulfilled|0
1190060|NCT02352948|2349748|FG000|Overall Study|Other|0
1190061|NCT02352948|2349749|FG001|Overall Study|Other|0
1190062|NCT02352948|2349750|FG002|Overall Study|Other|2
1190063|NCT02352948|2349751|FG003|Overall Study|Other|0
1190064|NCT02352948|2349752|FG004|Overall Study|Other|0
1190065|NCT02352948|2349753|FG005|Overall Study|Other|0
1190066|NCT02332590|2349775|FG000|DB Period (up to 24 Weeks)|Adverse Event|15
1190067|NCT02332590|2349776|FG001|DB Period (up to 24 Weeks)|Adverse Event|11
1190068|NCT02332590|2349775|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4
1190069|NCT02332590|2349776|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2
1190070|NCT02332590|2349775|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3
1190071|NCT02332590|2349776|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1
1190072|NCT02332590|2349775|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1
1190073|NCT02332590|2349776|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0
1190074|NCT02332590|2349775|FG000|DB Period (up to 24 Weeks)|Other than specified above|6
1190075|NCT02332590|2349776|FG001|DB Period (up to 24 Weeks)|Other than specified above|5
1190076|NCT02332590|2349775|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20
1190077|NCT02332590|2349776|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23
1190078|NCT02332590|2349775|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2
1190079|NCT02332590|2349776|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6
1190080|NCT02332590|2349775|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5
1190081|NCT02332590|2349776|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1
1190082|NCT02332590|2349775|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20
1190083|NCT02332590|2349776|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15
1190084|NCT02256631|2349791|FG000|Overall Study|Lost to Follow-up|1
1190085|NCT02256631|2349792|FG001|Overall Study|Lost to Follow-up|1
1190086|NCT02256631|2349793|FG002|Overall Study|Lost to Follow-up|0
1190087|NCT02256631|2349794|FG003|Overall Study|Lost to Follow-up|2
1190088|NCT02256631|2349795|FG004|Overall Study|Lost to Follow-up|0
1190089|NCT02256631|2349796|FG005|Overall Study|Lost to Follow-up|1
1190090|NCT02256631|2349797|FG006|Overall Study|Lost to Follow-up|1
1190091|NCT02256631|2349791|FG000|Overall Study|Withdrawal by Subject|0
1190092|NCT02256631|2349792|FG001|Overall Study|Withdrawal by Subject|0
1190093|NCT02256631|2349793|FG002|Overall Study|Withdrawal by Subject|0
1190094|NCT02256631|2349794|FG003|Overall Study|Withdrawal by Subject|1
1190095|NCT02256631|2349795|FG004|Overall Study|Withdrawal by Subject|1
881908|NCT00602927|1846945|FG000|Period 2: 14 Days|Protocol Violation|0
881909|NCT00602927|1846946|FG001|Period 2: 14 Days|Protocol Violation|2
881910|NCT00602927|1846945|FG000|Period 3: 13 Days|Protocol Violation|0
881911|NCT00602927|1846946|FG001|Period 3: 13 Days|Protocol Violation|1
881912|NCT00602927|1846945|FG000|Period 3: 13 Days|MRI data quality|2
881913|NCT00602927|1846946|FG001|Period 3: 13 Days|MRI data quality|2
881914|NCT00602979|1846978|FG000|Overall Study|Lost to Follow-up|3
881915|NCT00602979|1846979|FG001|Overall Study|Lost to Follow-up|2
881916|NCT00602979|1846980|FG002|Overall Study|Lost to Follow-up|3
881917|NCT00602979|1846981|FG003|Overall Study|Lost to Follow-up|2
881918|NCT00602979|1846982|FG004|Overall Study|Lost to Follow-up|3
881919|NCT00602979|1846978|FG000|Overall Study|Failed Intubation|0
881920|NCT00602979|1846979|FG001|Overall Study|Failed Intubation|1
881921|NCT00602979|1846980|FG002|Overall Study|Failed Intubation|0
881922|NCT00602979|1846981|FG003|Overall Study|Failed Intubation|1
881923|NCT00602979|1846982|FG004|Overall Study|Failed Intubation|0
881924|NCT00603239|1847014|FG000|Overall Study|Adverse Event|4
881925|NCT00603239|1847015|FG001|Overall Study|Adverse Event|1
881926|NCT00603239|1847014|FG000|Overall Study|Entry criteria not met|0
881927|NCT00603239|1847015|FG001|Overall Study|Entry criteria not met|1
881928|NCT00603239|1847014|FG000|Overall Study|Loss of glucose control|3
881929|NCT00603239|1847015|FG001|Overall Study|Loss of glucose control|0
881930|NCT00603239|1847014|FG000|Overall Study|Lost to Follow-up|2
881931|NCT00603239|1847015|FG001|Overall Study|Lost to Follow-up|1
881932|NCT00603239|1847014|FG000|Overall Study|Physician Decision|2
881933|NCT00603239|1847015|FG001|Overall Study|Physician Decision|0
881934|NCT00603239|1847014|FG000|Overall Study|Protocol Violation|2
881935|NCT00603239|1847015|FG001|Overall Study|Protocol Violation|0
881936|NCT00603239|1847014|FG000|Overall Study|Subject decision|2
881937|NCT00603239|1847015|FG001|Overall Study|Subject decision|1
881938|NCT00603265|1847024|FG000|Overall Study|Adverse Event|2
881939|NCT00603265|1847025|FG001|Overall Study|Adverse Event|11
881940|NCT00603265|1847026|FG002|Overall Study|Adverse Event|1
881941|NCT00603265|1847024|FG000|Overall Study|Withdrawal by Subject|1
881942|NCT00603265|1847025|FG001|Overall Study|Withdrawal by Subject|2
881943|NCT00603265|1847026|FG002|Overall Study|Withdrawal by Subject|1
881944|NCT00603265|1847024|FG000|Overall Study|Lack of Efficacy|3
881945|NCT00603265|1847025|FG001|Overall Study|Lack of Efficacy|0
881946|NCT00603265|1847026|FG002|Overall Study|Lack of Efficacy|3
1190096|NCT02256631|2349796|FG005|Overall Study|Withdrawal by Subject|0
1190097|NCT02256631|2349797|FG006|Overall Study|Withdrawal by Subject|1
1190098|NCT02256631|2349791|FG000|Overall Study|Unable to get to clinic|0
1190099|NCT02256631|2349792|FG001|Overall Study|Unable to get to clinic|2
1190100|NCT02256631|2349793|FG002|Overall Study|Unable to get to clinic|0
1190101|NCT02256631|2349794|FG003|Overall Study|Unable to get to clinic|1
1190102|NCT02256631|2349795|FG004|Overall Study|Unable to get to clinic|0
1190103|NCT02256631|2349796|FG005|Overall Study|Unable to get to clinic|1
1190104|NCT02256631|2349797|FG006|Overall Study|Unable to get to clinic|2
1190105|NCT01972217|2349817|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1190106|NCT01972217|2349818|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
1190107|NCT01972217|2349819|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1190108|NCT01972217|2349820|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1190109|NCT01972217|2349817|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
1190110|NCT01972217|2349818|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
1190111|NCT01972217|2349819|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
1190112|NCT01972217|2349820|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
1190113|NCT01972217|2349817|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0
1190114|NCT01972217|2349818|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1
1190115|NCT01972217|2349819|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0
1190116|NCT01972217|2349820|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0
1190117|NCT01972217|2349817|FG000|Part A: Open-label Safety Run-in Period|Death|0
1190118|NCT01972217|2349818|FG001|Part A: Open-label Safety Run-in Period|Death|1
1190119|NCT01972217|2349819|FG002|Part A: Open-label Safety Run-in Period|Death|0
1190120|NCT01972217|2349820|FG003|Part A: Open-label Safety Run-in Period|Death|0
1190121|NCT01972217|2349817|FG000|Part B Double-blind, Randomised Period|Death|0
1190122|NCT01972217|2349818|FG001|Part B Double-blind, Randomised Period|Death|0
1190123|NCT01972217|2349819|FG002|Part B Double-blind, Randomised Period|Death|43
1190124|NCT01972217|2349820|FG003|Part B Double-blind, Randomised Period|Death|44
1190125|NCT01972217|2349817|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0
1190126|NCT01972217|2349818|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0
881947|NCT00603265|1847024|FG000|Overall Study|Lost to Follow-up|0
881948|NCT00603265|1847025|FG001|Overall Study|Lost to Follow-up|1
881949|NCT00603265|1847026|FG002|Overall Study|Lost to Follow-up|0
881950|NCT00603265|1847024|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0
881951|NCT00603265|1847025|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1
881952|NCT00603265|1847026|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0
881953|NCT00603265|1847024|FG000|Overall Study|Participant Left Country, No Responses|0
881954|NCT00603265|1847025|FG001|Overall Study|Participant Left Country, No Responses|1
881955|NCT00603265|1847026|FG002|Overall Study|Participant Left Country, No Responses|0
881956|NCT00603265|1847024|FG000|Overall Study|Protocol Violation|1
881957|NCT00603265|1847025|FG001|Overall Study|Protocol Violation|0
881958|NCT00603265|1847026|FG002|Overall Study|Protocol Violation|0
881959|NCT00603278|1847040|FG000|Overall Study|Lack of Efficacy|35
881960|NCT00603278|1847041|FG001|Overall Study|Lack of Efficacy|10
881961|NCT00603278|1847042|FG002|Overall Study|Lack of Efficacy|11
881962|NCT00603278|1847043|FG003|Overall Study|Lack of Efficacy|8
881963|NCT00603278|1847044|FG004|Overall Study|Lack of Efficacy|7
881964|NCT00603278|1847045|FG005|Overall Study|Lack of Efficacy|14
881965|NCT00603278|1847040|FG000|Overall Study|Adverse Event|0
881966|NCT00603278|1847041|FG001|Overall Study|Adverse Event|3
881967|NCT00603278|1847042|FG002|Overall Study|Adverse Event|1
881968|NCT00603278|1847043|FG003|Overall Study|Adverse Event|0
881969|NCT00603278|1847044|FG004|Overall Study|Adverse Event|2
881970|NCT00603278|1847045|FG005|Overall Study|Adverse Event|1
881971|NCT00603278|1847040|FG000|Overall Study|Withdrawal by Subject|2
881972|NCT00603278|1847041|FG001|Overall Study|Withdrawal by Subject|3
881973|NCT00603278|1847042|FG002|Overall Study|Withdrawal by Subject|1
881974|NCT00603278|1847043|FG003|Overall Study|Withdrawal by Subject|2
881975|NCT00603278|1847044|FG004|Overall Study|Withdrawal by Subject|1
881976|NCT00603278|1847045|FG005|Overall Study|Withdrawal by Subject|2
881977|NCT00603278|1847040|FG000|Overall Study|Protocol Violation|3
881978|NCT00603278|1847041|FG001|Overall Study|Protocol Violation|0
881979|NCT00603278|1847042|FG002|Overall Study|Protocol Violation|1
881980|NCT00603278|1847043|FG003|Overall Study|Protocol Violation|1
881981|NCT00603278|1847044|FG004|Overall Study|Protocol Violation|0
881982|NCT00603278|1847045|FG005|Overall Study|Protocol Violation|1
881983|NCT00603278|1847040|FG000|Overall Study|Physician Decision|0
881984|NCT00603278|1847041|FG001|Overall Study|Physician Decision|1
881985|NCT00603278|1847042|FG002|Overall Study|Physician Decision|0
881986|NCT00603278|1847043|FG003|Overall Study|Physician Decision|0
881987|NCT00603278|1847044|FG004|Overall Study|Physician Decision|2
881988|NCT00603278|1847045|FG005|Overall Study|Physician Decision|1
881989|NCT00603278|1847040|FG000|Overall Study|Lost to Follow-up|1
881990|NCT00603278|1847041|FG001|Overall Study|Lost to Follow-up|0
881991|NCT00603278|1847042|FG002|Overall Study|Lost to Follow-up|0
881992|NCT00603278|1847043|FG003|Overall Study|Lost to Follow-up|0
881993|NCT00603278|1847044|FG004|Overall Study|Lost to Follow-up|1
881994|NCT00603278|1847045|FG005|Overall Study|Lost to Follow-up|0
1190127|NCT01972217|2349819|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1
1190128|NCT01972217|2349820|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0
1190129|NCT01972217|2349817|FG000|Part B Double-blind, Randomised Period|Screen failure|0
1190130|NCT01972217|2349818|FG001|Part B Double-blind, Randomised Period|Screen failure|0
1190131|NCT01972217|2349819|FG002|Part B Double-blind, Randomised Period|Screen failure|0
881995|NCT00603304|1847074|FG000|Overall Study|Lost to Follow-up|5
881996|NCT00603304|1847075|FG001|Overall Study|Lost to Follow-up|7
881997|NCT00603304|1847074|FG000|Overall Study|Withdrawal by Subject|8
881998|NCT00603304|1847075|FG001|Overall Study|Withdrawal by Subject|5
881999|NCT00603304|1847074|FG000|Overall Study|Protocol Violation|1
882000|NCT00603304|1847075|FG001|Overall Study|Protocol Violation|0
882001|NCT00603304|1847074|FG000|Overall Study|Adverse Event|4
882002|NCT00603304|1847075|FG001|Overall Study|Adverse Event|2
882003|NCT00603304|1847074|FG000|Overall Study|Unacceptable Treatment Toxicity|5
882004|NCT00603304|1847075|FG001|Overall Study|Unacceptable Treatment Toxicity|8
882005|NCT00603304|1847074|FG000|Overall Study|Crossed Over to Open Label Therapy|3
882006|NCT00603304|1847075|FG001|Overall Study|Crossed Over to Open Label Therapy|3
882007|NCT00603304|1847074|FG000|Overall Study|Exclusionary Medication|2
882008|NCT00603304|1847075|FG001|Overall Study|Exclusionary Medication|3
882009|NCT00603304|1847074|FG000|Overall Study|Non-Compliant|0
882010|NCT00603304|1847075|FG001|Overall Study|Non-Compliant|1
882011|NCT00603304|1847074|FG000|Overall Study|Moved Away|0
882012|NCT00603304|1847075|FG001|Overall Study|Moved Away|2
882013|NCT00603304|1847074|FG000|Overall Study|Other|2
882014|NCT00603304|1847075|FG001|Overall Study|Other|0
882015|NCT00603304|1847074|FG000|Overall Study|Patient Decision|2
882016|NCT00603304|1847075|FG001|Overall Study|Patient Decision|0
882017|NCT00603382|1847089|FG000|Overall Study|Adverse Event|0
882018|NCT00603382|1847090|FG001|Overall Study|Adverse Event|1
882019|NCT00603382|1847091|FG002|Overall Study|Adverse Event|1
882020|NCT00603382|1847092|FG003|Overall Study|Adverse Event|2
882021|NCT00603382|1847093|FG004|Overall Study|Adverse Event|1
882022|NCT00603382|1847094|FG005|Overall Study|Adverse Event|2
882023|NCT00603382|1847089|FG000|Overall Study|Lack of Efficacy|14
882024|NCT00603382|1847090|FG001|Overall Study|Lack of Efficacy|9
882025|NCT00603382|1847091|FG002|Overall Study|Lack of Efficacy|3
882026|NCT00603382|1847092|FG003|Overall Study|Lack of Efficacy|6
882027|NCT00603382|1847093|FG004|Overall Study|Lack of Efficacy|6
882028|NCT00603382|1847094|FG005|Overall Study|Lack of Efficacy|11
882029|NCT00603382|1847089|FG000|Overall Study|Protocol Violation|1
882030|NCT00603382|1847090|FG001|Overall Study|Protocol Violation|0
882031|NCT00603382|1847091|FG002|Overall Study|Protocol Violation|1
882032|NCT00603382|1847092|FG003|Overall Study|Protocol Violation|2
882033|NCT00603382|1847093|FG004|Overall Study|Protocol Violation|1
882034|NCT00603382|1847094|FG005|Overall Study|Protocol Violation|0
882035|NCT00603382|1847089|FG000|Overall Study|Lost to Follow-up|0
882036|NCT00603382|1847090|FG001|Overall Study|Lost to Follow-up|1
882037|NCT00603382|1847091|FG002|Overall Study|Lost to Follow-up|1
882038|NCT00603382|1847092|FG003|Overall Study|Lost to Follow-up|1
882039|NCT00603382|1847093|FG004|Overall Study|Lost to Follow-up|0
882040|NCT00603382|1847094|FG005|Overall Study|Lost to Follow-up|1
882041|NCT00603382|1847089|FG000|Overall Study|Physician Decision|0
882042|NCT00603382|1847090|FG001|Overall Study|Physician Decision|0
882043|NCT00603382|1847091|FG002|Overall Study|Physician Decision|2
882044|NCT00603382|1847092|FG003|Overall Study|Physician Decision|0
882045|NCT00603382|1847093|FG004|Overall Study|Physician Decision|1
882046|NCT00603382|1847094|FG005|Overall Study|Physician Decision|3
882047|NCT00603382|1847089|FG000|Overall Study|Withdrawal by Subject|3
882048|NCT00603382|1847090|FG001|Overall Study|Withdrawal by Subject|3
882049|NCT00603382|1847091|FG002|Overall Study|Withdrawal by Subject|1
882050|NCT00603382|1847092|FG003|Overall Study|Withdrawal by Subject|1
882051|NCT00603382|1847093|FG004|Overall Study|Withdrawal by Subject|0
882052|NCT00603382|1847094|FG005|Overall Study|Withdrawal by Subject|1
882053|NCT00603447|1847120|FG000|Overall Study|Adverse Event|0
882054|NCT00603447|1847121|FG001|Overall Study|Adverse Event|1
882055|NCT00603447|1847122|FG002|Overall Study|Adverse Event|1
882056|NCT00603447|1847123|FG003|Overall Study|Adverse Event|2
882057|NCT00603447|1847124|FG004|Overall Study|Adverse Event|1
882058|NCT00603447|1847125|FG005|Overall Study|Adverse Event|2
882059|NCT00603447|1847126|FG006|Overall Study|Adverse Event|10
882060|NCT00603447|1847120|FG000|Overall Study|Other|0
882061|NCT00603447|1847121|FG001|Overall Study|Other|0
882062|NCT00603447|1847122|FG002|Overall Study|Other|1
882063|NCT00603447|1847123|FG003|Overall Study|Other|0
882064|NCT00603447|1847124|FG004|Overall Study|Other|3
882065|NCT00603447|1847125|FG005|Overall Study|Other|0
882066|NCT00603447|1847126|FG006|Overall Study|Other|13
882067|NCT00603447|1847120|FG000|Overall Study|Withdrew Consent|0
882068|NCT00603447|1847121|FG001|Overall Study|Withdrew Consent|2
882069|NCT00603447|1847122|FG002|Overall Study|Withdrew Consent|0
882070|NCT00603447|1847123|FG003|Overall Study|Withdrew Consent|0
882071|NCT00603447|1847124|FG004|Overall Study|Withdrew Consent|1
882072|NCT00603447|1847125|FG005|Overall Study|Withdrew Consent|0
882073|NCT00603447|1847126|FG006|Overall Study|Withdrew Consent|1
882074|NCT00603473|1847142|FG000|Overall Study|Adverse Event|4
882075|NCT00603473|1847142|FG000|Overall Study|Lack of Efficacy|4
1190132|NCT01972217|2349820|FG003|Part B Double-blind, Randomised Period|Screen failure|1
1190133|NCT01972217|2349817|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0
1190134|NCT01972217|2349818|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0
882076|NCT00603473|1847142|FG000|Overall Study|Protocol Violation|1
882077|NCT00603512|1847151|FG000|Overall Study|Adverse Event|0
882078|NCT00603512|1847152|FG001|Overall Study|Adverse Event|2
882079|NCT00603512|1847153|FG002|Overall Study|Adverse Event|4
882080|NCT00603512|1847154|FG003|Overall Study|Adverse Event|4
882081|NCT00603512|1847155|FG004|Overall Study|Adverse Event|2
882082|NCT00603512|1847151|FG000|Overall Study|Lack of Efficacy|0
882083|NCT00603512|1847152|FG001|Overall Study|Lack of Efficacy|1
882084|NCT00603512|1847153|FG002|Overall Study|Lack of Efficacy|0
882085|NCT00603512|1847154|FG003|Overall Study|Lack of Efficacy|0
882086|NCT00603512|1847155|FG004|Overall Study|Lack of Efficacy|1
882087|NCT00603512|1847151|FG000|Overall Study|Other|2
882088|NCT00603512|1847152|FG001|Overall Study|Other|1
882089|NCT00603512|1847153|FG002|Overall Study|Other|0
882090|NCT00603512|1847154|FG003|Overall Study|Other|1
882091|NCT00603512|1847155|FG004|Overall Study|Other|1
882092|NCT00603512|1847151|FG000|Overall Study|Withdrawal by Subject|0
882093|NCT00603512|1847152|FG001|Overall Study|Withdrawal by Subject|0
882094|NCT00603512|1847153|FG002|Overall Study|Withdrawal by Subject|0
882095|NCT00603512|1847154|FG003|Overall Study|Withdrawal by Subject|0
882096|NCT00603512|1847155|FG004|Overall Study|Withdrawal by Subject|1
882097|NCT00603512|1847151|FG000|Overall Study|Randomized but not treated|0
882098|NCT00603512|1847152|FG001|Overall Study|Randomized but not treated|1
882099|NCT00603512|1847153|FG002|Overall Study|Randomized but not treated|1
882100|NCT00603512|1847154|FG003|Overall Study|Randomized but not treated|2
882101|NCT00603512|1847155|FG004|Overall Study|Randomized but not treated|0
882102|NCT00603525|1847169|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3
882103|NCT00603525|1847170|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9
882104|NCT00603525|1847171|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
882105|NCT00603525|1847169|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
882106|NCT00603525|1847170|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
882107|NCT00603525|1847171|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
882108|NCT00603525|1847169|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1
882109|NCT00603525|1847170|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2
882110|NCT00603525|1847171|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
882111|NCT00603525|1847169|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
882112|NCT00603525|1847170|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
882113|NCT00603525|1847171|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
882114|NCT00603525|1847169|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
882115|NCT00603525|1847170|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
882116|NCT00603525|1847171|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
882117|NCT00603525|1847169|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0
882118|NCT00603525|1847170|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1
882119|NCT00603525|1847171|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0
882120|NCT00603525|1847169|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
882121|NCT00603525|1847170|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
882122|NCT00603525|1847171|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
882123|NCT00603525|1847169|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
882124|NCT00603525|1847170|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12
882125|NCT00603525|1847171|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
882126|NCT00603525|1847169|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
882127|NCT00603525|1847170|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
882128|NCT00603525|1847171|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
882129|NCT00603525|1847169|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
882130|NCT00603525|1847170|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1
882131|NCT00603525|1847171|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
882132|NCT00603525|1847169|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
882133|NCT00603525|1847170|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
882134|NCT00603525|1847171|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
882135|NCT00603525|1847169|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
882136|NCT00603525|1847170|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
882137|NCT00603525|1847171|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
882138|NCT00603525|1847169|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
882139|NCT00603525|1847170|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2
882140|NCT00603525|1847171|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
882141|NCT00603525|1847169|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
882142|NCT00603525|1847170|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
882143|NCT00603525|1847171|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
882144|NCT00603525|1847169|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
882145|NCT00603525|1847170|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
882146|NCT00603525|1847171|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
882147|NCT00603538|1847185|FG000|Overall Study|Adverse Event|0
882148|NCT00603538|1847186|FG001|Overall Study|Adverse Event|4
1190135|NCT01972217|2349819|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2
1190136|NCT01972217|2349820|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1
1190137|NCT01972217|2349817|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1190138|NCT01972217|2349818|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1190139|NCT01972217|2349819|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1190140|NCT01972217|2349820|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
1190141|NCT01816165|2349834|FG000|Overall Study|Adverse Event|1
1190142|NCT01816165|2349835|FG001|Overall Study|Adverse Event|0
1190143|NCT01816165|2349836|FG002|Overall Study|Adverse Event|0
1190144|NCT01816165|2349837|FG003|Overall Study|Adverse Event|0
1190145|NCT01813929|2349859|FG000|Overall Study|Withdrawal by Subject|0
1190146|NCT01813929|2349860|FG001|Overall Study|Withdrawal by Subject|1
1190169|NCT00882050|2349890|FG000|Overall Study|Physician Decision|1
1190170|NCT00882050|2349891|FG001|Overall Study|Physician Decision|0
1190171|NCT00882050|2349892|FG002|Overall Study|Physician Decision|0
1190172|NCT00070564|2349906|FG000|Overall Study|Progression|2
1190173|NCT00070564|2349907|FG001|Overall Study|Progression|4
1190174|NCT00070564|2349908|FG002|Overall Study|Progression|7
1190175|NCT00070564|2349909|FG003|Overall Study|Progression|7
1190176|NCT00070564|2349910|FG004|Overall Study|Progression|1
1190177|NCT00070564|2349911|FG005|Overall Study|Progression|0
1190178|NCT00070564|2349906|FG000|Overall Study|Delinquent|1
1190179|NCT00070564|2349907|FG001|Overall Study|Delinquent|4
1190180|NCT00070564|2349908|FG002|Overall Study|Delinquent|2
1190181|NCT00070564|2349909|FG003|Overall Study|Delinquent|0
1190182|NCT00070564|2349910|FG004|Overall Study|Delinquent|0
1190183|NCT00070564|2349911|FG005|Overall Study|Delinquent|0
1190184|NCT00070564|2349906|FG000|Overall Study|Adverse Event|150
1190185|NCT00070564|2349907|FG001|Overall Study|Adverse Event|142
1190186|NCT00070564|2349908|FG002|Overall Study|Adverse Event|120
1190187|NCT00070564|2349909|FG003|Overall Study|Adverse Event|108
1190188|NCT00070564|2349910|FG004|Overall Study|Adverse Event|63
1190189|NCT00070564|2349911|FG005|Overall Study|Adverse Event|36
1190190|NCT00070564|2349906|FG000|Overall Study|Death|4
1190191|NCT00070564|2349907|FG001|Overall Study|Death|1
1190192|NCT00070564|2349908|FG002|Overall Study|Death|5
1190193|NCT00070564|2349909|FG003|Overall Study|Death|3
882149|NCT00603538|1847187|FG002|Overall Study|Adverse Event|2
882150|NCT00603538|1847185|FG000|Overall Study|Objective progression or relapse|3
882151|NCT00603538|1847186|FG001|Overall Study|Objective progression or relapse|0
882152|NCT00603538|1847187|FG002|Overall Study|Objective progression or relapse|0
882153|NCT00603590|1847209|FG000|Overall Study|Did not attend study clinic|39
882154|NCT00603590|1847210|FG001|Overall Study|Did not attend study clinic|30
882155|NCT00603590|1847209|FG000|Overall Study|Refused blood test|5
882156|NCT00603590|1847210|FG001|Overall Study|Refused blood test|1
882157|NCT00603590|1847209|FG000|Overall Study|Patient discontinued study drug|22
882158|NCT00603590|1847210|FG001|Overall Study|Patient discontinued study drug|15
882159|NCT00603590|1847209|FG000|Overall Study|Adverse Event|2
882160|NCT00603590|1847210|FG001|Overall Study|Adverse Event|0
1190194|NCT00070564|2349910|FG004|Overall Study|Death|0
1190195|NCT00070564|2349911|FG005|Overall Study|Death|1
1190196|NCT00070564|2349906|FG000|Overall Study|Other, not protocol specified|17
1190197|NCT00070564|2349907|FG001|Overall Study|Other, not protocol specified|15
1190198|NCT00070564|2349908|FG002|Overall Study|Other, not protocol specified|14
1190199|NCT00070564|2349909|FG003|Overall Study|Other, not protocol specified|19
1190200|NCT00070564|2349910|FG004|Overall Study|Other, not protocol specified|6
1190201|NCT00070564|2349911|FG005|Overall Study|Other, not protocol specified|7
1190202|NCT00070564|2349906|FG000|Overall Study|Withdrawal by Subject|26
1190203|NCT00070564|2349907|FG001|Overall Study|Withdrawal by Subject|37
1190204|NCT00070564|2349908|FG002|Overall Study|Withdrawal by Subject|23
1190205|NCT00070564|2349909|FG003|Overall Study|Withdrawal by Subject|30
1190206|NCT00070564|2349910|FG004|Overall Study|Withdrawal by Subject|8
1190207|NCT00070564|2349911|FG005|Overall Study|Withdrawal by Subject|8
1190208|NCT00070564|2349906|FG000|Overall Study|Not reported|0
1190209|NCT00070564|2349907|FG001|Overall Study|Not reported|0
1190210|NCT00070564|2349908|FG002|Overall Study|Not reported|0
1190211|NCT00070564|2349909|FG003|Overall Study|Not reported|0
1190212|NCT00070564|2349910|FG004|Overall Study|Not reported|1
1190213|NCT00070564|2349911|FG005|Overall Study|Not reported|0
1190214|NCT04425720|2349951|FG000|Overall Study|Withdrawal by Subject|0
1190215|NCT04425720|2349952|FG001|Overall Study|Withdrawal by Subject|20
1190216|NCT04409509|2349961|FG000|Overall Study|Failure to meet randomization requirement|1
1190217|NCT04409509|2349962|FG001|Overall Study|Failure to meet randomization requirement|0
1190218|NCT04409509|2349961|FG000|Overall Study|Adverse Event|0
1190219|NCT04409509|2349962|FG001|Overall Study|Adverse Event|1
1190220|NCT04409509|2349961|FG000|Overall Study|Death|11
1190221|NCT04409509|2349962|FG001|Overall Study|Death|10
1190222|NCT04409509|2349961|FG000|Overall Study|Non-compliance with study drug|0
1190223|NCT04409509|2349962|FG001|Overall Study|Non-compliance with study drug|1
1190224|NCT04409509|2349961|FG000|Overall Study|Lost to Follow-up|0
1190225|NCT04409509|2349962|FG001|Overall Study|Lost to Follow-up|3
1190226|NCT04409509|2349961|FG000|Overall Study|Withdrawal by Subject|0
1190227|NCT04409509|2349962|FG001|Overall Study|Withdrawal by Subject|3
1190228|NCT04409509|2349961|FG000|Overall Study|Randomized by mistake|0
1190229|NCT04409509|2349962|FG001|Overall Study|Randomized by mistake|1
1190230|NCT04409509|2349961|FG000|Overall Study|Other|1
1190231|NCT04409509|2349962|FG001|Overall Study|Other|1
1190232|NCT04380519|2349972|FG000|Overall Study|Withdrawal by Subject|4
1190233|NCT04380519|2349973|FG001|Overall Study|Withdrawal by Subject|0
1190234|NCT04380519|2349974|FG002|Overall Study|Withdrawal by Subject|1
1190235|NCT04380519|2349972|FG000|Overall Study|Death|14
1190236|NCT04380519|2349973|FG001|Overall Study|Death|9
1190237|NCT04380519|2349974|FG002|Overall Study|Death|6
1190238|NCT04380519|2349972|FG000|Overall Study|Adverse Event|0
1190239|NCT04380519|2349973|FG001|Overall Study|Adverse Event|1
1190240|NCT04380519|2349974|FG002|Overall Study|Adverse Event|0
1190241|NCT04380519|2349972|FG000|Overall Study|relatives' decision|0
1190242|NCT04380519|2349973|FG001|Overall Study|relatives' decision|1
1190243|NCT04380519|2349974|FG002|Overall Study|relatives' decision|0
1190244|NCT04362813|2349984|FG000|Overall Study|Death|12
1190245|NCT04362813|2349985|FG001|Overall Study|Death|16
1190246|NCT04362813|2349984|FG000|Overall Study|Withdrawal by Subject|3
1190247|NCT04362813|2349985|FG001|Overall Study|Withdrawal by Subject|1
1190248|NCT04362813|2349984|FG000|Overall Study|Protocol Violation|0
1190249|NCT04362813|2349985|FG001|Overall Study|Protocol Violation|3
1190250|NCT04362813|2349984|FG000|Overall Study|Lost to Follow-up|1
1190251|NCT04362813|2349985|FG001|Overall Study|Lost to Follow-up|1
1190252|NCT04362813|2349984|FG000|Overall Study|Enrolled but did not receive treatment|2
1190253|NCT04362813|2349985|FG001|Overall Study|Enrolled but did not receive treatment|4
1190254|NCT03922321|2350047|FG000|Overall Study|Participant Moved|1
1190255|NCT03922321|2350047|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1
1190256|NCT03911713|2350056|FG000|Overall Study|Lost to Follow-up|0
1190257|NCT03911713|2350057|FG001|Overall Study|Lost to Follow-up|2
1190258|NCT03911713|2350058|FG002|Overall Study|Lost to Follow-up|0
1190259|NCT03911713|2350059|FG003|Overall Study|Lost to Follow-up|0
1190260|NCT03911713|2350060|FG004|Overall Study|Lost to Follow-up|0
1190261|NCT03911713|2350056|FG000|Overall Study|Other|0
1190262|NCT03911713|2350057|FG001|Overall Study|Other|0
1190263|NCT03911713|2350058|FG002|Overall Study|Other|0
1190264|NCT03911713|2350059|FG003|Overall Study|Other|1
1190265|NCT03911713|2350060|FG004|Overall Study|Other|0
1190266|NCT03911713|2350056|FG000|Overall Study|Randomized, Never Dosed|1
1190267|NCT03911713|2350057|FG001|Overall Study|Randomized, Never Dosed|0
1190268|NCT03911713|2350058|FG002|Overall Study|Randomized, Never Dosed|0
1190269|NCT03911713|2350059|FG003|Overall Study|Randomized, Never Dosed|1
1190270|NCT03911713|2350060|FG004|Overall Study|Randomized, Never Dosed|0
1190271|NCT03875092|2350085|FG000|Overall Study|Adverse Event|2
1190272|NCT03875092|2350086|FG001|Overall Study|Adverse Event|5
1190273|NCT03875092|2350085|FG000|Overall Study|Death|28
1190274|NCT03875092|2350086|FG001|Overall Study|Death|41
1190275|NCT03875092|2350085|FG000|Overall Study|Ongoing in Study|35
1190276|NCT03875092|2350086|FG001|Overall Study|Ongoing in Study|14
1190277|NCT03852459|2350094|FG000|Overall Study|Adverse Event|2
1190278|NCT03852459|2350095|FG001|Overall Study|Adverse Event|2
1190279|NCT03852459|2350094|FG000|Overall Study|Withdrawal by Subject|1
1190280|NCT03852459|2350095|FG001|Overall Study|Withdrawal by Subject|1
1190281|NCT03740919|2350104|FG000|Lead-in Period|Lost to Follow-up|1
1190282|NCT03740919|2350105|FG001|Lead-in Period|Lost to Follow-up|0
1190283|NCT03740919|2350106|FG002|Lead-in Period|Lost to Follow-up|0
1190284|NCT03740919|2350107|FG003|Lead-in Period|Lost to Follow-up|0
1190285|NCT03740919|2350104|FG000|Lead-in Period|Physician Decision|2
1190286|NCT03740919|2350105|FG001|Lead-in Period|Physician Decision|0
1190287|NCT03740919|2350106|FG002|Lead-in Period|Physician Decision|0
1190288|NCT03740919|2350107|FG003|Lead-in Period|Physician Decision|0
1190289|NCT03740919|2350104|FG000|Lead-in Period|Protocol Violation|1
1190290|NCT03740919|2350105|FG001|Lead-in Period|Protocol Violation|0
1190291|NCT03740919|2350106|FG002|Lead-in Period|Protocol Violation|0
1190292|NCT03740919|2350107|FG003|Lead-in Period|Protocol Violation|0
1190293|NCT03740919|2350104|FG000|Lead-in Period|Withdrawal by Subject|10
1190294|NCT03740919|2350105|FG001|Lead-in Period|Withdrawal by Subject|0
1190295|NCT03740919|2350106|FG002|Lead-in Period|Withdrawal by Subject|0
1190296|NCT03740919|2350107|FG003|Lead-in Period|Withdrawal by Subject|0
1190297|NCT03740919|2350104|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18
1190298|NCT03740919|2350105|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
1190299|NCT03740919|2350106|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
1190300|NCT03740919|2350107|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
1190301|NCT03740919|2350104|FG000|Lead-in Period|Study Task Too Burdensome|1
1190302|NCT03740919|2350105|FG001|Lead-in Period|Study Task Too Burdensome|0
1190303|NCT03740919|2350106|FG002|Lead-in Period|Study Task Too Burdensome|0
1190304|NCT03740919|2350107|FG003|Lead-in Period|Study Task Too Burdensome|0
1190305|NCT03740919|2350104|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1
1190306|NCT03740919|2350105|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
1190307|NCT03740919|2350106|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
1190308|NCT03740919|2350107|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
1190309|NCT03740919|2350104|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1
1190310|NCT03740919|2350105|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0
1190311|NCT03740919|2350106|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0
1190312|NCT03740919|2350107|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0
1190313|NCT03740919|2350104|FG000|Treatment Period|Adverse Event|0
1190314|NCT03740919|2350105|FG001|Treatment Period|Adverse Event|0
1190315|NCT03740919|2350106|FG002|Treatment Period|Adverse Event|2
1190316|NCT03740919|2350107|FG003|Treatment Period|Adverse Event|0
1190317|NCT03740919|2350104|FG000|Treatment Period|Protocol Violation|0
1190318|NCT03740919|2350105|FG001|Treatment Period|Protocol Violation|1
1190319|NCT03740919|2350106|FG002|Treatment Period|Protocol Violation|0
1190320|NCT03740919|2350107|FG003|Treatment Period|Protocol Violation|0
1190321|NCT03740919|2350104|FG000|Treatment Period|Withdrawal by Subject|0
1190322|NCT03740919|2350105|FG001|Treatment Period|Withdrawal by Subject|7
1190323|NCT03740919|2350106|FG002|Treatment Period|Withdrawal by Subject|6
1190324|NCT03740919|2350107|FG003|Treatment Period|Withdrawal by Subject|2
1190325|NCT03740919|2350104|FG000|Treatment Period|Terminated by Sponsor|0
1190326|NCT03740919|2350105|FG001|Treatment Period|Terminated by Sponsor|1
1190327|NCT03740919|2350106|FG002|Treatment Period|Terminated by Sponsor|0
1190328|NCT03740919|2350107|FG003|Treatment Period|Terminated by Sponsor|0
1190329|NCT03740919|2350104|FG000|Treatment Period|Issue with Insulin Pump|0
1190330|NCT03740919|2350105|FG001|Treatment Period|Issue with Insulin Pump|1
1190331|NCT03740919|2350106|FG002|Treatment Period|Issue with Insulin Pump|0
1190332|NCT03740919|2350107|FG003|Treatment Period|Issue with Insulin Pump|0
1190333|NCT03740919|2350104|FG000|Treatment Period|Due to COVID-19 Pandemic|0
1190334|NCT03740919|2350105|FG001|Treatment Period|Due to COVID-19 Pandemic|0
1190335|NCT03740919|2350106|FG002|Treatment Period|Due to COVID-19 Pandemic|3
1190336|NCT03740919|2350107|FG003|Treatment Period|Due to COVID-19 Pandemic|1
1190337|NCT03740919|2350104|FG000|Treatment Period|Failure of Inclusion Criteria|0
1190338|NCT03740919|2350105|FG001|Treatment Period|Failure of Inclusion Criteria|0
1190339|NCT03740919|2350106|FG002|Treatment Period|Failure of Inclusion Criteria|1
1190340|NCT03740919|2350107|FG003|Treatment Period|Failure of Inclusion Criteria|0
1190341|NCT03740919|2350104|FG000|Treatment Period|Not Completing Diary|0
1190342|NCT03740919|2350105|FG001|Treatment Period|Not Completing Diary|0
1190343|NCT03740919|2350106|FG002|Treatment Period|Not Completing Diary|1
1190344|NCT03740919|2350107|FG003|Treatment Period|Not Completing Diary|0
1190345|NCT03740919|2350104|FG000|Treatment Period|Insulin Painful to Participant|0
1190346|NCT03740919|2350105|FG001|Treatment Period|Insulin Painful to Participant|0
1190347|NCT03740919|2350106|FG002|Treatment Period|Insulin Painful to Participant|1
1190348|NCT03740919|2350107|FG003|Treatment Period|Insulin Painful to Participant|0
1190350|NCT03647488|2350159|FG000|Overall Study|Progressive disease|10
1190351|NCT03647488|2350160|FG001|Overall Study|Progressive disease|0
1190352|NCT03647488|2350161|FG002|Overall Study|Progressive disease|0
1190353|NCT03647488|2350159|FG000|Overall Study|Adverse Event|5
1190354|NCT03647488|2350160|FG001|Overall Study|Adverse Event|0
1190355|NCT03647488|2350161|FG002|Overall Study|Adverse Event|0
1190356|NCT03647488|2350159|FG000|Overall Study|Clinical progression|2
1190357|NCT03647488|2350160|FG001|Overall Study|Clinical progression|0
1190358|NCT03647488|2350161|FG002|Overall Study|Clinical progression|0
1190359|NCT03647488|2350159|FG000|Overall Study|Participant refused to take investigational product|1
1190360|NCT03647488|2350160|FG001|Overall Study|Participant refused to take investigational product|0
1190361|NCT03647488|2350161|FG002|Overall Study|Participant refused to take investigational product|0
1190362|NCT03614923|2350170|FG000|Overall Study|Withdrawal by Subject|2
1190363|NCT03614923|2350171|FG001|Overall Study|Withdrawal by Subject|1
1190364|NCT03614923|2350172|FG002|Overall Study|Withdrawal by Subject|1
1190365|NCT03614923|2350170|FG000|Overall Study|Adverse Event|0
1190366|NCT03614923|2350171|FG001|Overall Study|Adverse Event|2
1190367|NCT03614923|2350172|FG002|Overall Study|Adverse Event|1
1190368|NCT03614923|2350170|FG000|Overall Study|Lost to Follow-up|1
1190369|NCT03614923|2350171|FG001|Overall Study|Lost to Follow-up|0
1190370|NCT03614923|2350172|FG002|Overall Study|Lost to Follow-up|1
1190371|NCT03614923|2350170|FG000|Overall Study|Lack of Efficacy|2
1190372|NCT03614923|2350171|FG001|Overall Study|Lack of Efficacy|0
1190373|NCT03614923|2350172|FG002|Overall Study|Lack of Efficacy|1
1190374|NCT03614923|2350170|FG000|Overall Study|Non-compliance|0
1190375|NCT03614923|2350171|FG001|Overall Study|Non-compliance|1
1190376|NCT03614923|2350172|FG002|Overall Study|Non-compliance|0
1190377|NCT03614923|2350170|FG000|Overall Study|Other|0
1190378|NCT03614923|2350171|FG001|Overall Study|Other|1
1190379|NCT03614923|2350172|FG002|Overall Study|Other|1
1190380|NCT03517540|2350184|FG000|Overall Study|Protocol Violation|2
1190381|NCT03517540|2350185|FG001|Overall Study|Protocol Violation|0
1190382|NCT03517540|2350186|FG002|Overall Study|Protocol Violation|0
1190383|NCT03517540|2350187|FG003|Overall Study|Protocol Violation|1
1190384|NCT03517540|2350184|FG000|Overall Study|Adverse Event|9
1190385|NCT03517540|2350185|FG001|Overall Study|Adverse Event|3
1190386|NCT03517540|2350186|FG002|Overall Study|Adverse Event|8
1190387|NCT03517540|2350187|FG003|Overall Study|Adverse Event|1
1190388|NCT03517540|2350184|FG000|Overall Study|Withdrawal by Subject|3
1190389|NCT03517540|2350185|FG001|Overall Study|Withdrawal by Subject|4
1190390|NCT03517540|2350186|FG002|Overall Study|Withdrawal by Subject|1
1190391|NCT03517540|2350187|FG003|Overall Study|Withdrawal by Subject|3
1190392|NCT03502187|2350200|FG000|Overall Study|Withdrawal by Subject|4
1190393|NCT03502187|2350201|FG001|Overall Study|Withdrawal by Subject|3
1190394|NCT03502187|2350202|FG002|Overall Study|Withdrawal by Subject|3
1190395|NCT03502187|2350200|FG000|Overall Study|Lost to Follow-up|5
1190396|NCT03502187|2350201|FG001|Overall Study|Lost to Follow-up|4
1190397|NCT03502187|2350202|FG002|Overall Study|Lost to Follow-up|5
1190398|NCT03447262|2350210|FG000|Overall Study|Adverse Event|7
1190399|NCT03447262|2350210|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
1190400|NCT03447262|2350210|FG000|Overall Study|Commercial Drug is Available for Participant|9
1190401|NCT03447262|2350210|FG000|Overall Study|Death|2
1190402|NCT03447262|2350210|FG000|Overall Study|Study Termination by Sponsor|455
1190403|NCT03447262|2350210|FG000|Overall Study|Other|4
1190404|NCT03432819|2350219|FG000|Overall Study|Lost to Follow-up|2
1190405|NCT03432819|2350220|FG001|Overall Study|Lost to Follow-up|2
1190406|NCT03432819|2350219|FG000|Overall Study|Withdrawal by Subject|5
1190407|NCT03432819|2350220|FG001|Overall Study|Withdrawal by Subject|3
1190408|NCT03365791|2350226|FG000|Overall Study|Adverse Event|5
1190409|NCT03365791|2350226|FG000|Overall Study|Death|1
1190410|NCT03365791|2350226|FG000|Overall Study|Lost to Follow-up|1
1190411|NCT03365791|2350226|FG000|Overall Study|Physician Decision|9
1190412|NCT03365791|2350226|FG000|Overall Study|Progressive disease|51
1190413|NCT03365791|2350226|FG000|Overall Study|Subject/guardian decision|5
1190414|NCT03323749|2350233|FG000|Double-blind Period|Lost to Follow-up|4
1190415|NCT03323749|2350234|FG001|Double-blind Period|Lost to Follow-up|5
1190416|NCT03323749|2350233|FG000|Double-blind Period|Adverse Event|3
1190417|NCT03323749|2350234|FG001|Double-blind Period|Adverse Event|1
1190418|NCT03323749|2350233|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83
1190419|NCT03323749|2350234|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88
1190420|NCT03323749|2350233|FG000|Open-Label Period|Adverse Event|3
1190421|NCT03323749|2350234|FG001|Open-Label Period|Adverse Event|10
1190422|NCT03323749|2350233|FG000|Open-Label Period|Withdrawal by Subject|7
1190423|NCT03323749|2350234|FG001|Open-Label Period|Withdrawal by Subject|5
1190424|NCT03322566|2350247|FG000|Overall Study|Death|34
1190425|NCT03322566|2350248|FG001|Overall Study|Death|35
1190426|NCT03322566|2350249|FG002|Overall Study|Death|23
1190427|NCT03322566|2350247|FG000|Overall Study|Physician Decision|6
1190428|NCT03322566|2350248|FG001|Overall Study|Physician Decision|7
1190429|NCT03322566|2350249|FG002|Overall Study|Physician Decision|2
1190430|NCT03322566|2350247|FG000|Overall Study|Withdrawal by Subject|4
1190431|NCT03322566|2350248|FG001|Overall Study|Withdrawal by Subject|3
1190432|NCT03322566|2350249|FG002|Overall Study|Withdrawal by Subject|6
1190433|NCT03322566|2350247|FG000|Overall Study|Lost to Follow-up|0
1190434|NCT03322566|2350248|FG001|Overall Study|Lost to Follow-up|0
1190435|NCT03322566|2350249|FG002|Overall Study|Lost to Follow-up|1
1190436|NCT03322566|2350247|FG000|Overall Study|Study terminated by sponsor|1
1190437|NCT03322566|2350248|FG001|Overall Study|Study terminated by sponsor|0
1190438|NCT03322566|2350249|FG002|Overall Study|Study terminated by sponsor|1
1190439|NCT03322540|2350259|FG000|Overall Study|Death|21
1190440|NCT03322540|2350260|FG001|Overall Study|Death|28
1190441|NCT03322540|2350259|FG000|Overall Study|Lost to Follow-up|0
1190442|NCT03322540|2350260|FG001|Overall Study|Lost to Follow-up|1
1190443|NCT03322540|2350259|FG000|Overall Study|Physician Decision|7
1190444|NCT03322540|2350260|FG001|Overall Study|Physician Decision|6
1190445|NCT03322540|2350259|FG000|Overall Study|Withdrawal by Subject|3
1190446|NCT03322540|2350260|FG001|Overall Study|Withdrawal by Subject|1
1190447|NCT03322540|2350259|FG000|Overall Study|Study terminated by sponsor|0
1190448|NCT03322540|2350260|FG001|Overall Study|Study terminated by sponsor|1
1190449|NCT03318003|2350270|FG000|Overall Study|Withdrawal by Subject|1
1190450|NCT03318003|2350271|FG001|Overall Study|Withdrawal by Subject|1
1190451|NCT03318003|2350270|FG000|Overall Study|fetal loss|0
1190452|NCT03318003|2350271|FG001|Overall Study|fetal loss|1
1190453|NCT03189719|2350297|FG000|Overall Study|Death|260
1190454|NCT03189719|2350298|FG001|Overall Study|Death|308
1190455|NCT03189719|2350297|FG000|Overall Study|Withdrawal by Subject|5
1190456|NCT03189719|2350298|FG001|Overall Study|Withdrawal by Subject|3
1190457|NCT03189719|2350297|FG000|Overall Study|Ongoing in Study|108
1190458|NCT03189719|2350298|FG001|Overall Study|Ongoing in Study|65
1190459|NCT03155997|2350306|FG000|Overall Study|Withdrawal by Subject|119
1190460|NCT03155997|2350307|FG001|Overall Study|Withdrawal by Subject|134
1190461|NCT03155997|2350306|FG000|Overall Study|Lost to Follow-up|12
1190462|NCT03155997|2350307|FG001|Overall Study|Lost to Follow-up|13
1190463|NCT03155997|2350306|FG000|Overall Study|Missing disposition data|0
1190464|NCT03155997|2350307|FG001|Overall Study|Missing disposition data|1
1190465|NCT03155997|2350306|FG000|Overall Study|On study treatment|2027
1190466|NCT03155997|2350307|FG001|Overall Study|On study treatment|2074
1190467|NCT03104400|2350317|FG000|Overall Study|Adverse Event|5
1190468|NCT03104400|2350318|FG001|Overall Study|Adverse Event|7
1190469|NCT03104400|2350319|FG002|Overall Study|Adverse Event|11
1190470|NCT03104400|2350320|FG003|Overall Study|Adverse Event|9
1190471|NCT03104400|2350321|FG004|Overall Study|Adverse Event|21
1190472|NCT03104400|2350317|FG000|Overall Study|Withdrawal by Subject|17
1190473|NCT03104400|2350318|FG001|Overall Study|Withdrawal by Subject|19
1190474|NCT03104400|2350319|FG002|Overall Study|Withdrawal by Subject|29
1190475|NCT03104400|2350320|FG003|Overall Study|Withdrawal by Subject|25
1190476|NCT03104400|2350321|FG004|Overall Study|Withdrawal by Subject|24
1190477|NCT03104400|2350317|FG000|Overall Study|Lost to Follow-up|4
1190478|NCT03104400|2350318|FG001|Overall Study|Lost to Follow-up|1
1190479|NCT03104400|2350319|FG002|Overall Study|Lost to Follow-up|4
1190480|NCT03104400|2350320|FG003|Overall Study|Lost to Follow-up|8
1190481|NCT03104400|2350321|FG004|Overall Study|Lost to Follow-up|7
1190482|NCT03104400|2350317|FG000|Overall Study|Lack of Efficacy|6
1190483|NCT03104400|2350318|FG001|Overall Study|Lack of Efficacy|3
1190484|NCT03104400|2350319|FG002|Overall Study|Lack of Efficacy|8
1190485|NCT03104400|2350320|FG003|Overall Study|Lack of Efficacy|2
1190486|NCT03104400|2350321|FG004|Overall Study|Lack of Efficacy|1
1190487|NCT03104400|2350317|FG000|Overall Study|COVID Logistical Restrictions|0
1190488|NCT03104400|2350318|FG001|Overall Study|COVID Logistical Restrictions|0
1190489|NCT03104400|2350319|FG002|Overall Study|COVID Logistical Restrictions|0
1190490|NCT03104400|2350320|FG003|Overall Study|COVID Logistical Restrictions|1
1190491|NCT03104400|2350321|FG004|Overall Study|COVID Logistical Restrictions|0
1190492|NCT03104400|2350317|FG000|Overall Study|Other|2
1190493|NCT03104400|2350318|FG001|Overall Study|Other|3
1190494|NCT03104400|2350319|FG002|Overall Study|Other|7
1190495|NCT03104400|2350320|FG003|Overall Study|Other|6
1190496|NCT03104400|2350321|FG004|Overall Study|Other|4
1190497|NCT03104400|2350317|FG000|Overall Study|Other|0
1190498|NCT03104400|2350318|FG001|Overall Study|Other|1
1190499|NCT03104400|2350319|FG002|Overall Study|Other|0
1190500|NCT03104400|2350320|FG003|Overall Study|Other|0
1190501|NCT03104400|2350321|FG004|Overall Study|Other|0
1190502|NCT03104374|2350338|FG000|Overall Study|Adverse Event|7
1190503|NCT03104374|2350339|FG001|Overall Study|Adverse Event|6
1190504|NCT03104374|2350340|FG002|Overall Study|Adverse Event|12
1190505|NCT03104374|2350341|FG003|Overall Study|Adverse Event|15
1190506|NCT03104374|2350338|FG000|Overall Study|Withdrawal by Subject|18
1190507|NCT03104374|2350339|FG001|Overall Study|Withdrawal by Subject|10
1190508|NCT03104374|2350340|FG002|Overall Study|Withdrawal by Subject|10
1190509|NCT03104374|2350341|FG003|Overall Study|Withdrawal by Subject|17
1190510|NCT03104374|2350338|FG000|Overall Study|Lost to Follow-up|4
1190511|NCT03104374|2350339|FG001|Overall Study|Lost to Follow-up|4
1190512|NCT03104374|2350340|FG002|Overall Study|Lost to Follow-up|6
1190513|NCT03104374|2350341|FG003|Overall Study|Lost to Follow-up|8
1190514|NCT03104374|2350338|FG000|Overall Study|Lack of Efficacy|6
1190515|NCT03104374|2350339|FG001|Overall Study|Lack of Efficacy|7
1190516|NCT03104374|2350340|FG002|Overall Study|Lack of Efficacy|12
1190517|NCT03104374|2350341|FG003|Overall Study|Lack of Efficacy|6
1190518|NCT03104374|2350338|FG000|Overall Study|Other|2
1190519|NCT03104374|2350339|FG001|Overall Study|Other|2
1190520|NCT03104374|2350340|FG002|Overall Study|Other|4
1190521|NCT03104374|2350341|FG003|Overall Study|Other|7
1190522|NCT03072043|2350354|FG000|Overall Study|Death|0
1190523|NCT03072043|2350355|FG001|Overall Study|Death|0
1190524|NCT03072043|2350356|FG002|Overall Study|Death|3
1190525|NCT03072043|2350354|FG000|Overall Study|Adverse Event|0
1190526|NCT03072043|2350355|FG001|Overall Study|Adverse Event|0
1190527|NCT03072043|2350356|FG002|Overall Study|Adverse Event|2
1190528|NCT03072043|2350354|FG000|Overall Study|Withdrawal by Subject|0
1190529|NCT03072043|2350355|FG001|Overall Study|Withdrawal by Subject|0
1190530|NCT03072043|2350356|FG002|Overall Study|Withdrawal by Subject|4
1190531|NCT02905032|2350384|FG000|Overall Study|Withdrawal by Subject|2
1190532|NCT02905032|2350385|FG001|Overall Study|Withdrawal by Subject|0
1190533|NCT02905032|2350386|FG002|Overall Study|Withdrawal by Subject|0
1190534|NCT02905032|2350384|FG000|Overall Study|Protocol Violation|6
1190535|NCT02905032|2350385|FG001|Overall Study|Protocol Violation|12
1190536|NCT02905032|2350386|FG002|Overall Study|Protocol Violation|0
1190545|NCT02837029|2350407|FG000|Screening|Failed to meet screening requirements.|7
1190546|NCT02837029|2350408|FG001|Screening|Failed to meet screening requirements.|3
1190547|NCT02837029|2350409|FG002|Screening|Failed to meet screening requirements.|0
1190548|NCT02837029|2350407|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2
1190549|NCT02837029|2350408|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
1190550|NCT02837029|2350409|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
1190551|NCT02837029|2350407|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
1190552|NCT02837029|2350408|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2
1190553|NCT02837029|2350409|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
1190554|NCT02837029|2350407|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
1190555|NCT02837029|2350408|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1
1190556|NCT02837029|2350409|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
1190557|NCT02837029|2350407|FG000|Cycle 2 and Beyond|Adverse Event|1
1190558|NCT02837029|2350408|FG001|Cycle 2 and Beyond|Adverse Event|0
1190559|NCT02837029|2350409|FG002|Cycle 2 and Beyond|Adverse Event|0
1190560|NCT02837029|2350407|FG000|2 Year Follow-up|Death|6
1190561|NCT02837029|2350408|FG001|2 Year Follow-up|Death|7
1190562|NCT02837029|2350409|FG002|2 Year Follow-up|Death|0
1190565|NCT02737475|2350475|FG000|Overall Study|Other reasons|0
1190566|NCT02737475|2350476|FG001|Overall Study|Other reasons|0
1190567|NCT02737475|2350477|FG002|Overall Study|Other reasons|0
1190568|NCT02737475|2350478|FG003|Overall Study|Other reasons|0
1190569|NCT02737475|2350479|FG004|Overall Study|Other reasons|1
1190570|NCT02737475|2350480|FG005|Overall Study|Other reasons|1
1190571|NCT02737475|2350481|FG006|Overall Study|Other reasons|0
1190572|NCT02737475|2350482|FG007|Overall Study|Other reasons|0
1190573|NCT02737475|2350483|FG008|Overall Study|Other reasons|1
1190574|NCT02737475|2350484|FG009|Overall Study|Other reasons|0
1190575|NCT02737475|2350485|FG010|Overall Study|Other reasons|1
1190576|NCT02737475|2350486|FG011|Overall Study|Other reasons|0
1190577|NCT02737475|2350487|FG012|Overall Study|Other reasons|0
1190578|NCT02737475|2350488|FG013|Overall Study|Other reasons|0
1190579|NCT02737475|2350489|FG014|Overall Study|Other reasons|0
1190580|NCT02737475|2350490|FG015|Overall Study|Other reasons|0
1190581|NCT02737475|2350491|FG016|Overall Study|Other reasons|0
1190582|NCT02737475|2350492|FG017|Overall Study|Other reasons|0
1190583|NCT02737475|2350493|FG018|Overall Study|Other reasons|0
1190584|NCT02737475|2350494|FG019|Overall Study|Other reasons|0
1190585|NCT02737475|2350495|FG020|Overall Study|Other reasons|0
1190586|NCT02737475|2350496|FG021|Overall Study|Other reasons|1
1190587|NCT02737475|2350497|FG022|Overall Study|Other reasons|0
1190588|NCT02737475|2350498|FG023|Overall Study|Other reasons|1
1190589|NCT02737475|2350499|FG024|Overall Study|Other reasons|1
1190590|NCT02737475|2350500|FG025|Overall Study|Other reasons|1
1190591|NCT02737475|2350501|FG026|Overall Study|Other reasons|0
1190592|NCT02737475|2350475|FG000|Overall Study|Death|1
1190593|NCT02737475|2350476|FG001|Overall Study|Death|0
1190594|NCT02737475|2350477|FG002|Overall Study|Death|0
1190595|NCT02737475|2350478|FG003|Overall Study|Death|1
1190596|NCT02737475|2350479|FG004|Overall Study|Death|0
1190597|NCT02737475|2350480|FG005|Overall Study|Death|0
1190598|NCT02737475|2350481|FG006|Overall Study|Death|0
1190599|NCT02737475|2350482|FG007|Overall Study|Death|2
1190600|NCT02737475|2350483|FG008|Overall Study|Death|0
1190601|NCT02737475|2350484|FG009|Overall Study|Death|0
1190602|NCT02737475|2350485|FG010|Overall Study|Death|0
1190603|NCT02737475|2350486|FG011|Overall Study|Death|4
1190604|NCT02737475|2350487|FG012|Overall Study|Death|2
1190605|NCT02737475|2350488|FG013|Overall Study|Death|2
1190606|NCT02737475|2350489|FG014|Overall Study|Death|0
1190607|NCT02737475|2350490|FG015|Overall Study|Death|2
1190608|NCT02737475|2350491|FG016|Overall Study|Death|2
1190609|NCT02737475|2350492|FG017|Overall Study|Death|2
1190610|NCT02737475|2350493|FG018|Overall Study|Death|1
1190611|NCT02737475|2350494|FG019|Overall Study|Death|0
1190612|NCT02737475|2350495|FG020|Overall Study|Death|0
1190613|NCT02737475|2350496|FG021|Overall Study|Death|0
1190614|NCT02737475|2350497|FG022|Overall Study|Death|0
1190615|NCT02737475|2350498|FG023|Overall Study|Death|0
1190616|NCT02737475|2350499|FG024|Overall Study|Death|0
1190617|NCT02737475|2350500|FG025|Overall Study|Death|0
1190618|NCT02737475|2350501|FG026|Overall Study|Death|0
1190619|NCT02737475|2350475|FG000|Overall Study|Participant withdrew consent|0
1190620|NCT02737475|2350476|FG001|Overall Study|Participant withdrew consent|0
1190621|NCT02737475|2350477|FG002|Overall Study|Participant withdrew consent|0
1190622|NCT02737475|2350478|FG003|Overall Study|Participant withdrew consent|0
1190623|NCT02737475|2350479|FG004|Overall Study|Participant withdrew consent|0
1190624|NCT02737475|2350480|FG005|Overall Study|Participant withdrew consent|2
1190625|NCT02737475|2350481|FG006|Overall Study|Participant withdrew consent|0
1190626|NCT02737475|2350482|FG007|Overall Study|Participant withdrew consent|0
1190627|NCT02737475|2350483|FG008|Overall Study|Participant withdrew consent|0
1190628|NCT02737475|2350484|FG009|Overall Study|Participant withdrew consent|0
1190629|NCT02737475|2350485|FG010|Overall Study|Participant withdrew consent|0
1190630|NCT02737475|2350486|FG011|Overall Study|Participant withdrew consent|0
1190631|NCT02737475|2350487|FG012|Overall Study|Participant withdrew consent|0
1190632|NCT02737475|2350488|FG013|Overall Study|Participant withdrew consent|0
1190633|NCT02737475|2350489|FG014|Overall Study|Participant withdrew consent|1
1190634|NCT02737475|2350490|FG015|Overall Study|Participant withdrew consent|0
1190635|NCT02737475|2350491|FG016|Overall Study|Participant withdrew consent|0
1190636|NCT02737475|2350492|FG017|Overall Study|Participant withdrew consent|2
1190637|NCT02737475|2350493|FG018|Overall Study|Participant withdrew consent|1
1190638|NCT02737475|2350494|FG019|Overall Study|Participant withdrew consent|0
1190639|NCT02737475|2350495|FG020|Overall Study|Participant withdrew consent|2
1190640|NCT02737475|2350496|FG021|Overall Study|Participant withdrew consent|0
1190641|NCT02737475|2350497|FG022|Overall Study|Participant withdrew consent|0
1190642|NCT02737475|2350498|FG023|Overall Study|Participant withdrew consent|0
1190643|NCT02737475|2350499|FG024|Overall Study|Participant withdrew consent|0
1190644|NCT02737475|2350500|FG025|Overall Study|Participant withdrew consent|0
1190645|NCT02737475|2350501|FG026|Overall Study|Participant withdrew consent|0
1190646|NCT02737475|2350475|FG000|Overall Study|Lost to Follow-up|0
1190647|NCT02737475|2350476|FG001|Overall Study|Lost to Follow-up|0
1190648|NCT02737475|2350477|FG002|Overall Study|Lost to Follow-up|0
1190649|NCT02737475|2350478|FG003|Overall Study|Lost to Follow-up|0
1190650|NCT02737475|2350479|FG004|Overall Study|Lost to Follow-up|0
1190651|NCT02737475|2350480|FG005|Overall Study|Lost to Follow-up|0
1190652|NCT02737475|2350481|FG006|Overall Study|Lost to Follow-up|0
1190653|NCT02737475|2350482|FG007|Overall Study|Lost to Follow-up|0
1190654|NCT02737475|2350483|FG008|Overall Study|Lost to Follow-up|0
1190655|NCT02737475|2350484|FG009|Overall Study|Lost to Follow-up|0
1190656|NCT02737475|2350485|FG010|Overall Study|Lost to Follow-up|0
1190657|NCT02737475|2350486|FG011|Overall Study|Lost to Follow-up|0
1190658|NCT02737475|2350487|FG012|Overall Study|Lost to Follow-up|0
1190659|NCT02737475|2350488|FG013|Overall Study|Lost to Follow-up|0
1190660|NCT02737475|2350489|FG014|Overall Study|Lost to Follow-up|0
1190661|NCT02737475|2350490|FG015|Overall Study|Lost to Follow-up|1
1190662|NCT02737475|2350491|FG016|Overall Study|Lost to Follow-up|0
1190663|NCT02737475|2350492|FG017|Overall Study|Lost to Follow-up|0
1190664|NCT02737475|2350493|FG018|Overall Study|Lost to Follow-up|0
1190665|NCT02737475|2350494|FG019|Overall Study|Lost to Follow-up|0
1190666|NCT02737475|2350495|FG020|Overall Study|Lost to Follow-up|0
882161|NCT00603590|1847209|FG000|Overall Study|Lost to Follow-up|8
882162|NCT00603590|1847210|FG001|Overall Study|Lost to Follow-up|4
882163|NCT00603590|1847209|FG000|Overall Study|Cardiovascular event|0
882164|NCT00603590|1847210|FG001|Overall Study|Cardiovascular event|1
882165|NCT00603733|1847248|FG000|Active Phase ITT|Adverse Event|8
882166|NCT00603733|1847249|FG001|Active Phase ITT|Adverse Event|7
882167|NCT00603733|1847248|FG000|Active Phase ITT|Withdrawal by Subject|0
882168|NCT00603733|1847249|FG001|Active Phase ITT|Withdrawal by Subject|3
882169|NCT00603733|1847248|FG000|Active Phase ITT|Lost to Follow-up|0
882170|NCT00603733|1847249|FG001|Active Phase ITT|Lost to Follow-up|1
882171|NCT00603733|1847248|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1
882172|NCT00603733|1847249|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3
882173|NCT00603733|1847248|FG000|Active Phase ITT|Lack of Efficacy|1
882174|NCT00603733|1847249|FG001|Active Phase ITT|Lack of Efficacy|2
882175|NCT00603733|1847248|FG000|Active Phase ITT|Subject moved, site closed|1
882176|NCT00603733|1847249|FG001|Active Phase ITT|Subject moved, site closed|1
882177|NCT00603733|1847248|FG000|Run-In Phase - 4 Weeks|Adverse Event|2
882178|NCT00603733|1847249|FG001|Run-In Phase - 4 Weeks|Adverse Event|1
882179|NCT00603733|1847248|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
882180|NCT00603733|1847249|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
882181|NCT00603733|1847248|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1
1190667|NCT02737475|2350496|FG021|Overall Study|Lost to Follow-up|0
1190668|NCT02737475|2350497|FG022|Overall Study|Lost to Follow-up|0
1190669|NCT02737475|2350498|FG023|Overall Study|Lost to Follow-up|0
1190670|NCT02737475|2350499|FG024|Overall Study|Lost to Follow-up|0
1190671|NCT02737475|2350500|FG025|Overall Study|Lost to Follow-up|0
1190672|NCT02737475|2350501|FG026|Overall Study|Lost to Follow-up|0
1190673|NCT02737475|2350475|FG000|Overall Study|Disease Progression|0
1190674|NCT02737475|2350476|FG001|Overall Study|Disease Progression|0
1190675|NCT02737475|2350477|FG002|Overall Study|Disease Progression|0
1190676|NCT02737475|2350478|FG003|Overall Study|Disease Progression|0
1190677|NCT02737475|2350479|FG004|Overall Study|Disease Progression|0
1190678|NCT02737475|2350480|FG005|Overall Study|Disease Progression|0
1190679|NCT02737475|2350481|FG006|Overall Study|Disease Progression|0
1190680|NCT02737475|2350482|FG007|Overall Study|Disease Progression|0
1190681|NCT02737475|2350483|FG008|Overall Study|Disease Progression|0
1190682|NCT02737475|2350484|FG009|Overall Study|Disease Progression|0
1190683|NCT02737475|2350485|FG010|Overall Study|Disease Progression|0
1190684|NCT02737475|2350486|FG011|Overall Study|Disease Progression|0
1190685|NCT02737475|2350487|FG012|Overall Study|Disease Progression|0
1190686|NCT02737475|2350488|FG013|Overall Study|Disease Progression|0
1190687|NCT02737475|2350489|FG014|Overall Study|Disease Progression|0
1190688|NCT02737475|2350490|FG015|Overall Study|Disease Progression|0
1190689|NCT02737475|2350491|FG016|Overall Study|Disease Progression|0
1190690|NCT02737475|2350492|FG017|Overall Study|Disease Progression|0
1190691|NCT02737475|2350493|FG018|Overall Study|Disease Progression|0
1190692|NCT02737475|2350494|FG019|Overall Study|Disease Progression|0
1190693|NCT02737475|2350495|FG020|Overall Study|Disease Progression|0
1190694|NCT02737475|2350496|FG021|Overall Study|Disease Progression|0
1190695|NCT02737475|2350497|FG022|Overall Study|Disease Progression|0
1190696|NCT02737475|2350498|FG023|Overall Study|Disease Progression|0
1190697|NCT02737475|2350499|FG024|Overall Study|Disease Progression|0
1190698|NCT02737475|2350500|FG025|Overall Study|Disease Progression|0
1190699|NCT02737475|2350501|FG026|Overall Study|Disease Progression|1
1190700|NCT02642965|2350593|FG000|Overall Study|Lack of Efficacy|4
1190701|NCT02642965|2350593|FG000|Overall Study|Physician Decision|9
1190702|NCT02629159|2350600|FG000|Overall Study|Adverse Event|17
1190703|NCT02629159|2350601|FG001|Overall Study|Adverse Event|20
1190704|NCT02629159|2350602|FG002|Overall Study|Adverse Event|22
1190705|NCT02629159|2350600|FG000|Overall Study|Withdrawal by Subject|22
1190706|NCT02629159|2350601|FG001|Overall Study|Withdrawal by Subject|11
1190707|NCT02629159|2350602|FG002|Overall Study|Withdrawal by Subject|15
1190708|NCT02629159|2350600|FG000|Overall Study|Lost to Follow-up|7
1190709|NCT02629159|2350601|FG001|Overall Study|Lost to Follow-up|4
1190710|NCT02629159|2350602|FG002|Overall Study|Lost to Follow-up|5
1190711|NCT02629159|2350600|FG000|Overall Study|Lack of Efficacy|4
1190712|NCT02629159|2350601|FG001|Overall Study|Lack of Efficacy|0
1190713|NCT02629159|2350602|FG002|Overall Study|Lack of Efficacy|1
1190714|NCT02629159|2350600|FG000|Overall Study|Other|6
1190715|NCT02629159|2350601|FG001|Overall Study|Other|4
1190716|NCT02629159|2350602|FG002|Overall Study|Other|8
1190717|NCT02604433|2350615|FG000|Overall Study|Withdrawal by Subject|37
1190718|NCT02604433|2350616|FG001|Overall Study|Withdrawal by Subject|16
1190719|NCT02604433|2350615|FG000|Overall Study|Adverse Event|4
1190720|NCT02604433|2350616|FG001|Overall Study|Adverse Event|0
1190721|NCT02604433|2350615|FG000|Overall Study|Other reasons|3
1190722|NCT02604433|2350616|FG001|Overall Study|Other reasons|5
1190723|NCT02604433|2350615|FG000|Overall Study|Death|4
1190724|NCT02604433|2350616|FG001|Overall Study|Death|1
1190725|NCT02604433|2350615|FG000|Overall Study|Transition to Rollover Protocol|169
1190726|NCT02604433|2350616|FG001|Overall Study|Transition to Rollover Protocol|82
1190727|NCT02604433|2350615|FG000|Overall Study|Physician Decision|1
1190728|NCT02604433|2350616|FG001|Overall Study|Physician Decision|1
1190729|NCT02604433|2350615|FG000|Overall Study|Lack of Efficacy|0
1190730|NCT02604433|2350616|FG001|Overall Study|Lack of Efficacy|1
1190731|NCT02550652|2350624|FG000|Overall Study|Death|1
1190732|NCT02550652|2350625|FG001|Overall Study|Death|4
1190733|NCT02550652|2350624|FG000|Overall Study|Lack of Efficacy|1
1190734|NCT02550652|2350625|FG001|Overall Study|Lack of Efficacy|0
1190735|NCT02550652|2350624|FG000|Overall Study|Withdrawal by Subject|3
1190736|NCT02550652|2350625|FG001|Overall Study|Withdrawal by Subject|7
1190737|NCT02550652|2350624|FG000|Overall Study|Post Trial Access|1
1190738|NCT02550652|2350625|FG001|Overall Study|Post Trial Access|0
1190739|NCT02550652|2350624|FG000|Overall Study|Lost to Follow-up|1
1190740|NCT02550652|2350625|FG001|Overall Study|Lost to Follow-up|3
1190741|NCT02550652|2350624|FG000|Overall Study|Physician Decision|0
1190742|NCT02550652|2350625|FG001|Overall Study|Physician Decision|2
1190743|NCT02550652|2350624|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14
1190744|NCT02550652|2350625|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5
1190745|NCT02420821|2350650|FG000|Overall Study|Lost to Follow-up|2
1190746|NCT02420821|2350651|FG001|Overall Study|Lost to Follow-up|0
1190747|NCT02420821|2350650|FG000|Overall Study|Non-compliance|1
1190748|NCT02420821|2350651|FG001|Overall Study|Non-compliance|2
1190749|NCT02420821|2350650|FG000|Overall Study|Physician Decision|5
1190750|NCT02420821|2350651|FG001|Overall Study|Physician Decision|2
1190751|NCT02420821|2350650|FG000|Overall Study|Withdrawal by Subject|31
1190752|NCT02420821|2350651|FG001|Overall Study|Withdrawal by Subject|17
1190753|NCT02420821|2350650|FG000|Overall Study|Death|129
1190754|NCT02420821|2350651|FG001|Overall Study|Death|116
1190755|NCT02412670|2350660|FG000|Overall Study|Adverse Event|4
1190756|NCT02412670|2350661|FG001|Overall Study|Adverse Event|1
1190757|NCT02412670|2350660|FG000|Overall Study|Physician Decision|1
1190758|NCT02412670|2350661|FG001|Overall Study|Physician Decision|0
1190759|NCT02412670|2350660|FG000|Overall Study|Withdrawal by Subject|1
1190760|NCT02412670|2350661|FG001|Overall Study|Withdrawal by Subject|0
1190761|NCT02412670|2350660|FG000|Overall Study|Ineligible|1
1190762|NCT02412670|2350661|FG001|Overall Study|Ineligible|0
1190763|NCT02410343|2350669|FG000|Core Period (24 Weeks)|Adverse Event|1
1190764|NCT02410343|2350670|FG001|Core Period (24 Weeks)|Adverse Event|0
1190765|NCT02410343|2350669|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4
1190766|NCT02410343|2350670|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7
1190767|NCT02410343|2350669|FG000|Extension Period (12 Months)|Adverse Event|1
1190768|NCT02410343|2350670|FG001|Extension Period (12 Months)|Adverse Event|0
1190769|NCT02410343|2350669|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0
1190770|NCT02410343|2350670|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1
1190771|NCT02339740|2350683|FG000|Overall Study|Death|1
1190772|NCT02339740|2350684|FG001|Overall Study|Death|0
1190773|NCT02339740|2350683|FG000|Overall Study|Physician Decision|0
1190774|NCT02339740|2350684|FG001|Overall Study|Physician Decision|2
1190775|NCT02339740|2350683|FG000|Overall Study|Withdrawal by Subject|5
1190776|NCT02339740|2350684|FG001|Overall Study|Withdrawal by Subject|1
1190777|NCT02339740|2350683|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3
1190778|NCT02339740|2350684|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1
1190779|NCT02125461|2350707|FG000|Overall Study|Withdrawal by Subject|30
1190780|NCT02125461|2350708|FG001|Overall Study|Withdrawal by Subject|16
1190781|NCT02125461|2350707|FG000|Overall Study|Lost to Follow-up|8
1190782|NCT02125461|2350708|FG001|Overall Study|Lost to Follow-up|3
1190783|NCT02125461|2350707|FG000|Overall Study|Death|260
1190784|NCT02125461|2350708|FG001|Overall Study|Death|149
1190785|NCT02125461|2350707|FG000|Overall Study|Missing Termination Reason|0
1190786|NCT02125461|2350708|FG001|Overall Study|Missing Termination Reason|1
1190787|NCT02045303|2350716|FG000|Overall Study|Protocol Violation|2
1190788|NCT02045303|2350717|FG001|Overall Study|Protocol Violation|1
1190789|NCT02045303|2350718|FG002|Overall Study|Protocol Violation|0
1190790|NCT02045303|2350716|FG000|Overall Study|Withdrawal by Subject|0
1190791|NCT02045303|2350717|FG001|Overall Study|Withdrawal by Subject|2
1190792|NCT02045303|2350718|FG002|Overall Study|Withdrawal by Subject|0
1190793|NCT02025556|2350730|FG000|Overall Study|Adverse Event|0
1190794|NCT02025556|2350731|FG001|Overall Study|Adverse Event|4
1190795|NCT02025556|2350732|FG002|Overall Study|Adverse Event|2
1190796|NCT02025556|2350730|FG000|Overall Study|Lack of Efficacy|2
1190797|NCT02025556|2350731|FG001|Overall Study|Lack of Efficacy|1
1190798|NCT02025556|2350732|FG002|Overall Study|Lack of Efficacy|0
1190799|NCT02025556|2350730|FG000|Overall Study|Protocol Violation|2
1190800|NCT02025556|2350731|FG001|Overall Study|Protocol Violation|1
1190801|NCT02025556|2350732|FG002|Overall Study|Protocol Violation|0
1190802|NCT02025556|2350730|FG000|Overall Study|Withdrawal by Subject|0
1190803|NCT02025556|2350731|FG001|Overall Study|Withdrawal by Subject|3
1190804|NCT02025556|2350732|FG002|Overall Study|Withdrawal by Subject|6
1190805|NCT02025556|2350730|FG000|Overall Study|Lost to Follow-up|2
1190806|NCT02025556|2350731|FG001|Overall Study|Lost to Follow-up|4
1190807|NCT02025556|2350732|FG002|Overall Study|Lost to Follow-up|0
1190808|NCT02025556|2350730|FG000|Overall Study|Reason not reported|0
1190809|NCT02025556|2350731|FG001|Overall Study|Reason not reported|0
1190810|NCT02025556|2350732|FG002|Overall Study|Reason not reported|1
1190811|NCT01986933|2350745|FG000|Placebo-controlled (Part A)|Adverse Event|1
1190812|NCT01986933|2350746|FG001|Placebo-controlled (Part A)|Adverse Event|5
1190813|NCT01986933|2350747|FG002|Placebo-controlled (Part A)|Adverse Event|2
1190814|NCT01986933|2350748|FG003|Placebo-controlled (Part A)|Adverse Event|2
1190815|NCT01986933|2350749|FG004|Placebo-controlled (Part A)|Adverse Event|4
1190816|NCT01986933|2350745|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3
1190817|NCT01986933|2350746|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1
1190818|NCT01986933|2350747|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1
1190819|NCT01986933|2350748|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2
1190820|NCT01986933|2350749|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1
1190821|NCT01986933|2350745|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5
1190822|NCT01986933|2350746|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2
1190823|NCT01986933|2350747|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6
1190824|NCT01986933|2350748|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2
1190825|NCT01986933|2350749|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7
1190826|NCT01986933|2350745|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0
1190827|NCT01986933|2350746|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1
1190828|NCT01986933|2350747|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0
1190829|NCT01986933|2350748|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1
1190830|NCT01986933|2350749|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0
1190831|NCT01986933|2350745|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0
1190832|NCT01986933|2350746|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0
1190833|NCT01986933|2350747|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0
1190834|NCT01986933|2350748|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0
1190835|NCT01986933|2350749|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2
882182|NCT00603733|1847249|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0
882183|NCT00603733|1847248|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
882184|NCT00603733|1847249|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
882185|NCT00603733|1847248|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2
882186|NCT00603733|1847249|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1
882187|NCT00603733|1847248|FG000|Maintenance Phase ITT|Adverse Event|3
882188|NCT00603733|1847249|FG001|Maintenance Phase ITT|Adverse Event|6
882189|NCT00603733|1847248|FG000|Maintenance Phase ITT|Withdrawal by Subject|1
882190|NCT00603733|1847249|FG001|Maintenance Phase ITT|Withdrawal by Subject|0
882191|NCT00603733|1847248|FG000|Maintenance Phase ITT|Protocol Violation|1
882192|NCT00603733|1847249|FG001|Maintenance Phase ITT|Protocol Violation|1
882193|NCT00603733|1847248|FG000|Maintenance Phase ITT|Lost to Follow-up|0
882194|NCT00603733|1847249|FG001|Maintenance Phase ITT|Lost to Follow-up|1
882195|NCT00603733|1847248|FG000|Maintenance Phase ITT|Lack of Efficacy|2
882196|NCT00603733|1847249|FG001|Maintenance Phase ITT|Lack of Efficacy|2
1190836|NCT01986933|2350745|FG000|Active-to-active (Part B)|Adverse Event|0
1190837|NCT01986933|2350746|FG001|Active-to-active (Part B)|Adverse Event|2
1190838|NCT01986933|2350747|FG002|Active-to-active (Part B)|Adverse Event|0
1190839|NCT01986933|2350748|FG003|Active-to-active (Part B)|Adverse Event|1
1190840|NCT01986933|2350749|FG004|Active-to-active (Part B)|Adverse Event|3
1190841|NCT01986933|2350745|FG000|Active-to-active (Part B)|Lack of Efficacy|0
1190842|NCT01986933|2350746|FG001|Active-to-active (Part B)|Lack of Efficacy|3
1190843|NCT01986933|2350747|FG002|Active-to-active (Part B)|Lack of Efficacy|2
1190844|NCT01986933|2350748|FG003|Active-to-active (Part B)|Lack of Efficacy|0
1190845|NCT01986933|2350749|FG004|Active-to-active (Part B)|Lack of Efficacy|4
1190846|NCT01986933|2350745|FG000|Active-to-active (Part B)|Pregnancy|0
1190847|NCT01986933|2350746|FG001|Active-to-active (Part B)|Pregnancy|0
1190848|NCT01986933|2350747|FG002|Active-to-active (Part B)|Pregnancy|0
1190849|NCT01986933|2350748|FG003|Active-to-active (Part B)|Pregnancy|0
1190850|NCT01986933|2350749|FG004|Active-to-active (Part B)|Pregnancy|1
1190851|NCT01986933|2350745|FG000|Active-to-active (Part B)|Physician Decision|0
1190852|NCT01986933|2350746|FG001|Active-to-active (Part B)|Physician Decision|0
1190853|NCT01986933|2350747|FG002|Active-to-active (Part B)|Physician Decision|1
1190854|NCT01986933|2350748|FG003|Active-to-active (Part B)|Physician Decision|1
1190855|NCT01986933|2350749|FG004|Active-to-active (Part B)|Physician Decision|0
1190856|NCT01986933|2350745|FG000|Active-to-active (Part B)|Withdrawal by Subject|0
1190857|NCT01986933|2350746|FG001|Active-to-active (Part B)|Withdrawal by Subject|4
1190858|NCT01986933|2350747|FG002|Active-to-active (Part B)|Withdrawal by Subject|7
1190859|NCT01986933|2350748|FG003|Active-to-active (Part B)|Withdrawal by Subject|6
1190860|NCT01986933|2350749|FG004|Active-to-active (Part B)|Withdrawal by Subject|6
1190861|NCT01986933|2350745|FG000|Active-to-active (Part B)|Lost to Follow-up|0
1190862|NCT01986933|2350746|FG001|Active-to-active (Part B)|Lost to Follow-up|0
1190863|NCT01986933|2350747|FG002|Active-to-active (Part B)|Lost to Follow-up|0
1190864|NCT01986933|2350748|FG003|Active-to-active (Part B)|Lost to Follow-up|0
1190865|NCT01986933|2350749|FG004|Active-to-active (Part B)|Lost to Follow-up|1
1190866|NCT01986933|2350745|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0
1190867|NCT01986933|2350746|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1
1190868|NCT01986933|2350747|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0
1190869|NCT01986933|2350748|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1
1190870|NCT01986933|2350749|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1
1190871|NCT01986933|2350745|FG000|Placebo-to-active (Part B)|Adverse Event|0
1190872|NCT01986933|2350746|FG001|Placebo-to-active (Part B)|Adverse Event|1
1190873|NCT01986933|2350747|FG002|Placebo-to-active (Part B)|Adverse Event|0
1190874|NCT01986933|2350748|FG003|Placebo-to-active (Part B)|Adverse Event|1
1190875|NCT01986933|2350749|FG004|Placebo-to-active (Part B)|Adverse Event|0
1190876|NCT01986933|2350745|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0
1190877|NCT01986933|2350746|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0
1190878|NCT01986933|2350747|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0
1190879|NCT01986933|2350748|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1
1190880|NCT01986933|2350749|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0
1190881|NCT01986933|2350745|FG000|Placebo-to-active (Part B)|Protocol Violation|0
1190882|NCT01986933|2350746|FG001|Placebo-to-active (Part B)|Protocol Violation|0
1190883|NCT01986933|2350747|FG002|Placebo-to-active (Part B)|Protocol Violation|1
1190884|NCT01986933|2350748|FG003|Placebo-to-active (Part B)|Protocol Violation|0
1190885|NCT01986933|2350749|FG004|Placebo-to-active (Part B)|Protocol Violation|0
1190886|NCT01986933|2350745|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0
1190887|NCT01986933|2350746|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3
1190888|NCT01986933|2350747|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4
1190889|NCT01986933|2350748|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3
1190890|NCT01986933|2350749|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0
1190891|NCT01986933|2350745|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0
1190892|NCT01986933|2350746|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1
1190893|NCT01986933|2350747|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0
1190894|NCT01986933|2350748|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0
1190895|NCT01986933|2350749|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0
1190896|NCT01942135|2350782|FG000|Overall Study|Adverse Event|9
1190897|NCT01942135|2350783|FG001|Overall Study|Adverse Event|3
1190898|NCT01942135|2350782|FG000|Overall Study|Global deterioration of health status|8
1190899|NCT01942135|2350783|FG001|Overall Study|Global deterioration of health status|3
1190900|NCT01942135|2350782|FG000|Overall Study|Randomized Not Treated|2
1190901|NCT01942135|2350783|FG001|Overall Study|Randomized Not Treated|2
1190902|NCT01942135|2350782|FG000|Overall Study|Death|0
1190903|NCT01942135|2350783|FG001|Overall Study|Death|1
1190904|NCT01942135|2350782|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85
1190905|NCT01942135|2350783|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87
1190906|NCT01942135|2350782|FG000|Overall Study|Participant Refused toContinue Treatment|1
1190907|NCT01942135|2350783|FG001|Overall Study|Participant Refused toContinue Treatment|1
1190908|NCT01942135|2350782|FG000|Overall Study|Withdrawal by Subject|4
1190909|NCT01942135|2350783|FG001|Overall Study|Withdrawal by Subject|2
1190910|NCT01942135|2350782|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
1190911|NCT01942135|2350783|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
1190912|NCT01835145|2350795|FG000|Overall Study|Ineligible prior to treatment|1
1190913|NCT01835145|2350796|FG001|Overall Study|Ineligible prior to treatment|0
1190914|NCT01701674|2350811|FG000|Overall Study|Unable to safely complete treatment|1
1190915|NCT01563107|2350873|FG000|Overall Study|Physician Decision|0
1190916|NCT01563107|2350874|FG001|Overall Study|Physician Decision|1
1190917|NCT01563107|2350875|FG002|Overall Study|Physician Decision|1
1190918|NCT01563107|2350876|FG003|Overall Study|Physician Decision|3
1190919|NCT01563107|2350873|FG000|Overall Study|Withdrawal by Subject|1
1190920|NCT01563107|2350874|FG001|Overall Study|Withdrawal by Subject|2
1190921|NCT01563107|2350875|FG002|Overall Study|Withdrawal by Subject|1
1190922|NCT01563107|2350876|FG003|Overall Study|Withdrawal by Subject|2
1190929|NCT01194570|2350957|FG000|Overall Study|Death|1
1190930|NCT01194570|2350958|FG001|Overall Study|Death|3
1190931|NCT01194570|2350957|FG000|Overall Study|Ongoing at CCOD|162
1190932|NCT01194570|2350958|FG001|Overall Study|Ongoing at CCOD|387
1190933|NCT01194570|2350957|FG000|Overall Study|Physician Decision|2
1190934|NCT01194570|2350958|FG001|Overall Study|Physician Decision|6
1190935|NCT01194570|2350957|FG000|Overall Study|Reason not specified|13
1190936|NCT01194570|2350958|FG001|Overall Study|Reason not specified|20
1190937|NCT01194570|2350957|FG000|Overall Study|Protocol Violation|0
1190938|NCT01194570|2350958|FG001|Overall Study|Protocol Violation|2
1190939|NCT01194570|2350957|FG000|Overall Study|Non-compliance with study drug|2
1190940|NCT01194570|2350958|FG001|Overall Study|Non-compliance with study drug|2
1190941|NCT01194570|2350957|FG000|Overall Study|Adverse Event|12
1190942|NCT01194570|2350958|FG001|Overall Study|Adverse Event|18
1190943|NCT01194570|2350957|FG000|Overall Study|Non-compliance|2
1190944|NCT01194570|2350958|FG001|Overall Study|Non-compliance|2
1190945|NCT01194570|2350957|FG000|Overall Study|Lack of Efficacy|27
1190946|NCT01194570|2350958|FG001|Overall Study|Lack of Efficacy|21
1190947|NCT01194570|2350957|FG000|Overall Study|Withdrawal by Subject|21
1190948|NCT01194570|2350958|FG001|Overall Study|Withdrawal by Subject|22
1190949|NCT01194570|2350957|FG000|Overall Study|Pregnancy|1
1190950|NCT01194570|2350958|FG001|Overall Study|Pregnancy|1
1190951|NCT01194570|2350957|FG000|Overall Study|Lost to Follow-up|1
1190952|NCT01194570|2350958|FG001|Overall Study|Lost to Follow-up|4
1190953|NCT01146652|2350966|FG000|Overall Study|Adverse Event|506
1190954|NCT01146652|2350967|FG001|Overall Study|Adverse Event|15
1190955|NCT01146652|2350966|FG000|Overall Study|Lack of Efficacy|91
1190956|NCT01146652|2350967|FG001|Overall Study|Lack of Efficacy|7
1190957|NCT01146652|2350966|FG000|Overall Study|Poor compliance to protocol|38
1190958|NCT01146652|2350967|FG001|Overall Study|Poor compliance to protocol|1
1190959|NCT01146652|2350966|FG000|Overall Study|Other unspecified reasons|314
1190960|NCT01146652|2350967|FG001|Overall Study|Other unspecified reasons|22
1190961|NCT01146652|2350966|FG000|Overall Study|Enrolled but not treated|2
1190962|NCT01146652|2350967|FG001|Overall Study|Enrolled but not treated|0
1190963|NCT01116648|2350995|FG000|Phase 1 Dose Level 3|Adverse Event|0
1190964|NCT01116648|2350996|FG001|Phase 1 Dose Level 3|Adverse Event|0
1190965|NCT01116648|2350997|FG002|Phase 1 Dose Level 3|Adverse Event|0
1190966|NCT01116648|2350998|FG003|Phase 1 Dose Level 3|Adverse Event|2
1190967|NCT01116648|2350999|FG004|Phase 1 Dose Level 3|Adverse Event|0
1190968|NCT01116648|2351000|FG005|Phase 1 Dose Level 3|Adverse Event|0
1190969|NCT01116648|2351001|FG006|Phase 1 Dose Level 3|Adverse Event|0
1190970|NCT01116648|2351002|FG007|Phase 1 Dose Level 3|Adverse Event|0
1190971|NCT01116648|2351003|FG008|Phase 1 Dose Level 3|Adverse Event|0
882197|NCT00603733|1847248|FG000|Maintenance Phase ITT|Physician Decision|0
882198|NCT00603733|1847249|FG001|Maintenance Phase ITT|Physician Decision|1
882199|NCT00603733|1847248|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
882200|NCT00603733|1847249|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
882201|NCT00603746|1847261|FG000|Overall Study|Adverse Event|2
882202|NCT00603746|1847262|FG001|Overall Study|Adverse Event|3
882203|NCT00603746|1847263|FG002|Overall Study|Adverse Event|0
882204|NCT00603746|1847264|FG003|Overall Study|Adverse Event|1
882205|NCT00603746|1847265|FG004|Overall Study|Adverse Event|0
882206|NCT00603746|1847266|FG005|Overall Study|Adverse Event|4
882207|NCT00603746|1847261|FG000|Overall Study|Lack of Efficacy|34
882208|NCT00603746|1847262|FG001|Overall Study|Lack of Efficacy|11
882209|NCT00603746|1847263|FG002|Overall Study|Lack of Efficacy|6
882210|NCT00603746|1847264|FG003|Overall Study|Lack of Efficacy|11
882211|NCT00603746|1847265|FG004|Overall Study|Lack of Efficacy|12
1190972|NCT01116648|2351004|FG009|Phase 1 Dose Level 3|Adverse Event|0
1190973|NCT01116648|2351005|FG010|Phase 1 Dose Level 3|Adverse Event|0
1190974|NCT01116648|2351006|FG011|Phase 1 Dose Level 3|Adverse Event|0
1190975|NCT01116648|2351007|FG012|Phase 1 Dose Level 3|Adverse Event|0
1190976|NCT01116648|2351008|FG013|Phase 1 Dose Level 3|Adverse Event|0
1190977|NCT01116648|2351009|FG014|Phase 1 Dose Level 3|Adverse Event|0
1190978|NCT01064648|2351037|FG000|Phase I Cohort1: Dose Level 1|Progression|5
1190979|NCT01064648|2351038|FG001|Phase I Cohort1: Dose Level 1|Progression|0
1190980|NCT01064648|2351039|FG002|Phase I Cohort1: Dose Level 1|Progression|0
1190981|NCT01064648|2351040|FG003|Phase I Cohort1: Dose Level 1|Progression|0
1190982|NCT01064648|2351037|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
1190983|NCT01064648|2351038|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
1190984|NCT01064648|2351039|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
1190985|NCT01064648|2351040|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
1190986|NCT01064648|2351037|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0
1190987|NCT01064648|2351038|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3
1190988|NCT01064648|2351039|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0
1190989|NCT01064648|2351040|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0
1190990|NCT01064648|2351037|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
1190991|NCT01064648|2351038|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
1190992|NCT01064648|2351039|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
1190993|NCT01064648|2351040|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
1190994|NCT01064648|2351037|FG000|Phase I Cohort 2: Dose Level 2|Progression|0
1190995|NCT01064648|2351038|FG001|Phase I Cohort 2: Dose Level 2|Progression|5
1190996|NCT01064648|2351039|FG002|Phase I Cohort 2: Dose Level 2|Progression|0
1190997|NCT01064648|2351040|FG003|Phase I Cohort 2: Dose Level 2|Progression|0
1190998|NCT01064648|2351037|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
1190999|NCT01064648|2351038|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
1191000|NCT01064648|2351039|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
1191001|NCT01064648|2351040|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
1191002|NCT01064648|2351037|FG000|Phase II|Adverse Event|0
1191003|NCT01064648|2351038|FG001|Phase II|Adverse Event|0
1191004|NCT01064648|2351039|FG002|Phase II|Adverse Event|15
1191005|NCT01064648|2351040|FG003|Phase II|Adverse Event|8
1191006|NCT01064648|2351037|FG000|Phase II|Death|0
1191007|NCT01064648|2351038|FG001|Phase II|Death|0
1191008|NCT01064648|2351039|FG002|Phase II|Death|4
1191009|NCT01064648|2351040|FG003|Phase II|Death|5
1191010|NCT01064648|2351037|FG000|Phase II|Withdrawal by Subject|0
1191011|NCT01064648|2351038|FG001|Phase II|Withdrawal by Subject|0
1191012|NCT01064648|2351039|FG002|Phase II|Withdrawal by Subject|2
1191013|NCT01064648|2351040|FG003|Phase II|Withdrawal by Subject|5
1191014|NCT01064648|2351037|FG000|Phase II|Progression|0
1191015|NCT01064648|2351038|FG001|Phase II|Progression|0
1191016|NCT01064648|2351039|FG002|Phase II|Progression|21
1191017|NCT01064648|2351040|FG003|Phase II|Progression|27
1191018|NCT01064648|2351037|FG000|Phase II|Non-protocol specified|0
1191019|NCT01064648|2351038|FG001|Phase II|Non-protocol specified|0
1191020|NCT01064648|2351039|FG002|Phase II|Non-protocol specified|5
1191021|NCT01064648|2351040|FG003|Phase II|Non-protocol specified|3
1191022|NCT01064648|2351037|FG000|Phase II|Under Review|0
882212|NCT00603746|1847266|FG005|Overall Study|Lack of Efficacy|8
882213|NCT00603746|1847261|FG000|Overall Study|Protocol Violation|0
882214|NCT00603746|1847262|FG001|Overall Study|Protocol Violation|3
882215|NCT00603746|1847263|FG002|Overall Study|Protocol Violation|1
882216|NCT00603746|1847264|FG003|Overall Study|Protocol Violation|0
882217|NCT00603746|1847265|FG004|Overall Study|Protocol Violation|1
882218|NCT00603746|1847266|FG005|Overall Study|Protocol Violation|0
882219|NCT00603746|1847261|FG000|Overall Study|Lost to Follow-up|0
882220|NCT00603746|1847262|FG001|Overall Study|Lost to Follow-up|1
882221|NCT00603746|1847263|FG002|Overall Study|Lost to Follow-up|1
882222|NCT00603746|1847264|FG003|Overall Study|Lost to Follow-up|0
882223|NCT00603746|1847265|FG004|Overall Study|Lost to Follow-up|0
882224|NCT00603746|1847266|FG005|Overall Study|Lost to Follow-up|0
882225|NCT00603746|1847261|FG000|Overall Study|Physician Decision|1
882226|NCT00603746|1847262|FG001|Overall Study|Physician Decision|0
882227|NCT00603746|1847263|FG002|Overall Study|Physician Decision|0
882228|NCT00603746|1847264|FG003|Overall Study|Physician Decision|0
882229|NCT00603746|1847265|FG004|Overall Study|Physician Decision|1
882230|NCT00603746|1847266|FG005|Overall Study|Physician Decision|0
882231|NCT00603746|1847261|FG000|Overall Study|Withdrawal by Subject|1
882232|NCT00603746|1847262|FG001|Overall Study|Withdrawal by Subject|0
882233|NCT00603746|1847263|FG002|Overall Study|Withdrawal by Subject|0
882234|NCT00603746|1847264|FG003|Overall Study|Withdrawal by Subject|1
882235|NCT00603746|1847265|FG004|Overall Study|Withdrawal by Subject|3
882236|NCT00603746|1847266|FG005|Overall Study|Withdrawal by Subject|1
882237|NCT00603798|1847283|FG000|Overall Study|Adverse Event|4
882238|NCT00603798|1847284|FG001|Overall Study|Adverse Event|2
882239|NCT00603798|1847285|FG002|Overall Study|Adverse Event|1
882240|NCT00603798|1847283|FG000|Overall Study|Withdrawal by Subject|4
882241|NCT00603798|1847284|FG001|Overall Study|Withdrawal by Subject|3
882242|NCT00603798|1847285|FG002|Overall Study|Withdrawal by Subject|4
882243|NCT00603798|1847283|FG000|Overall Study|Lost to Follow-up|1
1191023|NCT01064648|2351038|FG001|Phase II|Under Review|0
1191024|NCT01064648|2351039|FG002|Phase II|Under Review|2
1191025|NCT01064648|2351040|FG003|Phase II|Under Review|0
1191026|NCT01064479|2351055|FG000|Overall Study|Death|10
1191027|NCT01064479|2351056|FG001|Overall Study|Death|11
1191028|NCT01064479|2351055|FG000|Overall Study|Withdrawal by Subject|2
1191029|NCT01064479|2351056|FG001|Overall Study|Withdrawal by Subject|2
1191030|NCT01064479|2351055|FG000|Overall Study|Disease progression|1
1191031|NCT01064479|2351056|FG001|Overall Study|Disease progression|1
1191032|NCT01064479|2351055|FG000|Overall Study|Toxicity|1
1191033|NCT01064479|2351056|FG001|Overall Study|Toxicity|1
1191034|NCT01064479|2351055|FG000|Overall Study|Other|1
1191035|NCT01064479|2351056|FG001|Overall Study|Other|2
1191036|NCT01042522|2351064|FG000|Overall Study|Adverse Event|1
1191037|NCT01042522|2351065|FG001|Overall Study|Adverse Event|2
1191038|NCT01042522|2351064|FG000|Overall Study|Disease Progression|5
1191039|NCT01042522|2351065|FG001|Overall Study|Disease Progression|0
1191040|NCT01042522|2351064|FG000|Overall Study|Death|1
1191041|NCT01042522|2351065|FG001|Overall Study|Death|0
1191042|NCT01042522|2351064|FG000|Overall Study|Patient Refused|0
1191043|NCT01042522|2351065|FG001|Overall Study|Patient Refused|3
1191044|NCT01042522|2351064|FG000|Overall Study|Withdrawal by Subject|1
1191045|NCT01042522|2351065|FG001|Overall Study|Withdrawal by Subject|1
882244|NCT00603798|1847284|FG001|Overall Study|Lost to Follow-up|0
882245|NCT00603798|1847285|FG002|Overall Study|Lost to Follow-up|1
882246|NCT00603798|1847283|FG000|Overall Study|Non-compliance with study procedures|0
882247|NCT00603798|1847284|FG001|Overall Study|Non-compliance with study procedures|1
882248|NCT00603798|1847285|FG002|Overall Study|Non-compliance with study procedures|0
882249|NCT00603798|1847283|FG000|Overall Study|Not due to AE|1
882250|NCT00603798|1847284|FG001|Overall Study|Not due to AE|1
882251|NCT00603798|1847285|FG002|Overall Study|Not due to AE|4
882252|NCT00603837|1847295|FG000|Overall Study|Physician Decision|3
882253|NCT00603837|1847296|FG001|Overall Study|Physician Decision|0
882254|NCT00603915|1847319|FG000|Overall Study|Physician Decision|1
882255|NCT00603941|1847326|FG000|Overall Study|Disease progression|6
882256|NCT00603941|1847327|FG001|Overall Study|Disease progression|7
882257|NCT00603941|1847328|FG002|Overall Study|Disease progression|1
882258|NCT00603941|1847326|FG000|Overall Study|Adverse Event|1
882259|NCT00603941|1847327|FG001|Overall Study|Adverse Event|0
882260|NCT00603941|1847328|FG002|Overall Study|Adverse Event|1
882261|NCT00603941|1847326|FG000|Overall Study|Physician Decision|0
882262|NCT00603941|1847327|FG001|Overall Study|Physician Decision|1
882263|NCT00603941|1847328|FG002|Overall Study|Physician Decision|0
882264|NCT00603941|1847326|FG000|Overall Study|Withdrawal by Subject|0
882265|NCT00603941|1847327|FG001|Overall Study|Withdrawal by Subject|2
882266|NCT00603941|1847328|FG002|Overall Study|Withdrawal by Subject|0
1191062|NCT00710970|2351113|FG000|Overall Study|Never took drug|3
1191063|NCT00685919|2351121|FG000|Overall Study|Withdrawal by Subject|0
1191064|NCT00685919|2351122|FG001|Overall Study|Withdrawal by Subject|0
1191065|NCT00685919|2351123|FG002|Overall Study|Withdrawal by Subject|1
1191066|NCT00685919|2351124|FG003|Overall Study|Withdrawal by Subject|0
1191067|NCT00685919|2351121|FG000|Overall Study|Physician Decision|1
1191068|NCT00685919|2351122|FG001|Overall Study|Physician Decision|0
1191069|NCT00685919|2351123|FG002|Overall Study|Physician Decision|0
1191070|NCT00685919|2351124|FG003|Overall Study|Physician Decision|0
1191071|NCT00344487|2351134|FG000|Overall Study|immunologic failure|1
1191072|NCT00281658|2351142|FG000|Double-blind, Randomized Phase|Death|120
1191073|NCT00281658|2351143|FG001|Double-blind, Randomized Phase|Death|46
1191074|NCT00281658|2351144|FG002|Double-blind, Randomized Phase|Death|0
1191075|NCT00281658|2351142|FG000|Double-blind, Randomized Phase|Lost to Follow-up|12
1191076|NCT00281658|2351143|FG001|Double-blind, Randomized Phase|Lost to Follow-up|5
1191077|NCT00281658|2351144|FG002|Double-blind, Randomized Phase|Lost to Follow-up|0
1191078|NCT00281658|2351142|FG000|Double-blind, Randomized Phase|Withdrawal by Subject|4
1191079|NCT00281658|2351143|FG001|Double-blind, Randomized Phase|Withdrawal by Subject|1
1191080|NCT00281658|2351144|FG002|Double-blind, Randomized Phase|Withdrawal by Subject|0
1191081|NCT00281658|2351142|FG000|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1191082|NCT00281658|2351143|FG001|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1191083|NCT00281658|2351144|FG002|Double-blind, Randomized Phase|Participant Entered New Protocol|0
1191084|NCT00281658|2351142|FG000|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1191085|NCT00281658|2351143|FG001|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
1191086|NCT00281658|2351144|FG002|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1191087|NCT00281658|2351142|FG000|Open-label Monotherapy Extension Phase|Death|0
1191088|NCT00281658|2351143|FG001|Open-label Monotherapy Extension Phase|Death|0
1191089|NCT00281658|2351144|FG002|Open-label Monotherapy Extension Phase|Death|97
1191090|NCT00281658|2351142|FG000|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1191091|NCT00281658|2351143|FG001|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1191092|NCT00281658|2351144|FG002|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
1191093|NCT00281658|2351142|FG000|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1191094|NCT00281658|2351143|FG001|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1191095|NCT00281658|2351144|FG002|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
882267|NCT00603980|1847337|FG000|Study Qualification|Protocol Violation|3
882268|NCT00603980|1847337|FG000|Study Qualification|Inconsistent data reporting|13
882269|NCT00603980|1847337|FG000|Main Study|14th subject completed trial|1
882270|NCT00604162|1847379|FG000|Overall Study|Physician Decision|3
882271|NCT00604162|1847379|FG000|Overall Study|Withdrawal by Subject|1
882272|NCT00604175|1847389|FG000|Entry Through Week 28|Death|2
882273|NCT00604175|1847390|FG001|Entry Through Week 28|Death|0
882274|NCT00604175|1847391|FG002|Entry Through Week 28|Death|0
882275|NCT00604175|1847389|FG000|Entry Through Week 28|Withdrawal by Subject|1
882276|NCT00604175|1847390|FG001|Entry Through Week 28|Withdrawal by Subject|0
882277|NCT00604175|1847391|FG002|Entry Through Week 28|Withdrawal by Subject|0
882278|NCT00604175|1847389|FG000|Entry Through Week 28|Lost to Follow-up|4
882279|NCT00604175|1847390|FG001|Entry Through Week 28|Lost to Follow-up|3
882280|NCT00604175|1847391|FG002|Entry Through Week 28|Lost to Follow-up|0
882281|NCT00604175|1847389|FG000|Entry Through Week 28|Ineligible|1
882282|NCT00604175|1847390|FG001|Entry Through Week 28|Ineligible|0
1191096|NCT04034355|2351175|FG000|Overall Study|Study terminated by Sponsor|10
1191097|NCT04034355|2351176|FG001|Overall Study|Study terminated by Sponsor|17
1191098|NCT04034355|2351175|FG000|Overall Study|Withdrawal by Subject|12
1191099|NCT04034355|2351176|FG001|Overall Study|Withdrawal by Subject|11
1191100|NCT04034355|2351175|FG000|Overall Study|Site terminated by Sponsor|4
1191101|NCT04034355|2351176|FG001|Overall Study|Site terminated by Sponsor|5
1191102|NCT04034355|2351175|FG000|Overall Study|Adverse Event|2
1191103|NCT04034355|2351176|FG001|Overall Study|Adverse Event|0
1191104|NCT04034355|2351175|FG000|Overall Study|Death|1
1191105|NCT04034355|2351176|FG001|Overall Study|Death|1
1191106|NCT04034355|2351175|FG000|Overall Study|Not reported|2
1191107|NCT04034355|2351176|FG001|Overall Study|Not reported|0
1191108|NCT04034355|2351175|FG000|Overall Study|Lost to Follow-up|1
1191109|NCT04034355|2351176|FG001|Overall Study|Lost to Follow-up|0
1191110|NCT04034355|2351175|FG000|Overall Study|Physician Decision|1
1191111|NCT04034355|2351176|FG001|Overall Study|Physician Decision|0
1191112|NCT04034355|2351175|FG000|Overall Study|Protocol Violation|0
1191113|NCT04034355|2351176|FG001|Overall Study|Protocol Violation|1
1191114|NCT04034355|2351175|FG000|Overall Study|Progressive disease|1
1191115|NCT04034355|2351176|FG001|Overall Study|Progressive disease|0
1191116|NCT03721276|2351188|FG000|Overall Study|Lost to Follow-up|5
1191117|NCT03721276|2351189|FG001|Overall Study|Lost to Follow-up|3
1191118|NCT03721276|2351188|FG000|Overall Study|Adverse Event|0
1191119|NCT03721276|2351189|FG001|Overall Study|Adverse Event|1
1191120|NCT03637491|2351212|FG000|Overall Study|Death|9
1191121|NCT03637491|2351213|FG001|Overall Study|Death|9
1191122|NCT03637491|2351214|FG002|Overall Study|Death|5
1191123|NCT03637491|2351215|FG003|Overall Study|Death|3
1191124|NCT03637491|2351212|FG000|Overall Study|Lost to Follow-up|0
1191125|NCT03637491|2351213|FG001|Overall Study|Lost to Follow-up|1
1191126|NCT03637491|2351214|FG002|Overall Study|Lost to Follow-up|0
1191127|NCT03637491|2351215|FG003|Overall Study|Lost to Follow-up|1
1191128|NCT03637491|2351212|FG000|Overall Study|Study Terminated By Sponsor|0
1191129|NCT03637491|2351213|FG001|Overall Study|Study Terminated By Sponsor|2
1191130|NCT03637491|2351214|FG002|Overall Study|Study Terminated By Sponsor|1
1191131|NCT03637491|2351215|FG003|Overall Study|Study Terminated By Sponsor|0
1191132|NCT03637491|2351212|FG000|Overall Study|Withdrawal by Subject|1
1191133|NCT03637491|2351213|FG001|Overall Study|Withdrawal by Subject|0
1191134|NCT03637491|2351214|FG002|Overall Study|Withdrawal by Subject|1
1191135|NCT03637491|2351215|FG003|Overall Study|Withdrawal by Subject|2
1191136|NCT03334539|2351314|FG000|Overall Study|Adverse Event|3
1191137|NCT03334539|2351315|FG001|Overall Study|Adverse Event|5
1191138|NCT03334539|2351316|FG002|Overall Study|Adverse Event|0
1191139|NCT03334539|2351314|FG000|Overall Study|Withdrawal by Subject|0
1191140|NCT03334539|2351315|FG001|Overall Study|Withdrawal by Subject|1
1191141|NCT03334539|2351316|FG002|Overall Study|Withdrawal by Subject|1
1191142|NCT03334539|2351314|FG000|Overall Study|Administrative Reasons|1
1191143|NCT03334539|2351315|FG001|Overall Study|Administrative Reasons|0
1191144|NCT03334539|2351316|FG002|Overall Study|Administrative Reasons|0
1191145|NCT03334539|2351314|FG000|Overall Study|Hypertension Not Controlled|0
1191146|NCT03334539|2351315|FG001|Overall Study|Hypertension Not Controlled|1
1191147|NCT03334539|2351316|FG002|Overall Study|Hypertension Not Controlled|0
1191148|NCT03269344|2351338|FG000|Overall Study|Protocol Violation|4
1191149|NCT03269344|2351339|FG001|Overall Study|Protocol Violation|3
1191150|NCT03076775|2351353|FG000|Overall Study|Lost to Follow-up|1
1191151|NCT03076775|2351354|FG001|Overall Study|Lost to Follow-up|0
882283|NCT00604175|1847391|FG002|Entry Through Week 28|Ineligible|0
882284|NCT00604175|1847389|FG000|Entry Through Week 28|Did not start intervention|2
882285|NCT00604175|1847390|FG001|Entry Through Week 28|Did not start intervention|0
882286|NCT00604175|1847391|FG002|Entry Through Week 28|Did not start intervention|1
882287|NCT00604175|1847389|FG000|Week 29 Through Week 72|Death|0
882288|NCT00604175|1847390|FG001|Week 29 Through Week 72|Death|0
882289|NCT00604175|1847391|FG002|Week 29 Through Week 72|Death|1
882290|NCT00604175|1847389|FG000|Week 29 Through Week 72|Lost to Follow-up|12
882291|NCT00604175|1847390|FG001|Week 29 Through Week 72|Lost to Follow-up|6
882292|NCT00604175|1847391|FG002|Week 29 Through Week 72|Lost to Follow-up|2
882293|NCT00604175|1847389|FG000|Week 29 Through Week 72|Site closure|0
882294|NCT00604175|1847390|FG001|Week 29 Through Week 72|Site closure|1
882295|NCT00604175|1847391|FG002|Week 29 Through Week 72|Site closure|0
882296|NCT00604175|1847389|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0
882297|NCT00604175|1847390|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0
882298|NCT00604175|1847391|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1
882299|NCT00604188|1847425|FG000|Overall Study|Adverse Event|1
882300|NCT00604188|1847426|FG001|Overall Study|Adverse Event|4
882301|NCT00604188|1847425|FG000|Overall Study|Lost to Follow-up|17
882302|NCT00604188|1847426|FG001|Overall Study|Lost to Follow-up|15
882303|NCT00604188|1847425|FG000|Overall Study|Withdrawal by Subject|5
1191160|NCT02660827|2351405|FG000|From Study to End of Continued Access|Withdrawal by Subject|21
1191161|NCT02660827|2351405|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2
1191162|NCT02660827|2351405|FG000|From Study to End of Continued Access|Adverse Event|3
1191163|NCT02660827|2351405|FG000|From Study to End of Continued Access|didn't participate continued access period|5
1191164|NCT02660827|2351405|FG000|Period 1: Study Period|Withdrawal by Subject|1
1191165|NCT02660827|2351405|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20
1191166|NCT02660827|2351405|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2
1191167|NCT02660827|2351405|FG000|Period 2: Continued Access Period|Adverse Event|3
1191173|NCT02631941|2351426|FG000|Overall Study|Physician Decision|0
1191174|NCT02631941|2351427|FG001|Overall Study|Physician Decision|1
1191175|NCT02631941|2351428|FG002|Overall Study|Physician Decision|0
1191176|NCT02631941|2351429|FG003|Overall Study|Physician Decision|0
1191177|NCT02631941|2351430|FG004|Overall Study|Physician Decision|0
1191178|NCT02631941|2351431|FG005|Overall Study|Physician Decision|0
1191179|NCT02631941|2351432|FG006|Overall Study|Physician Decision|0
1191180|NCT02631941|2351433|FG007|Overall Study|Physician Decision|0
1191181|NCT02631941|2351434|FG008|Overall Study|Physician Decision|0
1191182|NCT02631941|2351435|FG009|Overall Study|Physician Decision|0
1191183|NCT02631941|2351426|FG000|Overall Study|Adverse Event|0
1191184|NCT02631941|2351427|FG001|Overall Study|Adverse Event|1
1191185|NCT02631941|2351428|FG002|Overall Study|Adverse Event|0
1191186|NCT02631941|2351429|FG003|Overall Study|Adverse Event|0
1191187|NCT02631941|2351430|FG004|Overall Study|Adverse Event|0
1191188|NCT02631941|2351431|FG005|Overall Study|Adverse Event|0
1191189|NCT02631941|2351432|FG006|Overall Study|Adverse Event|0
1191190|NCT02631941|2351433|FG007|Overall Study|Adverse Event|0
1191191|NCT02631941|2351434|FG008|Overall Study|Adverse Event|0
1191192|NCT02631941|2351435|FG009|Overall Study|Adverse Event|0
1191193|NCT02631941|2351426|FG000|Overall Study|Withdrawal by Subject|0
1191194|NCT02631941|2351427|FG001|Overall Study|Withdrawal by Subject|0
1191195|NCT02631941|2351428|FG002|Overall Study|Withdrawal by Subject|0
1191196|NCT02631941|2351429|FG003|Overall Study|Withdrawal by Subject|0
1191197|NCT02631941|2351430|FG004|Overall Study|Withdrawal by Subject|1
1191198|NCT02631941|2351431|FG005|Overall Study|Withdrawal by Subject|0
1191199|NCT02631941|2351432|FG006|Overall Study|Withdrawal by Subject|0
1191200|NCT02631941|2351433|FG007|Overall Study|Withdrawal by Subject|1
1191201|NCT02631941|2351434|FG008|Overall Study|Withdrawal by Subject|0
1191202|NCT02631941|2351435|FG009|Overall Study|Withdrawal by Subject|0
1191203|NCT02631941|2351426|FG000|Overall Study|Lost to Follow-up|0
1191204|NCT02631941|2351427|FG001|Overall Study|Lost to Follow-up|0
1191205|NCT02631941|2351428|FG002|Overall Study|Lost to Follow-up|0
1191206|NCT02631941|2351429|FG003|Overall Study|Lost to Follow-up|0
1191207|NCT02631941|2351430|FG004|Overall Study|Lost to Follow-up|0
1191208|NCT02631941|2351431|FG005|Overall Study|Lost to Follow-up|0
1191209|NCT02631941|2351432|FG006|Overall Study|Lost to Follow-up|0
1191210|NCT02631941|2351433|FG007|Overall Study|Lost to Follow-up|0
1191211|NCT02631941|2351434|FG008|Overall Study|Lost to Follow-up|1
1191212|NCT02631941|2351435|FG009|Overall Study|Lost to Follow-up|0
1191213|NCT02581930|2351454|FG000|Overall Study|Withdrawal by Subject|1
1191214|NCT02581930|2351454|FG000|Overall Study|patient declined further treatment|1
1191215|NCT02496676|2351460|FG000|Phase 1 - Period 1|Adverse Event|0
1191216|NCT02496676|2351461|FG001|Phase 1 - Period 1|Adverse Event|1
1191217|NCT02496676|2351460|FG000|Phase 2 - IV MgSO4|Adverse Event|0
1191218|NCT02496676|2351461|FG001|Phase 2 - IV MgSO4|Adverse Event|1
1191219|NCT02425644|2351477|FG000|Overall Study|Lost to Follow-up|2
1191220|NCT02425644|2351478|FG001|Overall Study|Lost to Follow-up|3
1191221|NCT02425644|2351477|FG000|Overall Study|Withdrawal by Subject|41
1191222|NCT02425644|2351478|FG001|Overall Study|Withdrawal by Subject|36
1191223|NCT02425644|2351477|FG000|Overall Study|Lack of Efficacy|3
1191224|NCT02425644|2351478|FG001|Overall Study|Lack of Efficacy|10
1191225|NCT02425644|2351477|FG000|Overall Study|Adverse Event|13
1191226|NCT02425644|2351478|FG001|Overall Study|Adverse Event|3
1191227|NCT02425644|2351477|FG000|Overall Study|Death|0
1191228|NCT02425644|2351478|FG001|Overall Study|Death|2
1191229|NCT02425644|2351477|FG000|Overall Study|Other|18
1191230|NCT02425644|2351478|FG001|Overall Study|Other|17
1191231|NCT02340221|2351491|FG000|Overall Study|Death|58
1191232|NCT02340221|2351492|FG001|Overall Study|Death|101
1191233|NCT02340221|2351491|FG000|Overall Study|Withdrawal by Participant|14
1191234|NCT02340221|2351492|FG001|Overall Study|Withdrawal by Participant|22
1191235|NCT02340221|2351491|FG000|Overall Study|Lost to Follow-up|2
1191236|NCT02340221|2351492|FG001|Overall Study|Lost to Follow-up|3
1191237|NCT02340221|2351491|FG000|Overall Study|Reason Not Specified|0
882304|NCT00604188|1847426|FG001|Overall Study|Withdrawal by Subject|1
1191238|NCT02340221|2351492|FG001|Overall Study|Reason Not Specified|1
1191239|NCT02340221|2351491|FG000|Overall Study|Continued on study|140
1191240|NCT02340221|2351492|FG001|Overall Study|Continued on study|290
1191241|NCT02270957|2351501|FG000|Overall Study|Lack of Efficacy|2
1191242|NCT02270957|2351502|FG001|Overall Study|Lack of Efficacy|4
1191243|NCT02270957|2351501|FG000|Overall Study|Adverse Event|2
1191244|NCT02270957|2351502|FG001|Overall Study|Adverse Event|0
1191246|NCT02237508|2351523|FG000|Overall Study|Withdrawal by Subject|0
1191247|NCT02237508|2351524|FG001|Overall Study|Withdrawal by Subject|2
1191248|NCT02237508|2351525|FG002|Overall Study|Withdrawal by Subject|0
1191249|NCT02237508|2351526|FG003|Overall Study|Withdrawal by Subject|1
1191250|NCT02237508|2351527|FG004|Overall Study|Withdrawal by Subject|0
1191251|NCT02237508|2351528|FG005|Overall Study|Withdrawal by Subject|1
1191252|NCT02237508|2351529|FG006|Overall Study|Withdrawal by Subject|1
1191253|NCT02237508|2351530|FG007|Overall Study|Withdrawal by Subject|0
1191254|NCT02237508|2351531|FG008|Overall Study|Withdrawal by Subject|1
1191255|NCT02237508|2351532|FG009|Overall Study|Withdrawal by Subject|0
1191256|NCT02237508|2351523|FG000|Overall Study|Physician Decision|0
1191257|NCT02237508|2351524|FG001|Overall Study|Physician Decision|1
1191258|NCT02237508|2351525|FG002|Overall Study|Physician Decision|0
1191259|NCT02237508|2351526|FG003|Overall Study|Physician Decision|0
1191260|NCT02237508|2351527|FG004|Overall Study|Physician Decision|0
1191261|NCT02237508|2351528|FG005|Overall Study|Physician Decision|0
1191262|NCT02237508|2351529|FG006|Overall Study|Physician Decision|0
1191263|NCT02237508|2351530|FG007|Overall Study|Physician Decision|0
1191264|NCT02237508|2351531|FG008|Overall Study|Physician Decision|0
1191265|NCT02237508|2351532|FG009|Overall Study|Physician Decision|0
1191266|NCT02237508|2351523|FG000|Overall Study|Protocol Violation|0
1191267|NCT02237508|2351524|FG001|Overall Study|Protocol Violation|0
1191268|NCT02237508|2351525|FG002|Overall Study|Protocol Violation|1
1191269|NCT02237508|2351526|FG003|Overall Study|Protocol Violation|0
1191270|NCT02237508|2351527|FG004|Overall Study|Protocol Violation|0
1191271|NCT02237508|2351528|FG005|Overall Study|Protocol Violation|0
1191272|NCT02237508|2351529|FG006|Overall Study|Protocol Violation|0
1191273|NCT02237508|2351530|FG007|Overall Study|Protocol Violation|0
1191274|NCT02237508|2351531|FG008|Overall Study|Protocol Violation|0
1191275|NCT02237508|2351532|FG009|Overall Study|Protocol Violation|0
1191276|NCT02157883|2351550|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
1191277|NCT02157883|2351550|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
1191278|NCT02157883|2351550|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
1191279|NCT02157883|2351550|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
1191280|NCT02157883|2351550|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3
1191281|NCT02134925|2351559|FG000|Overall Study|Withdrawal by Subject|1
1191282|NCT02134925|2351560|FG001|Overall Study|Withdrawal by Subject|0
1191283|NCT02134925|2351559|FG000|Overall Study|Cancel|1
1191284|NCT02134925|2351560|FG001|Overall Study|Cancel|6
1191285|NCT02054104|2351568|FG000|Overall Study|Did not want to continue due to college classes|1
1191286|NCT02054104|2351569|FG001|Overall Study|Did not want to continue due to college classes|0
1191287|NCT02054104|2351568|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1
1191288|NCT02054104|2351569|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0
1191289|NCT02054104|2351568|FG000|Overall Study|No evidence of immunologic response|2
1191290|NCT02054104|2351569|FG001|Overall Study|No evidence of immunologic response|2
1191291|NCT02054104|2351568|FG000|Overall Study|Disease Progression On Study|4
1191292|NCT02054104|2351569|FG001|Overall Study|Disease Progression On Study|5
1191293|NCT02054104|2351568|FG000|Overall Study|Diagnosis of lymphoma|0
1191294|NCT02054104|2351569|FG001|Overall Study|Diagnosis of lymphoma|1
1191295|NCT02054104|2351568|FG000|Overall Study|Inconclusive response|0
1191296|NCT02054104|2351569|FG001|Overall Study|Inconclusive response|1
1191297|NCT01899144|2351584|FG000|Treatment Period 2|Other|1
1191298|NCT01899144|2351584|FG000|Treatment Period 3|Other|2
1191299|NCT01899144|2351584|FG000|Treatment Period 5|Other|1
1191300|NCT01793610|2351599|FG000|Overall Study|Withdrawal by Subject|1
1191301|NCT01793610|2351600|FG001|Overall Study|Withdrawal by Subject|0
1191302|NCT01793610|2351601|FG002|Overall Study|Withdrawal by Subject|1
1191303|NCT01757665|2351615|FG000|Overall Study|Still on Study - Visit Completed|240
1191304|NCT01757665|2351616|FG001|Overall Study|Still on Study - Visit Completed|30
1191305|NCT01757665|2351615|FG000|Overall Study|Still on Study - Visit Pending|398
1191306|NCT01757665|2351616|FG001|Overall Study|Still on Study - Visit Pending|40
1191307|NCT01757665|2351615|FG000|Overall Study|Still on Study - Missed Visit|14
1191308|NCT01757665|2351616|FG001|Overall Study|Still on Study - Missed Visit|1
1191309|NCT01757665|2351615|FG000|Overall Study|Death|25
1191310|NCT01757665|2351616|FG001|Overall Study|Death|8
1191311|NCT01757665|2351615|FG000|Overall Study|Explant|1
1191312|NCT01757665|2351616|FG001|Overall Study|Explant|2
1191313|NCT01757665|2351615|FG000|Overall Study|Withdrawal by Subject|10
1191314|NCT01757665|2351616|FG001|Overall Study|Withdrawal by Subject|0
1191315|NCT01757665|2351615|FG000|Overall Study|Lost to Follow-up|1
1191316|NCT01757665|2351616|FG001|Overall Study|Lost to Follow-up|1
1191317|NCT01757665|2351615|FG000|Overall Study|Not Implanted with Device|5
1191318|NCT01757665|2351616|FG001|Overall Study|Not Implanted with Device|1
1191319|NCT00822120|2351657|FG000|Initial Registration|Adverse Event|1
1191320|NCT00822120|2351658|FG001|Initial Registration|Adverse Event|0
1191321|NCT00822120|2351659|FG002|Initial Registration|Adverse Event|0
1191322|NCT00822120|2351660|FG003|Initial Registration|Adverse Event|0
1191323|NCT00822120|2351661|FG004|Initial Registration|Adverse Event|0
1191324|NCT00822120|2351662|FG005|Initial Registration|Adverse Event|0
1191325|NCT00822120|2351657|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1
1191326|NCT00822120|2351658|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
1191327|NCT00822120|2351659|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0
1191328|NCT00822120|2351660|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0
1191329|NCT00822120|2351661|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0
1191330|NCT00822120|2351662|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0
1191331|NCT00822120|2351657|FG000|Initial Registration|Reasons not Protocol Specified|2
1191332|NCT00822120|2351658|FG001|Initial Registration|Reasons not Protocol Specified|0
1191333|NCT00822120|2351659|FG002|Initial Registration|Reasons not Protocol Specified|0
1191334|NCT00822120|2351660|FG003|Initial Registration|Reasons not Protocol Specified|0
1191335|NCT00822120|2351661|FG004|Initial Registration|Reasons not Protocol Specified|0
1191336|NCT00822120|2351662|FG005|Initial Registration|Reasons not Protocol Specified|0
1191337|NCT00822120|2351657|FG000|Initial Registration|Ineligible|22
1191338|NCT00822120|2351658|FG001|Initial Registration|Ineligible|1
1191339|NCT00822120|2351659|FG002|Initial Registration|Ineligible|0
1191340|NCT00822120|2351660|FG003|Initial Registration|Ineligible|0
1191341|NCT00822120|2351661|FG004|Initial Registration|Ineligible|0
1191342|NCT00822120|2351662|FG005|Initial Registration|Ineligible|0
1191343|NCT00822120|2351657|FG000|PET-directed Therapy|Adverse Event|0
1191344|NCT00822120|2351658|FG001|PET-directed Therapy|Adverse Event|0
1191345|NCT00822120|2351659|FG002|PET-directed Therapy|Adverse Event|0
1191346|NCT00822120|2351660|FG003|PET-directed Therapy|Adverse Event|1
1191347|NCT00822120|2351661|FG004|PET-directed Therapy|Adverse Event|0
1191348|NCT00822120|2351662|FG005|PET-directed Therapy|Adverse Event|0
1191349|NCT00822120|2351657|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1191350|NCT00822120|2351658|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1191351|NCT00822120|2351659|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1191352|NCT00822120|2351660|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
1191353|NCT00822120|2351661|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
882305|NCT00604188|1847425|FG000|Overall Study|Non-compliance with protocol|4
882306|NCT00604188|1847426|FG001|Overall Study|Non-compliance with protocol|4
882307|NCT00604188|1847425|FG000|Overall Study|Did not receive study drug|0
882308|NCT00604188|1847426|FG001|Overall Study|Did not receive study drug|1
882309|NCT00604214|1847438|FG000|Baseline to Day 28|Death|223
882310|NCT00604214|1847439|FG001|Baseline to Day 28|Death|202
882311|NCT00604214|1847438|FG000|Baseline to Day 28|Lost to Follow-up|2
882312|NCT00604214|1847439|FG001|Baseline to Day 28|Lost to Follow-up|4
882313|NCT00604214|1847438|FG000|Baseline to Day 28|Withdrawal by Subject|3
882314|NCT00604214|1847439|FG001|Baseline to Day 28|Withdrawal by Subject|7
882315|NCT00604214|1847438|FG000|Day 29 to Day 90|Death|64
882316|NCT00604214|1847439|FG001|Day 29 to Day 90|Death|67
882317|NCT00604214|1847438|FG000|Day 29 to Day 90|Lost to Follow-up|4
882318|NCT00604214|1847439|FG001|Day 29 to Day 90|Lost to Follow-up|6
882319|NCT00604214|1847438|FG000|Day 29 to Day 90|Withdrawal by Subject|0
882320|NCT00604214|1847439|FG001|Day 29 to Day 90|Withdrawal by Subject|6
882321|NCT00604214|1847438|FG000|Day 91 to Day 180|Death|19
882322|NCT00604214|1847439|FG001|Day 91 to Day 180|Death|23
882323|NCT00604214|1847438|FG000|Day 91 to Day 180|Lost to Follow-up|6
1191354|NCT00822120|2351662|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1191355|NCT00822120|2351657|FG000|PET-directed Therapy|Death|0
1191356|NCT00822120|2351658|FG001|PET-directed Therapy|Death|0
1191357|NCT00822120|2351659|FG002|PET-directed Therapy|Death|0
1191358|NCT00822120|2351660|FG003|PET-directed Therapy|Death|2
1191359|NCT00822120|2351661|FG004|PET-directed Therapy|Death|0
1191360|NCT00822120|2351662|FG005|PET-directed Therapy|Death|0
1191361|NCT00822120|2351657|FG000|PET-directed Therapy|Protocol Violation|0
1191362|NCT00822120|2351658|FG001|PET-directed Therapy|Protocol Violation|0
1191363|NCT00822120|2351659|FG002|PET-directed Therapy|Protocol Violation|0
1191364|NCT00822120|2351660|FG003|PET-directed Therapy|Protocol Violation|6
1191365|NCT00822120|2351661|FG004|PET-directed Therapy|Protocol Violation|0
1191366|NCT00822120|2351662|FG005|PET-directed Therapy|Protocol Violation|0
1191367|NCT00603954|2351685|FG000|Overall Study|Protocol Violation|1
1191368|NCT00603954|2351686|FG001|Overall Study|Protocol Violation|2
1191369|NCT04532294|2351700|FG000|Overall Study|Withdrawal by Subject|0
1191370|NCT04532294|2351701|FG001|Overall Study|Withdrawal by Subject|0
1191371|NCT04532294|2351702|FG002|Overall Study|Withdrawal by Subject|1
1191372|NCT04532294|2351700|FG000|Overall Study|Participants Not Dosed|0
1191373|NCT04532294|2351701|FG001|Overall Study|Participants Not Dosed|0
1191374|NCT04532294|2351702|FG002|Overall Study|Participants Not Dosed|2
1191375|NCT04250077|2351715|FG000|Overall Study|Withdrawal by Subject|0
1191376|NCT04250077|2351716|FG001|Overall Study|Withdrawal by Subject|1
1191377|NCT04250077|2351717|FG002|Overall Study|Withdrawal by Subject|0
1191378|NCT04250077|2351715|FG000|Overall Study|Lost to Follow-up|2
1191379|NCT04250077|2351716|FG001|Overall Study|Lost to Follow-up|3
1191380|NCT04250077|2351717|FG002|Overall Study|Lost to Follow-up|0
1191381|NCT03441360|2351771|FG000|Overall Study|Radiological disease progression|5
1191382|NCT03441360|2351772|FG001|Overall Study|Radiological disease progression|6
1191383|NCT03441360|2351773|FG002|Overall Study|Radiological disease progression|4
1191384|NCT03441360|2351771|FG000|Overall Study|Clinical disease progression|2
1191385|NCT03441360|2351772|FG001|Overall Study|Clinical disease progression|2
1191386|NCT03441360|2351773|FG002|Overall Study|Clinical disease progression|0
1191387|NCT03441360|2351771|FG000|Overall Study|Adverse Event|1
1191388|NCT03441360|2351772|FG001|Overall Study|Adverse Event|0
1191389|NCT03441360|2351773|FG002|Overall Study|Adverse Event|1
1191390|NCT03412565|2351785|FG000|Overall Study|Other|0
1191391|NCT03412565|2351786|FG001|Overall Study|Other|0
1191392|NCT03412565|2351787|FG002|Overall Study|Other|0
1191393|NCT03412565|2351788|FG003|Overall Study|Other|3
1191394|NCT03412565|2351785|FG000|Overall Study|Withdrawal by Subject|0
1191395|NCT03412565|2351786|FG001|Overall Study|Withdrawal by Subject|0
1191396|NCT03412565|2351787|FG002|Overall Study|Withdrawal by Subject|1
1191397|NCT03412565|2351788|FG003|Overall Study|Withdrawal by Subject|5
1191398|NCT03412565|2351785|FG000|Overall Study|Physician Decision|0
1191399|NCT03412565|2351786|FG001|Overall Study|Physician Decision|1
1191400|NCT03412565|2351787|FG002|Overall Study|Physician Decision|0
1191401|NCT03412565|2351788|FG003|Overall Study|Physician Decision|1
1191402|NCT03412565|2351785|FG000|Overall Study|Death|1
1191403|NCT03412565|2351786|FG001|Overall Study|Death|2
1191404|NCT03412565|2351787|FG002|Overall Study|Death|2
1191405|NCT03412565|2351788|FG003|Overall Study|Death|4
1191406|NCT03412565|2351785|FG000|Overall Study|Still ongoing|0
1191407|NCT03412565|2351786|FG001|Overall Study|Still ongoing|62
1191408|NCT03412565|2351787|FG002|Overall Study|Still ongoing|59
1191409|NCT03412565|2351788|FG003|Overall Study|Still ongoing|41
1191410|NCT03296553|2351805|FG000|Overall Study|Withdrawal by Subject|1
1191411|NCT03296553|2351806|FG001|Overall Study|Withdrawal by Subject|1
1191412|NCT03296553|2351805|FG000|Overall Study|Death|1
1191413|NCT03296553|2351806|FG001|Overall Study|Death|0
1191414|NCT03277105|2351814|FG000|Overall Study|Death|77
1191415|NCT03277105|2351815|FG001|Overall Study|Death|73
1191416|NCT03277105|2351814|FG000|Overall Study|Lost to Follow-up|0
1191417|NCT03277105|2351815|FG001|Overall Study|Lost to Follow-up|3
1191418|NCT03277105|2351814|FG000|Overall Study|Withdrawal by Subject|10
1191419|NCT03277105|2351815|FG001|Overall Study|Withdrawal by Subject|9
1191420|NCT03277105|2351814|FG000|Overall Study|Other|1
1191421|NCT03277105|2351815|FG001|Overall Study|Other|3
1191422|NCT03277105|2351814|FG000|Overall Study|Ongoing|171
1191423|NCT03277105|2351815|FG001|Overall Study|Ongoing|175
1191424|NCT03201965|2351824|FG000|Overall Study|Death|5
1191425|NCT03201965|2351825|FG001|Overall Study|Death|27
1191426|NCT03201965|2351826|FG002|Overall Study|Death|27
1191427|NCT03201965|2351824|FG000|Overall Study|Lost to Follow-up|0
1191428|NCT03201965|2351825|FG001|Overall Study|Lost to Follow-up|1
1191429|NCT03201965|2351826|FG002|Overall Study|Lost to Follow-up|0
1191430|NCT03201965|2351824|FG000|Overall Study|Withdrawal by Subject|3
1191431|NCT03201965|2351825|FG001|Overall Study|Withdrawal by Subject|13
1191432|NCT03201965|2351826|FG002|Overall Study|Withdrawal by Subject|4
1191433|NCT03201965|2351824|FG000|Overall Study|Ongoing|20
1191434|NCT03201965|2351825|FG001|Overall Study|Ongoing|152
1191435|NCT03201965|2351826|FG002|Overall Study|Ongoing|164
1191436|NCT03194646|2351837|FG000|Overall Study|Adverse Event|24
1191437|NCT03194646|2351838|FG001|Overall Study|Adverse Event|25
1191438|NCT03194646|2351839|FG002|Overall Study|Adverse Event|14
1191439|NCT03194646|2351840|FG003|Overall Study|Adverse Event|17
1191440|NCT03194646|2351837|FG000|Overall Study|Lack of Efficacy|4
1191441|NCT03194646|2351838|FG001|Overall Study|Lack of Efficacy|2
1191442|NCT03194646|2351839|FG002|Overall Study|Lack of Efficacy|2
1191443|NCT03194646|2351840|FG003|Overall Study|Lack of Efficacy|12
1191444|NCT03194646|2351837|FG000|Overall Study|Lost to Follow-up|30
1191445|NCT03194646|2351838|FG001|Overall Study|Lost to Follow-up|22
1191446|NCT03194646|2351839|FG002|Overall Study|Lost to Follow-up|12
1191447|NCT03194646|2351840|FG003|Overall Study|Lost to Follow-up|35
1191448|NCT03194646|2351837|FG000|Overall Study|Non-compliance with study drug|4
1191449|NCT03194646|2351838|FG001|Overall Study|Non-compliance with study drug|0
1191450|NCT03194646|2351839|FG002|Overall Study|Non-compliance with study drug|1
1191451|NCT03194646|2351840|FG003|Overall Study|Non-compliance with study drug|1
1191452|NCT03194646|2351837|FG000|Overall Study|Other|87
1191453|NCT03194646|2351838|FG001|Overall Study|Other|67
1191454|NCT03194646|2351839|FG002|Overall Study|Other|34
1191455|NCT03194646|2351840|FG003|Overall Study|Other|31
1191456|NCT03194646|2351837|FG000|Overall Study|Physician Decision|7
1191457|NCT03194646|2351838|FG001|Overall Study|Physician Decision|9
1191458|NCT03194646|2351839|FG002|Overall Study|Physician Decision|5
1191459|NCT03194646|2351840|FG003|Overall Study|Physician Decision|4
1191460|NCT03194646|2351837|FG000|Overall Study|Pregnancy|4
1191461|NCT03194646|2351838|FG001|Overall Study|Pregnancy|5
1191462|NCT03194646|2351839|FG002|Overall Study|Pregnancy|1
1191463|NCT03194646|2351840|FG003|Overall Study|Pregnancy|2
1191464|NCT03194646|2351837|FG000|Overall Study|Protocol Violation|4
1191465|NCT03194646|2351838|FG001|Overall Study|Protocol Violation|2
1191466|NCT03194646|2351839|FG002|Overall Study|Protocol Violation|1
1191467|NCT03194646|2351840|FG003|Overall Study|Protocol Violation|1
1191468|NCT03194646|2351837|FG000|Overall Study|Site terminated by sponsor|0
1191469|NCT03194646|2351838|FG001|Overall Study|Site terminated by sponsor|0
1191470|NCT03194646|2351839|FG002|Overall Study|Site terminated by sponsor|2
1191471|NCT03194646|2351840|FG003|Overall Study|Site terminated by sponsor|0
1191472|NCT03194646|2351837|FG000|Overall Study|Study terminated by sponsor|60
1191473|NCT03194646|2351838|FG001|Overall Study|Study terminated by sponsor|61
1191474|NCT03194646|2351839|FG002|Overall Study|Study terminated by sponsor|30
1191475|NCT03194646|2351840|FG003|Overall Study|Study terminated by sponsor|34
1191476|NCT03194646|2351837|FG000|Overall Study|Withdrawal by Subject|74
1191477|NCT03194646|2351838|FG001|Overall Study|Withdrawal by Subject|75
1191478|NCT03194646|2351839|FG002|Overall Study|Withdrawal by Subject|36
1191479|NCT03194646|2351840|FG003|Overall Study|Withdrawal by Subject|131
1191480|NCT03194646|2351837|FG000|Overall Study|Missing|4
1191481|NCT03194646|2351838|FG001|Overall Study|Missing|0
1191482|NCT03194646|2351839|FG002|Overall Study|Missing|1
1191483|NCT03194646|2351840|FG003|Overall Study|Missing|12
1191484|NCT03148795|2351855|FG000|Overall Study|Death|6
1191485|NCT03148795|2351855|FG000|Overall Study|Adverse Event|5
1191486|NCT03148795|2351855|FG000|Overall Study|Other|15
1191487|NCT03148795|2351855|FG000|Overall Study|No Longer Clinically Benefitting|2
1191488|NCT03148795|2351855|FG000|Overall Study|Global Deterioration Of Health Status|6
1191489|NCT03148795|2351855|FG000|Overall Study|Withdrawal by Subject|2
1191490|NCT03148795|2351855|FG000|Overall Study|Progressive Disease|62
1191491|NCT03148795|2351855|FG000|Overall Study|Ongoing|30
1191492|NCT03052608|2351874|FG000|Treatment Phase|Adverse Event|10
1191493|NCT03052608|2351875|FG001|Treatment Phase|Adverse Event|12
1191494|NCT03052608|2351874|FG000|Treatment Phase|Death|6
1191495|NCT03052608|2351875|FG001|Treatment Phase|Death|4
1191496|NCT03052608|2351874|FG000|Treatment Phase|Withdrawal by Subject|4
1191497|NCT03052608|2351875|FG001|Treatment Phase|Withdrawal by Subject|12
1191498|NCT03052608|2351874|FG000|Treatment Phase|Global Deterioration of Health Status|0
1191499|NCT03052608|2351875|FG001|Treatment Phase|Global Deterioration of Health Status|3
1191500|NCT03052608|2351874|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0
1191501|NCT03052608|2351875|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1
1191502|NCT03052608|2351874|FG000|Treatment Phase|Subject didn't receive study treatment.|0
1191503|NCT03052608|2351875|FG001|Treatment Phase|Subject didn't receive study treatment.|1
1191504|NCT03052608|2351874|FG000|Treatment Phase|Ongoing|103
1191505|NCT03052608|2351875|FG001|Treatment Phase|Ongoing|31
1191506|NCT03052608|2351874|FG000|Long-Term Follow-up Phase|Death|23
1191507|NCT03052608|2351875|FG001|Long-Term Follow-up Phase|Death|28
1191508|NCT03052608|2351874|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0
1191509|NCT03052608|2351875|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2
1191510|NCT03052608|2351874|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4
1191511|NCT03052608|2351875|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18
1191512|NCT03052608|2351874|FG000|Long-Term Follow-up Phase|Ongoing|122
1191513|NCT03052608|2351875|FG001|Long-Term Follow-up Phase|Ongoing|99
1191514|NCT03038438|2351881|FG000|Overall Study|Death|2
1191515|NCT03038438|2351881|FG000|Overall Study|Lost to Follow-up|4
1191516|NCT03038438|2351881|FG000|Overall Study|Subject Incarceration|1
1191517|NCT03038438|2351881|FG000|Overall Study|Withdrawal by Subject|2
1191518|NCT03038438|2351881|FG000|Overall Study|No 24-Month Follow-Up|43
1191519|NCT03000569|2351887|FG000|Overall Study|Withdrawal by Subject|1
1191520|NCT03000569|2351888|FG001|Overall Study|Withdrawal by Subject|0
1191521|NCT03000530|2351905|FG000|Overall Study|Adverse Event|0
1191522|NCT03000530|2351906|FG001|Overall Study|Adverse Event|0
1191523|NCT03000530|2351907|FG002|Overall Study|Adverse Event|2
1191524|NCT03000530|2351905|FG000|Overall Study|Lost to Follow-up|0
1191525|NCT03000530|2351906|FG001|Overall Study|Lost to Follow-up|3
1191526|NCT03000530|2351907|FG002|Overall Study|Lost to Follow-up|1
1191527|NCT03000530|2351905|FG000|Overall Study|Withdrawal by Subject|0
1191528|NCT03000530|2351906|FG001|Overall Study|Withdrawal by Subject|2
1191529|NCT03000530|2351907|FG002|Overall Study|Withdrawal by Subject|1
1191530|NCT02978781|2351921|FG000|Part A|Adverse Event|1
1191531|NCT02978781|2351922|FG001|Part A|Adverse Event|1
1191532|NCT02978781|2351923|FG002|Part A|Adverse Event|0
1191533|NCT02978781|2351924|FG003|Part A|Adverse Event|0
1191534|NCT02978781|2351925|FG004|Part A|Adverse Event|0
1191535|NCT02978781|2351921|FG000|Part A|Withdrawal by Subject|0
1191536|NCT02978781|2351922|FG001|Part A|Withdrawal by Subject|1
1191537|NCT02978781|2351923|FG002|Part A|Withdrawal by Subject|0
1191538|NCT02978781|2351924|FG003|Part A|Withdrawal by Subject|0
1191539|NCT02978781|2351925|FG004|Part A|Withdrawal by Subject|0
1191540|NCT02978781|2351921|FG000|Part B|Withdrawal by Subject|0
1191541|NCT02978781|2351922|FG001|Part B|Withdrawal by Subject|0
1191542|NCT02978781|2351923|FG002|Part B|Withdrawal by Subject|0
1191543|NCT02978781|2351924|FG003|Part B|Withdrawal by Subject|1
1191544|NCT02978781|2351925|FG004|Part B|Withdrawal by Subject|0
1191545|NCT02978781|2351921|FG000|Part C|Adverse Event|0
1191546|NCT02978781|2351922|FG001|Part C|Adverse Event|0
1191547|NCT02978781|2351923|FG002|Part C|Adverse Event|0
1191548|NCT02978781|2351924|FG003|Part C|Adverse Event|0
1191549|NCT02978781|2351925|FG004|Part C|Adverse Event|2
1191550|NCT02978781|2351921|FG000|Part C|Withdrawal by Subject|0
1191551|NCT02978781|2351922|FG001|Part C|Withdrawal by Subject|0
1191552|NCT02978781|2351923|FG002|Part C|Withdrawal by Subject|0
1191553|NCT02978781|2351924|FG003|Part C|Withdrawal by Subject|0
1191554|NCT02978781|2351925|FG004|Part C|Withdrawal by Subject|1
1191555|NCT02978781|2351921|FG000|Part C|Tremor not improved due to Topamax discontinuation|0
1191556|NCT02978781|2351922|FG001|Part C|Tremor not improved due to Topamax discontinuation|0
1191557|NCT02978781|2351923|FG002|Part C|Tremor not improved due to Topamax discontinuation|0
1191558|NCT02978781|2351924|FG003|Part C|Tremor not improved due to Topamax discontinuation|0
1191559|NCT02978781|2351925|FG004|Part C|Tremor not improved due to Topamax discontinuation|1
1191560|NCT02978326|2351954|FG000|Part B (Up to 45 Days)|Adverse Event|0
1191561|NCT02978326|2351955|FG001|Part B (Up to 45 Days)|Adverse Event|0
1191562|NCT02978326|2351956|FG002|Part B (Up to 45 Days)|Adverse Event|1
1191563|NCT02978326|2351954|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0
1191564|NCT02978326|2351955|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3
1191565|NCT02978326|2351956|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0
1191566|NCT02978326|2351954|FG000|Part B (Up to 45 Days)|Non-compliance|0
1191567|NCT02978326|2351955|FG001|Part B (Up to 45 Days)|Non-compliance|2
1191568|NCT02978326|2351956|FG002|Part B (Up to 45 Days)|Non-compliance|0
1191569|NCT02978326|2351954|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0
1191570|NCT02978326|2351955|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2
1191571|NCT02978326|2351956|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3
1191572|NCT02964507|2351974|FG000|Overall Study|Protocol specified Withdrawal criteria met|0
1191573|NCT02964507|2351975|FG001|Overall Study|Protocol specified Withdrawal criteria met|1
1191574|NCT02964507|2351976|FG002|Overall Study|Protocol specified Withdrawal criteria met|0
1191575|NCT02964507|2351977|FG003|Overall Study|Protocol specified Withdrawal criteria met|0
1191576|NCT02964507|2351978|FG004|Overall Study|Protocol specified Withdrawal criteria met|1
1191577|NCT02964507|2351979|FG005|Overall Study|Protocol specified Withdrawal criteria met|0
1191578|NCT02964507|2351980|FG006|Overall Study|Protocol specified Withdrawal criteria met|0
1191579|NCT02964507|2351981|FG007|Overall Study|Protocol specified Withdrawal criteria met|0
1191580|NCT02964507|2351974|FG000|Overall Study|Ongoing at the time of analysis|1
1191581|NCT02964507|2351975|FG001|Overall Study|Ongoing at the time of analysis|0
1191582|NCT02964507|2351976|FG002|Overall Study|Ongoing at the time of analysis|2
1191583|NCT02964507|2351977|FG003|Overall Study|Ongoing at the time of analysis|0
1191584|NCT02964507|2351978|FG004|Overall Study|Ongoing at the time of analysis|0
1191585|NCT02964507|2351979|FG005|Overall Study|Ongoing at the time of analysis|0
1191586|NCT02964507|2351980|FG006|Overall Study|Ongoing at the time of analysis|0
1191587|NCT02964507|2351981|FG007|Overall Study|Ongoing at the time of analysis|0
1191588|NCT02964507|2351974|FG000|Overall Study|Study terminated by Sponsor|9
1191589|NCT02964507|2351975|FG001|Overall Study|Study terminated by Sponsor|1
1191590|NCT02964507|2351976|FG002|Overall Study|Study terminated by Sponsor|9
1191591|NCT02964507|2351977|FG003|Overall Study|Study terminated by Sponsor|3
1191592|NCT02964507|2351978|FG004|Overall Study|Study terminated by Sponsor|3
1191593|NCT02964507|2351979|FG005|Overall Study|Study terminated by Sponsor|2
1191594|NCT02964507|2351980|FG006|Overall Study|Study terminated by Sponsor|0
1191595|NCT02964507|2351981|FG007|Overall Study|Study terminated by Sponsor|0
1191596|NCT02964507|2351974|FG000|Overall Study|Other|3
1191597|NCT02964507|2351975|FG001|Overall Study|Other|0
1191598|NCT02964507|2351976|FG002|Overall Study|Other|0
1191599|NCT02964507|2351977|FG003|Overall Study|Other|0
1191600|NCT02964507|2351978|FG004|Overall Study|Other|1
1191601|NCT02964507|2351979|FG005|Overall Study|Other|0
1191602|NCT02964507|2351980|FG006|Overall Study|Other|0
1191603|NCT02964507|2351981|FG007|Overall Study|Other|0
1191604|NCT02964507|2351974|FG000|Overall Study|Death|11
1191605|NCT02964507|2351975|FG001|Overall Study|Death|9
1191606|NCT02964507|2351976|FG002|Overall Study|Death|12
1191607|NCT02964507|2351977|FG003|Overall Study|Death|2
1191608|NCT02964507|2351978|FG004|Overall Study|Death|10
1191609|NCT02964507|2351979|FG005|Overall Study|Death|5
1191610|NCT02964507|2351980|FG006|Overall Study|Death|0
1191611|NCT02964507|2351981|FG007|Overall Study|Death|0
1191612|NCT02964507|2351974|FG000|Overall Study|Withdrawal by Subject|1
1191613|NCT02964507|2351975|FG001|Overall Study|Withdrawal by Subject|0
1191614|NCT02964507|2351976|FG002|Overall Study|Withdrawal by Subject|1
1191615|NCT02964507|2351977|FG003|Overall Study|Withdrawal by Subject|1
1191616|NCT02964507|2351978|FG004|Overall Study|Withdrawal by Subject|0
1191617|NCT02964507|2351979|FG005|Overall Study|Withdrawal by Subject|1
1191618|NCT02964507|2351980|FG006|Overall Study|Withdrawal by Subject|0
1191619|NCT02964507|2351981|FG007|Overall Study|Withdrawal by Subject|0
1191620|NCT02964507|2351974|FG000|Overall Study|Physician Decision|1
1191621|NCT02964507|2351975|FG001|Overall Study|Physician Decision|0
1191622|NCT02964507|2351976|FG002|Overall Study|Physician Decision|1
882324|NCT00604214|1847439|FG001|Day 91 to Day 180|Lost to Follow-up|8
882325|NCT00604214|1847438|FG000|Day 91 to Day 180|Withdrawal by Subject|1
882326|NCT00604214|1847439|FG001|Day 91 to Day 180|Withdrawal by Subject|1
882327|NCT00604279|1847447|FG000|Overall Study|Lack of Efficacy|22
882328|NCT00604279|1847448|FG001|Overall Study|Lack of Efficacy|9
882329|NCT00604279|1847447|FG000|Overall Study|Lost to Follow-up|9
882330|NCT00604279|1847448|FG001|Overall Study|Lost to Follow-up|14
882331|NCT00604279|1847447|FG000|Overall Study|Pregnancy|2
882332|NCT00604279|1847448|FG001|Overall Study|Pregnancy|0
882333|NCT00604279|1847447|FG000|Overall Study|Protocol Violation|3
882334|NCT00604279|1847448|FG001|Overall Study|Protocol Violation|1
882335|NCT00604279|1847447|FG000|Overall Study|Withdrawal by Subject|16
882336|NCT00604279|1847448|FG001|Overall Study|Withdrawal by Subject|5
882337|NCT00604279|1847447|FG000|Overall Study|Adverse Event|4
882338|NCT00604279|1847448|FG001|Overall Study|Adverse Event|5
882339|NCT00604279|1847447|FG000|Overall Study|Other|8
882340|NCT00604279|1847448|FG001|Overall Study|Other|4
882341|NCT00604383|1847456|FG000|Overall Study|Withdrawal by Subject|33
882342|NCT00604383|1847457|FG001|Overall Study|Withdrawal by Subject|31
882343|NCT00604383|1847456|FG000|Overall Study|Lost to Follow-up|24
1191623|NCT02964507|2351977|FG003|Overall Study|Physician Decision|0
1191624|NCT02964507|2351978|FG004|Overall Study|Physician Decision|1
1191625|NCT02964507|2351979|FG005|Overall Study|Physician Decision|0
1191626|NCT02964507|2351980|FG006|Overall Study|Physician Decision|0
1191627|NCT02964507|2351981|FG007|Overall Study|Physician Decision|0
1191628|NCT02942277|2352015|FG000|Year 1|Withdrawal by Subject|0
1191629|NCT02942277|2352016|FG001|Year 1|Withdrawal by Subject|0
1191630|NCT02942277|2352017|FG002|Year 1|Withdrawal by Subject|0
1191631|NCT02942277|2352018|FG003|Year 1|Withdrawal by Subject|0
1191632|NCT02942277|2352019|FG004|Year 1|Withdrawal by Subject|1
1191633|NCT02942277|2352020|FG005|Year 1|Withdrawal by Subject|3
1191634|NCT02942277|2352021|FG006|Year 1|Withdrawal by Subject|0
1191635|NCT02942277|2352022|FG007|Year 1|Withdrawal by Subject|1
1191636|NCT02942277|2352023|FG008|Year 1|Withdrawal by Subject|0
1191637|NCT02942277|2352024|FG009|Year 1|Withdrawal by Subject|0
1191638|NCT02942277|2352025|FG010|Year 1|Withdrawal by Subject|3
1191639|NCT02942277|2352015|FG000|Year 1|Travel|0
1191640|NCT02942277|2352016|FG001|Year 1|Travel|1
1191641|NCT02942277|2352017|FG002|Year 1|Travel|0
1191642|NCT02942277|2352018|FG003|Year 1|Travel|0
1191643|NCT02942277|2352019|FG004|Year 1|Travel|4
1191644|NCT02942277|2352020|FG005|Year 1|Travel|5
1191645|NCT02942277|2352021|FG006|Year 1|Travel|0
1191646|NCT02942277|2352022|FG007|Year 1|Travel|0
1191647|NCT02942277|2352023|FG008|Year 1|Travel|0
1191648|NCT02942277|2352024|FG009|Year 1|Travel|0
1191649|NCT02942277|2352025|FG010|Year 1|Travel|8
1191650|NCT02942277|2352015|FG000|Year 1|Joined Army|0
1191651|NCT02942277|2352016|FG001|Year 1|Joined Army|1
1191652|NCT02942277|2352017|FG002|Year 1|Joined Army|0
1191653|NCT02942277|2352018|FG003|Year 1|Joined Army|0
1191654|NCT02942277|2352019|FG004|Year 1|Joined Army|0
1191655|NCT02942277|2352020|FG005|Year 1|Joined Army|0
1191656|NCT02942277|2352021|FG006|Year 1|Joined Army|0
1191657|NCT02942277|2352022|FG007|Year 1|Joined Army|0
1191658|NCT02942277|2352023|FG008|Year 1|Joined Army|0
1191659|NCT02942277|2352024|FG009|Year 1|Joined Army|0
1191660|NCT02942277|2352025|FG010|Year 1|Joined Army|0
1191661|NCT02942277|2352015|FG000|Year 1|Subject met withdrawal criteria|0
1191662|NCT02942277|2352016|FG001|Year 1|Subject met withdrawal criteria|0
1191663|NCT02942277|2352017|FG002|Year 1|Subject met withdrawal criteria|0
1191664|NCT02942277|2352018|FG003|Year 1|Subject met withdrawal criteria|1
1191665|NCT02942277|2352019|FG004|Year 1|Subject met withdrawal criteria|0
1191666|NCT02942277|2352020|FG005|Year 1|Subject met withdrawal criteria|0
1191667|NCT02942277|2352021|FG006|Year 1|Subject met withdrawal criteria|0
1191668|NCT02942277|2352022|FG007|Year 1|Subject met withdrawal criteria|0
1191669|NCT02942277|2352023|FG008|Year 1|Subject met withdrawal criteria|0
1191670|NCT02942277|2352024|FG009|Year 1|Subject met withdrawal criteria|0
1191671|NCT02942277|2352025|FG010|Year 1|Subject met withdrawal criteria|0
1191672|NCT02942277|2352015|FG000|Year 1|Lost to Follow-up|0
882344|NCT00604383|1847457|FG001|Overall Study|Lost to Follow-up|19
882345|NCT00604383|1847456|FG000|Overall Study|Death|14
882346|NCT00604383|1847457|FG001|Overall Study|Death|22
882347|NCT00604383|1847456|FG000|Overall Study|Adverse Event|16
882348|NCT00604383|1847457|FG001|Overall Study|Adverse Event|9
882349|NCT00604383|1847456|FG000|Overall Study|Physician Decision|0
882350|NCT00604383|1847457|FG001|Overall Study|Physician Decision|3
882351|NCT00604500|1847467|FG000|Overall Study|Adverse Event|2
882352|NCT00604500|1847467|FG000|Overall Study|Protocol Violation|2
882353|NCT00604500|1847467|FG000|Overall Study|Treatment Failure|1
882354|NCT00604500|1847467|FG000|Overall Study|Withdrawal by Subject|4
882355|NCT00604500|1847467|FG000|Overall Study|Administrative|1
882356|NCT00604500|1847467|FG000|Overall Study|Did not meet protocol eligibility|1
882357|NCT00604565|1847484|FG000|Overall Study|Study terminated|0
882358|NCT00604565|1847485|FG001|Overall Study|Study terminated|3
882359|NCT00604669|1847491|FG000|Overall Study|lack of information in chart|7
882360|NCT00604695|1847497|FG000|Overall Study|Did not receive first bolus.|0
1191673|NCT02942277|2352016|FG001|Year 1|Lost to Follow-up|0
1191674|NCT02942277|2352017|FG002|Year 1|Lost to Follow-up|0
1191675|NCT02942277|2352018|FG003|Year 1|Lost to Follow-up|0
1191676|NCT02942277|2352019|FG004|Year 1|Lost to Follow-up|1
1191677|NCT02942277|2352020|FG005|Year 1|Lost to Follow-up|0
1191678|NCT02942277|2352021|FG006|Year 1|Lost to Follow-up|0
1191679|NCT02942277|2352022|FG007|Year 1|Lost to Follow-up|0
1191680|NCT02942277|2352023|FG008|Year 1|Lost to Follow-up|0
1191681|NCT02942277|2352024|FG009|Year 1|Lost to Follow-up|0
1191682|NCT02942277|2352025|FG010|Year 1|Lost to Follow-up|2
1191683|NCT02942277|2352015|FG000|Year 1|Protocol Violation|0
1191684|NCT02942277|2352016|FG001|Year 1|Protocol Violation|0
1191685|NCT02942277|2352017|FG002|Year 1|Protocol Violation|0
1191686|NCT02942277|2352018|FG003|Year 1|Protocol Violation|0
1191687|NCT02942277|2352019|FG004|Year 1|Protocol Violation|1
1191688|NCT02942277|2352020|FG005|Year 1|Protocol Violation|1
1191689|NCT02942277|2352021|FG006|Year 1|Protocol Violation|0
1191690|NCT02942277|2352022|FG007|Year 1|Protocol Violation|0
1191691|NCT02942277|2352023|FG008|Year 1|Protocol Violation|0
1191692|NCT02942277|2352024|FG009|Year 1|Protocol Violation|0
1191693|NCT02942277|2352025|FG010|Year 1|Protocol Violation|2
1191694|NCT02942277|2352015|FG000|Year 1|Pregnancy|0
1191695|NCT02942277|2352016|FG001|Year 1|Pregnancy|0
1191696|NCT02942277|2352017|FG002|Year 1|Pregnancy|0
1191697|NCT02942277|2352018|FG003|Year 1|Pregnancy|0
1191698|NCT02942277|2352019|FG004|Year 1|Pregnancy|0
1191699|NCT02942277|2352020|FG005|Year 1|Pregnancy|1
1191700|NCT02942277|2352021|FG006|Year 1|Pregnancy|0
1191701|NCT02942277|2352022|FG007|Year 1|Pregnancy|0
1191702|NCT02942277|2352023|FG008|Year 1|Pregnancy|0
1191703|NCT02942277|2352024|FG009|Year 1|Pregnancy|0
1191704|NCT02942277|2352025|FG010|Year 1|Pregnancy|0
1191705|NCT02942277|2352015|FG000|Year 2|Lost to Follow-up|0
1191706|NCT02942277|2352016|FG001|Year 2|Lost to Follow-up|0
1191707|NCT02942277|2352017|FG002|Year 2|Lost to Follow-up|0
1191708|NCT02942277|2352018|FG003|Year 2|Lost to Follow-up|0
1191709|NCT02942277|2352019|FG004|Year 2|Lost to Follow-up|2
1191710|NCT02942277|2352020|FG005|Year 2|Lost to Follow-up|1
1191711|NCT02942277|2352021|FG006|Year 2|Lost to Follow-up|0
1191712|NCT02942277|2352022|FG007|Year 2|Lost to Follow-up|0
1191713|NCT02942277|2352023|FG008|Year 2|Lost to Follow-up|0
1191714|NCT02942277|2352024|FG009|Year 2|Lost to Follow-up|0
1191715|NCT02942277|2352025|FG010|Year 2|Lost to Follow-up|0
1191716|NCT02942277|2352015|FG000|Year 2|Did not rescreen|0
1191717|NCT02942277|2352016|FG001|Year 2|Did not rescreen|0
1191718|NCT02942277|2352017|FG002|Year 2|Did not rescreen|1
1191719|NCT02942277|2352018|FG003|Year 2|Did not rescreen|1
1191720|NCT02942277|2352019|FG004|Year 2|Did not rescreen|9
1191721|NCT02942277|2352020|FG005|Year 2|Did not rescreen|6
1191722|NCT02942277|2352021|FG006|Year 2|Did not rescreen|0
1191723|NCT02942277|2352022|FG007|Year 2|Did not rescreen|1
1191724|NCT02942277|2352023|FG008|Year 2|Did not rescreen|0
1191725|NCT02942277|2352024|FG009|Year 2|Did not rescreen|0
1191726|NCT02942277|2352025|FG010|Year 2|Did not rescreen|21
1191727|NCT02942277|2352015|FG000|Year 2|Met withdrawal criteria|0
1191728|NCT02942277|2352016|FG001|Year 2|Met withdrawal criteria|0
1191729|NCT02942277|2352017|FG002|Year 2|Met withdrawal criteria|0
1191730|NCT02942277|2352018|FG003|Year 2|Met withdrawal criteria|0
1191731|NCT02942277|2352019|FG004|Year 2|Met withdrawal criteria|1
1191732|NCT02942277|2352020|FG005|Year 2|Met withdrawal criteria|2
1191733|NCT02942277|2352021|FG006|Year 2|Met withdrawal criteria|0
1191734|NCT02942277|2352022|FG007|Year 2|Met withdrawal criteria|0
1191735|NCT02942277|2352023|FG008|Year 2|Met withdrawal criteria|0
1191736|NCT02942277|2352024|FG009|Year 2|Met withdrawal criteria|0
1191737|NCT02942277|2352025|FG010|Year 2|Met withdrawal criteria|1
1191738|NCT02942277|2352015|FG000|Year 2|Travel|0
1191739|NCT02942277|2352016|FG001|Year 2|Travel|1
1191740|NCT02942277|2352017|FG002|Year 2|Travel|0
1191741|NCT02942277|2352018|FG003|Year 2|Travel|0
1191742|NCT02942277|2352019|FG004|Year 2|Travel|0
1191743|NCT02942277|2352020|FG005|Year 2|Travel|1
1191744|NCT02942277|2352021|FG006|Year 2|Travel|0
1191745|NCT02942277|2352022|FG007|Year 2|Travel|0
1191746|NCT02942277|2352023|FG008|Year 2|Travel|0
1191747|NCT02942277|2352024|FG009|Year 2|Travel|1
1191748|NCT02942277|2352025|FG010|Year 2|Travel|3
1191749|NCT02942277|2352015|FG000|Year 2|Non-compliant|0
1191750|NCT02942277|2352016|FG001|Year 2|Non-compliant|0
1191751|NCT02942277|2352017|FG002|Year 2|Non-compliant|0
1191752|NCT02942277|2352018|FG003|Year 2|Non-compliant|0
1191753|NCT02942277|2352019|FG004|Year 2|Non-compliant|1
1191754|NCT02942277|2352020|FG005|Year 2|Non-compliant|1
1191755|NCT02942277|2352021|FG006|Year 2|Non-compliant|0
1191756|NCT02942277|2352022|FG007|Year 2|Non-compliant|0
1191757|NCT02942277|2352023|FG008|Year 2|Non-compliant|0
1191758|NCT02942277|2352024|FG009|Year 2|Non-compliant|0
1191759|NCT02942277|2352025|FG010|Year 2|Non-compliant|0
1191760|NCT02942277|2352015|FG000|Year 2|Withdrawal by Subject|0
1191761|NCT02942277|2352016|FG001|Year 2|Withdrawal by Subject|0
1191762|NCT02942277|2352017|FG002|Year 2|Withdrawal by Subject|0
1191763|NCT02942277|2352018|FG003|Year 2|Withdrawal by Subject|0
1191764|NCT02942277|2352019|FG004|Year 2|Withdrawal by Subject|0
1191765|NCT02942277|2352020|FG005|Year 2|Withdrawal by Subject|0
1191766|NCT02942277|2352021|FG006|Year 2|Withdrawal by Subject|1
1191767|NCT02942277|2352022|FG007|Year 2|Withdrawal by Subject|0
1191768|NCT02942277|2352023|FG008|Year 2|Withdrawal by Subject|0
1191769|NCT02942277|2352024|FG009|Year 2|Withdrawal by Subject|0
1191770|NCT02942277|2352025|FG010|Year 2|Withdrawal by Subject|0
1191771|NCT02942017|2352054|FG000|Overall Study|Adverse Event|0
1191772|NCT02942017|2352055|FG001|Overall Study|Adverse Event|1
1191773|NCT02942017|2352054|FG000|Overall Study|Withdrawal by Subject|0
1191774|NCT02942017|2352055|FG001|Overall Study|Withdrawal by Subject|1
1191775|NCT02942017|2352054|FG000|Overall Study|Lost to Follow-up|1
1191776|NCT02942017|2352055|FG001|Overall Study|Lost to Follow-up|1
1191777|NCT02942017|2352054|FG000|Overall Study|Randomized but not dosed|1
1191778|NCT02942017|2352055|FG001|Overall Study|Randomized but not dosed|3
1191779|NCT02942004|2352064|FG000|Overall Study|Withdrawal by Subject|0
1191780|NCT02942004|2352065|FG001|Overall Study|Withdrawal by Subject|2
1191781|NCT02942004|2352066|FG002|Overall Study|Withdrawal by Subject|3
882361|NCT00604695|1847498|FG001|Overall Study|Did not receive first bolus.|4
882362|NCT00604708|1847506|FG000|Overall Study|Withdrawal by Subject|9
1191782|NCT02942004|2352064|FG000|Overall Study|Lost to Follow-up|1
1191783|NCT02942004|2352065|FG001|Overall Study|Lost to Follow-up|1
1191784|NCT02942004|2352066|FG002|Overall Study|Lost to Follow-up|2
1191785|NCT02942004|2352064|FG000|Overall Study|Randomized but not dosed|3
1191786|NCT02942004|2352065|FG001|Overall Study|Randomized but not dosed|9
1191787|NCT02942004|2352066|FG002|Overall Study|Randomized but not dosed|4
1191788|NCT02924064|2352076|FG000|Overall Study|Adverse Event|2
1191789|NCT02924064|2352077|FG001|Overall Study|Adverse Event|2
1191790|NCT02924064|2352076|FG000|Overall Study|Lost to Follow-up|0
1191791|NCT02924064|2352077|FG001|Overall Study|Lost to Follow-up|2
1191792|NCT02924064|2352076|FG000|Overall Study|Physician Decision|0
1191793|NCT02924064|2352077|FG001|Overall Study|Physician Decision|2
1191794|NCT02924064|2352076|FG000|Overall Study|Protocol Violation|1
1191795|NCT02924064|2352077|FG001|Overall Study|Protocol Violation|3
1191796|NCT02924064|2352076|FG000|Overall Study|Withdrawal by Subject|4
1191797|NCT02924064|2352077|FG001|Overall Study|Withdrawal by Subject|5
1191798|NCT02924064|2352076|FG000|Overall Study|Other|17
1191799|NCT02924064|2352077|FG001|Overall Study|Other|29
1191800|NCT02916706|2352085|FG000|Overall Study|Adverse Event|0
1191801|NCT02916706|2352086|FG001|Overall Study|Adverse Event|1
1191802|NCT02916706|2352085|FG000|Overall Study|Lost to Follow-up|0
1191803|NCT02916706|2352086|FG001|Overall Study|Lost to Follow-up|1
1191804|NCT02916706|2352085|FG000|Overall Study|Physician Decision|1
1191805|NCT02916706|2352086|FG001|Overall Study|Physician Decision|0
1191806|NCT02916706|2352085|FG000|Overall Study|Protocol Violation|3
1191807|NCT02916706|2352086|FG001|Overall Study|Protocol Violation|1
1191808|NCT02916706|2352085|FG000|Overall Study|Withdrawal by Subject|6
1191809|NCT02916706|2352086|FG001|Overall Study|Withdrawal by Subject|9
1191810|NCT02916706|2352085|FG000|Overall Study|Other|5
1191811|NCT02916706|2352086|FG001|Overall Study|Other|19
1191812|NCT02890355|2352094|FG000|Overall Study|Adverse Event|5
1191813|NCT02890355|2352095|FG001|Overall Study|Adverse Event|5
1191814|NCT02890355|2352094|FG000|Overall Study|Refusal unrelated to adverse event|5
1191815|NCT02890355|2352095|FG001|Overall Study|Refusal unrelated to adverse event|10
1191816|NCT02890355|2352094|FG000|Overall Study|Progression/relapse|46
1191817|NCT02890355|2352095|FG001|Overall Study|Progression/relapse|39
1191818|NCT02890355|2352094|FG000|Overall Study|Not protocol specified|3
1191819|NCT02890355|2352095|FG001|Overall Study|Not protocol specified|4
882363|NCT00604708|1847507|FG001|Overall Study|Withdrawal by Subject|10
882364|NCT00604708|1847506|FG000|Overall Study|Protocol Violation|2
882365|NCT00604708|1847507|FG001|Overall Study|Protocol Violation|8
882366|NCT00604708|1847506|FG000|Overall Study|Lost to Follow-up|5
882367|NCT00604708|1847507|FG001|Overall Study|Lost to Follow-up|5
882368|NCT00604708|1847506|FG000|Overall Study|administrative reasons|9
882369|NCT00604708|1847507|FG001|Overall Study|administrative reasons|11
882370|NCT00604708|1847506|FG000|Overall Study|Adverse Event|6
882371|NCT00604708|1847507|FG001|Overall Study|Adverse Event|6
882372|NCT00604721|1847513|FG000|Overall Study|Physician Decision|1
882373|NCT00604721|1847513|FG000|Overall Study|Withdrawal by Subject|1
882374|NCT00604786|1847520|FG000|Overall Study|Lost to Follow-up|2
882375|NCT00604786|1847521|FG001|Overall Study|Lost to Follow-up|0
882376|NCT00604825|1847550|FG000|Overall Study|Adverse Event|2
882377|NCT00604825|1847551|FG001|Overall Study|Adverse Event|6
882378|NCT00604825|1847552|FG002|Overall Study|Adverse Event|7
882379|NCT00604825|1847553|FG003|Overall Study|Adverse Event|4
882380|NCT00604825|1847550|FG000|Overall Study|Lost to Follow-up|0
882381|NCT00604825|1847551|FG001|Overall Study|Lost to Follow-up|3
882382|NCT00604825|1847552|FG002|Overall Study|Lost to Follow-up|1
882383|NCT00604825|1847553|FG003|Overall Study|Lost to Follow-up|0
882384|NCT00604825|1847550|FG000|Overall Study|Protocol Violation|0
882385|NCT00604825|1847551|FG001|Overall Study|Protocol Violation|1
882386|NCT00604825|1847552|FG002|Overall Study|Protocol Violation|0
882387|NCT00604825|1847553|FG003|Overall Study|Protocol Violation|0
882388|NCT00604825|1847550|FG000|Overall Study|Withdrawal by Subject|4
882389|NCT00604825|1847551|FG001|Overall Study|Withdrawal by Subject|3
882390|NCT00604825|1847552|FG002|Overall Study|Withdrawal by Subject|5
882391|NCT00604825|1847553|FG003|Overall Study|Withdrawal by Subject|5
882392|NCT00604825|1847550|FG000|Overall Study|Lack of Efficacy|3
882393|NCT00604825|1847551|FG001|Overall Study|Lack of Efficacy|2
882394|NCT00604825|1847552|FG002|Overall Study|Lack of Efficacy|1
1191820|NCT02874742|2352106|FG000|Overall Study|Death|3
1191821|NCT02874742|2352107|FG001|Overall Study|Death|1
1191822|NCT02874742|2352108|FG002|Overall Study|Death|1
1191823|NCT02874742|2352106|FG000|Overall Study|Lost to Follow-up|2
1191824|NCT02874742|2352107|FG001|Overall Study|Lost to Follow-up|0
1191825|NCT02874742|2352108|FG002|Overall Study|Lost to Follow-up|0
1191826|NCT02874742|2352106|FG000|Overall Study|Withdrawal by Subject|8
1191827|NCT02874742|2352107|FG001|Overall Study|Withdrawal by Subject|4
1191828|NCT02874742|2352108|FG002|Overall Study|Withdrawal by Subject|0
1191829|NCT02874742|2352106|FG000|Overall Study|Other|3
1191830|NCT02874742|2352107|FG001|Overall Study|Other|1
1191831|NCT02874742|2352108|FG002|Overall Study|Other|0
1191832|NCT02874742|2352106|FG000|Overall Study|Ongoing|87
1191833|NCT02874742|2352107|FG001|Overall Study|Ongoing|98
1191834|NCT02874742|2352108|FG002|Overall Study|Ongoing|15
1191835|NCT02861014|2352116|FG000|Primary Analysis|Adverse Event|7
1191836|NCT02861014|2352116|FG000|Primary Analysis|Death|1
1191837|NCT02861014|2352116|FG000|Primary Analysis|Lack of Efficacy|3
1191838|NCT02861014|2352116|FG000|Primary Analysis|Physician Decision|2
1191839|NCT02861014|2352116|FG000|Primary Analysis|Pregnancy|4
1191840|NCT02861014|2352116|FG000|Primary Analysis|Protocol Violation|2
1191841|NCT02861014|2352116|FG000|Primary Analysis|Study Terminated By Sponsor|3
1191842|NCT02861014|2352116|FG000|Primary Analysis|Withdrawal by Subject|14
1191843|NCT02861014|2352116|FG000|Primary Analysis|Commercial ocrelizumab|3
1191844|NCT02861014|2352116|FG000|Safety Follow-up|Adverse Event|1
1191845|NCT02861014|2352116|FG000|Safety Follow-up|Pregnancy|1
1191846|NCT02861014|2352116|FG000|Safety Follow-up|Withdrawal by Subject|9
1191847|NCT02861014|2352116|FG000|Safety Follow-up|Study terminated by sponsor|1
1191848|NCT02861014|2352116|FG000|Safety Follow-up|Physician Decision|1
1191849|NCT02861014|2352116|FG000|Safety Follow-up|Roll-over to a long term extension study|1
1191850|NCT02861014|2352116|FG000|Safety Follow-up|Commercial ocrelizumab|36
1191851|NCT02775435|2352124|FG000|Overall Study|Adverse Event|48
1191852|NCT02775435|2352125|FG001|Overall Study|Adverse Event|25
1191853|NCT02775435|2352124|FG000|Overall Study|Lost to Follow-up|0
1191854|NCT02775435|2352125|FG001|Overall Study|Lost to Follow-up|2
1191855|NCT02775435|2352124|FG000|Overall Study|Physician Decision|5
1191856|NCT02775435|2352125|FG001|Overall Study|Physician Decision|6
1191857|NCT02775435|2352124|FG000|Overall Study|Withdrawal by Subject|5
1191858|NCT02775435|2352125|FG001|Overall Study|Withdrawal by Subject|9
1191859|NCT02775435|2352124|FG000|Overall Study|Progressive Disease|86
1191860|NCT02775435|2352125|FG001|Overall Study|Progressive Disease|140
1191861|NCT02775435|2352124|FG000|Overall Study|Clinical Progression|13
1191862|NCT02775435|2352125|FG001|Overall Study|Clinical Progression|26
1191863|NCT02775435|2352124|FG000|Overall Study|Ongoing in Study|121
1191864|NCT02775435|2352125|FG001|Overall Study|Ongoing in Study|72
1191865|NCT02775435|2352124|FG000|Overall Study|Not Treated|0
1191866|NCT02775435|2352125|FG001|Overall Study|Not Treated|1
1191867|NCT02726880|2352140|FG000|Overall Study|Withdrawal by Subject|2
1191868|NCT02726880|2352141|FG001|Overall Study|Withdrawal by Subject|0
1191869|NCT02726880|2352140|FG000|Overall Study|Lost to Follow-up|1
1191870|NCT02726880|2352141|FG001|Overall Study|Lost to Follow-up|3
1191871|NCT02701777|2352152|FG000|Overall Study|Some subjects did not like the stimulation.|4
1191872|NCT02701777|2352153|FG001|Overall Study|Some subjects did not like the stimulation.|0
1191873|NCT02701777|2352154|FG002|Overall Study|Some subjects did not like the stimulation.|0
1191874|NCT02701777|2352155|FG003|Overall Study|Some subjects did not like the stimulation.|2
1191875|NCT02701777|2352152|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
1191876|NCT02701777|2352153|FG001|Overall Study|Some subjects were unable to commit to the training study.|3
1191877|NCT02701777|2352154|FG002|Overall Study|Some subjects were unable to commit to the training study.|4
1191878|NCT02701777|2352155|FG003|Overall Study|Some subjects were unable to commit to the training study.|0
1191879|NCT02677896|2352171|FG000|Overall Study|Adverse Event|28
1191880|NCT02677896|2352172|FG001|Overall Study|Adverse Event|21
1191881|NCT02677896|2352171|FG000|Overall Study|Death|9
1191882|NCT02677896|2352172|FG001|Overall Study|Death|7
1191883|NCT02677896|2352171|FG000|Overall Study|Lost to Follow-up|0
1191884|NCT02677896|2352172|FG001|Overall Study|Lost to Follow-up|1
1191885|NCT02677896|2352171|FG000|Overall Study|Progressive disease:|65
1191886|NCT02677896|2352172|FG001|Overall Study|Progressive disease:|171
1191887|NCT02677896|2352171|FG000|Overall Study|Protocol deviation|2
1191888|NCT02677896|2352172|FG001|Overall Study|Protocol deviation|1
1191889|NCT02677896|2352171|FG000|Overall Study|Withdrawal by patient:|25
1191890|NCT02677896|2352172|FG001|Overall Study|Withdrawal by patient:|30
1191891|NCT02677896|2352171|FG000|Overall Study|Miscellaneous|6
1191892|NCT02677896|2352172|FG001|Overall Study|Miscellaneous|11
1191893|NCT02677896|2352171|FG000|Overall Study|Did not receive study drug|2
1191894|NCT02677896|2352172|FG001|Overall Study|Did not receive study drug|2
1191895|NCT02642042|2352178|FG000|Overall Study|Adverse Event|22
1191896|NCT02642042|2352178|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
1191897|NCT02642042|2352178|FG000|Overall Study|Progression/Relapse|28
1191898|NCT02642042|2352178|FG000|Overall Study|Death|1
1191899|NCT02642042|2352178|FG000|Overall Study|Not Protocol Specified|2
1191900|NCT02601209|2352201|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
1191901|NCT02601209|2352202|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
1191902|NCT02601209|2352203|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
1191903|NCT02601209|2352204|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1191904|NCT02601209|2352205|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1191905|NCT02601209|2352206|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1191906|NCT02601209|2352207|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1191907|NCT02601209|2352208|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1191908|NCT02601209|2352209|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1191909|NCT02601209|2352201|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1191910|NCT02601209|2352202|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1191911|NCT02601209|2352203|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1191912|NCT02601209|2352204|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1191913|NCT02601209|2352205|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
1191914|NCT02601209|2352206|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
1191915|NCT02601209|2352207|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
1191916|NCT02601209|2352208|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1191917|NCT02601209|2352209|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1191918|NCT02592551|2352226|FG000|Overall Study|Not evaluable|1
1191919|NCT02592551|2352227|FG001|Overall Study|Not evaluable|3
1191920|NCT02592551|2352228|FG002|Overall Study|Not evaluable|0
1191921|NCT02583048|2352240|FG000|Overall Study|Withdrawal by Subject|0
1191922|NCT02583048|2352241|FG001|Overall Study|Withdrawal by Subject|1
1191923|NCT02583048|2352242|FG002|Overall Study|Withdrawal by Subject|0
1191924|NCT02583048|2352240|FG000|Overall Study|Failed to meet eligibility criterion|0
1191925|NCT02583048|2352241|FG001|Overall Study|Failed to meet eligibility criterion|0
1191926|NCT02583048|2352242|FG002|Overall Study|Failed to meet eligibility criterion|1
1191927|NCT02574481|2352257|FG000|Overall Study|Withdrawal by Subject|6
1191928|NCT02574481|2352258|FG001|Overall Study|Withdrawal by Subject|4
1191929|NCT02574481|2352259|FG002|Overall Study|Withdrawal by Subject|1
1191930|NCT02574481|2352260|FG003|Overall Study|Withdrawal by Subject|0
1191931|NCT02574481|2352257|FG000|Overall Study|Adverse Event|2
1191932|NCT02574481|2352258|FG001|Overall Study|Adverse Event|0
1191933|NCT02574481|2352259|FG002|Overall Study|Adverse Event|0
1191934|NCT02574481|2352260|FG003|Overall Study|Adverse Event|0
1191935|NCT02574481|2352257|FG000|Overall Study|Visit Missed|12
1191936|NCT02574481|2352258|FG001|Overall Study|Visit Missed|4
1191937|NCT02574481|2352259|FG002|Overall Study|Visit Missed|2
1191938|NCT02574481|2352260|FG003|Overall Study|Visit Missed|0
1191939|NCT02574481|2352257|FG000|Overall Study|Other|1
1191940|NCT02574481|2352258|FG001|Overall Study|Other|0
1191941|NCT02574481|2352259|FG002|Overall Study|Other|0
1191942|NCT02574481|2352260|FG003|Overall Study|Other|0
1191943|NCT02574481|2352257|FG000|Overall Study|Death|6
1191944|NCT02574481|2352258|FG001|Overall Study|Death|6
1191945|NCT02574481|2352259|FG002|Overall Study|Death|0
1191946|NCT02574481|2352260|FG003|Overall Study|Death|0
1191947|NCT02546986|2352275|FG000|Treatment Period|Progressive Disease|20
1191948|NCT02546986|2352276|FG001|Treatment Period|Progressive Disease|22
1191949|NCT02546986|2352275|FG000|Treatment Period|Adverse Event|14
1191950|NCT02546986|2352276|FG001|Treatment Period|Adverse Event|6
1191951|NCT02546986|2352275|FG000|Treatment Period|Symptomatic Deterioration|4
1191952|NCT02546986|2352276|FG001|Treatment Period|Symptomatic Deterioration|3
1191953|NCT02546986|2352275|FG000|Treatment Period|Death|3
882395|NCT00604825|1847553|FG003|Overall Study|Lack of Efficacy|0
882396|NCT00604825|1847550|FG000|Overall Study|Did not meet eligibility criteria|0
882397|NCT00604825|1847551|FG001|Overall Study|Did not meet eligibility criteria|0
882398|NCT00604825|1847552|FG002|Overall Study|Did not meet eligibility criteria|2
882399|NCT00604825|1847553|FG003|Overall Study|Did not meet eligibility criteria|0
882400|NCT00604825|1847550|FG000|Overall Study|Physician Decision|0
882401|NCT00604825|1847551|FG001|Overall Study|Physician Decision|0
882402|NCT00604825|1847552|FG002|Overall Study|Physician Decision|0
882403|NCT00604825|1847553|FG003|Overall Study|Physician Decision|1
882404|NCT00604825|1847550|FG000|Overall Study|Exclusion criterion met|0
882405|NCT00604825|1847551|FG001|Overall Study|Exclusion criterion met|0
882406|NCT00604825|1847552|FG002|Overall Study|Exclusion criterion met|0
882407|NCT00604825|1847553|FG003|Overall Study|Exclusion criterion met|1
882408|NCT00605033|1847587|FG000|Overall Study|Adverse Event|2
882409|NCT00605033|1847588|FG001|Overall Study|Adverse Event|2
882410|NCT00605033|1847587|FG000|Overall Study|Lost to Follow-up|1
882411|NCT00605033|1847588|FG001|Overall Study|Lost to Follow-up|1
882412|NCT00605033|1847587|FG000|Overall Study|Withdrawal by Subject|3
882413|NCT00605033|1847588|FG001|Overall Study|Withdrawal by Subject|4
882414|NCT00605033|1847587|FG000|Overall Study|Protocol Violation|1
1191954|NCT02546986|2352276|FG001|Treatment Period|Death|4
1191955|NCT02546986|2352275|FG000|Treatment Period|Physician Decision|1
882415|NCT00605033|1847588|FG001|Overall Study|Protocol Violation|1
882416|NCT00605085|1847609|FG000|Overall Study|Withdrawal by Subject|8
882417|NCT00605085|1847610|FG001|Overall Study|Withdrawal by Subject|5
882418|NCT00605085|1847609|FG000|Overall Study|Adverse Event|9
882419|NCT00605085|1847610|FG001|Overall Study|Adverse Event|5
1191956|NCT02546986|2352276|FG001|Treatment Period|Physician Decision|2
1191957|NCT02546986|2352275|FG000|Treatment Period|Protocol Violation|1
1191958|NCT02546986|2352276|FG001|Treatment Period|Protocol Violation|0
1191959|NCT02546986|2352275|FG000|Treatment Period|Withdrawal by Subject|1
1191960|NCT02546986|2352276|FG001|Treatment Period|Withdrawal by Subject|1
1191961|NCT02546986|2352275|FG000|Treatment Period|Non-compliance with Study Drug|0
1191962|NCT02546986|2352276|FG001|Treatment Period|Non-compliance with Study Drug|1
1191963|NCT02546986|2352275|FG000|Treatment Period|Study Terminated by Sponsor|0
1191964|NCT02546986|2352276|FG001|Treatment Period|Study Terminated by Sponsor|1
1191965|NCT02546986|2352275|FG000|Treatment Period|Miscellaneous|7
1191966|NCT02546986|2352276|FG001|Treatment Period|Miscellaneous|9
1191967|NCT02546986|2352275|FG000|Survival Follow-Up Phase|Missing Status|3
1191968|NCT02546986|2352276|FG001|Survival Follow-Up Phase|Missing Status|5
1191969|NCT02546986|2352275|FG000|Survival Follow-Up Phase|Death|18
1191970|NCT02546986|2352276|FG001|Survival Follow-Up Phase|Death|12
1191971|NCT02546986|2352275|FG000|Survival Follow-Up Phase|Alive|13
1191972|NCT02546986|2352276|FG001|Survival Follow-Up Phase|Alive|16
1191973|NCT02546986|2352275|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
1191974|NCT02546986|2352276|FG001|Survival Follow-Up Phase|Lost to Follow-up|2
1191975|NCT02539160|2352284|FG000|Phase 1 Pre-crossover|Adverse Event|3
1191976|NCT02539160|2352285|FG001|Phase 1 Pre-crossover|Adverse Event|3
1191977|NCT02539160|2352286|FG002|Phase 1 Pre-crossover|Adverse Event|2
1191978|NCT02539160|2352287|FG003|Phase 1 Pre-crossover|Adverse Event|1
1191979|NCT02539160|2352284|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2
1191980|NCT02539160|2352285|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1
1191981|NCT02539160|2352286|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1
1191982|NCT02539160|2352287|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0
1191983|NCT02539160|2352284|FG000|Phase 1 Pre-crossover|Protocol Violation|0
1191984|NCT02539160|2352285|FG001|Phase 1 Pre-crossover|Protocol Violation|0
1191985|NCT02539160|2352286|FG002|Phase 1 Pre-crossover|Protocol Violation|0
1191986|NCT02539160|2352287|FG003|Phase 1 Pre-crossover|Protocol Violation|2
1191987|NCT02507973|2352297|FG000|Overall Study|Adverse Event|1
1191988|NCT02500797|2352311|FG000|Overall Study|Cancel (rapid disease progression)|0
1191989|NCT02500797|2352312|FG001|Overall Study|Cancel (rapid disease progression)|0
1191990|NCT02500797|2352313|FG002|Overall Study|Cancel (rapid disease progression)|0
1191991|NCT02500797|2352314|FG003|Overall Study|Cancel (rapid disease progression)|0
1191992|NCT02500797|2352315|FG004|Overall Study|Cancel (rapid disease progression)|1
1191993|NCT02500797|2352316|FG005|Overall Study|Cancel (rapid disease progression)|1
1191994|NCT02500797|2352317|FG006|Overall Study|Cancel (rapid disease progression)|0
1191995|NCT02500797|2352318|FG007|Overall Study|Cancel (rapid disease progression)|0
1191996|NCT02500797|2352311|FG000|Overall Study|Withdrawal by Subject|1
1191997|NCT02500797|2352312|FG001|Overall Study|Withdrawal by Subject|0
1191998|NCT02500797|2352313|FG002|Overall Study|Withdrawal by Subject|0
1191999|NCT02500797|2352314|FG003|Overall Study|Withdrawal by Subject|0
1192000|NCT02500797|2352315|FG004|Overall Study|Withdrawal by Subject|0
1192001|NCT02500797|2352316|FG005|Overall Study|Withdrawal by Subject|0
1192002|NCT02500797|2352317|FG006|Overall Study|Withdrawal by Subject|0
1192003|NCT02500797|2352318|FG007|Overall Study|Withdrawal by Subject|0
1192004|NCT02489318|2352345|FG000|Randomized|Withdrawal by Subject|0
1192005|NCT02489318|2352346|FG001|Randomized|Withdrawal by Subject|1
1192006|NCT02489318|2352345|FG000|Treated|Adverse Event|19
1192007|NCT02489318|2352346|FG001|Treated|Adverse Event|62
1192008|NCT02489318|2352345|FG000|Treated|Death|13
1192009|NCT02489318|2352346|FG001|Treated|Death|11
1192010|NCT02489318|2352345|FG000|Treated|Physician Decision|4
1192011|NCT02489318|2352346|FG001|Treated|Physician Decision|6
1192012|NCT02489318|2352345|FG000|Treated|Protocol Violation|1
1192013|NCT02489318|2352346|FG001|Treated|Protocol Violation|2
1192014|NCT02489318|2352345|FG000|Treated|Withdrawal by Subject|37
1192015|NCT02489318|2352346|FG001|Treated|Withdrawal by Subject|36
1192016|NCT02489318|2352345|FG000|Treated|Other: Progressive Disease|245
1192017|NCT02489318|2352346|FG001|Treated|Other: Progressive Disease|138
1192018|NCT02489318|2352345|FG000|Treated|Other|0
1192019|NCT02489318|2352346|FG001|Treated|Other|2
1192020|NCT02489318|2352345|FG000|Treated|Ongoing|0
1192021|NCT02489318|2352346|FG001|Treated|Ongoing|267
1192022|NCT02477696|2352355|FG000|Overall Study|Adverse Event|40
1192023|NCT02477696|2352356|FG001|Overall Study|Adverse Event|59
1192024|NCT02477696|2352355|FG000|Overall Study|CLL Disease Progression|82
1192025|NCT02477696|2352356|FG001|Overall Study|CLL Disease Progression|68
1192026|NCT02477696|2352355|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2
1192027|NCT02477696|2352356|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10
1192028|NCT02477696|2352355|FG000|Overall Study|Death|5
1192029|NCT02477696|2352356|FG001|Overall Study|Death|6
1192030|NCT02477696|2352355|FG000|Overall Study|Withdrawal by Subject|7
1192031|NCT02477696|2352356|FG001|Overall Study|Withdrawal by Subject|7
1192032|NCT02477696|2352355|FG000|Overall Study|Physician Decision|5
1192033|NCT02477696|2352356|FG001|Overall Study|Physician Decision|5
882420|NCT00605085|1847609|FG000|Overall Study|Pregnancy|2
882421|NCT00605085|1847610|FG001|Overall Study|Pregnancy|0
882422|NCT00605085|1847609|FG000|Overall Study|Protocol Violation|3
1192034|NCT02477618|2352364|FG000|Overall Study|Completed Visits but Discontinued Drug|2
1192035|NCT02477618|2352365|FG001|Overall Study|Completed Visits but Discontinued Drug|1
1192036|NCT02477618|2352364|FG000|Overall Study|Died in Double-Blind Treatment Period|11
1192037|NCT02477618|2352365|FG001|Overall Study|Died in Double-Blind Treatment Period|11
1192038|NCT02477618|2352364|FG000|Overall Study|Adverse Event|1
1192039|NCT02477618|2352365|FG001|Overall Study|Adverse Event|1
1192040|NCT02477618|2352364|FG000|Overall Study|Transferred Away from Study Site|1
1192041|NCT02477618|2352365|FG001|Overall Study|Transferred Away from Study Site|0
1192042|NCT02477618|2352364|FG000|Overall Study|Left Study Site for Rehabilitation|0
1192043|NCT02477618|2352365|FG001|Overall Study|Left Study Site for Rehabilitation|1
1192044|NCT02277444|2352384|FG000|Overall Study|Adverse Event|10
1192045|NCT02277444|2352384|FG000|Overall Study|Withdrawal by Subject|3
1192046|NCT02277444|2352384|FG000|Overall Study|Other|1
1192047|NCT02277444|2352384|FG000|Overall Study|Enrolled and not Treated|3
1192048|NCT02277444|2352384|FG000|Overall Study|Ongoing|113
1192049|NCT02257528|2352388|FG000|Overall Study|Never received study treatment|1
1192050|NCT02252172|2352394|FG000|Overall Study|Lost to Follow-up|3
1192051|NCT02252172|2352395|FG001|Overall Study|Lost to Follow-up|1
1192052|NCT02252172|2352394|FG000|Overall Study|Ongoing|276
1192053|NCT02252172|2352395|FG001|Overall Study|Ongoing|298
1192054|NCT02195479|2352410|FG000|Overall Study|Lost to Follow-up|3
1192055|NCT02195479|2352411|FG001|Overall Study|Lost to Follow-up|0
1192056|NCT02195479|2352410|FG000|Overall Study|Death|48
1192057|NCT02195479|2352411|FG001|Overall Study|Death|45
1192058|NCT02195479|2352410|FG000|Overall Study|Physician Decision|1
1192059|NCT02195479|2352411|FG001|Overall Study|Physician Decision|0
1192060|NCT02195479|2352410|FG000|Overall Study|Withdrawal by Subject|11
1192061|NCT02195479|2352411|FG001|Overall Study|Withdrawal by Subject|6
1192062|NCT02195479|2352410|FG000|Overall Study|Other|2
1192063|NCT02195479|2352411|FG001|Overall Study|Other|2
1192064|NCT02195479|2352410|FG000|Overall Study|Ongoing|291
1192065|NCT02195479|2352411|FG001|Overall Study|Ongoing|297
1192066|NCT02136134|2352419|FG000|Overall Study|Death|35
1192067|NCT02136134|2352420|FG001|Overall Study|Death|29
1192068|NCT02136134|2352419|FG000|Overall Study|Withdrawal by Subject|14
1192069|NCT02136134|2352420|FG001|Overall Study|Withdrawal by Subject|4
1192070|NCT02136134|2352419|FG000|Overall Study|Other|3
1192071|NCT02136134|2352420|FG001|Overall Study|Other|3
1192072|NCT02136134|2352419|FG000|Overall Study|Ongoing|185
1192073|NCT02136134|2352420|FG001|Overall Study|Ongoing|207
1192074|NCT02136134|2352419|FG000|Overall Study|Subjects randomized but not treated|10
1192075|NCT02136134|2352420|FG001|Overall Study|Subjects randomized but not treated|8
1192076|NCT02076009|2352428|FG000|Overall Study|Death|44
1192077|NCT02076009|2352429|FG001|Overall Study|Death|30
1192078|NCT02076009|2352428|FG000|Overall Study|Withdrawal by Subject|9
1192079|NCT02076009|2352429|FG001|Overall Study|Withdrawal by Subject|3
1192080|NCT02076009|2352428|FG000|Overall Study|Lost to Follow-up|1
1192081|NCT02076009|2352429|FG001|Overall Study|Lost to Follow-up|1
1192082|NCT02076009|2352428|FG000|Overall Study|Progressive disease|1
1192083|NCT02076009|2352429|FG001|Overall Study|Progressive disease|0
1192084|NCT02076009|2352428|FG000|Overall Study|Ongoing|226
1192085|NCT02076009|2352429|FG001|Overall Study|Ongoing|249
1192086|NCT02076009|2352428|FG000|Overall Study|Subjects randomized but not treated|2
1192087|NCT02076009|2352429|FG001|Overall Study|Subjects randomized but not treated|3
1192088|NCT02003924|2352441|FG000|Double-blind Phase|Lost to Follow-up|2
1192089|NCT02003924|2352442|FG001|Double-blind Phase|Lost to Follow-up|1
1192090|NCT02003924|2352443|FG002|Double-blind Phase|Lost to Follow-up|0
1192091|NCT02003924|2352441|FG000|Double-blind Phase|Protocol Violation|1
1192092|NCT02003924|2352442|FG001|Double-blind Phase|Protocol Violation|2
1192093|NCT02003924|2352443|FG002|Double-blind Phase|Protocol Violation|0
1192094|NCT02003924|2352441|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71
1192095|NCT02003924|2352442|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47
1192096|NCT02003924|2352443|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0
1192097|NCT02003924|2352441|FG000|Double-blind Phase|Disease Progression|229
1192098|NCT02003924|2352442|FG001|Double-blind Phase|Disease Progression|247
1192099|NCT02003924|2352443|FG002|Double-blind Phase|Disease Progression|0
1192100|NCT02003924|2352441|FG000|Double-blind Phase|Adverse Event|120
1192101|NCT02003924|2352442|FG001|Double-blind Phase|Adverse Event|31
1192102|NCT02003924|2352443|FG002|Double-blind Phase|Adverse Event|0
1192103|NCT02003924|2352441|FG000|Double-blind Phase|Randomized But not Treated|3
1192104|NCT02003924|2352442|FG001|Double-blind Phase|Randomized But not Treated|3
1192105|NCT02003924|2352443|FG002|Double-blind Phase|Randomized But not Treated|0
1192106|NCT02003924|2352441|FG000|Double-blind Phase|Other|29
1192107|NCT02003924|2352442|FG001|Double-blind Phase|Other|50
1192108|NCT02003924|2352443|FG002|Double-blind Phase|Other|0
1192109|NCT02003924|2352441|FG000|Open-label Phase|Lost to Follow-up|0
1192110|NCT02003924|2352442|FG001|Open-label Phase|Lost to Follow-up|0
1192111|NCT02003924|2352443|FG002|Open-label Phase|Lost to Follow-up|1
1192112|NCT02003924|2352441|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9
1192113|NCT02003924|2352442|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0
1192114|NCT02003924|2352443|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1
1192115|NCT02003924|2352441|FG000|Open-label Phase|Disease Progression|59
1192116|NCT02003924|2352442|FG001|Open-label Phase|Disease Progression|0
1192117|NCT02003924|2352443|FG002|Open-label Phase|Disease Progression|5
1192118|NCT02003924|2352441|FG000|Open-label Phase|Adverse Event|25
1192119|NCT02003924|2352442|FG001|Open-label Phase|Adverse Event|0
1192120|NCT02003924|2352443|FG002|Open-label Phase|Adverse Event|10
1192121|NCT02003924|2352441|FG000|Open-label Phase|Other|7
1192122|NCT02003924|2352442|FG001|Open-label Phase|Other|0
1192123|NCT02003924|2352443|FG002|Open-label Phase|Other|0
1192124|NCT02003924|2352441|FG000|Long-term Follow-up Phase|Death|288
1192125|NCT02003924|2352442|FG001|Long-term Follow-up Phase|Death|174
1192126|NCT02003924|2352443|FG002|Long-term Follow-up Phase|Death|4
1192127|NCT02003924|2352441|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
1192128|NCT02003924|2352442|FG001|Long-term Follow-up Phase|Lost to Follow-up|6
1192129|NCT02003924|2352443|FG002|Long-term Follow-up Phase|Lost to Follow-up|1
1192130|NCT02003924|2352441|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66
1192131|NCT02003924|2352442|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55
1192132|NCT02003924|2352443|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1
1192133|NCT02003924|2352441|FG000|Long-term Follow-up Phase|Other|5
1192134|NCT02003924|2352442|FG001|Long-term Follow-up Phase|Other|2
1192135|NCT02003924|2352443|FG002|Long-term Follow-up Phase|Other|1
1192136|NCT01991067|2352452|FG000|Overall Study|Lost to Follow-up|6
1192137|NCT01991067|2352453|FG001|Overall Study|Lost to Follow-up|5
1192138|NCT01971970|2352461|FG000|Baseline Until Week 6|Stopped anti-TNF use|1
1192139|NCT01971970|2352462|FG001|Baseline Until Week 6|Stopped anti-TNF use|0
1192140|NCT01971970|2352461|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0
1192141|NCT01971970|2352462|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1
1192142|NCT01971970|2352461|FG000|Week 14 Until Week 22|Lost to Follow-up|0
1192143|NCT01971970|2352462|FG001|Week 14 Until Week 22|Lost to Follow-up|1
1192144|NCT01971970|2352461|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7
1192145|NCT01971970|2352462|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3
1192146|NCT01971970|2352461|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1
1192147|NCT01971970|2352462|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0
1192148|NCT01971970|2352461|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0
1192149|NCT01971970|2352462|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1
1192150|NCT01971970|2352461|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1
1192151|NCT01971970|2352462|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3
1192152|NCT01969409|2352475|FG000|Overall Study|Death|2
1192153|NCT01969409|2352476|FG001|Overall Study|Death|2
1192154|NCT01969409|2352475|FG000|Overall Study|Transplant|1
1192155|NCT01969409|2352476|FG001|Overall Study|Transplant|1
1192156|NCT01969409|2352475|FG000|Overall Study|Withdrawal by Subject|0
1192157|NCT01969409|2352476|FG001|Overall Study|Withdrawal by Subject|1
1192158|NCT01946204|2352484|FG000|Overall Study|Death|38
1192159|NCT01946204|2352485|FG001|Overall Study|Death|59
1192160|NCT01946204|2352484|FG000|Overall Study|Withdrawal by Subject|37
1192161|NCT01946204|2352485|FG001|Overall Study|Withdrawal by Subject|50
1192162|NCT01946204|2352484|FG000|Overall Study|Lost to Follow-up|3
1192163|NCT01946204|2352485|FG001|Overall Study|Lost to Follow-up|7
1192164|NCT01946204|2352484|FG000|Overall Study|Ongoing|316
1192165|NCT01946204|2352485|FG001|Overall Study|Ongoing|687
1192166|NCT01946204|2352484|FG000|Overall Study|Other|7
1192167|NCT01946204|2352485|FG001|Overall Study|Other|3
1192168|NCT01853748|2352493|FG000|Allocation|Withdrawal by Subject|1
1192169|NCT01853748|2352494|FG001|Allocation|Withdrawal by Subject|13
1192170|NCT01853748|2352493|FG000|Allocation|not sufficient to receive intervention|0
1192171|NCT01853748|2352494|FG001|Allocation|not sufficient to receive intervention|1
1192172|NCT01853748|2352493|FG000|Follow-Up|Withdrawal by Subject|7
1192173|NCT01853748|2352494|FG001|Follow-Up|Withdrawal by Subject|6
1192174|NCT01853748|2352493|FG000|Follow-Up|Adverse Event|67
1192175|NCT01853748|2352494|FG001|Follow-Up|Adverse Event|7
1192176|NCT01853748|2352493|FG000|Follow-Up|not available for data collection|16
1192177|NCT01853748|2352494|FG001|Follow-Up|not available for data collection|4
1192178|NCT01665144|2352511|FG000|Overall Study|New therapy for study indication|2
1192179|NCT01665144|2352512|FG001|Overall Study|New therapy for study indication|1
1192180|NCT01665144|2352511|FG000|Overall Study|Technical problems|2
1192181|NCT01665144|2352512|FG001|Overall Study|Technical problems|0
1192182|NCT01665144|2352511|FG000|Overall Study|Death|3
1192183|NCT01665144|2352512|FG001|Overall Study|Death|1
1192184|NCT01665144|2352511|FG000|Overall Study|Protocol deviation|3
1192185|NCT01665144|2352512|FG001|Overall Study|Protocol deviation|1
1192186|NCT01665144|2352511|FG000|Overall Study|Non-compliance w/study treatment|5
1192187|NCT01665144|2352512|FG001|Overall Study|Non-compliance w/study treatment|0
1192188|NCT01665144|2352511|FG000|Overall Study|Progressive disease|8
1192189|NCT01665144|2352512|FG001|Overall Study|Progressive disease|4
1192190|NCT01665144|2352511|FG000|Overall Study|Lost to Follow-up|9
1192191|NCT01665144|2352512|FG001|Overall Study|Lost to Follow-up|8
1192192|NCT01665144|2352511|FG000|Overall Study|Physician Decision|13
1192193|NCT01665144|2352512|FG001|Overall Study|Physician Decision|1
1192194|NCT01665144|2352511|FG000|Overall Study|Lack of Efficacy|16
1192195|NCT01665144|2352512|FG001|Overall Study|Lack of Efficacy|11
1192196|NCT01665144|2352511|FG000|Overall Study|Adverse Event|45
1192197|NCT01665144|2352512|FG001|Overall Study|Adverse Event|18
1192198|NCT01665144|2352511|FG000|Overall Study|Withdrawal by Subject|96
1192199|NCT01665144|2352512|FG001|Overall Study|Withdrawal by Subject|77
1192200|NCT01615029|2352523|FG000|Overall Study|Adverse Event|0
1192201|NCT01615029|2352524|FG001|Overall Study|Adverse Event|0
1192202|NCT01615029|2352525|FG002|Overall Study|Adverse Event|0
1192203|NCT01615029|2352526|FG003|Overall Study|Adverse Event|0
1192204|NCT01615029|2352527|FG004|Overall Study|Adverse Event|1
1192205|NCT01615029|2352523|FG000|Overall Study|Death|0
1192206|NCT01615029|2352524|FG001|Overall Study|Death|0
1192207|NCT01615029|2352525|FG002|Overall Study|Death|0
1192208|NCT01615029|2352526|FG003|Overall Study|Death|0
1192209|NCT01615029|2352527|FG004|Overall Study|Death|1
1192210|NCT01615029|2352523|FG000|Overall Study|Lost to Follow-up|0
882423|NCT00605085|1847610|FG001|Overall Study|Protocol Violation|2
882424|NCT00605085|1847609|FG000|Overall Study|Lost to Follow-up|10
882425|NCT00605085|1847610|FG001|Overall Study|Lost to Follow-up|5
882426|NCT00605085|1847609|FG000|Overall Study|administrative reasons|18
1192211|NCT01615029|2352524|FG001|Overall Study|Lost to Follow-up|0
1192212|NCT01615029|2352525|FG002|Overall Study|Lost to Follow-up|0
1192213|NCT01615029|2352526|FG003|Overall Study|Lost to Follow-up|0
1192214|NCT01615029|2352527|FG004|Overall Study|Lost to Follow-up|1
1192215|NCT01615029|2352523|FG000|Overall Study|Progressive disease|2
1192216|NCT01615029|2352524|FG001|Overall Study|Progressive disease|1
1192217|NCT01615029|2352525|FG002|Overall Study|Progressive disease|1
1192218|NCT01615029|2352526|FG003|Overall Study|Progressive disease|1
1192219|NCT01615029|2352527|FG004|Overall Study|Progressive disease|5
1192220|NCT01615029|2352523|FG000|Overall Study|Physician Decision|0
1192221|NCT01615029|2352524|FG001|Overall Study|Physician Decision|0
1192222|NCT01615029|2352525|FG002|Overall Study|Physician Decision|0
1192223|NCT01615029|2352526|FG003|Overall Study|Physician Decision|0
1192224|NCT01615029|2352527|FG004|Overall Study|Physician Decision|1
1192225|NCT01615029|2352523|FG000|Overall Study|Ongoing|1
1192226|NCT01615029|2352524|FG001|Overall Study|Ongoing|2
1192227|NCT01615029|2352525|FG002|Overall Study|Ongoing|3
1192228|NCT01615029|2352526|FG003|Overall Study|Ongoing|2
1192229|NCT01615029|2352527|FG004|Overall Study|Ongoing|23
1192230|NCT01385176|2352541|FG000|Randomization Phase|Death|1
1192231|NCT01385176|2352542|FG001|Randomization Phase|Death|2
1192232|NCT01385176|2352541|FG000|6-18 Month All VNS Active|Death|1
1192233|NCT01385176|2352542|FG001|6-18 Month All VNS Active|Death|2
1192234|NCT01385176|2352541|FG000|6-18 Month All VNS Active|Physician Decision|0
1192235|NCT01385176|2352542|FG001|6-18 Month All VNS Active|Physician Decision|1
1192236|NCT01385176|2352541|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2
1192237|NCT01385176|2352542|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0
1192238|NCT01385176|2352541|FG000|6-18 Month All VNS Active|Heart Transplant|1
1192239|NCT01385176|2352542|FG001|6-18 Month All VNS Active|Heart Transplant|0
1192240|NCT01314118|2352553|FG000|Overall Study|Adverse Event|9
1192241|NCT01314118|2352553|FG000|Overall Study|Progressive disease|27
1192242|NCT01314118|2352553|FG000|Overall Study|Physician Decision|11
1192243|NCT01314118|2352553|FG000|Overall Study|Death|4
1192244|NCT01314118|2352553|FG000|Overall Study|Protocol Violation|5
1192245|NCT01314118|2352553|FG000|Overall Study|Withdrawal by Subject|11
1192246|NCT01314118|2352553|FG000|Overall Study|Other|2
1192247|NCT01314118|2352553|FG000|Overall Study|Ongoing|62
1192248|NCT01307787|2352559|FG000|Overall Study|Withdrawal by Subject|2
1192249|NCT01307787|2352560|FG001|Overall Study|Withdrawal by Subject|0
1192250|NCT01275677|2352573|FG000|Overall Study|Not at risk for recurrence.|1
1192251|NCT01275677|2352574|FG001|Overall Study|Not at risk for recurrence.|1
1192252|NCT01275677|2352573|FG000|Overall Study|No follow-up|26
1192253|NCT01275677|2352574|FG001|Overall Study|No follow-up|37
1192254|NCT01275677|2352573|FG000|Overall Study|No clinical follow up.|1
1192255|NCT01275677|2352574|FG001|Overall Study|No clinical follow up.|4
1192256|NCT01250912|2352580|FG000|Overall Study|Lost to Follow-up|1
1192257|NCT01171898|2352600|FG000|Overall Study|Death|0
1192258|NCT01171898|2352601|FG001|Overall Study|Death|0
1192259|NCT01171898|2352602|FG002|Overall Study|Death|2
1192260|NCT01171898|2352603|FG003|Overall Study|Death|0
1192261|NCT01171898|2352600|FG000|Overall Study|Lost to Follow-up|0
1192262|NCT01171898|2352601|FG001|Overall Study|Lost to Follow-up|1
1192263|NCT01171898|2352602|FG002|Overall Study|Lost to Follow-up|1
1192264|NCT01171898|2352603|FG003|Overall Study|Lost to Follow-up|1
1192265|NCT01171898|2352600|FG000|Overall Study|Withdrawal by Subject|1
1192266|NCT01171898|2352601|FG001|Overall Study|Withdrawal by Subject|4
1192267|NCT01171898|2352602|FG002|Overall Study|Withdrawal by Subject|6
1192268|NCT01171898|2352603|FG003|Overall Study|Withdrawal by Subject|3
1192269|NCT01171898|2352600|FG000|Overall Study|Terminated by Sponsor|1
1192270|NCT01171898|2352601|FG001|Overall Study|Terminated by Sponsor|0
1192271|NCT01171898|2352602|FG002|Overall Study|Terminated by Sponsor|0
1192272|NCT01171898|2352603|FG003|Overall Study|Terminated by Sponsor|0
1192273|NCT01171898|2352600|FG000|Overall Study|Ongoing|1
1192274|NCT01171898|2352601|FG001|Overall Study|Ongoing|9
1192275|NCT01171898|2352602|FG002|Overall Study|Ongoing|3
1192276|NCT01171898|2352603|FG003|Overall Study|Ongoing|0
1192277|NCT01171898|2352600|FG000|Overall Study|Other|1
1192278|NCT01171898|2352601|FG001|Overall Study|Other|5
1192279|NCT01171898|2352602|FG002|Overall Study|Other|0
1192280|NCT01171898|2352603|FG003|Overall Study|Other|2
1192281|NCT01141712|2352616|FG000|Overall Study|Disease progression|3
1192282|NCT01015833|2352633|FG000|Overall Study|Death|1
1192283|NCT01015833|2352634|FG001|Overall Study|Death|0
1192284|NCT01015833|2352633|FG000|Overall Study|Withdrawal by Subject|3
1192285|NCT01015833|2352634|FG001|Overall Study|Withdrawal by Subject|2
1192286|NCT01015833|2352633|FG000|Overall Study|Adverse Event|0
1192287|NCT01015833|2352634|FG001|Overall Study|Adverse Event|1
1192288|NCT01015833|2352633|FG000|Overall Study|Physician Decision|2
1192289|NCT01015833|2352634|FG001|Overall Study|Physician Decision|0
1192290|NCT01015833|2352633|FG000|Overall Study|Symptomatic deterioration|0
1192291|NCT01015833|2352634|FG001|Overall Study|Symptomatic deterioration|1
1192292|NCT01015833|2352633|FG000|Overall Study|Other|5
1192293|NCT01015833|2352634|FG001|Overall Study|Other|1
1192294|NCT01015833|2352633|FG000|Overall Study|Motor Vehicle Accidents|1
1192295|NCT01015833|2352634|FG001|Overall Study|Motor Vehicle Accidents|0
1192296|NCT01015833|2352633|FG000|Overall Study|Did not start treatment|1
1192297|NCT01015833|2352634|FG001|Overall Study|Did not start treatment|0
1192298|NCT00843882|2352643|FG000|Step 1|Lack of Efficacy|14
1192299|NCT00843882|2352644|FG001|Step 1|Lack of Efficacy|10
1192300|NCT00843882|2352645|FG002|Step 1|Lack of Efficacy|21
1192301|NCT00843882|2352643|FG000|Step 1|Adverse Event|8
1192302|NCT00843882|2352644|FG001|Step 1|Adverse Event|17
1192303|NCT00843882|2352645|FG002|Step 1|Adverse Event|20
1192304|NCT00843882|2352643|FG000|Step 1|Death|1
1192305|NCT00843882|2352644|FG001|Step 1|Death|2
1192306|NCT00843882|2352645|FG002|Step 1|Death|4
1192307|NCT00843882|2352643|FG000|Step 1|Withdrawal by Subject|6
1192308|NCT00843882|2352644|FG001|Step 1|Withdrawal by Subject|12
1192309|NCT00843882|2352645|FG002|Step 1|Withdrawal by Subject|9
1192310|NCT00843882|2352643|FG000|Step 1|Physician Decision|0
1192311|NCT00843882|2352644|FG001|Step 1|Physician Decision|5
1192312|NCT00843882|2352645|FG002|Step 1|Physician Decision|1
1192313|NCT00843882|2352643|FG000|Step 1|Patient and physician's decision|0
1192314|NCT00843882|2352644|FG001|Step 1|Patient and physician's decision|0
1192315|NCT00843882|2352645|FG002|Step 1|Patient and physician's decision|1
1192316|NCT00843882|2352643|FG000|Step 1|Other complicating disease|1
1192317|NCT00843882|2352644|FG001|Step 1|Other complicating disease|3
1192318|NCT00843882|2352645|FG002|Step 1|Other complicating disease|4
1192319|NCT00843882|2352643|FG000|Step 1|Alternative therapy|0
1192320|NCT00843882|2352644|FG001|Step 1|Alternative therapy|1
1192321|NCT00843882|2352645|FG002|Step 1|Alternative therapy|1
1192322|NCT00843882|2352643|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0
1192323|NCT00843882|2352644|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4
1192324|NCT00843882|2352645|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0
1192325|NCT00843882|2352643|FG000|Step 1|Off treatment reason unknown|0
1192326|NCT00843882|2352644|FG001|Step 1|Off treatment reason unknown|1
1192327|NCT00843882|2352645|FG002|Step 1|Off treatment reason unknown|4
1192328|NCT00843882|2352643|FG000|Step 1|Never started treatment|2
1192329|NCT00843882|2352644|FG001|Step 1|Never started treatment|0
1192330|NCT00843882|2352645|FG002|Step 1|Never started treatment|0
1192331|NCT00843882|2352643|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1
1192332|NCT00843882|2352644|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9
1192333|NCT00843882|2352645|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0
1192334|NCT00843882|2352643|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0
1192335|NCT00843882|2352644|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6
1192336|NCT00843882|2352645|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0
1192337|NCT00843882|2352643|FG000|Step 2 (Cross-over to Arm B)|Death|0
1192338|NCT00843882|2352644|FG001|Step 2 (Cross-over to Arm B)|Death|3
1192339|NCT00843882|2352645|FG002|Step 2 (Cross-over to Arm B)|Death|0
1192340|NCT00843882|2352643|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2
1192341|NCT00843882|2352644|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5
1192342|NCT00843882|2352645|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0
1192343|NCT00843882|2352643|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1
1192344|NCT00843882|2352644|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1
1192345|NCT00843882|2352645|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0
1192346|NCT00843882|2352643|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0
1192347|NCT00843882|2352644|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1
1192348|NCT00843882|2352645|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0
1192349|NCT00843882|2352643|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
1192350|NCT00843882|2352644|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1
1192351|NCT00843882|2352645|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
1192352|NCT00659646|2352660|FG000|Overall Study|Protocol Violation|12
882427|NCT00605085|1847610|FG001|Overall Study|administrative reasons|8
1192353|NCT00659646|2352661|FG001|Overall Study|Protocol Violation|8
1192354|NCT00659646|2352660|FG000|Overall Study|Adverse Event|1
1192355|NCT00659646|2352661|FG001|Overall Study|Adverse Event|0
1192356|NCT00659646|2352660|FG000|Overall Study|Lost to Follow-up|1
1192357|NCT00659646|2352661|FG001|Overall Study|Lost to Follow-up|0
1192358|NCT00659646|2352660|FG000|Overall Study|protocol noncompliance after randomized|1
1192359|NCT00659646|2352661|FG001|Overall Study|protocol noncompliance after randomized|0
1192360|NCT00588770|2352671|FG000|Overall Study|Disease progression|85
1192361|NCT00588770|2352672|FG001|Overall Study|Disease progression|68
1192362|NCT00588770|2352671|FG000|Overall Study|Adverse Event|29
1192363|NCT00588770|2352672|FG001|Overall Study|Adverse Event|58
1192364|NCT00588770|2352671|FG000|Overall Study|Death|13
1192365|NCT00588770|2352672|FG001|Overall Study|Death|22
1192366|NCT00588770|2352671|FG000|Overall Study|Withdrawal by Subject|15
1192367|NCT00588770|2352672|FG001|Overall Study|Withdrawal by Subject|25
1192368|NCT00588770|2352671|FG000|Overall Study|Alternative therapy|2
1192369|NCT00588770|2352672|FG001|Overall Study|Alternative therapy|4
1192370|NCT00588770|2352671|FG000|Overall Study|Other complicating disease|3
1192371|NCT00588770|2352672|FG001|Overall Study|Other complicating disease|2
1192372|NCT00588770|2352671|FG000|Overall Study|Not start protocol therapy|0
1192373|NCT00588770|2352672|FG001|Overall Study|Not start protocol therapy|9
1192374|NCT00588770|2352671|FG000|Overall Study|Lack of Efficacy|8
1192375|NCT00588770|2352672|FG001|Overall Study|Lack of Efficacy|10
1192376|NCT00588770|2352671|FG000|Overall Study|Physician discretion|2
1192377|NCT00588770|2352672|FG001|Overall Study|Physician discretion|0
1192378|NCT00588770|2352671|FG000|Overall Study|Patient non-compliance|2
1192379|NCT00588770|2352672|FG001|Overall Study|Patient non-compliance|2
1192380|NCT00567580|2352681|FG000|Overall Study|Protocol Violation|28
1192381|NCT00567580|2352682|FG001|Overall Study|Protocol Violation|24
1192382|NCT00567580|2352683|FG002|Overall Study|Protocol Violation|24
1192383|NCT00477412|2352698|FG000|Overall Study|Death|0
1192384|NCT00477412|2352699|FG001|Overall Study|Death|0
1192385|NCT00477412|2352700|FG002|Overall Study|Death|0
1192386|NCT00477412|2352701|FG003|Overall Study|Death|4
1192387|NCT00477412|2352698|FG000|Overall Study|Lost to Follow-up|0
1192388|NCT00477412|2352699|FG001|Overall Study|Lost to Follow-up|0
1192389|NCT00477412|2352700|FG002|Overall Study|Lost to Follow-up|0
1192390|NCT00477412|2352701|FG003|Overall Study|Lost to Follow-up|1
1192391|NCT00477412|2352698|FG000|Overall Study|Withdrawal by Subject|0
1192392|NCT00477412|2352699|FG001|Overall Study|Withdrawal by Subject|0
1192393|NCT00477412|2352700|FG002|Overall Study|Withdrawal by Subject|0
1192394|NCT00477412|2352701|FG003|Overall Study|Withdrawal by Subject|2
1192395|NCT00477412|2352698|FG000|Overall Study|Second Malignancy|0
1192396|NCT00477412|2352699|FG001|Overall Study|Second Malignancy|0
1192397|NCT00477412|2352700|FG002|Overall Study|Second Malignancy|0
1192398|NCT00477412|2352701|FG003|Overall Study|Second Malignancy|1
1192399|NCT00477412|2352698|FG000|Overall Study|Adverse Event|1
1192400|NCT00477412|2352699|FG001|Overall Study|Adverse Event|0
1192401|NCT00477412|2352700|FG002|Overall Study|Adverse Event|1
1192402|NCT00477412|2352701|FG003|Overall Study|Adverse Event|0
1192403|NCT00369317|2352709|FG000|Overall Study|Adverse Event|3
1192404|NCT00369317|2352709|FG000|Overall Study|Death|1
1192405|NCT00369317|2352709|FG000|Overall Study|Lack of Efficacy|5
1192406|NCT00369317|2352709|FG000|Overall Study|Physician Decision|2
1192407|NCT00369317|2352709|FG000|Overall Study|Withdrawal by Subject|8
1192408|NCT00369317|2352709|FG000|Overall Study|Ineligible|1
1192409|NCT00261807|2352714|FG000|Overall Study|Lost to Follow-up|2
1192410|NCT00261807|2352714|FG000|Overall Study|Adverse Event|2
1192411|NCT00261807|2352714|FG000|Overall Study|Death|1
1192412|NCT00261807|2352714|FG000|Overall Study|Protocol Violation|2
882428|NCT00605176|1847623|FG000|Overall Study|Adverse Event|2
882429|NCT00605176|1847624|FG001|Overall Study|Adverse Event|1
882430|NCT00605176|1847625|FG002|Overall Study|Adverse Event|3
882431|NCT00605176|1847623|FG000|Overall Study|Withdrawal by Subject|4
882432|NCT00605176|1847624|FG001|Overall Study|Withdrawal by Subject|2
882433|NCT00605176|1847625|FG002|Overall Study|Withdrawal by Subject|4
882434|NCT00605176|1847623|FG000|Overall Study|Lost to Follow-up|2
882435|NCT00605176|1847624|FG001|Overall Study|Lost to Follow-up|2
882436|NCT00605176|1847625|FG002|Overall Study|Lost to Follow-up|1
882437|NCT00605176|1847623|FG000|Overall Study|Non-complicance with study procedures|1
882438|NCT00605176|1847624|FG001|Overall Study|Non-complicance with study procedures|0
882439|NCT00605176|1847625|FG002|Overall Study|Non-complicance with study procedures|0
882440|NCT00605176|1847623|FG000|Overall Study|Use of concomitant therapy|1
882441|NCT00605176|1847624|FG001|Overall Study|Use of concomitant therapy|0
882442|NCT00605176|1847625|FG002|Overall Study|Use of concomitant therapy|1
882443|NCT00605176|1847623|FG000|Overall Study|Other (not due to AE)|1
882444|NCT00605176|1847624|FG001|Overall Study|Other (not due to AE)|1
882445|NCT00605176|1847625|FG002|Overall Study|Other (not due to AE)|0
882446|NCT00605189|1847636|FG000|Overall Study|Adverse Event|1
882447|NCT00605189|1847637|FG001|Overall Study|Adverse Event|0
882448|NCT00605189|1847638|FG002|Overall Study|Adverse Event|0
882449|NCT00605189|1847636|FG000|Overall Study|Other|2
882450|NCT00605189|1847637|FG001|Overall Study|Other|2
882451|NCT00605189|1847638|FG002|Overall Study|Other|0
882452|NCT00605267|1847655|FG000|Overall Study|Adverse Event|0
1192413|NCT04620798|2352737|FG000|Overall Study|Lost to Follow-up|126
1192414|NCT04620798|2352738|FG001|Overall Study|Lost to Follow-up|138
1192415|NCT04256629|2352763|FG000|Overall Study|Adverse Event|0
1192416|NCT04256629|2352764|FG001|Overall Study|Adverse Event|0
1192417|NCT04256629|2352765|FG002|Overall Study|Adverse Event|0
1192418|NCT04256629|2352766|FG003|Overall Study|Adverse Event|0
1192419|NCT04256629|2352767|FG004|Overall Study|Adverse Event|0
1192420|NCT04256629|2352768|FG005|Overall Study|Adverse Event|1
1192421|NCT04256629|2352763|FG000|Overall Study|Protocol Violation|0
1192422|NCT04256629|2352764|FG001|Overall Study|Protocol Violation|1
1192423|NCT04256629|2352765|FG002|Overall Study|Protocol Violation|0
1192424|NCT04256629|2352766|FG003|Overall Study|Protocol Violation|0
1192425|NCT04256629|2352767|FG004|Overall Study|Protocol Violation|0
1192426|NCT04256629|2352768|FG005|Overall Study|Protocol Violation|0
1192427|NCT04014075|2352780|FG000|Overall Study|Progressive Disease|39
1192428|NCT04014075|2352780|FG000|Overall Study|Adverse Event|9
1192429|NCT04014075|2352780|FG000|Overall Study|Clinical Progression|2
1192430|NCT04014075|2352780|FG000|Overall Study|Death|2
1192431|NCT04014075|2352780|FG000|Overall Study|Withdrawal by Subject|2
1192432|NCT04014075|2352780|FG000|Overall Study|Miscellaneous|1
1192433|NCT04014075|2352780|FG000|Overall Study|Physician Decision|1
1192434|NCT03284853|2352803|FG000|Overall Study|Adverse Event|40
1192435|NCT03284853|2352804|FG001|Overall Study|Adverse Event|4
1192436|NCT03284853|2352803|FG000|Overall Study|Withdrawal by Subject|5
1192437|NCT03284853|2352804|FG001|Overall Study|Withdrawal by Subject|1
1192438|NCT03284853|2352803|FG000|Overall Study|Lost to Follow-up|1
1192439|NCT03284853|2352804|FG001|Overall Study|Lost to Follow-up|0
1192440|NCT03284853|2352803|FG000|Overall Study|Lack of Efficacy|1
1192441|NCT03284853|2352804|FG001|Overall Study|Lack of Efficacy|0
1192442|NCT03284853|2352803|FG000|Overall Study|Disallowed Concurrent Medication|1
1192443|NCT03284853|2352804|FG001|Overall Study|Disallowed Concurrent Medication|1
1192444|NCT03284853|2352803|FG000|Overall Study|Protocol Violation|3
882453|NCT00605267|1847656|FG001|Overall Study|Adverse Event|1
882454|NCT00605267|1847655|FG000|Overall Study|Lack of Efficacy|1
882455|NCT00605267|1847656|FG001|Overall Study|Lack of Efficacy|5
882456|NCT00605267|1847655|FG000|Overall Study|Withdrawal by Subject|2
882457|NCT00605267|1847656|FG001|Overall Study|Withdrawal by Subject|3
882458|NCT00605280|1847666|FG000|Year 1|Protocol Violation|0
882459|NCT00605280|1847667|FG001|Year 1|Protocol Violation|0
882460|NCT00605280|1847668|FG002|Year 1|Protocol Violation|0
882461|NCT00605280|1847669|FG003|Year 1|Protocol Violation|1
882462|NCT00605280|1847666|FG000|Year 1|Adverse Event|3
882463|NCT00605280|1847667|FG001|Year 1|Adverse Event|1
882464|NCT00605280|1847668|FG002|Year 1|Adverse Event|1
882465|NCT00605280|1847669|FG003|Year 1|Adverse Event|5
882466|NCT00605280|1847666|FG000|Year 1|Physician Decision|7
882467|NCT00605280|1847667|FG001|Year 1|Physician Decision|4
882468|NCT00605280|1847668|FG002|Year 1|Physician Decision|0
882469|NCT00605280|1847669|FG003|Year 1|Physician Decision|6
882470|NCT00605280|1847666|FG000|Year 1|Withdrawal by Subject|2
882471|NCT00605280|1847667|FG001|Year 1|Withdrawal by Subject|4
882472|NCT00605280|1847668|FG002|Year 1|Withdrawal by Subject|0
882473|NCT00605280|1847669|FG003|Year 1|Withdrawal by Subject|4
882474|NCT00605280|1847666|FG000|Year 1|Other|2
882475|NCT00605280|1847667|FG001|Year 1|Other|1
882476|NCT00605280|1847668|FG002|Year 1|Other|0
882477|NCT00605280|1847669|FG003|Year 1|Other|1
882478|NCT00605280|1847666|FG000|Year 1|Lost to Follow-up or Patient non-comply|5
882479|NCT00605280|1847667|FG001|Year 1|Lost to Follow-up or Patient non-comply|1
882480|NCT00605280|1847668|FG002|Year 1|Lost to Follow-up or Patient non-comply|0
882481|NCT00605280|1847669|FG003|Year 1|Lost to Follow-up or Patient non-comply|2
882482|NCT00605280|1847666|FG000|Year 2|Adverse Event|4
882483|NCT00605280|1847667|FG001|Year 2|Adverse Event|0
882484|NCT00605280|1847668|FG002|Year 2|Adverse Event|2
882485|NCT00605280|1847669|FG003|Year 2|Adverse Event|4
882486|NCT00605280|1847666|FG000|Year 2|Physician Decision|11
882487|NCT00605280|1847667|FG001|Year 2|Physician Decision|6
882488|NCT00605280|1847668|FG002|Year 2|Physician Decision|4
882489|NCT00605280|1847669|FG003|Year 2|Physician Decision|11
882490|NCT00605280|1847666|FG000|Year 2|Withdrawal by Subject|4
882491|NCT00605280|1847667|FG001|Year 2|Withdrawal by Subject|0
882492|NCT00605280|1847668|FG002|Year 2|Withdrawal by Subject|0
882493|NCT00605280|1847669|FG003|Year 2|Withdrawal by Subject|4
882494|NCT00605280|1847666|FG000|Year 2|Other|1
882495|NCT00605280|1847667|FG001|Year 2|Other|0
882496|NCT00605280|1847668|FG002|Year 2|Other|0
882497|NCT00605280|1847669|FG003|Year 2|Other|1
882498|NCT00605280|1847666|FG000|Year 2|Lost to Follow-up or Patient non-comply|4
882499|NCT00605280|1847667|FG001|Year 2|Lost to Follow-up or Patient non-comply|0
882500|NCT00605280|1847668|FG002|Year 2|Lost to Follow-up or Patient non-comply|0
882501|NCT00605280|1847669|FG003|Year 2|Lost to Follow-up or Patient non-comply|2
882502|NCT00605280|1847666|FG000|Year 3 Extension|Adverse Event|2
882503|NCT00605280|1847667|FG001|Year 3 Extension|Adverse Event|0
882504|NCT00605280|1847668|FG002|Year 3 Extension|Adverse Event|0
882505|NCT00605280|1847669|FG003|Year 3 Extension|Adverse Event|2
882506|NCT00605280|1847666|FG000|Year 3 Extension|Physician Decision|0
882507|NCT00605280|1847667|FG001|Year 3 Extension|Physician Decision|0
1192445|NCT03284853|2352804|FG001|Overall Study|Protocol Violation|3
1192446|NCT03284853|2352803|FG000|Overall Study|Death|0
1192447|NCT03284853|2352804|FG001|Overall Study|Death|1
1192448|NCT03284853|2352803|FG000|Overall Study|Other - Reason not reported in CSR|4
1192449|NCT03284853|2352804|FG001|Overall Study|Other - Reason not reported in CSR|3
1192450|NCT02774889|2352827|FG000|Overall Study|Lost to Follow-up|2
1192451|NCT02774889|2352828|FG001|Overall Study|Lost to Follow-up|1
1192452|NCT02625090|2352846|FG000|Overall Study|Participant wants to be pregnant|2
1192453|NCT02625090|2352846|FG000|Overall Study|For the Promoter|1
1192454|NCT02625090|2352846|FG000|Overall Study|Sponsor's Decision|9
1192455|NCT02625090|2352846|FG000|Overall Study|Somnolence|1
1192456|NCT02625090|2352846|FG000|Overall Study|Study terminated by Sponsor|7
1192457|NCT02625090|2352846|FG000|Overall Study|Negative Benefit/Risk|1
1192458|NCT02625090|2352846|FG000|Overall Study|Protocol Deviation|2
1192459|NCT02625090|2352846|FG000|Overall Study|Lack of Efficacy|16
1192460|NCT02625090|2352846|FG000|Overall Study|Adverse Event|3
1192461|NCT02367456|2352854|FG000|Overall Study|Death|8
1192462|NCT02367456|2352855|FG001|Overall Study|Death|21
1192463|NCT02367456|2352856|FG002|Overall Study|Death|14
1192464|NCT02367456|2352854|FG000|Overall Study|Lost to Follow-up|1
1192465|NCT02367456|2352855|FG001|Overall Study|Lost to Follow-up|3
1192466|NCT02367456|2352856|FG002|Overall Study|Lost to Follow-up|1
1192467|NCT02367456|2352854|FG000|Overall Study|Ongoing|0
1192468|NCT02367456|2352855|FG001|Overall Study|Ongoing|6
1192469|NCT02367456|2352856|FG002|Overall Study|Ongoing|15
1192470|NCT02367456|2352854|FG000|Overall Study|Other reason|3
1192471|NCT02367456|2352855|FG001|Overall Study|Other reason|0
1192472|NCT02367456|2352856|FG002|Overall Study|Other reason|0
1192473|NCT02297438|2352871|FG000|Overall Study|Death|79
1192474|NCT02297438|2352872|FG001|Overall Study|Death|86
1192475|NCT02297438|2352871|FG000|Overall Study|Lost to Follow-up|9
1192476|NCT02297438|2352872|FG001|Overall Study|Lost to Follow-up|7
1192477|NCT02297438|2352871|FG000|Overall Study|Withdrawal by Subject|7
1192478|NCT02297438|2352872|FG001|Overall Study|Withdrawal by Subject|0
1192479|NCT02297438|2352871|FG000|Overall Study|Other|9
1192480|NCT02297438|2352872|FG001|Overall Study|Other|5
1192481|NCT02297438|2352871|FG000|Overall Study|Ongoing|65
1192482|NCT02297438|2352872|FG001|Overall Study|Ongoing|73
1192483|NCT02297412|2352880|FG000|Overall Study|Canceled|1
1192484|NCT02297412|2352881|FG001|Overall Study|Canceled|1
1192485|NCT02288247|2352896|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52
1192486|NCT02288247|2352897|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0
1192487|NCT02288247|2352896|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35
1192488|NCT02288247|2352897|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0
1192489|NCT02288247|2352896|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1
1192490|NCT02288247|2352897|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0
1192491|NCT02288247|2352896|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392
1192492|NCT02288247|2352897|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0
1192493|NCT02288247|2352896|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9
1192494|NCT02288247|2352897|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0
1192495|NCT02288247|2352896|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52
1192496|NCT02288247|2352897|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0
1192497|NCT02288247|2352896|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106
1192498|NCT02288247|2352897|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0
1192499|NCT02288247|2352896|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10
1192500|NCT02288247|2352897|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8
1192501|NCT02288247|2352896|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8
1192502|NCT02288247|2352897|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4
1192503|NCT02288247|2352896|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1
1192504|NCT02288247|2352897|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0
1192505|NCT02288247|2352896|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87
1192506|NCT02288247|2352897|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94
1192507|NCT02288247|2352896|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2
1192508|NCT02288247|2352897|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1
1192509|NCT02288247|2352896|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
1192510|NCT02288247|2352897|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
1192511|NCT02288247|2352896|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20
1192512|NCT02288247|2352897|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21
1192513|NCT02288247|2352896|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1
1192514|NCT02288247|2352897|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0
1192515|NCT02250326|2352908|FG000|Treatment Period|Death|1
1192516|NCT02250326|2352909|FG001|Treatment Period|Death|12
1192517|NCT02250326|2352910|FG002|Treatment Period|Death|2
1192518|NCT02250326|2352908|FG000|Treatment Period|Adverse Event|8
1192519|NCT02250326|2352909|FG001|Treatment Period|Adverse Event|4
1192520|NCT02250326|2352910|FG002|Treatment Period|Adverse Event|8
1192521|NCT02250326|2352908|FG000|Treatment Period|Progressive Disease|42
1192522|NCT02250326|2352909|FG001|Treatment Period|Progressive Disease|36
1192523|NCT02250326|2352910|FG002|Treatment Period|Progressive Disease|45
1192524|NCT02250326|2352908|FG000|Treatment Period|Symptomatic Deterioration|9
1192525|NCT02250326|2352909|FG001|Treatment Period|Symptomatic Deterioration|4
1192526|NCT02250326|2352910|FG002|Treatment Period|Symptomatic Deterioration|10
1192527|NCT02250326|2352908|FG000|Treatment Period|Withdrawal by Subject|11
1192528|NCT02250326|2352909|FG001|Treatment Period|Withdrawal by Subject|5
1192529|NCT02250326|2352910|FG002|Treatment Period|Withdrawal by Subject|4
1192530|NCT02250326|2352908|FG000|Treatment Period|Miscellaneous|8
1192531|NCT02250326|2352909|FG001|Treatment Period|Miscellaneous|2
1192532|NCT02250326|2352910|FG002|Treatment Period|Miscellaneous|7
1192533|NCT02250326|2352908|FG000|Treatment Period|Randomized or assigned; not treated|2
1192534|NCT02250326|2352909|FG001|Treatment Period|Randomized or assigned; not treated|1
1192535|NCT02250326|2352910|FG002|Treatment Period|Randomized or assigned; not treated|1
1192536|NCT02250326|2352908|FG000|Follow-Up Period|Death|46
1192537|NCT02250326|2352909|FG001|Follow-Up Period|Death|26
1192538|NCT02250326|2352910|FG002|Follow-Up Period|Death|32
1192539|NCT02250326|2352908|FG000|Follow-Up Period|Unknown or Missing|2
1192540|NCT02250326|2352909|FG001|Follow-Up Period|Unknown or Missing|3
1192541|NCT02250326|2352910|FG002|Follow-Up Period|Unknown or Missing|3
1192542|NCT02250326|2352908|FG000|Follow-Up Period|Lost to Follow-up|1
1192543|NCT02250326|2352909|FG001|Follow-Up Period|Lost to Follow-up|1
1192544|NCT02250326|2352910|FG002|Follow-Up Period|Lost to Follow-up|3
1192545|NCT01503515|2352932|FG000|Overall Study|Adverse Event|4
1192546|NCT01503515|2352933|FG001|Overall Study|Adverse Event|5
1192547|NCT01503515|2352932|FG000|Overall Study|Death|0
1192548|NCT01503515|2352933|FG001|Overall Study|Death|1
1192549|NCT01503515|2352932|FG000|Overall Study|Physician Decision|14
1192550|NCT01503515|2352933|FG001|Overall Study|Physician Decision|23
1192551|NCT01503515|2352932|FG000|Overall Study|Withdrawal by Subject|0
1192552|NCT01503515|2352933|FG001|Overall Study|Withdrawal by Subject|1
1192553|NCT01503515|2352932|FG000|Overall Study|Institutional dx of proven/probable IFI|2
1192554|NCT01503515|2352933|FG001|Overall Study|Institutional dx of proven/probable IFI|4
1192555|NCT01503515|2352932|FG000|Overall Study|Ineligible|1
1192556|NCT01503515|2352933|FG001|Overall Study|Ineligible|1
1192557|NCT00565851|2352972|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9
1192558|NCT00565851|2352973|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9
1192559|NCT00565851|2352974|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3
1192560|NCT00565851|2352975|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18
1192561|NCT00565851|2352976|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0
1192562|NCT00565851|2352977|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2
1192563|NCT00565851|2352978|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0
1192564|NCT00565851|2352979|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2
1192565|NCT00565851|2352972|FG000|Chemotherapy Assignment|Still On Chemotherapy|0
1192566|NCT00565851|2352973|FG001|Chemotherapy Assignment|Still On Chemotherapy|14
1192567|NCT00565851|2352974|FG002|Chemotherapy Assignment|Still On Chemotherapy|0
1192568|NCT00565851|2352975|FG003|Chemotherapy Assignment|Still On Chemotherapy|18
1192569|NCT00565851|2352976|FG004|Chemotherapy Assignment|Still On Chemotherapy|0
1192570|NCT00565851|2352977|FG005|Chemotherapy Assignment|Still On Chemotherapy|1
1192571|NCT00565851|2352978|FG006|Chemotherapy Assignment|Still On Chemotherapy|0
1192572|NCT00565851|2352979|FG007|Chemotherapy Assignment|Still On Chemotherapy|1
1192573|NCT00245960|2353003|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6
1192574|NCT00245960|2353004|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7
1192575|NCT00245960|2353003|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0
1192576|NCT00245960|2353004|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1
1192577|NCT00245960|2353003|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2
1192578|NCT00245960|2353004|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0
1192579|NCT00245960|2353003|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2
1192580|NCT00245960|2353004|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1
1192581|NCT00245960|2353003|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3
1192582|NCT00245960|2353004|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0
1192583|NCT00245960|2353003|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
1192584|NCT00245960|2353004|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
1192585|NCT00245960|2353003|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8
1192586|NCT00245960|2353004|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4
1192587|NCT00245960|2353003|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
1192588|NCT00245960|2353004|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
1192589|NCT00245960|2353003|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2
1192590|NCT00245960|2353004|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5
1192591|NCT00245960|2353003|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1
1192592|NCT00245960|2353004|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3
1192593|NCT00245960|2353003|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1
1192594|NCT00245960|2353004|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3
1192595|NCT00245960|2353003|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0
1192596|NCT00245960|2353004|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1
1192597|NCT04015336|2353091|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1
1192598|NCT03920280|2353170|FG000|Overall Study|Adverse Event|2
1192599|NCT03920280|2353171|FG001|Overall Study|Adverse Event|3
1192600|NCT03920280|2353170|FG000|Overall Study|Lost to Follow-up|0
1192601|NCT03920280|2353171|FG001|Overall Study|Lost to Follow-up|1
1192602|NCT03920280|2353170|FG000|Overall Study|Withdrawal by Subject|1
1192603|NCT03920280|2353171|FG001|Overall Study|Withdrawal by Subject|1
1192604|NCT03920280|2353170|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0
1192605|NCT03920280|2353171|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1
1192606|NCT03913091|2353182|FG000|Overall Study|Lost to Follow-up|18
1192607|NCT03913091|2353183|FG001|Overall Study|Lost to Follow-up|11
1192608|NCT03913091|2353182|FG000|Overall Study|Required additional meds/surgery|1
1192609|NCT03913091|2353183|FG001|Overall Study|Required additional meds/surgery|2
1192610|NCT03913091|2353182|FG000|Overall Study|Chronic pain/history of substance abuse|1
1192611|NCT03913091|2353183|FG001|Overall Study|Chronic pain/history of substance abuse|1
1192612|NCT03802565|2353194|FG000|Overall Study|Adverse Event|0
1192613|NCT03802565|2353195|FG001|Overall Study|Adverse Event|1
1192614|NCT03802565|2353196|FG002|Overall Study|Adverse Event|2
1192615|NCT03802565|2353197|FG003|Overall Study|Adverse Event|1
1192616|NCT03802565|2353198|FG004|Overall Study|Adverse Event|1
1192617|NCT03802565|2353194|FG000|Overall Study|Withdrawal by Subject|2
1192618|NCT03802565|2353195|FG001|Overall Study|Withdrawal by Subject|2
1192619|NCT03802565|2353196|FG002|Overall Study|Withdrawal by Subject|2
1192620|NCT03802565|2353197|FG003|Overall Study|Withdrawal by Subject|0
1192621|NCT03802565|2353198|FG004|Overall Study|Withdrawal by Subject|1
1192622|NCT03802565|2353194|FG000|Overall Study|Protocol Violation|2
1192623|NCT03802565|2353195|FG001|Overall Study|Protocol Violation|1
1192624|NCT03802565|2353196|FG002|Overall Study|Protocol Violation|4
1192625|NCT03802565|2353197|FG003|Overall Study|Protocol Violation|5
1192626|NCT03802565|2353198|FG004|Overall Study|Protocol Violation|1
1192627|NCT03802565|2353194|FG000|Overall Study|Lost to Follow-up|0
1192628|NCT03802565|2353195|FG001|Overall Study|Lost to Follow-up|0
1192629|NCT03802565|2353196|FG002|Overall Study|Lost to Follow-up|1
1192630|NCT03802565|2353197|FG003|Overall Study|Lost to Follow-up|0
1192631|NCT03802565|2353198|FG004|Overall Study|Lost to Follow-up|0
1192632|NCT03802565|2353194|FG000|Overall Study|Subjects Related to Each Other|1
1192633|NCT03802565|2353195|FG001|Overall Study|Subjects Related to Each Other|0
1192634|NCT03802565|2353196|FG002|Overall Study|Subjects Related to Each Other|0
1192635|NCT03802565|2353197|FG003|Overall Study|Subjects Related to Each Other|2
1192636|NCT03802565|2353198|FG004|Overall Study|Subjects Related to Each Other|1
1192637|NCT03802565|2353194|FG000|Overall Study|Elevated Enzymes|0
1192638|NCT03802565|2353195|FG001|Overall Study|Elevated Enzymes|0
1192639|NCT03802565|2353196|FG002|Overall Study|Elevated Enzymes|0
1192640|NCT03802565|2353197|FG003|Overall Study|Elevated Enzymes|0
1192641|NCT03802565|2353198|FG004|Overall Study|Elevated Enzymes|2
1192642|NCT03769194|2353214|FG000|Overall Study|Withdrawal by Subject|0
1192643|NCT03769194|2353215|FG001|Overall Study|Withdrawal by Subject|7
1192644|NCT03769194|2353216|FG002|Overall Study|Withdrawal by Subject|4
1192645|NCT03769194|2353217|FG003|Overall Study|Withdrawal by Subject|1
1192646|NCT03769194|2353214|FG000|Overall Study|moved from study area|0
1192647|NCT03769194|2353215|FG001|Overall Study|moved from study area|2
1192648|NCT03769194|2353216|FG002|Overall Study|moved from study area|1
1192649|NCT03769194|2353217|FG003|Overall Study|moved from study area|1
1192650|NCT03769194|2353214|FG000|Overall Study|Lost to Follow-up|3
1192651|NCT03769194|2353215|FG001|Overall Study|Lost to Follow-up|6
1192652|NCT03769194|2353216|FG002|Overall Study|Lost to Follow-up|3
1192653|NCT03769194|2353217|FG003|Overall Study|Lost to Follow-up|6
1192654|NCT03769194|2353214|FG000|Overall Study|other|1
1192655|NCT03769194|2353215|FG001|Overall Study|other|3
1192656|NCT03769194|2353216|FG002|Overall Study|other|0
1192657|NCT03769194|2353217|FG003|Overall Study|other|1
1192658|NCT03738332|2353227|FG000|Overall Study|Withdrawal by Subject|1
1192659|NCT03688555|2353234|FG000|Overall Study|Adverse Event|0
1192660|NCT03688555|2353235|FG001|Overall Study|Adverse Event|1
1192661|NCT03416179|2353249|FG000|Overall Study|Death|67
1192662|NCT03416179|2353250|FG001|Overall Study|Death|60
1192663|NCT03416179|2353251|FG002|Overall Study|Death|96
1192664|NCT03416179|2353252|FG003|Overall Study|Death|88
1192665|NCT03416179|2353249|FG000|Overall Study|Withdrawal by Subject|13
1192666|NCT03416179|2353250|FG001|Overall Study|Withdrawal by Subject|19
1192667|NCT03416179|2353251|FG002|Overall Study|Withdrawal by Subject|5
1192668|NCT03416179|2353252|FG003|Overall Study|Withdrawal by Subject|6
1192669|NCT03416179|2353249|FG000|Overall Study|Ongoing|121
1192670|NCT03416179|2353250|FG001|Overall Study|Ongoing|123
1192671|NCT03416179|2353251|FG002|Overall Study|Ongoing|62
1192672|NCT03416179|2353252|FG003|Overall Study|Ongoing|66
1192673|NCT03416179|2353249|FG000|Overall Study|Lost to Follow-up|0
1192674|NCT03416179|2353250|FG001|Overall Study|Lost to Follow-up|0
1192675|NCT03416179|2353251|FG002|Overall Study|Lost to Follow-up|0
1192676|NCT03416179|2353252|FG003|Overall Study|Lost to Follow-up|2
1192677|NCT03416179|2353249|FG000|Overall Study|Other|0
1192678|NCT03416179|2353250|FG001|Overall Study|Other|1
1192679|NCT03416179|2353251|FG002|Overall Study|Other|0
1192680|NCT03416179|2353252|FG003|Overall Study|Other|0
1192681|NCT03353922|2353262|FG000|Overall Study|Withdrawal by Subject|1
1192682|NCT03353922|2353263|FG001|Overall Study|Withdrawal by Subject|0
1192683|NCT03353922|2353264|FG002|Overall Study|Withdrawal by Subject|1
1192684|NCT03353922|2353265|FG003|Overall Study|Withdrawal by Subject|1
1192685|NCT03353922|2353266|FG004|Overall Study|Withdrawal by Subject|0
1192686|NCT03353922|2353267|FG005|Overall Study|Withdrawal by Subject|0
1192687|NCT03353922|2353262|FG000|Overall Study|Adverse Event|0
1192688|NCT03353922|2353263|FG001|Overall Study|Adverse Event|1
1192689|NCT03353922|2353264|FG002|Overall Study|Adverse Event|0
1192690|NCT03353922|2353265|FG003|Overall Study|Adverse Event|0
1192691|NCT03353922|2353266|FG004|Overall Study|Adverse Event|0
1192692|NCT03353922|2353267|FG005|Overall Study|Adverse Event|0
1192693|NCT03173456|2353302|FG000|Baseline|Medication dispensing system malfunction'|0
1192694|NCT03173456|2353303|FG001|Baseline|Medication dispensing system malfunction'|1
1192695|NCT03173456|2353304|FG002|Baseline|Medication dispensing system malfunction'|0
1192696|NCT03173456|2353305|FG003|Baseline|Medication dispensing system malfunction'|0
1192697|NCT03173456|2353306|FG004|Baseline|Medication dispensing system malfunction'|2
1192698|NCT03173456|2353302|FG000|2 Hour Follow-up|Withdrawal by Subject|0
1192699|NCT03173456|2353303|FG001|2 Hour Follow-up|Withdrawal by Subject|1
1192700|NCT03173456|2353304|FG002|2 Hour Follow-up|Withdrawal by Subject|1
1192701|NCT03173456|2353305|FG003|2 Hour Follow-up|Withdrawal by Subject|1
1192702|NCT03173456|2353306|FG004|2 Hour Follow-up|Withdrawal by Subject|2
1192703|NCT03020160|2353329|FG000|Overall Study|Continuing to receive emicizumab|7
882508|NCT00605280|1847668|FG002|Year 3 Extension|Physician Decision|0
882509|NCT00605280|1847669|FG003|Year 3 Extension|Physician Decision|2
882510|NCT00605280|1847666|FG000|Year 3 Extension|Withdrawal by Subject|2
882511|NCT00605280|1847667|FG001|Year 3 Extension|Withdrawal by Subject|0
882512|NCT00605280|1847668|FG002|Year 3 Extension|Withdrawal by Subject|0
882513|NCT00605280|1847669|FG003|Year 3 Extension|Withdrawal by Subject|5
882514|NCT00605280|1847666|FG000|Year 3 Extension|Other|2
882515|NCT00605280|1847667|FG001|Year 3 Extension|Other|0
882516|NCT00605280|1847668|FG002|Year 3 Extension|Other|0
882517|NCT00605280|1847669|FG003|Year 3 Extension|Other|0
882518|NCT00605280|1847666|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
882519|NCT00605280|1847667|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
882520|NCT00605280|1847668|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
882521|NCT00605280|1847669|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
882522|NCT00605293|1847681|FG000|Overall Study|Death|2
882523|NCT00605293|1847682|FG001|Overall Study|Death|1
882524|NCT00605293|1847681|FG000|Overall Study|Insufficient Therapeutic Response|2
882525|NCT00605293|1847682|FG001|Overall Study|Insufficient Therapeutic Response|0
882526|NCT00605293|1847681|FG000|Overall Study|Adverse Event|1
882527|NCT00605293|1847682|FG001|Overall Study|Adverse Event|0
882528|NCT00605293|1847681|FG000|Overall Study|Holidays Dialysis Out|1
882529|NCT00605293|1847682|FG001|Overall Study|Holidays Dialysis Out|0
882530|NCT00605293|1847681|FG000|Overall Study|Blood Transfusion|7
882531|NCT00605293|1847682|FG001|Overall Study|Blood Transfusion|1
882532|NCT00605293|1847681|FG000|Overall Study|Renal Transplantation|3
882533|NCT00605293|1847682|FG001|Overall Study|Renal Transplantation|1
882534|NCT00605293|1847681|FG000|Overall Study|Incorrect Epoetin Beta Administration|1
882535|NCT00605293|1847682|FG001|Overall Study|Incorrect Epoetin Beta Administration|0
882536|NCT00605293|1847681|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0
882537|NCT00605293|1847682|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1
882538|NCT00605293|1847681|FG000|Overall Study|Principal Investigator Decision|0
882539|NCT00605293|1847682|FG001|Overall Study|Principal Investigator Decision|1
882540|NCT00605306|1847690|FG000|Overall Study|Adverse Event|0
882541|NCT00605306|1847691|FG001|Overall Study|Adverse Event|1
882542|NCT00605319|1847697|FG000|Overall Study|Adverse Event|6
882543|NCT00605345|1847709|FG000|Overall Study|Withdrawal by Subject|1
882544|NCT00605345|1847710|FG001|Overall Study|Withdrawal by Subject|0
882545|NCT00605345|1847709|FG000|Overall Study|Adverse Event|0
882546|NCT00605345|1847710|FG001|Overall Study|Adverse Event|1
882547|NCT00605345|1847709|FG000|Overall Study|Protocol Violation|0
882548|NCT00605345|1847710|FG001|Overall Study|Protocol Violation|2
882549|NCT00605475|1847753|FG000|Overall Study|Abnormal Laboratory Values|0
882550|NCT00605475|1847754|FG001|Overall Study|Abnormal Laboratory Values|0
882551|NCT00605475|1847755|FG002|Overall Study|Abnormal Laboratory Values|0
882552|NCT00605475|1847756|FG003|Overall Study|Abnormal Laboratory Values|0
882553|NCT00605475|1847757|FG004|Overall Study|Abnormal Laboratory Values|0
882554|NCT00605475|1847758|FG005|Overall Study|Abnormal Laboratory Values|0
882555|NCT00605475|1847759|FG006|Overall Study|Abnormal Laboratory Values|0
882556|NCT00605475|1847760|FG007|Overall Study|Abnormal Laboratory Values|0
882557|NCT00605475|1847761|FG008|Overall Study|Abnormal Laboratory Values|1
882558|NCT00605475|1847762|FG009|Overall Study|Abnormal Laboratory Values|0
882559|NCT00605475|1847753|FG000|Overall Study|Administrative problems|0
882560|NCT00605475|1847754|FG001|Overall Study|Administrative problems|0
882561|NCT00605475|1847755|FG002|Overall Study|Administrative problems|0
882562|NCT00605475|1847756|FG003|Overall Study|Administrative problems|0
882563|NCT00605475|1847757|FG004|Overall Study|Administrative problems|0
882564|NCT00605475|1847758|FG005|Overall Study|Administrative problems|0
882565|NCT00605475|1847759|FG006|Overall Study|Administrative problems|1
1192704|NCT03020160|2353330|FG001|Overall Study|Continuing to receive emicizumab|41
1192705|NCT03003520|2353339|FG000|Induction|Ongoing|1
1192706|NCT03003520|2353340|FG001|Induction|Ongoing|0
1192707|NCT03003520|2353339|FG000|Induction|Adverse Event|4
1192708|NCT03003520|2353340|FG001|Induction|Adverse Event|0
1192709|NCT03003520|2353339|FG000|Induction|Death|1
1192710|NCT03003520|2353340|FG001|Induction|Death|0
1192711|NCT03003520|2353339|FG000|Induction|Palliative care|1
1192712|NCT03003520|2353340|FG001|Induction|Palliative care|0
1192713|NCT03003520|2353339|FG000|Induction|Physician Decision|2
1192714|NCT03003520|2353340|FG001|Induction|Physician Decision|0
1192715|NCT03003520|2353339|FG000|Induction|Withdrawal by Subject|3
1192716|NCT03003520|2353340|FG001|Induction|Withdrawal by Subject|0
1192717|NCT03003520|2353339|FG000|Induction|Progressive disease|1
1192718|NCT03003520|2353340|FG001|Induction|Progressive disease|0
1192719|NCT03003520|2353339|FG000|Consolidation|Ongoing|18
1192720|NCT03003520|2353340|FG001|Consolidation|Ongoing|0
1192721|NCT03003520|2353339|FG000|Consolidation|Adverse Event|2
1192722|NCT03003520|2353340|FG001|Consolidation|Adverse Event|0
1192723|NCT03003520|2353339|FG000|Consolidation|Progressive disease|3
1192724|NCT03003520|2353340|FG001|Consolidation|Progressive disease|1
1192725|NCT03003520|2353339|FG000|Consolidation|Withdrawal by Subject|1
1192726|NCT03003520|2353340|FG001|Consolidation|Withdrawal by Subject|0
1192727|NCT03003520|2353339|FG000|Follow-up|Death|1
1192728|NCT03003520|2353340|FG001|Follow-up|Death|1
1192729|NCT03003520|2353339|FG000|Follow-up|Ongoing|12
1192730|NCT03003520|2353340|FG001|Follow-up|Ongoing|2
1192731|NCT03003520|2353339|FG000|Follow-up|Withdrawal by Subject|1
1192732|NCT03003520|2353340|FG001|Follow-up|Withdrawal by Subject|0
1192733|NCT02862457|2353372|FG000|Overall Study|Death|1
1192734|NCT02862457|2353373|FG001|Overall Study|Death|3
1192735|NCT02862457|2353374|FG002|Overall Study|Death|2
1192736|NCT02862457|2353375|FG003|Overall Study|Death|3
1192737|NCT02862457|2353376|FG004|Overall Study|Death|0
1192738|NCT02862457|2353377|FG005|Overall Study|Death|2
1192739|NCT02862457|2353378|FG006|Overall Study|Death|1
1192740|NCT02862457|2353372|FG000|Overall Study|Lost to Follow-up|1
1192741|NCT02862457|2353373|FG001|Overall Study|Lost to Follow-up|0
1192742|NCT02862457|2353374|FG002|Overall Study|Lost to Follow-up|0
1192743|NCT02862457|2353375|FG003|Overall Study|Lost to Follow-up|1
1192744|NCT02862457|2353376|FG004|Overall Study|Lost to Follow-up|0
1192745|NCT02862457|2353377|FG005|Overall Study|Lost to Follow-up|0
1192746|NCT02862457|2353378|FG006|Overall Study|Lost to Follow-up|0
1192747|NCT02862457|2353372|FG000|Overall Study|Withdrawal by Subject|0
1192748|NCT02862457|2353373|FG001|Overall Study|Withdrawal by Subject|0
882566|NCT00605475|1847760|FG007|Overall Study|Administrative problems|0
882567|NCT00605475|1847761|FG008|Overall Study|Administrative problems|0
882568|NCT00605475|1847762|FG009|Overall Study|Administrative problems|0
882569|NCT00605475|1847753|FG000|Overall Study|Lost to Follow-up|0
882570|NCT00605475|1847754|FG001|Overall Study|Lost to Follow-up|0
882571|NCT00605475|1847755|FG002|Overall Study|Lost to Follow-up|0
882572|NCT00605475|1847756|FG003|Overall Study|Lost to Follow-up|0
882573|NCT00605475|1847757|FG004|Overall Study|Lost to Follow-up|0
882574|NCT00605475|1847758|FG005|Overall Study|Lost to Follow-up|0
882575|NCT00605475|1847759|FG006|Overall Study|Lost to Follow-up|0
882576|NCT00605475|1847760|FG007|Overall Study|Lost to Follow-up|0
882577|NCT00605475|1847761|FG008|Overall Study|Lost to Follow-up|1
882578|NCT00605475|1847762|FG009|Overall Study|Lost to Follow-up|1
882579|NCT00605475|1847753|FG000|Overall Study|Protocol Violation|0
882580|NCT00605475|1847754|FG001|Overall Study|Protocol Violation|0
882581|NCT00605475|1847755|FG002|Overall Study|Protocol Violation|0
882582|NCT00605475|1847756|FG003|Overall Study|Protocol Violation|0
882583|NCT00605475|1847757|FG004|Overall Study|Protocol Violation|1
882584|NCT00605475|1847758|FG005|Overall Study|Protocol Violation|0
882585|NCT00605475|1847759|FG006|Overall Study|Protocol Violation|0
882586|NCT00605475|1847760|FG007|Overall Study|Protocol Violation|0
882587|NCT00605475|1847761|FG008|Overall Study|Protocol Violation|0
882588|NCT00605475|1847762|FG009|Overall Study|Protocol Violation|0
882589|NCT00605475|1847753|FG000|Overall Study|Withdrawal by Subject|0
882590|NCT00605475|1847754|FG001|Overall Study|Withdrawal by Subject|0
882591|NCT00605475|1847755|FG002|Overall Study|Withdrawal by Subject|0
882592|NCT00605475|1847756|FG003|Overall Study|Withdrawal by Subject|0
882593|NCT00605475|1847757|FG004|Overall Study|Withdrawal by Subject|0
882594|NCT00605475|1847758|FG005|Overall Study|Withdrawal by Subject|2
882595|NCT00605475|1847759|FG006|Overall Study|Withdrawal by Subject|0
882596|NCT00605475|1847760|FG007|Overall Study|Withdrawal by Subject|0
882597|NCT00605475|1847761|FG008|Overall Study|Withdrawal by Subject|0
882598|NCT00605475|1847762|FG009|Overall Study|Withdrawal by Subject|1
882599|NCT00605540|1847805|FG000|Overall Study|Death|15
882600|NCT00605540|1847805|FG000|Overall Study|Lost to Follow-up|23
882601|NCT00605566|1847809|FG000|Overall Study|Adverse Event|1
882602|NCT00605566|1847809|FG000|Overall Study|Clinical deterioration|1
882603|NCT00605566|1847809|FG000|Overall Study|Poor compliance in run-in period|1
882604|NCT00605657|1847834|FG000|Overall Study|Adverse Event|1
882605|NCT00605657|1847834|FG000|Overall Study|Protocol Violation|1
1192749|NCT02862457|2353374|FG002|Overall Study|Withdrawal by Subject|1
1192750|NCT02862457|2353375|FG003|Overall Study|Withdrawal by Subject|0
1192751|NCT02862457|2353376|FG004|Overall Study|Withdrawal by Subject|0
1192752|NCT02862457|2353377|FG005|Overall Study|Withdrawal by Subject|1
1192753|NCT02862457|2353378|FG006|Overall Study|Withdrawal by Subject|0
1192754|NCT02820753|2353404|FG000|2 Month|Withdrawal by Subject|3
1192755|NCT02820753|2353405|FG001|2 Month|Withdrawal by Subject|3
1192756|NCT02820753|2353404|FG000|2 Month|Lost to Follow-up|24
1192757|NCT02820753|2353405|FG001|2 Month|Lost to Follow-up|26
1192758|NCT02820753|2353404|FG000|2 Month|Stopped per NIH Hold|51
1192759|NCT02820753|2353405|FG001|2 Month|Stopped per NIH Hold|13
882606|NCT00605722|1847847|FG000|Overall Study|Adverse Event|6
882607|NCT00605722|1847847|FG000|Overall Study|Insufficient therapeutic response|44
882608|NCT00605722|1847847|FG000|Overall Study|Failure to return|1
882609|NCT00605813|1847851|FG000|Overall Study|Protocol Violation|25
882610|NCT00605839|1847876|FG000|Overall Study|Protocol Violation|1
882611|NCT00605839|1847877|FG001|Overall Study|Protocol Violation|0
882612|NCT00605839|1847878|FG002|Overall Study|Protocol Violation|0
882613|NCT00605865|1847886|FG000|Overall Study|Protocol Violation|115
882614|NCT00605917|1847927|FG000|Overall Study|Protocol Violation|79
882615|NCT00606008|1847962|FG000|Overall Study|Adverse Event|1
882616|NCT00606008|1847962|FG000|Overall Study|Withdrawal by Subject|4
882617|NCT00606021|1847972|FG000|Induction Phase|Death|73
882618|NCT00606021|1847973|FG001|Induction Phase|Death|0
882619|NCT00606021|1847974|FG002|Induction Phase|Death|0
882620|NCT00606021|1847972|FG000|Induction Phase|Physician Decision|2
882621|NCT00606021|1847973|FG001|Induction Phase|Physician Decision|0
882622|NCT00606021|1847974|FG002|Induction Phase|Physician Decision|0
882623|NCT00606021|1847972|FG000|Induction Phase|Withdrawal by Subject|2
882624|NCT00606021|1847973|FG001|Induction Phase|Withdrawal by Subject|0
882625|NCT00606021|1847974|FG002|Induction Phase|Withdrawal by Subject|0
882626|NCT00606021|1847972|FG000|Induction Phase|Lost to Follow-up|10
882627|NCT00606021|1847973|FG001|Induction Phase|Lost to Follow-up|0
882628|NCT00606021|1847974|FG002|Induction Phase|Lost to Follow-up|0
882629|NCT00606021|1847972|FG000|Maintenance Phase|Death|0
882630|NCT00606021|1847973|FG001|Maintenance Phase|Death|17
882631|NCT00606021|1847974|FG002|Maintenance Phase|Death|15
882632|NCT00606021|1847972|FG000|Maintenance Phase|Physician Decision|0
882633|NCT00606021|1847973|FG001|Maintenance Phase|Physician Decision|1
882634|NCT00606021|1847974|FG002|Maintenance Phase|Physician Decision|0
882635|NCT00606021|1847972|FG000|Maintenance Phase|Lost to Follow-up|0
882636|NCT00606021|1847973|FG001|Maintenance Phase|Lost to Follow-up|5
882637|NCT00606021|1847974|FG002|Maintenance Phase|Lost to Follow-up|2
882638|NCT00606034|1847982|FG000|Overall Study|incarceration|1
882639|NCT00606086|1847994|FG000|Overall Study|Adverse Event|1
882640|NCT00606086|1847995|FG001|Overall Study|Adverse Event|1
882641|NCT00606086|1847994|FG000|Overall Study|Lost to Follow-up|4
882642|NCT00606086|1847995|FG001|Overall Study|Lost to Follow-up|8
882643|NCT00606086|1847994|FG000|Overall Study|Protocol Violation|1
882644|NCT00606086|1847995|FG001|Overall Study|Protocol Violation|0
882645|NCT00606086|1847994|FG000|Overall Study|Withdrawal by Subject|5
882646|NCT00606086|1847995|FG001|Overall Study|Withdrawal by Subject|3
882647|NCT00606086|1847994|FG000|Overall Study|Non-compliance|0
882648|NCT00606086|1847995|FG001|Overall Study|Non-compliance|1
882649|NCT00606086|1847994|FG000|Overall Study|Randomized, not treated|1
882650|NCT00606086|1847995|FG001|Overall Study|Randomized, not treated|2
882651|NCT00606177|1848012|FG000|Overall Study|Adverse Event|9
882652|NCT00606177|1848013|FG001|Overall Study|Adverse Event|5
882653|NCT00606177|1848012|FG000|Overall Study|Lack of Efficacy|3
882654|NCT00606177|1848013|FG001|Overall Study|Lack of Efficacy|7
882655|NCT00606177|1848012|FG000|Overall Study|Physician Decision|1
882656|NCT00606177|1848013|FG001|Overall Study|Physician Decision|0
882657|NCT00606177|1848012|FG000|Overall Study|Protocol Violation|1
882658|NCT00606177|1848013|FG001|Overall Study|Protocol Violation|4
882659|NCT00606177|1848012|FG000|Overall Study|Withdrawal by Subject|5
882660|NCT00606177|1848013|FG001|Overall Study|Withdrawal by Subject|6
882661|NCT00606177|1848012|FG000|Overall Study|Progression to depressive phase|6
882662|NCT00606177|1848013|FG001|Overall Study|Progression to depressive phase|1
882663|NCT00606177|1848012|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1
882664|NCT00606177|1848013|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1
882665|NCT00606177|1848012|FG000|Overall Study|Change of residence or other commitments|1
882666|NCT00606177|1848013|FG001|Overall Study|Change of residence or other commitments|1
882667|NCT00606229|1848019|FG000|Overall Study|Adverse Event|11
882668|NCT00606229|1848019|FG000|Overall Study|Lack of Efficacy|1
882669|NCT00606229|1848019|FG000|Overall Study|Withdrawal by Subject|4
882670|NCT00606229|1848019|FG000|Overall Study|does not meet inclusion criterion 1-3|4
882671|NCT00606229|1848019|FG000|Overall Study|change of residence or other commitments|2
882672|NCT00606281|1848025|FG000|Overall Study|Adverse Event|11
882673|NCT00606281|1848026|FG001|Overall Study|Adverse Event|12
882674|NCT00606281|1848025|FG000|Overall Study|Death|1
882675|NCT00606281|1848026|FG001|Overall Study|Death|0
882676|NCT00606281|1848025|FG000|Overall Study|Lack of Efficacy|28
882677|NCT00606281|1848026|FG001|Overall Study|Lack of Efficacy|35
882678|NCT00606281|1848025|FG000|Overall Study|Physician Decision|0
882679|NCT00606281|1848026|FG001|Overall Study|Physician Decision|1
882680|NCT00606281|1848025|FG000|Overall Study|Protocol Violation|3
882681|NCT00606281|1848026|FG001|Overall Study|Protocol Violation|3
882682|NCT00606281|1848025|FG000|Overall Study|Withdrawal by Subject|11
882683|NCT00606281|1848026|FG001|Overall Study|Withdrawal by Subject|13
1192760|NCT02820753|2353404|FG000|6 Month|Withdrawal by Subject|2
1192761|NCT02820753|2353405|FG001|6 Month|Withdrawal by Subject|2
1192762|NCT02820753|2353404|FG000|6 Month|Lost to Follow-up|20
1192763|NCT02820753|2353405|FG001|6 Month|Lost to Follow-up|27
1192764|NCT02820753|2353404|FG000|6 Month|Stopped per NIH Hold|81
1192765|NCT02820753|2353405|FG001|6 Month|Stopped per NIH Hold|81
1192766|NCT02820753|2353404|FG000|6 Month|Death|0
1192767|NCT02820753|2353405|FG001|6 Month|Death|1
1192768|NCT02733042|2353430|FG000|Treatment Period|Adverse Event|1
1192769|NCT02733042|2353431|FG001|Treatment Period|Adverse Event|0
1192770|NCT02733042|2353432|FG002|Treatment Period|Adverse Event|1
1192771|NCT02733042|2353433|FG003|Treatment Period|Adverse Event|1
1192772|NCT02733042|2353434|FG004|Treatment Period|Adverse Event|0
1192773|NCT02733042|2353435|FG005|Treatment Period|Adverse Event|0
1192774|NCT02733042|2353436|FG006|Treatment Period|Adverse Event|0
1192775|NCT02733042|2353437|FG007|Treatment Period|Adverse Event|0
1192776|NCT02733042|2353438|FG008|Treatment Period|Adverse Event|0
1192777|NCT02733042|2353439|FG009|Treatment Period|Adverse Event|0
1192778|NCT02733042|2353440|FG010|Treatment Period|Adverse Event|2
1192779|NCT02733042|2353441|FG011|Treatment Period|Adverse Event|2
1192780|NCT02733042|2353442|FG012|Treatment Period|Adverse Event|0
1192781|NCT02733042|2353443|FG013|Treatment Period|Adverse Event|2
1192782|NCT02733042|2353444|FG014|Treatment Period|Adverse Event|0
1192783|NCT02733042|2353445|FG015|Treatment Period|Adverse Event|0
1192784|NCT02733042|2353446|FG016|Treatment Period|Adverse Event|0
1192785|NCT02733042|2353447|FG017|Treatment Period|Adverse Event|1
1192786|NCT02733042|2353448|FG018|Treatment Period|Adverse Event|0
882684|NCT00606281|1848025|FG000|Overall Study|Progression to depressive phase|1
882685|NCT00606281|1848026|FG001|Overall Study|Progression to depressive phase|1
882686|NCT00606281|1848025|FG000|Overall Study|Change of residence or other commitments|1
882687|NCT00606281|1848026|FG001|Overall Study|Change of residence or other commitments|1
882688|NCT00606294|1848034|FG000|Overall Study|Withdrawal by Subject|36
882689|NCT00606294|1848035|FG001|Overall Study|Withdrawal by Subject|0
882690|NCT00606307|1848041|FG000|Overall Study|Adverse Event|2
882691|NCT00606307|1848041|FG000|Overall Study|Withdrawal by Subject|2
882692|NCT00606307|1848041|FG000|Overall Study|Disease progression|6
882693|NCT00606307|1848041|FG000|Overall Study|QTc prolongation|1
882694|NCT00606320|1848045|FG000|Overall Study|Adverse Event|3
882695|NCT00606320|1848045|FG000|Overall Study|Lack of Efficacy|5
882696|NCT00606320|1848045|FG000|Overall Study|Physician Decision|7
882697|NCT00606320|1848045|FG000|Overall Study|Protocol Violation|8
882698|NCT00606320|1848045|FG000|Overall Study|Withdrawal by Subject|10
882699|NCT00606320|1848045|FG000|Overall Study|Progression to depressive phase|4
882700|NCT00606502|1848060|FG000|Randomization|Randomized but not treated|3
882701|NCT00606502|1848061|FG001|Randomization|Randomized but not treated|0
882702|NCT00606502|1848060|FG000|Treatment|Treatment ongoing at time of data cutoff|0
882703|NCT00606502|1848061|FG001|Treatment|Treatment ongoing at time of data cutoff|3
882704|NCT00606580|1848083|FG000|Overall Study|Lost to Follow-up|1
882705|NCT00606580|1848084|FG001|Overall Study|Lost to Follow-up|1
882706|NCT00606580|1848085|FG002|Overall Study|Lost to Follow-up|4
882707|NCT00606580|1848083|FG000|Overall Study|Clinical failures|1
882708|NCT00606580|1848084|FG001|Overall Study|Clinical failures|0
882709|NCT00606580|1848085|FG002|Overall Study|Clinical failures|12
882710|NCT00606580|1848083|FG000|Overall Study|Withdrawal by investigator|0
882711|NCT00606580|1848084|FG001|Overall Study|Withdrawal by investigator|1
882712|NCT00606580|1848085|FG002|Overall Study|Withdrawal by investigator|6
882713|NCT00606580|1848083|FG000|Overall Study|Withdrawal by Subject|0
882714|NCT00606580|1848084|FG001|Overall Study|Withdrawal by Subject|1
882715|NCT00606580|1848085|FG002|Overall Study|Withdrawal by Subject|0
882716|NCT00606593|1848093|FG000|Overall Study|Adverse Event|0
882717|NCT00606593|1848094|FG001|Overall Study|Adverse Event|0
882718|NCT00606593|1848095|FG002|Overall Study|Adverse Event|0
882719|NCT00606593|1848096|FG003|Overall Study|Adverse Event|1
882720|NCT00606593|1848097|FG004|Overall Study|Adverse Event|1
882721|NCT00606593|1848098|FG005|Overall Study|Adverse Event|0
882722|NCT00606593|1848099|FG006|Overall Study|Adverse Event|1
882723|NCT00606593|1848100|FG007|Overall Study|Adverse Event|2
882724|NCT00606593|1848101|FG008|Overall Study|Adverse Event|1
882725|NCT00606593|1848102|FG009|Overall Study|Adverse Event|0
882726|NCT00606593|1848093|FG000|Overall Study|Withdrawal of consent|1
882727|NCT00606593|1848094|FG001|Overall Study|Withdrawal of consent|0
882728|NCT00606593|1848095|FG002|Overall Study|Withdrawal of consent|1
882729|NCT00606593|1848096|FG003|Overall Study|Withdrawal of consent|0
882730|NCT00606593|1848097|FG004|Overall Study|Withdrawal of consent|0
882731|NCT00606593|1848098|FG005|Overall Study|Withdrawal of consent|0
882732|NCT00606593|1848099|FG006|Overall Study|Withdrawal of consent|0
882733|NCT00606593|1848100|FG007|Overall Study|Withdrawal of consent|0
882734|NCT00606593|1848101|FG008|Overall Study|Withdrawal of consent|0
882735|NCT00606593|1848102|FG009|Overall Study|Withdrawal of consent|0
882736|NCT00606593|1848093|FG000|Overall Study|Administrative/Other|0
882737|NCT00606593|1848094|FG001|Overall Study|Administrative/Other|0
882738|NCT00606593|1848095|FG002|Overall Study|Administrative/Other|1
882739|NCT00606593|1848096|FG003|Overall Study|Administrative/Other|0
882740|NCT00606593|1848097|FG004|Overall Study|Administrative/Other|0
1192787|NCT02733042|2353430|FG000|Treatment Period|Progressive Disease|2
1192788|NCT02733042|2353431|FG001|Treatment Period|Progressive Disease|1
1192789|NCT02733042|2353432|FG002|Treatment Period|Progressive Disease|3
1192790|NCT02733042|2353433|FG003|Treatment Period|Progressive Disease|1
1192791|NCT02733042|2353434|FG004|Treatment Period|Progressive Disease|1
1192792|NCT02733042|2353435|FG005|Treatment Period|Progressive Disease|3
1192793|NCT02733042|2353436|FG006|Treatment Period|Progressive Disease|0
1192794|NCT02733042|2353437|FG007|Treatment Period|Progressive Disease|3
1192795|NCT02733042|2353438|FG008|Treatment Period|Progressive Disease|3
1192796|NCT02733042|2353439|FG009|Treatment Period|Progressive Disease|0
1192797|NCT02733042|2353440|FG010|Treatment Period|Progressive Disease|2
1192798|NCT02733042|2353441|FG011|Treatment Period|Progressive Disease|2
1192799|NCT02733042|2353442|FG012|Treatment Period|Progressive Disease|8
1192800|NCT02733042|2353443|FG013|Treatment Period|Progressive Disease|1
1192801|NCT02733042|2353444|FG014|Treatment Period|Progressive Disease|4
1192802|NCT02733042|2353445|FG015|Treatment Period|Progressive Disease|7
1192803|NCT02733042|2353446|FG016|Treatment Period|Progressive Disease|2
1192804|NCT02733042|2353447|FG017|Treatment Period|Progressive Disease|3
1192805|NCT02733042|2353448|FG018|Treatment Period|Progressive Disease|4
1192806|NCT02733042|2353430|FG000|Treatment Period|Withdrawal by Subject|0
1192807|NCT02733042|2353431|FG001|Treatment Period|Withdrawal by Subject|1
1192808|NCT02733042|2353432|FG002|Treatment Period|Withdrawal by Subject|2
1192809|NCT02733042|2353433|FG003|Treatment Period|Withdrawal by Subject|1
1192810|NCT02733042|2353434|FG004|Treatment Period|Withdrawal by Subject|0
1192811|NCT02733042|2353435|FG005|Treatment Period|Withdrawal by Subject|0
1192812|NCT02733042|2353436|FG006|Treatment Period|Withdrawal by Subject|0
1192813|NCT02733042|2353437|FG007|Treatment Period|Withdrawal by Subject|0
1192814|NCT02733042|2353438|FG008|Treatment Period|Withdrawal by Subject|1
1192815|NCT02733042|2353439|FG009|Treatment Period|Withdrawal by Subject|1
1192816|NCT02733042|2353440|FG010|Treatment Period|Withdrawal by Subject|0
1192817|NCT02733042|2353441|FG011|Treatment Period|Withdrawal by Subject|2
1192818|NCT02733042|2353442|FG012|Treatment Period|Withdrawal by Subject|1
882741|NCT00606593|1848098|FG005|Overall Study|Administrative/Other|0
882742|NCT00606593|1848099|FG006|Overall Study|Administrative/Other|0
882743|NCT00606593|1848100|FG007|Overall Study|Administrative/Other|0
882744|NCT00606593|1848101|FG008|Overall Study|Administrative/Other|0
882745|NCT00606593|1848102|FG009|Overall Study|Administrative/Other|0
882746|NCT00606632|1848115|FG000|Overall Study|Withdrawal by Subject|13
882747|NCT00606632|1848115|FG000|Overall Study|Miscellaneous reasons|9
882748|NCT00606684|1848130|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
882749|NCT00606684|1848131|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
882750|NCT00606684|1848132|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
882751|NCT00606684|1848133|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
882752|NCT00606684|1848134|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
882753|NCT00606684|1848135|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
882754|NCT00606684|1848136|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
882755|NCT00606684|1848130|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
882756|NCT00606684|1848131|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
882757|NCT00606684|1848132|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
882758|NCT00606684|1848133|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
882759|NCT00606684|1848134|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
882760|NCT00606684|1848135|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
882761|NCT00606684|1848136|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
882762|NCT00606684|1848130|FG000|2-week Single-Blind Run-in Period|Physician Decision|18
882763|NCT00606684|1848131|FG001|2-week Single-Blind Run-in Period|Physician Decision|0
882764|NCT00606684|1848132|FG002|2-week Single-Blind Run-in Period|Physician Decision|0
882765|NCT00606684|1848133|FG003|2-week Single-Blind Run-in Period|Physician Decision|0
882766|NCT00606684|1848134|FG004|2-week Single-Blind Run-in Period|Physician Decision|0
882767|NCT00606684|1848135|FG005|2-week Single-Blind Run-in Period|Physician Decision|0
882768|NCT00606684|1848136|FG006|2-week Single-Blind Run-in Period|Physician Decision|0
882769|NCT00606684|1848130|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
882770|NCT00606684|1848131|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
882771|NCT00606684|1848132|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
882772|NCT00606684|1848133|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
882773|NCT00606684|1848134|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
882774|NCT00606684|1848135|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
882775|NCT00606684|1848136|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
882776|NCT00606684|1848130|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5
882777|NCT00606684|1848131|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0
882778|NCT00606684|1848132|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0
882779|NCT00606684|1848133|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0
882780|NCT00606684|1848134|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0
882781|NCT00606684|1848135|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0
882782|NCT00606684|1848136|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0
882783|NCT00606684|1848130|FG000|2-week Single-Blind Run-in Period|Adverse Event|2
1192819|NCT02733042|2353443|FG013|Treatment Period|Withdrawal by Subject|1
1192820|NCT02733042|2353444|FG014|Treatment Period|Withdrawal by Subject|0
1192821|NCT02733042|2353445|FG015|Treatment Period|Withdrawal by Subject|0
1192822|NCT02733042|2353446|FG016|Treatment Period|Withdrawal by Subject|0
1192823|NCT02733042|2353447|FG017|Treatment Period|Withdrawal by Subject|0
1192824|NCT02733042|2353448|FG018|Treatment Period|Withdrawal by Subject|0
1192825|NCT02733042|2353430|FG000|Treatment Period|Other|0
1192826|NCT02733042|2353431|FG001|Treatment Period|Other|0
1192827|NCT02733042|2353432|FG002|Treatment Period|Other|1
1192828|NCT02733042|2353433|FG003|Treatment Period|Other|0
1192829|NCT02733042|2353434|FG004|Treatment Period|Other|0
1192830|NCT02733042|2353435|FG005|Treatment Period|Other|0
1192831|NCT02733042|2353436|FG006|Treatment Period|Other|0
1192832|NCT02733042|2353437|FG007|Treatment Period|Other|0
1192833|NCT02733042|2353438|FG008|Treatment Period|Other|0
1192834|NCT02733042|2353439|FG009|Treatment Period|Other|1
1192835|NCT02733042|2353440|FG010|Treatment Period|Other|1
1192836|NCT02733042|2353441|FG011|Treatment Period|Other|0
1192837|NCT02733042|2353442|FG012|Treatment Period|Other|0
1192838|NCT02733042|2353443|FG013|Treatment Period|Other|0
1192839|NCT02733042|2353444|FG014|Treatment Period|Other|0
1192840|NCT02733042|2353445|FG015|Treatment Period|Other|1
1192841|NCT02733042|2353446|FG016|Treatment Period|Other|0
1192842|NCT02733042|2353447|FG017|Treatment Period|Other|1
1192843|NCT02733042|2353448|FG018|Treatment Period|Other|0
1192844|NCT02733042|2353430|FG000|Treatment Period|Ongoing on Assigned Treatment|0
1192845|NCT02733042|2353431|FG001|Treatment Period|Ongoing on Assigned Treatment|0
1192846|NCT02733042|2353432|FG002|Treatment Period|Ongoing on Assigned Treatment|0
1192847|NCT02733042|2353433|FG003|Treatment Period|Ongoing on Assigned Treatment|0
1192848|NCT02733042|2353434|FG004|Treatment Period|Ongoing on Assigned Treatment|3
1192849|NCT02733042|2353435|FG005|Treatment Period|Ongoing on Assigned Treatment|0
1192850|NCT02733042|2353436|FG006|Treatment Period|Ongoing on Assigned Treatment|0
1192851|NCT02733042|2353437|FG007|Treatment Period|Ongoing on Assigned Treatment|0
1192852|NCT02733042|2353438|FG008|Treatment Period|Ongoing on Assigned Treatment|0
1192853|NCT02733042|2353439|FG009|Treatment Period|Ongoing on Assigned Treatment|8
1192854|NCT02733042|2353440|FG010|Treatment Period|Ongoing on Assigned Treatment|4
1192855|NCT02733042|2353441|FG011|Treatment Period|Ongoing on Assigned Treatment|0
1192856|NCT02733042|2353442|FG012|Treatment Period|Ongoing on Assigned Treatment|0
1192857|NCT02733042|2353443|FG013|Treatment Period|Ongoing on Assigned Treatment|0
1192858|NCT02733042|2353444|FG014|Treatment Period|Ongoing on Assigned Treatment|0
1192859|NCT02733042|2353445|FG015|Treatment Period|Ongoing on Assigned Treatment|0
1192860|NCT02733042|2353446|FG016|Treatment Period|Ongoing on Assigned Treatment|0
1192861|NCT02733042|2353447|FG017|Treatment Period|Ongoing on Assigned Treatment|0
1192862|NCT02733042|2353448|FG018|Treatment Period|Ongoing on Assigned Treatment|1
1192863|NCT02733042|2353430|FG000|Treatment Period|Death|0
1192864|NCT02733042|2353431|FG001|Treatment Period|Death|0
1192865|NCT02733042|2353432|FG002|Treatment Period|Death|0
1192866|NCT02733042|2353433|FG003|Treatment Period|Death|0
1192867|NCT02733042|2353434|FG004|Treatment Period|Death|0
1192868|NCT02733042|2353435|FG005|Treatment Period|Death|0
1192869|NCT02733042|2353436|FG006|Treatment Period|Death|1
1192870|NCT02733042|2353437|FG007|Treatment Period|Death|0
1192871|NCT02733042|2353438|FG008|Treatment Period|Death|1
1192872|NCT02733042|2353439|FG009|Treatment Period|Death|0
1192873|NCT02733042|2353440|FG010|Treatment Period|Death|1
1192874|NCT02733042|2353441|FG011|Treatment Period|Death|0
1192875|NCT02733042|2353442|FG012|Treatment Period|Death|0
1192876|NCT02733042|2353443|FG013|Treatment Period|Death|0
1192877|NCT02733042|2353444|FG014|Treatment Period|Death|1
1192878|NCT02733042|2353445|FG015|Treatment Period|Death|2
1192879|NCT02733042|2353446|FG016|Treatment Period|Death|0
1192880|NCT02733042|2353447|FG017|Treatment Period|Death|0
1192881|NCT02733042|2353448|FG018|Treatment Period|Death|0
1192882|NCT02733042|2353430|FG000|Follow-up Period|Ongoing on Follow-up|2
1192883|NCT02733042|2353431|FG001|Follow-up Period|Ongoing on Follow-up|2
1192884|NCT02733042|2353432|FG002|Follow-up Period|Ongoing on Follow-up|4
882784|NCT00606684|1848131|FG001|2-week Single-Blind Run-in Period|Adverse Event|0
882785|NCT00606684|1848132|FG002|2-week Single-Blind Run-in Period|Adverse Event|0
882786|NCT00606684|1848133|FG003|2-week Single-Blind Run-in Period|Adverse Event|0
882787|NCT00606684|1848134|FG004|2-week Single-Blind Run-in Period|Adverse Event|0
882788|NCT00606684|1848135|FG005|2-week Single-Blind Run-in Period|Adverse Event|0
1192885|NCT02733042|2353433|FG003|Follow-up Period|Ongoing on Follow-up|2
1192886|NCT02733042|2353434|FG004|Follow-up Period|Ongoing on Follow-up|0
1192887|NCT02733042|2353435|FG005|Follow-up Period|Ongoing on Follow-up|0
1192888|NCT02733042|2353436|FG006|Follow-up Period|Ongoing on Follow-up|0
1192889|NCT02733042|2353437|FG007|Follow-up Period|Ongoing on Follow-up|1
1192890|NCT02733042|2353438|FG008|Follow-up Period|Ongoing on Follow-up|0
1192891|NCT02733042|2353439|FG009|Follow-up Period|Ongoing on Follow-up|2
1192892|NCT02733042|2353440|FG010|Follow-up Period|Ongoing on Follow-up|4
1192893|NCT02733042|2353441|FG011|Follow-up Period|Ongoing on Follow-up|9
1192894|NCT02733042|2353442|FG012|Follow-up Period|Ongoing on Follow-up|1
1192895|NCT02733042|2353443|FG013|Follow-up Period|Ongoing on Follow-up|3
1192896|NCT02733042|2353444|FG014|Follow-up Period|Ongoing on Follow-up|0
1192897|NCT02733042|2353445|FG015|Follow-up Period|Ongoing on Follow-up|0
1192898|NCT02733042|2353446|FG016|Follow-up Period|Ongoing on Follow-up|0
1192899|NCT02733042|2353447|FG017|Follow-up Period|Ongoing on Follow-up|1
1192900|NCT02733042|2353448|FG018|Follow-up Period|Ongoing on Follow-up|0
1192901|NCT02733042|2353430|FG000|Follow-up Period|Death|1
1192902|NCT02733042|2353431|FG001|Follow-up Period|Death|1
1192903|NCT02733042|2353432|FG002|Follow-up Period|Death|2
1192904|NCT02733042|2353433|FG003|Follow-up Period|Death|0
1192905|NCT02733042|2353434|FG004|Follow-up Period|Death|1
1192906|NCT02733042|2353435|FG005|Follow-up Period|Death|2
1192907|NCT02733042|2353436|FG006|Follow-up Period|Death|0
1192908|NCT02733042|2353437|FG007|Follow-up Period|Death|3
1192909|NCT02733042|2353438|FG008|Follow-up Period|Death|3
1192910|NCT02733042|2353439|FG009|Follow-up Period|Death|0
1192911|NCT02733042|2353440|FG010|Follow-up Period|Death|0
1192912|NCT02733042|2353441|FG011|Follow-up Period|Death|0
1192913|NCT02733042|2353442|FG012|Follow-up Period|Death|8
1192914|NCT02733042|2353443|FG013|Follow-up Period|Death|1
1192915|NCT02733042|2353444|FG014|Follow-up Period|Death|1
1192916|NCT02733042|2353445|FG015|Follow-up Period|Death|4
1192917|NCT02733042|2353446|FG016|Follow-up Period|Death|0
1192918|NCT02733042|2353447|FG017|Follow-up Period|Death|1
1192919|NCT02733042|2353448|FG018|Follow-up Period|Death|2
1192920|NCT02733042|2353430|FG000|Follow-up Period|Other|0
1192921|NCT02733042|2353431|FG001|Follow-up Period|Other|0
1192922|NCT02733042|2353432|FG002|Follow-up Period|Other|0
1192923|NCT02733042|2353433|FG003|Follow-up Period|Other|1
1192924|NCT02733042|2353434|FG004|Follow-up Period|Other|0
1192925|NCT02733042|2353435|FG005|Follow-up Period|Other|0
1192926|NCT02733042|2353436|FG006|Follow-up Period|Other|0
1192927|NCT02733042|2353437|FG007|Follow-up Period|Other|0
1192928|NCT02733042|2353438|FG008|Follow-up Period|Other|0
1192929|NCT02733042|2353439|FG009|Follow-up Period|Other|0
1192930|NCT02733042|2353440|FG010|Follow-up Period|Other|0
882789|NCT00606684|1848136|FG006|2-week Single-Blind Run-in Period|Adverse Event|0
882790|NCT00606684|1848130|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
882791|NCT00606684|1848131|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
882792|NCT00606684|1848132|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
882793|NCT00606684|1848133|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
882794|NCT00606684|1848134|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
882795|NCT00606684|1848135|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
882796|NCT00606684|1848136|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
882797|NCT00606684|1848130|FG000|Double-Blind Treatment Period|Adverse Event|0
882798|NCT00606684|1848131|FG001|Double-Blind Treatment Period|Adverse Event|3
882799|NCT00606684|1848132|FG002|Double-Blind Treatment Period|Adverse Event|2
882800|NCT00606684|1848133|FG003|Double-Blind Treatment Period|Adverse Event|4
882801|NCT00606684|1848134|FG004|Double-Blind Treatment Period|Adverse Event|2
882802|NCT00606684|1848135|FG005|Double-Blind Treatment Period|Adverse Event|0
882803|NCT00606684|1848136|FG006|Double-Blind Treatment Period|Adverse Event|1
882804|NCT00606684|1848130|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
882805|NCT00606684|1848131|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
882806|NCT00606684|1848132|FG002|Double-Blind Treatment Period|Lack of Efficacy|0
882807|NCT00606684|1848133|FG003|Double-Blind Treatment Period|Lack of Efficacy|0
882808|NCT00606684|1848134|FG004|Double-Blind Treatment Period|Lack of Efficacy|1
882809|NCT00606684|1848135|FG005|Double-Blind Treatment Period|Lack of Efficacy|0
882810|NCT00606684|1848136|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
882811|NCT00606684|1848130|FG000|Double-Blind Treatment Period|Protocol Violation|0
882812|NCT00606684|1848131|FG001|Double-Blind Treatment Period|Protocol Violation|5
882813|NCT00606684|1848132|FG002|Double-Blind Treatment Period|Protocol Violation|5
882814|NCT00606684|1848133|FG003|Double-Blind Treatment Period|Protocol Violation|3
882815|NCT00606684|1848134|FG004|Double-Blind Treatment Period|Protocol Violation|0
882816|NCT00606684|1848135|FG005|Double-Blind Treatment Period|Protocol Violation|3
882817|NCT00606684|1848136|FG006|Double-Blind Treatment Period|Protocol Violation|4
882818|NCT00606684|1848130|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
882819|NCT00606684|1848131|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
882820|NCT00606684|1848132|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
882821|NCT00606684|1848133|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
882822|NCT00606684|1848134|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
882823|NCT00606684|1848135|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
882824|NCT00606684|1848136|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
882825|NCT00606684|1848130|FG000|Double-Blind Treatment Period|Physician Decision|0
882826|NCT00606684|1848131|FG001|Double-Blind Treatment Period|Physician Decision|5
882827|NCT00606684|1848132|FG002|Double-Blind Treatment Period|Physician Decision|1
882828|NCT00606684|1848133|FG003|Double-Blind Treatment Period|Physician Decision|0
882829|NCT00606684|1848134|FG004|Double-Blind Treatment Period|Physician Decision|3
882830|NCT00606684|1848135|FG005|Double-Blind Treatment Period|Physician Decision|1
882831|NCT00606684|1848136|FG006|Double-Blind Treatment Period|Physician Decision|2
1192931|NCT02733042|2353441|FG011|Follow-up Period|Other|0
1192932|NCT02733042|2353442|FG012|Follow-up Period|Other|0
1192933|NCT02733042|2353443|FG013|Follow-up Period|Other|0
1192934|NCT02733042|2353444|FG014|Follow-up Period|Other|0
1192935|NCT02733042|2353445|FG015|Follow-up Period|Other|0
1192936|NCT02733042|2353446|FG016|Follow-up Period|Other|0
1192937|NCT02733042|2353447|FG017|Follow-up Period|Other|0
1192938|NCT02733042|2353448|FG018|Follow-up Period|Other|0
1192939|NCT02733042|2353430|FG000|Follow-up Period|Withdrawal by Subject|0
1192940|NCT02733042|2353431|FG001|Follow-up Period|Withdrawal by Subject|0
1192941|NCT02733042|2353432|FG002|Follow-up Period|Withdrawal by Subject|0
1192942|NCT02733042|2353433|FG003|Follow-up Period|Withdrawal by Subject|0
1192943|NCT02733042|2353434|FG004|Follow-up Period|Withdrawal by Subject|0
1192944|NCT02733042|2353435|FG005|Follow-up Period|Withdrawal by Subject|0
1192945|NCT02733042|2353436|FG006|Follow-up Period|Withdrawal by Subject|0
1192946|NCT02733042|2353437|FG007|Follow-up Period|Withdrawal by Subject|0
1192947|NCT02733042|2353438|FG008|Follow-up Period|Withdrawal by Subject|1
1192948|NCT02733042|2353439|FG009|Follow-up Period|Withdrawal by Subject|0
1192949|NCT02733042|2353440|FG010|Follow-up Period|Withdrawal by Subject|1
1192950|NCT02733042|2353441|FG011|Follow-up Period|Withdrawal by Subject|0
1192951|NCT02733042|2353442|FG012|Follow-up Period|Withdrawal by Subject|0
1192952|NCT02733042|2353443|FG013|Follow-up Period|Withdrawal by Subject|0
1192953|NCT02733042|2353444|FG014|Follow-up Period|Withdrawal by Subject|0
1192954|NCT02733042|2353445|FG015|Follow-up Period|Withdrawal by Subject|1
1192955|NCT02733042|2353446|FG016|Follow-up Period|Withdrawal by Subject|0
1192956|NCT02733042|2353447|FG017|Follow-up Period|Withdrawal by Subject|0
1192957|NCT02733042|2353448|FG018|Follow-up Period|Withdrawal by Subject|0
1192958|NCT02574286|2353509|FG000|Overall Study|Adverse Event|3
1192959|NCT02574286|2353509|FG000|Overall Study|Withdrawal by Subject|2
1192960|NCT02471144|2353517|FG000|Induction Period (Up to Week 12)|Adverse Event|0
1192961|NCT02471144|2353518|FG001|Induction Period (Up to Week 12)|Adverse Event|1
1192962|NCT02471144|2353519|FG002|Induction Period (Up to Week 12)|Adverse Event|1
1192963|NCT02471144|2353520|FG003|Induction Period (Up to Week 12)|Adverse Event|0
1192964|NCT02471144|2353521|FG004|Induction Period (Up to Week 12)|Adverse Event|0
1192965|NCT02471144|2353522|FG005|Induction Period (Up to Week 12)|Adverse Event|0
1192966|NCT02471144|2353523|FG006|Induction Period (Up to Week 12)|Adverse Event|0
1192967|NCT02471144|2353524|FG007|Induction Period (Up to Week 12)|Adverse Event|0
1192968|NCT02471144|2353525|FG008|Induction Period (Up to Week 12)|Adverse Event|0
1192969|NCT02471144|2353526|FG009|Induction Period (Up to Week 12)|Adverse Event|0
1192970|NCT02471144|2353527|FG010|Induction Period (Up to Week 12)|Adverse Event|0
1192971|NCT02471144|2353517|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0
1192972|NCT02471144|2353518|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0
1192973|NCT02471144|2353519|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0
1192974|NCT02471144|2353520|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1
1192975|NCT02471144|2353521|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0
1192976|NCT02471144|2353522|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0
1192977|NCT02471144|2353523|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0
1192978|NCT02471144|2353524|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0
1192979|NCT02471144|2353525|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0
1192980|NCT02471144|2353526|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0
1192981|NCT02471144|2353527|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0
1192982|NCT02471144|2353517|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0
1192983|NCT02471144|2353518|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0
1192984|NCT02471144|2353519|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1
1192985|NCT02471144|2353520|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0
1192986|NCT02471144|2353521|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0
1192987|NCT02471144|2353522|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0
1192988|NCT02471144|2353523|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0
1192989|NCT02471144|2353524|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0
1192990|NCT02471144|2353525|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0
882832|NCT00606684|1848130|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
882833|NCT00606684|1848131|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
882834|NCT00606684|1848132|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1
882835|NCT00606684|1848133|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2
882836|NCT00606684|1848134|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1
882837|NCT00606684|1848135|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2
882838|NCT00606684|1848136|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0
882839|NCT00606801|1848152|FG000|Intervention|Protocol Violation|3
882840|NCT00606801|1848153|FG001|Intervention|Protocol Violation|3
882841|NCT00606892|1848163|FG000|First Intervention|Protocol Violation|1
882842|NCT00606892|1848164|FG001|First Intervention|Protocol Violation|4
882843|NCT00606905|1848198|FG000|Overall Study|No Pregnancy|9
882844|NCT00606905|1848199|FG001|Overall Study|No Pregnancy|6
882845|NCT00606905|1848198|FG000|Overall Study|Non-Index Pregnancy|1
882846|NCT00606905|1848199|FG001|Overall Study|Non-Index Pregnancy|4
882847|NCT00606905|1848198|FG000|Overall Study|Withdrew|5
882848|NCT00606905|1848199|FG001|Overall Study|Withdrew|5
882849|NCT00606931|1848205|FG000|Overall Study|Withdrawal by Subject|3
882850|NCT00607022|1848221|FG000|Overall Study|Withdrawal by Subject|1
882851|NCT00607022|1848222|FG001|Overall Study|Withdrawal by Subject|0
882852|NCT00607022|1848223|FG002|Overall Study|Withdrawal by Subject|0
882853|NCT00607048|1848233|FG000|Overall Study|Adverse Event|0
1192991|NCT02471144|2353526|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0
1192992|NCT02471144|2353527|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0
1192993|NCT02471144|2353517|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
1192994|NCT02471144|2353518|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
1192995|NCT02471144|2353519|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1192996|NCT02471144|2353520|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1192997|NCT02471144|2353521|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1192998|NCT02471144|2353522|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1192999|NCT02471144|2353523|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1193000|NCT02471144|2353524|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1193001|NCT02471144|2353525|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1193002|NCT02471144|2353526|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1193003|NCT02471144|2353527|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1193004|NCT02471144|2353517|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1193005|NCT02471144|2353518|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1193006|NCT02471144|2353519|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1193007|NCT02471144|2353520|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1193008|NCT02471144|2353521|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
1193009|NCT02471144|2353522|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1193010|NCT02471144|2353523|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
1193011|NCT02471144|2353524|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1193012|NCT02471144|2353525|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
1193013|NCT02471144|2353526|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1193014|NCT02471144|2353527|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1193015|NCT02471144|2353517|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1193016|NCT02471144|2353518|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1193017|NCT02471144|2353519|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1193018|NCT02471144|2353520|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1193019|NCT02471144|2353521|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1193020|NCT02471144|2353522|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1
1193021|NCT02471144|2353523|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1193022|NCT02471144|2353524|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1193023|NCT02471144|2353525|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3
1193024|NCT02471144|2353526|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1193025|NCT02471144|2353527|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1193026|NCT02471144|2353517|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1193027|NCT02471144|2353518|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1193028|NCT02471144|2353519|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1193029|NCT02471144|2353520|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1193030|NCT02471144|2353521|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1193031|NCT02471144|2353522|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1193032|NCT02471144|2353523|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1193033|NCT02471144|2353524|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1193034|NCT02471144|2353525|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1
1193035|NCT02471144|2353526|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1193036|NCT02471144|2353527|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1193037|NCT02471144|2353517|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1193038|NCT02471144|2353518|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1193039|NCT02471144|2353519|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1193040|NCT02471144|2353520|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1193041|NCT02471144|2353521|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1193042|NCT02471144|2353522|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1193043|NCT02471144|2353523|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1193044|NCT02471144|2353524|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2
1193045|NCT02471144|2353525|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1
1193046|NCT02471144|2353526|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1193047|NCT02471144|2353527|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
882854|NCT00607048|1848234|FG001|Overall Study|Adverse Event|1
882855|NCT00607048|1848235|FG002|Overall Study|Adverse Event|0
882856|NCT00607048|1848236|FG003|Overall Study|Adverse Event|0
882857|NCT00607048|1848237|FG004|Overall Study|Adverse Event|4
882858|NCT00607048|1848238|FG005|Overall Study|Adverse Event|0
882859|NCT00607048|1848233|FG000|Overall Study|Global deterioration of health|1
882860|NCT00607048|1848234|FG001|Overall Study|Global deterioration of health|0
882861|NCT00607048|1848235|FG002|Overall Study|Global deterioration of health|0
882862|NCT00607048|1848236|FG003|Overall Study|Global deterioration of health|0
882863|NCT00607048|1848237|FG004|Overall Study|Global deterioration of health|0
882864|NCT00607048|1848238|FG005|Overall Study|Global deterioration of health|0
882865|NCT00607048|1848233|FG000|Overall Study|Objective disease progression - relapse|1
882866|NCT00607048|1848234|FG001|Overall Study|Objective disease progression - relapse|2
882867|NCT00607048|1848235|FG002|Overall Study|Objective disease progression - relapse|4
1193048|NCT02471144|2353517|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1193049|NCT02471144|2353518|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1193050|NCT02471144|2353519|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1193051|NCT02471144|2353520|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1193052|NCT02471144|2353521|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1193053|NCT02471144|2353522|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1193054|NCT02471144|2353523|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1193055|NCT02471144|2353524|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1193056|NCT02471144|2353525|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1193057|NCT02471144|2353526|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5
1193058|NCT02471144|2353527|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2
1193059|NCT02471144|2353517|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0
1193060|NCT02471144|2353518|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0
1193061|NCT02471144|2353519|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0
1193062|NCT02471144|2353520|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0
1193063|NCT02471144|2353521|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0
1193064|NCT02471144|2353522|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0
1193065|NCT02471144|2353523|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0
1193066|NCT02471144|2353524|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0
1193067|NCT02471144|2353525|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0
1193068|NCT02471144|2353526|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2
1193069|NCT02471144|2353527|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0
1193070|NCT02471144|2353517|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1193071|NCT02471144|2353518|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1193072|NCT02471144|2353519|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1193073|NCT02471144|2353520|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1193074|NCT02471144|2353521|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1193075|NCT02471144|2353522|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1193076|NCT02471144|2353523|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1193077|NCT02471144|2353524|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1193078|NCT02471144|2353525|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1193079|NCT02471144|2353526|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1193080|NCT02471144|2353527|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2
1193081|NCT02440464|2353545|FG000|Overall Study|Withdrawal by Subject|3
1193082|NCT02440464|2353546|FG001|Overall Study|Withdrawal by Subject|2
1193083|NCT02366728|2353563|FG000|Overall Study|Death|0
1193084|NCT02366728|2353564|FG001|Overall Study|Death|0
1193085|NCT02366728|2353565|FG002|Overall Study|Death|1
1193086|NCT02366728|2353563|FG000|Overall Study|Adverse Event|1
1193087|NCT02366728|2353564|FG001|Overall Study|Adverse Event|0
882868|NCT00607048|1848236|FG003|Overall Study|Objective disease progression - relapse|2
882869|NCT00607048|1848237|FG004|Overall Study|Objective disease progression - relapse|2
882870|NCT00607048|1848238|FG005|Overall Study|Objective disease progression - relapse|2
882871|NCT00607048|1848233|FG000|Overall Study|Withdrawal by Subject|0
882872|NCT00607048|1848234|FG001|Overall Study|Withdrawal by Subject|0
882873|NCT00607048|1848235|FG002|Overall Study|Withdrawal by Subject|0
882874|NCT00607048|1848236|FG003|Overall Study|Withdrawal by Subject|1
882875|NCT00607048|1848237|FG004|Overall Study|Withdrawal by Subject|0
882876|NCT00607048|1848238|FG005|Overall Study|Withdrawal by Subject|2
882877|NCT00607048|1848233|FG000|Overall Study|Other|1
882878|NCT00607048|1848234|FG001|Overall Study|Other|1
882879|NCT00607048|1848235|FG002|Overall Study|Other|0
882880|NCT00607048|1848236|FG003|Overall Study|Other|0
882881|NCT00607048|1848237|FG004|Overall Study|Other|0
882882|NCT00607048|1848238|FG005|Overall Study|Other|1
882883|NCT00607087|1848257|FG000|Overall Study|Withdrawal by Subject|9
882884|NCT00607087|1848258|FG001|Overall Study|Withdrawal by Subject|4
882885|NCT00607087|1848259|FG002|Overall Study|Withdrawal by Subject|4
882886|NCT00607087|1848257|FG000|Overall Study|Adverse Event|3
882887|NCT00607087|1848258|FG001|Overall Study|Adverse Event|2
882888|NCT00607087|1848259|FG002|Overall Study|Adverse Event|3
882889|NCT00607087|1848257|FG000|Overall Study|Other reason|1
882890|NCT00607087|1848258|FG001|Overall Study|Other reason|5
882891|NCT00607087|1848259|FG002|Overall Study|Other reason|2
882892|NCT00607087|1848257|FG000|Overall Study|Poor compliance to protocol|1
882893|NCT00607087|1848258|FG001|Overall Study|Poor compliance to protocol|0
882894|NCT00607087|1848259|FG002|Overall Study|Poor compliance to protocol|1
882895|NCT00607087|1848257|FG000|Overall Study|Lost to Follow-up|1
882896|NCT00607087|1848258|FG001|Overall Study|Lost to Follow-up|0
882897|NCT00607087|1848259|FG002|Overall Study|Lost to Follow-up|0
882898|NCT00607087|1848257|FG000|Period 1|Withdrawal by Subject|7
882899|NCT00607087|1848258|FG001|Period 1|Withdrawal by Subject|2
882900|NCT00607087|1848259|FG002|Period 1|Withdrawal by Subject|3
882901|NCT00607087|1848257|FG000|Period 1|Adverse Event|3
882902|NCT00607087|1848258|FG001|Period 1|Adverse Event|0
882903|NCT00607087|1848259|FG002|Period 1|Adverse Event|0
882904|NCT00607087|1848257|FG000|Period 1|Poor compliance to protocol|1
882905|NCT00607087|1848258|FG001|Period 1|Poor compliance to protocol|0
1193088|NCT02366728|2353565|FG002|Overall Study|Adverse Event|0
1193089|NCT02366728|2353563|FG000|Overall Study|Screen Failure|2
1193090|NCT02366728|2353564|FG001|Overall Study|Screen Failure|1
1193091|NCT02366728|2353565|FG002|Overall Study|Screen Failure|0
1193092|NCT02366728|2353563|FG000|Overall Study|Only yielded 2 vaccines|1
1193093|NCT02366728|2353564|FG001|Overall Study|Only yielded 2 vaccines|0
1193094|NCT02366728|2353565|FG002|Overall Study|Only yielded 2 vaccines|0
1193095|NCT02236572|2353573|FG000|Overall Study|Withdrawal by Subject|1
1193096|NCT02236572|2353573|FG000|Overall Study|Protocol Violation|1
1193097|NCT02236572|2353573|FG000|Overall Study|Lost to Follow-up|1
1193098|NCT02083354|2353577|FG000|Overall Study|Withdrawal by Subject|9
1193099|NCT02083354|2353577|FG000|Overall Study|Lost to Follow-up|1
1193100|NCT02083354|2353577|FG000|Overall Study|Adverse Event|3
1193101|NCT02083354|2353577|FG000|Overall Study|Disease progression|46
1193102|NCT02083354|2353577|FG000|Overall Study|Study closed/terminated|5
1193103|NCT02000882|2353581|FG000|Overall Study|Adverse Event|3
1193104|NCT02000882|2353581|FG000|Overall Study|Physician Decision|2
1193105|NCT02000882|2353581|FG000|Overall Study|Withdrawal by Subject|1
1193106|NCT01885078|2353593|FG000|Treatment Period|Adverse Event|52
1193107|NCT01885078|2353594|FG001|Treatment Period|Adverse Event|136
1193108|NCT01885078|2353595|FG002|Treatment Period|Adverse Event|30
1193109|NCT01885078|2353596|FG003|Treatment Period|Adverse Event|73
1193110|NCT01885078|2353597|FG004|Treatment Period|Adverse Event|17
1193111|NCT01885078|2353598|FG005|Treatment Period|Adverse Event|72
1193112|NCT01885078|2353599|FG006|Treatment Period|Adverse Event|24
1193113|NCT01885078|2353600|FG007|Treatment Period|Adverse Event|5
1193114|NCT01885078|2353601|FG008|Treatment Period|Adverse Event|0
1193115|NCT01885078|2353602|FG009|Treatment Period|Adverse Event|0
1193116|NCT01885078|2353593|FG000|Treatment Period|Death|13
1193117|NCT01885078|2353594|FG001|Treatment Period|Death|33
1193118|NCT01885078|2353595|FG002|Treatment Period|Death|5
1193119|NCT01885078|2353596|FG003|Treatment Period|Death|9
1193120|NCT01885078|2353597|FG004|Treatment Period|Death|2
1193121|NCT01885078|2353598|FG005|Treatment Period|Death|10
1193122|NCT01885078|2353599|FG006|Treatment Period|Death|3
1193123|NCT01885078|2353600|FG007|Treatment Period|Death|2
1193124|NCT01885078|2353601|FG008|Treatment Period|Death|0
1193125|NCT01885078|2353602|FG009|Treatment Period|Death|0
1193126|NCT01885078|2353593|FG000|Treatment Period|Lack of Efficacy|12
1193127|NCT01885078|2353594|FG001|Treatment Period|Lack of Efficacy|33
1193128|NCT01885078|2353595|FG002|Treatment Period|Lack of Efficacy|10
1193129|NCT01885078|2353596|FG003|Treatment Period|Lack of Efficacy|23
1193130|NCT01885078|2353597|FG004|Treatment Period|Lack of Efficacy|24
1193131|NCT01885078|2353598|FG005|Treatment Period|Lack of Efficacy|58
1193132|NCT01885078|2353599|FG006|Treatment Period|Lack of Efficacy|9
1193133|NCT01885078|2353600|FG007|Treatment Period|Lack of Efficacy|5
1193134|NCT01885078|2353601|FG008|Treatment Period|Lack of Efficacy|0
1193135|NCT01885078|2353602|FG009|Treatment Period|Lack of Efficacy|0
1193136|NCT01885078|2353593|FG000|Treatment Period|Lost to Follow-up|16
1193137|NCT01885078|2353594|FG001|Treatment Period|Lost to Follow-up|19
1193138|NCT01885078|2353595|FG002|Treatment Period|Lost to Follow-up|7
1193139|NCT01885078|2353596|FG003|Treatment Period|Lost to Follow-up|9
1193140|NCT01885078|2353597|FG004|Treatment Period|Lost to Follow-up|2
1193141|NCT01885078|2353598|FG005|Treatment Period|Lost to Follow-up|8
1193142|NCT01885078|2353599|FG006|Treatment Period|Lost to Follow-up|2
1193143|NCT01885078|2353600|FG007|Treatment Period|Lost to Follow-up|0
1193144|NCT01885078|2353601|FG008|Treatment Period|Lost to Follow-up|0
1193145|NCT01885078|2353602|FG009|Treatment Period|Lost to Follow-up|0
1193146|NCT01885078|2353593|FG000|Treatment Period|Physician Decision|19
1193147|NCT01885078|2353594|FG001|Treatment Period|Physician Decision|21
1193148|NCT01885078|2353595|FG002|Treatment Period|Physician Decision|5
1193149|NCT01885078|2353596|FG003|Treatment Period|Physician Decision|12
1193150|NCT01885078|2353597|FG004|Treatment Period|Physician Decision|9
1193151|NCT01885078|2353598|FG005|Treatment Period|Physician Decision|24
1193152|NCT01885078|2353599|FG006|Treatment Period|Physician Decision|4
1193153|NCT01885078|2353600|FG007|Treatment Period|Physician Decision|3
1193154|NCT01885078|2353601|FG008|Treatment Period|Physician Decision|0
1193155|NCT01885078|2353602|FG009|Treatment Period|Physician Decision|0
1193156|NCT01885078|2353593|FG000|Treatment Period|Protocol Violation|3
1193157|NCT01885078|2353594|FG001|Treatment Period|Protocol Violation|5
1193158|NCT01885078|2353595|FG002|Treatment Period|Protocol Violation|0
1193159|NCT01885078|2353596|FG003|Treatment Period|Protocol Violation|3
1193160|NCT01885078|2353597|FG004|Treatment Period|Protocol Violation|1
882906|NCT00607087|1848259|FG002|Period 1|Poor compliance to protocol|0
882907|NCT00607087|1848257|FG000|Period 1|Lost to Follow-up|1
882908|NCT00607087|1848258|FG001|Period 1|Lost to Follow-up|0
882909|NCT00607087|1848259|FG002|Period 1|Lost to Follow-up|0
882910|NCT00607087|1848257|FG000|Period 1|Other reason|0
882911|NCT00607087|1848258|FG001|Period 1|Other reason|4
882912|NCT00607087|1848259|FG002|Period 1|Other reason|2
882913|NCT00607087|1848257|FG000|Period 2|Withdrawal by Subject|0
882914|NCT00607087|1848258|FG001|Period 2|Withdrawal by Subject|1
882915|NCT00607087|1848259|FG002|Period 2|Withdrawal by Subject|1
1193161|NCT01885078|2353598|FG005|Treatment Period|Protocol Violation|6
1193162|NCT01885078|2353599|FG006|Treatment Period|Protocol Violation|0
1193163|NCT01885078|2353600|FG007|Treatment Period|Protocol Violation|0
1193164|NCT01885078|2353601|FG008|Treatment Period|Protocol Violation|0
1193165|NCT01885078|2353602|FG009|Treatment Period|Protocol Violation|0
1193166|NCT01885078|2353593|FG000|Treatment Period|Sponsor Decision|245
1193167|NCT01885078|2353594|FG001|Treatment Period|Sponsor Decision|648
1193168|NCT01885078|2353595|FG002|Treatment Period|Sponsor Decision|49
1193169|NCT01885078|2353596|FG003|Treatment Period|Sponsor Decision|90
1193170|NCT01885078|2353597|FG004|Treatment Period|Sponsor Decision|20
1193171|NCT01885078|2353598|FG005|Treatment Period|Sponsor Decision|38
1193172|NCT01885078|2353599|FG006|Treatment Period|Sponsor Decision|162
1193173|NCT01885078|2353600|FG007|Treatment Period|Sponsor Decision|3
1193174|NCT01885078|2353601|FG008|Treatment Period|Sponsor Decision|0
1193175|NCT01885078|2353602|FG009|Treatment Period|Sponsor Decision|0
882916|NCT00607087|1848257|FG000|Period 2|Other reason|1
882917|NCT00607087|1848258|FG001|Period 2|Other reason|1
882918|NCT00607087|1848259|FG002|Period 2|Other reason|0
882919|NCT00607087|1848257|FG000|Period 2|Adverse Event|0
882920|NCT00607087|1848258|FG001|Period 2|Adverse Event|1
882921|NCT00607087|1848259|FG002|Period 2|Adverse Event|3
882922|NCT00607087|1848257|FG000|Period 2|Poor compliance to protocol|0
882923|NCT00607087|1848258|FG001|Period 2|Poor compliance to protocol|0
882924|NCT00607087|1848259|FG002|Period 2|Poor compliance to protocol|1
882925|NCT00607087|1848257|FG000|Period 3|Withdrawal by Subject|2
882926|NCT00607087|1848258|FG001|Period 3|Withdrawal by Subject|1
882927|NCT00607087|1848259|FG002|Period 3|Withdrawal by Subject|0
882928|NCT00607087|1848257|FG000|Period 3|Adverse Event|0
882929|NCT00607087|1848258|FG001|Period 3|Adverse Event|1
882930|NCT00607087|1848259|FG002|Period 3|Adverse Event|0
882931|NCT00607373|1848310|FG000|Treatment Period|Adverse Event|0
882932|NCT00607373|1848311|FG001|Treatment Period|Adverse Event|4
882933|NCT00607373|1848310|FG000|Treatment Period|Physician Decision|0
882934|NCT00607373|1848311|FG001|Treatment Period|Physician Decision|1
882935|NCT00607373|1848310|FG000|Treatment Period|Withdrawal by Subject|0
882936|NCT00607373|1848311|FG001|Treatment Period|Withdrawal by Subject|1
882937|NCT00607373|1848310|FG000|Follow-up Period|Other|0
882938|NCT00607373|1848311|FG001|Follow-up Period|Other|1
882939|NCT00607373|1848310|FG000|Follow-up Period|Protocol Violation|0
882940|NCT00607373|1848311|FG001|Follow-up Period|Protocol Violation|1
882941|NCT00607373|1848310|FG000|Follow-up Period|Withdrawal by Subject|1
882942|NCT00607373|1848311|FG001|Follow-up Period|Withdrawal by Subject|3
882943|NCT00607386|1848317|FG000|Overall Study|Physician Decision|1
882944|NCT00607724|1848359|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7
882945|NCT00607724|1848360|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8
882946|NCT00607724|1848361|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4
882947|NCT00607724|1848362|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
882948|NCT00607724|1848363|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
882949|NCT00607724|1848364|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
882950|NCT00607724|1848365|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
882951|NCT00607724|1848359|FG000|Stage 2: Expanded Cohort|Adverse Event|0
882952|NCT00607724|1848360|FG001|Stage 2: Expanded Cohort|Adverse Event|0
882953|NCT00607724|1848361|FG002|Stage 2: Expanded Cohort|Adverse Event|0
882954|NCT00607724|1848362|FG003|Stage 2: Expanded Cohort|Adverse Event|0
882955|NCT00607724|1848363|FG004|Stage 2: Expanded Cohort|Adverse Event|0
882956|NCT00607724|1848364|FG005|Stage 2: Expanded Cohort|Adverse Event|0
882957|NCT00607724|1848365|FG006|Stage 2: Expanded Cohort|Adverse Event|1
882958|NCT00607724|1848359|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
882959|NCT00607724|1848360|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
882960|NCT00607724|1848361|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
882961|NCT00607724|1848362|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4
882962|NCT00607724|1848363|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8
882963|NCT00607724|1848364|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11
882964|NCT00607724|1848365|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10
882965|NCT00607724|1848359|FG000|Stage 2: Expanded Cohort|Physician Decision|0
882966|NCT00607724|1848360|FG001|Stage 2: Expanded Cohort|Physician Decision|0
882967|NCT00607724|1848361|FG002|Stage 2: Expanded Cohort|Physician Decision|0
882968|NCT00607724|1848362|FG003|Stage 2: Expanded Cohort|Physician Decision|0
882969|NCT00607724|1848363|FG004|Stage 2: Expanded Cohort|Physician Decision|1
882970|NCT00607724|1848364|FG005|Stage 2: Expanded Cohort|Physician Decision|1
882971|NCT00607724|1848365|FG006|Stage 2: Expanded Cohort|Physician Decision|0
882972|NCT00607724|1848359|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0
882973|NCT00607724|1848360|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0
882974|NCT00607724|1848361|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0
882975|NCT00607724|1848362|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1
882976|NCT00607724|1848363|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0
882977|NCT00607724|1848364|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0
882978|NCT00607724|1848365|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0
882979|NCT00607789|1848391|FG000|Overall Study|Adverse Event|3
882980|NCT00607789|1848392|FG001|Overall Study|Adverse Event|0
1193176|NCT01885078|2353593|FG000|Treatment Period|Withdrawal by Subject|72
1193177|NCT01885078|2353594|FG001|Treatment Period|Withdrawal by Subject|132
1193178|NCT01885078|2353595|FG002|Treatment Period|Withdrawal by Subject|25
1193179|NCT01885078|2353596|FG003|Treatment Period|Withdrawal by Subject|63
1193180|NCT01885078|2353597|FG004|Treatment Period|Withdrawal by Subject|15
1193181|NCT01885078|2353598|FG005|Treatment Period|Withdrawal by Subject|34
1193182|NCT01885078|2353599|FG006|Treatment Period|Withdrawal by Subject|17
1193183|NCT01885078|2353600|FG007|Treatment Period|Withdrawal by Subject|10
1193184|NCT01885078|2353601|FG008|Treatment Period|Withdrawal by Subject|0
1193185|NCT01885078|2353602|FG009|Treatment Period|Withdrawal by Subject|0
1193186|NCT01885078|2353593|FG000|Treatment Period|Other|0
1193187|NCT01885078|2353594|FG001|Treatment Period|Other|0
1193188|NCT01885078|2353595|FG002|Treatment Period|Other|0
1193189|NCT01885078|2353596|FG003|Treatment Period|Other|1
1193190|NCT01885078|2353597|FG004|Treatment Period|Other|0
1193191|NCT01885078|2353598|FG005|Treatment Period|Other|0
1193192|NCT01885078|2353599|FG006|Treatment Period|Other|0
1193193|NCT01885078|2353600|FG007|Treatment Period|Other|0
1193194|NCT01885078|2353601|FG008|Treatment Period|Other|0
1193195|NCT01885078|2353602|FG009|Treatment Period|Other|0
1193196|NCT01885078|2353593|FG000|Step-down Period|Sponsor Decision|0
1193197|NCT01885078|2353594|FG001|Step-down Period|Sponsor Decision|0
1193198|NCT01885078|2353595|FG002|Step-down Period|Sponsor Decision|0
1193199|NCT01885078|2353596|FG003|Step-down Period|Sponsor Decision|0
1193200|NCT01885078|2353597|FG004|Step-down Period|Sponsor Decision|0
1193201|NCT01885078|2353598|FG005|Step-down Period|Sponsor Decision|0
1193202|NCT01885078|2353599|FG006|Step-down Period|Sponsor Decision|0
1193203|NCT01885078|2353600|FG007|Step-down Period|Sponsor Decision|0
1193204|NCT01885078|2353601|FG008|Step-down Period|Sponsor Decision|1
1193205|NCT01885078|2353602|FG009|Step-down Period|Sponsor Decision|1
1193206|NCT01885078|2353593|FG000|Step-down Period|Adverse Event|0
1193207|NCT01885078|2353594|FG001|Step-down Period|Adverse Event|0
1193208|NCT01885078|2353595|FG002|Step-down Period|Adverse Event|0
1193209|NCT01885078|2353596|FG003|Step-down Period|Adverse Event|0
1193210|NCT01885078|2353597|FG004|Step-down Period|Adverse Event|0
1193211|NCT01885078|2353598|FG005|Step-down Period|Adverse Event|0
1193212|NCT01885078|2353599|FG006|Step-down Period|Adverse Event|0
1193213|NCT01885078|2353600|FG007|Step-down Period|Adverse Event|0
1193214|NCT01885078|2353601|FG008|Step-down Period|Adverse Event|29
1193215|NCT01885078|2353602|FG009|Step-down Period|Adverse Event|38
1193216|NCT01885078|2353593|FG000|Step-down Period|Withdrawal by Subject|0
1193217|NCT01885078|2353594|FG001|Step-down Period|Withdrawal by Subject|0
1193218|NCT01885078|2353595|FG002|Step-down Period|Withdrawal by Subject|0
1193219|NCT01885078|2353596|FG003|Step-down Period|Withdrawal by Subject|0
1193220|NCT01885078|2353597|FG004|Step-down Period|Withdrawal by Subject|0
1193221|NCT01885078|2353598|FG005|Step-down Period|Withdrawal by Subject|0
1193222|NCT01885078|2353599|FG006|Step-down Period|Withdrawal by Subject|0
1193223|NCT01885078|2353600|FG007|Step-down Period|Withdrawal by Subject|0
1193224|NCT01885078|2353601|FG008|Step-down Period|Withdrawal by Subject|25
1193225|NCT01885078|2353602|FG009|Step-down Period|Withdrawal by Subject|15
1193226|NCT01885078|2353593|FG000|Step-down Period|Physician Decision|0
1193227|NCT01885078|2353594|FG001|Step-down Period|Physician Decision|0
1193228|NCT01885078|2353595|FG002|Step-down Period|Physician Decision|0
1193229|NCT01885078|2353596|FG003|Step-down Period|Physician Decision|0
1193230|NCT01885078|2353597|FG004|Step-down Period|Physician Decision|0
1193231|NCT01885078|2353598|FG005|Step-down Period|Physician Decision|0
1193232|NCT01885078|2353599|FG006|Step-down Period|Physician Decision|0
1193233|NCT01885078|2353600|FG007|Step-down Period|Physician Decision|0
1193234|NCT01885078|2353601|FG008|Step-down Period|Physician Decision|7
1193235|NCT01885078|2353602|FG009|Step-down Period|Physician Decision|2
1193236|NCT01885078|2353593|FG000|Step-down Period|Death|0
1193237|NCT01885078|2353594|FG001|Step-down Period|Death|0
1193238|NCT01885078|2353595|FG002|Step-down Period|Death|0
1193239|NCT01885078|2353596|FG003|Step-down Period|Death|0
1193240|NCT01885078|2353597|FG004|Step-down Period|Death|0
1193241|NCT01885078|2353598|FG005|Step-down Period|Death|0
1193242|NCT01885078|2353599|FG006|Step-down Period|Death|0
882981|NCT00607789|1848391|FG000|Overall Study|Lack of Efficacy|0
882982|NCT00607789|1848392|FG001|Overall Study|Lack of Efficacy|1
882983|NCT00607789|1848391|FG000|Overall Study|Inadequate adherence|3
882984|NCT00607789|1848392|FG001|Overall Study|Inadequate adherence|0
882985|NCT00607789|1848391|FG000|Overall Study|Lost to Follow-up|0
882986|NCT00607789|1848392|FG001|Overall Study|Lost to Follow-up|5
882987|NCT00607789|1848391|FG000|Overall Study|Withdrawal by Subject|1
882988|NCT00607789|1848392|FG001|Overall Study|Withdrawal by Subject|0
882989|NCT00607880|1848420|FG000|Overall Study|Unable to place port due to occlusion|1
882990|NCT00607880|1848421|FG001|Overall Study|Unable to place port due to occlusion|0
882991|NCT00607893|1848429|FG000|Overall Study|Lost to Follow-up|4
882992|NCT00607893|1848430|FG001|Overall Study|Lost to Follow-up|0
882993|NCT00607893|1848429|FG000|Overall Study|withdrew due to loss of interest|0
882994|NCT00607893|1848430|FG001|Overall Study|withdrew due to loss of interest|1
882995|NCT00607893|1848429|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0
882996|NCT00607893|1848430|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1
882997|NCT00607893|1848429|FG000|Overall Study|withdrew could not tolerate CPAP|0
882998|NCT00607893|1848430|FG001|Overall Study|withdrew could not tolerate CPAP|1
1193243|NCT01885078|2353600|FG007|Step-down Period|Death|0
1193244|NCT01885078|2353601|FG008|Step-down Period|Death|4
1193245|NCT01885078|2353602|FG009|Step-down Period|Death|3
1193246|NCT01885078|2353593|FG000|Step-down Period|Lost to Follow-up|0
1193247|NCT01885078|2353594|FG001|Step-down Period|Lost to Follow-up|0
1193248|NCT01885078|2353595|FG002|Step-down Period|Lost to Follow-up|0
1193249|NCT01885078|2353596|FG003|Step-down Period|Lost to Follow-up|0
1193250|NCT01885078|2353597|FG004|Step-down Period|Lost to Follow-up|0
1193251|NCT01885078|2353598|FG005|Step-down Period|Lost to Follow-up|0
1193252|NCT01885078|2353599|FG006|Step-down Period|Lost to Follow-up|0
1193253|NCT01885078|2353600|FG007|Step-down Period|Lost to Follow-up|0
1193254|NCT01885078|2353601|FG008|Step-down Period|Lost to Follow-up|1
1193255|NCT01885078|2353602|FG009|Step-down Period|Lost to Follow-up|1
1193256|NCT01885078|2353593|FG000|Step-down Period|Lack of Efficacy|0
1193257|NCT01885078|2353594|FG001|Step-down Period|Lack of Efficacy|0
1193258|NCT01885078|2353595|FG002|Step-down Period|Lack of Efficacy|0
1193259|NCT01885078|2353596|FG003|Step-down Period|Lack of Efficacy|0
1193260|NCT01885078|2353597|FG004|Step-down Period|Lack of Efficacy|0
1193261|NCT01885078|2353598|FG005|Step-down Period|Lack of Efficacy|0
1193262|NCT01885078|2353599|FG006|Step-down Period|Lack of Efficacy|0
1193263|NCT01885078|2353600|FG007|Step-down Period|Lack of Efficacy|0
1193264|NCT01885078|2353601|FG008|Step-down Period|Lack of Efficacy|1
1193265|NCT01885078|2353602|FG009|Step-down Period|Lack of Efficacy|0
1193266|NCT01885078|2353593|FG000|Step-down Period|Protocol Violation|0
1193267|NCT01885078|2353594|FG001|Step-down Period|Protocol Violation|0
1193268|NCT01885078|2353595|FG002|Step-down Period|Protocol Violation|0
1193269|NCT01885078|2353596|FG003|Step-down Period|Protocol Violation|0
1193270|NCT01885078|2353597|FG004|Step-down Period|Protocol Violation|0
1193271|NCT01885078|2353598|FG005|Step-down Period|Protocol Violation|0
1193272|NCT01885078|2353599|FG006|Step-down Period|Protocol Violation|0
1193273|NCT01885078|2353600|FG007|Step-down Period|Protocol Violation|0
1193274|NCT01885078|2353601|FG008|Step-down Period|Protocol Violation|1
1193275|NCT01885078|2353602|FG009|Step-down Period|Protocol Violation|1
1193276|NCT01446016|2353653|FG000|Overall Study|Lost to Follow-up|3
1193277|NCT01446016|2353653|FG000|Overall Study|Withdrawal by Subject|1
1193278|NCT01446016|2353653|FG000|Overall Study|Toxicity|3
1193279|NCT01434602|2353675|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
1193280|NCT01434602|2353676|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1
1193281|NCT01434602|2353677|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
1193282|NCT01434602|2353678|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
1193283|NCT01434602|2353679|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
1193284|NCT01434602|2353675|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
1193285|NCT01434602|2353676|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
1193286|NCT01434602|2353677|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
1193287|NCT01434602|2353678|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1
1193288|NCT01434602|2353679|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
1193289|NCT01434602|2353675|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
1193290|NCT01434602|2353676|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
1193291|NCT01434602|2353677|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
1193292|NCT01434602|2353678|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1
1193293|NCT01434602|2353679|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
1193294|NCT01434602|2353675|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0
882999|NCT00607893|1848429|FG000|Overall Study|Declined to be treated|1
883000|NCT00607893|1848430|FG001|Overall Study|Declined to be treated|0
883001|NCT00607893|1848429|FG000|Overall Study|Withdrew due to hypertensive urgency|1
883002|NCT00607893|1848430|FG001|Overall Study|Withdrew due to hypertensive urgency|1
883003|NCT00607919|1848440|FG000|Acute Phase|Adverse Event|9
883004|NCT00607919|1848441|FG001|Acute Phase|Adverse Event|2
883005|NCT00607919|1848440|FG000|Acute Phase|Entry Criteria Not Met|1
883006|NCT00607919|1848441|FG001|Acute Phase|Entry Criteria Not Met|1
883007|NCT00607919|1848440|FG000|Acute Phase|Lack of Efficacy|1
883008|NCT00607919|1848441|FG001|Acute Phase|Lack of Efficacy|2
883009|NCT00607919|1848440|FG000|Acute Phase|Lost to Follow-up|9
883010|NCT00607919|1848441|FG001|Acute Phase|Lost to Follow-up|3
883011|NCT00607919|1848440|FG000|Acute Phase|Parent/Caregiver Decision|6
883012|NCT00607919|1848441|FG001|Acute Phase|Parent/Caregiver Decision|4
883013|NCT00607919|1848440|FG000|Acute Phase|Protocol Violation|5
883014|NCT00607919|1848441|FG001|Acute Phase|Protocol Violation|1
883015|NCT00607919|1848440|FG000|Acute Phase|Withdrawal by Subject|3
883016|NCT00607919|1848441|FG001|Acute Phase|Withdrawal by Subject|3
883017|NCT00607919|1848440|FG000|Open-Label Phase|Adverse Event|1
883018|NCT00607919|1848441|FG001|Open-Label Phase|Adverse Event|5
883019|NCT00607919|1848440|FG000|Open-Label Phase|Lost to Follow-up|4
1193295|NCT01434602|2353676|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0
1193296|NCT01434602|2353677|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0
1193297|NCT01434602|2353678|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1
1193298|NCT01434602|2353679|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0
1193299|NCT01434602|2353675|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
1193300|NCT01434602|2353676|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
1193301|NCT01434602|2353677|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
1193302|NCT01434602|2353678|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1
1193303|NCT01434602|2353679|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
1193304|NCT01434602|2353675|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0
1193305|NCT01434602|2353676|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0
1193306|NCT01434602|2353677|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0
1193307|NCT01434602|2353678|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1
1193308|NCT01434602|2353679|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0
1193309|NCT01434602|2353675|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
1193310|NCT01434602|2353676|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
1193311|NCT01434602|2353677|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
1193312|NCT01434602|2353678|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
1193313|NCT01434602|2353679|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1
1193314|NCT01434602|2353675|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0
1193315|NCT01434602|2353676|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0
1193316|NCT01434602|2353677|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0
1193317|NCT01434602|2353678|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1
1193318|NCT01434602|2353679|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1
1193319|NCT01434602|2353675|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
1193320|NCT01434602|2353676|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
1193321|NCT01434602|2353677|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
1193322|NCT01434602|2353678|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1
1193323|NCT01434602|2353679|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
1193324|NCT01434602|2353675|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0
1193325|NCT01434602|2353676|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0
1193326|NCT01434602|2353677|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0
1193327|NCT01434602|2353678|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2
1193328|NCT01434602|2353679|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0
1193329|NCT01411332|2353700|FG000|Overall Study|Lost to Follow-up|1
1193330|NCT01411332|2353701|FG001|Overall Study|Lost to Follow-up|0
883020|NCT00607919|1848441|FG001|Open-Label Phase|Lost to Follow-up|1
883021|NCT00607919|1848440|FG000|Open-Label Phase|Protocol Violation|2
883022|NCT00607919|1848441|FG001|Open-Label Phase|Protocol Violation|2
883023|NCT00607919|1848440|FG000|Open-Label Phase|Withdrawal by Subject|2
883024|NCT00607919|1848441|FG001|Open-Label Phase|Withdrawal by Subject|2
883025|NCT00607919|1848440|FG000|Open-Label Phase|Parent/Caregiver Decision|1
883026|NCT00607919|1848441|FG001|Open-Label Phase|Parent/Caregiver Decision|2
883027|NCT00607997|1848453|FG000|Overall Study|Lack of Efficacy|6
883028|NCT00607997|1848454|FG001|Overall Study|Lack of Efficacy|20
883029|NCT00607997|1848455|FG002|Overall Study|Lack of Efficacy|14
883030|NCT00607997|1848456|FG003|Overall Study|Lack of Efficacy|10
883031|NCT00607997|1848453|FG000|Overall Study|Death|8
883032|NCT00607997|1848454|FG001|Overall Study|Death|5
883033|NCT00607997|1848455|FG002|Overall Study|Death|2
883034|NCT00607997|1848456|FG003|Overall Study|Death|5
883035|NCT00607997|1848453|FG000|Overall Study|Adverse Event|3
883036|NCT00607997|1848454|FG001|Overall Study|Adverse Event|1
883037|NCT00607997|1848455|FG002|Overall Study|Adverse Event|2
883038|NCT00607997|1848456|FG003|Overall Study|Adverse Event|0
883039|NCT00607997|1848453|FG000|Overall Study|Physician Decision|4
883040|NCT00607997|1848454|FG001|Overall Study|Physician Decision|1
883041|NCT00607997|1848455|FG002|Overall Study|Physician Decision|0
883042|NCT00607997|1848456|FG003|Overall Study|Physician Decision|0
883043|NCT00607997|1848453|FG000|Overall Study|Relapse, recurrent illness|4
883044|NCT00607997|1848454|FG001|Overall Study|Relapse, recurrent illness|0
883045|NCT00607997|1848455|FG002|Overall Study|Relapse, recurrent illness|2
883046|NCT00607997|1848456|FG003|Overall Study|Relapse, recurrent illness|0
883047|NCT00607997|1848453|FG000|Overall Study|Other without explanation|2
883048|NCT00607997|1848454|FG001|Overall Study|Other without explanation|0
883049|NCT00607997|1848455|FG002|Overall Study|Other without explanation|4
883050|NCT00607997|1848456|FG003|Overall Study|Other without explanation|1
883051|NCT00608023|1848474|FG000|Overall Study|Withdrawal by Subject|8
883052|NCT00608023|1848475|FG001|Overall Study|Withdrawal by Subject|10
883053|NCT00608023|1848476|FG002|Overall Study|Withdrawal by Subject|7
883054|NCT00608023|1848474|FG000|Overall Study|Adverse Event|1
883055|NCT00608023|1848475|FG001|Overall Study|Adverse Event|4
883056|NCT00608023|1848476|FG002|Overall Study|Adverse Event|5
883057|NCT00608023|1848474|FG000|Overall Study|Lost to Follow-up|2
883058|NCT00608023|1848475|FG001|Overall Study|Lost to Follow-up|2
1193331|NCT01411332|2353700|FG000|Overall Study|Protocol Violation|1
1193332|NCT01411332|2353701|FG001|Overall Study|Protocol Violation|1
1193333|NCT01411332|2353700|FG000|Overall Study|Withdrawal by Subject|0
1193334|NCT01411332|2353701|FG001|Overall Study|Withdrawal by Subject|1
1193335|NCT01399918|2353707|FG000|Overall Study|Not eligible and not enrolled in the study|2
1193336|NCT01147653|2353717|FG000|Year 2|Withdrawal by Subject|2
1193337|NCT01147653|2353718|FG001|Year 2|Withdrawal by Subject|3
1193338|NCT01078454|2353738|FG000|Overall Study|Adverse Event|1
1193339|NCT01078454|2353739|FG001|Overall Study|Adverse Event|1
883059|NCT00608023|1848476|FG002|Overall Study|Lost to Follow-up|1
883060|NCT00608023|1848474|FG000|Overall Study|Protocol Violation|1
883061|NCT00608023|1848475|FG001|Overall Study|Protocol Violation|3
883062|NCT00608023|1848476|FG002|Overall Study|Protocol Violation|1
883063|NCT00608023|1848474|FG000|Overall Study|Unknown reason|0
883064|NCT00608023|1848475|FG001|Overall Study|Unknown reason|3
883065|NCT00608023|1848476|FG002|Overall Study|Unknown reason|0
883066|NCT00608205|1848534|FG000|Overall Study|Adverse Event|3
883067|NCT00608205|1848535|FG001|Overall Study|Adverse Event|2
883068|NCT00608205|1848534|FG000|Overall Study|Patient non-compliant|0
883069|NCT00608205|1848535|FG001|Overall Study|Patient non-compliant|1
883070|NCT00608244|1848543|FG000|Overall Study|Adverse Event|1
883071|NCT00608244|1848543|FG000|Overall Study|Low trough levels|1
883072|NCT00608322|1848551|FG000|Overall Study|Death|2
883073|NCT00608322|1848552|FG001|Overall Study|Death|1
883074|NCT00608426|1848560|FG000|Overall Study|Death|32
883075|NCT00608426|1848561|FG001|Overall Study|Death|36
883076|NCT00608426|1848560|FG000|Overall Study|Lost to Follow-up|485
883077|NCT00608426|1848561|FG001|Overall Study|Lost to Follow-up|521
883078|NCT00608426|1848560|FG000|Overall Study|refused, health issues, wrong address|319
883079|NCT00608426|1848561|FG001|Overall Study|refused, health issues, wrong address|348
883080|NCT00608517|1848579|FG000|Overall Study|Death|1
883081|NCT00608517|1848580|FG001|Overall Study|Death|0
883082|NCT00608517|1848581|FG002|Overall Study|Death|0
883083|NCT00608530|1848594|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
883084|NCT00608530|1848595|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
883085|NCT00608530|1848596|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
883086|NCT00608530|1848597|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
883087|NCT00608530|1848594|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
883088|NCT00608530|1848595|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
883089|NCT00608530|1848596|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
883090|NCT00608530|1848597|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
883091|NCT00608530|1848594|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
883092|NCT00608530|1848595|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
883093|NCT00608530|1848596|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
883094|NCT00608530|1848597|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
883095|NCT00608530|1848594|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0
883096|NCT00608530|1848595|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0
883097|NCT00608530|1848596|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2
883098|NCT00608530|1848597|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0
883099|NCT00608530|1848594|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0
883100|NCT00608530|1848595|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0
883101|NCT00608530|1848596|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4
883102|NCT00608530|1848597|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1
883103|NCT00608530|1848594|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
883104|NCT00608530|1848595|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
883105|NCT00608530|1848596|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
883106|NCT00608530|1848597|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
883107|NCT00608543|1848612|FG000|Overall Study|Adverse Event|4
883108|NCT00608569|1848619|FG000|Overall Study|Death|4
883109|NCT00608569|1848620|FG001|Overall Study|Death|3
883110|NCT00608569|1848619|FG000|Overall Study|Lost to Follow-up|4
883111|NCT00608569|1848620|FG001|Overall Study|Lost to Follow-up|5
883112|NCT00608569|1848619|FG000|Overall Study|Withdrawal by Subject|1
883113|NCT00608569|1848620|FG001|Overall Study|Withdrawal by Subject|0
883114|NCT00608569|1848619|FG000|Overall Study|Adverse Event|1
883115|NCT00608569|1848620|FG001|Overall Study|Adverse Event|0
883116|NCT00608569|1848619|FG000|Overall Study|Unable to adhere with study requirements|0
883117|NCT00608569|1848620|FG001|Overall Study|Unable to adhere with study requirements|1
883118|NCT00608582|1848628|FG000|Overall Study|Lost to Follow-up|2
883119|NCT00608582|1848629|FG001|Overall Study|Lost to Follow-up|0
883120|NCT00608582|1848628|FG000|Overall Study|No Best Response in Phase 1 located|1
883121|NCT00608582|1848629|FG001|Overall Study|No Best Response in Phase 1 located|1
883122|NCT00608582|1848628|FG000|Overall Study|Illicit Drug Use|1
883123|NCT00608582|1848629|FG001|Overall Study|Illicit Drug Use|0
883124|NCT00608582|1848628|FG000|Overall Study|Early stage Design Change|0
883125|NCT00608582|1848629|FG001|Overall Study|Early stage Design Change|3
883126|NCT00608829|1848652|FG000|Overall Study|Death|6
883127|NCT00608829|1848652|FG000|Overall Study|Withdrawal by Subject|4
1193340|NCT01078454|2353738|FG000|Overall Study|Death|0
1193341|NCT01078454|2353739|FG001|Overall Study|Death|1
1193342|NCT00687596|2353747|FG000|Overall Study|Adverse Event (AE)|10
1193343|NCT00687596|2353748|FG001|Overall Study|Adverse Event (AE)|3
1193344|NCT00687596|2353747|FG000|Overall Study|Radiological Disease Progression|6
1193345|NCT00687596|2353748|FG001|Overall Study|Radiological Disease Progression|2
1193346|NCT00687596|2353747|FG000|Overall Study|Clinical Disease Progression|1
1193347|NCT00687596|2353748|FG001|Overall Study|Clinical Disease Progression|3
1193348|NCT00687596|2353747|FG000|Overall Study|Investigator Discretion|3
1193349|NCT00687596|2353748|FG001|Overall Study|Investigator Discretion|1
1193350|NCT00687596|2353747|FG000|Overall Study|Sponsor Terminated Study|6
1193351|NCT00687596|2353748|FG001|Overall Study|Sponsor Terminated Study|17
1193352|NCT00458536|2353754|FG000|Overall Study|Disease progression prior to treatment|7
1193353|NCT00458536|2353754|FG000|Overall Study|Unable to make vaccine|3
1193354|NCT00458536|2353754|FG000|Overall Study|No measurable disease after surgery|2
1193355|NCT00458536|2353754|FG000|Overall Study|Did not have renal cell carcinoma|2
1193356|NCT00458536|2353754|FG000|Overall Study|Patient did not have surgery|1
1193357|NCT00458536|2353754|FG000|Overall Study|Ineligible due to toxicity|1
1193358|NCT00458536|2353754|FG000|Overall Study|Withdrawal by Subject|1
1193359|NCT00458536|2353754|FG000|Overall Study|Progressive disease during treatment|2
1193360|NCT00112840|2353761|FG000|Overall Study|Physician Decision|1
1193361|NCT00112840|2353762|FG001|Overall Study|Physician Decision|0
1193362|NCT00112840|2353763|FG002|Overall Study|Physician Decision|0
1193363|NCT00112840|2353761|FG000|Overall Study|Withdrawal by Subject|1
1193364|NCT00112840|2353762|FG001|Overall Study|Withdrawal by Subject|0
1193365|NCT00112840|2353763|FG002|Overall Study|Withdrawal by Subject|1
1193366|NCT00112840|2353761|FG000|Overall Study|Protocol Violation|0
1193367|NCT00112840|2353762|FG001|Overall Study|Protocol Violation|0
1193368|NCT00112840|2353763|FG002|Overall Study|Protocol Violation|5
883128|NCT00608829|1848652|FG000|Overall Study|Subject refuses to follow up or return.|5
883129|NCT00608842|1848660|FG000|Overall Study|Participant's Request|0
883130|NCT00608842|1848661|FG001|Overall Study|Participant's Request|1
883131|NCT00608842|1848662|FG002|Overall Study|Participant's Request|2
883132|NCT00608842|1848663|FG003|Overall Study|Participant's Request|1
883133|NCT00608842|1848660|FG000|Overall Study|Lost to Follow-up|1
883134|NCT00608842|1848661|FG001|Overall Study|Lost to Follow-up|0
883135|NCT00608842|1848662|FG002|Overall Study|Lost to Follow-up|0
883136|NCT00608842|1848663|FG003|Overall Study|Lost to Follow-up|0
883137|NCT00608868|1848673|FG000|Overall Study|Withdrawal by Subject|7
883138|NCT00608868|1848673|FG000|Overall Study|Protocol Violation|3
883139|NCT00608868|1848673|FG000|Overall Study|Lost to Follow-up|2
883140|NCT00608868|1848673|FG000|Overall Study|Adverse Event|1
883141|NCT00608868|1848673|FG000|Overall Study|Physician Decision|2
883142|NCT00608881|1848679|FG000|Overall Study|Death|22
883143|NCT00608881|1848680|FG001|Overall Study|Death|13
883144|NCT00608881|1848679|FG000|Overall Study|Adverse Event|5
883145|NCT00608881|1848680|FG001|Overall Study|Adverse Event|3
883146|NCT00608881|1848679|FG000|Overall Study|Lost to Follow-up|28
883147|NCT00608881|1848680|FG001|Overall Study|Lost to Follow-up|14
883148|NCT00608881|1848679|FG000|Overall Study|Withdrawal by Subject|18
883149|NCT00608881|1848680|FG001|Overall Study|Withdrawal by Subject|29
883150|NCT00608881|1848679|FG000|Overall Study|Physician Decision|5
883151|NCT00608881|1848680|FG001|Overall Study|Physician Decision|5
883152|NCT00608881|1848679|FG000|Overall Study|Institutionalized|1
883153|NCT00608881|1848680|FG001|Overall Study|Institutionalized|2
883154|NCT00608894|1848688|FG000|Overall Study|Withdrawal by Subject|0
883155|NCT00608894|1848689|FG001|Overall Study|Withdrawal by Subject|2
883156|NCT00608907|1848700|FG000|Overall Study|Adverse Event|6
883157|NCT00608907|1848701|FG001|Overall Study|Adverse Event|0
883158|NCT00608907|1848702|FG002|Overall Study|Adverse Event|1
883159|NCT00608907|1848700|FG000|Overall Study|Death|1
883160|NCT00608907|1848701|FG001|Overall Study|Death|0
883161|NCT00608907|1848702|FG002|Overall Study|Death|0
883162|NCT00608907|1848700|FG000|Overall Study|Withdrawal by Subject|4
883163|NCT00608907|1848701|FG001|Overall Study|Withdrawal by Subject|0
883164|NCT00608907|1848702|FG002|Overall Study|Withdrawal by Subject|0
883165|NCT00608907|1848700|FG000|Overall Study|Progressive Disease|1
883166|NCT00608907|1848701|FG001|Overall Study|Progressive Disease|0
883167|NCT00608907|1848702|FG002|Overall Study|Progressive Disease|0
883168|NCT00608959|1848712|FG000|Part 1|Did not meet eligibility criteria|1
883169|NCT00608985|1848726|FG000|Overall Study|Adverse Event|2
883170|NCT00608985|1848727|FG001|Overall Study|Adverse Event|7
883171|NCT00608985|1848728|FG002|Overall Study|Adverse Event|4
883172|NCT00608985|1848729|FG003|Overall Study|Adverse Event|6
883173|NCT00608985|1848726|FG000|Overall Study|Administrative/Other|7
883174|NCT00608985|1848727|FG001|Overall Study|Administrative/Other|4
883175|NCT00608985|1848728|FG002|Overall Study|Administrative/Other|1
883176|NCT00608985|1848729|FG003|Overall Study|Administrative/Other|2
883177|NCT00608985|1848726|FG000|Overall Study|Withdrawal of Consent|5
883178|NCT00608985|1848727|FG001|Overall Study|Withdrawal of Consent|1
883179|NCT00608985|1848728|FG002|Overall Study|Withdrawal of Consent|1
883180|NCT00608985|1848729|FG003|Overall Study|Withdrawal of Consent|1
883181|NCT00608985|1848726|FG000|Overall Study|Lost to Follow-up|2
883182|NCT00608985|1848727|FG001|Overall Study|Lost to Follow-up|1
883183|NCT00608985|1848728|FG002|Overall Study|Lost to Follow-up|0
883184|NCT00608985|1848729|FG003|Overall Study|Lost to Follow-up|0
883185|NCT00609167|1848746|FG000|Overall Study|Withdrawal by Subject|1
883186|NCT00609167|1848747|FG001|Overall Study|Withdrawal by Subject|0
883187|NCT00609167|1848746|FG000|Overall Study|Lack of Efficacy|1
883188|NCT00609167|1848747|FG001|Overall Study|Lack of Efficacy|0
883189|NCT00609167|1848746|FG000|Overall Study|Adverse Event|5
883190|NCT00609167|1848747|FG001|Overall Study|Adverse Event|1
883191|NCT00609167|1848746|FG000|Overall Study|Disease Progression|1
883192|NCT00609167|1848747|FG001|Overall Study|Disease Progression|0
883193|NCT00609167|1848746|FG000|Overall Study|Stem Cell Transplant|0
883194|NCT00609167|1848747|FG001|Overall Study|Stem Cell Transplant|6
883195|NCT00609245|1848753|FG000|Overall Study|Adverse Event|1
883196|NCT00609336|1848768|FG000|Overall Study|Protocol Violation|3
883197|NCT00609336|1848768|FG000|Overall Study|Death|1
883198|NCT00609336|1848768|FG000|Overall Study|LA or Met at Surgery|9
883199|NCT00609362|1848775|FG000|Overall Study|Withdrawal by Subject|2
883200|NCT00609362|1848776|FG001|Overall Study|Withdrawal by Subject|1
883201|NCT00609362|1848775|FG000|Overall Study|Adverse Event|1
883202|NCT00609362|1848776|FG001|Overall Study|Adverse Event|0
883203|NCT00609466|1848785|FG000|Overall Study|Withdrawal by Subject|0
883204|NCT00609466|1848786|FG001|Overall Study|Withdrawal by Subject|1
883205|NCT00609466|1848787|FG002|Overall Study|Withdrawal by Subject|1
883206|NCT00609466|1848785|FG000|Overall Study|Adverse Event|2
883207|NCT00609466|1848786|FG001|Overall Study|Adverse Event|3
883208|NCT00609466|1848787|FG002|Overall Study|Adverse Event|1
883209|NCT00609466|1848785|FG000|Overall Study|Lack of Efficacy|0
883210|NCT00609466|1848786|FG001|Overall Study|Lack of Efficacy|2
883211|NCT00609466|1848787|FG002|Overall Study|Lack of Efficacy|2
883212|NCT00609492|1848798|FG000|Overall Study|Withdrawal by Subject|0
883213|NCT00609492|1848799|FG001|Overall Study|Withdrawal by Subject|2
883214|NCT00609492|1848800|FG002|Overall Study|Withdrawal by Subject|3
883215|NCT00609492|1848798|FG000|Overall Study|Lost to Follow-up|1
883216|NCT00609492|1848799|FG001|Overall Study|Lost to Follow-up|1
883217|NCT00609492|1848800|FG002|Overall Study|Lost to Follow-up|4
883218|NCT00609518|1848812|FG000|Overall Study|Death from Study Disease|32
883219|NCT00609518|1848813|FG001|Overall Study|Death from Study Disease|32
883220|NCT00609518|1848812|FG000|Overall Study|Withdrawal by Subject|5
883221|NCT00609518|1848813|FG001|Overall Study|Withdrawal by Subject|3
883222|NCT00609518|1848812|FG000|Overall Study|Lost to Follow-up|3
883223|NCT00609518|1848813|FG001|Overall Study|Lost to Follow-up|0
883224|NCT00609518|1848812|FG000|Overall Study|Physician Decision|1
883225|NCT00609518|1848813|FG001|Overall Study|Physician Decision|3
883226|NCT00609518|1848812|FG000|Overall Study|Death from Adverse Event|2
883227|NCT00609518|1848813|FG001|Overall Study|Death from Adverse Event|2
883228|NCT00609609|1848821|FG000|Overall Study|Withdrawal by Subject|2
883229|NCT00609609|1848822|FG001|Overall Study|Withdrawal by Subject|0
883230|NCT00609609|1848821|FG000|Overall Study|Progression|4
883231|NCT00609609|1848822|FG001|Overall Study|Progression|2
883232|NCT00609622|1848830|FG000|Overall Study|Adverse Event|14
883233|NCT00609622|1848831|FG001|Overall Study|Adverse Event|10
883234|NCT00609622|1848830|FG000|Overall Study|Withdrawal by Subject|4
883235|NCT00609622|1848831|FG001|Overall Study|Withdrawal by Subject|20
883236|NCT00609622|1848830|FG000|Overall Study|Death|1
883237|NCT00609622|1848831|FG001|Overall Study|Death|4
883238|NCT00609622|1848830|FG000|Overall Study|Protocol Violation|1
883239|NCT00609622|1848831|FG001|Overall Study|Protocol Violation|1
883240|NCT00609622|1848830|FG000|Overall Study|Objective progression or relapse|47
883241|NCT00609622|1848831|FG001|Overall Study|Objective progression or relapse|41
883242|NCT00609622|1848830|FG000|Overall Study|Study terminated by sponsor|16
883243|NCT00609622|1848831|FG001|Overall Study|Study terminated by sponsor|3
883244|NCT00609622|1848830|FG000|Overall Study|Other|7
883245|NCT00609622|1848831|FG001|Overall Study|Other|14
883246|NCT00609622|1848830|FG000|Overall Study|Global deterioration of health status|6
883247|NCT00609622|1848831|FG001|Overall Study|Global deterioration of health status|2
883248|NCT00609674|1848839|FG000|Overall Study|Adverse Event|1
883249|NCT00609674|1848840|FG001|Overall Study|Adverse Event|1
883250|NCT00609674|1848839|FG000|Overall Study|Protocol Violation|3
883251|NCT00609674|1848840|FG001|Overall Study|Protocol Violation|5
883252|NCT00609674|1848839|FG000|Overall Study|Lost to Follow-up|1
883253|NCT00609674|1848840|FG001|Overall Study|Lost to Follow-up|0
883254|NCT00609674|1848839|FG000|Overall Study|Withdrew consent|2
883255|NCT00609674|1848840|FG001|Overall Study|Withdrew consent|1
883256|NCT00609869|1848862|FG000|Overall Study|Withdrawn, ischemic stroke|1
883257|NCT00609869|1848862|FG000|Overall Study|Severe hematologic toxicity|1
883258|NCT00609869|1848862|FG000|Overall Study|Withdrawal by Subject|1
883259|NCT00609869|1848862|FG000|Overall Study|Seizures|1
883260|NCT00609869|1848862|FG000|Overall Study|Severe tumor flare reaction|1
883261|NCT00609869|1848862|FG000|Overall Study|Hepatitis B infection|1
883262|NCT00609869|1848862|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1
883263|NCT00609869|1848862|FG000|Overall Study|Mantle cell: not evaluable|4
883264|NCT00609947|1848866|FG000|Overall Study|Death|1
883265|NCT00609973|1848873|FG000|Overall Study|Adverse Event|2
883266|NCT00609973|1848874|FG001|Overall Study|Adverse Event|1
883267|NCT00609973|1848873|FG000|Overall Study|Protocol Violation|4
883268|NCT00609973|1848874|FG001|Overall Study|Protocol Violation|3
883269|NCT00609973|1848873|FG000|Overall Study|Lost to Follow-up|2
883270|NCT00609973|1848874|FG001|Overall Study|Lost to Follow-up|1
883271|NCT00609973|1848873|FG000|Overall Study|Withdrawal by Subject|0
883272|NCT00609973|1848874|FG001|Overall Study|Withdrawal by Subject|1
883273|NCT00609986|1848882|FG000|Overall Study|Did not receive transplant or treatment|8
883274|NCT00609986|1848883|FG001|Overall Study|Did not receive transplant or treatment|3
883275|NCT00610129|1848893|FG000|Overall Study|Not treated since patients ineligible|3
883276|NCT00610155|1848897|FG000|Period 1|Withdrawal by Subject|0
883277|NCT00610155|1848898|FG001|Period 1|Withdrawal by Subject|0
883278|NCT00610155|1848899|FG002|Period 1|Withdrawal by Subject|1
883279|NCT00610155|1848900|FG003|Period 1|Withdrawal by Subject|0
883280|NCT00610155|1848901|FG004|Period 1|Withdrawal by Subject|0
883281|NCT00610155|1848902|FG005|Period 1|Withdrawal by Subject|0
883282|NCT00610155|1848897|FG000|Period 3|Adverse Event|1
883283|NCT00610155|1848898|FG001|Period 3|Adverse Event|0
883284|NCT00610155|1848899|FG002|Period 3|Adverse Event|0
883285|NCT00610155|1848900|FG003|Period 3|Adverse Event|0
883286|NCT00610155|1848901|FG004|Period 3|Adverse Event|0
883287|NCT00610155|1848902|FG005|Period 3|Adverse Event|0
883288|NCT00610168|1848912|FG000|Overall Study|Withdrawal by Subject|2
883289|NCT00610168|1848913|FG001|Overall Study|Withdrawal by Subject|0
883290|NCT00610207|1848919|FG000|Overall Study|Lost to Follow-up|3
883291|NCT00610363|1848929|FG000|Overall Study|Non-compliance with protocol|0
883292|NCT00610363|1848930|FG001|Overall Study|Non-compliance with protocol|1
883293|NCT00610363|1848929|FG000|Overall Study|Adverse Event|3
883294|NCT00610363|1848930|FG001|Overall Study|Adverse Event|1
883295|NCT00610363|1848929|FG000|Overall Study|Lack of Efficacy|2
883296|NCT00610363|1848930|FG001|Overall Study|Lack of Efficacy|0
883297|NCT00610363|1848929|FG000|Overall Study|Lost to Follow-up|4
883298|NCT00610363|1848930|FG001|Overall Study|Lost to Follow-up|0
883299|NCT00610363|1848929|FG000|Overall Study|Withdrawal by Subject|1
883300|NCT00610363|1848930|FG001|Overall Study|Withdrawal by Subject|0
883301|NCT00610363|1848929|FG000|Overall Study|Other than specified above|1
883302|NCT00610363|1848930|FG001|Overall Study|Other than specified above|1
883303|NCT00610441|1848954|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1
883304|NCT00610441|1848955|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1
883305|NCT00610441|1848956|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4
883306|NCT00610441|1848957|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1
883307|NCT00610441|1848954|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
883308|NCT00610441|1848955|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
883309|NCT00610441|1848956|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
883310|NCT00610441|1848957|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
883311|NCT00610441|1848954|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
883312|NCT00610441|1848955|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
883313|NCT00610441|1848956|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
883314|NCT00610441|1848957|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
883315|NCT00610441|1848954|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
883316|NCT00610441|1848955|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
883317|NCT00610441|1848956|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
883318|NCT00610441|1848957|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
883319|NCT00610441|1848954|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0
883320|NCT00610441|1848955|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0
883321|NCT00610441|1848956|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2
883322|NCT00610441|1848957|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0
883323|NCT00610441|1848954|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
883324|NCT00610441|1848955|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
883325|NCT00610441|1848956|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
883326|NCT00610441|1848957|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
883327|NCT00610441|1848954|FG000|Treatment Period 2 - 3 Weeks|Other|1
883328|NCT00610441|1848955|FG001|Treatment Period 2 - 3 Weeks|Other|1
883329|NCT00610441|1848956|FG002|Treatment Period 2 - 3 Weeks|Other|0
883330|NCT00610441|1848957|FG003|Treatment Period 2 - 3 Weeks|Other|1
883331|NCT00610441|1848954|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0
883332|NCT00610441|1848955|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0
883333|NCT00610441|1848956|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0
883334|NCT00610441|1848957|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1
883335|NCT00610441|1848954|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
883336|NCT00610441|1848955|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
883337|NCT00610441|1848956|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
883338|NCT00610441|1848957|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
883339|NCT00610649|1848989|FG000|Overall Study|Adverse Event|1
883340|NCT00610649|1848990|FG001|Overall Study|Adverse Event|0
883341|NCT00610649|1848991|FG002|Overall Study|Adverse Event|0
883342|NCT00610649|1848992|FG003|Overall Study|Adverse Event|0
883343|NCT00610649|1848993|FG004|Overall Study|Adverse Event|0
883344|NCT00610649|1848994|FG005|Overall Study|Adverse Event|0
883345|NCT00610649|1848995|FG006|Overall Study|Adverse Event|0
883346|NCT00610649|1848996|FG007|Overall Study|Adverse Event|0
883347|NCT00610649|1848997|FG008|Overall Study|Adverse Event|0
883348|NCT00610649|1848998|FG009|Overall Study|Adverse Event|0
883349|NCT00610649|1848999|FG010|Overall Study|Adverse Event|1
883350|NCT00610649|1848989|FG000|Overall Study|Family Emergency|0
883351|NCT00610649|1848990|FG001|Overall Study|Family Emergency|1
883352|NCT00610649|1848991|FG002|Overall Study|Family Emergency|0
883353|NCT00610649|1848992|FG003|Overall Study|Family Emergency|0
883354|NCT00610649|1848993|FG004|Overall Study|Family Emergency|0
883355|NCT00610649|1848994|FG005|Overall Study|Family Emergency|0
883356|NCT00610649|1848995|FG006|Overall Study|Family Emergency|0
883357|NCT00610649|1848996|FG007|Overall Study|Family Emergency|0
883358|NCT00610649|1848997|FG008|Overall Study|Family Emergency|0
883359|NCT00610649|1848998|FG009|Overall Study|Family Emergency|0
883360|NCT00610649|1848999|FG010|Overall Study|Family Emergency|0
883361|NCT00610649|1848989|FG000|Overall Study|Withdrawal by Subject|0
883362|NCT00610649|1848990|FG001|Overall Study|Withdrawal by Subject|0
883363|NCT00610649|1848991|FG002|Overall Study|Withdrawal by Subject|0
883364|NCT00610649|1848992|FG003|Overall Study|Withdrawal by Subject|0
883365|NCT00610649|1848993|FG004|Overall Study|Withdrawal by Subject|0
883366|NCT00610649|1848994|FG005|Overall Study|Withdrawal by Subject|0
883367|NCT00610649|1848995|FG006|Overall Study|Withdrawal by Subject|0
883368|NCT00610649|1848996|FG007|Overall Study|Withdrawal by Subject|0
883369|NCT00610649|1848997|FG008|Overall Study|Withdrawal by Subject|0
883370|NCT00610649|1848998|FG009|Overall Study|Withdrawal by Subject|1
883371|NCT00610649|1848999|FG010|Overall Study|Withdrawal by Subject|0
883372|NCT00610675|1849023|FG000|Overall Study|Untreated|4
883373|NCT00610675|1849023|FG000|Overall Study|Adverse Event|67
883374|NCT00610675|1849023|FG000|Overall Study|Insufficient Effect|31
883375|NCT00610675|1849023|FG000|Overall Study|Withdrawal by Subject|28
883376|NCT00610675|1849023|FG000|Overall Study|Reasons unrelated to trial|27
883377|NCT00610675|1849023|FG000|Overall Study|Lack of Compliance|7
883378|NCT00610675|1849023|FG000|Overall Study|Lost to Follow-up|31
883379|NCT00610675|1849023|FG000|Overall Study|Other reason (not specified)|25
883380|NCT00610714|1849051|FG000|Overall Study|Adverse Event|3
883381|NCT00610714|1849052|FG001|Overall Study|Adverse Event|1
883382|NCT00610714|1849051|FG000|Overall Study|Death|12
883383|NCT00610714|1849052|FG001|Overall Study|Death|18
883384|NCT00610714|1849051|FG000|Overall Study|Withdrawal by Subject|9
883385|NCT00610714|1849052|FG001|Overall Study|Withdrawal by Subject|3
883386|NCT00610714|1849051|FG000|Overall Study|Study completion at 120 PFS events|2
883387|NCT00610714|1849052|FG001|Overall Study|Study completion at 120 PFS events|2
883388|NCT00610857|1849091|FG000|Overall Study|Not evaluable for response|2
883389|NCT00610935|1849101|FG000|Overall Study|Lost to Follow-up|0
883390|NCT00610935|1849102|FG001|Overall Study|Lost to Follow-up|1
883391|NCT00610935|1849101|FG000|Overall Study|Withdrawal by Subject|0
883392|NCT00610935|1849102|FG001|Overall Study|Withdrawal by Subject|2
883393|NCT00610935|1849101|FG000|Overall Study|Sponsor Discontinuation|1
883394|NCT00610935|1849102|FG001|Overall Study|Sponsor Discontinuation|0
883395|NCT00611026|1849120|FG000|Randomized to Double-blind Treatment|Not treated|2
883396|NCT00611026|1849121|FG001|Randomized to Double-blind Treatment|Not treated|1
883397|NCT00611026|1849122|FG002|Randomized to Double-blind Treatment|Not treated|3
883398|NCT00611026|1849120|FG000|Double-blind Treatment Period|Death|1
883399|NCT00611026|1849121|FG001|Double-blind Treatment Period|Death|0
883400|NCT00611026|1849122|FG002|Double-blind Treatment Period|Death|0
883401|NCT00611026|1849120|FG000|Double-blind Treatment Period|Adverse Event|9
883402|NCT00611026|1849121|FG001|Double-blind Treatment Period|Adverse Event|28
883403|NCT00611026|1849122|FG002|Double-blind Treatment Period|Adverse Event|46
883404|NCT00611026|1849120|FG000|Double-blind Treatment Period|Lack of Efficacy|11
883405|NCT00611026|1849121|FG001|Double-blind Treatment Period|Lack of Efficacy|10
883406|NCT00611026|1849122|FG002|Double-blind Treatment Period|Lack of Efficacy|4
883407|NCT00611026|1849120|FG000|Double-blind Treatment Period|Lost to Follow-up|6
883408|NCT00611026|1849121|FG001|Double-blind Treatment Period|Lost to Follow-up|11
883409|NCT00611026|1849122|FG002|Double-blind Treatment Period|Lost to Follow-up|14
883410|NCT00611026|1849120|FG000|Double-blind Treatment Period|Withdrawal by Subject|7
883411|NCT00611026|1849121|FG001|Double-blind Treatment Period|Withdrawal by Subject|19
883412|NCT00611026|1849122|FG002|Double-blind Treatment Period|Withdrawal by Subject|16
883413|NCT00611026|1849120|FG000|Double-blind Treatment Period|Other|13
883414|NCT00611026|1849121|FG001|Double-blind Treatment Period|Other|20
883415|NCT00611026|1849122|FG002|Double-blind Treatment Period|Other|18
883416|NCT00611130|1849134|FG000|Overall Study|Lost to Follow-up|25
883417|NCT00611130|1849135|FG001|Overall Study|Lost to Follow-up|29
883418|NCT00611130|1849134|FG000|Overall Study|Protocol noncompliance|7
883419|NCT00611130|1849135|FG001|Overall Study|Protocol noncompliance|6
883420|NCT00611130|1849134|FG000|Overall Study|Withdrawal by Subject|6
883421|NCT00611130|1849135|FG001|Overall Study|Withdrawal by Subject|5
883422|NCT00611130|1849134|FG000|Overall Study|Other|5
883423|NCT00611130|1849135|FG001|Overall Study|Other|4
883424|NCT00611130|1849134|FG000|Overall Study|Incarceration|3
883425|NCT00611130|1849135|FG001|Overall Study|Incarceration|2
883426|NCT00611130|1849134|FG000|Overall Study|Administrative|1
883427|NCT00611130|1849135|FG001|Overall Study|Administrative|1
883428|NCT00611130|1849134|FG000|Overall Study|Adverse Event|1
883429|NCT00611130|1849135|FG001|Overall Study|Adverse Event|0
883430|NCT00611130|1849134|FG000|Overall Study|Death|1
883431|NCT00611130|1849135|FG001|Overall Study|Death|0
883432|NCT00611247|1849144|FG000|Overall Study|Death|1
883433|NCT00611247|1849145|FG001|Overall Study|Death|5
883434|NCT00611247|1849144|FG000|Overall Study|Lack of Efficacy|1
883435|NCT00611247|1849145|FG001|Overall Study|Lack of Efficacy|16
883436|NCT00611455|1849185|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2
883437|NCT00611455|1849186|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8
883438|NCT00611455|1849187|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
883439|NCT00611455|1849185|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
883440|NCT00611455|1849186|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
883441|NCT00611455|1849187|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
883442|NCT00611455|1849185|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4
883443|NCT00611455|1849186|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1
883444|NCT00611455|1849187|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
883445|NCT00611455|1849185|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
883446|NCT00611455|1849186|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
883447|NCT00611455|1849187|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
883448|NCT00611455|1849185|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
883449|NCT00611455|1849186|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
883450|NCT00611455|1849187|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
883451|NCT00611455|1849185|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
883452|NCT00611455|1849186|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
883453|NCT00611455|1849187|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
883454|NCT00611455|1849185|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
883455|NCT00611455|1849186|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17
883456|NCT00611455|1849187|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
883457|NCT00611455|1849185|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
883458|NCT00611455|1849186|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
883459|NCT00611455|1849187|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
883460|NCT00611455|1849185|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
883461|NCT00611455|1849186|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3
883462|NCT00611455|1849187|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
883463|NCT00611455|1849185|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
883464|NCT00611455|1849186|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
883465|NCT00611455|1849187|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
883466|NCT00611455|1849185|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
883467|NCT00611455|1849186|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
883468|NCT00611455|1849187|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
883469|NCT00611455|1849185|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
883470|NCT00611455|1849186|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
883471|NCT00611455|1849187|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
883472|NCT00611455|1849185|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
883473|NCT00611455|1849186|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5
883474|NCT00611455|1849187|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
883475|NCT00611455|1849185|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
883476|NCT00611455|1849186|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
883477|NCT00611455|1849187|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
883478|NCT00611455|1849185|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0
883479|NCT00611455|1849186|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0
883480|NCT00611455|1849187|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30
883481|NCT00611455|1849185|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
883482|NCT00611455|1849186|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
883483|NCT00611455|1849187|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
883484|NCT00611455|1849185|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
883485|NCT00611455|1849186|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
883486|NCT00611455|1849187|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
883487|NCT00611455|1849185|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
883488|NCT00611455|1849186|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
883489|NCT00611455|1849187|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
883490|NCT00611455|1849185|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
883491|NCT00611455|1849186|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
883492|NCT00611455|1849187|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
883493|NCT00611455|1849185|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
883494|NCT00611455|1849186|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
883495|NCT00611455|1849187|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
883496|NCT00611455|1849185|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
883497|NCT00611455|1849186|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
883498|NCT00611455|1849187|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
883499|NCT00611533|1849204|FG000|First Intervention (6 Weeks)|Never started study|0
883500|NCT00611533|1849205|FG001|First Intervention (6 Weeks)|Never started study|1
883501|NCT00611533|1849204|FG000|First Intervention (6 Weeks)|Adverse Event|0
883502|NCT00611533|1849205|FG001|First Intervention (6 Weeks)|Adverse Event|1
883503|NCT00611533|1849204|FG000|Second Intervention (6 Weeks)|Adverse Event|0
883504|NCT00611533|1849205|FG001|Second Intervention (6 Weeks)|Adverse Event|2
883505|NCT00611559|1849215|FG000|Overall Study|Lost to Follow-up|0
883506|NCT00611559|1849216|FG001|Overall Study|Lost to Follow-up|1
883507|NCT00611559|1849217|FG002|Overall Study|Lost to Follow-up|0
883508|NCT00611559|1849215|FG000|Overall Study|Protocol Violation|1
883509|NCT00611559|1849216|FG001|Overall Study|Protocol Violation|0
883510|NCT00611559|1849217|FG002|Overall Study|Protocol Violation|1
883511|NCT00611715|1849232|FG000|Overall Study|Disease Progression|24
883512|NCT00611715|1849233|FG001|Overall Study|Disease Progression|4
883513|NCT00611715|1849232|FG000|Overall Study|Withdrawal by Subject|5
883514|NCT00611715|1849233|FG001|Overall Study|Withdrawal by Subject|1
883515|NCT00611715|1849232|FG000|Overall Study|Adverse Event|9
883516|NCT00611715|1849233|FG001|Overall Study|Adverse Event|1
883517|NCT00611715|1849232|FG000|Overall Study|Death|1
883518|NCT00611715|1849233|FG001|Overall Study|Death|0
883519|NCT00611715|1849232|FG000|Overall Study|two patients are still on treatment|2
883520|NCT00611715|1849233|FG001|Overall Study|two patients are still on treatment|0
883521|NCT00611767|1849247|FG000|Overall Study|Withdrawal by Subject|4
883522|NCT00611767|1849248|FG001|Overall Study|Withdrawal by Subject|1
883523|NCT00611767|1849247|FG000|Overall Study|Thiopental not available|3
883524|NCT00611767|1849248|FG001|Overall Study|Thiopental not available|0
883525|NCT00611767|1849247|FG000|Overall Study|didn't like the medication|1
883526|NCT00611767|1849248|FG001|Overall Study|didn't like the medication|1
883527|NCT00611767|1849247|FG000|Overall Study|Physician Decision|1
883528|NCT00611767|1849248|FG001|Overall Study|Physician Decision|0
883529|NCT00611806|1849256|FG000|Overall Study|Withdrawal by Subject|8
883530|NCT00611806|1849257|FG001|Overall Study|Withdrawal by Subject|2
883531|NCT00611806|1849256|FG000|Overall Study|Adverse Event|2
883532|NCT00611806|1849257|FG001|Overall Study|Adverse Event|1
883533|NCT00611806|1849256|FG000|Overall Study|Lost to Follow-up|6
883534|NCT00611806|1849257|FG001|Overall Study|Lost to Follow-up|0
883535|NCT00611858|1849263|FG000|Overall Study|Adverse Event|2
883536|NCT00611858|1849263|FG000|Overall Study|Withdrawal by Subject|2
883537|NCT00611884|1849273|FG000|Overall Study|Adverse Event|1
883538|NCT00611884|1849274|FG001|Overall Study|Adverse Event|0
883539|NCT00611884|1849275|FG002|Overall Study|Adverse Event|0
883540|NCT00611884|1849276|FG003|Overall Study|Adverse Event|1
883541|NCT00611884|1849273|FG000|Overall Study|Non-Compliance|1
883542|NCT00611884|1849274|FG001|Overall Study|Non-Compliance|4
883543|NCT00611884|1849275|FG002|Overall Study|Non-Compliance|2
883544|NCT00611884|1849276|FG003|Overall Study|Non-Compliance|2
883545|NCT00611884|1849273|FG000|Overall Study|Lack of Efficacy|0
883546|NCT00611884|1849274|FG001|Overall Study|Lack of Efficacy|1
883547|NCT00611884|1849275|FG002|Overall Study|Lack of Efficacy|0
883548|NCT00611884|1849276|FG003|Overall Study|Lack of Efficacy|0
883549|NCT00611884|1849273|FG000|Overall Study|Unclassified|7
883550|NCT00611884|1849274|FG001|Overall Study|Unclassified|4
883551|NCT00611884|1849275|FG002|Overall Study|Unclassified|2
883552|NCT00611884|1849276|FG003|Overall Study|Unclassified|3
883553|NCT00611923|1849297|FG000|Overall Study|Withdrawal by Subject|2
883554|NCT00611923|1849298|FG001|Overall Study|Withdrawal by Subject|2
883555|NCT00611975|1849308|FG000|Overall Study|Withdrawal by Subject|3
883556|NCT00611975|1849309|FG001|Overall Study|Withdrawal by Subject|7
883557|NCT00611975|1849308|FG000|Overall Study|Pregnancy|2
883558|NCT00611975|1849309|FG001|Overall Study|Pregnancy|1
883559|NCT00612040|1849318|FG000|Overall Study|Adverse Event|0
883560|NCT00612040|1849319|FG001|Overall Study|Adverse Event|2
883561|NCT00612040|1849320|FG002|Overall Study|Adverse Event|1
883562|NCT00612040|1849318|FG000|Overall Study|Protocol Violation|1
883563|NCT00612040|1849319|FG001|Overall Study|Protocol Violation|2
883564|NCT00612040|1849320|FG002|Overall Study|Protocol Violation|1
883565|NCT00612040|1849318|FG000|Overall Study|Lack of Efficacy|2
883566|NCT00612040|1849319|FG001|Overall Study|Lack of Efficacy|1
883567|NCT00612040|1849320|FG002|Overall Study|Lack of Efficacy|0
883568|NCT00612040|1849318|FG000|Overall Study|Unclassified|2
883569|NCT00612040|1849319|FG001|Overall Study|Unclassified|2
883570|NCT00612040|1849320|FG002|Overall Study|Unclassified|5
883571|NCT00612066|1849328|FG000|Overall Study|Adverse Event|1
883572|NCT00612105|1849334|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18
883573|NCT00612105|1849335|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1
883574|NCT00612105|1849334|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
883575|NCT00612105|1849335|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
883576|NCT00612105|1849334|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
883577|NCT00612105|1849335|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
883578|NCT00612105|1849334|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1
883579|NCT00612105|1849335|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1
883580|NCT00612105|1849334|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
883581|NCT00612105|1849335|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
883582|NCT00612105|1849334|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
883583|NCT00612105|1849335|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
883584|NCT00612105|1849334|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
883585|NCT00612105|1849335|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
883586|NCT00612105|1849334|FG000|Period Title 1: 6-Week Titration Phase|Other|0
883587|NCT00612105|1849335|FG001|Period Title 1: 6-Week Titration Phase|Other|1
883588|NCT00612105|1849334|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
883589|NCT00612105|1849335|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
883590|NCT00612105|1849334|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
883591|NCT00612105|1849335|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
883592|NCT00612105|1849334|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
883593|NCT00612105|1849335|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
883594|NCT00612105|1849334|FG000|Period Title 3: 3-Week Taper Phase|Other|1
883595|NCT00612105|1849335|FG001|Period Title 3: 3-Week Taper Phase|Other|0
883596|NCT00612313|1849365|FG000|Overall Study|Withdrawal by Subject|6
883597|NCT00612313|1849366|FG001|Overall Study|Withdrawal by Subject|9
883598|NCT00612313|1849365|FG000|Overall Study|Lost to Follow-up|11
883599|NCT00612313|1849366|FG001|Overall Study|Lost to Follow-up|4
883600|NCT00612352|1849384|FG000|Overall Study|Adverse Event|1
883601|NCT00612352|1849385|FG001|Overall Study|Adverse Event|0
883602|NCT00612352|1849384|FG000|Overall Study|Withdrawal by Subject|3
883603|NCT00612352|1849385|FG001|Overall Study|Withdrawal by Subject|5
883604|NCT00612352|1849384|FG000|Overall Study|moved out of state|1
883605|NCT00612352|1849385|FG001|Overall Study|moved out of state|0
883606|NCT00612352|1849384|FG000|Overall Study|didn't return calls/show up on test date|4
883607|NCT00612352|1849385|FG001|Overall Study|didn't return calls/show up on test date|1
883608|NCT00612456|1849405|FG000|Overall Study|Adverse Event|1
883609|NCT00612456|1849406|FG001|Overall Study|Adverse Event|0
883610|NCT00612456|1849407|FG002|Overall Study|Adverse Event|0
883611|NCT00612456|1849405|FG000|Overall Study|Lack of Efficacy|1
883612|NCT00612456|1849406|FG001|Overall Study|Lack of Efficacy|1
883613|NCT00612456|1849407|FG002|Overall Study|Lack of Efficacy|0
883614|NCT00612456|1849405|FG000|Overall Study|Withdrawal by Subject|0
883615|NCT00612456|1849406|FG001|Overall Study|Withdrawal by Subject|1
883616|NCT00612456|1849407|FG002|Overall Study|Withdrawal by Subject|0
883617|NCT00612508|1849419|FG000|Overall Study|Withdrawal by Subject|3
883618|NCT00612508|1849420|FG001|Overall Study|Withdrawal by Subject|4
883619|NCT00612534|1849432|FG000|Overall Study|Adverse Event|0
883620|NCT00612534|1849433|FG001|Overall Study|Adverse Event|4
883621|NCT00612534|1849434|FG002|Overall Study|Adverse Event|2
883622|NCT00612534|1849435|FG003|Overall Study|Adverse Event|1
883623|NCT00612534|1849432|FG000|Overall Study|Lack of Efficacy|13
883624|NCT00612534|1849433|FG001|Overall Study|Lack of Efficacy|12
883625|NCT00612534|1849434|FG002|Overall Study|Lack of Efficacy|5
883626|NCT00612534|1849435|FG003|Overall Study|Lack of Efficacy|16
883627|NCT00612534|1849432|FG000|Overall Study|Other Reason|0
883628|NCT00612534|1849433|FG001|Overall Study|Other Reason|1
883629|NCT00612534|1849434|FG002|Overall Study|Other Reason|0
883630|NCT00612534|1849435|FG003|Overall Study|Other Reason|0
883631|NCT00612586|1849481|FG000|Overall Study|Adverse Event|6
883632|NCT00612586|1849482|FG001|Overall Study|Adverse Event|2
883633|NCT00612586|1849481|FG000|Overall Study|Death|1
883634|NCT00612586|1849482|FG001|Overall Study|Death|0
883635|NCT00612586|1849481|FG000|Overall Study|Entry Criteria Not Met|0
883636|NCT00612586|1849482|FG001|Overall Study|Entry Criteria Not Met|2
883637|NCT00612586|1849481|FG000|Overall Study|Withdrawal by Subject|7
883638|NCT00612586|1849482|FG001|Overall Study|Withdrawal by Subject|9
883639|NCT00612586|1849481|FG000|Overall Study|Physician Decision|1
883640|NCT00612586|1849482|FG001|Overall Study|Physician Decision|2
883641|NCT00612586|1849481|FG000|Overall Study|Sponsor Decision|1
883642|NCT00612586|1849482|FG001|Overall Study|Sponsor Decision|1
883643|NCT00612586|1849481|FG000|Overall Study|Progressive Disease|26
883644|NCT00612586|1849482|FG001|Overall Study|Progressive Disease|24
883645|NCT00612586|1849481|FG000|Overall Study|Randomized and Not Treated|1
883646|NCT00612586|1849482|FG001|Overall Study|Randomized and Not Treated|1
883647|NCT00612690|1849491|FG000|Overall Study|Lost to Follow-up|72
883648|NCT00612690|1849492|FG001|Overall Study|Lost to Follow-up|98
883649|NCT00612690|1849491|FG000|Overall Study|Withdrawal by Subject|32
883650|NCT00612690|1849492|FG001|Overall Study|Withdrawal by Subject|20
883651|NCT00612690|1849491|FG000|Overall Study|Withdrawal by Site|11
883652|NCT00612690|1849492|FG001|Overall Study|Withdrawal by Site|0
883653|NCT00612807|1849531|FG000|Overall Study|Withdrawal by Subject|2
883654|NCT00612807|1849532|FG001|Overall Study|Withdrawal by Subject|0
883655|NCT00613015|1849554|FG000|Overall Study|Lost to Follow-up|0
883656|NCT00613015|1849555|FG001|Overall Study|Lost to Follow-up|1
883657|NCT00613015|1849556|FG002|Overall Study|Lost to Follow-up|3
883658|NCT00613015|1849557|FG003|Overall Study|Lost to Follow-up|3
883659|NCT00613015|1849558|FG004|Overall Study|Lost to Follow-up|2
883660|NCT00613015|1849559|FG005|Overall Study|Lost to Follow-up|3
883661|NCT00613080|1849582|FG000|Overall Study|Ineligible / no protocol treatment|11
883662|NCT00613106|1849588|FG000|Overall Study|Adverse Event|3
883663|NCT00613106|1849589|FG001|Overall Study|Adverse Event|1
883664|NCT00613106|1849588|FG000|Overall Study|Withdrawal by Subject|6
883665|NCT00613106|1849589|FG001|Overall Study|Withdrawal by Subject|3
883666|NCT00613106|1849588|FG000|Overall Study|Lost to Follow-up|7
883667|NCT00613106|1849589|FG001|Overall Study|Lost to Follow-up|2
883668|NCT00613106|1849588|FG000|Overall Study|misc|4
883669|NCT00613106|1849589|FG001|Overall Study|misc|3
883670|NCT00613171|1849595|FG000|Overall Study|Adverse Event|7
883671|NCT00613171|1849595|FG000|Overall Study|Withdrawal by Subject|3
883672|NCT00613171|1849595|FG000|Overall Study|Reason not Specified|4
883673|NCT00613301|1849600|FG000|Overall Study|Adverse Event|49
883674|NCT00613301|1849600|FG000|Overall Study|Lost to Follow-up|88
883675|NCT00613301|1849600|FG000|Overall Study|Withdrawal by Subject|5
883676|NCT00613301|1849600|FG000|Overall Study|Death|6
883677|NCT00613301|1849600|FG000|Overall Study|Lack of Efficacy|13
883678|NCT00613301|1849600|FG000|Overall Study|Physician Decision|2
883679|NCT00613301|1849600|FG000|Overall Study|No data was collected|53
883680|NCT00613301|1849600|FG000|Overall Study|Irregularly enrolled patients|12
883681|NCT00613314|1849605|FG000|Overall Study|Adverse Event|5
883682|NCT00613314|1849605|FG000|Overall Study|Protocol Violation|14
883683|NCT00613314|1849605|FG000|Overall Study|Lost to Follow-up|46
883684|NCT00613314|1849605|FG000|Overall Study|Other reason not defined above|90
883685|NCT00613327|1849609|FG000|Overall Study|Adverse Event|38
883686|NCT00613327|1849609|FG000|Overall Study|Lost to Follow-up|8
883687|NCT00613327|1849609|FG000|Overall Study|Withdrawal by Subject|6
883688|NCT00613327|1849609|FG000|Overall Study|Protocol Violation|2
883689|NCT00613327|1849609|FG000|Overall Study|Other|47
883690|NCT00613366|1849615|FG000|Overall Study|Withdrawal by Subject|3
883691|NCT00613366|1849616|FG001|Overall Study|Withdrawal by Subject|2
883692|NCT00613509|1849646|FG000|Cycle 1|Adverse Event|2
883693|NCT00613509|1849647|FG001|Cycle 1|Adverse Event|1
883694|NCT00613509|1849646|FG000|Cycle 1|Disease Progression|2
883695|NCT00613509|1849647|FG001|Cycle 1|Disease Progression|6
883696|NCT00613509|1849646|FG000|Cycle 1|Unacceptable Toxicity|1
883697|NCT00613509|1849647|FG001|Cycle 1|Unacceptable Toxicity|0
883698|NCT00613509|1849646|FG000|Cycle 1|Other administrative reason|0
883699|NCT00613509|1849647|FG001|Cycle 1|Other administrative reason|1
883700|NCT00613574|1849653|FG000|Overall Study|Adverse Event|3
883701|NCT00613574|1849653|FG000|Overall Study|Lost to Follow-up|2
883702|NCT00613574|1849653|FG000|Overall Study|Other|1
883703|NCT00613626|1849660|FG000|Overall Study|Ineligible|0
883704|NCT00613626|1849661|FG001|Overall Study|Ineligible|1
883705|NCT00613626|1849662|FG002|Overall Study|Ineligible|0
883706|NCT00613821|1849671|FG000|Overall Study|Withdrawal by Subject|1
883707|NCT00613821|1849672|FG001|Overall Study|Withdrawal by Subject|0
883708|NCT00613821|1849671|FG000|Overall Study|Physician Decision|1
883709|NCT00613821|1849672|FG001|Overall Study|Physician Decision|1
883710|NCT00613834|1849680|FG000|Overall Study|Withdrawal by Subject|0
883711|NCT00613834|1849681|FG001|Overall Study|Withdrawal by Subject|3
883712|NCT00613925|1849691|FG000|Overall Study|1 did not tolerate outpatient biopsy|0
883713|NCT00613925|1849692|FG001|Overall Study|1 did not tolerate outpatient biopsy|1
883714|NCT00613938|1849702|FG000|Overall Study|Withdrawal by Subject|2
883715|NCT00613938|1849703|FG001|Overall Study|Withdrawal by Subject|4
883716|NCT00613938|1849704|FG002|Overall Study|Withdrawal by Subject|9
883717|NCT00613938|1849705|FG003|Overall Study|Withdrawal by Subject|9
883718|NCT00613938|1849702|FG000|Overall Study|Adverse Event|1
883719|NCT00613938|1849703|FG001|Overall Study|Adverse Event|4
883720|NCT00613938|1849704|FG002|Overall Study|Adverse Event|8
883721|NCT00613938|1849705|FG003|Overall Study|Adverse Event|5
883722|NCT00613938|1849702|FG000|Overall Study|Lack of Efficacy|16
883723|NCT00613938|1849703|FG001|Overall Study|Lack of Efficacy|18
883724|NCT00613938|1849704|FG002|Overall Study|Lack of Efficacy|5
883725|NCT00613938|1849705|FG003|Overall Study|Lack of Efficacy|9
883726|NCT00613938|1849702|FG000|Overall Study|Other|1
883727|NCT00613938|1849703|FG001|Overall Study|Other|2
883728|NCT00613938|1849704|FG002|Overall Study|Other|1
883729|NCT00613938|1849705|FG003|Overall Study|Other|3
883730|NCT00613951|1849718|FG000|Overall Study|Adverse Event|1
883731|NCT00613951|1849719|FG001|Overall Study|Adverse Event|0
883732|NCT00613951|1849720|FG002|Overall Study|Adverse Event|1
883733|NCT00613951|1849718|FG000|Overall Study|Lack of Efficacy|0
883734|NCT00613951|1849719|FG001|Overall Study|Lack of Efficacy|1
883735|NCT00613951|1849720|FG002|Overall Study|Lack of Efficacy|1
883736|NCT00613951|1849718|FG000|Overall Study|Protocol Violation|1
883737|NCT00613951|1849719|FG001|Overall Study|Protocol Violation|1
883738|NCT00613951|1849720|FG002|Overall Study|Protocol Violation|1
883739|NCT00613951|1849718|FG000|Overall Study|Unclassified|5
883740|NCT00613951|1849719|FG001|Overall Study|Unclassified|3
883741|NCT00613951|1849720|FG002|Overall Study|Unclassified|2
883742|NCT00614055|1849734|FG000|Overall Study|Adverse Event|1
883743|NCT00614055|1849735|FG001|Overall Study|Adverse Event|0
883744|NCT00614055|1849736|FG002|Overall Study|Adverse Event|0
883745|NCT00614055|1849734|FG000|Overall Study|Protocol Violation|2
883746|NCT00614055|1849735|FG001|Overall Study|Protocol Violation|2
883747|NCT00614055|1849736|FG002|Overall Study|Protocol Violation|1
883748|NCT00614055|1849734|FG000|Overall Study|Lack of Efficacy|0
883749|NCT00614055|1849735|FG001|Overall Study|Lack of Efficacy|0
883750|NCT00614055|1849736|FG002|Overall Study|Lack of Efficacy|2
883751|NCT00614055|1849734|FG000|Overall Study|Unclassified|1
883752|NCT00614055|1849735|FG001|Overall Study|Unclassified|4
883753|NCT00614055|1849736|FG002|Overall Study|Unclassified|2
883754|NCT00614120|1849751|FG000|Overall Study|Adverse Event|9
883755|NCT00614120|1849752|FG001|Overall Study|Adverse Event|22
883756|NCT00614120|1849753|FG002|Overall Study|Adverse Event|30
883757|NCT00614120|1849754|FG003|Overall Study|Adverse Event|3
883758|NCT00614120|1849751|FG000|Overall Study|Lack of Efficacy|3
883759|NCT00614120|1849752|FG001|Overall Study|Lack of Efficacy|3
883760|NCT00614120|1849753|FG002|Overall Study|Lack of Efficacy|2
883761|NCT00614120|1849754|FG003|Overall Study|Lack of Efficacy|2
883762|NCT00614120|1849751|FG000|Overall Study|Protocol Violation|2
883763|NCT00614120|1849752|FG001|Overall Study|Protocol Violation|5
883764|NCT00614120|1849753|FG002|Overall Study|Protocol Violation|3
883765|NCT00614120|1849754|FG003|Overall Study|Protocol Violation|1
883766|NCT00614120|1849751|FG000|Overall Study|Withdrawal criteria|1
883767|NCT00614120|1849752|FG001|Overall Study|Withdrawal criteria|0
883768|NCT00614120|1849753|FG002|Overall Study|Withdrawal criteria|0
883769|NCT00614120|1849754|FG003|Overall Study|Withdrawal criteria|0
883770|NCT00614120|1849751|FG000|Overall Study|Withdrawal by Subject|9
883771|NCT00614120|1849752|FG001|Overall Study|Withdrawal by Subject|10
883772|NCT00614120|1849753|FG002|Overall Study|Withdrawal by Subject|16
883773|NCT00614120|1849754|FG003|Overall Study|Withdrawal by Subject|3
883774|NCT00614120|1849751|FG000|Overall Study|Did not meet trial criteria|0
883775|NCT00614120|1849752|FG001|Overall Study|Did not meet trial criteria|1
883776|NCT00614120|1849753|FG002|Overall Study|Did not meet trial criteria|1
883777|NCT00614120|1849754|FG003|Overall Study|Did not meet trial criteria|1
883778|NCT00614120|1849751|FG000|Overall Study|hCG positive (not pregnant)|0
883779|NCT00614120|1849752|FG001|Overall Study|hCG positive (not pregnant)|0
883780|NCT00614120|1849753|FG002|Overall Study|hCG positive (not pregnant)|1
883781|NCT00614120|1849754|FG003|Overall Study|hCG positive (not pregnant)|0
883782|NCT00614120|1849751|FG000|Overall Study|Hypoglycaemia|0
883783|NCT00614120|1849752|FG001|Overall Study|Hypoglycaemia|0
883784|NCT00614120|1849753|FG002|Overall Study|Hypoglycaemia|0
883785|NCT00614120|1849754|FG003|Overall Study|Hypoglycaemia|1
883786|NCT00614120|1849751|FG000|Overall Study|Lack of trial product|3
883787|NCT00614120|1849752|FG001|Overall Study|Lack of trial product|3
883788|NCT00614120|1849753|FG002|Overall Study|Lack of trial product|2
883789|NCT00614120|1849754|FG003|Overall Study|Lack of trial product|0
883790|NCT00614120|1849751|FG000|Overall Study|Late syphilis, latent|1
883791|NCT00614120|1849752|FG001|Overall Study|Late syphilis, latent|0
883792|NCT00614120|1849753|FG002|Overall Study|Late syphilis, latent|0
883793|NCT00614120|1849754|FG003|Overall Study|Late syphilis, latent|0
883794|NCT00614120|1849751|FG000|Overall Study|Taken inhibition medication eg Prandin|0
883795|NCT00614120|1849752|FG001|Overall Study|Taken inhibition medication eg Prandin|0
883796|NCT00614120|1849753|FG002|Overall Study|Taken inhibition medication eg Prandin|1
883797|NCT00614120|1849754|FG003|Overall Study|Taken inhibition medication eg Prandin|1
883798|NCT00614120|1849751|FG000|Overall Study|Lost to Follow-up|1
883799|NCT00614120|1849752|FG001|Overall Study|Lost to Follow-up|2
883800|NCT00614120|1849753|FG002|Overall Study|Lost to Follow-up|3
883801|NCT00614120|1849754|FG003|Overall Study|Lost to Follow-up|4
883802|NCT00614380|1849781|FG000|Overall Study|Adverse Event|14
883803|NCT00614380|1849782|FG001|Overall Study|Adverse Event|4
883804|NCT00614380|1849783|FG002|Overall Study|Adverse Event|0
883805|NCT00614380|1849784|FG003|Overall Study|Adverse Event|0
883806|NCT00614380|1849781|FG000|Overall Study|Lost to Follow-up|6
883807|NCT00614380|1849782|FG001|Overall Study|Lost to Follow-up|1
883808|NCT00614380|1849783|FG002|Overall Study|Lost to Follow-up|0
883809|NCT00614380|1849784|FG003|Overall Study|Lost to Follow-up|0
883810|NCT00614380|1849781|FG000|Overall Study|Non compliant with the protocol|12
883811|NCT00614380|1849782|FG001|Overall Study|Non compliant with the protocol|2
883812|NCT00614380|1849783|FG002|Overall Study|Non compliant with the protocol|1
883813|NCT00614380|1849784|FG003|Overall Study|Non compliant with the protocol|2
883814|NCT00614380|1849781|FG000|Overall Study|Consent withdrawn|3
883815|NCT00614380|1849782|FG001|Overall Study|Consent withdrawn|1
883816|NCT00614380|1849783|FG002|Overall Study|Consent withdrawn|0
883817|NCT00614380|1849784|FG003|Overall Study|Consent withdrawn|0
883818|NCT00614393|1849804|FG000|Overall Study|Adverse Event|20
883819|NCT00614393|1849805|FG001|Overall Study|Adverse Event|2
883820|NCT00614393|1849806|FG002|Overall Study|Adverse Event|3
883821|NCT00614393|1849807|FG003|Overall Study|Adverse Event|13
883822|NCT00614393|1849808|FG004|Overall Study|Adverse Event|21
883823|NCT00614393|1849804|FG000|Overall Study|Lost to Follow-up|0
883824|NCT00614393|1849805|FG001|Overall Study|Lost to Follow-up|0
883825|NCT00614393|1849806|FG002|Overall Study|Lost to Follow-up|0
883826|NCT00614393|1849807|FG003|Overall Study|Lost to Follow-up|1
883827|NCT00614393|1849808|FG004|Overall Study|Lost to Follow-up|2
883828|NCT00614393|1849804|FG000|Overall Study|Physician Decision|17
883829|NCT00614393|1849805|FG001|Overall Study|Physician Decision|0
883830|NCT00614393|1849806|FG002|Overall Study|Physician Decision|1
883831|NCT00614393|1849807|FG003|Overall Study|Physician Decision|8
883832|NCT00614393|1849808|FG004|Overall Study|Physician Decision|9
883833|NCT00614393|1849804|FG000|Overall Study|Progressive Disease|118
883834|NCT00614393|1849805|FG001|Overall Study|Progressive Disease|5
883835|NCT00614393|1849806|FG002|Overall Study|Progressive Disease|5
883836|NCT00614393|1849807|FG003|Overall Study|Progressive Disease|138
883837|NCT00614393|1849808|FG004|Overall Study|Progressive Disease|130
883838|NCT00614393|1849804|FG000|Overall Study|Protocol Violation|1
883839|NCT00614393|1849805|FG001|Overall Study|Protocol Violation|0
883840|NCT00614393|1849806|FG002|Overall Study|Protocol Violation|0
883841|NCT00614393|1849807|FG003|Overall Study|Protocol Violation|0
883842|NCT00614393|1849808|FG004|Overall Study|Protocol Violation|0
883843|NCT00614393|1849804|FG000|Overall Study|Terminated by Sponsor|0
883844|NCT00614393|1849805|FG001|Overall Study|Terminated by Sponsor|0
883845|NCT00614393|1849806|FG002|Overall Study|Terminated by Sponsor|0
883846|NCT00614393|1849807|FG003|Overall Study|Terminated by Sponsor|0
883847|NCT00614393|1849808|FG004|Overall Study|Terminated by Sponsor|1
883848|NCT00614393|1849804|FG000|Overall Study|Withdrawal by Subject|20
883849|NCT00614393|1849805|FG001|Overall Study|Withdrawal by Subject|1
883850|NCT00614393|1849806|FG002|Overall Study|Withdrawal by Subject|1
883851|NCT00614393|1849807|FG003|Overall Study|Withdrawal by Subject|16
883852|NCT00614393|1849808|FG004|Overall Study|Withdrawal by Subject|13
883853|NCT00614393|1849804|FG000|Overall Study|Other|4
883854|NCT00614393|1849805|FG001|Overall Study|Other|0
883855|NCT00614393|1849806|FG002|Overall Study|Other|0
883856|NCT00614393|1849807|FG003|Overall Study|Other|4
883857|NCT00614393|1849808|FG004|Overall Study|Other|2
883858|NCT00614393|1849804|FG000|Overall Study|Not Treated|0
883859|NCT00614393|1849805|FG001|Overall Study|Not Treated|0
883860|NCT00614393|1849806|FG002|Overall Study|Not Treated|0
883861|NCT00614393|1849807|FG003|Overall Study|Not Treated|0
883862|NCT00614393|1849808|FG004|Overall Study|Not Treated|2
883863|NCT00614523|1849858|FG000|Overall Study|Adverse Event|4
883864|NCT00614523|1849859|FG001|Overall Study|Adverse Event|20
883865|NCT00614523|1849858|FG000|Overall Study|Death|5
883866|NCT00614523|1849859|FG001|Overall Study|Death|8
883867|NCT00614523|1849858|FG000|Overall Study|Lack of Efficacy|9
883868|NCT00614523|1849859|FG001|Overall Study|Lack of Efficacy|11
883869|NCT00614523|1849858|FG000|Overall Study|Lost to Follow-up|0
883870|NCT00614523|1849859|FG001|Overall Study|Lost to Follow-up|1
883871|NCT00614523|1849858|FG000|Overall Study|Protocol Violation|3
883872|NCT00614523|1849859|FG001|Overall Study|Protocol Violation|2
883873|NCT00614523|1849858|FG000|Overall Study|Withdrawal by Subject|12
883874|NCT00614523|1849859|FG001|Overall Study|Withdrawal by Subject|22
883875|NCT00614523|1849858|FG000|Overall Study|Other|6
883876|NCT00614523|1849859|FG001|Overall Study|Other|11
883877|NCT00614523|1849858|FG000|Overall Study|Ineligibility Determined|1
883878|NCT00614523|1849859|FG001|Overall Study|Ineligibility Determined|2
883879|NCT00614523|1849858|FG000|Overall Study|Disease Progression|0
883880|NCT00614523|1849859|FG001|Overall Study|Disease Progression|8
883881|NCT00614523|1849858|FG000|Overall Study|Administrative Decision|23
883882|NCT00614523|1849859|FG001|Overall Study|Administrative Decision|46
883883|NCT00614575|1849865|FG000|Overall Study|Adverse Event|106
883884|NCT00614575|1849865|FG000|Overall Study|Lost to Follow-up|55
883885|NCT00614575|1849865|FG000|Overall Study|Lack of Efficacy|14
883886|NCT00614575|1849865|FG000|Overall Study|Withdrawal by Subject|6
883887|NCT00614575|1849865|FG000|Overall Study|Death|3
883888|NCT00614575|1849865|FG000|Overall Study|Physician Decision|2
883889|NCT00614575|1849865|FG000|Overall Study|No data were collected.|18
883890|NCT00614575|1849865|FG000|Overall Study|Irregularly enrolled patients|23
883891|NCT00614575|1849865|FG000|Overall Study|No treatment|1
883892|NCT00614614|1849871|FG000|Primary Vaccination Phase|Adverse Event|6
883893|NCT00614614|1849872|FG001|Primary Vaccination Phase|Adverse Event|0
883894|NCT00614614|1849873|FG002|Primary Vaccination Phase|Adverse Event|0
883895|NCT00614614|1849874|FG003|Primary Vaccination Phase|Adverse Event|0
883896|NCT00614614|1849875|FG004|Primary Vaccination Phase|Adverse Event|0
883897|NCT00614614|1849871|FG000|Primary Vaccination Phase|Withdrawal by Subject|45
883898|NCT00614614|1849872|FG001|Primary Vaccination Phase|Withdrawal by Subject|6
883899|NCT00614614|1849873|FG002|Primary Vaccination Phase|Withdrawal by Subject|0
883900|NCT00614614|1849874|FG003|Primary Vaccination Phase|Withdrawal by Subject|0
883901|NCT00614614|1849875|FG004|Primary Vaccination Phase|Withdrawal by Subject|0
883902|NCT00614614|1849871|FG000|Primary Vaccination Phase|Lost to Follow-up|26
883903|NCT00614614|1849872|FG001|Primary Vaccination Phase|Lost to Follow-up|8
883904|NCT00614614|1849873|FG002|Primary Vaccination Phase|Lost to Follow-up|0
883905|NCT00614614|1849874|FG003|Primary Vaccination Phase|Lost to Follow-up|0
883906|NCT00614614|1849875|FG004|Primary Vaccination Phase|Lost to Follow-up|0
883907|NCT00614614|1849871|FG000|Primary Vaccination Phase|Protocol Violation|9
883908|NCT00614614|1849872|FG001|Primary Vaccination Phase|Protocol Violation|3
883909|NCT00614614|1849873|FG002|Primary Vaccination Phase|Protocol Violation|0
883910|NCT00614614|1849874|FG003|Primary Vaccination Phase|Protocol Violation|0
883911|NCT00614614|1849875|FG004|Primary Vaccination Phase|Protocol Violation|0
883912|NCT00614614|1849871|FG000|Primary Vaccination Phase|Other|4
883913|NCT00614614|1849872|FG001|Primary Vaccination Phase|Other|0
883914|NCT00614614|1849873|FG002|Primary Vaccination Phase|Other|0
883915|NCT00614614|1849874|FG003|Primary Vaccination Phase|Other|0
883916|NCT00614614|1849875|FG004|Primary Vaccination Phase|Other|0
883917|NCT00614614|1849871|FG000|Booster Vaccination Phase|Adverse Event|0
883918|NCT00614614|1849872|FG001|Booster Vaccination Phase|Adverse Event|0
883919|NCT00614614|1849873|FG002|Booster Vaccination Phase|Adverse Event|1
883920|NCT00614614|1849874|FG003|Booster Vaccination Phase|Adverse Event|1
883921|NCT00614614|1849875|FG004|Booster Vaccination Phase|Adverse Event|0
883922|NCT00614614|1849871|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
883923|NCT00614614|1849872|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
883924|NCT00614614|1849873|FG002|Booster Vaccination Phase|Withdrawal by Subject|4
883925|NCT00614614|1849874|FG003|Booster Vaccination Phase|Withdrawal by Subject|3
883926|NCT00614614|1849875|FG004|Booster Vaccination Phase|Withdrawal by Subject|4
883927|NCT00614614|1849871|FG000|Booster Vaccination Phase|Lost to Follow-up|0
883928|NCT00614614|1849872|FG001|Booster Vaccination Phase|Lost to Follow-up|5
883929|NCT00614614|1849873|FG002|Booster Vaccination Phase|Lost to Follow-up|17
883930|NCT00614614|1849874|FG003|Booster Vaccination Phase|Lost to Follow-up|10
883931|NCT00614614|1849875|FG004|Booster Vaccination Phase|Lost to Follow-up|8
883932|NCT00614614|1849871|FG000|Booster Vaccination Phase|Protocol Violation|0
883933|NCT00614614|1849872|FG001|Booster Vaccination Phase|Protocol Violation|0
883934|NCT00614614|1849873|FG002|Booster Vaccination Phase|Protocol Violation|2
883935|NCT00614614|1849874|FG003|Booster Vaccination Phase|Protocol Violation|3
883936|NCT00614614|1849875|FG004|Booster Vaccination Phase|Protocol Violation|0
883937|NCT00614614|1849871|FG000|Booster Vaccination Phase|Other|0
883938|NCT00614614|1849872|FG001|Booster Vaccination Phase|Other|1
883939|NCT00614614|1849873|FG002|Booster Vaccination Phase|Other|3
883940|NCT00614614|1849874|FG003|Booster Vaccination Phase|Other|2
883941|NCT00614614|1849875|FG004|Booster Vaccination Phase|Other|1
883942|NCT00614744|1849892|FG000|Overall Study|Lost to Follow-up|5
883943|NCT00614744|1849893|FG001|Overall Study|Lost to Follow-up|4
883944|NCT00614744|1849892|FG000|Overall Study|Incomplete for Behavior Issues|0
883945|NCT00614744|1849893|FG001|Overall Study|Incomplete for Behavior Issues|2
883946|NCT00614822|1849899|FG000|Overall Study|Adverse Event|3
883947|NCT00614874|1849904|FG000|Overall Study|Protocol Violation|1
883948|NCT00614874|1849904|FG000|Overall Study|Withdrawal by Subject|1
883949|NCT00614926|1849914|FG000|Overall Study|Burden of travel|1
883950|NCT00614926|1849915|FG001|Overall Study|Burden of travel|0
883951|NCT00614926|1849914|FG000|Overall Study|Adverse Event|3
883952|NCT00614926|1849915|FG001|Overall Study|Adverse Event|0
883953|NCT00614939|1849923|FG000|Overall Study|Withdrawal by Subject|10
883954|NCT00614939|1849924|FG001|Overall Study|Withdrawal by Subject|17
883955|NCT00614939|1849923|FG000|Overall Study|Study specific discontinuation criteris|13
883956|NCT00614939|1849924|FG001|Overall Study|Study specific discontinuation criteris|16
883957|NCT00614939|1849923|FG000|Overall Study|Adverse Event|2
883958|NCT00614939|1849924|FG001|Overall Study|Adverse Event|5
883959|NCT00614939|1849923|FG000|Overall Study|Incorrect enrollment|1
883960|NCT00614939|1849924|FG001|Overall Study|Incorrect enrollment|2
883961|NCT00614939|1849923|FG000|Overall Study|Death|4
883962|NCT00614939|1849924|FG001|Overall Study|Death|3
883963|NCT00614939|1849923|FG000|Overall Study|Poor/non-compliance|4
883964|NCT00614939|1849924|FG001|Overall Study|Poor/non-compliance|0
883965|NCT00614939|1849923|FG000|Overall Study|Hospitalized due to kidney transplant|1
883966|NCT00614939|1849924|FG001|Overall Study|Hospitalized due to kidney transplant|0
883967|NCT00614991|1849936|FG000|Overall Study|Adverse Event|3
883968|NCT00614991|1849937|FG001|Overall Study|Adverse Event|3
883969|NCT00614991|1849938|FG002|Overall Study|Adverse Event|0
883970|NCT00614991|1849939|FG003|Overall Study|Adverse Event|0
883971|NCT00614991|1849940|FG004|Overall Study|Adverse Event|1
883972|NCT00614991|1849941|FG005|Overall Study|Adverse Event|0
883973|NCT00615017|1849966|FG000|Overall Study|Adverse Event|0
883974|NCT00615017|1849967|FG001|Overall Study|Adverse Event|1
883975|NCT00615017|1849968|FG002|Overall Study|Adverse Event|2
883976|NCT00615017|1849969|FG003|Overall Study|Adverse Event|0
883977|NCT00615017|1849970|FG004|Overall Study|Adverse Event|0
883978|NCT00615017|1849971|FG005|Overall Study|Adverse Event|1
883979|NCT00615017|1849966|FG000|Overall Study|Death|0
883980|NCT00615017|1849967|FG001|Overall Study|Death|0
883981|NCT00615017|1849968|FG002|Overall Study|Death|2
883982|NCT00615017|1849969|FG003|Overall Study|Death|0
883983|NCT00615017|1849970|FG004|Overall Study|Death|1
883984|NCT00615017|1849971|FG005|Overall Study|Death|1
883985|NCT00615017|1849966|FG000|Overall Study|Sepsis resolved|0
883986|NCT00615017|1849967|FG001|Overall Study|Sepsis resolved|0
883987|NCT00615017|1849968|FG002|Overall Study|Sepsis resolved|1
883988|NCT00615017|1849969|FG003|Overall Study|Sepsis resolved|0
883989|NCT00615017|1849970|FG004|Overall Study|Sepsis resolved|0
883990|NCT00615017|1849971|FG005|Overall Study|Sepsis resolved|0
883991|NCT00615017|1849966|FG000|Overall Study|Transferred out of Intensive Care Unit|0
883992|NCT00615017|1849967|FG001|Overall Study|Transferred out of Intensive Care Unit|0
883993|NCT00615017|1849968|FG002|Overall Study|Transferred out of Intensive Care Unit|0
883994|NCT00615017|1849969|FG003|Overall Study|Transferred out of Intensive Care Unit|1
883995|NCT00615017|1849970|FG004|Overall Study|Transferred out of Intensive Care Unit|0
883996|NCT00615017|1849971|FG005|Overall Study|Transferred out of Intensive Care Unit|0
883997|NCT00615017|1849966|FG000|Overall Study|Physician discontinued drug|0
883998|NCT00615017|1849967|FG001|Overall Study|Physician discontinued drug|0
883999|NCT00615017|1849968|FG002|Overall Study|Physician discontinued drug|0
884000|NCT00615017|1849969|FG003|Overall Study|Physician discontinued drug|0
884001|NCT00615017|1849970|FG004|Overall Study|Physician discontinued drug|0
884002|NCT00615017|1849971|FG005|Overall Study|Physician discontinued drug|1
884003|NCT00615030|1849985|FG000|Period I|Administrative problem|0
884004|NCT00615030|1849986|FG001|Period I|Administrative problem|0
884005|NCT00615030|1849987|FG002|Period I|Administrative problem|0
884006|NCT00615030|1849988|FG003|Period I|Administrative problem|0
884007|NCT00615030|1849989|FG004|Period I|Administrative problem|1
884008|NCT00615030|1849990|FG005|Period I|Administrative problem|0
884009|NCT00615030|1849991|FG006|Period I|Administrative problem|0
884010|NCT00615030|1849992|FG007|Period I|Administrative problem|0
884011|NCT00615030|1849993|FG008|Period I|Administrative problem|0
884012|NCT00615030|1849994|FG009|Period I|Administrative problem|0
884013|NCT00615030|1849995|FG010|Period I|Administrative problem|0
884014|NCT00615030|1849996|FG011|Period I|Administrative problem|0
884015|NCT00615030|1849985|FG000|Period I|Protocol deviation|1
884016|NCT00615030|1849986|FG001|Period I|Protocol deviation|0
884017|NCT00615030|1849987|FG002|Period I|Protocol deviation|0
884018|NCT00615030|1849988|FG003|Period I|Protocol deviation|0
884019|NCT00615030|1849989|FG004|Period I|Protocol deviation|0
884020|NCT00615030|1849990|FG005|Period I|Protocol deviation|0
884021|NCT00615030|1849991|FG006|Period I|Protocol deviation|0
884022|NCT00615030|1849992|FG007|Period I|Protocol deviation|0
884023|NCT00615030|1849993|FG008|Period I|Protocol deviation|0
884024|NCT00615030|1849994|FG009|Period I|Protocol deviation|0
884025|NCT00615030|1849995|FG010|Period I|Protocol deviation|0
884026|NCT00615030|1849996|FG011|Period I|Protocol deviation|0
884027|NCT00615030|1849985|FG000|Period I|Subject withdrew consent|0
884028|NCT00615030|1849986|FG001|Period I|Subject withdrew consent|0
884029|NCT00615030|1849987|FG002|Period I|Subject withdrew consent|0
884030|NCT00615030|1849988|FG003|Period I|Subject withdrew consent|0
884031|NCT00615030|1849989|FG004|Period I|Subject withdrew consent|0
884032|NCT00615030|1849990|FG005|Period I|Subject withdrew consent|0
884033|NCT00615030|1849991|FG006|Period I|Subject withdrew consent|0
884034|NCT00615030|1849992|FG007|Period I|Subject withdrew consent|0
884035|NCT00615030|1849993|FG008|Period I|Subject withdrew consent|1
884036|NCT00615030|1849994|FG009|Period I|Subject withdrew consent|0
884037|NCT00615030|1849995|FG010|Period I|Subject withdrew consent|1
884038|NCT00615030|1849996|FG011|Period I|Subject withdrew consent|1
884039|NCT00615030|1849985|FG000|Period I|Abnormal laboratory value(s)|0
884040|NCT00615030|1849986|FG001|Period I|Abnormal laboratory value(s)|0
884041|NCT00615030|1849987|FG002|Period I|Abnormal laboratory value(s)|0
884042|NCT00615030|1849988|FG003|Period I|Abnormal laboratory value(s)|0
884043|NCT00615030|1849989|FG004|Period I|Abnormal laboratory value(s)|0
884044|NCT00615030|1849990|FG005|Period I|Abnormal laboratory value(s)|1
884045|NCT00615030|1849991|FG006|Period I|Abnormal laboratory value(s)|0
884046|NCT00615030|1849992|FG007|Period I|Abnormal laboratory value(s)|0
884047|NCT00615030|1849993|FG008|Period I|Abnormal laboratory value(s)|0
884048|NCT00615030|1849994|FG009|Period I|Abnormal laboratory value(s)|0
884049|NCT00615030|1849995|FG010|Period I|Abnormal laboratory value(s)|0
884050|NCT00615030|1849996|FG011|Period I|Abnormal laboratory value(s)|0
884051|NCT00615030|1849985|FG000|Period II|Adverse Event|0
884052|NCT00615030|1849986|FG001|Period II|Adverse Event|0
884053|NCT00615030|1849987|FG002|Period II|Adverse Event|1
884054|NCT00615030|1849988|FG003|Period II|Adverse Event|0
884055|NCT00615030|1849989|FG004|Period II|Adverse Event|0
884056|NCT00615030|1849990|FG005|Period II|Adverse Event|0
884057|NCT00615030|1849991|FG006|Period II|Adverse Event|0
884058|NCT00615030|1849992|FG007|Period II|Adverse Event|0
884059|NCT00615030|1849993|FG008|Period II|Adverse Event|1
884060|NCT00615030|1849994|FG009|Period II|Adverse Event|0
884061|NCT00615030|1849995|FG010|Period II|Adverse Event|0
884062|NCT00615030|1849996|FG011|Period II|Adverse Event|0
884063|NCT00615030|1849985|FG000|Period II|Subject withdrew consent|0
884064|NCT00615030|1849986|FG001|Period II|Subject withdrew consent|0
884065|NCT00615030|1849987|FG002|Period II|Subject withdrew consent|0
884066|NCT00615030|1849988|FG003|Period II|Subject withdrew consent|1
884067|NCT00615030|1849989|FG004|Period II|Subject withdrew consent|0
884068|NCT00615030|1849990|FG005|Period II|Subject withdrew consent|0
884069|NCT00615030|1849991|FG006|Period II|Subject withdrew consent|1
884070|NCT00615030|1849992|FG007|Period II|Subject withdrew consent|0
884071|NCT00615030|1849993|FG008|Period II|Subject withdrew consent|0
884072|NCT00615030|1849994|FG009|Period II|Subject withdrew consent|0
884073|NCT00615030|1849995|FG010|Period II|Subject withdrew consent|0
884074|NCT00615030|1849996|FG011|Period II|Subject withdrew consent|0
884075|NCT00615030|1849985|FG000|Period III|Administrative problems|1
884076|NCT00615030|1849986|FG001|Period III|Administrative problems|0
884077|NCT00615030|1849987|FG002|Period III|Administrative problems|0
884078|NCT00615030|1849988|FG003|Period III|Administrative problems|1
884079|NCT00615030|1849989|FG004|Period III|Administrative problems|0
884080|NCT00615030|1849990|FG005|Period III|Administrative problems|0
884081|NCT00615030|1849991|FG006|Period III|Administrative problems|0
884082|NCT00615030|1849992|FG007|Period III|Administrative problems|0
884083|NCT00615030|1849993|FG008|Period III|Administrative problems|0
884084|NCT00615030|1849994|FG009|Period III|Administrative problems|0
884085|NCT00615030|1849995|FG010|Period III|Administrative problems|0
884086|NCT00615030|1849996|FG011|Period III|Administrative problems|0
884087|NCT00615056|1850014|FG000|Overall Study|Death|31
884088|NCT00615056|1850015|FG001|Overall Study|Death|31
884089|NCT00615056|1850016|FG002|Overall Study|Death|21
884090|NCT00615056|1850017|FG003|Overall Study|Death|23
884091|NCT00615056|1850014|FG000|Overall Study|Lost to Follow-up|1
884092|NCT00615056|1850015|FG001|Overall Study|Lost to Follow-up|2
884093|NCT00615056|1850016|FG002|Overall Study|Lost to Follow-up|4
884094|NCT00615056|1850017|FG003|Overall Study|Lost to Follow-up|5
884095|NCT00615056|1850014|FG000|Overall Study|Other|13
884096|NCT00615056|1850015|FG001|Overall Study|Other|15
884097|NCT00615056|1850016|FG002|Overall Study|Other|10
884098|NCT00615056|1850017|FG003|Overall Study|Other|7
884099|NCT00615056|1850014|FG000|Overall Study|Objective progression or relapse|0
884100|NCT00615056|1850015|FG001|Overall Study|Objective progression or relapse|2
884101|NCT00615056|1850016|FG002|Overall Study|Objective progression or relapse|0
884102|NCT00615056|1850017|FG003|Overall Study|Objective progression or relapse|0
884103|NCT00615056|1850014|FG000|Overall Study|Withdrawal by Subject|0
884104|NCT00615056|1850015|FG001|Overall Study|Withdrawal by Subject|1
884105|NCT00615056|1850016|FG002|Overall Study|Withdrawal by Subject|1
884106|NCT00615056|1850017|FG003|Overall Study|Withdrawal by Subject|0
884107|NCT00615056|1850014|FG000|Overall Study|Discontinued by Sponsor|1
884108|NCT00615056|1850015|FG001|Overall Study|Discontinued by Sponsor|0
884109|NCT00615056|1850016|FG002|Overall Study|Discontinued by Sponsor|0
884110|NCT00615056|1850017|FG003|Overall Study|Discontinued by Sponsor|0
884111|NCT00615056|1850014|FG000|Overall Study|Randomized but not treated|3
884112|NCT00615056|1850015|FG001|Overall Study|Randomized but not treated|0
884113|NCT00615056|1850016|FG002|Overall Study|Randomized but not treated|0
884114|NCT00615056|1850017|FG003|Overall Study|Randomized but not treated|0
884115|NCT00615069|1850027|FG000|Overall Study|Death|10
884116|NCT00615069|1850027|FG000|Overall Study|Physician Decision|2
884117|NCT00615069|1850027|FG000|Overall Study|Withdrawal by Subject|4
884118|NCT00615108|1850031|FG000|Overall Study|Adverse Event|122
884119|NCT00615108|1850031|FG000|Overall Study|Other|370
884120|NCT00615108|1850031|FG000|Overall Study|Lost to Follow-up|15
884121|NCT00615199|1850041|FG000|Overall Study|Adverse Event|3
884122|NCT00615199|1850042|FG001|Overall Study|Adverse Event|1
884123|NCT00615199|1850043|FG002|Overall Study|Adverse Event|1
884124|NCT00615199|1850044|FG003|Overall Study|Adverse Event|0
884125|NCT00615199|1850041|FG000|Overall Study|Lack of Efficacy|2
884126|NCT00615199|1850042|FG001|Overall Study|Lack of Efficacy|0
884127|NCT00615199|1850043|FG002|Overall Study|Lack of Efficacy|0
884128|NCT00615199|1850044|FG003|Overall Study|Lack of Efficacy|1
884129|NCT00615199|1850041|FG000|Overall Study|Lost to Follow-up|1
884130|NCT00615199|1850042|FG001|Overall Study|Lost to Follow-up|0
884131|NCT00615199|1850043|FG002|Overall Study|Lost to Follow-up|0
884132|NCT00615199|1850044|FG003|Overall Study|Lost to Follow-up|0
884133|NCT00615199|1850041|FG000|Overall Study|Other|0
884134|NCT00615199|1850042|FG001|Overall Study|Other|0
884135|NCT00615199|1850043|FG002|Overall Study|Other|0
884136|NCT00615199|1850044|FG003|Overall Study|Other|1
884137|NCT00615199|1850041|FG000|Overall Study|Withdrawal by Subject|2
884138|NCT00615199|1850042|FG001|Overall Study|Withdrawal by Subject|1
884139|NCT00615199|1850043|FG002|Overall Study|Withdrawal by Subject|0
884140|NCT00615199|1850044|FG003|Overall Study|Withdrawal by Subject|0
884141|NCT00615264|1850056|FG000|Overall Study|Withdrawal by Subject|17
884142|NCT00615264|1850057|FG001|Overall Study|Withdrawal by Subject|19
884143|NCT00615264|1850056|FG000|Overall Study|Lost to Follow-up|6
884144|NCT00615264|1850057|FG001|Overall Study|Lost to Follow-up|13
884145|NCT00615264|1850056|FG000|Overall Study|Adverse Event|8
884146|NCT00615264|1850057|FG001|Overall Study|Adverse Event|5
884147|NCT00615264|1850056|FG000|Overall Study|Death|1
884148|NCT00615264|1850057|FG001|Overall Study|Death|1
884149|NCT00615264|1850056|FG000|Overall Study|Protocol Violation|11
884150|NCT00615264|1850057|FG001|Overall Study|Protocol Violation|7
884151|NCT00615264|1850056|FG000|Overall Study|Not defined|7
884152|NCT00615264|1850057|FG001|Overall Study|Not defined|4
884153|NCT00615264|1850056|FG000|Overall Study|Dermal Hypersensitivity|0
884154|NCT00615264|1850057|FG001|Overall Study|Dermal Hypersensitivity|3
884155|NCT00615290|1850063|FG000|Overall Study|Adverse Event|2
884156|NCT00615290|1850063|FG000|Overall Study|Lost to Follow-up|3
884157|NCT00615290|1850063|FG000|Overall Study|Withdrawal by Subject|1
884158|NCT00615290|1850063|FG000|Overall Study|Other|2
884159|NCT00615459|1850094|FG000|Period I|Adverse Event|2
884160|NCT00615459|1850095|FG001|Period I|Adverse Event|0
884161|NCT00615459|1850096|FG002|Period I|Adverse Event|1
884162|NCT00615459|1850097|FG003|Period I|Adverse Event|0
884163|NCT00615459|1850094|FG000|Period I|Subject withdrew consent|1
884164|NCT00615459|1850095|FG001|Period I|Subject withdrew consent|0
884165|NCT00615459|1850096|FG002|Period I|Subject withdrew consent|0
884166|NCT00615459|1850097|FG003|Period I|Subject withdrew consent|1
884167|NCT00615459|1850094|FG000|Period I|Abnormal test procedure results|1
884168|NCT00615459|1850095|FG001|Period I|Abnormal test procedure results|1
884169|NCT00615459|1850096|FG002|Period I|Abnormal test procedure results|1
884170|NCT00615459|1850097|FG003|Period I|Abnormal test procedure results|0
884171|NCT00615459|1850094|FG000|Period II|Adverse Event|1
884172|NCT00615459|1850095|FG001|Period II|Adverse Event|0
884173|NCT00615459|1850096|FG002|Period II|Adverse Event|0
884174|NCT00615459|1850097|FG003|Period II|Adverse Event|0
884175|NCT00615459|1850094|FG000|Period II|Lost to Follow-up|0
884176|NCT00615459|1850095|FG001|Period II|Lost to Follow-up|0
884177|NCT00615459|1850096|FG002|Period II|Lost to Follow-up|0
884178|NCT00615459|1850097|FG003|Period II|Lost to Follow-up|1
884179|NCT00615459|1850094|FG000|Period III|Adverse Event|0
884180|NCT00615459|1850095|FG001|Period III|Adverse Event|1
884181|NCT00615459|1850096|FG002|Period III|Adverse Event|0
884182|NCT00615459|1850097|FG003|Period III|Adverse Event|0
884183|NCT00615459|1850094|FG000|Period III|Administrative problems|0
884184|NCT00615459|1850095|FG001|Period III|Administrative problems|1
884185|NCT00615459|1850096|FG002|Period III|Administrative problems|1
884186|NCT00615459|1850097|FG003|Period III|Administrative problems|0
884187|NCT00615459|1850094|FG000|Period III|Unsatisfactory therapeutic effect|0
884188|NCT00615459|1850095|FG001|Period III|Unsatisfactory therapeutic effect|1
884189|NCT00615459|1850096|FG002|Period III|Unsatisfactory therapeutic effect|0
884190|NCT00615459|1850097|FG003|Period III|Unsatisfactory therapeutic effect|0
884191|NCT00615550|1850118|FG000|Overall Study|Lost to Follow-up|6
884192|NCT00615550|1850119|FG001|Overall Study|Lost to Follow-up|1
884193|NCT00615719|1850130|FG000|Overall Study|Physician Decision|5
884194|NCT00615836|1850142|FG000|Extension Study (FE992026 CS31)|Adverse Event|7
884195|NCT00615836|1850143|FG001|Extension Study (FE992026 CS31)|Adverse Event|12
884196|NCT00615836|1850144|FG002|Extension Study (FE992026 CS31)|Adverse Event|15
884197|NCT00615836|1850145|FG003|Extension Study (FE992026 CS31)|Adverse Event|13
884198|NCT00615836|1850146|FG004|Extension Study (FE992026 CS31)|Adverse Event|0
884199|NCT00615836|1850142|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
884200|NCT00615836|1850143|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
884201|NCT00615836|1850144|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
884202|NCT00615836|1850145|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
884203|NCT00615836|1850146|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
884204|NCT00615836|1850142|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
884205|NCT00615836|1850143|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
884206|NCT00615836|1850144|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
884207|NCT00615836|1850145|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
884208|NCT00615836|1850146|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
884209|NCT00615836|1850142|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4
884210|NCT00615836|1850143|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5
884211|NCT00615836|1850144|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2
884212|NCT00615836|1850145|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3
884213|NCT00615836|1850146|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0
884214|NCT00615836|1850142|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
884215|NCT00615836|1850143|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
884216|NCT00615836|1850144|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
884217|NCT00615836|1850145|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
884218|NCT00615836|1850146|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
884219|NCT00615836|1850142|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10
884220|NCT00615836|1850143|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14
884221|NCT00615836|1850144|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5
884222|NCT00615836|1850145|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10
884223|NCT00615836|1850146|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0
884224|NCT00615836|1850142|FG000|Extension Study (FE992026 CS31)|Other|10
884225|NCT00615836|1850143|FG001|Extension Study (FE992026 CS31)|Other|7
884226|NCT00615836|1850144|FG002|Extension Study (FE992026 CS31)|Other|8
884227|NCT00615836|1850145|FG003|Extension Study (FE992026 CS31)|Other|8
884228|NCT00615836|1850146|FG004|Extension Study (FE992026 CS31)|Other|0
884229|NCT00615836|1850142|FG000|Extension Study (FE992026 CS31)|Not reported|6
884230|NCT00615836|1850143|FG001|Extension Study (FE992026 CS31)|Not reported|4
884231|NCT00615836|1850144|FG002|Extension Study (FE992026 CS31)|Not reported|1
884232|NCT00615836|1850145|FG003|Extension Study (FE992026 CS31)|Not reported|4
884233|NCT00615836|1850146|FG004|Extension Study (FE992026 CS31)|Not reported|0
884234|NCT00615836|1850142|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
884235|NCT00615836|1850143|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
884236|NCT00615836|1850144|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
884237|NCT00615836|1850145|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
884238|NCT00615836|1850146|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
884239|NCT00615901|1850162|FG000|Overall Study|Withdrawal by Subject|2
884240|NCT00615901|1850162|FG000|Overall Study|Adverse Event|7
884241|NCT00615914|1850166|FG000|Overall Study|Adverse Event|274
884242|NCT00615914|1850166|FG000|Overall Study|Death|20
884243|NCT00615914|1850166|FG000|Overall Study|Lack of Efficacy|59
884244|NCT00615914|1850166|FG000|Overall Study|Lost to Follow-up|187
884245|NCT00615914|1850166|FG000|Overall Study|Withdrawal by Subject|16
884246|NCT00615914|1850166|FG000|Overall Study|Physician Decision|4
884247|NCT00615914|1850166|FG000|Overall Study|No data was collected.|65
884248|NCT00615914|1850166|FG000|Overall Study|No treatment|2
884249|NCT00615914|1850166|FG000|Overall Study|Irregularly enrolled patients|10
884250|NCT00615992|1850180|FG000|Overall Study|Protocol Violation|67
884251|NCT00616018|1850184|FG000|Overall Study|Protocol Violation|3
884252|NCT00616239|1850208|FG000|Overall Study|Withdrawal by Subject|2
884253|NCT00616421|1850215|FG000|Overall Study|Withdrawal by Subject|9
884254|NCT00616421|1850216|FG001|Overall Study|Withdrawal by Subject|11
884255|NCT00616421|1850217|FG002|Overall Study|Withdrawal by Subject|8
884256|NCT00616421|1850215|FG000|Overall Study|Lost to Follow-up|12
884257|NCT00616421|1850216|FG001|Overall Study|Lost to Follow-up|26
884258|NCT00616421|1850217|FG002|Overall Study|Lost to Follow-up|30
884259|NCT00616421|1850215|FG000|Overall Study|Inappropriate enrollment|3
884260|NCT00616421|1850216|FG001|Overall Study|Inappropriate enrollment|0
884261|NCT00616421|1850217|FG002|Overall Study|Inappropriate enrollment|1
884262|NCT00616421|1850215|FG000|Overall Study|Administrative reason|1
884263|NCT00616421|1850216|FG001|Overall Study|Administrative reason|0
884264|NCT00616421|1850217|FG002|Overall Study|Administrative reason|0
884265|NCT00616421|1850215|FG000|Overall Study|Protocol Violation|0
884266|NCT00616421|1850216|FG001|Overall Study|Protocol Violation|1
884267|NCT00616421|1850217|FG002|Overall Study|Protocol Violation|2
884268|NCT00616421|1850215|FG000|Overall Study|Unable to classify|1
884269|NCT00616421|1850216|FG001|Overall Study|Unable to classify|0
884270|NCT00616421|1850217|FG002|Overall Study|Unable to classify|0
884271|NCT00616434|1850241|FG000|Overall Study|Adverse Event|5
884272|NCT00616434|1850242|FG001|Overall Study|Adverse Event|2
884273|NCT00616434|1850241|FG000|Overall Study|Physician Decision|0
884274|NCT00616434|1850242|FG001|Overall Study|Physician Decision|4
884275|NCT00616434|1850241|FG000|Overall Study|Withdrawal by Subject|1
884276|NCT00616434|1850242|FG001|Overall Study|Withdrawal by Subject|1
884277|NCT00616434|1850241|FG000|Overall Study|Protocol deviation|0
884278|NCT00616434|1850242|FG001|Overall Study|Protocol deviation|1
884279|NCT00616629|1850253|FG000|Overall Study|Protocol Violation|1
884280|NCT00616629|1850254|FG001|Overall Study|Protocol Violation|2
884281|NCT00616629|1850255|FG002|Overall Study|Protocol Violation|1
884282|NCT00616629|1850256|FG003|Overall Study|Protocol Violation|0
884283|NCT00616629|1850257|FG004|Overall Study|Protocol Violation|0
884284|NCT00616629|1850253|FG000|Overall Study|AV-block|1
884285|NCT00616629|1850254|FG001|Overall Study|AV-block|0
884286|NCT00616629|1850255|FG002|Overall Study|AV-block|0
884287|NCT00616629|1850256|FG003|Overall Study|AV-block|0
884288|NCT00616629|1850257|FG004|Overall Study|AV-block|0
884289|NCT00616655|1850272|FG000|Overall Study|Adverse Event|10
884290|NCT00616655|1850273|FG001|Overall Study|Adverse Event|7
884291|NCT00616655|1850274|FG002|Overall Study|Adverse Event|12
884292|NCT00616655|1850272|FG000|Overall Study|Lack of Efficacy|5
884293|NCT00616655|1850273|FG001|Overall Study|Lack of Efficacy|5
884294|NCT00616655|1850274|FG002|Overall Study|Lack of Efficacy|5
884295|NCT00616655|1850272|FG000|Overall Study|Lost to Follow-up|3
884296|NCT00616655|1850273|FG001|Overall Study|Lost to Follow-up|12
884297|NCT00616655|1850274|FG002|Overall Study|Lost to Follow-up|10
884298|NCT00616655|1850272|FG000|Overall Study|Protocol Violation|2
884299|NCT00616655|1850273|FG001|Overall Study|Protocol Violation|4
884300|NCT00616655|1850274|FG002|Overall Study|Protocol Violation|3
884301|NCT00616655|1850272|FG000|Overall Study|Withdrawal by Subject|9
884302|NCT00616655|1850273|FG001|Overall Study|Withdrawal by Subject|7
884303|NCT00616655|1850274|FG002|Overall Study|Withdrawal by Subject|11
884304|NCT00616655|1850272|FG000|Overall Study|Does not meet in/ex criteria|0
884305|NCT00616655|1850273|FG001|Overall Study|Does not meet in/ex criteria|0
884306|NCT00616655|1850274|FG002|Overall Study|Does not meet in/ex criteria|2
884307|NCT00616655|1850272|FG000|Overall Study|Other|6
884308|NCT00616655|1850273|FG001|Overall Study|Other|6
884309|NCT00616655|1850274|FG002|Overall Study|Other|5
884310|NCT00616902|1850293|FG000|Overall Study|Termination of study|6
884311|NCT00616902|1850294|FG001|Overall Study|Termination of study|6
884312|NCT00616928|1850304|FG000|Overall Study|Adverse Event|6
884313|NCT00616928|1850305|FG001|Overall Study|Adverse Event|3
884314|NCT00616928|1850306|FG002|Overall Study|Adverse Event|2
884315|NCT00616928|1850307|FG003|Overall Study|Adverse Event|2
884316|NCT00616928|1850304|FG000|Overall Study|Other|51
884317|NCT00616928|1850305|FG001|Overall Study|Other|8
884318|NCT00616928|1850306|FG002|Overall Study|Other|15
884319|NCT00616928|1850307|FG003|Overall Study|Other|5
884320|NCT00616928|1850304|FG000|Overall Study|Lost to Follow-up|5
884321|NCT00616928|1850305|FG001|Overall Study|Lost to Follow-up|7
884322|NCT00616928|1850306|FG002|Overall Study|Lost to Follow-up|0
884323|NCT00616928|1850307|FG003|Overall Study|Lost to Follow-up|0
884324|NCT00616941|1850332|FG000|Overall Study|Progressive Disease|1
884325|NCT00616941|1850333|FG001|Overall Study|Progressive Disease|2
884326|NCT00616941|1850334|FG002|Overall Study|Progressive Disease|1
884327|NCT00616941|1850332|FG000|Overall Study|Adverse Event|0
884328|NCT00616941|1850333|FG001|Overall Study|Adverse Event|1
884329|NCT00616941|1850334|FG002|Overall Study|Adverse Event|1
884330|NCT00616941|1850332|FG000|Overall Study|Subject Non-compliance|0
884331|NCT00616941|1850333|FG001|Overall Study|Subject Non-compliance|0
884332|NCT00616941|1850334|FG002|Overall Study|Subject Non-compliance|1
884333|NCT00616941|1850332|FG000|Overall Study|Unrelated Medical Illness/Complication|0
884334|NCT00616941|1850333|FG001|Overall Study|Unrelated Medical Illness/Complication|2
884335|NCT00616941|1850334|FG002|Overall Study|Unrelated Medical Illness/Complication|0
884336|NCT00616941|1850332|FG000|Overall Study|Vaccination Suspended|0
884337|NCT00616941|1850333|FG001|Overall Study|Vaccination Suspended|0
884338|NCT00616941|1850334|FG002|Overall Study|Vaccination Suspended|3
884339|NCT00616967|1850344|FG000|Overall Study|Withdrawal by Subject|0
884340|NCT00616967|1850345|FG001|Overall Study|Withdrawal by Subject|0
884341|NCT00616967|1850346|FG002|Overall Study|Withdrawal by Subject|1
884342|NCT00617084|1850379|FG000|Overall Study|Withdrawal by Subject|5
884343|NCT00617084|1850380|FG001|Overall Study|Withdrawal by Subject|7
884344|NCT00617084|1850379|FG000|Overall Study|Missed 12 Months visit|16
884345|NCT00617084|1850380|FG001|Overall Study|Missed 12 Months visit|19
884346|NCT00617123|1850399|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36
884347|NCT00617123|1850400|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24
884348|NCT00617123|1850399|FG000|Referral Screening Period|Did Not Wish To Continue|3
884349|NCT00617123|1850400|FG001|Referral Screening Period|Did Not Wish To Continue|1
884350|NCT00617123|1850399|FG000|Referral Screening Period|Adverse Event|0
884351|NCT00617123|1850400|FG001|Referral Screening Period|Adverse Event|1
884352|NCT00617123|1850399|FG000|Study Treatment Period|Withdrawal by Subject|8
884353|NCT00617123|1850400|FG001|Study Treatment Period|Withdrawal by Subject|12
884354|NCT00617123|1850399|FG000|Study Treatment Period|Adverse Event|7
884355|NCT00617123|1850400|FG001|Study Treatment Period|Adverse Event|3
884356|NCT00617123|1850399|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2
884357|NCT00617123|1850400|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0
884358|NCT00617123|1850399|FG000|Study Treatment Period|Noncompliance with Protocol|0
884359|NCT00617123|1850400|FG001|Study Treatment Period|Noncompliance with Protocol|1
884360|NCT00617201|1850421|FG000|Overall Study|Lost to Follow-up|9
884361|NCT00617201|1850422|FG001|Overall Study|Lost to Follow-up|13
884362|NCT00617240|1850432|FG000|Overall Study|Lack of Efficacy|1
884363|NCT00617240|1850433|FG001|Overall Study|Lack of Efficacy|0
884364|NCT00617279|1850441|FG000|Overall Study|Study terminated by Sponsor|10
884365|NCT00617279|1850442|FG001|Overall Study|Study terminated by Sponsor|15
884366|NCT00617279|1850441|FG000|Overall Study|Graft abandonment|2
884367|NCT00617279|1850442|FG001|Overall Study|Graft abandonment|0
884368|NCT00617279|1850441|FG000|Overall Study|Lost to Follow-up|1
884369|NCT00617279|1850442|FG001|Overall Study|Lost to Follow-up|0
884370|NCT00617279|1850441|FG000|Overall Study|Death|1
884371|NCT00617279|1850442|FG001|Overall Study|Death|2
884372|NCT00617305|1850451|FG000|Overall Study|Adverse Event|4
884373|NCT00617305|1850452|FG001|Overall Study|Adverse Event|0
884374|NCT00617305|1850453|FG002|Overall Study|Adverse Event|0
884375|NCT00617305|1850451|FG000|Overall Study|Death|1
884376|NCT00617305|1850452|FG001|Overall Study|Death|0
884377|NCT00617305|1850453|FG002|Overall Study|Death|0
884378|NCT00617305|1850451|FG000|Overall Study|Physician Decision|1
884379|NCT00617305|1850452|FG001|Overall Study|Physician Decision|0
884380|NCT00617305|1850453|FG002|Overall Study|Physician Decision|0
884381|NCT00617305|1850451|FG000|Overall Study|Protocol Violation|1
884382|NCT00617305|1850452|FG001|Overall Study|Protocol Violation|0
884383|NCT00617305|1850453|FG002|Overall Study|Protocol Violation|1
884384|NCT00617305|1850451|FG000|Overall Study|Withdrawal by Subject|1
884385|NCT00617305|1850452|FG001|Overall Study|Withdrawal by Subject|0
884386|NCT00617305|1850453|FG002|Overall Study|Withdrawal by Subject|0
884387|NCT00617344|1850467|FG000|Overall Study|Serious adverse event|1
884388|NCT00617344|1850468|FG001|Overall Study|Serious adverse event|0
884389|NCT00617344|1850469|FG002|Overall Study|Serious adverse event|0
884390|NCT00617344|1850467|FG000|Overall Study|Other Adverse Event|1
884391|NCT00617344|1850468|FG001|Overall Study|Other Adverse Event|1
884392|NCT00617344|1850469|FG002|Overall Study|Other Adverse Event|0
884393|NCT00617344|1850467|FG000|Overall Study|Protocol Violation|10
884394|NCT00617344|1850468|FG001|Overall Study|Protocol Violation|8
884395|NCT00617344|1850469|FG002|Overall Study|Protocol Violation|5
884396|NCT00617344|1850467|FG000|Overall Study|Lost to Follow-up|5
884397|NCT00617344|1850468|FG001|Overall Study|Lost to Follow-up|4
884398|NCT00617344|1850469|FG002|Overall Study|Lost to Follow-up|1
884399|NCT00617344|1850467|FG000|Overall Study|Withdrawal by Subject|8
884400|NCT00617344|1850468|FG001|Overall Study|Withdrawal by Subject|9
884401|NCT00617344|1850469|FG002|Overall Study|Withdrawal by Subject|2
884402|NCT00617357|1850477|FG000|Overall Study|Lost to Follow-up|7
884403|NCT00617357|1850477|FG000|Overall Study|Death|5
884404|NCT00617357|1850477|FG000|Overall Study|insurance concerns|2
884405|NCT00617357|1850477|FG000|Overall Study|Withdrawal by Subject|1
884406|NCT00617357|1850477|FG000|Overall Study|Physician Decision|1
884407|NCT00617409|1850489|FG000|Overall Study|Withdrawal by Subject|4
884408|NCT00617409|1850490|FG001|Overall Study|Withdrawal by Subject|1
884409|NCT00617409|1850491|FG002|Overall Study|Withdrawal by Subject|2
884410|NCT00617409|1850489|FG000|Overall Study|Adverse Event|0
884411|NCT00617409|1850490|FG001|Overall Study|Adverse Event|2
884412|NCT00617409|1850491|FG002|Overall Study|Adverse Event|3
884413|NCT00617409|1850489|FG000|Overall Study|Disease Progression|8
884414|NCT00617409|1850490|FG001|Overall Study|Disease Progression|8
884415|NCT00617409|1850491|FG002|Overall Study|Disease Progression|18
884416|NCT00617409|1850489|FG000|Overall Study|Death|3
884417|NCT00617409|1850490|FG001|Overall Study|Death|5
884418|NCT00617409|1850491|FG002|Overall Study|Death|4
884419|NCT00617409|1850489|FG000|Overall Study|Alternative Therapy|1
884420|NCT00617409|1850490|FG001|Overall Study|Alternative Therapy|2
884421|NCT00617409|1850491|FG002|Overall Study|Alternative Therapy|0
884422|NCT00617461|1850500|FG000|First Treatment Intervention Period|Adverse Event|2
884423|NCT00617461|1850501|FG001|First Treatment Intervention Period|Adverse Event|0
884424|NCT00617461|1850500|FG000|First Treatment Intervention Period|Lack of Efficacy|1
884425|NCT00617461|1850501|FG001|First Treatment Intervention Period|Lack of Efficacy|0
884426|NCT00617461|1850500|FG000|First Treatment Intervention Period|Protocol Violation|2
884427|NCT00617461|1850501|FG001|First Treatment Intervention Period|Protocol Violation|1
884428|NCT00617461|1850500|FG000|First Treatment Intervention Period|Lost to Follow-up|0
884429|NCT00617461|1850501|FG001|First Treatment Intervention Period|Lost to Follow-up|1
884430|NCT00617461|1850500|FG000|First Treatment Intervention Period|Investigator Discretion|1
884431|NCT00617461|1850501|FG001|First Treatment Intervention Period|Investigator Discretion|1
884432|NCT00617461|1850500|FG000|First Treatment Intervention Period|Withdrawal by Subject|4
884433|NCT00617461|1850501|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
884434|NCT00617461|1850500|FG000|4-Day Crossover Period|Withdrawal by Subject|1
884435|NCT00617461|1850501|FG001|4-Day Crossover Period|Withdrawal by Subject|0
884436|NCT00617461|1850500|FG000|Second Treatment Intervention Period|Adverse Event|0
884437|NCT00617461|1850501|FG001|Second Treatment Intervention Period|Adverse Event|1
884438|NCT00617461|1850500|FG000|Second Treatment Intervention Period|Lack of Efficacy|0
884439|NCT00617461|1850501|FG001|Second Treatment Intervention Period|Lack of Efficacy|3
884440|NCT00617461|1850500|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1
884441|NCT00617461|1850501|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0
884442|NCT00617461|1850500|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
884443|NCT00617461|1850501|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
884444|NCT00617591|1850528|FG000|Overall Study|Withdrew consent during Induction|4
884445|NCT00617591|1850528|FG000|Overall Study|Withdrew consent during Maintenance|6
884446|NCT00617604|1850535|FG000|Overall Study|Death|2
884447|NCT00617604|1850536|FG001|Overall Study|Death|1
884448|NCT00617604|1850535|FG000|Overall Study|Lost to Follow-up|1
884449|NCT00617604|1850536|FG001|Overall Study|Lost to Follow-up|0
884450|NCT00617604|1850535|FG000|Overall Study|Miscellaneous Reasons|8
884451|NCT00617604|1850536|FG001|Overall Study|Miscellaneous Reasons|10
884452|NCT00617604|1850535|FG000|Overall Study|Withdrawal by Subject|4
884453|NCT00617604|1850536|FG001|Overall Study|Withdrawal by Subject|6
884454|NCT00617604|1850535|FG000|Overall Study|Randomized but Never Received Study Drug|3
884455|NCT00617604|1850536|FG001|Overall Study|Randomized but Never Received Study Drug|3
884456|NCT00617669|1850544|FG000|Overall Study|Withdrawal by Subject|71
884457|NCT00617669|1850545|FG001|Overall Study|Withdrawal by Subject|77
884458|NCT00617669|1850544|FG000|Overall Study|Lost to Follow-up|3
884459|NCT00617669|1850545|FG001|Overall Study|Lost to Follow-up|2
884460|NCT00617669|1850544|FG000|Overall Study|Adverse Event|87
884461|NCT00617669|1850545|FG001|Overall Study|Adverse Event|76
884462|NCT00617669|1850544|FG000|Overall Study|Protocol Violation|2
884463|NCT00617669|1850545|FG001|Overall Study|Protocol Violation|3
884464|NCT00617669|1850544|FG000|Overall Study|Reason not otherwise captured, eg; death|265
884465|NCT00617669|1850545|FG001|Overall Study|Reason not otherwise captured, eg; death|290
884466|NCT00617669|1850544|FG000|Overall Study|Patients randomized but not treated|2
884467|NCT00617669|1850545|FG001|Overall Study|Patients randomized but not treated|3
884468|NCT00617708|1850554|FG000|Overall Study|Adverse Event|0
884469|NCT00617708|1850555|FG001|Overall Study|Adverse Event|6
884470|NCT00617708|1850556|FG002|Overall Study|Adverse Event|9
884471|NCT00617708|1850554|FG000|Overall Study|Withdrawal by Subject|1
884472|NCT00617708|1850555|FG001|Overall Study|Withdrawal by Subject|1
884473|NCT00617708|1850556|FG002|Overall Study|Withdrawal by Subject|7
884474|NCT00617708|1850554|FG000|Overall Study|Death|0
884475|NCT00617708|1850555|FG001|Overall Study|Death|6
884476|NCT00617708|1850556|FG002|Overall Study|Death|5
884477|NCT00617708|1850554|FG000|Overall Study|Progression/Relapse|7
884478|NCT00617708|1850555|FG001|Overall Study|Progression/Relapse|40
884479|NCT00617708|1850556|FG002|Overall Study|Progression/Relapse|36
884480|NCT00617708|1850554|FG000|Overall Study|Not protocol specified|1
884481|NCT00617708|1850555|FG001|Overall Study|Not protocol specified|4
884482|NCT00617708|1850556|FG002|Overall Study|Not protocol specified|2
884483|NCT00617708|1850554|FG000|Overall Study|Not eligible|1
884484|NCT00617708|1850555|FG001|Overall Study|Not eligible|3
884485|NCT00617708|1850556|FG002|Overall Study|Not eligible|5
884486|NCT00617734|1850568|FG000|Overall Study|Withdrew Consent|2
884487|NCT00617734|1850569|FG001|Overall Study|Withdrew Consent|0
884488|NCT00617734|1850568|FG000|Overall Study|Adverse Event|4
884489|NCT00617734|1850569|FG001|Overall Study|Adverse Event|1
884490|NCT00617734|1850568|FG000|Overall Study|Protocol Violation|1
884491|NCT00617734|1850569|FG001|Overall Study|Protocol Violation|0
884492|NCT00617734|1850568|FG000|Overall Study|Found Ineligible After Randomization|1
884493|NCT00617734|1850569|FG001|Overall Study|Found Ineligible After Randomization|4
884494|NCT00617734|1850568|FG000|Overall Study|Lost to Follow-up|0
884495|NCT00617734|1850569|FG001|Overall Study|Lost to Follow-up|1
884496|NCT00617773|1850575|FG000|Overall Study|Physician Decision|1
884497|NCT00617773|1850575|FG000|Overall Study|Lack of compliance with the protocol|1
884498|NCT00617773|1850575|FG000|Overall Study|Withdrawal by Subject|1
884499|NCT00617773|1850575|FG000|Overall Study|Death|1
884500|NCT00617773|1850575|FG000|Overall Study|Progressive disease|19
884501|NCT00617773|1850575|FG000|Overall Study|Protocol Violation|1
884502|NCT00617851|1850583|FG000|Overall Study|Death|0
884503|NCT00617851|1850584|FG001|Overall Study|Death|0
884504|NCT00617851|1850585|FG002|Overall Study|Death|0
884505|NCT00617851|1850586|FG003|Overall Study|Death|1
884506|NCT00617851|1850583|FG000|Overall Study|Withdrawal by Subject|14
884507|NCT00617851|1850584|FG001|Overall Study|Withdrawal by Subject|7
884508|NCT00617851|1850585|FG002|Overall Study|Withdrawal by Subject|12
884509|NCT00617851|1850586|FG003|Overall Study|Withdrawal by Subject|4
884510|NCT00617851|1850583|FG000|Overall Study|Lost to Follow-up|27
884511|NCT00617851|1850584|FG001|Overall Study|Lost to Follow-up|29
884512|NCT00617851|1850585|FG002|Overall Study|Lost to Follow-up|31
884513|NCT00617851|1850586|FG003|Overall Study|Lost to Follow-up|19
884514|NCT00617851|1850583|FG000|Overall Study|Inappropriate Enrollment|5
884515|NCT00617851|1850584|FG001|Overall Study|Inappropriate Enrollment|4
884516|NCT00617851|1850585|FG002|Overall Study|Inappropriate Enrollment|1
884517|NCT00617851|1850586|FG003|Overall Study|Inappropriate Enrollment|1
884518|NCT00617851|1850583|FG000|Overall Study|Unable to classify|1
884519|NCT00617851|1850584|FG001|Overall Study|Unable to classify|0
884520|NCT00617851|1850585|FG002|Overall Study|Unable to classify|1
884521|NCT00617851|1850586|FG003|Overall Study|Unable to classify|0
884522|NCT00617890|1850610|FG000|Overall Study|Treatment ongoing at data cut-off|0
884523|NCT00617890|1850611|FG001|Overall Study|Treatment ongoing at data cut-off|0
884524|NCT00617890|1850612|FG002|Overall Study|Treatment ongoing at data cut-off|0
884525|NCT00617890|1850613|FG003|Overall Study|Treatment ongoing at data cut-off|5
884526|NCT00617890|1850610|FG000|Overall Study|Lack of Efficacy|23
884527|NCT00617890|1850611|FG001|Overall Study|Lack of Efficacy|26
884528|NCT00617890|1850612|FG002|Overall Study|Lack of Efficacy|30
884529|NCT00617890|1850613|FG003|Overall Study|Lack of Efficacy|97
884530|NCT00617890|1850610|FG000|Overall Study|Lost to Follow-up|0
884531|NCT00617890|1850611|FG001|Overall Study|Lost to Follow-up|0
884532|NCT00617890|1850612|FG002|Overall Study|Lost to Follow-up|1
884533|NCT00617890|1850613|FG003|Overall Study|Lost to Follow-up|2
884534|NCT00617890|1850610|FG000|Overall Study|Withdrawal by Subject|4
884535|NCT00617890|1850611|FG001|Overall Study|Withdrawal by Subject|1
884536|NCT00617890|1850612|FG002|Overall Study|Withdrawal by Subject|0
884537|NCT00617890|1850613|FG003|Overall Study|Withdrawal by Subject|2
884538|NCT00617890|1850610|FG000|Overall Study|Protocol Violation|2
884539|NCT00617890|1850611|FG001|Overall Study|Protocol Violation|1
884540|NCT00617890|1850612|FG002|Overall Study|Protocol Violation|0
884541|NCT00617890|1850613|FG003|Overall Study|Protocol Violation|0
884542|NCT00617890|1850610|FG000|Overall Study|Adverse Event|1
884543|NCT00617890|1850611|FG001|Overall Study|Adverse Event|0
884544|NCT00617890|1850612|FG002|Overall Study|Adverse Event|3
884545|NCT00617890|1850613|FG003|Overall Study|Adverse Event|8
884546|NCT00617890|1850610|FG000|Overall Study|Not treated|1
884547|NCT00617890|1850611|FG001|Overall Study|Not treated|0
884548|NCT00617890|1850612|FG002|Overall Study|Not treated|1
884549|NCT00617890|1850613|FG003|Overall Study|Not treated|1
884550|NCT00617903|1850628|FG000|Overall Study|Withdrawal by Subject|2
884551|NCT00617903|1850629|FG001|Overall Study|Withdrawal by Subject|3
884552|NCT00617903|1850628|FG000|Overall Study|Lost to Follow-up|1
884553|NCT00617903|1850629|FG001|Overall Study|Lost to Follow-up|1
884554|NCT00617903|1850628|FG000|Overall Study|Lack of Efficacy|0
884555|NCT00617903|1850629|FG001|Overall Study|Lack of Efficacy|1
884556|NCT00617903|1850628|FG000|Overall Study|Adverse Event|0
884557|NCT00617903|1850629|FG001|Overall Study|Adverse Event|1
884558|NCT00617903|1850628|FG000|Overall Study|noncompliance|0
884559|NCT00617903|1850629|FG001|Overall Study|noncompliance|1
884560|NCT00617929|1850635|FG000|Overall Study|Physician Decision|1
884561|NCT00618072|1850666|FG000|Overall Study|Lost to Follow-up|2
884562|NCT00618072|1850667|FG001|Overall Study|Lost to Follow-up|0
884563|NCT00618072|1850668|FG002|Overall Study|Lost to Follow-up|3
884564|NCT00618072|1850666|FG000|Overall Study|Physician Decision|0
884565|NCT00618072|1850667|FG001|Overall Study|Physician Decision|1
884566|NCT00618072|1850668|FG002|Overall Study|Physician Decision|1
884567|NCT00618371|1850685|FG000|Overall Study|Withdrawal by Subject|2
884568|NCT00618410|1850690|FG000|Washout Period (2 Weeks)|Physician Decision|0
884569|NCT00618410|1850691|FG001|Washout Period (2 Weeks)|Physician Decision|1
884570|NCT00618449|1850708|FG000|Overall Study|Lost to Follow-up|98
884571|NCT00618449|1850709|FG001|Overall Study|Lost to Follow-up|110
884572|NCT00618514|1850717|FG000|Overall Study|Lost to Follow-up|11
884573|NCT00618514|1850718|FG001|Overall Study|Lost to Follow-up|12
884574|NCT00618514|1850719|FG002|Overall Study|Lost to Follow-up|4
884575|NCT00618618|1850734|FG000|Overall Study|Patient Request|0
884576|NCT00618618|1850735|FG001|Overall Study|Patient Request|0
884577|NCT00618618|1850736|FG002|Overall Study|Patient Request|2
884578|NCT00618618|1850737|FG003|Overall Study|Patient Request|0
884579|NCT00618618|1850734|FG000|Overall Study|Inability to Complete Study Procedures|0
884580|NCT00618618|1850735|FG001|Overall Study|Inability to Complete Study Procedures|1
884581|NCT00618618|1850736|FG002|Overall Study|Inability to Complete Study Procedures|0
884582|NCT00618618|1850737|FG003|Overall Study|Inability to Complete Study Procedures|0
884583|NCT00618618|1850734|FG000|Overall Study|Lost to Follow-up|3
884584|NCT00618618|1850735|FG001|Overall Study|Lost to Follow-up|0
884585|NCT00618618|1850736|FG002|Overall Study|Lost to Follow-up|0
884586|NCT00618618|1850737|FG003|Overall Study|Lost to Follow-up|1
884587|NCT00618618|1850734|FG000|Overall Study|Non-compliance|1
884588|NCT00618618|1850735|FG001|Overall Study|Non-compliance|1
884589|NCT00618618|1850736|FG002|Overall Study|Non-compliance|0
884590|NCT00618618|1850737|FG003|Overall Study|Non-compliance|0
884591|NCT00618618|1850734|FG000|Overall Study|Did Not Meet Entry Criteria|0
884592|NCT00618618|1850735|FG001|Overall Study|Did Not Meet Entry Criteria|0
884593|NCT00618618|1850736|FG002|Overall Study|Did Not Meet Entry Criteria|1
884594|NCT00618618|1850737|FG003|Overall Study|Did Not Meet Entry Criteria|0
884595|NCT00618618|1850734|FG000|Overall Study|Death|0
884596|NCT00618618|1850735|FG001|Overall Study|Death|1
884597|NCT00618618|1850736|FG002|Overall Study|Death|0
884598|NCT00618618|1850737|FG003|Overall Study|Death|0
884599|NCT00618722|1850752|FG000|Overall Study|Refusal of Treatment|0
884600|NCT00618722|1850753|FG001|Overall Study|Refusal of Treatment|0
884601|NCT00618722|1850754|FG002|Overall Study|Refusal of Treatment|1
884602|NCT00618722|1850755|FG003|Overall Study|Refusal of Treatment|0
884603|NCT00618722|1850752|FG000|Overall Study|Patient Request|1
884604|NCT00618722|1850753|FG001|Overall Study|Patient Request|1
884605|NCT00618722|1850754|FG002|Overall Study|Patient Request|1
884606|NCT00618722|1850755|FG003|Overall Study|Patient Request|1
884607|NCT00618722|1850752|FG000|Overall Study|Inability to Complete Study Procedure|0
884608|NCT00618722|1850753|FG001|Overall Study|Inability to Complete Study Procedure|1
884609|NCT00618722|1850754|FG002|Overall Study|Inability to Complete Study Procedure|0
884610|NCT00618722|1850755|FG003|Overall Study|Inability to Complete Study Procedure|0
884611|NCT00618722|1850752|FG000|Overall Study|Lost to Follow-up|2
884612|NCT00618722|1850753|FG001|Overall Study|Lost to Follow-up|0
884613|NCT00618722|1850754|FG002|Overall Study|Lost to Follow-up|0
884614|NCT00618722|1850755|FG003|Overall Study|Lost to Follow-up|2
884615|NCT00618722|1850752|FG000|Overall Study|Miscellaneous Reasons|0
884616|NCT00618722|1850753|FG001|Overall Study|Miscellaneous Reasons|0
884617|NCT00618722|1850754|FG002|Overall Study|Miscellaneous Reasons|1
884618|NCT00618722|1850755|FG003|Overall Study|Miscellaneous Reasons|1
884619|NCT00618748|1850768|FG000|Overall Study|Adverse Event|4
884620|NCT00618748|1850769|FG001|Overall Study|Adverse Event|3
884621|NCT00618748|1850770|FG002|Overall Study|Adverse Event|8
884622|NCT00618748|1850768|FG000|Overall Study|Physician Decision|3
884623|NCT00618748|1850769|FG001|Overall Study|Physician Decision|1
884624|NCT00618748|1850770|FG002|Overall Study|Physician Decision|1
884625|NCT00618748|1850768|FG000|Overall Study|Withdrawal by Subject|4
884626|NCT00618748|1850769|FG001|Overall Study|Withdrawal by Subject|1
884627|NCT00618748|1850770|FG002|Overall Study|Withdrawal by Subject|5
884628|NCT00618774|1850780|FG000|Overall Study|Adverse Event|5
884629|NCT00618774|1850781|FG001|Overall Study|Adverse Event|3
884630|NCT00618774|1850780|FG000|Overall Study|Withdrawal by Subject|1
884631|NCT00618774|1850781|FG001|Overall Study|Withdrawal by Subject|0
884632|NCT00618787|1850789|FG000|Overall Study|Adverse Event|0
884633|NCT00618787|1850790|FG001|Overall Study|Adverse Event|1
884634|NCT00618787|1850789|FG000|Overall Study|Withdrawal by Subject|2
884635|NCT00618787|1850790|FG001|Overall Study|Withdrawal by Subject|1
884636|NCT00618787|1850789|FG000|Overall Study|Lost to Follow-up|1
884637|NCT00618787|1850790|FG001|Overall Study|Lost to Follow-up|0
884638|NCT00618813|1850796|FG000|Overall Study|Lack of Efficacy|1
884639|NCT00618813|1850796|FG000|Overall Study|Physician Decision|2
884640|NCT00618813|1850796|FG000|Overall Study|Withdrawal by Subject|1
884641|NCT00618826|1850800|FG000|Overall Study|Adverse Event|1
884642|NCT00618956|1850827|FG000|Overall Study|Adverse Event|10
884643|NCT00618956|1850828|FG001|Overall Study|Adverse Event|34
884644|NCT00618956|1850827|FG000|Overall Study|Lack of Efficacy|2
884645|NCT00618956|1850828|FG001|Overall Study|Lack of Efficacy|1
884646|NCT00618956|1850827|FG000|Overall Study|Withdrawal by Subject|5
884647|NCT00618956|1850828|FG001|Overall Study|Withdrawal by Subject|7
884648|NCT00618956|1850827|FG000|Overall Study|Lost to Follow-up|4
884649|NCT00618956|1850828|FG001|Overall Study|Lost to Follow-up|5
884650|NCT00618956|1850827|FG000|Overall Study|Protocol Violation|2
884651|NCT00618956|1850828|FG001|Overall Study|Protocol Violation|2
884652|NCT00618956|1850827|FG000|Overall Study|did not meet criteria, non-compliance|2
884653|NCT00618956|1850828|FG001|Overall Study|did not meet criteria, non-compliance|1
884654|NCT00618982|1850840|FG000|Overall Study|Adverse Event|23
884655|NCT00618982|1850840|FG000|Overall Study|Withdrawal by Subject|1
884656|NCT00618982|1850840|FG000|Overall Study|Protocol Violation|1
884657|NCT00618982|1850840|FG000|Overall Study|ongoing, still treated with study med.|25
884658|NCT00618995|1850847|FG000|Period 1|Adverse Event|0
884659|NCT00618995|1850848|FG001|Period 1|Adverse Event|0
884660|NCT00618995|1850849|FG002|Period 1|Adverse Event|1
884661|NCT00618995|1850850|FG003|Period 1|Adverse Event|0
884662|NCT00618995|1850847|FG000|Period 1|Protocol Violation|0
884663|NCT00618995|1850848|FG001|Period 1|Protocol Violation|1
884664|NCT00618995|1850849|FG002|Period 1|Protocol Violation|1
884665|NCT00618995|1850850|FG003|Period 1|Protocol Violation|0
884666|NCT00618995|1850847|FG000|Period 2|Protocol Violation|0
884667|NCT00618995|1850848|FG001|Period 2|Protocol Violation|0
884668|NCT00618995|1850849|FG002|Period 2|Protocol Violation|1
884669|NCT00618995|1850850|FG003|Period 2|Protocol Violation|0
884670|NCT00618995|1850847|FG000|Period 4|Adverse Event|1
884671|NCT00618995|1850848|FG001|Period 4|Adverse Event|0
884672|NCT00618995|1850849|FG002|Period 4|Adverse Event|0
884673|NCT00618995|1850850|FG003|Period 4|Adverse Event|0
884674|NCT00619099|1850878|FG000|Overall Study|Progressive Disease|7
884675|NCT00619099|1850879|FG001|Overall Study|Progressive Disease|5
884676|NCT00619099|1850878|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2
884677|NCT00619099|1850879|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1
884678|NCT00619099|1850878|FG000|Overall Study|Adverse Event|4
884679|NCT00619099|1850879|FG001|Overall Study|Adverse Event|3
884680|NCT00619099|1850878|FG000|Overall Study|Emergence of Clinically Significant Lab|1
884681|NCT00619099|1850879|FG001|Overall Study|Emergence of Clinically Significant Lab|2
884682|NCT00619099|1850878|FG000|Overall Study|Withdrawal by Subject|10
884683|NCT00619099|1850879|FG001|Overall Study|Withdrawal by Subject|2
884684|NCT00619099|1850878|FG000|Overall Study|Physician Decision|9
884685|NCT00619099|1850879|FG001|Overall Study|Physician Decision|6
884686|NCT00619112|1850887|FG000|Overall Study|Adverse Event|1
884687|NCT00619112|1850888|FG001|Overall Study|Adverse Event|2
884688|NCT00619177|1850897|FG000|Overall Study|Adverse Event|18
884689|NCT00619177|1850897|FG000|Overall Study|Lost to Follow-up|2
884690|NCT00619177|1850897|FG000|Overall Study|Lack of Efficacy|1
884691|NCT00619177|1850897|FG000|Overall Study|Missing termination information|481
884692|NCT00619177|1850897|FG000|Overall Study|Not specified reasons|6
884693|NCT00619229|1850912|FG000|Overall Study|Withdrawal by Subject|1
884694|NCT00619229|1850913|FG001|Overall Study|Withdrawal by Subject|1
884695|NCT00619229|1850912|FG000|Overall Study|Lost to Follow-up|1
884696|NCT00619229|1850913|FG001|Overall Study|Lost to Follow-up|0
884697|NCT00619229|1850912|FG000|Overall Study|Termination of the Study by the Sponsor|1
884698|NCT00619229|1850913|FG001|Overall Study|Termination of the Study by the Sponsor|1
884699|NCT00619229|1850912|FG000|Overall Study|Investigator planned Cataract Operation|1
884700|NCT00619229|1850913|FG001|Overall Study|Investigator planned Cataract Operation|0
884701|NCT00619307|1850930|FG000|Overall Study|Adverse Event|0
884702|NCT00619307|1850931|FG001|Overall Study|Adverse Event|1
884703|NCT00619307|1850930|FG000|Overall Study|Lost to Follow-up|0
884704|NCT00619307|1850931|FG001|Overall Study|Lost to Follow-up|1
884705|NCT00619307|1850930|FG000|Overall Study|Protocol Violation|3
884706|NCT00619307|1850931|FG001|Overall Study|Protocol Violation|0
884707|NCT00619307|1850930|FG000|Overall Study|Withdrew consent|1
884708|NCT00619307|1850931|FG001|Overall Study|Withdrew consent|0
884709|NCT00619307|1850930|FG000|Overall Study|Severe migraine|0
884710|NCT00619307|1850931|FG001|Overall Study|Severe migraine|1
884711|NCT00619307|1850930|FG000|Overall Study|MS attack plus steroids|0
884712|NCT00619307|1850931|FG001|Overall Study|MS attack plus steroids|1
884713|NCT00619359|1850939|FG000|Overall Study|Adverse Event|32
884714|NCT00619359|1850940|FG001|Overall Study|Adverse Event|36
884715|NCT00619359|1850939|FG000|Overall Study|Lost to Follow-up|12
884716|NCT00619359|1850940|FG001|Overall Study|Lost to Follow-up|16
884717|NCT00619359|1850939|FG000|Overall Study|Physician Decision|0
884718|NCT00619359|1850940|FG001|Overall Study|Physician Decision|7
884719|NCT00619359|1850939|FG000|Overall Study|Protocol Violation|1
884720|NCT00619359|1850940|FG001|Overall Study|Protocol Violation|1
884721|NCT00619359|1850939|FG000|Overall Study|Withdrawal by Subject|19
884722|NCT00619359|1850940|FG001|Overall Study|Withdrawal by Subject|20
884723|NCT00619359|1850939|FG000|Overall Study|Progressive Disease|3
884724|NCT00619359|1850940|FG001|Overall Study|Progressive Disease|1
884725|NCT00619385|1850949|FG000|Overall Study|Adverse Event|0
884726|NCT00619385|1850950|FG001|Overall Study|Adverse Event|0
884727|NCT00619385|1850951|FG002|Overall Study|Adverse Event|3
884728|NCT00619385|1850949|FG000|Overall Study|Other|1
884729|NCT00619385|1850950|FG001|Overall Study|Other|2
884730|NCT00619385|1850951|FG002|Overall Study|Other|1
884731|NCT00619476|1850966|FG000|Overall Study|Adverse Event|12
884732|NCT00619476|1850967|FG001|Overall Study|Adverse Event|6
884733|NCT00619476|1850968|FG002|Overall Study|Adverse Event|12
884734|NCT00619476|1850969|FG003|Overall Study|Adverse Event|16
884735|NCT00619476|1850966|FG000|Overall Study|Lack of Efficacy|6
884736|NCT00619476|1850967|FG001|Overall Study|Lack of Efficacy|1
884737|NCT00619476|1850968|FG002|Overall Study|Lack of Efficacy|1
884738|NCT00619476|1850969|FG003|Overall Study|Lack of Efficacy|4
884739|NCT00619476|1850966|FG000|Overall Study|Protocol Violation|5
884740|NCT00619476|1850967|FG001|Overall Study|Protocol Violation|4
884741|NCT00619476|1850968|FG002|Overall Study|Protocol Violation|4
884742|NCT00619476|1850969|FG003|Overall Study|Protocol Violation|9
884743|NCT00619476|1850966|FG000|Overall Study|Lost to Follow-up|1
884744|NCT00619476|1850967|FG001|Overall Study|Lost to Follow-up|2
884745|NCT00619476|1850968|FG002|Overall Study|Lost to Follow-up|0
884746|NCT00619476|1850969|FG003|Overall Study|Lost to Follow-up|1
884747|NCT00619476|1850966|FG000|Overall Study|Investigator Discretion|2
884748|NCT00619476|1850967|FG001|Overall Study|Investigator Discretion|2
884749|NCT00619476|1850968|FG002|Overall Study|Investigator Discretion|2
884750|NCT00619476|1850969|FG003|Overall Study|Investigator Discretion|0
884751|NCT00619476|1850966|FG000|Overall Study|Withdrawal by Subject|5
884752|NCT00619476|1850967|FG001|Overall Study|Withdrawal by Subject|7
884753|NCT00619476|1850968|FG002|Overall Study|Withdrawal by Subject|5
884754|NCT00619476|1850969|FG003|Overall Study|Withdrawal by Subject|4
884755|NCT00619489|1850981|FG000|Overall Study|Adverse Event|0
884756|NCT00619489|1850982|FG001|Overall Study|Adverse Event|7
884757|NCT00619489|1850981|FG000|Overall Study|Withdrawal by Subject|1
884758|NCT00619489|1850982|FG001|Overall Study|Withdrawal by Subject|1
884759|NCT00619489|1850981|FG000|Overall Study|Lack of Efficacy|0
884760|NCT00619489|1850982|FG001|Overall Study|Lack of Efficacy|11
884761|NCT00619489|1850981|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22
884762|NCT00619489|1850982|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15
884763|NCT00619502|1850990|FG000|Overall Study|Lost to Follow-up|8
884764|NCT00619502|1850991|FG001|Overall Study|Lost to Follow-up|10
884765|NCT00619619|1851007|FG000|Overall Study|Physician Decision|0
884766|NCT00619619|1851008|FG001|Overall Study|Physician Decision|0
884767|NCT00619619|1851009|FG002|Overall Study|Physician Decision|1
884768|NCT00619619|1851010|FG003|Overall Study|Physician Decision|0
884769|NCT00619619|1851011|FG004|Overall Study|Physician Decision|0
884770|NCT00619619|1851012|FG005|Overall Study|Physician Decision|0
884771|NCT00619619|1851013|FG006|Overall Study|Physician Decision|0
884772|NCT00619619|1851014|FG007|Overall Study|Physician Decision|0
884773|NCT00619619|1851007|FG000|Overall Study|Protocol Violation|0
884774|NCT00619619|1851008|FG001|Overall Study|Protocol Violation|0
884775|NCT00619619|1851009|FG002|Overall Study|Protocol Violation|0
884776|NCT00619619|1851010|FG003|Overall Study|Protocol Violation|1
884777|NCT00619619|1851011|FG004|Overall Study|Protocol Violation|0
884778|NCT00619619|1851012|FG005|Overall Study|Protocol Violation|0
884779|NCT00619619|1851013|FG006|Overall Study|Protocol Violation|1
884780|NCT00619619|1851014|FG007|Overall Study|Protocol Violation|1
884781|NCT00619619|1851007|FG000|Overall Study|Adverse Event|0
884782|NCT00619619|1851008|FG001|Overall Study|Adverse Event|0
884783|NCT00619619|1851009|FG002|Overall Study|Adverse Event|0
884784|NCT00619619|1851010|FG003|Overall Study|Adverse Event|0
884785|NCT00619619|1851011|FG004|Overall Study|Adverse Event|2
884786|NCT00619619|1851012|FG005|Overall Study|Adverse Event|0
884787|NCT00619619|1851013|FG006|Overall Study|Adverse Event|0
884788|NCT00619619|1851014|FG007|Overall Study|Adverse Event|2
884789|NCT00619645|1851035|FG000|Overall Study|Adverse Event|1
884790|NCT00619801|1851059|FG000|Overall Study|Lack of Efficacy|0
884791|NCT00619801|1851060|FG001|Overall Study|Lack of Efficacy|1
884792|NCT00619801|1851059|FG000|Overall Study|Withdrawal by Subject|1
884793|NCT00619801|1851060|FG001|Overall Study|Withdrawal by Subject|1
884794|NCT00619801|1851059|FG000|Overall Study|Loss of efficacy|0
884795|NCT00619801|1851060|FG001|Overall Study|Loss of efficacy|1
884796|NCT00619827|1851068|FG000|Overall Study|Adverse Event|1
884797|NCT00619827|1851069|FG001|Overall Study|Adverse Event|2
884798|NCT00619827|1851068|FG000|Overall Study|Withdrawal by Subject|2
884799|NCT00619827|1851069|FG001|Overall Study|Withdrawal by Subject|2
884800|NCT00619866|1851078|FG000|Weeks 1 - 12|Adverse Event|0
884801|NCT00619866|1851079|FG001|Weeks 1 - 12|Adverse Event|1
884802|NCT00619866|1851080|FG002|Weeks 1 - 12|Adverse Event|2
884803|NCT00619866|1851081|FG003|Weeks 1 - 12|Adverse Event|0
884804|NCT00619866|1851082|FG004|Weeks 1 - 12|Adverse Event|0
884805|NCT00619866|1851078|FG000|Weeks 1 - 12|Non-compliance|0
884806|NCT00619866|1851079|FG001|Weeks 1 - 12|Non-compliance|0
884807|NCT00619866|1851080|FG002|Weeks 1 - 12|Non-compliance|1
884808|NCT00619866|1851081|FG003|Weeks 1 - 12|Non-compliance|0
884809|NCT00619866|1851082|FG004|Weeks 1 - 12|Non-compliance|0
884810|NCT00619866|1851078|FG000|Weeks 1 - 12|Withdrawal by Subject|7
884811|NCT00619866|1851079|FG001|Weeks 1 - 12|Withdrawal by Subject|2
884812|NCT00619866|1851080|FG002|Weeks 1 - 12|Withdrawal by Subject|4
884813|NCT00619866|1851081|FG003|Weeks 1 - 12|Withdrawal by Subject|0
884814|NCT00619866|1851082|FG004|Weeks 1 - 12|Withdrawal by Subject|0
884815|NCT00619866|1851078|FG000|Weeks 1 - 12|Lack of Efficacy|3
884816|NCT00619866|1851079|FG001|Weeks 1 - 12|Lack of Efficacy|2
884817|NCT00619866|1851080|FG002|Weeks 1 - 12|Lack of Efficacy|1
884818|NCT00619866|1851081|FG003|Weeks 1 - 12|Lack of Efficacy|0
884819|NCT00619866|1851082|FG004|Weeks 1 - 12|Lack of Efficacy|0
884820|NCT00619866|1851078|FG000|Weeks 1 - 12|Lost to Follow-up|4
884821|NCT00619866|1851079|FG001|Weeks 1 - 12|Lost to Follow-up|0
884822|NCT00619866|1851080|FG002|Weeks 1 - 12|Lost to Follow-up|2
884823|NCT00619866|1851081|FG003|Weeks 1 - 12|Lost to Follow-up|0
884824|NCT00619866|1851082|FG004|Weeks 1 - 12|Lost to Follow-up|0
884825|NCT00619866|1851078|FG000|Weeks 1 - 12|Sponsor Decision|0
884826|NCT00619866|1851079|FG001|Weeks 1 - 12|Sponsor Decision|1
884827|NCT00619866|1851080|FG002|Weeks 1 - 12|Sponsor Decision|0
884828|NCT00619866|1851081|FG003|Weeks 1 - 12|Sponsor Decision|0
884829|NCT00619866|1851082|FG004|Weeks 1 - 12|Sponsor Decision|0
884830|NCT00619866|1851078|FG000|Weeks 13 - 24|Adverse Event|0
884831|NCT00619866|1851079|FG001|Weeks 13 - 24|Adverse Event|0
884832|NCT00619866|1851080|FG002|Weeks 13 - 24|Adverse Event|2
884833|NCT00619866|1851081|FG003|Weeks 13 - 24|Adverse Event|1
884834|NCT00619866|1851082|FG004|Weeks 13 - 24|Adverse Event|0
884835|NCT00619866|1851078|FG000|Weeks 13 - 24|Protocol Deviation|0
884836|NCT00619866|1851079|FG001|Weeks 13 - 24|Protocol Deviation|0
884837|NCT00619866|1851080|FG002|Weeks 13 - 24|Protocol Deviation|0
884838|NCT00619866|1851081|FG003|Weeks 13 - 24|Protocol Deviation|1
884839|NCT00619866|1851082|FG004|Weeks 13 - 24|Protocol Deviation|0
884840|NCT00619866|1851078|FG000|Weeks 13 - 24|Withdrawal by Subject|0
884841|NCT00619866|1851079|FG001|Weeks 13 - 24|Withdrawal by Subject|3
884842|NCT00619866|1851080|FG002|Weeks 13 - 24|Withdrawal by Subject|2
884843|NCT00619866|1851081|FG003|Weeks 13 - 24|Withdrawal by Subject|2
884844|NCT00619866|1851082|FG004|Weeks 13 - 24|Withdrawal by Subject|2
884845|NCT00619866|1851078|FG000|Weeks 13 - 24|Non-compliance|0
884846|NCT00619866|1851079|FG001|Weeks 13 - 24|Non-compliance|1
884847|NCT00619866|1851080|FG002|Weeks 13 - 24|Non-compliance|1
884848|NCT00619866|1851081|FG003|Weeks 13 - 24|Non-compliance|0
884849|NCT00619866|1851082|FG004|Weeks 13 - 24|Non-compliance|0
884850|NCT00619866|1851078|FG000|Weeks 13 - 24|Lost to Follow-up|0
884851|NCT00619866|1851079|FG001|Weeks 13 - 24|Lost to Follow-up|3
884852|NCT00619866|1851080|FG002|Weeks 13 - 24|Lost to Follow-up|0
884853|NCT00619866|1851081|FG003|Weeks 13 - 24|Lost to Follow-up|0
884854|NCT00619866|1851082|FG004|Weeks 13 - 24|Lost to Follow-up|0
884855|NCT00619892|1851096|FG000|Overall Study|Adverse Event|3
884856|NCT00619892|1851097|FG001|Overall Study|Adverse Event|0
884857|NCT00619892|1851096|FG000|Overall Study|Lost to Follow-up|0
884858|NCT00619892|1851097|FG001|Overall Study|Lost to Follow-up|1
884859|NCT00619892|1851096|FG000|Overall Study|Intercurrent illness|0
884860|NCT00619892|1851097|FG001|Overall Study|Intercurrent illness|1
884861|NCT00619918|1851107|FG000|Overall Study|Withdrawal by Subject|4
884862|NCT00619918|1851108|FG001|Overall Study|Withdrawal by Subject|3
884863|NCT00619918|1851107|FG000|Overall Study|Physician Decision|8
884864|NCT00619918|1851108|FG001|Overall Study|Physician Decision|8
884865|NCT00619918|1851107|FG000|Overall Study|Transfer to outside facility|3
884866|NCT00619918|1851108|FG001|Overall Study|Transfer to outside facility|3
884867|NCT00619918|1851107|FG000|Overall Study|Left before receiving first dose|5
884868|NCT00619918|1851108|FG001|Overall Study|Left before receiving first dose|8
884869|NCT00619957|1851116|FG000|Month 24 Double-Blind|Adverse Event|9
884870|NCT00619957|1851117|FG001|Month 24 Double-Blind|Adverse Event|7
884871|NCT00619957|1851116|FG000|Month 24 Double-Blind|Protocol Violation|1
884872|NCT00619957|1851117|FG001|Month 24 Double-Blind|Protocol Violation|0
884873|NCT00619957|1851116|FG000|Month 24 Double-Blind|Withdrawal by Subject|7
884874|NCT00619957|1851117|FG001|Month 24 Double-Blind|Withdrawal by Subject|9
884875|NCT00619957|1851116|FG000|Month 24 Double-Blind|Lost to Follow-up|1
884876|NCT00619957|1851117|FG001|Month 24 Double-Blind|Lost to Follow-up|0
884877|NCT00619957|1851116|FG000|Month 24 Double-Blind|Did not take any study medication|0
884878|NCT00619957|1851117|FG001|Month 24 Double-Blind|Did not take any study medication|1
884879|NCT00619957|1851116|FG000|Month 48 Open-Label|Adverse Event|4
884880|NCT00619957|1851117|FG001|Month 48 Open-Label|Adverse Event|4
884881|NCT00619957|1851116|FG000|Month 48 Open-Label|Lost to Follow-up|2
884882|NCT00619957|1851117|FG001|Month 48 Open-Label|Lost to Follow-up|4
884883|NCT00619957|1851116|FG000|Month 48 Open-Label|Withdrawal by Subject|6
884884|NCT00619957|1851117|FG001|Month 48 Open-Label|Withdrawal by Subject|9
884885|NCT00619983|1851144|FG000|Test Drug Alone|Withdrawal by Subject|1
884886|NCT00619983|1851145|FG001|Test Drug Alone|Withdrawal by Subject|0
884887|NCT00619983|1851146|FG002|Test Drug Alone|Withdrawal by Subject|0
884888|NCT00619983|1851147|FG003|Test Drug Alone|Withdrawal by Subject|1
884889|NCT00619983|1851144|FG000|Test Drug Alone|Failure of daily diary device|1
884890|NCT00619983|1851145|FG001|Test Drug Alone|Failure of daily diary device|1
884891|NCT00619983|1851146|FG002|Test Drug Alone|Failure of daily diary device|2
884892|NCT00619983|1851147|FG003|Test Drug Alone|Failure of daily diary device|2
884893|NCT00620022|1851157|FG000|Treatment Period 1|Adverse Event|4
884894|NCT00620022|1851158|FG001|Treatment Period 1|Adverse Event|6
884895|NCT00620022|1851157|FG000|Treatment Period 1|Subject withdrew consent|1
884896|NCT00620022|1851158|FG001|Treatment Period 1|Subject withdrew consent|0
884897|NCT00620022|1851157|FG000|Treatment Period 2|Adverse Event|2
884898|NCT00620022|1851158|FG001|Treatment Period 2|Adverse Event|2
884899|NCT00620035|1851164|FG000|Overall Study|Adverse Event|106
884900|NCT00620035|1851164|FG000|Overall Study|Withdrawal of Informed Consent|1
884901|NCT00620035|1851164|FG000|Overall Study|Other Reason|38
884902|NCT00620074|1851173|FG000|Overall Study|Adverse Event|1
884903|NCT00620113|1851181|FG000|Overall Study|Adverse Event|3
884904|NCT00620113|1851182|FG001|Overall Study|Adverse Event|2
884905|NCT00620113|1851183|FG002|Overall Study|Adverse Event|2
884906|NCT00620113|1851184|FG003|Overall Study|Adverse Event|1
884907|NCT00620113|1851181|FG000|Overall Study|Lack of Efficacy|2
884908|NCT00620113|1851182|FG001|Overall Study|Lack of Efficacy|3
884909|NCT00620113|1851183|FG002|Overall Study|Lack of Efficacy|0
884910|NCT00620113|1851184|FG003|Overall Study|Lack of Efficacy|2
884911|NCT00620113|1851181|FG000|Overall Study|Physician Decision|1
884912|NCT00620113|1851182|FG001|Overall Study|Physician Decision|0
884913|NCT00620113|1851183|FG002|Overall Study|Physician Decision|0
884914|NCT00620113|1851184|FG003|Overall Study|Physician Decision|2
884915|NCT00620113|1851181|FG000|Overall Study|Protocol Violation|2
884916|NCT00620113|1851182|FG001|Overall Study|Protocol Violation|1
884917|NCT00620113|1851183|FG002|Overall Study|Protocol Violation|0
884918|NCT00620113|1851184|FG003|Overall Study|Protocol Violation|0
884919|NCT00620113|1851181|FG000|Overall Study|Withdrawal by Subject|5
884920|NCT00620113|1851182|FG001|Overall Study|Withdrawal by Subject|1
884921|NCT00620113|1851183|FG002|Overall Study|Withdrawal by Subject|3
884922|NCT00620113|1851184|FG003|Overall Study|Withdrawal by Subject|5
884923|NCT00620282|1851220|FG000|Overall Study|Adverse Event|0
884924|NCT00620282|1851221|FG001|Overall Study|Adverse Event|1
884925|NCT00620282|1851222|FG002|Overall Study|Adverse Event|0
884926|NCT00620282|1851220|FG000|Overall Study|Arterial line unable to be placed|0
884927|NCT00620282|1851221|FG001|Overall Study|Arterial line unable to be placed|0
884928|NCT00620282|1851222|FG002|Overall Study|Arterial line unable to be placed|1
884929|NCT00620282|1851220|FG000|Overall Study|Withdrawal by Subject|0
884930|NCT00620282|1851221|FG001|Overall Study|Withdrawal by Subject|1
884931|NCT00620282|1851222|FG002|Overall Study|Withdrawal by Subject|0
884932|NCT00620321|1851232|FG000|Overall Study|Adverse Event|1
884933|NCT00620321|1851233|FG001|Overall Study|Adverse Event|1
884934|NCT00620321|1851232|FG000|Overall Study|Death|1
884935|NCT00620321|1851233|FG001|Overall Study|Death|1
884936|NCT00620321|1851232|FG000|Overall Study|Physician Decision|0
884937|NCT00620321|1851233|FG001|Overall Study|Physician Decision|7
884938|NCT00620321|1851232|FG000|Overall Study|Progressive Disease|5
884939|NCT00620321|1851233|FG001|Overall Study|Progressive Disease|5
884940|NCT00620321|1851232|FG000|Overall Study|Sponsor Decision|0
884941|NCT00620321|1851233|FG001|Overall Study|Sponsor Decision|1
884942|NCT00620321|1851232|FG000|Overall Study|Withdrawal by Subject|1
884943|NCT00620321|1851233|FG001|Overall Study|Withdrawal by Subject|1
884944|NCT00620373|1851239|FG000|Overall Study|Unverified cancer status|33
884945|NCT00620464|1851259|FG000|Overall Study|Adverse Event|15
884946|NCT00620464|1851260|FG001|Overall Study|Adverse Event|17
884947|NCT00620464|1851259|FG000|Overall Study|Lost to Follow-up|1
884948|NCT00620464|1851260|FG001|Overall Study|Lost to Follow-up|1
884949|NCT00620464|1851259|FG000|Overall Study|Planning Pregnancy|1
884950|NCT00620464|1851260|FG001|Overall Study|Planning Pregnancy|4
884951|NCT00620464|1851259|FG000|Overall Study|Personal|2
884952|NCT00620464|1851260|FG001|Overall Study|Personal|2
884953|NCT00620464|1851259|FG000|Overall Study|Used prohibited medication|1
884954|NCT00620464|1851260|FG001|Overall Study|Used prohibited medication|0
884955|NCT00620542|1851281|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12
884956|NCT00620542|1851282|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15
884957|NCT00620542|1851283|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0
884958|NCT00620542|1851284|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0
884959|NCT00620542|1851281|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406
884960|NCT00620542|1851282|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409
884961|NCT00620542|1851283|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
884962|NCT00620542|1851284|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
884963|NCT00620542|1851281|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
884964|NCT00620542|1851282|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
884965|NCT00620542|1851283|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
884966|NCT00620542|1851284|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
884967|NCT00620542|1851281|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
884968|NCT00620542|1851282|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
884969|NCT00620542|1851283|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
884970|NCT00620542|1851284|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
884971|NCT00620542|1851281|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0
884972|NCT00620542|1851282|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1
884973|NCT00620542|1851283|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
884974|NCT00620542|1851284|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
884975|NCT00620542|1851281|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0
884976|NCT00620542|1851282|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1
884977|NCT00620542|1851283|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0
884978|NCT00620542|1851284|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0
884979|NCT00620542|1851281|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4
884980|NCT00620542|1851282|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4
884981|NCT00620542|1851283|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0
884982|NCT00620542|1851284|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0
884983|NCT00620542|1851281|FG000|Part B (2 Year Core Study)|Adverse Event|0
884984|NCT00620542|1851282|FG001|Part B (2 Year Core Study)|Adverse Event|0
884985|NCT00620542|1851283|FG002|Part B (2 Year Core Study)|Adverse Event|46
884986|NCT00620542|1851284|FG003|Part B (2 Year Core Study)|Adverse Event|49
884987|NCT00620542|1851281|FG000|Part B (2 Year Core Study)|Protocol Violation|0
884988|NCT00620542|1851282|FG001|Part B (2 Year Core Study)|Protocol Violation|0
884989|NCT00620542|1851283|FG002|Part B (2 Year Core Study)|Protocol Violation|3
884990|NCT00620542|1851284|FG003|Part B (2 Year Core Study)|Protocol Violation|5
884991|NCT00620542|1851281|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0
884992|NCT00620542|1851282|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0
884993|NCT00620542|1851283|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55
884994|NCT00620542|1851284|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54
884995|NCT00620542|1851281|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0
884996|NCT00620542|1851282|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0
884997|NCT00620542|1851283|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20
884998|NCT00620542|1851284|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9
884999|NCT00620542|1851281|FG000|Part B (2 Year Core Study)|Protocol Violation|0
885000|NCT00620542|1851282|FG001|Part B (2 Year Core Study)|Protocol Violation|0
885001|NCT00620542|1851283|FG002|Part B (2 Year Core Study)|Protocol Violation|13
885002|NCT00620542|1851284|FG003|Part B (2 Year Core Study)|Protocol Violation|16
885003|NCT00620542|1851281|FG000|Part B (2 Year Core Study)|Safety reasons|0
885004|NCT00620542|1851282|FG001|Part B (2 Year Core Study)|Safety reasons|0
885005|NCT00620542|1851283|FG002|Part B (2 Year Core Study)|Safety reasons|2
885006|NCT00620542|1851284|FG003|Part B (2 Year Core Study)|Safety reasons|3
885007|NCT00620542|1851281|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
885008|NCT00620542|1851282|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
885009|NCT00620542|1851283|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
885010|NCT00620542|1851284|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
885011|NCT00620542|1851281|FG000|Part B (2 Year Core Study)|IVUS not available|0
885012|NCT00620542|1851282|FG001|Part B (2 Year Core Study)|IVUS not available|0
885013|NCT00620542|1851283|FG002|Part B (2 Year Core Study)|IVUS not available|3
885014|NCT00620542|1851284|FG003|Part B (2 Year Core Study)|IVUS not available|2
885015|NCT00620555|1851292|FG000|Overall Study|Adverse Event|4
885016|NCT00620555|1851292|FG000|Overall Study|Protocol Violation|2
885017|NCT00620555|1851292|FG000|Overall Study|Lack of Efficacy|12
885018|NCT00620555|1851292|FG000|Overall Study|Withdrawal by Subject|1
885019|NCT00620555|1851292|FG000|Overall Study|Choice of other treatment|1
885020|NCT00620555|1851292|FG000|Overall Study|Visit failure against planned|1
885021|NCT00620659|1851296|FG000|Treatment Period 1|Adverse Event|1
885022|NCT00620659|1851297|FG001|Treatment Period 1|Adverse Event|0
885023|NCT00620659|1851298|FG002|Treatment Period 1|Adverse Event|0
885024|NCT00620659|1851299|FG003|Treatment Period 1|Adverse Event|3
885025|NCT00620659|1851300|FG004|Treatment Period 1|Adverse Event|0
885026|NCT00620659|1851301|FG005|Treatment Period 1|Adverse Event|0
885027|NCT00620659|1851296|FG000|Treatment Period 1|Protocol Violation|1
885028|NCT00620659|1851297|FG001|Treatment Period 1|Protocol Violation|0
885029|NCT00620659|1851298|FG002|Treatment Period 1|Protocol Violation|0
885030|NCT00620659|1851299|FG003|Treatment Period 1|Protocol Violation|0
885031|NCT00620659|1851300|FG004|Treatment Period 1|Protocol Violation|0
885032|NCT00620659|1851301|FG005|Treatment Period 1|Protocol Violation|0
885033|NCT00620659|1851296|FG000|Treatment Period 1|Withdrawal by Subject|1
885034|NCT00620659|1851297|FG001|Treatment Period 1|Withdrawal by Subject|0
885035|NCT00620659|1851298|FG002|Treatment Period 1|Withdrawal by Subject|1
885036|NCT00620659|1851299|FG003|Treatment Period 1|Withdrawal by Subject|0
885037|NCT00620659|1851300|FG004|Treatment Period 1|Withdrawal by Subject|1
885038|NCT00620659|1851301|FG005|Treatment Period 1|Withdrawal by Subject|0
885039|NCT00620659|1851296|FG000|Placebo Washout Period 1|Withdrawal by Subject|0
885040|NCT00620659|1851297|FG001|Placebo Washout Period 1|Withdrawal by Subject|0
885041|NCT00620659|1851298|FG002|Placebo Washout Period 1|Withdrawal by Subject|0
885042|NCT00620659|1851299|FG003|Placebo Washout Period 1|Withdrawal by Subject|1
885043|NCT00620659|1851300|FG004|Placebo Washout Period 1|Withdrawal by Subject|0
885044|NCT00620659|1851301|FG005|Placebo Washout Period 1|Withdrawal by Subject|0
885045|NCT00620659|1851296|FG000|Treatment Period 2|Adverse Event|0
885046|NCT00620659|1851297|FG001|Treatment Period 2|Adverse Event|3
885047|NCT00620659|1851298|FG002|Treatment Period 2|Adverse Event|0
885048|NCT00620659|1851299|FG003|Treatment Period 2|Adverse Event|0
885049|NCT00620659|1851300|FG004|Treatment Period 2|Adverse Event|2
885050|NCT00620659|1851301|FG005|Treatment Period 2|Adverse Event|0
885051|NCT00620659|1851296|FG000|Treatment Period 2|Withdrawal by Subject|0
885052|NCT00620659|1851297|FG001|Treatment Period 2|Withdrawal by Subject|0
885053|NCT00620659|1851298|FG002|Treatment Period 2|Withdrawal by Subject|1
885054|NCT00620659|1851299|FG003|Treatment Period 2|Withdrawal by Subject|0
885055|NCT00620659|1851300|FG004|Treatment Period 2|Withdrawal by Subject|3
885056|NCT00620659|1851301|FG005|Treatment Period 2|Withdrawal by Subject|0
885057|NCT00620659|1851296|FG000|Placebo Washout Period 2|Adverse Event|2
885058|NCT00620659|1851297|FG001|Placebo Washout Period 2|Adverse Event|0
885059|NCT00620659|1851298|FG002|Placebo Washout Period 2|Adverse Event|0
885060|NCT00620659|1851299|FG003|Placebo Washout Period 2|Adverse Event|0
885061|NCT00620659|1851300|FG004|Placebo Washout Period 2|Adverse Event|0
885062|NCT00620659|1851301|FG005|Placebo Washout Period 2|Adverse Event|0
885063|NCT00620659|1851296|FG000|Treatment Period 3|Adverse Event|0
885064|NCT00620659|1851297|FG001|Treatment Period 3|Adverse Event|2
885065|NCT00620659|1851298|FG002|Treatment Period 3|Adverse Event|0
885066|NCT00620659|1851299|FG003|Treatment Period 3|Adverse Event|0
885067|NCT00620659|1851300|FG004|Treatment Period 3|Adverse Event|0
885068|NCT00620659|1851301|FG005|Treatment Period 3|Adverse Event|0
885069|NCT00620659|1851296|FG000|Treatment Period 3|Withdrawal by Subject|0
885070|NCT00620659|1851297|FG001|Treatment Period 3|Withdrawal by Subject|0
885071|NCT00620659|1851298|FG002|Treatment Period 3|Withdrawal by Subject|0
885072|NCT00620659|1851299|FG003|Treatment Period 3|Withdrawal by Subject|1
885073|NCT00620659|1851300|FG004|Treatment Period 3|Withdrawal by Subject|0
885074|NCT00620659|1851301|FG005|Treatment Period 3|Withdrawal by Subject|0
885075|NCT00620750|1851322|FG000|Overall Study|Lost to Follow-up|25
885076|NCT00620763|1851326|FG000|Period: First Intervention|Withdrawal by Subject|0
885077|NCT00620763|1851327|FG001|Period: First Intervention|Withdrawal by Subject|2
885078|NCT00620763|1851326|FG000|Period: First Intervention|Protocol Violation|0
885079|NCT00620763|1851327|FG001|Period: First Intervention|Protocol Violation|3
885080|NCT00620763|1851326|FG000|Period: Second Intervention|Withdrawal by Subject|1
885081|NCT00620763|1851327|FG001|Period: Second Intervention|Withdrawal by Subject|0
885082|NCT00620776|1851335|FG000|Overall Study|Did not receive treatment|3
885083|NCT00620776|1851336|FG001|Overall Study|Did not receive treatment|5
885084|NCT00620776|1851335|FG000|Overall Study|Adverse Event|2
885085|NCT00620776|1851336|FG001|Overall Study|Adverse Event|3
885086|NCT00620776|1851335|FG000|Overall Study|Lack of Efficacy|2
885087|NCT00620776|1851336|FG001|Overall Study|Lack of Efficacy|1
885088|NCT00620776|1851335|FG000|Overall Study|Lost to Follow-up|2
885089|NCT00620776|1851336|FG001|Overall Study|Lost to Follow-up|5
885090|NCT00620776|1851335|FG000|Overall Study|Withdrawal by Subject|3
885091|NCT00620776|1851336|FG001|Overall Study|Withdrawal by Subject|2
885092|NCT00620815|1851345|FG000|Overall Study|Adverse Event|1
885093|NCT00620815|1851346|FG001|Overall Study|Adverse Event|1
885094|NCT00620815|1851347|FG002|Overall Study|Adverse Event|2
885095|NCT00620815|1851345|FG000|Overall Study|Withdrawal by Subject|1
885096|NCT00620815|1851346|FG001|Overall Study|Withdrawal by Subject|2
885097|NCT00620815|1851347|FG002|Overall Study|Withdrawal by Subject|0
885098|NCT00620815|1851345|FG000|Overall Study|Lost to Follow-up|1
885099|NCT00620815|1851346|FG001|Overall Study|Lost to Follow-up|6
885100|NCT00620815|1851347|FG002|Overall Study|Lost to Follow-up|3
885101|NCT00620815|1851345|FG000|Overall Study|Inappropriate enrolment|0
885102|NCT00620815|1851346|FG001|Overall Study|Inappropriate enrolment|0
885103|NCT00620815|1851347|FG002|Overall Study|Inappropriate enrolment|1
885104|NCT00620815|1851345|FG000|Overall Study|Protocol Violation|1
885105|NCT00620815|1851346|FG001|Overall Study|Protocol Violation|2
885106|NCT00620815|1851347|FG002|Overall Study|Protocol Violation|1
885107|NCT00620854|1851386|FG000|Washout 1|Withdrawal by Subject|0
885108|NCT00620854|1851387|FG001|Washout 1|Withdrawal by Subject|0
885109|NCT00620854|1851388|FG002|Washout 1|Withdrawal by Subject|1
885110|NCT00620854|1851389|FG003|Washout 1|Withdrawal by Subject|1
885111|NCT00620854|1851390|FG004|Washout 1|Withdrawal by Subject|0
885112|NCT00620854|1851391|FG005|Washout 1|Withdrawal by Subject|0
885113|NCT00621023|1851406|FG000|Overall Study|Death|5
885114|NCT00621023|1851406|FG000|Overall Study|Follow up discontinued|1
885115|NCT00621140|1851421|FG000|Overall Study|Adverse Event|4
885116|NCT00621140|1851422|FG001|Overall Study|Adverse Event|5
885117|NCT00621140|1851421|FG000|Overall Study|Lost to Follow-up|1
885118|NCT00621140|1851422|FG001|Overall Study|Lost to Follow-up|2
885119|NCT00621140|1851421|FG000|Overall Study|Withdrawal by Subject|4
885120|NCT00621140|1851422|FG001|Overall Study|Withdrawal by Subject|6
885121|NCT00621140|1851421|FG000|Overall Study|Other incl. lack of efficacy|6
885122|NCT00621140|1851422|FG001|Overall Study|Other incl. lack of efficacy|5
885123|NCT00621153|1851430|FG000|Overall Study|Safety Reason|8
885124|NCT00621153|1851431|FG001|Overall Study|Safety Reason|7
885125|NCT00621153|1851430|FG000|Overall Study|Adverse Event|3
885126|NCT00621153|1851431|FG001|Overall Study|Adverse Event|2
885127|NCT00621153|1851430|FG000|Overall Study|Lost to Follow-up|5
885128|NCT00621153|1851431|FG001|Overall Study|Lost to Follow-up|1
885129|NCT00621153|1851430|FG000|Overall Study|Withdrawal by Subject|4
885130|NCT00621153|1851431|FG001|Overall Study|Withdrawal by Subject|5
885131|NCT00621192|1851458|FG000|Overall Study|Withdrawal by Subject|0
885132|NCT00621192|1851459|FG001|Overall Study|Withdrawal by Subject|0
885133|NCT00621192|1851460|FG002|Overall Study|Withdrawal by Subject|2
885134|NCT00621192|1851461|FG003|Overall Study|Withdrawal by Subject|0
885135|NCT00621192|1851458|FG000|Overall Study|Physician Decision|1
885136|NCT00621192|1851459|FG001|Overall Study|Physician Decision|3
885137|NCT00621192|1851460|FG002|Overall Study|Physician Decision|0
885138|NCT00621192|1851461|FG003|Overall Study|Physician Decision|0
885139|NCT00621192|1851458|FG000|Overall Study|Protocol Violation|1
885140|NCT00621192|1851459|FG001|Overall Study|Protocol Violation|0
885141|NCT00621192|1851460|FG002|Overall Study|Protocol Violation|0
885142|NCT00621192|1851461|FG003|Overall Study|Protocol Violation|1
885143|NCT00621192|1851458|FG000|Overall Study|Adverse Event|0
885144|NCT00621192|1851459|FG001|Overall Study|Adverse Event|1
885145|NCT00621192|1851460|FG002|Overall Study|Adverse Event|0
885146|NCT00621192|1851461|FG003|Overall Study|Adverse Event|1
885147|NCT00621192|1851458|FG000|Overall Study|Death|2
885148|NCT00621192|1851459|FG001|Overall Study|Death|5
885149|NCT00621192|1851460|FG002|Overall Study|Death|0
885150|NCT00621192|1851461|FG003|Overall Study|Death|0
885151|NCT00621192|1851458|FG000|Overall Study|Final Assessments not Completed|0
885152|NCT00621192|1851459|FG001|Overall Study|Final Assessments not Completed|0
885153|NCT00621192|1851460|FG002|Overall Study|Final Assessments not Completed|3
885154|NCT00621192|1851461|FG003|Overall Study|Final Assessments not Completed|1
885155|NCT00621244|1851475|FG000|Overall Study|Withdrawal by Subject|7
885156|NCT00621244|1851476|FG001|Overall Study|Withdrawal by Subject|3
885157|NCT00621244|1851477|FG002|Overall Study|Withdrawal by Subject|3
885158|NCT00621244|1851478|FG003|Overall Study|Withdrawal by Subject|3
885159|NCT00621244|1851475|FG000|Overall Study|Disease progression|44
885160|NCT00621244|1851476|FG001|Overall Study|Disease progression|20
885161|NCT00621244|1851477|FG002|Overall Study|Disease progression|20
885162|NCT00621244|1851478|FG003|Overall Study|Disease progression|15
885163|NCT00621244|1851475|FG000|Overall Study|Death|3
885164|NCT00621244|1851476|FG001|Overall Study|Death|3
885165|NCT00621244|1851477|FG002|Overall Study|Death|1
885166|NCT00621244|1851478|FG003|Overall Study|Death|1
885167|NCT00621244|1851475|FG000|Overall Study|Adverse Event|27
885168|NCT00621244|1851476|FG001|Overall Study|Adverse Event|7
885169|NCT00621244|1851477|FG002|Overall Study|Adverse Event|9
885170|NCT00621244|1851478|FG003|Overall Study|Adverse Event|2
885171|NCT00621244|1851475|FG000|Overall Study|Administrative problems|5
885172|NCT00621244|1851476|FG001|Overall Study|Administrative problems|1
885173|NCT00621244|1851477|FG002|Overall Study|Administrative problems|0
885174|NCT00621244|1851478|FG003|Overall Study|Administrative problems|2
885175|NCT00621257|1851557|FG000|Overall Study|Lost to Follow-up|4
885176|NCT00621257|1851558|FG001|Overall Study|Lost to Follow-up|0
885177|NCT00621257|1851559|FG002|Overall Study|Lost to Follow-up|2
885178|NCT00621257|1851560|FG003|Overall Study|Lost to Follow-up|4
885179|NCT00621257|1851561|FG004|Overall Study|Lost to Follow-up|7
885180|NCT00621257|1851557|FG000|Overall Study|Adverse Event|0
885181|NCT00621257|1851558|FG001|Overall Study|Adverse Event|1
885182|NCT00621257|1851559|FG002|Overall Study|Adverse Event|1
885183|NCT00621257|1851560|FG003|Overall Study|Adverse Event|0
885184|NCT00621257|1851561|FG004|Overall Study|Adverse Event|0
885185|NCT00621257|1851557|FG000|Overall Study|Physician Decision|0
885186|NCT00621257|1851558|FG001|Overall Study|Physician Decision|2
885187|NCT00621257|1851559|FG002|Overall Study|Physician Decision|0
885188|NCT00621257|1851560|FG003|Overall Study|Physician Decision|1
885189|NCT00621257|1851561|FG004|Overall Study|Physician Decision|1
885190|NCT00621257|1851557|FG000|Overall Study|Withdrawal by Subject|0
885191|NCT00621257|1851558|FG001|Overall Study|Withdrawal by Subject|0
885192|NCT00621257|1851559|FG002|Overall Study|Withdrawal by Subject|0
885193|NCT00621257|1851560|FG003|Overall Study|Withdrawal by Subject|1
885194|NCT00621257|1851561|FG004|Overall Study|Withdrawal by Subject|1
885195|NCT00621296|1851573|FG000|Overall Study|Adverse Event|2
885196|NCT00621296|1851573|FG000|Overall Study|Lack of Efficacy|1
885197|NCT00621296|1851573|FG000|Overall Study|Physician Decision|7
885198|NCT00621296|1851573|FG000|Overall Study|Unmatch Criteria|1
885199|NCT00621296|1851573|FG000|Overall Study|Stopping Criteria|3
885200|NCT00621309|1851577|FG000|Overall Study|Withdrawal by Subject|2
885201|NCT00621309|1851578|FG001|Overall Study|Withdrawal by Subject|0
885202|NCT00621309|1851579|FG002|Overall Study|Withdrawal by Subject|1
885203|NCT00621309|1851580|FG003|Overall Study|Withdrawal by Subject|1
885204|NCT00621309|1851581|FG004|Overall Study|Withdrawal by Subject|1
885205|NCT00621309|1851582|FG005|Overall Study|Withdrawal by Subject|1
885206|NCT00621322|1851594|FG000|Overall Study|Lost to Follow-up|0
885207|NCT00621322|1851595|FG001|Overall Study|Lost to Follow-up|0
885208|NCT00621322|1851596|FG002|Overall Study|Lost to Follow-up|0
885209|NCT00621322|1851597|FG003|Overall Study|Lost to Follow-up|0
885210|NCT00621322|1851598|FG004|Overall Study|Lost to Follow-up|1
885211|NCT00621322|1851599|FG005|Overall Study|Lost to Follow-up|0
885212|NCT00621322|1851594|FG000|Overall Study|Physician Decision|0
885213|NCT00621322|1851595|FG001|Overall Study|Physician Decision|0
885214|NCT00621322|1851596|FG002|Overall Study|Physician Decision|1
885215|NCT00621322|1851597|FG003|Overall Study|Physician Decision|1
885216|NCT00621322|1851598|FG004|Overall Study|Physician Decision|0
885217|NCT00621322|1851599|FG005|Overall Study|Physician Decision|0
885218|NCT00621322|1851594|FG000|Overall Study|Withdrawal by Subject|0
885219|NCT00621322|1851595|FG001|Overall Study|Withdrawal by Subject|0
885220|NCT00621322|1851596|FG002|Overall Study|Withdrawal by Subject|0
885221|NCT00621322|1851597|FG003|Overall Study|Withdrawal by Subject|1
885222|NCT00621322|1851598|FG004|Overall Study|Withdrawal by Subject|0
885223|NCT00621322|1851599|FG005|Overall Study|Withdrawal by Subject|2
885224|NCT00621322|1851594|FG000|Overall Study|Migrated/moved from study area|1
885225|NCT00621322|1851595|FG001|Overall Study|Migrated/moved from study area|0
885226|NCT00621322|1851596|FG002|Overall Study|Migrated/moved from study area|1
885227|NCT00621322|1851597|FG003|Overall Study|Migrated/moved from study area|1
885228|NCT00621322|1851598|FG004|Overall Study|Migrated/moved from study area|0
885229|NCT00621322|1851599|FG005|Overall Study|Migrated/moved from study area|2
885230|NCT00621504|1851628|FG000|Overall Study|Adverse Event|1
885231|NCT00621504|1851629|FG001|Overall Study|Adverse Event|3
885232|NCT00621504|1851628|FG000|Overall Study|At the request of sponsor/investigator|1
885233|NCT00621504|1851629|FG001|Overall Study|At the request of sponsor/investigator|0
885234|NCT00621504|1851628|FG000|Overall Study|Withdrew consent|9
885235|NCT00621504|1851629|FG001|Overall Study|Withdrew consent|6
885236|NCT00621504|1851628|FG000|Overall Study|Lost to Follow-up|8
885237|NCT00621504|1851629|FG001|Overall Study|Lost to Follow-up|10
885238|NCT00621504|1851628|FG000|Overall Study|Other|1
885239|NCT00621504|1851629|FG001|Overall Study|Other|0
885240|NCT00621504|1851628|FG000|Overall Study|Death|6
885241|NCT00621504|1851629|FG001|Overall Study|Death|6
885242|NCT00621517|1851637|FG000|Overall Study|Lost to Follow-up|3
885243|NCT00621517|1851638|FG001|Overall Study|Lost to Follow-up|3
885244|NCT00621517|1851637|FG000|Overall Study|Withdrawal by Subject|3
885245|NCT00621517|1851638|FG001|Overall Study|Withdrawal by Subject|4
885246|NCT00621517|1851637|FG000|Overall Study|Adverse Event|1
885247|NCT00621517|1851638|FG001|Overall Study|Adverse Event|0
885248|NCT00621543|1851656|FG000|Overall Study|Lost to Follow-up|23
885249|NCT00621582|1851660|FG000|Overall Study|Adverse Event|7
885250|NCT00621582|1851660|FG000|Overall Study|Protocol Violation|57
885251|NCT00621582|1851660|FG000|Overall Study|Lost to Follow-up|24
885252|NCT00621582|1851660|FG000|Overall Study|issues not identified by investigators|18
885253|NCT00621621|1851667|FG000|Overall Study|Subjects were exited at EP study|30
885254|NCT00621621|1851668|FG001|Overall Study|Subjects were exited at EP study|0
885255|NCT00621751|1851688|FG000|Overall Study|Adverse Event|0
885256|NCT00621751|1851689|FG001|Overall Study|Adverse Event|1
885257|NCT00621764|1851699|FG000|Overall Study|Protocol Violation|0
885258|NCT00621764|1851700|FG001|Overall Study|Protocol Violation|0
885259|NCT00621764|1851701|FG002|Overall Study|Protocol Violation|0
885260|NCT00621764|1851702|FG003|Overall Study|Protocol Violation|1
885261|NCT00621777|1851715|FG000|Open Phase|Adverse Event|20
885262|NCT00621777|1851716|FG001|Open Phase|Adverse Event|0
885263|NCT00621777|1851715|FG000|Open Phase|Did not abstain during open phase|56
885264|NCT00621777|1851716|FG001|Open Phase|Did not abstain during open phase|0
885265|NCT00621777|1851715|FG000|Open Phase|Withdrawal by Subject|17
885266|NCT00621777|1851716|FG001|Open Phase|Withdrawal by Subject|0
885267|NCT00621777|1851715|FG000|Open Phase|administrative|13
885268|NCT00621777|1851716|FG001|Open Phase|administrative|0
885269|NCT00621777|1851715|FG000|Open Phase|Lost to Follow-up|10
885270|NCT00621777|1851716|FG001|Open Phase|Lost to Follow-up|0
885271|NCT00621777|1851715|FG000|Randomized Phase|Adverse Event|3
885272|NCT00621777|1851716|FG001|Randomized Phase|Adverse Event|3
885273|NCT00621777|1851715|FG000|Randomized Phase|Lost to Follow-up|3
885274|NCT00621777|1851716|FG001|Randomized Phase|Lost to Follow-up|3
885275|NCT00621777|1851715|FG000|Randomized Phase|Withdrawal by Subject|1
885276|NCT00621777|1851716|FG001|Randomized Phase|Withdrawal by Subject|9
885277|NCT00621777|1851715|FG000|Randomized Phase|administrative|0
885278|NCT00621777|1851716|FG001|Randomized Phase|administrative|3
885279|NCT00621777|1851715|FG000|Randomized Phase|Death|0
885280|NCT00621777|1851716|FG001|Randomized Phase|Death|1
885281|NCT00621842|1851724|FG000|Overall Study|Adverse Event|6
885282|NCT00621842|1851724|FG000|Overall Study|Withdrawal by Subject|7
885283|NCT00621842|1851724|FG000|Overall Study|Protocol Violation|4
885284|NCT00621842|1851724|FG000|Overall Study|Lack of Efficacy|2
885285|NCT00621855|1851733|FG000|Overall Study|Adverse Event|32
885286|NCT00621855|1851734|FG001|Overall Study|Adverse Event|31
885287|NCT00621855|1851735|FG002|Overall Study|Adverse Event|48
885288|NCT00621855|1851736|FG003|Overall Study|Adverse Event|34
885289|NCT00621855|1851737|FG004|Overall Study|Adverse Event|31
885290|NCT00621855|1851733|FG000|Overall Study|Lost to Follow-up|0
885291|NCT00621855|1851734|FG001|Overall Study|Lost to Follow-up|1
885292|NCT00621855|1851735|FG002|Overall Study|Lost to Follow-up|3
885293|NCT00621855|1851736|FG003|Overall Study|Lost to Follow-up|4
885294|NCT00621855|1851737|FG004|Overall Study|Lost to Follow-up|1
885295|NCT00621855|1851733|FG000|Overall Study|Protocol Violation|16
885296|NCT00621855|1851734|FG001|Overall Study|Protocol Violation|8
885297|NCT00621855|1851735|FG002|Overall Study|Protocol Violation|6
885298|NCT00621855|1851736|FG003|Overall Study|Protocol Violation|7
885299|NCT00621855|1851737|FG004|Overall Study|Protocol Violation|8
885300|NCT00621855|1851733|FG000|Overall Study|Withdrawal by Subject|16
885301|NCT00621855|1851734|FG001|Overall Study|Withdrawal by Subject|11
885302|NCT00621855|1851735|FG002|Overall Study|Withdrawal by Subject|13
885303|NCT00621855|1851736|FG003|Overall Study|Withdrawal by Subject|13
885304|NCT00621855|1851737|FG004|Overall Study|Withdrawal by Subject|9
885305|NCT00621855|1851733|FG000|Overall Study|Other|9
885306|NCT00621855|1851734|FG001|Overall Study|Other|7
885307|NCT00621855|1851735|FG002|Overall Study|Other|6
885308|NCT00621855|1851736|FG003|Overall Study|Other|5
885309|NCT00621855|1851737|FG004|Overall Study|Other|4
885310|NCT00621855|1851733|FG000|Overall Study|Patients did not receive study drug|3
885311|NCT00621855|1851734|FG001|Overall Study|Patients did not receive study drug|3
885312|NCT00621855|1851735|FG002|Overall Study|Patients did not receive study drug|5
885313|NCT00621855|1851736|FG003|Overall Study|Patients did not receive study drug|4
885314|NCT00621855|1851737|FG004|Overall Study|Patients did not receive study drug|2
885315|NCT00621959|1851765|FG000|Overall Study|Adverse Event|4
885316|NCT00621959|1851766|FG001|Overall Study|Adverse Event|2
885317|NCT00621959|1851765|FG000|Overall Study|Lack of Efficacy|1
885318|NCT00621959|1851766|FG001|Overall Study|Lack of Efficacy|1
885319|NCT00621959|1851765|FG000|Overall Study|Lost to Follow-up|0
885320|NCT00621959|1851766|FG001|Overall Study|Lost to Follow-up|2
885321|NCT00621959|1851765|FG000|Overall Study|Withdrawal by Subject|1
885322|NCT00621959|1851766|FG001|Overall Study|Withdrawal by Subject|1
885323|NCT00621959|1851765|FG000|Overall Study|Other|1
885324|NCT00621959|1851766|FG001|Overall Study|Other|3
885325|NCT00621985|1851772|FG000|Dexamethasone Admission|Adverse Event|1
885326|NCT00622180|1851778|FG000|Overall Study|Lost to Follow-up|1
885327|NCT00622180|1851779|FG001|Overall Study|Lost to Follow-up|2
885328|NCT00622284|1851787|FG000|Overall Study|Lack of Efficacy|45
885329|NCT00622284|1851788|FG001|Overall Study|Lack of Efficacy|15
885330|NCT00622284|1851787|FG000|Overall Study|Adverse Event|61
885331|NCT00622284|1851788|FG001|Overall Study|Adverse Event|90
885332|NCT00622284|1851787|FG000|Overall Study|Protocol Violation|12
885333|NCT00622284|1851788|FG001|Overall Study|Protocol Violation|5
885334|NCT00622284|1851787|FG000|Overall Study|Lost to Follow-up|11
885335|NCT00622284|1851788|FG001|Overall Study|Lost to Follow-up|13
885336|NCT00622284|1851787|FG000|Overall Study|Withdrawal by Subject|27
885337|NCT00622284|1851788|FG001|Overall Study|Withdrawal by Subject|24
885338|NCT00622284|1851787|FG000|Overall Study|Other reason (not specified)|33
885339|NCT00622284|1851788|FG001|Overall Study|Other reason (not specified)|24
885340|NCT00622336|1851794|FG000|Treatment Phase|Progression of Disease|181
885341|NCT00622336|1851794|FG000|Treatment Phase|Adverse Event|46
885342|NCT00622336|1851794|FG000|Treatment Phase|Other|40
885343|NCT00622336|1851794|FG000|Treatment Phase|Death|14
885344|NCT00622336|1851794|FG000|Treatment Phase|Lack of therapeutic effect|13
885345|NCT00622336|1851794|FG000|Treatment Phase|Withdrawal by Subject|13
885346|NCT00622336|1851794|FG000|Treatment Phase|Lost to Follow-up|2
885347|NCT00622336|1851794|FG000|Extension Phase|Adverse Event|2
885348|NCT00622336|1851794|FG000|Extension Phase|Progressive Disease|6
885349|NCT00622336|1851794|FG000|Extension Phase|Lack of therapeutic effect|2
885350|NCT00622336|1851794|FG000|Extension Phase|Withdrawal by Subject|1
885351|NCT00622336|1851794|FG000|Extension Phase|Lost to Follow-up|1
885352|NCT00622336|1851794|FG000|Extension Phase|Other|9
885353|NCT00622388|1851800|FG000|Overall Study|Disease Progression|47
885354|NCT00622388|1851800|FG000|Overall Study|Adverse Event|6
885355|NCT00622388|1851800|FG000|Overall Study|Protocol Violation|3
885356|NCT00622388|1851800|FG000|Overall Study|Participant Refusal|1
885357|NCT00622388|1851800|FG000|Overall Study|Death|3
885358|NCT00622388|1851800|FG000|Overall Study|Received Alternate Anticancer Therapy|8
885359|NCT00622388|1851800|FG000|Overall Study|Took Prohibited Medication|2
885360|NCT00622388|1851800|FG000|Overall Study|Withdrew Consent|1
885361|NCT00622388|1851800|FG000|Overall Study|Insurance Expired|1
885362|NCT00622401|1851808|FG000|Overall Study|Disease progression prior to treatment|3
885363|NCT00622401|1851809|FG001|Overall Study|Disease progression prior to treatment|2
885364|NCT00622401|1851810|FG002|Overall Study|Disease progression prior to treatment|0
885365|NCT00622440|1851830|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4
885366|NCT00622440|1851831|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1
885367|NCT00622440|1851830|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
885368|NCT00622440|1851831|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
885369|NCT00622440|1851830|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
885370|NCT00622440|1851831|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
885371|NCT00622440|1851830|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
885372|NCT00622440|1851831|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
885373|NCT00622466|1851837|FG000|Overall Study|Death|1
885374|NCT00622466|1851837|FG000|Overall Study|Adverse Event|1
885375|NCT00622466|1851837|FG000|Overall Study|Withdrawal by Subject|2
885376|NCT00622505|1851843|FG000|Overall Study|Adverse Event|9
885377|NCT00622505|1851844|FG001|Overall Study|Adverse Event|7
885378|NCT00622505|1851843|FG000|Overall Study|Abnormal Laboratory Value(s)|3
885379|NCT00622505|1851844|FG001|Overall Study|Abnormal Laboratory Value(s)|5
885380|NCT00622505|1851843|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
885381|NCT00622505|1851844|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
885382|NCT00622505|1851843|FG000|Overall Study|Withdrawal by Subject|12
885383|NCT00622505|1851844|FG001|Overall Study|Withdrawal by Subject|5
885384|NCT00622505|1851843|FG000|Overall Study|Administrative Problems|2
885385|NCT00622505|1851844|FG001|Overall Study|Administrative Problems|4
885386|NCT00622505|1851843|FG000|Overall Study|Death|2
885387|NCT00622505|1851844|FG001|Overall Study|Death|2
885388|NCT00622635|1851863|FG000|Treatment Period 1|Adverse Event|0
885389|NCT00622635|1851864|FG001|Treatment Period 1|Adverse Event|0
885390|NCT00622635|1851865|FG002|Treatment Period 1|Adverse Event|1
885391|NCT00622635|1851866|FG003|Treatment Period 1|Adverse Event|0
885392|NCT00622635|1851867|FG004|Treatment Period 1|Adverse Event|0
885393|NCT00622635|1851868|FG005|Treatment Period 1|Adverse Event|0
885394|NCT00622635|1851863|FG000|Treatment Period 1|Withdrawal by Subject|0
885395|NCT00622635|1851864|FG001|Treatment Period 1|Withdrawal by Subject|1
885396|NCT00622635|1851865|FG002|Treatment Period 1|Withdrawal by Subject|0
885397|NCT00622635|1851866|FG003|Treatment Period 1|Withdrawal by Subject|0
885398|NCT00622635|1851867|FG004|Treatment Period 1|Withdrawal by Subject|0
885399|NCT00622635|1851868|FG005|Treatment Period 1|Withdrawal by Subject|0
885400|NCT00622635|1851863|FG000|Treatment Period 1|Abnormal test procedure result(s)|0
885401|NCT00622635|1851864|FG001|Treatment Period 1|Abnormal test procedure result(s)|0
885402|NCT00622635|1851865|FG002|Treatment Period 1|Abnormal test procedure result(s)|0
885403|NCT00622635|1851866|FG003|Treatment Period 1|Abnormal test procedure result(s)|0
885404|NCT00622635|1851867|FG004|Treatment Period 1|Abnormal test procedure result(s)|1
885405|NCT00622635|1851868|FG005|Treatment Period 1|Abnormal test procedure result(s)|0
885406|NCT00622635|1851863|FG000|Treatment Period 2|Adverse Event|1
885407|NCT00622635|1851864|FG001|Treatment Period 2|Adverse Event|0
885408|NCT00622635|1851865|FG002|Treatment Period 2|Adverse Event|0
885409|NCT00622635|1851866|FG003|Treatment Period 2|Adverse Event|0
885410|NCT00622635|1851867|FG004|Treatment Period 2|Adverse Event|0
885411|NCT00622635|1851868|FG005|Treatment Period 2|Adverse Event|0
885412|NCT00622635|1851863|FG000|Treatment Period 3|Adverse Event|0
885413|NCT00622635|1851864|FG001|Treatment Period 3|Adverse Event|0
885414|NCT00622635|1851865|FG002|Treatment Period 3|Adverse Event|0
885415|NCT00622635|1851866|FG003|Treatment Period 3|Adverse Event|2
885416|NCT00622635|1851867|FG004|Treatment Period 3|Adverse Event|0
885417|NCT00622635|1851868|FG005|Treatment Period 3|Adverse Event|0
885418|NCT00622635|1851863|FG000|Treatment Period 3|Withdrawal by Subject|0
885419|NCT00622635|1851864|FG001|Treatment Period 3|Withdrawal by Subject|0
885420|NCT00622635|1851865|FG002|Treatment Period 3|Withdrawal by Subject|0
885421|NCT00622635|1851866|FG003|Treatment Period 3|Withdrawal by Subject|1
885422|NCT00622635|1851867|FG004|Treatment Period 3|Withdrawal by Subject|0
885423|NCT00622635|1851868|FG005|Treatment Period 3|Withdrawal by Subject|0
885424|NCT00622700|1851879|FG000|Core Treatment Period|Randomized but Not Treated|0
885425|NCT00622700|1851880|FG001|Core Treatment Period|Randomized but Not Treated|2
885426|NCT00622700|1851881|FG002|Core Treatment Period|Randomized but Not Treated|2
885427|NCT00622700|1851882|FG003|Core Treatment Period|Randomized but Not Treated|0
885428|NCT00622700|1851883|FG004|Core Treatment Period|Randomized but Not Treated|0
885429|NCT00622700|1851884|FG005|Core Treatment Period|Randomized but Not Treated|0
885430|NCT00622700|1851885|FG006|Core Treatment Period|Randomized but Not Treated|0
885431|NCT00622700|1851879|FG000|Core Treatment Period|Adverse Event|18
885432|NCT00622700|1851880|FG001|Core Treatment Period|Adverse Event|25
885433|NCT00622700|1851881|FG002|Core Treatment Period|Adverse Event|18
885434|NCT00622700|1851882|FG003|Core Treatment Period|Adverse Event|0
885435|NCT00622700|1851883|FG004|Core Treatment Period|Adverse Event|0
885436|NCT00622700|1851884|FG005|Core Treatment Period|Adverse Event|0
885437|NCT00622700|1851885|FG006|Core Treatment Period|Adverse Event|0
885438|NCT00622700|1851879|FG000|Core Treatment Period|Lack of Efficacy|19
885439|NCT00622700|1851880|FG001|Core Treatment Period|Lack of Efficacy|6
885440|NCT00622700|1851881|FG002|Core Treatment Period|Lack of Efficacy|12
885441|NCT00622700|1851882|FG003|Core Treatment Period|Lack of Efficacy|0
885442|NCT00622700|1851883|FG004|Core Treatment Period|Lack of Efficacy|0
885443|NCT00622700|1851884|FG005|Core Treatment Period|Lack of Efficacy|0
885444|NCT00622700|1851885|FG006|Core Treatment Period|Lack of Efficacy|0
885445|NCT00622700|1851879|FG000|Core Treatment Period|Lost to Follow-up|1
885446|NCT00622700|1851880|FG001|Core Treatment Period|Lost to Follow-up|1
885447|NCT00622700|1851881|FG002|Core Treatment Period|Lost to Follow-up|1
885448|NCT00622700|1851882|FG003|Core Treatment Period|Lost to Follow-up|0
885449|NCT00622700|1851883|FG004|Core Treatment Period|Lost to Follow-up|0
885450|NCT00622700|1851884|FG005|Core Treatment Period|Lost to Follow-up|0
885451|NCT00622700|1851885|FG006|Core Treatment Period|Lost to Follow-up|0
885452|NCT00622700|1851879|FG000|Core Treatment Period|Death|1
885453|NCT00622700|1851880|FG001|Core Treatment Period|Death|0
885454|NCT00622700|1851881|FG002|Core Treatment Period|Death|0
885455|NCT00622700|1851882|FG003|Core Treatment Period|Death|0
885456|NCT00622700|1851883|FG004|Core Treatment Period|Death|0
885457|NCT00622700|1851884|FG005|Core Treatment Period|Death|0
885458|NCT00622700|1851885|FG006|Core Treatment Period|Death|0
885459|NCT00622700|1851879|FG000|Core Treatment Period|Progressive Disease|3
885460|NCT00622700|1851880|FG001|Core Treatment Period|Progressive Disease|1
885461|NCT00622700|1851881|FG002|Core Treatment Period|Progressive Disease|0
885462|NCT00622700|1851882|FG003|Core Treatment Period|Progressive Disease|0
885463|NCT00622700|1851883|FG004|Core Treatment Period|Progressive Disease|0
885464|NCT00622700|1851884|FG005|Core Treatment Period|Progressive Disease|0
885465|NCT00622700|1851885|FG006|Core Treatment Period|Progressive Disease|0
885466|NCT00622700|1851879|FG000|Core Treatment Period|Withdrawal by Subject|12
885467|NCT00622700|1851880|FG001|Core Treatment Period|Withdrawal by Subject|18
885468|NCT00622700|1851881|FG002|Core Treatment Period|Withdrawal by Subject|15
885469|NCT00622700|1851882|FG003|Core Treatment Period|Withdrawal by Subject|0
885470|NCT00622700|1851883|FG004|Core Treatment Period|Withdrawal by Subject|0
885471|NCT00622700|1851884|FG005|Core Treatment Period|Withdrawal by Subject|0
885472|NCT00622700|1851885|FG006|Core Treatment Period|Withdrawal by Subject|0
885473|NCT00622700|1851879|FG000|Core Treatment Period|Other than specified above|2
885474|NCT00622700|1851880|FG001|Core Treatment Period|Other than specified above|2
885475|NCT00622700|1851881|FG002|Core Treatment Period|Other than specified above|5
885476|NCT00622700|1851882|FG003|Core Treatment Period|Other than specified above|0
885477|NCT00622700|1851883|FG004|Core Treatment Period|Other than specified above|0
885478|NCT00622700|1851884|FG005|Core Treatment Period|Other than specified above|0
885479|NCT00622700|1851885|FG006|Core Treatment Period|Other than specified above|0
885480|NCT00622700|1851879|FG000|Extension Treatment Period|Adverse Event|0
885481|NCT00622700|1851880|FG001|Extension Treatment Period|Adverse Event|0
885482|NCT00622700|1851881|FG002|Extension Treatment Period|Adverse Event|0
885483|NCT00622700|1851882|FG003|Extension Treatment Period|Adverse Event|5
885484|NCT00622700|1851883|FG004|Extension Treatment Period|Adverse Event|9
885485|NCT00622700|1851884|FG005|Extension Treatment Period|Adverse Event|6
885486|NCT00622700|1851885|FG006|Extension Treatment Period|Adverse Event|8
885487|NCT00622700|1851879|FG000|Extension Treatment Period|Lack of Efficacy|0
885488|NCT00622700|1851880|FG001|Extension Treatment Period|Lack of Efficacy|0
885489|NCT00622700|1851881|FG002|Extension Treatment Period|Lack of Efficacy|0
885490|NCT00622700|1851882|FG003|Extension Treatment Period|Lack of Efficacy|2
885491|NCT00622700|1851883|FG004|Extension Treatment Period|Lack of Efficacy|8
885492|NCT00622700|1851884|FG005|Extension Treatment Period|Lack of Efficacy|1
885493|NCT00622700|1851885|FG006|Extension Treatment Period|Lack of Efficacy|9
885494|NCT00622700|1851879|FG000|Extension Treatment Period|Protocol Violation|0
885495|NCT00622700|1851880|FG001|Extension Treatment Period|Protocol Violation|0
885496|NCT00622700|1851881|FG002|Extension Treatment Period|Protocol Violation|0
885497|NCT00622700|1851882|FG003|Extension Treatment Period|Protocol Violation|0
885498|NCT00622700|1851883|FG004|Extension Treatment Period|Protocol Violation|0
885499|NCT00622700|1851884|FG005|Extension Treatment Period|Protocol Violation|2
885500|NCT00622700|1851885|FG006|Extension Treatment Period|Protocol Violation|0
885501|NCT00622700|1851879|FG000|Extension Treatment Period|Lost to Follow-up|0
885502|NCT00622700|1851880|FG001|Extension Treatment Period|Lost to Follow-up|0
885503|NCT00622700|1851881|FG002|Extension Treatment Period|Lost to Follow-up|0
885504|NCT00622700|1851882|FG003|Extension Treatment Period|Lost to Follow-up|0
885505|NCT00622700|1851883|FG004|Extension Treatment Period|Lost to Follow-up|1
885506|NCT00622700|1851884|FG005|Extension Treatment Period|Lost to Follow-up|0
885507|NCT00622700|1851885|FG006|Extension Treatment Period|Lost to Follow-up|0
885508|NCT00622700|1851879|FG000|Extension Treatment Period|Progressive Disease|0
885509|NCT00622700|1851880|FG001|Extension Treatment Period|Progressive Disease|0
885510|NCT00622700|1851881|FG002|Extension Treatment Period|Progressive Disease|0
885511|NCT00622700|1851882|FG003|Extension Treatment Period|Progressive Disease|1
885512|NCT00622700|1851883|FG004|Extension Treatment Period|Progressive Disease|2
885513|NCT00622700|1851884|FG005|Extension Treatment Period|Progressive Disease|0
885514|NCT00622700|1851885|FG006|Extension Treatment Period|Progressive Disease|2
885515|NCT00622700|1851879|FG000|Extension Treatment Period|Withdrawal by Subject|0
885516|NCT00622700|1851880|FG001|Extension Treatment Period|Withdrawal by Subject|0
885517|NCT00622700|1851881|FG002|Extension Treatment Period|Withdrawal by Subject|0
885518|NCT00622700|1851882|FG003|Extension Treatment Period|Withdrawal by Subject|11
885519|NCT00622700|1851883|FG004|Extension Treatment Period|Withdrawal by Subject|16
885520|NCT00622700|1851884|FG005|Extension Treatment Period|Withdrawal by Subject|6
885521|NCT00622700|1851885|FG006|Extension Treatment Period|Withdrawal by Subject|10
885522|NCT00622700|1851879|FG000|Extension Treatment Period|Missing|0
885523|NCT00622700|1851880|FG001|Extension Treatment Period|Missing|0
885524|NCT00622700|1851881|FG002|Extension Treatment Period|Missing|0
885525|NCT00622700|1851882|FG003|Extension Treatment Period|Missing|2
885526|NCT00622700|1851883|FG004|Extension Treatment Period|Missing|3
885527|NCT00622700|1851884|FG005|Extension Treatment Period|Missing|1
885528|NCT00622700|1851885|FG006|Extension Treatment Period|Missing|0
885529|NCT00622700|1851879|FG000|Extension Treatment Period|Other than specified above|0
885530|NCT00622700|1851880|FG001|Extension Treatment Period|Other than specified above|0
885531|NCT00622700|1851881|FG002|Extension Treatment Period|Other than specified above|0
885532|NCT00622700|1851882|FG003|Extension Treatment Period|Other than specified above|0
885533|NCT00622700|1851883|FG004|Extension Treatment Period|Other than specified above|0
885534|NCT00622700|1851884|FG005|Extension Treatment Period|Other than specified above|1
885535|NCT00622700|1851885|FG006|Extension Treatment Period|Other than specified above|1
885536|NCT00622713|1851902|FG000|Overall Study|Adverse Event|35
885537|NCT00622713|1851902|FG000|Overall Study|Administrative problems|4
885538|NCT00622713|1851902|FG000|Overall Study|Withdrawal by Subject|11
885539|NCT00622713|1851902|FG000|Overall Study|Lost to Follow-up|5
885540|NCT00622713|1851902|FG000|Overall Study|Death|2
885541|NCT00622713|1851902|FG000|Overall Study|Subject no longer required study drug|1
885542|NCT00622713|1851902|FG000|Overall Study|Did not meet eligibility criteria|1
885543|NCT00622726|1851908|FG000|March, 2008 to August, 2010|Death|5
885544|NCT00622726|1851909|FG001|March, 2008 to August, 2010|Death|2
885545|NCT00622726|1851908|FG000|August, 2010 to April, 2013|Death|1
885546|NCT00622726|1851909|FG001|August, 2010 to April, 2013|Death|5
885547|NCT00622739|1851921|FG000|Overall Study|Physician Decision|1
885548|NCT00622739|1851922|FG001|Overall Study|Physician Decision|0
885549|NCT00622739|1851921|FG000|Overall Study|Adverse Event|1
885550|NCT00622739|1851922|FG001|Overall Study|Adverse Event|2
885551|NCT00622739|1851921|FG000|Overall Study|Lack of Efficacy|0
885552|NCT00622739|1851922|FG001|Overall Study|Lack of Efficacy|2
885553|NCT00622739|1851921|FG000|Overall Study|Withdrawal by Subject|0
885554|NCT00622739|1851922|FG001|Overall Study|Withdrawal by Subject|1
885555|NCT00622739|1851921|FG000|Overall Study|Lost to Follow-up|0
885556|NCT00622739|1851922|FG001|Overall Study|Lost to Follow-up|1
885557|NCT00622869|1851933|FG000|Overall Study|Subject Withdrew Consent|13
885558|NCT00622869|1851934|FG001|Overall Study|Subject Withdrew Consent|17
885559|NCT00622869|1851935|FG002|Overall Study|Subject Withdrew Consent|11
885560|NCT00622869|1851933|FG000|Overall Study|Administrative Problems|11
885561|NCT00622869|1851934|FG001|Overall Study|Administrative Problems|17
885562|NCT00622869|1851935|FG002|Overall Study|Administrative Problems|13
885563|NCT00622869|1851933|FG000|Overall Study|Death|12
885564|NCT00622869|1851934|FG001|Overall Study|Death|15
885565|NCT00622869|1851935|FG002|Overall Study|Death|10
885566|NCT00622869|1851933|FG000|Overall Study|Lost to Follow-up|2
885567|NCT00622869|1851934|FG001|Overall Study|Lost to Follow-up|4
885568|NCT00622869|1851935|FG002|Overall Study|Lost to Follow-up|2
885569|NCT00622869|1851933|FG000|Overall Study|Graft Loss|5
885570|NCT00622869|1851934|FG001|Overall Study|Graft Loss|3
885571|NCT00622869|1851935|FG002|Overall Study|Graft Loss|2
885572|NCT00622869|1851933|FG000|Overall Study|Missing|0
885573|NCT00622869|1851934|FG001|Overall Study|Missing|1
885574|NCT00622869|1851935|FG002|Overall Study|Missing|1
885575|NCT00622908|1851952|FG000|Overall Study|Protocol Violation|1
885576|NCT00622908|1851953|FG001|Overall Study|Protocol Violation|0
885577|NCT00622908|1851952|FG000|Overall Study|Adverse Event|0
885578|NCT00622908|1851953|FG001|Overall Study|Adverse Event|1
885579|NCT00622908|1851952|FG000|Overall Study|Lack of Efficacy|1
885580|NCT00622908|1851953|FG001|Overall Study|Lack of Efficacy|7
885581|NCT00622908|1851952|FG000|Overall Study|Lost to Follow-up|1
885582|NCT00622908|1851953|FG001|Overall Study|Lost to Follow-up|0
885583|NCT00622908|1851952|FG000|Overall Study|Refusal|0
885584|NCT00622908|1851953|FG001|Overall Study|Refusal|1
885585|NCT00622908|1851952|FG000|Overall Study|Termination by study sponser|0
885586|NCT00622908|1851953|FG001|Overall Study|Termination by study sponser|1
885587|NCT00623103|1851965|FG000|Overall Study|Adverse Event|70
885588|NCT00623103|1851966|FG001|Overall Study|Adverse Event|60
885589|NCT00623103|1851965|FG000|Overall Study|Unsatisfactory therapeutic effect|4
885590|NCT00623103|1851966|FG001|Overall Study|Unsatisfactory therapeutic effect|12
885591|NCT00623103|1851965|FG000|Overall Study|Withdrawal by Subject|18
885592|NCT00623103|1851966|FG001|Overall Study|Withdrawal by Subject|24
885593|NCT00623103|1851965|FG000|Overall Study|Lost to Follow-up|4
885594|NCT00623103|1851966|FG001|Overall Study|Lost to Follow-up|1
885595|NCT00623103|1851965|FG000|Overall Study|Administrative problems|2
885596|NCT00623103|1851966|FG001|Overall Study|Administrative problems|4
885597|NCT00623103|1851965|FG000|Overall Study|Death|11
885598|NCT00623103|1851966|FG001|Overall Study|Death|11
885599|NCT00623103|1851965|FG000|Overall Study|Protocol deviation|2
885600|NCT00623103|1851966|FG001|Overall Study|Protocol deviation|1
885601|NCT00623194|1851985|FG000|Overall Study|Lack of Efficacy|1
885602|NCT00623194|1851985|FG000|Overall Study|Protocol Violation|3
885603|NCT00623194|1851985|FG000|Overall Study|Unclassified|1
885604|NCT00623233|1851989|FG000|Overall Study|Adverse Event|10
885605|NCT00623233|1851989|FG000|Overall Study|Physician Decision|10
885606|NCT00623233|1851989|FG000|Overall Study|Lost to Follow-up|1
885607|NCT00623233|1851989|FG000|Overall Study|Withdrawal by Subject|3
885608|NCT00623363|1851995|FG000|Overall Study|Adverse Event|2
885609|NCT00623363|1851996|FG001|Overall Study|Adverse Event|2
885610|NCT00623428|1852005|FG000|Treatment Period|Adverse event/intercurrent illness|0
885611|NCT00623428|1852006|FG001|Treatment Period|Adverse event/intercurrent illness|9
885612|NCT00623428|1852005|FG000|Treatment Period|Death|0
885613|NCT00623428|1852006|FG001|Treatment Period|Death|1
885614|NCT00623428|1852005|FG000|Treatment Period|Did not cooperate / refused treatment|0
885615|NCT00623428|1852006|FG001|Treatment Period|Did not cooperate / refused treatment|13
885616|NCT00623428|1852005|FG000|Treatment Period|Insufficient therapeutic response|0
885617|NCT00623428|1852006|FG001|Treatment Period|Insufficient therapeutic response|2
885618|NCT00623428|1852005|FG000|Treatment Period|Other|0
885619|NCT00623428|1852006|FG001|Treatment Period|Other|1
885620|NCT00623428|1852005|FG000|Treatment Period|Withdrawal by Subject|0
885621|NCT00623428|1852006|FG001|Treatment Period|Withdrawal by Subject|1
885622|NCT00623428|1852005|FG000|Follow-up Period|Relapse post-treatment|11
885623|NCT00623428|1852006|FG001|Follow-up Period|Relapse post-treatment|3
885624|NCT00623428|1852005|FG000|Follow-up Period|Failure to return|10
885625|NCT00623428|1852006|FG001|Follow-up Period|Failure to return|2
885626|NCT00623428|1852005|FG000|Follow-up Period|Patient withdrew consent|5
885627|NCT00623428|1852006|FG001|Follow-up Period|Patient withdrew consent|4
885628|NCT00623428|1852005|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2
885629|NCT00623428|1852006|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1
885630|NCT00623428|1852005|FG000|Follow-up Period|Did not cooperate|0
885631|NCT00623428|1852006|FG001|Follow-up Period|Did not cooperate|3
885632|NCT00623428|1852005|FG000|Follow-up Period|Reason not specified|1
885633|NCT00623428|1852006|FG001|Follow-up Period|Reason not specified|1
885634|NCT00623428|1852005|FG000|Follow-up Period|Death|0
885635|NCT00623428|1852006|FG001|Follow-up Period|Death|1
885636|NCT00623467|1852016|FG000|Overall Study|Lost to Follow-up|1
885637|NCT00623467|1852016|FG000|Overall Study|Protocol Violation|4
885638|NCT00623467|1852016|FG000|Overall Study|Withdrawal by Subject|2
885639|NCT00623480|1852024|FG000|Overall Study|Lost to Follow-up|0
885640|NCT00623480|1852025|FG001|Overall Study|Lost to Follow-up|1
885641|NCT00623480|1852024|FG000|Overall Study|Withdrawal by Subject|2
885642|NCT00623480|1852025|FG001|Overall Study|Withdrawal by Subject|4
885643|NCT00623480|1852024|FG000|Overall Study|Lack of Efficacy|1
885644|NCT00623480|1852025|FG001|Overall Study|Lack of Efficacy|0
885645|NCT00623480|1852024|FG000|Overall Study|Non-compliant with study medication|4
885646|NCT00623480|1852025|FG001|Overall Study|Non-compliant with study medication|0
885647|NCT00623480|1852024|FG000|Overall Study|Protocol Violation|0
885648|NCT00623480|1852025|FG001|Overall Study|Protocol Violation|1
885649|NCT00623480|1852024|FG000|Overall Study|Site closed by sponsor|0
885650|NCT00623480|1852025|FG001|Overall Study|Site closed by sponsor|1
885651|NCT00623545|1852040|FG000|Overall Study|Adverse Event|6
885652|NCT00623545|1852040|FG000|Overall Study|Withdrawal by Subject|4
885653|NCT00623597|1852047|FG000|Overall Study|Failed to return|1
885654|NCT00623597|1852048|FG001|Overall Study|Failed to return|0
885655|NCT00623623|1852058|FG000|Overall Study|Previous enrolment into this study|1
885656|NCT00623623|1852059|FG001|Overall Study|Previous enrolment into this study|1
885657|NCT00623727|1852084|FG000|Double Blind (DB)|Adverse Event|1
885658|NCT00623727|1852085|FG001|Double Blind (DB)|Adverse Event|3
885659|NCT00623727|1852084|FG000|Double Blind (DB)|Physician Decision|0
885660|NCT00623727|1852085|FG001|Double Blind (DB)|Physician Decision|1
885661|NCT00623727|1852084|FG000|Double Blind (DB)|Withdrawal by Subject|8
885662|NCT00623727|1852085|FG001|Double Blind (DB)|Withdrawal by Subject|2
885663|NCT00623727|1852084|FG000|Double Blind (DB)|Lack of Efficacy|2
885664|NCT00623727|1852085|FG001|Double Blind (DB)|Lack of Efficacy|2
885665|NCT00623727|1852084|FG000|Double Blind (DB)|Termination of the double-blind period|22
885666|NCT00623727|1852085|FG001|Double Blind (DB)|Termination of the double-blind period|21
885667|NCT00623727|1852084|FG000|Double Blind (DB)|Lost to Follow-up|1
885668|NCT00623727|1852085|FG001|Double Blind (DB)|Lost to Follow-up|1
885669|NCT00623727|1852084|FG000|Double Blind (DB)|Protocol Violation|2
885670|NCT00623727|1852085|FG001|Double Blind (DB)|Protocol Violation|2
885671|NCT00623727|1852084|FG000|Open Label Follow-up|Withdrawal by Subject|0
885672|NCT00623727|1852085|FG001|Open Label Follow-up|Withdrawal by Subject|1
885673|NCT00623727|1852084|FG000|Open Label Follow-up|Study termination|0
885674|NCT00623727|1852085|FG001|Open Label Follow-up|Study termination|6
885675|NCT00623727|1852084|FG000|Open Label Follow-up|Participant convenience|0
885676|NCT00623727|1852085|FG001|Open Label Follow-up|Participant convenience|1
885677|NCT00623766|1852095|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36
885678|NCT00623766|1852096|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16
885679|NCT00623766|1852095|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
885680|NCT00623766|1852096|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
885681|NCT00623766|1852095|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
885682|NCT00623766|1852096|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
885683|NCT00623766|1852095|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
885684|NCT00623766|1852096|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
885685|NCT00623766|1852095|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
885686|NCT00623766|1852096|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
885687|NCT00623779|1852109|FG000|Overall Study|Adverse Event|1
885688|NCT00623779|1852110|FG001|Overall Study|Adverse Event|3
885689|NCT00623779|1852111|FG002|Overall Study|Adverse Event|0
885690|NCT00623779|1852109|FG000|Overall Study|Criteria from CSR|2
885691|NCT00623779|1852110|FG001|Overall Study|Criteria from CSR|0
885692|NCT00623779|1852111|FG002|Overall Study|Criteria from CSR|1
885693|NCT00623805|1852121|FG000|Overall Study|Adverse Event|9
885694|NCT00623805|1852122|FG001|Overall Study|Adverse Event|6
885695|NCT00623805|1852121|FG000|Overall Study|Death|2
885696|NCT00623805|1852122|FG001|Overall Study|Death|0
885697|NCT00623805|1852121|FG000|Overall Study|Lack of Efficacy|3
885698|NCT00623805|1852122|FG001|Overall Study|Lack of Efficacy|7
885699|NCT00623805|1852121|FG000|Overall Study|Lost to Follow-up|2
885700|NCT00623805|1852122|FG001|Overall Study|Lost to Follow-up|2
885701|NCT00623805|1852121|FG000|Overall Study|Protocol Violation|1
885702|NCT00623805|1852122|FG001|Overall Study|Protocol Violation|1
885703|NCT00623805|1852121|FG000|Overall Study|Reason not Specified|3
885704|NCT00623805|1852122|FG001|Overall Study|Reason not Specified|6
885705|NCT00623831|1852130|FG000|Overall Study|Withdrawal by Subject|1
885706|NCT00623831|1852131|FG001|Overall Study|Withdrawal by Subject|0
885707|NCT00623831|1852130|FG000|Overall Study|Progressive Disease|0
885708|NCT00623831|1852131|FG001|Overall Study|Progressive Disease|1
885709|NCT00623935|1852140|FG000|Overall Study|Death|1
885710|NCT00623935|1852140|FG000|Overall Study|Patient Declined Transplant|1
885711|NCT00624052|1852159|FG000|Overall Study|Adverse Event|7
885712|NCT00624052|1852160|FG001|Overall Study|Adverse Event|6
885713|NCT00624052|1852161|FG002|Overall Study|Adverse Event|0
885714|NCT00624052|1852162|FG003|Overall Study|Adverse Event|3
885715|NCT00624052|1852159|FG000|Overall Study|Lack of Efficacy|1
885716|NCT00624052|1852160|FG001|Overall Study|Lack of Efficacy|1
885717|NCT00624052|1852161|FG002|Overall Study|Lack of Efficacy|0
885718|NCT00624052|1852162|FG003|Overall Study|Lack of Efficacy|0
885719|NCT00624052|1852159|FG000|Overall Study|Lost to Follow-up|2
885720|NCT00624052|1852160|FG001|Overall Study|Lost to Follow-up|3
885721|NCT00624052|1852161|FG002|Overall Study|Lost to Follow-up|1
885722|NCT00624052|1852162|FG003|Overall Study|Lost to Follow-up|0
885723|NCT00624052|1852159|FG000|Overall Study|Non compliant with the protocol|2
885724|NCT00624052|1852160|FG001|Overall Study|Non compliant with the protocol|1
885725|NCT00624052|1852161|FG002|Overall Study|Non compliant with the protocol|1
885726|NCT00624052|1852162|FG003|Overall Study|Non compliant with the protocol|1
885727|NCT00624052|1852159|FG000|Overall Study|Consent withdrawn|3
885728|NCT00624052|1852160|FG001|Overall Study|Consent withdrawn|1
885729|NCT00624052|1852161|FG002|Overall Study|Consent withdrawn|1
885730|NCT00624052|1852162|FG003|Overall Study|Consent withdrawn|0
885731|NCT00624052|1852159|FG000|Overall Study|Changed job/ran out if meds|0
885732|NCT00624052|1852160|FG001|Overall Study|Changed job/ran out if meds|2
885733|NCT00624052|1852161|FG002|Overall Study|Changed job/ran out if meds|0
885734|NCT00624052|1852162|FG003|Overall Study|Changed job/ran out if meds|0
885735|NCT00624065|1852178|FG000|Overall Study|Adverse Event|5
885736|NCT00624065|1852179|FG001|Overall Study|Adverse Event|6
885737|NCT00624065|1852178|FG000|Overall Study|Lost to Follow-up|4
885738|NCT00624065|1852179|FG001|Overall Study|Lost to Follow-up|1
885739|NCT00624065|1852178|FG000|Overall Study|Consent withdrawn|6
885740|NCT00624065|1852179|FG001|Overall Study|Consent withdrawn|5
885741|NCT00624065|1852178|FG000|Overall Study|Lack of Efficacy|0
885742|NCT00624065|1852179|FG001|Overall Study|Lack of Efficacy|3
885743|NCT00624065|1852178|FG000|Overall Study|Met protocol-defined stopping criteria|4
885744|NCT00624065|1852179|FG001|Overall Study|Met protocol-defined stopping criteria|9
885745|NCT00624286|1852230|FG000|Overall Study|Protocol Deviation|7
885746|NCT00624286|1852231|FG001|Overall Study|Protocol Deviation|9
885747|NCT00624286|1852230|FG000|Overall Study|Adverse Event|6
885748|NCT00624286|1852231|FG001|Overall Study|Adverse Event|3
885749|NCT00624286|1852230|FG000|Overall Study|Withdrawal by Subject|5
885750|NCT00624286|1852231|FG001|Overall Study|Withdrawal by Subject|4
885751|NCT00624286|1852230|FG000|Overall Study|Lost to Follow-up|3
885752|NCT00624286|1852231|FG001|Overall Study|Lost to Follow-up|2
885753|NCT00624286|1852230|FG000|Overall Study|Administrative problems|3
885754|NCT00624286|1852231|FG001|Overall Study|Administrative problems|0
885755|NCT00624286|1852230|FG000|Overall Study|Lack of Efficacy|1
885756|NCT00624286|1852231|FG001|Overall Study|Lack of Efficacy|6
885757|NCT00624286|1852230|FG000|Overall Study|Not stated|0
885758|NCT00624286|1852231|FG001|Overall Study|Not stated|1
885759|NCT00624286|1852230|FG000|Overall Study|Abnormal test procedure result(s)|0
885760|NCT00624286|1852231|FG001|Overall Study|Abnormal test procedure result(s)|1
885761|NCT00624286|1852230|FG000|Overall Study|Death|0
885762|NCT00624286|1852231|FG001|Overall Study|Death|1
885763|NCT00624338|1852240|FG000|Overall Study|Adverse Event|14
885764|NCT00624338|1852241|FG001|Overall Study|Adverse Event|14
885765|NCT00624338|1852242|FG002|Overall Study|Adverse Event|18
885766|NCT00624338|1852240|FG000|Overall Study|Lost to Follow-up|1
885767|NCT00624338|1852241|FG001|Overall Study|Lost to Follow-up|0
885768|NCT00624338|1852242|FG002|Overall Study|Lost to Follow-up|0
885769|NCT00624338|1852240|FG000|Overall Study|Lack of Efficacy|11
885770|NCT00624338|1852241|FG001|Overall Study|Lack of Efficacy|3
885771|NCT00624338|1852242|FG002|Overall Study|Lack of Efficacy|14
885772|NCT00624338|1852240|FG000|Overall Study|Protocol Violation|3
885773|NCT00624338|1852241|FG001|Overall Study|Protocol Violation|3
885774|NCT00624338|1852242|FG002|Overall Study|Protocol Violation|2
885775|NCT00624338|1852240|FG000|Overall Study|Death|0
885776|NCT00624338|1852241|FG001|Overall Study|Death|2
885777|NCT00624338|1852242|FG002|Overall Study|Death|0
885778|NCT00624338|1852240|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1
885779|NCT00624338|1852241|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0
885780|NCT00624338|1852242|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0
885781|NCT00624338|1852240|FG000|Overall Study|Termination of 150 mg group by Sponsor|0
885782|NCT00624338|1852241|FG001|Overall Study|Termination of 150 mg group by Sponsor|55
885783|NCT00624338|1852242|FG002|Overall Study|Termination of 150 mg group by Sponsor|0
885784|NCT00624338|1852240|FG000|Overall Study|Other|15
885785|NCT00624338|1852241|FG001|Overall Study|Other|5
885786|NCT00624338|1852242|FG002|Overall Study|Other|9
885787|NCT00624338|1852240|FG000|Overall Study|Randomized but not treated|2
885788|NCT00624338|1852241|FG001|Overall Study|Randomized but not treated|1
885789|NCT00624338|1852242|FG002|Overall Study|Randomized but not treated|3
885790|NCT00624377|1852250|FG000|Overall Study|Lost to Follow-up|355
885791|NCT00624377|1852250|FG000|Overall Study|Withdrawal by Subject|100
885792|NCT00624377|1852250|FG000|Overall Study|Adverse Event|14
885793|NCT00624377|1852250|FG000|Overall Study|Other|91
885794|NCT00624377|1852250|FG000|Overall Study|Non-evaluable population|84
885795|NCT00624468|1852302|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13
885796|NCT00624468|1852303|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12
885797|NCT00624468|1852304|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0
885798|NCT00624468|1852305|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0
885799|NCT00624468|1852302|FG000|Double-blind Period|Withdrew Prematurely|1
885800|NCT00624468|1852303|FG001|Double-blind Period|Withdrew Prematurely|1
885801|NCT00624468|1852304|FG002|Double-blind Period|Withdrew Prematurely|0
885802|NCT00624468|1852305|FG003|Double-blind Period|Withdrew Prematurely|0
885803|NCT00624468|1852302|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0
885804|NCT00624468|1852303|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0
885805|NCT00624468|1852304|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1
885806|NCT00624468|1852305|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2
885807|NCT00624468|1852302|FG000|Safety Follow-up (SFU) Period|Other|0
885808|NCT00624468|1852303|FG001|Safety Follow-up (SFU) Period|Other|0
885809|NCT00624468|1852304|FG002|Safety Follow-up (SFU) Period|Other|1
885810|NCT00624468|1852305|FG003|Safety Follow-up (SFU) Period|Other|1
885811|NCT00624520|1852315|FG000|Overall Study|Withdrawal by Subject|12
885812|NCT00624520|1852316|FG001|Overall Study|Withdrawal by Subject|7
885813|NCT00624520|1852315|FG000|Overall Study|Death|0
885814|NCT00624520|1852316|FG001|Overall Study|Death|1
885815|NCT00624585|1852339|FG000|Overall Study|Death|3
885816|NCT00624585|1852339|FG000|Overall Study|Disease Progression|6
885817|NCT00624585|1852339|FG000|Overall Study|Adverse Event|3
885818|NCT00624780|1852349|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7
885819|NCT00624780|1852350|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5
885820|NCT00624780|1852351|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15
885821|NCT00624780|1852352|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3
885822|NCT00624780|1852353|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9
885823|NCT00624780|1852354|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5
885824|NCT00624780|1852349|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
885825|NCT00624780|1852350|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
885826|NCT00624780|1852351|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
885827|NCT00624780|1852352|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
885828|NCT00624780|1852353|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
885829|NCT00624780|1852354|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
885830|NCT00624780|1852349|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
885831|NCT00624780|1852350|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
885832|NCT00624780|1852351|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
885833|NCT00624780|1852352|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
885834|NCT00624780|1852353|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
885835|NCT00624780|1852354|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
885836|NCT00624780|1852349|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
885837|NCT00624780|1852350|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
885838|NCT00624780|1852351|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
885839|NCT00624780|1852352|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
885840|NCT00624780|1852353|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
885841|NCT00624780|1852354|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
885842|NCT00624780|1852349|FG000|Treatment Optimization (Up to Week 12)|Other|10
885843|NCT00624780|1852350|FG001|Treatment Optimization (Up to Week 12)|Other|4
885844|NCT00624780|1852351|FG002|Treatment Optimization (Up to Week 12)|Other|8
885845|NCT00624780|1852352|FG003|Treatment Optimization (Up to Week 12)|Other|2
885846|NCT00624780|1852353|FG004|Treatment Optimization (Up to Week 12)|Other|9
885847|NCT00624780|1852354|FG005|Treatment Optimization (Up to Week 12)|Other|0
885848|NCT00624780|1852349|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
885849|NCT00624780|1852350|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
885850|NCT00624780|1852351|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
885851|NCT00624780|1852352|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
885852|NCT00624780|1852353|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
885853|NCT00624780|1852354|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
885854|NCT00624780|1852349|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
885855|NCT00624780|1852350|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
885856|NCT00624780|1852351|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
885857|NCT00624780|1852352|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
885858|NCT00624780|1852353|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
885859|NCT00624780|1852354|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
885860|NCT00624780|1852349|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
885861|NCT00624780|1852350|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
885862|NCT00624780|1852351|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
885863|NCT00624780|1852352|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
885864|NCT00624780|1852353|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
885865|NCT00624780|1852354|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
885866|NCT00624780|1852349|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
885867|NCT00624780|1852350|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
885868|NCT00624780|1852351|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
885869|NCT00624780|1852352|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
885870|NCT00624780|1852353|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
885871|NCT00624780|1852354|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
885872|NCT00624780|1852349|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5
885873|NCT00624780|1852350|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3
885874|NCT00624780|1852351|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4
885875|NCT00624780|1852352|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1
885876|NCT00624780|1852353|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4
885877|NCT00624780|1852354|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3
885878|NCT00624780|1852349|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1
885879|NCT00624780|1852350|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0
885880|NCT00624780|1852351|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2
885881|NCT00624780|1852352|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1
885882|NCT00624780|1852353|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0
885883|NCT00624780|1852354|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1
885884|NCT00624780|1852349|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
885885|NCT00624780|1852350|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
885886|NCT00624780|1852351|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
885887|NCT00624780|1852352|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
885888|NCT00624780|1852353|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
885889|NCT00624780|1852354|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
885890|NCT00624780|1852349|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
885891|NCT00624780|1852350|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
885892|NCT00624780|1852351|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
1006590|NCT01468701|2025299|FG014|Overall Study|Other reasons than listed|39
885893|NCT00624780|1852352|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
885894|NCT00624780|1852353|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
885895|NCT00624780|1852354|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
885896|NCT00624780|1852349|FG000|Follow-up (Week 26)|Death|0
885897|NCT00624780|1852350|FG001|Follow-up (Week 26)|Death|0
885898|NCT00624780|1852351|FG002|Follow-up (Week 26)|Death|1
885899|NCT00624780|1852352|FG003|Follow-up (Week 26)|Death|0
885900|NCT00624780|1852353|FG004|Follow-up (Week 26)|Death|0
885901|NCT00624780|1852354|FG005|Follow-up (Week 26)|Death|0
885902|NCT00624780|1852349|FG000|Follow-up (Week 26)|Adverse Event|0
885903|NCT00624780|1852350|FG001|Follow-up (Week 26)|Adverse Event|0
885904|NCT00624780|1852351|FG002|Follow-up (Week 26)|Adverse Event|0
885905|NCT00624780|1852352|FG003|Follow-up (Week 26)|Adverse Event|0
885906|NCT00624780|1852353|FG004|Follow-up (Week 26)|Adverse Event|1
885907|NCT00624780|1852354|FG005|Follow-up (Week 26)|Adverse Event|0
885908|NCT00624780|1852349|FG000|Follow-up (Week 26)|Lost to Follow-up|0
885909|NCT00624780|1852350|FG001|Follow-up (Week 26)|Lost to Follow-up|0
885910|NCT00624780|1852351|FG002|Follow-up (Week 26)|Lost to Follow-up|1
885911|NCT00624780|1852352|FG003|Follow-up (Week 26)|Lost to Follow-up|0
885912|NCT00624780|1852353|FG004|Follow-up (Week 26)|Lost to Follow-up|1
885913|NCT00624780|1852354|FG005|Follow-up (Week 26)|Lost to Follow-up|0
885914|NCT00624780|1852349|FG000|Follow-up (Week 26)|Withdrawal by Subject|1
885915|NCT00624780|1852350|FG001|Follow-up (Week 26)|Withdrawal by Subject|0
885916|NCT00624780|1852351|FG002|Follow-up (Week 26)|Withdrawal by Subject|0
885917|NCT00624780|1852352|FG003|Follow-up (Week 26)|Withdrawal by Subject|0
885918|NCT00624780|1852353|FG004|Follow-up (Week 26)|Withdrawal by Subject|0
885919|NCT00624780|1852354|FG005|Follow-up (Week 26)|Withdrawal by Subject|0
885920|NCT00624780|1852349|FG000|Follow-up (Week 26)|Other|1
885921|NCT00624780|1852350|FG001|Follow-up (Week 26)|Other|1
885922|NCT00624780|1852351|FG002|Follow-up (Week 26)|Other|0
885923|NCT00624780|1852352|FG003|Follow-up (Week 26)|Other|0
885924|NCT00624780|1852353|FG004|Follow-up (Week 26)|Other|0
885925|NCT00624780|1852354|FG005|Follow-up (Week 26)|Other|0
885926|NCT00624819|1852384|FG000|Follow-up Period: Year 4|Parents decision|0
885927|NCT00624819|1852385|FG001|Follow-up Period: Year 4|Parents decision|0
885928|NCT00624819|1852386|FG002|Follow-up Period: Year 4|Parents decision|1
885929|NCT00624819|1852387|FG003|Follow-up Period: Year 4|Parents decision|0
885930|NCT00624819|1852384|FG000|Follow-up Period: Year 4|Lost to Follow-up|1
885931|NCT00624819|1852385|FG001|Follow-up Period: Year 4|Lost to Follow-up|1
885932|NCT00624819|1852386|FG002|Follow-up Period: Year 4|Lost to Follow-up|0
885933|NCT00624819|1852387|FG003|Follow-up Period: Year 4|Lost to Follow-up|0
885934|NCT00624832|1852401|FG000|Overall Study|Adverse Event|0
885935|NCT00624832|1852402|FG001|Overall Study|Adverse Event|1
885936|NCT00624832|1852403|FG002|Overall Study|Adverse Event|0
885937|NCT00624832|1852404|FG003|Overall Study|Adverse Event|1
885938|NCT00624832|1852401|FG000|Overall Study|Abnormal Laboratory Value|2
885939|NCT00624832|1852402|FG001|Overall Study|Abnormal Laboratory Value|0
885940|NCT00624832|1852403|FG002|Overall Study|Abnormal Laboratory Value|0
885941|NCT00624832|1852404|FG003|Overall Study|Abnormal Laboratory Value|0
885942|NCT00625131|1852439|FG000|Overall Study|Lost to Follow-up|3
885943|NCT00625131|1852440|FG001|Overall Study|Lost to Follow-up|2
885944|NCT00625131|1852441|FG002|Overall Study|Lost to Follow-up|0
885945|NCT00625131|1852439|FG000|Overall Study|Withdrawal by Subject|1
885946|NCT00625131|1852440|FG001|Overall Study|Withdrawal by Subject|0
885947|NCT00625131|1852441|FG002|Overall Study|Withdrawal by Subject|5
885948|NCT00625183|1852447|FG000|Overall Study|Disease Progression|1
885949|NCT00625365|1852453|FG000|Overall Study|Withdrawal by Subject|1
885950|NCT00625365|1852453|FG000|Overall Study|No IV access|5
885951|NCT00625365|1852453|FG000|Overall Study|VSD|1
885952|NCT00625443|1852490|FG000|Overall Study|Adverse Event|1
885953|NCT00625443|1852491|FG001|Overall Study|Adverse Event|4
885954|NCT00625443|1852492|FG002|Overall Study|Adverse Event|0
885955|NCT00625443|1852490|FG000|Overall Study|Non-compliance with protocol|0
885956|NCT00625443|1852491|FG001|Overall Study|Non-compliance with protocol|1
885957|NCT00625443|1852492|FG002|Overall Study|Non-compliance with protocol|0
885958|NCT00625443|1852490|FG000|Overall Study|Platelet count increase >=500,000/mm3|1
885959|NCT00625443|1852491|FG001|Overall Study|Platelet count increase >=500,000/mm3|0
885960|NCT00625443|1852492|FG002|Overall Study|Platelet count increase >=500,000/mm3|0
885961|NCT00625443|1852490|FG000|Overall Study|Withdrawal by Subject|0
885962|NCT00625443|1852491|FG001|Overall Study|Withdrawal by Subject|1
885963|NCT00625443|1852492|FG002|Overall Study|Withdrawal by Subject|2
885964|NCT00625443|1852490|FG000|Overall Study|Physician Decision|0
885965|NCT00625443|1852491|FG001|Overall Study|Physician Decision|4
885966|NCT00625443|1852492|FG002|Overall Study|Physician Decision|2
885967|NCT00625443|1852490|FG000|Overall Study|Other|0
885968|NCT00625443|1852491|FG001|Overall Study|Other|1
885969|NCT00625443|1852492|FG002|Overall Study|Other|1
885970|NCT00625807|1852510|FG000|Overall Study|schedule conflict|2
885971|NCT00625807|1852511|FG001|Overall Study|schedule conflict|8
885972|NCT00625820|1852519|FG000|Overall Study|Withdrawal by Subject|1
885973|NCT00625846|1852528|FG000|Overall Study|Withdrawal by Subject|2
885974|NCT00625846|1852529|FG001|Overall Study|Withdrawal by Subject|0
885975|NCT00625846|1852530|FG002|Overall Study|Withdrawal by Subject|1
885976|NCT00625846|1852531|FG003|Overall Study|Withdrawal by Subject|2
885977|NCT00625872|1852547|FG000|Overall Study|Withdrawal by Subject|1
885978|NCT00625872|1852548|FG001|Overall Study|Withdrawal by Subject|0
885979|NCT00625872|1852547|FG000|Overall Study|Does not meet inclusion criteria|1
885980|NCT00625872|1852548|FG001|Overall Study|Does not meet inclusion criteria|0
885981|NCT00625872|1852547|FG000|Overall Study|Terminated by sponsor|2
885982|NCT00625872|1852548|FG001|Overall Study|Terminated by sponsor|5
885983|NCT00625872|1852547|FG000|Overall Study|Randomized but not treated|0
885984|NCT00625872|1852548|FG001|Overall Study|Randomized but not treated|1
885985|NCT00626028|1852562|FG000|Overall Study|Adverse Event|1
885986|NCT00626028|1852563|FG001|Overall Study|Adverse Event|1
885987|NCT00626028|1852562|FG000|Overall Study|Device Failure|0
885988|NCT00626028|1852563|FG001|Overall Study|Device Failure|1
885989|NCT00626028|1852562|FG000|Overall Study|Physician Decision|2
885990|NCT00626028|1852563|FG001|Overall Study|Physician Decision|1
885991|NCT00626028|1852562|FG000|Overall Study|Inclusion/Exclusion Criteria|3
885992|NCT00626028|1852563|FG001|Overall Study|Inclusion/Exclusion Criteria|6
885993|NCT00626093|1852569|FG000|Overall Study|Lost to Follow-up|5
885994|NCT00626093|1852569|FG000|Overall Study|Death|1
885995|NCT00626093|1852569|FG000|Overall Study|Physician Decision|4
885996|NCT00626093|1852569|FG000|Overall Study|Withdrawal by Subject|6
885997|NCT00626093|1852569|FG000|Overall Study|Protocol Violation|1
885998|NCT00626093|1852569|FG000|Overall Study|One of the required devices not implante|6
885999|NCT00626197|1852576|FG000|Overall Study|Did not cooperate|2
886000|NCT00626197|1852577|FG001|Overall Study|Did not cooperate|6
886001|NCT00626197|1852578|FG002|Overall Study|Did not cooperate|1
886002|NCT00626197|1852576|FG000|Overall Study|Failure to return|6
886003|NCT00626197|1852577|FG001|Overall Study|Failure to return|5
886004|NCT00626197|1852578|FG002|Overall Study|Failure to return|6
886005|NCT00626197|1852576|FG000|Overall Study|Adverse event, serious fatal|3
886006|NCT00626197|1852577|FG001|Overall Study|Adverse event, serious fatal|6
886007|NCT00626197|1852578|FG002|Overall Study|Adverse event, serious fatal|6
886008|NCT00626197|1852576|FG000|Overall Study|Adverse Event|1
886009|NCT00626197|1852577|FG001|Overall Study|Adverse Event|1
886010|NCT00626197|1852578|FG002|Overall Study|Adverse Event|2
886011|NCT00626197|1852576|FG000|Overall Study|Withdrawal by Subject|17
886012|NCT00626197|1852577|FG001|Overall Study|Withdrawal by Subject|17
886013|NCT00626197|1852578|FG002|Overall Study|Withdrawal by Subject|7
886014|NCT00626197|1852576|FG000|Overall Study|Administrative reasons|15
886015|NCT00626197|1852577|FG001|Overall Study|Administrative reasons|19
886016|NCT00626197|1852578|FG002|Overall Study|Administrative reasons|55
886017|NCT00626275|1852596|FG000|Part A - Treatment Period 1|Adverse Event|1
886018|NCT00626275|1852597|FG001|Part A - Treatment Period 1|Adverse Event|0
886019|NCT00626275|1852598|FG002|Part A - Treatment Period 1|Adverse Event|0
886020|NCT00626275|1852599|FG003|Part A - Treatment Period 1|Adverse Event|0
886021|NCT00626275|1852600|FG004|Part A - Treatment Period 1|Adverse Event|0
886022|NCT00626275|1852601|FG005|Part A - Treatment Period 1|Adverse Event|0
886023|NCT00626275|1852602|FG006|Part A - Treatment Period 1|Adverse Event|0
886024|NCT00626275|1852603|FG007|Part A - Treatment Period 1|Adverse Event|0
886025|NCT00626275|1852596|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0
886026|NCT00626275|1852597|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0
886027|NCT00626275|1852598|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1
886028|NCT00626275|1852599|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0
886029|NCT00626275|1852600|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0
886030|NCT00626275|1852601|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0
886031|NCT00626275|1852602|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0
886032|NCT00626275|1852603|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0
886033|NCT00626275|1852596|FG000|Part B|Lost to Follow-up|0
886034|NCT00626275|1852597|FG001|Part B|Lost to Follow-up|0
886035|NCT00626275|1852598|FG002|Part B|Lost to Follow-up|0
886036|NCT00626275|1852599|FG003|Part B|Lost to Follow-up|0
886037|NCT00626275|1852600|FG004|Part B|Lost to Follow-up|0
886038|NCT00626275|1852601|FG005|Part B|Lost to Follow-up|0
886039|NCT00626275|1852602|FG006|Part B|Lost to Follow-up|1
886040|NCT00626275|1852603|FG007|Part B|Lost to Follow-up|0
886041|NCT00626275|1852596|FG000|Part B|Withdrawal by Subject|0
886042|NCT00626275|1852597|FG001|Part B|Withdrawal by Subject|0
886043|NCT00626275|1852598|FG002|Part B|Withdrawal by Subject|0
886044|NCT00626275|1852599|FG003|Part B|Withdrawal by Subject|0
886045|NCT00626275|1852600|FG004|Part B|Withdrawal by Subject|0
886046|NCT00626275|1852601|FG005|Part B|Withdrawal by Subject|0
886047|NCT00626275|1852602|FG006|Part B|Withdrawal by Subject|0
886048|NCT00626275|1852603|FG007|Part B|Withdrawal by Subject|1
886049|NCT00626327|1852620|FG000|Overall Study|Withdrawal by Subject|21
886050|NCT00626327|1852621|FG001|Overall Study|Withdrawal by Subject|29
886051|NCT00626327|1852622|FG002|Overall Study|Withdrawal by Subject|30
886052|NCT00626327|1852620|FG000|Overall Study|Adverse Event|1
886053|NCT00626327|1852621|FG001|Overall Study|Adverse Event|0
886054|NCT00626327|1852622|FG002|Overall Study|Adverse Event|0
886055|NCT00626327|1852620|FG000|Overall Study|Lost to Follow-up|24
886056|NCT00626327|1852621|FG001|Overall Study|Lost to Follow-up|21
886057|NCT00626327|1852622|FG002|Overall Study|Lost to Follow-up|23
886058|NCT00626327|1852620|FG000|Overall Study|Inappropriate enrollment|4
886059|NCT00626327|1852621|FG001|Overall Study|Inappropriate enrollment|5
886060|NCT00626327|1852622|FG002|Overall Study|Inappropriate enrollment|3
886061|NCT00626327|1852620|FG000|Overall Study|Administrative Reason|2
886062|NCT00626327|1852621|FG001|Overall Study|Administrative Reason|0
886063|NCT00626327|1852622|FG002|Overall Study|Administrative Reason|6
886064|NCT00626327|1852620|FG000|Overall Study|Protocol Violation|26
886065|NCT00626327|1852621|FG001|Overall Study|Protocol Violation|4
886066|NCT00626327|1852622|FG002|Overall Study|Protocol Violation|26
886067|NCT00626392|1852657|FG000|Run-in Period|Adverse Event|0
886068|NCT00626392|1852658|FG001|Run-in Period|Adverse Event|0
886069|NCT00626392|1852659|FG002|Run-in Period|Adverse Event|1
886070|NCT00626392|1852660|FG003|Run-in Period|Adverse Event|0
886071|NCT00626392|1852661|FG004|Run-in Period|Adverse Event|1
886072|NCT00626392|1852662|FG005|Run-in Period|Adverse Event|0
886073|NCT00626392|1852657|FG000|Run-in Period|Withdrawal by Subject|0
886074|NCT00626392|1852658|FG001|Run-in Period|Withdrawal by Subject|1
886075|NCT00626392|1852659|FG002|Run-in Period|Withdrawal by Subject|1
886076|NCT00626392|1852660|FG003|Run-in Period|Withdrawal by Subject|1
886077|NCT00626392|1852661|FG004|Run-in Period|Withdrawal by Subject|3
886078|NCT00626392|1852662|FG005|Run-in Period|Withdrawal by Subject|1
886079|NCT00626392|1852657|FG000|Run-in Period|Noncompliance|1
886080|NCT00626392|1852658|FG001|Run-in Period|Noncompliance|0
886081|NCT00626392|1852659|FG002|Run-in Period|Noncompliance|1
886082|NCT00626392|1852660|FG003|Run-in Period|Noncompliance|0
886083|NCT00626392|1852661|FG004|Run-in Period|Noncompliance|0
886084|NCT00626392|1852662|FG005|Run-in Period|Noncompliance|0
886085|NCT00626392|1852657|FG000|Coadministration Period|Adverse Event|3
886086|NCT00626392|1852658|FG001|Coadministration Period|Adverse Event|1
886087|NCT00626392|1852659|FG002|Coadministration Period|Adverse Event|7
886088|NCT00626392|1852660|FG003|Coadministration Period|Adverse Event|4
886089|NCT00626392|1852661|FG004|Coadministration Period|Adverse Event|3
886090|NCT00626392|1852662|FG005|Coadministration Period|Adverse Event|4
886091|NCT00626392|1852657|FG000|Coadministration Period|Withdrawal by Subject|1
886092|NCT00626392|1852658|FG001|Coadministration Period|Withdrawal by Subject|1
886093|NCT00626392|1852659|FG002|Coadministration Period|Withdrawal by Subject|0
886094|NCT00626392|1852660|FG003|Coadministration Period|Withdrawal by Subject|1
886095|NCT00626392|1852661|FG004|Coadministration Period|Withdrawal by Subject|0
886096|NCT00626392|1852662|FG005|Coadministration Period|Withdrawal by Subject|1
886097|NCT00626392|1852657|FG000|Coadministration Period|Protocol Violation|0
886098|NCT00626392|1852658|FG001|Coadministration Period|Protocol Violation|1
886099|NCT00626392|1852659|FG002|Coadministration Period|Protocol Violation|0
886100|NCT00626392|1852660|FG003|Coadministration Period|Protocol Violation|1
886101|NCT00626392|1852661|FG004|Coadministration Period|Protocol Violation|1
886102|NCT00626392|1852662|FG005|Coadministration Period|Protocol Violation|0
886103|NCT00626392|1852657|FG000|Coadministration Period|Other|0
886104|NCT00626392|1852658|FG001|Coadministration Period|Other|2
886105|NCT00626392|1852659|FG002|Coadministration Period|Other|3
886106|NCT00626392|1852660|FG003|Coadministration Period|Other|1
886107|NCT00626392|1852661|FG004|Coadministration Period|Other|1
886108|NCT00626392|1852662|FG005|Coadministration Period|Other|1
886109|NCT00626405|1852670|FG000|Overall Study|Deemed Ineligible|1
886110|NCT00626405|1852671|FG001|Overall Study|Deemed Ineligible|0
886111|NCT00626405|1852670|FG000|Overall Study|Withdrawal by Subject|0
886112|NCT00626405|1852671|FG001|Overall Study|Withdrawal by Subject|1
886113|NCT00626522|1852692|FG000|Overall Study|Protocol Violation|0
886114|NCT00626522|1852693|FG001|Overall Study|Protocol Violation|0
886115|NCT00626522|1852694|FG002|Overall Study|Protocol Violation|0
886116|NCT00626522|1852695|FG003|Overall Study|Protocol Violation|0
886117|NCT00626522|1852696|FG004|Overall Study|Protocol Violation|1
886118|NCT00626522|1852697|FG005|Overall Study|Protocol Violation|0
886119|NCT00626522|1852692|FG000|Overall Study|Adverse Event|2
886120|NCT00626522|1852693|FG001|Overall Study|Adverse Event|1
886121|NCT00626522|1852694|FG002|Overall Study|Adverse Event|2
886122|NCT00626522|1852695|FG003|Overall Study|Adverse Event|0
886123|NCT00626522|1852696|FG004|Overall Study|Adverse Event|1
886124|NCT00626522|1852697|FG005|Overall Study|Adverse Event|1
886125|NCT00626522|1852692|FG000|Overall Study|Withdrawal by Subject|2
886126|NCT00626522|1852693|FG001|Overall Study|Withdrawal by Subject|5
886127|NCT00626522|1852694|FG002|Overall Study|Withdrawal by Subject|5
886128|NCT00626522|1852695|FG003|Overall Study|Withdrawal by Subject|0
886129|NCT00626522|1852696|FG004|Overall Study|Withdrawal by Subject|4
886130|NCT00626522|1852697|FG005|Overall Study|Withdrawal by Subject|1
886131|NCT00626522|1852692|FG000|Overall Study|COPD exacerbation|0
886132|NCT00626522|1852693|FG001|Overall Study|COPD exacerbation|0
886133|NCT00626522|1852694|FG002|Overall Study|COPD exacerbation|0
886134|NCT00626522|1852695|FG003|Overall Study|COPD exacerbation|1
886135|NCT00626522|1852696|FG004|Overall Study|COPD exacerbation|1
886136|NCT00626522|1852697|FG005|Overall Study|COPD exacerbation|0
886137|NCT00626522|1852692|FG000|Overall Study|Lost to Follow-up|0
886138|NCT00626522|1852693|FG001|Overall Study|Lost to Follow-up|1
886139|NCT00626522|1852694|FG002|Overall Study|Lost to Follow-up|0
886140|NCT00626522|1852695|FG003|Overall Study|Lost to Follow-up|0
886141|NCT00626522|1852696|FG004|Overall Study|Lost to Follow-up|0
886142|NCT00626522|1852697|FG005|Overall Study|Lost to Follow-up|0
886143|NCT00626522|1852692|FG000|Overall Study|Inconsistent reason reported|1
886144|NCT00626522|1852693|FG001|Overall Study|Inconsistent reason reported|0
886145|NCT00626522|1852694|FG002|Overall Study|Inconsistent reason reported|0
886146|NCT00626522|1852695|FG003|Overall Study|Inconsistent reason reported|0
886147|NCT00626522|1852696|FG004|Overall Study|Inconsistent reason reported|0
886148|NCT00626522|1852697|FG005|Overall Study|Inconsistent reason reported|0
886149|NCT00626522|1852692|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1
886150|NCT00626522|1852693|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0
886151|NCT00626522|1852694|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1
886152|NCT00626522|1852695|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1
886153|NCT00626522|1852696|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0
886154|NCT00626522|1852697|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0
886155|NCT00626548|1852713|FG000|Overall Study|Adverse Event|164
886156|NCT00626548|1852714|FG001|Overall Study|Adverse Event|44
886157|NCT00626548|1852713|FG000|Overall Study|Withdrawal by Subject|42
886158|NCT00626548|1852714|FG001|Overall Study|Withdrawal by Subject|46
886159|NCT00626548|1852713|FG000|Overall Study|Protocol Violation|4
886160|NCT00626548|1852714|FG001|Overall Study|Protocol Violation|11
886161|NCT00626548|1852713|FG000|Overall Study|Lost to Follow-up|2
886162|NCT00626548|1852714|FG001|Overall Study|Lost to Follow-up|2
886163|NCT00626548|1852713|FG000|Overall Study|Other termination reason|493
886164|NCT00626548|1852714|FG001|Overall Study|Other termination reason|613
886165|NCT00626639|1852743|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2
886166|NCT00626639|1852744|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2
886167|NCT00626795|1852775|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0
886168|NCT00626795|1852776|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1
886169|NCT00626795|1852777|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0
886170|NCT00626795|1852775|FG000|Blinded Treatment|Lack of Efficacy|2
886171|NCT00626795|1852776|FG001|Blinded Treatment|Lack of Efficacy|0
886172|NCT00626795|1852777|FG002|Blinded Treatment|Lack of Efficacy|0
886173|NCT00626795|1852775|FG000|Blinded Treatment|Unacceptable adverse event|0
886174|NCT00626795|1852776|FG001|Blinded Treatment|Unacceptable adverse event|0
886175|NCT00626795|1852777|FG002|Blinded Treatment|Unacceptable adverse event|1
886176|NCT00626795|1852775|FG000|Blinded Treatment|Protocol Violation|0
886177|NCT00626795|1852776|FG001|Blinded Treatment|Protocol Violation|1
886178|NCT00626795|1852777|FG002|Blinded Treatment|Protocol Violation|1
886179|NCT00626795|1852775|FG000|Blinded Treatment|Withdrawal by Subject|1
886180|NCT00626795|1852776|FG001|Blinded Treatment|Withdrawal by Subject|1
886181|NCT00626795|1852777|FG002|Blinded Treatment|Withdrawal by Subject|0
886182|NCT00626795|1852775|FG000|Blinded Treatment|Other reasons|2
886183|NCT00626795|1852776|FG001|Blinded Treatment|Other reasons|0
886184|NCT00626795|1852777|FG002|Blinded Treatment|Other reasons|2
886185|NCT00626795|1852775|FG000|Blinded Treatment|Missing reason for withdrawal|5
886186|NCT00626795|1852776|FG001|Blinded Treatment|Missing reason for withdrawal|3
886187|NCT00626795|1852777|FG002|Blinded Treatment|Missing reason for withdrawal|5
886188|NCT00626821|1852806|FG000|Overall Study|Adverse Event|44
886189|NCT00626821|1852806|FG000|Overall Study|Protocol Violation|33
886190|NCT00626821|1852806|FG000|Overall Study|Withdrawal by Subject|10
886191|NCT00626821|1852806|FG000|Overall Study|Physician Decision|9
886192|NCT00626821|1852806|FG000|Overall Study|Product dysfunction|21
886193|NCT00626821|1852806|FG000|Overall Study|other/unknown reason|104
886194|NCT00626925|1852830|FG000|Overall Study|Lost to Follow-up|1
886195|NCT00626925|1852831|FG001|Overall Study|Lost to Follow-up|2
886196|NCT00626925|1852830|FG000|Overall Study|relapse|1
886197|NCT00626925|1852831|FG001|Overall Study|relapse|0
886198|NCT00626925|1852830|FG000|Overall Study|Adverse effect|6
886199|NCT00626925|1852831|FG001|Overall Study|Adverse effect|2
886200|NCT00626925|1852830|FG000|Overall Study|Lack of Efficacy|1
886201|NCT00626925|1852831|FG001|Overall Study|Lack of Efficacy|4
886202|NCT00626925|1852830|FG000|Overall Study|Time constraints|3
886203|NCT00626925|1852831|FG001|Overall Study|Time constraints|1
886204|NCT00627016|1852853|FG000|Overall Study|Adverse Event|1
886205|NCT00627016|1852854|FG001|Overall Study|Adverse Event|1
886206|NCT00627016|1852853|FG000|Overall Study|Protocol Violation|0
886207|NCT00627016|1852854|FG001|Overall Study|Protocol Violation|2
886208|NCT00627016|1852853|FG000|Overall Study|Lost to Follow-up|0
886209|NCT00627016|1852854|FG001|Overall Study|Lost to Follow-up|1
886210|NCT00627016|1852853|FG000|Overall Study|Withdrawal by Subject|2
886211|NCT00627016|1852854|FG001|Overall Study|Withdrawal by Subject|1
886212|NCT00627016|1852853|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
886213|NCT00627016|1852854|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
886214|NCT00627016|1852853|FG000|Overall Study|Lack of Efficacy|1
886215|NCT00627016|1852854|FG001|Overall Study|Lack of Efficacy|0
886216|NCT00627016|1852853|FG000|Overall Study|Placed on Excluded Drugs|1
886217|NCT00627016|1852854|FG001|Overall Study|Placed on Excluded Drugs|0
886218|NCT00627016|1852853|FG000|Overall Study|Pregnancy|1
886219|NCT00627016|1852854|FG001|Overall Study|Pregnancy|0
886220|NCT00627042|1852860|FG000|Overall Study|Withdrawal by Subject|2
886221|NCT00627094|1852866|FG000|Overall Study|Adverse Event|8
886222|NCT00627094|1852867|FG001|Overall Study|Adverse Event|7
886223|NCT00627094|1852866|FG000|Overall Study|Lost to Follow-up|1
886224|NCT00627094|1852867|FG001|Overall Study|Lost to Follow-up|0
886225|NCT00627094|1852866|FG000|Overall Study|Withdrawal by Subject|1
886226|NCT00627094|1852867|FG001|Overall Study|Withdrawal by Subject|1
886227|NCT00627094|1852866|FG000|Overall Study|ulcer healed|1
886228|NCT00627094|1852867|FG001|Overall Study|ulcer healed|7
886229|NCT00627094|1852866|FG000|Overall Study|Other reason|1
886230|NCT00627094|1852867|FG001|Overall Study|Other reason|0
886231|NCT00627393|1852887|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5
886232|NCT00627393|1852888|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3
886233|NCT00627393|1852887|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
886234|NCT00627393|1852888|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
886235|NCT00627393|1852887|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
886236|NCT00627393|1852888|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
886237|NCT00627393|1852887|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
886238|NCT00627393|1852888|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
886239|NCT00627445|1852915|FG000|Overall Study|Adverse Event|3
886240|NCT00627445|1852916|FG001|Overall Study|Adverse Event|3
886241|NCT00627445|1852915|FG000|Overall Study|Lack of Efficacy|0
886242|NCT00627445|1852916|FG001|Overall Study|Lack of Efficacy|1
886243|NCT00627445|1852915|FG000|Overall Study|Other|6
886244|NCT00627445|1852916|FG001|Overall Study|Other|8
886245|NCT00627458|1852927|FG000|Overall Study|Migrated from study area|1
886246|NCT00627458|1852928|FG001|Overall Study|Migrated from study area|0
886247|NCT00627458|1852929|FG002|Overall Study|Migrated from study area|1
886248|NCT00627458|1852927|FG000|Overall Study|Withdrawal by Subject|2
886249|NCT00627458|1852928|FG001|Overall Study|Withdrawal by Subject|6
886250|NCT00627458|1852929|FG002|Overall Study|Withdrawal by Subject|5
886251|NCT00627458|1852927|FG000|Overall Study|Lost to Follow-up|1
886252|NCT00627458|1852928|FG001|Overall Study|Lost to Follow-up|1
886253|NCT00627458|1852929|FG002|Overall Study|Lost to Follow-up|0
886254|NCT00627497|1852942|FG000|Overall Study|Lost to Follow-up|1
886255|NCT00627497|1852943|FG001|Overall Study|Lost to Follow-up|1
886256|NCT00627497|1852944|FG002|Overall Study|Lost to Follow-up|0
886257|NCT00627497|1852945|FG003|Overall Study|Lost to Follow-up|0
886258|NCT00627523|1852957|FG000|Overall Study|Lack of Efficacy|1
886259|NCT00627523|1852958|FG001|Overall Study|Lack of Efficacy|0
886260|NCT00627523|1852957|FG000|Overall Study|Withdrawal by Subject|0
886261|NCT00627523|1852958|FG001|Overall Study|Withdrawal by Subject|2
886262|NCT00627523|1852957|FG000|Overall Study|Other|1
886263|NCT00627523|1852958|FG001|Overall Study|Other|0
886264|NCT00627705|1852979|FG000|Overall Study|Unwilling to take the compound (taste)|1
886265|NCT00627705|1852980|FG001|Overall Study|Unwilling to take the compound (taste)|3
886266|NCT00627705|1852979|FG000|Overall Study|Adverse Event|1
886267|NCT00627705|1852980|FG001|Overall Study|Adverse Event|0
886268|NCT00627705|1852979|FG000|Overall Study|Withdrawal by Subject|0
886269|NCT00627705|1852980|FG001|Overall Study|Withdrawal by Subject|2
886270|NCT00627705|1852979|FG000|Overall Study|Lost to Follow-up|0
886271|NCT00627705|1852980|FG001|Overall Study|Lost to Follow-up|1
886272|NCT00627926|1852995|FG000|Overall Study|Adverse Event|26
886273|NCT00627926|1852996|FG001|Overall Study|Adverse Event|37
886274|NCT00627926|1852997|FG002|Overall Study|Adverse Event|36
886275|NCT00627926|1852995|FG000|Overall Study|Death|1
886276|NCT00627926|1852996|FG001|Overall Study|Death|0
886277|NCT00627926|1852997|FG002|Overall Study|Death|0
886278|NCT00627926|1852995|FG000|Overall Study|Lost to Follow-up|4
886279|NCT00627926|1852996|FG001|Overall Study|Lost to Follow-up|3
886280|NCT00627926|1852997|FG002|Overall Study|Lost to Follow-up|4
886281|NCT00627926|1852995|FG000|Overall Study|Withdrawal by Subject|2
886282|NCT00627926|1852996|FG001|Overall Study|Withdrawal by Subject|1
886283|NCT00627926|1852997|FG002|Overall Study|Withdrawal by Subject|0
886284|NCT00627926|1852995|FG000|Overall Study|Lack of Efficacy|118
886285|NCT00627926|1852996|FG001|Overall Study|Lack of Efficacy|40
886286|NCT00627926|1852997|FG002|Overall Study|Lack of Efficacy|38
886287|NCT00627926|1852995|FG000|Overall Study|Noncompliance/unspecified|8
886288|NCT00627926|1852996|FG001|Overall Study|Noncompliance/unspecified|23
886289|NCT00627926|1852997|FG002|Overall Study|Noncompliance/unspecified|17
886290|NCT00628030|1853016|FG000|Baseline to Post-Assessment|Lost to Follow-up|28
886291|NCT00628030|1853017|FG001|Baseline to Post-Assessment|Lost to Follow-up|29
886292|NCT00628030|1853016|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5
886293|NCT00628030|1853017|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0
886294|NCT00628030|1853016|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32
886295|NCT00628030|1853017|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30
886296|NCT00628108|1853025|FG000|Overall Study|Adverse Event|0
886297|NCT00628108|1853026|FG001|Overall Study|Adverse Event|3
886298|NCT00628108|1853025|FG000|Overall Study|Withdrawal by Subject|1
886299|NCT00628108|1853026|FG001|Overall Study|Withdrawal by Subject|0
886300|NCT00628212|1853052|FG000|Overall Study|Adverse Event|2
886301|NCT00628212|1853053|FG001|Overall Study|Adverse Event|0
886302|NCT00628212|1853054|FG002|Overall Study|Adverse Event|1
886303|NCT00628212|1853055|FG003|Overall Study|Adverse Event|2
886304|NCT00628212|1853052|FG000|Overall Study|Physician Decision|1
886305|NCT00628212|1853053|FG001|Overall Study|Physician Decision|1
886306|NCT00628212|1853054|FG002|Overall Study|Physician Decision|2
886307|NCT00628212|1853055|FG003|Overall Study|Physician Decision|3
886308|NCT00628251|1853068|FG000|Randomised Part|Withdrawal by Subject|0
886309|NCT00628251|1853069|FG001|Randomised Part|Withdrawal by Subject|0
886310|NCT00628251|1853070|FG002|Randomised Part|Withdrawal by Subject|1
886311|NCT00628251|1853068|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1
886312|NCT00628251|1853069|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2
886313|NCT00628251|1853070|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3
886314|NCT00628251|1853068|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
886315|NCT00628251|1853069|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
886316|NCT00628251|1853070|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
886317|NCT00628251|1853068|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
886318|NCT00628251|1853069|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
886319|NCT00628251|1853070|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
886320|NCT00628251|1853068|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0
886321|NCT00628251|1853069|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1
886322|NCT00628251|1853070|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6
886323|NCT00628251|1853068|FG000|Ongoing Initial Study Treatment at DCO|Other|1
886324|NCT00628251|1853069|FG001|Ongoing Initial Study Treatment at DCO|Other|0
886325|NCT00628251|1853070|FG002|Ongoing Initial Study Treatment at DCO|Other|2
886326|NCT00628355|1853082|FG000|Overall Study|Withdrawal by Subject|1
886327|NCT00628355|1853083|FG001|Overall Study|Withdrawal by Subject|1
886328|NCT00628446|1853111|FG000|Overall Study|Lost to Follow-up|3
886329|NCT00628446|1853111|FG000|Overall Study|Withdrawal by Subject|1
886330|NCT00628446|1853111|FG000|Overall Study|Protocol Violation|3
886331|NCT00628758|1853144|FG000|Overall Study|Adverse Event|2
886332|NCT00628758|1853145|FG001|Overall Study|Adverse Event|3
886333|NCT00628758|1853144|FG000|Overall Study|Withdrawal by Subject|6
886334|NCT00628758|1853145|FG001|Overall Study|Withdrawal by Subject|3
886335|NCT00628758|1853144|FG000|Overall Study|Death|1
886336|NCT00628758|1853145|FG001|Overall Study|Death|0
886337|NCT00628758|1853144|FG000|Overall Study|Protocol Violation|5
886338|NCT00628758|1853145|FG001|Overall Study|Protocol Violation|1
886339|NCT00628758|1853144|FG000|Overall Study|Lost to Follow-up|25
886340|NCT00628758|1853145|FG001|Overall Study|Lost to Follow-up|31
886341|NCT00628758|1853144|FG000|Overall Study|Pregnancy|2
886342|NCT00628758|1853145|FG001|Overall Study|Pregnancy|2
886343|NCT00628758|1853144|FG000|Overall Study|Investigator Moved|3
886344|NCT00628758|1853145|FG001|Overall Study|Investigator Moved|0
886345|NCT00628758|1853144|FG000|Overall Study|Treatment Failure|0
886346|NCT00628758|1853145|FG001|Overall Study|Treatment Failure|2
886347|NCT00628862|1853156|FG000|Overall Study|Adverse Event|6
886348|NCT00628862|1853157|FG001|Overall Study|Adverse Event|8
886349|NCT00628862|1853158|FG002|Overall Study|Adverse Event|10
886350|NCT00628862|1853156|FG000|Overall Study|Withdrawal by Subject|4
886351|NCT00628862|1853157|FG001|Overall Study|Withdrawal by Subject|6
886352|NCT00628862|1853158|FG002|Overall Study|Withdrawal by Subject|11
886353|NCT00628862|1853156|FG000|Overall Study|Lost to Follow-up|0
886354|NCT00628862|1853157|FG001|Overall Study|Lost to Follow-up|2
886355|NCT00628862|1853158|FG002|Overall Study|Lost to Follow-up|1
886356|NCT00628862|1853156|FG000|Overall Study|Protocol Violation|1
886357|NCT00628862|1853157|FG001|Overall Study|Protocol Violation|0
886358|NCT00628862|1853158|FG002|Overall Study|Protocol Violation|0
886359|NCT00628862|1853156|FG000|Overall Study|COPD Exacerbation|0
886360|NCT00628862|1853157|FG001|Overall Study|COPD Exacerbation|1
886361|NCT00628862|1853158|FG002|Overall Study|COPD Exacerbation|0
886362|NCT00628927|1853177|FG000|Overall Study|Problems performing blood draw|6
886363|NCT00628927|1853178|FG001|Overall Study|Problems performing blood draw|0
886364|NCT00628927|1853177|FG000|Overall Study|Lost to Follow-up|1
886365|NCT00628927|1853178|FG001|Overall Study|Lost to Follow-up|0
886366|NCT00628927|1853177|FG000|Overall Study|Equipment failure|1
886367|NCT00628927|1853178|FG001|Overall Study|Equipment failure|0
886368|NCT00629083|1853200|FG000|Overall Study|Adverse Event|0
886369|NCT00629083|1853201|FG001|Overall Study|Adverse Event|2
886370|NCT00629083|1853200|FG000|Overall Study|Lack of Efficacy|3
886371|NCT00629083|1853201|FG001|Overall Study|Lack of Efficacy|1
886372|NCT00629083|1853200|FG000|Overall Study|Withdrawal by Subject|10
886373|NCT00629083|1853201|FG001|Overall Study|Withdrawal by Subject|2
886374|NCT00629083|1853200|FG000|Overall Study|Lost to Follow-up|12
886375|NCT00629083|1853201|FG001|Overall Study|Lost to Follow-up|8
886376|NCT00629083|1853200|FG000|Overall Study|Moved out of country/state|2
886377|NCT00629083|1853201|FG001|Overall Study|Moved out of country/state|1
886378|NCT00629083|1853200|FG000|Overall Study|Refused to return for 12 month visit|1
886379|NCT00629083|1853201|FG001|Overall Study|Refused to return for 12 month visit|0
886380|NCT00629239|1853220|FG000|Overall Study|Adverse Event|7
886381|NCT00629239|1853221|FG001|Overall Study|Adverse Event|4
886382|NCT00629239|1853220|FG000|Overall Study|Physician Decision|1
886383|NCT00629239|1853221|FG001|Overall Study|Physician Decision|0
886384|NCT00629265|1853229|FG000|Overall Study|Lost to Follow-up|4
886385|NCT00629265|1853230|FG001|Overall Study|Lost to Follow-up|5
886386|NCT00629265|1853229|FG000|Overall Study|Withdrawal by Subject|11
886387|NCT00629265|1853230|FG001|Overall Study|Withdrawal by Subject|8
886388|NCT00629265|1853229|FG000|Overall Study|Death|1
886389|NCT00629265|1853230|FG001|Overall Study|Death|0
886390|NCT00629265|1853229|FG000|Overall Study|Adverse Event|2
886391|NCT00629265|1853230|FG001|Overall Study|Adverse Event|0
886392|NCT00629265|1853229|FG000|Overall Study|HNC Recurrence|4
886393|NCT00629265|1853230|FG001|Overall Study|HNC Recurrence|0
886394|NCT00629265|1853229|FG000|Overall Study|Other CA Requiring Treatment|1
886395|NCT00629265|1853230|FG001|Overall Study|Other CA Requiring Treatment|3
886396|NCT00629265|1853229|FG000|Overall Study|Needed Esophageal Dilation|4
886397|NCT00629265|1853230|FG001|Overall Study|Needed Esophageal Dilation|1
886398|NCT00629265|1853229|FG000|Overall Study|Unrelated Medical Complications|3
886399|NCT00629265|1853230|FG001|Overall Study|Unrelated Medical Complications|1
886400|NCT00629265|1853229|FG000|Overall Study|Unknown Reason|2
886401|NCT00629265|1853230|FG001|Overall Study|Unknown Reason|2
886402|NCT00629707|1853246|FG000|Overall Study|Withdrawal by Subject|0
886403|NCT00629707|1853247|FG001|Overall Study|Withdrawal by Subject|1
886404|NCT00629707|1853246|FG000|Overall Study|Physician Decision|0
886405|NCT00629707|1853247|FG001|Overall Study|Physician Decision|1
886406|NCT00629772|1853255|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1
886407|NCT00629772|1853256|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1
886408|NCT00629772|1853255|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
886409|NCT00629772|1853256|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
886410|NCT00630032|1853265|FG000|Overall Study|Death|55
886411|NCT00630032|1853266|FG001|Overall Study|Death|49
886412|NCT00630032|1853265|FG000|Overall Study|Withdrawal by Subject|3
886413|NCT00630032|1853266|FG001|Overall Study|Withdrawal by Subject|2
886414|NCT00630032|1853265|FG000|Overall Study|Lost to Follow-up|18
886415|NCT00630032|1853266|FG001|Overall Study|Lost to Follow-up|31
886416|NCT00630032|1853265|FG000|Overall Study|Protocol Violation|1
886417|NCT00630032|1853266|FG001|Overall Study|Protocol Violation|0
886418|NCT00630032|1853265|FG000|Overall Study|Patient has moved|1
886419|NCT00630032|1853266|FG001|Overall Study|Patient has moved|1
886420|NCT00630032|1853265|FG000|Overall Study|Disease progression|1
886421|NCT00630032|1853266|FG001|Overall Study|Disease progression|1
886422|NCT00630032|1853265|FG000|Overall Study|End of monitoring in US centers|11
886423|NCT00630032|1853266|FG001|Overall Study|End of monitoring in US centers|11
886424|NCT00630058|1853274|FG000|Overall Study|Adverse Event|1
886425|NCT00630058|1853275|FG001|Overall Study|Adverse Event|1
886426|NCT00630058|1853274|FG000|Overall Study|Withdrawal by Subject|0
886427|NCT00630058|1853275|FG001|Overall Study|Withdrawal by Subject|1
886428|NCT00630058|1853274|FG000|Overall Study|stopping criteria|3
886429|NCT00630058|1853275|FG001|Overall Study|stopping criteria|2
886430|NCT00630305|1853294|FG000|Overall Study|Withdrawal by Subject|1
886431|NCT00630305|1853294|FG000|Overall Study|Inability to insert contact lens|1
886432|NCT00630331|1853310|FG000|Overall Study|Death|2
886433|NCT00630331|1853311|FG001|Overall Study|Death|1
886434|NCT00630331|1853312|FG002|Overall Study|Death|1
886435|NCT00630331|1853310|FG000|Overall Study|Adverse Event|1
886436|NCT00630331|1853311|FG001|Overall Study|Adverse Event|0
886437|NCT00630331|1853312|FG002|Overall Study|Adverse Event|0
886438|NCT00630331|1853310|FG000|Overall Study|Withdrawal by Subject|12
886439|NCT00630331|1853311|FG001|Overall Study|Withdrawal by Subject|7
886440|NCT00630331|1853312|FG002|Overall Study|Withdrawal by Subject|5
886441|NCT00630331|1853310|FG000|Overall Study|Lost to Follow-up|175
886442|NCT00630331|1853311|FG001|Overall Study|Lost to Follow-up|143
886443|NCT00630331|1853312|FG002|Overall Study|Lost to Follow-up|170
886444|NCT00630331|1853310|FG000|Overall Study|Inappropriate enrollment|3
886445|NCT00630331|1853311|FG001|Overall Study|Inappropriate enrollment|6
886446|NCT00630331|1853312|FG002|Overall Study|Inappropriate enrollment|3
886447|NCT00630331|1853310|FG000|Overall Study|Unable to classify|9
886448|NCT00630331|1853311|FG001|Overall Study|Unable to classify|4
886449|NCT00630331|1853312|FG002|Overall Study|Unable to classify|3
886450|NCT00630331|1853310|FG000|Overall Study|Protocol Violation|4
886451|NCT00630331|1853311|FG001|Overall Study|Protocol Violation|5
886452|NCT00630331|1853312|FG002|Overall Study|Protocol Violation|6
886453|NCT00630344|1853320|FG000|Overall Study|Adverse Event|5
886454|NCT00630344|1853320|FG000|Overall Study|Progressive Disease|19
886455|NCT00630344|1853320|FG000|Overall Study|Physician Decision|9
886456|NCT00630344|1853320|FG000|Overall Study|Withdrawal by Subject|1
886457|NCT00630344|1853320|FG000|Overall Study|Intercurrent Illness|1
886458|NCT00630344|1853320|FG000|Overall Study|Other|1
886459|NCT00630396|1853325|FG000|Overall Study|Death|4
886460|NCT00630396|1853325|FG000|Overall Study|Lost to Follow-up|3
886461|NCT00630539|1853338|FG000|Overall Study|Adverse Event|1
886462|NCT00630539|1853339|FG001|Overall Study|Adverse Event|3
886463|NCT00630539|1853340|FG002|Overall Study|Adverse Event|1
886464|NCT00630539|1853341|FG003|Overall Study|Adverse Event|2
886465|NCT00630539|1853338|FG000|Overall Study|Withdrawal by Subject|0
886466|NCT00630539|1853339|FG001|Overall Study|Withdrawal by Subject|1
886467|NCT00630539|1853340|FG002|Overall Study|Withdrawal by Subject|0
886468|NCT00630539|1853341|FG003|Overall Study|Withdrawal by Subject|1
886469|NCT00630747|1853373|FG000|Overall Study|Death|1
886470|NCT00630747|1853373|FG000|Overall Study|Transferred to Study TKT031NPU|7
886471|NCT00630747|1853373|FG000|Overall Study|Returned to country of origin|1
886472|NCT00630786|1853380|FG000|Overall Study|Physician Decision|0
886473|NCT00630786|1853381|FG001|Overall Study|Physician Decision|0
886474|NCT00630786|1853382|FG002|Overall Study|Physician Decision|1
886475|NCT00630786|1853380|FG000|Overall Study|Withdrawal by Subject|0
886476|NCT00630786|1853381|FG001|Overall Study|Withdrawal by Subject|1
886477|NCT00630786|1853382|FG002|Overall Study|Withdrawal by Subject|1
886478|NCT00630786|1853380|FG000|Overall Study|Lost to Follow-up|0
886479|NCT00630786|1853381|FG001|Overall Study|Lost to Follow-up|1
886480|NCT00630786|1853382|FG002|Overall Study|Lost to Follow-up|0
886481|NCT00630786|1853380|FG000|Overall Study|Other|1
886482|NCT00630786|1853381|FG001|Overall Study|Other|0
886483|NCT00630786|1853382|FG002|Overall Study|Other|0
886484|NCT00630812|1853390|FG000|Randomisation to First Dose|Adverse Event|1
886485|NCT00630812|1853391|FG001|Randomisation to First Dose|Adverse Event|1
886486|NCT00630812|1853390|FG000|Randomisation to First Dose|Withdrawal by Subject|2
886487|NCT00630812|1853391|FG001|Randomisation to First Dose|Withdrawal by Subject|3
886488|NCT00630812|1853390|FG000|Randomisation to First Dose|Lost to Follow-up|1
886489|NCT00630812|1853391|FG001|Randomisation to First Dose|Lost to Follow-up|0
886490|NCT00630812|1853390|FG000|Randomisation to First Dose|Protocol Violation|4
886491|NCT00630812|1853391|FG001|Randomisation to First Dose|Protocol Violation|1
886492|NCT00630812|1853390|FG000|Double Blind Treatment Period|Adverse Event|13
886493|NCT00630812|1853391|FG001|Double Blind Treatment Period|Adverse Event|5
886494|NCT00630812|1853390|FG000|Double Blind Treatment Period|Lost to Follow-up|1
886495|NCT00630812|1853391|FG001|Double Blind Treatment Period|Lost to Follow-up|0
886496|NCT00630812|1853390|FG000|Double Blind Treatment Period|Physician Decision|2
886497|NCT00630812|1853391|FG001|Double Blind Treatment Period|Physician Decision|1
886498|NCT00630812|1853390|FG000|Double Blind Treatment Period|Protocol Violation|1
886499|NCT00630812|1853391|FG001|Double Blind Treatment Period|Protocol Violation|0
886500|NCT00630812|1853390|FG000|Double Blind Treatment Period|Withdrawal by Subject|13
886501|NCT00630812|1853391|FG001|Double Blind Treatment Period|Withdrawal by Subject|7
886502|NCT00630812|1853390|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1
886503|NCT00630812|1853391|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0
886504|NCT00630812|1853390|FG000|Double Blind Treatment Period|Non-compliance|0
886505|NCT00630812|1853391|FG001|Double Blind Treatment Period|Non-compliance|1
886506|NCT00630825|1853401|FG000|Overall Study|Adverse Event|4
886507|NCT00630825|1853402|FG001|Overall Study|Adverse Event|4
886508|NCT00630825|1853403|FG002|Overall Study|Adverse Event|3
886509|NCT00630825|1853404|FG003|Overall Study|Adverse Event|1
886510|NCT00630825|1853401|FG000|Overall Study|Entry Criteria Not Met|1
886511|NCT00630825|1853402|FG001|Overall Study|Entry Criteria Not Met|0
886512|NCT00630825|1853403|FG002|Overall Study|Entry Criteria Not Met|2
886513|NCT00630825|1853404|FG003|Overall Study|Entry Criteria Not Met|1
886514|NCT00630825|1853401|FG000|Overall Study|Lost to Follow-up|1
886515|NCT00630825|1853402|FG001|Overall Study|Lost to Follow-up|1
886516|NCT00630825|1853403|FG002|Overall Study|Lost to Follow-up|1
886517|NCT00630825|1853404|FG003|Overall Study|Lost to Follow-up|1
886518|NCT00630825|1853401|FG000|Overall Study|Physician Decision|1
886519|NCT00630825|1853402|FG001|Overall Study|Physician Decision|0
886520|NCT00630825|1853403|FG002|Overall Study|Physician Decision|0
886521|NCT00630825|1853404|FG003|Overall Study|Physician Decision|0
886522|NCT00630825|1853401|FG000|Overall Study|Withdrawal by Subject|2
886523|NCT00630825|1853402|FG001|Overall Study|Withdrawal by Subject|2
886524|NCT00630825|1853403|FG002|Overall Study|Withdrawal by Subject|2
886525|NCT00630825|1853404|FG003|Overall Study|Withdrawal by Subject|3
886526|NCT00630838|1853416|FG000|Overall Study|Death|0
886527|NCT00630838|1853417|FG001|Overall Study|Death|1
886528|NCT00630838|1853416|FG000|Overall Study|Lost to Follow-up|0
886529|NCT00630838|1853417|FG001|Overall Study|Lost to Follow-up|1
886530|NCT00630864|1853425|FG000|Part 1 (up to Week 6)|Adverse Event|1
886531|NCT00630864|1853425|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
886532|NCT00630877|1853432|FG000|Overall Study|Adverse Event|11
886533|NCT00630877|1853433|FG001|Overall Study|Adverse Event|8
886534|NCT00630877|1853434|FG002|Overall Study|Adverse Event|7
886535|NCT00630877|1853432|FG000|Overall Study|Withdrawal by Subject|3
886536|NCT00630877|1853433|FG001|Overall Study|Withdrawal by Subject|4
886537|NCT00630877|1853434|FG002|Overall Study|Withdrawal by Subject|0
886538|NCT00630877|1853432|FG000|Overall Study|Lost to Follow-up|2
886539|NCT00630877|1853433|FG001|Overall Study|Lost to Follow-up|0
886540|NCT00630877|1853434|FG002|Overall Study|Lost to Follow-up|0
886541|NCT00630877|1853432|FG000|Overall Study|Noncompliance|2
886542|NCT00630877|1853433|FG001|Overall Study|Noncompliance|3
886543|NCT00630877|1853434|FG002|Overall Study|Noncompliance|1
886544|NCT00630877|1853432|FG000|Overall Study|Protocol violation|1
886545|NCT00630877|1853433|FG001|Overall Study|Protocol violation|0
886546|NCT00630877|1853434|FG002|Overall Study|Protocol violation|1
886547|NCT00630877|1853432|FG000|Overall Study|Personal reasons|0
886548|NCT00630877|1853433|FG001|Overall Study|Personal reasons|0
886549|NCT00630877|1853434|FG002|Overall Study|Personal reasons|1
886550|NCT00630916|1853446|FG000|Overall Study|Death|110
886551|NCT00630916|1853446|FG000|Overall Study|Explant|8
886552|NCT00630916|1853446|FG000|Overall Study|Lost to Follow-up|5
886553|NCT00630916|1853446|FG000|Overall Study|Withdrawal by Subject|30
886554|NCT00630916|1853446|FG000|Overall Study|Protocol Violation|7
886555|NCT00630916|1853446|FG000|Overall Study|Physician Decision|47
886556|NCT00630916|1853446|FG000|Overall Study|Lack of Efficacy|3
886557|NCT00630994|1853463|FG000|Overall Study|Adverse Event|1
886558|NCT00630994|1853463|FG000|Overall Study|Disease Progression|1
886559|NCT00630994|1853463|FG000|Overall Study|Lack of Efficacy|1
886560|NCT00630994|1853463|FG000|Overall Study|Other|1
886561|NCT00631007|1853473|FG000|Overall Study|Adverse Event|0
886562|NCT00631007|1853474|FG001|Overall Study|Adverse Event|2
886563|NCT00631007|1853475|FG002|Overall Study|Adverse Event|0
886564|NCT00631007|1853476|FG003|Overall Study|Adverse Event|2
886565|NCT00631007|1853477|FG004|Overall Study|Adverse Event|3
886566|NCT00631007|1853478|FG005|Overall Study|Adverse Event|2
886567|NCT00631007|1853473|FG000|Overall Study|Lost to Follow-up|2
886568|NCT00631007|1853474|FG001|Overall Study|Lost to Follow-up|1
886569|NCT00631007|1853475|FG002|Overall Study|Lost to Follow-up|2
886570|NCT00631007|1853476|FG003|Overall Study|Lost to Follow-up|4
886571|NCT00631007|1853477|FG004|Overall Study|Lost to Follow-up|5
886572|NCT00631007|1853478|FG005|Overall Study|Lost to Follow-up|3
886573|NCT00631007|1853473|FG000|Overall Study|Physician Decision|1
886574|NCT00631007|1853474|FG001|Overall Study|Physician Decision|0
886575|NCT00631007|1853475|FG002|Overall Study|Physician Decision|1
886576|NCT00631007|1853476|FG003|Overall Study|Physician Decision|0
886577|NCT00631007|1853477|FG004|Overall Study|Physician Decision|0
886578|NCT00631007|1853478|FG005|Overall Study|Physician Decision|2
886579|NCT00631007|1853473|FG000|Overall Study|Persistent Hyperglycemia|2
886580|NCT00631007|1853474|FG001|Overall Study|Persistent Hyperglycemia|2
886581|NCT00631007|1853475|FG002|Overall Study|Persistent Hyperglycemia|5
886582|NCT00631007|1853476|FG003|Overall Study|Persistent Hyperglycemia|1
886583|NCT00631007|1853477|FG004|Overall Study|Persistent Hyperglycemia|2
886584|NCT00631007|1853478|FG005|Overall Study|Persistent Hyperglycemia|5
886585|NCT00631007|1853473|FG000|Overall Study|Withdrawal by Subject|4
886586|NCT00631007|1853474|FG001|Overall Study|Withdrawal by Subject|5
886587|NCT00631007|1853475|FG002|Overall Study|Withdrawal by Subject|2
886588|NCT00631007|1853476|FG003|Overall Study|Withdrawal by Subject|2
886589|NCT00631007|1853477|FG004|Overall Study|Withdrawal by Subject|1
886590|NCT00631007|1853478|FG005|Overall Study|Withdrawal by Subject|3
886591|NCT00631007|1853473|FG000|Overall Study|Other|2
886592|NCT00631007|1853474|FG001|Overall Study|Other|1
886593|NCT00631007|1853475|FG002|Overall Study|Other|0
886594|NCT00631007|1853476|FG003|Overall Study|Other|0
886595|NCT00631007|1853477|FG004|Overall Study|Other|1
886596|NCT00631007|1853478|FG005|Overall Study|Other|0
886597|NCT00631020|1853492|FG000|Overall Study|Lost to Follow-up|7
886598|NCT00631020|1853492|FG000|Overall Study|Incarcerated|1
886599|NCT00631163|1853496|FG000|Number of Participants in Year 1|Adverse Event|12
886600|NCT00631163|1853496|FG000|Number of Participants in Year 1|Withdrawal by Subject|8
886601|NCT00631163|1853496|FG000|Number of Participants in Year 1|Death|6
886602|NCT00631163|1853496|FG000|Number of Participants in Year 1|Lost to Follow-up|1
886603|NCT00631163|1853496|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1
886604|NCT00631163|1853496|FG000|Number of Participants in Year 1|Administrative problems|6
886605|NCT00631163|1853496|FG000|Number of Participants in Year 2|Withdrawal by Subject|2
886606|NCT00631163|1853496|FG000|Number of Participants in Year 2|Adverse Event|1
886607|NCT00631163|1853496|FG000|Number of Participants in Year 2|Protocol Violation|1
886608|NCT00631163|1853496|FG000|Number of Participants in Year 2|Abnormal laboratory value|1
886609|NCT00631189|1853511|FG000|Initial Phase|Protocol Violation|347
886610|NCT00631189|1853512|FG001|Initial Phase|Protocol Violation|0
886611|NCT00631189|1853513|FG002|Initial Phase|Protocol Violation|0
886612|NCT00631189|1853514|FG003|Initial Phase|Protocol Violation|0
886613|NCT00631189|1853511|FG000|Initial Phase|Withdrawal by Subject|4
886614|NCT00631189|1853512|FG001|Initial Phase|Withdrawal by Subject|0
886615|NCT00631189|1853513|FG002|Initial Phase|Withdrawal by Subject|0
886616|NCT00631189|1853514|FG003|Initial Phase|Withdrawal by Subject|0
886617|NCT00631189|1853511|FG000|Treatment Phase|Withdrawal by Subject|0
886618|NCT00631189|1853512|FG001|Treatment Phase|Withdrawal by Subject|2
886619|NCT00631189|1853513|FG002|Treatment Phase|Withdrawal by Subject|1
886620|NCT00631189|1853514|FG003|Treatment Phase|Withdrawal by Subject|1
886621|NCT00631189|1853511|FG000|Treatment Phase|Protocol Violation|0
886622|NCT00631189|1853512|FG001|Treatment Phase|Protocol Violation|1
886623|NCT00631189|1853513|FG002|Treatment Phase|Protocol Violation|6
886624|NCT00631189|1853514|FG003|Treatment Phase|Protocol Violation|2
886625|NCT00631189|1853511|FG000|Treatment Phase|Adverse Event|0
886626|NCT00631189|1853512|FG001|Treatment Phase|Adverse Event|3
886627|NCT00631189|1853513|FG002|Treatment Phase|Adverse Event|2
886628|NCT00631189|1853514|FG003|Treatment Phase|Adverse Event|4
886629|NCT00631189|1853511|FG000|Treatment Phase|Lost to Follow-up|0
886630|NCT00631189|1853512|FG001|Treatment Phase|Lost to Follow-up|1
886631|NCT00631189|1853513|FG002|Treatment Phase|Lost to Follow-up|0
886632|NCT00631189|1853514|FG003|Treatment Phase|Lost to Follow-up|0
886633|NCT00631189|1853511|FG000|Treatment Phase|Pregnancy|0
886634|NCT00631189|1853512|FG001|Treatment Phase|Pregnancy|0
886635|NCT00631189|1853513|FG002|Treatment Phase|Pregnancy|1
886636|NCT00631189|1853514|FG003|Treatment Phase|Pregnancy|0
886637|NCT00631189|1853511|FG000|Treatment Phase|patient did not take pravastatin|0
886638|NCT00631189|1853512|FG001|Treatment Phase|patient did not take pravastatin|0
886639|NCT00631189|1853513|FG002|Treatment Phase|patient did not take pravastatin|1
886640|NCT00631189|1853514|FG003|Treatment Phase|patient did not take pravastatin|0
886641|NCT00631371|1853545|FG000|Overall Study|Lost to Follow-up|24
886642|NCT00631371|1853546|FG001|Overall Study|Lost to Follow-up|19
886643|NCT00631371|1853545|FG000|Overall Study|Other reason|5
886644|NCT00631371|1853546|FG001|Overall Study|Other reason|12
886645|NCT00631371|1853545|FG000|Overall Study|subject request|38
886646|NCT00631371|1853546|FG001|Overall Study|subject request|45
886647|NCT00631371|1853545|FG000|Overall Study|Discontinuation of study by Sponsor|70
886648|NCT00631371|1853546|FG001|Overall Study|Discontinuation of study by Sponsor|76
886649|NCT00631371|1853545|FG000|Overall Study|Death|263
886650|NCT00631371|1853546|FG001|Overall Study|Death|239
886651|NCT00631410|1853554|FG000|Overall Study|Adverse Event|1
886652|NCT00631410|1853555|FG001|Overall Study|Adverse Event|3
886653|NCT00631410|1853554|FG000|Overall Study|Objective Progression or Relapse|4
886654|NCT00631410|1853555|FG001|Overall Study|Objective Progression or Relapse|3
886655|NCT00631410|1853554|FG000|Overall Study|Surgery|1
886656|NCT00631410|1853555|FG001|Overall Study|Surgery|0
886657|NCT00631475|1853575|FG000|Overall Study|Death|18
886658|NCT00631475|1853575|FG000|Overall Study|Adverse Event|14
886659|NCT00631475|1853575|FG000|Overall Study|Withdrew consent|5
886660|NCT00631475|1853575|FG000|Overall Study|Preparation for lung transplant|8
886661|NCT00631488|1853582|FG000|Overall Study|Adverse Event|1
886662|NCT00631488|1853583|FG001|Overall Study|Adverse Event|0
886663|NCT00631488|1853584|FG002|Overall Study|Adverse Event|0
886664|NCT00631488|1853582|FG000|Overall Study|Lost to Follow-up|2
886665|NCT00631488|1853583|FG001|Overall Study|Lost to Follow-up|2
886666|NCT00631488|1853584|FG002|Overall Study|Lost to Follow-up|0
886667|NCT00631488|1853582|FG000|Overall Study|Physician Decision|1
886668|NCT00631488|1853583|FG001|Overall Study|Physician Decision|0
886669|NCT00631488|1853584|FG002|Overall Study|Physician Decision|1
886670|NCT00631488|1853582|FG000|Overall Study|Protocol Violation|0
886671|NCT00631488|1853583|FG001|Overall Study|Protocol Violation|0
886672|NCT00631488|1853584|FG002|Overall Study|Protocol Violation|1
886673|NCT00631540|1853592|FG000|Overall Study|Withdrawal by Subject|5
886674|NCT00631540|1853592|FG000|Overall Study|Death|4
886675|NCT00631540|1853592|FG000|Overall Study|Lost to Follow-up|2
886676|NCT00631540|1853592|FG000|Overall Study|Core Lab Data Unavailable|3
886677|NCT00631657|1853611|FG000|6-Month Treatment Period|Adverse Event|47
886678|NCT00631657|1853612|FG001|6-Month Treatment Period|Adverse Event|0
886679|NCT00631657|1853613|FG002|6-Month Treatment Period|Adverse Event|7
886680|NCT00631657|1853611|FG000|6-Month Treatment Period|Withdrawal by Subject|14
886681|NCT00631657|1853612|FG001|6-Month Treatment Period|Withdrawal by Subject|0
886682|NCT00631657|1853613|FG002|6-Month Treatment Period|Withdrawal by Subject|5
886683|NCT00631657|1853611|FG000|6-Month Treatment Period|Lack of Efficacy|34
886684|NCT00631657|1853612|FG001|6-Month Treatment Period|Lack of Efficacy|0
886685|NCT00631657|1853613|FG002|6-Month Treatment Period|Lack of Efficacy|25
886686|NCT00631657|1853611|FG000|6-Month Treatment Period|Lost to Follow-up|7
886687|NCT00631657|1853612|FG001|6-Month Treatment Period|Lost to Follow-up|0
886688|NCT00631657|1853613|FG002|6-Month Treatment Period|Lost to Follow-up|2
886689|NCT00631657|1853611|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
886690|NCT00631657|1853612|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
886691|NCT00631657|1853613|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
886692|NCT00631657|1853611|FG000|6-Month Treatment Period|Other|16
886693|NCT00631657|1853612|FG001|6-Month Treatment Period|Other|0
886694|NCT00631657|1853613|FG002|6-Month Treatment Period|Other|4
886695|NCT00631657|1853611|FG000|6-Month Treatment Period|Not Treated|2
886696|NCT00631657|1853612|FG001|6-Month Treatment Period|Not Treated|0
886697|NCT00631657|1853613|FG002|6-Month Treatment Period|Not Treated|1
886698|NCT00631657|1853611|FG000|7-Day Discontinuation Period|Not Treated|1
886699|NCT00631657|1853612|FG001|7-Day Discontinuation Period|Not Treated|1
886700|NCT00631657|1853613|FG002|7-Day Discontinuation Period|Not Treated|1
886701|NCT00631657|1853611|FG000|7-Day Discontinuation Period|Other|1
886702|NCT00631657|1853612|FG001|7-Day Discontinuation Period|Other|0
886703|NCT00631657|1853613|FG002|7-Day Discontinuation Period|Other|0
886704|NCT00631696|1853639|FG000|Overall Study|Entered, not randomized to treatment|1
886705|NCT00631696|1853640|FG001|Overall Study|Entered, not randomized to treatment|1
886706|NCT00631696|1853639|FG000|Overall Study|Discontinued after database release date|1
886707|NCT00631696|1853640|FG001|Overall Study|Discontinued after database release date|0
886708|NCT00631696|1853639|FG000|Overall Study|Follow up after database release date|1
886709|NCT00631696|1853640|FG001|Overall Study|Follow up after database release date|0
886710|NCT00631696|1853639|FG000|Overall Study|Lost to Follow-up|7
886711|NCT00631696|1853640|FG001|Overall Study|Lost to Follow-up|10
886712|NCT00631696|1853639|FG000|Overall Study|Withdrawal by Subject|2
886713|NCT00631696|1853640|FG001|Overall Study|Withdrawal by Subject|9
886714|NCT00631696|1853639|FG000|Overall Study|Other|8
886715|NCT00631696|1853640|FG001|Overall Study|Other|8
886716|NCT00631696|1853639|FG000|Overall Study|Protocol Violation|9
886717|NCT00631696|1853640|FG001|Overall Study|Protocol Violation|9
886718|NCT00631696|1853639|FG000|Overall Study|Study terminated by sponsor|3
886719|NCT00631696|1853640|FG001|Overall Study|Study terminated by sponsor|3
886720|NCT00631696|1853639|FG000|Overall Study|Adverse Event|5
886721|NCT00631696|1853640|FG001|Overall Study|Adverse Event|0
886722|NCT00631917|1853662|FG000|Overall Study|Adverse Event|34
886723|NCT00631917|1853663|FG001|Overall Study|Adverse Event|45
886724|NCT00631917|1853662|FG000|Overall Study|Abnormal laboratory value(s)|2
886725|NCT00631917|1853663|FG001|Overall Study|Abnormal laboratory value(s)|1
886726|NCT00631917|1853662|FG000|Overall Study|Abnormal test procedure result(s)|3
886727|NCT00631917|1853663|FG001|Overall Study|Abnormal test procedure result(s)|2
886728|NCT00631917|1853662|FG000|Overall Study|Unsatisfactory therapeutic effect|8
886729|NCT00631917|1853663|FG001|Overall Study|Unsatisfactory therapeutic effect|14
886730|NCT00631917|1853662|FG000|Overall Study|No longer required study drug|0
886731|NCT00631917|1853663|FG001|Overall Study|No longer required study drug|1
886732|NCT00631917|1853662|FG000|Overall Study|Protocol deviation|6
886733|NCT00631917|1853663|FG001|Overall Study|Protocol deviation|5
886734|NCT00631917|1853662|FG000|Overall Study|Subject withdrew consent|25
886735|NCT00631917|1853663|FG001|Overall Study|Subject withdrew consent|33
886736|NCT00631917|1853662|FG000|Overall Study|Lost to Follow-up|7
886737|NCT00631917|1853663|FG001|Overall Study|Lost to Follow-up|7
886738|NCT00631917|1853662|FG000|Overall Study|Administrative problems|2
886739|NCT00631917|1853663|FG001|Overall Study|Administrative problems|0
886740|NCT00631917|1853662|FG000|Overall Study|Death|1
886741|NCT00631917|1853663|FG001|Overall Study|Death|0
886742|NCT00631969|1853671|FG000|Overall Study|Adverse Event|3
886743|NCT00631969|1853672|FG001|Overall Study|Adverse Event|1
886744|NCT00631969|1853671|FG000|Overall Study|Lack of Efficacy|2
886745|NCT00631969|1853672|FG001|Overall Study|Lack of Efficacy|8
886746|NCT00631969|1853671|FG000|Overall Study|Lost to Follow-up|2
886747|NCT00631969|1853672|FG001|Overall Study|Lost to Follow-up|1
886748|NCT00631969|1853671|FG000|Overall Study|Protocol Violation|1
886749|NCT00631969|1853672|FG001|Overall Study|Protocol Violation|1
886750|NCT00631969|1853671|FG000|Overall Study|Consent Withdrawn|5
886751|NCT00631969|1853672|FG001|Overall Study|Consent Withdrawn|7
886752|NCT00631969|1853671|FG000|Overall Study|Noncompliant With Study Medication|0
886753|NCT00631969|1853672|FG001|Overall Study|Noncompliant With Study Medication|1
886754|NCT00631969|1853671|FG000|Overall Study|No Drug Exposure|2
886755|NCT00631969|1853672|FG001|Overall Study|No Drug Exposure|2
886756|NCT00632021|1853682|FG000|Overall Study|Withdrawal/death|4
886757|NCT00632021|1853683|FG001|Overall Study|Withdrawal/death|7
886758|NCT00632099|1853692|FG000|Overall Study|Lost to Follow-up|3
886759|NCT00632099|1853693|FG001|Overall Study|Lost to Follow-up|3
886760|NCT00632125|1853699|FG000|Overall Study|Death|82
886761|NCT00632125|1853699|FG000|Overall Study|Withdrawal by Subject|44
886762|NCT00632125|1853699|FG000|Overall Study|Adverse Event|36
886763|NCT00632125|1853699|FG000|Overall Study|Renal transplantation|17
886764|NCT00632125|1853699|FG000|Overall Study|Need for systemic immunosuppressive medi|8
886765|NCT00632125|1853699|FG000|Overall Study|Non-compliance|8
886766|NCT00632125|1853699|FG000|Overall Study|Development of uncontrolled hypertension|5
886767|NCT00632125|1853699|FG000|Overall Study|Moved to other dialysis unit, etc.|102
886768|NCT00632203|1853705|FG000|Overall Study|Did not start study treatment|1
886769|NCT00632203|1853706|FG001|Overall Study|Did not start study treatment|0
886770|NCT00632229|1853714|FG000|Overall Study|Adverse Event|6
886771|NCT00632229|1853715|FG001|Overall Study|Adverse Event|0
886772|NCT00632229|1853714|FG000|Overall Study|Lost to Follow-up|0
886773|NCT00632229|1853715|FG001|Overall Study|Lost to Follow-up|3
886774|NCT00632229|1853714|FG000|Overall Study|Lack of Efficacy|0
886775|NCT00632229|1853715|FG001|Overall Study|Lack of Efficacy|2
886776|NCT00632229|1853714|FG000|Overall Study|Undisclosed reasons within the first wee|0
886777|NCT00632229|1853715|FG001|Overall Study|Undisclosed reasons within the first wee|1
886778|NCT00632359|1853725|FG000|Overall Study|Withdrawal by Subject|2
886779|NCT00632424|1853742|FG000|Overall Study|Disease Progression|17
886780|NCT00632424|1853742|FG000|Overall Study|Study Drug Toxicity|1
886781|NCT00632463|1853759|FG000|Overall Study|Adverse Event|0
886782|NCT00632463|1853760|FG001|Overall Study|Adverse Event|1
886783|NCT00632463|1853761|FG002|Overall Study|Adverse Event|0
886784|NCT00632502|1853784|FG000|Overall Study|Adverse Event|0
886785|NCT00632502|1853785|FG001|Overall Study|Adverse Event|1
886786|NCT00632502|1853784|FG000|Overall Study|Randomized not treated|3
886787|NCT00632502|1853785|FG001|Overall Study|Randomized not treated|0
886788|NCT00632541|1853792|FG000|Overall Study|Adverse Event|7
886789|NCT00632736|1853814|FG000|Overall Study|Adverse Event|104
886790|NCT00632736|1853814|FG000|Overall Study|Lost to Follow-up|15
886791|NCT00632736|1853814|FG000|Overall Study|Protocol Violation|14
886792|NCT00632736|1853814|FG000|Overall Study|Withdrawal by Subject|99
886793|NCT00632736|1853814|FG000|Overall Study|Lack of Efficacy|5
886794|NCT00632736|1853814|FG000|Overall Study|Sponsor terminated study|5
886795|NCT00632736|1853814|FG000|Overall Study|Non-compliance|10
886796|NCT00632736|1853814|FG000|Overall Study|Other|16
886797|NCT00632749|1853832|FG000|Overall Study|Progressive disease|3
886798|NCT00632749|1853833|FG001|Overall Study|Progressive disease|2
886799|NCT00632749|1853834|FG002|Overall Study|Progressive disease|2
886800|NCT00632749|1853835|FG003|Overall Study|Progressive disease|2
886801|NCT00632749|1853836|FG004|Overall Study|Progressive disease|4
886802|NCT00632749|1853837|FG005|Overall Study|Progressive disease|4
886803|NCT00632749|1853838|FG006|Overall Study|Progressive disease|3
886804|NCT00632749|1853839|FG007|Overall Study|Progressive disease|2
886805|NCT00632749|1853840|FG008|Overall Study|Progressive disease|3
886806|NCT00632749|1853841|FG009|Overall Study|Progressive disease|2
886807|NCT00632749|1853842|FG010|Overall Study|Progressive disease|4
886808|NCT00632749|1853843|FG011|Overall Study|Progressive disease|3
886809|NCT00632749|1853844|FG012|Overall Study|Progressive disease|2
886810|NCT00632749|1853845|FG013|Overall Study|Progressive disease|4
886811|NCT00632749|1853832|FG000|Overall Study|Other Adverse event|1
886812|NCT00632749|1853833|FG001|Overall Study|Other Adverse event|1
886813|NCT00632749|1853834|FG002|Overall Study|Other Adverse event|1
886814|NCT00632749|1853835|FG003|Overall Study|Other Adverse event|1
886815|NCT00632749|1853836|FG004|Overall Study|Other Adverse event|2
886816|NCT00632749|1853837|FG005|Overall Study|Other Adverse event|4
886817|NCT00632749|1853838|FG006|Overall Study|Other Adverse event|1
886818|NCT00632749|1853839|FG007|Overall Study|Other Adverse event|2
886819|NCT00632749|1853840|FG008|Overall Study|Other Adverse event|2
886820|NCT00632749|1853841|FG009|Overall Study|Other Adverse event|0
886821|NCT00632749|1853842|FG010|Overall Study|Other Adverse event|1
886822|NCT00632749|1853843|FG011|Overall Study|Other Adverse event|0
886823|NCT00632749|1853844|FG012|Overall Study|Other Adverse event|1
886824|NCT00632749|1853845|FG013|Overall Study|Other Adverse event|0
886825|NCT00632749|1853832|FG000|Overall Study|Refuse to continue medication|0
886826|NCT00632749|1853833|FG001|Overall Study|Refuse to continue medication|0
886827|NCT00632749|1853834|FG002|Overall Study|Refuse to continue medication|0
886828|NCT00632749|1853835|FG003|Overall Study|Refuse to continue medication|1
886829|NCT00632749|1853836|FG004|Overall Study|Refuse to continue medication|0
886830|NCT00632749|1853837|FG005|Overall Study|Refuse to continue medication|0
886831|NCT00632749|1853838|FG006|Overall Study|Refuse to continue medication|0
886832|NCT00632749|1853839|FG007|Overall Study|Refuse to continue medication|0
886833|NCT00632749|1853840|FG008|Overall Study|Refuse to continue medication|0
886834|NCT00632749|1853841|FG009|Overall Study|Refuse to continue medication|1
886835|NCT00632749|1853842|FG010|Overall Study|Refuse to continue medication|0
886836|NCT00632749|1853843|FG011|Overall Study|Refuse to continue medication|0
886837|NCT00632749|1853844|FG012|Overall Study|Refuse to continue medication|0
886838|NCT00632749|1853845|FG013|Overall Study|Refuse to continue medication|0
886839|NCT00632749|1853832|FG000|Overall Study|Reason other than those specified above|0
886840|NCT00632749|1853833|FG001|Overall Study|Reason other than those specified above|2
886841|NCT00632749|1853834|FG002|Overall Study|Reason other than those specified above|0
886842|NCT00632749|1853835|FG003|Overall Study|Reason other than those specified above|0
886843|NCT00632749|1853836|FG004|Overall Study|Reason other than those specified above|1
886844|NCT00632749|1853837|FG005|Overall Study|Reason other than those specified above|0
886845|NCT00632749|1853838|FG006|Overall Study|Reason other than those specified above|1
886846|NCT00632749|1853839|FG007|Overall Study|Reason other than those specified above|0
886847|NCT00632749|1853840|FG008|Overall Study|Reason other than those specified above|0
886848|NCT00632749|1853841|FG009|Overall Study|Reason other than those specified above|0
886849|NCT00632749|1853842|FG010|Overall Study|Reason other than those specified above|2
886850|NCT00632749|1853843|FG011|Overall Study|Reason other than those specified above|1
886851|NCT00632749|1853844|FG012|Overall Study|Reason other than those specified above|0
886852|NCT00632749|1853845|FG013|Overall Study|Reason other than those specified above|2
886853|NCT00632827|1853894|FG000|Overall Study|Excluded after GVD (Not evaluable)|2
886854|NCT00632827|1853894|FG000|Overall Study|Death|2
886855|NCT00632827|1853894|FG000|Overall Study|Adverse Event|5
886856|NCT00632827|1853894|FG000|Overall Study|Lost to Follow-up|1
886857|NCT00632931|1853899|FG000|Part 1, Period 1|Protocol Violation|1
886858|NCT00632931|1853900|FG001|Part 1, Period 1|Protocol Violation|0
886859|NCT00632931|1853901|FG002|Part 1, Period 1|Protocol Violation|0
886860|NCT00632931|1853899|FG000|Part 1, Period 1|Withdrawal by Subject|1
886861|NCT00632931|1853900|FG001|Part 1, Period 1|Withdrawal by Subject|0
886862|NCT00632931|1853901|FG002|Part 1, Period 1|Withdrawal by Subject|0
886863|NCT00632931|1853899|FG000|Part 2|Adverse Event|0
886864|NCT00632931|1853900|FG001|Part 2|Adverse Event|0
886865|NCT00632931|1853901|FG002|Part 2|Adverse Event|3
886866|NCT00632931|1853899|FG000|Part 2|Death|0
886867|NCT00632931|1853900|FG001|Part 2|Death|0
886868|NCT00632931|1853901|FG002|Part 2|Death|1
886869|NCT00632931|1853899|FG000|Part 2|Lack of Efficacy|0
886870|NCT00632931|1853900|FG001|Part 2|Lack of Efficacy|0
886871|NCT00632931|1853901|FG002|Part 2|Lack of Efficacy|17
886872|NCT00632931|1853899|FG000|Part 2|Withdrawal by Subject|0
886873|NCT00632931|1853900|FG001|Part 2|Withdrawal by Subject|0
886874|NCT00632931|1853901|FG002|Part 2|Withdrawal by Subject|3
886875|NCT00633022|1853934|FG000|Overall Study|Adverse Event|1
886876|NCT00633022|1853935|FG001|Overall Study|Adverse Event|0
886877|NCT00633022|1853936|FG002|Overall Study|Adverse Event|5
886878|NCT00633022|1853934|FG000|Overall Study|Physician Decision|0
886879|NCT00633022|1853935|FG001|Overall Study|Physician Decision|1
886880|NCT00633022|1853936|FG002|Overall Study|Physician Decision|0
886881|NCT00633074|1853946|FG000|Overall Study|Adverse Event|1
886882|NCT00633074|1853947|FG001|Overall Study|Adverse Event|0
886883|NCT00633126|1853953|FG000|Overall Study|Did not receive full dose|1
886884|NCT00633139|1853960|FG000|Overall Study|Non compliance|0
886885|NCT00633139|1853961|FG001|Overall Study|Non compliance|0
886886|NCT00633139|1853962|FG002|Overall Study|Non compliance|1
886887|NCT00633139|1853960|FG000|Overall Study|Withdrawal by Subject|0
886888|NCT00633139|1853961|FG001|Overall Study|Withdrawal by Subject|1
886889|NCT00633139|1853962|FG002|Overall Study|Withdrawal by Subject|0
886890|NCT00633152|1853972|FG000|Overall Study|Adverse Event|1
886891|NCT00633152|1853973|FG001|Overall Study|Adverse Event|0
886892|NCT00633152|1853972|FG000|Overall Study|Randomized, did not receive study drug|5
886893|NCT00633152|1853973|FG001|Overall Study|Randomized, did not receive study drug|2
886894|NCT00633152|1853972|FG000|Overall Study|Withdrawal by Subject|1
886895|NCT00633152|1853973|FG001|Overall Study|Withdrawal by Subject|1
886896|NCT00633152|1853972|FG000|Overall Study|Lost to Follow-up|4
886897|NCT00633152|1853973|FG001|Overall Study|Lost to Follow-up|1
886898|NCT00633152|1853972|FG000|Overall Study|Miscellaneous Other|3
886899|NCT00633152|1853973|FG001|Overall Study|Miscellaneous Other|2
886900|NCT00633217|1853983|FG000|Overall Study|Adverse Event|5
886901|NCT00633217|1853984|FG001|Overall Study|Adverse Event|9
886902|NCT00633217|1853983|FG000|Overall Study|Lack of Efficacy|0
886903|NCT00633217|1853984|FG001|Overall Study|Lack of Efficacy|2
886904|NCT00633217|1853983|FG000|Overall Study|Protocol Violation|3
886905|NCT00633217|1853984|FG001|Overall Study|Protocol Violation|7
886906|NCT00633217|1853983|FG000|Overall Study|Lost to Follow-up|2
886907|NCT00633217|1853984|FG001|Overall Study|Lost to Follow-up|2
886908|NCT00633217|1853983|FG000|Overall Study|Investigator Discretion|2
886909|NCT00633217|1853984|FG001|Overall Study|Investigator Discretion|0
886910|NCT00633217|1853983|FG000|Overall Study|Withdrew Consent|3
886911|NCT00633217|1853984|FG001|Overall Study|Withdrew Consent|3
886912|NCT00633243|1853992|FG000|Overall Study|Withdrawal by Subject|0
886913|NCT00633243|1853993|FG001|Overall Study|Withdrawal by Subject|1
886914|NCT00633243|1853992|FG000|Overall Study|incarceration|0
886915|NCT00633243|1853993|FG001|Overall Study|incarceration|2
886916|NCT00633243|1853992|FG000|Overall Study|Homeless--no refrigeration for meds|0
886917|NCT00633243|1853993|FG001|Overall Study|Homeless--no refrigeration for meds|1
886918|NCT00633243|1853992|FG000|Overall Study|Not comfortable with self-injecting|0
886919|NCT00633243|1853993|FG001|Overall Study|Not comfortable with self-injecting|1
886920|NCT00633243|1853992|FG000|Overall Study|Mental Health--Depression|0
886921|NCT00633243|1853993|FG001|Overall Study|Mental Health--Depression|1
886922|NCT00633243|1853992|FG000|Overall Study|Couldn't tolerate side-effects|1
886923|NCT00633243|1853993|FG001|Overall Study|Couldn't tolerate side-effects|1
886924|NCT00633360|1854010|FG000|Overall Study|Lost to Follow-up|1
886925|NCT00633360|1854011|FG001|Overall Study|Lost to Follow-up|1
886926|NCT00633360|1854010|FG000|Overall Study|Adverse Event|3
886927|NCT00633360|1854011|FG001|Overall Study|Adverse Event|1
886928|NCT00633360|1854010|FG000|Overall Study|Protocol Violation|0
886929|NCT00633360|1854011|FG001|Overall Study|Protocol Violation|1
886930|NCT00633464|1854030|FG000|Overall Study|Never Treated (Not met study criteria)|0
886931|NCT00633464|1854031|FG001|Overall Study|Never Treated (Not met study criteria)|1
886932|NCT00633464|1854030|FG000|Overall Study|Never Treated (Randomized in error)|0
886933|NCT00633464|1854031|FG001|Overall Study|Never Treated (Randomized in error)|1
886934|NCT00633477|1854039|FG000|Overall Study|Death|1
886935|NCT00633477|1854040|FG001|Overall Study|Death|0
886936|NCT00633477|1854039|FG000|Overall Study|Randomized but not treated|1
886937|NCT00633477|1854040|FG001|Overall Study|Randomized but not treated|0
886938|NCT00633594|1854049|FG000|Overall Study|Adverse Event|0
886939|NCT00633594|1854050|FG001|Overall Study|Adverse Event|4
886940|NCT00633594|1854051|FG002|Overall Study|Adverse Event|7
886941|NCT00633594|1854049|FG000|Overall Study|Death|0
886942|NCT00633594|1854050|FG001|Overall Study|Death|1
886943|NCT00633594|1854051|FG002|Overall Study|Death|2
886944|NCT00633594|1854049|FG000|Overall Study|Disease Progression|0
886945|NCT00633594|1854050|FG001|Overall Study|Disease Progression|0
886946|NCT00633594|1854051|FG002|Overall Study|Disease Progression|1
886947|NCT00633750|1854062|FG000|Overall Study|Adverse Event|2
886948|NCT00633750|1854062|FG000|Overall Study|Withdrawal by Subject|3
886949|NCT00633880|1854080|FG000|Open Label Titration|Lack of Efficacy|1
886950|NCT00633880|1854081|FG001|Open Label Titration|Lack of Efficacy|0
886951|NCT00633880|1854082|FG002|Open Label Titration|Lack of Efficacy|0
886952|NCT00633880|1854080|FG000|Open Label Titration|Adverse Event|13
886953|NCT00633880|1854081|FG001|Open Label Titration|Adverse Event|0
886954|NCT00633880|1854082|FG002|Open Label Titration|Adverse Event|0
886955|NCT00633880|1854080|FG000|Open Label Titration|Treatment Failure|55
886956|NCT00633880|1854081|FG001|Open Label Titration|Treatment Failure|0
886957|NCT00633880|1854082|FG002|Open Label Titration|Treatment Failure|0
886958|NCT00633880|1854080|FG000|Open Label Titration|Protocol Violation|6
886959|NCT00633880|1854081|FG001|Open Label Titration|Protocol Violation|0
886960|NCT00633880|1854082|FG002|Open Label Titration|Protocol Violation|0
886961|NCT00633880|1854080|FG000|Open Label Titration|Physician Decision|1
886962|NCT00633880|1854081|FG001|Open Label Titration|Physician Decision|0
886963|NCT00633880|1854082|FG002|Open Label Titration|Physician Decision|0
886964|NCT00633880|1854080|FG000|Open Label Titration|Withdrawal by Subject|4
886965|NCT00633880|1854081|FG001|Open Label Titration|Withdrawal by Subject|0
886966|NCT00633880|1854082|FG002|Open Label Titration|Withdrawal by Subject|0
886967|NCT00633893|1854092|FG000|Overall Study|Death|1
886968|NCT00633893|1854093|FG001|Overall Study|Death|3
886969|NCT00633893|1854094|FG002|Overall Study|Death|9
886970|NCT00633893|1854092|FG000|Overall Study|Adverse Event|65
886971|NCT00633893|1854093|FG001|Overall Study|Adverse Event|58
886972|NCT00633893|1854094|FG002|Overall Study|Adverse Event|126
886973|NCT00633893|1854092|FG000|Overall Study|Withdrawal by Subject|7
886974|NCT00633893|1854093|FG001|Overall Study|Withdrawal by Subject|12
886975|NCT00633893|1854094|FG002|Overall Study|Withdrawal by Subject|6
886976|NCT00633893|1854092|FG000|Overall Study|Lost to Follow-up|2
886977|NCT00633893|1854093|FG001|Overall Study|Lost to Follow-up|4
886978|NCT00633893|1854094|FG002|Overall Study|Lost to Follow-up|8
886979|NCT00633893|1854092|FG000|Overall Study|Poor/non-compliance|5
886980|NCT00633893|1854093|FG001|Overall Study|Poor/non-compliance|12
886981|NCT00633893|1854094|FG002|Overall Study|Poor/non-compliance|3
886982|NCT00633893|1854092|FG000|Overall Study|Pregnancy|2
886983|NCT00633893|1854093|FG001|Overall Study|Pregnancy|1
886984|NCT00633893|1854094|FG002|Overall Study|Pregnancy|1
886985|NCT00633893|1854092|FG000|Overall Study|Not meet/no longer meets criteria|4
886986|NCT00633893|1854093|FG001|Overall Study|Not meet/no longer meets criteria|6
886987|NCT00633893|1854094|FG002|Overall Study|Not meet/no longer meets criteria|4
886988|NCT00633893|1854092|FG000|Overall Study|Other|28
886989|NCT00633893|1854093|FG001|Overall Study|Other|33
886990|NCT00633893|1854094|FG002|Overall Study|Other|31
886991|NCT00633932|1854114|FG000|Overall Study|Adverse Event|1
886992|NCT00633932|1854115|FG001|Overall Study|Adverse Event|3
886993|NCT00633932|1854116|FG002|Overall Study|Adverse Event|4
886994|NCT00633932|1854114|FG000|Overall Study|Withdrawal by Subject|3
886995|NCT00633932|1854115|FG001|Overall Study|Withdrawal by Subject|9
886996|NCT00633932|1854116|FG002|Overall Study|Withdrawal by Subject|1
886997|NCT00633932|1854114|FG000|Overall Study|Lost to Follow-up|1
886998|NCT00633932|1854115|FG001|Overall Study|Lost to Follow-up|0
886999|NCT00633932|1854116|FG002|Overall Study|Lost to Follow-up|2
887000|NCT00633932|1854114|FG000|Overall Study|Protocol Violation|5
887001|NCT00633932|1854115|FG001|Overall Study|Protocol Violation|2
887002|NCT00633932|1854116|FG002|Overall Study|Protocol Violation|3
887003|NCT00633932|1854114|FG000|Overall Study|Physician Decision|0
887004|NCT00633932|1854115|FG001|Overall Study|Physician Decision|0
887005|NCT00633932|1854116|FG002|Overall Study|Physician Decision|1
887006|NCT00633932|1854114|FG000|Overall Study|Doctor's judgement|1
887007|NCT00633932|1854115|FG001|Overall Study|Doctor's judgement|0
887008|NCT00633932|1854116|FG002|Overall Study|Doctor's judgement|0
887009|NCT00633932|1854114|FG000|Overall Study|Moved Away|1
887010|NCT00633932|1854115|FG001|Overall Study|Moved Away|0
887011|NCT00633932|1854116|FG002|Overall Study|Moved Away|0
887012|NCT00633945|1854124|FG000|Overall Study|Physician Decision|2
887013|NCT00633984|1854132|FG000|Overall Study|Lost to Follow-up|0
887014|NCT00633984|1854133|FG001|Overall Study|Lost to Follow-up|6
887015|NCT00633984|1854132|FG000|Overall Study|Withdrawal by Subject|8
887016|NCT00633984|1854133|FG001|Overall Study|Withdrawal by Subject|7
887017|NCT00633984|1854132|FG000|Overall Study|Hospitalized|1
887018|NCT00633984|1854133|FG001|Overall Study|Hospitalized|0
887019|NCT00634036|1854141|FG000|Overall Study|Lost to Follow-up|1
887020|NCT00634036|1854142|FG001|Overall Study|Lost to Follow-up|1
887021|NCT00634036|1854141|FG000|Overall Study|Withdrawal by Subject|1
887022|NCT00634036|1854142|FG001|Overall Study|Withdrawal by Subject|1
887023|NCT00634049|1854148|FG000|Overall Study|Never received study drug|1
887024|NCT00634049|1854148|FG000|Overall Study|Died prior to receiving study drug|1
887025|NCT00634049|1854148|FG000|Overall Study|Screening failure|1
887026|NCT00634088|1854185|FG000|Time Period 1: Dose Level 1|Disease progression|2
887027|NCT00634088|1854186|FG001|Time Period 1: Dose Level 1|Disease progression|0
887028|NCT00634088|1854187|FG002|Time Period 1: Dose Level 1|Disease progression|0
887029|NCT00634088|1854188|FG003|Time Period 1: Dose Level 1|Disease progression|0
887030|NCT00634088|1854185|FG000|Time Period 1: Dose Level 1|Physician Decision|1
887031|NCT00634088|1854186|FG001|Time Period 1: Dose Level 1|Physician Decision|0
887032|NCT00634088|1854187|FG002|Time Period 1: Dose Level 1|Physician Decision|0
887033|NCT00634088|1854188|FG003|Time Period 1: Dose Level 1|Physician Decision|0
887034|NCT00634088|1854185|FG000|Time Period 1: Dose Level 1|Adverse Event|3
887035|NCT00634088|1854186|FG001|Time Period 1: Dose Level 1|Adverse Event|0
887036|NCT00634088|1854187|FG002|Time Period 1: Dose Level 1|Adverse Event|0
887037|NCT00634088|1854188|FG003|Time Period 1: Dose Level 1|Adverse Event|0
887038|NCT00634088|1854185|FG000|Time Period 2: Dose Level 2|Adverse Event|0
887039|NCT00634088|1854186|FG001|Time Period 2: Dose Level 2|Adverse Event|2
887040|NCT00634088|1854187|FG002|Time Period 2: Dose Level 2|Adverse Event|0
887041|NCT00634088|1854188|FG003|Time Period 2: Dose Level 2|Adverse Event|0
887042|NCT00634088|1854185|FG000|Time Period 2: Dose Level 2|Progressive disease|0
887043|NCT00634088|1854186|FG001|Time Period 2: Dose Level 2|Progressive disease|1
887044|NCT00634088|1854187|FG002|Time Period 2: Dose Level 2|Progressive disease|0
887045|NCT00634088|1854188|FG003|Time Period 2: Dose Level 2|Progressive disease|0
887046|NCT00634088|1854185|FG000|Time Period 3: Dose Level 3|Progressive disease|0
887047|NCT00634088|1854186|FG001|Time Period 3: Dose Level 3|Progressive disease|0
887048|NCT00634088|1854187|FG002|Time Period 3: Dose Level 3|Progressive disease|1
887049|NCT00634088|1854188|FG003|Time Period 3: Dose Level 3|Progressive disease|0
887050|NCT00634101|1854200|FG000|Overall Study|Study Terminated|3
887051|NCT00634101|1854201|FG001|Overall Study|Study Terminated|3
887052|NCT00634101|1854200|FG000|Overall Study|Lost to Follow-up|2
887053|NCT00634101|1854201|FG001|Overall Study|Lost to Follow-up|0
887054|NCT00634114|1854210|FG000|Overall Study|Adverse Event|6
887055|NCT00634114|1854211|FG001|Overall Study|Adverse Event|8
887056|NCT00634114|1854212|FG002|Overall Study|Adverse Event|3
887057|NCT00634114|1854210|FG000|Overall Study|Withdrawal by Subject|9
887058|NCT00634114|1854211|FG001|Overall Study|Withdrawal by Subject|6
887059|NCT00634114|1854212|FG002|Overall Study|Withdrawal by Subject|11
887060|NCT00634114|1854210|FG000|Overall Study|Lost to Follow-up|0
887061|NCT00634114|1854211|FG001|Overall Study|Lost to Follow-up|0
887062|NCT00634114|1854212|FG002|Overall Study|Lost to Follow-up|1
887063|NCT00634114|1854210|FG000|Overall Study|Protocol Violation|3
887064|NCT00634114|1854211|FG001|Overall Study|Protocol Violation|3
887065|NCT00634114|1854212|FG002|Overall Study|Protocol Violation|1
887066|NCT00634114|1854210|FG000|Overall Study|Pregnancy|1
887067|NCT00634114|1854211|FG001|Overall Study|Pregnancy|0
887068|NCT00634114|1854212|FG002|Overall Study|Pregnancy|0
887069|NCT00634114|1854210|FG000|Overall Study|Incorrect enrolment|0
887070|NCT00634114|1854211|FG001|Overall Study|Incorrect enrolment|1
887071|NCT00634114|1854212|FG002|Overall Study|Incorrect enrolment|0
887072|NCT00634114|1854210|FG000|Overall Study|Recurrence of reflux esophagitis|5
887073|NCT00634114|1854211|FG001|Overall Study|Recurrence of reflux esophagitis|15
887074|NCT00634114|1854212|FG002|Overall Study|Recurrence of reflux esophagitis|21
887075|NCT00634114|1854210|FG000|Overall Study|Difficult to continue|3
887076|NCT00634114|1854211|FG001|Overall Study|Difficult to continue|1
887077|NCT00634114|1854212|FG002|Overall Study|Difficult to continue|1
887078|NCT00634114|1854210|FG000|Overall Study|Other reason|1
887079|NCT00634114|1854211|FG001|Overall Study|Other reason|1
887080|NCT00634114|1854212|FG002|Overall Study|Other reason|1
887081|NCT00634179|1854229|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1
887082|NCT00634244|1854239|FG000|Overall Study|Never started treatment|0
887083|NCT00634244|1854240|FG001|Overall Study|Never started treatment|1
887084|NCT00634244|1854241|FG002|Overall Study|Never started treatment|0
887085|NCT00634244|1854239|FG000|Overall Study|Death|1
887086|NCT00634244|1854240|FG001|Overall Study|Death|6
887087|NCT00634244|1854241|FG002|Overall Study|Death|0
887088|NCT00634244|1854239|FG000|Overall Study|Adverse Event|0
887089|NCT00634244|1854240|FG001|Overall Study|Adverse Event|2
887090|NCT00634244|1854241|FG002|Overall Study|Adverse Event|0
887091|NCT00634244|1854239|FG000|Overall Study|Withdrawal by Subject|0
887092|NCT00634244|1854240|FG001|Overall Study|Withdrawal by Subject|1
887093|NCT00634244|1854241|FG002|Overall Study|Withdrawal by Subject|0
887094|NCT00634244|1854239|FG000|Overall Study|Physician Decision|0
887095|NCT00634244|1854240|FG001|Overall Study|Physician Decision|1
887096|NCT00634244|1854241|FG002|Overall Study|Physician Decision|0
887097|NCT00634244|1854239|FG000|Overall Study|Disease progression/relapse|0
887098|NCT00634244|1854240|FG001|Overall Study|Disease progression/relapse|1
887099|NCT00634244|1854241|FG002|Overall Study|Disease progression/relapse|0
887100|NCT00634244|1854239|FG000|Overall Study|Other complicating disease|0
887101|NCT00634244|1854240|FG001|Overall Study|Other complicating disease|1
887102|NCT00634244|1854241|FG002|Overall Study|Other complicating disease|0
887103|NCT00634504|1854272|FG000|Overall Study|Protocol Violation|1
887104|NCT00634504|1854273|FG001|Overall Study|Protocol Violation|0
887105|NCT00634543|1854281|FG000|Overall Study|Other|1
887106|NCT00634543|1854282|FG001|Overall Study|Other|2
887107|NCT00634543|1854281|FG000|Overall Study|Protocol Violation|3
887108|NCT00634543|1854282|FG001|Overall Study|Protocol Violation|3
887109|NCT00634543|1854281|FG000|Overall Study|Adverse Event|11
887110|NCT00634543|1854282|FG001|Overall Study|Adverse Event|11
887111|NCT00634543|1854281|FG000|Overall Study|Withdrawal by Subject|4
887112|NCT00634543|1854282|FG001|Overall Study|Withdrawal by Subject|4
887113|NCT00634543|1854281|FG000|Overall Study|Lost to Follow-up|0
887114|NCT00634543|1854282|FG001|Overall Study|Lost to Follow-up|1
887115|NCT00634569|1854290|FG000|Overall Study|Withdrawal by Subject|0
887116|NCT00634569|1854291|FG001|Overall Study|Withdrawal by Subject|4
887117|NCT00634569|1854290|FG000|Overall Study|Physician Decision|0
887118|NCT00634569|1854291|FG001|Overall Study|Physician Decision|1
887119|NCT00634647|1854305|FG000|Overall Study|death on study|3
887120|NCT00634647|1854305|FG000|Overall Study|refused further treatment|3
887121|NCT00634647|1854305|FG000|Overall Study|declined to participate before treatment|1
887122|NCT00634751|1854313|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1
887123|NCT00634751|1854314|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0
887124|NCT00634751|1854315|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0
887125|NCT00634751|1854316|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0
887126|NCT00634751|1854313|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0
887127|NCT00634751|1854314|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1
887128|NCT00634751|1854315|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0
887129|NCT00634751|1854316|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0
887130|NCT00634751|1854313|FG000|Pancreatic and Bilial Tract Cancer|Death|0
887131|NCT00634751|1854314|FG001|Pancreatic and Bilial Tract Cancer|Death|0
887132|NCT00634751|1854315|FG002|Pancreatic and Bilial Tract Cancer|Death|1
887133|NCT00634751|1854316|FG003|Pancreatic and Bilial Tract Cancer|Death|1
887134|NCT00634803|1854329|FG000|Overall Study|Lost to Follow-up|6
887135|NCT00634803|1854330|FG001|Overall Study|Lost to Follow-up|7
887136|NCT00634803|1854331|FG002|Overall Study|Lost to Follow-up|7
887137|NCT00634842|1854341|FG000|Overall Study|Adverse Event|2
887138|NCT00634842|1854342|FG001|Overall Study|Adverse Event|3
887139|NCT00634842|1854341|FG000|Overall Study|Protocol Violation|8
887140|NCT00634842|1854342|FG001|Overall Study|Protocol Violation|4
887141|NCT00634842|1854341|FG000|Overall Study|Move to another state|1
887142|NCT00634842|1854342|FG001|Overall Study|Move to another state|0
887143|NCT00634842|1854341|FG000|Overall Study|Inclusion criteria were not met|1
887144|NCT00634842|1854342|FG001|Overall Study|Inclusion criteria were not met|0
887145|NCT00634842|1854341|FG000|Overall Study|Lost to Follow-up|1
887146|NCT00634842|1854342|FG001|Overall Study|Lost to Follow-up|2
887147|NCT00634842|1854341|FG000|Overall Study|Physician Decision|1
887148|NCT00634842|1854342|FG001|Overall Study|Physician Decision|0
887149|NCT00634842|1854341|FG000|Overall Study|Withdrawal by Subject|1
887150|NCT00634842|1854342|FG001|Overall Study|Withdrawal by Subject|3
887151|NCT00634842|1854341|FG000|Overall Study|Lack of time and intolerance to drug|0
887152|NCT00634842|1854342|FG001|Overall Study|Lack of time and intolerance to drug|1
887153|NCT00634842|1854341|FG000|Overall Study|Discontinued due to injection|0
887154|NCT00634842|1854342|FG001|Overall Study|Discontinued due to injection|2
887155|NCT00634842|1854341|FG000|Overall Study|No need of study drug to treat diabetes|0
887156|NCT00634842|1854342|FG001|Overall Study|No need of study drug to treat diabetes|1
887157|NCT00634842|1854341|FG000|Overall Study|No wish to keep taking Avandia|0
887158|NCT00634842|1854342|FG001|Overall Study|No wish to keep taking Avandia|1
887159|NCT00634842|1854341|FG000|Overall Study|Subject off study drug for too long|0
887160|NCT00634842|1854342|FG001|Overall Study|Subject off study drug for too long|1
887161|NCT00634907|1854350|FG000|Overall Study|Withdrawal by Subject|3
887162|NCT00634907|1854351|FG001|Overall Study|Withdrawal by Subject|0
887163|NCT00634907|1854350|FG000|Overall Study|Physician Decision|3
887164|NCT00634907|1854351|FG001|Overall Study|Physician Decision|9
887165|NCT00634907|1854350|FG000|Overall Study|Withdrawal by Subject|11
887166|NCT00634907|1854351|FG001|Overall Study|Withdrawal by Subject|8
887167|NCT00634920|1854360|FG000|Period 1 - Pre-Randomization|Adverse Event|0
887168|NCT00634920|1854361|FG001|Period 1 - Pre-Randomization|Adverse Event|0
887169|NCT00634920|1854362|FG002|Period 1 - Pre-Randomization|Adverse Event|36
887170|NCT00634920|1854360|FG000|Period 1 - Pre-Randomization|Wound healing problems|0
887171|NCT00634920|1854361|FG001|Period 1 - Pre-Randomization|Wound healing problems|0
887172|NCT00634920|1854362|FG002|Period 1 - Pre-Randomization|Wound healing problems|16
887173|NCT00634920|1854360|FG000|Period 1 - Pre-Randomization|Rejections|0
887174|NCT00634920|1854361|FG001|Period 1 - Pre-Randomization|Rejections|0
887175|NCT00634920|1854362|FG002|Period 1 - Pre-Randomization|Rejections|55
887176|NCT00634920|1854360|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0
887177|NCT00634920|1854361|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0
887178|NCT00634920|1854362|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21
887179|NCT00634920|1854360|FG000|Period 1 - Pre-Randomization|Non-Compliance|0
887180|NCT00634920|1854361|FG001|Period 1 - Pre-Randomization|Non-Compliance|0
887181|NCT00634920|1854362|FG002|Period 1 - Pre-Randomization|Non-Compliance|3
887182|NCT00634920|1854360|FG000|Period 1 - Pre-Randomization|Other issues|0
887183|NCT00634920|1854361|FG001|Period 1 - Pre-Randomization|Other issues|0
887184|NCT00634920|1854362|FG002|Period 1 - Pre-Randomization|Other issues|6
887185|NCT00634920|1854360|FG000|Period 2 - Post-Randomization|Adverse Event|37
887186|NCT00634920|1854361|FG001|Period 2 - Post-Randomization|Adverse Event|9
887187|NCT00634920|1854362|FG002|Period 2 - Post-Randomization|Adverse Event|0
887188|NCT00634920|1854360|FG000|Period 2 - Post-Randomization|Rejection|11
887189|NCT00634920|1854361|FG001|Period 2 - Post-Randomization|Rejection|5
887190|NCT00634920|1854362|FG002|Period 2 - Post-Randomization|Rejection|0
887191|NCT00634920|1854360|FG000|Period 2 - Post-Randomization|Death|2
887192|NCT00634920|1854361|FG001|Period 2 - Post-Randomization|Death|5
887193|NCT00634920|1854362|FG002|Period 2 - Post-Randomization|Death|0
887194|NCT00634920|1854360|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
887195|NCT00634920|1854361|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
887196|NCT00634920|1854362|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
887197|NCT00634920|1854360|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2
887198|NCT00634920|1854361|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0
887199|NCT00634920|1854362|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0
887200|NCT00634933|1854371|FG000|Part A: Baseline to Week 24|Adverse Event|4
887201|NCT00634933|1854372|FG001|Part A: Baseline to Week 24|Adverse Event|4
887202|NCT00634933|1854373|FG002|Part A: Baseline to Week 24|Adverse Event|8
887203|NCT00634933|1854374|FG003|Part A: Baseline to Week 24|Adverse Event|0
887204|NCT00634933|1854375|FG004|Part A: Baseline to Week 24|Adverse Event|0
887205|NCT00634933|1854371|FG000|Part A: Baseline to Week 24|Death|1
887206|NCT00634933|1854372|FG001|Part A: Baseline to Week 24|Death|0
887207|NCT00634933|1854373|FG002|Part A: Baseline to Week 24|Death|0
887208|NCT00634933|1854374|FG003|Part A: Baseline to Week 24|Death|0
887209|NCT00634933|1854375|FG004|Part A: Baseline to Week 24|Death|0
887210|NCT00634933|1854371|FG000|Part A: Baseline to Week 24|Failed to Return|1
887211|NCT00634933|1854372|FG001|Part A: Baseline to Week 24|Failed to Return|0
887212|NCT00634933|1854373|FG002|Part A: Baseline to Week 24|Failed to Return|0
887213|NCT00634933|1854374|FG003|Part A: Baseline to Week 24|Failed to Return|0
887214|NCT00634933|1854375|FG004|Part A: Baseline to Week 24|Failed to Return|0
887215|NCT00634933|1854371|FG000|Part A: Baseline to Week 24|Investigator Request|1
887216|NCT00634933|1854372|FG001|Part A: Baseline to Week 24|Investigator Request|1
887217|NCT00634933|1854373|FG002|Part A: Baseline to Week 24|Investigator Request|1
887218|NCT00634933|1854374|FG003|Part A: Baseline to Week 24|Investigator Request|0
887219|NCT00634933|1854375|FG004|Part A: Baseline to Week 24|Investigator Request|0
887220|NCT00634933|1854371|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0
887221|NCT00634933|1854372|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1
887222|NCT00634933|1854373|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1
887223|NCT00634933|1854374|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0
887224|NCT00634933|1854375|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0
887225|NCT00634933|1854371|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0
887226|NCT00634933|1854372|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3
887227|NCT00634933|1854373|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3
887228|NCT00634933|1854374|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0
887229|NCT00634933|1854375|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0
887230|NCT00634933|1854371|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3
887231|NCT00634933|1854372|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1
887232|NCT00634933|1854373|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0
887233|NCT00634933|1854374|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0
887234|NCT00634933|1854375|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0
887235|NCT00634933|1854371|FG000|Part A: Baseline to Week 24|Other|1
887236|NCT00634933|1854372|FG001|Part A: Baseline to Week 24|Other|8
887237|NCT00634933|1854373|FG002|Part A: Baseline to Week 24|Other|5
887238|NCT00634933|1854374|FG003|Part A: Baseline to Week 24|Other|0
887239|NCT00634933|1854375|FG004|Part A: Baseline to Week 24|Other|0
887240|NCT00634933|1854371|FG000|Between Part A and Part B|Physician Decision|0
887241|NCT00634933|1854372|FG001|Between Part A and Part B|Physician Decision|1
887242|NCT00634933|1854373|FG002|Between Part A and Part B|Physician Decision|0
887243|NCT00634933|1854374|FG003|Between Part A and Part B|Physician Decision|0
887244|NCT00634933|1854375|FG004|Between Part A and Part B|Physician Decision|0
887245|NCT00634933|1854371|FG000|Part B: Week 24 to Week 52|Adverse Event|0
887246|NCT00634933|1854372|FG001|Part B: Week 24 to Week 52|Adverse Event|1
887247|NCT00634933|1854373|FG002|Part B: Week 24 to Week 52|Adverse Event|1
887248|NCT00634933|1854374|FG003|Part B: Week 24 to Week 52|Adverse Event|1
887249|NCT00634933|1854375|FG004|Part B: Week 24 to Week 52|Adverse Event|0
887250|NCT00634933|1854371|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
887251|NCT00634933|1854372|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
887252|NCT00634933|1854373|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
887253|NCT00634933|1854374|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
887254|NCT00634933|1854375|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
887255|NCT00634933|1854371|FG000|Part B: Week 24 to Week 52|Physician Decision|0
887256|NCT00634933|1854372|FG001|Part B: Week 24 to Week 52|Physician Decision|1
887257|NCT00634933|1854373|FG002|Part B: Week 24 to Week 52|Physician Decision|1
887258|NCT00634933|1854374|FG003|Part B: Week 24 to Week 52|Physician Decision|0
887259|NCT00634933|1854375|FG004|Part B: Week 24 to Week 52|Physician Decision|0
887260|NCT00634933|1854371|FG000|Part B: Week 24 to Week 52|Protocol Violation|0
887261|NCT00634933|1854372|FG001|Part B: Week 24 to Week 52|Protocol Violation|0
887262|NCT00634933|1854373|FG002|Part B: Week 24 to Week 52|Protocol Violation|0
887263|NCT00634933|1854374|FG003|Part B: Week 24 to Week 52|Protocol Violation|0
887264|NCT00634933|1854375|FG004|Part B: Week 24 to Week 52|Protocol Violation|1
887265|NCT00634933|1854371|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0
887266|NCT00634933|1854372|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0
887267|NCT00634933|1854373|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0
887268|NCT00634933|1854374|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2
887269|NCT00634933|1854375|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1
887270|NCT00634933|1854371|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0
887271|NCT00634933|1854372|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1
887272|NCT00634933|1854373|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1
887273|NCT00634933|1854374|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0
887274|NCT00634933|1854375|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0
887275|NCT00634933|1854371|FG000|Part B: Week 24 to Week 52|Other|0
887276|NCT00634933|1854372|FG001|Part B: Week 24 to Week 52|Other|0
887277|NCT00634933|1854373|FG002|Part B: Week 24 to Week 52|Other|5
887278|NCT00634933|1854374|FG003|Part B: Week 24 to Week 52|Other|0
887279|NCT00634933|1854375|FG004|Part B: Week 24 to Week 52|Other|1
887280|NCT00635024|1854387|FG000|Overall Study|Adverse Event|1
887281|NCT00635050|1854391|FG000|Overall Study|Withdrawal by Subject|1
887282|NCT00635089|1854398|FG000|Overall Study|Adverse Event|7
887283|NCT00635089|1854398|FG000|Overall Study|Lack of Efficacy|28
887284|NCT00635089|1854398|FG000|Overall Study|Protocol Deviation|4
887285|NCT00635089|1854398|FG000|Overall Study|Lost to Follow-up|8
887286|NCT00635089|1854398|FG000|Overall Study|Other|31
887287|NCT00635102|1854417|FG000|Overall Study|Withdrawal by Subject|7
887288|NCT00635102|1854418|FG001|Overall Study|Withdrawal by Subject|8
887289|NCT00635154|1854435|FG000|Overall Study|Alternative Treatment|8
887290|NCT00635154|1854435|FG000|Overall Study|Other|4
887291|NCT00635154|1854435|FG000|Overall Study|Still on treatment|21
887292|NCT00635219|1854446|FG000|Overall Study|Adverse Event|12
887293|NCT00635219|1854447|FG001|Overall Study|Adverse Event|10
887294|NCT00635219|1854448|FG002|Overall Study|Adverse Event|18
887295|NCT00635219|1854449|FG003|Overall Study|Adverse Event|15
887296|NCT00635219|1854450|FG004|Overall Study|Adverse Event|19
887297|NCT00635219|1854446|FG000|Overall Study|Lack of Efficacy|5
887298|NCT00635219|1854447|FG001|Overall Study|Lack of Efficacy|6
887299|NCT00635219|1854448|FG002|Overall Study|Lack of Efficacy|3
887300|NCT00635219|1854449|FG003|Overall Study|Lack of Efficacy|4
887301|NCT00635219|1854450|FG004|Overall Study|Lack of Efficacy|6
887302|NCT00635219|1854446|FG000|Overall Study|Non-compliance With Study Product|0
887303|NCT00635219|1854447|FG001|Overall Study|Non-compliance With Study Product|0
887304|NCT00635219|1854448|FG002|Overall Study|Non-compliance With Study Product|0
887305|NCT00635219|1854449|FG003|Overall Study|Non-compliance With Study Product|2
887306|NCT00635219|1854450|FG004|Overall Study|Non-compliance With Study Product|1
887307|NCT00635219|1854446|FG000|Overall Study|Protocol Violation|0
887308|NCT00635219|1854447|FG001|Overall Study|Protocol Violation|2
887309|NCT00635219|1854448|FG002|Overall Study|Protocol Violation|3
887310|NCT00635219|1854449|FG003|Overall Study|Protocol Violation|2
887311|NCT00635219|1854450|FG004|Overall Study|Protocol Violation|4
887312|NCT00635219|1854446|FG000|Overall Study|Withdrawal of Consent|8
887313|NCT00635219|1854447|FG001|Overall Study|Withdrawal of Consent|6
887314|NCT00635219|1854448|FG002|Overall Study|Withdrawal of Consent|8
887315|NCT00635219|1854449|FG003|Overall Study|Withdrawal of Consent|11
887316|NCT00635219|1854450|FG004|Overall Study|Withdrawal of Consent|8
887317|NCT00635219|1854446|FG000|Overall Study|Lost to Follow-up|0
887318|NCT00635219|1854447|FG001|Overall Study|Lost to Follow-up|0
887319|NCT00635219|1854448|FG002|Overall Study|Lost to Follow-up|2
887320|NCT00635219|1854449|FG003|Overall Study|Lost to Follow-up|0
887321|NCT00635219|1854450|FG004|Overall Study|Lost to Follow-up|3
887322|NCT00635219|1854446|FG000|Overall Study|Administrative or Other Reasons|0
887323|NCT00635219|1854447|FG001|Overall Study|Administrative or Other Reasons|1
887324|NCT00635219|1854448|FG002|Overall Study|Administrative or Other Reasons|1
887325|NCT00635219|1854449|FG003|Overall Study|Administrative or Other Reasons|0
887326|NCT00635219|1854450|FG004|Overall Study|Administrative or Other Reasons|1
887327|NCT00635349|1854485|FG000|Overall Study|Other|8
887328|NCT00635349|1854486|FG001|Overall Study|Other|6
887329|NCT00635349|1854485|FG000|Overall Study|Protocol Violation|18
887330|NCT00635349|1854486|FG001|Overall Study|Protocol Violation|22
887331|NCT00635349|1854485|FG000|Overall Study|Withdrawal by Subject|3
887332|NCT00635349|1854486|FG001|Overall Study|Withdrawal by Subject|8
887333|NCT00635349|1854485|FG000|Overall Study|Lost to Follow-up|4
887334|NCT00635349|1854486|FG001|Overall Study|Lost to Follow-up|3
887335|NCT00635349|1854485|FG000|Overall Study|Adverse Event|11
887336|NCT00635349|1854486|FG001|Overall Study|Adverse Event|9
887337|NCT00635427|1854506|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0
887338|NCT00635427|1854507|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0
887339|NCT00635427|1854508|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1
887340|NCT00635427|1854509|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0
887341|NCT00635427|1854510|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0
887342|NCT00635427|1854506|FG000|Overall Study|Death|0
887343|NCT00635427|1854507|FG001|Overall Study|Death|0
887344|NCT00635427|1854508|FG002|Overall Study|Death|0
887345|NCT00635427|1854509|FG003|Overall Study|Death|1
887346|NCT00635427|1854510|FG004|Overall Study|Death|0
887347|NCT00635427|1854506|FG000|Overall Study|Termination Of Study By Sponsor|12
887348|NCT00635427|1854507|FG001|Overall Study|Termination Of Study By Sponsor|6
887349|NCT00635427|1854508|FG002|Overall Study|Termination Of Study By Sponsor|10
887350|NCT00635427|1854509|FG003|Overall Study|Termination Of Study By Sponsor|6
887351|NCT00635427|1854510|FG004|Overall Study|Termination Of Study By Sponsor|6
887352|NCT00635427|1854506|FG000|Overall Study|Withdrawal Of Consent|0
887353|NCT00635427|1854507|FG001|Overall Study|Withdrawal Of Consent|0
887354|NCT00635427|1854508|FG002|Overall Study|Withdrawal Of Consent|0
887355|NCT00635427|1854509|FG003|Overall Study|Withdrawal Of Consent|2
887356|NCT00635427|1854510|FG004|Overall Study|Withdrawal Of Consent|2
887357|NCT00635492|1854540|FG000|Overall Study|Death|12
887358|NCT00635492|1854541|FG001|Overall Study|Death|40
887359|NCT00635492|1854540|FG000|Overall Study|Lost to Follow-up|151
887360|NCT00635492|1854541|FG001|Overall Study|Lost to Follow-up|172
887361|NCT00635492|1854540|FG000|Overall Study|Physician Decision|32
887362|NCT00635492|1854541|FG001|Overall Study|Physician Decision|22
887363|NCT00635492|1854540|FG000|Overall Study|Sponsor decision|2
887364|NCT00635492|1854541|FG001|Overall Study|Sponsor decision|3
887365|NCT00635492|1854540|FG000|Overall Study|Withdrawal by Subject|82
887366|NCT00635492|1854541|FG001|Overall Study|Withdrawal by Subject|45
887367|NCT00635570|1854553|FG000|Overall Study|Lost to Follow-up|8
887368|NCT00635570|1854554|FG001|Overall Study|Lost to Follow-up|8
887369|NCT00635570|1854553|FG000|Overall Study|Withdrawal by Subject|1
887370|NCT00635570|1854554|FG001|Overall Study|Withdrawal by Subject|1
887371|NCT00635570|1854553|FG000|Overall Study|Adverse Event|2
887372|NCT00635570|1854554|FG001|Overall Study|Adverse Event|0
887373|NCT00635570|1854553|FG000|Overall Study|Physician Decision|1
887374|NCT00635570|1854554|FG001|Overall Study|Physician Decision|0
887375|NCT00635570|1854553|FG000|Overall Study|Did not complete survey|2
887376|NCT00635570|1854554|FG001|Overall Study|Did not complete survey|1
887377|NCT00635570|1854553|FG000|Overall Study|Early termination(No sexual activity)|1
887378|NCT00635570|1854554|FG001|Overall Study|Early termination(No sexual activity)|1
887379|NCT00635648|1854569|FG000|Overall Study|Adverse Event|12
887380|NCT00635648|1854569|FG000|Overall Study|Withdrawal by Subject|9
887381|NCT00635648|1854569|FG000|Overall Study|Physician Decision|4
887382|NCT00635648|1854569|FG000|Overall Study|Rapid progression of baseline disease|4
887383|NCT00635648|1854569|FG000|Overall Study|Use of other antifungal agent needed|1
887384|NCT00635648|1854569|FG000|Overall Study|No improvement after 7-10 days treatment|4
887385|NCT00635648|1854569|FG000|Overall Study|Noncompliance with protocol|1
887386|NCT00635648|1854569|FG000|Overall Study|Other reason|2
887387|NCT00635661|1854573|FG000|Overall Study|Withdrawal by Subject|4
887388|NCT00635778|1854602|FG000|Overall Study|Adverse Event|1
887389|NCT00635778|1854603|FG001|Overall Study|Adverse Event|0
887390|NCT00635778|1854604|FG002|Overall Study|Adverse Event|0
887391|NCT00635778|1854605|FG003|Overall Study|Adverse Event|3
887392|NCT00635778|1854606|FG004|Overall Study|Adverse Event|3
887393|NCT00635778|1854607|FG005|Overall Study|Adverse Event|6
887394|NCT00635778|1854608|FG006|Overall Study|Adverse Event|1
887395|NCT00635778|1854602|FG000|Overall Study|Withdrawal by Subject|0
887396|NCT00635778|1854603|FG001|Overall Study|Withdrawal by Subject|0
887397|NCT00635778|1854604|FG002|Overall Study|Withdrawal by Subject|0
887398|NCT00635778|1854605|FG003|Overall Study|Withdrawal by Subject|1
887399|NCT00635778|1854606|FG004|Overall Study|Withdrawal by Subject|0
887400|NCT00635778|1854607|FG005|Overall Study|Withdrawal by Subject|1
887401|NCT00635778|1854608|FG006|Overall Study|Withdrawal by Subject|1
887402|NCT00635778|1854602|FG000|Overall Study|Progressive disease|0
887403|NCT00635778|1854603|FG001|Overall Study|Progressive disease|3
887404|NCT00635778|1854604|FG002|Overall Study|Progressive disease|3
887405|NCT00635778|1854605|FG003|Overall Study|Progressive disease|4
887406|NCT00635778|1854606|FG004|Overall Study|Progressive disease|5
887407|NCT00635778|1854607|FG005|Overall Study|Progressive disease|14
887408|NCT00635778|1854608|FG006|Overall Study|Progressive disease|4
887409|NCT00635804|1854633|FG000|Overall Study|Adverse Event|0
887410|NCT00635804|1854634|FG001|Overall Study|Adverse Event|0
887411|NCT00635804|1854635|FG002|Overall Study|Adverse Event|0
887412|NCT00635804|1854636|FG003|Overall Study|Adverse Event|0
887413|NCT00635804|1854637|FG004|Overall Study|Adverse Event|0
887414|NCT00635804|1854638|FG005|Overall Study|Adverse Event|1
887415|NCT00635804|1854639|FG006|Overall Study|Adverse Event|0
887416|NCT00635804|1854640|FG007|Overall Study|Adverse Event|0
887417|NCT00635804|1854633|FG000|Overall Study|Withdrawal by Subject|1
887418|NCT00635804|1854634|FG001|Overall Study|Withdrawal by Subject|0
887419|NCT00635804|1854635|FG002|Overall Study|Withdrawal by Subject|0
887420|NCT00635804|1854636|FG003|Overall Study|Withdrawal by Subject|0
887421|NCT00635804|1854637|FG004|Overall Study|Withdrawal by Subject|0
887422|NCT00635804|1854638|FG005|Overall Study|Withdrawal by Subject|0
887423|NCT00635804|1854639|FG006|Overall Study|Withdrawal by Subject|0
887424|NCT00635804|1854640|FG007|Overall Study|Withdrawal by Subject|0
887425|NCT00635882|1854695|FG000|Overall Study|Protocol Violation|1
887426|NCT00635882|1854696|FG001|Overall Study|Protocol Violation|0
887427|NCT00635882|1854697|FG002|Overall Study|Protocol Violation|0
887428|NCT00635882|1854698|FG003|Overall Study|Protocol Violation|0
887429|NCT00635882|1854699|FG004|Overall Study|Protocol Violation|0
887430|NCT00635882|1854700|FG005|Overall Study|Protocol Violation|0
887431|NCT00635999|1854717|FG000|Overall Study|Withdrawal by Subject|4
887432|NCT00635999|1854718|FG001|Overall Study|Withdrawal by Subject|2
887433|NCT00635999|1854719|FG002|Overall Study|Withdrawal by Subject|1
887434|NCT00636155|1854740|FG000|Overall Study|Adverse Event|8
887435|NCT00636155|1854740|FG000|Overall Study|Lack of Efficacy|1
887436|NCT00636155|1854740|FG000|Overall Study|Withdrawal by Subject|3
887437|NCT00636155|1854740|FG000|Overall Study|Stem cell transplant|1
887438|NCT00636155|1854740|FG000|Overall Study|Physician Decision|5
887439|NCT00636168|1854746|FG000|Randomized to Study Drug|Withdrawal by Subject|2
887440|NCT00636168|1854747|FG001|Randomized to Study Drug|Withdrawal by Subject|2
887441|NCT00636168|1854746|FG000|Randomized to Study Drug|Adverse Event|1
887442|NCT00636168|1854747|FG001|Randomized to Study Drug|Adverse Event|0
887443|NCT00636168|1854746|FG000|Randomized to Study Drug|No longer meets study criteria|1
887444|NCT00636168|1854747|FG001|Randomized to Study Drug|No longer meets study criteria|0
887445|NCT00636168|1854746|FG000|Treated With Study Drug|Recurrence of disease|135
887446|NCT00636168|1854747|FG001|Treated With Study Drug|Recurrence of disease|282
887447|NCT00636168|1854746|FG000|Treated With Study Drug|Adverse Event|250
887448|NCT00636168|1854747|FG001|Treated With Study Drug|Adverse Event|22
887449|NCT00636168|1854746|FG000|Treated With Study Drug|Participant withdrew consent|16
887450|NCT00636168|1854747|FG001|Treated With Study Drug|Participant withdrew consent|21
887451|NCT00636168|1854746|FG000|Treated With Study Drug|Poor/non-compliance|1
887452|NCT00636168|1854747|FG001|Treated With Study Drug|Poor/non-compliance|3
887453|NCT00636168|1854746|FG000|Treated With Study Drug|Death|3
887454|NCT00636168|1854747|FG001|Treated With Study Drug|Death|0
887455|NCT00636168|1854746|FG000|Treated With Study Drug|Pregnancy|1
887456|NCT00636168|1854747|FG001|Treated With Study Drug|Pregnancy|0
887457|NCT00636168|1854746|FG000|Treated With Study Drug|No longer meets study criteria|1
887458|NCT00636168|1854747|FG001|Treated With Study Drug|No longer meets study criteria|0
887459|NCT00636168|1854746|FG000|Treated With Study Drug|Other reason|1
887460|NCT00636168|1854747|FG001|Treated With Study Drug|Other reason|3
887461|NCT00636168|1854746|FG000|Long Term Follow-Up|Lost to Follow-up|3
887462|NCT00636168|1854747|FG001|Long Term Follow-Up|Lost to Follow-up|3
887463|NCT00636168|1854746|FG000|Long Term Follow-Up|Participant withdrew consent|0
887464|NCT00636168|1854747|FG001|Long Term Follow-Up|Participant withdrew consent|2
887465|NCT00636168|1854746|FG000|Long Term Follow-Up|Death|8
887466|NCT00636168|1854747|FG001|Long Term Follow-Up|Death|9
887467|NCT00636181|1854756|FG000|Overall Study|Withdrawal by Subject|8
887468|NCT00636181|1854757|FG001|Overall Study|Withdrawal by Subject|6
887469|NCT00636181|1854758|FG002|Overall Study|Withdrawal by Subject|10
887470|NCT00636194|1854768|FG000|Overall Study|Study related symptoms and complaints|1
887471|NCT00636194|1854769|FG001|Overall Study|Study related symptoms and complaints|0
887472|NCT00636194|1854768|FG000|Overall Study|Protocol Violation|2
887473|NCT00636194|1854769|FG001|Overall Study|Protocol Violation|0
887474|NCT00636207|1854778|FG000|Overall Study|Adverse Event|1
887475|NCT00636207|1854779|FG001|Overall Study|Adverse Event|0
887476|NCT00636207|1854780|FG002|Overall Study|Adverse Event|0
887477|NCT00636207|1854781|FG003|Overall Study|Adverse Event|0
887478|NCT00636207|1854782|FG004|Overall Study|Adverse Event|0
887479|NCT00636207|1854783|FG005|Overall Study|Adverse Event|0
887480|NCT00636207|1854784|FG006|Overall Study|Adverse Event|0
887481|NCT00636207|1854778|FG000|Overall Study|Withdrawal by Subject|0
887482|NCT00636207|1854779|FG001|Overall Study|Withdrawal by Subject|1
887483|NCT00636207|1854780|FG002|Overall Study|Withdrawal by Subject|0
887484|NCT00636207|1854781|FG003|Overall Study|Withdrawal by Subject|0
887485|NCT00636207|1854782|FG004|Overall Study|Withdrawal by Subject|1
887486|NCT00636207|1854783|FG005|Overall Study|Withdrawal by Subject|0
887487|NCT00636207|1854784|FG006|Overall Study|Withdrawal by Subject|0
887488|NCT00636363|1854812|FG000|Overall Study|Conjunctivitis|0
887489|NCT00636363|1854813|FG001|Overall Study|Conjunctivitis|0
887490|NCT00636363|1854814|FG002|Overall Study|Conjunctivitis|1
887491|NCT00636363|1854812|FG000|Overall Study|Adverse Event|0
887492|NCT00636363|1854813|FG001|Overall Study|Adverse Event|0
887493|NCT00636363|1854814|FG002|Overall Study|Adverse Event|1
887494|NCT00636363|1854812|FG000|Overall Study|Positive slit lamp finding|0
887495|NCT00636363|1854813|FG001|Overall Study|Positive slit lamp finding|2
887496|NCT00636363|1854814|FG002|Overall Study|Positive slit lamp finding|1
887497|NCT00636363|1854812|FG000|Overall Study|Study related symptoms/complaints|8
887498|NCT00636363|1854813|FG001|Overall Study|Study related symptoms/complaints|7
887499|NCT00636363|1854814|FG002|Overall Study|Study related symptoms/complaints|4
887500|NCT00636363|1854812|FG000|Overall Study|Met ineligibility criteria|0
887501|NCT00636363|1854813|FG001|Overall Study|Met ineligibility criteria|0
887502|NCT00636363|1854814|FG002|Overall Study|Met ineligibility criteria|3
887503|NCT00636363|1854812|FG000|Overall Study|Missed > 1 visit|0
887504|NCT00636363|1854813|FG001|Overall Study|Missed > 1 visit|1
887505|NCT00636363|1854814|FG002|Overall Study|Missed > 1 visit|3
887506|NCT00636363|1854812|FG000|Overall Study|Lack of motivation|1
887507|NCT00636363|1854813|FG001|Overall Study|Lack of motivation|0
887508|NCT00636363|1854814|FG002|Overall Study|Lack of motivation|1
887509|NCT00636363|1854812|FG000|Overall Study|Protocol Violation|0
887510|NCT00636363|1854813|FG001|Overall Study|Protocol Violation|3
887511|NCT00636363|1854814|FG002|Overall Study|Protocol Violation|0
887512|NCT00636363|1854812|FG000|Overall Study|Lost to Follow-up|3
887513|NCT00636363|1854813|FG001|Overall Study|Lost to Follow-up|4
887514|NCT00636363|1854814|FG002|Overall Study|Lost to Follow-up|2
887515|NCT00636363|1854812|FG000|Overall Study|Withdrawal by Subject|1
887516|NCT00636363|1854813|FG001|Overall Study|Withdrawal by Subject|3
887517|NCT00636363|1854814|FG002|Overall Study|Withdrawal by Subject|2
887518|NCT00636441|1854836|FG000|Overall Study|Adverse Event|0
887519|NCT00636441|1854837|FG001|Overall Study|Adverse Event|1
887520|NCT00636441|1854838|FG002|Overall Study|Adverse Event|1
887521|NCT00636441|1854839|FG003|Overall Study|Adverse Event|0
887522|NCT00636441|1854840|FG004|Overall Study|Adverse Event|0
887523|NCT00636441|1854841|FG005|Overall Study|Adverse Event|1
887524|NCT00636441|1854842|FG006|Overall Study|Adverse Event|0
887525|NCT00636441|1854836|FG000|Overall Study|Late, ineligible|0
887526|NCT00636441|1854837|FG001|Overall Study|Late, ineligible|0
887527|NCT00636441|1854838|FG002|Overall Study|Late, ineligible|0
887528|NCT00636441|1854839|FG003|Overall Study|Late, ineligible|0
887529|NCT00636441|1854840|FG004|Overall Study|Late, ineligible|0
887530|NCT00636441|1854841|FG005|Overall Study|Late, ineligible|0
887531|NCT00636441|1854842|FG006|Overall Study|Late, ineligible|1
887532|NCT00636441|1854836|FG000|Overall Study|Screen Failure|0
887533|NCT00636441|1854837|FG001|Overall Study|Screen Failure|0
887534|NCT00636441|1854838|FG002|Overall Study|Screen Failure|0
887535|NCT00636441|1854839|FG003|Overall Study|Screen Failure|0
887536|NCT00636441|1854840|FG004|Overall Study|Screen Failure|0
887537|NCT00636441|1854841|FG005|Overall Study|Screen Failure|0
887538|NCT00636441|1854842|FG006|Overall Study|Screen Failure|17
887539|NCT00636506|1854853|FG000|Overall Study|Lost to Follow-up|8
887540|NCT00636506|1854853|FG000|Overall Study|Explanted|1
887541|NCT00636506|1854853|FG000|Overall Study|Withdrawal by Subject|6
887542|NCT00636506|1854853|FG000|Overall Study|Procedure aborted|1
887543|NCT00636610|1854877|FG000|Overall Study|Adverse Event|4
887544|NCT00636610|1854878|FG001|Overall Study|Adverse Event|4
887545|NCT00636610|1854877|FG000|Overall Study|Death|6
887546|NCT00636610|1854878|FG001|Overall Study|Death|3
887547|NCT00636610|1854877|FG000|Overall Study|Physician decision to withdraw patient|15
887548|NCT00636610|1854878|FG001|Overall Study|Physician decision to withdraw patient|9
887549|NCT00636610|1854877|FG000|Overall Study|Subject decision to withdraw|15
887550|NCT00636610|1854878|FG001|Overall Study|Subject decision to withdraw|11
887551|NCT00636610|1854877|FG000|Overall Study|Disease progression - radiographic|41
887552|NCT00636610|1854878|FG001|Overall Study|Disease progression - radiographic|51
887553|NCT00636610|1854877|FG000|Overall Study|Disease progression - clinical|8
887554|NCT00636610|1854878|FG001|Overall Study|Disease progression - clinical|3
887555|NCT00636610|1854877|FG000|Overall Study|Reason for discontinuation not available|3
887556|NCT00636610|1854878|FG001|Overall Study|Reason for discontinuation not available|2
887557|NCT00636636|1854888|FG000|Overall Study|Other reason|4
887558|NCT00636636|1854889|FG001|Overall Study|Other reason|6
887559|NCT00636636|1854888|FG000|Overall Study|Adverse Event|19
887560|NCT00636636|1854889|FG001|Overall Study|Adverse Event|8
887561|NCT00636636|1854888|FG000|Overall Study|Lack of Efficacy|7
887562|NCT00636636|1854889|FG001|Overall Study|Lack of Efficacy|12
887563|NCT00636636|1854888|FG000|Overall Study|Protocol Violation|2
887564|NCT00636636|1854889|FG001|Overall Study|Protocol Violation|2
887565|NCT00636636|1854888|FG000|Overall Study|Lost to Follow-up|0
887566|NCT00636636|1854889|FG001|Overall Study|Lost to Follow-up|1
887567|NCT00636636|1854888|FG000|Overall Study|Death|0
887568|NCT00636636|1854889|FG001|Overall Study|Death|1
887569|NCT00636636|1854888|FG000|Overall Study|Withdrawal by Subject|4
887570|NCT00636636|1854889|FG001|Overall Study|Withdrawal by Subject|9
887571|NCT00636675|1854910|FG000|Overall Study|Lost to Follow-up|121
887572|NCT00636675|1854911|FG001|Overall Study|Lost to Follow-up|31
887573|NCT00636675|1854910|FG000|Overall Study|Withdrawal by Subject|19
887574|NCT00636675|1854911|FG001|Overall Study|Withdrawal by Subject|10
887575|NCT00636792|1854926|FG000|Overall Study|Adverse Event|16
887576|NCT00636792|1854926|FG000|Overall Study|Physician Decision|7
887577|NCT00636792|1854926|FG000|Overall Study|Progressive Disease|4
887578|NCT00636792|1854926|FG000|Overall Study|Withdrawal by Subject|3
887579|NCT00636792|1854926|FG000|Overall Study|Other|3
887580|NCT00636818|1854934|FG000|Overall Study|Adverse Event|1
887581|NCT00636818|1854934|FG000|Overall Study|Lost to Follow-up|2
887582|NCT00636818|1854934|FG000|Overall Study|Entry Criteria Exclusion|3
887583|NCT00636818|1854934|FG000|Overall Study|Protocol Violation|1
887584|NCT00636818|1854934|FG000|Overall Study|Withdrawal by Subject|4
887585|NCT00636961|1854940|FG000|Period 1|Administrative problems|1
887586|NCT00636961|1854941|FG001|Period 1|Administrative problems|1
887587|NCT00636961|1854940|FG000|Period 2|Adverse Event|1
887588|NCT00636961|1854941|FG001|Period 2|Adverse Event|0
887589|NCT00636987|1854947|FG000|Overall Study|Death|44
887590|NCT00636987|1854947|FG000|Overall Study|Explanted|13
887591|NCT00636987|1854947|FG000|Overall Study|Lost to Follow-up|63
887592|NCT00636987|1854947|FG000|Overall Study|5 year visit window not complete|69
887593|NCT00637000|1854957|FG000|Overall Study|Withdrawal by Subject|4
887594|NCT00637000|1854958|FG001|Overall Study|Withdrawal by Subject|3
887595|NCT00637156|1854966|FG000|Overall Study|Withdrawal by Subject|0
887596|NCT00637156|1854967|FG001|Overall Study|Withdrawal by Subject|7
887597|NCT00637156|1854966|FG000|Overall Study|Death|0
887598|NCT00637156|1854967|FG001|Overall Study|Death|1
887599|NCT00637156|1854966|FG000|Overall Study|Lost to Follow-up|10
887600|NCT00637156|1854967|FG001|Overall Study|Lost to Follow-up|16
887601|NCT00637195|1854975|FG000|Overall Study|Lost to Follow-up|1
887602|NCT00637195|1854976|FG001|Overall Study|Lost to Follow-up|0
887603|NCT00637195|1854975|FG000|Overall Study|Other|2
887604|NCT00637195|1854976|FG001|Overall Study|Other|0
887605|NCT00637195|1854975|FG000|Overall Study|Withdrawal by Subject|0
887606|NCT00637195|1854976|FG001|Overall Study|Withdrawal by Subject|1
887607|NCT00637273|1854996|FG000|Overall Study|Adverse Event|11
887608|NCT00637273|1854997|FG001|Overall Study|Adverse Event|5
887609|NCT00637273|1854998|FG002|Overall Study|Adverse Event|7
887610|NCT00637273|1854996|FG000|Overall Study|Lost to Follow-up|8
887611|NCT00637273|1854997|FG001|Overall Study|Lost to Follow-up|9
887612|NCT00637273|1854998|FG002|Overall Study|Lost to Follow-up|13
887613|NCT00637273|1854996|FG000|Overall Study|Protocol Violation|2
887614|NCT00637273|1854997|FG001|Overall Study|Protocol Violation|4
887615|NCT00637273|1854998|FG002|Overall Study|Protocol Violation|1
887616|NCT00637273|1854996|FG000|Overall Study|Withdrawal of Consent|18
887617|NCT00637273|1854997|FG001|Overall Study|Withdrawal of Consent|6
887618|NCT00637273|1854998|FG002|Overall Study|Withdrawal of Consent|18
887619|NCT00637273|1854996|FG000|Overall Study|Investigator Decision|1
887620|NCT00637273|1854997|FG001|Overall Study|Investigator Decision|3
887621|NCT00637273|1854998|FG002|Overall Study|Investigator Decision|1
887622|NCT00637273|1854996|FG000|Overall Study|Administrative|2
887623|NCT00637273|1854997|FG001|Overall Study|Administrative|0
887624|NCT00637273|1854998|FG002|Overall Study|Administrative|0
887625|NCT00637273|1854996|FG000|Overall Study|Loss of Glucose Control|1
887626|NCT00637273|1854997|FG001|Overall Study|Loss of Glucose Control|1
887627|NCT00637273|1854998|FG002|Overall Study|Loss of Glucose Control|1
887628|NCT00637377|1855019|FG000|Overall Study|Adverse Event|2
887629|NCT00637377|1855020|FG001|Overall Study|Adverse Event|6
887630|NCT00637377|1855021|FG002|Overall Study|Adverse Event|8
887631|NCT00637377|1855022|FG003|Overall Study|Adverse Event|9
887632|NCT00637377|1855019|FG000|Overall Study|Death|1
887633|NCT00637377|1855020|FG001|Overall Study|Death|3
887634|NCT00637377|1855021|FG002|Overall Study|Death|2
887635|NCT00637377|1855022|FG003|Overall Study|Death|1
887636|NCT00637377|1855019|FG000|Overall Study|Lack of Efficacy|0
887637|NCT00637377|1855020|FG001|Overall Study|Lack of Efficacy|0
887638|NCT00637377|1855021|FG002|Overall Study|Lack of Efficacy|1
887639|NCT00637377|1855022|FG003|Overall Study|Lack of Efficacy|1
887640|NCT00637377|1855019|FG000|Overall Study|Lost to Follow-up|4
887641|NCT00637377|1855020|FG001|Overall Study|Lost to Follow-up|1
887642|NCT00637377|1855021|FG002|Overall Study|Lost to Follow-up|2
887643|NCT00637377|1855022|FG003|Overall Study|Lost to Follow-up|2
887644|NCT00637377|1855019|FG000|Overall Study|Protocol Violation|2
887645|NCT00637377|1855020|FG001|Overall Study|Protocol Violation|1
887646|NCT00637377|1855021|FG002|Overall Study|Protocol Violation|1
887647|NCT00637377|1855022|FG003|Overall Study|Protocol Violation|0
887648|NCT00637377|1855019|FG000|Overall Study|Withdrawal by Subject|11
887649|NCT00637377|1855020|FG001|Overall Study|Withdrawal by Subject|15
887650|NCT00637377|1855021|FG002|Overall Study|Withdrawal by Subject|13
887651|NCT00637377|1855022|FG003|Overall Study|Withdrawal by Subject|11
887652|NCT00637377|1855019|FG000|Overall Study|Other (no further information available)|7
887653|NCT00637377|1855020|FG001|Overall Study|Other (no further information available)|6
887654|NCT00637377|1855021|FG002|Overall Study|Other (no further information available)|10
887655|NCT00637377|1855022|FG003|Overall Study|Other (no further information available)|5
887656|NCT00637572|1855043|FG000|Overall Study|Adverse Event|1
887657|NCT00637572|1855044|FG001|Overall Study|Adverse Event|2
887658|NCT00637572|1855043|FG000|Overall Study|Death|0
887659|NCT00637572|1855044|FG001|Overall Study|Death|1
887660|NCT00637572|1855043|FG000|Overall Study|Lost to Follow-up|0
887661|NCT00637572|1855044|FG001|Overall Study|Lost to Follow-up|1
887662|NCT00637572|1855043|FG000|Overall Study|Physician Decision|1
887663|NCT00637572|1855044|FG001|Overall Study|Physician Decision|1
887664|NCT00637572|1855043|FG000|Overall Study|Withdrawal by Subject|0
887665|NCT00637572|1855044|FG001|Overall Study|Withdrawal by Subject|2
887666|NCT00637572|1855043|FG000|Overall Study|Illicit Drug Use|1
887667|NCT00637572|1855044|FG001|Overall Study|Illicit Drug Use|0
887668|NCT00638027|1855074|FG000|Overall Study|Adverse Event|0
887669|NCT00638027|1855075|FG001|Overall Study|Adverse Event|2
887670|NCT00638157|1855083|FG000|Overall Study|Adverse Event|0
887671|NCT00638157|1855084|FG001|Overall Study|Adverse Event|1
887672|NCT00638157|1855083|FG000|Overall Study|Clinical (symptomatic) failure|1
887673|NCT00638157|1855084|FG001|Overall Study|Clinical (symptomatic) failure|1
887674|NCT00638157|1855083|FG000|Overall Study|Microbiological failure|1
887675|NCT00638157|1855084|FG001|Overall Study|Microbiological failure|0
887676|NCT00638157|1855083|FG000|Overall Study|Lost to Follow-up|1
887677|NCT00638157|1855084|FG001|Overall Study|Lost to Follow-up|0
887678|NCT00638157|1855083|FG000|Overall Study|Physician Decision|1
887679|NCT00638157|1855084|FG001|Overall Study|Physician Decision|0
887680|NCT00638157|1855083|FG000|Overall Study|Other|1
887681|NCT00638157|1855084|FG001|Overall Study|Other|2
887682|NCT00638157|1855083|FG000|Overall Study|Randomized, not treated|2
887683|NCT00638157|1855084|FG001|Overall Study|Randomized, not treated|0
887684|NCT00638183|1855091|FG000|Overall Study|Adverse Event|23
887685|NCT00638183|1855091|FG000|Overall Study|Lack of Efficacy|14
887686|NCT00638183|1855091|FG000|Overall Study|Physician Decision|9
887687|NCT00638183|1855091|FG000|Overall Study|Lost to Follow-up|46
887688|NCT00638183|1855091|FG000|Overall Study|Other reason not defined above|27
887689|NCT00638235|1855104|FG000|Overall Study|Lost to Follow-up|31
887690|NCT00638235|1855105|FG001|Overall Study|Lost to Follow-up|3
887691|NCT00638235|1855106|FG002|Overall Study|Lost to Follow-up|18
887692|NCT00638235|1855107|FG003|Overall Study|Lost to Follow-up|10
887693|NCT00638235|1855108|FG004|Overall Study|Lost to Follow-up|13
887694|NCT00638235|1855109|FG005|Overall Study|Lost to Follow-up|26
887695|NCT00638235|1855110|FG006|Overall Study|Lost to Follow-up|0
887696|NCT00638235|1855111|FG007|Overall Study|Lost to Follow-up|1
887697|NCT00638235|1855112|FG008|Overall Study|Lost to Follow-up|18
887698|NCT00638378|1855161|FG000|Overall Study|Death|2
887699|NCT00638378|1855161|FG000|Overall Study|Adverse Event|1
887700|NCT00638378|1855161|FG000|Overall Study|Disease progression|15
887701|NCT00638378|1855161|FG000|Overall Study|Physician Decision|4
887702|NCT00638404|1855167|FG000|Overall Study|Physician Decision|8
887703|NCT00638404|1855168|FG001|Overall Study|Physician Decision|0
887704|NCT00638443|1855178|FG000|First Intervention|Adverse Event|2
887705|NCT00638443|1855179|FG001|First Intervention|Adverse Event|1
887706|NCT00638456|1855189|FG000|Overall Study|Withdrawal by Subject|6
887707|NCT00638456|1855190|FG001|Overall Study|Withdrawal by Subject|2
887708|NCT00638508|1855198|FG000|Overall Study|Physician Decision|5
887709|NCT00638508|1855199|FG001|Overall Study|Physician Decision|2
887710|NCT00638690|1855216|FG000|Overall Study|Death|655
887711|NCT00638690|1855217|FG001|Overall Study|Death|335
887712|NCT00638690|1855216|FG000|Overall Study|Withdrawal by Subject|22
887713|NCT00638690|1855217|FG001|Overall Study|Withdrawal by Subject|5
887714|NCT00638690|1855216|FG000|Overall Study|Lost to Follow-up|4
887715|NCT00638690|1855217|FG001|Overall Study|Lost to Follow-up|2
887716|NCT00638846|1855243|FG000|Overall Study|Adverse Event|0
887717|NCT00638846|1855244|FG001|Overall Study|Adverse Event|1
887718|NCT00638846|1855243|FG000|Overall Study|Lost to Follow-up|3
887719|NCT00638846|1855244|FG001|Overall Study|Lost to Follow-up|2
887720|NCT00638846|1855243|FG000|Overall Study|lens issue|1
887721|NCT00638846|1855244|FG001|Overall Study|lens issue|3
887722|NCT00638963|1855266|FG000|Overall Study|Withdrawal by Subject|1
887723|NCT00638963|1855267|FG001|Overall Study|Withdrawal by Subject|0
887724|NCT00638989|1855276|FG000|Overall Study|Lost to Follow-up|0
887725|NCT00638989|1855277|FG001|Overall Study|Lost to Follow-up|0
887726|NCT00638989|1855278|FG002|Overall Study|Lost to Follow-up|1
887727|NCT00639002|1855288|FG000|Overall Study|Death|1
887728|NCT00639002|1855288|FG000|Overall Study|Adverse Event|1
887729|NCT00639002|1855288|FG000|Overall Study|Protocol Violation|1
887730|NCT00639002|1855288|FG000|Overall Study|Disease progression|3
887731|NCT00639002|1855288|FG000|Overall Study|Physician Decision|6
887732|NCT00639002|1855288|FG000|Overall Study|Lack of Efficacy|1
887733|NCT00639223|1855313|FG000|Overall Study|Lost to Follow-up|0
887734|NCT00639223|1855314|FG001|Overall Study|Lost to Follow-up|2
887735|NCT00639379|1855320|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2
887736|NCT00639379|1855321|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0
887737|NCT00639379|1855320|FG000|Period 1 - 2 Weeks|lens issue|3
887738|NCT00639379|1855321|FG001|Period 1 - 2 Weeks|lens issue|0
887739|NCT00639457|1855350|FG000|Overall Study|Withdrawal by Subject|2
887740|NCT00639457|1855351|FG001|Overall Study|Withdrawal by Subject|3
887741|NCT00639509|1855357|FG000|Overall Study|Death|1
887742|NCT00639678|1855365|FG000|Overall Study|Withdrawal by Subject|3
887743|NCT00639678|1855366|FG001|Overall Study|Withdrawal by Subject|0
887744|NCT00639678|1855367|FG002|Overall Study|Withdrawal by Subject|4
887745|NCT00639678|1855368|FG003|Overall Study|Withdrawal by Subject|0
887746|NCT00639678|1855365|FG000|Overall Study|Lost to Follow-up|1
887747|NCT00639678|1855366|FG001|Overall Study|Lost to Follow-up|0
887748|NCT00639678|1855367|FG002|Overall Study|Lost to Follow-up|6
887749|NCT00639678|1855368|FG003|Overall Study|Lost to Follow-up|0
887750|NCT00639678|1855365|FG000|Overall Study|Adverse Event|0
887751|NCT00639678|1855366|FG001|Overall Study|Adverse Event|1
887752|NCT00639678|1855367|FG002|Overall Study|Adverse Event|0
887753|NCT00639678|1855368|FG003|Overall Study|Adverse Event|0
887754|NCT00639678|1855365|FG000|Overall Study|Lack of Compliance|0
887755|NCT00639678|1855366|FG001|Overall Study|Lack of Compliance|0
887756|NCT00639678|1855367|FG002|Overall Study|Lack of Compliance|1
887757|NCT00639678|1855368|FG003|Overall Study|Lack of Compliance|0
887758|NCT00639769|1855384|FG000|Overall Study|Death|2
887759|NCT00639769|1855384|FG000|Overall Study|Adverse Event|7
887760|NCT00639769|1855384|FG000|Overall Study|Lack of Efficacy|1
887761|NCT00639769|1855384|FG000|Overall Study|Disease progression|26
887762|NCT00639769|1855384|FG000|Overall Study|Withdrawal by Subject|4
887763|NCT00640016|1855396|FG000|Overall Study|Withdrawal by Subject|0
887764|NCT00640016|1855397|FG001|Overall Study|Withdrawal by Subject|1
887765|NCT00640016|1855398|FG002|Overall Study|Withdrawal by Subject|0
887766|NCT00640016|1855399|FG003|Overall Study|Withdrawal by Subject|0
887767|NCT00640016|1855396|FG000|Overall Study|Study termination|2
887768|NCT00640016|1855397|FG001|Overall Study|Study termination|1
887769|NCT00640016|1855398|FG002|Overall Study|Study termination|3
887770|NCT00640016|1855399|FG003|Overall Study|Study termination|2
887771|NCT00640016|1855396|FG000|Overall Study|Adverse Event|0
887772|NCT00640016|1855397|FG001|Overall Study|Adverse Event|0
887773|NCT00640016|1855398|FG002|Overall Study|Adverse Event|0
887774|NCT00640016|1855399|FG003|Overall Study|Adverse Event|1
887775|NCT00640042|1855416|FG000|Enrollment|Did not receive study drug|83
887776|NCT00640133|1855422|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1
887777|NCT00640133|1855423|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0
887778|NCT00640133|1855422|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
887779|NCT00640133|1855423|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
887780|NCT00640133|1855422|FG000|Open Label Phase (Month 4-12)|Adverse Event|1
887781|NCT00640133|1855423|FG001|Open Label Phase (Month 4-12)|Adverse Event|0
887782|NCT00640146|1855433|FG000|Overall Study|Adverse Event|2
887783|NCT00640146|1855434|FG001|Overall Study|Adverse Event|0
887784|NCT00640146|1855433|FG000|Overall Study|Lost to Follow-up|0
887785|NCT00640146|1855434|FG001|Overall Study|Lost to Follow-up|1
887786|NCT00640146|1855433|FG000|Overall Study|Lack of Efficacy|0
887787|NCT00640146|1855434|FG001|Overall Study|Lack of Efficacy|1
887788|NCT00640146|1855433|FG000|Overall Study|Withdrawal by Subject|1
887789|NCT00640146|1855434|FG001|Overall Study|Withdrawal by Subject|1
887790|NCT00640146|1855433|FG000|Overall Study|Randomized but not treated|1
887791|NCT00640146|1855434|FG001|Overall Study|Randomized but not treated|3
887792|NCT00640224|1855444|FG000|Overall Study|Lost to Follow-up|5
887793|NCT00640224|1855445|FG001|Overall Study|Lost to Follow-up|2
887794|NCT00640224|1855446|FG002|Overall Study|Lost to Follow-up|0
887795|NCT00640224|1855447|FG003|Overall Study|Lost to Follow-up|0
887796|NCT00640224|1855444|FG000|Overall Study|Withdrawal by Subject|1
887797|NCT00640224|1855445|FG001|Overall Study|Withdrawal by Subject|0
887798|NCT00640224|1855446|FG002|Overall Study|Withdrawal by Subject|0
887799|NCT00640224|1855447|FG003|Overall Study|Withdrawal by Subject|0
887800|NCT00640224|1855444|FG000|Overall Study|Headaches|0
887801|NCT00640224|1855445|FG001|Overall Study|Headaches|1
887802|NCT00640224|1855446|FG002|Overall Study|Headaches|0
887803|NCT00640224|1855447|FG003|Overall Study|Headaches|0
887804|NCT00640289|1855560|FG000|Overall Study|Death|3
887805|NCT00640289|1855560|FG000|Overall Study|Withdrawal by Subject|1
887806|NCT00640289|1855560|FG000|Overall Study|Lost to Follow-up|1
887807|NCT00640289|1855560|FG000|Overall Study|Data collected under different amendment|2
887808|NCT00640289|1855560|FG000|Overall Study|Transferred to another center|1
887809|NCT00640289|1855560|FG000|Overall Study|Missing status|5
887810|NCT00640315|1855566|FG000|Overall Study|Withdrawal by Subject|0
887811|NCT00640315|1855567|FG001|Overall Study|Withdrawal by Subject|1
887812|NCT00640328|1855579|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0
887813|NCT00640328|1855580|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1
887814|NCT00640328|1855581|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0
887815|NCT00640328|1855582|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0
887816|NCT00640328|1855583|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0
887817|NCT00640328|1855584|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0
887818|NCT00640328|1855579|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0
887819|NCT00640328|1855580|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0
887820|NCT00640328|1855581|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0
887821|NCT00640328|1855582|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0
887822|NCT00640328|1855583|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1
887823|NCT00640328|1855584|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0
887824|NCT00640328|1855579|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
887825|NCT00640328|1855580|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
887826|NCT00640328|1855581|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
887827|NCT00640328|1855582|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
887828|NCT00640328|1855583|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
887829|NCT00640328|1855584|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
887830|NCT00640328|1855579|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
887831|NCT00640328|1855580|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
887832|NCT00640328|1855581|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
887833|NCT00640328|1855582|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
887834|NCT00640328|1855583|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
887835|NCT00640328|1855584|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
887836|NCT00640341|1855608|FG000|Overall Study|Adverse Event|0
887837|NCT00640341|1855609|FG001|Overall Study|Adverse Event|0
887838|NCT00640341|1855610|FG002|Overall Study|Adverse Event|1
887839|NCT00640341|1855608|FG000|Overall Study|Positive Slit Lamp Findings|0
887840|NCT00640341|1855609|FG001|Overall Study|Positive Slit Lamp Findings|0
887841|NCT00640341|1855610|FG002|Overall Study|Positive Slit Lamp Findings|1
887842|NCT00640341|1855608|FG000|Overall Study|Study Related Symptoms/Complaints|2
887843|NCT00640341|1855609|FG001|Overall Study|Study Related Symptoms/Complaints|1
887844|NCT00640341|1855610|FG002|Overall Study|Study Related Symptoms/Complaints|2
887845|NCT00640341|1855608|FG000|Overall Study|Inability to Maintain Wearing Schedule|1
887846|NCT00640341|1855609|FG001|Overall Study|Inability to Maintain Wearing Schedule|1
887847|NCT00640341|1855610|FG002|Overall Study|Inability to Maintain Wearing Schedule|0
887848|NCT00640341|1855608|FG000|Overall Study|Failure to Follow Subject Instructions|1
887849|NCT00640341|1855609|FG001|Overall Study|Failure to Follow Subject Instructions|0
887850|NCT00640341|1855610|FG002|Overall Study|Failure to Follow Subject Instructions|0
887851|NCT00640341|1855608|FG000|Overall Study|Lost to Follow-up|2
887852|NCT00640341|1855609|FG001|Overall Study|Lost to Follow-up|0
887853|NCT00640341|1855610|FG002|Overall Study|Lost to Follow-up|0
887854|NCT00640341|1855608|FG000|Overall Study|Withdrawal by Subject|4
887855|NCT00640341|1855609|FG001|Overall Study|Withdrawal by Subject|0
887856|NCT00640341|1855610|FG002|Overall Study|Withdrawal by Subject|1
887857|NCT00640341|1855608|FG000|Overall Study|Unacceptable Lens Movement|1
887858|NCT00640341|1855609|FG001|Overall Study|Unacceptable Lens Movement|0
887859|NCT00640341|1855610|FG002|Overall Study|Unacceptable Lens Movement|0
887860|NCT00640341|1855608|FG000|Overall Study|Poor fit/Uncomfortable|4
887861|NCT00640341|1855609|FG001|Overall Study|Poor fit/Uncomfortable|0
887862|NCT00640341|1855610|FG002|Overall Study|Poor fit/Uncomfortable|0
887863|NCT00640341|1855608|FG000|Overall Study|Ineligable at Baseline|5
887864|NCT00640341|1855609|FG001|Overall Study|Ineligable at Baseline|3
887865|NCT00640341|1855610|FG002|Overall Study|Ineligable at Baseline|2
887866|NCT00640341|1855608|FG000|Overall Study|Adverse event and positive slit lamp|1
887867|NCT00640341|1855609|FG001|Overall Study|Adverse event and positive slit lamp|0
887868|NCT00640341|1855610|FG002|Overall Study|Adverse event and positive slit lamp|0
887869|NCT00640393|1855618|FG000|Part 1|Lost to Follow-up|2
887870|NCT00640393|1855619|FG001|Part 1|Lost to Follow-up|0
887871|NCT00640393|1855620|FG002|Part 1|Lost to Follow-up|0
887872|NCT00640393|1855618|FG000|Part 1|Withdrawal by Subject|3
887873|NCT00640393|1855619|FG001|Part 1|Withdrawal by Subject|0
887874|NCT00640393|1855620|FG002|Part 1|Withdrawal by Subject|0
887875|NCT00640393|1855618|FG000|Randomization|Withdrawn per protocol|17
887876|NCT00640393|1855619|FG001|Randomization|Withdrawn per protocol|0
887877|NCT00640393|1855620|FG002|Randomization|Withdrawn per protocol|0
887878|NCT00640393|1855618|FG000|Randomization|Never randomized by site|2
887879|NCT00640393|1855619|FG001|Randomization|Never randomized by site|0
887880|NCT00640393|1855620|FG002|Randomization|Never randomized by site|0
887881|NCT00640393|1855618|FG000|Part 2|Lost to Follow-up|0
887882|NCT00640393|1855619|FG001|Part 2|Lost to Follow-up|2
887883|NCT00640393|1855620|FG002|Part 2|Lost to Follow-up|2
887884|NCT00640393|1855618|FG000|Part 2|Withdrawal by Subject|0
887885|NCT00640393|1855619|FG001|Part 2|Withdrawal by Subject|6
887886|NCT00640393|1855620|FG002|Part 2|Withdrawal by Subject|1
887887|NCT00640393|1855618|FG000|Part 2|Non-adherence|0
887888|NCT00640393|1855619|FG001|Part 2|Non-adherence|1
887889|NCT00640393|1855620|FG002|Part 2|Non-adherence|0
887890|NCT00640393|1855618|FG000|Part 2|Adverse Event|0
887891|NCT00640393|1855619|FG001|Part 2|Adverse Event|1
887892|NCT00640393|1855620|FG002|Part 2|Adverse Event|0
887893|NCT00640510|1855630|FG000|Overall Study|Lack of Efficacy|0
887894|NCT00640510|1855631|FG001|Overall Study|Lack of Efficacy|1
887895|NCT00640510|1855630|FG000|Overall Study|Protocol Violation|1
887896|NCT00640510|1855631|FG001|Overall Study|Protocol Violation|0
887897|NCT00640510|1855630|FG000|Overall Study|Physician Decision|0
887898|NCT00640510|1855631|FG001|Overall Study|Physician Decision|1
887899|NCT00640562|1855639|FG000|Overall Study|Adverse Event|8
887900|NCT00640562|1855640|FG001|Overall Study|Adverse Event|5
887901|NCT00640562|1855639|FG000|Overall Study|Lack of Efficacy|1
887902|NCT00640562|1855640|FG001|Overall Study|Lack of Efficacy|4
887903|NCT00640562|1855639|FG000|Overall Study|Protocol Violation|2
887904|NCT00640562|1855640|FG001|Overall Study|Protocol Violation|4
887905|NCT00640562|1855639|FG000|Overall Study|Withdrawal by Subject|6
887906|NCT00640562|1855640|FG001|Overall Study|Withdrawal by Subject|10
887907|NCT00640562|1855639|FG000|Overall Study|Known risperidone intolerance|0
887908|NCT00640562|1855640|FG001|Overall Study|Known risperidone intolerance|1
887909|NCT00640562|1855639|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0
887910|NCT00640562|1855640|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1
887911|NCT00640562|1855639|FG000|Overall Study|Low study drug dose|0
887912|NCT00640562|1855640|FG001|Overall Study|Low study drug dose|1
887913|NCT00640562|1855639|FG000|Overall Study|Glycosylated Hemoglobin >8|1
887914|NCT00640562|1855640|FG001|Overall Study|Glycosylated Hemoglobin >8|0
887915|NCT00640601|1855646|FG000|Overall Study|Adverse Event|43
887916|NCT00640601|1855646|FG000|Overall Study|Withdrawal by Subject|20
887917|NCT00640601|1855646|FG000|Overall Study|Protocol Violation|6
887918|NCT00640601|1855646|FG000|Overall Study|Lack of Efficacy|16
887919|NCT00640601|1855646|FG000|Overall Study|Lost to Follow-up|9
887920|NCT00640601|1855646|FG000|Overall Study|Physician Decision|8
887921|NCT00640601|1855646|FG000|Overall Study|treatment naive, combination therapy|10
887922|NCT00640614|1855652|FG000|Overall Study|Lost to Follow-up|1
887923|NCT00640614|1855653|FG001|Overall Study|Lost to Follow-up|0
887924|NCT00640835|1855718|FG000|Overall Study|Adverse Event|5
887925|NCT00640835|1855719|FG001|Overall Study|Adverse Event|3
887926|NCT00640835|1855718|FG000|Overall Study|Withdrawal by Subject|12
887927|NCT00640835|1855719|FG001|Overall Study|Withdrawal by Subject|14
887928|NCT00640835|1855718|FG000|Overall Study|Physician Decision|10
887929|NCT00640835|1855719|FG001|Overall Study|Physician Decision|14
887930|NCT00640835|1855718|FG000|Overall Study|Sponsor's Decision|11
887931|NCT00640835|1855719|FG001|Overall Study|Sponsor's Decision|7
887932|NCT00640835|1855718|FG000|Overall Study|Protocol Violation|2
887933|NCT00640835|1855719|FG001|Overall Study|Protocol Violation|2
887934|NCT00640835|1855718|FG000|Overall Study|Lost to Follow-up|17
887935|NCT00640835|1855719|FG001|Overall Study|Lost to Follow-up|13
887936|NCT00640835|1855718|FG000|Overall Study|Other Reason|19
887937|NCT00640835|1855719|FG001|Overall Study|Other Reason|4
887938|NCT00640926|1855728|FG000|Overall Study|Adverse Event|2
887939|NCT00640926|1855729|FG001|Overall Study|Adverse Event|3
887940|NCT00640926|1855730|FG002|Overall Study|Adverse Event|2
887941|NCT00640926|1855728|FG000|Overall Study|Lack of Efficacy|0
887942|NCT00640926|1855729|FG001|Overall Study|Lack of Efficacy|2
887943|NCT00640926|1855730|FG002|Overall Study|Lack of Efficacy|1
887944|NCT00640926|1855728|FG000|Overall Study|Protocol Violation|2
887945|NCT00640926|1855729|FG001|Overall Study|Protocol Violation|0
887946|NCT00640926|1855730|FG002|Overall Study|Protocol Violation|2
887947|NCT00640926|1855728|FG000|Overall Study|Lost to Follow-up|3
887948|NCT00640926|1855729|FG001|Overall Study|Lost to Follow-up|1
887949|NCT00640926|1855730|FG002|Overall Study|Lost to Follow-up|2
887950|NCT00640926|1855728|FG000|Overall Study|Withdrawal by Subject|1
887951|NCT00640926|1855729|FG001|Overall Study|Withdrawal by Subject|0
887952|NCT00640926|1855730|FG002|Overall Study|Withdrawal by Subject|1
887953|NCT00641043|1855744|FG000|Overall Study|Adverse Event|6
887954|NCT00641043|1855745|FG001|Overall Study|Adverse Event|4
887955|NCT00641043|1855744|FG000|Overall Study|Protocol Violation|2
887956|NCT00641043|1855745|FG001|Overall Study|Protocol Violation|3
887957|NCT00641043|1855744|FG000|Overall Study|Lost to Follow-up|3
887958|NCT00641043|1855745|FG001|Overall Study|Lost to Follow-up|2
887959|NCT00641043|1855744|FG000|Overall Study|Withdrawal by Subject|4
887960|NCT00641043|1855745|FG001|Overall Study|Withdrawal by Subject|4
887961|NCT00641043|1855744|FG000|Overall Study|Other incl. lack of efficacy|4
887962|NCT00641043|1855745|FG001|Overall Study|Other incl. lack of efficacy|2
887963|NCT00641056|1855753|FG000|Overall Study|Adverse Event|12
887964|NCT00641056|1855754|FG001|Overall Study|Adverse Event|2
887965|NCT00641056|1855753|FG000|Overall Study|Lost to Follow-up|2
887966|NCT00641056|1855754|FG001|Overall Study|Lost to Follow-up|1
887967|NCT00641056|1855753|FG000|Overall Study|Physician Decision|3
887968|NCT00641056|1855754|FG001|Overall Study|Physician Decision|1
887969|NCT00641056|1855753|FG000|Overall Study|Protocol Violation|2
887970|NCT00641056|1855754|FG001|Overall Study|Protocol Violation|0
887971|NCT00641056|1855753|FG000|Overall Study|Entry Criteria Not Met|3
887972|NCT00641056|1855754|FG001|Overall Study|Entry Criteria Not Met|0
887973|NCT00641056|1855753|FG000|Overall Study|Subject Decision|6
887974|NCT00641056|1855754|FG001|Overall Study|Subject Decision|19
887975|NCT00641056|1855753|FG000|Overall Study|Sponsor Decision|1
887976|NCT00641056|1855754|FG001|Overall Study|Sponsor Decision|2
887977|NCT00641147|1855766|FG000|Completed 4 Months.|Physician Decision|1
887978|NCT00641147|1855767|FG001|Completed 4 Months.|Physician Decision|0
887979|NCT00641147|1855766|FG000|Completed 4 Months.|Adverse Event|1
887980|NCT00641147|1855767|FG001|Completed 4 Months.|Adverse Event|0
887981|NCT00641147|1855766|FG000|Completed 8 Months.|Physician Decision|2
887982|NCT00641147|1855767|FG001|Completed 8 Months.|Physician Decision|1
887983|NCT00641147|1855766|FG000|Completed 8 Months.|non compliance|1
887984|NCT00641147|1855767|FG001|Completed 8 Months.|non compliance|0
887985|NCT00641147|1855766|FG000|Completed 8 Months.|Withdrawal by Subject|0
887986|NCT00641147|1855767|FG001|Completed 8 Months.|Withdrawal by Subject|1
887987|NCT00641147|1855766|FG000|Completed 12 Months.|Physician Decision|1
887988|NCT00641147|1855767|FG001|Completed 12 Months.|Physician Decision|1
887989|NCT00641147|1855766|FG000|Completed 12 Months.|Withdrawal by Subject|0
887990|NCT00641147|1855767|FG001|Completed 12 Months.|Withdrawal by Subject|1
887991|NCT00641147|1855766|FG000|Completed 16 Months.|Physician Decision|1
887992|NCT00641147|1855767|FG001|Completed 16 Months.|Physician Decision|0
887993|NCT00641147|1855766|FG000|Completed 16 Months.|Lost to Follow-up|1
887994|NCT00641147|1855767|FG001|Completed 16 Months.|Lost to Follow-up|0
887995|NCT00641667|1855818|FG000|Overall Study|Withdrawal by Subject|1
887996|NCT00641667|1855818|FG000|Overall Study|Adverse Event|1
887997|NCT00641667|1855818|FG000|Overall Study|Physician Decision|1
887998|NCT00641667|1855818|FG000|Overall Study|Worsening of underlying disease|3
887999|NCT00641706|1855824|FG000|Overall Study|Adverse Event|2
888000|NCT00641706|1855825|FG001|Overall Study|Adverse Event|1
888001|NCT00641706|1855824|FG000|Overall Study|Withdrawal by Subject|6
888002|NCT00641706|1855825|FG001|Overall Study|Withdrawal by Subject|1
888003|NCT00641706|1855824|FG000|Overall Study|Clinical Decline|1
888004|NCT00641706|1855825|FG001|Overall Study|Clinical Decline|0
888005|NCT00641706|1855824|FG000|Overall Study|Lead Investigator Decision|0
888006|NCT00641706|1855825|FG001|Overall Study|Lead Investigator Decision|1
888007|NCT00641719|1855833|FG000|Overall Study|Lack of Efficacy|1
888008|NCT00641719|1855834|FG001|Overall Study|Lack of Efficacy|2
888009|NCT00641719|1855833|FG000|Overall Study|Adverse Event|24
888010|NCT00641719|1855834|FG001|Overall Study|Adverse Event|29
888011|NCT00641719|1855833|FG000|Overall Study|Withdrawal by Subject|4
888012|NCT00641719|1855834|FG001|Overall Study|Withdrawal by Subject|4
888013|NCT00641719|1855833|FG000|Overall Study|Reason Not Specified|1
888014|NCT00641719|1855834|FG001|Overall Study|Reason Not Specified|2
888015|NCT00642018|1855869|FG000|Overall Study|Adverse Event|11
888016|NCT00642018|1855870|FG001|Overall Study|Adverse Event|36
888017|NCT00642018|1855869|FG000|Overall Study|Withdrawal by Subject|4
888018|NCT00642018|1855870|FG001|Overall Study|Withdrawal by Subject|10
888019|NCT00642018|1855869|FG000|Overall Study|Progressive Disease|13
888020|NCT00642018|1855870|FG001|Overall Study|Progressive Disease|18
888021|NCT00642018|1855869|FG000|Overall Study|Physician Decision|0
888022|NCT00642018|1855870|FG001|Overall Study|Physician Decision|10
888023|NCT00642018|1855869|FG000|Overall Study|Protocol Violation|0
888024|NCT00642018|1855870|FG001|Overall Study|Protocol Violation|1
888025|NCT00642018|1855869|FG000|Overall Study|Death|0
888026|NCT00642018|1855870|FG001|Overall Study|Death|3
888027|NCT00642018|1855869|FG000|Overall Study|Entry Criteria Not Met|0
888028|NCT00642018|1855870|FG001|Overall Study|Entry Criteria Not Met|1
888029|NCT00642174|1855879|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0
888030|NCT00642174|1855880|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1
888031|NCT00642278|1855893|FG000|Overall Study|Adverse Event|2
888032|NCT00642278|1855894|FG001|Overall Study|Adverse Event|1
888033|NCT00642278|1855895|FG002|Overall Study|Adverse Event|3
888034|NCT00642278|1855896|FG003|Overall Study|Adverse Event|1
888035|NCT00642278|1855897|FG004|Overall Study|Adverse Event|2
888036|NCT00642278|1855898|FG005|Overall Study|Adverse Event|2
888037|NCT00642278|1855899|FG006|Overall Study|Adverse Event|0
888038|NCT00642278|1855893|FG000|Overall Study|Lack of Efficacy|0
888039|NCT00642278|1855894|FG001|Overall Study|Lack of Efficacy|1
888040|NCT00642278|1855895|FG002|Overall Study|Lack of Efficacy|0
888041|NCT00642278|1855896|FG003|Overall Study|Lack of Efficacy|0
888042|NCT00642278|1855897|FG004|Overall Study|Lack of Efficacy|0
888043|NCT00642278|1855898|FG005|Overall Study|Lack of Efficacy|0
888044|NCT00642278|1855899|FG006|Overall Study|Lack of Efficacy|0
888045|NCT00642278|1855893|FG000|Overall Study|Lost to Follow-up|5
888046|NCT00642278|1855894|FG001|Overall Study|Lost to Follow-up|1
888047|NCT00642278|1855895|FG002|Overall Study|Lost to Follow-up|0
888048|NCT00642278|1855896|FG003|Overall Study|Lost to Follow-up|1
888049|NCT00642278|1855897|FG004|Overall Study|Lost to Follow-up|0
888050|NCT00642278|1855898|FG005|Overall Study|Lost to Follow-up|1
888051|NCT00642278|1855899|FG006|Overall Study|Lost to Follow-up|1
888052|NCT00642278|1855893|FG000|Overall Study|Physician Decision|0
888053|NCT00642278|1855894|FG001|Overall Study|Physician Decision|0
888054|NCT00642278|1855895|FG002|Overall Study|Physician Decision|0
888055|NCT00642278|1855896|FG003|Overall Study|Physician Decision|1
888056|NCT00642278|1855897|FG004|Overall Study|Physician Decision|0
888057|NCT00642278|1855898|FG005|Overall Study|Physician Decision|0
888058|NCT00642278|1855899|FG006|Overall Study|Physician Decision|0
888059|NCT00642278|1855893|FG000|Overall Study|Protocol Violation|0
888060|NCT00642278|1855894|FG001|Overall Study|Protocol Violation|0
888061|NCT00642278|1855895|FG002|Overall Study|Protocol Violation|1
888062|NCT00642278|1855896|FG003|Overall Study|Protocol Violation|1
888063|NCT00642278|1855897|FG004|Overall Study|Protocol Violation|0
888064|NCT00642278|1855898|FG005|Overall Study|Protocol Violation|1
888065|NCT00642278|1855899|FG006|Overall Study|Protocol Violation|2
888066|NCT00642278|1855893|FG000|Overall Study|Withdrawal by Subject|1
888067|NCT00642278|1855894|FG001|Overall Study|Withdrawal by Subject|1
888068|NCT00642278|1855895|FG002|Overall Study|Withdrawal by Subject|1
888069|NCT00642278|1855896|FG003|Overall Study|Withdrawal by Subject|3
888070|NCT00642278|1855897|FG004|Overall Study|Withdrawal by Subject|6
888071|NCT00642278|1855898|FG005|Overall Study|Withdrawal by Subject|2
888072|NCT00642278|1855899|FG006|Overall Study|Withdrawal by Subject|2
888073|NCT00642278|1855893|FG000|Overall Study|Noncompliance with study drug regimen|0
888074|NCT00642278|1855894|FG001|Overall Study|Noncompliance with study drug regimen|0
888075|NCT00642278|1855895|FG002|Overall Study|Noncompliance with study drug regimen|0
888076|NCT00642278|1855896|FG003|Overall Study|Noncompliance with study drug regimen|1
888077|NCT00642278|1855897|FG004|Overall Study|Noncompliance with study drug regimen|0
888078|NCT00642278|1855898|FG005|Overall Study|Noncompliance with study drug regimen|0
888079|NCT00642278|1855899|FG006|Overall Study|Noncompliance with study drug regimen|0
888080|NCT00642278|1855893|FG000|Overall Study|Other|2
888081|NCT00642278|1855894|FG001|Overall Study|Other|1
888082|NCT00642278|1855895|FG002|Overall Study|Other|0
888083|NCT00642278|1855896|FG003|Overall Study|Other|1
888084|NCT00642278|1855897|FG004|Overall Study|Other|0
888085|NCT00642278|1855898|FG005|Overall Study|Other|1
888086|NCT00642278|1855899|FG006|Overall Study|Other|0
888087|NCT00642304|1855915|FG000|Overall Study|Adverse Event|1
888088|NCT00642304|1855915|FG000|Overall Study|Death|1
888089|NCT00642304|1855915|FG000|Overall Study|Blood transfusion|2
888090|NCT00642304|1855915|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1
888091|NCT00642304|1855915|FG000|Overall Study|Transplantation|1
888092|NCT00642356|1855921|FG000|Overall Study|Adverse Event|1
888093|NCT00642356|1855922|FG001|Overall Study|Adverse Event|0
888094|NCT00642356|1855921|FG000|Overall Study|Protocol Violation|0
888095|NCT00642356|1855922|FG001|Overall Study|Protocol Violation|3
888096|NCT00642356|1855921|FG000|Overall Study|Lack of Efficacy|1
888097|NCT00642356|1855922|FG001|Overall Study|Lack of Efficacy|0
888098|NCT00642369|1855930|FG000|Overall Study|Adverse Event|2
888099|NCT00642369|1855931|FG001|Overall Study|Adverse Event|3
888100|NCT00642369|1855930|FG000|Overall Study|Withdrawal by Subject|1
888101|NCT00642369|1855931|FG001|Overall Study|Withdrawal by Subject|0
888102|NCT00642369|1855930|FG000|Overall Study|misdiagnosis|0
888103|NCT00642369|1855931|FG001|Overall Study|misdiagnosis|1
888104|NCT00642369|1855930|FG000|Overall Study|Lack of Efficacy|2
888105|NCT00642369|1855931|FG001|Overall Study|Lack of Efficacy|2
888106|NCT00642460|1855941|FG000|Part I: 12 Week Double-Blind|Adverse Event|0
888107|NCT00642460|1855942|FG001|Part I: 12 Week Double-Blind|Adverse Event|1
888108|NCT00642460|1855943|FG002|Part I: 12 Week Double-Blind|Adverse Event|1
888109|NCT00642460|1855944|FG003|Part I: 12 Week Double-Blind|Adverse Event|0
888110|NCT00642460|1855945|FG004|Part I: 12 Week Double-Blind|Adverse Event|0
888111|NCT00642460|1855946|FG005|Part I: 12 Week Double-Blind|Adverse Event|0
888112|NCT00642460|1855941|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1
888113|NCT00642460|1855942|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0
888114|NCT00642460|1855943|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0
888115|NCT00642460|1855944|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0
888116|NCT00642460|1855945|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0
888117|NCT00642460|1855946|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0
888118|NCT00642460|1855941|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4
888119|NCT00642460|1855942|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2
888120|NCT00642460|1855943|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0
888121|NCT00642460|1855944|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0
888122|NCT00642460|1855945|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0
888123|NCT00642460|1855946|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0
888124|NCT00642460|1855941|FG000|Part II: Open-Label Up to Week 92|Death|0
888125|NCT00642460|1855942|FG001|Part II: Open-Label Up to Week 92|Death|1
888126|NCT00642460|1855943|FG002|Part II: Open-Label Up to Week 92|Death|0
888127|NCT00642460|1855944|FG003|Part II: Open-Label Up to Week 92|Death|2
888128|NCT00642460|1855945|FG004|Part II: Open-Label Up to Week 92|Death|0
888129|NCT00642460|1855946|FG005|Part II: Open-Label Up to Week 92|Death|0
888130|NCT00642460|1855941|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
888131|NCT00642460|1855942|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
888132|NCT00642460|1855943|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
888133|NCT00642460|1855944|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
888134|NCT00642460|1855945|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
888135|NCT00642460|1855946|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
888136|NCT00642460|1855941|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3
888137|NCT00642460|1855942|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1
888138|NCT00642460|1855943|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0
888139|NCT00642460|1855944|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0
888140|NCT00642460|1855945|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0
888141|NCT00642460|1855946|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0
888142|NCT00642460|1855941|FG000|Part II: Open-Label Up to Week 92|Failure to return|0
888143|NCT00642460|1855942|FG001|Part II: Open-Label Up to Week 92|Failure to return|1
888144|NCT00642460|1855943|FG002|Part II: Open-Label Up to Week 92|Failure to return|0
888145|NCT00642460|1855944|FG003|Part II: Open-Label Up to Week 92|Failure to return|0
888146|NCT00642460|1855945|FG004|Part II: Open-Label Up to Week 92|Failure to return|0
888147|NCT00642460|1855946|FG005|Part II: Open-Label Up to Week 92|Failure to return|0
888148|NCT00642460|1855941|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0
888149|NCT00642460|1855942|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0
888150|NCT00642460|1855943|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0
888151|NCT00642460|1855944|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1
888152|NCT00642460|1855945|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0
888153|NCT00642460|1855946|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0
888154|NCT00642460|1855941|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0
888155|NCT00642460|1855942|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0
888156|NCT00642460|1855943|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0
888157|NCT00642460|1855944|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0
888158|NCT00642460|1855945|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7
888159|NCT00642460|1855946|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6
888160|NCT00642460|1855941|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
888161|NCT00642460|1855942|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
888162|NCT00642460|1855943|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
888163|NCT00642460|1855944|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
888164|NCT00642460|1855945|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
888165|NCT00642460|1855946|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
888166|NCT00642460|1855941|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
888167|NCT00642460|1855942|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
888168|NCT00642460|1855943|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
888169|NCT00642460|1855944|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
888170|NCT00642460|1855945|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
888171|NCT00642460|1855946|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
888172|NCT00642460|1855941|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
888173|NCT00642460|1855942|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
888174|NCT00642460|1855943|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
888175|NCT00642460|1855944|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
888176|NCT00642460|1855945|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
888177|NCT00642460|1855946|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
888178|NCT00642460|1855941|FG000|Part III: Open-Label Up to Week 260|Other|0
888179|NCT00642460|1855942|FG001|Part III: Open-Label Up to Week 260|Other|0
888180|NCT00642460|1855943|FG002|Part III: Open-Label Up to Week 260|Other|0
888181|NCT00642460|1855944|FG003|Part III: Open-Label Up to Week 260|Other|0
888182|NCT00642460|1855945|FG004|Part III: Open-Label Up to Week 260|Other|2
888183|NCT00642460|1855946|FG005|Part III: Open-Label Up to Week 260|Other|2
888184|NCT00642460|1855941|FG000|Part III: Open-Label Up to Week 260|Death|0
888185|NCT00642460|1855942|FG001|Part III: Open-Label Up to Week 260|Death|0
888186|NCT00642460|1855943|FG002|Part III: Open-Label Up to Week 260|Death|0
888187|NCT00642460|1855944|FG003|Part III: Open-Label Up to Week 260|Death|0
888188|NCT00642460|1855945|FG004|Part III: Open-Label Up to Week 260|Death|0
888189|NCT00642460|1855946|FG005|Part III: Open-Label Up to Week 260|Death|3
888190|NCT00642460|1855941|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0
888191|NCT00642460|1855942|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0
888192|NCT00642460|1855943|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0
888193|NCT00642460|1855944|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0
888194|NCT00642460|1855945|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0
888195|NCT00642460|1855946|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1
888196|NCT00642460|1855941|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0
888197|NCT00642460|1855942|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0
888198|NCT00642460|1855943|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0
888199|NCT00642460|1855944|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0
888200|NCT00642460|1855945|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8
888201|NCT00642460|1855946|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3
888202|NCT00642473|1855958|FG000|Overall Study|Withdrawal by Subject|0
888203|NCT00642473|1855959|FG001|Overall Study|Withdrawal by Subject|5
888204|NCT00642473|1855958|FG000|Overall Study|Progression or death|2
888205|NCT00642473|1855959|FG001|Overall Study|Progression or death|4
888206|NCT00642473|1855958|FG000|Overall Study|Other|2
888207|NCT00642473|1855959|FG001|Overall Study|Other|2
888208|NCT00642616|1855972|FG000|Overall Study|Adverse Event|2
888209|NCT00642616|1855973|FG001|Overall Study|Adverse Event|0
888210|NCT00642616|1855974|FG002|Overall Study|Adverse Event|1
888211|NCT00642616|1855975|FG003|Overall Study|Adverse Event|0
888212|NCT00642616|1855972|FG000|Overall Study|Study Terminated by Sponsor|7
888213|NCT00642616|1855973|FG001|Overall Study|Study Terminated by Sponsor|6
888214|NCT00642616|1855974|FG002|Overall Study|Study Terminated by Sponsor|4
888215|NCT00642616|1855975|FG003|Overall Study|Study Terminated by Sponsor|5
888216|NCT00642616|1855972|FG000|Overall Study|Withdrawal by Subject|0
888217|NCT00642616|1855973|FG001|Overall Study|Withdrawal by Subject|1
888218|NCT00642616|1855974|FG002|Overall Study|Withdrawal by Subject|1
888219|NCT00642616|1855975|FG003|Overall Study|Withdrawal by Subject|1
888220|NCT00642616|1855972|FG000|Overall Study|Protocol Violation|0
888221|NCT00642616|1855973|FG001|Overall Study|Protocol Violation|0
888222|NCT00642616|1855974|FG002|Overall Study|Protocol Violation|2
888223|NCT00642616|1855975|FG003|Overall Study|Protocol Violation|0
888224|NCT00642616|1855972|FG000|Overall Study|Physician Decision|0
888225|NCT00642616|1855973|FG001|Overall Study|Physician Decision|0
888226|NCT00642616|1855974|FG002|Overall Study|Physician Decision|1
888227|NCT00642616|1855975|FG003|Overall Study|Physician Decision|1
888228|NCT00642642|1855987|FG000|Treatment & Follow Up|Adverse Event|2
888229|NCT00642642|1855987|FG000|Treatment & Follow Up|Withdrawal by Subject|5
888230|NCT00642642|1855987|FG000|Treatment & Follow Up|Lost to Follow-up|10
888231|NCT00642668|1855997|FG000|Overall Study|Lost to Follow-up|1
888232|NCT00642668|1855997|FG000|Overall Study|Adverse Event|2
888233|NCT00642668|1855997|FG000|Overall Study|Death|2
888234|NCT00642668|1855997|FG000|Overall Study|Insufficient Therapeutic Response|1
888235|NCT00642668|1855997|FG000|Overall Study|Failure to Return|1
888236|NCT00642668|1855997|FG000|Overall Study|Dialysis Initiation|5
888237|NCT00642668|1855997|FG000|Overall Study|Blood Transfusion|2
888238|NCT00642707|1856014|FG000|Overall Study|Adverse Event|0
888239|NCT00642707|1856015|FG001|Overall Study|Adverse Event|0
888240|NCT00642707|1856016|FG002|Overall Study|Adverse Event|0
888241|NCT00642707|1856017|FG003|Overall Study|Adverse Event|2
888242|NCT00642707|1856014|FG000|Overall Study|Withdrawal by Subject|1
888243|NCT00642707|1856015|FG001|Overall Study|Withdrawal by Subject|0
888244|NCT00642707|1856016|FG002|Overall Study|Withdrawal by Subject|0
888245|NCT00642707|1856017|FG003|Overall Study|Withdrawal by Subject|0
888246|NCT00642746|1856029|FG000|Overall Study|Patient unevaluable|1
888247|NCT00642746|1856030|FG001|Overall Study|Patient unevaluable|0
888248|NCT00642759|1856036|FG000|Overall Study|Protocol Violation|1
888249|NCT00642772|1856041|FG000|Overall Study|Lost to Follow-up|3
888250|NCT00642772|1856041|FG000|Overall Study|Withdrawal by Subject|7
888251|NCT00642811|1856051|FG000|Overall Study|Adverse Event|2
888252|NCT00642811|1856052|FG001|Overall Study|Adverse Event|3
888253|NCT00642811|1856053|FG002|Overall Study|Adverse Event|0
888254|NCT00642811|1856054|FG003|Overall Study|Adverse Event|0
888255|NCT00642811|1856055|FG004|Overall Study|Adverse Event|0
888256|NCT00642811|1856056|FG005|Overall Study|Adverse Event|1
888257|NCT00642811|1856051|FG000|Overall Study|Developement of discontinuation criteria|0
888258|NCT00642811|1856052|FG001|Overall Study|Developement of discontinuation criteria|0
888259|NCT00642811|1856053|FG002|Overall Study|Developement of discontinuation criteria|0
888260|NCT00642811|1856054|FG003|Overall Study|Developement of discontinuation criteria|0
888261|NCT00642811|1856055|FG004|Overall Study|Developement of discontinuation criteria|1
888262|NCT00642811|1856056|FG005|Overall Study|Developement of discontinuation criteria|0
888263|NCT00642811|1856051|FG000|Overall Study|Severe Non-compliance to protocol|1
888264|NCT00642811|1856052|FG001|Overall Study|Severe Non-compliance to protocol|0
888265|NCT00642811|1856053|FG002|Overall Study|Severe Non-compliance to protocol|0
888266|NCT00642811|1856054|FG003|Overall Study|Severe Non-compliance to protocol|0
888267|NCT00642811|1856055|FG004|Overall Study|Severe Non-compliance to protocol|0
888268|NCT00642811|1856056|FG005|Overall Study|Severe Non-compliance to protocol|0
888269|NCT00642811|1856051|FG000|Overall Study|Other|0
888270|NCT00642811|1856052|FG001|Overall Study|Other|1
888271|NCT00642811|1856053|FG002|Overall Study|Other|0
888272|NCT00642811|1856054|FG003|Overall Study|Other|1
888273|NCT00642811|1856055|FG004|Overall Study|Other|0
888274|NCT00642811|1856056|FG005|Overall Study|Other|0
888275|NCT00642850|1856070|FG000|Overall Study|Death|7
888276|NCT00642850|1856070|FG000|Overall Study|Adverse Event|2
888277|NCT00642850|1856070|FG000|Overall Study|Lack of Efficacy|1
888278|NCT00642850|1856070|FG000|Overall Study|Protocol Violation|2
888279|NCT00642850|1856070|FG000|Overall Study|Kidney transplantation|8
888280|NCT00642850|1856070|FG000|Overall Study|Blood transfusion|6
888281|NCT00642850|1856070|FG000|Overall Study|Other reasons|7
888282|NCT00642902|1856078|FG000|Overall Study|Adverse Event|0
888283|NCT00642902|1856079|FG001|Overall Study|Adverse Event|1
888284|NCT00642902|1856080|FG002|Overall Study|Adverse Event|3
888285|NCT00642902|1856081|FG003|Overall Study|Adverse Event|1
888286|NCT00642902|1856078|FG000|Overall Study|Lost to Follow-up|1
888287|NCT00642902|1856079|FG001|Overall Study|Lost to Follow-up|1
888288|NCT00642902|1856080|FG002|Overall Study|Lost to Follow-up|0
888289|NCT00642902|1856081|FG003|Overall Study|Lost to Follow-up|0
888290|NCT00642902|1856078|FG000|Overall Study|Lack of Efficacy|0
888291|NCT00642902|1856079|FG001|Overall Study|Lack of Efficacy|3
888292|NCT00642902|1856080|FG002|Overall Study|Lack of Efficacy|3
888293|NCT00642902|1856081|FG003|Overall Study|Lack of Efficacy|0
888294|NCT00642902|1856078|FG000|Overall Study|Death|1
888295|NCT00642902|1856079|FG001|Overall Study|Death|0
888296|NCT00642902|1856080|FG002|Overall Study|Death|0
888297|NCT00642902|1856081|FG003|Overall Study|Death|0
888298|NCT00642902|1856078|FG000|Overall Study|Premature termination of clinical trial|37
888299|NCT00642902|1856079|FG001|Overall Study|Premature termination of clinical trial|32
888300|NCT00642902|1856080|FG002|Overall Study|Premature termination of clinical trial|35
888301|NCT00642902|1856081|FG003|Overall Study|Premature termination of clinical trial|35
888302|NCT00642902|1856078|FG000|Overall Study|Randomized, but not treated|0
888303|NCT00642902|1856079|FG001|Overall Study|Randomized, but not treated|0
888304|NCT00642902|1856080|FG002|Overall Study|Randomized, but not treated|1
888305|NCT00642902|1856081|FG003|Overall Study|Randomized, but not treated|0
888306|NCT00642902|1856078|FG000|Overall Study|Other|1
888307|NCT00642902|1856079|FG001|Overall Study|Other|5
888308|NCT00642902|1856080|FG002|Overall Study|Other|1
888309|NCT00642902|1856081|FG003|Overall Study|Other|4
888310|NCT00642941|1856103|FG000|Overall Study|Physician Decision|3
888311|NCT00642941|1856104|FG001|Overall Study|Physician Decision|1
888312|NCT00642941|1856105|FG002|Overall Study|Physician Decision|0
888313|NCT00642941|1856106|FG003|Overall Study|Physician Decision|0
888314|NCT00642941|1856107|FG004|Overall Study|Physician Decision|0
888315|NCT00642941|1856108|FG005|Overall Study|Physician Decision|0
888316|NCT00642941|1856109|FG006|Overall Study|Physician Decision|1
888317|NCT00642941|1856110|FG007|Overall Study|Physician Decision|0
888318|NCT00642941|1856111|FG008|Overall Study|Physician Decision|0
888319|NCT00642941|1856112|FG009|Overall Study|Physician Decision|1
888320|NCT00642941|1856113|FG010|Overall Study|Physician Decision|0
888321|NCT00642941|1856114|FG011|Overall Study|Physician Decision|1
888322|NCT00642941|1856103|FG000|Overall Study|Death|4
888323|NCT00642941|1856104|FG001|Overall Study|Death|0
888324|NCT00642941|1856105|FG002|Overall Study|Death|1
888325|NCT00642941|1856106|FG003|Overall Study|Death|1
888326|NCT00642941|1856107|FG004|Overall Study|Death|2
888327|NCT00642941|1856108|FG005|Overall Study|Death|1
888328|NCT00642941|1856109|FG006|Overall Study|Death|0
888329|NCT00642941|1856110|FG007|Overall Study|Death|0
888330|NCT00642941|1856111|FG008|Overall Study|Death|0
888331|NCT00642941|1856112|FG009|Overall Study|Death|0
888332|NCT00642941|1856113|FG010|Overall Study|Death|0
888333|NCT00642941|1856114|FG011|Overall Study|Death|1
888334|NCT00642941|1856103|FG000|Overall Study|Study closed by Sponsor|0
888335|NCT00642941|1856104|FG001|Overall Study|Study closed by Sponsor|1
888336|NCT00642941|1856105|FG002|Overall Study|Study closed by Sponsor|0
888337|NCT00642941|1856106|FG003|Overall Study|Study closed by Sponsor|0
888338|NCT00642941|1856107|FG004|Overall Study|Study closed by Sponsor|0
888339|NCT00642941|1856108|FG005|Overall Study|Study closed by Sponsor|0
888340|NCT00642941|1856109|FG006|Overall Study|Study closed by Sponsor|0
888341|NCT00642941|1856110|FG007|Overall Study|Study closed by Sponsor|0
888342|NCT00642941|1856111|FG008|Overall Study|Study closed by Sponsor|0
888343|NCT00642941|1856112|FG009|Overall Study|Study closed by Sponsor|0
888344|NCT00642941|1856113|FG010|Overall Study|Study closed by Sponsor|0
888345|NCT00642941|1856114|FG011|Overall Study|Study closed by Sponsor|0
888346|NCT00642941|1856103|FG000|Overall Study|Withdrawal by Subject|1
888347|NCT00642941|1856104|FG001|Overall Study|Withdrawal by Subject|0
888348|NCT00642941|1856105|FG002|Overall Study|Withdrawal by Subject|0
888349|NCT00642941|1856106|FG003|Overall Study|Withdrawal by Subject|2
888350|NCT00642941|1856107|FG004|Overall Study|Withdrawal by Subject|0
888351|NCT00642941|1856108|FG005|Overall Study|Withdrawal by Subject|0
888352|NCT00642941|1856109|FG006|Overall Study|Withdrawal by Subject|2
888353|NCT00642941|1856110|FG007|Overall Study|Withdrawal by Subject|0
888354|NCT00642941|1856111|FG008|Overall Study|Withdrawal by Subject|1
888355|NCT00642941|1856112|FG009|Overall Study|Withdrawal by Subject|0
888356|NCT00642941|1856113|FG010|Overall Study|Withdrawal by Subject|0
888357|NCT00642941|1856114|FG011|Overall Study|Withdrawal by Subject|1
888358|NCT00642941|1856103|FG000|Overall Study|Protocol Violation|0
888359|NCT00642941|1856104|FG001|Overall Study|Protocol Violation|0
888360|NCT00642941|1856105|FG002|Overall Study|Protocol Violation|0
888361|NCT00642941|1856106|FG003|Overall Study|Protocol Violation|0
888362|NCT00642941|1856107|FG004|Overall Study|Protocol Violation|0
888363|NCT00642941|1856108|FG005|Overall Study|Protocol Violation|0
888364|NCT00642941|1856109|FG006|Overall Study|Protocol Violation|1
888365|NCT00642941|1856110|FG007|Overall Study|Protocol Violation|0
888366|NCT00642941|1856111|FG008|Overall Study|Protocol Violation|0
888367|NCT00642941|1856112|FG009|Overall Study|Protocol Violation|0
888368|NCT00642941|1856113|FG010|Overall Study|Protocol Violation|0
888369|NCT00642941|1856114|FG011|Overall Study|Protocol Violation|0
888370|NCT00642941|1856103|FG000|Overall Study|Adverse Event|1
888371|NCT00642941|1856104|FG001|Overall Study|Adverse Event|1
888372|NCT00642941|1856105|FG002|Overall Study|Adverse Event|0
888373|NCT00642941|1856106|FG003|Overall Study|Adverse Event|0
888374|NCT00642941|1856107|FG004|Overall Study|Adverse Event|0
888375|NCT00642941|1856108|FG005|Overall Study|Adverse Event|0
888376|NCT00642941|1856109|FG006|Overall Study|Adverse Event|1
888377|NCT00642941|1856110|FG007|Overall Study|Adverse Event|1
888378|NCT00642941|1856111|FG008|Overall Study|Adverse Event|0
888379|NCT00642941|1856112|FG009|Overall Study|Adverse Event|1
888380|NCT00642941|1856113|FG010|Overall Study|Adverse Event|0
888381|NCT00642941|1856114|FG011|Overall Study|Adverse Event|0
888382|NCT00642941|1856103|FG000|Overall Study|Other|1
888383|NCT00642941|1856104|FG001|Overall Study|Other|1
888384|NCT00642941|1856105|FG002|Overall Study|Other|1
888385|NCT00642941|1856106|FG003|Overall Study|Other|1
888386|NCT00642941|1856107|FG004|Overall Study|Other|0
888387|NCT00642941|1856108|FG005|Overall Study|Other|1
888388|NCT00642941|1856109|FG006|Overall Study|Other|0
888389|NCT00642941|1856110|FG007|Overall Study|Other|1
888390|NCT00642941|1856111|FG008|Overall Study|Other|0
888391|NCT00642941|1856112|FG009|Overall Study|Other|0
888392|NCT00642941|1856113|FG010|Overall Study|Other|0
888393|NCT00642941|1856114|FG011|Overall Study|Other|1
888394|NCT00642941|1856103|FG000|Overall Study|Disease progression|60
888395|NCT00642941|1856104|FG001|Overall Study|Disease progression|50
888396|NCT00642941|1856105|FG002|Overall Study|Disease progression|5
888397|NCT00642941|1856106|FG003|Overall Study|Disease progression|36
888398|NCT00642941|1856107|FG004|Overall Study|Disease progression|23
888399|NCT00642941|1856108|FG005|Overall Study|Disease progression|39
888400|NCT00642941|1856109|FG006|Overall Study|Disease progression|18
888401|NCT00642941|1856110|FG007|Overall Study|Disease progression|12
888402|NCT00642941|1856111|FG008|Overall Study|Disease progression|10
888403|NCT00642941|1856112|FG009|Overall Study|Disease progression|7
888404|NCT00642941|1856113|FG010|Overall Study|Disease progression|12
888405|NCT00642941|1856114|FG011|Overall Study|Disease progression|7
888406|NCT00642954|1856166|FG000|Overall Study|Progressive Disease|3
888407|NCT00642954|1856167|FG001|Overall Study|Progressive Disease|3
888408|NCT00642954|1856168|FG002|Overall Study|Progressive Disease|3
888409|NCT00642954|1856169|FG003|Overall Study|Progressive Disease|3
888410|NCT00642954|1856170|FG004|Overall Study|Progressive Disease|9
888411|NCT00642954|1856166|FG000|Overall Study|Withdrawal by Subject|0
888412|NCT00642954|1856167|FG001|Overall Study|Withdrawal by Subject|0
888413|NCT00642954|1856168|FG002|Overall Study|Withdrawal by Subject|0
888414|NCT00642954|1856169|FG003|Overall Study|Withdrawal by Subject|0
888415|NCT00642954|1856170|FG004|Overall Study|Withdrawal by Subject|1
888416|NCT00642954|1856166|FG000|Overall Study|Adverse Event|1
888417|NCT00642954|1856167|FG001|Overall Study|Adverse Event|1
888418|NCT00642954|1856168|FG002|Overall Study|Adverse Event|0
888419|NCT00642954|1856169|FG003|Overall Study|Adverse Event|0
888420|NCT00642954|1856170|FG004|Overall Study|Adverse Event|6
888421|NCT00642993|1856184|FG000|Overall Study|Adverse Event|85
888422|NCT00642993|1856185|FG001|Overall Study|Adverse Event|4
888423|NCT00642993|1856184|FG000|Overall Study|Lost to Follow-up|8
888424|NCT00642993|1856185|FG001|Overall Study|Lost to Follow-up|4
888425|NCT00642993|1856184|FG000|Overall Study|Withdrew - reason unrelated to treatment|11
888426|NCT00642993|1856185|FG001|Overall Study|Withdrew - reason unrelated to treatment|3
888427|NCT00642993|1856184|FG000|Overall Study|Protocol Violation|1
888428|NCT00642993|1856185|FG001|Overall Study|Protocol Violation|4
888429|NCT00642993|1856184|FG000|Overall Study|Did not meet protocol eligibility|0
888430|NCT00642993|1856185|FG001|Overall Study|Did not meet protocol eligibility|1
888431|NCT00642993|1856184|FG000|Overall Study|Administrative|1
888432|NCT00642993|1856185|FG001|Overall Study|Administrative|0
888433|NCT00643006|1856193|FG000|Overall Study|Lost to Follow-up|5
888434|NCT00643006|1856194|FG001|Overall Study|Lost to Follow-up|4
888435|NCT00643123|1856217|FG000|Overall Study|Lost to Follow-up|4
888436|NCT00643123|1856218|FG001|Overall Study|Lost to Follow-up|0
888437|NCT00643123|1856217|FG000|Overall Study|Withdrawal by Subject|1
888438|NCT00643123|1856218|FG001|Overall Study|Withdrawal by Subject|1
888439|NCT00643162|1856226|FG000|Overall Study|Withdrawal by Subject|1
888440|NCT00643162|1856227|FG001|Overall Study|Withdrawal by Subject|1
888441|NCT00643201|1856235|FG000|Randomized, Completed 6 Months of Study|Death|20
888442|NCT00643201|1856236|FG001|Randomized, Completed 6 Months of Study|Death|26
888443|NCT00643201|1856235|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150
888444|NCT00643201|1856236|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182
888445|NCT00643201|1856235|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
888446|NCT00643201|1856236|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
888447|NCT00643201|1856235|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
888448|NCT00643201|1856236|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
888449|NCT00643201|1856235|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
888450|NCT00643201|1856236|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
888451|NCT00643201|1856235|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3
888452|NCT00643201|1856236|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2
888453|NCT00643201|1856235|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
888454|NCT00643201|1856236|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
888455|NCT00643201|1856235|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1
888456|NCT00643201|1856236|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1
888457|NCT00643201|1856235|FG000|Randomized, Completed 6 Months of Study|Other|107
888458|NCT00643201|1856236|FG001|Randomized, Completed 6 Months of Study|Other|107
888459|NCT00643201|1856235|FG000|Completed Study Follow Up|Death|28
888460|NCT00643201|1856236|FG001|Completed Study Follow Up|Death|34
888461|NCT00643201|1856235|FG000|Completed Study Follow Up|Withdrawal by Subject|23
888462|NCT00643201|1856236|FG001|Completed Study Follow Up|Withdrawal by Subject|29
888463|NCT00643201|1856235|FG000|Completed Study Follow Up|Lost to Follow-up|18
888464|NCT00643201|1856236|FG001|Completed Study Follow Up|Lost to Follow-up|16
888465|NCT00643201|1856235|FG000|Completed Study Follow Up|non-specified|1
888466|NCT00643201|1856236|FG001|Completed Study Follow Up|non-specified|0
888467|NCT00643279|1856246|FG000|Overall Study|Death|13
888468|NCT00643279|1856247|FG001|Overall Study|Death|11
888469|NCT00643279|1856246|FG000|Overall Study|Withdrawal by Subject|3
888470|NCT00643279|1856247|FG001|Overall Study|Withdrawal by Subject|0
888471|NCT00643279|1856246|FG000|Overall Study|Lost to Follow-up|0
888472|NCT00643279|1856247|FG001|Overall Study|Lost to Follow-up|1
888473|NCT00643279|1856246|FG000|Overall Study|Physician Decision|0
888474|NCT00643279|1856247|FG001|Overall Study|Physician Decision|1
888475|NCT00643448|1856258|FG000|Overall Study|Lack of Efficacy|2
888476|NCT00643448|1856259|FG001|Overall Study|Lack of Efficacy|0
888477|NCT00643448|1856260|FG002|Overall Study|Lack of Efficacy|4
888478|NCT00643448|1856258|FG000|Overall Study|Adverse Event|2
888479|NCT00643448|1856259|FG001|Overall Study|Adverse Event|2
888480|NCT00643448|1856260|FG002|Overall Study|Adverse Event|2
888481|NCT00643448|1856258|FG000|Overall Study|QTcF>550 ms|0
888482|NCT00643448|1856259|FG001|Overall Study|QTcF>550 ms|3
888483|NCT00643448|1856260|FG002|Overall Study|QTcF>550 ms|0
888484|NCT00643487|1856270|FG000|Overall Study|Technical difficulty|3
888485|NCT00643565|1856276|FG000|Overall Study|Death|12
888486|NCT00643565|1856277|FG001|Overall Study|Death|11
888487|NCT00643565|1856276|FG000|Overall Study|Withdrawal by Subject|4
888488|NCT00643565|1856277|FG001|Overall Study|Withdrawal by Subject|1
888489|NCT00643565|1856276|FG000|Overall Study|Lost to Follow-up|0
888490|NCT00643565|1856277|FG001|Overall Study|Lost to Follow-up|6
888491|NCT00643565|1856276|FG000|Overall Study|Other|7
888492|NCT00643565|1856277|FG001|Overall Study|Other|8
888493|NCT00643565|1856276|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0
888494|NCT00643565|1856277|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1
888495|NCT00643565|1856276|FG000|Overall Study|Recurrence of Disease|2
888496|NCT00643565|1856277|FG001|Overall Study|Recurrence of Disease|1
888497|NCT00643565|1856276|FG000|Overall Study|Progression of Disease|18
888498|NCT00643565|1856277|FG001|Overall Study|Progression of Disease|14
888499|NCT00643565|1856276|FG000|Overall Study|Protocol Violation|3
888500|NCT00643565|1856277|FG001|Overall Study|Protocol Violation|0
888501|NCT00643565|1856276|FG000|Overall Study|Did Not Cooperate|0
888502|NCT00643565|1856277|FG001|Overall Study|Did Not Cooperate|1
888503|NCT00643565|1856276|FG000|Overall Study|Administrative|22
888504|NCT00643565|1856277|FG001|Overall Study|Administrative|16
888505|NCT00643565|1856276|FG000|Overall Study|Adverse Event|5
888506|NCT00643565|1856277|FG001|Overall Study|Adverse Event|8
888507|NCT00643604|1856293|FG000|Overall Study|Death|1
888508|NCT00643682|1856299|FG000|Overall Study|did not keep appointment|522
888509|NCT00643682|1856300|FG001|Overall Study|did not keep appointment|509
888510|NCT00643760|1856311|FG000|Overall Study|Adverse Event|11
888511|NCT00643760|1856312|FG001|Overall Study|Adverse Event|5
888512|NCT00643760|1856313|FG002|Overall Study|Adverse Event|12
888513|NCT00643760|1856314|FG003|Overall Study|Adverse Event|21
888514|NCT00643760|1856315|FG004|Overall Study|Adverse Event|6
888515|NCT00643760|1856311|FG000|Overall Study|Lack of Efficacy|3
888516|NCT00643760|1856312|FG001|Overall Study|Lack of Efficacy|1
888517|NCT00643760|1856313|FG002|Overall Study|Lack of Efficacy|0
888518|NCT00643760|1856314|FG003|Overall Study|Lack of Efficacy|4
888519|NCT00643760|1856315|FG004|Overall Study|Lack of Efficacy|3
888520|NCT00643760|1856311|FG000|Overall Study|Protocol Violation|7
888521|NCT00643760|1856312|FG001|Overall Study|Protocol Violation|6
888522|NCT00643760|1856313|FG002|Overall Study|Protocol Violation|4
888523|NCT00643760|1856314|FG003|Overall Study|Protocol Violation|4
888524|NCT00643760|1856315|FG004|Overall Study|Protocol Violation|6
888525|NCT00643760|1856311|FG000|Overall Study|Lost to Follow-up|6
888526|NCT00643760|1856312|FG001|Overall Study|Lost to Follow-up|2
888527|NCT00643760|1856313|FG002|Overall Study|Lost to Follow-up|1
888528|NCT00643760|1856314|FG003|Overall Study|Lost to Follow-up|3
888529|NCT00643760|1856315|FG004|Overall Study|Lost to Follow-up|3
888530|NCT00643760|1856311|FG000|Overall Study|Investigator Discretion|0
888531|NCT00643760|1856312|FG001|Overall Study|Investigator Discretion|0
888532|NCT00643760|1856313|FG002|Overall Study|Investigator Discretion|0
888533|NCT00643760|1856314|FG003|Overall Study|Investigator Discretion|2
888534|NCT00643760|1856315|FG004|Overall Study|Investigator Discretion|0
888535|NCT00643760|1856311|FG000|Overall Study|Withdrawal by Subject|3
888536|NCT00643760|1856312|FG001|Overall Study|Withdrawal by Subject|1
888537|NCT00643760|1856313|FG002|Overall Study|Withdrawal by Subject|2
888538|NCT00643760|1856314|FG003|Overall Study|Withdrawal by Subject|4
888539|NCT00643760|1856315|FG004|Overall Study|Withdrawal by Subject|1
888540|NCT00643851|1856330|FG000|Overall Study|Death|0
888541|NCT00643851|1856331|FG001|Overall Study|Death|1
888542|NCT00643851|1856332|FG002|Overall Study|Death|0
888543|NCT00643851|1856330|FG000|Overall Study|Lack of Efficacy|0
888544|NCT00643851|1856331|FG001|Overall Study|Lack of Efficacy|1
888545|NCT00643851|1856332|FG002|Overall Study|Lack of Efficacy|0
888546|NCT00643851|1856330|FG000|Overall Study|Adverse Event|2
888547|NCT00643851|1856331|FG001|Overall Study|Adverse Event|6
888548|NCT00643851|1856332|FG002|Overall Study|Adverse Event|6
888549|NCT00643851|1856330|FG000|Overall Study|Lost to Follow-up|4
888550|NCT00643851|1856331|FG001|Overall Study|Lost to Follow-up|6
888551|NCT00643851|1856332|FG002|Overall Study|Lost to Follow-up|9
888552|NCT00643851|1856330|FG000|Overall Study|Withdrawal by Subject|8
888553|NCT00643851|1856331|FG001|Overall Study|Withdrawal by Subject|15
888554|NCT00643851|1856332|FG002|Overall Study|Withdrawal by Subject|9
888555|NCT00643851|1856330|FG000|Overall Study|Non-compl., not met criteria, etc.|3
888556|NCT00643851|1856331|FG001|Overall Study|Non-compl., not met criteria, etc.|4
888557|NCT00643851|1856332|FG002|Overall Study|Non-compl., not met criteria, etc.|6
888558|NCT00643916|1856351|FG000|Overall Study|Protocol Violation|0
888559|NCT00643916|1856352|FG001|Overall Study|Protocol Violation|1
888560|NCT00643916|1856353|FG002|Overall Study|Protocol Violation|1
888561|NCT00643916|1856354|FG003|Overall Study|Protocol Violation|1
888562|NCT00643916|1856355|FG004|Overall Study|Protocol Violation|0
888563|NCT00643916|1856356|FG005|Overall Study|Protocol Violation|0
888564|NCT00643916|1856351|FG000|Overall Study|Lost to Follow-up|0
888565|NCT00643916|1856352|FG001|Overall Study|Lost to Follow-up|1
888566|NCT00643916|1856353|FG002|Overall Study|Lost to Follow-up|0
888567|NCT00643916|1856354|FG003|Overall Study|Lost to Follow-up|0
888568|NCT00643916|1856355|FG004|Overall Study|Lost to Follow-up|0
888569|NCT00643916|1856356|FG005|Overall Study|Lost to Follow-up|0
888570|NCT00643916|1856351|FG000|Overall Study|Withdrawal by Subject|2
888571|NCT00643916|1856352|FG001|Overall Study|Withdrawal by Subject|2
888572|NCT00643916|1856353|FG002|Overall Study|Withdrawal by Subject|2
888573|NCT00643916|1856354|FG003|Overall Study|Withdrawal by Subject|1
888574|NCT00643916|1856355|FG004|Overall Study|Withdrawal by Subject|0
888575|NCT00643916|1856356|FG005|Overall Study|Withdrawal by Subject|1
888576|NCT00643916|1856351|FG000|Overall Study|Not Vaccinated|2
888577|NCT00643916|1856352|FG001|Overall Study|Not Vaccinated|2
888578|NCT00643916|1856353|FG002|Overall Study|Not Vaccinated|3
888579|NCT00643916|1856354|FG003|Overall Study|Not Vaccinated|0
888580|NCT00643916|1856355|FG004|Overall Study|Not Vaccinated|2
888581|NCT00643916|1856356|FG005|Overall Study|Not Vaccinated|0
888582|NCT00644059|1856373|FG000|Overall Study|Lost to Follow-up|37
888583|NCT00644059|1856374|FG001|Overall Study|Lost to Follow-up|34
888584|NCT00644059|1856375|FG002|Overall Study|Lost to Follow-up|16
888585|NCT00644059|1856373|FG000|Overall Study|Withdrawal by Subject|52
888586|NCT00644059|1856374|FG001|Overall Study|Withdrawal by Subject|60
888587|NCT00644059|1856375|FG002|Overall Study|Withdrawal by Subject|30
888588|NCT00644059|1856373|FG000|Overall Study|Adverse Event|8
888589|NCT00644059|1856374|FG001|Overall Study|Adverse Event|5
888590|NCT00644059|1856375|FG002|Overall Study|Adverse Event|1
888591|NCT00644059|1856373|FG000|Overall Study|Inappropriate Enrollment|1
888592|NCT00644059|1856374|FG001|Overall Study|Inappropriate Enrollment|3
888593|NCT00644059|1856375|FG002|Overall Study|Inappropriate Enrollment|0
888594|NCT00644059|1856373|FG000|Overall Study|Protocol Deviation/violation|20
888595|NCT00644059|1856374|FG001|Overall Study|Protocol Deviation/violation|19
888596|NCT00644059|1856375|FG002|Overall Study|Protocol Deviation/violation|15
888597|NCT00644059|1856373|FG000|Overall Study|Unable to classify|6
888598|NCT00644059|1856374|FG001|Overall Study|Unable to classify|2
888599|NCT00644059|1856375|FG002|Overall Study|Unable to classify|3
888600|NCT00644228|1856435|FG000|Randomization & Eligibility|Ineligible|31
888601|NCT00644228|1856436|FG001|Randomization & Eligibility|Ineligible|21
888602|NCT00644228|1856435|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
888603|NCT00644228|1856436|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
888604|NCT00644228|1856435|FG000|Randomization & Eligibility|Invalid Consent|0
888605|NCT00644228|1856436|FG001|Randomization & Eligibility|Invalid Consent|1
888606|NCT00644228|1856435|FG000|Induction Therapy|Adverse Event|22
888607|NCT00644228|1856436|FG001|Induction Therapy|Adverse Event|55
888608|NCT00644228|1856435|FG000|Induction Therapy|Withdrawal by Subject|10
888609|NCT00644228|1856436|FG001|Induction Therapy|Withdrawal by Subject|3
888610|NCT00644228|1856435|FG000|Induction Therapy|Progression/Relapse|24
888611|NCT00644228|1856436|FG001|Induction Therapy|Progression/Relapse|12
888612|NCT00644228|1856435|FG000|Induction Therapy|Death|3
888613|NCT00644228|1856436|FG001|Induction Therapy|Death|7
888614|NCT00644228|1856435|FG000|Induction Therapy|Not Protocol-Specified|24
888615|NCT00644228|1856436|FG001|Induction Therapy|Not Protocol-Specified|28
888616|NCT00644228|1856435|FG000|Maintenance|Adverse Event|27
888617|NCT00644228|1856436|FG001|Maintenance|Adverse Event|31
888618|NCT00644228|1856435|FG000|Maintenance|Withdrawal by Subject|6
888619|NCT00644228|1856436|FG001|Maintenance|Withdrawal by Subject|4
888620|NCT00644228|1856435|FG000|Maintenance|Progression/Relapse|67
888621|NCT00644228|1856436|FG001|Maintenance|Progression/Relapse|42
888622|NCT00644228|1856435|FG000|Maintenance|Death|3
888623|NCT00644228|1856436|FG001|Maintenance|Death|3
888624|NCT00644228|1856435|FG000|Maintenance|Not Protocol-Specified|14
888625|NCT00644228|1856436|FG001|Maintenance|Not Protocol-Specified|15
888626|NCT00644228|1856435|FG000|Maintenance|On Treatment|26
888627|NCT00644228|1856436|FG001|Maintenance|On Treatment|40
888628|NCT00644332|1856451|FG000|Overall Study|Adverse Event|11
888629|NCT00644332|1856451|FG000|Overall Study|Withdrawal by Subject|6
888630|NCT00644332|1856451|FG000|Overall Study|Completion Status Unknown|2
888631|NCT00644332|1856451|FG000|Overall Study|Did Not Meet Eligibility Requirements|1
888632|NCT00644332|1856451|FG000|Overall Study|Could Not Attend Scheduled Visits|1
888633|NCT00644358|1856455|FG000|Overall Study|Adverse Event|124
888634|NCT00644358|1856455|FG000|Overall Study|Lost to Follow-up|105
888635|NCT00644358|1856455|FG000|Overall Study|Consent Withdrawal|64
888636|NCT00644358|1856455|FG000|Overall Study|Lack of Effectiveness|39
888637|NCT00644358|1856455|FG000|Overall Study|Protocol Violation|5
888638|NCT00644358|1856455|FG000|Overall Study|Noncompliance|14
888639|NCT00644358|1856455|FG000|Overall Study|Other Unspecified|11
888640|NCT00644423|1856461|FG000|Overall Study|Lost to Follow-up|1
888641|NCT00644423|1856462|FG001|Overall Study|Lost to Follow-up|1
888642|NCT00644787|1856481|FG000|Period 1: Titration Phase|Adverse Event|11
888643|NCT00644787|1856482|FG001|Period 1: Titration Phase|Adverse Event|0
888644|NCT00644787|1856483|FG002|Period 1: Titration Phase|Adverse Event|0
888645|NCT00644787|1856481|FG000|Period 1: Titration Phase|Withdrawal by Subject|2
888646|NCT00644787|1856482|FG001|Period 1: Titration Phase|Withdrawal by Subject|0
888647|NCT00644787|1856483|FG002|Period 1: Titration Phase|Withdrawal by Subject|0
888648|NCT00644787|1856481|FG000|Period 1: Titration Phase|Physician Decision|1
888649|NCT00644787|1856482|FG001|Period 1: Titration Phase|Physician Decision|0
888650|NCT00644787|1856483|FG002|Period 1: Titration Phase|Physician Decision|0
888651|NCT00644787|1856481|FG000|Period 1: Titration Phase|Worsening of underlying disease|5
888652|NCT00644787|1856482|FG001|Period 1: Titration Phase|Worsening of underlying disease|0
888653|NCT00644787|1856483|FG002|Period 1: Titration Phase|Worsening of underlying disease|0
888654|NCT00644787|1856481|FG000|Period 1: Titration Phase|Worsening of complications|1
888655|NCT00644787|1856482|FG001|Period 1: Titration Phase|Worsening of complications|0
888656|NCT00644787|1856483|FG002|Period 1: Titration Phase|Worsening of complications|0
888657|NCT00644787|1856481|FG000|Period 1: Titration Phase|Worsening of symptoms|1
888658|NCT00644787|1856482|FG001|Period 1: Titration Phase|Worsening of symptoms|0
888659|NCT00644787|1856483|FG002|Period 1: Titration Phase|Worsening of symptoms|0
888660|NCT00644787|1856481|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
888661|NCT00644787|1856482|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
888662|NCT00644787|1856483|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
888663|NCT00644787|1856481|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3
1006591|NCT01468701|2025300|FG015|Overall Study|Other reasons than listed|172
888664|NCT00644787|1856482|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0
888665|NCT00644787|1856483|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0
888666|NCT00644787|1856481|FG000|Period 2: Double Blind Phase|Adverse Event|0
888667|NCT00644787|1856482|FG001|Period 2: Double Blind Phase|Adverse Event|2
888668|NCT00644787|1856483|FG002|Period 2: Double Blind Phase|Adverse Event|4
888669|NCT00644787|1856481|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0
888670|NCT00644787|1856482|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1
888671|NCT00644787|1856483|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0
888672|NCT00644787|1856481|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0
888673|NCT00644787|1856482|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6
888674|NCT00644787|1856483|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2
888675|NCT00644787|1856481|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0
888676|NCT00644787|1856482|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0
888677|NCT00644787|1856483|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1
888678|NCT00644878|1856491|FG000|Overall Study|Adverse Event|2
888679|NCT00644878|1856491|FG000|Overall Study|Abnormal laboratory value|3
888680|NCT00644878|1856491|FG000|Overall Study|Protocol deviation|2
888681|NCT00644878|1856491|FG000|Overall Study|Treatment duration completed as per protocol|11
888682|NCT00644917|1856495|FG000|Overall Study|Withdrawal by Subject|2
888683|NCT00644969|1856505|FG000|Treatment Phase|Randomized, not treated|1
888684|NCT00644969|1856506|FG001|Treatment Phase|Randomized, not treated|0
888685|NCT00644969|1856505|FG000|Treatment Phase|Adverse Event|3
888686|NCT00644969|1856506|FG001|Treatment Phase|Adverse Event|0
888687|NCT00644969|1856505|FG000|Treatment Phase|Withdrawal by Subject|4
888688|NCT00644969|1856506|FG001|Treatment Phase|Withdrawal by Subject|0
888689|NCT00644969|1856505|FG000|Treatment Phase|Lost to Follow-up|2
888690|NCT00644969|1856506|FG001|Treatment Phase|Lost to Follow-up|2
888691|NCT00644969|1856505|FG000|Treatment Phase|Other|4
888692|NCT00644969|1856506|FG001|Treatment Phase|Other|1
888693|NCT00644969|1856505|FG000|Post Treatment Phase|Death|1
888694|NCT00644969|1856506|FG001|Post Treatment Phase|Death|0
888695|NCT00644969|1856505|FG000|Post Treatment Phase|Withdrawal by Subject|4
888696|NCT00644969|1856506|FG001|Post Treatment Phase|Withdrawal by Subject|2
888697|NCT00644969|1856505|FG000|Post Treatment Phase|Lost to Follow-up|4
888698|NCT00644969|1856506|FG001|Post Treatment Phase|Lost to Follow-up|1
888699|NCT00644969|1856505|FG000|Post Treatment Phase|Other|1
888700|NCT00644969|1856506|FG001|Post Treatment Phase|Other|0
888701|NCT00644995|1856514|FG000|Overall Study|Lost to Follow-up|1
888702|NCT00644995|1856515|FG001|Overall Study|Lost to Follow-up|4
888703|NCT00644995|1856514|FG000|Overall Study|Refused|1
888704|NCT00644995|1856515|FG001|Overall Study|Refused|0
888705|NCT00645099|1856534|FG000|Overall Study|Lack of Efficacy|15
888706|NCT00645099|1856535|FG001|Overall Study|Lack of Efficacy|6
888707|NCT00645099|1856534|FG000|Overall Study|Withdrawal by Subject|30
888708|NCT00645099|1856535|FG001|Overall Study|Withdrawal by Subject|22
888709|NCT00645099|1856534|FG000|Overall Study|Lost to Follow-up|6
888710|NCT00645099|1856535|FG001|Overall Study|Lost to Follow-up|4
888711|NCT00645099|1856534|FG000|Overall Study|Adverse Event|11
888712|NCT00645099|1856535|FG001|Overall Study|Adverse Event|5
888713|NCT00645099|1856534|FG000|Overall Study|Other|9
888714|NCT00645099|1856535|FG001|Overall Study|Other|5
888715|NCT00645164|1856541|FG000|Overall Study|Lost to Follow-up|2
888716|NCT00645164|1856541|FG000|Overall Study|Withdrawal by Subject|4
888717|NCT00645164|1856541|FG000|Overall Study|Protocol Violation|1
888718|NCT00645411|1856553|FG000|Overall Study|Adverse Event|0
888719|NCT00645411|1856554|FG001|Overall Study|Adverse Event|0
888720|NCT00645411|1856555|FG002|Overall Study|Adverse Event|0
888721|NCT00645411|1856556|FG003|Overall Study|Adverse Event|2
888722|NCT00645411|1856553|FG000|Overall Study|Withdrawal by Subject|2
888723|NCT00645411|1856554|FG001|Overall Study|Withdrawal by Subject|1
888724|NCT00645411|1856555|FG002|Overall Study|Withdrawal by Subject|19
888725|NCT00645411|1856556|FG003|Overall Study|Withdrawal by Subject|21
888726|NCT00645411|1856553|FG000|Overall Study|Lost to Follow-up|10
888727|NCT00645411|1856554|FG001|Overall Study|Lost to Follow-up|5
888728|NCT00645411|1856555|FG002|Overall Study|Lost to Follow-up|124
888729|NCT00645411|1856556|FG003|Overall Study|Lost to Follow-up|75
888730|NCT00645411|1856553|FG000|Overall Study|Protocol Violation|1
888731|NCT00645411|1856554|FG001|Overall Study|Protocol Violation|0
888732|NCT00645411|1856555|FG002|Overall Study|Protocol Violation|1
888733|NCT00645411|1856556|FG003|Overall Study|Protocol Violation|0
888734|NCT00645411|1856553|FG000|Overall Study|Inappropriate enrollment|0
888735|NCT00645411|1856554|FG001|Overall Study|Inappropriate enrollment|0
888736|NCT00645411|1856555|FG002|Overall Study|Inappropriate enrollment|4
888737|NCT00645411|1856556|FG003|Overall Study|Inappropriate enrollment|1
888738|NCT00645411|1856553|FG000|Overall Study|Unable to classify|0
888739|NCT00645411|1856554|FG001|Overall Study|Unable to classify|0
888740|NCT00645411|1856555|FG002|Overall Study|Unable to classify|3
888741|NCT00645411|1856556|FG003|Overall Study|Unable to classify|4
888742|NCT00645528|1856582|FG000|Overall Study|Did not show up for Visit 2|7
888743|NCT00645593|1856588|FG000|Overall Study|Later found to be ineligible|1
888744|NCT00645593|1856589|FG001|Overall Study|Later found to be ineligible|0
888745|NCT00645671|1856597|FG000|Overall Study|Protocol Violation|1
888746|NCT00645671|1856598|FG001|Overall Study|Protocol Violation|0
888747|NCT00645671|1856597|FG000|Overall Study|Withdrawal by Subject|0
888748|NCT00645671|1856598|FG001|Overall Study|Withdrawal by Subject|4
888749|NCT00645671|1856597|FG000|Overall Study|Adverse Event|0
888750|NCT00645671|1856598|FG001|Overall Study|Adverse Event|1
888751|NCT00645671|1856597|FG000|Overall Study|Physician Decision|0
888752|NCT00645671|1856598|FG001|Overall Study|Physician Decision|1
888753|NCT00645788|1856628|FG000|Overall Study|Did not receive study drug|1
888754|NCT00645788|1856629|FG001|Overall Study|Did not receive study drug|1
888755|NCT00645788|1856630|FG002|Overall Study|Did not receive study drug|0
888756|NCT00645788|1856631|FG003|Overall Study|Did not receive study drug|0
888757|NCT00645788|1856628|FG000|Overall Study|Adverse Event|4
888758|NCT00645788|1856629|FG001|Overall Study|Adverse Event|9
888759|NCT00645788|1856630|FG002|Overall Study|Adverse Event|5
888760|NCT00645788|1856631|FG003|Overall Study|Adverse Event|3
888761|NCT00645788|1856628|FG000|Overall Study|Lost to Follow-up|1
888762|NCT00645788|1856629|FG001|Overall Study|Lost to Follow-up|0
888763|NCT00645788|1856630|FG002|Overall Study|Lost to Follow-up|0
888764|NCT00645788|1856631|FG003|Overall Study|Lost to Follow-up|0
888765|NCT00645788|1856628|FG000|Overall Study|Protocol Violation|1
888766|NCT00645788|1856629|FG001|Overall Study|Protocol Violation|0
888767|NCT00645788|1856630|FG002|Overall Study|Protocol Violation|2
888768|NCT00645788|1856631|FG003|Overall Study|Protocol Violation|0
888769|NCT00645788|1856628|FG000|Overall Study|Withdrawal by Subject|0
888770|NCT00645788|1856629|FG001|Overall Study|Withdrawal by Subject|1
888771|NCT00645788|1856630|FG002|Overall Study|Withdrawal by Subject|0
888772|NCT00645788|1856631|FG003|Overall Study|Withdrawal by Subject|2
888773|NCT00645788|1856628|FG000|Overall Study|Pulmonary exacerbation|13
888774|NCT00645788|1856629|FG001|Overall Study|Pulmonary exacerbation|16
888775|NCT00645788|1856630|FG002|Overall Study|Pulmonary exacerbation|11
888776|NCT00645788|1856631|FG003|Overall Study|Pulmonary exacerbation|9
888777|NCT00645840|1856650|FG000|Overall Study|Protocol Violation|3
888778|NCT00645853|1856656|FG000|Overall Study|Adverse Event|18
888779|NCT00645853|1856657|FG001|Overall Study|Adverse Event|7
888780|NCT00645853|1856656|FG000|Overall Study|AZ study closure in Hungary|60
888781|NCT00645853|1856657|FG001|Overall Study|AZ study closure in Hungary|40
888782|NCT00645853|1856656|FG000|Overall Study|Withdrawal by Subject|5
888783|NCT00645853|1856657|FG001|Overall Study|Withdrawal by Subject|2
888784|NCT00645853|1856656|FG000|Overall Study|Protocol Violation|0
888785|NCT00645853|1856657|FG001|Overall Study|Protocol Violation|2
888786|NCT00645853|1856656|FG000|Overall Study|Discontinuation criteria|2
888787|NCT00645853|1856657|FG001|Overall Study|Discontinuation criteria|2
888788|NCT00645853|1856656|FG000|Overall Study|recall of ICF, planned operation, death|7
888789|NCT00645853|1856657|FG001|Overall Study|recall of ICF, planned operation, death|4
888790|NCT00645944|1856665|FG000|Randomized|Withdrawal by Subject|1
888791|NCT00645944|1856666|FG001|Randomized|Withdrawal by Subject|2
888792|NCT00645944|1856665|FG000|Received Medication|Adverse Event|2
888793|NCT00645944|1856666|FG001|Received Medication|Adverse Event|1
888794|NCT00645944|1856665|FG000|Received Medication|Withdrawal by Subject|1
888795|NCT00645944|1856666|FG001|Received Medication|Withdrawal by Subject|1
888796|NCT00645944|1856665|FG000|Received Medication|Lost to Follow-up|1
888797|NCT00645944|1856666|FG001|Received Medication|Lost to Follow-up|0
888798|NCT00645944|1856665|FG000|Received Medication|Protocol Violation|2
888799|NCT00645944|1856666|FG001|Received Medication|Protocol Violation|1
888800|NCT00646113|1856685|FG000|Overall Study|Lost to Follow-up|5
888801|NCT00646113|1856685|FG000|Overall Study|Adverse Event|3
888802|NCT00646399|1856691|FG000|Overall Study|Death|63
888803|NCT00646399|1856692|FG001|Overall Study|Death|53
888804|NCT00646399|1856691|FG000|Overall Study|Withdrawal by Subject|9
888805|NCT00646399|1856692|FG001|Overall Study|Withdrawal by Subject|10
888806|NCT00646399|1856691|FG000|Overall Study|Other Reason|11
888807|NCT00646399|1856692|FG001|Overall Study|Other Reason|11
888808|NCT00646451|1856698|FG000|Overall Study|Adverse Event|3
888809|NCT00646451|1856699|FG001|Overall Study|Adverse Event|0
888810|NCT00646451|1856698|FG000|Overall Study|Exacerbation of pre-existing condition|1
888811|NCT00646451|1856699|FG001|Overall Study|Exacerbation of pre-existing condition|0
888812|NCT00646776|1856744|FG000|Overall Study|Adverse Event|1
888813|NCT00646776|1856745|FG001|Overall Study|Adverse Event|9
888814|NCT00646776|1856744|FG000|Overall Study|Investigator discretion|0
888815|NCT00646776|1856745|FG001|Overall Study|Investigator discretion|4
888816|NCT00646906|1856758|FG000|Crossover Period 1|Withdrawal by Subject|1
888817|NCT00646906|1856759|FG001|Crossover Period 1|Withdrawal by Subject|0
888818|NCT00646906|1856760|FG002|Crossover Period 1|Withdrawal by Subject|0
888819|NCT00646906|1856761|FG003|Crossover Period 1|Withdrawal by Subject|0
888820|NCT00646906|1856762|FG004|Crossover Period 1|Withdrawal by Subject|0
888821|NCT00646906|1856763|FG005|Crossover Period 1|Withdrawal by Subject|1
888822|NCT00646906|1856764|FG006|Crossover Period 1|Withdrawal by Subject|0
888823|NCT00646906|1856758|FG000|Crossover Period 2|Withdrawal by Subject|0
888824|NCT00646906|1856759|FG001|Crossover Period 2|Withdrawal by Subject|1
888825|NCT00646906|1856760|FG002|Crossover Period 2|Withdrawal by Subject|2
888826|NCT00646906|1856761|FG003|Crossover Period 2|Withdrawal by Subject|1
888827|NCT00646906|1856762|FG004|Crossover Period 2|Withdrawal by Subject|0
888828|NCT00646906|1856763|FG005|Crossover Period 2|Withdrawal by Subject|0
888829|NCT00646906|1856764|FG006|Crossover Period 2|Withdrawal by Subject|0
888830|NCT00646906|1856758|FG000|Crossover Period 2|Physician Decision|0
888831|NCT00646906|1856759|FG001|Crossover Period 2|Physician Decision|0
888832|NCT00646906|1856760|FG002|Crossover Period 2|Physician Decision|0
888833|NCT00646906|1856761|FG003|Crossover Period 2|Physician Decision|0
888834|NCT00646906|1856762|FG004|Crossover Period 2|Physician Decision|0
888835|NCT00646906|1856763|FG005|Crossover Period 2|Physician Decision|0
888836|NCT00646906|1856764|FG006|Crossover Period 2|Physician Decision|1
888837|NCT00646958|1856780|FG000|Overall Study|Lack of Efficacy|1
888838|NCT00646958|1856781|FG001|Overall Study|Lack of Efficacy|0
888839|NCT00646958|1856782|FG002|Overall Study|Lack of Efficacy|0
888840|NCT00646958|1856780|FG000|Overall Study|Adverse Event|4
888841|NCT00646958|1856781|FG001|Overall Study|Adverse Event|0
888842|NCT00646958|1856782|FG002|Overall Study|Adverse Event|0
888843|NCT00646958|1856780|FG000|Overall Study|Lost to Follow-up|1
888844|NCT00646958|1856781|FG001|Overall Study|Lost to Follow-up|5
888845|NCT00646958|1856782|FG002|Overall Study|Lost to Follow-up|7
888846|NCT00646958|1856780|FG000|Overall Study|Protocol Violation|1
888847|NCT00646958|1856781|FG001|Overall Study|Protocol Violation|1
888848|NCT00646958|1856782|FG002|Overall Study|Protocol Violation|0
888849|NCT00646958|1856780|FG000|Overall Study|Abnormal screening lab tests|1
888850|NCT00646958|1856781|FG001|Overall Study|Abnormal screening lab tests|1
888851|NCT00646958|1856782|FG002|Overall Study|Abnormal screening lab tests|0
888852|NCT00646958|1856780|FG000|Overall Study|Withdrawal by Subject|1
888853|NCT00646958|1856781|FG001|Overall Study|Withdrawal by Subject|2
888854|NCT00646958|1856782|FG002|Overall Study|Withdrawal by Subject|0
888855|NCT00646958|1856780|FG000|Overall Study|Did not receive study drug|2
888856|NCT00646958|1856781|FG001|Overall Study|Did not receive study drug|0
888857|NCT00646958|1856782|FG002|Overall Study|Did not receive study drug|2
888858|NCT00647270|1856793|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
888859|NCT00647270|1856794|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
888860|NCT00647270|1856795|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
888861|NCT00647270|1856793|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
888862|NCT00647270|1856794|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
888863|NCT00647270|1856795|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
888864|NCT00647270|1856793|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
888865|NCT00647270|1856794|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
888866|NCT00647270|1856795|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
888867|NCT00647270|1856793|FG000|Period 1, Placebo-control (12 Weeks)|Other|4
888868|NCT00647270|1856794|FG001|Period 1, Placebo-control (12 Weeks)|Other|4
888869|NCT00647270|1856795|FG002|Period 1, Placebo-control (12 Weeks)|Other|8
888870|NCT00647270|1856793|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
888871|NCT00647270|1856794|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
888872|NCT00647270|1856795|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
888873|NCT00647270|1856793|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
888874|NCT00647270|1856794|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
888875|NCT00647270|1856795|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
888876|NCT00647270|1856793|FG000|Period 2, Placebo Switched to Adalimumab|Other|2
888877|NCT00647270|1856794|FG001|Period 2, Placebo Switched to Adalimumab|Other|6
888878|NCT00647270|1856795|FG002|Period 2, Placebo Switched to Adalimumab|Other|0
888879|NCT00647296|1856810|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
888880|NCT00647296|1856811|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
888881|NCT00647296|1856812|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
888882|NCT00647296|1856813|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1
888883|NCT00647296|1856810|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
888884|NCT00647296|1856811|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
888885|NCT00647296|1856812|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
888886|NCT00647296|1856813|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
888887|NCT00647296|1856810|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
888888|NCT00647296|1856811|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1
888889|NCT00647296|1856812|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
888890|NCT00647296|1856813|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
888891|NCT00647296|1856810|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1
888892|NCT00647296|1856811|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
888893|NCT00647296|1856812|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
888894|NCT00647296|1856813|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
888895|NCT00647296|1856810|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1
888896|NCT00647296|1856811|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
888897|NCT00647296|1856812|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
888898|NCT00647296|1856813|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
888899|NCT00647296|1856810|FG000|Part 2: 4-week Placebo Washout|Death|3
888900|NCT00647296|1856811|FG001|Part 2: 4-week Placebo Washout|Death|0
888901|NCT00647296|1856812|FG002|Part 2: 4-week Placebo Washout|Death|0
888902|NCT00647296|1856813|FG003|Part 2: 4-week Placebo Washout|Death|0
888903|NCT00647296|1856810|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
888904|NCT00647296|1856811|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5
888905|NCT00647296|1856812|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
888906|NCT00647296|1856813|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4
888907|NCT00647296|1856810|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
888908|NCT00647296|1856811|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1
888909|NCT00647296|1856812|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
888910|NCT00647296|1856813|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4
888911|NCT00647296|1856810|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
888912|NCT00647296|1856811|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1
888913|NCT00647296|1856812|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
888914|NCT00647296|1856813|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
888915|NCT00647296|1856810|FG000|Part 2: 76-week Double-Blind Treatment|Death|0
888916|NCT00647296|1856811|FG001|Part 2: 76-week Double-Blind Treatment|Death|7
888917|NCT00647296|1856812|FG002|Part 2: 76-week Double-Blind Treatment|Death|0
888918|NCT00647296|1856813|FG003|Part 2: 76-week Double-Blind Treatment|Death|5
888919|NCT00647296|1856810|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
888920|NCT00647296|1856811|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
888921|NCT00647296|1856812|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
888922|NCT00647296|1856813|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
888923|NCT00647348|1856837|FG000|Overall Study|Lost to Follow-up|3
888924|NCT00647348|1856838|FG001|Overall Study|Lost to Follow-up|6
888925|NCT00647556|1856855|FG000|Overall Study|Adverse Event|0
888926|NCT00647556|1856856|FG001|Overall Study|Adverse Event|1
888927|NCT00647556|1856855|FG000|Overall Study|Lost to Follow-up|1
888928|NCT00647556|1856856|FG001|Overall Study|Lost to Follow-up|0
888929|NCT00647556|1856855|FG000|Overall Study|Protocol Violation|0
888930|NCT00647556|1856856|FG001|Overall Study|Protocol Violation|1
888931|NCT00647556|1856855|FG000|Overall Study|Withdrawal by Subject|1
888932|NCT00647556|1856856|FG001|Overall Study|Withdrawal by Subject|0
888933|NCT00647556|1856855|FG000|Overall Study|Surgery for pre-existing neck pain|1
888934|NCT00647556|1856856|FG001|Overall Study|Surgery for pre-existing neck pain|0
888935|NCT00647699|1856864|FG000|Overall Study|Lost to Follow-up|5
888936|NCT00647699|1856865|FG001|Overall Study|Lost to Follow-up|4
888937|NCT00647699|1856864|FG000|Overall Study|Withdrawal by Subject|3
888938|NCT00647699|1856865|FG001|Overall Study|Withdrawal by Subject|8
888939|NCT00648037|1856882|FG000|Overall Study|Not Treated|1
888940|NCT00648037|1856882|FG000|Overall Study|Withdrawal by Subject|1
888941|NCT00648037|1856882|FG000|Overall Study|Adverse Event|11
888942|NCT00648037|1856882|FG000|Overall Study|Relapse|2
888943|NCT00648037|1856882|FG000|Overall Study|Other|1
888944|NCT00648167|1856899|FG000|Overall Study|Adverse Event|6
888945|NCT00648167|1856899|FG000|Overall Study|unable to swallow tablets|1
888946|NCT00648739|1857025|FG000|Overall Study|Adverse Event|1
888947|NCT00648739|1857026|FG001|Overall Study|Adverse Event|0
888948|NCT00648739|1857027|FG002|Overall Study|Adverse Event|1
888949|NCT00648739|1857028|FG003|Overall Study|Adverse Event|2
888950|NCT00648739|1857029|FG004|Overall Study|Adverse Event|1
888951|NCT00648739|1857030|FG005|Overall Study|Adverse Event|0
888952|NCT00648739|1857031|FG006|Overall Study|Adverse Event|0
888953|NCT00648739|1857025|FG000|Overall Study|Withdrawal by Subject|1
888954|NCT00648739|1857026|FG001|Overall Study|Withdrawal by Subject|0
888955|NCT00648739|1857027|FG002|Overall Study|Withdrawal by Subject|1
888956|NCT00648739|1857028|FG003|Overall Study|Withdrawal by Subject|0
888957|NCT00648739|1857029|FG004|Overall Study|Withdrawal by Subject|0
888958|NCT00648739|1857030|FG005|Overall Study|Withdrawal by Subject|2
888959|NCT00648739|1857031|FG006|Overall Study|Withdrawal by Subject|0
888960|NCT00648739|1857025|FG000|Overall Study|Lack of Efficacy|0
888961|NCT00648739|1857026|FG001|Overall Study|Lack of Efficacy|0
888962|NCT00648739|1857027|FG002|Overall Study|Lack of Efficacy|0
888963|NCT00648739|1857028|FG003|Overall Study|Lack of Efficacy|0
888964|NCT00648739|1857029|FG004|Overall Study|Lack of Efficacy|1
888965|NCT00648739|1857030|FG005|Overall Study|Lack of Efficacy|2
888966|NCT00648739|1857031|FG006|Overall Study|Lack of Efficacy|0
888967|NCT00648739|1857025|FG000|Overall Study|Investigator Considered it Advisable|0
888968|NCT00648739|1857026|FG001|Overall Study|Investigator Considered it Advisable|0
888969|NCT00648739|1857027|FG002|Overall Study|Investigator Considered it Advisable|0
888970|NCT00648739|1857028|FG003|Overall Study|Investigator Considered it Advisable|0
888971|NCT00648739|1857029|FG004|Overall Study|Investigator Considered it Advisable|0
888972|NCT00648739|1857030|FG005|Overall Study|Investigator Considered it Advisable|1
888973|NCT00648739|1857031|FG006|Overall Study|Investigator Considered it Advisable|1
888974|NCT00648739|1857025|FG000|Overall Study|Death|0
888975|NCT00648739|1857026|FG001|Overall Study|Death|1
888976|NCT00648739|1857027|FG002|Overall Study|Death|0
888977|NCT00648739|1857028|FG003|Overall Study|Death|0
888978|NCT00648739|1857029|FG004|Overall Study|Death|0
888979|NCT00648739|1857030|FG005|Overall Study|Death|0
888980|NCT00648739|1857031|FG006|Overall Study|Death|0
888981|NCT00648739|1857025|FG000|Overall Study|Positive Human Anti-human Antibody|0
888982|NCT00648739|1857026|FG001|Overall Study|Positive Human Anti-human Antibody|0
888983|NCT00648739|1857027|FG002|Overall Study|Positive Human Anti-human Antibody|1
888984|NCT00648739|1857028|FG003|Overall Study|Positive Human Anti-human Antibody|0
888985|NCT00648739|1857029|FG004|Overall Study|Positive Human Anti-human Antibody|0
888986|NCT00648739|1857030|FG005|Overall Study|Positive Human Anti-human Antibody|0
888987|NCT00648739|1857031|FG006|Overall Study|Positive Human Anti-human Antibody|0
888988|NCT00648739|1857025|FG000|Overall Study|Follow-up Visits Not Completed|0
888989|NCT00648739|1857026|FG001|Overall Study|Follow-up Visits Not Completed|1
888990|NCT00648739|1857027|FG002|Overall Study|Follow-up Visits Not Completed|0
888991|NCT00648739|1857028|FG003|Overall Study|Follow-up Visits Not Completed|0
888992|NCT00648739|1857029|FG004|Overall Study|Follow-up Visits Not Completed|0
888993|NCT00648739|1857030|FG005|Overall Study|Follow-up Visits Not Completed|0
888994|NCT00648739|1857031|FG006|Overall Study|Follow-up Visits Not Completed|0
888995|NCT00649220|1857057|FG000|Overall Study|Adverse Event|2
888996|NCT00649220|1857057|FG000|Overall Study|Withdrawal by Subject|1
888997|NCT00649389|1857065|FG000|Overall Study|Adverse Event|22
888998|NCT00649389|1857066|FG001|Overall Study|Adverse Event|46
888999|NCT00649389|1857067|FG002|Overall Study|Adverse Event|38
889000|NCT00649389|1857068|FG003|Overall Study|Adverse Event|48
889001|NCT00649389|1857065|FG000|Overall Study|Lost to Follow-up|15
889002|NCT00649389|1857066|FG001|Overall Study|Lost to Follow-up|17
889003|NCT00649389|1857067|FG002|Overall Study|Lost to Follow-up|21
889004|NCT00649389|1857068|FG003|Overall Study|Lost to Follow-up|26
889005|NCT00649389|1857065|FG000|Overall Study|Protocol Violation|11
889006|NCT00649389|1857066|FG001|Overall Study|Protocol Violation|13
889007|NCT00649389|1857067|FG002|Overall Study|Protocol Violation|9
889008|NCT00649389|1857068|FG003|Overall Study|Protocol Violation|8
889009|NCT00649389|1857065|FG000|Overall Study|Withdrawal by Subject|20
889010|NCT00649389|1857066|FG001|Overall Study|Withdrawal by Subject|21
889011|NCT00649389|1857067|FG002|Overall Study|Withdrawal by Subject|19
889012|NCT00649389|1857068|FG003|Overall Study|Withdrawal by Subject|23
889013|NCT00649389|1857065|FG000|Overall Study|Other|3
889014|NCT00649389|1857066|FG001|Overall Study|Other|9
889015|NCT00649389|1857067|FG002|Overall Study|Other|1
889016|NCT00649389|1857068|FG003|Overall Study|Other|6
889017|NCT00649428|1857080|FG000|Overall Study|Adverse Event|2
889018|NCT00649428|1857081|FG001|Overall Study|Adverse Event|2
889019|NCT00649428|1857080|FG000|Overall Study|Withdrawal by Subject|6
889020|NCT00649428|1857081|FG001|Overall Study|Withdrawal by Subject|6
889021|NCT00649428|1857080|FG000|Overall Study|Lost to Follow-up|1
889022|NCT00649428|1857081|FG001|Overall Study|Lost to Follow-up|3
889023|NCT00649428|1857080|FG000|Overall Study|Insufficient manufacturing yield|5
889024|NCT00649428|1857081|FG001|Overall Study|Insufficient manufacturing yield|1
889025|NCT00649428|1857080|FG000|Overall Study|Protocol Violation|6
889026|NCT00649428|1857081|FG001|Overall Study|Protocol Violation|2
889027|NCT00649428|1857080|FG000|Overall Study|Physician Decision|0
889028|NCT00649428|1857081|FG001|Overall Study|Physician Decision|1
889029|NCT00650091|1857107|FG000|Amended Study Design|Withdrawal by Subject|12
889030|NCT00650091|1857108|FG001|Amended Study Design|Withdrawal by Subject|11
889031|NCT00650091|1857109|FG002|Amended Study Design|Withdrawal by Subject|0
889032|NCT00650091|1857107|FG000|Amended Study Design|Physician Decision|5
889033|NCT00650091|1857108|FG001|Amended Study Design|Physician Decision|0
889034|NCT00650091|1857109|FG002|Amended Study Design|Physician Decision|0
889035|NCT00650091|1857107|FG000|Amended Study Design|Adverse Event|1
889036|NCT00650091|1857108|FG001|Amended Study Design|Adverse Event|4
889037|NCT00650091|1857109|FG002|Amended Study Design|Adverse Event|0
889038|NCT00650091|1857107|FG000|Amended Study Design|Lung transplantation|4
889039|NCT00650091|1857108|FG001|Amended Study Design|Lung transplantation|2
889040|NCT00650091|1857109|FG002|Amended Study Design|Lung transplantation|0
889041|NCT00650091|1857107|FG000|Amended Study Design|Other|1
889042|NCT00650091|1857108|FG001|Amended Study Design|Other|3
889043|NCT00650091|1857109|FG002|Amended Study Design|Other|0
889044|NCT00650104|1857117|FG000|Overall Study|Adverse Event|17
889045|NCT00650104|1857117|FG000|Overall Study|Death|2
889046|NCT00650104|1857117|FG000|Overall Study|Withdrawal by Subject|11
889047|NCT00650104|1857117|FG000|Overall Study|Physician Decision|7
889048|NCT00650104|1857117|FG000|Overall Study|Lost to Follow-up|1
889049|NCT00650104|1857117|FG000|Overall Study|Non-compliance|2
889050|NCT00650104|1857117|FG000|Overall Study|Sponsor Terminated Dosing|1
889051|NCT00650585|1857137|FG000|Overall Study|Lost to Follow-up|505
889052|NCT00650585|1857138|FG001|Overall Study|Lost to Follow-up|482
889053|NCT00650585|1857137|FG000|Overall Study|No parental consent|935
889054|NCT00650585|1857138|FG001|Overall Study|No parental consent|866
889055|NCT00650585|1857137|FG000|Overall Study|Excluded/ruled ineligible|357
889056|NCT00650585|1857138|FG001|Overall Study|Excluded/ruled ineligible|129
889057|NCT00650767|1857148|FG000|Overall Study|Adverse Event|0
889058|NCT00650767|1857149|FG001|Overall Study|Adverse Event|3
889059|NCT00650767|1857150|FG002|Overall Study|Adverse Event|10
889060|NCT00650767|1857151|FG003|Overall Study|Adverse Event|8
889061|NCT00650767|1857148|FG000|Overall Study|Death|1
889062|NCT00650767|1857149|FG001|Overall Study|Death|0
889063|NCT00650767|1857150|FG002|Overall Study|Death|0
889064|NCT00650767|1857151|FG003|Overall Study|Death|0
889065|NCT00650767|1857148|FG000|Overall Study|Withdrawal by Subject|2
889066|NCT00650767|1857149|FG001|Overall Study|Withdrawal by Subject|4
889067|NCT00650767|1857150|FG002|Overall Study|Withdrawal by Subject|3
889068|NCT00650767|1857151|FG003|Overall Study|Withdrawal by Subject|3
889069|NCT00650767|1857148|FG000|Overall Study|Lost to Follow-up|1
889070|NCT00650767|1857149|FG001|Overall Study|Lost to Follow-up|1
889071|NCT00650767|1857150|FG002|Overall Study|Lost to Follow-up|1
889072|NCT00650767|1857151|FG003|Overall Study|Lost to Follow-up|0
889073|NCT00650767|1857148|FG000|Overall Study|Other|1
889074|NCT00650767|1857149|FG001|Overall Study|Other|1
889075|NCT00650767|1857150|FG002|Overall Study|Other|0
889076|NCT00650767|1857151|FG003|Overall Study|Other|0
889077|NCT00650806|1857165|FG000|Overall Study|Adverse Event|0
889078|NCT00650806|1857166|FG001|Overall Study|Adverse Event|5
889079|NCT00650806|1857167|FG002|Overall Study|Adverse Event|3
889080|NCT00650806|1857168|FG003|Overall Study|Adverse Event|4
889081|NCT00650806|1857165|FG000|Overall Study|Lost to Follow-up|7
889082|NCT00650806|1857166|FG001|Overall Study|Lost to Follow-up|6
889083|NCT00650806|1857167|FG002|Overall Study|Lost to Follow-up|11
889084|NCT00650806|1857168|FG003|Overall Study|Lost to Follow-up|10
889085|NCT00650806|1857165|FG000|Overall Study|Protocol Violation|0
889086|NCT00650806|1857166|FG001|Overall Study|Protocol Violation|0
889087|NCT00650806|1857167|FG002|Overall Study|Protocol Violation|0
889088|NCT00650806|1857168|FG003|Overall Study|Protocol Violation|1
889089|NCT00650806|1857165|FG000|Overall Study|Pregnancy|0
889090|NCT00650806|1857166|FG001|Overall Study|Pregnancy|0
889091|NCT00650806|1857167|FG002|Overall Study|Pregnancy|0
889092|NCT00650806|1857168|FG003|Overall Study|Pregnancy|1
889093|NCT00650806|1857165|FG000|Overall Study|Withdrawal by Subject|7
889094|NCT00650806|1857166|FG001|Overall Study|Withdrawal by Subject|5
889095|NCT00650806|1857167|FG002|Overall Study|Withdrawal by Subject|8
889096|NCT00650806|1857168|FG003|Overall Study|Withdrawal by Subject|6
889097|NCT00650806|1857165|FG000|Overall Study|Noncompliance with study drug regimen|1
889098|NCT00650806|1857166|FG001|Overall Study|Noncompliance with study drug regimen|1
889099|NCT00650806|1857167|FG002|Overall Study|Noncompliance with study drug regimen|0
889100|NCT00650806|1857168|FG003|Overall Study|Noncompliance with study drug regimen|0
889101|NCT00650806|1857165|FG000|Overall Study|Study terminated by sponsor|2
889102|NCT00650806|1857166|FG001|Overall Study|Study terminated by sponsor|3
889103|NCT00650806|1857167|FG002|Overall Study|Study terminated by sponsor|5
889104|NCT00650806|1857168|FG003|Overall Study|Study terminated by sponsor|4
889105|NCT00650806|1857165|FG000|Overall Study|Other|1
889106|NCT00650806|1857166|FG001|Overall Study|Other|1
889107|NCT00650806|1857167|FG002|Overall Study|Other|2
889108|NCT00650806|1857168|FG003|Overall Study|Other|0
889109|NCT00650845|1857182|FG000|Overall Study|Withdrawal by Subject|5
889110|NCT00650845|1857183|FG001|Overall Study|Withdrawal by Subject|0
889111|NCT00650845|1857182|FG000|Overall Study|Protocol Violation|0
889112|NCT00650845|1857183|FG001|Overall Study|Protocol Violation|13
889113|NCT00651118|1857220|FG000|Overall Study|Adverse Event|4
889114|NCT00651118|1857221|FG001|Overall Study|Adverse Event|0
889115|NCT00651118|1857222|FG002|Overall Study|Adverse Event|1
889116|NCT00651118|1857223|FG003|Overall Study|Adverse Event|1
889117|NCT00651118|1857220|FG000|Overall Study|Protocol Violation|2
889118|NCT00651118|1857221|FG001|Overall Study|Protocol Violation|2
889119|NCT00651118|1857222|FG002|Overall Study|Protocol Violation|6
889120|NCT00651118|1857223|FG003|Overall Study|Protocol Violation|2
889121|NCT00651118|1857220|FG000|Overall Study|Lost to Follow-up|2
889122|NCT00651118|1857221|FG001|Overall Study|Lost to Follow-up|0
889123|NCT00651118|1857222|FG002|Overall Study|Lost to Follow-up|1
889124|NCT00651118|1857223|FG003|Overall Study|Lost to Follow-up|2
889125|NCT00651118|1857220|FG000|Overall Study|administrative|1
889126|NCT00651118|1857221|FG001|Overall Study|administrative|4
889127|NCT00651118|1857222|FG002|Overall Study|administrative|2
889128|NCT00651118|1857223|FG003|Overall Study|administrative|1
889129|NCT00651118|1857220|FG000|Overall Study|Withdrawal by Subject|0
889130|NCT00651118|1857221|FG001|Overall Study|Withdrawal by Subject|1
889131|NCT00651118|1857222|FG002|Overall Study|Withdrawal by Subject|1
889132|NCT00651118|1857223|FG003|Overall Study|Withdrawal by Subject|1
889133|NCT00651157|1857236|FG000|Overall Study|Death|1
889134|NCT00651157|1857236|FG000|Overall Study|Protocol Violation|1
889135|NCT00651183|1857242|FG000|Overall Study|Lack of Efficacy|1
889136|NCT00651183|1857243|FG001|Overall Study|Lack of Efficacy|0
889137|NCT00651183|1857242|FG000|Overall Study|Efficacy insufficient + patients wish|0
889138|NCT00651183|1857243|FG001|Overall Study|Efficacy insufficient + patients wish|1
889139|NCT00651183|1857242|FG000|Overall Study|Tolerability insufficient|5
889140|NCT00651183|1857243|FG001|Overall Study|Tolerability insufficient|2
889141|NCT00651183|1857242|FG000|Overall Study|Tolerability insufficient +Patients wish|0
889142|NCT00651183|1857243|FG001|Overall Study|Tolerability insufficient +Patients wish|1
889143|NCT00651183|1857242|FG000|Overall Study|Withdrawal by Subject|6
889144|NCT00651183|1857243|FG001|Overall Study|Withdrawal by Subject|3
889145|NCT00651183|1857242|FG000|Overall Study|Lost to Follow-up|3
889146|NCT00651183|1857243|FG001|Overall Study|Lost to Follow-up|1
889147|NCT00651183|1857242|FG000|Overall Study|Other reasons|4
889148|NCT00651183|1857243|FG001|Overall Study|Other reasons|2
889149|NCT00651183|1857242|FG000|Overall Study|missing|1
889150|NCT00651183|1857243|FG001|Overall Study|missing|0
889151|NCT00651261|1857251|FG000|Overall Study|Adverse Event|32
889152|NCT00651261|1857252|FG001|Overall Study|Adverse Event|22
889153|NCT00651261|1857251|FG000|Overall Study|Death|18
889154|NCT00651261|1857252|FG001|Overall Study|Death|18
889155|NCT00651261|1857251|FG000|Overall Study|Withdrawal by Subject|22
889156|NCT00651261|1857252|FG001|Overall Study|Withdrawal by Subject|40
889157|NCT00651261|1857251|FG000|Overall Study|Induction failure|24
889158|NCT00651261|1857252|FG001|Overall Study|Induction failure|35
889159|NCT00651261|1857251|FG000|Overall Study|Disease progression|58
889160|NCT00651261|1857252|FG001|Overall Study|Disease progression|58
889161|NCT00651261|1857251|FG000|Overall Study|Alternative therapy|109
889162|NCT00651261|1857252|FG001|Overall Study|Alternative therapy|107
889163|NCT00651261|1857251|FG000|Overall Study|Other disease or participant decisions|23
889164|NCT00651261|1857252|FG001|Overall Study|Other disease or participant decisions|23
889165|NCT00651261|1857251|FG000|Overall Study|Never treated|5
889166|NCT00651261|1857252|FG001|Overall Study|Never treated|3
889167|NCT00651313|1857260|FG000|Overall Study|Adverse Event|0
889168|NCT00651313|1857261|FG001|Overall Study|Adverse Event|1
889169|NCT00651313|1857260|FG000|Overall Study|Withdrawal by Subject|3
889170|NCT00651313|1857261|FG001|Overall Study|Withdrawal by Subject|1
889171|NCT00651313|1857260|FG000|Overall Study|Lost to Follow-up|1
889172|NCT00651313|1857261|FG001|Overall Study|Lost to Follow-up|1
889173|NCT00651313|1857260|FG000|Overall Study|Adminstrative Discontinuation|2
889174|NCT00651313|1857261|FG001|Overall Study|Adminstrative Discontinuation|3
889175|NCT00651664|1857300|FG000|Overall Study|Occurrence of Adverse Event(s)|0
889176|NCT00651664|1857301|FG001|Overall Study|Occurrence of Adverse Event(s)|0
889177|NCT00651664|1857302|FG002|Overall Study|Occurrence of Adverse Event(s)|0
889178|NCT00651664|1857303|FG003|Overall Study|Occurrence of Adverse Event(s)|0
889179|NCT00651664|1857304|FG004|Overall Study|Occurrence of Adverse Event(s)|0
889180|NCT00651664|1857305|FG005|Overall Study|Occurrence of Adverse Event(s)|0
889181|NCT00651664|1857306|FG006|Overall Study|Occurrence of Adverse Event(s)|1
889182|NCT00651664|1857307|FG007|Overall Study|Occurrence of Adverse Event(s)|0
889183|NCT00651664|1857308|FG008|Overall Study|Occurrence of Adverse Event(s)|1
889184|NCT00651664|1857309|FG009|Overall Study|Occurrence of Adverse Event(s)|0
889185|NCT00651664|1857300|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
889186|NCT00651664|1857301|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
889187|NCT00651664|1857302|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
889188|NCT00651664|1857303|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
889189|NCT00651664|1857304|FG004|Overall Study|Unsatisfactory Therapeutic Response|1
889190|NCT00651664|1857305|FG005|Overall Study|Unsatisfactory Therapeutic Response|1
889191|NCT00651664|1857306|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
889192|NCT00651664|1857307|FG007|Overall Study|Unsatisfactory Therapeutic Response|1
889193|NCT00651664|1857308|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
889194|NCT00651664|1857309|FG009|Overall Study|Unsatisfactory Therapeutic Response|1
889195|NCT00651664|1857300|FG000|Overall Study|Progressive Disease|3
889196|NCT00651664|1857301|FG001|Overall Study|Progressive Disease|3
889197|NCT00651664|1857302|FG002|Overall Study|Progressive Disease|3
889198|NCT00651664|1857303|FG003|Overall Study|Progressive Disease|12
889199|NCT00651664|1857304|FG004|Overall Study|Progressive Disease|4
889200|NCT00651664|1857305|FG005|Overall Study|Progressive Disease|1
889201|NCT00651664|1857306|FG006|Overall Study|Progressive Disease|3
889202|NCT00651664|1857307|FG007|Overall Study|Progressive Disease|6
889203|NCT00651664|1857308|FG008|Overall Study|Progressive Disease|5
889204|NCT00651664|1857309|FG009|Overall Study|Progressive Disease|5
889205|NCT00651664|1857300|FG000|Overall Study|Patient Declined Further Treatment|0
889206|NCT00651664|1857301|FG001|Overall Study|Patient Declined Further Treatment|0
889207|NCT00651664|1857302|FG002|Overall Study|Patient Declined Further Treatment|0
889208|NCT00651664|1857303|FG003|Overall Study|Patient Declined Further Treatment|1
889209|NCT00651664|1857304|FG004|Overall Study|Patient Declined Further Treatment|1
889210|NCT00651664|1857305|FG005|Overall Study|Patient Declined Further Treatment|1
889211|NCT00651664|1857306|FG006|Overall Study|Patient Declined Further Treatment|0
889212|NCT00651664|1857307|FG007|Overall Study|Patient Declined Further Treatment|0
889213|NCT00651664|1857308|FG008|Overall Study|Patient Declined Further Treatment|0
889214|NCT00651664|1857309|FG009|Overall Study|Patient Declined Further Treatment|1
889215|NCT00651664|1857300|FG000|Overall Study|Symptomatic Deterioration|0
889216|NCT00651664|1857301|FG001|Overall Study|Symptomatic Deterioration|0
889217|NCT00651664|1857302|FG002|Overall Study|Symptomatic Deterioration|0
889218|NCT00651664|1857303|FG003|Overall Study|Symptomatic Deterioration|1
889219|NCT00651664|1857304|FG004|Overall Study|Symptomatic Deterioration|0
889220|NCT00651664|1857305|FG005|Overall Study|Symptomatic Deterioration|0
889221|NCT00651664|1857306|FG006|Overall Study|Symptomatic Deterioration|1
889222|NCT00651664|1857307|FG007|Overall Study|Symptomatic Deterioration|0
889223|NCT00651664|1857308|FG008|Overall Study|Symptomatic Deterioration|1
889224|NCT00651664|1857309|FG009|Overall Study|Symptomatic Deterioration|0
889225|NCT00651664|1857300|FG000|Overall Study|Reason not Specified|0
889226|NCT00651664|1857301|FG001|Overall Study|Reason not Specified|0
889227|NCT00651664|1857302|FG002|Overall Study|Reason not Specified|0
889228|NCT00651664|1857303|FG003|Overall Study|Reason not Specified|0
889229|NCT00651664|1857304|FG004|Overall Study|Reason not Specified|0
889230|NCT00651664|1857305|FG005|Overall Study|Reason not Specified|0
889231|NCT00651664|1857306|FG006|Overall Study|Reason not Specified|1
889232|NCT00651664|1857307|FG007|Overall Study|Reason not Specified|0
889233|NCT00651664|1857308|FG008|Overall Study|Reason not Specified|0
889234|NCT00651664|1857309|FG009|Overall Study|Reason not Specified|0
889235|NCT00651755|1857335|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
889236|NCT00651755|1857336|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
889237|NCT00651755|1857335|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0
889238|NCT00651755|1857336|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1
889239|NCT00651820|1857356|FG000|Overall Study|Lost to Follow-up|2
889240|NCT00651924|1857364|FG000|Overall Study|Withdrawal by PI|0
889241|NCT00651924|1857365|FG001|Overall Study|Withdrawal by PI|2
889242|NCT00651924|1857364|FG000|Overall Study|Withdrawal by Subject|0
889243|NCT00651924|1857365|FG001|Overall Study|Withdrawal by Subject|5
889244|NCT00651937|1857373|FG000|Overall Study|Withdrawal by Subject|4
889245|NCT00651937|1857374|FG001|Overall Study|Withdrawal by Subject|1
889246|NCT00652028|1857384|FG000|Overall Study|Adverse Event|1
889247|NCT00652028|1857385|FG001|Overall Study|Adverse Event|0
889248|NCT00652028|1857386|FG002|Overall Study|Adverse Event|0
889249|NCT00652028|1857387|FG003|Overall Study|Adverse Event|0
889250|NCT00652028|1857384|FG000|Overall Study|No Longer Meets Entry Criteria|0
889251|NCT00652028|1857385|FG001|Overall Study|No Longer Meets Entry Criteria|1
889252|NCT00652028|1857386|FG002|Overall Study|No Longer Meets Entry Criteria|0
889253|NCT00652028|1857387|FG003|Overall Study|No Longer Meets Entry Criteria|0
889254|NCT00652028|1857384|FG000|Overall Study|Physician Decision|0
889255|NCT00652028|1857385|FG001|Overall Study|Physician Decision|0
889256|NCT00652028|1857386|FG002|Overall Study|Physician Decision|1
889257|NCT00652028|1857387|FG003|Overall Study|Physician Decision|0
889258|NCT00652093|1857409|FG000|Overall Study|Withdrawal by Subject|0
889259|NCT00652093|1857410|FG001|Overall Study|Withdrawal by Subject|0
889260|NCT00652093|1857411|FG002|Overall Study|Withdrawal by Subject|1
889261|NCT00652093|1857412|FG003|Overall Study|Withdrawal by Subject|0
889262|NCT00652093|1857413|FG004|Overall Study|Withdrawal by Subject|1
889263|NCT00652093|1857414|FG005|Overall Study|Withdrawal by Subject|0
889264|NCT00652093|1857409|FG000|Overall Study|Physician Decision|0
889265|NCT00652093|1857410|FG001|Overall Study|Physician Decision|0
889266|NCT00652093|1857411|FG002|Overall Study|Physician Decision|0
889267|NCT00652093|1857412|FG003|Overall Study|Physician Decision|0
889268|NCT00652093|1857413|FG004|Overall Study|Physician Decision|1
889269|NCT00652093|1857414|FG005|Overall Study|Physician Decision|0
889270|NCT00652327|1857450|FG000|Overall Study|Adverse Event|0
889271|NCT00652327|1857451|FG001|Overall Study|Adverse Event|2
889272|NCT00652327|1857450|FG000|Overall Study|Lost to Follow-up|0
889273|NCT00652327|1857451|FG001|Overall Study|Lost to Follow-up|3
889274|NCT00652340|1857459|FG000|Overall Study|Had not progressed.|4
889275|NCT00652340|1857460|FG001|Overall Study|Had not progressed.|3
889276|NCT00652366|1857471|FG000|Overall Study|Adverse Event|8
889277|NCT00652366|1857472|FG001|Overall Study|Adverse Event|4
889278|NCT00652366|1857473|FG002|Overall Study|Adverse Event|7
889279|NCT00652366|1857474|FG003|Overall Study|Adverse Event|17
889280|NCT00652366|1857475|FG004|Overall Study|Adverse Event|13
889281|NCT00652366|1857471|FG000|Overall Study|Death|5
889282|NCT00652366|1857472|FG001|Overall Study|Death|4
889283|NCT00652366|1857473|FG002|Overall Study|Death|1
889284|NCT00652366|1857474|FG003|Overall Study|Death|8
889285|NCT00652366|1857475|FG004|Overall Study|Death|5
889286|NCT00652366|1857471|FG000|Overall Study|Lack of Efficacy|84
889287|NCT00652366|1857472|FG001|Overall Study|Lack of Efficacy|58
889288|NCT00652366|1857473|FG002|Overall Study|Lack of Efficacy|53
889289|NCT00652366|1857474|FG003|Overall Study|Lack of Efficacy|133
889290|NCT00652366|1857475|FG004|Overall Study|Lack of Efficacy|13
889291|NCT00652366|1857471|FG000|Overall Study|Violation of Selection Criteria|0
889292|NCT00652366|1857472|FG001|Overall Study|Violation of Selection Criteria|0
889293|NCT00652366|1857473|FG002|Overall Study|Violation of Selection Criteria|1
889294|NCT00652366|1857474|FG003|Overall Study|Violation of Selection Criteria|0
889295|NCT00652366|1857475|FG004|Overall Study|Violation of Selection Criteria|0
889296|NCT00652366|1857471|FG000|Overall Study|Protocol Violation|1
889297|NCT00652366|1857472|FG001|Overall Study|Protocol Violation|0
889298|NCT00652366|1857473|FG002|Overall Study|Protocol Violation|0
889299|NCT00652366|1857474|FG003|Overall Study|Protocol Violation|0
889300|NCT00652366|1857475|FG004|Overall Study|Protocol Violation|0
889301|NCT00652366|1857471|FG000|Overall Study|Refused treatment|3
889302|NCT00652366|1857472|FG001|Overall Study|Refused treatment|7
889303|NCT00652366|1857473|FG002|Overall Study|Refused treatment|6
889304|NCT00652366|1857474|FG003|Overall Study|Refused treatment|17
889305|NCT00652366|1857475|FG004|Overall Study|Refused treatment|5
889306|NCT00652366|1857471|FG000|Overall Study|Other|5
889307|NCT00652366|1857472|FG001|Overall Study|Other|2
889308|NCT00652366|1857473|FG002|Overall Study|Other|3
889309|NCT00652366|1857474|FG003|Overall Study|Other|4
889310|NCT00652366|1857475|FG004|Overall Study|Other|0
889311|NCT00652626|1857496|FG000|Initial Treatment Phase|Adverse Event|0
889312|NCT00652626|1857497|FG001|Initial Treatment Phase|Adverse Event|0
889313|NCT00652626|1857498|FG002|Initial Treatment Phase|Adverse Event|0
889314|NCT00652626|1857499|FG003|Initial Treatment Phase|Adverse Event|0
889315|NCT00652626|1857500|FG004|Initial Treatment Phase|Adverse Event|1
889316|NCT00652626|1857501|FG005|Initial Treatment Phase|Adverse Event|0
889317|NCT00652626|1857502|FG006|Initial Treatment Phase|Adverse Event|0
889318|NCT00652626|1857496|FG000|Initial Treatment Phase|Protocol Violation|0
889319|NCT00652626|1857497|FG001|Initial Treatment Phase|Protocol Violation|0
889320|NCT00652626|1857498|FG002|Initial Treatment Phase|Protocol Violation|0
889321|NCT00652626|1857499|FG003|Initial Treatment Phase|Protocol Violation|1
889322|NCT00652626|1857500|FG004|Initial Treatment Phase|Protocol Violation|0
889323|NCT00652626|1857501|FG005|Initial Treatment Phase|Protocol Violation|0
889324|NCT00652626|1857502|FG006|Initial Treatment Phase|Protocol Violation|0
889325|NCT00652626|1857496|FG000|Initial Treatment Phase|Physician Decision|0
889326|NCT00652626|1857497|FG001|Initial Treatment Phase|Physician Decision|0
889327|NCT00652626|1857498|FG002|Initial Treatment Phase|Physician Decision|0
889328|NCT00652626|1857499|FG003|Initial Treatment Phase|Physician Decision|0
889329|NCT00652626|1857500|FG004|Initial Treatment Phase|Physician Decision|1
889330|NCT00652626|1857501|FG005|Initial Treatment Phase|Physician Decision|0
889331|NCT00652626|1857502|FG006|Initial Treatment Phase|Physician Decision|0
889332|NCT00652626|1857496|FG000|Initial Treatment Phase|Sponsor Request|0
889333|NCT00652626|1857497|FG001|Initial Treatment Phase|Sponsor Request|0
889334|NCT00652626|1857498|FG002|Initial Treatment Phase|Sponsor Request|1
889335|NCT00652626|1857499|FG003|Initial Treatment Phase|Sponsor Request|0
889336|NCT00652626|1857500|FG004|Initial Treatment Phase|Sponsor Request|0
889337|NCT00652626|1857501|FG005|Initial Treatment Phase|Sponsor Request|0
889338|NCT00652626|1857502|FG006|Initial Treatment Phase|Sponsor Request|0
889339|NCT00652626|1857496|FG000|Initial Treatment Phase|Lost to Follow-up|0
889340|NCT00652626|1857497|FG001|Initial Treatment Phase|Lost to Follow-up|0
889341|NCT00652626|1857498|FG002|Initial Treatment Phase|Lost to Follow-up|0
889342|NCT00652626|1857499|FG003|Initial Treatment Phase|Lost to Follow-up|0
889343|NCT00652626|1857500|FG004|Initial Treatment Phase|Lost to Follow-up|1
889344|NCT00652626|1857501|FG005|Initial Treatment Phase|Lost to Follow-up|0
889345|NCT00652626|1857502|FG006|Initial Treatment Phase|Lost to Follow-up|0
889346|NCT00652626|1857496|FG000|Extension Phase|Withdrawal by Subject|0
889347|NCT00652626|1857497|FG001|Extension Phase|Withdrawal by Subject|0
889348|NCT00652626|1857498|FG002|Extension Phase|Withdrawal by Subject|0
889349|NCT00652626|1857499|FG003|Extension Phase|Withdrawal by Subject|0
889350|NCT00652626|1857500|FG004|Extension Phase|Withdrawal by Subject|0
889351|NCT00652626|1857501|FG005|Extension Phase|Withdrawal by Subject|2
889352|NCT00652626|1857502|FG006|Extension Phase|Withdrawal by Subject|0
889353|NCT00652626|1857496|FG000|Extension Phase|Adverse Event|0
889354|NCT00652626|1857497|FG001|Extension Phase|Adverse Event|0
889355|NCT00652626|1857498|FG002|Extension Phase|Adverse Event|0
889356|NCT00652626|1857499|FG003|Extension Phase|Adverse Event|0
889357|NCT00652626|1857500|FG004|Extension Phase|Adverse Event|0
889358|NCT00652626|1857501|FG005|Extension Phase|Adverse Event|2
889359|NCT00652626|1857502|FG006|Extension Phase|Adverse Event|1
889360|NCT00652626|1857496|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0
889361|NCT00652626|1857497|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0
889362|NCT00652626|1857498|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0
889363|NCT00652626|1857499|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0
889364|NCT00652626|1857500|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0
889365|NCT00652626|1857501|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6
889366|NCT00652626|1857502|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0
889367|NCT00652626|1857496|FG000|Extension Phase|Physician Decision|0
889368|NCT00652626|1857497|FG001|Extension Phase|Physician Decision|0
889369|NCT00652626|1857498|FG002|Extension Phase|Physician Decision|0
889370|NCT00652626|1857499|FG003|Extension Phase|Physician Decision|0
889371|NCT00652626|1857500|FG004|Extension Phase|Physician Decision|0
889372|NCT00652626|1857501|FG005|Extension Phase|Physician Decision|1
889373|NCT00652626|1857502|FG006|Extension Phase|Physician Decision|1
889374|NCT00652626|1857496|FG000|Extension Phase|Death|0
889375|NCT00652626|1857497|FG001|Extension Phase|Death|0
889376|NCT00652626|1857498|FG002|Extension Phase|Death|0
889377|NCT00652626|1857499|FG003|Extension Phase|Death|0
889378|NCT00652626|1857500|FG004|Extension Phase|Death|0
889379|NCT00652626|1857501|FG005|Extension Phase|Death|1
889380|NCT00652626|1857502|FG006|Extension Phase|Death|1
889381|NCT00652743|1857523|FG000|Months 12-18|Lost to Follow-up|1
889382|NCT00652743|1857524|FG001|Months 12-18|Lost to Follow-up|2
889383|NCT00652743|1857525|FG002|Months 12-18|Lost to Follow-up|7
889384|NCT00652743|1857523|FG000|Months 24-30|Other|5
889385|NCT00652743|1857524|FG001|Months 24-30|Other|1
889386|NCT00652743|1857525|FG002|Months 24-30|Other|11
889387|NCT00652743|1857523|FG000|Months 36-42|Serious Adverse Events|0
889388|NCT00652743|1857524|FG001|Months 36-42|Serious Adverse Events|1
889389|NCT00652743|1857525|FG002|Months 36-42|Serious Adverse Events|1
889390|NCT00652743|1857523|FG000|Months 36-42|Withdrawal by Subject|1
889391|NCT00652743|1857524|FG001|Months 36-42|Withdrawal by Subject|1
889392|NCT00652743|1857525|FG002|Months 36-42|Withdrawal by Subject|0
889393|NCT00652743|1857523|FG000|Months 36-42|Lost to Follow-up|0
889394|NCT00652743|1857524|FG001|Months 36-42|Lost to Follow-up|1
889395|NCT00652743|1857525|FG002|Months 36-42|Lost to Follow-up|0
889396|NCT00652743|1857523|FG000|Months 36-42|Migrated/moved from study area|1
889397|NCT00652743|1857524|FG001|Months 36-42|Migrated/moved from study area|0
889398|NCT00652743|1857525|FG002|Months 36-42|Migrated/moved from study area|0
889399|NCT00652743|1857523|FG000|Months 36-42|Other|4
889400|NCT00652743|1857524|FG001|Months 36-42|Other|2
889401|NCT00652743|1857525|FG002|Months 36-42|Other|8
889402|NCT00652834|1857536|FG000|Overall Study|Withdrawal by Subject|3
889403|NCT00652834|1857536|FG000|Overall Study|Lost to Follow-up|2
889404|NCT00652899|1857540|FG000|Overall Study|Death|1
889405|NCT00652899|1857540|FG000|Overall Study|Treating physician decision|1
889406|NCT00652938|1857551|FG000|Overall Study|Adverse Event|1
889407|NCT00652938|1857552|FG001|Overall Study|Adverse Event|0
889408|NCT00652938|1857553|FG002|Overall Study|Adverse Event|2
889409|NCT00652938|1857551|FG000|Overall Study|Withdrawal by Subject|0
889410|NCT00652938|1857552|FG001|Overall Study|Withdrawal by Subject|6
889411|NCT00652938|1857553|FG002|Overall Study|Withdrawal by Subject|1
889412|NCT00652938|1857551|FG000|Overall Study|Lost to Follow-up|0
889413|NCT00652938|1857552|FG001|Overall Study|Lost to Follow-up|0
889414|NCT00652938|1857553|FG002|Overall Study|Lost to Follow-up|2
889415|NCT00652938|1857551|FG000|Overall Study|fear of blood sampling|0
889416|NCT00652938|1857552|FG001|Overall Study|fear of blood sampling|1
889417|NCT00652938|1857553|FG002|Overall Study|fear of blood sampling|0
889418|NCT00652951|1857564|FG000|Booster Phase|Adverse event, non-fatal|0
889419|NCT00652951|1857565|FG001|Booster Phase|Adverse event, non-fatal|1
889420|NCT00652951|1857566|FG002|Booster Phase|Adverse event, non-fatal|0
889421|NCT00652951|1857564|FG000|Booster Phase|Other|1
889422|NCT00652951|1857565|FG001|Booster Phase|Other|0
889423|NCT00652951|1857566|FG002|Booster Phase|Other|0
889424|NCT00653068|1857578|FG000|Overall Study|Death|9
889425|NCT00653068|1857578|FG000|Overall Study|Lack of Efficacy|34
889426|NCT00653068|1857578|FG000|Overall Study|Physician Decision|4
889427|NCT00653068|1857578|FG000|Overall Study|Withdrawal by Subject|1
889428|NCT00653068|1857578|FG000|Overall Study|Ineligible|2
889429|NCT00653159|1857596|FG000|Overall Study|Adverse Event|4
889430|NCT00653159|1857597|FG001|Overall Study|Adverse Event|1
889431|NCT00653159|1857596|FG000|Overall Study|Lost to Follow-up|1
889432|NCT00653159|1857597|FG001|Overall Study|Lost to Follow-up|2
889433|NCT00653224|1857605|FG000|Overall Study|Adverse Event|2
889434|NCT00653224|1857606|FG001|Overall Study|Adverse Event|1
889435|NCT00653224|1857605|FG000|Overall Study|Lack of Efficacy|1
889436|NCT00653224|1857606|FG001|Overall Study|Lack of Efficacy|2
889437|NCT00653224|1857605|FG000|Overall Study|Loss of efficacy|1
889438|NCT00653224|1857606|FG001|Overall Study|Loss of efficacy|0
889439|NCT00653224|1857605|FG000|Overall Study|Lost to Follow-up|1
889440|NCT00653224|1857606|FG001|Overall Study|Lost to Follow-up|0
889441|NCT00653224|1857605|FG000|Overall Study|Other|2
889442|NCT00653224|1857606|FG001|Overall Study|Other|4
889443|NCT00653263|1857612|FG000|Overall Study|Withdrawal by Subject|1
889444|NCT00653263|1857612|FG000|Overall Study|Physician Decision|1
889445|NCT00653328|1857616|FG000|Overall Study|Withdrawal by Subject|1
889446|NCT00653328|1857616|FG000|Overall Study|Adverse Event|2
889447|NCT00653328|1857616|FG000|Overall Study|Disease progression|10
889448|NCT00653328|1857616|FG000|Overall Study|Drug manufacturer no longing making drug|2
889449|NCT00653432|1857622|FG000|Overall Study|Adverse Event|4
889450|NCT00653432|1857623|FG001|Overall Study|Adverse Event|1
889451|NCT00653432|1857622|FG000|Overall Study|Withdrawal by Subject|4
889452|NCT00653432|1857623|FG001|Overall Study|Withdrawal by Subject|5
889453|NCT00653432|1857622|FG000|Overall Study|Lost to Follow-up|7
889454|NCT00653432|1857623|FG001|Overall Study|Lost to Follow-up|6
889455|NCT00653432|1857622|FG000|Overall Study|Use/Need of Con Therapy|2
889456|NCT00653432|1857623|FG001|Overall Study|Use/Need of Con Therapy|1
889457|NCT00653432|1857622|FG000|Overall Study|Other - Reason Not Provided|5
889458|NCT00653432|1857623|FG001|Overall Study|Other - Reason Not Provided|3
889459|NCT00653523|1857629|FG000|Overall Study|Drop in low density lipoprotein (1)|2
889460|NCT00653523|1857629|FG000|Overall Study|Elevated creatine phosphokinase (2)|1
889461|NCT00653523|1857629|FG000|Overall Study|Adverse Event|7
889462|NCT00653523|1857629|FG000|Overall Study|Withdrawal by Subject|6
889463|NCT00653523|1857629|FG000|Overall Study|Elevated alanine aminotransferase (3)|2
889464|NCT00653523|1857629|FG000|Overall Study|Adverse reaction did not improve (4)|1
889465|NCT00653939|1857644|FG000|Overall Study|Adverse Event|1
889466|NCT00653939|1857645|FG001|Overall Study|Adverse Event|3
889467|NCT00653939|1857644|FG000|Overall Study|Withdrawal by Subject|3
889468|NCT00653939|1857645|FG001|Overall Study|Withdrawal by Subject|3
889469|NCT00653939|1857644|FG000|Overall Study|Physician Decision|4
889470|NCT00653939|1857645|FG001|Overall Study|Physician Decision|0
889471|NCT00653939|1857644|FG000|Overall Study|Disease Progression|2
889472|NCT00653939|1857645|FG001|Overall Study|Disease Progression|3
889473|NCT00653939|1857644|FG000|Overall Study|Other|2
889474|NCT00653939|1857645|FG001|Overall Study|Other|6
889475|NCT00653991|1857655|FG000|3 Month Follow-up|Participant would not respond|150
889476|NCT00653991|1857656|FG001|3 Month Follow-up|Participant would not respond|157
889477|NCT00653991|1857655|FG000|6 Month Follow-up|Participant would not respond|133
889478|NCT00653991|1857656|FG001|6 Month Follow-up|Participant would not respond|141
889479|NCT00654004|1857666|FG000|Overall Study|Lost to Follow-up|1
889480|NCT00654004|1857667|FG001|Overall Study|Lost to Follow-up|0
889481|NCT00654095|1857690|FG000|Overall Study|Drop in low density lipoprotein (1)|2
889482|NCT00654095|1857690|FG000|Overall Study|Elevated triglyceride level (2)|1
889483|NCT00654095|1857690|FG000|Overall Study|Elevated alanine aminotransferase (3)|1
889484|NCT00654095|1857690|FG000|Overall Study|Adverse Event|11
889485|NCT00654095|1857690|FG000|Overall Study|Withdrawal by Subject|5
889486|NCT00654095|1857690|FG000|Overall Study|Elevated alanine aminotransferase (4)|7
889487|NCT00654095|1857690|FG000|Overall Study|Adverse reaction did not improve (5)|4
889488|NCT00654095|1857690|FG000|Overall Study|Did not meet inclusion criteria|1
889489|NCT00654186|1857703|FG000|Overall Study|Withdrawal by Subject|5
889490|NCT00654238|1857707|FG000|Overall Study|Screen Failures|4
889491|NCT00654355|1857731|FG000|Overall Study|Lost to Follow-up|2
889492|NCT00654355|1857732|FG001|Overall Study|Lost to Follow-up|2
889493|NCT00654368|1857741|FG000|Overall Study|Ineligibility determined|6
889494|NCT00654368|1857742|FG001|Overall Study|Ineligibility determined|0
889495|NCT00654368|1857743|FG002|Overall Study|Ineligibility determined|0
889496|NCT00654368|1857741|FG000|Overall Study|Protocol deviation|3
889497|NCT00654368|1857742|FG001|Overall Study|Protocol deviation|2
889498|NCT00654368|1857743|FG002|Overall Study|Protocol deviation|1
889499|NCT00654368|1857741|FG000|Overall Study|Non-compliance|2
889500|NCT00654368|1857742|FG001|Overall Study|Non-compliance|1
889501|NCT00654368|1857743|FG002|Overall Study|Non-compliance|2
889502|NCT00654368|1857741|FG000|Overall Study|Withdrawal by Subject|5
889503|NCT00654368|1857742|FG001|Overall Study|Withdrawal by Subject|2
889504|NCT00654368|1857743|FG002|Overall Study|Withdrawal by Subject|2
889505|NCT00654368|1857741|FG000|Overall Study|Disease progression|21
889506|NCT00654368|1857742|FG001|Overall Study|Disease progression|31
889507|NCT00654368|1857743|FG002|Overall Study|Disease progression|13
889508|NCT00654368|1857741|FG000|Overall Study|Requirement for alternative therapy|1
889509|NCT00654368|1857742|FG001|Overall Study|Requirement for alternative therapy|1
889510|NCT00654368|1857743|FG002|Overall Study|Requirement for alternative therapy|1
889511|NCT00654368|1857741|FG000|Overall Study|Physician Decision|0
889512|NCT00654368|1857742|FG001|Overall Study|Physician Decision|0
889513|NCT00654368|1857743|FG002|Overall Study|Physician Decision|2
889514|NCT00654368|1857741|FG000|Overall Study|Death|1
889515|NCT00654368|1857742|FG001|Overall Study|Death|0
889516|NCT00654368|1857743|FG002|Overall Study|Death|0
889517|NCT00654368|1857741|FG000|Overall Study|Pregnancy|0
889518|NCT00654368|1857742|FG001|Overall Study|Pregnancy|0
889519|NCT00654368|1857743|FG002|Overall Study|Pregnancy|2
889520|NCT00654368|1857741|FG000|Overall Study|Other|0
889521|NCT00654368|1857742|FG001|Overall Study|Other|2
889522|NCT00654368|1857743|FG002|Overall Study|Other|3
889523|NCT00654368|1857741|FG000|Overall Study|Adverse Event|14
889524|NCT00654368|1857742|FG001|Overall Study|Adverse Event|9
889525|NCT00654368|1857743|FG002|Overall Study|Adverse Event|6
889526|NCT00654381|1857754|FG000|1st Stage|Adverse Event|3
889527|NCT00654381|1857755|FG001|1st Stage|Adverse Event|3
889528|NCT00654381|1857756|FG002|1st Stage|Adverse Event|3
889529|NCT00654381|1857757|FG003|1st Stage|Adverse Event|3
889530|NCT00654381|1857758|FG004|1st Stage|Adverse Event|2
889531|NCT00654381|1857759|FG005|1st Stage|Adverse Event|1
889532|NCT00654381|1857754|FG000|1st Stage|Withdrawal by Subject|0
889533|NCT00654381|1857755|FG001|1st Stage|Withdrawal by Subject|0
889534|NCT00654381|1857756|FG002|1st Stage|Withdrawal by Subject|0
889535|NCT00654381|1857757|FG003|1st Stage|Withdrawal by Subject|1
889536|NCT00654381|1857758|FG004|1st Stage|Withdrawal by Subject|0
889537|NCT00654381|1857759|FG005|1st Stage|Withdrawal by Subject|1
889538|NCT00654381|1857754|FG000|1st Stage|Investigator's decision|0
889539|NCT00654381|1857755|FG001|1st Stage|Investigator's decision|0
889540|NCT00654381|1857756|FG002|1st Stage|Investigator's decision|0
889541|NCT00654381|1857757|FG003|1st Stage|Investigator's decision|1
889542|NCT00654381|1857758|FG004|1st Stage|Investigator's decision|0
889543|NCT00654381|1857759|FG005|1st Stage|Investigator's decision|0
889544|NCT00654381|1857754|FG000|2nd Stage|Adverse Event|2
889545|NCT00654381|1857755|FG001|2nd Stage|Adverse Event|0
889546|NCT00654381|1857756|FG002|2nd Stage|Adverse Event|2
889547|NCT00654381|1857757|FG003|2nd Stage|Adverse Event|3
889548|NCT00654381|1857758|FG004|2nd Stage|Adverse Event|7
889549|NCT00654381|1857759|FG005|2nd Stage|Adverse Event|2
889550|NCT00654381|1857754|FG000|2nd Stage|Withdrawal by Subject|0
889551|NCT00654381|1857755|FG001|2nd Stage|Withdrawal by Subject|0
889552|NCT00654381|1857756|FG002|2nd Stage|Withdrawal by Subject|0
889553|NCT00654381|1857757|FG003|2nd Stage|Withdrawal by Subject|0
889554|NCT00654381|1857758|FG004|2nd Stage|Withdrawal by Subject|1
889555|NCT00654381|1857759|FG005|2nd Stage|Withdrawal by Subject|1
889556|NCT00654381|1857754|FG000|2nd Stage|Investigator's decision|0
889557|NCT00654381|1857755|FG001|2nd Stage|Investigator's decision|0
889558|NCT00654381|1857756|FG002|2nd Stage|Investigator's decision|1
889559|NCT00654381|1857757|FG003|2nd Stage|Investigator's decision|1
889560|NCT00654381|1857758|FG004|2nd Stage|Investigator's decision|0
889561|NCT00654381|1857759|FG005|2nd Stage|Investigator's decision|0
889562|NCT00654381|1857754|FG000|Extension Stage|Adverse Event|1
889563|NCT00654381|1857755|FG001|Extension Stage|Adverse Event|2
889564|NCT00654381|1857756|FG002|Extension Stage|Adverse Event|9
889565|NCT00654381|1857757|FG003|Extension Stage|Adverse Event|7
889566|NCT00654381|1857758|FG004|Extension Stage|Adverse Event|1
889567|NCT00654381|1857759|FG005|Extension Stage|Adverse Event|1
889568|NCT00654381|1857754|FG000|Extension Stage|Protocol Violation|0
889569|NCT00654381|1857755|FG001|Extension Stage|Protocol Violation|0
889570|NCT00654381|1857756|FG002|Extension Stage|Protocol Violation|0
889571|NCT00654381|1857757|FG003|Extension Stage|Protocol Violation|1
889572|NCT00654381|1857758|FG004|Extension Stage|Protocol Violation|0
889573|NCT00654381|1857759|FG005|Extension Stage|Protocol Violation|0
889574|NCT00654381|1857754|FG000|Extension Stage|Lack of Efficacy|0
889575|NCT00654381|1857755|FG001|Extension Stage|Lack of Efficacy|0
889576|NCT00654381|1857756|FG002|Extension Stage|Lack of Efficacy|1
889577|NCT00654381|1857757|FG003|Extension Stage|Lack of Efficacy|0
889578|NCT00654381|1857758|FG004|Extension Stage|Lack of Efficacy|0
889579|NCT00654381|1857759|FG005|Extension Stage|Lack of Efficacy|0
889580|NCT00654381|1857754|FG000|Extension Stage|Withdrawal by Subject|0
889581|NCT00654381|1857755|FG001|Extension Stage|Withdrawal by Subject|0
889582|NCT00654381|1857756|FG002|Extension Stage|Withdrawal by Subject|1
889583|NCT00654381|1857757|FG003|Extension Stage|Withdrawal by Subject|1
889584|NCT00654381|1857758|FG004|Extension Stage|Withdrawal by Subject|1
889585|NCT00654381|1857759|FG005|Extension Stage|Withdrawal by Subject|1
889586|NCT00654381|1857754|FG000|Extension Stage|Closure of the trial site|0
889587|NCT00654381|1857755|FG001|Extension Stage|Closure of the trial site|0
889588|NCT00654381|1857756|FG002|Extension Stage|Closure of the trial site|0
889589|NCT00654381|1857757|FG003|Extension Stage|Closure of the trial site|0
889590|NCT00654381|1857758|FG004|Extension Stage|Closure of the trial site|1
889591|NCT00654381|1857759|FG005|Extension Stage|Closure of the trial site|1
889592|NCT00654420|1857780|FG000|Phase I (Dose Escalation)|Adverse Event|0
889593|NCT00654420|1857781|FG001|Phase I (Dose Escalation)|Adverse Event|1
889594|NCT00654420|1857782|FG002|Phase I (Dose Escalation)|Adverse Event|0
889595|NCT00654420|1857783|FG003|Phase I (Dose Escalation)|Adverse Event|0
889596|NCT00654420|1857780|FG000|Phase I (Dose Escalation)|Progressive Disease|4
889597|NCT00654420|1857781|FG001|Phase I (Dose Escalation)|Progressive Disease|15
889598|NCT00654420|1857782|FG002|Phase I (Dose Escalation)|Progressive Disease|0
889599|NCT00654420|1857783|FG003|Phase I (Dose Escalation)|Progressive Disease|0
889600|NCT00654420|1857780|FG000|Phase II|Adverse Event|0
889601|NCT00654420|1857781|FG001|Phase II|Adverse Event|0
889602|NCT00654420|1857782|FG002|Phase II|Adverse Event|3
889603|NCT00654420|1857783|FG003|Phase II|Adverse Event|3
889604|NCT00654420|1857780|FG000|Phase II|Lost to Follow-up|0
889605|NCT00654420|1857781|FG001|Phase II|Lost to Follow-up|0
889606|NCT00654420|1857782|FG002|Phase II|Lost to Follow-up|0
889607|NCT00654420|1857783|FG003|Phase II|Lost to Follow-up|1
889608|NCT00654420|1857780|FG000|Phase II|Physician Decision|0
889609|NCT00654420|1857781|FG001|Phase II|Physician Decision|0
889610|NCT00654420|1857782|FG002|Phase II|Physician Decision|0
889611|NCT00654420|1857783|FG003|Phase II|Physician Decision|4
889612|NCT00654420|1857780|FG000|Phase II|Progressive Disease|0
889613|NCT00654420|1857781|FG001|Phase II|Progressive Disease|0
889614|NCT00654420|1857782|FG002|Phase II|Progressive Disease|29
889615|NCT00654420|1857783|FG003|Phase II|Progressive Disease|29
889616|NCT00654420|1857780|FG000|Phase II|Withdrawal by Subject|0
889617|NCT00654420|1857781|FG001|Phase II|Withdrawal by Subject|0
889618|NCT00654420|1857782|FG002|Phase II|Withdrawal by Subject|4
889619|NCT00654420|1857783|FG003|Phase II|Withdrawal by Subject|1
889620|NCT00654420|1857780|FG000|Phase II|Missing Disposition Record|0
889621|NCT00654420|1857781|FG001|Phase II|Missing Disposition Record|0
889622|NCT00654420|1857782|FG002|Phase II|Missing Disposition Record|1
889623|NCT00654420|1857783|FG003|Phase II|Missing Disposition Record|0
889624|NCT00654498|1857795|FG000|Overall Study|Not Treated|1
889625|NCT00654498|1857796|FG001|Overall Study|Not Treated|0
889626|NCT00654498|1857795|FG000|Overall Study|Adverse Event|6
889627|NCT00654498|1857796|FG001|Overall Study|Adverse Event|1
889628|NCT00654498|1857795|FG000|Overall Study|Protocol Violation|1
889629|NCT00654498|1857796|FG001|Overall Study|Protocol Violation|1
889630|NCT00654498|1857795|FG000|Overall Study|Lost to Follow-up|1
889631|NCT00654498|1857796|FG001|Overall Study|Lost to Follow-up|5
889632|NCT00654498|1857795|FG000|Overall Study|Withdrawal by Subject|1
889633|NCT00654498|1857796|FG001|Overall Study|Withdrawal by Subject|0
889634|NCT00654498|1857795|FG000|Overall Study|Other reason not defined above|4
889635|NCT00654498|1857796|FG001|Overall Study|Other reason not defined above|5
889636|NCT00654628|1857832|FG000|6-week Active Treatment Period|Adverse Event|9
889637|NCT00654628|1857832|FG000|6-week Active Treatment Period|Lost to Follow-up|10
889638|NCT00654628|1857832|FG000|6-week Active Treatment Period|Transferred to branch hospital|1
889639|NCT00654628|1857832|FG000|6-week Active Treatment Period|Out of window period|1
889640|NCT00654628|1857832|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4
889641|NCT00654628|1857832|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1
889642|NCT00654641|1857838|FG000|Overall Study|Lost to Follow-up|2
889643|NCT00654641|1857839|FG001|Overall Study|Lost to Follow-up|3
889644|NCT00654732|1857851|FG000|Overall Study|Adverse Event|4
889645|NCT00654732|1857852|FG001|Overall Study|Adverse Event|6
889646|NCT00654745|1857858|FG000|Overall Study|Adverse Event|12
889647|NCT00654745|1857858|FG000|Overall Study|Lost to Follow-up|7
889648|NCT00654745|1857858|FG000|Overall Study|Protocol Violation|11
889649|NCT00654745|1857858|FG000|Overall Study|Withdrawal by Subject|10
889650|NCT00654745|1857858|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3
889651|NCT00654875|1857883|FG000|Overall Study|Adverse Event|5
889652|NCT00654875|1857884|FG001|Overall Study|Adverse Event|5
889653|NCT00654875|1857883|FG000|Overall Study|Withdrawal by Subject|4
889654|NCT00654875|1857884|FG001|Overall Study|Withdrawal by Subject|4
889655|NCT00654875|1857883|FG000|Overall Study|Protocol Violation|3
889656|NCT00654875|1857884|FG001|Overall Study|Protocol Violation|3
889657|NCT00654875|1857883|FG000|Overall Study|Lack of Efficacy|2
889658|NCT00654875|1857884|FG001|Overall Study|Lack of Efficacy|2
889659|NCT00654875|1857883|FG000|Overall Study|Lost to Follow-up|1
889660|NCT00654875|1857884|FG001|Overall Study|Lost to Follow-up|3
889661|NCT00654875|1857883|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
889662|NCT00654875|1857884|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
889663|NCT00654875|1857883|FG000|Overall Study|Administrative Problems|1
889664|NCT00654875|1857884|FG001|Overall Study|Administrative Problems|0
889665|NCT00654901|1857894|FG000|Overall Study|Lost to Follow-up|1
889666|NCT00654901|1857895|FG001|Overall Study|Lost to Follow-up|0
889667|NCT00654901|1857896|FG002|Overall Study|Lost to Follow-up|1
889668|NCT00654901|1857897|FG003|Overall Study|Lost to Follow-up|0
889669|NCT00654901|1857894|FG000|Overall Study|Withdrawal by Subject|3
889670|NCT00654901|1857895|FG001|Overall Study|Withdrawal by Subject|0
889671|NCT00654901|1857896|FG002|Overall Study|Withdrawal by Subject|1
889672|NCT00654901|1857897|FG003|Overall Study|Withdrawal by Subject|0
889673|NCT00654940|1857913|FG000|Period 1|Adverse Event|0
889674|NCT00654940|1857914|FG001|Period 1|Adverse Event|1
889675|NCT00654940|1857913|FG000|Period 1|Intolerable Pain Level|1
889676|NCT00654940|1857914|FG001|Period 1|Intolerable Pain Level|0
889677|NCT00655356|1857957|FG000|Overall Study|Withdrawal by Subject|3
889678|NCT00655356|1857958|FG001|Overall Study|Withdrawal by Subject|4
889679|NCT00655356|1857957|FG000|Overall Study|Sponsor Request|10
889680|NCT00655356|1857958|FG001|Overall Study|Sponsor Request|4
889681|NCT00655356|1857957|FG000|Overall Study|Adverse Event|1
889682|NCT00655356|1857958|FG001|Overall Study|Adverse Event|1
889683|NCT00655356|1857957|FG000|Overall Study|Protocol Violation|2
889684|NCT00655356|1857958|FG001|Overall Study|Protocol Violation|1
889685|NCT00655356|1857957|FG000|Overall Study|Other Reason|1
889686|NCT00655356|1857958|FG001|Overall Study|Other Reason|0
889687|NCT00655486|1857973|FG000|Overall Study|Adverse Event|10
889688|NCT00655486|1857973|FG000|Overall Study|Lack of Efficacy|8
889689|NCT00655486|1857973|FG000|Overall Study|Withdrawal by Subject|4
889690|NCT00655486|1857973|FG000|Overall Study|Protocol Violation|1
889691|NCT00655486|1857973|FG000|Overall Study|Unsatisfactory compliance|2
889692|NCT00655486|1857973|FG000|Overall Study|Other: Pregnancy|1
889693|NCT00655486|1857973|FG000|Overall Study|Other: Could not tolerate BID dosing|1
889694|NCT00655486|1857973|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
889695|NCT00655499|1857977|FG000|Overall Study|not eligible|4
889696|NCT00655551|1857994|FG000|All Periods Combined|Adverse Event|0
889697|NCT00655551|1857995|FG001|All Periods Combined|Adverse Event|3
889698|NCT00655551|1857996|FG002|All Periods Combined|Adverse Event|4
889699|NCT00655551|1857994|FG000|Period 2 (up to 7 Days)|Adverse Event|0
889700|NCT00655551|1857995|FG001|Period 2 (up to 7 Days)|Adverse Event|1
889701|NCT00655551|1857996|FG002|Period 2 (up to 7 Days)|Adverse Event|0
889702|NCT00655551|1857994|FG000|Period 3 (up to 7 Days)|Adverse Event|0
889703|NCT00655551|1857995|FG001|Period 3 (up to 7 Days)|Adverse Event|0
889704|NCT00655551|1857996|FG002|Period 3 (up to 7 Days)|Adverse Event|4
889705|NCT00655551|1857994|FG000|Period 4 (up to 7 Days)|Adverse Event|0
889706|NCT00655551|1857995|FG001|Period 4 (up to 7 Days)|Adverse Event|2
889707|NCT00655551|1857996|FG002|Period 4 (up to 7 Days)|Adverse Event|0
889708|NCT00655564|1858004|FG000|Overall Study|Adverse Event|1
889709|NCT00655564|1858004|FG000|Overall Study|Lost to Follow-up|1
889710|NCT00655564|1858004|FG000|Overall Study|Desired Alternate Therapy|1
889711|NCT00655629|1858011|FG000|Overall Study|Adverse Event|4
889712|NCT00655629|1858012|FG001|Overall Study|Adverse Event|1
889713|NCT00655629|1858011|FG000|Overall Study|Lack of Efficacy|2
889714|NCT00655629|1858012|FG001|Overall Study|Lack of Efficacy|12
889715|NCT00655629|1858011|FG000|Overall Study|Lost to Follow-up|4
889716|NCT00655629|1858012|FG001|Overall Study|Lost to Follow-up|3
889717|NCT00655629|1858011|FG000|Overall Study|Protocol Violation|5
889718|NCT00655629|1858012|FG001|Overall Study|Protocol Violation|3
889719|NCT00655629|1858011|FG000|Overall Study|consent withdrawn|6
889720|NCT00655629|1858012|FG001|Overall Study|consent withdrawn|4
889721|NCT00655668|1858035|FG000|Overall Study|Adverse Event|6
889722|NCT00655668|1858035|FG000|Overall Study|Death|5
889723|NCT00655668|1858035|FG000|Overall Study|Disease Progression|27
889724|NCT00655668|1858035|FG000|Overall Study|Study Terminated|9
889725|NCT00655668|1858035|FG000|Overall Study|Other|1
889726|NCT00655668|1858035|FG000|Overall Study|New Lymphoma Treatment Started|4
889727|NCT00655668|1858035|FG000|Overall Study|Withdrawal by Subject|2
889728|NCT00655733|1858046|FG000|Overall Study|Lost to Follow-up|2
889729|NCT00655733|1858047|FG001|Overall Study|Lost to Follow-up|2
889730|NCT00655733|1858046|FG000|Overall Study|Adverse Event|2
889731|NCT00655733|1858047|FG001|Overall Study|Adverse Event|2
889732|NCT00655733|1858046|FG000|Overall Study|Withdrawal by Subject|3
889733|NCT00655733|1858047|FG001|Overall Study|Withdrawal by Subject|3
889734|NCT00655733|1858046|FG000|Overall Study|Physician Decision|0
889735|NCT00655733|1858047|FG001|Overall Study|Physician Decision|1
889736|NCT00655746|1858055|FG000|Overall Study|Withdrawal by Subject|1
889737|NCT00655850|1858077|FG000|Overall Study|Death|2
889738|NCT00655850|1858077|FG000|Overall Study|Withdrawal by Subject|1
889739|NCT00655863|1858086|FG000|Overall Study|Lost to Follow-up|0
889740|NCT00655863|1858087|FG001|Overall Study|Lost to Follow-up|0
889741|NCT00655863|1858088|FG002|Overall Study|Lost to Follow-up|1
889742|NCT00655876|1858098|FG000|Overall Study|Protocol Violation|9
889743|NCT00655876|1858099|FG001|Overall Study|Protocol Violation|7
889744|NCT00655889|1858105|FG000|Overall Study|Inadequate cell growth|1
889745|NCT00655889|1858105|FG000|Overall Study|Protocol Violation|1
889746|NCT00655928|1858111|FG000|Overall Study|Withdrawal by Subject|2
889747|NCT00655928|1858112|FG001|Overall Study|Withdrawal by Subject|1
889748|NCT00655928|1858111|FG000|Overall Study|Physician Decision|1
889749|NCT00655928|1858112|FG001|Overall Study|Physician Decision|1
889750|NCT00655980|1858121|FG000|Overall Study|surgery canceled; or subject or anesthes|26
889751|NCT00655980|1858122|FG001|Overall Study|surgery canceled; or subject or anesthes|31
889752|NCT00655980|1858123|FG002|Overall Study|surgery canceled; or subject or anesthes|5
889753|NCT00656019|1858138|FG000|Overall Study|Not Eligible|10
889754|NCT00656019|1858139|FG001|Overall Study|Not Eligible|0
889755|NCT00656019|1858140|FG002|Overall Study|Not Eligible|0
889756|NCT00656019|1858141|FG003|Overall Study|Not Eligible|0
889757|NCT00656019|1858138|FG000|Overall Study|Withdrawal by Subject|2
889758|NCT00656019|1858139|FG001|Overall Study|Withdrawal by Subject|0
889759|NCT00656019|1858140|FG002|Overall Study|Withdrawal by Subject|0
889760|NCT00656019|1858141|FG003|Overall Study|Withdrawal by Subject|0
889761|NCT00656019|1858138|FG000|Overall Study|Lost to Follow-up|2
889762|NCT00656019|1858139|FG001|Overall Study|Lost to Follow-up|1
889763|NCT00656019|1858140|FG002|Overall Study|Lost to Follow-up|0
889764|NCT00656019|1858141|FG003|Overall Study|Lost to Follow-up|0
889765|NCT00656058|1858151|FG000|Overall Study|Withdrawal by Subject|2
889766|NCT00656058|1858151|FG000|Overall Study|Withdrawal by Subject|4
889767|NCT00656084|1858155|FG000|Overall Study|Adverse Event|4
889768|NCT00656084|1858155|FG000|Overall Study|Withdrawal by Subject|1
889769|NCT00656084|1858155|FG000|Overall Study|Patient Request|1
889770|NCT00656084|1858155|FG000|Overall Study|Investigator Request|1
889771|NCT00656136|1858161|FG000|Overall Study|Progressive disease|177
889772|NCT00656136|1858162|FG001|Overall Study|Progressive disease|322
889773|NCT00656136|1858161|FG000|Overall Study|Other Adverse Event|5
889774|NCT00656136|1858162|FG001|Overall Study|Other Adverse Event|51
889775|NCT00656136|1858161|FG000|Overall Study|Protocol Violation|2
889776|NCT00656136|1858162|FG001|Overall Study|Protocol Violation|3
889777|NCT00656136|1858161|FG000|Overall Study|Patient refused to take study medication|7
889778|NCT00656136|1858162|FG001|Overall Study|Patient refused to take study medication|10
889779|NCT00656136|1858161|FG000|Overall Study|Unknown and others|4
889780|NCT00656136|1858162|FG001|Overall Study|Unknown and others|4
889781|NCT00656175|1858170|FG000|Overall Study|Adverse Event|1
889782|NCT00656175|1858171|FG001|Overall Study|Adverse Event|0
889783|NCT00656175|1858170|FG000|Overall Study|Transportation issues|0
889784|NCT00656175|1858171|FG001|Overall Study|Transportation issues|1
889785|NCT00656292|1858188|FG000|Overall Study|Withdrawal by Subject|2
889786|NCT00656292|1858189|FG001|Overall Study|Withdrawal by Subject|3
889787|NCT00656292|1858188|FG000|Overall Study|Screen failure|1
889788|NCT00656292|1858189|FG001|Overall Study|Screen failure|2
889789|NCT00656370|1858204|FG000|Overall Study|Screen Failures|7
889790|NCT00656370|1858204|FG000|Overall Study|Alternates|3
889791|NCT00656474|1858220|FG000|Overall Study|Other Reason|1
889792|NCT00656513|1858241|FG000|Overall Study|Protocol Violation|1
889793|NCT00656513|1858242|FG001|Overall Study|Protocol Violation|0
889794|NCT00656513|1858243|FG002|Overall Study|Protocol Violation|2
889795|NCT00656513|1858241|FG000|Overall Study|Withdrawal by Subject|0
889796|NCT00656513|1858242|FG001|Overall Study|Withdrawal by Subject|11
889797|NCT00656513|1858243|FG002|Overall Study|Withdrawal by Subject|4
889798|NCT00656513|1858241|FG000|Overall Study|Death|0
889799|NCT00656513|1858242|FG001|Overall Study|Death|0
889800|NCT00656513|1858243|FG002|Overall Study|Death|1
889801|NCT00656513|1858241|FG000|Overall Study|Missing data|0
889802|NCT00656513|1858242|FG001|Overall Study|Missing data|11
889803|NCT00656513|1858243|FG002|Overall Study|Missing data|9
889804|NCT00656513|1858241|FG000|Overall Study|Incomplete treatment|3
889805|NCT00656513|1858242|FG001|Overall Study|Incomplete treatment|0
889806|NCT00656513|1858243|FG002|Overall Study|Incomplete treatment|0
889807|NCT00656513|1858241|FG000|Overall Study|Treatment completed outside of timeframe|0
889808|NCT00656513|1858242|FG001|Overall Study|Treatment completed outside of timeframe|3
889809|NCT00656513|1858243|FG002|Overall Study|Treatment completed outside of timeframe|1
889810|NCT00656513|1858241|FG000|Overall Study|Missing baseline form|0
889811|NCT00656513|1858242|FG001|Overall Study|Missing baseline form|5
889812|NCT00656513|1858243|FG002|Overall Study|Missing baseline form|5
889813|NCT00656617|1858251|FG000|Overall Study|Adverse Event|1
889814|NCT00656617|1858251|FG000|Overall Study|Death|2
889815|NCT00656617|1858251|FG000|Overall Study|Insurance Issues|2
889816|NCT00656617|1858251|FG000|Overall Study|Move to different clinical trial|2
889817|NCT00656669|1858273|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
889818|NCT00656669|1858273|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
889819|NCT00656669|1858273|FG000|AC (Cycles 6-9)|Adverse Event|1
889820|NCT00656669|1858273|FG000|AC (Cycles 6-9)|Did not start segment 3|1
889821|NCT00656799|1858282|FG000|Overall Study|Death|2
889822|NCT00656851|1858288|FG000|Overall Study|Withdrawal by Subject|0
889823|NCT00656851|1858289|FG001|Overall Study|Withdrawal by Subject|4
889824|NCT00657020|1858304|FG000|PERIOD 1|Adverse Event|0
889825|NCT00657020|1858305|FG001|PERIOD 1|Adverse Event|1
889826|NCT00657046|1858320|FG000|Overall Study|Adverse Event|1
889827|NCT00657046|1858321|FG001|Overall Study|Adverse Event|1
889828|NCT00657046|1858322|FG002|Overall Study|Adverse Event|0
889829|NCT00657046|1858320|FG000|Overall Study|Protocol Violation|2
889830|NCT00657046|1858321|FG001|Overall Study|Protocol Violation|2
889831|NCT00657046|1858322|FG002|Overall Study|Protocol Violation|0
889832|NCT00657046|1858320|FG000|Overall Study|Withdrawal by Subject|1
889833|NCT00657046|1858321|FG001|Overall Study|Withdrawal by Subject|0
889834|NCT00657046|1858322|FG002|Overall Study|Withdrawal by Subject|0
889835|NCT00657046|1858320|FG000|Overall Study|Death|0
889836|NCT00657046|1858321|FG001|Overall Study|Death|0
889837|NCT00657046|1858322|FG002|Overall Study|Death|1
889838|NCT00657046|1858320|FG000|Overall Study|Surgery|0
889839|NCT00657046|1858321|FG001|Overall Study|Surgery|0
889840|NCT00657046|1858322|FG002|Overall Study|Surgery|1
889841|NCT00657150|1858332|FG000|Overall Study|Adverse Event|19
889842|NCT00657150|1858333|FG001|Overall Study|Adverse Event|10
889843|NCT00657150|1858332|FG000|Overall Study|Non-compliant with protocol|5
889844|NCT00657150|1858333|FG001|Overall Study|Non-compliant with protocol|9
889845|NCT00657150|1858332|FG000|Overall Study|Lost to Follow-up|2
889846|NCT00657150|1858333|FG001|Overall Study|Lost to Follow-up|0
889847|NCT00657150|1858332|FG000|Overall Study|Withdrawal by Subject|51
889848|NCT00657150|1858333|FG001|Overall Study|Withdrawal by Subject|36
889849|NCT00657150|1858332|FG000|Overall Study|Other|38
889850|NCT00657150|1858333|FG001|Overall Study|Other|38
889851|NCT00657150|1858332|FG000|Treatment|Adverse Event|60
889852|NCT00657150|1858333|FG001|Treatment|Adverse Event|53
889853|NCT00657150|1858332|FG000|Treatment|Non-compliant with protocol|10
889854|NCT00657150|1858333|FG001|Treatment|Non-compliant with protocol|9
889855|NCT00657150|1858332|FG000|Treatment|Lost to Follow-up|1
889856|NCT00657150|1858333|FG001|Treatment|Lost to Follow-up|0
889857|NCT00657150|1858332|FG000|Treatment|Withdrawal by Subject|23
889858|NCT00657150|1858333|FG001|Treatment|Withdrawal by Subject|20
889859|NCT00657150|1858332|FG000|Treatment|Other|13
889860|NCT00657150|1858333|FG001|Treatment|Other|15
889861|NCT00657267|1858339|FG000|Overall Study|Progressive disease|45
889862|NCT00657267|1858339|FG000|Overall Study|Adverse Event|9
889863|NCT00657358|1858349|FG000|Overall Study|Lack of Efficacy|6
889864|NCT00657371|1858354|FG000|Overall Study|Poor bowel preparation|15
889865|NCT00657371|1858354|FG000|Overall Study|Unable to intubate the cecum|5
889866|NCT00657371|1858354|FG000|Overall Study|Protocol Violation|2
889867|NCT00657371|1858354|FG000|Overall Study|Device- related reasons|13
889868|NCT00657371|1858354|FG000|Overall Study|Pre-existing medical condition|4
889869|NCT00657540|1858360|FG000|Overall Study|Lost to Follow-up|1
889870|NCT00657540|1858361|FG001|Overall Study|Lost to Follow-up|4
889871|NCT00657618|1858371|FG000|Overall Study|Adverse Event|32
889872|NCT00657618|1858371|FG000|Overall Study|Withdrawal by Subject|8
889873|NCT00657618|1858371|FG000|Overall Study|negative for leishmaniasis|2
889874|NCT00657618|1858371|FG000|Overall Study|didn't start due to schedule conflicts|1
889875|NCT00657709|1858384|FG000|Overall Study|AE or Death|7
889876|NCT00657709|1858385|FG001|Overall Study|AE or Death|7
889877|NCT00657709|1858386|FG002|Overall Study|AE or Death|6
889878|NCT00657709|1858387|FG003|Overall Study|AE or Death|7
889879|NCT00657709|1858388|FG004|Overall Study|AE or Death|1
889880|NCT00657709|1858384|FG000|Overall Study|Withdrawal by Subject|7
889881|NCT00657709|1858385|FG001|Overall Study|Withdrawal by Subject|15
889882|NCT00657709|1858386|FG002|Overall Study|Withdrawal by Subject|15
889883|NCT00657709|1858387|FG003|Overall Study|Withdrawal by Subject|5
889884|NCT00657709|1858388|FG004|Overall Study|Withdrawal by Subject|9
889885|NCT00657709|1858384|FG000|Overall Study|Lost to Follow-up|9
889886|NCT00657709|1858385|FG001|Overall Study|Lost to Follow-up|9
889887|NCT00657709|1858386|FG002|Overall Study|Lost to Follow-up|7
889888|NCT00657709|1858387|FG003|Overall Study|Lost to Follow-up|1
889889|NCT00657709|1858388|FG004|Overall Study|Lost to Follow-up|21
889890|NCT00657709|1858384|FG000|Overall Study|Protocol Violation|0
889891|NCT00657709|1858385|FG001|Overall Study|Protocol Violation|2
889892|NCT00657709|1858386|FG002|Overall Study|Protocol Violation|0
889893|NCT00657709|1858387|FG003|Overall Study|Protocol Violation|1
889894|NCT00657709|1858388|FG004|Overall Study|Protocol Violation|2
889895|NCT00658021|1858417|FG000|28-Week Treatment Period|Adverse Event|3
889896|NCT00658021|1858418|FG001|28-Week Treatment Period|Adverse Event|1
889897|NCT00658021|1858419|FG002|28-Week Treatment Period|Adverse Event|0
889898|NCT00658021|1858417|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0
889899|NCT00658021|1858418|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2
889900|NCT00658021|1858419|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0
889901|NCT00658021|1858417|FG000|28-Week Treatment Period|Protocol Violation|0
889902|NCT00658021|1858418|FG001|28-Week Treatment Period|Protocol Violation|2
889903|NCT00658021|1858419|FG002|28-Week Treatment Period|Protocol Violation|1
889904|NCT00658021|1858417|FG000|28-Week Treatment Period|Withdrawal by Subject|1
889905|NCT00658021|1858418|FG001|28-Week Treatment Period|Withdrawal by Subject|1
889906|NCT00658021|1858419|FG002|28-Week Treatment Period|Withdrawal by Subject|3
889907|NCT00658021|1858417|FG000|28-Week Treatment Period|Physician Decision|1
889908|NCT00658021|1858418|FG001|28-Week Treatment Period|Physician Decision|2
889909|NCT00658021|1858419|FG002|28-Week Treatment Period|Physician Decision|1
889910|NCT00658021|1858417|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1
889911|NCT00658021|1858418|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1
889912|NCT00658021|1858419|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1
889913|NCT00658021|1858417|FG000|28-Week Treatment Period|Loss of glucose control|1
889914|NCT00658021|1858418|FG001|28-Week Treatment Period|Loss of glucose control|1
889915|NCT00658021|1858419|FG002|28-Week Treatment Period|Loss of glucose control|10
889916|NCT00658021|1858417|FG000|28-Week Treatment Period|Other|2
889917|NCT00658021|1858418|FG001|28-Week Treatment Period|Other|3
889918|NCT00658021|1858419|FG002|28-Week Treatment Period|Other|1
889919|NCT00658021|1858417|FG000|28-Week Treatment Period|Did not receive treatment|2
889920|NCT00658021|1858418|FG001|28-Week Treatment Period|Did not receive treatment|0
889921|NCT00658021|1858419|FG002|28-Week Treatment Period|Did not receive treatment|0
889922|NCT00658021|1858417|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0
889923|NCT00658021|1858418|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1
889924|NCT00658021|1858419|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0
889925|NCT00658021|1858417|FG000|Long-term Safety Follow-up Period|Physician Decision|0
889926|NCT00658021|1858418|FG001|Long-term Safety Follow-up Period|Physician Decision|2
889927|NCT00658021|1858419|FG002|Long-term Safety Follow-up Period|Physician Decision|0
889928|NCT00658320|1858440|FG000|Core Study: 12 Months|Subject withdrew consent|5
889929|NCT00658320|1858441|FG001|Core Study: 12 Months|Subject withdrew consent|3
889930|NCT00658320|1858440|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
889931|NCT00658320|1858441|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
889932|NCT00658320|1858440|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
889933|NCT00658320|1858441|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
889934|NCT00658320|1858440|FG000|Extension Study: After Month 24|Subject withdrew consent|2
889935|NCT00658320|1858441|FG001|Extension Study: After Month 24|Subject withdrew consent|0
889936|NCT00658333|1858451|FG000|Overall Study|Adverse Event|2
889937|NCT00658333|1858452|FG001|Overall Study|Adverse Event|1
889938|NCT00658359|1858461|FG000|Overall Study|Death|3
889939|NCT00658359|1858462|FG001|Overall Study|Death|1
889940|NCT00658359|1858463|FG002|Overall Study|Death|2
889941|NCT00658359|1858461|FG000|Overall Study|Adverse Event|13
889942|NCT00658359|1858462|FG001|Overall Study|Adverse Event|6
889943|NCT00658359|1858463|FG002|Overall Study|Adverse Event|9
889944|NCT00658359|1858461|FG000|Overall Study|Protocol Violation|1
889945|NCT00658359|1858462|FG001|Overall Study|Protocol Violation|0
889946|NCT00658359|1858463|FG002|Overall Study|Protocol Violation|0
889947|NCT00658359|1858461|FG000|Overall Study|Includes protocol Amendments 3 and 4|2
889948|NCT00658359|1858462|FG001|Overall Study|Includes protocol Amendments 3 and 4|31
889949|NCT00658359|1858463|FG002|Overall Study|Includes protocol Amendments 3 and 4|29
889950|NCT00658359|1858461|FG000|Overall Study|Withdrawal by Subject|7
889951|NCT00658359|1858462|FG001|Overall Study|Withdrawal by Subject|4
889952|NCT00658359|1858463|FG002|Overall Study|Withdrawal by Subject|2
889953|NCT00658359|1858461|FG000|Overall Study|Lost to Follow-up|2
889954|NCT00658359|1858462|FG001|Overall Study|Lost to Follow-up|2
889955|NCT00658359|1858463|FG002|Overall Study|Lost to Follow-up|4
889956|NCT00658359|1858461|FG000|Overall Study|Lack of Efficacy|0
889957|NCT00658359|1858462|FG001|Overall Study|Lack of Efficacy|1
889958|NCT00658359|1858463|FG002|Overall Study|Lack of Efficacy|0
889959|NCT00658528|1858496|FG000|Overall Study|Adverse Event|5
889960|NCT00658528|1858497|FG001|Overall Study|Adverse Event|7
889961|NCT00658528|1858496|FG000|Overall Study|Lost to Follow-up|14
889962|NCT00658528|1858497|FG001|Overall Study|Lost to Follow-up|22
889963|NCT00658528|1858496|FG000|Overall Study|Withdrawal by Subject|8
889964|NCT00658528|1858497|FG001|Overall Study|Withdrawal by Subject|6
889965|NCT00658528|1858496|FG000|Overall Study|Withdrawal of consent|5
889966|NCT00658528|1858497|FG001|Overall Study|Withdrawal of consent|6
889967|NCT00658528|1858496|FG000|Overall Study|Other|8
889968|NCT00658528|1858497|FG001|Overall Study|Other|4
889969|NCT00658541|1858503|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
889970|NCT00658541|1858504|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
889971|NCT00658541|1858503|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
889972|NCT00658541|1858504|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
889973|NCT00658567|1858513|FG000|Overall Study|Adverse Event|5
889974|NCT00658567|1858514|FG001|Overall Study|Adverse Event|2
889975|NCT00658567|1858515|FG002|Overall Study|Adverse Event|3
889976|NCT00658567|1858513|FG000|Overall Study|Voluntary Withdrawal of Consent|2
889977|NCT00658567|1858514|FG001|Overall Study|Voluntary Withdrawal of Consent|0
889978|NCT00658567|1858515|FG002|Overall Study|Voluntary Withdrawal of Consent|2
889979|NCT00658567|1858513|FG000|Overall Study|Physician Decision|0
889980|NCT00658567|1858514|FG001|Overall Study|Physician Decision|1
889981|NCT00658567|1858515|FG002|Overall Study|Physician Decision|0
889982|NCT00658567|1858513|FG000|Overall Study|At Discretion of Sponsor|1
889983|NCT00658567|1858514|FG001|Overall Study|At Discretion of Sponsor|1
889984|NCT00658567|1858515|FG002|Overall Study|At Discretion of Sponsor|1
889985|NCT00658606|1858525|FG000|Overall Study|Adverse Event|2
889986|NCT00658606|1858526|FG001|Overall Study|Adverse Event|1
889987|NCT00658606|1858525|FG000|Overall Study|Lack of Efficacy|6
889988|NCT00658606|1858526|FG001|Overall Study|Lack of Efficacy|3
889989|NCT00658606|1858525|FG000|Overall Study|Lost to Follow-up|1
889990|NCT00658606|1858526|FG001|Overall Study|Lost to Follow-up|0
889991|NCT00658606|1858525|FG000|Overall Study|Withdrawal by Subject|7
889992|NCT00658606|1858526|FG001|Overall Study|Withdrawal by Subject|16
889993|NCT00658606|1858525|FG000|Overall Study|Lack of Compliance|0
889994|NCT00658606|1858526|FG001|Overall Study|Lack of Compliance|3
889995|NCT00658632|1858552|FG000|Overall Study|Adverse Event|13
889996|NCT00658632|1858553|FG001|Overall Study|Adverse Event|11
889997|NCT00658632|1858552|FG000|Overall Study|Lost to Follow-up|25
889998|NCT00658632|1858553|FG001|Overall Study|Lost to Follow-up|23
889999|NCT00658632|1858552|FG000|Overall Study|Withdrawal by Subject|10
890000|NCT00658632|1858553|FG001|Overall Study|Withdrawal by Subject|7
890001|NCT00658632|1858552|FG000|Overall Study|Lack of Efficacy|0
890002|NCT00658632|1858553|FG001|Overall Study|Lack of Efficacy|1
890003|NCT00658632|1858552|FG000|Overall Study|Withdrawal of consent|8
890004|NCT00658632|1858553|FG001|Overall Study|Withdrawal of consent|14
890005|NCT00658632|1858552|FG000|Overall Study|Pregnancy|1
890006|NCT00658632|1858553|FG001|Overall Study|Pregnancy|1
890007|NCT00658632|1858552|FG000|Overall Study|Other|7
890008|NCT00658632|1858553|FG001|Overall Study|Other|8
890009|NCT00658658|1858564|FG000|Overall Study|Withdrawal by Subject|0
890010|NCT00658658|1858565|FG001|Overall Study|Withdrawal by Subject|1
890011|NCT00658658|1858566|FG002|Overall Study|Withdrawal by Subject|0
890012|NCT00658658|1858567|FG003|Overall Study|Withdrawal by Subject|0
890013|NCT00658658|1858568|FG004|Overall Study|Withdrawal by Subject|0
890014|NCT00658658|1858564|FG000|Overall Study|Death|4
890015|NCT00658658|1858565|FG001|Overall Study|Death|0
890016|NCT00658658|1858566|FG002|Overall Study|Death|0
890017|NCT00658658|1858567|FG003|Overall Study|Death|1
890018|NCT00658658|1858568|FG004|Overall Study|Death|1
890019|NCT00658658|1858564|FG000|Overall Study|Disease Progression|0
890020|NCT00658658|1858565|FG001|Overall Study|Disease Progression|1
890021|NCT00658658|1858566|FG002|Overall Study|Disease Progression|0
890022|NCT00658658|1858567|FG003|Overall Study|Disease Progression|1
890023|NCT00658658|1858568|FG004|Overall Study|Disease Progression|3
890024|NCT00658658|1858564|FG000|Overall Study|Protocol-specified Criteria|1
890025|NCT00658658|1858565|FG001|Overall Study|Protocol-specified Criteria|0
890026|NCT00658658|1858566|FG002|Overall Study|Protocol-specified Criteria|0
890027|NCT00658658|1858567|FG003|Overall Study|Protocol-specified Criteria|0
890028|NCT00658658|1858568|FG004|Overall Study|Protocol-specified Criteria|0
890029|NCT00658658|1858564|FG000|Overall Study|Other|0
890030|NCT00658658|1858565|FG001|Overall Study|Other|0
890031|NCT00658658|1858566|FG002|Overall Study|Other|0
890032|NCT00658658|1858567|FG003|Overall Study|Other|0
890033|NCT00658658|1858568|FG004|Overall Study|Other|1
890034|NCT00658684|1858583|FG000|Overall Study|Adverse Event|10
890035|NCT00658684|1858584|FG001|Overall Study|Adverse Event|8
890036|NCT00658684|1858585|FG002|Overall Study|Adverse Event|2
890037|NCT00658684|1858586|FG003|Overall Study|Adverse Event|0
890038|NCT00658684|1858583|FG000|Overall Study|Withdrawal by Subject|6
890039|NCT00658684|1858584|FG001|Overall Study|Withdrawal by Subject|4
890040|NCT00658684|1858585|FG002|Overall Study|Withdrawal by Subject|1
890041|NCT00658684|1858586|FG003|Overall Study|Withdrawal by Subject|1
890042|NCT00658684|1858583|FG000|Overall Study|Lack of Efficacy|1
890043|NCT00658684|1858584|FG001|Overall Study|Lack of Efficacy|1
890044|NCT00658684|1858585|FG002|Overall Study|Lack of Efficacy|0
890045|NCT00658684|1858586|FG003|Overall Study|Lack of Efficacy|0
890046|NCT00658684|1858583|FG000|Overall Study|Protocol Violation|1
890047|NCT00658684|1858584|FG001|Overall Study|Protocol Violation|1
890048|NCT00658684|1858585|FG002|Overall Study|Protocol Violation|0
890049|NCT00658684|1858586|FG003|Overall Study|Protocol Violation|0
890050|NCT00658684|1858583|FG000|Overall Study|Pregnancy|1
890051|NCT00658684|1858584|FG001|Overall Study|Pregnancy|1
890052|NCT00658684|1858585|FG002|Overall Study|Pregnancy|0
890053|NCT00658684|1858586|FG003|Overall Study|Pregnancy|0
890054|NCT00658723|1858604|FG000|Overall Study|Lost to Follow-up|0
890055|NCT00658723|1858605|FG001|Overall Study|Lost to Follow-up|2
890056|NCT00658723|1858606|FG002|Overall Study|Lost to Follow-up|2
890057|NCT00658723|1858604|FG000|Overall Study|Death|2
890058|NCT00658723|1858605|FG001|Overall Study|Death|1
890059|NCT00658723|1858606|FG002|Overall Study|Death|4
890060|NCT00658723|1858604|FG000|Overall Study|Scheduling Issue|1
890061|NCT00658723|1858605|FG001|Overall Study|Scheduling Issue|1
890062|NCT00658723|1858606|FG002|Overall Study|Scheduling Issue|0
890063|NCT00658723|1858604|FG000|Overall Study|Withdrawal by Subject|1
890064|NCT00658723|1858605|FG001|Overall Study|Withdrawal by Subject|0
890065|NCT00658723|1858606|FG002|Overall Study|Withdrawal by Subject|1
890066|NCT00658775|1858628|FG000|Overall Study|Adverse Event|4
890067|NCT00658775|1858629|FG001|Overall Study|Adverse Event|6
890068|NCT00658775|1858628|FG000|Overall Study|Lost to Follow-up|17
890069|NCT00658775|1858629|FG001|Overall Study|Lost to Follow-up|18
890070|NCT00658775|1858628|FG000|Overall Study|Withdrawal by Subject|6
890071|NCT00658775|1858629|FG001|Overall Study|Withdrawal by Subject|4
890072|NCT00658775|1858628|FG000|Overall Study|Withdrawal of consent|8
890073|NCT00658775|1858629|FG001|Overall Study|Withdrawal of consent|7
890074|NCT00658775|1858628|FG000|Overall Study|Other|7
890075|NCT00658775|1858629|FG001|Overall Study|Other|8
890076|NCT00658788|1858635|FG000|Overall Study|Adverse Event|11
890077|NCT00658788|1858635|FG000|Overall Study|Withdrawal by Subject|13
890078|NCT00658788|1858635|FG000|Overall Study|Lost to Follow-up|18
890079|NCT00658788|1858635|FG000|Overall Study|Treatment Discontinuation|32
890080|NCT00658814|1858650|FG000|Remission Induction Chemotherapy|Adverse Event|1
890081|NCT00658814|1858651|FG001|Remission Induction Chemotherapy|Adverse Event|3
890082|NCT00658814|1858650|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3
890083|NCT00658814|1858651|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4
890084|NCT00658814|1858650|FG000|Remission Induction Chemotherapy|Progression/Relapse|0
890085|NCT00658814|1858651|FG001|Remission Induction Chemotherapy|Progression/Relapse|1
890086|NCT00658814|1858650|FG000|Remission Induction Chemotherapy|Death|1
890087|NCT00658814|1858651|FG001|Remission Induction Chemotherapy|Death|4
890088|NCT00658814|1858650|FG000|Remission Induction Chemotherapy|Not protocol specified|2
890089|NCT00658814|1858651|FG001|Remission Induction Chemotherapy|Not protocol specified|4
890090|NCT00658814|1858650|FG000|Remission Induction Chemotherapy|Not eligible|1
890091|NCT00658814|1858651|FG001|Remission Induction Chemotherapy|Not eligible|2
890092|NCT00658814|1858650|FG000|Consolidation Therapy|Not protocol specified|0
890093|NCT00658814|1858651|FG001|Consolidation Therapy|Not protocol specified|1
890094|NCT00658814|1858650|FG000|Consolidation Therapy|Not eligible|2
890095|NCT00658814|1858651|FG001|Consolidation Therapy|Not eligible|2
890096|NCT00658814|1858650|FG000|Maintenance Therapy|Adverse Event|1
890097|NCT00658814|1858651|FG001|Maintenance Therapy|Adverse Event|1
890098|NCT00658814|1858650|FG000|Maintenance Therapy|Not protocol specified|1
890099|NCT00658814|1858651|FG001|Maintenance Therapy|Not protocol specified|0
890100|NCT00658814|1858650|FG000|Maintenance Therapy|Not eligible|1
890101|NCT00658814|1858651|FG001|Maintenance Therapy|Not eligible|0
890102|NCT00658879|1858661|FG000|Overall Study|Protocol Violation|1
890103|NCT00658996|1858665|FG000|First Intervention|Positive slit lamp finding|1
890104|NCT00658996|1858666|FG001|First Intervention|Positive slit lamp finding|0
890105|NCT00658996|1858665|FG000|First Intervention|Lack of lenses|0
890106|NCT00658996|1858666|FG001|First Intervention|Lack of lenses|1
890107|NCT00658996|1858665|FG000|Crossover Period|Physician Decision|1
890108|NCT00658996|1858666|FG001|Crossover Period|Physician Decision|0
890109|NCT00658996|1858665|FG000|Crossover Period|Ineligible|1
890110|NCT00658996|1858666|FG001|Crossover Period|Ineligible|1
890111|NCT00658996|1858665|FG000|Second Intervention|Developed a stye on upper lid|1
890112|NCT00658996|1858666|FG001|Second Intervention|Developed a stye on upper lid|0
890113|NCT00658996|1858665|FG000|Second Intervention|Positive slit lamp finding|0
890114|NCT00658996|1858666|FG001|Second Intervention|Positive slit lamp finding|1
890115|NCT00659061|1858674|FG000|Overall Study|Migration due to political unrest|21
890116|NCT00659061|1858675|FG001|Overall Study|Migration due to political unrest|15
890117|NCT00659230|1858690|FG000|Overall Study|Lost to Follow-up|2
890118|NCT00659230|1858691|FG001|Overall Study|Lost to Follow-up|5
890119|NCT00659230|1858690|FG000|Overall Study|Lost source documentation|5
890120|NCT00659230|1858691|FG001|Overall Study|Lost source documentation|4
890121|NCT00659230|1858690|FG000|Overall Study|Did not return post-randomization|2
890122|NCT00659230|1858691|FG001|Overall Study|Did not return post-randomization|3
890123|NCT00659269|1858699|FG000|Overall Study|Physician Decision|1
890124|NCT00659269|1858700|FG001|Overall Study|Physician Decision|1
890125|NCT00659334|1858731|FG000|Overall Study|Screen Failure|8
890126|NCT00659334|1858732|FG001|Overall Study|Screen Failure|5
890127|NCT00659334|1858733|FG002|Overall Study|Screen Failure|0
890128|NCT00659334|1858734|FG003|Overall Study|Screen Failure|0
890129|NCT00659334|1858735|FG004|Overall Study|Screen Failure|0
890130|NCT00659334|1858736|FG005|Overall Study|Screen Failure|0
890131|NCT00659334|1858737|FG006|Overall Study|Screen Failure|1
890132|NCT00659373|1858761|FG000|Overall Study|Withdrawal by Subject|3
890133|NCT00659373|1858762|FG001|Overall Study|Withdrawal by Subject|5
890134|NCT00659373|1858761|FG000|Overall Study|Assessment Missed|2
890135|NCT00659373|1858762|FG001|Overall Study|Assessment Missed|2
890136|NCT00659425|1858778|FG000|Overall Study|Disease progression|1
890137|NCT00659425|1858779|FG001|Overall Study|Disease progression|0
890138|NCT00659425|1858780|FG002|Overall Study|Disease progression|0
890139|NCT00659425|1858781|FG003|Overall Study|Disease progression|1
890140|NCT00659425|1858782|FG004|Overall Study|Disease progression|0
890141|NCT00659425|1858783|FG005|Overall Study|Disease progression|2
890142|NCT00659425|1858784|FG006|Overall Study|Disease progression|4
890143|NCT00659425|1858785|FG007|Overall Study|Disease progression|3
890144|NCT00659425|1858786|FG008|Overall Study|Disease progression|5
890145|NCT00659425|1858787|FG009|Overall Study|Disease progression|3
890146|NCT00659425|1858778|FG000|Overall Study|Death|0
890147|NCT00659425|1858779|FG001|Overall Study|Death|0
890148|NCT00659425|1858780|FG002|Overall Study|Death|0
890149|NCT00659425|1858781|FG003|Overall Study|Death|1
890150|NCT00659425|1858782|FG004|Overall Study|Death|0
890151|NCT00659425|1858783|FG005|Overall Study|Death|0
890152|NCT00659425|1858784|FG006|Overall Study|Death|1
890153|NCT00659425|1858785|FG007|Overall Study|Death|0
890154|NCT00659425|1858786|FG008|Overall Study|Death|0
890155|NCT00659425|1858787|FG009|Overall Study|Death|0
890156|NCT00659425|1858778|FG000|Overall Study|Adverse Event|0
890157|NCT00659425|1858779|FG001|Overall Study|Adverse Event|0
890158|NCT00659425|1858780|FG002|Overall Study|Adverse Event|0
890159|NCT00659425|1858781|FG003|Overall Study|Adverse Event|0
890160|NCT00659425|1858782|FG004|Overall Study|Adverse Event|0
890161|NCT00659425|1858783|FG005|Overall Study|Adverse Event|1
890162|NCT00659425|1858784|FG006|Overall Study|Adverse Event|0
890163|NCT00659425|1858785|FG007|Overall Study|Adverse Event|3
890164|NCT00659425|1858786|FG008|Overall Study|Adverse Event|1
890165|NCT00659425|1858787|FG009|Overall Study|Adverse Event|4
890166|NCT00659425|1858778|FG000|Overall Study|Investigator Discretion|0
890167|NCT00659425|1858779|FG001|Overall Study|Investigator Discretion|0
890168|NCT00659425|1858780|FG002|Overall Study|Investigator Discretion|0
890169|NCT00659425|1858781|FG003|Overall Study|Investigator Discretion|0
890170|NCT00659425|1858782|FG004|Overall Study|Investigator Discretion|0
890171|NCT00659425|1858783|FG005|Overall Study|Investigator Discretion|1
890172|NCT00659425|1858784|FG006|Overall Study|Investigator Discretion|0
890173|NCT00659425|1858785|FG007|Overall Study|Investigator Discretion|3
890174|NCT00659425|1858786|FG008|Overall Study|Investigator Discretion|0
890175|NCT00659425|1858787|FG009|Overall Study|Investigator Discretion|0
890176|NCT00659425|1858778|FG000|Overall Study|Other|0
890177|NCT00659425|1858779|FG001|Overall Study|Other|1
890178|NCT00659425|1858780|FG002|Overall Study|Other|1
890179|NCT00659425|1858781|FG003|Overall Study|Other|2
890180|NCT00659425|1858782|FG004|Overall Study|Other|4
890181|NCT00659425|1858783|FG005|Overall Study|Other|0
890182|NCT00659425|1858784|FG006|Overall Study|Other|3
890183|NCT00659425|1858785|FG007|Overall Study|Other|2
890184|NCT00659425|1858786|FG008|Overall Study|Other|0
890185|NCT00659425|1858787|FG009|Overall Study|Other|6
890186|NCT00659438|1858824|FG000|Overall Study|Withdrawal by Subject|2
890187|NCT00659438|1858825|FG001|Overall Study|Withdrawal by Subject|2
890188|NCT00659438|1858824|FG000|Overall Study|Death|11
890189|NCT00659438|1858825|FG001|Overall Study|Death|6
890190|NCT00659438|1858824|FG000|Overall Study|Lost to Follow-up|1
890191|NCT00659438|1858825|FG001|Overall Study|Lost to Follow-up|0
890192|NCT00659490|1858834|FG000|Overall Study|Lost to Follow-up|2
890193|NCT00659490|1858835|FG001|Overall Study|Lost to Follow-up|0
890194|NCT00659490|1858836|FG002|Overall Study|Lost to Follow-up|1
890195|NCT00659529|1858844|FG000|Overall Study|Withdrawal by Subject|4
890196|NCT00659529|1858844|FG000|Overall Study|Protocol Violation|3
890197|NCT00659529|1858844|FG000|Overall Study|Screen failure|9
890198|NCT00659581|1858848|FG000|Overall Study|Adverse Event|1006
890199|NCT00659581|1858848|FG000|Overall Study|Lack of Efficacy|1183
890200|NCT00659581|1858848|FG000|Overall Study|Other|6393
890201|NCT00659607|1858852|FG000|Overall Study|No blood pressure recorded|147
890202|NCT00659607|1858852|FG000|Overall Study|Unknown measuring date of blood pressure|85
890203|NCT00659607|1858852|FG000|Overall Study|'Unable to evaluate' for the final asses|67
890204|NCT00659607|1858852|FG000|Overall Study|No recorded efficacy data|15
890205|NCT00659607|1858852|FG000|Overall Study|Inconsistent BP measuring date|2
890214|NCT00659815|1858912|FG000|Overall Study|Study related symptoms and complaints|2
890215|NCT00659815|1858913|FG001|Overall Study|Study related symptoms and complaints|1
890216|NCT00659815|1858912|FG000|Overall Study|Inability to maintain wearing schedule|1
890217|NCT00659815|1858913|FG001|Overall Study|Inability to maintain wearing schedule|2
890218|NCT00659815|1858912|FG000|Overall Study|Withdrawal by Subject|1
890219|NCT00659815|1858913|FG001|Overall Study|Withdrawal by Subject|1
890220|NCT00659880|1858923|FG000|Overall Study|Lost to Follow-up|5
890221|NCT00659984|1858937|FG000|Overall Study|Adverse Event|1
890222|NCT00660010|1858947|FG000|Overall Study|Withdrawal by Subject|2
890223|NCT00660010|1858947|FG000|Overall Study|Lost to Follow-up|3
890224|NCT00660010|1858947|FG000|Overall Study|Adverse Event|1
890225|NCT00660010|1858947|FG000|Overall Study|Noncompliance with visit schedule|3
890226|NCT00660023|1858951|FG000|Overall Study|Adverse Event|2
890227|NCT00660023|1858951|FG000|Overall Study|Death|8
890228|NCT00660023|1858951|FG000|Overall Study|Blood Transfusion|5
890229|NCT00660023|1858951|FG000|Overall Study|Renal Transplantation|3
890230|NCT00660023|1858951|FG000|Overall Study|Withdrawal by Subject|1
890231|NCT00660023|1858951|FG000|Overall Study|Missed Pregnancy Test|1
890232|NCT00660023|1858951|FG000|Overall Study|Other Screening Failure|9
890233|NCT00660179|1858971|FG000|Overall Study|Death|44
890234|NCT00660179|1858972|FG001|Overall Study|Death|47
890235|NCT00660179|1858973|FG002|Overall Study|Death|34
890236|NCT00660179|1858971|FG000|Overall Study|Withdrawal of consent|4
890237|NCT00660179|1858972|FG001|Overall Study|Withdrawal of consent|6
890238|NCT00660179|1858973|FG002|Overall Study|Withdrawal of consent|4
890239|NCT00660179|1858971|FG000|Overall Study|Lost to Follow-up|7
890240|NCT00660179|1858972|FG001|Overall Study|Lost to Follow-up|5
890241|NCT00660179|1858973|FG002|Overall Study|Lost to Follow-up|2
890242|NCT00660179|1858971|FG000|Overall Study|Administrative reason|0
890243|NCT00660179|1858972|FG001|Overall Study|Administrative reason|0
890244|NCT00660179|1858973|FG002|Overall Study|Administrative reason|1
890245|NCT00660179|1858971|FG000|Overall Study|Incorrect randomization|1
890246|NCT00660179|1858972|FG001|Overall Study|Incorrect randomization|0
890247|NCT00660179|1858973|FG002|Overall Study|Incorrect randomization|0
890248|NCT00660192|1858983|FG000|Overall Study|Lost to Follow-up|2
890249|NCT00660192|1858984|FG001|Overall Study|Lost to Follow-up|3
890250|NCT00660309|1858992|FG000|Overall Study|Adverse Event|2
890251|NCT00660309|1858993|FG001|Overall Study|Adverse Event|0
890252|NCT00660309|1858992|FG000|Overall Study|Withdrawal by Subject|0
890253|NCT00660309|1858993|FG001|Overall Study|Withdrawal by Subject|3
890254|NCT00660387|1859002|FG000|Overall Study|Adverse Event|1
890255|NCT00660387|1859003|FG001|Overall Study|Adverse Event|2
890256|NCT00660387|1859002|FG000|Overall Study|Lack of Efficacy|0
890257|NCT00660387|1859003|FG001|Overall Study|Lack of Efficacy|1
890258|NCT00660387|1859002|FG000|Overall Study|Protocol Violation|1
890259|NCT00660387|1859003|FG001|Overall Study|Protocol Violation|0
890260|NCT00660400|1859009|FG000|Overall Study|Lack of insurance approval|1
890261|NCT00660400|1859009|FG000|Overall Study|Suboptimal organ function|1
890262|NCT00660400|1859009|FG000|Overall Study|Intracranial hemorrhage|1
890263|NCT00660400|1859009|FG000|Overall Study|Withdrawal by Subject|1
890264|NCT00660660|1859057|FG000|Overall Study|Adverse Event|1
890265|NCT00660660|1859058|FG001|Overall Study|Adverse Event|0
890266|NCT00660660|1859057|FG000|Overall Study|Lost to Follow-up|0
890267|NCT00660660|1859058|FG001|Overall Study|Lost to Follow-up|6
890268|NCT00660660|1859057|FG000|Overall Study|Lack of Efficacy|0
890269|NCT00660660|1859058|FG001|Overall Study|Lack of Efficacy|2
890270|NCT00660660|1859057|FG000|Overall Study|Withdrawal by Subject|3
890271|NCT00660660|1859058|FG001|Overall Study|Withdrawal by Subject|0
890272|NCT00660660|1859057|FG000|Overall Study|Incorrect enrollment and other|0
890273|NCT00660660|1859058|FG001|Overall Study|Incorrect enrollment and other|1
890274|NCT00660660|1859057|FG000|Overall Study|New medication after randomization|1
890275|NCT00660660|1859058|FG001|Overall Study|New medication after randomization|0
890276|NCT00660699|1859064|FG000|Overall Study|Withdrawal by Subject|2
890277|NCT00660790|1859068|FG000|Baseline to 3 Months|Death|1
890278|NCT00660790|1859068|FG000|Baseline to 3 Months|Withdrawal by Subject|2
890279|NCT00660790|1859068|FG000|3 Months to 2 Years|Withdrawal by Subject|17
890280|NCT00660816|1859074|FG000|Overall Study|Adverse Event|1
890281|NCT00660816|1859075|FG001|Overall Study|Adverse Event|2
890282|NCT00660816|1859074|FG000|Overall Study|Withdrawal by Subject|1
890283|NCT00660816|1859075|FG001|Overall Study|Withdrawal by Subject|0
890284|NCT00660816|1859074|FG000|Overall Study|Death|0
890285|NCT00660816|1859075|FG001|Overall Study|Death|2
890286|NCT00660816|1859074|FG000|Overall Study|Lack of Efficacy|1
890287|NCT00660816|1859075|FG001|Overall Study|Lack of Efficacy|0
890288|NCT00660816|1859074|FG000|Overall Study|Physician Decision|0
890289|NCT00660816|1859075|FG001|Overall Study|Physician Decision|2
890290|NCT00660816|1859074|FG000|Overall Study|Protocol Violation|1
890291|NCT00660816|1859075|FG001|Overall Study|Protocol Violation|0
890292|NCT00660816|1859074|FG000|Overall Study|Disease Progression|16
890293|NCT00660816|1859075|FG001|Overall Study|Disease Progression|12
890294|NCT00660816|1859074|FG000|Overall Study|Complicating Disease|0
890295|NCT00660816|1859075|FG001|Overall Study|Complicating Disease|1
890296|NCT00660829|1859083|FG000|Overall Study|Adverse Event|3
890297|NCT00660829|1859084|FG001|Overall Study|Adverse Event|4
890298|NCT00660829|1859083|FG000|Overall Study|Lack of Efficacy|2
890299|NCT00660829|1859084|FG001|Overall Study|Lack of Efficacy|3
890300|NCT00660829|1859083|FG000|Overall Study|Non-Compliance|0
890301|NCT00660829|1859084|FG001|Overall Study|Non-Compliance|4
890302|NCT00660829|1859083|FG000|Overall Study|Withdrawal by Subject|1
890303|NCT00660829|1859084|FG001|Overall Study|Withdrawal by Subject|2
890304|NCT00660829|1859083|FG000|Overall Study|Lost to Follow-up|3
890305|NCT00660829|1859084|FG001|Overall Study|Lost to Follow-up|2
890306|NCT00660829|1859083|FG000|Overall Study|Other|9
890307|NCT00660829|1859084|FG001|Overall Study|Other|4
890308|NCT00660907|1859092|FG000|Overall Study|Incorrect Enrollment|1
890309|NCT00660907|1859093|FG001|Overall Study|Incorrect Enrollment|1
890310|NCT00660907|1859092|FG000|Overall Study|Adverse Event|33
890311|NCT00660907|1859093|FG001|Overall Study|Adverse Event|19
890312|NCT00660907|1859092|FG000|Overall Study|Subject No Longer Meets Study Criteria|6
890313|NCT00660907|1859093|FG001|Overall Study|Subject No Longer Meets Study Criteria|27
890314|NCT00660907|1859092|FG000|Overall Study|Withdrawal by Subject|23
890315|NCT00660907|1859093|FG001|Overall Study|Withdrawal by Subject|32
890316|NCT00660907|1859092|FG000|Overall Study|Lost to Follow-up|3
890317|NCT00660907|1859093|FG001|Overall Study|Lost to Follow-up|3
890318|NCT00660907|1859092|FG000|Overall Study|Poor/Non-Compliance|5
890319|NCT00660907|1859093|FG001|Overall Study|Poor/Non-Compliance|1
890320|NCT00660907|1859092|FG000|Overall Study|Safety|1
890321|NCT00660907|1859093|FG001|Overall Study|Safety|0
890322|NCT00660907|1859092|FG000|Overall Study|Death|1
890323|NCT00660907|1859093|FG001|Overall Study|Death|3
890324|NCT00660907|1859092|FG000|Overall Study|Various|11
890325|NCT00660907|1859093|FG001|Overall Study|Various|8
890326|NCT00661089|1859121|FG000|Overall Study|1 subject withdrawal|0
890327|NCT00661089|1859122|FG001|Overall Study|1 subject withdrawal|1
890328|NCT00661089|1859121|FG000|Overall Study|death at 8 weeks due to new stroke|0
890329|NCT00661089|1859122|FG001|Overall Study|death at 8 weeks due to new stroke|1
890330|NCT00661193|1859158|FG000|Overall Study|Adverse Event|2
890331|NCT00661193|1859159|FG001|Overall Study|Adverse Event|1
890332|NCT00661193|1859158|FG000|Overall Study|Withdrawal by Subject|3
890333|NCT00661193|1859159|FG001|Overall Study|Withdrawal by Subject|1
890334|NCT00661193|1859158|FG000|Overall Study|Progression|27
890335|NCT00661193|1859159|FG001|Overall Study|Progression|24
890336|NCT00661193|1859158|FG000|Overall Study|Not protocol specified|1
890337|NCT00661193|1859159|FG001|Overall Study|Not protocol specified|0
890338|NCT00661258|1859167|FG000|Overall Study|Death|1
890339|NCT00661258|1859168|FG001|Overall Study|Death|0
890340|NCT00661258|1859167|FG000|Overall Study|caught by police and in detox center|2
890341|NCT00661258|1859168|FG001|Overall Study|caught by police and in detox center|1
890342|NCT00661271|1859176|FG000|Overall Study|Lost to Follow-up|28
890343|NCT00661271|1859177|FG001|Overall Study|Lost to Follow-up|25
890344|NCT00661362|1859185|FG000|Overall Study|Adverse Event|5
890345|NCT00661362|1859186|FG001|Overall Study|Adverse Event|4
890346|NCT00661362|1859185|FG000|Overall Study|Incorrect enrollment|2
890347|NCT00661362|1859186|FG001|Overall Study|Incorrect enrollment|0
890348|NCT00661362|1859185|FG000|Overall Study|Study specific discontinuation criteria|4
890349|NCT00661362|1859186|FG001|Overall Study|Study specific discontinuation criteria|11
890350|NCT00661362|1859185|FG000|Overall Study|Withdrawal by Subject|13
890351|NCT00661362|1859186|FG001|Overall Study|Withdrawal by Subject|23
890352|NCT00661362|1859185|FG000|Overall Study|Lost to Follow-up|3
890353|NCT00661362|1859186|FG001|Overall Study|Lost to Follow-up|1
890354|NCT00661362|1859185|FG000|Overall Study|Severe non-compliance to protocol|0
890355|NCT00661362|1859186|FG001|Overall Study|Severe non-compliance to protocol|1
890356|NCT00661362|1859185|FG000|Overall Study|Safety reasons|1
890357|NCT00661362|1859186|FG001|Overall Study|Safety reasons|0
890358|NCT00661362|1859185|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
890359|NCT00661362|1859186|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
890360|NCT00661388|1859192|FG000|Overall Study|Adverse Event|14
890361|NCT00661388|1859192|FG000|Overall Study|Protocol Violation|7
890362|NCT00661388|1859192|FG000|Overall Study|Renal transplantation|1
890363|NCT00661388|1859192|FG000|Overall Study|Dialysis initiation|1
890364|NCT00661388|1859192|FG000|Overall Study|Administrative reasons|1
890365|NCT00661427|1859198|FG000|Overall Study|Adverse Event|5
890366|NCT00661427|1859199|FG001|Overall Study|Adverse Event|5
890367|NCT00661427|1859198|FG000|Overall Study|Patient not treated|0
890368|NCT00661427|1859199|FG001|Overall Study|Patient not treated|2
890369|NCT00661492|1859227|FG000|Overall Study|Adverse Event|16
890370|NCT00661492|1859228|FG001|Overall Study|Adverse Event|13
890371|NCT00661492|1859227|FG000|Overall Study|Disease Progression|44
890372|NCT00661492|1859228|FG001|Overall Study|Disease Progression|14
890373|NCT00661492|1859227|FG000|Overall Study|Patient Request|6
890374|NCT00661492|1859228|FG001|Overall Study|Patient Request|1
890375|NCT00661492|1859227|FG000|Overall Study|Investigator Request|1
890376|NCT00661492|1859228|FG001|Overall Study|Investigator Request|0
890377|NCT00661492|1859227|FG000|Overall Study|Lost to Follow-up|0
890378|NCT00661492|1859228|FG001|Overall Study|Lost to Follow-up|1
890379|NCT00661492|1859227|FG000|Overall Study|Other|1
890380|NCT00661492|1859228|FG001|Overall Study|Other|0
890381|NCT00661505|1859234|FG000|Overall Study|Adverse Event|3
890382|NCT00661505|1859234|FG000|Overall Study|Protocol Violation|14
890383|NCT00661505|1859234|FG000|Overall Study|Withdrawal by Subject|8
890384|NCT00661505|1859234|FG000|Overall Study|Lost to Follow-up|3
890385|NCT00661505|1859234|FG000|Overall Study|Other|2
890386|NCT00661531|1859239|FG000|Overall Study|Withdrawal by Subject|3
890387|NCT00661609|1859273|FG000|Overall Study|Adverse Event|4
890388|NCT00661609|1859273|FG000|Overall Study|Death|20
890389|NCT00661609|1859273|FG000|Overall Study|Withdrawal by Subject|2
890390|NCT00661609|1859273|FG000|Overall Study|PI Decision|1
890391|NCT00661609|1859273|FG000|Overall Study|Survival follow up stage discontinued|11
890392|NCT00661609|1859273|FG000|Overall Study|Disease progression|3
890393|NCT00661622|1859279|FG000|Overall Study|Protocol Violation|1
890394|NCT00661622|1859280|FG001|Overall Study|Protocol Violation|0
890395|NCT00661661|1859289|FG000|Overall Study|Adverse Event|99
890396|NCT00661661|1859290|FG001|Overall Study|Adverse Event|24
890397|NCT00661661|1859289|FG000|Overall Study|Lack of Efficacy|3
890398|NCT00661661|1859290|FG001|Overall Study|Lack of Efficacy|2
890399|NCT00661661|1859289|FG000|Overall Study|Lost to Follow-up|0
890400|NCT00661661|1859290|FG001|Overall Study|Lost to Follow-up|1
890401|NCT00661661|1859289|FG000|Overall Study|Withdrawal by Subject|15
890402|NCT00661661|1859290|FG001|Overall Study|Withdrawal by Subject|5
890403|NCT00661661|1859289|FG000|Overall Study|Other|22
890404|NCT00661661|1859290|FG001|Overall Study|Other|7
890405|NCT00661661|1859289|FG000|Overall Study|Not assigned treatment|1
890406|NCT00661661|1859290|FG001|Overall Study|Not assigned treatment|0
890407|NCT00661687|1859311|FG000|Overall Study|Study related symptoms and complaints|5
890408|NCT00661687|1859311|FG000|Overall Study|Positive slit lamp findings|4
890409|NCT00661687|1859311|FG000|Overall Study|Inability to maintain wearing schedule|3
890410|NCT00661687|1859311|FG000|Overall Study|Physician Decision|1
890411|NCT00661687|1859311|FG000|Overall Study|Adverse Event|2
890412|NCT00661713|1859325|FG000|Overall Study|Death|1
890413|NCT00661713|1859326|FG001|Overall Study|Death|0
890414|NCT00661713|1859327|FG002|Overall Study|Death|0
890415|NCT00661713|1859328|FG003|Overall Study|Death|0
890416|NCT00661713|1859329|FG004|Overall Study|Death|1
890417|NCT00661713|1859330|FG005|Overall Study|Death|0
890418|NCT00661713|1859331|FG006|Overall Study|Death|0
890419|NCT00661713|1859332|FG007|Overall Study|Death|0
890420|NCT00661713|1859325|FG000|Overall Study|Unable to Classify|1
890421|NCT00661713|1859326|FG001|Overall Study|Unable to Classify|0
890422|NCT00661713|1859327|FG002|Overall Study|Unable to Classify|0
890423|NCT00661713|1859328|FG003|Overall Study|Unable to Classify|0
890424|NCT00661713|1859329|FG004|Overall Study|Unable to Classify|0
890425|NCT00661713|1859330|FG005|Overall Study|Unable to Classify|0
890426|NCT00661713|1859331|FG006|Overall Study|Unable to Classify|0
890427|NCT00661713|1859332|FG007|Overall Study|Unable to Classify|0
890428|NCT00661713|1859325|FG000|Overall Study|Protocol Violation|1
890429|NCT00661713|1859326|FG001|Overall Study|Protocol Violation|6
890430|NCT00661713|1859327|FG002|Overall Study|Protocol Violation|3
890431|NCT00661713|1859328|FG003|Overall Study|Protocol Violation|3
890432|NCT00661713|1859329|FG004|Overall Study|Protocol Violation|0
890433|NCT00661713|1859330|FG005|Overall Study|Protocol Violation|2
890434|NCT00661713|1859331|FG006|Overall Study|Protocol Violation|2
890435|NCT00661713|1859332|FG007|Overall Study|Protocol Violation|1
890436|NCT00661713|1859325|FG000|Overall Study|Withdrawal by Subject|11
890437|NCT00661713|1859326|FG001|Overall Study|Withdrawal by Subject|25
890438|NCT00661713|1859327|FG002|Overall Study|Withdrawal by Subject|12
890439|NCT00661713|1859328|FG003|Overall Study|Withdrawal by Subject|21
890440|NCT00661713|1859329|FG004|Overall Study|Withdrawal by Subject|12
890441|NCT00661713|1859330|FG005|Overall Study|Withdrawal by Subject|26
890442|NCT00661713|1859331|FG006|Overall Study|Withdrawal by Subject|45
890443|NCT00661713|1859332|FG007|Overall Study|Withdrawal by Subject|9
890444|NCT00661713|1859325|FG000|Overall Study|Lost to Follow-up|2
890445|NCT00661713|1859326|FG001|Overall Study|Lost to Follow-up|7
890446|NCT00661713|1859327|FG002|Overall Study|Lost to Follow-up|2
890447|NCT00661713|1859328|FG003|Overall Study|Lost to Follow-up|2
890448|NCT00661713|1859329|FG004|Overall Study|Lost to Follow-up|5
890449|NCT00661713|1859330|FG005|Overall Study|Lost to Follow-up|7
890450|NCT00661713|1859331|FG006|Overall Study|Lost to Follow-up|14
890451|NCT00661713|1859332|FG007|Overall Study|Lost to Follow-up|1
890452|NCT00661713|1859325|FG000|Overall Study|Administrative Reason|0
890453|NCT00661713|1859326|FG001|Overall Study|Administrative Reason|1
890454|NCT00661713|1859327|FG002|Overall Study|Administrative Reason|0
890455|NCT00661713|1859328|FG003|Overall Study|Administrative Reason|2
890456|NCT00661713|1859329|FG004|Overall Study|Administrative Reason|2
890457|NCT00661713|1859330|FG005|Overall Study|Administrative Reason|2
890458|NCT00661713|1859331|FG006|Overall Study|Administrative Reason|1
890459|NCT00661713|1859332|FG007|Overall Study|Administrative Reason|0
890460|NCT00661713|1859325|FG000|Overall Study|Adverse Event|0
890461|NCT00661713|1859326|FG001|Overall Study|Adverse Event|0
890462|NCT00661713|1859327|FG002|Overall Study|Adverse Event|0
890463|NCT00661713|1859328|FG003|Overall Study|Adverse Event|0
890464|NCT00661713|1859329|FG004|Overall Study|Adverse Event|0
890465|NCT00661713|1859330|FG005|Overall Study|Adverse Event|0
890466|NCT00661713|1859331|FG006|Overall Study|Adverse Event|1
890467|NCT00661713|1859332|FG007|Overall Study|Adverse Event|0
890468|NCT00661713|1859325|FG000|Overall Study|Inappropriate Enrollment|0
890469|NCT00661713|1859326|FG001|Overall Study|Inappropriate Enrollment|0
890470|NCT00661713|1859327|FG002|Overall Study|Inappropriate Enrollment|0
890471|NCT00661713|1859328|FG003|Overall Study|Inappropriate Enrollment|0
890472|NCT00661713|1859329|FG004|Overall Study|Inappropriate Enrollment|0
890473|NCT00661713|1859330|FG005|Overall Study|Inappropriate Enrollment|0
890474|NCT00661713|1859331|FG006|Overall Study|Inappropriate Enrollment|1
890475|NCT00661713|1859332|FG007|Overall Study|Inappropriate Enrollment|0
890476|NCT00661726|1859352|FG000|Overall Study|Adverse Event|1
890477|NCT00661778|1859356|FG000|Overall Study|Disease Progression|23
890478|NCT00661778|1859356|FG000|Overall Study|Adverse Event|18
890479|NCT00661778|1859356|FG000|Overall Study|Reason not Specified|6
890480|NCT00661778|1859356|FG000|Overall Study|Protocol Violation|2
890481|NCT00661778|1859356|FG000|Overall Study|Withdrawal of Consent|1
890482|NCT00661830|1859362|FG000|Overall Study|Death|37
890483|NCT00661830|1859363|FG001|Overall Study|Death|33
890484|NCT00661830|1859362|FG000|Overall Study|Lost to Follow-up|1
890485|NCT00661830|1859363|FG001|Overall Study|Lost to Follow-up|3
890486|NCT00661830|1859362|FG000|Overall Study|Withdrawal by Subject|1
890487|NCT00661830|1859363|FG001|Overall Study|Withdrawal by Subject|1
890488|NCT00661830|1859362|FG000|Overall Study|Other reason|1
890489|NCT00661830|1859363|FG001|Overall Study|Other reason|5
890490|NCT00661999|1859394|FG000|Overall Study|Adverse Event|11
890491|NCT00661999|1859395|FG001|Overall Study|Adverse Event|5
890492|NCT00661999|1859396|FG002|Overall Study|Adverse Event|8
890493|NCT00661999|1859394|FG000|Overall Study|Death|8
890494|NCT00661999|1859395|FG001|Overall Study|Death|6
890495|NCT00661999|1859396|FG002|Overall Study|Death|3
890496|NCT00661999|1859394|FG000|Overall Study|Other Reasons|5
890497|NCT00661999|1859395|FG001|Overall Study|Other Reasons|12
890498|NCT00661999|1859396|FG002|Overall Study|Other Reasons|23
890499|NCT00661999|1859394|FG000|Overall Study|Withdrawal by Subject|30
890500|NCT00661999|1859395|FG001|Overall Study|Withdrawal by Subject|23
890501|NCT00661999|1859396|FG002|Overall Study|Withdrawal by Subject|14
890502|NCT00661999|1859394|FG000|Overall Study|Alternative Treatment|1
890503|NCT00661999|1859395|FG001|Overall Study|Alternative Treatment|0
890504|NCT00661999|1859396|FG002|Overall Study|Alternative Treatment|0
890505|NCT00661999|1859394|FG000|Overall Study|Other Medical Problems|4
890506|NCT00661999|1859395|FG001|Overall Study|Other Medical Problems|4
890507|NCT00661999|1859396|FG002|Overall Study|Other Medical Problems|9
890508|NCT00662012|1859404|FG000|Overall Study|Lost to Follow-up|85
890509|NCT00662012|1859404|FG000|Overall Study|Death|1
890510|NCT00662012|1859404|FG000|Overall Study|Withdrawal by Subject|1
890511|NCT00662025|1859408|FG000|Overall Study|Objective progression or relapse|51
890512|NCT00662025|1859408|FG000|Overall Study|Adverse Event|7
890513|NCT00662025|1859408|FG000|Overall Study|Withdrawal by Subject|1
890514|NCT00662025|1859408|FG000|Overall Study|Results of other clinical study|2
890515|NCT00662025|1859408|FG000|Overall Study|Target lesion cannot be evaluated|1
890516|NCT00662025|1859408|FG000|Overall Study|Domestic circumstances|1
890517|NCT00662038|1859412|FG000|Overall Study|Reason not specified|3
890518|NCT00662038|1859412|FG000|Overall Study|Withdrawn consent|22
890519|NCT00662038|1859412|FG000|Overall Study|Withdrawal by Subject|83
890520|NCT00662038|1859412|FG000|Overall Study|Sponsor decision|1
890521|NCT00662038|1859412|FG000|Overall Study|Physician Decision|19
890522|NCT00662038|1859412|FG000|Overall Study|Lung transplantation|44
890523|NCT00662038|1859412|FG000|Overall Study|Lost to Follow-up|1
890524|NCT00662038|1859412|FG000|Overall Study|Death|95
890525|NCT00662038|1859412|FG000|Overall Study|Adverse Event|358
890526|NCT00662038|1859412|FG000|Overall Study|Continued treatment|5
890527|NCT00662129|1859416|FG000|Overall Study|Protocol Violation|1
890528|NCT00662129|1859416|FG000|Overall Study|Cancel prior to beginning treatment|1
890529|NCT00662129|1859416|FG000|Overall Study|Ineligible|1
890530|NCT00662259|1859443|FG000|Overall Study|Adverse Event|2
890531|NCT00662259|1859444|FG001|Overall Study|Adverse Event|0
890532|NCT00662311|1859457|FG000|Overall Study|Respiratory Infection|1
890533|NCT00662311|1859458|FG001|Overall Study|Respiratory Infection|0
890534|NCT00662311|1859459|FG002|Overall Study|Respiratory Infection|0
890535|NCT00662363|1859469|FG000|Overall Study|Withdrawal by Subject|6
890536|NCT00662363|1859470|FG001|Overall Study|Withdrawal by Subject|5
890537|NCT00662363|1859469|FG000|Overall Study|Adverse Event|0
890538|NCT00662363|1859470|FG001|Overall Study|Adverse Event|3
890539|NCT00662363|1859469|FG000|Overall Study|Discharged early from rehab|4
890540|NCT00662363|1859470|FG001|Overall Study|Discharged early from rehab|1
890541|NCT00662363|1859469|FG000|Overall Study|Protocol Violation|1
890542|NCT00662363|1859470|FG001|Overall Study|Protocol Violation|1
890543|NCT00662532|1859483|FG000|Overall Study|Adverse Event|0
890544|NCT00662532|1859484|FG001|Overall Study|Adverse Event|1
890545|NCT00662532|1859483|FG000|Overall Study|Lost to Follow-up|0
890546|NCT00662532|1859484|FG001|Overall Study|Lost to Follow-up|1
890547|NCT00662558|1859501|FG000|Overall Study|Adverse Event|21
890548|NCT00662558|1859502|FG001|Overall Study|Adverse Event|59
890549|NCT00662558|1859501|FG000|Overall Study|Lack of Efficacy|4
890550|NCT00662558|1859502|FG001|Overall Study|Lack of Efficacy|7
890551|NCT00662558|1859501|FG000|Overall Study|Lost to Follow-up|13
890552|NCT00662558|1859502|FG001|Overall Study|Lost to Follow-up|10
890553|NCT00662558|1859501|FG000|Overall Study|Other|9
890554|NCT00662558|1859502|FG001|Overall Study|Other|14
890555|NCT00662558|1859501|FG000|Overall Study|Withdrawal by Subject|7
890556|NCT00662558|1859502|FG001|Overall Study|Withdrawal by Subject|12
890557|NCT00662558|1859501|FG000|Overall Study|Randomized But Did Not Receive Treatment|2
890558|NCT00662558|1859502|FG001|Overall Study|Randomized But Did Not Receive Treatment|8
890559|NCT00662649|1859512|FG000|Core Study (24 Months)|Withdrawal by Subject|31
890560|NCT00662649|1859513|FG001|Core Study (24 Months)|Withdrawal by Subject|17
890561|NCT00662649|1859514|FG002|Core Study (24 Months)|Withdrawal by Subject|28
890562|NCT00662649|1859515|FG003|Core Study (24 Months)|Withdrawal by Subject|0
890563|NCT00662649|1859516|FG004|Core Study (24 Months)|Withdrawal by Subject|0
890564|NCT00662649|1859512|FG000|Core Study (24 Months)|Adverse Event|22
890565|NCT00662649|1859513|FG001|Core Study (24 Months)|Adverse Event|13
890566|NCT00662649|1859514|FG002|Core Study (24 Months)|Adverse Event|18
890567|NCT00662649|1859515|FG003|Core Study (24 Months)|Adverse Event|0
890568|NCT00662649|1859516|FG004|Core Study (24 Months)|Adverse Event|0
890569|NCT00662649|1859512|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
890570|NCT00662649|1859513|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
890571|NCT00662649|1859514|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
890572|NCT00662649|1859515|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
890573|NCT00662649|1859516|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
890574|NCT00662649|1859512|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20
890575|NCT00662649|1859513|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9
890576|NCT00662649|1859514|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1
890577|NCT00662649|1859515|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0
890578|NCT00662649|1859516|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0
890579|NCT00662649|1859512|FG000|Core Study (24 Months)|Lost to Follow-up|3
890580|NCT00662649|1859513|FG001|Core Study (24 Months)|Lost to Follow-up|5
890581|NCT00662649|1859514|FG002|Core Study (24 Months)|Lost to Follow-up|7
890582|NCT00662649|1859515|FG003|Core Study (24 Months)|Lost to Follow-up|0
890583|NCT00662649|1859516|FG004|Core Study (24 Months)|Lost to Follow-up|0
890584|NCT00662649|1859512|FG000|Core Study (24 Months)|Protocol Violation|5
890585|NCT00662649|1859513|FG001|Core Study (24 Months)|Protocol Violation|5
890586|NCT00662649|1859514|FG002|Core Study (24 Months)|Protocol Violation|4
890587|NCT00662649|1859515|FG003|Core Study (24 Months)|Protocol Violation|0
890588|NCT00662649|1859516|FG004|Core Study (24 Months)|Protocol Violation|0
890589|NCT00662649|1859512|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2
890590|NCT00662649|1859513|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1
890591|NCT00662649|1859514|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1
890592|NCT00662649|1859515|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0
890593|NCT00662649|1859516|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0
890594|NCT00662649|1859512|FG000|Core Study (24 Months)|Death|1
890595|NCT00662649|1859513|FG001|Core Study (24 Months)|Death|0
890596|NCT00662649|1859514|FG002|Core Study (24 Months)|Death|2
890597|NCT00662649|1859515|FG003|Core Study (24 Months)|Death|0
890598|NCT00662649|1859516|FG004|Core Study (24 Months)|Death|0
890599|NCT00662649|1859512|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
890600|NCT00662649|1859513|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
890601|NCT00662649|1859514|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
890602|NCT00662649|1859515|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
890603|NCT00662649|1859516|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
890604|NCT00662649|1859512|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
890605|NCT00662649|1859513|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
890606|NCT00662649|1859514|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
890607|NCT00662649|1859515|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
890608|NCT00662649|1859516|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
890609|NCT00662649|1859512|FG000|Extension Study (Month 24 to 60)|Administrative problems|0
890610|NCT00662649|1859513|FG001|Extension Study (Month 24 to 60)|Administrative problems|0
890611|NCT00662649|1859514|FG002|Extension Study (Month 24 to 60)|Administrative problems|0
890612|NCT00662649|1859515|FG003|Extension Study (Month 24 to 60)|Administrative problems|1
890613|NCT00662649|1859516|FG004|Extension Study (Month 24 to 60)|Administrative problems|0
890614|NCT00662649|1859512|FG000|Extension Study (Month 24 to 60)|Adverse Event|6
890615|NCT00662649|1859513|FG001|Extension Study (Month 24 to 60)|Adverse Event|9
890616|NCT00662649|1859514|FG002|Extension Study (Month 24 to 60)|Adverse Event|0
890617|NCT00662649|1859515|FG003|Extension Study (Month 24 to 60)|Adverse Event|6
890618|NCT00662649|1859516|FG004|Extension Study (Month 24 to 60)|Adverse Event|10
890619|NCT00662649|1859512|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2
890620|NCT00662649|1859513|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0
890621|NCT00662649|1859514|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0
890622|NCT00662649|1859515|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1
890623|NCT00662649|1859516|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1
890624|NCT00662649|1859512|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1
890625|NCT00662649|1859513|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1
890626|NCT00662649|1859514|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0
890627|NCT00662649|1859515|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0
890628|NCT00662649|1859516|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0
890629|NCT00662649|1859512|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19
890630|NCT00662649|1859513|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23
890631|NCT00662649|1859514|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0
890632|NCT00662649|1859515|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15
890633|NCT00662649|1859516|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9
890634|NCT00662649|1859512|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
890635|NCT00662649|1859513|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
890636|NCT00662649|1859514|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
890637|NCT00662649|1859515|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
890638|NCT00662649|1859516|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1006592|NCT01468701|2025301|FG016|Overall Study|Other reasons than listed|0
890639|NCT00662649|1859512|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
890640|NCT00662649|1859513|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
890641|NCT00662649|1859514|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
890642|NCT00662649|1859515|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
890643|NCT00662649|1859516|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
890644|NCT00662831|1859552|FG000|Overall Study|Death|4
890645|NCT00662831|1859553|FG001|Overall Study|Death|1
890646|NCT00662831|1859552|FG000|Overall Study|Lack of Efficacy|6
890647|NCT00662831|1859553|FG001|Overall Study|Lack of Efficacy|6
890648|NCT00662831|1859552|FG000|Overall Study|Lost to Follow-up|1
890649|NCT00662831|1859553|FG001|Overall Study|Lost to Follow-up|0
890650|NCT00662831|1859552|FG000|Overall Study|Withdrawal by Subject|2
890651|NCT00662831|1859553|FG001|Overall Study|Withdrawal by Subject|1
890652|NCT00662831|1859552|FG000|Overall Study|Other|62
890653|NCT00662831|1859553|FG001|Overall Study|Other|31
890654|NCT00662831|1859552|FG000|Overall Study|Protocol Violation|8
890655|NCT00662831|1859553|FG001|Overall Study|Protocol Violation|4
890656|NCT00662831|1859552|FG000|Overall Study|Adverse Event|23
890657|NCT00662831|1859553|FG001|Overall Study|Adverse Event|16
890658|NCT00662857|1859559|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0
890659|NCT00662857|1859560|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1
890660|NCT00662857|1859559|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
890661|NCT00662857|1859560|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
890662|NCT00662857|1859559|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
890663|NCT00662857|1859560|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
890664|NCT00662909|1859572|FG000|Overall Study|Adverse Event|17
890665|NCT00662909|1859573|FG001|Overall Study|Adverse Event|18
890666|NCT00662909|1859574|FG002|Overall Study|Adverse Event|19
890667|NCT00662909|1859572|FG000|Overall Study|Lack of Efficacy|9
890668|NCT00662909|1859573|FG001|Overall Study|Lack of Efficacy|1
890669|NCT00662909|1859574|FG002|Overall Study|Lack of Efficacy|5
890670|NCT00662909|1859572|FG000|Overall Study|Withdrawal by Subject|29
890671|NCT00662909|1859573|FG001|Overall Study|Withdrawal by Subject|22
890672|NCT00662909|1859574|FG002|Overall Study|Withdrawal by Subject|16
890673|NCT00662909|1859572|FG000|Overall Study|Lost to Follow-up|2
890674|NCT00662909|1859573|FG001|Overall Study|Lost to Follow-up|9
890675|NCT00662909|1859574|FG002|Overall Study|Lost to Follow-up|3
890676|NCT00662909|1859572|FG000|Overall Study|Protocol Violation|7
890677|NCT00662909|1859573|FG001|Overall Study|Protocol Violation|4
890678|NCT00662909|1859574|FG002|Overall Study|Protocol Violation|5
890679|NCT00662909|1859572|FG000|Overall Study|Randomized- never received study drug|1
890680|NCT00662909|1859573|FG001|Overall Study|Randomized- never received study drug|0
890681|NCT00662909|1859574|FG002|Overall Study|Randomized- never received study drug|0
890682|NCT00662909|1859572|FG000|Overall Study|Non-compliance with study procedures|3
890683|NCT00662909|1859573|FG001|Overall Study|Non-compliance with study procedures|3
890684|NCT00662909|1859574|FG002|Overall Study|Non-compliance with study procedures|2
890685|NCT00662909|1859572|FG000|Overall Study|Physician Decision|1
890686|NCT00662909|1859573|FG001|Overall Study|Physician Decision|1
890687|NCT00662909|1859574|FG002|Overall Study|Physician Decision|2
890688|NCT00662909|1859572|FG000|Overall Study|Eligibility criterion not met|0
890689|NCT00662909|1859573|FG001|Overall Study|Eligibility criterion not met|1
890690|NCT00662909|1859574|FG002|Overall Study|Eligibility criterion not met|1
890691|NCT00663026|1859585|FG000|Overall Study|Lost to Follow-up|1
890692|NCT00663026|1859586|FG001|Overall Study|Lost to Follow-up|0
890693|NCT00663026|1859587|FG002|Overall Study|Lost to Follow-up|0
890694|NCT00663026|1859585|FG000|Overall Study|Other|1
890695|NCT00663026|1859586|FG001|Overall Study|Other|2
890696|NCT00663026|1859587|FG002|Overall Study|Other|0
890697|NCT00663026|1859585|FG000|Overall Study|Adverse Event|0
890698|NCT00663026|1859586|FG001|Overall Study|Adverse Event|2
890699|NCT00663026|1859587|FG002|Overall Study|Adverse Event|3
890700|NCT00663026|1859585|FG000|Overall Study|Caregiver Request|0
890701|NCT00663026|1859586|FG001|Overall Study|Caregiver Request|2
890702|NCT00663026|1859587|FG002|Overall Study|Caregiver Request|0
890703|NCT00663026|1859585|FG000|Overall Study|Withdrawal by Subject|0
890704|NCT00663026|1859586|FG001|Overall Study|Withdrawal by Subject|0
890705|NCT00663026|1859587|FG002|Overall Study|Withdrawal by Subject|1
890706|NCT00663117|1859615|FG000|Overall Study|Lack of Efficacy|1
890707|NCT00663117|1859616|FG001|Overall Study|Lack of Efficacy|0
890708|NCT00663208|1859644|FG000|Treatment Period|Lost to Follow-up|0
890709|NCT00663208|1859645|FG001|Treatment Period|Lost to Follow-up|1
890710|NCT00663208|1859646|FG002|Treatment Period|Lost to Follow-up|0
890711|NCT00663208|1859647|FG003|Treatment Period|Lost to Follow-up|0
890712|NCT00663208|1859648|FG004|Treatment Period|Lost to Follow-up|0
890713|NCT00663208|1859649|FG005|Treatment Period|Lost to Follow-up|0
890714|NCT00663208|1859650|FG006|Treatment Period|Lost to Follow-up|0
890715|NCT00663208|1859644|FG000|Follow-up Period|Lost to Follow-up|2
890716|NCT00663208|1859645|FG001|Follow-up Period|Lost to Follow-up|0
890717|NCT00663208|1859646|FG002|Follow-up Period|Lost to Follow-up|3
890718|NCT00663208|1859647|FG003|Follow-up Period|Lost to Follow-up|2
890719|NCT00663208|1859648|FG004|Follow-up Period|Lost to Follow-up|0
890720|NCT00663208|1859649|FG005|Follow-up Period|Lost to Follow-up|0
890721|NCT00663208|1859650|FG006|Follow-up Period|Lost to Follow-up|0
890722|NCT00663208|1859644|FG000|Follow-up Period|Other reason|1
890723|NCT00663208|1859645|FG001|Follow-up Period|Other reason|0
890724|NCT00663208|1859646|FG002|Follow-up Period|Other reason|0
890725|NCT00663208|1859647|FG003|Follow-up Period|Other reason|0
890726|NCT00663208|1859648|FG004|Follow-up Period|Other reason|0
890727|NCT00663208|1859649|FG005|Follow-up Period|Other reason|0
890728|NCT00663208|1859650|FG006|Follow-up Period|Other reason|1
890729|NCT00663234|1859668|FG000|Overall Study|Not willing to adhere to requirements|1
890730|NCT00663260|1859679|FG000|Overall Study|Lack of Efficacy|2
890731|NCT00663260|1859680|FG001|Overall Study|Lack of Efficacy|0
890732|NCT00663260|1859681|FG002|Overall Study|Lack of Efficacy|0
890733|NCT00663260|1859679|FG000|Overall Study|Adverse Event|12
890734|NCT00663260|1859680|FG001|Overall Study|Adverse Event|7
890735|NCT00663260|1859681|FG002|Overall Study|Adverse Event|6
890736|NCT00663260|1859679|FG000|Overall Study|Withdrawal by Subject|3
890737|NCT00663260|1859680|FG001|Overall Study|Withdrawal by Subject|1
890738|NCT00663260|1859681|FG002|Overall Study|Withdrawal by Subject|6
890739|NCT00663260|1859679|FG000|Overall Study|Death|1
890740|NCT00663260|1859680|FG001|Overall Study|Death|0
890741|NCT00663260|1859681|FG002|Overall Study|Death|1
890742|NCT00663260|1859679|FG000|Overall Study|Lost to Follow-up|0
890743|NCT00663260|1859680|FG001|Overall Study|Lost to Follow-up|1
890744|NCT00663260|1859681|FG002|Overall Study|Lost to Follow-up|0
890745|NCT00663260|1859679|FG000|Overall Study|non-compliance, not met criteria, etc.|3
890746|NCT00663260|1859680|FG001|Overall Study|non-compliance, not met criteria, etc.|2
890747|NCT00663260|1859681|FG002|Overall Study|non-compliance, not met criteria, etc.|3
890748|NCT00663702|1859695|FG000|Overall Study|Adverse Event|8
890749|NCT00663702|1859696|FG001|Overall Study|Adverse Event|4
890750|NCT00663702|1859695|FG000|Overall Study|Withdrawal by Subject|3
890751|NCT00663702|1859696|FG001|Overall Study|Withdrawal by Subject|1
890752|NCT00663702|1859695|FG000|Overall Study|Pregnancy|0
890753|NCT00663702|1859696|FG001|Overall Study|Pregnancy|1
890754|NCT00663702|1859695|FG000|Overall Study|Lost to Follow-up|3
890755|NCT00663702|1859696|FG001|Overall Study|Lost to Follow-up|0
890756|NCT00663702|1859695|FG000|Overall Study|Death|1
890757|NCT00663702|1859696|FG001|Overall Study|Death|1
890758|NCT00663702|1859695|FG000|Overall Study|Lack of Efficacy|3
890759|NCT00663702|1859696|FG001|Overall Study|Lack of Efficacy|3
890760|NCT00663858|1859725|FG000|Overall Study|Adverse Event|9
890761|NCT00663858|1859726|FG001|Overall Study|Adverse Event|1
890762|NCT00663858|1859727|FG002|Overall Study|Adverse Event|6
890763|NCT00663858|1859725|FG000|Overall Study|Lack of Efficacy|5
890764|NCT00663858|1859726|FG001|Overall Study|Lack of Efficacy|1
890765|NCT00663858|1859727|FG002|Overall Study|Lack of Efficacy|3
890766|NCT00663858|1859725|FG000|Overall Study|Withdrawal by Subject|7
890767|NCT00663858|1859726|FG001|Overall Study|Withdrawal by Subject|3
890768|NCT00663858|1859727|FG002|Overall Study|Withdrawal by Subject|3
890769|NCT00663858|1859725|FG000|Overall Study|Protocol Violation|5
890770|NCT00663858|1859726|FG001|Overall Study|Protocol Violation|3
890771|NCT00663858|1859727|FG002|Overall Study|Protocol Violation|4
890772|NCT00663858|1859725|FG000|Overall Study|Other|8
890773|NCT00663858|1859726|FG001|Overall Study|Other|2
890774|NCT00663858|1859727|FG002|Overall Study|Other|4
890775|NCT00663871|1859737|FG000|Overall Study|Lost to Follow-up|5
890776|NCT00663871|1859738|FG001|Overall Study|Lost to Follow-up|5
890777|NCT00663871|1859737|FG000|Overall Study|Withdrawal by Subject|5
890778|NCT00663871|1859738|FG001|Overall Study|Withdrawal by Subject|2
890779|NCT00663923|1859746|FG000|Overall Study|Lost to Follow-up|2
890780|NCT00663962|1859754|FG000|Overall Study|somnolence|1
890781|NCT00663962|1859755|FG001|Overall Study|somnolence|0
890782|NCT00664105|1859761|FG000|Overall Study|Death|3
890783|NCT00664105|1859761|FG000|Overall Study|Withdrawal by Subject|5
890784|NCT00664105|1859761|FG000|Overall Study|Adverse Event|9
890785|NCT00664105|1859761|FG000|Overall Study|Disease progression|7
890786|NCT00664209|1859766|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7
890787|NCT00664209|1859766|FG000|Study Treatment Period|Physician Decision|4
890788|NCT00664209|1859766|FG000|Study Treatment Period|Withdrawal by Subject|2
890789|NCT00664326|1859771|FG000|Overall Study|Adverse Event|14
890790|NCT00664326|1859771|FG000|Overall Study|Noncompliance with study medication|3
890791|NCT00664326|1859771|FG000|Overall Study|Withdrawal by Subject|1
890792|NCT00664326|1859771|FG000|Overall Study|Physician Decision|1
890793|NCT00664326|1859771|FG000|Overall Study|Other Reasons|3
890794|NCT00664326|1859771|FG000|Overall Study|Death|2
890795|NCT00664326|1859771|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24
890796|NCT00664521|1859781|FG000|Overall Study|Adverse Event|4
890797|NCT00664521|1859782|FG001|Overall Study|Adverse Event|1
890798|NCT00664521|1859781|FG000|Overall Study|Lost to Follow-up|1
890799|NCT00664521|1859782|FG001|Overall Study|Lost to Follow-up|0
890800|NCT00664521|1859781|FG000|Overall Study|Other|1
890801|NCT00664521|1859782|FG001|Overall Study|Other|0
890802|NCT00664534|1859790|FG000|Overall Study|Adverse Event|2
890803|NCT00664534|1859791|FG001|Overall Study|Adverse Event|3
890804|NCT00664534|1859790|FG000|Overall Study|Lost to Follow-up|6
890805|NCT00664534|1859791|FG001|Overall Study|Lost to Follow-up|10
890806|NCT00664534|1859790|FG000|Overall Study|Protocol Violation|10
890807|NCT00664534|1859791|FG001|Overall Study|Protocol Violation|8
890808|NCT00664534|1859790|FG000|Overall Study|Withdrawal by Subject|7
890809|NCT00664534|1859791|FG001|Overall Study|Withdrawal by Subject|6
890810|NCT00664534|1859790|FG000|Overall Study|Physician Decision|8
890811|NCT00664534|1859791|FG001|Overall Study|Physician Decision|0
890812|NCT00664534|1859790|FG000|Overall Study|Sponsor decision|8
890813|NCT00664534|1859791|FG001|Overall Study|Sponsor decision|6
890814|NCT00664560|1859800|FG000|Overall Study|Adverse Event|19
890815|NCT00664560|1859801|FG001|Overall Study|Adverse Event|16
890816|NCT00664560|1859802|FG002|Overall Study|Adverse Event|7
890817|NCT00664560|1859800|FG000|Overall Study|Withdrawal by Subject|9
890818|NCT00664560|1859801|FG001|Overall Study|Withdrawal by Subject|13
890819|NCT00664560|1859802|FG002|Overall Study|Withdrawal by Subject|7
890820|NCT00664560|1859800|FG000|Overall Study|Lost to Follow-up|0
890821|NCT00664560|1859801|FG001|Overall Study|Lost to Follow-up|2
890822|NCT00664560|1859802|FG002|Overall Study|Lost to Follow-up|0
890823|NCT00664560|1859800|FG000|Overall Study|Other|11
890824|NCT00664560|1859801|FG001|Overall Study|Other|4
890825|NCT00664560|1859802|FG002|Overall Study|Other|5
890826|NCT00664742|1859810|FG000|Overall Study|Withdrawn due to adverse events|3
890827|NCT00664742|1859810|FG000|Overall Study|Withdrawal by Subject|31
890828|NCT00664742|1859810|FG000|Overall Study|Lost to Follow-up|92
890829|NCT00664859|1859826|FG000|Overall Study|Adverse Event|2
890830|NCT00664859|1859827|FG001|Overall Study|Adverse Event|1
890831|NCT00664859|1859828|FG002|Overall Study|Adverse Event|3
890832|NCT00664859|1859826|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
890833|NCT00664859|1859827|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
890834|NCT00664859|1859828|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
890835|NCT00664859|1859826|FG000|Overall Study|Noncompliance with protocol|1
890836|NCT00664859|1859827|FG001|Overall Study|Noncompliance with protocol|0
890837|NCT00664859|1859828|FG002|Overall Study|Noncompliance with protocol|4
890838|NCT00664859|1859826|FG000|Overall Study|Laboratory abnormality|2
890839|NCT00664859|1859827|FG001|Overall Study|Laboratory abnormality|1
890840|NCT00664859|1859828|FG002|Overall Study|Laboratory abnormality|4
890841|NCT00664859|1859826|FG000|Overall Study|Withdrawal by Subject|4
890842|NCT00664859|1859827|FG001|Overall Study|Withdrawal by Subject|1
890843|NCT00664859|1859828|FG002|Overall Study|Withdrawal by Subject|3
890844|NCT00664859|1859826|FG000|Overall Study|Lost to Follow-up|2
890845|NCT00664859|1859827|FG001|Overall Study|Lost to Follow-up|2
890846|NCT00664859|1859828|FG002|Overall Study|Lost to Follow-up|1
890847|NCT00664859|1859826|FG000|Overall Study|Other|0
890848|NCT00664859|1859827|FG001|Overall Study|Other|1
890849|NCT00664859|1859828|FG002|Overall Study|Other|2
890850|NCT00665002|1859836|FG000|Overall Study|Progression/relapse during treatment|11
890851|NCT00665002|1859836|FG000|Overall Study|Cytogenetic resistance|1
890852|NCT00665353|1859844|FG000|Study Step 1|Adverse Event|1
890853|NCT00665353|1859844|FG000|Study Step 1|Withdrawal by Subject|2
890854|NCT00665353|1859844|FG000|Study Step 2|Lost to Follow-up|2
890855|NCT00665353|1859844|FG000|Study Step 2|Lack of Efficacy|12
890856|NCT00665366|1859850|FG000|Overall Study|Lack of Efficacy|11
890857|NCT00665366|1859851|FG001|Overall Study|Lack of Efficacy|10
890858|NCT00665366|1859850|FG000|Overall Study|Adverse Event|25
890859|NCT00665366|1859851|FG001|Overall Study|Adverse Event|23
890860|NCT00665366|1859850|FG000|Overall Study|Withdrawal by Subject|11
890861|NCT00665366|1859851|FG001|Overall Study|Withdrawal by Subject|14
890862|NCT00665366|1859850|FG000|Overall Study|Lost to Follow-up|3
890863|NCT00665366|1859851|FG001|Overall Study|Lost to Follow-up|5
890864|NCT00665366|1859850|FG000|Overall Study|Poor compliance/noncompliance|3
890865|NCT00665366|1859851|FG001|Overall Study|Poor compliance/noncompliance|5
890866|NCT00665366|1859850|FG000|Overall Study|Pregnancy|1
890867|NCT00665366|1859851|FG001|Overall Study|Pregnancy|0
890868|NCT00665366|1859850|FG000|Overall Study|No longer meets study criteria|0
890869|NCT00665366|1859851|FG001|Overall Study|No longer meets study criteria|1
890870|NCT00665366|1859850|FG000|Overall Study|Other reasons|4
890871|NCT00665366|1859851|FG001|Overall Study|Other reasons|1
890872|NCT00665392|1859857|FG000|Overall Study|not treated|1
890873|NCT00665431|1859865|FG000|Overall Study|Adverse Event|16
890874|NCT00665431|1859866|FG001|Overall Study|Adverse Event|22
890875|NCT00665431|1859867|FG002|Overall Study|Adverse Event|6
890876|NCT00665431|1859865|FG000|Overall Study|Withdrawal by Subject|17
890877|NCT00665431|1859866|FG001|Overall Study|Withdrawal by Subject|25
890878|NCT00665431|1859867|FG002|Overall Study|Withdrawal by Subject|15
890879|NCT00665431|1859865|FG000|Overall Study|Lost to Follow-up|3
890880|NCT00665431|1859866|FG001|Overall Study|Lost to Follow-up|3
890881|NCT00665431|1859867|FG002|Overall Study|Lost to Follow-up|1
890882|NCT00665431|1859865|FG000|Overall Study|Other|4
890883|NCT00665431|1859866|FG001|Overall Study|Other|7
890884|NCT00665431|1859867|FG002|Overall Study|Other|2
890885|NCT00665561|1859890|FG000|Overall Study|Death recorded on subject summary pages|75
890886|NCT00665561|1859891|FG001|Overall Study|Death recorded on subject summary pages|75
890887|NCT00665561|1859890|FG000|Overall Study|Does not meet entrance criteria|19
890888|NCT00665561|1859891|FG001|Overall Study|Does not meet entrance criteria|21
890889|NCT00665561|1859890|FG000|Overall Study|Lost to Follow-up|203
890890|NCT00665561|1859891|FG001|Overall Study|Lost to Follow-up|264
890891|NCT00665561|1859890|FG000|Overall Study|Withdrawal by Subject|74
890892|NCT00665561|1859891|FG001|Overall Study|Withdrawal by Subject|65
890893|NCT00665561|1859890|FG000|Overall Study|Other|123
890894|NCT00665561|1859891|FG001|Overall Study|Other|108
890895|NCT00665561|1859890|FG000|Overall Study|Site closed|8
890896|NCT00665561|1859891|FG001|Overall Study|Site closed|0
890897|NCT00665561|1859890|FG000|Overall Study|Withdrawn due to pregnancy|0
890898|NCT00665561|1859891|FG001|Overall Study|Withdrawn due to pregnancy|1
890899|NCT00665626|1859899|FG000|Overall Study|Lack of Efficacy|8
890900|NCT00665626|1859900|FG001|Overall Study|Lack of Efficacy|5
890901|NCT00665626|1859899|FG000|Overall Study|Lost to Follow-up|0
890902|NCT00665626|1859900|FG001|Overall Study|Lost to Follow-up|2
890903|NCT00665626|1859899|FG000|Overall Study|Withdrawal by Subject|0
890904|NCT00665626|1859900|FG001|Overall Study|Withdrawal by Subject|1
890905|NCT00665626|1859899|FG000|Overall Study|Protocol Violation|0
890906|NCT00665626|1859900|FG001|Overall Study|Protocol Violation|2
890907|NCT00665626|1859899|FG000|Overall Study|Adverse Event|1
890908|NCT00665626|1859900|FG001|Overall Study|Adverse Event|9
890909|NCT00665626|1859899|FG000|Overall Study|Due to exclusion criteria|0
890910|NCT00665626|1859900|FG001|Overall Study|Due to exclusion criteria|1
890911|NCT00665626|1859899|FG000|Overall Study|Did not fulfil inclusion criteria|0
890912|NCT00665626|1859900|FG001|Overall Study|Did not fulfil inclusion criteria|1
890913|NCT00665626|1859899|FG000|Overall Study|Unably to comply with dosing regimen|0
890914|NCT00665626|1859900|FG001|Overall Study|Unably to comply with dosing regimen|1
890915|NCT00665626|1859899|FG000|Overall Study|Death|1
890916|NCT00665626|1859900|FG001|Overall Study|Death|0
890917|NCT00665652|1859906|FG000|Overall Study|Adverse Event|4
890918|NCT00665652|1859906|FG000|Overall Study|Death|1
890919|NCT00665652|1859906|FG000|Overall Study|No longer met inclusion criteria.|1
890920|NCT00665847|1859914|FG000|Overall Study|Adverse Event|8
890921|NCT00665847|1859914|FG000|Overall Study|Withdrawal by Subject|2
890922|NCT00665847|1859914|FG000|Overall Study|Subject non-compliant|8
890923|NCT00665847|1859914|FG000|Overall Study|Subject reached a virologic endpoint|4
890924|NCT00665847|1859914|FG000|Overall Study|Resistance to TMC125|1
890925|NCT00665847|1859914|FG000|Overall Study|Subject ineligible to continue the trial|1
890926|NCT00665847|1859914|FG000|Overall Study|Switch to Commercial Medication|1
890927|NCT00665925|1859922|FG000|Overall Study|Lack of Efficacy|10
890928|NCT00665925|1859923|FG001|Overall Study|Lack of Efficacy|8
890929|NCT00665925|1859924|FG002|Overall Study|Lack of Efficacy|9
890930|NCT00665925|1859925|FG003|Overall Study|Lack of Efficacy|8
890931|NCT00665925|1859922|FG000|Overall Study|Lost to Follow-up|1
890932|NCT00665925|1859923|FG001|Overall Study|Lost to Follow-up|2
890933|NCT00665925|1859924|FG002|Overall Study|Lost to Follow-up|2
890934|NCT00665925|1859925|FG003|Overall Study|Lost to Follow-up|2
890935|NCT00665925|1859922|FG000|Overall Study|Withdrawal by Subject|2
890936|NCT00665925|1859923|FG001|Overall Study|Withdrawal by Subject|2
890937|NCT00665925|1859924|FG002|Overall Study|Withdrawal by Subject|3
890938|NCT00665925|1859925|FG003|Overall Study|Withdrawal by Subject|2
890939|NCT00665925|1859922|FG000|Overall Study|Physician Decision|0
890940|NCT00665925|1859923|FG001|Overall Study|Physician Decision|0
890941|NCT00665925|1859924|FG002|Overall Study|Physician Decision|1
890942|NCT00665925|1859925|FG003|Overall Study|Physician Decision|2
890943|NCT00665925|1859922|FG000|Overall Study|Severe Non-Compliance to Protocol|0
890944|NCT00665925|1859923|FG001|Overall Study|Severe Non-Compliance to Protocol|0
890945|NCT00665925|1859924|FG002|Overall Study|Severe Non-Compliance to Protocol|1
890946|NCT00665925|1859925|FG003|Overall Study|Severe Non-Compliance to Protocol|1
890947|NCT00665925|1859922|FG000|Overall Study|Adverse Event|1
890948|NCT00665925|1859923|FG001|Overall Study|Adverse Event|5
890949|NCT00665925|1859924|FG002|Overall Study|Adverse Event|10
890950|NCT00665925|1859925|FG003|Overall Study|Adverse Event|5
890951|NCT00665925|1859922|FG000|Overall Study|Enrolled by mistake|0
890952|NCT00665925|1859923|FG001|Overall Study|Enrolled by mistake|0
890953|NCT00665925|1859924|FG002|Overall Study|Enrolled by mistake|0
890954|NCT00665925|1859925|FG003|Overall Study|Enrolled by mistake|1
890955|NCT00665925|1859922|FG000|Overall Study|Due to exclusion criteria|1
890956|NCT00665925|1859923|FG001|Overall Study|Due to exclusion criteria|0
890957|NCT00665925|1859924|FG002|Overall Study|Due to exclusion criteria|0
890958|NCT00665925|1859925|FG003|Overall Study|Due to exclusion criteria|0
890959|NCT00666198|1859946|FG000|Overall Study|Protocol Violation|10
890960|NCT00666198|1859946|FG000|Overall Study|No Visit After First Day of Treatment|13
890961|NCT00666198|1859946|FG000|Overall Study|Safety Not Assessable|6
890962|NCT00666198|1859946|FG000|Overall Study|No Drug Administration|4
890963|NCT00666211|1859952|FG000|Overall Study|Withdrawal by Subject|10
890964|NCT00666211|1859953|FG001|Overall Study|Withdrawal by Subject|13
890965|NCT00666211|1859952|FG000|Overall Study|went off medication, no more pain|1
890966|NCT00666211|1859953|FG001|Overall Study|went off medication, no more pain|0
890967|NCT00666211|1859952|FG000|Overall Study|patient non-compliant|6
890968|NCT00666211|1859953|FG001|Overall Study|patient non-compliant|6
890969|NCT00666211|1859952|FG000|Overall Study|disease progression|1
890970|NCT00666211|1859953|FG001|Overall Study|disease progression|8
890971|NCT00666211|1859952|FG000|Overall Study|Lost to Follow-up|2
890972|NCT00666211|1859953|FG001|Overall Study|Lost to Follow-up|0
890973|NCT00666211|1859952|FG000|Overall Study|toxicity|0
890974|NCT00666211|1859953|FG001|Overall Study|toxicity|2
890975|NCT00666211|1859952|FG000|Overall Study|hospital admission|0
890976|NCT00666211|1859953|FG001|Overall Study|hospital admission|5
890977|NCT00666211|1859952|FG000|Overall Study|Death|0
890978|NCT00666211|1859953|FG001|Overall Study|Death|2
890979|NCT00666211|1859952|FG000|Overall Study|off tx for other complicating disease|0
890980|NCT00666211|1859953|FG001|Overall Study|off tx for other complicating disease|1
890981|NCT00666211|1859952|FG000|Overall Study|Physician Decision|0
890982|NCT00666211|1859953|FG001|Overall Study|Physician Decision|1
890983|NCT00666224|1859961|FG000|Double-Blind|Adverse Event|15
890984|NCT00666224|1859962|FG001|Double-Blind|Adverse Event|5
890985|NCT00666224|1859961|FG000|Double-Blind|Lost to Follow-up|2
890986|NCT00666224|1859962|FG001|Double-Blind|Lost to Follow-up|2
890987|NCT00666224|1859961|FG000|Double-Blind|Withdrawal by Subject|18
890988|NCT00666224|1859962|FG001|Double-Blind|Withdrawal by Subject|14
890989|NCT00666224|1859961|FG000|Double-Blind|Physician Decision|0
890990|NCT00666224|1859962|FG001|Double-Blind|Physician Decision|3
890991|NCT00666224|1859961|FG000|Double-Blind|Sponsor decision|1
890992|NCT00666224|1859962|FG001|Double-Blind|Sponsor decision|0
890993|NCT00666224|1859961|FG000|Double-Blind|Pregnancy|3
890994|NCT00666224|1859962|FG001|Double-Blind|Pregnancy|2
890995|NCT00666224|1859961|FG000|Double-Blind|Noncompliance|1
890996|NCT00666224|1859962|FG001|Double-Blind|Noncompliance|0
890997|NCT00666224|1859961|FG000|Double-Blind|Death|1
890998|NCT00666224|1859962|FG001|Double-Blind|Death|0
890999|NCT00666224|1859961|FG000|Double-Blind|Undefined/Unknown|4
891000|NCT00666224|1859962|FG001|Double-Blind|Undefined/Unknown|1
891001|NCT00666224|1859961|FG000|Open-Label|Adverse Event|8
891002|NCT00666224|1859962|FG001|Open-Label|Adverse Event|43
891003|NCT00666224|1859961|FG000|Open-Label|Lost to Follow-up|4
891004|NCT00666224|1859962|FG001|Open-Label|Lost to Follow-up|5
891005|NCT00666224|1859961|FG000|Open-Label|Withdrawal by Subject|12
891006|NCT00666224|1859962|FG001|Open-Label|Withdrawal by Subject|25
891007|NCT00666224|1859961|FG000|Open-Label|Physician Decision|7
891008|NCT00666224|1859962|FG001|Open-Label|Physician Decision|5
891009|NCT00666224|1859961|FG000|Open-Label|Pregnancy|1
891010|NCT00666224|1859962|FG001|Open-Label|Pregnancy|5
891011|NCT00666224|1859961|FG000|Open-Label|Noncompliance|2
891012|NCT00666224|1859962|FG001|Open-Label|Noncompliance|1
891013|NCT00666224|1859961|FG000|Open-Label|Undefined/Unknown|1
891014|NCT00666224|1859962|FG001|Open-Label|Undefined/Unknown|1
891015|NCT00666263|1859969|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
891016|NCT00666263|1859970|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
891017|NCT00666263|1859969|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1
891018|NCT00666263|1859970|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0
891019|NCT00666263|1859969|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
891020|NCT00666263|1859970|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
891021|NCT00666276|1860015|FG000|Overall Study|Protocol Violation|34
891022|NCT00666328|1860038|FG000|Overall Study|Death|2
891023|NCT00666328|1860038|FG000|Overall Study|Lost to Follow-up|2
891024|NCT00666328|1860038|FG000|Overall Study|No longer met eligibility criteria|1
891025|NCT00666458|1860052|FG000|Overall Study|Adverse Event|8
891026|NCT00666458|1860053|FG001|Overall Study|Adverse Event|7
891027|NCT00666458|1860052|FG000|Overall Study|Withdrawal by Subject|5
891028|NCT00666458|1860053|FG001|Overall Study|Withdrawal by Subject|4
891029|NCT00666458|1860052|FG000|Overall Study|Lost to Follow-up|0
891030|NCT00666458|1860053|FG001|Overall Study|Lost to Follow-up|3
891031|NCT00666458|1860052|FG000|Overall Study|Administrative reason by sponsor|1
891032|NCT00666458|1860053|FG001|Overall Study|Administrative reason by sponsor|1
891033|NCT00666458|1860052|FG000|Overall Study|Incorrect enrollment|7
891034|NCT00666458|1860053|FG001|Overall Study|Incorrect enrollment|1
891035|NCT00666458|1860052|FG000|Overall Study|Study specific discontinuation criteria|14
891036|NCT00666458|1860053|FG001|Overall Study|Study specific discontinuation criteria|7
891037|NCT00666458|1860052|FG000|Overall Study|Severe non-compliance to the protocol|1
891038|NCT00666458|1860053|FG001|Overall Study|Severe non-compliance to the protocol|1
891039|NCT00666458|1860052|FG000|Overall Study|Safety reasons|1
891040|NCT00666458|1860053|FG001|Overall Study|Safety reasons|0
891041|NCT00666458|1860052|FG000|Overall Study|Medical history of anemia|1
891042|NCT00666458|1860053|FG001|Overall Study|Medical history of anemia|0
891043|NCT00666536|1860061|FG000|Overall Study|Adverse Event|9
891044|NCT00666536|1860062|FG001|Overall Study|Adverse Event|19
891045|NCT00666536|1860061|FG000|Overall Study|Unsatisfactory therapeutic effect|2
891046|NCT00666536|1860062|FG001|Overall Study|Unsatisfactory therapeutic effect|0
891047|NCT00666536|1860061|FG000|Overall Study|Protocol deviation(s)|8
891048|NCT00666536|1860062|FG001|Overall Study|Protocol deviation(s)|6
891049|NCT00666536|1860061|FG000|Overall Study|Withdrawal by Subject|10
891050|NCT00666536|1860062|FG001|Overall Study|Withdrawal by Subject|9
891051|NCT00666536|1860061|FG000|Overall Study|Lost to Follow-up|4
891052|NCT00666536|1860062|FG001|Overall Study|Lost to Follow-up|3
891053|NCT00666562|1860071|FG000|Overall Study|Withdrawal by Subject|0
891054|NCT00666562|1860072|FG001|Overall Study|Withdrawal by Subject|1
891055|NCT00666562|1860073|FG002|Overall Study|Withdrawal by Subject|0
891056|NCT00666562|1860071|FG000|Overall Study|Concomitant Medication|0
891057|NCT00666562|1860072|FG001|Overall Study|Concomitant Medication|1
891058|NCT00666562|1860073|FG002|Overall Study|Concomitant Medication|0
891059|NCT00666588|1860092|FG000|Overall Study|ineligible|2
891060|NCT00666588|1860093|FG001|Overall Study|ineligible|0
891061|NCT00666588|1860094|FG002|Overall Study|ineligible|0
891062|NCT00666588|1860095|FG003|Overall Study|ineligible|2
891063|NCT00666588|1860092|FG000|Overall Study|inevaluable|2
891064|NCT00666588|1860093|FG001|Overall Study|inevaluable|0
891065|NCT00666588|1860094|FG002|Overall Study|inevaluable|0
891066|NCT00666588|1860095|FG003|Overall Study|inevaluable|0
891067|NCT00666679|1860111|FG000|First Intervention|Lost to Follow-up|1
891068|NCT00666679|1860112|FG001|First Intervention|Lost to Follow-up|0
891069|NCT00666679|1860111|FG000|First Intervention|Protocol Violation|1
891070|NCT00666679|1860112|FG001|First Intervention|Protocol Violation|0
891071|NCT00666679|1860111|FG000|First Intervention|Withdrawal by Subject|1
891072|NCT00666679|1860112|FG001|First Intervention|Withdrawal by Subject|0
891073|NCT00666679|1860111|FG000|First Intervention|Randomized did not start treatment|1
891074|NCT00666679|1860112|FG001|First Intervention|Randomized did not start treatment|1
891075|NCT00666679|1860111|FG000|Washout Period of 1 Week|Lost to Follow-up|0
891076|NCT00666679|1860112|FG001|Washout Period of 1 Week|Lost to Follow-up|1
891077|NCT00666679|1860111|FG000|Washout Period of 1 Week|Protocol Violation|0
891078|NCT00666679|1860112|FG001|Washout Period of 1 Week|Protocol Violation|1
891079|NCT00666679|1860111|FG000|Second Intervention|Adverse Event|1
891080|NCT00666679|1860112|FG001|Second Intervention|Adverse Event|0
891081|NCT00666679|1860111|FG000|Second Intervention|Death|0
891082|NCT00666679|1860112|FG001|Second Intervention|Death|1
891083|NCT00666705|1860118|FG000|Overall Study|Withdrawal by Subject|1
891084|NCT00666718|1860129|FG000|Overall Study|Adverse Event|0
891085|NCT00666718|1860130|FG001|Overall Study|Adverse Event|1
891086|NCT00666718|1860129|FG000|Overall Study|Death|1
891087|NCT00666718|1860130|FG001|Overall Study|Death|0
891088|NCT00666718|1860129|FG000|Overall Study|Lost to Follow-up|1
891089|NCT00666718|1860130|FG001|Overall Study|Lost to Follow-up|0
891090|NCT00666718|1860129|FG000|Overall Study|Entry Criteria Not Met|2
891091|NCT00666718|1860130|FG001|Overall Study|Entry Criteria Not Met|0
891092|NCT00666718|1860129|FG000|Overall Study|Protocol Violation|1
891093|NCT00666718|1860130|FG001|Overall Study|Protocol Violation|3
891094|NCT00666718|1860129|FG000|Overall Study|Withdrawal by Subject|7
891095|NCT00666718|1860130|FG001|Overall Study|Withdrawal by Subject|12
891096|NCT00666718|1860129|FG000|Overall Study|Physician Decision|0
891097|NCT00666718|1860130|FG001|Overall Study|Physician Decision|2
891098|NCT00666757|1860138|FG000|Overall Study|Lost to Follow-up|39
891099|NCT00666757|1860139|FG001|Overall Study|Lost to Follow-up|35
891100|NCT00666757|1860138|FG000|Overall Study|Protocol Violation|23
891101|NCT00666757|1860139|FG001|Overall Study|Protocol Violation|24
891102|NCT00666757|1860138|FG000|Overall Study|Adverse Event|22
891103|NCT00666757|1860139|FG001|Overall Study|Adverse Event|12
891104|NCT00666757|1860138|FG000|Overall Study|Withdrawal by Subject|13
891105|NCT00666757|1860139|FG001|Overall Study|Withdrawal by Subject|17
891106|NCT00666757|1860138|FG000|Overall Study|Lack of Efficacy|3
891107|NCT00666757|1860139|FG001|Overall Study|Lack of Efficacy|6
891108|NCT00666757|1860138|FG000|Overall Study|Physician Decision|0
891109|NCT00666757|1860139|FG001|Overall Study|Physician Decision|2
891110|NCT00666757|1860138|FG000|Overall Study|Sponsor decision|0
891111|NCT00666757|1860139|FG001|Overall Study|Sponsor decision|1
891112|NCT00666835|1860150|FG000|Overall Study|Withdrawal by Subject|5
891113|NCT00666835|1860151|FG001|Overall Study|Withdrawal by Subject|2
891114|NCT00666835|1860150|FG000|Overall Study|Lack of Efficacy|0
891115|NCT00666835|1860151|FG001|Overall Study|Lack of Efficacy|1
891116|NCT00666835|1860150|FG000|Overall Study|Incl./excl. not fulfilled|7
891117|NCT00666835|1860151|FG001|Overall Study|Incl./excl. not fulfilled|2
891118|NCT00666835|1860150|FG000|Overall Study|Adverse Event|7
891119|NCT00666835|1860151|FG001|Overall Study|Adverse Event|6
891120|NCT00666835|1860150|FG000|Overall Study|Protocol Violation|2
891121|NCT00666835|1860151|FG001|Overall Study|Protocol Violation|0
891122|NCT00666835|1860150|FG000|Overall Study|Death|15
891123|NCT00666835|1860151|FG001|Overall Study|Death|4
891124|NCT00666835|1860150|FG000|Overall Study|Kidney Transplantation (NTX)|10
891125|NCT00666835|1860151|FG001|Overall Study|Kidney Transplantation (NTX)|2
891126|NCT00666835|1860150|FG000|Overall Study|Hemoglobulin concentration|4
891127|NCT00666835|1860151|FG001|Overall Study|Hemoglobulin concentration|3
891128|NCT00666835|1860150|FG000|Overall Study|Planned operation|2
891129|NCT00666835|1860151|FG001|Overall Study|Planned operation|0
891130|NCT00666835|1860150|FG000|Overall Study|Physician Decision|1
891131|NCT00666835|1860151|FG001|Overall Study|Physician Decision|2
891132|NCT00666926|1860171|FG000|Overall Study|Adverse Event|0
891133|NCT00666926|1860172|FG001|Overall Study|Adverse Event|0
891134|NCT00666926|1860173|FG002|Overall Study|Adverse Event|0
891135|NCT00666926|1860174|FG003|Overall Study|Adverse Event|0
891136|NCT00666926|1860175|FG004|Overall Study|Adverse Event|0
891137|NCT00666926|1860176|FG005|Overall Study|Adverse Event|0
891138|NCT00666926|1860177|FG006|Overall Study|Adverse Event|0
891139|NCT00666926|1860178|FG007|Overall Study|Adverse Event|0
891140|NCT00666926|1860179|FG008|Overall Study|Adverse Event|0
891141|NCT00666926|1860180|FG009|Overall Study|Adverse Event|2
891142|NCT00666926|1860181|FG010|Overall Study|Adverse Event|2
891143|NCT00666926|1860182|FG011|Overall Study|Adverse Event|2
891144|NCT00666926|1860183|FG012|Overall Study|Adverse Event|0
891145|NCT00666926|1860184|FG013|Overall Study|Adverse Event|1
891146|NCT00666926|1860185|FG014|Overall Study|Adverse Event|0
891147|NCT00666926|1860186|FG015|Overall Study|Adverse Event|0
891148|NCT00666926|1860171|FG000|Overall Study|Laboratory abnormality|0
891149|NCT00666926|1860172|FG001|Overall Study|Laboratory abnormality|0
891150|NCT00666926|1860173|FG002|Overall Study|Laboratory abnormality|0
891151|NCT00666926|1860174|FG003|Overall Study|Laboratory abnormality|0
891152|NCT00666926|1860175|FG004|Overall Study|Laboratory abnormality|0
891153|NCT00666926|1860176|FG005|Overall Study|Laboratory abnormality|0
891154|NCT00666926|1860177|FG006|Overall Study|Laboratory abnormality|0
891155|NCT00666926|1860178|FG007|Overall Study|Laboratory abnormality|0
891156|NCT00666926|1860179|FG008|Overall Study|Laboratory abnormality|0
891157|NCT00666926|1860180|FG009|Overall Study|Laboratory abnormality|0
891158|NCT00666926|1860181|FG010|Overall Study|Laboratory abnormality|1
891159|NCT00666926|1860182|FG011|Overall Study|Laboratory abnormality|0
891160|NCT00666926|1860183|FG012|Overall Study|Laboratory abnormality|0
891161|NCT00666926|1860184|FG013|Overall Study|Laboratory abnormality|0
891162|NCT00666926|1860185|FG014|Overall Study|Laboratory abnormality|0
891163|NCT00666926|1860186|FG015|Overall Study|Laboratory abnormality|1
891164|NCT00666926|1860171|FG000|Overall Study|Lack of Efficacy|0
891165|NCT00666926|1860172|FG001|Overall Study|Lack of Efficacy|0
891166|NCT00666926|1860173|FG002|Overall Study|Lack of Efficacy|0
891167|NCT00666926|1860174|FG003|Overall Study|Lack of Efficacy|0
891168|NCT00666926|1860175|FG004|Overall Study|Lack of Efficacy|0
891169|NCT00666926|1860176|FG005|Overall Study|Lack of Efficacy|1
891170|NCT00666926|1860177|FG006|Overall Study|Lack of Efficacy|0
891171|NCT00666926|1860178|FG007|Overall Study|Lack of Efficacy|0
891172|NCT00666926|1860179|FG008|Overall Study|Lack of Efficacy|0
891173|NCT00666926|1860180|FG009|Overall Study|Lack of Efficacy|0
891174|NCT00666926|1860181|FG010|Overall Study|Lack of Efficacy|0
891175|NCT00666926|1860182|FG011|Overall Study|Lack of Efficacy|1
891176|NCT00666926|1860183|FG012|Overall Study|Lack of Efficacy|0
891177|NCT00666926|1860184|FG013|Overall Study|Lack of Efficacy|0
891178|NCT00666926|1860185|FG014|Overall Study|Lack of Efficacy|0
891179|NCT00666926|1860186|FG015|Overall Study|Lack of Efficacy|0
891180|NCT00666926|1860171|FG000|Overall Study|Lost to Follow-up|0
891181|NCT00666926|1860172|FG001|Overall Study|Lost to Follow-up|0
891182|NCT00666926|1860173|FG002|Overall Study|Lost to Follow-up|0
891183|NCT00666926|1860174|FG003|Overall Study|Lost to Follow-up|1
891184|NCT00666926|1860175|FG004|Overall Study|Lost to Follow-up|0
891185|NCT00666926|1860176|FG005|Overall Study|Lost to Follow-up|0
891186|NCT00666926|1860177|FG006|Overall Study|Lost to Follow-up|0
891187|NCT00666926|1860178|FG007|Overall Study|Lost to Follow-up|0
891188|NCT00666926|1860179|FG008|Overall Study|Lost to Follow-up|0
891189|NCT00666926|1860180|FG009|Overall Study|Lost to Follow-up|0
891190|NCT00666926|1860181|FG010|Overall Study|Lost to Follow-up|0
891191|NCT00666926|1860182|FG011|Overall Study|Lost to Follow-up|0
891192|NCT00666926|1860183|FG012|Overall Study|Lost to Follow-up|0
891193|NCT00666926|1860184|FG013|Overall Study|Lost to Follow-up|0
891194|NCT00666926|1860185|FG014|Overall Study|Lost to Follow-up|0
891195|NCT00666926|1860186|FG015|Overall Study|Lost to Follow-up|0
891196|NCT00666926|1860171|FG000|Overall Study|Other|2
891197|NCT00666926|1860172|FG001|Overall Study|Other|4
891198|NCT00666926|1860173|FG002|Overall Study|Other|3
891199|NCT00666926|1860174|FG003|Overall Study|Other|3
891200|NCT00666926|1860175|FG004|Overall Study|Other|3
891201|NCT00666926|1860176|FG005|Overall Study|Other|3
891202|NCT00666926|1860177|FG006|Overall Study|Other|4
891203|NCT00666926|1860178|FG007|Overall Study|Other|0
891204|NCT00666926|1860179|FG008|Overall Study|Other|3
891205|NCT00666926|1860180|FG009|Overall Study|Other|5
891206|NCT00666926|1860181|FG010|Overall Study|Other|3
891207|NCT00666926|1860182|FG011|Overall Study|Other|26
891208|NCT00666926|1860183|FG012|Overall Study|Other|3
891209|NCT00666926|1860184|FG013|Overall Study|Other|2
891210|NCT00666926|1860185|FG014|Overall Study|Other|4
891211|NCT00666926|1860186|FG015|Overall Study|Other|4
891212|NCT00666926|1860171|FG000|Overall Study|Withdrawal by Subject|0
891213|NCT00666926|1860172|FG001|Overall Study|Withdrawal by Subject|0
891214|NCT00666926|1860173|FG002|Overall Study|Withdrawal by Subject|0
891215|NCT00666926|1860174|FG003|Overall Study|Withdrawal by Subject|0
891216|NCT00666926|1860175|FG004|Overall Study|Withdrawal by Subject|0
891217|NCT00666926|1860176|FG005|Overall Study|Withdrawal by Subject|0
891218|NCT00666926|1860177|FG006|Overall Study|Withdrawal by Subject|0
891219|NCT00666926|1860178|FG007|Overall Study|Withdrawal by Subject|1
891220|NCT00666926|1860179|FG008|Overall Study|Withdrawal by Subject|0
891221|NCT00666926|1860180|FG009|Overall Study|Withdrawal by Subject|3
891222|NCT00666926|1860181|FG010|Overall Study|Withdrawal by Subject|0
891223|NCT00666926|1860182|FG011|Overall Study|Withdrawal by Subject|3
891224|NCT00666926|1860183|FG012|Overall Study|Withdrawal by Subject|0
891225|NCT00666926|1860184|FG013|Overall Study|Withdrawal by Subject|1
891226|NCT00666926|1860185|FG014|Overall Study|Withdrawal by Subject|3
891227|NCT00666926|1860186|FG015|Overall Study|Withdrawal by Subject|3
891228|NCT00666926|1860171|FG000|Overall Study|Death|0
891229|NCT00666926|1860172|FG001|Overall Study|Death|0
891230|NCT00666926|1860173|FG002|Overall Study|Death|0
891231|NCT00666926|1860174|FG003|Overall Study|Death|0
891232|NCT00666926|1860175|FG004|Overall Study|Death|0
891233|NCT00666926|1860176|FG005|Overall Study|Death|0
891234|NCT00666926|1860177|FG006|Overall Study|Death|0
891235|NCT00666926|1860178|FG007|Overall Study|Death|0
891236|NCT00666926|1860179|FG008|Overall Study|Death|0
891237|NCT00666926|1860180|FG009|Overall Study|Death|0
891238|NCT00666926|1860181|FG010|Overall Study|Death|0
891239|NCT00666926|1860182|FG011|Overall Study|Death|1
891240|NCT00666926|1860183|FG012|Overall Study|Death|0
891241|NCT00666926|1860184|FG013|Overall Study|Death|0
891242|NCT00666926|1860185|FG014|Overall Study|Death|0
891243|NCT00666926|1860186|FG015|Overall Study|Death|0
891244|NCT00666965|1860241|FG000|Overall Study|Adverse Event|0
891245|NCT00666965|1860242|FG001|Overall Study|Adverse Event|2
891246|NCT00666965|1860243|FG002|Overall Study|Adverse Event|1
891247|NCT00666965|1860244|FG003|Overall Study|Adverse Event|9
891248|NCT00666965|1860241|FG000|Overall Study|Lack of Efficacy|1
891249|NCT00666965|1860242|FG001|Overall Study|Lack of Efficacy|1
891250|NCT00666965|1860243|FG002|Overall Study|Lack of Efficacy|0
891251|NCT00666965|1860244|FG003|Overall Study|Lack of Efficacy|0
891252|NCT00666965|1860241|FG000|Overall Study|Protocol Violation|0
891253|NCT00666965|1860242|FG001|Overall Study|Protocol Violation|0
891254|NCT00666965|1860243|FG002|Overall Study|Protocol Violation|0
891255|NCT00666965|1860244|FG003|Overall Study|Protocol Violation|2
891256|NCT00666965|1860241|FG000|Overall Study|Discontinuation criteria|2
891257|NCT00666965|1860242|FG001|Overall Study|Discontinuation criteria|1
891258|NCT00666965|1860243|FG002|Overall Study|Discontinuation criteria|1
891259|NCT00666965|1860244|FG003|Overall Study|Discontinuation criteria|2
891260|NCT00666965|1860241|FG000|Overall Study|Withdrawal by Subject|0
891261|NCT00666965|1860242|FG001|Overall Study|Withdrawal by Subject|0
891262|NCT00666965|1860243|FG002|Overall Study|Withdrawal by Subject|0
891263|NCT00666965|1860244|FG003|Overall Study|Withdrawal by Subject|2
891264|NCT00667095|1860276|FG000|Overall Study|Withdrawal by Subject|0
891265|NCT00667095|1860277|FG001|Overall Study|Withdrawal by Subject|1
891266|NCT00667225|1860294|FG000|Overall Study|Subject had no more lesions to treat.|1
891267|NCT00667225|1860295|FG001|Overall Study|Subject had no more lesions to treat.|0
891268|NCT00667225|1860294|FG000|Overall Study|Lost to Follow-up|0
891269|NCT00667225|1860295|FG001|Overall Study|Lost to Follow-up|1
891270|NCT00667251|1860303|FG000|Overall Study|Adverse Event|13
891271|NCT00667251|1860304|FG001|Overall Study|Adverse Event|4
891272|NCT00667251|1860303|FG000|Overall Study|Withdrawal by Subject|6
891273|NCT00667251|1860304|FG001|Overall Study|Withdrawal by Subject|2
891274|NCT00667251|1860303|FG000|Overall Study|Other/missing|46
891275|NCT00667251|1860304|FG001|Overall Study|Other/missing|84
891276|NCT00667251|1860303|FG000|Overall Study|Intercurrent Illness|4
891277|NCT00667251|1860304|FG001|Overall Study|Intercurrent Illness|3
891278|NCT00667251|1860303|FG000|Overall Study|Symptomatic progression|1
891279|NCT00667251|1860304|FG001|Overall Study|Symptomatic progression|2
891280|NCT00667277|1860310|FG000|Overall Study|Withdrawal by Subject|2
891281|NCT00667342|1860317|FG000|Overall Study|Protocol Violation|1
891282|NCT00667342|1860318|FG001|Overall Study|Protocol Violation|0
891283|NCT00667342|1860319|FG002|Overall Study|Protocol Violation|0
891284|NCT00667342|1860317|FG000|Overall Study|Withdrawal by Subject|1
891285|NCT00667342|1860318|FG001|Overall Study|Withdrawal by Subject|0
891286|NCT00667342|1860319|FG002|Overall Study|Withdrawal by Subject|0
891287|NCT00667342|1860317|FG000|Overall Study|Physician Decision|3
891288|NCT00667342|1860318|FG001|Overall Study|Physician Decision|0
891289|NCT00667342|1860319|FG002|Overall Study|Physician Decision|0
891290|NCT00667342|1860317|FG000|Overall Study|Relapse or tumor progression|9
891291|NCT00667342|1860318|FG001|Overall Study|Relapse or tumor progression|0
891292|NCT00667342|1860319|FG002|Overall Study|Relapse or tumor progression|7
891293|NCT00667342|1860317|FG000|Overall Study|Adverse Event|0
891294|NCT00667342|1860318|FG001|Overall Study|Adverse Event|0
891295|NCT00667342|1860319|FG002|Overall Study|Adverse Event|1
891296|NCT00667342|1860317|FG000|Overall Study|Ineligible|0
891297|NCT00667342|1860318|FG001|Overall Study|Ineligible|0
891298|NCT00667342|1860319|FG002|Overall Study|Ineligible|1
891299|NCT00667355|1860333|FG000|Overall Study|Adverse Event|5
891300|NCT00667355|1860333|FG000|Overall Study|Lost to Follow-up|1
891301|NCT00667355|1860333|FG000|Overall Study|Other reason was not specified|5
891302|NCT00667368|1860339|FG000|Overall Study|Lost to Follow-up|176
891303|NCT00667368|1860340|FG001|Overall Study|Lost to Follow-up|155
891304|NCT00667368|1860339|FG000|Overall Study|Discontinued early|24
891305|NCT00667368|1860340|FG001|Overall Study|Discontinued early|17
891306|NCT00667394|1860357|FG000|Overall Study|Adverse Event|3
891307|NCT00667394|1860358|FG001|Overall Study|Adverse Event|0
891308|NCT00667394|1860357|FG000|Overall Study|Progressive disease|1
891309|NCT00667394|1860358|FG001|Overall Study|Progressive disease|0
891310|NCT00667420|1860364|FG000|Overall Study|Adverse Event|2
891311|NCT00667420|1860364|FG000|Overall Study|Lack of Efficacy|5
891312|NCT00667420|1860364|FG000|Overall Study|Physician Decision|1
891313|NCT00667420|1860364|FG000|Overall Study|Withdrawal by Subject|2
891314|NCT00667446|1860371|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13
891315|NCT00667446|1860372|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15
891316|NCT00667446|1860371|FG000|Treatment Period (36 Months)|Other|2
891317|NCT00667446|1860372|FG001|Treatment Period (36 Months)|Other|2
891318|NCT00667446|1860371|FG000|Treatment Period (36 Months)|Personal reasons|2
891319|NCT00667446|1860372|FG001|Treatment Period (36 Months)|Personal reasons|2
891320|NCT00667446|1860371|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0
891321|NCT00667446|1860372|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4
891322|NCT00667446|1860371|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
891323|NCT00667446|1860372|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
891324|NCT00667446|1860371|FG000|Treatment Period (36 Months)|Lost to Follow-up|1
891325|NCT00667446|1860372|FG001|Treatment Period (36 Months)|Lost to Follow-up|0
891326|NCT00667446|1860371|FG000|Treatment Period (36 Months)|Protocol Violation|1
891327|NCT00667446|1860372|FG001|Treatment Period (36 Months)|Protocol Violation|1
891328|NCT00667446|1860371|FG000|Treatment Period (36 Months)|Therapeutic Failure|1
891329|NCT00667446|1860372|FG001|Treatment Period (36 Months)|Therapeutic Failure|1
891330|NCT00667446|1860371|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
891331|NCT00667446|1860372|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
891332|NCT00667459|1860380|FG000|Overall Study|Death|0
891333|NCT00667459|1860381|FG001|Overall Study|Death|2
891334|NCT00667459|1860380|FG000|Overall Study|Lost to Follow-up|8
891335|NCT00667459|1860381|FG001|Overall Study|Lost to Follow-up|43
891336|NCT00667563|1860393|FG000|Overall Study|Protocol Violation|24
891337|NCT00667576|1860402|FG000|Overall Study|Withdrawal by Subject|1
891338|NCT00667576|1860403|FG001|Overall Study|Withdrawal by Subject|0
891339|NCT00667576|1860404|FG002|Overall Study|Withdrawal by Subject|1
891340|NCT00667576|1860405|FG003|Overall Study|Withdrawal by Subject|1
891341|NCT00667576|1860406|FG004|Overall Study|Withdrawal by Subject|1
891342|NCT00667576|1860402|FG000|Overall Study|Adverse Event|1
891343|NCT00667576|1860403|FG001|Overall Study|Adverse Event|1
891344|NCT00667576|1860404|FG002|Overall Study|Adverse Event|0
891345|NCT00667576|1860405|FG003|Overall Study|Adverse Event|0
891346|NCT00667576|1860406|FG004|Overall Study|Adverse Event|0
891347|NCT00667576|1860402|FG000|Overall Study|Lost to Follow-up|0
891348|NCT00667576|1860403|FG001|Overall Study|Lost to Follow-up|0
891349|NCT00667576|1860404|FG002|Overall Study|Lost to Follow-up|1
891350|NCT00667576|1860405|FG003|Overall Study|Lost to Follow-up|0
891351|NCT00667576|1860406|FG004|Overall Study|Lost to Follow-up|0
891352|NCT00667576|1860402|FG000|Overall Study|Protocol Violation|0
891353|NCT00667576|1860403|FG001|Overall Study|Protocol Violation|0
891354|NCT00667576|1860404|FG002|Overall Study|Protocol Violation|0
891355|NCT00667576|1860405|FG003|Overall Study|Protocol Violation|1
891356|NCT00667576|1860406|FG004|Overall Study|Protocol Violation|0
891357|NCT00667576|1860402|FG000|Overall Study|Physician Decision|0
891358|NCT00667576|1860403|FG001|Overall Study|Physician Decision|0
891359|NCT00667576|1860404|FG002|Overall Study|Physician Decision|0
891360|NCT00667576|1860405|FG003|Overall Study|Physician Decision|1
891361|NCT00667576|1860406|FG004|Overall Study|Physician Decision|0
891362|NCT00667576|1860402|FG000|Overall Study|Missed Visit|0
891363|NCT00667576|1860403|FG001|Overall Study|Missed Visit|0
891364|NCT00667576|1860404|FG002|Overall Study|Missed Visit|0
891365|NCT00667576|1860405|FG003|Overall Study|Missed Visit|1
891366|NCT00667576|1860406|FG004|Overall Study|Missed Visit|0
891367|NCT00667602|1860438|FG000|Overall Study|Withdrawal by Subject|4
891368|NCT00667602|1860439|FG001|Overall Study|Withdrawal by Subject|9
891369|NCT00667602|1860440|FG002|Overall Study|Withdrawal by Subject|10
891370|NCT00667602|1860438|FG000|Overall Study|Lost to Follow-up|4
891371|NCT00667602|1860439|FG001|Overall Study|Lost to Follow-up|5
891372|NCT00667602|1860440|FG002|Overall Study|Lost to Follow-up|6
891373|NCT00667602|1860438|FG000|Overall Study|Administrative reason|0
891374|NCT00667602|1860439|FG001|Overall Study|Administrative reason|0
891375|NCT00667602|1860440|FG002|Overall Study|Administrative reason|2
891376|NCT00667602|1860438|FG000|Overall Study|Protocol Violation|0
891377|NCT00667602|1860439|FG001|Overall Study|Protocol Violation|1
891378|NCT00667602|1860440|FG002|Overall Study|Protocol Violation|0
891379|NCT00667719|1860466|FG000|Overall Study|Adverse Event|39
891380|NCT00667719|1860466|FG000|Overall Study|Abnormal Test Procedure|1
891381|NCT00667719|1860466|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
891382|NCT00667719|1860466|FG000|Overall Study|Protocol Violation|3
891383|NCT00667719|1860466|FG000|Overall Study|Withdrawal by Subject|17
891384|NCT00667719|1860466|FG000|Overall Study|Lost to Follow-up|8
891385|NCT00667732|1860477|FG000|Run -In (8 Weeks)|Adverse Event|4
891386|NCT00667732|1860478|FG001|Run -In (8 Weeks)|Adverse Event|0
891387|NCT00667732|1860479|FG002|Run -In (8 Weeks)|Adverse Event|0
891388|NCT00667732|1860477|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3
891389|NCT00667732|1860478|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0
891390|NCT00667732|1860479|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0
891391|NCT00667732|1860477|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0
891392|NCT00667732|1860478|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1
891393|NCT00667732|1860479|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0
891394|NCT00667810|1860503|FG000|Overall Study|Adverse Event|13
891395|NCT00667810|1860504|FG001|Overall Study|Adverse Event|14
891396|NCT00667810|1860505|FG002|Overall Study|Adverse Event|19
891397|NCT00667810|1860506|FG003|Overall Study|Adverse Event|1
891398|NCT00667810|1860503|FG000|Overall Study|Death|1
891399|NCT00667810|1860504|FG001|Overall Study|Death|1
891400|NCT00667810|1860505|FG002|Overall Study|Death|3
891401|NCT00667810|1860506|FG003|Overall Study|Death|0
891402|NCT00667810|1860503|FG000|Overall Study|Lack of Efficacy|1
891403|NCT00667810|1860504|FG001|Overall Study|Lack of Efficacy|0
891404|NCT00667810|1860505|FG002|Overall Study|Lack of Efficacy|2
891405|NCT00667810|1860506|FG003|Overall Study|Lack of Efficacy|0
891406|NCT00667810|1860503|FG000|Overall Study|Lost to Follow-up|1
891407|NCT00667810|1860504|FG001|Overall Study|Lost to Follow-up|4
891408|NCT00667810|1860505|FG002|Overall Study|Lost to Follow-up|2
891409|NCT00667810|1860506|FG003|Overall Study|Lost to Follow-up|0
891410|NCT00667810|1860503|FG000|Overall Study|Physician Decision|1
891411|NCT00667810|1860504|FG001|Overall Study|Physician Decision|1
891412|NCT00667810|1860505|FG002|Overall Study|Physician Decision|2
891413|NCT00667810|1860506|FG003|Overall Study|Physician Decision|0
891414|NCT00667810|1860503|FG000|Overall Study|Protocol Violation|0
891415|NCT00667810|1860504|FG001|Overall Study|Protocol Violation|2
891416|NCT00667810|1860505|FG002|Overall Study|Protocol Violation|0
891417|NCT00667810|1860506|FG003|Overall Study|Protocol Violation|0
891418|NCT00667810|1860503|FG000|Overall Study|Withdrawal by Subject|14
891419|NCT00667810|1860504|FG001|Overall Study|Withdrawal by Subject|20
891420|NCT00667810|1860505|FG002|Overall Study|Withdrawal by Subject|29
891421|NCT00667810|1860506|FG003|Overall Study|Withdrawal by Subject|1
891422|NCT00667810|1860503|FG000|Overall Study|Discontinuation of Study by Sponsor|130
891423|NCT00667810|1860504|FG001|Overall Study|Discontinuation of Study by Sponsor|118
891424|NCT00667810|1860505|FG002|Overall Study|Discontinuation of Study by Sponsor|155
891425|NCT00667810|1860506|FG003|Overall Study|Discontinuation of Study by Sponsor|0
891426|NCT00667810|1860503|FG000|Overall Study|Failed to Return|0
891427|NCT00667810|1860504|FG001|Overall Study|Failed to Return|0
891428|NCT00667810|1860505|FG002|Overall Study|Failed to Return|2
891429|NCT00667810|1860506|FG003|Overall Study|Failed to Return|0
891430|NCT00667810|1860503|FG000|Overall Study|Loss of Caregiver|0
891431|NCT00667810|1860504|FG001|Overall Study|Loss of Caregiver|1
891432|NCT00667810|1860505|FG002|Overall Study|Loss of Caregiver|3
891433|NCT00667810|1860506|FG003|Overall Study|Loss of Caregiver|0
891434|NCT00667810|1860503|FG000|Overall Study|Vasogenic Edema Recurrence|0
891435|NCT00667810|1860504|FG001|Overall Study|Vasogenic Edema Recurrence|3
891436|NCT00667810|1860505|FG002|Overall Study|Vasogenic Edema Recurrence|0
891437|NCT00667810|1860506|FG003|Overall Study|Vasogenic Edema Recurrence|0
891438|NCT00667810|1860503|FG000|Overall Study|Other|6
891439|NCT00667810|1860504|FG001|Overall Study|Other|6
891440|NCT00667810|1860505|FG002|Overall Study|Other|5
891441|NCT00667810|1860506|FG003|Overall Study|Other|0
891442|NCT00667862|1860533|FG000|Overall Study|Adverse Event|9
891443|NCT00667862|1860533|FG000|Overall Study|Death|1
891444|NCT00667862|1860533|FG000|Overall Study|Disease Progression|22
891445|NCT00667862|1860533|FG000|Overall Study|Withdrawal by Subject|3
891446|NCT00667875|1860540|FG000|Overall Study|Adverse Event|0
891447|NCT00667875|1860541|FG001|Overall Study|Adverse Event|2
891448|NCT00667875|1860542|FG002|Overall Study|Adverse Event|6
891449|NCT00667875|1860540|FG000|Overall Study|Withdrawal by Subject|10
891450|NCT00667875|1860541|FG001|Overall Study|Withdrawal by Subject|9
891451|NCT00667875|1860542|FG002|Overall Study|Withdrawal by Subject|7
891452|NCT00667888|1860558|FG000|Overall Study|Death|1
891453|NCT00667888|1860559|FG001|Overall Study|Death|1
891454|NCT00667888|1860558|FG000|Overall Study|Withdrawal by Subject|6
891455|NCT00667888|1860559|FG001|Overall Study|Withdrawal by Subject|3
891456|NCT00667888|1860558|FG000|Overall Study|Proceed with other treatment|3
891457|NCT00667888|1860559|FG001|Overall Study|Proceed with other treatment|3
891458|NCT00667888|1860558|FG000|Overall Study|Ineligible after SIM|0
891459|NCT00667888|1860559|FG001|Overall Study|Ineligible after SIM|2
891460|NCT00667992|1860567|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
891461|NCT00667992|1860568|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
891462|NCT00667992|1860567|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
891463|NCT00667992|1860568|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
891464|NCT00667992|1860567|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
891465|NCT00667992|1860568|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
891466|NCT00667992|1860567|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1
891467|NCT00667992|1860568|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0
891468|NCT00667992|1860567|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
891469|NCT00667992|1860568|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
891470|NCT00667992|1860567|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
891471|NCT00667992|1860568|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
891472|NCT00667992|1860567|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
891473|NCT00667992|1860568|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
891474|NCT00667992|1860567|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
891475|NCT00667992|1860568|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
891476|NCT00667992|1860567|FG000|Wash-out|Not within one doubling dilution|4
891477|NCT00667992|1860568|FG001|Wash-out|Not within one doubling dilution|3
891478|NCT00667992|1860567|FG000|Wash-out|Failure to wash-out|2
891479|NCT00667992|1860568|FG001|Wash-out|Failure to wash-out|2
891480|NCT00667992|1860567|FG000|Wash-out|Withdrawal by Subject|1
891481|NCT00667992|1860568|FG001|Wash-out|Withdrawal by Subject|0
891482|NCT00667992|1860567|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
891483|NCT00667992|1860568|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
891484|NCT00667992|1860567|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
891485|NCT00667992|1860568|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
891486|NCT00668148|1860584|FG000|Overall Study|Adverse Event|5
891487|NCT00668148|1860584|FG000|Overall Study|Subject Non-compliance|1
891488|NCT00668148|1860584|FG000|Overall Study|Progressive Disease Before Treatment|2
891489|NCT00668148|1860584|FG000|Overall Study|Withdrawal of Consent|2
891490|NCT00668200|1860599|FG000|Overall Study|Withdrawal by Subject|2
891491|NCT00668200|1860599|FG000|Overall Study|Lost to Follow-up|1
891492|NCT00668317|1860603|FG000|Overall Study|Adverse Event|2
891493|NCT00668395|1860614|FG000|Overall Study|Withdrawal by Subject|4
891494|NCT00668395|1860615|FG001|Overall Study|Withdrawal by Subject|4
891495|NCT00668395|1860616|FG002|Overall Study|Withdrawal by Subject|1
891496|NCT00668395|1860614|FG000|Overall Study|Adverse Event|1
891497|NCT00668395|1860615|FG001|Overall Study|Adverse Event|1
891498|NCT00668395|1860616|FG002|Overall Study|Adverse Event|0
891499|NCT00668395|1860614|FG000|Overall Study|Physician Decision|1
891500|NCT00668395|1860615|FG001|Overall Study|Physician Decision|1
891501|NCT00668395|1860616|FG002|Overall Study|Physician Decision|0
891502|NCT00668707|1860652|FG000|Overall Study|Cancer Recurrence|58
891503|NCT00668707|1860653|FG001|Overall Study|Cancer Recurrence|58
891504|NCT00668707|1860652|FG000|Overall Study|Withdrawal by Subject|117
891505|NCT00668707|1860653|FG001|Overall Study|Withdrawal by Subject|100
891506|NCT00668707|1860652|FG000|Overall Study|Lost to Follow-up|3
891507|NCT00668707|1860653|FG001|Overall Study|Lost to Follow-up|6
891508|NCT00668707|1860652|FG000|Overall Study|Protocol Violation|10
891509|NCT00668707|1860653|FG001|Overall Study|Protocol Violation|12
891510|NCT00668707|1860652|FG000|Overall Study|Death|11
891511|NCT00668707|1860653|FG001|Overall Study|Death|4
891512|NCT00668733|1860666|FG000|Overall Study|Lost to Follow-up|2
891513|NCT00668733|1860667|FG001|Overall Study|Lost to Follow-up|3
891514|NCT00668733|1860666|FG000|Overall Study|Withdrawal by Subject|0
891515|NCT00668733|1860667|FG001|Overall Study|Withdrawal by Subject|4
891516|NCT00668746|1860675|FG000|Overall Study|Lost to Follow-up|2
891517|NCT00668746|1860676|FG001|Overall Study|Lost to Follow-up|1
891518|NCT00668863|1860696|FG000|Overall Study|Objective Progression or Relapse|42
891519|NCT00668863|1860696|FG000|Overall Study|Adverse Event|13
891520|NCT00668863|1860696|FG000|Overall Study|Study Terminated by Sponsor|8
891521|NCT00668863|1860696|FG000|Overall Study|Global Deterioration of Health Status|4
891522|NCT00668863|1860696|FG000|Overall Study|Withdrawal by Subject|1
891523|NCT00668863|1860696|FG000|Overall Study|Surgery|1
891524|NCT00668863|1860696|FG000|Overall Study|Subject's work scheduling problem|1
891525|NCT00668863|1860696|FG000|Overall Study|Physician Decision|1
891526|NCT00669032|1860719|FG000|Overall Study|Lost to Follow-up|6
891527|NCT00669032|1860720|FG001|Overall Study|Lost to Follow-up|5
891528|NCT00669032|1860719|FG000|Overall Study|Lack of Efficacy|8
891529|NCT00669032|1860720|FG001|Overall Study|Lack of Efficacy|19
891530|NCT00669032|1860719|FG000|Overall Study|Withdrawal by Subject|12
891531|NCT00669032|1860720|FG001|Overall Study|Withdrawal by Subject|13
891532|NCT00669032|1860719|FG000|Overall Study|Adverse Event|12
891533|NCT00669032|1860720|FG001|Overall Study|Adverse Event|16
891534|NCT00669032|1860719|FG000|Overall Study|Physician Decision|1
891535|NCT00669032|1860720|FG001|Overall Study|Physician Decision|1
891536|NCT00669032|1860719|FG000|Overall Study|No fulfilment of the selection criteria|5
891537|NCT00669032|1860720|FG001|Overall Study|No fulfilment of the selection criteria|5
891538|NCT00669071|1860726|FG000|Overall Study|Lost to Follow-up|3
891539|NCT00669071|1860726|FG000|Overall Study|Final visit 40 days out of window|1
891540|NCT00669110|1860734|FG000|Overall Study|Adverse Event|4
891541|NCT00669110|1860735|FG001|Overall Study|Adverse Event|3
891542|NCT00669110|1860734|FG000|Overall Study|Caregiver request|3
891543|NCT00669110|1860735|FG001|Overall Study|Caregiver request|2
891544|NCT00669110|1860734|FG000|Overall Study|Physician Decision|0
891545|NCT00669110|1860735|FG001|Overall Study|Physician Decision|1
891546|NCT00669110|1860734|FG000|Overall Study|Lost to Follow-up|1
891547|NCT00669110|1860735|FG001|Overall Study|Lost to Follow-up|0
891548|NCT00669110|1860734|FG000|Overall Study|Protocol Violation|0
891549|NCT00669110|1860735|FG001|Overall Study|Protocol Violation|5
891550|NCT00669110|1860734|FG000|Overall Study|Withdrawal by Subject|0
891551|NCT00669110|1860735|FG001|Overall Study|Withdrawal by Subject|2
891552|NCT00669162|1860741|FG000|Overall Study|Withdrawal by Subject|1
891553|NCT00669240|1860758|FG000|Overall Study|Lack of Efficacy|33
891554|NCT00669240|1860758|FG000|Overall Study|Withdrawal by Subject|42
891555|NCT00669240|1860758|FG000|Overall Study|Lost to Follow-up|34
891556|NCT00669240|1860758|FG000|Overall Study|Adverse Event|21
891557|NCT00669240|1860758|FG000|Overall Study|Other|19
891558|NCT00669240|1860758|FG000|Overall Study|Enrolled but not treated|15
891559|NCT00669240|1860758|FG000|Overall Study|Enrolled but no dosing record|1
891560|NCT00669318|1860771|FG000|Overall Study|Withdrawal by Subject|2
891561|NCT00669331|1860777|FG000|Randomisation to First Dose|Adverse Event|1
891562|NCT00669331|1860778|FG001|Randomisation to First Dose|Adverse Event|0
891563|NCT00669331|1860777|FG000|Randomisation to First Dose|Protocol Violation|1
891564|NCT00669331|1860778|FG001|Randomisation to First Dose|Protocol Violation|0
891565|NCT00669331|1860777|FG000|Randomisation to First Dose|Withdrawal by Subject|3
891566|NCT00669331|1860778|FG001|Randomisation to First Dose|Withdrawal by Subject|2
891567|NCT00669331|1860777|FG000|Randomisation to First Dose|Lost to Follow-up|2
891568|NCT00669331|1860778|FG001|Randomisation to First Dose|Lost to Follow-up|0
891569|NCT00669331|1860777|FG000|Randomisation to First Dose|Death|1
891570|NCT00669331|1860778|FG001|Randomisation to First Dose|Death|0
891571|NCT00669331|1860777|FG000|Randomisation to First Dose|Sponsor decision|0
891572|NCT00669331|1860778|FG001|Randomisation to First Dose|Sponsor decision|1
891573|NCT00669331|1860777|FG000|Randomisation to First Dose|Randomised in error|3
891574|NCT00669331|1860778|FG001|Randomisation to First Dose|Randomised in error|10
891575|NCT00669331|1860777|FG000|Blinded Treatment Period|Adverse Event|16
891576|NCT00669331|1860778|FG001|Blinded Treatment Period|Adverse Event|10
891577|NCT00669331|1860777|FG000|Blinded Treatment Period|Protocol Violation|1
891578|NCT00669331|1860778|FG001|Blinded Treatment Period|Protocol Violation|1
891579|NCT00669331|1860777|FG000|Blinded Treatment Period|Withdrawal by Subject|17
891580|NCT00669331|1860778|FG001|Blinded Treatment Period|Withdrawal by Subject|19
891581|NCT00669331|1860777|FG000|Blinded Treatment Period|Lost to Follow-up|3
891582|NCT00669331|1860778|FG001|Blinded Treatment Period|Lost to Follow-up|2
891583|NCT00669331|1860777|FG000|Blinded Treatment Period|Death|0
891584|NCT00669331|1860778|FG001|Blinded Treatment Period|Death|2
891585|NCT00669331|1860777|FG000|Blinded Treatment Period|Physician Decision|3
891586|NCT00669331|1860778|FG001|Blinded Treatment Period|Physician Decision|3
891587|NCT00669331|1860777|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
891588|NCT00669331|1860778|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
891589|NCT00669396|1860797|FG000|Overall Study|Lost to Follow-up|10
891590|NCT00669396|1860798|FG001|Overall Study|Lost to Follow-up|12
891591|NCT00669409|1860810|FG000|Part 2|Withdrawal by Subject|0
891592|NCT00669409|1860811|FG001|Part 2|Withdrawal by Subject|0
891593|NCT00669409|1860812|FG002|Part 2|Withdrawal by Subject|0
891594|NCT00669409|1860813|FG003|Part 2|Withdrawal by Subject|0
891595|NCT00669409|1860814|FG004|Part 2|Withdrawal by Subject|0
891596|NCT00669409|1860815|FG005|Part 2|Withdrawal by Subject|0
891597|NCT00669409|1860816|FG006|Part 2|Withdrawal by Subject|0
891598|NCT00669409|1860817|FG007|Part 2|Withdrawal by Subject|0
891599|NCT00669409|1860818|FG008|Part 2|Withdrawal by Subject|0
891600|NCT00669409|1860819|FG009|Part 2|Withdrawal by Subject|1
891601|NCT00669409|1860820|FG010|Part 2|Withdrawal by Subject|0
891602|NCT00669617|1860870|FG000|Period 1|Withdrawal by Subject|0
891603|NCT00669617|1860871|FG001|Period 1|Withdrawal by Subject|0
891604|NCT00669617|1860872|FG002|Period 1|Withdrawal by Subject|1
891605|NCT00669617|1860873|FG003|Period 1|Withdrawal by Subject|0
891606|NCT00669617|1860874|FG004|Period 1|Withdrawal by Subject|0
891607|NCT00669617|1860870|FG000|Period 1|Protocol Deviation|0
891608|NCT00669617|1860871|FG001|Period 1|Protocol Deviation|0
891609|NCT00669617|1860872|FG002|Period 1|Protocol Deviation|0
891610|NCT00669617|1860873|FG003|Period 1|Protocol Deviation|0
891611|NCT00669617|1860874|FG004|Period 1|Protocol Deviation|1
891612|NCT00669617|1860870|FG000|Period 3|Lost to Follow-up|1
891613|NCT00669617|1860871|FG001|Period 3|Lost to Follow-up|0
891614|NCT00669617|1860872|FG002|Period 3|Lost to Follow-up|0
891615|NCT00669617|1860873|FG003|Period 3|Lost to Follow-up|0
891616|NCT00669617|1860874|FG004|Period 3|Lost to Follow-up|0
891617|NCT00669669|1860886|FG000|Overall Study|To late to start treatment|1
891618|NCT00669864|1860895|FG000|Overall Study|Lost to Follow-up|2
891619|NCT00669864|1860895|FG000|Overall Study|Protocol Violation|2
891620|NCT00669864|1860895|FG000|Overall Study|Withdrawal by Subject|3
891621|NCT00669864|1860895|FG000|Overall Study|Other|2
891622|NCT00669877|1860899|FG000|Overall Study|Disease Progression/Death|4
891623|NCT00669903|1860907|FG000|Overall Study|Adverse Event|0
891624|NCT00669903|1860908|FG001|Overall Study|Adverse Event|1
891625|NCT00669903|1860909|FG002|Overall Study|Adverse Event|3
891626|NCT00669903|1860910|FG003|Overall Study|Adverse Event|1
891627|NCT00669903|1860907|FG000|Overall Study|Withdrawal by Subject|0
891628|NCT00669903|1860908|FG001|Overall Study|Withdrawal by Subject|2
891629|NCT00669903|1860909|FG002|Overall Study|Withdrawal by Subject|2
891630|NCT00669903|1860910|FG003|Overall Study|Withdrawal by Subject|2
891631|NCT00669903|1860907|FG000|Overall Study|Lost to Follow-up|1
891632|NCT00669903|1860908|FG001|Overall Study|Lost to Follow-up|1
891633|NCT00669903|1860909|FG002|Overall Study|Lost to Follow-up|0
891634|NCT00669903|1860910|FG003|Overall Study|Lost to Follow-up|1
891635|NCT00669903|1860907|FG000|Overall Study|Protocol Violation|0
891636|NCT00669903|1860908|FG001|Overall Study|Protocol Violation|1
891637|NCT00669903|1860909|FG002|Overall Study|Protocol Violation|0
891638|NCT00669903|1860910|FG003|Overall Study|Protocol Violation|0
891639|NCT00669942|1860941|FG000|Parts 2 and 3|Adverse Event|0
891640|NCT00669942|1860942|FG001|Parts 2 and 3|Adverse Event|0
891641|NCT00669942|1860943|FG002|Parts 2 and 3|Adverse Event|0
891642|NCT00669942|1860944|FG003|Parts 2 and 3|Adverse Event|0
891643|NCT00669942|1860945|FG004|Parts 2 and 3|Adverse Event|0
891644|NCT00669942|1860946|FG005|Parts 2 and 3|Adverse Event|0
891645|NCT00669942|1860947|FG006|Parts 2 and 3|Adverse Event|0
891646|NCT00669942|1860948|FG007|Parts 2 and 3|Adverse Event|2
891647|NCT00669942|1860949|FG008|Parts 2 and 3|Adverse Event|1
891648|NCT00669942|1860950|FG009|Parts 2 and 3|Adverse Event|0
891649|NCT00669942|1860951|FG010|Parts 2 and 3|Adverse Event|0
891650|NCT00669942|1860952|FG011|Parts 2 and 3|Adverse Event|0
891651|NCT00669942|1860941|FG000|Parts 2 and 3|Withdrawal by Subject|0
891652|NCT00669942|1860942|FG001|Parts 2 and 3|Withdrawal by Subject|0
891653|NCT00669942|1860943|FG002|Parts 2 and 3|Withdrawal by Subject|0
891654|NCT00669942|1860944|FG003|Parts 2 and 3|Withdrawal by Subject|0
891655|NCT00669942|1860945|FG004|Parts 2 and 3|Withdrawal by Subject|0
891656|NCT00669942|1860946|FG005|Parts 2 and 3|Withdrawal by Subject|1
891657|NCT00669942|1860947|FG006|Parts 2 and 3|Withdrawal by Subject|0
891658|NCT00669942|1860948|FG007|Parts 2 and 3|Withdrawal by Subject|0
891659|NCT00669942|1860949|FG008|Parts 2 and 3|Withdrawal by Subject|2
891660|NCT00669942|1860950|FG009|Parts 2 and 3|Withdrawal by Subject|0
891661|NCT00669942|1860951|FG010|Parts 2 and 3|Withdrawal by Subject|0
891662|NCT00669942|1860952|FG011|Parts 2 and 3|Withdrawal by Subject|0
891663|NCT00669942|1860941|FG000|Parts 2 and 3|Protocol Violation|0
891664|NCT00669942|1860942|FG001|Parts 2 and 3|Protocol Violation|0
891665|NCT00669942|1860943|FG002|Parts 2 and 3|Protocol Violation|0
891666|NCT00669942|1860944|FG003|Parts 2 and 3|Protocol Violation|0
891667|NCT00669942|1860945|FG004|Parts 2 and 3|Protocol Violation|0
891668|NCT00669942|1860946|FG005|Parts 2 and 3|Protocol Violation|1
891669|NCT00669942|1860947|FG006|Parts 2 and 3|Protocol Violation|0
891670|NCT00669942|1860948|FG007|Parts 2 and 3|Protocol Violation|0
891671|NCT00669942|1860949|FG008|Parts 2 and 3|Protocol Violation|0
891672|NCT00669942|1860950|FG009|Parts 2 and 3|Protocol Violation|0
891673|NCT00669942|1860951|FG010|Parts 2 and 3|Protocol Violation|0
891674|NCT00669942|1860952|FG011|Parts 2 and 3|Protocol Violation|0
891675|NCT00669955|1860977|FG000|Overall Study|Adverse Event|3
891676|NCT00669955|1860978|FG001|Overall Study|Adverse Event|5
891677|NCT00669955|1860977|FG000|Overall Study|Death|0
891678|NCT00669955|1860978|FG001|Overall Study|Death|1
891679|NCT00669955|1860977|FG000|Overall Study|Withdrawal by Subject|2
891680|NCT00669955|1860978|FG001|Overall Study|Withdrawal by Subject|3
891681|NCT00669955|1860977|FG000|Overall Study|Lost to Follow-up|5
891682|NCT00669955|1860978|FG001|Overall Study|Lost to Follow-up|7
891683|NCT00669955|1860977|FG000|Overall Study|Protocol Violation|2
891684|NCT00669955|1860978|FG001|Overall Study|Protocol Violation|7
891685|NCT00669955|1860977|FG000|Overall Study|Investigator Sponsor Judgement|0
891686|NCT00669955|1860978|FG001|Overall Study|Investigator Sponsor Judgement|1
891687|NCT00669955|1860977|FG000|Overall Study|not compliant with study drug/visit|2
891688|NCT00669955|1860978|FG001|Overall Study|not compliant with study drug/visit|3
891689|NCT00670007|1860984|FG000|Overall Study|Drug abuse|1
891690|NCT00670007|1860984|FG000|Overall Study|Lung transplant|1
891691|NCT00670007|1860984|FG000|Overall Study|Travel/Vacation|1
891692|NCT00670007|1860984|FG000|Overall Study|Adverse event, serious fatal|1
891693|NCT00670007|1860984|FG000|Overall Study|Adverse Event|1
891694|NCT00670007|1860984|FG000|Overall Study|Withdrawal by Subject|4
891695|NCT00670046|1860991|FG000|Overall Study|Lost to Follow-up|1
891696|NCT00670046|1860992|FG001|Overall Study|Lost to Follow-up|1
891697|NCT00670046|1860991|FG000|Overall Study|Withdrawal by Subject|0
891698|NCT00670046|1860992|FG001|Overall Study|Withdrawal by Subject|1
891699|NCT00670111|1861001|FG000|Enrollment to One Month|Testing Failure|0
891700|NCT00670111|1861002|FG001|Enrollment to One Month|Testing Failure|0
891701|NCT00670111|1861003|FG002|Enrollment to One Month|Testing Failure|13
891702|NCT00670111|1861001|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0
891703|NCT00670111|1861002|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0
891704|NCT00670111|1861003|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6
891705|NCT00670111|1861001|FG000|Enrollment to One Month|Physician Decision|1
891706|NCT00670111|1861002|FG001|Enrollment to One Month|Physician Decision|0
891707|NCT00670111|1861003|FG002|Enrollment to One Month|Physician Decision|0
891708|NCT00670228|1861022|FG000|Overall Study|Adverse Event|1
891709|NCT00670228|1861023|FG001|Overall Study|Adverse Event|0
891710|NCT00670228|1861022|FG000|Overall Study|Death or MACE|0
891711|NCT00670228|1861023|FG001|Overall Study|Death or MACE|1
891712|NCT00670228|1861022|FG000|Overall Study|Not treated|2
891713|NCT00670228|1861023|FG001|Overall Study|Not treated|2
891714|NCT00670228|1861022|FG000|Overall Study|Not meeting the selection criteria|2
891715|NCT00670228|1861023|FG001|Overall Study|Not meeting the selection criteria|0
891716|NCT00670306|1861048|FG000|Overall Study|Adverse Event|8
891717|NCT00670306|1861048|FG000|Overall Study|Lack of Efficacy|10
891718|NCT00670306|1861048|FG000|Overall Study|Withdrawal by Subject|9
891719|NCT00670306|1861048|FG000|Overall Study|Physician Decision|1
891720|NCT00670306|1861048|FG000|Overall Study|Lost to Follow-up|8
891721|NCT00670306|1861048|FG000|Overall Study|incl/excl criterias did not meet|19
891722|NCT00670449|1861056|FG000|Overall Study|Adverse Event|6
891723|NCT00670449|1861057|FG001|Overall Study|Adverse Event|2
891724|NCT00670449|1861058|FG002|Overall Study|Adverse Event|8
891725|NCT00670449|1861059|FG003|Overall Study|Adverse Event|5
891726|NCT00670449|1861056|FG000|Overall Study|Protocol Deviation|1
891727|NCT00670449|1861057|FG001|Overall Study|Protocol Deviation|2
891728|NCT00670449|1861058|FG002|Overall Study|Protocol Deviation|0
891729|NCT00670449|1861059|FG003|Overall Study|Protocol Deviation|1
891730|NCT00670449|1861056|FG000|Overall Study|Administrative Problems|0
891731|NCT00670449|1861057|FG001|Overall Study|Administrative Problems|2
891732|NCT00670449|1861058|FG002|Overall Study|Administrative Problems|0
891733|NCT00670449|1861059|FG003|Overall Study|Administrative Problems|1
891734|NCT00670449|1861056|FG000|Overall Study|Subject Withdrew Consent|0
891735|NCT00670449|1861057|FG001|Overall Study|Subject Withdrew Consent|2
891736|NCT00670449|1861058|FG002|Overall Study|Subject Withdrew Consent|0
891737|NCT00670449|1861059|FG003|Overall Study|Subject Withdrew Consent|1
891738|NCT00670449|1861056|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2
891739|NCT00670449|1861057|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
891740|NCT00670449|1861058|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
891741|NCT00670449|1861059|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
891742|NCT00670449|1861056|FG000|Overall Study|Abnormal Laboratory Value(s)|0
891743|NCT00670449|1861057|FG001|Overall Study|Abnormal Laboratory Value(s)|2
891744|NCT00670449|1861058|FG002|Overall Study|Abnormal Laboratory Value(s)|0
891745|NCT00670449|1861059|FG003|Overall Study|Abnormal Laboratory Value(s)|0
891746|NCT00670488|1861089|FG000|Overall Study|Adverse Event|0
891747|NCT00670488|1861090|FG001|Overall Study|Adverse Event|7
891748|NCT00670488|1861091|FG002|Overall Study|Adverse Event|0
891749|NCT00670488|1861092|FG003|Overall Study|Adverse Event|3
891750|NCT00670488|1861093|FG004|Overall Study|Adverse Event|1
891751|NCT00670488|1861094|FG005|Overall Study|Adverse Event|1
891752|NCT00670488|1861095|FG006|Overall Study|Adverse Event|5
891753|NCT00670488|1861096|FG007|Overall Study|Adverse Event|1
891754|NCT00670488|1861097|FG008|Overall Study|Adverse Event|0
891755|NCT00670488|1861098|FG009|Overall Study|Adverse Event|1
891756|NCT00670488|1861089|FG000|Overall Study|Physician Decision|1
891757|NCT00670488|1861090|FG001|Overall Study|Physician Decision|9
891758|NCT00670488|1861091|FG002|Overall Study|Physician Decision|0
891759|NCT00670488|1861092|FG003|Overall Study|Physician Decision|1
891760|NCT00670488|1861093|FG004|Overall Study|Physician Decision|0
891761|NCT00670488|1861094|FG005|Overall Study|Physician Decision|0
891762|NCT00670488|1861095|FG006|Overall Study|Physician Decision|0
891763|NCT00670488|1861096|FG007|Overall Study|Physician Decision|0
891764|NCT00670488|1861097|FG008|Overall Study|Physician Decision|0
891765|NCT00670488|1861098|FG009|Overall Study|Physician Decision|0
891766|NCT00670488|1861089|FG000|Overall Study|Progressive Disease|2
891767|NCT00670488|1861090|FG001|Overall Study|Progressive Disease|41
891768|NCT00670488|1861091|FG002|Overall Study|Progressive Disease|3
891769|NCT00670488|1861092|FG003|Overall Study|Progressive Disease|2
891770|NCT00670488|1861093|FG004|Overall Study|Progressive Disease|2
891771|NCT00670488|1861094|FG005|Overall Study|Progressive Disease|4
891772|NCT00670488|1861095|FG006|Overall Study|Progressive Disease|11
891773|NCT00670488|1861096|FG007|Overall Study|Progressive Disease|2
891774|NCT00670488|1861097|FG008|Overall Study|Progressive Disease|2
891775|NCT00670488|1861098|FG009|Overall Study|Progressive Disease|1
891776|NCT00670488|1861089|FG000|Overall Study|Withdrawal by Subject|0
891777|NCT00670488|1861090|FG001|Overall Study|Withdrawal by Subject|1
891778|NCT00670488|1861091|FG002|Overall Study|Withdrawal by Subject|0
891779|NCT00670488|1861092|FG003|Overall Study|Withdrawal by Subject|1
891780|NCT00670488|1861093|FG004|Overall Study|Withdrawal by Subject|0
891781|NCT00670488|1861094|FG005|Overall Study|Withdrawal by Subject|0
891782|NCT00670488|1861095|FG006|Overall Study|Withdrawal by Subject|1
891783|NCT00670488|1861096|FG007|Overall Study|Withdrawal by Subject|0
891784|NCT00670488|1861097|FG008|Overall Study|Withdrawal by Subject|1
891785|NCT00670488|1861098|FG009|Overall Study|Withdrawal by Subject|0
891786|NCT00670540|1861120|FG000|Overall Study|ineligible|17
891787|NCT00670540|1861120|FG000|Overall Study|not living in France|348
891788|NCT00670540|1861120|FG000|Overall Study|refused to participate|189
891789|NCT00670540|1861120|FG000|Overall Study|controls randomised for no follow up|2770
891790|NCT00670540|1861120|FG000|Overall Study|missing information inclusion criteria|1
891791|NCT00670748|1861137|FG000|Overall Study|Death during treatment|1
891792|NCT00670748|1861138|FG001|Overall Study|Death during treatment|1
891793|NCT00670748|1861139|FG002|Overall Study|Death during treatment|1
891794|NCT00670748|1861140|FG003|Overall Study|Death during treatment|0
891795|NCT00670748|1861137|FG000|Overall Study|Not off study|2
891796|NCT00670748|1861138|FG001|Overall Study|Not off study|1
891797|NCT00670748|1861139|FG002|Overall Study|Not off study|1
891798|NCT00670748|1861140|FG003|Overall Study|Not off study|1
891799|NCT00670800|1861156|FG000|Overall Study|2 controls were insulin resistant|0
891800|NCT00670800|1861157|FG001|Overall Study|2 controls were insulin resistant|2
891801|NCT00670930|1861167|FG000|Overall Study|Adminstrative Problem|0
891802|NCT00670930|1861168|FG001|Overall Study|Adminstrative Problem|1
891803|NCT00670930|1861167|FG000|Overall Study|Lost to Follow-up|1
891804|NCT00670930|1861168|FG001|Overall Study|Lost to Follow-up|0
891805|NCT00671034|1861189|FG000|Overall Study|Adverse Event|5
891806|NCT00671034|1861190|FG001|Overall Study|Adverse Event|7
891807|NCT00671034|1861191|FG002|Overall Study|Adverse Event|1
891808|NCT00671034|1861189|FG000|Overall Study|Death|3
891809|NCT00671034|1861190|FG001|Overall Study|Death|2
891810|NCT00671034|1861191|FG002|Overall Study|Death|1
891811|NCT00671034|1861189|FG000|Overall Study|Physician Decision|12
891812|NCT00671034|1861190|FG001|Overall Study|Physician Decision|4
891813|NCT00671034|1861191|FG002|Overall Study|Physician Decision|5
891814|NCT00671034|1861189|FG000|Overall Study|VHR ALL feature|8
891815|NCT00671034|1861190|FG001|Overall Study|VHR ALL feature|3
891816|NCT00671034|1861191|FG002|Overall Study|VHR ALL feature|5
891817|NCT00671034|1861189|FG000|Overall Study|Refusal|5
891818|NCT00671034|1861190|FG001|Overall Study|Refusal|3
891819|NCT00671034|1861191|FG002|Overall Study|Refusal|5
891820|NCT00671034|1861189|FG000|Overall Study|includes Alternative therapy, etc.|6
891821|NCT00671034|1861190|FG001|Overall Study|includes Alternative therapy, etc.|1
891822|NCT00671034|1861191|FG002|Overall Study|includes Alternative therapy, etc.|7
891823|NCT00671060|1861202|FG000|Overall Study|Protocol Violation|1
891824|NCT00671060|1861203|FG001|Overall Study|Protocol Violation|0
891825|NCT00671060|1861202|FG000|Overall Study|Physician Decision|0
891826|NCT00671060|1861203|FG001|Overall Study|Physician Decision|1
891827|NCT00671437|1861218|FG000|Overall Study|Progressive disease before C1 week 8|8
891828|NCT00671437|1861218|FG000|Overall Study|Cutaneous SCC of head and neck|3
891829|NCT00671437|1861218|FG000|Overall Study|Adverse Event|3
891830|NCT00671437|1861218|FG000|Overall Study|Ineligible post-hoc|1
891831|NCT00671554|1861260|FG000|Overall Study|Disease progression|3
891832|NCT00671658|1861265|FG000|Overall Study|Physician Decision|5
891833|NCT00671749|1861292|FG000|Overall Study|Adverse Event|2
891834|NCT00671749|1861292|FG000|Overall Study|Withdrawal by Subject|4
891835|NCT00671749|1861292|FG000|Overall Study|Protocol Violation|1
891836|NCT00671749|1861292|FG000|Overall Study|Lost to Follow-up|1
891837|NCT00671788|1861296|FG000|Overall Study|Adverse Event|8
891838|NCT00671788|1861296|FG000|Overall Study|Refused further treatment|3
891839|NCT00671788|1861296|FG000|Overall Study|Ineligible|1
891840|NCT00671788|1861296|FG000|Overall Study|MD Decision|1
891841|NCT00671788|1861296|FG000|Overall Study|Other|1
891842|NCT00671853|1861302|FG000|Overall Study|Lack of Efficacy|3
891843|NCT00671853|1861303|FG001|Overall Study|Lack of Efficacy|7
891844|NCT00671853|1861302|FG000|Overall Study|Adverse Event|7
891845|NCT00671853|1861303|FG001|Overall Study|Adverse Event|1
891846|NCT00671853|1861302|FG000|Overall Study|Withdrawal by Subject|1
891847|NCT00671853|1861303|FG001|Overall Study|Withdrawal by Subject|5
891848|NCT00671853|1861302|FG000|Overall Study|Lost to Follow-up|8
891849|NCT00671853|1861303|FG001|Overall Study|Lost to Follow-up|8
891850|NCT00671853|1861302|FG000|Overall Study|Physician Decision|0
891851|NCT00671853|1861303|FG001|Overall Study|Physician Decision|2
891852|NCT00671853|1861302|FG000|Overall Study|Non-adherence with study procedures|1
891853|NCT00671853|1861303|FG001|Overall Study|Non-adherence with study procedures|4
891854|NCT00671879|1861314|FG000|Overall Study|Withdrawal by Subject|0
891855|NCT00671879|1861315|FG001|Overall Study|Withdrawal by Subject|4
891856|NCT00671879|1861316|FG002|Overall Study|Withdrawal by Subject|6
891857|NCT00671931|1861335|FG000|Overall Study|Physician Decision|1
891858|NCT00671931|1861336|FG001|Overall Study|Physician Decision|0
891859|NCT00671931|1861337|FG002|Overall Study|Physician Decision|0
891860|NCT00671931|1861338|FG003|Overall Study|Physician Decision|2
891861|NCT00671931|1861339|FG004|Overall Study|Physician Decision|1
891862|NCT00672139|1861391|FG000|Overall Study|Death|14
891863|NCT00672139|1861392|FG001|Overall Study|Death|23
891864|NCT00672139|1861391|FG000|Overall Study|Withdrawal by Subject|2
891865|NCT00672139|1861392|FG001|Overall Study|Withdrawal by Subject|11
891866|NCT00672139|1861391|FG000|Overall Study|Adverse Event|4
891867|NCT00672139|1861392|FG001|Overall Study|Adverse Event|7
891868|NCT00672139|1861391|FG000|Overall Study|Physician Decision|2
891869|NCT00672139|1861392|FG001|Overall Study|Physician Decision|0
891870|NCT00672139|1861391|FG000|Overall Study|Lack of Efficacy|4
891871|NCT00672139|1861392|FG001|Overall Study|Lack of Efficacy|1
891872|NCT00672139|1861391|FG000|Overall Study|Protocol Violation|1
891873|NCT00672139|1861392|FG001|Overall Study|Protocol Violation|1
891874|NCT00672139|1861391|FG000|Overall Study|hospice discharge, caregiver requests|3
891875|NCT00672139|1861392|FG001|Overall Study|hospice discharge, caregiver requests|2
891876|NCT00672256|1861407|FG000|Overall Study|PI dropped, bad data|44
891877|NCT00672477|1861431|FG000|Overall Study|Adverse Event|10
891878|NCT00672477|1861432|FG001|Overall Study|Adverse Event|7
891879|NCT00672477|1861431|FG000|Overall Study|Death|7
891880|NCT00672477|1861432|FG001|Overall Study|Death|11
891881|NCT00672477|1861431|FG000|Overall Study|Physician Decision|2
891882|NCT00672477|1861432|FG001|Overall Study|Physician Decision|0
891883|NCT00672477|1861431|FG000|Overall Study|Protocol Violation|1
891884|NCT00672477|1861432|FG001|Overall Study|Protocol Violation|1
891885|NCT00672477|1861431|FG000|Overall Study|Withdrawal by Subject|5
891886|NCT00672477|1861432|FG001|Overall Study|Withdrawal by Subject|3
891887|NCT00672477|1861431|FG000|Overall Study|Lack of Efficacy|1
891888|NCT00672477|1861432|FG001|Overall Study|Lack of Efficacy|1
891889|NCT00672477|1861431|FG000|Overall Study|no study drug for low GFR, health cond.|1
891890|NCT00672477|1861432|FG001|Overall Study|no study drug for low GFR, health cond.|3
891891|NCT00672490|1861440|FG000|Overall Study|Withdrawal by Subject|8
891892|NCT00672490|1861441|FG001|Overall Study|Withdrawal by Subject|8
891893|NCT00672490|1861440|FG000|Overall Study|Lack of Compliance|2
891894|NCT00672490|1861441|FG001|Overall Study|Lack of Compliance|7
891895|NCT00672490|1861440|FG000|Overall Study|Mismatch Include/Exclude Criteria|1
891896|NCT00672490|1861441|FG001|Overall Study|Mismatch Include/Exclude Criteria|0
891897|NCT00672490|1861440|FG000|Overall Study|Adverse Event|5
891898|NCT00672490|1861441|FG001|Overall Study|Adverse Event|8
891899|NCT00672490|1861440|FG000|Overall Study|Violation of Concomitant Medicine|1
891900|NCT00672490|1861441|FG001|Overall Study|Violation of Concomitant Medicine|0
891901|NCT00672490|1861440|FG000|Overall Study|Intolerance|0
891902|NCT00672490|1861441|FG001|Overall Study|Intolerance|2
891903|NCT00672490|1861440|FG000|Overall Study|Lost to Follow-up|1
891904|NCT00672490|1861441|FG001|Overall Study|Lost to Follow-up|5
891905|NCT00672490|1861440|FG000|Overall Study|No reason was provided|6
891906|NCT00672490|1861441|FG001|Overall Study|No reason was provided|2
891907|NCT00672555|1861447|FG000|Overall Study|Lost to Follow-up|4
891908|NCT00672555|1861447|FG000|Overall Study|Did not want to answer questionnaire|2
891909|NCT00672620|1861459|FG000|Overall Study|Adverse Event|7
891910|NCT00672620|1861460|FG001|Overall Study|Adverse Event|7
891911|NCT00672620|1861461|FG002|Overall Study|Adverse Event|12
891912|NCT00672620|1861462|FG003|Overall Study|Adverse Event|17
891913|NCT00672620|1861459|FG000|Overall Study|Lack of Efficacy|1
891914|NCT00672620|1861460|FG001|Overall Study|Lack of Efficacy|2
891915|NCT00672620|1861461|FG002|Overall Study|Lack of Efficacy|2
891916|NCT00672620|1861462|FG003|Overall Study|Lack of Efficacy|0
891917|NCT00672620|1861459|FG000|Overall Study|Noncompliance with Study Drug|3
891918|NCT00672620|1861460|FG001|Overall Study|Noncompliance with Study Drug|4
891919|NCT00672620|1861461|FG002|Overall Study|Noncompliance with Study Drug|0
891920|NCT00672620|1861462|FG003|Overall Study|Noncompliance with Study Drug|2
891921|NCT00672620|1861459|FG000|Overall Study|Protocol Deviations|5
891922|NCT00672620|1861460|FG001|Overall Study|Protocol Deviations|7
891923|NCT00672620|1861461|FG002|Overall Study|Protocol Deviations|2
891924|NCT00672620|1861462|FG003|Overall Study|Protocol Deviations|5
891925|NCT00672620|1861459|FG000|Overall Study|Withdrawal of Consent|6
891926|NCT00672620|1861460|FG001|Overall Study|Withdrawal of Consent|12
891927|NCT00672620|1861461|FG002|Overall Study|Withdrawal of Consent|5
891928|NCT00672620|1861462|FG003|Overall Study|Withdrawal of Consent|6
891929|NCT00672620|1861459|FG000|Overall Study|Lost to Follow-up|8
891930|NCT00672620|1861460|FG001|Overall Study|Lost to Follow-up|19
891931|NCT00672620|1861461|FG002|Overall Study|Lost to Follow-up|8
891932|NCT00672620|1861462|FG003|Overall Study|Lost to Follow-up|11
891933|NCT00672620|1861459|FG000|Overall Study|Reason not Specified|3
891934|NCT00672620|1861460|FG001|Overall Study|Reason not Specified|3
891935|NCT00672620|1861461|FG002|Overall Study|Reason not Specified|2
891936|NCT00672620|1861462|FG003|Overall Study|Reason not Specified|1
891937|NCT00672633|1861474|FG000|Overall Study|Withdrawal by Subject|0
891938|NCT00672633|1861475|FG001|Overall Study|Withdrawal by Subject|1
891939|NCT00672646|1861484|FG000|Overall Study|Lost to Follow-up|0
891940|NCT00672646|1861485|FG001|Overall Study|Lost to Follow-up|1
891941|NCT00672646|1861486|FG002|Overall Study|Lost to Follow-up|2
891942|NCT00672646|1861484|FG000|Overall Study|Withdrawal by Subject|0
891943|NCT00672646|1861485|FG001|Overall Study|Withdrawal by Subject|0
891944|NCT00672646|1861486|FG002|Overall Study|Withdrawal by Subject|1
891945|NCT00672841|1861501|FG000|Overall Study|Comfort care|1
891946|NCT00672841|1861502|FG001|Overall Study|Comfort care|4
891947|NCT00672841|1861501|FG000|Overall Study|icteric specimens|0
891948|NCT00672841|1861502|FG001|Overall Study|icteric specimens|3
891949|NCT00672841|1861501|FG000|Overall Study|Antifungal therapy, negative glucan|0
891950|NCT00672841|1861502|FG001|Overall Study|Antifungal therapy, negative glucan|4
891951|NCT00672841|1861501|FG000|Overall Study|Adverse Event|0
891952|NCT00672841|1861502|FG001|Overall Study|Adverse Event|3
891953|NCT00672841|1861501|FG000|Overall Study|Pregnancy|0
891954|NCT00672841|1861502|FG001|Overall Study|Pregnancy|1
891955|NCT00672958|1861533|FG000|Overall Study|Adverse Event|11
891956|NCT00672958|1861534|FG001|Overall Study|Adverse Event|9
891957|NCT00672958|1861533|FG000|Overall Study|Lack of Efficacy|6
891958|NCT00672958|1861534|FG001|Overall Study|Lack of Efficacy|11
891959|NCT00672958|1861533|FG000|Overall Study|Non-compliance with study drug|2
891960|NCT00672958|1861534|FG001|Overall Study|Non-compliance with study drug|3
891961|NCT00672958|1861533|FG000|Overall Study|Protocol deviations|11
891962|NCT00672958|1861534|FG001|Overall Study|Protocol deviations|5
891963|NCT00672958|1861533|FG000|Overall Study|Voluntary withdrawal|12
891964|NCT00672958|1861534|FG001|Overall Study|Voluntary withdrawal|8
891965|NCT00672958|1861533|FG000|Overall Study|Lost to Follow-up|22
891966|NCT00672958|1861534|FG001|Overall Study|Lost to Follow-up|17
891967|NCT00672958|1861533|FG000|Overall Study|Reason not specified|0
891968|NCT00672958|1861534|FG001|Overall Study|Reason not specified|3
891969|NCT00672984|1861543|FG000|First Intervention|Adverse Event|5
891970|NCT00672984|1861544|FG001|First Intervention|Adverse Event|0
891971|NCT00672984|1861545|FG002|First Intervention|Adverse Event|0
891972|NCT00672984|1861543|FG000|First Intervention|Withdrawal by Subject|1
891973|NCT00672984|1861544|FG001|First Intervention|Withdrawal by Subject|2
891974|NCT00672984|1861545|FG002|First Intervention|Withdrawal by Subject|2
891975|NCT00672984|1861543|FG000|First Intervention|Sponsor decision|3
891976|NCT00672984|1861544|FG001|First Intervention|Sponsor decision|0
891977|NCT00672984|1861545|FG002|First Intervention|Sponsor decision|0
891978|NCT00672984|1861543|FG000|Second Intervention|Non-compliance with facility policies|0
891979|NCT00672984|1861544|FG001|Second Intervention|Non-compliance with facility policies|2
891980|NCT00672984|1861545|FG002|Second Intervention|Non-compliance with facility policies|0
891981|NCT00672984|1861543|FG000|Second Intervention|Withdrawal by Subject|0
891982|NCT00672984|1861544|FG001|Second Intervention|Withdrawal by Subject|3
891983|NCT00672984|1861545|FG002|Second Intervention|Withdrawal by Subject|0
891984|NCT00672984|1861543|FG000|Second Intervention|Protocol Violation|0
891985|NCT00672984|1861544|FG001|Second Intervention|Protocol Violation|1
891986|NCT00672984|1861545|FG002|Second Intervention|Protocol Violation|1
891987|NCT00672984|1861543|FG000|Third Intervention|Adverse Event|1
891988|NCT00672984|1861544|FG001|Third Intervention|Adverse Event|0
891989|NCT00672984|1861545|FG002|Third Intervention|Adverse Event|1
891990|NCT00673049|1861557|FG000|Before Progression on Erlotinib|Randomized but not treated|3
891991|NCT00673049|1861558|FG001|Before Progression on Erlotinib|Randomized but not treated|1
891992|NCT00673049|1861559|FG002|Before Progression on Erlotinib|Randomized but not treated|0
891993|NCT00673049|1861560|FG003|Before Progression on Erlotinib|Randomized but not treated|0
891994|NCT00673049|1861557|FG000|Before Progression on Erlotinib|Death|235
891995|NCT00673049|1861558|FG001|Before Progression on Erlotinib|Death|167
891996|NCT00673049|1861559|FG002|Before Progression on Erlotinib|Death|1
891997|NCT00673049|1861560|FG003|Before Progression on Erlotinib|Death|0
891998|NCT00673049|1861557|FG000|Before Progression on Erlotinib|Lost to Follow-up|9
891999|NCT00673049|1861558|FG001|Before Progression on Erlotinib|Lost to Follow-up|5
892000|NCT00673049|1861559|FG002|Before Progression on Erlotinib|Lost to Follow-up|0
892001|NCT00673049|1861560|FG003|Before Progression on Erlotinib|Lost to Follow-up|0
892002|NCT00673049|1861557|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26
892003|NCT00673049|1861558|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18
892004|NCT00673049|1861559|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0
892005|NCT00673049|1861560|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0
892006|NCT00673049|1861557|FG000|Before Progression on Erlotinib|Other|1
892007|NCT00673049|1861558|FG001|Before Progression on Erlotinib|Other|2
892008|NCT00673049|1861559|FG002|Before Progression on Erlotinib|Other|0
892009|NCT00673049|1861560|FG003|Before Progression on Erlotinib|Other|0
892010|NCT00673049|1861557|FG000|Before Progression on Erlotinib|study terminated by sponsor|18
892011|NCT00673049|1861558|FG001|Before Progression on Erlotinib|study terminated by sponsor|14
892012|NCT00673049|1861559|FG002|Before Progression on Erlotinib|study terminated by sponsor|0
892013|NCT00673049|1861560|FG003|Before Progression on Erlotinib|study terminated by sponsor|0
892014|NCT00673049|1861557|FG000|Before Progression on Erlotinib|Switched to figitumumab|0
892015|NCT00673049|1861558|FG001|Before Progression on Erlotinib|Switched to figitumumab|83
892016|NCT00673049|1861559|FG002|Before Progression on Erlotinib|Switched to figitumumab|0
892017|NCT00673049|1861560|FG003|Before Progression on Erlotinib|Switched to figitumumab|0
892018|NCT00673049|1861557|FG000|After Progression on Erlotinib|Death|0
892019|NCT00673049|1861558|FG001|After Progression on Erlotinib|Death|0
892020|NCT00673049|1861559|FG002|After Progression on Erlotinib|Death|0
892021|NCT00673049|1861560|FG003|After Progression on Erlotinib|Death|71
892022|NCT00673049|1861557|FG000|After Progression on Erlotinib|Lost to Follow-up|0
892023|NCT00673049|1861558|FG001|After Progression on Erlotinib|Lost to Follow-up|0
892024|NCT00673049|1861559|FG002|After Progression on Erlotinib|Lost to Follow-up|0
892025|NCT00673049|1861560|FG003|After Progression on Erlotinib|Lost to Follow-up|3
892026|NCT00673049|1861557|FG000|After Progression on Erlotinib|Withdrawal by Subject|0
892027|NCT00673049|1861558|FG001|After Progression on Erlotinib|Withdrawal by Subject|0
892028|NCT00673049|1861559|FG002|After Progression on Erlotinib|Withdrawal by Subject|0
892029|NCT00673049|1861560|FG003|After Progression on Erlotinib|Withdrawal by Subject|5
892030|NCT00673049|1861557|FG000|After Progression on Erlotinib|study terminated by sponsor|0
892031|NCT00673049|1861558|FG001|After Progression on Erlotinib|study terminated by sponsor|0
892032|NCT00673049|1861559|FG002|After Progression on Erlotinib|study terminated by sponsor|0
892033|NCT00673049|1861560|FG003|After Progression on Erlotinib|study terminated by sponsor|4
892034|NCT00673231|1861596|FG000|Overall Study|Withdrawal by Subject|14
892035|NCT00673231|1861597|FG001|Overall Study|Withdrawal by Subject|10
892036|NCT00673231|1861598|FG002|Overall Study|Withdrawal by Subject|8
892037|NCT00673231|1861599|FG003|Overall Study|Withdrawal by Subject|6
892038|NCT00673231|1861596|FG000|Overall Study|Adverse Event|6
892039|NCT00673231|1861597|FG001|Overall Study|Adverse Event|5
892040|NCT00673231|1861598|FG002|Overall Study|Adverse Event|9
892041|NCT00673231|1861599|FG003|Overall Study|Adverse Event|6
892042|NCT00673231|1861596|FG000|Overall Study|Lost to Follow-up|1
892043|NCT00673231|1861597|FG001|Overall Study|Lost to Follow-up|2
892044|NCT00673231|1861598|FG002|Overall Study|Lost to Follow-up|1
892045|NCT00673231|1861599|FG003|Overall Study|Lost to Follow-up|2
892046|NCT00673231|1861596|FG000|Overall Study|Death|0
892047|NCT00673231|1861597|FG001|Overall Study|Death|0
892048|NCT00673231|1861598|FG002|Overall Study|Death|1
892049|NCT00673231|1861599|FG003|Overall Study|Death|0
892050|NCT00673231|1861596|FG000|Overall Study|Study criteria,compliance,safety, other|8
892051|NCT00673231|1861597|FG001|Overall Study|Study criteria,compliance,safety, other|5
892052|NCT00673231|1861598|FG002|Overall Study|Study criteria,compliance,safety, other|7
892053|NCT00673231|1861599|FG003|Overall Study|Study criteria,compliance,safety, other|4
892054|NCT00673257|1861618|FG000|Overall Study|Withdrawal by Subject|4
892055|NCT00673257|1861618|FG000|Overall Study|Unable to obtain specimen|1
892056|NCT00673387|1861630|FG000|Overall Study|Withdrawal by Subject|15
892057|NCT00673387|1861631|FG001|Overall Study|Withdrawal by Subject|16
892058|NCT00673387|1861632|FG002|Overall Study|Withdrawal by Subject|20
892059|NCT00673387|1861633|FG003|Overall Study|Withdrawal by Subject|16
892060|NCT00673387|1861634|FG004|Overall Study|Withdrawal by Subject|18
892061|NCT00673387|1861635|FG005|Overall Study|Withdrawal by Subject|21
892062|NCT00673387|1861636|FG006|Overall Study|Withdrawal by Subject|15
892063|NCT00673387|1861637|FG007|Overall Study|Withdrawal by Subject|21
892064|NCT00673387|1861630|FG000|Overall Study|Adverse Event|3
892065|NCT00673387|1861631|FG001|Overall Study|Adverse Event|1
892066|NCT00673387|1861632|FG002|Overall Study|Adverse Event|5
892067|NCT00673387|1861633|FG003|Overall Study|Adverse Event|2
892068|NCT00673387|1861634|FG004|Overall Study|Adverse Event|6
892069|NCT00673387|1861635|FG005|Overall Study|Adverse Event|2
892070|NCT00673387|1861636|FG006|Overall Study|Adverse Event|5
892071|NCT00673387|1861637|FG007|Overall Study|Adverse Event|5
892072|NCT00673387|1861630|FG000|Overall Study|Physician Decision|0
892073|NCT00673387|1861631|FG001|Overall Study|Physician Decision|0
892074|NCT00673387|1861632|FG002|Overall Study|Physician Decision|0
892075|NCT00673387|1861633|FG003|Overall Study|Physician Decision|0
892076|NCT00673387|1861634|FG004|Overall Study|Physician Decision|0
892077|NCT00673387|1861635|FG005|Overall Study|Physician Decision|5
892078|NCT00673387|1861636|FG006|Overall Study|Physician Decision|1
892079|NCT00673387|1861637|FG007|Overall Study|Physician Decision|1
892080|NCT00673387|1861630|FG000|Overall Study|Protocol Violation|3
892081|NCT00673387|1861631|FG001|Overall Study|Protocol Violation|0
892082|NCT00673387|1861632|FG002|Overall Study|Protocol Violation|1
892083|NCT00673387|1861633|FG003|Overall Study|Protocol Violation|2
892084|NCT00673387|1861634|FG004|Overall Study|Protocol Violation|0
892085|NCT00673387|1861635|FG005|Overall Study|Protocol Violation|1
892086|NCT00673387|1861636|FG006|Overall Study|Protocol Violation|1
892087|NCT00673387|1861637|FG007|Overall Study|Protocol Violation|3
892088|NCT00673387|1861630|FG000|Overall Study|Lost to Follow-up|8
892089|NCT00673387|1861631|FG001|Overall Study|Lost to Follow-up|6
892090|NCT00673387|1861632|FG002|Overall Study|Lost to Follow-up|5
892091|NCT00673387|1861633|FG003|Overall Study|Lost to Follow-up|6
892092|NCT00673387|1861634|FG004|Overall Study|Lost to Follow-up|6
892093|NCT00673387|1861635|FG005|Overall Study|Lost to Follow-up|5
892094|NCT00673387|1861636|FG006|Overall Study|Lost to Follow-up|8
892095|NCT00673387|1861637|FG007|Overall Study|Lost to Follow-up|5
892096|NCT00673452|1861682|FG000|Acute Double-Blind Phase|Adverse Event|41
892097|NCT00673452|1861683|FG001|Acute Double-Blind Phase|Adverse Event|24
892098|NCT00673452|1861682|FG000|Acute Double-Blind Phase|Lack of Efficacy|9
892099|NCT00673452|1861683|FG001|Acute Double-Blind Phase|Lack of Efficacy|14
892100|NCT00673452|1861682|FG000|Acute Double-Blind Phase|Lost to Follow-up|16
892101|NCT00673452|1861683|FG001|Acute Double-Blind Phase|Lost to Follow-up|19
892102|NCT00673452|1861682|FG000|Acute Double-Blind Phase|Physician Decision|0
892103|NCT00673452|1861683|FG001|Acute Double-Blind Phase|Physician Decision|6
892104|NCT00673452|1861682|FG000|Acute Double-Blind Phase|Protocol Violation|5
892105|NCT00673452|1861683|FG001|Acute Double-Blind Phase|Protocol Violation|3
892106|NCT00673452|1861682|FG000|Acute Double-Blind Phase|Sponsor Decision|0
892107|NCT00673452|1861683|FG001|Acute Double-Blind Phase|Sponsor Decision|1
892108|NCT00673452|1861682|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16
892109|NCT00673452|1861683|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13
892110|NCT00673452|1861682|FG000|Continuation Double-Blind Phase|Adverse Event|5
892111|NCT00673452|1861683|FG001|Continuation Double-Blind Phase|Adverse Event|13
892112|NCT00673452|1861682|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9
892113|NCT00673452|1861683|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5
892114|NCT00673452|1861682|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4
892115|NCT00673452|1861683|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5
892116|NCT00673452|1861682|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2
892117|NCT00673452|1861683|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5
892118|NCT00673452|1861682|FG000|Continuation Double-Blind Phase|Protocol Violation|2
892119|NCT00673452|1861683|FG001|Continuation Double-Blind Phase|Protocol Violation|3
892120|NCT00673452|1861682|FG000|Continuation Double-Blind Phase|Sponsor Decision|0
892121|NCT00673452|1861683|FG001|Continuation Double-Blind Phase|Sponsor Decision|3
892122|NCT00673452|1861682|FG000|Continuation Double-Blind Phase|Physician Decision|2
892123|NCT00673452|1861683|FG001|Continuation Double-Blind Phase|Physician Decision|0
892124|NCT00673452|1861682|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
892125|NCT00673452|1861683|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
892126|NCT00673465|1861689|FG000|Part 1/Period 1 (United States)|Protocol Violation|0
892127|NCT00673465|1861690|FG001|Part 1/Period 1 (United States)|Protocol Violation|0
892128|NCT00673465|1861691|FG002|Part 1/Period 1 (United States)|Protocol Violation|0
892129|NCT00673465|1861692|FG003|Part 1/Period 1 (United States)|Protocol Violation|0
892130|NCT00673465|1861693|FG004|Part 1/Period 1 (United States)|Protocol Violation|1
892131|NCT00673465|1861694|FG005|Part 1/Period 1 (United States)|Protocol Violation|1
892132|NCT00673465|1861695|FG006|Part 1/Period 1 (United States)|Protocol Violation|0
892133|NCT00673465|1861696|FG007|Part 1/Period 1 (United States)|Protocol Violation|0
892134|NCT00673465|1861697|FG008|Part 1/Period 1 (United States)|Protocol Violation|0
892135|NCT00673465|1861698|FG009|Part 1/Period 1 (United States)|Protocol Violation|0
892136|NCT00673465|1861699|FG010|Part 1/Period 1 (United States)|Protocol Violation|0
892137|NCT00673465|1861700|FG011|Part 1/Period 1 (United States)|Protocol Violation|0
892138|NCT00673465|1861689|FG000|Part 1/Period 2 (United States)|Protocol Violation|0
892139|NCT00673465|1861690|FG001|Part 1/Period 2 (United States)|Protocol Violation|0
892140|NCT00673465|1861691|FG002|Part 1/Period 2 (United States)|Protocol Violation|0
892141|NCT00673465|1861692|FG003|Part 1/Period 2 (United States)|Protocol Violation|0
892142|NCT00673465|1861693|FG004|Part 1/Period 2 (United States)|Protocol Violation|1
892143|NCT00673465|1861694|FG005|Part 1/Period 2 (United States)|Protocol Violation|0
892144|NCT00673465|1861695|FG006|Part 1/Period 2 (United States)|Protocol Violation|0
892145|NCT00673465|1861696|FG007|Part 1/Period 2 (United States)|Protocol Violation|0
892146|NCT00673465|1861697|FG008|Part 1/Period 2 (United States)|Protocol Violation|0
892147|NCT00673465|1861698|FG009|Part 1/Period 2 (United States)|Protocol Violation|0
892148|NCT00673465|1861699|FG010|Part 1/Period 2 (United States)|Protocol Violation|0
892149|NCT00673465|1861700|FG011|Part 1/Period 2 (United States)|Protocol Violation|0
892150|NCT00673660|1861708|FG000|Overall Study|Lost to Follow-up|107
892151|NCT00673673|1861717|FG000|Overall Study|Progressive disease|27
892152|NCT00673673|1861717|FG000|Overall Study|Adverse Event|4
892153|NCT00673673|1861717|FG000|Overall Study|Withdrawal by Subject|3
892154|NCT00673673|1861717|FG000|Overall Study|Investigators' discretion|2
892155|NCT00673790|1861744|FG000|Overall Study|Adverse Event|23
892156|NCT00673790|1861745|FG001|Overall Study|Adverse Event|14
892157|NCT00673790|1861746|FG002|Overall Study|Adverse Event|2
892158|NCT00673790|1861744|FG000|Overall Study|Lack of Efficacy|2
892159|NCT00673790|1861745|FG001|Overall Study|Lack of Efficacy|2
892160|NCT00673790|1861746|FG002|Overall Study|Lack of Efficacy|2
892161|NCT00673790|1861744|FG000|Overall Study|Protocol Violation|6
892162|NCT00673790|1861745|FG001|Overall Study|Protocol Violation|9
892163|NCT00673790|1861746|FG002|Overall Study|Protocol Violation|1
892164|NCT00673790|1861744|FG000|Overall Study|Withdrawal by Subject|7
892165|NCT00673790|1861745|FG001|Overall Study|Withdrawal by Subject|4
892166|NCT00673790|1861746|FG002|Overall Study|Withdrawal by Subject|1
892167|NCT00673790|1861744|FG000|Overall Study|Lost to Follow-up|6
892168|NCT00673790|1861745|FG001|Overall Study|Lost to Follow-up|6
892169|NCT00673790|1861746|FG002|Overall Study|Lost to Follow-up|5
892170|NCT00673790|1861744|FG000|Overall Study|Sponsor Terminated due to PI oversight|0
892171|NCT00673790|1861745|FG001|Overall Study|Sponsor Terminated due to PI oversight|1
892172|NCT00673790|1861746|FG002|Overall Study|Sponsor Terminated due to PI oversight|0
892173|NCT00673790|1861744|FG000|Overall Study|Poor compliance|1
892174|NCT00673790|1861745|FG001|Overall Study|Poor compliance|0
892175|NCT00673790|1861746|FG002|Overall Study|Poor compliance|0
892176|NCT00673790|1861744|FG000|Overall Study|Participated in two Nebivolol studies|0
892177|NCT00673790|1861745|FG001|Overall Study|Participated in two Nebivolol studies|0
892178|NCT00673790|1861746|FG002|Overall Study|Participated in two Nebivolol studies|1
892179|NCT00673790|1861744|FG000|Overall Study|Unconfirmed pregnancy|0
892180|NCT00673790|1861745|FG001|Overall Study|Unconfirmed pregnancy|1
892181|NCT00673790|1861746|FG002|Overall Study|Unconfirmed pregnancy|0
892182|NCT00673790|1861744|FG000|Overall Study|Randomization criteria not met|0
892183|NCT00673790|1861745|FG001|Overall Study|Randomization criteria not met|1
892184|NCT00673790|1861746|FG002|Overall Study|Randomization criteria not met|0
892185|NCT00673816|1861755|FG000|Overall Study|Adverse Event|1
892186|NCT00673816|1861755|FG000|Overall Study|Withdrawal by Subject|1
892187|NCT00673881|1861767|FG000|Overall Study|Withdrawal by Subject|1
892188|NCT00673894|1861773|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1
892189|NCT00673894|1861774|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0
892190|NCT00673894|1861773|FG000|First Intervention 4 Weeks|Adverse Event|1
892191|NCT00673894|1861774|FG001|First Intervention 4 Weeks|Adverse Event|0
892192|NCT00673920|1861788|FG000|Baseline up to Week 48|Withdrew consent|1
892193|NCT00673920|1861789|FG001|Baseline up to Week 48|Withdrew consent|0
892194|NCT00673920|1861790|FG002|Baseline up to Week 48|Withdrew consent|2
892195|NCT00673920|1861791|FG003|Baseline up to Week 48|Withdrew consent|0
892196|NCT00673920|1861792|FG004|Baseline up to Week 48|Withdrew consent|0
892197|NCT00673920|1861793|FG005|Baseline up to Week 48|Withdrew consent|0
892198|NCT00673920|1861794|FG006|Baseline up to Week 48|Withdrew consent|0
892199|NCT00673920|1861795|FG007|Baseline up to Week 48|Withdrew consent|0
892200|NCT00673920|1861788|FG000|Baseline up to Week 48|Refused treatment|1
892201|NCT00673920|1861789|FG001|Baseline up to Week 48|Refused treatment|0
892202|NCT00673920|1861790|FG002|Baseline up to Week 48|Refused treatment|0
892203|NCT00673920|1861791|FG003|Baseline up to Week 48|Refused treatment|0
892204|NCT00673920|1861792|FG004|Baseline up to Week 48|Refused treatment|0
892205|NCT00673920|1861793|FG005|Baseline up to Week 48|Refused treatment|0
892206|NCT00673920|1861794|FG006|Baseline up to Week 48|Refused treatment|0
892207|NCT00673920|1861795|FG007|Baseline up to Week 48|Refused treatment|0
892208|NCT00673920|1861788|FG000|Baseline up to Week 48|Insufficient therapeutic response|2
892209|NCT00673920|1861789|FG001|Baseline up to Week 48|Insufficient therapeutic response|1
892210|NCT00673920|1861790|FG002|Baseline up to Week 48|Insufficient therapeutic response|0
892211|NCT00673920|1861791|FG003|Baseline up to Week 48|Insufficient therapeutic response|0
892212|NCT00673920|1861792|FG004|Baseline up to Week 48|Insufficient therapeutic response|0
892213|NCT00673920|1861793|FG005|Baseline up to Week 48|Insufficient therapeutic response|0
892214|NCT00673920|1861794|FG006|Baseline up to Week 48|Insufficient therapeutic response|0
892215|NCT00673920|1861795|FG007|Baseline up to Week 48|Insufficient therapeutic response|0
892216|NCT00673920|1861788|FG000|Baseline up to Week 48|Protocol Violation|0
892217|NCT00673920|1861789|FG001|Baseline up to Week 48|Protocol Violation|0
892218|NCT00673920|1861790|FG002|Baseline up to Week 48|Protocol Violation|1
892219|NCT00673920|1861791|FG003|Baseline up to Week 48|Protocol Violation|0
892220|NCT00673920|1861792|FG004|Baseline up to Week 48|Protocol Violation|0
892221|NCT00673920|1861793|FG005|Baseline up to Week 48|Protocol Violation|0
892222|NCT00673920|1861794|FG006|Baseline up to Week 48|Protocol Violation|0
892223|NCT00673920|1861795|FG007|Baseline up to Week 48|Protocol Violation|0
892224|NCT00673920|1861788|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0
892225|NCT00673920|1861789|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0
892226|NCT00673920|1861790|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1
892227|NCT00673920|1861791|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0
892228|NCT00673920|1861792|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0
892229|NCT00673920|1861793|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0
892230|NCT00673920|1861794|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0
892231|NCT00673920|1861795|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0
892232|NCT00673920|1861788|FG000|Baseline up to Week 48|Administrative/Other|0
892233|NCT00673920|1861789|FG001|Baseline up to Week 48|Administrative/Other|1
892234|NCT00673920|1861790|FG002|Baseline up to Week 48|Administrative/Other|2
892235|NCT00673920|1861791|FG003|Baseline up to Week 48|Administrative/Other|0
892236|NCT00673920|1861792|FG004|Baseline up to Week 48|Administrative/Other|0
892237|NCT00673920|1861793|FG005|Baseline up to Week 48|Administrative/Other|0
892238|NCT00673920|1861794|FG006|Baseline up to Week 48|Administrative/Other|0
892239|NCT00673920|1861795|FG007|Baseline up to Week 48|Administrative/Other|0
892240|NCT00673920|1861788|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0
892241|NCT00673920|1861789|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1
892242|NCT00673920|1861790|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1
892243|NCT00673920|1861791|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0
892244|NCT00673920|1861792|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0
892245|NCT00673920|1861793|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0
892246|NCT00673920|1861794|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0
892247|NCT00673920|1861795|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0
892248|NCT00673920|1861788|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0
892249|NCT00673920|1861789|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0
1018310|NCT01570244|2043148|FG000|Microgynon+Faldaprevir|Adverse Event|1
892250|NCT00673920|1861790|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0
892251|NCT00673920|1861791|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0
892252|NCT00673920|1861792|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0
892253|NCT00673920|1861793|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0
892254|NCT00673920|1861794|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1
892255|NCT00673920|1861795|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0
892256|NCT00673920|1861788|FG000|Week 24 to Week 48|Failure to return|0
892257|NCT00673920|1861789|FG001|Week 24 to Week 48|Failure to return|0
892258|NCT00673920|1861790|FG002|Week 24 to Week 48|Failure to return|0
892259|NCT00673920|1861791|FG003|Week 24 to Week 48|Failure to return|0
892260|NCT00673920|1861792|FG004|Week 24 to Week 48|Failure to return|0
892261|NCT00673920|1861793|FG005|Week 24 to Week 48|Failure to return|1
892262|NCT00673920|1861794|FG006|Week 24 to Week 48|Failure to return|0
892263|NCT00673920|1861795|FG007|Week 24 to Week 48|Failure to return|0
892264|NCT00673920|1861788|FG000|Week 24 to Week 48|Insufficient therapeutic response|0
892265|NCT00673920|1861789|FG001|Week 24 to Week 48|Insufficient therapeutic response|0
892266|NCT00673920|1861790|FG002|Week 24 to Week 48|Insufficient therapeutic response|0
892267|NCT00673920|1861791|FG003|Week 24 to Week 48|Insufficient therapeutic response|0
892268|NCT00673920|1861792|FG004|Week 24 to Week 48|Insufficient therapeutic response|0
892269|NCT00673920|1861793|FG005|Week 24 to Week 48|Insufficient therapeutic response|1
892270|NCT00673920|1861794|FG006|Week 24 to Week 48|Insufficient therapeutic response|0
892271|NCT00673920|1861795|FG007|Week 24 to Week 48|Insufficient therapeutic response|0
892272|NCT00673920|1861788|FG000|Week 24 to Week 48|Death|0
892273|NCT00673920|1861789|FG001|Week 24 to Week 48|Death|0
892274|NCT00673920|1861790|FG002|Week 24 to Week 48|Death|0
892275|NCT00673920|1861791|FG003|Week 24 to Week 48|Death|0
892276|NCT00673920|1861792|FG004|Week 24 to Week 48|Death|0
892277|NCT00673920|1861793|FG005|Week 24 to Week 48|Death|1
892278|NCT00673920|1861794|FG006|Week 24 to Week 48|Death|0
892279|NCT00673920|1861795|FG007|Week 24 to Week 48|Death|0
892280|NCT00673920|1861788|FG000|Week 24 to Week 48|Adminstrative/Other|0
892281|NCT00673920|1861789|FG001|Week 24 to Week 48|Adminstrative/Other|0
892282|NCT00673920|1861790|FG002|Week 24 to Week 48|Adminstrative/Other|0
892283|NCT00673920|1861791|FG003|Week 24 to Week 48|Adminstrative/Other|1
892284|NCT00673920|1861792|FG004|Week 24 to Week 48|Adminstrative/Other|0
892285|NCT00673920|1861793|FG005|Week 24 to Week 48|Adminstrative/Other|0
892286|NCT00673920|1861794|FG006|Week 24 to Week 48|Adminstrative/Other|0
892287|NCT00673920|1861795|FG007|Week 24 to Week 48|Adminstrative/Other|0
892288|NCT00673933|1861817|FG000|Overall Study|Withdrawal by Subject|2
892289|NCT00673933|1861817|FG000|Overall Study|Lost to Follow-up|1
892290|NCT00674128|1861844|FG000|Overall Study|Withdrawal by Subject|25
892291|NCT00674128|1861845|FG001|Overall Study|Withdrawal by Subject|23
892292|NCT00674154|1861853|FG000|Overall Study|Withdrawal by Subject|3
892293|NCT00674154|1861854|FG001|Overall Study|Withdrawal by Subject|1
892294|NCT00674154|1861853|FG000|Overall Study|Did not want parathyroidectomy|0
892295|NCT00674154|1861854|FG001|Overall Study|Did not want parathyroidectomy|2
892296|NCT00674323|1861886|FG000|Overall Study|Adverse Event|0
892297|NCT00674323|1861887|FG001|Overall Study|Adverse Event|1
892298|NCT00674323|1861888|FG002|Overall Study|Adverse Event|0
892299|NCT00674323|1861886|FG000|Overall Study|Protocol Violation|1
892300|NCT00674323|1861887|FG001|Overall Study|Protocol Violation|0
892301|NCT00674323|1861888|FG002|Overall Study|Protocol Violation|0
892302|NCT00674362|1861898|FG000|Double Blind|Adverse Event|6
892303|NCT00674362|1861899|FG001|Double Blind|Adverse Event|6
892304|NCT00674362|1861898|FG000|Double Blind|Lack of Efficacy|2
892305|NCT00674362|1861899|FG001|Double Blind|Lack of Efficacy|6
892306|NCT00674362|1861898|FG000|Double Blind|Loss of efficacy|0
892307|NCT00674362|1861899|FG001|Double Blind|Loss of efficacy|1
892308|NCT00674362|1861898|FG000|Double Blind|Withdrawal by Subject|4
892309|NCT00674362|1861899|FG001|Double Blind|Withdrawal by Subject|3
892310|NCT00674362|1861898|FG000|Double Blind|Other: Loss of Patient Compliance|0
892311|NCT00674362|1861899|FG001|Double Blind|Other: Loss of Patient Compliance|1
892312|NCT00674362|1861898|FG000|Double Blind|Other: Surgery|0
892313|NCT00674362|1861899|FG001|Double Blind|Other: Surgery|1
892314|NCT00674362|1861898|FG000|Open Label|Adverse Event|1
892315|NCT00674362|1861899|FG001|Open Label|Adverse Event|0
892316|NCT00674362|1861898|FG000|Open Label|Other: Subject moved to extension study|1
892317|NCT00674362|1861899|FG001|Open Label|Other: Subject moved to extension study|0
892318|NCT00674570|1861930|FG000|Overall Study|Withdrawal by Subject|0
892319|NCT00674570|1861931|FG001|Overall Study|Withdrawal by Subject|2
892320|NCT00674570|1861932|FG002|Overall Study|Withdrawal by Subject|0
892321|NCT00674661|1861981|FG000|Overall Study|Other|5
892322|NCT00674661|1861982|FG001|Overall Study|Other|7
892323|NCT00674661|1861981|FG000|Overall Study|Lost to Follow-up|6
892324|NCT00674661|1861982|FG001|Overall Study|Lost to Follow-up|3
892325|NCT00674661|1861981|FG000|Overall Study|Withdrawal by Subject|0
892326|NCT00674661|1861982|FG001|Overall Study|Withdrawal by Subject|5
892327|NCT00674700|1861991|FG000|Year 1|Adverse Event|17
892328|NCT00674700|1861992|FG001|Year 1|Adverse Event|20
892329|NCT00674700|1861993|FG002|Year 1|Adverse Event|5
892330|NCT00674700|1861991|FG000|Year 1|Withdrawal by Subject|7
892331|NCT00674700|1861992|FG001|Year 1|Withdrawal by Subject|7
892332|NCT00674700|1861993|FG002|Year 1|Withdrawal by Subject|6
892333|NCT00674700|1861991|FG000|Year 1|Any other reason not above-mentioned|7
892334|NCT00674700|1861992|FG001|Year 1|Any other reason not above-mentioned|7
892335|NCT00674700|1861993|FG002|Year 1|Any other reason not above-mentioned|6
892336|NCT00674700|1861991|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0
892337|NCT00674700|1861992|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1
892338|NCT00674700|1861993|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1
892339|NCT00674700|1861991|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
892340|NCT00674700|1861992|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
892341|NCT00674700|1861993|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
892342|NCT00674700|1861991|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
892343|NCT00674700|1861992|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
892344|NCT00674700|1861993|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
892345|NCT00674817|1862023|FG000|Period 1|Withdrawal by Subject|2
892346|NCT00674817|1862023|FG000|Period 1|Protocol Violation|1
892347|NCT00674817|1862023|FG000|Period 3|Adverse Event|1
892348|NCT00674817|1862023|FG000|Period 3|Protocol Violation|1
892349|NCT00674817|1862023|FG000|Period 4|Adverse Event|1
892350|NCT00674973|1862039|FG000|Overall Study|Insufficient Therapeutic Response|77
892351|NCT00674973|1862040|FG001|Overall Study|Insufficient Therapeutic Response|72
892352|NCT00674973|1862039|FG000|Overall Study|Refused Treatment|1
892353|NCT00674973|1862040|FG001|Overall Study|Refused Treatment|5
892354|NCT00674973|1862039|FG000|Overall Study|Failure to Return|1
892355|NCT00674973|1862040|FG001|Overall Study|Failure to Return|0
892356|NCT00674973|1862039|FG000|Overall Study|Adverse Event|2
892357|NCT00674973|1862040|FG001|Overall Study|Adverse Event|9
892358|NCT00674973|1862039|FG000|Overall Study|Death|19
892359|NCT00674973|1862040|FG001|Overall Study|Death|15
892360|NCT00674973|1862039|FG000|Overall Study|Protocol Violation|0
892361|NCT00674973|1862040|FG001|Overall Study|Protocol Violation|1
892362|NCT00674986|1862048|FG000|Overall Study|Adverse Event|2
892363|NCT00674986|1862049|FG001|Overall Study|Adverse Event|1
892364|NCT00674986|1862048|FG000|Overall Study|Subject withdrew consent|12
892365|NCT00674986|1862049|FG001|Overall Study|Subject withdrew consent|19
892366|NCT00674986|1862048|FG000|Overall Study|Lost to Follow-up|25
892367|NCT00674986|1862049|FG001|Overall Study|Lost to Follow-up|53
892368|NCT00674986|1862048|FG000|Overall Study|Other reasons|4
892369|NCT00674986|1862049|FG001|Overall Study|Other reasons|8
892370|NCT00675025|1862058|FG000|Overall Study|Study Terminated by Sponsor|38
892371|NCT00675025|1862059|FG001|Overall Study|Study Terminated by Sponsor|42
892372|NCT00675025|1862058|FG000|Overall Study|Adverse Event|6
892373|NCT00675025|1862059|FG001|Overall Study|Adverse Event|11
892374|NCT00675025|1862058|FG000|Overall Study|Lost to Follow-up|6
892375|NCT00675025|1862059|FG001|Overall Study|Lost to Follow-up|4
892376|NCT00675025|1862058|FG000|Overall Study|Withdrawal by Subject|4
892377|NCT00675025|1862059|FG001|Overall Study|Withdrawal by Subject|6
892378|NCT00675103|1862065|FG000|Overall Study|Lack of Efficacy|2
892379|NCT00675103|1862065|FG000|Overall Study|Adverse Event|1
892380|NCT00675428|1862088|FG000|Overall Study|Disease Progression|2
892381|NCT00675428|1862089|FG001|Overall Study|Disease Progression|2
892382|NCT00675428|1862088|FG000|Overall Study|No Disease Response After Cycle 6|0
892383|NCT00675428|1862089|FG001|Overall Study|No Disease Response After Cycle 6|1
892384|NCT00675428|1862088|FG000|Overall Study|Physician Decision|1
892385|NCT00675428|1862089|FG001|Overall Study|Physician Decision|0
892386|NCT00675441|1862095|FG000|Overall Study|Withdrawal by Subject|2
892387|NCT00675441|1862095|FG000|Overall Study|Death|1
892388|NCT00675506|1862101|FG000|Overall Study|Lost to Follow-up|1
892389|NCT00675506|1862102|FG001|Overall Study|Lost to Follow-up|5
892390|NCT00675506|1862101|FG000|Overall Study|Lost interest|3
892391|NCT00675506|1862102|FG001|Overall Study|Lost interest|5
892392|NCT00675506|1862101|FG000|Overall Study|Elevated fasting glucose|2
892393|NCT00675506|1862102|FG001|Overall Study|Elevated fasting glucose|1
892394|NCT00675506|1862101|FG000|Overall Study|Elevated IGF-1 prior to treatment|1
892395|NCT00675506|1862102|FG001|Overall Study|Elevated IGF-1 prior to treatment|0
892396|NCT00675506|1862101|FG000|Overall Study|Elevated IGF-1|2
892397|NCT00675506|1862102|FG001|Overall Study|Elevated IGF-1|0
892398|NCT00675506|1862101|FG000|Overall Study|Hypersensitivity Reaction|1
892399|NCT00675506|1862102|FG001|Overall Study|Hypersensitivity Reaction|0
892400|NCT00675506|1862101|FG000|Overall Study|Disclosed history of cancer|1
892401|NCT00675506|1862102|FG001|Overall Study|Disclosed history of cancer|0
892402|NCT00675506|1862101|FG000|Overall Study|Declined participation|1
892403|NCT00675506|1862102|FG001|Overall Study|Declined participation|0
892404|NCT00675506|1862101|FG000|Overall Study|Schedule conflict|0
892405|NCT00675506|1862102|FG001|Overall Study|Schedule conflict|1
892406|NCT00675597|1862131|FG000|Overall Study|Withdrawal by Subject|3
892407|NCT00675766|1862139|FG000|Overall Study|Lost to Follow-up|6
892408|NCT00675766|1862140|FG001|Overall Study|Lost to Follow-up|5
892409|NCT00675766|1862141|FG002|Overall Study|Lost to Follow-up|21
892410|NCT00675766|1862142|FG003|Overall Study|Lost to Follow-up|26
892411|NCT00675948|1862181|FG000|Overall Study|Adverse Event|23
892412|NCT00675948|1862182|FG001|Overall Study|Adverse Event|1
892413|NCT00675948|1862181|FG000|Overall Study|Lack of Efficacy|3
892414|NCT00675948|1862182|FG001|Overall Study|Lack of Efficacy|0
892415|NCT00675948|1862181|FG000|Overall Study|Withdrawal by Subject|7
892416|NCT00675948|1862182|FG001|Overall Study|Withdrawal by Subject|0
892417|NCT00675948|1862181|FG000|Overall Study|Lost to Follow-up|2
892418|NCT00675948|1862182|FG001|Overall Study|Lost to Follow-up|0
892419|NCT00675948|1862181|FG000|Overall Study|Protocol Violation|1
892420|NCT00675948|1862182|FG001|Overall Study|Protocol Violation|0
892421|NCT00675948|1862181|FG000|Overall Study|Pain under control|1
892422|NCT00675948|1862182|FG001|Overall Study|Pain under control|0
892423|NCT00675948|1862181|FG000|Overall Study|Sponsor decision|0
892424|NCT00675948|1862182|FG001|Overall Study|Sponsor decision|1
892425|NCT00675948|1862181|FG000|Overall Study|Patient died|1
892426|NCT00675948|1862182|FG001|Overall Study|Patient died|0
892427|NCT00675948|1862181|FG000|Overall Study|Patient unable to comply with diaries|1
892428|NCT00675948|1862182|FG001|Overall Study|Patient unable to comply with diaries|0
892429|NCT00675948|1862181|FG000|Overall Study|Patient feels unable to take medication|0
892430|NCT00675948|1862182|FG001|Overall Study|Patient feels unable to take medication|1
892431|NCT00676052|1862213|FG000|Overall Study|Adverse Event|0
892432|NCT00676052|1862214|FG001|Overall Study|Adverse Event|1
892433|NCT00676052|1862215|FG002|Overall Study|Adverse Event|1
892434|NCT00676052|1862216|FG003|Overall Study|Adverse Event|2
892435|NCT00676052|1862217|FG004|Overall Study|Adverse Event|2
892436|NCT00676052|1862218|FG005|Overall Study|Adverse Event|2
892437|NCT00676052|1862213|FG000|Overall Study|Lack of Efficacy|2
892438|NCT00676052|1862214|FG001|Overall Study|Lack of Efficacy|2
892439|NCT00676052|1862215|FG002|Overall Study|Lack of Efficacy|1
892440|NCT00676052|1862216|FG003|Overall Study|Lack of Efficacy|1
892441|NCT00676052|1862217|FG004|Overall Study|Lack of Efficacy|2
892442|NCT00676052|1862218|FG005|Overall Study|Lack of Efficacy|1
892443|NCT00676052|1862213|FG000|Overall Study|Protocol Violation|5
892444|NCT00676052|1862214|FG001|Overall Study|Protocol Violation|3
892445|NCT00676052|1862215|FG002|Overall Study|Protocol Violation|2
892446|NCT00676052|1862216|FG003|Overall Study|Protocol Violation|2
892447|NCT00676052|1862217|FG004|Overall Study|Protocol Violation|1
892448|NCT00676052|1862218|FG005|Overall Study|Protocol Violation|2
892449|NCT00676052|1862213|FG000|Overall Study|Lost to Follow-up|0
892450|NCT00676052|1862214|FG001|Overall Study|Lost to Follow-up|0
892451|NCT00676052|1862215|FG002|Overall Study|Lost to Follow-up|0
892452|NCT00676052|1862216|FG003|Overall Study|Lost to Follow-up|0
892453|NCT00676052|1862217|FG004|Overall Study|Lost to Follow-up|1
892454|NCT00676052|1862218|FG005|Overall Study|Lost to Follow-up|0
892455|NCT00676052|1862213|FG000|Overall Study|Physician Decision|1
892456|NCT00676052|1862214|FG001|Overall Study|Physician Decision|1
892457|NCT00676052|1862215|FG002|Overall Study|Physician Decision|1
892458|NCT00676052|1862216|FG003|Overall Study|Physician Decision|0
892459|NCT00676052|1862217|FG004|Overall Study|Physician Decision|0
892460|NCT00676052|1862218|FG005|Overall Study|Physician Decision|1
892461|NCT00676052|1862213|FG000|Overall Study|Withdrawal by Subject|1
892462|NCT00676052|1862214|FG001|Overall Study|Withdrawal by Subject|0
892463|NCT00676052|1862215|FG002|Overall Study|Withdrawal by Subject|1
892464|NCT00676052|1862216|FG003|Overall Study|Withdrawal by Subject|0
892465|NCT00676052|1862217|FG004|Overall Study|Withdrawal by Subject|0
892466|NCT00676052|1862218|FG005|Overall Study|Withdrawal by Subject|0
892467|NCT00676091|1862247|FG000|Infant Series|Parent or legal guardian request|10
892468|NCT00676091|1862248|FG001|Infant Series|Parent or legal guardian request|8
892469|NCT00676091|1862247|FG000|Infant Series|Protocol Violation|6
892470|NCT00676091|1862248|FG001|Infant Series|Protocol Violation|3
892471|NCT00676091|1862247|FG000|Infant Series|Adverse Event|2
892472|NCT00676091|1862248|FG001|Infant Series|Adverse Event|3
892473|NCT00676091|1862247|FG000|Infant Series|Failed to return|1
892474|NCT00676091|1862248|FG001|Infant Series|Failed to return|3
892475|NCT00676091|1862247|FG000|Infant Series|Lost to Follow-up|1
892476|NCT00676091|1862248|FG001|Infant Series|Lost to Follow-up|0
892477|NCT00676091|1862247|FG000|Infant Series|Died prior to receiving 7vPnC|0
892478|NCT00676091|1862248|FG001|Infant Series|Died prior to receiving 7vPnC|1
892479|NCT00676091|1862247|FG000|After Infant Series|Adverse Event|0
892480|NCT00676091|1862248|FG001|After Infant Series|Adverse Event|1
892481|NCT00676091|1862247|FG000|After Infant Series|Protocol Violation|0
892482|NCT00676091|1862248|FG001|After Infant Series|Protocol Violation|1
892483|NCT00676091|1862247|FG000|After Infant Series|Failed to return|1
892484|NCT00676091|1862248|FG001|After Infant Series|Failed to return|1
892485|NCT00676091|1862247|FG000|Toddler Dose|Failed to return|2
892486|NCT00676091|1862248|FG001|Toddler Dose|Failed to return|0
892487|NCT00676091|1862247|FG000|Toddler Dose|Parent or legal guardian request|1
892488|NCT00676091|1862248|FG001|Toddler Dose|Parent or legal guardian request|0
892489|NCT00676130|1862260|FG000|Overall Study|Lost to Follow-up|0
892490|NCT00676130|1862261|FG001|Overall Study|Lost to Follow-up|1
892491|NCT00676130|1862260|FG000|Overall Study|Found ineligible|3
892492|NCT00676130|1862261|FG001|Overall Study|Found ineligible|2
892493|NCT00676130|1862260|FG000|Overall Study|Withdrawal by Subject|0
892494|NCT00676130|1862261|FG001|Overall Study|Withdrawal by Subject|1
892495|NCT00676143|1862269|FG000|Overall Study|Adverse Event|34
892496|NCT00676143|1862270|FG001|Overall Study|Adverse Event|60
892497|NCT00676143|1862269|FG000|Overall Study|Death|4
892498|NCT00676143|1862270|FG001|Overall Study|Death|4
892499|NCT00676143|1862269|FG000|Overall Study|Lack of Efficacy|0
892500|NCT00676143|1862270|FG001|Overall Study|Lack of Efficacy|6
892501|NCT00676143|1862269|FG000|Overall Study|Lost to Follow-up|0
892502|NCT00676143|1862270|FG001|Overall Study|Lost to Follow-up|13
892503|NCT00676143|1862269|FG000|Overall Study|Physician Decision|5
892504|NCT00676143|1862270|FG001|Overall Study|Physician Decision|8
892505|NCT00676143|1862269|FG000|Overall Study|Protocol Violation|4
892506|NCT00676143|1862270|FG001|Overall Study|Protocol Violation|8
892507|NCT00676143|1862269|FG000|Overall Study|Withdrawal by Subject|24
892508|NCT00676143|1862270|FG001|Overall Study|Withdrawal by Subject|42
892509|NCT00676143|1862269|FG000|Overall Study|Discontinuation of study by sponsor|65
892510|NCT00676143|1862270|FG001|Overall Study|Discontinuation of study by sponsor|88
892511|NCT00676143|1862269|FG000|Overall Study|Failed to return|2
892512|NCT00676143|1862270|FG001|Overall Study|Failed to return|1
892513|NCT00676143|1862269|FG000|Overall Study|Loss of caregiver|5
892514|NCT00676143|1862270|FG001|Overall Study|Loss of caregiver|3
892515|NCT00676143|1862269|FG000|Overall Study|Other|11
892516|NCT00676143|1862270|FG001|Overall Study|Other|20
892517|NCT00676143|1862269|FG000|Overall Study|Participant participation unknown|1
892518|NCT00676143|1862270|FG001|Overall Study|Participant participation unknown|4
892519|NCT00676143|1862269|FG000|Overall Study|Vasogenic edema recurrence|1
892520|NCT00676143|1862270|FG001|Overall Study|Vasogenic edema recurrence|3
892521|NCT00676195|1862289|FG000|Overall Study|Lost to Follow-up|1
892522|NCT00676195|1862289|FG000|Overall Study|Adverse Event|1
892523|NCT00676195|1862289|FG000|Overall Study|Physician Decision|1
892524|NCT00676208|1862296|FG000|Overall Study|Lost to Follow-up|0
892525|NCT00676208|1862297|FG001|Overall Study|Lost to Follow-up|2
892526|NCT00676208|1862296|FG000|Overall Study|Incomplete data|2
892527|NCT00676208|1862297|FG001|Overall Study|Incomplete data|4
892528|NCT00676338|1862309|FG000|Overall Study|Adverse Event|6
892529|NCT00676338|1862310|FG001|Overall Study|Adverse Event|6
892530|NCT00676338|1862311|FG002|Overall Study|Adverse Event|5
892531|NCT00676338|1862312|FG003|Overall Study|Adverse Event|1
892532|NCT00676338|1862309|FG000|Overall Study|Lost to Follow-up|4
892533|NCT00676338|1862310|FG001|Overall Study|Lost to Follow-up|1
892534|NCT00676338|1862311|FG002|Overall Study|Lost to Follow-up|3
892535|NCT00676338|1862312|FG003|Overall Study|Lost to Follow-up|4
892536|NCT00676338|1862309|FG000|Overall Study|Physician Decision|3
892537|NCT00676338|1862310|FG001|Overall Study|Physician Decision|3
892538|NCT00676338|1862311|FG002|Overall Study|Physician Decision|2
892539|NCT00676338|1862312|FG003|Overall Study|Physician Decision|3
892540|NCT00676338|1862309|FG000|Overall Study|Protocol Violation|5
892541|NCT00676338|1862310|FG001|Overall Study|Protocol Violation|9
892542|NCT00676338|1862311|FG002|Overall Study|Protocol Violation|2
892543|NCT00676338|1862312|FG003|Overall Study|Protocol Violation|5
892544|NCT00676338|1862309|FG000|Overall Study|Withdrawal by Subject|17
892545|NCT00676338|1862310|FG001|Overall Study|Withdrawal by Subject|9
892546|NCT00676338|1862311|FG002|Overall Study|Withdrawal by Subject|12
892547|NCT00676338|1862312|FG003|Overall Study|Withdrawal by Subject|6
892548|NCT00676338|1862309|FG000|Overall Study|Entry Criteria Not Met|0
892549|NCT00676338|1862310|FG001|Overall Study|Entry Criteria Not Met|2
892550|NCT00676338|1862311|FG002|Overall Study|Entry Criteria Not Met|1
892551|NCT00676338|1862312|FG003|Overall Study|Entry Criteria Not Met|1
892552|NCT00676338|1862309|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
892553|NCT00676338|1862310|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
892554|NCT00676338|1862311|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
892555|NCT00676338|1862312|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
892556|NCT00676403|1862339|FG000|Overall Study|Adverse Event|1
892557|NCT00676403|1862340|FG001|Overall Study|Adverse Event|2
892558|NCT00676403|1862341|FG002|Overall Study|Adverse Event|0
892559|NCT00676403|1862342|FG003|Overall Study|Adverse Event|5
892560|NCT00676403|1862343|FG004|Overall Study|Adverse Event|1
892561|NCT00676403|1862344|FG005|Overall Study|Adverse Event|2
892562|NCT00676403|1862339|FG000|Overall Study|Lost to Follow-up|0
892563|NCT00676403|1862340|FG001|Overall Study|Lost to Follow-up|0
892564|NCT00676403|1862341|FG002|Overall Study|Lost to Follow-up|0
892565|NCT00676403|1862342|FG003|Overall Study|Lost to Follow-up|0
892566|NCT00676403|1862343|FG004|Overall Study|Lost to Follow-up|0
892567|NCT00676403|1862344|FG005|Overall Study|Lost to Follow-up|1
892568|NCT00676403|1862339|FG000|Overall Study|Reason Unspecified|1
892569|NCT00676403|1862340|FG001|Overall Study|Reason Unspecified|0
892570|NCT00676403|1862341|FG002|Overall Study|Reason Unspecified|1
892571|NCT00676403|1862342|FG003|Overall Study|Reason Unspecified|0
892572|NCT00676403|1862343|FG004|Overall Study|Reason Unspecified|0
892573|NCT00676403|1862344|FG005|Overall Study|Reason Unspecified|1
892574|NCT00676403|1862339|FG000|Overall Study|Withdrawal by Subject|0
892575|NCT00676403|1862340|FG001|Overall Study|Withdrawal by Subject|0
892576|NCT00676403|1862341|FG002|Overall Study|Withdrawal by Subject|0
892577|NCT00676403|1862342|FG003|Overall Study|Withdrawal by Subject|0
892578|NCT00676403|1862343|FG004|Overall Study|Withdrawal by Subject|0
892579|NCT00676403|1862344|FG005|Overall Study|Withdrawal by Subject|1
892580|NCT00676494|1862364|FG000|Overall Study|Missed Visit|8
892581|NCT00676494|1862364|FG000|Overall Study|Withdrawal by Subject|6
892582|NCT00676520|1862367|FG000|Overall Study|Withdrawal by Subject|163
892583|NCT00676520|1862367|FG000|Overall Study|Lost to Follow-up|162
892584|NCT00676520|1862367|FG000|Overall Study|Death|159
892585|NCT00676520|1862367|FG000|Overall Study|Physician Decision|20
892586|NCT00676520|1862367|FG000|Overall Study|Ineligible for Randomization to DAPT|209
892587|NCT00676520|1862367|FG000|Overall Study|Other Reason|18
892588|NCT00676650|1862396|FG000|Overall Study|Death|45
892589|NCT00676650|1862397|FG001|Overall Study|Death|14
892590|NCT00676650|1862396|FG000|Overall Study|Adverse Event|159
892591|NCT00676650|1862397|FG001|Overall Study|Adverse Event|21
892592|NCT00676650|1862396|FG000|Overall Study|Global deterioration of health status|66
892593|NCT00676650|1862397|FG001|Overall Study|Global deterioration of health status|31
892594|NCT00676650|1862396|FG000|Overall Study|Lost to Follow-up|0
892595|NCT00676650|1862397|FG001|Overall Study|Lost to Follow-up|1
892596|NCT00676650|1862396|FG000|Overall Study|Objective progression or relapse|189
892597|NCT00676650|1862397|FG001|Overall Study|Objective progression or relapse|140
892598|NCT00676650|1862396|FG000|Overall Study|Other|14
892599|NCT00676650|1862397|FG001|Overall Study|Other|10
892600|NCT00676650|1862396|FG000|Overall Study|Protocol Violation|3
892601|NCT00676650|1862397|FG001|Overall Study|Protocol Violation|1
892602|NCT00676650|1862396|FG000|Overall Study|Study terminated by sponsor|57
892603|NCT00676650|1862397|FG001|Overall Study|Study terminated by sponsor|43
892604|NCT00676650|1862396|FG000|Overall Study|Withdrawal by Subject|48
892605|NCT00676650|1862397|FG001|Overall Study|Withdrawal by Subject|24
892606|NCT00676650|1862396|FG000|Overall Study|Randomized but not treated|3
892607|NCT00676650|1862397|FG001|Overall Study|Randomized but not treated|4
892608|NCT00676663|1862405|FG000|Overall Study|Death|43
892609|NCT00676663|1862406|FG001|Overall Study|Death|27
892610|NCT00676663|1862405|FG000|Overall Study|Withdrew Consent|1
892611|NCT00676663|1862406|FG001|Overall Study|Withdrew Consent|8
892612|NCT00676663|1862405|FG000|Overall Study|Lost to Follow-up|1
892613|NCT00676663|1862406|FG001|Overall Study|Lost to Follow-up|3
892614|NCT00676689|1862418|FG000|Overall Study|Screen Failure|2
892615|NCT00676689|1862418|FG000|Overall Study|Death|2
892616|NCT00676689|1862418|FG000|Overall Study|Lost to Follow-up|4
892617|NCT00676689|1862418|FG000|Overall Study|Physician Decision|1
892618|NCT00676689|1862418|FG000|Overall Study|Withdrawal by Subject|3
892619|NCT00676689|1862418|FG000|Overall Study|Continuing FU|49
892644|NCT00677014|1862475|FG000|Overall Study|Lost to Follow-up|20
892645|NCT00677014|1862476|FG001|Overall Study|Lost to Follow-up|12
892646|NCT00677014|1862477|FG002|Overall Study|Lost to Follow-up|24
892647|NCT00677014|1862475|FG000|Overall Study|Death|6
892648|NCT00677014|1862476|FG001|Overall Study|Death|15
892649|NCT00677014|1862477|FG002|Overall Study|Death|7
892650|NCT00677014|1862475|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18
892651|NCT00677014|1862476|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14
892652|NCT00677014|1862477|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18
892653|NCT00677092|1862490|FG000|Overall Study|Adverse Event|1
892654|NCT00677092|1862490|FG000|Overall Study|Lost to Follow-up|1
892655|NCT00677092|1862490|FG000|Overall Study|Withdrawal by Subject|3
892656|NCT00677092|1862490|FG000|Overall Study|Death Prior to Receiving Treatment|1
892657|NCT00677235|1862497|FG000|Overall Study|Withdrawal by Subject|1
892658|NCT00677235|1862498|FG001|Overall Study|Withdrawal by Subject|1
892659|NCT00677235|1862497|FG000|Overall Study|Lost to Follow-up|2
892660|NCT00677235|1862498|FG001|Overall Study|Lost to Follow-up|1
892661|NCT00677235|1862497|FG000|Overall Study|Death|37
892662|NCT00677235|1862498|FG001|Overall Study|Death|36
892663|NCT00677235|1862497|FG000|Overall Study|Adverse Experience|1
892664|NCT00677235|1862498|FG001|Overall Study|Adverse Experience|0
892665|NCT00677352|1862506|FG000|Treatment Phase|Adverse Event|14
892666|NCT00677352|1862507|FG001|Treatment Phase|Adverse Event|22
892667|NCT00677352|1862506|FG000|Treatment Phase|Lack of Efficacy|2
892668|NCT00677352|1862507|FG001|Treatment Phase|Lack of Efficacy|3
892669|NCT00677352|1862506|FG000|Treatment Phase|Lost to Follow-up|0
892670|NCT00677352|1862507|FG001|Treatment Phase|Lost to Follow-up|1
892671|NCT00677352|1862506|FG000|Treatment Phase|Withdrawal by Subject|7
892672|NCT00677352|1862507|FG001|Treatment Phase|Withdrawal by Subject|7
892673|NCT00677352|1862506|FG000|Treatment Phase|Physician Decision|1
892674|NCT00677352|1862507|FG001|Treatment Phase|Physician Decision|0
892675|NCT00677352|1862506|FG000|Treatment Phase|Pregnancy|0
892676|NCT00677352|1862507|FG001|Treatment Phase|Pregnancy|1
892677|NCT00677352|1862506|FG000|Treatment Phase|Protocol Violation|1
892678|NCT00677352|1862507|FG001|Treatment Phase|Protocol Violation|1
892679|NCT00677352|1862506|FG000|Treatment Phase|Transference or work related matter|0
892680|NCT00677352|1862507|FG001|Treatment Phase|Transference or work related matter|5
892681|NCT00677352|1862506|FG000|Treatment Phase|Not treated|0
892682|NCT00677352|1862507|FG001|Treatment Phase|Not treated|2
892683|NCT00677352|1862506|FG000|Tapering Phase|Adverse Event|1
892684|NCT00677352|1862507|FG001|Tapering Phase|Adverse Event|5
892685|NCT00677352|1862506|FG000|Tapering Phase|Withdrawal by Subject|5
892686|NCT00677352|1862507|FG001|Tapering Phase|Withdrawal by Subject|3
892687|NCT00677352|1862506|FG000|Tapering Phase|Pregnancy|0
892688|NCT00677352|1862507|FG001|Tapering Phase|Pregnancy|1
892689|NCT00677352|1862506|FG000|Tapering Phase|Job transfer|0
892690|NCT00677352|1862507|FG001|Tapering Phase|Job transfer|1
892691|NCT00677365|1862517|FG000|Overall Study|Adverse Event|2
892692|NCT00677365|1862518|FG001|Overall Study|Adverse Event|1
892693|NCT00677365|1862519|FG002|Overall Study|Adverse Event|1
892694|NCT00677365|1862520|FG003|Overall Study|Adverse Event|2
892695|NCT00677365|1862517|FG000|Overall Study|Withdrawal by Subject|0
892696|NCT00677365|1862518|FG001|Overall Study|Withdrawal by Subject|0
892697|NCT00677365|1862519|FG002|Overall Study|Withdrawal by Subject|1
892698|NCT00677365|1862520|FG003|Overall Study|Withdrawal by Subject|0
892699|NCT00677365|1862517|FG000|Overall Study|Other reason|0
892700|NCT00677365|1862518|FG001|Overall Study|Other reason|0
892701|NCT00677365|1862519|FG002|Overall Study|Other reason|0
892702|NCT00677365|1862520|FG003|Overall Study|Other reason|1
892703|NCT00677534|1862530|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1
892704|NCT00677534|1862530|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
892705|NCT00677534|1862530|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
892706|NCT00677807|1862546|FG000|Overall Study|Adverse Event|4
892707|NCT00677807|1862547|FG001|Overall Study|Adverse Event|1
892708|NCT00677807|1862548|FG002|Overall Study|Adverse Event|6
892709|NCT00677807|1862546|FG000|Overall Study|Lack of Efficacy|0
892710|NCT00677807|1862547|FG001|Overall Study|Lack of Efficacy|0
892711|NCT00677807|1862548|FG002|Overall Study|Lack of Efficacy|2
892712|NCT00677807|1862546|FG000|Overall Study|Participant no longer needs study drug|0
892713|NCT00677807|1862547|FG001|Overall Study|Participant no longer needs study drug|0
892714|NCT00677807|1862548|FG002|Overall Study|Participant no longer needs study drug|1
892715|NCT00677807|1862546|FG000|Overall Study|Withdrawal by Subject|10
892716|NCT00677807|1862547|FG001|Overall Study|Withdrawal by Subject|3
892717|NCT00677807|1862548|FG002|Overall Study|Withdrawal by Subject|6
892718|NCT00677807|1862546|FG000|Overall Study|Lost to Follow-up|2
892719|NCT00677807|1862547|FG001|Overall Study|Lost to Follow-up|2
892720|NCT00677807|1862548|FG002|Overall Study|Lost to Follow-up|2
892721|NCT00677807|1862546|FG000|Overall Study|Administrative problems|1
892722|NCT00677807|1862547|FG001|Overall Study|Administrative problems|1
892723|NCT00677807|1862548|FG002|Overall Study|Administrative problems|2
892724|NCT00677807|1862546|FG000|Overall Study|Death|0
892725|NCT00677807|1862547|FG001|Overall Study|Death|1
892726|NCT00677807|1862548|FG002|Overall Study|Death|1
892727|NCT00677807|1862546|FG000|Overall Study|Protocol Deviation|1
892728|NCT00677807|1862547|FG001|Overall Study|Protocol Deviation|3
892729|NCT00677807|1862548|FG002|Overall Study|Protocol Deviation|0
892730|NCT00677820|1862558|FG000|Overall Study|Lost to Follow-up|1
892731|NCT00677820|1862559|FG001|Overall Study|Lost to Follow-up|0
892732|NCT00677833|1862569|FG000|Overall Study|Withdrawal by Subject|4
892733|NCT00677833|1862570|FG001|Overall Study|Withdrawal by Subject|0
892734|NCT00677833|1862571|FG002|Overall Study|Withdrawal by Subject|1
892735|NCT00677833|1862572|FG003|Overall Study|Withdrawal by Subject|3
892736|NCT00677833|1862569|FG000|Overall Study|Lost to Follow-up|0
892737|NCT00677833|1862570|FG001|Overall Study|Lost to Follow-up|0
892738|NCT00677833|1862571|FG002|Overall Study|Lost to Follow-up|1
892739|NCT00677833|1862572|FG003|Overall Study|Lost to Follow-up|0
892740|NCT00678080|1862604|FG000|Overall Study|Physician Decision|2
892741|NCT00678080|1862605|FG001|Overall Study|Physician Decision|0
892742|NCT00678080|1862604|FG000|Overall Study|Lost to Follow-up|1
892743|NCT00678080|1862605|FG001|Overall Study|Lost to Follow-up|0
892744|NCT00678080|1862604|FG000|Overall Study|Withdrawal by Subject|0
892745|NCT00678080|1862605|FG001|Overall Study|Withdrawal by Subject|1
892746|NCT00678210|1862615|FG000|Overall Study|Adverse Event|1
892747|NCT00678210|1862616|FG001|Overall Study|Adverse Event|2
892748|NCT00678210|1862617|FG002|Overall Study|Adverse Event|3
892749|NCT00678210|1862618|FG003|Overall Study|Adverse Event|3
892750|NCT00678210|1862615|FG000|Overall Study|Lack of Efficacy|2
892751|NCT00678210|1862616|FG001|Overall Study|Lack of Efficacy|3
892752|NCT00678210|1862617|FG002|Overall Study|Lack of Efficacy|1
892753|NCT00678210|1862618|FG003|Overall Study|Lack of Efficacy|9
892754|NCT00678210|1862615|FG000|Overall Study|Lost to Follow-up|4
892755|NCT00678210|1862616|FG001|Overall Study|Lost to Follow-up|2
892756|NCT00678210|1862617|FG002|Overall Study|Lost to Follow-up|0
892757|NCT00678210|1862618|FG003|Overall Study|Lost to Follow-up|1
892758|NCT00678210|1862615|FG000|Overall Study|Withdrawal by Subject|3
892759|NCT00678210|1862616|FG001|Overall Study|Withdrawal by Subject|4
892760|NCT00678210|1862617|FG002|Overall Study|Withdrawal by Subject|1
892761|NCT00678210|1862618|FG003|Overall Study|Withdrawal by Subject|7
892762|NCT00678210|1862615|FG000|Overall Study|Other|1
892763|NCT00678210|1862616|FG001|Overall Study|Other|0
892764|NCT00678210|1862617|FG002|Overall Study|Other|1
892765|NCT00678210|1862618|FG003|Overall Study|Other|0
892766|NCT00678301|1862643|FG000|Overall Study|Non-compliance with study procedures|0
892767|NCT00678301|1862644|FG001|Overall Study|Non-compliance with study procedures|1
892768|NCT00678301|1862643|FG000|Overall Study|Adverse Event|1
892769|NCT00678301|1862644|FG001|Overall Study|Adverse Event|0
892770|NCT00678301|1862643|FG000|Overall Study|Withdrawal by Subject|4
892771|NCT00678301|1862644|FG001|Overall Study|Withdrawal by Subject|0
892772|NCT00678301|1862643|FG000|Overall Study|Lost to Follow-up|3
892773|NCT00678301|1862644|FG001|Overall Study|Lost to Follow-up|1
892774|NCT00678379|1862653|FG000|Overall Study|Injection performed after tonsillectomy|2
892775|NCT00678379|1862654|FG001|Overall Study|Injection performed after tonsillectomy|0
892776|NCT00678379|1862655|FG002|Overall Study|Injection performed after tonsillectomy|1
892777|NCT00678379|1862653|FG000|Overall Study|Incomplete Data|4
892778|NCT00678379|1862654|FG001|Overall Study|Incomplete Data|3
892779|NCT00678379|1862655|FG002|Overall Study|Incomplete Data|3
892780|NCT00678392|1862665|FG000|Overall Study|Adverse Event|0
892781|NCT00678392|1862666|FG001|Overall Study|Adverse Event|6
892782|NCT00678392|1862665|FG000|Overall Study|Death|280
892783|NCT00678392|1862666|FG001|Overall Study|Death|269
892784|NCT00678392|1862665|FG000|Overall Study|Lost to Follow-up|15
892785|NCT00678392|1862666|FG001|Overall Study|Lost to Follow-up|13
892786|NCT00678392|1862665|FG000|Overall Study|Objective Progression or Relapse|3
892787|NCT00678392|1862666|FG001|Overall Study|Objective Progression or Relapse|8
892788|NCT00678392|1862665|FG000|Overall Study|Sponsor's Decision|1
892789|NCT00678392|1862666|FG001|Overall Study|Sponsor's Decision|2
892790|NCT00678392|1862665|FG000|Overall Study|Withdrawal by Subject|4
892791|NCT00678392|1862666|FG001|Overall Study|Withdrawal by Subject|4
892792|NCT00678392|1862665|FG000|Overall Study|Randomized But Not Treated|2
892793|NCT00678392|1862666|FG001|Overall Study|Randomized But Not Treated|7
892794|NCT00678392|1862665|FG000|Overall Study|Other|56
892795|NCT00678392|1862666|FG001|Overall Study|Other|53
892796|NCT00678561|1862722|FG000|Overall Study|Adverse Event|0
892797|NCT00678561|1862723|FG001|Overall Study|Adverse Event|1
892798|NCT00678561|1862724|FG002|Overall Study|Adverse Event|1
892799|NCT00678561|1862725|FG003|Overall Study|Adverse Event|0
892800|NCT00678561|1862726|FG004|Overall Study|Adverse Event|1
892801|NCT00678561|1862727|FG005|Overall Study|Adverse Event|0
892802|NCT00678561|1862728|FG006|Overall Study|Adverse Event|0
892803|NCT00678561|1862729|FG007|Overall Study|Adverse Event|0
892804|NCT00678561|1862722|FG000|Overall Study|Protocol Violation|0
892805|NCT00678561|1862723|FG001|Overall Study|Protocol Violation|0
892806|NCT00678561|1862724|FG002|Overall Study|Protocol Violation|0
892807|NCT00678561|1862725|FG003|Overall Study|Protocol Violation|0
892808|NCT00678561|1862726|FG004|Overall Study|Protocol Violation|1
892809|NCT00678561|1862727|FG005|Overall Study|Protocol Violation|1
892810|NCT00678561|1862728|FG006|Overall Study|Protocol Violation|0
892811|NCT00678561|1862729|FG007|Overall Study|Protocol Violation|0
892812|NCT00678561|1862722|FG000|Overall Study|Withdrawal by Subject|0
892813|NCT00678561|1862723|FG001|Overall Study|Withdrawal by Subject|0
892814|NCT00678561|1862724|FG002|Overall Study|Withdrawal by Subject|0
892815|NCT00678561|1862725|FG003|Overall Study|Withdrawal by Subject|0
892816|NCT00678561|1862726|FG004|Overall Study|Withdrawal by Subject|0
892817|NCT00678561|1862727|FG005|Overall Study|Withdrawal by Subject|0
892818|NCT00678561|1862728|FG006|Overall Study|Withdrawal by Subject|0
892819|NCT00678561|1862729|FG007|Overall Study|Withdrawal by Subject|1
892820|NCT00678587|1862756|FG000|Overall Study|Adverse Event|3
892821|NCT00678587|1862757|FG001|Overall Study|Adverse Event|3
892822|NCT00678587|1862756|FG000|Overall Study|Lack of Efficacy|1
892823|NCT00678587|1862757|FG001|Overall Study|Lack of Efficacy|0
892824|NCT00678587|1862756|FG000|Overall Study|Protocol Violation|2
892825|NCT00678587|1862757|FG001|Overall Study|Protocol Violation|1
892826|NCT00678587|1862756|FG000|Overall Study|Study Closed/Terminated|1
892827|NCT00678587|1862757|FG001|Overall Study|Study Closed/Terminated|0
892828|NCT00678587|1862756|FG000|Overall Study|Lost to Follow-up|3
892829|NCT00678587|1862757|FG001|Overall Study|Lost to Follow-up|5
892830|NCT00678587|1862756|FG000|Overall Study|Investigator Discretion|2
892831|NCT00678587|1862757|FG001|Overall Study|Investigator Discretion|6
892832|NCT00678587|1862756|FG000|Overall Study|Withdrew Consent|8
892833|NCT00678587|1862757|FG001|Overall Study|Withdrew Consent|3
892834|NCT00678639|1862766|FG000|Overall Study|Lost to Follow-up at 30 days|2
892835|NCT00678639|1862767|FG001|Overall Study|Lost to Follow-up at 30 days|0
892836|NCT00678652|1862778|FG000|Overall Study|Protocol Violation|2
892837|NCT00678652|1862779|FG001|Overall Study|Protocol Violation|0
892838|NCT00678652|1862780|FG002|Overall Study|Protocol Violation|0
892839|NCT00678652|1862781|FG003|Overall Study|Protocol Violation|0
892840|NCT00678652|1862778|FG000|Overall Study|Pregnancy|0
892841|NCT00678652|1862779|FG001|Overall Study|Pregnancy|0
892842|NCT00678652|1862780|FG002|Overall Study|Pregnancy|1
892843|NCT00678652|1862781|FG003|Overall Study|Pregnancy|0
892844|NCT00678652|1862778|FG000|Overall Study|Relocation|1
892845|NCT00678652|1862779|FG001|Overall Study|Relocation|0
892846|NCT00678652|1862780|FG002|Overall Study|Relocation|0
892847|NCT00678652|1862781|FG003|Overall Study|Relocation|0
892848|NCT00678691|1862793|FG000|Overall Study|Adverse Event|6
892849|NCT00678691|1862794|FG001|Overall Study|Adverse Event|4
892850|NCT00678795|1862802|FG000|Overall Study|Adverse Event|7
892851|NCT00678795|1862803|FG001|Overall Study|Adverse Event|3
892852|NCT00678795|1862802|FG000|Overall Study|Withdrawal by Subject|3
892853|NCT00678795|1862803|FG001|Overall Study|Withdrawal by Subject|0
892854|NCT00678795|1862802|FG000|Overall Study|Protocol Violation|0
892855|NCT00678795|1862803|FG001|Overall Study|Protocol Violation|1
892856|NCT00678795|1862802|FG000|Overall Study|Lost to Follow-up|0
892857|NCT00678795|1862803|FG001|Overall Study|Lost to Follow-up|1
892858|NCT00678795|1862802|FG000|Overall Study|Lack of Efficacy|1
892859|NCT00678795|1862803|FG001|Overall Study|Lack of Efficacy|1
892860|NCT00678886|1862834|FG000|Overall Study|Withdrawal by Subject|0
892861|NCT00678886|1862835|FG001|Overall Study|Withdrawal by Subject|0
892862|NCT00678886|1862836|FG002|Overall Study|Withdrawal by Subject|4
892863|NCT00678886|1862837|FG003|Overall Study|Withdrawal by Subject|6
892864|NCT00678886|1862834|FG000|Overall Study|Physician Decision|0
892865|NCT00678886|1862835|FG001|Overall Study|Physician Decision|0
892866|NCT00678886|1862836|FG002|Overall Study|Physician Decision|1
892867|NCT00678886|1862837|FG003|Overall Study|Physician Decision|1
892868|NCT00678886|1862834|FG000|Overall Study|Lost to Follow-up|0
892869|NCT00678886|1862835|FG001|Overall Study|Lost to Follow-up|0
892870|NCT00678886|1862836|FG002|Overall Study|Lost to Follow-up|3
892871|NCT00678886|1862837|FG003|Overall Study|Lost to Follow-up|2
892872|NCT00678886|1862834|FG000|Overall Study|Other|0
892873|NCT00678886|1862835|FG001|Overall Study|Other|0
892874|NCT00678886|1862836|FG002|Overall Study|Other|1
892875|NCT00678886|1862837|FG003|Overall Study|Other|0
892876|NCT00678899|1862846|FG000|Overall Study|Adverse Event|1
892877|NCT00679029|1862851|FG000|Overall Study|Adverse Event|3
892878|NCT00679029|1862851|FG000|Overall Study|Withdrawal by Subject|1
892879|NCT00679029|1862851|FG000|Overall Study|Lost to Follow-up|1
892880|NCT00679042|1862855|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2
892881|NCT00679042|1862855|FG000|5-Year Follow Up|In follow-up (ongoing)|6
892882|NCT00679042|1862855|FG000|5-Year Follow Up|Death|1
892883|NCT00679042|1862855|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7
892884|NCT00679042|1862855|FG000|10-Year Follow Up|In follow-up (ongoing)|5
892885|NCT00679055|1862861|FG000|Overall Study|Adverse Event|0
892886|NCT00679055|1862862|FG001|Overall Study|Adverse Event|1
892887|NCT00679055|1862861|FG000|Overall Study|Other|0
892888|NCT00679055|1862862|FG001|Overall Study|Other|3
892889|NCT00679055|1862861|FG000|Overall Study|Study Terminated|2
892890|NCT00679055|1862862|FG001|Overall Study|Study Terminated|1
892891|NCT00679081|1862868|FG000|Overall Study|Lost to Follow-up|1
892892|NCT00679172|1862881|FG000|Overall Study|Non-compliance|1
892893|NCT00679172|1862882|FG001|Overall Study|Non-compliance|1
892894|NCT00679172|1862883|FG002|Overall Study|Non-compliance|0
892895|NCT00679172|1862884|FG003|Overall Study|Non-compliance|1
892896|NCT00679172|1862885|FG004|Overall Study|Non-compliance|0
892897|NCT00679172|1862881|FG000|Overall Study|Other not specified|0
892898|NCT00679172|1862882|FG001|Overall Study|Other not specified|0
892899|NCT00679172|1862883|FG002|Overall Study|Other not specified|1
892900|NCT00679172|1862884|FG003|Overall Study|Other not specified|0
892901|NCT00679172|1862885|FG004|Overall Study|Other not specified|0
892902|NCT00679211|1862900|FG000|Overall Study|Progressive disease|82
892903|NCT00679211|1862900|FG000|Overall Study|Adverse Event|7
892904|NCT00679211|1862900|FG000|Overall Study|Withdrawal by Subject|2
892905|NCT00679211|1862900|FG000|Overall Study|Physician Decision|5
892906|NCT00679211|1862900|FG000|Overall Study|Refused to undergo protocol procedures|1
892907|NCT00679211|1862900|FG000|Overall Study|Transferred to extension study TDM4529g|12
892908|NCT00679211|1862900|FG000|Overall Study|Other|1
892909|NCT00679263|1862909|FG000|Visit 2/Dose 1|Adverse Event|1
892910|NCT00679263|1862910|FG001|Visit 2/Dose 1|Adverse Event|0
892911|NCT00679263|1862911|FG002|Visit 2/Dose 1|Adverse Event|0
892912|NCT00679263|1862909|FG000|Visit 2/Dose 1|subject not compliance|1
892913|NCT00679263|1862910|FG001|Visit 2/Dose 1|subject not compliance|1
892914|NCT00679263|1862911|FG002|Visit 2/Dose 1|subject not compliance|0
892915|NCT00679289|1862922|FG000|Overall Study|Progressive disease|4
892916|NCT00679289|1862923|FG001|Overall Study|Progressive disease|5
892917|NCT00679289|1862924|FG002|Overall Study|Progressive disease|18
892918|NCT00679289|1862922|FG000|Overall Study|Withdrawal by Subject|0
892919|NCT00679289|1862923|FG001|Overall Study|Withdrawal by Subject|1
892920|NCT00679289|1862924|FG002|Overall Study|Withdrawal by Subject|1
892921|NCT00679289|1862922|FG000|Overall Study|Adverse Event|0
892922|NCT00679289|1862923|FG001|Overall Study|Adverse Event|0
892923|NCT00679289|1862924|FG002|Overall Study|Adverse Event|3
892924|NCT00679289|1862922|FG000|Overall Study|Physician Decision|1
892925|NCT00679289|1862923|FG001|Overall Study|Physician Decision|0
892926|NCT00679289|1862924|FG002|Overall Study|Physician Decision|1
892927|NCT00679302|1862936|FG000|Overall Study|Lost to Follow-up|8
892928|NCT00679302|1862937|FG001|Overall Study|Lost to Follow-up|4
892929|NCT00679341|1862945|FG000|Overall Study|Disease progression|42
892930|NCT00679341|1862946|FG001|Overall Study|Disease progression|36
892931|NCT00679341|1862945|FG000|Overall Study|Adverse Event|5
892932|NCT00679341|1862946|FG001|Overall Study|Adverse Event|6
892933|NCT00679341|1862945|FG000|Overall Study|Subject/guardian decision to discontinue|3
892934|NCT00679341|1862946|FG001|Overall Study|Subject/guardian decision to discontinue|0
892935|NCT00679341|1862945|FG000|Overall Study|Death|1
892936|NCT00679341|1862946|FG001|Overall Study|Death|1
892937|NCT00679341|1862945|FG000|Overall Study|Other|1
892938|NCT00679341|1862946|FG001|Overall Study|Other|0
892939|NCT00679341|1862945|FG000|Overall Study|Physician Decision|1
892940|NCT00679341|1862946|FG001|Overall Study|Physician Decision|0
892941|NCT00679341|1862945|FG000|Overall Study|Not treated|0
892942|NCT00679341|1862946|FG001|Overall Study|Not treated|2
892943|NCT00679341|1862945|FG000|Overall Study|Physician/patient decision to withdraw|0
892944|NCT00679341|1862946|FG001|Overall Study|Physician/patient decision to withdraw|6
892945|NCT00679354|1862953|FG000|Overall Study|Death|3
892946|NCT00679354|1862953|FG000|Overall Study|Lack of Efficacy|22
892947|NCT00679354|1862953|FG000|Overall Study|Physician Decision|4
892948|NCT00679354|1862953|FG000|Overall Study|Ineligible|1
892949|NCT00679367|1862958|FG000|Overall Study|Adverse Event|7
892950|NCT00679367|1862958|FG000|Overall Study|inability to swallow oral drugs|1
892951|NCT00679367|1862958|FG000|Overall Study|Lack of Efficacy|3
892952|NCT00679367|1862958|FG000|Overall Study|Withdrawal by Subject|1
892953|NCT00679432|1862984|FG000|Overall Study|Adverse Event|5
892954|NCT00679432|1862985|FG001|Overall Study|Adverse Event|6
892955|NCT00679432|1862986|FG002|Overall Study|Adverse Event|10
892956|NCT00679432|1862987|FG003|Overall Study|Adverse Event|7
892957|NCT00679432|1862984|FG000|Overall Study|Protocol Violation|1
892958|NCT00679432|1862985|FG001|Overall Study|Protocol Violation|1
892959|NCT00679432|1862986|FG002|Overall Study|Protocol Violation|2
892960|NCT00679432|1862987|FG003|Overall Study|Protocol Violation|1
892961|NCT00679432|1862984|FG000|Overall Study|Withdrawal by Subject|8
892962|NCT00679432|1862985|FG001|Overall Study|Withdrawal by Subject|11
892963|NCT00679432|1862986|FG002|Overall Study|Withdrawal by Subject|10
892964|NCT00679432|1862987|FG003|Overall Study|Withdrawal by Subject|9
892965|NCT00679432|1862984|FG000|Overall Study|Lost to Follow-up|1
892966|NCT00679432|1862985|FG001|Overall Study|Lost to Follow-up|5
892967|NCT00679432|1862986|FG002|Overall Study|Lost to Follow-up|4
892968|NCT00679432|1862987|FG003|Overall Study|Lost to Follow-up|2
892969|NCT00679432|1862984|FG000|Overall Study|Physician Decision|3
892970|NCT00679432|1862985|FG001|Overall Study|Physician Decision|2
892971|NCT00679432|1862986|FG002|Overall Study|Physician Decision|2
892972|NCT00679432|1862987|FG003|Overall Study|Physician Decision|2
892973|NCT00679432|1862984|FG000|Overall Study|Sponsor decision|1
892974|NCT00679432|1862985|FG001|Overall Study|Sponsor decision|0
892975|NCT00679432|1862986|FG002|Overall Study|Sponsor decision|0
892976|NCT00679432|1862987|FG003|Overall Study|Sponsor decision|0
892977|NCT00679432|1862984|FG000|Overall Study|Lack of Efficacy|13
892978|NCT00679432|1862985|FG001|Overall Study|Lack of Efficacy|9
892979|NCT00679432|1862986|FG002|Overall Study|Lack of Efficacy|14
892980|NCT00679432|1862987|FG003|Overall Study|Lack of Efficacy|8
892981|NCT00679432|1862984|FG000|Overall Study|Infectious colitis, normal histology|5
892982|NCT00679432|1862985|FG001|Overall Study|Infectious colitis, normal histology|4
892983|NCT00679432|1862986|FG002|Overall Study|Infectious colitis, normal histology|8
892984|NCT00679432|1862987|FG003|Overall Study|Infectious colitis, normal histology|3
892985|NCT00679432|1862984|FG000|Overall Study|Randomization error, return to prior Rx|0
892986|NCT00679432|1862985|FG001|Overall Study|Randomization error, return to prior Rx|0
892987|NCT00679432|1862986|FG002|Overall Study|Randomization error, return to prior Rx|3
892988|NCT00679432|1862987|FG003|Overall Study|Randomization error, return to prior Rx|0
892989|NCT00679549|1862999|FG000|Overall Study|dropout|2
892990|NCT00679549|1863000|FG001|Overall Study|dropout|4
892991|NCT00679549|1862999|FG000|Overall Study|missing outcome echocardiograms|4
892992|NCT00679549|1863000|FG001|Overall Study|missing outcome echocardiograms|5
892993|NCT00679627|1863008|FG000|Overall Study|Death|41
892994|NCT00679627|1863009|FG001|Overall Study|Death|29
892995|NCT00679627|1863008|FG000|Overall Study|Adverse Event|43
892996|NCT00679627|1863009|FG001|Overall Study|Adverse Event|53
892997|NCT00679627|1863008|FG000|Overall Study|Withdrawal by Subject|168
892998|NCT00679627|1863009|FG001|Overall Study|Withdrawal by Subject|172
892999|NCT00679627|1863008|FG000|Overall Study|Lost to Follow-up|22
893000|NCT00679627|1863009|FG001|Overall Study|Lost to Follow-up|26
893001|NCT00679627|1863008|FG000|Overall Study|Early Study Closure|425
893002|NCT00679627|1863009|FG001|Overall Study|Early Study Closure|405
893003|NCT00679783|1863022|FG000|Overall Study|Adverse Event|0
893004|NCT00679783|1863023|FG001|Overall Study|Adverse Event|0
893005|NCT00679783|1863024|FG002|Overall Study|Adverse Event|0
893006|NCT00679783|1863025|FG003|Overall Study|Adverse Event|3
893007|NCT00679783|1863026|FG004|Overall Study|Adverse Event|0
893008|NCT00679783|1863027|FG005|Overall Study|Adverse Event|0
893009|NCT00679783|1863028|FG006|Overall Study|Adverse Event|1
893010|NCT00679783|1863022|FG000|Overall Study|Lack of Efficacy|0
893011|NCT00679783|1863023|FG001|Overall Study|Lack of Efficacy|1
893012|NCT00679783|1863024|FG002|Overall Study|Lack of Efficacy|0
893013|NCT00679783|1863025|FG003|Overall Study|Lack of Efficacy|2
893014|NCT00679783|1863026|FG004|Overall Study|Lack of Efficacy|0
893015|NCT00679783|1863027|FG005|Overall Study|Lack of Efficacy|0
893016|NCT00679783|1863028|FG006|Overall Study|Lack of Efficacy|0
893017|NCT00679783|1863022|FG000|Overall Study|Withdrawal by Subject|0
893018|NCT00679783|1863023|FG001|Overall Study|Withdrawal by Subject|0
893019|NCT00679783|1863024|FG002|Overall Study|Withdrawal by Subject|1
893020|NCT00679783|1863025|FG003|Overall Study|Withdrawal by Subject|1
893021|NCT00679783|1863026|FG004|Overall Study|Withdrawal by Subject|0
893022|NCT00679783|1863027|FG005|Overall Study|Withdrawal by Subject|0
893023|NCT00679783|1863028|FG006|Overall Study|Withdrawal by Subject|0
893024|NCT00679783|1863022|FG000|Overall Study|Not Captured|0
893025|NCT00679783|1863023|FG001|Overall Study|Not Captured|0
893026|NCT00679783|1863024|FG002|Overall Study|Not Captured|0
893027|NCT00679783|1863025|FG003|Overall Study|Not Captured|5
893028|NCT00679783|1863026|FG004|Overall Study|Not Captured|0
893029|NCT00679783|1863027|FG005|Overall Study|Not Captured|0
893030|NCT00679783|1863028|FG006|Overall Study|Not Captured|0
893031|NCT00679783|1863022|FG000|Overall Study|Ongoing at data cut-off|2
893032|NCT00679783|1863023|FG001|Overall Study|Ongoing at data cut-off|2
893033|NCT00679783|1863024|FG002|Overall Study|Ongoing at data cut-off|0
893034|NCT00679783|1863025|FG003|Overall Study|Ongoing at data cut-off|9
893035|NCT00679783|1863026|FG004|Overall Study|Ongoing at data cut-off|1
893036|NCT00679783|1863027|FG005|Overall Study|Ongoing at data cut-off|0
893037|NCT00679783|1863028|FG006|Overall Study|Ongoing at data cut-off|0
893038|NCT00679913|1863046|FG000|Overall Study|Protocol Violation|18
893039|NCT00679913|1863047|FG001|Overall Study|Protocol Violation|13
893040|NCT00679939|1863056|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17
893041|NCT00679939|1863057|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13
893042|NCT00679939|1863056|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14
893043|NCT00679939|1863057|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12
893044|NCT00679939|1863056|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5
893045|NCT00679939|1863057|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0
893046|NCT00679939|1863056|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1
893047|NCT00679939|1863057|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0
893048|NCT00679939|1863056|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
893049|NCT00679939|1863057|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
893050|NCT00679939|1863056|FG000|24-Week Open-Label (OL) Period|Adverse Event|0
893051|NCT00679939|1863057|FG001|24-Week Open-Label (OL) Period|Adverse Event|1
893052|NCT00679939|1863056|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1
893053|NCT00679939|1863057|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1
893054|NCT00679939|1863056|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
893055|NCT00679939|1863057|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
893056|NCT00679939|1863056|FG000|24-Week Open-Label (OL) Period|Physician Decision|1
893057|NCT00679939|1863057|FG001|24-Week Open-Label (OL) Period|Physician Decision|0
893058|NCT00679939|1863056|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
893059|NCT00679939|1863057|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
893060|NCT00680017|1863078|FG000|Overall Study|Adverse Event|13
893061|NCT00680017|1863079|FG001|Overall Study|Adverse Event|7
893062|NCT00680017|1863078|FG000|Overall Study|Withdrawal by Subject|2
893063|NCT00680017|1863079|FG001|Overall Study|Withdrawal by Subject|5
893064|NCT00680017|1863078|FG000|Overall Study|Lost to Follow-up|2
893065|NCT00680017|1863079|FG001|Overall Study|Lost to Follow-up|0
893066|NCT00680043|1863088|FG000|Overall Study|Withdrawal by Subject|1
893067|NCT00680043|1863089|FG001|Overall Study|Withdrawal by Subject|0
893068|NCT00680043|1863090|FG002|Overall Study|Withdrawal by Subject|0
893069|NCT00680043|1863088|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0
893070|NCT00680043|1863089|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1
893071|NCT00680043|1863090|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0
893072|NCT00680043|1863088|FG000|Overall Study|Renal Transplant|1
893073|NCT00680043|1863089|FG001|Overall Study|Renal Transplant|0
893074|NCT00680043|1863090|FG002|Overall Study|Renal Transplant|4
893075|NCT00680056|1863100|FG000|First Intervention|Mainly Exacerbation of COPD|1
893076|NCT00680056|1863101|FG001|First Intervention|Mainly Exacerbation of COPD|2
893077|NCT00680056|1863100|FG000|Second Intervention|Protocol Violation|3
893078|NCT00680056|1863101|FG001|Second Intervention|Protocol Violation|1
893079|NCT00680121|1863110|FG000|Overall Study|Lost to Follow-up|27
893080|NCT00680121|1863111|FG001|Overall Study|Lost to Follow-up|23
893081|NCT00680186|1863119|FG000|Overall Study|Adverse Event|47
893082|NCT00680186|1863120|FG001|Overall Study|Adverse Event|44
893083|NCT00680186|1863119|FG000|Overall Study|Protocol Violation|31
893084|NCT00680186|1863120|FG001|Overall Study|Protocol Violation|26
893085|NCT00680186|1863119|FG000|Overall Study|Lost to Follow-up|11
893086|NCT00680186|1863120|FG001|Overall Study|Lost to Follow-up|6
893087|NCT00680186|1863119|FG000|Overall Study|Withdrawal by Subject|32
893088|NCT00680186|1863120|FG001|Overall Study|Withdrawal by Subject|39
893089|NCT00680186|1863119|FG000|Overall Study|Other|4
893090|NCT00680186|1863120|FG001|Overall Study|Other|1
893091|NCT00680368|1863130|FG000|Overall Study|not supervised, not eligible|15
893092|NCT00680407|1863139|FG000|Overall Study|Lost to Follow-up|3
893093|NCT00680407|1863140|FG001|Overall Study|Lost to Follow-up|3
893094|NCT00680407|1863141|FG002|Overall Study|Lost to Follow-up|1
893095|NCT00680407|1863139|FG000|Overall Study|Withdrawal by Subject|5
893096|NCT00680407|1863140|FG001|Overall Study|Withdrawal by Subject|2
893097|NCT00680407|1863141|FG002|Overall Study|Withdrawal by Subject|2
893098|NCT00680745|1863184|FG000|Overall Study|Withdrawal by Subject|8
893099|NCT00680745|1863185|FG001|Overall Study|Withdrawal by Subject|3
893100|NCT00680745|1863186|FG002|Overall Study|Withdrawal by Subject|2
893101|NCT00680745|1863187|FG003|Overall Study|Withdrawal by Subject|8
893102|NCT00680745|1863184|FG000|Overall Study|Lost to Follow-up|0
893103|NCT00680745|1863185|FG001|Overall Study|Lost to Follow-up|1
893104|NCT00680745|1863186|FG002|Overall Study|Lost to Follow-up|1
893105|NCT00680745|1863187|FG003|Overall Study|Lost to Follow-up|0
893106|NCT00680745|1863184|FG000|Overall Study|Death|1
893107|NCT00680745|1863185|FG001|Overall Study|Death|0
893108|NCT00680745|1863186|FG002|Overall Study|Death|1
893109|NCT00680745|1863187|FG003|Overall Study|Death|0
893110|NCT00680745|1863184|FG000|Overall Study|Adverse Event|5
893111|NCT00680745|1863185|FG001|Overall Study|Adverse Event|3
893112|NCT00680745|1863186|FG002|Overall Study|Adverse Event|3
893113|NCT00680745|1863187|FG003|Overall Study|Adverse Event|3
893114|NCT00680745|1863184|FG000|Overall Study|Poor/Non-compliance|0
893115|NCT00680745|1863185|FG001|Overall Study|Poor/Non-compliance|3
893116|NCT00680745|1863186|FG002|Overall Study|Poor/Non-compliance|0
893117|NCT00680745|1863187|FG003|Overall Study|Poor/Non-compliance|0
893118|NCT00680745|1863184|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
893119|NCT00680745|1863185|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
893120|NCT00680745|1863186|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
893121|NCT00680745|1863187|FG003|Overall Study|Subject No Longer Meets Study Criteria|2
893122|NCT00680745|1863184|FG000|Overall Study|False Treatment|0
893123|NCT00680745|1863185|FG001|Overall Study|False Treatment|1
893124|NCT00680745|1863186|FG002|Overall Study|False Treatment|3
893125|NCT00680745|1863187|FG003|Overall Study|False Treatment|0
893126|NCT00680771|1863200|FG000|Overall Study|Withdrawal by Subject|1
893127|NCT00680771|1863201|FG001|Overall Study|Withdrawal by Subject|0
893128|NCT00680771|1863200|FG000|Overall Study|Sleep Apnea suspected after PSG|1
893129|NCT00680771|1863201|FG001|Overall Study|Sleep Apnea suspected after PSG|0
893130|NCT00680771|1863200|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
893131|NCT00680771|1863201|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
893132|NCT00680836|1863239|FG000|Overall Study|Withdrawal by Subject|3
893133|NCT00680836|1863240|FG001|Overall Study|Withdrawal by Subject|0
893134|NCT00680836|1863239|FG000|Overall Study|Lost to Follow-up|3
893135|NCT00680836|1863240|FG001|Overall Study|Lost to Follow-up|1
893136|NCT00680836|1863239|FG000|Overall Study|Physician Decision|2
893137|NCT00680836|1863240|FG001|Overall Study|Physician Decision|1
893138|NCT00680901|1863253|FG000|Overall Study|Lost to Follow-up|8
893139|NCT00680901|1863254|FG001|Overall Study|Lost to Follow-up|8
893140|NCT00680901|1863253|FG000|Overall Study|Withdrawal by Subject|4
893141|NCT00680901|1863254|FG001|Overall Study|Withdrawal by Subject|13
893142|NCT00680901|1863253|FG000|Overall Study|Physician Decision|0
893143|NCT00680901|1863254|FG001|Overall Study|Physician Decision|1
893144|NCT00680901|1863253|FG000|Overall Study|Ongoing: On Study Treatment|16
893145|NCT00680901|1863254|FG001|Overall Study|Ongoing: On Study Treatment|13
893146|NCT00680901|1863253|FG000|Overall Study|Ongoing: In Follow Up|45
893147|NCT00680901|1863254|FG001|Overall Study|Ongoing: In Follow Up|41
893148|NCT00680914|1863262|FG000|Overall Study|Consent withdrawal|6
893149|NCT00680914|1863263|FG001|Overall Study|Consent withdrawal|3
893150|NCT00680914|1863262|FG000|Overall Study|Lost to Follow-up|4
893151|NCT00680914|1863263|FG001|Overall Study|Lost to Follow-up|0
893152|NCT00680914|1863262|FG000|Overall Study|serious adverse event (SAE)|0
893153|NCT00680914|1863263|FG001|Overall Study|serious adverse event (SAE)|1
893154|NCT00680992|1863285|FG000|Overall Study|Complete Resection (as per protocol)|25
893155|NCT00680992|1863286|FG001|Overall Study|Complete Resection (as per protocol)|121
893156|NCT00680992|1863287|FG002|Overall Study|Complete Resection (as per protocol)|0
893157|NCT00680992|1863285|FG000|Overall Study|Administrative Decision|83
893158|NCT00680992|1863286|FG001|Overall Study|Administrative Decision|42
893159|NCT00680992|1863287|FG002|Overall Study|Administrative Decision|5
893160|NCT00680992|1863285|FG000|Overall Study|End of Trial|32
893161|NCT00680992|1863286|FG001|Overall Study|End of Trial|12
893162|NCT00680992|1863287|FG002|Overall Study|End of Trial|3
893163|NCT00680992|1863285|FG000|Overall Study|Withdrawal by Subject|33
893164|NCT00680992|1863286|FG001|Overall Study|Withdrawal by Subject|11
893165|NCT00680992|1863287|FG002|Overall Study|Withdrawal by Subject|1
893166|NCT00680992|1863285|FG000|Overall Study|Adverse Event|21
893167|NCT00680992|1863286|FG001|Overall Study|Adverse Event|19
893168|NCT00680992|1863287|FG002|Overall Study|Adverse Event|1
893169|NCT00680992|1863285|FG000|Overall Study|Other|19
893170|NCT00680992|1863286|FG001|Overall Study|Other|14
893171|NCT00680992|1863287|FG002|Overall Study|Other|1
893172|NCT00680992|1863285|FG000|Overall Study|Disease Progression|21
893173|NCT00680992|1863286|FG001|Overall Study|Disease Progression|9
893174|NCT00680992|1863287|FG002|Overall Study|Disease Progression|0
893175|NCT00680992|1863285|FG000|Overall Study|Lost to Follow-up|12
893176|NCT00680992|1863286|FG001|Overall Study|Lost to Follow-up|14
893177|NCT00680992|1863287|FG002|Overall Study|Lost to Follow-up|0
893178|NCT00680992|1863285|FG000|Overall Study|Noncompliance|4
893179|NCT00680992|1863286|FG001|Overall Study|Noncompliance|6
893180|NCT00680992|1863287|FG002|Overall Study|Noncompliance|0
893181|NCT00680992|1863285|FG000|Overall Study|Requirement for Alternative Therapy|8
893182|NCT00680992|1863286|FG001|Overall Study|Requirement for Alternative Therapy|2
893183|NCT00680992|1863287|FG002|Overall Study|Requirement for Alternative Therapy|0
893184|NCT00680992|1863285|FG000|Overall Study|Pregnancy|5
893185|NCT00680992|1863286|FG001|Overall Study|Pregnancy|0
893186|NCT00680992|1863287|FG002|Overall Study|Pregnancy|1
893187|NCT00680992|1863285|FG000|Overall Study|Death|5
893188|NCT00680992|1863286|FG001|Overall Study|Death|1
893189|NCT00680992|1863287|FG002|Overall Study|Death|0
893190|NCT00680992|1863285|FG000|Overall Study|Ineligibility Determined|0
893191|NCT00680992|1863286|FG001|Overall Study|Ineligibility Determined|1
893192|NCT00680992|1863287|FG002|Overall Study|Ineligibility Determined|0
893193|NCT00681109|1863310|FG000|Overall Study|Lost to Follow-up|2
893194|NCT00681109|1863311|FG001|Overall Study|Lost to Follow-up|6
893195|NCT00681109|1863312|FG002|Overall Study|Lost to Follow-up|0
893196|NCT00681187|1863325|FG000|Overall Study|Withdrawal by Subject|1
893197|NCT00681187|1863326|FG001|Overall Study|Withdrawal by Subject|0
893198|NCT00681187|1863325|FG000|Overall Study|Death|0
893199|NCT00681187|1863326|FG001|Overall Study|Death|1
893200|NCT00681187|1863325|FG000|Overall Study|Adverse Event|0
893201|NCT00681187|1863326|FG001|Overall Study|Adverse Event|1
893202|NCT00681564|1863375|FG000|Overall Study|Lost to Follow-up|6
893203|NCT00681564|1863376|FG001|Overall Study|Lost to Follow-up|6
893204|NCT00681564|1863375|FG000|Overall Study|Withdrawal by Subject|0
893205|NCT00681564|1863376|FG001|Overall Study|Withdrawal by Subject|1
893206|NCT00681564|1863375|FG000|Overall Study|Death|0
893207|NCT00681564|1863376|FG001|Overall Study|Death|1
893208|NCT00681590|1863384|FG000|Overall Study|Withdrawal by Subject|2
893209|NCT00681590|1863385|FG001|Overall Study|Withdrawal by Subject|12
893210|NCT00681668|1863391|FG000|Overall Study|Protocol Violation|1
893211|NCT00681668|1863391|FG000|Overall Study|Withdrawal by Subject|1
893212|NCT00681811|1863397|FG000|Overall Study|Adverse Event|1
893213|NCT00681811|1863398|FG001|Overall Study|Adverse Event|1
893214|NCT00681811|1863397|FG000|Overall Study|Withdrawal by Subject|2
893215|NCT00681811|1863398|FG001|Overall Study|Withdrawal by Subject|2
893216|NCT00681811|1863397|FG000|Overall Study|Non-compliance|0
893217|NCT00681811|1863398|FG001|Overall Study|Non-compliance|1
893218|NCT00681824|1863418|FG000|Overall Study|withdrawn by investigator|0
893219|NCT00681824|1863419|FG001|Overall Study|withdrawn by investigator|0
893220|NCT00681824|1863420|FG002|Overall Study|withdrawn by investigator|1
893221|NCT00681824|1863418|FG000|Overall Study|scheduling conflict|1
893222|NCT00681824|1863419|FG001|Overall Study|scheduling conflict|0
893223|NCT00681824|1863420|FG002|Overall Study|scheduling conflict|0
893224|NCT00681824|1863418|FG000|Overall Study|Death|0
893225|NCT00681824|1863419|FG001|Overall Study|Death|1
893226|NCT00681824|1863420|FG002|Overall Study|Death|0
893227|NCT00681863|1863428|FG000|Overall Study|Adverse Event|1
893228|NCT00681863|1863428|FG000|Overall Study|Lost to Follow-up|2
893229|NCT00681863|1863428|FG000|Overall Study|Lack of Efficacy|2
893230|NCT00681863|1863428|FG000|Overall Study|Other|18
893231|NCT00682435|1863449|FG000|Overall Study|Insufficient data|5
893232|NCT00682435|1863449|FG000|Overall Study|Erroneously enrolled twice|2
893233|NCT00682448|1863455|FG000|Overall Study|Adverse Event|1
893234|NCT00682448|1863456|FG001|Overall Study|Adverse Event|2
893235|NCT00682448|1863455|FG000|Overall Study|Lack of Efficacy|1
893236|NCT00682448|1863456|FG001|Overall Study|Lack of Efficacy|0
893237|NCT00682448|1863455|FG000|Overall Study|Lost to Follow-up|1
893238|NCT00682448|1863456|FG001|Overall Study|Lost to Follow-up|3
893239|NCT00682448|1863455|FG000|Overall Study|Pregnancy|0
893240|NCT00682448|1863456|FG001|Overall Study|Pregnancy|1
893241|NCT00682448|1863455|FG000|Overall Study|Withdrawal by Subject|2
893242|NCT00682448|1863456|FG001|Overall Study|Withdrawal by Subject|0
893243|NCT00682461|1863464|FG000|Overall Study|Adverse Event|5
893244|NCT00682461|1863465|FG001|Overall Study|Adverse Event|7
893245|NCT00682461|1863464|FG000|Overall Study|Lost to Follow-up|8
893246|NCT00682461|1863465|FG001|Overall Study|Lost to Follow-up|5
893247|NCT00682461|1863464|FG000|Overall Study|Withdrawal by Subject|12
893248|NCT00682461|1863465|FG001|Overall Study|Withdrawal by Subject|19
893249|NCT00682539|1863475|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
893250|NCT00682539|1863476|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
893251|NCT00682539|1863477|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
893252|NCT00682539|1863475|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
893253|NCT00682539|1863476|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
893254|NCT00682539|1863477|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
893255|NCT00682643|1863510|FG000|Overall Study|Adverse Event|12
893256|NCT00682643|1863511|FG001|Overall Study|Adverse Event|23
893257|NCT00682643|1863510|FG000|Overall Study|Lack of Efficacy|2
893258|NCT00682643|1863511|FG001|Overall Study|Lack of Efficacy|0
893259|NCT00682643|1863510|FG000|Overall Study|Protocol Violation|38
893260|NCT00682643|1863511|FG001|Overall Study|Protocol Violation|76
1093459|NCT02282813|2163578|FG000|Overall Study|Withdrawal by Subject|4
1093460|NCT02282813|2163579|FG001|Overall Study|Withdrawal by Subject|5
1093461|NCT02282813|2163580|FG002|Overall Study|Withdrawal by Subject|0
1093462|NCT02282813|2163578|FG000|Overall Study|Adverse Event|3
1093463|NCT02282813|2163579|FG001|Overall Study|Adverse Event|10
1093464|NCT02282813|2163580|FG002|Overall Study|Adverse Event|1
1093465|NCT02282813|2163578|FG000|Overall Study|Subject non-compliance|1
1093466|NCT02282813|2163579|FG001|Overall Study|Subject non-compliance|4
1093467|NCT02282813|2163580|FG002|Overall Study|Subject non-compliance|0
1093468|NCT02282813|2163578|FG000|Overall Study|Physician Decision|0
1093469|NCT02282813|2163579|FG001|Overall Study|Physician Decision|3
1093470|NCT02282813|2163580|FG002|Overall Study|Physician Decision|1
1093471|NCT02282813|2163578|FG000|Overall Study|Lost to Follow-up|2
1093472|NCT02282813|2163579|FG001|Overall Study|Lost to Follow-up|0
1093473|NCT02282813|2163580|FG002|Overall Study|Lost to Follow-up|1
1093474|NCT02282813|2163578|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1
1093475|NCT02282813|2163579|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0
1093476|NCT02282813|2163580|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0
1093477|NCT02282813|2163578|FG000|Overall Study|Lack of Efficacy|1
1093478|NCT02282813|2163579|FG001|Overall Study|Lack of Efficacy|0
1093479|NCT02282813|2163580|FG002|Overall Study|Lack of Efficacy|0
1093480|NCT02282813|2163578|FG000|Overall Study|Administrative reasons|0
1093481|NCT02282813|2163579|FG001|Overall Study|Administrative reasons|1
1093482|NCT02282813|2163580|FG002|Overall Study|Administrative reasons|0
1093483|NCT02282982|2163598|FG000|Overall Study|Lost to Follow-up|15
1093484|NCT02282982|2163598|FG000|Overall Study|Withdrew consent|2
1093485|NCT02282982|2163598|FG000|Overall Study|Death|4
1093486|NCT02282982|2163598|FG000|Overall Study|Lack of product|156
1093487|NCT02282982|2163598|FG000|Overall Study|Palivizumab is ended|11
1093488|NCT02282982|2163598|FG000|Overall Study|Other, not specified|18
1093489|NCT02283268|2163602|FG000|Overall Study|Withdrawal by Subject|1
1093490|NCT02283294|2163616|FG000|Overall Study|Lost to Follow-up|1
1093491|NCT02283294|2163617|FG001|Overall Study|Lost to Follow-up|1
1093492|NCT02283294|2163616|FG000|Overall Study|Withdrawal by Subject|1
1093493|NCT02283294|2163617|FG001|Overall Study|Withdrawal by Subject|6
1093494|NCT02283294|2163616|FG000|Overall Study|Protocol Violation|1
1093495|NCT02283294|2163617|FG001|Overall Study|Protocol Violation|0
1093496|NCT02283294|2163616|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0
1093497|NCT02283294|2163617|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1
1093498|NCT02283411|2163633|FG000|Overall Study|Withdrawal by Subject|3
1093499|NCT02283411|2163633|FG000|Overall Study|Screen Failed|28
1093500|NCT02283658|2163646|FG000|Overall Study|Withdrawal by Subject|1
1093501|NCT02283762|2163656|FG000|Main Treatment Phase (MT)|Adverse Event|9
1093502|NCT02283762|2163657|FG001|Main Treatment Phase (MT)|Adverse Event|9
1093503|NCT02283762|2163656|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1
1093504|NCT02283762|2163657|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0
1093505|NCT02283762|2163656|FG000|Main Treatment Phase (MT)|Physician Decision|1
1093506|NCT02283762|2163657|FG001|Main Treatment Phase (MT)|Physician Decision|1
1093507|NCT02283762|2163656|FG000|Main Treatment Phase (MT)|Pregnancy|0
1093508|NCT02283762|2163657|FG001|Main Treatment Phase (MT)|Pregnancy|1
1093509|NCT02283762|2163656|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7
1093510|NCT02283762|2163657|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4
1093511|NCT02283762|2163656|FG000|Long-term Extension Phase (LTE)|Adverse Event|2
1093512|NCT02283762|2163657|FG001|Long-term Extension Phase (LTE)|Adverse Event|6
1093513|NCT02283762|2163656|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1
1093514|NCT02283762|2163657|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1
1093515|NCT02283762|2163656|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1
1093516|NCT02283762|2163657|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0
1093517|NCT02283762|2163656|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
1093518|NCT02283762|2163657|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
1093519|NCT02283762|2163656|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1
1093520|NCT02283762|2163657|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1
1093521|NCT02283762|2163656|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0
1093522|NCT02283762|2163657|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1
1093523|NCT02283762|2163656|FG000|Long-term Extension Phase (LTE)|Physician Decision|1
1093524|NCT02283762|2163657|FG001|Long-term Extension Phase (LTE)|Physician Decision|2
1093525|NCT02283788|2163669|FG000|Overall Study|Adverse Event|1
1093526|NCT02283788|2163670|FG001|Overall Study|Adverse Event|3
1093527|NCT02283788|2163671|FG002|Overall Study|Adverse Event|5
1093528|NCT02283788|2163672|FG003|Overall Study|Adverse Event|1
1093529|NCT02283788|2163669|FG000|Overall Study|Withdrawal by Subject|0
1093530|NCT02283788|2163670|FG001|Overall Study|Withdrawal by Subject|1
1093531|NCT02283788|2163671|FG002|Overall Study|Withdrawal by Subject|0
1093532|NCT02283788|2163672|FG003|Overall Study|Withdrawal by Subject|1
1093533|NCT02284009|2163724|FG000|Overall Study|Adverse Event|3
1093534|NCT02284009|2163725|FG001|Overall Study|Adverse Event|0
1093535|NCT02284009|2163724|FG000|Overall Study|Lost to Follow-up|1
1093536|NCT02284009|2163725|FG001|Overall Study|Lost to Follow-up|3
1093537|NCT02284009|2163724|FG000|Overall Study|Physician Decision|0
1093538|NCT02284009|2163725|FG001|Overall Study|Physician Decision|2
1093539|NCT02284009|2163724|FG000|Overall Study|Withdrawal by Subject|2
1093540|NCT02284009|2163725|FG001|Overall Study|Withdrawal by Subject|5
1093541|NCT02284178|2163755|FG000|Overall Study|Met exclusion criteria|49
1093542|NCT02284178|2163756|FG001|Overall Study|Met exclusion criteria|54
1093543|NCT02284243|2163764|FG000|Overall Study|Lack of Efficacy|3
1093544|NCT02284243|2163765|FG001|Overall Study|Lack of Efficacy|3
1093545|NCT02284243|2163764|FG000|Overall Study|Adverse Event|1
1093546|NCT02284243|2163765|FG001|Overall Study|Adverse Event|0
1093547|NCT02284347|2163771|FG000|Overall Study|Lost to Follow-up|2
1093548|NCT02284347|2163771|FG000|Overall Study|Withdrawn prior to treatment|1
1093549|NCT02284568|2163815|FG000|Overall Study|Adverse Event|2
1093550|NCT02284568|2163816|FG001|Overall Study|Adverse Event|9
1093551|NCT02284568|2163817|FG002|Overall Study|Adverse Event|4
1093552|NCT02284568|2163815|FG000|Overall Study|Withdrawal by Subject|22
1093553|NCT02284568|2163816|FG001|Overall Study|Withdrawal by Subject|21
1093554|NCT02284568|2163817|FG002|Overall Study|Withdrawal by Subject|1
1093555|NCT02284568|2163815|FG000|Overall Study|Noncompliance with study drug admin|1
1093556|NCT02284568|2163816|FG001|Overall Study|Noncompliance with study drug admin|2
1093557|NCT02284568|2163817|FG002|Overall Study|Noncompliance with study drug admin|0
1093558|NCT02284568|2163815|FG000|Overall Study|Noncompliance|1
1093559|NCT02284568|2163816|FG001|Overall Study|Noncompliance|0
1093560|NCT02284568|2163817|FG002|Overall Study|Noncompliance|0
1093561|NCT02284568|2163815|FG000|Overall Study|Protocol Violation|0
1093562|NCT02284568|2163816|FG001|Overall Study|Protocol Violation|1
1093563|NCT02284568|2163817|FG002|Overall Study|Protocol Violation|0
1093564|NCT02284568|2163815|FG000|Overall Study|Sponsor requested patient stop treatment|0
1093565|NCT02284568|2163816|FG001|Overall Study|Sponsor requested patient stop treatment|0
1093566|NCT02284568|2163817|FG002|Overall Study|Sponsor requested patient stop treatment|90
1093567|NCT02284568|2163815|FG000|Overall Study|Lost to Follow-up|0
1093568|NCT02284568|2163816|FG001|Overall Study|Lost to Follow-up|3
1093569|NCT02284568|2163817|FG002|Overall Study|Lost to Follow-up|0
1093570|NCT02284568|2163815|FG000|Overall Study|Lack of Efficacy|4
1093571|NCT02284568|2163816|FG001|Overall Study|Lack of Efficacy|7
1093572|NCT02284568|2163817|FG002|Overall Study|Lack of Efficacy|0
1093573|NCT02284568|2163815|FG000|Overall Study|Other|1
1093574|NCT02284568|2163816|FG001|Overall Study|Other|2
1093575|NCT02284568|2163817|FG002|Overall Study|Other|0
1093576|NCT02284568|2163815|FG000|Overall Study|Withdrew before taking study drug|0
1093577|NCT02284568|2163816|FG001|Overall Study|Withdrew before taking study drug|1
1093578|NCT02284568|2163817|FG002|Overall Study|Withdrew before taking study drug|0
1093579|NCT02284893|2163874|FG000|26 Week (Short Term)|Adverse Event|1
1093580|NCT02284893|2163875|FG001|26 Week (Short Term)|Adverse Event|9
1093581|NCT02284893|2163874|FG000|26 Week (Short Term)|Discontinuation by the subject|2
1093582|NCT02284893|2163875|FG001|26 Week (Short Term)|Discontinuation by the subject|2
1093583|NCT02284893|2163874|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7
1093584|NCT02284893|2163875|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10
1093585|NCT02284893|2163874|FG000|26 Week (Short Term)|Lost to Follow-up|3
1093586|NCT02284893|2163875|FG001|26 Week (Short Term)|Lost to Follow-up|1
1093587|NCT02284893|2163874|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5
1093588|NCT02284893|2163875|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8
1093589|NCT02284893|2163874|FG000|26 Week (Short Term)|Other|1
1093590|NCT02284893|2163875|FG001|26 Week (Short Term)|Other|1
1093591|NCT02284893|2163874|FG000|52 Week (Long Term)|Adverse Event|3
1093592|NCT02284893|2163875|FG001|52 Week (Long Term)|Adverse Event|1
1093593|NCT02284893|2163874|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0
1093594|NCT02284893|2163875|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1
1093595|NCT02284893|2163874|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4
1093596|NCT02284893|2163875|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6
1093597|NCT02284893|2163874|FG000|52 Week (Long Term)|Lost to Follow-up|2
1093598|NCT02284893|2163875|FG001|52 Week (Long Term)|Lost to Follow-up|2
1093599|NCT02284893|2163874|FG000|52 Week (Long Term)|Non-Compliance|2
1093600|NCT02284893|2163875|FG001|52 Week (Long Term)|Non-Compliance|3
1093601|NCT02285010|2163883|FG000|Overall Study|not abdominal hysterectomy|2
1093602|NCT02285010|2163884|FG001|Overall Study|not abdominal hysterectomy|0
1093603|NCT02285010|2163883|FG000|Overall Study|Not spinal anesthesia|3
1093604|NCT02285010|2163884|FG001|Overall Study|Not spinal anesthesia|1
1093605|NCT02285062|2163902|FG000|Overall Study|Withdrawal by Subject|12
1093606|NCT02285062|2163903|FG001|Overall Study|Withdrawal by Subject|17
1093607|NCT02285062|2163902|FG000|Overall Study|Death|58
1093608|NCT02285062|2163903|FG001|Overall Study|Death|62
1093609|NCT02285062|2163902|FG000|Overall Study|Lost to Follow-up|8
1093610|NCT02285062|2163903|FG001|Overall Study|Lost to Follow-up|5
1093611|NCT02285114|2163912|FG000|Overall Study|Investigator's Discretion|0
1093612|NCT02285114|2163913|FG001|Overall Study|Investigator's Discretion|2
1093613|NCT02285114|2163914|FG002|Overall Study|Investigator's Discretion|0
1093614|NCT02285114|2163912|FG000|Overall Study|Withdrew Consent|0
1093615|NCT02285114|2163913|FG001|Overall Study|Withdrew Consent|0
1093616|NCT02285114|2163914|FG002|Overall Study|Withdrew Consent|1
1093617|NCT02285114|2163912|FG000|Overall Study|Enrolled but not treated|1
1093618|NCT02285114|2163913|FG001|Overall Study|Enrolled but not treated|0
1093619|NCT02285114|2163914|FG002|Overall Study|Enrolled but not treated|0
1093620|NCT02285114|2163912|FG000|Overall Study|Still on study|21
893261|NCT00682643|1863510|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
893262|NCT00682643|1863511|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4
893263|NCT00682643|1863510|FG000|Overall Study|Lost to Follow-up|1
893264|NCT00682643|1863511|FG001|Overall Study|Lost to Follow-up|6
893265|NCT00682643|1863510|FG000|Overall Study|Physician Decision|2
893266|NCT00682643|1863511|FG001|Overall Study|Physician Decision|6
893267|NCT00682643|1863510|FG000|Overall Study|Withdrawal by Subject|19
893268|NCT00682643|1863511|FG001|Overall Study|Withdrawal by Subject|53
893269|NCT00682643|1863510|FG000|Overall Study|Did Not Receive Study Drug|1
893270|NCT00682643|1863511|FG001|Overall Study|Did Not Receive Study Drug|1
893271|NCT00682786|1863533|FG000|Overall Study|Withdrawal by Subject|2
893272|NCT00682786|1863534|FG001|Overall Study|Withdrawal by Subject|2
893273|NCT00682786|1863533|FG000|Overall Study|Did not receive irinotecan|0
1093621|NCT02285114|2163913|FG001|Overall Study|Still on study|5
1093622|NCT02285114|2163914|FG002|Overall Study|Still on study|2
1093623|NCT02285153|2163930|FG000|Overall Study|Adverse Event|1
1093624|NCT02285153|2163931|FG001|Overall Study|Adverse Event|0
1093625|NCT02285361|2163946|FG000|Overall Study|Protocol Violation|43
1093626|NCT02285361|2163946|FG000|Overall Study|Lost to Follow-up|5
1093627|NCT02285361|2163946|FG000|Overall Study|Not taken GIOTRIF|2
1093628|NCT02285361|2163946|FG000|Overall Study|Consented prior to the contract date|1
1093629|NCT02285777|2163970|FG000|Overall Study|Withdrawal by Subject|1
1093630|NCT02285777|2163971|FG001|Overall Study|Withdrawal by Subject|1
1093631|NCT02285777|2163970|FG000|Overall Study|Lost to Follow-up|4
1093632|NCT02285777|2163971|FG001|Overall Study|Lost to Follow-up|2
1093633|NCT02285855|2163979|FG000|Overall Study|Withdrawal by Subject|2
1093634|NCT02285855|2163980|FG001|Overall Study|Withdrawal by Subject|1
1093635|NCT02285920|2164003|FG000|Overall Study|Kidney transplantation|2
1093636|NCT02285920|2164004|FG001|Overall Study|Kidney transplantation|2
1093637|NCT02285920|2164005|FG002|Overall Study|Kidney transplantation|2
1093638|NCT02285920|2164006|FG003|Overall Study|Kidney transplantation|0
1093639|NCT02285920|2164003|FG000|Overall Study|Change to peritoneal dialysis|0
1093640|NCT02285920|2164004|FG001|Overall Study|Change to peritoneal dialysis|0
1093641|NCT02285920|2164005|FG002|Overall Study|Change to peritoneal dialysis|1
1093642|NCT02285920|2164006|FG003|Overall Study|Change to peritoneal dialysis|0
1093643|NCT02285920|2164003|FG000|Overall Study|Transfer to non-participating unit|0
1093644|NCT02285920|2164004|FG001|Overall Study|Transfer to non-participating unit|1
1093645|NCT02285920|2164005|FG002|Overall Study|Transfer to non-participating unit|0
1093646|NCT02285920|2164006|FG003|Overall Study|Transfer to non-participating unit|0
1093647|NCT02285920|2164003|FG000|Overall Study|Dialysis discontinuation|0
1093648|NCT02285920|2164004|FG001|Overall Study|Dialysis discontinuation|1
1093649|NCT02285920|2164005|FG002|Overall Study|Dialysis discontinuation|0
1093650|NCT02285920|2164006|FG003|Overall Study|Dialysis discontinuation|0
1093651|NCT02285920|2164003|FG000|Overall Study|Death|2
1093652|NCT02285920|2164004|FG001|Overall Study|Death|0
1093653|NCT02285920|2164005|FG002|Overall Study|Death|2
1093654|NCT02285920|2164006|FG003|Overall Study|Death|1
1093655|NCT02285998|2164018|FG000|Overall Study|Adverse Event|9
1093656|NCT02285998|2164019|FG001|Overall Study|Adverse Event|8
1093657|NCT02285998|2164018|FG000|Overall Study|Physician Decision|1
1093658|NCT02285998|2164019|FG001|Overall Study|Physician Decision|2
1093659|NCT02285998|2164018|FG000|Overall Study|Lost to Follow-up|176
1093660|NCT02285998|2164019|FG001|Overall Study|Lost to Follow-up|172
1093661|NCT02285998|2164018|FG000|Overall Study|Withdrawal by Subject|53
1093662|NCT02285998|2164019|FG001|Overall Study|Withdrawal by Subject|61
1093663|NCT02285998|2164018|FG000|Overall Study|Other Reasons|7
1093664|NCT02285998|2164019|FG001|Overall Study|Other Reasons|10
1093665|NCT02286102|2164027|FG000|Overall Study|Screen Failure|1
1093666|NCT02286102|2164028|FG001|Overall Study|Screen Failure|1
1093667|NCT02286193|2164034|FG000|Overall Study|Referred: CRS unable to make contact|62
1093668|NCT02286193|2164034|FG000|Overall Study|Referred: unable to reach/resource sent|104
1093669|NCT02286193|2164034|FG000|Overall Study|Referred: Declined service|38
1093670|NCT02286466|2164041|FG000|Overall Study|Death|1
1093671|NCT02286466|2164042|FG001|Overall Study|Death|3
1093672|NCT02286466|2164041|FG000|Overall Study|Withdrawal by Subject|5
1093673|NCT02286466|2164042|FG001|Overall Study|Withdrawal by Subject|2
1093674|NCT02286466|2164041|FG000|Overall Study|Lost to Follow-up|1
1093675|NCT02286466|2164042|FG001|Overall Study|Lost to Follow-up|4
1093676|NCT02286466|2164041|FG000|Overall Study|Declined Clinician Assessment|0
1093677|NCT02286466|2164042|FG001|Overall Study|Declined Clinician Assessment|1
1093678|NCT02286713|2164123|FG000|One Week Follow-Up|Death|1
1093679|NCT02286713|2164124|FG001|One Week Follow-Up|Death|0
1093680|NCT02286713|2164123|FG000|One Week Follow-Up|Lost to Follow-up|17
1093681|NCT02286713|2164124|FG001|One Week Follow-Up|Lost to Follow-up|21
1093682|NCT02286713|2164123|FG000|One Week Follow-Up|Withdrawal by Subject|6
1093683|NCT02286713|2164124|FG001|One Week Follow-Up|Withdrawal by Subject|3
1093684|NCT02286713|2164123|FG000|Three Month Follow-Up|Death|1
1093685|NCT02286713|2164124|FG001|Three Month Follow-Up|Death|1
1093686|NCT02286713|2164123|FG000|Three Month Follow-Up|Lost to Follow-up|26
1093687|NCT02286713|2164124|FG001|Three Month Follow-Up|Lost to Follow-up|24
1093688|NCT02286713|2164123|FG000|Three Month Follow-Up|Withdrawal by Subject|1
1093689|NCT02286713|2164124|FG001|Three Month Follow-Up|Withdrawal by Subject|1
1093690|NCT02286713|2164123|FG000|Six Month Follow-Up|Death|2
1093691|NCT02286713|2164124|FG001|Six Month Follow-Up|Death|0
1093692|NCT02286713|2164123|FG000|Six Month Follow-Up|Lost to Follow-up|30
1093693|NCT02286713|2164124|FG001|Six Month Follow-Up|Lost to Follow-up|27
1093694|NCT02286843|2164143|FG000|Overall Study|Not Treated|4
1093695|NCT02286843|2164143|FG000|Overall Study|Protocol Violation|1
1093696|NCT02286843|2164143|FG000|Overall Study|Withdrawal by Subject|1
1093697|NCT02286895|2164149|FG000|Assessed for Measles Seroconversion|Protocol Violation|1
1093698|NCT02286895|2164150|FG001|Assessed for Measles Seroconversion|Protocol Violation|4
1093699|NCT02286895|2164149|FG000|Assessed for Measles Seroconversion|Missing measurement|6
1093700|NCT02286895|2164150|FG001|Assessed for Measles Seroconversion|Missing measurement|3
1093701|NCT02286895|2164149|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41
1093702|NCT02286895|2164150|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32
1093703|NCT02286947|2164165|FG000|Overall Study|Withdrawal by Subject|2
1093704|NCT02286960|2164173|FG000|Overall Study|Lost to Follow-up|3
1093705|NCT02286960|2164174|FG001|Overall Study|Lost to Follow-up|3
1093706|NCT02287038|2164182|FG000|Overall Study|Stopped attending appointments|3
1093707|NCT02287038|2164183|FG001|Overall Study|Stopped attending appointments|2
1093708|NCT02287038|2164182|FG000|Overall Study|Anxiety after starting medication|0
1093709|NCT02287038|2164183|FG001|Overall Study|Anxiety after starting medication|1
1093710|NCT02287038|2164182|FG000|Overall Study|Nausea after starting medication|1
1093711|NCT02287038|2164183|FG001|Overall Study|Nausea after starting medication|0
1093712|NCT02287038|2164182|FG000|Overall Study|Abnormal ECG after starting medication|1
1093713|NCT02287038|2164183|FG001|Overall Study|Abnormal ECG after starting medication|0
1093714|NCT02287402|2164199|FG000|Treatment Period|Adverse Event|17
1093715|NCT02287402|2164199|FG000|Treatment Period|Voluntary Withdrawal|10
1093716|NCT02287402|2164199|FG000|Follow-up|Lost to Follow-up|1
1093717|NCT02287402|2164199|FG000|Follow-up|Voluntary Withdrawal|2
1093718|NCT02287467|2164209|FG000|Overall Study|Protocol Violation|12
1093719|NCT02287467|2164210|FG001|Overall Study|Protocol Violation|9
1093720|NCT02287584|2164235|FG000|the Double-blind Phase|Adverse Event|17
1093721|NCT02287584|2164236|FG001|the Double-blind Phase|Adverse Event|17
1093722|NCT02287584|2164237|FG002|the Double-blind Phase|Adverse Event|12
1093723|NCT02287584|2164238|FG003|the Double-blind Phase|Adverse Event|0
1093724|NCT02287584|2164239|FG004|the Double-blind Phase|Adverse Event|0
1093725|NCT02287584|2164240|FG005|the Double-blind Phase|Adverse Event|0
1093726|NCT02287584|2164235|FG000|the Double-blind Phase|Lack of Efficacy|18
1093727|NCT02287584|2164236|FG001|the Double-blind Phase|Lack of Efficacy|8
1093728|NCT02287584|2164237|FG002|the Double-blind Phase|Lack of Efficacy|8
1093729|NCT02287584|2164238|FG003|the Double-blind Phase|Lack of Efficacy|0
1093730|NCT02287584|2164239|FG004|the Double-blind Phase|Lack of Efficacy|0
1093731|NCT02287584|2164240|FG005|the Double-blind Phase|Lack of Efficacy|0
1093732|NCT02287584|2164235|FG000|the Double-blind Phase|Lost to Follow-up|0
1093733|NCT02287584|2164236|FG001|the Double-blind Phase|Lost to Follow-up|1
1093734|NCT02287584|2164237|FG002|the Double-blind Phase|Lost to Follow-up|1
893274|NCT00682786|1863534|FG001|Overall Study|Did not receive irinotecan|1
893275|NCT00682890|1863574|FG000|Overall Study|Lost to Follow-up|1
893276|NCT00682890|1863575|FG001|Overall Study|Lost to Follow-up|1
893277|NCT00682890|1863574|FG000|Overall Study|subject moved away|0
893278|NCT00682890|1863575|FG001|Overall Study|subject moved away|1
893279|NCT00682890|1863574|FG000|Overall Study|heavy menstrual bleeding|1
893280|NCT00682890|1863575|FG001|Overall Study|heavy menstrual bleeding|0
893281|NCT00682929|1863584|FG000|Overall Study|Adverse Event|4
893282|NCT00682929|1863585|FG001|Overall Study|Adverse Event|1
1093735|NCT02287584|2164238|FG003|the Double-blind Phase|Lost to Follow-up|0
1093736|NCT02287584|2164239|FG004|the Double-blind Phase|Lost to Follow-up|0
1093737|NCT02287584|2164240|FG005|the Double-blind Phase|Lost to Follow-up|0
1093738|NCT02287584|2164235|FG000|the Double-blind Phase|Withdrawal by Subject|17
1093739|NCT02287584|2164236|FG001|the Double-blind Phase|Withdrawal by Subject|17
1093740|NCT02287584|2164237|FG002|the Double-blind Phase|Withdrawal by Subject|11
1093741|NCT02287584|2164238|FG003|the Double-blind Phase|Withdrawal by Subject|0
1093742|NCT02287584|2164239|FG004|the Double-blind Phase|Withdrawal by Subject|0
1093743|NCT02287584|2164240|FG005|the Double-blind Phase|Withdrawal by Subject|0
1093744|NCT02287584|2164235|FG000|the Double-blind Phase|Pregnancy|0
1093745|NCT02287584|2164236|FG001|the Double-blind Phase|Pregnancy|1
1093746|NCT02287584|2164237|FG002|the Double-blind Phase|Pregnancy|0
1093747|NCT02287584|2164238|FG003|the Double-blind Phase|Pregnancy|0
1093748|NCT02287584|2164239|FG004|the Double-blind Phase|Pregnancy|0
1093749|NCT02287584|2164240|FG005|the Double-blind Phase|Pregnancy|0
1093750|NCT02287584|2164235|FG000|the Double-blind Phase|Protocol Violation|0
1093751|NCT02287584|2164236|FG001|the Double-blind Phase|Protocol Violation|3
1093752|NCT02287584|2164237|FG002|the Double-blind Phase|Protocol Violation|0
1093753|NCT02287584|2164238|FG003|the Double-blind Phase|Protocol Violation|0
1093754|NCT02287584|2164239|FG004|the Double-blind Phase|Protocol Violation|0
1093755|NCT02287584|2164240|FG005|the Double-blind Phase|Protocol Violation|0
1093756|NCT02287584|2164235|FG000|the Double-blind Phase|other reasons|0
1093757|NCT02287584|2164236|FG001|the Double-blind Phase|other reasons|0
1093758|NCT02287584|2164237|FG002|the Double-blind Phase|other reasons|1
1093759|NCT02287584|2164238|FG003|the Double-blind Phase|other reasons|0
1093760|NCT02287584|2164239|FG004|the Double-blind Phase|other reasons|0
1093761|NCT02287584|2164240|FG005|the Double-blind Phase|other reasons|0
1093762|NCT02287584|2164235|FG000|the Open-label Phase|Did not receive drug|0
1093763|NCT02287584|2164236|FG001|the Open-label Phase|Did not receive drug|0
1093764|NCT02287584|2164237|FG002|the Open-label Phase|Did not receive drug|0
1093765|NCT02287584|2164238|FG003|the Open-label Phase|Did not receive drug|7
1093766|NCT02287584|2164239|FG004|the Open-label Phase|Did not receive drug|6
1093767|NCT02287584|2164240|FG005|the Open-label Phase|Did not receive drug|4
1093768|NCT02287584|2164235|FG000|the Open-label Phase|Adverse Event|0
1093769|NCT02287584|2164236|FG001|the Open-label Phase|Adverse Event|0
1093770|NCT02287584|2164237|FG002|the Open-label Phase|Adverse Event|0
1093771|NCT02287584|2164238|FG003|the Open-label Phase|Adverse Event|15
1093772|NCT02287584|2164239|FG004|the Open-label Phase|Adverse Event|12
1093773|NCT02287584|2164240|FG005|the Open-label Phase|Adverse Event|16
1093774|NCT02287584|2164235|FG000|the Open-label Phase|Lack of Efficacy|0
1093775|NCT02287584|2164236|FG001|the Open-label Phase|Lack of Efficacy|0
1093776|NCT02287584|2164237|FG002|the Open-label Phase|Lack of Efficacy|0
1093777|NCT02287584|2164238|FG003|the Open-label Phase|Lack of Efficacy|8
1093778|NCT02287584|2164239|FG004|the Open-label Phase|Lack of Efficacy|3
1093779|NCT02287584|2164240|FG005|the Open-label Phase|Lack of Efficacy|7
1093780|NCT02287584|2164235|FG000|the Open-label Phase|Lost to Follow-up|0
1093781|NCT02287584|2164236|FG001|the Open-label Phase|Lost to Follow-up|0
1093782|NCT02287584|2164237|FG002|the Open-label Phase|Lost to Follow-up|0
1093783|NCT02287584|2164238|FG003|the Open-label Phase|Lost to Follow-up|4
1093784|NCT02287584|2164239|FG004|the Open-label Phase|Lost to Follow-up|1
1093785|NCT02287584|2164240|FG005|the Open-label Phase|Lost to Follow-up|2
1093786|NCT02287584|2164235|FG000|the Open-label Phase|Withdrawal by Subject|0
1093787|NCT02287584|2164236|FG001|the Open-label Phase|Withdrawal by Subject|0
1093788|NCT02287584|2164237|FG002|the Open-label Phase|Withdrawal by Subject|0
1093789|NCT02287584|2164238|FG003|the Open-label Phase|Withdrawal by Subject|18
1093790|NCT02287584|2164239|FG004|the Open-label Phase|Withdrawal by Subject|29
1093791|NCT02287584|2164240|FG005|the Open-label Phase|Withdrawal by Subject|21
1093792|NCT02287584|2164235|FG000|the Open-label Phase|non-compliance|0
1093793|NCT02287584|2164236|FG001|the Open-label Phase|non-compliance|0
1093794|NCT02287584|2164237|FG002|the Open-label Phase|non-compliance|0
1093795|NCT02287584|2164238|FG003|the Open-label Phase|non-compliance|2
1093796|NCT02287584|2164239|FG004|the Open-label Phase|non-compliance|5
1093797|NCT02287584|2164240|FG005|the Open-label Phase|non-compliance|1
1093798|NCT02287584|2164235|FG000|the Open-label Phase|other reasons|0
1093799|NCT02287584|2164236|FG001|the Open-label Phase|other reasons|0
1093800|NCT02287584|2164237|FG002|the Open-label Phase|other reasons|0
1093801|NCT02287584|2164238|FG003|the Open-label Phase|other reasons|3
1093802|NCT02287584|2164239|FG004|the Open-label Phase|other reasons|6
1093803|NCT02287584|2164240|FG005|the Open-label Phase|other reasons|6
1093804|NCT02287610|2164254|FG000|Overall Study|Lost to Follow-up|3
1093805|NCT02287610|2164254|FG000|Overall Study|Withdrawal by Subject|8
1093806|NCT02287610|2164254|FG000|Overall Study|Excluded-investigator non-responsiveness|5
1093807|NCT02287623|2164260|FG000|Overall Study|Protocol Violation|0
1093808|NCT02287623|2164261|FG001|Overall Study|Protocol Violation|1
1093809|NCT02287883|2164328|FG000|Overall Study|Death|8
1093810|NCT02287883|2164329|FG001|Overall Study|Death|7
1093811|NCT02287883|2164328|FG000|Overall Study|No longer eligible|222
1093812|NCT02287883|2164329|FG001|Overall Study|No longer eligible|182
1093813|NCT02287883|2164328|FG000|Overall Study|Non-response to survey|229
1093814|NCT02287883|2164329|FG001|Overall Study|Non-response to survey|237
1093815|NCT02287896|2164337|FG000|Second Injection Visit|Withdrawal by Subject|0
1093816|NCT02287896|2164338|FG001|Second Injection Visit|Withdrawal by Subject|1
1093817|NCT02287922|2164371|FG000|Overall Study|Adverse Event|1
1093818|NCT02287922|2164372|FG001|Overall Study|Adverse Event|1
1093819|NCT02287922|2164373|FG002|Overall Study|Adverse Event|3
1093820|NCT02287922|2164374|FG003|Overall Study|Adverse Event|4
1093821|NCT02287922|2164371|FG000|Overall Study|Withdrawal by Subject|1
1093822|NCT02287922|2164372|FG001|Overall Study|Withdrawal by Subject|1
1093823|NCT02287922|2164373|FG002|Overall Study|Withdrawal by Subject|1
1093824|NCT02287922|2164374|FG003|Overall Study|Withdrawal by Subject|2
1093825|NCT02287922|2164371|FG000|Overall Study|Lost to Follow-up|0
1093826|NCT02287922|2164372|FG001|Overall Study|Lost to Follow-up|0
1093827|NCT02287922|2164373|FG002|Overall Study|Lost to Follow-up|1
893283|NCT00682929|1863586|FG002|Overall Study|Adverse Event|1
893284|NCT00682929|1863584|FG000|Overall Study|Withdrawal by Subject|1
893285|NCT00682929|1863585|FG001|Overall Study|Withdrawal by Subject|2
1093828|NCT02287922|2164374|FG003|Overall Study|Lost to Follow-up|0
1093829|NCT02287922|2164371|FG000|Overall Study|Sponsor's decision|0
1093830|NCT02287922|2164372|FG001|Overall Study|Sponsor's decision|0
1093831|NCT02287922|2164373|FG002|Overall Study|Sponsor's decision|0
1093832|NCT02287922|2164374|FG003|Overall Study|Sponsor's decision|1
1093833|NCT02287922|2164371|FG000|Overall Study|Other|1
1093834|NCT02287922|2164372|FG001|Overall Study|Other|0
1093835|NCT02287922|2164373|FG002|Overall Study|Other|2
1093836|NCT02287922|2164374|FG003|Overall Study|Other|0
1093837|NCT02288091|2164385|FG000|Overall Study|Lost to Follow-up|1
1093838|NCT02288091|2164385|FG000|Overall Study|Screen fail|7
1093839|NCT02288182|2164410|FG000|Overall Study|Adverse Event|0
1093840|NCT02288182|2164411|FG001|Overall Study|Adverse Event|1
1093841|NCT02288182|2164410|FG000|Overall Study|Lost to Follow-up|0
1093842|NCT02288182|2164411|FG001|Overall Study|Lost to Follow-up|1
1093843|NCT02288312|2164431|FG000|Overall Study|Pregnancy|1
1093844|NCT02288312|2164432|FG001|Overall Study|Pregnancy|0
1093845|NCT02288312|2164433|FG002|Overall Study|Pregnancy|0
1093846|NCT02288325|2164441|FG000|Run-in Period|Adverse Event|48
1093847|NCT02288325|2164442|FG001|Run-in Period|Adverse Event|0
1093848|NCT02288325|2164443|FG002|Run-in Period|Adverse Event|0
1093849|NCT02288325|2164441|FG000|Run-in Period|Lack of Efficacy|16
1093850|NCT02288325|2164442|FG001|Run-in Period|Lack of Efficacy|0
1093851|NCT02288325|2164443|FG002|Run-in Period|Lack of Efficacy|0
1093852|NCT02288325|2164441|FG000|Run-in Period|Withdrawal of Consent|28
1093853|NCT02288325|2164442|FG001|Run-in Period|Withdrawal of Consent|0
1093854|NCT02288325|2164443|FG002|Run-in Period|Withdrawal of Consent|0
1093855|NCT02288325|2164441|FG000|Run-in Period|Lost to Follow-up|25
1093856|NCT02288325|2164442|FG001|Run-in Period|Lost to Follow-up|0
1093857|NCT02288325|2164443|FG002|Run-in Period|Lost to Follow-up|0
1093858|NCT02288325|2164441|FG000|Run-in Period|Protocol Violation|17
1093859|NCT02288325|2164442|FG001|Run-in Period|Protocol Violation|0
1093860|NCT02288325|2164443|FG002|Run-in Period|Protocol Violation|0
1093861|NCT02288325|2164441|FG000|Run-in Period|Non-Compliance With Study Drug|3
1093862|NCT02288325|2164442|FG001|Run-in Period|Non-Compliance With Study Drug|0
1093863|NCT02288325|2164443|FG002|Run-in Period|Non-Compliance With Study Drug|0
1093864|NCT02288325|2164441|FG000|Run-in Period|Reason not Specified|8
1093865|NCT02288325|2164442|FG001|Run-in Period|Reason not Specified|0
1093866|NCT02288325|2164443|FG002|Run-in Period|Reason not Specified|0
1093867|NCT02288325|2164441|FG000|Stabilization Period|Adverse Event|13
1093868|NCT02288325|2164442|FG001|Stabilization Period|Adverse Event|0
1093869|NCT02288325|2164443|FG002|Stabilization Period|Adverse Event|0
1093870|NCT02288325|2164441|FG000|Stabilization Period|Lack of Efficacy|22
1093871|NCT02288325|2164442|FG001|Stabilization Period|Lack of Efficacy|0
1093872|NCT02288325|2164443|FG002|Stabilization Period|Lack of Efficacy|0
1093873|NCT02288325|2164441|FG000|Stabilization Period|Withdrawal of Consent|23
1093874|NCT02288325|2164442|FG001|Stabilization Period|Withdrawal of Consent|0
1093875|NCT02288325|2164443|FG002|Stabilization Period|Withdrawal of Consent|0
1093876|NCT02288325|2164441|FG000|Stabilization Period|Lost to Follow-up|12
1093877|NCT02288325|2164442|FG001|Stabilization Period|Lost to Follow-up|0
1093878|NCT02288325|2164443|FG002|Stabilization Period|Lost to Follow-up|0
1093879|NCT02288325|2164441|FG000|Stabilization Period|Protocol Violation|8
1093880|NCT02288325|2164442|FG001|Stabilization Period|Protocol Violation|0
1093881|NCT02288325|2164443|FG002|Stabilization Period|Protocol Violation|0
1093882|NCT02288325|2164441|FG000|Stabilization Period|Non-Compliance With Study Drug|5
1093883|NCT02288325|2164442|FG001|Stabilization Period|Non-Compliance With Study Drug|0
1093884|NCT02288325|2164443|FG002|Stabilization Period|Non-Compliance With Study Drug|0
1093885|NCT02288325|2164441|FG000|Stabilization Period|Reason not Specified|15
1093886|NCT02288325|2164442|FG001|Stabilization Period|Reason not Specified|0
1093887|NCT02288325|2164443|FG002|Stabilization Period|Reason not Specified|0
1093888|NCT02288325|2164441|FG000|Double-blind Treatment Period|Adverse Event|0
1093889|NCT02288325|2164442|FG001|Double-blind Treatment Period|Adverse Event|2
1093890|NCT02288325|2164443|FG002|Double-blind Treatment Period|Adverse Event|5
1093891|NCT02288325|2164441|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
1093892|NCT02288325|2164442|FG001|Double-blind Treatment Period|Withdrawal of Consent|8
1093893|NCT02288325|2164443|FG002|Double-blind Treatment Period|Withdrawal of Consent|8
1093894|NCT02288325|2164441|FG000|Double-blind Treatment Period|Lost to Follow-up|0
1093895|NCT02288325|2164442|FG001|Double-blind Treatment Period|Lost to Follow-up|4
1093896|NCT02288325|2164443|FG002|Double-blind Treatment Period|Lost to Follow-up|5
1093897|NCT02288325|2164441|FG000|Double-blind Treatment Period|Protocol Violation|0
1093898|NCT02288325|2164442|FG001|Double-blind Treatment Period|Protocol Violation|1
1093899|NCT02288325|2164443|FG002|Double-blind Treatment Period|Protocol Violation|2
1093900|NCT02288325|2164441|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0
1093901|NCT02288325|2164442|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1
1093902|NCT02288325|2164443|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4
1093903|NCT02288325|2164441|FG000|Double-blind Treatment Period|Multiple Reasons|0
1093904|NCT02288325|2164442|FG001|Double-blind Treatment Period|Multiple Reasons|8
1093905|NCT02288325|2164443|FG002|Double-blind Treatment Period|Multiple Reasons|2
1093906|NCT02288559|2164472|FG000|Overall Study|Adverse Event|1
1093907|NCT02288559|2164473|FG001|Overall Study|Adverse Event|1
1093908|NCT02288559|2164474|FG002|Overall Study|Adverse Event|5
1093909|NCT02288559|2164475|FG003|Overall Study|Adverse Event|0
1093910|NCT02288559|2164472|FG000|Overall Study|Death|0
1093911|NCT02288559|2164473|FG001|Overall Study|Death|0
1093912|NCT02288559|2164474|FG002|Overall Study|Death|1
1093913|NCT02288559|2164475|FG003|Overall Study|Death|0
1093914|NCT02288559|2164472|FG000|Overall Study|Lost to Follow-up|0
1093915|NCT02288559|2164473|FG001|Overall Study|Lost to Follow-up|0
1093916|NCT02288559|2164474|FG002|Overall Study|Lost to Follow-up|0
1093917|NCT02288559|2164475|FG003|Overall Study|Lost to Follow-up|1
1093918|NCT02288559|2164472|FG000|Overall Study|Withdrawal by Subject|0
1093919|NCT02288559|2164473|FG001|Overall Study|Withdrawal by Subject|0
1093920|NCT02288559|2164474|FG002|Overall Study|Withdrawal by Subject|2
1093921|NCT02288559|2164475|FG003|Overall Study|Withdrawal by Subject|1
1093922|NCT02288559|2164472|FG000|Overall Study|Reason Not Specified|0
1093923|NCT02288559|2164473|FG001|Overall Study|Reason Not Specified|0
1093924|NCT02288559|2164474|FG002|Overall Study|Reason Not Specified|3
1093925|NCT02288559|2164475|FG003|Overall Study|Reason Not Specified|0
1093926|NCT02289079|2164493|FG000|Overall Study|Physician Decision|2
1093927|NCT02289079|2164494|FG001|Overall Study|Physician Decision|0
1093928|NCT02289079|2164493|FG000|Overall Study|Lost to Follow-up|0
1093929|NCT02289079|2164494|FG001|Overall Study|Lost to Follow-up|1
1093930|NCT02289352|2164525|FG000|Overall Study|Withdrawal by Subject|1
1093931|NCT02289352|2164526|FG001|Overall Study|Withdrawal by Subject|1
1093932|NCT02289352|2164527|FG002|Overall Study|Withdrawal by Subject|0
1093933|NCT02289417|2164539|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
1093934|NCT02289417|2164540|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
1093935|NCT02289417|2164541|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
1093936|NCT02289417|2164542|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
1093937|NCT02289417|2164543|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
1093938|NCT02289417|2164544|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
1093939|NCT02289417|2164545|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
1093940|NCT02289417|2164546|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
1093941|NCT02289417|2164547|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
1093942|NCT02289417|2164539|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
1093943|NCT02289417|2164540|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
1093944|NCT02289417|2164541|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
1093945|NCT02289417|2164542|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
1093946|NCT02289417|2164543|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
1093947|NCT02289417|2164544|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
1093948|NCT02289417|2164545|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
1093949|NCT02289417|2164546|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
1093950|NCT02289417|2164547|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
1093951|NCT02289417|2164539|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
1093952|NCT02289417|2164540|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
1093953|NCT02289417|2164541|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
1093954|NCT02289417|2164542|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
1093955|NCT02289417|2164543|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
1093956|NCT02289417|2164544|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
1093957|NCT02289417|2164545|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
1093958|NCT02289417|2164546|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
1093959|NCT02289417|2164547|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
1093960|NCT02289417|2164539|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
1093961|NCT02289417|2164540|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
1093962|NCT02289417|2164541|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
1093963|NCT02289417|2164542|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
1093964|NCT02289417|2164543|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
1093965|NCT02289417|2164544|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
1093966|NCT02289417|2164545|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
893286|NCT00682929|1863586|FG002|Overall Study|Withdrawal by Subject|1
893287|NCT00682929|1863584|FG000|Overall Study|dosing compliance < 80%|0
893288|NCT00682929|1863585|FG001|Overall Study|dosing compliance < 80%|2
893289|NCT00682929|1863586|FG002|Overall Study|dosing compliance < 80%|0
893290|NCT00682929|1863584|FG000|Overall Study|lag in DEA renewal|1
893291|NCT00682929|1863585|FG001|Overall Study|lag in DEA renewal|0
893292|NCT00682929|1863586|FG002|Overall Study|lag in DEA renewal|0
893293|NCT00683293|1863622|FG000|Overall Study|Withdrawal by Subject|2
893294|NCT00683293|1863623|FG001|Overall Study|Withdrawal by Subject|3
893295|NCT00683384|1863633|FG000|Overall Study|Death|1
893296|NCT00683384|1863633|FG000|Overall Study|Adverse Event|1
893297|NCT00683449|1863646|FG000|Overall Study|Lost to Follow-up|0
893298|NCT00683449|1863647|FG001|Overall Study|Lost to Follow-up|1
893299|NCT00683449|1863648|FG002|Overall Study|Lost to Follow-up|0
893300|NCT00683449|1863649|FG003|Overall Study|Lost to Follow-up|0
893301|NCT00683449|1863650|FG004|Overall Study|Lost to Follow-up|0
893302|NCT00683475|1863669|FG000|Overall Study|Withdrawal by Subject|1
893303|NCT00683475|1863670|FG001|Overall Study|Withdrawal by Subject|0
893304|NCT00683475|1863669|FG000|Overall Study|Never Treated: Adverse Event|2
893305|NCT00683475|1863670|FG001|Overall Study|Never Treated: Adverse Event|3
893306|NCT00683475|1863669|FG000|Overall Study|Never Treated: Progressive Disease|1
893307|NCT00683475|1863670|FG001|Overall Study|Never Treated: Progressive Disease|0
893308|NCT00683592|1863679|FG000|Overall Study|Adverse Event|12
893309|NCT00683592|1863680|FG001|Overall Study|Adverse Event|4
893310|NCT00683592|1863679|FG000|Overall Study|Withdrawal by Subject|11
1093967|NCT02289417|2164546|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
1093968|NCT02289417|2164547|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
1093969|NCT02289417|2164539|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0
1093970|NCT02289417|2164540|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1
1093971|NCT02289417|2164541|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4
1093972|NCT02289417|2164542|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2
1093973|NCT02289417|2164543|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2
1093974|NCT02289417|2164544|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1
1093975|NCT02289417|2164545|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0
1093976|NCT02289417|2164546|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0
1093977|NCT02289417|2164547|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0
1093978|NCT02289417|2164539|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0
1093979|NCT02289417|2164540|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0
1093980|NCT02289417|2164541|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1
1093981|NCT02289417|2164542|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0
1093982|NCT02289417|2164543|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0
1093983|NCT02289417|2164544|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0
1093984|NCT02289417|2164545|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0
1093985|NCT02289417|2164546|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0
1093986|NCT02289417|2164547|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0
1093987|NCT02289417|2164539|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
1093988|NCT02289417|2164540|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
1093989|NCT02289417|2164541|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
1093990|NCT02289417|2164542|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
1093991|NCT02289417|2164543|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
1093992|NCT02289417|2164544|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
1093993|NCT02289417|2164545|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
1093994|NCT02289417|2164546|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
1093995|NCT02289417|2164547|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
1093996|NCT02289417|2164539|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
1093997|NCT02289417|2164540|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
1093998|NCT02289417|2164541|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
1093999|NCT02289417|2164542|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
1094000|NCT02289417|2164543|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
1094001|NCT02289417|2164544|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
1094002|NCT02289417|2164545|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
1094003|NCT02289417|2164546|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
1094004|NCT02289417|2164547|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
1094005|NCT02289417|2164539|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
1094006|NCT02289417|2164540|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
1094007|NCT02289417|2164541|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
1094008|NCT02289417|2164542|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
1094009|NCT02289417|2164543|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
1094010|NCT02289417|2164544|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
1094011|NCT02289417|2164545|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
1094012|NCT02289417|2164546|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
1094013|NCT02289417|2164547|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
1094014|NCT02289417|2164539|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0
1094015|NCT02289417|2164540|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0
1094016|NCT02289417|2164541|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0
1094017|NCT02289417|2164542|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1
1094018|NCT02289417|2164543|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0
1094019|NCT02289417|2164544|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0
1094020|NCT02289417|2164545|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1
1094021|NCT02289417|2164546|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0
1094022|NCT02289417|2164547|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0
1094023|NCT02289417|2164539|FG000|Extension Phase Weeks 52-104|Adverse Event|0
1094024|NCT02289417|2164540|FG001|Extension Phase Weeks 52-104|Adverse Event|0
1094025|NCT02289417|2164541|FG002|Extension Phase Weeks 52-104|Adverse Event|0
1094026|NCT02289417|2164542|FG003|Extension Phase Weeks 52-104|Adverse Event|0
1094027|NCT02289417|2164543|FG004|Extension Phase Weeks 52-104|Adverse Event|0
1094028|NCT02289417|2164544|FG005|Extension Phase Weeks 52-104|Adverse Event|0
1094029|NCT02289417|2164545|FG006|Extension Phase Weeks 52-104|Adverse Event|0
1094030|NCT02289417|2164546|FG007|Extension Phase Weeks 52-104|Adverse Event|2
1094031|NCT02289417|2164547|FG008|Extension Phase Weeks 52-104|Adverse Event|3
1094032|NCT02289417|2164539|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0
1094033|NCT02289417|2164540|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0
1094034|NCT02289417|2164541|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0
1094035|NCT02289417|2164542|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0
1094036|NCT02289417|2164543|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0
1094037|NCT02289417|2164544|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0
1094038|NCT02289417|2164545|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0
1094039|NCT02289417|2164546|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2
1094040|NCT02289417|2164547|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2
1094041|NCT02289417|2164539|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0
1094042|NCT02289417|2164540|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0
1094043|NCT02289417|2164541|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0
1094044|NCT02289417|2164542|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0
1094045|NCT02289417|2164543|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0
1094046|NCT02289417|2164544|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0
1094047|NCT02289417|2164545|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0
1094048|NCT02289417|2164546|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2
1094049|NCT02289417|2164547|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1
1094050|NCT02289417|2164539|FG000|Extension Phase Weeks 52-104|Miscellaneous|0
1094051|NCT02289417|2164540|FG001|Extension Phase Weeks 52-104|Miscellaneous|0
1094052|NCT02289417|2164541|FG002|Extension Phase Weeks 52-104|Miscellaneous|0
1094053|NCT02289417|2164542|FG003|Extension Phase Weeks 52-104|Miscellaneous|0
1094054|NCT02289417|2164543|FG004|Extension Phase Weeks 52-104|Miscellaneous|0
1094055|NCT02289417|2164544|FG005|Extension Phase Weeks 52-104|Miscellaneous|0
1094056|NCT02289417|2164545|FG006|Extension Phase Weeks 52-104|Miscellaneous|0
1094057|NCT02289417|2164546|FG007|Extension Phase Weeks 52-104|Miscellaneous|1
1094058|NCT02289417|2164547|FG008|Extension Phase Weeks 52-104|Miscellaneous|0
1094059|NCT02289456|2164563|FG000|Induction Period|Death|2
1094060|NCT02289456|2164563|FG000|Induction Period|Adverse Event|11
1094061|NCT02289456|2164563|FG000|Induction Period|Progressive Disease (PD)|4
1094062|NCT02289456|2164563|FG000|Induction Period|Symptomatic Deterioration|4
1094063|NCT02289456|2164563|FG000|Induction Period|Withdrawal by Subject|2
1094064|NCT02289456|2164563|FG000|Induction Period|Miscellaneous|1
1094065|NCT02289456|2164563|FG000|Monotherapy Period|Death|1
1094066|NCT02289456|2164563|FG000|Monotherapy Period|Adverse Event|1
1094067|NCT02289456|2164563|FG000|Monotherapy Period|Progressive Disease (PD)|8
1094068|NCT02289456|2164563|FG000|Monotherapy Period|Symptomatic Deterioration|1
1094069|NCT02289456|2164563|FG000|Monotherapy Period|Withdrawal by Subject|2
1094070|NCT02289456|2164563|FG000|Monotherapy Period|Study Terminated by Sponsor|2
1094071|NCT02289456|2164563|FG000|Monotherapy Period|Miscellaneous|1
1094072|NCT02289469|2164574|FG000|Overall Study|Unable to match a control|6
1094073|NCT02289469|2164575|FG001|Overall Study|Unable to match a control|0
1094074|NCT02289690|2164591|FG000|Overall Study|Adverse Event Related to Progression|0
1094075|NCT02289690|2164592|FG001|Overall Study|Adverse Event Related to Progression|1
1094076|NCT02289690|2164593|FG002|Overall Study|Adverse Event Related to Progression|1
1094077|NCT02289690|2164594|FG003|Overall Study|Adverse Event Related to Progression|0
1094078|NCT02289690|2164595|FG004|Overall Study|Adverse Event Related to Progression|1
1094079|NCT02289690|2164596|FG005|Overall Study|Adverse Event Related to Progression|0
1094080|NCT02289690|2164597|FG006|Overall Study|Adverse Event Related to Progression|1
1094081|NCT02289690|2164598|FG007|Overall Study|Adverse Event Related to Progression|0
1094082|NCT02289690|2164599|FG008|Overall Study|Adverse Event Related to Progression|0
1094083|NCT02289690|2164600|FG009|Overall Study|Adverse Event Related to Progression|0
1094084|NCT02289690|2164591|FG000|Overall Study|Withdrawal by Subject|1
1094085|NCT02289690|2164592|FG001|Overall Study|Withdrawal by Subject|0
1094086|NCT02289690|2164593|FG002|Overall Study|Withdrawal by Subject|0
1094087|NCT02289690|2164594|FG003|Overall Study|Withdrawal by Subject|0
1094088|NCT02289690|2164595|FG004|Overall Study|Withdrawal by Subject|1
1094089|NCT02289690|2164596|FG005|Overall Study|Withdrawal by Subject|1
1094090|NCT02289690|2164597|FG006|Overall Study|Withdrawal by Subject|0
1094091|NCT02289690|2164598|FG007|Overall Study|Withdrawal by Subject|0
1094092|NCT02289690|2164599|FG008|Overall Study|Withdrawal by Subject|4
1094093|NCT02289690|2164600|FG009|Overall Study|Withdrawal by Subject|2
1094094|NCT02289690|2164591|FG000|Overall Study|Progressive Disease, Per Protocol|3
1094095|NCT02289690|2164592|FG001|Overall Study|Progressive Disease, Per Protocol|2
1094096|NCT02289690|2164593|FG002|Overall Study|Progressive Disease, Per Protocol|3
1094097|NCT02289690|2164594|FG003|Overall Study|Progressive Disease, Per Protocol|2
1094098|NCT02289690|2164595|FG004|Overall Study|Progressive Disease, Per Protocol|5
1094099|NCT02289690|2164596|FG005|Overall Study|Progressive Disease, Per Protocol|13
1094100|NCT02289690|2164597|FG006|Overall Study|Progressive Disease, Per Protocol|2
1094101|NCT02289690|2164598|FG007|Overall Study|Progressive Disease, Per Protocol|0
1094102|NCT02289690|2164599|FG008|Overall Study|Progressive Disease, Per Protocol|0
1094103|NCT02289690|2164600|FG009|Overall Study|Progressive Disease, Per Protocol|0
1094104|NCT02289690|2164591|FG000|Overall Study|Lost to Follow-up|0
1094105|NCT02289690|2164592|FG001|Overall Study|Lost to Follow-up|0
1094106|NCT02289690|2164593|FG002|Overall Study|Lost to Follow-up|0
1094107|NCT02289690|2164594|FG003|Overall Study|Lost to Follow-up|0
1094108|NCT02289690|2164595|FG004|Overall Study|Lost to Follow-up|0
1094109|NCT02289690|2164596|FG005|Overall Study|Lost to Follow-up|0
1094110|NCT02289690|2164597|FG006|Overall Study|Lost to Follow-up|0
1094111|NCT02289690|2164598|FG007|Overall Study|Lost to Follow-up|1
1094112|NCT02289690|2164599|FG008|Overall Study|Lost to Follow-up|0
1094113|NCT02289690|2164600|FG009|Overall Study|Lost to Follow-up|2
1094114|NCT02289690|2164591|FG000|Overall Study|Death|0
1094115|NCT02289690|2164592|FG001|Overall Study|Death|0
1094116|NCT02289690|2164593|FG002|Overall Study|Death|0
1094117|NCT02289690|2164594|FG003|Overall Study|Death|0
1094118|NCT02289690|2164595|FG004|Overall Study|Death|0
1094119|NCT02289690|2164596|FG005|Overall Study|Death|0
1094120|NCT02289690|2164597|FG006|Overall Study|Death|0
1094121|NCT02289690|2164598|FG007|Overall Study|Death|49
1094122|NCT02289690|2164599|FG008|Overall Study|Death|45
1094123|NCT02289690|2164600|FG009|Overall Study|Death|41
1094124|NCT02289690|2164591|FG000|Overall Study|Sponsor Discontinued Study|0
1094125|NCT02289690|2164592|FG001|Overall Study|Sponsor Discontinued Study|0
1094126|NCT02289690|2164593|FG002|Overall Study|Sponsor Discontinued Study|0
1094127|NCT02289690|2164594|FG003|Overall Study|Sponsor Discontinued Study|0
1094128|NCT02289690|2164595|FG004|Overall Study|Sponsor Discontinued Study|0
1094129|NCT02289690|2164596|FG005|Overall Study|Sponsor Discontinued Study|0
1094130|NCT02289690|2164597|FG006|Overall Study|Sponsor Discontinued Study|0
1094131|NCT02289690|2164598|FG007|Overall Study|Sponsor Discontinued Study|9
1094132|NCT02289690|2164599|FG008|Overall Study|Sponsor Discontinued Study|7
1094133|NCT02289690|2164600|FG009|Overall Study|Sponsor Discontinued Study|15
1094134|NCT02289690|2164591|FG000|Overall Study|Other|0
1094135|NCT02289690|2164592|FG001|Overall Study|Other|0
1094136|NCT02289690|2164593|FG002|Overall Study|Other|0
1094137|NCT02289690|2164594|FG003|Overall Study|Other|1
1094138|NCT02289690|2164595|FG004|Overall Study|Other|1
1094139|NCT02289690|2164596|FG005|Overall Study|Other|0
1094140|NCT02289690|2164597|FG006|Overall Study|Other|1
1094141|NCT02289690|2164598|FG007|Overall Study|Other|2
1094142|NCT02289690|2164599|FG008|Overall Study|Other|3
1094143|NCT02289690|2164600|FG009|Overall Study|Other|1
1094144|NCT02289729|2164636|FG000|Overall Study|Lack of Efficacy|3
1094145|NCT02289729|2164636|FG000|Overall Study|Very Narrow Therapeutic Margin|1
1094146|NCT02289729|2164636|FG000|Overall Study|Withdrawal by Subject|1
1094147|NCT02289729|2164636|FG000|Overall Study|Death|1
1094148|NCT02289742|2164642|FG000|First Wear Period|Adverse event prior to treatment|0
1094149|NCT02289742|2164643|FG001|First Wear Period|Adverse event prior to treatment|1
1094150|NCT02289742|2164644|FG002|First Wear Period|Adverse event prior to treatment|0
1094151|NCT02289742|2164645|FG003|First Wear Period|Adverse event prior to treatment|0
1094152|NCT02289742|2164642|FG000|First Wear Period|Adverse Event|0
1094153|NCT02289742|2164643|FG001|First Wear Period|Adverse Event|0
1094154|NCT02289742|2164644|FG002|First Wear Period|Adverse Event|1
1094155|NCT02289742|2164645|FG003|First Wear Period|Adverse Event|0
1094156|NCT02289742|2164642|FG000|First Wear Period|Other prior to treatment|0
1094157|NCT02289742|2164643|FG001|First Wear Period|Other prior to treatment|0
1094158|NCT02289742|2164644|FG002|First Wear Period|Other prior to treatment|0
1094159|NCT02289742|2164645|FG003|First Wear Period|Other prior to treatment|1
1094160|NCT02289742|2164642|FG000|Third Wear Period|Adverse Event|0
1094161|NCT02289742|2164643|FG001|Third Wear Period|Adverse Event|1
1094162|NCT02289742|2164644|FG002|Third Wear Period|Adverse Event|0
1094163|NCT02289742|2164645|FG003|Third Wear Period|Adverse Event|0
1094164|NCT02289742|2164642|FG000|Third Wear Period|Reason not given|0
1094165|NCT02289742|2164643|FG001|Third Wear Period|Reason not given|0
1094166|NCT02289742|2164644|FG002|Third Wear Period|Reason not given|0
1094167|NCT02289742|2164645|FG003|Third Wear Period|Reason not given|1
1094168|NCT02289820|2164670|FG000|Overall Study|Withdrawal by Subject|2
1094169|NCT02289820|2164671|FG001|Overall Study|Withdrawal by Subject|1
1094170|NCT02289820|2164672|FG002|Overall Study|Withdrawal by Subject|2
1094171|NCT02289820|2164673|FG003|Overall Study|Withdrawal by Subject|1
1094172|NCT02289820|2164674|FG004|Overall Study|Withdrawal by Subject|0
1094173|NCT02289820|2164675|FG005|Overall Study|Withdrawal by Subject|0
1094174|NCT02289820|2164676|FG006|Overall Study|Withdrawal by Subject|1
1094175|NCT02289820|2164670|FG000|Overall Study|Death|0
1094176|NCT02289820|2164671|FG001|Overall Study|Death|0
1094177|NCT02289820|2164672|FG002|Overall Study|Death|1
1094178|NCT02289820|2164673|FG003|Overall Study|Death|0
1094179|NCT02289820|2164674|FG004|Overall Study|Death|0
1094180|NCT02289820|2164675|FG005|Overall Study|Death|0
1094181|NCT02289820|2164676|FG006|Overall Study|Death|0
1094182|NCT02289820|2164670|FG000|Overall Study|Lost to Follow-up|0
1094183|NCT02289820|2164671|FG001|Overall Study|Lost to Follow-up|0
1094184|NCT02289820|2164672|FG002|Overall Study|Lost to Follow-up|3
1094185|NCT02289820|2164673|FG003|Overall Study|Lost to Follow-up|1
1094186|NCT02289820|2164674|FG004|Overall Study|Lost to Follow-up|0
1094187|NCT02289820|2164675|FG005|Overall Study|Lost to Follow-up|1
1094188|NCT02289820|2164676|FG006|Overall Study|Lost to Follow-up|1
1094189|NCT02289820|2164670|FG000|Overall Study|withdrawal of consent|0
1094190|NCT02289820|2164671|FG001|Overall Study|withdrawal of consent|1
1094191|NCT02289820|2164672|FG002|Overall Study|withdrawal of consent|0
1094192|NCT02289820|2164673|FG003|Overall Study|withdrawal of consent|0
1094193|NCT02289820|2164674|FG004|Overall Study|withdrawal of consent|0
1094194|NCT02289820|2164675|FG005|Overall Study|withdrawal of consent|0
1094195|NCT02289820|2164676|FG006|Overall Study|withdrawal of consent|0
1094196|NCT02289833|2164698|FG000|Overall Study|Study discontinuation|0
1094197|NCT02289833|2164699|FG001|Overall Study|Study discontinuation|1
1094198|NCT02289833|2164698|FG000|Overall Study|Lost to Follow-up|4
1094199|NCT02289833|2164699|FG001|Overall Study|Lost to Follow-up|0
1094200|NCT02289833|2164698|FG000|Overall Study|Death|23
1094201|NCT02289833|2164699|FG001|Overall Study|Death|16
1094202|NCT02289898|2164710|FG000|Overall Study|Death|5
1094203|NCT02289898|2164711|FG001|Overall Study|Death|4
1094204|NCT02289898|2164712|FG002|Overall Study|Death|3
1094205|NCT02289898|2164710|FG000|Overall Study|Physician Decision|2
1094206|NCT02289898|2164711|FG001|Overall Study|Physician Decision|5
1094207|NCT02289898|2164712|FG002|Overall Study|Physician Decision|2
1094208|NCT02289898|2164710|FG000|Overall Study|Withdrawal by Subject|0
1094209|NCT02289898|2164711|FG001|Overall Study|Withdrawal by Subject|4
1094210|NCT02289898|2164712|FG002|Overall Study|Withdrawal by Subject|1
1094211|NCT02289898|2164710|FG000|Overall Study|Adverse Event|3
1094212|NCT02289898|2164711|FG001|Overall Study|Adverse Event|5
1094213|NCT02289898|2164712|FG002|Overall Study|Adverse Event|5
1094214|NCT02289898|2164710|FG000|Overall Study|Disease progression|34
1094215|NCT02289898|2164711|FG001|Overall Study|Disease progression|28
1094216|NCT02289898|2164712|FG002|Overall Study|Disease progression|34
1094217|NCT02289898|2164710|FG000|Overall Study|Use of another anticancer therapy|0
1094218|NCT02289898|2164711|FG001|Overall Study|Use of another anticancer therapy|0
1094219|NCT02289898|2164712|FG002|Overall Study|Use of another anticancer therapy|1
1094220|NCT02289898|2164710|FG000|Overall Study|Other|8
1094221|NCT02289898|2164711|FG001|Overall Study|Other|7
1094222|NCT02289898|2164712|FG002|Overall Study|Other|10
1094223|NCT02289950|2164721|FG000|Overall Study|Progressive disease by RECIST 1.1|99
1094224|NCT02289950|2164722|FG001|Overall Study|Progressive disease by RECIST 1.1|52
1094225|NCT02289950|2164721|FG000|Overall Study|Progressive disease by Clinical Assessment|4
1094226|NCT02289950|2164722|FG001|Overall Study|Progressive disease by Clinical Assessment|4
1094227|NCT02289950|2164721|FG000|Overall Study|Lost to Follow-up|1
1094228|NCT02289950|2164722|FG001|Overall Study|Lost to Follow-up|0
1094229|NCT02289950|2164721|FG000|Overall Study|Physician Decision|9
1094230|NCT02289950|2164722|FG001|Overall Study|Physician Decision|3
1094231|NCT02289950|2164721|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9
1094232|NCT02289950|2164722|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2
1094233|NCT02289950|2164721|FG000|Overall Study|Withdrawal by Subject|1
1094234|NCT02289950|2164722|FG001|Overall Study|Withdrawal by Subject|3
1094235|NCT02289950|2164721|FG000|Overall Study|Test article held for greater than 28 days|0
1094236|NCT02289950|2164722|FG001|Overall Study|Test article held for greater than 28 days|1
1094237|NCT02289950|2164721|FG000|Overall Study|Adverse Event|11
1094238|NCT02289950|2164722|FG001|Overall Study|Adverse Event|3
1094239|NCT02289950|2164721|FG000|Overall Study|Death|1
1094240|NCT02289950|2164722|FG001|Overall Study|Death|1
1094241|NCT02289950|2164721|FG000|Overall Study|Other|5
1094242|NCT02289950|2164722|FG001|Overall Study|Other|2
1094243|NCT02289950|2164721|FG000|Overall Study|Not Treated|2
1094244|NCT02289950|2164722|FG001|Overall Study|Not Treated|1
1094245|NCT02289963|2164730|FG000|Overall Study|Adverse Event|1
1094246|NCT02289963|2164731|FG001|Overall Study|Adverse Event|2
1094247|NCT02289963|2164730|FG000|Overall Study|Poor compliance to protocol|1
1094248|NCT02289963|2164731|FG001|Overall Study|Poor compliance to protocol|0
1094249|NCT02289963|2164730|FG000|Overall Study|Withdrawal by Subject|1
1094250|NCT02289963|2164731|FG001|Overall Study|Withdrawal by Subject|0
1094251|NCT02289963|2164730|FG000|Overall Study|Last injection missed|2
1094252|NCT02289963|2164731|FG001|Overall Study|Last injection missed|2
1094253|NCT02289963|2164730|FG000|Overall Study|End treatment visit outside visit window|0
1094254|NCT02289963|2164731|FG001|Overall Study|End treatment visit outside visit window|4
1094255|NCT02289963|2164730|FG000|Overall Study|Other than specified above|0
1094256|NCT02289963|2164731|FG001|Overall Study|Other than specified above|2
1094257|NCT02290028|2164746|FG000|Overall Study|Death|217
1094258|NCT02290028|2164746|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186
1094259|NCT02290028|2164746|FG000|Overall Study|No longer under care of study physician|76
1094260|NCT02290028|2164746|FG000|Overall Study|Sentus lead or required CRT-D explanted|55
1094261|NCT02290028|2164746|FG000|Overall Study|Withdrawal by Subject|52
1094262|NCT02290028|2164746|FG000|Overall Study|Study site closure|44
1094263|NCT02290028|2164746|FG000|Overall Study|Lost to Follow-up|34
1094264|NCT02290028|2164746|FG000|Overall Study|Miscellaneous|10
1094265|NCT02290028|2164746|FG000|Overall Study|Transition to EP PASSION|1295
1094266|NCT02290028|2164746|FG000|Overall Study|Planned study completion at 12 months|257
1094267|NCT02290223|2164779|FG000|6 Months|Lost to Follow-up|9
1094268|NCT02290223|2164780|FG001|6 Months|Lost to Follow-up|6
1094269|NCT02290223|2164779|FG000|6 Months|Withdrawal by Subject|5
1094270|NCT02290223|2164780|FG001|6 Months|Withdrawal by Subject|0
1094271|NCT02290223|2164779|FG000|6 Months|deceased (not related to study)|2
1094272|NCT02290223|2164780|FG001|6 Months|deceased (not related to study)|0
1094273|NCT02290223|2164779|FG000|12 Months|Lost to Follow-up|16
1094274|NCT02290223|2164780|FG001|12 Months|Lost to Follow-up|10
1094275|NCT02290223|2164779|FG000|12 Months|Refusal|0
1094276|NCT02290223|2164780|FG001|12 Months|Refusal|1
1094277|NCT02290340|2164790|FG000|Overall Study|Lost to Follow-up|0
1094278|NCT02290340|2164791|FG001|Overall Study|Lost to Follow-up|0
1094279|NCT02290340|2164792|FG002|Overall Study|Lost to Follow-up|0
1094280|NCT02290340|2164793|FG003|Overall Study|Lost to Follow-up|1
1094281|NCT02290340|2164790|FG000|Overall Study|Withdrawal by Subject|1
1094282|NCT02290340|2164791|FG001|Overall Study|Withdrawal by Subject|0
1094283|NCT02290340|2164792|FG002|Overall Study|Withdrawal by Subject|0
1094284|NCT02290340|2164793|FG003|Overall Study|Withdrawal by Subject|0
1094285|NCT02290340|2164790|FG000|Overall Study|Other|1
1094286|NCT02290340|2164791|FG001|Overall Study|Other|0
1094287|NCT02290340|2164792|FG002|Overall Study|Other|0
1094288|NCT02290340|2164793|FG003|Overall Study|Other|1
1094289|NCT02290405|2164808|FG000|Overall Study|Withdrawal by Subject|1
1094290|NCT02290405|2164809|FG001|Overall Study|Withdrawal by Subject|0
1094291|NCT02290691|2164853|FG000|Overall Study|Noncompliance|0
1094292|NCT02290691|2164854|FG001|Overall Study|Noncompliance|1
1094293|NCT02290691|2164853|FG000|Overall Study|Withdrawal by Subject|1
1094294|NCT02290691|2164854|FG001|Overall Study|Withdrawal by Subject|1
1094295|NCT02290691|2164853|FG000|Overall Study|Lost to Follow-up|7
1094296|NCT02290691|2164854|FG001|Overall Study|Lost to Follow-up|7
1094297|NCT02290821|2164862|FG000|Overall Study|Withdrawal by Subject|1
1094298|NCT02290821|2164863|FG001|Overall Study|Withdrawal by Subject|1
1094299|NCT02290821|2164862|FG000|Overall Study|Unable or unwilling to cooperate with|2
1094300|NCT02290821|2164863|FG001|Overall Study|Unable or unwilling to cooperate with|0
1094301|NCT02290821|2164862|FG000|Overall Study|Lost to Follow-up|3
1094302|NCT02290821|2164863|FG001|Overall Study|Lost to Follow-up|2
1094303|NCT02290873|2164872|FG000|Overall Study|Withdrawal by Subject|0
1094304|NCT02290873|2164873|FG001|Overall Study|Withdrawal by Subject|1
1094305|NCT02290873|2164874|FG002|Overall Study|Withdrawal by Subject|1
1094306|NCT02290873|2164872|FG000|Overall Study|Nellcor device error|1
1094307|NCT02290873|2164873|FG001|Overall Study|Nellcor device error|0
1094308|NCT02290873|2164874|FG002|Overall Study|Nellcor device error|0
1094309|NCT02290873|2164872|FG000|Overall Study|Esophagogastroduodenoscopy was added|1
1094310|NCT02290873|2164873|FG001|Overall Study|Esophagogastroduodenoscopy was added|0
1094311|NCT02290873|2164874|FG002|Overall Study|Esophagogastroduodenoscopy was added|0
1094312|NCT02290873|2164872|FG000|Overall Study|Protocol Violation|0
1094313|NCT02290873|2164873|FG001|Overall Study|Protocol Violation|0
1094314|NCT02290873|2164874|FG002|Overall Study|Protocol Violation|1
1094315|NCT02290925|2164885|FG000|First Period of Three Months|Lost to Follow-up|2
1094316|NCT02290925|2164886|FG001|First Period of Three Months|Lost to Follow-up|1
1094317|NCT02290925|2164885|FG000|First Period of Three Months|Death|1
1094318|NCT02290925|2164886|FG001|First Period of Three Months|Death|0
1094319|NCT02290925|2164885|FG000|First Period of Three Months|Insulin Started|1
1094320|NCT02290925|2164886|FG001|First Period of Three Months|Insulin Started|1
1094321|NCT02290925|2164885|FG000|Second Period of 3 Months|Lost to Follow-up|1
1094322|NCT02290925|2164886|FG001|Second Period of 3 Months|Lost to Follow-up|3
1094323|NCT02290925|2164885|FG000|Second Period of 3 Months|insulin started|0
1094324|NCT02290925|2164886|FG001|Second Period of 3 Months|insulin started|1
1094325|NCT02291029|2164910|FG000|Overall Study|Withdrawal by Subject|0
1094326|NCT02291029|2164911|FG001|Overall Study|Withdrawal by Subject|0
1094327|NCT02291029|2164912|FG002|Overall Study|Withdrawal by Subject|1
1094328|NCT02291029|2164913|FG003|Overall Study|Withdrawal by Subject|0
1094329|NCT02291029|2164914|FG004|Overall Study|Withdrawal by Subject|0
1094330|NCT02291029|2164915|FG005|Overall Study|Withdrawal by Subject|0
1094331|NCT02291029|2164910|FG000|Overall Study|Adverse Event|0
1094332|NCT02291029|2164911|FG001|Overall Study|Adverse Event|1
1094333|NCT02291029|2164912|FG002|Overall Study|Adverse Event|0
1094334|NCT02291029|2164913|FG003|Overall Study|Adverse Event|0
1094335|NCT02291029|2164914|FG004|Overall Study|Adverse Event|0
1094336|NCT02291029|2164915|FG005|Overall Study|Adverse Event|0
1094337|NCT02291237|2164935|FG000|Overall Study|Study Terminated by Sponsor|72
1094338|NCT02291237|2164936|FG001|Overall Study|Study Terminated by Sponsor|67
1094339|NCT02291237|2164935|FG000|Overall Study|Adverse Event|1
1094340|NCT02291237|2164936|FG001|Overall Study|Adverse Event|3
1094341|NCT02291237|2164935|FG000|Overall Study|Investigator's Discretion|0
1094342|NCT02291237|2164936|FG001|Overall Study|Investigator's Discretion|3
1094343|NCT02291237|2164935|FG000|Overall Study|Withdrew Consent|11
1094344|NCT02291237|2164936|FG001|Overall Study|Withdrew Consent|11
1094345|NCT02291237|2164935|FG000|Overall Study|Lost to Follow-up|0
1094346|NCT02291237|2164936|FG001|Overall Study|Lost to Follow-up|2
1094347|NCT02291237|2164935|FG000|Overall Study|Subject Required Prohibited Medication|2
1094348|NCT02291237|2164936|FG001|Overall Study|Subject Required Prohibited Medication|0
1094349|NCT02291289|2164946|FG000|Induction Treatment|Not Dosed|2
1094350|NCT02291289|2164947|FG001|Induction Treatment|Not Dosed|0
1094351|NCT02291289|2164948|FG002|Induction Treatment|Not Dosed|0
1094352|NCT02291289|2164949|FG003|Induction Treatment|Not Dosed|9
1094353|NCT02291289|2164950|FG004|Induction Treatment|Not Dosed|0
1094354|NCT02291289|2164951|FG005|Induction Treatment|Not Dosed|0
1094355|NCT02291289|2164952|FG006|Induction Treatment|Not Dosed|0
1094356|NCT02291289|2164953|FG007|Induction Treatment|Not Dosed|0
1094357|NCT02291289|2164954|FG008|Induction Treatment|Not Dosed|0
1094358|NCT02291289|2164955|FG009|Induction Treatment|Not Dosed|1
1094359|NCT02291289|2164956|FG010|Induction Treatment|Not Dosed|0
1094360|NCT02291289|2164957|FG011|Induction Treatment|Not Dosed|0
1094361|NCT02291289|2164946|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
1094362|NCT02291289|2164947|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0
1094363|NCT02291289|2164948|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0
1094364|NCT02291289|2164949|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0
1094365|NCT02291289|2164950|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13
1094366|NCT02291289|2164951|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11
1094367|NCT02291289|2164952|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0
1094368|NCT02291289|2164953|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0
1094369|NCT02291289|2164954|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0
1094370|NCT02291289|2164955|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0
1094371|NCT02291289|2164956|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2
1094372|NCT02291289|2164957|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3
1094373|NCT02291289|2164946|FG000|Maintenance Treatment Phase|Protocol Violation|0
1094374|NCT02291289|2164947|FG001|Maintenance Treatment Phase|Protocol Violation|1
1094375|NCT02291289|2164948|FG002|Maintenance Treatment Phase|Protocol Violation|0
1094376|NCT02291289|2164949|FG003|Maintenance Treatment Phase|Protocol Violation|0
1094377|NCT02291289|2164950|FG004|Maintenance Treatment Phase|Protocol Violation|2
1094378|NCT02291289|2164951|FG005|Maintenance Treatment Phase|Protocol Violation|1
1094379|NCT02291289|2164952|FG006|Maintenance Treatment Phase|Protocol Violation|0
1094380|NCT02291289|2164953|FG007|Maintenance Treatment Phase|Protocol Violation|0
1094381|NCT02291289|2164954|FG008|Maintenance Treatment Phase|Protocol Violation|0
1094382|NCT02291289|2164955|FG009|Maintenance Treatment Phase|Protocol Violation|0
1094383|NCT02291289|2164956|FG010|Maintenance Treatment Phase|Protocol Violation|0
1094384|NCT02291289|2164957|FG011|Maintenance Treatment Phase|Protocol Violation|0
1094385|NCT02291289|2164946|FG000|Maintenance Treatment Phase|Death|0
1094386|NCT02291289|2164947|FG001|Maintenance Treatment Phase|Death|23
1094387|NCT02291289|2164948|FG002|Maintenance Treatment Phase|Death|13
1094388|NCT02291289|2164949|FG003|Maintenance Treatment Phase|Death|0
1094389|NCT02291289|2164950|FG004|Maintenance Treatment Phase|Death|185
1094390|NCT02291289|2164951|FG005|Maintenance Treatment Phase|Death|100
1094391|NCT02291289|2164952|FG006|Maintenance Treatment Phase|Death|0
1094392|NCT02291289|2164953|FG007|Maintenance Treatment Phase|Death|1
1094393|NCT02291289|2164954|FG008|Maintenance Treatment Phase|Death|1
1094394|NCT02291289|2164955|FG009|Maintenance Treatment Phase|Death|0
1094395|NCT02291289|2164956|FG010|Maintenance Treatment Phase|Death|26
1094396|NCT02291289|2164957|FG011|Maintenance Treatment Phase|Death|11
1094397|NCT02291289|2164946|FG000|Maintenance Treatment Phase|Adverse Event|0
1094398|NCT02291289|2164947|FG001|Maintenance Treatment Phase|Adverse Event|0
1094399|NCT02291289|2164948|FG002|Maintenance Treatment Phase|Adverse Event|0
1094400|NCT02291289|2164949|FG003|Maintenance Treatment Phase|Adverse Event|0
1094401|NCT02291289|2164950|FG004|Maintenance Treatment Phase|Adverse Event|1
1094402|NCT02291289|2164951|FG005|Maintenance Treatment Phase|Adverse Event|0
1094403|NCT02291289|2164952|FG006|Maintenance Treatment Phase|Adverse Event|0
1094404|NCT02291289|2164953|FG007|Maintenance Treatment Phase|Adverse Event|0
1094405|NCT02291289|2164954|FG008|Maintenance Treatment Phase|Adverse Event|0
1094406|NCT02291289|2164955|FG009|Maintenance Treatment Phase|Adverse Event|0
1094407|NCT02291289|2164956|FG010|Maintenance Treatment Phase|Adverse Event|0
1094408|NCT02291289|2164957|FG011|Maintenance Treatment Phase|Adverse Event|0
1094409|NCT02291289|2164946|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
1094410|NCT02291289|2164947|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
1094411|NCT02291289|2164948|FG002|Maintenance Treatment Phase|Lost to Follow-up|0
1094412|NCT02291289|2164949|FG003|Maintenance Treatment Phase|Lost to Follow-up|0
1094413|NCT02291289|2164950|FG004|Maintenance Treatment Phase|Lost to Follow-up|12
1094414|NCT02291289|2164951|FG005|Maintenance Treatment Phase|Lost to Follow-up|3
1094415|NCT02291289|2164952|FG006|Maintenance Treatment Phase|Lost to Follow-up|0
1094416|NCT02291289|2164953|FG007|Maintenance Treatment Phase|Lost to Follow-up|1
1094417|NCT02291289|2164954|FG008|Maintenance Treatment Phase|Lost to Follow-up|0
1094418|NCT02291289|2164955|FG009|Maintenance Treatment Phase|Lost to Follow-up|0
1094419|NCT02291289|2164956|FG010|Maintenance Treatment Phase|Lost to Follow-up|2
1094420|NCT02291289|2164957|FG011|Maintenance Treatment Phase|Lost to Follow-up|1
1094421|NCT02291289|2164946|FG000|Maintenance Treatment Phase|Other|0
1094422|NCT02291289|2164947|FG001|Maintenance Treatment Phase|Other|0
1094423|NCT02291289|2164948|FG002|Maintenance Treatment Phase|Other|1
1094424|NCT02291289|2164949|FG003|Maintenance Treatment Phase|Other|0
1094425|NCT02291289|2164950|FG004|Maintenance Treatment Phase|Other|29
1094426|NCT02291289|2164951|FG005|Maintenance Treatment Phase|Other|8
1094427|NCT02291289|2164952|FG006|Maintenance Treatment Phase|Other|0
1094428|NCT02291289|2164953|FG007|Maintenance Treatment Phase|Other|0
1094429|NCT02291289|2164954|FG008|Maintenance Treatment Phase|Other|1
1094430|NCT02291289|2164955|FG009|Maintenance Treatment Phase|Other|0
1094431|NCT02291289|2164956|FG010|Maintenance Treatment Phase|Other|0
1094432|NCT02291289|2164957|FG011|Maintenance Treatment Phase|Other|0
1094433|NCT02291289|2164946|FG000|Maintenance Treatment Phase|Physician Decision|0
1094434|NCT02291289|2164947|FG001|Maintenance Treatment Phase|Physician Decision|0
1094435|NCT02291289|2164948|FG002|Maintenance Treatment Phase|Physician Decision|0
1094436|NCT02291289|2164949|FG003|Maintenance Treatment Phase|Physician Decision|0
1094437|NCT02291289|2164950|FG004|Maintenance Treatment Phase|Physician Decision|2
1094438|NCT02291289|2164951|FG005|Maintenance Treatment Phase|Physician Decision|0
1094439|NCT02291289|2164952|FG006|Maintenance Treatment Phase|Physician Decision|0
1094440|NCT02291289|2164953|FG007|Maintenance Treatment Phase|Physician Decision|0
1094441|NCT02291289|2164954|FG008|Maintenance Treatment Phase|Physician Decision|0
1162052|NCT03381339|2283995|FG001|Overall Study|Protocol Violation|3
1094442|NCT02291289|2164955|FG009|Maintenance Treatment Phase|Physician Decision|0
1094443|NCT02291289|2164956|FG010|Maintenance Treatment Phase|Physician Decision|0
1094444|NCT02291289|2164957|FG011|Maintenance Treatment Phase|Physician Decision|1
1094445|NCT02291289|2164946|FG000|Maintenance Treatment Phase|Multiple Reasons|0
1094446|NCT02291289|2164947|FG001|Maintenance Treatment Phase|Multiple Reasons|0
1094447|NCT02291289|2164948|FG002|Maintenance Treatment Phase|Multiple Reasons|0
1094448|NCT02291289|2164949|FG003|Maintenance Treatment Phase|Multiple Reasons|0
1094449|NCT02291289|2164950|FG004|Maintenance Treatment Phase|Multiple Reasons|4
1094450|NCT02291289|2164951|FG005|Maintenance Treatment Phase|Multiple Reasons|1
1094451|NCT02291289|2164952|FG006|Maintenance Treatment Phase|Multiple Reasons|0
1094452|NCT02291289|2164953|FG007|Maintenance Treatment Phase|Multiple Reasons|0
1094453|NCT02291289|2164954|FG008|Maintenance Treatment Phase|Multiple Reasons|0
1094454|NCT02291289|2164955|FG009|Maintenance Treatment Phase|Multiple Reasons|0
1094455|NCT02291289|2164956|FG010|Maintenance Treatment Phase|Multiple Reasons|0
1094456|NCT02291289|2164957|FG011|Maintenance Treatment Phase|Multiple Reasons|0
1094457|NCT02291289|2164946|FG000|Maintenance Treatment Phase|No Treatment Received|0
1094458|NCT02291289|2164947|FG001|Maintenance Treatment Phase|No Treatment Received|0
1094459|NCT02291289|2164948|FG002|Maintenance Treatment Phase|No Treatment Received|2
1094460|NCT02291289|2164949|FG003|Maintenance Treatment Phase|No Treatment Received|0
1094461|NCT02291289|2164950|FG004|Maintenance Treatment Phase|No Treatment Received|4
1094462|NCT02291289|2164951|FG005|Maintenance Treatment Phase|No Treatment Received|5
1094463|NCT02291289|2164952|FG006|Maintenance Treatment Phase|No Treatment Received|0
1094464|NCT02291289|2164953|FG007|Maintenance Treatment Phase|No Treatment Received|0
1094465|NCT02291289|2164954|FG008|Maintenance Treatment Phase|No Treatment Received|0
1094466|NCT02291289|2164955|FG009|Maintenance Treatment Phase|No Treatment Received|0
1094467|NCT02291289|2164956|FG010|Maintenance Treatment Phase|No Treatment Received|1
1094468|NCT02291289|2164957|FG011|Maintenance Treatment Phase|No Treatment Received|0
1094469|NCT02291419|2165001|FG000|Overall Study|Early study termination|1
1094470|NCT02291419|2165002|FG001|Overall Study|Early study termination|5
893311|NCT00683592|1863680|FG001|Overall Study|Withdrawal by Subject|11
893312|NCT00683592|1863679|FG000|Overall Study|Lost to Follow-up|17
893313|NCT00683592|1863680|FG001|Overall Study|Lost to Follow-up|17
893314|NCT00683592|1863679|FG000|Overall Study|Lack of Efficacy|3
893315|NCT00683592|1863680|FG001|Overall Study|Lack of Efficacy|7
893316|NCT00683592|1863679|FG000|Overall Study|Physician Decision|0
893317|NCT00683592|1863680|FG001|Overall Study|Physician Decision|1
893318|NCT00683592|1863679|FG000|Overall Study|Non-compliance|3
893319|NCT00683592|1863680|FG001|Overall Study|Non-compliance|5
893320|NCT00683592|1863679|FG000|Overall Study|Other|1
893321|NCT00683592|1863680|FG001|Overall Study|Other|1
893322|NCT00683618|1863689|FG000|Randomised Treatment Period|Withdrawal by Subject|4
893323|NCT00683618|1863690|FG001|Randomised Treatment Period|Withdrawal by Subject|1
893324|NCT00683618|1863691|FG002|Randomised Treatment Period|Withdrawal by Subject|2
893325|NCT00683618|1863689|FG000|Randomised Treatment Period|Protocol Violation|0
893326|NCT00683618|1863690|FG001|Randomised Treatment Period|Protocol Violation|1
893327|NCT00683618|1863691|FG002|Randomised Treatment Period|Protocol Violation|0
893328|NCT00683618|1863689|FG000|Randomised Treatment Period|Adverse Event|2
893329|NCT00683618|1863690|FG001|Randomised Treatment Period|Adverse Event|0
893330|NCT00683618|1863691|FG002|Randomised Treatment Period|Adverse Event|2
893331|NCT00683618|1863689|FG000|Randomised Treatment Period|Reason not provided|0
1094471|NCT02291432|2165008|FG000|Overall Study|Withdrawal by Subject|2
1094472|NCT02291510|2165016|FG000|Overall Study|Adverse Event|0
1094473|NCT02291510|2165017|FG001|Overall Study|Adverse Event|0
1094474|NCT02291510|2165018|FG002|Overall Study|Adverse Event|0
1094475|NCT02291510|2165019|FG003|Overall Study|Adverse Event|1
1094476|NCT02291549|2165031|FG000|Overall Study|Lost to Follow-up|1
1094477|NCT02291549|2165032|FG001|Overall Study|Lost to Follow-up|0
1094478|NCT02291549|2165031|FG000|Overall Study|Withdrawal by Subject|0
1094479|NCT02291549|2165032|FG001|Overall Study|Withdrawal by Subject|1
1094480|NCT02291601|2165040|FG000|Abdomen|Did not qualify|333
1094481|NCT02291601|2165041|FG001|Abdomen|Did not qualify|54
1094482|NCT02291601|2165042|FG002|Abdomen|Did not qualify|339
1094483|NCT02291601|2165040|FG000|Groin|Did not qualify|183
1094484|NCT02291601|2165041|FG001|Groin|Did not qualify|30
1094485|NCT02291601|2165042|FG002|Groin|Did not qualify|177
1094486|NCT02291614|2165064|FG000|Overall Study|Lost to Follow-up|0
1094487|NCT02291614|2165065|FG001|Overall Study|Lost to Follow-up|0
1094488|NCT02291614|2165066|FG002|Overall Study|Lost to Follow-up|0
1094489|NCT02291614|2165067|FG003|Overall Study|Lost to Follow-up|0
1094490|NCT02291614|2165068|FG004|Overall Study|Lost to Follow-up|0
1094491|NCT02291614|2165069|FG005|Overall Study|Lost to Follow-up|0
1094492|NCT02291614|2165070|FG006|Overall Study|Lost to Follow-up|0
1094493|NCT02291614|2165071|FG007|Overall Study|Lost to Follow-up|1
1094494|NCT02291614|2165072|FG008|Overall Study|Lost to Follow-up|0
1094495|NCT02291614|2165073|FG009|Overall Study|Lost to Follow-up|0
1094496|NCT02291614|2165074|FG010|Overall Study|Lost to Follow-up|0
1094497|NCT02291614|2165064|FG000|Overall Study|Withdrawal by Subject|0
1094498|NCT02291614|2165065|FG001|Overall Study|Withdrawal by Subject|1
1094499|NCT02291614|2165066|FG002|Overall Study|Withdrawal by Subject|0
1094500|NCT02291614|2165067|FG003|Overall Study|Withdrawal by Subject|0
1094501|NCT02291614|2165068|FG004|Overall Study|Withdrawal by Subject|0
1094502|NCT02291614|2165069|FG005|Overall Study|Withdrawal by Subject|0
1094503|NCT02291614|2165070|FG006|Overall Study|Withdrawal by Subject|0
1094504|NCT02291614|2165071|FG007|Overall Study|Withdrawal by Subject|0
1094505|NCT02291614|2165072|FG008|Overall Study|Withdrawal by Subject|0
1094506|NCT02291614|2165073|FG009|Overall Study|Withdrawal by Subject|2
1094507|NCT02291614|2165074|FG010|Overall Study|Withdrawal by Subject|2
1094508|NCT02291614|2165064|FG000|Overall Study|Decision by sponsor|0
1094509|NCT02291614|2165065|FG001|Overall Study|Decision by sponsor|0
1094510|NCT02291614|2165066|FG002|Overall Study|Decision by sponsor|0
1094511|NCT02291614|2165067|FG003|Overall Study|Decision by sponsor|1
1094512|NCT02291614|2165068|FG004|Overall Study|Decision by sponsor|0
1094513|NCT02291614|2165069|FG005|Overall Study|Decision by sponsor|0
1094514|NCT02291614|2165070|FG006|Overall Study|Decision by sponsor|0
1094515|NCT02291614|2165071|FG007|Overall Study|Decision by sponsor|0
1094516|NCT02291614|2165072|FG008|Overall Study|Decision by sponsor|0
1094517|NCT02291614|2165073|FG009|Overall Study|Decision by sponsor|0
1094518|NCT02291614|2165074|FG010|Overall Study|Decision by sponsor|0
1094519|NCT02291614|2165064|FG000|Overall Study|Death|0
1094520|NCT02291614|2165065|FG001|Overall Study|Death|0
1094521|NCT02291614|2165066|FG002|Overall Study|Death|1
1094522|NCT02291614|2165067|FG003|Overall Study|Death|0
1094523|NCT02291614|2165068|FG004|Overall Study|Death|1
1094524|NCT02291614|2165069|FG005|Overall Study|Death|1
1094525|NCT02291614|2165070|FG006|Overall Study|Death|1
1094526|NCT02291614|2165071|FG007|Overall Study|Death|0
1094527|NCT02291614|2165072|FG008|Overall Study|Death|0
1094528|NCT02291614|2165073|FG009|Overall Study|Death|0
1094529|NCT02291614|2165074|FG010|Overall Study|Death|0
1094530|NCT02291679|2165107|FG000|Overall Study|Adverse Event|2
1094531|NCT02291679|2165108|FG001|Overall Study|Adverse Event|12
1094532|NCT02291679|2165109|FG002|Overall Study|Adverse Event|19
1094533|NCT02291679|2165107|FG000|Overall Study|Protocol Violation|5
1094534|NCT02291679|2165108|FG001|Overall Study|Protocol Violation|1
1094535|NCT02291679|2165109|FG002|Overall Study|Protocol Violation|7
1094536|NCT02291679|2165107|FG000|Overall Study|Withdrew Consent|18
1094537|NCT02291679|2165108|FG001|Overall Study|Withdrew Consent|10
1094538|NCT02291679|2165109|FG002|Overall Study|Withdrew Consent|15
1094539|NCT02291679|2165107|FG000|Overall Study|Lost to Follow-up|12
1094540|NCT02291679|2165108|FG001|Overall Study|Lost to Follow-up|10
1094541|NCT02291679|2165109|FG002|Overall Study|Lost to Follow-up|9
1094542|NCT02291679|2165107|FG000|Overall Study|Insufficient Therapeutic Response|5
1094543|NCT02291679|2165108|FG001|Overall Study|Insufficient Therapeutic Response|5
1094544|NCT02291679|2165109|FG002|Overall Study|Insufficient Therapeutic Response|7
1094545|NCT02291679|2165107|FG000|Overall Study|Other|2
1094546|NCT02291679|2165108|FG001|Overall Study|Other|4
1094547|NCT02291679|2165109|FG002|Overall Study|Other|2
1094548|NCT02291861|2165133|FG000|Overall Study|Adverse Event|2
1094549|NCT02291861|2165134|FG001|Overall Study|Adverse Event|4
1094550|NCT02291861|2165135|FG002|Overall Study|Adverse Event|1
1094551|NCT02291861|2165136|FG003|Overall Study|Adverse Event|2
1094552|NCT02291861|2165133|FG000|Overall Study|Death|0
1094553|NCT02291861|2165134|FG001|Overall Study|Death|0
1094554|NCT02291861|2165135|FG002|Overall Study|Death|1
1094555|NCT02291861|2165136|FG003|Overall Study|Death|1
1094556|NCT02291861|2165133|FG000|Overall Study|Protocol Violation|1
1094557|NCT02291861|2165134|FG001|Overall Study|Protocol Violation|0
1094558|NCT02291861|2165135|FG002|Overall Study|Protocol Violation|0
1094559|NCT02291861|2165136|FG003|Overall Study|Protocol Violation|1
1094560|NCT02291861|2165133|FG000|Overall Study|Withdrawal by Subject|1
1094561|NCT02291861|2165134|FG001|Overall Study|Withdrawal by Subject|2
1094562|NCT02291861|2165135|FG002|Overall Study|Withdrawal by Subject|1
1094563|NCT02291861|2165136|FG003|Overall Study|Withdrawal by Subject|4
1094564|NCT02291861|2165133|FG000|Overall Study|Noncompliance|1
1094565|NCT02291861|2165134|FG001|Overall Study|Noncompliance|1
1094566|NCT02291861|2165135|FG002|Overall Study|Noncompliance|2
1094567|NCT02291861|2165136|FG003|Overall Study|Noncompliance|1
1094568|NCT02291861|2165133|FG000|Overall Study|Lost to Follow-up|2
1094569|NCT02291861|2165134|FG001|Overall Study|Lost to Follow-up|1
1094570|NCT02291861|2165135|FG002|Overall Study|Lost to Follow-up|4
1094571|NCT02291861|2165136|FG003|Overall Study|Lost to Follow-up|0
1094572|NCT02291861|2165133|FG000|Overall Study|Other|0
1094573|NCT02291861|2165134|FG001|Overall Study|Other|0
1094574|NCT02291861|2165135|FG002|Overall Study|Other|0
1094575|NCT02291861|2165136|FG003|Overall Study|Other|1
1094576|NCT02291913|2165146|FG000|Overall Study|Progressive Disease|32
1094577|NCT02291913|2165146|FG000|Overall Study|Adverse Event|11
1094578|NCT02291913|2165146|FG000|Overall Study|Death|2
1094579|NCT02291913|2165146|FG000|Overall Study|Physician Decision|1
1094580|NCT02291913|2165146|FG000|Overall Study|Withdrawal by Subject|1
1094581|NCT02291913|2165146|FG000|Overall Study|Protocol Violation|1
1094582|NCT02292212|2165163|FG000|ViE Phase|Withdrawal by Subject|1
1094583|NCT02292212|2165163|FG000|ViE Phase|Protocol Violation|2
1094584|NCT02292446|2165187|FG000|Overall Study|Adverse Event|12
1094585|NCT02292446|2165187|FG000|Overall Study|Death|1
1094586|NCT02292446|2165187|FG000|Overall Study|Disease progression|2
1094587|NCT02292446|2165187|FG000|Overall Study|Subject/guardian decision|2
1094588|NCT02292446|2165187|FG000|Overall Study|Withdrawal by Subject|3
1094589|NCT02292719|2165228|FG000|Overall Study|Withdrawal by Subject|0
1094590|NCT02292719|2165229|FG001|Overall Study|Withdrawal by Subject|0
1094591|NCT02292719|2165230|FG002|Overall Study|Withdrawal by Subject|0
1094592|NCT02292719|2165231|FG003|Overall Study|Withdrawal by Subject|1
1094593|NCT02292719|2165232|FG004|Overall Study|Withdrawal by Subject|1
1094594|NCT02292719|2165233|FG005|Overall Study|Withdrawal by Subject|0
1094595|NCT02292719|2165228|FG000|Overall Study|Subject enrolled in new study.|0
1094596|NCT02292719|2165229|FG001|Overall Study|Subject enrolled in new study.|0
1094597|NCT02292719|2165230|FG002|Overall Study|Subject enrolled in new study.|1
1094598|NCT02292719|2165231|FG003|Overall Study|Subject enrolled in new study.|0
1094599|NCT02292719|2165232|FG004|Overall Study|Subject enrolled in new study.|0
1094600|NCT02292719|2165233|FG005|Overall Study|Subject enrolled in new study.|0
1094601|NCT02292771|2165258|FG000|Overall Study|Withdrawal by Subject|2
1094602|NCT02292771|2165259|FG001|Overall Study|Withdrawal by Subject|1
1094603|NCT02292771|2165258|FG000|Overall Study|Lost to Follow-up|2
1094604|NCT02292771|2165259|FG001|Overall Study|Lost to Follow-up|1
1094605|NCT02292784|2165272|FG000|Overall Study|Lost to Follow-up|1
1094606|NCT02292784|2165273|FG001|Overall Study|Lost to Follow-up|17
1094607|NCT02292784|2165274|FG002|Overall Study|Lost to Follow-up|18
1094608|NCT02292784|2165272|FG000|Overall Study|Withdrawal by Subject|0
1094609|NCT02292784|2165273|FG001|Overall Study|Withdrawal by Subject|3
1094610|NCT02292784|2165274|FG002|Overall Study|Withdrawal by Subject|3
1094611|NCT02292849|2165285|FG000|Overall Study|Lost to Follow-up|0
1094612|NCT02292849|2165286|FG001|Overall Study|Lost to Follow-up|2
1094613|NCT02292849|2165287|FG002|Overall Study|Lost to Follow-up|2
1094614|NCT02292849|2165285|FG000|Overall Study|Physician Decision|4
1094615|NCT02292849|2165286|FG001|Overall Study|Physician Decision|0
1094616|NCT02292849|2165287|FG002|Overall Study|Physician Decision|0
1094617|NCT02292927|2165297|FG000|Overall Study|Protocol Violation|13
1094618|NCT02292927|2165298|FG001|Overall Study|Protocol Violation|7
1094619|NCT02293395|2165327|FG000|Overall Study|Lost to Follow-up|1
1094620|NCT02293395|2165328|FG001|Overall Study|Lost to Follow-up|0
1094621|NCT02293395|2165327|FG000|Overall Study|Withdrawal by Subject|8
1094622|NCT02293395|2165328|FG001|Overall Study|Withdrawal by Subject|7
1094623|NCT02293460|2165334|FG000|Overall Study|Protocol Violation|1
1094624|NCT02293460|2165334|FG000|Overall Study|Lack of Efficacy|2
1094625|NCT02293460|2165334|FG000|Overall Study|Adverse Event|2
1094626|NCT02293460|2165334|FG000|Overall Study|Withdrawal by Subject|1
1094627|NCT02293499|2165341|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
1094628|NCT02293499|2165342|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
1094629|NCT02293499|2165343|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10
1094630|NCT02293499|2165341|FG000|Intervention - Camp|Withdrawal by Subject|3
1094631|NCT02293499|2165342|FG001|Intervention - Camp|Withdrawal by Subject|6
1094632|NCT02293499|2165343|FG002|Intervention - Camp|Withdrawal by Subject|2
1094633|NCT02293499|2165341|FG000|Intervention - Camp|these are those not showing up at camp|24
1094634|NCT02293499|2165342|FG001|Intervention - Camp|these are those not showing up at camp|28
1094635|NCT02293499|2165343|FG002|Intervention - Camp|these are those not showing up at camp|4
1094636|NCT02293499|2165341|FG000|3 Month Follow Up|Withdrawal by Subject|1
1094637|NCT02293499|2165342|FG001|3 Month Follow Up|Withdrawal by Subject|0
1094638|NCT02293499|2165343|FG002|3 Month Follow Up|Withdrawal by Subject|4
1094639|NCT02293499|2165341|FG000|3 Month Follow Up|Lost to Follow-up|14
1094640|NCT02293499|2165342|FG001|3 Month Follow Up|Lost to Follow-up|15
1094641|NCT02293499|2165343|FG002|3 Month Follow Up|Lost to Follow-up|6
1094642|NCT02293499|2165341|FG000|6 Month Follow Up|Lost to Follow-up|17
1094643|NCT02293499|2165342|FG001|6 Month Follow Up|Lost to Follow-up|27
1094644|NCT02293499|2165343|FG002|6 Month Follow Up|Lost to Follow-up|6
1094645|NCT02293499|2165341|FG000|6 Month Follow Up|Withdrawal by Subject|0
1094646|NCT02293499|2165342|FG001|6 Month Follow Up|Withdrawal by Subject|0
1094647|NCT02293499|2165343|FG002|6 Month Follow Up|Withdrawal by Subject|1
1094648|NCT02293499|2165341|FG000|9 Month Follow Up|Withdrawal by Subject|2
1094649|NCT02293499|2165342|FG001|9 Month Follow Up|Withdrawal by Subject|0
1094650|NCT02293499|2165343|FG002|9 Month Follow Up|Withdrawal by Subject|0
1094651|NCT02293499|2165341|FG000|9 Month Follow Up|Lost to Follow-up|24
1094652|NCT02293499|2165342|FG001|9 Month Follow Up|Lost to Follow-up|28
1094653|NCT02293499|2165343|FG002|9 Month Follow Up|Lost to Follow-up|4
1094654|NCT02293499|2165341|FG000|12 Month Follow Up|Lost to Follow-up|26
1094655|NCT02293499|2165342|FG001|12 Month Follow Up|Lost to Follow-up|25
1094656|NCT02293499|2165343|FG002|12 Month Follow Up|Lost to Follow-up|6
1094657|NCT02293499|2165341|FG000|12 Month Follow Up|Withdrawal by Subject|0
1094658|NCT02293499|2165342|FG001|12 Month Follow Up|Withdrawal by Subject|1
1094659|NCT02293499|2165343|FG002|12 Month Follow Up|Withdrawal by Subject|0
1094660|NCT02293499|2165341|FG000|15 Month Follow Up|Lost to Follow-up|22
1094661|NCT02293499|2165342|FG001|15 Month Follow Up|Lost to Follow-up|22
1094662|NCT02293499|2165343|FG002|15 Month Follow Up|Lost to Follow-up|7
1094663|NCT02293538|2165371|FG000|Overall Study|Adverse Event|0
1094664|NCT02293538|2165372|FG001|Overall Study|Adverse Event|1
1094665|NCT02293538|2165371|FG000|Overall Study|Lost to Follow-up|1
1094666|NCT02293538|2165372|FG001|Overall Study|Lost to Follow-up|0
1094667|NCT02293538|2165371|FG000|Overall Study|Withdrawal by Subject|0
1094668|NCT02293538|2165372|FG001|Overall Study|Withdrawal by Subject|1
1094669|NCT02293837|2165387|FG000|Overall Study|Lost to Follow-up|0
1094670|NCT02293837|2165388|FG001|Overall Study|Lost to Follow-up|2
1094671|NCT02293837|2165389|FG002|Overall Study|Lost to Follow-up|1
1094672|NCT02293837|2165390|FG003|Overall Study|Lost to Follow-up|0
1094673|NCT02293837|2165387|FG000|Overall Study|Withdrawal by Subject|2
1094674|NCT02293837|2165388|FG001|Overall Study|Withdrawal by Subject|1
1094675|NCT02293837|2165389|FG002|Overall Study|Withdrawal by Subject|2
1094676|NCT02293837|2165390|FG003|Overall Study|Withdrawal by Subject|1
1094677|NCT02293837|2165387|FG000|Overall Study|COVID-19 Related|1
1094678|NCT02293837|2165388|FG001|Overall Study|COVID-19 Related|1
1094679|NCT02293837|2165389|FG002|Overall Study|COVID-19 Related|0
1094680|NCT02293837|2165390|FG003|Overall Study|COVID-19 Related|0
1094681|NCT02293837|2165387|FG000|Overall Study|Participant ill and could not be infused|0
1094682|NCT02293837|2165388|FG001|Overall Study|Participant ill and could not be infused|0
1094683|NCT02293837|2165389|FG002|Overall Study|Participant ill and could not be infused|1
1094684|NCT02293837|2165390|FG003|Overall Study|Participant ill and could not be infused|0
1094685|NCT02293863|2165407|FG000|Overall Study|Death|4
1094686|NCT02293863|2165408|FG001|Overall Study|Death|6
1094687|NCT02293863|2165409|FG002|Overall Study|Death|4
1094688|NCT02293863|2165407|FG000|Overall Study|Lost to Follow-up|2
1094689|NCT02293863|2165408|FG001|Overall Study|Lost to Follow-up|2
1094690|NCT02293863|2165409|FG002|Overall Study|Lost to Follow-up|2
1094691|NCT02293863|2165407|FG000|Overall Study|Withdrawal by Subject|3
1094692|NCT02293863|2165408|FG001|Overall Study|Withdrawal by Subject|3
1094693|NCT02293863|2165409|FG002|Overall Study|Withdrawal by Subject|1
1094694|NCT02293863|2165407|FG000|Overall Study|Reason Not Specified|0
1094695|NCT02293863|2165408|FG001|Overall Study|Reason Not Specified|2
1094696|NCT02293863|2165409|FG002|Overall Study|Reason Not Specified|2
1094697|NCT02293902|2165422|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5
1094698|NCT02293902|2165423|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6
1094699|NCT02293902|2165424|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8
1094700|NCT02293902|2165425|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0
1094701|NCT02293902|2165426|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0
1094702|NCT02293902|2165422|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
1094703|NCT02293902|2165423|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
1094704|NCT02293902|2165424|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
1094705|NCT02293902|2165425|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
1094706|NCT02293902|2165426|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
1094707|NCT02293902|2165422|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
1094708|NCT02293902|2165423|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1094709|NCT02293902|2165424|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1094710|NCT02293902|2165425|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1094711|NCT02293902|2165426|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1094712|NCT02293902|2165422|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
1094713|NCT02293902|2165423|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
1094714|NCT02293902|2165424|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
1094715|NCT02293902|2165425|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
1094716|NCT02293902|2165426|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
1094717|NCT02293902|2165422|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1094718|NCT02293902|2165423|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
1094719|NCT02293902|2165424|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
1094720|NCT02293902|2165425|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1094721|NCT02293902|2165426|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1094722|NCT02293993|2165448|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
1094723|NCT02293993|2165449|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
1094724|NCT02293993|2165450|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
1094725|NCT02293993|2165451|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
1094726|NCT02293993|2165448|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0
1094727|NCT02293993|2165449|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2
1094728|NCT02293993|2165450|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1
1094729|NCT02293993|2165451|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0
1094730|NCT02293993|2165448|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
1094731|NCT02293993|2165449|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
1094732|NCT02293993|2165450|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1
1094733|NCT02293993|2165451|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
1094734|NCT02293993|2165448|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
1094735|NCT02293993|2165449|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
1094736|NCT02293993|2165450|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3
893332|NCT00683618|1863690|FG001|Randomised Treatment Period|Reason not provided|0
893333|NCT00683618|1863691|FG002|Randomised Treatment Period|Reason not provided|2
893334|NCT00683618|1863689|FG000|Extension Treatment Period|Withdrawal by Subject|1
1094737|NCT02293993|2165451|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1
1094738|NCT02293993|2165448|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
1094739|NCT02293993|2165449|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1
1094740|NCT02293993|2165450|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
1094741|NCT02293993|2165451|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
1094742|NCT02294019|2165469|FG000|Overall Study|Adverse Event|2
1094743|NCT02294019|2165469|FG000|Overall Study|Protocol Violation|68
1094744|NCT02294019|2165469|FG000|Overall Study|Lost to Follow-up|31
1094745|NCT02294019|2165469|FG000|Overall Study|Other|1
1094746|NCT02294019|2165469|FG000|Overall Study|Withdrawal by Subject|1
1094747|NCT02294058|2165476|FG000|Overall Study|Adverse Event|16
1094748|NCT02294058|2165477|FG001|Overall Study|Adverse Event|7
1094749|NCT02294058|2165478|FG002|Overall Study|Adverse Event|13
1094750|NCT02294058|2165476|FG000|Overall Study|Lack of Efficacy|3
1094751|NCT02294058|2165477|FG001|Overall Study|Lack of Efficacy|3
1094752|NCT02294058|2165478|FG002|Overall Study|Lack of Efficacy|0
1094753|NCT02294058|2165476|FG000|Overall Study|Lost to Follow-up|1
1094754|NCT02294058|2165477|FG001|Overall Study|Lost to Follow-up|0
1094755|NCT02294058|2165478|FG002|Overall Study|Lost to Follow-up|2
1094756|NCT02294058|2165476|FG000|Overall Study|Withdrawal by Subject|10
1094757|NCT02294058|2165477|FG001|Overall Study|Withdrawal by Subject|14
1094758|NCT02294058|2165478|FG002|Overall Study|Withdrawal by Subject|13
1094759|NCT02294058|2165476|FG000|Overall Study|Physician Decision|2
1094760|NCT02294058|2165477|FG001|Overall Study|Physician Decision|1
1094761|NCT02294058|2165478|FG002|Overall Study|Physician Decision|0
1094762|NCT02294058|2165476|FG000|Overall Study|Miscellaneous|4
1094763|NCT02294058|2165477|FG001|Overall Study|Miscellaneous|1
1094764|NCT02294058|2165478|FG002|Overall Study|Miscellaneous|1
1094765|NCT02294175|2165489|FG000|Overall Study|Withdrawal by Subject|1
1094766|NCT02294175|2165490|FG001|Overall Study|Withdrawal by Subject|2
1094767|NCT02294175|2165489|FG000|Overall Study|pt taking excluded medication|3
1094768|NCT02294175|2165490|FG001|Overall Study|pt taking excluded medication|1
1094769|NCT02294175|2165489|FG000|Overall Study|Protocol Violation|1
1094770|NCT02294175|2165490|FG001|Overall Study|Protocol Violation|0
1094771|NCT02294175|2165489|FG000|Overall Study|Lost to Follow-up|0
1094772|NCT02294175|2165490|FG001|Overall Study|Lost to Follow-up|1
1094773|NCT02294175|2165489|FG000|Overall Study|wound healed|0
1094774|NCT02294175|2165490|FG001|Overall Study|wound healed|2
1094775|NCT02294227|2165499|FG000|Overall Study|Death|0
1094776|NCT02294227|2165500|FG001|Overall Study|Death|0
1094777|NCT02294227|2165501|FG002|Overall Study|Death|1
1094778|NCT02294227|2165499|FG000|Overall Study|Subject/Guardian Decision|6
1094779|NCT02294227|2165500|FG001|Overall Study|Subject/Guardian Decision|3
1094780|NCT02294227|2165501|FG002|Overall Study|Subject/Guardian Decision|7
1094781|NCT02294227|2165499|FG000|Overall Study|Physician Decision|1
1094782|NCT02294227|2165500|FG001|Overall Study|Physician Decision|2
1094783|NCT02294227|2165501|FG002|Overall Study|Physician Decision|1
1094784|NCT02294227|2165499|FG000|Overall Study|Lost to Follow-up|1
1094785|NCT02294227|2165500|FG001|Overall Study|Lost to Follow-up|0
1094786|NCT02294227|2165501|FG002|Overall Study|Lost to Follow-up|0
1094787|NCT02294227|2165499|FG000|Overall Study|Lack of Efficacy|11
1094788|NCT02294227|2165500|FG001|Overall Study|Lack of Efficacy|12
1094789|NCT02294227|2165501|FG002|Overall Study|Lack of Efficacy|8
1094790|NCT02294227|2165499|FG000|Overall Study|Adverse Event|6
1094791|NCT02294227|2165500|FG001|Overall Study|Adverse Event|8
1094792|NCT02294227|2165501|FG002|Overall Study|Adverse Event|2
893335|NCT00683618|1863690|FG001|Extension Treatment Period|Withdrawal by Subject|0
893336|NCT00683618|1863691|FG002|Extension Treatment Period|Withdrawal by Subject|0
893337|NCT00683618|1863689|FG000|Extension Treatment Period|Adverse Event|1
893338|NCT00683618|1863690|FG001|Extension Treatment Period|Adverse Event|0
893339|NCT00683618|1863691|FG002|Extension Treatment Period|Adverse Event|0
893340|NCT00683618|1863689|FG000|Extension Treatment Period|Protocol Violation|1
893341|NCT00683618|1863690|FG001|Extension Treatment Period|Protocol Violation|0
893342|NCT00683618|1863691|FG002|Extension Treatment Period|Protocol Violation|0
893343|NCT00683644|1863703|FG000|Overall Study|Withdrawal by Subject|4
893344|NCT00683644|1863704|FG001|Overall Study|Withdrawal by Subject|2
893345|NCT00683644|1863703|FG000|Overall Study|Lost to Follow-up|1
893346|NCT00683644|1863704|FG001|Overall Study|Lost to Follow-up|4
893347|NCT00683644|1863703|FG000|Overall Study|Adverse Event|1
893348|NCT00683644|1863704|FG001|Overall Study|Adverse Event|2
893349|NCT00683644|1863703|FG000|Overall Study|Low copper, other health problems,|7
893350|NCT00683644|1863704|FG001|Overall Study|Low copper, other health problems,|6
893351|NCT00683657|1863716|FG000|Overall Study|Adverse Event|0
893352|NCT00683657|1863717|FG001|Overall Study|Adverse Event|1
893353|NCT00683657|1863716|FG000|Overall Study|Subject Withdrew Consent|1
893354|NCT00683657|1863717|FG001|Overall Study|Subject Withdrew Consent|0
893355|NCT00683696|1863725|FG000|Overall Study|Withdrawn due to study closure|337
1094793|NCT02294318|2165517|FG000|Overall Study|Worsening of drinking|3
1094794|NCT02294318|2165518|FG001|Overall Study|Worsening of drinking|0
1094795|NCT02294318|2165517|FG000|Overall Study|Not exposed to intervention|0
1094796|NCT02294318|2165518|FG001|Overall Study|Not exposed to intervention|2
1094797|NCT02294396|2165528|FG000|Overall Study|Adverse Event|26
1094798|NCT02294396|2165529|FG001|Overall Study|Adverse Event|25
1094799|NCT02294396|2165530|FG002|Overall Study|Adverse Event|21
1094800|NCT02294396|2165531|FG003|Overall Study|Adverse Event|24
1094801|NCT02294396|2165528|FG000|Overall Study|Electrocardiogram adviser's judgment|1
1094802|NCT02294396|2165529|FG001|Overall Study|Electrocardiogram adviser's judgment|0
1094803|NCT02294396|2165530|FG002|Overall Study|Electrocardiogram adviser's judgment|0
1094804|NCT02294396|2165531|FG003|Overall Study|Electrocardiogram adviser's judgment|1
1094805|NCT02294396|2165528|FG000|Overall Study|Withdrawal by Subject|8
1094806|NCT02294396|2165529|FG001|Overall Study|Withdrawal by Subject|6
1094807|NCT02294396|2165530|FG002|Overall Study|Withdrawal by Subject|6
1094808|NCT02294396|2165531|FG003|Overall Study|Withdrawal by Subject|8
1094809|NCT02294396|2165528|FG000|Overall Study|Lost to Follow-up|0
1094810|NCT02294396|2165529|FG001|Overall Study|Lost to Follow-up|0
1094811|NCT02294396|2165530|FG002|Overall Study|Lost to Follow-up|1
1094812|NCT02294396|2165531|FG003|Overall Study|Lost to Follow-up|1
1094813|NCT02294396|2165528|FG000|Overall Study|Protocol Deviation|3
1094814|NCT02294396|2165529|FG001|Overall Study|Protocol Deviation|2
1094815|NCT02294396|2165530|FG002|Overall Study|Protocol Deviation|2
1094816|NCT02294396|2165531|FG003|Overall Study|Protocol Deviation|1
1094817|NCT02294396|2165528|FG000|Overall Study|Miscellaneous|2
1094818|NCT02294396|2165529|FG001|Overall Study|Miscellaneous|0
1094819|NCT02294396|2165530|FG002|Overall Study|Miscellaneous|5
1094820|NCT02294396|2165531|FG003|Overall Study|Miscellaneous|2
1094821|NCT02294461|2165543|FG000|Overall Study|Death|3
1094822|NCT02294461|2165544|FG001|Overall Study|Death|3
1094823|NCT02294461|2165543|FG000|Overall Study|Protocol Violation|0
1094824|NCT02294461|2165544|FG001|Overall Study|Protocol Violation|2
1094825|NCT02294461|2165543|FG000|Overall Study|Withdrawal by Subject|14
1094826|NCT02294461|2165544|FG001|Overall Study|Withdrawal by Subject|45
1094827|NCT02294461|2165543|FG000|Overall Study|Disease Progression|23
1094828|NCT02294461|2165544|FG001|Overall Study|Disease Progression|39
1094829|NCT02294461|2165543|FG000|Overall Study|Adverse Event|11
1094830|NCT02294461|2165544|FG001|Overall Study|Adverse Event|10
1094831|NCT02294461|2165543|FG000|Overall Study|Miscellaneous|11
1094832|NCT02294461|2165544|FG001|Overall Study|Miscellaneous|32
1094833|NCT02294474|2165562|FG000|Overall Study|Adverse Event|7
1094834|NCT02294474|2165563|FG001|Overall Study|Adverse Event|7
1094835|NCT02294474|2165562|FG000|Overall Study|Lack of Efficacy|2
1094836|NCT02294474|2165563|FG001|Overall Study|Lack of Efficacy|1
1094837|NCT02294474|2165562|FG000|Overall Study|Protocol Violation|4
1094838|NCT02294474|2165563|FG001|Overall Study|Protocol Violation|2
1094839|NCT02294474|2165562|FG000|Overall Study|Other than specified above|12
1094840|NCT02294474|2165563|FG001|Overall Study|Other than specified above|12
1094841|NCT02294604|2165573|FG000|Overall Study|Did not provide samples for culture|0
1094842|NCT02294604|2165574|FG001|Overall Study|Did not provide samples for culture|1
1094843|NCT02294604|2165575|FG002|Overall Study|Did not provide samples for culture|0
1094844|NCT02294604|2165573|FG000|Overall Study|Culture contamination|1
1094845|NCT02294604|2165574|FG001|Overall Study|Culture contamination|2
1094846|NCT02294604|2165575|FG002|Overall Study|Culture contamination|0
1094847|NCT02294682|2165602|FG000|Overall Study|Could not swallow pills|1
1094848|NCT02294682|2165603|FG001|Overall Study|Could not swallow pills|0
1094849|NCT02294734|2165611|FG000|Overall Study|Adverse Event|5
1094850|NCT02294734|2165612|FG001|Overall Study|Adverse Event|5
1094851|NCT02294734|2165611|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1
1094852|NCT02294734|2165612|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0
1094853|NCT02294734|2165611|FG000|Overall Study|Lost to Follow-up|2
1094854|NCT02294734|2165612|FG001|Overall Study|Lost to Follow-up|0
1094855|NCT02294734|2165611|FG000|Overall Study|Physician Decision|2
1094856|NCT02294734|2165612|FG001|Overall Study|Physician Decision|1
1094857|NCT02294734|2165611|FG000|Overall Study|Withdrawal by Subject|4
1094858|NCT02294734|2165612|FG001|Overall Study|Withdrawal by Subject|2
1094859|NCT02294773|2165622|FG000|Overall Study|Withdrawal by Subject|0
1094860|NCT02294773|2165623|FG001|Overall Study|Withdrawal by Subject|2
1094861|NCT02294786|2165631|FG000|Overall Study|Withdrawal by Subject|0
1094862|NCT02294786|2165632|FG001|Overall Study|Withdrawal by Subject|1
1094863|NCT02294786|2165631|FG000|Overall Study|Physician Decision|6
1094864|NCT02294786|2165632|FG001|Overall Study|Physician Decision|7
1094865|NCT02294786|2165631|FG000|Overall Study|Lost to Follow-up|1
1094866|NCT02294786|2165632|FG001|Overall Study|Lost to Follow-up|2
1094867|NCT02294786|2165631|FG000|Overall Study|Protocol Violation|1
1094868|NCT02294786|2165632|FG001|Overall Study|Protocol Violation|0
1094869|NCT02294786|2165631|FG000|Overall Study|Adverse Event|1
1094870|NCT02294786|2165632|FG001|Overall Study|Adverse Event|1
1094871|NCT02294786|2165631|FG000|Overall Study|Death|2
1094872|NCT02294786|2165632|FG001|Overall Study|Death|3
1094873|NCT02295020|2165641|FG000|Overall Study|Adverse Event|0
1094874|NCT02295020|2165642|FG001|Overall Study|Adverse Event|1
1094875|NCT02295020|2165641|FG000|Overall Study|Withdrawal by Subject|3
1094876|NCT02295020|2165642|FG001|Overall Study|Withdrawal by Subject|2
1094877|NCT02295280|2165656|FG000|Overall Study|Adverse Event|0
1094878|NCT02295280|2165657|FG001|Overall Study|Adverse Event|1
1094879|NCT02295644|2165684|FG000|Overall Study|Did not meet inclusion criterion|0
1094880|NCT02295644|2165685|FG001|Overall Study|Did not meet inclusion criterion|0
1094881|NCT02295644|2165686|FG002|Overall Study|Did not meet inclusion criterion|1
1094882|NCT02295644|2165687|FG003|Overall Study|Did not meet inclusion criterion|2
1094883|NCT02295774|2165706|FG000|Overall Study|Physician Decision|1
1094884|NCT02295774|2165706|FG000|Overall Study|Withdrawal by Subject|2
1094885|NCT02295995|2165713|FG000|Overall Study|Lost to Follow-up|5
1094886|NCT02295995|2165714|FG001|Overall Study|Lost to Follow-up|1
1094887|NCT02296112|2165730|FG000|Overall Study|Disease progression|7
1094888|NCT02296112|2165730|FG000|Overall Study|Toxicity|1
1094889|NCT02296112|2165730|FG000|Overall Study|Began an alternate therapy|1
1094890|NCT02296125|2165741|FG000|Overall Study|Withdrawal by Subject|18
1094891|NCT02296125|2165742|FG001|Overall Study|Withdrawal by Subject|8
1094892|NCT02296125|2165743|FG002|Overall Study|Withdrawal by Subject|6
1094893|NCT02296125|2165744|FG003|Overall Study|Withdrawal by Subject|2
1094894|NCT02296125|2165741|FG000|Overall Study|Adverse Event|41
1094895|NCT02296125|2165742|FG001|Overall Study|Adverse Event|52
1094896|NCT02296125|2165743|FG002|Overall Study|Adverse Event|9
1094897|NCT02296125|2165744|FG003|Overall Study|Adverse Event|4
1094898|NCT02296125|2165741|FG000|Overall Study|Severe non-compliance to protocol|0
1094899|NCT02296125|2165742|FG001|Overall Study|Severe non-compliance to protocol|1
1094900|NCT02296125|2165743|FG002|Overall Study|Severe non-compliance to protocol|0
1094901|NCT02296125|2165744|FG003|Overall Study|Severe non-compliance to protocol|0
1094902|NCT02296125|2165741|FG000|Overall Study|Condition under investigation worsened|153
1094903|NCT02296125|2165742|FG001|Overall Study|Condition under investigation worsened|199
1094904|NCT02296125|2165743|FG002|Overall Study|Condition under investigation worsened|39
1094905|NCT02296125|2165744|FG003|Overall Study|Condition under investigation worsened|56
1094906|NCT02296125|2165741|FG000|Overall Study|Any reason not specifically recorded|6
1094907|NCT02296125|2165742|FG001|Overall Study|Any reason not specifically recorded|4
1094908|NCT02296125|2165743|FG002|Overall Study|Any reason not specifically recorded|2
1094909|NCT02296125|2165744|FG003|Overall Study|Any reason not specifically recorded|0
1094910|NCT02296138|2165757|FG000|Overall Study|Adverse Event|348
1094911|NCT02296138|2165758|FG001|Overall Study|Adverse Event|259
1094912|NCT02296138|2165757|FG000|Overall Study|Lack of Efficacy|59
1094913|NCT02296138|2165758|FG001|Overall Study|Lack of Efficacy|37
1094914|NCT02296138|2165757|FG000|Overall Study|Protocol Violation|35
1094915|NCT02296138|2165758|FG001|Overall Study|Protocol Violation|36
1094916|NCT02296138|2165757|FG000|Overall Study|Lost to Follow-up|9
1094917|NCT02296138|2165758|FG001|Overall Study|Lost to Follow-up|12
1094918|NCT02296138|2165757|FG000|Overall Study|Withdrawal by Subject|184
1094919|NCT02296138|2165758|FG001|Overall Study|Withdrawal by Subject|131
1094920|NCT02296138|2165757|FG000|Overall Study|Not Treated|1
1094921|NCT02296138|2165758|FG001|Overall Study|Not Treated|1
1094922|NCT02296138|2165757|FG000|Overall Study|Patients with data irregularities|10
1094923|NCT02296138|2165758|FG001|Overall Study|Patients with data irregularities|11
1094924|NCT02296138|2165757|FG000|Overall Study|Other than specified|15
1094925|NCT02296138|2165758|FG001|Overall Study|Other than specified|13
1094926|NCT02296190|2165774|FG000|Overall Study|Lost to Follow-up|0
1094927|NCT02296190|2165775|FG001|Overall Study|Lost to Follow-up|0
1094928|NCT02296190|2165776|FG002|Overall Study|Lost to Follow-up|0
1094929|NCT02296190|2165777|FG003|Overall Study|Lost to Follow-up|0
1094930|NCT02296190|2165778|FG004|Overall Study|Lost to Follow-up|1
1094931|NCT02296190|2165779|FG005|Overall Study|Lost to Follow-up|0
1094932|NCT02296190|2165774|FG000|Overall Study|Failure to induce PSVT|6
1094933|NCT02296190|2165775|FG001|Overall Study|Failure to induce PSVT|10
1094934|NCT02296190|2165776|FG002|Overall Study|Failure to induce PSVT|5
1094935|NCT02296190|2165777|FG003|Overall Study|Failure to induce PSVT|13
1094936|NCT02296190|2165778|FG004|Overall Study|Failure to induce PSVT|8
1094937|NCT02296190|2165779|FG005|Overall Study|Failure to induce PSVT|0
1094938|NCT02296190|2165774|FG000|Overall Study|Physician Decision|1
1094939|NCT02296190|2165775|FG001|Overall Study|Physician Decision|1
1094940|NCT02296190|2165776|FG002|Overall Study|Physician Decision|0
1094941|NCT02296190|2165777|FG003|Overall Study|Physician Decision|1
1094942|NCT02296190|2165778|FG004|Overall Study|Physician Decision|2
1094943|NCT02296190|2165779|FG005|Overall Study|Physician Decision|0
1094944|NCT02296190|2165774|FG000|Overall Study|Withdrawal by Subject|0
1094945|NCT02296190|2165775|FG001|Overall Study|Withdrawal by Subject|1
1094946|NCT02296190|2165776|FG002|Overall Study|Withdrawal by Subject|0
1094947|NCT02296190|2165777|FG003|Overall Study|Withdrawal by Subject|0
1094948|NCT02296190|2165778|FG004|Overall Study|Withdrawal by Subject|0
1094949|NCT02296190|2165779|FG005|Overall Study|Withdrawal by Subject|0
1094950|NCT02296190|2165774|FG000|Overall Study|PSVT < 5 minutes|5
1094951|NCT02296190|2165775|FG001|Overall Study|PSVT < 5 minutes|6
1094952|NCT02296190|2165776|FG002|Overall Study|PSVT < 5 minutes|6
1094953|NCT02296190|2165777|FG003|Overall Study|PSVT < 5 minutes|6
1094954|NCT02296190|2165778|FG004|Overall Study|PSVT < 5 minutes|5
1094955|NCT02296190|2165779|FG005|Overall Study|PSVT < 5 minutes|0
1094956|NCT02296190|2165774|FG000|Overall Study|Patient was given Propofol|0
1094957|NCT02296190|2165775|FG001|Overall Study|Patient was given Propofol|1
1094958|NCT02296190|2165776|FG002|Overall Study|Patient was given Propofol|0
1094959|NCT02296190|2165777|FG003|Overall Study|Patient was given Propofol|1
1094960|NCT02296190|2165778|FG004|Overall Study|Patient was given Propofol|0
1094961|NCT02296190|2165779|FG005|Overall Study|Patient was given Propofol|0
1094962|NCT02296190|2165774|FG000|Overall Study|Patient with Atrial Tachycardia|0
1094963|NCT02296190|2165775|FG001|Overall Study|Patient with Atrial Tachycardia|0
1094964|NCT02296190|2165776|FG002|Overall Study|Patient with Atrial Tachycardia|0
1094965|NCT02296190|2165777|FG003|Overall Study|Patient with Atrial Tachycardia|1
1094966|NCT02296190|2165778|FG004|Overall Study|Patient with Atrial Tachycardia|0
1094967|NCT02296190|2165779|FG005|Overall Study|Patient with Atrial Tachycardia|0
1094968|NCT02296190|2165774|FG000|Overall Study|Blood pressure <100 after sedation|0
1094969|NCT02296190|2165775|FG001|Overall Study|Blood pressure <100 after sedation|0
1094970|NCT02296190|2165776|FG002|Overall Study|Blood pressure <100 after sedation|0
1094971|NCT02296190|2165777|FG003|Overall Study|Blood pressure <100 after sedation|1
1094972|NCT02296190|2165778|FG004|Overall Study|Blood pressure <100 after sedation|0
1094973|NCT02296190|2165779|FG005|Overall Study|Blood pressure <100 after sedation|0
1094974|NCT02296190|2165774|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0
1094975|NCT02296190|2165775|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1
1094976|NCT02296190|2165776|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1
1094977|NCT02296190|2165777|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0
1094978|NCT02296190|2165778|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0
1094979|NCT02296190|2165779|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0
1094980|NCT02296190|2165774|FG000|Overall Study|Patient on antiarrhythmic medication|1
1094981|NCT02296190|2165775|FG001|Overall Study|Patient on antiarrhythmic medication|0
1094982|NCT02296190|2165776|FG002|Overall Study|Patient on antiarrhythmic medication|0
1094983|NCT02296190|2165777|FG003|Overall Study|Patient on antiarrhythmic medication|0
1094984|NCT02296190|2165778|FG004|Overall Study|Patient on antiarrhythmic medication|0
1094985|NCT02296190|2165779|FG005|Overall Study|Patient on antiarrhythmic medication|0
1094986|NCT02296190|2165774|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0
1094987|NCT02296190|2165775|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1
1094988|NCT02296190|2165776|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0
1094989|NCT02296190|2165777|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0
1094990|NCT02296190|2165778|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0
1094991|NCT02296190|2165779|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0
1094992|NCT02296190|2165774|FG000|Overall Study|Lab result not available in time|1
1094993|NCT02296190|2165775|FG001|Overall Study|Lab result not available in time|0
1094994|NCT02296190|2165776|FG002|Overall Study|Lab result not available in time|0
1094995|NCT02296190|2165777|FG003|Overall Study|Lab result not available in time|0
1094996|NCT02296190|2165778|FG004|Overall Study|Lab result not available in time|0
1094997|NCT02296190|2165779|FG005|Overall Study|Lab result not available in time|0
1094998|NCT02296242|2165797|FG000|Overall Study|Death|1
1094999|NCT02296242|2165798|FG001|Overall Study|Death|1
1095000|NCT02296242|2165799|FG002|Overall Study|Death|1
1095001|NCT02296242|2165800|FG003|Overall Study|Death|1
1095002|NCT02296242|2165801|FG004|Overall Study|Death|1
1095003|NCT02296242|2165797|FG000|Overall Study|Withdrawal by Subject|0
1095004|NCT02296242|2165798|FG001|Overall Study|Withdrawal by Subject|0
1095005|NCT02296242|2165799|FG002|Overall Study|Withdrawal by Subject|1
1095006|NCT02296242|2165800|FG003|Overall Study|Withdrawal by Subject|1
1095007|NCT02296242|2165801|FG004|Overall Study|Withdrawal by Subject|3
1095008|NCT02296242|2165797|FG000|Overall Study|Disease Progression|1
1095009|NCT02296242|2165798|FG001|Overall Study|Disease Progression|3
1095010|NCT02296242|2165799|FG002|Overall Study|Disease Progression|2
1095011|NCT02296242|2165800|FG003|Overall Study|Disease Progression|8
1095012|NCT02296242|2165801|FG004|Overall Study|Disease Progression|11
1095013|NCT02296242|2165797|FG000|Overall Study|Unacceptable Toxicity|0
1095014|NCT02296242|2165798|FG001|Overall Study|Unacceptable Toxicity|0
1095015|NCT02296242|2165799|FG002|Overall Study|Unacceptable Toxicity|0
1095016|NCT02296242|2165800|FG003|Overall Study|Unacceptable Toxicity|0
1095017|NCT02296242|2165801|FG004|Overall Study|Unacceptable Toxicity|1
1095018|NCT02296242|2165797|FG000|Overall Study|Patient Condition Changed|0
1095019|NCT02296242|2165798|FG001|Overall Study|Patient Condition Changed|0
1095020|NCT02296242|2165799|FG002|Overall Study|Patient Condition Changed|2
1095021|NCT02296242|2165800|FG003|Overall Study|Patient Condition Changed|0
1095022|NCT02296242|2165801|FG004|Overall Study|Patient Condition Changed|1
1095023|NCT02296242|2165797|FG000|Overall Study|At Least 3 Drug Interruptions|0
1095024|NCT02296242|2165798|FG001|Overall Study|At Least 3 Drug Interruptions|0
1095025|NCT02296242|2165799|FG002|Overall Study|At Least 3 Drug Interruptions|1
1095026|NCT02296242|2165800|FG003|Overall Study|At Least 3 Drug Interruptions|1
1095027|NCT02296242|2165801|FG004|Overall Study|At Least 3 Drug Interruptions|1
1095028|NCT02296242|2165797|FG000|Overall Study|Lost to Follow-up|1
1095029|NCT02296242|2165798|FG001|Overall Study|Lost to Follow-up|0
1095030|NCT02296242|2165799|FG002|Overall Study|Lost to Follow-up|0
1095031|NCT02296242|2165800|FG003|Overall Study|Lost to Follow-up|0
1095032|NCT02296242|2165801|FG004|Overall Study|Lost to Follow-up|0
1095033|NCT02296242|2165797|FG000|Overall Study|Need for Hydroxyurea|2
1095034|NCT02296242|2165798|FG001|Overall Study|Need for Hydroxyurea|0
1095035|NCT02296242|2165799|FG002|Overall Study|Need for Hydroxyurea|0
1095036|NCT02296242|2165800|FG003|Overall Study|Need for Hydroxyurea|0
1095037|NCT02296242|2165801|FG004|Overall Study|Need for Hydroxyurea|0
1095038|NCT02296242|2165797|FG000|Overall Study|Screened for Other Protocol|0
1095039|NCT02296242|2165798|FG001|Overall Study|Screened for Other Protocol|1
1095040|NCT02296242|2165799|FG002|Overall Study|Screened for Other Protocol|0
1095041|NCT02296242|2165800|FG003|Overall Study|Screened for Other Protocol|0
1095042|NCT02296242|2165801|FG004|Overall Study|Screened for Other Protocol|0
1095043|NCT02296242|2165797|FG000|Overall Study|Physician Decision|0
1095044|NCT02296242|2165798|FG001|Overall Study|Physician Decision|1
1095045|NCT02296242|2165799|FG002|Overall Study|Physician Decision|0
1095046|NCT02296242|2165800|FG003|Overall Study|Physician Decision|1
1095047|NCT02296242|2165801|FG004|Overall Study|Physician Decision|0
1095048|NCT02296242|2165797|FG000|Overall Study|Alternative Treatment|0
1095049|NCT02296242|2165798|FG001|Overall Study|Alternative Treatment|0
1095050|NCT02296242|2165799|FG002|Overall Study|Alternative Treatment|0
1095051|NCT02296242|2165800|FG003|Overall Study|Alternative Treatment|1
1095052|NCT02296242|2165801|FG004|Overall Study|Alternative Treatment|0
1095053|NCT02296242|2165797|FG000|Overall Study|Adverse Event|0
1095054|NCT02296242|2165798|FG001|Overall Study|Adverse Event|0
1095055|NCT02296242|2165799|FG002|Overall Study|Adverse Event|0
1095056|NCT02296242|2165800|FG003|Overall Study|Adverse Event|1
1095057|NCT02296242|2165801|FG004|Overall Study|Adverse Event|0
1095058|NCT02296242|2165797|FG000|Overall Study|Lack of Efficacy|0
1095059|NCT02296242|2165798|FG001|Overall Study|Lack of Efficacy|0
1095060|NCT02296242|2165799|FG002|Overall Study|Lack of Efficacy|0
1095061|NCT02296242|2165800|FG003|Overall Study|Lack of Efficacy|0
1095062|NCT02296242|2165801|FG004|Overall Study|Lack of Efficacy|3
1095063|NCT02296320|2165824|FG000|Overall Study|Withdrawal by Subject|4
1095064|NCT02296320|2165825|FG001|Overall Study|Withdrawal by Subject|0
1095065|NCT02296320|2165826|FG002|Overall Study|Withdrawal by Subject|2
1095066|NCT02296320|2165824|FG000|Overall Study|Death|24
1095067|NCT02296320|2165825|FG001|Overall Study|Death|3
1095068|NCT02296320|2165826|FG002|Overall Study|Death|27
1095069|NCT02296320|2165824|FG000|Overall Study|Lost to Follow-up|5
1095070|NCT02296320|2165825|FG001|Overall Study|Lost to Follow-up|2
1095071|NCT02296320|2165826|FG002|Overall Study|Lost to Follow-up|7
1095072|NCT02296320|2165824|FG000|Overall Study|Not treated|2
1095073|NCT02296320|2165825|FG001|Overall Study|Not treated|0
1095074|NCT02296320|2165826|FG002|Overall Study|Not treated|0
1095075|NCT02296320|2165824|FG000|Overall Study|Not - specified|0
1095076|NCT02296320|2165825|FG001|Overall Study|Not - specified|0
1095077|NCT02296320|2165826|FG002|Overall Study|Not - specified|1
1095078|NCT02296424|2165849|FG000|Part 1|New therapy for study indication|0
1095079|NCT02296424|2165850|FG001|Part 1|New therapy for study indication|1
1095080|NCT02296424|2165851|FG002|Part 1|New therapy for study indication|0
1095081|NCT02296424|2165852|FG003|Part 1|New therapy for study indication|0
1095082|NCT02296424|2165849|FG000|Part 1|Protocol Violation|0
1095083|NCT02296424|2165850|FG001|Part 1|Protocol Violation|1
1095084|NCT02296424|2165851|FG002|Part 1|Protocol Violation|0
1095085|NCT02296424|2165852|FG003|Part 1|Protocol Violation|0
1095086|NCT02296424|2165849|FG000|Part 1|Withdrawal by Subject|0
1095087|NCT02296424|2165850|FG001|Part 1|Withdrawal by Subject|2
1095088|NCT02296424|2165851|FG002|Part 1|Withdrawal by Subject|0
1095089|NCT02296424|2165852|FG003|Part 1|Withdrawal by Subject|0
1095090|NCT02296424|2165849|FG000|Part 1|Study terminated by sponsor|0
1095091|NCT02296424|2165850|FG001|Part 1|Study terminated by sponsor|1
1095092|NCT02296424|2165851|FG002|Part 1|Study terminated by sponsor|0
1095093|NCT02296424|2165852|FG003|Part 1|Study terminated by sponsor|0
1095094|NCT02296424|2165849|FG000|Part 1|Adverse Event|2
1095095|NCT02296424|2165850|FG001|Part 1|Adverse Event|11
1095096|NCT02296424|2165851|FG002|Part 1|Adverse Event|0
1095097|NCT02296424|2165852|FG003|Part 1|Adverse Event|0
1095098|NCT02296424|2165849|FG000|Part 1|Lack of Efficacy|5
1095099|NCT02296424|2165850|FG001|Part 1|Lack of Efficacy|17
1095100|NCT02296424|2165851|FG002|Part 1|Lack of Efficacy|0
1095101|NCT02296424|2165852|FG003|Part 1|Lack of Efficacy|0
1095102|NCT02296424|2165849|FG000|Part 1|16 directly started part II|16
1095103|NCT02296424|2165850|FG001|Part 1|16 directly started part II|0
1095104|NCT02296424|2165851|FG002|Part 1|16 directly started part II|0
1095105|NCT02296424|2165852|FG003|Part 1|16 directly started part II|0
1095106|NCT02296424|2165849|FG000|Part 2|Lack of Efficacy|0
1095107|NCT02296424|2165850|FG001|Part 2|Lack of Efficacy|0
1095108|NCT02296424|2165851|FG002|Part 2|Lack of Efficacy|1
1095109|NCT02296424|2165852|FG003|Part 2|Lack of Efficacy|0
1095110|NCT02296424|2165849|FG000|Part 2|Adverse Event|0
1095111|NCT02296424|2165850|FG001|Part 2|Adverse Event|0
1095112|NCT02296424|2165851|FG002|Part 2|Adverse Event|1
1095113|NCT02296424|2165852|FG003|Part 2|Adverse Event|0
1095114|NCT02296424|2165849|FG000|Part 2|Lost to Follow-up|0
1095115|NCT02296424|2165850|FG001|Part 2|Lost to Follow-up|0
1095116|NCT02296424|2165851|FG002|Part 2|Lost to Follow-up|1
1095117|NCT02296424|2165852|FG003|Part 2|Lost to Follow-up|0
1095118|NCT02296476|2165863|FG000|Overall Study|Disease Progression|6
1095119|NCT02296476|2165864|FG001|Overall Study|Disease Progression|4
1095120|NCT02296476|2165865|FG002|Overall Study|Disease Progression|2
1095121|NCT02296840|2165912|FG000|Overall Study|Adverse Event|1
1095122|NCT02296840|2165913|FG001|Overall Study|Adverse Event|1
1095123|NCT02296840|2165912|FG000|Overall Study|Protocol Violation|2
1095124|NCT02296840|2165913|FG001|Overall Study|Protocol Violation|1
1095125|NCT02296840|2165912|FG000|Overall Study|Lost to Follow-up|6
1095126|NCT02296840|2165913|FG001|Overall Study|Lost to Follow-up|17
1095127|NCT02296892|2165931|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7
1095128|NCT02296892|2165932|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4
1095129|NCT02296892|2165933|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4
1095130|NCT02296892|2165931|FG000|Overall Study|Lost to Follow-up|5
1095131|NCT02296892|2165932|FG001|Overall Study|Lost to Follow-up|0
1095132|NCT02296892|2165933|FG002|Overall Study|Lost to Follow-up|1
1095133|NCT02296931|2165943|FG000|Overall Study|Protocol Violation|0
1095134|NCT02296931|2165944|FG001|Overall Study|Protocol Violation|2
1095147|NCT02297503|2165984|FG000|Overall Study|Withdrawal by Subject|1
1095148|NCT02297503|2165985|FG001|Overall Study|Withdrawal by Subject|1
1095149|NCT02297503|2165984|FG000|Overall Study|Protocol Violation|1
1095150|NCT02297503|2165985|FG001|Overall Study|Protocol Violation|0
1095151|NCT02297503|2165984|FG000|Overall Study|Pregnancy|0
1095152|NCT02297503|2165985|FG001|Overall Study|Pregnancy|1
1095153|NCT02297503|2165984|FG000|Overall Study|Lost to Follow-up|0
1095154|NCT02297503|2165985|FG001|Overall Study|Lost to Follow-up|1
1095155|NCT02297503|2165984|FG000|Overall Study|Medical reason|0
1095156|NCT02297503|2165985|FG001|Overall Study|Medical reason|1
1095157|NCT02297516|2166002|FG000|Single Treatment Phase (6 Months)|Medical reason|1
1095158|NCT02297516|2166003|FG001|Single Treatment Phase (6 Months)|Medical reason|0
1095159|NCT02297516|2166002|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0
1095160|NCT02297516|2166003|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2
1095161|NCT02297516|2166002|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
1095162|NCT02297516|2166003|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
1095163|NCT02297815|2166018|FG000|Overall Study|Lost to Follow-up|236
1095164|NCT02297815|2166019|FG001|Overall Study|Lost to Follow-up|140
1095165|NCT02297841|2166027|FG000|Overall Study|Withdrawal by Subject|1
1095166|NCT02297841|2166027|FG000|Overall Study|Protocol Violation|7
1095167|NCT02298023|2166034|FG000|Overall Study|Withdrawal by Subject|1
1095168|NCT02298023|2166035|FG001|Overall Study|Withdrawal by Subject|0
1095169|NCT02298023|2166036|FG002|Overall Study|Withdrawal by Subject|0
1095170|NCT02298179|2166059|FG000|Overall Study|Lost to Follow-up|0
1095171|NCT02298179|2166060|FG001|Overall Study|Lost to Follow-up|0
1095172|NCT02298179|2166061|FG002|Overall Study|Lost to Follow-up|1
1095173|NCT02298179|2166062|FG003|Overall Study|Lost to Follow-up|0
1095174|NCT02298179|2166063|FG004|Overall Study|Lost to Follow-up|0
1095175|NCT02298179|2166064|FG005|Overall Study|Lost to Follow-up|0
1095176|NCT02298179|2166065|FG006|Overall Study|Lost to Follow-up|0
1095177|NCT02298179|2166066|FG007|Overall Study|Lost to Follow-up|1
1095178|NCT02298179|2166067|FG008|Overall Study|Lost to Follow-up|0
1095179|NCT02298179|2166068|FG009|Overall Study|Lost to Follow-up|0
1095180|NCT02298179|2166069|FG010|Overall Study|Lost to Follow-up|0
1095181|NCT02298179|2166070|FG011|Overall Study|Lost to Follow-up|0
1095182|NCT02298192|2166098|FG000|Overall Study|Unclassified|3
1095183|NCT02298192|2166099|FG001|Overall Study|Unclassified|2
1095184|NCT02298192|2166098|FG000|Overall Study|Withdrawal criteria|2
1095185|NCT02298192|2166099|FG001|Overall Study|Withdrawal criteria|0
1095186|NCT02298192|2166098|FG000|Overall Study|Withdrawal by Subject|6
1095187|NCT02298192|2166099|FG001|Overall Study|Withdrawal by Subject|1
1095188|NCT02298192|2166098|FG000|Overall Study|Lost to Follow-up|2
1095189|NCT02298192|2166099|FG001|Overall Study|Lost to Follow-up|1
1095190|NCT02298192|2166098|FG000|Overall Study|Adverse Event|6
1095191|NCT02298192|2166099|FG001|Overall Study|Adverse Event|2
1095192|NCT02298868|2166151|FG000|Overall Study|Adverse Event|1
1095193|NCT02298868|2166151|FG000|Overall Study|Death|1
1095194|NCT02298868|2166151|FG000|Overall Study|Patient underwent transplant|1
1095195|NCT02298946|2166161|FG000|Overall Study|Did not receive treatment|2
1095196|NCT02298946|2166162|FG001|Overall Study|Did not receive treatment|0
1095197|NCT02298946|2166161|FG000|Overall Study|Unevaluable|2
1095198|NCT02298946|2166162|FG001|Overall Study|Unevaluable|1
1095199|NCT02299076|2166175|FG000|Overall Study|Fraudulent Entries|20
1095200|NCT02299076|2166176|FG001|Overall Study|Fraudulent Entries|14
1095201|NCT02299167|2166220|FG000|Overall Study|patients were excluded from the study|11
1095202|NCT02299336|2166237|FG000|Overall Study|Withdrawal by Subject|11
1095203|NCT02299336|2166237|FG000|Overall Study|Adverse Event|1
1095204|NCT02299336|2166237|FG000|Overall Study|Death|1
1095205|NCT02299336|2166237|FG000|Overall Study|Lost to Follow-up|1
1095206|NCT02299375|2166252|FG000|Overall Study|Adverse Event, serious fatal|1
1095207|NCT02299375|2166253|FG001|Overall Study|Adverse Event, serious fatal|3
1095208|NCT02299375|2166252|FG000|Overall Study|Adverse Event, non-fatal|8
1095209|NCT02299375|2166253|FG001|Overall Study|Adverse Event, non-fatal|9
1095210|NCT02299375|2166252|FG000|Overall Study|Lack of Efficacy|1
1095211|NCT02299375|2166253|FG001|Overall Study|Lack of Efficacy|3
1095212|NCT02299375|2166252|FG000|Overall Study|Protocol Violation|1
1095213|NCT02299375|2166253|FG001|Overall Study|Protocol Violation|3
1095214|NCT02299375|2166252|FG000|Overall Study|Other: Met stopping criteria|1
1095215|NCT02299375|2166253|FG001|Overall Study|Other: Met stopping criteria|0
1095216|NCT02299375|2166252|FG000|Overall Study|Other: Study closed/terminated|66
1095217|NCT02299375|2166253|FG001|Overall Study|Other: Study closed/terminated|55
1095218|NCT02299375|2166252|FG000|Overall Study|Lost to Follow-up|0
1095219|NCT02299375|2166253|FG001|Overall Study|Lost to Follow-up|2
1095220|NCT02299375|2166252|FG000|Overall Study|Physician Decision|1
1095221|NCT02299375|2166253|FG001|Overall Study|Physician Decision|1
1095222|NCT02299375|2166252|FG000|Overall Study|Withdrawal by Subject|1
1095223|NCT02299375|2166253|FG001|Overall Study|Withdrawal by Subject|4
1095224|NCT02299388|2166262|FG000|Overall Study|Withdrawal by Subject|0
1095225|NCT02299388|2166263|FG001|Overall Study|Withdrawal by Subject|1
1095226|NCT02299427|2166271|FG000|Overall Study|Withdrawal by Subject|1
1095227|NCT02299427|2166272|FG001|Overall Study|Withdrawal by Subject|0
1095228|NCT02299427|2166271|FG000|Overall Study|Lost to Follow-up|1
1095229|NCT02299427|2166272|FG001|Overall Study|Lost to Follow-up|3
1095230|NCT02299427|2166271|FG000|Overall Study|not adherent to dog website use|21
1095231|NCT02299427|2166272|FG001|Overall Study|not adherent to dog website use|0
1095232|NCT02299635|2166300|FG000|Overall Study|Adverse Event|2
1095233|NCT02299635|2166300|FG000|Overall Study|Death|1
1095234|NCT02299635|2166300|FG000|Overall Study|Global deterioration of health status|1
1095235|NCT02299635|2166300|FG000|Overall Study|Objective progression or relapse|10
1095236|NCT02299635|2166300|FG000|Overall Study|Withdrawal by Subject|2
1095237|NCT02299635|2166300|FG000|Overall Study|Other|3
1095238|NCT02300103|2166358|FG000|Overall Study|Lack of Efficacy|3
1095239|NCT02300103|2166358|FG000|Overall Study|Protocol Violation|1
1095240|NCT02300103|2166358|FG000|Overall Study|Withdrew Consent|2
1095241|NCT02300129|2166362|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1095242|NCT02300129|2166363|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
1095243|NCT02300129|2166364|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1095244|NCT02300129|2166365|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1095245|NCT02300129|2166362|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1095246|NCT02300129|2166363|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1095247|NCT02300129|2166364|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1095248|NCT02300129|2166365|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
1095249|NCT02300129|2166362|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
1095250|NCT02300129|2166363|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1095251|NCT02300129|2166364|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1095252|NCT02300129|2166365|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1095253|NCT02300220|2166377|FG000|Overall Study|Lost to Follow-up|1
1095254|NCT02300220|2166378|FG001|Overall Study|Lost to Follow-up|2
1095255|NCT02300220|2166377|FG000|Overall Study|Death|1
1095256|NCT02300220|2166378|FG001|Overall Study|Death|1
1095257|NCT02300220|2166377|FG000|Overall Study|Adverse Event|1
1095258|NCT02300220|2166378|FG001|Overall Study|Adverse Event|1
1095259|NCT02300220|2166377|FG000|Overall Study|Protocol Violation|1
1095260|NCT02300220|2166378|FG001|Overall Study|Protocol Violation|0
1095261|NCT02300220|2166377|FG000|Overall Study|Withdrawal by Subject|0
1095262|NCT02300220|2166378|FG001|Overall Study|Withdrawal by Subject|2
1095263|NCT02300220|2166377|FG000|Overall Study|Did not tolerate IMP|0
1095264|NCT02300220|2166378|FG001|Overall Study|Did not tolerate IMP|1
1095265|NCT02300259|2166387|FG000|Period 1|Adverse Event|0
1095266|NCT02300259|2166388|FG001|Period 1|Adverse Event|0
1095267|NCT02300259|2166389|FG002|Period 1|Adverse Event|1
1095268|NCT02300259|2166387|FG000|Period 1|Withdrawal by Subject|0
1095269|NCT02300259|2166388|FG001|Period 1|Withdrawal by Subject|0
1095270|NCT02300259|2166389|FG002|Period 1|Withdrawal by Subject|1
1095271|NCT02300259|2166387|FG000|Period 2|Adverse Event|1
1095272|NCT02300259|2166388|FG001|Period 2|Adverse Event|0
1095273|NCT02300259|2166389|FG002|Period 2|Adverse Event|0
1095274|NCT02300259|2166387|FG000|Period 2|Withdrawal by Subject|0
1095275|NCT02300259|2166388|FG001|Period 2|Withdrawal by Subject|0
1095276|NCT02300259|2166389|FG002|Period 2|Withdrawal by Subject|1
1095277|NCT02300298|2166417|FG000|Disposition for Nintedanib|Progressive disease|10
1095278|NCT02300298|2166418|FG001|Disposition for Nintedanib|Progressive disease|0
1095279|NCT02300298|2166417|FG000|Disposition for Docetaxel|Progressive disease|0
1095280|NCT02300298|2166418|FG001|Disposition for Docetaxel|Progressive disease|6
1095281|NCT02300298|2166417|FG000|Disposition for Docetaxel|other adverse event|0
1095282|NCT02300298|2166418|FG001|Disposition for Docetaxel|other adverse event|4
1095283|NCT02300311|2166424|FG000|Overall Study|Other than the reason specified|1
1095284|NCT02300311|2166425|FG001|Overall Study|Other than the reason specified|0
1095285|NCT02300311|2166424|FG000|Overall Study|Refused to continue taking medication|18
1095286|NCT02300311|2166425|FG001|Overall Study|Refused to continue taking medication|0
1095287|NCT02300558|2166435|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
1095288|NCT02300558|2166435|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2
1095289|NCT02300558|2166435|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1
1095290|NCT02300558|2166435|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
1095291|NCT02300610|2166446|FG000|Overall Study|Withdrawal by Subject|1
1095292|NCT02300610|2166447|FG001|Overall Study|Withdrawal by Subject|0
1095293|NCT02300610|2166448|FG002|Overall Study|Withdrawal by Subject|1
1095294|NCT02300987|2166485|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1
1095295|NCT02300987|2166486|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0
893356|NCT00683696|1863726|FG001|Overall Study|Withdrawn due to study closure|338
1095296|NCT02300987|2166485|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2
1095297|NCT02300987|2166486|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0
1095298|NCT02300987|2166485|FG000|Primary Phase : Prior to Cross-over|progressive disease|3
1095299|NCT02300987|2166486|FG001|Primary Phase : Prior to Cross-over|progressive disease|2
1095300|NCT02300987|2166485|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1
1095301|NCT02300987|2166486|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0
1095302|NCT02300987|2166485|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0
1095303|NCT02300987|2166486|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1
1095304|NCT02301143|2166506|FG000|Induction Period|Enrolled But Not Treated|1
1095305|NCT02301143|2166507|FG001|Induction Period|Enrolled But Not Treated|0
1095306|NCT02301143|2166506|FG000|Induction Period|Death|1
1095307|NCT02301143|2166507|FG001|Induction Period|Death|0
1095308|NCT02301143|2166506|FG000|Induction Period|Adverse Event|22
1095309|NCT02301143|2166507|FG001|Induction Period|Adverse Event|0
1095310|NCT02301143|2166506|FG000|Induction Period|Progressive Disease|8
1095311|NCT02301143|2166507|FG001|Induction Period|Progressive Disease|0
1095312|NCT02301143|2166506|FG000|Induction Period|Withdrawal by Subject|3
1095313|NCT02301143|2166507|FG001|Induction Period|Withdrawal by Subject|0
1095314|NCT02301143|2166506|FG000|Induction Period|Noncompliance with Study Drug|1
1095315|NCT02301143|2166507|FG001|Induction Period|Noncompliance with Study Drug|0
1095316|NCT02301143|2166506|FG000|Induction Period|Physician Decision|4
1095317|NCT02301143|2166507|FG001|Induction Period|Physician Decision|0
1095318|NCT02301143|2166506|FG000|Induction Period|Symptomatic Deterioration|2
1095319|NCT02301143|2166507|FG001|Induction Period|Symptomatic Deterioration|0
1095320|NCT02301143|2166506|FG000|Induction Period|Protocol Violation|2
1095321|NCT02301143|2166507|FG001|Induction Period|Protocol Violation|0
1095322|NCT02301143|2166506|FG000|Induction Period|Other|1
1095323|NCT02301143|2166507|FG001|Induction Period|Other|0
1095324|NCT02301143|2166506|FG000|Investigator's Choice|Adverse Event|0
1095325|NCT02301143|2166507|FG001|Investigator's Choice|Adverse Event|3
1095326|NCT02301143|2166506|FG000|Investigator's Choice|Progressive Disease|0
1095327|NCT02301143|2166507|FG001|Investigator's Choice|Progressive Disease|3
1095328|NCT02301143|2166506|FG000|Investigator's Choice|Noncompliance With Study Drug|0
1095329|NCT02301143|2166507|FG001|Investigator's Choice|Noncompliance With Study Drug|1
1095330|NCT02301143|2166506|FG000|Investigator's Choice|Symptomatic Deterioration|0
1095331|NCT02301143|2166507|FG001|Investigator's Choice|Symptomatic Deterioration|1
1095332|NCT02301143|2166506|FG000|Investigator's Choice|Other|0
1095333|NCT02301143|2166507|FG001|Investigator's Choice|Other|1
1095334|NCT02301143|2166506|FG000|Investigator's Choice|Unresectable Surgery|0
1095335|NCT02301143|2166507|FG001|Investigator's Choice|Unresectable Surgery|1
1095336|NCT02301169|2166520|FG000|Overall Study|Adverse Event|1
1095337|NCT02301169|2166521|FG001|Overall Study|Adverse Event|0
1095338|NCT02301390|2166549|FG000|Overall Study|Withdrawal by Subject|3
1095339|NCT02301390|2166550|FG001|Overall Study|Withdrawal by Subject|5
1095340|NCT02301390|2166549|FG000|Overall Study|Protocol Violation|1
1095341|NCT02301390|2166550|FG001|Overall Study|Protocol Violation|0
1095342|NCT02301390|2166549|FG000|Overall Study|Physician Decision|1
1095343|NCT02301390|2166550|FG001|Overall Study|Physician Decision|0
1095344|NCT02301390|2166549|FG000|Overall Study|Lost to Follow-up|0
1095345|NCT02301390|2166550|FG001|Overall Study|Lost to Follow-up|1
1095346|NCT02301390|2166549|FG000|Overall Study|Death|2
1095347|NCT02301390|2166550|FG001|Overall Study|Death|2
1095348|NCT02301390|2166549|FG000|Overall Study|Procedure not completed|0
1095349|NCT02301390|2166550|FG001|Overall Study|Procedure not completed|4
1095350|NCT02301390|2166549|FG000|Overall Study|Missed multiple visits|1
1095351|NCT02301390|2166550|FG001|Overall Study|Missed multiple visits|1
1095352|NCT02301390|2166549|FG000|Overall Study|study terminated|2
1095353|NCT02301390|2166550|FG001|Overall Study|study terminated|0
1095354|NCT02301403|2166558|FG000|Overall Study|Withdrawal by Subject|28
1095355|NCT02301403|2166559|FG001|Overall Study|Withdrawal by Subject|41
1095356|NCT02301429|2166574|FG000|Overall Study|not acceptable vascular anatomy|3
1095357|NCT02301546|2166580|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7
1095358|NCT02301546|2166581|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8
1095359|NCT02301546|2166580|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10
1095360|NCT02301546|2166581|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7
1095361|NCT02301546|2166580|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1
1095362|NCT02301546|2166581|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0
1095363|NCT02301546|2166580|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
1095364|NCT02301546|2166581|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
1095365|NCT02301546|2166580|FG000|Long Term Effectiveness (~1 Year)|Death|2
1095366|NCT02301546|2166581|FG001|Long Term Effectiveness (~1 Year)|Death|0
1095367|NCT02301546|2166580|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6
1095368|NCT02301546|2166581|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2
1095369|NCT02301546|2166580|FG000|Long Term Effectiveness (~1 Year)|moved away|1
1095370|NCT02301546|2166581|FG001|Long Term Effectiveness (~1 Year)|moved away|2
1095371|NCT02301624|2166589|FG000|Blind Induction Phase|Withdrawal by Subject|1
1095372|NCT02301624|2166590|FG001|Blind Induction Phase|Withdrawal by Subject|0
1095373|NCT02301624|2166589|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4
1095374|NCT02301624|2166590|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8
1095375|NCT02301624|2166589|FG000|Open-label Maintenance Phase|Adverse Event|2
1095376|NCT02301624|2166590|FG001|Open-label Maintenance Phase|Adverse Event|5
1095377|NCT02301624|2166589|FG000|Open-label Maintenance Phase|Physician Decision|3
1095378|NCT02301624|2166590|FG001|Open-label Maintenance Phase|Physician Decision|3
1095379|NCT02301624|2166589|FG000|Open-label Maintenance Phase|Death|2
1095380|NCT02301624|2166590|FG001|Open-label Maintenance Phase|Death|1
1095381|NCT02301624|2166589|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1
1095382|NCT02301624|2166590|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0
1095383|NCT02301897|2166609|FG000|Treatment Course 1|Non-Compliance|0
1095384|NCT02301897|2166610|FG001|Treatment Course 1|Non-Compliance|0
1095385|NCT02301897|2166611|FG002|Treatment Course 1|Non-Compliance|1
1095386|NCT02301897|2166609|FG000|Treatment Course 1|Adverse Event|1
1095387|NCT02301897|2166610|FG001|Treatment Course 1|Adverse Event|1
1095388|NCT02301897|2166611|FG002|Treatment Course 1|Adverse Event|0
1095389|NCT02301897|2166609|FG000|Treatment Course 1|Lost to Follow-up|1
1095390|NCT02301897|2166610|FG001|Treatment Course 1|Lost to Follow-up|2
1095391|NCT02301897|2166611|FG002|Treatment Course 1|Lost to Follow-up|1
1095392|NCT02301897|2166609|FG000|Treatment Course 1|Withdrawal by Sponsor|0
1095393|NCT02301897|2166610|FG001|Treatment Course 1|Withdrawal by Sponsor|0
1095394|NCT02301897|2166611|FG002|Treatment Course 1|Withdrawal by Sponsor|2
1095395|NCT02301897|2166609|FG000|Treatment Course 1|Withdrawal by Subject|0
1095396|NCT02301897|2166610|FG001|Treatment Course 1|Withdrawal by Subject|0
1095397|NCT02301897|2166611|FG002|Treatment Course 1|Withdrawal by Subject|2
1095398|NCT02301897|2166609|FG000|Treatment Course 1|Other Miscellaneous Reasons|1
1095399|NCT02301897|2166610|FG001|Treatment Course 1|Other Miscellaneous Reasons|0
1095400|NCT02301897|2166611|FG002|Treatment Course 1|Other Miscellaneous Reasons|0
1095401|NCT02301897|2166609|FG000|Treatment Course 2|Lost to Follow-up|0
1095402|NCT02301897|2166610|FG001|Treatment Course 2|Lost to Follow-up|2
1095403|NCT02301897|2166611|FG002|Treatment Course 2|Lost to Follow-up|0
1095404|NCT02301897|2166609|FG000|Treatment Course 2|Pregnancy|0
1095405|NCT02301897|2166610|FG001|Treatment Course 2|Pregnancy|1
1095406|NCT02301897|2166611|FG002|Treatment Course 2|Pregnancy|1
1095407|NCT02301897|2166609|FG000|Treatment Course 2|Withdrawal by Subject|0
1095408|NCT02301897|2166610|FG001|Treatment Course 2|Withdrawal by Subject|2
1095409|NCT02301897|2166611|FG002|Treatment Course 2|Withdrawal by Subject|0
1095410|NCT02301897|2166609|FG000|Treatment Course 2|Other Miscellaneous Reasons|1
1095411|NCT02301897|2166610|FG001|Treatment Course 2|Other Miscellaneous Reasons|0
1095412|NCT02301897|2166611|FG002|Treatment Course 2|Other Miscellaneous Reasons|0
1095413|NCT02301936|2166621|FG000|Overall Study|Lost to Follow-up|1
1095414|NCT02301936|2166622|FG001|Overall Study|Lost to Follow-up|0
1095415|NCT02301975|2166631|FG000|Overall Study|Adverse Event|8
1095416|NCT02301975|2166632|FG001|Overall Study|Adverse Event|3
1095417|NCT02301975|2166633|FG002|Overall Study|Adverse Event|2
1095418|NCT02301975|2166631|FG000|Overall Study|Lack of Efficacy|1
1095419|NCT02301975|2166632|FG001|Overall Study|Lack of Efficacy|1
1095420|NCT02301975|2166633|FG002|Overall Study|Lack of Efficacy|1
1095421|NCT02301975|2166631|FG000|Overall Study|Protocol Violation|3
1095422|NCT02301975|2166632|FG001|Overall Study|Protocol Violation|5
1095423|NCT02301975|2166633|FG002|Overall Study|Protocol Violation|3
1095424|NCT02301975|2166631|FG000|Overall Study|Lost to Follow-up|0
1095425|NCT02301975|2166632|FG001|Overall Study|Lost to Follow-up|2
1095426|NCT02301975|2166633|FG002|Overall Study|Lost to Follow-up|2
1095427|NCT02301975|2166631|FG000|Overall Study|Physician Decision|4
1095428|NCT02301975|2166632|FG001|Overall Study|Physician Decision|2
1095429|NCT02301975|2166633|FG002|Overall Study|Physician Decision|3
1095430|NCT02301975|2166631|FG000|Overall Study|Withdrawal by Subject|15
1095431|NCT02301975|2166632|FG001|Overall Study|Withdrawal by Subject|12
1095432|NCT02301975|2166633|FG002|Overall Study|Withdrawal by Subject|11
1095433|NCT02301988|2166643|FG000|Overall Study|Withdrawal by Subject|2
1095434|NCT02301988|2166644|FG001|Overall Study|Withdrawal by Subject|1
1095435|NCT02301988|2166643|FG000|Overall Study|Physician Decision|2
1095436|NCT02301988|2166644|FG001|Overall Study|Physician Decision|2
1095437|NCT02301988|2166643|FG000|Overall Study|Unknown Reason|1
1095438|NCT02301988|2166644|FG001|Overall Study|Unknown Reason|3
1095439|NCT02301988|2166643|FG000|Overall Study|Lack of Efficacy|3
1095440|NCT02301988|2166644|FG001|Overall Study|Lack of Efficacy|2
1095441|NCT02301988|2166643|FG000|Overall Study|Death|1
1095442|NCT02301988|2166644|FG001|Overall Study|Death|0
1095443|NCT02301988|2166643|FG000|Overall Study|Adverse Event|1
1095444|NCT02301988|2166644|FG001|Overall Study|Adverse Event|1
1095445|NCT02302066|2166654|FG000|Overall Study|Adverse Event|1
1095446|NCT02302066|2166655|FG001|Overall Study|Adverse Event|1
1095447|NCT02302066|2166656|FG002|Overall Study|Adverse Event|3
1095448|NCT02302066|2166657|FG003|Overall Study|Adverse Event|0
1095449|NCT02302066|2166654|FG000|Overall Study|Lost to Follow-up|4
1095450|NCT02302066|2166655|FG001|Overall Study|Lost to Follow-up|5
1095451|NCT02302066|2166656|FG002|Overall Study|Lost to Follow-up|24
1095452|NCT02302066|2166657|FG003|Overall Study|Lost to Follow-up|7
1095453|NCT02302066|2166654|FG000|Overall Study|Withdrawal by Subject|25
1095454|NCT02302066|2166655|FG001|Overall Study|Withdrawal by Subject|58
1095455|NCT02302066|2166656|FG002|Overall Study|Withdrawal by Subject|124
1095456|NCT02302066|2166657|FG003|Overall Study|Withdrawal by Subject|33
1095457|NCT02302066|2166654|FG000|Overall Study|Pregnancy|2
1095458|NCT02302066|2166655|FG001|Overall Study|Pregnancy|10
1095459|NCT02302066|2166656|FG002|Overall Study|Pregnancy|12
1095460|NCT02302066|2166657|FG003|Overall Study|Pregnancy|0
1095461|NCT02302066|2166654|FG000|Overall Study|Reason Not Specified|1
1095462|NCT02302066|2166655|FG001|Overall Study|Reason Not Specified|1
1095463|NCT02302066|2166656|FG002|Overall Study|Reason Not Specified|9
1095464|NCT02302066|2166657|FG003|Overall Study|Reason Not Specified|1
1095465|NCT02302222|2166714|FG000|Overall Study|Physician Decision|0
1095466|NCT02302222|2166715|FG001|Overall Study|Physician Decision|4
1095467|NCT02302222|2166714|FG000|Overall Study|Lost to Follow-up|1
1095468|NCT02302222|2166715|FG001|Overall Study|Lost to Follow-up|0
1095469|NCT02302222|2166714|FG000|Overall Study|Treatment discontinued before day 5|0
1095470|NCT02302222|2166715|FG001|Overall Study|Treatment discontinued before day 5|1
1095471|NCT02302222|2166714|FG000|Overall Study|Withdrawn prior to any treatment|0
1095472|NCT02302222|2166715|FG001|Overall Study|Withdrawn prior to any treatment|1
1095473|NCT02302339|2166725|FG000|Overall Study|Lost to Follow-up|1
1095474|NCT02302339|2166726|FG001|Overall Study|Lost to Follow-up|0
1095475|NCT02302339|2166727|FG002|Overall Study|Lost to Follow-up|0
1095476|NCT02302339|2166728|FG003|Overall Study|Lost to Follow-up|0
1095477|NCT02302339|2166725|FG000|Overall Study|Withdrawal by Subject|0
1095478|NCT02302339|2166726|FG001|Overall Study|Withdrawal by Subject|2
1095479|NCT02302339|2166727|FG002|Overall Study|Withdrawal by Subject|1
1095480|NCT02302339|2166728|FG003|Overall Study|Withdrawal by Subject|0
1095481|NCT02302716|2166749|FG000|Overall Study|Adverse Event|1
1095482|NCT02302716|2166750|FG001|Overall Study|Adverse Event|1
1095483|NCT02302716|2166749|FG000|Overall Study|Death|0
1095484|NCT02302716|2166750|FG001|Overall Study|Death|1
1095485|NCT02302716|2166749|FG000|Overall Study|Lack of Efficacy|0
1095486|NCT02302716|2166750|FG001|Overall Study|Lack of Efficacy|1
1095487|NCT02302716|2166749|FG000|Overall Study|Lost to Follow-up|2
1095488|NCT02302716|2166750|FG001|Overall Study|Lost to Follow-up|4
1095489|NCT02302716|2166749|FG000|Overall Study|Physician Decision|3
1095490|NCT02302716|2166750|FG001|Overall Study|Physician Decision|4
1095491|NCT02302716|2166749|FG000|Overall Study|Withdrawal by Subject|13
1095492|NCT02302716|2166750|FG001|Overall Study|Withdrawal by Subject|7
1095493|NCT02302716|2166749|FG000|Overall Study|Protocol Violation|0
1095494|NCT02302716|2166750|FG001|Overall Study|Protocol Violation|1
1095495|NCT02302807|2166758|FG000|Overall Study|Withdrawal by Subject|28
1095496|NCT02302807|2166759|FG001|Overall Study|Withdrawal by Subject|11
1095497|NCT02302807|2166758|FG000|Overall Study|Lost to Follow-up|4
1095498|NCT02302807|2166759|FG001|Overall Study|Lost to Follow-up|6
1095499|NCT02302807|2166758|FG000|Overall Study|Death|397
1095500|NCT02302807|2166759|FG001|Overall Study|Death|385
1095501|NCT02302807|2166758|FG000|Overall Study|Study Terminated By Sponsor|35
1095502|NCT02302807|2166759|FG001|Overall Study|Study Terminated By Sponsor|64
1095503|NCT02302807|2166758|FG000|Overall Study|Physician Decision|0
1095504|NCT02302807|2166759|FG001|Overall Study|Physician Decision|1
1095505|NCT02302846|2166778|FG000|Overall Study|Withdrawal by Subject|1
1095506|NCT02303041|2166784|FG000|Overall Study|Adverse Event|1
1095507|NCT02303041|2166785|FG001|Overall Study|Adverse Event|2
1095508|NCT02303262|2166816|FG000|Overall Study|Withdrawal by Subject|2
1095509|NCT02303574|2166841|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1095510|NCT02303574|2166842|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1095511|NCT02303574|2166843|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
1095512|NCT02303574|2166844|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1095513|NCT02303574|2166845|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1095514|NCT02303574|2166846|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1095515|NCT02303574|2166847|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1095516|NCT02303574|2166848|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1095517|NCT02303574|2166849|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1095518|NCT02303574|2166850|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1095519|NCT02303574|2166841|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1095520|NCT02303574|2166842|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1095521|NCT02303574|2166843|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1095522|NCT02303574|2166844|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1095523|NCT02303574|2166845|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1095524|NCT02303574|2166846|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1095525|NCT02303574|2166847|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1095526|NCT02303574|2166848|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
1095527|NCT02303574|2166849|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1095528|NCT02303574|2166850|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1095529|NCT02303704|2166885|FG000|Overall Study|Protocol Violation|5
1095530|NCT02303704|2166886|FG001|Overall Study|Protocol Violation|9
1095531|NCT02304367|2166919|FG000|Overall Study|Lack of Phosphorus Increase|1
1095532|NCT02304367|2166919|FG000|Overall Study|Sponsor Decision|3
1095533|NCT02304367|2166919|FG000|Overall Study|Death|1
1095534|NCT02304367|2166919|FG000|Overall Study|Ongoing in Study|12
1095535|NCT02304380|2166936|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
1095536|NCT02304380|2166937|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
1095537|NCT02304380|2166938|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
1095538|NCT02304380|2166939|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34
1095539|NCT02304380|2166940|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
1095540|NCT02304380|2166941|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
1095541|NCT02304484|2166977|FG000|Overall Study|Death|9
1095542|NCT02304484|2166977|FG000|Overall Study|Withdrawal by Subject|14
1095543|NCT02304484|2166977|FG000|Overall Study|Lost to Follow-up|2
1095544|NCT02304705|2166983|FG000|Overall Study|Withdrawal by Subject|2
1095545|NCT02304705|2166984|FG001|Overall Study|Withdrawal by Subject|0
1095546|NCT02304705|2166983|FG000|Overall Study|Physician Decision|2
1095547|NCT02304705|2166984|FG001|Overall Study|Physician Decision|4
1095548|NCT02304705|2166983|FG000|Overall Study|Death|0
1095549|NCT02304705|2166984|FG001|Overall Study|Death|1
1095550|NCT02304705|2166983|FG000|Overall Study|Lost to Follow-up|0
1095551|NCT02304705|2166984|FG001|Overall Study|Lost to Follow-up|2
1095552|NCT02304926|2167001|FG000|Overall Study|Lost to Follow-up|2
1095553|NCT02304926|2167002|FG001|Overall Study|Lost to Follow-up|1
1095554|NCT02305238|2167026|FG000|Overall Study|Death|2
1095555|NCT02305238|2167027|FG001|Overall Study|Death|1
1095556|NCT02305238|2167028|FG002|Overall Study|Death|0
1095557|NCT02305238|2167026|FG000|Overall Study|Progressive disease|4
1095558|NCT02305238|2167027|FG001|Overall Study|Progressive disease|4
1095559|NCT02305238|2167028|FG002|Overall Study|Progressive disease|0
1095560|NCT02305238|2167026|FG000|Overall Study|Logistical difficulties|1
1095561|NCT02305238|2167027|FG001|Overall Study|Logistical difficulties|3
1095562|NCT02305238|2167028|FG002|Overall Study|Logistical difficulties|0
1095563|NCT02305238|2167026|FG000|Overall Study|Protocol Violation|0
1095564|NCT02305238|2167027|FG001|Overall Study|Protocol Violation|3
1095565|NCT02305238|2167028|FG002|Overall Study|Protocol Violation|0
1095566|NCT02305238|2167026|FG000|Overall Study|Physician Decision|2
1095567|NCT02305238|2167027|FG001|Overall Study|Physician Decision|1
1095568|NCT02305238|2167028|FG002|Overall Study|Physician Decision|0
1095569|NCT02305238|2167026|FG000|Overall Study|Adverse Event|4
1095570|NCT02305238|2167027|FG001|Overall Study|Adverse Event|2
1095571|NCT02305238|2167028|FG002|Overall Study|Adverse Event|0
1095572|NCT02305238|2167026|FG000|Overall Study|Withdrawal by Subject|3
1095573|NCT02305238|2167027|FG001|Overall Study|Withdrawal by Subject|4
1095574|NCT02305238|2167028|FG002|Overall Study|Withdrawal by Subject|0
1095575|NCT02305238|2167026|FG000|Overall Study|Randomized failure|0
1095576|NCT02305238|2167027|FG001|Overall Study|Randomized failure|0
1095577|NCT02305238|2167028|FG002|Overall Study|Randomized failure|8
1095578|NCT02305238|2167026|FG000|Overall Study|Required procedure failed|0
1095579|NCT02305238|2167027|FG001|Overall Study|Required procedure failed|1
1095580|NCT02305238|2167028|FG002|Overall Study|Required procedure failed|0
1095581|NCT02305381|2167089|FG000|Overall Study|Unclassified|5
1095582|NCT02305381|2167090|FG001|Overall Study|Unclassified|5
1095583|NCT02305381|2167091|FG002|Overall Study|Unclassified|7
1095584|NCT02305446|2167099|FG000|Overall Study|Adverse Event|1
1095585|NCT02305563|2167108|FG000|Treatment Period|Disease progression|0
1095586|NCT02305563|2167109|FG001|Treatment Period|Disease progression|0
1095587|NCT02305563|2167110|FG002|Treatment Period|Disease progression|15
1095588|NCT02305563|2167111|FG003|Treatment Period|Disease progression|6
1095589|NCT02305563|2167112|FG004|Treatment Period|Disease progression|6
1095590|NCT02305563|2167108|FG000|Treatment Period|Study drug toxicity|0
1095591|NCT02305563|2167109|FG001|Treatment Period|Study drug toxicity|0
1095592|NCT02305563|2167110|FG002|Treatment Period|Study drug toxicity|0
1095593|NCT02305563|2167111|FG003|Treatment Period|Study drug toxicity|1
1095594|NCT02305563|2167112|FG004|Treatment Period|Study drug toxicity|2
1095595|NCT02305563|2167108|FG000|Treatment Period|Death|0
1095596|NCT02305563|2167109|FG001|Treatment Period|Death|0
1095597|NCT02305563|2167110|FG002|Treatment Period|Death|1
1095598|NCT02305563|2167111|FG003|Treatment Period|Death|2
1095599|NCT02305563|2167112|FG004|Treatment Period|Death|1
1095600|NCT02305563|2167108|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0
1095601|NCT02305563|2167109|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0
1095602|NCT02305563|2167110|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7
1095603|NCT02305563|2167111|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1
1095604|NCT02305563|2167112|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2
1095605|NCT02305563|2167108|FG000|Treatment Period|Participant request to stop therapy|0
1095606|NCT02305563|2167109|FG001|Treatment Period|Participant request to stop therapy|2
1095607|NCT02305563|2167110|FG002|Treatment Period|Participant request to stop therapy|0
1095608|NCT02305563|2167111|FG003|Treatment Period|Participant request to stop therapy|1
1095609|NCT02305563|2167112|FG004|Treatment Period|Participant request to stop therapy|0
1095610|NCT02305563|2167108|FG000|Treatment Period|Participant withdrew consent|0
1095611|NCT02305563|2167109|FG001|Treatment Period|Participant withdrew consent|0
1095612|NCT02305563|2167110|FG002|Treatment Period|Participant withdrew consent|1
1095613|NCT02305563|2167111|FG003|Treatment Period|Participant withdrew consent|1
1095614|NCT02305563|2167112|FG004|Treatment Period|Participant withdrew consent|1
1095615|NCT02305563|2167108|FG000|Treatment Period|Maximum clinical benefit|0
1095616|NCT02305563|2167109|FG001|Treatment Period|Maximum clinical benefit|0
1095617|NCT02305563|2167110|FG002|Treatment Period|Maximum clinical benefit|0
1095618|NCT02305563|2167111|FG003|Treatment Period|Maximum clinical benefit|0
1095619|NCT02305563|2167112|FG004|Treatment Period|Maximum clinical benefit|1
1095620|NCT02305563|2167108|FG000|Treatment Period|Poor/non-compliance|0
1095621|NCT02305563|2167109|FG001|Treatment Period|Poor/non-compliance|0
1095622|NCT02305563|2167110|FG002|Treatment Period|Poor/non-compliance|0
1095623|NCT02305563|2167111|FG003|Treatment Period|Poor/non-compliance|0
1095624|NCT02305563|2167112|FG004|Treatment Period|Poor/non-compliance|1
1095625|NCT02305563|2167108|FG000|Treatment Period|Administrative reason by Sponsor|0
1095626|NCT02305563|2167109|FG001|Treatment Period|Administrative reason by Sponsor|0
1095627|NCT02305563|2167110|FG002|Treatment Period|Administrative reason by Sponsor|0
1095628|NCT02305563|2167111|FG003|Treatment Period|Administrative reason by Sponsor|0
1095629|NCT02305563|2167112|FG004|Treatment Period|Administrative reason by Sponsor|1
1095630|NCT02305563|2167108|FG000|Treatment Period|other reason|2
1095631|NCT02305563|2167109|FG001|Treatment Period|other reason|0
1095632|NCT02305563|2167110|FG002|Treatment Period|other reason|2
1095633|NCT02305563|2167111|FG003|Treatment Period|other reason|2
1095634|NCT02305563|2167112|FG004|Treatment Period|other reason|1
1095635|NCT02305563|2167108|FG000|Treatment Period|Randomized but not treated|0
1095636|NCT02305563|2167109|FG001|Treatment Period|Randomized but not treated|0
1095637|NCT02305563|2167110|FG002|Treatment Period|Randomized but not treated|0
1095638|NCT02305563|2167111|FG003|Treatment Period|Randomized but not treated|0
1095639|NCT02305563|2167112|FG004|Treatment Period|Randomized but not treated|2
1095640|NCT02305563|2167108|FG000|Treatment Period|added ULO, then disease progression|0
1095641|NCT02305563|2167109|FG001|Treatment Period|added ULO, then disease progression|0
1095642|NCT02305563|2167110|FG002|Treatment Period|added ULO, then disease progression|0
1095643|NCT02305563|2167111|FG003|Treatment Period|added ULO, then disease progression|0
1095644|NCT02305563|2167112|FG004|Treatment Period|added ULO, then disease progression|4
1095645|NCT02305563|2167108|FG000|Treatment Period|added ULO; then other reason|0
1095646|NCT02305563|2167109|FG001|Treatment Period|added ULO; then other reason|0
1095647|NCT02305563|2167110|FG002|Treatment Period|added ULO; then other reason|0
1095648|NCT02305563|2167111|FG003|Treatment Period|added ULO; then other reason|0
1095649|NCT02305563|2167112|FG004|Treatment Period|added ULO; then other reason|1
1095650|NCT02305563|2167108|FG000|Treatment Period|added ULO, then request to stop|0
1095651|NCT02305563|2167109|FG001|Treatment Period|added ULO, then request to stop|0
1095652|NCT02305563|2167110|FG002|Treatment Period|added ULO, then request to stop|0
1095653|NCT02305563|2167111|FG003|Treatment Period|added ULO, then request to stop|0
1095654|NCT02305563|2167112|FG004|Treatment Period|added ULO, then request to stop|1
1095655|NCT02305563|2167108|FG000|Follow-up Period|Death|0
1095656|NCT02305563|2167109|FG001|Follow-up Period|Death|0
1095657|NCT02305563|2167110|FG002|Follow-up Period|Death|5
1095658|NCT02305563|2167111|FG003|Follow-up Period|Death|4
1095659|NCT02305563|2167112|FG004|Follow-up Period|Death|7
1095660|NCT02305563|2167108|FG000|Follow-up Period|Participant withdrew consent|0
1095661|NCT02305563|2167109|FG001|Follow-up Period|Participant withdrew consent|0
1095662|NCT02305563|2167110|FG002|Follow-up Period|Participant withdrew consent|2
1095663|NCT02305563|2167111|FG003|Follow-up Period|Participant withdrew consent|1
1095664|NCT02305563|2167112|FG004|Follow-up Period|Participant withdrew consent|0
1095665|NCT02305563|2167108|FG000|Follow-up Period|other reason|0
1095666|NCT02305563|2167109|FG001|Follow-up Period|other reason|0
1095667|NCT02305563|2167110|FG002|Follow-up Period|other reason|0
1095668|NCT02305563|2167111|FG003|Follow-up Period|other reason|0
1095669|NCT02305563|2167112|FG004|Follow-up Period|other reason|1
1095670|NCT02305563|2167108|FG000|Follow-up Period|Followup no longer required per protocol|3
1095671|NCT02305563|2167109|FG001|Follow-up Period|Followup no longer required per protocol|3
1095672|NCT02305563|2167110|FG002|Follow-up Period|Followup no longer required per protocol|4
1095673|NCT02305563|2167111|FG003|Follow-up Period|Followup no longer required per protocol|1
1095674|NCT02305563|2167112|FG004|Follow-up Period|Followup no longer required per protocol|4
1095675|NCT02305758|2167135|FG000|Overall Study|Death|27
1095676|NCT02305758|2167136|FG001|Overall Study|Death|27
1095677|NCT02305758|2167135|FG000|Overall Study|Withdrew consent|9
1095678|NCT02305758|2167136|FG001|Overall Study|Withdrew consent|2
1095679|NCT02305758|2167135|FG000|Overall Study|Lost to Follow-up|6
1095680|NCT02305758|2167136|FG001|Overall Study|Lost to Follow-up|1
1095681|NCT02305758|2167135|FG000|Overall Study|Study Terminated by Sponsor|21
1095682|NCT02305758|2167136|FG001|Overall Study|Study Terminated by Sponsor|34
1095683|NCT02305758|2167135|FG000|Overall Study|Other, not specified|2
1095684|NCT02305758|2167136|FG001|Overall Study|Other, not specified|1
1095685|NCT02305797|2167144|FG000|Overall Study|Adverse Event|11
1095686|NCT02305797|2167145|FG001|Overall Study|Adverse Event|2
1095687|NCT02305797|2167144|FG000|Overall Study|Withdrawal by Subject|9
1095688|NCT02305797|2167145|FG001|Overall Study|Withdrawal by Subject|10
1095689|NCT02305797|2167144|FG000|Overall Study|Lack of Efficacy|6
1095690|NCT02305797|2167145|FG001|Overall Study|Lack of Efficacy|0
1095691|NCT02305797|2167144|FG000|Overall Study|Lost to Follow-up|5
1095692|NCT02305797|2167145|FG001|Overall Study|Lost to Follow-up|11
1095693|NCT02305797|2167144|FG000|Overall Study|Pregnancy|0
1095694|NCT02305797|2167145|FG001|Overall Study|Pregnancy|2
1095695|NCT02305797|2167144|FG000|Overall Study|Noncompliance|14
1095696|NCT02305797|2167145|FG001|Overall Study|Noncompliance|12
1095697|NCT02305797|2167144|FG000|Overall Study|Reason not collected|0
1095698|NCT02305797|2167145|FG001|Overall Study|Reason not collected|1
1095699|NCT02305849|2167154|FG000|Overall Study|Adverse Event|10
1095700|NCT02305849|2167155|FG001|Overall Study|Adverse Event|12
1095701|NCT02305849|2167156|FG002|Overall Study|Adverse Event|7
1095702|NCT02305849|2167157|FG003|Overall Study|Adverse Event|3
1095703|NCT02305849|2167154|FG000|Overall Study|Lack of Efficacy|10
1095704|NCT02305849|2167155|FG001|Overall Study|Lack of Efficacy|6
1095705|NCT02305849|2167156|FG002|Overall Study|Lack of Efficacy|3
1095706|NCT02305849|2167157|FG003|Overall Study|Lack of Efficacy|9
1095707|NCT02305849|2167154|FG000|Overall Study|Withdrawal by Subject|2
1095708|NCT02305849|2167155|FG001|Overall Study|Withdrawal by Subject|2
1095709|NCT02305849|2167156|FG002|Overall Study|Withdrawal by Subject|1
1095710|NCT02305849|2167157|FG003|Overall Study|Withdrawal by Subject|4
1095711|NCT02305849|2167154|FG000|Overall Study|Lost to Follow-up|0
1095712|NCT02305849|2167155|FG001|Overall Study|Lost to Follow-up|2
1095713|NCT02305849|2167156|FG002|Overall Study|Lost to Follow-up|0
1095714|NCT02305849|2167157|FG003|Overall Study|Lost to Follow-up|0
1095715|NCT02305849|2167154|FG000|Overall Study|Protocol Violation|3
1095716|NCT02305849|2167155|FG001|Overall Study|Protocol Violation|2
1095717|NCT02305849|2167156|FG002|Overall Study|Protocol Violation|1
1095718|NCT02305849|2167157|FG003|Overall Study|Protocol Violation|1
1095719|NCT02305849|2167154|FG000|Overall Study|Lab data met discontinuation criteria|0
1095720|NCT02305849|2167155|FG001|Overall Study|Lab data met discontinuation criteria|1
1095721|NCT02305849|2167156|FG002|Overall Study|Lab data met discontinuation criteria|2
1095722|NCT02305849|2167157|FG003|Overall Study|Lab data met discontinuation criteria|1
1095723|NCT02305849|2167154|FG000|Overall Study|Miscellaneous|1
1095724|NCT02305849|2167155|FG001|Overall Study|Miscellaneous|2
1095725|NCT02305849|2167156|FG002|Overall Study|Miscellaneous|4
1095726|NCT02305849|2167157|FG003|Overall Study|Miscellaneous|1
1095727|NCT02305849|2167154|FG000|Overall Study|Not fulfill eligibility criteria|1
1095728|NCT02305849|2167155|FG001|Overall Study|Not fulfill eligibility criteria|1
1095729|NCT02305849|2167156|FG002|Overall Study|Not fulfill eligibility criteria|0
1095730|NCT02305849|2167157|FG003|Overall Study|Not fulfill eligibility criteria|0
1095731|NCT02305888|2167191|FG000|Overall Study|Lost to Follow-up|0
1095732|NCT02305888|2167192|FG001|Overall Study|Lost to Follow-up|0
1095733|NCT02305888|2167193|FG002|Overall Study|Lost to Follow-up|1
1095734|NCT02305888|2167191|FG000|Overall Study|Adverse Event|0
1095735|NCT02305888|2167192|FG001|Overall Study|Adverse Event|1
1095736|NCT02305888|2167193|FG002|Overall Study|Adverse Event|0
1095737|NCT02306265|2167201|FG000|Overall Study|Withdrawal by Subject|1
1095738|NCT02306694|2167206|FG000|Overall Study|Withdrawal by Subject|3
1095739|NCT02306694|2167206|FG000|Overall Study|Lost to Follow-up|1
1095740|NCT02306850|2167221|FG000|Overall Study|Lack of Efficacy|2
1095741|NCT02307266|2167237|FG000|Overall Study|Adverse Event|3
1095742|NCT02307266|2167238|FG001|Overall Study|Adverse Event|1
1095743|NCT02307266|2167239|FG002|Overall Study|Adverse Event|5
1095744|NCT02307266|2167237|FG000|Overall Study|Withdrawal by Subject|2
1095745|NCT02307266|2167238|FG001|Overall Study|Withdrawal by Subject|0
1095746|NCT02307266|2167239|FG002|Overall Study|Withdrawal by Subject|1
1095747|NCT02307266|2167237|FG000|Overall Study|Lost to Follow-up|3
1095748|NCT02307266|2167238|FG001|Overall Study|Lost to Follow-up|0
1095749|NCT02307266|2167239|FG002|Overall Study|Lost to Follow-up|0
1095750|NCT02307370|2167251|FG000|Overall Study|Death|5
1095751|NCT02307370|2167251|FG000|Overall Study|Lost to Follow-up|1
1095752|NCT02307370|2167251|FG000|Overall Study|Withdrawal by Subject|1
1095753|NCT02307370|2167251|FG000|Overall Study|Declined Addendum ICF|6
1095754|NCT02307370|2167251|FG000|Overall Study|No response during telephone contact|5
1095755|NCT02307370|2167251|FG000|Overall Study|Protocol Violation|1
1095756|NCT02307513|2167259|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
1095757|NCT02307513|2167260|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
1095758|NCT02307513|2167259|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
1095759|NCT02307513|2167260|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
1095760|NCT02307513|2167259|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
1095761|NCT02307513|2167260|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
1095762|NCT02307513|2167259|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
1095763|NCT02307513|2167260|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
1095764|NCT02307513|2167259|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
1095765|NCT02307513|2167260|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
1095766|NCT02307513|2167259|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
1095767|NCT02307513|2167260|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
1095768|NCT02307513|2167259|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
1095769|NCT02307513|2167260|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
1095770|NCT02307513|2167259|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
1095771|NCT02307513|2167260|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
1095772|NCT02307513|2167259|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
1095773|NCT02307513|2167260|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
1095774|NCT02307513|2167259|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
1095775|NCT02307513|2167260|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
1095776|NCT02307513|2167259|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
1095777|NCT02307513|2167260|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
1095778|NCT02307513|2167259|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
1095779|NCT02307513|2167260|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
1095780|NCT02307513|2167259|FG000|Long-term Extension|Physician Decision|1
1095781|NCT02307513|2167260|FG001|Long-term Extension|Physician Decision|0
1095782|NCT02307682|2167283|FG000|Overall Study|Adverse Event|9
1095783|NCT02307682|2167284|FG001|Overall Study|Adverse Event|8
1095784|NCT02307682|2167285|FG002|Overall Study|Adverse Event|12
1095785|NCT02307682|2167283|FG000|Overall Study|Lack of Efficacy|1
1095786|NCT02307682|2167284|FG001|Overall Study|Lack of Efficacy|0
1095787|NCT02307682|2167285|FG002|Overall Study|Lack of Efficacy|1
1095788|NCT02307682|2167283|FG000|Overall Study|Physician Decision|2
1095789|NCT02307682|2167284|FG001|Overall Study|Physician Decision|2
1095790|NCT02307682|2167285|FG002|Overall Study|Physician Decision|8
1095791|NCT02307682|2167283|FG000|Overall Study|Progressive Disease|1
1095792|NCT02307682|2167284|FG001|Overall Study|Progressive Disease|0
1095793|NCT02307682|2167285|FG002|Overall Study|Progressive Disease|0
1095794|NCT02307682|2167283|FG000|Overall Study|Withdrawal by Subject|26
1095795|NCT02307682|2167284|FG001|Overall Study|Withdrawal by Subject|34
1095796|NCT02307682|2167285|FG002|Overall Study|Withdrawal by Subject|23
1095797|NCT02307682|2167283|FG000|Overall Study|Death|9
1095798|NCT02307682|2167284|FG001|Overall Study|Death|7
1095799|NCT02307682|2167285|FG002|Overall Study|Death|12
1095800|NCT02307682|2167283|FG000|Overall Study|Lost to Follow-up|1
1095801|NCT02307682|2167284|FG001|Overall Study|Lost to Follow-up|5
1095802|NCT02307682|2167285|FG002|Overall Study|Lost to Follow-up|6
1095803|NCT02307682|2167283|FG000|Overall Study|Protocol Deviation|0
1095804|NCT02307682|2167284|FG001|Overall Study|Protocol Deviation|0
1095805|NCT02307682|2167285|FG002|Overall Study|Protocol Deviation|2
1095806|NCT02307682|2167283|FG000|Overall Study|Other|1
1095807|NCT02307682|2167284|FG001|Overall Study|Other|1
1095808|NCT02307682|2167285|FG002|Overall Study|Other|0
1095809|NCT02308007|2167319|FG000|Overall Study|Normal Gram stain or neg yeast culture|66
1095810|NCT02308007|2167320|FG001|Overall Study|Normal Gram stain or neg yeast culture|64
1095811|NCT02308007|2167321|FG002|Overall Study|Normal Gram stain or neg yeast culture|67
1095812|NCT02308007|2167319|FG000|Overall Study|Positive for STD at Baseline|7
1095813|NCT02308007|2167320|FG001|Overall Study|Positive for STD at Baseline|11
1095814|NCT02308007|2167321|FG002|Overall Study|Positive for STD at Baseline|7
1095815|NCT02308007|2167319|FG000|Overall Study|Lost to Follow-up|3
1095816|NCT02308007|2167320|FG001|Overall Study|Lost to Follow-up|0
1095817|NCT02308007|2167321|FG002|Overall Study|Lost to Follow-up|1
1095818|NCT02308020|2167335|FG000|Overall Study|Lost to Follow-up|1
1095819|NCT02308020|2167336|FG001|Overall Study|Lost to Follow-up|7
1095820|NCT02308020|2167337|FG002|Overall Study|Lost to Follow-up|0
1095821|NCT02308020|2167338|FG003|Overall Study|Lost to Follow-up|0
1095822|NCT02308020|2167339|FG004|Overall Study|Lost to Follow-up|1
1095823|NCT02308020|2167340|FG005|Overall Study|Lost to Follow-up|2
1095824|NCT02308020|2167335|FG000|Overall Study|Sponsor Decision|0
1095825|NCT02308020|2167336|FG001|Overall Study|Sponsor Decision|8
1095826|NCT02308020|2167337|FG002|Overall Study|Sponsor Decision|0
1095827|NCT02308020|2167338|FG003|Overall Study|Sponsor Decision|2
1095828|NCT02308020|2167339|FG004|Overall Study|Sponsor Decision|2
1095829|NCT02308020|2167340|FG005|Overall Study|Sponsor Decision|1
1095830|NCT02308020|2167335|FG000|Overall Study|Withdrawal by Subject|3
1095831|NCT02308020|2167336|FG001|Overall Study|Withdrawal by Subject|5
1095832|NCT02308020|2167337|FG002|Overall Study|Withdrawal by Subject|3
1095833|NCT02308020|2167338|FG003|Overall Study|Withdrawal by Subject|2
1095834|NCT02308020|2167339|FG004|Overall Study|Withdrawal by Subject|1
1095835|NCT02308020|2167340|FG005|Overall Study|Withdrawal by Subject|2
1095836|NCT02308033|2167362|FG000|Overall Study|Normal Gram stain at Baseline|13
1095837|NCT02308033|2167363|FG001|Overall Study|Normal Gram stain at Baseline|10
1095838|NCT02308033|2167362|FG000|Overall Study|Positive for STD at Baseline|7
1095839|NCT02308033|2167363|FG001|Overall Study|Positive for STD at Baseline|4
1095840|NCT02308033|2167362|FG000|Overall Study|Lost to Follow-up|6
1095841|NCT02308033|2167363|FG001|Overall Study|Lost to Follow-up|5
1095842|NCT02308046|2167371|FG000|Overall Study|Negative yeast culture at Baseline|32
1095843|NCT02308046|2167372|FG001|Overall Study|Negative yeast culture at Baseline|33
1095844|NCT02308046|2167371|FG000|Overall Study|Positive for STD at Baseline|1
1095845|NCT02308046|2167372|FG001|Overall Study|Positive for STD at Baseline|2
1095846|NCT02308046|2167371|FG000|Overall Study|Lost to Follow-up|1
1095847|NCT02308046|2167372|FG001|Overall Study|Lost to Follow-up|3
1095848|NCT02308124|2167381|FG000|Overall Study|Lost to Follow-up|6
1095849|NCT02308124|2167382|FG001|Overall Study|Lost to Follow-up|6
1095850|NCT02308124|2167383|FG002|Overall Study|Lost to Follow-up|6
1095851|NCT02308124|2167381|FG000|Overall Study|Adverse Event|0
1095852|NCT02308124|2167382|FG001|Overall Study|Adverse Event|2
1095853|NCT02308124|2167383|FG002|Overall Study|Adverse Event|2
1095854|NCT02308163|2167395|FG000|Overall Study|Not fulfill eligible criteria|1
1095855|NCT02308163|2167396|FG001|Overall Study|Not fulfill eligible criteria|2
1095856|NCT02308163|2167397|FG002|Overall Study|Not fulfill eligible criteria|0
1095857|NCT02308163|2167398|FG003|Overall Study|Not fulfill eligible criteria|1
1095858|NCT02308163|2167399|FG004|Overall Study|Not fulfill eligible criteria|1
1095859|NCT02308163|2167395|FG000|Overall Study|Adverse Event|9
1095860|NCT02308163|2167396|FG001|Overall Study|Adverse Event|5
1095861|NCT02308163|2167397|FG002|Overall Study|Adverse Event|2
1095862|NCT02308163|2167398|FG003|Overall Study|Adverse Event|2
1095863|NCT02308163|2167399|FG004|Overall Study|Adverse Event|11
1095864|NCT02308163|2167395|FG000|Overall Study|Lack of Efficacy|11
1095865|NCT02308163|2167396|FG001|Overall Study|Lack of Efficacy|3
1095866|NCT02308163|2167397|FG002|Overall Study|Lack of Efficacy|8
1095867|NCT02308163|2167398|FG003|Overall Study|Lack of Efficacy|4
1095868|NCT02308163|2167399|FG004|Overall Study|Lack of Efficacy|6
1095869|NCT02308163|2167395|FG000|Overall Study|Withdrawal of consent|2
1095870|NCT02308163|2167396|FG001|Overall Study|Withdrawal of consent|3
1095871|NCT02308163|2167397|FG002|Overall Study|Withdrawal of consent|0
1095872|NCT02308163|2167398|FG003|Overall Study|Withdrawal of consent|2
1095873|NCT02308163|2167399|FG004|Overall Study|Withdrawal of consent|6
1095874|NCT02308163|2167395|FG000|Overall Study|Protocol Violation|3
1095875|NCT02308163|2167396|FG001|Overall Study|Protocol Violation|3
1095876|NCT02308163|2167397|FG002|Overall Study|Protocol Violation|3
1095877|NCT02308163|2167398|FG003|Overall Study|Protocol Violation|2
1095878|NCT02308163|2167399|FG004|Overall Study|Protocol Violation|5
1095879|NCT02308163|2167395|FG000|Overall Study|Lab data met discontinuation criteria|3
1095880|NCT02308163|2167396|FG001|Overall Study|Lab data met discontinuation criteria|0
1095881|NCT02308163|2167397|FG002|Overall Study|Lab data met discontinuation criteria|0
1095882|NCT02308163|2167398|FG003|Overall Study|Lab data met discontinuation criteria|2
1095883|NCT02308163|2167399|FG004|Overall Study|Lab data met discontinuation criteria|0
1095884|NCT02308163|2167395|FG000|Overall Study|Miscellaneous|2
1095885|NCT02308163|2167396|FG001|Overall Study|Miscellaneous|2
1095886|NCT02308163|2167397|FG002|Overall Study|Miscellaneous|1
1095887|NCT02308163|2167398|FG003|Overall Study|Miscellaneous|0
1095888|NCT02308163|2167399|FG004|Overall Study|Miscellaneous|5
1095889|NCT02308228|2167437|FG000|Overall Study|Adverse Event|3
1095890|NCT02308228|2167438|FG001|Overall Study|Adverse Event|4
1095891|NCT02308228|2167437|FG000|Overall Study|Withdrawal by Subject|5
1095892|NCT02308228|2167438|FG001|Overall Study|Withdrawal by Subject|3
1095893|NCT02308540|2167476|FG000|Overall Study|Lost to Follow-up|0
1095894|NCT02308540|2167477|FG001|Overall Study|Lost to Follow-up|0
1095895|NCT02308540|2167478|FG002|Overall Study|Lost to Follow-up|0
1095896|NCT02308540|2167479|FG003|Overall Study|Lost to Follow-up|0
1095897|NCT02308540|2167480|FG004|Overall Study|Lost to Follow-up|0
1095898|NCT02308540|2167481|FG005|Overall Study|Lost to Follow-up|1
1095899|NCT02308696|2167532|FG000|Overall Study|Lost to Follow-up|28
1095900|NCT02308696|2167533|FG001|Overall Study|Lost to Follow-up|21
1095901|NCT02308696|2167532|FG000|Overall Study|Death|8
1095902|NCT02308696|2167533|FG001|Overall Study|Death|4
1095903|NCT02308696|2167532|FG000|Overall Study|Moved to a Higher Level of Care|17
1095904|NCT02308696|2167533|FG001|Overall Study|Moved to a Higher Level of Care|6
1095905|NCT02308748|2167539|FG000|Period 1|Withdrawal by Subject|0
1095906|NCT02308748|2167540|FG001|Period 1|Withdrawal by Subject|0
1095907|NCT02308748|2167541|FG002|Period 1|Withdrawal by Subject|1
1095908|NCT02308748|2167542|FG003|Period 1|Withdrawal by Subject|0
1095909|NCT02308748|2167543|FG004|Period 1|Withdrawal by Subject|0
1095910|NCT02308748|2167544|FG005|Period 1|Withdrawal by Subject|0
1095911|NCT02308748|2167545|FG006|Period 1|Withdrawal by Subject|0
1095912|NCT02308748|2167546|FG007|Period 1|Withdrawal by Subject|0
1095913|NCT02308748|2167547|FG008|Period 1|Withdrawal by Subject|0
1095914|NCT02308748|2167548|FG009|Period 1|Withdrawal by Subject|0
1095915|NCT02308748|2167539|FG000|Period 2|Adverse Event|0
1095916|NCT02308748|2167540|FG001|Period 2|Adverse Event|0
1095917|NCT02308748|2167541|FG002|Period 2|Adverse Event|0
1095918|NCT02308748|2167542|FG003|Period 2|Adverse Event|0
1095919|NCT02308748|2167543|FG004|Period 2|Adverse Event|0
1095920|NCT02308748|2167544|FG005|Period 2|Adverse Event|0
1095921|NCT02308748|2167545|FG006|Period 2|Adverse Event|0
1095922|NCT02308748|2167546|FG007|Period 2|Adverse Event|1
1095923|NCT02308748|2167547|FG008|Period 2|Adverse Event|0
1095924|NCT02308748|2167548|FG009|Period 2|Adverse Event|0
1095925|NCT02308748|2167539|FG000|Period 3|Protocol Violation|0
1095926|NCT02308748|2167540|FG001|Period 3|Protocol Violation|0
1095927|NCT02308748|2167541|FG002|Period 3|Protocol Violation|0
1095928|NCT02308748|2167542|FG003|Period 3|Protocol Violation|0
1095929|NCT02308748|2167543|FG004|Period 3|Protocol Violation|0
1095930|NCT02308748|2167544|FG005|Period 3|Protocol Violation|0
1095931|NCT02308748|2167545|FG006|Period 3|Protocol Violation|0
1095932|NCT02308748|2167546|FG007|Period 3|Protocol Violation|0
1095933|NCT02308748|2167547|FG008|Period 3|Protocol Violation|0
1095934|NCT02308748|2167548|FG009|Period 3|Protocol Violation|1
1095935|NCT02308748|2167539|FG000|Period 5|Adverse Event|1
1095936|NCT02308748|2167540|FG001|Period 5|Adverse Event|0
1095937|NCT02308748|2167541|FG002|Period 5|Adverse Event|0
1095938|NCT02308748|2167542|FG003|Period 5|Adverse Event|0
1095939|NCT02308748|2167543|FG004|Period 5|Adverse Event|0
1095940|NCT02308748|2167544|FG005|Period 5|Adverse Event|0
1095941|NCT02308748|2167545|FG006|Period 5|Adverse Event|0
1095942|NCT02308748|2167546|FG007|Period 5|Adverse Event|0
1095943|NCT02308748|2167547|FG008|Period 5|Adverse Event|1
1095944|NCT02308748|2167548|FG009|Period 5|Adverse Event|0
1095945|NCT02309099|2167570|FG000|Overall Study|Adverse Event|2
1095946|NCT02309099|2167571|FG001|Overall Study|Adverse Event|0
1095947|NCT02309112|2167580|FG000|Overall Study|Withdrawal by Subject|1
1095948|NCT02309112|2167581|FG001|Overall Study|Withdrawal by Subject|0
1095949|NCT02309112|2167582|FG002|Overall Study|Withdrawal by Subject|1
1095950|NCT02309112|2167580|FG000|Overall Study|Lost to Follow-up|0
1095951|NCT02309112|2167581|FG001|Overall Study|Lost to Follow-up|1
1095952|NCT02309112|2167582|FG002|Overall Study|Lost to Follow-up|0
1095953|NCT02309138|2167594|FG000|Overall Study|Withdrawal by Subject|44
1095954|NCT02309138|2167595|FG001|Overall Study|Withdrawal by Subject|15
1095955|NCT02309138|2167594|FG000|Overall Study|Protocol Violation|4
1095956|NCT02309138|2167595|FG001|Overall Study|Protocol Violation|2
1095957|NCT02309138|2167594|FG000|Overall Study|delivered before visit 2|0
1095958|NCT02309138|2167595|FG001|Overall Study|delivered before visit 2|1
1095959|NCT02309294|2167611|FG000|Overall Study|Withdrawal by Subject|2
1095960|NCT02309359|2167620|FG000|Overall Study|Adverse Event|4
1095961|NCT02309359|2167621|FG001|Overall Study|Adverse Event|5
1095962|NCT02309359|2167622|FG002|Overall Study|Adverse Event|5
1095963|NCT02309359|2167623|FG003|Overall Study|Adverse Event|4
1095964|NCT02309359|2167624|FG004|Overall Study|Adverse Event|4
1095965|NCT02309359|2167620|FG000|Overall Study|Death|1
1095966|NCT02309359|2167621|FG001|Overall Study|Death|0
1095967|NCT02309359|2167622|FG002|Overall Study|Death|0
1095968|NCT02309359|2167623|FG003|Overall Study|Death|0
1095969|NCT02309359|2167624|FG004|Overall Study|Death|0
1095970|NCT02309359|2167620|FG000|Overall Study|Withdrawal by Subject|2
1095971|NCT02309359|2167621|FG001|Overall Study|Withdrawal by Subject|2
1095972|NCT02309359|2167622|FG002|Overall Study|Withdrawal by Subject|4
1095973|NCT02309359|2167623|FG003|Overall Study|Withdrawal by Subject|4
1095974|NCT02309359|2167624|FG004|Overall Study|Withdrawal by Subject|0
1095975|NCT02309359|2167620|FG000|Overall Study|Lack of Efficacy|3
1095976|NCT02309359|2167621|FG001|Overall Study|Lack of Efficacy|1
1095977|NCT02309359|2167622|FG002|Overall Study|Lack of Efficacy|0
1095978|NCT02309359|2167623|FG003|Overall Study|Lack of Efficacy|0
1095979|NCT02309359|2167624|FG004|Overall Study|Lack of Efficacy|3
1095980|NCT02309359|2167620|FG000|Overall Study|Lost to Follow-up|0
1095981|NCT02309359|2167621|FG001|Overall Study|Lost to Follow-up|0
1095982|NCT02309359|2167622|FG002|Overall Study|Lost to Follow-up|0
1095983|NCT02309359|2167623|FG003|Overall Study|Lost to Follow-up|1
1095984|NCT02309359|2167624|FG004|Overall Study|Lost to Follow-up|0
1095985|NCT02309359|2167620|FG000|Overall Study|Other|2
1095986|NCT02309359|2167621|FG001|Overall Study|Other|0
1095987|NCT02309359|2167622|FG002|Overall Study|Other|2
1095988|NCT02309359|2167623|FG003|Overall Study|Other|3
1095989|NCT02309359|2167624|FG004|Overall Study|Other|2
1095990|NCT02309372|2167639|FG000|Overall Study|Lost to Follow-up|3
1095991|NCT02309372|2167640|FG001|Overall Study|Lost to Follow-up|2
1095992|NCT02309411|2167649|FG000|Overall Study|Physician Decision|1
1095993|NCT02309411|2167650|FG001|Overall Study|Physician Decision|0
1095994|NCT02309411|2167651|FG002|Overall Study|Physician Decision|0
1095995|NCT02309411|2167649|FG000|Overall Study|Withdrawal by Subject|1
1095996|NCT02309411|2167650|FG001|Overall Study|Withdrawal by Subject|1
1095997|NCT02309411|2167651|FG002|Overall Study|Withdrawal by Subject|0
1095998|NCT02309515|2167669|FG000|Overall Study|Withdrawal by Subject|0
1095999|NCT02309515|2167670|FG001|Overall Study|Withdrawal by Subject|1
1096000|NCT02309723|2167679|FG000|Overall Study|Withdrawal by Subject|24
1096001|NCT02309723|2167680|FG001|Overall Study|Withdrawal by Subject|23
1096002|NCT02309723|2167681|FG002|Overall Study|Withdrawal by Subject|24
1096003|NCT02310100|2167698|FG000|Overall Study|Physician Decision|3
1096004|NCT02310100|2167698|FG000|Overall Study|Withdrawal by Subject|10
1096005|NCT02310100|2167698|FG000|Overall Study|Enrollment closure|1
1096006|NCT02310100|2167698|FG000|Overall Study|Unapproved ablation operator|1
1096007|NCT02310100|2167698|FG000|Overall Study|Visit compliance|1
1096008|NCT02310100|2167698|FG000|Overall Study|Lost to Follow-up|2
1096009|NCT02310126|2167705|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0
1096010|NCT02310126|2167706|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1
1096011|NCT02310126|2167705|FG000|Period 1 (15 Minutes)|Protocol Violation|0
1096012|NCT02310126|2167706|FG001|Period 1 (15 Minutes)|Protocol Violation|1
1096013|NCT02310568|2167717|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1096014|NCT02310568|2167718|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1096015|NCT02310568|2167719|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1096016|NCT02310568|2167720|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1096017|NCT02310568|2167721|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
1096018|NCT02310568|2167717|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
1096019|NCT02310568|2167718|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1096020|NCT02310568|2167719|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1096021|NCT02310568|2167720|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1096022|NCT02310568|2167721|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1096023|NCT02310568|2167717|FG000|Stage 1 ( 4 Weeks)|Other|1
1096024|NCT02310568|2167718|FG001|Stage 1 ( 4 Weeks)|Other|1
1096025|NCT02310568|2167719|FG002|Stage 1 ( 4 Weeks)|Other|0
1096026|NCT02310568|2167720|FG003|Stage 1 ( 4 Weeks)|Other|0
1096027|NCT02310568|2167721|FG004|Stage 1 ( 4 Weeks)|Other|0
1096028|NCT02310568|2167717|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1
1096029|NCT02310568|2167718|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1
1096030|NCT02310568|2167719|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1
1096031|NCT02310568|2167720|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0
1096032|NCT02310568|2167721|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0
1096033|NCT02310568|2167717|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1096034|NCT02310568|2167718|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1096035|NCT02310568|2167719|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1096036|NCT02310568|2167720|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
1096037|NCT02310568|2167721|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
893357|NCT00683696|1863725|FG000|Overall Study|Withdrawn prior to study closure|13
893358|NCT00683696|1863726|FG001|Overall Study|Withdrawn prior to study closure|28
893359|NCT00683696|1863725|FG000|Overall Study|Lost to Follow-up|5
893360|NCT00683696|1863726|FG001|Overall Study|Lost to Follow-up|6
893361|NCT00683696|1863725|FG000|Overall Study|Vital status follow-up only|3
893362|NCT00683696|1863726|FG001|Overall Study|Vital status follow-up only|3
893363|NCT00683696|1863725|FG000|Overall Study|Death|46
893364|NCT00683696|1863726|FG001|Overall Study|Death|30
893365|NCT00683774|1863735|FG000|Overall Study|Withdrawal by Subject|0
893366|NCT00683774|1863736|FG001|Overall Study|Withdrawal by Subject|1
893367|NCT00683774|1863735|FG000|Overall Study|Physician Decision|3
893368|NCT00683774|1863736|FG001|Overall Study|Physician Decision|0
893369|NCT00683800|1863744|FG000|Overall Study|Adverse Event|195
893370|NCT00683800|1863745|FG001|Overall Study|Adverse Event|102
893371|NCT00683800|1863744|FG000|Overall Study|Death|0
893372|NCT00683800|1863745|FG001|Overall Study|Death|1
893373|NCT00683800|1863744|FG000|Overall Study|Lost to Follow-up|57
893374|NCT00683800|1863745|FG001|Overall Study|Lost to Follow-up|44
893375|NCT00683800|1863744|FG000|Overall Study|Other|5
893376|NCT00683800|1863745|FG001|Overall Study|Other|2
893377|NCT00683800|1863744|FG000|Overall Study|Protocol Violation|13
893378|NCT00683800|1863745|FG001|Overall Study|Protocol Violation|16
893379|NCT00683800|1863744|FG000|Overall Study|Withdrawal by Subject|66
893380|NCT00683800|1863745|FG001|Overall Study|Withdrawal by Subject|64
893381|NCT00683800|1863744|FG000|Overall Study|Lack of Efficacy|61
893382|NCT00683800|1863745|FG001|Overall Study|Lack of Efficacy|104
893383|NCT00683800|1863744|FG000|Overall Study|Randomized, not treated|35
893384|NCT00683800|1863745|FG001|Overall Study|Randomized, not treated|33
893385|NCT00683878|1863784|FG000|Overall Study|Lack of Efficacy|3
893386|NCT00683878|1863785|FG001|Overall Study|Lack of Efficacy|0
893387|NCT00683878|1863786|FG002|Overall Study|Lack of Efficacy|1
893388|NCT00683878|1863784|FG000|Overall Study|Adverse Event|4
893389|NCT00683878|1863785|FG001|Overall Study|Adverse Event|3
893390|NCT00683878|1863786|FG002|Overall Study|Adverse Event|3
893391|NCT00683878|1863784|FG000|Overall Study|Withdrawal by Subject|9
1096038|NCT02310568|2167717|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1096039|NCT02310568|2167718|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1096040|NCT02310568|2167719|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1096041|NCT02310568|2167720|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
1096042|NCT02310568|2167721|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1096043|NCT02310568|2167717|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1
1096044|NCT02310568|2167718|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1096045|NCT02310568|2167719|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1096046|NCT02310568|2167720|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1
1096047|NCT02310568|2167721|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1096048|NCT02310568|2167717|FG000|Stage 2 (4 Weeks)|Other|0
1096049|NCT02310568|2167718|FG001|Stage 2 (4 Weeks)|Other|1
1096050|NCT02310568|2167719|FG002|Stage 2 (4 Weeks)|Other|1
1096051|NCT02310568|2167720|FG003|Stage 2 (4 Weeks)|Other|0
1096052|NCT02310568|2167721|FG004|Stage 2 (4 Weeks)|Other|0
1096053|NCT02310568|2167717|FG000|Stage 2 (4 Weeks)|Adverse Event|0
1096054|NCT02310568|2167718|FG001|Stage 2 (4 Weeks)|Adverse Event|0
1096055|NCT02310568|2167719|FG002|Stage 2 (4 Weeks)|Adverse Event|0
1096056|NCT02310568|2167720|FG003|Stage 2 (4 Weeks)|Adverse Event|1
1096057|NCT02310568|2167721|FG004|Stage 2 (4 Weeks)|Adverse Event|1
1096058|NCT02310568|2167717|FG000|Stage 2 (4 Weeks)|Protocol Violation|0
1096059|NCT02310568|2167718|FG001|Stage 2 (4 Weeks)|Protocol Violation|0
1096060|NCT02310568|2167719|FG002|Stage 2 (4 Weeks)|Protocol Violation|0
1096061|NCT02310568|2167720|FG003|Stage 2 (4 Weeks)|Protocol Violation|1
1096062|NCT02310568|2167721|FG004|Stage 2 (4 Weeks)|Protocol Violation|0
1096063|NCT02310568|2167717|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0
1096064|NCT02310568|2167718|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0
1096065|NCT02310568|2167719|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0
1096066|NCT02310568|2167720|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2
1096067|NCT02310568|2167721|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0
1096068|NCT02310581|2167743|FG000|Overall Study|Adverse Event|1
1096069|NCT02310581|2167744|FG001|Overall Study|Adverse Event|1
1096070|NCT02310581|2167745|FG002|Overall Study|Adverse Event|1
1096071|NCT02310581|2167746|FG003|Overall Study|Adverse Event|0
1096072|NCT02310581|2167743|FG000|Overall Study|Withdrawal by Subject|2
1096073|NCT02310581|2167744|FG001|Overall Study|Withdrawal by Subject|1
1096074|NCT02310581|2167745|FG002|Overall Study|Withdrawal by Subject|0
1096075|NCT02310581|2167746|FG003|Overall Study|Withdrawal by Subject|1
1096076|NCT02310646|2167758|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
1096077|NCT02310646|2167759|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
1096078|NCT02310646|2167758|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
1096079|NCT02310646|2167759|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
1096080|NCT02310672|2167781|FG000|Overall Study|Death|1
1096081|NCT02310672|2167781|FG000|Overall Study|Lost to Follow-up|1
1096082|NCT02310672|2167781|FG000|Overall Study|Withdrawal by Subject|1
893392|NCT00683878|1863785|FG001|Overall Study|Withdrawal by Subject|8
893393|NCT00683878|1863786|FG002|Overall Study|Withdrawal by Subject|6
893394|NCT00683878|1863784|FG000|Overall Study|Death|0
893395|NCT00683878|1863785|FG001|Overall Study|Death|1
1096083|NCT02310672|2167781|FG000|Overall Study|Sponsor's decision|12
1096084|NCT02310750|2167796|FG000|HP Period 1|Lost to Follow-up|0
1096085|NCT02310750|2167797|FG001|HP Period 1|Lost to Follow-up|0
1096086|NCT02310750|2167798|FG002|HP Period 1|Lost to Follow-up|0
1096087|NCT02310750|2167799|FG003|HP Period 1|Lost to Follow-up|0
1096088|NCT02310750|2167800|FG004|HP Period 1|Lost to Follow-up|0
1096089|NCT02310750|2167801|FG005|HP Period 1|Lost to Follow-up|0
1096090|NCT02310750|2167802|FG006|HP Period 1|Lost to Follow-up|1
1096091|NCT02310750|2167803|FG007|HP Period 1|Lost to Follow-up|0
1096092|NCT02310750|2167804|FG008|HP Period 1|Lost to Follow-up|0
1096093|NCT02310750|2167805|FG009|HP Period 1|Lost to Follow-up|0
1096094|NCT02310750|2167806|FG010|HP Period 1|Lost to Follow-up|0
1096095|NCT02310750|2167807|FG011|HP Period 1|Lost to Follow-up|0
1096096|NCT02310750|2167808|FG012|HP Period 1|Lost to Follow-up|0
1096097|NCT02310750|2167809|FG013|HP Period 1|Lost to Follow-up|0
1096098|NCT02310750|2167810|FG014|HP Period 1|Lost to Follow-up|0
1096099|NCT02310750|2167811|FG015|HP Period 1|Lost to Follow-up|0
1096100|NCT02310750|2167796|FG000|HP Period 1|Withdrawal by Subject|1
1096101|NCT02310750|2167797|FG001|HP Period 1|Withdrawal by Subject|0
1096102|NCT02310750|2167798|FG002|HP Period 1|Withdrawal by Subject|0
1096103|NCT02310750|2167799|FG003|HP Period 1|Withdrawal by Subject|1
1096104|NCT02310750|2167800|FG004|HP Period 1|Withdrawal by Subject|0
1096105|NCT02310750|2167801|FG005|HP Period 1|Withdrawal by Subject|0
1096106|NCT02310750|2167802|FG006|HP Period 1|Withdrawal by Subject|0
1096107|NCT02310750|2167803|FG007|HP Period 1|Withdrawal by Subject|0
1096108|NCT02310750|2167804|FG008|HP Period 1|Withdrawal by Subject|0
1096109|NCT02310750|2167805|FG009|HP Period 1|Withdrawal by Subject|0
1096110|NCT02310750|2167806|FG010|HP Period 1|Withdrawal by Subject|0
1096111|NCT02310750|2167807|FG011|HP Period 1|Withdrawal by Subject|0
1096112|NCT02310750|2167808|FG012|HP Period 1|Withdrawal by Subject|0
1096113|NCT02310750|2167809|FG013|HP Period 1|Withdrawal by Subject|0
1096114|NCT02310750|2167810|FG014|HP Period 1|Withdrawal by Subject|0
1096115|NCT02310750|2167811|FG015|HP Period 1|Withdrawal by Subject|0
1096116|NCT02310750|2167796|FG000|HP Washout 1|Lost to Follow-up|0
1096117|NCT02310750|2167797|FG001|HP Washout 1|Lost to Follow-up|0
1096118|NCT02310750|2167798|FG002|HP Washout 1|Lost to Follow-up|1
1096119|NCT02310750|2167799|FG003|HP Washout 1|Lost to Follow-up|1
1096120|NCT02310750|2167800|FG004|HP Washout 1|Lost to Follow-up|2
1096121|NCT02310750|2167801|FG005|HP Washout 1|Lost to Follow-up|2
1096122|NCT02310750|2167802|FG006|HP Washout 1|Lost to Follow-up|3
1096123|NCT02310750|2167803|FG007|HP Washout 1|Lost to Follow-up|0
1096124|NCT02310750|2167804|FG008|HP Washout 1|Lost to Follow-up|0
1096125|NCT02310750|2167805|FG009|HP Washout 1|Lost to Follow-up|0
1096126|NCT02310750|2167806|FG010|HP Washout 1|Lost to Follow-up|0
1096127|NCT02310750|2167807|FG011|HP Washout 1|Lost to Follow-up|0
1096128|NCT02310750|2167808|FG012|HP Washout 1|Lost to Follow-up|0
1096129|NCT02310750|2167809|FG013|HP Washout 1|Lost to Follow-up|0
1096130|NCT02310750|2167810|FG014|HP Washout 1|Lost to Follow-up|0
1096131|NCT02310750|2167811|FG015|HP Washout 1|Lost to Follow-up|0
1096132|NCT02310750|2167796|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096133|NCT02310750|2167797|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096134|NCT02310750|2167798|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096135|NCT02310750|2167799|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
1096136|NCT02310750|2167800|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096137|NCT02310750|2167801|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
1096138|NCT02310750|2167802|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096139|NCT02310750|2167803|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096140|NCT02310750|2167804|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
1096141|NCT02310750|2167805|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
1096142|NCT02310750|2167806|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096143|NCT02310750|2167807|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096144|NCT02310750|2167808|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096145|NCT02310750|2167809|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096146|NCT02310750|2167810|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096147|NCT02310750|2167811|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1096148|NCT02310750|2167796|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096149|NCT02310750|2167797|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096150|NCT02310750|2167798|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096151|NCT02310750|2167799|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096152|NCT02310750|2167800|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096153|NCT02310750|2167801|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096154|NCT02310750|2167802|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096155|NCT02310750|2167803|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096156|NCT02310750|2167804|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096157|NCT02310750|2167805|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
1096158|NCT02310750|2167806|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096159|NCT02310750|2167807|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096160|NCT02310750|2167808|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096161|NCT02310750|2167809|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096162|NCT02310750|2167810|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096163|NCT02310750|2167811|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1096164|NCT02310750|2167796|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096165|NCT02310750|2167797|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096166|NCT02310750|2167798|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096167|NCT02310750|2167799|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096168|NCT02310750|2167800|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096169|NCT02310750|2167801|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096170|NCT02310750|2167802|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096171|NCT02310750|2167803|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1096172|NCT02310750|2167804|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1096173|NCT02310750|2167805|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1096174|NCT02310750|2167806|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096175|NCT02310750|2167807|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096176|NCT02310750|2167808|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096177|NCT02310750|2167809|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096178|NCT02310750|2167810|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096179|NCT02310750|2167811|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1096180|NCT02310750|2167796|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096181|NCT02310750|2167797|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096182|NCT02310750|2167798|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096183|NCT02310750|2167799|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096184|NCT02310750|2167800|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096185|NCT02310750|2167801|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096186|NCT02310750|2167802|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096187|NCT02310750|2167803|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
1096188|NCT02310750|2167804|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
1096189|NCT02310750|2167805|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096190|NCT02310750|2167806|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096191|NCT02310750|2167807|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096192|NCT02310750|2167808|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096193|NCT02310750|2167809|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096194|NCT02310750|2167810|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096195|NCT02310750|2167811|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1096196|NCT02310750|2167796|FG000|HP Washout 2|Lost to Follow-up|0
1096197|NCT02310750|2167797|FG001|HP Washout 2|Lost to Follow-up|0
1096198|NCT02310750|2167798|FG002|HP Washout 2|Lost to Follow-up|0
1096199|NCT02310750|2167799|FG003|HP Washout 2|Lost to Follow-up|0
1096200|NCT02310750|2167800|FG004|HP Washout 2|Lost to Follow-up|1
1096201|NCT02310750|2167801|FG005|HP Washout 2|Lost to Follow-up|0
1096202|NCT02310750|2167802|FG006|HP Washout 2|Lost to Follow-up|7
1096203|NCT02310750|2167803|FG007|HP Washout 2|Lost to Follow-up|0
1096204|NCT02310750|2167804|FG008|HP Washout 2|Lost to Follow-up|0
1096205|NCT02310750|2167805|FG009|HP Washout 2|Lost to Follow-up|0
1096206|NCT02310750|2167806|FG010|HP Washout 2|Lost to Follow-up|0
1096207|NCT02310750|2167807|FG011|HP Washout 2|Lost to Follow-up|0
1096208|NCT02310750|2167808|FG012|HP Washout 2|Lost to Follow-up|0
1096209|NCT02310750|2167809|FG013|HP Washout 2|Lost to Follow-up|0
1096210|NCT02310750|2167810|FG014|HP Washout 2|Lost to Follow-up|0
1096211|NCT02310750|2167811|FG015|HP Washout 2|Lost to Follow-up|0
1096212|NCT02310763|2167895|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
1096213|NCT02310763|2167896|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
1096214|NCT02310763|2167897|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
1096215|NCT02310763|2167895|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
1096216|NCT02310763|2167896|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
1096217|NCT02310763|2167897|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
1096218|NCT02310763|2167895|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
1096219|NCT02310763|2167896|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
893396|NCT00683878|1863786|FG002|Overall Study|Death|0
893397|NCT00683878|1863784|FG000|Overall Study|Lost to Follow-up|4
893398|NCT00683878|1863785|FG001|Overall Study|Lost to Follow-up|2
893399|NCT00683878|1863786|FG002|Overall Study|Lost to Follow-up|4
893400|NCT00683878|1863784|FG000|Overall Study|Non-compliance, not met criteria etc.|3
893401|NCT00683878|1863785|FG001|Overall Study|Non-compliance, not met criteria etc.|2
893402|NCT00683878|1863786|FG002|Overall Study|Non-compliance, not met criteria etc.|0
893403|NCT00683904|1863796|FG000|Dose Level 1|Disease progression|2
893404|NCT00683904|1863797|FG001|Dose Level 1|Disease progression|0
893405|NCT00683904|1863796|FG000|Dose Level 1|Adverse Event|1
893406|NCT00683904|1863797|FG001|Dose Level 1|Adverse Event|0
893407|NCT00683904|1863796|FG000|Dose Level 2|Adverse Event|0
893408|NCT00683904|1863797|FG001|Dose Level 2|Adverse Event|2
1096220|NCT02310763|2167897|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
1096221|NCT02310763|2167895|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1
1096222|NCT02310763|2167896|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0
1096223|NCT02310763|2167897|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0
1096224|NCT02310763|2167895|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
1096225|NCT02310763|2167896|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
1096226|NCT02310763|2167897|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
1096227|NCT02310789|2167927|FG000|Overall Study|Adverse Event|1
1096228|NCT02310906|2167935|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
1096229|NCT02310906|2167936|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
1096230|NCT02310906|2167937|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
1096231|NCT02310906|2167938|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2
1096232|NCT02310906|2167935|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
1096233|NCT02310906|2167936|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
1096234|NCT02310906|2167937|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2
1096235|NCT02310906|2167938|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4
1096236|NCT02310906|2167935|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
1096237|NCT02310906|2167936|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
1096238|NCT02310906|2167937|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
1096239|NCT02310906|2167938|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1
1096240|NCT02310906|2167935|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
1096241|NCT02310906|2167936|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
1096242|NCT02310906|2167937|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
1096243|NCT02310906|2167938|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1
1096244|NCT02311153|2167961|FG000|Overall Study|Lost to Follow-up|5
1096245|NCT02311153|2167962|FG001|Overall Study|Lost to Follow-up|7
1096246|NCT02311361|2167985|FG000|Overall Study|Did not receive treatment|0
1096247|NCT02311361|2167986|FG001|Overall Study|Did not receive treatment|1
1096248|NCT02311361|2167987|FG002|Overall Study|Did not receive treatment|0
1096249|NCT02311361|2167988|FG003|Overall Study|Did not receive treatment|1
1096250|NCT02311478|2168002|FG000|Overall Study|Withdrawal by Subject|1
1096251|NCT02311478|2168002|FG000|Overall Study|Lost to Follow-up|5
1096252|NCT02311478|2168002|FG000|Overall Study|Failed IUD Insertion|1
1096253|NCT02311881|2168009|FG000|Overall Study|Did not meet the study criteria|2
1096254|NCT02311881|2168010|FG001|Overall Study|Did not meet the study criteria|2
1096255|NCT02311881|2168011|FG002|Overall Study|Did not meet the study criteria|0
1096256|NCT02311881|2168009|FG000|Overall Study|Adverse Event|7
1096257|NCT02311881|2168010|FG001|Overall Study|Adverse Event|15
1096258|NCT02311881|2168011|FG002|Overall Study|Adverse Event|8
1096259|NCT02311881|2168009|FG000|Overall Study|Lost to Follow-up|3
1096260|NCT02311881|2168010|FG001|Overall Study|Lost to Follow-up|3
1096261|NCT02311881|2168011|FG002|Overall Study|Lost to Follow-up|2
1096262|NCT02311881|2168009|FG000|Overall Study|Protocol Violation|1
1096263|NCT02311881|2168010|FG001|Overall Study|Protocol Violation|2
1096264|NCT02311881|2168011|FG002|Overall Study|Protocol Violation|3
1096265|NCT02311881|2168009|FG000|Overall Study|Withdrawal of consent|14
1096266|NCT02311881|2168010|FG001|Overall Study|Withdrawal of consent|16
1096267|NCT02311881|2168011|FG002|Overall Study|Withdrawal of consent|17
1096268|NCT02311881|2168009|FG000|Overall Study|Other|0
1096269|NCT02311881|2168010|FG001|Overall Study|Other|0
1096270|NCT02311881|2168011|FG002|Overall Study|Other|1
1096271|NCT02311881|2168009|FG000|Overall Study|Lack of Efficacy|1
1096272|NCT02311881|2168010|FG001|Overall Study|Lack of Efficacy|2
1096273|NCT02311881|2168011|FG002|Overall Study|Lack of Efficacy|0
1096274|NCT02311881|2168009|FG000|Overall Study|Subject has border line pregnancy test|1
1096275|NCT02311881|2168010|FG001|Overall Study|Subject has border line pregnancy test|0
1096276|NCT02311881|2168011|FG002|Overall Study|Subject has border line pregnancy test|0
1096277|NCT02311881|2168009|FG000|Overall Study|Withdrawal by Subject|3
1096278|NCT02311881|2168010|FG001|Overall Study|Withdrawal by Subject|1
1096279|NCT02311881|2168011|FG002|Overall Study|Withdrawal by Subject|4
1096280|NCT02311881|2168009|FG000|Overall Study|Sponsor Decision|1
1096281|NCT02311881|2168010|FG001|Overall Study|Sponsor Decision|1
1096282|NCT02311881|2168011|FG002|Overall Study|Sponsor Decision|1
1096283|NCT02311881|2168009|FG000|Overall Study|Protocol Deviation|1
1096284|NCT02311881|2168010|FG001|Overall Study|Protocol Deviation|0
1096285|NCT02311881|2168011|FG002|Overall Study|Protocol Deviation|0
1096286|NCT02311881|2168009|FG000|Overall Study|Non-Compliance|1
1096287|NCT02311881|2168010|FG001|Overall Study|Non-Compliance|0
1096288|NCT02311881|2168011|FG002|Overall Study|Non-Compliance|2
1096289|NCT02311881|2168009|FG000|Overall Study|Physician Decision|0
1096290|NCT02311881|2168010|FG001|Overall Study|Physician Decision|0
1096291|NCT02311881|2168011|FG002|Overall Study|Physician Decision|1
1096292|NCT02311881|2168009|FG000|Overall Study|Medical Monitor Discretion|0
1096293|NCT02311881|2168010|FG001|Overall Study|Medical Monitor Discretion|0
1096294|NCT02311881|2168011|FG002|Overall Study|Medical Monitor Discretion|1
1096295|NCT02311881|2168009|FG000|Overall Study|Participant taking another medication|0
1096296|NCT02311881|2168010|FG001|Overall Study|Participant taking another medication|0
1096297|NCT02311881|2168011|FG002|Overall Study|Participant taking another medication|1
1096298|NCT02311881|2168009|FG000|Overall Study|Serious Adverse Event|0
1096299|NCT02311881|2168010|FG001|Overall Study|Serious Adverse Event|1
1096300|NCT02311881|2168011|FG002|Overall Study|Serious Adverse Event|0
1096301|NCT02311894|2168022|FG000|Overall Study|Discontinued in error|1
1096302|NCT02311894|2168022|FG000|Overall Study|Lost to Follow-up|1
1096303|NCT02311894|2168022|FG000|Overall Study|Adverse Event|1
1096304|NCT02311894|2168022|FG000|Overall Study|Withdrawal by Subject|1
1096305|NCT02312063|2168056|FG000|Overall Study|Withdrawal by Subject|0
1096306|NCT02312063|2168057|FG001|Overall Study|Withdrawal by Subject|1
1096307|NCT02312206|2168071|FG000|Overall Study|Adverse Event|3
1096308|NCT02312206|2168072|FG001|Overall Study|Adverse Event|6
1096309|NCT02312206|2168071|FG000|Overall Study|Withdrawal by Subject|7
1096310|NCT02312206|2168072|FG001|Overall Study|Withdrawal by Subject|6
1096311|NCT02312206|2168071|FG000|Overall Study|Physician Decision|7
1096312|NCT02312206|2168072|FG001|Overall Study|Physician Decision|6
1096313|NCT02312206|2168071|FG000|Overall Study|Death|30
1096314|NCT02312206|2168072|FG001|Overall Study|Death|36
1096315|NCT02312206|2168071|FG000|Overall Study|Study Terminated by Sponsor|81
1096316|NCT02312206|2168072|FG001|Overall Study|Study Terminated by Sponsor|74
1096317|NCT02312206|2168071|FG000|Overall Study|Disease Progression|1
1096318|NCT02312206|2168072|FG001|Overall Study|Disease Progression|0
1096319|NCT02312206|2168071|FG000|Overall Study|Patient progression and new therapy|1
1096320|NCT02312206|2168072|FG001|Overall Study|Patient progression and new therapy|0
1096321|NCT02312206|2168071|FG000|Overall Study|Patient transferred to hospice|0
1096322|NCT02312206|2168072|FG001|Overall Study|Patient transferred to hospice|1
1096323|NCT02312206|2168071|FG000|Overall Study|Subject missed 3 consecutive tx visits|0
1096324|NCT02312206|2168072|FG001|Overall Study|Subject missed 3 consecutive tx visits|1
1096325|NCT02312219|2168080|FG000|Overall Study|Withdrawal by Subject|1
1096326|NCT02312219|2168081|FG001|Overall Study|Withdrawal by Subject|2
1096327|NCT02312219|2168080|FG000|Overall Study|could not schedule imaging in time|0
1096328|NCT02312219|2168081|FG001|Overall Study|could not schedule imaging in time|2
1096329|NCT02312219|2168080|FG000|Overall Study|Other|0
1096330|NCT02312219|2168081|FG001|Overall Study|Other|1
1096331|NCT02312219|2168080|FG000|Overall Study|Not randomized. Ineligible|0
1096332|NCT02312219|2168081|FG001|Overall Study|Not randomized. Ineligible|1
1096345|NCT02312687|2168133|FG000|Overall Study|Other, Not Specified|1
1096346|NCT02312856|2168177|FG000|Overall Study|Death|1
1096347|NCT02312856|2168177|FG000|Overall Study|Lost to Follow-up|3
1096348|NCT02312934|2168187|FG000|Overall Study|Lost to Follow-up|1
1096349|NCT02312934|2168188|FG001|Overall Study|Lost to Follow-up|0
1096350|NCT02312934|2168187|FG000|Overall Study|Physician Decision|1
1096351|NCT02312934|2168188|FG001|Overall Study|Physician Decision|0
1096352|NCT02313155|2168201|FG000|Overall Study|Lost to Follow-up|0
1096353|NCT02313155|2168202|FG001|Overall Study|Lost to Follow-up|1
1096354|NCT02313233|2168210|FG000|Overall Study|Withdrawal by Subject|1
1096355|NCT02313233|2168211|FG001|Overall Study|Withdrawal by Subject|2
1096356|NCT02313233|2168210|FG000|Overall Study|Administrative reason|1
1096357|NCT02313233|2168211|FG001|Overall Study|Administrative reason|1
1096358|NCT02313558|2168238|FG000|Overall Study|Withdrawal by Subject|2
1096359|NCT02313558|2168239|FG001|Overall Study|Withdrawal by Subject|0
1096360|NCT02313558|2168238|FG000|Overall Study|Lost to Follow-up|4
1096361|NCT02313558|2168239|FG001|Overall Study|Lost to Follow-up|4
1096362|NCT02313766|2168274|FG000|Overall Study|surgery cancelled|1
1096363|NCT02313766|2168275|FG001|Overall Study|surgery cancelled|0
1096364|NCT02313766|2168276|FG002|Overall Study|surgery cancelled|0
1096365|NCT02313766|2168274|FG000|Overall Study|Lost to Follow-up|0
1096366|NCT02313766|2168275|FG001|Overall Study|Lost to Follow-up|2
1096367|NCT02313766|2168276|FG002|Overall Study|Lost to Follow-up|0
1096368|NCT02313766|2168274|FG000|Overall Study|Adverse Event|0
1096369|NCT02313766|2168275|FG001|Overall Study|Adverse Event|1
1096370|NCT02313766|2168276|FG002|Overall Study|Adverse Event|0
1096371|NCT02313909|2168286|FG000|Overall Study|Consent withdrawn by participant|33
1096372|NCT02313909|2168287|FG001|Overall Study|Consent withdrawn by participant|33
1096373|NCT02313909|2168286|FG000|Overall Study|Lost to Follow-up|24
1096374|NCT02313909|2168287|FG001|Overall Study|Lost to Follow-up|17
1096375|NCT02314026|2168303|FG000|Overall Study|Protocol Violation|28
1096376|NCT02314052|2168307|FG000|Cycle One|Adverse Event|0
1096377|NCT02314052|2168308|FG001|Cycle One|Adverse Event|0
1096378|NCT02314052|2168309|FG002|Cycle One|Adverse Event|0
1096379|NCT02314052|2168310|FG003|Cycle One|Adverse Event|1
1096380|NCT02314052|2168311|FG004|Cycle One|Adverse Event|0
1096381|NCT02314052|2168312|FG005|Cycle One|Adverse Event|0
1096382|NCT02314117|2168341|FG000|Overall Study|Lost to Follow-up|9
1096383|NCT02314117|2168342|FG001|Overall Study|Lost to Follow-up|14
1096384|NCT02314117|2168341|FG000|Overall Study|Withdrawal by Subject|3
1096385|NCT02314117|2168342|FG001|Overall Study|Withdrawal by Subject|2
1096386|NCT02314143|2168352|FG000|Overall Study|Adverse Event|0
1096387|NCT02314143|2168353|FG001|Overall Study|Adverse Event|6
1096388|NCT02314143|2168354|FG002|Overall Study|Adverse Event|4
1096389|NCT02314143|2168352|FG000|Overall Study|Other (Study Closed/Terminated)|5
1096390|NCT02314143|2168353|FG001|Overall Study|Other (Study Closed/Terminated)|3
1096391|NCT02314143|2168354|FG002|Overall Study|Other (Study Closed/Terminated)|4
1096392|NCT02314143|2168352|FG000|Overall Study|Physician Decision|2
1096393|NCT02314143|2168353|FG001|Overall Study|Physician Decision|1
1096394|NCT02314143|2168354|FG002|Overall Study|Physician Decision|0
1096395|NCT02314143|2168352|FG000|Overall Study|Withdrawal by Subject|1
1096396|NCT02314143|2168353|FG001|Overall Study|Withdrawal by Subject|0
1096397|NCT02314143|2168354|FG002|Overall Study|Withdrawal by Subject|1
1096398|NCT02314247|2168365|FG000|Overall Study|Adverse Event|2
1096399|NCT02314247|2168366|FG001|Overall Study|Adverse Event|1
1096400|NCT02314247|2168367|FG002|Overall Study|Adverse Event|0
1096401|NCT02314247|2168365|FG000|Overall Study|Withdrawal by Subject|1
1096402|NCT02314247|2168366|FG001|Overall Study|Withdrawal by Subject|3
1096403|NCT02314247|2168367|FG002|Overall Study|Withdrawal by Subject|1
1096404|NCT02314247|2168365|FG000|Overall Study|Progression of Disease|6
1096405|NCT02314247|2168366|FG001|Overall Study|Progression of Disease|2
1096406|NCT02314247|2168367|FG002|Overall Study|Progression of Disease|0
1096407|NCT02314637|2168414|FG000|Overall Study|Adverse Event|4
1096408|NCT02314637|2168415|FG001|Overall Study|Adverse Event|8
1096409|NCT02314637|2168414|FG000|Overall Study|Lack of Efficacy|1
1096410|NCT02314637|2168415|FG001|Overall Study|Lack of Efficacy|0
1096411|NCT02314637|2168414|FG000|Overall Study|Physician Decision|5
1096412|NCT02314637|2168415|FG001|Overall Study|Physician Decision|2
1096413|NCT02314637|2168414|FG000|Overall Study|Withdrawal by Subject|5
1096414|NCT02314637|2168415|FG001|Overall Study|Withdrawal by Subject|4
1096415|NCT02314637|2168414|FG000|Overall Study|Other Reason|1
1096416|NCT02314637|2168415|FG001|Overall Study|Other Reason|0
1096417|NCT02314728|2168427|FG000|Overall Study|Protocol Violation|1
1096418|NCT02314728|2168428|FG001|Overall Study|Protocol Violation|0
1096419|NCT02314728|2168427|FG000|Overall Study|Lost to Follow-up|0
1096420|NCT02314728|2168428|FG001|Overall Study|Lost to Follow-up|1
1096421|NCT02314780|2168439|FG000|Overall Study|organizational reasons|0
1096422|NCT02314780|2168440|FG001|Overall Study|organizational reasons|2
1096423|NCT02314780|2168441|FG002|Overall Study|organizational reasons|0
1096424|NCT02314780|2168439|FG000|Overall Study|Adverse Event|0
1096425|NCT02314780|2168440|FG001|Overall Study|Adverse Event|1
1096426|NCT02314780|2168441|FG002|Overall Study|Adverse Event|0
1096427|NCT02315560|2168561|FG000|Overall Study|noncompliance by subjects|3
1096428|NCT02315625|2168567|FG000|First Intervention|Disease Progression|1
1096429|NCT02315625|2168568|FG001|First Intervention|Disease Progression|0
1096430|NCT02315625|2168567|FG000|Second Intervention|Physician Decision|2
1096431|NCT02315625|2168568|FG001|Second Intervention|Physician Decision|1
1096432|NCT02315625|2168567|FG000|Second Intervention|Study closure|1
1096433|NCT02315625|2168568|FG001|Second Intervention|Study closure|0
1096434|NCT02315625|2168567|FG000|Second Intervention|Disease Progression|1
1096435|NCT02315625|2168568|FG001|Second Intervention|Disease Progression|0
1096436|NCT02315664|2168578|FG000|Overall Study|Lost to Follow-up|1
1096437|NCT02315664|2168579|FG001|Overall Study|Lost to Follow-up|1
1096438|NCT02315664|2168578|FG000|Overall Study|Withdrawal by Subject|0
1096439|NCT02315664|2168579|FG001|Overall Study|Withdrawal by Subject|3
1096488|NCT02316171|2168645|FG000|Overall Study|difficulties with urinary catheter|1
1096489|NCT02316171|2168646|FG001|Overall Study|difficulties with urinary catheter|0
1096490|NCT02316171|2168647|FG002|Overall Study|difficulties with urinary catheter|0
1096491|NCT02316171|2168648|FG003|Overall Study|difficulties with urinary catheter|0
1096492|NCT02316223|2168657|FG000|Overall Study|Lack of Efficacy|0
1096493|NCT02316223|2168658|FG001|Overall Study|Lack of Efficacy|1
1096494|NCT02316223|2168659|FG002|Overall Study|Lack of Efficacy|1
1096495|NCT02316223|2168657|FG000|Overall Study|Lost to Follow-up|27
1096496|NCT02316223|2168658|FG001|Overall Study|Lost to Follow-up|34
1096497|NCT02316223|2168659|FG002|Overall Study|Lost to Follow-up|36
1096498|NCT02316223|2168657|FG000|Overall Study|COPD Diagnosis|3
1096499|NCT02316223|2168658|FG001|Overall Study|COPD Diagnosis|2
1096500|NCT02316223|2168659|FG002|Overall Study|COPD Diagnosis|3
1096501|NCT02316223|2168657|FG000|Overall Study|Reside outside study area|1
1096502|NCT02316223|2168658|FG001|Overall Study|Reside outside study area|1
1096503|NCT02316223|2168659|FG002|Overall Study|Reside outside study area|1
1096504|NCT02316223|2168657|FG000|Overall Study|No asthma|2
1096505|NCT02316223|2168658|FG001|Overall Study|No asthma|0
1096506|NCT02316223|2168659|FG002|Overall Study|No asthma|0
1096507|NCT02316223|2168657|FG000|Overall Study|Discontinued by PI|11
1096508|NCT02316223|2168658|FG001|Overall Study|Discontinued by PI|19
1096509|NCT02316223|2168659|FG002|Overall Study|Discontinued by PI|3
1096510|NCT02316353|2168669|FG000|Overall Study|Pregnancy|1
1096511|NCT02316353|2168670|FG001|Overall Study|Pregnancy|3
1096512|NCT02316353|2168669|FG000|Overall Study|Adverse Event|1
1096513|NCT02316353|2168670|FG001|Overall Study|Adverse Event|3
1096514|NCT02316353|2168669|FG000|Overall Study|Withdrawal by Subject|6
1096515|NCT02316353|2168670|FG001|Overall Study|Withdrawal by Subject|2
1096516|NCT02316548|2168707|FG000|Overall Study|Protocol Violation|0
1096517|NCT02316548|2168708|FG001|Overall Study|Protocol Violation|1
1096518|NCT02316613|2168714|FG000|Overall Study|Death|63
1096519|NCT02316613|2168714|FG000|Overall Study|Lost to Follow-up|9
1096520|NCT02316613|2168714|FG000|Overall Study|Lymphoma transformation|2
1096521|NCT02316613|2168714|FG000|Overall Study|Participant moved/changed medical team|11
1096522|NCT02316613|2168714|FG000|Overall Study|No data and duplicate cases|5
1096523|NCT02316613|2168714|FG000|Overall Study|Did not met selection criteria|14
1096524|NCT02316717|2168741|FG000|Overall Study|Adverse Event|2
1096525|NCT02316717|2168742|FG001|Overall Study|Adverse Event|2
1096526|NCT02316717|2168743|FG002|Overall Study|Adverse Event|0
1096527|NCT02316717|2168741|FG000|Overall Study|Lost to Follow-up|1
1096528|NCT02316717|2168742|FG001|Overall Study|Lost to Follow-up|2
1096529|NCT02316717|2168743|FG002|Overall Study|Lost to Follow-up|1
1096530|NCT02316717|2168741|FG000|Overall Study|Non compliance|3
1096531|NCT02316717|2168742|FG001|Overall Study|Non compliance|1
1096532|NCT02316717|2168743|FG002|Overall Study|Non compliance|0
1096533|NCT02316717|2168741|FG000|Overall Study|Protocol Violation|2
1096534|NCT02316717|2168742|FG001|Overall Study|Protocol Violation|0
1096535|NCT02316717|2168743|FG002|Overall Study|Protocol Violation|0
1096536|NCT02316717|2168741|FG000|Overall Study|Withdrawal by Subject|2
1096537|NCT02316717|2168742|FG001|Overall Study|Withdrawal by Subject|1
1096538|NCT02316717|2168743|FG002|Overall Study|Withdrawal by Subject|1
1096539|NCT02316717|2168741|FG000|Overall Study|Death|0
1096540|NCT02316717|2168742|FG001|Overall Study|Death|0
1096541|NCT02316717|2168743|FG002|Overall Study|Death|1
1096542|NCT02316717|2168741|FG000|Overall Study|Physician Decision|0
1096543|NCT02316717|2168742|FG001|Overall Study|Physician Decision|1
1096544|NCT02316717|2168743|FG002|Overall Study|Physician Decision|0
1096545|NCT02316717|2168741|FG000|Overall Study|TBC|1
1096546|NCT02316717|2168742|FG001|Overall Study|TBC|0
1096547|NCT02316717|2168743|FG002|Overall Study|TBC|0
1096548|NCT02316769|2168756|FG000|Overall Study|Physician Decision|1
1096549|NCT02316769|2168757|FG001|Overall Study|Physician Decision|0
1096550|NCT02316769|2168756|FG000|Overall Study|Withdrawal by Subject|1
1096551|NCT02316769|2168757|FG001|Overall Study|Withdrawal by Subject|0
1096552|NCT02316847|2168765|FG000|Overall Study|Adverse Event|0
1096553|NCT02316847|2168766|FG001|Overall Study|Adverse Event|3
1096554|NCT02316847|2168765|FG000|Overall Study|Lost to Follow-up|0
1096555|NCT02316847|2168766|FG001|Overall Study|Lost to Follow-up|2
1096556|NCT02316847|2168765|FG000|Overall Study|Physician Decision|0
1096557|NCT02316847|2168766|FG001|Overall Study|Physician Decision|1
1096558|NCT02316847|2168765|FG000|Overall Study|Pregnancy|0
1096559|NCT02316847|2168766|FG001|Overall Study|Pregnancy|1
1096560|NCT02316847|2168765|FG000|Overall Study|Withdrawal by Subject|2
1096561|NCT02316847|2168766|FG001|Overall Study|Withdrawal by Subject|9
1096562|NCT02316847|2168765|FG000|Overall Study|Noncompliance with study drug|0
1096563|NCT02316847|2168766|FG001|Overall Study|Noncompliance with study drug|3
1096564|NCT02316847|2168765|FG000|Overall Study|Withdrawn due to termination by Sponsor|7
1096565|NCT02316847|2168766|FG001|Overall Study|Withdrawn due to termination by Sponsor|67
1096566|NCT02317016|2168774|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
1096567|NCT02317016|2168774|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
1096568|NCT02317016|2168774|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
1096569|NCT02317016|2168774|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
1096570|NCT02317016|2168774|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
1096571|NCT02317016|2168774|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
1096572|NCT02317016|2168774|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5
1096573|NCT02317432|2168793|FG000|Overall Study|Death|4
1096574|NCT02317432|2168794|FG001|Overall Study|Death|1
1096575|NCT02317432|2168793|FG000|Overall Study|Lost to Follow-up|0
1096576|NCT02317432|2168794|FG001|Overall Study|Lost to Follow-up|5
1096577|NCT02317432|2168793|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27
1096578|NCT02317432|2168794|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0
1096579|NCT02317510|2168802|FG000|Overall Study|Adverse Event|0
1096580|NCT02317510|2168803|FG001|Overall Study|Adverse Event|1
1096581|NCT02317562|2168821|FG000|Overall Study|Physician Decision|1
1096582|NCT02317562|2168821|FG000|Overall Study|early termination of the study|8
1096583|NCT02317562|2168821|FG000|Overall Study|Lack of Efficacy|4
1096584|NCT02317562|2168821|FG000|Overall Study|Withdrawal by Subject|1
1096585|NCT02317575|2168825|FG000|Period 1|Difficulty with venous cannulation|0
1096586|NCT02317575|2168826|FG001|Period 1|Difficulty with venous cannulation|1
1096587|NCT02317575|2168827|FG002|Period 1|Difficulty with venous cannulation|0
1096588|NCT02317575|2168828|FG003|Period 1|Difficulty with venous cannulation|0
1096589|NCT02317575|2168829|FG004|Period 1|Difficulty with venous cannulation|0
1096590|NCT02317575|2168825|FG000|Period 1|Withdrawal by Subject|1
893409|NCT00684021|1863827|FG000|Overall Study|MRI Contraindicated|1
893410|NCT00684021|1863828|FG001|Overall Study|MRI Contraindicated|1
893411|NCT00684021|1863829|FG002|Overall Study|MRI Contraindicated|1
893412|NCT00684021|1863830|FG003|Overall Study|MRI Contraindicated|0
893413|NCT00684021|1863827|FG000|Overall Study|MRI not performed|0
893414|NCT00684021|1863828|FG001|Overall Study|MRI not performed|1
893415|NCT00684021|1863829|FG002|Overall Study|MRI not performed|1
893416|NCT00684021|1863830|FG003|Overall Study|MRI not performed|2
893417|NCT00684021|1863827|FG000|Overall Study|Death|1
893418|NCT00684021|1863828|FG001|Overall Study|Death|0
893419|NCT00684021|1863829|FG002|Overall Study|Death|0
893420|NCT00684021|1863830|FG003|Overall Study|Death|0
893421|NCT00684060|1863855|FG000|Overall Study|Lost to Follow-up|1
893422|NCT00684060|1863856|FG001|Overall Study|Lost to Follow-up|0
893423|NCT00684060|1863855|FG000|Overall Study|New stenosis identified|1
893424|NCT00684060|1863856|FG001|Overall Study|New stenosis identified|0
893425|NCT00684060|1863855|FG000|Overall Study|Unable to collect MRI|1
893426|NCT00684060|1863856|FG001|Overall Study|Unable to collect MRI|2
893427|NCT00684060|1863855|FG000|Overall Study|Death|0
893428|NCT00684060|1863856|FG001|Overall Study|Death|1
893429|NCT00684073|1863862|FG000|Selection|Selection/non-selection criteria|3
893430|NCT00684073|1863862|FG000|Selection|Death|1
893431|NCT00684073|1863862|FG000|Selection|noncompliance|1
893432|NCT00684073|1863862|FG000|Selection|Lost to Follow-up|1
1096591|NCT02317575|2168826|FG001|Period 1|Withdrawal by Subject|0
1096592|NCT02317575|2168827|FG002|Period 1|Withdrawal by Subject|0
1096593|NCT02317575|2168828|FG003|Period 1|Withdrawal by Subject|0
1096594|NCT02317575|2168829|FG004|Period 1|Withdrawal by Subject|0
1096595|NCT02317614|2168849|FG000|Overall Study|Lost to Follow-up|1
1096596|NCT02317614|2168850|FG001|Overall Study|Lost to Follow-up|1
1096597|NCT02317614|2168849|FG000|Overall Study|Withdrawal by Subject|1
1096598|NCT02317614|2168850|FG001|Overall Study|Withdrawal by Subject|0
1096599|NCT02317614|2168849|FG000|Overall Study|Death|1
1096600|NCT02317614|2168850|FG001|Overall Study|Death|1
1096601|NCT02317627|2168859|FG000|Overall Study|Withdrawal by Subject|0
1096602|NCT02317627|2168860|FG001|Overall Study|Withdrawal by Subject|1
1096603|NCT02317627|2168861|FG002|Overall Study|Withdrawal by Subject|1
1096604|NCT02317627|2168859|FG000|Overall Study|Lost to Follow-up|2
1096605|NCT02317627|2168860|FG001|Overall Study|Lost to Follow-up|0
1096606|NCT02317627|2168861|FG002|Overall Study|Lost to Follow-up|0
1096607|NCT02317627|2168859|FG000|Overall Study|Stopped by Investigator|0
1096608|NCT02317627|2168860|FG001|Overall Study|Stopped by Investigator|1
1096609|NCT02317627|2168861|FG002|Overall Study|Stopped by Investigator|0
1096610|NCT02317627|2168859|FG000|Overall Study|Adverse Event|0
1096611|NCT02317627|2168860|FG001|Overall Study|Adverse Event|2
1096612|NCT02317627|2168861|FG002|Overall Study|Adverse Event|3
1096613|NCT02317627|2168859|FG000|Overall Study|Non-compliance with study drug|0
1096614|NCT02317627|2168860|FG001|Overall Study|Non-compliance with study drug|1
1096615|NCT02317627|2168861|FG002|Overall Study|Non-compliance with study drug|0
1096616|NCT02317809|2168893|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2
1096617|NCT02317809|2168894|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0
1096618|NCT02317809|2168893|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
1096619|NCT02317809|2168894|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
1096620|NCT02318095|2168903|FG000|Overall Study|Adverse Event|1
1096621|NCT02318134|2168910|FG000|Overall Study|Withdrawal by Subject|2
1096622|NCT02318134|2168911|FG001|Overall Study|Withdrawal by Subject|1
1096729|NCT02318368|2169052|FG000|Overall Study|Withdrawal by Subject|2
1096730|NCT02318368|2169053|FG001|Overall Study|Withdrawal by Subject|0
1096731|NCT02318368|2169052|FG000|Overall Study|Study terminated by the sponsor|5
1096732|NCT02318368|2169053|FG001|Overall Study|Study terminated by the sponsor|2
1096733|NCT02318368|2169052|FG000|Overall Study|Death|0
1096734|NCT02318368|2169053|FG001|Overall Study|Death|1
1096735|NCT02318602|2169066|FG000|Overall Study|Adverse Event|0
1096736|NCT02318602|2169067|FG001|Overall Study|Adverse Event|1
1096737|NCT02318602|2169068|FG002|Overall Study|Adverse Event|1
1096738|NCT02318602|2169066|FG000|Overall Study|Withdrawal by Subject|0
1096739|NCT02318602|2169067|FG001|Overall Study|Withdrawal by Subject|3
1096740|NCT02318602|2169068|FG002|Overall Study|Withdrawal by Subject|0
1096741|NCT02318602|2169066|FG000|Overall Study|Death|1
1096742|NCT02318602|2169067|FG001|Overall Study|Death|0
1096743|NCT02318602|2169068|FG002|Overall Study|Death|0
1096744|NCT02318602|2169066|FG000|Overall Study|Guardian decision to withdraw|0
1096745|NCT02318602|2169067|FG001|Overall Study|Guardian decision to withdraw|0
1096746|NCT02318602|2169068|FG002|Overall Study|Guardian decision to withdraw|1
1096747|NCT02318667|2169082|FG000|Overall Study|Adverse Event|1
1096748|NCT02318667|2169082|FG000|Overall Study|Lack of Efficacy|6
1096749|NCT02318667|2169082|FG000|Overall Study|Protocol Violation|2
1096750|NCT02318693|2169092|FG000|Overall Study|Protocol Violation|0
1096751|NCT02318693|2169093|FG001|Overall Study|Protocol Violation|1
1096752|NCT02318706|2169103|FG000|Double-blind Phase|Adverse Event|7
1096753|NCT02318706|2169104|FG001|Double-blind Phase|Adverse Event|4
1096754|NCT02318706|2169105|FG002|Double-blind Phase|Adverse Event|3
1096755|NCT02318706|2169106|FG003|Double-blind Phase|Adverse Event|10
1096756|NCT02318706|2169107|FG004|Double-blind Phase|Adverse Event|0
1096757|NCT02318706|2169103|FG000|Double-blind Phase|Lost to Follow-up|1
1096758|NCT02318706|2169104|FG001|Double-blind Phase|Lost to Follow-up|0
1096759|NCT02318706|2169105|FG002|Double-blind Phase|Lost to Follow-up|0
1096760|NCT02318706|2169106|FG003|Double-blind Phase|Lost to Follow-up|0
1096761|NCT02318706|2169107|FG004|Double-blind Phase|Lost to Follow-up|0
1096762|NCT02318706|2169103|FG000|Double-blind Phase|Protocol Violation|4
1096763|NCT02318706|2169104|FG001|Double-blind Phase|Protocol Violation|2
1096764|NCT02318706|2169105|FG002|Double-blind Phase|Protocol Violation|4
1096765|NCT02318706|2169106|FG003|Double-blind Phase|Protocol Violation|3
1096766|NCT02318706|2169107|FG004|Double-blind Phase|Protocol Violation|0
1096767|NCT02318706|2169103|FG000|Double-blind Phase|Withdrawal by Subject|9
1096768|NCT02318706|2169104|FG001|Double-blind Phase|Withdrawal by Subject|5
1096769|NCT02318706|2169105|FG002|Double-blind Phase|Withdrawal by Subject|7
1096770|NCT02318706|2169106|FG003|Double-blind Phase|Withdrawal by Subject|10
1096771|NCT02318706|2169107|FG004|Double-blind Phase|Withdrawal by Subject|0
1096772|NCT02318706|2169103|FG000|Double-blind Phase|Other|4
1096773|NCT02318706|2169104|FG001|Double-blind Phase|Other|1
1096774|NCT02318706|2169105|FG002|Double-blind Phase|Other|2
1096775|NCT02318706|2169106|FG003|Double-blind Phase|Other|1
1096776|NCT02318706|2169107|FG004|Double-blind Phase|Other|0
1096777|NCT02318706|2169103|FG000|Double-blind Phase|Death|0
1096778|NCT02318706|2169104|FG001|Double-blind Phase|Death|0
1096779|NCT02318706|2169105|FG002|Double-blind Phase|Death|2
1096780|NCT02318706|2169106|FG003|Double-blind Phase|Death|0
1096781|NCT02318706|2169107|FG004|Double-blind Phase|Death|0
1096782|NCT02318706|2169103|FG000|Open-label Extension Phase|Adverse Event|0
1096783|NCT02318706|2169104|FG001|Open-label Extension Phase|Adverse Event|0
1096784|NCT02318706|2169105|FG002|Open-label Extension Phase|Adverse Event|0
1096785|NCT02318706|2169106|FG003|Open-label Extension Phase|Adverse Event|0
1096786|NCT02318706|2169107|FG004|Open-label Extension Phase|Adverse Event|21
1096787|NCT02318706|2169103|FG000|Open-label Extension Phase|Lack of Efficacy|0
1096788|NCT02318706|2169104|FG001|Open-label Extension Phase|Lack of Efficacy|0
1096789|NCT02318706|2169105|FG002|Open-label Extension Phase|Lack of Efficacy|0
1096790|NCT02318706|2169106|FG003|Open-label Extension Phase|Lack of Efficacy|0
1096791|NCT02318706|2169107|FG004|Open-label Extension Phase|Lack of Efficacy|1
1096792|NCT02318706|2169103|FG000|Open-label Extension Phase|Death|0
1096793|NCT02318706|2169104|FG001|Open-label Extension Phase|Death|0
1096794|NCT02318706|2169105|FG002|Open-label Extension Phase|Death|0
1096795|NCT02318706|2169106|FG003|Open-label Extension Phase|Death|0
1096796|NCT02318706|2169107|FG004|Open-label Extension Phase|Death|1
1096797|NCT02318706|2169103|FG000|Open-label Extension Phase|Withdrawal by Subject|0
1096798|NCT02318706|2169104|FG001|Open-label Extension Phase|Withdrawal by Subject|0
1096799|NCT02318706|2169105|FG002|Open-label Extension Phase|Withdrawal by Subject|0
1096800|NCT02318706|2169106|FG003|Open-label Extension Phase|Withdrawal by Subject|0
1096801|NCT02318706|2169107|FG004|Open-label Extension Phase|Withdrawal by Subject|19
1096802|NCT02318719|2169123|FG000|Double-blind Phase|Adverse Event|7
1096803|NCT02318719|2169124|FG001|Double-blind Phase|Adverse Event|6
1096804|NCT02318719|2169125|FG002|Double-blind Phase|Adverse Event|12
1096805|NCT02318719|2169126|FG003|Double-blind Phase|Adverse Event|4
1096806|NCT02318719|2169127|FG004|Double-blind Phase|Adverse Event|0
1096807|NCT02318719|2169123|FG000|Double-blind Phase|Lack of Efficacy|5
1096808|NCT02318719|2169124|FG001|Double-blind Phase|Lack of Efficacy|0
1096809|NCT02318719|2169125|FG002|Double-blind Phase|Lack of Efficacy|1
1096810|NCT02318719|2169126|FG003|Double-blind Phase|Lack of Efficacy|1
1096811|NCT02318719|2169127|FG004|Double-blind Phase|Lack of Efficacy|0
1096812|NCT02318719|2169123|FG000|Double-blind Phase|Protocol Violation|0
1096813|NCT02318719|2169124|FG001|Double-blind Phase|Protocol Violation|1
1096814|NCT02318719|2169125|FG002|Double-blind Phase|Protocol Violation|3
1096815|NCT02318719|2169126|FG003|Double-blind Phase|Protocol Violation|0
1096816|NCT02318719|2169127|FG004|Double-blind Phase|Protocol Violation|0
1096817|NCT02318719|2169123|FG000|Double-blind Phase|Withdrawal by Subject|25
1096818|NCT02318719|2169124|FG001|Double-blind Phase|Withdrawal by Subject|7
1096819|NCT02318719|2169125|FG002|Double-blind Phase|Withdrawal by Subject|9
1096820|NCT02318719|2169126|FG003|Double-blind Phase|Withdrawal by Subject|10
1096821|NCT02318719|2169127|FG004|Double-blind Phase|Withdrawal by Subject|0
1096822|NCT02318719|2169123|FG000|Double-blind Phase|Other|1
1096823|NCT02318719|2169124|FG001|Double-blind Phase|Other|2
1096824|NCT02318719|2169125|FG002|Double-blind Phase|Other|0
1096825|NCT02318719|2169126|FG003|Double-blind Phase|Other|0
1096826|NCT02318719|2169127|FG004|Double-blind Phase|Other|0
1096827|NCT02318719|2169123|FG000|Open-label Extension Phase|Adverse Event|0
1096828|NCT02318719|2169124|FG001|Open-label Extension Phase|Adverse Event|0
1096829|NCT02318719|2169125|FG002|Open-label Extension Phase|Adverse Event|0
1096830|NCT02318719|2169126|FG003|Open-label Extension Phase|Adverse Event|0
1096831|NCT02318719|2169127|FG004|Open-label Extension Phase|Adverse Event|15
1096832|NCT02318719|2169123|FG000|Open-label Extension Phase|Death|0
1096833|NCT02318719|2169124|FG001|Open-label Extension Phase|Death|0
1096834|NCT02318719|2169125|FG002|Open-label Extension Phase|Death|0
1096835|NCT02318719|2169126|FG003|Open-label Extension Phase|Death|0
1096836|NCT02318719|2169127|FG004|Open-label Extension Phase|Death|1
1096837|NCT02318719|2169123|FG000|Open-label Extension Phase|Lack of Efficacy|0
1096838|NCT02318719|2169124|FG001|Open-label Extension Phase|Lack of Efficacy|0
1096839|NCT02318719|2169125|FG002|Open-label Extension Phase|Lack of Efficacy|0
1096840|NCT02318719|2169126|FG003|Open-label Extension Phase|Lack of Efficacy|0
1096841|NCT02318719|2169127|FG004|Open-label Extension Phase|Lack of Efficacy|1
1096842|NCT02318719|2169123|FG000|Open-label Extension Phase|Withdrawal by Subject|0
1096843|NCT02318719|2169124|FG001|Open-label Extension Phase|Withdrawal by Subject|0
1096844|NCT02318719|2169125|FG002|Open-label Extension Phase|Withdrawal by Subject|0
1096845|NCT02318719|2169126|FG003|Open-label Extension Phase|Withdrawal by Subject|0
1096846|NCT02318719|2169127|FG004|Open-label Extension Phase|Withdrawal by Subject|31
1096847|NCT02318719|2169123|FG000|Open-label Extension Phase|Other|0
1096848|NCT02318719|2169124|FG001|Open-label Extension Phase|Other|0
1096849|NCT02318719|2169125|FG002|Open-label Extension Phase|Other|0
1096850|NCT02318719|2169126|FG003|Open-label Extension Phase|Other|0
1096851|NCT02318719|2169127|FG004|Open-label Extension Phase|Other|7
1096852|NCT02318797|2169141|FG000|Overall Study|Death|3
1096853|NCT02318797|2169142|FG001|Overall Study|Death|6
1096854|NCT02318797|2169141|FG000|Overall Study|Lost to Follow-up|85
1096855|NCT02318797|2169142|FG001|Overall Study|Lost to Follow-up|96
1096856|NCT02318940|2169150|FG000|Overall Study|lost the record|1
1096857|NCT02318940|2169151|FG001|Overall Study|lost the record|0
1096858|NCT02319031|2169185|FG000|Treatment Period|Death|1
1096859|NCT02319031|2169186|FG001|Treatment Period|Death|0
1096860|NCT02319044|2169195|FG000|Overall Study|Death, PI/sponsor decision, med history|0
1096861|NCT02319044|2169196|FG001|Overall Study|Death, PI/sponsor decision, med history|1
1096862|NCT02319044|2169197|FG002|Overall Study|Death, PI/sponsor decision, med history|4
1096863|NCT02319044|2169195|FG000|Overall Study|Withdrawal by Subject|3
1096864|NCT02319044|2169196|FG001|Overall Study|Withdrawal by Subject|3
1096865|NCT02319044|2169197|FG002|Overall Study|Withdrawal by Subject|6
1096866|NCT02319044|2169195|FG000|Overall Study|Condition under investigation worsened|100
1096867|NCT02319044|2169196|FG001|Overall Study|Condition under investigation worsened|50
1096868|NCT02319044|2169197|FG002|Overall Study|Condition under investigation worsened|46
1096869|NCT02319044|2169195|FG000|Overall Study|Adverse Event|17
1096870|NCT02319044|2169196|FG001|Overall Study|Adverse Event|2
1096871|NCT02319044|2169197|FG002|Overall Study|Adverse Event|8
1096872|NCT02319044|2169195|FG000|Overall Study|Study specific discontinuation criteria|2
1096873|NCT02319044|2169196|FG001|Overall Study|Study specific discontinuation criteria|2
1096874|NCT02319044|2169197|FG002|Overall Study|Study specific discontinuation criteria|1
1096875|NCT02319044|2169195|FG000|Overall Study|Not treated|0
1096876|NCT02319044|2169196|FG001|Overall Study|Not treated|2
1096877|NCT02319044|2169197|FG002|Overall Study|Not treated|2
1096878|NCT02319148|2169209|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0
1096879|NCT02319148|2169210|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0
1096880|NCT02319148|2169211|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1
1096881|NCT02319148|2169212|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1
1096882|NCT02319148|2169209|FG000|Second Intervention Period|No longer willing to participate|0
1096883|NCT02319148|2169210|FG001|Second Intervention Period|No longer willing to participate|1
1096884|NCT02319148|2169211|FG002|Second Intervention Period|No longer willing to participate|0
1096885|NCT02319148|2169212|FG003|Second Intervention Period|No longer willing to participate|0
1096886|NCT02319148|2169209|FG000|Second Intervention Period|Other|0
1096887|NCT02319148|2169210|FG001|Second Intervention Period|Other|0
1096888|NCT02319148|2169211|FG002|Second Intervention Period|Other|0
1096889|NCT02319148|2169212|FG003|Second Intervention Period|Other|1
1096890|NCT02319525|2169320|FG000|Overall Study|Withdrawal by Subject|2
1096891|NCT02319525|2169321|FG001|Overall Study|Withdrawal by Subject|1
1096892|NCT02319642|2169329|FG000|Overall Study|Adverse Event|2
1096893|NCT02319642|2169330|FG001|Overall Study|Adverse Event|4
1096894|NCT02319642|2169329|FG000|Overall Study|Lack of Efficacy|1
1096895|NCT02319642|2169330|FG001|Overall Study|Lack of Efficacy|1
1096896|NCT02319642|2169329|FG000|Overall Study|Withdrawal by Subject|1
1096897|NCT02319642|2169330|FG001|Overall Study|Withdrawal by Subject|1
1096898|NCT02319668|2169340|FG000|Overall Study|Other (Not specified)|0
1096899|NCT02319668|2169341|FG001|Overall Study|Other (Not specified)|2
1096900|NCT02319759|2169352|FG000|Week 0 - 16|Lack of Efficacy|1
1096901|NCT02319759|2169353|FG001|Week 0 - 16|Lack of Efficacy|0
1096902|NCT02319759|2169354|FG002|Week 0 - 16|Lack of Efficacy|0
1096903|NCT02319759|2169355|FG003|Week 0 - 16|Lack of Efficacy|0
1096904|NCT02319759|2169356|FG004|Week 0 - 16|Lack of Efficacy|0
1096905|NCT02319759|2169352|FG000|Week 0 - 16|Not met all Inclusion Criteria|0
1096906|NCT02319759|2169353|FG001|Week 0 - 16|Not met all Inclusion Criteria|0
1096907|NCT02319759|2169354|FG002|Week 0 - 16|Not met all Inclusion Criteria|1
1096908|NCT02319759|2169355|FG003|Week 0 - 16|Not met all Inclusion Criteria|0
1096909|NCT02319759|2169356|FG004|Week 0 - 16|Not met all Inclusion Criteria|0
1096910|NCT02319759|2169352|FG000|Week 16 - 24|Lack of Efficacy|1
1096911|NCT02319759|2169353|FG001|Week 16 - 24|Lack of Efficacy|0
1096912|NCT02319759|2169354|FG002|Week 16 - 24|Lack of Efficacy|1
1096913|NCT02319759|2169355|FG003|Week 16 - 24|Lack of Efficacy|0
1096914|NCT02319759|2169356|FG004|Week 16 - 24|Lack of Efficacy|0
1096915|NCT02319759|2169352|FG000|Week 16 - 24|Lost to Follow-up|1
1096916|NCT02319759|2169353|FG001|Week 16 - 24|Lost to Follow-up|0
1096917|NCT02319759|2169354|FG002|Week 16 - 24|Lost to Follow-up|0
1096918|NCT02319759|2169355|FG003|Week 16 - 24|Lost to Follow-up|0
1096919|NCT02319759|2169356|FG004|Week 16 - 24|Lost to Follow-up|0
1096920|NCT02319759|2169352|FG000|Week 16 - 24|Withdrawal by Subject|0
1096921|NCT02319759|2169353|FG001|Week 16 - 24|Withdrawal by Subject|0
1096922|NCT02319759|2169354|FG002|Week 16 - 24|Withdrawal by Subject|2
1096923|NCT02319759|2169355|FG003|Week 16 - 24|Withdrawal by Subject|0
1096924|NCT02319759|2169356|FG004|Week 16 - 24|Withdrawal by Subject|0
1096925|NCT02319759|2169352|FG000|Week 24 - 56|Adverse Event|0
1096926|NCT02319759|2169353|FG001|Week 24 - 56|Adverse Event|0
1096927|NCT02319759|2169354|FG002|Week 24 - 56|Adverse Event|2
1096928|NCT02319759|2169355|FG003|Week 24 - 56|Adverse Event|0
1096929|NCT02319759|2169356|FG004|Week 24 - 56|Adverse Event|0
1096930|NCT02319759|2169352|FG000|Week 24 - 56|Lack of Efficacy|0
1096931|NCT02319759|2169353|FG001|Week 24 - 56|Lack of Efficacy|0
1096932|NCT02319759|2169354|FG002|Week 24 - 56|Lack of Efficacy|0
1096933|NCT02319759|2169355|FG003|Week 24 - 56|Lack of Efficacy|2
1096934|NCT02319759|2169356|FG004|Week 24 - 56|Lack of Efficacy|1
1096935|NCT02319759|2169352|FG000|Week 24 - 56|Withdrawal by Subject|0
1096936|NCT02319759|2169353|FG001|Week 24 - 56|Withdrawal by Subject|1
1096937|NCT02319759|2169354|FG002|Week 24 - 56|Withdrawal by Subject|0
1096938|NCT02319759|2169355|FG003|Week 24 - 56|Withdrawal by Subject|0
1096939|NCT02319759|2169356|FG004|Week 24 - 56|Withdrawal by Subject|0
1096940|NCT02319759|2169352|FG000|Week 24 - 56|Lost to Follow-up|0
1096941|NCT02319759|2169353|FG001|Week 24 - 56|Lost to Follow-up|0
1096942|NCT02319759|2169354|FG002|Week 24 - 56|Lost to Follow-up|0
1096943|NCT02319759|2169355|FG003|Week 24 - 56|Lost to Follow-up|0
1096944|NCT02319759|2169356|FG004|Week 24 - 56|Lost to Follow-up|1
1096945|NCT02320058|2169389|FG000|Overall Study|Death|25
1096946|NCT02320058|2169390|FG001|Overall Study|Death|10
1096947|NCT02320058|2169389|FG000|Overall Study|Lost to Follow-up|4
1096948|NCT02320058|2169390|FG001|Overall Study|Lost to Follow-up|0
1096949|NCT02320058|2169389|FG000|Overall Study|Other reasons|4
1096950|NCT02320058|2169390|FG001|Overall Study|Other reasons|1
1096951|NCT02320058|2169389|FG000|Overall Study|Withdrawal by Subject|8
1096952|NCT02320058|2169390|FG001|Overall Study|Withdrawal by Subject|2
1096953|NCT02320058|2169389|FG000|Overall Study|Not reported|1
1096954|NCT02320058|2169390|FG001|Overall Study|Not reported|0
1096955|NCT02320123|2169398|FG000|Overall Study|Lost to Follow-up|4
1096956|NCT02320123|2169399|FG001|Overall Study|Lost to Follow-up|6
1096957|NCT02320123|2169398|FG000|Overall Study|Death|6
1096958|NCT02320123|2169399|FG001|Overall Study|Death|5
1096959|NCT02320149|2169411|FG000|Overall Study|Adverse Event|3
1096960|NCT02320149|2169412|FG001|Overall Study|Adverse Event|7
1096961|NCT02320149|2169411|FG000|Overall Study|Withdrawal of Consent|28
1096962|NCT02320149|2169412|FG001|Overall Study|Withdrawal of Consent|32
1096963|NCT02320149|2169411|FG000|Overall Study|Lost to Follow-up|21
1096964|NCT02320149|2169412|FG001|Overall Study|Lost to Follow-up|34
1096965|NCT02320149|2169411|FG000|Overall Study|Protocol Violation|2
1096966|NCT02320149|2169412|FG001|Overall Study|Protocol Violation|1
1096967|NCT02320149|2169411|FG000|Overall Study|Noncompliance with Study Treatment|7
1096968|NCT02320149|2169412|FG001|Overall Study|Noncompliance with Study Treatment|2
1096969|NCT02320149|2169411|FG000|Overall Study|Lack of Efficacy|0
1096970|NCT02320149|2169412|FG001|Overall Study|Lack of Efficacy|1
1096971|NCT02320149|2169411|FG000|Overall Study|Other Miscellaneous Reasons|2
1096972|NCT02320149|2169412|FG001|Overall Study|Other Miscellaneous Reasons|3
1096973|NCT02320253|2169442|FG000|Overall Study|Withdrawal by Subject|3
1096974|NCT02320253|2169443|FG001|Overall Study|Withdrawal by Subject|0
1096975|NCT02320253|2169444|FG002|Overall Study|Withdrawal by Subject|0
1096976|NCT02320253|2169442|FG000|Overall Study|Lost to Follow-up|2
1096977|NCT02320253|2169443|FG001|Overall Study|Lost to Follow-up|2
1096978|NCT02320253|2169444|FG002|Overall Study|Lost to Follow-up|1
1096979|NCT02320253|2169442|FG000|Overall Study|Death|1
1096980|NCT02320253|2169443|FG001|Overall Study|Death|0
1096981|NCT02320253|2169444|FG002|Overall Study|Death|1
1096982|NCT02320396|2169454|FG000|Overall Study|Adverse Event|2
1096983|NCT02320396|2169455|FG001|Overall Study|Adverse Event|2
1096984|NCT02320396|2169454|FG000|Overall Study|Pregnancy|0
1096985|NCT02320396|2169455|FG001|Overall Study|Pregnancy|1
1096986|NCT02320396|2169454|FG000|Overall Study|Protocol Violation|0
1096987|NCT02320396|2169455|FG001|Overall Study|Protocol Violation|1
1096988|NCT02320396|2169454|FG000|Overall Study|Withdrawal by Subject|2
1096989|NCT02320396|2169455|FG001|Overall Study|Withdrawal by Subject|0
1096990|NCT02320487|2169461|FG000|Overall Study|Reason not Specified|1
1096991|NCT02320487|2169461|FG000|Overall Study|Physician Decision|5
1096992|NCT02320487|2169461|FG000|Overall Study|Withdrawal by Subject|1
1096993|NCT02320487|2169461|FG000|Overall Study|Death|3
1096994|NCT02320487|2169461|FG000|Overall Study|Adverse Event|11
1096995|NCT02320721|2169476|FG000|Overall Study|Adverse Event|6
1096996|NCT02320721|2169477|FG001|Overall Study|Adverse Event|6
1096997|NCT02320721|2169476|FG000|Overall Study|Lack of Efficacy|2
1096998|NCT02320721|2169477|FG001|Overall Study|Lack of Efficacy|0
1096999|NCT02320721|2169476|FG000|Overall Study|Poor compliance to protocol|3
1097000|NCT02320721|2169477|FG001|Overall Study|Poor compliance to protocol|7
1097001|NCT02320721|2169476|FG000|Overall Study|Randomized but not treated|0
1097002|NCT02320721|2169477|FG001|Overall Study|Randomized but not treated|1
1097003|NCT02320721|2169476|FG000|Overall Study|Hypoglycemia|1
1097004|NCT02320721|2169477|FG001|Overall Study|Hypoglycemia|0
1097005|NCT02320721|2169476|FG000|Overall Study|Other than specified above|15
1097006|NCT02320721|2169477|FG001|Overall Study|Other than specified above|20
1097007|NCT02320903|2169506|FG000|Overall Study|Withdrawal by Subject|0
1097008|NCT02320903|2169507|FG001|Overall Study|Withdrawal by Subject|9
1097009|NCT02320903|2169508|FG002|Overall Study|Withdrawal by Subject|9
1097010|NCT02320903|2169506|FG000|Overall Study|Exited therapy; no longer eligible|8
1097011|NCT02320903|2169507|FG001|Overall Study|Exited therapy; no longer eligible|2
1097012|NCT02320903|2169508|FG002|Overall Study|Exited therapy; no longer eligible|2
1097013|NCT02320903|2169506|FG000|Overall Study|Lost to Follow-up|0
1097014|NCT02320903|2169507|FG001|Overall Study|Lost to Follow-up|5
1097015|NCT02320903|2169508|FG002|Overall Study|Lost to Follow-up|5
1097016|NCT02321098|2169520|FG000|12 Weeks Treament|Lost to Follow-up|1
1097017|NCT02321098|2169521|FG001|12 Weeks Treament|Lost to Follow-up|1
1097018|NCT02321098|2169522|FG002|12 Weeks Treament|Lost to Follow-up|0
1097019|NCT02321098|2169520|FG000|Additional 15 Months Treatment|Lack of Efficacy|0
1097020|NCT02321098|2169521|FG001|Additional 15 Months Treatment|Lack of Efficacy|0
1097021|NCT02321098|2169522|FG002|Additional 15 Months Treatment|Lack of Efficacy|6
1097022|NCT02321098|2169520|FG000|Additional 15 Months Treatment|Lost to Follow-up|0
1097023|NCT02321098|2169521|FG001|Additional 15 Months Treatment|Lost to Follow-up|0
1097024|NCT02321098|2169522|FG002|Additional 15 Months Treatment|Lost to Follow-up|1
1097025|NCT02321098|2169520|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0
1097026|NCT02321098|2169521|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0
1097027|NCT02321098|2169522|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1
1097028|NCT02321319|2169544|FG000|Overall Study|Product discontinued|5
1097029|NCT02321436|2169550|FG000|Overall Study|Withdrawal by Subject|1
1097030|NCT02321436|2169551|FG001|Overall Study|Withdrawal by Subject|0
1097031|NCT02321436|2169550|FG000|Overall Study|Lost to Follow-up|0
1097032|NCT02321436|2169551|FG001|Overall Study|Lost to Follow-up|1
1097033|NCT02321462|2169560|FG000|Overall Study|Withdrawal by Subject|5
1097034|NCT02321462|2169561|FG001|Overall Study|Withdrawal by Subject|2
1097035|NCT02321462|2169560|FG000|Overall Study|Subject withdrawn before any treatment|1
1097036|NCT02321462|2169561|FG001|Overall Study|Subject withdrawn before any treatment|1
1097040|NCT02321800|2169590|FG000|Overall Study|Withdrawal by Subject|3
1097041|NCT02321800|2169591|FG001|Overall Study|Withdrawal by Subject|3
1097042|NCT02321800|2169590|FG000|Overall Study|Death|1
1097043|NCT02321800|2169591|FG001|Overall Study|Death|0
1097044|NCT02321800|2169590|FG000|Overall Study|Protocol Violation|1
1097045|NCT02321800|2169591|FG001|Overall Study|Protocol Violation|0
1097046|NCT02321800|2169590|FG000|Overall Study|Lost to Follow-up|10
1097047|NCT02321800|2169591|FG001|Overall Study|Lost to Follow-up|4
1097048|NCT02321800|2169590|FG000|Overall Study|Adverse Event|2
1097049|NCT02321800|2169591|FG001|Overall Study|Adverse Event|3
1097050|NCT02321800|2169590|FG000|Overall Study|Other, Miscellaneous|3
1097051|NCT02321800|2169591|FG001|Overall Study|Other, Miscellaneous|1
1097052|NCT02321930|2169597|FG000|Overall Study|Lost to Follow-up|1
1097053|NCT02322021|2169605|FG000|Core Phase|Adverse Event|1
1097054|NCT02322021|2169606|FG001|Core Phase|Adverse Event|3
1097055|NCT02322021|2169607|FG002|Core Phase|Adverse Event|4
1097056|NCT02322021|2169608|FG003|Core Phase|Adverse Event|2
1097057|NCT02322021|2169609|FG004|Core Phase|Adverse Event|0
1097058|NCT02322021|2169605|FG000|Core Phase|Participant Choice|4
1097059|NCT02322021|2169606|FG001|Core Phase|Participant Choice|5
1097060|NCT02322021|2169607|FG002|Core Phase|Participant Choice|4
1097061|NCT02322021|2169608|FG003|Core Phase|Participant Choice|2
1097062|NCT02322021|2169609|FG004|Core Phase|Participant Choice|0
1097063|NCT02322021|2169605|FG000|Core Phase|Lost to Follow-up|0
1097064|NCT02322021|2169606|FG001|Core Phase|Lost to Follow-up|0
1097065|NCT02322021|2169607|FG002|Core Phase|Lost to Follow-up|0
1097066|NCT02322021|2169608|FG003|Core Phase|Lost to Follow-up|1
1097067|NCT02322021|2169609|FG004|Core Phase|Lost to Follow-up|0
1097068|NCT02322021|2169605|FG000|Core Phase|Other|0
1097069|NCT02322021|2169606|FG001|Core Phase|Other|0
1097070|NCT02322021|2169607|FG002|Core Phase|Other|1
1097071|NCT02322021|2169608|FG003|Core Phase|Other|0
1097072|NCT02322021|2169609|FG004|Core Phase|Other|0
1097073|NCT02322021|2169605|FG000|Extension Phase|Adverse Event|0
1097074|NCT02322021|2169606|FG001|Extension Phase|Adverse Event|0
893433|NCT00684073|1863862|FG000|Selection|request of the sponsor|1
893434|NCT00684073|1863862|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
893435|NCT00684177|1863883|FG000|Overall Study|Adverse Event|4
893436|NCT00684177|1863884|FG001|Overall Study|Adverse Event|3
893437|NCT00684177|1863883|FG000|Overall Study|Lack of Efficacy|10
893438|NCT00684177|1863884|FG001|Overall Study|Lack of Efficacy|15
893439|NCT00684177|1863883|FG000|Overall Study|Protocol Violation|1
893440|NCT00684177|1863884|FG001|Overall Study|Protocol Violation|0
893441|NCT00684177|1863883|FG000|Overall Study|Lost to Follow-up|2
893442|NCT00684177|1863884|FG001|Overall Study|Lost to Follow-up|1
893443|NCT00684177|1863883|FG000|Overall Study|Physician Decision|2
893444|NCT00684177|1863884|FG001|Overall Study|Physician Decision|0
893445|NCT00684177|1863883|FG000|Overall Study|Withdrawal by Subject|1
893446|NCT00684177|1863884|FG001|Overall Study|Withdrawal by Subject|2
893447|NCT00684177|1863883|FG000|Overall Study|Other|1
893448|NCT00684177|1863884|FG001|Overall Study|Other|2
893449|NCT00684203|1863896|FG000|Overall Study|Adverse Event|6
893450|NCT00684203|1863897|FG001|Overall Study|Adverse Event|4
893451|NCT00684203|1863898|FG002|Overall Study|Adverse Event|8
1097075|NCT02322021|2169607|FG002|Extension Phase|Adverse Event|0
1097076|NCT02322021|2169608|FG003|Extension Phase|Adverse Event|0
1097077|NCT02322021|2169609|FG004|Extension Phase|Adverse Event|3
1097078|NCT02322021|2169605|FG000|Extension Phase|Participant Choice|0
1097079|NCT02322021|2169606|FG001|Extension Phase|Participant Choice|0
1097080|NCT02322021|2169607|FG002|Extension Phase|Participant Choice|0
1097081|NCT02322021|2169608|FG003|Extension Phase|Participant Choice|0
1097082|NCT02322021|2169609|FG004|Extension Phase|Participant Choice|6
1097083|NCT02322021|2169605|FG000|Extension Phase|Other|0
1097084|NCT02322021|2169606|FG001|Extension Phase|Other|0
1097085|NCT02322021|2169607|FG002|Extension Phase|Other|0
1097086|NCT02322021|2169608|FG003|Extension Phase|Other|0
1097087|NCT02322021|2169609|FG004|Extension Phase|Other|3
1097088|NCT02322021|2169605|FG000|Extension Phase|Lost to Follow-up|0
1097089|NCT02322021|2169606|FG001|Extension Phase|Lost to Follow-up|0
1097090|NCT02322021|2169607|FG002|Extension Phase|Lost to Follow-up|0
1097091|NCT02322021|2169608|FG003|Extension Phase|Lost to Follow-up|0
1097092|NCT02322021|2169609|FG004|Extension Phase|Lost to Follow-up|1
1097093|NCT02322021|2169605|FG000|Extension Phase|Study terminated by sponsor|0
1097094|NCT02322021|2169606|FG001|Extension Phase|Study terminated by sponsor|0
1097095|NCT02322021|2169607|FG002|Extension Phase|Study terminated by sponsor|0
1097096|NCT02322021|2169608|FG003|Extension Phase|Study terminated by sponsor|0
1097097|NCT02322021|2169609|FG004|Extension Phase|Study terminated by sponsor|28
1097098|NCT02322047|2169628|FG000|Overall Study|Physician Decision|1
1097099|NCT02322047|2169629|FG001|Overall Study|Physician Decision|0
1097100|NCT02322047|2169630|FG002|Overall Study|Physician Decision|0
1097101|NCT02322047|2169631|FG003|Overall Study|Physician Decision|0
1097102|NCT02322047|2169628|FG000|Overall Study|Withdrawal by Subject|1
1097103|NCT02322047|2169629|FG001|Overall Study|Withdrawal by Subject|0
1097104|NCT02322047|2169630|FG002|Overall Study|Withdrawal by Subject|0
1097105|NCT02322047|2169631|FG003|Overall Study|Withdrawal by Subject|1
1097106|NCT02322047|2169628|FG000|Overall Study|Adverse Event|0
1097107|NCT02322047|2169629|FG001|Overall Study|Adverse Event|1
1097108|NCT02322047|2169630|FG002|Overall Study|Adverse Event|0
1097109|NCT02322047|2169631|FG003|Overall Study|Adverse Event|0
1097110|NCT02322047|2169628|FG000|Overall Study|Lost to Follow-up|0
1097111|NCT02322047|2169629|FG001|Overall Study|Lost to Follow-up|0
1097112|NCT02322047|2169630|FG002|Overall Study|Lost to Follow-up|1
1097113|NCT02322047|2169631|FG003|Overall Study|Lost to Follow-up|1
1097114|NCT02322125|2169641|FG000|Overall Study|Withdrawal by Subject|2
1097115|NCT02322190|2169645|FG000|Overall Study|Death on study|1
1097116|NCT02322190|2169646|FG001|Overall Study|Death on study|0
1097117|NCT02322216|2169653|FG000|Overall Study|Adverse Event|1
1097118|NCT02322216|2169654|FG001|Overall Study|Adverse Event|0
1097119|NCT02322216|2169653|FG000|Overall Study|Withdrawal by Subject|1
1097120|NCT02322216|2169654|FG001|Overall Study|Withdrawal by Subject|4
1097121|NCT02322229|2169661|FG000|Overall Study|Physician Decision|2
1097122|NCT02322281|2169678|FG000|Overall Study|Progressive Disease|42
1097123|NCT02322281|2169679|FG001|Overall Study|Progressive Disease|14
1097124|NCT02322281|2169680|FG002|Overall Study|Progressive Disease|49
1097125|NCT02322281|2169678|FG000|Overall Study|Adverse Event|3
1097126|NCT02322281|2169679|FG001|Overall Study|Adverse Event|4
1097127|NCT02322281|2169680|FG002|Overall Study|Adverse Event|6
1097128|NCT02322281|2169678|FG000|Overall Study|Death|3
1097129|NCT02322281|2169679|FG001|Overall Study|Death|3
1097130|NCT02322281|2169680|FG002|Overall Study|Death|3
1097131|NCT02322281|2169678|FG000|Overall Study|Withdrawal by Subject|1
1097132|NCT02322281|2169679|FG001|Overall Study|Withdrawal by Subject|1
1097133|NCT02322281|2169680|FG002|Overall Study|Withdrawal by Subject|6
1097134|NCT02322281|2169678|FG000|Overall Study|Physician Decision|2
1097135|NCT02322281|2169679|FG001|Overall Study|Physician Decision|0
1097136|NCT02322281|2169680|FG002|Overall Study|Physician Decision|5
1097137|NCT02322281|2169678|FG000|Overall Study|Study Terminated by Sponsor|2
1097138|NCT02322281|2169679|FG001|Overall Study|Study Terminated by Sponsor|0
1097139|NCT02322281|2169680|FG002|Overall Study|Study Terminated by Sponsor|0
1097140|NCT02322281|2169678|FG000|Overall Study|Missing|0
1097141|NCT02322281|2169679|FG001|Overall Study|Missing|0
1097142|NCT02322281|2169680|FG002|Overall Study|Missing|1
1097143|NCT02322281|2169678|FG000|Overall Study|Miscellaneous|0
1097144|NCT02322281|2169679|FG001|Overall Study|Miscellaneous|0
1097145|NCT02322281|2169680|FG002|Overall Study|Miscellaneous|4
1097146|NCT02322411|2169714|FG000|Overall Study|Lost to Follow-up|4
1097147|NCT02322411|2169715|FG001|Overall Study|Lost to Follow-up|7
1097148|NCT02322411|2169714|FG000|Overall Study|Withdrawal by Subject|1
1097149|NCT02322411|2169715|FG001|Overall Study|Withdrawal by Subject|0
1097150|NCT02322710|2169727|FG000|Overall Study|No efficacy assessment post-baseline|0
1097151|NCT02322710|2169728|FG001|Overall Study|No efficacy assessment post-baseline|1
1097152|NCT02322710|2169727|FG000|Overall Study|Protocol Violation|20
1097153|NCT02322710|2169728|FG001|Overall Study|Protocol Violation|25
1097154|NCT02322749|2169734|FG000|Period 2|Adverse Event|0
1097155|NCT02322749|2169735|FG001|Period 2|Adverse Event|0
1097156|NCT02322749|2169736|FG002|Period 2|Adverse Event|0
1097157|NCT02322749|2169737|FG003|Period 2|Adverse Event|1
1097158|NCT02322749|2169738|FG004|Period 2|Adverse Event|0
1097159|NCT02322749|2169739|FG005|Period 2|Adverse Event|0
1097160|NCT02322749|2169734|FG000|Period 2|Withdrawal by Subject|0
1097161|NCT02322749|2169735|FG001|Period 2|Withdrawal by Subject|0
1097162|NCT02322749|2169736|FG002|Period 2|Withdrawal by Subject|0
1097163|NCT02322749|2169737|FG003|Period 2|Withdrawal by Subject|1
1097164|NCT02322749|2169738|FG004|Period 2|Withdrawal by Subject|0
1097165|NCT02322749|2169739|FG005|Period 2|Withdrawal by Subject|0
1097166|NCT02322749|2169734|FG000|Period 3|Withdrawal by Subject|0
1097167|NCT02322749|2169735|FG001|Period 3|Withdrawal by Subject|0
1097168|NCT02322749|2169736|FG002|Period 3|Withdrawal by Subject|1
1097169|NCT02322749|2169737|FG003|Period 3|Withdrawal by Subject|0
1097170|NCT02322749|2169738|FG004|Period 3|Withdrawal by Subject|0
1097171|NCT02322749|2169739|FG005|Period 3|Withdrawal by Subject|0
1097172|NCT02322775|2169750|FG000|Overall Study|Adverse Event|1
1097173|NCT02322775|2169751|FG001|Overall Study|Adverse Event|0
1097174|NCT02322775|2169750|FG000|Overall Study|Lost to Follow-up|0
1097175|NCT02322775|2169751|FG001|Overall Study|Lost to Follow-up|1
1097176|NCT02322775|2169750|FG000|Overall Study|Protocol Violation|1
1097177|NCT02322775|2169751|FG001|Overall Study|Protocol Violation|0
1097178|NCT02322775|2169750|FG000|Overall Study|Withdrawal by Subject|3
1097179|NCT02322775|2169751|FG001|Overall Study|Withdrawal by Subject|4
1097180|NCT02322775|2169750|FG000|Overall Study|Not willing to perform all FU visits|0
1097181|NCT02322775|2169751|FG001|Overall Study|Not willing to perform all FU visits|1
1097182|NCT02322814|2169775|FG000|Overall Study|Ongoing Study|0
1097183|NCT02322814|2169776|FG001|Overall Study|Ongoing Study|13
1097184|NCT02322814|2169777|FG002|Overall Study|Ongoing Study|14
1097185|NCT02322814|2169778|FG003|Overall Study|Ongoing Study|20
1097186|NCT02322814|2169779|FG004|Overall Study|Ongoing Study|22
1097187|NCT02322814|2169775|FG000|Overall Study|Progressive Disease|0
1097188|NCT02322814|2169776|FG001|Overall Study|Progressive Disease|2
1097189|NCT02322814|2169777|FG002|Overall Study|Progressive Disease|0
1097190|NCT02322814|2169778|FG003|Overall Study|Progressive Disease|1
1097191|NCT02322814|2169779|FG004|Overall Study|Progressive Disease|0
1097192|NCT02322814|2169775|FG000|Overall Study|Lost to Follow-up|1
1097193|NCT02322814|2169776|FG001|Overall Study|Lost to Follow-up|2
1097194|NCT02322814|2169777|FG002|Overall Study|Lost to Follow-up|1
1097195|NCT02322814|2169778|FG003|Overall Study|Lost to Follow-up|0
1097196|NCT02322814|2169779|FG004|Overall Study|Lost to Follow-up|0
1097197|NCT02322814|2169775|FG000|Overall Study|Other|2
1097198|NCT02322814|2169776|FG001|Overall Study|Other|0
1097199|NCT02322814|2169777|FG002|Overall Study|Other|0
1097200|NCT02322814|2169778|FG003|Overall Study|Other|0
1097201|NCT02322814|2169779|FG004|Overall Study|Other|0
1097202|NCT02322814|2169775|FG000|Overall Study|Protocol Violation|1
1097203|NCT02322814|2169776|FG001|Overall Study|Protocol Violation|0
1097204|NCT02322814|2169777|FG002|Overall Study|Protocol Violation|0
1097205|NCT02322814|2169778|FG003|Overall Study|Protocol Violation|0
1097206|NCT02322814|2169779|FG004|Overall Study|Protocol Violation|0
1097207|NCT02322814|2169775|FG000|Overall Study|Death|7
1097208|NCT02322814|2169776|FG001|Overall Study|Death|22
1097209|NCT02322814|2169777|FG002|Overall Study|Death|30
1097210|NCT02322814|2169778|FG003|Overall Study|Death|10
1097211|NCT02322814|2169779|FG004|Overall Study|Death|6
1097212|NCT02322814|2169775|FG000|Overall Study|Withdrawal by Subject|5
1097213|NCT02322814|2169776|FG001|Overall Study|Withdrawal by Subject|4
1097214|NCT02322814|2169777|FG002|Overall Study|Withdrawal by Subject|2
1097215|NCT02322814|2169778|FG003|Overall Study|Withdrawal by Subject|1
1097216|NCT02322814|2169779|FG004|Overall Study|Withdrawal by Subject|3
1097217|NCT02322866|2169792|FG000|Overall Study|Adverse Event|6
1097218|NCT02322866|2169793|FG001|Overall Study|Adverse Event|11
1097219|NCT02322866|2169792|FG000|Overall Study|Withdrawal of Consent|16
1097220|NCT02322866|2169793|FG001|Overall Study|Withdrawal of Consent|25
1097221|NCT02322866|2169792|FG000|Overall Study|Lost to Follow-up|36
1097222|NCT02322866|2169793|FG001|Overall Study|Lost to Follow-up|39
1097223|NCT02322866|2169792|FG000|Overall Study|Protocol Violation|1
1097224|NCT02322866|2169793|FG001|Overall Study|Protocol Violation|0
1097225|NCT02322866|2169792|FG000|Overall Study|Noncompliance with Treatment|3
1097226|NCT02322866|2169793|FG001|Overall Study|Noncompliance with Treatment|4
1097227|NCT02322866|2169792|FG000|Overall Study|Lack of Efficacy|3
1097228|NCT02322866|2169793|FG001|Overall Study|Lack of Efficacy|1
1097229|NCT02322866|2169792|FG000|Overall Study|Other Miscellaneous Reasons|6
1097230|NCT02322866|2169793|FG001|Overall Study|Other Miscellaneous Reasons|6
1097231|NCT02322879|2169801|FG000|First Intervention|Physician Decision|1
1097232|NCT02322879|2169802|FG001|First Intervention|Physician Decision|0
1097233|NCT02322892|2169810|FG000|Overall Study|Surgery cancelled|1
1097234|NCT02322892|2169811|FG001|Overall Study|Surgery cancelled|2
1097235|NCT02322892|2169810|FG000|Overall Study|Met exclusion criteria|0
1097236|NCT02322892|2169811|FG001|Overall Study|Met exclusion criteria|1
1097237|NCT02322892|2169810|FG000|Overall Study|Protocol Violation|1
1097238|NCT02322892|2169811|FG001|Overall Study|Protocol Violation|0
1097239|NCT02323113|2169845|FG000|Overall Study|Adverse Event|3
1097240|NCT02323113|2169846|FG001|Overall Study|Adverse Event|3
1097241|NCT02323113|2169847|FG002|Overall Study|Adverse Event|2
1097242|NCT02323113|2169848|FG003|Overall Study|Adverse Event|5
1097243|NCT02323113|2169849|FG004|Overall Study|Adverse Event|8
1097244|NCT02323113|2169850|FG005|Overall Study|Adverse Event|3
1097245|NCT02323113|2169851|FG006|Overall Study|Adverse Event|6
1097246|NCT02323113|2169852|FG007|Overall Study|Adverse Event|0
1097247|NCT02323113|2169845|FG000|Overall Study|Progressive Disease|0
1097248|NCT02323113|2169846|FG001|Overall Study|Progressive Disease|1
893452|NCT00684203|1863899|FG003|Overall Study|Adverse Event|0
893453|NCT00684203|1863900|FG004|Overall Study|Adverse Event|0
1097249|NCT02323113|2169847|FG002|Overall Study|Progressive Disease|1
1097250|NCT02323113|2169848|FG003|Overall Study|Progressive Disease|0
1097251|NCT02323113|2169849|FG004|Overall Study|Progressive Disease|0
1097252|NCT02323113|2169850|FG005|Overall Study|Progressive Disease|3
1097253|NCT02323113|2169851|FG006|Overall Study|Progressive Disease|0
1097254|NCT02323113|2169852|FG007|Overall Study|Progressive Disease|0
1097255|NCT02323113|2169845|FG000|Overall Study|Symptomatic Deterioration|0
1097256|NCT02323113|2169846|FG001|Overall Study|Symptomatic Deterioration|0
1097257|NCT02323113|2169847|FG002|Overall Study|Symptomatic Deterioration|1
1097258|NCT02323113|2169848|FG003|Overall Study|Symptomatic Deterioration|0
1097259|NCT02323113|2169849|FG004|Overall Study|Symptomatic Deterioration|1
1097260|NCT02323113|2169850|FG005|Overall Study|Symptomatic Deterioration|0
1097261|NCT02323113|2169851|FG006|Overall Study|Symptomatic Deterioration|0
1097262|NCT02323113|2169852|FG007|Overall Study|Symptomatic Deterioration|0
1097263|NCT02323113|2169845|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
1097264|NCT02323113|2169846|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
1097265|NCT02323113|2169847|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
1097266|NCT02323113|2169848|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
1097267|NCT02323113|2169849|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
1097268|NCT02323113|2169850|FG005|Overall Study|Unsatisfactory Therapeutic Response|2
1097269|NCT02323113|2169851|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
1097270|NCT02323113|2169852|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
1097271|NCT02323113|2169845|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
1097272|NCT02323113|2169846|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1
1097273|NCT02323113|2169847|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
1097274|NCT02323113|2169848|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
1097275|NCT02323113|2169849|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
1097276|NCT02323113|2169850|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
1097277|NCT02323113|2169851|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
1097278|NCT02323113|2169852|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
1097279|NCT02323126|2169873|FG000|Overall Study|ongoing|0
1097280|NCT02323126|2169874|FG001|Overall Study|ongoing|1
1097281|NCT02323126|2169873|FG000|Overall Study|subject / guardian decision|1
1097282|NCT02323126|2169874|FG001|Overall Study|subject / guardian decision|1
1097283|NCT02323126|2169873|FG000|Overall Study|study terminated by sponsor|1
1097284|NCT02323126|2169874|FG001|Overall Study|study terminated by sponsor|0
1097285|NCT02323126|2169873|FG000|Overall Study|progressive disease|8
1097286|NCT02323126|2169874|FG001|Overall Study|progressive disease|15
1097287|NCT02323126|2169873|FG000|Overall Study|Physician Decision|0
1097288|NCT02323126|2169874|FG001|Overall Study|Physician Decision|3
1097289|NCT02323126|2169873|FG000|Overall Study|Death|1
1097290|NCT02323126|2169874|FG001|Overall Study|Death|4
1097291|NCT02323126|2169873|FG000|Overall Study|Adverse Event|5
1097292|NCT02323126|2169874|FG001|Overall Study|Adverse Event|6
1097293|NCT02323204|2169885|FG000|Baseline Survey Completion|Withdrawal by Subject|10
1097294|NCT02323204|2169886|FG001|Baseline Survey Completion|Withdrawal by Subject|9
1097295|NCT02323204|2169887|FG002|Baseline Survey Completion|Withdrawal by Subject|5
1097296|NCT02323204|2169888|FG003|Baseline Survey Completion|Withdrawal by Subject|3
1097297|NCT02323204|2169885|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29
1097298|NCT02323204|2169886|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28
1097299|NCT02323204|2169887|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39
1097300|NCT02323204|2169888|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35
1097301|NCT02323204|2169885|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12
1097302|NCT02323204|2169886|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8
1097303|NCT02323204|2169887|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3
1097304|NCT02323204|2169888|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2
1097305|NCT02323204|2169885|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0
1097306|NCT02323204|2169886|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35
1097307|NCT02323204|2169887|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0
1097308|NCT02323204|2169888|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34
1097309|NCT02323204|2169885|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
1097310|NCT02323204|2169886|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
1097311|NCT02323204|2169887|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
1097312|NCT02323204|2169888|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
1097313|NCT02323204|2169885|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54
1097314|NCT02323204|2169886|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45
1097315|NCT02323204|2169887|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41
1097316|NCT02323204|2169888|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42
1097317|NCT02323204|2169885|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0
1097318|NCT02323204|2169886|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2
1097319|NCT02323204|2169887|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0
1097320|NCT02323204|2169888|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2
1097321|NCT02323204|2169885|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49
1097322|NCT02323204|2169886|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50
1097323|NCT02323204|2169887|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38
1097324|NCT02323204|2169888|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43
1097325|NCT02323204|2169885|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0
1097326|NCT02323204|2169886|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0
1097327|NCT02323204|2169887|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3
1097328|NCT02323204|2169888|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1
1097329|NCT02323334|2169912|FG000|Period 3|Lost to Follow-up|0
1097330|NCT02323334|2169913|FG001|Period 3|Lost to Follow-up|0
1097331|NCT02323334|2169914|FG002|Period 3|Lost to Follow-up|1
1097332|NCT02323334|2169915|FG003|Period 3|Lost to Follow-up|0
1097333|NCT02323334|2169916|FG004|Period 3|Lost to Follow-up|0
1097334|NCT02323334|2169917|FG005|Period 3|Lost to Follow-up|0
1097335|NCT02323334|2169918|FG006|Period 3|Lost to Follow-up|0
1097336|NCT02323334|2169919|FG007|Period 3|Lost to Follow-up|0
1097337|NCT02323334|2169920|FG008|Period 3|Lost to Follow-up|0
1097338|NCT02323334|2169921|FG009|Period 3|Lost to Follow-up|0
1097339|NCT02323334|2169922|FG010|Period 3|Lost to Follow-up|0
1097340|NCT02323334|2169923|FG011|Period 3|Lost to Follow-up|0
1097341|NCT02323334|2169924|FG012|Period 3|Lost to Follow-up|0
1097342|NCT02323334|2169925|FG013|Period 3|Lost to Follow-up|0
1097343|NCT02323334|2169926|FG014|Period 3|Lost to Follow-up|0
1097344|NCT02323334|2169927|FG015|Period 3|Lost to Follow-up|0
1097345|NCT02323334|2169928|FG016|Period 3|Lost to Follow-up|0
1097346|NCT02323334|2169912|FG000|Period 3|Withdrawal by Subject|1
1097347|NCT02323334|2169913|FG001|Period 3|Withdrawal by Subject|0
1097348|NCT02323334|2169914|FG002|Period 3|Withdrawal by Subject|0
1097349|NCT02323334|2169915|FG003|Period 3|Withdrawal by Subject|0
1097350|NCT02323334|2169916|FG004|Period 3|Withdrawal by Subject|0
1097351|NCT02323334|2169917|FG005|Period 3|Withdrawal by Subject|0
1097352|NCT02323334|2169918|FG006|Period 3|Withdrawal by Subject|0
1097353|NCT02323334|2169919|FG007|Period 3|Withdrawal by Subject|0
1097354|NCT02323334|2169920|FG008|Period 3|Withdrawal by Subject|0
1097355|NCT02323334|2169921|FG009|Period 3|Withdrawal by Subject|0
1097356|NCT02323334|2169922|FG010|Period 3|Withdrawal by Subject|0
1097357|NCT02323334|2169923|FG011|Period 3|Withdrawal by Subject|0
1097358|NCT02323334|2169924|FG012|Period 3|Withdrawal by Subject|0
1097359|NCT02323334|2169925|FG013|Period 3|Withdrawal by Subject|0
1097360|NCT02323334|2169926|FG014|Period 3|Withdrawal by Subject|0
1097361|NCT02323334|2169927|FG015|Period 3|Withdrawal by Subject|0
1097362|NCT02323334|2169928|FG016|Period 3|Withdrawal by Subject|0
1097363|NCT02323646|2169993|FG000|Treatment Course 1|Adverse Event|1
1097364|NCT02323646|2169994|FG001|Treatment Course 1|Adverse Event|0
1097365|NCT02323646|2169995|FG002|Treatment Course 1|Adverse Event|1
1097366|NCT02323646|2169993|FG000|Treatment Course 1|Heavy Bleeding|1
1097367|NCT02323646|2169994|FG001|Treatment Course 1|Heavy Bleeding|1
1097368|NCT02323646|2169995|FG002|Treatment Course 1|Heavy Bleeding|0
1097369|NCT02323646|2169993|FG000|Treatment Course 1|Lost to Follow-up|1
1097370|NCT02323646|2169994|FG001|Treatment Course 1|Lost to Follow-up|0
1097371|NCT02323646|2169995|FG002|Treatment Course 1|Lost to Follow-up|2
1097372|NCT02323646|2169993|FG000|Treatment Course 1|Withdrawal by Subject|0
1097373|NCT02323646|2169994|FG001|Treatment Course 1|Withdrawal by Subject|2
1097374|NCT02323646|2169995|FG002|Treatment Course 1|Withdrawal by Subject|0
1097375|NCT02323646|2169993|FG000|Treatment Course 2|Adverse Event|1
1097376|NCT02323646|2169994|FG001|Treatment Course 2|Adverse Event|0
1097377|NCT02323646|2169995|FG002|Treatment Course 2|Adverse Event|1
1097378|NCT02323646|2169993|FG000|Treatment Course 2|Lost to Follow-up|0
1097379|NCT02323646|2169994|FG001|Treatment Course 2|Lost to Follow-up|0
1097380|NCT02323646|2169995|FG002|Treatment Course 2|Lost to Follow-up|1
1097381|NCT02323646|2169993|FG000|Treatment Course 2|Non-compliance|0
1097382|NCT02323646|2169994|FG001|Treatment Course 2|Non-compliance|1
1097383|NCT02323646|2169995|FG002|Treatment Course 2|Non-compliance|1
1097384|NCT02324049|2170007|FG000|Part C|Study terminated|11
1097385|NCT02324153|2170023|FG000|Overall Study|Withdrawal by Subject|4
1097386|NCT02324153|2170024|FG001|Overall Study|Withdrawal by Subject|1
1097387|NCT02324153|2170023|FG000|Overall Study|Surgery postponed after randomization|3
1097388|NCT02324153|2170024|FG001|Overall Study|Surgery postponed after randomization|0
1097389|NCT02324153|2170023|FG000|Overall Study|Developed delirium preoperatively|1
1097390|NCT02324153|2170024|FG001|Overall Study|Developed delirium preoperatively|0
1097391|NCT02324205|2170030|FG000|Overall Study|Withdrawal by Subject|37
1097392|NCT02324270|2170037|FG000|Overall Study|Withdrawal by Subject|0
1097393|NCT02324270|2170038|FG001|Overall Study|Withdrawal by Subject|1
1097394|NCT02324270|2170039|FG002|Overall Study|Withdrawal by Subject|0
1097395|NCT02324270|2170037|FG000|Overall Study|Lost to Follow-up|4
1097396|NCT02324270|2170038|FG001|Overall Study|Lost to Follow-up|3
1097397|NCT02324270|2170039|FG002|Overall Study|Lost to Follow-up|4
1097398|NCT02324270|2170037|FG000|Overall Study|Protocol Violation|0
1097399|NCT02324270|2170038|FG001|Overall Study|Protocol Violation|1
1097400|NCT02324270|2170039|FG002|Overall Study|Protocol Violation|1
1097401|NCT02324270|2170037|FG000|Overall Study|Non Compliance with Study Drug|1
1097402|NCT02324270|2170038|FG001|Overall Study|Non Compliance with Study Drug|2
1097403|NCT02324270|2170039|FG002|Overall Study|Non Compliance with Study Drug|0
1097404|NCT02324361|2170058|FG000|Overall Study|Lost to Follow-up|5
1097405|NCT02324361|2170059|FG001|Overall Study|Lost to Follow-up|2
1097406|NCT02324465|2170067|FG000|Overall Study|device failure|0
1097407|NCT02324465|2170068|FG001|Overall Study|device failure|1
1097408|NCT02324569|2170104|FG000|Overall Study|Pretreatment Event/Adverse Event|9
1097409|NCT02324569|2170105|FG001|Overall Study|Pretreatment Event/Adverse Event|10
1097410|NCT02324569|2170104|FG000|Overall Study|Voluntary Withdrawal|3
1097411|NCT02324569|2170105|FG001|Overall Study|Voluntary Withdrawal|6
1097412|NCT02324569|2170104|FG000|Overall Study|Lack of Efficacy|2
1097413|NCT02324569|2170105|FG001|Overall Study|Lack of Efficacy|3
1097414|NCT02324569|2170104|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0
1097415|NCT02324569|2170105|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2
1097416|NCT02324569|2170104|FG000|Overall Study|Inconvenient Schedule|2
1097417|NCT02324569|2170105|FG001|Overall Study|Inconvenient Schedule|0
1097418|NCT02324699|2170129|FG000|Overall Study|study terminated|1
1097419|NCT02324842|2170140|FG000|Overall Study|Lost to Follow-up|1
1097420|NCT02324842|2170141|FG001|Overall Study|Lost to Follow-up|1
1097421|NCT02324842|2170142|FG002|Overall Study|Lost to Follow-up|2
1097422|NCT02325219|2170171|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6
1097423|NCT02325219|2170172|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1
1097424|NCT02325219|2170173|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0
1097425|NCT02325219|2170174|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0
1097426|NCT02325219|2170175|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0
1097427|NCT02325219|2170171|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
1097428|NCT02325219|2170172|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
1097429|NCT02325219|2170173|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
1097430|NCT02325219|2170174|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
1097431|NCT02325219|2170175|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
1097432|NCT02325219|2170171|FG000|Controlled Period (Week 0 - 16)|Other|0
1097433|NCT02325219|2170172|FG001|Controlled Period (Week 0 - 16)|Other|0
1097434|NCT02325219|2170173|FG002|Controlled Period (Week 0 - 16)|Other|1
1097435|NCT02325219|2170174|FG003|Controlled Period (Week 0 - 16)|Other|0
1097436|NCT02325219|2170175|FG004|Controlled Period (Week 0 - 16)|Other|0
1097437|NCT02325219|2170171|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
1097438|NCT02325219|2170172|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0
1097439|NCT02325219|2170173|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0
1097440|NCT02325219|2170174|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0
1097441|NCT02325219|2170175|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1
1097442|NCT02325219|2170171|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
1097443|NCT02325219|2170172|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
1097444|NCT02325219|2170173|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
1097445|NCT02325219|2170174|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
1097446|NCT02325219|2170175|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
1097447|NCT02325219|2170171|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
1097448|NCT02325219|2170172|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1
1097449|NCT02325219|2170173|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
1097450|NCT02325219|2170174|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0
1097451|NCT02325219|2170175|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0
1097452|NCT02325401|2170191|FG000|Overall Study|Withdrawal by Subject|0
1097453|NCT02325401|2170192|FG001|Overall Study|Withdrawal by Subject|1
1097454|NCT02325401|2170193|FG002|Overall Study|Withdrawal by Subject|1
1097455|NCT02325414|2170209|FG000|Overall Study|Withdrawal by Subject|3
1097456|NCT02325414|2170210|FG001|Overall Study|Withdrawal by Subject|1
1097457|NCT02325414|2170209|FG000|Overall Study|Lost to Follow-up|5
1097458|NCT02325414|2170210|FG001|Overall Study|Lost to Follow-up|5
1097459|NCT02325518|2170220|FG000|Overall Study|Adverse Event|4
1097460|NCT02325518|2170221|FG001|Overall Study|Adverse Event|1
1097461|NCT02325518|2170220|FG000|Overall Study|Physician Decision|0
1097462|NCT02325518|2170221|FG001|Overall Study|Physician Decision|1
1097463|NCT02325518|2170220|FG000|Overall Study|Withdrawal by Subject|0
1097464|NCT02325518|2170221|FG001|Overall Study|Withdrawal by Subject|1
1162053|NCT03381339|2283994|FG000|Overall Study|Lost to Follow-up|0
1162054|NCT03381339|2283995|FG001|Overall Study|Lost to Follow-up|1
1162055|NCT03382262|2284027|FG000|Overall Study|Physician Decision|0
1162056|NCT03382262|2284028|FG001|Overall Study|Physician Decision|0
1162057|NCT03382262|2284029|FG002|Overall Study|Physician Decision|1
1162058|NCT03382262|2284030|FG003|Overall Study|Physician Decision|0
1162059|NCT03382262|2284027|FG000|Overall Study|Withdrawal by Subject|0
1162060|NCT03382262|2284028|FG001|Overall Study|Withdrawal by Subject|0
1162061|NCT03382262|2284029|FG002|Overall Study|Withdrawal by Subject|0
893454|NCT00684203|1863901|FG005|Overall Study|Adverse Event|0
893455|NCT00684203|1863896|FG000|Overall Study|Protocol-defined clinical event|3
893456|NCT00684203|1863897|FG001|Overall Study|Protocol-defined clinical event|1
893457|NCT00684203|1863898|FG002|Overall Study|Protocol-defined clinical event|0
893458|NCT00684203|1863899|FG003|Overall Study|Protocol-defined clinical event|0
893459|NCT00684203|1863900|FG004|Overall Study|Protocol-defined clinical event|0
893460|NCT00684203|1863901|FG005|Overall Study|Protocol-defined clinical event|0
1097465|NCT02325713|2170257|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097466|NCT02325713|2170258|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097467|NCT02325713|2170259|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097468|NCT02325713|2170260|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097469|NCT02325713|2170261|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097470|NCT02325713|2170262|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097471|NCT02325713|2170263|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097472|NCT02325713|2170264|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097473|NCT02325713|2170265|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097474|NCT02325713|2170266|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097475|NCT02325713|2170267|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
1097476|NCT02325713|2170268|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097477|NCT02325713|2170269|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097478|NCT02325713|2170270|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097479|NCT02325713|2170271|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097480|NCT02325713|2170272|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1097481|NCT02325713|2170257|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
1097482|NCT02325713|2170258|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097483|NCT02325713|2170259|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097484|NCT02325713|2170260|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097485|NCT02325713|2170261|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097486|NCT02325713|2170262|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097487|NCT02325713|2170263|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097488|NCT02325713|2170264|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097489|NCT02325713|2170265|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097490|NCT02325713|2170266|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097491|NCT02325713|2170267|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097492|NCT02325713|2170268|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097493|NCT02325713|2170269|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097494|NCT02325713|2170270|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097495|NCT02325713|2170271|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097496|NCT02325713|2170272|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1097497|NCT02325713|2170257|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097498|NCT02325713|2170258|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097499|NCT02325713|2170259|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097500|NCT02325713|2170260|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097501|NCT02325713|2170261|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097502|NCT02325713|2170262|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097503|NCT02325713|2170263|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097504|NCT02325713|2170264|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097505|NCT02325713|2170265|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097506|NCT02325713|2170266|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
1097507|NCT02325713|2170267|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097508|NCT02325713|2170268|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097509|NCT02325713|2170269|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097510|NCT02325713|2170270|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097511|NCT02325713|2170271|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097512|NCT02325713|2170272|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1097513|NCT02325739|2170298|FG000|Phase I Part|Adverse Event|1
1097514|NCT02325739|2170299|FG001|Phase I Part|Adverse Event|0
1097515|NCT02325739|2170300|FG002|Phase I Part|Adverse Event|1
1097516|NCT02325739|2170301|FG003|Phase I Part|Adverse Event|2
1097517|NCT02325739|2170302|FG004|Phase I Part|Adverse Event|3
1097518|NCT02325739|2170303|FG005|Phase I Part|Adverse Event|1
1097519|NCT02325739|2170304|FG006|Phase I Part|Adverse Event|0
1097520|NCT02325739|2170305|FG007|Phase I Part|Adverse Event|2
1097521|NCT02325739|2170306|FG008|Phase I Part|Adverse Event|0
1097522|NCT02325739|2170307|FG009|Phase I Part|Adverse Event|0
1097523|NCT02325739|2170308|FG010|Phase I Part|Adverse Event|0
1097524|NCT02325739|2170298|FG000|Phase I Part|Progressive disease|9
1097525|NCT02325739|2170299|FG001|Phase I Part|Progressive disease|6
1097526|NCT02325739|2170300|FG002|Phase I Part|Progressive disease|3
1097527|NCT02325739|2170301|FG003|Phase I Part|Progressive disease|23
1097528|NCT02325739|2170302|FG004|Phase I Part|Progressive disease|14
1097529|NCT02325739|2170303|FG005|Phase I Part|Progressive disease|6
1097530|NCT02325739|2170304|FG006|Phase I Part|Progressive disease|6
1097531|NCT02325739|2170305|FG007|Phase I Part|Progressive disease|3
1097532|NCT02325739|2170306|FG008|Phase I Part|Progressive disease|0
1097533|NCT02325739|2170307|FG009|Phase I Part|Progressive disease|0
1097534|NCT02325739|2170308|FG010|Phase I Part|Progressive disease|0
1097535|NCT02325739|2170298|FG000|Phase I Part|Subject/guardian decision|1
1097536|NCT02325739|2170299|FG001|Phase I Part|Subject/guardian decision|0
1097537|NCT02325739|2170300|FG002|Phase I Part|Subject/guardian decision|1
1097538|NCT02325739|2170301|FG003|Phase I Part|Subject/guardian decision|1
1097539|NCT02325739|2170302|FG004|Phase I Part|Subject/guardian decision|0
1097540|NCT02325739|2170303|FG005|Phase I Part|Subject/guardian decision|0
1097541|NCT02325739|2170304|FG006|Phase I Part|Subject/guardian decision|0
1097542|NCT02325739|2170305|FG007|Phase I Part|Subject/guardian decision|1
1097543|NCT02325739|2170306|FG008|Phase I Part|Subject/guardian decision|0
1097544|NCT02325739|2170307|FG009|Phase I Part|Subject/guardian decision|0
1097545|NCT02325739|2170308|FG010|Phase I Part|Subject/guardian decision|0
1097546|NCT02325739|2170298|FG000|Phase I Part|Death|0
1097547|NCT02325739|2170299|FG001|Phase I Part|Death|0
1097548|NCT02325739|2170300|FG002|Phase I Part|Death|0
1097549|NCT02325739|2170301|FG003|Phase I Part|Death|0
1097550|NCT02325739|2170302|FG004|Phase I Part|Death|2
1097551|NCT02325739|2170303|FG005|Phase I Part|Death|0
1097552|NCT02325739|2170304|FG006|Phase I Part|Death|0
1097553|NCT02325739|2170305|FG007|Phase I Part|Death|0
1097554|NCT02325739|2170306|FG008|Phase I Part|Death|0
1097555|NCT02325739|2170307|FG009|Phase I Part|Death|0
1097556|NCT02325739|2170308|FG010|Phase I Part|Death|0
1097557|NCT02325739|2170298|FG000|Phase II Part|Adverse Event|0
1097558|NCT02325739|2170299|FG001|Phase II Part|Adverse Event|0
1097559|NCT02325739|2170300|FG002|Phase II Part|Adverse Event|0
1097560|NCT02325739|2170301|FG003|Phase II Part|Adverse Event|0
1097561|NCT02325739|2170302|FG004|Phase II Part|Adverse Event|0
1097562|NCT02325739|2170303|FG005|Phase II Part|Adverse Event|0
1097563|NCT02325739|2170304|FG006|Phase II Part|Adverse Event|0
1097564|NCT02325739|2170305|FG007|Phase II Part|Adverse Event|0
1097565|NCT02325739|2170306|FG008|Phase II Part|Adverse Event|4
1097566|NCT02325739|2170307|FG009|Phase II Part|Adverse Event|5
1097567|NCT02325739|2170308|FG010|Phase II Part|Adverse Event|1
1097568|NCT02325739|2170298|FG000|Phase II Part|Physician Decision|0
1097569|NCT02325739|2170299|FG001|Phase II Part|Physician Decision|0
1097570|NCT02325739|2170300|FG002|Phase II Part|Physician Decision|0
1097571|NCT02325739|2170301|FG003|Phase II Part|Physician Decision|0
1097572|NCT02325739|2170302|FG004|Phase II Part|Physician Decision|0
1097573|NCT02325739|2170303|FG005|Phase II Part|Physician Decision|0
1097574|NCT02325739|2170304|FG006|Phase II Part|Physician Decision|0
1097575|NCT02325739|2170305|FG007|Phase II Part|Physician Decision|0
1097576|NCT02325739|2170306|FG008|Phase II Part|Physician Decision|0
1097577|NCT02325739|2170307|FG009|Phase II Part|Physician Decision|1
1097578|NCT02325739|2170308|FG010|Phase II Part|Physician Decision|0
1097579|NCT02325739|2170298|FG000|Phase II Part|Progressive disease|0
1097580|NCT02325739|2170299|FG001|Phase II Part|Progressive disease|0
1097581|NCT02325739|2170300|FG002|Phase II Part|Progressive disease|0
1097582|NCT02325739|2170301|FG003|Phase II Part|Progressive disease|0
1097583|NCT02325739|2170302|FG004|Phase II Part|Progressive disease|0
1097584|NCT02325739|2170303|FG005|Phase II Part|Progressive disease|0
1097585|NCT02325739|2170304|FG006|Phase II Part|Progressive disease|0
1097586|NCT02325739|2170305|FG007|Phase II Part|Progressive disease|0
1097587|NCT02325739|2170306|FG008|Phase II Part|Progressive disease|22
1097588|NCT02325739|2170307|FG009|Phase II Part|Progressive disease|29
1097589|NCT02325739|2170308|FG010|Phase II Part|Progressive disease|18
1097590|NCT02325739|2170298|FG000|Phase II Part|Subject/guardian decision|0
1097591|NCT02325739|2170299|FG001|Phase II Part|Subject/guardian decision|0
1097592|NCT02325739|2170300|FG002|Phase II Part|Subject/guardian decision|0
1097593|NCT02325739|2170301|FG003|Phase II Part|Subject/guardian decision|0
1097594|NCT02325739|2170302|FG004|Phase II Part|Subject/guardian decision|0
1097595|NCT02325739|2170303|FG005|Phase II Part|Subject/guardian decision|0
1097596|NCT02325739|2170304|FG006|Phase II Part|Subject/guardian decision|0
1097597|NCT02325739|2170305|FG007|Phase II Part|Subject/guardian decision|0
1097598|NCT02325739|2170306|FG008|Phase II Part|Subject/guardian decision|4
1097599|NCT02325739|2170307|FG009|Phase II Part|Subject/guardian decision|1
1097600|NCT02325739|2170308|FG010|Phase II Part|Subject/guardian decision|1
1097601|NCT02325791|2170357|FG000|Overall Study|Adverse Event|0
1097602|NCT02325791|2170358|FG001|Overall Study|Adverse Event|1
1097603|NCT02325791|2170359|FG002|Overall Study|Adverse Event|1
1097604|NCT02325791|2170360|FG003|Overall Study|Adverse Event|0
1097605|NCT02325791|2170357|FG000|Overall Study|Death|0
1097606|NCT02325791|2170358|FG001|Overall Study|Death|3
1097607|NCT02325791|2170359|FG002|Overall Study|Death|0
1097608|NCT02325791|2170360|FG003|Overall Study|Death|1
1097609|NCT02325791|2170357|FG000|Overall Study|Lost to Follow-up|0
1097610|NCT02325791|2170358|FG001|Overall Study|Lost to Follow-up|15
1097611|NCT02325791|2170359|FG002|Overall Study|Lost to Follow-up|14
1097612|NCT02325791|2170360|FG003|Overall Study|Lost to Follow-up|9
1097613|NCT02325791|2170357|FG000|Overall Study|Physician Decision|0
1097614|NCT02325791|2170358|FG001|Overall Study|Physician Decision|1
1097615|NCT02325791|2170359|FG002|Overall Study|Physician Decision|1
1097616|NCT02325791|2170360|FG003|Overall Study|Physician Decision|0
1097617|NCT02325791|2170357|FG000|Overall Study|Protocol Violation|0
1097618|NCT02325791|2170358|FG001|Overall Study|Protocol Violation|0
1097619|NCT02325791|2170359|FG002|Overall Study|Protocol Violation|1
1097620|NCT02325791|2170360|FG003|Overall Study|Protocol Violation|0
1097621|NCT02325791|2170357|FG000|Overall Study|Withdrawal by Subject|0
1097622|NCT02325791|2170358|FG001|Overall Study|Withdrawal by Subject|5
1097623|NCT02325791|2170359|FG002|Overall Study|Withdrawal by Subject|8
1097624|NCT02325791|2170360|FG003|Overall Study|Withdrawal by Subject|16
1097625|NCT02326025|2170384|FG000|Overall Study|Adverse Event|3
1097626|NCT02326025|2170385|FG001|Overall Study|Adverse Event|0
1097627|NCT02326025|2170384|FG000|Overall Study|Physician Decision|1
1097628|NCT02326025|2170385|FG001|Overall Study|Physician Decision|2
1097629|NCT02326025|2170384|FG000|Overall Study|Physician and Participant Decision|1
1097630|NCT02326025|2170385|FG001|Overall Study|Physician and Participant Decision|0
1097631|NCT02326025|2170384|FG000|Overall Study|Withdrawal by Subject|0
1097632|NCT02326025|2170385|FG001|Overall Study|Withdrawal by Subject|2
1097633|NCT02326025|2170384|FG000|Overall Study|Protocol Violation|0
1097634|NCT02326025|2170385|FG001|Overall Study|Protocol Violation|1
1097635|NCT02326220|2170406|FG000|Double-blind Treatment Period|Adverse Event|1
1097636|NCT02326220|2170407|FG001|Double-blind Treatment Period|Adverse Event|2
1097637|NCT02326220|2170408|FG002|Double-blind Treatment Period|Adverse Event|0
1097638|NCT02326220|2170406|FG000|Double-blind Treatment Period|Protocol Violation|0
1097639|NCT02326220|2170407|FG001|Double-blind Treatment Period|Protocol Violation|1
1097640|NCT02326220|2170408|FG002|Double-blind Treatment Period|Protocol Violation|0
1097641|NCT02326220|2170406|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
1097642|NCT02326220|2170407|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
1097643|NCT02326220|2170408|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
1097644|NCT02326220|2170406|FG000|Open-label Treatment Period|Withdrawal by Subject|0
1097645|NCT02326220|2170407|FG001|Open-label Treatment Period|Withdrawal by Subject|0
1097646|NCT02326220|2170408|FG002|Open-label Treatment Period|Withdrawal by Subject|1
1097647|NCT02326220|2170406|FG000|Open-label Treatment Period|Lost to Follow-up|0
1097648|NCT02326220|2170407|FG001|Open-label Treatment Period|Lost to Follow-up|0
1097649|NCT02326220|2170408|FG002|Open-label Treatment Period|Lost to Follow-up|1
1097650|NCT02326272|2170430|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097651|NCT02326272|2170431|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3
1097652|NCT02326272|2170432|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
1097653|NCT02326272|2170433|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097654|NCT02326272|2170434|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097655|NCT02326272|2170435|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097656|NCT02326272|2170436|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097657|NCT02326272|2170437|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097658|NCT02326272|2170438|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097659|NCT02326272|2170439|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097660|NCT02326272|2170440|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097661|NCT02326272|2170441|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097662|NCT02326272|2170442|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097663|NCT02326272|2170443|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097664|NCT02326272|2170444|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0
1097665|NCT02326272|2170430|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
1097666|NCT02326272|2170431|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
1097667|NCT02326272|2170432|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097668|NCT02326272|2170433|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097669|NCT02326272|2170434|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097670|NCT02326272|2170435|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097671|NCT02326272|2170436|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097672|NCT02326272|2170437|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097673|NCT02326272|2170438|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097674|NCT02326272|2170439|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097675|NCT02326272|2170440|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097676|NCT02326272|2170441|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097677|NCT02326272|2170442|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097678|NCT02326272|2170443|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097679|NCT02326272|2170444|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1097680|NCT02326272|2170430|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
1097681|NCT02326272|2170431|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
1097682|NCT02326272|2170432|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1097683|NCT02326272|2170433|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097684|NCT02326272|2170434|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097685|NCT02326272|2170435|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097686|NCT02326272|2170436|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097687|NCT02326272|2170437|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097688|NCT02326272|2170438|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097689|NCT02326272|2170439|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097690|NCT02326272|2170440|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097691|NCT02326272|2170441|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097692|NCT02326272|2170442|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097693|NCT02326272|2170443|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097694|NCT02326272|2170444|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1097695|NCT02326272|2170430|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097696|NCT02326272|2170431|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097697|NCT02326272|2170432|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1
1097698|NCT02326272|2170433|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097699|NCT02326272|2170434|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097700|NCT02326272|2170435|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097701|NCT02326272|2170436|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097702|NCT02326272|2170437|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097703|NCT02326272|2170438|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097704|NCT02326272|2170439|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097705|NCT02326272|2170440|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097706|NCT02326272|2170441|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097707|NCT02326272|2170442|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097708|NCT02326272|2170443|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097709|NCT02326272|2170444|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1097710|NCT02326272|2170430|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097711|NCT02326272|2170431|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097712|NCT02326272|2170432|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1
1097713|NCT02326272|2170433|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097714|NCT02326272|2170434|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097715|NCT02326272|2170435|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097716|NCT02326272|2170436|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097717|NCT02326272|2170437|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097718|NCT02326272|2170438|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097719|NCT02326272|2170439|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097720|NCT02326272|2170440|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097721|NCT02326272|2170441|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097722|NCT02326272|2170442|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097723|NCT02326272|2170443|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097724|NCT02326272|2170444|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0
1097725|NCT02326272|2170430|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097726|NCT02326272|2170431|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097727|NCT02326272|2170432|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
1097728|NCT02326272|2170433|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097729|NCT02326272|2170434|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097730|NCT02326272|2170435|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097731|NCT02326272|2170436|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097732|NCT02326272|2170437|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097733|NCT02326272|2170438|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097734|NCT02326272|2170439|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097735|NCT02326272|2170440|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097736|NCT02326272|2170441|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097737|NCT02326272|2170442|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097738|NCT02326272|2170443|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097739|NCT02326272|2170444|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1097740|NCT02326272|2170430|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097741|NCT02326272|2170431|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097742|NCT02326272|2170432|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
1097743|NCT02326272|2170433|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097744|NCT02326272|2170434|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097745|NCT02326272|2170435|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097746|NCT02326272|2170436|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097747|NCT02326272|2170437|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097748|NCT02326272|2170438|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097749|NCT02326272|2170439|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097750|NCT02326272|2170440|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097751|NCT02326272|2170441|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097752|NCT02326272|2170442|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097753|NCT02326272|2170443|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097754|NCT02326272|2170444|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1097755|NCT02326272|2170430|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1097756|NCT02326272|2170431|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1097757|NCT02326272|2170432|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1097758|NCT02326272|2170433|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1097759|NCT02326272|2170434|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
1097760|NCT02326272|2170435|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
1097761|NCT02326272|2170436|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
1097762|NCT02326272|2170437|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
1097763|NCT02326272|2170438|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
1097764|NCT02326272|2170439|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1097765|NCT02326272|2170440|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1097766|NCT02326272|2170441|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1097767|NCT02326272|2170442|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1097768|NCT02326272|2170443|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1097769|NCT02326272|2170444|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1097770|NCT02326272|2170430|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1097771|NCT02326272|2170431|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1097772|NCT02326272|2170432|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1097773|NCT02326272|2170433|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1097774|NCT02326272|2170434|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1097775|NCT02326272|2170435|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
1097776|NCT02326272|2170436|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1097777|NCT02326272|2170437|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1097778|NCT02326272|2170438|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1097779|NCT02326272|2170439|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1097780|NCT02326272|2170440|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1097781|NCT02326272|2170441|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1097782|NCT02326272|2170442|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1097783|NCT02326272|2170443|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1097784|NCT02326272|2170444|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1097785|NCT02326272|2170430|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097786|NCT02326272|2170431|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097787|NCT02326272|2170432|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097788|NCT02326272|2170433|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097789|NCT02326272|2170434|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097790|NCT02326272|2170435|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
1097791|NCT02326272|2170436|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097792|NCT02326272|2170437|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
1097793|NCT02326272|2170438|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097794|NCT02326272|2170439|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097795|NCT02326272|2170440|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097796|NCT02326272|2170441|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097797|NCT02326272|2170442|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097798|NCT02326272|2170443|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097799|NCT02326272|2170444|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1097800|NCT02326272|2170430|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1097801|NCT02326272|2170431|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1097802|NCT02326272|2170432|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1097803|NCT02326272|2170433|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1097804|NCT02326272|2170434|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1097805|NCT02326272|2170435|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
1097806|NCT02326272|2170436|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1097807|NCT02326272|2170437|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1097808|NCT02326272|2170438|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1097809|NCT02326272|2170439|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1097810|NCT02326272|2170440|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1097811|NCT02326272|2170441|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1097812|NCT02326272|2170442|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1097813|NCT02326272|2170443|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1097814|NCT02326272|2170444|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1097815|NCT02326272|2170430|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097816|NCT02326272|2170431|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097817|NCT02326272|2170432|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097818|NCT02326272|2170433|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097819|NCT02326272|2170434|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097820|NCT02326272|2170435|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097821|NCT02326272|2170436|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097822|NCT02326272|2170437|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
1097823|NCT02326272|2170438|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097824|NCT02326272|2170439|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097825|NCT02326272|2170440|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097826|NCT02326272|2170441|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097827|NCT02326272|2170442|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097828|NCT02326272|2170443|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097829|NCT02326272|2170444|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1097830|NCT02326272|2170430|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097831|NCT02326272|2170431|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097832|NCT02326272|2170432|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097833|NCT02326272|2170433|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097834|NCT02326272|2170434|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097835|NCT02326272|2170435|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097836|NCT02326272|2170436|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
1097837|NCT02326272|2170437|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097838|NCT02326272|2170438|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097839|NCT02326272|2170439|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097840|NCT02326272|2170440|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097841|NCT02326272|2170441|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097842|NCT02326272|2170442|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097843|NCT02326272|2170443|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097844|NCT02326272|2170444|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1097845|NCT02326272|2170430|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097846|NCT02326272|2170431|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097847|NCT02326272|2170432|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097848|NCT02326272|2170433|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097849|NCT02326272|2170434|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097850|NCT02326272|2170435|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097851|NCT02326272|2170436|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097852|NCT02326272|2170437|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097853|NCT02326272|2170438|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
1097854|NCT02326272|2170439|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097855|NCT02326272|2170440|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097856|NCT02326272|2170441|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097857|NCT02326272|2170442|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097858|NCT02326272|2170443|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097859|NCT02326272|2170444|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1097860|NCT02326272|2170430|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1097861|NCT02326272|2170431|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1097862|NCT02326272|2170432|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1097863|NCT02326272|2170433|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1097864|NCT02326272|2170434|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1097865|NCT02326272|2170435|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
1097866|NCT02326272|2170436|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
1097867|NCT02326272|2170437|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
1097868|NCT02326272|2170438|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
1097869|NCT02326272|2170439|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1097870|NCT02326272|2170440|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1097871|NCT02326272|2170441|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1097872|NCT02326272|2170442|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1097873|NCT02326272|2170443|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1097874|NCT02326272|2170444|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1097875|NCT02326272|2170430|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097876|NCT02326272|2170431|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097877|NCT02326272|2170432|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097878|NCT02326272|2170433|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097879|NCT02326272|2170434|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097880|NCT02326272|2170435|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
1097881|NCT02326272|2170436|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097882|NCT02326272|2170437|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097883|NCT02326272|2170438|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097884|NCT02326272|2170439|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097885|NCT02326272|2170440|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097886|NCT02326272|2170441|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
893461|NCT00684203|1863896|FG000|Overall Study|Withdrawal by Subject|0
893462|NCT00684203|1863897|FG001|Overall Study|Withdrawal by Subject|2
893463|NCT00684203|1863898|FG002|Overall Study|Withdrawal by Subject|1
893464|NCT00684203|1863899|FG003|Overall Study|Withdrawal by Subject|0
893465|NCT00684203|1863900|FG004|Overall Study|Withdrawal by Subject|0
893466|NCT00684203|1863901|FG005|Overall Study|Withdrawal by Subject|0
893467|NCT00684203|1863896|FG000|Overall Study|Did not meet protocol eligibility|0
893468|NCT00684203|1863897|FG001|Overall Study|Did not meet protocol eligibility|1
893469|NCT00684203|1863898|FG002|Overall Study|Did not meet protocol eligibility|0
893470|NCT00684203|1863899|FG003|Overall Study|Did not meet protocol eligibility|0
1097887|NCT02326272|2170442|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097888|NCT02326272|2170443|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097889|NCT02326272|2170444|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1097890|NCT02326272|2170430|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097891|NCT02326272|2170431|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097892|NCT02326272|2170432|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097893|NCT02326272|2170433|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097894|NCT02326272|2170434|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097895|NCT02326272|2170435|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097896|NCT02326272|2170436|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
1097897|NCT02326272|2170437|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097898|NCT02326272|2170438|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097899|NCT02326272|2170439|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097900|NCT02326272|2170440|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097901|NCT02326272|2170441|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097902|NCT02326272|2170442|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097903|NCT02326272|2170443|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097904|NCT02326272|2170444|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1097905|NCT02326272|2170430|FG000|Open-label Period (Week 48 to Week 144)|Death|0
1097906|NCT02326272|2170431|FG001|Open-label Period (Week 48 to Week 144)|Death|0
1097907|NCT02326272|2170432|FG002|Open-label Period (Week 48 to Week 144)|Death|0
1097908|NCT02326272|2170433|FG003|Open-label Period (Week 48 to Week 144)|Death|0
1097909|NCT02326272|2170434|FG004|Open-label Period (Week 48 to Week 144)|Death|0
1097910|NCT02326272|2170435|FG005|Open-label Period (Week 48 to Week 144)|Death|0
1097911|NCT02326272|2170436|FG006|Open-label Period (Week 48 to Week 144)|Death|0
1097912|NCT02326272|2170437|FG007|Open-label Period (Week 48 to Week 144)|Death|0
1097913|NCT02326272|2170438|FG008|Open-label Period (Week 48 to Week 144)|Death|0
1097914|NCT02326272|2170439|FG009|Open-label Period (Week 48 to Week 144)|Death|0
1097915|NCT02326272|2170440|FG010|Open-label Period (Week 48 to Week 144)|Death|0
1097916|NCT02326272|2170441|FG011|Open-label Period (Week 48 to Week 144)|Death|0
1097917|NCT02326272|2170442|FG012|Open-label Period (Week 48 to Week 144)|Death|1
1097918|NCT02326272|2170443|FG013|Open-label Period (Week 48 to Week 144)|Death|0
1097919|NCT02326272|2170444|FG014|Open-label Period (Week 48 to Week 144)|Death|0
1097920|NCT02326272|2170430|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1097921|NCT02326272|2170431|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1097922|NCT02326272|2170432|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1097923|NCT02326272|2170433|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1097924|NCT02326272|2170434|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1097925|NCT02326272|2170435|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1097926|NCT02326272|2170436|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1097927|NCT02326272|2170437|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1097928|NCT02326272|2170438|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1097929|NCT02326272|2170439|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
893471|NCT00684203|1863900|FG004|Overall Study|Did not meet protocol eligibility|0
893472|NCT00684203|1863901|FG005|Overall Study|Did not meet protocol eligibility|0
893473|NCT00684307|1863931|FG000|Overall Study|Adverse Event|11
893474|NCT00684307|1863932|FG001|Overall Study|Adverse Event|6
893475|NCT00684307|1863933|FG002|Overall Study|Adverse Event|15
893476|NCT00684307|1863934|FG003|Overall Study|Adverse Event|16
893477|NCT00684307|1863935|FG004|Overall Study|Adverse Event|8
893478|NCT00684307|1863931|FG000|Overall Study|Development of increasing Liver Function|0
893479|NCT00684307|1863932|FG001|Overall Study|Development of increasing Liver Function|2
893480|NCT00684307|1863933|FG002|Overall Study|Development of increasing Liver Function|0
893481|NCT00684307|1863934|FG003|Overall Study|Development of increasing Liver Function|1
893482|NCT00684307|1863935|FG004|Overall Study|Development of increasing Liver Function|0
893483|NCT00684307|1863931|FG000|Overall Study|Fullfillment of exclusion criteria|1
893484|NCT00684307|1863932|FG001|Overall Study|Fullfillment of exclusion criteria|0
893485|NCT00684307|1863933|FG002|Overall Study|Fullfillment of exclusion criteria|0
893486|NCT00684307|1863934|FG003|Overall Study|Fullfillment of exclusion criteria|3
893487|NCT00684307|1863935|FG004|Overall Study|Fullfillment of exclusion criteria|1
893488|NCT00684307|1863931|FG000|Overall Study|Incorrect enrolment or randomization|4
893489|NCT00684307|1863932|FG001|Overall Study|Incorrect enrolment or randomization|0
893490|NCT00684307|1863933|FG002|Overall Study|Incorrect enrolment or randomization|0
893491|NCT00684307|1863934|FG003|Overall Study|Incorrect enrolment or randomization|0
893492|NCT00684307|1863935|FG004|Overall Study|Incorrect enrolment or randomization|0
893493|NCT00684307|1863931|FG000|Overall Study|Interupted IP for more than 7 days|0
893494|NCT00684307|1863932|FG001|Overall Study|Interupted IP for more than 7 days|4
893495|NCT00684307|1863933|FG002|Overall Study|Interupted IP for more than 7 days|1
893496|NCT00684307|1863934|FG003|Overall Study|Interupted IP for more than 7 days|3
893497|NCT00684307|1863935|FG004|Overall Study|Interupted IP for more than 7 days|3
1097930|NCT02326272|2170440|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1
1097931|NCT02326272|2170441|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8
1097932|NCT02326272|2170442|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
1097933|NCT02326272|2170443|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1097934|NCT02326272|2170444|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1
1097935|NCT02326272|2170430|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097936|NCT02326272|2170431|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097937|NCT02326272|2170432|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097938|NCT02326272|2170433|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097939|NCT02326272|2170434|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097940|NCT02326272|2170435|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097941|NCT02326272|2170436|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097942|NCT02326272|2170437|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097943|NCT02326272|2170438|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097944|NCT02326272|2170439|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097945|NCT02326272|2170440|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
1097946|NCT02326272|2170441|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097947|NCT02326272|2170442|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
1097948|NCT02326272|2170443|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097949|NCT02326272|2170444|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1097950|NCT02326272|2170430|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097951|NCT02326272|2170431|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097952|NCT02326272|2170432|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097953|NCT02326272|2170433|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097954|NCT02326272|2170434|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097955|NCT02326272|2170435|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097956|NCT02326272|2170436|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097957|NCT02326272|2170437|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097958|NCT02326272|2170438|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097959|NCT02326272|2170439|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097960|NCT02326272|2170440|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097961|NCT02326272|2170441|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
1097962|NCT02326272|2170442|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097963|NCT02326272|2170443|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097964|NCT02326272|2170444|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1097965|NCT02326272|2170430|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097966|NCT02326272|2170431|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097967|NCT02326272|2170432|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097968|NCT02326272|2170433|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097969|NCT02326272|2170434|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097970|NCT02326272|2170435|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097971|NCT02326272|2170436|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097972|NCT02326272|2170437|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097973|NCT02326272|2170438|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097974|NCT02326272|2170439|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097975|NCT02326272|2170440|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
1097976|NCT02326272|2170441|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097977|NCT02326272|2170442|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
1097978|NCT02326272|2170443|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1097979|NCT02326272|2170444|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
1097980|NCT02326272|2170430|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097981|NCT02326272|2170431|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097982|NCT02326272|2170432|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097983|NCT02326272|2170433|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097984|NCT02326272|2170434|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097985|NCT02326272|2170435|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097986|NCT02326272|2170436|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097987|NCT02326272|2170437|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097988|NCT02326272|2170438|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097989|NCT02326272|2170439|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097990|NCT02326272|2170440|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097991|NCT02326272|2170441|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
1097992|NCT02326272|2170442|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097993|NCT02326272|2170443|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1097994|NCT02326272|2170444|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
1097995|NCT02326272|2170430|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1097996|NCT02326272|2170431|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
893498|NCT00684307|1863931|FG000|Overall Study|Severe non compliance to protocol|1
893499|NCT00684307|1863932|FG001|Overall Study|Severe non compliance to protocol|0
893500|NCT00684307|1863933|FG002|Overall Study|Severe non compliance to protocol|0
893501|NCT00684307|1863934|FG003|Overall Study|Severe non compliance to protocol|1
893502|NCT00684307|1863935|FG004|Overall Study|Severe non compliance to protocol|2
893503|NCT00684307|1863931|FG000|Overall Study|Participant not willing to continue|7
893504|NCT00684307|1863932|FG001|Overall Study|Participant not willing to continue|10
893505|NCT00684307|1863933|FG002|Overall Study|Participant not willing to continue|11
893506|NCT00684307|1863934|FG003|Overall Study|Participant not willing to continue|5
1097997|NCT02326272|2170432|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1097998|NCT02326272|2170433|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1097999|NCT02326272|2170434|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098000|NCT02326272|2170435|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098001|NCT02326272|2170436|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098002|NCT02326272|2170437|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098003|NCT02326272|2170438|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098004|NCT02326272|2170439|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098005|NCT02326272|2170440|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098006|NCT02326272|2170441|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
1098007|NCT02326272|2170442|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
1098008|NCT02326272|2170443|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098009|NCT02326272|2170444|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
1098010|NCT02326272|2170430|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098011|NCT02326272|2170431|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098012|NCT02326272|2170432|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098013|NCT02326272|2170433|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098014|NCT02326272|2170434|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098015|NCT02326272|2170435|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098016|NCT02326272|2170436|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098017|NCT02326272|2170437|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098018|NCT02326272|2170438|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098019|NCT02326272|2170439|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098020|NCT02326272|2170440|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098021|NCT02326272|2170441|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
1098022|NCT02326272|2170442|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098023|NCT02326272|2170443|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098024|NCT02326272|2170444|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1098025|NCT02326272|2170430|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098026|NCT02326272|2170431|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098027|NCT02326272|2170432|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098028|NCT02326272|2170433|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098029|NCT02326272|2170434|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098030|NCT02326272|2170435|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098031|NCT02326272|2170436|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098032|NCT02326272|2170437|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098033|NCT02326272|2170438|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098034|NCT02326272|2170439|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098035|NCT02326272|2170440|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098036|NCT02326272|2170441|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098037|NCT02326272|2170442|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1
1098038|NCT02326272|2170443|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098039|NCT02326272|2170444|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1098040|NCT02326298|2170456|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098041|NCT02326298|2170457|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098042|NCT02326298|2170458|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
1098043|NCT02326298|2170459|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098044|NCT02326298|2170460|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098045|NCT02326298|2170461|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098046|NCT02326298|2170462|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098047|NCT02326298|2170463|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098048|NCT02326298|2170464|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098049|NCT02326298|2170465|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098050|NCT02326298|2170466|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098051|NCT02326298|2170467|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098052|NCT02326298|2170468|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098053|NCT02326298|2170469|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
1098054|NCT02326298|2170456|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
1098055|NCT02326298|2170457|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098056|NCT02326298|2170458|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098057|NCT02326298|2170459|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098058|NCT02326298|2170460|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098059|NCT02326298|2170461|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098060|NCT02326298|2170462|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098061|NCT02326298|2170463|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098062|NCT02326298|2170464|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098063|NCT02326298|2170465|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098064|NCT02326298|2170466|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098065|NCT02326298|2170467|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098066|NCT02326298|2170468|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098067|NCT02326298|2170469|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1098068|NCT02326298|2170456|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
1098069|NCT02326298|2170457|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
1098070|NCT02326298|2170458|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1098071|NCT02326298|2170459|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1098072|NCT02326298|2170460|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
893507|NCT00684307|1863935|FG004|Overall Study|Participant not willing to continue|8
893508|NCT00684307|1863931|FG000|Overall Study|Criteria from the CSR|0
893509|NCT00684307|1863932|FG001|Overall Study|Criteria from the CSR|0
893510|NCT00684307|1863933|FG002|Overall Study|Criteria from the CSR|1
893511|NCT00684307|1863934|FG003|Overall Study|Criteria from the CSR|3
893512|NCT00684307|1863935|FG004|Overall Study|Criteria from the CSR|3
893513|NCT00684411|1863956|FG000|Overall Study|New Primary Cancer|1
893514|NCT00684411|1863956|FG000|Overall Study|Disease Progression|10
893515|NCT00684411|1863956|FG000|Overall Study|Adverse Event|1
1098073|NCT02326298|2170461|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1098074|NCT02326298|2170462|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1098075|NCT02326298|2170463|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1098076|NCT02326298|2170464|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1098077|NCT02326298|2170465|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1098078|NCT02326298|2170466|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1098079|NCT02326298|2170467|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1098080|NCT02326298|2170468|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1098081|NCT02326298|2170469|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1098082|NCT02326298|2170456|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
1098083|NCT02326298|2170457|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
1098084|NCT02326298|2170458|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098085|NCT02326298|2170459|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098086|NCT02326298|2170460|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098087|NCT02326298|2170461|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098088|NCT02326298|2170462|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098089|NCT02326298|2170463|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098090|NCT02326298|2170464|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098091|NCT02326298|2170465|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098092|NCT02326298|2170466|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098093|NCT02326298|2170467|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098094|NCT02326298|2170468|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098095|NCT02326298|2170469|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1098096|NCT02326298|2170456|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098097|NCT02326298|2170457|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098098|NCT02326298|2170458|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
1098099|NCT02326298|2170459|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098100|NCT02326298|2170460|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098101|NCT02326298|2170461|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098102|NCT02326298|2170462|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098103|NCT02326298|2170463|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098104|NCT02326298|2170464|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098105|NCT02326298|2170465|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098106|NCT02326298|2170466|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098107|NCT02326298|2170467|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098108|NCT02326298|2170468|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098109|NCT02326298|2170469|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1098110|NCT02326298|2170456|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1098111|NCT02326298|2170457|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1098112|NCT02326298|2170458|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1098113|NCT02326298|2170459|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1098114|NCT02326298|2170460|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1098115|NCT02326298|2170461|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1098116|NCT02326298|2170462|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
1098117|NCT02326298|2170463|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1162062|NCT03382262|2284030|FG003|Overall Study|Withdrawal by Subject|1
1098118|NCT02326298|2170464|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1098119|NCT02326298|2170465|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1098120|NCT02326298|2170466|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1098121|NCT02326298|2170467|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1098122|NCT02326298|2170468|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1098123|NCT02326298|2170469|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1098124|NCT02326298|2170456|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1098125|NCT02326298|2170457|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1098126|NCT02326298|2170458|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1098127|NCT02326298|2170459|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1098128|NCT02326298|2170460|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1098129|NCT02326298|2170461|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
1098130|NCT02326298|2170462|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
1098131|NCT02326298|2170463|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1098132|NCT02326298|2170464|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
1098133|NCT02326298|2170465|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1098134|NCT02326298|2170466|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1098135|NCT02326298|2170467|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1098136|NCT02326298|2170468|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1098137|NCT02326298|2170469|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1098138|NCT02326298|2170456|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098139|NCT02326298|2170457|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098140|NCT02326298|2170458|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098141|NCT02326298|2170459|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098142|NCT02326298|2170460|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098143|NCT02326298|2170461|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
1098144|NCT02326298|2170462|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098145|NCT02326298|2170463|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098146|NCT02326298|2170464|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098147|NCT02326298|2170465|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098148|NCT02326298|2170466|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098149|NCT02326298|2170467|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098150|NCT02326298|2170468|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098151|NCT02326298|2170469|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1098152|NCT02326298|2170456|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098153|NCT02326298|2170457|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098154|NCT02326298|2170458|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098155|NCT02326298|2170459|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098156|NCT02326298|2170460|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098157|NCT02326298|2170461|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098158|NCT02326298|2170462|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
1098159|NCT02326298|2170463|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098160|NCT02326298|2170464|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098161|NCT02326298|2170465|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098162|NCT02326298|2170466|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098163|NCT02326298|2170467|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098164|NCT02326298|2170468|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098165|NCT02326298|2170469|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1098166|NCT02326298|2170456|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098167|NCT02326298|2170457|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098168|NCT02326298|2170458|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098169|NCT02326298|2170459|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098170|NCT02326298|2170460|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098171|NCT02326298|2170461|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098172|NCT02326298|2170462|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098173|NCT02326298|2170463|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
1098174|NCT02326298|2170464|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098175|NCT02326298|2170465|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098176|NCT02326298|2170466|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098177|NCT02326298|2170467|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098178|NCT02326298|2170468|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098179|NCT02326298|2170469|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1098180|NCT02326298|2170456|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098181|NCT02326298|2170457|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098182|NCT02326298|2170458|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098183|NCT02326298|2170459|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098184|NCT02326298|2170460|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098185|NCT02326298|2170461|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098186|NCT02326298|2170462|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
1098187|NCT02326298|2170463|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
1098188|NCT02326298|2170464|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098189|NCT02326298|2170465|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098190|NCT02326298|2170466|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098191|NCT02326298|2170467|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098192|NCT02326298|2170468|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098193|NCT02326298|2170469|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1098194|NCT02326298|2170456|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098195|NCT02326298|2170457|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098196|NCT02326298|2170458|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098197|NCT02326298|2170459|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098198|NCT02326298|2170460|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098199|NCT02326298|2170461|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098200|NCT02326298|2170462|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098201|NCT02326298|2170463|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
1098202|NCT02326298|2170464|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098203|NCT02326298|2170465|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098204|NCT02326298|2170466|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098205|NCT02326298|2170467|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098206|NCT02326298|2170468|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098207|NCT02326298|2170469|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1098208|NCT02326298|2170456|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098209|NCT02326298|2170457|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098210|NCT02326298|2170458|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098211|NCT02326298|2170459|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098212|NCT02326298|2170460|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098213|NCT02326298|2170461|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
1098214|NCT02326298|2170462|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098215|NCT02326298|2170463|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098216|NCT02326298|2170464|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098217|NCT02326298|2170465|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098218|NCT02326298|2170466|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098219|NCT02326298|2170467|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098220|NCT02326298|2170468|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098221|NCT02326298|2170469|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1098222|NCT02326298|2170456|FG000|Open-label Period (Week 48 to Week 144)|Death|0
1098223|NCT02326298|2170457|FG001|Open-label Period (Week 48 to Week 144)|Death|0
1098224|NCT02326298|2170458|FG002|Open-label Period (Week 48 to Week 144)|Death|0
1098225|NCT02326298|2170459|FG003|Open-label Period (Week 48 to Week 144)|Death|0
1098226|NCT02326298|2170460|FG004|Open-label Period (Week 48 to Week 144)|Death|0
893516|NCT00684424|1863960|FG000|Overall Study|Adverse Event|1
893517|NCT00684424|1863960|FG000|Overall Study|Lost to Follow-up|2
893518|NCT00684424|1863960|FG000|Overall Study|Other|2
893519|NCT00684515|1863968|FG000|Overall Study|Adverse Event|3
893520|NCT00684515|1863969|FG001|Overall Study|Adverse Event|3
893521|NCT00684515|1863970|FG002|Overall Study|Adverse Event|1
893522|NCT00684515|1863968|FG000|Overall Study|Protocol-Defined Clinical Event|1
893523|NCT00684515|1863969|FG001|Overall Study|Protocol-Defined Clinical Event|0
893524|NCT00684515|1863970|FG002|Overall Study|Protocol-Defined Clinical Event|0
893525|NCT00684567|1863997|FG000|Concomitant Radiotherapy Period|Adverse Event|2
893526|NCT00684567|1863997|FG000|Monotherapy Period|Adverse Event|2
893527|NCT00684567|1863997|FG000|Monotherapy Period|Death|1
893528|NCT00684567|1863997|FG000|Monotherapy Period|Progression of primary disease|11
893529|NCT00684593|1864003|FG000|Overall Study|Adverse Event|0
893530|NCT00684593|1864004|FG001|Overall Study|Adverse Event|2
893531|NCT00684645|1864010|FG000|Overall Study|Death|2
893532|NCT00684645|1864010|FG000|Overall Study|Progressive disease|67
893533|NCT00684645|1864010|FG000|Overall Study|Adverse Event|27
893534|NCT00684645|1864010|FG000|Overall Study|Lost to Follow-up|3
893535|NCT00684645|1864010|FG000|Overall Study|Other|15
893536|NCT00684671|1864017|FG000|Overall Study|Adverse Event|1
893537|NCT00684671|1864018|FG001|Overall Study|Adverse Event|0
893538|NCT00684671|1864019|FG002|Overall Study|Adverse Event|0
893539|NCT00684671|1864017|FG000|Overall Study|Lost to Follow-up|1
893540|NCT00684671|1864018|FG001|Overall Study|Lost to Follow-up|0
893541|NCT00684671|1864019|FG002|Overall Study|Lost to Follow-up|0
1098227|NCT02326298|2170461|FG005|Open-label Period (Week 48 to Week 144)|Death|0
1098228|NCT02326298|2170462|FG006|Open-label Period (Week 48 to Week 144)|Death|0
1098229|NCT02326298|2170463|FG007|Open-label Period (Week 48 to Week 144)|Death|0
1098230|NCT02326298|2170464|FG008|Open-label Period (Week 48 to Week 144)|Death|0
1098231|NCT02326298|2170465|FG009|Open-label Period (Week 48 to Week 144)|Death|0
1098232|NCT02326298|2170466|FG010|Open-label Period (Week 48 to Week 144)|Death|0
1098233|NCT02326298|2170467|FG011|Open-label Period (Week 48 to Week 144)|Death|1
1098234|NCT02326298|2170468|FG012|Open-label Period (Week 48 to Week 144)|Death|0
1098235|NCT02326298|2170469|FG013|Open-label Period (Week 48 to Week 144)|Death|0
1098236|NCT02326298|2170456|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098237|NCT02326298|2170457|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098238|NCT02326298|2170458|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098239|NCT02326298|2170459|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098240|NCT02326298|2170460|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098241|NCT02326298|2170461|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098242|NCT02326298|2170462|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098243|NCT02326298|2170463|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098244|NCT02326298|2170464|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098245|NCT02326298|2170465|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098246|NCT02326298|2170466|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098247|NCT02326298|2170467|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3
1098248|NCT02326298|2170468|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
1098249|NCT02326298|2170469|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1098250|NCT02326298|2170456|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098251|NCT02326298|2170457|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098252|NCT02326298|2170458|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098253|NCT02326298|2170459|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098254|NCT02326298|2170460|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098255|NCT02326298|2170461|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098256|NCT02326298|2170462|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098257|NCT02326298|2170463|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098258|NCT02326298|2170464|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098259|NCT02326298|2170465|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098260|NCT02326298|2170466|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098261|NCT02326298|2170467|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
1098262|NCT02326298|2170468|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
1098263|NCT02326298|2170469|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1098264|NCT02326298|2170456|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098265|NCT02326298|2170457|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098266|NCT02326298|2170458|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098267|NCT02326298|2170459|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098268|NCT02326298|2170460|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098269|NCT02326298|2170461|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098270|NCT02326298|2170462|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098271|NCT02326298|2170463|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
893542|NCT00684671|1864017|FG000|Overall Study|Alcoholic dependance|1
893543|NCT00684671|1864018|FG001|Overall Study|Alcoholic dependance|0
893544|NCT00684671|1864019|FG002|Overall Study|Alcoholic dependance|0
893545|NCT00684762|1864038|FG000|Washout Period of 7 Days|Withdrawal by Subject|2
893546|NCT00684762|1864039|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
893547|NCT00684814|1864077|FG000|Washout Period of 7 Days|Adverse Event|1
893548|NCT00684814|1864078|FG001|Washout Period of 7 Days|Adverse Event|2
893549|NCT00684814|1864077|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
893550|NCT00684814|1864078|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
893551|NCT00684814|1864077|FG000|Second Intervention|Adverse Event|1
893552|NCT00684814|1864078|FG001|Second Intervention|Adverse Event|0
893553|NCT00684996|1864095|FG000|Overall Study|Adverse Event|1
893554|NCT00684996|1864095|FG000|Overall Study|Refusal unrelated to adverse event|1
893555|NCT00684996|1864095|FG000|Overall Study|Progression/relapse|2
893556|NCT00684996|1864095|FG000|Overall Study|Other reasons not protocol specified|1
1098272|NCT02326298|2170464|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098273|NCT02326298|2170465|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098274|NCT02326298|2170466|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098275|NCT02326298|2170467|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098276|NCT02326298|2170468|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1098277|NCT02326298|2170469|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
1098278|NCT02326298|2170456|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1098279|NCT02326298|2170457|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1098280|NCT02326298|2170458|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
893557|NCT00685035|1864102|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
1018311|NCT01570283|2043157|FG000|Cohort 1: Dose Level 1|Death|0
1098281|NCT02326298|2170459|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1098282|NCT02326298|2170460|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1098283|NCT02326298|2170461|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1098284|NCT02326298|2170462|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1098285|NCT02326298|2170463|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1098286|NCT02326298|2170464|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1098287|NCT02326298|2170465|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1098288|NCT02326298|2170466|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1098289|NCT02326298|2170467|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
1098290|NCT02326298|2170468|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
1098291|NCT02326298|2170469|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
1098292|NCT02326298|2170456|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098293|NCT02326298|2170457|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098294|NCT02326298|2170458|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098295|NCT02326298|2170459|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098296|NCT02326298|2170460|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098297|NCT02326298|2170461|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098298|NCT02326298|2170462|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098299|NCT02326298|2170463|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098300|NCT02326298|2170464|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098301|NCT02326298|2170465|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098302|NCT02326298|2170466|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1098303|NCT02326298|2170467|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
1098304|NCT02326298|2170468|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
1098305|NCT02326298|2170469|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
1098306|NCT02326298|2170456|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
893558|NCT00685035|1864103|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
893559|NCT00685165|1864134|FG000|Washout Period of 14 Days|Adverse Event|1
893560|NCT00685165|1864135|FG001|Washout Period of 14 Days|Adverse Event|0
893561|NCT00685178|1864145|FG000|Overall Study|Adverse Event|1
893562|NCT00685178|1864146|FG001|Overall Study|Adverse Event|5
893563|NCT00685178|1864147|FG002|Overall Study|Adverse Event|2
893564|NCT00685178|1864148|FG003|Overall Study|Adverse Event|4
893565|NCT00685178|1864145|FG000|Overall Study|missed 3 consecutive methadone clin days|7
893566|NCT00685178|1864146|FG001|Overall Study|missed 3 consecutive methadone clin days|5
893567|NCT00685178|1864147|FG002|Overall Study|missed 3 consecutive methadone clin days|2
893568|NCT00685178|1864148|FG003|Overall Study|missed 3 consecutive methadone clin days|6
893569|NCT00685178|1864145|FG000|Overall Study|voluntary study discharge|4
893570|NCT00685178|1864146|FG001|Overall Study|voluntary study discharge|5
893571|NCT00685178|1864147|FG002|Overall Study|voluntary study discharge|1
893572|NCT00685178|1864148|FG003|Overall Study|voluntary study discharge|1
893573|NCT00685178|1864145|FG000|Overall Study|incarcerated|1
893574|NCT00685178|1864146|FG001|Overall Study|incarcerated|3
893575|NCT00685178|1864147|FG002|Overall Study|incarcerated|7
893576|NCT00685178|1864148|FG003|Overall Study|incarcerated|0
893577|NCT00685178|1864145|FG000|Overall Study|administrative (disciplinary) discharge|0
893578|NCT00685178|1864146|FG001|Overall Study|administrative (disciplinary) discharge|1
893579|NCT00685178|1864147|FG002|Overall Study|administrative (disciplinary) discharge|0
893580|NCT00685178|1864148|FG003|Overall Study|administrative (disciplinary) discharge|2
893581|NCT00685178|1864145|FG000|Overall Study|Pregnancy|0
893582|NCT00685178|1864146|FG001|Overall Study|Pregnancy|0
893583|NCT00685178|1864147|FG002|Overall Study|Pregnancy|0
893584|NCT00685178|1864148|FG003|Overall Study|Pregnancy|1
893585|NCT00685334|1864171|FG000|Overall Study|Withdrawal by Subject|5
893586|NCT00685334|1864172|FG001|Overall Study|Withdrawal by Subject|6
893587|NCT00685334|1864171|FG000|Overall Study|Lost to Follow-up|4
893588|NCT00685334|1864172|FG001|Overall Study|Lost to Follow-up|0
893589|NCT00685334|1864171|FG000|Overall Study|Chose to enter hospital|1
893590|NCT00685334|1864172|FG001|Overall Study|Chose to enter hospital|1
893591|NCT00685373|1864178|FG000|Overall Study|Adverse Event|3
893592|NCT00685373|1864178|FG000|Overall Study|Withdrawal by Subject|5
893593|NCT00685373|1864178|FG000|Overall Study|Lack of Efficacy|3
1098307|NCT02326298|2170457|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1098308|NCT02326298|2170458|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1098309|NCT02326298|2170459|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1098310|NCT02326298|2170460|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1098311|NCT02326298|2170461|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1098312|NCT02326298|2170462|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1098313|NCT02326298|2170463|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1098314|NCT02326298|2170464|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1098315|NCT02326298|2170465|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
893594|NCT00685373|1864178|FG000|Overall Study|Condition no longer requires study drug|1
893595|NCT00685373|1864178|FG000|Overall Study|Lost to Follow-up|2
1098316|NCT02326298|2170466|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1098317|NCT02326298|2170467|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
1098318|NCT02326298|2170468|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
1098319|NCT02326298|2170469|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
1098320|NCT02326467|2170489|FG000|Overall Study|Withdrawal by Subject|1
1098321|NCT02326597|2170496|FG000|Overall Study|Lost to Follow-up|42
1098322|NCT02326597|2170497|FG001|Overall Study|Lost to Follow-up|32
1098323|NCT02326883|2170525|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84
1098324|NCT02326883|2170526|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85
1098325|NCT02326883|2170527|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69
1098326|NCT02326974|2170535|FG000|Overall Study|Withdrawal by Subject|2
1098327|NCT02326974|2170535|FG000|Overall Study|failed heterogenity evaluation|5
1098328|NCT02327013|2170546|FG000|Overall Study|Adverse Event|4
1098329|NCT02327013|2170547|FG001|Overall Study|Adverse Event|4
1098330|NCT02327013|2170548|FG002|Overall Study|Adverse Event|3
1098331|NCT02327013|2170549|FG003|Overall Study|Adverse Event|0
1098332|NCT02327013|2170550|FG004|Overall Study|Adverse Event|1
1098333|NCT02327013|2170546|FG000|Overall Study|Lack of Efficacy|2
1098334|NCT02327013|2170547|FG001|Overall Study|Lack of Efficacy|0
1098335|NCT02327013|2170548|FG002|Overall Study|Lack of Efficacy|5
1098336|NCT02327013|2170549|FG003|Overall Study|Lack of Efficacy|0
1098337|NCT02327013|2170550|FG004|Overall Study|Lack of Efficacy|1
1098338|NCT02327013|2170546|FG000|Overall Study|Non-compliance with IMP|1
1098339|NCT02327013|2170547|FG001|Overall Study|Non-compliance with IMP|2
1098340|NCT02327013|2170548|FG002|Overall Study|Non-compliance with IMP|7
1098341|NCT02327013|2170549|FG003|Overall Study|Non-compliance with IMP|0
1098342|NCT02327013|2170550|FG004|Overall Study|Non-compliance with IMP|0
1098343|NCT02327013|2170546|FG000|Overall Study|Withdrawal of Consent|1
1098344|NCT02327013|2170547|FG001|Overall Study|Withdrawal of Consent|0
1098345|NCT02327013|2170548|FG002|Overall Study|Withdrawal of Consent|3
1098346|NCT02327013|2170549|FG003|Overall Study|Withdrawal of Consent|0
1098347|NCT02327013|2170550|FG004|Overall Study|Withdrawal of Consent|0
1098348|NCT02327013|2170546|FG000|Overall Study|Lost to Follow-up|2
1098349|NCT02327013|2170547|FG001|Overall Study|Lost to Follow-up|4
1098350|NCT02327013|2170548|FG002|Overall Study|Lost to Follow-up|5
1098351|NCT02327013|2170549|FG003|Overall Study|Lost to Follow-up|0
1098352|NCT02327013|2170550|FG004|Overall Study|Lost to Follow-up|0
1098353|NCT02327013|2170546|FG000|Overall Study|Administrative or other reason(s)|1
1098354|NCT02327013|2170547|FG001|Overall Study|Administrative or other reason(s)|5
1098355|NCT02327013|2170548|FG002|Overall Study|Administrative or other reason(s)|11
1098356|NCT02327013|2170549|FG003|Overall Study|Administrative or other reason(s)|1
1098357|NCT02327013|2170550|FG004|Overall Study|Administrative or other reason(s)|1
1098358|NCT02327013|2170546|FG000|Overall Study|Protocol Violation|0
1098359|NCT02327013|2170547|FG001|Overall Study|Protocol Violation|0
1098360|NCT02327013|2170548|FG002|Overall Study|Protocol Violation|3
1098361|NCT02327013|2170549|FG003|Overall Study|Protocol Violation|0
1098362|NCT02327013|2170550|FG004|Overall Study|Protocol Violation|1
1098363|NCT02327013|2170546|FG000|Overall Study|Withdrawal before treatment|2
1098364|NCT02327013|2170547|FG001|Overall Study|Withdrawal before treatment|1
1098365|NCT02327013|2170548|FG002|Overall Study|Withdrawal before treatment|5
1098366|NCT02327013|2170549|FG003|Overall Study|Withdrawal before treatment|0
1098367|NCT02327013|2170550|FG004|Overall Study|Withdrawal before treatment|0
1098368|NCT02327130|2170583|FG000|Overall Study|Discharged in less than 5 days|5
1098369|NCT02327130|2170583|FG000|Overall Study|Physician Decision|2
1098370|NCT02327130|2170583|FG000|Overall Study|Unable to provide breath sample|1
1098371|NCT02327130|2170583|FG000|Overall Study|Incorrectly place ventilator adaptor|1
1098372|NCT02327130|2170583|FG000|Overall Study|Met exclusion criteria|3
1098373|NCT02327169|2170612|FG000|Overall Study|Progressive Disease|1
1098374|NCT02327169|2170613|FG001|Overall Study|Progressive Disease|3
1098375|NCT02327169|2170614|FG002|Overall Study|Progressive Disease|4
1098376|NCT02327169|2170615|FG003|Overall Study|Progressive Disease|3
1098377|NCT02327169|2170616|FG004|Overall Study|Progressive Disease|4
1098378|NCT02327169|2170617|FG005|Overall Study|Progressive Disease|3
1098379|NCT02327169|2170618|FG006|Overall Study|Progressive Disease|3
1098380|NCT02327169|2170619|FG007|Overall Study|Progressive Disease|3
1098381|NCT02327169|2170620|FG008|Overall Study|Progressive Disease|4
1098382|NCT02327169|2170621|FG009|Overall Study|Progressive Disease|4
1098383|NCT02327169|2170622|FG010|Overall Study|Progressive Disease|4
1098384|NCT02327169|2170623|FG011|Overall Study|Progressive Disease|3
1098385|NCT02327169|2170624|FG012|Overall Study|Progressive Disease|1
1098386|NCT02327169|2170625|FG013|Overall Study|Progressive Disease|3
1098387|NCT02327169|2170626|FG014|Overall Study|Progressive Disease|3
1098388|NCT02327169|2170612|FG000|Overall Study|Adverse Event|2
1098389|NCT02327169|2170613|FG001|Overall Study|Adverse Event|0
1098390|NCT02327169|2170614|FG002|Overall Study|Adverse Event|1
1098391|NCT02327169|2170615|FG003|Overall Study|Adverse Event|0
1098392|NCT02327169|2170616|FG004|Overall Study|Adverse Event|1
1098393|NCT02327169|2170617|FG005|Overall Study|Adverse Event|0
1098394|NCT02327169|2170618|FG006|Overall Study|Adverse Event|0
1098395|NCT02327169|2170619|FG007|Overall Study|Adverse Event|0
1098396|NCT02327169|2170620|FG008|Overall Study|Adverse Event|0
1098397|NCT02327169|2170621|FG009|Overall Study|Adverse Event|2
1098398|NCT02327169|2170622|FG010|Overall Study|Adverse Event|0
1098399|NCT02327169|2170623|FG011|Overall Study|Adverse Event|3
1098400|NCT02327169|2170624|FG012|Overall Study|Adverse Event|0
1098401|NCT02327169|2170625|FG013|Overall Study|Adverse Event|2
1098402|NCT02327169|2170626|FG014|Overall Study|Adverse Event|1
1098403|NCT02327169|2170612|FG000|Overall Study|Symptomatic Deterioration|0
1098404|NCT02327169|2170613|FG001|Overall Study|Symptomatic Deterioration|0
1098405|NCT02327169|2170614|FG002|Overall Study|Symptomatic Deterioration|1
1098406|NCT02327169|2170615|FG003|Overall Study|Symptomatic Deterioration|0
1098407|NCT02327169|2170616|FG004|Overall Study|Symptomatic Deterioration|1
1098408|NCT02327169|2170617|FG005|Overall Study|Symptomatic Deterioration|1
1098409|NCT02327169|2170618|FG006|Overall Study|Symptomatic Deterioration|0
1098410|NCT02327169|2170619|FG007|Overall Study|Symptomatic Deterioration|0
1098411|NCT02327169|2170620|FG008|Overall Study|Symptomatic Deterioration|2
1098412|NCT02327169|2170621|FG009|Overall Study|Symptomatic Deterioration|1
1098413|NCT02327169|2170622|FG010|Overall Study|Symptomatic Deterioration|0
1098414|NCT02327169|2170623|FG011|Overall Study|Symptomatic Deterioration|0
1098415|NCT02327169|2170624|FG012|Overall Study|Symptomatic Deterioration|0
1098416|NCT02327169|2170625|FG013|Overall Study|Symptomatic Deterioration|2
1098417|NCT02327169|2170626|FG014|Overall Study|Symptomatic Deterioration|1
1098418|NCT02327169|2170612|FG000|Overall Study|Reason Not Specified|0
1098419|NCT02327169|2170613|FG001|Overall Study|Reason Not Specified|0
1098420|NCT02327169|2170614|FG002|Overall Study|Reason Not Specified|1
1098421|NCT02327169|2170615|FG003|Overall Study|Reason Not Specified|0
1098422|NCT02327169|2170616|FG004|Overall Study|Reason Not Specified|0
1098423|NCT02327169|2170617|FG005|Overall Study|Reason Not Specified|0
1098424|NCT02327169|2170618|FG006|Overall Study|Reason Not Specified|0
1098425|NCT02327169|2170619|FG007|Overall Study|Reason Not Specified|0
1098426|NCT02327169|2170620|FG008|Overall Study|Reason Not Specified|0
1098427|NCT02327169|2170621|FG009|Overall Study|Reason Not Specified|1
1098428|NCT02327169|2170622|FG010|Overall Study|Reason Not Specified|2
1098429|NCT02327169|2170623|FG011|Overall Study|Reason Not Specified|1
1098430|NCT02327169|2170624|FG012|Overall Study|Reason Not Specified|0
1098431|NCT02327169|2170625|FG013|Overall Study|Reason Not Specified|0
1098432|NCT02327169|2170626|FG014|Overall Study|Reason Not Specified|2
1098433|NCT02327169|2170612|FG000|Overall Study|Withdrawal by Subject|1
1098434|NCT02327169|2170613|FG001|Overall Study|Withdrawal by Subject|0
1098435|NCT02327169|2170614|FG002|Overall Study|Withdrawal by Subject|0
1098436|NCT02327169|2170615|FG003|Overall Study|Withdrawal by Subject|0
1098437|NCT02327169|2170616|FG004|Overall Study|Withdrawal by Subject|1
1098438|NCT02327169|2170617|FG005|Overall Study|Withdrawal by Subject|0
1098439|NCT02327169|2170618|FG006|Overall Study|Withdrawal by Subject|0
1098440|NCT02327169|2170619|FG007|Overall Study|Withdrawal by Subject|1
1098441|NCT02327169|2170620|FG008|Overall Study|Withdrawal by Subject|0
1098442|NCT02327169|2170621|FG009|Overall Study|Withdrawal by Subject|0
1098443|NCT02327169|2170622|FG010|Overall Study|Withdrawal by Subject|0
1098444|NCT02327169|2170623|FG011|Overall Study|Withdrawal by Subject|0
1098445|NCT02327169|2170624|FG012|Overall Study|Withdrawal by Subject|0
1098446|NCT02327169|2170625|FG013|Overall Study|Withdrawal by Subject|0
1098447|NCT02327169|2170626|FG014|Overall Study|Withdrawal by Subject|3
1098448|NCT02327169|2170612|FG000|Overall Study|Lost to Follow-up|0
1098449|NCT02327169|2170613|FG001|Overall Study|Lost to Follow-up|0
1098450|NCT02327169|2170614|FG002|Overall Study|Lost to Follow-up|0
1098451|NCT02327169|2170615|FG003|Overall Study|Lost to Follow-up|0
1098452|NCT02327169|2170616|FG004|Overall Study|Lost to Follow-up|1
1098453|NCT02327169|2170617|FG005|Overall Study|Lost to Follow-up|0
1098454|NCT02327169|2170618|FG006|Overall Study|Lost to Follow-up|0
1098455|NCT02327169|2170619|FG007|Overall Study|Lost to Follow-up|0
1098456|NCT02327169|2170620|FG008|Overall Study|Lost to Follow-up|0
1098457|NCT02327169|2170621|FG009|Overall Study|Lost to Follow-up|0
1098458|NCT02327169|2170622|FG010|Overall Study|Lost to Follow-up|0
1098459|NCT02327169|2170623|FG011|Overall Study|Lost to Follow-up|0
1098460|NCT02327169|2170624|FG012|Overall Study|Lost to Follow-up|0
1098461|NCT02327169|2170625|FG013|Overall Study|Lost to Follow-up|0
1098462|NCT02327169|2170626|FG014|Overall Study|Lost to Follow-up|0
1098463|NCT02327260|2170671|FG000|Overall Study|Lost to Follow-up|2
1098464|NCT02327260|2170672|FG001|Overall Study|Lost to Follow-up|3
1098465|NCT02327260|2170673|FG002|Overall Study|Lost to Follow-up|2
1098466|NCT02327260|2170671|FG000|Overall Study|invalid phone number|1
1098467|NCT02327260|2170672|FG001|Overall Study|invalid phone number|1
1098468|NCT02327260|2170673|FG002|Overall Study|invalid phone number|0
1098469|NCT02327260|2170671|FG000|Overall Study|non-adherence to protocol|2
1098470|NCT02327260|2170672|FG001|Overall Study|non-adherence to protocol|0
1098471|NCT02327260|2170673|FG002|Overall Study|non-adherence to protocol|0
1098472|NCT02327260|2170671|FG000|Overall Study|cognitive concerns|1
1098473|NCT02327260|2170672|FG001|Overall Study|cognitive concerns|0
1098474|NCT02327260|2170673|FG002|Overall Study|cognitive concerns|0
1098475|NCT02327325|2170685|FG000|Overall Study|Withdrawal by Subject|1
1098476|NCT02327325|2170686|FG001|Overall Study|Withdrawal by Subject|4
1098477|NCT02327325|2170687|FG002|Overall Study|Withdrawal by Subject|4
1098478|NCT02327325|2170685|FG000|Overall Study|Excluded by Study Team|0
1098479|NCT02327325|2170686|FG001|Overall Study|Excluded by Study Team|0
1098480|NCT02327325|2170687|FG002|Overall Study|Excluded by Study Team|1
1098509|NCT02328027|2170735|FG000|Overall Study|Withdrawal by Subject|0
1098510|NCT02328027|2170736|FG001|Overall Study|Withdrawal by Subject|1
1098511|NCT02328040|2170743|FG000|First Intervention (2 Days)|Withdrawal by Subject|1
1098512|NCT02328040|2170744|FG001|First Intervention (2 Days)|Withdrawal by Subject|1
1098513|NCT02328105|2170750|FG000|Overall Study|Death|6
1098514|NCT02328105|2170750|FG000|Overall Study|Withdrawal by Subject|1
1098515|NCT02328105|2170750|FG000|Overall Study|Still On Study in Follow-Up|4
1098516|NCT02328326|2170756|FG000|Overall Study|Withdrawal by Subject|10
1098517|NCT02328326|2170757|FG001|Overall Study|Withdrawal by Subject|3
1098518|NCT02328326|2170756|FG000|Overall Study|Death|2
1098519|NCT02328326|2170757|FG001|Overall Study|Death|1
1098520|NCT02328326|2170756|FG000|Overall Study|Lost to Follow-up|10
1098521|NCT02328326|2170757|FG001|Overall Study|Lost to Follow-up|4
1098522|NCT02328547|2170780|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
1098523|NCT02328547|2170781|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0
1098524|NCT02328547|2170780|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2
1098525|NCT02328547|2170781|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
1098526|NCT02328937|2170814|FG000|Period 1|Lost to Follow-up|0
1098527|NCT02328937|2170815|FG001|Period 1|Lost to Follow-up|0
1098528|NCT02328937|2170816|FG002|Period 1|Lost to Follow-up|0
1098529|NCT02328937|2170817|FG003|Period 1|Lost to Follow-up|1
1098530|NCT02328937|2170818|FG004|Period 1|Lost to Follow-up|0
1098531|NCT02328937|2170819|FG005|Period 1|Lost to Follow-up|0
1098532|NCT02328937|2170814|FG000|Period 2|Adverse Event|0
1098533|NCT02328937|2170815|FG001|Period 2|Adverse Event|0
1098534|NCT02328937|2170816|FG002|Period 2|Adverse Event|1
1098535|NCT02328937|2170817|FG003|Period 2|Adverse Event|0
1098536|NCT02328937|2170818|FG004|Period 2|Adverse Event|0
1098537|NCT02328937|2170819|FG005|Period 2|Adverse Event|0
1098538|NCT02329223|2170839|FG000|Overall Study|Withdrawal by Subject|1
1098539|NCT02329223|2170840|FG001|Overall Study|Withdrawal by Subject|2
1098540|NCT02329223|2170841|FG002|Overall Study|Withdrawal by Subject|5
1098541|NCT02329223|2170839|FG000|Overall Study|Physician Decision|0
1098542|NCT02329223|2170840|FG001|Overall Study|Physician Decision|0
1098543|NCT02329223|2170841|FG002|Overall Study|Physician Decision|1
1098544|NCT02329223|2170839|FG000|Overall Study|Adverse Event|0
1098545|NCT02329223|2170840|FG001|Overall Study|Adverse Event|1
1098546|NCT02329223|2170841|FG002|Overall Study|Adverse Event|0
1098547|NCT02329431|2170851|FG000|Overall Study|Lost to Follow-up|20
1098548|NCT02329431|2170852|FG001|Overall Study|Lost to Follow-up|13
1098549|NCT02329730|2170884|FG000|Overall Study|Protocol Violation|0
1098550|NCT02329730|2170885|FG001|Overall Study|Protocol Violation|0
1098551|NCT02329730|2170886|FG002|Overall Study|Protocol Violation|0
1098552|NCT02329730|2170887|FG003|Overall Study|Protocol Violation|0
1098553|NCT02329730|2170888|FG004|Overall Study|Protocol Violation|2
1098554|NCT02329730|2170889|FG005|Overall Study|Protocol Violation|2
1098555|NCT02329730|2170890|FG006|Overall Study|Protocol Violation|0
1098556|NCT02329730|2170891|FG007|Overall Study|Protocol Violation|0
1098557|NCT02329730|2170892|FG008|Overall Study|Protocol Violation|0
1098558|NCT02329730|2170893|FG009|Overall Study|Protocol Violation|0
1098559|NCT02329730|2170894|FG010|Overall Study|Protocol Violation|0
1098560|NCT02329730|2170895|FG011|Overall Study|Protocol Violation|0
1098561|NCT02329730|2170884|FG000|Overall Study|Withdrawal by Subject|0
1098562|NCT02329730|2170885|FG001|Overall Study|Withdrawal by Subject|0
1098563|NCT02329730|2170886|FG002|Overall Study|Withdrawal by Subject|0
1098564|NCT02329730|2170887|FG003|Overall Study|Withdrawal by Subject|0
1098565|NCT02329730|2170888|FG004|Overall Study|Withdrawal by Subject|1
1098566|NCT02329730|2170889|FG005|Overall Study|Withdrawal by Subject|0
1098567|NCT02329730|2170890|FG006|Overall Study|Withdrawal by Subject|1
1098568|NCT02329730|2170891|FG007|Overall Study|Withdrawal by Subject|1
1098569|NCT02329730|2170892|FG008|Overall Study|Withdrawal by Subject|1
1098570|NCT02329730|2170893|FG009|Overall Study|Withdrawal by Subject|1
1098571|NCT02329730|2170894|FG010|Overall Study|Withdrawal by Subject|0
1098572|NCT02329730|2170895|FG011|Overall Study|Withdrawal by Subject|0
1098573|NCT02329743|2170916|FG000|Overall Study|Adverse Event|1
1098574|NCT02329743|2170917|FG001|Overall Study|Adverse Event|1
1098575|NCT02329743|2170918|FG002|Overall Study|Adverse Event|3
1098576|NCT02329743|2170916|FG000|Overall Study|Lost to Follow-up|1
1098577|NCT02329743|2170917|FG001|Overall Study|Lost to Follow-up|0
1098578|NCT02329743|2170918|FG002|Overall Study|Lost to Follow-up|1
1098579|NCT02329743|2170916|FG000|Overall Study|Withdrawal by Subject|4
1098580|NCT02329743|2170917|FG001|Overall Study|Withdrawal by Subject|4
1098581|NCT02329743|2170918|FG002|Overall Study|Withdrawal by Subject|1
1098582|NCT02329743|2170916|FG000|Overall Study|Other|0
1098583|NCT02329743|2170917|FG001|Overall Study|Other|2
1098584|NCT02329743|2170918|FG002|Overall Study|Other|3
1098585|NCT02330055|2170937|FG000|Overall Study|technical issues|2
1098586|NCT02330055|2170938|FG001|Overall Study|technical issues|0
1098587|NCT02330055|2170937|FG000|Overall Study|participant forgot to wear device|5
1098588|NCT02330055|2170938|FG001|Overall Study|participant forgot to wear device|5
1098589|NCT02330055|2170937|FG000|Overall Study|data for less than 60 minutes|3
1098590|NCT02330055|2170938|FG001|Overall Study|data for less than 60 minutes|3
1098591|NCT02330055|2170937|FG000|Overall Study|participant did not sleep|0
1098592|NCT02330055|2170938|FG001|Overall Study|participant did not sleep|1
1098593|NCT02330081|2170944|FG000|Overall Study|Adverse Event|1
1098594|NCT02330081|2170944|FG000|Overall Study|Donation did not meet criteria|1
1098595|NCT02330081|2170944|FG000|Overall Study|Protocol Violation|6
1098596|NCT02330549|2171002|FG000|Overall Study|Adverse Event|1
1098597|NCT02330549|2171003|FG001|Overall Study|Adverse Event|0
1098598|NCT02330549|2171002|FG000|Overall Study|Subject withdrew consent|2
1098599|NCT02330549|2171003|FG001|Overall Study|Subject withdrew consent|1
1098600|NCT02330549|2171002|FG000|Overall Study|Failure to meet randomization criteria|1
1098601|NCT02330549|2171003|FG001|Overall Study|Failure to meet randomization criteria|0
1098602|NCT02331368|2171091|FG000|Overall Study|Withdrawal by Subject|3
1098603|NCT02331394|2171095|FG000|Overall Study|Disease progression|1
1098604|NCT02331446|2171114|FG000|Overall Study|Lost to Follow-up|2
1098605|NCT02331446|2171115|FG001|Overall Study|Lost to Follow-up|1
1098606|NCT02331446|2171116|FG002|Overall Study|Lost to Follow-up|0
1098607|NCT02331446|2171117|FG003|Overall Study|Lost to Follow-up|1
1098608|NCT02331446|2171114|FG000|Overall Study|Personal Problem|2
1098609|NCT02331446|2171115|FG001|Overall Study|Personal Problem|0
1098610|NCT02331446|2171116|FG002|Overall Study|Personal Problem|0
1098611|NCT02331446|2171117|FG003|Overall Study|Personal Problem|0
1098612|NCT02331446|2171114|FG000|Overall Study|Disease|0
1098613|NCT02331446|2171115|FG001|Overall Study|Disease|2
1098614|NCT02331446|2171116|FG002|Overall Study|Disease|2
1098615|NCT02331446|2171117|FG003|Overall Study|Disease|1
1098616|NCT02331446|2171114|FG000|Overall Study|Physician Decision|0
1098617|NCT02331446|2171115|FG001|Overall Study|Physician Decision|1
1098618|NCT02331446|2171116|FG002|Overall Study|Physician Decision|0
1098619|NCT02331446|2171117|FG003|Overall Study|Physician Decision|1
1098620|NCT02331446|2171114|FG000|Overall Study|Lost before baseline analysis|0
1098621|NCT02331446|2171115|FG001|Overall Study|Lost before baseline analysis|1
1098622|NCT02331446|2171116|FG002|Overall Study|Lost before baseline analysis|1
1098623|NCT02331446|2171117|FG003|Overall Study|Lost before baseline analysis|0
1098624|NCT02331680|2171139|FG000|Overall Study|Adverse Event|3
1098625|NCT02331680|2171140|FG001|Overall Study|Adverse Event|0
1098626|NCT02331680|2171141|FG002|Overall Study|Adverse Event|2
1098627|NCT02331680|2171139|FG000|Overall Study|Physician Decision|1
1098628|NCT02331680|2171140|FG001|Overall Study|Physician Decision|1
1098629|NCT02331680|2171141|FG002|Overall Study|Physician Decision|2
1098630|NCT02331680|2171139|FG000|Overall Study|Withdrawal by Subject|0
1098631|NCT02331680|2171140|FG001|Overall Study|Withdrawal by Subject|1
1098632|NCT02331680|2171141|FG002|Overall Study|Withdrawal by Subject|2
1098633|NCT02331680|2171139|FG000|Overall Study|Met withdrawal criteria|2
1098634|NCT02331680|2171140|FG001|Overall Study|Met withdrawal criteria|2
1098635|NCT02331680|2171141|FG002|Overall Study|Met withdrawal criteria|5
1098636|NCT02331680|2171139|FG000|Overall Study|Non-compliance with study drug|0
1098637|NCT02331680|2171140|FG001|Overall Study|Non-compliance with study drug|0
1098638|NCT02331680|2171141|FG002|Overall Study|Non-compliance with study drug|1
1098639|NCT02331680|2171139|FG000|Overall Study|Protocol Violation|0
1098640|NCT02331680|2171140|FG001|Overall Study|Protocol Violation|0
1098641|NCT02331680|2171141|FG002|Overall Study|Protocol Violation|3
1098642|NCT02332239|2171164|FG000|Overall Study|Lost to Follow-up|4
1098643|NCT02332239|2171165|FG001|Overall Study|Lost to Follow-up|6
1098644|NCT02332291|2171175|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3
1098645|NCT02332291|2171176|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5
1098646|NCT02332291|2171175|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0
1098647|NCT02332291|2171176|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4
1098648|NCT02332291|2171175|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1
1098649|NCT02332291|2171176|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0
1098650|NCT02332291|2171175|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2
1098651|NCT02332291|2171176|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7
1098652|NCT02332291|2171175|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0
1098653|NCT02332291|2171176|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1
1098654|NCT02332291|2171175|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1
1098655|NCT02332291|2171176|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0
1098666|NCT02332707|2171213|FG000|Overall Study|Adverse Event|0
1098667|NCT02332707|2171214|FG001|Overall Study|Adverse Event|0
1098668|NCT02332707|2171215|FG002|Overall Study|Adverse Event|0
1098669|NCT02332707|2171216|FG003|Overall Study|Adverse Event|0
1098670|NCT02332707|2171217|FG004|Overall Study|Adverse Event|0
1098671|NCT02332707|2171218|FG005|Overall Study|Adverse Event|0
1098672|NCT02332707|2171219|FG006|Overall Study|Adverse Event|0
1098673|NCT02332707|2171220|FG007|Overall Study|Adverse Event|0
1098674|NCT02332707|2171221|FG008|Overall Study|Adverse Event|0
1098675|NCT02332707|2171222|FG009|Overall Study|Adverse Event|0
1098676|NCT02332707|2171223|FG010|Overall Study|Adverse Event|0
1098677|NCT02332707|2171224|FG011|Overall Study|Adverse Event|0
1098678|NCT02332707|2171225|FG012|Overall Study|Adverse Event|1
1098679|NCT02332707|2171226|FG013|Overall Study|Adverse Event|0
1098680|NCT02332707|2171227|FG014|Overall Study|Adverse Event|0
1098681|NCT02332707|2171228|FG015|Overall Study|Adverse Event|0
1098682|NCT02332707|2171229|FG016|Overall Study|Adverse Event|0
1098683|NCT02332707|2171230|FG017|Overall Study|Adverse Event|0
1098684|NCT02332707|2171213|FG000|Overall Study|Lost to Follow-up|0
1098685|NCT02332707|2171214|FG001|Overall Study|Lost to Follow-up|0
1098686|NCT02332707|2171215|FG002|Overall Study|Lost to Follow-up|0
1098687|NCT02332707|2171216|FG003|Overall Study|Lost to Follow-up|0
1098688|NCT02332707|2171217|FG004|Overall Study|Lost to Follow-up|0
1098689|NCT02332707|2171218|FG005|Overall Study|Lost to Follow-up|1
1098690|NCT02332707|2171219|FG006|Overall Study|Lost to Follow-up|0
1098691|NCT02332707|2171220|FG007|Overall Study|Lost to Follow-up|0
1098692|NCT02332707|2171221|FG008|Overall Study|Lost to Follow-up|0
1098693|NCT02332707|2171222|FG009|Overall Study|Lost to Follow-up|0
1098694|NCT02332707|2171223|FG010|Overall Study|Lost to Follow-up|2
1098695|NCT02332707|2171224|FG011|Overall Study|Lost to Follow-up|0
1098696|NCT02332707|2171225|FG012|Overall Study|Lost to Follow-up|3
1098697|NCT02332707|2171226|FG013|Overall Study|Lost to Follow-up|0
1098698|NCT02332707|2171227|FG014|Overall Study|Lost to Follow-up|0
1098699|NCT02332707|2171228|FG015|Overall Study|Lost to Follow-up|0
1098700|NCT02332707|2171229|FG016|Overall Study|Lost to Follow-up|0
1098701|NCT02332707|2171230|FG017|Overall Study|Lost to Follow-up|0
1098702|NCT02332707|2171213|FG000|Overall Study|Physician Decision|0
1098703|NCT02332707|2171214|FG001|Overall Study|Physician Decision|0
1098704|NCT02332707|2171215|FG002|Overall Study|Physician Decision|0
1098705|NCT02332707|2171216|FG003|Overall Study|Physician Decision|1
1098706|NCT02332707|2171217|FG004|Overall Study|Physician Decision|0
1098707|NCT02332707|2171218|FG005|Overall Study|Physician Decision|0
1098708|NCT02332707|2171219|FG006|Overall Study|Physician Decision|0
1098709|NCT02332707|2171220|FG007|Overall Study|Physician Decision|0
1098710|NCT02332707|2171221|FG008|Overall Study|Physician Decision|0
1098711|NCT02332707|2171222|FG009|Overall Study|Physician Decision|0
1098712|NCT02332707|2171223|FG010|Overall Study|Physician Decision|0
1098713|NCT02332707|2171224|FG011|Overall Study|Physician Decision|0
1098714|NCT02332707|2171225|FG012|Overall Study|Physician Decision|1
1098715|NCT02332707|2171226|FG013|Overall Study|Physician Decision|0
1098716|NCT02332707|2171227|FG014|Overall Study|Physician Decision|0
1098717|NCT02332707|2171228|FG015|Overall Study|Physician Decision|0
1098718|NCT02332707|2171229|FG016|Overall Study|Physician Decision|0
1098719|NCT02332707|2171230|FG017|Overall Study|Physician Decision|0
1098720|NCT02332707|2171213|FG000|Overall Study|Withdrawal by Subject|0
1098721|NCT02332707|2171214|FG001|Overall Study|Withdrawal by Subject|0
1098722|NCT02332707|2171215|FG002|Overall Study|Withdrawal by Subject|1
1098723|NCT02332707|2171216|FG003|Overall Study|Withdrawal by Subject|0
1098724|NCT02332707|2171217|FG004|Overall Study|Withdrawal by Subject|0
1098725|NCT02332707|2171218|FG005|Overall Study|Withdrawal by Subject|0
1098726|NCT02332707|2171219|FG006|Overall Study|Withdrawal by Subject|0
1098727|NCT02332707|2171220|FG007|Overall Study|Withdrawal by Subject|0
1098728|NCT02332707|2171221|FG008|Overall Study|Withdrawal by Subject|0
1098729|NCT02332707|2171222|FG009|Overall Study|Withdrawal by Subject|3
1098730|NCT02332707|2171223|FG010|Overall Study|Withdrawal by Subject|0
1098731|NCT02332707|2171224|FG011|Overall Study|Withdrawal by Subject|0
1098732|NCT02332707|2171225|FG012|Overall Study|Withdrawal by Subject|0
1098733|NCT02332707|2171226|FG013|Overall Study|Withdrawal by Subject|0
1098734|NCT02332707|2171227|FG014|Overall Study|Withdrawal by Subject|0
1098735|NCT02332707|2171228|FG015|Overall Study|Withdrawal by Subject|0
1098736|NCT02332707|2171229|FG016|Overall Study|Withdrawal by Subject|0
1098737|NCT02332707|2171230|FG017|Overall Study|Withdrawal by Subject|0
1098738|NCT02332720|2171291|FG000|Part A and Part B|Lost to Follow-up|1
1098739|NCT02332720|2171292|FG001|Part A and Part B|Lost to Follow-up|0
1098740|NCT02332720|2171293|FG002|Part A and Part B|Lost to Follow-up|0
1098741|NCT02332720|2171294|FG003|Part A and Part B|Lost to Follow-up|0
1098742|NCT02332720|2171295|FG004|Part A and Part B|Lost to Follow-up|0
1098743|NCT02332720|2171296|FG005|Part A and Part B|Lost to Follow-up|2
1098744|NCT02332720|2171297|FG006|Part A and Part B|Lost to Follow-up|1
1098745|NCT02332720|2171298|FG007|Part A and Part B|Lost to Follow-up|1
1098746|NCT02332720|2171299|FG008|Part A and Part B|Lost to Follow-up|0
1098747|NCT02332720|2171300|FG009|Part A and Part B|Lost to Follow-up|0
1098748|NCT02332720|2171301|FG010|Part A and Part B|Lost to Follow-up|0
1098749|NCT02332720|2171302|FG011|Part A and Part B|Lost to Follow-up|0
1098750|NCT02332720|2171303|FG012|Part A and Part B|Lost to Follow-up|0
1098751|NCT02332720|2171304|FG013|Part A and Part B|Lost to Follow-up|0
1098752|NCT02332720|2171305|FG014|Part A and Part B|Lost to Follow-up|0
1098753|NCT02332720|2171306|FG015|Part A and Part B|Lost to Follow-up|1
1098754|NCT02332720|2171307|FG016|Part A and Part B|Lost to Follow-up|0
1098755|NCT02332720|2171308|FG017|Part A and Part B|Lost to Follow-up|0
1098756|NCT02332720|2171309|FG018|Part A and Part B|Lost to Follow-up|0
1098757|NCT02332720|2171310|FG019|Part A and Part B|Lost to Follow-up|0
893596|NCT00685373|1864178|FG000|Overall Study|Protocol Violation|1
893597|NCT00685399|1864189|FG000|Treatment Period 1|Withdrawal by Subject|2
893598|NCT00685399|1864190|FG001|Treatment Period 1|Withdrawal by Subject|0
893599|NCT00685399|1864191|FG002|Treatment Period 1|Withdrawal by Subject|0
893600|NCT00685399|1864192|FG003|Treatment Period 1|Withdrawal by Subject|0
893601|NCT00685399|1864193|FG004|Treatment Period 1|Withdrawal by Subject|0
1098758|NCT02332720|2171311|FG020|Part A and Part B|Lost to Follow-up|0
1098759|NCT02332720|2171312|FG021|Part A and Part B|Lost to Follow-up|0
1098760|NCT02332720|2171313|FG022|Part A and Part B|Lost to Follow-up|0
1098761|NCT02332720|2171291|FG000|Part A and Part B|Adverse Event|0
1098762|NCT02332720|2171292|FG001|Part A and Part B|Adverse Event|0
1098763|NCT02332720|2171293|FG002|Part A and Part B|Adverse Event|0
1098764|NCT02332720|2171294|FG003|Part A and Part B|Adverse Event|0
1098765|NCT02332720|2171295|FG004|Part A and Part B|Adverse Event|0
1098766|NCT02332720|2171296|FG005|Part A and Part B|Adverse Event|0
1098767|NCT02332720|2171297|FG006|Part A and Part B|Adverse Event|0
1098768|NCT02332720|2171298|FG007|Part A and Part B|Adverse Event|0
1098769|NCT02332720|2171299|FG008|Part A and Part B|Adverse Event|0
1098770|NCT02332720|2171300|FG009|Part A and Part B|Adverse Event|0
1098771|NCT02332720|2171301|FG010|Part A and Part B|Adverse Event|0
1098772|NCT02332720|2171302|FG011|Part A and Part B|Adverse Event|0
1098773|NCT02332720|2171303|FG012|Part A and Part B|Adverse Event|0
1098774|NCT02332720|2171304|FG013|Part A and Part B|Adverse Event|0
1098775|NCT02332720|2171305|FG014|Part A and Part B|Adverse Event|0
1098776|NCT02332720|2171306|FG015|Part A and Part B|Adverse Event|0
1098777|NCT02332720|2171307|FG016|Part A and Part B|Adverse Event|0
1098778|NCT02332720|2171308|FG017|Part A and Part B|Adverse Event|1
1098779|NCT02332720|2171309|FG018|Part A and Part B|Adverse Event|0
1098780|NCT02332720|2171310|FG019|Part A and Part B|Adverse Event|0
1098781|NCT02332720|2171311|FG020|Part A and Part B|Adverse Event|0
1098782|NCT02332720|2171312|FG021|Part A and Part B|Adverse Event|0
1098783|NCT02332720|2171313|FG022|Part A and Part B|Adverse Event|0
1098784|NCT02332720|2171291|FG000|Part A and Part B|Physician Decision|0
1098785|NCT02332720|2171292|FG001|Part A and Part B|Physician Decision|0
1098786|NCT02332720|2171293|FG002|Part A and Part B|Physician Decision|0
1098787|NCT02332720|2171294|FG003|Part A and Part B|Physician Decision|0
1098788|NCT02332720|2171295|FG004|Part A and Part B|Physician Decision|0
1098789|NCT02332720|2171296|FG005|Part A and Part B|Physician Decision|0
1098790|NCT02332720|2171297|FG006|Part A and Part B|Physician Decision|0
1098791|NCT02332720|2171298|FG007|Part A and Part B|Physician Decision|0
1098792|NCT02332720|2171299|FG008|Part A and Part B|Physician Decision|0
1098793|NCT02332720|2171300|FG009|Part A and Part B|Physician Decision|0
893602|NCT00685399|1864194|FG005|Treatment Period 1|Withdrawal by Subject|0
893603|NCT00685399|1864195|FG006|Treatment Period 1|Withdrawal by Subject|0
893604|NCT00685399|1864196|FG007|Treatment Period 1|Withdrawal by Subject|0
893605|NCT00685399|1864189|FG000|Treatment Period 1|Protocol Violation|1
893606|NCT00685399|1864190|FG001|Treatment Period 1|Protocol Violation|0
893607|NCT00685399|1864191|FG002|Treatment Period 1|Protocol Violation|0
893608|NCT00685399|1864192|FG003|Treatment Period 1|Protocol Violation|0
893609|NCT00685399|1864193|FG004|Treatment Period 1|Protocol Violation|0
893610|NCT00685399|1864194|FG005|Treatment Period 1|Protocol Violation|0
893611|NCT00685399|1864195|FG006|Treatment Period 1|Protocol Violation|0
893612|NCT00685399|1864196|FG007|Treatment Period 1|Protocol Violation|0
893613|NCT00685399|1864189|FG000|Treatment Period 1|Administrative|2
893614|NCT00685399|1864190|FG001|Treatment Period 1|Administrative|0
893615|NCT00685399|1864191|FG002|Treatment Period 1|Administrative|0
893616|NCT00685399|1864192|FG003|Treatment Period 1|Administrative|0
893617|NCT00685399|1864193|FG004|Treatment Period 1|Administrative|0
1098794|NCT02332720|2171301|FG010|Part A and Part B|Physician Decision|0
1098795|NCT02332720|2171302|FG011|Part A and Part B|Physician Decision|0
1098796|NCT02332720|2171303|FG012|Part A and Part B|Physician Decision|0
1098797|NCT02332720|2171304|FG013|Part A and Part B|Physician Decision|0
1098798|NCT02332720|2171305|FG014|Part A and Part B|Physician Decision|0
1098799|NCT02332720|2171306|FG015|Part A and Part B|Physician Decision|0
1098800|NCT02332720|2171307|FG016|Part A and Part B|Physician Decision|0
1098801|NCT02332720|2171308|FG017|Part A and Part B|Physician Decision|0
1098802|NCT02332720|2171309|FG018|Part A and Part B|Physician Decision|1
1098803|NCT02332720|2171310|FG019|Part A and Part B|Physician Decision|0
1098804|NCT02332720|2171311|FG020|Part A and Part B|Physician Decision|0
1098805|NCT02332720|2171312|FG021|Part A and Part B|Physician Decision|0
1098806|NCT02332720|2171313|FG022|Part A and Part B|Physician Decision|0
1098807|NCT02332720|2171291|FG000|Part A and Part B|Withdrawal by Subject|0
1098808|NCT02332720|2171292|FG001|Part A and Part B|Withdrawal by Subject|0
1098809|NCT02332720|2171293|FG002|Part A and Part B|Withdrawal by Subject|0
1098810|NCT02332720|2171294|FG003|Part A and Part B|Withdrawal by Subject|0
1098811|NCT02332720|2171295|FG004|Part A and Part B|Withdrawal by Subject|0
1098812|NCT02332720|2171296|FG005|Part A and Part B|Withdrawal by Subject|1
1098813|NCT02332720|2171297|FG006|Part A and Part B|Withdrawal by Subject|0
1098814|NCT02332720|2171298|FG007|Part A and Part B|Withdrawal by Subject|0
1098815|NCT02332720|2171299|FG008|Part A and Part B|Withdrawal by Subject|0
1098816|NCT02332720|2171300|FG009|Part A and Part B|Withdrawal by Subject|0
1098817|NCT02332720|2171301|FG010|Part A and Part B|Withdrawal by Subject|0
1098818|NCT02332720|2171302|FG011|Part A and Part B|Withdrawal by Subject|0
1098819|NCT02332720|2171303|FG012|Part A and Part B|Withdrawal by Subject|0
1098820|NCT02332720|2171304|FG013|Part A and Part B|Withdrawal by Subject|0
1098821|NCT02332720|2171305|FG014|Part A and Part B|Withdrawal by Subject|0
1098822|NCT02332720|2171306|FG015|Part A and Part B|Withdrawal by Subject|0
1098823|NCT02332720|2171307|FG016|Part A and Part B|Withdrawal by Subject|0
1098824|NCT02332720|2171308|FG017|Part A and Part B|Withdrawal by Subject|0
1098825|NCT02332720|2171309|FG018|Part A and Part B|Withdrawal by Subject|0
1098826|NCT02332720|2171310|FG019|Part A and Part B|Withdrawal by Subject|1
1098827|NCT02332720|2171311|FG020|Part A and Part B|Withdrawal by Subject|0
1098828|NCT02332720|2171312|FG021|Part A and Part B|Withdrawal by Subject|0
1098829|NCT02332720|2171313|FG022|Part A and Part B|Withdrawal by Subject|0
1098830|NCT02332798|2171378|FG000|Overall Study|Unwilling to Participate in Study|0
1098831|NCT02332798|2171379|FG001|Overall Study|Unwilling to Participate in Study|1
1098832|NCT02332798|2171380|FG002|Overall Study|Unwilling to Participate in Study|1
1098833|NCT02332798|2171378|FG000|Overall Study|Positive Urine Drug Test|0
1098834|NCT02332798|2171379|FG001|Overall Study|Positive Urine Drug Test|1
1098835|NCT02332798|2171380|FG002|Overall Study|Positive Urine Drug Test|0
1098836|NCT02332798|2171378|FG000|Overall Study|Abnormal Laboratory Findings|1
1098837|NCT02332798|2171379|FG001|Overall Study|Abnormal Laboratory Findings|0
1098838|NCT02332798|2171380|FG002|Overall Study|Abnormal Laboratory Findings|0
1098839|NCT02332824|2171394|FG000|Overall Study|Pretreatment Event/Adverse Event|4
1098840|NCT02332824|2171395|FG001|Overall Study|Pretreatment Event/Adverse Event|0
1098841|NCT02332824|2171396|FG002|Overall Study|Pretreatment Event/Adverse Event|1
1098842|NCT02332824|2171397|FG003|Overall Study|Pretreatment Event/Adverse Event|1
1098843|NCT02332824|2171398|FG004|Overall Study|Pretreatment Event/Adverse Event|4
1098844|NCT02332824|2171399|FG005|Overall Study|Pretreatment Event/Adverse Event|1
1098845|NCT02332824|2171394|FG000|Overall Study|Voluntary Withdrawal|1
1098846|NCT02332824|2171395|FG001|Overall Study|Voluntary Withdrawal|0
1098847|NCT02332824|2171396|FG002|Overall Study|Voluntary Withdrawal|0
1098848|NCT02332824|2171397|FG003|Overall Study|Voluntary Withdrawal|0
1098849|NCT02332824|2171398|FG004|Overall Study|Voluntary Withdrawal|0
1098850|NCT02332824|2171399|FG005|Overall Study|Voluntary Withdrawal|0
1098851|NCT02332824|2171394|FG000|Overall Study|Inconvenient schedule|1
1098852|NCT02332824|2171395|FG001|Overall Study|Inconvenient schedule|1
1098853|NCT02332824|2171396|FG002|Overall Study|Inconvenient schedule|0
1098854|NCT02332824|2171397|FG003|Overall Study|Inconvenient schedule|0
1098855|NCT02332824|2171398|FG004|Overall Study|Inconvenient schedule|0
1098856|NCT02332824|2171399|FG005|Overall Study|Inconvenient schedule|0
1098857|NCT02332824|2171394|FG000|Overall Study|Transfer|0
1098858|NCT02332824|2171395|FG001|Overall Study|Transfer|0
1098859|NCT02332824|2171396|FG002|Overall Study|Transfer|1
1098860|NCT02332824|2171397|FG003|Overall Study|Transfer|1
1098861|NCT02332824|2171398|FG004|Overall Study|Transfer|0
1098862|NCT02332824|2171399|FG005|Overall Study|Transfer|0
1098863|NCT02332876|2171424|FG000|Overall Study|Lost to Follow-up|1
1098864|NCT02332876|2171425|FG001|Overall Study|Lost to Follow-up|1
1098865|NCT02332889|2171431|FG000|Overall Study|Physician Decision|1
1098866|NCT02332915|2171441|FG000|Overall Study|Moved out of region|3
1098867|NCT02332915|2171442|FG001|Overall Study|Moved out of region|0
1098868|NCT02332915|2171441|FG000|Overall Study|Unrelated illness|1
1098869|NCT02332915|2171442|FG001|Overall Study|Unrelated illness|1
1098870|NCT02332915|2171441|FG000|Overall Study|Travel distance prohibitive|0
1098871|NCT02332915|2171442|FG001|Overall Study|Travel distance prohibitive|1
1098872|NCT02332915|2171441|FG000|Overall Study|did not meet inclusion criteria|2
1098873|NCT02332915|2171442|FG001|Overall Study|did not meet inclusion criteria|4
1098874|NCT02333331|2171477|FG000|Overall Study|Adverse Event|1
1098875|NCT02333331|2171478|FG001|Overall Study|Adverse Event|0
1098876|NCT02333331|2171479|FG002|Overall Study|Adverse Event|4
1098877|NCT02333331|2171480|FG003|Overall Study|Adverse Event|1
1098878|NCT02333331|2171477|FG000|Overall Study|Death|0
1098879|NCT02333331|2171478|FG001|Overall Study|Death|0
1098880|NCT02333331|2171479|FG002|Overall Study|Death|2
1098881|NCT02333331|2171480|FG003|Overall Study|Death|0
1098882|NCT02333331|2171477|FG000|Overall Study|Lost to Follow-up|0
1098883|NCT02333331|2171478|FG001|Overall Study|Lost to Follow-up|0
1098884|NCT02333331|2171479|FG002|Overall Study|Lost to Follow-up|1
1098885|NCT02333331|2171480|FG003|Overall Study|Lost to Follow-up|0
1098886|NCT02333331|2171477|FG000|Overall Study|Physician Decision|0
1098887|NCT02333331|2171478|FG001|Overall Study|Physician Decision|1
1098888|NCT02333331|2171479|FG002|Overall Study|Physician Decision|0
1098889|NCT02333331|2171480|FG003|Overall Study|Physician Decision|0
1098890|NCT02333331|2171477|FG000|Overall Study|Protocol Deviation|0
1098891|NCT02333331|2171478|FG001|Overall Study|Protocol Deviation|3
1098892|NCT02333331|2171479|FG002|Overall Study|Protocol Deviation|2
1098893|NCT02333331|2171480|FG003|Overall Study|Protocol Deviation|1
1098894|NCT02333331|2171477|FG000|Overall Study|Patient/Guardian Decision|1
1098895|NCT02333331|2171478|FG001|Overall Study|Patient/Guardian Decision|2
1098896|NCT02333331|2171479|FG002|Overall Study|Patient/Guardian Decision|9
1098897|NCT02333331|2171480|FG003|Overall Study|Patient/Guardian Decision|1
1098898|NCT02333383|2171490|FG000|Overall Study|Adalimumab discontinuation|21
1098899|NCT02333383|2171490|FG000|Overall Study|Lost to Follow-up|15
1098900|NCT02333383|2171490|FG000|Overall Study|Withdrawal by Subject|3
1098901|NCT02333383|2171490|FG000|Overall Study|Transfer to another hospital|2
1098902|NCT02333487|2171497|FG000|Overall Study|Adverse Event|0
1098903|NCT02333487|2171498|FG001|Overall Study|Adverse Event|2
1098904|NCT02333487|2171499|FG002|Overall Study|Adverse Event|0
1098905|NCT02333630|2171510|FG000|Overall Study|Lost to Follow-up|5
1098906|NCT02333630|2171511|FG001|Overall Study|Lost to Follow-up|2
1098907|NCT02334215|2171537|FG000|Overall Study|Death|1
1098908|NCT02334215|2171538|FG001|Overall Study|Death|1
1098909|NCT02334215|2171539|FG002|Overall Study|Death|0
1098910|NCT02334215|2171537|FG000|Overall Study|Lost to Follow-up|1
1098911|NCT02334215|2171538|FG001|Overall Study|Lost to Follow-up|0
1098912|NCT02334215|2171539|FG002|Overall Study|Lost to Follow-up|4
1098913|NCT02334215|2171537|FG000|Overall Study|Withdrawal by Subject|2
1098914|NCT02334215|2171538|FG001|Overall Study|Withdrawal by Subject|2
1098915|NCT02334215|2171539|FG002|Overall Study|Withdrawal by Subject|1
1098916|NCT02334215|2171537|FG000|Overall Study|Not released from incarceration on time|3
1098917|NCT02334215|2171538|FG001|Overall Study|Not released from incarceration on time|3
1098918|NCT02334215|2171539|FG002|Overall Study|Not released from incarceration on time|3
1098919|NCT02334215|2171537|FG000|Overall Study|Incarcerated|0
1098920|NCT02334215|2171538|FG001|Overall Study|Incarcerated|0
1098921|NCT02334215|2171539|FG002|Overall Study|Incarcerated|7
1098922|NCT02334306|2171564|FG000|Double-blind Period|Adverse Event|0
1098923|NCT02334306|2171565|FG001|Double-blind Period|Adverse Event|1
1098924|NCT02334306|2171564|FG000|Double-blind Period|Withdrawal by Subject|1
1098925|NCT02334306|2171565|FG001|Double-blind Period|Withdrawal by Subject|1
1098926|NCT02334384|2171578|FG000|Overall Study|Lost to Follow-up|1
1098927|NCT02334384|2171579|FG001|Overall Study|Lost to Follow-up|1
1098928|NCT02334423|2171587|FG000|Overall Study|Protocol Violation|10
1098929|NCT02334423|2171588|FG001|Overall Study|Protocol Violation|3
1098930|NCT02334683|2171613|FG000|First 12 Week Period|Lost to Follow-up|1
1098931|NCT02334683|2171614|FG001|First 12 Week Period|Lost to Follow-up|0
1098932|NCT02334683|2171613|FG000|Second 12 Week Period|Adverse Event|0
1098933|NCT02334683|2171614|FG001|Second 12 Week Period|Adverse Event|1
1098934|NCT02334748|2171620|FG000|Overall Study|Adverse Event|1
1098935|NCT02334748|2171620|FG000|Overall Study|Inclusion in the CACZ8852306 study|1
1098936|NCT02334748|2171620|FG000|Overall Study|Patient no longer required study drug|2
1098937|NCT02334748|2171620|FG000|Overall Study|Lack of Efficacy|4
1098938|NCT02335346|2171755|FG000|Overall Study|Adverse Event|11
1098939|NCT02335346|2171755|FG000|Overall Study|Withdrawal by Subject|1
1098947|NCT02335450|2171763|FG000|Overall Study|Pregnancy|1
1098948|NCT02335489|2171773|FG000|Overall Study|Sponsor terminated study|4
1098949|NCT02335489|2171773|FG000|Overall Study|Lost to Follow-up|1
1098950|NCT02335489|2171773|FG000|Overall Study|Withdrawal by Subject|2
1098951|NCT02335489|2171773|FG000|Overall Study|Physician Decision|2
1098952|NCT02335489|2171773|FG000|Overall Study|Lack of Efficacy|1
1098953|NCT02335658|2171783|FG000|Overall Study|Adverse Event|18
1098954|NCT02335658|2171784|FG001|Overall Study|Adverse Event|12
1098955|NCT02335658|2171783|FG000|Overall Study|Lack of Efficacy|4
1098956|NCT02335658|2171784|FG001|Overall Study|Lack of Efficacy|5
1098957|NCT02335658|2171783|FG000|Overall Study|Pregnancy|1
1098958|NCT02335658|2171784|FG001|Overall Study|Pregnancy|0
1098959|NCT02335658|2171783|FG000|Overall Study|Withdrawal by Subject|13
1098960|NCT02335658|2171784|FG001|Overall Study|Withdrawal by Subject|21
1098961|NCT02335658|2171783|FG000|Overall Study|non-compliance|2
1098962|NCT02335658|2171784|FG001|Overall Study|non-compliance|3
1098963|NCT02335658|2171783|FG000|Overall Study|other reason|2
1098964|NCT02335658|2171784|FG001|Overall Study|other reason|3
1098965|NCT02335983|2171811|FG000|Overall Study|Sponsor Decision|0
1098966|NCT02335983|2171812|FG001|Overall Study|Sponsor Decision|0
1098967|NCT02335983|2171813|FG002|Overall Study|Sponsor Decision|1
1098968|NCT02335983|2171814|FG003|Overall Study|Sponsor Decision|1
1098969|NCT02335983|2171815|FG004|Overall Study|Sponsor Decision|0
1098970|NCT02335983|2171816|FG005|Overall Study|Sponsor Decision|1
1098971|NCT02335983|2171811|FG000|Overall Study|Withdrawal by Subject|3
1098972|NCT02335983|2171812|FG001|Overall Study|Withdrawal by Subject|2
1098973|NCT02335983|2171813|FG002|Overall Study|Withdrawal by Subject|2
1098974|NCT02335983|2171814|FG003|Overall Study|Withdrawal by Subject|1
1098975|NCT02335983|2171815|FG004|Overall Study|Withdrawal by Subject|3
1098976|NCT02335983|2171816|FG005|Overall Study|Withdrawal by Subject|9
1098977|NCT02335983|2171811|FG000|Overall Study|Death|0
1098978|NCT02335983|2171812|FG001|Overall Study|Death|0
1098979|NCT02335983|2171813|FG002|Overall Study|Death|2
1098980|NCT02335983|2171814|FG003|Overall Study|Death|0
1098981|NCT02335983|2171815|FG004|Overall Study|Death|0
1098982|NCT02335983|2171816|FG005|Overall Study|Death|0
1098983|NCT02335983|2171811|FG000|Overall Study|Lost to Follow-up|0
1098984|NCT02335983|2171812|FG001|Overall Study|Lost to Follow-up|0
1098985|NCT02335983|2171813|FG002|Overall Study|Lost to Follow-up|0
1098986|NCT02335983|2171814|FG003|Overall Study|Lost to Follow-up|0
1098987|NCT02335983|2171815|FG004|Overall Study|Lost to Follow-up|0
1098988|NCT02335983|2171816|FG005|Overall Study|Lost to Follow-up|1
1098989|NCT02335983|2171811|FG000|Overall Study|Protocol Specified Criteria|5
1098990|NCT02335983|2171812|FG001|Overall Study|Protocol Specified Criteria|7
1098991|NCT02335983|2171813|FG002|Overall Study|Protocol Specified Criteria|27
1098992|NCT02335983|2171814|FG003|Overall Study|Protocol Specified Criteria|7
1098993|NCT02335983|2171815|FG004|Overall Study|Protocol Specified Criteria|5
1098994|NCT02335983|2171816|FG005|Overall Study|Protocol Specified Criteria|21
1098995|NCT02336074|2171841|FG000|Overall Study|Adverse Event|0
1098996|NCT02336074|2171842|FG001|Overall Study|Adverse Event|2
1098997|NCT02336165|2171858|FG000|Overall Study|Death|3
1098998|NCT02336165|2171859|FG001|Overall Study|Death|0
1098999|NCT02336165|2171860|FG002|Overall Study|Death|0
1099000|NCT02336165|2171861|FG003|Overall Study|Death|0
1099001|NCT02336165|2171862|FG004|Overall Study|Death|1
1099002|NCT02336165|2171858|FG000|Overall Study|Physician Decision|2
1099003|NCT02336165|2171859|FG001|Overall Study|Physician Decision|2
1099004|NCT02336165|2171860|FG002|Overall Study|Physician Decision|1
1099005|NCT02336165|2171861|FG003|Overall Study|Physician Decision|1
1099006|NCT02336165|2171862|FG004|Overall Study|Physician Decision|0
1099007|NCT02336165|2171858|FG000|Overall Study|Withdrawal by Subject|0
1099008|NCT02336165|2171859|FG001|Overall Study|Withdrawal by Subject|0
1099009|NCT02336165|2171860|FG002|Overall Study|Withdrawal by Subject|1
1099010|NCT02336165|2171861|FG003|Overall Study|Withdrawal by Subject|0
1099011|NCT02336165|2171862|FG004|Overall Study|Withdrawal by Subject|1
1099012|NCT02336165|2171858|FG000|Overall Study|Adverse Event|4
893618|NCT00685399|1864194|FG005|Treatment Period 1|Administrative|0
893619|NCT00685399|1864195|FG006|Treatment Period 1|Administrative|0
893620|NCT00685399|1864196|FG007|Treatment Period 1|Administrative|0
893621|NCT00685399|1864189|FG000|Treatment Period 1|Lack of Efficacy|1
893622|NCT00685399|1864190|FG001|Treatment Period 1|Lack of Efficacy|0
893623|NCT00685399|1864191|FG002|Treatment Period 1|Lack of Efficacy|0
893624|NCT00685399|1864192|FG003|Treatment Period 1|Lack of Efficacy|0
893625|NCT00685399|1864193|FG004|Treatment Period 1|Lack of Efficacy|0
893626|NCT00685399|1864194|FG005|Treatment Period 1|Lack of Efficacy|0
893627|NCT00685399|1864195|FG006|Treatment Period 1|Lack of Efficacy|0
893628|NCT00685399|1864196|FG007|Treatment Period 1|Lack of Efficacy|0
893629|NCT00685399|1864189|FG000|Treatment Period 2|Administrative Problems|0
893630|NCT00685399|1864190|FG001|Treatment Period 2|Administrative Problems|2
893631|NCT00685399|1864191|FG002|Treatment Period 2|Administrative Problems|1
893632|NCT00685399|1864192|FG003|Treatment Period 2|Administrative Problems|0
893633|NCT00685399|1864193|FG004|Treatment Period 2|Administrative Problems|0
893634|NCT00685399|1864194|FG005|Treatment Period 2|Administrative Problems|0
893635|NCT00685399|1864195|FG006|Treatment Period 2|Administrative Problems|0
893636|NCT00685399|1864196|FG007|Treatment Period 2|Administrative Problems|0
893637|NCT00685399|1864189|FG000|Treatment Period 2|Withdrawal by Subject|0
893638|NCT00685399|1864190|FG001|Treatment Period 2|Withdrawal by Subject|0
893639|NCT00685399|1864191|FG002|Treatment Period 2|Withdrawal by Subject|0
893640|NCT00685399|1864192|FG003|Treatment Period 2|Withdrawal by Subject|0
893641|NCT00685399|1864193|FG004|Treatment Period 2|Withdrawal by Subject|0
893642|NCT00685399|1864194|FG005|Treatment Period 2|Withdrawal by Subject|0
893643|NCT00685399|1864195|FG006|Treatment Period 2|Withdrawal by Subject|0
893644|NCT00685399|1864196|FG007|Treatment Period 2|Withdrawal by Subject|2
893645|NCT00685399|1864189|FG000|Treatment Period 2|Adverse Event|0
893646|NCT00685399|1864190|FG001|Treatment Period 2|Adverse Event|0
893647|NCT00685399|1864191|FG002|Treatment Period 2|Adverse Event|0
893648|NCT00685399|1864192|FG003|Treatment Period 2|Adverse Event|0
893649|NCT00685399|1864193|FG004|Treatment Period 2|Adverse Event|0
893650|NCT00685399|1864194|FG005|Treatment Period 2|Adverse Event|1
893651|NCT00685399|1864195|FG006|Treatment Period 2|Adverse Event|0
1099013|NCT02336165|2171859|FG001|Overall Study|Adverse Event|1
1099014|NCT02336165|2171860|FG002|Overall Study|Adverse Event|2
1099015|NCT02336165|2171861|FG003|Overall Study|Adverse Event|4
1099016|NCT02336165|2171862|FG004|Overall Study|Adverse Event|1
1099017|NCT02336165|2171858|FG000|Overall Study|Progressive disease|23
1099018|NCT02336165|2171859|FG001|Overall Study|Progressive disease|22
1099019|NCT02336165|2171860|FG002|Overall Study|Progressive disease|27
1099020|NCT02336165|2171861|FG003|Overall Study|Progressive disease|24
1099021|NCT02336165|2171862|FG004|Overall Study|Progressive disease|19
1099022|NCT02336165|2171858|FG000|Overall Study|Non-compliance|1
1099023|NCT02336165|2171859|FG001|Overall Study|Non-compliance|0
1099024|NCT02336165|2171860|FG002|Overall Study|Non-compliance|0
1099025|NCT02336165|2171861|FG003|Overall Study|Non-compliance|1
1099026|NCT02336165|2171862|FG004|Overall Study|Non-compliance|0
1099027|NCT02336165|2171858|FG000|Overall Study|Other|1
1099028|NCT02336165|2171859|FG001|Overall Study|Other|0
1099029|NCT02336165|2171860|FG002|Overall Study|Other|0
1099030|NCT02336165|2171861|FG003|Overall Study|Other|1
1099031|NCT02336165|2171862|FG004|Overall Study|Other|0
1099032|NCT02336178|2171878|FG000|Overall Study|Lost to Follow-up|1
1099033|NCT02336178|2171878|FG000|Overall Study|Protocol Violation|1
1099034|NCT02336178|2171878|FG000|Overall Study|Withdrawal by Subject|1
1099035|NCT02336178|2171878|FG000|Overall Study|Other|1
1099036|NCT02336282|2171890|FG000|Overall Study|Unrelated illness|1
1099037|NCT02336282|2171890|FG000|Overall Study|Uncomfortable with technology|1
1099038|NCT02336282|2171890|FG000|Overall Study|Lost to Follow-up|1
1099039|NCT02336282|2171890|FG000|Overall Study|Not enough time to complete sessions|2
1099040|NCT02336373|2171906|FG000|Overall Study|Protocol closed early|4
1099041|NCT02336373|2171906|FG000|Overall Study|Physician Decision|14
1099042|NCT02336451|2171921|FG000|Overall Study|Adverse Event|1
1099043|NCT02336451|2171922|FG001|Overall Study|Adverse Event|2
1099044|NCT02336451|2171923|FG002|Overall Study|Adverse Event|0
1099045|NCT02336451|2171924|FG003|Overall Study|Adverse Event|6
1099046|NCT02336451|2171925|FG004|Overall Study|Adverse Event|4
1099047|NCT02336451|2171921|FG000|Overall Study|Death|6
1099048|NCT02336451|2171922|FG001|Overall Study|Death|2
1099049|NCT02336451|2171923|FG002|Overall Study|Death|3
1099050|NCT02336451|2171924|FG003|Overall Study|Death|6
1099051|NCT02336451|2171925|FG004|Overall Study|Death|6
1099052|NCT02336451|2171921|FG000|Overall Study|Physician Decision|9
1099053|NCT02336451|2171922|FG001|Overall Study|Physician Decision|6
1099054|NCT02336451|2171923|FG002|Overall Study|Physician Decision|7
893652|NCT00685399|1864196|FG007|Treatment Period 2|Adverse Event|0
893653|NCT00685399|1864189|FG000|Treatment Period 2|Lack of Efficacy|0
893654|NCT00685399|1864190|FG001|Treatment Period 2|Lack of Efficacy|10
893655|NCT00685399|1864191|FG002|Treatment Period 2|Lack of Efficacy|2
893656|NCT00685399|1864192|FG003|Treatment Period 2|Lack of Efficacy|0
893657|NCT00685399|1864193|FG004|Treatment Period 2|Lack of Efficacy|0
893658|NCT00685399|1864194|FG005|Treatment Period 2|Lack of Efficacy|1
893659|NCT00685399|1864195|FG006|Treatment Period 2|Lack of Efficacy|0
893660|NCT00685399|1864196|FG007|Treatment Period 2|Lack of Efficacy|0
893661|NCT00685399|1864189|FG000|Extension|Administrative Issues|0
893662|NCT00685399|1864190|FG001|Extension|Administrative Issues|0
893663|NCT00685399|1864191|FG002|Extension|Administrative Issues|0
893664|NCT00685399|1864192|FG003|Extension|Administrative Issues|1
893665|NCT00685399|1864193|FG004|Extension|Administrative Issues|0
893666|NCT00685399|1864194|FG005|Extension|Administrative Issues|0
893667|NCT00685399|1864195|FG006|Extension|Administrative Issues|0
893668|NCT00685399|1864196|FG007|Extension|Administrative Issues|0
893669|NCT00685399|1864189|FG000|Extension|Withdrawal by Subject|0
893670|NCT00685399|1864190|FG001|Extension|Withdrawal by Subject|0
893671|NCT00685399|1864191|FG002|Extension|Withdrawal by Subject|0
893672|NCT00685399|1864192|FG003|Extension|Withdrawal by Subject|1
893673|NCT00685399|1864193|FG004|Extension|Withdrawal by Subject|0
893674|NCT00685399|1864194|FG005|Extension|Withdrawal by Subject|0
893675|NCT00685399|1864195|FG006|Extension|Withdrawal by Subject|0
893676|NCT00685399|1864196|FG007|Extension|Withdrawal by Subject|0
893677|NCT00685399|1864189|FG000|Extension|Protocol Violation|0
893678|NCT00685399|1864190|FG001|Extension|Protocol Violation|0
893679|NCT00685399|1864191|FG002|Extension|Protocol Violation|0
893680|NCT00685399|1864192|FG003|Extension|Protocol Violation|1
893681|NCT00685399|1864193|FG004|Extension|Protocol Violation|0
893682|NCT00685399|1864194|FG005|Extension|Protocol Violation|0
893683|NCT00685399|1864195|FG006|Extension|Protocol Violation|0
893684|NCT00685399|1864196|FG007|Extension|Protocol Violation|0
893685|NCT00685399|1864189|FG000|Extension|Lack of Efficacy|0
893686|NCT00685399|1864190|FG001|Extension|Lack of Efficacy|0
893687|NCT00685399|1864191|FG002|Extension|Lack of Efficacy|0
893688|NCT00685399|1864192|FG003|Extension|Lack of Efficacy|2
893689|NCT00685399|1864193|FG004|Extension|Lack of Efficacy|0
893690|NCT00685399|1864194|FG005|Extension|Lack of Efficacy|0
1099055|NCT02336451|2171924|FG003|Overall Study|Physician Decision|16
1099056|NCT02336451|2171925|FG004|Overall Study|Physician Decision|3
1099057|NCT02336451|2171921|FG000|Overall Study|Progressive disease|23
1099058|NCT02336451|2171922|FG001|Overall Study|Progressive disease|26
1099059|NCT02336451|2171923|FG002|Overall Study|Progressive disease|2
1099060|NCT02336451|2171924|FG003|Overall Study|Progressive disease|14
1099061|NCT02336451|2171925|FG004|Overall Study|Progressive disease|4
1099062|NCT02336451|2171921|FG000|Overall Study|Protocol Violation|1
1099063|NCT02336451|2171922|FG001|Overall Study|Protocol Violation|0
1099064|NCT02336451|2171923|FG002|Overall Study|Protocol Violation|0
1099065|NCT02336451|2171924|FG003|Overall Study|Protocol Violation|0
1099066|NCT02336451|2171925|FG004|Overall Study|Protocol Violation|0
1099067|NCT02336451|2171921|FG000|Overall Study|Patient/guardian decision|2
1099068|NCT02336451|2171922|FG001|Overall Study|Patient/guardian decision|4
1099069|NCT02336451|2171923|FG002|Overall Study|Patient/guardian decision|0
1099070|NCT02336451|2171924|FG003|Overall Study|Patient/guardian decision|2
1099071|NCT02336451|2171925|FG004|Overall Study|Patient/guardian decision|1
1099072|NCT02336555|2171941|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1099073|NCT02336555|2171942|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1099074|NCT02336555|2171941|FG000|Treatment Period 1 (28 Days)|Physician Decision|2
1099075|NCT02336555|2171942|FG001|Treatment Period 1 (28 Days)|Physician Decision|0
1099076|NCT02336555|2171941|FG000|Treatment Period 2 (28 Days)|Adverse Event|0
1099077|NCT02336555|2171942|FG001|Treatment Period 2 (28 Days)|Adverse Event|1
1099078|NCT02336607|2171972|FG000|Overall Study|Physician Decision|1
1099079|NCT02336607|2171973|FG001|Overall Study|Physician Decision|4
1099080|NCT02336607|2171974|FG002|Overall Study|Physician Decision|3
1099081|NCT02336607|2171975|FG003|Overall Study|Physician Decision|15
1099082|NCT02336607|2171972|FG000|Overall Study|Lack of Efficacy|1
1099083|NCT02336607|2171973|FG001|Overall Study|Lack of Efficacy|0
1099084|NCT02336607|2171974|FG002|Overall Study|Lack of Efficacy|0
1099085|NCT02336607|2171975|FG003|Overall Study|Lack of Efficacy|2
1099086|NCT02336607|2171972|FG000|Overall Study|Lost to Follow-up|2
1099087|NCT02336607|2171973|FG001|Overall Study|Lost to Follow-up|1
1099088|NCT02336607|2171974|FG002|Overall Study|Lost to Follow-up|0
1099089|NCT02336607|2171975|FG003|Overall Study|Lost to Follow-up|21
1099090|NCT02336607|2171972|FG000|Overall Study|Protocol Violation|0
1099091|NCT02336607|2171973|FG001|Overall Study|Protocol Violation|1
1099092|NCT02336607|2171974|FG002|Overall Study|Protocol Violation|1
1099093|NCT02336607|2171975|FG003|Overall Study|Protocol Violation|3
1099094|NCT02336607|2171972|FG000|Overall Study|Adverse Event|0
1099095|NCT02336607|2171973|FG001|Overall Study|Adverse Event|2
1099096|NCT02336607|2171974|FG002|Overall Study|Adverse Event|2
1099097|NCT02336607|2171975|FG003|Overall Study|Adverse Event|26
1099098|NCT02336607|2171972|FG000|Overall Study|Withdrawal by Subject|0
1099099|NCT02336607|2171973|FG001|Overall Study|Withdrawal by Subject|2
1099100|NCT02336607|2171974|FG002|Overall Study|Withdrawal by Subject|0
1099101|NCT02336607|2171975|FG003|Overall Study|Withdrawal by Subject|20
1099102|NCT02336737|2171985|FG000|Overall Study|Withdrawal by Subject|5
1099103|NCT02336737|2171985|FG000|Overall Study|Physician Decision|8
1099104|NCT02337361|2172032|FG000|3-month Follow-up|Lost to Follow-up|19
1099105|NCT02337361|2172033|FG001|3-month Follow-up|Lost to Follow-up|14
1099106|NCT02337361|2172032|FG000|6-month Follow-up|Lost to Follow-up|2
1099107|NCT02337361|2172033|FG001|6-month Follow-up|Lost to Follow-up|4
1099108|NCT02337387|2172044|FG000|Overall Study|Adverse Event|0
1099109|NCT02337387|2172045|FG001|Overall Study|Adverse Event|1
1099110|NCT02337387|2172046|FG002|Overall Study|Adverse Event|0
1099111|NCT02337387|2172047|FG003|Overall Study|Adverse Event|0
1099112|NCT02337387|2172044|FG000|Overall Study|Sponsor Decision to Terminate Study|14
1099113|NCT02337387|2172045|FG001|Overall Study|Sponsor Decision to Terminate Study|7
1099114|NCT02337387|2172046|FG002|Overall Study|Sponsor Decision to Terminate Study|3
1099115|NCT02337387|2172047|FG003|Overall Study|Sponsor Decision to Terminate Study|3
1099116|NCT02337478|2172061|FG000|Overall Study|Lack of Efficacy|5
1099117|NCT02337491|2172067|FG000|Overall Study|Death|1
1099118|NCT02337491|2172068|FG001|Overall Study|Death|1
1099119|NCT02337491|2172067|FG000|Overall Study|Adverse Event|0
1099120|NCT02337491|2172068|FG001|Overall Study|Adverse Event|1
1099121|NCT02337491|2172067|FG000|Overall Study|Withdrawal by Subject|3
1099122|NCT02337491|2172068|FG001|Overall Study|Withdrawal by Subject|0
1099123|NCT02337491|2172067|FG000|Overall Study|Progressive Disease|44
1099124|NCT02337491|2172068|FG001|Overall Study|Progressive Disease|28
1099125|NCT02337491|2172067|FG000|Overall Study|On Treatment|2
1099126|NCT02337491|2172068|FG001|Overall Study|On Treatment|0
1099127|NCT02337725|2172094|FG000|Overall Study|Pretreatment Event/AE before Treatment|0
1099128|NCT02337725|2172095|FG001|Overall Study|Pretreatment Event/AE before Treatment|1
1099129|NCT02337725|2172094|FG000|Overall Study|Pretreatment Event/AE in Treatment|8
1099130|NCT02337725|2172095|FG001|Overall Study|Pretreatment Event/AE in Treatment|3
1099131|NCT02337725|2172094|FG000|Overall Study|Major Protocol Deviation|0
1099132|NCT02337725|2172095|FG001|Overall Study|Major Protocol Deviation|1
1099133|NCT02337725|2172094|FG000|Overall Study|Voluntary Withdrawal|14
1099134|NCT02337725|2172095|FG001|Overall Study|Voluntary Withdrawal|3
1099135|NCT02337725|2172094|FG000|Overall Study|Lack of Efficacy|4
1099136|NCT02337725|2172095|FG001|Overall Study|Lack of Efficacy|0
1099137|NCT02337738|2172104|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
1099138|NCT02337738|2172105|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
1099139|NCT02337738|2172106|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
1099140|NCT02337738|2172104|FG000|Overall Study|Pretreatment Event/Adverse Event|9
1099141|NCT02337738|2172105|FG001|Overall Study|Pretreatment Event/Adverse Event|18
1099142|NCT02337738|2172106|FG002|Overall Study|Pretreatment Event/Adverse Event|21
1099143|NCT02337738|2172104|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0
1099144|NCT02337738|2172105|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1
1099145|NCT02337738|2172106|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0
1099146|NCT02337738|2172104|FG000|Overall Study|Voluntary Withdrawal|10
1099147|NCT02337738|2172105|FG001|Overall Study|Voluntary Withdrawal|5
1099148|NCT02337738|2172106|FG002|Overall Study|Voluntary Withdrawal|2
1099149|NCT02337738|2172104|FG000|Overall Study|Lack of Efficacy|2
1099150|NCT02337738|2172105|FG001|Overall Study|Lack of Efficacy|4
1099151|NCT02337738|2172106|FG002|Overall Study|Lack of Efficacy|0
1099152|NCT02337738|2172104|FG000|Overall Study|Investigator's Judgment|1
1099153|NCT02337738|2172105|FG001|Overall Study|Investigator's Judgment|1
1099154|NCT02337738|2172106|FG002|Overall Study|Investigator's Judgment|3
1099155|NCT02337751|2172116|FG000|Overall Study|Pretreatment Event/Adverse Event|2
1099156|NCT02337751|2172117|FG001|Overall Study|Pretreatment Event/Adverse Event|3
1099157|NCT02337751|2172116|FG000|Overall Study|Voluntary Withdrawal|6
1099158|NCT02337751|2172117|FG001|Overall Study|Voluntary Withdrawal|8
1099159|NCT02337751|2172116|FG000|Overall Study|Lack of Efficacy|2
1099160|NCT02337751|2172117|FG001|Overall Study|Lack of Efficacy|5
1099161|NCT02337751|2172116|FG000|Overall Study|Investigator's Judgement|1
1099162|NCT02337751|2172117|FG001|Overall Study|Investigator's Judgement|0
1099163|NCT02337764|2172124|FG000|Overall Study|Pretreatment Event/Adverse Event|46
1099164|NCT02337764|2172124|FG000|Overall Study|Voluntary Withdrawal|12
1099165|NCT02337764|2172124|FG000|Overall Study|Lack of Efficacy|2
1099178|NCT02337907|2172153|FG000|Overall Study|Other than listed|1
1099179|NCT02337907|2172154|FG001|Overall Study|Other than listed|0
1099180|NCT02337907|2172155|FG002|Overall Study|Other than listed|0
1099181|NCT02337907|2172156|FG003|Overall Study|Other than listed|1
1099182|NCT02337907|2172157|FG004|Overall Study|Other than listed|1
1099183|NCT02337907|2172158|FG005|Overall Study|Other than listed|0
1099184|NCT02337907|2172153|FG000|Overall Study|Withdrawal by Subject|2
1099185|NCT02337907|2172154|FG001|Overall Study|Withdrawal by Subject|3
1099186|NCT02337907|2172155|FG002|Overall Study|Withdrawal by Subject|0
1099187|NCT02337907|2172156|FG003|Overall Study|Withdrawal by Subject|2
1099188|NCT02337907|2172157|FG004|Overall Study|Withdrawal by Subject|5
1099189|NCT02337907|2172158|FG005|Overall Study|Withdrawal by Subject|0
1099190|NCT02337907|2172153|FG000|Overall Study|Lost to Follow-up|0
1099191|NCT02337907|2172154|FG001|Overall Study|Lost to Follow-up|0
1099192|NCT02337907|2172155|FG002|Overall Study|Lost to Follow-up|0
1099193|NCT02337907|2172156|FG003|Overall Study|Lost to Follow-up|0
1099194|NCT02337907|2172157|FG004|Overall Study|Lost to Follow-up|0
1099195|NCT02337907|2172158|FG005|Overall Study|Lost to Follow-up|1
1099196|NCT02337907|2172153|FG000|Overall Study|Adverse Event|1
1099197|NCT02337907|2172154|FG001|Overall Study|Adverse Event|1
1099198|NCT02337907|2172155|FG002|Overall Study|Adverse Event|1
1099199|NCT02337907|2172156|FG003|Overall Study|Adverse Event|1
1099200|NCT02337907|2172157|FG004|Overall Study|Adverse Event|4
1099201|NCT02337907|2172158|FG005|Overall Study|Adverse Event|0
1099202|NCT02337946|2172182|FG000|Protocol Treatment 1 Period|Adverse Event|7
1099203|NCT02337946|2172183|FG001|Protocol Treatment 1 Period|Adverse Event|0
1099204|NCT02337946|2172184|FG002|Protocol Treatment 1 Period|Adverse Event|0
1099205|NCT02337946|2172182|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1
1099206|NCT02337946|2172183|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0
1099207|NCT02337946|2172184|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0
1099208|NCT02337946|2172182|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6
1099209|NCT02337946|2172183|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0
1099210|NCT02337946|2172184|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0
1099211|NCT02337946|2172182|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15
1099212|NCT02337946|2172183|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0
1099213|NCT02337946|2172184|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0
1099214|NCT02337946|2172182|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3
1099215|NCT02337946|2172183|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0
1099216|NCT02337946|2172184|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0
1099217|NCT02337946|2172182|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
1099218|NCT02337946|2172183|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
1099219|NCT02337946|2172184|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
1099220|NCT02337946|2172182|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
1099221|NCT02337946|2172183|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
1099222|NCT02337946|2172184|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
1099223|NCT02337946|2172182|FG000|Protocol Treatment 1 Period|Reason not specified|8
1099224|NCT02337946|2172183|FG001|Protocol Treatment 1 Period|Reason not specified|0
1099225|NCT02337946|2172184|FG002|Protocol Treatment 1 Period|Reason not specified|0
1099226|NCT02337946|2172182|FG000|In-between Period|Without Informed Consent|1
1099227|NCT02337946|2172183|FG001|In-between Period|Without Informed Consent|0
1099228|NCT02337946|2172184|FG002|In-between Period|Without Informed Consent|0
1099229|NCT02337946|2172182|FG000|Protocol Treatment 2 Period|Adverse Event|0
1099230|NCT02337946|2172183|FG001|Protocol Treatment 2 Period|Adverse Event|9
1099231|NCT02337946|2172184|FG002|Protocol Treatment 2 Period|Adverse Event|9
1099232|NCT02337946|2172182|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0
1099233|NCT02337946|2172183|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3
1099234|NCT02337946|2172184|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1
1099235|NCT02337946|2172182|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0
1099236|NCT02337946|2172183|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29
1099237|NCT02337946|2172184|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29
1099238|NCT02337946|2172182|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0
1099239|NCT02337946|2172183|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1
1099240|NCT02337946|2172184|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0
1099241|NCT02337946|2172182|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
1099242|NCT02337946|2172183|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
1099243|NCT02337946|2172184|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
1099244|NCT02337946|2172182|FG000|Protocol Treatment 2 Period|Reason not specified|0
1099245|NCT02337946|2172183|FG001|Protocol Treatment 2 Period|Reason not specified|4
1099246|NCT02337946|2172184|FG002|Protocol Treatment 2 Period|Reason not specified|4
1099247|NCT02338154|2172209|FG000|Overall Study|Death|46
1099248|NCT02338154|2172209|FG000|Overall Study|Valve Implant Failure|17
1099249|NCT02338154|2172209|FG000|Overall Study|Valve Explant|11
1099250|NCT02338154|2172209|FG000|Overall Study|Withdrawal by Subject or by Investigator|10
1099251|NCT02338154|2172209|FG000|Overall Study|Lost to Follow-up|8
1099252|NCT02338154|2172209|FG000|Overall Study|Other Reason|3
1099253|NCT02338154|2172209|FG000|Overall Study|Patients Without Exit Form|47
1099254|NCT02338154|2172209|FG000|Overall Study|Missing Exit Reason on Exit Form|1
1099255|NCT02338193|2172224|FG000|Overall Study|Withdrawal by Subject|0
1099256|NCT02338193|2172225|FG001|Overall Study|Withdrawal by Subject|0
1099257|NCT02338193|2172226|FG002|Overall Study|Withdrawal by Subject|2
1099258|NCT02338193|2172224|FG000|Overall Study|Pregnancy|0
1099259|NCT02338193|2172225|FG001|Overall Study|Pregnancy|1
1099260|NCT02338193|2172226|FG002|Overall Study|Pregnancy|1
1099261|NCT02338193|2172224|FG000|Overall Study|Noncompliant with visits|2
1099262|NCT02338193|2172225|FG001|Overall Study|Noncompliant with visits|2
1099263|NCT02338193|2172226|FG002|Overall Study|Noncompliant with visits|7
1099264|NCT02338193|2172224|FG000|Overall Study|moved out of state|0
1099265|NCT02338193|2172225|FG001|Overall Study|moved out of state|1
1099266|NCT02338193|2172226|FG002|Overall Study|moved out of state|0
1099267|NCT02338193|2172224|FG000|Overall Study|intolerant of side effects|1
1099268|NCT02338193|2172225|FG001|Overall Study|intolerant of side effects|0
1099269|NCT02338193|2172226|FG002|Overall Study|intolerant of side effects|0
1099270|NCT02338362|2172247|FG000|Overall Study|Withdrawal by Subject|1
1099271|NCT02338362|2172248|FG001|Overall Study|Withdrawal by Subject|1
1099272|NCT02338492|2172254|FG000|Overall Study|Death|32
1099273|NCT02338492|2172254|FG000|Overall Study|Adverse Event|3
1099274|NCT02338492|2172254|FG000|Overall Study|Lost to Follow-up|4
1099275|NCT02338492|2172254|FG000|Overall Study|Reason not captured above|6
1099276|NCT02338843|2172266|FG000|Overall Study|Adverse Event|2
1099277|NCT02338843|2172267|FG001|Overall Study|Adverse Event|1
1099278|NCT02338843|2172266|FG000|Overall Study|Death|40
1099279|NCT02338843|2172267|FG001|Overall Study|Death|53
1099280|NCT02338843|2172266|FG000|Overall Study|Physician Decision|1
1099281|NCT02338843|2172267|FG001|Overall Study|Physician Decision|0
1099282|NCT02338843|2172266|FG000|Overall Study|Withdrawal by Subject|0
1099283|NCT02338843|2172267|FG001|Overall Study|Withdrawal by Subject|2
1099284|NCT02338843|2172266|FG000|Overall Study|Subject Recovered|0
1099285|NCT02338843|2172267|FG001|Overall Study|Subject Recovered|2
1099286|NCT02338843|2172266|FG000|Overall Study|Discontinued prior to randomizat|1
1099287|NCT02338843|2172267|FG001|Overall Study|Discontinued prior to randomizat|0
1099288|NCT02338882|2172275|FG000|Overall Study|Death|1
1099289|NCT02338882|2172276|FG001|Overall Study|Death|0
1099290|NCT02338882|2172275|FG000|Overall Study|Lost to Follow-up|6
1099291|NCT02338882|2172276|FG001|Overall Study|Lost to Follow-up|3
1099292|NCT02338999|2172382|FG000|First Intervention|Withdrawal by Subject|3
1099293|NCT02338999|2172383|FG001|First Intervention|Withdrawal by Subject|1
1099294|NCT02338999|2172382|FG000|Washout Period|Withdrawal by Subject|0
1099295|NCT02338999|2172383|FG001|Washout Period|Withdrawal by Subject|2
1099296|NCT02338999|2172382|FG000|Second Intervention|Withdrawal by Subject|0
1099297|NCT02338999|2172383|FG001|Second Intervention|Withdrawal by Subject|2
1099298|NCT02339155|2172395|FG000|Overall Study|Adverse Event|0
1099299|NCT02339155|2172396|FG001|Overall Study|Adverse Event|6
1099300|NCT02339155|2172395|FG000|Overall Study|Death|1
1099301|NCT02339155|2172396|FG001|Overall Study|Death|1
1099302|NCT02339155|2172395|FG000|Overall Study|Lost to Follow-up|8
1099303|NCT02339155|2172396|FG001|Overall Study|Lost to Follow-up|9
1099304|NCT02339155|2172395|FG000|Overall Study|Physician Decision|2
1099305|NCT02339155|2172396|FG001|Overall Study|Physician Decision|1
1099306|NCT02339155|2172395|FG000|Overall Study|Withdrawal by Subject|4
1099307|NCT02339155|2172396|FG001|Overall Study|Withdrawal by Subject|4
1099308|NCT02339285|2172419|FG000|Overall Study|Withdrawal by Subject|0
1099309|NCT02339285|2172420|FG001|Overall Study|Withdrawal by Subject|1
1099310|NCT02339285|2172421|FG002|Overall Study|Withdrawal by Subject|1
1099311|NCT02339285|2172419|FG000|Overall Study|Lost to Follow-up|1
1099312|NCT02339285|2172420|FG001|Overall Study|Lost to Follow-up|1
1099313|NCT02339285|2172421|FG002|Overall Study|Lost to Follow-up|1
1099314|NCT02339285|2172419|FG000|Overall Study|Protocol Deviation|0
1099315|NCT02339285|2172420|FG001|Overall Study|Protocol Deviation|1
1099316|NCT02339285|2172421|FG002|Overall Study|Protocol Deviation|0
1099317|NCT02339506|2172445|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
1099318|NCT02339506|2172446|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
1099319|NCT02339506|2172445|FG000|Washout (Period 2)|Withdrawal by Subject|2
1099320|NCT02339506|2172446|FG001|Washout (Period 2)|Withdrawal by Subject|0
1099321|NCT02339584|2172463|FG000|Overall Study|Adverse Event|11
1099322|NCT02339584|2172464|FG001|Overall Study|Adverse Event|7
1099323|NCT02339584|2172463|FG000|Overall Study|Lack of Efficacy|0
1099324|NCT02339584|2172464|FG001|Overall Study|Lack of Efficacy|1
1099325|NCT02339584|2172463|FG000|Overall Study|Physician Decision|1
1099326|NCT02339584|2172464|FG001|Overall Study|Physician Decision|2
1099327|NCT02339584|2172463|FG000|Overall Study|Protocol Violation|1
1099328|NCT02339584|2172464|FG001|Overall Study|Protocol Violation|1
1099329|NCT02339584|2172463|FG000|Overall Study|Withdrawal by Subject|2
1099330|NCT02339584|2172464|FG001|Overall Study|Withdrawal by Subject|4
1099331|NCT02339909|2172482|FG000|Overall Study|Became ineligible after randomisation|89
1099332|NCT02339909|2172483|FG001|Overall Study|Became ineligible after randomisation|63
1099333|NCT02339909|2172484|FG002|Overall Study|Became ineligible after randomisation|71
1099334|NCT02340000|2172494|FG000|Time Period 1|Withdrawal by Subject|6
1099335|NCT02340000|2172495|FG001|Time Period 1|Withdrawal by Subject|8
1099336|NCT02340000|2172494|FG000|Time Period 1|Lost to Follow-up|6
1099337|NCT02340000|2172495|FG001|Time Period 1|Lost to Follow-up|7
1099338|NCT02340000|2172494|FG000|Time Period 2|Withdrawal by Subject|9
1099339|NCT02340000|2172495|FG001|Time Period 2|Withdrawal by Subject|7
1099340|NCT02340000|2172494|FG000|Time Period 2|Lost to Follow-up|10
1099341|NCT02340000|2172495|FG001|Time Period 2|Lost to Follow-up|8
1099342|NCT02340078|2172508|FG000|Overall Study|Protocol Violation|1
1099353|NCT02340520|2172575|FG000|Overall Study|Lost to Follow-up|1
1099354|NCT02340520|2172575|FG000|Overall Study|Patient did not take drug as specified|1
1099355|NCT02340520|2172575|FG000|Overall Study|Withdrawal by Subject|1
1099356|NCT02340663|2172581|FG000|Overall Study|Lost to Follow-up|1
1099357|NCT02340663|2172582|FG001|Overall Study|Lost to Follow-up|0
1099358|NCT02340663|2172581|FG000|Overall Study|Protocol Violation|1
1099359|NCT02340663|2172582|FG001|Overall Study|Protocol Violation|0
1099360|NCT02340663|2172581|FG000|Overall Study|Withdrawal by Subject|3
1099361|NCT02340663|2172582|FG001|Overall Study|Withdrawal by Subject|1
1099362|NCT02340780|2172628|FG000|Overall Study|Ineligible|1
1099363|NCT02340806|2172634|FG000|Overall Study|Protocol Violation|2
1099364|NCT02340806|2172635|FG001|Overall Study|Protocol Violation|0
1099365|NCT02340806|2172634|FG000|Overall Study|epidural catheter replaced|2
1099366|NCT02340806|2172635|FG001|Overall Study|epidural catheter replaced|1
1099367|NCT02340806|2172634|FG000|Overall Study|history of chronic pain medication|1
1099368|NCT02340806|2172635|FG001|Overall Study|history of chronic pain medication|0
1099369|NCT02340806|2172634|FG000|Overall Study|re-dose < 90 min of CSE|1
1099370|NCT02340806|2172635|FG001|Overall Study|re-dose < 90 min of CSE|3
1099371|NCT02340819|2172641|FG000|Overall Study|Adverse Event|1
1099372|NCT02340819|2172641|FG000|Overall Study|Withdrawal by Subject|2
1099373|NCT02340819|2172641|FG000|Overall Study|Discontinued with other reason|1
1099374|NCT02340949|2172647|FG000|Overall Study|Adverse Event|4
1099375|NCT02340949|2172648|FG001|Overall Study|Adverse Event|2
1099376|NCT02340949|2172647|FG000|Overall Study|Withdrawal by Subject|2
1099377|NCT02340949|2172648|FG001|Overall Study|Withdrawal by Subject|0
1099378|NCT02340949|2172647|FG000|Overall Study|Progression disease|6
1099379|NCT02340949|2172648|FG001|Overall Study|Progression disease|2
1099380|NCT02340949|2172647|FG000|Overall Study|Death|3
1099381|NCT02340949|2172648|FG001|Overall Study|Death|0
1099382|NCT02340949|2172647|FG000|Overall Study|Physician Decision|1
1099383|NCT02340949|2172648|FG001|Overall Study|Physician Decision|0
1099384|NCT02340962|2172656|FG000|Overall Study|Lost to Follow-up|1
1099385|NCT02340962|2172657|FG001|Overall Study|Lost to Follow-up|0
1099386|NCT02340975|2172669|FG000|Overall Study|Death|6
1099387|NCT02340975|2172670|FG001|Overall Study|Death|23
1099388|NCT02340975|2172671|FG002|Overall Study|Death|21
1099389|NCT02340975|2172672|FG003|Overall Study|Death|7
1099390|NCT02340975|2172673|FG004|Overall Study|Death|21
1099391|NCT02340975|2172674|FG005|Overall Study|Death|13
1099392|NCT02340975|2172669|FG000|Overall Study|Lost to Follow-up|0
1099393|NCT02340975|2172670|FG001|Overall Study|Lost to Follow-up|0
1099394|NCT02340975|2172671|FG002|Overall Study|Lost to Follow-up|0
1099395|NCT02340975|2172672|FG003|Overall Study|Lost to Follow-up|0
1099396|NCT02340975|2172673|FG004|Overall Study|Lost to Follow-up|2
1099397|NCT02340975|2172674|FG005|Overall Study|Lost to Follow-up|0
1099398|NCT02340975|2172669|FG000|Overall Study|Withdrawal by Subject|0
1099399|NCT02340975|2172670|FG001|Overall Study|Withdrawal by Subject|0
1099400|NCT02340975|2172671|FG002|Overall Study|Withdrawal by Subject|3
1099401|NCT02340975|2172672|FG003|Overall Study|Withdrawal by Subject|3
1099402|NCT02340975|2172673|FG004|Overall Study|Withdrawal by Subject|2
1099403|NCT02340975|2172674|FG005|Overall Study|Withdrawal by Subject|0
1099404|NCT02340975|2172669|FG000|Overall Study|Other|0
1099405|NCT02340975|2172670|FG001|Overall Study|Other|4
893691|NCT00685399|1864195|FG006|Extension|Lack of Efficacy|0
893692|NCT00685399|1864196|FG007|Extension|Lack of Efficacy|0
893693|NCT00685399|1864189|FG000|Extension|Adverse Event|0
893694|NCT00685399|1864190|FG001|Extension|Adverse Event|0
893695|NCT00685399|1864191|FG002|Extension|Adverse Event|0
893696|NCT00685399|1864192|FG003|Extension|Adverse Event|2
893697|NCT00685399|1864193|FG004|Extension|Adverse Event|0
893698|NCT00685399|1864194|FG005|Extension|Adverse Event|0
893699|NCT00685399|1864195|FG006|Extension|Adverse Event|0
893700|NCT00685399|1864196|FG007|Extension|Adverse Event|0
893701|NCT00685685|1864266|FG000|Washout Period of 7 Days|Adverse Event|2
893702|NCT00685685|1864267|FG001|Washout Period of 7 Days|Adverse Event|0
893703|NCT00685685|1864266|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
893704|NCT00685685|1864267|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
893705|NCT00685698|1864273|FG000|Overall Study|Withdrawal by Subject|1
893706|NCT00685698|1864273|FG000|Overall Study|Protocol Violation|6
893707|NCT00685698|1864273|FG000|Overall Study|Adverse Event|3
893708|NCT00685698|1864273|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1
893709|NCT00685698|1864273|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1
893710|NCT00685698|1864273|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
893711|NCT00685750|1864296|FG000|Overall Study|Tumor sampling failure|0
893712|NCT00685750|1864297|FG001|Overall Study|Tumor sampling failure|0
893713|NCT00685750|1864298|FG002|Overall Study|Tumor sampling failure|1
893714|NCT00685750|1864299|FG003|Overall Study|Tumor sampling failure|0
893715|NCT00685750|1864300|FG004|Overall Study|Tumor sampling failure|0
893716|NCT00685750|1864301|FG005|Overall Study|Tumor sampling failure|0
893717|NCT00685750|1864302|FG006|Overall Study|Tumor sampling failure|0
893718|NCT00685750|1864296|FG000|Overall Study|Patient didn't receive the treatment|0
893719|NCT00685750|1864297|FG001|Overall Study|Patient didn't receive the treatment|0
893720|NCT00685750|1864298|FG002|Overall Study|Patient didn't receive the treatment|0
893721|NCT00685750|1864299|FG003|Overall Study|Patient didn't receive the treatment|0
893722|NCT00685750|1864300|FG004|Overall Study|Patient didn't receive the treatment|0
893723|NCT00685750|1864301|FG005|Overall Study|Patient didn't receive the treatment|0
893724|NCT00685750|1864302|FG006|Overall Study|Patient didn't receive the treatment|1
893725|NCT00685750|1864296|FG000|Overall Study|Eligibility criteria not fulfilled|0
893726|NCT00685750|1864297|FG001|Overall Study|Eligibility criteria not fulfilled|0
893727|NCT00685750|1864298|FG002|Overall Study|Eligibility criteria not fulfilled|1
893728|NCT00685750|1864299|FG003|Overall Study|Eligibility criteria not fulfilled|0
893729|NCT00685750|1864300|FG004|Overall Study|Eligibility criteria not fulfilled|0
893730|NCT00685750|1864301|FG005|Overall Study|Eligibility criteria not fulfilled|0
893731|NCT00685750|1864302|FG006|Overall Study|Eligibility criteria not fulfilled|0
893732|NCT00685763|1864322|FG000|Overall Study|Intercurrent death-incomplete treatment|1
893733|NCT00685763|1864322|FG000|Overall Study|Protocol Violation|1
893734|NCT00685802|1864326|FG000|Washout Period of 7 Days|Protocol Violation|2
893735|NCT00685802|1864327|FG001|Washout Period of 7 Days|Protocol Violation|0
893736|NCT00685802|1864326|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
893737|NCT00685802|1864327|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
893746|NCT00685945|1864359|FG000|L-NMMA + Bradykinin|Physician Decision|1
893747|NCT00686075|1864379|FG000|Overall Study|Withdrawal by Subject|4
893748|NCT00686075|1864380|FG001|Overall Study|Withdrawal by Subject|3
893749|NCT00686075|1864381|FG002|Overall Study|Withdrawal by Subject|3
893750|NCT00686075|1864382|FG003|Overall Study|Withdrawal by Subject|7
893751|NCT00686075|1864383|FG004|Overall Study|Withdrawal by Subject|1
893752|NCT00686075|1864384|FG005|Overall Study|Withdrawal by Subject|0
893753|NCT00686075|1864385|FG006|Overall Study|Withdrawal by Subject|0
893754|NCT00686075|1864386|FG007|Overall Study|Withdrawal by Subject|2
893755|NCT00686075|1864387|FG008|Overall Study|Withdrawal by Subject|4
1099406|NCT02340975|2172671|FG002|Overall Study|Other|0
1099407|NCT02340975|2172672|FG003|Overall Study|Other|2
1099408|NCT02340975|2172673|FG004|Overall Study|Other|0
1099409|NCT02340975|2172674|FG005|Overall Study|Other|6
1099410|NCT02341417|2172701|FG000|Overall Study|Withdrawal by Subject|0
1099411|NCT02341417|2172702|FG001|Overall Study|Withdrawal by Subject|2
1099412|NCT02341417|2172703|FG002|Overall Study|Withdrawal by Subject|0
1099413|NCT02341417|2172701|FG000|Overall Study|Decision by sponsor|2
1099414|NCT02341417|2172702|FG001|Overall Study|Decision by sponsor|0
1099415|NCT02341417|2172703|FG002|Overall Study|Decision by sponsor|0
1099416|NCT02341417|2172701|FG000|Overall Study|Death|0
1099417|NCT02341417|2172702|FG001|Overall Study|Death|0
1099418|NCT02341417|2172703|FG002|Overall Study|Death|1
1099419|NCT02341456|2172715|FG000|Overall Study|Disease progression|2
1099420|NCT02341456|2172716|FG001|Overall Study|Disease progression|3
1099421|NCT02341456|2172717|FG002|Overall Study|Disease progression|1
1099422|NCT02341456|2172715|FG000|Overall Study|Death|1
1099423|NCT02341456|2172716|FG001|Overall Study|Death|1
1099424|NCT02341456|2172717|FG002|Overall Study|Death|1
1099425|NCT02341456|2172715|FG000|Overall Study|Withdrawal by Subject|0
1099426|NCT02341456|2172716|FG001|Overall Study|Withdrawal by Subject|1
1099427|NCT02341456|2172717|FG002|Overall Study|Withdrawal by Subject|1
1099428|NCT02341456|2172715|FG000|Overall Study|Moved to local access programme.|0
1099429|NCT02341456|2172716|FG001|Overall Study|Moved to local access programme.|1
1099430|NCT02341456|2172717|FG002|Overall Study|Moved to local access programme.|1
1099431|NCT02341456|2172715|FG000|Overall Study|Physician Decision|1
1099432|NCT02341456|2172716|FG001|Overall Study|Physician Decision|0
1099433|NCT02341456|2172717|FG002|Overall Study|Physician Decision|0
1099434|NCT02341482|2172725|FG000|Overall Study|Adverse Event|1
893756|NCT00686075|1864388|FG009|Overall Study|Withdrawal by Subject|6
893757|NCT00686075|1864379|FG000|Overall Study|Lost to Follow-up|3
893758|NCT00686075|1864380|FG001|Overall Study|Lost to Follow-up|6
893759|NCT00686075|1864381|FG002|Overall Study|Lost to Follow-up|3
893760|NCT00686075|1864382|FG003|Overall Study|Lost to Follow-up|2
893761|NCT00686075|1864383|FG004|Overall Study|Lost to Follow-up|3
893762|NCT00686075|1864384|FG005|Overall Study|Lost to Follow-up|3
893763|NCT00686075|1864385|FG006|Overall Study|Lost to Follow-up|0
893764|NCT00686075|1864386|FG007|Overall Study|Lost to Follow-up|0
893765|NCT00686075|1864387|FG008|Overall Study|Lost to Follow-up|2
893766|NCT00686075|1864388|FG009|Overall Study|Lost to Follow-up|3
893767|NCT00686075|1864379|FG000|Overall Study|Other|1
893768|NCT00686075|1864380|FG001|Overall Study|Other|1
893769|NCT00686075|1864381|FG002|Overall Study|Other|0
893770|NCT00686075|1864382|FG003|Overall Study|Other|0
893771|NCT00686075|1864383|FG004|Overall Study|Other|0
893772|NCT00686075|1864384|FG005|Overall Study|Other|0
893773|NCT00686075|1864385|FG006|Overall Study|Other|0
893774|NCT00686075|1864386|FG007|Overall Study|Other|0
893775|NCT00686075|1864387|FG008|Overall Study|Other|0
893776|NCT00686075|1864388|FG009|Overall Study|Other|1
893777|NCT00686127|1864412|FG000|Overall Study|Withdrawal by Subject|14
893778|NCT00686127|1864413|FG001|Overall Study|Withdrawal by Subject|6
893779|NCT00686166|1864419|FG000|Overall Study|Adverse Event|7
893780|NCT00686166|1864419|FG000|Overall Study|Withdrawal by Subject|1
893781|NCT00686166|1864419|FG000|Overall Study|Progression/Relapse|1
893782|NCT00686166|1864419|FG000|Overall Study|Death|1
893783|NCT00686166|1864419|FG000|Overall Study|Not Protocol Specified|1
893784|NCT00686166|1864419|FG000|Overall Study|Ineligible|5
893785|NCT00686166|1864419|FG000|Overall Study|Did not begin protocol therapy|4
893786|NCT00686205|1864430|FG000|Overall Study|Protocol Violation|127
893787|NCT00686205|1864431|FG001|Overall Study|Protocol Violation|0
893788|NCT00686205|1864430|FG000|Overall Study|Withdrawal by Subject|2
893789|NCT00686205|1864431|FG001|Overall Study|Withdrawal by Subject|0
893790|NCT00686205|1864430|FG000|Overall Study|Specimen handling procedure altered|5878
893791|NCT00686205|1864431|FG001|Overall Study|Specimen handling procedure altered|0
893792|NCT00686205|1864430|FG000|Overall Study|Specimens not confirmed HIV positive|0
893793|NCT00686205|1864431|FG001|Overall Study|Specimens not confirmed HIV positive|981
893794|NCT00686335|1864461|FG000|Run-in Period|Adverse Event|1
893795|NCT00686335|1864461|FG000|Run-in Period|asthma exacerbation|1
893796|NCT00686335|1864461|FG000|Run-in Period|violation of inclusion/exclusion criteri|3
893797|NCT00686517|1864474|FG000|Treatment|Serious Adverse Event|1
893798|NCT00686517|1864475|FG001|Treatment|Serious Adverse Event|2
893799|NCT00686517|1864476|FG002|Treatment|Serious Adverse Event|1
893800|NCT00686517|1864474|FG000|Treatment|Adverse Event|2
893801|NCT00686517|1864475|FG001|Treatment|Adverse Event|0
893802|NCT00686517|1864476|FG002|Treatment|Adverse Event|0
893803|NCT00686517|1864474|FG000|Treatment|Poor Protocol Compliance|1
893804|NCT00686517|1864475|FG001|Treatment|Poor Protocol Compliance|0
893805|NCT00686517|1864476|FG002|Treatment|Poor Protocol Compliance|0
893806|NCT00686517|1864474|FG000|Treatment|Protocol Violation|2
893807|NCT00686517|1864475|FG001|Treatment|Protocol Violation|1
893808|NCT00686517|1864476|FG002|Treatment|Protocol Violation|0
893809|NCT00686543|1864488|FG000|Overall Study|Adverse Event|9
893810|NCT00686543|1864489|FG001|Overall Study|Adverse Event|1
893811|NCT00686543|1864490|FG002|Overall Study|Adverse Event|3
893812|NCT00686543|1864491|FG003|Overall Study|Adverse Event|2
893813|NCT00686543|1864488|FG000|Overall Study|Withdrawal by Subject|2
1099435|NCT02342171|2172778|FG000|Overall Study|Death|4
1099436|NCT02342171|2172779|FG001|Overall Study|Death|87
1099437|NCT02342171|2172778|FG000|Overall Study|Received favipiravir|10
1099438|NCT02342171|2172779|FG001|Overall Study|Received favipiravir|0
1099439|NCT02342171|2172778|FG000|Overall Study|Missing cycle treshold value|1
1099440|NCT02342171|2172779|FG001|Overall Study|Missing cycle treshold value|0
1099441|NCT02342171|2172778|FG000|Overall Study|Unknown outcome|0
1099442|NCT02342171|2172779|FG001|Overall Study|Unknown outcome|1
1099443|NCT02342171|2172778|FG000|Overall Study|Missing age data|0
1099444|NCT02342171|2172779|FG001|Overall Study|Missing age data|1
893814|NCT00686543|1864489|FG001|Overall Study|Withdrawal by Subject|0
893815|NCT00686543|1864490|FG002|Overall Study|Withdrawal by Subject|0
893816|NCT00686543|1864491|FG003|Overall Study|Withdrawal by Subject|0
893817|NCT00686543|1864488|FG000|Overall Study|Protocol Violation|3
893818|NCT00686543|1864489|FG001|Overall Study|Protocol Violation|0
893819|NCT00686543|1864490|FG002|Overall Study|Protocol Violation|2
893820|NCT00686543|1864491|FG003|Overall Study|Protocol Violation|1
893821|NCT00686595|1864512|FG000|Overall Study|Adverse Event|3
893822|NCT00686595|1864512|FG000|Overall Study|Protocol Violation|1
893823|NCT00686595|1864512|FG000|Overall Study|Lost to Follow-up|1
893824|NCT00686595|1864512|FG000|Overall Study|Lack of Efficacy|1
893825|NCT00686595|1864512|FG000|Overall Study|Poor Compliance|1
893826|NCT00686634|1864516|FG000|Overall Study|Protocol Violation|6
893827|NCT00686647|1864521|FG000|Overall Study|Lost to Follow-up|1
893828|NCT00686647|1864521|FG000|Overall Study|Death|1
893829|NCT00686686|1864526|FG000|Overall Study|Non-compliance|1
893830|NCT00686686|1864526|FG000|Overall Study|Adverse Event|2
893831|NCT00686686|1864526|FG000|Overall Study|Lost to Follow-up|3
893832|NCT00686699|1864532|FG000|Treatment Period 1|Adverse Event|0
893833|NCT00686699|1864533|FG001|Treatment Period 1|Adverse Event|2
893834|NCT00686712|1864542|FG000|Overall Study|Protocol Violation|8
893835|NCT00686712|1864543|FG001|Overall Study|Protocol Violation|8
893836|NCT00686712|1864544|FG002|Overall Study|Protocol Violation|10
893837|NCT00686712|1864542|FG000|Overall Study|Lost to Follow-up|1
893838|NCT00686712|1864543|FG001|Overall Study|Lost to Follow-up|2
893839|NCT00686712|1864544|FG002|Overall Study|Lost to Follow-up|3
893840|NCT00686712|1864542|FG000|Overall Study|Adverse Event|1
893841|NCT00686712|1864543|FG001|Overall Study|Adverse Event|1
893842|NCT00686712|1864544|FG002|Overall Study|Adverse Event|0
893843|NCT00686725|1864557|FG000|Overall Study|Adverse Event|1
893844|NCT00686725|1864558|FG001|Overall Study|Adverse Event|1
893845|NCT00686725|1864557|FG000|Overall Study|Progressive Disease|17
893846|NCT00686725|1864558|FG001|Overall Study|Progressive Disease|23
893847|NCT00686725|1864557|FG000|Overall Study|Lost to Follow-up|7
893848|NCT00686725|1864558|FG001|Overall Study|Lost to Follow-up|5
893849|NCT00686725|1864557|FG000|Overall Study|Death|6
893850|NCT00686725|1864558|FG001|Overall Study|Death|3
893851|NCT00686725|1864557|FG000|Overall Study|Withdrawal by Subject|13
893852|NCT00686725|1864558|FG001|Overall Study|Withdrawal by Subject|4
893853|NCT00686725|1864557|FG000|Overall Study|Protocol Violation|1
893854|NCT00686725|1864558|FG001|Overall Study|Protocol Violation|3
893855|NCT00686725|1864557|FG000|Overall Study|Other|1
893856|NCT00686725|1864558|FG001|Overall Study|Other|3
893857|NCT00686777|1864564|FG000|Overall Study|Adverse Event|2
893858|NCT00686777|1864564|FG000|Overall Study|Pregnancy|1
893859|NCT00686777|1864564|FG000|Overall Study|Withdrawal by Subject|2
893860|NCT00686777|1864564|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4
893861|NCT00686777|1864564|FG000|Overall Study|No Visit|1
893862|NCT00686790|1864568|FG000|Overall Study|Adverse Event|2
893863|NCT00686790|1864568|FG000|Overall Study|Withdrawal by Subject|1
893864|NCT00686790|1864568|FG000|Overall Study|Death|1
893865|NCT00686790|1864568|FG000|Overall Study|Lost to Follow-up|12
893866|NCT00686829|1864585|FG000|Overall Study|Adverse Event|5
893867|NCT00686829|1864585|FG000|Overall Study|Lack of Efficacy|6
893868|NCT00686829|1864585|FG000|Overall Study|Lost to Follow-up|4
893869|NCT00686829|1864585|FG000|Overall Study|Withdrawal by Subject|14
893870|NCT00686829|1864585|FG000|Overall Study|Protocol Violation|3
893871|NCT00686829|1864585|FG000|Overall Study|Sponsor discontinued VCV|47
893872|NCT00686855|1864595|FG000|Overall Study|Lost to Follow-up|1
893873|NCT00686855|1864596|FG001|Overall Study|Lost to Follow-up|0
893874|NCT00686855|1864595|FG000|Overall Study|Progressive GVHD|0
893875|NCT00686855|1864596|FG001|Overall Study|Progressive GVHD|1
893876|NCT00686881|1864604|FG000|Overall Study|Withdrawal by Subject|11
893877|NCT00686881|1864605|FG001|Overall Study|Withdrawal by Subject|18
893878|NCT00686881|1864604|FG000|Overall Study|Lost to Follow-up|0
893879|NCT00686881|1864605|FG001|Overall Study|Lost to Follow-up|1
893880|NCT00686881|1864604|FG000|Overall Study|Treatment-related adverse event|10
893881|NCT00686881|1864605|FG001|Overall Study|Treatment-related adverse event|9
893882|NCT00686881|1864604|FG000|Overall Study|Met discontinuation criteria|5
893883|NCT00686881|1864605|FG001|Overall Study|Met discontinuation criteria|0
893884|NCT00686881|1864604|FG000|Overall Study|Onset of malignant tumor|11
893885|NCT00686881|1864605|FG001|Overall Study|Onset of malignant tumor|11
893886|NCT00686881|1864604|FG000|Overall Study|Lack of Efficacy|4
893887|NCT00686881|1864605|FG001|Overall Study|Lack of Efficacy|3
893888|NCT00686881|1864604|FG000|Overall Study|Physician Decision|1
1099445|NCT02342223|2172793|FG000|Overall Study|Lost to Follow-up|1
1099446|NCT02342288|2172799|FG000|Overall Study|no protocol anesthesiologist available|3
1099447|NCT02342288|2172800|FG001|Overall Study|no protocol anesthesiologist available|2
1099448|NCT02342288|2172799|FG000|Overall Study|anesthesia leak in system|1
1099449|NCT02342288|2172800|FG001|Overall Study|anesthesia leak in system|0
1099450|NCT02342288|2172799|FG000|Overall Study|Withdrawal by Subject|1
1099451|NCT02342288|2172800|FG001|Overall Study|Withdrawal by Subject|0
1099452|NCT02342288|2172799|FG000|Overall Study|coordinator contaminated with blood|0
1099453|NCT02342288|2172800|FG001|Overall Study|coordinator contaminated with blood|1
1099454|NCT02342288|2172799|FG000|Overall Study|subject cannot tolerate numbing drops|0
1099455|NCT02342288|2172800|FG001|Overall Study|subject cannot tolerate numbing drops|1
1099456|NCT02342288|2172799|FG000|Overall Study|coordinator not available|0
1099457|NCT02342288|2172800|FG001|Overall Study|coordinator not available|2
1099458|NCT02342418|2172910|FG000|Overall Study|Adverse Event|0
1099459|NCT02342418|2172911|FG001|Overall Study|Adverse Event|1
1099460|NCT02342548|2172924|FG000|Overall Study|Adverse Event|12
1099461|NCT02342548|2172925|FG001|Overall Study|Adverse Event|17
1099462|NCT02342548|2172926|FG002|Overall Study|Adverse Event|13
1099463|NCT02342548|2172924|FG000|Overall Study|Lost to Follow-up|0
1099464|NCT02342548|2172925|FG001|Overall Study|Lost to Follow-up|1
1099465|NCT02342548|2172926|FG002|Overall Study|Lost to Follow-up|0
1099466|NCT02342548|2172924|FG000|Overall Study|Study terminated by sponsor|20
1099467|NCT02342548|2172925|FG001|Overall Study|Study terminated by sponsor|39
1099468|NCT02342548|2172926|FG002|Overall Study|Study terminated by sponsor|25
1099469|NCT02342548|2172924|FG000|Overall Study|Protocol Violation|0
1099470|NCT02342548|2172925|FG001|Overall Study|Protocol Violation|1
1099471|NCT02342548|2172926|FG002|Overall Study|Protocol Violation|0
1099472|NCT02342548|2172924|FG000|Overall Study|Withdrawal by Subject|1
1099473|NCT02342548|2172925|FG001|Overall Study|Withdrawal by Subject|3
1099474|NCT02342548|2172926|FG002|Overall Study|Withdrawal by Subject|4
1099475|NCT02342548|2172924|FG000|Overall Study|Other|1
1099476|NCT02342548|2172925|FG001|Overall Study|Other|1
1099477|NCT02342548|2172926|FG002|Overall Study|Other|1
1099478|NCT02342639|2172944|FG000|Overall Study|Acute illness, unrelated to study drug|2
1099479|NCT02342639|2172945|FG001|Overall Study|Acute illness, unrelated to study drug|3
1099480|NCT02342639|2172944|FG000|Overall Study|Protocol Violation|0
1099481|NCT02342639|2172945|FG001|Overall Study|Protocol Violation|2
1099482|NCT02342678|2172955|FG000|Overall Study|Lost to Follow-up|0
1099483|NCT02342678|2172956|FG001|Overall Study|Lost to Follow-up|1
1099484|NCT02342678|2172955|FG000|Overall Study|Too busy to complete study|0
1099485|NCT02342678|2172956|FG001|Overall Study|Too busy to complete study|2
1099486|NCT02342678|2172955|FG000|Overall Study|Family illness/emergency|0
1099487|NCT02342678|2172956|FG001|Overall Study|Family illness/emergency|1
1099488|NCT02342678|2172955|FG000|Overall Study|Illness/medical reason|1
1099489|NCT02342678|2172956|FG001|Overall Study|Illness/medical reason|1
1099490|NCT02342704|2172964|FG000|Overall Study|Physician Decision|0
1099491|NCT02342704|2172965|FG001|Overall Study|Physician Decision|3
1099492|NCT02342704|2172964|FG000|Overall Study|Sponsor Termination|49
1099493|NCT02342704|2172965|FG001|Overall Study|Sponsor Termination|43
1099494|NCT02342704|2172964|FG000|Overall Study|Other|0
1099495|NCT02342704|2172965|FG001|Overall Study|Other|1
1099496|NCT02342704|2172964|FG000|Overall Study|Withdrawal by Subject|1
1099497|NCT02342704|2172965|FG001|Overall Study|Withdrawal by Subject|0
1099498|NCT02342704|2172964|FG000|Overall Study|Lost to Follow-up|2
1099499|NCT02342704|2172965|FG001|Overall Study|Lost to Follow-up|1
1099500|NCT02342704|2172964|FG000|Overall Study|Adverse Event|1
1099501|NCT02342704|2172965|FG001|Overall Study|Adverse Event|3
1099502|NCT02342743|2172971|FG000|Baseline Period|Withdrawal by Subject|3
1099503|NCT02342743|2172971|FG000|Baseline Period|Lost to Follow-up|2
1099504|NCT02342743|2172971|FG000|Baseline Period|Change in prophylactic medication|3
1099505|NCT02342743|2172971|FG000|Baseline Period|Screening failure regarding baseline|7
1099506|NCT02342743|2172971|FG000|Treatment Period|Withdrawal by Subject|2
1099507|NCT02342743|2172971|FG000|Treatment Period|Lost to Follow-up|8
1099508|NCT02342743|2172971|FG000|Treatment Period|Change in prophylactic medication|1
1099509|NCT02342886|2172980|FG000|Overall Study|Treatment non-compliance|1
1099510|NCT02342886|2172981|FG001|Overall Study|Treatment non-compliance|0
1099511|NCT02342886|2172982|FG002|Overall Study|Treatment non-compliance|0
1099512|NCT02342886|2172983|FG003|Overall Study|Treatment non-compliance|1
1099513|NCT02342886|2172984|FG004|Overall Study|Treatment non-compliance|0
1099514|NCT02342886|2172980|FG000|Overall Study|Late exclusion: rifampicin resistance|1
1099515|NCT02342886|2172981|FG001|Overall Study|Late exclusion: rifampicin resistance|0
1099516|NCT02342886|2172982|FG002|Overall Study|Late exclusion: rifampicin resistance|0
1099517|NCT02342886|2172983|FG003|Overall Study|Late exclusion: rifampicin resistance|0
1099518|NCT02342886|2172984|FG004|Overall Study|Late exclusion: rifampicin resistance|0
1099519|NCT02342886|2172980|FG000|Overall Study|Adverse event/specific toxicity|4
1099520|NCT02342886|2172981|FG001|Overall Study|Adverse event/specific toxicity|3
893889|NCT00686881|1864605|FG001|Overall Study|Physician Decision|0
893890|NCT00686881|1864604|FG000|Overall Study|Circumstances of site|1
893891|NCT00686881|1864605|FG001|Overall Study|Circumstances of site|1
893892|NCT00686881|1864604|FG000|Overall Study|Did not meet protocol eligibility|1
893893|NCT00686881|1864605|FG001|Overall Study|Did not meet protocol eligibility|0
893894|NCT00686881|1864604|FG000|Overall Study|Irregular visits|1
1099521|NCT02342886|2172982|FG002|Overall Study|Adverse event/specific toxicity|11
1099522|NCT02342886|2172983|FG003|Overall Study|Adverse event/specific toxicity|2
1099523|NCT02342886|2172984|FG004|Overall Study|Adverse event/specific toxicity|1
1099524|NCT02342886|2172980|FG000|Overall Study|Lost to Follow-up|1
1099525|NCT02342886|2172981|FG001|Overall Study|Lost to Follow-up|0
1099526|NCT02342886|2172982|FG002|Overall Study|Lost to Follow-up|0
1099527|NCT02342886|2172983|FG003|Overall Study|Lost to Follow-up|0
1099528|NCT02342886|2172984|FG004|Overall Study|Lost to Follow-up|0
1099529|NCT02342886|2172980|FG000|Overall Study|Death|1
1099530|NCT02342886|2172981|FG001|Overall Study|Death|2
1099531|NCT02342886|2172982|FG002|Overall Study|Death|1
1099532|NCT02342886|2172983|FG003|Overall Study|Death|0
1099533|NCT02342886|2172984|FG004|Overall Study|Death|1
1099534|NCT02342886|2172980|FG000|Overall Study|Withdrawal by Subject|0
1099535|NCT02342886|2172981|FG001|Overall Study|Withdrawal by Subject|1
1099536|NCT02342886|2172982|FG002|Overall Study|Withdrawal by Subject|0
1099537|NCT02342886|2172983|FG003|Overall Study|Withdrawal by Subject|1
1099538|NCT02342886|2172984|FG004|Overall Study|Withdrawal by Subject|0
1099539|NCT02342886|2172980|FG000|Overall Study|Investigator/sponsor decision|0
1099540|NCT02342886|2172981|FG001|Overall Study|Investigator/sponsor decision|2
1099541|NCT02342886|2172982|FG002|Overall Study|Investigator/sponsor decision|0
1099542|NCT02342886|2172983|FG003|Overall Study|Investigator/sponsor decision|3
1099543|NCT02342886|2172984|FG004|Overall Study|Investigator/sponsor decision|1
1099544|NCT02342886|2172980|FG000|Overall Study|Pregnancy|0
1099545|NCT02342886|2172981|FG001|Overall Study|Pregnancy|0
1099546|NCT02342886|2172982|FG002|Overall Study|Pregnancy|2
1099547|NCT02342886|2172983|FG003|Overall Study|Pregnancy|0
1099548|NCT02342886|2172984|FG004|Overall Study|Pregnancy|0
1099549|NCT02342886|2172980|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0
1099550|NCT02342886|2172981|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0
1099551|NCT02342886|2172982|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1
1099552|NCT02342886|2172983|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0
1099553|NCT02342886|2172984|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0
1099554|NCT02342886|2172980|FG000|Overall Study|Protocol Violation|0
1099555|NCT02342886|2172981|FG001|Overall Study|Protocol Violation|0
1099556|NCT02342886|2172982|FG002|Overall Study|Protocol Violation|0
1099557|NCT02342886|2172983|FG003|Overall Study|Protocol Violation|2
1099558|NCT02342886|2172984|FG004|Overall Study|Protocol Violation|0
1099559|NCT02343003|2172998|FG000|Overall Study|Withdrawal by Subject|9
893895|NCT00686881|1864605|FG001|Overall Study|Irregular visits|0
893896|NCT00686881|1864604|FG000|Overall Study|Study discontinuation|35
893897|NCT00686881|1864605|FG001|Overall Study|Study discontinuation|32
893898|NCT00686881|1864604|FG000|Overall Study|Never received study drug|2
893899|NCT00686881|1864605|FG001|Overall Study|Never received study drug|6
893900|NCT00686894|1864613|FG000|Overall Study|Relapse|2
893901|NCT00686894|1864613|FG000|Overall Study|Protocol Violation|4
893902|NCT00686920|1864619|FG000|Overall Study|Death|45
893903|NCT00686920|1864620|FG001|Overall Study|Death|14
893904|NCT00686920|1864619|FG000|Overall Study|Liver Transplant|23
893905|NCT00686920|1864620|FG001|Overall Study|Liver Transplant|8
893906|NCT00686920|1864619|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
893907|NCT00686920|1864620|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
893908|NCT00686920|1864619|FG000|Overall Study|Withdrawal by Subject|23
893909|NCT00686920|1864620|FG001|Overall Study|Withdrawal by Subject|5
893910|NCT00686920|1864619|FG000|Overall Study|Protocol Violation|2
893911|NCT00686920|1864620|FG001|Overall Study|Protocol Violation|1
893912|NCT00686920|1864619|FG000|Overall Study|Adverse Event|10
893913|NCT00686920|1864620|FG001|Overall Study|Adverse Event|2
893914|NCT00686920|1864619|FG000|Overall Study|Personal Reason|0
893915|NCT00686920|1864620|FG001|Overall Study|Personal Reason|1
893916|NCT00686920|1864619|FG000|Overall Study|Lost to Follow-up|15
893917|NCT00686920|1864620|FG001|Overall Study|Lost to Follow-up|3
893918|NCT00686920|1864619|FG000|Overall Study|Moved to Another State|1
893919|NCT00686920|1864620|FG001|Overall Study|Moved to Another State|0
893920|NCT00686920|1864619|FG000|Overall Study|Transferred to Nursing Home|1
893921|NCT00686920|1864620|FG001|Overall Study|Transferred to Nursing Home|0
893922|NCT00686920|1864619|FG000|Overall Study|Noncompliance|9
893923|NCT00686920|1864620|FG001|Overall Study|Noncompliance|0
893924|NCT00686920|1864619|FG000|Overall Study|Principal Investigator Decision|2
893925|NCT00686920|1864620|FG001|Overall Study|Principal Investigator Decision|0
893926|NCT00686959|1864628|FG000|Overall Study|Participants censored (no death events)|124
893927|NCT00686959|1864629|FG001|Overall Study|Participants censored (no death events)|117
893928|NCT00686998|1864638|FG000|Overall Study|Adverse Event|3
893929|NCT00686998|1864639|FG001|Overall Study|Adverse Event|2
893930|NCT00686998|1864640|FG002|Overall Study|Adverse Event|1
893931|NCT00686998|1864638|FG000|Overall Study|Withdrawal by Subject|2
893932|NCT00686998|1864639|FG001|Overall Study|Withdrawal by Subject|1
893933|NCT00686998|1864640|FG002|Overall Study|Withdrawal by Subject|2
893934|NCT00686998|1864638|FG000|Overall Study|Lack of Efficacy|7
893935|NCT00686998|1864639|FG001|Overall Study|Lack of Efficacy|5
893936|NCT00686998|1864640|FG002|Overall Study|Lack of Efficacy|0
1099560|NCT02343003|2172999|FG001|Overall Study|Withdrawal by Subject|4
1099561|NCT02343003|2172998|FG000|Overall Study|Lost to Follow-up|5
1099562|NCT02343003|2172999|FG001|Overall Study|Lost to Follow-up|1
1099563|NCT02343003|2172998|FG000|Overall Study|Protocol Violation|1
1099564|NCT02343003|2172999|FG001|Overall Study|Protocol Violation|0
1099565|NCT02343003|2172998|FG000|Overall Study|Death|0
1099566|NCT02343003|2172999|FG001|Overall Study|Death|1
1099567|NCT02343003|2172998|FG000|Overall Study|exclusion criteria met|1
1099568|NCT02343003|2172999|FG001|Overall Study|exclusion criteria met|1
1099569|NCT02343003|2172998|FG000|Overall Study|terminated by sponsor|2
1099570|NCT02343003|2172999|FG001|Overall Study|terminated by sponsor|0
1099571|NCT02343406|2173047|FG000|Overall Study|Progressive disease|72
1099572|NCT02343406|2173048|FG001|Overall Study|Progressive disease|70
1099573|NCT02343406|2173049|FG002|Overall Study|Progressive disease|43
1099574|NCT02343406|2173050|FG003|Overall Study|Progressive disease|15
1099575|NCT02343406|2173051|FG004|Overall Study|Progressive disease|5
1099576|NCT02343406|2173047|FG000|Overall Study|Adverse Event|6
1099577|NCT02343406|2173048|FG001|Overall Study|Adverse Event|8
1099578|NCT02343406|2173049|FG002|Overall Study|Adverse Event|6
1099579|NCT02343406|2173050|FG003|Overall Study|Adverse Event|3
1099580|NCT02343406|2173051|FG004|Overall Study|Adverse Event|0
1099581|NCT02343406|2173047|FG000|Overall Study|Withdrawal by Subject|6
1099582|NCT02343406|2173048|FG001|Overall Study|Withdrawal by Subject|4
1099583|NCT02343406|2173049|FG002|Overall Study|Withdrawal by Subject|8
1099584|NCT02343406|2173050|FG003|Overall Study|Withdrawal by Subject|3
1099585|NCT02343406|2173051|FG004|Overall Study|Withdrawal by Subject|0
1099586|NCT02343406|2173047|FG000|Overall Study|Death|2
1099587|NCT02343406|2173048|FG001|Overall Study|Death|1
1099588|NCT02343406|2173049|FG002|Overall Study|Death|0
1099589|NCT02343406|2173050|FG003|Overall Study|Death|0
1099590|NCT02343406|2173051|FG004|Overall Study|Death|0
1099591|NCT02343406|2173047|FG000|Overall Study|Start of a new anti-cancer treatment|0
1099592|NCT02343406|2173048|FG001|Overall Study|Start of a new anti-cancer treatment|1
1099593|NCT02343406|2173049|FG002|Overall Study|Start of a new anti-cancer treatment|0
1099594|NCT02343406|2173050|FG003|Overall Study|Start of a new anti-cancer treatment|1
1099595|NCT02343406|2173051|FG004|Overall Study|Start of a new anti-cancer treatment|0
1099596|NCT02343406|2173047|FG000|Overall Study|Other primary malignancy|0
1099597|NCT02343406|2173048|FG001|Overall Study|Other primary malignancy|1
1099598|NCT02343406|2173049|FG002|Overall Study|Other primary malignancy|0
1099599|NCT02343406|2173050|FG003|Overall Study|Other primary malignancy|0
1099600|NCT02343406|2173051|FG004|Overall Study|Other primary malignancy|0
1099601|NCT02343406|2173047|FG000|Overall Study|Other, not specified|2
1099602|NCT02343406|2173048|FG001|Overall Study|Other, not specified|1
1099603|NCT02343406|2173049|FG002|Overall Study|Other, not specified|1
1099604|NCT02343406|2173050|FG003|Overall Study|Other, not specified|4
1099605|NCT02343406|2173051|FG004|Overall Study|Other, not specified|0
1099606|NCT02343458|2173066|FG000|Overall Study|Adverse Event|15
1099607|NCT02343458|2173067|FG001|Overall Study|Adverse Event|14
1099608|NCT02343458|2173068|FG002|Overall Study|Adverse Event|15
1099609|NCT02343458|2173069|FG003|Overall Study|Adverse Event|3
1099610|NCT02343458|2173066|FG000|Overall Study|Lack of Efficacy|3
1099611|NCT02343458|2173067|FG001|Overall Study|Lack of Efficacy|8
1099612|NCT02343458|2173068|FG002|Overall Study|Lack of Efficacy|4
1099613|NCT02343458|2173069|FG003|Overall Study|Lack of Efficacy|8
1099614|NCT02343458|2173066|FG000|Overall Study|Withdrawal by Subject|18
1099615|NCT02343458|2173067|FG001|Overall Study|Withdrawal by Subject|17
1099616|NCT02343458|2173068|FG002|Overall Study|Withdrawal by Subject|23
1099617|NCT02343458|2173069|FG003|Overall Study|Withdrawal by Subject|14
1099618|NCT02343458|2173066|FG000|Overall Study|Physician Decision|1
1099619|NCT02343458|2173067|FG001|Overall Study|Physician Decision|4
1099620|NCT02343458|2173068|FG002|Overall Study|Physician Decision|2
1099621|NCT02343458|2173069|FG003|Overall Study|Physician Decision|2
1099622|NCT02343458|2173066|FG000|Overall Study|Lost to Follow-up|5
1099623|NCT02343458|2173067|FG001|Overall Study|Lost to Follow-up|5
1099624|NCT02343458|2173068|FG002|Overall Study|Lost to Follow-up|3
1099625|NCT02343458|2173069|FG003|Overall Study|Lost to Follow-up|1
893937|NCT00686998|1864638|FG000|Overall Study|Other|0
893938|NCT00686998|1864639|FG001|Overall Study|Other|0
893939|NCT00686998|1864640|FG002|Overall Study|Other|1
893940|NCT00686998|1864638|FG000|Overall Study|Safety Reasons|1
893941|NCT00686998|1864639|FG001|Overall Study|Safety Reasons|0
893942|NCT00686998|1864640|FG002|Overall Study|Safety Reasons|0
893943|NCT00687193|1864679|FG000|Overall Study|Adverse Event|0
893944|NCT00687193|1864680|FG001|Overall Study|Adverse Event|1
893945|NCT00687193|1864681|FG002|Overall Study|Adverse Event|2
893946|NCT00687193|1864682|FG003|Overall Study|Adverse Event|3
893947|NCT00687193|1864683|FG004|Overall Study|Adverse Event|0
893948|NCT00687193|1864684|FG005|Overall Study|Adverse Event|2
893949|NCT00687193|1864679|FG000|Overall Study|Lack of Efficacy|1
893950|NCT00687193|1864680|FG001|Overall Study|Lack of Efficacy|1
893951|NCT00687193|1864681|FG002|Overall Study|Lack of Efficacy|0
893952|NCT00687193|1864682|FG003|Overall Study|Lack of Efficacy|0
893953|NCT00687193|1864683|FG004|Overall Study|Lack of Efficacy|0
893954|NCT00687193|1864684|FG005|Overall Study|Lack of Efficacy|2
893955|NCT00687193|1864679|FG000|Overall Study|Protocol Violation|1
893956|NCT00687193|1864680|FG001|Overall Study|Protocol Violation|2
1099626|NCT02343458|2173066|FG000|Overall Study|Protocol Violation|2
1099627|NCT02343458|2173067|FG001|Overall Study|Protocol Violation|5
1099628|NCT02343458|2173068|FG002|Overall Study|Protocol Violation|2
1099629|NCT02343458|2173069|FG003|Overall Study|Protocol Violation|2
1099630|NCT02343458|2173066|FG000|Overall Study|Protocol Specified Criteria|17
1099631|NCT02343458|2173067|FG001|Overall Study|Protocol Specified Criteria|13
1099632|NCT02343458|2173068|FG002|Overall Study|Protocol Specified Criteria|14
1099633|NCT02343458|2173069|FG003|Overall Study|Protocol Specified Criteria|8
1099634|NCT02343549|2173079|FG000|Overall Study|Death|11
1099635|NCT02343549|2173079|FG000|Overall Study|Withdrawal by Subject|2
1099636|NCT02343939|2173110|FG000|Overall Study|Death|0
1099637|NCT02343939|2173111|FG001|Overall Study|Death|15
1099638|NCT02343939|2173112|FG002|Overall Study|Death|4
1099639|NCT02343939|2173113|FG003|Overall Study|Death|2
1099640|NCT02343939|2173114|FG004|Overall Study|Death|5
1099641|NCT02343939|2173115|FG005|Overall Study|Death|11
1099642|NCT02343939|2173116|FG006|Overall Study|Death|8
1099643|NCT02343939|2173117|FG007|Overall Study|Death|22
1099644|NCT02343939|2173118|FG008|Overall Study|Death|1
1099645|NCT02343939|2173110|FG000|Overall Study|Study terminated by sponsor|0
1099646|NCT02343939|2173111|FG001|Overall Study|Study terminated by sponsor|27
1099647|NCT02343939|2173112|FG002|Overall Study|Study terminated by sponsor|0
1099648|NCT02343939|2173113|FG003|Overall Study|Study terminated by sponsor|1
893957|NCT00687193|1864681|FG002|Overall Study|Protocol Violation|0
893958|NCT00687193|1864682|FG003|Overall Study|Protocol Violation|1
893959|NCT00687193|1864683|FG004|Overall Study|Protocol Violation|2
893960|NCT00687193|1864684|FG005|Overall Study|Protocol Violation|0
893961|NCT00687219|1864701|FG000|Overall Study|Adverse Event|8
893962|NCT00687219|1864701|FG000|Overall Study|Discontinuance criteria met|7
893963|NCT00687219|1864701|FG000|Overall Study|HCV-RNA positive conversion|34
893964|NCT00687219|1864701|FG000|Overall Study|Withdrawal by Subject|1
893965|NCT00687219|1864701|FG000|Overall Study|Lack of Efficacy|1
893966|NCT00687271|1864709|FG000|Overall Study|Adverse Event|1
893967|NCT00687271|1864710|FG001|Overall Study|Adverse Event|3
893968|NCT00687271|1864711|FG002|Overall Study|Adverse Event|1
893969|NCT00687271|1864712|FG003|Overall Study|Adverse Event|0
893970|NCT00687271|1864709|FG000|Overall Study|Lost to Follow-up|0
893971|NCT00687271|1864710|FG001|Overall Study|Lost to Follow-up|1
893972|NCT00687271|1864711|FG002|Overall Study|Lost to Follow-up|0
893973|NCT00687271|1864712|FG003|Overall Study|Lost to Follow-up|0
893974|NCT00687271|1864709|FG000|Overall Study|Protocol Violation|2
893975|NCT00687271|1864710|FG001|Overall Study|Protocol Violation|1
893976|NCT00687271|1864711|FG002|Overall Study|Protocol Violation|1
893977|NCT00687271|1864712|FG003|Overall Study|Protocol Violation|0
893978|NCT00687271|1864709|FG000|Overall Study|Withdrawal by Subject|0
893979|NCT00687271|1864710|FG001|Overall Study|Withdrawal by Subject|1
893980|NCT00687271|1864711|FG002|Overall Study|Withdrawal by Subject|3
893981|NCT00687271|1864712|FG003|Overall Study|Withdrawal by Subject|0
893982|NCT00687297|1864724|FG000|Randomization|Withdrawal by Subject|2
893983|NCT00687297|1864725|FG001|Randomization|Withdrawal by Subject|0
893984|NCT00687297|1864724|FG000|Randomization|Withdrew before treatment, ineligible|1
893985|NCT00687297|1864725|FG001|Randomization|Withdrew before treatment, ineligible|1
893986|NCT00687297|1864724|FG000|Induction|Withdrawal by Subject|4
893987|NCT00687297|1864725|FG001|Induction|Withdrawal by Subject|4
893988|NCT00687297|1864724|FG000|Induction|Adverse Event|16
893989|NCT00687297|1864725|FG001|Induction|Adverse Event|15
893990|NCT00687297|1864724|FG000|Induction|Death|7
893991|NCT00687297|1864725|FG001|Induction|Death|11
893992|NCT00687297|1864724|FG000|Induction|Lack of Efficacy|17
893993|NCT00687297|1864725|FG001|Induction|Lack of Efficacy|21
893994|NCT00687297|1864724|FG000|Induction|Ineligible|0
893995|NCT00687297|1864725|FG001|Induction|Ineligible|1
893996|NCT00687297|1864724|FG000|Induction|Patient Noncompliance|1
893997|NCT00687297|1864725|FG001|Induction|Patient Noncompliance|0
893998|NCT00687297|1864724|FG000|Induction|Physician Decision|0
893999|NCT00687297|1864725|FG001|Induction|Physician Decision|2
894000|NCT00687297|1864724|FG000|Induction|Other|0
894001|NCT00687297|1864725|FG001|Induction|Other|1
894002|NCT00687323|1864733|FG000|Overall Study|Death|25
894003|NCT00687323|1864733|FG000|Overall Study|Withdrawal by Subject|1
894004|NCT00687323|1864733|FG000|Overall Study|Excluded from efficacy evaluations|6
894005|NCT00687323|1864733|FG000|Overall Study|Screen failure|148
894006|NCT00687362|1864737|FG000|Overall Study|Protocol Violation|2
894007|NCT00687362|1864737|FG000|Overall Study|Withdrawal by Subject|1
894008|NCT00687401|1864741|FG000|Overall Study|Protocol Violation|7
894009|NCT00687401|1864741|FG000|Overall Study|Adverse Event|6
894010|NCT00687401|1864741|FG000|Overall Study|Lack of Efficacy|6
894011|NCT00687401|1864741|FG000|Overall Study|Withdrawal by Subject|4
894012|NCT00687401|1864741|FG000|Overall Study|Did not return for visit|3
894013|NCT00687401|1864741|FG000|Overall Study|For reasons different from those above|4
894014|NCT00687440|1864746|FG000|Overall Study|Adverse Event|3
894015|NCT00687440|1864746|FG000|Overall Study|Lost to Follow-up|3
894016|NCT00687440|1864746|FG000|Overall Study|Lack of Efficacy|2
894017|NCT00687440|1864746|FG000|Overall Study|Death|2
894018|NCT00687440|1864746|FG000|Overall Study|Other|1
894019|NCT00687440|1864746|FG000|Overall Study|Missing|1
894020|NCT00687531|1864759|FG000|Overall Study|Did not meet protocol eligibility|104
1099649|NCT02343939|2173114|FG004|Overall Study|Study terminated by sponsor|1
1099650|NCT02343939|2173115|FG005|Overall Study|Study terminated by sponsor|5
1099651|NCT02343939|2173116|FG006|Overall Study|Study terminated by sponsor|3
1099652|NCT02343939|2173117|FG007|Overall Study|Study terminated by sponsor|4
1099653|NCT02343939|2173118|FG008|Overall Study|Study terminated by sponsor|0
1099654|NCT02343939|2173110|FG000|Overall Study|Withdrew consent|3
1099655|NCT02343939|2173111|FG001|Overall Study|Withdrew consent|6
1099656|NCT02343939|2173112|FG002|Overall Study|Withdrew consent|1
1099657|NCT02343939|2173113|FG003|Overall Study|Withdrew consent|2
1099658|NCT02343939|2173114|FG004|Overall Study|Withdrew consent|2
1099659|NCT02343939|2173115|FG005|Overall Study|Withdrew consent|0
1099660|NCT02343939|2173116|FG006|Overall Study|Withdrew consent|0
1099661|NCT02343939|2173117|FG007|Overall Study|Withdrew consent|8
1099662|NCT02343939|2173118|FG008|Overall Study|Withdrew consent|6
1099663|NCT02343939|2173110|FG000|Overall Study|Treatment failure|0
1099664|NCT02343939|2173111|FG001|Overall Study|Treatment failure|0
1099665|NCT02343939|2173112|FG002|Overall Study|Treatment failure|0
1099666|NCT02343939|2173113|FG003|Overall Study|Treatment failure|0
1099667|NCT02343939|2173114|FG004|Overall Study|Treatment failure|0
1099668|NCT02343939|2173115|FG005|Overall Study|Treatment failure|0
1099669|NCT02343939|2173116|FG006|Overall Study|Treatment failure|2
1099670|NCT02343939|2173117|FG007|Overall Study|Treatment failure|1
1099671|NCT02343939|2173118|FG008|Overall Study|Treatment failure|0
1099672|NCT02343939|2173110|FG000|Overall Study|Investigator's discretion|0
1099673|NCT02343939|2173111|FG001|Overall Study|Investigator's discretion|0
1099674|NCT02343939|2173112|FG002|Overall Study|Investigator's discretion|0
1099675|NCT02343939|2173113|FG003|Overall Study|Investigator's discretion|1
1099676|NCT02343939|2173114|FG004|Overall Study|Investigator's discretion|0
1099677|NCT02343939|2173115|FG005|Overall Study|Investigator's discretion|0
1099678|NCT02343939|2173116|FG006|Overall Study|Investigator's discretion|1
1099679|NCT02343939|2173117|FG007|Overall Study|Investigator's discretion|0
1099680|NCT02343939|2173118|FG008|Overall Study|Investigator's discretion|0
1099681|NCT02343939|2173110|FG000|Overall Study|Adverse Event|0
1099682|NCT02343939|2173111|FG001|Overall Study|Adverse Event|0
1099683|NCT02343939|2173112|FG002|Overall Study|Adverse Event|0
1099684|NCT02343939|2173113|FG003|Overall Study|Adverse Event|0
1099685|NCT02343939|2173114|FG004|Overall Study|Adverse Event|0
1099686|NCT02343939|2173115|FG005|Overall Study|Adverse Event|1
1099687|NCT02343939|2173116|FG006|Overall Study|Adverse Event|0
1099688|NCT02343939|2173117|FG007|Overall Study|Adverse Event|0
1099689|NCT02343939|2173118|FG008|Overall Study|Adverse Event|0
1099690|NCT02343939|2173110|FG000|Overall Study|Never Treated With ENTO|0
1099691|NCT02343939|2173111|FG001|Overall Study|Never Treated With ENTO|0
1099692|NCT02343939|2173112|FG002|Overall Study|Never Treated With ENTO|0
1099693|NCT02343939|2173113|FG003|Overall Study|Never Treated With ENTO|0
1099694|NCT02343939|2173114|FG004|Overall Study|Never Treated With ENTO|0
1099695|NCT02343939|2173115|FG005|Overall Study|Never Treated With ENTO|0
1099696|NCT02343939|2173116|FG006|Overall Study|Never Treated With ENTO|1
1099697|NCT02343939|2173117|FG007|Overall Study|Never Treated With ENTO|2
1099698|NCT02343939|2173118|FG008|Overall Study|Never Treated With ENTO|0
1099699|NCT02344004|2173154|FG000|Overall Study|Adverse Event|11
1099700|NCT02344004|2173155|FG001|Overall Study|Adverse Event|1
1099701|NCT02344004|2173154|FG000|Overall Study|Death|9
1099702|NCT02344004|2173155|FG001|Overall Study|Death|7
1099703|NCT02344004|2173154|FG000|Overall Study|Physician Decision|4
1099704|NCT02344004|2173155|FG001|Overall Study|Physician Decision|1
1099705|NCT02344004|2173154|FG000|Overall Study|Withdrawal by Subject|22
1099706|NCT02344004|2173155|FG001|Overall Study|Withdrawal by Subject|5
1099707|NCT02344004|2173154|FG000|Overall Study|Rescue Medication|2
894021|NCT00687531|1864759|FG000|Overall Study|Adverse Event|5
894022|NCT00687531|1864759|FG000|Overall Study|Lost to Follow-up|26
894023|NCT00687609|1864767|FG000|Overall Study|Physician Decision|1
894024|NCT00687609|1864767|FG000|Overall Study|Withdrawal by Subject|2
894025|NCT00687739|1864790|FG000|Overall Study|Lost to Follow-up|2
894026|NCT00687739|1864791|FG001|Overall Study|Lost to Follow-up|2
894027|NCT00687739|1864792|FG002|Overall Study|Lost to Follow-up|1
894028|NCT00687739|1864793|FG003|Overall Study|Lost to Follow-up|2
894029|NCT00687739|1864790|FG000|Overall Study|Adverse Event|0
894030|NCT00687739|1864791|FG001|Overall Study|Adverse Event|1
894031|NCT00687739|1864792|FG002|Overall Study|Adverse Event|1
894032|NCT00687739|1864793|FG003|Overall Study|Adverse Event|0
894033|NCT00687804|1864808|FG000|Core Study|Adverse Event|5
894034|NCT00687804|1864809|FG001|Core Study|Adverse Event|3
894035|NCT00687804|1864810|FG002|Core Study|Adverse Event|3
894036|NCT00687804|1864808|FG000|Core Study|Abnormal laboratory value(s)|1
894037|NCT00687804|1864809|FG001|Core Study|Abnormal laboratory value(s)|0
894038|NCT00687804|1864810|FG002|Core Study|Abnormal laboratory value(s)|0
894039|NCT00687804|1864808|FG000|Core Study|Lack of Efficacy|1
894040|NCT00687804|1864809|FG001|Core Study|Lack of Efficacy|1
894041|NCT00687804|1864810|FG002|Core Study|Lack of Efficacy|1
894042|NCT00687804|1864808|FG000|Core Study|Withdrawal by Subject|4
894043|NCT00687804|1864809|FG001|Core Study|Withdrawal by Subject|7
894044|NCT00687804|1864810|FG002|Core Study|Withdrawal by Subject|7
894045|NCT00687804|1864808|FG000|Core Study|Lost to Follow-up|0
894046|NCT00687804|1864809|FG001|Core Study|Lost to Follow-up|1
894047|NCT00687804|1864810|FG002|Core Study|Lost to Follow-up|0
1099708|NCT02344004|2173155|FG001|Overall Study|Rescue Medication|0
1099709|NCT02344004|2173154|FG000|Overall Study|Other Not Specified|12
1099710|NCT02344004|2173155|FG001|Overall Study|Other Not Specified|0
1099711|NCT02344004|2173154|FG000|Overall Study|Protocol Violation|1
1099712|NCT02344004|2173155|FG001|Overall Study|Protocol Violation|0
1099713|NCT02344173|2173162|FG000|Procedure|Ablation Procedure Not Performed|7
1099714|NCT02344173|2173162|FG000|12-month Visit|Death|8
1099715|NCT02344173|2173162|FG000|12-month Visit|Withdrawal by Subject|30
1099716|NCT02344173|2173162|FG000|12-month Visit|Lost to Follow-up|58
1099717|NCT02344342|2173222|FG000|Overall Study|Industry partner dropped out|11
1099718|NCT02344342|2173223|FG001|Overall Study|Industry partner dropped out|9
1099719|NCT02344342|2173224|FG002|Overall Study|Industry partner dropped out|14
1099720|NCT02344342|2173225|FG003|Overall Study|Industry partner dropped out|10
1099721|NCT02344576|2173256|FG000|Enrollment|Agreed to Medical Record Review Only|7
1099722|NCT02344576|2173257|FG001|Enrollment|Agreed to Medical Record Review Only|8
1099723|NCT02344576|2173258|FG002|Enrollment|Agreed to Medical Record Review Only|0
1099724|NCT02344576|2173259|FG003|Enrollment|Agreed to Medical Record Review Only|0
1099725|NCT02344576|2173256|FG000|1-Month Follow-Up|Death|13
1099726|NCT02344576|2173257|FG001|1-Month Follow-Up|Death|8
1099727|NCT02344576|2173258|FG002|1-Month Follow-Up|Death|0
1099728|NCT02344576|2173259|FG003|1-Month Follow-Up|Death|0
1099729|NCT02344576|2173256|FG000|1-Month Follow-Up|Withdrawal by Subject|3
1099730|NCT02344576|2173257|FG001|1-Month Follow-Up|Withdrawal by Subject|14
1099731|NCT02344576|2173258|FG002|1-Month Follow-Up|Withdrawal by Subject|8
1099732|NCT02344576|2173259|FG003|1-Month Follow-Up|Withdrawal by Subject|10
1099733|NCT02344576|2173256|FG000|1-Month Follow-Up|Lost to Follow-up|2
1099734|NCT02344576|2173257|FG001|1-Month Follow-Up|Lost to Follow-up|5
1099735|NCT02344576|2173258|FG002|1-Month Follow-Up|Lost to Follow-up|11
1099736|NCT02344576|2173259|FG003|1-Month Follow-Up|Lost to Follow-up|3
1099737|NCT02344576|2173256|FG000|6-Month Follow-Up|Death|14
1099738|NCT02344576|2173257|FG001|6-Month Follow-Up|Death|14
1099739|NCT02344576|2173258|FG002|6-Month Follow-Up|Death|0
1099740|NCT02344576|2173259|FG003|6-Month Follow-Up|Death|0
1099741|NCT02344576|2173256|FG000|6-Month Follow-Up|Withdrawal by Subject|1
1099742|NCT02344576|2173257|FG001|6-Month Follow-Up|Withdrawal by Subject|0
894048|NCT00687804|1864808|FG000|Core Study|Death|2
894049|NCT00687804|1864809|FG001|Core Study|Death|2
894050|NCT00687804|1864810|FG002|Core Study|Death|2
894051|NCT00687804|1864808|FG000|Core Study|Protocol Violation|1
894052|NCT00687804|1864809|FG001|Core Study|Protocol Violation|1
894053|NCT00687804|1864810|FG002|Core Study|Protocol Violation|0
894054|NCT00687804|1864808|FG000|Open-Label Extension Study|Adverse Event|2
894055|NCT00687804|1864809|FG001|Open-Label Extension Study|Adverse Event|2
894056|NCT00687804|1864810|FG002|Open-Label Extension Study|Adverse Event|2
894057|NCT00687804|1864808|FG000|Open-Label Extension Study|Subject withdrew consent|3
894058|NCT00687804|1864809|FG001|Open-Label Extension Study|Subject withdrew consent|4
894059|NCT00687804|1864810|FG002|Open-Label Extension Study|Subject withdrew consent|4
894060|NCT00687804|1864808|FG000|Open-Label Extension Study|Lost to Follow-up|2
894061|NCT00687804|1864809|FG001|Open-Label Extension Study|Lost to Follow-up|1
894062|NCT00687804|1864810|FG002|Open-Label Extension Study|Lost to Follow-up|2
894063|NCT00687804|1864808|FG000|Open-Label Extension Study|Administrative problems|1
894064|NCT00687804|1864809|FG001|Open-Label Extension Study|Administrative problems|1
894065|NCT00687804|1864810|FG002|Open-Label Extension Study|Administrative problems|0
894066|NCT00687804|1864808|FG000|Open-Label Extension Study|Death|2
894067|NCT00687804|1864809|FG001|Open-Label Extension Study|Death|3
894068|NCT00687804|1864810|FG002|Open-Label Extension Study|Death|3
894069|NCT00687973|1864848|FG000|Overall Study|Adverse Event|18
894070|NCT00687973|1864849|FG001|Overall Study|Adverse Event|28
894071|NCT00687973|1864848|FG000|Overall Study|Lack of Efficacy|2
894072|NCT00687973|1864849|FG001|Overall Study|Lack of Efficacy|3
894073|NCT00687973|1864848|FG000|Overall Study|Protocol Violation|1
894074|NCT00687973|1864849|FG001|Overall Study|Protocol Violation|2
894075|NCT00687973|1864848|FG000|Overall Study|Administrative Reasons|0
894076|NCT00687973|1864849|FG001|Overall Study|Administrative Reasons|2
894077|NCT00687973|1864848|FG000|Overall Study|Withdrawal by Subject|3
894078|NCT00687973|1864849|FG001|Overall Study|Withdrawal by Subject|3
894079|NCT00688064|1864858|FG000|Overall Study|Protocol Violation|0
894080|NCT00688064|1864859|FG001|Overall Study|Protocol Violation|1
894081|NCT00688064|1864858|FG000|Overall Study|Adverse Event|2
894082|NCT00688064|1864859|FG001|Overall Study|Adverse Event|4
894083|NCT00688064|1864858|FG000|Overall Study|Withdrawal by Subject|7
894084|NCT00688064|1864859|FG001|Overall Study|Withdrawal by Subject|7
894085|NCT00688064|1864858|FG000|Overall Study|Lost to Follow-up|10
894086|NCT00688064|1864859|FG001|Overall Study|Lost to Follow-up|10
894087|NCT00688064|1864858|FG000|Overall Study|Lack of Efficacy|0
894088|NCT00688064|1864859|FG001|Overall Study|Lack of Efficacy|1
894089|NCT00688064|1864858|FG000|Overall Study|Pregnancy|1
894090|NCT00688064|1864859|FG001|Overall Study|Pregnancy|0
894091|NCT00688064|1864858|FG000|Overall Study|Any other reasons|1
894092|NCT00688064|1864859|FG001|Overall Study|Any other reasons|3
894093|NCT00688103|1864867|FG000|Overall Study|Adverse Event|4
894094|NCT00688103|1864868|FG001|Overall Study|Adverse Event|1
894095|NCT00688103|1864867|FG000|Overall Study|Lack of Efficacy|11
894096|NCT00688103|1864868|FG001|Overall Study|Lack of Efficacy|1
1099743|NCT02344576|2173258|FG002|6-Month Follow-Up|Withdrawal by Subject|1
1099744|NCT02344576|2173259|FG003|6-Month Follow-Up|Withdrawal by Subject|2
1099745|NCT02344576|2173256|FG000|6-Month Follow-Up|Lost to Follow-up|4
1099746|NCT02344576|2173257|FG001|6-Month Follow-Up|Lost to Follow-up|5
1099747|NCT02344576|2173258|FG002|6-Month Follow-Up|Lost to Follow-up|13
1099748|NCT02344576|2173259|FG003|6-Month Follow-Up|Lost to Follow-up|6
1099749|NCT02344745|2173282|FG000|Overall Study|Data collection sheets were lost|2
1099750|NCT02344745|2173283|FG001|Overall Study|Data collection sheets were lost|0
1099751|NCT02345070|2173303|FG000|Overall Study|Adverse Event|12
1099752|NCT02345070|2173304|FG001|Overall Study|Adverse Event|8
1099753|NCT02345070|2173305|FG002|Overall Study|Adverse Event|16
1099754|NCT02345070|2173303|FG000|Overall Study|Poor compliance to protocol|2
1099755|NCT02345070|2173304|FG001|Overall Study|Poor compliance to protocol|0
1099756|NCT02345070|2173305|FG002|Overall Study|Poor compliance to protocol|0
1099757|NCT02345070|2173303|FG000|Overall Study|Other than specified above|6
1099758|NCT02345070|2173304|FG001|Overall Study|Other than specified above|3
1099759|NCT02345070|2173305|FG002|Overall Study|Other than specified above|7
1099760|NCT02345161|2173315|FG000|Overall Study|Withdrawal by Subject|25
1099761|NCT02345161|2173316|FG001|Overall Study|Withdrawal by Subject|33
1099762|NCT02345161|2173315|FG000|Overall Study|Adverse Event|16
1099763|NCT02345161|2173316|FG001|Overall Study|Adverse Event|19
1099764|NCT02345161|2173315|FG000|Overall Study|Physician Decision|4
1099765|NCT02345161|2173316|FG001|Overall Study|Physician Decision|4
1099766|NCT02345161|2173315|FG000|Overall Study|Lost to Follow-up|0
1099767|NCT02345161|2173316|FG001|Overall Study|Lost to Follow-up|1
1099768|NCT02345226|2173329|FG000|Double-Blind Phase|Adverse Event|5
1099769|NCT02345226|2173330|FG001|Double-Blind Phase|Adverse Event|6
1099770|NCT02345226|2173329|FG000|Double-Blind Phase|Death|3
1099771|NCT02345226|2173330|FG001|Double-Blind Phase|Death|0
1099772|NCT02345226|2173329|FG000|Double-Blind Phase|Pregnancy|0
1099773|NCT02345226|2173330|FG001|Double-Blind Phase|Pregnancy|1
1099774|NCT02345226|2173329|FG000|Double-Blind Phase|Lack of Efficacy|1
1099775|NCT02345226|2173330|FG001|Double-Blind Phase|Lack of Efficacy|0
1099776|NCT02345226|2173329|FG000|Double-Blind Phase|Investigator's Discretion|4
1099777|NCT02345226|2173330|FG001|Double-Blind Phase|Investigator's Discretion|3
1099778|NCT02345226|2173329|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
1099779|NCT02345226|2173330|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
1099780|NCT02345226|2173329|FG000|Double-Blind Phase|Withdrew Consent|41
1099781|NCT02345226|2173330|FG001|Double-Blind Phase|Withdrew Consent|39
1099782|NCT02345226|2173329|FG000|Double-Blind Phase|Lost to Follow-up|12
1099783|NCT02345226|2173330|FG001|Double-Blind Phase|Lost to Follow-up|16
1099784|NCT02345226|2173329|FG000|Double-Blind Phase|Randomized but Never Treated|2
894097|NCT00688103|1864867|FG000|Overall Study|Withdrawal by Subject|4
894098|NCT00688103|1864868|FG001|Overall Study|Withdrawal by Subject|2
894099|NCT00688103|1864867|FG000|Overall Study|complex reasons|11
894100|NCT00688103|1864868|FG001|Overall Study|complex reasons|9
894101|NCT00688155|1864880|FG000|Overall Study|Withdrawal by Subject|2
894102|NCT00688155|1864881|FG001|Overall Study|Withdrawal by Subject|2
894103|NCT00688155|1864882|FG002|Overall Study|Withdrawal by Subject|1
894104|NCT00688155|1864883|FG003|Overall Study|Withdrawal by Subject|1
894105|NCT00688181|1864893|FG000|Overall Study|Lost to Follow-up|17
894106|NCT00688181|1864893|FG000|Overall Study|Unknown Reason|4
894107|NCT00688181|1864893|FG000|Overall Study|Non-clinical Reason|2
894108|NCT00688259|1864901|FG000|Overall Study|Lost to Follow-up|2
894109|NCT00688259|1864902|FG001|Overall Study|Lost to Follow-up|4
894110|NCT00688259|1864901|FG000|Overall Study|Physician Decision|1
894111|NCT00688259|1864902|FG001|Overall Study|Physician Decision|0
894112|NCT00688259|1864901|FG000|Overall Study|Withdrawal by Subject|2
894113|NCT00688259|1864902|FG001|Overall Study|Withdrawal by Subject|0
894114|NCT00688259|1864901|FG000|Overall Study|Declined Interview|2
894115|NCT00688259|1864902|FG001|Overall Study|Declined Interview|3
894116|NCT00688259|1864901|FG000|Overall Study|Hospitalized at Follow-up|0
894117|NCT00688259|1864902|FG001|Overall Study|Hospitalized at Follow-up|1
894118|NCT00688324|1864908|FG000|Overall Study|Withdrawal by Subject|2
894119|NCT00688324|1864908|FG000|Overall Study|Physician Decision|5
894120|NCT00688324|1864908|FG000|Overall Study|Lost to Follow-up|1
894137|NCT00688467|1864926|FG000|Treatment Period 1|Adverse Event|2
1099785|NCT02345226|2173330|FG001|Double-Blind Phase|Randomized but Never Treated|4
1099786|NCT02345226|2173329|FG000|Open-Label Extension Phase|Lost to Follow-up|0
1099787|NCT02345226|2173330|FG001|Open-Label Extension Phase|Lost to Follow-up|1
1099788|NCT02345252|2173340|FG000|Double-Blind Phase|Adverse Event|2
1099789|NCT02345252|2173341|FG001|Double-Blind Phase|Adverse Event|3
1099790|NCT02345252|2173340|FG000|Double-Blind Phase|Death|1
1099791|NCT02345252|2173341|FG001|Double-Blind Phase|Death|2
1099792|NCT02345252|2173340|FG000|Double-Blind Phase|Lack of Efficacy|1
1099793|NCT02345252|2173341|FG001|Double-Blind Phase|Lack of Efficacy|0
1099794|NCT02345252|2173340|FG000|Double-Blind Phase|Investigator's Discretion|4
1099795|NCT02345252|2173341|FG001|Double-Blind Phase|Investigator's Discretion|6
1099796|NCT02345252|2173340|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
1099797|NCT02345252|2173341|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
1099798|NCT02345252|2173340|FG000|Double-Blind Phase|Protocol Violation|2
1099799|NCT02345252|2173341|FG001|Double-Blind Phase|Protocol Violation|1
1099800|NCT02345252|2173340|FG000|Double-Blind Phase|Withdrew Consent|21
1099801|NCT02345252|2173341|FG001|Double-Blind Phase|Withdrew Consent|23
1099802|NCT02345252|2173340|FG000|Double-Blind Phase|Lost to Follow-up|8
1099803|NCT02345252|2173341|FG001|Double-Blind Phase|Lost to Follow-up|10
1099804|NCT02345252|2173340|FG000|Double-Blind Phase|Randomized but Never Treated|0
894138|NCT00688467|1864927|FG001|Treatment Period 1|Adverse Event|1
894139|NCT00688467|1864926|FG000|Treatment Period 1|Did not meet protocol eligibility|0
894140|NCT00688467|1864927|FG001|Treatment Period 1|Did not meet protocol eligibility|1
894141|NCT00688467|1864926|FG000|Treatment Period 2|Protocol Violation|0
894142|NCT00688467|1864927|FG001|Treatment Period 2|Protocol Violation|1
894143|NCT00688467|1864926|FG000|Treatment Period 2|Adverse Event|0
894144|NCT00688467|1864927|FG001|Treatment Period 2|Adverse Event|1
894145|NCT00688519|1864935|FG000|Overall Study|Adverse Event|2
894146|NCT00688519|1864936|FG001|Overall Study|Adverse Event|3
894147|NCT00688519|1864935|FG000|Overall Study|Lost to Follow-up|3
1099805|NCT02345252|2173341|FG001|Double-Blind Phase|Randomized but Never Treated|2
1099806|NCT02345330|2173349|FG000|Overall Study|Death|1
1099807|NCT02345330|2173349|FG000|Overall Study|Progressive Disease|2
894148|NCT00688519|1864936|FG001|Overall Study|Lost to Follow-up|3
894149|NCT00688519|1864935|FG000|Overall Study|Lack of Efficacy|3
894150|NCT00688519|1864936|FG001|Overall Study|Lack of Efficacy|1
894151|NCT00688519|1864935|FG000|Overall Study|Withdrawal by Subject|7
894152|NCT00688519|1864936|FG001|Overall Study|Withdrawal by Subject|6
894153|NCT00688519|1864935|FG000|Overall Study|Prohibited medication|1
894154|NCT00688519|1864936|FG001|Overall Study|Prohibited medication|0
894155|NCT00688519|1864935|FG000|Overall Study|Non-compliance|0
894156|NCT00688519|1864936|FG001|Overall Study|Non-compliance|1
894157|NCT00688519|1864935|FG000|Overall Study|Subject moved out of state|1
894158|NCT00688519|1864936|FG001|Overall Study|Subject moved out of state|0
894159|NCT00688519|1864935|FG000|Overall Study|Investigator decision|1
894160|NCT00688519|1864936|FG001|Overall Study|Investigator decision|0
894161|NCT00688519|1864935|FG000|Overall Study|Subject moved out of area|1
894162|NCT00688519|1864936|FG001|Overall Study|Subject moved out of area|0
894163|NCT00688519|1864935|FG000|Overall Study|Pregnancy|0
894164|NCT00688519|1864936|FG001|Overall Study|Pregnancy|1
894165|NCT00688545|1864944|FG000|Overall Study|Lost to Follow-up|1
894166|NCT00688545|1864945|FG001|Overall Study|Lost to Follow-up|4
894167|NCT00688545|1864944|FG000|Overall Study|Insurance/cost of drug|0
894168|NCT00688545|1864945|FG001|Overall Study|Insurance/cost of drug|1
894169|NCT00688545|1864944|FG000|Overall Study|Withdrawal by Subject|2
894170|NCT00688545|1864945|FG001|Overall Study|Withdrawal by Subject|3
894171|NCT00688545|1864944|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2
894172|NCT00688545|1864945|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7
894173|NCT00688597|1864956|FG000|Overall Study|Adverse Event|2
894174|NCT00688597|1864957|FG001|Overall Study|Adverse Event|0
894175|NCT00688597|1864958|FG002|Overall Study|Adverse Event|0
894176|NCT00688597|1864956|FG000|Overall Study|Physician Decision|1
894177|NCT00688597|1864957|FG001|Overall Study|Physician Decision|0
894178|NCT00688597|1864958|FG002|Overall Study|Physician Decision|0
894179|NCT00688623|1864966|FG000|Overall Study|Adverse Event|22
894180|NCT00688623|1864966|FG000|Overall Study|abnormal lab value|1
894181|NCT00688623|1864966|FG000|Overall Study|Withdrawal by Subject|4
894182|NCT00688623|1864966|FG000|Overall Study|Death|3
894183|NCT00688623|1864966|FG000|Overall Study|disease progression|23
894184|NCT00688623|1864966|FG000|Overall Study|Protocol Violation|2
894185|NCT00688636|1864972|FG000|Overall Study|Adverse Event|2
894186|NCT00688636|1864973|FG001|Overall Study|Adverse Event|1
894187|NCT00688688|1864992|FG000|Overall Study|Eligibility criterion not met|7
894188|NCT00688688|1864993|FG001|Overall Study|Eligibility criterion not met|7
894189|NCT00688688|1864994|FG002|Overall Study|Eligibility criterion not met|10
894190|NCT00688688|1864992|FG000|Overall Study|Adverse Event|52
894191|NCT00688688|1864993|FG001|Overall Study|Adverse Event|51
894192|NCT00688688|1864994|FG002|Overall Study|Adverse Event|50
894193|NCT00688688|1864992|FG000|Overall Study|Lack of Efficacy|34
894194|NCT00688688|1864993|FG001|Overall Study|Lack of Efficacy|25
894195|NCT00688688|1864994|FG002|Overall Study|Lack of Efficacy|45
894196|NCT00688688|1864992|FG000|Overall Study|Withdrawal by Subject|66
894197|NCT00688688|1864993|FG001|Overall Study|Withdrawal by Subject|75
1099808|NCT02345434|2173355|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5
1099809|NCT02345434|2173356|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2
1099810|NCT02345512|2173371|FG000|Overall Study|Adverse Event|1
1099811|NCT02345512|2173371|FG000|Overall Study|Withdrawal by Subject|1
1099812|NCT02345811|2173393|FG000|First Intervention|Withdrawal by Subject|1
1099813|NCT02345811|2173394|FG001|First Intervention|Withdrawal by Subject|1
1099814|NCT02345889|2173406|FG000|Overall Study|Inadequate Bowel Prep|17
1099815|NCT02345889|2173407|FG001|Overall Study|Inadequate Bowel Prep|16
1099816|NCT02345889|2173408|FG002|Overall Study|Inadequate Bowel Prep|18
1099817|NCT02345889|2173409|FG003|Overall Study|Inadequate Bowel Prep|14
1099818|NCT02345889|2173406|FG000|Overall Study|Polyposis identified during procedure|1
1099819|NCT02345889|2173407|FG001|Overall Study|Polyposis identified during procedure|1
1099820|NCT02345889|2173408|FG002|Overall Study|Polyposis identified during procedure|0
1099821|NCT02345889|2173409|FG003|Overall Study|Polyposis identified during procedure|1
1099822|NCT02345889|2173406|FG000|Overall Study|Recognized ineligible post-randomization|1
1099823|NCT02345889|2173407|FG001|Overall Study|Recognized ineligible post-randomization|0
1099824|NCT02345889|2173408|FG002|Overall Study|Recognized ineligible post-randomization|2
1099825|NCT02345889|2173409|FG003|Overall Study|Recognized ineligible post-randomization|1
1099826|NCT02345889|2173406|FG000|Overall Study|Ulcerative Colitis identified|1
1099827|NCT02345889|2173407|FG001|Overall Study|Ulcerative Colitis identified|0
1099828|NCT02345889|2173408|FG002|Overall Study|Ulcerative Colitis identified|0
1099829|NCT02345889|2173409|FG003|Overall Study|Ulcerative Colitis identified|0
1099830|NCT02345889|2173406|FG000|Overall Study|Cecum not intubated|1
1099831|NCT02345889|2173407|FG001|Overall Study|Cecum not intubated|0
1099832|NCT02345889|2173408|FG002|Overall Study|Cecum not intubated|0
1099833|NCT02345889|2173409|FG003|Overall Study|Cecum not intubated|0
1099834|NCT02346136|2173421|FG000|Overall Study|Withdrawal by Subject|7
1099835|NCT02346136|2173422|FG001|Overall Study|Withdrawal by Subject|5
1099836|NCT02346136|2173421|FG000|Overall Study|Death|1
1099837|NCT02346136|2173422|FG001|Overall Study|Death|0
1099838|NCT02346136|2173421|FG000|Overall Study|Study termination|14
1099839|NCT02346136|2173422|FG001|Overall Study|Study termination|18
1099840|NCT02346240|2173432|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0
894198|NCT00688688|1864994|FG002|Overall Study|Withdrawal by Subject|65
894199|NCT00688688|1864992|FG000|Overall Study|Lost to Follow-up|14
894200|NCT00688688|1864993|FG001|Overall Study|Lost to Follow-up|7
894201|NCT00688688|1864994|FG002|Overall Study|Lost to Follow-up|7
894202|NCT00688688|1864992|FG000|Overall Study|Protocol Violation|6
894203|NCT00688688|1864993|FG001|Overall Study|Protocol Violation|9
894204|NCT00688688|1864994|FG002|Overall Study|Protocol Violation|11
894205|NCT00688688|1864992|FG000|Overall Study|Randomized but never received study drug|1
894206|NCT00688688|1864993|FG001|Overall Study|Randomized but never received study drug|0
894207|NCT00688688|1864994|FG002|Overall Study|Randomized but never received study drug|0
894208|NCT00688688|1864992|FG000|Overall Study|Non-compliance with study procedures|5
894209|NCT00688688|1864993|FG001|Overall Study|Non-compliance with study procedures|3
894210|NCT00688688|1864994|FG002|Overall Study|Non-compliance with study procedures|4
894211|NCT00688688|1864992|FG000|Overall Study|Taking exclusionary medications|1
894212|NCT00688688|1864993|FG001|Overall Study|Taking exclusionary medications|0
894213|NCT00688688|1864994|FG002|Overall Study|Taking exclusionary medications|0
894214|NCT00688688|1864992|FG000|Overall Study|Site closure|0
894215|NCT00688688|1864993|FG001|Overall Study|Site closure|1
894216|NCT00688688|1864994|FG002|Overall Study|Site closure|0
894217|NCT00688688|1864992|FG000|Overall Study|Violation of exclusion criterion|0
894218|NCT00688688|1864993|FG001|Overall Study|Violation of exclusion criterion|1
894219|NCT00688688|1864994|FG002|Overall Study|Violation of exclusion criterion|0
894220|NCT00688701|1865005|FG000|Overall Study|Adverse Event|1
894221|NCT00688701|1865006|FG001|Overall Study|Adverse Event|0
894222|NCT00688701|1865007|FG002|Overall Study|Adverse Event|5
894223|NCT00688701|1865008|FG003|Overall Study|Adverse Event|3
894224|NCT00688701|1865005|FG000|Overall Study|Lack of Efficacy|0
894225|NCT00688701|1865006|FG001|Overall Study|Lack of Efficacy|1
894226|NCT00688701|1865007|FG002|Overall Study|Lack of Efficacy|0
894227|NCT00688701|1865008|FG003|Overall Study|Lack of Efficacy|0
894228|NCT00688701|1865005|FG000|Overall Study|Withdrawal by Subject|3
894229|NCT00688701|1865006|FG001|Overall Study|Withdrawal by Subject|3
894230|NCT00688701|1865007|FG002|Overall Study|Withdrawal by Subject|4
894231|NCT00688701|1865008|FG003|Overall Study|Withdrawal by Subject|8
894232|NCT00688701|1865005|FG000|Overall Study|Poor compliance to protocol|0
894233|NCT00688701|1865006|FG001|Overall Study|Poor compliance to protocol|1
894234|NCT00688701|1865007|FG002|Overall Study|Poor compliance to protocol|1
894235|NCT00688701|1865008|FG003|Overall Study|Poor compliance to protocol|0
894236|NCT00688740|1865021|FG000|Overall Study|Adverse Event|45
894237|NCT00688740|1865022|FG001|Overall Study|Adverse Event|8
894238|NCT00688740|1865021|FG000|Overall Study|Death|2
894239|NCT00688740|1865022|FG001|Overall Study|Death|2
894240|NCT00688740|1865021|FG000|Overall Study|Lost to Follow-up|0
894241|NCT00688740|1865022|FG001|Overall Study|Lost to Follow-up|1
894242|NCT00688740|1865021|FG000|Overall Study|Consent Withdrawn|17
894243|NCT00688740|1865022|FG001|Overall Study|Consent Withdrawn|17
894244|NCT00688740|1865021|FG000|Overall Study|Breast Cancer Relapse|1
1099841|NCT02346240|2173433|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4
1099842|NCT02346240|2173434|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1
1099843|NCT02346240|2173435|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1
1099844|NCT02346240|2173436|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0
1099845|NCT02346240|2173437|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0
1099846|NCT02346240|2173438|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0
1099847|NCT02346240|2173439|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0
1099848|NCT02346240|2173440|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0
1099849|NCT02346240|2173441|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0
1099850|NCT02346240|2173442|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0
1099851|NCT02346240|2173443|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0
1099852|NCT02346240|2173444|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0
1099853|NCT02346240|2173445|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0
1099854|NCT02346240|2173446|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0
1099855|NCT02346240|2173447|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0
1099856|NCT02346240|2173448|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0
1099857|NCT02346240|2173449|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0
1099858|NCT02346240|2173450|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0
1099859|NCT02346240|2173451|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0
1099860|NCT02346240|2173452|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0
1099861|NCT02346240|2173453|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0
1099862|NCT02346240|2173454|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0
1099863|NCT02346240|2173455|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0
1099864|NCT02346240|2173432|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099865|NCT02346240|2173433|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
894245|NCT00688740|1865022|FG001|Overall Study|Breast Cancer Relapse|4
894246|NCT00688740|1865021|FG000|Overall Study|Violation of Inclusion Criteria|1
894247|NCT00688740|1865022|FG001|Overall Study|Violation of Inclusion Criteria|3
894248|NCT00688753|1865028|FG000|Overall Study|Disease progression|55
894249|NCT00688753|1865028|FG000|Overall Study|Missing|1
894250|NCT00688753|1865028|FG000|Overall Study|Death|9
894251|NCT00688753|1865028|FG000|Overall Study|Withdrawal by Subject|3
894252|NCT00688753|1865028|FG000|Overall Study|Adverse Event|20
1099866|NCT02346240|2173434|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099867|NCT02346240|2173435|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099868|NCT02346240|2173436|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099869|NCT02346240|2173437|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099870|NCT02346240|2173438|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099871|NCT02346240|2173439|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099872|NCT02346240|2173440|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099873|NCT02346240|2173441|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099874|NCT02346240|2173442|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099875|NCT02346240|2173443|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099876|NCT02346240|2173444|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099877|NCT02346240|2173445|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099878|NCT02346240|2173446|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099879|NCT02346240|2173447|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099880|NCT02346240|2173448|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099881|NCT02346240|2173449|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099882|NCT02346240|2173450|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099883|NCT02346240|2173451|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099884|NCT02346240|2173452|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099885|NCT02346240|2173453|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099886|NCT02346240|2173454|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099887|NCT02346240|2173455|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1099888|NCT02346240|2173432|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0
894253|NCT00688753|1865028|FG000|Overall Study|Protocol Violation|1
894254|NCT00688753|1865028|FG000|Overall Study|Lost to Follow-up|3
894255|NCT00688844|1865032|FG000|Overall Study|Lost to Follow-up|10
894256|NCT00688870|1865038|FG000|Infant Series|Parent or legal guardian request|4
894257|NCT00688870|1865039|FG001|Infant Series|Parent or legal guardian request|0
894258|NCT00688909|1865049|FG000|Overall Study|Adverse Event|28
894259|NCT00688909|1865049|FG000|Overall Study|Patient withdrew consent|2
894260|NCT00688909|1865049|FG000|Overall Study|Administrative problems|1
894261|NCT00688909|1865049|FG000|Overall Study|Protocol Violation|2
894262|NCT00689026|1865056|FG000|Overall Study|Withdrawal by Subject|13
894263|NCT00689026|1865057|FG001|Overall Study|Withdrawal by Subject|6
894264|NCT00689104|1865097|FG000|Overall Study|Eligibility criterion not met|5
894265|NCT00689104|1865098|FG001|Overall Study|Eligibility criterion not met|8
894266|NCT00689104|1865099|FG002|Overall Study|Eligibility criterion not met|0
894267|NCT00689104|1865100|FG003|Overall Study|Eligibility criterion not met|4
894268|NCT00689104|1865097|FG000|Overall Study|Adverse Event|13
894269|NCT00689104|1865098|FG001|Overall Study|Adverse Event|25
894270|NCT00689104|1865099|FG002|Overall Study|Adverse Event|16
894271|NCT00689104|1865100|FG003|Overall Study|Adverse Event|24
894272|NCT00689104|1865097|FG000|Overall Study|Lack of Efficacy|5
894273|NCT00689104|1865098|FG001|Overall Study|Lack of Efficacy|6
894274|NCT00689104|1865099|FG002|Overall Study|Lack of Efficacy|2
894275|NCT00689104|1865100|FG003|Overall Study|Lack of Efficacy|3
1099889|NCT02346240|2173433|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1
1099890|NCT02346240|2173434|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099891|NCT02346240|2173435|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099892|NCT02346240|2173436|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099893|NCT02346240|2173437|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0
894276|NCT00689104|1865097|FG000|Overall Study|Withdrawal by Subject|12
894277|NCT00689104|1865098|FG001|Overall Study|Withdrawal by Subject|11
894278|NCT00689104|1865099|FG002|Overall Study|Withdrawal by Subject|18
894279|NCT00689104|1865100|FG003|Overall Study|Withdrawal by Subject|11
894280|NCT00689104|1865097|FG000|Overall Study|Lost to Follow-up|4
894281|NCT00689104|1865098|FG001|Overall Study|Lost to Follow-up|3
894282|NCT00689104|1865099|FG002|Overall Study|Lost to Follow-up|2
894283|NCT00689104|1865100|FG003|Overall Study|Lost to Follow-up|5
894284|NCT00689104|1865097|FG000|Overall Study|Protocol Violation|2
894285|NCT00689104|1865098|FG001|Overall Study|Protocol Violation|3
894286|NCT00689104|1865099|FG002|Overall Study|Protocol Violation|5
894287|NCT00689104|1865100|FG003|Overall Study|Protocol Violation|3
894288|NCT00689104|1865097|FG000|Overall Study|Randomized but never received study drug|2
894289|NCT00689104|1865098|FG001|Overall Study|Randomized but never received study drug|1
894290|NCT00689104|1865099|FG002|Overall Study|Randomized but never received study drug|1
894291|NCT00689104|1865100|FG003|Overall Study|Randomized but never received study drug|0
894292|NCT00689104|1865097|FG000|Overall Study|Physician Decision|1
894293|NCT00689104|1865098|FG001|Overall Study|Physician Decision|0
894294|NCT00689104|1865099|FG002|Overall Study|Physician Decision|0
894295|NCT00689104|1865100|FG003|Overall Study|Physician Decision|0
894296|NCT00689104|1865097|FG000|Overall Study|Non-compliance with study procedures|0
894297|NCT00689104|1865098|FG001|Overall Study|Non-compliance with study procedures|0
894298|NCT00689104|1865099|FG002|Overall Study|Non-compliance with study procedures|1
894299|NCT00689104|1865100|FG003|Overall Study|Non-compliance with study procedures|0
894300|NCT00689117|1865114|FG000|Overall Study|Adverse Event|6
894301|NCT00689117|1865115|FG001|Overall Study|Adverse Event|0
894302|NCT00689117|1865116|FG002|Overall Study|Adverse Event|5
894303|NCT00689117|1865117|FG003|Overall Study|Adverse Event|0
894304|NCT00689117|1865114|FG000|Overall Study|Lost to Follow-up|26
894305|NCT00689117|1865115|FG001|Overall Study|Lost to Follow-up|19
894306|NCT00689117|1865116|FG002|Overall Study|Lost to Follow-up|17
894307|NCT00689117|1865117|FG003|Overall Study|Lost to Follow-up|11
894308|NCT00689117|1865114|FG000|Overall Study|Lack of Efficacy|1
894309|NCT00689117|1865115|FG001|Overall Study|Lack of Efficacy|2
894310|NCT00689117|1865116|FG002|Overall Study|Lack of Efficacy|2
894311|NCT00689117|1865117|FG003|Overall Study|Lack of Efficacy|2
894312|NCT00689117|1865114|FG000|Overall Study|Non-Compliance with Study Treatment|3
894313|NCT00689117|1865115|FG001|Overall Study|Non-Compliance with Study Treatment|3
894314|NCT00689117|1865116|FG002|Overall Study|Non-Compliance with Study Treatment|3
894315|NCT00689117|1865117|FG003|Overall Study|Non-Compliance with Study Treatment|1
894316|NCT00689117|1865114|FG000|Overall Study|Withdrawal by Subject|19
894317|NCT00689117|1865115|FG001|Overall Study|Withdrawal by Subject|18
894318|NCT00689117|1865116|FG002|Overall Study|Withdrawal by Subject|26
894319|NCT00689117|1865117|FG003|Overall Study|Withdrawal by Subject|13
894320|NCT00689117|1865114|FG000|Overall Study|Unable to Comply with Visit Schedule|0
894321|NCT00689117|1865115|FG001|Overall Study|Unable to Comply with Visit Schedule|0
894322|NCT00689117|1865116|FG002|Overall Study|Unable to Comply with Visit Schedule|1
894323|NCT00689117|1865117|FG003|Overall Study|Unable to Comply with Visit Schedule|1
894324|NCT00689117|1865114|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
894325|NCT00689117|1865115|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
894326|NCT00689117|1865116|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
894327|NCT00689117|1865117|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
894328|NCT00689117|1865114|FG000|Overall Study|Non-compliance with Treatment Regimen|0
894329|NCT00689117|1865115|FG001|Overall Study|Non-compliance with Treatment Regimen|1
894330|NCT00689117|1865116|FG002|Overall Study|Non-compliance with Treatment Regimen|0
894331|NCT00689117|1865117|FG003|Overall Study|Non-compliance with Treatment Regimen|0
894332|NCT00689117|1865114|FG000|Overall Study|Change/Discontinuation of Birth Control|1
894333|NCT00689117|1865115|FG001|Overall Study|Change/Discontinuation of Birth Control|1
894334|NCT00689117|1865116|FG002|Overall Study|Change/Discontinuation of Birth Control|1
894335|NCT00689117|1865117|FG003|Overall Study|Change/Discontinuation of Birth Control|0
894336|NCT00689117|1865114|FG000|Overall Study|Use of Prohibitive Medication|2
894337|NCT00689117|1865115|FG001|Overall Study|Use of Prohibitive Medication|1
894338|NCT00689117|1865116|FG002|Overall Study|Use of Prohibitive Medication|3
894339|NCT00689117|1865117|FG003|Overall Study|Use of Prohibitive Medication|0
894340|NCT00689117|1865114|FG000|Overall Study|Pregnancy|0
894341|NCT00689117|1865115|FG001|Overall Study|Pregnancy|2
894342|NCT00689117|1865116|FG002|Overall Study|Pregnancy|0
894343|NCT00689117|1865117|FG003|Overall Study|Pregnancy|2
894344|NCT00689117|1865114|FG000|Overall Study|Incarceration|2
1099894|NCT02346240|2173438|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099895|NCT02346240|2173439|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099896|NCT02346240|2173440|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099897|NCT02346240|2173441|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099898|NCT02346240|2173442|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099899|NCT02346240|2173443|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099900|NCT02346240|2173444|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099901|NCT02346240|2173445|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099902|NCT02346240|2173446|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099903|NCT02346240|2173447|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099904|NCT02346240|2173448|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099905|NCT02346240|2173449|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099906|NCT02346240|2173450|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099907|NCT02346240|2173451|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099908|NCT02346240|2173452|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099909|NCT02346240|2173453|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099910|NCT02346240|2173454|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099911|NCT02346240|2173455|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0
1099912|NCT02346240|2173432|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
1099913|NCT02346240|2173433|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
1099914|NCT02346240|2173434|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
1099915|NCT02346240|2173435|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
1099916|NCT02346240|2173436|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099917|NCT02346240|2173437|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099918|NCT02346240|2173438|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099919|NCT02346240|2173439|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099920|NCT02346240|2173440|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099921|NCT02346240|2173441|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099922|NCT02346240|2173442|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099923|NCT02346240|2173443|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099924|NCT02346240|2173444|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1162063|NCT03382418|2284043|FG000|Overall Study|Withdrawal by Subject|1
894345|NCT00689117|1865115|FG001|Overall Study|Incarceration|0
894346|NCT00689117|1865116|FG002|Overall Study|Incarceration|0
894347|NCT00689117|1865117|FG003|Overall Study|Incarceration|0
894348|NCT00689117|1865114|FG000|Overall Study|Fear of Birth Defects|0
894349|NCT00689117|1865115|FG001|Overall Study|Fear of Birth Defects|0
894350|NCT00689117|1865116|FG002|Overall Study|Fear of Birth Defects|1
894351|NCT00689117|1865117|FG003|Overall Study|Fear of Birth Defects|0
894352|NCT00689117|1865114|FG000|Overall Study|Transportation|1
894353|NCT00689117|1865115|FG001|Overall Study|Transportation|0
894354|NCT00689117|1865116|FG002|Overall Study|Transportation|0
894355|NCT00689117|1865117|FG003|Overall Study|Transportation|0
894356|NCT00689117|1865114|FG000|Overall Study|Patient Withdrew from Study|0
894357|NCT00689117|1865115|FG001|Overall Study|Patient Withdrew from Study|0
894358|NCT00689117|1865116|FG002|Overall Study|Patient Withdrew from Study|0
894359|NCT00689117|1865117|FG003|Overall Study|Patient Withdrew from Study|1
894360|NCT00689117|1865114|FG000|Overall Study|Personal Reason|0
894361|NCT00689117|1865115|FG001|Overall Study|Personal Reason|1
894362|NCT00689117|1865116|FG002|Overall Study|Personal Reason|0
894363|NCT00689117|1865117|FG003|Overall Study|Personal Reason|0
894364|NCT00689117|1865114|FG000|Overall Study|Dispensing Error|0
894365|NCT00689117|1865115|FG001|Overall Study|Dispensing Error|1
894366|NCT00689117|1865116|FG002|Overall Study|Dispensing Error|0
894367|NCT00689117|1865117|FG003|Overall Study|Dispensing Error|0
894368|NCT00689221|1865129|FG000|Overall Study|Ongoing at cut-off date|39
894369|NCT00689221|1865130|FG001|Overall Study|Ongoing at cut-off date|36
894370|NCT00689273|1865150|FG000|Overall Study|Adverse Event|3
894371|NCT00689273|1865151|FG001|Overall Study|Adverse Event|1
894372|NCT00689273|1865150|FG000|Overall Study|Lack of Efficacy|3
894373|NCT00689273|1865151|FG001|Overall Study|Lack of Efficacy|0
894374|NCT00689273|1865150|FG000|Overall Study|Lost to Follow-up|0
894375|NCT00689273|1865151|FG001|Overall Study|Lost to Follow-up|2
894376|NCT00689273|1865150|FG000|Overall Study|Other|6
894377|NCT00689273|1865151|FG001|Overall Study|Other|2
894378|NCT00689273|1865150|FG000|Overall Study|Randomized but not Treated|1
894379|NCT00689273|1865151|FG001|Overall Study|Randomized but not Treated|0
894380|NCT00689299|1865160|FG000|Overall Study|Adverse Event|2
894381|NCT00689299|1865161|FG001|Overall Study|Adverse Event|1
894382|NCT00689299|1865162|FG002|Overall Study|Adverse Event|1
894383|NCT00689299|1865160|FG000|Overall Study|Lost to Follow-up|0
894384|NCT00689299|1865161|FG001|Overall Study|Lost to Follow-up|1
894385|NCT00689299|1865162|FG002|Overall Study|Lost to Follow-up|1
894386|NCT00689299|1865160|FG000|Overall Study|Withdrawal by Subject|4
894387|NCT00689299|1865161|FG001|Overall Study|Withdrawal by Subject|1
894388|NCT00689299|1865162|FG002|Overall Study|Withdrawal by Subject|3
894389|NCT00689299|1865160|FG000|Overall Study|Protocol Violation|1
894390|NCT00689299|1865161|FG001|Overall Study|Protocol Violation|0
894391|NCT00689299|1865162|FG002|Overall Study|Protocol Violation|0
894392|NCT00689338|1865170|FG000|Overall Study|Death|65
894393|NCT00689338|1865170|FG000|Overall Study|Adverse Event|13
894394|NCT00689338|1865170|FG000|Overall Study|Insufficient Clinical Response|1
894395|NCT00689338|1865170|FG000|Overall Study|Lack of Efficacy|6
894396|NCT00689338|1865170|FG000|Overall Study|Other|8
894397|NCT00689338|1865170|FG000|Overall Study|Did not Meet Entrance Criteria|27
894398|NCT00689338|1865170|FG000|Overall Study|Lost to Follow-up|5
894399|NCT00689338|1865170|FG000|Overall Study|Withdrawal by Subject|3
894400|NCT00689338|1865170|FG000|Overall Study|Protocol Violation|15
894401|NCT00689351|1865176|FG000|Infant Series of Dosing|Parent/legal guardian request|5
1099925|NCT02346240|2173445|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099926|NCT02346240|2173446|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099927|NCT02346240|2173447|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099928|NCT02346240|2173448|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099929|NCT02346240|2173449|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099930|NCT02346240|2173450|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099931|NCT02346240|2173451|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099932|NCT02346240|2173452|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099933|NCT02346240|2173453|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099934|NCT02346240|2173454|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099935|NCT02346240|2173455|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1099936|NCT02346240|2173432|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
1099937|NCT02346240|2173433|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
1099938|NCT02346240|2173434|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
1099939|NCT02346240|2173435|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
1099940|NCT02346240|2173436|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099941|NCT02346240|2173437|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099942|NCT02346240|2173438|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
894402|NCT00689351|1865177|FG001|Infant Series of Dosing|Parent/legal guardian request|0
894403|NCT00689351|1865176|FG000|Infant Series of Dosing|Adverse Event|1
894404|NCT00689351|1865177|FG001|Infant Series of Dosing|Adverse Event|0
894405|NCT00689351|1865176|FG000|Infant Series of Dosing|Lost to Follow-up|0
894406|NCT00689351|1865177|FG001|Infant Series of Dosing|Lost to Follow-up|1
894407|NCT00689351|1865176|FG000|After Infant Series|Parent/legal guardian request|1
894408|NCT00689351|1865177|FG001|After Infant Series|Parent/legal guardian request|0
894409|NCT00689390|1865189|FG000|Overall Study|Adverse Event|19
894410|NCT00689390|1865190|FG001|Overall Study|Adverse Event|0
894411|NCT00689390|1865189|FG000|Overall Study|Lost to Follow-up|179
894412|NCT00689390|1865190|FG001|Overall Study|Lost to Follow-up|7
894413|NCT00689390|1865189|FG000|Overall Study|Withdrawal by Subject|117
894414|NCT00689390|1865190|FG001|Overall Study|Withdrawal by Subject|3
894415|NCT00689390|1865189|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52
894416|NCT00689390|1865190|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0
894417|NCT00689390|1865189|FG000|Overall Study|Non-Compliance With Protocol|21
894418|NCT00689390|1865190|FG001|Overall Study|Non-Compliance With Protocol|0
894419|NCT00689390|1865189|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
894420|NCT00689390|1865190|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
894421|NCT00689390|1865189|FG000|Overall Study|Administrative|37
894422|NCT00689390|1865190|FG001|Overall Study|Administrative|0
894423|NCT00689481|1865203|FG000|Overall Study|Adverse Event|7
894424|NCT00689481|1865204|FG001|Overall Study|Adverse Event|1
894425|NCT00689481|1865203|FG000|Overall Study|Lost to Follow-up|4
894426|NCT00689481|1865204|FG001|Overall Study|Lost to Follow-up|3
894427|NCT00689481|1865203|FG000|Overall Study|Lack of Efficacy|4
894428|NCT00689481|1865204|FG001|Overall Study|Lack of Efficacy|3
894429|NCT00689481|1865203|FG000|Overall Study|Non-compliance with study treatment|1
894430|NCT00689481|1865204|FG001|Overall Study|Non-compliance with study treatment|1
894431|NCT00689481|1865203|FG000|Overall Study|Withdrawal by Subject|8
894432|NCT00689481|1865204|FG001|Overall Study|Withdrawal by Subject|4
894433|NCT00689481|1865203|FG000|Overall Study|Excluded medication started during study|0
894434|NCT00689481|1865204|FG001|Overall Study|Excluded medication started during study|1
894435|NCT00689481|1865203|FG000|Overall Study|Subject early term, left on vacation|0
894436|NCT00689481|1865204|FG001|Overall Study|Subject early term, left on vacation|1
894437|NCT00689611|1865221|FG000|Overall Study|Death|6
894438|NCT00689611|1865222|FG001|Overall Study|Death|9
894439|NCT00689611|1865221|FG000|Overall Study|Withdrawal by Subject|8
894440|NCT00689611|1865222|FG001|Overall Study|Withdrawal by Subject|9
894441|NCT00689611|1865221|FG000|Overall Study|Lost to Follow-up|27
894442|NCT00689611|1865222|FG001|Overall Study|Lost to Follow-up|28
894443|NCT00689728|1865231|FG000|Double-Blind Treatment|Adverse Event|1
894444|NCT00689728|1865232|FG001|Double-Blind Treatment|Adverse Event|0
894445|NCT00689728|1865233|FG002|Double-Blind Treatment|Adverse Event|0
894446|NCT00689728|1865231|FG000|Double-Blind Treatment|Protocol Violation|0
894447|NCT00689728|1865232|FG001|Double-Blind Treatment|Protocol Violation|0
894448|NCT00689728|1865233|FG002|Double-Blind Treatment|Protocol Violation|1
894449|NCT00689728|1865231|FG000|Double-Blind Treatment|Withdrawal by Subject|3
894450|NCT00689728|1865232|FG001|Double-Blind Treatment|Withdrawal by Subject|3
1099943|NCT02346240|2173439|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099944|NCT02346240|2173440|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099945|NCT02346240|2173441|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099946|NCT02346240|2173442|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099947|NCT02346240|2173443|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099948|NCT02346240|2173444|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099949|NCT02346240|2173445|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099950|NCT02346240|2173446|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099951|NCT02346240|2173447|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099952|NCT02346240|2173448|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099953|NCT02346240|2173449|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099954|NCT02346240|2173450|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099955|NCT02346240|2173451|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099956|NCT02346240|2173452|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099957|NCT02346240|2173453|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099958|NCT02346240|2173454|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1099959|NCT02346240|2173455|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
894451|NCT00689728|1865233|FG002|Double-Blind Treatment|Withdrawal by Subject|2
894452|NCT00689728|1865231|FG000|Double-Blind Treatment|Lack of Efficacy|0
894453|NCT00689728|1865232|FG001|Double-Blind Treatment|Lack of Efficacy|1
894454|NCT00689728|1865233|FG002|Double-Blind Treatment|Lack of Efficacy|2
894455|NCT00689728|1865231|FG000|Rescue|Adverse Event|0
894456|NCT00689728|1865232|FG001|Rescue|Adverse Event|1
894457|NCT00689728|1865233|FG002|Rescue|Adverse Event|0
894458|NCT00689728|1865231|FG000|Rescue|Withdrawal by Subject|1
894459|NCT00689728|1865232|FG001|Rescue|Withdrawal by Subject|1
894460|NCT00689728|1865233|FG002|Rescue|Withdrawal by Subject|1
894461|NCT00689728|1865231|FG000|Optional Follow-Up|Adverse Event|1
894462|NCT00689728|1865232|FG001|Optional Follow-Up|Adverse Event|0
894463|NCT00689728|1865233|FG002|Optional Follow-Up|Adverse Event|0
894464|NCT00689728|1865231|FG000|Optional Follow-Up|Lack of Efficacy|0
894465|NCT00689728|1865232|FG001|Optional Follow-Up|Lack of Efficacy|1
894466|NCT00689728|1865233|FG002|Optional Follow-Up|Lack of Efficacy|1
894467|NCT00689728|1865231|FG000|Optional Follow-Up|Lost to Follow-up|0
894468|NCT00689728|1865232|FG001|Optional Follow-Up|Lost to Follow-up|1
894469|NCT00689728|1865233|FG002|Optional Follow-Up|Lost to Follow-up|1
894470|NCT00689728|1865231|FG000|Optional Follow-Up|Protocol Violation|0
894471|NCT00689728|1865232|FG001|Optional Follow-Up|Protocol Violation|0
894472|NCT00689728|1865233|FG002|Optional Follow-Up|Protocol Violation|1
894473|NCT00689728|1865231|FG000|Optional Follow-Up|Withdrawal by Subject|2
894474|NCT00689728|1865232|FG001|Optional Follow-Up|Withdrawal by Subject|4
894475|NCT00689728|1865233|FG002|Optional Follow-Up|Withdrawal by Subject|3
894476|NCT00689793|1865264|FG000|Overall Study|Lost to Follow-up|4
894477|NCT00689793|1865265|FG001|Overall Study|Lost to Follow-up|5
894478|NCT00689871|1865286|FG000|Overall Study|Lost to Follow-up|123
894479|NCT00689871|1865287|FG001|Overall Study|Lost to Follow-up|13
894480|NCT00689871|1865288|FG002|Overall Study|Lost to Follow-up|37
894481|NCT00689871|1865289|FG003|Overall Study|Lost to Follow-up|1
894482|NCT00689871|1865286|FG000|Overall Study|Explanted of All Study Devices|36
894483|NCT00689871|1865287|FG001|Overall Study|Explanted of All Study Devices|25
894484|NCT00689871|1865288|FG002|Overall Study|Explanted of All Study Devices|29
894485|NCT00689871|1865289|FG003|Overall Study|Explanted of All Study Devices|3
894486|NCT00689871|1865286|FG000|Overall Study|Withdrawal by Subject|13
894487|NCT00689871|1865287|FG001|Overall Study|Withdrawal by Subject|3
894488|NCT00689871|1865288|FG002|Overall Study|Withdrawal by Subject|4
894489|NCT00689871|1865289|FG003|Overall Study|Withdrawal by Subject|1
894490|NCT00689871|1865286|FG000|Overall Study|Death|1
894491|NCT00689871|1865287|FG001|Overall Study|Death|10
894492|NCT00689871|1865288|FG002|Overall Study|Death|2
894493|NCT00689871|1865289|FG003|Overall Study|Death|2
894494|NCT00689871|1865286|FG000|Overall Study|Physician Decision|2
894495|NCT00689871|1865287|FG001|Overall Study|Physician Decision|1
894496|NCT00689871|1865288|FG002|Overall Study|Physician Decision|1
894497|NCT00689871|1865289|FG003|Overall Study|Physician Decision|0
894498|NCT00689936|1865302|FG000|Active Treatment Phase|Adverse Event|68
894499|NCT00689936|1865303|FG001|Active Treatment Phase|Adverse Event|71
894500|NCT00689936|1865304|FG002|Active Treatment Phase|Adverse Event|76
894501|NCT00689936|1865302|FG000|Active Treatment Phase|Disease Progression|273
894502|NCT00689936|1865303|FG001|Active Treatment Phase|Disease Progression|362
894503|NCT00689936|1865304|FG002|Active Treatment Phase|Disease Progression|339
894504|NCT00689936|1865302|FG000|Active Treatment Phase|Withdrawal by Subject|16
894505|NCT00689936|1865303|FG001|Active Treatment Phase|Withdrawal by Subject|16
894506|NCT00689936|1865304|FG002|Active Treatment Phase|Withdrawal by Subject|21
894507|NCT00689936|1865302|FG000|Active Treatment Phase|Death|60
894508|NCT00689936|1865303|FG001|Active Treatment Phase|Death|28
894509|NCT00689936|1865304|FG002|Active Treatment Phase|Death|37
894510|NCT00689936|1865302|FG000|Active Treatment Phase|Lost to Follow-up|0
894511|NCT00689936|1865303|FG001|Active Treatment Phase|Lost to Follow-up|2
894512|NCT00689936|1865304|FG002|Active Treatment Phase|Lost to Follow-up|2
1099960|NCT02346240|2173432|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0
1099961|NCT02346240|2173433|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1
1099962|NCT02346240|2173434|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0
1099963|NCT02346240|2173435|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1
1099964|NCT02346240|2173436|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0
1099965|NCT02346240|2173437|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0
1099966|NCT02346240|2173438|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0
1099967|NCT02346240|2173439|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0
1099968|NCT02346240|2173440|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0
1099969|NCT02346240|2173441|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0
1099970|NCT02346240|2173442|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0
1099971|NCT02346240|2173443|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0
1099972|NCT02346240|2173444|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0
1099973|NCT02346240|2173445|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0
1099974|NCT02346240|2173446|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0
1099975|NCT02346240|2173447|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0
1099976|NCT02346240|2173448|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0
1099977|NCT02346240|2173449|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0
1099978|NCT02346240|2173450|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0
1099979|NCT02346240|2173451|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0
894513|NCT00689936|1865302|FG000|Active Treatment Phase|Protocol Violation|2
894514|NCT00689936|1865303|FG001|Active Treatment Phase|Protocol Violation|2
894515|NCT00689936|1865304|FG002|Active Treatment Phase|Protocol Violation|4
894516|NCT00689936|1865302|FG000|Active Treatment Phase|Study Close Out|64
894517|NCT00689936|1865303|FG001|Active Treatment Phase|Study Close Out|26
894518|NCT00689936|1865304|FG002|Active Treatment Phase|Study Close Out|21
894519|NCT00689936|1865302|FG000|Active Treatment Phase|Miscellaneous|52
894520|NCT00689936|1865303|FG001|Active Treatment Phase|Miscellaneous|34
894521|NCT00689936|1865304|FG002|Active Treatment Phase|Miscellaneous|47
894522|NCT00689936|1865302|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
894523|NCT00689936|1865303|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
894524|NCT00689936|1865304|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
894525|NCT00690378|1865358|FG000|Overall Study|Adverse Event|1
894526|NCT00690378|1865359|FG001|Overall Study|Adverse Event|0
894527|NCT00690378|1865358|FG000|Overall Study|Withdrawal by Subject|2
894528|NCT00690378|1865359|FG001|Overall Study|Withdrawal by Subject|0
894529|NCT00690378|1865358|FG000|Overall Study|Protocol Violation|1
894530|NCT00690378|1865359|FG001|Overall Study|Protocol Violation|0
894531|NCT00690378|1865358|FG000|Overall Study|Lost to Follow-up|2
894532|NCT00690378|1865359|FG001|Overall Study|Lost to Follow-up|3
894533|NCT00690378|1865358|FG000|Overall Study|Did not meet inc/exc criteria|13
894534|NCT00690378|1865359|FG001|Overall Study|Did not meet inc/exc criteria|11
894535|NCT00690378|1865358|FG000|Overall Study|Social problem|1
894536|NCT00690378|1865359|FG001|Overall Study|Social problem|0
894537|NCT00690430|1865367|FG000|Core Phase|Abnormal Laboratory value|0
894538|NCT00690430|1865368|FG001|Core Phase|Abnormal Laboratory value|1
894539|NCT00690430|1865369|FG002|Core Phase|Abnormal Laboratory value|0
894540|NCT00690430|1865367|FG000|Core Phase|Adverse Event|5
894541|NCT00690430|1865368|FG001|Core Phase|Adverse Event|1
894542|NCT00690430|1865369|FG002|Core Phase|Adverse Event|0
894543|NCT00690430|1865367|FG000|Core Phase|Death|0
894544|NCT00690430|1865368|FG001|Core Phase|Death|2
894545|NCT00690430|1865369|FG002|Core Phase|Death|0
894546|NCT00690430|1865367|FG000|Core Phase|Protocol Violation|1
894547|NCT00690430|1865368|FG001|Core Phase|Protocol Violation|0
894548|NCT00690430|1865369|FG002|Core Phase|Protocol Violation|0
894549|NCT00690430|1865367|FG000|Core Phase|Withdrawal by Subject|3
894550|NCT00690430|1865368|FG001|Core Phase|Withdrawal by Subject|3
894551|NCT00690430|1865369|FG002|Core Phase|Withdrawal by Subject|0
894552|NCT00690430|1865367|FG000|Core Phase|Subject no longer requires study drug|1
894553|NCT00690430|1865368|FG001|Core Phase|Subject no longer requires study drug|0
894554|NCT00690430|1865369|FG002|Core Phase|Subject no longer requires study drug|0
894555|NCT00690430|1865367|FG000|Core Phase|Lack of Efficacy|8
894556|NCT00690430|1865368|FG001|Core Phase|Lack of Efficacy|10
894557|NCT00690430|1865369|FG002|Core Phase|Lack of Efficacy|0
894558|NCT00690430|1865367|FG000|Core Phase|Administrative Problems|0
894559|NCT00690430|1865368|FG001|Core Phase|Administrative Problems|1
894560|NCT00690430|1865369|FG002|Core Phase|Administrative Problems|0
894561|NCT00690430|1865367|FG000|Core Phase|Early Termination|0
894562|NCT00690430|1865368|FG001|Core Phase|Early Termination|5
894563|NCT00690430|1865369|FG002|Core Phase|Early Termination|0
894564|NCT00690430|1865367|FG000|Extension Phase|Lack of Efficacy|3
894565|NCT00690430|1865368|FG001|Extension Phase|Lack of Efficacy|1
894566|NCT00690430|1865369|FG002|Extension Phase|Lack of Efficacy|4
894567|NCT00690430|1865367|FG000|Extension Phase|Abnormal Lab Values|1
894568|NCT00690430|1865368|FG001|Extension Phase|Abnormal Lab Values|0
894569|NCT00690430|1865369|FG002|Extension Phase|Abnormal Lab Values|0
894570|NCT00690430|1865367|FG000|Extension Phase|Abnormal test procedure results|1
894571|NCT00690430|1865368|FG001|Extension Phase|Abnormal test procedure results|0
894572|NCT00690430|1865369|FG002|Extension Phase|Abnormal test procedure results|0
1099980|NCT02346240|2173452|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0
1099981|NCT02346240|2173453|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0
1099982|NCT02346240|2173454|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0
1099983|NCT02346240|2173455|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0
1099984|NCT02346240|2173432|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099985|NCT02346240|2173433|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099986|NCT02346240|2173434|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
1099987|NCT02346240|2173435|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099988|NCT02346240|2173436|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099989|NCT02346240|2173437|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099990|NCT02346240|2173438|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099991|NCT02346240|2173439|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099992|NCT02346240|2173440|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099993|NCT02346240|2173441|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099994|NCT02346240|2173442|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099995|NCT02346240|2173443|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099996|NCT02346240|2173444|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099997|NCT02346240|2173445|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099998|NCT02346240|2173446|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1099999|NCT02346240|2173447|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
894573|NCT00690430|1865367|FG000|Extension Phase|Administrative Problems|0
894574|NCT00690430|1865368|FG001|Extension Phase|Administrative Problems|1
894575|NCT00690430|1865369|FG002|Extension Phase|Administrative Problems|1
894576|NCT00690430|1865367|FG000|Extension Phase|Adverse Event|2
894577|NCT00690430|1865368|FG001|Extension Phase|Adverse Event|1
894578|NCT00690430|1865369|FG002|Extension Phase|Adverse Event|2
894579|NCT00690430|1865367|FG000|Extension Phase|Death|1
894580|NCT00690430|1865368|FG001|Extension Phase|Death|1
894581|NCT00690430|1865369|FG002|Extension Phase|Death|1
894582|NCT00690430|1865367|FG000|Extension Phase|Withdrawal by Subject|0
894583|NCT00690430|1865368|FG001|Extension Phase|Withdrawal by Subject|0
894584|NCT00690430|1865369|FG002|Extension Phase|Withdrawal by Subject|2
894585|NCT00690430|1865367|FG000|Extension Phase|Early Termination|10
894586|NCT00690430|1865368|FG001|Extension Phase|Early Termination|1
894587|NCT00690430|1865369|FG002|Extension Phase|Early Termination|3
894588|NCT00690443|1865380|FG000|Overall Study|Adverse Event|1
894589|NCT00690443|1865381|FG001|Overall Study|Adverse Event|2
894590|NCT00690482|1865389|FG000|Overall Study|Adverse Event|2
894591|NCT00690482|1865390|FG001|Overall Study|Adverse Event|1
894592|NCT00690482|1865389|FG000|Overall Study|Incorrect enrolment|0
894593|NCT00690482|1865390|FG001|Overall Study|Incorrect enrolment|1
894594|NCT00690482|1865389|FG000|Overall Study|Study-specific discontinuation criteria|1
894595|NCT00690482|1865390|FG001|Overall Study|Study-specific discontinuation criteria|0
894596|NCT00690482|1865389|FG000|Overall Study|Intake of prohibited medicine|1
894597|NCT00690482|1865390|FG001|Overall Study|Intake of prohibited medicine|0
894598|NCT00690482|1865389|FG000|Overall Study|withdrew consent at rand.day|0
894599|NCT00690482|1865390|FG001|Overall Study|withdrew consent at rand.day|1
894600|NCT00690573|1865405|FG000|Overall Study|Lack of Efficacy|8
894601|NCT00690573|1865405|FG000|Overall Study|Withdrawal by Subject|1
894602|NCT00690612|1865409|FG000|Overall Study|Adverse Event|1
894603|NCT00690612|1865409|FG000|Overall Study|Withdrawal by Subject|2
894604|NCT00690755|1865420|FG000|Overall Study|Physician Decision|2
894605|NCT00690755|1865421|FG001|Overall Study|Physician Decision|0
894606|NCT00690755|1865422|FG002|Overall Study|Physician Decision|46
894607|NCT00690755|1865423|FG003|Overall Study|Physician Decision|5
894608|NCT00690755|1865424|FG004|Overall Study|Physician Decision|0
894609|NCT00690755|1865425|FG005|Overall Study|Physician Decision|4
894610|NCT00690755|1865426|FG006|Overall Study|Physician Decision|0
894611|NCT00690794|1865444|FG000|Overall Study|Adverse Event|12
894612|NCT00690794|1865445|FG001|Overall Study|Adverse Event|10
894613|NCT00690794|1865444|FG000|Overall Study|Lost to Follow-up|1
894614|NCT00690794|1865445|FG001|Overall Study|Lost to Follow-up|4
894615|NCT00690794|1865444|FG000|Overall Study|Withdrawal by Subject|0
894616|NCT00690794|1865445|FG001|Overall Study|Withdrawal by Subject|9
894617|NCT00690794|1865444|FG000|Overall Study|Protocol Violation|6
894618|NCT00690794|1865445|FG001|Overall Study|Protocol Violation|7
894619|NCT00690794|1865444|FG000|Overall Study|Noncompliance|1
894620|NCT00690794|1865445|FG001|Overall Study|Noncompliance|2
894621|NCT00690794|1865444|FG000|Overall Study|Other not specified|1
894622|NCT00690794|1865445|FG001|Overall Study|Other not specified|3
894623|NCT00690820|1865453|FG000|Period 1|Withdrawal by Subject|0
894624|NCT00690820|1865454|FG001|Period 1|Withdrawal by Subject|1
894625|NCT00690898|1865464|FG000|SCREENING|Screen failure|18
894626|NCT00690898|1865464|FG000|TREATMENT|Adverse Event|3
894627|NCT00690898|1865464|FG000|TREATMENT|Lack of Efficacy|18
894628|NCT00690898|1865464|FG000|TREATMENT|Withdrawal by Subject|4
894629|NCT00690898|1865464|FG000|TREATMENT|Other (not otherwise specified)|1
894630|NCT00691015|1865491|FG000|Overall Study|Refused further treatment|1
894631|NCT00691028|1865498|FG000|Open-label Period|Adverse Event|0
1100000|NCT02346240|2173448|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1100001|NCT02346240|2173449|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1100002|NCT02346240|2173450|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1100003|NCT02346240|2173451|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1100004|NCT02346240|2173452|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1100005|NCT02346240|2173453|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1100006|NCT02346240|2173454|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1100007|NCT02346240|2173455|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1100008|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100009|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100010|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100011|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100012|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100013|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100014|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100015|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
1100016|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
1100017|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100018|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100019|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100020|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100021|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
1100022|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
1100023|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
1100024|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
1100025|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100026|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100027|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100028|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100029|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100030|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100031|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1100032|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100033|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100034|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100035|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100036|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100037|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100038|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100039|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100040|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100041|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100042|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100043|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100044|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100045|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1100046|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
894632|NCT00691028|1865499|FG001|Open-label Period|Adverse Event|0
894633|NCT00691028|1865500|FG002|Open-label Period|Adverse Event|0
894634|NCT00691028|1865501|FG003|Open-label Period|Adverse Event|16
894635|NCT00691028|1865498|FG000|Open-label Period|Withdrawal by Subject|0
894636|NCT00691028|1865499|FG001|Open-label Period|Withdrawal by Subject|0
894637|NCT00691028|1865500|FG002|Open-label Period|Withdrawal by Subject|0
894638|NCT00691028|1865501|FG003|Open-label Period|Withdrawal by Subject|3
894639|NCT00691028|1865498|FG000|Open-label Period|not come to a hospital|0
894640|NCT00691028|1865499|FG001|Open-label Period|not come to a hospital|0
894641|NCT00691028|1865500|FG002|Open-label Period|not come to a hospital|0
894642|NCT00691028|1865501|FG003|Open-label Period|not come to a hospital|1
894643|NCT00691028|1865498|FG000|Double-blind Period|Adverse Event|8
894644|NCT00691028|1865499|FG001|Double-blind Period|Adverse Event|9
894645|NCT00691028|1865500|FG002|Double-blind Period|Adverse Event|6
894646|NCT00691028|1865501|FG003|Double-blind Period|Adverse Event|0
894647|NCT00691028|1865498|FG000|Double-blind Period|Lack of Efficacy|4
894648|NCT00691028|1865499|FG001|Double-blind Period|Lack of Efficacy|3
894649|NCT00691028|1865500|FG002|Double-blind Period|Lack of Efficacy|2
894650|NCT00691028|1865501|FG003|Double-blind Period|Lack of Efficacy|0
894651|NCT00691028|1865498|FG000|Double-blind Period|Withdrawal by Subject|1
894652|NCT00691028|1865499|FG001|Double-blind Period|Withdrawal by Subject|0
894653|NCT00691028|1865500|FG002|Double-blind Period|Withdrawal by Subject|1
894654|NCT00691028|1865501|FG003|Double-blind Period|Withdrawal by Subject|0
894655|NCT00691028|1865498|FG000|Double-blind Period|not come to a hospital.|0
894656|NCT00691028|1865499|FG001|Double-blind Period|not come to a hospital.|1
894657|NCT00691028|1865500|FG002|Double-blind Period|not come to a hospital.|0
1100047|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
1100048|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100049|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100050|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
894658|NCT00691028|1865501|FG003|Double-blind Period|not come to a hospital.|0
894659|NCT00691054|1865513|FG000|Overall Study|Withdrawal by Subject|1
894660|NCT00691093|1865519|FG000|Overall Study|Adverse Event|1
894661|NCT00691093|1865519|FG000|Overall Study|Lost to Follow-up|1
894662|NCT00691093|1865519|FG000|Overall Study|Lack of Efficacy|1
894663|NCT00691093|1865519|FG000|Overall Study|Ongoing at Date of Cut-Off|4
894664|NCT00691132|1865530|FG000|Overall Study|Adverse Event|2
894665|NCT00691132|1865531|FG001|Overall Study|Adverse Event|3
894666|NCT00691132|1865530|FG000|Overall Study|Withdrawal by Subject|10
894667|NCT00691132|1865531|FG001|Overall Study|Withdrawal by Subject|10
894668|NCT00691210|1865564|FG000|Overall Study|Progression of Disease|0
894669|NCT00691210|1865565|FG001|Overall Study|Progression of Disease|0
894670|NCT00691210|1865566|FG002|Overall Study|Progression of Disease|0
894671|NCT00691210|1865567|FG003|Overall Study|Progression of Disease|2
894672|NCT00691210|1865568|FG004|Overall Study|Progression of Disease|0
894673|NCT00691210|1865569|FG005|Overall Study|Progression of Disease|0
894674|NCT00691210|1865570|FG006|Overall Study|Progression of Disease|0
894675|NCT00691210|1865571|FG007|Overall Study|Progression of Disease|0
894676|NCT00691210|1865564|FG000|Overall Study|Lack of Efficacy|0
894677|NCT00691210|1865565|FG001|Overall Study|Lack of Efficacy|0
894678|NCT00691210|1865566|FG002|Overall Study|Lack of Efficacy|0
894679|NCT00691210|1865567|FG003|Overall Study|Lack of Efficacy|1
894680|NCT00691210|1865568|FG004|Overall Study|Lack of Efficacy|0
894681|NCT00691210|1865569|FG005|Overall Study|Lack of Efficacy|1
894682|NCT00691210|1865570|FG006|Overall Study|Lack of Efficacy|0
894683|NCT00691210|1865571|FG007|Overall Study|Lack of Efficacy|0
894684|NCT00691301|1865589|FG000|Overall Study|Adverse Event|10
894685|NCT00691301|1865589|FG000|Overall Study|Death|2
894686|NCT00691301|1865589|FG000|Overall Study|Lack of Efficacy|32
894687|NCT00691301|1865589|FG000|Overall Study|Withdrawal by Subject|4
894688|NCT00691301|1865589|FG000|Overall Study|Concurrent illness|2
894689|NCT00691301|1865589|FG000|Overall Study|other reason|3
894690|NCT00691301|1865589|FG000|Overall Study|Did not initiate study treatment|1
894691|NCT00691483|1865610|FG000|Overall Study|Adverse Event|14
894692|NCT00691483|1865611|FG001|Overall Study|Adverse Event|6
894693|NCT00691483|1865610|FG000|Overall Study|Lost to Follow-up|17
894694|NCT00691483|1865611|FG001|Overall Study|Lost to Follow-up|10
894695|NCT00691483|1865610|FG000|Overall Study|Withdrawal by Subject|24
894696|NCT00691483|1865611|FG001|Overall Study|Withdrawal by Subject|7
894697|NCT00691483|1865610|FG000|Overall Study|Other known cause|6
894698|NCT00691483|1865611|FG001|Overall Study|Other known cause|1
894699|NCT00691483|1865610|FG000|Overall Study|Randomized by not treated|7
894700|NCT00691483|1865611|FG001|Overall Study|Randomized by not treated|1
894701|NCT00691704|1865635|FG000|Induction Therapy|Disease Progression|1
894702|NCT00691704|1865635|FG000|Induction Therapy|Active Hepatitis|1
894703|NCT00691704|1865635|FG000|Two Years of Maintenance Therapy|Disease Progression|8
894704|NCT00691704|1865635|FG000|Two Years of Maintenance Therapy|Physician Decision|4
894705|NCT00691704|1865635|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1
894706|NCT00691938|1865659|FG000|Overall Study|QTc prolongation|1
894707|NCT00691938|1865660|FG001|Overall Study|QTc prolongation|0
894708|NCT00691938|1865661|FG002|Overall Study|QTc prolongation|0
894709|NCT00691938|1865662|FG003|Overall Study|QTc prolongation|0
894710|NCT00691938|1865663|FG004|Overall Study|QTc prolongation|0
894711|NCT00691938|1865664|FG005|Overall Study|QTc prolongation|0
894712|NCT00691938|1865665|FG006|Overall Study|QTc prolongation|0
894713|NCT00692237|1865708|FG000|Overall Study|Withdrawal by Subject|1
894714|NCT00692237|1865709|FG001|Overall Study|Withdrawal by Subject|3
894715|NCT00692237|1865708|FG000|Overall Study|Adverse Event|0
894716|NCT00692237|1865709|FG001|Overall Study|Adverse Event|1
894717|NCT00692406|1865737|FG000|Overall Study|PI dropped, bad data|57
894718|NCT00692770|1865763|FG000|Overall Study|Protocol Violation|2
894719|NCT00692770|1865764|FG001|Overall Study|Protocol Violation|7
894720|NCT00692770|1865763|FG000|Overall Study|Withdrawal by Subject|97
894721|NCT00692770|1865764|FG001|Overall Study|Withdrawal by Subject|36
894722|NCT00692770|1865763|FG000|Overall Study|Adverse Event|136
894723|NCT00692770|1865764|FG001|Overall Study|Adverse Event|41
894724|NCT00692770|1865763|FG000|Overall Study|Death|10
894725|NCT00692770|1865764|FG001|Overall Study|Death|5
894726|NCT00692770|1865763|FG000|Overall Study|Lost to Follow-up|7
894727|NCT00692770|1865764|FG001|Overall Study|Lost to Follow-up|3
894728|NCT00692770|1865763|FG000|Overall Study|Non-compliant with study medication|11
894729|NCT00692770|1865764|FG001|Overall Study|Non-compliant with study medication|5
894730|NCT00692770|1865763|FG000|Overall Study|Progression by clinical judgment|2
894731|NCT00692770|1865764|FG001|Overall Study|Progression by clinical judgment|3
894732|NCT00692770|1865763|FG000|Overall Study|Physician decision not protocol driven|10
894733|NCT00692770|1865764|FG001|Overall Study|Physician decision not protocol driven|14
894734|NCT00692770|1865763|FG000|Overall Study|Disease progression, recurrence/relapse|170
894735|NCT00692770|1865764|FG001|Overall Study|Disease progression, recurrence/relapse|279
1100051|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100052|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100053|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100054|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100055|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1100056|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100057|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100058|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100059|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100060|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100061|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100062|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100063|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100064|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100065|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100066|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100067|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100068|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100069|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100070|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
1100071|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100072|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100073|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100074|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100075|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100076|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100077|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
894736|NCT00692770|1865763|FG000|Overall Study|Protocol driven decision point|3
894737|NCT00692770|1865764|FG001|Overall Study|Protocol driven decision point|7
894738|NCT00692770|1865763|FG000|Overall Study|Completed all planned assessments|79
894739|NCT00692770|1865764|FG001|Overall Study|Completed all planned assessments|101
894740|NCT00692770|1865763|FG000|Overall Study|Radiological and clinical progression|8
894741|NCT00692770|1865764|FG001|Overall Study|Radiological and clinical progression|8
894742|NCT00692770|1865763|FG000|Overall Study|Clinical endpoint reached|16
894743|NCT00692770|1865764|FG001|Overall Study|Clinical endpoint reached|43
894744|NCT00692770|1865763|FG000|Overall Study|Study terminated by sponsor|2
894745|NCT00692770|1865764|FG001|Overall Study|Study terminated by sponsor|2
894746|NCT00692770|1865763|FG000|Overall Study|Randomized but not treated|3
894747|NCT00692770|1865764|FG001|Overall Study|Randomized but not treated|4
894748|NCT00692913|1865778|FG000|Overall Study|Adverse Event|8
894749|NCT00692913|1865779|FG001|Overall Study|Adverse Event|4
894750|NCT00692913|1865778|FG000|Overall Study|Lost to Follow-up|3
894751|NCT00692913|1865779|FG001|Overall Study|Lost to Follow-up|5
894752|NCT00692913|1865778|FG000|Overall Study|Physician Decision|2
894753|NCT00692913|1865779|FG001|Overall Study|Physician Decision|0
894754|NCT00692913|1865778|FG000|Overall Study|Protocol Violation|1
894755|NCT00692913|1865779|FG001|Overall Study|Protocol Violation|1
894756|NCT00692913|1865778|FG000|Overall Study|Withdrawal by Subject|15
894757|NCT00692913|1865779|FG001|Overall Study|Withdrawal by Subject|20
894758|NCT00693225|1865817|FG000|Overall Study|Lost to Follow-up|1
894759|NCT00693225|1865818|FG001|Overall Study|Lost to Follow-up|2
894760|NCT00693225|1865817|FG000|Overall Study|Adverse Event|1
894761|NCT00693225|1865818|FG001|Overall Study|Adverse Event|3
894762|NCT00693420|1865839|FG000|Overall Study|Adverse Event|4
894763|NCT00693420|1865840|FG001|Overall Study|Adverse Event|4
894764|NCT00693420|1865839|FG000|Overall Study|Lost to Follow-up|0
894765|NCT00693420|1865840|FG001|Overall Study|Lost to Follow-up|3
894766|NCT00693420|1865839|FG000|Overall Study|Withdrawal by Subject|1
894767|NCT00693420|1865840|FG001|Overall Study|Withdrawal by Subject|0
894768|NCT00693420|1865839|FG000|Overall Study|Protocol Violation|0
894769|NCT00693420|1865840|FG001|Overall Study|Protocol Violation|2
894770|NCT00693420|1865839|FG000|Overall Study|Sponsor Request - Conflict of Interest|0
894771|NCT00693420|1865840|FG001|Overall Study|Sponsor Request - Conflict of Interest|2
894772|NCT00693420|1865839|FG000|Overall Study|Personal Reasons|1
894773|NCT00693420|1865840|FG001|Overall Study|Personal Reasons|4
894774|NCT00693472|1865850|FG000|Part 1|Adverse Event|1
894775|NCT00693472|1865851|FG001|Part 1|Adverse Event|1
894776|NCT00693472|1865852|FG002|Part 1|Adverse Event|0
894777|NCT00693472|1865853|FG003|Part 1|Adverse Event|0
894778|NCT00693472|1865850|FG000|Part 1|Lost to Follow-up|0
894779|NCT00693472|1865851|FG001|Part 1|Lost to Follow-up|1
894780|NCT00693472|1865852|FG002|Part 1|Lost to Follow-up|0
894781|NCT00693472|1865853|FG003|Part 1|Lost to Follow-up|0
894782|NCT00693472|1865850|FG000|Part 1|Withdrew - reason unrelated to treatment|5
894783|NCT00693472|1865851|FG001|Part 1|Withdrew - reason unrelated to treatment|2
894784|NCT00693472|1865852|FG002|Part 1|Withdrew - reason unrelated to treatment|0
894785|NCT00693472|1865853|FG003|Part 1|Withdrew - reason unrelated to treatment|0
894786|NCT00693472|1865850|FG000|Part 2|Adverse Event|0
894787|NCT00693472|1865851|FG001|Part 2|Adverse Event|0
1100078|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100079|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1100080|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100081|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100082|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100083|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100084|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100085|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
894788|NCT00693472|1865852|FG002|Part 2|Adverse Event|1
894789|NCT00693472|1865853|FG003|Part 2|Adverse Event|0
894790|NCT00693472|1865850|FG000|Part 2|Withdrew - reason unrelated to treatment|0
894791|NCT00693472|1865851|FG001|Part 2|Withdrew - reason unrelated to treatment|0
894792|NCT00693472|1865852|FG002|Part 2|Withdrew - reason unrelated to treatment|1
894793|NCT00693472|1865853|FG003|Part 2|Withdrew - reason unrelated to treatment|2
894794|NCT00693693|1865898|FG000|Overall Study|Lost to Follow-up|1
894795|NCT00693693|1865899|FG001|Overall Study|Lost to Follow-up|1
894796|NCT00693693|1865900|FG002|Overall Study|Lost to Follow-up|2
894797|NCT00693706|1865910|FG000|Overall Study|Protocol Violation|0
894798|NCT00693706|1865911|FG001|Overall Study|Protocol Violation|1
894799|NCT00693784|1865921|FG000|Overall Study|Lost to Follow-up|2
894800|NCT00693784|1865921|FG000|Overall Study|Withdrawal by Subject|2
894801|NCT00694096|1865947|FG000|Overall Study|Withdrawal by Subject|5
894802|NCT00694109|1865951|FG000|Overall Study|Physician Decision|3
894803|NCT00694109|1865951|FG000|Overall Study|Adverse Event|74
894804|NCT00694109|1865951|FG000|Overall Study|Not consent of more 2 years of treatment|18
894805|NCT00694109|1865951|FG000|Overall Study|Lack of Efficacy|2
894806|NCT00694109|1865951|FG000|Overall Study|Withdrawal by Subject|13
894807|NCT00694109|1865951|FG000|Overall Study|Pregnancy|1
894808|NCT00694109|1865951|FG000|Overall Study|Enrolled but not treated|1
894809|NCT00694109|1865951|FG000|Overall Study|Other|2
894810|NCT00694109|1865951|FG000|Overall Study|Consented but no additional treatment|3
894811|NCT00694122|1865956|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
894812|NCT00694122|1865957|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
894813|NCT00694122|1865956|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1
894814|NCT00694122|1865957|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1
894815|NCT00694122|1865956|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
894816|NCT00694122|1865957|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
894817|NCT00694161|1865968|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
894818|NCT00694161|1865968|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
894819|NCT00694161|1865968|FG000|Part 2 (After Week 6 up to Month 12)|Death|1
894820|NCT00694304|1865972|FG000|Overall Study|Adverse Event|42
894821|NCT00694304|1865972|FG000|Overall Study|Lack of Efficacy|35
894822|NCT00694304|1865972|FG000|Overall Study|Non-compliance With Study Product|16
894823|NCT00694304|1865972|FG000|Overall Study|Protocol Violation|6
894824|NCT00694304|1865972|FG000|Overall Study|Withdrawal of Consent|61
894825|NCT00694304|1865972|FG000|Overall Study|Lost to Follow-up|15
894826|NCT00694304|1865972|FG000|Overall Study|Administrative or Other Reasons|32
894827|NCT00694356|1865979|FG000|Overall Study|Adverse Event|1
894828|NCT00694356|1865980|FG001|Overall Study|Adverse Event|0
894829|NCT00694356|1865981|FG002|Overall Study|Adverse Event|0
894830|NCT00694356|1865979|FG000|Overall Study|Progressive Disease|2
894831|NCT00694356|1865980|FG001|Overall Study|Progressive Disease|6
894832|NCT00694356|1865981|FG002|Overall Study|Progressive Disease|6
894833|NCT00694369|1865994|FG000|Overall Study|Adverse Event|0
894834|NCT00694369|1865995|FG001|Overall Study|Adverse Event|1
894835|NCT00694369|1865996|FG002|Overall Study|Adverse Event|0
894836|NCT00694369|1865997|FG003|Overall Study|Adverse Event|1
894837|NCT00694369|1865998|FG004|Overall Study|Adverse Event|3
894838|NCT00694369|1865994|FG000|Overall Study|Lost to Follow-up|0
894839|NCT00694369|1865995|FG001|Overall Study|Lost to Follow-up|0
894840|NCT00694369|1865996|FG002|Overall Study|Lost to Follow-up|1
894841|NCT00694369|1865997|FG003|Overall Study|Lost to Follow-up|1
894842|NCT00694369|1865998|FG004|Overall Study|Lost to Follow-up|0
894843|NCT00694369|1865994|FG000|Overall Study|Physician Decision|0
894844|NCT00694369|1865995|FG001|Overall Study|Physician Decision|0
894845|NCT00694369|1865996|FG002|Overall Study|Physician Decision|0
894846|NCT00694369|1865997|FG003|Overall Study|Physician Decision|0
894847|NCT00694369|1865998|FG004|Overall Study|Physician Decision|1
894848|NCT00694369|1865994|FG000|Overall Study|Protocol Violation|0
894849|NCT00694369|1865995|FG001|Overall Study|Protocol Violation|1
894850|NCT00694369|1865996|FG002|Overall Study|Protocol Violation|0
894851|NCT00694369|1865997|FG003|Overall Study|Protocol Violation|0
894852|NCT00694369|1865998|FG004|Overall Study|Protocol Violation|0
894853|NCT00694369|1865994|FG000|Overall Study|Withdrawal by Subject|1
894854|NCT00694369|1865995|FG001|Overall Study|Withdrawal by Subject|1
894855|NCT00694369|1865996|FG002|Overall Study|Withdrawal by Subject|1
894856|NCT00694369|1865997|FG003|Overall Study|Withdrawal by Subject|1
894857|NCT00694369|1865998|FG004|Overall Study|Withdrawal by Subject|2
894858|NCT00694551|1866017|FG000|Overall Study|Disease Progression|1
894859|NCT00694551|1866018|FG001|Overall Study|Disease Progression|0
894860|NCT00694551|1866019|FG002|Overall Study|Disease Progression|1
1100086|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1100087|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1100088|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1100089|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100090|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1100091|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
1100092|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100093|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
1100094|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
1100095|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
1100096|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1100097|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100098|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100099|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100100|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100101|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100102|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100103|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1100104|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100105|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100106|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100107|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100108|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100109|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100110|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100111|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100112|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100113|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100114|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100115|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100116|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100117|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
1100118|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
1100119|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
1100120|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
1100121|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100122|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100123|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100124|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100125|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100126|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100127|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1100128|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100129|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100130|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100131|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100132|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100133|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100134|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
1100135|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100136|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100137|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100138|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
894861|NCT00694707|1866041|FG000|Overall Study|Did Not Receive Treatment|0
894862|NCT00694707|1866042|FG001|Overall Study|Did Not Receive Treatment|0
894863|NCT00694707|1866043|FG002|Overall Study|Did Not Receive Treatment|1
894864|NCT00694707|1866044|FG003|Overall Study|Did Not Receive Treatment|1
894865|NCT00694707|1866045|FG004|Overall Study|Did Not Receive Treatment|1
894866|NCT00694707|1866041|FG000|Overall Study|Adverse Event|22
894867|NCT00694707|1866042|FG001|Overall Study|Adverse Event|14
894868|NCT00694707|1866043|FG002|Overall Study|Adverse Event|8
894869|NCT00694707|1866044|FG003|Overall Study|Adverse Event|12
894870|NCT00694707|1866045|FG004|Overall Study|Adverse Event|13
894871|NCT00694707|1866041|FG000|Overall Study|Insufficient Therapeutic Response|33
894872|NCT00694707|1866042|FG001|Overall Study|Insufficient Therapeutic Response|18
894873|NCT00694707|1866043|FG002|Overall Study|Insufficient Therapeutic Response|17
894874|NCT00694707|1866044|FG003|Overall Study|Insufficient Therapeutic Response|15
894875|NCT00694707|1866045|FG004|Overall Study|Insufficient Therapeutic Response|10
1100139|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100140|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100141|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100142|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100143|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100144|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100145|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100146|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100147|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100148|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100149|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100150|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100151|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
1100152|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100153|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100154|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100155|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100156|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100157|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100158|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100159|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100160|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
1100161|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100162|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100163|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
1100164|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100165|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
1100166|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
1100167|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100168|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100169|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100170|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100171|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100172|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100173|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100174|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100175|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
1100176|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100177|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100178|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100179|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100180|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100181|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100182|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100183|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100184|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100185|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
1100186|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100187|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100188|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100189|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100190|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100191|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100192|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100193|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100194|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100195|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100196|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
894876|NCT00694707|1866041|FG000|Overall Study|Protocol Violation|1
1100197|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100198|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100199|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
1100200|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100201|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100202|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100203|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100204|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100205|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100206|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100207|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100208|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100209|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100210|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1
1100211|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100212|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100213|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100214|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100215|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100216|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100217|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100218|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100219|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100220|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100221|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100222|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100223|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
1100224|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100225|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100226|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100227|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100228|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100229|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100230|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100231|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100232|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100233|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100234|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100235|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100236|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100237|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100238|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
1100239|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100240|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100241|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100242|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100243|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100244|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100245|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100246|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100247|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
1100248|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100249|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100250|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100251|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100252|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100253|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100254|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100255|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100256|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100257|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100258|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100259|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100260|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100261|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100262|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
1100263|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100264|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100265|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100266|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100267|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100268|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100269|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100270|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100271|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
1100272|NCT02346240|2173432|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100273|NCT02346240|2173433|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100274|NCT02346240|2173434|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100275|NCT02346240|2173435|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100276|NCT02346240|2173436|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100277|NCT02346240|2173437|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100278|NCT02346240|2173438|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100279|NCT02346240|2173439|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100280|NCT02346240|2173440|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100281|NCT02346240|2173441|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100282|NCT02346240|2173442|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100283|NCT02346240|2173443|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100284|NCT02346240|2173444|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100285|NCT02346240|2173445|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100286|NCT02346240|2173446|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
1100287|NCT02346240|2173447|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100288|NCT02346240|2173448|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100289|NCT02346240|2173449|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100290|NCT02346240|2173450|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100291|NCT02346240|2173451|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100292|NCT02346240|2173452|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100293|NCT02346240|2173453|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100294|NCT02346240|2173454|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100295|NCT02346240|2173455|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
1100296|NCT02346240|2173432|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100297|NCT02346240|2173433|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100298|NCT02346240|2173434|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100299|NCT02346240|2173435|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100300|NCT02346240|2173436|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100301|NCT02346240|2173437|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100302|NCT02346240|2173438|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100303|NCT02346240|2173439|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100304|NCT02346240|2173440|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100305|NCT02346240|2173441|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100306|NCT02346240|2173442|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100307|NCT02346240|2173443|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100308|NCT02346240|2173444|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100309|NCT02346240|2173445|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100310|NCT02346240|2173446|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100311|NCT02346240|2173447|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100312|NCT02346240|2173448|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
1100313|NCT02346240|2173449|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
1100314|NCT02346240|2173450|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
1100315|NCT02346240|2173451|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
1100316|NCT02346240|2173452|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
1100317|NCT02346240|2173453|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
1100318|NCT02346240|2173454|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
1100319|NCT02346240|2173455|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
1100320|NCT02346240|2173432|FG000|Open-Label Period (Week 48 to Week 144)|Death|0
1100321|NCT02346240|2173433|FG001|Open-Label Period (Week 48 to Week 144)|Death|0
1100322|NCT02346240|2173434|FG002|Open-Label Period (Week 48 to Week 144)|Death|0
1100323|NCT02346240|2173435|FG003|Open-Label Period (Week 48 to Week 144)|Death|0
1100324|NCT02346240|2173436|FG004|Open-Label Period (Week 48 to Week 144)|Death|0
1100325|NCT02346240|2173437|FG005|Open-Label Period (Week 48 to Week 144)|Death|0
1100326|NCT02346240|2173438|FG006|Open-Label Period (Week 48 to Week 144)|Death|0
1100327|NCT02346240|2173439|FG007|Open-Label Period (Week 48 to Week 144)|Death|0
1100328|NCT02346240|2173440|FG008|Open-Label Period (Week 48 to Week 144)|Death|0
1100329|NCT02346240|2173441|FG009|Open-Label Period (Week 48 to Week 144)|Death|0
1100330|NCT02346240|2173442|FG010|Open-Label Period (Week 48 to Week 144)|Death|0
1100331|NCT02346240|2173443|FG011|Open-Label Period (Week 48 to Week 144)|Death|0
1100332|NCT02346240|2173444|FG012|Open-Label Period (Week 48 to Week 144)|Death|0
1100333|NCT02346240|2173445|FG013|Open-Label Period (Week 48 to Week 144)|Death|0
1100334|NCT02346240|2173446|FG014|Open-Label Period (Week 48 to Week 144)|Death|0
1100335|NCT02346240|2173447|FG015|Open-Label Period (Week 48 to Week 144)|Death|0
1100336|NCT02346240|2173448|FG016|Open-Label Period (Week 48 to Week 144)|Death|0
1100337|NCT02346240|2173449|FG017|Open-Label Period (Week 48 to Week 144)|Death|0
1100338|NCT02346240|2173450|FG018|Open-Label Period (Week 48 to Week 144)|Death|1
1100339|NCT02346240|2173451|FG019|Open-Label Period (Week 48 to Week 144)|Death|1
1100340|NCT02346240|2173452|FG020|Open-Label Period (Week 48 to Week 144)|Death|0
894877|NCT00694707|1866042|FG001|Overall Study|Protocol Violation|2
894878|NCT00694707|1866043|FG002|Overall Study|Protocol Violation|1
894879|NCT00694707|1866044|FG003|Overall Study|Protocol Violation|3
894880|NCT00694707|1866045|FG004|Overall Study|Protocol Violation|1
894881|NCT00694707|1866041|FG000|Overall Study|Withdrawal of Consent|14
894882|NCT00694707|1866042|FG001|Overall Study|Withdrawal of Consent|18
894883|NCT00694707|1866043|FG002|Overall Study|Withdrawal of Consent|22
894884|NCT00694707|1866044|FG003|Overall Study|Withdrawal of Consent|16
894885|NCT00694707|1866045|FG004|Overall Study|Withdrawal of Consent|15
894886|NCT00694707|1866041|FG000|Overall Study|Lost to Follow-up|0
894887|NCT00694707|1866042|FG001|Overall Study|Lost to Follow-up|1
894888|NCT00694707|1866043|FG002|Overall Study|Lost to Follow-up|2
894889|NCT00694707|1866044|FG003|Overall Study|Lost to Follow-up|0
894890|NCT00694707|1866045|FG004|Overall Study|Lost to Follow-up|0
894891|NCT00694707|1866041|FG000|Overall Study|Jeopardizing Parole Status|1
894892|NCT00694707|1866042|FG001|Overall Study|Jeopardizing Parole Status|0
894893|NCT00694707|1866043|FG002|Overall Study|Jeopardizing Parole Status|0
894894|NCT00694707|1866044|FG003|Overall Study|Jeopardizing Parole Status|0
894895|NCT00694707|1866045|FG004|Overall Study|Jeopardizing Parole Status|0
894896|NCT00694707|1866041|FG000|Overall Study|Death in the Family|1
894897|NCT00694707|1866042|FG001|Overall Study|Death in the Family|0
894898|NCT00694707|1866043|FG002|Overall Study|Death in the Family|0
894899|NCT00694707|1866044|FG003|Overall Study|Death in the Family|0
894900|NCT00694707|1866045|FG004|Overall Study|Death in the Family|0
894901|NCT00694707|1866041|FG000|Overall Study|Arrest by Police|0
894902|NCT00694707|1866042|FG001|Overall Study|Arrest by Police|1
894903|NCT00694707|1866043|FG002|Overall Study|Arrest by Police|0
894904|NCT00694707|1866044|FG003|Overall Study|Arrest by Police|0
894905|NCT00694707|1866045|FG004|Overall Study|Arrest by Police|0
894906|NCT00694707|1866041|FG000|Overall Study|Administrative Reasons|0
894907|NCT00694707|1866042|FG001|Overall Study|Administrative Reasons|1
894908|NCT00694707|1866043|FG002|Overall Study|Administrative Reasons|0
894909|NCT00694707|1866044|FG003|Overall Study|Administrative Reasons|2
894910|NCT00694707|1866045|FG004|Overall Study|Administrative Reasons|0
894911|NCT00694707|1866041|FG000|Overall Study|Notification of Past Head Injury|0
894912|NCT00694707|1866042|FG001|Overall Study|Notification of Past Head Injury|0
894913|NCT00694707|1866043|FG002|Overall Study|Notification of Past Head Injury|0
894914|NCT00694707|1866044|FG003|Overall Study|Notification of Past Head Injury|1
894915|NCT00694707|1866045|FG004|Overall Study|Notification of Past Head Injury|0
894916|NCT00695019|1866060|FG000|Overall Study|Withdrawal by Subject|8
894917|NCT00695019|1866061|FG001|Overall Study|Withdrawal by Subject|6
894918|NCT00695019|1866062|FG002|Overall Study|Withdrawal by Subject|4
894919|NCT00695019|1866060|FG000|Overall Study|Protocol Violation|1
894920|NCT00695019|1866061|FG001|Overall Study|Protocol Violation|3
894921|NCT00695019|1866062|FG002|Overall Study|Protocol Violation|1
894922|NCT00695019|1866060|FG000|Overall Study|Lack of Efficacy|0
894923|NCT00695019|1866061|FG001|Overall Study|Lack of Efficacy|0
894924|NCT00695019|1866062|FG002|Overall Study|Lack of Efficacy|1
894925|NCT00695019|1866060|FG000|Overall Study|Various|4
894926|NCT00695019|1866061|FG001|Overall Study|Various|5
894927|NCT00695019|1866062|FG002|Overall Study|Various|4
894928|NCT00695110|1866079|FG000|Treatment Period 1|Adverse Event|1
894929|NCT00695110|1866079|FG000|Treatment Period 1|Withdrawal by Subject|2
894930|NCT00695110|1866079|FG000|Treatment Period 3|Withdrawal by Subject|1
894931|NCT00695110|1866079|FG000|Treatment Period 4|Adverse Event|1
894932|NCT00695136|1866086|FG000|Overall Study|Withdrawal by Subject|1
894933|NCT00695136|1866086|FG000|Overall Study|unrelated adverse event|1
894934|NCT00695318|1866110|FG000|Overall Study|Lost to Follow-up|1
894935|NCT00695318|1866111|FG001|Overall Study|Lost to Follow-up|0
894936|NCT00695318|1866110|FG000|Overall Study|Withdrawal by Subject|2
894937|NCT00695318|1866111|FG001|Overall Study|Withdrawal by Subject|0
894938|NCT00695318|1866110|FG000|Overall Study|Death|1
1100341|NCT02346240|2173453|FG021|Open-Label Period (Week 48 to Week 144)|Death|1
1100342|NCT02346240|2173454|FG022|Open-Label Period (Week 48 to Week 144)|Death|0
1100343|NCT02346240|2173455|FG023|Open-Label Period (Week 48 to Week 144)|Death|0
1100344|NCT02346240|2173432|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100345|NCT02346240|2173433|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100346|NCT02346240|2173434|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100347|NCT02346240|2173435|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100348|NCT02346240|2173436|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100349|NCT02346240|2173437|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100350|NCT02346240|2173438|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100351|NCT02346240|2173439|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100352|NCT02346240|2173440|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100353|NCT02346240|2173441|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100354|NCT02346240|2173442|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100355|NCT02346240|2173443|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100356|NCT02346240|2173444|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100357|NCT02346240|2173445|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100358|NCT02346240|2173446|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100359|NCT02346240|2173447|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100360|NCT02346240|2173448|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100361|NCT02346240|2173449|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100362|NCT02346240|2173450|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
1100363|NCT02346240|2173451|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100364|NCT02346240|2173452|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100365|NCT02346240|2173453|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
1100366|NCT02346240|2173454|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100367|NCT02346240|2173455|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
1100368|NCT02346240|2173432|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100369|NCT02346240|2173433|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100370|NCT02346240|2173434|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100371|NCT02346240|2173435|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100372|NCT02346240|2173436|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100373|NCT02346240|2173437|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100374|NCT02346240|2173438|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100375|NCT02346240|2173439|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100376|NCT02346240|2173440|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100377|NCT02346240|2173441|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100378|NCT02346240|2173442|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100379|NCT02346240|2173443|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100380|NCT02346240|2173444|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100381|NCT02346240|2173445|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100382|NCT02346240|2173446|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100383|NCT02346240|2173447|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100384|NCT02346240|2173448|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100385|NCT02346240|2173449|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100386|NCT02346240|2173450|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100387|NCT02346240|2173451|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100388|NCT02346240|2173452|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100389|NCT02346240|2173453|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
1100390|NCT02346240|2173454|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100391|NCT02346240|2173455|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
1100392|NCT02346240|2173432|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100393|NCT02346240|2173433|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100394|NCT02346240|2173434|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100395|NCT02346240|2173435|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100396|NCT02346240|2173436|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100397|NCT02346240|2173437|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100398|NCT02346240|2173438|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100399|NCT02346240|2173439|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100400|NCT02346240|2173440|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100401|NCT02346240|2173441|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100402|NCT02346240|2173442|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100403|NCT02346240|2173443|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100404|NCT02346240|2173444|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100405|NCT02346240|2173445|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100406|NCT02346240|2173446|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100407|NCT02346240|2173447|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100408|NCT02346240|2173448|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100409|NCT02346240|2173449|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
1100410|NCT02346240|2173450|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
1100411|NCT02346240|2173451|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
1100412|NCT02346240|2173452|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
1100413|NCT02346240|2173453|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
1100414|NCT02346240|2173454|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
1100415|NCT02346240|2173455|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
1100416|NCT02346240|2173432|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100417|NCT02346240|2173433|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100418|NCT02346240|2173434|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100419|NCT02346240|2173435|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100420|NCT02346240|2173436|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100421|NCT02346240|2173437|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100422|NCT02346240|2173438|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100423|NCT02346240|2173439|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100424|NCT02346240|2173440|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100425|NCT02346240|2173441|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100426|NCT02346240|2173442|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100427|NCT02346240|2173443|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100428|NCT02346240|2173444|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100429|NCT02346240|2173445|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100430|NCT02346240|2173446|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100431|NCT02346240|2173447|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100432|NCT02346240|2173448|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100433|NCT02346240|2173449|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100434|NCT02346240|2173450|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
1100435|NCT02346240|2173451|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
1100436|NCT02346240|2173452|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1100437|NCT02346240|2173453|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
1100438|NCT02346240|2173454|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
1100439|NCT02346240|2173455|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
1100440|NCT02346240|2173432|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100441|NCT02346240|2173433|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100442|NCT02346240|2173434|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100443|NCT02346240|2173435|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100444|NCT02346240|2173436|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100445|NCT02346240|2173437|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100446|NCT02346240|2173438|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100447|NCT02346240|2173439|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100448|NCT02346240|2173440|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100449|NCT02346240|2173441|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100450|NCT02346240|2173442|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100451|NCT02346240|2173443|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100452|NCT02346240|2173444|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100453|NCT02346240|2173445|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100454|NCT02346240|2173446|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100455|NCT02346240|2173447|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100456|NCT02346240|2173448|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100457|NCT02346240|2173449|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100458|NCT02346240|2173450|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
1100459|NCT02346240|2173451|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100460|NCT02346240|2173452|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
1100461|NCT02346240|2173453|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
1100462|NCT02346240|2173454|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
1100463|NCT02346240|2173455|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
1100464|NCT02346240|2173432|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100465|NCT02346240|2173433|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100466|NCT02346240|2173434|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100467|NCT02346240|2173435|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100468|NCT02346240|2173436|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100469|NCT02346240|2173437|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100470|NCT02346240|2173438|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100471|NCT02346240|2173439|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100472|NCT02346240|2173440|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100473|NCT02346240|2173441|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100474|NCT02346240|2173442|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100475|NCT02346240|2173443|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100476|NCT02346240|2173444|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100477|NCT02346240|2173445|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100478|NCT02346240|2173446|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100479|NCT02346240|2173447|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100480|NCT02346240|2173448|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100481|NCT02346240|2173449|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100482|NCT02346240|2173450|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
1100483|NCT02346240|2173451|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100484|NCT02346240|2173452|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100485|NCT02346240|2173453|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100486|NCT02346240|2173454|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100487|NCT02346240|2173455|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
1100488|NCT02346370|2173480|FG000|Overall Study|Not treated|1
1100489|NCT02346370|2173481|FG001|Overall Study|Not treated|0
1100490|NCT02346370|2173482|FG002|Overall Study|Not treated|0
1100491|NCT02346370|2173480|FG000|Overall Study|Withdrawal of consent|1
1100492|NCT02346370|2173481|FG001|Overall Study|Withdrawal of consent|0
1100493|NCT02346370|2173482|FG002|Overall Study|Withdrawal of consent|0
1100494|NCT02346370|2173480|FG000|Overall Study|Death|1
1100495|NCT02346370|2173481|FG001|Overall Study|Death|3
1100496|NCT02346370|2173482|FG002|Overall Study|Death|1
1100497|NCT02346370|2173480|FG000|Overall Study|Sponsor discontinued study|5
1100498|NCT02346370|2173481|FG001|Overall Study|Sponsor discontinued study|0
1100499|NCT02346370|2173482|FG002|Overall Study|Sponsor discontinued study|2
1100500|NCT02346370|2173480|FG000|Overall Study|Radiologic progression|0
1100501|NCT02346370|2173481|FG001|Overall Study|Radiologic progression|0
1100502|NCT02346370|2173482|FG002|Overall Study|Radiologic progression|1
1100503|NCT02346370|2173480|FG000|Overall Study|Physician Decision|0
1100504|NCT02346370|2173481|FG001|Overall Study|Physician Decision|1
1100505|NCT02346370|2173482|FG002|Overall Study|Physician Decision|0
1100506|NCT02346708|2173516|FG000|Overall Study|Adverse Event|2
1100507|NCT02346708|2173517|FG001|Overall Study|Adverse Event|0
1100508|NCT02346708|2173516|FG000|Overall Study|Protocol Violation|0
1100509|NCT02346708|2173517|FG001|Overall Study|Protocol Violation|1
1100510|NCT02346721|2173524|FG000|Overall Study|Withdrew Consent|3
1100511|NCT02346721|2173524|FG000|Overall Study|Lack of Efficacy|1
1100512|NCT02347072|2173538|FG000|Overall Study|Adverse Event|2
1100513|NCT02347072|2173538|FG000|Overall Study|Withdrawal by Subject|6
1100514|NCT02347072|2173538|FG000|Overall Study|Physician Decision|1
1100515|NCT02347072|2173538|FG000|Overall Study|Lost to Follow-up|2
1100516|NCT02347072|2173538|FG000|Overall Study|Protocol Violation|1
1100517|NCT02347072|2173538|FG000|Overall Study|Disc due to Protocol-specified Criteria|6
1100518|NCT02347085|2173546|FG000|Overall Study|Adverse Event|2
1100519|NCT02347085|2173546|FG000|Overall Study|Lack of Efficacy|1
1100520|NCT02347085|2173546|FG000|Overall Study|Withdrawal by Subject|4
1100521|NCT02347085|2173546|FG000|Overall Study|Lost to Follow-up|1
1100522|NCT02347085|2173546|FG000|Overall Study|Protocol Criteria|2
1100523|NCT02347098|2173554|FG000|Overall Study|Death|1
1100524|NCT02347098|2173555|FG001|Overall Study|Death|0
1100525|NCT02347098|2173554|FG000|Overall Study|Withdrawal by Subject|1
1100526|NCT02347098|2173555|FG001|Overall Study|Withdrawal by Subject|0
1100527|NCT02347098|2173554|FG000|Overall Study|Lost to Follow-up|2
1100528|NCT02347098|2173555|FG001|Overall Study|Lost to Follow-up|2
1100529|NCT02347098|2173554|FG000|Overall Study|Refuse Follow-up Visit|1
1100530|NCT02347098|2173555|FG001|Overall Study|Refuse Follow-up Visit|5
1100531|NCT02347098|2173554|FG000|Overall Study|no visit due to illness|2
1100532|NCT02347098|2173555|FG001|Overall Study|no visit due to illness|1
1100533|NCT02347176|2173574|FG000|Overall Study|Lost to Follow-up|2
1100534|NCT02347176|2173575|FG001|Overall Study|Lost to Follow-up|3
1100535|NCT02347176|2173576|FG002|Overall Study|Lost to Follow-up|1
1100536|NCT02347176|2173577|FG003|Overall Study|Lost to Follow-up|1
1100537|NCT02347176|2173574|FG000|Overall Study|Withdrawal by Subject|9
1100538|NCT02347176|2173575|FG001|Overall Study|Withdrawal by Subject|5
1100539|NCT02347176|2173576|FG002|Overall Study|Withdrawal by Subject|5
1100540|NCT02347176|2173577|FG003|Overall Study|Withdrawal by Subject|3
1100541|NCT02347176|2173574|FG000|Overall Study|Other|1
1100542|NCT02347176|2173575|FG001|Overall Study|Other|2
1100543|NCT02347176|2173576|FG002|Overall Study|Other|2
1100544|NCT02347176|2173577|FG003|Overall Study|Other|0
1100545|NCT02347189|2173587|FG000|Overall Study|No implant attempted of study device|9
1100546|NCT02347189|2173587|FG000|Overall Study|No primary outcome data available|2
1100547|NCT02347332|2173604|FG000|Overall Study|Not treated|5
1100548|NCT02347332|2173605|FG001|Overall Study|Not treated|2
1100549|NCT02347332|2173604|FG000|Overall Study|Progressive disease|141
1100550|NCT02347332|2173605|FG001|Overall Study|Progressive disease|159
1100551|NCT02347332|2173604|FG000|Overall Study|Adverse Event|50
1100552|NCT02347332|2173605|FG001|Overall Study|Adverse Event|41
1100553|NCT02347332|2173604|FG000|Overall Study|Death (Unknown, Various reasons)|6
1100554|NCT02347332|2173605|FG001|Overall Study|Death (Unknown, Various reasons)|6
1100555|NCT02347332|2173604|FG000|Overall Study|Protocol Violation|1
1100556|NCT02347332|2173605|FG001|Overall Study|Protocol Violation|1
1100557|NCT02347332|2173604|FG000|Overall Study|Lost to Follow-up|2
1100558|NCT02347332|2173605|FG001|Overall Study|Lost to Follow-up|1
1100559|NCT02347332|2173604|FG000|Overall Study|Physician Decision|4
1100560|NCT02347332|2173605|FG001|Overall Study|Physician Decision|3
1100561|NCT02347332|2173604|FG000|Overall Study|Withdrawal by Subject|20
1100562|NCT02347332|2173605|FG001|Overall Study|Withdrawal by Subject|14
1100563|NCT02347332|2173604|FG000|Overall Study|Protocol requirement|1
1100564|NCT02347332|2173605|FG001|Overall Study|Protocol requirement|1
1100565|NCT02347332|2173604|FG000|Overall Study|Switch Post-Trial program|0
1100566|NCT02347332|2173605|FG001|Overall Study|Switch Post-Trial program|1
1100567|NCT02347631|2173664|FG000|First Intervention (2 Months)|Adverse Event|1
1100568|NCT02347631|2173665|FG001|First Intervention (2 Months)|Adverse Event|1
1100569|NCT02347631|2173664|FG000|First Intervention (2 Months)|Pregnancy|1
1100570|NCT02347631|2173665|FG001|First Intervention (2 Months)|Pregnancy|0
1100571|NCT02347631|2173664|FG000|First Intervention (2 Months)|Moved out of area|0
1100572|NCT02347631|2173665|FG001|First Intervention (2 Months)|Moved out of area|2
1100573|NCT02347631|2173664|FG000|First Intervention (2 Months)|Lost to Follow-up|5
1100574|NCT02347631|2173665|FG001|First Intervention (2 Months)|Lost to Follow-up|3
1100575|NCT02347631|2173664|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2
1100576|NCT02347631|2173665|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2
1100577|NCT02347631|2173664|FG000|Washout 2 (1 Month)|Lost to Follow-up|0
1100578|NCT02347631|2173665|FG001|Washout 2 (1 Month)|Lost to Follow-up|1
1100579|NCT02347631|2173664|FG000|Second Intervention (2 Months)|Lost to Follow-up|7
1100580|NCT02347631|2173665|FG001|Second Intervention (2 Months)|Lost to Follow-up|4
1100581|NCT02347631|2173664|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6
1100582|NCT02347631|2173665|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0
1100583|NCT02347657|2173675|FG000|Overall Study|Physician Decision|0
1100584|NCT02347657|2173676|FG001|Overall Study|Physician Decision|1
1100585|NCT02347657|2173675|FG000|Overall Study|Adverse Event|8
1100586|NCT02347657|2173676|FG001|Overall Study|Adverse Event|4
1100587|NCT02347657|2173675|FG000|Overall Study|Withdrawal by Subject|6
1100588|NCT02347657|2173676|FG001|Overall Study|Withdrawal by Subject|7
1100589|NCT02347657|2173675|FG000|Overall Study|Randomized but not treated|1
1100590|NCT02347657|2173676|FG001|Overall Study|Randomized but not treated|0
1100591|NCT02347657|2173675|FG000|Overall Study|Other|3
1100592|NCT02347657|2173676|FG001|Overall Study|Other|3
1100593|NCT02347761|2173686|FG000|All Collected|Death|1
1100594|NCT02347761|2173687|FG001|All Collected|Death|0
1100595|NCT02347761|2173688|FG002|All Collected|Death|0
1100596|NCT02347761|2173686|FG000|All Collected|Lost to Follow-up|3
1100597|NCT02347761|2173687|FG001|All Collected|Lost to Follow-up|2
1100598|NCT02347761|2173688|FG002|All Collected|Lost to Follow-up|3
1100599|NCT02347761|2173686|FG000|All Collected|Withdrawal by Subject|11
1100600|NCT02347761|2173687|FG001|All Collected|Withdrawal by Subject|11
1100601|NCT02347761|2173688|FG002|All Collected|Withdrawal by Subject|22
1100602|NCT02347761|2173686|FG000|All Collected|invetigator disretion|2
1100603|NCT02347761|2173687|FG001|All Collected|invetigator disretion|0
1100604|NCT02347761|2173688|FG002|All Collected|invetigator disretion|0
1100605|NCT02347761|2173686|FG000|All Collected|instillation site pain|0
1100606|NCT02347761|2173687|FG001|All Collected|instillation site pain|0
1100607|NCT02347761|2173688|FG002|All Collected|instillation site pain|1
1100608|NCT02347761|2173686|FG000|All Collected|exacerbation of COPD|0
1100609|NCT02347761|2173687|FG001|All Collected|exacerbation of COPD|0
1100610|NCT02347761|2173688|FG002|All Collected|exacerbation of COPD|1
1100611|NCT02347761|2173686|FG000|All Collected|moved/travel|0
1100612|NCT02347761|2173687|FG001|All Collected|moved/travel|1
1100613|NCT02347761|2173688|FG002|All Collected|moved/travel|0
1100614|NCT02347761|2173686|FG000|On Study Treatment|Lack of Efficacy|2
1100615|NCT02347761|2173687|FG001|On Study Treatment|Lack of Efficacy|3
1100616|NCT02347761|2173688|FG002|On Study Treatment|Lack of Efficacy|4
894939|NCT00695318|1866111|FG001|Overall Study|Death|1
894940|NCT00695318|1866110|FG000|Overall Study|Study Terminated|1
894941|NCT00695318|1866111|FG001|Overall Study|Study Terminated|0
894942|NCT00695396|1866125|FG000|Overall Study|Study Closed Prematurely|5
894943|NCT00695396|1866126|FG001|Overall Study|Study Closed Prematurely|6
894944|NCT00695396|1866127|FG002|Overall Study|Study Closed Prematurely|8
894945|NCT00695396|1866125|FG000|Overall Study|Withdrawal by Subject|2
894946|NCT00695396|1866126|FG001|Overall Study|Withdrawal by Subject|2
894947|NCT00695396|1866127|FG002|Overall Study|Withdrawal by Subject|0
894948|NCT00695565|1866161|FG000|Overall Study|Lost to Follow-up|4
894949|NCT00695565|1866162|FG001|Overall Study|Lost to Follow-up|4
894950|NCT00695565|1866161|FG000|Overall Study|Adverse Event|3
894951|NCT00695565|1866162|FG001|Overall Study|Adverse Event|1
894952|NCT00695565|1866161|FG000|Overall Study|Protocol Violation|3
894953|NCT00695565|1866162|FG001|Overall Study|Protocol Violation|1
894954|NCT00695565|1866161|FG000|Overall Study|Withdrawal by Subject|1
1100617|NCT02347761|2173686|FG000|On Study Treatment|non-compliance with study medication|0
1100618|NCT02347761|2173687|FG001|On Study Treatment|non-compliance with study medication|0
1100619|NCT02347761|2173688|FG002|On Study Treatment|non-compliance with study medication|2
1100620|NCT02347761|2173686|FG000|On Study Treatment|Withdrawal by Subject|7
1100621|NCT02347761|2173687|FG001|On Study Treatment|Withdrawal by Subject|3
1100622|NCT02347761|2173688|FG002|On Study Treatment|Withdrawal by Subject|5
1100623|NCT02347761|2173686|FG000|On Study Treatment|move/travel|2
1100624|NCT02347761|2173687|FG001|On Study Treatment|move/travel|6
1100625|NCT02347761|2173688|FG002|On Study Treatment|move/travel|5
1100626|NCT02347761|2173686|FG000|On Study Treatment|dissastisfaction with device|2
1100627|NCT02347761|2173687|FG001|On Study Treatment|dissastisfaction with device|1
1100628|NCT02347761|2173688|FG002|On Study Treatment|dissastisfaction with device|4
1100629|NCT02347761|2173686|FG000|On Study Treatment|Lost to Follow-up|2
1100630|NCT02347761|2173687|FG001|On Study Treatment|Lost to Follow-up|1
1100631|NCT02347761|2173688|FG002|On Study Treatment|Lost to Follow-up|1
1100632|NCT02347761|2173686|FG000|On Study Treatment|investigator discretion|2
1100633|NCT02347761|2173687|FG001|On Study Treatment|investigator discretion|0
1100634|NCT02347761|2173688|FG002|On Study Treatment|investigator discretion|0
1100635|NCT02347761|2173686|FG000|On Study Treatment|durg not working|0
1100636|NCT02347761|2173687|FG001|On Study Treatment|durg not working|1
1100637|NCT02347761|2173688|FG002|On Study Treatment|durg not working|1
1100638|NCT02347761|2173686|FG000|On Study Treatment|Adverse Event|10
1100639|NCT02347761|2173687|FG001|On Study Treatment|Adverse Event|8
1100640|NCT02347761|2173688|FG002|On Study Treatment|Adverse Event|20
1100641|NCT02347774|2173699|FG000|Study Participation|Lost to Follow-up|3
1100642|NCT02347774|2173700|FG001|Study Participation|Lost to Follow-up|6
1100643|NCT02347774|2173701|FG002|Study Participation|Lost to Follow-up|2
1100644|NCT02347774|2173699|FG000|Study Participation|Withdrawal by Subject|8
1100645|NCT02347774|2173700|FG001|Study Participation|Withdrawal by Subject|9
1100646|NCT02347774|2173701|FG002|Study Participation|Withdrawal by Subject|15
1100647|NCT02347774|2173699|FG000|Study Participation|Adverse Event|1
1100648|NCT02347774|2173700|FG001|Study Participation|Adverse Event|4
1100649|NCT02347774|2173701|FG002|Study Participation|Adverse Event|6
1100650|NCT02347774|2173699|FG000|Study Participation|withdrew consent|1
1100651|NCT02347774|2173700|FG001|Study Participation|withdrew consent|1
1100652|NCT02347774|2173701|FG002|Study Participation|withdrew consent|1
1100653|NCT02347774|2173699|FG000|Study Participation|Met Prolonged QT criteria|1
1100654|NCT02347774|2173700|FG001|Study Participation|Met Prolonged QT criteria|0
1100655|NCT02347774|2173701|FG002|Study Participation|Met Prolonged QT criteria|0
1100656|NCT02347774|2173699|FG000|Study Participation|non-compliance with study drug|0
1100657|NCT02347774|2173700|FG001|Study Participation|non-compliance with study drug|1
1100658|NCT02347774|2173701|FG002|Study Participation|non-compliance with study drug|0
1100659|NCT02347774|2173699|FG000|Study Participation|incarceration|1
1100660|NCT02347774|2173700|FG001|Study Participation|incarceration|0
1100661|NCT02347774|2173701|FG002|Study Participation|incarceration|0
1100662|NCT02347774|2173699|FG000|Study Participation|randomized in error|0
1100663|NCT02347774|2173700|FG001|Study Participation|randomized in error|0
1100664|NCT02347774|2173701|FG002|Study Participation|randomized in error|1
1100665|NCT02347774|2173699|FG000|On Study Treatment|Adverse Event|9
1100666|NCT02347774|2173700|FG001|On Study Treatment|Adverse Event|15
1100667|NCT02347774|2173701|FG002|On Study Treatment|Adverse Event|19
1100668|NCT02347774|2173699|FG000|On Study Treatment|Lack of Efficacy|3
1100669|NCT02347774|2173700|FG001|On Study Treatment|Lack of Efficacy|0
1100670|NCT02347774|2173701|FG002|On Study Treatment|Lack of Efficacy|2
1100671|NCT02347774|2173699|FG000|On Study Treatment|non-complicance with study medication|0
1100672|NCT02347774|2173700|FG001|On Study Treatment|non-complicance with study medication|2
1100673|NCT02347774|2173701|FG002|On Study Treatment|non-complicance with study medication|0
1100674|NCT02347774|2173699|FG000|On Study Treatment|Protocol Violation|0
1100675|NCT02347774|2173700|FG001|On Study Treatment|Protocol Violation|0
1100676|NCT02347774|2173701|FG002|On Study Treatment|Protocol Violation|1
1100677|NCT02347774|2173699|FG000|On Study Treatment|withdrew consent|9
1100678|NCT02347774|2173700|FG001|On Study Treatment|withdrew consent|8
1100679|NCT02347774|2173701|FG002|On Study Treatment|withdrew consent|12
1100680|NCT02347774|2173699|FG000|On Study Treatment|Lost to Follow-up|2
1100681|NCT02347774|2173700|FG001|On Study Treatment|Lost to Follow-up|6
1100682|NCT02347774|2173701|FG002|On Study Treatment|Lost to Follow-up|1
1100683|NCT02347774|2173699|FG000|On Study Treatment|Met Prolonged QT criteria|1
1100684|NCT02347774|2173700|FG001|On Study Treatment|Met Prolonged QT criteria|0
1100685|NCT02347774|2173701|FG002|On Study Treatment|Met Prolonged QT criteria|0
1100686|NCT02347774|2173699|FG000|On Study Treatment|ranomized in error|0
1100687|NCT02347774|2173700|FG001|On Study Treatment|ranomized in error|0
1100688|NCT02347774|2173701|FG002|On Study Treatment|ranomized in error|1
1100689|NCT02347787|2173711|FG000|6 Month Follow-Up|Lost to Follow-up|63
1100690|NCT02347787|2173712|FG001|6 Month Follow-Up|Lost to Follow-up|47
1100691|NCT02347787|2173711|FG000|6 Month Follow-Up|Withdrawal by Subject|3
1100692|NCT02347787|2173712|FG001|6 Month Follow-Up|Withdrawal by Subject|9
1100693|NCT02347787|2173711|FG000|9 Month Follow-Up|Lost to Follow-up|52
1100694|NCT02347787|2173712|FG001|9 Month Follow-Up|Lost to Follow-up|59
1100695|NCT02347787|2173711|FG000|9 Month Follow-Up|Withdrawal by Subject|9
1100696|NCT02347787|2173712|FG001|9 Month Follow-Up|Withdrawal by Subject|12
1100697|NCT02347813|2173725|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1
1100698|NCT02347813|2173726|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1
1100699|NCT02347813|2173725|FG000|First Intervention, 24 Weeks|Adverse Event|1
1100700|NCT02347813|2173726|FG001|First Intervention, 24 Weeks|Adverse Event|1
1100701|NCT02348008|2173751|FG000|Overall Study|Adverse Event|2
1100702|NCT02348008|2173752|FG001|Overall Study|Adverse Event|3
1100703|NCT02348008|2173753|FG002|Overall Study|Adverse Event|3
1100704|NCT02348008|2173751|FG000|Overall Study|Disease Progression|1
1100705|NCT02348008|2173752|FG001|Overall Study|Disease Progression|5
1100706|NCT02348008|2173753|FG002|Overall Study|Disease Progression|16
1100707|NCT02348008|2173751|FG000|Overall Study|Withdrawal by Subject|0
1100708|NCT02348008|2173752|FG001|Overall Study|Withdrawal by Subject|1
1100709|NCT02348008|2173753|FG002|Overall Study|Withdrawal by Subject|0
1100710|NCT02348008|2173751|FG000|Overall Study|Symptomatic Deterioration|0
1100711|NCT02348008|2173752|FG001|Overall Study|Symptomatic Deterioration|1
1100712|NCT02348008|2173753|FG002|Overall Study|Symptomatic Deterioration|0
1100713|NCT02348216|2173775|FG000|Overall Study|Death|4
1100714|NCT02348216|2173776|FG001|Overall Study|Death|27
1100715|NCT02348216|2173777|FG002|Overall Study|Death|3
1100716|NCT02348216|2173778|FG003|Overall Study|Death|18
1100717|NCT02348216|2173779|FG004|Overall Study|Death|9
1100718|NCT02348216|2173780|FG005|Overall Study|Death|23
1100719|NCT02348216|2173781|FG006|Overall Study|Death|6
1100720|NCT02348216|2173775|FG000|Overall Study|Full consent withdrawal|0
1100721|NCT02348216|2173776|FG001|Overall Study|Full consent withdrawal|0
1100722|NCT02348216|2173777|FG002|Overall Study|Full consent withdrawal|0
1100723|NCT02348216|2173778|FG003|Overall Study|Full consent withdrawal|1
1100724|NCT02348216|2173779|FG004|Overall Study|Full consent withdrawal|0
1100725|NCT02348216|2173780|FG005|Overall Study|Full consent withdrawal|0
1100726|NCT02348216|2173781|FG006|Overall Study|Full consent withdrawal|1
1100727|NCT02348216|2173775|FG000|Overall Study|Lost to Follow-up|0
1100728|NCT02348216|2173776|FG001|Overall Study|Lost to Follow-up|0
1100729|NCT02348216|2173777|FG002|Overall Study|Lost to Follow-up|0
1100730|NCT02348216|2173778|FG003|Overall Study|Lost to Follow-up|0
1100731|NCT02348216|2173779|FG004|Overall Study|Lost to Follow-up|0
1100732|NCT02348216|2173780|FG005|Overall Study|Lost to Follow-up|0
1100733|NCT02348216|2173781|FG006|Overall Study|Lost to Follow-up|1
1100734|NCT02348216|2173775|FG000|Overall Study|Still on study|3
1100735|NCT02348216|2173776|FG001|Overall Study|Still on study|50
1100736|NCT02348216|2173777|FG002|Overall Study|Still on study|21
1100737|NCT02348216|2173778|FG003|Overall Study|Still on study|19
1100738|NCT02348216|2173779|FG004|Overall Study|Still on study|32
894955|NCT00695565|1866162|FG001|Overall Study|Withdrawal by Subject|1
894956|NCT00695565|1866161|FG000|Overall Study|Lack of Efficacy|1
894957|NCT00695565|1866162|FG001|Overall Study|Lack of Efficacy|1
894958|NCT00695565|1866161|FG000|Overall Study|Subject did not follow instructions|1
894959|NCT00695565|1866162|FG001|Overall Study|Subject did not follow instructions|1
894960|NCT00695669|1866181|FG000|Overall Study|Adverse Event|0
894961|NCT00695669|1866182|FG001|Overall Study|Adverse Event|0
894962|NCT00695669|1866183|FG002|Overall Study|Adverse Event|2
894963|NCT00695669|1866184|FG003|Overall Study|Adverse Event|0
894964|NCT00695669|1866181|FG000|Overall Study|Lost to Follow-up|4
894965|NCT00695669|1866182|FG001|Overall Study|Lost to Follow-up|4
894966|NCT00695669|1866183|FG002|Overall Study|Lost to Follow-up|1
894967|NCT00695669|1866184|FG003|Overall Study|Lost to Follow-up|4
894968|NCT00695786|1866201|FG000|Overall Study|Adverse Event|0
894969|NCT00695786|1866202|FG001|Overall Study|Adverse Event|3
894970|NCT00695786|1866203|FG002|Overall Study|Adverse Event|4
894971|NCT00695786|1866204|FG003|Overall Study|Adverse Event|2
894972|NCT00695786|1866201|FG000|Overall Study|Lost to Follow-up|0
894973|NCT00695786|1866202|FG001|Overall Study|Lost to Follow-up|5
894974|NCT00695786|1866203|FG002|Overall Study|Lost to Follow-up|1
894975|NCT00695786|1866204|FG003|Overall Study|Lost to Follow-up|1
894976|NCT00695786|1866201|FG000|Overall Study|Withdrawal by Subject|0
894977|NCT00695786|1866202|FG001|Overall Study|Withdrawal by Subject|4
894978|NCT00695786|1866203|FG002|Overall Study|Withdrawal by Subject|3
894979|NCT00695786|1866204|FG003|Overall Study|Withdrawal by Subject|1
894980|NCT00695786|1866201|FG000|Overall Study|Deemed Ineligible|1
894981|NCT00695786|1866202|FG001|Overall Study|Deemed Ineligible|0
894982|NCT00695786|1866203|FG002|Overall Study|Deemed Ineligible|0
894983|NCT00695786|1866204|FG003|Overall Study|Deemed Ineligible|0
894984|NCT00695786|1866201|FG000|Overall Study|Lack of Efficacy|0
894985|NCT00695786|1866202|FG001|Overall Study|Lack of Efficacy|0
894986|NCT00695786|1866203|FG002|Overall Study|Lack of Efficacy|0
894987|NCT00695786|1866204|FG003|Overall Study|Lack of Efficacy|4
894988|NCT00695864|1866214|FG000|Placebo|Withdrawal by Subject|1
894989|NCT00695864|1866214|FG000|Placebo|Physician Decision|4
894990|NCT00695903|1866222|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0
894991|NCT00695903|1866223|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2
894992|NCT00695903|1866222|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
894993|NCT00695903|1866223|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
894994|NCT00695903|1866222|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1
894995|NCT00695903|1866223|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0
894996|NCT00695903|1866222|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
1100739|NCT02348216|2173780|FG005|Overall Study|Still on study|27
1100740|NCT02348216|2173781|FG006|Overall Study|Still on study|32
1100741|NCT02348216|2173775|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1
1100742|NCT02348216|2173776|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
1100743|NCT02348216|2173777|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6
1100744|NCT02348216|2173778|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
1100745|NCT02348216|2173779|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5
1100746|NCT02348216|2173780|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8
1100747|NCT02348216|2173781|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2
1100748|NCT02348489|2173849|FG000|Overall Study|Death|336
1100749|NCT02348489|2173850|FG001|Overall Study|Death|335
1100750|NCT02348489|2173849|FG000|Overall Study|Withdrawal by Subject|14
1100751|NCT02348489|2173850|FG001|Overall Study|Withdrawal by Subject|27
1100752|NCT02348489|2173849|FG000|Overall Study|Lost to Follow-up|3
1100753|NCT02348489|2173850|FG001|Overall Study|Lost to Follow-up|5
1100754|NCT02348723|2173923|FG000|Overall Study|No ablation|21
1100755|NCT02348723|2173924|FG001|Overall Study|No ablation|20
1100756|NCT02348723|2173923|FG000|Overall Study|Non-compliant with Protocol|1
1100757|NCT02348723|2173924|FG001|Overall Study|Non-compliant with Protocol|0
1100758|NCT02348723|2173923|FG000|Overall Study|Lost to Follow-up|1
1100759|NCT02348723|2173924|FG001|Overall Study|Lost to Follow-up|1
1100760|NCT02348723|2173923|FG000|Overall Study|Consent withdrawn|1
1100761|NCT02348723|2173924|FG001|Overall Study|Consent withdrawn|3
1100762|NCT02348723|2173923|FG000|Overall Study|Reason other than specified|1
1100763|NCT02348723|2173924|FG001|Overall Study|Reason other than specified|1
1100764|NCT02348723|2173923|FG000|Overall Study|Adverse Event|3
1100765|NCT02348723|2173924|FG001|Overall Study|Adverse Event|1
1100766|NCT02348840|2173943|FG000|Overall Study|Withdrawal by Subject|2
1100767|NCT02348840|2173944|FG001|Overall Study|Withdrawal by Subject|1
1100768|NCT02348840|2173945|FG002|Overall Study|Withdrawal by Subject|0
1100769|NCT02348840|2173946|FG003|Overall Study|Withdrawal by Subject|0
1100770|NCT02349048|2173995|FG000|Overall Study|Withdrawal by Subject|4
1100771|NCT02349048|2173996|FG001|Overall Study|Withdrawal by Subject|0
1100772|NCT02349048|2173995|FG000|Overall Study|Lost to Follow-up|1
1100773|NCT02349048|2173996|FG001|Overall Study|Lost to Follow-up|0
1100774|NCT02349061|2174004|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4
1100775|NCT02349061|2174005|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3
1100776|NCT02349061|2174006|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0
1100777|NCT02349061|2174004|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
1100778|NCT02349061|2174005|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
1100779|NCT02349061|2174006|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
1100780|NCT02349061|2174004|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1
1100781|NCT02349061|2174005|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0
1100782|NCT02349061|2174006|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0
1100783|NCT02349061|2174004|FG000|Main Study: PCP (Up to Week 24)|Other|1
1100784|NCT02349061|2174005|FG001|Main Study: PCP (Up to Week 24)|Other|1
1100785|NCT02349061|2174006|FG002|Main Study: PCP (Up to Week 24)|Other|0
1100786|NCT02349061|2174004|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
1100787|NCT02349061|2174005|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
1100788|NCT02349061|2174006|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
1100789|NCT02349061|2174004|FG000|Main Study: Week 24 to 56|Adverse Event|0
1100790|NCT02349061|2174005|FG001|Main Study: Week 24 to 56|Adverse Event|2
1100791|NCT02349061|2174006|FG002|Main Study: Week 24 to 56|Adverse Event|1
1100792|NCT02349061|2174004|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0
1100793|NCT02349061|2174005|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1
1100794|NCT02349061|2174006|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0
1100795|NCT02349061|2174004|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0
1100796|NCT02349061|2174005|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0
1100797|NCT02349061|2174006|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1
1100798|NCT02349061|2174004|FG000|Main Study: Week 24 to 56|Physician Decision|0
1100799|NCT02349061|2174005|FG001|Main Study: Week 24 to 56|Physician Decision|0
1100800|NCT02349061|2174006|FG002|Main Study: Week 24 to 56|Physician Decision|1
1100801|NCT02349061|2174004|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0
1100802|NCT02349061|2174005|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3
1100803|NCT02349061|2174006|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0
1100804|NCT02349061|2174004|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
1100805|NCT02349061|2174005|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
1100806|NCT02349061|2174006|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
1100807|NCT02349061|2174004|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
1162064|NCT03382418|2284044|FG001|Overall Study|Withdrawal by Subject|0
894997|NCT00695903|1866223|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
894998|NCT00695903|1866222|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0
894999|NCT00695903|1866223|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1
895000|NCT00695903|1866222|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1
895001|NCT00695903|1866223|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2
895002|NCT00695903|1866222|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
1100808|NCT02349061|2174005|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
1100809|NCT02349061|2174006|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
1100810|NCT02349061|2174004|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0
1100811|NCT02349061|2174005|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0
1100812|NCT02349061|2174006|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1
1100813|NCT02349295|2174032|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7
1100814|NCT02349295|2174033|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5
1100815|NCT02349295|2174034|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5
1100816|NCT02349295|2174035|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0
1100817|NCT02349295|2174036|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0
1100818|NCT02349295|2174037|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0
1100819|NCT02349295|2174038|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0
1100820|NCT02349295|2174039|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0
1100821|NCT02349295|2174040|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0
1100822|NCT02349295|2174041|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0
1100823|NCT02349295|2174042|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0
1100824|NCT02349295|2174043|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0
1100825|NCT02349295|2174044|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0
1100826|NCT02349295|2174045|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0
1100827|NCT02349295|2174032|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
1100828|NCT02349295|2174033|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
1100829|NCT02349295|2174034|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
1100830|NCT02349295|2174035|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1100831|NCT02349295|2174036|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1100832|NCT02349295|2174037|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1100833|NCT02349295|2174038|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1100834|NCT02349295|2174039|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1100835|NCT02349295|2174040|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1100836|NCT02349295|2174041|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1100837|NCT02349295|2174042|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1100838|NCT02349295|2174043|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1100839|NCT02349295|2174044|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1100840|NCT02349295|2174045|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1100841|NCT02349295|2174032|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
1100842|NCT02349295|2174033|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
1100843|NCT02349295|2174034|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
1100844|NCT02349295|2174035|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1100845|NCT02349295|2174036|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1100846|NCT02349295|2174037|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1100847|NCT02349295|2174038|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1100848|NCT02349295|2174039|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1100849|NCT02349295|2174040|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1100850|NCT02349295|2174041|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1100851|NCT02349295|2174042|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1100852|NCT02349295|2174043|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1100853|NCT02349295|2174044|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1100854|NCT02349295|2174045|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1100855|NCT02349295|2174032|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
895003|NCT00695903|1866223|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
895004|NCT00695903|1866222|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
895005|NCT00695903|1866223|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
895006|NCT00695903|1866222|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0
895007|NCT00695903|1866223|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1
895008|NCT00695955|1866229|FG000|Cohort 1|Adverse Event|26
895009|NCT00695955|1866229|FG000|Cohort 1|Protocol Violation|2
895010|NCT00695955|1866229|FG000|Cohort 1|Lost to Follow-up|30
895011|NCT00695955|1866229|FG000|Cohort 1|Withdrawal by Subject|25
895012|NCT00695955|1866229|FG000|Cohort 1|Lack of Efficacy|3
1100856|NCT02349295|2174033|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
1100857|NCT02349295|2174034|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
1100858|NCT02349295|2174035|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1100859|NCT02349295|2174036|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1100860|NCT02349295|2174037|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1100861|NCT02349295|2174038|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1100862|NCT02349295|2174039|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1100863|NCT02349295|2174040|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1100864|NCT02349295|2174041|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1100865|NCT02349295|2174042|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1100866|NCT02349295|2174043|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1100867|NCT02349295|2174044|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1100868|NCT02349295|2174045|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1100869|NCT02349295|2174032|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100870|NCT02349295|2174033|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
1100871|NCT02349295|2174034|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
1100872|NCT02349295|2174035|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100873|NCT02349295|2174036|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100874|NCT02349295|2174037|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100875|NCT02349295|2174038|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100876|NCT02349295|2174039|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100877|NCT02349295|2174040|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100878|NCT02349295|2174041|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100879|NCT02349295|2174042|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100880|NCT02349295|2174043|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100881|NCT02349295|2174044|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100882|NCT02349295|2174045|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1100883|NCT02349295|2174032|FG000|IR (Week 16-24)|Lack of Efficacy|0
1100884|NCT02349295|2174033|FG001|IR (Week 16-24)|Lack of Efficacy|0
1100885|NCT02349295|2174034|FG002|IR (Week 16-24)|Lack of Efficacy|0
1100886|NCT02349295|2174035|FG003|IR (Week 16-24)|Lack of Efficacy|1
1100887|NCT02349295|2174036|FG004|IR (Week 16-24)|Lack of Efficacy|0
1100888|NCT02349295|2174037|FG005|IR (Week 16-24)|Lack of Efficacy|0
1100889|NCT02349295|2174038|FG006|IR (Week 16-24)|Lack of Efficacy|0
1100890|NCT02349295|2174039|FG007|IR (Week 16-24)|Lack of Efficacy|0
1100891|NCT02349295|2174040|FG008|IR (Week 16-24)|Lack of Efficacy|0
1100892|NCT02349295|2174041|FG009|IR (Week 16-24)|Lack of Efficacy|0
1100893|NCT02349295|2174042|FG010|IR (Week 16-24)|Lack of Efficacy|0
1100894|NCT02349295|2174043|FG011|IR (Week 16-24)|Lack of Efficacy|0
1100895|NCT02349295|2174044|FG012|IR (Week 16-24)|Lack of Efficacy|0
1100896|NCT02349295|2174045|FG013|IR (Week 16-24)|Lack of Efficacy|0
1100897|NCT02349295|2174032|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
1100898|NCT02349295|2174033|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
1100899|NCT02349295|2174034|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
1100900|NCT02349295|2174035|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
1100901|NCT02349295|2174036|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
1100902|NCT02349295|2174037|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
1100903|NCT02349295|2174038|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
1100904|NCT02349295|2174039|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32
1100905|NCT02349295|2174040|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25
1100906|NCT02349295|2174041|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19
1100907|NCT02349295|2174042|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18
1100908|NCT02349295|2174043|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
1100909|NCT02349295|2174044|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
1100910|NCT02349295|2174045|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
1100911|NCT02349295|2174032|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0
1100912|NCT02349295|2174033|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0
1100913|NCT02349295|2174034|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0
1100914|NCT02349295|2174035|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0
1100915|NCT02349295|2174036|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0
1100916|NCT02349295|2174037|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0
1100917|NCT02349295|2174038|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0
1100918|NCT02349295|2174039|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9
1100919|NCT02349295|2174040|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9
1100920|NCT02349295|2174041|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2
1100921|NCT02349295|2174042|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2
1100922|NCT02349295|2174043|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0
1100923|NCT02349295|2174044|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0
1100924|NCT02349295|2174045|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0
1100925|NCT02349295|2174032|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100926|NCT02349295|2174033|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100927|NCT02349295|2174034|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100928|NCT02349295|2174035|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100929|NCT02349295|2174036|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100930|NCT02349295|2174037|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100931|NCT02349295|2174038|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100932|NCT02349295|2174039|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2
1100933|NCT02349295|2174040|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100934|NCT02349295|2174041|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3
1100935|NCT02349295|2174042|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100936|NCT02349295|2174043|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100937|NCT02349295|2174044|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100938|NCT02349295|2174045|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
1100939|NCT02349295|2174032|FG000|Long-Term Extension Period (Week 24-156)|Death|0
1100940|NCT02349295|2174033|FG001|Long-Term Extension Period (Week 24-156)|Death|0
1100941|NCT02349295|2174034|FG002|Long-Term Extension Period (Week 24-156)|Death|0
1100942|NCT02349295|2174035|FG003|Long-Term Extension Period (Week 24-156)|Death|0
1100943|NCT02349295|2174036|FG004|Long-Term Extension Period (Week 24-156)|Death|0
1100944|NCT02349295|2174037|FG005|Long-Term Extension Period (Week 24-156)|Death|0
1100945|NCT02349295|2174038|FG006|Long-Term Extension Period (Week 24-156)|Death|0
1100946|NCT02349295|2174039|FG007|Long-Term Extension Period (Week 24-156)|Death|1
1100947|NCT02349295|2174040|FG008|Long-Term Extension Period (Week 24-156)|Death|1
1100948|NCT02349295|2174041|FG009|Long-Term Extension Period (Week 24-156)|Death|1
1100949|NCT02349295|2174042|FG010|Long-Term Extension Period (Week 24-156)|Death|0
1100950|NCT02349295|2174043|FG011|Long-Term Extension Period (Week 24-156)|Death|0
1100951|NCT02349295|2174044|FG012|Long-Term Extension Period (Week 24-156)|Death|0
1100952|NCT02349295|2174045|FG013|Long-Term Extension Period (Week 24-156)|Death|0
1100953|NCT02349295|2174032|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
1100954|NCT02349295|2174033|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
1100955|NCT02349295|2174034|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
1100956|NCT02349295|2174035|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
1100957|NCT02349295|2174036|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
1100958|NCT02349295|2174037|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
1100959|NCT02349295|2174038|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
1100960|NCT02349295|2174039|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4
1100961|NCT02349295|2174040|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2
1100962|NCT02349295|2174041|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1
1100963|NCT02349295|2174042|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3
1100964|NCT02349295|2174043|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
1100965|NCT02349295|2174044|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
1100966|NCT02349295|2174045|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
1100967|NCT02349295|2174032|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100968|NCT02349295|2174033|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100969|NCT02349295|2174034|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100970|NCT02349295|2174035|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100971|NCT02349295|2174036|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100972|NCT02349295|2174037|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100973|NCT02349295|2174038|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100974|NCT02349295|2174039|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
1100975|NCT02349295|2174040|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
1100976|NCT02349295|2174041|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100977|NCT02349295|2174042|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100978|NCT02349295|2174043|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100979|NCT02349295|2174044|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100980|NCT02349295|2174045|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
1100981|NCT02349295|2174032|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1100982|NCT02349295|2174033|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1100983|NCT02349295|2174034|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1100984|NCT02349295|2174035|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1100985|NCT02349295|2174036|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1100986|NCT02349295|2174037|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1100987|NCT02349295|2174038|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1100988|NCT02349295|2174039|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2
1100989|NCT02349295|2174040|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2
1100990|NCT02349295|2174041|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1100991|NCT02349295|2174042|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1100992|NCT02349295|2174043|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1100993|NCT02349295|2174044|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1162065|NCT03382418|2284045|FG002|Overall Study|Withdrawal by Subject|0
1100994|NCT02349295|2174045|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0
1100995|NCT02349295|2174032|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
1100996|NCT02349295|2174033|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
1100997|NCT02349295|2174034|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
1100998|NCT02349295|2174035|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
1100999|NCT02349295|2174036|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
1101000|NCT02349295|2174037|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
1101001|NCT02349295|2174038|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
1101002|NCT02349295|2174039|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
1101003|NCT02349295|2174040|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
1101004|NCT02349295|2174041|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
1101005|NCT02349295|2174042|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
1101006|NCT02349295|2174043|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
1101007|NCT02349295|2174044|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5
1101008|NCT02349295|2174045|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
1101009|NCT02349295|2174032|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101010|NCT02349295|2174033|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101011|NCT02349295|2174034|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101012|NCT02349295|2174035|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101013|NCT02349295|2174036|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101014|NCT02349295|2174037|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101015|NCT02349295|2174038|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101016|NCT02349295|2174039|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101017|NCT02349295|2174040|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101018|NCT02349295|2174041|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101019|NCT02349295|2174042|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101020|NCT02349295|2174043|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1
1101021|NCT02349295|2174044|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2
1101022|NCT02349295|2174045|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
1101023|NCT02349295|2174032|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101024|NCT02349295|2174033|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101025|NCT02349295|2174034|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101026|NCT02349295|2174035|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101027|NCT02349295|2174036|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101028|NCT02349295|2174037|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101029|NCT02349295|2174038|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101030|NCT02349295|2174039|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101031|NCT02349295|2174040|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101032|NCT02349295|2174041|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101033|NCT02349295|2174042|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101034|NCT02349295|2174043|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
1101035|NCT02349295|2174044|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
1101036|NCT02349295|2174045|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
1101037|NCT02349295|2174032|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101038|NCT02349295|2174033|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101039|NCT02349295|2174034|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101040|NCT02349295|2174035|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101041|NCT02349295|2174036|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101042|NCT02349295|2174037|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101043|NCT02349295|2174038|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101044|NCT02349295|2174039|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101045|NCT02349295|2174040|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101046|NCT02349295|2174041|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101047|NCT02349295|2174042|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101048|NCT02349295|2174043|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2
1101049|NCT02349295|2174044|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101050|NCT02349295|2174045|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
1101051|NCT02349295|2174032|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101052|NCT02349295|2174033|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101053|NCT02349295|2174034|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101054|NCT02349295|2174035|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101055|NCT02349295|2174036|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101056|NCT02349295|2174037|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101057|NCT02349295|2174038|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101058|NCT02349295|2174039|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101059|NCT02349295|2174040|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101060|NCT02349295|2174041|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101061|NCT02349295|2174042|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101062|NCT02349295|2174043|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4
1101063|NCT02349295|2174044|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101064|NCT02349295|2174045|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
1101065|NCT02349360|2174072|FG000|Overall Study|Withdrawal by Subject|0
1101066|NCT02349360|2174073|FG001|Overall Study|Withdrawal by Subject|1
1101067|NCT02349412|2174081|FG000|Overall Study|Withdrawal by Subject|7
1101068|NCT02349412|2174082|FG001|Overall Study|Withdrawal by Subject|7
1101069|NCT02349425|2174092|FG000|Period 1|Adverse Event|1
1101070|NCT02349425|2174093|FG001|Period 1|Adverse Event|1
1101071|NCT02349425|2174094|FG002|Period 1|Adverse Event|0
1101072|NCT02349425|2174095|FG003|Period 1|Adverse Event|0
1101073|NCT02349425|2174092|FG000|Period 2|Adverse Event|0
1101074|NCT02349425|2174093|FG001|Period 2|Adverse Event|1
1101075|NCT02349425|2174094|FG002|Period 2|Adverse Event|1
1101076|NCT02349425|2174095|FG003|Period 2|Adverse Event|0
1101077|NCT02349451|2174144|FG000|Overall Study|Withdrawal by Subject|0
1101078|NCT02349451|2174145|FG001|Overall Study|Withdrawal by Subject|1
1101079|NCT02349451|2174146|FG002|Overall Study|Withdrawal by Subject|2
1101080|NCT02349451|2174147|FG003|Overall Study|Withdrawal by Subject|1
1101081|NCT02349542|2174173|FG000|Overall Study|Withdrawal by Subject|5
1101082|NCT02349711|2174284|FG000|Overall Study|Withdrawal by Subject|2
1101083|NCT02349711|2174285|FG001|Overall Study|Withdrawal by Subject|1
1101084|NCT02349711|2174284|FG000|Overall Study|Lost to Follow-up|1
1101085|NCT02349711|2174285|FG001|Overall Study|Lost to Follow-up|1
1101086|NCT02349789|2174291|FG000|Overall Study|Withdrawal by Subject|2
1101087|NCT02350127|2174297|FG000|4-Month Assessment|Withdrawal by Subject|10
1101088|NCT02350127|2174298|FG001|4-Month Assessment|Withdrawal by Subject|9
1101089|NCT02350127|2174297|FG000|4-Month Assessment|Death|1
1101090|NCT02350127|2174298|FG001|4-Month Assessment|Death|0
1101091|NCT02350127|2174297|FG000|8-Month Assessment|Death|1
1101092|NCT02350127|2174298|FG001|8-Month Assessment|Death|1
1101093|NCT02350127|2174297|FG000|8-Month Assessment|Withdrawal by Subject|5
1101094|NCT02350127|2174298|FG001|8-Month Assessment|Withdrawal by Subject|8
1101095|NCT02350309|2174311|FG000|Treatment Period 1 (2 Days)|Physician Decision|0
1101096|NCT02350309|2174312|FG001|Treatment Period 1 (2 Days)|Physician Decision|0
1101097|NCT02350309|2174313|FG002|Treatment Period 1 (2 Days)|Physician Decision|1
1101098|NCT02350309|2174314|FG003|Treatment Period 1 (2 Days)|Physician Decision|0
1101099|NCT02350309|2174315|FG004|Treatment Period 1 (2 Days)|Physician Decision|0
1101100|NCT02350309|2174316|FG005|Treatment Period 1 (2 Days)|Physician Decision|0
1101101|NCT02350309|2174311|FG000|Treatment Period 4 (2 Days)|Death in the Family|0
1101102|NCT02350309|2174312|FG001|Treatment Period 4 (2 Days)|Death in the Family|0
1101103|NCT02350309|2174313|FG002|Treatment Period 4 (2 Days)|Death in the Family|0
1101104|NCT02350309|2174314|FG003|Treatment Period 4 (2 Days)|Death in the Family|0
1101105|NCT02350309|2174315|FG004|Treatment Period 4 (2 Days)|Death in the Family|0
1101106|NCT02350309|2174316|FG005|Treatment Period 4 (2 Days)|Death in the Family|1
1101107|NCT02350478|2174333|FG000|Overall Study|Lost to Follow-up|5
1101108|NCT02350478|2174334|FG001|Overall Study|Lost to Follow-up|1
1101109|NCT02351167|2174450|FG000|Overall Study|Withdrawal by Subject|19
1101110|NCT02351167|2174451|FG001|Overall Study|Withdrawal by Subject|18
1101111|NCT02351167|2174452|FG002|Overall Study|Withdrawal by Subject|21
1101112|NCT02351349|2174480|FG000|Overall Study|Withdrawal by Subject|2
1101113|NCT02351349|2174481|FG001|Overall Study|Withdrawal by Subject|3
1101114|NCT02351817|2174517|FG000|Period 1|Adverse Event|1
1101115|NCT02351817|2174518|FG001|Period 1|Adverse Event|2
1101116|NCT02351817|2174517|FG000|Period 1|Lack of Efficacy|0
1101117|NCT02351817|2174518|FG001|Period 1|Lack of Efficacy|1
1101118|NCT02351817|2174517|FG000|Period 2|Adverse Event|0
1101119|NCT02351817|2174518|FG001|Period 2|Adverse Event|2
1101120|NCT02351817|2174517|FG000|Period 2|Protocol Violation|1
1101121|NCT02351817|2174518|FG001|Period 2|Protocol Violation|0
1101122|NCT02351934|2174527|FG000|Allocation|POD weight<pre-op weight|3
1101123|NCT02351934|2174528|FG001|Allocation|POD weight<pre-op weight|0
1101124|NCT02351934|2174527|FG000|Allocation|Hypotension preventing administration|2
1101125|NCT02351934|2174528|FG001|Allocation|Hypotension preventing administration|0
1101126|NCT02351934|2174527|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1
1101127|NCT02351934|2174528|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0
1101128|NCT02351934|2174527|FG000|Follow-Up|POD weight<pre-op weight|3
1101129|NCT02351934|2174528|FG001|Follow-Up|POD weight<pre-op weight|0
1101130|NCT02351934|2174527|FG000|Follow-Up|Acute Kidney Injury|1
1101131|NCT02351934|2174528|FG001|Follow-Up|Acute Kidney Injury|0
1101132|NCT02351934|2174527|FG000|Follow-Up|Early dismissal|3
1101133|NCT02351934|2174528|FG001|Follow-Up|Early dismissal|0
1101134|NCT02351934|2174527|FG000|Follow-Up|Hypotension|3
1101135|NCT02351934|2174528|FG001|Follow-Up|Hypotension|0
1101136|NCT02351934|2174527|FG000|Follow-Up|No documentation|2
1101137|NCT02351934|2174528|FG001|Follow-Up|No documentation|0
1101138|NCT02351934|2174527|FG000|Follow-Up|1 ERAS Component Noncompliant|0
1101139|NCT02351934|2174528|FG001|Follow-Up|1 ERAS Component Noncompliant|6
1101140|NCT02351934|2174527|FG000|Follow-Up|2 ERAS Components Noncompliant|0
1101141|NCT02351934|2174528|FG001|Follow-Up|2 ERAS Components Noncompliant|4
1101142|NCT02351960|2174536|FG000|Overall Study|Pretreatment Event/Adverse Event|6
1101143|NCT02351960|2174537|FG001|Overall Study|Pretreatment Event/Adverse Event|3
1101144|NCT02351960|2174536|FG000|Overall Study|Voluntary Withdrawal|5
1101145|NCT02351960|2174537|FG001|Overall Study|Voluntary Withdrawal|4
1101146|NCT02351960|2174536|FG000|Overall Study|Significant Protocol Deviation|0
1101147|NCT02351960|2174537|FG001|Overall Study|Significant Protocol Deviation|5
1101148|NCT02352090|2174547|FG000|Overall Study|general malaise|1
1101149|NCT02352090|2174548|FG001|Overall Study|general malaise|0
1101150|NCT02352090|2174549|FG002|Overall Study|general malaise|0
1101151|NCT02352090|2174547|FG000|Overall Study|non-specified mild side-effects|0
1101152|NCT02352090|2174548|FG001|Overall Study|non-specified mild side-effects|0
1101153|NCT02352090|2174549|FG002|Overall Study|non-specified mild side-effects|2
1101154|NCT02352493|2174602|FG000|Overall Study|Pregnancy|0
1101155|NCT02352493|2174603|FG001|Overall Study|Pregnancy|0
1101156|NCT02352493|2174604|FG002|Overall Study|Pregnancy|0
1101157|NCT02352493|2174605|FG003|Overall Study|Pregnancy|0
1101158|NCT02352493|2174606|FG004|Overall Study|Pregnancy|0
1101159|NCT02352493|2174607|FG005|Overall Study|Pregnancy|0
1101160|NCT02352493|2174608|FG006|Overall Study|Pregnancy|1
1101161|NCT02352493|2174609|FG007|Overall Study|Pregnancy|0
1101162|NCT02352493|2174610|FG008|Overall Study|Pregnancy|1
1101163|NCT02352493|2174611|FG009|Overall Study|Pregnancy|0
1101164|NCT02352493|2174612|FG010|Overall Study|Pregnancy|0
1101165|NCT02352493|2174613|FG011|Overall Study|Pregnancy|0
1101166|NCT02352493|2174614|FG012|Overall Study|Pregnancy|0
1101167|NCT02352493|2174615|FG013|Overall Study|Pregnancy|0
1101168|NCT02352493|2174616|FG014|Overall Study|Pregnancy|0
1101169|NCT02352493|2174617|FG015|Overall Study|Pregnancy|0
1101170|NCT02352493|2174618|FG016|Overall Study|Pregnancy|0
1101171|NCT02352493|2174619|FG017|Overall Study|Pregnancy|0
1101172|NCT02352493|2174602|FG000|Overall Study|Withdrawal by Subject|0
1101173|NCT02352493|2174603|FG001|Overall Study|Withdrawal by Subject|0
1101174|NCT02352493|2174604|FG002|Overall Study|Withdrawal by Subject|0
1101175|NCT02352493|2174605|FG003|Overall Study|Withdrawal by Subject|0
1101176|NCT02352493|2174606|FG004|Overall Study|Withdrawal by Subject|0
1101177|NCT02352493|2174607|FG005|Overall Study|Withdrawal by Subject|0
1101178|NCT02352493|2174608|FG006|Overall Study|Withdrawal by Subject|0
1101179|NCT02352493|2174609|FG007|Overall Study|Withdrawal by Subject|0
1101180|NCT02352493|2174610|FG008|Overall Study|Withdrawal by Subject|1
1101181|NCT02352493|2174611|FG009|Overall Study|Withdrawal by Subject|0
1101182|NCT02352493|2174612|FG010|Overall Study|Withdrawal by Subject|0
1101183|NCT02352493|2174613|FG011|Overall Study|Withdrawal by Subject|0
1101184|NCT02352493|2174614|FG012|Overall Study|Withdrawal by Subject|0
1101185|NCT02352493|2174615|FG013|Overall Study|Withdrawal by Subject|0
1101186|NCT02352493|2174616|FG014|Overall Study|Withdrawal by Subject|1
1101187|NCT02352493|2174617|FG015|Overall Study|Withdrawal by Subject|0
1101188|NCT02352493|2174618|FG016|Overall Study|Withdrawal by Subject|0
1101189|NCT02352493|2174619|FG017|Overall Study|Withdrawal by Subject|0
1101190|NCT02352493|2174602|FG000|Overall Study|Lost to Follow-up|0
1101191|NCT02352493|2174603|FG001|Overall Study|Lost to Follow-up|0
1101192|NCT02352493|2174604|FG002|Overall Study|Lost to Follow-up|0
1101193|NCT02352493|2174605|FG003|Overall Study|Lost to Follow-up|0
1101194|NCT02352493|2174606|FG004|Overall Study|Lost to Follow-up|0
1101195|NCT02352493|2174607|FG005|Overall Study|Lost to Follow-up|0
1101196|NCT02352493|2174608|FG006|Overall Study|Lost to Follow-up|0
1101197|NCT02352493|2174609|FG007|Overall Study|Lost to Follow-up|0
1101198|NCT02352493|2174610|FG008|Overall Study|Lost to Follow-up|0
1101199|NCT02352493|2174611|FG009|Overall Study|Lost to Follow-up|1
1101200|NCT02352493|2174612|FG010|Overall Study|Lost to Follow-up|0
1101201|NCT02352493|2174613|FG011|Overall Study|Lost to Follow-up|0
1101202|NCT02352493|2174614|FG012|Overall Study|Lost to Follow-up|1
1101203|NCT02352493|2174615|FG013|Overall Study|Lost to Follow-up|2
1101204|NCT02352493|2174616|FG014|Overall Study|Lost to Follow-up|0
1101205|NCT02352493|2174617|FG015|Overall Study|Lost to Follow-up|0
1101206|NCT02352493|2174618|FG016|Overall Study|Lost to Follow-up|0
1101207|NCT02352493|2174619|FG017|Overall Study|Lost to Follow-up|0
1101208|NCT02352779|2174677|FG000|Overall Study|Personal Issues|1
1101209|NCT02352779|2174678|FG001|Overall Study|Personal Issues|1
1101210|NCT02352779|2174679|FG002|Overall Study|Personal Issues|0
1101211|NCT02352779|2174677|FG000|Overall Study|Too Many Forms|2
1101212|NCT02352779|2174678|FG001|Overall Study|Too Many Forms|0
1101213|NCT02352779|2174679|FG002|Overall Study|Too Many Forms|0
1101214|NCT02352779|2174677|FG000|Overall Study|Feeling Overwhelmed|1
1101215|NCT02352779|2174678|FG001|Overall Study|Feeling Overwhelmed|0
1101216|NCT02352779|2174679|FG002|Overall Study|Feeling Overwhelmed|0
1101217|NCT02352779|2174677|FG000|Overall Study|Disliked Intervention|1
1101218|NCT02352779|2174678|FG001|Overall Study|Disliked Intervention|0
1101219|NCT02352779|2174679|FG002|Overall Study|Disliked Intervention|0
1101220|NCT02352779|2174677|FG000|Overall Study|Changed Mind|1
1101221|NCT02352779|2174678|FG001|Overall Study|Changed Mind|0
1101222|NCT02352779|2174679|FG002|Overall Study|Changed Mind|0
1101223|NCT02352779|2174677|FG000|Overall Study|Study Related Symptoms|1
1101224|NCT02352779|2174678|FG001|Overall Study|Study Related Symptoms|0
1101225|NCT02352779|2174679|FG002|Overall Study|Study Related Symptoms|0
1101226|NCT02352779|2174677|FG000|Overall Study|Absence of Symptoms|1
1101227|NCT02352779|2174678|FG001|Overall Study|Absence of Symptoms|0
1101228|NCT02352779|2174679|FG002|Overall Study|Absence of Symptoms|0
1101229|NCT02352779|2174677|FG000|Overall Study|Other Medical Reason|0
1101230|NCT02352779|2174678|FG001|Overall Study|Other Medical Reason|0
895013|NCT00695955|1866229|FG000|Cohort 1|Other|16
895014|NCT00695955|1866229|FG000|Cohort 2|Adverse Event|24
895015|NCT00695955|1866229|FG000|Cohort 2|Protocol Violation|5
895016|NCT00695955|1866229|FG000|Cohort 2|Lost to Follow-up|38
895017|NCT00695955|1866229|FG000|Cohort 2|Withdrawal by Subject|28
895018|NCT00695955|1866229|FG000|Cohort 2|Lack of Efficacy|4
895019|NCT00695955|1866229|FG000|Cohort 2|Other|5
895020|NCT00696020|1866239|FG000|Overall Study|Adverse Event|3
895021|NCT00696020|1866240|FG001|Overall Study|Adverse Event|1
895022|NCT00696020|1866241|FG002|Overall Study|Adverse Event|2
895023|NCT00696020|1866242|FG003|Overall Study|Adverse Event|1
895024|NCT00696020|1866239|FG000|Overall Study|Lack of Efficacy|1
895025|NCT00696020|1866240|FG001|Overall Study|Lack of Efficacy|0
895026|NCT00696020|1866241|FG002|Overall Study|Lack of Efficacy|0
895027|NCT00696020|1866242|FG003|Overall Study|Lack of Efficacy|0
895028|NCT00696020|1866239|FG000|Overall Study|Protocol Violation|0
895029|NCT00696020|1866240|FG001|Overall Study|Protocol Violation|0
895030|NCT00696020|1866241|FG002|Overall Study|Protocol Violation|0
895031|NCT00696020|1866242|FG003|Overall Study|Protocol Violation|1
895032|NCT00696020|1866239|FG000|Overall Study|Withdrawal by Subject|0
895033|NCT00696020|1866240|FG001|Overall Study|Withdrawal by Subject|1
895034|NCT00696020|1866241|FG002|Overall Study|Withdrawal by Subject|0
895035|NCT00696020|1866242|FG003|Overall Study|Withdrawal by Subject|1
895036|NCT00696020|1866239|FG000|Overall Study|Other not stated above|0
895037|NCT00696020|1866240|FG001|Overall Study|Other not stated above|0
895038|NCT00696020|1866241|FG002|Overall Study|Other not stated above|1
895039|NCT00696020|1866242|FG003|Overall Study|Other not stated above|1
895040|NCT00696072|1866256|FG000|Overall Study|continuing active treatment|10
895041|NCT00696072|1866257|FG001|Overall Study|continuing active treatment|13
895042|NCT00696072|1866256|FG000|Overall Study|Adverse Event|10
895043|NCT00696072|1866257|FG001|Overall Study|Adverse Event|6
895044|NCT00696072|1866256|FG000|Overall Study|Patient Request|3
895045|NCT00696072|1866257|FG001|Overall Study|Patient Request|7
895046|NCT00696072|1866256|FG000|Overall Study|Investigator Request|1
895047|NCT00696072|1866257|FG001|Overall Study|Investigator Request|4
895048|NCT00696072|1866256|FG000|Overall Study|Sponsor Request|0
895049|NCT00696072|1866257|FG001|Overall Study|Sponsor Request|1
895050|NCT00696072|1866256|FG000|Overall Study|Disease Progression|32
895051|NCT00696072|1866257|FG001|Overall Study|Disease Progression|30
895052|NCT00696072|1866256|FG000|Overall Study|Non-specified|1
895053|NCT00696072|1866257|FG001|Overall Study|Non-specified|2
895054|NCT00696137|1866264|FG000|Overall Study|Withdrawal by Subject|2
895055|NCT00696241|1866273|FG000|Overall Study|Adverse Event|11
895056|NCT00696241|1866274|FG001|Overall Study|Adverse Event|3
895057|NCT00696241|1866275|FG002|Overall Study|Adverse Event|6
895058|NCT00696241|1866276|FG003|Overall Study|Adverse Event|4
895059|NCT00696241|1866277|FG004|Overall Study|Adverse Event|5
895060|NCT00696241|1866273|FG000|Overall Study|Protocol Violation|1
895061|NCT00696241|1866274|FG001|Overall Study|Protocol Violation|1
895062|NCT00696241|1866275|FG002|Overall Study|Protocol Violation|2
895063|NCT00696241|1866276|FG003|Overall Study|Protocol Violation|0
895064|NCT00696241|1866277|FG004|Overall Study|Protocol Violation|3
895065|NCT00696241|1866273|FG000|Overall Study|Lost to Follow-up|1
895066|NCT00696241|1866274|FG001|Overall Study|Lost to Follow-up|4
895067|NCT00696241|1866275|FG002|Overall Study|Lost to Follow-up|1
895068|NCT00696241|1866276|FG003|Overall Study|Lost to Follow-up|2
895069|NCT00696241|1866277|FG004|Overall Study|Lost to Follow-up|0
895070|NCT00696241|1866273|FG000|Overall Study|Withdrawal by Subject|4
895071|NCT00696241|1866274|FG001|Overall Study|Withdrawal by Subject|8
895072|NCT00696241|1866275|FG002|Overall Study|Withdrawal by Subject|6
895073|NCT00696241|1866276|FG003|Overall Study|Withdrawal by Subject|1
895074|NCT00696241|1866277|FG004|Overall Study|Withdrawal by Subject|0
895075|NCT00696241|1866273|FG000|Overall Study|Lack of Efficacy|1
895076|NCT00696241|1866274|FG001|Overall Study|Lack of Efficacy|5
895077|NCT00696241|1866275|FG002|Overall Study|Lack of Efficacy|4
895078|NCT00696241|1866276|FG003|Overall Study|Lack of Efficacy|5
895079|NCT00696241|1866277|FG004|Overall Study|Lack of Efficacy|3
895080|NCT00696241|1866273|FG000|Overall Study|Other|6
895081|NCT00696241|1866274|FG001|Overall Study|Other|1
895082|NCT00696241|1866275|FG002|Overall Study|Other|5
895083|NCT00696241|1866276|FG003|Overall Study|Other|2
895084|NCT00696241|1866277|FG004|Overall Study|Other|1
895085|NCT00696384|1866294|FG000|Open Label Phase|Adverse Event|27
895086|NCT00696384|1866295|FG001|Open Label Phase|Adverse Event|0
895087|NCT00696384|1866296|FG002|Open Label Phase|Adverse Event|0
895088|NCT00696384|1866294|FG000|Open Label Phase|Protocol Violation|18
895089|NCT00696384|1866295|FG001|Open Label Phase|Protocol Violation|0
895090|NCT00696384|1866296|FG002|Open Label Phase|Protocol Violation|0
895091|NCT00696384|1866294|FG000|Open Label Phase|Lost to Follow-up|24
1101231|NCT02352779|2174679|FG002|Overall Study|Other Medical Reason|1
1101232|NCT02352779|2174677|FG000|Overall Study|No Reason|0
1101233|NCT02352779|2174678|FG001|Overall Study|No Reason|0
1101234|NCT02352779|2174679|FG002|Overall Study|No Reason|1
1101265|NCT02353169|2174768|FG000|Overall Study|QTc > 450 msec|1
1101266|NCT02353169|2174769|FG001|Overall Study|QTc > 450 msec|1
1101267|NCT02353169|2174770|FG002|Overall Study|QTc > 450 msec|1
1101268|NCT02353169|2174771|FG003|Overall Study|QTc > 450 msec|1
1101269|NCT02353169|2174768|FG000|Overall Study|OR team declined|2
1101270|NCT02353169|2174769|FG001|Overall Study|OR team declined|0
1101271|NCT02353169|2174770|FG002|Overall Study|OR team declined|0
1101272|NCT02353169|2174771|FG003|Overall Study|OR team declined|0
1101273|NCT02353169|2174768|FG000|Overall Study|Inhalational induction|0
1101274|NCT02353169|2174769|FG001|Overall Study|Inhalational induction|2
1101275|NCT02353169|2174770|FG002|Overall Study|Inhalational induction|0
1101276|NCT02353169|2174771|FG003|Overall Study|Inhalational induction|0
1101277|NCT02353169|2174768|FG000|Overall Study|ECG data error|0
1101278|NCT02353169|2174769|FG001|Overall Study|ECG data error|3
1101279|NCT02353169|2174770|FG002|Overall Study|ECG data error|2
1101280|NCT02353169|2174771|FG003|Overall Study|ECG data error|2
1101281|NCT02353169|2174768|FG000|Overall Study|Pre-op medication|0
1101282|NCT02353169|2174769|FG001|Overall Study|Pre-op medication|0
1101283|NCT02353169|2174770|FG002|Overall Study|Pre-op medication|1
1101284|NCT02353169|2174771|FG003|Overall Study|Pre-op medication|0
1101285|NCT02353442|2174804|FG000|Overall Study|Withdrawal by Subject|3
1101286|NCT02353442|2174805|FG001|Overall Study|Withdrawal by Subject|4
1101287|NCT02353871|2174845|FG000|Overall Study|Protocol deviation|0
1101288|NCT02353871|2174846|FG001|Overall Study|Protocol deviation|1
1101289|NCT02353871|2174845|FG000|Overall Study|Consent withdrawn|1
1101290|NCT02353871|2174846|FG001|Overall Study|Consent withdrawn|8
1101291|NCT02353871|2174845|FG000|Overall Study|Lost to Follow-up|2
1101292|NCT02353871|2174846|FG001|Overall Study|Lost to Follow-up|0
1101293|NCT02354222|2174872|FG000|Overall Study|Adverse Event|0
1101294|NCT02354222|2174873|FG001|Overall Study|Adverse Event|3
1101295|NCT02354222|2174872|FG000|Overall Study|Physician Decision|1
1101296|NCT02354222|2174873|FG001|Overall Study|Physician Decision|1
1101297|NCT02354222|2174872|FG000|Overall Study|Pregnancy|1
1101298|NCT02354222|2174873|FG001|Overall Study|Pregnancy|0
1101299|NCT02354222|2174872|FG000|Overall Study|Withdrawal by Subject|2
1101300|NCT02354222|2174873|FG001|Overall Study|Withdrawal by Subject|3
1101301|NCT02354222|2174872|FG000|Overall Study|Conflict with the stopping criteria|0
1101302|NCT02354222|2174873|FG001|Overall Study|Conflict with the stopping criteria|4
1101303|NCT02354235|2174881|FG000|Overall Study|Adverse Event|2
1101304|NCT02354235|2174882|FG001|Overall Study|Adverse Event|2
1101305|NCT02354235|2174881|FG000|Overall Study|Physician Decision|0
1101306|NCT02354235|2174882|FG001|Overall Study|Physician Decision|1
1101307|NCT02354235|2174881|FG000|Overall Study|Withdrawal by Subject|1
1101308|NCT02354235|2174882|FG001|Overall Study|Withdrawal by Subject|3
1101309|NCT02354235|2174881|FG000|Overall Study|Conflict with the stopping criteria|0
1101310|NCT02354235|2174882|FG001|Overall Study|Conflict with the stopping criteria|1
1101311|NCT02354417|2174915|FG000|Overall Study|Physician Decision|1
1101312|NCT02354586|2175008|FG000|Overall Study|Death|168
1101313|NCT02354586|2175008|FG000|Overall Study|Withdrawal by Subject|51
1101314|NCT02354586|2175008|FG000|Overall Study|Lost to Follow-up|6
1101315|NCT02354586|2175008|FG000|Overall Study|Disease progression|116
1101316|NCT02354599|2175018|FG000|Overall Study|Pretreatment Event/Adverse Event|0
1101317|NCT02354599|2175019|FG001|Overall Study|Pretreatment Event/Adverse Event|0
1101318|NCT02354599|2175020|FG002|Overall Study|Pretreatment Event/Adverse Event|0
1101319|NCT02354599|2175021|FG003|Overall Study|Pretreatment Event/Adverse Event|0
1101320|NCT02354599|2175022|FG004|Overall Study|Pretreatment Event/Adverse Event|0
1101321|NCT02354599|2175023|FG005|Overall Study|Pretreatment Event/Adverse Event|1
1101322|NCT02354599|2175018|FG000|Overall Study|Withdrawal by Subject|1
1101323|NCT02354599|2175019|FG001|Overall Study|Withdrawal by Subject|1
1101324|NCT02354599|2175020|FG002|Overall Study|Withdrawal by Subject|0
1101325|NCT02354599|2175021|FG003|Overall Study|Withdrawal by Subject|0
1101326|NCT02354599|2175022|FG004|Overall Study|Withdrawal by Subject|0
1101327|NCT02354599|2175023|FG005|Overall Study|Withdrawal by Subject|0
1101328|NCT02354690|2175043|FG000|Overall Study|Physician Decision|1
1101329|NCT02354976|2175086|FG000|Overall Study|Other - reason not specified|1
1101330|NCT02354976|2175087|FG001|Overall Study|Other - reason not specified|0
1101331|NCT02354976|2175088|FG002|Overall Study|Other - reason not specified|1
1101332|NCT02354976|2175086|FG000|Overall Study|Study-specifc withdrawal criteria|0
1101333|NCT02354976|2175087|FG001|Overall Study|Study-specifc withdrawal criteria|1
1101334|NCT02354976|2175088|FG002|Overall Study|Study-specifc withdrawal criteria|0
1101335|NCT02354976|2175086|FG000|Overall Study|Adverse Event|1
1101336|NCT02354976|2175087|FG001|Overall Study|Adverse Event|0
1101337|NCT02354976|2175088|FG002|Overall Study|Adverse Event|2
1101338|NCT02355028|2175098|FG000|Overall Study|Adverse Event|2
1101339|NCT02355028|2175099|FG001|Overall Study|Adverse Event|0
1101340|NCT02355028|2175098|FG000|Overall Study|Withdrawal by Subject|1
1101341|NCT02355028|2175099|FG001|Overall Study|Withdrawal by Subject|1
1101342|NCT02355028|2175098|FG000|Overall Study|Deemed ineligible after randomization|8
1101343|NCT02355028|2175099|FG001|Overall Study|Deemed ineligible after randomization|4
1101344|NCT02355665|2175154|FG000|Overall Study|Adverse Event|16
1101345|NCT02355665|2175155|FG001|Overall Study|Adverse Event|24
1101346|NCT02355665|2175154|FG000|Overall Study|Protocol Violation|2
1101347|NCT02355665|2175155|FG001|Overall Study|Protocol Violation|0
1101348|NCT02355665|2175154|FG000|Overall Study|Withdrawal by Subject|90
1101349|NCT02355665|2175155|FG001|Overall Study|Withdrawal by Subject|100
1101350|NCT02355665|2175154|FG000|Overall Study|Lost to Follow-up|131
1101351|NCT02355665|2175155|FG001|Overall Study|Lost to Follow-up|103
1101352|NCT02355665|2175154|FG000|Overall Study|Death|4
1101353|NCT02355665|2175155|FG001|Overall Study|Death|2
1101354|NCT02355665|2175154|FG000|Overall Study|Compliance, PI decision, move, eligible|6
1101355|NCT02355665|2175155|FG001|Overall Study|Compliance, PI decision, move, eligible|3
1101356|NCT02355691|2175163|FG000|Overall Study|Loss of Research Personnel|7
1101357|NCT02355691|2175164|FG001|Overall Study|Loss of Research Personnel|9
1101358|NCT02355743|2175170|FG000|Overall Study|Withdrawal by Subject|1
1101359|NCT02355743|2175170|FG000|Overall Study|Lost to Follow-up|1
1101360|NCT02356211|2175225|FG000|Overall Study|Withdrawal by Subject|2
1101361|NCT02356211|2175226|FG001|Overall Study|Withdrawal by Subject|2
1101362|NCT02356211|2175225|FG000|Overall Study|ineligible|1
1101363|NCT02356211|2175226|FG001|Overall Study|ineligible|8
1101364|NCT02356562|2175242|FG000|Overall Study|Withdrawal by Subject|0
1101365|NCT02356562|2175243|FG001|Overall Study|Withdrawal by Subject|1
1101366|NCT02356562|2175242|FG000|Overall Study|Re-entered treatment in a previous study|1
1101367|NCT02356562|2175243|FG001|Overall Study|Re-entered treatment in a previous study|0
1101368|NCT02356562|2175242|FG000|Overall Study|site closure|1
1101369|NCT02356562|2175243|FG001|Overall Study|site closure|0
1101370|NCT02356588|2175261|FG000|Overall Study|Lack of Efficacy|4
1101371|NCT02356588|2175262|FG001|Overall Study|Lack of Efficacy|10
1101372|NCT02356588|2175261|FG000|Overall Study|Adverse Event|0
1101373|NCT02356588|2175262|FG001|Overall Study|Adverse Event|2
1101374|NCT02356588|2175261|FG000|Overall Study|Withdrawal by Subject|1
1101375|NCT02356588|2175262|FG001|Overall Study|Withdrawal by Subject|0
1101376|NCT02356588|2175261|FG000|Overall Study|Protocol Violation|0
1101377|NCT02356588|2175262|FG001|Overall Study|Protocol Violation|1
1101378|NCT02356783|2175292|FG000|Overall Study|Lost to Follow-up|1
1101379|NCT02356783|2175293|FG001|Overall Study|Lost to Follow-up|3
1101380|NCT02356887|2175299|FG000|Overall Study|poor compliance|2
1101381|NCT02357134|2175326|FG000|Overall Study|Lost to Follow-up|1
1101382|NCT02357134|2175327|FG001|Overall Study|Lost to Follow-up|0
1101383|NCT02357134|2175328|FG002|Overall Study|Lost to Follow-up|0
1101384|NCT02357134|2175329|FG003|Overall Study|Lost to Follow-up|0
1101385|NCT02357147|2175341|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
1101386|NCT02357147|2175342|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
1101387|NCT02357147|2175341|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
1101388|NCT02357147|2175342|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
1101389|NCT02357147|2175341|FG000|Combination Treatment Phase|Investigator Discretion|1
1101390|NCT02357147|2175342|FG001|Combination Treatment Phase|Investigator Discretion|1
1101391|NCT02357147|2175341|FG000|Combination Treatment Phase|Withdrawal by Subject|4
1101392|NCT02357147|2175342|FG001|Combination Treatment Phase|Withdrawal by Subject|2
1101393|NCT02357147|2175341|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
1101394|NCT02357147|2175342|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
1101395|NCT02357147|2175341|FG000|Combination Treatment Phase|Adverse Event|12
1101396|NCT02357147|2175342|FG001|Combination Treatment Phase|Adverse Event|4
1101397|NCT02357147|2175341|FG000|Combination Treatment Phase|Death|1
1101398|NCT02357147|2175342|FG001|Combination Treatment Phase|Death|1
1101399|NCT02357147|2175341|FG000|Combination Treatment Phase|Sponsor Decision|0
1101400|NCT02357147|2175342|FG001|Combination Treatment Phase|Sponsor Decision|12
1101401|NCT02357147|2175341|FG000|Combination Treatment Phase|Other|1
1101402|NCT02357147|2175342|FG001|Combination Treatment Phase|Other|0
1101403|NCT02357147|2175341|FG000|Combination Treatment Phase|Not treated|0
1101404|NCT02357147|2175342|FG001|Combination Treatment Phase|Not treated|2
1101405|NCT02357147|2175341|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
1101406|NCT02357147|2175342|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
1101407|NCT02357147|2175341|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
1101408|NCT02357147|2175342|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1
1101409|NCT02357147|2175341|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
1101410|NCT02357147|2175342|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
1101411|NCT02357147|2175341|FG000|Maintenance Treatment Phase|Adverse Event|0
1101412|NCT02357147|2175342|FG001|Maintenance Treatment Phase|Adverse Event|3
1101413|NCT02357147|2175341|FG000|Maintenance Treatment Phase|Sponsor Decision|0
1101414|NCT02357147|2175342|FG001|Maintenance Treatment Phase|Sponsor Decision|15
1101415|NCT02357147|2175341|FG000|Maintenance Treatment Phase|Not Treated|1
1101416|NCT02357147|2175342|FG001|Maintenance Treatment Phase|Not Treated|0
1101417|NCT02357342|2175380|FG000|First 6 Months|Death|2
1101418|NCT02357342|2175381|FG001|First 6 Months|Death|0
1101419|NCT02357368|2175391|FG000|Overall Study|Lost to Follow-up|0
1101420|NCT02357368|2175392|FG001|Overall Study|Lost to Follow-up|0
1101421|NCT02357368|2175393|FG002|Overall Study|Lost to Follow-up|0
1101422|NCT02357368|2175394|FG003|Overall Study|Lost to Follow-up|1
1101423|NCT02357368|2175391|FG000|Overall Study|Pregnancy|3
1101424|NCT02357368|2175392|FG001|Overall Study|Pregnancy|2
1101425|NCT02357368|2175393|FG002|Overall Study|Pregnancy|0
1101426|NCT02357368|2175394|FG003|Overall Study|Pregnancy|0
1101427|NCT02357368|2175391|FG000|Overall Study|Withdrawal by Subject|3
1101428|NCT02357368|2175392|FG001|Overall Study|Withdrawal by Subject|1
1101429|NCT02357368|2175393|FG002|Overall Study|Withdrawal by Subject|1
1101430|NCT02357368|2175394|FG003|Overall Study|Withdrawal by Subject|2
1101431|NCT02357420|2175417|FG000|Overall Study|Adverse Event|3
1101432|NCT02357420|2175418|FG001|Overall Study|Adverse Event|3
1101433|NCT02357420|2175419|FG002|Overall Study|Adverse Event|8
1101434|NCT02357420|2175420|FG003|Overall Study|Adverse Event|9
1101435|NCT02357420|2175417|FG000|Overall Study|Investigator Decision|1
1101436|NCT02357420|2175418|FG001|Overall Study|Investigator Decision|0
1101437|NCT02357420|2175419|FG002|Overall Study|Investigator Decision|0
1101438|NCT02357420|2175420|FG003|Overall Study|Investigator Decision|0
1101439|NCT02357420|2175417|FG000|Overall Study|Prohibited Medication|1
1101440|NCT02357420|2175418|FG001|Overall Study|Prohibited Medication|1
1101441|NCT02357420|2175419|FG002|Overall Study|Prohibited Medication|0
1101442|NCT02357420|2175420|FG003|Overall Study|Prohibited Medication|0
1101443|NCT02357420|2175417|FG000|Overall Study|Protocol Non-compliance|0
1101444|NCT02357420|2175418|FG001|Overall Study|Protocol Non-compliance|0
1101445|NCT02357420|2175419|FG002|Overall Study|Protocol Non-compliance|0
1101446|NCT02357420|2175420|FG003|Overall Study|Protocol Non-compliance|1
1101447|NCT02357420|2175417|FG000|Overall Study|Withdrawn Consent|4
1101448|NCT02357420|2175418|FG001|Overall Study|Withdrawn Consent|8
1101449|NCT02357420|2175419|FG002|Overall Study|Withdrawn Consent|6
1101450|NCT02357420|2175420|FG003|Overall Study|Withdrawn Consent|6
1101451|NCT02357420|2175417|FG000|Overall Study|Lost to Follow-up|3
1101452|NCT02357420|2175418|FG001|Overall Study|Lost to Follow-up|0
1101453|NCT02357420|2175419|FG002|Overall Study|Lost to Follow-up|2
1101454|NCT02357420|2175420|FG003|Overall Study|Lost to Follow-up|3
1101455|NCT02357459|2175433|FG000|Overall Study|Adverse Event|0
1101456|NCT02357459|2175434|FG001|Overall Study|Adverse Event|1
1101457|NCT02357459|2175435|FG002|Overall Study|Adverse Event|1
1101458|NCT02357459|2175433|FG000|Overall Study|Withdrawal by Subject|5
1101459|NCT02357459|2175434|FG001|Overall Study|Withdrawal by Subject|3
1101460|NCT02357459|2175435|FG002|Overall Study|Withdrawal by Subject|3
1101461|NCT02357459|2175433|FG000|Overall Study|Physician Decision|0
1101462|NCT02357459|2175434|FG001|Overall Study|Physician Decision|2
1101463|NCT02357459|2175435|FG002|Overall Study|Physician Decision|0
1101464|NCT02357459|2175433|FG000|Overall Study|Protocol Violation|1
1101465|NCT02357459|2175434|FG001|Overall Study|Protocol Violation|1
1101466|NCT02357459|2175435|FG002|Overall Study|Protocol Violation|0
1101467|NCT02357459|2175433|FG000|Overall Study|Lost to Follow-up|1
1101468|NCT02357459|2175434|FG001|Overall Study|Lost to Follow-up|3
1101469|NCT02357459|2175435|FG002|Overall Study|Lost to Follow-up|0
1101470|NCT02357459|2175433|FG000|Overall Study|Lack of Efficacy|7
1101471|NCT02357459|2175434|FG001|Overall Study|Lack of Efficacy|4
1101472|NCT02357459|2175435|FG002|Overall Study|Lack of Efficacy|4
1101473|NCT02357459|2175433|FG000|Overall Study|Patient Relocated|2
1101474|NCT02357459|2175434|FG001|Overall Study|Patient Relocated|0
1101475|NCT02357459|2175435|FG002|Overall Study|Patient Relocated|0
1101476|NCT02357459|2175433|FG000|Overall Study|Instruction from PCP|1
1101477|NCT02357459|2175434|FG001|Overall Study|Instruction from PCP|0
1101478|NCT02357459|2175435|FG002|Overall Study|Instruction from PCP|0
1101479|NCT02357459|2175433|FG000|Overall Study|Incarceration|0
1101480|NCT02357459|2175434|FG001|Overall Study|Incarceration|0
1101481|NCT02357459|2175435|FG002|Overall Study|Incarceration|1
1101482|NCT02357459|2175433|FG000|Overall Study|Pre-planned Knee surgery|0
1101483|NCT02357459|2175434|FG001|Overall Study|Pre-planned Knee surgery|0
1101484|NCT02357459|2175435|FG002|Overall Study|Pre-planned Knee surgery|2
1101485|NCT02357459|2175433|FG000|Overall Study|Job Commitments|0
1101486|NCT02357459|2175434|FG001|Overall Study|Job Commitments|0
1101487|NCT02357459|2175435|FG002|Overall Study|Job Commitments|1
1101488|NCT02357576|2175453|FG000|Treatment Period|Withdrawal by Subject|0
1101489|NCT02357576|2175454|FG001|Treatment Period|Withdrawal by Subject|1
1101490|NCT02357576|2175453|FG000|Treatment Period|Physician Decision|0
1101491|NCT02357576|2175454|FG001|Treatment Period|Physician Decision|1
1101492|NCT02357576|2175453|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1
1101493|NCT02357576|2175454|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1
1101494|NCT02357576|2175453|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
1101495|NCT02357576|2175454|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
1101496|NCT02357576|2175453|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
1101497|NCT02357576|2175454|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
1101498|NCT02357576|2175453|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
1101499|NCT02357576|2175454|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
1101500|NCT02357810|2175483|FG000|Registered and Started Treatment|Withdrawal by Subject|1
1101501|NCT02357810|2175483|FG000|Registered and Started Treatment|Found not to be eligible for the study|26
1101502|NCT02357810|2175483|FG000|Reached 12 Weeks Response|Adverse Event|5
1101503|NCT02357810|2175483|FG000|Reached 12 Weeks Response|Progressive Disease|39
1101504|NCT02357810|2175483|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8
1101505|NCT02357810|2175483|FG000|Reached 12 Weeks Response|Protocol Violation|1
1101506|NCT02357810|2175483|FG000|Reached 12 Weeks Response|Death|1
1101507|NCT02357810|2175483|FG000|Reached 12 Weeks Response|Physician Decision|1
1101508|NCT02357810|2175483|FG000|Reached 12 Weeks Response|Other|1
1101509|NCT02357810|2175483|FG000|12 Week Response and Further Treatment|Adverse Event|5
1101510|NCT02357810|2175483|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1
1101511|NCT02357810|2175483|FG000|12 Week Response and Further Treatment|Progressive Disease|15
1101512|NCT02357810|2175483|FG000|12 Week Response and Further Treatment|Wound Complications|1
1101513|NCT02357810|2175483|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4
1101514|NCT02357810|2175483|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3
1101515|NCT02357810|2175483|FG000|Follow-up at Treatment Discontinuation|Still in Follow-up|11
1101516|NCT02357901|2175495|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161
1101517|NCT02357901|2175496|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1101518|NCT02357901|2175497|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1101519|NCT02357901|2175498|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1101520|NCT02357901|2175495|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
1101521|NCT02357901|2175496|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
1101522|NCT02357901|2175497|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
1101523|NCT02357901|2175498|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
1101524|NCT02357901|2175495|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
1101525|NCT02357901|2175496|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
1101526|NCT02357901|2175497|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
1101527|NCT02357901|2175498|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
1101528|NCT02357901|2175495|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
1101529|NCT02357901|2175496|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
1101530|NCT02357901|2175497|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
1101531|NCT02357901|2175498|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
1101532|NCT02357901|2175495|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0
1101533|NCT02357901|2175496|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6
1101534|NCT02357901|2175497|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10
1101535|NCT02357901|2175498|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2
1101536|NCT02357901|2175495|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
1101537|NCT02357901|2175496|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
1101538|NCT02357901|2175497|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
1101539|NCT02357901|2175498|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
1101540|NCT02357901|2175495|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
1101541|NCT02357901|2175496|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
1101542|NCT02357901|2175497|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
1101543|NCT02357901|2175498|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
1101544|NCT02357901|2175495|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
1101545|NCT02357901|2175496|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
1101546|NCT02357901|2175497|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
1101547|NCT02357901|2175498|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
1101548|NCT02357901|2175495|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
1101549|NCT02357901|2175496|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
1101550|NCT02357901|2175497|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
1101551|NCT02357901|2175498|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
1101552|NCT02357901|2175495|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0
1101553|NCT02357901|2175496|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0
1101554|NCT02357901|2175497|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1
1101555|NCT02357901|2175498|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1
1101556|NCT02357901|2175495|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
1101557|NCT02357901|2175496|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
1101558|NCT02357901|2175497|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
1101559|NCT02357901|2175498|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
1101560|NCT02357940|2175508|FG000|Overall Study|Adverse Event|0
1101561|NCT02357940|2175509|FG001|Overall Study|Adverse Event|1
1101562|NCT02357940|2175508|FG000|Overall Study|Investigator's judgement|0
1101563|NCT02357940|2175509|FG001|Overall Study|Investigator's judgement|1
1101564|NCT02357979|2175517|FG000|Overall Study|Lost to Follow-up|5
1101565|NCT02357979|2175518|FG001|Overall Study|Lost to Follow-up|5
1101566|NCT02358031|2175527|FG000|Overall Study|Death|226
1101567|NCT02358031|2175528|FG001|Overall Study|Death|204
1101568|NCT02358031|2175529|FG002|Overall Study|Death|249
1101569|NCT02358031|2175527|FG000|Overall Study|Lost to Follow-up|0
1101570|NCT02358031|2175528|FG001|Overall Study|Lost to Follow-up|1
1101571|NCT02358031|2175529|FG002|Overall Study|Lost to Follow-up|1
1101572|NCT02358031|2175527|FG000|Overall Study|Withdrawal by Subject|14
1101573|NCT02358031|2175528|FG001|Overall Study|Withdrawal by Subject|12
1101574|NCT02358031|2175529|FG002|Overall Study|Withdrawal by Subject|17
1101575|NCT02358031|2175527|FG000|Overall Study|Ongoing in Study|61
1101576|NCT02358031|2175528|FG001|Overall Study|Ongoing in Study|64
1101577|NCT02358031|2175529|FG002|Overall Study|Ongoing in Study|33
1101578|NCT02358044|2175539|FG000|Overall Study|Adverse Event|0
1101579|NCT02358044|2175540|FG001|Overall Study|Adverse Event|1
1101580|NCT02358044|2175539|FG000|Overall Study|Lost to Follow-up|2
1101581|NCT02358044|2175540|FG001|Overall Study|Lost to Follow-up|1
1101582|NCT02358044|2175539|FG000|Overall Study|Physician Decision|0
1101583|NCT02358044|2175540|FG001|Overall Study|Physician Decision|1
1101584|NCT02358044|2175539|FG000|Overall Study|Withdrawal by Subject|0
1101585|NCT02358044|2175540|FG001|Overall Study|Withdrawal by Subject|4
1101586|NCT02358343|2175560|FG000|Screening Intervention|Death|0
1101587|NCT02358343|2175561|FG001|Screening Intervention|Death|2
1101588|NCT02358343|2175562|FG002|Screening Intervention|Death|0
1101589|NCT02358343|2175563|FG003|Screening Intervention|Death|0
1101590|NCT02358343|2175564|FG004|Screening Intervention|Death|0
1101591|NCT02358343|2175560|FG000|Screening Intervention|Withdrawal by Subject|1
1101592|NCT02358343|2175561|FG001|Screening Intervention|Withdrawal by Subject|0
1101593|NCT02358343|2175562|FG002|Screening Intervention|Withdrawal by Subject|0
1101594|NCT02358343|2175563|FG003|Screening Intervention|Withdrawal by Subject|0
1101595|NCT02358343|2175564|FG004|Screening Intervention|Withdrawal by Subject|0
1101596|NCT02358343|2175560|FG000|Screening Intervention|Determined Ineligible|5
1101597|NCT02358343|2175561|FG001|Screening Intervention|Determined Ineligible|6
1101598|NCT02358343|2175562|FG002|Screening Intervention|Determined Ineligible|0
1101599|NCT02358343|2175563|FG003|Screening Intervention|Determined Ineligible|0
1101600|NCT02358343|2175564|FG004|Screening Intervention|Determined Ineligible|0
1101601|NCT02358343|2175560|FG000|Comparative Efficacy Trial / Observation|Death|0
1101602|NCT02358343|2175561|FG001|Comparative Efficacy Trial / Observation|Death|0
1101603|NCT02358343|2175562|FG002|Comparative Efficacy Trial / Observation|Death|2
1101604|NCT02358343|2175563|FG003|Comparative Efficacy Trial / Observation|Death|0
1101605|NCT02358343|2175564|FG004|Comparative Efficacy Trial / Observation|Death|0
1101606|NCT02358343|2175560|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
1101607|NCT02358343|2175561|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
1101608|NCT02358343|2175562|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
1101609|NCT02358343|2175563|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
1101610|NCT02358343|2175564|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
1101611|NCT02358343|2175560|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
1101612|NCT02358343|2175561|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
1101613|NCT02358343|2175562|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
1101614|NCT02358343|2175563|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
1101615|NCT02358343|2175564|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
1101616|NCT02358369|2175578|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35
1101617|NCT02358369|2175579|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0
1101618|NCT02358369|2175580|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0
1101619|NCT02358369|2175581|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0
1101620|NCT02358369|2175582|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0
1101621|NCT02358369|2175578|FG000|Treatment Period A/B|Adverse Event|0
1101622|NCT02358369|2175579|FG001|Treatment Period A/B|Adverse Event|0
1101623|NCT02358369|2175580|FG002|Treatment Period A/B|Adverse Event|1
1101624|NCT02358369|2175581|FG003|Treatment Period A/B|Adverse Event|2
1101625|NCT02358369|2175582|FG004|Treatment Period A/B|Adverse Event|0
1101626|NCT02358369|2175578|FG000|Treatment Period A/B|Death|0
1101627|NCT02358369|2175579|FG001|Treatment Period A/B|Death|0
1101628|NCT02358369|2175580|FG002|Treatment Period A/B|Death|1
1101629|NCT02358369|2175581|FG003|Treatment Period A/B|Death|0
1101630|NCT02358369|2175582|FG004|Treatment Period A/B|Death|0
1101631|NCT02358369|2175578|FG000|Treatment Period A/B|Withdrawal by Subject|0
1101632|NCT02358369|2175579|FG001|Treatment Period A/B|Withdrawal by Subject|2
1101633|NCT02358369|2175580|FG002|Treatment Period A/B|Withdrawal by Subject|0
1101634|NCT02358369|2175581|FG003|Treatment Period A/B|Withdrawal by Subject|2
1101635|NCT02358369|2175582|FG004|Treatment Period A/B|Withdrawal by Subject|0
1101636|NCT02358369|2175578|FG000|Treatment Period C|Adverse Event|0
1101637|NCT02358369|2175579|FG001|Treatment Period C|Adverse Event|0
1101638|NCT02358369|2175580|FG002|Treatment Period C|Adverse Event|0
1101639|NCT02358369|2175581|FG003|Treatment Period C|Adverse Event|0
1101640|NCT02358369|2175582|FG004|Treatment Period C|Adverse Event|7
1101641|NCT02358473|2175592|FG000|Overall Study|Disease Progession|6
1101642|NCT02358473|2175592|FG000|Overall Study|Adverse Event|3
1101643|NCT02358473|2175592|FG000|Overall Study|Withdrawal by Subject|2
1101644|NCT02358473|2175592|FG000|Overall Study|Physician Decision|2
1101645|NCT02358668|2175608|FG000|Overall Study|Adverse Event|2
1101646|NCT02358668|2175609|FG001|Overall Study|Adverse Event|0
1101647|NCT02358668|2175610|FG002|Overall Study|Adverse Event|0
1101648|NCT02358668|2175608|FG000|Overall Study|Withdrawal by Subject|0
1101649|NCT02358668|2175609|FG001|Overall Study|Withdrawal by Subject|1
1101650|NCT02358668|2175610|FG002|Overall Study|Withdrawal by Subject|0
1101651|NCT02358863|2175618|FG000|Overall Study|Physician Decision|3
1101652|NCT02359045|2175656|FG000|Overall Study|Eligibility criteria not fulfilled|3
1101653|NCT02359045|2175657|FG001|Overall Study|Eligibility criteria not fulfilled|1
1101654|NCT02359045|2175656|FG000|Overall Study|Lost to Follow-up|1
1101655|NCT02359045|2175657|FG001|Overall Study|Lost to Follow-up|1
1101656|NCT02359045|2175656|FG000|Overall Study|Adverse Event|0
1101657|NCT02359045|2175657|FG001|Overall Study|Adverse Event|1
1101658|NCT02359435|2175707|FG000|Overall Study|Lost to Follow-up|4
1101659|NCT02359435|2175708|FG001|Overall Study|Lost to Follow-up|4
1101660|NCT02359552|2175716|FG000|Overall Study|Lost to Follow-up|3
1101661|NCT02359552|2175717|FG001|Overall Study|Lost to Follow-up|4
1101662|NCT02359851|2175723|FG000|Overall Study|Death|1
1101663|NCT02359851|2175723|FG000|Overall Study|Disease progression|1
1101664|NCT02359877|2175731|FG000|Overall Study|Withdrawal by Subject|1
1101665|NCT02359877|2175732|FG001|Overall Study|Withdrawal by Subject|0
1101666|NCT02359877|2175733|FG002|Overall Study|Withdrawal by Subject|0
1101667|NCT02359877|2175734|FG003|Overall Study|Withdrawal by Subject|2
1101668|NCT02359877|2175731|FG000|Overall Study|Adverse Event|0
1101669|NCT02359877|2175732|FG001|Overall Study|Adverse Event|0
1101670|NCT02359877|2175733|FG002|Overall Study|Adverse Event|0
1101671|NCT02359877|2175734|FG003|Overall Study|Adverse Event|1
1101672|NCT02359890|2175762|FG000|Overall Study|Not meeting eligibility|4
1101673|NCT02359890|2175762|FG000|Overall Study|Never treated with study catheter|6
1101674|NCT02359903|2175768|FG000|Overall Study|Adverse Event|0
1101675|NCT02359903|2175769|FG001|Overall Study|Adverse Event|2
1101676|NCT02360098|2175835|FG000|Overall Study|Physician Decision|7
1101677|NCT02360228|2175868|FG000|Overall Study|Withdrawal by Subject|1
1101678|NCT02360228|2175869|FG001|Overall Study|Withdrawal by Subject|0
1101679|NCT02360228|2175870|FG002|Overall Study|Withdrawal by Subject|0
1101680|NCT02360228|2175868|FG000|Overall Study|Self-discontinued medication|0
1101681|NCT02360228|2175869|FG001|Overall Study|Self-discontinued medication|1
1101682|NCT02360228|2175870|FG002|Overall Study|Self-discontinued medication|0
1101683|NCT02360228|2175868|FG000|Overall Study|Unstable symptoms during screening|0
1101684|NCT02360228|2175869|FG001|Overall Study|Unstable symptoms during screening|0
1101685|NCT02360228|2175870|FG002|Overall Study|Unstable symptoms during screening|1
1101686|NCT02360280|2175880|FG000|Overall Study|Withdrawal by Subject|2
1101687|NCT02360280|2175881|FG001|Overall Study|Withdrawal by Subject|0
1101688|NCT02360280|2175880|FG000|Overall Study|Adverse Event|0
1101689|NCT02360280|2175881|FG001|Overall Study|Adverse Event|1
1101690|NCT02360280|2175880|FG000|Overall Study|Lost to Follow-up|1
1101691|NCT02360280|2175881|FG001|Overall Study|Lost to Follow-up|0
1101692|NCT02360293|2175889|FG000|Overall Study|Lost to Follow-up|73
1101693|NCT02360293|2175890|FG001|Overall Study|Lost to Follow-up|95
1101694|NCT02360293|2175889|FG000|Overall Study|Withdrawal by Subject|2
1101695|NCT02360293|2175890|FG001|Overall Study|Withdrawal by Subject|1
1101696|NCT02360293|2175889|FG000|Overall Study|Excluded|1
1101697|NCT02360293|2175890|FG001|Overall Study|Excluded|0
1101698|NCT02360397|2175918|FG000|Overall Study|Incomplete screening|3
1101699|NCT02360397|2175918|FG000|Overall Study|Adverse Event|1
1101700|NCT02360475|2175927|FG000|Overall Study|Lost to Follow-up|4
1101701|NCT02360475|2175928|FG001|Overall Study|Lost to Follow-up|12
1101702|NCT02360475|2175929|FG002|Overall Study|Lost to Follow-up|6
1101703|NCT02360475|2175930|FG003|Overall Study|Lost to Follow-up|4
1101704|NCT02360475|2175927|FG000|Overall Study|Withdrawal by Subject|0
1101705|NCT02360475|2175928|FG001|Overall Study|Withdrawal by Subject|1
1101706|NCT02360475|2175929|FG002|Overall Study|Withdrawal by Subject|2
1101707|NCT02360475|2175930|FG003|Overall Study|Withdrawal by Subject|0
1101708|NCT02360475|2175927|FG000|Overall Study|Migrated/moved from study area|0
1101709|NCT02360475|2175928|FG001|Overall Study|Migrated/moved from study area|0
1101710|NCT02360475|2175929|FG002|Overall Study|Migrated/moved from study area|0
1101711|NCT02360475|2175930|FG003|Overall Study|Migrated/moved from study area|1
1101712|NCT02360605|2175951|FG000|Overall Study|Withdrawal by Subject|4
1101713|NCT02360605|2175952|FG001|Overall Study|Withdrawal by Subject|9
1101714|NCT02360605|2175951|FG000|Overall Study|Lost to Follow-up|7
1101715|NCT02360605|2175952|FG001|Overall Study|Lost to Follow-up|8
1101716|NCT02360605|2175951|FG000|Overall Study|Death|0
1101717|NCT02360605|2175952|FG001|Overall Study|Death|1
1101718|NCT02360995|2175983|FG000|Overall Study|Lost to Follow-up|2
1101719|NCT02360995|2175984|FG001|Overall Study|Lost to Follow-up|0
1101720|NCT02360995|2175985|FG002|Overall Study|Lost to Follow-up|2
1101721|NCT02360995|2175983|FG000|Overall Study|Withdrawal by Subject|0
1101722|NCT02360995|2175984|FG001|Overall Study|Withdrawal by Subject|1
1101723|NCT02360995|2175985|FG002|Overall Study|Withdrawal by Subject|0
1101724|NCT02361216|2175995|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
1101725|NCT02361216|2175996|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
1101726|NCT02361216|2175995|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
1101727|NCT02361216|2175996|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
1101728|NCT02361216|2175995|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
1101729|NCT02361216|2175996|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
1101730|NCT02361216|2175995|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
1101731|NCT02361216|2175996|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
1101732|NCT02361216|2175995|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
1101733|NCT02361216|2175996|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
1101734|NCT02361216|2175995|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
1101735|NCT02361216|2175996|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
1101736|NCT02361307|2176007|FG000|Overall Study|Unstable medical condition.|0
1101737|NCT02361307|2176008|FG001|Overall Study|Unstable medical condition.|1
1101738|NCT02361762|2176034|FG000|Overall Study|Withdrawal by Subject|0
1101739|NCT02361762|2176035|FG001|Overall Study|Withdrawal by Subject|1
1101740|NCT02361762|2176034|FG000|Overall Study|Lost to Follow-up|0
1101741|NCT02361762|2176035|FG001|Overall Study|Lost to Follow-up|1
1101742|NCT02362269|2176056|FG000|Overall Study|Moved|1
1101743|NCT02362269|2176057|FG001|Overall Study|Moved|0
1101744|NCT02362269|2176056|FG000|Overall Study|Lost to Follow-up|0
1101745|NCT02362269|2176057|FG001|Overall Study|Lost to Follow-up|6
1101746|NCT02362282|2176065|FG000|Overall Study|Withdrawal by Subject|1
1101747|NCT02362282|2176066|FG001|Overall Study|Withdrawal by Subject|0
1101748|NCT02362360|2176081|FG000|Period 1|Lack of Efficacy|1
1101749|NCT02362360|2176082|FG001|Period 1|Lack of Efficacy|0
1101750|NCT02362360|2176081|FG000|Period 1|Withdrawal by Subject|2
1101751|NCT02362360|2176082|FG001|Period 1|Withdrawal by Subject|1
1101752|NCT02362412|2176092|FG000|Treatment Period III|Lost to Follow-up|0
1101753|NCT02362412|2176093|FG001|Treatment Period III|Lost to Follow-up|1
1101754|NCT02362425|2176109|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
1101755|NCT02362425|2176110|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
1101756|NCT02362425|2176111|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
1101757|NCT02362425|2176112|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
1101758|NCT02362425|2176109|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1
1101759|NCT02362425|2176110|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0
1101760|NCT02362425|2176111|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0
1101761|NCT02362425|2176112|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0
1101762|NCT02362425|2176109|FG000|Phase 1 (up to 6 Months)|Screening failure|1
1101763|NCT02362425|2176110|FG001|Phase 1 (up to 6 Months)|Screening failure|0
1101764|NCT02362425|2176111|FG002|Phase 1 (up to 6 Months)|Screening failure|0
1101765|NCT02362425|2176112|FG003|Phase 1 (up to 6 Months)|Screening failure|0
1101766|NCT02362425|2176109|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
1101767|NCT02362425|2176110|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
1101768|NCT02362425|2176111|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
1101769|NCT02362425|2176112|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
1101770|NCT02362425|2176109|FG000|Phase 1 (up to 6 Months)|Study closure|9
1101771|NCT02362425|2176110|FG001|Phase 1 (up to 6 Months)|Study closure|0
1101772|NCT02362425|2176111|FG002|Phase 1 (up to 6 Months)|Study closure|0
1101773|NCT02362425|2176112|FG003|Phase 1 (up to 6 Months)|Study closure|0
1101774|NCT02362425|2176109|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
1101775|NCT02362425|2176110|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
1101776|NCT02362425|2176111|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
1101777|NCT02362425|2176112|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
1101778|NCT02362425|2176109|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
1101779|NCT02362425|2176110|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
1101780|NCT02362425|2176111|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
1101781|NCT02362425|2176112|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
1101782|NCT02362425|2176109|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
1101783|NCT02362425|2176110|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
1101784|NCT02362425|2176111|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
1101785|NCT02362425|2176112|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
1101786|NCT02362503|2176126|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0
1101787|NCT02362503|2176127|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2
1101788|NCT02362503|2176128|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0
1101789|NCT02362503|2176126|FG000|Double-blind Period-Up to 8 Days|Death|1
1101790|NCT02362503|2176127|FG001|Double-blind Period-Up to 8 Days|Death|0
1101791|NCT02362503|2176128|FG002|Double-blind Period-Up to 8 Days|Death|0
1101792|NCT02362503|2176126|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
1101793|NCT02362503|2176127|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
1101794|NCT02362503|2176128|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
1101795|NCT02362503|2176126|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
1101796|NCT02362503|2176127|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
1101797|NCT02362503|2176128|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
1101798|NCT02362503|2176126|FG000|Open Label Period-Up to 96 Weeks|Other|0
1101799|NCT02362503|2176127|FG001|Open Label Period-Up to 96 Weeks|Other|1
1101800|NCT02362503|2176128|FG002|Open Label Period-Up to 96 Weeks|Other|1
1101801|NCT02362503|2176126|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0
1101802|NCT02362503|2176127|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
1101803|NCT02362503|2176128|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
1101804|NCT02362503|2176126|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0
1101805|NCT02362503|2176127|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1
1101806|NCT02362503|2176128|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0
1101807|NCT02362503|2176126|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3
1101808|NCT02362503|2176127|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8
1101809|NCT02362503|2176128|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6
1101810|NCT02362503|2176126|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4
1101811|NCT02362503|2176127|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3
1101812|NCT02362503|2176128|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1
1101813|NCT02362503|2176126|FG000|Open Label Period-Up to 96 Weeks|Death|1
1101814|NCT02362503|2176127|FG001|Open Label Period-Up to 96 Weeks|Death|7
1101815|NCT02362503|2176128|FG002|Open Label Period-Up to 96 Weeks|Death|15
1101816|NCT02362503|2176126|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0
1101817|NCT02362503|2176127|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5
1101818|NCT02362503|2176128|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1
1101819|NCT02362503|2176126|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3
1101820|NCT02362503|2176127|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2
1101821|NCT02362503|2176128|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4
1101822|NCT02362503|2176126|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3
1101823|NCT02362503|2176127|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9
1101824|NCT02362503|2176128|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6
1101825|NCT02362503|2176126|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54
1101826|NCT02362503|2176127|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159
1101827|NCT02362503|2176128|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61
1101828|NCT02362646|2176150|FG000|Overall Study|Death|15
1101829|NCT02362646|2176151|FG001|Overall Study|Death|8
1101830|NCT02362646|2176150|FG000|Overall Study|Withdrawal by Subject|2
1101831|NCT02362646|2176151|FG001|Overall Study|Withdrawal by Subject|2
1101832|NCT02362646|2176150|FG000|Overall Study|received transplant|21
1101833|NCT02362646|2176151|FG001|Overall Study|received transplant|14
1101834|NCT02362724|2176174|FG000|Overall Study|Withdrawal by Subject|3
1101835|NCT02362724|2176175|FG001|Overall Study|Withdrawal by Subject|1
1101836|NCT02362724|2176174|FG000|Overall Study|Adverse Event|3
1101837|NCT02362724|2176175|FG001|Overall Study|Adverse Event|0
1101838|NCT02362789|2176183|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
1101839|NCT02362789|2176184|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
1101840|NCT02362789|2176185|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
1101841|NCT02362789|2176183|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1
1101842|NCT02362789|2176184|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0
1101843|NCT02362789|2176185|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0
1101844|NCT02362789|2176183|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
1101845|NCT02362789|2176184|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
1101846|NCT02362789|2176185|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
1101847|NCT02362789|2176183|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
1101848|NCT02362789|2176184|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
1101849|NCT02362789|2176185|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
1101850|NCT02362789|2176183|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
1101851|NCT02362789|2176184|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
1101852|NCT02362789|2176185|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
1101853|NCT02363283|2176214|FG000|Overall Study|Withdrawal by Subject|1
1101854|NCT02363283|2176214|FG000|Overall Study|Not eligible due to transaminitis|1
1101855|NCT02363322|2176220|FG000|Overall Study|Lost to Follow-up|1
1101856|NCT02363322|2176221|FG001|Overall Study|Lost to Follow-up|0
895092|NCT00696384|1866295|FG001|Open Label Phase|Lost to Follow-up|0
895093|NCT00696384|1866296|FG002|Open Label Phase|Lost to Follow-up|0
1101857|NCT02363439|2176227|FG000|Overall Study|Lack of Efficacy|4
1101858|NCT02363478|2176231|FG000|Overall Study|Lost to Follow-up|4
1101859|NCT02363478|2176231|FG000|Overall Study|Adverse Event|4
1101860|NCT02363686|2176245|FG000|Overall Study|Withdrawal by Subject|22
1101861|NCT02363686|2176245|FG000|Overall Study|incomplete FEES examinations|13
1101862|NCT02363738|2176251|FG000|Overall Study|Adverse Event|5
1101863|NCT02363738|2176252|FG001|Overall Study|Adverse Event|2
1101864|NCT02363738|2176251|FG000|Overall Study|Lack of Efficacy|1
1101865|NCT02363738|2176252|FG001|Overall Study|Lack of Efficacy|2
1101866|NCT02363738|2176251|FG000|Overall Study|Lost to Follow-up|2
1101867|NCT02363738|2176252|FG001|Overall Study|Lost to Follow-up|1
1101868|NCT02363946|2176294|FG000|Overall Study|Lost to Follow-up|0
1101869|NCT02363946|2176295|FG001|Overall Study|Lost to Follow-up|0
1101870|NCT02363946|2176296|FG002|Overall Study|Lost to Follow-up|0
1101871|NCT02363946|2176297|FG003|Overall Study|Lost to Follow-up|0
1101872|NCT02363946|2176298|FG004|Overall Study|Lost to Follow-up|0
1101873|NCT02363946|2176299|FG005|Overall Study|Lost to Follow-up|0
1101874|NCT02363946|2176300|FG006|Overall Study|Lost to Follow-up|0
1101875|NCT02363946|2176301|FG007|Overall Study|Lost to Follow-up|1
1101876|NCT02363946|2176302|FG008|Overall Study|Lost to Follow-up|0
1101877|NCT02363946|2176303|FG009|Overall Study|Lost to Follow-up|0
1101878|NCT02363946|2176304|FG010|Overall Study|Lost to Follow-up|0
1101879|NCT02363946|2176305|FG011|Overall Study|Lost to Follow-up|0
1101880|NCT02363946|2176306|FG012|Overall Study|Lost to Follow-up|0
1101881|NCT02363959|2176336|FG000|Overall Study|Medical instability|1
1101882|NCT02363959|2176337|FG001|Overall Study|Medical instability|0
1101883|NCT02364037|2176369|FG000|Overall Study|Withdrawal by Subject|7
1101884|NCT02364037|2176370|FG001|Overall Study|Withdrawal by Subject|4
1101885|NCT02364037|2176369|FG000|Overall Study|Lost to Follow-up|37
1101886|NCT02364037|2176370|FG001|Overall Study|Lost to Follow-up|49
1101887|NCT02364180|2176380|FG000|Overall Study|Screen Fail|1
1101888|NCT02364336|2176396|FG000|Overall Study|Adverse Event|0
1101889|NCT02364336|2176397|FG001|Overall Study|Adverse Event|1
1101890|NCT02364388|2176404|FG000|Overall Study|Protocol Violation|1
1101891|NCT02364388|2176404|FG000|Overall Study|Technical Failure|3
1101892|NCT02364388|2176404|FG000|Overall Study|No OA/US data|2
1101893|NCT02364388|2176404|FG000|Overall Study|No Biopsy|2
1101894|NCT02364947|2176448|FG000|Overall Study|Withdrawal by Subject|10
1101895|NCT02364947|2176449|FG001|Overall Study|Withdrawal by Subject|8
1101896|NCT02364947|2176450|FG002|Overall Study|Withdrawal by Subject|9
1101897|NCT02364947|2176448|FG000|Overall Study|Adverse Event|45
1101898|NCT02364947|2176449|FG001|Overall Study|Adverse Event|33
1101899|NCT02364947|2176450|FG002|Overall Study|Adverse Event|11
1101900|NCT02364947|2176448|FG000|Overall Study|Protocol Violation|1
1101901|NCT02364947|2176449|FG001|Overall Study|Protocol Violation|1
1101902|NCT02364947|2176450|FG002|Overall Study|Protocol Violation|1
1101903|NCT02364947|2176448|FG000|Overall Study|Physician Decision|3
1101904|NCT02364947|2176449|FG001|Overall Study|Physician Decision|2
1101905|NCT02364947|2176450|FG002|Overall Study|Physician Decision|5
1101906|NCT02364947|2176448|FG000|Overall Study|Death|0
1101907|NCT02364947|2176449|FG001|Overall Study|Death|1
1101908|NCT02364947|2176450|FG002|Overall Study|Death|0
1101909|NCT02364999|2176460|FG000|Overall Study|Death|136
1101910|NCT02364999|2176461|FG001|Overall Study|Death|138
1101911|NCT02364999|2176460|FG000|Overall Study|Lost to Follow-up|10
1101912|NCT02364999|2176461|FG001|Overall Study|Lost to Follow-up|15
1101913|NCT02364999|2176460|FG000|Overall Study|Protocol Violation|3
1101914|NCT02364999|2176461|FG001|Overall Study|Protocol Violation|2
1101915|NCT02364999|2176460|FG000|Overall Study|Withdrawal by Subject|14
1101916|NCT02364999|2176461|FG001|Overall Study|Withdrawal by Subject|14
1101917|NCT02364999|2176460|FG000|Overall Study|Other|0
1101918|NCT02364999|2176461|FG001|Overall Study|Other|1
1101919|NCT02364999|2176460|FG000|Overall Study|Randomized but did not receive treatment|2
1101920|NCT02364999|2176461|FG001|Overall Study|Randomized but did not receive treatment|3
1101921|NCT02365064|2176470|FG000|Overall Study|Patients met baseline exclusion requirem|2
1101922|NCT02365064|2176471|FG001|Overall Study|Patients met baseline exclusion requirem|15
1101923|NCT02365064|2176470|FG000|Overall Study|Withdrawal by Subject|6
1101924|NCT02365064|2176471|FG001|Overall Study|Withdrawal by Subject|9
1101925|NCT02365064|2176470|FG000|Overall Study|Treatment intolerance|2
1101926|NCT02365064|2176471|FG001|Overall Study|Treatment intolerance|4
1101927|NCT02365285|2176481|FG000|Overall Study|Physician Decision|0
1101928|NCT02365285|2176482|FG001|Overall Study|Physician Decision|1
1101929|NCT02365285|2176483|FG002|Overall Study|Physician Decision|1
1101930|NCT02365285|2176484|FG003|Overall Study|Physician Decision|0
1101931|NCT02365285|2176481|FG000|Overall Study|Adverse Event|0
1101932|NCT02365285|2176482|FG001|Overall Study|Adverse Event|0
1101933|NCT02365285|2176483|FG002|Overall Study|Adverse Event|0
1101934|NCT02365285|2176484|FG003|Overall Study|Adverse Event|2
1101935|NCT02365298|2176496|FG000|Period 2|incorrect Rx dispensed|1
1101936|NCT02365298|2176497|FG001|Period 2|incorrect Rx dispensed|0
1101937|NCT02365298|2176496|FG000|Period 2|Discontinued at request of Sponsor|1
1101938|NCT02365298|2176497|FG001|Period 2|Discontinued at request of Sponsor|0
1101939|NCT02365298|2176496|FG000|Period 2|Test Article longer available|0
1101940|NCT02365298|2176497|FG001|Period 2|Test Article longer available|1
1101941|NCT02365298|2176496|FG000|Period 2|Protocol Violation|0
1101942|NCT02365298|2176497|FG001|Period 2|Protocol Violation|1
1101943|NCT02365480|2176505|FG000|Overall Study|Withdrawal by Subject|2
1101944|NCT02365480|2176506|FG001|Overall Study|Withdrawal by Subject|0
1101945|NCT02365506|2176515|FG000|Overall Study|Investigator's Discretion|0
1101946|NCT02365506|2176516|FG001|Overall Study|Investigator's Discretion|0
1101947|NCT02365506|2176517|FG002|Overall Study|Investigator's Discretion|1
1101948|NCT02365519|2176527|FG000|Randomized and Treated|Adverse Event|0
1101949|NCT02365519|2176528|FG001|Randomized and Treated|Adverse Event|1
1101950|NCT02365519|2176529|FG002|Randomized and Treated|Adverse Event|0
1101951|NCT02365519|2176527|FG000|Randomized and Treated|Withdrawal by Subject|0
1101952|NCT02365519|2176528|FG001|Randomized and Treated|Withdrawal by Subject|1
1101953|NCT02365519|2176529|FG002|Randomized and Treated|Withdrawal by Subject|1
1101954|NCT02365558|2176538|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1
1101955|NCT02365558|2176539|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0
1101956|NCT02365558|2176538|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
1101957|NCT02365558|2176539|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
1101958|NCT02365584|2176550|FG000|Overall Study|Adverse Event|2
1101959|NCT02365584|2176551|FG001|Overall Study|Adverse Event|2
1101960|NCT02365584|2176550|FG000|Overall Study|Withdrawal by Subject|1
1101961|NCT02365584|2176551|FG001|Overall Study|Withdrawal by Subject|0
1101962|NCT02365584|2176550|FG000|Overall Study|Disease Progression|9
1101963|NCT02365584|2176551|FG001|Overall Study|Disease Progression|12
1101964|NCT02365636|2176560|FG000|Overall Study|Adverse Event|3
1101965|NCT02365636|2176561|FG001|Overall Study|Adverse Event|3
1101966|NCT02365636|2176562|FG002|Overall Study|Adverse Event|2
1101967|NCT02365636|2176560|FG000|Overall Study|Protocol Violation|1
1101968|NCT02365636|2176561|FG001|Overall Study|Protocol Violation|4
1101969|NCT02365636|2176562|FG002|Overall Study|Protocol Violation|0
1101970|NCT02365636|2176560|FG000|Overall Study|Lost to Follow-up|0
1101971|NCT02365636|2176561|FG001|Overall Study|Lost to Follow-up|0
1101972|NCT02365636|2176562|FG002|Overall Study|Lost to Follow-up|1
1101973|NCT02365636|2176560|FG000|Overall Study|Other|2
1101974|NCT02365636|2176561|FG001|Overall Study|Other|0
1101975|NCT02365636|2176562|FG002|Overall Study|Other|0
1101976|NCT02366091|2176596|FG000|Overall Study|Withdrawal by Subject|3
1101977|NCT02366091|2176597|FG001|Overall Study|Withdrawal by Subject|7
1101978|NCT02366091|2176598|FG002|Overall Study|Withdrawal by Subject|3
1101979|NCT02366091|2176599|FG003|Overall Study|Withdrawal by Subject|1
1101980|NCT02366130|2176609|FG000|Overall Study|Withdrawal by Subject|3
1101981|NCT02366130|2176609|FG000|Overall Study|Ineligible|6
1101982|NCT02366143|2176616|FG000|Overall Study|Death|307
1101983|NCT02366143|2176617|FG001|Overall Study|Death|278
1101984|NCT02366143|2176618|FG002|Overall Study|Death|280
1101985|NCT02366143|2176616|FG000|Overall Study|Lost to Follow-up|2
1101986|NCT02366143|2176617|FG001|Overall Study|Lost to Follow-up|4
1101987|NCT02366143|2176618|FG002|Overall Study|Lost to Follow-up|2
1101988|NCT02366143|2176616|FG000|Overall Study|Physician Decision|1
1101989|NCT02366143|2176617|FG001|Overall Study|Physician Decision|2
1101990|NCT02366143|2176618|FG002|Overall Study|Physician Decision|1
1101991|NCT02366143|2176616|FG000|Overall Study|Protocol Violation|0
1101992|NCT02366143|2176617|FG001|Overall Study|Protocol Violation|0
1101993|NCT02366143|2176618|FG002|Overall Study|Protocol Violation|2
1101994|NCT02366143|2176616|FG000|Overall Study|Withdrawal by Subject|16
1101995|NCT02366143|2176617|FG001|Overall Study|Withdrawal by Subject|17
1101996|NCT02366143|2176618|FG002|Overall Study|Withdrawal by Subject|22
1101997|NCT02366143|2176616|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0
1101998|NCT02366143|2176617|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6
1101999|NCT02366143|2176618|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0
1102000|NCT02366143|2176616|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0
1102001|NCT02366143|2176617|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1
1102002|NCT02366143|2176618|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0
1102003|NCT02366143|2176616|FG000|Overall Study|Randomization Error|1
1102004|NCT02366143|2176617|FG001|Overall Study|Randomization Error|0
1102005|NCT02366143|2176618|FG002|Overall Study|Randomization Error|0
1102006|NCT02366143|2176616|FG000|Overall Study|PI Move and Site Closure|1
1102007|NCT02366143|2176617|FG001|Overall Study|PI Move and Site Closure|0
1102008|NCT02366143|2176618|FG002|Overall Study|PI Move and Site Closure|1
1102009|NCT02366143|2176616|FG000|Overall Study|Study Terminated By Sponsor|0
1102010|NCT02366143|2176617|FG001|Overall Study|Study Terminated By Sponsor|0
1102011|NCT02366143|2176618|FG002|Overall Study|Study Terminated By Sponsor|2
1102012|NCT02366143|2176616|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70
1102013|NCT02366143|2176617|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57
1102014|NCT02366143|2176618|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52
1102015|NCT02366143|2176616|FG000|Overall Study|Patient moved to roll-over study|1
1102016|NCT02366143|2176617|FG001|Overall Study|Patient moved to roll-over study|19
1102017|NCT02366143|2176618|FG002|Overall Study|Patient moved to roll-over study|28
1102018|NCT02366143|2176616|FG000|Overall Study|Patient moved to commercial stock|0
1102019|NCT02366143|2176617|FG001|Overall Study|Patient moved to commercial stock|0
1102020|NCT02366143|2176618|FG002|Overall Study|Patient moved to commercial stock|1
1102021|NCT02366143|2176616|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
1102022|NCT02366143|2176617|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
1102023|NCT02366143|2176618|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1
1102024|NCT02366143|2176616|FG000|Overall Study|Patient rolling over to patient assistance program|0
1102025|NCT02366143|2176617|FG001|Overall Study|Patient rolling over to patient assistance program|0
1102026|NCT02366143|2176618|FG002|Overall Study|Patient rolling over to patient assistance program|1
1102027|NCT02366143|2176616|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
1102028|NCT02366143|2176617|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
895094|NCT00696384|1866294|FG000|Open Label Phase|Withdrawal by Subject|37
895095|NCT00696384|1866295|FG001|Open Label Phase|Withdrawal by Subject|0
895096|NCT00696384|1866296|FG002|Open Label Phase|Withdrawal by Subject|0
895097|NCT00696384|1866294|FG000|Open Label Phase|Other|6
895098|NCT00696384|1866295|FG001|Open Label Phase|Other|0
895099|NCT00696384|1866296|FG002|Open Label Phase|Other|0
895100|NCT00696384|1866294|FG000|Open Label Phase|Lack of Efficacy|3
895101|NCT00696384|1866295|FG001|Open Label Phase|Lack of Efficacy|0
895102|NCT00696384|1866296|FG002|Open Label Phase|Lack of Efficacy|0
895103|NCT00696384|1866294|FG000|Open Label Phase|Physician Decision|4
1102029|NCT02366143|2176618|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1
1102030|NCT02366143|2176616|FG000|Overall Study|Requester's instructions|1
1102031|NCT02366143|2176617|FG001|Overall Study|Requester's instructions|1
1102032|NCT02366143|2176618|FG002|Overall Study|Requester's instructions|1
1102033|NCT02366143|2176616|FG000|Overall Study|Uneligible|0
1102034|NCT02366143|2176617|FG001|Overall Study|Uneligible|1
1102035|NCT02366143|2176618|FG002|Overall Study|Uneligible|0
1102036|NCT02366143|2176616|FG000|Overall Study|Post Trial Migration|0
1102037|NCT02366143|2176617|FG001|Overall Study|Post Trial Migration|1
1102038|NCT02366143|2176618|FG002|Overall Study|Post Trial Migration|0
1102039|NCT02366143|2176616|FG000|Overall Study|Patient moving onto PTAP commercial stock|0
1102040|NCT02366143|2176617|FG001|Overall Study|Patient moving onto PTAP commercial stock|1
1102041|NCT02366143|2176618|FG002|Overall Study|Patient moving onto PTAP commercial stock|0
1102042|NCT02366143|2176616|FG000|Overall Study|Patient switched to PTAP|0
1102043|NCT02366143|2176617|FG001|Overall Study|Patient switched to PTAP|1
1102044|NCT02366143|2176618|FG002|Overall Study|Patient switched to PTAP|0
1102045|NCT02366143|2176616|FG000|Overall Study|Patient moved to commercial atezolizumab use|0
1102046|NCT02366143|2176617|FG001|Overall Study|Patient moved to commercial atezolizumab use|11
1102047|NCT02366143|2176618|FG002|Overall Study|Patient moved to commercial atezolizumab use|7
1102048|NCT02366195|2176630|FG000|Overall Study|Protocol-specified criteria|3
1102049|NCT02366195|2176630|FG000|Overall Study|Withdrawal by Subject|9
1102050|NCT02366195|2176630|FG000|Overall Study|Lost to Follow-up|1
1102051|NCT02366195|2176630|FG000|Overall Study|Death|41
1102052|NCT02366312|2176636|FG000|Overall Study|Lost to Follow-up|0
1102053|NCT02366312|2176637|FG001|Overall Study|Lost to Follow-up|1
1102054|NCT02366468|2176667|FG000|Overall Study|Adverse Event|2
1102055|NCT02366468|2176668|FG001|Overall Study|Adverse Event|0
1102056|NCT02366468|2176667|FG000|Overall Study|Withdrawal by Subject|1
1102057|NCT02366468|2176668|FG001|Overall Study|Withdrawal by Subject|5
1102058|NCT02366468|2176667|FG000|Overall Study|Lost to Follow-up|2
1102059|NCT02366468|2176668|FG001|Overall Study|Lost to Follow-up|0
1102060|NCT02366468|2176667|FG000|Overall Study|Death|1
1102061|NCT02366468|2176668|FG001|Overall Study|Death|2
1102062|NCT02366468|2176667|FG000|Overall Study|Other|0
1102063|NCT02366468|2176668|FG001|Overall Study|Other|2
1102064|NCT02366637|2176684|FG000|First Intervention Period|Adverse Event|0
1102065|NCT02366637|2176685|FG001|First Intervention Period|Adverse Event|1
1102066|NCT02366637|2176684|FG000|First Intervention Period|Study Terminated by Sponsor|6
1102067|NCT02366637|2176685|FG001|First Intervention Period|Study Terminated by Sponsor|4
1102068|NCT02366637|2176684|FG000|Second Intervention Period|Study Terminated by Sponsor|1
1102069|NCT02366637|2176685|FG001|Second Intervention Period|Study Terminated by Sponsor|1
1102070|NCT02366689|2176703|FG000|Overall Study|Withdrawal by Subject|1
1102071|NCT02366689|2176704|FG001|Overall Study|Withdrawal by Subject|0
1102072|NCT02366689|2176705|FG002|Overall Study|Withdrawal by Subject|1
1102073|NCT02366689|2176703|FG000|Overall Study|Lost to Follow-up|3
1102074|NCT02366689|2176704|FG001|Overall Study|Lost to Follow-up|2
1102075|NCT02366689|2176705|FG002|Overall Study|Lost to Follow-up|0
1102076|NCT02366689|2176703|FG000|Overall Study|Pregnancy|0
1102077|NCT02366689|2176704|FG001|Overall Study|Pregnancy|1
1102078|NCT02366689|2176705|FG002|Overall Study|Pregnancy|1
1102079|NCT02366767|2176715|FG000|Overall Study|left for home after 1 day at camp|1
1102080|NCT02366767|2176716|FG001|Overall Study|left for home after 1 day at camp|0
1102081|NCT02366910|2176740|FG000|Overall Study|Withdrawal by Subject|2
1102082|NCT02366910|2176740|FG000|Overall Study|Screen Failure|3
1102083|NCT02366923|2176746|FG000|Overall Study|Withdrawal by Subject|1
1102084|NCT02366923|2176746|FG000|Overall Study|Positive Slit Lamp Findings|2
1102085|NCT02366923|2176746|FG000|Overall Study|High Astigmatism|3
1102086|NCT02366936|2176751|FG000|Overall Study|Withdrawal by Subject|2
1102087|NCT02366936|2176751|FG000|Overall Study|Lost to Follow-up|4
1102088|NCT02366936|2176751|FG000|Overall Study|Physician Decision|2
1102089|NCT02367131|2176803|FG000|Overall Study|Adverse Event|64
1102090|NCT02367131|2176803|FG000|Overall Study|No visit since the first visit|4
1102091|NCT02367131|2176803|FG000|Overall Study|Request by patient|54
1102092|NCT02367131|2176803|FG000|Overall Study|Improvement/remission|2
1102093|NCT02367131|2176803|FG000|Overall Study|No change/progressive disease|78
1102094|NCT02367131|2176803|FG000|Overall Study|Other than stated above|20
1102095|NCT02367352|2176807|FG000|Overall Study|Progressive disease|7
1102096|NCT02367352|2176808|FG001|Overall Study|Progressive disease|0
1102097|NCT02367352|2176809|FG002|Overall Study|Progressive disease|0
1102098|NCT02367352|2176807|FG000|Overall Study|Participant Received Alternative Therapy|1
1102099|NCT02367352|2176808|FG001|Overall Study|Participant Received Alternative Therapy|0
1102100|NCT02367352|2176809|FG002|Overall Study|Participant Received Alternative Therapy|0
1102101|NCT02367352|2176807|FG000|Overall Study|Adverse Event|1
1102102|NCT02367352|2176808|FG001|Overall Study|Adverse Event|0
1102103|NCT02367352|2176809|FG002|Overall Study|Adverse Event|0
1102116|NCT02367521|2176848|FG000|Overall Study|severe headache after intervention|2
1102117|NCT02367521|2176849|FG001|Overall Study|severe headache after intervention|0
1102118|NCT02367521|2176848|FG000|Overall Study|unable to find transportation|2
1102119|NCT02367521|2176849|FG001|Overall Study|unable to find transportation|0
1102120|NCT02367716|2176864|FG000|Overall Study|Patient did not meet inclusion criteria|1
1102121|NCT02367729|2176871|FG000|Overall Study|Organic disorder diagnosed|2
1102122|NCT02367729|2176872|FG001|Overall Study|Organic disorder diagnosed|1
1102123|NCT02367729|2176871|FG000|Overall Study|Adverse Event|1
1102124|NCT02367729|2176872|FG001|Overall Study|Adverse Event|2
1102125|NCT02367729|2176871|FG000|Overall Study|Withdrawal by Subject|0
1102126|NCT02367729|2176872|FG001|Overall Study|Withdrawal by Subject|5
1102127|NCT02367781|2176881|FG000|Overall Study|Withdrawal by Subject|20
1102128|NCT02367781|2176882|FG001|Overall Study|Withdrawal by Subject|13
1102129|NCT02367781|2176881|FG000|Overall Study|Protocol Violation|0
1102130|NCT02367781|2176882|FG001|Overall Study|Protocol Violation|1
1102131|NCT02367781|2176881|FG000|Overall Study|Physician Decision|7
1102132|NCT02367781|2176882|FG001|Overall Study|Physician Decision|0
1102133|NCT02367781|2176881|FG000|Overall Study|Randomized in Error|5
1102134|NCT02367781|2176882|FG001|Overall Study|Randomized in Error|4
1102135|NCT02367781|2176881|FG000|Overall Study|Non-Compliance|1
1102136|NCT02367781|2176882|FG001|Overall Study|Non-Compliance|0
1102137|NCT02367781|2176881|FG000|Overall Study|Lost to Follow-up|1
1102138|NCT02367781|2176882|FG001|Overall Study|Lost to Follow-up|2
1102139|NCT02367781|2176881|FG000|Overall Study|Death|330
1102140|NCT02367781|2176882|FG001|Overall Study|Death|176
1102141|NCT02367781|2176881|FG000|Overall Study|Patient Moving to Roll-Over Study|17
1102142|NCT02367781|2176882|FG001|Overall Study|Patient Moving to Roll-Over Study|5
1102143|NCT02367781|2176881|FG000|Overall Study|Prolonged Hospitalization|1
1102144|NCT02367781|2176882|FG001|Overall Study|Prolonged Hospitalization|0
1102145|NCT02367781|2176881|FG000|Overall Study|Death Prior First Dose|1
1102146|NCT02367781|2176882|FG001|Overall Study|Death Prior First Dose|0
1102147|NCT02367781|2176881|FG000|Overall Study|Administrative-Change Facility|1
1102148|NCT02367781|2176882|FG001|Overall Study|Administrative-Change Facility|0
1102149|NCT02367781|2176881|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78
1102150|NCT02367781|2176882|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29
1102151|NCT02367781|2176881|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14
1102152|NCT02367781|2176882|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9
1102153|NCT02367781|2176881|FG000|Overall Study|Study Terminated by Sponsor|3
1102154|NCT02367781|2176882|FG001|Overall Study|Study Terminated by Sponsor|1
1102155|NCT02367781|2176881|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1
1102156|NCT02367781|2176882|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0
1102157|NCT02367781|2176881|FG000|Overall Study|Sponsor Decision|2
1102158|NCT02367781|2176882|FG001|Overall Study|Sponsor Decision|0
1102159|NCT02367781|2176881|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1
1102160|NCT02367781|2176882|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0
1102161|NCT02367794|2176893|FG000|Overall Study|Death|230
1102162|NCT02367794|2176894|FG001|Overall Study|Death|223
1102163|NCT02367794|2176895|FG002|Overall Study|Death|229
1102164|NCT02367794|2176893|FG000|Overall Study|Lost to Follow-up|1
1102165|NCT02367794|2176894|FG001|Overall Study|Lost to Follow-up|2
1102166|NCT02367794|2176895|FG002|Overall Study|Lost to Follow-up|1
1102167|NCT02367794|2176893|FG000|Overall Study|Physician Decision|0
1102168|NCT02367794|2176894|FG001|Overall Study|Physician Decision|3
1102169|NCT02367794|2176895|FG002|Overall Study|Physician Decision|1
1102170|NCT02367794|2176893|FG000|Overall Study|Protocol Violation|1
1102171|NCT02367794|2176894|FG001|Overall Study|Protocol Violation|0
1102172|NCT02367794|2176895|FG002|Overall Study|Protocol Violation|1
1102173|NCT02367794|2176893|FG000|Overall Study|Withdrawal by Subject|25
1102174|NCT02367794|2176894|FG001|Overall Study|Withdrawal by Subject|12
1102175|NCT02367794|2176895|FG002|Overall Study|Withdrawal by Subject|14
1102176|NCT02367794|2176893|FG000|Overall Study|Brain metastasis|1
1102177|NCT02367794|2176894|FG001|Overall Study|Brain metastasis|0
1102178|NCT02367794|2176895|FG002|Overall Study|Brain metastasis|0
1102179|NCT02367794|2176893|FG000|Overall Study|Randomized in error|0
1102180|NCT02367794|2176894|FG001|Overall Study|Randomized in error|0
1102181|NCT02367794|2176895|FG002|Overall Study|Randomized in error|1
1102182|NCT02367794|2176893|FG000|Overall Study|Patient unable to receive carboplatin|0
1102183|NCT02367794|2176894|FG001|Overall Study|Patient unable to receive carboplatin|0
1102184|NCT02367794|2176895|FG002|Overall Study|Patient unable to receive carboplatin|1
1102185|NCT02367794|2176893|FG000|Overall Study|Hypercalcemia prior to C1D1|0
1102186|NCT02367794|2176894|FG001|Overall Study|Hypercalcemia prior to C1D1|0
1102187|NCT02367794|2176895|FG002|Overall Study|Hypercalcemia prior to C1D1|1
1102188|NCT02367833|2176920|FG000|Overall Study|Withdrawal by Subject|1
1102189|NCT02367833|2176921|FG001|Overall Study|Withdrawal by Subject|1
1102190|NCT02367833|2176922|FG002|Overall Study|Withdrawal by Subject|0
1102191|NCT02367885|2176979|FG000|Overall Study|Lost to Follow-up|1
1102192|NCT02367885|2176980|FG001|Overall Study|Lost to Follow-up|0
1102193|NCT02367885|2176981|FG002|Overall Study|Lost to Follow-up|0
1102194|NCT02367885|2176979|FG000|Overall Study|Withdrawal by Subject|1
1102195|NCT02367885|2176980|FG001|Overall Study|Withdrawal by Subject|0
1102196|NCT02367885|2176981|FG002|Overall Study|Withdrawal by Subject|0
1102197|NCT02367911|2176994|FG000|Overall Study|Withdrawal by Subject|3
1102198|NCT02367911|2176995|FG001|Overall Study|Withdrawal by Subject|2
1102199|NCT02367911|2176994|FG000|Overall Study|Lost to Follow-up|2
1102200|NCT02367911|2176995|FG001|Overall Study|Lost to Follow-up|2
1102201|NCT02368210|2177012|FG000|Overall Study|Withdrawal by Subject|1
1102202|NCT02368210|2177013|FG001|Overall Study|Withdrawal by Subject|0
1102203|NCT02368210|2177012|FG000|Overall Study|Adverse Event|0
1102204|NCT02368210|2177013|FG001|Overall Study|Adverse Event|1
1102205|NCT02368314|2177021|FG000|Overall Study|Withdrawal by Subject|2
1102206|NCT02368314|2177022|FG001|Overall Study|Withdrawal by Subject|1
1102207|NCT02368314|2177021|FG000|Overall Study|Adverse Event|1
1102208|NCT02368314|2177022|FG001|Overall Study|Adverse Event|2
1102209|NCT02368691|2177047|FG000|Overall Study|Death|13
1102210|NCT02368691|2177047|FG000|Overall Study|Lack of Efficacy|15
1102211|NCT02368691|2177047|FG000|Overall Study|Physician Decision|4
1102220|NCT02369159|2177077|FG000|Overall Study|Adverse Event|0
1102221|NCT02369159|2177078|FG001|Overall Study|Adverse Event|1
1102222|NCT02369159|2177077|FG000|Overall Study|Lost to Follow-up|1
1102223|NCT02369159|2177078|FG001|Overall Study|Lost to Follow-up|1
1102224|NCT02369159|2177077|FG000|Overall Study|Withdrawal by Subject|7
1102225|NCT02369159|2177078|FG001|Overall Study|Withdrawal by Subject|0
1102226|NCT02369341|2177128|FG000|Overall Study|Migrated/moved from study area|1
1102227|NCT02369341|2177129|FG001|Overall Study|Migrated/moved from study area|0
1102228|NCT02369510|2177146|FG000|Overall Study|Spilled Medication|1
1102229|NCT02369510|2177147|FG001|Overall Study|Spilled Medication|2
1102230|NCT02369510|2177148|FG002|Overall Study|Spilled Medication|1
1102231|NCT02369510|2177146|FG000|Overall Study|Epidural Activation|1
1102232|NCT02369510|2177147|FG001|Overall Study|Epidural Activation|1
1102233|NCT02369510|2177148|FG002|Overall Study|Epidural Activation|5
1102234|NCT02369848|2177197|FG000|Overall Study|Death|1
1102235|NCT02369848|2177197|FG000|Overall Study|Withdrawal by Subject|2
1102236|NCT02369848|2177197|FG000|Overall Study|Lost to Follow-up|1
1102237|NCT02369874|2177204|FG000|Overall Study|Lost to Follow-up|2
1102238|NCT02369874|2177205|FG001|Overall Study|Lost to Follow-up|2
1102239|NCT02369874|2177206|FG002|Overall Study|Lost to Follow-up|2
1102240|NCT02369874|2177204|FG000|Overall Study|Withdrawal by Subject|7
1102241|NCT02369874|2177205|FG001|Overall Study|Withdrawal by Subject|9
1102242|NCT02369874|2177206|FG002|Overall Study|Withdrawal by Subject|27
1102243|NCT02369874|2177204|FG000|Overall Study|Miscellaneous|1
1102244|NCT02369874|2177205|FG001|Overall Study|Miscellaneous|1
1102245|NCT02369874|2177206|FG002|Overall Study|Miscellaneous|0
1102246|NCT02369874|2177204|FG000|Overall Study|On Treatment/Off Study|34
1102247|NCT02369874|2177205|FG001|Overall Study|On Treatment/Off Study|45
1102248|NCT02369874|2177206|FG002|Overall Study|On Treatment/Off Study|32
1102249|NCT02370043|2177232|FG000|Overall Study|Withdrawal by Subject|0
1102250|NCT02370043|2177233|FG001|Overall Study|Withdrawal by Subject|0
1102251|NCT02370043|2177234|FG002|Overall Study|Withdrawal by Subject|0
1102252|NCT02370043|2177235|FG003|Overall Study|Withdrawal by Subject|0
1102253|NCT02370043|2177236|FG004|Overall Study|Withdrawal by Subject|1
1102254|NCT02370043|2177237|FG005|Overall Study|Withdrawal by Subject|1
1102255|NCT02370095|2177276|FG000|Overall Study|Withdrawal by Subject|0
1102256|NCT02370095|2177277|FG001|Overall Study|Withdrawal by Subject|1
1102257|NCT02370121|2177285|FG000|Overall Study|Lost to Follow-up|1
1102258|NCT02370121|2177286|FG001|Overall Study|Lost to Follow-up|1
1102259|NCT02370160|2177292|FG000|Overall Study|Death|3
1102260|NCT02370160|2177293|FG001|Overall Study|Death|4
1102261|NCT02370160|2177294|FG002|Overall Study|Death|1
1102262|NCT02370238|2177309|FG000|Overall Study|Death|42
1102263|NCT02370238|2177310|FG001|Overall Study|Death|35
1102264|NCT02370238|2177309|FG000|Overall Study|Lost to Follow-up|1
1102265|NCT02370238|2177310|FG001|Overall Study|Lost to Follow-up|3
1102266|NCT02370238|2177309|FG000|Overall Study|Withdrawal by Subject|2
1102267|NCT02370238|2177310|FG001|Overall Study|Withdrawal by Subject|6
1102268|NCT02370238|2177309|FG000|Overall Study|Other|2
1102269|NCT02370238|2177310|FG001|Overall Study|Other|1
1102270|NCT02370251|2177320|FG000|Overall Study|Received less than 8 days of Omegaven|7
1102271|NCT02370251|2177320|FG000|Overall Study|Death|4
1102272|NCT02370368|2177326|FG000|Overall Study|Adverse Event|1
1102273|NCT02370368|2177327|FG001|Overall Study|Adverse Event|2
1102274|NCT02370368|2177326|FG000|Overall Study|Withdrawal by Subject|5
1102275|NCT02370368|2177327|FG001|Overall Study|Withdrawal by Subject|4
1102276|NCT02370394|2177335|FG000|Overall Study|Lost to Follow-up|2
1102277|NCT02370394|2177336|FG001|Overall Study|Lost to Follow-up|1
1102278|NCT02370394|2177335|FG000|Overall Study|Withdrawal by Subject|0
1102279|NCT02370394|2177336|FG001|Overall Study|Withdrawal by Subject|1
1102280|NCT02370420|2177358|FG000|Overall Study|Physician Decision|3
1102281|NCT02370420|2177359|FG001|Overall Study|Physician Decision|3
1102282|NCT02370420|2177358|FG000|Overall Study|Lost to Follow-up|11
1102283|NCT02370420|2177359|FG001|Overall Study|Lost to Follow-up|9
1102284|NCT02370498|2177367|FG000|Overall Study|Adverse Event|10
1102285|NCT02370498|2177368|FG001|Overall Study|Adverse Event|8
1102286|NCT02370498|2177367|FG000|Overall Study|Death|222
1102287|NCT02370498|2177368|FG001|Overall Study|Death|242
1102288|NCT02370498|2177367|FG000|Overall Study|Lost to Follow-up|1
1102289|NCT02370498|2177368|FG001|Overall Study|Lost to Follow-up|0
1102290|NCT02370498|2177367|FG000|Overall Study|Protocol Violation|1
1102291|NCT02370498|2177368|FG001|Overall Study|Protocol Violation|2
1102292|NCT02370498|2177367|FG000|Overall Study|Withdrawal by Subject|6
1102293|NCT02370498|2177368|FG001|Overall Study|Withdrawal by Subject|11
1102294|NCT02370498|2177367|FG000|Overall Study|Ongoing In Trial|56
1102295|NCT02370498|2177368|FG001|Overall Study|Ongoing In Trial|33
1102296|NCT02370511|2177377|FG000|Overall Study|Death|10
1102297|NCT02370511|2177378|FG001|Overall Study|Death|7
1102298|NCT02370511|2177379|FG002|Overall Study|Death|1
1102299|NCT02370511|2177377|FG000|Overall Study|Withdrawal by Subject|2
1102300|NCT02370511|2177378|FG001|Overall Study|Withdrawal by Subject|0
1102301|NCT02370511|2177379|FG002|Overall Study|Withdrawal by Subject|0
1102302|NCT02370511|2177377|FG000|Overall Study|Lost to Follow-up|0
1102303|NCT02370511|2177378|FG001|Overall Study|Lost to Follow-up|4
1102304|NCT02370511|2177379|FG002|Overall Study|Lost to Follow-up|0
1102305|NCT02370537|2177390|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0
1102306|NCT02370537|2177391|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1
1102307|NCT02370537|2177392|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0
1102308|NCT02370537|2177390|FG000|Part A (Open-label Recruitment)|Adverse Event|0
1102309|NCT02370537|2177391|FG001|Part A (Open-label Recruitment)|Adverse Event|0
1102310|NCT02370537|2177392|FG002|Part A (Open-label Recruitment)|Adverse Event|1
1102311|NCT02370537|2177390|FG000|Part B|Not randomised to receive treatment|1
1102312|NCT02370537|2177391|FG001|Part B|Not randomised to receive treatment|2
1102313|NCT02370537|2177392|FG002|Part B|Not randomised to receive treatment|259
1102314|NCT02370537|2177390|FG000|Part B|Withdrawal by Subject|0
1102315|NCT02370537|2177391|FG001|Part B|Withdrawal by Subject|1
1102316|NCT02370537|2177392|FG002|Part B|Withdrawal by Subject|0
1102317|NCT02370602|2177415|FG000|Overall Study|Pretreatment Event/Adverse Event|1
1102318|NCT02370602|2177416|FG001|Overall Study|Pretreatment Event/Adverse Event|0
1102319|NCT02370602|2177417|FG002|Overall Study|Pretreatment Event/Adverse Event|0
1102320|NCT02370602|2177418|FG003|Overall Study|Pretreatment Event/Adverse Event|0
1102321|NCT02370602|2177419|FG004|Overall Study|Pretreatment Event/Adverse Event|0
1102322|NCT02370602|2177420|FG005|Overall Study|Pretreatment Event/Adverse Event|0
1102323|NCT02370615|2177439|FG000|Overall Study|Adverse Event|1
1102324|NCT02370615|2177440|FG001|Overall Study|Adverse Event|0
1102325|NCT02370641|2177455|FG000|Overall Study|dropped study|4
1102326|NCT02370641|2177456|FG001|Overall Study|dropped study|2
1102327|NCT02370667|2177465|FG000|Overall Study|Lost to Follow-up|0
1102328|NCT02370667|2177466|FG001|Overall Study|Lost to Follow-up|1
1102329|NCT02370667|2177467|FG002|Overall Study|Lost to Follow-up|0
1102330|NCT02370784|2177487|FG000|Overall Study|Patient started prohibited medication|0
1102331|NCT02370784|2177488|FG001|Overall Study|Patient started prohibited medication|1
1102332|NCT02370914|2177507|FG000|Overall Study|Protocol Violation|2
1102333|NCT02371369|2177552|FG000|Part 1|Physician Decision|0
1102334|NCT02371369|2177553|FG001|Part 1|Physician Decision|3
1102335|NCT02371369|2177552|FG000|Part 1|Adverse Event|8
1102336|NCT02371369|2177553|FG001|Part 1|Adverse Event|0
1102337|NCT02371369|2177552|FG000|Part 1|Withdrawal by Subject|1
1102338|NCT02371369|2177553|FG001|Part 1|Withdrawal by Subject|6
1102339|NCT02371369|2177552|FG000|Part 1|Disease progression|0
1102340|NCT02371369|2177553|FG001|Part 1|Disease progression|1
1102341|NCT02371369|2177552|FG000|Part 1|Protocol Violation|0
1102342|NCT02371369|2177553|FG001|Part 1|Protocol Violation|1
1102343|NCT02371369|2177552|FG000|Part 2|Adverse Event|3
1102344|NCT02371369|2177553|FG001|Part 2|Adverse Event|2
1102345|NCT02371369|2177552|FG000|Part 2|Withdrawal by Subject|5
1102346|NCT02371369|2177553|FG001|Part 2|Withdrawal by Subject|1
1102347|NCT02371369|2177552|FG000|Part 2|Physician Decision|1
1102348|NCT02371369|2177553|FG001|Part 2|Physician Decision|0
1102349|NCT02371369|2177552|FG000|Part 2|Death|0
1102350|NCT02371369|2177553|FG001|Part 2|Death|1
1102351|NCT02371616|2177580|FG000|Overall Study|Protocol Violation|2
1102352|NCT02371616|2177581|FG001|Overall Study|Protocol Violation|1
1102353|NCT02371616|2177580|FG000|Overall Study|Adverse Event|0
1102354|NCT02371616|2177581|FG001|Overall Study|Adverse Event|1
1102355|NCT02371616|2177580|FG000|Overall Study|Withdrawal of Consent|1
1102356|NCT02371616|2177581|FG001|Overall Study|Withdrawal of Consent|0
1102357|NCT02371616|2177580|FG000|Overall Study|Other (Not specified)|1
1102358|NCT02371616|2177581|FG001|Overall Study|Other (Not specified)|5
1102359|NCT02371629|2177589|FG000|Overall Study|Patient decision|14
1102360|NCT02371629|2177590|FG001|Overall Study|Patient decision|10
1102361|NCT02371629|2177589|FG000|Overall Study|Adverse Event|8
1102362|NCT02371629|2177590|FG001|Overall Study|Adverse Event|8
1102363|NCT02371629|2177589|FG000|Overall Study|Physician Decision|2
1102364|NCT02371629|2177590|FG001|Overall Study|Physician Decision|3
1102365|NCT02371629|2177589|FG000|Overall Study|Death|1
1102366|NCT02371629|2177590|FG001|Overall Study|Death|1
1102367|NCT02371629|2177589|FG000|Overall Study|Noncompliance with study treatment|1
1102368|NCT02371629|2177590|FG001|Overall Study|Noncompliance with study treatment|0
1102369|NCT02371629|2177589|FG000|Overall Study|Lack of Efficacy|0
1102370|NCT02371629|2177590|FG001|Overall Study|Lack of Efficacy|2
1102371|NCT02371629|2177589|FG000|Overall Study|Protocol deviation|0
1102372|NCT02371629|2177590|FG001|Overall Study|Protocol deviation|1
1102373|NCT02371746|2177612|FG000|Overall Study|Consent withdrawn|0
1102374|NCT02371746|2177613|FG001|Overall Study|Consent withdrawn|0
1102375|NCT02371746|2177614|FG002|Overall Study|Consent withdrawn|0
1102376|NCT02371746|2177615|FG003|Overall Study|Consent withdrawn|0
1102377|NCT02371746|2177616|FG004|Overall Study|Consent withdrawn|0
1102378|NCT02371746|2177617|FG005|Overall Study|Consent withdrawn|0
1102379|NCT02371746|2177618|FG006|Overall Study|Consent withdrawn|1
1102380|NCT02371759|2177642|FG000|Overall Study|Protocol Violation|3
1102381|NCT02371759|2177643|FG001|Overall Study|Protocol Violation|1
1102382|NCT02371759|2177644|FG002|Overall Study|Protocol Violation|1
1102383|NCT02371759|2177645|FG003|Overall Study|Protocol Violation|0
1102384|NCT02371759|2177646|FG004|Overall Study|Protocol Violation|3
1102385|NCT02371759|2177647|FG005|Overall Study|Protocol Violation|1
1102386|NCT02371759|2177648|FG006|Overall Study|Protocol Violation|0
1102387|NCT02371759|2177649|FG007|Overall Study|Protocol Violation|3
1102388|NCT02371759|2177642|FG000|Overall Study|Withdrawal by Subject|0
1102389|NCT02371759|2177643|FG001|Overall Study|Withdrawal by Subject|0
1102390|NCT02371759|2177644|FG002|Overall Study|Withdrawal by Subject|0
1102391|NCT02371759|2177645|FG003|Overall Study|Withdrawal by Subject|0
1102392|NCT02371759|2177646|FG004|Overall Study|Withdrawal by Subject|0
1102393|NCT02371759|2177647|FG005|Overall Study|Withdrawal by Subject|0
1102394|NCT02371759|2177648|FG006|Overall Study|Withdrawal by Subject|0
1102395|NCT02371759|2177649|FG007|Overall Study|Withdrawal by Subject|1
1102406|NCT02371980|2177709|FG000|Open-label Period|Pretreatment Event/Adverse Event|63
1102407|NCT02371980|2177710|FG001|Open-label Period|Pretreatment Event/Adverse Event|0
1102408|NCT02371980|2177711|FG002|Open-label Period|Pretreatment Event/Adverse Event|0
1102409|NCT02371980|2177712|FG003|Open-label Period|Pretreatment Event/Adverse Event|0
1102410|NCT02371980|2177713|FG004|Open-label Period|Pretreatment Event/Adverse Event|0
1102411|NCT02371980|2177709|FG000|Open-label Period|Significant Protocol Deviation|19
1102412|NCT02371980|2177710|FG001|Open-label Period|Significant Protocol Deviation|0
1102413|NCT02371980|2177711|FG002|Open-label Period|Significant Protocol Deviation|0
1102414|NCT02371980|2177712|FG003|Open-label Period|Significant Protocol Deviation|0
1102415|NCT02371980|2177713|FG004|Open-label Period|Significant Protocol Deviation|0
1102416|NCT02371980|2177709|FG000|Open-label Period|Noncompliance with Study Drug|10
1102417|NCT02371980|2177710|FG001|Open-label Period|Noncompliance with Study Drug|0
1102418|NCT02371980|2177711|FG002|Open-label Period|Noncompliance with Study Drug|0
1102419|NCT02371980|2177712|FG003|Open-label Period|Noncompliance with Study Drug|0
1102420|NCT02371980|2177713|FG004|Open-label Period|Noncompliance with Study Drug|0
1102421|NCT02371980|2177709|FG000|Open-label Period|Lost to Follow-up|55
1102422|NCT02371980|2177710|FG001|Open-label Period|Lost to Follow-up|0
1102423|NCT02371980|2177711|FG002|Open-label Period|Lost to Follow-up|0
1102424|NCT02371980|2177712|FG003|Open-label Period|Lost to Follow-up|0
1102425|NCT02371980|2177713|FG004|Open-label Period|Lost to Follow-up|0
1102426|NCT02371980|2177709|FG000|Open-label Period|Voluntary Withdrawal|91
1102427|NCT02371980|2177710|FG001|Open-label Period|Voluntary Withdrawal|0
1102428|NCT02371980|2177711|FG002|Open-label Period|Voluntary Withdrawal|0
1102429|NCT02371980|2177712|FG003|Open-label Period|Voluntary Withdrawal|0
1102430|NCT02371980|2177713|FG004|Open-label Period|Voluntary Withdrawal|0
1102431|NCT02371980|2177709|FG000|Open-label Period|Pregnancy|1
1102432|NCT02371980|2177710|FG001|Open-label Period|Pregnancy|0
1102433|NCT02371980|2177711|FG002|Open-label Period|Pregnancy|0
1102434|NCT02371980|2177712|FG003|Open-label Period|Pregnancy|0
1102435|NCT02371980|2177713|FG004|Open-label Period|Pregnancy|0
1102436|NCT02371980|2177709|FG000|Open-label Period|Lack of Efficacy|116
1102437|NCT02371980|2177710|FG001|Open-label Period|Lack of Efficacy|0
1102438|NCT02371980|2177711|FG002|Open-label Period|Lack of Efficacy|0
1102439|NCT02371980|2177712|FG003|Open-label Period|Lack of Efficacy|0
1102440|NCT02371980|2177713|FG004|Open-label Period|Lack of Efficacy|0
1102441|NCT02371980|2177709|FG000|Open-label Period|Did not Meet Randomization Criteria|162
1102442|NCT02371980|2177710|FG001|Open-label Period|Did not Meet Randomization Criteria|0
1102443|NCT02371980|2177711|FG002|Open-label Period|Did not Meet Randomization Criteria|0
1102444|NCT02371980|2177712|FG003|Open-label Period|Did not Meet Randomization Criteria|0
1102445|NCT02371980|2177713|FG004|Open-label Period|Did not Meet Randomization Criteria|0
1102446|NCT02371980|2177709|FG000|Open-label Period|Reason not Specified|9
1102447|NCT02371980|2177710|FG001|Open-label Period|Reason not Specified|0
1102448|NCT02371980|2177711|FG002|Open-label Period|Reason not Specified|0
1102449|NCT02371980|2177712|FG003|Open-label Period|Reason not Specified|0
1102450|NCT02371980|2177713|FG004|Open-label Period|Reason not Specified|0
1102451|NCT02371980|2177709|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0
1102452|NCT02371980|2177710|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4
1102453|NCT02371980|2177711|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3
1102454|NCT02371980|2177712|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2
1102455|NCT02371980|2177713|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9
1102456|NCT02371980|2177709|FG000|Double-blind Period|Significant Protocol Deviation|0
1102457|NCT02371980|2177710|FG001|Double-blind Period|Significant Protocol Deviation|2
1102458|NCT02371980|2177711|FG002|Double-blind Period|Significant Protocol Deviation|7
1102459|NCT02371980|2177712|FG003|Double-blind Period|Significant Protocol Deviation|3
1102460|NCT02371980|2177713|FG004|Double-blind Period|Significant Protocol Deviation|3
1102461|NCT02371980|2177709|FG000|Double-blind Period|Noncompliance with Study Drug|0
1102462|NCT02371980|2177710|FG001|Double-blind Period|Noncompliance with Study Drug|1
1102463|NCT02371980|2177711|FG002|Double-blind Period|Noncompliance with Study Drug|2
1102464|NCT02371980|2177712|FG003|Double-blind Period|Noncompliance with Study Drug|2
1102465|NCT02371980|2177713|FG004|Double-blind Period|Noncompliance with Study Drug|3
1102466|NCT02371980|2177709|FG000|Double-blind Period|Lost to Follow-up|0
1102467|NCT02371980|2177710|FG001|Double-blind Period|Lost to Follow-up|8
1102468|NCT02371980|2177711|FG002|Double-blind Period|Lost to Follow-up|8
1102469|NCT02371980|2177712|FG003|Double-blind Period|Lost to Follow-up|6
1102470|NCT02371980|2177713|FG004|Double-blind Period|Lost to Follow-up|5
1102471|NCT02371980|2177709|FG000|Double-blind Period|Voluntary Withdrawal|0
1102472|NCT02371980|2177710|FG001|Double-blind Period|Voluntary Withdrawal|12
1102473|NCT02371980|2177711|FG002|Double-blind Period|Voluntary Withdrawal|8
1102474|NCT02371980|2177712|FG003|Double-blind Period|Voluntary Withdrawal|9
1102475|NCT02371980|2177713|FG004|Double-blind Period|Voluntary Withdrawal|11
1102476|NCT02371980|2177709|FG000|Double-blind Period|Relapse|0
1102477|NCT02371980|2177710|FG001|Double-blind Period|Relapse|50
1102478|NCT02371980|2177711|FG002|Double-blind Period|Relapse|25
1102479|NCT02371980|2177712|FG003|Double-blind Period|Relapse|25
1102480|NCT02371980|2177713|FG004|Double-blind Period|Relapse|26
1102481|NCT02371980|2177709|FG000|Double-blind Period|Reason not Specified|0
1102482|NCT02371980|2177710|FG001|Double-blind Period|Reason not Specified|3
1102483|NCT02371980|2177711|FG002|Double-blind Period|Reason not Specified|3
1102484|NCT02371980|2177712|FG003|Double-blind Period|Reason not Specified|2
1102485|NCT02371980|2177713|FG004|Double-blind Period|Reason not Specified|1
1102486|NCT02371980|2177709|FG000|Double-blind Period|Missing|0
1102487|NCT02371980|2177710|FG001|Double-blind Period|Missing|1
1102488|NCT02371980|2177711|FG002|Double-blind Period|Missing|0
1102489|NCT02371980|2177712|FG003|Double-blind Period|Missing|0
1102490|NCT02371980|2177713|FG004|Double-blind Period|Missing|0
1102491|NCT02372006|2177727|FG000|Overall Study|Progressive disease|8
1102492|NCT02372006|2177728|FG001|Overall Study|Progressive disease|7
1102493|NCT02372006|2177729|FG002|Overall Study|Progressive disease|34
1102494|NCT02372006|2177727|FG000|Overall Study|Dose limiting toxicity|0
1102495|NCT02372006|2177728|FG001|Overall Study|Dose limiting toxicity|1
1102496|NCT02372006|2177729|FG002|Overall Study|Dose limiting toxicity|0
1102497|NCT02372006|2177727|FG000|Overall Study|Adverse Event|0
1102498|NCT02372006|2177728|FG001|Overall Study|Adverse Event|0
1102499|NCT02372006|2177729|FG002|Overall Study|Adverse Event|3
1102500|NCT02372006|2177727|FG000|Overall Study|Withdrawal by Subject|0
1102501|NCT02372006|2177728|FG001|Overall Study|Withdrawal by Subject|1
1102502|NCT02372006|2177729|FG002|Overall Study|Withdrawal by Subject|1
1102503|NCT02372006|2177727|FG000|Overall Study|Other reason for not completing|0
1102504|NCT02372006|2177728|FG001|Overall Study|Other reason for not completing|0
1102505|NCT02372006|2177729|FG002|Overall Study|Other reason for not completing|1
1102506|NCT02372058|2177738|FG000|Overall Study|Withdrawal by Subject|3
1102507|NCT02372071|2177744|FG000|Overall Study|Protocol Violation|18
1102508|NCT02372136|2177760|FG000|Overall Study|Death|3
1102509|NCT02372136|2177761|FG001|Overall Study|Death|1
1102510|NCT02372253|2177771|FG000|Overall Study|Non Compliance|2
1102511|NCT02372253|2177772|FG001|Overall Study|Non Compliance|0
1102512|NCT02372383|2177792|FG000|First Intervention (1 Day)|Unable to collect blood|0
1102513|NCT02372383|2177793|FG001|First Intervention (1 Day)|Unable to collect blood|1
1102514|NCT02372383|2177794|FG002|First Intervention (1 Day)|Unable to collect blood|0
1102515|NCT02372396|2177806|FG000|Overall Study|Lost to Follow-up|7
1102516|NCT02372396|2177807|FG001|Overall Study|Lost to Follow-up|9
1102517|NCT02372799|2177832|FG000|Treatment Period|Adverse Event|3
1102518|NCT02372799|2177833|FG001|Treatment Period|Adverse Event|10
1102519|NCT02372799|2177834|FG002|Treatment Period|Adverse Event|6
1102520|NCT02372799|2177832|FG000|Treatment Period|Insufficient therapeutic response|2
1102521|NCT02372799|2177833|FG001|Treatment Period|Insufficient therapeutic response|2
1102522|NCT02372799|2177834|FG002|Treatment Period|Insufficient therapeutic response|0
1102523|NCT02372799|2177832|FG000|Treatment Period|Withdrawal by Subject|10
1102524|NCT02372799|2177833|FG001|Treatment Period|Withdrawal by Subject|10
1102525|NCT02372799|2177834|FG002|Treatment Period|Withdrawal by Subject|2
1102526|NCT02372799|2177832|FG000|Treatment Period|Lost to Follow-up|11
1102527|NCT02372799|2177833|FG001|Treatment Period|Lost to Follow-up|5
1102528|NCT02372799|2177834|FG002|Treatment Period|Lost to Follow-up|3
1102529|NCT02372799|2177832|FG000|Treatment Period|Protocol Violation|3
1102530|NCT02372799|2177833|FG001|Treatment Period|Protocol Violation|0
1102531|NCT02372799|2177834|FG002|Treatment Period|Protocol Violation|0
1102532|NCT02372799|2177832|FG000|Treatment Period|Non-compliance with study drug|4
1102533|NCT02372799|2177833|FG001|Treatment Period|Non-compliance with study drug|4
1102534|NCT02372799|2177834|FG002|Treatment Period|Non-compliance with study drug|4
1102535|NCT02372799|2177832|FG000|Treatment Period|Miscellaneous Reasons|1
1102536|NCT02372799|2177833|FG001|Treatment Period|Miscellaneous Reasons|1
1102537|NCT02372799|2177834|FG002|Treatment Period|Miscellaneous Reasons|0
1102538|NCT02372799|2177832|FG000|Down-taper Period|Lost to Follow-up|1
1102539|NCT02372799|2177833|FG001|Down-taper Period|Lost to Follow-up|2
1102540|NCT02372799|2177834|FG002|Down-taper Period|Lost to Follow-up|2
1102541|NCT02373098|2177844|FG000|Overall Study|Lost to Follow-up|1
1102542|NCT02373098|2177845|FG001|Overall Study|Lost to Follow-up|0
1102543|NCT02373098|2177844|FG000|Overall Study|Protocol Violation|3
1102544|NCT02373098|2177845|FG001|Overall Study|Protocol Violation|0
1102545|NCT02373098|2177844|FG000|Overall Study|Withdrawal by Subject|5
1102546|NCT02373098|2177845|FG001|Overall Study|Withdrawal by Subject|0
1102547|NCT02373098|2177844|FG000|Overall Study|Adverse Event|3
1102548|NCT02373098|2177845|FG001|Overall Study|Adverse Event|0
1102549|NCT02373202|2177875|FG000|Overall Study|Adverse Event|2
1102550|NCT02373202|2177876|FG001|Overall Study|Adverse Event|5
1102551|NCT02373202|2177877|FG002|Overall Study|Adverse Event|2
1102552|NCT02373202|2177878|FG003|Overall Study|Adverse Event|1
1102553|NCT02373202|2177875|FG000|Overall Study|Lack of Efficacy|0
1102554|NCT02373202|2177876|FG001|Overall Study|Lack of Efficacy|0
1102555|NCT02373202|2177877|FG002|Overall Study|Lack of Efficacy|1
1102556|NCT02373202|2177878|FG003|Overall Study|Lack of Efficacy|0
1102557|NCT02373202|2177875|FG000|Overall Study|Other|0
1102558|NCT02373202|2177876|FG001|Overall Study|Other|1
1102559|NCT02373202|2177877|FG002|Overall Study|Other|0
1102560|NCT02373202|2177878|FG003|Overall Study|Other|0
1102561|NCT02373813|2177900|FG000|Run-In Period|Other, Not Specified|5
1102562|NCT02373813|2177901|FG001|Run-In Period|Other, Not Specified|0
1102563|NCT02373813|2177902|FG002|Run-In Period|Other, Not Specified|0
1102564|NCT02373813|2177903|FG003|Run-In Period|Other, Not Specified|0
1102565|NCT02373813|2177900|FG000|Run-In Period|Withdrawal by Subject|16
1102566|NCT02373813|2177901|FG001|Run-In Period|Withdrawal by Subject|0
1102567|NCT02373813|2177902|FG002|Run-In Period|Withdrawal by Subject|0
1102568|NCT02373813|2177903|FG003|Run-In Period|Withdrawal by Subject|0
1102569|NCT02373813|2177900|FG000|Run-In Period|Decision by Sponsor|11
1102570|NCT02373813|2177901|FG001|Run-In Period|Decision by Sponsor|0
1102571|NCT02373813|2177902|FG002|Run-In Period|Decision by Sponsor|0
1102572|NCT02373813|2177903|FG003|Run-In Period|Decision by Sponsor|0
1102573|NCT02373813|2177900|FG000|Run-In Period|Protocol Violation|75
1102574|NCT02373813|2177901|FG001|Run-In Period|Protocol Violation|0
1102575|NCT02373813|2177902|FG002|Run-In Period|Protocol Violation|0
1102576|NCT02373813|2177903|FG003|Run-In Period|Protocol Violation|0
1102577|NCT02373813|2177900|FG000|Run-In Period|Lost to Follow-up|2
1102578|NCT02373813|2177901|FG001|Run-In Period|Lost to Follow-up|0
1102579|NCT02373813|2177902|FG002|Run-In Period|Lost to Follow-up|0
1102580|NCT02373813|2177903|FG003|Run-In Period|Lost to Follow-up|0
1102581|NCT02373813|2177900|FG000|Run-In Period|Adverse Event|3
1102582|NCT02373813|2177901|FG001|Run-In Period|Adverse Event|0
1102583|NCT02373813|2177902|FG002|Run-In Period|Adverse Event|0
1102584|NCT02373813|2177903|FG003|Run-In Period|Adverse Event|0
1102585|NCT02373813|2177900|FG000|Run-In Period|Noncompliance|1
1102586|NCT02373813|2177901|FG001|Run-In Period|Noncompliance|0
1102587|NCT02373813|2177902|FG002|Run-In Period|Noncompliance|0
1102588|NCT02373813|2177903|FG003|Run-In Period|Noncompliance|0
1102589|NCT02373813|2177900|FG000|Run-In Period|Ineligibility Determined|3
1102590|NCT02373813|2177901|FG001|Run-In Period|Ineligibility Determined|0
1102591|NCT02373813|2177902|FG002|Run-In Period|Ineligibility Determined|0
1102592|NCT02373813|2177903|FG003|Run-In Period|Ineligibility Determined|0
1102593|NCT02373813|2177900|FG000|Double-Blind Treatment Period|Decision by Sponsor|0
1102594|NCT02373813|2177901|FG001|Double-Blind Treatment Period|Decision by Sponsor|1
1102595|NCT02373813|2177902|FG002|Double-Blind Treatment Period|Decision by Sponsor|2
1102596|NCT02373813|2177903|FG003|Double-Blind Treatment Period|Decision by Sponsor|0
1102597|NCT02373813|2177900|FG000|Double-Blind Treatment Period|Protocol Violation|0
1102598|NCT02373813|2177901|FG001|Double-Blind Treatment Period|Protocol Violation|2
1102599|NCT02373813|2177902|FG002|Double-Blind Treatment Period|Protocol Violation|0
1102600|NCT02373813|2177903|FG003|Double-Blind Treatment Period|Protocol Violation|0
1102601|NCT02373813|2177900|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
1102602|NCT02373813|2177901|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
1102603|NCT02373813|2177902|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
1102604|NCT02373813|2177903|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
1102605|NCT02373813|2177900|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
1102606|NCT02373813|2177901|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10
1102607|NCT02373813|2177902|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6
1102608|NCT02373813|2177903|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3
1102609|NCT02374099|2177933|FG000|Overall Study|Adverse Event|1
1102610|NCT02374099|2177934|FG001|Overall Study|Adverse Event|0
1102611|NCT02374099|2177933|FG000|Overall Study|Progressive Disease|35
1102612|NCT02374099|2177934|FG001|Overall Study|Progressive Disease|40
1102613|NCT02374099|2177933|FG000|Overall Study|Withdrawal by Subject|5
1102614|NCT02374099|2177934|FG001|Overall Study|Withdrawal by Subject|1
1102615|NCT02374099|2177933|FG000|Overall Study|Miscellaneous|2
1102616|NCT02374099|2177934|FG001|Overall Study|Miscellaneous|3
1102617|NCT02374099|2177933|FG000|Overall Study|Randomized, but not treated|2
1102618|NCT02374099|2177934|FG001|Overall Study|Randomized, but not treated|1
1102619|NCT02374099|2177933|FG000|Overall Study|Study Terminated by Sponsor|3
1102620|NCT02374099|2177934|FG001|Overall Study|Study Terminated by Sponsor|4
1102621|NCT02374255|2177967|FG000|Overall Study|Withdrawal by Subject|2
1102622|NCT02374255|2177968|FG001|Overall Study|Withdrawal by Subject|0
1102623|NCT02374255|2177969|FG002|Overall Study|Withdrawal by Subject|0
1102624|NCT02374255|2177970|FG003|Overall Study|Withdrawal by Subject|0
1102625|NCT02374307|2177988|FG000|3-months Follow-up|Lost to Follow-up|1
1102626|NCT02374307|2177989|FG001|3-months Follow-up|Lost to Follow-up|2
1102627|NCT02374307|2177988|FG000|3-months Follow-up|Withdrawal by Subject|1
1102628|NCT02374307|2177989|FG001|3-months Follow-up|Withdrawal by Subject|4
1102629|NCT02374307|2177988|FG000|3-months Follow-up|Death|1
1102630|NCT02374307|2177989|FG001|3-months Follow-up|Death|2
1102631|NCT02374307|2177988|FG000|3-months Follow-up|Missed first follow-up|5
1102632|NCT02374307|2177989|FG001|3-months Follow-up|Missed first follow-up|1
1102633|NCT02374307|2177988|FG000|6-months Follow-up|Lost to Follow-up|1
1102634|NCT02374307|2177989|FG001|6-months Follow-up|Lost to Follow-up|2
1102635|NCT02374307|2177988|FG000|6-months Follow-up|Death|2
1102636|NCT02374307|2177989|FG001|6-months Follow-up|Death|1
1102637|NCT02374307|2177988|FG000|6-months Follow-up|Withdrawal by Subject|0
1102638|NCT02374307|2177989|FG001|6-months Follow-up|Withdrawal by Subject|3
1102639|NCT02374346|2177995|FG000|Overall Study|operated or discharged during weekend|48
1102640|NCT02374463|2178021|FG000|Overall Study|Withdrawal by Subject|3
1102641|NCT02374463|2178022|FG001|Overall Study|Withdrawal by Subject|3
1102642|NCT02374593|2178031|FG000|Overall Study|non-compliant|2
1102643|NCT02374593|2178032|FG001|Overall Study|non-compliant|0
1102644|NCT02374671|2178045|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0
1102645|NCT02374671|2178046|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0
1102646|NCT02374671|2178047|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4
1102647|NCT02374671|2178045|FG000|Observation (Deferred Implantation)|Adverse Event|0
1102648|NCT02374671|2178046|FG001|Observation (Deferred Implantation)|Adverse Event|0
1102649|NCT02374671|2178047|FG002|Observation (Deferred Implantation)|Adverse Event|1
1102650|NCT02374671|2178045|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
1102651|NCT02374671|2178046|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
1102652|NCT02374671|2178047|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
1102653|NCT02374671|2178045|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7
1102654|NCT02374671|2178046|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0
1102655|NCT02374671|2178047|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1
1102656|NCT02374671|2178045|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
1102657|NCT02374671|2178046|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
1102658|NCT02374671|2178047|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
1102659|NCT02374918|2178057|FG000|Overall Study|Protocol Violation|2
1102660|NCT02374918|2178058|FG001|Overall Study|Protocol Violation|0
1102661|NCT02374918|2178059|FG002|Overall Study|Protocol Violation|2
1102662|NCT02374918|2178060|FG003|Overall Study|Protocol Violation|1
1102663|NCT02374918|2178057|FG000|Overall Study|Withdrawal by Subject|1
1102664|NCT02374918|2178058|FG001|Overall Study|Withdrawal by Subject|1
1102665|NCT02374918|2178059|FG002|Overall Study|Withdrawal by Subject|1
1102666|NCT02374918|2178060|FG003|Overall Study|Withdrawal by Subject|0
1102667|NCT02374918|2178057|FG000|Overall Study|Lack of Efficacy|0
1102668|NCT02374918|2178058|FG001|Overall Study|Lack of Efficacy|0
1102669|NCT02374918|2178059|FG002|Overall Study|Lack of Efficacy|1
1102670|NCT02374918|2178060|FG003|Overall Study|Lack of Efficacy|1
1102671|NCT02374957|2178070|FG000|Overall Study|Patient did not complete forms correctly|1
1102672|NCT02374957|2178071|FG001|Overall Study|Patient did not complete forms correctly|0
1102673|NCT02375347|2178077|FG000|Overall Study|Protocol Violation|1
1102674|NCT02375373|2178081|FG000|Overall Study|Withdrawal by Subject|11
1102675|NCT02375672|2178085|FG000|Overall Study|remain on follow up|20
1102676|NCT02375698|2178091|FG000|Overall Study|Withdrawal by Subject|0
1102677|NCT02375698|2178092|FG001|Overall Study|Withdrawal by Subject|2
1102678|NCT02375698|2178091|FG000|Overall Study|Physician Decision|2
1102679|NCT02375698|2178092|FG001|Overall Study|Physician Decision|0
1102680|NCT02375724|2178100|FG000|Overall Study|Lack of Efficacy|1
1102681|NCT02375724|2178101|FG001|Overall Study|Lack of Efficacy|1
1102682|NCT02375724|2178100|FG000|Overall Study|Withdrawal by Subject|1
1102683|NCT02375724|2178101|FG001|Overall Study|Withdrawal by Subject|1
1102684|NCT02375724|2178100|FG000|Overall Study|Lost to Follow-up|1
1102685|NCT02375724|2178101|FG001|Overall Study|Lost to Follow-up|0
1102686|NCT02375724|2178100|FG000|Overall Study|Protocol Violation|1
1102687|NCT02375724|2178101|FG001|Overall Study|Protocol Violation|0
1102688|NCT02375724|2178100|FG000|Overall Study|Adverse Event|2
1102689|NCT02375724|2178101|FG001|Overall Study|Adverse Event|4
1102690|NCT02375971|2178110|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
1102691|NCT02375971|2178111|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
1102692|NCT02375971|2178112|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
1102693|NCT02375971|2178110|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1
1102694|NCT02375971|2178111|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1
1102695|NCT02375971|2178112|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1
1102696|NCT02375971|2178110|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
1102697|NCT02375971|2178111|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
1102698|NCT02375971|2178112|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
1102699|NCT02375971|2178110|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0
1102700|NCT02375971|2178111|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0
1102701|NCT02375971|2178112|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1
1102702|NCT02375971|2178110|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1
1102703|NCT02375971|2178111|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0
1102704|NCT02375971|2178112|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0
1102705|NCT02375971|2178110|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
1102706|NCT02375971|2178111|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
1102707|NCT02375971|2178112|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
1102708|NCT02375971|2178110|FG000|Follow-Up Phase (up to Day 169)|Death|4
1102709|NCT02375971|2178111|FG001|Follow-Up Phase (up to Day 169)|Death|4
1102710|NCT02375971|2178112|FG002|Follow-Up Phase (up to Day 169)|Death|4
1102711|NCT02375971|2178110|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
1102712|NCT02375971|2178111|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
1102713|NCT02375971|2178112|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
1102714|NCT02376166|2178133|FG000|Overall Study|Adverse Event|1
1102715|NCT02376166|2178133|FG000|Overall Study|Discontinued metformin early|2
1102716|NCT02376790|2178197|FG000|Overall Study|Withdrawal by Subject|43
1102717|NCT02376790|2178198|FG001|Overall Study|Withdrawal by Subject|36
1102718|NCT02376790|2178199|FG002|Overall Study|Withdrawal by Subject|37
1102719|NCT02376790|2178197|FG000|Overall Study|Decision by Sponsor|2
1102720|NCT02376790|2178198|FG001|Overall Study|Decision by Sponsor|1
1102721|NCT02376790|2178199|FG002|Overall Study|Decision by Sponsor|4
1102722|NCT02376790|2178197|FG000|Overall Study|Lost to Follow-up|15
1102723|NCT02376790|2178198|FG001|Overall Study|Lost to Follow-up|10
1102724|NCT02376790|2178199|FG002|Overall Study|Lost to Follow-up|12
1102725|NCT02377063|2178211|FG000|Overall Study|Non-compliance|5
1102726|NCT02377349|2178217|FG000|Overall Study|Serious Adverse Event|1
1102727|NCT02377349|2178218|FG001|Overall Study|Serious Adverse Event|0
1102728|NCT02377349|2178217|FG000|Overall Study|Protocol Violation|3
1102729|NCT02377349|2178218|FG001|Overall Study|Protocol Violation|2
1102730|NCT02377349|2178217|FG000|Overall Study|Withdrawal by Subject|5
1102731|NCT02377349|2178218|FG001|Overall Study|Withdrawal by Subject|3
1102732|NCT02377349|2178217|FG000|Overall Study|Lost to follow-up (partial vaccination)|1
1102733|NCT02377349|2178218|FG001|Overall Study|Lost to follow-up (partial vaccination)|0
1102734|NCT02377349|2178217|FG000|Overall Study|Lost to follow-up (complete vaccination)|6
1102735|NCT02377349|2178218|FG001|Overall Study|Lost to follow-up (complete vaccination)|5
1102736|NCT02377349|2178217|FG000|Overall Study|Other|0
1102737|NCT02377349|2178218|FG001|Overall Study|Other|1
1102738|NCT02377362|2178246|FG000|Part A Second Treatment|Protocol Violation|0
1102739|NCT02377362|2178247|FG001|Part A Second Treatment|Protocol Violation|0
1102740|NCT02377362|2178248|FG002|Part A Second Treatment|Protocol Violation|0
1102741|NCT02377362|2178249|FG003|Part A Second Treatment|Protocol Violation|0
1102742|NCT02377362|2178250|FG004|Part A Second Treatment|Protocol Violation|1
1102743|NCT02377362|2178251|FG005|Part A Second Treatment|Protocol Violation|0
1102744|NCT02377362|2178252|FG006|Part A Second Treatment|Protocol Violation|0
1102745|NCT02377362|2178253|FG007|Part A Second Treatment|Protocol Violation|0
1102746|NCT02377362|2178254|FG008|Part A Second Treatment|Protocol Violation|0
1102747|NCT02377362|2178255|FG009|Part A Second Treatment|Protocol Violation|0
1102748|NCT02377362|2178256|FG010|Part A Second Treatment|Protocol Violation|0
1102749|NCT02377362|2178257|FG011|Part A Second Treatment|Protocol Violation|0
1102750|NCT02377362|2178258|FG012|Part A Second Treatment|Protocol Violation|0
1102751|NCT02377362|2178246|FG000|Part A Third Treatment|Highest dose level 1200 not used|0
1102752|NCT02377362|2178247|FG001|Part A Third Treatment|Highest dose level 1200 not used|0
1102753|NCT02377362|2178248|FG002|Part A Third Treatment|Highest dose level 1200 not used|0
1102754|NCT02377362|2178249|FG003|Part A Third Treatment|Highest dose level 1200 not used|4
1102755|NCT02377362|2178250|FG004|Part A Third Treatment|Highest dose level 1200 not used|3
1102756|NCT02377362|2178251|FG005|Part A Third Treatment|Highest dose level 1200 not used|4
1102757|NCT02377362|2178252|FG006|Part A Third Treatment|Highest dose level 1200 not used|0
1102758|NCT02377362|2178253|FG007|Part A Third Treatment|Highest dose level 1200 not used|0
1102759|NCT02377362|2178254|FG008|Part A Third Treatment|Highest dose level 1200 not used|0
1102760|NCT02377362|2178255|FG009|Part A Third Treatment|Highest dose level 1200 not used|0
1102761|NCT02377362|2178256|FG010|Part A Third Treatment|Highest dose level 1200 not used|0
1102762|NCT02377362|2178257|FG011|Part A Third Treatment|Highest dose level 1200 not used|0
1102763|NCT02377362|2178258|FG012|Part A Third Treatment|Highest dose level 1200 not used|0
1102764|NCT02377362|2178246|FG000|Part B Overall|Protocol Violation|0
1102765|NCT02377362|2178247|FG001|Part B Overall|Protocol Violation|0
1102766|NCT02377362|2178248|FG002|Part B Overall|Protocol Violation|0
1102767|NCT02377362|2178249|FG003|Part B Overall|Protocol Violation|0
1102768|NCT02377362|2178250|FG004|Part B Overall|Protocol Violation|0
1102769|NCT02377362|2178251|FG005|Part B Overall|Protocol Violation|0
1102770|NCT02377362|2178252|FG006|Part B Overall|Protocol Violation|0
1102771|NCT02377362|2178253|FG007|Part B Overall|Protocol Violation|0
1102772|NCT02377362|2178254|FG008|Part B Overall|Protocol Violation|0
1102773|NCT02377362|2178255|FG009|Part B Overall|Protocol Violation|1
1102774|NCT02377362|2178256|FG010|Part B Overall|Protocol Violation|0
1102775|NCT02377362|2178257|FG011|Part B Overall|Protocol Violation|0
1102776|NCT02377362|2178258|FG012|Part B Overall|Protocol Violation|0
1102777|NCT02377362|2178246|FG000|Part B Overall|Adverse Event|0
1102778|NCT02377362|2178247|FG001|Part B Overall|Adverse Event|0
1102779|NCT02377362|2178248|FG002|Part B Overall|Adverse Event|0
1102780|NCT02377362|2178249|FG003|Part B Overall|Adverse Event|0
1102781|NCT02377362|2178250|FG004|Part B Overall|Adverse Event|0
1102782|NCT02377362|2178251|FG005|Part B Overall|Adverse Event|0
1102783|NCT02377362|2178252|FG006|Part B Overall|Adverse Event|1
1102784|NCT02377362|2178253|FG007|Part B Overall|Adverse Event|1
1102785|NCT02377362|2178254|FG008|Part B Overall|Adverse Event|0
1102786|NCT02377362|2178255|FG009|Part B Overall|Adverse Event|0
1102787|NCT02377362|2178256|FG010|Part B Overall|Adverse Event|0
1102788|NCT02377362|2178257|FG011|Part B Overall|Adverse Event|0
1102789|NCT02377362|2178258|FG012|Part B Overall|Adverse Event|0
1102790|NCT02377362|2178246|FG000|Part B Overall|Withdrawal by Subject|0
1102791|NCT02377362|2178247|FG001|Part B Overall|Withdrawal by Subject|0
1102792|NCT02377362|2178248|FG002|Part B Overall|Withdrawal by Subject|0
1102793|NCT02377362|2178249|FG003|Part B Overall|Withdrawal by Subject|0
1102794|NCT02377362|2178250|FG004|Part B Overall|Withdrawal by Subject|0
1102795|NCT02377362|2178251|FG005|Part B Overall|Withdrawal by Subject|0
1102796|NCT02377362|2178252|FG006|Part B Overall|Withdrawal by Subject|1
1102797|NCT02377362|2178253|FG007|Part B Overall|Withdrawal by Subject|0
1102798|NCT02377362|2178254|FG008|Part B Overall|Withdrawal by Subject|0
1102799|NCT02377362|2178255|FG009|Part B Overall|Withdrawal by Subject|0
1102800|NCT02377362|2178256|FG010|Part B Overall|Withdrawal by Subject|0
1102801|NCT02377362|2178257|FG011|Part B Overall|Withdrawal by Subject|1
1102802|NCT02377362|2178258|FG012|Part B Overall|Withdrawal by Subject|0
1102803|NCT02377427|2178298|FG000|Part A (Up to Week 20)|Physician Decision|1
1102804|NCT02377427|2178299|FG001|Part A (Up to Week 20)|Physician Decision|0
1102805|NCT02377427|2178300|FG002|Part A (Up to Week 20)|Physician Decision|0
1102806|NCT02377427|2178301|FG003|Part A (Up to Week 20)|Physician Decision|0
1102807|NCT02377427|2178302|FG004|Part A (Up to Week 20)|Physician Decision|0
1102808|NCT02377427|2178298|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
1102809|NCT02377427|2178299|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1102810|NCT02377427|2178300|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1102811|NCT02377427|2178301|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1102812|NCT02377427|2178302|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1102813|NCT02377427|2178298|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2
1102814|NCT02377427|2178299|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0
1102815|NCT02377427|2178300|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0
1102816|NCT02377427|2178301|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0
1102817|NCT02377427|2178302|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0
1102818|NCT02377427|2178298|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1102819|NCT02377427|2178299|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1102820|NCT02377427|2178300|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
1102821|NCT02377427|2178301|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1102822|NCT02377427|2178302|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1102823|NCT02377466|2178317|FG000|Overall Study|Other: Randomized and not treated|0
1102824|NCT02377466|2178318|FG001|Overall Study|Other: Randomized and not treated|2
1102825|NCT02377817|2178361|FG000|Overall Study|Transportation/childcare barriers.|2
1102826|NCT02377817|2178362|FG001|Overall Study|Transportation/childcare barriers.|0
1102827|NCT02377817|2178361|FG000|Overall Study|Unrelated injury prevented lateral sleep|1
1102828|NCT02377817|2178362|FG001|Overall Study|Unrelated injury prevented lateral sleep|0
1102829|NCT02377921|2178372|FG000|Overall Study|Subject non-compliance|1
1102830|NCT02377921|2178373|FG001|Overall Study|Subject non-compliance|1
1102831|NCT02378220|2178419|FG000|Overall Study|Death|6
1102832|NCT02378220|2178420|FG001|Overall Study|Death|1
1102833|NCT02378480|2178442|FG000|Overall Study|Physician Decision|1
1102834|NCT02378480|2178443|FG001|Overall Study|Physician Decision|1
1102835|NCT02378480|2178442|FG000|Overall Study|Death|1
1102836|NCT02378480|2178443|FG001|Overall Study|Death|2
1102837|NCT02378480|2178442|FG000|Overall Study|Randomized, but Not Treated|6
1102838|NCT02378480|2178443|FG001|Overall Study|Randomized, but Not Treated|4
1102839|NCT02378480|2178442|FG000|Overall Study|Adverse Event|0
1102840|NCT02378480|2178443|FG001|Overall Study|Adverse Event|1
1102841|NCT02378480|2178442|FG000|Overall Study|Missed EOT/PTE Visit|1
1102842|NCT02378480|2178443|FG001|Overall Study|Missed EOT/PTE Visit|2
1102843|NCT02378480|2178442|FG000|Overall Study|Withdrawal by Subject|9
1102844|NCT02378480|2178443|FG001|Overall Study|Withdrawal by Subject|4
1102845|NCT02378480|2178442|FG000|Overall Study|Lost to Follow-up|10
1102846|NCT02378480|2178443|FG001|Overall Study|Lost to Follow-up|18
1102847|NCT02378506|2178449|FG000|Overall Study|Lack of Efficacy|3
1102848|NCT02378506|2178449|FG000|Overall Study|Withdrawal by Subject|4
1102849|NCT02378506|2178449|FG000|Overall Study|Protocol Violation|2
1102850|NCT02378506|2178449|FG000|Overall Study|Death|1
1102851|NCT02378506|2178449|FG000|Overall Study|Adverse Event|14
1102852|NCT02378506|2178449|FG000|Overall Study|Randomized But Not Treated|1
1102853|NCT02378662|2178455|FG000|Overall Study|Early Discontinuation|2
1102854|NCT02378662|2178456|FG001|Overall Study|Early Discontinuation|0
1102855|NCT02378883|2178524|FG000|Enrollment|Subject did not meet Inclusion criteria|6
1102856|NCT02378883|2178524|FG000|Enrollment|Attempt to use Apollo was not performed|3
1102857|NCT02378883|2178524|FG000|30 Day Follow-Up|Withdrawal by Subject|1
1102858|NCT02378883|2178524|FG000|30 Day Follow-Up|Physician Decision|2
1102859|NCT02378883|2178524|FG000|30 Day Follow-Up|Missed Visit|2
1102860|NCT02378883|2178524|FG000|30 Day Follow-Up|Death|1
1102861|NCT02378883|2178524|FG000|12 Months Follow-Up|Lost to Follow-up|3
1102862|NCT02378883|2178524|FG000|12 Months Follow-Up|Death|2
1102863|NCT02378935|2178536|FG000|Overall Study|Lack of Efficacy|10
1102864|NCT02378935|2178537|FG001|Overall Study|Lack of Efficacy|0
1102865|NCT02378935|2178538|FG002|Overall Study|Lack of Efficacy|2
1102866|NCT02378935|2178539|FG003|Overall Study|Lack of Efficacy|6
1102867|NCT02378935|2178540|FG004|Overall Study|Lack of Efficacy|0
1102868|NCT02378935|2178541|FG005|Overall Study|Lack of Efficacy|0
1102869|NCT02378935|2178542|FG006|Overall Study|Lack of Efficacy|0
1102870|NCT02378935|2178536|FG000|Overall Study|Death|0
1102871|NCT02378935|2178537|FG001|Overall Study|Death|0
1102872|NCT02378935|2178538|FG002|Overall Study|Death|1
1102873|NCT02378935|2178539|FG003|Overall Study|Death|0
1102874|NCT02378935|2178540|FG004|Overall Study|Death|0
1102875|NCT02378935|2178541|FG005|Overall Study|Death|0
1102876|NCT02378935|2178542|FG006|Overall Study|Death|0
1102877|NCT02378961|2178562|FG000|Overall Study|Lack of Efficacy|4
1102878|NCT02378961|2178563|FG001|Overall Study|Lack of Efficacy|2
1102879|NCT02378961|2178564|FG002|Overall Study|Lack of Efficacy|0
1102880|NCT02378961|2178565|FG003|Overall Study|Lack of Efficacy|1
1102881|NCT02378961|2178562|FG000|Overall Study|Death|0
1102882|NCT02378961|2178563|FG001|Overall Study|Death|0
1102883|NCT02378961|2178564|FG002|Overall Study|Death|1
1102884|NCT02378961|2178565|FG003|Overall Study|Death|0
1102885|NCT02379052|2178577|FG000|Overall Study|Protocol Violation|0
1102886|NCT02379052|2178578|FG001|Overall Study|Protocol Violation|1
1102887|NCT02379052|2178577|FG000|Overall Study|Adverse Event|0
1102888|NCT02379052|2178578|FG001|Overall Study|Adverse Event|1
1102889|NCT02379052|2178577|FG000|Overall Study|Physician Decision|1
1102890|NCT02379052|2178578|FG001|Overall Study|Physician Decision|1
1102891|NCT02379052|2178577|FG000|Overall Study|Withdrawal by Subject|2
1102892|NCT02379052|2178578|FG001|Overall Study|Withdrawal by Subject|0
1102893|NCT02379052|2178577|FG000|Overall Study|Lost to Follow-up|2
1102894|NCT02379052|2178578|FG001|Overall Study|Lost to Follow-up|1
1102895|NCT02379052|2178577|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
1102896|NCT02379052|2178578|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
1102897|NCT02379052|2178577|FG000|Overall Study|Subject was Incarcerated|0
1102898|NCT02379052|2178578|FG001|Overall Study|Subject was Incarcerated|1
1102899|NCT02379078|2178586|FG000|Overall Study|Lost to Follow-up|33
1102900|NCT02379078|2178587|FG001|Overall Study|Lost to Follow-up|30
1102901|NCT02379078|2178586|FG000|Overall Study|Withdrawal by Subject|6
1102902|NCT02379078|2178587|FG001|Overall Study|Withdrawal by Subject|5
1102903|NCT02379091|2178597|FG000|Overall Study|Pretreatment Event/Adverse Event|0
1102904|NCT02379091|2178598|FG001|Overall Study|Pretreatment Event/Adverse Event|2
1102905|NCT02379091|2178599|FG002|Overall Study|Pretreatment Event/Adverse Event|0
1102906|NCT02379091|2178600|FG003|Overall Study|Pretreatment Event/Adverse Event|1
1102907|NCT02379091|2178597|FG000|Overall Study|Principal Investigator Discretion|0
1102908|NCT02379091|2178598|FG001|Overall Study|Principal Investigator Discretion|1
1102909|NCT02379091|2178599|FG002|Overall Study|Principal Investigator Discretion|0
1102910|NCT02379091|2178600|FG003|Overall Study|Principal Investigator Discretion|0
1102911|NCT02379091|2178597|FG000|Overall Study|Lost to Follow-up|0
1102912|NCT02379091|2178598|FG001|Overall Study|Lost to Follow-up|0
1102913|NCT02379091|2178599|FG002|Overall Study|Lost to Follow-up|0
1102914|NCT02379091|2178600|FG003|Overall Study|Lost to Follow-up|1
1102915|NCT02379091|2178597|FG000|Overall Study|Voluntary Withdrawal|2
1102916|NCT02379091|2178598|FG001|Overall Study|Voluntary Withdrawal|5
1102917|NCT02379091|2178599|FG002|Overall Study|Voluntary Withdrawal|2
1102918|NCT02379091|2178600|FG003|Overall Study|Voluntary Withdrawal|4
1102919|NCT02379091|2178597|FG000|Overall Study|Study Termination|7
1102920|NCT02379091|2178598|FG001|Overall Study|Study Termination|2
1102921|NCT02379091|2178599|FG002|Overall Study|Study Termination|5
1102922|NCT02379091|2178600|FG003|Overall Study|Study Termination|8
1102923|NCT02379091|2178597|FG000|Overall Study|Lack of Efficacy|3
1102924|NCT02379091|2178598|FG001|Overall Study|Lack of Efficacy|0
1102925|NCT02379091|2178599|FG002|Overall Study|Lack of Efficacy|0
1102926|NCT02379091|2178600|FG003|Overall Study|Lack of Efficacy|0
1102927|NCT02379221|2178625|FG000|Overall Study|Lost to Follow-up|1
1102928|NCT02379637|2178664|FG000|Overall Study|Protocol Violation|0
1102929|NCT02379637|2178665|FG001|Overall Study|Protocol Violation|1
1102930|NCT02379637|2178664|FG000|Overall Study|Adverse Event|1
1102931|NCT02379637|2178665|FG001|Overall Study|Adverse Event|0
1102932|NCT02379637|2178664|FG000|Overall Study|Withdrawal by Subject|1
1102933|NCT02379637|2178665|FG001|Overall Study|Withdrawal by Subject|0
1102934|NCT02379728|2178673|FG000|Overall Study|Lost to Follow-up|1
1102935|NCT02379728|2178674|FG001|Overall Study|Lost to Follow-up|0
1102936|NCT02379728|2178675|FG002|Overall Study|Lost to Follow-up|3
1102937|NCT02379728|2178676|FG003|Overall Study|Lost to Follow-up|0
1102938|NCT02379728|2178673|FG000|Overall Study|Withdrawal by Subject|5
1102939|NCT02379728|2178674|FG001|Overall Study|Withdrawal by Subject|0
1102940|NCT02379728|2178675|FG002|Overall Study|Withdrawal by Subject|5
1102941|NCT02379728|2178676|FG003|Overall Study|Withdrawal by Subject|3
1102942|NCT02379728|2178673|FG000|Overall Study|Protocol Violation|0
1102943|NCT02379728|2178674|FG001|Overall Study|Protocol Violation|0
1102944|NCT02379728|2178675|FG002|Overall Study|Protocol Violation|2
1102945|NCT02379728|2178676|FG003|Overall Study|Protocol Violation|0
1102946|NCT02379923|2178694|FG000|Overall Study|Death|5
1102947|NCT02380248|2178710|FG000|Overall Study|Lost to Follow-up|11
1102948|NCT02380248|2178710|FG000|Overall Study|Withdrawal by Subject|3
1102949|NCT02380287|2178727|FG000|Overall Study|Adverse Event|0
1102950|NCT02380287|2178728|FG001|Overall Study|Adverse Event|0
1102951|NCT02380287|2178729|FG002|Overall Study|Adverse Event|1
1102952|NCT02380287|2178730|FG003|Overall Study|Adverse Event|0
1102953|NCT02380287|2178731|FG004|Overall Study|Adverse Event|0
1102954|NCT02380287|2178732|FG005|Overall Study|Adverse Event|0
1102955|NCT02380287|2178733|FG006|Overall Study|Adverse Event|0
1102956|NCT02380287|2178734|FG007|Overall Study|Adverse Event|0
1102957|NCT02380677|2178778|FG000|Overall Study|Adverse Event|0
1102958|NCT02380677|2178779|FG001|Overall Study|Adverse Event|0
1102959|NCT02380677|2178780|FG002|Overall Study|Adverse Event|0
1102960|NCT02380677|2178781|FG003|Overall Study|Adverse Event|1
1102961|NCT02380677|2178782|FG004|Overall Study|Adverse Event|1
1102962|NCT02380677|2178783|FG005|Overall Study|Adverse Event|4
1102963|NCT02380677|2178784|FG006|Overall Study|Adverse Event|2
1102964|NCT02380677|2178785|FG007|Overall Study|Adverse Event|2
1102965|NCT02380677|2178786|FG008|Overall Study|Adverse Event|2
1102966|NCT02380677|2178787|FG009|Overall Study|Adverse Event|1
1102967|NCT02380677|2178788|FG010|Overall Study|Adverse Event|2
1102968|NCT02380677|2178789|FG011|Overall Study|Adverse Event|1
1102969|NCT02380677|2178778|FG000|Overall Study|Physician Decision|1
1102970|NCT02380677|2178779|FG001|Overall Study|Physician Decision|0
1102971|NCT02380677|2178780|FG002|Overall Study|Physician Decision|1
1102972|NCT02380677|2178781|FG003|Overall Study|Physician Decision|1
1102973|NCT02380677|2178782|FG004|Overall Study|Physician Decision|0
1102974|NCT02380677|2178783|FG005|Overall Study|Physician Decision|0
1102975|NCT02380677|2178784|FG006|Overall Study|Physician Decision|0
1102976|NCT02380677|2178785|FG007|Overall Study|Physician Decision|0
1102977|NCT02380677|2178786|FG008|Overall Study|Physician Decision|0
1102978|NCT02380677|2178787|FG009|Overall Study|Physician Decision|0
1102979|NCT02380677|2178788|FG010|Overall Study|Physician Decision|0
1102980|NCT02380677|2178789|FG011|Overall Study|Physician Decision|0
1102981|NCT02380677|2178778|FG000|Overall Study|Lack of Efficacy|0
1102982|NCT02380677|2178779|FG001|Overall Study|Lack of Efficacy|1
1102983|NCT02380677|2178780|FG002|Overall Study|Lack of Efficacy|2
1102984|NCT02380677|2178781|FG003|Overall Study|Lack of Efficacy|0
1102985|NCT02380677|2178782|FG004|Overall Study|Lack of Efficacy|4
1102986|NCT02380677|2178783|FG005|Overall Study|Lack of Efficacy|1
1102987|NCT02380677|2178784|FG006|Overall Study|Lack of Efficacy|1
1102988|NCT02380677|2178785|FG007|Overall Study|Lack of Efficacy|2
1102989|NCT02380677|2178786|FG008|Overall Study|Lack of Efficacy|2
1102990|NCT02380677|2178787|FG009|Overall Study|Lack of Efficacy|0
1102991|NCT02380677|2178788|FG010|Overall Study|Lack of Efficacy|2
1102992|NCT02380677|2178789|FG011|Overall Study|Lack of Efficacy|1
1102993|NCT02380677|2178778|FG000|Overall Study|Withdrawal by Subject|0
1102994|NCT02380677|2178779|FG001|Overall Study|Withdrawal by Subject|0
1102995|NCT02380677|2178780|FG002|Overall Study|Withdrawal by Subject|0
1102996|NCT02380677|2178781|FG003|Overall Study|Withdrawal by Subject|0
1102997|NCT02380677|2178782|FG004|Overall Study|Withdrawal by Subject|0
1102998|NCT02380677|2178783|FG005|Overall Study|Withdrawal by Subject|0
1102999|NCT02380677|2178784|FG006|Overall Study|Withdrawal by Subject|0
1103000|NCT02380677|2178785|FG007|Overall Study|Withdrawal by Subject|0
1103001|NCT02380677|2178786|FG008|Overall Study|Withdrawal by Subject|0
1103002|NCT02380677|2178787|FG009|Overall Study|Withdrawal by Subject|1
1103003|NCT02380677|2178788|FG010|Overall Study|Withdrawal by Subject|0
1103004|NCT02380677|2178789|FG011|Overall Study|Withdrawal by Subject|3
1103005|NCT02380677|2178778|FG000|Overall Study|Other|0
1103006|NCT02380677|2178779|FG001|Overall Study|Other|0
1103007|NCT02380677|2178780|FG002|Overall Study|Other|0
1103008|NCT02380677|2178781|FG003|Overall Study|Other|1
1103009|NCT02380677|2178782|FG004|Overall Study|Other|1
1103010|NCT02380677|2178783|FG005|Overall Study|Other|1
1103011|NCT02380677|2178784|FG006|Overall Study|Other|0
1103012|NCT02380677|2178785|FG007|Overall Study|Other|0
1103013|NCT02380677|2178786|FG008|Overall Study|Other|0
1103014|NCT02380677|2178787|FG009|Overall Study|Other|0
1103015|NCT02380677|2178788|FG010|Overall Study|Other|0
1103016|NCT02380677|2178789|FG011|Overall Study|Other|0
1103017|NCT02380690|2178819|FG000|Overall Study|Lost to Follow-up|14
1103018|NCT02380690|2178820|FG001|Overall Study|Lost to Follow-up|4
1103019|NCT02380690|2178819|FG000|Overall Study|Withdrawal by Subject|20
1103020|NCT02380690|2178820|FG001|Overall Study|Withdrawal by Subject|8
1103021|NCT02380703|2178828|FG000|Overall Study|Withdrawal by Subject|12
1103022|NCT02380703|2178829|FG001|Overall Study|Withdrawal by Subject|9
1103023|NCT02380703|2178828|FG000|Overall Study|Lost to Follow-up|12
1103024|NCT02380703|2178829|FG001|Overall Study|Lost to Follow-up|12
1103025|NCT02380703|2178828|FG000|Overall Study|Caregiver death|1
1103026|NCT02380703|2178829|FG001|Overall Study|Caregiver death|0
1103027|NCT02380703|2178828|FG000|Overall Study|Person with dementia (PWD) death|7
1103028|NCT02380703|2178829|FG001|Overall Study|Person with dementia (PWD) death|8
1103029|NCT02380703|2178828|FG000|Overall Study|Entered Long-term Care|4
1103030|NCT02380703|2178829|FG001|Overall Study|Entered Long-term Care|7
1103031|NCT02380742|2178837|FG000|Overall Study|Withdrawal by Subject|1
1103032|NCT02380742|2178838|FG001|Overall Study|Withdrawal by Subject|0
1103033|NCT02380859|2178846|FG000|Overall Study|Withdrawal by Subject|2
1103034|NCT02380859|2178847|FG001|Overall Study|Withdrawal by Subject|0
1103035|NCT02381652|2178912|FG000|Overall Study|Withdrawal by Subject|0
1103036|NCT02381652|2178913|FG001|Overall Study|Withdrawal by Subject|0
1103037|NCT02381652|2178914|FG002|Overall Study|Withdrawal by Subject|1
1103038|NCT02381795|2178929|FG000|Overall Study|Withdrawal by Subject|1
1103039|NCT02381795|2178929|FG000|Overall Study|Study Terminated|2
1103040|NCT02382016|2178935|FG000|Double-blind (DB) Treatment Period|Physician Decision|3
1103041|NCT02382016|2178936|FG001|Double-blind (DB) Treatment Period|Physician Decision|0
1103042|NCT02382016|2178935|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1
1103043|NCT02382016|2178936|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0
1103044|NCT02382016|2178935|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
1103045|NCT02382016|2178936|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
1103046|NCT02382016|2178935|FG000|Open-label (OL) Treatment Period|Physician Decision|3
1103047|NCT02382016|2178936|FG001|Open-label (OL) Treatment Period|Physician Decision|0
1103048|NCT02382016|2178935|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2
1103049|NCT02382016|2178936|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0
1103050|NCT02382016|2178935|FG000|Open-label (OL) Treatment Period|Death|4
1103051|NCT02382016|2178936|FG001|Open-label (OL) Treatment Period|Death|0
1103052|NCT02382016|2178935|FG000|OL Extension Period|Physician Decision|3
1103053|NCT02382016|2178936|FG001|OL Extension Period|Physician Decision|0
1103054|NCT02382016|2178935|FG000|OL Extension Period|Death|2
1103055|NCT02382016|2178936|FG001|OL Extension Period|Death|0
1103056|NCT02382016|2178935|FG000|OL Extension Period|Withdrawal by Subject|1
1103057|NCT02382016|2178936|FG001|OL Extension Period|Withdrawal by Subject|0
1103058|NCT02382133|2178944|FG000|Overall Study|Death|22
1103059|NCT02382133|2178944|FG000|Overall Study|transfer out of ICU|4
1103060|NCT02382133|2178944|FG000|Overall Study|Physician Decision|2
1103061|NCT02382133|2178944|FG000|Overall Study|arterial catheter loss|4
1103062|NCT02382133|2178944|FG000|Overall Study|pressure injury both sites|1
1103063|NCT02382276|2178951|FG000|Overall Study|Withdrawal by Subject|4
1103064|NCT02382276|2178952|FG001|Overall Study|Withdrawal by Subject|8
1103065|NCT02382276|2178953|FG002|Overall Study|Withdrawal by Subject|5
1103066|NCT02382276|2178951|FG000|Overall Study|Adverse Event|7
1103067|NCT02382276|2178952|FG001|Overall Study|Adverse Event|2
1103068|NCT02382276|2178953|FG002|Overall Study|Adverse Event|32
1103069|NCT02382276|2178951|FG000|Overall Study|Physician Decision|0
1103070|NCT02382276|2178952|FG001|Overall Study|Physician Decision|0
1103071|NCT02382276|2178953|FG002|Overall Study|Physician Decision|2
1103072|NCT02382640|2178963|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
1103073|NCT02382640|2178964|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1103074|NCT02382640|2178965|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1103075|NCT02382640|2178966|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1103076|NCT02382796|2178993|FG000|Overall Study|Global deterioration of health status|1
1103077|NCT02382796|2178993|FG000|Overall Study|Objective progression or relapse|3
1103078|NCT02382796|2178993|FG000|Overall Study|Commercial dacomitinib became available|3
1103079|NCT02382939|2179047|FG000|Overall Study|Adverse Event|1
1103080|NCT02382939|2179048|FG001|Overall Study|Adverse Event|1
1103081|NCT02382939|2179047|FG000|Overall Study|Withdrawal by Subject|2
1103082|NCT02382939|2179048|FG001|Overall Study|Withdrawal by Subject|2
1103083|NCT02382991|2179057|FG000|Overall Study|Adverse Event|1
1103084|NCT02382991|2179058|FG001|Overall Study|Adverse Event|2
1103085|NCT02382991|2179057|FG000|Overall Study|Lost to Follow-up|1
1103086|NCT02382991|2179058|FG001|Overall Study|Lost to Follow-up|0
1103087|NCT02382991|2179057|FG000|Overall Study|Withdrawal by Subject|0
1103088|NCT02382991|2179058|FG001|Overall Study|Withdrawal by Subject|1
1103089|NCT02383017|2179065|FG000|Overall Study|Injury Sustained Outside Study|1
1103090|NCT02383017|2179066|FG001|Overall Study|Injury Sustained Outside Study|0
1103091|NCT02383017|2179065|FG000|Overall Study|Compliance|3
1103092|NCT02383017|2179066|FG001|Overall Study|Compliance|2
1103093|NCT02383017|2179065|FG000|Overall Study|Found to be Hypogonadal|1
1103094|NCT02383017|2179066|FG001|Overall Study|Found to be Hypogonadal|0
1103095|NCT02383056|2179088|FG000|Overall Study|Adverse Event|1
1103096|NCT02383056|2179089|FG001|Overall Study|Adverse Event|0
1103097|NCT02383056|2179088|FG000|Overall Study|Lost to Follow-up|0
1103098|NCT02383056|2179089|FG001|Overall Study|Lost to Follow-up|2
1103099|NCT02383173|2179097|FG000|Overall Study|Palliative Care Team withdrew|0
1103100|NCT02383173|2179098|FG001|Overall Study|Palliative Care Team withdrew|2
1103101|NCT02383355|2179106|FG000|Overall Study|Adverse Event|2
1103102|NCT02383355|2179107|FG001|Overall Study|Adverse Event|0
1103103|NCT02383472|2179128|FG000|Overall Study|Withdrawal by Subject|1
1103104|NCT02383472|2179129|FG001|Overall Study|Withdrawal by Subject|1
1103105|NCT02383576|2179139|FG000|Overall Study|Death|53
1103106|NCT02383576|2179140|FG001|Overall Study|Death|33
1103107|NCT02383576|2179139|FG000|Overall Study|Lost to Follow-up|7
1103108|NCT02383576|2179140|FG001|Overall Study|Lost to Follow-up|1
1103109|NCT02383576|2179139|FG000|Overall Study|Withdrew Consent|1
1103110|NCT02383576|2179140|FG001|Overall Study|Withdrew Consent|6
1103111|NCT02383576|2179139|FG000|Overall Study|Investigator's Decision|0
1103112|NCT02383576|2179140|FG001|Overall Study|Investigator's Decision|1
1103113|NCT02383576|2179139|FG000|Overall Study|Administrative/Other|2
1103114|NCT02383576|2179140|FG001|Overall Study|Administrative/Other|4
1103115|NCT02383589|2179148|FG000|Treatment Period|Adverse Event|1
1103116|NCT02383589|2179149|FG001|Treatment Period|Adverse Event|3
1103117|NCT02383589|2179148|FG000|Treatment Period|Lost to Follow-up|0
1103118|NCT02383589|2179149|FG001|Treatment Period|Lost to Follow-up|1
1103119|NCT02383589|2179148|FG000|Treatment Period|Withdrawal by Subject|0
1103120|NCT02383589|2179149|FG001|Treatment Period|Withdrawal by Subject|5
1103121|NCT02383589|2179148|FG000|Treatment Period|Non-compliance with study drug|0
1103122|NCT02383589|2179149|FG001|Treatment Period|Non-compliance with study drug|1
1103123|NCT02383589|2179148|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2
1103124|NCT02383589|2179149|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4
1103125|NCT02383589|2179148|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5
1103126|NCT02383589|2179149|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0
1103127|NCT02383589|2179148|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0
1103128|NCT02383589|2179149|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1
1103129|NCT02383758|2179172|FG000|Overall Study|Withdrawal by Subject|0
1103130|NCT02383758|2179173|FG001|Overall Study|Withdrawal by Subject|2
1103131|NCT02383862|2179181|FG000|3 Month Follow up|Lost to Follow-up|23
1103132|NCT02383862|2179182|FG001|3 Month Follow up|Lost to Follow-up|21
1103133|NCT02383940|2179197|FG000|Overall Study|Adverse Event|1
1103134|NCT02383940|2179198|FG001|Overall Study|Adverse Event|0
1103135|NCT02383940|2179197|FG000|Overall Study|Lost to Follow-up|2
1103136|NCT02383940|2179198|FG001|Overall Study|Lost to Follow-up|2
1103137|NCT02383940|2179197|FG000|Overall Study|Physician Decision|2
1103138|NCT02383940|2179198|FG001|Overall Study|Physician Decision|0
1103139|NCT02383940|2179197|FG000|Overall Study|Withdrawal by Subject|1
1103140|NCT02383940|2179198|FG001|Overall Study|Withdrawal by Subject|1
1103141|NCT02383940|2179197|FG000|Overall Study|Randomized but not treated|2
1103142|NCT02383940|2179198|FG001|Overall Study|Randomized but not treated|0
1103143|NCT02383940|2179197|FG000|Overall Study|Other than specified above|1
1103144|NCT02383940|2179198|FG001|Overall Study|Other than specified above|0
1103145|NCT02383966|2179206|FG000|Overall Study|Ongoing at clinical cut-off date|25
1103146|NCT02383966|2179207|FG001|Overall Study|Ongoing at clinical cut-off date|4
1103147|NCT02383966|2179206|FG000|Overall Study|Randomized, but not treated|1
1103148|NCT02383966|2179207|FG001|Overall Study|Randomized, but not treated|3
1103149|NCT02384382|2179252|FG000|Overall Study|Transitioned to study-NCT02960022|5
1103150|NCT02384382|2179252|FG000|Overall Study|Death|1
1103151|NCT02384382|2179252|FG000|Overall Study|Adverse Event|1
1103152|NCT02384382|2179252|FG000|Overall Study|Disease progression|16
1103153|NCT02384395|2179256|FG000|Overall Study|Physician Decision|4
1103154|NCT02384395|2179256|FG000|Overall Study|Withdrawal by Subject|3
1103155|NCT02384395|2179256|FG000|Overall Study|Lost to Follow-up|3
1103156|NCT02384460|2179262|FG000|Overall Study|Protocol Violation|0
1103157|NCT02384460|2179263|FG001|Overall Study|Protocol Violation|1
1103158|NCT02384460|2179262|FG000|Overall Study|Returned to previous therapeutic regimen|0
1103159|NCT02384460|2179263|FG001|Overall Study|Returned to previous therapeutic regimen|1
1103160|NCT02384460|2179262|FG000|Overall Study|Adverse Event|5
1103161|NCT02384460|2179263|FG001|Overall Study|Adverse Event|2
1103162|NCT02384460|2179262|FG000|Overall Study|Withdrawal by Subject|0
1103163|NCT02384460|2179263|FG001|Overall Study|Withdrawal by Subject|3
1103164|NCT02384460|2179262|FG000|Overall Study|Elective medical treatment|1
1103165|NCT02384460|2179263|FG001|Overall Study|Elective medical treatment|0
1103166|NCT02384460|2179262|FG000|Overall Study|Non-compliance|1
1103167|NCT02384460|2179263|FG001|Overall Study|Non-compliance|0
1103168|NCT02384538|2179271|FG000|Overall Study|Adverse Event|1
1103169|NCT02384538|2179272|FG001|Overall Study|Adverse Event|4
1103170|NCT02384538|2179271|FG000|Overall Study|Lack of Efficacy|4
1103171|NCT02384538|2179272|FG001|Overall Study|Lack of Efficacy|4
1103172|NCT02384538|2179271|FG000|Overall Study|Withdrew Consent|0
1103173|NCT02384538|2179272|FG001|Overall Study|Withdrew Consent|4
1103174|NCT02384538|2179271|FG000|Overall Study|Other|1
1103175|NCT02384538|2179272|FG001|Overall Study|Other|3
1103176|NCT02384941|2179281|FG000|Overall Study|Adverse Event|11
1103177|NCT02384941|2179282|FG001|Overall Study|Adverse Event|13
1103178|NCT02384941|2179283|FG002|Overall Study|Adverse Event|17
1103179|NCT02384941|2179281|FG000|Overall Study|Lost to Follow-up|3
1103180|NCT02384941|2179282|FG001|Overall Study|Lost to Follow-up|2
1103181|NCT02384941|2179283|FG002|Overall Study|Lost to Follow-up|1
1103182|NCT02384941|2179281|FG000|Overall Study|Non-Compliance With Study Drug|2
1103183|NCT02384941|2179282|FG001|Overall Study|Non-Compliance With Study Drug|0
1103184|NCT02384941|2179283|FG002|Overall Study|Non-Compliance With Study Drug|1
1103185|NCT02384941|2179281|FG000|Overall Study|Physician Decision|1
1103186|NCT02384941|2179282|FG001|Overall Study|Physician Decision|1
1103187|NCT02384941|2179283|FG002|Overall Study|Physician Decision|0
1103188|NCT02384941|2179281|FG000|Overall Study|Protocol Violation|3
1103189|NCT02384941|2179282|FG001|Overall Study|Protocol Violation|0
1103190|NCT02384941|2179283|FG002|Overall Study|Protocol Violation|0
1103191|NCT02384941|2179281|FG000|Overall Study|Withdrawal by Subject|26
1103192|NCT02384941|2179282|FG001|Overall Study|Withdrawal by Subject|19
1103193|NCT02384941|2179283|FG002|Overall Study|Withdrawal by Subject|20
1103194|NCT02384941|2179281|FG000|Overall Study|Pregnancy|0
1103195|NCT02384941|2179282|FG001|Overall Study|Pregnancy|0
1103196|NCT02384941|2179283|FG002|Overall Study|Pregnancy|1
1103197|NCT02384941|2179281|FG000|Overall Study|Other than specified above|4
1103198|NCT02384941|2179282|FG001|Overall Study|Other than specified above|0
1103199|NCT02384941|2179283|FG002|Overall Study|Other than specified above|1
1103202|NCT02385084|2179302|FG000|Period 2|Protocol Violation|0
1103203|NCT02385084|2179303|FG001|Period 2|Protocol Violation|0
1103204|NCT02385084|2179304|FG002|Period 2|Protocol Violation|1
1103205|NCT02385084|2179305|FG003|Period 2|Protocol Violation|0
1103206|NCT02385084|2179306|FG004|Period 2|Protocol Violation|0
1103207|NCT02385084|2179307|FG005|Period 2|Protocol Violation|0
1103208|NCT02385526|2179354|FG000|Overall Study|Withdrawal by Subject|0
1103209|NCT02385526|2179355|FG001|Overall Study|Withdrawal by Subject|2
1103210|NCT02385526|2179356|FG002|Overall Study|Withdrawal by Subject|0
1103211|NCT02385526|2179354|FG000|Overall Study|Lost to Follow-up|0
1103212|NCT02385526|2179355|FG001|Overall Study|Lost to Follow-up|1
1103213|NCT02385526|2179356|FG002|Overall Study|Lost to Follow-up|0
1103214|NCT02385526|2179354|FG000|Overall Study|Physician Decision|1
1103215|NCT02385526|2179355|FG001|Overall Study|Physician Decision|0
1103216|NCT02385526|2179356|FG002|Overall Study|Physician Decision|0
1103217|NCT02385526|2179354|FG000|Overall Study|Protocol Violation|1
1103218|NCT02385526|2179355|FG001|Overall Study|Protocol Violation|0
1103219|NCT02385526|2179356|FG002|Overall Study|Protocol Violation|0
1103220|NCT02385669|2179364|FG000|Overall Study|Adverse Event|2
1103221|NCT02385708|2179370|FG000|Overall Study|Withdrawal by Subject|0
1103222|NCT02385708|2179371|FG001|Overall Study|Withdrawal by Subject|2
1103223|NCT02385708|2179370|FG000|Overall Study|Withdrawn - surgery canceled|2
1103224|NCT02385708|2179371|FG001|Overall Study|Withdrawn - surgery canceled|5
1103225|NCT02385708|2179370|FG000|Overall Study|Investigator decision|5
1103226|NCT02385708|2179371|FG001|Overall Study|Investigator decision|7
1103227|NCT02385708|2179370|FG000|Overall Study|Protocol Violation|1
1103228|NCT02385708|2179371|FG001|Overall Study|Protocol Violation|1
1103229|NCT02385799|2179383|FG000|Overall Study|Lost to Follow-up|1
1103230|NCT02385799|2179384|FG001|Overall Study|Lost to Follow-up|2
1103231|NCT02385799|2179383|FG000|Overall Study|Adverse Event|4
1103232|NCT02385799|2179384|FG001|Overall Study|Adverse Event|2
1103233|NCT02385799|2179383|FG000|Overall Study|Withdrawal by Subject|0
1103234|NCT02385799|2179384|FG001|Overall Study|Withdrawal by Subject|4
1103235|NCT02386189|2179413|FG000|Overall Study|Lost to Follow-up|2
1103236|NCT02386189|2179414|FG001|Overall Study|Lost to Follow-up|3
1103237|NCT02386189|2179413|FG000|Overall Study|Withdrawal by Subject|1
1103238|NCT02386189|2179414|FG001|Overall Study|Withdrawal by Subject|0
1103239|NCT02386189|2179413|FG000|Overall Study|Death|1
1103240|NCT02386189|2179414|FG001|Overall Study|Death|0
1103241|NCT02386345|2179429|FG000|Overall Study|Not treated|14
1103242|NCT02386345|2179429|FG000|Overall Study|Lost to Follow-up|1
1103243|NCT02386345|2179429|FG000|Overall Study|Adverse Event|5
1103244|NCT02386345|2179429|FG000|Overall Study|Repeat Procedure|10
1103245|NCT02386345|2179429|FG000|Overall Study|Did not complete 12-month follow-up|72
1103246|NCT02387164|2179462|FG000|Overall Study|Lost to Follow-up|2
1103247|NCT02387164|2179463|FG001|Overall Study|Lost to Follow-up|0
1103248|NCT02387164|2179462|FG000|Overall Study|Diagnosed|1
1103249|NCT02387164|2179463|FG001|Overall Study|Diagnosed|2
1103250|NCT02387216|2179471|FG000|Overall Study|Progressive disease|2
1103251|NCT02387216|2179472|FG001|Overall Study|Progressive disease|0
1103252|NCT02387216|2179471|FG000|Overall Study|Withdrawal by Subject|3
1103253|NCT02387216|2179472|FG001|Overall Study|Withdrawal by Subject|5
1103254|NCT02387216|2179471|FG000|Overall Study|Physician Decision|2
1103255|NCT02387216|2179472|FG001|Overall Study|Physician Decision|0
1103256|NCT02387216|2179471|FG000|Overall Study|Sponsor Decision|28
1103257|NCT02387216|2179472|FG001|Overall Study|Sponsor Decision|12
1103258|NCT02387216|2179471|FG000|Overall Study|Death|60
1103259|NCT02387216|2179472|FG001|Overall Study|Death|23
1103260|NCT02387216|2179471|FG000|Overall Study|Other|5
1103261|NCT02387216|2179472|FG001|Overall Study|Other|4
1103262|NCT02387216|2179471|FG000|Overall Study|Lost to Follow-up|0
1103263|NCT02387216|2179472|FG001|Overall Study|Lost to Follow-up|3
1103264|NCT02387372|2179507|FG000|Overall Study|Not Treated|1
1103265|NCT02387372|2179508|FG001|Overall Study|Not Treated|0
1103266|NCT02387580|2179569|FG000|Overall Study|Withdrawal by Subject|0
1103267|NCT02387580|2179570|FG001|Overall Study|Withdrawal by Subject|0
1103268|NCT02387580|2179571|FG002|Overall Study|Withdrawal by Subject|0
1103269|NCT02387580|2179572|FG003|Overall Study|Withdrawal by Subject|1
1103270|NCT02387580|2179573|FG004|Overall Study|Withdrawal by Subject|0
1103271|NCT02387580|2179574|FG005|Overall Study|Withdrawal by Subject|0
1103272|NCT02387762|2179610|FG000|Overall Study|Withdrawal by Subject|1
1103273|NCT02387762|2179611|FG001|Overall Study|Withdrawal by Subject|0
1103274|NCT02387840|2179651|FG000|Overall Study|Death|0
1103275|NCT02387840|2179652|FG001|Overall Study|Death|0
1103276|NCT02387840|2179653|FG002|Overall Study|Death|0
1103277|NCT02387840|2179654|FG003|Overall Study|Death|0
1103278|NCT02387840|2179655|FG004|Overall Study|Death|0
1103279|NCT02387840|2179656|FG005|Overall Study|Death|1
1103280|NCT02387957|2179683|FG000|Overall Study|The study was discontinued|21
1103281|NCT02387957|2179684|FG001|Overall Study|The study was discontinued|21
1103282|NCT02387957|2179685|FG002|Overall Study|The study was discontinued|20
1103283|NCT02387970|2179695|FG000|Overall Study|Did not complete 1-year follow up|1
1103284|NCT02387970|2179696|FG001|Overall Study|Did not complete 1-year follow up|2
1103285|NCT02387983|2179702|FG000|Overall Study|Adverse Event|4
1103286|NCT02387983|2179702|FG000|Overall Study|Protocol Violation|1
1103287|NCT02387983|2179702|FG000|Overall Study|Withdrawal by Subject|2
1103288|NCT02387996|2179706|FG000|Overall Study|Disease Progression|144
1103289|NCT02387996|2179706|FG000|Overall Study|Study Drug Toxicity|14
1103290|NCT02387996|2179706|FG000|Overall Study|Adverse Event Unrelated to Study Drug|34
1103291|NCT02387996|2179706|FG000|Overall Study|Subject Request to Discontinue Treatment|9
1103292|NCT02387996|2179706|FG000|Overall Study|Subject Withdrew Consent|1
1103293|NCT02387996|2179706|FG000|Overall Study|Lost to Follow-up|1
1103294|NCT02387996|2179706|FG000|Overall Study|Poor/Non-Compliance|1
1103295|NCT02388074|2179710|FG000|Overall Study|Lost in Transit|2
1103296|NCT02388074|2179710|FG000|Overall Study|Sample Not Returned|1
1103297|NCT02388165|2179716|FG000|Overall Study|Study terminated by sponsor|5
1103298|NCT02388165|2179717|FG001|Overall Study|Study terminated by sponsor|5
1103299|NCT02388165|2179716|FG000|Overall Study|Other|11
1103300|NCT02388165|2179717|FG001|Overall Study|Other|13
1103301|NCT02388165|2179716|FG000|Overall Study|No longer meet eligibility criteria|40
1103302|NCT02388165|2179717|FG001|Overall Study|No longer meet eligibility criteria|43
1103303|NCT02388165|2179716|FG000|Overall Study|Withdrawal of consent|31
1103304|NCT02388165|2179717|FG001|Overall Study|Withdrawal of consent|32
1103305|NCT02388165|2179716|FG000|Overall Study|Lost to Follow-up|19
1103306|NCT02388165|2179717|FG001|Overall Study|Lost to Follow-up|20
1103307|NCT02388165|2179716|FG000|Overall Study|Death|13
1103308|NCT02388165|2179717|FG001|Overall Study|Death|10
1103309|NCT02388165|2179716|FG000|Overall Study|Adverse Event|3
1103310|NCT02388165|2179717|FG001|Overall Study|Adverse Event|5
1103311|NCT02388165|2179716|FG000|Overall Study|Did not meet entrance criteria|5
1103312|NCT02388165|2179717|FG001|Overall Study|Did not meet entrance criteria|2
1103313|NCT02388191|2179725|FG000|Overall Study|Patient did not receive IUD|1
1103314|NCT02388191|2179726|FG001|Overall Study|Patient did not receive IUD|0
1103315|NCT02388269|2179736|FG000|Overall Study|Adverse Event|2
1103316|NCT02388269|2179737|FG001|Overall Study|Adverse Event|0
1103317|NCT02388269|2179738|FG002|Overall Study|Adverse Event|0
1103318|NCT02388269|2179736|FG000|Overall Study|Withdrawal by Subject|1
1103319|NCT02388269|2179737|FG001|Overall Study|Withdrawal by Subject|2
1103320|NCT02388269|2179738|FG002|Overall Study|Withdrawal by Subject|0
1103321|NCT02388269|2179736|FG000|Overall Study|less than 50% stimulations|1
1103322|NCT02388269|2179737|FG001|Overall Study|less than 50% stimulations|0
1103323|NCT02388269|2179738|FG002|Overall Study|less than 50% stimulations|0
1103324|NCT02388269|2179736|FG000|Overall Study|no diary data|3
1103325|NCT02388269|2179737|FG001|Overall Study|no diary data|0
1103326|NCT02388269|2179738|FG002|Overall Study|no diary data|0
1103327|NCT02388269|2179736|FG000|Overall Study|Protocol Violation|2
1103328|NCT02388269|2179737|FG001|Overall Study|Protocol Violation|0
1103329|NCT02388269|2179738|FG002|Overall Study|Protocol Violation|0
1103330|NCT02388269|2179736|FG000|Overall Study|Screen Failure|0
1103331|NCT02388269|2179737|FG001|Overall Study|Screen Failure|0
1103332|NCT02388269|2179738|FG002|Overall Study|Screen Failure|10
1103333|NCT02388295|2179765|FG000|Dose Escalation Week 1|Adverse Event|1
1103334|NCT02388295|2179766|FG001|Dose Escalation Week 1|Adverse Event|2
1103335|NCT02388295|2179767|FG002|Dose Escalation Week 1|Adverse Event|1
1103336|NCT02388295|2179765|FG000|Dose Escalation Week 1|Determined not eligible|1
1103337|NCT02388295|2179766|FG001|Dose Escalation Week 1|Determined not eligible|1
1103338|NCT02388295|2179767|FG002|Dose Escalation Week 1|Determined not eligible|1
1103339|NCT02388295|2179765|FG000|Dose Escalation Week 2|Protocol Violation|0
1103340|NCT02388295|2179766|FG001|Dose Escalation Week 2|Protocol Violation|1
1103341|NCT02388295|2179767|FG002|Dose Escalation Week 2|Protocol Violation|0
1103342|NCT02388295|2179765|FG000|Dose Escalation Week 2|Determined not eligible|1
1103343|NCT02388295|2179766|FG001|Dose Escalation Week 2|Determined not eligible|1
1103344|NCT02388295|2179767|FG002|Dose Escalation Week 2|Determined not eligible|1
1103345|NCT02388295|2179765|FG000|Treatment Weeks 3 to 12|Adverse Event|1
1103346|NCT02388295|2179766|FG001|Treatment Weeks 3 to 12|Adverse Event|1
1103347|NCT02388295|2179767|FG002|Treatment Weeks 3 to 12|Adverse Event|0
1103348|NCT02388347|2179789|FG000|Overall Study|Withdrawal by Subject|0
1103349|NCT02388347|2179790|FG001|Overall Study|Withdrawal by Subject|0
1103350|NCT02388347|2179791|FG002|Overall Study|Withdrawal by Subject|1
1103351|NCT02388347|2179792|FG003|Overall Study|Withdrawal by Subject|0
895104|NCT00696384|1866295|FG001|Open Label Phase|Physician Decision|0
895105|NCT00696384|1866296|FG002|Open Label Phase|Physician Decision|0
895106|NCT00696384|1866294|FG000|Double Blind Phase|Adverse Event|0
895107|NCT00696384|1866295|FG001|Double Blind Phase|Adverse Event|2
895108|NCT00696384|1866296|FG002|Double Blind Phase|Adverse Event|2
895109|NCT00696384|1866294|FG000|Double Blind Phase|Lost to Follow-up|0
895110|NCT00696384|1866295|FG001|Double Blind Phase|Lost to Follow-up|2
895111|NCT00696384|1866296|FG002|Double Blind Phase|Lost to Follow-up|1
895112|NCT00696384|1866294|FG000|Double Blind Phase|Withdrawal by Subject|0
895113|NCT00696384|1866295|FG001|Double Blind Phase|Withdrawal by Subject|4
895114|NCT00696384|1866296|FG002|Double Blind Phase|Withdrawal by Subject|3
895115|NCT00696384|1866294|FG000|Double Blind Phase|Lack of Efficacy|0
895116|NCT00696384|1866295|FG001|Double Blind Phase|Lack of Efficacy|1
895117|NCT00696384|1866296|FG002|Double Blind Phase|Lack of Efficacy|0
895118|NCT00696384|1866294|FG000|Double Blind Phase|Physician Decision|0
895119|NCT00696384|1866295|FG001|Double Blind Phase|Physician Decision|2
895120|NCT00696384|1866296|FG002|Double Blind Phase|Physician Decision|0
895121|NCT00696410|1866307|FG000|Overall Study|Lost to Follow-up|2
895122|NCT00696410|1866308|FG001|Overall Study|Lost to Follow-up|0
895123|NCT00696410|1866307|FG000|Overall Study|Withdrawal by Subject|8
895124|NCT00696410|1866308|FG001|Overall Study|Withdrawal by Subject|0
895125|NCT00696410|1866307|FG000|Overall Study|Physician Decision|3
895126|NCT00696410|1866308|FG001|Overall Study|Physician Decision|0
895127|NCT00696423|1866321|FG000|Overall Study|Lost to Follow-up|0
895128|NCT00696423|1866322|FG001|Overall Study|Lost to Follow-up|5
895129|NCT00696436|1866333|FG000|Overall Study|Adverse Event|7
895130|NCT00696436|1866334|FG001|Overall Study|Adverse Event|9
895131|NCT00696436|1866335|FG002|Overall Study|Adverse Event|8
895132|NCT00696436|1866336|FG003|Overall Study|Adverse Event|6
895133|NCT00696436|1866337|FG004|Overall Study|Adverse Event|4
895134|NCT00696436|1866333|FG000|Overall Study|Protocol Violation|3
895135|NCT00696436|1866334|FG001|Overall Study|Protocol Violation|2
895136|NCT00696436|1866335|FG002|Overall Study|Protocol Violation|2
895137|NCT00696436|1866336|FG003|Overall Study|Protocol Violation|0
895138|NCT00696436|1866337|FG004|Overall Study|Protocol Violation|1
895139|NCT00696436|1866333|FG000|Overall Study|Lost to Follow-up|1
895140|NCT00696436|1866334|FG001|Overall Study|Lost to Follow-up|6
895141|NCT00696436|1866335|FG002|Overall Study|Lost to Follow-up|2
895142|NCT00696436|1866336|FG003|Overall Study|Lost to Follow-up|4
895143|NCT00696436|1866337|FG004|Overall Study|Lost to Follow-up|3
895144|NCT00696436|1866333|FG000|Overall Study|Withdrawal by Subject|4
895145|NCT00696436|1866334|FG001|Overall Study|Withdrawal by Subject|11
895146|NCT00696436|1866335|FG002|Overall Study|Withdrawal by Subject|5
895147|NCT00696436|1866336|FG003|Overall Study|Withdrawal by Subject|7
895148|NCT00696436|1866337|FG004|Overall Study|Withdrawal by Subject|1
895149|NCT00696436|1866333|FG000|Overall Study|Lack of Efficacy|3
895150|NCT00696436|1866334|FG001|Overall Study|Lack of Efficacy|1
895151|NCT00696436|1866335|FG002|Overall Study|Lack of Efficacy|5
895152|NCT00696436|1866336|FG003|Overall Study|Lack of Efficacy|2
895153|NCT00696436|1866337|FG004|Overall Study|Lack of Efficacy|4
895154|NCT00696436|1866333|FG000|Overall Study|Participant Unavailability|2
895155|NCT00696436|1866334|FG001|Overall Study|Participant Unavailability|0
895156|NCT00696436|1866335|FG002|Overall Study|Participant Unavailability|2
895157|NCT00696436|1866336|FG003|Overall Study|Participant Unavailability|1
895158|NCT00696436|1866337|FG004|Overall Study|Participant Unavailability|0
895159|NCT00696436|1866333|FG000|Overall Study|Administrative Error|2
895160|NCT00696436|1866334|FG001|Overall Study|Administrative Error|0
1103352|NCT02388347|2179793|FG004|Overall Study|Withdrawal by Subject|0
1103353|NCT02388724|2179845|FG000|Overall Study|Reason not Specified|0
1103354|NCT02388724|2179846|FG001|Overall Study|Reason not Specified|1
1103355|NCT02388724|2179845|FG000|Overall Study|Major Protocol Deviation|3
1103356|NCT02388724|2179846|FG001|Overall Study|Major Protocol Deviation|3
1103357|NCT02388724|2179845|FG000|Overall Study|Pretreatment Event/Adverse Event|3
1103358|NCT02388724|2179846|FG001|Overall Study|Pretreatment Event/Adverse Event|2
1103359|NCT02388724|2179845|FG000|Overall Study|Voluntary Withdrawal|6
1103360|NCT02388724|2179846|FG001|Overall Study|Voluntary Withdrawal|5
1103361|NCT02388724|2179845|FG000|Overall Study|Randomized but not Treated|0
1103362|NCT02388724|2179846|FG001|Overall Study|Randomized but not Treated|2
1103363|NCT02388737|2179855|FG000|Overall Study|Pretreatment Event/Adverse Event|13
1103364|NCT02388737|2179856|FG001|Overall Study|Pretreatment Event/Adverse Event|11
1103365|NCT02388737|2179857|FG002|Overall Study|Pretreatment Event/Adverse Event|12
1103366|NCT02388737|2179855|FG000|Overall Study|Major Protocol Deviation|18
1103367|NCT02388737|2179856|FG001|Overall Study|Major Protocol Deviation|25
1103368|NCT02388737|2179857|FG002|Overall Study|Major Protocol Deviation|22
1103369|NCT02388737|2179855|FG000|Overall Study|Lost to Follow-up|5
1103370|NCT02388737|2179856|FG001|Overall Study|Lost to Follow-up|1
1103371|NCT02388737|2179857|FG002|Overall Study|Lost to Follow-up|4
1103372|NCT02388737|2179855|FG000|Overall Study|Voluntary Withdrawal|10
1103373|NCT02388737|2179856|FG001|Overall Study|Voluntary Withdrawal|18
1103374|NCT02388737|2179857|FG002|Overall Study|Voluntary Withdrawal|17
1103375|NCT02388737|2179855|FG000|Overall Study|Lack of Efficacy|3
1103376|NCT02388737|2179856|FG001|Overall Study|Lack of Efficacy|0
1103377|NCT02388737|2179857|FG002|Overall Study|Lack of Efficacy|3
1103378|NCT02388737|2179855|FG000|Overall Study|Reason Not Specified|5
1103379|NCT02388737|2179856|FG001|Overall Study|Reason Not Specified|5
1103380|NCT02388737|2179857|FG002|Overall Study|Reason Not Specified|4
1103381|NCT02388763|2179865|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1
1103382|NCT02388763|2179866|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1
1103383|NCT02388763|2179865|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1
1103384|NCT02388763|2179866|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1
1103385|NCT02388906|2179885|FG000|Pre-Treatment Period|Participant withdrew consent|1
1103386|NCT02388906|2179886|FG001|Pre-Treatment Period|Participant withdrew consent|0
1103387|NCT02388906|2179885|FG000|Treatment Period|Disease progression|121
1103388|NCT02388906|2179886|FG001|Treatment Period|Disease progression|101
1103389|NCT02388906|2179885|FG000|Treatment Period|Study drug toxicity|41
1103390|NCT02388906|2179886|FG001|Treatment Period|Study drug toxicity|208
1103391|NCT02388906|2179885|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5
1103392|NCT02388906|2179886|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5
1103393|NCT02388906|2179885|FG000|Treatment Period|Participant request to stop treatment|5
1103394|NCT02388906|2179886|FG001|Treatment Period|Participant request to stop treatment|9
1103395|NCT02388906|2179885|FG000|Treatment Period|Participant withdrew consent|2
1103396|NCT02388906|2179886|FG001|Treatment Period|Participant withdrew consent|3
1103397|NCT02388906|2179885|FG000|Treatment Period|Poor/non-compliance|0
1103398|NCT02388906|2179886|FG001|Treatment Period|Poor/non-compliance|1
1103399|NCT02388906|2179885|FG000|Treatment Period|Participant no longer meets study criteria|0
1103400|NCT02388906|2179886|FG001|Treatment Period|Participant no longer meets study criteria|1
1103401|NCT02388906|2179885|FG000|Treatment Period|Other reasons|3
1103402|NCT02388906|2179886|FG001|Treatment Period|Other reasons|3
1103403|NCT02388932|2179892|FG000|Overall Study|Death|1
1103404|NCT02388997|2179899|FG000|Overall Study|Adverse Event|1
1103405|NCT02388997|2179900|FG001|Overall Study|Adverse Event|2
1103406|NCT02388997|2179899|FG000|Overall Study|Withdrawal by Subject|2
1103407|NCT02388997|2179900|FG001|Overall Study|Withdrawal by Subject|1
1103408|NCT02388997|2179899|FG000|Overall Study|Lung function exclusion criteria|0
1103409|NCT02388997|2179900|FG001|Overall Study|Lung function exclusion criteria|2
1103410|NCT02388997|2179899|FG000|Overall Study|Tested positive for virus during run-in|0
1103411|NCT02388997|2179900|FG001|Overall Study|Tested positive for virus during run-in|1
1103412|NCT02389452|2179947|FG000|Overall Study|Lost to Follow-up|13
1103413|NCT02389452|2179947|FG000|Overall Study|Adverse Event|1
1103414|NCT02389452|2179947|FG000|Overall Study|Withdrawal by Subject|5
1103415|NCT02389452|2179947|FG000|Overall Study|Enrolled but Not Eligible for Study|6
1103416|NCT02389621|2179954|FG000|Treatment Period|Withdrawal by Subject|1
1103417|NCT02389621|2179955|FG001|Treatment Period|Withdrawal by Subject|1
1103418|NCT02389621|2179954|FG000|Posttreatment Period|Adverse Event|3
1103419|NCT02389621|2179955|FG001|Posttreatment Period|Adverse Event|1
1103420|NCT02389621|2179954|FG000|Posttreatment Period|Withdrawal by Subject|3
1103421|NCT02389621|2179955|FG001|Posttreatment Period|Withdrawal by Subject|2
1103422|NCT02389621|2179954|FG000|Posttreatment Period|Lost to Follow-up|1
1103423|NCT02389621|2179955|FG001|Posttreatment Period|Lost to Follow-up|1
1103424|NCT02389621|2179954|FG000|Posttreatment Period|Other - Miscellaneous|2
1103425|NCT02389621|2179955|FG001|Posttreatment Period|Other - Miscellaneous|0
1103426|NCT02389764|2179980|FG000|Overall Study|Lack of Efficacy|9
1103427|NCT02389816|2179987|FG000|Overall Study|Randomized but Not Treated|1
1103428|NCT02389816|2179988|FG001|Overall Study|Randomized but Not Treated|0
1103429|NCT02389816|2179989|FG002|Overall Study|Randomized but Not Treated|0
1103430|NCT02389816|2179987|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4
1103431|NCT02389816|2179988|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6
1103432|NCT02389816|2179989|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7
1103433|NCT02389816|2179987|FG000|Overall Study|Major Protocol Deviation|1
1103434|NCT02389816|2179988|FG001|Overall Study|Major Protocol Deviation|0
1103435|NCT02389816|2179989|FG002|Overall Study|Major Protocol Deviation|0
1103436|NCT02389816|2179987|FG000|Overall Study|Lost to Follow-up|1
1103437|NCT02389816|2179988|FG001|Overall Study|Lost to Follow-up|0
1103438|NCT02389816|2179989|FG002|Overall Study|Lost to Follow-up|0
1103439|NCT02389816|2179987|FG000|Overall Study|Withdrawal of Consent|6
1103440|NCT02389816|2179988|FG001|Overall Study|Withdrawal of Consent|4
1103441|NCT02389816|2179989|FG002|Overall Study|Withdrawal of Consent|4
1103442|NCT02389816|2179987|FG000|Overall Study|Lack of Efficacy|1
1103443|NCT02389816|2179988|FG001|Overall Study|Lack of Efficacy|0
1103444|NCT02389816|2179989|FG002|Overall Study|Lack of Efficacy|0
1103445|NCT02389816|2179987|FG000|Overall Study|Non Compliance with Study Drug|1
1103446|NCT02389816|2179988|FG001|Overall Study|Non Compliance with Study Drug|1
1103447|NCT02389816|2179989|FG002|Overall Study|Non Compliance with Study Drug|1
1103448|NCT02389816|2179987|FG000|Overall Study|Reason not Specified|0
1103449|NCT02389816|2179988|FG001|Overall Study|Reason not Specified|2
1103450|NCT02389816|2179989|FG002|Overall Study|Reason not Specified|0
1103451|NCT02389829|2179999|FG000|Overall Study|Lost to Follow-up|0
1103452|NCT02389829|2180000|FG001|Overall Study|Lost to Follow-up|1
1103453|NCT02389894|2180038|FG000|Overall Study|Death|4
1103454|NCT02389894|2180039|FG001|Overall Study|Death|5
1103455|NCT02389894|2180040|FG002|Overall Study|Death|3
1103456|NCT02389894|2180038|FG000|Overall Study|Withdrawal by Subject|2
1103457|NCT02389894|2180039|FG001|Overall Study|Withdrawal by Subject|4
1103458|NCT02389894|2180040|FG002|Overall Study|Withdrawal by Subject|5
1103459|NCT02389894|2180038|FG000|Overall Study|Lost to Follow-up|2
1103460|NCT02389894|2180039|FG001|Overall Study|Lost to Follow-up|1
1103461|NCT02389894|2180040|FG002|Overall Study|Lost to Follow-up|1
1103462|NCT02389998|2180068|FG000|Overall Study|car accident|1
1103463|NCT02389998|2180069|FG001|Overall Study|car accident|0
1103464|NCT02390076|2180097|FG000|Overall Study|Lost to Follow-up|2
1103465|NCT02390076|2180098|FG001|Overall Study|Lost to Follow-up|1
1103466|NCT02390076|2180099|FG002|Overall Study|Lost to Follow-up|4
1103467|NCT02390167|2180107|FG000|Overall Study|Lost to Follow-up|1
1103468|NCT02390219|2180115|FG000|Overall Study|Death|1
1103469|NCT02390219|2180115|FG000|Overall Study|Physician Decision|1
1103470|NCT02390219|2180115|FG000|Overall Study|Adverse Event|6
1103471|NCT02390219|2180115|FG000|Overall Study|Withdrawal by Subject|1
1103472|NCT02390219|2180115|FG000|Overall Study|Lost to Follow-up|2
1103473|NCT02390219|2180115|FG000|Overall Study|Other|2
1103474|NCT02390557|2180122|FG000|Wave 2|Survey non-respondent|72
1103475|NCT02390557|2180123|FG001|Wave 2|Survey non-respondent|41
1103476|NCT02390557|2180124|FG002|Wave 2|Survey non-respondent|23
1103477|NCT02391038|2180167|FG000|Overall Study|Progressive disease|3
1103478|NCT02391038|2180168|FG001|Overall Study|Progressive disease|3
1103479|NCT02391038|2180169|FG002|Overall Study|Progressive disease|6
1103480|NCT02391116|2180178|FG000|Treatment|Withdrawal by Subject|1
1103481|NCT02391116|2180178|FG000|Treatment|Protocol Violation|1
1103482|NCT02391116|2180178|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9
1103483|NCT02391116|2180178|FG000|Treatment|AE with Clinical PD|3
1103484|NCT02391116|2180178|FG000|Safety Follow-up|Adverse Event|1
1103485|NCT02391116|2180178|FG000|Safety Follow-up|Withdrawal by Subject|4
1103486|NCT02391116|2180178|FG000|Safety Follow-up|Switching to Other Therapy|4
1103487|NCT02391116|2180178|FG000|Safety Follow-up|No Follow Up|1
1103488|NCT02391116|2180178|FG000|Safety Follow-up|Deterioration of General Conditions|3
1103489|NCT02391116|2180178|FG000|Active Follow-up|Withdrawal by Subject|1
1103490|NCT02391116|2180178|FG000|Active Follow-up|Switching to Other Therapy|2
1103491|NCT02391116|2180178|FG000|Survival Follow-up|Withdrawal by Subject|3
1103492|NCT02391116|2180178|FG000|Survival Follow-up|Switching to Other Therapy|1
1103493|NCT02391311|2180191|FG000|Overall Study|Lost to Follow-up|2
1103494|NCT02391311|2180192|FG001|Overall Study|Lost to Follow-up|1
1103495|NCT02391311|2180191|FG000|Overall Study|deemed ineligible after baseline|1
1103496|NCT02391311|2180192|FG001|Overall Study|deemed ineligible after baseline|1
1103497|NCT02391337|2180200|FG000|6 Months Follow-up|Death|5
1103498|NCT02391337|2180201|FG001|6 Months Follow-up|Death|4
1103499|NCT02391337|2180200|FG000|6 Months Follow-up|Withdrawal by Subject|1
1103500|NCT02391337|2180201|FG001|6 Months Follow-up|Withdrawal by Subject|1
1103501|NCT02391337|2180200|FG000|12 Months Follow-up|Death|2
1103502|NCT02391337|2180201|FG001|12 Months Follow-up|Death|0
1103503|NCT02391337|2180200|FG000|12 Months Follow-up|Withdrawal by Subject|0
1103504|NCT02391337|2180201|FG001|12 Months Follow-up|Withdrawal by Subject|1
1103505|NCT02391337|2180200|FG000|12 Months Follow-up|Lost to Follow-up|0
1103506|NCT02391337|2180201|FG001|12 Months Follow-up|Lost to Follow-up|2
1103507|NCT02391363|2180218|FG000|Overall Study|Lost to Follow-up|5
1103508|NCT02391363|2180219|FG001|Overall Study|Lost to Follow-up|5
1103509|NCT02391363|2180218|FG000|Overall Study|Withdrawal by Subject|6
1103510|NCT02391363|2180219|FG001|Overall Study|Withdrawal by Subject|3
1103511|NCT02391545|2180227|FG000|Overall Study|Death|0
1103512|NCT02391545|2180228|FG001|Overall Study|Death|2
1103513|NCT02391545|2180227|FG000|Overall Study|Lost to Follow-up|0
1103514|NCT02391545|2180228|FG001|Overall Study|Lost to Follow-up|1
1162066|NCT03382418|2284043|FG000|Overall Study|Lost to Follow-up|2
1103515|NCT02391545|2180227|FG000|Overall Study|Termination of study by sponsor|20
1103516|NCT02391545|2180228|FG001|Overall Study|Termination of study by sponsor|20
1103517|NCT02391545|2180227|FG000|Overall Study|Withdrawal by Subject|0
1103518|NCT02391545|2180228|FG001|Overall Study|Withdrawal by Subject|1
1103519|NCT02391545|2180227|FG000|Overall Study|Other Reasons|6
1103520|NCT02391545|2180228|FG001|Overall Study|Other Reasons|4
1103521|NCT02391584|2180237|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1
1103522|NCT02391584|2180238|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2
1103523|NCT02391584|2180237|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
1103524|NCT02391584|2180238|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
1103525|NCT02391584|2180237|FG000|3 Month|Lost to Follow-up|1
1103526|NCT02391584|2180238|FG001|3 Month|Lost to Follow-up|0
1103527|NCT02391584|2180237|FG000|6 Month|Withdrawal by Subject|1
1103528|NCT02391584|2180238|FG001|6 Month|Withdrawal by Subject|0
1103529|NCT02391584|2180237|FG000|12 Month (End of Study)|Lost to Follow-up|2
1103530|NCT02391584|2180238|FG001|12 Month (End of Study)|Lost to Follow-up|0
1103531|NCT02391961|2180293|FG000|First Intervention (4 Weeks)|Adverse Event|2
1103532|NCT02391961|2180294|FG001|First Intervention (4 Weeks)|Adverse Event|0
1103533|NCT02391961|2180293|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
1103534|NCT02391961|2180294|FG001|Washout (2 Weeks)|Withdrawal by Subject|1
1103535|NCT02391961|2180293|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1103536|NCT02391961|2180294|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1103537|NCT02392000|2180309|FG000|Overall Study|Greater than mild sleep apnea exclusion|18
1103538|NCT02392000|2180309|FG000|Overall Study|Withdrawal by Subject|1
1103539|NCT02392000|2180309|FG000|Overall Study|Lost to Follow-up|8
1103540|NCT02392104|2180314|FG000|Overall Study|discontinuation of warfarin|3
1103541|NCT02392104|2180314|FG000|Overall Study|bleeding event|1
1103542|NCT02392104|2180314|FG000|Overall Study|transferred care to another doctor|2
1103543|NCT02392104|2180314|FG000|Overall Study|INR goal range changed|1
1103544|NCT02392104|2180314|FG000|Overall Study|admitted to skilled nursing facility|3
1103545|NCT02392104|2180314|FG000|Overall Study|INRs drawn by visiting nurse services|1
1103546|NCT02392195|2180318|FG000|Overall Study|Lost to Follow-up|4
1103547|NCT02392195|2180318|FG000|Overall Study|Withdrawal by Subject|4
1103548|NCT02392234|2180333|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1
1103549|NCT02392234|2180334|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0
1103550|NCT02392234|2180335|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1
1103551|NCT02392234|2180336|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0
1103552|NCT02392234|2180337|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1
1103553|NCT02392234|2180338|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1
1103554|NCT02392234|2180333|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1103555|NCT02392234|2180334|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1103556|NCT02392234|2180335|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1103557|NCT02392234|2180336|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1103558|NCT02392234|2180337|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
1103559|NCT02392234|2180338|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1103560|NCT02392234|2180333|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1103561|NCT02392234|2180334|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1103562|NCT02392234|2180335|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1103563|NCT02392234|2180336|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1103564|NCT02392234|2180337|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1103565|NCT02392234|2180338|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
1103566|NCT02392234|2180333|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1
1103567|NCT02392234|2180334|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0
1103568|NCT02392234|2180335|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0
1103569|NCT02392234|2180336|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1
1103570|NCT02392234|2180337|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0
1103571|NCT02392234|2180338|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0
1103572|NCT02392234|2180333|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0
1103573|NCT02392234|2180334|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0
1103574|NCT02392234|2180335|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0
1103575|NCT02392234|2180336|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0
1103576|NCT02392234|2180337|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0
1103577|NCT02392234|2180338|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1
1103578|NCT02392234|2180333|FG000|Treatment Period 1 (8 Weeks)|Other|1
1103579|NCT02392234|2180334|FG001|Treatment Period 1 (8 Weeks)|Other|0
1103580|NCT02392234|2180335|FG002|Treatment Period 1 (8 Weeks)|Other|0
1103581|NCT02392234|2180336|FG003|Treatment Period 1 (8 Weeks)|Other|0
1103582|NCT02392234|2180337|FG004|Treatment Period 1 (8 Weeks)|Other|0
1103583|NCT02392234|2180338|FG005|Treatment Period 1 (8 Weeks)|Other|0
1103584|NCT02392234|2180333|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1103585|NCT02392234|2180334|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1103586|NCT02392234|2180335|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
1103587|NCT02392234|2180336|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1103588|NCT02392234|2180337|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
1103589|NCT02392234|2180338|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1103590|NCT02392234|2180333|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1
1103591|NCT02392234|2180334|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0
1103592|NCT02392234|2180335|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0
1103593|NCT02392234|2180336|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0
1103594|NCT02392234|2180337|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0
1103595|NCT02392234|2180338|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0
1103596|NCT02392247|2180349|FG000|Overall Study|Withdrawal by Subject|1
1103597|NCT02392247|2180349|FG000|Overall Study|Surgery cancelled; no data|1
1103598|NCT02392403|2180371|FG000|Overall Study|Adverse Event|1
1103599|NCT02392403|2180371|FG000|Overall Study|Death|1
1103600|NCT02392403|2180371|FG000|Overall Study|Withdrawal by Subject|1
1103601|NCT02392481|2180379|FG000|Overall Study|Adverse Event|0
1103602|NCT02392481|2180380|FG001|Overall Study|Adverse Event|0
1103603|NCT02392481|2180381|FG002|Overall Study|Adverse Event|1
1103604|NCT02392481|2180382|FG003|Overall Study|Adverse Event|2
1103605|NCT02392481|2180379|FG000|Overall Study|Withdrawal by Subject|0
1103606|NCT02392481|2180380|FG001|Overall Study|Withdrawal by Subject|0
1103607|NCT02392481|2180381|FG002|Overall Study|Withdrawal by Subject|1
1103608|NCT02392481|2180382|FG003|Overall Study|Withdrawal by Subject|0
1103609|NCT02392507|2180406|FG000|Induction Regimen|Death|3
1103610|NCT02392507|2180406|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1
1103611|NCT02392507|2180406|FG000|Induction Regimen|Physician Decision|1
1103612|NCT02392507|2180406|FG000|Induction Regimen|Withdrawal by Subject|2
1103613|NCT02392507|2180406|FG000|Maintenance Regimen|Death|1
1103614|NCT02392507|2180406|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1
1103615|NCT02392559|2180417|FG000|Overall Study|Withdrawal by Subject|0
1103616|NCT02392559|2180418|FG001|Overall Study|Withdrawal by Subject|1
1103617|NCT02392611|2180434|FG000|Overall Study|Adverse Event|0
1103618|NCT02392611|2180435|FG001|Overall Study|Adverse Event|0
1103619|NCT02392611|2180436|FG002|Overall Study|Adverse Event|0
1103620|NCT02392611|2180437|FG003|Overall Study|Adverse Event|1
1103621|NCT02392611|2180438|FG004|Overall Study|Adverse Event|0
1103622|NCT02392611|2180439|FG005|Overall Study|Adverse Event|0
1103623|NCT02392611|2180440|FG006|Overall Study|Adverse Event|0
1103624|NCT02392611|2180441|FG007|Overall Study|Adverse Event|0
1103625|NCT02392611|2180442|FG008|Overall Study|Adverse Event|0
1103626|NCT02392611|2180434|FG000|Overall Study|Progressive disease|0
1103627|NCT02392611|2180435|FG001|Overall Study|Progressive disease|0
1103628|NCT02392611|2180436|FG002|Overall Study|Progressive disease|0
1103629|NCT02392611|2180437|FG003|Overall Study|Progressive disease|2
1103630|NCT02392611|2180438|FG004|Overall Study|Progressive disease|1
1103631|NCT02392611|2180439|FG005|Overall Study|Progressive disease|0
1103632|NCT02392611|2180440|FG006|Overall Study|Progressive disease|0
1103633|NCT02392611|2180441|FG007|Overall Study|Progressive disease|0
1103634|NCT02392611|2180442|FG008|Overall Study|Progressive disease|0
1103635|NCT02392611|2180434|FG000|Overall Study|Death|1
1103636|NCT02392611|2180435|FG001|Overall Study|Death|0
1103637|NCT02392611|2180436|FG002|Overall Study|Death|0
1103638|NCT02392611|2180437|FG003|Overall Study|Death|0
1103639|NCT02392611|2180438|FG004|Overall Study|Death|0
1103640|NCT02392611|2180439|FG005|Overall Study|Death|1
1103641|NCT02392611|2180440|FG006|Overall Study|Death|0
1103642|NCT02392611|2180441|FG007|Overall Study|Death|0
1103643|NCT02392611|2180442|FG008|Overall Study|Death|0
1103644|NCT02392611|2180434|FG000|Overall Study|Withdrawal by Subject|0
1103645|NCT02392611|2180435|FG001|Overall Study|Withdrawal by Subject|0
1103646|NCT02392611|2180436|FG002|Overall Study|Withdrawal by Subject|0
1103647|NCT02392611|2180437|FG003|Overall Study|Withdrawal by Subject|1
1103648|NCT02392611|2180438|FG004|Overall Study|Withdrawal by Subject|0
1103649|NCT02392611|2180439|FG005|Overall Study|Withdrawal by Subject|0
1103650|NCT02392611|2180440|FG006|Overall Study|Withdrawal by Subject|0
1103651|NCT02392611|2180441|FG007|Overall Study|Withdrawal by Subject|0
1103652|NCT02392611|2180442|FG008|Overall Study|Withdrawal by Subject|0
1103653|NCT02392611|2180434|FG000|Overall Study|Lost to Follow-up|0
1103654|NCT02392611|2180435|FG001|Overall Study|Lost to Follow-up|0
1103655|NCT02392611|2180436|FG002|Overall Study|Lost to Follow-up|0
1103656|NCT02392611|2180437|FG003|Overall Study|Lost to Follow-up|0
1103657|NCT02392611|2180438|FG004|Overall Study|Lost to Follow-up|0
1103658|NCT02392611|2180439|FG005|Overall Study|Lost to Follow-up|0
1103659|NCT02392611|2180440|FG006|Overall Study|Lost to Follow-up|1
1103660|NCT02392611|2180441|FG007|Overall Study|Lost to Follow-up|0
1103661|NCT02392611|2180442|FG008|Overall Study|Lost to Follow-up|0
1103662|NCT02392611|2180434|FG000|Overall Study|Enrolled, not treated|0
1103663|NCT02392611|2180435|FG001|Overall Study|Enrolled, not treated|0
1103664|NCT02392611|2180436|FG002|Overall Study|Enrolled, not treated|0
1103665|NCT02392611|2180437|FG003|Overall Study|Enrolled, not treated|2
1103666|NCT02392611|2180438|FG004|Overall Study|Enrolled, not treated|0
1103667|NCT02392611|2180439|FG005|Overall Study|Enrolled, not treated|0
1103668|NCT02392611|2180440|FG006|Overall Study|Enrolled, not treated|0
1103669|NCT02392611|2180441|FG007|Overall Study|Enrolled, not treated|0
1103670|NCT02392611|2180442|FG008|Overall Study|Enrolled, not treated|0
1103671|NCT02392624|2180465|FG000|Overall Study|Withdrawal by Subject|15
1103672|NCT02392624|2180466|FG001|Overall Study|Withdrawal by Subject|12
1103673|NCT02392624|2180467|FG002|Overall Study|Withdrawal by Subject|9
1103674|NCT02392624|2180465|FG000|Overall Study|Adverse Event|4
1103675|NCT02392624|2180466|FG001|Overall Study|Adverse Event|1
1103676|NCT02392624|2180467|FG002|Overall Study|Adverse Event|2
1103677|NCT02392624|2180465|FG000|Overall Study|Pregnancy|1
1103678|NCT02392624|2180466|FG001|Overall Study|Pregnancy|0
1103679|NCT02392624|2180467|FG002|Overall Study|Pregnancy|0
1103680|NCT02392624|2180465|FG000|Overall Study|Protocol Violation|0
1103681|NCT02392624|2180466|FG001|Overall Study|Protocol Violation|0
1103682|NCT02392624|2180467|FG002|Overall Study|Protocol Violation|1
1103683|NCT02392624|2180465|FG000|Overall Study|Sponsor/Investigator Decision|2
1103684|NCT02392624|2180466|FG001|Overall Study|Sponsor/Investigator Decision|1
1103685|NCT02392624|2180467|FG002|Overall Study|Sponsor/Investigator Decision|0
1103686|NCT02392624|2180465|FG000|Overall Study|Other|49
1103687|NCT02392624|2180466|FG001|Overall Study|Other|1
1103688|NCT02392624|2180467|FG002|Overall Study|Other|1
1103689|NCT02393209|2180497|FG000|Overall Study|Study Terminated by Sponsor|1
1103690|NCT02393209|2180498|FG001|Overall Study|Study Terminated by Sponsor|1
1103691|NCT02393209|2180499|FG002|Overall Study|Study Terminated by Sponsor|0
1103692|NCT02393209|2180500|FG003|Overall Study|Study Terminated by Sponsor|0
1103693|NCT02393209|2180497|FG000|Overall Study|Withdrawal by Patient|1
1103694|NCT02393209|2180498|FG001|Overall Study|Withdrawal by Patient|0
1103695|NCT02393209|2180499|FG002|Overall Study|Withdrawal by Patient|0
1103696|NCT02393209|2180500|FG003|Overall Study|Withdrawal by Patient|0
1103697|NCT02393209|2180497|FG000|Overall Study|Death|2
1103698|NCT02393209|2180498|FG001|Overall Study|Death|2
1103699|NCT02393209|2180499|FG002|Overall Study|Death|0
1103700|NCT02393209|2180500|FG003|Overall Study|Death|0
1103701|NCT02393209|2180497|FG000|Overall Study|Death due to Disease Progression|2
1103702|NCT02393209|2180498|FG001|Overall Study|Death due to Disease Progression|2
1103703|NCT02393209|2180499|FG002|Overall Study|Death due to Disease Progression|0
1103704|NCT02393209|2180500|FG003|Overall Study|Death due to Disease Progression|0
1103705|NCT02393209|2180497|FG000|Overall Study|Death from Legionella Infection|0
1103706|NCT02393209|2180498|FG001|Overall Study|Death from Legionella Infection|1
1103707|NCT02393209|2180499|FG002|Overall Study|Death from Legionella Infection|0
1103708|NCT02393209|2180500|FG003|Overall Study|Death from Legionella Infection|0
1103709|NCT02393209|2180497|FG000|Overall Study|Patient Seen by Another Oncologist|0
1103710|NCT02393209|2180498|FG001|Overall Study|Patient Seen by Another Oncologist|1
1103711|NCT02393209|2180499|FG002|Overall Study|Patient Seen by Another Oncologist|0
1103712|NCT02393209|2180500|FG003|Overall Study|Patient Seen by Another Oncologist|0
1103713|NCT02393209|2180497|FG000|Overall Study|Lost to Follow-up|0
1103714|NCT02393209|2180498|FG001|Overall Study|Lost to Follow-up|1
1103715|NCT02393209|2180499|FG002|Overall Study|Lost to Follow-up|0
1103716|NCT02393209|2180500|FG003|Overall Study|Lost to Follow-up|0
1103717|NCT02393547|2180545|FG000|Overall Study|Adverse Event|2
1103718|NCT02393547|2180545|FG000|Overall Study|Withdrawal by Subject|3
1103719|NCT02393547|2180545|FG000|Overall Study|Lost to Follow-up|1
1103720|NCT02393755|2180569|FG000|Overall Study|Withdrawal by Subject|0
1103721|NCT02393755|2180570|FG001|Overall Study|Withdrawal by Subject|3
1103722|NCT02393755|2180569|FG000|Overall Study|Adverse Event|0
1103723|NCT02393755|2180570|FG001|Overall Study|Adverse Event|2
1103724|NCT02393755|2180569|FG000|Overall Study|Physician Decision|0
1103725|NCT02393755|2180570|FG001|Overall Study|Physician Decision|2
1103726|NCT02393859|2180577|FG000|Overall Study|Decision by Sponsor|1
1103727|NCT02393859|2180578|FG001|Overall Study|Decision by Sponsor|1
1103728|NCT02393859|2180577|FG000|Overall Study|Withdrawal by Subject|5
1103729|NCT02393859|2180578|FG001|Overall Study|Withdrawal by Subject|2
1103730|NCT02393859|2180577|FG000|Overall Study|Death|16
1103731|NCT02393859|2180578|FG001|Overall Study|Death|8
1103732|NCT02393859|2180577|FG000|Overall Study|Continuing Study|32
1103733|NCT02393859|2180578|FG001|Overall Study|Continuing Study|43
1103734|NCT02393950|2180587|FG000|Overall Study|Adverse Event|1
1103735|NCT02393950|2180588|FG001|Overall Study|Adverse Event|0
1103736|NCT02393950|2180587|FG000|Overall Study|Withdrawal by Subject|0
1103737|NCT02393950|2180588|FG001|Overall Study|Withdrawal by Subject|1
1103738|NCT02394275|2180623|FG000|Overall Study|Adverse Event|22
1103739|NCT02394275|2180623|FG000|Overall Study|Lost to Follow-up|7
1103740|NCT02394340|2180628|FG000|Overall Study|Failed drug screen test|1
1103741|NCT02394340|2180628|FG000|Overall Study|Adverse Event|1
1103742|NCT02394561|2180647|FG000|CORE Phase|Adverse Event|7
1103743|NCT02394561|2180648|FG001|CORE Phase|Adverse Event|9
1103744|NCT02394561|2180647|FG000|CORE Phase|Death|0
1103745|NCT02394561|2180648|FG001|CORE Phase|Death|1
1103746|NCT02394561|2180647|FG000|CORE Phase|Pregnancy|1
1103747|NCT02394561|2180648|FG001|CORE Phase|Pregnancy|0
1103748|NCT02394561|2180647|FG000|CORE Phase|Lost to Follow-up|1
1103749|NCT02394561|2180648|FG001|CORE Phase|Lost to Follow-up|0
1103750|NCT02394561|2180647|FG000|CORE Phase|Physician Decision|1
1103751|NCT02394561|2180648|FG001|CORE Phase|Physician Decision|1
1103752|NCT02394561|2180647|FG000|CORE Phase|Withdrawal by Subject|2
1103753|NCT02394561|2180648|FG001|CORE Phase|Withdrawal by Subject|2
1103754|NCT02394561|2180647|FG000|CORE Phase|Lack of Efficacy|1
1103755|NCT02394561|2180648|FG001|CORE Phase|Lack of Efficacy|6
1103756|NCT02394561|2180647|FG000|Extension Phase|Adverse Event|6
1103757|NCT02394561|2180648|FG001|Extension Phase|Adverse Event|1
1103758|NCT02394561|2180647|FG000|Extension Phase|Death|0
1103759|NCT02394561|2180648|FG001|Extension Phase|Death|1
1103760|NCT02394561|2180647|FG000|Extension Phase|Protocol Violation|1
1103761|NCT02394561|2180648|FG001|Extension Phase|Protocol Violation|0
1103762|NCT02394561|2180647|FG000|Extension Phase|Lost to Follow-up|1
1103763|NCT02394561|2180648|FG001|Extension Phase|Lost to Follow-up|0
1103764|NCT02394561|2180647|FG000|Extension Phase|Physician Decision|0
1103765|NCT02394561|2180648|FG001|Extension Phase|Physician Decision|2
1103766|NCT02394561|2180647|FG000|Extension Phase|Withdrawal by Subject|0
1103767|NCT02394561|2180648|FG001|Extension Phase|Withdrawal by Subject|5
1103768|NCT02394561|2180647|FG000|Extension Phase|Lack of Efficacy|3
1103769|NCT02394561|2180648|FG001|Extension Phase|Lack of Efficacy|3
1103770|NCT02394600|2180659|FG000|Overall Study|Adverse Event|3
1103771|NCT02394600|2180660|FG001|Overall Study|Adverse Event|0
1103772|NCT02394600|2180659|FG000|Overall Study|Lost to Follow-up|0
1103773|NCT02394600|2180660|FG001|Overall Study|Lost to Follow-up|1
1103774|NCT02394600|2180659|FG000|Overall Study|Withdrawal by Subject|0
1103775|NCT02394600|2180660|FG001|Overall Study|Withdrawal by Subject|1
1103776|NCT02394600|2180659|FG000|Overall Study|Protocol Violation|1
1103777|NCT02394600|2180660|FG001|Overall Study|Protocol Violation|0
1103778|NCT02394730|2180668|FG000|Overall Study|Lost to Follow-up|1
1103779|NCT02394730|2180669|FG001|Overall Study|Lost to Follow-up|0
1103780|NCT02394730|2180668|FG000|Overall Study|Withdrawal by Subject|0
1103781|NCT02394730|2180669|FG001|Overall Study|Withdrawal by Subject|1
1103782|NCT02394756|2180675|FG000|Period 1|Lens Discomfort|0
1103783|NCT02394756|2180676|FG001|Period 1|Lens Discomfort|0
1103784|NCT02394756|2180677|FG002|Period 1|Lens Discomfort|0
1103785|NCT02394756|2180678|FG003|Period 1|Lens Discomfort|0
1103786|NCT02394756|2180679|FG004|Period 1|Lens Discomfort|0
1103787|NCT02394756|2180680|FG005|Period 1|Lens Discomfort|1
1103788|NCT02394756|2180675|FG000|Period 1|Withdrawal by Subject|0
1103789|NCT02394756|2180676|FG001|Period 1|Withdrawal by Subject|1
1103790|NCT02394756|2180677|FG002|Period 1|Withdrawal by Subject|1
1103791|NCT02394756|2180678|FG003|Period 1|Withdrawal by Subject|1
1103792|NCT02394756|2180679|FG004|Period 1|Withdrawal by Subject|0
1103793|NCT02394756|2180680|FG005|Period 1|Withdrawal by Subject|0
1103794|NCT02394756|2180675|FG000|Period 2|Unsatisfactory Visual Response|0
1103795|NCT02394756|2180676|FG001|Period 2|Unsatisfactory Visual Response|0
1103796|NCT02394756|2180677|FG002|Period 2|Unsatisfactory Visual Response|0
1103797|NCT02394756|2180678|FG003|Period 2|Unsatisfactory Visual Response|0
1103798|NCT02394756|2180679|FG004|Period 2|Unsatisfactory Visual Response|1
1103799|NCT02394756|2180680|FG005|Period 2|Unsatisfactory Visual Response|0
1103800|NCT02394808|2180701|FG000|Period 1|Unsatisfactory lens fitting|0
1103801|NCT02394808|2180702|FG001|Period 1|Unsatisfactory lens fitting|1
1103802|NCT02394808|2180701|FG000|Period 2|Lost to Follow-up|1
1103803|NCT02394808|2180702|FG001|Period 2|Lost to Follow-up|0
1103804|NCT02394925|2180714|FG000|Overall Study|Adverse Event|1
1103805|NCT02394925|2180714|FG000|Overall Study|Lens Discomfort|3
1103806|NCT02394925|2180714|FG000|Overall Study|Lens handling difficulities|5
1103807|NCT02394925|2180714|FG000|Overall Study|Lost to Follow-up|9
1103808|NCT02394925|2180714|FG000|Overall Study|Protocol Violation|5
1103809|NCT02394925|2180714|FG000|Overall Study|No longer meet eligibility criteria|1
1103810|NCT02394925|2180714|FG000|Overall Study|Unsatisfactory Visual Response|5
1103811|NCT02395042|2180730|FG000|Treatment 1 Period|Adverse Event|1
1103812|NCT02395042|2180731|FG001|Treatment 1 Period|Adverse Event|3
1103813|NCT02395042|2180732|FG002|Treatment 1 Period|Adverse Event|1
1103814|NCT02395042|2180730|FG000|Treatment 1 Period|Lack of Efficacy|1
1103815|NCT02395042|2180731|FG001|Treatment 1 Period|Lack of Efficacy|1
1103816|NCT02395042|2180732|FG002|Treatment 1 Period|Lack of Efficacy|0
1103817|NCT02395042|2180730|FG000|Treatment 1 Period|Lost to Follow-up|1
1103818|NCT02395042|2180731|FG001|Treatment 1 Period|Lost to Follow-up|0
1103819|NCT02395042|2180732|FG002|Treatment 1 Period|Lost to Follow-up|0
1103820|NCT02395042|2180730|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0
1103821|NCT02395042|2180731|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2
1103822|NCT02395042|2180732|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1
1103823|NCT02395042|2180730|FG000|Treatment 2 Period|Lack of Efficacy|1
1103824|NCT02395042|2180731|FG001|Treatment 2 Period|Lack of Efficacy|1
1103825|NCT02395042|2180732|FG002|Treatment 2 Period|Lack of Efficacy|0
1103826|NCT02395055|2180745|FG000|Overall Study|Withdrawal by Subject|7
1103827|NCT02395055|2180746|FG001|Overall Study|Withdrawal by Subject|3
1103828|NCT02395081|2180755|FG000|Overall Study|Withdrawal by Subject|1
1103829|NCT02395081|2180756|FG001|Overall Study|Withdrawal by Subject|1
1103830|NCT02395081|2180757|FG002|Overall Study|Withdrawal by Subject|0
1103831|NCT02395081|2180755|FG000|Overall Study|Moved where blood couldn't be collected|4
1103832|NCT02395081|2180756|FG001|Overall Study|Moved where blood couldn't be collected|1
1103833|NCT02395081|2180757|FG002|Overall Study|Moved where blood couldn't be collected|3
1103834|NCT02395081|2180755|FG000|Overall Study|Fetal Loss|2
1103835|NCT02395081|2180756|FG001|Overall Study|Fetal Loss|3
1103836|NCT02395081|2180757|FG002|Overall Study|Fetal Loss|1
1103837|NCT02395133|2180772|FG000|Overall Study|Adverse Event|4
1103838|NCT02395133|2180773|FG001|Overall Study|Adverse Event|1
1103839|NCT02395133|2180774|FG002|Overall Study|Adverse Event|3
1103840|NCT02395133|2180775|FG003|Overall Study|Adverse Event|0
1103841|NCT02395133|2180772|FG000|Overall Study|Lack of Efficacy|1
1103842|NCT02395133|2180773|FG001|Overall Study|Lack of Efficacy|0
1103843|NCT02395133|2180774|FG002|Overall Study|Lack of Efficacy|1
1103844|NCT02395133|2180775|FG003|Overall Study|Lack of Efficacy|1
1103845|NCT02395133|2180772|FG000|Overall Study|Protocol Violation|1
1103846|NCT02395133|2180773|FG001|Overall Study|Protocol Violation|1
1103847|NCT02395133|2180774|FG002|Overall Study|Protocol Violation|0
1103848|NCT02395133|2180775|FG003|Overall Study|Protocol Violation|3
1103849|NCT02395133|2180772|FG000|Overall Study|Lost to Follow-up|0
1103850|NCT02395133|2180773|FG001|Overall Study|Lost to Follow-up|1
1103851|NCT02395133|2180774|FG002|Overall Study|Lost to Follow-up|1
1103852|NCT02395133|2180775|FG003|Overall Study|Lost to Follow-up|0
1103853|NCT02395133|2180772|FG000|Overall Study|Pregnancy|0
1103854|NCT02395133|2180773|FG001|Overall Study|Pregnancy|0
1103855|NCT02395133|2180774|FG002|Overall Study|Pregnancy|3
1103856|NCT02395133|2180775|FG003|Overall Study|Pregnancy|0
1103857|NCT02395133|2180772|FG000|Overall Study|Consent withdrawn with no reason given|1
1103858|NCT02395133|2180773|FG001|Overall Study|Consent withdrawn with no reason given|3
1103859|NCT02395133|2180774|FG002|Overall Study|Consent withdrawn with no reason given|0
1103860|NCT02395133|2180775|FG003|Overall Study|Consent withdrawn with no reason given|2
1103861|NCT02395133|2180772|FG000|Overall Study|Consent withdrawn with personal reason|0
1103862|NCT02395133|2180773|FG001|Overall Study|Consent withdrawn with personal reason|1
1103863|NCT02395133|2180774|FG002|Overall Study|Consent withdrawn with personal reason|0
1103864|NCT02395133|2180775|FG003|Overall Study|Consent withdrawn with personal reason|3
1103865|NCT02395133|2180772|FG000|Overall Study|Sponsor decision|2
895161|NCT00696436|1866335|FG002|Overall Study|Administrative Error|2
895162|NCT00696436|1866336|FG003|Overall Study|Administrative Error|0
895163|NCT00696436|1866337|FG004|Overall Study|Administrative Error|0
1103866|NCT02395133|2180773|FG001|Overall Study|Sponsor decision|0
1103867|NCT02395133|2180774|FG002|Overall Study|Sponsor decision|0
1103868|NCT02395133|2180775|FG003|Overall Study|Sponsor decision|1
1103869|NCT02395133|2180772|FG000|Overall Study|Other than specified above|5
1103870|NCT02395133|2180773|FG001|Overall Study|Other than specified above|2
1103871|NCT02395133|2180774|FG002|Overall Study|Other than specified above|2
1103872|NCT02395133|2180775|FG003|Overall Study|Other than specified above|4
1103873|NCT02395172|2180787|FG000|Overall Study|Participants randomized but not treated|3
1103874|NCT02395172|2180788|FG001|Overall Study|Participants randomized but not treated|31
1103875|NCT02395302|2180802|FG000|Overall Study|Screen Failure|3
1103876|NCT02395302|2180802|FG000|Overall Study|Run In Failure|7
1103877|NCT02395302|2180802|FG000|Overall Study|Withdrawal by Subject|2
1103878|NCT02395302|2180802|FG000|Overall Study|Physician Decision|2
1103879|NCT02395471|2180808|FG000|Overall Study|Lost to Follow-up|2
1103880|NCT02395471|2180809|FG001|Overall Study|Lost to Follow-up|0
1103881|NCT02395471|2180808|FG000|Overall Study|Withdrawal by Subject|2
1103882|NCT02395471|2180809|FG001|Overall Study|Withdrawal by Subject|1
1103883|NCT02395471|2180808|FG000|Overall Study|Physician Decision|1
1103884|NCT02395471|2180809|FG001|Overall Study|Physician Decision|0
1103885|NCT02395471|2180808|FG000|Overall Study|Protocol Violation|0
1103886|NCT02395471|2180809|FG001|Overall Study|Protocol Violation|1
1103887|NCT02395471|2180808|FG000|Overall Study|Failure to swollow sponge twice|1
1103888|NCT02395471|2180809|FG001|Overall Study|Failure to swollow sponge twice|0
1103889|NCT02395471|2180808|FG000|Overall Study|Patient did not return for procedure|0
1103890|NCT02395471|2180809|FG001|Overall Study|Patient did not return for procedure|1
1103891|NCT02395471|2180808|FG000|Overall Study|Subject not eligible|1
1103892|NCT02395471|2180809|FG001|Overall Study|Subject not eligible|0
1103893|NCT02395536|2180826|FG000|Overall Study|Lost to Follow-up|4
1103894|NCT02395536|2180827|FG001|Overall Study|Lost to Follow-up|4
1103895|NCT02395536|2180826|FG000|Overall Study|Death|2
1103896|NCT02395536|2180827|FG001|Overall Study|Death|0
1103897|NCT02395536|2180826|FG000|Overall Study|Physician Decision|4
1103898|NCT02395536|2180827|FG001|Overall Study|Physician Decision|6
1103899|NCT02395536|2180826|FG000|Overall Study|Withdrawal by Subject|9
1103900|NCT02395536|2180827|FG001|Overall Study|Withdrawal by Subject|17
1103901|NCT02395536|2180826|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1
1103902|NCT02395536|2180827|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2
1103903|NCT02395536|2180826|FG000|Overall Study|Insurance issue|0
1103904|NCT02395536|2180827|FG001|Overall Study|Insurance issue|1
1103905|NCT02395627|2180836|FG000|Overall Study|Withdrawal by Subject|0
1103906|NCT02395627|2180837|FG001|Overall Study|Withdrawal by Subject|2
1103907|NCT02395627|2180838|FG002|Overall Study|Withdrawal by Subject|0
1103908|NCT02395627|2180836|FG000|Overall Study|Did not receive pembrolizumab|3
1103909|NCT02395627|2180837|FG001|Overall Study|Did not receive pembrolizumab|1
1103910|NCT02395627|2180838|FG002|Overall Study|Did not receive pembrolizumab|0
1103911|NCT02395653|2180848|FG000|Overall Study|Exclusion Criteria Met at Screening|4
1103912|NCT02395653|2180848|FG000|Overall Study|Consent Withdrawn at Screening|1
1103913|NCT02395653|2180848|FG000|Overall Study|SSEC Application But With 0 Dose|1
1103914|NCT02395653|2180848|FG000|Overall Study|Investigator Decision at Screening|1
1103915|NCT02395653|2180848|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3
1103916|NCT02395653|2180848|FG000|Overall Study|Withdrawal by Subject|1
1103917|NCT02395653|2180848|FG000|Overall Study|Lost to Follow-up|1
1103924|NCT02395822|2180873|FG000|Overall Study|Withdrawal by Subject|1
1103925|NCT02395822|2180873|FG000|Overall Study|Death|1
1103926|NCT02396212|2180930|FG000|Overall Study|Adverse Event|1
1103927|NCT02396212|2180930|FG000|Overall Study|Lack of Efficacy|2
1103928|NCT02396316|2180944|FG000|Overall Study|Physician Decision|1
1103929|NCT02396316|2180945|FG001|Overall Study|Physician Decision|0
1103930|NCT02396316|2180944|FG000|Overall Study|Progressive disease|6
1103931|NCT02396316|2180945|FG001|Overall Study|Progressive disease|3
1103932|NCT02396316|2180944|FG000|Overall Study|Protocol Violation|0
1103933|NCT02396316|2180945|FG001|Overall Study|Protocol Violation|1
1103934|NCT02396316|2180944|FG000|Overall Study|Treatment unblinded|0
1103935|NCT02396316|2180945|FG001|Overall Study|Treatment unblinded|1
1103936|NCT02396381|2180957|FG000|Overall Study|Adverse Event|3
1103937|NCT02396381|2180958|FG001|Overall Study|Adverse Event|2
1103938|NCT02396381|2180957|FG000|Overall Study|Withdrawal by Subject|33
1103939|NCT02396381|2180958|FG001|Overall Study|Withdrawal by Subject|24
1103940|NCT02396381|2180957|FG000|Overall Study|Lost to Follow-up|49
1103941|NCT02396381|2180958|FG001|Overall Study|Lost to Follow-up|31
1103942|NCT02396381|2180957|FG000|Overall Study|Protocol Violation|1
1103943|NCT02396381|2180958|FG001|Overall Study|Protocol Violation|0
1103944|NCT02396381|2180957|FG000|Overall Study|Site terminated by sponsor|7
1103945|NCT02396381|2180958|FG001|Overall Study|Site terminated by sponsor|8
1103946|NCT02396381|2180957|FG000|Overall Study|Physician Decision|5
1103947|NCT02396381|2180958|FG001|Overall Study|Physician Decision|5
1103948|NCT02396381|2180957|FG000|Overall Study|Pregnancy|2
1103949|NCT02396381|2180958|FG001|Overall Study|Pregnancy|0
1103950|NCT02396381|2180957|FG000|Overall Study|Non-compliance with study procedures|1
1103951|NCT02396381|2180958|FG001|Overall Study|Non-compliance with study procedures|0
1103952|NCT02396381|2180957|FG000|Overall Study|Moved out of town/state|1
1103953|NCT02396381|2180958|FG001|Overall Study|Moved out of town/state|3
1103954|NCT02396381|2180957|FG000|Overall Study|Could not complete visit|1
1103955|NCT02396381|2180958|FG001|Overall Study|Could not complete visit|0
1103956|NCT02396381|2180957|FG000|Overall Study|Possible conflict of interest|1
1103957|NCT02396381|2180958|FG001|Overall Study|Possible conflict of interest|0
1103958|NCT02396381|2180957|FG000|Overall Study|Randomization/Screening Error|3
1103959|NCT02396381|2180958|FG001|Overall Study|Randomization/Screening Error|1
1103960|NCT02396420|2180967|FG000|Overall Study|Death|1
1103961|NCT02396537|2180978|FG000|Overall Study|Protocol Violation|0
1103962|NCT02396537|2180979|FG001|Overall Study|Protocol Violation|1
1103963|NCT02396758|2181002|FG000|Overall Study|Withdrawal by Subject|2
1103964|NCT02396758|2181003|FG001|Overall Study|Withdrawal by Subject|0
1103965|NCT02396758|2181004|FG002|Overall Study|Withdrawal by Subject|0
1103966|NCT02396758|2181005|FG003|Overall Study|Withdrawal by Subject|1
1103967|NCT02396758|2181002|FG000|Overall Study|Lost to Follow-up|8
1103968|NCT02396758|2181003|FG001|Overall Study|Lost to Follow-up|5
1103969|NCT02396758|2181004|FG002|Overall Study|Lost to Follow-up|3
1103970|NCT02396758|2181005|FG003|Overall Study|Lost to Follow-up|3
1103971|NCT02396758|2181002|FG000|Overall Study|Death|1
1103972|NCT02396758|2181003|FG001|Overall Study|Death|1
1103973|NCT02396758|2181004|FG002|Overall Study|Death|0
1103974|NCT02396758|2181005|FG003|Overall Study|Death|1
1103975|NCT02396758|2181002|FG000|Overall Study|Randomized but not treated|1
1103976|NCT02396758|2181003|FG001|Overall Study|Randomized but not treated|0
1103977|NCT02396758|2181004|FG002|Overall Study|Randomized but not treated|1
1103978|NCT02396758|2181005|FG003|Overall Study|Randomized but not treated|0
1103979|NCT02396849|2181017|FG000|Overall Study|Lost to Follow-up|1
1103980|NCT02396849|2181018|FG001|Overall Study|Lost to Follow-up|1
1103981|NCT02396849|2181017|FG000|Overall Study|Did not tolerate intervention|1
1103982|NCT02396849|2181018|FG001|Overall Study|Did not tolerate intervention|1
1103983|NCT02396953|2181029|FG000|Overall Study|Withdrawal by Subject|0
1103984|NCT02396953|2181030|FG001|Overall Study|Withdrawal by Subject|0
1103985|NCT02396953|2181031|FG002|Overall Study|Withdrawal by Subject|1
1103986|NCT02396953|2181029|FG000|Overall Study|Insulin like Growth Factor-1 increased|3
1103987|NCT02396953|2181030|FG001|Overall Study|Insulin like Growth Factor-1 increased|2
1103988|NCT02396953|2181031|FG002|Overall Study|Insulin like Growth Factor-1 increased|2
1103989|NCT02396953|2181029|FG000|Overall Study|Personal Reasons|1
1103990|NCT02396953|2181030|FG001|Overall Study|Personal Reasons|1
1103991|NCT02396953|2181031|FG002|Overall Study|Personal Reasons|0
1103992|NCT02397057|2181048|FG000|Overall Study|Withdrawal by Subject|6
1103993|NCT02397057|2181049|FG001|Overall Study|Withdrawal by Subject|7
1103994|NCT02397057|2181048|FG000|Overall Study|Lost to Follow-up|4
1103995|NCT02397057|2181049|FG001|Overall Study|Lost to Follow-up|3
1103996|NCT02397057|2181048|FG000|Overall Study|Death|1
1103997|NCT02397057|2181049|FG001|Overall Study|Death|0
1103998|NCT02397057|2181048|FG000|Overall Study|Adverse Event|0
1103999|NCT02397057|2181049|FG001|Overall Study|Adverse Event|1
1104000|NCT02397057|2181048|FG000|Overall Study|Physician Decision|0
1104001|NCT02397057|2181049|FG001|Overall Study|Physician Decision|1
1104002|NCT02397057|2181048|FG000|Overall Study|Subject did not receive study drug|0
1104003|NCT02397057|2181049|FG001|Overall Study|Subject did not receive study drug|1
1104004|NCT02397096|2181057|FG000|Day 1 to Week 24|Adverse Event|7
1104005|NCT02397096|2181058|FG001|Day 1 to Week 24|Adverse Event|1
1104006|NCT02397096|2181057|FG000|Day 1 to Week 24|Death|1
1104007|NCT02397096|2181058|FG001|Day 1 to Week 24|Death|0
1104008|NCT02397096|2181057|FG000|Day 1 to Week 24|Lack of Efficacy|0
1104009|NCT02397096|2181058|FG001|Day 1 to Week 24|Lack of Efficacy|1
1104010|NCT02397096|2181057|FG000|Day 1 to Week 24|Lost to Follow-up|3
1104011|NCT02397096|2181058|FG001|Day 1 to Week 24|Lost to Follow-up|4
1104012|NCT02397096|2181057|FG000|Day 1 to Week 24|Physician Decision|2
1104013|NCT02397096|2181058|FG001|Day 1 to Week 24|Physician Decision|3
1104014|NCT02397096|2181057|FG000|Day 1 to Week 24|Protocol Violation|1
1104015|NCT02397096|2181058|FG001|Day 1 to Week 24|Protocol Violation|4
1104016|NCT02397096|2181057|FG000|Day 1 to Week 24|Withdrawal by Subject|6
1104017|NCT02397096|2181058|FG001|Day 1 to Week 24|Withdrawal by Subject|1
1104018|NCT02397096|2181057|FG000|Week 24 to Week 48|Adverse Event|6
1104019|NCT02397096|2181058|FG001|Week 24 to Week 48|Adverse Event|2
1104020|NCT02397096|2181057|FG000|Week 24 to Week 48|Lack of Efficacy|5
1104021|NCT02397096|2181058|FG001|Week 24 to Week 48|Lack of Efficacy|1
1104022|NCT02397096|2181057|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0
1104023|NCT02397096|2181058|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1
1104024|NCT02397096|2181057|FG000|Week 24 to Week 48|Physician Decision|2
1104025|NCT02397096|2181058|FG001|Week 24 to Week 48|Physician Decision|1
1104026|NCT02397096|2181057|FG000|Week 24 to Week 48|Withdrawal by Subject|5
1104027|NCT02397096|2181058|FG001|Week 24 to Week 48|Withdrawal by Subject|2
1104028|NCT02397096|2181057|FG000|Week 24 to Week 48|Lost to Follow-up|2
1104029|NCT02397096|2181058|FG001|Week 24 to Week 48|Lost to Follow-up|0
1104030|NCT02397096|2181057|FG000|Study Extensions|Ongoing|399
1104031|NCT02397096|2181058|FG001|Study Extensions|Ongoing|202
1104032|NCT02397278|2181093|FG000|Overall Study|Withdrawal by Subject|0
1104033|NCT02397278|2181094|FG001|Overall Study|Withdrawal by Subject|2
1104034|NCT02397278|2181093|FG000|Overall Study|Deemed ineligible following surgery|1
1104035|NCT02397278|2181094|FG001|Overall Study|Deemed ineligible following surgery|1
1104036|NCT02397408|2181109|FG000|Overall Study|Physician Decision|4
1104037|NCT02397408|2181109|FG000|Overall Study|Surgery not completed within protocol timeframe|2
1104038|NCT02397447|2181115|FG000|Overall Study|Lost to Follow-up|2
1104039|NCT02397447|2181116|FG001|Overall Study|Lost to Follow-up|2
1104040|NCT02397460|2181130|FG000|Treatment Period 2|Adverse Event|0
1104041|NCT02397460|2181131|FG001|Treatment Period 2|Adverse Event|0
1104042|NCT02397460|2181132|FG002|Treatment Period 2|Adverse Event|0
1104043|NCT02397460|2181133|FG003|Treatment Period 2|Adverse Event|0
1104044|NCT02397460|2181134|FG004|Treatment Period 2|Adverse Event|0
1104045|NCT02397460|2181135|FG005|Treatment Period 2|Adverse Event|0
1104046|NCT02397460|2181136|FG006|Treatment Period 2|Adverse Event|0
1104047|NCT02397460|2181137|FG007|Treatment Period 2|Adverse Event|1
1104048|NCT02397460|2181130|FG000|Treatment Period 4|Adverse Event|0
1104049|NCT02397460|2181131|FG001|Treatment Period 4|Adverse Event|1
1104050|NCT02397460|2181132|FG002|Treatment Period 4|Adverse Event|0
1104051|NCT02397460|2181133|FG003|Treatment Period 4|Adverse Event|0
1104052|NCT02397460|2181134|FG004|Treatment Period 4|Adverse Event|0
1104053|NCT02397460|2181135|FG005|Treatment Period 4|Adverse Event|0
1104054|NCT02397460|2181136|FG006|Treatment Period 4|Adverse Event|0
1104055|NCT02397460|2181137|FG007|Treatment Period 4|Adverse Event|0
1104056|NCT02397460|2181130|FG000|Treatment Period 4|Physician Decision|0
1104057|NCT02397460|2181131|FG001|Treatment Period 4|Physician Decision|0
1104058|NCT02397460|2181132|FG002|Treatment Period 4|Physician Decision|0
1104059|NCT02397460|2181133|FG003|Treatment Period 4|Physician Decision|0
1104060|NCT02397460|2181134|FG004|Treatment Period 4|Physician Decision|1
1104061|NCT02397460|2181135|FG005|Treatment Period 4|Physician Decision|0
1104062|NCT02397460|2181136|FG006|Treatment Period 4|Physician Decision|0
1104063|NCT02397460|2181137|FG007|Treatment Period 4|Physician Decision|0
1104064|NCT02397473|2181213|FG000|Treatment Phase|Adverse Event|1
1104065|NCT02397473|2181214|FG001|Treatment Phase|Adverse Event|2
1104066|NCT02397473|2181213|FG000|Treatment Phase|Lack of Efficacy|8
1104067|NCT02397473|2181214|FG001|Treatment Phase|Lack of Efficacy|1
1104068|NCT02397473|2181213|FG000|Treatment Phase|Lost to Follow-up|1
1104069|NCT02397473|2181214|FG001|Treatment Phase|Lost to Follow-up|0
1104070|NCT02397473|2181213|FG000|Treatment Phase|Withdrawal by Subject|2
1104071|NCT02397473|2181214|FG001|Treatment Phase|Withdrawal by Subject|1
1104072|NCT02397473|2181213|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0
1104073|NCT02397473|2181214|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3
1104074|NCT02397473|2181213|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1
1104075|NCT02397473|2181214|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1
1104076|NCT02397473|2181213|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1
1104077|NCT02397473|2181214|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0
1104078|NCT02397473|2181213|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
1104079|NCT02397473|2181214|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
1104080|NCT02397473|2181213|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0
1104081|NCT02397473|2181214|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
1104082|NCT02397655|2181228|FG000|Overall Study|data not completed|1301
1104083|NCT02397694|2181234|FG000|Double-Blinded Phase|Adverse Event|1
1104084|NCT02397694|2181235|FG001|Double-Blinded Phase|Adverse Event|0
1104085|NCT02397694|2181234|FG000|Double-Blinded Phase|Non-compliance with study drug|0
1104086|NCT02397694|2181235|FG001|Double-Blinded Phase|Non-compliance with study drug|2
1104087|NCT02397694|2181234|FG000|Double-Blinded Phase|Withdrawal by Subject|1
1104088|NCT02397694|2181235|FG001|Double-Blinded Phase|Withdrawal by Subject|0
1104089|NCT02397694|2181234|FG000|Double-Blinded Phase|Lost to Follow-up|1
1104090|NCT02397694|2181235|FG001|Double-Blinded Phase|Lost to Follow-up|1
1104091|NCT02397694|2181234|FG000|Open Label Extension Phase|Protocol Violation|1
1104092|NCT02397694|2181235|FG001|Open Label Extension Phase|Protocol Violation|0
1104093|NCT02397694|2181234|FG000|Open Label Extension Phase|Withdrew Consent|3
1104094|NCT02397694|2181235|FG001|Open Label Extension Phase|Withdrew Consent|1
1104095|NCT02397694|2181234|FG000|Open Label Extension Phase|Lost to Follow-up|4
1104096|NCT02397694|2181235|FG001|Open Label Extension Phase|Lost to Follow-up|0
1104097|NCT02397837|2181270|FG000|Overall Study|Withdrawal by Subject|6
1104098|NCT02397837|2181271|FG001|Overall Study|Withdrawal by Subject|5
1104099|NCT02397837|2181270|FG000|Overall Study|Physician Decision|1
1104100|NCT02397837|2181271|FG001|Overall Study|Physician Decision|1
1104101|NCT02397889|2181279|FG000|Overall Study|Physician Decision|1
1104102|NCT02397889|2181280|FG001|Overall Study|Physician Decision|0
1104103|NCT02397915|2181286|FG000|Period 1|Protocol Violation|0
1104104|NCT02397915|2181287|FG001|Period 1|Protocol Violation|1
1104105|NCT02397915|2181288|FG002|Period 1|Protocol Violation|0
1104106|NCT02397915|2181289|FG003|Period 1|Protocol Violation|0
1104107|NCT02397915|2181286|FG000|Period 1|Physician Decision|1
1104108|NCT02397915|2181287|FG001|Period 1|Physician Decision|0
1104109|NCT02397915|2181288|FG002|Period 1|Physician Decision|0
1104110|NCT02397915|2181289|FG003|Period 1|Physician Decision|0
1104111|NCT02398188|2181303|FG000|Overall Study|Adverse Event|2
1104112|NCT02398188|2181304|FG001|Overall Study|Adverse Event|3
1104113|NCT02398188|2181303|FG000|Overall Study|Lost to Follow-up|5
1104114|NCT02398188|2181304|FG001|Overall Study|Lost to Follow-up|0
1104115|NCT02398188|2181303|FG000|Overall Study|Non-compliance|4
1104116|NCT02398188|2181304|FG001|Overall Study|Non-compliance|4
1104117|NCT02398188|2181303|FG000|Overall Study|Protocol Violation|6
1104118|NCT02398188|2181304|FG001|Overall Study|Protocol Violation|10
1104119|NCT02398188|2181303|FG000|Overall Study|Sponsor Decision|2
1104120|NCT02398188|2181304|FG001|Overall Study|Sponsor Decision|1
1104121|NCT02398188|2181303|FG000|Overall Study|Pregnancy|1
1104122|NCT02398188|2181304|FG001|Overall Study|Pregnancy|0
1104123|NCT02398188|2181303|FG000|Overall Study|Withdrawal by Subject|7
1104124|NCT02398188|2181304|FG001|Overall Study|Withdrawal by Subject|16
1104125|NCT02398227|2181312|FG000|Overall Study|Lost to Follow-up|21
1104126|NCT02398227|2181313|FG001|Overall Study|Lost to Follow-up|12
1104127|NCT02398227|2181312|FG000|Overall Study|Withdrawal by Subject|5
1104128|NCT02398227|2181313|FG001|Overall Study|Withdrawal by Subject|6
1104129|NCT02398227|2181312|FG000|Overall Study|Removed from treatment and dropped out|1
1104130|NCT02398227|2181313|FG001|Overall Study|Removed from treatment and dropped out|0
1104131|NCT02399163|2181332|FG000|Overall Study|Adverse Event|2
1104132|NCT02399163|2181332|FG000|Overall Study|Protocol Deviation|2
1104133|NCT02399163|2181332|FG000|Overall Study|Withdrawal by Participant|5
1104134|NCT02399254|2181348|FG000|Overall Study|Physician Decision|2
1104135|NCT02399475|2181359|FG000|Overall Study|Physician Decision|1
1104136|NCT02399475|2181360|FG001|Overall Study|Physician Decision|0
1104137|NCT02400307|2181386|FG000|Overall Study|Enrolled and Never Dosed|1
1104138|NCT02400307|2181387|FG001|Overall Study|Enrolled and Never Dosed|0
1104139|NCT02400333|2181397|FG000|Overall Study|Withdrawal by Subject|0
1104140|NCT02400333|2181398|FG001|Overall Study|Withdrawal by Subject|1
1104141|NCT02400333|2181399|FG002|Overall Study|Withdrawal by Subject|0
1104142|NCT02400333|2181400|FG003|Overall Study|Withdrawal by Subject|1
1104143|NCT02400333|2181397|FG000|Overall Study|Protocol Violation|1
1104144|NCT02400333|2181398|FG001|Overall Study|Protocol Violation|0
1104145|NCT02400333|2181399|FG002|Overall Study|Protocol Violation|2
1104146|NCT02400333|2181400|FG003|Overall Study|Protocol Violation|1
1104147|NCT02400346|2181411|FG000|Overall Study|Adverse Event|24
1104148|NCT02400346|2181411|FG000|Overall Study|Lack of Efficacy|9
1104149|NCT02400346|2181411|FG000|Overall Study|Non-compliance with IMP|1
1104150|NCT02400346|2181411|FG000|Overall Study|Withdrawal by Subject|7
1104151|NCT02400346|2181411|FG000|Overall Study|Administrative or other reason(s)|2
1104152|NCT02400346|2181411|FG000|Overall Study|Lost to Follow-up|1
1104153|NCT02400580|2181427|FG000|Overall Study|Withdrawal by Subject|1
1104154|NCT02400580|2181428|FG001|Overall Study|Withdrawal by Subject|1
1104155|NCT02400580|2181427|FG000|Overall Study|Adverse Event|1
1104156|NCT02400580|2181428|FG001|Overall Study|Adverse Event|0
1104157|NCT02400736|2181445|FG000|Overall Study|Lost to Follow-up|6
1104158|NCT02400736|2181446|FG001|Overall Study|Lost to Follow-up|6
1104159|NCT02400736|2181445|FG000|Overall Study|Withdrawal by Subject|2
1104160|NCT02400736|2181446|FG001|Overall Study|Withdrawal by Subject|1
1104161|NCT02400736|2181445|FG000|Overall Study|Moved from the area|3
1104162|NCT02400736|2181446|FG001|Overall Study|Moved from the area|1
1104163|NCT02400749|2181456|FG000|Week 0 -16|Withdrawal by Subject|5
1104164|NCT02400749|2181457|FG001|Week 0 -16|Withdrawal by Subject|5
1104165|NCT02400749|2181456|FG000|Week 0 -16|Adverse Event|3
1104166|NCT02400749|2181457|FG001|Week 0 -16|Adverse Event|1
1104167|NCT02400749|2181456|FG000|Week 0 -16|Lost to Follow-up|2
1104168|NCT02400749|2181457|FG001|Week 0 -16|Lost to Follow-up|0
1104169|NCT02400749|2181456|FG000|Week 0 -16|Protocol Violation|1
1104170|NCT02400749|2181457|FG001|Week 0 -16|Protocol Violation|0
1104171|NCT02400749|2181456|FG000|Week 17 - 32|Withdrawal by Subject|3
1104172|NCT02400749|2181457|FG001|Week 17 - 32|Withdrawal by Subject|2
1104173|NCT02400749|2181456|FG000|Week 17 - 32|Adverse Event|2
1104174|NCT02400749|2181457|FG001|Week 17 - 32|Adverse Event|1
1104175|NCT02400905|2181463|FG000|Overall Study|Death|24
1104176|NCT02400905|2181463|FG000|Overall Study|Lost to Follow-up|18
1104177|NCT02400905|2181463|FG000|Overall Study|Withdrawal by Subject|16
1104178|NCT02400905|2181463|FG000|Overall Study|Physician Decision|4
1104179|NCT02400905|2181463|FG000|Overall Study|Other|1
1104180|NCT02401230|2181498|FG000|Overall Study|Adverse Event|3
1104181|NCT02401230|2181499|FG001|Overall Study|Adverse Event|2
1104182|NCT02401230|2181500|FG002|Overall Study|Adverse Event|0
1104183|NCT02401230|2181498|FG000|Overall Study|Withdrawal by Subject|2
1104184|NCT02401230|2181499|FG001|Overall Study|Withdrawal by Subject|1
895164|NCT00696436|1866333|FG000|Overall Study|Participant Non-compliance|0
895165|NCT00696436|1866334|FG001|Overall Study|Participant Non-compliance|0
895166|NCT00696436|1866335|FG002|Overall Study|Participant Non-compliance|1
895167|NCT00696436|1866336|FG003|Overall Study|Participant Non-compliance|2
895168|NCT00696436|1866337|FG004|Overall Study|Participant Non-compliance|0
895169|NCT00696436|1866333|FG000|Overall Study|Administrative Decision|1
895170|NCT00696436|1866334|FG001|Overall Study|Administrative Decision|0
895171|NCT00696436|1866335|FG002|Overall Study|Administrative Decision|0
1104185|NCT02401230|2181500|FG002|Overall Study|Withdrawal by Subject|1
1104186|NCT02401230|2181498|FG000|Overall Study|Lost to Follow-up|1
1104187|NCT02401230|2181499|FG001|Overall Study|Lost to Follow-up|3
1104188|NCT02401230|2181500|FG002|Overall Study|Lost to Follow-up|3
1104189|NCT02401256|2181512|FG000|Overall Study|Adverse Event|5
1104190|NCT02401256|2181512|FG000|Overall Study|Withdrawal by Subject|12
1104191|NCT02401412|2181520|FG000|Overall Study|Lost to Follow-up|1
1104192|NCT02401412|2181521|FG001|Overall Study|Lost to Follow-up|0
1104193|NCT02401412|2181520|FG000|Overall Study|Discontinued Intervention|15
1104194|NCT02401412|2181521|FG001|Overall Study|Discontinued Intervention|21
1104195|NCT02401412|2181520|FG000|Overall Study|Withdrawal by Subject|4
1104196|NCT02401412|2181521|FG001|Overall Study|Withdrawal by Subject|4
1104197|NCT02401412|2181520|FG000|Overall Study|Subject withdrawal prior to intervention|0
1104198|NCT02401412|2181521|FG001|Overall Study|Subject withdrawal prior to intervention|1
1104199|NCT02401412|2181520|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10
1104200|NCT02401412|2181521|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6
1104201|NCT02401529|2181548|FG000|Overall Study|Lost to Follow-up|2
1104202|NCT02401529|2181549|FG001|Overall Study|Lost to Follow-up|1
1104203|NCT02401529|2181548|FG000|Overall Study|Physician Decision|2
1104204|NCT02401529|2181549|FG001|Overall Study|Physician Decision|6
1104205|NCT02401529|2181548|FG000|Overall Study|Protocol Violation|5
1104206|NCT02401529|2181549|FG001|Overall Study|Protocol Violation|0
1104207|NCT02401672|2181586|FG000|Overall Study|Withdrawal by Subject|1
1104208|NCT02401672|2181587|FG001|Overall Study|Withdrawal by Subject|3
1104209|NCT02401867|2181593|FG000|Specimen Collection|Didn't receive 1 or more tests|10
1104210|NCT02401867|2181593|FG000|Analysis|Cervical assay could not be conducted|9
1104211|NCT02402166|2181628|FG000|Overall Study|Adverse Event|2
1104212|NCT02402166|2181628|FG000|Overall Study|Withdrawal by Subject|2
1104213|NCT02402166|2181628|FG000|Overall Study|Lost to Follow-up|1
1104214|NCT02402218|2181649|FG000|Overall Study|Did not pickup study medication|12
1104215|NCT02402218|2181650|FG001|Overall Study|Did not pickup study medication|9
1104216|NCT02402218|2181651|FG002|Overall Study|Did not pickup study medication|13
1104217|NCT02402218|2181649|FG000|Overall Study|Lack of Efficacy|0
1104218|NCT02402218|2181650|FG001|Overall Study|Lack of Efficacy|1
1104219|NCT02402218|2181651|FG002|Overall Study|Lack of Efficacy|1
1104220|NCT02402218|2181649|FG000|Overall Study|Death|1
1104221|NCT02402218|2181650|FG001|Overall Study|Death|0
1104222|NCT02402218|2181651|FG002|Overall Study|Death|0
1104223|NCT02402218|2181649|FG000|Overall Study|Reinfection|0
1104224|NCT02402218|2181650|FG001|Overall Study|Reinfection|0
1104225|NCT02402218|2181651|FG002|Overall Study|Reinfection|1
1104226|NCT02402218|2181649|FG000|Overall Study|Adverse Event|0
1104227|NCT02402218|2181650|FG001|Overall Study|Adverse Event|2
1104228|NCT02402218|2181651|FG002|Overall Study|Adverse Event|1
1104229|NCT02402218|2181649|FG000|Overall Study|Withdrawal by Subject|1
1104230|NCT02402218|2181650|FG001|Overall Study|Withdrawal by Subject|1
1104231|NCT02402218|2181651|FG002|Overall Study|Withdrawal by Subject|1
1104232|NCT02402322|2181671|FG000|Pretreatment|Withdrawal by Subject|3
1104233|NCT02402322|2181672|FG001|Pretreatment|Withdrawal by Subject|1
1104234|NCT02402322|2181673|FG002|Pretreatment|Withdrawal by Subject|1
1104235|NCT02402322|2181671|FG000|Follow-up|Withdrawal by Subject|6
1104236|NCT02402322|2181672|FG001|Follow-up|Withdrawal by Subject|3
1104237|NCT02402322|2181673|FG002|Follow-up|Withdrawal by Subject|24
1104238|NCT02402907|2181705|FG000|Overall Study|Delivered vaginally|9
1104239|NCT02402907|2181706|FG001|Overall Study|Delivered vaginally|3
1104240|NCT02402907|2181705|FG000|Overall Study|Delivered outside of Sinai|1
1104241|NCT02402907|2181706|FG001|Overall Study|Delivered outside of Sinai|1
1104242|NCT02402907|2181705|FG000|Overall Study|Lost to follow up after C-Section|10
1104243|NCT02402907|2181706|FG001|Overall Study|Lost to follow up after C-Section|23
1104244|NCT02402933|2181712|FG000|Overall Study|Withdrawal by Subject|4
1104245|NCT02402933|2181712|FG000|Overall Study|Discontinued; Site Termination|10
1104246|NCT02403180|2181718|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
1104247|NCT02403180|2181719|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
1104248|NCT02403180|2181718|FG000|Period 2 (5 Days)|Withdrawal by Subject|0
1104249|NCT02403180|2181719|FG001|Period 2 (5 Days)|Withdrawal by Subject|1
1104250|NCT02403206|2181727|FG000|Overall Study|Lost to Follow-up|4
1104251|NCT02403206|2181728|FG001|Overall Study|Lost to Follow-up|3
1104252|NCT02403206|2181727|FG000|Overall Study|Physician Decision|2
1104253|NCT02403206|2181728|FG001|Overall Study|Physician Decision|0
1104254|NCT02403206|2181727|FG000|Overall Study|Withdrawal by Subject|3
1104255|NCT02403206|2181728|FG001|Overall Study|Withdrawal by Subject|3
1104256|NCT02403206|2181727|FG000|Overall Study|Reason not given|2
1104257|NCT02403206|2181728|FG001|Overall Study|Reason not given|4
1104258|NCT02403271|2181735|FG000|Period 1|Other varied reasons|1
1104259|NCT02403271|2181736|FG001|Period 1|Other varied reasons|0
1104260|NCT02403271|2181735|FG000|Period 2|Withdrawal by Subject|0
1104261|NCT02403271|2181736|FG001|Period 2|Withdrawal by Subject|14
1104262|NCT02403271|2181735|FG000|Period 2|Death|0
1104263|NCT02403271|2181736|FG001|Period 2|Death|84
1104264|NCT02403271|2181735|FG000|Period 2|Lost to Follow-up|0
1104265|NCT02403271|2181736|FG001|Period 2|Lost to Follow-up|2
1104266|NCT02403271|2181735|FG000|Period 2|Study Terminated by Sponsor|0
1104267|NCT02403271|2181736|FG001|Period 2|Study Terminated by Sponsor|14
1104268|NCT02403271|2181735|FG000|Period 2|Other varied reasons|0
1104269|NCT02403271|2181736|FG001|Period 2|Other varied reasons|10
1104270|NCT02403635|2181757|FG000|Overall Study|Not eligible|9
1104271|NCT02403674|2181779|FG000|Overall Study|Adverse Event|10
1104272|NCT02403674|2181780|FG001|Overall Study|Adverse Event|23
1104273|NCT02403674|2181779|FG000|Overall Study|Death|1
1104274|NCT02403674|2181780|FG001|Overall Study|Death|3
1104275|NCT02403674|2181779|FG000|Overall Study|Lack of Efficacy|18
1104276|NCT02403674|2181780|FG001|Overall Study|Lack of Efficacy|10
1104277|NCT02403674|2181779|FG000|Overall Study|Lost to Follow-up|6
1104278|NCT02403674|2181780|FG001|Overall Study|Lost to Follow-up|7
1104279|NCT02403674|2181779|FG000|Overall Study|Noncompliance with study drug|1
1104280|NCT02403674|2181780|FG001|Overall Study|Noncompliance with study drug|2
1104281|NCT02403674|2181779|FG000|Overall Study|Withdrawal by Subject|8
1104282|NCT02403674|2181780|FG001|Overall Study|Withdrawal by Subject|11
1104283|NCT02403674|2181779|FG000|Overall Study|Physician Decision|2
1104284|NCT02403674|2181780|FG001|Overall Study|Physician Decision|2
1104285|NCT02403674|2181779|FG000|Overall Study|Not treated with study drug|4
1104286|NCT02403674|2181780|FG001|Overall Study|Not treated with study drug|2
1104287|NCT02403674|2181779|FG000|Overall Study|Pregnancy|1
1104288|NCT02403674|2181780|FG001|Overall Study|Pregnancy|1
1104289|NCT02403674|2181779|FG000|Overall Study|Protocol Violation|4
1104290|NCT02403674|2181780|FG001|Overall Study|Protocol Violation|2
1104291|NCT02403817|2181797|FG000|Overall Study|Withdrawal by Subject|5
1104292|NCT02403817|2181798|FG001|Overall Study|Withdrawal by Subject|0
1104293|NCT02404025|2181837|FG000|Overall Study|Adverse Event|1
1104294|NCT02404025|2181837|FG000|Overall Study|Lack of Efficacy|3
1104295|NCT02404103|2181843|FG000|Overall Study|Adverse Event|1
1104296|NCT02404103|2181844|FG001|Overall Study|Adverse Event|0
1104297|NCT02404103|2181843|FG000|Overall Study|Lost to Follow-up|3
1104298|NCT02404103|2181844|FG001|Overall Study|Lost to Follow-up|3
1104299|NCT02404220|2181870|FG000|Overall Study|Adverse Event|0
1104300|NCT02404220|2181871|FG001|Overall Study|Adverse Event|0
1104301|NCT02404220|2181872|FG002|Overall Study|Adverse Event|1
1104302|NCT02404220|2181873|FG003|Overall Study|Adverse Event|0
1104303|NCT02404220|2181870|FG000|Overall Study|Death|5
1104304|NCT02404220|2181871|FG001|Overall Study|Death|5
1104305|NCT02404220|2181872|FG002|Overall Study|Death|3
1104306|NCT02404220|2181873|FG003|Overall Study|Death|8
1104307|NCT02404220|2181870|FG000|Overall Study|Progressive Disease|0
1104308|NCT02404220|2181871|FG001|Overall Study|Progressive Disease|0
1104309|NCT02404220|2181872|FG002|Overall Study|Progressive Disease|1
1104310|NCT02404220|2181873|FG003|Overall Study|Progressive Disease|1
1104311|NCT02404220|2181870|FG000|Overall Study|Study Terminated by Sponsor|0
1104312|NCT02404220|2181871|FG001|Overall Study|Study Terminated by Sponsor|0
1104313|NCT02404220|2181872|FG002|Overall Study|Study Terminated by Sponsor|2
1104314|NCT02404220|2181873|FG003|Overall Study|Study Terminated by Sponsor|1
1104315|NCT02404220|2181870|FG000|Overall Study|Withdrawal by Subject|0
1104316|NCT02404220|2181871|FG001|Overall Study|Withdrawal by Subject|1
1104317|NCT02404220|2181872|FG002|Overall Study|Withdrawal by Subject|0
1104318|NCT02404220|2181873|FG003|Overall Study|Withdrawal by Subject|0
1104319|NCT02404220|2181870|FG000|Overall Study|Enrolled but Never Treated|0
1104320|NCT02404220|2181871|FG001|Overall Study|Enrolled but Never Treated|2
1104321|NCT02404220|2181872|FG002|Overall Study|Enrolled but Never Treated|0
1104322|NCT02404220|2181873|FG003|Overall Study|Enrolled but Never Treated|0
1104323|NCT02404311|2181903|FG000|Part A: Month 0-18|Death|2
1104324|NCT02404311|2181904|FG001|Part A: Month 0-18|Death|0
1104325|NCT02404311|2181905|FG002|Part A: Month 0-18|Death|0
1104326|NCT02404311|2181906|FG003|Part A: Month 0-18|Death|0
1104327|NCT02404311|2181907|FG004|Part A: Month 0-18|Death|0
1104328|NCT02404311|2181903|FG000|Part A: Month 0-18|Physician Decision|1
1104329|NCT02404311|2181904|FG001|Part A: Month 0-18|Physician Decision|0
1104330|NCT02404311|2181905|FG002|Part A: Month 0-18|Physician Decision|0
1104331|NCT02404311|2181906|FG003|Part A: Month 0-18|Physician Decision|0
1104332|NCT02404311|2181907|FG004|Part A: Month 0-18|Physician Decision|0
1104333|NCT02404311|2181903|FG000|Part A: Month 0-18|Lost to Follow-up|4
1104334|NCT02404311|2181904|FG001|Part A: Month 0-18|Lost to Follow-up|2
1104335|NCT02404311|2181905|FG002|Part A: Month 0-18|Lost to Follow-up|0
1104336|NCT02404311|2181906|FG003|Part A: Month 0-18|Lost to Follow-up|0
1104337|NCT02404311|2181907|FG004|Part A: Month 0-18|Lost to Follow-up|0
1104338|NCT02404311|2181903|FG000|Part A: Month 0-18|Withdrawal by Subject|6
1104339|NCT02404311|2181904|FG001|Part A: Month 0-18|Withdrawal by Subject|2
1104340|NCT02404311|2181905|FG002|Part A: Month 0-18|Withdrawal by Subject|0
1104341|NCT02404311|2181906|FG003|Part A: Month 0-18|Withdrawal by Subject|0
1104342|NCT02404311|2181907|FG004|Part A: Month 0-18|Withdrawal by Subject|0
1104343|NCT02404311|2181903|FG000|Part A: Month 0-18|HIV Infection|6
1104344|NCT02404311|2181904|FG001|Part A: Month 0-18|HIV Infection|2
1104345|NCT02404311|2181905|FG002|Part A: Month 0-18|HIV Infection|0
1104346|NCT02404311|2181906|FG003|Part A: Month 0-18|HIV Infection|0
1104347|NCT02404311|2181907|FG004|Part A: Month 0-18|HIV Infection|0
1104348|NCT02404311|2181903|FG000|Part A: Month 0-18|Participant unable to adhere|7
1104349|NCT02404311|2181904|FG001|Part A: Month 0-18|Participant unable to adhere|0
1104350|NCT02404311|2181905|FG002|Part A: Month 0-18|Participant unable to adhere|0
1104351|NCT02404311|2181906|FG003|Part A: Month 0-18|Participant unable to adhere|0
1104352|NCT02404311|2181907|FG004|Part A: Month 0-18|Participant unable to adhere|0
1104353|NCT02404350|2181923|FG000|Overall Study|Adverse Event|2
1104354|NCT02404350|2181924|FG001|Overall Study|Adverse Event|2
1104355|NCT02404350|2181925|FG002|Overall Study|Adverse Event|3
1104356|NCT02404350|2181926|FG003|Overall Study|Adverse Event|9
1104357|NCT02404350|2181923|FG000|Overall Study|Lack of Efficacy|3
1104358|NCT02404350|2181924|FG001|Overall Study|Lack of Efficacy|1
1104359|NCT02404350|2181925|FG002|Overall Study|Lack of Efficacy|0
1104360|NCT02404350|2181926|FG003|Overall Study|Lack of Efficacy|3
1104361|NCT02404350|2181923|FG000|Overall Study|Lost to Follow-up|2
1104362|NCT02404350|2181924|FG001|Overall Study|Lost to Follow-up|0
1104363|NCT02404350|2181925|FG002|Overall Study|Lost to Follow-up|0
1104364|NCT02404350|2181926|FG003|Overall Study|Lost to Follow-up|1
1104365|NCT02404350|2181923|FG000|Overall Study|Physician Decision|1
1104366|NCT02404350|2181924|FG001|Overall Study|Physician Decision|0
1104367|NCT02404350|2181925|FG002|Overall Study|Physician Decision|0
1104368|NCT02404350|2181926|FG003|Overall Study|Physician Decision|2
1104369|NCT02404350|2181923|FG000|Overall Study|Pregnancy|0
1104370|NCT02404350|2181924|FG001|Overall Study|Pregnancy|0
1104371|NCT02404350|2181925|FG002|Overall Study|Pregnancy|0
1104372|NCT02404350|2181926|FG003|Overall Study|Pregnancy|1
1104373|NCT02404350|2181923|FG000|Overall Study|Withdrawal by Subject|7
1104374|NCT02404350|2181924|FG001|Overall Study|Withdrawal by Subject|3
1104375|NCT02404350|2181925|FG002|Overall Study|Withdrawal by Subject|3
1104376|NCT02404350|2181926|FG003|Overall Study|Withdrawal by Subject|19
1104377|NCT02404350|2181923|FG000|Overall Study|Due to Non-compliance with treatment|0
1104378|NCT02404350|2181924|FG001|Overall Study|Due to Non-compliance with treatment|0
1104379|NCT02404350|2181925|FG002|Overall Study|Due to Non-compliance with treatment|0
1104380|NCT02404350|2181926|FG003|Overall Study|Due to Non-compliance with treatment|1
1104381|NCT02404350|2181923|FG000|Overall Study|Due to Technical problems|0
1104382|NCT02404350|2181924|FG001|Overall Study|Due to Technical problems|0
1104383|NCT02404350|2181925|FG002|Overall Study|Due to Technical problems|0
1104384|NCT02404350|2181926|FG003|Overall Study|Due to Technical problems|1
1104385|NCT02404389|2181942|FG000|Overall Study|Adverse Event|1
1104386|NCT02404389|2181943|FG001|Overall Study|Adverse Event|0
1104387|NCT02404389|2181944|FG002|Overall Study|Adverse Event|1
1104388|NCT02404389|2181945|FG003|Overall Study|Adverse Event|0
1104389|NCT02404389|2181946|FG004|Overall Study|Adverse Event|2
1104390|NCT02404389|2181942|FG000|Overall Study|Subject/guardian decision|1
1104391|NCT02404389|2181943|FG001|Overall Study|Subject/guardian decision|0
1104392|NCT02404389|2181944|FG002|Overall Study|Subject/guardian decision|0
1104393|NCT02404389|2181945|FG003|Overall Study|Subject/guardian decision|1
1104394|NCT02404389|2181946|FG004|Overall Study|Subject/guardian decision|1
1104395|NCT02404441|2181970|FG000|Phase 1 Part|Adverse Event|1
1104396|NCT02404441|2181971|FG001|Phase 1 Part|Adverse Event|0
1104397|NCT02404441|2181972|FG002|Phase 1 Part|Adverse Event|0
1104398|NCT02404441|2181973|FG003|Phase 1 Part|Adverse Event|0
1104399|NCT02404441|2181974|FG004|Phase 1 Part|Adverse Event|0
1104400|NCT02404441|2181975|FG005|Phase 1 Part|Adverse Event|0
1104401|NCT02404441|2181976|FG006|Phase 1 Part|Adverse Event|0
1104402|NCT02404441|2181977|FG007|Phase 1 Part|Adverse Event|0
1104403|NCT02404441|2181978|FG008|Phase 1 Part|Adverse Event|0
1104404|NCT02404441|2181979|FG009|Phase 1 Part|Adverse Event|0
1104405|NCT02404441|2181970|FG000|Phase 1 Part|Physician Decision|0
1104406|NCT02404441|2181971|FG001|Phase 1 Part|Physician Decision|1
1104407|NCT02404441|2181972|FG002|Phase 1 Part|Physician Decision|0
1104408|NCT02404441|2181973|FG003|Phase 1 Part|Physician Decision|0
1104409|NCT02404441|2181974|FG004|Phase 1 Part|Physician Decision|0
1104410|NCT02404441|2181975|FG005|Phase 1 Part|Physician Decision|0
1104411|NCT02404441|2181976|FG006|Phase 1 Part|Physician Decision|0
1104412|NCT02404441|2181977|FG007|Phase 1 Part|Physician Decision|0
1104413|NCT02404441|2181978|FG008|Phase 1 Part|Physician Decision|0
1104414|NCT02404441|2181979|FG009|Phase 1 Part|Physician Decision|0
1104415|NCT02404441|2181970|FG000|Phase 1 Part|Progressive Disease|14
1104416|NCT02404441|2181971|FG001|Phase 1 Part|Progressive Disease|11
1104417|NCT02404441|2181972|FG002|Phase 1 Part|Progressive Disease|7
1104418|NCT02404441|2181973|FG003|Phase 1 Part|Progressive Disease|6
1104419|NCT02404441|2181974|FG004|Phase 1 Part|Progressive Disease|9
1104420|NCT02404441|2181975|FG005|Phase 1 Part|Progressive Disease|0
1104421|NCT02404441|2181976|FG006|Phase 1 Part|Progressive Disease|0
1104422|NCT02404441|2181977|FG007|Phase 1 Part|Progressive Disease|0
1104423|NCT02404441|2181978|FG008|Phase 1 Part|Progressive Disease|0
1104424|NCT02404441|2181979|FG009|Phase 1 Part|Progressive Disease|0
1104425|NCT02404441|2181970|FG000|Phase 1 Part|Subject/Guardian Decision|0
1104426|NCT02404441|2181971|FG001|Phase 1 Part|Subject/Guardian Decision|2
1104427|NCT02404441|2181972|FG002|Phase 1 Part|Subject/Guardian Decision|3
1104428|NCT02404441|2181973|FG003|Phase 1 Part|Subject/Guardian Decision|0
1104429|NCT02404441|2181974|FG004|Phase 1 Part|Subject/Guardian Decision|0
1104430|NCT02404441|2181975|FG005|Phase 1 Part|Subject/Guardian Decision|0
1104431|NCT02404441|2181976|FG006|Phase 1 Part|Subject/Guardian Decision|0
1104432|NCT02404441|2181977|FG007|Phase 1 Part|Subject/Guardian Decision|0
1104433|NCT02404441|2181978|FG008|Phase 1 Part|Subject/Guardian Decision|0
1104434|NCT02404441|2181979|FG009|Phase 1 Part|Subject/Guardian Decision|0
1104435|NCT02404441|2181970|FG000|Phase 1 Part|Death|1
1104436|NCT02404441|2181971|FG001|Phase 1 Part|Death|1
1104437|NCT02404441|2181972|FG002|Phase 1 Part|Death|1
1104438|NCT02404441|2181973|FG003|Phase 1 Part|Death|0
1104439|NCT02404441|2181974|FG004|Phase 1 Part|Death|1
1104440|NCT02404441|2181975|FG005|Phase 1 Part|Death|0
1104441|NCT02404441|2181976|FG006|Phase 1 Part|Death|0
1104442|NCT02404441|2181977|FG007|Phase 1 Part|Death|0
1104443|NCT02404441|2181978|FG008|Phase 1 Part|Death|0
1104444|NCT02404441|2181979|FG009|Phase 1 Part|Death|0
1104445|NCT02404441|2181970|FG000|Phase 2 Part|Adverse Event|0
1104446|NCT02404441|2181971|FG001|Phase 2 Part|Adverse Event|0
1104447|NCT02404441|2181972|FG002|Phase 2 Part|Adverse Event|0
1104448|NCT02404441|2181973|FG003|Phase 2 Part|Adverse Event|0
1104449|NCT02404441|2181974|FG004|Phase 2 Part|Adverse Event|0
1104450|NCT02404441|2181975|FG005|Phase 2 Part|Adverse Event|2
1104451|NCT02404441|2181976|FG006|Phase 2 Part|Adverse Event|3
1104452|NCT02404441|2181977|FG007|Phase 2 Part|Adverse Event|3
1104453|NCT02404441|2181978|FG008|Phase 2 Part|Adverse Event|6
1104454|NCT02404441|2181979|FG009|Phase 2 Part|Adverse Event|1
1104455|NCT02404441|2181970|FG000|Phase 2 Part|Physician Decision|0
1104456|NCT02404441|2181971|FG001|Phase 2 Part|Physician Decision|0
1104457|NCT02404441|2181972|FG002|Phase 2 Part|Physician Decision|0
1104458|NCT02404441|2181973|FG003|Phase 2 Part|Physician Decision|0
1104459|NCT02404441|2181974|FG004|Phase 2 Part|Physician Decision|0
1104460|NCT02404441|2181975|FG005|Phase 2 Part|Physician Decision|7
1104461|NCT02404441|2181976|FG006|Phase 2 Part|Physician Decision|9
1104462|NCT02404441|2181977|FG007|Phase 2 Part|Physician Decision|2
1104463|NCT02404441|2181978|FG008|Phase 2 Part|Physician Decision|1
1104464|NCT02404441|2181979|FG009|Phase 2 Part|Physician Decision|3
1104465|NCT02404441|2181970|FG000|Phase 2 Part|Progressive disease|0
1104466|NCT02404441|2181971|FG001|Phase 2 Part|Progressive disease|0
1104467|NCT02404441|2181972|FG002|Phase 2 Part|Progressive disease|0
1104468|NCT02404441|2181973|FG003|Phase 2 Part|Progressive disease|0
1104469|NCT02404441|2181974|FG004|Phase 2 Part|Progressive disease|0
1104470|NCT02404441|2181975|FG005|Phase 2 Part|Progressive disease|43
1104471|NCT02404441|2181976|FG006|Phase 2 Part|Progressive disease|32
1104472|NCT02404441|2181977|FG007|Phase 2 Part|Progressive disease|31
1104473|NCT02404441|2181978|FG008|Phase 2 Part|Progressive disease|39
1104474|NCT02404441|2181979|FG009|Phase 2 Part|Progressive disease|27
1104475|NCT02404441|2181970|FG000|Phase 2 Part|Subject/guardian decision|0
1104476|NCT02404441|2181971|FG001|Phase 2 Part|Subject/guardian decision|0
1104477|NCT02404441|2181972|FG002|Phase 2 Part|Subject/guardian decision|0
1104478|NCT02404441|2181973|FG003|Phase 2 Part|Subject/guardian decision|0
1104479|NCT02404441|2181974|FG004|Phase 2 Part|Subject/guardian decision|0
1104480|NCT02404441|2181975|FG005|Phase 2 Part|Subject/guardian decision|3
1104481|NCT02404441|2181976|FG006|Phase 2 Part|Subject/guardian decision|9
1104482|NCT02404441|2181977|FG007|Phase 2 Part|Subject/guardian decision|0
1104483|NCT02404441|2181978|FG008|Phase 2 Part|Subject/guardian decision|3
1104484|NCT02404441|2181979|FG009|Phase 2 Part|Subject/guardian decision|2
895172|NCT00696436|1866336|FG003|Overall Study|Administrative Decision|0
895173|NCT00696436|1866337|FG004|Overall Study|Administrative Decision|0
895174|NCT00696436|1866333|FG000|Overall Study|Missing|0
895175|NCT00696436|1866334|FG001|Overall Study|Missing|1
895176|NCT00696436|1866335|FG002|Overall Study|Missing|1
895177|NCT00696436|1866336|FG003|Overall Study|Missing|0
895178|NCT00696436|1866337|FG004|Overall Study|Missing|0
1104485|NCT02404441|2181970|FG000|Phase 2 Part|Death|0
1104486|NCT02404441|2181971|FG001|Phase 2 Part|Death|0
1104487|NCT02404441|2181972|FG002|Phase 2 Part|Death|0
1104488|NCT02404441|2181973|FG003|Phase 2 Part|Death|0
1104489|NCT02404441|2181974|FG004|Phase 2 Part|Death|0
1104490|NCT02404441|2181975|FG005|Phase 2 Part|Death|4
1104491|NCT02404441|2181976|FG006|Phase 2 Part|Death|8
1104492|NCT02404441|2181977|FG007|Phase 2 Part|Death|4
1104493|NCT02404441|2181978|FG008|Phase 2 Part|Death|10
1104494|NCT02404441|2181979|FG009|Phase 2 Part|Death|9
1104495|NCT02404493|2182025|FG000|Overall Study|Adverse Event|1
1104496|NCT02404493|2182026|FG001|Overall Study|Adverse Event|1
1104497|NCT02404649|2182052|FG000|Overall Study|Adverse Event|1
1104498|NCT02404649|2182053|FG001|Overall Study|Adverse Event|2
1104499|NCT02404805|2182076|FG000|Overall Study|Withdrawal by Subject|1
1104500|NCT02404805|2182077|FG001|Overall Study|Withdrawal by Subject|0
1104501|NCT02404805|2182078|FG002|Overall Study|Withdrawal by Subject|0
1104502|NCT02404805|2182079|FG003|Overall Study|Withdrawal by Subject|0
895179|NCT00696657|1866392|FG000|Overall Study|Protocol Violation|0
895180|NCT00696657|1866393|FG001|Overall Study|Protocol Violation|0
895181|NCT00696657|1866394|FG002|Overall Study|Protocol Violation|0
895182|NCT00696657|1866395|FG003|Overall Study|Protocol Violation|0
895183|NCT00696657|1866396|FG004|Overall Study|Protocol Violation|0
895184|NCT00696657|1866397|FG005|Overall Study|Protocol Violation|1
895185|NCT00696657|1866398|FG006|Overall Study|Protocol Violation|0
895186|NCT00696657|1866399|FG007|Overall Study|Protocol Violation|0
895187|NCT00696657|1866400|FG008|Overall Study|Protocol Violation|1
895188|NCT00696657|1866392|FG000|Overall Study|Lack of Efficacy|0
895189|NCT00696657|1866393|FG001|Overall Study|Lack of Efficacy|1
895190|NCT00696657|1866394|FG002|Overall Study|Lack of Efficacy|0
895191|NCT00696657|1866395|FG003|Overall Study|Lack of Efficacy|0
895192|NCT00696657|1866396|FG004|Overall Study|Lack of Efficacy|0
895193|NCT00696657|1866397|FG005|Overall Study|Lack of Efficacy|0
895194|NCT00696657|1866398|FG006|Overall Study|Lack of Efficacy|0
895195|NCT00696657|1866399|FG007|Overall Study|Lack of Efficacy|0
895196|NCT00696657|1866400|FG008|Overall Study|Lack of Efficacy|0
895197|NCT00696657|1866392|FG000|Overall Study|Withdrawal criteria|1
895198|NCT00696657|1866393|FG001|Overall Study|Withdrawal criteria|3
895199|NCT00696657|1866394|FG002|Overall Study|Withdrawal criteria|2
895200|NCT00696657|1866395|FG003|Overall Study|Withdrawal criteria|2
895201|NCT00696657|1866396|FG004|Overall Study|Withdrawal criteria|0
895202|NCT00696657|1866397|FG005|Overall Study|Withdrawal criteria|0
895203|NCT00696657|1866398|FG006|Overall Study|Withdrawal criteria|1
895204|NCT00696657|1866399|FG007|Overall Study|Withdrawal criteria|1
895205|NCT00696657|1866400|FG008|Overall Study|Withdrawal criteria|2
895206|NCT00696657|1866392|FG000|Overall Study|Unclassified|0
895207|NCT00696657|1866393|FG001|Overall Study|Unclassified|1
895208|NCT00696657|1866394|FG002|Overall Study|Unclassified|3
895209|NCT00696657|1866395|FG003|Overall Study|Unclassified|2
895210|NCT00696657|1866396|FG004|Overall Study|Unclassified|4
895211|NCT00696657|1866397|FG005|Overall Study|Unclassified|2
895212|NCT00696657|1866398|FG006|Overall Study|Unclassified|0
895213|NCT00696657|1866399|FG007|Overall Study|Unclassified|0
895214|NCT00696657|1866400|FG008|Overall Study|Unclassified|1
895215|NCT00696657|1866392|FG000|Overall Study|Adverse Event|0
895216|NCT00696657|1866393|FG001|Overall Study|Adverse Event|0
895217|NCT00696657|1866394|FG002|Overall Study|Adverse Event|3
895218|NCT00696657|1866395|FG003|Overall Study|Adverse Event|7
895219|NCT00696657|1866396|FG004|Overall Study|Adverse Event|6
895220|NCT00696657|1866397|FG005|Overall Study|Adverse Event|9
895221|NCT00696657|1866398|FG006|Overall Study|Adverse Event|14
1104503|NCT02404805|2182080|FG004|Overall Study|Withdrawal by Subject|0
1104504|NCT02404805|2182081|FG005|Overall Study|Withdrawal by Subject|0
1104505|NCT02405091|2182093|FG000|Overall Study|Adverse Event|16
1104506|NCT02405091|2182094|FG001|Overall Study|Adverse Event|10
1104507|NCT02405091|2182095|FG002|Overall Study|Adverse Event|0
1104508|NCT02405091|2182093|FG000|Overall Study|Protocol Violation|1
1104509|NCT02405091|2182094|FG001|Overall Study|Protocol Violation|0
1104510|NCT02405091|2182095|FG002|Overall Study|Protocol Violation|0
1104511|NCT02405091|2182093|FG000|Overall Study|Noncompliance|1
1104512|NCT02405091|2182094|FG001|Overall Study|Noncompliance|6
1104513|NCT02405091|2182095|FG002|Overall Study|Noncompliance|2
1104514|NCT02405091|2182093|FG000|Overall Study|Withdrawal by Subject|4
1104515|NCT02405091|2182094|FG001|Overall Study|Withdrawal by Subject|8
1104516|NCT02405091|2182095|FG002|Overall Study|Withdrawal by Subject|0
1104517|NCT02405091|2182093|FG000|Overall Study|Death|0
1104518|NCT02405091|2182094|FG001|Overall Study|Death|1
1104519|NCT02405091|2182095|FG002|Overall Study|Death|0
1104520|NCT02405091|2182093|FG000|Overall Study|Lost to Follow-up|5
1104521|NCT02405091|2182094|FG001|Overall Study|Lost to Follow-up|6
1104522|NCT02405091|2182095|FG002|Overall Study|Lost to Follow-up|0
1104523|NCT02405091|2182093|FG000|Overall Study|Physician Decision|2
1104524|NCT02405091|2182094|FG001|Overall Study|Physician Decision|2
1104525|NCT02405091|2182095|FG002|Overall Study|Physician Decision|0
1104526|NCT02405442|2182136|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0
1104527|NCT02405442|2182137|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2
1104528|NCT02405442|2182138|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4
1104529|NCT02405442|2182139|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1
1104530|NCT02405442|2182136|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
1104531|NCT02405442|2182137|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
1104532|NCT02405442|2182138|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
1104533|NCT02405442|2182139|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
1104534|NCT02405442|2182136|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
1104535|NCT02405442|2182137|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
1104536|NCT02405442|2182138|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
1104537|NCT02405442|2182139|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
1104538|NCT02405442|2182136|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
1104539|NCT02405442|2182137|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
1104540|NCT02405442|2182138|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
1104541|NCT02405442|2182139|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
1104542|NCT02405442|2182136|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
1104543|NCT02405442|2182137|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
1104544|NCT02405442|2182138|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
1104545|NCT02405442|2182139|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
1104546|NCT02405442|2182136|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
1104547|NCT02405442|2182137|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
1104548|NCT02405442|2182138|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
1104549|NCT02405442|2182139|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
1104550|NCT02405442|2182136|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6
1104551|NCT02405442|2182137|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1
1104552|NCT02405442|2182138|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2
1104553|NCT02405442|2182139|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6
1104554|NCT02405442|2182136|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
1104555|NCT02405442|2182137|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
1104556|NCT02405442|2182138|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
1104557|NCT02405442|2182139|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
1104558|NCT02405442|2182136|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1
1104559|NCT02405442|2182137|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2
1104560|NCT02405442|2182138|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1
1104561|NCT02405442|2182139|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1
1104562|NCT02405442|2182136|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
1104563|NCT02405442|2182137|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
1104564|NCT02405442|2182138|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
1104565|NCT02405442|2182139|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
1104566|NCT02405442|2182136|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
1104567|NCT02405442|2182137|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
1104568|NCT02405442|2182138|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
1104569|NCT02405442|2182139|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
1104570|NCT02405442|2182136|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
1104571|NCT02405442|2182137|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
1104572|NCT02405442|2182138|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
1104573|NCT02405442|2182139|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
1104574|NCT02405442|2182136|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
1104575|NCT02405442|2182137|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
1104576|NCT02405442|2182138|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
1104577|NCT02405442|2182139|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
1104578|NCT02405442|2182136|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
1104579|NCT02405442|2182137|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
1104580|NCT02405442|2182138|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
1104581|NCT02405442|2182139|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
1104582|NCT02405780|2182157|FG000|Period I|Adverse Event|8
1104583|NCT02405780|2182158|FG001|Period I|Adverse Event|0
1104584|NCT02405780|2182159|FG002|Period I|Adverse Event|3
1104585|NCT02405780|2182160|FG003|Period I|Adverse Event|7
1104586|NCT02405780|2182157|FG000|Period I|Medical reasons|1
1104587|NCT02405780|2182158|FG001|Period I|Medical reasons|1
1104588|NCT02405780|2182159|FG002|Period I|Medical reasons|0
1104589|NCT02405780|2182160|FG003|Period I|Medical reasons|1
1104590|NCT02405780|2182157|FG000|Period I|Screening Failure|1
1104591|NCT02405780|2182158|FG001|Period I|Screening Failure|0
1104592|NCT02405780|2182159|FG002|Period I|Screening Failure|1
1104593|NCT02405780|2182160|FG003|Period I|Screening Failure|0
1104594|NCT02405780|2182157|FG000|Period I|Withdrawal by Subject|9
1104595|NCT02405780|2182158|FG001|Period I|Withdrawal by Subject|1
1104596|NCT02405780|2182159|FG002|Period I|Withdrawal by Subject|3
1104597|NCT02405780|2182160|FG003|Period I|Withdrawal by Subject|4
1104598|NCT02405780|2182157|FG000|Period I|Non-compliance with study procedures|8
1104599|NCT02405780|2182158|FG001|Period I|Non-compliance with study procedures|6
1104600|NCT02405780|2182159|FG002|Period I|Non-compliance with study procedures|8
1104601|NCT02405780|2182160|FG003|Period I|Non-compliance with study procedures|11
1104602|NCT02405780|2182157|FG000|Period II|Adverse Event|3
1104603|NCT02405780|2182158|FG001|Period II|Adverse Event|5
1104604|NCT02405780|2182159|FG002|Period II|Adverse Event|4
1104605|NCT02405780|2182160|FG003|Period II|Adverse Event|11
1104606|NCT02405780|2182157|FG000|Period II|Medical reason|0
1104607|NCT02405780|2182158|FG001|Period II|Medical reason|1
1104608|NCT02405780|2182159|FG002|Period II|Medical reason|0
1104609|NCT02405780|2182160|FG003|Period II|Medical reason|0
1104610|NCT02405780|2182157|FG000|Period II|Pregnancy|0
1104611|NCT02405780|2182158|FG001|Period II|Pregnancy|0
1104612|NCT02405780|2182159|FG002|Period II|Pregnancy|1
1104613|NCT02405780|2182160|FG003|Period II|Pregnancy|0
1104614|NCT02405780|2182157|FG000|Period II|Withdrawal by Subject|7
1104615|NCT02405780|2182158|FG001|Period II|Withdrawal by Subject|4
1104616|NCT02405780|2182159|FG002|Period II|Withdrawal by Subject|0
1104617|NCT02405780|2182160|FG003|Period II|Withdrawal by Subject|3
1104618|NCT02405780|2182157|FG000|Period II|Non-compliance with study procedures|5
1104619|NCT02405780|2182158|FG001|Period II|Non-compliance with study procedures|2
1104620|NCT02405780|2182159|FG002|Period II|Non-compliance with study procedures|7
1104621|NCT02405780|2182160|FG003|Period II|Non-compliance with study procedures|4
1104622|NCT02405962|2182187|FG000|Overall Study|Lost to Follow-up|1
1104623|NCT02405962|2182188|FG001|Overall Study|Lost to Follow-up|4
1104624|NCT02405962|2182187|FG000|Overall Study|A participant has moved to another place|0
1104625|NCT02405962|2182188|FG001|Overall Study|A participant has moved to another place|1
1104626|NCT02406248|2182219|FG000|Overall Study|Death|7
1104627|NCT02406248|2182219|FG000|Overall Study|Withdrawal by Subject|2
1104628|NCT02406261|2182225|FG000|Period 1|Lost to Follow-up|2
1104629|NCT02406261|2182226|FG001|Period 1|Lost to Follow-up|0
1104630|NCT02406261|2182225|FG000|Period 1|Adverse Event|1
1104631|NCT02406261|2182226|FG001|Period 1|Adverse Event|0
1104632|NCT02406261|2182225|FG000|Period 2|Physician Decision|0
1104633|NCT02406261|2182226|FG001|Period 2|Physician Decision|1
1104634|NCT02406261|2182225|FG000|Period 2|Protocol Violation|0
1104635|NCT02406261|2182226|FG001|Period 2|Protocol Violation|1
1104636|NCT02406261|2182225|FG000|Period 2|Withdrawal by Subject|0
1104637|NCT02406261|2182226|FG001|Period 2|Withdrawal by Subject|1
1104638|NCT02406586|2182262|FG000|Overall Study|Lost to Follow-up|0
1104639|NCT02406586|2182263|FG001|Overall Study|Lost to Follow-up|4
1104640|NCT02406586|2182264|FG002|Overall Study|Lost to Follow-up|2
1104641|NCT02406586|2182262|FG000|Overall Study|Withdrawal by Subject|1
1104642|NCT02406586|2182263|FG001|Overall Study|Withdrawal by Subject|0
1104643|NCT02406586|2182264|FG002|Overall Study|Withdrawal by Subject|0
1104644|NCT02406612|2182277|FG000|Overall Study|Screening Failure|3
1104645|NCT02406612|2182278|FG001|Overall Study|Screening Failure|0
1104646|NCT02406612|2182277|FG000|Overall Study|Intra-procedural Exclusion|1
1104647|NCT02406612|2182278|FG001|Overall Study|Intra-procedural Exclusion|3
1104648|NCT02406612|2182277|FG000|Overall Study|Guidewire Failure|0
1104649|NCT02406612|2182278|FG001|Overall Study|Guidewire Failure|1
1104650|NCT02406651|2182284|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3
1104651|NCT02406677|2182291|FG000|Overall Study|Death|16
1104652|NCT02406677|2182292|FG001|Overall Study|Death|8
1104653|NCT02406677|2182291|FG000|Overall Study|Discharged without P2Y12|1
1104654|NCT02406677|2182292|FG001|Overall Study|Discharged without P2Y12|3
1104655|NCT02406677|2182291|FG000|Overall Study|Discharged on prasugrel|283
1104656|NCT02406677|2182292|FG001|Overall Study|Discharged on prasugrel|587
1104657|NCT02406677|2182291|FG000|Overall Study|Withdrawal by Subject|1
1104658|NCT02406677|2182292|FG001|Overall Study|Withdrawal by Subject|0
1104659|NCT02406742|2182305|FG000|Overall Study|Progression of Disease|5
1104660|NCT02406742|2182306|FG001|Overall Study|Progression of Disease|1
1104661|NCT02406742|2182307|FG002|Overall Study|Progression of Disease|6
1104662|NCT02406742|2182305|FG000|Overall Study|Adverse Event|3
1104663|NCT02406742|2182306|FG001|Overall Study|Adverse Event|0
1104664|NCT02406742|2182307|FG002|Overall Study|Adverse Event|2
1104665|NCT02406742|2182305|FG000|Overall Study|Death|1
1104666|NCT02406742|2182306|FG001|Overall Study|Death|0
1104667|NCT02406742|2182307|FG002|Overall Study|Death|0
1104668|NCT02406742|2182305|FG000|Overall Study|Lack of Efficacy|0
1104669|NCT02406742|2182306|FG001|Overall Study|Lack of Efficacy|0
1104670|NCT02406742|2182307|FG002|Overall Study|Lack of Efficacy|1
1104671|NCT02406742|2182305|FG000|Overall Study|Withdrawal by Participant|1
1104672|NCT02406742|2182306|FG001|Overall Study|Withdrawal by Participant|2
1104673|NCT02406742|2182307|FG002|Overall Study|Withdrawal by Participant|0
1104674|NCT02406742|2182305|FG000|Overall Study|Physician Decision|1
1104675|NCT02406742|2182306|FG001|Overall Study|Physician Decision|2
1104676|NCT02406742|2182307|FG002|Overall Study|Physician Decision|1
1104677|NCT02406742|2182305|FG000|Overall Study|Transition to other treatment|2
1104678|NCT02406742|2182306|FG001|Overall Study|Transition to other treatment|0
1104679|NCT02406742|2182307|FG002|Overall Study|Transition to other treatment|1
1104680|NCT02406742|2182305|FG000|Overall Study|Other Reasons|1
1104681|NCT02406742|2182306|FG001|Overall Study|Other Reasons|11
1104682|NCT02406742|2182307|FG002|Overall Study|Other Reasons|5
1104683|NCT02407054|2182369|FG000|Overall Study|Adverse Event|1
1104684|NCT02407054|2182370|FG001|Overall Study|Adverse Event|4
1104685|NCT02407054|2182371|FG002|Overall Study|Adverse Event|1
1104686|NCT02407054|2182369|FG000|Overall Study|Non-compliance with Study|0
1104687|NCT02407054|2182370|FG001|Overall Study|Non-compliance with Study|2
1104688|NCT02407054|2182371|FG002|Overall Study|Non-compliance with Study|1
1104689|NCT02407054|2182369|FG000|Overall Study|Physician Decision|1
1104690|NCT02407054|2182370|FG001|Overall Study|Physician Decision|3
1104691|NCT02407054|2182371|FG002|Overall Study|Physician Decision|3
1104692|NCT02407054|2182369|FG000|Overall Study|Withdrawal by Subject|5
1104693|NCT02407054|2182370|FG001|Overall Study|Withdrawal by Subject|9
1104694|NCT02407054|2182371|FG002|Overall Study|Withdrawal by Subject|2
1104695|NCT02407223|2182392|FG000|Overall Study|Adverse Event|1
1104696|NCT02407223|2182393|FG001|Overall Study|Adverse Event|0
1104697|NCT02407223|2182394|FG002|Overall Study|Adverse Event|1
1104698|NCT02407223|2182392|FG000|Overall Study|Lack of Efficacy|6
1104699|NCT02407223|2182393|FG001|Overall Study|Lack of Efficacy|6
1104700|NCT02407223|2182394|FG002|Overall Study|Lack of Efficacy|4
1104701|NCT02407223|2182392|FG000|Overall Study|Lost to Follow-up|1
1104702|NCT02407223|2182393|FG001|Overall Study|Lost to Follow-up|0
895222|NCT00696657|1866399|FG007|Overall Study|Adverse Event|2
895223|NCT00696657|1866400|FG008|Overall Study|Adverse Event|5
895224|NCT00696696|1866420|FG000|Overall Study|Adverse Event|5
895225|NCT00696696|1866420|FG000|Overall Study|Withdrawal by Subject|8
895226|NCT00696696|1866420|FG000|Overall Study|Physician Decision|2
895227|NCT00696696|1866420|FG000|Overall Study|Death|3
895228|NCT00696709|1866429|FG000|Overall Study|Withdrawal by Subject|1
895229|NCT00696709|1866430|FG001|Overall Study|Withdrawal by Subject|2
895230|NCT00696709|1866431|FG002|Overall Study|Withdrawal by Subject|1
895231|NCT00696709|1866432|FG003|Overall Study|Withdrawal by Subject|4
895232|NCT00696709|1866433|FG004|Overall Study|Withdrawal by Subject|3
895233|NCT00696709|1866429|FG000|Overall Study|Protocol Violation|1
895234|NCT00696709|1866430|FG001|Overall Study|Protocol Violation|0
895235|NCT00696709|1866431|FG002|Overall Study|Protocol Violation|0
895236|NCT00696709|1866432|FG003|Overall Study|Protocol Violation|0
895237|NCT00696709|1866433|FG004|Overall Study|Protocol Violation|0
895238|NCT00696709|1866429|FG000|Overall Study|Lost to Follow-up|1
895239|NCT00696709|1866430|FG001|Overall Study|Lost to Follow-up|1
895240|NCT00696709|1866431|FG002|Overall Study|Lost to Follow-up|0
895241|NCT00696709|1866432|FG003|Overall Study|Lost to Follow-up|0
895242|NCT00696709|1866433|FG004|Overall Study|Lost to Follow-up|0
895243|NCT00696709|1866429|FG000|Overall Study|Adverse Event|0
895244|NCT00696709|1866430|FG001|Overall Study|Adverse Event|0
895245|NCT00696709|1866431|FG002|Overall Study|Adverse Event|0
895246|NCT00696709|1866432|FG003|Overall Study|Adverse Event|1
895247|NCT00696709|1866433|FG004|Overall Study|Adverse Event|0
895248|NCT00696774|1866477|FG000|Period II|Adverse Event|0
895249|NCT00696774|1866478|FG001|Period II|Adverse Event|0
895250|NCT00696774|1866479|FG002|Period II|Adverse Event|15
895251|NCT00696774|1866477|FG000|Period II|Lost to Follow-up|0
895252|NCT00696774|1866478|FG001|Period II|Lost to Follow-up|0
895253|NCT00696774|1866479|FG002|Period II|Lost to Follow-up|4
895254|NCT00696774|1866477|FG000|Period II|Protocol Violation|0
895255|NCT00696774|1866478|FG001|Period II|Protocol Violation|0
895256|NCT00696774|1866479|FG002|Period II|Protocol Violation|11
895257|NCT00696774|1866477|FG000|Period II|Withdrawal by Subject|0
895258|NCT00696774|1866478|FG001|Period II|Withdrawal by Subject|0
895259|NCT00696774|1866479|FG002|Period II|Withdrawal by Subject|4
895260|NCT00696774|1866477|FG000|Period II|Sponsor Decision|0
895261|NCT00696774|1866478|FG001|Period II|Sponsor Decision|0
895262|NCT00696774|1866479|FG002|Period II|Sponsor Decision|0
895263|NCT00696774|1866477|FG000|Period II|Lack of Efficacy|0
895264|NCT00696774|1866478|FG001|Period II|Lack of Efficacy|0
895265|NCT00696774|1866479|FG002|Period II|Lack of Efficacy|2
895266|NCT00696774|1866477|FG000|Period III|Adverse Event|1
895267|NCT00696774|1866478|FG001|Period III|Adverse Event|1
895268|NCT00696774|1866479|FG002|Period III|Adverse Event|0
895269|NCT00696774|1866477|FG000|Period III|Lost to Follow-up|2
895270|NCT00696774|1866478|FG001|Period III|Lost to Follow-up|1
895271|NCT00696774|1866479|FG002|Period III|Lost to Follow-up|0
895272|NCT00696774|1866477|FG000|Period III|Protocol Violation|1
895273|NCT00696774|1866478|FG001|Period III|Protocol Violation|1
1104703|NCT02407223|2182394|FG002|Overall Study|Lost to Follow-up|2
1104704|NCT02407223|2182392|FG000|Overall Study|Withdrawal by Subject|2
1104705|NCT02407223|2182393|FG001|Overall Study|Withdrawal by Subject|4
1104706|NCT02407223|2182394|FG002|Overall Study|Withdrawal by Subject|4
1104707|NCT02407223|2182392|FG000|Overall Study|Study Terminated by Sponsor|77
1104708|NCT02407223|2182393|FG001|Overall Study|Study Terminated by Sponsor|80
1104709|NCT02407223|2182394|FG002|Overall Study|Study Terminated by Sponsor|86
1104710|NCT02407223|2182392|FG000|Overall Study|Subject Refused Further Study Treatment|0
1104711|NCT02407223|2182393|FG001|Overall Study|Subject Refused Further Study Treatment|1
1104712|NCT02407223|2182394|FG002|Overall Study|Subject Refused Further Study Treatment|0
1104713|NCT02407223|2182392|FG000|Overall Study|Other|29
1104714|NCT02407223|2182393|FG001|Overall Study|Other|27
1104715|NCT02407223|2182394|FG002|Overall Study|Other|25
1104716|NCT02407236|2182412|FG000|Induction Study (8 Weeks)|Adverse Event|3
1104717|NCT02407236|2182413|FG001|Induction Study (8 Weeks)|Adverse Event|0
1104718|NCT02407236|2182414|FG002|Induction Study (8 Weeks)|Adverse Event|1
1104719|NCT02407236|2182415|FG003|Induction Study (8 Weeks)|Adverse Event|0
895274|NCT00696774|1866479|FG002|Period III|Protocol Violation|0
895275|NCT00696774|1866477|FG000|Period III|Withdrawal by Subject|1
895276|NCT00696774|1866478|FG001|Period III|Withdrawal by Subject|2
895277|NCT00696774|1866479|FG002|Period III|Withdrawal by Subject|0
895278|NCT00696774|1866477|FG000|Period III|Sponsor Decision|2
895279|NCT00696774|1866478|FG001|Period III|Sponsor Decision|0
895280|NCT00696774|1866479|FG002|Period III|Sponsor Decision|0
1104720|NCT02407236|2182416|FG004|Induction Study (8 Weeks)|Adverse Event|0
1104721|NCT02407236|2182417|FG005|Induction Study (8 Weeks)|Adverse Event|0
1104722|NCT02407236|2182418|FG006|Induction Study (8 Weeks)|Adverse Event|0
1104723|NCT02407236|2182419|FG007|Induction Study (8 Weeks)|Adverse Event|0
1104724|NCT02407236|2182412|FG000|Induction Study (8 Weeks)|Death|0
1104725|NCT02407236|2182413|FG001|Induction Study (8 Weeks)|Death|0
1104726|NCT02407236|2182414|FG002|Induction Study (8 Weeks)|Death|1
1104727|NCT02407236|2182415|FG003|Induction Study (8 Weeks)|Death|0
1104728|NCT02407236|2182416|FG004|Induction Study (8 Weeks)|Death|0
1104729|NCT02407236|2182417|FG005|Induction Study (8 Weeks)|Death|0
1104730|NCT02407236|2182418|FG006|Induction Study (8 Weeks)|Death|0
1104731|NCT02407236|2182419|FG007|Induction Study (8 Weeks)|Death|0
1104732|NCT02407236|2182412|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17
1104733|NCT02407236|2182413|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9
1104734|NCT02407236|2182414|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7
1104735|NCT02407236|2182415|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0
1104736|NCT02407236|2182416|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0
1104737|NCT02407236|2182417|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0
1104738|NCT02407236|2182418|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0
1104739|NCT02407236|2182419|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0
1104740|NCT02407236|2182412|FG000|Induction Study (8 Weeks)|Lost to Follow-up|0
1104741|NCT02407236|2182413|FG001|Induction Study (8 Weeks)|Lost to Follow-up|0
1104742|NCT02407236|2182414|FG002|Induction Study (8 Weeks)|Lost to Follow-up|1
1104743|NCT02407236|2182415|FG003|Induction Study (8 Weeks)|Lost to Follow-up|0
1104744|NCT02407236|2182416|FG004|Induction Study (8 Weeks)|Lost to Follow-up|0
1104745|NCT02407236|2182417|FG005|Induction Study (8 Weeks)|Lost to Follow-up|0
1104746|NCT02407236|2182418|FG006|Induction Study (8 Weeks)|Lost to Follow-up|0
1104747|NCT02407236|2182419|FG007|Induction Study (8 Weeks)|Lost to Follow-up|0
1104748|NCT02407236|2182412|FG000|Induction Study (8 Weeks)|Physician Decision|1
1104749|NCT02407236|2182413|FG001|Induction Study (8 Weeks)|Physician Decision|1
1104750|NCT02407236|2182414|FG002|Induction Study (8 Weeks)|Physician Decision|0
1104751|NCT02407236|2182415|FG003|Induction Study (8 Weeks)|Physician Decision|0
1104752|NCT02407236|2182416|FG004|Induction Study (8 Weeks)|Physician Decision|0
1104753|NCT02407236|2182417|FG005|Induction Study (8 Weeks)|Physician Decision|0
1104754|NCT02407236|2182418|FG006|Induction Study (8 Weeks)|Physician Decision|0
1104755|NCT02407236|2182419|FG007|Induction Study (8 Weeks)|Physician Decision|0
1104756|NCT02407236|2182412|FG000|Induction Study (8 Weeks)|Other|2
1104757|NCT02407236|2182413|FG001|Induction Study (8 Weeks)|Other|1
1104758|NCT02407236|2182414|FG002|Induction Study (8 Weeks)|Other|5
1104759|NCT02407236|2182415|FG003|Induction Study (8 Weeks)|Other|0
1104760|NCT02407236|2182416|FG004|Induction Study (8 Weeks)|Other|0
1104761|NCT02407236|2182417|FG005|Induction Study (8 Weeks)|Other|0
1104762|NCT02407236|2182418|FG006|Induction Study (8 Weeks)|Other|0
1104763|NCT02407236|2182419|FG007|Induction Study (8 Weeks)|Other|0
1104764|NCT02407236|2182412|FG000|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1104765|NCT02407236|2182413|FG001|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1104766|NCT02407236|2182414|FG002|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1104767|NCT02407236|2182415|FG003|Maintenance Study (44 Weeks)|Lost to Follow-up|1
1104768|NCT02407236|2182416|FG004|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1104769|NCT02407236|2182417|FG005|Maintenance Study (44 Weeks)|Lost to Follow-up|1
1104770|NCT02407236|2182418|FG006|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1104771|NCT02407236|2182419|FG007|Maintenance Study (44 Weeks)|Lost to Follow-up|1
1104772|NCT02407236|2182412|FG000|Maintenance Study (44 Weeks)|Death|0
1104773|NCT02407236|2182413|FG001|Maintenance Study (44 Weeks)|Death|0
1104774|NCT02407236|2182414|FG002|Maintenance Study (44 Weeks)|Death|0
1104775|NCT02407236|2182415|FG003|Maintenance Study (44 Weeks)|Death|0
1104776|NCT02407236|2182416|FG004|Maintenance Study (44 Weeks)|Death|0
1104777|NCT02407236|2182417|FG005|Maintenance Study (44 Weeks)|Death|0
1104778|NCT02407236|2182418|FG006|Maintenance Study (44 Weeks)|Death|0
1104779|NCT02407236|2182419|FG007|Maintenance Study (44 Weeks)|Death|1
1104780|NCT02407236|2182412|FG000|Maintenance Study (44 Weeks)|Withdraw of consent|0
1104781|NCT02407236|2182413|FG001|Maintenance Study (44 Weeks)|Withdraw of consent|0
1104782|NCT02407236|2182414|FG002|Maintenance Study (44 Weeks)|Withdraw of consent|0
1104783|NCT02407236|2182415|FG003|Maintenance Study (44 Weeks)|Withdraw of consent|8
1104784|NCT02407236|2182416|FG004|Maintenance Study (44 Weeks)|Withdraw of consent|10
1104785|NCT02407236|2182417|FG005|Maintenance Study (44 Weeks)|Withdraw of consent|5
1104786|NCT02407236|2182418|FG006|Maintenance Study (44 Weeks)|Withdraw of consent|7
1104787|NCT02407236|2182419|FG007|Maintenance Study (44 Weeks)|Withdraw of consent|5
1104788|NCT02407236|2182412|FG000|Maintenance Study (44 Weeks)|Sponsor decision|0
1104789|NCT02407236|2182413|FG001|Maintenance Study (44 Weeks)|Sponsor decision|0
1104790|NCT02407236|2182414|FG002|Maintenance Study (44 Weeks)|Sponsor decision|0
1104791|NCT02407236|2182415|FG003|Maintenance Study (44 Weeks)|Sponsor decision|1
1104792|NCT02407236|2182416|FG004|Maintenance Study (44 Weeks)|Sponsor decision|0
1104793|NCT02407236|2182417|FG005|Maintenance Study (44 Weeks)|Sponsor decision|1
1104794|NCT02407236|2182418|FG006|Maintenance Study (44 Weeks)|Sponsor decision|0
895281|NCT00696774|1866477|FG000|Period III|Lack of Efficacy|0
895282|NCT00696774|1866478|FG001|Period III|Lack of Efficacy|2
895283|NCT00696774|1866479|FG002|Period III|Lack of Efficacy|0
895284|NCT00696787|1866490|FG000|Overall Study|Adverse Event|1
1104795|NCT02407236|2182419|FG007|Maintenance Study (44 Weeks)|Sponsor decision|0
1104796|NCT02407236|2182412|FG000|Maintenance Study (44 Weeks)|Other|0
1104797|NCT02407236|2182413|FG001|Maintenance Study (44 Weeks)|Other|0
1104798|NCT02407236|2182414|FG002|Maintenance Study (44 Weeks)|Other|0
1104799|NCT02407236|2182415|FG003|Maintenance Study (44 Weeks)|Other|0
1104800|NCT02407236|2182416|FG004|Maintenance Study (44 Weeks)|Other|1
1104801|NCT02407236|2182417|FG005|Maintenance Study (44 Weeks)|Other|1
1104802|NCT02407236|2182418|FG006|Maintenance Study (44 Weeks)|Other|2
1104803|NCT02407236|2182419|FG007|Maintenance Study (44 Weeks)|Other|1
1104804|NCT02407249|2182437|FG000|Overall Study|Did not complete 12-month follow-up|13
1104805|NCT02407249|2182437|FG000|Overall Study|Not treated|13
1104806|NCT02407457|2182443|FG000|1 Month|Death|3
1104807|NCT02407457|2182444|FG001|1 Month|Death|0
1104808|NCT02407457|2182443|FG000|1 Month|Lost to Follow-up|1
1104809|NCT02407457|2182444|FG001|1 Month|Lost to Follow-up|1
1104810|NCT02407457|2182443|FG000|1 Month|missed visit|2
1104811|NCT02407457|2182444|FG001|1 Month|missed visit|6
1104812|NCT02407457|2182443|FG000|6-Month|Death|2
1104813|NCT02407457|2182444|FG001|6-Month|Death|8
1104814|NCT02407457|2182443|FG000|6-Month|Lost to Follow-up|2
1104815|NCT02407457|2182444|FG001|6-Month|Lost to Follow-up|2
1104816|NCT02407457|2182443|FG000|6-Month|missed visit|15
1104817|NCT02407457|2182444|FG001|6-Month|missed visit|12
1104818|NCT02407457|2182443|FG000|6-Month|Over Due|1
1104819|NCT02407457|2182444|FG001|6-Month|Over Due|2
1104820|NCT02407457|2182443|FG000|6-Month|Open Repair|0
1104821|NCT02407457|2182444|FG001|6-Month|Open Repair|1
1104822|NCT02407457|2182443|FG000|1 Year|Death|6
1104823|NCT02407457|2182444|FG001|1 Year|Death|11
1104824|NCT02407457|2182443|FG000|1 Year|Lost to Follow-up|3
1104825|NCT02407457|2182444|FG001|1 Year|Lost to Follow-up|2
1104826|NCT02407457|2182443|FG000|1 Year|Missed Visit|18
1104827|NCT02407457|2182444|FG001|1 Year|Missed Visit|10
1104828|NCT02407457|2182443|FG000|1 Year|Over Due|6
1104829|NCT02407457|2182444|FG001|1 Year|Over Due|4
1104830|NCT02407457|2182443|FG000|1 Year|Open Repair|0
1104831|NCT02407457|2182444|FG001|1 Year|Open Repair|1
1104832|NCT02407457|2182443|FG000|2-year|Death|14
1104833|NCT02407457|2182444|FG001|2-year|Death|8
1104834|NCT02407457|2182443|FG000|2-year|Lost to Follow-up|6
1104835|NCT02407457|2182444|FG001|2-year|Lost to Follow-up|9
1104836|NCT02407457|2182443|FG000|2-year|Missed Visit|13
1104837|NCT02407457|2182444|FG001|2-year|Missed Visit|11
1104838|NCT02407457|2182443|FG000|2-year|Over Due|1
1104839|NCT02407457|2182444|FG001|2-year|Over Due|5
1104840|NCT02407457|2182443|FG000|2-year|Open Repair|0
1104841|NCT02407457|2182444|FG001|2-year|Open Repair|2
1104842|NCT02407457|2182443|FG000|3-year|Death|11
1104843|NCT02407457|2182444|FG001|3-year|Death|10
1104844|NCT02407457|2182443|FG000|3-year|Lost to Follow-up|6
1104845|NCT02407457|2182444|FG001|3-year|Lost to Follow-up|9
1104846|NCT02407457|2182443|FG000|3-year|Missed Visit|21
1104847|NCT02407457|2182444|FG001|3-year|Missed Visit|16
895285|NCT00696787|1866491|FG001|Overall Study|Adverse Event|0
895286|NCT00696787|1866492|FG002|Overall Study|Adverse Event|6
895287|NCT00696787|1866490|FG000|Overall Study|Discontinuation by Sponsor|9
895288|NCT00696787|1866491|FG001|Overall Study|Discontinuation by Sponsor|13
895289|NCT00696787|1866492|FG002|Overall Study|Discontinuation by Sponsor|14
895290|NCT00696787|1866490|FG000|Overall Study|Lack of Efficacy|0
895291|NCT00696787|1866491|FG001|Overall Study|Lack of Efficacy|1
895292|NCT00696787|1866492|FG002|Overall Study|Lack of Efficacy|0
895293|NCT00696787|1866490|FG000|Overall Study|Lost to Follow-up|4
895294|NCT00696787|1866491|FG001|Overall Study|Lost to Follow-up|0
895295|NCT00696787|1866492|FG002|Overall Study|Lost to Follow-up|3
895296|NCT00696787|1866490|FG000|Overall Study|Withdrawal by Subject|0
895297|NCT00696787|1866491|FG001|Overall Study|Withdrawal by Subject|3
895298|NCT00696787|1866492|FG002|Overall Study|Withdrawal by Subject|2
895299|NCT00696787|1866490|FG000|Overall Study|Failed to return|1
895300|NCT00696787|1866491|FG001|Overall Study|Failed to return|3
895301|NCT00696787|1866492|FG002|Overall Study|Failed to return|1
895302|NCT00696800|1866502|FG000|Overall Study|Adverse Event|16
895303|NCT00696800|1866503|FG001|Overall Study|Adverse Event|3
895304|NCT00696800|1866502|FG000|Overall Study|Insufficient compliance with medication|2
895305|NCT00696800|1866503|FG001|Overall Study|Insufficient compliance with medication|1
895306|NCT00696800|1866502|FG000|Overall Study|Insufficient ovarian response on Day 8|4
895307|NCT00696800|1866503|FG001|Overall Study|Insufficient ovarian response on Day 8|1
895308|NCT00696800|1866502|FG000|Overall Study|Insufficient ovarian response|4
895309|NCT00696800|1866503|FG001|Overall Study|Insufficient ovarian response|1
895310|NCT00696800|1866502|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
895311|NCT00696800|1866503|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
895312|NCT00696800|1866502|FG000|Overall Study|Too high ovarian response|6
895313|NCT00696800|1866503|FG001|Overall Study|Too high ovarian response|1
895314|NCT00696800|1866502|FG000|Overall Study|No/too few/bad quality oocytes|4
895315|NCT00696800|1866503|FG001|Overall Study|No/too few/bad quality oocytes|3
1104848|NCT02407457|2182443|FG000|3-year|Over Due|4
1104849|NCT02407457|2182444|FG001|3-year|Over Due|3
1104850|NCT02407457|2182443|FG000|4-year|Death|14
1104851|NCT02407457|2182444|FG001|4-year|Death|7
1104852|NCT02407457|2182443|FG000|4-year|Lost to Follow-up|9
1104853|NCT02407457|2182444|FG001|4-year|Lost to Follow-up|12
1104854|NCT02407457|2182443|FG000|4-year|Over Due|10
1104855|NCT02407457|2182444|FG001|4-year|Over Due|5
1104856|NCT02407457|2182443|FG000|4-year|Missed Visit|13
1104857|NCT02407457|2182444|FG001|4-year|Missed Visit|13
1104858|NCT02407457|2182443|FG000|4-year|Pending visit|19
1104859|NCT02407457|2182444|FG001|4-year|Pending visit|14
1104860|NCT02407457|2182443|FG000|4-year|Not Due|16
1104861|NCT02407457|2182444|FG001|4-year|Not Due|10
1104862|NCT02407457|2182443|FG000|5-year|Death|6
1104863|NCT02407457|2182444|FG001|5-year|Death|1
1104864|NCT02407457|2182443|FG000|5-year|Lost to Follow-up|4
1104865|NCT02407457|2182444|FG001|5-year|Lost to Follow-up|4
1104866|NCT02407457|2182443|FG000|5-year|Missed Visit|10
1104867|NCT02407457|2182444|FG001|5-year|Missed Visit|9
1104868|NCT02407457|2182443|FG000|5-year|Pending Visit|18
1104869|NCT02407457|2182444|FG001|5-year|Pending Visit|17
1104870|NCT02407457|2182443|FG000|5-year|Not Due|54
1104871|NCT02407457|2182444|FG001|5-year|Not Due|46
1104872|NCT02407704|2182454|FG000|Overall Study|Lost to Follow-up|0
1104873|NCT02407704|2182455|FG001|Overall Study|Lost to Follow-up|0
1104874|NCT02407704|2182456|FG002|Overall Study|Lost to Follow-up|0
1104875|NCT02407704|2182457|FG003|Overall Study|Lost to Follow-up|2
1104876|NCT02407704|2182454|FG000|Overall Study|Protocol Violation|0
1104877|NCT02407704|2182455|FG001|Overall Study|Protocol Violation|0
1104878|NCT02407704|2182456|FG002|Overall Study|Protocol Violation|0
1104879|NCT02407704|2182457|FG003|Overall Study|Protocol Violation|1
1104880|NCT02407704|2182454|FG000|Overall Study|Withdrawal by Subject|0
1104881|NCT02407704|2182455|FG001|Overall Study|Withdrawal by Subject|0
1104882|NCT02407704|2182456|FG002|Overall Study|Withdrawal by Subject|1
1104883|NCT02407704|2182457|FG003|Overall Study|Withdrawal by Subject|0
1104884|NCT02407990|2182496|FG000|Overall Study|Death|2
1104885|NCT02407990|2182497|FG001|Overall Study|Death|22
1104886|NCT02407990|2182498|FG002|Overall Study|Death|23
1104887|NCT02407990|2182499|FG003|Overall Study|Death|7
1104888|NCT02407990|2182500|FG004|Overall Study|Death|17
1104889|NCT02407990|2182501|FG005|Overall Study|Death|16
1104890|NCT02407990|2182502|FG006|Overall Study|Death|10
1104891|NCT02407990|2182503|FG007|Overall Study|Death|248
1104892|NCT02407990|2182496|FG000|Overall Study|Lost to Follow-up|0
1104893|NCT02407990|2182497|FG001|Overall Study|Lost to Follow-up|1
1104894|NCT02407990|2182498|FG002|Overall Study|Lost to Follow-up|0
1104895|NCT02407990|2182499|FG003|Overall Study|Lost to Follow-up|0
1104896|NCT02407990|2182500|FG004|Overall Study|Lost to Follow-up|0
1104897|NCT02407990|2182501|FG005|Overall Study|Lost to Follow-up|0
1104898|NCT02407990|2182502|FG006|Overall Study|Lost to Follow-up|0
1104899|NCT02407990|2182503|FG007|Overall Study|Lost to Follow-up|17
1104900|NCT02407990|2182496|FG000|Overall Study|Progressive Disease|0
1104901|NCT02407990|2182497|FG001|Overall Study|Progressive Disease|0
1104902|NCT02407990|2182498|FG002|Overall Study|Progressive Disease|0
1104903|NCT02407990|2182499|FG003|Overall Study|Progressive Disease|0
1104904|NCT02407990|2182500|FG004|Overall Study|Progressive Disease|0
1104905|NCT02407990|2182501|FG005|Overall Study|Progressive Disease|0
1104906|NCT02407990|2182502|FG006|Overall Study|Progressive Disease|0
1104907|NCT02407990|2182503|FG007|Overall Study|Progressive Disease|1
1104908|NCT02407990|2182496|FG000|Overall Study|Withdrawal by Subject|0
1104909|NCT02407990|2182497|FG001|Overall Study|Withdrawal by Subject|0
1104910|NCT02407990|2182498|FG002|Overall Study|Withdrawal by Subject|0
1104911|NCT02407990|2182499|FG003|Overall Study|Withdrawal by Subject|0
1104912|NCT02407990|2182500|FG004|Overall Study|Withdrawal by Subject|1
1104913|NCT02407990|2182501|FG005|Overall Study|Withdrawal by Subject|0
1104914|NCT02407990|2182502|FG006|Overall Study|Withdrawal by Subject|0
1104915|NCT02407990|2182503|FG007|Overall Study|Withdrawal by Subject|30
1104916|NCT02407990|2182496|FG000|Overall Study|Study Terminated by Sponsor|1
1104917|NCT02407990|2182497|FG001|Overall Study|Study Terminated by Sponsor|3
1104918|NCT02407990|2182498|FG002|Overall Study|Study Terminated by Sponsor|3
1104919|NCT02407990|2182499|FG003|Overall Study|Study Terminated by Sponsor|0
1104920|NCT02407990|2182500|FG004|Overall Study|Study Terminated by Sponsor|3
1104921|NCT02407990|2182501|FG005|Overall Study|Study Terminated by Sponsor|4
1104922|NCT02407990|2182502|FG006|Overall Study|Study Terminated by Sponsor|3
1104923|NCT02407990|2182503|FG007|Overall Study|Study Terminated by Sponsor|37
1104924|NCT02407990|2182496|FG000|Overall Study|Logistics|0
1104925|NCT02407990|2182497|FG001|Overall Study|Logistics|0
1104926|NCT02407990|2182498|FG002|Overall Study|Logistics|0
1104927|NCT02407990|2182499|FG003|Overall Study|Logistics|0
1104928|NCT02407990|2182500|FG004|Overall Study|Logistics|0
1104929|NCT02407990|2182501|FG005|Overall Study|Logistics|0
1104930|NCT02407990|2182502|FG006|Overall Study|Logistics|0
1104931|NCT02407990|2182503|FG007|Overall Study|Logistics|1
1104932|NCT02407990|2182496|FG000|Overall Study|Rolled into long-term extension study|0
1104933|NCT02407990|2182497|FG001|Overall Study|Rolled into long-term extension study|0
1104934|NCT02407990|2182498|FG002|Overall Study|Rolled into long-term extension study|0
1104935|NCT02407990|2182499|FG003|Overall Study|Rolled into long-term extension study|0
1104936|NCT02407990|2182500|FG004|Overall Study|Rolled into long-term extension study|0
1104937|NCT02407990|2182501|FG005|Overall Study|Rolled into long-term extension study|0
1104938|NCT02407990|2182502|FG006|Overall Study|Rolled into long-term extension study|0
1104939|NCT02407990|2182503|FG007|Overall Study|Rolled into long-term extension study|1
1104940|NCT02408016|2182530|FG000|Overall Study|Death|6
1104941|NCT02408016|2182531|FG001|Overall Study|Death|1
1104942|NCT02408016|2182532|FG002|Overall Study|Death|0
1104943|NCT02408016|2182530|FG000|Overall Study|Physician Decision|0
1104944|NCT02408016|2182531|FG001|Overall Study|Physician Decision|2
1104945|NCT02408016|2182532|FG002|Overall Study|Physician Decision|0
1104946|NCT02408068|2182540|FG000|Treatment 3 (1.5 Days)|Adverse Event|0
1104947|NCT02408068|2182541|FG001|Treatment 3 (1.5 Days)|Adverse Event|0
1104948|NCT02408068|2182542|FG002|Treatment 3 (1.5 Days)|Adverse Event|1
1104949|NCT02408068|2182543|FG003|Treatment 3 (1.5 Days)|Adverse Event|0
1104950|NCT02408068|2182544|FG004|Treatment 3 (1.5 Days)|Adverse Event|0
1104951|NCT02408068|2182545|FG005|Treatment 3 (1.5 Days)|Adverse Event|0
1104952|NCT02408120|2182558|FG000|Overall Study|Withdrawal by Subject|0
1104953|NCT02408120|2182559|FG001|Overall Study|Withdrawal by Subject|1
1104954|NCT02408120|2182558|FG000|Overall Study|Treatment Refusal|1
1104955|NCT02408120|2182559|FG001|Overall Study|Treatment Refusal|0
1104956|NCT02408120|2182558|FG000|Overall Study|Received Steroids|1
1104957|NCT02408120|2182559|FG001|Overall Study|Received Steroids|1
1104958|NCT02408120|2182558|FG000|Overall Study|Discharged same day|1
1104959|NCT02408120|2182559|FG001|Overall Study|Discharged same day|1
1104960|NCT02408120|2182558|FG000|Overall Study|Did not receive insulin|1
1104961|NCT02408120|2182559|FG001|Overall Study|Did not receive insulin|2
1104962|NCT02408484|2182597|FG000|Overall Study|Withdrawal by Subject|3
1104963|NCT02408484|2182597|FG000|Overall Study|Not treated during study period|1
1104964|NCT02408523|2182619|FG000|Overall Study|Adverse Event|4
1104965|NCT02408523|2182620|FG001|Overall Study|Adverse Event|10
1104966|NCT02408523|2182619|FG000|Overall Study|Lack of Efficacy|0
1104967|NCT02408523|2182620|FG001|Overall Study|Lack of Efficacy|1
1104968|NCT02408523|2182619|FG000|Overall Study|Protocol Violation|1
1104969|NCT02408523|2182620|FG001|Overall Study|Protocol Violation|2
1104970|NCT02408523|2182619|FG000|Overall Study|Lost to Follow-up|2
1104971|NCT02408523|2182620|FG001|Overall Study|Lost to Follow-up|3
1104972|NCT02408523|2182619|FG000|Overall Study|Withdrawal by Subject|3
1104973|NCT02408523|2182620|FG001|Overall Study|Withdrawal by Subject|1
1104974|NCT02408523|2182619|FG000|Overall Study|Sponsor request|1
1104975|NCT02408523|2182620|FG001|Overall Study|Sponsor request|0
1104976|NCT02408523|2182619|FG000|Overall Study|Did not satisfy extension conditions|0
1104977|NCT02408523|2182620|FG001|Overall Study|Did not satisfy extension conditions|1
1104978|NCT02409342|2182706|FG000|Overall Study|Death|181
1104979|NCT02409342|2182707|FG001|Overall Study|Death|174
1104980|NCT02409342|2182706|FG000|Overall Study|Withdrawal by Subject|24
1104981|NCT02409342|2182707|FG001|Overall Study|Withdrawal by Subject|16
1104982|NCT02409342|2182706|FG000|Overall Study|On-going in study|79
1104983|NCT02409342|2182707|FG001|Overall Study|On-going in study|92
1104984|NCT02409342|2182706|FG000|Overall Study|Lost to Follow-up|3
1104985|NCT02409342|2182707|FG001|Overall Study|Lost to Follow-up|3
1105022|NCT02409667|2182738|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
1105023|NCT02409667|2182739|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
1105024|NCT02409667|2182740|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
1105025|NCT02409667|2182741|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
1105026|NCT02409667|2182742|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
1105027|NCT02409667|2182738|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
1105028|NCT02409667|2182739|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
1105029|NCT02409667|2182740|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
1105030|NCT02409667|2182741|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
1105031|NCT02409667|2182742|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
1105032|NCT02409667|2182738|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
1105033|NCT02409667|2182739|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
1105034|NCT02409667|2182740|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
1105035|NCT02409667|2182741|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
1105036|NCT02409667|2182742|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
1105037|NCT02409667|2182738|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1
1105038|NCT02409667|2182739|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0
1105039|NCT02409667|2182740|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0
1105040|NCT02409667|2182741|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0
1105041|NCT02409667|2182742|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0
1105042|NCT02409667|2182738|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4
1105043|NCT02409667|2182739|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0
1105044|NCT02409667|2182740|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0
1105045|NCT02409667|2182741|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0
1105046|NCT02409667|2182742|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0
1105047|NCT02409667|2182738|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
1105048|NCT02409667|2182739|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
1105049|NCT02409667|2182740|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
1105050|NCT02409667|2182741|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
1105051|NCT02409667|2182742|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
1105052|NCT02409667|2182738|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
1105053|NCT02409667|2182739|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
1105054|NCT02409667|2182740|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
1105055|NCT02409667|2182741|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
1105056|NCT02409667|2182742|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
1105057|NCT02409667|2182738|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
1105058|NCT02409667|2182739|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
1105059|NCT02409667|2182740|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
1105060|NCT02409667|2182741|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
1105061|NCT02409667|2182742|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
1105062|NCT02409667|2182738|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25
1105063|NCT02409667|2182739|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0
1105064|NCT02409667|2182740|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0
1105065|NCT02409667|2182741|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0
1105066|NCT02409667|2182742|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0
1105067|NCT02409667|2182738|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
1105068|NCT02409667|2182739|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
1105069|NCT02409667|2182740|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
1105070|NCT02409667|2182741|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
1105071|NCT02409667|2182742|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
1105072|NCT02409667|2182738|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
1105073|NCT02409667|2182739|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
1105074|NCT02409667|2182740|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
1105075|NCT02409667|2182741|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
1105076|NCT02409667|2182742|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
1105077|NCT02409667|2182738|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
1105078|NCT02409667|2182739|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
1105079|NCT02409667|2182740|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
1105080|NCT02409667|2182741|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
1105081|NCT02409667|2182742|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
1105082|NCT02409667|2182738|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
1105083|NCT02409667|2182739|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
1105084|NCT02409667|2182740|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
1105085|NCT02409667|2182741|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
1105086|NCT02409667|2182742|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
1105087|NCT02409667|2182738|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
1105088|NCT02409667|2182739|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
1105089|NCT02409667|2182740|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
1105090|NCT02409667|2182741|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
1105091|NCT02409667|2182742|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
1105092|NCT02409667|2182738|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
1105093|NCT02409667|2182739|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
1105094|NCT02409667|2182740|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
1105095|NCT02409667|2182741|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
1105096|NCT02409667|2182742|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
1105097|NCT02409667|2182738|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
1105098|NCT02409667|2182739|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
1105099|NCT02409667|2182740|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
1105100|NCT02409667|2182741|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
1105101|NCT02409667|2182742|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
1105102|NCT02409680|2182755|FG000|Overall Study|Lost to Follow-up|15
1105103|NCT02409680|2182756|FG001|Overall Study|Lost to Follow-up|30
1105104|NCT02409719|2182764|FG000|Overall Study|Lost to Follow-up|3
1105105|NCT02409719|2182765|FG001|Overall Study|Lost to Follow-up|3
1105106|NCT02409732|2182771|FG000|Overall Study|Withdrawal by Subject|4
1105107|NCT02409732|2182771|FG000|Overall Study|Lost to Follow-up|2
1105108|NCT02410200|2182807|FG000|Overall Study|Adverse Event|2
1105109|NCT02410252|2182818|FG000|Overall Study|Withdrawal by Subject|4
1105110|NCT02410252|2182818|FG000|Overall Study|Physician Decision|2
1105111|NCT02410278|2182826|FG000|Run-in Period|Adverse Event|5
1105112|NCT02410278|2182827|FG001|Run-in Period|Adverse Event|0
1105113|NCT02410278|2182828|FG002|Run-in Period|Adverse Event|0
1105114|NCT02410278|2182826|FG000|Run-in Period|GSRS Threshold Not Met|30
1105115|NCT02410278|2182827|FG001|Run-in Period|GSRS Threshold Not Met|0
1105116|NCT02410278|2182828|FG002|Run-in Period|GSRS Threshold Not Met|0
1105117|NCT02410278|2182826|FG000|Run-in Period|Lost to Follow-up|1
1105118|NCT02410278|2182827|FG001|Run-in Period|Lost to Follow-up|0
1105119|NCT02410278|2182828|FG002|Run-in Period|Lost to Follow-up|0
1105120|NCT02410278|2182826|FG000|Run-in Period|Withdrawal by Subject|1
1105121|NCT02410278|2182827|FG001|Run-in Period|Withdrawal by Subject|0
1105122|NCT02410278|2182828|FG002|Run-in Period|Withdrawal by Subject|0
1105123|NCT02410278|2182826|FG000|Run-in Period|Pregnancy|1
1105124|NCT02410278|2182827|FG001|Run-in Period|Pregnancy|0
1105125|NCT02410278|2182828|FG002|Run-in Period|Pregnancy|0
1105126|NCT02410278|2182826|FG000|Study Treatment Period|Adverse Event|0
1105127|NCT02410278|2182827|FG001|Study Treatment Period|Adverse Event|6
1105128|NCT02410278|2182828|FG002|Study Treatment Period|Adverse Event|3
1105129|NCT02410278|2182826|FG000|Study Treatment Period|Physician Decision|0
1105130|NCT02410278|2182827|FG001|Study Treatment Period|Physician Decision|0
1105131|NCT02410278|2182828|FG002|Study Treatment Period|Physician Decision|1
1105132|NCT02410278|2182826|FG000|Study Treatment Period|Withdrawal by Subject|0
1105133|NCT02410278|2182827|FG001|Study Treatment Period|Withdrawal by Subject|1
1105134|NCT02410278|2182828|FG002|Study Treatment Period|Withdrawal by Subject|0
1105135|NCT02410278|2182826|FG000|Study Treatment Period|Other|0
1105136|NCT02410278|2182827|FG001|Study Treatment Period|Other|3
1105137|NCT02410278|2182828|FG002|Study Treatment Period|Other|0
1105138|NCT02410278|2182826|FG000|Study Treatment Period|GSRS Threshold Not Met|0
1105139|NCT02410278|2182827|FG001|Study Treatment Period|GSRS Threshold Not Met|1
1105140|NCT02410278|2182828|FG002|Study Treatment Period|GSRS Threshold Not Met|0
1105149|NCT02410629|2182865|FG000|Overall Study|Family cannot commit to the study|2
1105150|NCT02410629|2182866|FG001|Overall Study|Family cannot commit to the study|1
1105151|NCT02410629|2182865|FG000|Overall Study|Subject returned to work|1
1105152|NCT02410629|2182866|FG001|Overall Study|Subject returned to work|0
1105153|NCT02410629|2182865|FG000|Overall Study|Subject moved back to home country|0
1105154|NCT02410629|2182866|FG001|Overall Study|Subject moved back to home country|1
1105155|NCT02410629|2182865|FG000|Overall Study|Subject underwent heart surgery|0
1105156|NCT02410629|2182866|FG001|Overall Study|Subject underwent heart surgery|1
1105157|NCT02410772|2182881|FG000|Overall Study|Death|3
1105158|NCT02410772|2182882|FG001|Overall Study|Death|4
1105159|NCT02410772|2182883|FG002|Overall Study|Death|8
1105160|NCT02410772|2182881|FG000|Overall Study|Lost to Follow-up|31
1105161|NCT02410772|2182882|FG001|Overall Study|Lost to Follow-up|23
1105162|NCT02410772|2182883|FG002|Overall Study|Lost to Follow-up|22
1105163|NCT02410772|2182881|FG000|Overall Study|Pregnancy|8
1105164|NCT02410772|2182882|FG001|Overall Study|Pregnancy|4
1105165|NCT02410772|2182883|FG002|Overall Study|Pregnancy|5
1105166|NCT02410772|2182881|FG000|Overall Study|Protocol Violation|8
1105167|NCT02410772|2182882|FG001|Overall Study|Protocol Violation|8
1105168|NCT02410772|2182883|FG002|Overall Study|Protocol Violation|4
1105169|NCT02410772|2182881|FG000|Overall Study|Baseline Drug Resistance|49
1105170|NCT02410772|2182882|FG001|Overall Study|Baseline Drug Resistance|40
1105171|NCT02410772|2182883|FG002|Overall Study|Baseline Drug Resistance|51
1105172|NCT02410772|2182881|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4
1105173|NCT02410772|2182882|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6
1105174|NCT02410772|2182883|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3
1105175|NCT02410772|2182881|FG000|Overall Study|Reinfection with a new strain of MTB|0
1105176|NCT02410772|2182882|FG001|Overall Study|Reinfection with a new strain of MTB|1
1105177|NCT02410772|2182883|FG002|Overall Study|Reinfection with a new strain of MTB|0
1105178|NCT02410811|2182900|FG000|Overall Study|Withdrawal by Subject|0
1105179|NCT02410811|2182901|FG001|Overall Study|Withdrawal by Subject|0
1105180|NCT02410811|2182902|FG002|Overall Study|Withdrawal by Subject|1
1105181|NCT02410811|2182903|FG003|Overall Study|Withdrawal by Subject|0
1105182|NCT02410824|2182913|FG000|First Intervention (One Week)|Headache|0
1105183|NCT02410824|2182914|FG001|First Intervention (One Week)|Headache|1
1105184|NCT02410837|2182921|FG000|Overall Study|Death|387
1105185|NCT02410837|2182921|FG000|Overall Study|Lost to Follow-up|50
1105186|NCT02410837|2182921|FG000|Overall Study|Withdrawal by Subject|44
1105187|NCT02410837|2182921|FG000|Overall Study|Physician Decision|6
1105188|NCT02410837|2182921|FG000|Overall Study|Moved to nursing home, cannot communicat|1
1105189|NCT02411084|2182936|FG000|Overall Study|Lack of Efficacy|6
1105190|NCT02411084|2182937|FG001|Overall Study|Lack of Efficacy|3
1105191|NCT02411084|2182936|FG000|Overall Study|Death|5
1105192|NCT02411084|2182937|FG001|Overall Study|Death|4
1105193|NCT02411084|2182936|FG000|Overall Study|Adverse Event|2
1105194|NCT02411084|2182937|FG001|Overall Study|Adverse Event|1
1105195|NCT02411084|2182936|FG000|Overall Study|Other reasons|0
1105196|NCT02411084|2182937|FG001|Overall Study|Other reasons|5
1105197|NCT02411110|2182945|FG000|Treatment Period 1|Adverse Event|4
1105198|NCT02411110|2182946|FG001|Treatment Period 1|Adverse Event|2
1105199|NCT02411110|2182945|FG000|Treatment Period 1|Lost to Follow-up|1
1105200|NCT02411110|2182946|FG001|Treatment Period 1|Lost to Follow-up|0
1105201|NCT02411110|2182945|FG000|Treatment Period 1|Personal Reasons|2
1105202|NCT02411110|2182946|FG001|Treatment Period 1|Personal Reasons|5
1105203|NCT02411110|2182945|FG000|Treatment Period 1|Other Miscellaneous Reasons|2
1105204|NCT02411110|2182946|FG001|Treatment Period 1|Other Miscellaneous Reasons|0
1105205|NCT02411110|2182945|FG000|Treatment Period 2|Adverse Event|1
1105206|NCT02411110|2182946|FG001|Treatment Period 2|Adverse Event|0
1105207|NCT02411110|2182945|FG000|Treatment Period 2|Lost to Follow-up|0
1105208|NCT02411110|2182946|FG001|Treatment Period 2|Lost to Follow-up|2
1105209|NCT02411110|2182945|FG000|Treatment Period 2|Personal Reasons|0
1105210|NCT02411110|2182946|FG001|Treatment Period 2|Personal Reasons|2
1105211|NCT02411201|2182954|FG000|Overall Study|Adverse Event|2
1105212|NCT02411201|2182954|FG000|Overall Study|Withdrawal by Subject|2
1105213|NCT02411201|2182954|FG000|Overall Study|Age group completed|2
1105214|NCT02411292|2182960|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16
1105215|NCT02411292|2182960|FG000|Overall Study|Death|2
1105216|NCT02411292|2182960|FG000|Overall Study|Lost to Follow-up|3
1105217|NCT02411396|2182966|FG000|Overall Study|Lost to Follow-up|31
1105218|NCT02411396|2182966|FG000|Overall Study|Death|10
1105219|NCT02411448|2182978|FG000|Overall Study|Withdrawal by Subject|1
1105220|NCT02411448|2182979|FG001|Overall Study|Withdrawal by Subject|14
1105221|NCT02411448|2182980|FG002|Overall Study|Withdrawal by Subject|9
1105222|NCT02411448|2182978|FG000|Overall Study|Other|0
1105223|NCT02411448|2182979|FG001|Overall Study|Other|2
1105224|NCT02411448|2182980|FG002|Overall Study|Other|0
1105225|NCT02411448|2182978|FG000|Overall Study|Did not receive study treatment|0
1105226|NCT02411448|2182979|FG001|Overall Study|Did not receive study treatment|3
1105227|NCT02411448|2182980|FG002|Overall Study|Did not receive study treatment|0
1105228|NCT02411448|2182978|FG000|Overall Study|Alive on study treatment|3
1105229|NCT02411448|2182979|FG001|Overall Study|Alive on study treatment|64
1105230|NCT02411448|2182980|FG002|Overall Study|Alive on study treatment|43
1105231|NCT02411539|2183007|FG000|Overall Study|Lost to Follow-up|2
1105232|NCT02411539|2183008|FG001|Overall Study|Lost to Follow-up|0
1105233|NCT02411539|2183007|FG000|Overall Study|Confounding medical condition|0
1105234|NCT02411539|2183008|FG001|Overall Study|Confounding medical condition|1
1105235|NCT02411578|2183028|FG000|Crossover Trial Phase|Pregnancy|0
1105236|NCT02411578|2183029|FG001|Crossover Trial Phase|Pregnancy|1
1105237|NCT02411591|2183040|FG000|Overall Study|Adverse Event|0
1105238|NCT02411591|2183041|FG001|Overall Study|Adverse Event|4
1105239|NCT02411591|2183042|FG002|Overall Study|Adverse Event|2
1105240|NCT02411591|2183040|FG000|Overall Study|Withdrawal by Subject|0
1105241|NCT02411591|2183041|FG001|Overall Study|Withdrawal by Subject|3
1105242|NCT02411591|2183042|FG002|Overall Study|Withdrawal by Subject|0
1105243|NCT02411591|2183040|FG000|Overall Study|Physician Decision|0
1105244|NCT02411591|2183041|FG001|Overall Study|Physician Decision|3
1105245|NCT02411591|2183042|FG002|Overall Study|Physician Decision|1
1105246|NCT02411747|2183060|FG000|Overall Study|Withdrawal by Subject|1
1105247|NCT02411747|2183061|FG001|Overall Study|Withdrawal by Subject|0
1105248|NCT02411747|2183060|FG000|Overall Study|Protocol Violation|2
1105249|NCT02411747|2183061|FG001|Overall Study|Protocol Violation|4
1105250|NCT02412111|2183104|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
1105251|NCT02412111|2183105|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
1105252|NCT02412111|2183106|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
1105253|NCT02412111|2183104|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
1105254|NCT02412111|2183105|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
1105255|NCT02412111|2183106|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
1105256|NCT02412111|2183104|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0
1105257|NCT02412111|2183105|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0
1105258|NCT02412111|2183106|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2
1105259|NCT02412111|2183104|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
1105260|NCT02412111|2183105|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
1105261|NCT02412111|2183106|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
1105262|NCT02412111|2183104|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
1105263|NCT02412111|2183105|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
1105264|NCT02412111|2183106|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
1105265|NCT02412111|2183104|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0
1105266|NCT02412111|2183105|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1
1105267|NCT02412111|2183106|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0
1105268|NCT02412111|2183104|FG000|Active Comparator Period (8 Weeks)|Other|0
1105269|NCT02412111|2183105|FG001|Active Comparator Period (8 Weeks)|Other|0
1105270|NCT02412111|2183106|FG002|Active Comparator Period (8 Weeks)|Other|2
1105271|NCT02412306|2183125|FG000|Overall Study|Lost to Follow-up|0
1105272|NCT02412306|2183126|FG001|Overall Study|Lost to Follow-up|1
1105273|NCT02412306|2183127|FG002|Overall Study|Lost to Follow-up|0
1105274|NCT02412306|2183128|FG003|Overall Study|Lost to Follow-up|0
1105275|NCT02412306|2183129|FG004|Overall Study|Lost to Follow-up|0
1105276|NCT02412306|2183125|FG000|Overall Study|Withdrawal by Subject|0
1105277|NCT02412306|2183126|FG001|Overall Study|Withdrawal by Subject|0
1105278|NCT02412306|2183127|FG002|Overall Study|Withdrawal by Subject|1
1105279|NCT02412306|2183128|FG003|Overall Study|Withdrawal by Subject|0
1105280|NCT02412306|2183129|FG004|Overall Study|Withdrawal by Subject|0
1105281|NCT02412306|2183125|FG000|Overall Study|Death|5
1105282|NCT02412306|2183126|FG001|Overall Study|Death|7
1105283|NCT02412306|2183127|FG002|Overall Study|Death|15
1105284|NCT02412306|2183128|FG003|Overall Study|Death|0
1105285|NCT02412306|2183129|FG004|Overall Study|Death|2
1105286|NCT02412371|2183156|FG000|Overall Study|Withdrawal by Subject|0
1105287|NCT02412371|2183157|FG001|Overall Study|Withdrawal by Subject|2
1105288|NCT02412371|2183158|FG002|Overall Study|Withdrawal by Subject|0
1105289|NCT02412371|2183159|FG003|Overall Study|Withdrawal by Subject|1
1105290|NCT02412371|2183160|FG004|Overall Study|Withdrawal by Subject|1
1105291|NCT02412371|2183161|FG005|Overall Study|Withdrawal by Subject|0
1105292|NCT02412371|2183156|FG000|Overall Study|Sponsor Discontinued Study|1
1105293|NCT02412371|2183157|FG001|Overall Study|Sponsor Discontinued Study|4
1105294|NCT02412371|2183158|FG002|Overall Study|Sponsor Discontinued Study|6
1105295|NCT02412371|2183159|FG003|Overall Study|Sponsor Discontinued Study|4
1105296|NCT02412371|2183160|FG004|Overall Study|Sponsor Discontinued Study|5
1105297|NCT02412371|2183161|FG005|Overall Study|Sponsor Discontinued Study|0
1105298|NCT02412371|2183156|FG000|Overall Study|Death|4
1105299|NCT02412371|2183157|FG001|Overall Study|Death|2
1105300|NCT02412371|2183158|FG002|Overall Study|Death|1
1105301|NCT02412371|2183159|FG003|Overall Study|Death|3
1105302|NCT02412371|2183160|FG004|Overall Study|Death|5
1105303|NCT02412371|2183161|FG005|Overall Study|Death|2
1105304|NCT02412371|2183156|FG000|Overall Study|Other|2
1105305|NCT02412371|2183157|FG001|Overall Study|Other|1
1105306|NCT02412371|2183158|FG002|Overall Study|Other|0
1105307|NCT02412371|2183159|FG003|Overall Study|Other|0
1105308|NCT02412371|2183160|FG004|Overall Study|Other|1
1105309|NCT02412371|2183161|FG005|Overall Study|Other|3
1105310|NCT02412436|2183176|FG000|Overall Study|Protocol-mandated Discontinuation|7
1105311|NCT02412436|2183176|FG000|Overall Study|Lost to Follow-up|6
1105312|NCT02412436|2183176|FG000|Overall Study|Unable to get to clinic|3
1105313|NCT02412436|2183176|FG000|Overall Study|Death|1
1105314|NCT02412436|2183176|FG000|Overall Study|Not Willing to Adhere to Requirements|1
1105315|NCT02412488|2183180|FG000|Overall Study|Lost to Follow-up|10
1105316|NCT02412488|2183180|FG000|Overall Study|Withdrawal by Subject|5
1105317|NCT02412488|2183180|FG000|Overall Study|Physician Decision|1
1105318|NCT02412488|2183180|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1
1105319|NCT02412488|2183180|FG000|Overall Study|Reveal LINQ explant|1
1105320|NCT02412631|2183191|FG000|Overall Study|Adverse Event|1
1105321|NCT02412631|2183192|FG001|Overall Study|Adverse Event|2
1105322|NCT02412631|2183191|FG000|Overall Study|Lost to Follow-up|5
1105323|NCT02412631|2183192|FG001|Overall Study|Lost to Follow-up|9
1105324|NCT02412631|2183191|FG000|Overall Study|Withdrawal by Subject|9
1105325|NCT02412631|2183192|FG001|Overall Study|Withdrawal by Subject|3
1105326|NCT02412631|2183191|FG000|Overall Study|Early stop by FDA|5
1105327|NCT02412631|2183192|FG001|Overall Study|Early stop by FDA|2
1105328|NCT02412631|2183191|FG000|Overall Study|Unspecified reason|6
1105329|NCT02412631|2183192|FG001|Overall Study|Unspecified reason|8
1105330|NCT02412657|2183214|FG000|Overall Study|Lost to Follow-up|1
1105331|NCT02412657|2183215|FG001|Overall Study|Lost to Follow-up|0
1105332|NCT02412657|2183216|FG002|Overall Study|Lost to Follow-up|0
1105333|NCT02412657|2183214|FG000|Overall Study|Protocol Violation|0
1105334|NCT02412657|2183215|FG001|Overall Study|Protocol Violation|2
1105335|NCT02412657|2183216|FG002|Overall Study|Protocol Violation|3
1105344|NCT02412722|2183239|FG000|Overall Study|Adverse Event|0
1105345|NCT02412722|2183240|FG001|Overall Study|Adverse Event|2
1105346|NCT02412722|2183241|FG002|Overall Study|Adverse Event|0
1105347|NCT02412722|2183242|FG003|Overall Study|Adverse Event|3
1105348|NCT02412722|2183243|FG004|Overall Study|Adverse Event|0
1105349|NCT02412722|2183244|FG005|Overall Study|Adverse Event|3
1105350|NCT02412722|2183239|FG000|Overall Study|Progressive Disease|6
1105351|NCT02412722|2183240|FG001|Overall Study|Progressive Disease|4
1105352|NCT02412722|2183241|FG002|Overall Study|Progressive Disease|4
1105353|NCT02412722|2183242|FG003|Overall Study|Progressive Disease|9
1105354|NCT02412722|2183243|FG004|Overall Study|Progressive Disease|3
1105355|NCT02412722|2183244|FG005|Overall Study|Progressive Disease|3
1105356|NCT02412722|2183239|FG000|Overall Study|Withdrawal by Subject|2
1105357|NCT02412722|2183240|FG001|Overall Study|Withdrawal by Subject|0
1105358|NCT02412722|2183241|FG002|Overall Study|Withdrawal by Subject|1
1105359|NCT02412722|2183242|FG003|Overall Study|Withdrawal by Subject|2
1105360|NCT02412722|2183243|FG004|Overall Study|Withdrawal by Subject|1
1105361|NCT02412722|2183244|FG005|Overall Study|Withdrawal by Subject|1
1105362|NCT02412722|2183239|FG000|Overall Study|Lost to Follow-up|0
1105363|NCT02412722|2183240|FG001|Overall Study|Lost to Follow-up|0
1105364|NCT02412722|2183241|FG002|Overall Study|Lost to Follow-up|0
1105365|NCT02412722|2183242|FG003|Overall Study|Lost to Follow-up|0
1105366|NCT02412722|2183243|FG004|Overall Study|Lost to Follow-up|1
1105367|NCT02412722|2183244|FG005|Overall Study|Lost to Follow-up|0
1105368|NCT02412722|2183239|FG000|Overall Study|Received drug in run-in and discontinued|0
1105369|NCT02412722|2183240|FG001|Overall Study|Received drug in run-in and discontinued|2
1105370|NCT02412722|2183241|FG002|Overall Study|Received drug in run-in and discontinued|0
1105371|NCT02412722|2183242|FG003|Overall Study|Received drug in run-in and discontinued|0
1105372|NCT02412722|2183243|FG004|Overall Study|Received drug in run-in and discontinued|0
1105373|NCT02412722|2183244|FG005|Overall Study|Received drug in run-in and discontinued|0
1105374|NCT02412722|2183239|FG000|Overall Study|Reason not Specified|3
1105375|NCT02412722|2183240|FG001|Overall Study|Reason not Specified|0
1105376|NCT02412722|2183241|FG002|Overall Study|Reason not Specified|2
1105377|NCT02412722|2183242|FG003|Overall Study|Reason not Specified|1
1105378|NCT02412722|2183243|FG004|Overall Study|Reason not Specified|2
1105379|NCT02412722|2183244|FG005|Overall Study|Reason not Specified|6
1105380|NCT02412761|2183278|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
1105381|NCT02412761|2183279|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
1105382|NCT02412761|2183280|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1
1105383|NCT02412761|2183281|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0
1105384|NCT02412761|2183282|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0
1105385|NCT02412761|2183283|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1
1105386|NCT02412852|2183295|FG000|Overall Study|Withdrawal by Subject|0
1105387|NCT02412852|2183296|FG001|Overall Study|Withdrawal by Subject|1
1105388|NCT02412852|2183297|FG002|Overall Study|Withdrawal by Subject|0
1105389|NCT02412852|2183298|FG003|Overall Study|Withdrawal by Subject|0
1105390|NCT02412852|2183295|FG000|Overall Study|Physician Decision|0
1105391|NCT02412852|2183296|FG001|Overall Study|Physician Decision|0
1105392|NCT02412852|2183297|FG002|Overall Study|Physician Decision|0
1105393|NCT02412852|2183298|FG003|Overall Study|Physician Decision|1
1105394|NCT02412878|2183308|FG000|Overall Study|Withdrawal by Subject|19
1105395|NCT02412878|2183309|FG001|Overall Study|Withdrawal by Subject|10
1105396|NCT02412878|2183308|FG000|Overall Study|Lost to Follow-up|2
1105397|NCT02412878|2183309|FG001|Overall Study|Lost to Follow-up|3
1105398|NCT02413229|2183386|FG000|Overall Study|Adverse Event|0
1105399|NCT02413229|2183387|FG001|Overall Study|Adverse Event|0
1105400|NCT02413229|2183388|FG002|Overall Study|Adverse Event|0
1105401|NCT02413229|2183389|FG003|Overall Study|Adverse Event|1
1105402|NCT02413229|2183390|FG004|Overall Study|Adverse Event|0
1105403|NCT02413229|2183391|FG005|Overall Study|Adverse Event|0
1105404|NCT02413229|2183392|FG006|Overall Study|Adverse Event|0
1105405|NCT02413229|2183393|FG007|Overall Study|Adverse Event|1
1105406|NCT02413229|2183386|FG000|Overall Study|Lost to Follow-up|0
1105407|NCT02413229|2183387|FG001|Overall Study|Lost to Follow-up|0
1105408|NCT02413229|2183388|FG002|Overall Study|Lost to Follow-up|1
1105409|NCT02413229|2183389|FG003|Overall Study|Lost to Follow-up|0
1105410|NCT02413229|2183390|FG004|Overall Study|Lost to Follow-up|2
1105411|NCT02413229|2183391|FG005|Overall Study|Lost to Follow-up|0
1105412|NCT02413229|2183392|FG006|Overall Study|Lost to Follow-up|0
1105413|NCT02413229|2183393|FG007|Overall Study|Lost to Follow-up|0
1105414|NCT02413229|2183386|FG000|Overall Study|Withdrawal by Subject|1
1105415|NCT02413229|2183387|FG001|Overall Study|Withdrawal by Subject|1
1105416|NCT02413229|2183388|FG002|Overall Study|Withdrawal by Subject|0
1105417|NCT02413229|2183389|FG003|Overall Study|Withdrawal by Subject|0
1105418|NCT02413229|2183390|FG004|Overall Study|Withdrawal by Subject|1
1105419|NCT02413229|2183391|FG005|Overall Study|Withdrawal by Subject|0
1105420|NCT02413229|2183392|FG006|Overall Study|Withdrawal by Subject|0
1105421|NCT02413229|2183393|FG007|Overall Study|Withdrawal by Subject|2
1105422|NCT02413229|2183386|FG000|Overall Study|Progressive Disease|0
1105423|NCT02413229|2183387|FG001|Overall Study|Progressive Disease|0
1105424|NCT02413229|2183388|FG002|Overall Study|Progressive Disease|0
1105425|NCT02413229|2183389|FG003|Overall Study|Progressive Disease|0
1105426|NCT02413229|2183390|FG004|Overall Study|Progressive Disease|0
1105427|NCT02413229|2183391|FG005|Overall Study|Progressive Disease|0
1105428|NCT02413229|2183392|FG006|Overall Study|Progressive Disease|0
1105429|NCT02413229|2183393|FG007|Overall Study|Progressive Disease|1
1105430|NCT02413255|2183428|FG000|Overall Study|Voluntary Withdrawal|0
1105431|NCT02413255|2183429|FG001|Overall Study|Voluntary Withdrawal|0
1105432|NCT02413255|2183430|FG002|Overall Study|Voluntary Withdrawal|0
1105433|NCT02413255|2183431|FG003|Overall Study|Voluntary Withdrawal|0
1105434|NCT02413255|2183432|FG004|Overall Study|Voluntary Withdrawal|0
1105435|NCT02413255|2183433|FG005|Overall Study|Voluntary Withdrawal|0
1105436|NCT02413255|2183434|FG006|Overall Study|Voluntary Withdrawal|0
1105437|NCT02413255|2183435|FG007|Overall Study|Voluntary Withdrawal|0
1105438|NCT02413255|2183436|FG008|Overall Study|Voluntary Withdrawal|0
1105439|NCT02413255|2183437|FG009|Overall Study|Voluntary Withdrawal|0
1105440|NCT02413255|2183438|FG010|Overall Study|Voluntary Withdrawal|0
1105441|NCT02413255|2183439|FG011|Overall Study|Voluntary Withdrawal|0
1105442|NCT02413255|2183440|FG012|Overall Study|Voluntary Withdrawal|0
1105443|NCT02413255|2183441|FG013|Overall Study|Voluntary Withdrawal|0
1105444|NCT02413255|2183442|FG014|Overall Study|Voluntary Withdrawal|1
1105445|NCT02413255|2183443|FG015|Overall Study|Voluntary Withdrawal|0
1105446|NCT02413255|2183444|FG016|Overall Study|Voluntary Withdrawal|0
1105447|NCT02413294|2183495|FG000|Overall Study|Withdrawal by Subject|1
1105448|NCT02413333|2183512|FG000|Period 1|Adverse Event|1
1105449|NCT02413333|2183513|FG001|Period 1|Adverse Event|0
1105450|NCT02413333|2183512|FG000|Period 1|Reason Not Specified|0
1105451|NCT02413333|2183513|FG001|Period 1|Reason Not Specified|1
1105452|NCT02413333|2183512|FG000|Period 2|Protocol Deviation|1
1105453|NCT02413333|2183513|FG001|Period 2|Protocol Deviation|0
1105454|NCT02413346|2183521|FG000|Overall Study|Adverse Event|6
1105455|NCT02413346|2183522|FG001|Overall Study|Adverse Event|6
1105456|NCT02413346|2183521|FG000|Overall Study|Withdrawal by Subject|30
1105457|NCT02413346|2183522|FG001|Overall Study|Withdrawal by Subject|40
1105458|NCT02413346|2183521|FG000|Overall Study|Lost to Follow-up|17
1105459|NCT02413346|2183522|FG001|Overall Study|Lost to Follow-up|21
1105460|NCT02413346|2183521|FG000|Overall Study|Protocol Violation|2
1105461|NCT02413346|2183522|FG001|Overall Study|Protocol Violation|0
1105462|NCT02413346|2183521|FG000|Overall Study|Other Miscellaneous Reasons|4
1105463|NCT02413346|2183522|FG001|Overall Study|Other Miscellaneous Reasons|3
1105464|NCT02413372|2183531|FG000|Treatment|Lost to Follow-up|0
1105465|NCT02413372|2183532|FG001|Treatment|Lost to Follow-up|2
1105466|NCT02413372|2183533|FG002|Treatment|Lost to Follow-up|1
1105467|NCT02413372|2183531|FG000|Treatment|Withdrawal by Subject|1
1105468|NCT02413372|2183532|FG001|Treatment|Withdrawal by Subject|0
1105469|NCT02413372|2183533|FG002|Treatment|Withdrawal by Subject|0
1105470|NCT02413372|2183531|FG000|Follow-up|Lost to Follow-up|1
1105471|NCT02413372|2183532|FG001|Follow-up|Lost to Follow-up|1
1105472|NCT02413372|2183533|FG002|Follow-up|Lost to Follow-up|0
1105473|NCT02413372|2183531|FG000|Follow-up|Subject Withdrew Consent|1
1105474|NCT02413372|2183532|FG001|Follow-up|Subject Withdrew Consent|0
1105475|NCT02413372|2183533|FG002|Follow-up|Subject Withdrew Consent|1
1105476|NCT02413372|2183531|FG000|Follow-up|Subject unable to return for visit|0
1105477|NCT02413372|2183532|FG001|Follow-up|Subject unable to return for visit|0
1105478|NCT02413372|2183533|FG002|Follow-up|Subject unable to return for visit|1
1105479|NCT02413398|2183543|FG000|Overall Study|Lost to Follow-up|2
1105480|NCT02413398|2183544|FG001|Overall Study|Lost to Follow-up|4
1105481|NCT02413398|2183543|FG000|Overall Study|Withdrawal by Subject|1
1105482|NCT02413398|2183544|FG001|Overall Study|Withdrawal by Subject|1
1105483|NCT02413398|2183543|FG000|Overall Study|Other Eligibility criteria|1
1105484|NCT02413398|2183544|FG001|Overall Study|Other Eligibility criteria|2
1105485|NCT02413489|2183562|FG000|Overall Study|Death|11
1105486|NCT02413489|2183563|FG001|Overall Study|Death|3
1105487|NCT02413489|2183564|FG002|Overall Study|Death|4
1105488|NCT02413489|2183562|FG000|Overall Study|Withdrawal by Subject|2
1105489|NCT02413489|2183563|FG001|Overall Study|Withdrawal by Subject|0
1105490|NCT02413489|2183564|FG002|Overall Study|Withdrawal by Subject|0
1105491|NCT02413489|2183562|FG000|Overall Study|Study Terminated By Sponsor|2
1105492|NCT02413489|2183563|FG001|Overall Study|Study Terminated By Sponsor|13
1105493|NCT02413489|2183564|FG002|Overall Study|Study Terminated By Sponsor|1
1105494|NCT02413593|2183576|FG000|Overall Study|Lost to Follow-up|3
1105495|NCT02413593|2183576|FG000|Overall Study|Adverse Event|1
1105496|NCT02413996|2183597|FG000|Overall Study|not comfortable with the intervention|9
1105497|NCT02413996|2183598|FG001|Overall Study|not comfortable with the intervention|2
1105498|NCT02414828|2183631|FG000|Overall Study|Lost to Follow-up|0
1105499|NCT02414828|2183632|FG001|Overall Study|Lost to Follow-up|1
1105500|NCT02414828|2183633|FG002|Overall Study|Lost to Follow-up|1
1105501|NCT02414828|2183634|FG003|Overall Study|Lost to Follow-up|2
1105502|NCT02414841|2183647|FG000|Overall Study|Withdrawal by Subject|7
1105503|NCT02414841|2183648|FG001|Overall Study|Withdrawal by Subject|5
1105504|NCT02414841|2183647|FG000|Overall Study|Lost to Follow-up|13
1105505|NCT02414841|2183648|FG001|Overall Study|Lost to Follow-up|6
1105506|NCT02414841|2183647|FG000|Overall Study|Death|17
1105507|NCT02414841|2183648|FG001|Overall Study|Death|14
1105508|NCT02414841|2183647|FG000|Overall Study|Received a Kidney Transplant|13
1105509|NCT02414841|2183648|FG001|Overall Study|Received a Kidney Transplant|4
1105510|NCT02414841|2183647|FG000|Overall Study|Randomized But Not Treated|6
1105511|NCT02414841|2183648|FG001|Overall Study|Randomized But Not Treated|4
1105512|NCT02414854|2183660|FG000|Overall Study|Adverse Event|9
1105513|NCT02414854|2183661|FG001|Overall Study|Adverse Event|7
1105514|NCT02414854|2183662|FG002|Overall Study|Adverse Event|1
1105515|NCT02414854|2183663|FG003|Overall Study|Adverse Event|12
1105516|NCT02414854|2183660|FG000|Overall Study|Poor compliance to protocol|1
1105517|NCT02414854|2183661|FG001|Overall Study|Poor compliance to protocol|1
1105518|NCT02414854|2183662|FG002|Overall Study|Poor compliance to protocol|2
1105519|NCT02414854|2183663|FG003|Overall Study|Poor compliance to protocol|2
1105520|NCT02414854|2183660|FG000|Overall Study|Other than specified above|12
1105521|NCT02414854|2183661|FG001|Overall Study|Other than specified above|37
1105522|NCT02414854|2183662|FG002|Overall Study|Other than specified above|17
1105523|NCT02414854|2183663|FG003|Overall Study|Other than specified above|37
1105524|NCT02414932|2183675|FG000|Overall Study|Withdrawal by Subject|2
1105525|NCT02414932|2183676|FG001|Overall Study|Withdrawal by Subject|3
1105526|NCT02414932|2183675|FG000|Overall Study|Adverse Event|1
1105527|NCT02414932|2183676|FG001|Overall Study|Adverse Event|0
1105528|NCT02414958|2183685|FG000|Overall Study|Adverse Event|6
1105529|NCT02414958|2183686|FG001|Overall Study|Adverse Event|6
1105530|NCT02414958|2183687|FG002|Overall Study|Adverse Event|3
1105531|NCT02414958|2183685|FG000|Overall Study|Protocol Violation|10
1105532|NCT02414958|2183686|FG001|Overall Study|Protocol Violation|3
895316|NCT00696800|1866502|FG000|Overall Study|No/abnormal fertilization|11
895317|NCT00696800|1866503|FG001|Overall Study|No/abnormal fertilization|13
895318|NCT00696800|1866502|FG000|Overall Study|No/too few/bad quality embryos|24
895319|NCT00696800|1866503|FG001|Overall Study|No/too few/bad quality embryos|18
895320|NCT00696800|1866502|FG000|Overall Study|Other Reasons|5
1105533|NCT02414958|2183687|FG002|Overall Study|Protocol Violation|1
1105534|NCT02414958|2183685|FG000|Overall Study|Lost to Follow-up|7
1105535|NCT02414958|2183686|FG001|Overall Study|Lost to Follow-up|4
1105536|NCT02414958|2183687|FG002|Overall Study|Lost to Follow-up|0
1105537|NCT02414958|2183685|FG000|Overall Study|Withdrawal by Subject|5
1105538|NCT02414958|2183686|FG001|Overall Study|Withdrawal by Subject|3
1105539|NCT02414958|2183687|FG002|Overall Study|Withdrawal by Subject|5
1105540|NCT02414958|2183685|FG000|Overall Study|Other than specified|4
1105541|NCT02414958|2183686|FG001|Overall Study|Other than specified|4
1105542|NCT02414958|2183687|FG002|Overall Study|Other than specified|5
1105543|NCT02415127|2183697|FG000|Overall Study|Adverse Event|1
1105544|NCT02415127|2183698|FG001|Overall Study|Adverse Event|0
1105545|NCT02415400|2183717|FG000|Overall Study|Adverse Event|0
1105546|NCT02415400|2183718|FG001|Overall Study|Adverse Event|1
1105547|NCT02415400|2183719|FG002|Overall Study|Adverse Event|1
1105548|NCT02415400|2183720|FG003|Overall Study|Adverse Event|2
1105549|NCT02415400|2183717|FG000|Overall Study|Participant request to stop therapy|4
1105550|NCT02415400|2183718|FG001|Overall Study|Participant request to stop therapy|3
1105551|NCT02415400|2183719|FG002|Overall Study|Participant request to stop therapy|8
1105552|NCT02415400|2183720|FG003|Overall Study|Participant request to stop therapy|6
1105553|NCT02415400|2183717|FG000|Overall Study|Participant withdrew consent|14
1105554|NCT02415400|2183718|FG001|Overall Study|Participant withdrew consent|12
1105555|NCT02415400|2183719|FG002|Overall Study|Participant withdrew consent|30
1105556|NCT02415400|2183720|FG003|Overall Study|Participant withdrew consent|21
1105557|NCT02415400|2183717|FG000|Overall Study|Death|39
1105558|NCT02415400|2183718|FG001|Overall Study|Death|41
1105559|NCT02415400|2183719|FG002|Overall Study|Death|35
1105560|NCT02415400|2183720|FG003|Overall Study|Death|42
1105561|NCT02415400|2183717|FG000|Overall Study|Lost to Follow-up|3
1105562|NCT02415400|2183718|FG001|Overall Study|Lost to Follow-up|3
1105563|NCT02415400|2183719|FG002|Overall Study|Lost to Follow-up|2
1105564|NCT02415400|2183720|FG003|Overall Study|Lost to Follow-up|5
1105565|NCT02415400|2183717|FG000|Overall Study|Poor/Non-Compliance|0
1105566|NCT02415400|2183718|FG001|Overall Study|Poor/Non-Compliance|1
1105567|NCT02415400|2183719|FG002|Overall Study|Poor/Non-Compliance|3
1105568|NCT02415400|2183720|FG003|Overall Study|Poor/Non-Compliance|4
1105569|NCT02415400|2183717|FG000|Overall Study|Participant no longer meets criteria|2
1105570|NCT02415400|2183718|FG001|Overall Study|Participant no longer meets criteria|0
1105571|NCT02415400|2183719|FG002|Overall Study|Participant no longer meets criteria|0
1105572|NCT02415400|2183720|FG003|Overall Study|Participant no longer meets criteria|1
1105573|NCT02415400|2183717|FG000|Overall Study|Participant doesn't answer phone|1
1105574|NCT02415400|2183718|FG001|Overall Study|Participant doesn't answer phone|0
1105575|NCT02415400|2183719|FG002|Overall Study|Participant doesn't answer phone|0
1105576|NCT02415400|2183720|FG003|Overall Study|Participant doesn't answer phone|0
1105577|NCT02415400|2183717|FG000|Overall Study|Participant wanted home visits|1
1105578|NCT02415400|2183718|FG001|Overall Study|Participant wanted home visits|0
1162067|NCT03382418|2284044|FG001|Overall Study|Lost to Follow-up|3
1105579|NCT02415400|2183719|FG002|Overall Study|Participant wanted home visits|0
1105580|NCT02415400|2183720|FG003|Overall Study|Participant wanted home visits|0
1105581|NCT02415400|2183717|FG000|Overall Study|Randomized in error|2
1105582|NCT02415400|2183718|FG001|Overall Study|Randomized in error|0
1105583|NCT02415400|2183719|FG002|Overall Study|Randomized in error|0
1105584|NCT02415400|2183720|FG003|Overall Study|Randomized in error|0
1105585|NCT02415400|2183717|FG000|Overall Study|No study drug on site|0
1105586|NCT02415400|2183718|FG001|Overall Study|No study drug on site|1
1105587|NCT02415400|2183719|FG002|Overall Study|No study drug on site|0
1105588|NCT02415400|2183720|FG003|Overall Study|No study drug on site|0
1105589|NCT02415400|2183717|FG000|Overall Study|Stroke and stroke rehabilitation|0
1105590|NCT02415400|2183718|FG001|Overall Study|Stroke and stroke rehabilitation|0
1105591|NCT02415400|2183719|FG002|Overall Study|Stroke and stroke rehabilitation|1
1105592|NCT02415400|2183720|FG003|Overall Study|Stroke and stroke rehabilitation|0
1105593|NCT02415400|2183717|FG000|Overall Study|Coagulation values cannot be set|0
1105594|NCT02415400|2183718|FG001|Overall Study|Coagulation values cannot be set|0
1105595|NCT02415400|2183719|FG002|Overall Study|Coagulation values cannot be set|1
1105596|NCT02415400|2183720|FG003|Overall Study|Coagulation values cannot be set|0
1105597|NCT02415400|2183717|FG000|Overall Study|State regulations prevent participation|0
1105598|NCT02415400|2183718|FG001|Overall Study|State regulations prevent participation|0
1105599|NCT02415400|2183719|FG002|Overall Study|State regulations prevent participation|1
1105600|NCT02415400|2183720|FG003|Overall Study|State regulations prevent participation|0
1105601|NCT02415400|2183717|FG000|Overall Study|Poor treatment monitoring|0
1105602|NCT02415400|2183718|FG001|Overall Study|Poor treatment monitoring|0
1105603|NCT02415400|2183719|FG002|Overall Study|Poor treatment monitoring|1
1105604|NCT02415400|2183720|FG003|Overall Study|Poor treatment monitoring|0
1105605|NCT02415400|2183717|FG000|Overall Study|Participant in jail|0
1105606|NCT02415400|2183718|FG001|Overall Study|Participant in jail|0
1105607|NCT02415400|2183719|FG002|Overall Study|Participant in jail|1
1105608|NCT02415400|2183720|FG003|Overall Study|Participant in jail|0
1105609|NCT02415400|2183717|FG000|Overall Study|Investigator decision|0
1105610|NCT02415400|2183718|FG001|Overall Study|Investigator decision|0
1105611|NCT02415400|2183719|FG002|Overall Study|Investigator decision|1
1105612|NCT02415400|2183720|FG003|Overall Study|Investigator decision|1
1105613|NCT02415400|2183717|FG000|Overall Study|Site closure; participant won't transfer|0
1105614|NCT02415400|2183718|FG001|Overall Study|Site closure; participant won't transfer|0
1105615|NCT02415400|2183719|FG002|Overall Study|Site closure; participant won't transfer|0
1105616|NCT02415400|2183720|FG003|Overall Study|Site closure; participant won't transfer|1
1105617|NCT02415556|2183793|FG000|Overall Study|Adverse Event|3
1105618|NCT02415556|2183794|FG001|Overall Study|Adverse Event|4
1105619|NCT02415556|2183795|FG002|Overall Study|Adverse Event|2
1105620|NCT02415556|2183796|FG003|Overall Study|Adverse Event|4
1105621|NCT02415556|2183793|FG000|Overall Study|Lost to Follow-up|4
1105622|NCT02415556|2183794|FG001|Overall Study|Lost to Follow-up|5
1105623|NCT02415556|2183795|FG002|Overall Study|Lost to Follow-up|4
1105624|NCT02415556|2183796|FG003|Overall Study|Lost to Follow-up|1
1105625|NCT02415556|2183793|FG000|Overall Study|Withdrawal by Subject|13
1105626|NCT02415556|2183794|FG001|Overall Study|Withdrawal by Subject|4
1105627|NCT02415556|2183795|FG002|Overall Study|Withdrawal by Subject|14
1105628|NCT02415556|2183796|FG003|Overall Study|Withdrawal by Subject|12
1105629|NCT02415556|2183793|FG000|Overall Study|Physician Decision|1
1105630|NCT02415556|2183794|FG001|Overall Study|Physician Decision|3
1105631|NCT02415556|2183795|FG002|Overall Study|Physician Decision|1
1105632|NCT02415556|2183796|FG003|Overall Study|Physician Decision|2
1105633|NCT02415556|2183793|FG000|Overall Study|Censored - study completion|4
1105634|NCT02415556|2183794|FG001|Overall Study|Censored - study completion|5
1105635|NCT02415556|2183795|FG002|Overall Study|Censored - study completion|1
1105636|NCT02415556|2183796|FG003|Overall Study|Censored - study completion|0
1105637|NCT02415556|2183793|FG000|Overall Study|Family-related issues|0
1105638|NCT02415556|2183794|FG001|Overall Study|Family-related issues|0
1105639|NCT02415556|2183795|FG002|Overall Study|Family-related issues|0
1105640|NCT02415556|2183796|FG003|Overall Study|Family-related issues|1
1105641|NCT02415959|2183917|FG000|Overall Study|Adverse Event|0
1105642|NCT02415959|2183918|FG001|Overall Study|Adverse Event|1
1105643|NCT02415959|2183919|FG002|Overall Study|Adverse Event|0
1105644|NCT02415959|2183920|FG003|Overall Study|Adverse Event|0
1105645|NCT02415959|2183921|FG004|Overall Study|Adverse Event|0
1105646|NCT02415959|2183917|FG000|Overall Study|Protocol Violation|0
1105647|NCT02415959|2183918|FG001|Overall Study|Protocol Violation|0
1105648|NCT02415959|2183919|FG002|Overall Study|Protocol Violation|0
1105649|NCT02415959|2183920|FG003|Overall Study|Protocol Violation|1
1105650|NCT02415959|2183921|FG004|Overall Study|Protocol Violation|0
1105651|NCT02416180|2183976|FG000|Overall Study|Withdrawal by Subject|1
1105652|NCT02416453|2184000|FG000|Overall Study|Adverse Event|0
1105653|NCT02416453|2184001|FG001|Overall Study|Adverse Event|0
1105654|NCT02416453|2184002|FG002|Overall Study|Adverse Event|0
1105655|NCT02416453|2184003|FG003|Overall Study|Adverse Event|2
1105656|NCT02416453|2184004|FG004|Overall Study|Adverse Event|0
1105657|NCT02416453|2184005|FG005|Overall Study|Adverse Event|1
1105658|NCT02416453|2184006|FG006|Overall Study|Adverse Event|0
1105659|NCT02416453|2184007|FG007|Overall Study|Adverse Event|0
1105660|NCT02416453|2184008|FG008|Overall Study|Adverse Event|0
895321|NCT00696800|1866503|FG001|Overall Study|Other Reasons|3
895322|NCT00696800|1866502|FG000|Overall Study|Not treated|1
895323|NCT00696800|1866503|FG001|Overall Study|Not treated|2
895324|NCT00696878|1866509|FG000|Overall Study|Adverse Event|8
895325|NCT00696878|1866509|FG000|Overall Study|Withdrawal by Subject|87
895326|NCT00696878|1866509|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
1105661|NCT02416453|2184009|FG009|Overall Study|Adverse Event|0
1105662|NCT02416453|2184010|FG010|Overall Study|Adverse Event|0
1105663|NCT02416453|2184000|FG000|Overall Study|Lost to Follow-up|1
1105664|NCT02416453|2184001|FG001|Overall Study|Lost to Follow-up|3
1105665|NCT02416453|2184002|FG002|Overall Study|Lost to Follow-up|0
1105666|NCT02416453|2184003|FG003|Overall Study|Lost to Follow-up|8
1105667|NCT02416453|2184004|FG004|Overall Study|Lost to Follow-up|0
1105668|NCT02416453|2184005|FG005|Overall Study|Lost to Follow-up|5
1105669|NCT02416453|2184006|FG006|Overall Study|Lost to Follow-up|1
1105670|NCT02416453|2184007|FG007|Overall Study|Lost to Follow-up|3
1105671|NCT02416453|2184008|FG008|Overall Study|Lost to Follow-up|1
1105672|NCT02416453|2184009|FG009|Overall Study|Lost to Follow-up|0
1105673|NCT02416453|2184010|FG010|Overall Study|Lost to Follow-up|0
1105674|NCT02416453|2184000|FG000|Overall Study|Physician Decision|0
1105675|NCT02416453|2184001|FG001|Overall Study|Physician Decision|0
1105676|NCT02416453|2184002|FG002|Overall Study|Physician Decision|0
1105677|NCT02416453|2184003|FG003|Overall Study|Physician Decision|0
1105678|NCT02416453|2184004|FG004|Overall Study|Physician Decision|0
1105679|NCT02416453|2184005|FG005|Overall Study|Physician Decision|1
1105680|NCT02416453|2184006|FG006|Overall Study|Physician Decision|1
1105681|NCT02416453|2184007|FG007|Overall Study|Physician Decision|1
1105682|NCT02416453|2184008|FG008|Overall Study|Physician Decision|0
1105683|NCT02416453|2184009|FG009|Overall Study|Physician Decision|0
1105684|NCT02416453|2184010|FG010|Overall Study|Physician Decision|0
1105685|NCT02416453|2184000|FG000|Overall Study|Withdrawal by Subject|2
1105686|NCT02416453|2184001|FG001|Overall Study|Withdrawal by Subject|0
1105687|NCT02416453|2184002|FG002|Overall Study|Withdrawal by Subject|0
1105688|NCT02416453|2184003|FG003|Overall Study|Withdrawal by Subject|5
1105689|NCT02416453|2184004|FG004|Overall Study|Withdrawal by Subject|1
1105690|NCT02416453|2184005|FG005|Overall Study|Withdrawal by Subject|8
1105691|NCT02416453|2184006|FG006|Overall Study|Withdrawal by Subject|0
1105692|NCT02416453|2184007|FG007|Overall Study|Withdrawal by Subject|8
1105693|NCT02416453|2184008|FG008|Overall Study|Withdrawal by Subject|4
1105694|NCT02416453|2184009|FG009|Overall Study|Withdrawal by Subject|0
1105695|NCT02416453|2184010|FG010|Overall Study|Withdrawal by Subject|0
1105696|NCT02416453|2184000|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
1105697|NCT02416453|2184001|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
1105698|NCT02416453|2184002|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1
1105699|NCT02416453|2184003|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
1105700|NCT02416453|2184004|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
1105701|NCT02416453|2184005|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
1105702|NCT02416453|2184006|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
1105703|NCT02416453|2184007|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
1105704|NCT02416453|2184008|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
1105705|NCT02416453|2184009|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
1105706|NCT02416453|2184010|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
1105707|NCT02416453|2184000|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
1105708|NCT02416453|2184001|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
1105709|NCT02416453|2184002|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
1105710|NCT02416453|2184003|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
1105711|NCT02416453|2184004|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
1105712|NCT02416453|2184005|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1
1105713|NCT02416453|2184006|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
1105714|NCT02416453|2184007|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
1105715|NCT02416453|2184008|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
1105716|NCT02416453|2184009|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
1105717|NCT02416453|2184010|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
1105718|NCT02416791|2184073|FG000|6 Months|Lost to Follow-up|0
1105719|NCT02416791|2184074|FG001|6 Months|Lost to Follow-up|0
1105720|NCT02416791|2184075|FG002|6 Months|Lost to Follow-up|1
1105721|NCT02416908|2184086|FG000|Dose Escalation Phase|Adverse Event|0
1105722|NCT02416908|2184087|FG001|Dose Escalation Phase|Adverse Event|0
1105723|NCT02416908|2184088|FG002|Dose Escalation Phase|Adverse Event|3
1105724|NCT02416908|2184089|FG003|Dose Escalation Phase|Adverse Event|0
1105725|NCT02416908|2184086|FG000|Dose Escalation Phase|Withdrawal by Subject|0
1105726|NCT02416908|2184087|FG001|Dose Escalation Phase|Withdrawal by Subject|0
1105727|NCT02416908|2184088|FG002|Dose Escalation Phase|Withdrawal by Subject|1
1105728|NCT02416908|2184089|FG003|Dose Escalation Phase|Withdrawal by Subject|0
1105729|NCT02416934|2184098|FG000|Overall Study|given steroids|1
1105730|NCT02416934|2184099|FG001|Overall Study|given steroids|2
1105731|NCT02416934|2184098|FG000|Overall Study|Lost to Follow-up|0
1105732|NCT02416934|2184099|FG001|Overall Study|Lost to Follow-up|2
1105733|NCT02416934|2184098|FG000|Overall Study|Withdrawal by Subject|1
1105734|NCT02416934|2184099|FG001|Overall Study|Withdrawal by Subject|0
1105735|NCT02416934|2184098|FG000|Overall Study|recruited during continuing renewal proc|0
1105736|NCT02416934|2184099|FG001|Overall Study|recruited during continuing renewal proc|1
1105737|NCT02416934|2184098|FG000|Overall Study|Protocol Violation|0
1105738|NCT02416934|2184099|FG001|Overall Study|Protocol Violation|1
1105739|NCT02416934|2184098|FG000|Overall Study|surgery started late|0
1105740|NCT02416934|2184099|FG001|Overall Study|surgery started late|1
1105741|NCT02416934|2184098|FG000|Overall Study|re-operation|1
1105742|NCT02416934|2184099|FG001|Overall Study|re-operation|0
1105743|NCT02417064|2184127|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
1105744|NCT02417064|2184128|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
1105745|NCT02417064|2184129|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
1105746|NCT02417064|2184127|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
1105747|NCT02417064|2184128|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
1105748|NCT02417064|2184129|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
1105749|NCT02417064|2184127|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
1105750|NCT02417064|2184128|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
1105751|NCT02417064|2184129|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
1105752|NCT02417064|2184127|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
1105753|NCT02417064|2184128|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
1105754|NCT02417064|2184129|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
1105755|NCT02417064|2184127|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
1105756|NCT02417064|2184128|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
1105757|NCT02417064|2184129|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
1105758|NCT02417064|2184127|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
1105759|NCT02417064|2184128|FG001|Double-blind Induction Phase (4 Weeks)|Other|4
1105760|NCT02417064|2184129|FG002|Double-blind Induction Phase (4 Weeks)|Other|2
1105761|NCT02417064|2184127|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
1105762|NCT02417064|2184128|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
1105763|NCT02417064|2184129|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
1105764|NCT02417064|2184127|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0
1105765|NCT02417064|2184128|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0
1105766|NCT02417064|2184129|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1
1105767|NCT02417064|2184127|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
1105768|NCT02417064|2184128|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
1105769|NCT02417064|2184129|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
1105770|NCT02417064|2184127|FG000|Follow-up Phase (24 Weeks)|PI Decision|34
1105771|NCT02417064|2184128|FG001|Follow-up Phase (24 Weeks)|PI Decision|29
1105772|NCT02417064|2184129|FG002|Follow-up Phase (24 Weeks)|PI Decision|44
1105773|NCT02417064|2184127|FG000|Follow-up Phase (24 Weeks)|Other|2
1105774|NCT02417064|2184128|FG001|Follow-up Phase (24 Weeks)|Other|2
1105775|NCT02417064|2184129|FG002|Follow-up Phase (24 Weeks)|Other|3
1105776|NCT02417233|2184159|FG000|Overall Study|Death|4
1105777|NCT02417233|2184160|FG001|Overall Study|Death|10
1105778|NCT02417233|2184161|FG002|Overall Study|Death|14
1105779|NCT02417233|2184159|FG000|Overall Study|Lost to Follow-up|27
1105780|NCT02417233|2184160|FG001|Overall Study|Lost to Follow-up|39
1105781|NCT02417233|2184161|FG002|Overall Study|Lost to Follow-up|34
1105782|NCT02417233|2184159|FG000|Overall Study|Protocol Violation|2
1105783|NCT02417233|2184160|FG001|Overall Study|Protocol Violation|0
1105784|NCT02417233|2184161|FG002|Overall Study|Protocol Violation|2
1105785|NCT02417233|2184159|FG000|Overall Study|Withdrawal by Subject|2
1105786|NCT02417233|2184160|FG001|Overall Study|Withdrawal by Subject|1
1105787|NCT02417233|2184161|FG002|Overall Study|Withdrawal by Subject|8
1105788|NCT02417233|2184159|FG000|Overall Study|Relocation out of study area|1
1105789|NCT02417233|2184160|FG001|Overall Study|Relocation out of study area|0
1105790|NCT02417233|2184161|FG002|Overall Study|Relocation out of study area|1
1105791|NCT02417233|2184159|FG000|Overall Study|Mentally unstable|0
1105792|NCT02417233|2184160|FG001|Overall Study|Mentally unstable|1
1105793|NCT02417233|2184161|FG002|Overall Study|Mentally unstable|0
1105794|NCT02417246|2184172|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
1105795|NCT02417246|2184173|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
1105796|NCT02417246|2184172|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
1105797|NCT02417246|2184173|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
1105798|NCT02417246|2184172|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
1105799|NCT02417246|2184173|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
1105800|NCT02417246|2184172|FG000|Phase 2 1st Generic Administered|Physician Decision|1
1105801|NCT02417246|2184173|FG001|Phase 2 1st Generic Administered|Physician Decision|0
1105802|NCT02417441|2184192|FG000|Overall Study|Inconclusive due to missing data|52
1105803|NCT02417441|2184193|FG001|Overall Study|Inconclusive due to missing data|19
1105804|NCT02417753|2184206|FG000|Overall Study|Death|1
1105805|NCT02417935|2184226|FG000|Treatment Period|Adverse Event|12
1105806|NCT02417935|2184227|FG001|Treatment Period|Adverse Event|10
1105807|NCT02417935|2184226|FG000|Treatment Period|Lost to Follow-up|1
1105808|NCT02417935|2184227|FG001|Treatment Period|Lost to Follow-up|0
1105809|NCT02417935|2184226|FG000|Treatment Period|Entry Criteria not met|0
1105810|NCT02417935|2184227|FG001|Treatment Period|Entry Criteria not met|1
1105811|NCT02417935|2184226|FG000|Treatment Period|Protocol Violation|2
1105812|NCT02417935|2184227|FG001|Treatment Period|Protocol Violation|1
1105813|NCT02417935|2184226|FG000|Treatment Period|Withdrawal by Subject|3
1105814|NCT02417935|2184227|FG001|Treatment Period|Withdrawal by Subject|3
1105815|NCT02417935|2184226|FG000|Treatment Period|Physician Decision|3
1105816|NCT02417935|2184227|FG001|Treatment Period|Physician Decision|1
1105817|NCT02417961|2184233|FG000|Overall Study|Adverse Event|1
1105818|NCT02417961|2184233|FG000|Overall Study|Lost to Follow-up|1
1105819|NCT02417961|2184233|FG000|Overall Study|Withdrawal by Subject|2
1105820|NCT02418000|2184242|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
1105821|NCT02418000|2184243|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
1105822|NCT02418000|2184244|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
1105823|NCT02418000|2184245|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
1105824|NCT02418000|2184246|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
1105825|NCT02418000|2184242|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
1105826|NCT02418000|2184243|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
1105827|NCT02418000|2184244|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
1105828|NCT02418000|2184245|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
1105829|NCT02418000|2184246|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
1105830|NCT02418000|2184242|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
1105831|NCT02418000|2184243|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
1105832|NCT02418000|2184244|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
1105833|NCT02418000|2184245|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
1105834|NCT02418000|2184246|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
1105835|NCT02418000|2184242|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
1105836|NCT02418000|2184243|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
1105837|NCT02418000|2184244|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
1105838|NCT02418000|2184245|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
1105839|NCT02418000|2184246|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
1105840|NCT02418000|2184242|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
1105841|NCT02418000|2184243|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
1105842|NCT02418000|2184244|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
1105843|NCT02418000|2184245|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
1105844|NCT02418000|2184246|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
1105845|NCT02418000|2184242|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105846|NCT02418000|2184243|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105847|NCT02418000|2184244|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
1105848|NCT02418000|2184245|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105849|NCT02418000|2184246|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105850|NCT02418000|2184242|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105851|NCT02418000|2184243|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105852|NCT02418000|2184244|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105853|NCT02418000|2184245|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
1105854|NCT02418000|2184246|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105855|NCT02418000|2184242|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
1105856|NCT02418000|2184243|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
1105857|NCT02418000|2184244|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
1105858|NCT02418000|2184245|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
1105859|NCT02418000|2184246|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
1105860|NCT02418000|2184242|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105861|NCT02418000|2184243|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105862|NCT02418000|2184244|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105863|NCT02418000|2184245|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
1105864|NCT02418000|2184246|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
1105865|NCT02418156|2184279|FG000|Overall Study|Lost to Follow-up|12
1105866|NCT02418156|2184279|FG000|Overall Study|Death|2
1105867|NCT02418156|2184279|FG000|Overall Study|Physician Decision|1
1105868|NCT02418156|2184279|FG000|Overall Study|Withdrawal by Subject|1
1105869|NCT02418156|2184279|FG000|Overall Study|Subject refused to return|1
1105870|NCT02418182|2184285|FG000|Overall Study|Unable to re-consent|18
1105871|NCT02418182|2184286|FG001|Overall Study|Unable to re-consent|15
1105872|NCT02418182|2184285|FG000|Overall Study|Lost to Follow-up|0
1105873|NCT02418182|2184286|FG001|Overall Study|Lost to Follow-up|2
1105874|NCT02418455|2184309|FG000|48-Week Treatment Period|Other- Not Specified|1
1105875|NCT02418455|2184309|FG000|Continuation Period|Sponsor Decision|7
1105876|NCT02418468|2184317|FG000|Overall Study|Adverse Event|1
1105877|NCT02418468|2184318|FG001|Overall Study|Adverse Event|0
1105878|NCT02418468|2184317|FG000|Overall Study|Withdrawal of informed consent|1
1105879|NCT02418468|2184318|FG001|Overall Study|Withdrawal of informed consent|1
1105880|NCT02418585|2184339|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
1105881|NCT02418585|2184340|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
1105882|NCT02418585|2184339|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
1105883|NCT02418585|2184340|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
1105884|NCT02418585|2184339|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
1105885|NCT02418585|2184340|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
1105886|NCT02418585|2184339|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
1105887|NCT02418585|2184340|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
1105888|NCT02418585|2184339|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
1105889|NCT02418585|2184340|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
1105890|NCT02418585|2184339|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0
1105891|NCT02418585|2184340|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1
1105892|NCT02418585|2184339|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
1105893|NCT02418585|2184340|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
1105894|NCT02418585|2184339|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
1105895|NCT02418585|2184340|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
1105896|NCT02418585|2184339|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6
1105897|NCT02418585|2184340|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17
1105898|NCT02418585|2184339|FG000|Follow-up Phase (24 Weeks)|Other|3
1105899|NCT02418585|2184340|FG001|Follow-up Phase (24 Weeks)|Other|2
1105900|NCT02418754|2184364|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0
1105901|NCT02418754|2184365|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2
1105902|NCT02418754|2184366|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0
1105903|NCT02418754|2184367|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0
1105904|NCT02418754|2184368|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0
1105905|NCT02418754|2184364|FG000|Period 1 (Day 1 to Week 12)|Death|1
1105906|NCT02418754|2184365|FG001|Period 1 (Day 1 to Week 12)|Death|0
1105907|NCT02418754|2184366|FG002|Period 1 (Day 1 to Week 12)|Death|0
1105908|NCT02418754|2184367|FG003|Period 1 (Day 1 to Week 12)|Death|0
1105909|NCT02418754|2184368|FG004|Period 1 (Day 1 to Week 12)|Death|0
1105910|NCT02418754|2184364|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1
1105911|NCT02418754|2184365|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0
1105912|NCT02418754|2184366|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0
1105913|NCT02418754|2184367|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0
1105914|NCT02418754|2184368|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0
1105915|NCT02418754|2184364|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
1105916|NCT02418754|2184365|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2
1105917|NCT02418754|2184366|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1
1105918|NCT02418754|2184367|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
1105919|NCT02418754|2184368|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
1105920|NCT02418754|2184364|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
1105921|NCT02418754|2184365|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
1105922|NCT02418754|2184366|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1
1105923|NCT02418754|2184367|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
1105924|NCT02418754|2184368|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
1105925|NCT02418754|2184364|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3
1105926|NCT02418754|2184365|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7
1105927|NCT02418754|2184366|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6
1105928|NCT02418754|2184367|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
1105929|NCT02418754|2184368|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
1105930|NCT02418754|2184364|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1
1105931|NCT02418754|2184365|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0
1105932|NCT02418754|2184366|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0
1105933|NCT02418754|2184367|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0
1105934|NCT02418754|2184368|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0
1105935|NCT02418754|2184364|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
1105936|NCT02418754|2184365|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28
1105937|NCT02418754|2184366|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
1105938|NCT02418754|2184367|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21
1105939|NCT02418754|2184368|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24
1105940|NCT02418754|2184364|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3
1105941|NCT02418754|2184365|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
1105942|NCT02418754|2184366|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
1105943|NCT02418754|2184367|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1
1105944|NCT02418754|2184368|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0
1105945|NCT02418754|2184364|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0
1105946|NCT02418754|2184365|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
1105947|NCT02418754|2184366|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
1105948|NCT02418754|2184367|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
1105949|NCT02418754|2184368|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
1105950|NCT02418754|2184364|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
1105951|NCT02418754|2184365|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
1105952|NCT02418754|2184366|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
1105953|NCT02418754|2184367|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
1105954|NCT02418754|2184368|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
1105955|NCT02418819|2184382|FG000|Overall Study|Adverse Event|0
1105956|NCT02418819|2184383|FG001|Overall Study|Adverse Event|0
1105957|NCT02418819|2184384|FG002|Overall Study|Adverse Event|1
1105958|NCT02418819|2184385|FG003|Overall Study|Adverse Event|0
1105959|NCT02418819|2184382|FG000|Overall Study|Lost to Follow-up|1
1105960|NCT02418819|2184383|FG001|Overall Study|Lost to Follow-up|0
1105961|NCT02418819|2184384|FG002|Overall Study|Lost to Follow-up|0
1105962|NCT02418819|2184385|FG003|Overall Study|Lost to Follow-up|0
1105963|NCT02418819|2184382|FG000|Overall Study|No longer meets eligibility criteria|0
1105964|NCT02418819|2184383|FG001|Overall Study|No longer meets eligibility criteria|0
1105965|NCT02418819|2184384|FG002|Overall Study|No longer meets eligibility criteria|1
1105966|NCT02418819|2184385|FG003|Overall Study|No longer meets eligibility criteria|0
1105967|NCT02418819|2184382|FG000|Overall Study|No longer willing to participate|0
1105968|NCT02418819|2184383|FG001|Overall Study|No longer willing to participate|0
1105969|NCT02418819|2184384|FG002|Overall Study|No longer willing to participate|2
1105970|NCT02418819|2184385|FG003|Overall Study|No longer willing to participate|1
1105971|NCT02418845|2184397|FG000|Overall Study|Lost to Follow-up|7
1105972|NCT02418845|2184398|FG001|Overall Study|Lost to Follow-up|2
1105973|NCT02418845|2184397|FG000|Overall Study|Lack of Efficacy|0
1105974|NCT02418845|2184398|FG001|Overall Study|Lack of Efficacy|3
1105975|NCT02418845|2184397|FG000|Overall Study|Physician Decision|5
1105976|NCT02418845|2184398|FG001|Overall Study|Physician Decision|5
1105977|NCT02418845|2184397|FG000|Overall Study|Protocol Violation|1
1105978|NCT02418845|2184398|FG001|Overall Study|Protocol Violation|0
1105979|NCT02418845|2184397|FG000|Overall Study|Withdrawal by Subject|3
1105980|NCT02418845|2184398|FG001|Overall Study|Withdrawal by Subject|2
1105981|NCT02418910|2184404|FG000|Overall Study|Lost to Follow-up|3
1105982|NCT02418910|2184404|FG000|Overall Study|Withdrawal by Subject|4
1105983|NCT02418949|2184412|FG000|Overall Study|Withdrawal by Subject|1
1105984|NCT02418949|2184413|FG001|Overall Study|Withdrawal by Subject|0
1105985|NCT02418949|2184414|FG002|Overall Study|Withdrawal by Subject|1
1105986|NCT02418949|2184415|FG003|Overall Study|Withdrawal by Subject|1
1105987|NCT02418949|2184412|FG000|Overall Study|Lost to Follow-up|1
1105988|NCT02418949|2184413|FG001|Overall Study|Lost to Follow-up|0
1105989|NCT02418949|2184414|FG002|Overall Study|Lost to Follow-up|1
1105990|NCT02418949|2184415|FG003|Overall Study|Lost to Follow-up|0
1105991|NCT02418949|2184412|FG000|Overall Study|Physician Decision|1
1105992|NCT02418949|2184413|FG001|Overall Study|Physician Decision|1
1105993|NCT02418949|2184414|FG002|Overall Study|Physician Decision|1
1105994|NCT02418949|2184415|FG003|Overall Study|Physician Decision|0
1105995|NCT02419001|2184427|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
1105996|NCT02419001|2184428|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
1105997|NCT02419313|2184434|FG000|First Intervention|Lost to Follow-up|2
1105998|NCT02419313|2184435|FG001|First Intervention|Lost to Follow-up|0
1105999|NCT02419313|2184434|FG000|Second Intervention|Lost to Follow-up|1
1106000|NCT02419313|2184435|FG001|Second Intervention|Lost to Follow-up|0
1106001|NCT02419469|2184441|FG000|Overall Study|Withdrawal by Subject|1
1106002|NCT02419508|2184447|FG000|Overall Study|Adverse Event|9
1106003|NCT02419508|2184448|FG001|Overall Study|Adverse Event|3
1106004|NCT02419508|2184447|FG000|Overall Study|Withdrawal by Subject|1
1106005|NCT02419508|2184448|FG001|Overall Study|Withdrawal by Subject|0
1106006|NCT02419508|2184447|FG000|Overall Study|Other - Reason not specified|0
1106007|NCT02419508|2184448|FG001|Overall Study|Other - Reason not specified|1
1106008|NCT02419573|2184464|FG000|Overall Study|Lost to Follow-up|3
1106009|NCT02419573|2184465|FG001|Overall Study|Lost to Follow-up|0
1106010|NCT02419573|2184464|FG000|Overall Study|Withdrawal by Subject|1
1106011|NCT02419573|2184465|FG001|Overall Study|Withdrawal by Subject|0
1106012|NCT02419612|2184473|FG000|Short-term Treatment Period|Adverse Event|1
1106013|NCT02419612|2184474|FG001|Short-term Treatment Period|Adverse Event|1
1106014|NCT02419612|2184473|FG000|Short-term Treatment Period|Death|0
1106015|NCT02419612|2184474|FG001|Short-term Treatment Period|Death|2
1106016|NCT02419612|2184473|FG000|Short-term Treatment Period|Lost to Follow-up|6
1106017|NCT02419612|2184474|FG001|Short-term Treatment Period|Lost to Follow-up|6
1106018|NCT02419612|2184473|FG000|Short-term Treatment Period|Withdrawal by Subject|9
1106019|NCT02419612|2184474|FG001|Short-term Treatment Period|Withdrawal by Subject|9
1106020|NCT02419612|2184473|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
1106021|NCT02419612|2184474|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
1106022|NCT02419612|2184473|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0
1106023|NCT02419612|2184474|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2
1106024|NCT02419612|2184473|FG000|Short-term Treatment Period|Worsening of liver function|0
1106025|NCT02419612|2184474|FG001|Short-term Treatment Period|Worsening of liver function|1
1106026|NCT02419612|2184473|FG000|Short-term Treatment Period|Subject moved out of state|0
1106027|NCT02419612|2184474|FG001|Short-term Treatment Period|Subject moved out of state|1
1106028|NCT02419612|2184473|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1
1106029|NCT02419612|2184474|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1
1106030|NCT02419612|2184473|FG000|Long-term Treatment Period|Lost to Follow-up|6
1106031|NCT02419612|2184474|FG001|Long-term Treatment Period|Lost to Follow-up|4
1106032|NCT02419612|2184473|FG000|Long-term Treatment Period|Lack of Efficacy|1
1106033|NCT02419612|2184474|FG001|Long-term Treatment Period|Lack of Efficacy|1
1106034|NCT02419612|2184473|FG000|Long-term Treatment Period|Death|0
1106035|NCT02419612|2184474|FG001|Long-term Treatment Period|Death|1
1106036|NCT02419612|2184473|FG000|Long-term Treatment Period|Adverse Event|0
1106037|NCT02419612|2184474|FG001|Long-term Treatment Period|Adverse Event|5
1106038|NCT02419612|2184473|FG000|Long-term Treatment Period|Other|4
1106039|NCT02419612|2184474|FG001|Long-term Treatment Period|Other|4
1106040|NCT02419612|2184473|FG000|Long-term Treatment Period|Subject Decision|2
1106041|NCT02419612|2184474|FG001|Long-term Treatment Period|Subject Decision|4
1106042|NCT02419612|2184473|FG000|Long-term Treatment Period|Withdrawal by Subject|8
1106043|NCT02419612|2184474|FG001|Long-term Treatment Period|Withdrawal by Subject|2
1106044|NCT02419755|2184491|FG000|Overall Study|Death|1
1106045|NCT02419755|2184492|FG001|Overall Study|Death|3
1106046|NCT02419755|2184491|FG000|Overall Study|Relapse|0
1106047|NCT02419755|2184492|FG001|Overall Study|Relapse|1
1106048|NCT02419755|2184491|FG000|Overall Study|Ineligible|1
1106049|NCT02419755|2184492|FG001|Overall Study|Ineligible|0
1106050|NCT02419755|2184491|FG000|Overall Study|Withdrawal by Subject|1
1106051|NCT02419755|2184492|FG001|Overall Study|Withdrawal by Subject|0
1106052|NCT02419807|2184498|FG000|Overall Study|Withdrawal by Subject|4
1106053|NCT02419807|2184498|FG000|Overall Study|Physician Decision|1
1106054|NCT02419807|2184498|FG000|Overall Study|Protocol Violation|5
1106055|NCT02419937|2184508|FG000|Overall Study|Lost to Follow-up|1
1106056|NCT02419937|2184509|FG001|Overall Study|Lost to Follow-up|0
1106057|NCT02420093|2184535|FG000|Overall Study|Withdrawal by Subject|1
1106058|NCT02420093|2184536|FG001|Overall Study|Withdrawal by Subject|1
1106059|NCT02420223|2184548|FG000|Overall Study|Adverse Event|1
1106060|NCT02420223|2184549|FG001|Overall Study|Adverse Event|0
1106061|NCT02420223|2184548|FG000|Overall Study|Physician Decision|0
1106062|NCT02420223|2184549|FG001|Overall Study|Physician Decision|2
1106063|NCT02420262|2184557|FG000|Overall Study|Adverse Event|1
1106064|NCT02420262|2184558|FG001|Overall Study|Adverse Event|0
1106065|NCT02420262|2184557|FG000|Overall Study|Withdrawal by Subject|1
1106066|NCT02420262|2184558|FG001|Overall Study|Withdrawal by Subject|4
1106067|NCT02420262|2184557|FG000|Overall Study|Unclassified|0
1106068|NCT02420262|2184558|FG001|Overall Study|Unclassified|1
1106069|NCT02420327|2184564|FG000|Overall Study|Adverse Event|7
1106070|NCT02420327|2184564|FG000|Overall Study|Pregnancy|1
1106071|NCT02420327|2184564|FG000|Overall Study|Withdrawal by Subject|6
1106072|NCT02420327|2184564|FG000|Overall Study|Lost to Follow-up|1
1106073|NCT02420327|2184564|FG000|Overall Study|Protocol Violation|1
1106074|NCT02420353|2184576|FG000|Overall Study|Withdrawal by Subject|0
1106075|NCT02420353|2184577|FG001|Overall Study|Withdrawal by Subject|1
1106076|NCT02420379|2184585|FG000|Overall Study|Withdrawal by Subject|0
1106077|NCT02420379|2184586|FG001|Overall Study|Withdrawal by Subject|3
1106078|NCT02420379|2184585|FG000|Overall Study|Unable to complete due to schooling|0
1106079|NCT02420379|2184586|FG001|Overall Study|Unable to complete due to schooling|1
1106080|NCT02420379|2184585|FG000|Overall Study|Transitioned to commercial drug|1
1106081|NCT02420379|2184586|FG001|Overall Study|Transitioned to commercial drug|0
1106082|NCT02420691|2184596|FG000|Overall Study|Adverse Event|3
1106083|NCT02420691|2184596|FG000|Overall Study|Withdrawal by Subject|3
1106094|NCT02421120|2184654|FG000|Overall Study|Adverse Event|1
1106095|NCT02421172|2184677|FG000|Period 1|Adverse Event|1
1106096|NCT02421172|2184678|FG001|Period 1|Adverse Event|0
1106097|NCT02421172|2184679|FG002|Period 1|Adverse Event|0
1106098|NCT02421172|2184680|FG003|Period 1|Adverse Event|0
1106099|NCT02421172|2184681|FG004|Period 1|Adverse Event|0
1106100|NCT02421172|2184677|FG000|Period 1|Lost to Follow-up|3
1106101|NCT02421172|2184678|FG001|Period 1|Lost to Follow-up|1
1106102|NCT02421172|2184679|FG002|Period 1|Lost to Follow-up|0
1106103|NCT02421172|2184680|FG003|Period 1|Lost to Follow-up|0
1106104|NCT02421172|2184681|FG004|Period 1|Lost to Follow-up|0
1106105|NCT02421172|2184677|FG000|Period 1|Patient/guardian decision|0
1106106|NCT02421172|2184678|FG001|Period 1|Patient/guardian decision|1
1106107|NCT02421172|2184679|FG002|Period 1|Patient/guardian decision|0
1106108|NCT02421172|2184680|FG003|Period 1|Patient/guardian decision|0
1106109|NCT02421172|2184681|FG004|Period 1|Patient/guardian decision|0
1106110|NCT02421172|2184677|FG000|Period 2|Adverse Event|0
1106111|NCT02421172|2184678|FG001|Period 2|Adverse Event|0
1106112|NCT02421172|2184679|FG002|Period 2|Adverse Event|4
1106113|NCT02421172|2184680|FG003|Period 2|Adverse Event|0
1106114|NCT02421172|2184681|FG004|Period 2|Adverse Event|0
1106115|NCT02421172|2184677|FG000|Period 2|Lost to Follow-up|0
1106116|NCT02421172|2184678|FG001|Period 2|Lost to Follow-up|0
1106117|NCT02421172|2184679|FG002|Period 2|Lost to Follow-up|0
1106118|NCT02421172|2184680|FG003|Period 2|Lost to Follow-up|1
1106119|NCT02421172|2184681|FG004|Period 2|Lost to Follow-up|0
1106120|NCT02421172|2184677|FG000|Period 2|Patient/guardian decision|0
1106121|NCT02421172|2184678|FG001|Period 2|Patient/guardian decision|0
1106122|NCT02421172|2184679|FG002|Period 2|Patient/guardian decision|3
1106123|NCT02421172|2184680|FG003|Period 2|Patient/guardian decision|2
1106124|NCT02421172|2184681|FG004|Period 2|Patient/guardian decision|1
1106125|NCT02421419|2184749|FG000|Overall Study|Physician Decision|0
1106126|NCT02421419|2184750|FG001|Overall Study|Physician Decision|0
1106127|NCT02421419|2184751|FG002|Overall Study|Physician Decision|1
1106128|NCT02421510|2184762|FG000|Overall Study|Other|4
1106129|NCT02421510|2184763|FG001|Overall Study|Other|2
1106130|NCT02421510|2184764|FG002|Overall Study|Other|3
1106131|NCT02421510|2184762|FG000|Overall Study|Protocol Violation|1
1106132|NCT02421510|2184763|FG001|Overall Study|Protocol Violation|2
1106133|NCT02421510|2184764|FG002|Overall Study|Protocol Violation|0
1106134|NCT02421510|2184762|FG000|Overall Study|Death|1
1106135|NCT02421510|2184763|FG001|Overall Study|Death|0
1106136|NCT02421510|2184764|FG002|Overall Study|Death|0
1106137|NCT02421510|2184762|FG000|Overall Study|Noncompliance with study drug|1
1106138|NCT02421510|2184763|FG001|Overall Study|Noncompliance with study drug|0
1106139|NCT02421510|2184764|FG002|Overall Study|Noncompliance with study drug|0
1106140|NCT02421510|2184762|FG000|Overall Study|Physician Decision|1
1106141|NCT02421510|2184763|FG001|Overall Study|Physician Decision|1
1106142|NCT02421510|2184764|FG002|Overall Study|Physician Decision|3
1106143|NCT02421510|2184762|FG000|Overall Study|Adverse Event|9
1106144|NCT02421510|2184763|FG001|Overall Study|Adverse Event|10
1106145|NCT02421510|2184764|FG002|Overall Study|Adverse Event|18
1106146|NCT02421510|2184762|FG000|Overall Study|Pregnancy|1
1106147|NCT02421510|2184763|FG001|Overall Study|Pregnancy|1
1106148|NCT02421510|2184764|FG002|Overall Study|Pregnancy|0
1106149|NCT02421510|2184762|FG000|Overall Study|Withdrawal by Subject|14
1106150|NCT02421510|2184763|FG001|Overall Study|Withdrawal by Subject|18
1106151|NCT02421510|2184764|FG002|Overall Study|Withdrawal by Subject|12
1106152|NCT02421510|2184762|FG000|Overall Study|Lost to Follow-up|1
1106153|NCT02421510|2184763|FG001|Overall Study|Lost to Follow-up|1
1106154|NCT02421510|2184764|FG002|Overall Study|Lost to Follow-up|0
1106155|NCT02421588|2184774|FG000|Overall Study|Non-treatment-related AE|8
1106156|NCT02421588|2184775|FG001|Overall Study|Non-treatment-related AE|8
1106157|NCT02421588|2184774|FG000|Overall Study|Progressive disease|152
1106158|NCT02421588|2184775|FG001|Overall Study|Progressive disease|135
1106159|NCT02421588|2184774|FG000|Overall Study|Death|11
1106160|NCT02421588|2184775|FG001|Overall Study|Death|3
1106161|NCT02421588|2184774|FG000|Overall Study|Physician Decision|8
1106162|NCT02421588|2184775|FG001|Overall Study|Physician Decision|17
1106163|NCT02421588|2184774|FG000|Overall Study|Other reason not specified|3
1106164|NCT02421588|2184775|FG001|Overall Study|Other reason not specified|1
1106165|NCT02421588|2184774|FG000|Overall Study|Symptomatic deterioration|13
1106166|NCT02421588|2184775|FG001|Overall Study|Symptomatic deterioration|19
1106167|NCT02421588|2184774|FG000|Overall Study|Treatment-related AE|10
1106168|NCT02421588|2184775|FG001|Overall Study|Treatment-related AE|14
1106169|NCT02421588|2184774|FG000|Overall Study|Withdrawal by Subject|14
1106170|NCT02421588|2184775|FG001|Overall Study|Withdrawal by Subject|16
1106171|NCT02421588|2184774|FG000|Overall Study|Not treated|2
1106172|NCT02421588|2184775|FG001|Overall Study|Not treated|8
1106173|NCT02421601|2184781|FG000|Overall Study|Adverse Event|4
1106174|NCT02421601|2184781|FG000|Overall Study|Lack of Efficacy|5
1106175|NCT02421601|2184781|FG000|Overall Study|Physician Decision|1
1106176|NCT02421601|2184781|FG000|Overall Study|Withdrawal by Subject|31
1106177|NCT02421601|2184781|FG000|Overall Study|Others|41
1106178|NCT02421666|2184787|FG000|6-month Follow-up|Lost to Follow-up|8
1106179|NCT02421666|2184788|FG001|6-month Follow-up|Lost to Follow-up|7
1106180|NCT02421666|2184787|FG000|6-month Follow-up|Withdrawal by Subject|5
1106181|NCT02421666|2184788|FG001|6-month Follow-up|Withdrawal by Subject|6
1106182|NCT02421666|2184787|FG000|12-month Follow-up|Lost to Follow-up|5
1106183|NCT02421666|2184788|FG001|12-month Follow-up|Lost to Follow-up|5
1106184|NCT02421666|2184787|FG000|12-month Follow-up|Withdrawal by Subject|6
1106185|NCT02421666|2184788|FG001|12-month Follow-up|Withdrawal by Subject|11
1106186|NCT02421887|2184805|FG000|Overall Study|Lost to Follow-up|5
1106187|NCT02421887|2184806|FG001|Overall Study|Lost to Follow-up|0
1106188|NCT02421887|2184805|FG000|Overall Study|Withdrawal by Subject|8
1106189|NCT02421887|2184806|FG001|Overall Study|Withdrawal by Subject|5
1106190|NCT02421887|2184805|FG000|Overall Study|Physician Decision|2
1106191|NCT02421887|2184806|FG001|Overall Study|Physician Decision|4
1106192|NCT02421887|2184805|FG000|Overall Study|Adverse Event|2
1106193|NCT02421887|2184806|FG001|Overall Study|Adverse Event|0
1106194|NCT02421939|2184814|FG000|Overall Study|Progressive disease|70
1106195|NCT02421939|2184815|FG001|Overall Study|Progressive disease|16
1106196|NCT02421939|2184814|FG000|Overall Study|Lack of Efficacy|21
1106197|NCT02421939|2184815|FG001|Overall Study|Lack of Efficacy|31
1106198|NCT02421939|2184814|FG000|Overall Study|Death|36
1106199|NCT02421939|2184815|FG001|Overall Study|Death|10
1106200|NCT02421939|2184814|FG000|Overall Study|Disease relapse|33
1106201|NCT02421939|2184815|FG001|Overall Study|Disease relapse|2
1106202|NCT02421939|2184814|FG000|Overall Study|Adverse Event|28
1106203|NCT02421939|2184815|FG001|Overall Study|Adverse Event|5
1106204|NCT02421939|2184814|FG000|Overall Study|Withdrawal by Subject|5
1106205|NCT02421939|2184815|FG001|Overall Study|Withdrawal by Subject|24
1106206|NCT02421939|2184814|FG000|Overall Study|Physician Decision|11
1106207|NCT02421939|2184815|FG001|Overall Study|Physician Decision|11
1106208|NCT02421939|2184814|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
1106209|NCT02421939|2184815|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
1106210|NCT02421939|2184814|FG000|Overall Study|Miscellaneous|4
1106211|NCT02421939|2184815|FG001|Overall Study|Miscellaneous|5
1106212|NCT02421939|2184814|FG000|Overall Study|Protocol deviation|1
1106213|NCT02421939|2184815|FG001|Overall Study|Protocol deviation|1
1106214|NCT02421952|2184821|FG000|Overall Study|Diary Not Returned|93
1106215|NCT02421952|2184821|FG000|Overall Study|Failed seriation task|13
1106216|NCT02421952|2184821|FG000|Overall Study|Subject uncooperative for baseline test|2
1106217|NCT02421952|2184821|FG000|Overall Study|Surgery cancelled|1
1106218|NCT02422186|2184830|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
1106219|NCT02422186|2184831|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
1106220|NCT02422186|2184830|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
1106221|NCT02422186|2184831|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
1106222|NCT02422186|2184830|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
1106223|NCT02422186|2184831|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
1106224|NCT02422186|2184830|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
1106225|NCT02422186|2184831|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
1106226|NCT02422186|2184830|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
1106227|NCT02422186|2184831|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
1106228|NCT02422186|2184830|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
1106229|NCT02422186|2184831|FG001|Double-blind Induction Phase (4 Weeks)|Other|0
1106230|NCT02422186|2184830|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
1106231|NCT02422186|2184831|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
1106232|NCT02422186|2184830|FG000|Follow-up Phase (2 Weeks)|Other|3
1106233|NCT02422186|2184831|FG001|Follow-up Phase (2 Weeks)|Other|0
1106234|NCT02422264|2184841|FG000|Overall Study|Serious Adverse Event|1
1106235|NCT02422264|2184842|FG001|Overall Study|Serious Adverse Event|0
1106236|NCT02422264|2184841|FG000|Overall Study|Withdrawal by Subject|1
1106237|NCT02422264|2184842|FG001|Overall Study|Withdrawal by Subject|2
1106238|NCT02422264|2184841|FG000|Overall Study|Migrated/moved from study area|3
1106239|NCT02422264|2184842|FG001|Overall Study|Migrated/moved from study area|1
1106240|NCT02422264|2184841|FG000|Overall Study|Subject vaccinated outside of the study|0
1106241|NCT02422264|2184842|FG001|Overall Study|Subject vaccinated outside of the study|1
895327|NCT00696878|1866509|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304
895328|NCT00696878|1866509|FG000|Overall Study|Trial stopped|32
895329|NCT00696878|1866509|FG000|Overall Study|Other reason (not specified)|55
895330|NCT00697073|1866513|FG000|Overall Study|Withdrawal by Subject|2
895331|NCT00697073|1866513|FG000|Overall Study|Pregnancy|1
895332|NCT00697073|1866513|FG000|Overall Study|non compliance and other|6
895333|NCT00697112|1866517|FG000|Overall Study|Adverse Event|8
895334|NCT00697112|1866517|FG000|Overall Study|Lost to Follow-up|1
895335|NCT00697112|1866517|FG000|Overall Study|Did not meet inclusion criteria|1
895336|NCT00697255|1866551|FG000|Stage 1a|Insufficient ovarian response|1
895337|NCT00697255|1866552|FG001|Stage 1a|Insufficient ovarian response|0
895338|NCT00697255|1866551|FG000|Stage 1a|Multifollicular growth|1
895339|NCT00697255|1866552|FG001|Stage 1a|Multifollicular growth|0
895340|NCT00697255|1866551|FG000|Stage 1a|Not growing of dominant follicle|1
895341|NCT00697255|1866552|FG001|Stage 1a|Not growing of dominant follicle|0
895342|NCT00697255|1866551|FG000|Stage 1b|Not growing of dominant follicle|0
895343|NCT00697255|1866552|FG001|Stage 1b|Not growing of dominant follicle|1
895344|NCT00697255|1866551|FG000|Stage 1b|Insufficient ovarian response|0
895345|NCT00697255|1866552|FG001|Stage 1b|Insufficient ovarian response|1
895346|NCT00697346|1866561|FG000|Overall Study|Adverse Event|4
895347|NCT00697346|1866562|FG001|Overall Study|Adverse Event|5
895348|NCT00697346|1866563|FG002|Overall Study|Adverse Event|0
895349|NCT00697346|1866561|FG000|Overall Study|Progressive Disease|19
895350|NCT00697346|1866562|FG001|Overall Study|Progressive Disease|18
895351|NCT00697346|1866563|FG002|Overall Study|Progressive Disease|0
895352|NCT00697346|1866561|FG000|Overall Study|Symptomatic Deterioration|0
895353|NCT00697346|1866562|FG001|Overall Study|Symptomatic Deterioration|1
895354|NCT00697346|1866563|FG002|Overall Study|Symptomatic Deterioration|0
895355|NCT00697346|1866561|FG000|Overall Study|Withdrawal by Subject|2
895356|NCT00697346|1866562|FG001|Overall Study|Withdrawal by Subject|2
895357|NCT00697346|1866563|FG002|Overall Study|Withdrawal by Subject|0
895358|NCT00697346|1866561|FG000|Overall Study|Reason not Specified|3
895359|NCT00697346|1866562|FG001|Overall Study|Reason not Specified|0
895360|NCT00697346|1866563|FG002|Overall Study|Reason not Specified|1
895361|NCT00697463|1866590|FG000|Overall Study|Withdrawal by Subject|1
1106284|NCT02423109|2184931|FG000|Lens 1|Adverse Event|1
1106285|NCT02423109|2184932|FG001|Lens 1|Adverse Event|0
1106286|NCT02423291|2184959|FG000|Overall Study|Lack of Efficacy|14
1106287|NCT02423291|2184959|FG000|Overall Study|Adverse Event|1
1106288|NCT02423343|2184978|FG000|Overall Study|Withdrawal by Subject|0
1106289|NCT02423343|2184979|FG001|Overall Study|Withdrawal by Subject|1
1106290|NCT02423343|2184980|FG002|Overall Study|Withdrawal by Subject|0
1106291|NCT02423343|2184981|FG003|Overall Study|Withdrawal by Subject|0
1106292|NCT02423343|2184982|FG004|Overall Study|Withdrawal by Subject|0
1106293|NCT02423343|2184983|FG005|Overall Study|Withdrawal by Subject|0
1106294|NCT02423343|2184978|FG000|Overall Study|Progressive Disease|0
1106295|NCT02423343|2184979|FG001|Overall Study|Progressive Disease|0
1106296|NCT02423343|2184980|FG002|Overall Study|Progressive Disease|0
1106297|NCT02423343|2184981|FG003|Overall Study|Progressive Disease|0
1106298|NCT02423343|2184982|FG004|Overall Study|Progressive Disease|2
1106299|NCT02423343|2184983|FG005|Overall Study|Progressive Disease|0
1106300|NCT02423343|2184978|FG000|Overall Study|Adverse Event|0
1106301|NCT02423343|2184979|FG001|Overall Study|Adverse Event|0
1106302|NCT02423343|2184980|FG002|Overall Study|Adverse Event|0
1106303|NCT02423343|2184981|FG003|Overall Study|Adverse Event|0
1106304|NCT02423343|2184982|FG004|Overall Study|Adverse Event|2
1106305|NCT02423343|2184983|FG005|Overall Study|Adverse Event|0
1106306|NCT02423343|2184978|FG000|Overall Study|Death|0
1106307|NCT02423343|2184979|FG001|Overall Study|Death|0
1106308|NCT02423343|2184980|FG002|Overall Study|Death|0
1106309|NCT02423343|2184981|FG003|Overall Study|Death|0
1106310|NCT02423343|2184982|FG004|Overall Study|Death|1
1106311|NCT02423343|2184983|FG005|Overall Study|Death|0
1106312|NCT02423798|2185039|FG000|Overall Study|Withdrawal by Subject|3
1106313|NCT02424097|2185069|FG000|Overall Study|Lost to Follow-up|1
1106314|NCT02424097|2185070|FG001|Overall Study|Lost to Follow-up|2
1106315|NCT02424149|2185078|FG000|Overall Study|surgery cancelled|2
1106316|NCT02424149|2185079|FG001|Overall Study|surgery cancelled|0
1106317|NCT02424149|2185078|FG000|Overall Study|Withdrawal by Subject|0
1106318|NCT02424149|2185079|FG001|Overall Study|Withdrawal by Subject|1
1106319|NCT02424253|2185091|FG000|Overall Study|Other, unspecified|1
1106320|NCT02424253|2185092|FG001|Overall Study|Other, unspecified|0
1106321|NCT02424253|2185091|FG000|Overall Study|Compliance problems|1
1106322|NCT02424253|2185092|FG001|Overall Study|Compliance problems|0
1106323|NCT02424253|2185091|FG000|Overall Study|Physician Decision|2
1106324|NCT02424253|2185092|FG001|Overall Study|Physician Decision|0
1106325|NCT02424253|2185091|FG000|Overall Study|Lack of Efficacy|0
1106326|NCT02424253|2185092|FG001|Overall Study|Lack of Efficacy|7
1106327|NCT02424253|2185091|FG000|Overall Study|Adverse Event|2
1106328|NCT02424253|2185092|FG001|Overall Study|Adverse Event|0
1106329|NCT02424253|2185091|FG000|Overall Study|Consent withdrawn by subject|4
1106330|NCT02424253|2185092|FG001|Overall Study|Consent withdrawn by subject|1
1106331|NCT02424253|2185091|FG000|Overall Study|Lost to Follow-up|1
1106332|NCT02424253|2185092|FG001|Overall Study|Lost to Follow-up|1
1106333|NCT02424344|2185100|FG000|Overall Study|Lack of Efficacy|0
1106334|NCT02424344|2185101|FG001|Overall Study|Lack of Efficacy|1
1106335|NCT02424344|2185100|FG000|Overall Study|Withdrawal by Subject|2
1106336|NCT02424344|2185101|FG001|Overall Study|Withdrawal by Subject|1
1106337|NCT02424344|2185100|FG000|Overall Study|Lost to Follow-up|1
1106338|NCT02424344|2185101|FG001|Overall Study|Lost to Follow-up|0
1106339|NCT02424344|2185100|FG000|Overall Study|Adverse Event|4
1106340|NCT02424344|2185101|FG001|Overall Study|Adverse Event|8
1106341|NCT02424383|2185118|FG000|Overall Study|Withdrawal by Subject|32
1106342|NCT02424383|2185118|FG000|Overall Study|Death|170
1106343|NCT02424383|2185118|FG000|Overall Study|Sponsor's decision|3
1106344|NCT02424383|2185118|FG000|Overall Study|Investigator's decision|44
1106345|NCT02424383|2185118|FG000|Overall Study|Lost to Follow-up|81
1106346|NCT02424383|2185118|FG000|Overall Study|Other|7
1106347|NCT02424383|2185118|FG000|Overall Study|Ineligible for Major Protocol Deviation|39
1106348|NCT02424539|2185136|FG000|Overall Study|Adverse Event|0
1106349|NCT02424539|2185137|FG001|Overall Study|Adverse Event|0
1106350|NCT02424539|2185138|FG002|Overall Study|Adverse Event|1
1106351|NCT02424539|2185136|FG000|Overall Study|Physician Decision|0
1106352|NCT02424539|2185137|FG001|Overall Study|Physician Decision|0
1106353|NCT02424539|2185138|FG002|Overall Study|Physician Decision|1
1106354|NCT02424539|2185136|FG000|Overall Study|Withdrawal by Subject|3
1106355|NCT02424539|2185137|FG001|Overall Study|Withdrawal by Subject|1
1106356|NCT02424539|2185138|FG002|Overall Study|Withdrawal by Subject|0
1106357|NCT02424539|2185136|FG000|Overall Study|Other: Reached stopping criteria|11
1106358|NCT02424539|2185137|FG001|Overall Study|Other: Reached stopping criteria|7
1106359|NCT02424539|2185138|FG002|Overall Study|Other: Reached stopping criteria|6
1106360|NCT02424578|2185148|FG000|Overall Study|Withdrawal by Subject|0
1106361|NCT02424578|2185149|FG001|Overall Study|Withdrawal by Subject|1
1106362|NCT02424591|2185157|FG000|Overall Study|Protocol Violation|2
1106363|NCT02424591|2185158|FG001|Overall Study|Protocol Violation|3
1106364|NCT02424630|2185166|FG000|Overall Study|No rotator cuff tear|1
1106365|NCT02424630|2185167|FG001|Overall Study|No rotator cuff tear|2
1106366|NCT02424630|2185166|FG000|Overall Study|Open procedure|0
1106367|NCT02424630|2185167|FG001|Overall Study|Open procedure|1
1106368|NCT02424734|2185176|FG000|Overall Study|Treatment stopped to be discharged home|2
1106369|NCT02424734|2185177|FG001|Overall Study|Treatment stopped to be discharged home|2
1106370|NCT02424734|2185178|FG002|Overall Study|Treatment stopped to be discharged home|0
1106371|NCT02425111|2185243|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
1106372|NCT02425111|2185243|FG000|Part A: Treatment Period|Lack of Efficacy|15
1106373|NCT02425111|2185243|FG000|Part A: Treatment Period|Voluntary Withdrawal|4
1106374|NCT02425111|2185243|FG000|Part A: Treatment Period|Lost to Follow-up|2
1106375|NCT02425111|2185243|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
1106376|NCT02425111|2185243|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7
895362|NCT00697515|1866594|FG000|Dose Optimization Period|Adverse Event|4
895363|NCT00697515|1866595|FG001|Dose Optimization Period|Adverse Event|0
895364|NCT00697515|1866594|FG000|Dose Optimization Period|Withdrawal by Subject|5
895365|NCT00697515|1866595|FG001|Dose Optimization Period|Withdrawal by Subject|0
895366|NCT00697515|1866594|FG000|Dose Optimization Period|Lost to Follow-up|2
895367|NCT00697515|1866595|FG001|Dose Optimization Period|Lost to Follow-up|0
895368|NCT00697515|1866594|FG000|Dose Optimization Period|sponsor request|2
895369|NCT00697515|1866595|FG001|Dose Optimization Period|sponsor request|0
895370|NCT00697515|1866594|FG000|Dose Optimization Period|called to active duty|1
895371|NCT00697515|1866595|FG001|Dose Optimization Period|called to active duty|0
895372|NCT00697515|1866594|FG000|Dose Optimization Period|elevated QTc|1
895373|NCT00697515|1866595|FG001|Dose Optimization Period|elevated QTc|0
895374|NCT00697515|1866594|FG000|First Intervention (Crossover Period)|Natural disaster|8
895375|NCT00697515|1866595|FG001|First Intervention (Crossover Period)|Natural disaster|9
895376|NCT00697515|1866594|FG000|First Intervention (Crossover Period)|Adverse Event|0
895377|NCT00697515|1866595|FG001|First Intervention (Crossover Period)|Adverse Event|2
895378|NCT00697515|1866594|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2
895379|NCT00697515|1866595|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1
895380|NCT00697515|1866594|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1
895381|NCT00697515|1866595|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1
895382|NCT00697593|1866611|FG000|Overall Study|Adverse Event|3
895383|NCT00697593|1866611|FG000|Overall Study|Protocol Violation|1
895384|NCT00697593|1866611|FG000|Overall Study|Lack of Efficacy|3
895385|NCT00697593|1866611|FG000|Overall Study|Suspension of the study by sponsor|12
895386|NCT00697619|1866617|FG000|Overall Study|Lack of Efficacy|2
895387|NCT00697619|1866618|FG001|Overall Study|Lack of Efficacy|2
895388|NCT00697619|1866617|FG000|Overall Study|Adverse Event|4
895389|NCT00697619|1866618|FG001|Overall Study|Adverse Event|6
895390|NCT00697788|1866633|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1106389|NCT02425826|2185297|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
1106390|NCT02425826|2185298|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
1106391|NCT02425826|2185299|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
1106392|NCT02425826|2185297|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
1106393|NCT02425826|2185298|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
1106394|NCT02425826|2185299|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
1106395|NCT02425826|2185297|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
1106396|NCT02425826|2185298|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
1106397|NCT02425826|2185299|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
1106398|NCT02425826|2185297|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
1106399|NCT02425826|2185298|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
1106400|NCT02425826|2185299|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
1106401|NCT02425826|2185297|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3
1106402|NCT02425826|2185298|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1
1106403|NCT02425826|2185299|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0
1106404|NCT02425826|2185297|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
1106405|NCT02425826|2185298|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
1106406|NCT02425826|2185299|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
1106407|NCT02425826|2185297|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
1106408|NCT02425826|2185298|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
1106409|NCT02425826|2185299|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
1106410|NCT02425826|2185297|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
1106411|NCT02425826|2185298|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
1106412|NCT02425826|2185299|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
1106413|NCT02425826|2185297|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
1106414|NCT02425826|2185298|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
1106415|NCT02425826|2185299|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
1106416|NCT02425826|2185297|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
1106417|NCT02425826|2185298|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
1106418|NCT02425826|2185299|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
1106419|NCT02425891|2185311|FG000|Overall Study|Death|332
1106420|NCT02425891|2185312|FG001|Overall Study|Death|314
1106421|NCT02425891|2185311|FG000|Overall Study|Lost to Follow-up|4
1106422|NCT02425891|2185312|FG001|Overall Study|Lost to Follow-up|6
1106423|NCT02425891|2185311|FG000|Overall Study|Non-Compliance|1
1106424|NCT02425891|2185312|FG001|Overall Study|Non-Compliance|0
1106425|NCT02425891|2185311|FG000|Overall Study|Accidentally randomized screen failure participant|0
1106426|NCT02425891|2185312|FG001|Overall Study|Accidentally randomized screen failure participant|1
1106427|NCT02425891|2185311|FG000|Overall Study|Physician Decision|0
1106428|NCT02425891|2185312|FG001|Overall Study|Physician Decision|1
1106429|NCT02425891|2185311|FG000|Overall Study|Protocol Violation|1
1106430|NCT02425891|2185312|FG001|Overall Study|Protocol Violation|1
1106431|NCT02425891|2185311|FG000|Overall Study|Study Terminated By Sponsor|1
1106432|NCT02425891|2185312|FG001|Overall Study|Study Terminated By Sponsor|0
1106433|NCT02425891|2185311|FG000|Overall Study|Withdrawal by Subject|27
1106434|NCT02425891|2185312|FG001|Overall Study|Withdrawal by Subject|32
1106435|NCT02425891|2185311|FG000|Overall Study|On-going in Study|79
1106436|NCT02425891|2185312|FG001|Overall Study|On-going in Study|90
1106437|NCT02425891|2185311|FG000|Overall Study|Not treated|6
1106438|NCT02425891|2185312|FG001|Overall Study|Not treated|6
1106439|NCT02426086|2185325|FG000|Overall Study|Death|33
895391|NCT00697788|1866634|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
895392|NCT00697788|1866635|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
895393|NCT00697788|1866636|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
895394|NCT00697788|1866637|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
895395|NCT00697788|1866638|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
895396|NCT00697788|1866639|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
895397|NCT00697788|1866640|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
895398|NCT00697788|1866633|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
895399|NCT00697788|1866634|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
895400|NCT00697788|1866635|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
895401|NCT00697788|1866636|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
895402|NCT00697788|1866637|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
895403|NCT00697788|1866638|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
895404|NCT00697788|1866639|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
895405|NCT00697788|1866640|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1106440|NCT02426086|2185326|FG001|Overall Study|Death|36
1106441|NCT02426086|2185325|FG000|Overall Study|Lost to Follow-up|2
1106442|NCT02426086|2185326|FG001|Overall Study|Lost to Follow-up|0
1106443|NCT02426086|2185325|FG000|Overall Study|Study Terminated by Sponsor|5
1106444|NCT02426086|2185326|FG001|Overall Study|Study Terminated by Sponsor|14
1106445|NCT02426086|2185325|FG000|Overall Study|Withdrawal by Subject|8
1106446|NCT02426086|2185326|FG001|Overall Study|Withdrawal by Subject|9
1106453|NCT02426138|2185350|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
1106454|NCT02426138|2185351|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
1106455|NCT02426541|2185372|FG000|Overall Study|Protocol Violation|1
1106456|NCT02426541|2185373|FG001|Overall Study|Protocol Violation|0
1106457|NCT02426580|2185381|FG000|Overall Study|Death|2
1106458|NCT02426580|2185382|FG001|Overall Study|Death|2
1106459|NCT02426580|2185381|FG000|Overall Study|Lost to Follow-up|0
1106460|NCT02426580|2185382|FG001|Overall Study|Lost to Follow-up|9
1106461|NCT02426580|2185381|FG000|Overall Study|transfer to hemodialysis|5
1106462|NCT02426580|2185382|FG001|Overall Study|transfer to hemodialysis|5
1106463|NCT02426580|2185381|FG000|Overall Study|Kidney transplant|3
1106464|NCT02426580|2185382|FG001|Overall Study|Kidney transplant|0
1106465|NCT02426580|2185381|FG000|Overall Study|Allergic to egg white|1
1106466|NCT02426580|2185382|FG001|Overall Study|Allergic to egg white|0
1106467|NCT02426658|2185388|FG000|Overall Study|Withdrawal by Subject|1
1106468|NCT02426658|2185388|FG000|Overall Study|Patient expired before treatment|2
1106469|NCT02426918|2185406|FG000|Overall Study|Adverse Event|2
1106470|NCT02426918|2185407|FG001|Overall Study|Adverse Event|2
1106471|NCT02426918|2185408|FG002|Overall Study|Adverse Event|0
1106472|NCT02426918|2185406|FG000|Overall Study|Physician Decision|1
1106473|NCT02426918|2185407|FG001|Overall Study|Physician Decision|1
1106474|NCT02426918|2185408|FG002|Overall Study|Physician Decision|1
1106475|NCT02426918|2185406|FG000|Overall Study|Withdrawal by Subject|5
1106476|NCT02426918|2185407|FG001|Overall Study|Withdrawal by Subject|5
1106477|NCT02426918|2185408|FG002|Overall Study|Withdrawal by Subject|4
1106478|NCT02426918|2185406|FG000|Overall Study|Other|9
1106479|NCT02426918|2185407|FG001|Overall Study|Other|11
1106480|NCT02426918|2185408|FG002|Overall Study|Other|9
1106481|NCT02427100|2185418|FG000|Overall Study|Lost to Follow-up|0
1106482|NCT02427100|2185419|FG001|Overall Study|Lost to Follow-up|2
1106483|NCT02427399|2185430|FG000|Overall Study|Protocol Violation|14
1106484|NCT02427399|2185431|FG001|Overall Study|Protocol Violation|16
1106485|NCT02427399|2185432|FG002|Overall Study|Protocol Violation|12
1106486|NCT02427399|2185433|FG003|Overall Study|Protocol Violation|18
1106487|NCT02427399|2185434|FG004|Overall Study|Protocol Violation|15
1106488|NCT02427477|2185448|FG000|Period 1|Adverse Event|1
1106489|NCT02427477|2185449|FG001|Period 1|Adverse Event|0
1106490|NCT02427607|2185468|FG000|Overall Study|Withdrawal by Subject|1
1106491|NCT02427646|2185474|FG000|Overall Study|Lack of Efficacy|2
1106492|NCT02427646|2185475|FG001|Overall Study|Lack of Efficacy|3
1106493|NCT02427646|2185474|FG000|Overall Study|Physician Decision|1
1106494|NCT02427646|2185475|FG001|Overall Study|Physician Decision|4
1106495|NCT02427646|2185474|FG000|Overall Study|Protocol Violation|3
1106496|NCT02427646|2185475|FG001|Overall Study|Protocol Violation|3
1106497|NCT02427646|2185474|FG000|Overall Study|Bothersome hand weakness|2
1106498|NCT02427646|2185475|FG001|Overall Study|Bothersome hand weakness|4
1106499|NCT02427802|2185522|FG000|Overall Study|Adverse Event|11
1106500|NCT02427802|2185523|FG001|Overall Study|Adverse Event|3
1106501|NCT02427802|2185524|FG002|Overall Study|Adverse Event|7
1106502|NCT02427802|2185522|FG000|Overall Study|Death|0
1106503|NCT02427802|2185523|FG001|Overall Study|Death|4
1106504|NCT02427802|2185524|FG002|Overall Study|Death|1
1106505|NCT02427802|2185522|FG000|Overall Study|Lost to Follow-up|13
1106506|NCT02427802|2185523|FG001|Overall Study|Lost to Follow-up|8
1106507|NCT02427802|2185524|FG002|Overall Study|Lost to Follow-up|8
1106508|NCT02427802|2185522|FG000|Overall Study|Physician Decision|4
1106509|NCT02427802|2185523|FG001|Overall Study|Physician Decision|2
1106510|NCT02427802|2185524|FG002|Overall Study|Physician Decision|4
1106511|NCT02427802|2185522|FG000|Overall Study|Withdrawal by Subject|10
1106512|NCT02427802|2185523|FG001|Overall Study|Withdrawal by Subject|5
1106513|NCT02427802|2185524|FG002|Overall Study|Withdrawal by Subject|11
1106514|NCT02427802|2185522|FG000|Overall Study|Protocol Violation|3
1106515|NCT02427802|2185523|FG001|Overall Study|Protocol Violation|1
1106516|NCT02427802|2185524|FG002|Overall Study|Protocol Violation|1
1106517|NCT02427802|2185522|FG000|Overall Study|protocol specific treatment unrelated|18
1106518|NCT02427802|2185523|FG001|Overall Study|protocol specific treatment unrelated|11
1106519|NCT02427802|2185524|FG002|Overall Study|protocol specific treatment unrelated|11
1106520|NCT02427841|2185532|FG000|Overall Study|Physician Decision|8
1106521|NCT02427958|2185536|FG000|Overall Study|Pretreatment Event (PTE) or AE|3
1106522|NCT02427958|2185536|FG000|Overall Study|Lost to Follow-up|6
1106523|NCT02427958|2185536|FG000|Overall Study|Withdrawal by Subject|14
1106524|NCT02427958|2185536|FG000|Overall Study|Lack of Efficacy|1
1106525|NCT02427984|2185543|FG000|Overall Study|Lost to Follow-up|13
1106526|NCT02427984|2185544|FG001|Overall Study|Lost to Follow-up|5
1106527|NCT02427984|2185545|FG002|Overall Study|Lost to Follow-up|18
1106528|NCT02428296|2185564|FG000|Overall Study|Adverse Event|7
1106529|NCT02428296|2185564|FG000|Overall Study|Withdrawal by Subject|2
1106530|NCT02428413|2185578|FG000|Overall Study|Device to measure WAG malfunctioned|3
1106531|NCT02428413|2185579|FG001|Overall Study|Device to measure WAG malfunctioned|5
1106532|NCT02428413|2185578|FG000|Overall Study|Protocol Violation|1
1106533|NCT02428413|2185579|FG001|Overall Study|Protocol Violation|2
1106534|NCT02428413|2185578|FG000|Overall Study|Case Cancelled|2
1106535|NCT02428413|2185579|FG001|Overall Study|Case Cancelled|0
1106536|NCT02428413|2185578|FG000|Overall Study|Missed Cases|1
1106537|NCT02428413|2185579|FG001|Overall Study|Missed Cases|2
1106538|NCT02428413|2185578|FG000|Overall Study|Nurse Refusal|1
1106539|NCT02428413|2185579|FG001|Overall Study|Nurse Refusal|0
1106540|NCT02428608|2185605|FG000|Overall Study|Pregnancy|2
1106541|NCT02428608|2185605|FG000|Overall Study|Lost to Follow-up|37
1106542|NCT02428608|2185605|FG000|Overall Study|Withdrawal by Subject|2
1106543|NCT02428608|2185605|FG000|Overall Study|scheduling conflicts|15
1106544|NCT02428608|2185605|FG000|Overall Study|moved away|10
1106545|NCT02428608|2185605|FG000|Overall Study|Death|1
1106546|NCT02428608|2185605|FG000|Overall Study|various|16
1106547|NCT02428699|2185610|FG000|Washout Period 1|Screen Failure|1
1106548|NCT02428699|2185611|FG001|Washout Period 1|Screen Failure|2
1106549|NCT02428855|2185622|FG000|Overall Study|Withdrawal by Subject|2
1106550|NCT02429258|2185653|FG000|Overall Study|Withdrawal by Subject|2
1106551|NCT02429258|2185654|FG001|Overall Study|Withdrawal by Subject|0
1106552|NCT02429258|2185653|FG000|Overall Study|Protocol Violation|0
1106553|NCT02429258|2185654|FG001|Overall Study|Protocol Violation|1
1106554|NCT02429310|2185662|FG000|Overall Study|Lost to Follow-up|1
1106555|NCT02429310|2185663|FG001|Overall Study|Lost to Follow-up|2
1106556|NCT02429310|2185662|FG000|Overall Study|Protocol Violation|1
1106557|NCT02429310|2185663|FG001|Overall Study|Protocol Violation|1
1106558|NCT02429427|2185671|FG000|Overall Study|Adverse Event|220
1106559|NCT02429427|2185672|FG001|Overall Study|Adverse Event|92
1106560|NCT02429427|2185671|FG000|Overall Study|Protocol Violation|10
1106561|NCT02429427|2185672|FG001|Overall Study|Protocol Violation|6
1106562|NCT02429427|2185671|FG000|Overall Study|Lost to Follow-up|15
1106563|NCT02429427|2185672|FG001|Overall Study|Lost to Follow-up|6
1106564|NCT02429427|2185671|FG000|Overall Study|Withdrawal by Subject|64
1106565|NCT02429427|2185672|FG001|Overall Study|Withdrawal by Subject|34
1106566|NCT02429427|2185671|FG000|Overall Study|Other|62
1106567|NCT02429427|2185672|FG001|Overall Study|Other|41
1106568|NCT02429778|2185680|FG000|Overall Study|Lost to Follow-up|2
1106569|NCT02429778|2185681|FG001|Overall Study|Lost to Follow-up|0
1106570|NCT02429778|2185680|FG000|Overall Study|Withdrawal by Subject|5
1106571|NCT02429778|2185681|FG001|Overall Study|Withdrawal by Subject|0
1106596|NCT02429856|2185705|FG000|Overall Study|Death|12
1106597|NCT02429856|2185706|FG001|Overall Study|Death|13
1106598|NCT02429856|2185705|FG000|Overall Study|Lost to Follow-up|6
1106599|NCT02429856|2185706|FG001|Overall Study|Lost to Follow-up|5
1106600|NCT02429856|2185705|FG000|Overall Study|Withdrawal by Subject|1
1106601|NCT02429856|2185706|FG001|Overall Study|Withdrawal by Subject|1
1106602|NCT02429934|2185720|FG000|Overall Study|Withdrawal by Subject|0
1106603|NCT02429934|2185721|FG001|Overall Study|Withdrawal by Subject|2
1106604|NCT02429934|2185720|FG000|Overall Study|Adverse Event|2
1106605|NCT02429934|2185721|FG001|Overall Study|Adverse Event|0
1106606|NCT02429934|2185720|FG000|Overall Study|Lost to Follow-up|1
1106607|NCT02429934|2185721|FG001|Overall Study|Lost to Follow-up|1
1106608|NCT02429934|2185720|FG000|Overall Study|Physician Decision|1
1106609|NCT02429934|2185721|FG001|Overall Study|Physician Decision|0
1106610|NCT02430311|2185744|FG000|Part A|Adverse Event|0
1106611|NCT02430311|2185745|FG001|Part A|Adverse Event|1
1106612|NCT02430311|2185744|FG000|Part A|Withdrawal by Subject|1
1106613|NCT02430311|2185745|FG001|Part A|Withdrawal by Subject|0
1106614|NCT02430311|2185744|FG000|Part B|Meet study-specific withdrawal criteria|6
1106615|NCT02430311|2185745|FG001|Part B|Meet study-specific withdrawal criteria|6
1106616|NCT02430311|2185744|FG000|Part B|Withdrawal by Subject|2
1106617|NCT02430311|2185745|FG001|Part B|Withdrawal by Subject|2
1106618|NCT02430311|2185744|FG000|Part B|Adverse Event|1
1106619|NCT02430311|2185745|FG001|Part B|Adverse Event|0
1106620|NCT02430311|2185744|FG000|Part B|Death|1
1106621|NCT02430311|2185745|FG001|Part B|Death|0
1106622|NCT02430480|2185782|FG000|Overall Study|Death|1
1106623|NCT02430480|2185782|FG000|Overall Study|Anesthesia concerns|1
1106624|NCT02430480|2185782|FG000|Overall Study|Progressed on treatment|1
1106625|NCT02430870|2185810|FG000|Part 2|Voluntary Withdrawal|0
1106626|NCT02430870|2185811|FG001|Part 2|Voluntary Withdrawal|0
1106627|NCT02430870|2185812|FG002|Part 2|Voluntary Withdrawal|0
1106628|NCT02430870|2185813|FG003|Part 2|Voluntary Withdrawal|0
1106629|NCT02430870|2185814|FG004|Part 2|Voluntary Withdrawal|0
1106630|NCT02430870|2185815|FG005|Part 2|Voluntary Withdrawal|0
1106631|NCT02430870|2185816|FG006|Part 2|Voluntary Withdrawal|1
1106632|NCT02430870|2185817|FG007|Part 2|Voluntary Withdrawal|0
1106633|NCT02430870|2185810|FG000|Part 2|Other Reason Not Specified|0
1106634|NCT02430870|2185811|FG001|Part 2|Other Reason Not Specified|0
1106635|NCT02430870|2185812|FG002|Part 2|Other Reason Not Specified|0
1106636|NCT02430870|2185813|FG003|Part 2|Other Reason Not Specified|0
1106637|NCT02430870|2185814|FG004|Part 2|Other Reason Not Specified|0
1106638|NCT02430870|2185815|FG005|Part 2|Other Reason Not Specified|0
1106639|NCT02430870|2185816|FG006|Part 2|Other Reason Not Specified|0
1106640|NCT02430870|2185817|FG007|Part 2|Other Reason Not Specified|1
1106655|NCT02431260|2185886|FG000|Overall Study|Subject Decision|0
1106656|NCT02431260|2185887|FG001|Overall Study|Subject Decision|1
1106657|NCT02431260|2185888|FG002|Overall Study|Subject Decision|1
1106658|NCT02431260|2185889|FG003|Overall Study|Subject Decision|0
1106659|NCT02431260|2185890|FG004|Overall Study|Subject Decision|0
1106660|NCT02431260|2185891|FG005|Overall Study|Subject Decision|0
1106661|NCT02431260|2185892|FG006|Overall Study|Subject Decision|0
1106662|NCT02431260|2185893|FG007|Overall Study|Subject Decision|0
1106663|NCT02431260|2185894|FG008|Overall Study|Subject Decision|1
1106664|NCT02431260|2185895|FG009|Overall Study|Subject Decision|1
1106665|NCT02431260|2185896|FG010|Overall Study|Subject Decision|0
1106666|NCT02431260|2185897|FG011|Overall Study|Subject Decision|1
1106667|NCT02431260|2185898|FG012|Overall Study|Subject Decision|0
1106668|NCT02431260|2185899|FG013|Overall Study|Subject Decision|0
1106669|NCT02431260|2185886|FG000|Overall Study|Death|4
1106670|NCT02431260|2185887|FG001|Overall Study|Death|4
1106671|NCT02431260|2185888|FG002|Overall Study|Death|3
1106672|NCT02431260|2185889|FG003|Overall Study|Death|4
1106673|NCT02431260|2185890|FG004|Overall Study|Death|2
1106674|NCT02431260|2185891|FG005|Overall Study|Death|2
1106675|NCT02431260|2185892|FG006|Overall Study|Death|3
1106676|NCT02431260|2185893|FG007|Overall Study|Death|1
1106677|NCT02431260|2185894|FG008|Overall Study|Death|6
1106678|NCT02431260|2185895|FG009|Overall Study|Death|6
1106679|NCT02431260|2185896|FG010|Overall Study|Death|3
1106680|NCT02431260|2185897|FG011|Overall Study|Death|2
1106681|NCT02431260|2185898|FG012|Overall Study|Death|5
1106682|NCT02431260|2185899|FG013|Overall Study|Death|1
1106683|NCT02431260|2185886|FG000|Overall Study|Lost to Follow-up|0
1106684|NCT02431260|2185887|FG001|Overall Study|Lost to Follow-up|0
1106685|NCT02431260|2185888|FG002|Overall Study|Lost to Follow-up|0
1106686|NCT02431260|2185889|FG003|Overall Study|Lost to Follow-up|0
1106687|NCT02431260|2185890|FG004|Overall Study|Lost to Follow-up|0
1106688|NCT02431260|2185891|FG005|Overall Study|Lost to Follow-up|1
1106689|NCT02431260|2185892|FG006|Overall Study|Lost to Follow-up|0
1106690|NCT02431260|2185893|FG007|Overall Study|Lost to Follow-up|0
1106691|NCT02431260|2185894|FG008|Overall Study|Lost to Follow-up|0
1106692|NCT02431260|2185895|FG009|Overall Study|Lost to Follow-up|0
1106693|NCT02431260|2185896|FG010|Overall Study|Lost to Follow-up|0
1106694|NCT02431260|2185897|FG011|Overall Study|Lost to Follow-up|0
1106695|NCT02431260|2185898|FG012|Overall Study|Lost to Follow-up|0
1106696|NCT02431260|2185899|FG013|Overall Study|Lost to Follow-up|0
1106697|NCT02431260|2185886|FG000|Overall Study|Study Terminated by the Sponsor|0
1106698|NCT02431260|2185887|FG001|Overall Study|Study Terminated by the Sponsor|0
1106699|NCT02431260|2185888|FG002|Overall Study|Study Terminated by the Sponsor|2
1106700|NCT02431260|2185889|FG003|Overall Study|Study Terminated by the Sponsor|1
1106701|NCT02431260|2185890|FG004|Overall Study|Study Terminated by the Sponsor|1
1106702|NCT02431260|2185891|FG005|Overall Study|Study Terminated by the Sponsor|0
1106703|NCT02431260|2185892|FG006|Overall Study|Study Terminated by the Sponsor|1
1106704|NCT02431260|2185893|FG007|Overall Study|Study Terminated by the Sponsor|2
1106705|NCT02431260|2185894|FG008|Overall Study|Study Terminated by the Sponsor|1
1106706|NCT02431260|2185895|FG009|Overall Study|Study Terminated by the Sponsor|1
1106707|NCT02431260|2185896|FG010|Overall Study|Study Terminated by the Sponsor|1
1106708|NCT02431260|2185897|FG011|Overall Study|Study Terminated by the Sponsor|0
1106709|NCT02431260|2185898|FG012|Overall Study|Study Terminated by the Sponsor|4
1106710|NCT02431260|2185899|FG013|Overall Study|Study Terminated by the Sponsor|0
1106711|NCT02431260|2185886|FG000|Overall Study|Physician Decision|0
1106712|NCT02431260|2185887|FG001|Overall Study|Physician Decision|0
1106713|NCT02431260|2185888|FG002|Overall Study|Physician Decision|0
1106714|NCT02431260|2185889|FG003|Overall Study|Physician Decision|0
1106715|NCT02431260|2185890|FG004|Overall Study|Physician Decision|0
1106716|NCT02431260|2185891|FG005|Overall Study|Physician Decision|1
1106717|NCT02431260|2185892|FG006|Overall Study|Physician Decision|0
1106718|NCT02431260|2185893|FG007|Overall Study|Physician Decision|0
1106719|NCT02431260|2185894|FG008|Overall Study|Physician Decision|0
1106720|NCT02431260|2185895|FG009|Overall Study|Physician Decision|0
1106721|NCT02431260|2185896|FG010|Overall Study|Physician Decision|0
1106722|NCT02431260|2185897|FG011|Overall Study|Physician Decision|0
1106723|NCT02431260|2185898|FG012|Overall Study|Physician Decision|0
1106724|NCT02431260|2185899|FG013|Overall Study|Physician Decision|0
1106725|NCT02431260|2185886|FG000|Overall Study|Other Unspecified|0
1106726|NCT02431260|2185887|FG001|Overall Study|Other Unspecified|0
1106727|NCT02431260|2185888|FG002|Overall Study|Other Unspecified|0
1106728|NCT02431260|2185889|FG003|Overall Study|Other Unspecified|0
1106729|NCT02431260|2185890|FG004|Overall Study|Other Unspecified|0
1106730|NCT02431260|2185891|FG005|Overall Study|Other Unspecified|0
1106731|NCT02431260|2185892|FG006|Overall Study|Other Unspecified|0
1106732|NCT02431260|2185893|FG007|Overall Study|Other Unspecified|0
1106733|NCT02431260|2185894|FG008|Overall Study|Other Unspecified|0
1106734|NCT02431260|2185895|FG009|Overall Study|Other Unspecified|0
1106735|NCT02431260|2185896|FG010|Overall Study|Other Unspecified|0
1106736|NCT02431260|2185897|FG011|Overall Study|Other Unspecified|1
1106737|NCT02431260|2185898|FG012|Overall Study|Other Unspecified|1
1106738|NCT02431260|2185899|FG013|Overall Study|Other Unspecified|0
1106739|NCT02431364|2185964|FG000|Overall Study|Adverse Event|0
1106740|NCT02431364|2185965|FG001|Overall Study|Adverse Event|1
1106741|NCT02431364|2185966|FG002|Overall Study|Adverse Event|0
1106742|NCT02431364|2185967|FG003|Overall Study|Adverse Event|0
1106743|NCT02431364|2185968|FG004|Overall Study|Adverse Event|0
1106744|NCT02431364|2185964|FG000|Overall Study|Randomized but never treated|0
1106745|NCT02431364|2185965|FG001|Overall Study|Randomized but never treated|0
1106746|NCT02431364|2185966|FG002|Overall Study|Randomized but never treated|0
1106747|NCT02431364|2185967|FG003|Overall Study|Randomized but never treated|1
1106748|NCT02431364|2185968|FG004|Overall Study|Randomized but never treated|0
1106749|NCT02431468|2185996|FG000|Overall Study|Adverse Event|2
1106750|NCT02431468|2185997|FG001|Overall Study|Adverse Event|4
1106751|NCT02431468|2185998|FG002|Overall Study|Adverse Event|5
1106752|NCT02431468|2185996|FG000|Overall Study|Withdrawal by Subject|4
1106753|NCT02431468|2185997|FG001|Overall Study|Withdrawal by Subject|12
1106754|NCT02431468|2185998|FG002|Overall Study|Withdrawal by Subject|2
1106755|NCT02431468|2185996|FG000|Overall Study|noncompliance, investigator termination,|2
1106756|NCT02431468|2185997|FG001|Overall Study|noncompliance, investigator termination,|2
1106757|NCT02431468|2185998|FG002|Overall Study|noncompliance, investigator termination,|2
1106758|NCT02431533|2186014|FG000|Overall Study|Withdrawal by Subject|1
1106759|NCT02431533|2186015|FG001|Overall Study|Withdrawal by Subject|3
1106760|NCT02431533|2186014|FG000|Overall Study|Developed Exclusionary criteria|1
1106761|NCT02431533|2186015|FG001|Overall Study|Developed Exclusionary criteria|0
1106762|NCT02431559|2186025|FG000|Overall Study|Adverse Event|0
1106763|NCT02431559|2186026|FG001|Overall Study|Adverse Event|1
1106764|NCT02431559|2186027|FG002|Overall Study|Adverse Event|0
1106765|NCT02431559|2186028|FG003|Overall Study|Adverse Event|4
1106766|NCT02431559|2186025|FG000|Overall Study|Progressive disease|2
1106767|NCT02431559|2186026|FG001|Overall Study|Progressive disease|1
1106768|NCT02431559|2186027|FG002|Overall Study|Progressive disease|4
1106769|NCT02431559|2186028|FG003|Overall Study|Progressive disease|22
1106770|NCT02431559|2186025|FG000|Overall Study|Withdrawal by Subject|0
1106771|NCT02431559|2186026|FG001|Overall Study|Withdrawal by Subject|1
1106772|NCT02431559|2186027|FG002|Overall Study|Withdrawal by Subject|0
1106773|NCT02431559|2186028|FG003|Overall Study|Withdrawal by Subject|4
1106774|NCT02431559|2186025|FG000|Overall Study|Physician Decision|0
1106775|NCT02431559|2186026|FG001|Overall Study|Physician Decision|0
1106776|NCT02431559|2186027|FG002|Overall Study|Physician Decision|0
1106777|NCT02431559|2186028|FG003|Overall Study|Physician Decision|1
1106778|NCT02431676|2186089|FG000|Overall Study|no lab obtained|0
1106779|NCT02431676|2186090|FG001|Overall Study|no lab obtained|1
1106780|NCT02431676|2186091|FG002|Overall Study|no lab obtained|2
895406|NCT00697827|1866682|FG000|Overall Study|enrolled but not treated|2
895407|NCT00697827|1866683|FG001|Overall Study|enrolled but not treated|1
895408|NCT00698204|1866729|FG000|Overall Study|Withdrawal by Subject|1
895409|NCT00698204|1866730|FG001|Overall Study|Withdrawal by Subject|0
895410|NCT00698451|1866738|FG000|Overall Study|Adverse Event|22
895411|NCT00698451|1866738|FG000|Overall Study|Physician Decision|2
895412|NCT00698451|1866738|FG000|Overall Study|Protocol Violation|6
895413|NCT00698451|1866738|FG000|Overall Study|Withdrawal by Subject|6
895414|NCT00698451|1866738|FG000|Overall Study|Disease progression|3
895415|NCT00698516|1866742|FG000|Overall Study|Study Termination|2
895416|NCT00698516|1866742|FG000|Overall Study|Withdrawal by Subject|3
1106886|NCT02431793|2186139|FG000|Overall Study|Ineligible doe to not filling Rx|11
1106887|NCT02431793|2186140|FG001|Overall Study|Ineligible doe to not filling Rx|7
1106888|NCT02431793|2186141|FG002|Overall Study|Ineligible doe to not filling Rx|8
1106889|NCT02431793|2186139|FG000|Overall Study|Withdrawal by Subject|7
1106890|NCT02431793|2186140|FG001|Overall Study|Withdrawal by Subject|5
1106891|NCT02431793|2186141|FG002|Overall Study|Withdrawal by Subject|5
1106892|NCT02431793|2186139|FG000|Overall Study|Lost to Follow-up|101
1106893|NCT02431793|2186140|FG001|Overall Study|Lost to Follow-up|122
1106894|NCT02431793|2186141|FG002|Overall Study|Lost to Follow-up|104
1106895|NCT02431806|2186153|FG000|Double-blind Treatment Period|Did not Receive Treatment|1
1106896|NCT02431806|2186154|FG001|Double-blind Treatment Period|Did not Receive Treatment|2
1106897|NCT02431806|2186155|FG002|Double-blind Treatment Period|Did not Receive Treatment|1
1106898|NCT02431806|2186156|FG003|Double-blind Treatment Period|Did not Receive Treatment|1
1106899|NCT02431806|2186153|FG000|Double-blind Treatment Period|Adverse Event|4
1106900|NCT02431806|2186154|FG001|Double-blind Treatment Period|Adverse Event|7
1106901|NCT02431806|2186155|FG002|Double-blind Treatment Period|Adverse Event|11
1106902|NCT02431806|2186156|FG003|Double-blind Treatment Period|Adverse Event|7
1106903|NCT02431806|2186153|FG000|Double-blind Treatment Period|Lack of Efficacy|2
1106904|NCT02431806|2186154|FG001|Double-blind Treatment Period|Lack of Efficacy|0
1106905|NCT02431806|2186155|FG002|Double-blind Treatment Period|Lack of Efficacy|2
1106906|NCT02431806|2186156|FG003|Double-blind Treatment Period|Lack of Efficacy|2
1106907|NCT02431806|2186153|FG000|Double-blind Treatment Period|Withdrawal of Consent|10
1106908|NCT02431806|2186154|FG001|Double-blind Treatment Period|Withdrawal of Consent|7
1106909|NCT02431806|2186155|FG002|Double-blind Treatment Period|Withdrawal of Consent|5
1106910|NCT02431806|2186156|FG003|Double-blind Treatment Period|Withdrawal of Consent|5
1106911|NCT02431806|2186153|FG000|Double-blind Treatment Period|Lost to Follow-up|7
1106912|NCT02431806|2186154|FG001|Double-blind Treatment Period|Lost to Follow-up|4
1106913|NCT02431806|2186155|FG002|Double-blind Treatment Period|Lost to Follow-up|5
1106914|NCT02431806|2186156|FG003|Double-blind Treatment Period|Lost to Follow-up|8
1106915|NCT02431806|2186153|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1
1106916|NCT02431806|2186154|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0
1106917|NCT02431806|2186155|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3
1106918|NCT02431806|2186156|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1
1106919|NCT02431806|2186153|FG000|Double-blind Treatment Period|Reason Not Specified|0
1106920|NCT02431806|2186154|FG001|Double-blind Treatment Period|Reason Not Specified|1
1106921|NCT02431806|2186155|FG002|Double-blind Treatment Period|Reason Not Specified|5
1106922|NCT02431806|2186156|FG003|Double-blind Treatment Period|Reason Not Specified|2
1106923|NCT02432040|2186168|FG000|Overall Study|Lack of Efficacy|3
1106924|NCT02432040|2186169|FG001|Overall Study|Lack of Efficacy|0
1106925|NCT02432040|2186168|FG000|Overall Study|Lost to Follow-up|4
1106926|NCT02432040|2186169|FG001|Overall Study|Lost to Follow-up|5
1106927|NCT02432040|2186168|FG000|Overall Study|Physician Decision|1
1106928|NCT02432040|2186169|FG001|Overall Study|Physician Decision|1
1106929|NCT02432105|2186178|FG000|Overall Study|Lost to Follow-up|1
1106930|NCT02432105|2186179|FG001|Overall Study|Lost to Follow-up|1
1106931|NCT02432105|2186180|FG002|Overall Study|Lost to Follow-up|0
1106932|NCT02432105|2186178|FG000|Overall Study|Withdrawal by Subject|1
1106933|NCT02432105|2186179|FG001|Overall Study|Withdrawal by Subject|0
1106934|NCT02432105|2186180|FG002|Overall Study|Withdrawal by Subject|1
1106935|NCT02432105|2186178|FG000|Overall Study|Culture positive for yeast|0
1106936|NCT02432105|2186179|FG001|Overall Study|Culture positive for yeast|1
1106937|NCT02432105|2186180|FG002|Overall Study|Culture positive for yeast|0
1106938|NCT02432105|2186178|FG000|Overall Study|Randomized in error|0
1106939|NCT02432105|2186179|FG001|Overall Study|Randomized in error|0
1106940|NCT02432105|2186180|FG002|Overall Study|Randomized in error|2
1106941|NCT02432144|2186189|FG000|Overall Study|Participant Non-Compliance|1
1106942|NCT02432196|2186210|FG000|Overall Study|Not Implanted with Device|1
1106943|NCT02432196|2186210|FG000|Overall Study|Death|2
1106944|NCT02432196|2186210|FG000|Overall Study|Reoperation|3
1106945|NCT02432196|2186210|FG000|Overall Study|On Study|20
1106946|NCT02432235|2186235|FG000|Overall Study|Death|1
1106947|NCT02432235|2186236|FG001|Overall Study|Death|1
1106948|NCT02432235|2186237|FG002|Overall Study|Death|2
1106949|NCT02432235|2186238|FG003|Overall Study|Death|2
1106950|NCT02432235|2186239|FG004|Overall Study|Death|1
1106951|NCT02432235|2186240|FG005|Overall Study|Death|3
1106952|NCT02432235|2186241|FG006|Overall Study|Death|11
1106953|NCT02432235|2186242|FG007|Overall Study|Death|15
1106954|NCT02432235|2186243|FG008|Overall Study|Death|15
1106955|NCT02432235|2186244|FG009|Overall Study|Death|3
1106956|NCT02432235|2186245|FG010|Overall Study|Death|1
1106957|NCT02432235|2186246|FG011|Overall Study|Death|0
1106958|NCT02432235|2186235|FG000|Overall Study|Withdrawal by Subject|0
1106959|NCT02432235|2186236|FG001|Overall Study|Withdrawal by Subject|1
1106960|NCT02432235|2186237|FG002|Overall Study|Withdrawal by Subject|0
1106961|NCT02432235|2186238|FG003|Overall Study|Withdrawal by Subject|0
1106962|NCT02432235|2186239|FG004|Overall Study|Withdrawal by Subject|0
1106963|NCT02432235|2186240|FG005|Overall Study|Withdrawal by Subject|2
1106964|NCT02432235|2186241|FG006|Overall Study|Withdrawal by Subject|5
1106965|NCT02432235|2186242|FG007|Overall Study|Withdrawal by Subject|3
1106966|NCT02432235|2186243|FG008|Overall Study|Withdrawal by Subject|1
1106967|NCT02432235|2186244|FG009|Overall Study|Withdrawal by Subject|0
1106968|NCT02432235|2186245|FG010|Overall Study|Withdrawal by Subject|0
1106969|NCT02432235|2186246|FG011|Overall Study|Withdrawal by Subject|0
1106970|NCT02432235|2186235|FG000|Overall Study|Lost to Follow-up|0
1106971|NCT02432235|2186236|FG001|Overall Study|Lost to Follow-up|0
1106972|NCT02432235|2186237|FG002|Overall Study|Lost to Follow-up|0
1106973|NCT02432235|2186238|FG003|Overall Study|Lost to Follow-up|0
1106974|NCT02432235|2186239|FG004|Overall Study|Lost to Follow-up|0
895417|NCT00698581|1866752|FG000|Overall Study|Lack of Efficacy|23
895418|NCT00698581|1866753|FG001|Overall Study|Lack of Efficacy|11
895419|NCT00698581|1866752|FG000|Overall Study|Withdrawal by Subject|6
895420|NCT00698581|1866753|FG001|Overall Study|Withdrawal by Subject|0
895421|NCT00698581|1866752|FG000|Overall Study|Other reason|9
895422|NCT00698581|1866753|FG001|Overall Study|Other reason|1
895423|NCT00698581|1866752|FG000|Overall Study|SAE, non-fatal|1
895424|NCT00698581|1866753|FG001|Overall Study|SAE, non-fatal|0
895425|NCT00698581|1866752|FG000|Overall Study|AE, non-serious non-fatal|4
895426|NCT00698581|1866753|FG001|Overall Study|AE, non-serious non-fatal|0
895427|NCT00698581|1866752|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
895428|NCT00698581|1866753|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
895429|NCT00698581|1866752|FG000|Overall Study|AE of unknown type|1
895430|NCT00698581|1866753|FG001|Overall Study|AE of unknown type|0
895431|NCT00698646|1866763|FG000|Overall Study|Adverse Event|8
895432|NCT00698646|1866764|FG001|Overall Study|Adverse Event|7
895433|NCT00698646|1866765|FG002|Overall Study|Adverse Event|8
1106975|NCT02432235|2186240|FG005|Overall Study|Lost to Follow-up|1
1106976|NCT02432235|2186241|FG006|Overall Study|Lost to Follow-up|0
1106977|NCT02432235|2186242|FG007|Overall Study|Lost to Follow-up|0
1106978|NCT02432235|2186243|FG008|Overall Study|Lost to Follow-up|1
1106979|NCT02432235|2186244|FG009|Overall Study|Lost to Follow-up|0
1106980|NCT02432235|2186245|FG010|Overall Study|Lost to Follow-up|0
1106981|NCT02432235|2186246|FG011|Overall Study|Lost to Follow-up|0
1106982|NCT02432235|2186235|FG000|Overall Study|Miscellaneous|0
1106983|NCT02432235|2186236|FG001|Overall Study|Miscellaneous|0
1106984|NCT02432235|2186237|FG002|Overall Study|Miscellaneous|0
1106985|NCT02432235|2186238|FG003|Overall Study|Miscellaneous|0
1106986|NCT02432235|2186239|FG004|Overall Study|Miscellaneous|1
1106987|NCT02432235|2186240|FG005|Overall Study|Miscellaneous|6
1106988|NCT02432235|2186241|FG006|Overall Study|Miscellaneous|2
1106989|NCT02432235|2186242|FG007|Overall Study|Miscellaneous|2
1106990|NCT02432235|2186243|FG008|Overall Study|Miscellaneous|4
1106991|NCT02432235|2186244|FG009|Overall Study|Miscellaneous|0
1106992|NCT02432235|2186245|FG010|Overall Study|Miscellaneous|0
1106993|NCT02432235|2186246|FG011|Overall Study|Miscellaneous|1
1106994|NCT02432703|2186345|FG000|Overall Study|Adverse Event|1
1106995|NCT02432703|2186346|FG001|Overall Study|Adverse Event|4
1106996|NCT02432703|2186345|FG000|Overall Study|Lack of Efficacy|1
1106997|NCT02432703|2186346|FG001|Overall Study|Lack of Efficacy|0
1106998|NCT02432703|2186345|FG000|Overall Study|Lost to Follow-up|5
1106999|NCT02432703|2186346|FG001|Overall Study|Lost to Follow-up|3
1107000|NCT02432703|2186345|FG000|Overall Study|Withdrawal by Subject|9
1107001|NCT02432703|2186346|FG001|Overall Study|Withdrawal by Subject|6
1107002|NCT02432703|2186345|FG000|Overall Study|Other|6
1107003|NCT02432703|2186346|FG001|Overall Study|Other|5
1107004|NCT02433080|2186373|FG000|Overall Study|Lost to Follow-up|1
1107005|NCT02433080|2186374|FG001|Overall Study|Lost to Follow-up|2
1107006|NCT02433080|2186373|FG000|Overall Study|Withdrawal by Subject|0
1107007|NCT02433080|2186374|FG001|Overall Study|Withdrawal by Subject|2
1107008|NCT02433288|2186383|FG000|Overall Study|Severe non-compliance to protocol|13
1107009|NCT02433288|2186384|FG001|Overall Study|Severe non-compliance to protocol|7
1107010|NCT02433288|2186383|FG000|Overall Study|Eligibility criteria not fullfilled|7
1107011|NCT02433288|2186384|FG001|Overall Study|Eligibility criteria not fullfilled|3
1107012|NCT02433288|2186383|FG000|Overall Study|Withdrawal by Subject|101
1107013|NCT02433288|2186384|FG001|Overall Study|Withdrawal by Subject|99
1107014|NCT02433288|2186383|FG000|Overall Study|Lost to Follow-up|2
1107015|NCT02433288|2186384|FG001|Overall Study|Lost to Follow-up|14
1107016|NCT02433288|2186383|FG000|Overall Study|Death|0
1107017|NCT02433288|2186384|FG001|Overall Study|Death|3
1107018|NCT02433340|2186394|FG000|Overall Study|Adverse Event|0
1107019|NCT02433340|2186395|FG001|Overall Study|Adverse Event|0
1107020|NCT02433340|2186396|FG002|Overall Study|Adverse Event|1
1107021|NCT02433340|2186397|FG003|Overall Study|Adverse Event|0
1107022|NCT02433340|2186394|FG000|Overall Study|Withdrawal by Subject|1
1107023|NCT02433340|2186395|FG001|Overall Study|Withdrawal by Subject|0
1107024|NCT02433340|2186396|FG002|Overall Study|Withdrawal by Subject|1
1107025|NCT02433340|2186397|FG003|Overall Study|Withdrawal by Subject|2
1107026|NCT02433340|2186394|FG000|Overall Study|Lost to Follow-up|0
1107027|NCT02433340|2186395|FG001|Overall Study|Lost to Follow-up|1
1107028|NCT02433340|2186396|FG002|Overall Study|Lost to Follow-up|0
1107029|NCT02433340|2186397|FG003|Overall Study|Lost to Follow-up|0
1107030|NCT02433340|2186394|FG000|Overall Study|Required Alternative/Prohibited Therapy|1
1107031|NCT02433340|2186395|FG001|Overall Study|Required Alternative/Prohibited Therapy|0
1107032|NCT02433340|2186396|FG002|Overall Study|Required Alternative/Prohibited Therapy|0
1107033|NCT02433340|2186397|FG003|Overall Study|Required Alternative/Prohibited Therapy|0
1107034|NCT02433340|2186394|FG000|Overall Study|Other|0
1107035|NCT02433340|2186395|FG001|Overall Study|Other|1
1107036|NCT02433340|2186396|FG002|Overall Study|Other|0
1107037|NCT02433340|2186397|FG003|Overall Study|Other|0
1107038|NCT02433379|2186418|FG000|Overall Study|Screen Failures|55
1107039|NCT02433379|2186418|FG000|Overall Study|Death|57
1107040|NCT02433379|2186418|FG000|Overall Study|Total Withdrawals|209
1107041|NCT02433483|2186424|FG000|Overall Study|Unacceptable toxicity|1
1107042|NCT02433483|2186424|FG000|Overall Study|Other antineoplastic therapy/HSCT|1
1107043|NCT02433678|2186455|FG000|Overall Study|Lost to Follow-up|1
1107044|NCT02433678|2186456|FG001|Overall Study|Lost to Follow-up|2
1107045|NCT02433834|2186462|FG000|Overall Study|Protocol-specified criteria|7
1107046|NCT02433834|2186462|FG000|Overall Study|Protocol Violation|3
1107047|NCT02433834|2186462|FG000|Overall Study|Lost to Follow-up|6
1107048|NCT02433834|2186462|FG000|Overall Study|Withdrawal by Subject|14
1107049|NCT02433834|2186462|FG000|Overall Study|Adverse Event|6
1107050|NCT02433834|2186462|FG000|Overall Study|Physician Decision|1
1107051|NCT02434081|2186482|FG000|Overall Study|Death (never started treatment)|2
1107052|NCT02434081|2186482|FG000|Overall Study|Death|2
1107053|NCT02434081|2186482|FG000|Overall Study|Progression|20
1107054|NCT02434081|2186482|FG000|Overall Study|Adverse Event|20
1107055|NCT02434081|2186482|FG000|Overall Study|Physician Decision|2
1107056|NCT02434081|2186482|FG000|Overall Study|Withdrawal by Subject|1
1107057|NCT02434081|2186482|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1
895434|NCT00698646|1866763|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11
895435|NCT00698646|1866764|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11
1107058|NCT02434328|2186488|FG000|Overall Study|Adverse Event|9
1107059|NCT02434328|2186489|FG001|Overall Study|Adverse Event|4
1107060|NCT02434328|2186488|FG000|Overall Study|Lack of Efficacy|0
1107061|NCT02434328|2186489|FG001|Overall Study|Lack of Efficacy|2
1107062|NCT02434328|2186488|FG000|Overall Study|Physician Decision|0
1107063|NCT02434328|2186489|FG001|Overall Study|Physician Decision|1
1107064|NCT02434328|2186488|FG000|Overall Study|Withdrawal by Subject|12
1107065|NCT02434328|2186489|FG001|Overall Study|Withdrawal by Subject|21
1107066|NCT02434328|2186488|FG000|Overall Study|Death|4
1107067|NCT02434328|2186489|FG001|Overall Study|Death|7
1107068|NCT02434328|2186488|FG000|Overall Study|Lost to Follow-up|1
1107069|NCT02434328|2186489|FG001|Overall Study|Lost to Follow-up|6
1107070|NCT02434328|2186488|FG000|Overall Study|Other|4
1107071|NCT02434328|2186489|FG001|Overall Study|Other|1
1107073|NCT02434471|2186500|FG000|Overall Study|Physician Decision|9
1107074|NCT02434770|2186525|FG000|Week 1 to Week 18|Lost to Follow-up|0
1107075|NCT02434770|2186526|FG001|Week 1 to Week 18|Lost to Follow-up|0
1107076|NCT02434770|2186527|FG002|Week 1 to Week 18|Lost to Follow-up|2
1107077|NCT02434770|2186525|FG000|Week 1 to Week 18|Withdrawal by Subject|6
1107078|NCT02434770|2186526|FG001|Week 1 to Week 18|Withdrawal by Subject|12
1107079|NCT02434770|2186527|FG002|Week 1 to Week 18|Withdrawal by Subject|5
1107080|NCT02434770|2186525|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8
1107081|NCT02434770|2186526|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10
1107082|NCT02434770|2186527|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9
1107083|NCT02434770|2186525|FG000|Week 1 to Week 18|Relocated Out of Study Area|0
1107084|NCT02434770|2186526|FG001|Week 1 to Week 18|Relocated Out of Study Area|0
1107085|NCT02434770|2186527|FG002|Week 1 to Week 18|Relocated Out of Study Area|1
1107086|NCT02434770|2186525|FG000|Week 1 to Week 18|Death|1
1107087|NCT02434770|2186526|FG001|Week 1 to Week 18|Death|0
1107088|NCT02434770|2186527|FG002|Week 1 to Week 18|Death|0
1107089|NCT02434770|2186525|FG000|Week 18 to Week|Lost to Follow-up|2
1107090|NCT02434770|2186526|FG001|Week 18 to Week|Lost to Follow-up|2
1107091|NCT02434770|2186527|FG002|Week 18 to Week|Lost to Follow-up|1
1107092|NCT02434770|2186525|FG000|Week 18 to Week|Withdrawal by Subject|0
1107093|NCT02434770|2186526|FG001|Week 18 to Week|Withdrawal by Subject|0
1107094|NCT02434770|2186527|FG002|Week 18 to Week|Withdrawal by Subject|2
1107095|NCT02434770|2186525|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6
1107096|NCT02434770|2186526|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6
1107097|NCT02434770|2186527|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3
1107098|NCT02434939|2186539|FG000|Overall Study|Lack of Efficacy|34
1107099|NCT02434939|2186540|FG001|Overall Study|Lack of Efficacy|48
1107100|NCT02434939|2186539|FG000|Overall Study|Withdrawal by Subject|3
1107101|NCT02434939|2186540|FG001|Overall Study|Withdrawal by Subject|0
1107102|NCT02434939|2186539|FG000|Overall Study|Adverse Event|0
1107103|NCT02434939|2186540|FG001|Overall Study|Adverse Event|1
1107104|NCT02435069|2186547|FG000|Dose Response - First Intervention|Adverse Event|0
1107105|NCT02435069|2186548|FG001|Dose Response - First Intervention|Adverse Event|1
1107106|NCT02435069|2186549|FG002|Dose Response - First Intervention|Adverse Event|1
1107107|NCT02435069|2186550|FG003|Dose Response - First Intervention|Adverse Event|0
1107108|NCT02435069|2186551|FG004|Dose Response - First Intervention|Adverse Event|0
1107109|NCT02435069|2186547|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0
1107110|NCT02435069|2186548|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0
1107111|NCT02435069|2186549|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0
895436|NCT00698646|1866765|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7
895437|NCT00698646|1866763|FG000|Overall Study|Protocol Deviation|6
895438|NCT00698646|1866764|FG001|Overall Study|Protocol Deviation|2
895439|NCT00698646|1866765|FG002|Overall Study|Protocol Deviation|3
895440|NCT00698646|1866763|FG000|Overall Study|Withdrawal by Subject|10
895441|NCT00698646|1866764|FG001|Overall Study|Withdrawal by Subject|11
895442|NCT00698646|1866765|FG002|Overall Study|Withdrawal by Subject|8
895443|NCT00698646|1866763|FG000|Overall Study|Lost to Follow-up|0
895444|NCT00698646|1866764|FG001|Overall Study|Lost to Follow-up|0
895445|NCT00698646|1866765|FG002|Overall Study|Lost to Follow-up|2
895446|NCT00698646|1866763|FG000|Overall Study|Administrative problems|1
895447|NCT00698646|1866764|FG001|Overall Study|Administrative problems|0
895448|NCT00698646|1866765|FG002|Overall Study|Administrative problems|1
895449|NCT00698685|1866773|FG000|Overall Study|Sister withdrew as donor|1
895450|NCT00698685|1866773|FG000|Overall Study|Off study pre transplant by clinic MD|1
895451|NCT00698815|1866780|FG000|Overall Study|Death|1
895452|NCT00698815|1866781|FG001|Overall Study|Death|2
895453|NCT00698815|1866782|FG002|Overall Study|Death|4
895454|NCT00698815|1866780|FG000|Overall Study|Withdrawal by Subject|6
895455|NCT00698815|1866781|FG001|Overall Study|Withdrawal by Subject|3
895456|NCT00698815|1866782|FG002|Overall Study|Withdrawal by Subject|2
895457|NCT00698815|1866780|FG000|Overall Study|MD discretion|2
895458|NCT00698815|1866781|FG001|Overall Study|MD discretion|7
895459|NCT00698815|1866782|FG002|Overall Study|MD discretion|2
895460|NCT00698815|1866780|FG000|Overall Study|Did not receive protocol treatment|1
895461|NCT00698815|1866781|FG001|Overall Study|Did not receive protocol treatment|2
895462|NCT00698815|1866782|FG002|Overall Study|Did not receive protocol treatment|2
1107112|NCT02435069|2186550|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0
1107113|NCT02435069|2186551|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1
1107114|NCT02435147|2186571|FG000|Overall Study|non-evaluable DXA scan|11
1107115|NCT02435277|2186579|FG000|Overall Study|Adverse Event|1
1107116|NCT02435277|2186580|FG001|Overall Study|Adverse Event|1
1107117|NCT02435277|2186581|FG002|Overall Study|Adverse Event|0
1107118|NCT02435277|2186582|FG003|Overall Study|Adverse Event|0
1107119|NCT02435277|2186579|FG000|Overall Study|Withdrawal by Subject|1
1107120|NCT02435277|2186580|FG001|Overall Study|Withdrawal by Subject|0
1107121|NCT02435277|2186581|FG002|Overall Study|Withdrawal by Subject|0
1107122|NCT02435277|2186582|FG003|Overall Study|Withdrawal by Subject|0
1107123|NCT02435381|2186592|FG000|Overall Study|Lost to Follow-up|2
1107124|NCT02435381|2186593|FG001|Overall Study|Lost to Follow-up|1
1107140|NCT02435680|2186644|FG000|Overall Study|Physician Decision|3
1107141|NCT02435680|2186645|FG001|Overall Study|Physician Decision|0
1107142|NCT02435680|2186646|FG002|Overall Study|Physician Decision|0
1107143|NCT02435680|2186644|FG000|Overall Study|subject / guardian decision|0
1107144|NCT02435680|2186645|FG001|Overall Study|subject / guardian decision|3
1107145|NCT02435680|2186646|FG002|Overall Study|subject / guardian decision|2
1107146|NCT02435680|2186644|FG000|Overall Study|Adverse Event|8
1107147|NCT02435680|2186645|FG001|Overall Study|Adverse Event|3
895463|NCT00698841|1866803|FG000|Overall Study|Withdrawal by Subject|2
895464|NCT00698841|1866803|FG000|Overall Study|Adverse Event|3
895465|NCT00698841|1866803|FG000|Overall Study|Disease progression|7
895466|NCT00698841|1866803|FG000|Overall Study|Failure to meet eligibility criteria|2
895467|NCT00698841|1866803|FG000|Overall Study|Study drug toxicity|2
895468|NCT00698841|1866803|FG000|Overall Study|Other|2
895469|NCT00698932|1866813|FG000|Overall Study|Adverse Event|0
895470|NCT00698932|1866814|FG001|Overall Study|Adverse Event|2
895471|NCT00698932|1866813|FG000|Overall Study|Incorrect enrollment|0
895472|NCT00698932|1866814|FG001|Overall Study|Incorrect enrollment|2
895473|NCT00698932|1866813|FG000|Overall Study|Study specific discontinuation criteria|3
895474|NCT00698932|1866814|FG001|Overall Study|Study specific discontinuation criteria|4
895475|NCT00698932|1866813|FG000|Overall Study|Withdrawal by Subject|11
895476|NCT00698932|1866814|FG001|Overall Study|Withdrawal by Subject|23
895477|NCT00698932|1866813|FG000|Overall Study|Lost to Follow-up|6
895478|NCT00698932|1866814|FG001|Overall Study|Lost to Follow-up|1
895479|NCT00698932|1866813|FG000|Overall Study|Severe non-compliance to protocol|1
895480|NCT00698932|1866814|FG001|Overall Study|Severe non-compliance to protocol|2
895481|NCT00698932|1866813|FG000|Overall Study|Safety reasons|0
895482|NCT00698932|1866814|FG001|Overall Study|Safety reasons|2
895483|NCT00698932|1866813|FG000|Overall Study|Death|1
895484|NCT00698932|1866814|FG001|Overall Study|Death|0
895485|NCT00698997|1866822|FG000|Overall Study|Lost to Follow-up|3
895486|NCT00698997|1866823|FG001|Overall Study|Lost to Follow-up|0
895487|NCT00698997|1866822|FG000|Overall Study|Withdrawal by Subject|7
895488|NCT00698997|1866823|FG001|Overall Study|Withdrawal by Subject|27
895489|NCT00699153|1866849|FG000|Overall Study|Lost to Follow-up|1
895490|NCT00699153|1866850|FG001|Overall Study|Lost to Follow-up|0
895491|NCT00699153|1866849|FG000|Overall Study|Adverse Event|0
895492|NCT00699153|1866850|FG001|Overall Study|Adverse Event|2
895493|NCT00699153|1866849|FG000|Overall Study|Protocol Violation|1
895494|NCT00699153|1866850|FG001|Overall Study|Protocol Violation|0
895495|NCT00699153|1866849|FG000|Overall Study|Travel Problem|1
895496|NCT00699153|1866850|FG001|Overall Study|Travel Problem|0
895497|NCT00699192|1866859|FG000|Overall Study|Missing|1
895498|NCT00699192|1866860|FG001|Overall Study|Missing|1
895499|NCT00699192|1866861|FG002|Overall Study|Missing|1
895500|NCT00699192|1866859|FG000|Overall Study|Adverse Event|9
895501|NCT00699192|1866860|FG001|Overall Study|Adverse Event|4
895502|NCT00699192|1866861|FG002|Overall Study|Adverse Event|3
895503|NCT00699192|1866859|FG000|Overall Study|Abnormal test procedure result(s)|0
895504|NCT00699192|1866860|FG001|Overall Study|Abnormal test procedure result(s)|0
895505|NCT00699192|1866861|FG002|Overall Study|Abnormal test procedure result(s)|1
895506|NCT00699192|1866859|FG000|Overall Study|Lack of Efficacy|0
895507|NCT00699192|1866860|FG001|Overall Study|Lack of Efficacy|0
895508|NCT00699192|1866861|FG002|Overall Study|Lack of Efficacy|1
895509|NCT00699192|1866859|FG000|Overall Study|Withdrawal by Subject|3
895510|NCT00699192|1866860|FG001|Overall Study|Withdrawal by Subject|2
895511|NCT00699192|1866861|FG002|Overall Study|Withdrawal by Subject|4
1107148|NCT02435680|2186646|FG002|Overall Study|Adverse Event|2
1107149|NCT02435680|2186644|FG000|Overall Study|progressive disease|10
1107150|NCT02435680|2186645|FG001|Overall Study|progressive disease|7
1107151|NCT02435680|2186646|FG002|Overall Study|progressive disease|11
1107152|NCT02435680|2186644|FG000|Overall Study|not treated|0
1107153|NCT02435680|2186645|FG001|Overall Study|not treated|0
1107154|NCT02435680|2186646|FG002|Overall Study|not treated|1
1107155|NCT02435836|2186667|FG000|Overall Study|Lost to Follow-up|21
1107156|NCT02435836|2186667|FG000|Overall Study|Lack of Efficacy|1
1107157|NCT02435836|2186667|FG000|Overall Study|Withdrawal by Subject|236
1107158|NCT02435836|2186667|FG000|Overall Study|Insufficient Clinical Response|26
1107159|NCT02435836|2186667|FG000|Overall Study|Adverse Event|44
1107160|NCT02435836|2186667|FG000|Overall Study|Sponsor discontinued trial|167
1107161|NCT02435836|2186667|FG000|Overall Study|Noncompliance|27
1107162|NCT02435836|2186667|FG000|Overall Study|Protocol Violation|6
1107163|NCT02435836|2186667|FG000|Overall Study|Met Withdrawal Criteria|7
1107164|NCT02435836|2186667|FG000|Overall Study|AE of Worsening Schizophrenia|96
1107165|NCT02435849|2186671|FG000|Overall Study|Enrolled but not infused|18
1107166|NCT02435849|2186671|FG000|Overall Study|Death|16
1107167|NCT02435849|2186671|FG000|Overall Study|Lack of Efficacy|9
1107168|NCT02435849|2186671|FG000|Overall Study|New therapy for study indication|7
1107169|NCT02435849|2186671|FG000|Overall Study|Subject/guardian decision|2
1107170|NCT02435849|2186671|FG000|Overall Study|Study follow-up ongoing|45
1107171|NCT02435914|2186684|FG000|Overall Study|Ocular Adverse Event|1
1107172|NCT02435914|2186685|FG001|Overall Study|Ocular Adverse Event|0
1107173|NCT02435914|2186686|FG002|Overall Study|Ocular Adverse Event|0
1107174|NCT02435914|2186687|FG003|Overall Study|Ocular Adverse Event|0
1107175|NCT02435914|2186684|FG000|Overall Study|Withdrawal by Subject|0
1107176|NCT02435914|2186685|FG001|Overall Study|Withdrawal by Subject|1
1107177|NCT02435914|2186686|FG002|Overall Study|Withdrawal by Subject|0
1107178|NCT02435914|2186687|FG003|Overall Study|Withdrawal by Subject|0
1107179|NCT02435914|2186684|FG000|Overall Study|Other Miscellaneous Reason|0
1107180|NCT02435914|2186685|FG001|Overall Study|Other Miscellaneous Reason|0
1107181|NCT02435914|2186686|FG002|Overall Study|Other Miscellaneous Reason|1
1107182|NCT02435914|2186687|FG003|Overall Study|Other Miscellaneous Reason|0
1107183|NCT02435966|2186700|FG000|Overall Study|Withdrawal by Subject|0
1107184|NCT02435966|2186701|FG001|Overall Study|Withdrawal by Subject|1
1107185|NCT02435966|2186702|FG002|Overall Study|Withdrawal by Subject|0
1107186|NCT02435992|2186715|FG000|Overall Study|non compliance with protocol|2
1107187|NCT02435992|2186716|FG001|Overall Study|non compliance with protocol|0
1107188|NCT02435992|2186717|FG002|Overall Study|non compliance with protocol|1
1107189|NCT02435992|2186718|FG003|Overall Study|non compliance with protocol|0
1107190|NCT02435992|2186719|FG004|Overall Study|non compliance with protocol|0
1107191|NCT02435992|2186715|FG000|Overall Study|Adverse Event|11
1107192|NCT02435992|2186716|FG001|Overall Study|Adverse Event|6
1107193|NCT02435992|2186717|FG002|Overall Study|Adverse Event|12
1107194|NCT02435992|2186718|FG003|Overall Study|Adverse Event|0
1107195|NCT02435992|2186719|FG004|Overall Study|Adverse Event|0
1107196|NCT02435992|2186715|FG000|Overall Study|Lack of Efficacy|4
1107197|NCT02435992|2186716|FG001|Overall Study|Lack of Efficacy|10
1107198|NCT02435992|2186717|FG002|Overall Study|Lack of Efficacy|9
1107199|NCT02435992|2186718|FG003|Overall Study|Lack of Efficacy|0
1107200|NCT02435992|2186719|FG004|Overall Study|Lack of Efficacy|0
1107201|NCT02435992|2186715|FG000|Overall Study|Withdrawal by Subject|10
1107202|NCT02435992|2186716|FG001|Overall Study|Withdrawal by Subject|8
1107203|NCT02435992|2186717|FG002|Overall Study|Withdrawal by Subject|20
1107204|NCT02435992|2186718|FG003|Overall Study|Withdrawal by Subject|0
1107205|NCT02435992|2186719|FG004|Overall Study|Withdrawal by Subject|0
1107206|NCT02435992|2186715|FG000|Overall Study|Other Reason|1
1107207|NCT02435992|2186716|FG001|Overall Study|Other Reason|0
1107208|NCT02435992|2186717|FG002|Overall Study|Other Reason|0
1107209|NCT02435992|2186718|FG003|Overall Study|Other Reason|0
1107210|NCT02435992|2186719|FG004|Overall Study|Other Reason|0
1107211|NCT02435992|2186715|FG000|Overall Study|Physician Decision|0
1107212|NCT02435992|2186716|FG001|Overall Study|Physician Decision|0
1107213|NCT02435992|2186717|FG002|Overall Study|Physician Decision|1
1107214|NCT02435992|2186718|FG003|Overall Study|Physician Decision|0
1107215|NCT02435992|2186719|FG004|Overall Study|Physician Decision|0
1107216|NCT02436005|2186731|FG000|Second Intervention|Adverse Event|0
1107217|NCT02436005|2186732|FG001|Second Intervention|Adverse Event|1
1107218|NCT02436135|2186747|FG000|Overall Study|Progressive Disease|3
1107219|NCT02436135|2186748|FG001|Overall Study|Progressive Disease|1
1107220|NCT02436135|2186747|FG000|Overall Study|Investigator Discretion|1
1107221|NCT02436135|2186748|FG001|Overall Study|Investigator Discretion|2
1107222|NCT02436135|2186747|FG000|Overall Study|Adverse Event|1
1107223|NCT02436135|2186748|FG001|Overall Study|Adverse Event|0
1107224|NCT02436135|2186747|FG000|Overall Study|Withdrawal by Participant|1
1107225|NCT02436135|2186748|FG001|Overall Study|Withdrawal by Participant|0
1107226|NCT02436135|2186747|FG000|Overall Study|Study Terminated By Sponsor|0
1107227|NCT02436135|2186748|FG001|Overall Study|Study Terminated By Sponsor|1
1107228|NCT02436200|2186754|FG000|Overall Study|Significant outlier|1
1107229|NCT02436239|2186762|FG000|Open-Lable Treatment Period|Adverse Event|12
1107230|NCT02436239|2186763|FG001|Open-Lable Treatment Period|Adverse Event|3
1107231|NCT02436239|2186764|FG002|Open-Lable Treatment Period|Adverse Event|4
1107232|NCT02436239|2186765|FG003|Open-Lable Treatment Period|Adverse Event|2
1107233|NCT02436239|2186762|FG000|Open-Lable Treatment Period|Lack of Efficacy|1
1107234|NCT02436239|2186763|FG001|Open-Lable Treatment Period|Lack of Efficacy|6
1107235|NCT02436239|2186764|FG002|Open-Lable Treatment Period|Lack of Efficacy|6
1107236|NCT02436239|2186765|FG003|Open-Lable Treatment Period|Lack of Efficacy|1
1107237|NCT02436239|2186762|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10
1107238|NCT02436239|2186763|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15
1107239|NCT02436239|2186764|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9
1107240|NCT02436239|2186765|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0
1107241|NCT02436239|2186762|FG000|Open-Lable Treatment Period|Lost to Follow-up|4
1107242|NCT02436239|2186763|FG001|Open-Lable Treatment Period|Lost to Follow-up|2
1107243|NCT02436239|2186764|FG002|Open-Lable Treatment Period|Lost to Follow-up|4
1107244|NCT02436239|2186765|FG003|Open-Lable Treatment Period|Lost to Follow-up|1
1107245|NCT02436239|2186762|FG000|Open-Lable Treatment Period|Protocol Violation|0
1107246|NCT02436239|2186763|FG001|Open-Lable Treatment Period|Protocol Violation|1
1107247|NCT02436239|2186764|FG002|Open-Lable Treatment Period|Protocol Violation|1
1107248|NCT02436239|2186765|FG003|Open-Lable Treatment Period|Protocol Violation|0
1107249|NCT02436239|2186762|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5
1107250|NCT02436239|2186763|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6
1107251|NCT02436239|2186764|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3
1107252|NCT02436239|2186765|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1
1107253|NCT02436239|2186762|FG000|Open-Lable Treatment Period|Other Reason|1
1107254|NCT02436239|2186763|FG001|Open-Lable Treatment Period|Other Reason|1
1107255|NCT02436239|2186764|FG002|Open-Lable Treatment Period|Other Reason|0
1107256|NCT02436239|2186765|FG003|Open-Lable Treatment Period|Other Reason|0
1107257|NCT02436239|2186762|FG000|Down-Taper Period|Withdrawal by Subject|4
1107258|NCT02436239|2186763|FG001|Down-Taper Period|Withdrawal by Subject|4
1107259|NCT02436239|2186764|FG002|Down-Taper Period|Withdrawal by Subject|1
1107260|NCT02436239|2186765|FG003|Down-Taper Period|Withdrawal by Subject|2
1107261|NCT02436304|2186778|FG000|Overall Study|Lost to Follow-up|0
1107262|NCT02436304|2186779|FG001|Overall Study|Lost to Follow-up|1
1107263|NCT02436304|2186780|FG002|Overall Study|Lost to Follow-up|0
1107264|NCT02436304|2186778|FG000|Overall Study|Withdrawal by Subject|0
1107265|NCT02436304|2186779|FG001|Overall Study|Withdrawal by Subject|1
1107266|NCT02436304|2186780|FG002|Overall Study|Withdrawal by Subject|0
1107267|NCT02436304|2186778|FG000|Overall Study|Randomized in error didn't meet I/E crit|0
1107268|NCT02436304|2186779|FG001|Overall Study|Randomized in error didn't meet I/E crit|0
1107269|NCT02436304|2186780|FG002|Overall Study|Randomized in error didn't meet I/E crit|1
1107270|NCT02436330|2186791|FG000|Cohort 1|Lost to Follow-up|5
1107271|NCT02436330|2186792|FG001|Cohort 1|Lost to Follow-up|2
1107272|NCT02436330|2186791|FG000|Cohort 1|Withdrawal by Subject|0
1107273|NCT02436330|2186792|FG001|Cohort 1|Withdrawal by Subject|1
895512|NCT00699192|1866859|FG000|Overall Study|Administrative problems|1
895513|NCT00699192|1866860|FG001|Overall Study|Administrative problems|3
895514|NCT00699192|1866861|FG002|Overall Study|Administrative problems|1
895515|NCT00699192|1866859|FG000|Overall Study|Protocol Violation|2
895516|NCT00699192|1866860|FG001|Overall Study|Protocol Violation|2
895517|NCT00699192|1866861|FG002|Overall Study|Protocol Violation|0
895518|NCT00699283|1866875|FG000|Overall Study|Lack of Efficacy|15
895519|NCT00699283|1866876|FG001|Overall Study|Lack of Efficacy|5
895520|NCT00699283|1866875|FG000|Overall Study|Lost to Follow-up|2
895521|NCT00699283|1866876|FG001|Overall Study|Lost to Follow-up|0
895522|NCT00699283|1866875|FG000|Overall Study|Withdrawal by Subject|1
895523|NCT00699283|1866876|FG001|Overall Study|Withdrawal by Subject|0
895524|NCT00699283|1866875|FG000|Overall Study|Other Reason|5
895525|NCT00699283|1866876|FG001|Overall Study|Other Reason|1
895526|NCT00699283|1866875|FG000|Overall Study|SAE, non-fatal|1
895527|NCT00699283|1866876|FG001|Overall Study|SAE, non-fatal|1
895528|NCT00699283|1866875|FG000|Overall Study|AE, non-serious non-fatal|8
895529|NCT00699283|1866876|FG001|Overall Study|AE, non-serious non-fatal|1
895530|NCT00699283|1866875|FG000|Overall Study|AE of unknown type|1
895531|NCT00699283|1866876|FG001|Overall Study|AE of unknown type|0
895532|NCT00699335|1866881|FG000|Overall Study|Combination of multiple reasons|176
895533|NCT00699335|1866881|FG000|Overall Study|Missing data|52
895534|NCT00699348|1866888|FG000|Overall Study|Death|6
895535|NCT00699348|1866888|FG000|Overall Study|Adverse Event|15
895536|NCT00699348|1866888|FG000|Overall Study|Withdrawal by Subject|11
895537|NCT00699348|1866888|FG000|Overall Study|Protocol Violation|10
895538|NCT00699348|1866888|FG000|Overall Study|Lack of Efficacy|8
895539|NCT00699348|1866888|FG000|Overall Study|Failure to return|1
895540|NCT00699348|1866888|FG000|Overall Study|Blood transfusion|24
895541|NCT00699348|1866888|FG000|Overall Study|Renal transplantation|10
895542|NCT00699348|1866888|FG000|Overall Study|Other|5
895543|NCT00699374|1866894|FG000|Overall Study|Death|93
895544|NCT00699374|1866895|FG001|Overall Study|Death|83
895545|NCT00699374|1866894|FG000|Overall Study|Adverse Event|70
895546|NCT00699374|1866895|FG001|Overall Study|Adverse Event|67
895547|NCT00699374|1866894|FG000|Overall Study|Global deterioration of health status|7
895548|NCT00699374|1866895|FG001|Overall Study|Global deterioration of health status|8
895549|NCT00699374|1866894|FG000|Overall Study|Lost to Follow-up|3
895550|NCT00699374|1866895|FG001|Overall Study|Lost to Follow-up|5
1107274|NCT02436330|2186791|FG000|Cohort 2|Lost to Follow-up|2
1107275|NCT02436330|2186792|FG001|Cohort 2|Lost to Follow-up|0
1107276|NCT02436330|2186791|FG000|Cohort 2|Withdrawal by Subject|2
1107277|NCT02436330|2186792|FG001|Cohort 2|Withdrawal by Subject|3
1107278|NCT02436330|2186791|FG000|Cohort 3|Lost to Follow-up|1
1107279|NCT02436330|2186792|FG001|Cohort 3|Lost to Follow-up|0
1107280|NCT02436330|2186791|FG000|Cohort 3|Withdrawal by Subject|4
1107281|NCT02436330|2186792|FG001|Cohort 3|Withdrawal by Subject|0
1107282|NCT02436330|2186791|FG000|Cohort 4|Lost to Follow-up|1
1107283|NCT02436330|2186792|FG001|Cohort 4|Lost to Follow-up|0
1107284|NCT02436330|2186791|FG000|Cohort 4|Withdrawal by Subject|1
1107285|NCT02436330|2186792|FG001|Cohort 4|Withdrawal by Subject|0
1107286|NCT02436330|2186791|FG000|Cohort 5|Lost to Follow-up|3
1107287|NCT02436330|2186792|FG001|Cohort 5|Lost to Follow-up|2
1107288|NCT02436330|2186791|FG000|Cohort 5|Withdrawal by Subject|3
1107289|NCT02436330|2186792|FG001|Cohort 5|Withdrawal by Subject|2
1107290|NCT02436330|2186791|FG000|Cohort 6|Lost to Follow-up|2
1107291|NCT02436330|2186792|FG001|Cohort 6|Lost to Follow-up|0
1107292|NCT02436330|2186791|FG000|Cohort 6|Withdrawal by Subject|1
1107293|NCT02436330|2186792|FG001|Cohort 6|Withdrawal by Subject|1
1107294|NCT02436356|2186807|FG000|Overall Study|Excluded by MRI Screening|0
1107295|NCT02436356|2186808|FG001|Overall Study|Excluded by MRI Screening|0
1107296|NCT02436356|2186809|FG002|Overall Study|Excluded by MRI Screening|2
1107297|NCT02436356|2186807|FG000|Overall Study|Lost to Follow-up|0
1107298|NCT02436356|2186808|FG001|Overall Study|Lost to Follow-up|1
1107299|NCT02436356|2186809|FG002|Overall Study|Lost to Follow-up|0
1107300|NCT02436356|2186807|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1
1107301|NCT02436356|2186808|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0
1107302|NCT02436356|2186809|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0
1107303|NCT02436356|2186807|FG000|Overall Study|Excluded due to other medical conditions|3
1107304|NCT02436356|2186808|FG001|Overall Study|Excluded due to other medical conditions|0
1107305|NCT02436356|2186809|FG002|Overall Study|Excluded due to other medical conditions|0
1107306|NCT02436356|2186807|FG000|Overall Study|Withdrawal by Subject|1
1107307|NCT02436356|2186808|FG001|Overall Study|Withdrawal by Subject|0
1107308|NCT02436356|2186809|FG002|Overall Study|Withdrawal by Subject|0
1107309|NCT02436408|2186822|FG000|Overall Study|Death|1
1107310|NCT02436577|2186832|FG000|Overall Study|Protocol Deviation|0
1107311|NCT02436577|2186833|FG001|Overall Study|Protocol Deviation|1
1107312|NCT02436577|2186834|FG002|Overall Study|Protocol Deviation|0
1107313|NCT02436577|2186835|FG003|Overall Study|Protocol Deviation|0
1107314|NCT02436577|2186836|FG004|Overall Study|Protocol Deviation|0
1107315|NCT02436577|2186837|FG005|Overall Study|Protocol Deviation|0
1107316|NCT02436681|2186857|FG000|Overall Study|Lost to Follow-up|10
1107317|NCT02436681|2186857|FG000|Overall Study|Withdrawal by Subject|2
1107318|NCT02436681|2186857|FG000|Overall Study|Death|2
1107319|NCT02436759|2186863|FG000|Overall Study|Adverse Event|3
1107320|NCT02436759|2186864|FG001|Overall Study|Adverse Event|0
1107321|NCT02436759|2186863|FG000|Overall Study|Protocol Violation|1
1107322|NCT02436759|2186864|FG001|Overall Study|Protocol Violation|0
1107323|NCT02436759|2186863|FG000|Overall Study|Withdrawal by Subject|0
1107324|NCT02436759|2186864|FG001|Overall Study|Withdrawal by Subject|1
1107325|NCT02436811|2186873|FG000|Overall Study|Lost to Follow-up|2
1107326|NCT02436811|2186874|FG001|Overall Study|Lost to Follow-up|9
1107327|NCT02436811|2186875|FG002|Overall Study|Lost to Follow-up|7
1107328|NCT02436876|2186887|FG000|Overall Study|Lost to Follow-up|0
1107329|NCT02436876|2186888|FG001|Overall Study|Lost to Follow-up|1
1107330|NCT02436876|2186889|FG002|Overall Study|Lost to Follow-up|1
1107331|NCT02436876|2186890|FG003|Overall Study|Lost to Follow-up|1
1107332|NCT02436876|2186887|FG000|Overall Study|Withdrawal by Subject|1
1107333|NCT02436876|2186888|FG001|Overall Study|Withdrawal by Subject|0
1107334|NCT02436876|2186889|FG002|Overall Study|Withdrawal by Subject|0
1107335|NCT02436876|2186890|FG003|Overall Study|Withdrawal by Subject|1
1107336|NCT02436876|2186887|FG000|Overall Study|Physician Decision|0
1107337|NCT02436876|2186888|FG001|Overall Study|Physician Decision|2
1107338|NCT02436876|2186889|FG002|Overall Study|Physician Decision|1
1107339|NCT02436876|2186890|FG003|Overall Study|Physician Decision|0
1107340|NCT02436876|2186887|FG000|Overall Study|Inadequate amount of study drug available for randomization|0
1107341|NCT02436876|2186888|FG001|Overall Study|Inadequate amount of study drug available for randomization|1
1107342|NCT02436876|2186889|FG002|Overall Study|Inadequate amount of study drug available for randomization|0
1107343|NCT02436876|2186890|FG003|Overall Study|Inadequate amount of study drug available for randomization|0
1107344|NCT02436889|2186907|FG000|Overall Study|No improvement in symptoms|1
1107345|NCT02436889|2186908|FG001|Overall Study|No improvement in symptoms|0
1107346|NCT02436889|2186907|FG000|Overall Study|Does not like/could not tolerate medicat|0
1107347|NCT02436889|2186908|FG001|Overall Study|Does not like/could not tolerate medicat|1
1107348|NCT02436915|2186916|FG000|Overall Study|Withdrawal by Subject|0
1107349|NCT02436915|2186917|FG001|Overall Study|Withdrawal by Subject|1
1107350|NCT02437084|2186925|FG000|Overall Study|Withdrawal by Subject|2
1107351|NCT02437084|2186925|FG000|Overall Study|Physician Decision|1
1107352|NCT02437162|2186932|FG000|Overall Study|Protocol Violation|0
1107353|NCT02437162|2186933|FG001|Overall Study|Protocol Violation|1
1107354|NCT02437162|2186934|FG002|Overall Study|Protocol Violation|0
1107355|NCT02437162|2186932|FG000|Overall Study|Randomized but not treated|0
1107356|NCT02437162|2186933|FG001|Overall Study|Randomized but not treated|0
1107357|NCT02437162|2186934|FG002|Overall Study|Randomized but not treated|1
1107358|NCT02437162|2186932|FG000|Overall Study|Study discontinued by Sponsor|93
1107359|NCT02437162|2186933|FG001|Overall Study|Study discontinued by Sponsor|98
1107360|NCT02437162|2186934|FG002|Overall Study|Study discontinued by Sponsor|97
1107361|NCT02437162|2186932|FG000|Overall Study|Withdrawal by Subject|13
1107362|NCT02437162|2186933|FG001|Overall Study|Withdrawal by Subject|7
1107363|NCT02437162|2186934|FG002|Overall Study|Withdrawal by Subject|9
1107364|NCT02437162|2186932|FG000|Overall Study|Adverse Event|0
1107365|NCT02437162|2186933|FG001|Overall Study|Adverse Event|1
1107366|NCT02437162|2186934|FG002|Overall Study|Adverse Event|0
1107367|NCT02437162|2186932|FG000|Overall Study|Lost to Follow-up|1
1107368|NCT02437162|2186933|FG001|Overall Study|Lost to Follow-up|0
1107369|NCT02437162|2186934|FG002|Overall Study|Lost to Follow-up|1
1107370|NCT02437162|2186932|FG000|Overall Study|Death|0
1107371|NCT02437162|2186933|FG001|Overall Study|Death|1
1107372|NCT02437162|2186934|FG002|Overall Study|Death|0
1107373|NCT02437162|2186932|FG000|Overall Study|Other|0
1107374|NCT02437162|2186933|FG001|Overall Study|Other|0
1107375|NCT02437162|2186934|FG002|Overall Study|Other|1
1107376|NCT02437188|2186949|FG000|Overall Study|Randomized but did not receive surgery|4
1107377|NCT02437188|2186950|FG001|Overall Study|Randomized but did not receive surgery|8
1107378|NCT02437188|2186949|FG000|Overall Study|Adverse Event|0
1107379|NCT02437188|2186950|FG001|Overall Study|Adverse Event|1
1107380|NCT02437305|2186972|FG000|Overall Study|Lost to Follow-up|18
1107381|NCT02437305|2186973|FG001|Overall Study|Lost to Follow-up|12
895551|NCT00699374|1866894|FG000|Overall Study|Withdrawal by Subject|34
895552|NCT00699374|1866895|FG001|Overall Study|Withdrawal by Subject|44
895553|NCT00699374|1866894|FG000|Overall Study|Objective progression or relapse|281
895554|NCT00699374|1866895|FG001|Overall Study|Objective progression or relapse|277
895555|NCT00699374|1866894|FG000|Overall Study|Other|18
895556|NCT00699374|1866895|FG001|Overall Study|Other|15
895557|NCT00699374|1866894|FG000|Overall Study|Protocol Violation|2
895558|NCT00699374|1866895|FG001|Overall Study|Protocol Violation|6
895559|NCT00699374|1866894|FG000|Overall Study|Study terminated by sponsor|13
895560|NCT00699374|1866895|FG001|Overall Study|Study terminated by sponsor|28
895561|NCT00699374|1866894|FG000|Overall Study|Randomized but not treated|4
895562|NCT00699374|1866895|FG001|Overall Study|Randomized but not treated|2
895563|NCT00699374|1866894|FG000|Overall Study|Died 28 days after last dose|5
895564|NCT00699374|1866895|FG001|Overall Study|Died 28 days after last dose|9
895565|NCT00699582|1866953|FG000|Overall Study|Adverse Event|4
895566|NCT00699582|1866954|FG001|Overall Study|Adverse Event|11
895567|NCT00699582|1866955|FG002|Overall Study|Adverse Event|23
895568|NCT00699582|1866953|FG000|Overall Study|Withdrawal by Subject|6
895569|NCT00699582|1866954|FG001|Overall Study|Withdrawal by Subject|7
895570|NCT00699582|1866955|FG002|Overall Study|Withdrawal by Subject|4
895571|NCT00699582|1866953|FG000|Overall Study|Lack of Efficacy|1
895572|NCT00699582|1866954|FG001|Overall Study|Lack of Efficacy|0
895573|NCT00699582|1866955|FG002|Overall Study|Lack of Efficacy|1
895574|NCT00699582|1866953|FG000|Overall Study|Progressive Disease|1
895575|NCT00699582|1866954|FG001|Overall Study|Progressive Disease|0
895576|NCT00699582|1866955|FG002|Overall Study|Progressive Disease|0
895577|NCT00699582|1866953|FG000|Overall Study|Administrative/Other|4
895578|NCT00699582|1866954|FG001|Overall Study|Administrative/Other|3
895579|NCT00699582|1866955|FG002|Overall Study|Administrative/Other|0
895580|NCT00699582|1866953|FG000|Overall Study|Randomized, Not Treated|2
895581|NCT00699582|1866954|FG001|Overall Study|Randomized, Not Treated|1
895582|NCT00699582|1866955|FG002|Overall Study|Randomized, Not Treated|0
895583|NCT00699608|1866963|FG000|First Intervention|Withdrawal by Subject|0
895584|NCT00699608|1866964|FG001|First Intervention|Withdrawal by Subject|0
895585|NCT00699608|1866965|FG002|First Intervention|Withdrawal by Subject|1
895586|NCT00699608|1866966|FG003|First Intervention|Withdrawal by Subject|0
895587|NCT00699608|1866967|FG004|First Intervention|Withdrawal by Subject|0
895588|NCT00699608|1866968|FG005|First Intervention|Withdrawal by Subject|0
895589|NCT00699608|1866963|FG000|First Intervention|Protocol Violation|0
895590|NCT00699608|1866964|FG001|First Intervention|Protocol Violation|0
895591|NCT00699608|1866965|FG002|First Intervention|Protocol Violation|0
895592|NCT00699608|1866966|FG003|First Intervention|Protocol Violation|0
895593|NCT00699608|1866967|FG004|First Intervention|Protocol Violation|1
895594|NCT00699608|1866968|FG005|First Intervention|Protocol Violation|0
895595|NCT00699608|1866963|FG000|Second Intervention|Adverse Event|0
895596|NCT00699608|1866964|FG001|Second Intervention|Adverse Event|0
1107396|NCT02437409|2187001|FG000|Overall Study|Withdrawal by Subject|3
1107397|NCT02437409|2187001|FG000|Overall Study|Screening failure|12
1107398|NCT02437513|2187015|FG000|Overall Study|Withdrawal by Subject|2
1107399|NCT02437864|2187026|FG000|Overall Study|Protocol Violation|4
1107400|NCT02437864|2187027|FG001|Overall Study|Protocol Violation|0
1107401|NCT02437890|2187038|FG000|Overall Study|Non-compliance to study drug|0
1107402|NCT02437890|2187039|FG001|Overall Study|Non-compliance to study drug|1
1107403|NCT02437890|2187040|FG002|Overall Study|Non-compliance to study drug|0
1107404|NCT02437890|2187041|FG003|Overall Study|Non-compliance to study drug|0
1107405|NCT02437890|2187042|FG004|Overall Study|Non-compliance to study drug|1
1107406|NCT02437890|2187038|FG000|Overall Study|Sponsor's decision|1
1107407|NCT02437890|2187039|FG001|Overall Study|Sponsor's decision|1
1107408|NCT02437890|2187040|FG002|Overall Study|Sponsor's decision|4
1107409|NCT02437890|2187041|FG003|Overall Study|Sponsor's decision|0
1107410|NCT02437890|2187042|FG004|Overall Study|Sponsor's decision|2
1107411|NCT02437890|2187038|FG000|Overall Study|Physician Decision|0
1107412|NCT02437890|2187039|FG001|Overall Study|Physician Decision|0
1107413|NCT02437890|2187040|FG002|Overall Study|Physician Decision|0
1107414|NCT02437890|2187041|FG003|Overall Study|Physician Decision|1
1107415|NCT02437890|2187042|FG004|Overall Study|Physician Decision|0
1107416|NCT02437890|2187038|FG000|Overall Study|Unable to attend visit(s)|1
1107417|NCT02437890|2187039|FG001|Overall Study|Unable to attend visit(s)|0
1107418|NCT02437890|2187040|FG002|Overall Study|Unable to attend visit(s)|0
1107419|NCT02437890|2187041|FG003|Overall Study|Unable to attend visit(s)|0
1107420|NCT02437890|2187042|FG004|Overall Study|Unable to attend visit(s)|0
1107421|NCT02437890|2187038|FG000|Overall Study|Lack of Efficacy|1
1107422|NCT02437890|2187039|FG001|Overall Study|Lack of Efficacy|3
1107423|NCT02437890|2187040|FG002|Overall Study|Lack of Efficacy|0
1107424|NCT02437890|2187041|FG003|Overall Study|Lack of Efficacy|3
1107425|NCT02437890|2187042|FG004|Overall Study|Lack of Efficacy|1
1107426|NCT02437890|2187038|FG000|Overall Study|Adverse Event|4
1107427|NCT02437890|2187039|FG001|Overall Study|Adverse Event|9
895597|NCT00699608|1866965|FG002|Second Intervention|Adverse Event|1
895598|NCT00699608|1866966|FG003|Second Intervention|Adverse Event|0
895599|NCT00699608|1866967|FG004|Second Intervention|Adverse Event|0
895600|NCT00699608|1866968|FG005|Second Intervention|Adverse Event|0
895601|NCT00699608|1866963|FG000|Second Intervention|Withdrawal by Subject|0
895602|NCT00699608|1866964|FG001|Second Intervention|Withdrawal by Subject|0
895603|NCT00699608|1866965|FG002|Second Intervention|Withdrawal by Subject|0
895604|NCT00699608|1866966|FG003|Second Intervention|Withdrawal by Subject|1
895605|NCT00699608|1866967|FG004|Second Intervention|Withdrawal by Subject|0
895606|NCT00699608|1866968|FG005|Second Intervention|Withdrawal by Subject|0
895607|NCT00699660|1866978|FG000|Overall Study|Lost to Follow-up|4
895608|NCT00699660|1866979|FG001|Overall Study|Lost to Follow-up|2
895609|NCT00699660|1866978|FG000|Overall Study|missing reports and recording failures|10
895610|NCT00699660|1866979|FG001|Overall Study|missing reports and recording failures|6
895611|NCT00699699|1866985|FG000|Overall Study|Adverse Event|36
895612|NCT00699699|1866985|FG000|Overall Study|Individual different reasons|21
895613|NCT00699751|1866991|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27
895614|NCT00699751|1866992|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27
895615|NCT00699751|1866991|FG000|Period 1: Without/Before Drug Switch|Death|28
895616|NCT00699751|1866992|FG001|Period 1: Without/Before Drug Switch|Death|29
895617|NCT00699751|1866991|FG000|Period 1: Without/Before Drug Switch|Subject Request|43
895618|NCT00699751|1866992|FG001|Period 1: Without/Before Drug Switch|Subject Request|23
895619|NCT00699751|1866991|FG000|Period 1: Without/Before Drug Switch|Other|30
895620|NCT00699751|1866992|FG001|Period 1: Without/Before Drug Switch|Other|20
895621|NCT00699751|1866991|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97
895622|NCT00699751|1866992|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63
895623|NCT00699751|1866991|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
895624|NCT00699751|1866992|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
895625|NCT00699751|1866991|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
895626|NCT00699751|1866992|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
895627|NCT00699751|1866991|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
895628|NCT00699751|1866992|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
895629|NCT00699816|1867010|FG000|Overall Study|Protocol Violation|1
895630|NCT00699816|1867011|FG001|Overall Study|Protocol Violation|3
895631|NCT00699907|1867020|FG000|Overall Study|Withdrawal by Subject|2
895632|NCT00699907|1867021|FG001|Overall Study|Withdrawal by Subject|1
895633|NCT00699907|1867022|FG002|Overall Study|Withdrawal by Subject|0
895634|NCT00699907|1867020|FG000|Overall Study|No usable sample|0
895635|NCT00699907|1867021|FG001|Overall Study|No usable sample|9
895636|NCT00699907|1867022|FG002|Overall Study|No usable sample|8
895637|NCT00699972|1867033|FG000|Overall Study|Adverse Event|7
895638|NCT00699972|1867034|FG001|Overall Study|Adverse Event|9
895639|NCT00699972|1867035|FG002|Overall Study|Adverse Event|24
895640|NCT00699972|1867033|FG000|Overall Study|Lost to Follow-up|0
895641|NCT00699972|1867034|FG001|Overall Study|Lost to Follow-up|2
895642|NCT00699972|1867035|FG002|Overall Study|Lost to Follow-up|0
895643|NCT00699972|1867033|FG000|Overall Study|Withdrawal by Subject|3
1107428|NCT02437890|2187040|FG002|Overall Study|Adverse Event|5
1107429|NCT02437890|2187041|FG003|Overall Study|Adverse Event|11
1107430|NCT02437890|2187042|FG004|Overall Study|Adverse Event|7
1107431|NCT02437890|2187038|FG000|Overall Study|Withdrawal by Subject|1
1107432|NCT02437890|2187039|FG001|Overall Study|Withdrawal by Subject|2
1107433|NCT02437890|2187040|FG002|Overall Study|Withdrawal by Subject|6
1107434|NCT02437890|2187041|FG003|Overall Study|Withdrawal by Subject|5
1107435|NCT02437890|2187042|FG004|Overall Study|Withdrawal by Subject|5
1107436|NCT02437890|2187038|FG000|Overall Study|Death|0
1107437|NCT02437890|2187039|FG001|Overall Study|Death|0
1107438|NCT02437890|2187040|FG002|Overall Study|Death|0
1107439|NCT02437890|2187041|FG003|Overall Study|Death|2
1107440|NCT02437890|2187042|FG004|Overall Study|Death|0
1107441|NCT02437903|2187058|FG000|Overall Study|Adverse Event|1
1107442|NCT02437903|2187058|FG000|Overall Study|Withdrawal by Subject|1
1107443|NCT02437903|2187058|FG000|Overall Study|Lost to Follow-up|3
1107444|NCT02438137|2187065|FG000|Overall Study|Lost to Follow-up|3
1107445|NCT02438137|2187066|FG001|Overall Study|Lost to Follow-up|2
1107446|NCT02438137|2187065|FG000|Overall Study|Adverse Event|1
1107447|NCT02438137|2187066|FG001|Overall Study|Adverse Event|0
1107448|NCT02438137|2187065|FG000|Overall Study|Withdrawal by Subject|4
1107449|NCT02438137|2187066|FG001|Overall Study|Withdrawal by Subject|3
1107450|NCT02438137|2187065|FG000|Overall Study|Physician Decision|0
1107451|NCT02438137|2187066|FG001|Overall Study|Physician Decision|1
1107452|NCT02438280|2187076|FG000|Overall Study|Physician Decision|1
1107453|NCT02438280|2187077|FG001|Overall Study|Physician Decision|0
1107454|NCT02438371|2187086|FG000|Overall Study|Lost to Follow-up|3
1107455|NCT02438371|2187087|FG001|Overall Study|Lost to Follow-up|2
1107456|NCT02438371|2187086|FG000|Overall Study|Withdrawal by Subject|1
1107457|NCT02438371|2187087|FG001|Overall Study|Withdrawal by Subject|1
1107458|NCT02438384|2187096|FG000|Overall Study|Lost to Follow-up|8
1107459|NCT02438384|2187097|FG001|Overall Study|Lost to Follow-up|6
1107460|NCT02438384|2187098|FG002|Overall Study|Lost to Follow-up|4
1107461|NCT02438722|2187146|FG000|Overall Study|Adverse Event|12
1107462|NCT02438722|2187147|FG001|Overall Study|Adverse Event|9
1107463|NCT02438722|2187146|FG000|Overall Study|Refusal unrelated to AE|2
1107464|NCT02438722|2187147|FG001|Overall Study|Refusal unrelated to AE|5
1107465|NCT02438722|2187146|FG000|Overall Study|Disease progression/relapse|46
1107466|NCT02438722|2187147|FG001|Overall Study|Disease progression/relapse|51
1107467|NCT02438722|2187146|FG000|Overall Study|Death|0
1107468|NCT02438722|2187147|FG001|Overall Study|Death|3
895644|NCT00699972|1867034|FG001|Overall Study|Withdrawal by Subject|7
895645|NCT00699972|1867035|FG002|Overall Study|Withdrawal by Subject|4
895646|NCT00699972|1867033|FG000|Overall Study|Lack of Efficacy|2
895647|NCT00699972|1867034|FG001|Overall Study|Lack of Efficacy|0
895648|NCT00699972|1867035|FG002|Overall Study|Lack of Efficacy|2
895649|NCT00699972|1867033|FG000|Overall Study|Administrative/Other|3
895650|NCT00699972|1867034|FG001|Overall Study|Administrative/Other|1
895651|NCT00699972|1867035|FG002|Overall Study|Administrative/Other|4
895652|NCT00699972|1867033|FG000|Overall Study|Randomized, Not Treated|1
895653|NCT00699972|1867034|FG001|Overall Study|Randomized, Not Treated|0
895654|NCT00699972|1867035|FG002|Overall Study|Randomized, Not Treated|1
895655|NCT00699998|1867047|FG000|Overall Study|Withdrawal by Subject|194
895656|NCT00699998|1867048|FG001|Overall Study|Withdrawal by Subject|83
895657|NCT00699998|1867049|FG002|Overall Study|Withdrawal by Subject|202
895658|NCT00699998|1867050|FG003|Overall Study|Withdrawal by Subject|80
895659|NCT00699998|1867047|FG000|Overall Study|Physician Decision|3
895660|NCT00699998|1867048|FG001|Overall Study|Physician Decision|2
895661|NCT00699998|1867049|FG002|Overall Study|Physician Decision|1
895662|NCT00699998|1867050|FG003|Overall Study|Physician Decision|1
895663|NCT00699998|1867047|FG000|Overall Study|Lost to Follow-up|2
895664|NCT00699998|1867048|FG001|Overall Study|Lost to Follow-up|1
895665|NCT00699998|1867049|FG002|Overall Study|Lost to Follow-up|3
895666|NCT00699998|1867050|FG003|Overall Study|Lost to Follow-up|1
895667|NCT00700011|1867067|FG000|Overall Study|Death|0
895668|NCT00700011|1867068|FG001|Overall Study|Death|1
895669|NCT00700102|1867109|FG000|Overall Study|Died|394
895670|NCT00700102|1867110|FG001|Overall Study|Died|385
895671|NCT00700102|1867109|FG000|Overall Study|Lost to Follow-up|8
895672|NCT00700102|1867110|FG001|Overall Study|Lost to Follow-up|10
895673|NCT00700115|1867118|FG000|Overall Study|Withdrawal by Subject|1
895674|NCT00700115|1867119|FG001|Overall Study|Withdrawal by Subject|0
895675|NCT00700115|1867118|FG000|Overall Study|Lost to Follow-up|0
895676|NCT00700115|1867119|FG001|Overall Study|Lost to Follow-up|1
895677|NCT00700180|1867131|FG000|Overall Study|Death|99
895678|NCT00700180|1867132|FG001|Overall Study|Death|114
895679|NCT00700180|1867131|FG000|Overall Study|Alive on treatment|5
895680|NCT00700180|1867132|FG001|Overall Study|Alive on treatment|3
895681|NCT00700180|1867131|FG000|Overall Study|Alive in follow-up|46
895682|NCT00700180|1867132|FG001|Overall Study|Alive in follow-up|27
895683|NCT00700180|1867131|FG000|Overall Study|Lost to Follow-up|4
895684|NCT00700180|1867132|FG001|Overall Study|Lost to Follow-up|5
895685|NCT00700271|1867140|FG000|Overall Study|Adverse Event|4
1107469|NCT02438722|2187146|FG000|Overall Study|Physician Decision|2
1107470|NCT02438722|2187147|FG001|Overall Study|Physician Decision|2
1107471|NCT02438722|2187146|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1
1107472|NCT02438722|2187147|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0
1107473|NCT02438722|2187146|FG000|Overall Study|Withdrawal by Subject|0
1107474|NCT02438722|2187147|FG001|Overall Study|Withdrawal by Subject|1
1107475|NCT02438722|2187146|FG000|Overall Study|On protocol treatment|15
1107476|NCT02438722|2187147|FG001|Overall Study|On protocol treatment|14
1107477|NCT02438722|2187146|FG000|Overall Study|Did not receive protocol treatment|5
1107478|NCT02438722|2187147|FG001|Overall Study|Did not receive protocol treatment|0
1107479|NCT02438787|2187156|FG000|Overall Study|Adverse Event|1
1107480|NCT02438787|2187157|FG001|Overall Study|Adverse Event|0
1107481|NCT02438787|2187158|FG002|Overall Study|Adverse Event|2
1107482|NCT02438787|2187156|FG000|Overall Study|Lack of Efficacy|1
1107483|NCT02438787|2187157|FG001|Overall Study|Lack of Efficacy|2
1107484|NCT02438787|2187158|FG002|Overall Study|Lack of Efficacy|0
1107485|NCT02438787|2187156|FG000|Overall Study|Lost to Follow-up|0
1107486|NCT02438787|2187157|FG001|Overall Study|Lost to Follow-up|1
1107487|NCT02438787|2187158|FG002|Overall Study|Lost to Follow-up|0
1107488|NCT02438787|2187156|FG000|Overall Study|Protocol Violation|0
1107489|NCT02438787|2187157|FG001|Overall Study|Protocol Violation|0
1107490|NCT02438787|2187158|FG002|Overall Study|Protocol Violation|1
1107491|NCT02438787|2187156|FG000|Overall Study|Withdrawal by Subject|15
1107492|NCT02438787|2187157|FG001|Overall Study|Withdrawal by Subject|7
1107493|NCT02438787|2187158|FG002|Overall Study|Withdrawal by Subject|10
1107494|NCT02438787|2187156|FG000|Overall Study|Study discontinued by sponsor|64
1107495|NCT02438787|2187157|FG001|Overall Study|Study discontinued by sponsor|72
1107496|NCT02438787|2187158|FG002|Overall Study|Study discontinued by sponsor|69
1107497|NCT02438787|2187156|FG000|Overall Study|Other|0
1107498|NCT02438787|2187157|FG001|Overall Study|Other|1
1107499|NCT02438787|2187158|FG002|Overall Study|Other|0
1107500|NCT02438787|2187156|FG000|Overall Study|Site terminated by sponsor|0
895686|NCT00700271|1867141|FG001|Overall Study|Adverse Event|6
895687|NCT00700271|1867140|FG000|Overall Study|Protocol Violation|1
895688|NCT00700271|1867141|FG001|Overall Study|Protocol Violation|0
895689|NCT00700271|1867140|FG000|Overall Study|Administrative Reasons|1
895690|NCT00700271|1867141|FG001|Overall Study|Administrative Reasons|0
895691|NCT00700271|1867140|FG000|Overall Study|Withdrawal by Subject|6
895692|NCT00700271|1867141|FG001|Overall Study|Withdrawal by Subject|4
895693|NCT00700271|1867140|FG000|Overall Study|Lost to Follow-up|2
895694|NCT00700271|1867141|FG001|Overall Study|Lost to Follow-up|2
895695|NCT00700310|1867151|FG000|Overall Study|Adverse Event|6
895696|NCT00700310|1867152|FG001|Overall Study|Adverse Event|10
895697|NCT00700310|1867153|FG002|Overall Study|Adverse Event|5
895698|NCT00700310|1867154|FG003|Overall Study|Adverse Event|11
895699|NCT00700310|1867151|FG000|Overall Study|Lost to Follow-up|4
895700|NCT00700310|1867152|FG001|Overall Study|Lost to Follow-up|1
895701|NCT00700310|1867153|FG002|Overall Study|Lost to Follow-up|0
895702|NCT00700310|1867154|FG003|Overall Study|Lost to Follow-up|1
895703|NCT00700310|1867151|FG000|Overall Study|Withdrawal by Subject|8
895704|NCT00700310|1867152|FG001|Overall Study|Withdrawal by Subject|9
895705|NCT00700310|1867153|FG002|Overall Study|Withdrawal by Subject|8
895706|NCT00700310|1867154|FG003|Overall Study|Withdrawal by Subject|8
895707|NCT00700310|1867151|FG000|Overall Study|Lack of Efficacy|0
895708|NCT00700310|1867152|FG001|Overall Study|Lack of Efficacy|3
895709|NCT00700310|1867153|FG002|Overall Study|Lack of Efficacy|0
895710|NCT00700310|1867154|FG003|Overall Study|Lack of Efficacy|1
895711|NCT00700310|1867151|FG000|Overall Study|Administrative/Other|1
895712|NCT00700310|1867152|FG001|Overall Study|Administrative/Other|3
895713|NCT00700310|1867153|FG002|Overall Study|Administrative/Other|1
895714|NCT00700310|1867154|FG003|Overall Study|Administrative/Other|3
895715|NCT00700310|1867151|FG000|Overall Study|Randomized, Not Treated|2
895716|NCT00700310|1867152|FG001|Overall Study|Randomized, Not Treated|0
895717|NCT00700310|1867153|FG002|Overall Study|Randomized, Not Treated|2
895718|NCT00700310|1867154|FG003|Overall Study|Randomized, Not Treated|2
895719|NCT00700401|1867185|FG000|Overall Study|Detectable HCV RNA after Week 4|82
895720|NCT00700401|1867185|FG000|Overall Study|Adverse Event|5
895721|NCT00700401|1867185|FG000|Overall Study|Refused Treatment|2
895722|NCT00700401|1867185|FG000|Overall Study|Lost to Follow-up|1
895723|NCT00700401|1867185|FG000|Overall Study|Treatment never started|1
895724|NCT00700401|1867185|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1
895725|NCT00700401|1867185|FG000|Overall Study|Withdrawal by Subject|2
895726|NCT00700427|1867189|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
895727|NCT00700427|1867190|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
895728|NCT00700427|1867191|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
895729|NCT00700427|1867192|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
895730|NCT00700427|1867193|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
895731|NCT00700427|1867189|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
895732|NCT00700427|1867190|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
895733|NCT00700427|1867191|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
895734|NCT00700427|1867192|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
895735|NCT00700427|1867193|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
895736|NCT00700427|1867189|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
895737|NCT00700427|1867190|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1107501|NCT02438787|2187157|FG001|Overall Study|Site terminated by sponsor|0
1107502|NCT02438787|2187158|FG002|Overall Study|Site terminated by sponsor|1
1107503|NCT02438813|2187171|FG000|Overall Study|Patient Decision|59
1107504|NCT02438813|2187171|FG000|Overall Study|Patient Lost to Follow-Up|137
1107505|NCT02438813|2187171|FG000|Overall Study|Study Ended by Sponsor|80
1107506|NCT02438813|2187171|FG000|Overall Study|Patients Not Treated/No EOT Visit|249
1107507|NCT02438826|2187187|FG000|Double-Blind Treatment Phase|Adverse Event|1
1107508|NCT02438826|2187188|FG001|Double-Blind Treatment Phase|Adverse Event|1
1107509|NCT02438826|2187189|FG002|Double-Blind Treatment Phase|Adverse Event|0
1107510|NCT02438826|2187190|FG003|Double-Blind Treatment Phase|Adverse Event|0
1107511|NCT02438826|2187187|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1
1107512|NCT02438826|2187188|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0
1107513|NCT02438826|2187189|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0
1107514|NCT02438826|2187190|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0
1107515|NCT02438826|2187187|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1
1107516|NCT02438826|2187188|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1
1107517|NCT02438826|2187189|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0
1107518|NCT02438826|2187190|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0
1107519|NCT02438826|2187187|FG000|Double-Blind Treatment Phase|Protocol Violation|1
1107520|NCT02438826|2187188|FG001|Double-Blind Treatment Phase|Protocol Violation|2
1107521|NCT02438826|2187189|FG002|Double-Blind Treatment Phase|Protocol Violation|0
1107522|NCT02438826|2187190|FG003|Double-Blind Treatment Phase|Protocol Violation|0
1107523|NCT02438826|2187187|FG000|Double-Blind Treatment Phase|Screen Failure|2
1107524|NCT02438826|2187188|FG001|Double-Blind Treatment Phase|Screen Failure|0
1107525|NCT02438826|2187189|FG002|Double-Blind Treatment Phase|Screen Failure|0
1107526|NCT02438826|2187190|FG003|Double-Blind Treatment Phase|Screen Failure|0
1107527|NCT02438826|2187187|FG000|Open-Label Treatment Phase|Adverse Event|11
1107528|NCT02438826|2187188|FG001|Open-Label Treatment Phase|Adverse Event|6
1107529|NCT02438826|2187189|FG002|Open-Label Treatment Phase|Adverse Event|0
1107530|NCT02438826|2187190|FG003|Open-Label Treatment Phase|Adverse Event|0
1107531|NCT02438826|2187187|FG000|Open-Label Treatment Phase|Lack of Efficacy|27
1107532|NCT02438826|2187188|FG001|Open-Label Treatment Phase|Lack of Efficacy|18
1107533|NCT02438826|2187189|FG002|Open-Label Treatment Phase|Lack of Efficacy|0
1107534|NCT02438826|2187190|FG003|Open-Label Treatment Phase|Lack of Efficacy|0
1107535|NCT02438826|2187187|FG000|Open-Label Treatment Phase|Lost to Follow-up|0
1107536|NCT02438826|2187188|FG001|Open-Label Treatment Phase|Lost to Follow-up|2
1107537|NCT02438826|2187189|FG002|Open-Label Treatment Phase|Lost to Follow-up|0
1107538|NCT02438826|2187190|FG003|Open-Label Treatment Phase|Lost to Follow-up|0
1107539|NCT02438826|2187187|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6
1107540|NCT02438826|2187188|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7
1107541|NCT02438826|2187189|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0
1107542|NCT02438826|2187190|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0
895738|NCT00700427|1867191|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
895739|NCT00700427|1867192|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
895740|NCT00700427|1867193|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
895741|NCT00700427|1867189|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
895742|NCT00700427|1867190|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
895743|NCT00700427|1867191|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
895744|NCT00700427|1867192|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
895745|NCT00700427|1867193|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
895746|NCT00700427|1867189|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
895747|NCT00700427|1867190|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
895748|NCT00700427|1867191|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
895749|NCT00700427|1867192|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
895750|NCT00700427|1867193|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
895751|NCT00700427|1867189|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
895752|NCT00700427|1867190|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
895753|NCT00700427|1867191|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
895754|NCT00700427|1867192|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
895755|NCT00700427|1867193|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
895756|NCT00700427|1867189|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
895757|NCT00700427|1867190|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
895758|NCT00700427|1867191|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
895759|NCT00700427|1867192|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
895760|NCT00700427|1867193|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
895761|NCT00700427|1867189|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
895762|NCT00700427|1867190|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
895763|NCT00700427|1867191|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
895764|NCT00700427|1867192|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
895765|NCT00700427|1867193|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
895766|NCT00700427|1867189|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
895767|NCT00700427|1867190|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1107543|NCT02438826|2187187|FG000|Post-Treatment Phase|Adverse Event|3
1107544|NCT02438826|2187188|FG001|Post-Treatment Phase|Adverse Event|0
1107545|NCT02438826|2187189|FG002|Post-Treatment Phase|Adverse Event|0
1107546|NCT02438826|2187190|FG003|Post-Treatment Phase|Adverse Event|0
1107547|NCT02438826|2187187|FG000|Post-Treatment Phase|Lack of Efficacy|4
1107548|NCT02438826|2187188|FG001|Post-Treatment Phase|Lack of Efficacy|0
1107549|NCT02438826|2187189|FG002|Post-Treatment Phase|Lack of Efficacy|0
1107550|NCT02438826|2187190|FG003|Post-Treatment Phase|Lack of Efficacy|0
1107551|NCT02438826|2187187|FG000|Post-Treatment Phase|Physician Decision|1
1107552|NCT02438826|2187188|FG001|Post-Treatment Phase|Physician Decision|0
1107553|NCT02438826|2187189|FG002|Post-Treatment Phase|Physician Decision|0
1107554|NCT02438826|2187190|FG003|Post-Treatment Phase|Physician Decision|0
1107555|NCT02438826|2187187|FG000|Post-Treatment Phase|Withdrawal by Subject|1
1107556|NCT02438826|2187188|FG001|Post-Treatment Phase|Withdrawal by Subject|1
1107557|NCT02438826|2187189|FG002|Post-Treatment Phase|Withdrawal by Subject|0
1107558|NCT02438826|2187190|FG003|Post-Treatment Phase|Withdrawal by Subject|0
1107559|NCT02439138|2187205|FG000|Overall Study|Adverse Event|1
1107560|NCT02439138|2187205|FG000|Overall Study|PI decision to terminate the study|2
1107561|NCT02439320|2187233|FG000|Overall Study|Adverse Event|0
1107562|NCT02439320|2187234|FG001|Overall Study|Adverse Event|2
1107563|NCT02439320|2187235|FG002|Overall Study|Adverse Event|0
1107564|NCT02439320|2187233|FG000|Overall Study|Lost to Follow-up|37
1107565|NCT02439320|2187234|FG001|Overall Study|Lost to Follow-up|34
1107566|NCT02439320|2187235|FG002|Overall Study|Lost to Follow-up|42
1107567|NCT02439320|2187233|FG000|Overall Study|Death|0
1107568|NCT02439320|2187234|FG001|Overall Study|Death|1
1107569|NCT02439320|2187235|FG002|Overall Study|Death|0
1107570|NCT02439320|2187233|FG000|Overall Study|Noncompliance with Protocol|10
1107571|NCT02439320|2187234|FG001|Overall Study|Noncompliance with Protocol|11
1107572|NCT02439320|2187235|FG002|Overall Study|Noncompliance with Protocol|7
1107573|NCT02439320|2187233|FG000|Overall Study|Pregnancy|0
1107574|NCT02439320|2187234|FG001|Overall Study|Pregnancy|1
1107575|NCT02439320|2187235|FG002|Overall Study|Pregnancy|1
1107576|NCT02439320|2187233|FG000|Overall Study|Withdrawal by Subject|12
1107577|NCT02439320|2187234|FG001|Overall Study|Withdrawal by Subject|16
1107578|NCT02439320|2187235|FG002|Overall Study|Withdrawal by Subject|14
1107579|NCT02439320|2187233|FG000|Overall Study|Physician Decision|2
1107580|NCT02439320|2187234|FG001|Overall Study|Physician Decision|1
1107581|NCT02439320|2187235|FG002|Overall Study|Physician Decision|0
1107582|NCT02439320|2187233|FG000|Overall Study|Sponsor Request|0
1107583|NCT02439320|2187234|FG001|Overall Study|Sponsor Request|2
1107584|NCT02439320|2187235|FG002|Overall Study|Sponsor Request|1
1107585|NCT02439320|2187233|FG000|Overall Study|Randomization Failure|35
1107586|NCT02439320|2187234|FG001|Overall Study|Randomization Failure|46
1107587|NCT02439320|2187235|FG002|Overall Study|Randomization Failure|34
1107588|NCT02440425|2187324|FG000|Overall Study|Death likely due to disease progression|1
1107589|NCT02440425|2187324|FG000|Overall Study|Withdrawal by Subject|2
1107590|NCT02440425|2187324|FG000|Overall Study|Adverse Event|1
1107591|NCT02440425|2187324|FG000|Overall Study|Adverse Event/Ineligible|1
1107592|NCT02440568|2187336|FG000|Overall Study|Death|1
1107593|NCT02440568|2187337|FG001|Overall Study|Death|3
1107594|NCT02440568|2187338|FG002|Overall Study|Death|4
1107595|NCT02440568|2187339|FG003|Overall Study|Death|2
1107596|NCT02440568|2187336|FG000|Overall Study|Lack of Efficacy|2
1107597|NCT02440568|2187337|FG001|Overall Study|Lack of Efficacy|0
1107598|NCT02440568|2187338|FG002|Overall Study|Lack of Efficacy|1
1107599|NCT02440568|2187339|FG003|Overall Study|Lack of Efficacy|0
1107600|NCT02440568|2187336|FG000|Overall Study|Lost to Follow-up|1
1107601|NCT02440568|2187337|FG001|Overall Study|Lost to Follow-up|0
1107602|NCT02440568|2187338|FG002|Overall Study|Lost to Follow-up|0
1107603|NCT02440568|2187339|FG003|Overall Study|Lost to Follow-up|0
1107604|NCT02440594|2187358|FG000|Overall Study|Lost to Follow-up|34
1107605|NCT02440594|2187359|FG001|Overall Study|Lost to Follow-up|33
1107606|NCT02440594|2187360|FG002|Overall Study|Lost to Follow-up|54
1107607|NCT02440594|2187361|FG003|Overall Study|Lost to Follow-up|47
1107608|NCT02440594|2187362|FG004|Overall Study|Lost to Follow-up|5
1107609|NCT02440594|2187363|FG005|Overall Study|Lost to Follow-up|4
1107610|NCT02440594|2187364|FG006|Overall Study|Lost to Follow-up|28
1107611|NCT02440594|2187365|FG007|Overall Study|Lost to Follow-up|48
1107612|NCT02440594|2187358|FG000|Overall Study|Cognitive Impairment/Communication Issue|14
1107613|NCT02440594|2187359|FG001|Overall Study|Cognitive Impairment/Communication Issue|6
1107614|NCT02440594|2187360|FG002|Overall Study|Cognitive Impairment/Communication Issue|4
1107615|NCT02440594|2187361|FG003|Overall Study|Cognitive Impairment/Communication Issue|4
1107616|NCT02440594|2187362|FG004|Overall Study|Cognitive Impairment/Communication Issue|2
1107617|NCT02440594|2187363|FG005|Overall Study|Cognitive Impairment/Communication Issue|1
1107618|NCT02440594|2187364|FG006|Overall Study|Cognitive Impairment/Communication Issue|0
1107619|NCT02440594|2187365|FG007|Overall Study|Cognitive Impairment/Communication Issue|0
1107620|NCT02440594|2187358|FG000|Overall Study|Withdrawal by Subject|81
1107621|NCT02440594|2187359|FG001|Overall Study|Withdrawal by Subject|67
1107622|NCT02440594|2187360|FG002|Overall Study|Withdrawal by Subject|59
1107623|NCT02440594|2187361|FG003|Overall Study|Withdrawal by Subject|38
1107624|NCT02440594|2187362|FG004|Overall Study|Withdrawal by Subject|2
1107625|NCT02440594|2187363|FG005|Overall Study|Withdrawal by Subject|2
1107626|NCT02440594|2187364|FG006|Overall Study|Withdrawal by Subject|7
1107627|NCT02440594|2187365|FG007|Overall Study|Withdrawal by Subject|7
1107628|NCT02440594|2187358|FG000|Overall Study|Administratively w/drawn|3
1107629|NCT02440594|2187359|FG001|Overall Study|Administratively w/drawn|2
1107630|NCT02440594|2187360|FG002|Overall Study|Administratively w/drawn|0
1107631|NCT02440594|2187361|FG003|Overall Study|Administratively w/drawn|0
1107632|NCT02440594|2187362|FG004|Overall Study|Administratively w/drawn|0
1107633|NCT02440594|2187363|FG005|Overall Study|Administratively w/drawn|0
1107634|NCT02440594|2187364|FG006|Overall Study|Administratively w/drawn|2
1107635|NCT02440594|2187365|FG007|Overall Study|Administratively w/drawn|1
1107636|NCT02440789|2187407|FG000|Overall Study|Withdrawal by Subject|3
1107637|NCT02440789|2187407|FG000|Overall Study|Not willing to adhere to reqs|1
1107638|NCT02441114|2187415|FG000|Washout2|Withdrawal by Subject|4
1107639|NCT02441179|2187421|FG000|Overall Study|Withdrawal by Subject|1
1107640|NCT02441179|2187422|FG001|Overall Study|Withdrawal by Subject|1
1107641|NCT02441218|2187431|FG000|Overall Study|Death|503
1107642|NCT02441218|2187432|FG001|Overall Study|Death|553
1107643|NCT02441218|2187431|FG000|Overall Study|Withdrawal by Subject|73
1107644|NCT02441218|2187432|FG001|Overall Study|Withdrawal by Subject|58
1107645|NCT02441218|2187431|FG000|Overall Study|Lost to Follow-up|2
1107646|NCT02441218|2187432|FG001|Overall Study|Lost to Follow-up|1
1107647|NCT02441283|2187438|FG000|Overall Study|Withdrew consent|15
1107648|NCT02441283|2187438|FG000|Overall Study|Lost to Follow-up|42
1107649|NCT02441283|2187438|FG000|Overall Study|Death|1
1107650|NCT02441283|2187438|FG000|Overall Study|Other, not specified|32
1107651|NCT02441309|2187445|FG000|Overall Study|Disease progression|2
1107652|NCT02441309|2187446|FG001|Overall Study|Disease progression|1
1107653|NCT02441309|2187447|FG002|Overall Study|Disease progression|2
1107654|NCT02441309|2187445|FG000|Overall Study|Adverse Event|0
1107655|NCT02441309|2187446|FG001|Overall Study|Adverse Event|1
1107656|NCT02441309|2187447|FG002|Overall Study|Adverse Event|0
1107657|NCT02441309|2187445|FG000|Overall Study|Withdrawal by Subject|1
1107658|NCT02441309|2187446|FG001|Overall Study|Withdrawal by Subject|0
1107659|NCT02441309|2187447|FG002|Overall Study|Withdrawal by Subject|1
1107660|NCT02441517|2187458|FG000|Overall Study|Lost to Follow-up|1
1107661|NCT02441517|2187458|FG000|Overall Study|Withdrawal by Subject|2
1107662|NCT02441517|2187458|FG000|Overall Study|Study Terminated by Sponsor|1
1107663|NCT02441946|2187465|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
1107664|NCT02441946|2187466|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
1107665|NCT02441946|2187467|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
1107666|NCT02441946|2187465|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
1107667|NCT02441946|2187466|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
1107668|NCT02441946|2187467|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
1107669|NCT02441946|2187465|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
1107670|NCT02441946|2187466|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
1107671|NCT02441946|2187467|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
1107672|NCT02441946|2187465|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
1107673|NCT02441946|2187466|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
1107674|NCT02441946|2187467|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
1107675|NCT02441946|2187465|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
1107676|NCT02441946|2187466|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
1107677|NCT02441946|2187467|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
1107678|NCT02441946|2187465|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
1107679|NCT02441946|2187466|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
1107680|NCT02441946|2187467|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
1107681|NCT02441946|2187465|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
1107682|NCT02441946|2187466|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
1107683|NCT02441946|2187467|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
1107684|NCT02441946|2187465|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
1107685|NCT02441946|2187466|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
1107686|NCT02441946|2187467|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
1107687|NCT02441946|2187465|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
1107688|NCT02441946|2187466|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
1107689|NCT02441946|2187467|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
1107690|NCT02441946|2187465|FG000|Extension Period (8 Weeks)|Adverse Event|1
1107691|NCT02441946|2187466|FG001|Extension Period (8 Weeks)|Adverse Event|0
1107692|NCT02441946|2187467|FG002|Extension Period (8 Weeks)|Adverse Event|0
1107693|NCT02441946|2187465|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1
1107694|NCT02441946|2187466|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0
1107695|NCT02441946|2187467|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0
1107696|NCT02442206|2187480|FG000|Period 1|Adverse Event|1
1107697|NCT02442206|2187481|FG001|Period 1|Adverse Event|1
1107698|NCT02442206|2187480|FG000|Period 1|withdrew consent|0
1107699|NCT02442206|2187481|FG001|Period 1|withdrew consent|1
1107700|NCT02442206|2187480|FG000|Period 1|COPD exacerbation|0
1107701|NCT02442206|2187481|FG001|Period 1|COPD exacerbation|1
1107702|NCT02442206|2187480|FG000|Period 2|Adverse Event|1
1107703|NCT02442206|2187481|FG001|Period 2|Adverse Event|0
1107704|NCT02442271|2187488|FG000|Overall Study|Adverse Event|1
1107705|NCT02442271|2187488|FG000|Overall Study|Withdrew Consent|1
1107706|NCT02442271|2187488|FG000|Overall Study|Lost to Follow-up|1
1107707|NCT02442271|2187488|FG000|Overall Study|Other|1
1107708|NCT02442284|2187506|FG000|Overall Study|Adverse Event|1
1107709|NCT02442284|2187506|FG000|Overall Study|Withdrew Consent|2
1107710|NCT02442284|2187506|FG000|Overall Study|Lost to Follow-up|3
1107711|NCT02442284|2187506|FG000|Overall Study|Other|1
1107712|NCT02442310|2187510|FG000|Overall Study|Adverse Event|2
1107713|NCT02442310|2187510|FG000|Overall Study|Withdrawal by Subject|1
1107714|NCT02442336|2187520|FG000|Overall Study|6 patients assisted with the intervention development only.|6
1107715|NCT02442336|2187520|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19
1107716|NCT02442336|2187520|FG000|Overall Study|Lost to Follow-up|11
1107717|NCT02442622|2187526|FG000|Overall Study|Withdrawal by Subject|3
1107718|NCT02442622|2187527|FG001|Overall Study|Withdrawal by Subject|1
1107719|NCT02442804|2187558|FG000|Overall Study|Withdrawal by Subject|0
1107720|NCT02442804|2187559|FG001|Overall Study|Withdrawal by Subject|1
895768|NCT00700427|1867191|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
895769|NCT00700427|1867192|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
895770|NCT00700427|1867193|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
895771|NCT00700427|1867189|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1107721|NCT02442804|2187558|FG000|Overall Study|Adverse Event|1
1107722|NCT02442804|2187559|FG001|Overall Study|Adverse Event|0
895772|NCT00700427|1867190|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50
895773|NCT00700427|1867191|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0
895774|NCT00700427|1867192|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0
895775|NCT00700427|1867193|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0
895776|NCT00700427|1867189|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
895777|NCT00700427|1867190|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
895778|NCT00700427|1867191|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
895779|NCT00700427|1867192|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
895780|NCT00700427|1867193|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
895781|NCT00700427|1867189|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
895782|NCT00700427|1867190|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
895783|NCT00700427|1867191|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
895784|NCT00700427|1867192|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
895785|NCT00700427|1867193|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
895786|NCT00700427|1867189|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
895787|NCT00700427|1867190|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
895788|NCT00700427|1867191|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
895789|NCT00700427|1867192|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
895790|NCT00700427|1867193|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
895791|NCT00700427|1867189|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
895792|NCT00700427|1867190|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
895793|NCT00700427|1867191|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
895794|NCT00700427|1867192|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
895795|NCT00700427|1867193|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
895796|NCT00700427|1867189|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
895797|NCT00700427|1867190|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
895798|NCT00700427|1867191|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
895799|NCT00700427|1867192|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
895800|NCT00700427|1867193|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
895801|NCT00700427|1867189|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
895802|NCT00700427|1867190|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
895803|NCT00700427|1867191|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
895804|NCT00700427|1867192|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
895805|NCT00700427|1867193|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
895806|NCT00700427|1867189|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
895807|NCT00700427|1867190|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
895808|NCT00700427|1867191|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
895809|NCT00700427|1867192|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
895810|NCT00700427|1867193|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
895811|NCT00700427|1867189|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0
895812|NCT00700427|1867190|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2
895813|NCT00700427|1867191|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0
895814|NCT00700427|1867192|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0
895815|NCT00700427|1867193|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0
895816|NCT00700427|1867189|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
895817|NCT00700427|1867190|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
895818|NCT00700427|1867191|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1018312|NCT01570283|2043158|FG001|Cohort 1: Dose Level 1|Death|1
1107723|NCT02442830|2187567|FG000|Overall Study|Technical Failure|0
1107724|NCT02442830|2187568|FG001|Overall Study|Technical Failure|1
1107725|NCT02443103|2187614|FG000|Overall Study|Adverse Event|2
1107726|NCT02443103|2187614|FG000|Overall Study|Noncompliance|1
1107727|NCT02443155|2187622|FG000|Overall Study|Adverse Event|3
1107728|NCT02443155|2187623|FG001|Overall Study|Adverse Event|4
1107729|NCT02443155|2187624|FG002|Overall Study|Adverse Event|1
1107730|NCT02443155|2187625|FG003|Overall Study|Adverse Event|2
1107731|NCT02443155|2187622|FG000|Overall Study|Unclassified|0
1107732|NCT02443155|2187623|FG001|Overall Study|Unclassified|0
1107733|NCT02443155|2187624|FG002|Overall Study|Unclassified|2
1107734|NCT02443155|2187625|FG003|Overall Study|Unclassified|1
1107735|NCT02443155|2187622|FG000|Overall Study|Withdrawal by Subject|4
1107736|NCT02443155|2187623|FG001|Overall Study|Withdrawal by Subject|7
1107737|NCT02443155|2187624|FG002|Overall Study|Withdrawal by Subject|3
1107738|NCT02443155|2187625|FG003|Overall Study|Withdrawal by Subject|9
1107739|NCT02443155|2187622|FG000|Overall Study|Pregnancy|3
1107740|NCT02443155|2187623|FG001|Overall Study|Pregnancy|1
1107741|NCT02443155|2187624|FG002|Overall Study|Pregnancy|1
1107742|NCT02443155|2187625|FG003|Overall Study|Pregnancy|2
1107743|NCT02443155|2187622|FG000|Overall Study|Lost to Follow-up|1
1107744|NCT02443155|2187623|FG001|Overall Study|Lost to Follow-up|2
1107745|NCT02443155|2187624|FG002|Overall Study|Lost to Follow-up|0
1107746|NCT02443155|2187625|FG003|Overall Study|Lost to Follow-up|1
1107747|NCT02443155|2187622|FG000|Overall Study|Protocol Violation|1
1107748|NCT02443155|2187623|FG001|Overall Study|Protocol Violation|0
1107749|NCT02443155|2187624|FG002|Overall Study|Protocol Violation|1
1107750|NCT02443155|2187625|FG003|Overall Study|Protocol Violation|1
1107751|NCT02443155|2187622|FG000|Overall Study|Death|0
1107752|NCT02443155|2187623|FG001|Overall Study|Death|0
1107753|NCT02443155|2187624|FG002|Overall Study|Death|1
1107754|NCT02443155|2187625|FG003|Overall Study|Death|0
1107755|NCT02443298|2187638|FG000|Overall Study|Adverse Event|3
1107756|NCT02443298|2187639|FG001|Overall Study|Adverse Event|3
1107757|NCT02443298|2187638|FG000|Overall Study|Withdrawal by Subject|1
1107758|NCT02443298|2187639|FG001|Overall Study|Withdrawal by Subject|2
1107759|NCT02443337|2187647|FG000|Overall Study|Adverse Event|0
1107760|NCT02443337|2187648|FG001|Overall Study|Adverse Event|1
1107761|NCT02443337|2187647|FG000|Overall Study|Clinical Progressive Disease|3
1107762|NCT02443337|2187648|FG001|Overall Study|Clinical Progressive Disease|0
1107763|NCT02443337|2187647|FG000|Overall Study|Withdrawal by Subject|2
1107764|NCT02443337|2187648|FG001|Overall Study|Withdrawal by Subject|1
1107765|NCT02443402|2187661|FG000|Overall Study|Withdrawal by Subject|3
1107766|NCT02443402|2187662|FG001|Overall Study|Withdrawal by Subject|1
1107767|NCT02443402|2187661|FG000|Overall Study|Screen Failure|1
1107768|NCT02443402|2187662|FG001|Overall Study|Screen Failure|2
1107769|NCT02443688|2187693|FG000|Overall Study|Adverse Event|2
1107770|NCT02443688|2187694|FG001|Overall Study|Adverse Event|3
1107771|NCT02443688|2187695|FG002|Overall Study|Adverse Event|2
1107772|NCT02443688|2187693|FG000|Overall Study|Lost to Follow-up|1
1107773|NCT02443688|2187694|FG001|Overall Study|Lost to Follow-up|0
1107774|NCT02443688|2187695|FG002|Overall Study|Lost to Follow-up|0
1107775|NCT02443688|2187693|FG000|Overall Study|Physician Decision|3
1107776|NCT02443688|2187694|FG001|Overall Study|Physician Decision|0
1107777|NCT02443688|2187695|FG002|Overall Study|Physician Decision|1
1107778|NCT02443688|2187693|FG000|Overall Study|Pregnancy|0
1107779|NCT02443688|2187694|FG001|Overall Study|Pregnancy|0
1107780|NCT02443688|2187695|FG002|Overall Study|Pregnancy|1
1107781|NCT02443688|2187693|FG000|Overall Study|Withdrawal by Subject|3
895819|NCT00700427|1867192|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
895820|NCT00700427|1867193|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
895821|NCT00700427|1867189|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
895822|NCT00700427|1867190|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
895823|NCT00700427|1867191|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
895824|NCT00700427|1867192|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
895825|NCT00700427|1867193|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
895826|NCT00700427|1867189|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
895827|NCT00700427|1867190|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
895828|NCT00700427|1867191|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
895829|NCT00700427|1867192|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
895830|NCT00700427|1867193|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
895831|NCT00700427|1867189|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
895832|NCT00700427|1867190|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
895833|NCT00700427|1867191|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
895834|NCT00700427|1867192|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
895835|NCT00700427|1867193|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
895836|NCT00700427|1867189|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
895837|NCT00700427|1867190|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
895838|NCT00700427|1867191|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
895839|NCT00700427|1867192|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
895840|NCT00700427|1867193|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
895841|NCT00700427|1867189|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
1107782|NCT02443688|2187694|FG001|Overall Study|Withdrawal by Subject|3
1107783|NCT02443688|2187695|FG002|Overall Study|Withdrawal by Subject|4
1107784|NCT02443688|2187693|FG000|Overall Study|Non-compliance with study drug|1
1107785|NCT02443688|2187694|FG001|Overall Study|Non-compliance with study drug|2
1107786|NCT02443688|2187695|FG002|Overall Study|Non-compliance with study drug|4
1107787|NCT02443688|2187693|FG000|Overall Study|Sponsor Request|2
1107788|NCT02443688|2187694|FG001|Overall Study|Sponsor Request|1
1107789|NCT02443688|2187695|FG002|Overall Study|Sponsor Request|0
1107790|NCT02443740|2187711|FG000|Intervention Period 1 (3 Days)|Adverse Event|0
1107791|NCT02443740|2187712|FG001|Intervention Period 1 (3 Days)|Adverse Event|0
1107792|NCT02443740|2187713|FG002|Intervention Period 1 (3 Days)|Adverse Event|0
1107793|NCT02443740|2187714|FG003|Intervention Period 1 (3 Days)|Adverse Event|0
1107794|NCT02443740|2187715|FG004|Intervention Period 1 (3 Days)|Adverse Event|0
1107795|NCT02443740|2187716|FG005|Intervention Period 1 (3 Days)|Adverse Event|1
1107796|NCT02443740|2187717|FG006|Intervention Period 1 (3 Days)|Adverse Event|0
1107797|NCT02443740|2187718|FG007|Intervention Period 1 (3 Days)|Adverse Event|0
895842|NCT00700427|1867190|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
895843|NCT00700427|1867191|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
895844|NCT00700427|1867192|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
895845|NCT00700427|1867193|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
895846|NCT00700427|1867189|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
895847|NCT00700427|1867190|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
895848|NCT00700427|1867191|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
895849|NCT00700427|1867192|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
895850|NCT00700427|1867193|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
895851|NCT00700427|1867189|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
895852|NCT00700427|1867190|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
895853|NCT00700427|1867191|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
895854|NCT00700427|1867192|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
895855|NCT00700427|1867193|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
895856|NCT00700427|1867189|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0
895857|NCT00700427|1867190|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0
895858|NCT00700427|1867191|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1
895859|NCT00700427|1867192|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1
895860|NCT00700427|1867193|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0
895861|NCT00700427|1867189|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
895862|NCT00700427|1867190|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
895863|NCT00700427|1867191|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
895864|NCT00700427|1867192|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
895865|NCT00700427|1867193|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
895866|NCT00700427|1867189|FG000|Study Period 3B (Randomized Withdrawal)|Death|0
895867|NCT00700427|1867190|FG001|Study Period 3B (Randomized Withdrawal)|Death|0
895868|NCT00700427|1867191|FG002|Study Period 3B (Randomized Withdrawal)|Death|1
895869|NCT00700427|1867192|FG003|Study Period 3B (Randomized Withdrawal)|Death|0
895870|NCT00700427|1867193|FG004|Study Period 3B (Randomized Withdrawal)|Death|0
895871|NCT00700427|1867189|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0
895872|NCT00700427|1867190|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0
895873|NCT00700427|1867191|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0
895874|NCT00700427|1867192|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0
895875|NCT00700427|1867193|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16
895876|NCT00700427|1867189|FG000|Study Period 4 (Open-Label Extension)|Death|0
895877|NCT00700427|1867190|FG001|Study Period 4 (Open-Label Extension)|Death|0
895878|NCT00700427|1867191|FG002|Study Period 4 (Open-Label Extension)|Death|0
895879|NCT00700427|1867192|FG003|Study Period 4 (Open-Label Extension)|Death|0
895880|NCT00700427|1867193|FG004|Study Period 4 (Open-Label Extension)|Death|1
895881|NCT00700427|1867189|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0
895882|NCT00700427|1867190|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0
895883|NCT00700427|1867191|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0
895884|NCT00700427|1867192|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0
895885|NCT00700427|1867193|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12
895886|NCT00700427|1867189|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
895887|NCT00700427|1867190|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
895888|NCT00700427|1867191|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
895889|NCT00700427|1867192|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
895890|NCT00700427|1867193|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
895891|NCT00700427|1867189|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0
895892|NCT00700427|1867190|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0
895893|NCT00700427|1867191|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0
895894|NCT00700427|1867192|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0
895895|NCT00700427|1867193|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2
895896|NCT00700427|1867189|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1107798|NCT02443740|2187719|FG008|Intervention Period 1 (3 Days)|Adverse Event|0
1107799|NCT02443740|2187720|FG009|Intervention Period 1 (3 Days)|Adverse Event|0
1107800|NCT02443740|2187721|FG010|Intervention Period 1 (3 Days)|Adverse Event|0
1107801|NCT02443740|2187711|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1
1107802|NCT02443740|2187712|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0
1107803|NCT02443740|2187713|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0
1107804|NCT02443740|2187714|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0
1107805|NCT02443740|2187715|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0
1107806|NCT02443740|2187716|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0
1107807|NCT02443740|2187717|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1
1107808|NCT02443740|2187718|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0
1107809|NCT02443740|2187719|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0
1107810|NCT02443740|2187720|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0
1107811|NCT02443740|2187721|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0
1107812|NCT02443740|2187711|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1107813|NCT02443740|2187712|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1107814|NCT02443740|2187713|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1107815|NCT02443740|2187714|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1107816|NCT02443740|2187715|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1107817|NCT02443740|2187716|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
1107818|NCT02443740|2187717|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1107819|NCT02443740|2187718|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1107820|NCT02443740|2187719|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1107821|NCT02443740|2187720|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1107822|NCT02443740|2187721|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1107823|NCT02443805|2187762|FG000|Overall Study|Adverse Event|100
1107824|NCT02443805|2187763|FG001|Overall Study|Adverse Event|18
1107825|NCT02443805|2187762|FG000|Overall Study|Withdrawal by Subject|73
1107826|NCT02443805|2187763|FG001|Overall Study|Withdrawal by Subject|74
1107827|NCT02443805|2187762|FG000|Overall Study|Lost to Follow-up|19
1107828|NCT02443805|2187763|FG001|Overall Study|Lost to Follow-up|14
1107829|NCT02443805|2187762|FG000|Overall Study|Pregnancy|6
1107830|NCT02443805|2187763|FG001|Overall Study|Pregnancy|5
1107831|NCT02443805|2187762|FG000|Overall Study|Protocol Violation|2
1107832|NCT02443805|2187763|FG001|Overall Study|Protocol Violation|4
1107833|NCT02443805|2187762|FG000|Overall Study|Lack of Efficacy|1
1107834|NCT02443805|2187763|FG001|Overall Study|Lack of Efficacy|1
1107835|NCT02443805|2187762|FG000|Overall Study|Non-compliance with study drug|6
1107836|NCT02443805|2187763|FG001|Overall Study|Non-compliance with study drug|4
1107837|NCT02443805|2187762|FG000|Overall Study|Withdrawal by parent/guardian|3
1107838|NCT02443805|2187763|FG001|Overall Study|Withdrawal by parent/guardian|5
1107839|NCT02443805|2187762|FG000|Overall Study|Any other reason not above-mentioned|3
1107840|NCT02443805|2187763|FG001|Overall Study|Any other reason not above-mentioned|2
1107841|NCT02443883|2187773|FG000|Overall Study|Adverse Event|0
1107842|NCT02443883|2187774|FG001|Overall Study|Adverse Event|1
1107843|NCT02443883|2187775|FG002|Overall Study|Adverse Event|0
1107844|NCT02443883|2187776|FG003|Overall Study|Adverse Event|0
895897|NCT00700427|1867190|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
895898|NCT00700427|1867191|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
895899|NCT00700427|1867192|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
895900|NCT00700427|1867193|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
895901|NCT00700427|1867189|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
895902|NCT00700427|1867190|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
895903|NCT00700427|1867191|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
895904|NCT00700427|1867192|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
895905|NCT00700427|1867193|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
895906|NCT00700427|1867189|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
895907|NCT00700427|1867190|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
895908|NCT00700427|1867191|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
895909|NCT00700427|1867192|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
895910|NCT00700427|1867193|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
895911|NCT00700427|1867189|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
895912|NCT00700427|1867190|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
895913|NCT00700427|1867191|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
895914|NCT00700427|1867192|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
895915|NCT00700427|1867193|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
895916|NCT00700570|1867207|FG000|Overall Study|Adverse Event|2
895917|NCT00700570|1867208|FG001|Overall Study|Adverse Event|6
895918|NCT00700570|1867207|FG000|Overall Study|Discretion of Investigator or Sponsor|0
895919|NCT00700570|1867208|FG001|Overall Study|Discretion of Investigator or Sponsor|3
895920|NCT00700570|1867207|FG000|Overall Study|Disease Progression|8
895921|NCT00700570|1867208|FG001|Overall Study|Disease Progression|11
895922|NCT00700570|1867207|FG000|Overall Study|Withdrawal by Subject|1
895923|NCT00700570|1867208|FG001|Overall Study|Withdrawal by Subject|6
895924|NCT00700622|1867216|FG000|Overall Study|Adverse Event|4
895925|NCT00700622|1867217|FG001|Overall Study|Adverse Event|0
1107845|NCT02443883|2187773|FG000|Overall Study|Lost to Follow-up|3
1107846|NCT02443883|2187774|FG001|Overall Study|Lost to Follow-up|2
1107847|NCT02443883|2187775|FG002|Overall Study|Lost to Follow-up|1
1107848|NCT02443883|2187776|FG003|Overall Study|Lost to Follow-up|0
1107849|NCT02443883|2187773|FG000|Overall Study|Physician Decision|1
1107850|NCT02443883|2187774|FG001|Overall Study|Physician Decision|1
1107851|NCT02443883|2187775|FG002|Overall Study|Physician Decision|0
1107852|NCT02443883|2187776|FG003|Overall Study|Physician Decision|3
1107853|NCT02443883|2187773|FG000|Overall Study|Withdrawal by Subject|1
1107854|NCT02443883|2187774|FG001|Overall Study|Withdrawal by Subject|0
1107855|NCT02443883|2187775|FG002|Overall Study|Withdrawal by Subject|0
1107856|NCT02443883|2187776|FG003|Overall Study|Withdrawal by Subject|2
1107857|NCT02443883|2187773|FG000|Overall Study|Randomized, but never treated|1
1107858|NCT02443883|2187774|FG001|Overall Study|Randomized, but never treated|0
1107859|NCT02443883|2187775|FG002|Overall Study|Randomized, but never treated|0
1107860|NCT02443883|2187776|FG003|Overall Study|Randomized, but never treated|0
1107861|NCT02444182|2187799|FG000|Overall Study|non-compliance|2
1107862|NCT02444182|2187800|FG001|Overall Study|non-compliance|1
1107863|NCT02444182|2187799|FG000|Overall Study|Lost to Follow-up|0
1107864|NCT02444182|2187800|FG001|Overall Study|Lost to Follow-up|4
1107865|NCT02444533|2187817|FG000|Overall Study|Not able to complete forms|0
1107866|NCT02444533|2187818|FG001|Overall Study|Not able to complete forms|2
1107867|NCT02444533|2187817|FG000|Overall Study|Only gave post-procedure complications|2
1107868|NCT02444533|2187818|FG001|Overall Study|Only gave post-procedure complications|2
1107869|NCT02445573|2187934|FG000|Overall Study|Withdrawal by Subject|1
1107870|NCT02445573|2187935|FG001|Overall Study|Withdrawal by Subject|1
1107871|NCT02445573|2187934|FG000|Overall Study|Lost to Follow-up|0
1107872|NCT02445573|2187935|FG001|Overall Study|Lost to Follow-up|1
1107873|NCT02445586|2187941|FG000|Overall Study|Death|14
1107874|NCT02445586|2187941|FG000|Overall Study|Withdrawal by Subject|13
1107875|NCT02445586|2187941|FG000|Overall Study|Disease Progression|10
1107876|NCT02445586|2187941|FG000|Overall Study|Protocol Violation|1
1107877|NCT02445586|2187941|FG000|Overall Study|Medical Condition|1
1107878|NCT02445755|2187950|FG000|Overall Study|Withdrawal by Subject|2
1107879|NCT02445755|2187950|FG000|Overall Study|Protocol Violation|6
1107880|NCT02445755|2187950|FG000|Overall Study|Screen Failure|5
1107881|NCT02445794|2187961|FG000|Overall Study|Adverse Event|0
1107882|NCT02445794|2187962|FG001|Overall Study|Adverse Event|0
1107883|NCT02445794|2187963|FG002|Overall Study|Adverse Event|2
1107884|NCT02445794|2187964|FG003|Overall Study|Adverse Event|0
1107885|NCT02445963|2188018|FG000|Overall Study|Lost to Follow-up|1
1107886|NCT02445963|2188019|FG001|Overall Study|Lost to Follow-up|0
1107887|NCT02445963|2188020|FG002|Overall Study|Lost to Follow-up|0
1107888|NCT02445963|2188021|FG003|Overall Study|Lost to Follow-up|0
1107889|NCT02445963|2188018|FG000|Overall Study|Change in employment|1
1107890|NCT02445963|2188019|FG001|Overall Study|Change in employment|0
1107891|NCT02445963|2188020|FG002|Overall Study|Change in employment|0
1107892|NCT02445963|2188021|FG003|Overall Study|Change in employment|0
1107893|NCT02445963|2188018|FG000|Overall Study|Symptoms post-vaccination|0
1107894|NCT02445963|2188019|FG001|Overall Study|Symptoms post-vaccination|0
1107895|NCT02445963|2188020|FG002|Overall Study|Symptoms post-vaccination|1
1107896|NCT02445963|2188021|FG003|Overall Study|Symptoms post-vaccination|0
1107897|NCT02446015|2188035|FG000|Overall Study|Adverse Event|0
1107898|NCT02446015|2188036|FG001|Overall Study|Adverse Event|1
1107899|NCT02446015|2188035|FG000|Overall Study|Withdrawal by Subject|1
1107900|NCT02446015|2188036|FG001|Overall Study|Withdrawal by Subject|0
1107901|NCT02446171|2188047|FG000|Overall Study|Withdrawal by Subject|0
1107902|NCT02446171|2188048|FG001|Overall Study|Withdrawal by Subject|0
1107903|NCT02446171|2188049|FG002|Overall Study|Withdrawal by Subject|2
1107904|NCT02446171|2188050|FG003|Overall Study|Withdrawal by Subject|0
1107905|NCT02446418|2188089|FG000|Overall Study|Adverse Event|4
1107906|NCT02446418|2188090|FG001|Overall Study|Adverse Event|8
1107907|NCT02446418|2188089|FG000|Overall Study|Physician Decision|5
1107908|NCT02446418|2188090|FG001|Overall Study|Physician Decision|1
1107909|NCT02446418|2188089|FG000|Overall Study|Withdrawal by Subject|3
1107910|NCT02446418|2188090|FG001|Overall Study|Withdrawal by Subject|3
1107911|NCT02446418|2188089|FG000|Overall Study|Lost to Follow-up|2
1107912|NCT02446418|2188090|FG001|Overall Study|Lost to Follow-up|2
1107913|NCT02446418|2188089|FG000|Overall Study|Protocol Violation|1
1107914|NCT02446418|2188090|FG001|Overall Study|Protocol Violation|2
1107915|NCT02446418|2188089|FG000|Overall Study|Lack of Efficacy|2
1107916|NCT02446418|2188090|FG001|Overall Study|Lack of Efficacy|0
1107917|NCT02446418|2188089|FG000|Overall Study|Protocol defined stopping criteria reach|1
1107918|NCT02446418|2188090|FG001|Overall Study|Protocol defined stopping criteria reach|0
1107919|NCT02446600|2188113|FG000|Overall Study|Never treated|20
1107920|NCT02446600|2188114|FG001|Overall Study|Never treated|2
1107921|NCT02446600|2188115|FG002|Overall Study|Never treated|6
1107922|NCT02446600|2188116|FG003|Overall Study|Never treated|0
1107923|NCT02446600|2188113|FG000|Overall Study|Withdrawal by Subject|19
1107924|NCT02446600|2188114|FG001|Overall Study|Withdrawal by Subject|5
1107925|NCT02446600|2188115|FG002|Overall Study|Withdrawal by Subject|17
1107926|NCT02446600|2188116|FG003|Overall Study|Withdrawal by Subject|0
1107927|NCT02446600|2188113|FG000|Overall Study|Ineligible|1
1107928|NCT02446600|2188114|FG001|Overall Study|Ineligible|4
1107929|NCT02446600|2188115|FG002|Overall Study|Ineligible|4
1107930|NCT02446600|2188116|FG003|Overall Study|Ineligible|1
1107931|NCT02446600|2188113|FG000|Overall Study|Duplicate Enrollment|0
1107932|NCT02446600|2188114|FG001|Overall Study|Duplicate Enrollment|1
1107933|NCT02446600|2188115|FG002|Overall Study|Duplicate Enrollment|0
1107934|NCT02446600|2188116|FG003|Overall Study|Duplicate Enrollment|0
1107935|NCT02446691|2188139|FG000|Overall Study|Withdrawal by Subject|2
1107936|NCT02446691|2188139|FG000|Overall Study|Lost to Follow-up|8
1107937|NCT02446691|2188139|FG000|Overall Study|Protocol Violation|1
1107938|NCT02446717|2188148|FG000|Overall Study|Adverse Event|0
1107939|NCT02446717|2188149|FG001|Overall Study|Adverse Event|0
1107940|NCT02446717|2188150|FG002|Overall Study|Adverse Event|1
1107941|NCT02446717|2188151|FG003|Overall Study|Adverse Event|0
1107942|NCT02446717|2188152|FG004|Overall Study|Adverse Event|0
1107943|NCT02446717|2188148|FG000|Overall Study|Lost to Follow-up|0
1107944|NCT02446717|2188149|FG001|Overall Study|Lost to Follow-up|1
1107945|NCT02446717|2188150|FG002|Overall Study|Lost to Follow-up|1
1107946|NCT02446717|2188151|FG003|Overall Study|Lost to Follow-up|0
1107947|NCT02446717|2188152|FG004|Overall Study|Lost to Follow-up|1
1107948|NCT02446717|2188148|FG000|Overall Study|Withdrew consent|0
1107949|NCT02446717|2188149|FG001|Overall Study|Withdrew consent|0
1107950|NCT02446717|2188150|FG002|Overall Study|Withdrew consent|0
1107951|NCT02446717|2188151|FG003|Overall Study|Withdrew consent|1
1107952|NCT02446717|2188152|FG004|Overall Study|Withdrew consent|0
1107953|NCT02446743|2188166|FG000|Overall Study|Withdrawal by Subject|1
1107954|NCT02446743|2188167|FG001|Overall Study|Withdrawal by Subject|1
1107955|NCT02446743|2188166|FG000|Overall Study|Lost to Follow-up|1
1107956|NCT02446743|2188167|FG001|Overall Study|Lost to Follow-up|0
1107957|NCT02446743|2188166|FG000|Overall Study|Adverse Event|1
1107958|NCT02446743|2188167|FG001|Overall Study|Adverse Event|1
1107959|NCT02446743|2188166|FG000|Overall Study|Other|2
1107960|NCT02446743|2188167|FG001|Overall Study|Other|3
1107961|NCT02446769|2188182|FG000|Screening Period|Screen Failure|11
1107962|NCT02446769|2188183|FG001|Screening Period|Screen Failure|0
1107963|NCT02446769|2188184|FG002|Screening Period|Screen Failure|0
1107964|NCT02446769|2188182|FG000|Study Period|Randomized in Error|0
1107965|NCT02446769|2188183|FG001|Study Period|Randomized in Error|2
1107966|NCT02446769|2188184|FG002|Study Period|Randomized in Error|0
1107967|NCT02446886|2188202|FG000|Overall Study|Adverse Event|1
1107968|NCT02446886|2188203|FG001|Overall Study|Adverse Event|3
1107969|NCT02446886|2188202|FG000|Overall Study|Withdrawal by Subject|1
1107970|NCT02446886|2188203|FG001|Overall Study|Withdrawal by Subject|1
1107971|NCT02446899|2188212|FG000|Overall Study|Adverse Event|4
1107972|NCT02446899|2188213|FG001|Overall Study|Adverse Event|7
1107973|NCT02446899|2188212|FG000|Overall Study|Condition Under Investigation Worsened|1
1107974|NCT02446899|2188213|FG001|Overall Study|Condition Under Investigation Worsened|4
1107975|NCT02446899|2188212|FG000|Overall Study|Study Specific Withdrawal Criteria|1
1107976|NCT02446899|2188213|FG001|Overall Study|Study Specific Withdrawal Criteria|0
1107977|NCT02446899|2188212|FG000|Overall Study|Lack of Efficacy|2
1107978|NCT02446899|2188213|FG001|Overall Study|Lack of Efficacy|8
1107979|NCT02446899|2188212|FG000|Overall Study|Lost to Follow-up|1
1107980|NCT02446899|2188213|FG001|Overall Study|Lost to Follow-up|3
1107981|NCT02446899|2188212|FG000|Overall Study|Severe Non-Compliance to Protocol|0
1107982|NCT02446899|2188213|FG001|Overall Study|Severe Non-Compliance to Protocol|1
1107983|NCT02446899|2188212|FG000|Overall Study|Withdrawal by Subject|11
1107984|NCT02446899|2188213|FG001|Overall Study|Withdrawal by Subject|19
1107985|NCT02446899|2188212|FG000|Overall Study|Miscellaneous|5
1107986|NCT02446899|2188213|FG001|Overall Study|Miscellaneous|4
1107987|NCT02446899|2188212|FG000|Overall Study|Failure to Meet Randomization Criteria|0
1107988|NCT02446899|2188213|FG001|Overall Study|Failure to Meet Randomization Criteria|2
1107989|NCT02446912|2188222|FG000|Overall Study|Adverse Event|3
1107990|NCT02446912|2188223|FG001|Overall Study|Adverse Event|13
1107991|NCT02446912|2188224|FG002|Overall Study|Adverse Event|5
1162068|NCT03382418|2284045|FG002|Overall Study|Lost to Follow-up|0
895926|NCT00700622|1867216|FG000|Overall Study|Lost to Follow-up|0
895927|NCT00700622|1867217|FG001|Overall Study|Lost to Follow-up|1
895928|NCT00700622|1867216|FG000|Overall Study|Physician Decision|2
895929|NCT00700622|1867217|FG001|Overall Study|Physician Decision|1
895930|NCT00700622|1867216|FG000|Overall Study|Protocol Violation|0
895931|NCT00700622|1867217|FG001|Overall Study|Protocol Violation|1
895932|NCT00700622|1867216|FG000|Overall Study|Withdrawal by Subject|4
895933|NCT00700622|1867217|FG001|Overall Study|Withdrawal by Subject|1
895934|NCT00700622|1867216|FG000|Overall Study|Other|3
895935|NCT00700622|1867217|FG001|Overall Study|Other|1
895936|NCT00700635|1867226|FG000|Overall Study|Adverse Event|1
895937|NCT00700635|1867227|FG001|Overall Study|Adverse Event|0
895938|NCT00700635|1867228|FG002|Overall Study|Adverse Event|0
895939|NCT00700635|1867226|FG000|Overall Study|Lost to Follow-up|1
895940|NCT00700635|1867227|FG001|Overall Study|Lost to Follow-up|3
895941|NCT00700635|1867228|FG002|Overall Study|Lost to Follow-up|0
895942|NCT00700635|1867226|FG000|Overall Study|Protocol Violation|2
895943|NCT00700635|1867227|FG001|Overall Study|Protocol Violation|2
895944|NCT00700635|1867228|FG002|Overall Study|Protocol Violation|0
895945|NCT00700635|1867226|FG000|Overall Study|Withdrawal by Subject|7
895946|NCT00700635|1867227|FG001|Overall Study|Withdrawal by Subject|3
895947|NCT00700635|1867228|FG002|Overall Study|Withdrawal by Subject|1
1107992|NCT02446912|2188222|FG000|Overall Study|Condition under investigation worsened|0
1107993|NCT02446912|2188223|FG001|Overall Study|Condition under investigation worsened|1
1107994|NCT02446912|2188224|FG002|Overall Study|Condition under investigation worsened|1
1107995|NCT02446912|2188222|FG000|Overall Study|Study-specific withdrawal criteria|1
895948|NCT00700713|1867239|FG000|Overall Study|Protocol Violation|1
895949|NCT00700713|1867240|FG001|Overall Study|Protocol Violation|0
895950|NCT00700713|1867241|FG002|Overall Study|Protocol Violation|1
895951|NCT00700713|1867239|FG000|Overall Study|Withdrawal by Subject|0
895952|NCT00700713|1867240|FG001|Overall Study|Withdrawal by Subject|0
895953|NCT00700713|1867241|FG002|Overall Study|Withdrawal by Subject|1
895954|NCT00700739|1867251|FG000|Overall Study|Lost to Follow-up|4
895955|NCT00700739|1867252|FG001|Overall Study|Lost to Follow-up|4
895956|NCT00700752|1867259|FG000|First Intervention|Withdrawal by Subject|0
895957|NCT00700752|1867260|FG001|First Intervention|Withdrawal by Subject|2
895958|NCT00700804|1867268|FG000|Overall Study|Withdrawal by Subject|1
895959|NCT00700804|1867269|FG001|Overall Study|Withdrawal by Subject|2
895960|NCT00700804|1867268|FG000|Overall Study|Protocol Violation|1
895961|NCT00700804|1867269|FG001|Overall Study|Protocol Violation|1
895962|NCT00700804|1867268|FG000|Overall Study|Loose Stools|1
895963|NCT00700804|1867269|FG001|Overall Study|Loose Stools|1
895964|NCT00700817|1867280|FG000|Week 0-26 (Main Period)|Adverse Event|14
895965|NCT00700817|1867281|FG001|Week 0-26 (Main Period)|Adverse Event|15
895966|NCT00700817|1867282|FG002|Week 0-26 (Main Period)|Adverse Event|4
895967|NCT00700817|1867283|FG003|Week 0-26 (Main Period)|Adverse Event|0
895968|NCT00700817|1867284|FG004|Week 0-26 (Main Period)|Adverse Event|0
895969|NCT00700817|1867280|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4
895970|NCT00700817|1867281|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0
895971|NCT00700817|1867282|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4
895972|NCT00700817|1867283|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0
895973|NCT00700817|1867284|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0
895974|NCT00700817|1867280|FG000|Week 0-26 (Main Period)|Protocol Violation|14
895975|NCT00700817|1867281|FG001|Week 0-26 (Main Period)|Protocol Violation|4
895976|NCT00700817|1867282|FG002|Week 0-26 (Main Period)|Protocol Violation|4
895977|NCT00700817|1867283|FG003|Week 0-26 (Main Period)|Protocol Violation|0
895978|NCT00700817|1867284|FG004|Week 0-26 (Main Period)|Protocol Violation|0
895979|NCT00700817|1867280|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10
895980|NCT00700817|1867281|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7
895981|NCT00700817|1867282|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5
895982|NCT00700817|1867283|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0
895983|NCT00700817|1867284|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0
895984|NCT00700817|1867280|FG000|Week 0-26 (Main Period)|Unclassified|14
895985|NCT00700817|1867281|FG001|Week 0-26 (Main Period)|Unclassified|4
895986|NCT00700817|1867282|FG002|Week 0-26 (Main Period)|Unclassified|8
895987|NCT00700817|1867283|FG003|Week 0-26 (Main Period)|Unclassified|0
895988|NCT00700817|1867284|FG004|Week 0-26 (Main Period)|Unclassified|0
895989|NCT00700817|1867280|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5
895990|NCT00700817|1867281|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10
895991|NCT00700817|1867282|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3
895992|NCT00700817|1867283|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0
895993|NCT00700817|1867284|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0
895994|NCT00700817|1867280|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3
895995|NCT00700817|1867281|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2
895996|NCT00700817|1867282|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2
895997|NCT00700817|1867283|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0
895998|NCT00700817|1867284|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0
895999|NCT00700817|1867280|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
896000|NCT00700817|1867281|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
896001|NCT00700817|1867282|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
896002|NCT00700817|1867283|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
896003|NCT00700817|1867284|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
896004|NCT00700817|1867280|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
896005|NCT00700817|1867281|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
896006|NCT00700817|1867282|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
896007|NCT00700817|1867283|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
896008|NCT00700817|1867284|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
896009|NCT00700817|1867280|FG000|Week 26-52 (Extension Period 1)|Unclassified|4
896010|NCT00700817|1867281|FG001|Week 26-52 (Extension Period 1)|Unclassified|3
896011|NCT00700817|1867282|FG002|Week 26-52 (Extension Period 1)|Unclassified|1
896012|NCT00700817|1867283|FG003|Week 26-52 (Extension Period 1)|Unclassified|0
896013|NCT00700817|1867284|FG004|Week 26-52 (Extension Period 1)|Unclassified|0
896014|NCT00700817|1867280|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0
896015|NCT00700817|1867281|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3
896016|NCT00700817|1867282|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0
896017|NCT00700817|1867283|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6
896018|NCT00700817|1867284|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0
896019|NCT00700817|1867280|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1
896020|NCT00700817|1867281|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2
1107996|NCT02446912|2188223|FG001|Overall Study|Study-specific withdrawal criteria|0
1107997|NCT02446912|2188224|FG002|Overall Study|Study-specific withdrawal criteria|0
1107998|NCT02446912|2188222|FG000|Overall Study|Lack of Efficacy|1
1107999|NCT02446912|2188223|FG001|Overall Study|Lack of Efficacy|4
1108000|NCT02446912|2188224|FG002|Overall Study|Lack of Efficacy|7
1108001|NCT02446912|2188222|FG000|Overall Study|Lost to Follow-up|0
1108002|NCT02446912|2188223|FG001|Overall Study|Lost to Follow-up|0
1108003|NCT02446912|2188224|FG002|Overall Study|Lost to Follow-up|2
1108004|NCT02446912|2188222|FG000|Overall Study|Severe non-compliance to protocol|1
1108005|NCT02446912|2188223|FG001|Overall Study|Severe non-compliance to protocol|0
1108006|NCT02446912|2188224|FG002|Overall Study|Severe non-compliance to protocol|1
1108007|NCT02446912|2188222|FG000|Overall Study|Withdrawal by Subject|10
1108008|NCT02446912|2188223|FG001|Overall Study|Withdrawal by Subject|15
1108009|NCT02446912|2188224|FG002|Overall Study|Withdrawal by Subject|15
1108010|NCT02446912|2188222|FG000|Overall Study|Miscellaneous|2
1108011|NCT02446912|2188223|FG001|Overall Study|Miscellaneous|2
1108012|NCT02446912|2188224|FG002|Overall Study|Miscellaneous|4
1108013|NCT02446990|2188234|FG000|Overall Study|Death|485
1108014|NCT02446990|2188235|FG001|Overall Study|Death|458
1108015|NCT02446990|2188234|FG000|Overall Study|Lost to Follow-up|3
1108016|NCT02446990|2188235|FG001|Overall Study|Lost to Follow-up|1
1108017|NCT02446990|2188234|FG000|Overall Study|Physician Decision|1
1108018|NCT02446990|2188235|FG001|Overall Study|Physician Decision|0
1108019|NCT02446990|2188234|FG000|Overall Study|Withdrawal by Subject|231
1108020|NCT02446990|2188235|FG001|Overall Study|Withdrawal by Subject|199
1108021|NCT02447003|2188243|FG000|Overall Study|Other|0
1108022|NCT02447003|2188244|FG001|Overall Study|Other|4
1108023|NCT02447003|2188243|FG000|Overall Study|Site discontinued|0
1108024|NCT02447003|2188244|FG001|Overall Study|Site discontinued|2
896021|NCT00700817|1867282|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0
896022|NCT00700817|1867283|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1
896023|NCT00700817|1867284|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1
896024|NCT00700817|1867280|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
896025|NCT00700817|1867281|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
896026|NCT00700817|1867282|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
896027|NCT00700817|1867283|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
896028|NCT00700817|1867284|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
896029|NCT00700817|1867280|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
896030|NCT00700817|1867281|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
896031|NCT00700817|1867282|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
896032|NCT00700817|1867283|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
896033|NCT00700817|1867284|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
896034|NCT00700817|1867280|FG000|Week 52-78 (Extension Period 2)|Unclassified|2
896035|NCT00700817|1867281|FG001|Week 52-78 (Extension Period 2)|Unclassified|4
896036|NCT00700817|1867282|FG002|Week 52-78 (Extension Period 2)|Unclassified|0
896037|NCT00700817|1867283|FG003|Week 52-78 (Extension Period 2)|Unclassified|0
896038|NCT00700817|1867284|FG004|Week 52-78 (Extension Period 2)|Unclassified|1
896039|NCT00700882|1867294|FG000|Overall Study|Never received treatment|6
896040|NCT00700882|1867294|FG000|Overall Study|Ineligible|2
896041|NCT00700882|1867294|FG000|Overall Study|No KIT mutation|51
896042|NCT00700999|1867309|FG000|Overall Study|Lost to Follow-up|7
896043|NCT00700999|1867310|FG001|Overall Study|Lost to Follow-up|7
896044|NCT00700999|1867309|FG000|Overall Study|Excluded - did not meet study criteria|0
896045|NCT00700999|1867310|FG001|Overall Study|Excluded - did not meet study criteria|1
896046|NCT00700999|1867309|FG000|Overall Study|Withdrawal by Subject|8
896047|NCT00700999|1867310|FG001|Overall Study|Withdrawal by Subject|1
896048|NCT00701038|1867318|FG000|Overall Study|study amended pilot group of patients|4
896049|NCT00701038|1867319|FG001|Overall Study|study amended pilot group of patients|4
896050|NCT00701051|1867327|FG000|Screening|Failed Screening|40
896051|NCT00701051|1867328|FG001|Screening|Failed Screening|0
896052|NCT00701051|1867329|FG002|Screening|Failed Screening|0
896053|NCT00701051|1867327|FG000|Screening|Time conflicts|19
896054|NCT00701051|1867328|FG001|Screening|Time conflicts|0
896055|NCT00701051|1867329|FG002|Screening|Time conflicts|0
896056|NCT00701051|1867327|FG000|Exercise Intervention|time conflict; non-study related illness|0
896057|NCT00701051|1867328|FG001|Exercise Intervention|time conflict; non-study related illness|5
896058|NCT00701051|1867329|FG002|Exercise Intervention|time conflict; non-study related illness|3
896059|NCT00701064|1867337|FG000|Overall Study|Protocol Violation|1
896060|NCT00701064|1867338|FG001|Overall Study|Protocol Violation|1
896061|NCT00701064|1867337|FG000|Overall Study|Withdrawal by Subject|1
896062|NCT00701064|1867338|FG001|Overall Study|Withdrawal by Subject|1
896063|NCT00701064|1867337|FG000|Overall Study|initiated other PTSD treatment|2
896064|NCT00701064|1867338|FG001|Overall Study|initiated other PTSD treatment|2
896065|NCT00701090|1867346|FG000|Overall Study|Adverse Event|11
896066|NCT00701090|1867347|FG001|Overall Study|Adverse Event|2
896067|NCT00701090|1867346|FG000|Overall Study|Death|0
896068|NCT00701090|1867347|FG001|Overall Study|Death|1
896069|NCT00701090|1867346|FG000|Overall Study|Lack of Efficacy|5
896070|NCT00701090|1867347|FG001|Overall Study|Lack of Efficacy|4
896071|NCT00701090|1867346|FG000|Overall Study|Lost to Follow-up|9
896072|NCT00701090|1867347|FG001|Overall Study|Lost to Follow-up|9
1108025|NCT02447003|2188243|FG000|Overall Study|Physician Decision|0
1108026|NCT02447003|2188244|FG001|Overall Study|Physician Decision|1
1108027|NCT02447003|2188243|FG000|Overall Study|Withdrawal by Subject|4
1108028|NCT02447003|2188244|FG001|Overall Study|Withdrawal by Subject|3
1108029|NCT02447003|2188243|FG000|Overall Study|Sponsor Decision|6
1108030|NCT02447003|2188244|FG001|Overall Study|Sponsor Decision|11
1108031|NCT02447003|2188243|FG000|Overall Study|Progressive Disease|1
1108032|NCT02447003|2188244|FG001|Overall Study|Progressive Disease|0
1108033|NCT02447003|2188243|FG000|Overall Study|Lost to Follow-up|5
1108034|NCT02447003|2188244|FG001|Overall Study|Lost to Follow-up|0
1108035|NCT02447003|2188243|FG000|Overall Study|Death|154
1108036|NCT02447003|2188244|FG001|Overall Study|Death|63
1108037|NCT02447029|2188254|FG000|Overall Study|Withdrawal by Subject|3
1108038|NCT02447029|2188255|FG001|Overall Study|Withdrawal by Subject|2
1108039|NCT02447081|2188261|FG000|Overall Study|Death|161
1108040|NCT02447081|2188261|FG000|Overall Study|Lost to Follow-up|36
1108041|NCT02447081|2188261|FG000|Overall Study|Visit not completed|17
1108042|NCT02447081|2188261|FG000|Overall Study|unsuccessful implant procedure|10
1108043|NCT02447172|2188274|FG000|Overall Study|Adverse Event|11
1108044|NCT02447172|2188275|FG001|Overall Study|Adverse Event|8
1108045|NCT02447172|2188276|FG002|Overall Study|Adverse Event|7
1108046|NCT02447172|2188274|FG000|Overall Study|Death|3
1108047|NCT02447172|2188275|FG001|Overall Study|Death|1
1108048|NCT02447172|2188276|FG002|Overall Study|Death|0
1108049|NCT02447172|2188274|FG000|Overall Study|Protocol Violation|2
1108050|NCT02447172|2188275|FG001|Overall Study|Protocol Violation|1
1108051|NCT02447172|2188276|FG002|Overall Study|Protocol Violation|2
1108052|NCT02447172|2188274|FG000|Overall Study|Lost to Follow-up|7
1108053|NCT02447172|2188275|FG001|Overall Study|Lost to Follow-up|4
1108054|NCT02447172|2188276|FG002|Overall Study|Lost to Follow-up|4
1108055|NCT02447172|2188274|FG000|Overall Study|Withdrawal by Subject|5
1108056|NCT02447172|2188275|FG001|Overall Study|Withdrawal by Subject|1
1108057|NCT02447172|2188276|FG002|Overall Study|Withdrawal by Subject|3
1108058|NCT02447172|2188274|FG000|Overall Study|protocol specific treatment unrelated|3
1108059|NCT02447172|2188275|FG001|Overall Study|protocol specific treatment unrelated|0
1108060|NCT02447172|2188276|FG002|Overall Study|protocol specific treatment unrelated|2
1108061|NCT02447250|2188284|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
1108062|NCT02447250|2188284|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
1108063|NCT02447250|2188284|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
1108064|NCT02447302|2188292|FG000|Overall Study|Physician Decision|1
1108065|NCT02447302|2188293|FG001|Overall Study|Physician Decision|0
1108066|NCT02447302|2188294|FG002|Overall Study|Physician Decision|0
1108067|NCT02447302|2188292|FG000|Overall Study|Adverse Event|4
1108068|NCT02447302|2188293|FG001|Overall Study|Adverse Event|3
1108069|NCT02447302|2188294|FG002|Overall Study|Adverse Event|0
1108070|NCT02447302|2188292|FG000|Overall Study|Withdrawal by Subject|0
1108071|NCT02447302|2188293|FG001|Overall Study|Withdrawal by Subject|1
1108072|NCT02447302|2188294|FG002|Overall Study|Withdrawal by Subject|5
1108073|NCT02447302|2188292|FG000|Overall Study|Sponsor Decision|0
1108074|NCT02447302|2188293|FG001|Overall Study|Sponsor Decision|0
1108075|NCT02447302|2188294|FG002|Overall Study|Sponsor Decision|1
1108076|NCT02447328|2188302|FG000|Overall Study|Withdrawal by Subject|1
1108077|NCT02447432|2188308|FG000|Epoch 001|Adverse Event|1
1108078|NCT02447432|2188309|FG001|Epoch 001|Adverse Event|1
1108079|NCT02447432|2188308|FG000|Epoch 001|Withdrawal by Subject|0
1108080|NCT02447432|2188309|FG001|Epoch 001|Withdrawal by Subject|4
1108081|NCT02447432|2188308|FG000|Epoch 001|Migrated/moved from study area|3
1108082|NCT02447432|2188309|FG001|Epoch 001|Migrated/moved from study area|5
1108083|NCT02447432|2188308|FG000|Epoch 001|Lost to Follow-up|1
1108084|NCT02447432|2188309|FG001|Epoch 001|Lost to Follow-up|3
1108085|NCT02447458|2188321|FG000|Overall Study|Other|0
1108086|NCT02447458|2188322|FG001|Overall Study|Other|0
896073|NCT00701090|1867346|FG000|Overall Study|Physician Decision|3
896074|NCT00701090|1867347|FG001|Overall Study|Physician Decision|4
896075|NCT00701090|1867346|FG000|Overall Study|Protocol Violation|2
896076|NCT00701090|1867347|FG001|Overall Study|Protocol Violation|3
896077|NCT00701090|1867346|FG000|Overall Study|Withdrawal by Subject|11
896078|NCT00701090|1867347|FG001|Overall Study|Withdrawal by Subject|16
896079|NCT00701090|1867346|FG000|Overall Study|Other|7
896080|NCT00701090|1867347|FG001|Overall Study|Other|12
896081|NCT00701103|1867364|FG000|Overall Study|Adverse Event|0
896082|NCT00701103|1867365|FG001|Overall Study|Adverse Event|0
896083|NCT00701103|1867366|FG002|Overall Study|Adverse Event|1
896084|NCT00701103|1867367|FG003|Overall Study|Adverse Event|1
896085|NCT00701103|1867368|FG004|Overall Study|Adverse Event|0
896086|NCT00701103|1867369|FG005|Overall Study|Adverse Event|1
896087|NCT00701103|1867370|FG006|Overall Study|Adverse Event|1
1108087|NCT02447458|2188323|FG002|Overall Study|Other|1
1108088|NCT02447458|2188324|FG003|Overall Study|Other|0
1108089|NCT02447458|2188325|FG004|Overall Study|Other|0
1108090|NCT02447458|2188326|FG005|Overall Study|Other|0
1108091|NCT02447497|2188349|FG000|Overall Study|Did not meet treatment day baseline.|6
1108092|NCT02447497|2188350|FG001|Overall Study|Did not meet treatment day baseline.|5
1108093|NCT02447497|2188351|FG002|Overall Study|Did not meet treatment day baseline.|2
1108094|NCT02447497|2188352|FG003|Overall Study|Did not meet treatment day baseline.|2
1108095|NCT02447497|2188349|FG000|Overall Study|Dressing was compromised|0
1108096|NCT02447497|2188350|FG001|Overall Study|Dressing was compromised|1
1108097|NCT02447497|2188351|FG002|Overall Study|Dressing was compromised|0
1108098|NCT02447497|2188352|FG003|Overall Study|Dressing was compromised|0
1108099|NCT02447718|2188376|FG000|Overall Study|Lost to Follow-up|8
1108100|NCT02447718|2188377|FG001|Overall Study|Lost to Follow-up|0
1108101|NCT02447718|2188376|FG000|Overall Study|Withdrawal by Subject|3
896088|NCT00701103|1867371|FG007|Overall Study|Adverse Event|0
896089|NCT00701103|1867372|FG008|Overall Study|Adverse Event|0
896090|NCT00701103|1867373|FG009|Overall Study|Adverse Event|2
896091|NCT00701103|1867374|FG010|Overall Study|Adverse Event|0
896092|NCT00701103|1867364|FG000|Overall Study|Progressive Disease|5
896093|NCT00701103|1867365|FG001|Overall Study|Progressive Disease|2
896094|NCT00701103|1867366|FG002|Overall Study|Progressive Disease|6
896095|NCT00701103|1867367|FG003|Overall Study|Progressive Disease|5
896096|NCT00701103|1867368|FG004|Overall Study|Progressive Disease|6
896097|NCT00701103|1867369|FG005|Overall Study|Progressive Disease|5
896098|NCT00701103|1867370|FG006|Overall Study|Progressive Disease|7
896099|NCT00701103|1867371|FG007|Overall Study|Progressive Disease|7
896100|NCT00701103|1867372|FG008|Overall Study|Progressive Disease|8
896101|NCT00701103|1867373|FG009|Overall Study|Progressive Disease|8
896102|NCT00701103|1867374|FG010|Overall Study|Progressive Disease|11
896103|NCT00701103|1867364|FG000|Overall Study|Withdrawal by Subject|0
896104|NCT00701103|1867365|FG001|Overall Study|Withdrawal by Subject|1
896105|NCT00701103|1867366|FG002|Overall Study|Withdrawal by Subject|1
896106|NCT00701103|1867367|FG003|Overall Study|Withdrawal by Subject|0
896107|NCT00701103|1867368|FG004|Overall Study|Withdrawal by Subject|0
896108|NCT00701103|1867369|FG005|Overall Study|Withdrawal by Subject|0
896109|NCT00701103|1867370|FG006|Overall Study|Withdrawal by Subject|0
896110|NCT00701103|1867371|FG007|Overall Study|Withdrawal by Subject|0
896111|NCT00701103|1867372|FG008|Overall Study|Withdrawal by Subject|0
896112|NCT00701103|1867373|FG009|Overall Study|Withdrawal by Subject|0
896113|NCT00701103|1867374|FG010|Overall Study|Withdrawal by Subject|0
896114|NCT00701103|1867364|FG000|Overall Study|Other|0
896115|NCT00701103|1867365|FG001|Overall Study|Other|0
896116|NCT00701103|1867366|FG002|Overall Study|Other|0
896117|NCT00701103|1867367|FG003|Overall Study|Other|0
896118|NCT00701103|1867368|FG004|Overall Study|Other|0
896119|NCT00701103|1867369|FG005|Overall Study|Other|0
896120|NCT00701103|1867370|FG006|Overall Study|Other|0
896121|NCT00701103|1867371|FG007|Overall Study|Other|0
896122|NCT00701103|1867372|FG008|Overall Study|Other|1
896123|NCT00701103|1867373|FG009|Overall Study|Other|1
896124|NCT00701103|1867374|FG010|Overall Study|Other|0
896125|NCT00701129|1867402|FG000|Overall Study|Death|2
896126|NCT00701311|1867406|FG000|Overall Study|Lack of Efficacy|3
896127|NCT00701311|1867406|FG000|Overall Study|Adverse Event|3
896128|NCT00701311|1867406|FG000|Overall Study|Withdrawal by Subject|2
896129|NCT00701363|1867414|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
896130|NCT00701363|1867415|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
896131|NCT00701363|1867416|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
896132|NCT00701363|1867417|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
896133|NCT00701363|1867414|FG000|Treatment Phase 1|Does not meet entry Criteria|1
896134|NCT00701363|1867415|FG001|Treatment Phase 1|Does not meet entry Criteria|0
896135|NCT00701363|1867416|FG002|Treatment Phase 1|Does not meet entry Criteria|0
896136|NCT00701363|1867417|FG003|Treatment Phase 1|Does not meet entry Criteria|0
896137|NCT00701363|1867414|FG000|Treatment Phase 1|Adverse Event|7
896138|NCT00701363|1867415|FG001|Treatment Phase 1|Adverse Event|0
896139|NCT00701363|1867416|FG002|Treatment Phase 1|Adverse Event|0
896140|NCT00701363|1867417|FG003|Treatment Phase 1|Adverse Event|0
896141|NCT00701363|1867414|FG000|Treatment Phase 1|Protocol Violation|1
896142|NCT00701363|1867415|FG001|Treatment Phase 1|Protocol Violation|0
896143|NCT00701363|1867416|FG002|Treatment Phase 1|Protocol Violation|0
896144|NCT00701363|1867417|FG003|Treatment Phase 1|Protocol Violation|0
896145|NCT00701363|1867414|FG000|Treatment Phase 1|Withdrawal by Subject|5
896146|NCT00701363|1867415|FG001|Treatment Phase 1|Withdrawal by Subject|0
896147|NCT00701363|1867416|FG002|Treatment Phase 1|Withdrawal by Subject|0
896148|NCT00701363|1867417|FG003|Treatment Phase 1|Withdrawal by Subject|0
896149|NCT00701363|1867414|FG000|Treatment Phase 1|Lack of Efficacy|1
896150|NCT00701363|1867415|FG001|Treatment Phase 1|Lack of Efficacy|0
896151|NCT00701363|1867416|FG002|Treatment Phase 1|Lack of Efficacy|0
896152|NCT00701363|1867417|FG003|Treatment Phase 1|Lack of Efficacy|0
896153|NCT00701363|1867414|FG000|Treatment Phase 2|Adverse Event|0
896154|NCT00701363|1867415|FG001|Treatment Phase 2|Adverse Event|0
896155|NCT00701363|1867416|FG002|Treatment Phase 2|Adverse Event|1
896156|NCT00701363|1867417|FG003|Treatment Phase 2|Adverse Event|0
896157|NCT00701363|1867414|FG000|Treatment Phase 2|Withdrawal by Subject|0
896158|NCT00701363|1867415|FG001|Treatment Phase 2|Withdrawal by Subject|0
896159|NCT00701363|1867416|FG002|Treatment Phase 2|Withdrawal by Subject|1
896160|NCT00701363|1867417|FG003|Treatment Phase 2|Withdrawal by Subject|0
896161|NCT00701415|1867461|FG000|Overall Study|Adverse Event|0
896162|NCT00701415|1867462|FG001|Overall Study|Adverse Event|1
896163|NCT00701415|1867461|FG000|Overall Study|Social/family issues and needle phobia|1
896164|NCT00701415|1867462|FG001|Overall Study|Social/family issues and needle phobia|0
1108102|NCT02447718|2188377|FG001|Overall Study|Withdrawal by Subject|0
1108103|NCT02447718|2188376|FG000|Overall Study|Screen Failure|1
1108104|NCT02447718|2188377|FG001|Overall Study|Screen Failure|0
1108105|NCT02447744|2188386|FG000|Overall Study|Withdrawal by Subject|3
896165|NCT00701441|1867470|FG000|Overall Study|failure in cpap compliance|0
896166|NCT00701441|1867471|FG001|Overall Study|failure in cpap compliance|4
896167|NCT00701558|1867481|FG000|Overall Study|Death|7
896168|NCT00701558|1867481|FG000|Overall Study|Lost to Follow-up|8
896169|NCT00701662|1867493|FG000|Overall Study|Lack of Efficacy|1
896170|NCT00701701|1867512|FG000|Overall Study|Withdrawal by Subject|0
896171|NCT00701701|1867513|FG001|Overall Study|Withdrawal by Subject|1
896172|NCT00701701|1867512|FG000|Overall Study|Adverse Event|0
896173|NCT00701701|1867513|FG001|Overall Study|Adverse Event|1
896174|NCT00701727|1867533|FG000|First Treatment Period|Adverse Event|0
896175|NCT00701727|1867534|FG001|First Treatment Period|Adverse Event|0
896176|NCT00701727|1867533|FG000|First Treatment Period|Withdrawal by Subject|1
896177|NCT00701727|1867534|FG001|First Treatment Period|Withdrawal by Subject|0
896178|NCT00701727|1867533|FG000|First Treatment Period|sponsor decision|0
896179|NCT00701727|1867534|FG001|First Treatment Period|sponsor decision|1
896180|NCT00701727|1867533|FG000|First Treatment Period|Lost to Follow-up|0
896181|NCT00701727|1867534|FG001|First Treatment Period|Lost to Follow-up|1
896182|NCT00701727|1867533|FG000|Second Treatment Period|Withdrawal by Subject|2
896183|NCT00701727|1867534|FG001|Second Treatment Period|Withdrawal by Subject|0
896184|NCT00701779|1867540|FG000|Overall Study|Adverse Event|6
896185|NCT00701779|1867540|FG000|Overall Study|Lost to Follow-up|1
896186|NCT00701779|1867540|FG000|Overall Study|Withdrawal by Subject|2
896187|NCT00701805|1867548|FG000|Overall Study|Withdrawal by Subject|3
896188|NCT00701805|1867549|FG001|Overall Study|Withdrawal by Subject|1
896189|NCT00701805|1867550|FG002|Overall Study|Withdrawal by Subject|4
896190|NCT00701805|1867551|FG003|Overall Study|Withdrawal by Subject|3
896191|NCT00701805|1867548|FG000|Overall Study|Adverse Event|0
896192|NCT00701805|1867549|FG001|Overall Study|Adverse Event|1
896193|NCT00701805|1867550|FG002|Overall Study|Adverse Event|1
896194|NCT00701805|1867551|FG003|Overall Study|Adverse Event|0
896195|NCT00701805|1867548|FG000|Overall Study|Missed 7 consecutive doses|0
896196|NCT00701805|1867549|FG001|Overall Study|Missed 7 consecutive doses|1
896197|NCT00701805|1867550|FG002|Overall Study|Missed 7 consecutive doses|0
896198|NCT00701805|1867551|FG003|Overall Study|Missed 7 consecutive doses|0
896199|NCT00701805|1867548|FG000|Overall Study|Admitted to hospital for 2 weeks|0
896200|NCT00701805|1867549|FG001|Overall Study|Admitted to hospital for 2 weeks|0
896201|NCT00701805|1867550|FG002|Overall Study|Admitted to hospital for 2 weeks|1
896202|NCT00701805|1867551|FG003|Overall Study|Admitted to hospital for 2 weeks|0
896203|NCT00701805|1867548|FG000|Overall Study|Physician decision, change of therapy|0
896204|NCT00701805|1867549|FG001|Overall Study|Physician decision, change of therapy|0
896205|NCT00701805|1867550|FG002|Overall Study|Physician decision, change of therapy|0
896206|NCT00701805|1867551|FG003|Overall Study|Physician decision, change of therapy|1
896207|NCT00701805|1867548|FG000|Overall Study|Difficult to travel to dialysis site|0
896208|NCT00701805|1867549|FG001|Overall Study|Difficult to travel to dialysis site|0
896209|NCT00701805|1867550|FG002|Overall Study|Difficult to travel to dialysis site|1
896210|NCT00701805|1867551|FG003|Overall Study|Difficult to travel to dialysis site|0
896211|NCT00701805|1867548|FG000|Overall Study|Resumption criteria were not met|0
896212|NCT00701805|1867549|FG001|Overall Study|Resumption criteria were not met|1
896213|NCT00701805|1867550|FG002|Overall Study|Resumption criteria were not met|0
896214|NCT00701805|1867551|FG003|Overall Study|Resumption criteria were not met|0
896215|NCT00702052|1867579|FG000|Overall Study|Adverse Event|23
896216|NCT00702052|1867579|FG000|Overall Study|Disease Progression|30
896217|NCT00702052|1867579|FG000|Overall Study|Withdrawal by Subject|5
896218|NCT00702143|1867586|FG000|Overall Study|Lost to Follow-up|0
896219|NCT00702143|1867587|FG001|Overall Study|Lost to Follow-up|0
896220|NCT00702143|1867588|FG002|Overall Study|Lost to Follow-up|1
896221|NCT00702208|1867594|FG000|Overall Study|Lost to Follow-up|28
896222|NCT00702208|1867594|FG000|Overall Study|Did not self-lavage|1
896223|NCT00702208|1867594|FG000|Overall Study|Unsatisfactory colposcopy|2
896224|NCT00702221|1867601|FG000|Overall Study|Adverse Event|4
896225|NCT00702221|1867602|FG001|Overall Study|Adverse Event|3
896226|NCT00702325|1867634|FG000|Overall Study|Adverse Event|1
896227|NCT00702325|1867635|FG001|Overall Study|Adverse Event|0
896228|NCT00702325|1867634|FG000|Overall Study|Withdrawal by Subject|7
896229|NCT00702325|1867635|FG001|Overall Study|Withdrawal by Subject|7
896230|NCT00702325|1867634|FG000|Overall Study|Lost to Follow-up|3
896231|NCT00702325|1867635|FG001|Overall Study|Lost to Follow-up|4
896232|NCT00702325|1867634|FG000|Overall Study|Incorrect enrollment|5
896233|NCT00702325|1867635|FG001|Overall Study|Incorrect enrollment|7
896234|NCT00702325|1867634|FG000|Overall Study|Developed study discontinuation criteria|18
896235|NCT00702325|1867635|FG001|Overall Study|Developed study discontinuation criteria|28
896236|NCT00702325|1867634|FG000|Overall Study|Severe noncompliance to protocol|3
896237|NCT00702325|1867635|FG001|Overall Study|Severe noncompliance to protocol|3
896238|NCT00702325|1867634|FG000|Overall Study|Termination due to lab results|1
896239|NCT00702325|1867635|FG001|Overall Study|Termination due to lab results|0
896240|NCT00702325|1867634|FG000|Overall Study|Didn't follow study medication dosage|0
1108106|NCT02447744|2188387|FG001|Overall Study|Withdrawal by Subject|1
1108107|NCT02447744|2188386|FG000|Overall Study|Data not collected b/c logistic reasons|3
1108108|NCT02447744|2188387|FG001|Overall Study|Data not collected b/c logistic reasons|0
1108109|NCT02447848|2188393|FG000|Overall Study|Patient discharged|3
1108110|NCT02447848|2188393|FG000|Overall Study|Lack of Efficacy|4
1108111|NCT02447848|2188393|FG000|Overall Study|Withdrawal by Subject|4
896241|NCT00702325|1867635|FG001|Overall Study|Didn't follow study medication dosage|2
896242|NCT00702325|1867634|FG000|Overall Study|Withdrew consent|0
896243|NCT00702325|1867635|FG001|Overall Study|Withdrew consent|1
896244|NCT00702325|1867634|FG000|Overall Study|Incorrectly Discontinued|0
896245|NCT00702325|1867635|FG001|Overall Study|Incorrectly Discontinued|1
896246|NCT00702403|1867669|FG000|From Consent to Engraftment|Progressive leukemia|6
896247|NCT00702403|1867669|FG000|From Consent to Engraftment|Critically ill|2
896248|NCT00702403|1867669|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
896249|NCT00702403|1867669|FG000|From Consent to Engraftment|Myocardial infarction|1
896250|NCT00702403|1867669|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
896251|NCT00702403|1867669|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
896252|NCT00702403|1867669|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
896253|NCT00702403|1867669|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
896254|NCT00702403|1867669|FG000|From Engraftment to Study Completion|Non-compliance|2
896255|NCT00702403|1867669|FG000|From Engraftment to Study Completion|Adenocarcinoma|1
896256|NCT00702403|1867669|FG000|From Engraftment to Study Completion|Liver GVHD|1
896257|NCT00702403|1867669|FG000|From Engraftment to Study Completion|Suicide|1
896258|NCT00702403|1867669|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
896259|NCT00702403|1867669|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
896260|NCT00702403|1867669|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
896261|NCT00702507|1867685|FG000|Initial Treatment Phase|Adverse Event|2
896262|NCT00702507|1867685|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
896263|NCT00702507|1867685|FG000|Initial Treatment Phase|Lost to Follow-up|2
896264|NCT00702507|1867685|FG000|Initial Treatment Phase|Negative Candida Culture|34
896265|NCT00702507|1867685|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
896266|NCT00702507|1867685|FG000|Follow-up Phase|Protocol Violation|2
896267|NCT00702507|1867685|FG000|Follow-up Phase|Lost to Follow-up|23
896268|NCT00702507|1867685|FG000|Follow-up Phase|Late Enrollment|1
896269|NCT00702520|1867692|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
896270|NCT00702520|1867693|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
896271|NCT00702520|1867694|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
896272|NCT00702520|1867695|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
896273|NCT00702520|1867692|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3
896274|NCT00702520|1867693|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6
896275|NCT00702520|1867694|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0
896276|NCT00702520|1867695|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0
896277|NCT00702520|1867692|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
896278|NCT00702520|1867693|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
896279|NCT00702520|1867694|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
896280|NCT00702520|1867695|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
896281|NCT00702650|1867732|FG000|Overall Study|Withdrawal by Subject|9
896282|NCT00702650|1867732|FG000|Overall Study|Non-Compliance of Study Drug|3
896283|NCT00702650|1867732|FG000|Overall Study|Lost to Follow-up|2
896284|NCT00702650|1867732|FG000|Overall Study|Non-Compliance with Site Directives|1
896285|NCT00702650|1867732|FG000|Overall Study|Sponsor Request|1
896286|NCT00702650|1867732|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1
896287|NCT00702650|1867732|FG000|Overall Study|Adverse Event|3
896288|NCT00702689|1867736|FG000|Overall Study|Withdrawal by Subject|4
896289|NCT00702689|1867736|FG000|Overall Study|Recurrent malignancy|1
896290|NCT00702689|1867736|FG000|Overall Study|Adverse Event|1
896291|NCT00702715|1867742|FG000|Overall Study|Lost to Follow-up|1
896292|NCT00702715|1867743|FG001|Overall Study|Lost to Follow-up|0
896293|NCT00702845|1867764|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2
896294|NCT00702845|1867765|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2
896295|NCT00702845|1867764|FG000|Overall Study|Too high ovarian response|5
896296|NCT00702845|1867765|FG001|Overall Study|Too high ovarian response|1
896297|NCT00702845|1867764|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1
896298|NCT00702845|1867765|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0
896299|NCT00702845|1867764|FG000|Overall Study|Insufficient ovarian response|1
896300|NCT00702845|1867765|FG001|Overall Study|Insufficient ovarian response|0
896301|NCT00702845|1867764|FG000|Overall Study|No/too few/bad quality embryos retrieved|7
896302|NCT00702845|1867765|FG001|Overall Study|No/too few/bad quality embryos retrieved|1
896303|NCT00702845|1867764|FG000|Overall Study|No or abnormal fertilization|4
896304|NCT00702845|1867765|FG001|Overall Study|No or abnormal fertilization|2
896305|NCT00702845|1867764|FG000|Overall Study|Patient's decision|2
896306|NCT00702845|1867765|FG001|Overall Study|Patient's decision|1
896307|NCT00702845|1867764|FG000|Overall Study|Not randomized|0
896308|NCT00702845|1867765|FG001|Overall Study|Not randomized|1
1108112|NCT02447952|2188401|FG000|Overall Study|Adverse Event|2
1108113|NCT02447952|2188401|FG000|Overall Study|Physician Decision|1
1108114|NCT02447952|2188401|FG000|Overall Study|Withdrawal by Subject|4
1108115|NCT02447991|2188407|FG000|Overall Study|Withdrawn by subject - no data|0
1108116|NCT02447991|2188408|FG001|Overall Study|Withdrawn by subject - no data|2
1108117|NCT02447991|2188407|FG000|Overall Study|Withdrawn by Subject - with data|4
1108118|NCT02447991|2188408|FG001|Overall Study|Withdrawn by Subject - with data|4
1108119|NCT02447991|2188407|FG000|Overall Study|Lost to Follow-up - no data|3
1108120|NCT02447991|2188408|FG001|Overall Study|Lost to Follow-up - no data|6
1108121|NCT02447991|2188407|FG000|Overall Study|Lost to follow-up - with data|0
1108122|NCT02447991|2188408|FG001|Overall Study|Lost to follow-up - with data|3
1108123|NCT02447991|2188407|FG000|Overall Study|End of study - no treatment results|3
896309|NCT00702923|1867778|FG000|Overall Study|Adverse Event|1
896310|NCT00702949|1867786|FG000|Overall Study|Refusal|3
896311|NCT00702949|1867787|FG001|Overall Study|Refusal|2
896312|NCT00702949|1867788|FG002|Overall Study|Refusal|2
896313|NCT00702949|1867786|FG000|Overall Study|Adverse Event|1
896314|NCT00702949|1867787|FG001|Overall Study|Adverse Event|6
896315|NCT00702949|1867788|FG002|Overall Study|Adverse Event|3
896316|NCT00702949|1867786|FG000|Overall Study|Other Medical Reason/unknown|1
896317|NCT00702949|1867787|FG001|Overall Study|Other Medical Reason/unknown|1
896318|NCT00702949|1867788|FG002|Overall Study|Other Medical Reason/unknown|3
896319|NCT00703014|1867800|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
896320|NCT00703014|1867801|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
896321|NCT00703014|1867802|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
896322|NCT00703014|1867803|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
896323|NCT00703014|1867800|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
896324|NCT00703014|1867801|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
896325|NCT00703014|1867802|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
896326|NCT00703014|1867803|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
896327|NCT00703118|1867855|FG000|Overall Study|Adverse Event|1
896328|NCT00703118|1867856|FG001|Overall Study|Adverse Event|2
896329|NCT00703118|1867857|FG002|Overall Study|Adverse Event|2
896330|NCT00703118|1867855|FG000|Overall Study|Subject Ineligible To Continue The Trial|6
896331|NCT00703118|1867856|FG001|Overall Study|Subject Ineligible To Continue The Trial|3
896332|NCT00703118|1867857|FG002|Overall Study|Subject Ineligible To Continue The Trial|2
896333|NCT00703118|1867855|FG000|Overall Study|Lost to Follow-up|6
896334|NCT00703118|1867856|FG001|Overall Study|Lost to Follow-up|4
896335|NCT00703118|1867857|FG002|Overall Study|Lost to Follow-up|4
896336|NCT00703118|1867855|FG000|Overall Study|Withdrawal by Subject|8
896337|NCT00703118|1867856|FG001|Overall Study|Withdrawal by Subject|7
896338|NCT00703118|1867857|FG002|Overall Study|Withdrawal by Subject|13
896339|NCT00703118|1867855|FG000|Overall Study|Other|0
896340|NCT00703118|1867856|FG001|Overall Study|Other|0
896341|NCT00703118|1867857|FG002|Overall Study|Other|1
896342|NCT00703157|1867870|FG000|Overall Study|Lost to Follow-up|0
896343|NCT00703157|1867871|FG001|Overall Study|Lost to Follow-up|1
896344|NCT00703157|1867870|FG000|Overall Study|source data permanently lost/ other|4
896345|NCT00703157|1867871|FG001|Overall Study|source data permanently lost/ other|1
896352|NCT00703677|1867927|FG000|Overall Study|Dropout-withdrawal not related to drug|3
896353|NCT00703781|1867942|FG000|Overall Study|Withdrawal by Subject|1
896354|NCT00703781|1867943|FG001|Overall Study|Withdrawal by Subject|2
896355|NCT00703781|1867942|FG000|Overall Study|Cancelled surgery|1
896356|NCT00703781|1867943|FG001|Overall Study|Cancelled surgery|0
896357|NCT00703820|1867951|FG000|Overall Study|Adverse Event|12
896358|NCT00703820|1867952|FG001|Overall Study|Adverse Event|17
896359|NCT00703820|1867951|FG000|Overall Study|Death|5
896360|NCT00703820|1867952|FG001|Overall Study|Death|0
896361|NCT00703820|1867951|FG000|Overall Study|Lack of Efficacy|11
896362|NCT00703820|1867952|FG001|Overall Study|Lack of Efficacy|11
896363|NCT00703820|1867951|FG000|Overall Study|Received non-protocol therapy|1
896364|NCT00703820|1867952|FG001|Overall Study|Received non-protocol therapy|0
896365|NCT00703820|1867951|FG000|Overall Study|Physician Decision|4
896366|NCT00703820|1867952|FG001|Overall Study|Physician Decision|5
896367|NCT00703820|1867951|FG000|Overall Study|Withdrawal by Subject|2
896368|NCT00703820|1867952|FG001|Overall Study|Withdrawal by Subject|1
896369|NCT00703846|1867960|FG000|Overall Study|Adverse Event|8
896370|NCT00703846|1867960|FG000|Overall Study|Lost to Follow-up|55
896371|NCT00703846|1867960|FG000|Overall Study|Lack of Efficacy|15
896372|NCT00703846|1867960|FG000|Overall Study|Noncompliance with Study Treatment|2
896373|NCT00703846|1867960|FG000|Overall Study|Withdrawal by Subject|40
896374|NCT00703846|1867960|FG000|Overall Study|Death|1
896375|NCT00703846|1867960|FG000|Overall Study|Other|14
896376|NCT00703846|1867960|FG000|Overall Study|Did Not Receive Study Drug|2
1108124|NCT02447991|2188408|FG001|Overall Study|End of study - no treatment results|6
1108125|NCT02447991|2188407|FG000|Overall Study|End of study - partial treatment results|0
1108126|NCT02447991|2188408|FG001|Overall Study|End of study - partial treatment results|9
1108127|NCT02448043|2188420|FG000|Overall Study|Withdrawal by Subject|2
1108128|NCT02448043|2188421|FG001|Overall Study|Withdrawal by Subject|2
1108129|NCT02448043|2188420|FG000|Overall Study|Protocol Violation|1
1108130|NCT02448043|2188421|FG001|Overall Study|Protocol Violation|2
1108131|NCT02448446|2188480|FG000|Overall Study|Withdrawal by Subject|1
1108132|NCT02448446|2188481|FG001|Overall Study|Withdrawal by Subject|0
1108133|NCT02448537|2188490|FG000|Overall Study|Withdrawal by Subject|1
1108134|NCT02448537|2188491|FG001|Overall Study|Withdrawal by Subject|1
1108135|NCT02448537|2188492|FG002|Overall Study|Withdrawal by Subject|1
1108136|NCT02448563|2188504|FG000|Overall Study|Lost to Follow-up|16
1108137|NCT02448563|2188505|FG001|Overall Study|Lost to Follow-up|10
1108138|NCT02448563|2188504|FG000|Overall Study|Withdrawal by Subject|0
1108139|NCT02448563|2188505|FG001|Overall Study|Withdrawal by Subject|1
1108140|NCT02448680|2188546|FG000|Overall Study|Physician Decision|1
1108141|NCT02448680|2188547|FG001|Overall Study|Physician Decision|1
1108142|NCT02448680|2188546|FG000|Overall Study|Withdrawal by Subject|0
1108143|NCT02448680|2188547|FG001|Overall Study|Withdrawal by Subject|2
1108144|NCT02448706|2188555|FG000|Overall Study|Withdrawal by Subject|4
1108145|NCT02448706|2188556|FG001|Overall Study|Withdrawal by Subject|3
1108146|NCT02448706|2188555|FG000|Overall Study|Protocol Violation|1
1108147|NCT02448706|2188556|FG001|Overall Study|Protocol Violation|1
1108148|NCT02448719|2188575|FG000|Overall Study|Withdrawal by Subject|0
1108149|NCT02448719|2188576|FG001|Overall Study|Withdrawal by Subject|0
1108150|NCT02448719|2188577|FG002|Overall Study|Withdrawal by Subject|0
1108151|NCT02448719|2188578|FG003|Overall Study|Withdrawal by Subject|0
1108152|NCT02448719|2188579|FG004|Overall Study|Withdrawal by Subject|1
1108153|NCT02448719|2188580|FG005|Overall Study|Withdrawal by Subject|0
1108154|NCT02448719|2188581|FG006|Overall Study|Withdrawal by Subject|0
1108155|NCT02448719|2188582|FG007|Overall Study|Withdrawal by Subject|0
1108156|NCT02448719|2188583|FG008|Overall Study|Withdrawal by Subject|0
1108157|NCT02448719|2188584|FG009|Overall Study|Withdrawal by Subject|0
1108158|NCT02448719|2188585|FG010|Overall Study|Withdrawal by Subject|0
896377|NCT00703911|1867964|FG000|Overall Study|Death|1
896378|NCT00703911|1867964|FG000|Overall Study|Physician Decision|6
896379|NCT00703911|1867964|FG000|Overall Study|Lost to Follow-up|1
896380|NCT00703911|1867964|FG000|Overall Study|Withdrawal by Subject|2
896381|NCT00703924|1867970|FG000|Overall Study|Withdrawal by Subject|1
896382|NCT00703924|1867971|FG001|Overall Study|Withdrawal by Subject|1
896383|NCT00703963|1867992|FG000|Overall Study|Withdrawal by Subject|7
896384|NCT00703963|1867993|FG001|Overall Study|Withdrawal by Subject|13
896385|NCT00703963|1867992|FG000|Overall Study|Physician Decision|0
896386|NCT00703963|1867993|FG001|Overall Study|Physician Decision|1
896387|NCT00704132|1868021|FG000|Overall Study|Clinical Adverse Experience|1
896388|NCT00704132|1868022|FG001|Overall Study|Clinical Adverse Experience|0
896389|NCT00704132|1868021|FG000|Overall Study|Lack of Efficacy|0
896390|NCT00704132|1868022|FG001|Overall Study|Lack of Efficacy|1
896391|NCT00704132|1868021|FG000|Overall Study|Withdrawal by Subject|0
896392|NCT00704132|1868022|FG001|Overall Study|Withdrawal by Subject|1
896393|NCT00704171|1868030|FG000|Overall Study|Withdrawal by Subject|1
896394|NCT00704171|1868031|FG001|Overall Study|Withdrawal by Subject|0
896395|NCT00704184|1868042|FG000|Double-Blind Treatment|Withdrawal by Subject|1
896396|NCT00704184|1868043|FG001|Double-Blind Treatment|Withdrawal by Subject|0
896397|NCT00704184|1868044|FG002|Double-Blind Treatment|Withdrawal by Subject|0
896398|NCT00704184|1868045|FG003|Double-Blind Treatment|Withdrawal by Subject|0
896399|NCT00704184|1868046|FG004|Double-Blind Treatment|Withdrawal by Subject|0
896400|NCT00704184|1868042|FG000|Open-Label Treatment|Adverse Event|0
896401|NCT00704184|1868043|FG001|Open-Label Treatment|Adverse Event|0
896402|NCT00704184|1868044|FG002|Open-Label Treatment|Adverse Event|2
896403|NCT00704184|1868045|FG003|Open-Label Treatment|Adverse Event|0
896404|NCT00704184|1868046|FG004|Open-Label Treatment|Adverse Event|1
896405|NCT00704184|1868042|FG000|Open-Label Treatment|Lack of Efficacy|0
896406|NCT00704184|1868043|FG001|Open-Label Treatment|Lack of Efficacy|2
896407|NCT00704184|1868044|FG002|Open-Label Treatment|Lack of Efficacy|2
896408|NCT00704184|1868045|FG003|Open-Label Treatment|Lack of Efficacy|2
896409|NCT00704184|1868046|FG004|Open-Label Treatment|Lack of Efficacy|1
896410|NCT00704184|1868042|FG000|Open-Label Treatment|Physician Decision|0
896411|NCT00704184|1868043|FG001|Open-Label Treatment|Physician Decision|0
896412|NCT00704184|1868044|FG002|Open-Label Treatment|Physician Decision|0
896413|NCT00704184|1868045|FG003|Open-Label Treatment|Physician Decision|0
896414|NCT00704184|1868046|FG004|Open-Label Treatment|Physician Decision|1
896415|NCT00704184|1868042|FG000|Open-Label Treatment|Withdrawal by Subject|1
896416|NCT00704184|1868043|FG001|Open-Label Treatment|Withdrawal by Subject|0
896417|NCT00704184|1868044|FG002|Open-Label Treatment|Withdrawal by Subject|0
896418|NCT00704184|1868045|FG003|Open-Label Treatment|Withdrawal by Subject|3
896419|NCT00704184|1868046|FG004|Open-Label Treatment|Withdrawal by Subject|0
1108159|NCT02448771|2188646|FG000|Overall Study|Disease Progression|30
1108160|NCT02448771|2188646|FG000|Overall Study|Unacceptable Toxicity|1
1108161|NCT02448771|2188646|FG000|Overall Study|Physician Decision|3
1108162|NCT02448771|2188646|FG000|Overall Study|Started new therapy|2
1108163|NCT02448810|2188659|FG000|Overall Study|Adverse Event|0
896420|NCT00704340|1868064|FG000|Overall Study|Lost to Follow-up|2
896421|NCT00704340|1868065|FG001|Overall Study|Lost to Follow-up|1
896422|NCT00704340|1868064|FG000|Overall Study|Death|0
896423|NCT00704340|1868065|FG001|Overall Study|Death|1
896424|NCT00704405|1868096|FG000|Overall Study (NC Population)|Adverse Event|1
896425|NCT00704405|1868097|FG001|Overall Study (NC Population)|Adverse Event|0
896426|NCT00704405|1868098|FG002|Overall Study (NC Population)|Adverse Event|0
896427|NCT00704405|1868099|FG003|Overall Study (NC Population)|Adverse Event|0
896428|NCT00704405|1868100|FG004|Overall Study (NC Population)|Adverse Event|0
896429|NCT00704405|1868096|FG000|Overall Study (NC Population)|Lost to Follow-up|2
896430|NCT00704405|1868097|FG001|Overall Study (NC Population)|Lost to Follow-up|1
896431|NCT00704405|1868098|FG002|Overall Study (NC Population)|Lost to Follow-up|1
896432|NCT00704405|1868099|FG003|Overall Study (NC Population)|Lost to Follow-up|2
896433|NCT00704405|1868100|FG004|Overall Study (NC Population)|Lost to Follow-up|2
896434|NCT00704405|1868096|FG000|Overall Study (NC Population)|Withdrawal by Subject|2
896435|NCT00704405|1868097|FG001|Overall Study (NC Population)|Withdrawal by Subject|3
896436|NCT00704405|1868098|FG002|Overall Study (NC Population)|Withdrawal by Subject|2
896437|NCT00704405|1868099|FG003|Overall Study (NC Population)|Withdrawal by Subject|2
896438|NCT00704405|1868100|FG004|Overall Study (NC Population)|Withdrawal by Subject|2
896439|NCT00704405|1868096|FG000|Overall Study (NC Population)|Other|0
896440|NCT00704405|1868097|FG001|Overall Study (NC Population)|Other|0
896441|NCT00704405|1868098|FG002|Overall Study (NC Population)|Other|0
896442|NCT00704405|1868099|FG003|Overall Study (NC Population)|Other|0
896443|NCT00704405|1868100|FG004|Overall Study (NC Population)|Other|1
896444|NCT00704405|1868096|FG000|Overall Study (C Population)|Withdrawal by Subject|1
896445|NCT00704405|1868097|FG001|Overall Study (C Population)|Withdrawal by Subject|1
896446|NCT00704405|1868098|FG002|Overall Study (C Population)|Withdrawal by Subject|1
896447|NCT00704405|1868099|FG003|Overall Study (C Population)|Withdrawal by Subject|1
896448|NCT00704405|1868100|FG004|Overall Study (C Population)|Withdrawal by Subject|0
896449|NCT00704405|1868096|FG000|Overall Study (C Population)|Lost to Follow-up|0
896450|NCT00704405|1868097|FG001|Overall Study (C Population)|Lost to Follow-up|2
896451|NCT00704405|1868098|FG002|Overall Study (C Population)|Lost to Follow-up|0
896452|NCT00704405|1868099|FG003|Overall Study (C Population)|Lost to Follow-up|0
896453|NCT00704405|1868100|FG004|Overall Study (C Population)|Lost to Follow-up|0
896454|NCT00704418|1868120|FG000|Overall Study|Withdrawal by Subject|2
896455|NCT00704418|1868121|FG001|Overall Study|Withdrawal by Subject|0
896456|NCT00704418|1868120|FG000|Overall Study|Over-enrolled/surgery postponed|3
896457|NCT00704418|1868121|FG001|Overall Study|Over-enrolled/surgery postponed|6
896458|NCT00704522|1868129|FG000|Overall Study|Lack of Efficacy|65
896459|NCT00704522|1868130|FG001|Overall Study|Lack of Efficacy|17
896460|NCT00704522|1868129|FG000|Overall Study|Failure to appear again at hospital|56
896461|NCT00704522|1868130|FG001|Overall Study|Failure to appear again at hospital|10
896462|NCT00704522|1868129|FG000|Overall Study|Withdrawal by Subject|17
896463|NCT00704522|1868130|FG001|Overall Study|Withdrawal by Subject|8
896464|NCT00704522|1868129|FG000|Overall Study|Adverse Event|9
896465|NCT00704522|1868130|FG001|Overall Study|Adverse Event|1
896466|NCT00704522|1868129|FG000|Overall Study|Undefined causes|9
896467|NCT00704522|1868130|FG001|Overall Study|Undefined causes|7
896468|NCT00704522|1868129|FG000|Overall Study|No information on therapy end|27
896469|NCT00704522|1868130|FG001|Overall Study|No information on therapy end|2
896470|NCT00704535|1868135|FG000|Overall Study|Adverse Event|2
896471|NCT00704535|1868135|FG000|Overall Study|Death|2
896472|NCT00704535|1868135|FG000|Overall Study|Lost to Follow-up|8
896473|NCT00704535|1868135|FG000|Overall Study|Protocol Violation|10
896474|NCT00704535|1868135|FG000|Overall Study|Completed status not on Case Report Form|124
896475|NCT00704730|1868145|FG000|Overall Study|Adverse Event|35
896476|NCT00704730|1868146|FG001|Overall Study|Adverse Event|9
896477|NCT00704730|1868145|FG000|Overall Study|Death|11
896478|NCT00704730|1868146|FG001|Overall Study|Death|5
896479|NCT00704730|1868145|FG000|Overall Study|Physician Decision|2
896480|NCT00704730|1868146|FG001|Overall Study|Physician Decision|0
896481|NCT00704730|1868145|FG000|Overall Study|Did not receive drug|5
896482|NCT00704730|1868146|FG001|Overall Study|Did not receive drug|2
896483|NCT00704730|1868145|FG000|Overall Study|Disease progression per PI|58
896484|NCT00704730|1868146|FG001|Overall Study|Disease progression per PI|67
896485|NCT00704730|1868145|FG000|Overall Study|data unavailable|1
896486|NCT00704730|1868146|FG001|Overall Study|data unavailable|0
896487|NCT00704730|1868145|FG000|Overall Study|Withdrawal by Subject|9
896488|NCT00704730|1868146|FG001|Overall Study|Withdrawal by Subject|13
896489|NCT00704808|1868157|FG000|Overall Study|Discontinued prior to starting treatment|14
896490|NCT00704808|1868157|FG000|Overall Study|Death|7
896491|NCT00704808|1868157|FG000|Overall Study|Tumor progression|80
896492|NCT00704808|1868157|FG000|Overall Study|Patient's decision|11
896493|NCT00704808|1868157|FG000|Overall Study|Early therapy discontinuation|16
896494|NCT00704808|1868157|FG000|Overall Study|Adverse Event|1
896495|NCT00704808|1868157|FG000|Overall Study|Lost to Follow-up|1
896496|NCT00704808|1868157|FG000|Overall Study|Treatment change|1
896497|NCT00704964|1868192|FG000|Overall Study|Not completed on time|328
896498|NCT00705016|1868213|FG000|Overall Study|Adverse Event|6
1108164|NCT02448810|2188660|FG001|Overall Study|Adverse Event|0
1108165|NCT02448810|2188661|FG002|Overall Study|Adverse Event|1
1108166|NCT02448810|2188662|FG003|Overall Study|Adverse Event|0
1108167|NCT02448810|2188663|FG004|Overall Study|Adverse Event|0
1108168|NCT02448810|2188664|FG005|Overall Study|Adverse Event|0
1108169|NCT02448810|2188665|FG006|Overall Study|Adverse Event|0
1108170|NCT02448810|2188666|FG007|Overall Study|Adverse Event|0
1108171|NCT02448810|2188659|FG000|Overall Study|Withdrawal by Subject|0
1108172|NCT02448810|2188660|FG001|Overall Study|Withdrawal by Subject|0
1108173|NCT02448810|2188661|FG002|Overall Study|Withdrawal by Subject|1
1108174|NCT02448810|2188662|FG003|Overall Study|Withdrawal by Subject|0
1108175|NCT02448810|2188663|FG004|Overall Study|Withdrawal by Subject|3
1108176|NCT02448810|2188664|FG005|Overall Study|Withdrawal by Subject|5
1108177|NCT02448810|2188665|FG006|Overall Study|Withdrawal by Subject|0
1108178|NCT02448810|2188666|FG007|Overall Study|Withdrawal by Subject|2
1108179|NCT02448810|2188659|FG000|Overall Study|Other (study terminated by sponsor)|0
1108180|NCT02448810|2188660|FG001|Overall Study|Other (study terminated by sponsor)|0
1108181|NCT02448810|2188661|FG002|Overall Study|Other (study terminated by sponsor)|0
1108182|NCT02448810|2188662|FG003|Overall Study|Other (study terminated by sponsor)|0
1108183|NCT02448810|2188663|FG004|Overall Study|Other (study terminated by sponsor)|4
1108184|NCT02448810|2188664|FG005|Overall Study|Other (study terminated by sponsor)|2
1108185|NCT02448810|2188665|FG006|Overall Study|Other (study terminated by sponsor)|2
1108186|NCT02448810|2188666|FG007|Overall Study|Other (study terminated by sponsor)|1
1108187|NCT02448810|2188659|FG000|Overall Study|Death|1
1108188|NCT02448810|2188660|FG001|Overall Study|Death|0
1108189|NCT02448810|2188661|FG002|Overall Study|Death|1
1108190|NCT02448810|2188662|FG003|Overall Study|Death|0
1108191|NCT02448810|2188663|FG004|Overall Study|Death|1
1108192|NCT02448810|2188664|FG005|Overall Study|Death|0
1108193|NCT02448810|2188665|FG006|Overall Study|Death|0
1108194|NCT02448810|2188666|FG007|Overall Study|Death|0
1108195|NCT02448810|2188659|FG000|Overall Study|Other (Progressive disease)|2
1108196|NCT02448810|2188660|FG001|Overall Study|Other (Progressive disease)|2
1108197|NCT02448810|2188661|FG002|Overall Study|Other (Progressive disease)|0
1108198|NCT02448810|2188662|FG003|Overall Study|Other (Progressive disease)|3
1108199|NCT02448810|2188663|FG004|Overall Study|Other (Progressive disease)|23
1108200|NCT02448810|2188664|FG005|Overall Study|Other (Progressive disease)|9
1108201|NCT02448810|2188665|FG006|Overall Study|Other (Progressive disease)|14
1108202|NCT02448810|2188666|FG007|Overall Study|Other (Progressive disease)|5
1108203|NCT02448810|2188659|FG000|Overall Study|Lost to Follow-up|0
1108204|NCT02448810|2188660|FG001|Overall Study|Lost to Follow-up|1
1108205|NCT02448810|2188661|FG002|Overall Study|Lost to Follow-up|0
1108206|NCT02448810|2188662|FG003|Overall Study|Lost to Follow-up|0
1108207|NCT02448810|2188663|FG004|Overall Study|Lost to Follow-up|0
1108208|NCT02448810|2188664|FG005|Overall Study|Lost to Follow-up|0
1108209|NCT02448810|2188665|FG006|Overall Study|Lost to Follow-up|0
1108210|NCT02448810|2188666|FG007|Overall Study|Lost to Follow-up|0
1108211|NCT02448810|2188659|FG000|Overall Study|Other (unspecified)|0
1108212|NCT02448810|2188660|FG001|Overall Study|Other (unspecified)|0
1108213|NCT02448810|2188661|FG002|Overall Study|Other (unspecified)|0
1108214|NCT02448810|2188662|FG003|Overall Study|Other (unspecified)|0
1108215|NCT02448810|2188663|FG004|Overall Study|Other (unspecified)|0
1108216|NCT02448810|2188664|FG005|Overall Study|Other (unspecified)|0
1108217|NCT02448810|2188665|FG006|Overall Study|Other (unspecified)|2
1108218|NCT02448810|2188666|FG007|Overall Study|Other (unspecified)|0
1108219|NCT02448875|2188700|FG000|Overall Study|Adverse Event|2
1108220|NCT02448875|2188701|FG001|Overall Study|Adverse Event|1
1108221|NCT02448875|2188702|FG002|Overall Study|Adverse Event|0
1108222|NCT02448875|2188700|FG000|Overall Study|Lost to Follow-up|1
1108223|NCT02448875|2188701|FG001|Overall Study|Lost to Follow-up|0
1108224|NCT02448875|2188702|FG002|Overall Study|Lost to Follow-up|0
1108225|NCT02448875|2188700|FG000|Overall Study|Investigator Decision|3
1108226|NCT02448875|2188701|FG001|Overall Study|Investigator Decision|0
1108227|NCT02448875|2188702|FG002|Overall Study|Investigator Decision|1
1108228|NCT02448875|2188700|FG000|Overall Study|Withdrawal by Subject|1
1108229|NCT02448875|2188701|FG001|Overall Study|Withdrawal by Subject|0
1108230|NCT02448875|2188702|FG002|Overall Study|Withdrawal by Subject|0
1108231|NCT02449018|2188723|FG000|Overall Study|Abnormal laboratory value|0
896499|NCT00705016|1868214|FG001|Overall Study|Adverse Event|11
896500|NCT00705016|1868215|FG002|Overall Study|Adverse Event|10
896501|NCT00705016|1868213|FG000|Overall Study|Death|5
896502|NCT00705016|1868214|FG001|Overall Study|Death|7
896503|NCT00705016|1868215|FG002|Overall Study|Death|5
896504|NCT00705016|1868213|FG000|Overall Study|Protocol Violation|0
896505|NCT00705016|1868214|FG001|Overall Study|Protocol Violation|1
896506|NCT00705016|1868215|FG002|Overall Study|Protocol Violation|1
896507|NCT00705016|1868213|FG000|Overall Study|Withdrawal by Subject|4
896508|NCT00705016|1868214|FG001|Overall Study|Withdrawal by Subject|3
896509|NCT00705016|1868215|FG002|Overall Study|Withdrawal by Subject|2
896510|NCT00705016|1868213|FG000|Overall Study|Progressive Disease|33
1108232|NCT02449018|2188724|FG001|Overall Study|Abnormal laboratory value|1
1108233|NCT02449018|2188723|FG000|Overall Study|Administrative problems|1
1108234|NCT02449018|2188724|FG001|Overall Study|Administrative problems|0
1108235|NCT02449018|2188723|FG000|Overall Study|Adverse Event|5
1108236|NCT02449018|2188724|FG001|Overall Study|Adverse Event|1
1108237|NCT02449018|2188723|FG000|Overall Study|Protocol deviation|4
1108238|NCT02449018|2188724|FG001|Overall Study|Protocol deviation|0
1108239|NCT02449018|2188723|FG000|Overall Study|Patient decision|2
1108240|NCT02449018|2188724|FG001|Overall Study|Patient decision|0
1108241|NCT02449044|2188730|FG000|Overall Study|Lost to Follow-up|2
1108242|NCT02449044|2188730|FG000|Overall Study|Withdrawal by Subject|13
1108243|NCT02449044|2188730|FG000|Overall Study|Adverse Event|30
1108244|NCT02449044|2188730|FG000|Overall Study|Met Withdrawal Criteria|7
1108245|NCT02449044|2188730|FG000|Overall Study|Physician Decision|9
1108246|NCT02449044|2188730|FG000|Overall Study|Sponsor Discontinued Trial|3
1108247|NCT02449889|2188795|FG000|Overall Study|Adverse Event|1
1108248|NCT02449889|2188796|FG001|Overall Study|Adverse Event|2
1108249|NCT02449889|2188797|FG002|Overall Study|Adverse Event|0
1108250|NCT02449889|2188795|FG000|Overall Study|Protocol Violation|0
1108251|NCT02449889|2188796|FG001|Overall Study|Protocol Violation|4
1108252|NCT02449889|2188797|FG002|Overall Study|Protocol Violation|1
1108253|NCT02449902|2188807|FG000|Overall Study|Adverse Event|0
1108254|NCT02449902|2188808|FG001|Overall Study|Adverse Event|1
1108255|NCT02449902|2188807|FG000|Overall Study|Withdrawal by Subject|0
1108256|NCT02449902|2188808|FG001|Overall Study|Withdrawal by Subject|1
1108257|NCT02449915|2188818|FG000|Overall Study|Exclusion criteria - drug use|1
1108258|NCT02449915|2188819|FG001|Overall Study|Exclusion criteria - drug use|0
1108259|NCT02449915|2188818|FG000|Overall Study|Withdrawal by Subject|0
1108260|NCT02449915|2188819|FG001|Overall Study|Withdrawal by Subject|2
1108261|NCT02449915|2188818|FG000|Overall Study|Intraoperative surgical findings|1
1108262|NCT02449915|2188819|FG001|Overall Study|Intraoperative surgical findings|1
1108263|NCT02449915|2188818|FG000|Overall Study|Abnormal preop lab|0
1108264|NCT02449915|2188819|FG001|Overall Study|Abnormal preop lab|1
1108275|NCT02450487|2188844|FG000|Overall Study|Lost to Follow-up|3
1108276|NCT02450526|2188853|FG000|DB Period (Cycle 1)|Adverse Event|0
1108277|NCT02450526|2188854|FG001|DB Period (Cycle 1)|Adverse Event|0
1108278|NCT02450526|2188855|FG002|DB Period (Cycle 1)|Adverse Event|2
1108279|NCT02450526|2188856|FG003|DB Period (Cycle 1)|Adverse Event|0
1108280|NCT02450526|2188857|FG004|DB Period (Cycle 1)|Adverse Event|0
1108281|NCT02450526|2188853|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28
896511|NCT00705016|1868214|FG001|Overall Study|Progressive Disease|29
896512|NCT00705016|1868215|FG002|Overall Study|Progressive Disease|33
896513|NCT00705016|1868213|FG000|Overall Study|Symptomatic Deterioration|3
896514|NCT00705016|1868214|FG001|Overall Study|Symptomatic Deterioration|1
896515|NCT00705016|1868215|FG002|Overall Study|Symptomatic Deterioration|1
896516|NCT00705016|1868213|FG000|Overall Study|Other|9
896517|NCT00705016|1868214|FG001|Overall Study|Other|6
896518|NCT00705016|1868215|FG002|Overall Study|Other|6
896519|NCT00705146|1868242|FG000|Overall Study|Lost to Follow-up|1
1108282|NCT02450526|2188854|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3
1108283|NCT02450526|2188855|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8
1108284|NCT02450526|2188856|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1
1108285|NCT02450526|2188857|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0
1108286|NCT02450526|2188853|FG000|DB Period (Cycle 1)|Lost to Follow-up|1
1108287|NCT02450526|2188854|FG001|DB Period (Cycle 1)|Lost to Follow-up|0
1108288|NCT02450526|2188855|FG002|DB Period (Cycle 1)|Lost to Follow-up|0
1108289|NCT02450526|2188856|FG003|DB Period (Cycle 1)|Lost to Follow-up|0
1108290|NCT02450526|2188857|FG004|DB Period (Cycle 1)|Lost to Follow-up|0
1108291|NCT02450526|2188853|FG000|DB Period (Cycle 1)|Protocol Violation|2
1108292|NCT02450526|2188854|FG001|DB Period (Cycle 1)|Protocol Violation|0
1108293|NCT02450526|2188855|FG002|DB Period (Cycle 1)|Protocol Violation|0
1108294|NCT02450526|2188856|FG003|DB Period (Cycle 1)|Protocol Violation|1
1108295|NCT02450526|2188857|FG004|DB Period (Cycle 1)|Protocol Violation|0
1108296|NCT02450526|2188853|FG000|OL Period (Cycles 2-5)|Adverse Event|0
1108297|NCT02450526|2188854|FG001|OL Period (Cycles 2-5)|Adverse Event|0
1108298|NCT02450526|2188855|FG002|OL Period (Cycles 2-5)|Adverse Event|0
1108299|NCT02450526|2188856|FG003|OL Period (Cycles 2-5)|Adverse Event|0
1108300|NCT02450526|2188857|FG004|OL Period (Cycles 2-5)|Adverse Event|2
1108301|NCT02450526|2188853|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0
1108302|NCT02450526|2188854|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0
1108303|NCT02450526|2188855|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0
1108304|NCT02450526|2188856|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0
1108305|NCT02450526|2188857|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31
1108306|NCT02450526|2188853|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0
1108307|NCT02450526|2188854|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0
1108308|NCT02450526|2188855|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0
1108309|NCT02450526|2188856|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0
1108310|NCT02450526|2188857|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1
1108311|NCT02450526|2188853|FG000|OL Period (Cycles 2-5)|Protocol Violation|0
1108312|NCT02450526|2188854|FG001|OL Period (Cycles 2-5)|Protocol Violation|0
1108313|NCT02450526|2188855|FG002|OL Period (Cycles 2-5)|Protocol Violation|0
1108314|NCT02450526|2188856|FG003|OL Period (Cycles 2-5)|Protocol Violation|0
1108315|NCT02450526|2188857|FG004|OL Period (Cycles 2-5)|Protocol Violation|7
1108316|NCT02450539|2188879|FG000|Overall Study|Withdrawal by Subject|12
1108317|NCT02450539|2188880|FG001|Overall Study|Withdrawal by Subject|6
1108318|NCT02450539|2188879|FG000|Overall Study|Lost to Follow-up|4
1108319|NCT02450539|2188880|FG001|Overall Study|Lost to Follow-up|1
1108320|NCT02450552|2188892|FG000|Overall Study|Withdrawal by Subject|4
1108321|NCT02450552|2188893|FG001|Overall Study|Withdrawal by Subject|0
1108322|NCT02450552|2188894|FG002|Overall Study|Withdrawal by Subject|4
1108323|NCT02450552|2188892|FG000|Overall Study|Physician Decision|1
1108324|NCT02450552|2188893|FG001|Overall Study|Physician Decision|0
1108325|NCT02450552|2188894|FG002|Overall Study|Physician Decision|1
1108326|NCT02450578|2188906|FG000|Overall Study|ECG abnormality so not treated|1
1108327|NCT02450578|2188907|FG001|Overall Study|ECG abnormality so not treated|0
1108328|NCT02450578|2188908|FG002|Overall Study|ECG abnormality so not treated|0
1108329|NCT02450578|2188909|FG003|Overall Study|ECG abnormality so not treated|0
1108330|NCT02450903|2188947|FG000|Overall Study|Adverse Event|3
1108331|NCT02450903|2188947|FG000|Overall Study|Progressive disease|15
1108332|NCT02450903|2188947|FG000|Overall Study|Switched to commercial drug|1
1108333|NCT02450903|2188947|FG000|Overall Study|Subject/guardian decision|1
1108334|NCT02451007|2188951|FG000|Overall Study|Withdrawal by Subject|4
1108335|NCT02451007|2188951|FG000|Overall Study|Adverse Event|1
1108336|NCT02451007|2188951|FG000|Overall Study|Disease Progression|2
1108337|NCT02451124|2188955|FG000|Overall Study|Withdrawal by Subject|1
1108338|NCT02451137|2188965|FG000|Overall Study|Randomized but not treated|19
1108339|NCT02451137|2188966|FG001|Overall Study|Randomized but not treated|27
1108340|NCT02451137|2188965|FG000|Overall Study|Adverse Event|43
1108341|NCT02451137|2188966|FG001|Overall Study|Adverse Event|42
1108342|NCT02451137|2188965|FG000|Overall Study|Lack of Efficacy|4
1108343|NCT02451137|2188966|FG001|Overall Study|Lack of Efficacy|9
1108344|NCT02451137|2188965|FG000|Overall Study|Participant decision:discontinue insulin|41
1108345|NCT02451137|2188966|FG001|Overall Study|Participant decision:discontinue insulin|43
1108346|NCT02451137|2188965|FG000|Overall Study|Hypoglycemia|2
1108347|NCT02451137|2188966|FG001|Overall Study|Hypoglycemia|1
1108348|NCT02451137|2188965|FG000|Overall Study|Investigator's decision|23
1108349|NCT02451137|2188966|FG001|Overall Study|Investigator's decision|19
1108350|NCT02451137|2188965|FG000|Overall Study|Lost to Follow-up|53
1108351|NCT02451137|2188966|FG001|Overall Study|Lost to Follow-up|61
1108352|NCT02451137|2188965|FG000|Overall Study|Physician Decision|6
1108353|NCT02451137|2188966|FG001|Overall Study|Physician Decision|5
1108354|NCT02451137|2188965|FG000|Overall Study|Sponsor decision|13
1108355|NCT02451137|2188966|FG001|Overall Study|Sponsor decision|25
1108356|NCT02451137|2188965|FG000|Overall Study|Withdrawal by Subject|40
1108357|NCT02451137|2188966|FG001|Overall Study|Withdrawal by Subject|63
1108358|NCT02451137|2188965|FG000|Overall Study|Other than specified above|2
1108359|NCT02451137|2188966|FG001|Overall Study|Other than specified above|3
1108360|NCT02451358|2188996|FG000|Overall Study|Withdrawal by Subject|1
1108361|NCT02451358|2188997|FG001|Overall Study|Withdrawal by Subject|1
1108362|NCT02451358|2188998|FG002|Overall Study|Withdrawal by Subject|0
1108363|NCT02451358|2188999|FG003|Overall Study|Withdrawal by Subject|0
1108364|NCT02451358|2188996|FG000|Overall Study|Protocol Violation|0
1108365|NCT02451358|2188997|FG001|Overall Study|Protocol Violation|1
1108366|NCT02451358|2188998|FG002|Overall Study|Protocol Violation|1
1108367|NCT02451358|2188999|FG003|Overall Study|Protocol Violation|0
1108368|NCT02451670|2189041|FG000|Overall Study|Did not have qualifying follow-up visit.|714
1108369|NCT02451670|2189042|FG001|Overall Study|Did not have qualifying follow-up visit.|696
1108370|NCT02451696|2189050|FG000|Overall Study|Surgery postponed|1
1108371|NCT02451696|2189051|FG001|Overall Study|Surgery postponed|0
1108372|NCT02451917|2189071|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2
1108373|NCT02451917|2189072|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0
1108374|NCT02451917|2189071|FG000|First Intervention (24 Weeks)|Death|0
1108375|NCT02451917|2189072|FG001|First Intervention (24 Weeks)|Death|1
1108376|NCT02451917|2189071|FG000|First Intervention (24 Weeks)|Adverse Event|0
1108377|NCT02451917|2189072|FG001|First Intervention (24 Weeks)|Adverse Event|2
1108378|NCT02451930|2189084|FG000|Overall Study|Death|0
1108379|NCT02451930|2189085|FG001|Overall Study|Death|15
1108380|NCT02451930|2189084|FG000|Overall Study|Lost to Follow-up|0
1108381|NCT02451930|2189085|FG001|Overall Study|Lost to Follow-up|3
1108382|NCT02451930|2189084|FG000|Overall Study|Sponsor Decision|2
1108383|NCT02451930|2189085|FG001|Overall Study|Sponsor Decision|10
1108384|NCT02451930|2189084|FG000|Overall Study|Withdrawal by Subject|0
1108385|NCT02451930|2189085|FG001|Overall Study|Withdrawal by Subject|1
1108386|NCT02451930|2189084|FG000|Overall Study|Other|0
1108387|NCT02451930|2189085|FG001|Overall Study|Other|1
1108388|NCT02451943|2189103|FG000|Overall Study|On Treatment|4
1108389|NCT02451943|2189104|FG001|Overall Study|On Treatment|4
1108390|NCT02451943|2189103|FG000|Overall Study|Withdrawal by Subject|13
1108391|NCT02451943|2189104|FG001|Overall Study|Withdrawal by Subject|16
1108392|NCT02451943|2189103|FG000|Overall Study|Lost to Follow-up|3
1108393|NCT02451943|2189104|FG001|Overall Study|Lost to Follow-up|4
1108394|NCT02452034|2189125|FG000|Overall Study|Adverse Event|0
1108395|NCT02452034|2189126|FG001|Overall Study|Adverse Event|0
1108396|NCT02452034|2189127|FG002|Overall Study|Adverse Event|0
1108397|NCT02452034|2189128|FG003|Overall Study|Adverse Event|0
1108398|NCT02452034|2189129|FG004|Overall Study|Adverse Event|0
1108399|NCT02452034|2189130|FG005|Overall Study|Adverse Event|1
1108400|NCT02452034|2189125|FG000|Overall Study|Death|0
1108401|NCT02452034|2189126|FG001|Overall Study|Death|0
1108402|NCT02452034|2189127|FG002|Overall Study|Death|0
1108403|NCT02452034|2189128|FG003|Overall Study|Death|0
1108404|NCT02452034|2189129|FG004|Overall Study|Death|1
1108405|NCT02452034|2189130|FG005|Overall Study|Death|1
1108406|NCT02452034|2189125|FG000|Overall Study|Physician Decision|0
1108407|NCT02452034|2189126|FG001|Overall Study|Physician Decision|1
1108408|NCT02452034|2189127|FG002|Overall Study|Physician Decision|1
1108409|NCT02452034|2189128|FG003|Overall Study|Physician Decision|0
1108410|NCT02452034|2189129|FG004|Overall Study|Physician Decision|0
1108411|NCT02452034|2189130|FG005|Overall Study|Physician Decision|0
1108412|NCT02452034|2189125|FG000|Overall Study|Protocol Violation|0
1108413|NCT02452034|2189126|FG001|Overall Study|Protocol Violation|0
1108414|NCT02452034|2189127|FG002|Overall Study|Protocol Violation|0
1108415|NCT02452034|2189128|FG003|Overall Study|Protocol Violation|0
1108416|NCT02452034|2189129|FG004|Overall Study|Protocol Violation|0
1108417|NCT02452034|2189130|FG005|Overall Study|Protocol Violation|1
1108418|NCT02452034|2189125|FG000|Overall Study|Screen Failure|1
1108419|NCT02452034|2189126|FG001|Overall Study|Screen Failure|0
1108420|NCT02452034|2189127|FG002|Overall Study|Screen Failure|0
1108421|NCT02452034|2189128|FG003|Overall Study|Screen Failure|1
1108422|NCT02452034|2189129|FG004|Overall Study|Screen Failure|0
1108423|NCT02452034|2189130|FG005|Overall Study|Screen Failure|0
1108424|NCT02452034|2189125|FG000|Overall Study|Withdrawn by Parent/Guardian|1
1108425|NCT02452034|2189126|FG001|Overall Study|Withdrawn by Parent/Guardian|0
1108426|NCT02452034|2189127|FG002|Overall Study|Withdrawn by Parent/Guardian|0
1108427|NCT02452034|2189128|FG003|Overall Study|Withdrawn by Parent/Guardian|0
1108428|NCT02452034|2189129|FG004|Overall Study|Withdrawn by Parent/Guardian|0
1108429|NCT02452034|2189130|FG005|Overall Study|Withdrawn by Parent/Guardian|0
1108430|NCT02452047|2189147|FG000|Overall Study|Adverse Event|0
1108431|NCT02452047|2189148|FG001|Overall Study|Adverse Event|1
1108432|NCT02452047|2189149|FG002|Overall Study|Adverse Event|1
1108433|NCT02452047|2189147|FG000|Overall Study|Death|1
1108434|NCT02452047|2189148|FG001|Overall Study|Death|3
1108435|NCT02452047|2189149|FG002|Overall Study|Death|1
1108436|NCT02452047|2189147|FG000|Overall Study|Physician Decision|1
1108437|NCT02452047|2189148|FG001|Overall Study|Physician Decision|0
1108438|NCT02452047|2189149|FG002|Overall Study|Physician Decision|0
1108439|NCT02452047|2189147|FG000|Overall Study|Lost to Follow-up|1
1108440|NCT02452047|2189148|FG001|Overall Study|Lost to Follow-up|1
1108441|NCT02452047|2189149|FG002|Overall Study|Lost to Follow-up|0
1108442|NCT02452047|2189147|FG000|Overall Study|Withdrawal by Subject|1
1108443|NCT02452047|2189148|FG001|Overall Study|Withdrawal by Subject|0
1108444|NCT02452047|2189149|FG002|Overall Study|Withdrawal by Subject|0
1108445|NCT02452190|2189168|FG000|Overall Study|Withdrawal by Sponsor|1
1108446|NCT02452190|2189169|FG001|Overall Study|Withdrawal by Sponsor|3
1108447|NCT02452190|2189168|FG000|Overall Study|Pregnancy|1
1108448|NCT02452190|2189169|FG001|Overall Study|Pregnancy|0
1108449|NCT02452190|2189168|FG000|Overall Study|Investigator's Decision|2
1108450|NCT02452190|2189169|FG001|Overall Study|Investigator's Decision|0
1108451|NCT02452190|2189168|FG000|Overall Study|Lack of Efficacy|3
1108452|NCT02452190|2189169|FG001|Overall Study|Lack of Efficacy|1
1108453|NCT02452190|2189168|FG000|Overall Study|Lost to Follow-up|4
1108454|NCT02452190|2189169|FG001|Overall Study|Lost to Follow-up|3
1108455|NCT02452190|2189168|FG000|Overall Study|Adverse Event|2
1108456|NCT02452190|2189169|FG001|Overall Study|Adverse Event|5
1108457|NCT02452190|2189168|FG000|Overall Study|Withdrawal by Subject|20
1108458|NCT02452190|2189169|FG001|Overall Study|Withdrawal by Subject|11
1108459|NCT02452190|2189168|FG000|Overall Study|Noncompliance with study drug|1
1108460|NCT02452190|2189169|FG001|Overall Study|Noncompliance with study drug|0
1108461|NCT02452190|2189168|FG000|Overall Study|Participant traveled abroad|1
1108462|NCT02452190|2189169|FG001|Overall Study|Participant traveled abroad|0
1108463|NCT02452190|2189168|FG000|Overall Study|Death|0
1108464|NCT02452190|2189169|FG001|Overall Study|Death|1
1108465|NCT02452320|2189177|FG000|Overall Study|Adverse Event|0
1108466|NCT02452320|2189178|FG001|Overall Study|Adverse Event|1
1108467|NCT02452424|2189199|FG000|Overall Study|Death|2
1108468|NCT02452424|2189200|FG001|Overall Study|Death|2
1108469|NCT02452424|2189201|FG002|Overall Study|Death|2
1108470|NCT02452424|2189202|FG003|Overall Study|Death|6
1108471|NCT02452424|2189203|FG004|Overall Study|Death|2
1108472|NCT02452424|2189204|FG005|Overall Study|Death|0
1108473|NCT02452424|2189205|FG006|Overall Study|Death|5
1108474|NCT02452424|2189206|FG007|Overall Study|Death|1
1108475|NCT02452424|2189207|FG008|Overall Study|Death|3
1108476|NCT02452424|2189208|FG009|Overall Study|Death|1
1108477|NCT02452424|2189209|FG010|Overall Study|Death|0
1108478|NCT02452424|2189199|FG000|Overall Study|Lost to Follow-up|0
1108479|NCT02452424|2189200|FG001|Overall Study|Lost to Follow-up|1
1108480|NCT02452424|2189201|FG002|Overall Study|Lost to Follow-up|1
1108481|NCT02452424|2189202|FG003|Overall Study|Lost to Follow-up|0
1108482|NCT02452424|2189203|FG004|Overall Study|Lost to Follow-up|0
1108483|NCT02452424|2189204|FG005|Overall Study|Lost to Follow-up|0
1108484|NCT02452424|2189205|FG006|Overall Study|Lost to Follow-up|0
1108485|NCT02452424|2189206|FG007|Overall Study|Lost to Follow-up|0
1108486|NCT02452424|2189207|FG008|Overall Study|Lost to Follow-up|0
1108487|NCT02452424|2189208|FG009|Overall Study|Lost to Follow-up|0
1108488|NCT02452424|2189209|FG010|Overall Study|Lost to Follow-up|0
1108489|NCT02452424|2189199|FG000|Overall Study|Withdrawal by Subject|0
1108490|NCT02452424|2189200|FG001|Overall Study|Withdrawal by Subject|0
1108491|NCT02452424|2189201|FG002|Overall Study|Withdrawal by Subject|3
1108492|NCT02452424|2189202|FG003|Overall Study|Withdrawal by Subject|2
1108493|NCT02452424|2189203|FG004|Overall Study|Withdrawal by Subject|0
1108494|NCT02452424|2189204|FG005|Overall Study|Withdrawal by Subject|0
1108495|NCT02452424|2189205|FG006|Overall Study|Withdrawal by Subject|1
1108496|NCT02452424|2189206|FG007|Overall Study|Withdrawal by Subject|0
1108497|NCT02452424|2189207|FG008|Overall Study|Withdrawal by Subject|1
1108498|NCT02452424|2189208|FG009|Overall Study|Withdrawal by Subject|1
1108499|NCT02452424|2189209|FG010|Overall Study|Withdrawal by Subject|0
1108500|NCT02452424|2189199|FG000|Overall Study|Other|0
1108501|NCT02452424|2189200|FG001|Overall Study|Other|0
1108502|NCT02452424|2189201|FG002|Overall Study|Other|1
1108503|NCT02452424|2189202|FG003|Overall Study|Other|0
1108504|NCT02452424|2189203|FG004|Overall Study|Other|0
1108505|NCT02452424|2189204|FG005|Overall Study|Other|1
1108506|NCT02452424|2189205|FG006|Overall Study|Other|4
1108507|NCT02452424|2189206|FG007|Overall Study|Other|3
1108508|NCT02452424|2189207|FG008|Overall Study|Other|0
1108509|NCT02452424|2189208|FG009|Overall Study|Other|0
1108510|NCT02452424|2189209|FG010|Overall Study|Other|1
1108511|NCT02452424|2189199|FG000|Overall Study|Progressive disease (per RECIST)|0
1108512|NCT02452424|2189200|FG001|Overall Study|Progressive disease (per RECIST)|0
1108513|NCT02452424|2189201|FG002|Overall Study|Progressive disease (per RECIST)|0
1108514|NCT02452424|2189202|FG003|Overall Study|Progressive disease (per RECIST)|0
1108515|NCT02452424|2189203|FG004|Overall Study|Progressive disease (per RECIST)|0
1108516|NCT02452424|2189204|FG005|Overall Study|Progressive disease (per RECIST)|0
1108517|NCT02452424|2189205|FG006|Overall Study|Progressive disease (per RECIST)|0
1108518|NCT02452424|2189206|FG007|Overall Study|Progressive disease (per RECIST)|0
1108519|NCT02452424|2189207|FG008|Overall Study|Progressive disease (per RECIST)|2
1108520|NCT02452424|2189208|FG009|Overall Study|Progressive disease (per RECIST)|0
1108521|NCT02452424|2189209|FG010|Overall Study|Progressive disease (per RECIST)|0
1108522|NCT02452424|2189199|FG000|Overall Study|Adverse Event|0
1108523|NCT02452424|2189200|FG001|Overall Study|Adverse Event|0
1108524|NCT02452424|2189201|FG002|Overall Study|Adverse Event|0
1108525|NCT02452424|2189202|FG003|Overall Study|Adverse Event|0
1108526|NCT02452424|2189203|FG004|Overall Study|Adverse Event|0
1108527|NCT02452424|2189204|FG005|Overall Study|Adverse Event|0
1108528|NCT02452424|2189205|FG006|Overall Study|Adverse Event|0
1108529|NCT02452424|2189206|FG007|Overall Study|Adverse Event|0
1108530|NCT02452424|2189207|FG008|Overall Study|Adverse Event|0
1108531|NCT02452424|2189208|FG009|Overall Study|Adverse Event|0
1108532|NCT02452424|2189209|FG010|Overall Study|Adverse Event|1
1108533|NCT02452463|2189238|FG000|Overall Study|Death|1
1108534|NCT02452463|2189239|FG001|Overall Study|Death|0
1108535|NCT02452463|2189240|FG002|Overall Study|Death|0
1108536|NCT02452463|2189238|FG000|Overall Study|Study Suspended|1
1108537|NCT02452463|2189239|FG001|Overall Study|Study Suspended|0
1108538|NCT02452463|2189240|FG002|Overall Study|Study Suspended|0
1108539|NCT02452463|2189238|FG000|Overall Study|Recommended by DSMB|0
1108540|NCT02452463|2189239|FG001|Overall Study|Recommended by DSMB|1
1108541|NCT02452463|2189240|FG002|Overall Study|Recommended by DSMB|0
1108542|NCT02452463|2189238|FG000|Overall Study|Withdrawal by Subject|0
1108543|NCT02452463|2189239|FG001|Overall Study|Withdrawal by Subject|1
1108544|NCT02452463|2189240|FG002|Overall Study|Withdrawal by Subject|0
1108545|NCT02452476|2189250|FG000|Overall Study|Death|4
1108546|NCT02452476|2189251|FG001|Overall Study|Death|7
1108547|NCT02452476|2189250|FG000|Overall Study|Lost to Follow-up|1
1108548|NCT02452476|2189251|FG001|Overall Study|Lost to Follow-up|1
1108549|NCT02452476|2189250|FG000|Overall Study|Physician Decision|1
1108550|NCT02452476|2189251|FG001|Overall Study|Physician Decision|1
1108551|NCT02452476|2189250|FG000|Overall Study|Not treated|5
1108552|NCT02452476|2189251|FG001|Overall Study|Not treated|1
1108589|NCT02452762|2189294|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4
1108590|NCT02452762|2189295|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3
1108591|NCT02452762|2189294|FG000|Overall Study|Withdrawal by Subject|1
1108592|NCT02452762|2189295|FG001|Overall Study|Withdrawal by Subject|0
1108593|NCT02452892|2189310|FG000|Week 1 Initial Randommization|Adverse Event|1
1108594|NCT02452892|2189311|FG001|Week 1 Initial Randommization|Adverse Event|0
1108595|NCT02452892|2189312|FG002|Week 1 Initial Randommization|Adverse Event|0
1108596|NCT02452892|2189313|FG003|Week 1 Initial Randommization|Adverse Event|0
1108597|NCT02452892|2189310|FG000|Week 1 Initial Randommization|Lost to Follow-up|0
1108598|NCT02452892|2189311|FG001|Week 1 Initial Randommization|Lost to Follow-up|0
1108599|NCT02452892|2189312|FG002|Week 1 Initial Randommization|Lost to Follow-up|1
1108600|NCT02452892|2189313|FG003|Week 1 Initial Randommization|Lost to Follow-up|0
1108601|NCT02452892|2189310|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1108602|NCT02452892|2189311|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1108603|NCT02452892|2189312|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1108604|NCT02452892|2189313|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
1108605|NCT02452892|2189310|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
1108606|NCT02452892|2189311|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1108607|NCT02452892|2189312|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1108608|NCT02452892|2189313|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1108609|NCT02452892|2189310|FG000|Follow-up|Withdrawal by Subject|0
1108610|NCT02452892|2189311|FG001|Follow-up|Withdrawal by Subject|0
1108611|NCT02452892|2189312|FG002|Follow-up|Withdrawal by Subject|0
1108612|NCT02452892|2189313|FG003|Follow-up|Withdrawal by Subject|1
1108613|NCT02452892|2189310|FG000|Follow-up|Subject left town on Day 42|1
1108614|NCT02452892|2189311|FG001|Follow-up|Subject left town on Day 42|0
1108615|NCT02452892|2189312|FG002|Follow-up|Subject left town on Day 42|0
1108616|NCT02452892|2189313|FG003|Follow-up|Subject left town on Day 42|0
1108617|NCT02453048|2189346|FG000|Overall Study|Only part of initial 6 mo. study|0
1108618|NCT02453048|2189347|FG001|Overall Study|Only part of initial 6 mo. study|0
1108619|NCT02453048|2189348|FG002|Overall Study|Only part of initial 6 mo. study|0
1108620|NCT02453048|2189349|FG003|Overall Study|Only part of initial 6 mo. study|0
1108621|NCT02453048|2189350|FG004|Overall Study|Only part of initial 6 mo. study|6
1108622|NCT02453048|2189346|FG000|Overall Study|Lost to Follow-up|0
1108623|NCT02453048|2189347|FG001|Overall Study|Lost to Follow-up|1
1108624|NCT02453048|2189348|FG002|Overall Study|Lost to Follow-up|2
1108625|NCT02453048|2189349|FG003|Overall Study|Lost to Follow-up|0
896520|NCT00705146|1868243|FG001|Overall Study|Lost to Follow-up|1
896521|NCT00705159|1868253|FG000|Overall Study|Withdrawal by Subject|0
896522|NCT00705159|1868254|FG001|Overall Study|Withdrawal by Subject|1
896523|NCT00705159|1868255|FG002|Overall Study|Withdrawal by Subject|1
896524|NCT00705159|1868256|FG003|Overall Study|Withdrawal by Subject|1
896525|NCT00705159|1868253|FG000|Overall Study|Protocol Violation|0
896526|NCT00705159|1868254|FG001|Overall Study|Protocol Violation|1
896527|NCT00705159|1868255|FG002|Overall Study|Protocol Violation|0
896528|NCT00705159|1868256|FG003|Overall Study|Protocol Violation|0
896529|NCT00705159|1868253|FG000|Overall Study|Adverse Event|0
1108626|NCT02453048|2189350|FG004|Overall Study|Lost to Follow-up|0
1108627|NCT02453191|2189366|FG000|Overall Study|Withdrawal by Subject|1
1108628|NCT02453256|2189372|FG000|Double Blind Period|Death|1
1108629|NCT02453256|2189373|FG001|Double Blind Period|Death|1
1108630|NCT02453256|2189372|FG000|Double Blind Period|Adverse Event|3
1108631|NCT02453256|2189373|FG001|Double Blind Period|Adverse Event|2
1108632|NCT02453256|2189372|FG000|Double Blind Period|Withdrawal by Subject|9
1108633|NCT02453256|2189373|FG001|Double Blind Period|Withdrawal by Subject|5
1108634|NCT02453256|2189372|FG000|Double Blind Period|Other|0
1108635|NCT02453256|2189373|FG001|Double Blind Period|Other|1
1108636|NCT02453256|2189372|FG000|Open Label Period|Adverse Event|1
1108637|NCT02453256|2189373|FG001|Open Label Period|Adverse Event|3
1108638|NCT02453256|2189372|FG000|Open Label Period|Death|0
1108639|NCT02453256|2189373|FG001|Open Label Period|Death|1
1108640|NCT02453256|2189372|FG000|Open Label Period|Lost to Follow-up|1
1108641|NCT02453256|2189373|FG001|Open Label Period|Lost to Follow-up|0
1108642|NCT02453256|2189372|FG000|Open Label Period|Other|0
1108643|NCT02453256|2189373|FG001|Open Label Period|Other|2
1108644|NCT02453256|2189372|FG000|Open Label Period|Withdrawal by Subject|5
1108645|NCT02453256|2189373|FG001|Open Label Period|Withdrawal by Subject|1
1108646|NCT02453282|2189389|FG000|Overall Study|Death|275
1108647|NCT02453282|2189390|FG001|Overall Study|Death|277
1108648|NCT02453282|2189391|FG002|Overall Study|Death|296
1108649|NCT02453282|2189389|FG000|Overall Study|Lost to Follow-up|1
1108650|NCT02453282|2189390|FG001|Overall Study|Lost to Follow-up|0
1108651|NCT02453282|2189391|FG002|Overall Study|Lost to Follow-up|2
1108652|NCT02453282|2189389|FG000|Overall Study|Withdrawal by Subject|12
1108653|NCT02453282|2189390|FG001|Overall Study|Withdrawal by Subject|10
1108654|NCT02453282|2189391|FG002|Overall Study|Withdrawal by Subject|11
1108655|NCT02453282|2189389|FG000|Overall Study|Participants ongoing at data cut-off|85
1108656|NCT02453282|2189390|FG001|Overall Study|Participants ongoing at data cut-off|84
1108657|NCT02453282|2189391|FG002|Overall Study|Participants ongoing at data cut-off|62
1108658|NCT02453282|2189389|FG000|Overall Study|Other|1
1108659|NCT02453282|2189390|FG001|Overall Study|Other|1
1108660|NCT02453282|2189391|FG002|Overall Study|Other|1
1108661|NCT02453321|2189404|FG000|Overall Study|Weakness|1
1108662|NCT02453321|2189405|FG001|Overall Study|Weakness|1
1108663|NCT02453321|2189406|FG002|Overall Study|Weakness|2
1108664|NCT02453321|2189404|FG000|Overall Study|Deep Venous Thrombosis|0
1108665|NCT02453321|2189405|FG001|Overall Study|Deep Venous Thrombosis|1
1108666|NCT02453321|2189406|FG002|Overall Study|Deep Venous Thrombosis|0
1108667|NCT02453334|2189419|FG000|Overall Study|Death|15
1108668|NCT02453334|2189420|FG001|Overall Study|Death|13
1108669|NCT02453334|2189419|FG000|Overall Study|Adverse Event|2
1108670|NCT02453334|2189420|FG001|Overall Study|Adverse Event|1
1108671|NCT02453334|2189419|FG000|Overall Study|Lost to Follow-up|5
1108672|NCT02453334|2189420|FG001|Overall Study|Lost to Follow-up|9
1108673|NCT02453334|2189419|FG000|Overall Study|Physician Decision|1
1108674|NCT02453334|2189420|FG001|Overall Study|Physician Decision|0
1108675|NCT02453334|2189419|FG000|Overall Study|Withdrawal by Subject|17
1108676|NCT02453334|2189420|FG001|Overall Study|Withdrawal by Subject|13
1108677|NCT02453334|2189419|FG000|Overall Study|Other reason|1
1108678|NCT02453334|2189420|FG001|Overall Study|Other reason|4
1108679|NCT02453386|2189446|FG000|Overall Study|Adverse Event|22
1108680|NCT02453386|2189447|FG001|Overall Study|Adverse Event|30
1108681|NCT02453386|2189448|FG002|Overall Study|Adverse Event|15
1108682|NCT02453386|2189446|FG000|Overall Study|Protocol Violation|1
1108683|NCT02453386|2189447|FG001|Overall Study|Protocol Violation|0
1108684|NCT02453386|2189448|FG002|Overall Study|Protocol Violation|1
1108685|NCT02453386|2189446|FG000|Overall Study|Withdrawal by Subject|10
1108686|NCT02453386|2189447|FG001|Overall Study|Withdrawal by Subject|9
1108687|NCT02453386|2189448|FG002|Overall Study|Withdrawal by Subject|9
1108688|NCT02453386|2189446|FG000|Overall Study|Sponsor Terminated Study|14
1108689|NCT02453386|2189447|FG001|Overall Study|Sponsor Terminated Study|8
1108690|NCT02453386|2189448|FG002|Overall Study|Sponsor Terminated Study|11
1108691|NCT02453386|2189446|FG000|Overall Study|Subject Terminated by Sponsor|1
1108692|NCT02453386|2189447|FG001|Overall Study|Subject Terminated by Sponsor|1
1108693|NCT02453386|2189448|FG002|Overall Study|Subject Terminated by Sponsor|1
1108694|NCT02453386|2189446|FG000|Overall Study|Sponsor Terminated by Investigator|0
1108695|NCT02453386|2189447|FG001|Overall Study|Sponsor Terminated by Investigator|1
1108696|NCT02453386|2189448|FG002|Overall Study|Sponsor Terminated by Investigator|2
1108697|NCT02453386|2189446|FG000|Overall Study|Lost to Follow-up|0
1108698|NCT02453386|2189447|FG001|Overall Study|Lost to Follow-up|0
1108699|NCT02453386|2189448|FG002|Overall Study|Lost to Follow-up|1
1108700|NCT02453386|2189446|FG000|Overall Study|Other|1
1108701|NCT02453386|2189447|FG001|Overall Study|Other|0
1108702|NCT02453386|2189448|FG002|Overall Study|Other|1
1108703|NCT02453555|2189465|FG000|24-week Double-blind Treatment Period|Adverse Event|2
1108704|NCT02453555|2189466|FG001|24-week Double-blind Treatment Period|Adverse Event|0
1108705|NCT02453555|2189467|FG002|24-week Double-blind Treatment Period|Adverse Event|0
1108706|NCT02453555|2189468|FG003|24-week Double-blind Treatment Period|Adverse Event|0
1108707|NCT02453555|2189469|FG004|24-week Double-blind Treatment Period|Adverse Event|0
1108708|NCT02453555|2189470|FG005|24-week Double-blind Treatment Period|Adverse Event|0
1108709|NCT02453555|2189465|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1
1108710|NCT02453555|2189466|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0
1108711|NCT02453555|2189467|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0
1108712|NCT02453555|2189468|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0
1108713|NCT02453555|2189469|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0
1108714|NCT02453555|2189470|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0
1108715|NCT02453555|2189465|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2
1108716|NCT02453555|2189466|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4
1108717|NCT02453555|2189467|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0
1108718|NCT02453555|2189468|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0
896530|NCT00705159|1868254|FG001|Overall Study|Adverse Event|0
896531|NCT00705159|1868255|FG002|Overall Study|Adverse Event|1
1108719|NCT02453555|2189469|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0
1108720|NCT02453555|2189470|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0
1108721|NCT02453555|2189465|FG000|24-week Double-blind Treatment Period|Other than specified above|0
1108722|NCT02453555|2189466|FG001|24-week Double-blind Treatment Period|Other than specified above|3
1108723|NCT02453555|2189467|FG002|24-week Double-blind Treatment Period|Other than specified above|0
1108724|NCT02453555|2189468|FG003|24-week Double-blind Treatment Period|Other than specified above|0
1108725|NCT02453555|2189469|FG004|24-week Double-blind Treatment Period|Other than specified above|0
1108726|NCT02453555|2189470|FG005|24-week Double-blind Treatment Period|Other than specified above|0
1108727|NCT02453555|2189465|FG000|Extension Period|Adverse Event|0
1108728|NCT02453555|2189466|FG001|Extension Period|Adverse Event|0
1108729|NCT02453555|2189467|FG002|Extension Period|Adverse Event|1
1108730|NCT02453555|2189468|FG003|Extension Period|Adverse Event|2
1108731|NCT02453555|2189469|FG004|Extension Period|Adverse Event|1
1108732|NCT02453555|2189470|FG005|Extension Period|Adverse Event|1
1108733|NCT02453555|2189465|FG000|Extension Period|Protocol Violation|0
1108734|NCT02453555|2189466|FG001|Extension Period|Protocol Violation|0
1108735|NCT02453555|2189467|FG002|Extension Period|Protocol Violation|1
1108736|NCT02453555|2189468|FG003|Extension Period|Protocol Violation|0
1108737|NCT02453555|2189469|FG004|Extension Period|Protocol Violation|0
1108738|NCT02453555|2189470|FG005|Extension Period|Protocol Violation|0
1108739|NCT02453555|2189465|FG000|Extension Period|Withdrawal by Subject|0
1108740|NCT02453555|2189466|FG001|Extension Period|Withdrawal by Subject|0
1108741|NCT02453555|2189467|FG002|Extension Period|Withdrawal by Subject|1
1108742|NCT02453555|2189468|FG003|Extension Period|Withdrawal by Subject|0
1108743|NCT02453555|2189469|FG004|Extension Period|Withdrawal by Subject|0
1108744|NCT02453555|2189470|FG005|Extension Period|Withdrawal by Subject|0
1108745|NCT02453685|2189514|FG000|Overall Study|Adverse Event|0
1108746|NCT02453685|2189515|FG001|Overall Study|Adverse Event|1
1108747|NCT02453685|2189514|FG000|Overall Study|Protocol Violation|7
1108748|NCT02453685|2189515|FG001|Overall Study|Protocol Violation|4
1108749|NCT02453685|2189514|FG000|Overall Study|Lost to Follow-up|0
1108750|NCT02453685|2189515|FG001|Overall Study|Lost to Follow-up|1
1108751|NCT02453685|2189514|FG000|Overall Study|Withdrawal by Subject|8
1108752|NCT02453685|2189515|FG001|Overall Study|Withdrawal by Subject|4
1108753|NCT02453685|2189514|FG000|Overall Study|Unclassified|4
1108754|NCT02453685|2189515|FG001|Overall Study|Unclassified|2
1108755|NCT02453711|2189530|FG000|Overall Study|Withdrawal by Subject|5
1108756|NCT02453711|2189531|FG001|Overall Study|Withdrawal by Subject|4
1108757|NCT02453711|2189532|FG002|Overall Study|Withdrawal by Subject|6
1108758|NCT02453711|2189533|FG003|Overall Study|Withdrawal by Subject|4
1108759|NCT02453711|2189534|FG004|Overall Study|Withdrawal by Subject|1
1108760|NCT02453711|2189535|FG005|Overall Study|Withdrawal by Subject|1
1108761|NCT02453711|2189536|FG006|Overall Study|Withdrawal by Subject|0
1108762|NCT02453711|2189537|FG007|Overall Study|Withdrawal by Subject|1
1108763|NCT02453711|2189538|FG008|Overall Study|Withdrawal by Subject|7
1108764|NCT02453711|2189530|FG000|Overall Study|Lost to Follow-up|5
1108765|NCT02453711|2189531|FG001|Overall Study|Lost to Follow-up|3
1108766|NCT02453711|2189532|FG002|Overall Study|Lost to Follow-up|2
1108767|NCT02453711|2189533|FG003|Overall Study|Lost to Follow-up|3
1108768|NCT02453711|2189534|FG004|Overall Study|Lost to Follow-up|1
1108769|NCT02453711|2189535|FG005|Overall Study|Lost to Follow-up|5
1108770|NCT02453711|2189536|FG006|Overall Study|Lost to Follow-up|2
1108771|NCT02453711|2189537|FG007|Overall Study|Lost to Follow-up|6
1108772|NCT02453711|2189538|FG008|Overall Study|Lost to Follow-up|6
1108773|NCT02453711|2189530|FG000|Overall Study|Death|0
1108774|NCT02453711|2189531|FG001|Overall Study|Death|0
1108775|NCT02453711|2189532|FG002|Overall Study|Death|0
1108776|NCT02453711|2189533|FG003|Overall Study|Death|0
1108777|NCT02453711|2189534|FG004|Overall Study|Death|0
1108778|NCT02453711|2189535|FG005|Overall Study|Death|0
1108779|NCT02453711|2189536|FG006|Overall Study|Death|1
1108780|NCT02453711|2189537|FG007|Overall Study|Death|0
1108781|NCT02453711|2189538|FG008|Overall Study|Death|0
1108782|NCT02453711|2189530|FG000|Overall Study|Unclassified|1
1108783|NCT02453711|2189531|FG001|Overall Study|Unclassified|0
1108784|NCT02453711|2189532|FG002|Overall Study|Unclassified|1
1108785|NCT02453711|2189533|FG003|Overall Study|Unclassified|0
1108786|NCT02453711|2189534|FG004|Overall Study|Unclassified|0
1108787|NCT02453711|2189535|FG005|Overall Study|Unclassified|0
1108788|NCT02453711|2189536|FG006|Overall Study|Unclassified|0
1108789|NCT02453711|2189537|FG007|Overall Study|Unclassified|0
1108790|NCT02453711|2189538|FG008|Overall Study|Unclassified|0
1108791|NCT02453841|2189565|FG000|Overall Study|Protocol Violation|1
1108792|NCT02453841|2189565|FG000|Overall Study|Unable to obtain blood samples|2
1108793|NCT02454101|2189577|FG000|Overall Study|Adverse Event|2
1108794|NCT02454101|2189578|FG001|Overall Study|Adverse Event|3
1108795|NCT02454101|2189577|FG000|Overall Study|Lost to Follow-up|3
1108796|NCT02454101|2189578|FG001|Overall Study|Lost to Follow-up|4
1108797|NCT02454478|2189640|FG000|Overall Study|Incomplete DLT Evaluation|1
1108798|NCT02454530|2189646|FG000|Overall Study|Other|8
1108799|NCT02454530|2189647|FG001|Overall Study|Other|13
1108800|NCT02454530|2189646|FG000|Overall Study|Missing information|56
1108801|NCT02454530|2189647|FG001|Overall Study|Missing information|69
1108802|NCT02454530|2189646|FG000|Overall Study|Death|2
1108803|NCT02454530|2189647|FG001|Overall Study|Death|41
1108804|NCT02454530|2189646|FG000|Overall Study|Lost to Follow-up|4
1108805|NCT02454530|2189647|FG001|Overall Study|Lost to Follow-up|4
1108806|NCT02454608|2189657|FG000|Double-Blind Period|Lack of Efficacy|0
1108807|NCT02454608|2189658|FG001|Double-Blind Period|Lack of Efficacy|2
1108808|NCT02454608|2189659|FG002|Double-Blind Period|Lack of Efficacy|0
1108809|NCT02454608|2189657|FG000|Open Label Period|Lost to Follow-up|0
1108810|NCT02454608|2189658|FG001|Open Label Period|Lost to Follow-up|0
1108811|NCT02454608|2189659|FG002|Open Label Period|Lost to Follow-up|11
1108812|NCT02454608|2189657|FG000|Open Label Period|Withdrawal by Subject|0
1108813|NCT02454608|2189658|FG001|Open Label Period|Withdrawal by Subject|0
1108814|NCT02454608|2189659|FG002|Open Label Period|Withdrawal by Subject|8
1108815|NCT02454959|2189667|FG000|Overall Study|Protocol-Specified Criteria|3
1108816|NCT02454959|2189667|FG000|Overall Study|Physician Decision|1
1108817|NCT02454959|2189667|FG000|Overall Study|Withdrawal by Subject|3
1108818|NCT02454959|2189667|FG000|Overall Study|Adverse Event|2
1108819|NCT02454972|2189682|FG000|Overall Study|Progressive disease|17
1108820|NCT02454972|2189683|FG001|Overall Study|Progressive disease|16
1108821|NCT02454972|2189684|FG002|Overall Study|Progressive disease|59
1108822|NCT02454972|2189685|FG003|Overall Study|Progressive disease|23
1108823|NCT02454972|2189686|FG004|Overall Study|Progressive disease|16
1108824|NCT02454972|2189687|FG005|Overall Study|Progressive disease|12
1108825|NCT02454972|2189688|FG006|Overall Study|Progressive disease|19
1108826|NCT02454972|2189689|FG007|Overall Study|Progressive disease|27
1108827|NCT02454972|2189690|FG008|Overall Study|Progressive disease|84
1108828|NCT02454972|2189682|FG000|Overall Study|Death|0
1108829|NCT02454972|2189683|FG001|Overall Study|Death|0
1108830|NCT02454972|2189684|FG002|Overall Study|Death|5
1108831|NCT02454972|2189685|FG003|Overall Study|Death|1
1108832|NCT02454972|2189686|FG004|Overall Study|Death|0
1108833|NCT02454972|2189687|FG005|Overall Study|Death|0
1108834|NCT02454972|2189688|FG006|Overall Study|Death|0
1108835|NCT02454972|2189689|FG007|Overall Study|Death|0
1108836|NCT02454972|2189690|FG008|Overall Study|Death|2
1108837|NCT02454972|2189682|FG000|Overall Study|Physician Decision|0
1108838|NCT02454972|2189683|FG001|Overall Study|Physician Decision|1
1108839|NCT02454972|2189684|FG002|Overall Study|Physician Decision|2
1108840|NCT02454972|2189685|FG003|Overall Study|Physician Decision|1
1108841|NCT02454972|2189686|FG004|Overall Study|Physician Decision|2
1108842|NCT02454972|2189687|FG005|Overall Study|Physician Decision|0
1108843|NCT02454972|2189688|FG006|Overall Study|Physician Decision|0
1108844|NCT02454972|2189689|FG007|Overall Study|Physician Decision|1
1108845|NCT02454972|2189690|FG008|Overall Study|Physician Decision|4
1108846|NCT02454972|2189682|FG000|Overall Study|Non treatment-related adverse event|2
1108847|NCT02454972|2189683|FG001|Overall Study|Non treatment-related adverse event|0
1108848|NCT02454972|2189684|FG002|Overall Study|Non treatment-related adverse event|1
1108849|NCT02454972|2189685|FG003|Overall Study|Non treatment-related adverse event|0
1108850|NCT02454972|2189686|FG004|Overall Study|Non treatment-related adverse event|0
1108851|NCT02454972|2189687|FG005|Overall Study|Non treatment-related adverse event|1
1108852|NCT02454972|2189688|FG006|Overall Study|Non treatment-related adverse event|0
1108853|NCT02454972|2189689|FG007|Overall Study|Non treatment-related adverse event|1
1108854|NCT02454972|2189690|FG008|Overall Study|Non treatment-related adverse event|0
1108855|NCT02454972|2189682|FG000|Overall Study|Treatment-related adverse events|0
1108856|NCT02454972|2189683|FG001|Overall Study|Treatment-related adverse events|1
1108857|NCT02454972|2189684|FG002|Overall Study|Treatment-related adverse events|1
1108858|NCT02454972|2189685|FG003|Overall Study|Treatment-related adverse events|0
1108859|NCT02454972|2189686|FG004|Overall Study|Treatment-related adverse events|2
1108860|NCT02454972|2189687|FG005|Overall Study|Treatment-related adverse events|0
1108861|NCT02454972|2189688|FG006|Overall Study|Treatment-related adverse events|0
1108862|NCT02454972|2189689|FG007|Overall Study|Treatment-related adverse events|2
1108863|NCT02454972|2189690|FG008|Overall Study|Treatment-related adverse events|2
1108864|NCT02454972|2189682|FG000|Overall Study|Patient moves to compassionate use|0
1108865|NCT02454972|2189683|FG001|Overall Study|Patient moves to compassionate use|0
1108866|NCT02454972|2189684|FG002|Overall Study|Patient moves to compassionate use|0
1108867|NCT02454972|2189685|FG003|Overall Study|Patient moves to compassionate use|0
1108868|NCT02454972|2189686|FG004|Overall Study|Patient moves to compassionate use|0
1108869|NCT02454972|2189687|FG005|Overall Study|Patient moves to compassionate use|0
1108870|NCT02454972|2189688|FG006|Overall Study|Patient moves to compassionate use|2
1108871|NCT02454972|2189689|FG007|Overall Study|Patient moves to compassionate use|0
1108872|NCT02454972|2189690|FG008|Overall Study|Patient moves to compassionate use|11
1108873|NCT02454972|2189682|FG000|Overall Study|Withdrawal by Subject|0
1108874|NCT02454972|2189683|FG001|Overall Study|Withdrawal by Subject|1
1108875|NCT02454972|2189684|FG002|Overall Study|Withdrawal by Subject|5
1108876|NCT02454972|2189685|FG003|Overall Study|Withdrawal by Subject|2
1108877|NCT02454972|2189686|FG004|Overall Study|Withdrawal by Subject|3
1108878|NCT02454972|2189687|FG005|Overall Study|Withdrawal by Subject|2
1108879|NCT02454972|2189688|FG006|Overall Study|Withdrawal by Subject|0
1108880|NCT02454972|2189689|FG007|Overall Study|Withdrawal by Subject|1
1108881|NCT02454972|2189690|FG008|Overall Study|Withdrawal by Subject|2
1108882|NCT02454972|2189682|FG000|Overall Study|Multiple delay/holds on treatment|0
1108883|NCT02454972|2189683|FG001|Overall Study|Multiple delay/holds on treatment|0
1108884|NCT02454972|2189684|FG002|Overall Study|Multiple delay/holds on treatment|0
1108885|NCT02454972|2189685|FG003|Overall Study|Multiple delay/holds on treatment|1
1108886|NCT02454972|2189686|FG004|Overall Study|Multiple delay/holds on treatment|0
1108887|NCT02454972|2189687|FG005|Overall Study|Multiple delay/holds on treatment|0
1108888|NCT02454972|2189688|FG006|Overall Study|Multiple delay/holds on treatment|0
1108889|NCT02454972|2189689|FG007|Overall Study|Multiple delay/holds on treatment|0
1108890|NCT02454972|2189690|FG008|Overall Study|Multiple delay/holds on treatment|0
1108891|NCT02454972|2189682|FG000|Overall Study|Never treated|0
1108892|NCT02454972|2189683|FG001|Overall Study|Never treated|0
1108893|NCT02454972|2189684|FG002|Overall Study|Never treated|3
1108894|NCT02454972|2189685|FG003|Overall Study|Never treated|1
1108895|NCT02454972|2189686|FG004|Overall Study|Never treated|1
1108896|NCT02454972|2189687|FG005|Overall Study|Never treated|0
1108897|NCT02454972|2189688|FG006|Overall Study|Never treated|0
1108898|NCT02454972|2189689|FG007|Overall Study|Never treated|0
1108899|NCT02454972|2189690|FG008|Overall Study|Never treated|5
1108900|NCT02455050|2189706|FG000|Treatment Period 1|Lost to Follow-up|1
1108901|NCT02455050|2189707|FG001|Treatment Period 1|Lost to Follow-up|1
1108902|NCT02455050|2189708|FG002|Treatment Period 1|Lost to Follow-up|1
1108903|NCT02455050|2189709|FG003|Treatment Period 1|Lost to Follow-up|2
1108904|NCT02455050|2189706|FG000|Treatment Period 2|Lost to Follow-up|1
1108905|NCT02455050|2189707|FG001|Treatment Period 2|Lost to Follow-up|0
1108906|NCT02455050|2189708|FG002|Treatment Period 2|Lost to Follow-up|2
1108907|NCT02455050|2189709|FG003|Treatment Period 2|Lost to Follow-up|1
1108908|NCT02455076|2189734|FG000|Inpatient|Withdrawal by Subject|1
1108909|NCT02455076|2189735|FG001|Inpatient|Withdrawal by Subject|0
1108910|NCT02455076|2189736|FG002|Inpatient|Withdrawal by Subject|0
1108911|NCT02455076|2189737|FG003|Inpatient|Withdrawal by Subject|0
1108912|NCT02455076|2189738|FG004|Inpatient|Withdrawal by Subject|0
1108913|NCT02455076|2189734|FG000|Inpatient|Discharged <24 h after admission|0
1108914|NCT02455076|2189735|FG001|Inpatient|Discharged <24 h after admission|1
896532|NCT00705159|1868256|FG003|Overall Study|Adverse Event|0
896533|NCT00705159|1868253|FG000|Overall Study|Lost to Follow-up|0
896534|NCT00705159|1868254|FG001|Overall Study|Lost to Follow-up|0
896535|NCT00705159|1868255|FG002|Overall Study|Lost to Follow-up|3
896536|NCT00705159|1868256|FG003|Overall Study|Lost to Follow-up|2
896537|NCT00705159|1868253|FG000|Overall Study|Screen Failure|0
896538|NCT00705159|1868254|FG001|Overall Study|Screen Failure|0
896539|NCT00705159|1868255|FG002|Overall Study|Screen Failure|0
896540|NCT00705159|1868256|FG003|Overall Study|Screen Failure|1
896541|NCT00705224|1868266|FG000|Overall Study|Adverse Event|1
896542|NCT00705224|1868266|FG000|Overall Study|Lack of Efficacy|2
896543|NCT00705224|1868266|FG000|Overall Study|Withdrawal by Subject|3
1108915|NCT02455076|2189736|FG002|Inpatient|Discharged <24 h after admission|0
1108916|NCT02455076|2189737|FG003|Inpatient|Discharged <24 h after admission|0
1108917|NCT02455076|2189738|FG004|Inpatient|Discharged <24 h after admission|0
1108918|NCT02455076|2189734|FG000|Inpatient|Adverse Event|3
1108919|NCT02455076|2189735|FG001|Inpatient|Adverse Event|0
1108920|NCT02455076|2189736|FG002|Inpatient|Adverse Event|0
1108921|NCT02455076|2189737|FG003|Inpatient|Adverse Event|0
1108922|NCT02455076|2189738|FG004|Inpatient|Adverse Event|0
1108923|NCT02455076|2189734|FG000|Outpatient|Adverse Event|0
1108924|NCT02455076|2189735|FG001|Outpatient|Adverse Event|0
1108925|NCT02455076|2189736|FG002|Outpatient|Adverse Event|0
1108926|NCT02455076|2189737|FG003|Outpatient|Adverse Event|5
1108927|NCT02455076|2189738|FG004|Outpatient|Adverse Event|0
1108928|NCT02455076|2189734|FG000|Outpatient|Lost to Follow-up|0
1108929|NCT02455076|2189735|FG001|Outpatient|Lost to Follow-up|0
1108930|NCT02455076|2189736|FG002|Outpatient|Lost to Follow-up|0
1108931|NCT02455076|2189737|FG003|Outpatient|Lost to Follow-up|1
1108932|NCT02455076|2189738|FG004|Outpatient|Lost to Follow-up|12
1108933|NCT02455336|2189756|FG000|Overall Study|Withdrawal by Subject|0
1108934|NCT02455336|2189757|FG001|Overall Study|Withdrawal by Subject|2
1108935|NCT02455336|2189756|FG000|Overall Study|Adverse Event|3
1108936|NCT02455336|2189757|FG001|Overall Study|Adverse Event|0
1108937|NCT02455336|2189756|FG000|Overall Study|Non-responder to treatment|2
1108938|NCT02455336|2189757|FG001|Overall Study|Non-responder to treatment|0
1108939|NCT02455388|2189765|FG000|Overall Study|Protocol Violation|1
1108940|NCT02455388|2189766|FG001|Overall Study|Protocol Violation|0
1108941|NCT02455388|2189767|FG002|Overall Study|Protocol Violation|4
1108942|NCT02455388|2189765|FG000|Overall Study|Withdrawal by Subject|0
1108943|NCT02455388|2189766|FG001|Overall Study|Withdrawal by Subject|0
1108944|NCT02455388|2189767|FG002|Overall Study|Withdrawal by Subject|7
1108945|NCT02455518|2189783|FG000|Overall Study|Protocol Violation|0
1108946|NCT02455518|2189784|FG001|Overall Study|Protocol Violation|1
1108947|NCT02455518|2189785|FG002|Overall Study|Protocol Violation|1
1108948|NCT02455518|2189786|FG003|Overall Study|Protocol Violation|3
1108949|NCT02455557|2189796|FG000|Overall Study|Withdrawal by Subject|2
1108950|NCT02456103|2189800|FG000|Overall Study|Study Closure|207
1108951|NCT02456103|2189800|FG000|Overall Study|Physician Decision|1
1108952|NCT02456103|2189800|FG000|Overall Study|Required prohibited medications|5
1108953|NCT02456103|2189800|FG000|Overall Study|Protocol Violation|1
1108954|NCT02456103|2189800|FG000|Overall Study|Adverse Event|5
1108955|NCT02456103|2189800|FG000|Overall Study|Abnormal Laboratory Value|2
1108956|NCT02456103|2189800|FG000|Overall Study|Lost to Follow-up|1
1108957|NCT02456103|2189800|FG000|Overall Study|Withdrawal by Subject|24
1108958|NCT02456636|2189807|FG000|Overall Study|Death|0
1108959|NCT02456636|2189808|FG001|Overall Study|Death|3
1108960|NCT02456636|2189809|FG002|Overall Study|Death|0
1108961|NCT02456636|2189807|FG000|Overall Study|Pregnancy|1
1108962|NCT02456636|2189808|FG001|Overall Study|Pregnancy|3
1108963|NCT02456636|2189809|FG002|Overall Study|Pregnancy|5
1108964|NCT02456636|2189807|FG000|Overall Study|Physician Decision|4
1108965|NCT02456636|2189808|FG001|Overall Study|Physician Decision|5
1108966|NCT02456636|2189809|FG002|Overall Study|Physician Decision|4
1108967|NCT02456636|2189807|FG000|Overall Study|Withdrawal by Subject|13
1108968|NCT02456636|2189808|FG001|Overall Study|Withdrawal by Subject|14
1108969|NCT02456636|2189809|FG002|Overall Study|Withdrawal by Subject|16
1108970|NCT02456636|2189807|FG000|Overall Study|Lost to Follow-up|50
1108971|NCT02456636|2189808|FG001|Overall Study|Lost to Follow-up|44
1108972|NCT02456636|2189809|FG002|Overall Study|Lost to Follow-up|50
1108973|NCT02456662|2189819|FG000|Overall Study|Lost to Follow-up|2
1108974|NCT02456662|2189820|FG001|Overall Study|Lost to Follow-up|1
1108975|NCT02456727|2189828|FG000|Overall Study|Lost to Follow-up|63
1108976|NCT02456727|2189829|FG001|Overall Study|Lost to Follow-up|65
1108977|NCT02456727|2189828|FG000|Overall Study|Death|2
1108978|NCT02456727|2189829|FG001|Overall Study|Death|1
1108979|NCT02456727|2189828|FG000|Overall Study|Withdrawal by Subject|1
1108980|NCT02456727|2189829|FG001|Overall Study|Withdrawal by Subject|10
1108981|NCT02456727|2189828|FG000|Overall Study|Never Initiated Treatment|43
1108982|NCT02456727|2189829|FG001|Overall Study|Never Initiated Treatment|30
1108983|NCT02456740|2189854|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1108984|NCT02456740|2189855|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1108985|NCT02456740|2189856|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1108986|NCT02456740|2189857|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1108987|NCT02456740|2189858|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1108988|NCT02456740|2189859|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1108989|NCT02456740|2189860|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1108990|NCT02456740|2189861|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1108991|NCT02456740|2189862|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1108992|NCT02456740|2189854|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
1108993|NCT02456740|2189855|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
1108994|NCT02456740|2189856|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
1108995|NCT02456740|2189857|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1108996|NCT02456740|2189858|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1108997|NCT02456740|2189859|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1108998|NCT02456740|2189860|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1108999|NCT02456740|2189861|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1109000|NCT02456740|2189862|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1109001|NCT02456740|2189854|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
1109002|NCT02456740|2189855|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
1109003|NCT02456740|2189856|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
1109004|NCT02456740|2189857|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1109005|NCT02456740|2189858|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1109006|NCT02456740|2189859|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1109007|NCT02456740|2189860|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1109008|NCT02456740|2189861|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1109009|NCT02456740|2189862|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1109010|NCT02456740|2189854|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1109011|NCT02456740|2189855|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1109012|NCT02456740|2189856|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1109013|NCT02456740|2189857|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
1109014|NCT02456740|2189858|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
1109015|NCT02456740|2189859|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1109016|NCT02456740|2189860|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1109017|NCT02456740|2189861|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1109018|NCT02456740|2189862|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
1109019|NCT02456740|2189854|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1109020|NCT02456740|2189855|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1109021|NCT02456740|2189856|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1109022|NCT02456740|2189857|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
1109023|NCT02456740|2189858|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
1109024|NCT02456740|2189859|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
1109025|NCT02456740|2189860|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
1109026|NCT02456740|2189861|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
1109027|NCT02456740|2189862|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
1109028|NCT02456740|2189854|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0
1109029|NCT02456740|2189855|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0
1109030|NCT02456740|2189856|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0
1109031|NCT02456740|2189857|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0
1109032|NCT02456740|2189858|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0
1109033|NCT02456740|2189859|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0
1109034|NCT02456740|2189860|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0
1109035|NCT02456740|2189861|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1
1109036|NCT02456740|2189862|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0
1109037|NCT02456740|2189854|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1109038|NCT02456740|2189855|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1109039|NCT02456740|2189856|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1109040|NCT02456740|2189857|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
1109041|NCT02456740|2189858|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
1109042|NCT02456740|2189859|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
1109043|NCT02456740|2189860|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
1109044|NCT02456740|2189861|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
1109045|NCT02456740|2189862|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
1109046|NCT02456909|2189883|FG000|Overall Study|Did not receive allocated intervention|24
1109047|NCT02456909|2189884|FG001|Overall Study|Did not receive allocated intervention|26
1109048|NCT02456909|2189883|FG000|Overall Study|Did not complete the primary outcome|0
1109049|NCT02456909|2189884|FG001|Overall Study|Did not complete the primary outcome|1
1109050|NCT02457065|2189892|FG000|Overall Study|Lost to Follow-up|9
1109051|NCT02457065|2189893|FG001|Overall Study|Lost to Follow-up|11
1109052|NCT02457182|2189901|FG000|Overall Study|Lost to Follow-up|1
1109053|NCT02457182|2189902|FG001|Overall Study|Lost to Follow-up|0
1109054|NCT02457195|2189908|FG000|Overall Study|Adverse Event|3
1109055|NCT02457195|2189908|FG000|Overall Study|Protocol Violation|2
1109056|NCT02457195|2189908|FG000|Overall Study|Withdrawal by Subject|4
1109057|NCT02457247|2189916|FG000|Period 1|Pretreatment Event/Adverse Event|0
1109058|NCT02457247|2189917|FG001|Period 1|Pretreatment Event/Adverse Event|1
1109059|NCT02457247|2189918|FG002|Period 1|Pretreatment Event/Adverse Event|0
1109060|NCT02457247|2189919|FG003|Period 1|Pretreatment Event/Adverse Event|0
1109061|NCT02457247|2189916|FG000|Period 1|Significant Protocol Deviation|1
1109062|NCT02457247|2189917|FG001|Period 1|Significant Protocol Deviation|1
1109063|NCT02457247|2189918|FG002|Period 1|Significant Protocol Deviation|0
1109064|NCT02457247|2189919|FG003|Period 1|Significant Protocol Deviation|0
1109065|NCT02457247|2189916|FG000|Period 1|Voluntary Withdrawal|1
1109066|NCT02457247|2189917|FG001|Period 1|Voluntary Withdrawal|0
1109067|NCT02457247|2189918|FG002|Period 1|Voluntary Withdrawal|0
1109068|NCT02457247|2189919|FG003|Period 1|Voluntary Withdrawal|0
1109069|NCT02457247|2189916|FG000|Period 2|Pretreatment Event/Adverse Event|0
1109070|NCT02457247|2189917|FG001|Period 2|Pretreatment Event/Adverse Event|1
1109071|NCT02457247|2189918|FG002|Period 2|Pretreatment Event/Adverse Event|0
1109072|NCT02457247|2189919|FG003|Period 2|Pretreatment Event/Adverse Event|0
1109073|NCT02457247|2189916|FG000|Period 2|Significant Protocol Deviation|1
1109074|NCT02457247|2189917|FG001|Period 2|Significant Protocol Deviation|0
1109075|NCT02457247|2189918|FG002|Period 2|Significant Protocol Deviation|0
1109076|NCT02457247|2189919|FG003|Period 2|Significant Protocol Deviation|0
1109077|NCT02457247|2189916|FG000|Period 2|Lost to Follow-up|0
1109078|NCT02457247|2189917|FG001|Period 2|Lost to Follow-up|1
1109079|NCT02457247|2189918|FG002|Period 2|Lost to Follow-up|0
1109080|NCT02457247|2189919|FG003|Period 2|Lost to Follow-up|0
1109081|NCT02457247|2189916|FG000|Period 2|Voluntary Withdrawal|1
1109082|NCT02457247|2189917|FG001|Period 2|Voluntary Withdrawal|1
1109083|NCT02457247|2189918|FG002|Period 2|Voluntary Withdrawal|0
1109084|NCT02457247|2189919|FG003|Period 2|Voluntary Withdrawal|0
1109085|NCT02457325|2189951|FG000|First Intervention (1 Day)|Lost to Follow-up|2
1109086|NCT02457325|2189952|FG001|First Intervention (1 Day)|Lost to Follow-up|2
1109087|NCT02457520|2189969|FG000|Active Treatment Phase|Adverse Event|10
1109088|NCT02457520|2189969|FG000|Active Treatment Phase|Lost to Follow-up|8
1109089|NCT02457520|2189969|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3
1109090|NCT02457520|2189969|FG000|Active Treatment Phase|other|4
1109091|NCT02457520|2189969|FG000|Active Treatment Phase|Physician Decision|1
1109092|NCT02457520|2189969|FG000|Active Treatment Phase|Protocol Violation|1
1109093|NCT02457520|2189969|FG000|Active Treatment Phase|Withdrawal by Subject|7
1109094|NCT02457520|2189969|FG000|Post-treatment Period|Other: Retreatment Required|7
1109095|NCT02457520|2189969|FG000|Post-treatment Period|Lost to Follow-up|23
1109096|NCT02457520|2189969|FG000|Post-treatment Period|Other|3
1109097|NCT02457520|2189969|FG000|Post-treatment Period|Physician Decision|1
1109098|NCT02457520|2189969|FG000|Post-treatment Period|Withdrawal by Subject|14
1109099|NCT02457546|2190001|FG000|Overall Study|Other reasons|4
1109100|NCT02457546|2190002|FG001|Overall Study|Other reasons|1
1109101|NCT02457546|2190001|FG000|Overall Study|Refused to complete study/procedures|1
1109102|NCT02457546|2190002|FG001|Overall Study|Refused to complete study/procedures|1
1109103|NCT02457546|2190001|FG000|Overall Study|Lost to Follow-up|4
1109104|NCT02457546|2190002|FG001|Overall Study|Lost to Follow-up|1
1109105|NCT02457546|2190001|FG000|Overall Study|Adverse Event|0
1109106|NCT02457546|2190002|FG001|Overall Study|Adverse Event|1
1109107|NCT02457611|2190008|FG000|Overall Study|Lost to Follow-up|3
1109108|NCT02457637|2190012|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71
1109109|NCT02457793|2190027|FG000|Overall Study|Reason not specified|0
1109110|NCT02457793|2190028|FG001|Overall Study|Reason not specified|0
1109111|NCT02457793|2190029|FG002|Overall Study|Reason not specified|0
1109112|NCT02457793|2190030|FG003|Overall Study|Reason not specified|1
1109113|NCT02457793|2190031|FG004|Overall Study|Reason not specified|1
1109114|NCT02457793|2190032|FG005|Overall Study|Reason not specified|1
1109115|NCT02457793|2190027|FG000|Overall Study|Withdrawal by Subject|0
1109116|NCT02457793|2190028|FG001|Overall Study|Withdrawal by Subject|4
1109117|NCT02457793|2190029|FG002|Overall Study|Withdrawal by Subject|2
1109118|NCT02457793|2190030|FG003|Overall Study|Withdrawal by Subject|2
1109119|NCT02457793|2190031|FG004|Overall Study|Withdrawal by Subject|2
1109120|NCT02457793|2190032|FG005|Overall Study|Withdrawal by Subject|2
1109121|NCT02457793|2190027|FG000|Overall Study|Adverse Event|0
1109122|NCT02457793|2190028|FG001|Overall Study|Adverse Event|0
1109123|NCT02457793|2190029|FG002|Overall Study|Adverse Event|0
1109124|NCT02457793|2190030|FG003|Overall Study|Adverse Event|1
1109125|NCT02457793|2190031|FG004|Overall Study|Adverse Event|0
1109126|NCT02457793|2190032|FG005|Overall Study|Adverse Event|0
1109127|NCT02457793|2190027|FG000|Overall Study|Physician Decision|1
1109128|NCT02457793|2190028|FG001|Overall Study|Physician Decision|0
1109129|NCT02457793|2190029|FG002|Overall Study|Physician Decision|1
1109130|NCT02457793|2190030|FG003|Overall Study|Physician Decision|1
1109131|NCT02457793|2190031|FG004|Overall Study|Physician Decision|1
1109132|NCT02457793|2190032|FG005|Overall Study|Physician Decision|3
1109133|NCT02457819|2190047|FG000|Overall Study|reason not given|8
1109134|NCT02457819|2190047|FG000|Overall Study|Withdrawal by Subject|24
1109135|NCT02457819|2190047|FG000|Overall Study|Protocol Violation|1
1109136|NCT02457819|2190047|FG000|Overall Study|non compliance with study drug|4
1109137|NCT02457819|2190047|FG000|Overall Study|Lost to Follow-up|10
1109138|NCT02457819|2190047|FG000|Overall Study|Lack of Efficacy|19
1109139|NCT02457819|2190047|FG000|Overall Study|Adverse Event|33
1109140|NCT02457910|2190061|FG000|Overall Study|Withdrawal by Subject|0
1109141|NCT02457910|2190062|FG001|Overall Study|Withdrawal by Subject|0
1109142|NCT02457910|2190063|FG002|Overall Study|Withdrawal by Subject|0
1109143|NCT02457910|2190064|FG003|Overall Study|Withdrawal by Subject|0
1109144|NCT02457910|2190065|FG004|Overall Study|Withdrawal by Subject|0
1109145|NCT02457910|2190066|FG005|Overall Study|Withdrawal by Subject|1
1109146|NCT02457910|2190061|FG000|Overall Study|Adverse Event|0
1109147|NCT02457910|2190062|FG001|Overall Study|Adverse Event|2
1109148|NCT02457910|2190063|FG002|Overall Study|Adverse Event|1
1109149|NCT02457910|2190064|FG003|Overall Study|Adverse Event|1
1109150|NCT02457910|2190065|FG004|Overall Study|Adverse Event|1
1109151|NCT02457910|2190066|FG005|Overall Study|Adverse Event|3
1109152|NCT02457910|2190061|FG000|Overall Study|Disease progression|3
1109153|NCT02457910|2190062|FG001|Overall Study|Disease progression|3
1109154|NCT02457910|2190063|FG002|Overall Study|Disease progression|1
1109155|NCT02457910|2190064|FG003|Overall Study|Disease progression|1
1109156|NCT02457910|2190065|FG004|Overall Study|Disease progression|4
1109157|NCT02457910|2190066|FG005|Overall Study|Disease progression|6
1109158|NCT02457910|2190061|FG000|Overall Study|Other complicating illness|0
1109159|NCT02457910|2190062|FG001|Overall Study|Other complicating illness|0
1109160|NCT02457910|2190063|FG002|Overall Study|Other complicating illness|0
1109161|NCT02457910|2190064|FG003|Overall Study|Other complicating illness|0
1109162|NCT02457910|2190065|FG004|Overall Study|Other complicating illness|0
1109163|NCT02457910|2190066|FG005|Overall Study|Other complicating illness|1
1109164|NCT02457910|2190061|FG000|Overall Study|Death|0
1109165|NCT02457910|2190062|FG001|Overall Study|Death|0
1109166|NCT02457910|2190063|FG002|Overall Study|Death|1
1109167|NCT02457910|2190064|FG003|Overall Study|Death|0
1109168|NCT02457910|2190065|FG004|Overall Study|Death|0
1109169|NCT02457910|2190066|FG005|Overall Study|Death|0
1109170|NCT02458092|2190085|FG000|Overall Study|Withdrawal by Subject|1
1109171|NCT02458092|2190086|FG001|Overall Study|Withdrawal by Subject|0
1109172|NCT02458287|2190101|FG000|Overall Study|Adverse Event|0
1109173|NCT02458287|2190102|FG001|Overall Study|Adverse Event|0
1109174|NCT02458287|2190103|FG002|Overall Study|Adverse Event|0
1109175|NCT02458287|2190104|FG003|Overall Study|Adverse Event|1
1109176|NCT02458287|2190101|FG000|Overall Study|Lost to Follow-up|0
1109177|NCT02458287|2190102|FG001|Overall Study|Lost to Follow-up|1
1109178|NCT02458287|2190103|FG002|Overall Study|Lost to Follow-up|1
1109179|NCT02458287|2190104|FG003|Overall Study|Lost to Follow-up|0
1109180|NCT02458287|2190101|FG000|Overall Study|Protocol Violation|0
1109181|NCT02458287|2190102|FG001|Overall Study|Protocol Violation|1
1109182|NCT02458287|2190103|FG002|Overall Study|Protocol Violation|0
1109183|NCT02458287|2190104|FG003|Overall Study|Protocol Violation|0
1109184|NCT02458287|2190101|FG000|Overall Study|Withdrawal by Subject|0
1109185|NCT02458287|2190102|FG001|Overall Study|Withdrawal by Subject|2
1109186|NCT02458287|2190103|FG002|Overall Study|Withdrawal by Subject|2
1109187|NCT02458287|2190104|FG003|Overall Study|Withdrawal by Subject|1
1109188|NCT02458287|2190101|FG000|Overall Study|Relocated Out of State|0
1109189|NCT02458287|2190102|FG001|Overall Study|Relocated Out of State|0
1109190|NCT02458287|2190103|FG002|Overall Study|Relocated Out of State|0
1109191|NCT02458287|2190104|FG003|Overall Study|Relocated Out of State|1
1109192|NCT02458469|2190136|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0
1109193|NCT02458469|2190137|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
1109194|NCT02458469|2190138|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1
1109195|NCT02458469|2190139|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0
1109196|NCT02458469|2190140|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0
1109197|NCT02458469|2190141|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0
1109198|NCT02458469|2190136|FG000|First Intervention (2 Weeks)|Physician Decision|1
1109199|NCT02458469|2190137|FG001|First Intervention (2 Weeks)|Physician Decision|0
1109200|NCT02458469|2190138|FG002|First Intervention (2 Weeks)|Physician Decision|0
1109201|NCT02458469|2190139|FG003|First Intervention (2 Weeks)|Physician Decision|0
1109202|NCT02458469|2190140|FG004|First Intervention (2 Weeks)|Physician Decision|0
1109203|NCT02458469|2190141|FG005|First Intervention (2 Weeks)|Physician Decision|0
1109204|NCT02458469|2190136|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0
1109205|NCT02458469|2190137|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0
1109206|NCT02458469|2190138|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0
1109207|NCT02458469|2190139|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0
1109208|NCT02458469|2190140|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0
1109209|NCT02458469|2190141|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1
1109210|NCT02458638|2190149|FG000|Overall Study|Death|309
1109211|NCT02458638|2190149|FG000|Overall Study|End of Cohort/End of Study|67
1109212|NCT02458638|2190149|FG000|Overall Study|Lost to Follow-up|31
1109213|NCT02458638|2190149|FG000|Overall Study|Other Reasons|4
1109214|NCT02458638|2190149|FG000|Overall Study|Physician Decision|1
1109215|NCT02458638|2190149|FG000|Overall Study|Withdrawal by Subject|47
1109216|NCT02459093|2190186|FG000|Overall Study|Protocol Violation|6
1109217|NCT02459093|2190187|FG001|Overall Study|Protocol Violation|11
1109218|NCT02459093|2190186|FG000|Overall Study|Lost to Follow-up|6
1109219|NCT02459093|2190187|FG001|Overall Study|Lost to Follow-up|7
1109220|NCT02459262|2190217|FG000|Overall Study|Withdrawal by Subject|0
1109221|NCT02459262|2190218|FG001|Overall Study|Withdrawal by Subject|0
1109222|NCT02459262|2190219|FG002|Overall Study|Withdrawal by Subject|0
1109223|NCT02459262|2190220|FG003|Overall Study|Withdrawal by Subject|0
1109224|NCT02459262|2190221|FG004|Overall Study|Withdrawal by Subject|0
1109225|NCT02459262|2190222|FG005|Overall Study|Withdrawal by Subject|0
1109226|NCT02459262|2190223|FG006|Overall Study|Withdrawal by Subject|0
1109227|NCT02459262|2190224|FG007|Overall Study|Withdrawal by Subject|0
1109228|NCT02459262|2190225|FG008|Overall Study|Withdrawal by Subject|0
1109229|NCT02459262|2190226|FG009|Overall Study|Withdrawal by Subject|1
1109230|NCT02459262|2190227|FG010|Overall Study|Withdrawal by Subject|0
1109231|NCT02459418|2190262|FG000|Overall Study|Exclusion Criteria|4
1109232|NCT02459418|2190263|FG001|Overall Study|Exclusion Criteria|0
1109233|NCT02459418|2190262|FG000|Overall Study|Protocol Violation|0
1109234|NCT02459418|2190263|FG001|Overall Study|Protocol Violation|2
1109235|NCT02459418|2190262|FG000|Overall Study|Physician Decision|0
1109236|NCT02459418|2190263|FG001|Overall Study|Physician Decision|2
1109237|NCT02459418|2190262|FG000|Overall Study|Endometrial thickness of >5 mm|1
1109238|NCT02459418|2190263|FG001|Overall Study|Endometrial thickness of >5 mm|0
1109239|NCT02459418|2190262|FG000|Overall Study|Adverse Event|0
1109240|NCT02459418|2190263|FG001|Overall Study|Adverse Event|1
1109241|NCT02459418|2190262|FG000|Overall Study|Withdrawal by Subject|1
1109242|NCT02459418|2190263|FG001|Overall Study|Withdrawal by Subject|1
1109243|NCT02459418|2190262|FG000|Overall Study|Elevated Creatine Kinase|1
1109244|NCT02459418|2190263|FG001|Overall Study|Elevated Creatine Kinase|0
1109245|NCT02459418|2190262|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1
1109246|NCT02459418|2190263|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0
1109247|NCT02459587|2190274|FG000|3-Month Follow-up Assessment|Death|0
1109248|NCT02459587|2190275|FG001|3-Month Follow-up Assessment|Death|2
1109249|NCT02459587|2190274|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3
1109250|NCT02459587|2190275|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3
1109251|NCT02459587|2190274|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27
1109252|NCT02459587|2190275|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22
1109253|NCT02459587|2190274|FG000|3-Month Follow-up Assessment|Researcher withdrew|2
1109254|NCT02459587|2190275|FG001|3-Month Follow-up Assessment|Researcher withdrew|4
1109255|NCT02459587|2190274|FG000|6-month Follow-up Assessment|Death|2
1109256|NCT02459587|2190275|FG001|6-month Follow-up Assessment|Death|1
1109257|NCT02459587|2190274|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1
1109258|NCT02459587|2190275|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2
1109259|NCT02459587|2190274|FG000|6-month Follow-up Assessment|Lost to Follow-up|21
1109260|NCT02459587|2190275|FG001|6-month Follow-up Assessment|Lost to Follow-up|22
1109261|NCT02459587|2190274|FG000|12-month Follow-up Assessment|Death|2
1109262|NCT02459587|2190275|FG001|12-month Follow-up Assessment|Death|0
1109263|NCT02459587|2190274|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2
1109264|NCT02459587|2190275|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4
1109265|NCT02459587|2190274|FG000|12-month Follow-up Assessment|Lost to Follow-up|18
1109266|NCT02459587|2190275|FG001|12-month Follow-up Assessment|Lost to Follow-up|22
1109267|NCT02459587|2190274|FG000|12-month Follow-up Assessment|Researcher withdrew|0
1109268|NCT02459587|2190275|FG001|12-month Follow-up Assessment|Researcher withdrew|1
1109269|NCT02459665|2190286|FG000|Overall Study|Withdrawal by Subject|0
1109270|NCT02459665|2190287|FG001|Overall Study|Withdrawal by Subject|1
1109271|NCT02459665|2190288|FG002|Overall Study|Withdrawal by Subject|1
1109272|NCT02459665|2190289|FG003|Overall Study|Withdrawal by Subject|2
1109273|NCT02459899|2190323|FG000|Overall Study|Adverse Event|1
1109274|NCT02459899|2190324|FG001|Overall Study|Adverse Event|1
1109275|NCT02459899|2190325|FG002|Overall Study|Adverse Event|0
1109276|NCT02459899|2190326|FG003|Overall Study|Adverse Event|0
1109277|NCT02459899|2190323|FG000|Overall Study|Lost to Follow-up|1
1109278|NCT02459899|2190324|FG001|Overall Study|Lost to Follow-up|2
1109279|NCT02459899|2190325|FG002|Overall Study|Lost to Follow-up|0
1109280|NCT02459899|2190326|FG003|Overall Study|Lost to Follow-up|1
1109281|NCT02459899|2190323|FG000|Overall Study|Non-compliance with the treatment|0
1109282|NCT02459899|2190324|FG001|Overall Study|Non-compliance with the treatment|0
1109283|NCT02459899|2190325|FG002|Overall Study|Non-compliance with the treatment|0
1109284|NCT02459899|2190326|FG003|Overall Study|Non-compliance with the treatment|1
1109285|NCT02459899|2190323|FG000|Overall Study|Withdrawal by Subject|1
1109286|NCT02459899|2190324|FG001|Overall Study|Withdrawal by Subject|3
1109287|NCT02459899|2190325|FG002|Overall Study|Withdrawal by Subject|0
1109288|NCT02459899|2190326|FG003|Overall Study|Withdrawal by Subject|0
1109289|NCT02459951|2190336|FG000|Overall Study|Unable to meet holding requirement|1
1109290|NCT02459964|2190344|FG000|Overall Study|Withdrawal by Subject|0
1109291|NCT02459964|2190345|FG001|Overall Study|Withdrawal by Subject|0
1109292|NCT02459964|2190346|FG002|Overall Study|Withdrawal by Subject|1
1109293|NCT02459964|2190344|FG000|Overall Study|Abnormal EKG changes|0
1109294|NCT02459964|2190345|FG001|Overall Study|Abnormal EKG changes|0
1109295|NCT02459964|2190346|FG002|Overall Study|Abnormal EKG changes|1
1109296|NCT02460159|2190355|FG000|Overall Study|Adverse Event|4
1109297|NCT02460159|2190356|FG001|Overall Study|Adverse Event|1
1109298|NCT02460159|2190355|FG000|Overall Study|Withdrawal by Subject|2
1109299|NCT02460159|2190356|FG001|Overall Study|Withdrawal by Subject|0
1109300|NCT02460198|2190370|FG000|Overall Study|Adverse Event|1
1109301|NCT02460198|2190371|FG001|Overall Study|Adverse Event|3
1109302|NCT02460198|2190370|FG000|Overall Study|Death|32
1109303|NCT02460198|2190371|FG001|Overall Study|Death|25
1109304|NCT02460198|2190370|FG000|Overall Study|Lost to Follow-up|1
1109305|NCT02460198|2190371|FG001|Overall Study|Lost to Follow-up|1
1109306|NCT02460198|2190370|FG000|Overall Study|Withdrawal by Subject|2
1109307|NCT02460198|2190371|FG001|Overall Study|Withdrawal by Subject|4
1109308|NCT02460198|2190370|FG000|Overall Study|Ongoing|25
1109309|NCT02460198|2190371|FG001|Overall Study|Ongoing|30
1109310|NCT02460263|2190377|FG000|Transition Period|Withdrawal by Subject|1
1109311|NCT02460263|2190377|FG000|Transition Period|Death|1
1109312|NCT02460380|2190387|FG000|Overall Study|Withdrawal by Subject|10
1109313|NCT02460380|2190388|FG001|Overall Study|Withdrawal by Subject|5
1109314|NCT02460458|2190395|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47
1109315|NCT02460458|2190395|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27
1109316|NCT02460458|2190395|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14
1109317|NCT02460458|2190395|FG000|First Prospective Phase|Lost to Follow-up|16
1109318|NCT02460458|2190395|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9
1109319|NCT02460562|2190401|FG000|Overall Study|Lost to Follow-up|15
1109320|NCT02460562|2190402|FG001|Overall Study|Lost to Follow-up|16
1109321|NCT02460575|2190410|FG000|Overall Study|Lost to Follow-up|1
1109322|NCT02460575|2190411|FG001|Overall Study|Lost to Follow-up|0
1109323|NCT02460679|2190426|FG000|Overall Study|Investigator Decision|1
1109324|NCT02460679|2190426|FG000|Overall Study|Withdrawal by Subject|4
1109325|NCT02460822|2190430|FG000|Overall Study|Withdrawal by Subject|1
1109326|NCT02460978|2190437|FG000|Overall Study|Adverse Event|17
1109327|NCT02460978|2190438|FG001|Overall Study|Adverse Event|11
1109328|NCT02460978|2190439|FG002|Overall Study|Adverse Event|11
1109329|NCT02460978|2190437|FG000|Overall Study|Withdrawal by Subject|5
1109330|NCT02460978|2190438|FG001|Overall Study|Withdrawal by Subject|5
1109331|NCT02460978|2190439|FG002|Overall Study|Withdrawal by Subject|14
1109332|NCT02460978|2190437|FG000|Overall Study|Lost to Follow-up|2
1109333|NCT02460978|2190438|FG001|Overall Study|Lost to Follow-up|3
1109334|NCT02460978|2190439|FG002|Overall Study|Lost to Follow-up|1
1109335|NCT02460978|2190437|FG000|Overall Study|Protocol Violation|1
1109336|NCT02460978|2190438|FG001|Overall Study|Protocol Violation|1
1109337|NCT02460978|2190439|FG002|Overall Study|Protocol Violation|1
1109338|NCT02460978|2190437|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2
1109339|NCT02460978|2190438|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5
1109340|NCT02460978|2190439|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4
1109341|NCT02460978|2190437|FG000|Overall Study|Pregnancy|0
1109342|NCT02460978|2190438|FG001|Overall Study|Pregnancy|0
1109343|NCT02460978|2190439|FG002|Overall Study|Pregnancy|2
1109344|NCT02460991|2190449|FG000|Overall Study|Withdrawal by Subject|0
1109345|NCT02460991|2190450|FG001|Overall Study|Withdrawal by Subject|2
1109346|NCT02461134|2190461|FG000|Overall Study|Adverse Event|1
1109347|NCT02461160|2190478|FG000|Overall Study|Lost to Follow-up|0
1109348|NCT02461160|2190479|FG001|Overall Study|Lost to Follow-up|0
1109349|NCT02461160|2190480|FG002|Overall Study|Lost to Follow-up|0
1109350|NCT02461160|2190481|FG003|Overall Study|Lost to Follow-up|0
1109351|NCT02461160|2190482|FG004|Overall Study|Lost to Follow-up|0
1109352|NCT02461160|2190483|FG005|Overall Study|Lost to Follow-up|0
1109353|NCT02461160|2190484|FG006|Overall Study|Lost to Follow-up|0
1109354|NCT02461160|2190485|FG007|Overall Study|Lost to Follow-up|1
1109355|NCT02461160|2190486|FG008|Overall Study|Lost to Follow-up|0
1109356|NCT02461160|2190487|FG009|Overall Study|Lost to Follow-up|0
1109357|NCT02461160|2190488|FG010|Overall Study|Lost to Follow-up|0
1109358|NCT02461160|2190489|FG011|Overall Study|Lost to Follow-up|0
1109359|NCT02461160|2190490|FG012|Overall Study|Lost to Follow-up|0
1109360|NCT02461290|2190539|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7
1109361|NCT02461290|2190539|FG000|Overall Study|Lost to Follow-up|3
1109362|NCT02461589|2190585|FG000|Overall Study|Withdrawal by Subject|5
1109363|NCT02461589|2190586|FG001|Overall Study|Withdrawal by Subject|1
1109364|NCT02461589|2190587|FG002|Overall Study|Withdrawal by Subject|3
1109365|NCT02461589|2190588|FG003|Overall Study|Withdrawal by Subject|2
1109366|NCT02461589|2190589|FG004|Overall Study|Withdrawal by Subject|1
1109367|NCT02461589|2190590|FG005|Overall Study|Withdrawal by Subject|2
1109368|NCT02461589|2190591|FG006|Overall Study|Withdrawal by Subject|1
1109369|NCT02461589|2190592|FG007|Overall Study|Withdrawal by Subject|3
1109370|NCT02461589|2190593|FG008|Overall Study|Withdrawal by Subject|3
1109371|NCT02461589|2190594|FG009|Overall Study|Withdrawal by Subject|1
1109372|NCT02461589|2190585|FG000|Overall Study|Lost to Follow-up|0
1109373|NCT02461589|2190586|FG001|Overall Study|Lost to Follow-up|0
1109374|NCT02461589|2190587|FG002|Overall Study|Lost to Follow-up|2
1109375|NCT02461589|2190588|FG003|Overall Study|Lost to Follow-up|3
1109376|NCT02461589|2190589|FG004|Overall Study|Lost to Follow-up|1
1109377|NCT02461589|2190590|FG005|Overall Study|Lost to Follow-up|1
1109378|NCT02461589|2190591|FG006|Overall Study|Lost to Follow-up|3
1109379|NCT02461589|2190592|FG007|Overall Study|Lost to Follow-up|1
1109380|NCT02461589|2190593|FG008|Overall Study|Lost to Follow-up|3
1109381|NCT02461589|2190594|FG009|Overall Study|Lost to Follow-up|1
1109382|NCT02461589|2190585|FG000|Overall Study|Death|0
1109383|NCT02461589|2190586|FG001|Overall Study|Death|0
1109384|NCT02461589|2190587|FG002|Overall Study|Death|0
1109385|NCT02461589|2190588|FG003|Overall Study|Death|0
1109386|NCT02461589|2190589|FG004|Overall Study|Death|0
1109387|NCT02461589|2190590|FG005|Overall Study|Death|0
1109388|NCT02461589|2190591|FG006|Overall Study|Death|0
1109389|NCT02461589|2190592|FG007|Overall Study|Death|1
1109390|NCT02461589|2190593|FG008|Overall Study|Death|0
1109391|NCT02461589|2190594|FG009|Overall Study|Death|0
1109392|NCT02461589|2190585|FG000|Overall Study|Unclassified|0
1109393|NCT02461589|2190586|FG001|Overall Study|Unclassified|0
1109394|NCT02461589|2190587|FG002|Overall Study|Unclassified|0
1109395|NCT02461589|2190588|FG003|Overall Study|Unclassified|0
1109396|NCT02461589|2190589|FG004|Overall Study|Unclassified|0
1109397|NCT02461589|2190590|FG005|Overall Study|Unclassified|0
1109398|NCT02461589|2190591|FG006|Overall Study|Unclassified|1
1109399|NCT02461589|2190592|FG007|Overall Study|Unclassified|0
1109400|NCT02461589|2190593|FG008|Overall Study|Unclassified|0
1109401|NCT02461589|2190594|FG009|Overall Study|Unclassified|2
1109402|NCT02461589|2190585|FG000|Overall Study|Missing follow-up information|1
1109403|NCT02461589|2190586|FG001|Overall Study|Missing follow-up information|1
1109404|NCT02461589|2190587|FG002|Overall Study|Missing follow-up information|0
1109405|NCT02461589|2190588|FG003|Overall Study|Missing follow-up information|0
1109406|NCT02461589|2190589|FG004|Overall Study|Missing follow-up information|0
1109407|NCT02461589|2190590|FG005|Overall Study|Missing follow-up information|0
1109408|NCT02461589|2190591|FG006|Overall Study|Missing follow-up information|1
1109409|NCT02461589|2190592|FG007|Overall Study|Missing follow-up information|0
1109410|NCT02461589|2190593|FG008|Overall Study|Missing follow-up information|0
1109411|NCT02461589|2190594|FG009|Overall Study|Missing follow-up information|0
1109412|NCT02461589|2190585|FG000|Overall Study|Withdrawal from trial before exposure|0
1109413|NCT02461589|2190586|FG001|Overall Study|Withdrawal from trial before exposure|0
1109414|NCT02461589|2190587|FG002|Overall Study|Withdrawal from trial before exposure|0
1109415|NCT02461589|2190588|FG003|Overall Study|Withdrawal from trial before exposure|0
1109416|NCT02461589|2190589|FG004|Overall Study|Withdrawal from trial before exposure|0
1109417|NCT02461589|2190590|FG005|Overall Study|Withdrawal from trial before exposure|0
1109418|NCT02461589|2190591|FG006|Overall Study|Withdrawal from trial before exposure|0
1109419|NCT02461589|2190592|FG007|Overall Study|Withdrawal from trial before exposure|0
1109420|NCT02461589|2190593|FG008|Overall Study|Withdrawal from trial before exposure|0
1109421|NCT02461589|2190594|FG009|Overall Study|Withdrawal from trial before exposure|1
1109422|NCT02461628|2190618|FG000|Overall Study|Refused to complete survey|4
1109423|NCT02461628|2190619|FG001|Overall Study|Refused to complete survey|7
1109424|NCT02461745|2190636|FG000|Overall Study|Lack of Efficacy|9
1109425|NCT02461745|2190637|FG001|Overall Study|Lack of Efficacy|1
1109426|NCT02461745|2190636|FG000|Overall Study|Lost to Follow-up|2
1109427|NCT02461745|2190637|FG001|Overall Study|Lost to Follow-up|2
1109428|NCT02461745|2190636|FG000|Overall Study|Withdrawal by Subject|3
1109429|NCT02461745|2190637|FG001|Overall Study|Withdrawal by Subject|1
1109430|NCT02461758|2190649|FG000|Overall Study|Lost to Follow-up|0
1109431|NCT02461758|2190650|FG001|Overall Study|Lost to Follow-up|1
1109432|NCT02461758|2190651|FG002|Overall Study|Lost to Follow-up|1
1109433|NCT02461758|2190652|FG003|Overall Study|Lost to Follow-up|0
1109434|NCT02462057|2190700|FG000|Overall Study|Left Vitality|32
1109435|NCT02462057|2190701|FG001|Overall Study|Left Vitality|27
1109436|NCT02462057|2190702|FG002|Overall Study|Left Vitality|23
1109437|NCT02462057|2190703|FG003|Overall Study|Left Vitality|35
1109438|NCT02462057|2190704|FG004|Overall Study|Left Vitality|33
1109439|NCT02462057|2190700|FG000|Overall Study|Joined HealthyFood Before Intervention|22
1109440|NCT02462057|2190701|FG001|Overall Study|Joined HealthyFood Before Intervention|13
1109441|NCT02462057|2190702|FG002|Overall Study|Joined HealthyFood Before Intervention|23
1109442|NCT02462057|2190703|FG003|Overall Study|Joined HealthyFood Before Intervention|16
1109443|NCT02462057|2190704|FG004|Overall Study|Joined HealthyFood Before Intervention|17
1109444|NCT02462083|2190725|FG000|Overall Study|Sponsor request|39
1109445|NCT02462083|2190725|FG000|Overall Study|Withdrawal by Subject|87
1109446|NCT02462083|2190725|FG000|Overall Study|Lost to Follow-up|41
1109447|NCT02462083|2190725|FG000|Overall Study|Lack of Efficacy|151
1109448|NCT02462083|2190725|FG000|Overall Study|Pregnancy|1
1109449|NCT02462083|2190725|FG000|Overall Study|Protocol Violation|6
1109450|NCT02462083|2190725|FG000|Overall Study|Adverse Event|33
1109451|NCT02462083|2190725|FG000|Overall Study|Worsening condition|16
1109452|NCT02462083|2190725|FG000|Overall Study|Other than specified|45
1109453|NCT02462473|2190774|FG000|Overall Study|Death|1
1109454|NCT02462473|2190774|FG000|Overall Study|Other|3
1109455|NCT02462486|2190781|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
1109456|NCT02462486|2190782|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
1109457|NCT02462486|2190783|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3
1109458|NCT02462486|2190781|FG000|Overall Study|Adverse Event|53
1109459|NCT02462486|2190782|FG001|Overall Study|Adverse Event|48
1109460|NCT02462486|2190783|FG002|Overall Study|Adverse Event|21
1109461|NCT02462486|2190781|FG000|Overall Study|Lack of Efficacy|6
1109462|NCT02462486|2190782|FG001|Overall Study|Lack of Efficacy|12
1109463|NCT02462486|2190783|FG002|Overall Study|Lack of Efficacy|3
1109464|NCT02462486|2190781|FG000|Overall Study|Lost to Follow-up|3
1109465|NCT02462486|2190782|FG001|Overall Study|Lost to Follow-up|4
1109466|NCT02462486|2190783|FG002|Overall Study|Lost to Follow-up|2
1109467|NCT02462486|2190781|FG000|Overall Study|Withdrawal by Subject|25
1109468|NCT02462486|2190782|FG001|Overall Study|Withdrawal by Subject|22
1109469|NCT02462486|2190783|FG002|Overall Study|Withdrawal by Subject|19
1109470|NCT02462486|2190781|FG000|Overall Study|Protocol Violation|3
1109471|NCT02462486|2190782|FG001|Overall Study|Protocol Violation|1
1109472|NCT02462486|2190783|FG002|Overall Study|Protocol Violation|1
1109473|NCT02462486|2190781|FG000|Overall Study|Reason not Specified|3
1109474|NCT02462486|2190782|FG001|Overall Study|Reason not Specified|4
1109475|NCT02462486|2190783|FG002|Overall Study|Reason not Specified|3
1109476|NCT02462720|2190791|FG000|Part 2|Withdrawal by Subject|1
1109477|NCT02462720|2190792|FG001|Part 2|Withdrawal by Subject|0
1109478|NCT02462720|2190791|FG000|Part 2|Protocol Violation|0
1109479|NCT02462720|2190792|FG001|Part 2|Protocol Violation|1
1109480|NCT02462759|2190802|FG000|Part 1: Double Blind|Death|1
1109481|NCT02462759|2190803|FG001|Part 1: Double Blind|Death|0
1109482|NCT02462759|2190804|FG002|Part 1: Double Blind|Death|0
1109483|NCT02462876|2190815|FG000|Overall Study|Death|3
1109484|NCT02462876|2190815|FG000|Overall Study|Lost to Follow-up|4
1109485|NCT02462876|2190815|FG000|Overall Study|Surgical Bypass|9
1109486|NCT02462876|2190815|FG000|Overall Study|Amputation Above the Metatarsals|1
1109487|NCT02462876|2190815|FG000|Overall Study|Other|6
1109488|NCT02462876|2190815|FG000|Overall Study|Ongoing|10
1109489|NCT02462928|2190822|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
1109490|NCT02462928|2190823|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
1109491|NCT02462928|2190824|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2
1109492|NCT02462928|2190822|FG000|Overall Study|Adverse Event|47
1109493|NCT02462928|2190823|FG001|Overall Study|Adverse Event|51
1109494|NCT02462928|2190824|FG002|Overall Study|Adverse Event|25
1109495|NCT02462928|2190822|FG000|Overall Study|Lack of Efficacy|3
1109496|NCT02462928|2190823|FG001|Overall Study|Lack of Efficacy|8
1109497|NCT02462928|2190824|FG002|Overall Study|Lack of Efficacy|3
1109498|NCT02462928|2190822|FG000|Overall Study|Lost to Follow-up|4
1109499|NCT02462928|2190823|FG001|Overall Study|Lost to Follow-up|4
1109500|NCT02462928|2190824|FG002|Overall Study|Lost to Follow-up|1
1109501|NCT02462928|2190822|FG000|Overall Study|Withdrawal by Patient|31
1109502|NCT02462928|2190823|FG001|Overall Study|Withdrawal by Patient|21
1109503|NCT02462928|2190824|FG002|Overall Study|Withdrawal by Patient|21
1109504|NCT02462928|2190822|FG000|Overall Study|Protocol Violation|0
1109505|NCT02462928|2190823|FG001|Overall Study|Protocol Violation|1
1109506|NCT02462928|2190824|FG002|Overall Study|Protocol Violation|0
1109507|NCT02462928|2190822|FG000|Overall Study|Reason not Specified|4
1109508|NCT02462928|2190823|FG001|Overall Study|Reason not Specified|6
1109509|NCT02462928|2190824|FG002|Overall Study|Reason not Specified|5
1109510|NCT02463032|2190847|FG000|Overall Study|Lack of Efficacy|61
1109511|NCT02463032|2190848|FG001|Overall Study|Lack of Efficacy|50
1109512|NCT02463032|2190847|FG000|Overall Study|Death|8
1109513|NCT02463032|2190848|FG001|Overall Study|Death|8
1109514|NCT02463032|2190847|FG000|Overall Study|Adverse Event|2
1109515|NCT02463032|2190848|FG001|Overall Study|Adverse Event|6
1109516|NCT02463071|2190857|FG000|Overall Study|Adverse Event|3
1109517|NCT02463071|2190858|FG001|Overall Study|Adverse Event|5
1109518|NCT02463071|2190859|FG002|Overall Study|Adverse Event|1
1109519|NCT02463071|2190857|FG000|Overall Study|Death|1
1109520|NCT02463071|2190858|FG001|Overall Study|Death|0
1109521|NCT02463071|2190859|FG002|Overall Study|Death|0
1109522|NCT02463071|2190857|FG000|Overall Study|Eligibility criteria not fulfilled|1
1109523|NCT02463071|2190858|FG001|Overall Study|Eligibility criteria not fulfilled|0
1109524|NCT02463071|2190859|FG002|Overall Study|Eligibility criteria not fulfilled|0
1109525|NCT02463071|2190857|FG000|Overall Study|Reason not specified|7
1109526|NCT02463071|2190858|FG001|Overall Study|Reason not specified|9
1109527|NCT02463071|2190859|FG002|Overall Study|Reason not specified|4
1109528|NCT02463071|2190857|FG000|Overall Study|Protocol Violation|0
1109529|NCT02463071|2190858|FG001|Overall Study|Protocol Violation|2
1109530|NCT02463071|2190859|FG002|Overall Study|Protocol Violation|0
1109531|NCT02463071|2190857|FG000|Overall Study|Lost to Follow-up|0
1109532|NCT02463071|2190858|FG001|Overall Study|Lost to Follow-up|0
1109533|NCT02463071|2190859|FG002|Overall Study|Lost to Follow-up|1
1109534|NCT02463097|2190867|FG000|Overall Study|Withdrawal by Subject|1
1109535|NCT02463331|2190877|FG000|Overall Study|Adverse Event|4
1109536|NCT02463331|2190878|FG001|Overall Study|Adverse Event|2
1109537|NCT02463331|2190877|FG000|Overall Study|Lost to Follow-up|1
1109538|NCT02463331|2190878|FG001|Overall Study|Lost to Follow-up|1
1109539|NCT02463331|2190877|FG000|Overall Study|Pregnancy|2
1109540|NCT02463331|2190878|FG001|Overall Study|Pregnancy|3
1109541|NCT02463331|2190877|FG000|Overall Study|Lack of Efficacy|6
1109542|NCT02463331|2190878|FG001|Overall Study|Lack of Efficacy|0
1109543|NCT02463331|2190877|FG000|Overall Study|Physician Decision|3
1109544|NCT02463331|2190878|FG001|Overall Study|Physician Decision|0
1109545|NCT02463357|2190889|FG000|Overall Study|Withdrawal by Subject|1
1109546|NCT02463357|2190890|FG001|Overall Study|Withdrawal by Subject|0
1109547|NCT02463357|2190891|FG002|Overall Study|Withdrawal by Subject|0
1109548|NCT02463357|2190892|FG003|Overall Study|Withdrawal by Subject|0
1109549|NCT02463357|2190893|FG004|Overall Study|Withdrawal by Subject|0
1109550|NCT02463357|2190889|FG000|Overall Study|Withdrawal by Subject|0
1109551|NCT02463357|2190890|FG001|Overall Study|Withdrawal by Subject|0
1109552|NCT02463357|2190891|FG002|Overall Study|Withdrawal by Subject|0
1109553|NCT02463357|2190892|FG003|Overall Study|Withdrawal by Subject|0
1109554|NCT02463357|2190893|FG004|Overall Study|Withdrawal by Subject|1
1109555|NCT02463409|2190905|FG000|Overall Study|Withdrawal by Subject|1
1109556|NCT02463409|2190905|FG000|Overall Study|Screen failure|1
1109557|NCT02464059|2190941|FG000|Overall Study|Lost to Follow-up|6
1109558|NCT02465034|2191016|FG000|Overall Study|Withdrawal by Subject|1
1109559|NCT02465034|2191017|FG001|Overall Study|Withdrawal by Subject|1
1109560|NCT02465034|2191016|FG000|Overall Study|Screen fail|2
1109561|NCT02465034|2191017|FG001|Overall Study|Screen fail|0
1109562|NCT02465034|2191016|FG000|Overall Study|Could not be scheduled for study visit|0
1109563|NCT02465034|2191017|FG001|Overall Study|Could not be scheduled for study visit|5
1109564|NCT02465203|2191056|FG000|Overall Study|Protocol Violation|1
1109565|NCT02465203|2191057|FG001|Overall Study|Protocol Violation|1
1109566|NCT02465203|2191058|FG002|Overall Study|Protocol Violation|1
1109567|NCT02465203|2191056|FG000|Overall Study|Study terminated by sponsor|50
1109568|NCT02465203|2191057|FG001|Overall Study|Study terminated by sponsor|34
1109569|NCT02465203|2191058|FG002|Overall Study|Study terminated by sponsor|11
1109570|NCT02465203|2191056|FG000|Overall Study|New therapy for study indication|4
1109571|NCT02465203|2191057|FG001|Overall Study|New therapy for study indication|0
1109572|NCT02465203|2191058|FG002|Overall Study|New therapy for study indication|0
1109573|NCT02465203|2191056|FG000|Overall Study|Patient/guardian decision|1
1109574|NCT02465203|2191057|FG001|Overall Study|Patient/guardian decision|1
1109575|NCT02465203|2191058|FG002|Overall Study|Patient/guardian decision|1
1109576|NCT02465437|2191099|FG000|Overall Study|Physician Decision|0
1109577|NCT02465437|2191100|FG001|Overall Study|Physician Decision|0
1109578|NCT02465437|2191101|FG002|Overall Study|Physician Decision|1
1109579|NCT02465437|2191102|FG003|Overall Study|Physician Decision|0
1109580|NCT02465437|2191099|FG000|Overall Study|Withdrawal by Subject|1
1109581|NCT02465437|2191100|FG001|Overall Study|Withdrawal by Subject|0
1109582|NCT02465437|2191101|FG002|Overall Study|Withdrawal by Subject|0
1109583|NCT02465437|2191102|FG003|Overall Study|Withdrawal by Subject|1
1109584|NCT02465437|2191099|FG000|Overall Study|Adverse Event|0
1109585|NCT02465437|2191100|FG001|Overall Study|Adverse Event|1
1109586|NCT02465437|2191101|FG002|Overall Study|Adverse Event|0
1109587|NCT02465437|2191102|FG003|Overall Study|Adverse Event|0
1109588|NCT02465463|2191138|FG000|Overall Study|Lost to Follow-up|2
1109589|NCT02465463|2191139|FG001|Overall Study|Lost to Follow-up|1
1109590|NCT02465463|2191138|FG000|Overall Study|Death|1
1109591|NCT02465463|2191139|FG001|Overall Study|Death|0
1109592|NCT02465463|2191138|FG000|Overall Study|Protocol Violation|1
1109593|NCT02465463|2191139|FG001|Overall Study|Protocol Violation|0
1109594|NCT02465489|2191146|FG000|Overall Study|Adverse Event|5
1109595|NCT02465515|2191160|FG000|Overall Study|Investigator site closed|4
1109596|NCT02465515|2191161|FG001|Overall Study|Investigator site closed|5
1109597|NCT02465515|2191160|FG000|Overall Study|Withdrawal by Subject|74
1109598|NCT02465515|2191161|FG001|Overall Study|Withdrawal by Subject|43
1109599|NCT02465515|2191160|FG000|Overall Study|Physician Decision|8
1109600|NCT02465515|2191161|FG001|Overall Study|Physician Decision|12
1109601|NCT02465515|2191160|FG000|Overall Study|Lost to Follow-up|68
1109602|NCT02465515|2191161|FG001|Overall Study|Lost to Follow-up|51
1109603|NCT02465528|2191171|FG000|Overall Study|Progressive disease|0
1109604|NCT02465528|2191172|FG001|Overall Study|Progressive disease|2
1109605|NCT02465528|2191173|FG002|Overall Study|Progressive disease|9
1109606|NCT02465528|2191174|FG003|Overall Study|Progressive disease|4
1109607|NCT02465528|2191171|FG000|Overall Study|Study terminated by sponsor|1
1109608|NCT02465528|2191172|FG001|Overall Study|Study terminated by sponsor|2
1109609|NCT02465528|2191173|FG002|Overall Study|Study terminated by sponsor|0
1109610|NCT02465528|2191174|FG003|Overall Study|Study terminated by sponsor|0
1109611|NCT02465528|2191171|FG000|Overall Study|Withdrawal by Subject|0
1109612|NCT02465528|2191172|FG001|Overall Study|Withdrawal by Subject|0
1109613|NCT02465528|2191173|FG002|Overall Study|Withdrawal by Subject|2
1109614|NCT02465528|2191174|FG003|Overall Study|Withdrawal by Subject|0
1109615|NCT02465528|2191171|FG000|Overall Study|Adverse Event|0
1109616|NCT02465528|2191172|FG001|Overall Study|Adverse Event|0
1109617|NCT02465528|2191173|FG002|Overall Study|Adverse Event|0
1109618|NCT02465528|2191174|FG003|Overall Study|Adverse Event|1
1109619|NCT02465528|2191171|FG000|Overall Study|Physician Decision|0
1109620|NCT02465528|2191172|FG001|Overall Study|Physician Decision|0
1109621|NCT02465528|2191173|FG002|Overall Study|Physician Decision|1
1109622|NCT02465528|2191174|FG003|Overall Study|Physician Decision|0
1109623|NCT02465567|2191190|FG000|Overall Study|Adverse Event|118
1109624|NCT02465567|2191191|FG001|Overall Study|Adverse Event|113
1109625|NCT02465567|2191192|FG002|Overall Study|Adverse Event|147
1109626|NCT02465567|2191193|FG003|Overall Study|Adverse Event|138
1109627|NCT02465567|2191190|FG000|Overall Study|Lack of Efficacy|103
1109628|NCT02465567|2191191|FG001|Overall Study|Lack of Efficacy|102
1109629|NCT02465567|2191192|FG002|Overall Study|Lack of Efficacy|171
1109630|NCT02465567|2191193|FG003|Overall Study|Lack of Efficacy|135
1109631|NCT02465567|2191190|FG000|Overall Study|Withdrawal by Subject|104
1109632|NCT02465567|2191191|FG001|Overall Study|Withdrawal by Subject|94
1109633|NCT02465567|2191192|FG002|Overall Study|Withdrawal by Subject|123
1109634|NCT02465567|2191193|FG003|Overall Study|Withdrawal by Subject|130
1109635|NCT02465567|2191190|FG000|Overall Study|Physician Decision|23
1109636|NCT02465567|2191191|FG001|Overall Study|Physician Decision|33
1109637|NCT02465567|2191192|FG002|Overall Study|Physician Decision|38
1109638|NCT02465567|2191193|FG003|Overall Study|Physician Decision|28
1109639|NCT02465567|2191190|FG000|Overall Study|Major Protocol Deviation|24
1109640|NCT02465567|2191191|FG001|Overall Study|Major Protocol Deviation|26
1109641|NCT02465567|2191192|FG002|Overall Study|Major Protocol Deviation|22
1109642|NCT02465567|2191193|FG003|Overall Study|Major Protocol Deviation|25
1109643|NCT02465567|2191190|FG000|Overall Study|Lost to Follow-up|25
1109644|NCT02465567|2191191|FG001|Overall Study|Lost to Follow-up|21
1109645|NCT02465567|2191192|FG002|Overall Study|Lost to Follow-up|19
1109646|NCT02465567|2191193|FG003|Overall Study|Lost to Follow-up|15
1109647|NCT02465567|2191190|FG000|Overall Study|Protocol Specified Criteria|20
1109648|NCT02465567|2191191|FG001|Overall Study|Protocol Specified Criteria|10
1109649|NCT02465567|2191192|FG002|Overall Study|Protocol Specified Criteria|9
1109650|NCT02465567|2191193|FG003|Overall Study|Protocol Specified Criteria|12
1109651|NCT02465567|2191190|FG000|Overall Study|Administrative Reasons|12
1109652|NCT02465567|2191191|FG001|Overall Study|Administrative Reasons|9
1109653|NCT02465567|2191192|FG002|Overall Study|Administrative Reasons|11
1109654|NCT02465567|2191193|FG003|Overall Study|Administrative Reasons|5
1109655|NCT02465567|2191190|FG000|Overall Study|Randomized but not treated|1
1109656|NCT02465567|2191191|FG001|Overall Study|Randomized but not treated|5
1109657|NCT02465567|2191192|FG002|Overall Study|Randomized but not treated|4
1109658|NCT02465567|2191193|FG003|Overall Study|Randomized but not treated|5
1109659|NCT02465567|2191190|FG000|Overall Study|enrolled in >1 studies|18
1109660|NCT02465567|2191191|FG001|Overall Study|enrolled in >1 studies|11
1109661|NCT02465567|2191192|FG002|Overall Study|enrolled in >1 studies|19
1109662|NCT02465567|2191193|FG003|Overall Study|enrolled in >1 studies|15
1109663|NCT02465567|2191190|FG000|Overall Study|missing PI Signature|1
1109664|NCT02465567|2191191|FG001|Overall Study|missing PI Signature|0
1109665|NCT02465567|2191192|FG002|Overall Study|missing PI Signature|0
1109666|NCT02465567|2191193|FG003|Overall Study|missing PI Signature|0
1109667|NCT02465866|2191217|FG000|Period 3|Withdrawal by Subject|0
1109668|NCT02465866|2191218|FG001|Period 3|Withdrawal by Subject|1
1109669|NCT02465866|2191219|FG002|Period 3|Withdrawal by Subject|0
1109670|NCT02465866|2191220|FG003|Period 3|Withdrawal by Subject|0
1109671|NCT02465931|2191232|FG000|Overall Study|Lost to Follow-up|9
1109672|NCT02465931|2191233|FG001|Overall Study|Lost to Follow-up|11
1109673|NCT02465931|2191232|FG000|Overall Study|Protocol Violation|1
1109674|NCT02465931|2191233|FG001|Overall Study|Protocol Violation|0
1109675|NCT02465931|2191232|FG000|Overall Study|Withdrawal by Subject|1
1109676|NCT02465931|2191233|FG001|Overall Study|Withdrawal by Subject|0
1109677|NCT02466386|2191264|FG000|Overall Study|Adverse Event|5
1109678|NCT02466386|2191264|FG000|Overall Study|Protocol Violation|2
1109679|NCT02466386|2191264|FG000|Overall Study|Withdrawal by Subject|14
1109680|NCT02466386|2191264|FG000|Overall Study|Lost to Follow-up|5
1109681|NCT02466386|2191264|FG000|Overall Study|Lack of Efficacy|8
1109682|NCT02466386|2191264|FG000|Overall Study|Other|10
1109683|NCT02466399|2191270|FG000|Overall Study|Adverse Event|1
1109684|NCT02466399|2191271|FG001|Overall Study|Adverse Event|0
1109685|NCT02466399|2191270|FG000|Overall Study|Early exit due to family emergency|1
1109686|NCT02466399|2191271|FG001|Overall Study|Early exit due to family emergency|0
1109687|NCT02466425|2191289|FG000|Overall Study|Adverse Event|3
1109688|NCT02466425|2191290|FG001|Overall Study|Adverse Event|11
1109689|NCT02466425|2191289|FG000|Overall Study|Lack of Efficacy|4
1109690|NCT02466425|2191290|FG001|Overall Study|Lack of Efficacy|1
1109691|NCT02466425|2191289|FG000|Overall Study|Lost to Follow-up|3
1109692|NCT02466425|2191290|FG001|Overall Study|Lost to Follow-up|0
1109693|NCT02466425|2191289|FG000|Overall Study|Protocol Violation|1
1109694|NCT02466425|2191290|FG001|Overall Study|Protocol Violation|0
1109695|NCT02466425|2191289|FG000|Overall Study|Withdrawal by Subject|0
1109696|NCT02466425|2191290|FG001|Overall Study|Withdrawal by Subject|1
1109697|NCT02466425|2191289|FG000|Overall Study|Other|1
1109698|NCT02466425|2191290|FG001|Overall Study|Other|3
1109699|NCT02466425|2191289|FG000|Overall Study|Withdrawal by Parent/Guardian|2
1109700|NCT02466425|2191290|FG001|Overall Study|Withdrawal by Parent/Guardian|0
1109701|NCT02466516|2191301|FG000|Overall Study|Adverse Event|1
1109702|NCT02466516|2191302|FG001|Overall Study|Adverse Event|1
1109703|NCT02466516|2191303|FG002|Overall Study|Adverse Event|0
1109704|NCT02466516|2191304|FG003|Overall Study|Adverse Event|0
1109705|NCT02466516|2191305|FG004|Overall Study|Adverse Event|0
1109706|NCT02466516|2191301|FG000|Overall Study|Withdrew Consent|1
1109707|NCT02466516|2191302|FG001|Overall Study|Withdrew Consent|0
1109708|NCT02466516|2191303|FG002|Overall Study|Withdrew Consent|0
1109709|NCT02466516|2191304|FG003|Overall Study|Withdrew Consent|0
1109710|NCT02466516|2191305|FG004|Overall Study|Withdrew Consent|0
1109711|NCT02466516|2191301|FG000|Overall Study|Lost to Follow-up|2
1109712|NCT02466516|2191302|FG001|Overall Study|Lost to Follow-up|0
1109713|NCT02466516|2191303|FG002|Overall Study|Lost to Follow-up|1
1109714|NCT02466516|2191304|FG003|Overall Study|Lost to Follow-up|0
1109715|NCT02466516|2191305|FG004|Overall Study|Lost to Follow-up|0
1109716|NCT02466555|2191317|FG000|Overall Study|Lost to Follow-up|2
1109717|NCT02466659|2191340|FG000|Overall Study|Lost to Follow-up|5
1109718|NCT02466659|2191341|FG001|Overall Study|Lost to Follow-up|2
1109719|NCT02467192|2191380|FG000|Overall Study|Death|1
1109720|NCT02467192|2191380|FG000|Overall Study|revealed to have pneumonia before|2
1109757|NCT02468414|2191498|FG000|Overall Study|Early Study Termination by Sponsor|1
1109758|NCT02468414|2191499|FG001|Overall Study|Early Study Termination by Sponsor|0
1109759|NCT02468414|2191498|FG000|Overall Study|Poor in-vitro secreting TARGTs|1
1109760|NCT02468414|2191499|FG001|Overall Study|Poor in-vitro secreting TARGTs|0
1109761|NCT02468414|2191498|FG000|Overall Study|Screen Failure|1
1109762|NCT02468414|2191499|FG001|Overall Study|Screen Failure|0
1109763|NCT02468557|2191505|FG000|Overall Study|Adverse Event|1
1109764|NCT02468557|2191505|FG000|Overall Study|Death|1
1109765|NCT02468557|2191505|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10
1109766|NCT02468557|2191505|FG000|Overall Study|All Enrolled but Never Dosed|4
1109767|NCT02468648|2191522|FG000|Overall Study|Death|1
1109768|NCT02468674|2191535|FG000|Overall Study|Adverse Event|0
1109769|NCT02468674|2191536|FG001|Overall Study|Adverse Event|0
1109770|NCT02468674|2191537|FG002|Overall Study|Adverse Event|0
1109771|NCT02468674|2191538|FG003|Overall Study|Adverse Event|1
1109772|NCT02468674|2191539|FG004|Overall Study|Adverse Event|0
1109773|NCT02468674|2191540|FG005|Overall Study|Adverse Event|1
1109774|NCT02468674|2191541|FG006|Overall Study|Adverse Event|0
1109775|NCT02468674|2191542|FG007|Overall Study|Adverse Event|0
1109776|NCT02468674|2191543|FG008|Overall Study|Adverse Event|0
1109777|NCT02468674|2191535|FG000|Overall Study|Lost to Follow-up|1
1109778|NCT02468674|2191536|FG001|Overall Study|Lost to Follow-up|0
1109779|NCT02468674|2191537|FG002|Overall Study|Lost to Follow-up|0
1109780|NCT02468674|2191538|FG003|Overall Study|Lost to Follow-up|0
1109781|NCT02468674|2191539|FG004|Overall Study|Lost to Follow-up|0
1109782|NCT02468674|2191540|FG005|Overall Study|Lost to Follow-up|0
1109783|NCT02468674|2191541|FG006|Overall Study|Lost to Follow-up|0
1109784|NCT02468674|2191542|FG007|Overall Study|Lost to Follow-up|1
1109785|NCT02468674|2191543|FG008|Overall Study|Lost to Follow-up|1
1109786|NCT02468674|2191535|FG000|Overall Study|Physician Decision|0
1109787|NCT02468674|2191536|FG001|Overall Study|Physician Decision|0
1109788|NCT02468674|2191537|FG002|Overall Study|Physician Decision|0
1109789|NCT02468674|2191538|FG003|Overall Study|Physician Decision|0
1109790|NCT02468674|2191539|FG004|Overall Study|Physician Decision|0
1109791|NCT02468674|2191540|FG005|Overall Study|Physician Decision|0
1109792|NCT02468674|2191541|FG006|Overall Study|Physician Decision|1
1109793|NCT02468674|2191542|FG007|Overall Study|Physician Decision|0
1109794|NCT02468674|2191543|FG008|Overall Study|Physician Decision|0
1109795|NCT02468674|2191535|FG000|Overall Study|Patient/Guardian Decision|0
1109796|NCT02468674|2191536|FG001|Overall Study|Patient/Guardian Decision|0
1109797|NCT02468674|2191537|FG002|Overall Study|Patient/Guardian Decision|0
1109798|NCT02468674|2191538|FG003|Overall Study|Patient/Guardian Decision|0
1109799|NCT02468674|2191539|FG004|Overall Study|Patient/Guardian Decision|1
1109800|NCT02468674|2191540|FG005|Overall Study|Patient/Guardian Decision|0
1109801|NCT02468674|2191541|FG006|Overall Study|Patient/Guardian Decision|0
1109802|NCT02468674|2191542|FG007|Overall Study|Patient/Guardian Decision|2
1109803|NCT02468674|2191543|FG008|Overall Study|Patient/Guardian Decision|1
1109804|NCT02468674|2191535|FG000|Overall Study|Protocol Deviation|0
1109805|NCT02468674|2191536|FG001|Overall Study|Protocol Deviation|0
1109806|NCT02468674|2191537|FG002|Overall Study|Protocol Deviation|0
1109807|NCT02468674|2191538|FG003|Overall Study|Protocol Deviation|0
1109808|NCT02468674|2191539|FG004|Overall Study|Protocol Deviation|0
1109809|NCT02468674|2191540|FG005|Overall Study|Protocol Deviation|0
1109810|NCT02468674|2191541|FG006|Overall Study|Protocol Deviation|0
1109811|NCT02468674|2191542|FG007|Overall Study|Protocol Deviation|1
1109812|NCT02468674|2191543|FG008|Overall Study|Protocol Deviation|1
1109813|NCT02468934|2191585|FG000|Overall Study|Withdrawal by Subject|4
1109814|NCT02468934|2191585|FG000|Overall Study|Screen Failure|3
1109815|NCT02469038|2191593|FG000|Overall Study|Physician Decision|4
1109816|NCT02469038|2191594|FG001|Overall Study|Physician Decision|5
1109817|NCT02469064|2191602|FG000|Overall Study|Request not to receive intervention.|1
1109818|NCT02469064|2191603|FG001|Overall Study|Request not to receive intervention.|3
1109819|NCT02469077|2191611|FG000|Post Randomization/Intervention Period|Scheduling issues|3
1109820|NCT02469077|2191612|FG001|Post Randomization/Intervention Period|Scheduling issues|2
1109821|NCT02469077|2191611|FG000|Post Randomization/Intervention Period|Relocated|1
1109822|NCT02469077|2191612|FG001|Post Randomization/Intervention Period|Relocated|1
1109823|NCT02469077|2191611|FG000|Post Randomization/Intervention Period|Conflicting health issues|0
1109824|NCT02469077|2191612|FG001|Post Randomization/Intervention Period|Conflicting health issues|1
1109825|NCT02469077|2191611|FG000|Post Intervention /Followup|Withdrawal by Subject|2
1109826|NCT02469077|2191612|FG001|Post Intervention /Followup|Withdrawal by Subject|1
1109827|NCT02469090|2191624|FG000|Period 1: Dose Titration Phase|Adverse Event|12
1109828|NCT02469090|2191625|FG001|Period 1: Dose Titration Phase|Adverse Event|0
1109829|NCT02469090|2191626|FG002|Period 1: Dose Titration Phase|Adverse Event|0
1109830|NCT02469090|2191624|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8
1109831|NCT02469090|2191625|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0
1109832|NCT02469090|2191626|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0
1109833|NCT02469090|2191624|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1
1109834|NCT02469090|2191625|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0
1109835|NCT02469090|2191626|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0
1109836|NCT02469090|2191624|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11
1109837|NCT02469090|2191625|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0
1109838|NCT02469090|2191626|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0
1109839|NCT02469090|2191624|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0
1109840|NCT02469090|2191625|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5
1109841|NCT02469090|2191626|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15
1109842|NCT02469090|2191624|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0
1109843|NCT02469090|2191625|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3
1109844|NCT02469090|2191626|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4
1109845|NCT02469090|2191624|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
1109846|NCT02469090|2191625|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1
1109847|NCT02469090|2191626|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
1109848|NCT02469090|2191624|FG000|Period 2: Maintenance Treatment Phase|Death|0
1109849|NCT02469090|2191625|FG001|Period 2: Maintenance Treatment Phase|Death|0
1109850|NCT02469090|2191626|FG002|Period 2: Maintenance Treatment Phase|Death|1
896544|NCT00705224|1868266|FG000|Overall Study|Lost to Follow-up|5
896545|NCT00705250|1868273|FG000|Overall Study|Withdrawal by Subject|1
896546|NCT00705250|1868273|FG000|Overall Study|Patient died in car accident|1
896547|NCT00705263|1868277|FG000|Overall Study|Withdrawal by Subject|2
896548|NCT00705289|1868281|FG000|Overall Study|Subject or treating physician's choice|131
896549|NCT00705341|1868304|FG000|Phase 2: Trial|Withdrawal by Subject|0
896550|NCT00705341|1868305|FG001|Phase 2: Trial|Withdrawal by Subject|0
896551|NCT00705341|1868306|FG002|Phase 2: Trial|Withdrawal by Subject|6
896552|NCT00705341|1868307|FG003|Phase 2: Trial|Withdrawal by Subject|4
896553|NCT00705341|1868304|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0
896554|NCT00705341|1868305|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0
896555|NCT00705341|1868306|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1
896556|NCT00705341|1868307|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0
896557|NCT00705367|1868317|FG000|Long-term Extension Period|Adverse Event|2
896558|NCT00705367|1868318|FG001|Long-term Extension Period|Adverse Event|0
896559|NCT00705367|1868317|FG000|Long-term Extension Period|Withdrawal by Subject|2
896560|NCT00705367|1868318|FG001|Long-term Extension Period|Withdrawal by Subject|0
896561|NCT00705367|1868317|FG000|Long-term Extension Period|Lack of Efficacy|1
896562|NCT00705367|1868318|FG001|Long-term Extension Period|Lack of Efficacy|0
896563|NCT00705367|1868317|FG000|Long-term Extension Period|No longer met study criteria|1
896564|NCT00705367|1868318|FG001|Long-term Extension Period|No longer met study criteria|0
896565|NCT00705367|1868317|FG000|Long-term Extension Period|Administrative reason by sponsor|3
896566|NCT00705367|1868318|FG001|Long-term Extension Period|Administrative reason by sponsor|0
896567|NCT00705406|1868328|FG000|Overall Study|Lost to Follow-up|3
1109851|NCT02469168|2191639|FG000|Overall Study|Trial closed|1
1109852|NCT02469168|2191640|FG001|Overall Study|Trial closed|0
1109853|NCT02469246|2191648|FG000|Double-Blind Phase|Randomized and Never Treated|5
1109854|NCT02469246|2191649|FG001|Double-Blind Phase|Randomized and Never Treated|6
1109855|NCT02469246|2191648|FG000|Double-Blind Phase|Adverse Event|12
1109856|NCT02469246|2191649|FG001|Double-Blind Phase|Adverse Event|9
1109857|NCT02469246|2191648|FG000|Double-Blind Phase|Death|2
1109858|NCT02469246|2191649|FG001|Double-Blind Phase|Death|0
1109859|NCT02469246|2191648|FG000|Double-Blind Phase|Lack of Efficacy|2
1109860|NCT02469246|2191649|FG001|Double-Blind Phase|Lack of Efficacy|1
1109861|NCT02469246|2191648|FG000|Double-Blind Phase|Investigator's Discretion|8
1109862|NCT02469246|2191649|FG001|Double-Blind Phase|Investigator's Discretion|8
1109863|NCT02469246|2191648|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
1109864|NCT02469246|2191649|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
1109865|NCT02469246|2191648|FG000|Double-Blind Phase|Protocol Violation|1
1109866|NCT02469246|2191649|FG001|Double-Blind Phase|Protocol Violation|1
1109867|NCT02469246|2191648|FG000|Double-Blind Phase|Withdrew Consent|25
1109868|NCT02469246|2191649|FG001|Double-Blind Phase|Withdrew Consent|25
1109869|NCT02469246|2191648|FG000|Double-Blind Phase|Lost to Follow-up|9
1109870|NCT02469246|2191649|FG001|Double-Blind Phase|Lost to Follow-up|5
1109871|NCT02469298|2191661|FG000|Overall Study|Protocol Violation|0
1109872|NCT02469298|2191662|FG001|Overall Study|Protocol Violation|1
1109873|NCT02469298|2191663|FG002|Overall Study|Protocol Violation|1
1109874|NCT02469298|2191664|FG003|Overall Study|Protocol Violation|0
1109875|NCT02469298|2191661|FG000|Overall Study|Lost to Follow-up|1
1109876|NCT02469298|2191662|FG001|Overall Study|Lost to Follow-up|0
1109877|NCT02469298|2191663|FG002|Overall Study|Lost to Follow-up|1
1109878|NCT02469298|2191664|FG003|Overall Study|Lost to Follow-up|0
1109879|NCT02469298|2191661|FG000|Overall Study|Physician Decision|0
1109880|NCT02469298|2191662|FG001|Overall Study|Physician Decision|0
1109881|NCT02469298|2191663|FG002|Overall Study|Physician Decision|0
1109882|NCT02469298|2191664|FG003|Overall Study|Physician Decision|1
1109883|NCT02469298|2191661|FG000|Overall Study|Withdrawal by Subject|0
1109884|NCT02469298|2191662|FG001|Overall Study|Withdrawal by Subject|0
1109885|NCT02469298|2191663|FG002|Overall Study|Withdrawal by Subject|0
1109886|NCT02469298|2191664|FG003|Overall Study|Withdrawal by Subject|1
1109887|NCT02469610|2191701|FG000|Overall Study|Death|1
1109888|NCT02469610|2191702|FG001|Overall Study|Death|0
1109889|NCT02469610|2191701|FG000|Overall Study|Lost to Follow-up|1
1109890|NCT02469610|2191702|FG001|Overall Study|Lost to Follow-up|0
1109891|NCT02469610|2191701|FG000|Overall Study|exclusion criteria|2
1109892|NCT02469610|2191702|FG001|Overall Study|exclusion criteria|1
1109893|NCT02469623|2191708|FG000|Overall Study|Not consented for long-term follow-up|4
1109894|NCT02469623|2191708|FG000|Overall Study|Lost to Follow-up|4
1109895|NCT02469623|2191708|FG000|Overall Study|Withdrawal by Subject|2
1109896|NCT02469623|2191708|FG000|Overall Study|Death|3
1109897|NCT02469857|2191728|FG000|Overall Study|Death|24
1109898|NCT02469857|2191729|FG001|Overall Study|Death|29
1109899|NCT02469857|2191728|FG000|Overall Study|Discontinuation|1
1109900|NCT02469857|2191729|FG001|Overall Study|Discontinuation|3
1109901|NCT02469896|2191751|FG000|Overall Study|Withdrawal by Subject|2
1109902|NCT02469896|2191752|FG001|Overall Study|Withdrawal by Subject|0
1109903|NCT02469961|2191764|FG000|Overall Study|Physician Decision|4
1109904|NCT02469961|2191765|FG001|Overall Study|Physician Decision|1
1109905|NCT02470091|2191778|FG000|Overall Study|Withdrawal by Subject|1
1109906|NCT02470091|2191779|FG001|Overall Study|Withdrawal by Subject|0
1109907|NCT02470091|2191778|FG000|Overall Study|Ineligible|0
1109908|NCT02470091|2191779|FG001|Overall Study|Ineligible|2
1109909|NCT02470403|2191830|FG000|Overall Study|Adverse Event|1
1109910|NCT02470403|2191831|FG001|Overall Study|Adverse Event|0
1109911|NCT02470403|2191832|FG002|Overall Study|Adverse Event|0
1109912|NCT02470403|2191833|FG003|Overall Study|Adverse Event|0
1109913|NCT02470403|2191834|FG004|Overall Study|Adverse Event|0
1109914|NCT02470403|2191830|FG000|Overall Study|Lost to Follow-up|0
1109915|NCT02470403|2191831|FG001|Overall Study|Lost to Follow-up|1
1109916|NCT02470403|2191832|FG002|Overall Study|Lost to Follow-up|0
1109917|NCT02470403|2191833|FG003|Overall Study|Lost to Follow-up|0
1109918|NCT02470403|2191834|FG004|Overall Study|Lost to Follow-up|0
1109919|NCT02470403|2191830|FG000|Overall Study|Subject/guardian decision|1
1109920|NCT02470403|2191831|FG001|Overall Study|Subject/guardian decision|0
1109921|NCT02470403|2191832|FG002|Overall Study|Subject/guardian decision|0
1109922|NCT02470403|2191833|FG003|Overall Study|Subject/guardian decision|4
1109923|NCT02470403|2191834|FG004|Overall Study|Subject/guardian decision|0
1109924|NCT02470429|2191851|FG000|Overall Study|Adverse Event|1
1109925|NCT02470429|2191852|FG001|Overall Study|Adverse Event|0
1109926|NCT02470429|2191851|FG000|Overall Study|Withdrawal by Subject|1
1109927|NCT02470429|2191852|FG001|Overall Study|Withdrawal by Subject|0
1109928|NCT02470585|2191866|FG000|Overall Study|Death|82
1109929|NCT02470585|2191867|FG001|Overall Study|Death|87
1109930|NCT02470585|2191868|FG002|Overall Study|Death|86
1109931|NCT02470585|2191866|FG000|Overall Study|Withdrawal by Subject|19
1109932|NCT02470585|2191867|FG001|Overall Study|Withdrawal by Subject|21
1109933|NCT02470585|2191868|FG002|Overall Study|Withdrawal by Subject|29
1109934|NCT02470585|2191866|FG000|Overall Study|Lost to Follow-up|2
1109935|NCT02470585|2191867|FG001|Overall Study|Lost to Follow-up|5
1109936|NCT02470585|2191868|FG002|Overall Study|Lost to Follow-up|4
1109937|NCT02470585|2191866|FG000|Overall Study|Other|4
1109938|NCT02470585|2191867|FG001|Overall Study|Other|4
1109939|NCT02470585|2191868|FG002|Overall Study|Other|6
1109940|NCT02470806|2191894|FG000|Overall Study|Lost to Follow-up|1
1109941|NCT02470806|2191895|FG001|Overall Study|Lost to Follow-up|1
1109942|NCT02470806|2191894|FG000|Overall Study|Adverse Event|5
1109943|NCT02470806|2191895|FG001|Overall Study|Adverse Event|2
1109944|NCT02470806|2191894|FG000|Overall Study|Protocol Violation|4
1109945|NCT02470806|2191895|FG001|Overall Study|Protocol Violation|11
1109946|NCT02470806|2191894|FG000|Overall Study|Physician Decision|0
1109947|NCT02470806|2191895|FG001|Overall Study|Physician Decision|3
1109948|NCT02470806|2191894|FG000|Overall Study|Withdrawal by Subject|3
1109949|NCT02470806|2191895|FG001|Overall Study|Withdrawal by Subject|10
1109950|NCT02470806|2191894|FG000|Overall Study|Lack of Efficacy|5
1109951|NCT02470806|2191895|FG001|Overall Study|Lack of Efficacy|15
1109952|NCT02471014|2191919|FG000|Overall Study|Lost to Follow-up|2
1109953|NCT02471014|2191920|FG001|Overall Study|Lost to Follow-up|2
1110075|NCT02471183|2191956|FG000|Main Treatment Period|Adverse Event|1
1110076|NCT02471183|2191956|FG000|Main Treatment Period|Withdrawal by Subject|1
1110077|NCT02471183|2191956|FG000|Extended Treatment Period|Lack of Efficacy|1
1110078|NCT02471404|2191971|FG000|Overall Study|Adverse Event|7
1110079|NCT02471404|2191972|FG001|Overall Study|Adverse Event|1
1110080|NCT02471404|2191973|FG002|Overall Study|Adverse Event|2
1110081|NCT02471404|2191971|FG000|Overall Study|Developed Study Withdrawal Criteria|4
1110082|NCT02471404|2191972|FG001|Overall Study|Developed Study Withdrawal Criteria|1
1110083|NCT02471404|2191973|FG002|Overall Study|Developed Study Withdrawal Criteria|2
1110084|NCT02471404|2191971|FG000|Overall Study|Failure to Meet Randomization Criteria|2
1110085|NCT02471404|2191972|FG001|Overall Study|Failure to Meet Randomization Criteria|0
1110086|NCT02471404|2191973|FG002|Overall Study|Failure to Meet Randomization Criteria|1
1110087|NCT02471404|2191971|FG000|Overall Study|Lost to Follow-up|1
1110088|NCT02471404|2191972|FG001|Overall Study|Lost to Follow-up|1
1110089|NCT02471404|2191973|FG002|Overall Study|Lost to Follow-up|3
1110090|NCT02471404|2191971|FG000|Overall Study|Protocol Violation|1
1110091|NCT02471404|2191972|FG001|Overall Study|Protocol Violation|0
1110092|NCT02471404|2191973|FG002|Overall Study|Protocol Violation|0
1110093|NCT02471404|2191971|FG000|Overall Study|Withdrawal by Subject|8
1110094|NCT02471404|2191972|FG001|Overall Study|Withdrawal by Subject|4
1110095|NCT02471404|2191973|FG002|Overall Study|Withdrawal by Subject|5
1110096|NCT02471404|2191971|FG000|Overall Study|Other reasons not specified|10
1110097|NCT02471404|2191972|FG001|Overall Study|Other reasons not specified|7
1110098|NCT02471404|2191973|FG002|Overall Study|Other reasons not specified|12
1110099|NCT02471586|2191993|FG000|Overall Study|Lost to Follow-up|3
1110100|NCT02471586|2191994|FG001|Overall Study|Lost to Follow-up|8
1110101|NCT02471586|2191995|FG002|Overall Study|Lost to Follow-up|4
1110102|NCT02471586|2191993|FG000|Overall Study|Death|2
1110103|NCT02471586|2191994|FG001|Overall Study|Death|2
1110104|NCT02471586|2191995|FG002|Overall Study|Death|0
1110105|NCT02471612|2192005|FG000|Overall Study|Lost to Follow-up|2
1110106|NCT02471716|2192036|FG000|Overall Study|Withdrawal by Subject|0
1110107|NCT02471716|2192037|FG001|Overall Study|Withdrawal by Subject|1
1110108|NCT02471716|2192038|FG002|Overall Study|Withdrawal by Subject|0
1110109|NCT02471716|2192039|FG003|Overall Study|Withdrawal by Subject|2
1110110|NCT02471716|2192040|FG004|Overall Study|Withdrawal by Subject|5
1110111|NCT02471716|2192036|FG000|Overall Study|Study Terminiated by sponsor|0
1110112|NCT02471716|2192037|FG001|Overall Study|Study Terminiated by sponsor|0
1110113|NCT02471716|2192038|FG002|Overall Study|Study Terminiated by sponsor|0
1110114|NCT02471716|2192039|FG003|Overall Study|Study Terminiated by sponsor|1
1110115|NCT02471716|2192040|FG004|Overall Study|Study Terminiated by sponsor|0
1110116|NCT02471716|2192036|FG000|Overall Study|Lost to Follow-up|0
1110117|NCT02471716|2192037|FG001|Overall Study|Lost to Follow-up|0
1110118|NCT02471716|2192038|FG002|Overall Study|Lost to Follow-up|0
1110119|NCT02471716|2192039|FG003|Overall Study|Lost to Follow-up|3
1110120|NCT02471716|2192040|FG004|Overall Study|Lost to Follow-up|2
1110121|NCT02471716|2192036|FG000|Overall Study|Death|0
1110122|NCT02471716|2192037|FG001|Overall Study|Death|0
1110123|NCT02471716|2192038|FG002|Overall Study|Death|0
1110124|NCT02471716|2192039|FG003|Overall Study|Death|1
1110125|NCT02471716|2192040|FG004|Overall Study|Death|0
1110126|NCT02471716|2192036|FG000|Overall Study|Other|0
1110127|NCT02471716|2192037|FG001|Overall Study|Other|0
1110128|NCT02471716|2192038|FG002|Overall Study|Other|0
1110129|NCT02471716|2192039|FG003|Overall Study|Other|8
1110130|NCT02471716|2192040|FG004|Overall Study|Other|9
1110131|NCT02471755|2192056|FG000|Overall Study|Withdrawal by Subject|1
1110132|NCT02471755|2192057|FG001|Overall Study|Withdrawal by Subject|0
1110133|NCT02471755|2192056|FG000|Overall Study|Lost to Follow-up|0
1110134|NCT02471755|2192057|FG001|Overall Study|Lost to Follow-up|1
1110135|NCT02472145|2192066|FG000|Overall Study|Death|10
1110136|NCT02472145|2192067|FG001|Overall Study|Death|101
1110137|NCT02472145|2192068|FG002|Overall Study|Death|99
1110138|NCT02472145|2192066|FG000|Overall Study|Lost to Follow-up|0
1110139|NCT02472145|2192067|FG001|Overall Study|Lost to Follow-up|1
1110140|NCT02472145|2192068|FG002|Overall Study|Lost to Follow-up|0
1110141|NCT02472145|2192066|FG000|Overall Study|Withdrawal by Subject|0
1110142|NCT02472145|2192067|FG001|Overall Study|Withdrawal by Subject|9
1110143|NCT02472145|2192068|FG002|Overall Study|Withdrawal by Subject|13
1110144|NCT02472145|2192066|FG000|Overall Study|Sponsor decision|0
1110145|NCT02472145|2192067|FG001|Overall Study|Sponsor decision|3
1110146|NCT02472145|2192068|FG002|Overall Study|Sponsor decision|2
1110147|NCT02472145|2192066|FG000|Overall Study|Other|0
1110148|NCT02472145|2192067|FG001|Overall Study|Other|45
1110149|NCT02472145|2192068|FG002|Overall Study|Other|43
1110150|NCT02472353|2192108|FG000|Overall Study|Lost to Follow-up|1
1110151|NCT02472353|2192109|FG001|Overall Study|Lost to Follow-up|1
1110152|NCT02472353|2192108|FG000|Overall Study|Withdrawal by Subject|2
1110153|NCT02472353|2192109|FG001|Overall Study|Withdrawal by Subject|1
1110154|NCT02472353|2192108|FG000|Overall Study|Study Termination|1
1110155|NCT02472353|2192109|FG001|Overall Study|Study Termination|4
1110156|NCT02472366|2192117|FG000|Overall Study|Lost to Follow-up|1
1110157|NCT02472366|2192118|FG001|Overall Study|Lost to Follow-up|0
1110158|NCT02472405|2192124|FG000|Overall Study|Lost to Follow-up|9
1110159|NCT02472405|2192124|FG000|Overall Study|Adverse Event|1
1110160|NCT02472652|2192150|FG000|Overall Study|Lost to Follow-up|1
1110161|NCT02472756|2192163|FG000|Induction (Approximately 6 Months)|Adverse Event|1
1110162|NCT02472756|2192163|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
1110163|NCT02472756|2192163|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7
1110164|NCT02472756|2192163|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2
1110165|NCT02472756|2192163|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1
1110166|NCT02472795|2192172|FG000|Overall Study|Adverse Event|0
1110167|NCT02472795|2192173|FG001|Overall Study|Adverse Event|1
1110168|NCT02472795|2192174|FG002|Overall Study|Adverse Event|0
1110169|NCT02472795|2192175|FG003|Overall Study|Adverse Event|0
1110170|NCT02472795|2192176|FG004|Overall Study|Adverse Event|2
1110171|NCT02472795|2192172|FG000|Overall Study|Withdrawal by Subject|0
1110172|NCT02472795|2192173|FG001|Overall Study|Withdrawal by Subject|0
1110173|NCT02472795|2192174|FG002|Overall Study|Withdrawal by Subject|0
1110174|NCT02472795|2192175|FG003|Overall Study|Withdrawal by Subject|0
1110175|NCT02472795|2192176|FG004|Overall Study|Withdrawal by Subject|1
1110176|NCT02472847|2192190|FG000|Overall Study|Withdrawal by Subject|1
1110177|NCT02472847|2192191|FG001|Overall Study|Withdrawal by Subject|5
1110178|NCT02472886|2192200|FG000|Overall Study|Lack of Efficacy|0
1110179|NCT02472886|2192201|FG001|Overall Study|Lack of Efficacy|2
1110180|NCT02472886|2192202|FG002|Overall Study|Lack of Efficacy|1
1110181|NCT02472964|2192217|FG000|Part 1 (up to Week 24)|Adverse Event|2
1110182|NCT02472964|2192218|FG001|Part 1 (up to Week 24)|Adverse Event|4
1110183|NCT02472964|2192217|FG000|Part 1 (up to Week 24)|disease progression|58
1110184|NCT02472964|2192218|FG001|Part 1 (up to Week 24)|disease progression|47
1110185|NCT02472964|2192217|FG000|Part 1 (up to Week 24)|Death|3
1110186|NCT02472964|2192218|FG001|Part 1 (up to Week 24)|Death|6
1110187|NCT02472964|2192217|FG000|Part 1 (up to Week 24)|Physician Decision|3
1110188|NCT02472964|2192218|FG001|Part 1 (up to Week 24)|Physician Decision|1
1110189|NCT02472964|2192217|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0
1110190|NCT02472964|2192218|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1
1110191|NCT02472964|2192217|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7
1110192|NCT02472964|2192218|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2
1110193|NCT02472964|2192217|FG000|Part 1 (up to Week 24)|Other|2
1110194|NCT02472964|2192218|FG001|Part 1 (up to Week 24)|Other|1
1110195|NCT02472964|2192217|FG000|Part 2 (Week 24-week 48)|Adverse Event|4
1110196|NCT02472964|2192218|FG001|Part 2 (Week 24-week 48)|Adverse Event|2
1110197|NCT02472964|2192217|FG000|Part 2 (Week 24-week 48)|Disease Progression|52
1110198|NCT02472964|2192218|FG001|Part 2 (Week 24-week 48)|Disease Progression|56
1110199|NCT02472964|2192217|FG000|Part 2 (Week 24-week 48)|Death|0
1110200|NCT02472964|2192218|FG001|Part 2 (Week 24-week 48)|Death|1
1110201|NCT02472964|2192217|FG000|Part 2 (Week 24-week 48)|Physician Decision|1
1110202|NCT02472964|2192218|FG001|Part 2 (Week 24-week 48)|Physician Decision|1
1110203|NCT02472964|2192217|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2
1110204|NCT02472964|2192218|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1
1110205|NCT02472964|2192217|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
1110206|NCT02472964|2192218|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
1110207|NCT02472964|2192217|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3
1110208|NCT02472964|2192218|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1
1110209|NCT02472977|2192227|FG000|Overall Study|Disease progression|4
1110210|NCT02472977|2192228|FG001|Overall Study|Disease progression|25
1110211|NCT02472977|2192229|FG002|Overall Study|Disease progression|6
1110212|NCT02472977|2192227|FG000|Overall Study|Withdrawal by Subject|0
1110213|NCT02472977|2192228|FG001|Overall Study|Withdrawal by Subject|1
1110214|NCT02472977|2192229|FG002|Overall Study|Withdrawal by Subject|0
1110215|NCT02472977|2192227|FG000|Overall Study|Study drug toxicity|2
1110216|NCT02472977|2192228|FG001|Overall Study|Study drug toxicity|0
1110217|NCT02472977|2192229|FG002|Overall Study|Study drug toxicity|2
1110218|NCT02472977|2192227|FG000|Overall Study|Subject request to discontinue treatment|0
1110219|NCT02472977|2192228|FG001|Overall Study|Subject request to discontinue treatment|1
1110220|NCT02472977|2192229|FG002|Overall Study|Subject request to discontinue treatment|0
1110221|NCT02473250|2192237|FG000|Overall Study|Lost to Follow-up|10
1110222|NCT02473250|2192237|FG000|Overall Study|Physician Decision|5
1110223|NCT02473250|2192237|FG000|Overall Study|Did not tolerate medication washout|3
1110224|NCT02473250|2192237|FG000|Overall Study|Antidepressant effect of divalproex|2
1110225|NCT02473289|2192244|FG000|Overall Study|Adverse Event|2
1110226|NCT02473289|2192245|FG001|Overall Study|Adverse Event|3
1110227|NCT02473289|2192244|FG000|Overall Study|Lost to Follow-up|1
1110228|NCT02473289|2192245|FG001|Overall Study|Lost to Follow-up|1
1110229|NCT02473289|2192244|FG000|Overall Study|Protocol Violation|0
1110230|NCT02473289|2192245|FG001|Overall Study|Protocol Violation|1
1110231|NCT02473289|2192244|FG000|Overall Study|Withdrawal of consent|6
1110232|NCT02473289|2192245|FG001|Overall Study|Withdrawal of consent|7
1110233|NCT02473289|2192244|FG000|Overall Study|Treatment Unblinded + Adverse event|0
1110234|NCT02473289|2192245|FG001|Overall Study|Treatment Unblinded + Adverse event|1
1110235|NCT02473289|2192244|FG000|Overall Study|Other|2
1110236|NCT02473289|2192245|FG001|Overall Study|Other|0
1110237|NCT02473367|2192251|FG000|Wait 1|Withdrawal by Subject|1
1110238|NCT02473367|2192251|FG000|Period 4|Lost to Follow-up|1
1110239|NCT02473393|2192265|FG000|Overall Study|Adverse Event|0
1110240|NCT02473393|2192266|FG001|Overall Study|Adverse Event|0
1110241|NCT02473393|2192267|FG002|Overall Study|Adverse Event|1
1110242|NCT02473393|2192268|FG003|Overall Study|Adverse Event|0
1110243|NCT02473393|2192265|FG000|Overall Study|Withdrawal by Subject|0
1110244|NCT02473393|2192266|FG001|Overall Study|Withdrawal by Subject|0
1110245|NCT02473393|2192267|FG002|Overall Study|Withdrawal by Subject|1
1110246|NCT02473393|2192268|FG003|Overall Study|Withdrawal by Subject|1
1110247|NCT02473471|2192278|FG000|Overall Study|poor oral hygiene|2
1110248|NCT02473471|2192278|FG000|Overall Study|Lost to Follow-up|1
1110249|NCT02473510|2192290|FG000|Overall Study|Lost to Follow-up|1
1110250|NCT02473510|2192291|FG001|Overall Study|Lost to Follow-up|2
1110251|NCT02473614|2192297|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1
1110252|NCT02473614|2192298|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0
1110253|NCT02473640|2192305|FG000|Treatment Period 1|Adverse Event|1
1110254|NCT02473913|2192333|FG000|Overall Study|Lost to Follow-up|3
1110255|NCT02473913|2192334|FG001|Overall Study|Lost to Follow-up|3
1110256|NCT02473952|2192342|FG000|Overall Study|Adverse Event|2
1110257|NCT02473952|2192343|FG001|Overall Study|Adverse Event|2
1110258|NCT02473952|2192342|FG000|Overall Study|Withdrawal by Subject|0
1110259|NCT02473952|2192343|FG001|Overall Study|Withdrawal by Subject|6
1110260|NCT02473965|2192351|FG000|Overall Study|Adverse Event|6
1110261|NCT02473965|2192352|FG001|Overall Study|Adverse Event|4
1110262|NCT02473965|2192351|FG000|Overall Study|MG worsening|4
1110263|NCT02473965|2192352|FG001|Overall Study|MG worsening|1
1110264|NCT02473965|2192351|FG000|Overall Study|Withdrawal by Subject|2
1110265|NCT02473965|2192352|FG001|Overall Study|Withdrawal by Subject|3
1110266|NCT02473965|2192351|FG000|Overall Study|Physician Decision|0
1110267|NCT02473965|2192352|FG001|Overall Study|Physician Decision|2
1110268|NCT02474069|2192362|FG000|Selection Phase (SP)|Adverse Event|8
1110269|NCT02474069|2192363|FG001|Selection Phase (SP)|Adverse Event|0
1110270|NCT02474069|2192364|FG002|Selection Phase (SP)|Adverse Event|0
1110271|NCT02474069|2192362|FG000|Selection Phase (SP)|Lack of Efficacy|1
1110272|NCT02474069|2192363|FG001|Selection Phase (SP)|Lack of Efficacy|0
1110273|NCT02474069|2192364|FG002|Selection Phase (SP)|Lack of Efficacy|0
1110274|NCT02474069|2192362|FG000|Selection Phase (SP)|Lost to Follow-up|4
1110275|NCT02474069|2192363|FG001|Selection Phase (SP)|Lost to Follow-up|0
1110276|NCT02474069|2192364|FG002|Selection Phase (SP)|Lost to Follow-up|0
1110277|NCT02474069|2192362|FG000|Selection Phase (SP)|Physician Decision|1
1110278|NCT02474069|2192363|FG001|Selection Phase (SP)|Physician Decision|0
1110279|NCT02474069|2192364|FG002|Selection Phase (SP)|Physician Decision|0
1110280|NCT02474069|2192362|FG000|Selection Phase (SP)|Protocol Violation|1
1110281|NCT02474069|2192363|FG001|Selection Phase (SP)|Protocol Violation|0
1110282|NCT02474069|2192364|FG002|Selection Phase (SP)|Protocol Violation|0
1110283|NCT02474069|2192362|FG000|Selection Phase (SP)|No longer requires treatment|1
1110284|NCT02474069|2192363|FG001|Selection Phase (SP)|No longer requires treatment|0
1110285|NCT02474069|2192364|FG002|Selection Phase (SP)|No longer requires treatment|0
1110286|NCT02474069|2192362|FG000|Selection Phase (SP)|Technical Problem|1
1110287|NCT02474069|2192363|FG001|Selection Phase (SP)|Technical Problem|0
1110288|NCT02474069|2192364|FG002|Selection Phase (SP)|Technical Problem|0
1110289|NCT02474069|2192362|FG000|Selection Phase (SP)|Withdrawal by Subject|3
1110290|NCT02474069|2192363|FG001|Selection Phase (SP)|Withdrawal by Subject|0
1110291|NCT02474069|2192364|FG002|Selection Phase (SP)|Withdrawal by Subject|0
1110292|NCT02474069|2192362|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3
1110293|NCT02474069|2192363|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0
1110294|NCT02474069|2192364|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0
1110295|NCT02474069|2192362|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0
1110296|NCT02474069|2192363|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3
1110297|NCT02474069|2192364|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2
1110298|NCT02474069|2192362|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
1110299|NCT02474069|2192363|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
1110300|NCT02474069|2192364|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
1110301|NCT02474069|2192362|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
1110302|NCT02474069|2192363|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
1110303|NCT02474069|2192364|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
1110304|NCT02474069|2192362|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
1110305|NCT02474069|2192363|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
1110306|NCT02474069|2192364|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
1110307|NCT02474082|2192376|FG000|Overall Study|Adverse Event|2
1110308|NCT02474082|2192377|FG001|Overall Study|Adverse Event|32
1110309|NCT02474082|2192376|FG000|Overall Study|Withdrawal of informed consent|1
1110310|NCT02474082|2192377|FG001|Overall Study|Withdrawal of informed consent|11
1110311|NCT02474082|2192376|FG000|Overall Study|Lost to Follow-up|2
1110312|NCT02474082|2192377|FG001|Overall Study|Lost to Follow-up|2
1110313|NCT02474082|2192376|FG000|Overall Study|Dose tapering not achieved|0
1110314|NCT02474082|2192377|FG001|Overall Study|Dose tapering not achieved|4
1110315|NCT02474082|2192376|FG000|Overall Study|Participant/guardian decision|1
1110316|NCT02474082|2192377|FG001|Overall Study|Participant/guardian decision|2
1110317|NCT02474082|2192376|FG000|Overall Study|Non-compliance with study treatment|0
1110318|NCT02474082|2192377|FG001|Overall Study|Non-compliance with study treatment|2
1110319|NCT02474082|2192376|FG000|Overall Study|Protocol deviation|0
1110320|NCT02474082|2192377|FG001|Overall Study|Protocol deviation|1
1110321|NCT02474199|2192385|FG000|Overall Study|Lost to Follow-up|1
1110322|NCT02474199|2192386|FG001|Overall Study|Lost to Follow-up|0
1110323|NCT02474199|2192387|FG002|Overall Study|Lost to Follow-up|0
1110324|NCT02474199|2192388|FG003|Overall Study|Lost to Follow-up|0
1110325|NCT02474199|2192385|FG000|Overall Study|Withdrawal by Subject|1
1110326|NCT02474199|2192386|FG001|Overall Study|Withdrawal by Subject|2
1110327|NCT02474199|2192387|FG002|Overall Study|Withdrawal by Subject|0
1110328|NCT02474199|2192388|FG003|Overall Study|Withdrawal by Subject|1
1110329|NCT02474199|2192385|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0
1110330|NCT02474199|2192386|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1
1110331|NCT02474199|2192387|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0
1110332|NCT02474199|2192388|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0
1110333|NCT02474199|2192385|FG000|Overall Study|Did not meet eligibility criteria|0
1110334|NCT02474199|2192386|FG001|Overall Study|Did not meet eligibility criteria|0
1110335|NCT02474199|2192387|FG002|Overall Study|Did not meet eligibility criteria|2
1110336|NCT02474199|2192388|FG003|Overall Study|Did not meet eligibility criteria|2
1110337|NCT02474355|2192395|FG000|Overall Study|Other|43
1110338|NCT02474355|2192395|FG000|Overall Study|Eligibility Criteria not Fulfilled|2
1110339|NCT02474355|2192395|FG000|Overall Study|Lost to Follow-up|98
1110340|NCT02474355|2192395|FG000|Overall Study|Withdrawal by Subject|124
1110341|NCT02474355|2192395|FG000|Overall Study|Death|1361
1110342|NCT02474589|2192445|FG000|Overall Study|Adverse Event|6
1110343|NCT02474589|2192446|FG001|Overall Study|Adverse Event|2
1110344|NCT02474589|2192445|FG000|Overall Study|Lost to Follow-up|6
1110345|NCT02474589|2192446|FG001|Overall Study|Lost to Follow-up|1
1110346|NCT02474589|2192445|FG000|Overall Study|Protocol Violation|4
1110347|NCT02474589|2192446|FG001|Overall Study|Protocol Violation|1
1110348|NCT02474589|2192445|FG000|Overall Study|Withdrawal by Subject|4
1110349|NCT02474589|2192446|FG001|Overall Study|Withdrawal by Subject|0
1110350|NCT02474589|2192445|FG000|Overall Study|Inability to complete study procedures|5
1110351|NCT02474589|2192446|FG001|Overall Study|Inability to complete study procedures|1
1110352|NCT02475265|2192482|FG000|Overall Study|Physician Decision|1
1110353|NCT02475265|2192482|FG000|Overall Study|Withdrawal by Subject|2
1110354|NCT02475278|2192486|FG000|Overall Study|Lost to Follow-up|1
1110355|NCT02475278|2192486|FG000|Overall Study|Reason Not Specified|1
1110356|NCT02475369|2192490|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7
1110357|NCT02475369|2192491|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2
1110358|NCT02475395|2192504|FG000|Overall Study|Protocol Violation|30
1110359|NCT02475395|2192505|FG001|Overall Study|Protocol Violation|3
1110360|NCT02475564|2192513|FG000|Overall Study|Withdrawal by Subject|1
1110361|NCT02475564|2192514|FG001|Overall Study|Withdrawal by Subject|0
1110362|NCT02475564|2192513|FG000|Overall Study|Lost to Follow-up|2
1110363|NCT02475564|2192514|FG001|Overall Study|Lost to Follow-up|1
1110364|NCT02475564|2192513|FG000|Overall Study|Intense Menstrual bleeding|1
1110365|NCT02475564|2192514|FG001|Overall Study|Intense Menstrual bleeding|0
1110366|NCT02475629|2192520|FG000|Overall Study|Adverse Event|1
1110367|NCT02475629|2192520|FG000|Overall Study|Death|4
1110368|NCT02475629|2192520|FG000|Overall Study|Physician Decision|1
1110369|NCT02475629|2192520|FG000|Overall Study|Withdrawal by Subject|1
1110370|NCT02475629|2192520|FG000|Overall Study|Lost to Follow-up|1
1110371|NCT02475629|2192520|FG000|Overall Study|Subject non-compliance|1
1110372|NCT02475733|2192535|FG000|Overall Study|Withdrawal by Subject|1
1110373|NCT02475733|2192536|FG001|Overall Study|Withdrawal by Subject|0
1110374|NCT02475733|2192535|FG000|Overall Study|Physician Decision|1
1110375|NCT02475733|2192536|FG001|Overall Study|Physician Decision|0
1110376|NCT02475850|2192553|FG000|Overall Study|Death|155
1110377|NCT02475850|2192554|FG001|Overall Study|Death|141
1110378|NCT02475850|2192553|FG000|Overall Study|Lost to Follow-up|217
1110379|NCT02475850|2192554|FG001|Overall Study|Lost to Follow-up|188
1110380|NCT02475850|2192553|FG000|Overall Study|Withdrawal by Subject|221
1110381|NCT02475850|2192554|FG001|Overall Study|Withdrawal by Subject|155
1110382|NCT02475954|2192563|FG000|Overall Study|Withdrawal by Subject|2
1110383|NCT02475954|2192564|FG001|Overall Study|Withdrawal by Subject|2
1110384|NCT02475954|2192563|FG000|Overall Study|Lost to Follow-up|11
1110385|NCT02475954|2192564|FG001|Overall Study|Lost to Follow-up|9
1110386|NCT02475954|2192563|FG000|Overall Study|Death|1
1110387|NCT02475954|2192564|FG001|Overall Study|Death|1
1110388|NCT02475980|2192571|FG000|Overall Study|Lost to Follow-up|4
1110389|NCT02475980|2192571|FG000|Overall Study|Withdrawal by Subject|1
1110390|NCT02476006|2192575|FG000|Overall Study|Death|4
1110391|NCT02476006|2192575|FG000|Overall Study|Lack of treatment efficacy|2
1110392|NCT02476006|2192575|FG000|Overall Study|Pregnancy|1
1110393|NCT02476006|2192575|FG000|Overall Study|Participant did not wish to continue|39
1110394|NCT02476006|2192575|FG000|Overall Study|Adverse Event|41
1110395|NCT02476006|2192575|FG000|Overall Study|Poor compliance to study protocol|3
1110396|NCT02476006|2192575|FG000|Overall Study|Sponsor decision|6
1110397|NCT02476006|2192575|FG000|Overall Study|Lost to Follow-up|5
1110398|NCT02476006|2192575|FG000|Overall Study|Physician Decision|5
1110399|NCT02476006|2192575|FG000|Overall Study|Study ended treatment not available|4
1110400|NCT02476006|2192575|FG000|Overall Study|Switched to commercial drug|4
1110401|NCT02476006|2192575|FG000|Overall Study|Excluded from study|1
1110402|NCT02476006|2192575|FG000|Overall Study|Protocol Violation|1
1110403|NCT02476006|2192575|FG000|Overall Study|Enrolled but not treated|4
1110404|NCT02476175|2192595|FG000|Overall Study|Adverse Event|2
1110405|NCT02476201|2192599|FG000|Overall Study|Unable to program MPP|9
1110406|NCT02476201|2192599|FG000|Overall Study|Study echo not performed|5
1110407|NCT02476201|2192599|FG000|Overall Study|Adverse Event|4
1110408|NCT02476201|2192599|FG000|Overall Study|Death|2
1110409|NCT02476201|2192599|FG000|Overall Study|Lost to Follow-up|2
1110410|NCT02476201|2192599|FG000|Overall Study|MPP programmed to OFF|2
1110411|NCT02476201|2192599|FG000|Overall Study|Withdrawal by Subject|1
1110412|NCT02476201|2192599|FG000|Overall Study|Unsuccessful implant|1
1110413|NCT02476422|2192617|FG000|Overall Study|Subject/guardian decision|0
1110414|NCT02476422|2192618|FG001|Overall Study|Subject/guardian decision|1
1110415|NCT02476578|2192652|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35
1110416|NCT02476578|2192653|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43
1110417|NCT02476578|2192652|FG000|Overall Study|Lost to Follow-up|6
1110418|NCT02476578|2192653|FG001|Overall Study|Lost to Follow-up|13
1110419|NCT02476617|2192659|FG000|Overall Study|Adverse Event|1
1110420|NCT02476617|2192659|FG000|Overall Study|Lost to Follow-up|1
1110421|NCT02476916|2192684|FG000|Core Period|Adverse Event|2
1110422|NCT02476916|2192685|FG001|Core Period|Adverse Event|2
1110423|NCT02476916|2192684|FG000|Core Period|Investigator decision|1
1110424|NCT02476916|2192685|FG001|Core Period|Investigator decision|1
1110425|NCT02476916|2192684|FG000|Core Period|Withdrawal by Subject|3
1110426|NCT02476916|2192685|FG001|Core Period|Withdrawal by Subject|0
1110427|NCT02476916|2192684|FG000|Extension Period|Prematurely Discontinued Treatment|6
1110428|NCT02476916|2192685|FG001|Extension Period|Prematurely Discontinued Treatment|1
1110429|NCT02476916|2192684|FG000|Extension Period|On Treatment|12
1110430|NCT02476916|2192685|FG001|Extension Period|On Treatment|17
1110446|NCT02477020|2192709|FG000|Overall Study|Pretreatment Event/Adverse Event|6
1110447|NCT02477020|2192710|FG001|Overall Study|Pretreatment Event/Adverse Event|6
1110448|NCT02477020|2192709|FG000|Overall Study|Voluntary Withdrawal|7
1110449|NCT02477020|2192710|FG001|Overall Study|Voluntary Withdrawal|16
1110450|NCT02477020|2192709|FG000|Overall Study|Reason not Specified|3
1110451|NCT02477020|2192710|FG001|Overall Study|Reason not Specified|1
1110452|NCT02477020|2192709|FG000|Overall Study|Lack of Efficacy|14
1110453|NCT02477020|2192710|FG001|Overall Study|Lack of Efficacy|5
1110454|NCT02477111|2192716|FG000|Overall Study|Death|5
1110455|NCT02477111|2192716|FG000|Overall Study|Withdrawal by Subject|2
1110456|NCT02477111|2192716|FG000|Overall Study|missed visit|4
1110457|NCT02477215|2192726|FG000|Dose Escalation Phase|Physician Decision|1
1110458|NCT02477215|2192727|FG001|Dose Escalation Phase|Physician Decision|2
1110459|NCT02477215|2192728|FG002|Dose Escalation Phase|Physician Decision|0
1110460|NCT02477215|2192726|FG000|Fixed Dose Phase|Physician Decision|0
1110461|NCT02477215|2192727|FG001|Fixed Dose Phase|Physician Decision|7
1110462|NCT02477215|2192728|FG002|Fixed Dose Phase|Physician Decision|0
1110463|NCT02477332|2192759|FG000|Overall Study|Adverse Event|0
1110464|NCT02477332|2192760|FG001|Overall Study|Adverse Event|1
1110465|NCT02477332|2192761|FG002|Overall Study|Adverse Event|1
1110466|NCT02477332|2192762|FG003|Overall Study|Adverse Event|2
1110467|NCT02477332|2192763|FG004|Overall Study|Adverse Event|1
1110468|NCT02477332|2192764|FG005|Overall Study|Adverse Event|2
1110469|NCT02477332|2192759|FG000|Overall Study|Lack of Efficacy|1
1110470|NCT02477332|2192760|FG001|Overall Study|Lack of Efficacy|2
1110471|NCT02477332|2192761|FG002|Overall Study|Lack of Efficacy|1
1110472|NCT02477332|2192762|FG003|Overall Study|Lack of Efficacy|2
1110473|NCT02477332|2192763|FG004|Overall Study|Lack of Efficacy|1
1110474|NCT02477332|2192764|FG005|Overall Study|Lack of Efficacy|1
1110475|NCT02477332|2192759|FG000|Overall Study|Non-compliance with study treatment|0
1110476|NCT02477332|2192760|FG001|Overall Study|Non-compliance with study treatment|1
1110477|NCT02477332|2192761|FG002|Overall Study|Non-compliance with study treatment|2
1110478|NCT02477332|2192762|FG003|Overall Study|Non-compliance with study treatment|0
1110479|NCT02477332|2192763|FG004|Overall Study|Non-compliance with study treatment|0
1110480|NCT02477332|2192764|FG005|Overall Study|Non-compliance with study treatment|0
1110481|NCT02477332|2192759|FG000|Overall Study|Pregnancy|0
1110482|NCT02477332|2192760|FG001|Overall Study|Pregnancy|0
1110483|NCT02477332|2192761|FG002|Overall Study|Pregnancy|0
1110484|NCT02477332|2192762|FG003|Overall Study|Pregnancy|1
1110485|NCT02477332|2192763|FG004|Overall Study|Pregnancy|0
1110486|NCT02477332|2192764|FG005|Overall Study|Pregnancy|0
1110487|NCT02477332|2192759|FG000|Overall Study|Protocol Violation|2
1110488|NCT02477332|2192760|FG001|Overall Study|Protocol Violation|0
1110489|NCT02477332|2192761|FG002|Overall Study|Protocol Violation|3
1110490|NCT02477332|2192762|FG003|Overall Study|Protocol Violation|3
1110491|NCT02477332|2192763|FG004|Overall Study|Protocol Violation|1
1110492|NCT02477332|2192764|FG005|Overall Study|Protocol Violation|1
1110493|NCT02477332|2192759|FG000|Overall Study|Technical problems|0
1110494|NCT02477332|2192760|FG001|Overall Study|Technical problems|0
1110495|NCT02477332|2192761|FG002|Overall Study|Technical problems|1
1110496|NCT02477332|2192762|FG003|Overall Study|Technical problems|0
1110497|NCT02477332|2192763|FG004|Overall Study|Technical problems|0
1110498|NCT02477332|2192764|FG005|Overall Study|Technical problems|0
1110499|NCT02477332|2192759|FG000|Overall Study|Lost to Follow-up|0
1110500|NCT02477332|2192760|FG001|Overall Study|Lost to Follow-up|0
1110501|NCT02477332|2192761|FG002|Overall Study|Lost to Follow-up|2
1110502|NCT02477332|2192762|FG003|Overall Study|Lost to Follow-up|0
1110503|NCT02477332|2192763|FG004|Overall Study|Lost to Follow-up|0
1110504|NCT02477332|2192764|FG005|Overall Study|Lost to Follow-up|0
1110505|NCT02477332|2192759|FG000|Overall Study|Physician Decision|0
1110506|NCT02477332|2192760|FG001|Overall Study|Physician Decision|0
1110507|NCT02477332|2192761|FG002|Overall Study|Physician Decision|1
1110508|NCT02477332|2192762|FG003|Overall Study|Physician Decision|3
1110509|NCT02477332|2192763|FG004|Overall Study|Physician Decision|0
1110510|NCT02477332|2192764|FG005|Overall Study|Physician Decision|1
1110511|NCT02477332|2192759|FG000|Overall Study|Withdrawal by Subject|0
1110512|NCT02477332|2192760|FG001|Overall Study|Withdrawal by Subject|3
1110513|NCT02477332|2192761|FG002|Overall Study|Withdrawal by Subject|1
1110514|NCT02477332|2192762|FG003|Overall Study|Withdrawal by Subject|2
1110515|NCT02477332|2192763|FG004|Overall Study|Withdrawal by Subject|1
1110516|NCT02477332|2192764|FG005|Overall Study|Withdrawal by Subject|0
1110517|NCT02477527|2192800|FG000|Overall Study|Lost to Follow-up|2
1110518|NCT02477527|2192800|FG000|Overall Study|Withdrawal by Subject|1
1110519|NCT02477527|2192800|FG000|Overall Study|Screen Failure|3
1110520|NCT02477553|2192806|FG000|Overall Study|Screening up-to-date|12
1110521|NCT02477553|2192807|FG001|Overall Study|Screening up-to-date|13
1110522|NCT02477553|2192806|FG000|Overall Study|No MD visit|1
1110523|NCT02477553|2192807|FG001|Overall Study|No MD visit|1
1110524|NCT02477553|2192806|FG000|Overall Study|Workup consistent w/CRC|1
1110525|NCT02477553|2192807|FG001|Overall Study|Workup consistent w/CRC|1
1110526|NCT02477553|2192806|FG000|Overall Study|Technical issues with intervention|2
1110527|NCT02477553|2192807|FG001|Overall Study|Technical issues with intervention|0
1110528|NCT02477553|2192806|FG000|Overall Study|Elevated risk for CRC|2
1110529|NCT02477553|2192807|FG001|Overall Study|Elevated risk for CRC|2
1110530|NCT02477553|2192806|FG000|Overall Study|MD advised against screening|1
1110531|NCT02477553|2192807|FG001|Overall Study|MD advised against screening|3
1110532|NCT02477553|2192806|FG000|Overall Study|patient deceased|1
1110533|NCT02477553|2192807|FG001|Overall Study|patient deceased|0
1110534|NCT02477605|2192815|FG000|Overall Study|Discontinued prior to treatment|1
1110535|NCT02477605|2192816|FG001|Overall Study|Discontinued prior to treatment|0
1110536|NCT02477605|2192815|FG000|Overall Study|Lost to Follow-up|0
1110537|NCT02477605|2192816|FG001|Overall Study|Lost to Follow-up|2
1110538|NCT02477605|2192815|FG000|Overall Study|Withdrawal by Subject|0
1110539|NCT02477605|2192816|FG001|Overall Study|Withdrawal by Subject|1
1110540|NCT02477605|2192815|FG000|Overall Study|Administered gas during surgery|0
1110541|NCT02477605|2192816|FG001|Overall Study|Administered gas during surgery|1
1110552|NCT02477670|2192837|FG000|Stage 1|Adverse Event|2
1110553|NCT02477670|2192838|FG001|Stage 1|Adverse Event|7
1110554|NCT02477670|2192839|FG002|Stage 1|Adverse Event|0
1110555|NCT02477670|2192840|FG003|Stage 1|Adverse Event|0
1110556|NCT02477670|2192841|FG004|Stage 1|Adverse Event|0
1110557|NCT02477670|2192842|FG005|Stage 1|Adverse Event|0
1110558|NCT02477670|2192843|FG006|Stage 1|Adverse Event|0
1110559|NCT02477670|2192837|FG000|Stage 1|Lost to Follow-up|0
1110560|NCT02477670|2192838|FG001|Stage 1|Lost to Follow-up|2
1110561|NCT02477670|2192839|FG002|Stage 1|Lost to Follow-up|0
1110562|NCT02477670|2192840|FG003|Stage 1|Lost to Follow-up|0
1110563|NCT02477670|2192841|FG004|Stage 1|Lost to Follow-up|0
1110564|NCT02477670|2192842|FG005|Stage 1|Lost to Follow-up|0
1110565|NCT02477670|2192843|FG006|Stage 1|Lost to Follow-up|0
1110566|NCT02477670|2192837|FG000|Stage 1|Withdrawal by Subject|1
1110567|NCT02477670|2192838|FG001|Stage 1|Withdrawal by Subject|2
1110568|NCT02477670|2192839|FG002|Stage 1|Withdrawal by Subject|0
1110569|NCT02477670|2192840|FG003|Stage 1|Withdrawal by Subject|0
1110570|NCT02477670|2192841|FG004|Stage 1|Withdrawal by Subject|0
1110571|NCT02477670|2192842|FG005|Stage 1|Withdrawal by Subject|0
1110572|NCT02477670|2192843|FG006|Stage 1|Withdrawal by Subject|0
1110573|NCT02477670|2192837|FG000|Stage 1|Non-compliance with Study Drug|1
1110574|NCT02477670|2192838|FG001|Stage 1|Non-compliance with Study Drug|2
1110575|NCT02477670|2192839|FG002|Stage 1|Non-compliance with Study Drug|0
1110576|NCT02477670|2192840|FG003|Stage 1|Non-compliance with Study Drug|0
1110577|NCT02477670|2192841|FG004|Stage 1|Non-compliance with Study Drug|0
1110578|NCT02477670|2192842|FG005|Stage 1|Non-compliance with Study Drug|0
1110579|NCT02477670|2192843|FG006|Stage 1|Non-compliance with Study Drug|0
1110580|NCT02477670|2192837|FG000|Stage 2|Adverse Event|0
1110581|NCT02477670|2192838|FG001|Stage 2|Adverse Event|0
1110582|NCT02477670|2192839|FG002|Stage 2|Adverse Event|1
1110583|NCT02477670|2192840|FG003|Stage 2|Adverse Event|0
1110584|NCT02477670|2192841|FG004|Stage 2|Adverse Event|0
1110585|NCT02477670|2192842|FG005|Stage 2|Adverse Event|0
1110586|NCT02477670|2192843|FG006|Stage 2|Adverse Event|0
1110587|NCT02477670|2192837|FG000|Stage 2|Antipsychotic Medication Changed|0
1110588|NCT02477670|2192838|FG001|Stage 2|Antipsychotic Medication Changed|0
1110589|NCT02477670|2192839|FG002|Stage 2|Antipsychotic Medication Changed|1
1110590|NCT02477670|2192840|FG003|Stage 2|Antipsychotic Medication Changed|0
1110591|NCT02477670|2192841|FG004|Stage 2|Antipsychotic Medication Changed|0
1110592|NCT02477670|2192842|FG005|Stage 2|Antipsychotic Medication Changed|0
1110593|NCT02477670|2192843|FG006|Stage 2|Antipsychotic Medication Changed|0
1110594|NCT02477670|2192837|FG000|Stage 2|Withdrawal by Subject|0
1110595|NCT02477670|2192838|FG001|Stage 2|Withdrawal by Subject|0
1110596|NCT02477670|2192839|FG002|Stage 2|Withdrawal by Subject|0
1110597|NCT02477670|2192840|FG003|Stage 2|Withdrawal by Subject|1
1110598|NCT02477670|2192841|FG004|Stage 2|Withdrawal by Subject|0
1110599|NCT02477670|2192842|FG005|Stage 2|Withdrawal by Subject|0
1110600|NCT02477670|2192843|FG006|Stage 2|Withdrawal by Subject|0
1110601|NCT02477800|2192861|FG000|Placebo-Controlled Period|Adverse Event|16
1110602|NCT02477800|2192862|FG001|Placebo-Controlled Period|Adverse Event|25
1110603|NCT02477800|2192863|FG002|Placebo-Controlled Period|Adverse Event|28
1110604|NCT02477800|2192864|FG003|Placebo-Controlled Period|Adverse Event|0
1110605|NCT02477800|2192865|FG004|Placebo-Controlled Period|Adverse Event|0
1110606|NCT02477800|2192866|FG005|Placebo-Controlled Period|Adverse Event|0
1110607|NCT02477800|2192867|FG006|Placebo-Controlled Period|Adverse Event|0
1110608|NCT02477800|2192861|FG000|Placebo-Controlled Period|Change of Treatment|1
1110609|NCT02477800|2192862|FG001|Placebo-Controlled Period|Change of Treatment|2
1110610|NCT02477800|2192863|FG002|Placebo-Controlled Period|Change of Treatment|1
1110611|NCT02477800|2192864|FG003|Placebo-Controlled Period|Change of Treatment|0
1110612|NCT02477800|2192865|FG004|Placebo-Controlled Period|Change of Treatment|0
1110613|NCT02477800|2192866|FG005|Placebo-Controlled Period|Change of Treatment|0
1110614|NCT02477800|2192867|FG006|Placebo-Controlled Period|Change of Treatment|0
1110615|NCT02477800|2192861|FG000|Placebo-Controlled Period|Consent Withdrawn|26
1110616|NCT02477800|2192862|FG001|Placebo-Controlled Period|Consent Withdrawn|16
1110617|NCT02477800|2192863|FG002|Placebo-Controlled Period|Consent Withdrawn|27
1110618|NCT02477800|2192864|FG003|Placebo-Controlled Period|Consent Withdrawn|0
1110619|NCT02477800|2192865|FG004|Placebo-Controlled Period|Consent Withdrawn|0
1110620|NCT02477800|2192866|FG005|Placebo-Controlled Period|Consent Withdrawn|0
1110621|NCT02477800|2192867|FG006|Placebo-Controlled Period|Consent Withdrawn|0
1110622|NCT02477800|2192861|FG000|Placebo-Controlled Period|Death|0
1110623|NCT02477800|2192862|FG001|Placebo-Controlled Period|Death|3
1110624|NCT02477800|2192863|FG002|Placebo-Controlled Period|Death|2
1110625|NCT02477800|2192864|FG003|Placebo-Controlled Period|Death|0
1110626|NCT02477800|2192865|FG004|Placebo-Controlled Period|Death|0
1110627|NCT02477800|2192866|FG005|Placebo-Controlled Period|Death|0
1110628|NCT02477800|2192867|FG006|Placebo-Controlled Period|Death|0
896568|NCT00705406|1868329|FG001|Overall Study|Lost to Follow-up|3
896569|NCT00705406|1868328|FG000|Overall Study|Did not receive study drug|1
896570|NCT00705406|1868329|FG001|Overall Study|Did not receive study drug|2
896571|NCT00705432|1868342|FG000|Treatment Period|Adverse Event|45
896572|NCT00705432|1868343|FG001|Treatment Period|Adverse Event|37
896573|NCT00705432|1868344|FG002|Treatment Period|Adverse Event|51
896574|NCT00705432|1868345|FG003|Treatment Period|Adverse Event|12
896575|NCT00705432|1868346|FG004|Treatment Period|Adverse Event|8
896576|NCT00705432|1868347|FG005|Treatment Period|Adverse Event|9
896577|NCT00705432|1868342|FG000|Treatment Period|Treatment failure|92
896578|NCT00705432|1868343|FG001|Treatment Period|Treatment failure|42
896579|NCT00705432|1868344|FG002|Treatment Period|Treatment failure|33
896580|NCT00705432|1868345|FG003|Treatment Period|Treatment failure|25
896581|NCT00705432|1868346|FG004|Treatment Period|Treatment failure|13
896582|NCT00705432|1868347|FG005|Treatment Period|Treatment failure|14
1110629|NCT02477800|2192861|FG000|Placebo-Controlled Period|Disease Progression|1
1110630|NCT02477800|2192862|FG001|Placebo-Controlled Period|Disease Progression|0
1110631|NCT02477800|2192863|FG002|Placebo-Controlled Period|Disease Progression|1
1110632|NCT02477800|2192864|FG003|Placebo-Controlled Period|Disease Progression|0
1110633|NCT02477800|2192865|FG004|Placebo-Controlled Period|Disease Progression|0
1110634|NCT02477800|2192866|FG005|Placebo-Controlled Period|Disease Progression|0
1110635|NCT02477800|2192867|FG006|Placebo-Controlled Period|Disease Progression|0
1110636|NCT02477800|2192861|FG000|Placebo-Controlled Period|Investigator Decision|3
1110637|NCT02477800|2192862|FG001|Placebo-Controlled Period|Investigator Decision|2
1110638|NCT02477800|2192863|FG002|Placebo-Controlled Period|Investigator Decision|1
1110639|NCT02477800|2192864|FG003|Placebo-Controlled Period|Investigator Decision|0
1110640|NCT02477800|2192865|FG004|Placebo-Controlled Period|Investigator Decision|0
1110641|NCT02477800|2192866|FG005|Placebo-Controlled Period|Investigator Decision|0
1110642|NCT02477800|2192867|FG006|Placebo-Controlled Period|Investigator Decision|0
1110643|NCT02477800|2192861|FG000|Placebo-Controlled Period|Lost to Follow-up|1
1110644|NCT02477800|2192862|FG001|Placebo-Controlled Period|Lost to Follow-up|3
1110645|NCT02477800|2192863|FG002|Placebo-Controlled Period|Lost to Follow-up|3
1110646|NCT02477800|2192864|FG003|Placebo-Controlled Period|Lost to Follow-up|0
1110647|NCT02477800|2192865|FG004|Placebo-Controlled Period|Lost to Follow-up|0
1110648|NCT02477800|2192866|FG005|Placebo-Controlled Period|Lost to Follow-up|0
1110649|NCT02477800|2192867|FG006|Placebo-Controlled Period|Lost to Follow-up|0
1110650|NCT02477800|2192861|FG000|Placebo-Controlled Period|Relocation|2
1110651|NCT02477800|2192862|FG001|Placebo-Controlled Period|Relocation|0
1110652|NCT02477800|2192863|FG002|Placebo-Controlled Period|Relocation|0
1110653|NCT02477800|2192864|FG003|Placebo-Controlled Period|Relocation|0
1110654|NCT02477800|2192865|FG004|Placebo-Controlled Period|Relocation|0
1110655|NCT02477800|2192866|FG005|Placebo-Controlled Period|Relocation|0
1110656|NCT02477800|2192867|FG006|Placebo-Controlled Period|Relocation|0
1110657|NCT02477800|2192861|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1
1110658|NCT02477800|2192862|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1
1110659|NCT02477800|2192863|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1
1110660|NCT02477800|2192864|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0
1110661|NCT02477800|2192865|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0
1110662|NCT02477800|2192866|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0
1110663|NCT02477800|2192867|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0
1110664|NCT02477800|2192861|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2
1110665|NCT02477800|2192862|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1
1110666|NCT02477800|2192863|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0
1110667|NCT02477800|2192864|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0
1110668|NCT02477800|2192865|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0
1110669|NCT02477800|2192866|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0
1110670|NCT02477800|2192867|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0
1110671|NCT02477800|2192861|FG000|Placebo-Controlled Period|Study Visit Burden|5
1110672|NCT02477800|2192862|FG001|Placebo-Controlled Period|Study Visit Burden|3
1110673|NCT02477800|2192863|FG002|Placebo-Controlled Period|Study Visit Burden|11
1110674|NCT02477800|2192864|FG003|Placebo-Controlled Period|Study Visit Burden|0
1110675|NCT02477800|2192865|FG004|Placebo-Controlled Period|Study Visit Burden|0
1110676|NCT02477800|2192866|FG005|Placebo-Controlled Period|Study Visit Burden|0
1110677|NCT02477800|2192867|FG006|Placebo-Controlled Period|Study Visit Burden|0
1110678|NCT02477800|2192861|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
1110679|NCT02477800|2192862|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5
1110680|NCT02477800|2192863|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3
1110681|NCT02477800|2192864|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
1110682|NCT02477800|2192865|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
1110683|NCT02477800|2192866|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
1110684|NCT02477800|2192867|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
1110685|NCT02477800|2192861|FG000|Placebo-Controlled Period|Reason not Specified|161
1110686|NCT02477800|2192862|FG001|Placebo-Controlled Period|Reason not Specified|161
1110687|NCT02477800|2192863|FG002|Placebo-Controlled Period|Reason not Specified|189
1110688|NCT02477800|2192864|FG003|Placebo-Controlled Period|Reason not Specified|0
1110689|NCT02477800|2192865|FG004|Placebo-Controlled Period|Reason not Specified|0
1110690|NCT02477800|2192866|FG005|Placebo-Controlled Period|Reason not Specified|0
1110691|NCT02477800|2192867|FG006|Placebo-Controlled Period|Reason not Specified|0
1110692|NCT02477800|2192861|FG000|Long Term Extension Period|Adverse Event|0
1110693|NCT02477800|2192862|FG001|Long Term Extension Period|Adverse Event|0
1110694|NCT02477800|2192863|FG002|Long Term Extension Period|Adverse Event|0
1110695|NCT02477800|2192864|FG003|Long Term Extension Period|Adverse Event|6
1110696|NCT02477800|2192865|FG004|Long Term Extension Period|Adverse Event|2
1110697|NCT02477800|2192866|FG005|Long Term Extension Period|Adverse Event|4
1110698|NCT02477800|2192867|FG006|Long Term Extension Period|Adverse Event|3
1110699|NCT02477800|2192861|FG000|Long Term Extension Period|Death|0
1110700|NCT02477800|2192862|FG001|Long Term Extension Period|Death|0
1110701|NCT02477800|2192863|FG002|Long Term Extension Period|Death|0
1110702|NCT02477800|2192864|FG003|Long Term Extension Period|Death|1
1110703|NCT02477800|2192865|FG004|Long Term Extension Period|Death|1
1110704|NCT02477800|2192866|FG005|Long Term Extension Period|Death|1
1110705|NCT02477800|2192867|FG006|Long Term Extension Period|Death|2
1110706|NCT02477800|2192861|FG000|Long Term Extension Period|Consent Withdrawn|0
1110707|NCT02477800|2192862|FG001|Long Term Extension Period|Consent Withdrawn|0
1110708|NCT02477800|2192863|FG002|Long Term Extension Period|Consent Withdrawn|0
1110709|NCT02477800|2192864|FG003|Long Term Extension Period|Consent Withdrawn|10
1110710|NCT02477800|2192865|FG004|Long Term Extension Period|Consent Withdrawn|4
1110711|NCT02477800|2192866|FG005|Long Term Extension Period|Consent Withdrawn|13
1110712|NCT02477800|2192867|FG006|Long Term Extension Period|Consent Withdrawn|16
1110713|NCT02477800|2192861|FG000|Long Term Extension Period|Disease Progression|0
1110714|NCT02477800|2192862|FG001|Long Term Extension Period|Disease Progression|0
1110715|NCT02477800|2192863|FG002|Long Term Extension Period|Disease Progression|0
1110716|NCT02477800|2192864|FG003|Long Term Extension Period|Disease Progression|3
1110717|NCT02477800|2192865|FG004|Long Term Extension Period|Disease Progression|1
1110718|NCT02477800|2192866|FG005|Long Term Extension Period|Disease Progression|1
1110719|NCT02477800|2192867|FG006|Long Term Extension Period|Disease Progression|0
1110720|NCT02477800|2192861|FG000|Long Term Extension Period|Investigator Decision|0
1110721|NCT02477800|2192862|FG001|Long Term Extension Period|Investigator Decision|0
1110722|NCT02477800|2192863|FG002|Long Term Extension Period|Investigator Decision|0
1110723|NCT02477800|2192864|FG003|Long Term Extension Period|Investigator Decision|0
1110724|NCT02477800|2192865|FG004|Long Term Extension Period|Investigator Decision|0
1110725|NCT02477800|2192866|FG005|Long Term Extension Period|Investigator Decision|0
1110726|NCT02477800|2192867|FG006|Long Term Extension Period|Investigator Decision|2
1110727|NCT02477800|2192861|FG000|Long Term Extension Period|Lost to Follow-up|0
1110728|NCT02477800|2192862|FG001|Long Term Extension Period|Lost to Follow-up|0
1110729|NCT02477800|2192863|FG002|Long Term Extension Period|Lost to Follow-up|0
1110730|NCT02477800|2192864|FG003|Long Term Extension Period|Lost to Follow-up|0
1110731|NCT02477800|2192865|FG004|Long Term Extension Period|Lost to Follow-up|1
1110732|NCT02477800|2192866|FG005|Long Term Extension Period|Lost to Follow-up|3
1110733|NCT02477800|2192867|FG006|Long Term Extension Period|Lost to Follow-up|0
1110734|NCT02477800|2192861|FG000|Long Term Extension Period|Site Terminated By Sponsor|0
1110735|NCT02477800|2192862|FG001|Long Term Extension Period|Site Terminated By Sponsor|0
1110736|NCT02477800|2192863|FG002|Long Term Extension Period|Site Terminated By Sponsor|0
1110737|NCT02477800|2192864|FG003|Long Term Extension Period|Site Terminated By Sponsor|0
1110738|NCT02477800|2192865|FG004|Long Term Extension Period|Site Terminated By Sponsor|0
1110739|NCT02477800|2192866|FG005|Long Term Extension Period|Site Terminated By Sponsor|2
1110740|NCT02477800|2192867|FG006|Long Term Extension Period|Site Terminated By Sponsor|1
1110741|NCT02477800|2192861|FG000|Long Term Extension Period|Study Visit Burden|0
1110742|NCT02477800|2192862|FG001|Long Term Extension Period|Study Visit Burden|0
1110743|NCT02477800|2192863|FG002|Long Term Extension Period|Study Visit Burden|0
1110744|NCT02477800|2192864|FG003|Long Term Extension Period|Study Visit Burden|3
1110745|NCT02477800|2192865|FG004|Long Term Extension Period|Study Visit Burden|0
1110746|NCT02477800|2192866|FG005|Long Term Extension Period|Study Visit Burden|2
1110747|NCT02477800|2192867|FG006|Long Term Extension Period|Study Visit Burden|2
1110748|NCT02477800|2192861|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0
1110749|NCT02477800|2192862|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0
1110750|NCT02477800|2192863|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0
1110751|NCT02477800|2192864|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1
1110752|NCT02477800|2192865|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3
1110753|NCT02477800|2192866|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3
1110754|NCT02477800|2192867|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1
1110755|NCT02477800|2192861|FG000|Long Term Extension Period|Reason not Specified|0
1110756|NCT02477800|2192862|FG001|Long Term Extension Period|Reason not Specified|0
1110757|NCT02477800|2192863|FG002|Long Term Extension Period|Reason not Specified|0
1110758|NCT02477800|2192864|FG003|Long Term Extension Period|Reason not Specified|126
1110759|NCT02477800|2192865|FG004|Long Term Extension Period|Reason not Specified|140
1110760|NCT02477800|2192866|FG005|Long Term Extension Period|Reason not Specified|270
1110761|NCT02477800|2192867|FG006|Long Term Extension Period|Reason not Specified|224
1110762|NCT02477839|2192881|FG000|Overall Study|Adverse Event|0
1110763|NCT02477839|2192882|FG001|Overall Study|Adverse Event|1
1110764|NCT02477839|2192881|FG000|Overall Study|Protocol Violation|0
1110765|NCT02477839|2192882|FG001|Overall Study|Protocol Violation|2
1110766|NCT02477839|2192881|FG000|Overall Study|Withdrawal by Subject|3
1110767|NCT02477839|2192882|FG001|Overall Study|Withdrawal by Subject|3
1110768|NCT02477839|2192881|FG000|Overall Study|Participant had PGS during V6|0
1110769|NCT02477839|2192882|FG001|Overall Study|Participant had PGS during V6|1
1110770|NCT02477839|2192881|FG000|Overall Study|Parents decided to stop medication|0
1110771|NCT02477839|2192882|FG001|Overall Study|Parents decided to stop medication|1
1110772|NCT02477839|2192881|FG000|Overall Study|Lack of tolerability|0
1110773|NCT02477839|2192882|FG001|Overall Study|Lack of tolerability|1
1110774|NCT02477839|2192881|FG000|Overall Study|Exclusion criterion|0
1110775|NCT02477839|2192882|FG001|Overall Study|Exclusion criterion|1
1110776|NCT02478164|2192890|FG000|Overall Study|Lack of Efficacy|13
1110777|NCT02478164|2192890|FG000|Overall Study|Adverse Event|1
1110778|NCT02478164|2192890|FG000|Overall Study|Withdrawal by Subject|1
1110779|NCT02478359|2192896|FG000|Overall Study|Disenrolled from health plan|106
1110780|NCT02478359|2192897|FG001|Overall Study|Disenrolled from health plan|65
1110781|NCT02478372|2192907|FG000|Overall Study|Protocol Violation|12
1110782|NCT02478372|2192908|FG001|Overall Study|Protocol Violation|8
1110783|NCT02478372|2192907|FG000|Overall Study|Lost to Follow-up|1
1110784|NCT02478372|2192908|FG001|Overall Study|Lost to Follow-up|4
1110785|NCT02478372|2192907|FG000|Overall Study|Death|0
1110786|NCT02478372|2192908|FG001|Overall Study|Death|2
1110787|NCT02478398|2192916|FG000|Overall Study|Adverse Event|20
1110788|NCT02478398|2192917|FG001|Overall Study|Adverse Event|5
1110789|NCT02478398|2192916|FG000|Overall Study|Lost to Follow-up|5
1110790|NCT02478398|2192917|FG001|Overall Study|Lost to Follow-up|4
1110791|NCT02478398|2192916|FG000|Overall Study|Non-Compliance With Study Drug|5
1110792|NCT02478398|2192917|FG001|Overall Study|Non-Compliance With Study Drug|1
1110793|NCT02478398|2192916|FG000|Overall Study|Protocol Violation|3
1110794|NCT02478398|2192917|FG001|Overall Study|Protocol Violation|1
1110795|NCT02478398|2192916|FG000|Overall Study|Withdrawal By Parent/Guardian|9
1110796|NCT02478398|2192917|FG001|Overall Study|Withdrawal By Parent/Guardian|6
1110797|NCT02478398|2192916|FG000|Overall Study|Withdrawal By Participant|10
1110798|NCT02478398|2192917|FG001|Overall Study|Withdrawal By Participant|4
1110799|NCT02478463|2192924|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1
1110800|NCT02478463|2192924|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1
1110801|NCT02478463|2192924|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1
1110802|NCT02478632|2192952|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
1110803|NCT02478632|2192953|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
1110804|NCT02478632|2192952|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
1110805|NCT02478632|2192953|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
1110806|NCT02478632|2192952|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
1110807|NCT02478632|2192953|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
1110808|NCT02479139|2192973|FG000|Overall Study|Lost to Follow-up|2
1110809|NCT02479139|2192974|FG001|Overall Study|Lost to Follow-up|4
1110810|NCT02479139|2192975|FG002|Overall Study|Lost to Follow-up|4
1110811|NCT02479139|2192976|FG003|Overall Study|Lost to Follow-up|2
1110812|NCT02479139|2192977|FG004|Overall Study|Lost to Follow-up|3
1110813|NCT02479139|2192978|FG005|Overall Study|Lost to Follow-up|5
1110814|NCT02479139|2192973|FG000|Overall Study|Withdrew Consent|5
1110815|NCT02479139|2192974|FG001|Overall Study|Withdrew Consent|6
1110816|NCT02479139|2192975|FG002|Overall Study|Withdrew Consent|1
1110817|NCT02479139|2192976|FG003|Overall Study|Withdrew Consent|4
1110818|NCT02479139|2192977|FG004|Overall Study|Withdrew Consent|1
1110819|NCT02479139|2192978|FG005|Overall Study|Withdrew Consent|1
1110820|NCT02479139|2192973|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0
1110821|NCT02479139|2192974|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0
1110822|NCT02479139|2192975|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1
1110823|NCT02479139|2192976|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0
1110824|NCT02479139|2192977|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0
1110825|NCT02479139|2192978|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0
1110826|NCT02479139|2192973|FG000|Overall Study|Other Miscellaneous Reasons|1
1110827|NCT02479139|2192974|FG001|Overall Study|Other Miscellaneous Reasons|0
1110828|NCT02479139|2192975|FG002|Overall Study|Other Miscellaneous Reasons|1
1110829|NCT02479139|2192976|FG003|Overall Study|Other Miscellaneous Reasons|1
1110830|NCT02479139|2192977|FG004|Overall Study|Other Miscellaneous Reasons|1
1110831|NCT02479139|2192978|FG005|Overall Study|Other Miscellaneous Reasons|0
1110832|NCT02479412|2193001|FG000|Overall Study|Adverse Event|0
1110833|NCT02479412|2193002|FG001|Overall Study|Adverse Event|0
1110834|NCT02479412|2193003|FG002|Overall Study|Adverse Event|1
1110835|NCT02479412|2193004|FG003|Overall Study|Adverse Event|0
1110836|NCT02479412|2193005|FG004|Overall Study|Adverse Event|0
1110837|NCT02479412|2193006|FG005|Overall Study|Adverse Event|0
1110838|NCT02479412|2193007|FG006|Overall Study|Adverse Event|0
1110839|NCT02479412|2193008|FG007|Overall Study|Adverse Event|0
1110840|NCT02479412|2193009|FG008|Overall Study|Adverse Event|0
1110841|NCT02479412|2193001|FG000|Overall Study|Study-specific withdrawal criteria|0
1110842|NCT02479412|2193002|FG001|Overall Study|Study-specific withdrawal criteria|0
1110843|NCT02479412|2193003|FG002|Overall Study|Study-specific withdrawal criteria|1
1110844|NCT02479412|2193004|FG003|Overall Study|Study-specific withdrawal criteria|1
1110845|NCT02479412|2193005|FG004|Overall Study|Study-specific withdrawal criteria|0
1110846|NCT02479412|2193006|FG005|Overall Study|Study-specific withdrawal criteria|0
1110847|NCT02479412|2193007|FG006|Overall Study|Study-specific withdrawal criteria|0
1110848|NCT02479412|2193008|FG007|Overall Study|Study-specific withdrawal criteria|1
1110849|NCT02479412|2193009|FG008|Overall Study|Study-specific withdrawal criteria|1
1110850|NCT02479412|2193001|FG000|Overall Study|Randomization to wrong PK sampling group|0
1110851|NCT02479412|2193002|FG001|Overall Study|Randomization to wrong PK sampling group|0
1110852|NCT02479412|2193003|FG002|Overall Study|Randomization to wrong PK sampling group|0
1110853|NCT02479412|2193004|FG003|Overall Study|Randomization to wrong PK sampling group|0
1110854|NCT02479412|2193005|FG004|Overall Study|Randomization to wrong PK sampling group|1
1110855|NCT02479412|2193006|FG005|Overall Study|Randomization to wrong PK sampling group|0
1110856|NCT02479412|2193007|FG006|Overall Study|Randomization to wrong PK sampling group|0
1110857|NCT02479412|2193008|FG007|Overall Study|Randomization to wrong PK sampling group|0
1110858|NCT02479412|2193009|FG008|Overall Study|Randomization to wrong PK sampling group|0
1110859|NCT02479802|2193034|FG000|Overall Study|Lost to Follow-up|1
1110860|NCT02479802|2193034|FG000|Overall Study|Adverse Event|1
1110861|NCT02479880|2193040|FG000|Overall Study|Study Terminated by Sponsor|13
1110862|NCT02479880|2193041|FG001|Overall Study|Study Terminated by Sponsor|12
1110863|NCT02479880|2193040|FG000|Overall Study|Pregnancy|0
1110864|NCT02479880|2193041|FG001|Overall Study|Pregnancy|1
1110865|NCT02480010|2193049|FG000|Overall Study|Adverse Event|3
1110866|NCT02480010|2193050|FG001|Overall Study|Adverse Event|1
1110867|NCT02480010|2193049|FG000|Overall Study|Death|1
1110868|NCT02480010|2193050|FG001|Overall Study|Death|0
1110869|NCT02480010|2193049|FG000|Overall Study|Insufficient therapeutic response|31
1110870|NCT02480010|2193050|FG001|Overall Study|Insufficient therapeutic response|29
1110871|NCT02480010|2193049|FG000|Overall Study|Refused Treatment|0
1110872|NCT02480010|2193050|FG001|Overall Study|Refused Treatment|3
1110873|NCT02480114|2193058|FG000|Overall Study|Not completing surveys|3
1110874|NCT02480114|2193059|FG001|Overall Study|Not completing surveys|2
1110875|NCT02480114|2193058|FG000|Overall Study|Withdrawal by Subject|2
1110876|NCT02480114|2193059|FG001|Overall Study|Withdrawal by Subject|4
1110877|NCT02480114|2193058|FG000|Overall Study|Disease progression|3
1110878|NCT02480114|2193059|FG001|Overall Study|Disease progression|0
1110879|NCT02480114|2193058|FG000|Overall Study|Improper completion of survey|1
1110880|NCT02480114|2193059|FG001|Overall Study|Improper completion of survey|1
1110881|NCT02480114|2193058|FG000|Overall Study|Not eligible|0
1110882|NCT02480114|2193059|FG001|Overall Study|Not eligible|1
1110883|NCT02480153|2193067|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
1110884|NCT02480153|2193068|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
1110885|NCT02480153|2193069|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
1110886|NCT02480153|2193067|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
1110887|NCT02480153|2193068|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
1110888|NCT02480153|2193069|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
1110889|NCT02480153|2193067|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
1110890|NCT02480153|2193068|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
1110891|NCT02480153|2193069|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
1110892|NCT02480153|2193067|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
1110893|NCT02480153|2193068|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
1110894|NCT02480153|2193069|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
1110895|NCT02480153|2193067|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0
1110896|NCT02480153|2193068|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1
1110897|NCT02480153|2193069|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0
1110898|NCT02480153|2193067|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0
1110899|NCT02480153|2193068|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1
1110900|NCT02480153|2193069|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0
1110901|NCT02480153|2193067|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
1110902|NCT02480153|2193068|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
1110903|NCT02480153|2193069|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
1110904|NCT02480153|2193067|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
1110905|NCT02480153|2193068|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
1110906|NCT02480153|2193069|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
1110907|NCT02480153|2193067|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
1110908|NCT02480153|2193068|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
1110909|NCT02480153|2193069|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
1110910|NCT02480153|2193067|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
1110911|NCT02480153|2193068|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
1110912|NCT02480153|2193069|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
1110913|NCT02480153|2193067|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
1110914|NCT02480153|2193068|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
1110915|NCT02480153|2193069|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
1110916|NCT02480153|2193067|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2
1110917|NCT02480153|2193068|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0
1110918|NCT02480153|2193069|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0
1110919|NCT02480153|2193067|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
1110920|NCT02480153|2193068|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
1110921|NCT02480153|2193069|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
1110922|NCT02480153|2193067|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
1110923|NCT02480153|2193068|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
1110924|NCT02480153|2193069|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
1110925|NCT02480153|2193067|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
1110926|NCT02480153|2193068|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
1110927|NCT02480153|2193069|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
1110928|NCT02480153|2193067|FG000|Period 3: Week 52 Dosing to Week 78|Other|0
1110929|NCT02480153|2193068|FG001|Period 3: Week 52 Dosing to Week 78|Other|0
1110930|NCT02480153|2193069|FG002|Period 3: Week 52 Dosing to Week 78|Other|1
1110931|NCT02480153|2193067|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
1110932|NCT02480153|2193068|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
1110933|NCT02480153|2193069|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
1110934|NCT02480153|2193067|FG000|Period 3: Week 52 Dosing to Week 78|Death|0
1110935|NCT02480153|2193068|FG001|Period 3: Week 52 Dosing to Week 78|Death|1
1110936|NCT02480153|2193069|FG002|Period 3: Week 52 Dosing to Week 78|Death|0
1110937|NCT02480621|2193139|FG000|Randomization|Withdrawal by Subject|1
1110938|NCT02480621|2193140|FG001|Randomization|Withdrawal by Subject|0
1110939|NCT02480621|2193139|FG000|Randomization|Surgeon did not give intervention|0
1110940|NCT02480621|2193140|FG001|Randomization|Surgeon did not give intervention|1
1110941|NCT02480621|2193139|FG000|Follow Up|Lost to Follow-up|4
1110942|NCT02480621|2193140|FG001|Follow Up|Lost to Follow-up|2
1110943|NCT02480712|2193146|FG000|Overall Study|Enrolled but Never Treated|1
1110944|NCT02480712|2193146|FG000|Overall Study|Lost to Follow-up|5
1110945|NCT02480712|2193146|FG000|Overall Study|Withdrew Consent|3
1110946|NCT02480712|2193146|FG000|Overall Study|Death|1
1110947|NCT02480712|2193146|FG000|Overall Study|Lack of Efficacy|1
1110948|NCT02480764|2193159|FG000|Overall Study|Pretreatment Event/Adverse Event|3
1110949|NCT02480764|2193160|FG001|Overall Study|Pretreatment Event/Adverse Event|6
1110950|NCT02480764|2193161|FG002|Overall Study|Pretreatment Event/Adverse Event|3
1110951|NCT02480764|2193159|FG000|Overall Study|Major Protocol Deviation|1
1110952|NCT02480764|2193160|FG001|Overall Study|Major Protocol Deviation|4
1110953|NCT02480764|2193161|FG002|Overall Study|Major Protocol Deviation|3
1110954|NCT02480764|2193159|FG000|Overall Study|Lost to Follow-up|0
1110955|NCT02480764|2193160|FG001|Overall Study|Lost to Follow-up|1
1110956|NCT02480764|2193161|FG002|Overall Study|Lost to Follow-up|2
1110957|NCT02480764|2193159|FG000|Overall Study|Voluntary Withdrawal|6
1110958|NCT02480764|2193160|FG001|Overall Study|Voluntary Withdrawal|5
1110959|NCT02480764|2193161|FG002|Overall Study|Voluntary Withdrawal|10
1110960|NCT02480764|2193159|FG000|Overall Study|Lack of Efficacy|0
1110961|NCT02480764|2193160|FG001|Overall Study|Lack of Efficacy|3
1110962|NCT02480764|2193161|FG002|Overall Study|Lack of Efficacy|3
1110963|NCT02480764|2193159|FG000|Overall Study|Reason not Specified|0
1110964|NCT02480764|2193160|FG001|Overall Study|Reason not Specified|1
1110965|NCT02480764|2193161|FG002|Overall Study|Reason not Specified|0
1110966|NCT02481050|2193184|FG000|Overall Study|Adverse Event|1
1110967|NCT02481050|2193184|FG000|Overall Study|Disease Progression|47
1110968|NCT02481050|2193184|FG000|Overall Study|Withdrawal by Subject|7
1110969|NCT02481050|2193184|FG000|Overall Study|Other|3
1110970|NCT02481830|2193329|FG000|Overall Study|No longer meets Study Criteria|1
1110971|NCT02481830|2193330|FG001|Overall Study|No longer meets Study Criteria|4
1110972|NCT02481830|2193329|FG000|Overall Study|Withdrawal by Subject|0
1110973|NCT02481830|2193330|FG001|Overall Study|Withdrawal by Subject|14
1110974|NCT02481830|2193329|FG000|Overall Study|Disease Progression|1
1110975|NCT02481830|2193330|FG001|Overall Study|Disease Progression|1
1110976|NCT02481830|2193329|FG000|Overall Study|Participant not eligible for trial|0
1110977|NCT02481830|2193330|FG001|Overall Study|Participant not eligible for trial|1
1110978|NCT02481869|2193338|FG000|Overall Study|Lost to Follow-up|3
1110979|NCT02481869|2193339|FG001|Overall Study|Lost to Follow-up|4
1110980|NCT02481869|2193338|FG000|Overall Study|Withdrawal by Subject|2
1110981|NCT02481869|2193339|FG001|Overall Study|Withdrawal by Subject|0
1110982|NCT02481934|2193346|FG000|Overall Study|Death|2
1110983|NCT02481947|2193352|FG000|Overall Study|Withdrawal by Subject|24
1110984|NCT02481947|2193353|FG001|Overall Study|Withdrawal by Subject|10
1110985|NCT02481947|2193352|FG000|Overall Study|Lost to Follow-up|11
1110986|NCT02481947|2193353|FG001|Overall Study|Lost to Follow-up|5
1110987|NCT02481947|2193352|FG000|Overall Study|Adverse Event|6
1110988|NCT02481947|2193353|FG001|Overall Study|Adverse Event|11
1110989|NCT02481947|2193352|FG000|Overall Study|Physician Decision|4
1110990|NCT02481947|2193353|FG001|Overall Study|Physician Decision|5
1110991|NCT02481947|2193352|FG000|Overall Study|Protocol Violation|1
1110992|NCT02481947|2193353|FG001|Overall Study|Protocol Violation|5
1110993|NCT02482129|2193370|FG000|Overall Study|Adverse Event-prior to treatment|0
1110994|NCT02482129|2193371|FG001|Overall Study|Adverse Event-prior to treatment|1
1110995|NCT02482129|2193370|FG000|Overall Study|Withdrawal by subject-prior to treatment|0
1110996|NCT02482129|2193371|FG001|Overall Study|Withdrawal by subject-prior to treatment|1
1110997|NCT02482129|2193370|FG000|Overall Study|Unable to draw blood-prior to treatment|1
1110998|NCT02482129|2193371|FG001|Overall Study|Unable to draw blood-prior to treatment|0
1110999|NCT02482129|2193370|FG000|Overall Study|Criteria not met-prior to treatment|1
1111000|NCT02482129|2193371|FG001|Overall Study|Criteria not met-prior to treatment|0
1111001|NCT02482129|2193370|FG000|Overall Study|Adverse Event|1
1111002|NCT02482129|2193371|FG001|Overall Study|Adverse Event|0
1111003|NCT02482129|2193370|FG000|Overall Study|Withdrawal by Subject|2
1111004|NCT02482129|2193371|FG001|Overall Study|Withdrawal by Subject|0
1111005|NCT02482129|2193370|FG000|Overall Study|Criteria not met|1
1111006|NCT02482129|2193371|FG001|Overall Study|Criteria not met|0
1111007|NCT02482233|2193381|FG000|Overall Study|Lost to Follow-up|1
1111008|NCT02482233|2193382|FG001|Overall Study|Lost to Follow-up|1
1111009|NCT02482298|2193393|FG000|Overall Study|Withdrawal by Subject|2
1111010|NCT02482298|2193394|FG001|Overall Study|Withdrawal by Subject|1
1111011|NCT02482298|2193395|FG002|Overall Study|Withdrawal by Subject|2
1111012|NCT02482298|2193393|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0
1111013|NCT02482298|2193394|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1
1111014|NCT02482298|2193395|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0
1111015|NCT02482298|2193393|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
1111016|NCT02482298|2193394|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
1111017|NCT02482298|2193395|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
1111018|NCT02482298|2193393|FG000|Overall Study|Lost to Follow-up|0
1111019|NCT02482298|2193394|FG001|Overall Study|Lost to Follow-up|1
1111020|NCT02482298|2193395|FG002|Overall Study|Lost to Follow-up|0
1111021|NCT02482428|2193408|FG000|Overall Study|Lost to Follow-up|4
1111022|NCT02482428|2193409|FG001|Overall Study|Lost to Follow-up|9
1111023|NCT02482428|2193410|FG002|Overall Study|Lost to Follow-up|1
1111024|NCT02482428|2193411|FG003|Overall Study|Lost to Follow-up|2
1111025|NCT02482428|2193412|FG004|Overall Study|Lost to Follow-up|4
1111026|NCT02482428|2193408|FG000|Overall Study|Physician Decision|0
1111027|NCT02482428|2193409|FG001|Overall Study|Physician Decision|0
1111028|NCT02482428|2193410|FG002|Overall Study|Physician Decision|0
1111029|NCT02482428|2193411|FG003|Overall Study|Physician Decision|0
1111030|NCT02482428|2193412|FG004|Overall Study|Physician Decision|1
1111031|NCT02482428|2193408|FG000|Overall Study|protocol deviation|1
1111032|NCT02482428|2193409|FG001|Overall Study|protocol deviation|1
1111033|NCT02482428|2193410|FG002|Overall Study|protocol deviation|0
1111034|NCT02482428|2193411|FG003|Overall Study|protocol deviation|0
1111035|NCT02482428|2193412|FG004|Overall Study|protocol deviation|0
1111036|NCT02482428|2193408|FG000|Overall Study|subject/guardian decision|4
1111037|NCT02482428|2193409|FG001|Overall Study|subject/guardian decision|2
1111038|NCT02482428|2193410|FG002|Overall Study|subject/guardian decision|0
1111039|NCT02482428|2193411|FG003|Overall Study|subject/guardian decision|0
1111040|NCT02482428|2193412|FG004|Overall Study|subject/guardian decision|2
1111041|NCT02482571|2193426|FG000|Overall Study|Adverse Event|1
1111042|NCT02482571|2193426|FG000|Overall Study|Scanner or Respiract failure|3
1111043|NCT02482571|2193426|FG000|Overall Study|Withdrawal by Subject|4
1111044|NCT02482805|2193482|FG000|Overall Study|Lost to Follow-up|4
1111045|NCT02482805|2193483|FG001|Overall Study|Lost to Follow-up|4
1111046|NCT02482805|2193484|FG002|Overall Study|Lost to Follow-up|0
1111047|NCT02482935|2193507|FG000|Period 1|Withdrawal by Subject|1
1111048|NCT02482935|2193508|FG001|Period 1|Withdrawal by Subject|0
1111049|NCT02483520|2193533|FG000|Overall Study|Lost to Follow-up|3
1111050|NCT02483520|2193534|FG001|Overall Study|Lost to Follow-up|4
1111051|NCT02483520|2193533|FG000|Overall Study|Withdrawal by Subject|4
1111052|NCT02483520|2193534|FG001|Overall Study|Withdrawal by Subject|14
1111053|NCT02483520|2193533|FG000|Overall Study|Hospitalized|2
1111054|NCT02483520|2193534|FG001|Overall Study|Hospitalized|3
1111055|NCT02483520|2193533|FG000|Overall Study|Moved to LTC|2
1111056|NCT02483520|2193534|FG001|Overall Study|Moved to LTC|3
1111057|NCT02483572|2193542|FG000|Overall Study|Withdrawal by Subject|1
1111058|NCT02483572|2193543|FG001|Overall Study|Withdrawal by Subject|0
1111059|NCT02483572|2193542|FG000|Overall Study|Lost to Follow-up|1
1111060|NCT02483572|2193543|FG001|Overall Study|Lost to Follow-up|0
1111061|NCT02483572|2193542|FG000|Overall Study|Physician Decision|0
1111062|NCT02483572|2193543|FG001|Overall Study|Physician Decision|1
1111063|NCT02483585|2193551|FG000|Double-blind Treatment Phase|Decision by Sponsor|1
1111064|NCT02483585|2193552|FG001|Double-blind Treatment Phase|Decision by Sponsor|1
1111065|NCT02483585|2193551|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12
1111066|NCT02483585|2193552|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12
1111067|NCT02483585|2193551|FG000|Double-blind Treatment Phase|Lost to Follow-up|3
1111068|NCT02483585|2193552|FG001|Double-blind Treatment Phase|Lost to Follow-up|2
1111069|NCT02483585|2193551|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6
1111070|NCT02483585|2193552|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5
1111071|NCT02483585|2193551|FG000|Open-label Treatment Phase|Decision by Sponsor|0
1111072|NCT02483585|2193552|FG001|Open-label Treatment Phase|Decision by Sponsor|1
1111073|NCT02483585|2193551|FG000|Open-label Treatment Phase|Withdrawal by Subject|18
1111074|NCT02483585|2193552|FG001|Open-label Treatment Phase|Withdrawal by Subject|14
1111075|NCT02483585|2193551|FG000|Open-label Treatment Phase|Lost to Follow-up|3
1111076|NCT02483585|2193552|FG001|Open-label Treatment Phase|Lost to Follow-up|5
1111077|NCT02483611|2193565|FG000|Overall Study|Protocol Violation|0
1111078|NCT02483611|2193566|FG001|Overall Study|Protocol Violation|0
1111079|NCT02483611|2193567|FG002|Overall Study|Protocol Violation|1
1111080|NCT02483975|2193586|FG000|Overall Study|Adverse Event|0
1111081|NCT02483975|2193587|FG001|Overall Study|Adverse Event|1
1111082|NCT02483975|2193586|FG000|Overall Study|Lost to Follow-up|0
1111083|NCT02483975|2193587|FG001|Overall Study|Lost to Follow-up|1
1111084|NCT02483975|2193586|FG000|Overall Study|Physician Decision|2
1111085|NCT02483975|2193587|FG001|Overall Study|Physician Decision|0
1111086|NCT02484443|2193606|FG000|Overall Study|Lack of Efficacy|28
1111087|NCT02484443|2193606|FG000|Overall Study|Physician Decision|2
1111088|NCT02484443|2193606|FG000|Overall Study|Ineligible|2
1111089|NCT02484547|2193613|FG000|Placebo-Controlled Period|Adverse Event|10
1111090|NCT02484547|2193614|FG001|Placebo-Controlled Period|Adverse Event|13
1111091|NCT02484547|2193615|FG002|Placebo-Controlled Period|Adverse Event|20
1111092|NCT02484547|2193616|FG003|Placebo-Controlled Period|Adverse Event|0
1111093|NCT02484547|2193617|FG004|Placebo-Controlled Period|Adverse Event|0
1111094|NCT02484547|2193618|FG005|Placebo-Controlled Period|Adverse Event|0
1111095|NCT02484547|2193619|FG006|Placebo-Controlled Period|Adverse Event|0
1111096|NCT02484547|2193613|FG000|Placebo-Controlled Period|Change of Treatment|0
1111097|NCT02484547|2193614|FG001|Placebo-Controlled Period|Change of Treatment|0
1111098|NCT02484547|2193615|FG002|Placebo-Controlled Period|Change of Treatment|1
1111099|NCT02484547|2193616|FG003|Placebo-Controlled Period|Change of Treatment|0
1111100|NCT02484547|2193617|FG004|Placebo-Controlled Period|Change of Treatment|0
1111101|NCT02484547|2193618|FG005|Placebo-Controlled Period|Change of Treatment|0
1111102|NCT02484547|2193619|FG006|Placebo-Controlled Period|Change of Treatment|0
1111103|NCT02484547|2193613|FG000|Placebo-Controlled Period|Consent Withdrawn|15
1111104|NCT02484547|2193614|FG001|Placebo-Controlled Period|Consent Withdrawn|32
1111105|NCT02484547|2193615|FG002|Placebo-Controlled Period|Consent Withdrawn|26
1111106|NCT02484547|2193616|FG003|Placebo-Controlled Period|Consent Withdrawn|0
1111107|NCT02484547|2193617|FG004|Placebo-Controlled Period|Consent Withdrawn|0
1111108|NCT02484547|2193618|FG005|Placebo-Controlled Period|Consent Withdrawn|0
1111109|NCT02484547|2193619|FG006|Placebo-Controlled Period|Consent Withdrawn|0
1111110|NCT02484547|2193613|FG000|Placebo-Controlled Period|Death|5
1111111|NCT02484547|2193614|FG001|Placebo-Controlled Period|Death|0
1111112|NCT02484547|2193615|FG002|Placebo-Controlled Period|Death|6
1111113|NCT02484547|2193616|FG003|Placebo-Controlled Period|Death|0
1111114|NCT02484547|2193617|FG004|Placebo-Controlled Period|Death|0
1111115|NCT02484547|2193618|FG005|Placebo-Controlled Period|Death|0
1111116|NCT02484547|2193619|FG006|Placebo-Controlled Period|Death|0
1111117|NCT02484547|2193613|FG000|Placebo-Controlled Period|Disease Progression|2
1111118|NCT02484547|2193614|FG001|Placebo-Controlled Period|Disease Progression|0
1111119|NCT02484547|2193615|FG002|Placebo-Controlled Period|Disease Progression|1
1111120|NCT02484547|2193616|FG003|Placebo-Controlled Period|Disease Progression|0
1111121|NCT02484547|2193617|FG004|Placebo-Controlled Period|Disease Progression|0
1111122|NCT02484547|2193618|FG005|Placebo-Controlled Period|Disease Progression|0
1111123|NCT02484547|2193619|FG006|Placebo-Controlled Period|Disease Progression|0
1111124|NCT02484547|2193613|FG000|Placebo-Controlled Period|Investigator Decision|2
1111125|NCT02484547|2193614|FG001|Placebo-Controlled Period|Investigator Decision|2
1111126|NCT02484547|2193615|FG002|Placebo-Controlled Period|Investigator Decision|5
1111127|NCT02484547|2193616|FG003|Placebo-Controlled Period|Investigator Decision|0
1111128|NCT02484547|2193617|FG004|Placebo-Controlled Period|Investigator Decision|0
1111129|NCT02484547|2193618|FG005|Placebo-Controlled Period|Investigator Decision|0
1111130|NCT02484547|2193619|FG006|Placebo-Controlled Period|Investigator Decision|0
1111131|NCT02484547|2193613|FG000|Placebo-Controlled Period|Lost to Follow-up|3
1111132|NCT02484547|2193614|FG001|Placebo-Controlled Period|Lost to Follow-up|1
1111133|NCT02484547|2193615|FG002|Placebo-Controlled Period|Lost to Follow-up|3
1111134|NCT02484547|2193616|FG003|Placebo-Controlled Period|Lost to Follow-up|0
1111135|NCT02484547|2193617|FG004|Placebo-Controlled Period|Lost to Follow-up|0
1111136|NCT02484547|2193618|FG005|Placebo-Controlled Period|Lost to Follow-up|0
1111137|NCT02484547|2193619|FG006|Placebo-Controlled Period|Lost to Follow-up|0
1111138|NCT02484547|2193613|FG000|Placebo-Controlled Period|Relocation|1
1111139|NCT02484547|2193614|FG001|Placebo-Controlled Period|Relocation|1
1111140|NCT02484547|2193615|FG002|Placebo-Controlled Period|Relocation|1
1111141|NCT02484547|2193616|FG003|Placebo-Controlled Period|Relocation|0
1111142|NCT02484547|2193617|FG004|Placebo-Controlled Period|Relocation|0
1111143|NCT02484547|2193618|FG005|Placebo-Controlled Period|Relocation|0
1111144|NCT02484547|2193619|FG006|Placebo-Controlled Period|Relocation|0
1111145|NCT02484547|2193613|FG000|Placebo-Controlled Period|Study Visit Burden|2
1111146|NCT02484547|2193614|FG001|Placebo-Controlled Period|Study Visit Burden|8
1111147|NCT02484547|2193615|FG002|Placebo-Controlled Period|Study Visit Burden|5
1111148|NCT02484547|2193616|FG003|Placebo-Controlled Period|Study Visit Burden|0
1111149|NCT02484547|2193617|FG004|Placebo-Controlled Period|Study Visit Burden|0
1111150|NCT02484547|2193618|FG005|Placebo-Controlled Period|Study Visit Burden|0
1111151|NCT02484547|2193619|FG006|Placebo-Controlled Period|Study Visit Burden|0
1111152|NCT02484547|2193613|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4
1111153|NCT02484547|2193614|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
896583|NCT00705432|1868342|FG000|Treatment Period|Non medical reason|26
1111154|NCT02484547|2193615|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
1111155|NCT02484547|2193616|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
1111156|NCT02484547|2193617|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
1111157|NCT02484547|2193618|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
1111158|NCT02484547|2193619|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
1111159|NCT02484547|2193613|FG000|Placebo-Controlled Period|Reason not Specified|216
1111160|NCT02484547|2193614|FG001|Placebo-Controlled Period|Reason not Specified|194
1111161|NCT02484547|2193615|FG002|Placebo-Controlled Period|Reason not Specified|183
1111162|NCT02484547|2193616|FG003|Placebo-Controlled Period|Reason not Specified|0
1111163|NCT02484547|2193617|FG004|Placebo-Controlled Period|Reason not Specified|0
1111164|NCT02484547|2193618|FG005|Placebo-Controlled Period|Reason not Specified|0
1111165|NCT02484547|2193619|FG006|Placebo-Controlled Period|Reason not Specified|0
1111166|NCT02484547|2193613|FG000|Long-Term Extension Period|Adverse Event|0
1111167|NCT02484547|2193614|FG001|Long-Term Extension Period|Adverse Event|0
1111168|NCT02484547|2193615|FG002|Long-Term Extension Period|Adverse Event|0
1111169|NCT02484547|2193616|FG003|Long-Term Extension Period|Adverse Event|0
1111170|NCT02484547|2193617|FG004|Long-Term Extension Period|Adverse Event|1
1111171|NCT02484547|2193618|FG005|Long-Term Extension Period|Adverse Event|3
1111172|NCT02484547|2193619|FG006|Long-Term Extension Period|Adverse Event|2
1111173|NCT02484547|2193613|FG000|Long-Term Extension Period|Death|0
1111174|NCT02484547|2193614|FG001|Long-Term Extension Period|Death|0
1111175|NCT02484547|2193615|FG002|Long-Term Extension Period|Death|0
1111176|NCT02484547|2193616|FG003|Long-Term Extension Period|Death|0
1111177|NCT02484547|2193617|FG004|Long-Term Extension Period|Death|0
1111178|NCT02484547|2193618|FG005|Long-Term Extension Period|Death|3
1111179|NCT02484547|2193619|FG006|Long-Term Extension Period|Death|0
1111180|NCT02484547|2193613|FG000|Long-Term Extension Period|Disease Progression|0
1111181|NCT02484547|2193614|FG001|Long-Term Extension Period|Disease Progression|0
1111182|NCT02484547|2193615|FG002|Long-Term Extension Period|Disease Progression|0
1111183|NCT02484547|2193616|FG003|Long-Term Extension Period|Disease Progression|0
1111184|NCT02484547|2193617|FG004|Long-Term Extension Period|Disease Progression|2
1111185|NCT02484547|2193618|FG005|Long-Term Extension Period|Disease Progression|4
1111186|NCT02484547|2193619|FG006|Long-Term Extension Period|Disease Progression|0
1111187|NCT02484547|2193613|FG000|Long-Term Extension Period|Lost to Follow-up|0
1111188|NCT02484547|2193614|FG001|Long-Term Extension Period|Lost to Follow-up|0
1111189|NCT02484547|2193615|FG002|Long-Term Extension Period|Lost to Follow-up|0
1111190|NCT02484547|2193616|FG003|Long-Term Extension Period|Lost to Follow-up|1
1111191|NCT02484547|2193617|FG004|Long-Term Extension Period|Lost to Follow-up|1
1111192|NCT02484547|2193618|FG005|Long-Term Extension Period|Lost to Follow-up|2
1111193|NCT02484547|2193619|FG006|Long-Term Extension Period|Lost to Follow-up|0
1111194|NCT02484547|2193613|FG000|Long-Term Extension Period|Loss of Capacity|0
1111195|NCT02484547|2193614|FG001|Long-Term Extension Period|Loss of Capacity|0
1111196|NCT02484547|2193615|FG002|Long-Term Extension Period|Loss of Capacity|0
1111197|NCT02484547|2193616|FG003|Long-Term Extension Period|Loss of Capacity|0
1111198|NCT02484547|2193617|FG004|Long-Term Extension Period|Loss of Capacity|1
1111199|NCT02484547|2193618|FG005|Long-Term Extension Period|Loss of Capacity|0
1111200|NCT02484547|2193619|FG006|Long-Term Extension Period|Loss of Capacity|0
1111201|NCT02484547|2193613|FG000|Long-Term Extension Period|Change of Treatment|0
1111202|NCT02484547|2193614|FG001|Long-Term Extension Period|Change of Treatment|0
1111203|NCT02484547|2193615|FG002|Long-Term Extension Period|Change of Treatment|0
1111204|NCT02484547|2193616|FG003|Long-Term Extension Period|Change of Treatment|0
1111205|NCT02484547|2193617|FG004|Long-Term Extension Period|Change of Treatment|0
1111206|NCT02484547|2193618|FG005|Long-Term Extension Period|Change of Treatment|0
1111207|NCT02484547|2193619|FG006|Long-Term Extension Period|Change of Treatment|1
1111208|NCT02484547|2193613|FG000|Long-Term Extension Period|Consent Withdrawn|0
1111209|NCT02484547|2193614|FG001|Long-Term Extension Period|Consent Withdrawn|0
1111210|NCT02484547|2193615|FG002|Long-Term Extension Period|Consent Withdrawn|0
1111211|NCT02484547|2193616|FG003|Long-Term Extension Period|Consent Withdrawn|6
1111212|NCT02484547|2193617|FG004|Long-Term Extension Period|Consent Withdrawn|7
1111213|NCT02484547|2193618|FG005|Long-Term Extension Period|Consent Withdrawn|13
1111214|NCT02484547|2193619|FG006|Long-Term Extension Period|Consent Withdrawn|17
1111215|NCT02484547|2193613|FG000|Long-Term Extension Period|Investigator Decision|0
1111216|NCT02484547|2193614|FG001|Long-Term Extension Period|Investigator Decision|0
1111217|NCT02484547|2193615|FG002|Long-Term Extension Period|Investigator Decision|0
1111218|NCT02484547|2193616|FG003|Long-Term Extension Period|Investigator Decision|2
1111219|NCT02484547|2193617|FG004|Long-Term Extension Period|Investigator Decision|1
1111220|NCT02484547|2193618|FG005|Long-Term Extension Period|Investigator Decision|0
1111221|NCT02484547|2193619|FG006|Long-Term Extension Period|Investigator Decision|1
1111222|NCT02484547|2193613|FG000|Long-Term Extension Period|Relocation|0
1111223|NCT02484547|2193614|FG001|Long-Term Extension Period|Relocation|0
1111224|NCT02484547|2193615|FG002|Long-Term Extension Period|Relocation|0
1111225|NCT02484547|2193616|FG003|Long-Term Extension Period|Relocation|1
1111226|NCT02484547|2193617|FG004|Long-Term Extension Period|Relocation|1
1111227|NCT02484547|2193618|FG005|Long-Term Extension Period|Relocation|0
1111228|NCT02484547|2193619|FG006|Long-Term Extension Period|Relocation|0
1111229|NCT02484547|2193613|FG000|Long-Term Extension Period|Study Visit Burden|0
1111230|NCT02484547|2193614|FG001|Long-Term Extension Period|Study Visit Burden|0
1111231|NCT02484547|2193615|FG002|Long-Term Extension Period|Study Visit Burden|0
1111232|NCT02484547|2193616|FG003|Long-Term Extension Period|Study Visit Burden|2
1111233|NCT02484547|2193617|FG004|Long-Term Extension Period|Study Visit Burden|0
1111234|NCT02484547|2193618|FG005|Long-Term Extension Period|Study Visit Burden|0
1111235|NCT02484547|2193619|FG006|Long-Term Extension Period|Study Visit Burden|3
1111236|NCT02484547|2193613|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
1111237|NCT02484547|2193614|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
1111238|NCT02484547|2193615|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
1111239|NCT02484547|2193616|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
1111240|NCT02484547|2193617|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1
1111241|NCT02484547|2193618|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3
1111242|NCT02484547|2193619|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2
1111243|NCT02484547|2193613|FG000|Long-Term Extension Period|Reason not Specified|0
1111244|NCT02484547|2193614|FG001|Long-Term Extension Period|Reason not Specified|0
1111245|NCT02484547|2193615|FG002|Long-Term Extension Period|Reason not Specified|0
1111246|NCT02484547|2193616|FG003|Long-Term Extension Period|Reason not Specified|119
1111247|NCT02484547|2193617|FG004|Long-Term Extension Period|Reason not Specified|117
1111248|NCT02484547|2193618|FG005|Long-Term Extension Period|Reason not Specified|223
1111249|NCT02484547|2193619|FG006|Long-Term Extension Period|Reason not Specified|231
1111250|NCT02484651|2193633|FG000|Overall Study|Patients' data files were corrupted.|1
1111251|NCT02484651|2193634|FG001|Overall Study|Patients' data files were corrupted.|1
1111252|NCT02484651|2193633|FG000|Overall Study|BIS monitoring failed.|1
1111253|NCT02484651|2193634|FG001|Overall Study|BIS monitoring failed.|1
1111254|NCT02484651|2193633|FG000|Overall Study|Time of the procedure less than 90 min.|1
1111255|NCT02484651|2193634|FG001|Overall Study|Time of the procedure less than 90 min.|2
1111256|NCT02484690|2193646|FG000|Overall Study|Adverse Event|1
1111257|NCT02484690|2193647|FG001|Overall Study|Adverse Event|3
1111258|NCT02484690|2193648|FG002|Overall Study|Adverse Event|0
1111259|NCT02484690|2193649|FG003|Overall Study|Adverse Event|0
1111260|NCT02484690|2193650|FG004|Overall Study|Adverse Event|5
1111261|NCT02484690|2193646|FG000|Overall Study|Death|0
1111262|NCT02484690|2193647|FG001|Overall Study|Death|0
1111263|NCT02484690|2193648|FG002|Overall Study|Death|0
1111264|NCT02484690|2193649|FG003|Overall Study|Death|0
1111265|NCT02484690|2193650|FG004|Overall Study|Death|1
1111266|NCT02484690|2193646|FG000|Overall Study|Withdrawal by Subject|1
1111267|NCT02484690|2193647|FG001|Overall Study|Withdrawal by Subject|3
1111268|NCT02484690|2193648|FG002|Overall Study|Withdrawal by Subject|1
1111269|NCT02484690|2193649|FG003|Overall Study|Withdrawal by Subject|2
1111270|NCT02484690|2193650|FG004|Overall Study|Withdrawal by Subject|0
1111271|NCT02484690|2193646|FG000|Overall Study|Physician Decision|2
1111272|NCT02484690|2193647|FG001|Overall Study|Physician Decision|0
1111273|NCT02484690|2193648|FG002|Overall Study|Physician Decision|1
1111274|NCT02484690|2193649|FG003|Overall Study|Physician Decision|0
1111275|NCT02484690|2193650|FG004|Overall Study|Physician Decision|0
1111276|NCT02484690|2193646|FG000|Overall Study|Lost to Follow-up|0
1111277|NCT02484690|2193647|FG001|Overall Study|Lost to Follow-up|0
1111278|NCT02484690|2193648|FG002|Overall Study|Lost to Follow-up|1
1111279|NCT02484690|2193649|FG003|Overall Study|Lost to Follow-up|0
1111280|NCT02484690|2193650|FG004|Overall Study|Lost to Follow-up|0
1111281|NCT02484729|2193673|FG000|Overall Study|Failure of IntelliCap Error|0
1111282|NCT02484729|2193674|FG001|Overall Study|Failure of IntelliCap Error|0
1111283|NCT02484729|2193675|FG002|Overall Study|Failure of IntelliCap Error|0
1111284|NCT02484729|2193676|FG003|Overall Study|Failure of IntelliCap Error|0
1111285|NCT02484729|2193677|FG004|Overall Study|Failure of IntelliCap Error|0
1111286|NCT02484729|2193678|FG005|Overall Study|Failure of IntelliCap Error|0
1111287|NCT02484729|2193679|FG006|Overall Study|Failure of IntelliCap Error|0
1111288|NCT02484729|2193680|FG007|Overall Study|Failure of IntelliCap Error|0
1111289|NCT02484729|2193681|FG008|Overall Study|Failure of IntelliCap Error|0
1111290|NCT02484729|2193682|FG009|Overall Study|Failure of IntelliCap Error|1
1111291|NCT02484911|2193759|FG000|Overall Study|Withdrawal by Subject|2
1111292|NCT02484911|2193760|FG001|Overall Study|Withdrawal by Subject|1
1111293|NCT02484911|2193759|FG000|Overall Study|Protocol Violation|2
1111294|NCT02484911|2193760|FG001|Overall Study|Protocol Violation|1
1111295|NCT02485158|2193767|FG000|Overall Study|Withdrawal by Subject|3
1111296|NCT02485158|2193767|FG000|Overall Study|expected drug side effect|1
1111297|NCT02485301|2193778|FG000|Overall Study|Serious Adverse Events|2
1111298|NCT02485301|2193779|FG001|Overall Study|Serious Adverse Events|1
1111299|NCT02485301|2193778|FG000|Overall Study|Protocol Violation|0
1111300|NCT02485301|2193779|FG001|Overall Study|Protocol Violation|1
1111301|NCT02485301|2193778|FG000|Overall Study|Withdrawal by Subject|6
1111302|NCT02485301|2193779|FG001|Overall Study|Withdrawal by Subject|7
1111303|NCT02485301|2193778|FG000|Overall Study|Migrated/moved from study area|10
1111304|NCT02485301|2193779|FG001|Overall Study|Migrated/moved from study area|19
1111305|NCT02485301|2193778|FG000|Overall Study|Lost to Follow-up|17
1111306|NCT02485301|2193779|FG001|Overall Study|Lost to Follow-up|17
1111307|NCT02485301|2193778|FG000|Overall Study|Other|3
1111308|NCT02485301|2193779|FG001|Overall Study|Other|4
1111309|NCT02485353|2193785|FG000|Overall Study|Death|1
1111310|NCT02485353|2193785|FG000|Overall Study|Disease Progression|1
1111311|NCT02485483|2193791|FG000|Overall Study|Depression at baseline|15
1111312|NCT02485483|2193792|FG001|Overall Study|Depression at baseline|0
1111313|NCT02485483|2193791|FG000|Overall Study|Discontinued after baseline|39
1111314|NCT02485483|2193792|FG001|Overall Study|Discontinued after baseline|0
1111316|NCT02485704|2193820|FG000|Overall Study|Lost to Follow-up|4
1111317|NCT02485704|2193821|FG001|Overall Study|Lost to Follow-up|5
1111318|NCT02485704|2193820|FG000|Overall Study|Withdrawal by Subject|0
1111319|NCT02485704|2193821|FG001|Overall Study|Withdrawal by Subject|3
1111320|NCT02485704|2193820|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1
1111321|NCT02485704|2193821|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0
1111322|NCT02485717|2193830|FG000|Overall Study|Lost to Follow-up|6
1111323|NCT02485717|2193831|FG001|Overall Study|Lost to Follow-up|0
1111324|NCT02485717|2193832|FG002|Overall Study|Lost to Follow-up|0
1111325|NCT02485717|2193830|FG000|Overall Study|Withdrawal by Subject|0
1111326|NCT02485717|2193831|FG001|Overall Study|Withdrawal by Subject|0
1111327|NCT02485717|2193832|FG002|Overall Study|Withdrawal by Subject|1
1111328|NCT02485717|2193830|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0
1111329|NCT02485717|2193831|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1
1111330|NCT02485717|2193832|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0
1111331|NCT02485717|2193830|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0
1111332|NCT02485717|2193831|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1
1111333|NCT02485717|2193832|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0
1111334|NCT02485925|2193855|FG000|Overall Study|Withdrawal by Subject|3
1111335|NCT02485925|2193855|FG000|Overall Study|Death|1
1111336|NCT02485925|2193855|FG000|Overall Study|Lost to Follow-up|11
1111337|NCT02486302|2193892|FG000|Overall Study|Discontinued prematurely|410
1111338|NCT02486302|2193892|FG000|Overall Study|Documentation not completed|255
1111339|NCT02486302|2193892|FG000|Overall Study|Excluded due to legal reasons|8
1111340|NCT02486302|2193892|FG000|Overall Study|Not treated|3
1111341|NCT02486406|2193918|FG000|Overall Study|Withdrew consent|1
1111342|NCT02486406|2193919|FG001|Overall Study|Withdrew consent|0
1111343|NCT02486406|2193920|FG002|Overall Study|Withdrew consent|0
1111344|NCT02486406|2193921|FG003|Overall Study|Withdrew consent|1
1111345|NCT02486406|2193918|FG000|Overall Study|Lost to Follow-up|1
1111346|NCT02486406|2193919|FG001|Overall Study|Lost to Follow-up|3
1111347|NCT02486406|2193920|FG002|Overall Study|Lost to Follow-up|1
1111348|NCT02486406|2193921|FG003|Overall Study|Lost to Follow-up|3
1111349|NCT02486406|2193918|FG000|Overall Study|Other, not specified|0
1111350|NCT02486406|2193919|FG001|Overall Study|Other, not specified|0
1111351|NCT02486406|2193920|FG002|Overall Study|Other, not specified|1
1111352|NCT02486406|2193921|FG003|Overall Study|Other, not specified|0
1111353|NCT02486588|2193959|FG000|Overall Study|Randomized in error- ineligible|738
1111354|NCT02486588|2193960|FG001|Overall Study|Randomized in error- ineligible|750
1111355|NCT02486588|2193961|FG002|Overall Study|Randomized in error- ineligible|755
1111356|NCT02486588|2193962|FG003|Overall Study|Randomized in error- ineligible|738
1111357|NCT02486588|2193963|FG004|Overall Study|Randomized in error- ineligible|746
1111358|NCT02486588|2193964|FG005|Overall Study|Randomized in error- ineligible|746
1111359|NCT02486627|2193985|FG000|Overall Study|Death|1
1111360|NCT02486627|2193986|FG001|Overall Study|Death|0
1111361|NCT02486627|2193985|FG000|Overall Study|Other Unspecified|0
1111362|NCT02486627|2193986|FG001|Overall Study|Other Unspecified|2
1111363|NCT02486627|2193985|FG000|Overall Study|Consent Withdrawn by Participant|4
1111364|NCT02486627|2193986|FG001|Overall Study|Consent Withdrawn by Participant|3
1111365|NCT02486627|2193985|FG000|Overall Study|Significant Participant Noncompliance|1
1111366|NCT02486627|2193986|FG001|Overall Study|Significant Participant Noncompliance|1
1111367|NCT02486627|2193985|FG000|Overall Study|Lost to Follow-up|1
1111368|NCT02486627|2193986|FG001|Overall Study|Lost to Follow-up|3
1111369|NCT02486653|2193994|FG000|Overall Study|Withdrawal by Subject|1
1111370|NCT02486653|2193995|FG001|Overall Study|Withdrawal by Subject|3
1111371|NCT02486653|2193994|FG000|Overall Study|Protocol Violation|1
1111372|NCT02486653|2193995|FG001|Overall Study|Protocol Violation|0
1111373|NCT02486653|2193994|FG000|Overall Study|surgery cancelled|4
1111374|NCT02486653|2193995|FG001|Overall Study|surgery cancelled|1
1111375|NCT02486692|2194003|FG000|Overall Study|did not login for randomization|4
1111376|NCT02486692|2194004|FG001|Overall Study|did not login for randomization|7
1111377|NCT02486757|2194010|FG000|Overall Study|Lost to Follow-up|1
1111378|NCT02486796|2194016|FG000|Overall Study|Withdrawal by Subject|1
1111379|NCT02486796|2194017|FG001|Overall Study|Withdrawal by Subject|1
1111380|NCT02486796|2194016|FG000|Overall Study|Physician Decision|1
1111381|NCT02486796|2194017|FG001|Overall Study|Physician Decision|0
1111382|NCT02486952|2194032|FG000|Overall Study|Not Started Induction Therapy|3
1111383|NCT02486952|2194032|FG000|Overall Study|Adverse Event|1
1111384|NCT02486952|2194032|FG000|Overall Study|Death|15
1111385|NCT02486952|2194032|FG000|Overall Study|Lack of Efficacy|3
1111386|NCT02486952|2194032|FG000|Overall Study|Lost to Follow-up|26
1111387|NCT02486952|2194032|FG000|Overall Study|Other|2
1111388|NCT02487030|2194043|FG000|Overall Study|Lack of Efficacy|2
1111389|NCT02487030|2194044|FG001|Overall Study|Lack of Efficacy|4
1111390|NCT02487030|2194045|FG002|Overall Study|Lack of Efficacy|1
1111391|NCT02487030|2194046|FG003|Overall Study|Lack of Efficacy|0
1111392|NCT02487030|2194047|FG004|Overall Study|Lack of Efficacy|1
1111393|NCT02487030|2194048|FG005|Overall Study|Lack of Efficacy|0
1111394|NCT02487030|2194049|FG006|Overall Study|Lack of Efficacy|0
1111395|NCT02487030|2194043|FG000|Overall Study|Lost to Follow-up|0
1111396|NCT02487030|2194044|FG001|Overall Study|Lost to Follow-up|0
1111397|NCT02487030|2194045|FG002|Overall Study|Lost to Follow-up|1
1111398|NCT02487030|2194046|FG003|Overall Study|Lost to Follow-up|1
1111399|NCT02487030|2194047|FG004|Overall Study|Lost to Follow-up|0
1111400|NCT02487030|2194048|FG005|Overall Study|Lost to Follow-up|1
1111401|NCT02487030|2194049|FG006|Overall Study|Lost to Follow-up|0
1111402|NCT02487030|2194043|FG000|Overall Study|Adverse Event|0
1111403|NCT02487030|2194044|FG001|Overall Study|Adverse Event|0
1111404|NCT02487030|2194045|FG002|Overall Study|Adverse Event|0
1111405|NCT02487030|2194046|FG003|Overall Study|Adverse Event|1
1111406|NCT02487030|2194047|FG004|Overall Study|Adverse Event|0
1111407|NCT02487030|2194048|FG005|Overall Study|Adverse Event|0
1111408|NCT02487030|2194049|FG006|Overall Study|Adverse Event|0
1111409|NCT02487030|2194043|FG000|Overall Study|Death|0
1111410|NCT02487030|2194044|FG001|Overall Study|Death|0
1111411|NCT02487030|2194045|FG002|Overall Study|Death|0
1111412|NCT02487030|2194046|FG003|Overall Study|Death|0
1111413|NCT02487030|2194047|FG004|Overall Study|Death|1
1111414|NCT02487030|2194048|FG005|Overall Study|Death|0
1111415|NCT02487030|2194049|FG006|Overall Study|Death|0
1111416|NCT02487199|2194073|FG000|Overall Study|Withdrew Consent|0
1111417|NCT02487199|2194074|FG001|Overall Study|Withdrew Consent|1
1111418|NCT02487446|2194105|FG000|Period 1|Physician Decision|0
1111419|NCT02487446|2194106|FG001|Period 1|Physician Decision|1
1111420|NCT02487446|2194105|FG000|Period 1|Lack of Efficacy|1
1111421|NCT02487446|2194106|FG001|Period 1|Lack of Efficacy|0
1111422|NCT02487446|2194105|FG000|Period 1|Protocol deviation|3
1111423|NCT02487446|2194106|FG001|Period 1|Protocol deviation|2
1111424|NCT02487446|2194105|FG000|Period 1|Lost to Follow-up|2
1111425|NCT02487446|2194106|FG001|Period 1|Lost to Follow-up|0
1111426|NCT02487446|2194105|FG000|Period 1|Withdrawal by Subject|2
1111427|NCT02487446|2194106|FG001|Period 1|Withdrawal by Subject|0
1111428|NCT02487446|2194105|FG000|Period 1|Adverse Event|5
1111429|NCT02487446|2194106|FG001|Period 1|Adverse Event|5
1111430|NCT02487446|2194105|FG000|Washout|Lost to Follow-up|0
1111431|NCT02487446|2194106|FG001|Washout|Lost to Follow-up|2
1111432|NCT02487446|2194105|FG000|Washout|Withdrawal by Subject|1
1111433|NCT02487446|2194106|FG001|Washout|Withdrawal by Subject|4
1111434|NCT02487446|2194105|FG000|Washout|Adverse Event|2
1111435|NCT02487446|2194106|FG001|Washout|Adverse Event|2
1111436|NCT02487446|2194105|FG000|Period 2|Protocol deviation|0
1111437|NCT02487446|2194106|FG001|Period 2|Protocol deviation|1
1111438|NCT02487446|2194105|FG000|Period 2|Lost to Follow-up|1
1111439|NCT02487446|2194106|FG001|Period 2|Lost to Follow-up|1
1111440|NCT02487446|2194105|FG000|Period 2|Withdrawal by Subject|1
1111441|NCT02487446|2194106|FG001|Period 2|Withdrawal by Subject|1
1111442|NCT02487446|2194105|FG000|Period 2|Adverse Event|6
1111443|NCT02487446|2194106|FG001|Period 2|Adverse Event|2
1111444|NCT02487472|2194113|FG000|Overall Study|Did not complete telephonic interviews|9
1111445|NCT02487472|2194113|FG000|Overall Study|Other|2
1111446|NCT02487498|2194128|FG000|Period: Period 1|Adverse Event|2
1111447|NCT02487498|2194129|FG001|Period: Period 1|Adverse Event|4
1111448|NCT02487498|2194128|FG000|Period: Period 1|Subject/guardian decision|2
1111449|NCT02487498|2194129|FG001|Period: Period 1|Subject/guardian decision|4
1111450|NCT02487498|2194128|FG000|Period: Period 1|Lost to Follow-up|0
1111451|NCT02487498|2194129|FG001|Period: Period 1|Lost to Follow-up|2
1111452|NCT02487498|2194128|FG000|Period: Period 1|Lack of Efficacy|1
1111453|NCT02487498|2194129|FG001|Period: Period 1|Lack of Efficacy|0
1111454|NCT02487498|2194128|FG000|Period: Period 1|Physician Decision|0
1111455|NCT02487498|2194129|FG001|Period: Period 1|Physician Decision|1
1111456|NCT02487498|2194128|FG000|Period: Period 1|Protocol deviation|1
1111457|NCT02487498|2194129|FG001|Period: Period 1|Protocol deviation|0
1111458|NCT02487498|2194128|FG000|Period: Washout|Subject/guardian decision|0
1111459|NCT02487498|2194129|FG001|Period: Washout|Subject/guardian decision|5
1111460|NCT02487498|2194128|FG000|Period: Washout|Lack of Efficacy|1
1111461|NCT02487498|2194129|FG001|Period: Washout|Lack of Efficacy|1
1111462|NCT02487498|2194128|FG000|Period: Washout|Physician Decision|1
1111463|NCT02487498|2194129|FG001|Period: Washout|Physician Decision|0
1111464|NCT02487498|2194128|FG000|Period: Washout|Non-compliance with study treatment|0
1111465|NCT02487498|2194129|FG001|Period: Washout|Non-compliance with study treatment|1
1111466|NCT02487498|2194128|FG000|Period: Period 2|Adverse Event|2
1111467|NCT02487498|2194129|FG001|Period: Period 2|Adverse Event|2
1111468|NCT02487498|2194128|FG000|Period: Period 2|Subject/guardian decision|2
1111469|NCT02487498|2194129|FG001|Period: Period 2|Subject/guardian decision|1
1111470|NCT02487498|2194128|FG000|Period: Period 2|Lost to Follow-up|1
1111471|NCT02487498|2194129|FG001|Period: Period 2|Lost to Follow-up|1
1111472|NCT02487498|2194128|FG000|Period: Period 2|Death|0
1111473|NCT02487498|2194129|FG001|Period: Period 2|Death|1
1111474|NCT02487498|2194128|FG000|Period: Period 2|Physician Decision|1
1111475|NCT02487498|2194129|FG001|Period: Period 2|Physician Decision|0
1111476|NCT02487771|2194154|FG000|Overall Study|Lost to Follow-up|2
1111477|NCT02487771|2194155|FG001|Overall Study|Lost to Follow-up|3
1111478|NCT02487771|2194154|FG000|Overall Study|Moved out of area|5
1111479|NCT02487771|2194155|FG001|Overall Study|Moved out of area|6
1111480|NCT02487771|2194154|FG000|Overall Study|Withdrawal by Subject|3
1111481|NCT02487771|2194155|FG001|Overall Study|Withdrawal by Subject|5
1111482|NCT02487810|2194163|FG000|Overall Study|Withdrawal by Subject|1
1111483|NCT02487810|2194164|FG001|Overall Study|Withdrawal by Subject|0
1111487|NCT02488005|2194191|FG000|Overall Study|Lost to Follow-up|2
1111488|NCT02488109|2194206|FG000|Treatment in Hospital|Withdrawal by Subject|0
1111489|NCT02488109|2194207|FG001|Treatment in Hospital|Withdrawal by Subject|5
1111490|NCT02488109|2194206|FG000|12-month Follow-Up|Lost to Follow-up|4
1111491|NCT02488109|2194207|FG001|12-month Follow-Up|Lost to Follow-up|7
1111492|NCT02488239|2194215|FG000|Overall Study|Death|3
1111493|NCT02488239|2194215|FG000|Overall Study|Withdrawal by Subject|3
1111494|NCT02488239|2194215|FG000|Overall Study|Physician Decision|2
1111495|NCT02488239|2194215|FG000|Overall Study|Consent ineligible|1
1111496|NCT02488239|2194215|FG000|Overall Study|Did not undergo implant procedure|1
1111497|NCT02488330|2194233|FG000|Overall Study|Adverse Event|1
1111498|NCT02488330|2194233|FG000|Overall Study|Physician Decision|2
1111499|NCT02488330|2194233|FG000|Overall Study|Death|2
1111500|NCT02488330|2194233|FG000|Overall Study|Disease Progression|3
1111501|NCT02488330|2194233|FG000|Overall Study|Study Termination by Sponsor|4
1111502|NCT02488681|2194237|FG000|Overall Study|Implant unsuccessful|7
1111503|NCT02488824|2194243|FG000|Overall Study|Adverse Event|1
1111504|NCT02488824|2194244|FG001|Overall Study|Adverse Event|1
1111505|NCT02488915|2194250|FG000|Overall Study|Death|21
1111506|NCT02488915|2194250|FG000|Overall Study|Lost to Follow-up|4
1111507|NCT02488915|2194250|FG000|Overall Study|Withdrawal by Subject|1
1111508|NCT02488980|2194257|FG000|Overall Study|Protocol Violation|2
1111509|NCT02488980|2194258|FG001|Overall Study|Protocol Violation|2
1111510|NCT02488980|2194259|FG002|Overall Study|Protocol Violation|2
1111511|NCT02489045|2194267|FG000|Overall Study|unable to collect usable data|53
1111512|NCT02489045|2194267|FG000|Follow-up|Lost to Follow-up|10
1111513|NCT02489279|2194301|FG000|Overall Study|Lost to Follow-up|12
1111514|NCT02489279|2194302|FG001|Overall Study|Lost to Follow-up|10
1111515|NCT02489344|2194308|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
1111516|NCT02489344|2194308|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
1111517|NCT02489344|2194308|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1
1111518|NCT02489344|2194308|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
1111519|NCT02489500|2194328|FG000|Overall Study|Death|1
1111520|NCT02489500|2194329|FG001|Overall Study|Death|1
1111521|NCT02489630|2194337|FG000|Overall Study|Oversedation|1
1111522|NCT02489630|2194338|FG001|Overall Study|Oversedation|1
1111523|NCT02489630|2194337|FG000|Overall Study|Time to med. admin. > protocol limit|1
1111524|NCT02489630|2194338|FG001|Overall Study|Time to med. admin. > protocol limit|1
1111525|NCT02489773|2194355|FG000|Overall Study|Lost to Follow-up|4
1111526|NCT02489773|2194356|FG001|Overall Study|Lost to Follow-up|1
1111527|NCT02489773|2194355|FG000|Overall Study|Physician Decision|1
1111528|NCT02489773|2194356|FG001|Overall Study|Physician Decision|0
1111529|NCT02489773|2194355|FG000|Overall Study|Withdrawal by Subject|1
1111530|NCT02489773|2194356|FG001|Overall Study|Withdrawal by Subject|0
1111531|NCT02489773|2194355|FG000|Overall Study|Leave the country or the state|1
1111532|NCT02489773|2194356|FG001|Overall Study|Leave the country or the state|1
1111533|NCT02489799|2194364|FG000|Overall Study|Lost to Follow-up|4
1111534|NCT02489799|2194365|FG001|Overall Study|Lost to Follow-up|1
1111535|NCT02489799|2194364|FG000|Overall Study|Failure to Maintain Eligibility|4
1111536|NCT02489799|2194365|FG001|Overall Study|Failure to Maintain Eligibility|6
1111537|NCT02489799|2194364|FG000|Overall Study|Withdrawal by Subject|1
1111538|NCT02489799|2194365|FG001|Overall Study|Withdrawal by Subject|1
1111539|NCT02489799|2194364|FG000|Overall Study|Death|0
1111540|NCT02489799|2194365|FG001|Overall Study|Death|1
1111541|NCT02489968|2194373|FG000|Open-label Treatment Period|Adverse Event|14
1111542|NCT02489968|2194374|FG001|Open-label Treatment Period|Adverse Event|7
1111543|NCT02489968|2194375|FG002|Open-label Treatment Period|Adverse Event|0
1111544|NCT02489968|2194376|FG003|Open-label Treatment Period|Adverse Event|0
1111545|NCT02489968|2194377|FG004|Open-label Treatment Period|Adverse Event|0
1111546|NCT02489968|2194378|FG005|Open-label Treatment Period|Adverse Event|0
1111547|NCT02489968|2194373|FG000|Open-label Treatment Period|Protocol Violation|2
1111548|NCT02489968|2194374|FG001|Open-label Treatment Period|Protocol Violation|2
1111549|NCT02489968|2194375|FG002|Open-label Treatment Period|Protocol Violation|0
1111550|NCT02489968|2194376|FG003|Open-label Treatment Period|Protocol Violation|0
1111551|NCT02489968|2194377|FG004|Open-label Treatment Period|Protocol Violation|0
1111552|NCT02489968|2194378|FG005|Open-label Treatment Period|Protocol Violation|0
1111553|NCT02489968|2194373|FG000|Open-label Treatment Period|Lost to Follow-up|0
1111554|NCT02489968|2194374|FG001|Open-label Treatment Period|Lost to Follow-up|3
1111555|NCT02489968|2194375|FG002|Open-label Treatment Period|Lost to Follow-up|0
1111556|NCT02489968|2194376|FG003|Open-label Treatment Period|Lost to Follow-up|0
1111557|NCT02489968|2194377|FG004|Open-label Treatment Period|Lost to Follow-up|0
1111558|NCT02489968|2194378|FG005|Open-label Treatment Period|Lost to Follow-up|0
1111559|NCT02489968|2194373|FG000|Open-label Treatment Period|Withdrawal by Subject|4
1111560|NCT02489968|2194374|FG001|Open-label Treatment Period|Withdrawal by Subject|7
1111561|NCT02489968|2194375|FG002|Open-label Treatment Period|Withdrawal by Subject|0
1111562|NCT02489968|2194376|FG003|Open-label Treatment Period|Withdrawal by Subject|0
1111563|NCT02489968|2194377|FG004|Open-label Treatment Period|Withdrawal by Subject|0
1111564|NCT02489968|2194378|FG005|Open-label Treatment Period|Withdrawal by Subject|0
1111565|NCT02489968|2194373|FG000|Open-label Treatment Period|Other than specified above|204
1111566|NCT02489968|2194374|FG001|Open-label Treatment Period|Other than specified above|189
1111567|NCT02489968|2194375|FG002|Open-label Treatment Period|Other than specified above|0
1111568|NCT02489968|2194376|FG003|Open-label Treatment Period|Other than specified above|0
1111569|NCT02489968|2194377|FG004|Open-label Treatment Period|Other than specified above|0
1111570|NCT02489968|2194378|FG005|Open-label Treatment Period|Other than specified above|0
1111571|NCT02489968|2194373|FG000|Double-blind Treatment Period|Adverse Event|0
1111572|NCT02489968|2194374|FG001|Double-blind Treatment Period|Adverse Event|0
1111573|NCT02489968|2194375|FG002|Double-blind Treatment Period|Adverse Event|2
1111574|NCT02489968|2194376|FG003|Double-blind Treatment Period|Adverse Event|6
1111575|NCT02489968|2194377|FG004|Double-blind Treatment Period|Adverse Event|4
1111576|NCT02489968|2194378|FG005|Double-blind Treatment Period|Adverse Event|5
1111577|NCT02489968|2194373|FG000|Double-blind Treatment Period|Protocol Violation|0
1111578|NCT02489968|2194374|FG001|Double-blind Treatment Period|Protocol Violation|0
1111579|NCT02489968|2194375|FG002|Double-blind Treatment Period|Protocol Violation|0
1111580|NCT02489968|2194376|FG003|Double-blind Treatment Period|Protocol Violation|0
1111581|NCT02489968|2194377|FG004|Double-blind Treatment Period|Protocol Violation|1
1111582|NCT02489968|2194378|FG005|Double-blind Treatment Period|Protocol Violation|1
1111583|NCT02489968|2194373|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
1111584|NCT02489968|2194374|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
1111585|NCT02489968|2194375|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
1111586|NCT02489968|2194376|FG003|Double-blind Treatment Period|Withdrawal by Subject|2
1111587|NCT02489968|2194377|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
1111588|NCT02489968|2194378|FG005|Double-blind Treatment Period|Withdrawal by Subject|2
1111589|NCT02489968|2194373|FG000|Double-blind Treatment Period|Other than specified above|0
1111590|NCT02489968|2194374|FG001|Double-blind Treatment Period|Other than specified above|0
1111591|NCT02489968|2194375|FG002|Double-blind Treatment Period|Other than specified above|0
1111592|NCT02489968|2194376|FG003|Double-blind Treatment Period|Other than specified above|0
1111593|NCT02489968|2194377|FG004|Double-blind Treatment Period|Other than specified above|1
1111594|NCT02489968|2194378|FG005|Double-blind Treatment Period|Other than specified above|0
1111595|NCT02489981|2194390|FG000|Overall Study|Adverse Event|21
1111596|NCT02489981|2194390|FG000|Overall Study|Insufficient effectiveness|16
1111597|NCT02489981|2194390|FG000|Overall Study|Improved|31
1111598|NCT02489981|2194390|FG000|Overall Study|Lost to Follow-up|31
1111599|NCT02489981|2194390|FG000|Overall Study|Other than listed|28
1111600|NCT02490371|2194405|FG000|Overall Study|Lost to Follow-up|1
1111601|NCT02490371|2194406|FG001|Overall Study|Lost to Follow-up|1
1111602|NCT02490475|2194416|FG000|Period 1: First 6 Cycles|Adverse Event|2
1111603|NCT02490475|2194417|FG001|Period 1: First 6 Cycles|Adverse Event|1
1111604|NCT02490475|2194418|FG002|Period 1: First 6 Cycles|Adverse Event|0
1111605|NCT02490475|2194419|FG003|Period 1: First 6 Cycles|Adverse Event|1
1111606|NCT02490475|2194416|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1111607|NCT02490475|2194417|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
1111608|NCT02490475|2194418|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1111609|NCT02490475|2194419|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1111610|NCT02490475|2194416|FG000|Period 1: First 6 Cycles|Refused Treatment|1
1111611|NCT02490475|2194417|FG001|Period 1: First 6 Cycles|Refused Treatment|0
1111612|NCT02490475|2194418|FG002|Period 1: First 6 Cycles|Refused Treatment|0
1111613|NCT02490475|2194419|FG003|Period 1: First 6 Cycles|Refused Treatment|0
1111614|NCT02490475|2194416|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1111615|NCT02490475|2194417|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1111616|NCT02490475|2194418|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
1111617|NCT02490475|2194419|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
1111618|NCT02490475|2194416|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1
1111619|NCT02490475|2194417|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1111620|NCT02490475|2194418|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2
1111621|NCT02490475|2194419|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1111622|NCT02490475|2194416|FG000|Period 2: Extension Phase|Refused Treatment|0
1111623|NCT02490475|2194417|FG001|Period 2: Extension Phase|Refused Treatment|0
1111624|NCT02490475|2194418|FG002|Period 2: Extension Phase|Refused Treatment|0
1111625|NCT02490475|2194419|FG003|Period 2: Extension Phase|Refused Treatment|1
1111626|NCT02490475|2194416|FG000|Period 2: Extension Phase|Adverse Event|0
1111627|NCT02490475|2194417|FG001|Period 2: Extension Phase|Adverse Event|0
1111628|NCT02490475|2194418|FG002|Period 2: Extension Phase|Adverse Event|1
1111629|NCT02490475|2194419|FG003|Period 2: Extension Phase|Adverse Event|0
1111630|NCT02490878|2194460|FG000|Overall Study|deemed ineligible|0
1111631|NCT02490878|2194461|FG001|Overall Study|deemed ineligible|1
1111632|NCT02490878|2194460|FG000|Overall Study|progression prior to treatment|0
1111633|NCT02490878|2194461|FG001|Overall Study|progression prior to treatment|1
1111634|NCT02490878|2194460|FG000|Overall Study|only submitted baseline QOL|0
1111635|NCT02490878|2194461|FG001|Overall Study|only submitted baseline QOL|1
1111636|NCT02491073|2194469|FG000|Overall Study|screen failure|1
1111637|NCT02491073|2194470|FG001|Overall Study|screen failure|0
1111638|NCT02491463|2194513|FG000|Overall Study|Withdrawal by Subject|1
1111639|NCT02491463|2194514|FG001|Overall Study|Withdrawal by Subject|2
1111640|NCT02491463|2194515|FG002|Overall Study|Withdrawal by Subject|0
1111641|NCT02491463|2194516|FG003|Overall Study|Withdrawal by Subject|0
1111642|NCT02491463|2194513|FG000|Overall Study|Migrated/moved from study area|1
1111643|NCT02491463|2194514|FG001|Overall Study|Migrated/moved from study area|5
1111644|NCT02491463|2194515|FG002|Overall Study|Migrated/moved from study area|1
1111645|NCT02491463|2194516|FG003|Overall Study|Migrated/moved from study area|1
1111646|NCT02491463|2194513|FG000|Overall Study|Lost to Follow-up|0
1111647|NCT02491463|2194514|FG001|Overall Study|Lost to Follow-up|3
1111648|NCT02491463|2194515|FG002|Overall Study|Lost to Follow-up|3
1111649|NCT02491463|2194516|FG003|Overall Study|Lost to Follow-up|0
1111650|NCT02491671|2194528|FG000|Overall Study|Adverse Event|6
1111651|NCT02491671|2194529|FG001|Overall Study|Adverse Event|8
1111652|NCT02491671|2194528|FG000|Overall Study|Death|0
1111653|NCT02491671|2194529|FG001|Overall Study|Death|2
1111654|NCT02491671|2194528|FG000|Overall Study|Use of sealants other than Hemopatch|5
1111655|NCT02491671|2194529|FG001|Overall Study|Use of sealants other than Hemopatch|3
1111656|NCT02491684|2194537|FG000|Treatment Phase|Adverse Event|2
1111657|NCT02491684|2194538|FG001|Treatment Phase|Adverse Event|2
1111658|NCT02491684|2194537|FG000|Treatment Phase|Incorrect randomisation|1
1111659|NCT02491684|2194538|FG001|Treatment Phase|Incorrect randomisation|0
1111660|NCT02491684|2194537|FG000|Treatment Phase|Investigator and Sponsor decision|0
1111661|NCT02491684|2194538|FG001|Treatment Phase|Investigator and Sponsor decision|1
1111662|NCT02491892|2194555|FG000|Overall Study|Adverse Event|1
1111663|NCT02491892|2194556|FG001|Overall Study|Adverse Event|1
1111664|NCT02491892|2194555|FG000|Overall Study|Death|1
1111665|NCT02491892|2194556|FG001|Overall Study|Death|1
1111666|NCT02491892|2194555|FG000|Overall Study|Lack of Efficacy|37
1111667|NCT02491892|2194556|FG001|Overall Study|Lack of Efficacy|36
1111668|NCT02491892|2194555|FG000|Overall Study|Refused Treatment|1
1111669|NCT02491892|2194556|FG001|Overall Study|Refused Treatment|0
1111670|NCT02491892|2194555|FG000|Overall Study|Lost to Follow-up|1
1111671|NCT02491892|2194556|FG001|Overall Study|Lost to Follow-up|0
1111672|NCT02492100|2194566|FG000|Overall Study|Death|1
1111673|NCT02492165|2194575|FG000|Overall Study|Withdrawal by Subject|0
1111674|NCT02492165|2194576|FG001|Overall Study|Withdrawal by Subject|1
1111675|NCT02492165|2194577|FG002|Overall Study|Withdrawal by Subject|0
1111676|NCT02492165|2194578|FG003|Overall Study|Withdrawal by Subject|0
1111677|NCT02492763|2194618|FG000|Overall Study|Withdrawal by Subject|0
1111678|NCT02492763|2194619|FG001|Overall Study|Withdrawal by Subject|2
1111679|NCT02492763|2194620|FG002|Overall Study|Withdrawal by Subject|1
1111680|NCT02492763|2194621|FG003|Overall Study|Withdrawal by Subject|0
1111681|NCT02492763|2194618|FG000|Overall Study|Adverse Event|3
1111682|NCT02492763|2194619|FG001|Overall Study|Adverse Event|1
1111683|NCT02492763|2194620|FG002|Overall Study|Adverse Event|1
1111684|NCT02492763|2194621|FG003|Overall Study|Adverse Event|2
1111685|NCT02492763|2194618|FG000|Overall Study|Death|0
1111686|NCT02492763|2194619|FG001|Overall Study|Death|0
1111687|NCT02492763|2194620|FG002|Overall Study|Death|1
1111688|NCT02492763|2194621|FG003|Overall Study|Death|0
1111689|NCT02492763|2194618|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0
1111690|NCT02492763|2194619|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1
1111691|NCT02492763|2194620|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0
1111692|NCT02492763|2194621|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0
1111693|NCT02492763|2194618|FG000|Overall Study|Lost to Follow-up|0
1111694|NCT02492763|2194619|FG001|Overall Study|Lost to Follow-up|0
1111695|NCT02492763|2194620|FG002|Overall Study|Lost to Follow-up|1
1111696|NCT02492763|2194621|FG003|Overall Study|Lost to Follow-up|0
1111697|NCT02492763|2194618|FG000|Overall Study|Non-Compliance With Study Drug|0
1111698|NCT02492763|2194619|FG001|Overall Study|Non-Compliance With Study Drug|1
1111699|NCT02492763|2194620|FG002|Overall Study|Non-Compliance With Study Drug|0
1111700|NCT02492763|2194621|FG003|Overall Study|Non-Compliance With Study Drug|0
1111701|NCT02492763|2194618|FG000|Overall Study|Screen Failure|0
1111702|NCT02492763|2194619|FG001|Overall Study|Screen Failure|0
1111703|NCT02492763|2194620|FG002|Overall Study|Screen Failure|0
1111704|NCT02492763|2194621|FG003|Overall Study|Screen Failure|1
1111705|NCT02492763|2194618|FG000|Overall Study|Study Terminated by Sponsor|13
1111706|NCT02492763|2194619|FG001|Overall Study|Study Terminated by Sponsor|10
1111707|NCT02492763|2194620|FG002|Overall Study|Study Terminated by Sponsor|6
1111708|NCT02492763|2194621|FG003|Overall Study|Study Terminated by Sponsor|10
1111709|NCT02492841|2194638|FG000|Overall Study|Lost to Follow-up|34
1111710|NCT02492841|2194639|FG001|Overall Study|Lost to Follow-up|31
1111711|NCT02492841|2194640|FG002|Overall Study|Lost to Follow-up|35
1111712|NCT02492880|2194660|FG000|Overall Study|Lost to Follow-up|1
1111713|NCT02492880|2194660|FG000|Overall Study|Protocol Violation|1
1111714|NCT02492958|2194668|FG000|Overall Study|Withdrawal by Subject|0
1111715|NCT02492958|2194669|FG001|Overall Study|Withdrawal by Subject|0
1111716|NCT02492958|2194670|FG002|Overall Study|Withdrawal by Subject|1
1111717|NCT02492958|2194671|FG003|Overall Study|Withdrawal by Subject|0
1111718|NCT02492958|2194668|FG000|Overall Study|Adverse Event|1
1111719|NCT02492958|2194669|FG001|Overall Study|Adverse Event|0
1111720|NCT02492958|2194670|FG002|Overall Study|Adverse Event|1
1111721|NCT02492958|2194671|FG003|Overall Study|Adverse Event|0
1111722|NCT02492984|2194683|FG000|Overall Study|Adverse Event|1
1111723|NCT02492984|2194684|FG001|Overall Study|Adverse Event|0
1111724|NCT02492984|2194683|FG000|Overall Study|Protocol Violation|1
1111725|NCT02492984|2194684|FG001|Overall Study|Protocol Violation|0
1111726|NCT02492984|2194683|FG000|Overall Study|Withdrawal by Subject|1
1111727|NCT02492984|2194684|FG001|Overall Study|Withdrawal by Subject|0
1111728|NCT02492997|2194695|FG000|Overall Study|Withdrawal by Subject|1
1111729|NCT02492997|2194696|FG001|Overall Study|Withdrawal by Subject|0
1111730|NCT02492997|2194695|FG000|Overall Study|Gained Weight|1
1111731|NCT02492997|2194696|FG001|Overall Study|Gained Weight|0
1111732|NCT02492997|2194695|FG000|Overall Study|Lost to Follow-up|0
1111733|NCT02492997|2194696|FG001|Overall Study|Lost to Follow-up|1
1111734|NCT02493062|2194715|FG000|Overall Study|Physician Decision|12
1111735|NCT02493127|2194725|FG000|Overall Study|Lost to Follow-up|1
1111736|NCT02493127|2194726|FG001|Overall Study|Lost to Follow-up|1
1111737|NCT02493361|2194743|FG000|Overall Study|Withdrawal by Subject|3
1111738|NCT02493517|2194762|FG000|Overall Study|Protocol Violation|1
1111739|NCT02493517|2194763|FG001|Overall Study|Protocol Violation|2
1111740|NCT02493517|2194762|FG000|Overall Study|Withdrawal by Subject|1
1111741|NCT02493517|2194763|FG001|Overall Study|Withdrawal by Subject|2
1111742|NCT02493517|2194762|FG000|Overall Study|Adverse Event|0
1111743|NCT02493517|2194763|FG001|Overall Study|Adverse Event|2
1111744|NCT02493517|2194762|FG000|Overall Study|Missed study visit|0
1111745|NCT02493517|2194763|FG001|Overall Study|Missed study visit|1
1111746|NCT02493660|2194791|FG000|Overall Study|Physician Decision|0
1111747|NCT02493660|2194792|FG001|Overall Study|Physician Decision|1
1111748|NCT02493712|2194801|FG000|Overall Study|Withdrawal by Subject|1
1111749|NCT02493712|2194802|FG001|Overall Study|Withdrawal by Subject|0
1111750|NCT02493712|2194803|FG002|Overall Study|Withdrawal by Subject|2
1111751|NCT02493712|2194801|FG000|Overall Study|Protocol Violation|0
1111752|NCT02493712|2194802|FG001|Overall Study|Protocol Violation|0
1111753|NCT02493712|2194803|FG002|Overall Study|Protocol Violation|1
1111754|NCT02493712|2194801|FG000|Overall Study|Lost to Follow-up|1
1111755|NCT02493712|2194802|FG001|Overall Study|Lost to Follow-up|0
1111756|NCT02493712|2194803|FG002|Overall Study|Lost to Follow-up|0
1111757|NCT02493712|2194801|FG000|Overall Study|Physician Decision|0
1111758|NCT02493712|2194802|FG001|Overall Study|Physician Decision|1
1111759|NCT02493712|2194803|FG002|Overall Study|Physician Decision|0
1111760|NCT02493712|2194801|FG000|Overall Study|Lack of Efficacy|0
1111761|NCT02493712|2194802|FG001|Overall Study|Lack of Efficacy|5
1111762|NCT02493712|2194803|FG002|Overall Study|Lack of Efficacy|3
1111763|NCT02493751|2194813|FG000|Overall Study|Lost to Follow-up|0
1111764|NCT02493751|2194814|FG001|Overall Study|Lost to Follow-up|1
1111765|NCT02493751|2194813|FG000|Overall Study|Withdrawal by Subject|2
1111766|NCT02493751|2194814|FG001|Overall Study|Withdrawal by Subject|5
1111767|NCT02493751|2194813|FG000|Overall Study|Ongoing|11
1111768|NCT02493751|2194814|FG001|Overall Study|Ongoing|23
1111769|NCT02493764|2194821|FG000|Overall Study|Adverse Event|2
1111770|NCT02493764|2194822|FG001|Overall Study|Adverse Event|2
1111771|NCT02493764|2194821|FG000|Overall Study|Death|44
1111772|NCT02493764|2194822|FG001|Overall Study|Death|58
1111773|NCT02493764|2194821|FG000|Overall Study|Lost to Follow-up|2
1111774|NCT02493764|2194822|FG001|Overall Study|Lost to Follow-up|1
1111775|NCT02493764|2194821|FG000|Overall Study|Protocol Violation|6
1111776|NCT02493764|2194822|FG001|Overall Study|Protocol Violation|7
1111777|NCT02493764|2194821|FG000|Overall Study|Physician Decision|1
1111778|NCT02493764|2194822|FG001|Overall Study|Physician Decision|1
1111779|NCT02493764|2194821|FG000|Overall Study|Participant moved|17
1111780|NCT02493764|2194822|FG001|Overall Study|Participant moved|5
1111781|NCT02493764|2194821|FG000|Overall Study|Withdrawal parent/guardian|0
1111782|NCT02493764|2194822|FG001|Overall Study|Withdrawal parent/guardian|1
1111783|NCT02493764|2194821|FG000|Overall Study|Withdrawal by Subject|11
1111784|NCT02493764|2194822|FG001|Overall Study|Withdrawal by Subject|7
1111785|NCT02493777|2194830|FG000|Overall Study|Lost to Follow-up|0
1111786|NCT02493777|2194831|FG001|Overall Study|Lost to Follow-up|1
1111787|NCT02493855|2194840|FG000|Overall Study|Non-compliance|1
1111788|NCT02493855|2194841|FG001|Overall Study|Non-compliance|0
1111789|NCT02493855|2194842|FG002|Overall Study|Non-compliance|0
1111790|NCT02493855|2194840|FG000|Overall Study|Adverse Event|0
1111791|NCT02493855|2194841|FG001|Overall Study|Adverse Event|1
1111792|NCT02493855|2194842|FG002|Overall Study|Adverse Event|0
1111793|NCT02493855|2194840|FG000|Overall Study|Withdrawal by Subject|1
1111794|NCT02493855|2194841|FG001|Overall Study|Withdrawal by Subject|0
1111795|NCT02493855|2194842|FG002|Overall Study|Withdrawal by Subject|0
1111796|NCT02493868|2194850|FG000|Induction Phase: DE Participants|Adverse Event|22
1111797|NCT02493868|2194851|FG001|Induction Phase: DE Participants|Adverse Event|0
1111798|NCT02493868|2194850|FG000|Induction Phase: DE Participants|Lost to Follow-up|1
1111799|NCT02493868|2194851|FG001|Induction Phase: DE Participants|Lost to Follow-up|0
1111800|NCT02493868|2194850|FG000|Induction Phase: DE Participants|Lack of Efficacy|2
1111801|NCT02493868|2194851|FG001|Induction Phase: DE Participants|Lack of Efficacy|0
1111802|NCT02493868|2194850|FG000|Induction Phase: DE Participants|Protocol Violation|2
1111803|NCT02493868|2194851|FG001|Induction Phase: DE Participants|Protocol Violation|0
1111804|NCT02493868|2194850|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15
1111805|NCT02493868|2194851|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0
1111806|NCT02493868|2194850|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
1111807|NCT02493868|2194851|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
1111808|NCT02493868|2194850|FG000|Induction Phase: DE Participants|Other|8
1111809|NCT02493868|2194851|FG001|Induction Phase: DE Participants|Other|0
1111810|NCT02493868|2194850|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5
1111811|NCT02493868|2194851|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0
1111812|NCT02493868|2194850|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
1111813|NCT02493868|2194851|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
1111814|NCT02493868|2194850|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
1111815|NCT02493868|2194851|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
1111816|NCT02493868|2194850|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4
1111817|NCT02493868|2194851|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1
1111818|NCT02493868|2194850|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
1111819|NCT02493868|2194851|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
1111820|NCT02493868|2194850|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
1111821|NCT02493868|2194851|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
1111822|NCT02493868|2194850|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
1111823|NCT02493868|2194851|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
1111824|NCT02493868|2194850|FG000|Optimization Phase: DE+TE Participants|Other|10
1111825|NCT02493868|2194851|FG001|Optimization Phase: DE+TE Participants|Other|2
1111826|NCT02493868|2194850|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1
1111827|NCT02493868|2194851|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4
1111828|NCT02493868|2194850|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
1111829|NCT02493868|2194851|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
1111830|NCT02493868|2194850|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1
1111831|NCT02493868|2194851|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1
1111832|NCT02493868|2194850|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
1111833|NCT02493868|2194851|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
1111834|NCT02493868|2194850|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1
1111835|NCT02493868|2194851|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0
1111836|NCT02493868|2194850|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
1111837|NCT02493868|2194851|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
1111838|NCT02493868|2194850|FG000|Maintenance Phase: DE+TE Participants|Other|4
1111839|NCT02493868|2194851|FG001|Maintenance Phase: DE+TE Participants|Other|9
1111840|NCT02493868|2194850|FG000|Follow-up Phase|Lost to Follow-up|1
1111841|NCT02493868|2194851|FG001|Follow-up Phase|Lost to Follow-up|0
1111842|NCT02493868|2194850|FG000|Follow-up Phase|Withdrawal by Subject|3
1111843|NCT02493868|2194851|FG001|Follow-up Phase|Withdrawal by Subject|0
1111844|NCT02493868|2194850|FG000|Follow-up Phase|Investigator Decision|5
1111845|NCT02493868|2194851|FG001|Follow-up Phase|Investigator Decision|1
1111846|NCT02493868|2194850|FG000|Follow-up Phase|Other|2
1111847|NCT02493868|2194851|FG001|Follow-up Phase|Other|1
1111848|NCT02493946|2194866|FG000|DB Period|Withdrawal by Subject|8
1111849|NCT02493946|2194867|FG001|DB Period|Withdrawal by Subject|5
1111850|NCT02493946|2194868|FG002|DB Period|Withdrawal by Subject|0
1111851|NCT02493946|2194866|FG000|Open Label Period|Withdrawal by Subject|0
1111852|NCT02493946|2194867|FG001|Open Label Period|Withdrawal by Subject|0
1111853|NCT02493946|2194868|FG002|Open Label Period|Withdrawal by Subject|74
1111854|NCT02493946|2194866|FG000|Open Label Period|Adverse Event|0
1111855|NCT02493946|2194867|FG001|Open Label Period|Adverse Event|0
1111856|NCT02493946|2194868|FG002|Open Label Period|Adverse Event|4
1111857|NCT02493946|2194866|FG000|Open Label Period|Lost to Follow-up|0
1111858|NCT02493946|2194867|FG001|Open Label Period|Lost to Follow-up|0
1111859|NCT02493946|2194868|FG002|Open Label Period|Lost to Follow-up|1
1111860|NCT02493946|2194866|FG000|Open Label Period|Investigator decision, non-compliance|0
1111861|NCT02493946|2194867|FG001|Open Label Period|Investigator decision, non-compliance|0
1111862|NCT02493946|2194868|FG002|Open Label Period|Investigator decision, non-compliance|2
1111863|NCT02493946|2194866|FG000|Open Label Period|Investigator decision, non-availability|0
1111864|NCT02493946|2194867|FG001|Open Label Period|Investigator decision, non-availability|0
1111865|NCT02493946|2194868|FG002|Open Label Period|Investigator decision, non-availability|1
1111866|NCT02493946|2194866|FG000|Open Label Period|Pregnancy|0
1111867|NCT02493946|2194867|FG001|Open Label Period|Pregnancy|0
1111868|NCT02493946|2194868|FG002|Open Label Period|Pregnancy|3
1111869|NCT02493946|2194866|FG000|Open Label Period|Site error|0
1111870|NCT02493946|2194867|FG001|Open Label Period|Site error|0
1111871|NCT02493946|2194868|FG002|Open Label Period|Site error|1
1111872|NCT02494401|2194922|FG000|Overall Study|Lost to Follow-up|22
1111873|NCT02494401|2194923|FG001|Overall Study|Lost to Follow-up|25
1111874|NCT02494401|2194922|FG000|Overall Study|Withdrawal by Subject|3
1111875|NCT02494401|2194923|FG001|Overall Study|Withdrawal by Subject|2
1111876|NCT02494583|2194949|FG000|Overall Study|Death|195
1111877|NCT02494583|2194950|FG001|Overall Study|Death|189
1111878|NCT02494583|2194951|FG002|Overall Study|Death|201
1111879|NCT02494583|2194949|FG000|Overall Study|Lost to Follow-up|1
1111880|NCT02494583|2194950|FG001|Overall Study|Lost to Follow-up|0
1111881|NCT02494583|2194951|FG002|Overall Study|Lost to Follow-up|0
1111882|NCT02494583|2194949|FG000|Overall Study|Protocol Violation|1
1111883|NCT02494583|2194950|FG001|Overall Study|Protocol Violation|2
1111884|NCT02494583|2194951|FG002|Overall Study|Protocol Violation|0
1111885|NCT02494583|2194949|FG000|Overall Study|Withdrawal by Subject|3
1111886|NCT02494583|2194950|FG001|Overall Study|Withdrawal by Subject|15
1111887|NCT02494583|2194951|FG002|Overall Study|Withdrawal by Subject|15
1111888|NCT02494583|2194949|FG000|Overall Study|Ongoing in Study|56
1111889|NCT02494583|2194950|FG001|Overall Study|Ongoing in Study|51
1111890|NCT02494583|2194951|FG002|Overall Study|Ongoing in Study|34
1111891|NCT02494596|2194959|FG000|Overall Study|Insufficient Therapeutic Response|3
1111892|NCT02494596|2194960|FG001|Overall Study|Insufficient Therapeutic Response|3
1111893|NCT02494596|2194961|FG002|Overall Study|Insufficient Therapeutic Response|1
1111894|NCT02494596|2194959|FG000|Overall Study|Adverse Event|0
1111895|NCT02494596|2194960|FG001|Overall Study|Adverse Event|1
1111896|NCT02494596|2194961|FG002|Overall Study|Adverse Event|0
1111897|NCT02494596|2194959|FG000|Overall Study|Refused Treatment|0
1111898|NCT02494596|2194960|FG001|Overall Study|Refused Treatment|1
1111899|NCT02494596|2194961|FG002|Overall Study|Refused Treatment|0
1111900|NCT02494778|2194976|FG000|Overall Study|Death|3
1111901|NCT02494778|2194976|FG000|Overall Study|Other|173
1111902|NCT02494778|2194976|FG000|Overall Study|Lack of Efficacy|4
1111903|NCT02494778|2194976|FG000|Overall Study|Adverse Event|18
1111904|NCT02494778|2194976|FG000|Overall Study|Withdrawal by Subject|20
1111905|NCT02494778|2194976|FG000|Overall Study|Lost to Follow-up|2
1111906|NCT02494778|2194976|FG000|Overall Study|Noncompliant with study drug admin.|1
1111907|NCT02495025|2194991|FG000|Overall Study|Lost to Follow-up|21
1111908|NCT02495025|2194992|FG001|Overall Study|Lost to Follow-up|14
1111909|NCT02495025|2194991|FG000|Overall Study|Withdrawal by Subject|5
1111910|NCT02495025|2194992|FG001|Overall Study|Withdrawal by Subject|0
1111911|NCT02495168|2195025|FG000|Overall Study|Other than Specified|18
1111912|NCT02495168|2195026|FG001|Overall Study|Other than Specified|22
1111913|NCT02495168|2195027|FG002|Overall Study|Other than Specified|5
1111914|NCT02495168|2195025|FG000|Overall Study|Did not Complete Final Visit On Time|4
1111915|NCT02495168|2195026|FG001|Overall Study|Did not Complete Final Visit On Time|3
1111916|NCT02495168|2195027|FG002|Overall Study|Did not Complete Final Visit On Time|2
1111917|NCT02495168|2195025|FG000|Overall Study|Physician Decision|1
1111918|NCT02495168|2195026|FG001|Overall Study|Physician Decision|1
1111919|NCT02495168|2195027|FG002|Overall Study|Physician Decision|0
1111920|NCT02495168|2195025|FG000|Overall Study|Lost to Follow-up|10
1111921|NCT02495168|2195026|FG001|Overall Study|Lost to Follow-up|6
1111922|NCT02495168|2195027|FG002|Overall Study|Lost to Follow-up|1
1111923|NCT02495168|2195025|FG000|Overall Study|Withdrawal by Subject|1
1111924|NCT02495168|2195026|FG001|Overall Study|Withdrawal by Subject|4
1111925|NCT02495168|2195027|FG002|Overall Study|Withdrawal by Subject|2
1111926|NCT02495168|2195025|FG000|Overall Study|Protocol Violation|0
1111927|NCT02495168|2195026|FG001|Overall Study|Protocol Violation|10
1111928|NCT02495168|2195027|FG002|Overall Study|Protocol Violation|1
1111929|NCT02495168|2195025|FG000|Overall Study|Adverse Event|4
1111930|NCT02495168|2195026|FG001|Overall Study|Adverse Event|8
1111931|NCT02495168|2195027|FG002|Overall Study|Adverse Event|3
1111932|NCT02495168|2195025|FG000|Overall Study|Lack of Efficacy|0
1111933|NCT02495168|2195026|FG001|Overall Study|Lack of Efficacy|0
1111934|NCT02495168|2195027|FG002|Overall Study|Lack of Efficacy|3
1111935|NCT02495233|2195037|FG000|Overall Study|Miscellaneous|0
1111936|NCT02495233|2195038|FG001|Overall Study|Miscellaneous|1
1111937|NCT02495389|2195057|FG000|Overall Study|Withdrawal by Subject|40
1111938|NCT02495844|2195101|FG000|Overall Study|Lack of Efficacy|1
1111939|NCT02495844|2195102|FG001|Overall Study|Lack of Efficacy|2
1111940|NCT02495844|2195101|FG000|Overall Study|AE, non-fatal|0
1111941|NCT02495844|2195102|FG001|Overall Study|AE, non-fatal|1
1111942|NCT02495844|2195101|FG000|Overall Study|Hepatitis Positivity|0
1111943|NCT02495844|2195102|FG001|Overall Study|Hepatitis Positivity|1
1111944|NCT02495857|2195113|FG000|Overall Study|Adverse Event|5
1111945|NCT02495857|2195114|FG001|Overall Study|Adverse Event|0
1111946|NCT02495857|2195115|FG002|Overall Study|Adverse Event|1
1111947|NCT02495857|2195113|FG000|Overall Study|Withdrawal by Subject|9
1111948|NCT02495857|2195114|FG001|Overall Study|Withdrawal by Subject|6
1111949|NCT02495857|2195115|FG002|Overall Study|Withdrawal by Subject|10
1111950|NCT02495857|2195113|FG000|Overall Study|Physician Decision|0
1111951|NCT02495857|2195114|FG001|Overall Study|Physician Decision|1
1111952|NCT02495857|2195115|FG002|Overall Study|Physician Decision|0
1111953|NCT02495857|2195113|FG000|Overall Study|Protocol Violation|1
1111954|NCT02495857|2195114|FG001|Overall Study|Protocol Violation|1
1111955|NCT02495857|2195115|FG002|Overall Study|Protocol Violation|2
1111956|NCT02495857|2195113|FG000|Overall Study|Lost to Follow-up|4
1111957|NCT02495857|2195114|FG001|Overall Study|Lost to Follow-up|5
1111958|NCT02495857|2195115|FG002|Overall Study|Lost to Follow-up|3
1111959|NCT02495857|2195113|FG000|Overall Study|Other|3
1111960|NCT02495857|2195114|FG001|Overall Study|Other|3
1111961|NCT02495857|2195115|FG002|Overall Study|Other|2
1111962|NCT02495883|2195125|FG000|Overall Study|Excessive head motion|1
1111963|NCT02495883|2195126|FG001|Overall Study|Excessive head motion|0
1111964|NCT02495948|2195131|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
1111965|NCT02495948|2195132|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
1111966|NCT02495948|2195131|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1111967|NCT02495948|2195132|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1111968|NCT02496000|2195142|FG000|Overall Study|Withdrawal by Subject|1
1111969|NCT02496000|2195143|FG001|Overall Study|Withdrawal by Subject|2
1111970|NCT02496000|2195144|FG002|Overall Study|Withdrawal by Subject|0
1111971|NCT02496000|2195142|FG000|Overall Study|Lost to Follow-up|1
1111972|NCT02496000|2195143|FG001|Overall Study|Lost to Follow-up|0
1111973|NCT02496000|2195144|FG002|Overall Study|Lost to Follow-up|1
1111974|NCT02496000|2195142|FG000|Overall Study|Protocol Violation|0
1111975|NCT02496000|2195143|FG001|Overall Study|Protocol Violation|0
1111976|NCT02496000|2195144|FG002|Overall Study|Protocol Violation|1
1111977|NCT02496000|2195142|FG000|Overall Study|Non-compliance or lack of cooperation|0
1111978|NCT02496000|2195143|FG001|Overall Study|Non-compliance or lack of cooperation|2
1111979|NCT02496000|2195144|FG002|Overall Study|Non-compliance or lack of cooperation|0
1111980|NCT02496000|2195142|FG000|Overall Study|undetermined|0
1111981|NCT02496000|2195143|FG001|Overall Study|undetermined|1
1111982|NCT02496000|2195144|FG002|Overall Study|undetermined|0
1111983|NCT02496091|2195153|FG000|Overall Study|Eligibility criteria not fulfilled|2
1111984|NCT02496221|2195158|FG000|Treatment Period 2 - 4 Days|Adverse Event|0
1111985|NCT02496221|2195159|FG001|Treatment Period 2 - 4 Days|Adverse Event|1
1111986|NCT02496221|2195158|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1
1111987|NCT02496221|2195159|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0
1111988|NCT02496221|2195158|FG000|Treatment Period 2 - 4 Days|Physician Decision|1
1111989|NCT02496221|2195159|FG001|Treatment Period 2 - 4 Days|Physician Decision|0
1111990|NCT02496533|2195169|FG000|Overall Study|Lack of data on outcome|3
1111991|NCT02496533|2195170|FG001|Overall Study|Lack of data on outcome|0
1111992|NCT02496533|2195169|FG000|Overall Study|Patient did not complete all measures|0
1111993|NCT02496533|2195170|FG001|Overall Study|Patient did not complete all measures|4
1111994|NCT02496533|2195169|FG000|Overall Study|Late for radiologic testing|0
1111995|NCT02496533|2195170|FG001|Overall Study|Late for radiologic testing|2
1111996|NCT02496702|2195178|FG000|Overall Study|Lost to Follow-up|8
1111997|NCT02496702|2195179|FG001|Overall Study|Lost to Follow-up|6
1111998|NCT02496702|2195178|FG000|Overall Study|Only partially tested|0
1111999|NCT02496702|2195179|FG001|Overall Study|Only partially tested|2
1112000|NCT02496767|2195189|FG000|Open-label Lead-in Phase|Adverse Event|176
1112001|NCT02496767|2195190|FG001|Open-label Lead-in Phase|Adverse Event|0
1112002|NCT02496767|2195191|FG002|Open-label Lead-in Phase|Adverse Event|0
1112003|NCT02496767|2195192|FG003|Open-label Lead-in Phase|Adverse Event|0
1112004|NCT02496767|2195193|FG004|Open-label Lead-in Phase|Adverse Event|0
1112005|NCT02496767|2195194|FG005|Open-label Lead-in Phase|Adverse Event|0
1112006|NCT02496767|2195195|FG006|Open-label Lead-in Phase|Adverse Event|0
1112007|NCT02496767|2195196|FG007|Open-label Lead-in Phase|Adverse Event|0
1112008|NCT02496767|2195189|FG000|Open-label Lead-in Phase|Protocol Violation|2
1112009|NCT02496767|2195190|FG001|Open-label Lead-in Phase|Protocol Violation|0
1112010|NCT02496767|2195191|FG002|Open-label Lead-in Phase|Protocol Violation|0
1112011|NCT02496767|2195192|FG003|Open-label Lead-in Phase|Protocol Violation|0
1112012|NCT02496767|2195193|FG004|Open-label Lead-in Phase|Protocol Violation|0
1112013|NCT02496767|2195194|FG005|Open-label Lead-in Phase|Protocol Violation|0
1112014|NCT02496767|2195195|FG006|Open-label Lead-in Phase|Protocol Violation|0
1112015|NCT02496767|2195196|FG007|Open-label Lead-in Phase|Protocol Violation|0
1112016|NCT02496767|2195189|FG000|Open-label Lead-in Phase|Lost to Follow-up|1
1112017|NCT02496767|2195190|FG001|Open-label Lead-in Phase|Lost to Follow-up|0
1112018|NCT02496767|2195191|FG002|Open-label Lead-in Phase|Lost to Follow-up|0
1112019|NCT02496767|2195192|FG003|Open-label Lead-in Phase|Lost to Follow-up|0
1112020|NCT02496767|2195193|FG004|Open-label Lead-in Phase|Lost to Follow-up|0
1112021|NCT02496767|2195194|FG005|Open-label Lead-in Phase|Lost to Follow-up|0
1112022|NCT02496767|2195195|FG006|Open-label Lead-in Phase|Lost to Follow-up|0
1112023|NCT02496767|2195196|FG007|Open-label Lead-in Phase|Lost to Follow-up|0
1112024|NCT02496767|2195189|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
1112025|NCT02496767|2195190|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13
1112026|NCT02496767|2195191|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23
1112027|NCT02496767|2195192|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43
1112028|NCT02496767|2195193|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43
1112029|NCT02496767|2195194|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0
1112030|NCT02496767|2195195|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0
1112031|NCT02496767|2195196|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0
1112032|NCT02496767|2195189|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0
1112033|NCT02496767|2195190|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13
1112034|NCT02496767|2195191|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9
1112035|NCT02496767|2195192|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8
1112036|NCT02496767|2195193|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14
1112037|NCT02496767|2195194|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0
1112038|NCT02496767|2195195|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0
1112039|NCT02496767|2195196|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0
1112040|NCT02496767|2195189|FG000|Double-blind, Placebo-controlled Phase|Death|0
1112041|NCT02496767|2195190|FG001|Double-blind, Placebo-controlled Phase|Death|10
1112042|NCT02496767|2195191|FG002|Double-blind, Placebo-controlled Phase|Death|6
1112043|NCT02496767|2195192|FG003|Double-blind, Placebo-controlled Phase|Death|2
1112044|NCT02496767|2195193|FG004|Double-blind, Placebo-controlled Phase|Death|4
1112045|NCT02496767|2195194|FG005|Double-blind, Placebo-controlled Phase|Death|0
1112046|NCT02496767|2195195|FG006|Double-blind, Placebo-controlled Phase|Death|0
1112047|NCT02496767|2195196|FG007|Double-blind, Placebo-controlled Phase|Death|0
1112048|NCT02496767|2195189|FG000|Double-blind, Placebo-controlled Phase|Various|0
1112049|NCT02496767|2195190|FG001|Double-blind, Placebo-controlled Phase|Various|9
1112050|NCT02496767|2195191|FG002|Double-blind, Placebo-controlled Phase|Various|4
1112051|NCT02496767|2195192|FG003|Double-blind, Placebo-controlled Phase|Various|5
1112052|NCT02496767|2195193|FG004|Double-blind, Placebo-controlled Phase|Various|2
1112053|NCT02496767|2195194|FG005|Double-blind, Placebo-controlled Phase|Various|0
1112054|NCT02496767|2195195|FG006|Double-blind, Placebo-controlled Phase|Various|0
1112055|NCT02496767|2195196|FG007|Double-blind, Placebo-controlled Phase|Various|0
1112056|NCT02496767|2195189|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1112057|NCT02496767|2195190|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4
1112058|NCT02496767|2195191|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3
1112059|NCT02496767|2195192|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1
1112060|NCT02496767|2195193|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2
1112061|NCT02496767|2195194|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1112062|NCT02496767|2195195|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1112063|NCT02496767|2195196|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1112064|NCT02496767|2195189|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
1112065|NCT02496767|2195190|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4
1112066|NCT02496767|2195191|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1
1112067|NCT02496767|2195192|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0
1112068|NCT02496767|2195193|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0
1112069|NCT02496767|2195194|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0
1112070|NCT02496767|2195195|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0
1112071|NCT02496767|2195196|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0
1112072|NCT02496767|2195189|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1112073|NCT02496767|2195190|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
1112074|NCT02496767|2195191|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1112075|NCT02496767|2195192|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
1112076|NCT02496767|2195193|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1
1112077|NCT02496767|2195194|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1112078|NCT02496767|2195195|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1112079|NCT02496767|2195196|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1112080|NCT02496767|2195189|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0
1112081|NCT02496767|2195190|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1
1112082|NCT02496767|2195191|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0
1112083|NCT02496767|2195192|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0
1112084|NCT02496767|2195193|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0
1112085|NCT02496767|2195194|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0
1112086|NCT02496767|2195195|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0
1112087|NCT02496767|2195196|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0
1112088|NCT02496767|2195189|FG000|Double-blind, Withdrawal Phase|Progressive disease|0
1112089|NCT02496767|2195190|FG001|Double-blind, Withdrawal Phase|Progressive disease|0
1112090|NCT02496767|2195191|FG002|Double-blind, Withdrawal Phase|Progressive disease|0
1112091|NCT02496767|2195192|FG003|Double-blind, Withdrawal Phase|Progressive disease|0
1112092|NCT02496767|2195193|FG004|Double-blind, Withdrawal Phase|Progressive disease|0
1112093|NCT02496767|2195194|FG005|Double-blind, Withdrawal Phase|Progressive disease|4
1112094|NCT02496767|2195195|FG006|Double-blind, Withdrawal Phase|Progressive disease|0
1112095|NCT02496767|2195196|FG007|Double-blind, Withdrawal Phase|Progressive disease|1
1112096|NCT02496767|2195189|FG000|Double-blind, Withdrawal Phase|Adverse Event|0
1112097|NCT02496767|2195190|FG001|Double-blind, Withdrawal Phase|Adverse Event|0
1112098|NCT02496767|2195191|FG002|Double-blind, Withdrawal Phase|Adverse Event|0
1112099|NCT02496767|2195192|FG003|Double-blind, Withdrawal Phase|Adverse Event|0
1112100|NCT02496767|2195193|FG004|Double-blind, Withdrawal Phase|Adverse Event|0
1112101|NCT02496767|2195194|FG005|Double-blind, Withdrawal Phase|Adverse Event|1
1112102|NCT02496767|2195195|FG006|Double-blind, Withdrawal Phase|Adverse Event|2
1112103|NCT02496767|2195196|FG007|Double-blind, Withdrawal Phase|Adverse Event|1
1112104|NCT02496767|2195189|FG000|Double-blind, Withdrawal Phase|Death|0
1112105|NCT02496767|2195190|FG001|Double-blind, Withdrawal Phase|Death|0
1112106|NCT02496767|2195191|FG002|Double-blind, Withdrawal Phase|Death|0
1112107|NCT02496767|2195192|FG003|Double-blind, Withdrawal Phase|Death|0
1112108|NCT02496767|2195193|FG004|Double-blind, Withdrawal Phase|Death|0
1112109|NCT02496767|2195194|FG005|Double-blind, Withdrawal Phase|Death|0
1112110|NCT02496767|2195195|FG006|Double-blind, Withdrawal Phase|Death|1
1112111|NCT02496767|2195196|FG007|Double-blind, Withdrawal Phase|Death|2
1112112|NCT02496767|2195189|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
1112113|NCT02496767|2195190|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
1112114|NCT02496767|2195191|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
1112115|NCT02496767|2195192|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
1112116|NCT02496767|2195193|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
1112117|NCT02496767|2195194|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
1112118|NCT02496767|2195195|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
1112119|NCT02496767|2195196|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
1112120|NCT02496884|2195214|FG000|Overall Study|Counted twice as enrolled|2
1112121|NCT02496884|2195215|FG001|Overall Study|Counted twice as enrolled|0
1112122|NCT02496884|2195216|FG002|Overall Study|Counted twice as enrolled|0
1112123|NCT02496884|2195217|FG003|Overall Study|Counted twice as enrolled|0
1112124|NCT02496884|2195214|FG000|Overall Study|Withdrawal by Subject|0
1112125|NCT02496884|2195215|FG001|Overall Study|Withdrawal by Subject|3
1112126|NCT02496884|2195216|FG002|Overall Study|Withdrawal by Subject|0
1112127|NCT02496884|2195217|FG003|Overall Study|Withdrawal by Subject|0
1112128|NCT02497001|2195231|FG000|Overall Study|Lost to Follow-up|10
1112129|NCT02497001|2195232|FG001|Overall Study|Lost to Follow-up|2
1112130|NCT02497001|2195233|FG002|Overall Study|Lost to Follow-up|0
1112131|NCT02497001|2195234|FG003|Overall Study|Lost to Follow-up|2
1112132|NCT02497001|2195231|FG000|Overall Study|Adverse Event|28
1112133|NCT02497001|2195232|FG001|Overall Study|Adverse Event|30
1112134|NCT02497001|2195233|FG002|Overall Study|Adverse Event|11
1112135|NCT02497001|2195234|FG003|Overall Study|Adverse Event|11
1112136|NCT02497001|2195231|FG000|Overall Study|Withdrawal by Subject|14
1112137|NCT02497001|2195232|FG001|Overall Study|Withdrawal by Subject|37
1112138|NCT02497001|2195233|FG002|Overall Study|Withdrawal by Subject|19
1112139|NCT02497001|2195234|FG003|Overall Study|Withdrawal by Subject|15
1112140|NCT02497001|2195231|FG000|Overall Study|Physician Decision|5
1112141|NCT02497001|2195232|FG001|Overall Study|Physician Decision|11
1112142|NCT02497001|2195233|FG002|Overall Study|Physician Decision|5
1112143|NCT02497001|2195234|FG003|Overall Study|Physician Decision|1
1112144|NCT02497001|2195231|FG000|Overall Study|subjects that were not treated|1
1112145|NCT02497001|2195232|FG001|Overall Study|subjects that were not treated|2
1112146|NCT02497001|2195233|FG002|Overall Study|subjects that were not treated|2
1112147|NCT02497001|2195234|FG003|Overall Study|subjects that were not treated|1
1112148|NCT02497001|2195231|FG000|Overall Study|Major Protocol Deviation|3
1112149|NCT02497001|2195232|FG001|Overall Study|Major Protocol Deviation|4
1112150|NCT02497001|2195233|FG002|Overall Study|Major Protocol Deviation|4
1112151|NCT02497001|2195234|FG003|Overall Study|Major Protocol Deviation|4
1112152|NCT02497001|2195231|FG000|Overall Study|Lack of Efficacy|10
1112153|NCT02497001|2195232|FG001|Overall Study|Lack of Efficacy|16
1112154|NCT02497001|2195233|FG002|Overall Study|Lack of Efficacy|6
1112155|NCT02497001|2195234|FG003|Overall Study|Lack of Efficacy|6
1112156|NCT02497001|2195231|FG000|Overall Study|Protocol Violation|3
1112157|NCT02497001|2195232|FG001|Overall Study|Protocol Violation|1
1112158|NCT02497001|2195233|FG002|Overall Study|Protocol Violation|3
1112159|NCT02497001|2195234|FG003|Overall Study|Protocol Violation|1
1112160|NCT02497287|2195284|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
1112161|NCT02497287|2195284|FG000|Induction Phase (4 Weeks)|Adverse Event|52
1112162|NCT02497287|2195284|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22
1112163|NCT02497287|2195284|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21
1112164|NCT02497287|2195284|FG000|Induction Phase (4 Weeks)|Other|13
1112165|NCT02497287|2195284|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5
1112166|NCT02497287|2195284|FG000|Induction Phase (4 Weeks)|Protocol Violation|1
1112167|NCT02497287|2195284|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
1112168|NCT02497287|2195284|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
1112169|NCT02497287|2195284|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
1112170|NCT02497287|2195284|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25
1112171|NCT02497287|2195284|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
1112172|NCT02497287|2195284|FG000|Optimization/Maintenance (48 Weeks)|Other|21
1112173|NCT02497287|2195284|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
1112174|NCT02497287|2195284|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
1112175|NCT02497287|2195284|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
1112176|NCT02497287|2195284|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2
1112177|NCT02497287|2195284|FG000|Optimization/Maintenance (48 Weeks)|Death|2
1112178|NCT02497287|2195284|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
1112179|NCT02497287|2195284|FG000|Follow-up Phase (4 Week)|PI Decision|12
1112180|NCT02497287|2195284|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10
1112181|NCT02497287|2195284|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5
1112182|NCT02497287|2195284|FG000|Follow-up Phase (4 Week)|Adverse Event|3
1112183|NCT02497287|2195284|FG000|Follow-up Phase (4 Week)|Other|1
1112184|NCT02497391|2195290|FG000|Period 2 (14 Days)|Withdrawal by Subject|1
1112185|NCT02497391|2195291|FG001|Period 2 (14 Days)|Withdrawal by Subject|0
1112186|NCT02497391|2195292|FG002|Period 2 (14 Days)|Withdrawal by Subject|1
1112187|NCT02497391|2195293|FG003|Period 2 (14 Days)|Withdrawal by Subject|0
1112188|NCT02497391|2195294|FG004|Period 2 (14 Days)|Withdrawal by Subject|0
1112189|NCT02497391|2195295|FG005|Period 2 (14 Days)|Withdrawal by Subject|0
1112190|NCT02497391|2195290|FG000|Period 2 (14 Days)|Sponsor Decision|3
1112191|NCT02497391|2195291|FG001|Period 2 (14 Days)|Sponsor Decision|1
1112192|NCT02497391|2195292|FG002|Period 2 (14 Days)|Sponsor Decision|2
1112193|NCT02497391|2195293|FG003|Period 2 (14 Days)|Sponsor Decision|3
1112194|NCT02497391|2195294|FG004|Period 2 (14 Days)|Sponsor Decision|2
1112195|NCT02497391|2195295|FG005|Period 2 (14 Days)|Sponsor Decision|3
1112196|NCT02497391|2195290|FG000|Period 3 (14 Days)|Adverse Event|0
1112197|NCT02497391|2195291|FG001|Period 3 (14 Days)|Adverse Event|1
1112198|NCT02497391|2195292|FG002|Period 3 (14 Days)|Adverse Event|0
1112199|NCT02497391|2195293|FG003|Period 3 (14 Days)|Adverse Event|0
1112200|NCT02497391|2195294|FG004|Period 3 (14 Days)|Adverse Event|0
1112201|NCT02497391|2195295|FG005|Period 3 (14 Days)|Adverse Event|0
1112202|NCT02497391|2195290|FG000|Period 3 (14 Days)|Sponsor Decision|0
1112203|NCT02497391|2195291|FG001|Period 3 (14 Days)|Sponsor Decision|0
1112204|NCT02497391|2195292|FG002|Period 3 (14 Days)|Sponsor Decision|0
1112205|NCT02497391|2195293|FG003|Period 3 (14 Days)|Sponsor Decision|0
1112206|NCT02497391|2195294|FG004|Period 3 (14 Days)|Sponsor Decision|1
1112207|NCT02497391|2195295|FG005|Period 3 (14 Days)|Sponsor Decision|0
1112208|NCT02497391|2195290|FG000|Period 3 (14 Days)|Withdrawal by Subject|0
1112209|NCT02497391|2195291|FG001|Period 3 (14 Days)|Withdrawal by Subject|0
1112210|NCT02497391|2195292|FG002|Period 3 (14 Days)|Withdrawal by Subject|1
1112211|NCT02497391|2195293|FG003|Period 3 (14 Days)|Withdrawal by Subject|0
1112212|NCT02497391|2195294|FG004|Period 3 (14 Days)|Withdrawal by Subject|0
1112213|NCT02497391|2195295|FG005|Period 3 (14 Days)|Withdrawal by Subject|0
1112214|NCT02497404|2195303|FG000|Overall Study|Adverse Event|1
1112215|NCT02497469|2195309|FG000|Overall Study|Randomized but not Treated|0
1112216|NCT02497469|2195310|FG001|Overall Study|Randomized but not Treated|2
1112217|NCT02497469|2195309|FG000|Overall Study|Pretreatment Event/Adverse Event|18
1112218|NCT02497469|2195310|FG001|Overall Study|Pretreatment Event/Adverse Event|16
1112219|NCT02497469|2195309|FG000|Overall Study|Leukopenia or Lymphopenia|1
1112220|NCT02497469|2195310|FG001|Overall Study|Leukopenia or Lymphopenia|0
1112221|NCT02497469|2195309|FG000|Overall Study|Significant Protocol Deviation|4
1112222|NCT02497469|2195310|FG001|Overall Study|Significant Protocol Deviation|5
1112223|NCT02497469|2195309|FG000|Overall Study|Lost to Follow-up|14
1112224|NCT02497469|2195310|FG001|Overall Study|Lost to Follow-up|4
1112225|NCT02497469|2195309|FG000|Overall Study|Voluntary Withdrawal|39
1112226|NCT02497469|2195310|FG001|Overall Study|Voluntary Withdrawal|41
1112227|NCT02497469|2195309|FG000|Overall Study|Pregnancy|1
1112228|NCT02497469|2195310|FG001|Overall Study|Pregnancy|1
1112229|NCT02497469|2195309|FG000|Overall Study|Lack of Efficacy|86
1112230|NCT02497469|2195310|FG001|Overall Study|Lack of Efficacy|40
1112231|NCT02497469|2195309|FG000|Overall Study|Reason not Specified|6
1112232|NCT02497469|2195310|FG001|Overall Study|Reason not Specified|6
1112233|NCT02497612|2195320|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57
1112234|NCT02497612|2195321|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51
1112235|NCT02497612|2195322|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39
1112236|NCT02497612|2195323|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41
1112237|NCT02497612|2195320|FG000|Overall Study|Participant's request|2
1112238|NCT02497612|2195321|FG001|Overall Study|Participant's request|3
1112239|NCT02497612|2195322|FG002|Overall Study|Participant's request|4
1112240|NCT02497612|2195323|FG003|Overall Study|Participant's request|1
1112241|NCT02497612|2195320|FG000|Overall Study|Investigator's judgement|1
1112242|NCT02497612|2195321|FG001|Overall Study|Investigator's judgement|0
1112243|NCT02497612|2195322|FG002|Overall Study|Investigator's judgement|0
1112244|NCT02497612|2195323|FG003|Overall Study|Investigator's judgement|2
1112245|NCT02497612|2195320|FG000|Overall Study|Adverse Event|3
1112246|NCT02497612|2195321|FG001|Overall Study|Adverse Event|1
1112247|NCT02497612|2195322|FG002|Overall Study|Adverse Event|4
1112248|NCT02497612|2195323|FG003|Overall Study|Adverse Event|1
1112249|NCT02497612|2195320|FG000|Overall Study|Lost to Follow-up|1
1112250|NCT02497612|2195321|FG001|Overall Study|Lost to Follow-up|1
1112251|NCT02497612|2195322|FG002|Overall Study|Lost to Follow-up|0
1112252|NCT02497612|2195323|FG003|Overall Study|Lost to Follow-up|1
1112253|NCT02497612|2195320|FG000|Overall Study|Other unspecified|1
1112254|NCT02497612|2195321|FG001|Overall Study|Other unspecified|1
1112255|NCT02497612|2195322|FG002|Overall Study|Other unspecified|2
1112256|NCT02497612|2195323|FG003|Overall Study|Other unspecified|0
1112257|NCT02497612|2195320|FG000|Overall Study|Not eligible|1
1112258|NCT02497612|2195321|FG001|Overall Study|Not eligible|0
1112259|NCT02497612|2195322|FG002|Overall Study|Not eligible|0
1112260|NCT02497612|2195323|FG003|Overall Study|Not eligible|1
1112261|NCT02497755|2195335|FG000|Overall Study|Protocol Violation|1
1112262|NCT02497755|2195336|FG001|Overall Study|Protocol Violation|0
1112263|NCT02497781|2195345|FG000|Overall Study|Withdrawal by Subject|2
1112264|NCT02497781|2195346|FG001|Overall Study|Withdrawal by Subject|0
1112265|NCT02497781|2195345|FG000|Overall Study|Lack of Efficacy|0
1112266|NCT02497781|2195346|FG001|Overall Study|Lack of Efficacy|1
1112267|NCT02497781|2195345|FG000|Overall Study|Randomised but not treated|1
1112268|NCT02497781|2195346|FG001|Overall Study|Randomised but not treated|1
1112269|NCT02497781|2195345|FG000|Overall Study|Lost to Follow-up|1
1112270|NCT02497781|2195346|FG001|Overall Study|Lost to Follow-up|1
1112271|NCT02497976|2195362|FG000|Overall Study|Withdrawal by Subject|2
1112272|NCT02497976|2195363|FG001|Overall Study|Withdrawal by Subject|0
1112273|NCT02497976|2195362|FG000|Overall Study|Moved out of area|0
1112274|NCT02497976|2195363|FG001|Overall Study|Moved out of area|1
1112275|NCT02498067|2195369|FG000|Overall Study|Lost to Follow-up|22
1112276|NCT02498067|2195369|FG000|Overall Study|Did not meet inclusion criteria|11
1112277|NCT02498236|2195383|FG000|Overall Study|Did not show for testing|1
1112278|NCT02498236|2195384|FG001|Overall Study|Did not show for testing|0
1112279|NCT02498236|2195385|FG002|Overall Study|Did not show for testing|0
1112280|NCT02498236|2195386|FG003|Overall Study|Did not show for testing|0
1112281|NCT02498236|2195387|FG004|Overall Study|Did not show for testing|0
1112282|NCT02498236|2195388|FG005|Overall Study|Did not show for testing|0
1112283|NCT02498236|2195389|FG006|Overall Study|Did not show for testing|0
1112284|NCT02498236|2195390|FG007|Overall Study|Did not show for testing|1
1112285|NCT02498236|2195383|FG000|Overall Study|Equipment failure|0
1112286|NCT02498236|2195384|FG001|Overall Study|Equipment failure|0
1112287|NCT02498236|2195385|FG002|Overall Study|Equipment failure|0
1112288|NCT02498236|2195386|FG003|Overall Study|Equipment failure|0
1112289|NCT02498236|2195387|FG004|Overall Study|Equipment failure|0
1112290|NCT02498236|2195388|FG005|Overall Study|Equipment failure|0
1112291|NCT02498236|2195389|FG006|Overall Study|Equipment failure|1
1112292|NCT02498236|2195390|FG007|Overall Study|Equipment failure|0
1112293|NCT02498236|2195383|FG000|Overall Study|Withdrawal by Subject|0
1112294|NCT02498236|2195384|FG001|Overall Study|Withdrawal by Subject|0
1112295|NCT02498236|2195385|FG002|Overall Study|Withdrawal by Subject|0
1112296|NCT02498236|2195386|FG003|Overall Study|Withdrawal by Subject|0
1112297|NCT02498236|2195387|FG004|Overall Study|Withdrawal by Subject|1
1112298|NCT02498236|2195388|FG005|Overall Study|Withdrawal by Subject|0
1112299|NCT02498236|2195389|FG006|Overall Study|Withdrawal by Subject|0
1112300|NCT02498236|2195390|FG007|Overall Study|Withdrawal by Subject|0
1112301|NCT02498418|2195414|FG000|Overall Study|Lack of Efficacy|0
1112302|NCT02498418|2195415|FG001|Overall Study|Lack of Efficacy|0
1112303|NCT02498418|2195416|FG002|Overall Study|Lack of Efficacy|1
1112304|NCT02498418|2195414|FG000|Overall Study|Withdrawal by Subject|2
1112305|NCT02498418|2195415|FG001|Overall Study|Withdrawal by Subject|0
1112306|NCT02498418|2195416|FG002|Overall Study|Withdrawal by Subject|3
1112307|NCT02498418|2195414|FG000|Overall Study|Lost to Follow-up|0
1112308|NCT02498418|2195415|FG001|Overall Study|Lost to Follow-up|1
1112309|NCT02498418|2195416|FG002|Overall Study|Lost to Follow-up|1
1112310|NCT02498418|2195414|FG000|Overall Study|Participant taken prohibited medication|0
1112311|NCT02498418|2195415|FG001|Overall Study|Participant taken prohibited medication|1
1112312|NCT02498418|2195416|FG002|Overall Study|Participant taken prohibited medication|1
1112313|NCT02498652|2195453|FG000|Overall Study|Protocol Violation|0
1112314|NCT02498652|2195454|FG001|Overall Study|Protocol Violation|1
1112315|NCT02498678|2195480|FG000|Overall Study|interference from the surgical team|0
1112316|NCT02498678|2195481|FG001|Overall Study|interference from the surgical team|2
1112317|NCT02498821|2195498|FG000|Overall Study|Screen failure|3
1112318|NCT02498821|2195499|FG001|Overall Study|Screen failure|5
1112319|NCT02499029|2195516|FG000|Overall Study|Lost to Follow-up|2
1112320|NCT02499029|2195517|FG001|Overall Study|Lost to Follow-up|2
1112321|NCT02499029|2195516|FG000|Overall Study|Physician Decision|2
1112322|NCT02499029|2195517|FG001|Overall Study|Physician Decision|1
1112323|NCT02499029|2195516|FG000|Overall Study|Death|1
1112324|NCT02499029|2195517|FG001|Overall Study|Death|0
1112325|NCT02499120|2195529|FG000|Overall Study|Death|45
1112326|NCT02499120|2195530|FG001|Overall Study|Death|42
1112327|NCT02499120|2195529|FG000|Overall Study|Lost to Follow-up|1
1112328|NCT02499120|2195530|FG001|Overall Study|Lost to Follow-up|2
1112329|NCT02499120|2195529|FG000|Overall Study|Participant refused further follow-up|1
1112330|NCT02499120|2195530|FG001|Overall Study|Participant refused further follow-up|0
1112331|NCT02499120|2195529|FG000|Overall Study|Withdrawal by Subject|2
1112332|NCT02499120|2195530|FG001|Overall Study|Withdrawal by Subject|5
1112333|NCT02499120|2195529|FG000|Overall Study|Other|1
1112334|NCT02499120|2195530|FG001|Overall Study|Other|0
1112335|NCT02499120|2195529|FG000|Overall Study|Ongoing on study|15
1112336|NCT02499120|2195530|FG001|Overall Study|Ongoing on study|11
1112337|NCT02499146|2195536|FG000|Overall Study|Lost to Follow-up|1
1112338|NCT02499146|2195536|FG000|Overall Study|Withdrawal by Subject|1
1112339|NCT02499146|2195536|FG000|Overall Study|Other|2
1112340|NCT02499146|2195536|FG000|Overall Study|Ongoing at date of cut-off|9
1112341|NCT02499146|2195536|FG000|Overall Study|Began other treatment/therapy|13
1112342|NCT02499159|2195542|FG000|Randomization|Protocol Violation|1
1112343|NCT02499159|2195543|FG001|Randomization|Protocol Violation|1
1112344|NCT02499159|2195542|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
1112345|NCT02499159|2195543|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
1112346|NCT02499159|2195542|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3
1112347|NCT02499159|2195543|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1
1112348|NCT02499159|2195542|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
1112349|NCT02499159|2195543|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
1112350|NCT02499159|2195542|FG000|30-Day Follow-Up Phone Call|Other|1
1112351|NCT02499159|2195543|FG001|30-Day Follow-Up Phone Call|Other|0
1112352|NCT02499172|2195553|FG000|Overall Study|Financial reason|0
1112353|NCT02499172|2195554|FG001|Overall Study|Financial reason|0
1112354|NCT02499172|2195555|FG002|Overall Study|Financial reason|523
1112355|NCT02499172|2195556|FG003|Overall Study|Financial reason|436
1112356|NCT02499172|2195553|FG000|Overall Study|Lost to Follow-up|65
1112357|NCT02499172|2195554|FG001|Overall Study|Lost to Follow-up|64
1112358|NCT02499172|2195555|FG002|Overall Study|Lost to Follow-up|0
1112359|NCT02499172|2195556|FG003|Overall Study|Lost to Follow-up|0
1112360|NCT02499263|2195566|FG000|Overall Study|Lost to Follow-up|9
1112361|NCT02499263|2195566|FG000|Overall Study|Participant's withdrawal of consent|4
1112362|NCT02499263|2195566|FG000|Overall Study|Lack of Efficacy|22
1112363|NCT02499263|2195566|FG000|Overall Study|investigator's judgment|12
1112364|NCT02499263|2195566|FG000|Overall Study|Adverse Events/Serious Adverse Events|11
1112365|NCT02499263|2195566|FG000|Overall Study|Participant's decision|3
1112366|NCT02499263|2195566|FG000|Overall Study|Pregnancy|1
1112367|NCT02499328|2195589|FG000|Overall Study|Withdrawal by Subject|1
1112368|NCT02499328|2195590|FG001|Overall Study|Withdrawal by Subject|1
1112369|NCT02499328|2195591|FG002|Overall Study|Withdrawal by Subject|5
1112370|NCT02499328|2195592|FG003|Overall Study|Withdrawal by Subject|3
1112371|NCT02499328|2195593|FG004|Overall Study|Withdrawal by Subject|5
1112372|NCT02499328|2195594|FG005|Overall Study|Withdrawal by Subject|0
1112373|NCT02499328|2195595|FG006|Overall Study|Withdrawal by Subject|0
1112374|NCT02499328|2195596|FG007|Overall Study|Withdrawal by Subject|0
1112375|NCT02499328|2195597|FG008|Overall Study|Withdrawal by Subject|2
1112376|NCT02499328|2195598|FG009|Overall Study|Withdrawal by Subject|2
1112377|NCT02499328|2195599|FG010|Overall Study|Withdrawal by Subject|0
1112378|NCT02499328|2195600|FG011|Overall Study|Withdrawal by Subject|3
1112379|NCT02499328|2195601|FG012|Overall Study|Withdrawal by Subject|7
1112380|NCT02499328|2195602|FG013|Overall Study|Withdrawal by Subject|3
1112381|NCT02499328|2195603|FG014|Overall Study|Withdrawal by Subject|1
1112382|NCT02499328|2195604|FG015|Overall Study|Withdrawal by Subject|0
1112383|NCT02499328|2195605|FG016|Overall Study|Withdrawal by Subject|0
1112384|NCT02499328|2195606|FG017|Overall Study|Withdrawal by Subject|3
1112385|NCT02499328|2195607|FG018|Overall Study|Withdrawal by Subject|0
1112386|NCT02499328|2195589|FG000|Overall Study|Lost to Follow-up|0
896584|NCT00705432|1868343|FG001|Treatment Period|Non medical reason|32
896585|NCT00705432|1868344|FG002|Treatment Period|Non medical reason|37
896586|NCT00705432|1868345|FG003|Treatment Period|Non medical reason|4
896587|NCT00705432|1868346|FG004|Treatment Period|Non medical reason|7
896588|NCT00705432|1868347|FG005|Treatment Period|Non medical reason|7
896589|NCT00705432|1868342|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2
896590|NCT00705432|1868343|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1
896591|NCT00705432|1868344|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1
896592|NCT00705432|1868345|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0
896593|NCT00705432|1868346|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0
896594|NCT00705432|1868347|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0
896595|NCT00705432|1868342|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69
896596|NCT00705432|1868343|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42
896597|NCT00705432|1868344|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24
896598|NCT00705432|1868345|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14
1112387|NCT02499328|2195590|FG001|Overall Study|Lost to Follow-up|1
1112388|NCT02499328|2195591|FG002|Overall Study|Lost to Follow-up|1
1112389|NCT02499328|2195592|FG003|Overall Study|Lost to Follow-up|2
1112390|NCT02499328|2195593|FG004|Overall Study|Lost to Follow-up|0
1112391|NCT02499328|2195594|FG005|Overall Study|Lost to Follow-up|0
1112392|NCT02499328|2195595|FG006|Overall Study|Lost to Follow-up|0
1112393|NCT02499328|2195596|FG007|Overall Study|Lost to Follow-up|2
1112394|NCT02499328|2195597|FG008|Overall Study|Lost to Follow-up|3
1112395|NCT02499328|2195598|FG009|Overall Study|Lost to Follow-up|0
1112396|NCT02499328|2195599|FG010|Overall Study|Lost to Follow-up|0
1112397|NCT02499328|2195600|FG011|Overall Study|Lost to Follow-up|0
1112398|NCT02499328|2195601|FG012|Overall Study|Lost to Follow-up|0
1112399|NCT02499328|2195602|FG013|Overall Study|Lost to Follow-up|0
1112400|NCT02499328|2195603|FG014|Overall Study|Lost to Follow-up|0
1112401|NCT02499328|2195604|FG015|Overall Study|Lost to Follow-up|0
1112402|NCT02499328|2195605|FG016|Overall Study|Lost to Follow-up|0
1112403|NCT02499328|2195606|FG017|Overall Study|Lost to Follow-up|0
1112404|NCT02499328|2195607|FG018|Overall Study|Lost to Follow-up|1
1112405|NCT02499328|2195589|FG000|Overall Study|Death|0
1112406|NCT02499328|2195590|FG001|Overall Study|Death|3
1112407|NCT02499328|2195591|FG002|Overall Study|Death|3
1112408|NCT02499328|2195592|FG003|Overall Study|Death|2
1112409|NCT02499328|2195593|FG004|Overall Study|Death|4
1112410|NCT02499328|2195594|FG005|Overall Study|Death|7
1112411|NCT02499328|2195595|FG006|Overall Study|Death|3
1112412|NCT02499328|2195596|FG007|Overall Study|Death|0
1112413|NCT02499328|2195597|FG008|Overall Study|Death|2
1112414|NCT02499328|2195598|FG009|Overall Study|Death|6
1112415|NCT02499328|2195599|FG010|Overall Study|Death|6
1112416|NCT02499328|2195600|FG011|Overall Study|Death|20
1112417|NCT02499328|2195601|FG012|Overall Study|Death|9
1112418|NCT02499328|2195602|FG013|Overall Study|Death|7
1112419|NCT02499328|2195603|FG014|Overall Study|Death|3
1112420|NCT02499328|2195604|FG015|Overall Study|Death|1
1112421|NCT02499328|2195605|FG016|Overall Study|Death|1
1112422|NCT02499328|2195606|FG017|Overall Study|Death|16
1112423|NCT02499328|2195607|FG018|Overall Study|Death|5
1112424|NCT02499328|2195589|FG000|Overall Study|"Other"|2
1112425|NCT02499328|2195590|FG001|Overall Study|"Other"|2
1112426|NCT02499328|2195591|FG002|Overall Study|"Other"|1
1112427|NCT02499328|2195592|FG003|Overall Study|"Other"|3
1112428|NCT02499328|2195593|FG004|Overall Study|"Other"|6
1112429|NCT02499328|2195594|FG005|Overall Study|"Other"|2
1112430|NCT02499328|2195595|FG006|Overall Study|"Other"|3
1112431|NCT02499328|2195596|FG007|Overall Study|"Other"|4
1112432|NCT02499328|2195597|FG008|Overall Study|"Other"|6
1112433|NCT02499328|2195598|FG009|Overall Study|"Other"|16
1112434|NCT02499328|2195599|FG010|Overall Study|"Other"|13
1112435|NCT02499328|2195600|FG011|Overall Study|"Other"|31
1112436|NCT02499328|2195601|FG012|Overall Study|"Other"|8
1112437|NCT02499328|2195602|FG013|Overall Study|"Other"|7
1112438|NCT02499328|2195603|FG014|Overall Study|"Other"|6
1112439|NCT02499328|2195604|FG015|Overall Study|"Other"|0
1112440|NCT02499328|2195605|FG016|Overall Study|"Other"|0
1112441|NCT02499328|2195606|FG017|Overall Study|"Other"|34
1112442|NCT02499328|2195607|FG018|Overall Study|"Other"|43
1112443|NCT02499328|2195589|FG000|Overall Study|Disease Progression|0
1112444|NCT02499328|2195590|FG001|Overall Study|Disease Progression|0
1112445|NCT02499328|2195591|FG002|Overall Study|Disease Progression|0
1112446|NCT02499328|2195592|FG003|Overall Study|Disease Progression|0
1112447|NCT02499328|2195593|FG004|Overall Study|Disease Progression|0
1112448|NCT02499328|2195594|FG005|Overall Study|Disease Progression|0
1112449|NCT02499328|2195595|FG006|Overall Study|Disease Progression|1
1112450|NCT02499328|2195596|FG007|Overall Study|Disease Progression|0
896599|NCT00705432|1868346|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6
896600|NCT00705432|1868347|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7
896601|NCT00705484|1868360|FG000|Overall Study|Adverse Event|28
896602|NCT00705484|1868361|FG001|Overall Study|Adverse Event|27
896603|NCT00705484|1868360|FG000|Overall Study|Lost to Follow-up|169
896604|NCT00705484|1868361|FG001|Overall Study|Lost to Follow-up|250
896605|NCT00705484|1868360|FG000|Overall Study|Withdrawal by Subject|96
896606|NCT00705484|1868361|FG001|Overall Study|Withdrawal by Subject|72
896607|NCT00705484|1868360|FG000|Overall Study|Administrative|89
896608|NCT00705484|1868361|FG001|Overall Study|Administrative|59
896609|NCT00705523|1868371|FG000|Overall Study|Lost to Follow-up|2
896610|NCT00705523|1868372|FG001|Overall Study|Lost to Follow-up|3
896611|NCT00705536|1868380|FG000|Start Period 1|Withdrawal by Subject|0
896612|NCT00705536|1868381|FG001|Start Period 1|Withdrawal by Subject|0
896613|NCT00705536|1868382|FG002|Start Period 1|Withdrawal by Subject|0
896614|NCT00705536|1868383|FG003|Start Period 1|Withdrawal by Subject|1
896615|NCT00705575|1868404|FG000|Overall Study|Abnormal laboratory value(s)|0
896616|NCT00705575|1868405|FG001|Overall Study|Abnormal laboratory value(s)|3
896617|NCT00705575|1868404|FG000|Overall Study|Abnormal test procedure result(s)|2
896618|NCT00705575|1868405|FG001|Overall Study|Abnormal test procedure result(s)|12
1112451|NCT02499328|2195597|FG008|Overall Study|Disease Progression|1
1112452|NCT02499328|2195598|FG009|Overall Study|Disease Progression|0
1112453|NCT02499328|2195599|FG010|Overall Study|Disease Progression|1
1112454|NCT02499328|2195600|FG011|Overall Study|Disease Progression|0
1112455|NCT02499328|2195601|FG012|Overall Study|Disease Progression|0
1112456|NCT02499328|2195602|FG013|Overall Study|Disease Progression|0
1112457|NCT02499328|2195603|FG014|Overall Study|Disease Progression|0
1112458|NCT02499328|2195604|FG015|Overall Study|Disease Progression|0
1112459|NCT02499328|2195605|FG016|Overall Study|Disease Progression|0
896619|NCT00705575|1868404|FG000|Overall Study|Adverse Event|11
896620|NCT00705575|1868405|FG001|Overall Study|Adverse Event|15
896621|NCT00705575|1868404|FG000|Overall Study|Lost to Follow-up|3
896622|NCT00705575|1868405|FG001|Overall Study|Lost to Follow-up|4
896623|NCT00705575|1868404|FG000|Overall Study|Protocol Violation|2
896624|NCT00705575|1868405|FG001|Overall Study|Protocol Violation|2
1112460|NCT02499328|2195606|FG017|Overall Study|Disease Progression|2
1112461|NCT02499328|2195607|FG018|Overall Study|Disease Progression|0
1112462|NCT02499328|2195589|FG000|Overall Study|Adverse Event|1
1112463|NCT02499328|2195590|FG001|Overall Study|Adverse Event|0
1112464|NCT02499328|2195591|FG002|Overall Study|Adverse Event|0
1112465|NCT02499328|2195592|FG003|Overall Study|Adverse Event|1
1112466|NCT02499328|2195593|FG004|Overall Study|Adverse Event|0
1112467|NCT02499328|2195594|FG005|Overall Study|Adverse Event|0
1112468|NCT02499328|2195595|FG006|Overall Study|Adverse Event|0
1112469|NCT02499328|2195596|FG007|Overall Study|Adverse Event|0
1112470|NCT02499328|2195597|FG008|Overall Study|Adverse Event|0
1112471|NCT02499328|2195598|FG009|Overall Study|Adverse Event|0
1112472|NCT02499328|2195599|FG010|Overall Study|Adverse Event|0
1112473|NCT02499328|2195600|FG011|Overall Study|Adverse Event|0
1112474|NCT02499328|2195601|FG012|Overall Study|Adverse Event|1
1112475|NCT02499328|2195602|FG013|Overall Study|Adverse Event|0
1112476|NCT02499328|2195603|FG014|Overall Study|Adverse Event|0
1112477|NCT02499328|2195604|FG015|Overall Study|Adverse Event|0
1112478|NCT02499328|2195605|FG016|Overall Study|Adverse Event|0
1112479|NCT02499328|2195606|FG017|Overall Study|Adverse Event|0
1112480|NCT02499328|2195607|FG018|Overall Study|Adverse Event|0
1112481|NCT02499406|2195694|FG000|Overall Study|missed 3 treatment sessions|4
1112482|NCT02499575|2195717|FG000|Overall Study|Protocol Violation|0
1112483|NCT02499575|2195718|FG001|Overall Study|Protocol Violation|1
1112484|NCT02499770|2195730|FG000|Overall Study|Death|17
1112485|NCT02499770|2195731|FG001|Overall Study|Death|56
1112486|NCT02499770|2195730|FG000|Overall Study|Study completion|1
1112487|NCT02499770|2195731|FG001|Overall Study|Study completion|10
1112488|NCT02499770|2195730|FG000|Overall Study|Withdrawal by Subject|0
1112489|NCT02499770|2195731|FG001|Overall Study|Withdrawal by Subject|7
1112490|NCT02499770|2195730|FG000|Overall Study|Lost to Follow-up|0
1112491|NCT02499770|2195731|FG001|Overall Study|Lost to Follow-up|2
1112492|NCT02499770|2195730|FG000|Overall Study|Subject declined further treatment|1
1112493|NCT02499770|2195731|FG001|Overall Study|Subject declined further treatment|0
1112494|NCT02499770|2195730|FG000|Overall Study|Withdrawn by PI for compassionate reason|0
1112495|NCT02499770|2195731|FG001|Overall Study|Withdrawn by PI for compassionate reason|1
1112496|NCT02499770|2195730|FG000|Overall Study|Randomized but not enrolled|0
1112497|NCT02499770|2195731|FG001|Overall Study|Randomized but not enrolled|1
1112498|NCT02499783|2195745|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
1112499|NCT02499783|2195746|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
1112500|NCT02499783|2195747|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
1112501|NCT02499783|2195745|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
1112502|NCT02499783|2195746|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
1112503|NCT02499783|2195747|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
1112504|NCT02499783|2195745|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
1112505|NCT02499783|2195746|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
1112506|NCT02499783|2195747|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
1112507|NCT02499783|2195745|FG000|DB Period: Weeks 0-8|Adverse Event|8
1112508|NCT02499783|2195746|FG001|DB Period: Weeks 0-8|Adverse Event|6
1112509|NCT02499783|2195747|FG002|DB Period: Weeks 0-8|Adverse Event|0
1112510|NCT02499783|2195745|FG000|DB Period: Weeks 0-8|Withdrew Consent|1
1112511|NCT02499783|2195746|FG001|DB Period: Weeks 0-8|Withdrew Consent|0
1112512|NCT02499783|2195747|FG002|DB Period: Weeks 0-8|Withdrew Consent|0
1112513|NCT02499783|2195745|FG000|DB Period: Weeks 0-8|Other|1
1112514|NCT02499783|2195746|FG001|DB Period: Weeks 0-8|Other|1
1112515|NCT02499783|2195747|FG002|DB Period: Weeks 0-8|Other|0
1112516|NCT02499783|2195745|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0
1112517|NCT02499783|2195746|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0
1112518|NCT02499783|2195747|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16
1112519|NCT02499783|2195745|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
1112520|NCT02499783|2195746|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
1112521|NCT02499783|2195747|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
1112522|NCT02499783|2195745|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
1112523|NCT02499783|2195746|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
1112524|NCT02499783|2195747|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
1112525|NCT02499783|2195745|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
1112526|NCT02499783|2195746|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
1112527|NCT02499783|2195747|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
896625|NCT00705575|1868404|FG000|Overall Study|Withdrawal by Subject|5
896626|NCT00705575|1868405|FG001|Overall Study|Withdrawal by Subject|10
1112564|NCT02499952|2195772|FG000|Overall Study|Lost to Follow-up|1
1112565|NCT02499952|2195772|FG000|Overall Study|Death|9
1112566|NCT02500043|2195778|FG000|Overall Study|Randomized, but not Treated|2
1112567|NCT02500043|2195779|FG001|Overall Study|Randomized, but not Treated|2
1112568|NCT02500043|2195778|FG000|Overall Study|Ongoing at Date of Cut-Off|19
1112569|NCT02500043|2195779|FG001|Overall Study|Ongoing at Date of Cut-Off|3
1112570|NCT02500043|2195778|FG000|Overall Study|Adverse Event|33
1112571|NCT02500043|2195779|FG001|Overall Study|Adverse Event|11
1112572|NCT02500043|2195778|FG000|Overall Study|Clinical Progression|54
1112573|NCT02500043|2195779|FG001|Overall Study|Clinical Progression|35
1112574|NCT02500043|2195778|FG000|Overall Study|Radiological Progression|192
1112575|NCT02500043|2195779|FG001|Overall Study|Radiological Progression|110
1112576|NCT02500043|2195778|FG000|Overall Study|Physician's Decision|11
1112577|NCT02500043|2195779|FG001|Overall Study|Physician's Decision|3
1112578|NCT02500043|2195778|FG000|Overall Study|Withdrawal by Subject|14
1112579|NCT02500043|2195779|FG001|Overall Study|Withdrawal by Subject|4
1112580|NCT02500043|2195778|FG000|Overall Study|Death|11
1112581|NCT02500043|2195779|FG001|Overall Study|Death|2
1112582|NCT02500043|2195778|FG000|Overall Study|Protocol Deviation|1
1112583|NCT02500043|2195779|FG001|Overall Study|Protocol Deviation|0
1112584|NCT02500056|2195787|FG000|Overall Study|Lost to Follow-up|3
1112585|NCT02500056|2195788|FG001|Overall Study|Lost to Follow-up|7
1112586|NCT02500056|2195787|FG000|Overall Study|Recurrence|1
1112587|NCT02500056|2195788|FG001|Overall Study|Recurrence|0
1112588|NCT02500056|2195787|FG000|Overall Study|Death|3
1112589|NCT02500056|2195788|FG001|Overall Study|Death|1
1112590|NCT02500537|2195803|FG000|Overall Study|Death|2
1112591|NCT02500537|2195804|FG001|Overall Study|Death|0
1112592|NCT02500537|2195803|FG000|Overall Study|Lost to Follow-up|0
1112593|NCT02500537|2195804|FG001|Overall Study|Lost to Follow-up|1
1112594|NCT02500537|2195803|FG000|Overall Study|Withdrawal by Subject|1
1112595|NCT02500537|2195804|FG001|Overall Study|Withdrawal by Subject|0
1112596|NCT02500550|2195811|FG000|Overall Study|Death|7
1112597|NCT02500641|2195839|FG000|Overall Study|Adverse Event|0
1112598|NCT02500641|2195840|FG001|Overall Study|Adverse Event|2
1112599|NCT02500641|2195839|FG000|Overall Study|Withdrawal by Subject|4
1112600|NCT02500641|2195840|FG001|Overall Study|Withdrawal by Subject|5
1112601|NCT02500641|2195839|FG000|Overall Study|Unable to follow study procedures|3
1112602|NCT02500641|2195840|FG001|Overall Study|Unable to follow study procedures|2
1112603|NCT02500641|2195839|FG000|Overall Study|Protocol Violation|1
1112604|NCT02500641|2195840|FG001|Overall Study|Protocol Violation|2
1112605|NCT02500641|2195839|FG000|Overall Study|Lost to Follow-up|1
1112606|NCT02500641|2195840|FG001|Overall Study|Lost to Follow-up|0
1112607|NCT02500641|2195839|FG000|Overall Study|Sponsor decision|1
1112608|NCT02500641|2195840|FG001|Overall Study|Sponsor decision|0
1112609|NCT02500641|2195839|FG000|Overall Study|Non compliance to study drug|0
1112610|NCT02500641|2195840|FG001|Overall Study|Non compliance to study drug|1
1112611|NCT02500706|2195849|FG000|Overall Study|Adverse Event|0
1112612|NCT02500706|2195850|FG001|Overall Study|Adverse Event|0
1112613|NCT02500706|2195851|FG002|Overall Study|Adverse Event|1
1112614|NCT02500706|2195849|FG000|Overall Study|Lost to Follow-up|0
1112615|NCT02500706|2195850|FG001|Overall Study|Lost to Follow-up|1
1112616|NCT02500706|2195851|FG002|Overall Study|Lost to Follow-up|1
1112617|NCT02500706|2195849|FG000|Overall Study|Withdrawal by Subject|4
1112618|NCT02500706|2195850|FG001|Overall Study|Withdrawal by Subject|6
1112619|NCT02500706|2195851|FG002|Overall Study|Withdrawal by Subject|4
1112620|NCT02500706|2195849|FG000|Overall Study|Unclassified|0
1112621|NCT02500706|2195850|FG001|Overall Study|Unclassified|0
1112622|NCT02500706|2195851|FG002|Overall Study|Unclassified|1
1112623|NCT02500719|2195861|FG000|Overall Study|Lost to Follow-up|2
1112624|NCT02500719|2195862|FG001|Overall Study|Lost to Follow-up|3
1112625|NCT02500719|2195861|FG000|Overall Study|Trauma history|1
1112626|NCT02500719|2195862|FG001|Overall Study|Trauma history|0
1112627|NCT02500719|2195861|FG000|Overall Study|MRI data found to be unusable during analysis|0
1112628|NCT02500719|2195862|FG001|Overall Study|MRI data found to be unusable during analysis|1
1112629|NCT02500719|2195861|FG000|Overall Study|Did not meet criteria for PTSD|0
1112630|NCT02500719|2195862|FG001|Overall Study|Did not meet criteria for PTSD|1
1112631|NCT02500719|2195861|FG000|Overall Study|Claustrophobia|0
1112632|NCT02500719|2195862|FG001|Overall Study|Claustrophobia|1
1112633|NCT02500719|2195861|FG000|Overall Study|History of head trauma|0
1112634|NCT02500719|2195862|FG001|Overall Study|History of head trauma|1
1112635|NCT02500732|2195870|FG000|Overall Study|Physician Decision|0
1112636|NCT02500732|2195871|FG001|Overall Study|Physician Decision|1
1112637|NCT02500758|2195879|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0
1112638|NCT02500758|2195880|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1
1112639|NCT02500758|2195879|FG000|Washout (1 Week)|Lost to Follow-up|2
1112640|NCT02500758|2195880|FG001|Washout (1 Week)|Lost to Follow-up|2
1112641|NCT02500758|2195879|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2
1112642|NCT02500758|2195880|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0
1112643|NCT02500758|2195879|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0
1112644|NCT02500758|2195880|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1
1112645|NCT02500758|2195879|FG000|Second Intervention (2 Minutes)|Protocol Violation|1
1112646|NCT02500758|2195880|FG001|Second Intervention (2 Minutes)|Protocol Violation|1
896627|NCT00705614|1868413|FG000|Initial Intervention|Adverse Event|40
896628|NCT00705614|1868414|FG001|Initial Intervention|Adverse Event|21
896629|NCT00705614|1868413|FG000|Initial Intervention|Lost to Follow-up|310
896630|NCT00705614|1868414|FG001|Initial Intervention|Lost to Follow-up|191
896631|NCT00705614|1868413|FG000|Initial Intervention|Withdrawal by Subject|114
896632|NCT00705614|1868414|FG001|Initial Intervention|Withdrawal by Subject|71
896633|NCT00705614|1868413|FG000|Initial Intervention|Administrative Reason|51
896634|NCT00705614|1868414|FG001|Initial Intervention|Administrative Reason|38
896635|NCT00705614|1868413|FG000|Initial Intervention|Status completion unknown|3
896636|NCT00705614|1868414|FG001|Initial Intervention|Status completion unknown|0
896637|NCT00705614|1868413|FG000|Switch to Remicade|Adverse Event|0
896638|NCT00705614|1868414|FG001|Switch to Remicade|Adverse Event|5
896639|NCT00705614|1868413|FG000|Switch to Remicade|Lost to Follow-up|0
896640|NCT00705614|1868414|FG001|Switch to Remicade|Lost to Follow-up|23
896641|NCT00705614|1868413|FG000|Switch to Remicade|Withdrawal by Subject|0
896642|NCT00705614|1868414|FG001|Switch to Remicade|Withdrawal by Subject|12
896643|NCT00705614|1868413|FG000|Switch to Remicade|Administrative Reason|0
896644|NCT00705614|1868414|FG001|Switch to Remicade|Administrative Reason|9
896645|NCT00705666|1868426|FG000|Overall Study|No post-treatment questionnaire|279
896646|NCT00705666|1868426|FG000|Overall Study|Withdrawal by Subject|21
896647|NCT00705666|1868426|FG000|Overall Study|Physician Decision|7
896648|NCT00705666|1868426|FG000|Overall Study|Lost to Follow-up|5
896649|NCT00705666|1868426|FG000|Overall Study|Death|1
896650|NCT00705666|1868426|FG000|Overall Study|Adverse Event|4
896651|NCT00705666|1868426|FG000|Overall Study|Other|12
896652|NCT00705666|1868426|FG000|Overall Study|Other|2
896653|NCT00705666|1868426|FG000|Overall Study|Lack of data|3
896654|NCT00705666|1868426|FG000|Overall Study|Untreated|5
896655|NCT00705679|1868435|FG000|Overall Study|Adverse Event|1
896656|NCT00705679|1868436|FG001|Overall Study|Adverse Event|1
896657|NCT00705679|1868437|FG002|Overall Study|Adverse Event|0
1112663|NCT02500979|2195942|FG000|Period 1|Hyperglycemia|1
1112664|NCT02500979|2195943|FG001|Period 1|Hyperglycemia|0
1112665|NCT02500979|2195942|FG000|Period 1|Severe non-compliance to protocol|0
1112666|NCT02500979|2195943|FG001|Period 1|Severe non-compliance to protocol|1
1112667|NCT02500979|2195942|FG000|Period 1|Adverse Event|1
1112668|NCT02500979|2195943|FG001|Period 1|Adverse Event|0
1112669|NCT02500979|2195942|FG000|Period 1|Subject decision|2
1112670|NCT02500979|2195943|FG001|Period 1|Subject decision|0
1112671|NCT02500979|2195942|FG000|Period 2|Change in risk|1
1112672|NCT02500979|2195943|FG001|Period 2|Change in risk|0
1112673|NCT02501161|2195961|FG000|Overall Study|Adverse Event|2
1112674|NCT02501161|2195962|FG001|Overall Study|Adverse Event|6
1112675|NCT02501161|2195961|FG000|Overall Study|Lost to Follow-up|7
1112676|NCT02501161|2195962|FG001|Overall Study|Lost to Follow-up|4
1112677|NCT02501161|2195961|FG000|Overall Study|Withdrawal by Subject|10
1112678|NCT02501161|2195962|FG001|Overall Study|Withdrawal by Subject|15
1112679|NCT02501161|2195961|FG000|Overall Study|Other|3
1112680|NCT02501161|2195962|FG001|Overall Study|Other|0
1112681|NCT02501473|2195992|FG000|Overall Study|Study Terminated|2
1112682|NCT02501473|2195993|FG001|Overall Study|Study Terminated|3
1112683|NCT02501473|2195994|FG002|Overall Study|Study Terminated|7
1112684|NCT02501473|2195995|FG003|Overall Study|Study Terminated|9
1112685|NCT02501473|2195996|FG004|Overall Study|Study Terminated|2
1112686|NCT02501473|2195997|FG005|Overall Study|Study Terminated|10
1112687|NCT02501473|2195998|FG006|Overall Study|Study Terminated|1
1112688|NCT02501473|2195999|FG007|Overall Study|Study Terminated|0
1112689|NCT02501473|2195992|FG000|Overall Study|Withdrawal by Subject|0
1112690|NCT02501473|2195993|FG001|Overall Study|Withdrawal by Subject|0
1112691|NCT02501473|2195994|FG002|Overall Study|Withdrawal by Subject|3
1112692|NCT02501473|2195995|FG003|Overall Study|Withdrawal by Subject|3
1112693|NCT02501473|2195996|FG004|Overall Study|Withdrawal by Subject|2
1112694|NCT02501473|2195997|FG005|Overall Study|Withdrawal by Subject|2
1112695|NCT02501473|2195998|FG006|Overall Study|Withdrawal by Subject|0
1112696|NCT02501473|2195999|FG007|Overall Study|Withdrawal by Subject|0
1112697|NCT02501473|2195992|FG000|Overall Study|Death|0
1112698|NCT02501473|2195993|FG001|Overall Study|Death|0
1112699|NCT02501473|2195994|FG002|Overall Study|Death|1
1112700|NCT02501473|2195995|FG003|Overall Study|Death|1
1112701|NCT02501473|2195996|FG004|Overall Study|Death|0
1112702|NCT02501473|2195997|FG005|Overall Study|Death|1
1112703|NCT02501473|2195998|FG006|Overall Study|Death|0
1112704|NCT02501473|2195999|FG007|Overall Study|Death|0
1112705|NCT02501473|2195992|FG000|Overall Study|Lost to Follow-up|1
1112706|NCT02501473|2195993|FG001|Overall Study|Lost to Follow-up|0
1112707|NCT02501473|2195994|FG002|Overall Study|Lost to Follow-up|1
1112708|NCT02501473|2195995|FG003|Overall Study|Lost to Follow-up|0
1112709|NCT02501473|2195996|FG004|Overall Study|Lost to Follow-up|0
1112710|NCT02501473|2195997|FG005|Overall Study|Lost to Follow-up|1
1112711|NCT02501473|2195998|FG006|Overall Study|Lost to Follow-up|0
1112712|NCT02501473|2195999|FG007|Overall Study|Lost to Follow-up|0
1112713|NCT02501473|2195992|FG000|Overall Study|Reason not specified|0
1112714|NCT02501473|2195993|FG001|Overall Study|Reason not specified|0
1112715|NCT02501473|2195994|FG002|Overall Study|Reason not specified|1
1112716|NCT02501473|2195995|FG003|Overall Study|Reason not specified|1
1112717|NCT02501473|2195996|FG004|Overall Study|Reason not specified|0
1112718|NCT02501473|2195997|FG005|Overall Study|Reason not specified|0
1112719|NCT02501473|2195998|FG006|Overall Study|Reason not specified|0
1112720|NCT02501473|2195999|FG007|Overall Study|Reason not specified|0
1112721|NCT02501629|2196033|FG000|Overall Study|Death|0
1112722|NCT02501629|2196034|FG001|Overall Study|Death|1
1112723|NCT02501629|2196033|FG000|Overall Study|Withdrawn from study by sponsor|1
1112724|NCT02501629|2196034|FG001|Overall Study|Withdrawn from study by sponsor|0
1112725|NCT02501629|2196033|FG000|Overall Study|Early termination by sponsor|1
1112726|NCT02501629|2196034|FG001|Overall Study|Early termination by sponsor|0
1112727|NCT02501629|2196033|FG000|Overall Study|Withdrawal by Subject|3
1112728|NCT02501629|2196034|FG001|Overall Study|Withdrawal by Subject|5
1112729|NCT02501629|2196033|FG000|Overall Study|Subject did not return to site|0
1112730|NCT02501629|2196034|FG001|Overall Study|Subject did not return to site|1
1112731|NCT02501642|2196042|FG000|Overall Study|Lost to Follow-up|7
1112732|NCT02501642|2196043|FG001|Overall Study|Lost to Follow-up|11
1112733|NCT02501811|2196053|FG000|Overall Study|Death|1
1112734|NCT02501811|2196054|FG001|Overall Study|Death|3
1112735|NCT02501811|2196055|FG002|Overall Study|Death|2
1112736|NCT02501811|2196056|FG003|Overall Study|Death|3
1112737|NCT02501811|2196053|FG000|Overall Study|Withdrawal by Subject|3
1112738|NCT02501811|2196054|FG001|Overall Study|Withdrawal by Subject|3
1112739|NCT02501811|2196055|FG002|Overall Study|Withdrawal by Subject|2
1112740|NCT02501811|2196056|FG003|Overall Study|Withdrawal by Subject|3
1112741|NCT02501811|2196053|FG000|Overall Study|Lost to Follow-up|0
1112742|NCT02501811|2196054|FG001|Overall Study|Lost to Follow-up|0
1112743|NCT02501811|2196055|FG002|Overall Study|Lost to Follow-up|2
1112744|NCT02501811|2196056|FG003|Overall Study|Lost to Follow-up|1
1112745|NCT02501902|2196074|FG000|Overall Study|Subject Refused Further Follow-up|0
1112746|NCT02501902|2196075|FG001|Overall Study|Subject Refused Further Follow-up|0
1112747|NCT02501902|2196076|FG002|Overall Study|Subject Refused Further Follow-up|0
1112748|NCT02501902|2196077|FG003|Overall Study|Subject Refused Further Follow-up|0
1112749|NCT02501902|2196078|FG004|Overall Study|Subject Refused Further Follow-up|0
1112750|NCT02501902|2196079|FG005|Overall Study|Subject Refused Further Follow-up|0
1112751|NCT02501902|2196080|FG006|Overall Study|Subject Refused Further Follow-up|0
1112752|NCT02501902|2196081|FG007|Overall Study|Subject Refused Further Follow-up|1
1112753|NCT02501902|2196074|FG000|Overall Study|Study Terminated by Sponsor|0
1112754|NCT02501902|2196075|FG001|Overall Study|Study Terminated by Sponsor|3
1112755|NCT02501902|2196076|FG002|Overall Study|Study Terminated by Sponsor|0
1112756|NCT02501902|2196077|FG003|Overall Study|Study Terminated by Sponsor|1
1112757|NCT02501902|2196078|FG004|Overall Study|Study Terminated by Sponsor|1
1112758|NCT02501902|2196079|FG005|Overall Study|Study Terminated by Sponsor|0
1112759|NCT02501902|2196080|FG006|Overall Study|Study Terminated by Sponsor|2
1112760|NCT02501902|2196081|FG007|Overall Study|Study Terminated by Sponsor|4
1112761|NCT02501902|2196074|FG000|Overall Study|Death|3
1112762|NCT02501902|2196075|FG001|Overall Study|Death|4
1112763|NCT02501902|2196076|FG002|Overall Study|Death|4
1112764|NCT02501902|2196077|FG003|Overall Study|Death|10
1112765|NCT02501902|2196078|FG004|Overall Study|Death|10
1112766|NCT02501902|2196079|FG005|Overall Study|Death|11
1112767|NCT02501902|2196080|FG006|Overall Study|Death|7
1112768|NCT02501902|2196081|FG007|Overall Study|Death|15
1112769|NCT02501928|2196107|FG000|Overall Study|Withdrawal By Parent/Guardian|0
1112770|NCT02501928|2196108|FG001|Overall Study|Withdrawal By Parent/Guardian|0
1112771|NCT02501928|2196109|FG002|Overall Study|Withdrawal By Parent/Guardian|0
1112772|NCT02501928|2196110|FG003|Overall Study|Withdrawal By Parent/Guardian|0
1112773|NCT02501928|2196111|FG004|Overall Study|Withdrawal By Parent/Guardian|1
1112774|NCT02501928|2196112|FG005|Overall Study|Withdrawal By Parent/Guardian|0
1112775|NCT02502097|2196141|FG000|Period 1|Adverse Event|0
1112776|NCT02502097|2196142|FG001|Period 1|Adverse Event|0
1112777|NCT02502097|2196143|FG002|Period 1|Adverse Event|1
1112778|NCT02502097|2196144|FG003|Period 1|Adverse Event|0
1112779|NCT02502097|2196141|FG000|Wash Out Period|Adverse Event|0
1112780|NCT02502097|2196142|FG001|Wash Out Period|Adverse Event|1
1112781|NCT02502097|2196143|FG002|Wash Out Period|Adverse Event|1
1112782|NCT02502097|2196144|FG003|Wash Out Period|Adverse Event|1
1112783|NCT02502097|2196141|FG000|Period 2|Adverse Event|0
1112784|NCT02502097|2196142|FG001|Period 2|Adverse Event|0
1112785|NCT02502097|2196143|FG002|Period 2|Adverse Event|1
1112786|NCT02502097|2196144|FG003|Period 2|Adverse Event|0
1112787|NCT02502149|2196151|FG000|Intermediate|Discontinued prematurely|1
1112788|NCT02502149|2196152|FG001|Intermediate|Discontinued prematurely|0
1112789|NCT02502149|2196153|FG002|Intermediate|Discontinued prematurely|0
1112790|NCT02502149|2196154|FG003|Intermediate|Discontinued prematurely|0
1112791|NCT02502149|2196155|FG004|Intermediate|Discontinued prematurely|0
1112792|NCT02502526|2196197|FG000|Overall Study|Lost to Follow-up|2
1112793|NCT02502526|2196198|FG001|Overall Study|Lost to Follow-up|2
1112794|NCT02502526|2196199|FG002|Overall Study|Lost to Follow-up|3
1112795|NCT02502526|2196197|FG000|Overall Study|Withdrawal by Subject|0
1112796|NCT02502526|2196198|FG001|Overall Study|Withdrawal by Subject|1
1112797|NCT02502526|2196199|FG002|Overall Study|Withdrawal by Subject|1
1112798|NCT02502526|2196197|FG000|Overall Study|Disqualified due to cataract grading|0
1112799|NCT02502526|2196198|FG001|Overall Study|Disqualified due to cataract grading|0
1112800|NCT02502526|2196199|FG002|Overall Study|Disqualified due to cataract grading|1
1112801|NCT02502526|2196197|FG000|Overall Study|Enrollment suspension|4
1112802|NCT02502526|2196198|FG001|Overall Study|Enrollment suspension|1
1112803|NCT02502526|2196199|FG002|Overall Study|Enrollment suspension|1
1112804|NCT02502734|2196208|FG000|Double-blind Treatment Period 1|Adverse Event|1
1112805|NCT02502734|2196209|FG001|Double-blind Treatment Period 1|Adverse Event|0
1112806|NCT02502734|2196208|FG000|Washout Period|Adverse Event|1
1112807|NCT02502734|2196209|FG001|Washout Period|Adverse Event|0
1112808|NCT02502864|2196217|FG000|Overall Study|Withdrawal by Subject|1
1112809|NCT02503085|2196221|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1
1112810|NCT02503085|2196222|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0
1112811|NCT02503085|2196223|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1
1112812|NCT02503085|2196224|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0
1112813|NCT02503202|2196236|FG000|Base Study: Up to Month 6|Death|1
1112814|NCT02503202|2196237|FG001|Base Study: Up to Month 6|Death|1
1112815|NCT02503202|2196238|FG002|Base Study: Up to Month 6|Death|0
1112816|NCT02503202|2196239|FG003|Base Study: Up to Month 6|Death|0
1112817|NCT02503202|2196240|FG004|Base Study: Up to Month 6|Death|0
1112818|NCT02503202|2196236|FG000|Base Study: Up to Month 6|Lost to Follow-up|11
1112819|NCT02503202|2196237|FG001|Base Study: Up to Month 6|Lost to Follow-up|8
1112820|NCT02503202|2196238|FG002|Base Study: Up to Month 6|Lost to Follow-up|10
1112821|NCT02503202|2196239|FG003|Base Study: Up to Month 6|Lost to Follow-up|5
1112822|NCT02503202|2196240|FG004|Base Study: Up to Month 6|Lost to Follow-up|1
1112823|NCT02503202|2196236|FG000|Base Study: Up to Month 6|Physician Decision|0
1112824|NCT02503202|2196237|FG001|Base Study: Up to Month 6|Physician Decision|0
1112825|NCT02503202|2196238|FG002|Base Study: Up to Month 6|Physician Decision|0
1112826|NCT02503202|2196239|FG003|Base Study: Up to Month 6|Physician Decision|0
1112827|NCT02503202|2196240|FG004|Base Study: Up to Month 6|Physician Decision|1
1112828|NCT02503202|2196236|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6
1112829|NCT02503202|2196237|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3
1112830|NCT02503202|2196238|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4
1112831|NCT02503202|2196239|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4
1112832|NCT02503202|2196240|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1
1112833|NCT02503202|2196236|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0
1112834|NCT02503202|2196237|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0
1112835|NCT02503202|2196238|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1
1112836|NCT02503202|2196239|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2
1112837|NCT02503202|2196240|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0
1112838|NCT02503202|2196236|FG000|Extension: Month 6 to 24|Protocol Violation|0
1112839|NCT02503202|2196237|FG001|Extension: Month 6 to 24|Protocol Violation|0
1112840|NCT02503202|2196238|FG002|Extension: Month 6 to 24|Protocol Violation|0
1112841|NCT02503202|2196239|FG003|Extension: Month 6 to 24|Protocol Violation|1
1112842|NCT02503202|2196240|FG004|Extension: Month 6 to 24|Protocol Violation|0
1112843|NCT02503202|2196236|FG000|Extension: Month 6 to 24|Death|1
1112844|NCT02503202|2196237|FG001|Extension: Month 6 to 24|Death|0
1112845|NCT02503202|2196238|FG002|Extension: Month 6 to 24|Death|0
1112846|NCT02503202|2196239|FG003|Extension: Month 6 to 24|Death|0
1112847|NCT02503202|2196240|FG004|Extension: Month 6 to 24|Death|0
1112848|NCT02503202|2196236|FG000|Extension: Month 6 to 24|Lost to Follow-up|4
1112849|NCT02503202|2196237|FG001|Extension: Month 6 to 24|Lost to Follow-up|8
1112850|NCT02503202|2196238|FG002|Extension: Month 6 to 24|Lost to Follow-up|6
1112851|NCT02503202|2196239|FG003|Extension: Month 6 to 24|Lost to Follow-up|10
1112852|NCT02503202|2196240|FG004|Extension: Month 6 to 24|Lost to Follow-up|1
1112853|NCT02503202|2196236|FG000|Extension: Month 6 to 24|Physician Decision|1
1112854|NCT02503202|2196237|FG001|Extension: Month 6 to 24|Physician Decision|0
1112855|NCT02503202|2196238|FG002|Extension: Month 6 to 24|Physician Decision|1
1112856|NCT02503202|2196239|FG003|Extension: Month 6 to 24|Physician Decision|3
1112857|NCT02503202|2196240|FG004|Extension: Month 6 to 24|Physician Decision|0
1112858|NCT02503202|2196236|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5
1112859|NCT02503202|2196237|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8
1112860|NCT02503202|2196238|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2
1112861|NCT02503202|2196239|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4
1112862|NCT02503202|2196240|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0
1112863|NCT02503215|2196252|FG000|Overall Study|Unable to wear compression stockings|1
1112864|NCT02503215|2196252|FG000|Overall Study|Unable to use positive airway pressure|2
1112865|NCT02503332|2196269|FG000|Overall Study|Adverse Event|17
1112866|NCT02503332|2196270|FG001|Overall Study|Adverse Event|5
1112867|NCT02503332|2196271|FG002|Overall Study|Adverse Event|3
1112868|NCT02503332|2196272|FG003|Overall Study|Adverse Event|1
1112869|NCT02503332|2196269|FG000|Overall Study|Investigator's Decision|5
1112870|NCT02503332|2196270|FG001|Overall Study|Investigator's Decision|1
1112871|NCT02503332|2196271|FG002|Overall Study|Investigator's Decision|0
1112872|NCT02503332|2196272|FG003|Overall Study|Investigator's Decision|0
1112873|NCT02503332|2196269|FG000|Overall Study|Sponsor's Decision|1
1112874|NCT02503332|2196270|FG001|Overall Study|Sponsor's Decision|0
1112875|NCT02503332|2196271|FG002|Overall Study|Sponsor's Decision|0
1112876|NCT02503332|2196272|FG003|Overall Study|Sponsor's Decision|1
1112877|NCT02503332|2196269|FG000|Overall Study|Subject Request|6
1112878|NCT02503332|2196270|FG001|Overall Study|Subject Request|5
1112879|NCT02503332|2196271|FG002|Overall Study|Subject Request|2
1112880|NCT02503332|2196272|FG003|Overall Study|Subject Request|1
1112881|NCT02503332|2196269|FG000|Overall Study|Death|0
1112882|NCT02503332|2196270|FG001|Overall Study|Death|2
1112883|NCT02503332|2196271|FG002|Overall Study|Death|2
1112884|NCT02503332|2196272|FG003|Overall Study|Death|0
1112885|NCT02503332|2196269|FG000|Overall Study|Other|5
1112886|NCT02503332|2196270|FG001|Overall Study|Other|6
1112887|NCT02503332|2196271|FG002|Overall Study|Other|1
1112888|NCT02503332|2196272|FG003|Overall Study|Other|1
1112889|NCT02503501|2196302|FG000|Overall Study|Physician Decision|1
1112890|NCT02503501|2196303|FG001|Overall Study|Physician Decision|0
1112891|NCT02503501|2196302|FG000|Overall Study|Protocol Violation|0
1112892|NCT02503501|2196303|FG001|Overall Study|Protocol Violation|1
1112893|NCT02503501|2196302|FG000|Overall Study|Withdrawal by Subject|0
1112894|NCT02503501|2196303|FG001|Overall Study|Withdrawal by Subject|2
1112895|NCT02503540|2196309|FG000|Overall Study|Death|2
1112896|NCT02503540|2196309|FG000|Overall Study|Withdrawal by Subject|1
1112897|NCT02503787|2196323|FG000|Enrollment|Withdrawal by Subject|6
1112898|NCT02503787|2196323|FG000|Enrollment|Inclusion/exclusion criteria not met|4
1112899|NCT02503787|2196323|FG000|Enrollment|Physician Decision|2
1112900|NCT02503787|2196323|FG000|Enrollment|Insurance issue|2
1112901|NCT02503787|2196323|FG000|Enrollment|Lost to Follow-up|1
1112902|NCT02503787|2196323|FG000|Enrollment|Study closure|1
1112903|NCT02503787|2196323|FG000|Enrollment|Adverse Event|1
1112904|NCT02503787|2196323|FG000|Enrollment|Protocol Violation|1
1112905|NCT02503787|2196323|FG000|Enrollment|Inability to implant system|1
1112906|NCT02503787|2196323|FG000|Enrollment|Unable to be programmed|1
1112907|NCT02503787|2196323|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6
1112908|NCT02503787|2196323|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
1112909|NCT02503787|2196323|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
1112910|NCT02503787|2196323|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2
1112911|NCT02503787|2196323|FG000|Implant to 3 Month Endpoint|Adverse Event|2
1112912|NCT02503787|2196323|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1
1112913|NCT02503865|2196347|FG000|Overall Study|Moved out of area|1
1112914|NCT02503865|2196348|FG001|Overall Study|Moved out of area|8
1112915|NCT02503865|2196349|FG002|Overall Study|Moved out of area|0
1112916|NCT02503865|2196347|FG000|Overall Study|Refused treatment|4
1112917|NCT02503865|2196348|FG001|Overall Study|Refused treatment|39
1112918|NCT02503865|2196349|FG002|Overall Study|Refused treatment|2
1112919|NCT02504216|2196369|FG000|Overall Study|Lost to Follow-up|3
1112920|NCT02504216|2196370|FG001|Overall Study|Lost to Follow-up|3
1112921|NCT02504216|2196369|FG000|Overall Study|Withdrawal by Subject|8
1112922|NCT02504216|2196370|FG001|Overall Study|Withdrawal by Subject|12
1112923|NCT02504268|2196379|FG000|Overall Study|Adverse Event|18
1112924|NCT02504268|2196380|FG001|Overall Study|Adverse Event|8
1112925|NCT02504268|2196381|FG002|Overall Study|Adverse Event|14
1112926|NCT02504268|2196382|FG003|Overall Study|Adverse Event|0
1112927|NCT02504268|2196383|FG004|Overall Study|Adverse Event|0
1112928|NCT02504268|2196384|FG005|Overall Study|Adverse Event|0
1112929|NCT02504268|2196385|FG006|Overall Study|Adverse Event|0
1112930|NCT02504268|2196386|FG007|Overall Study|Adverse Event|0
1112931|NCT02504268|2196387|FG008|Overall Study|Adverse Event|0
1112932|NCT02504268|2196379|FG000|Overall Study|Withdrawal of Consent|11
1112933|NCT02504268|2196380|FG001|Overall Study|Withdrawal of Consent|10
1112934|NCT02504268|2196381|FG002|Overall Study|Withdrawal of Consent|3
1112935|NCT02504268|2196382|FG003|Overall Study|Withdrawal of Consent|0
1112936|NCT02504268|2196383|FG004|Overall Study|Withdrawal of Consent|0
1112937|NCT02504268|2196384|FG005|Overall Study|Withdrawal of Consent|0
1112938|NCT02504268|2196385|FG006|Overall Study|Withdrawal of Consent|0
1112939|NCT02504268|2196386|FG007|Overall Study|Withdrawal of Consent|0
1112940|NCT02504268|2196387|FG008|Overall Study|Withdrawal of Consent|0
1112941|NCT02504268|2196379|FG000|Overall Study|Pregnancy|2
1112942|NCT02504268|2196380|FG001|Overall Study|Pregnancy|0
1112943|NCT02504268|2196381|FG002|Overall Study|Pregnancy|0
1112944|NCT02504268|2196382|FG003|Overall Study|Pregnancy|0
1112945|NCT02504268|2196383|FG004|Overall Study|Pregnancy|0
1112946|NCT02504268|2196384|FG005|Overall Study|Pregnancy|0
1112947|NCT02504268|2196385|FG006|Overall Study|Pregnancy|0
1112948|NCT02504268|2196386|FG007|Overall Study|Pregnancy|0
1112949|NCT02504268|2196387|FG008|Overall Study|Pregnancy|0
1112950|NCT02504268|2196379|FG000|Overall Study|Lost to Follow-up|3
1112951|NCT02504268|2196380|FG001|Overall Study|Lost to Follow-up|6
1112952|NCT02504268|2196381|FG002|Overall Study|Lost to Follow-up|4
1112953|NCT02504268|2196382|FG003|Overall Study|Lost to Follow-up|0
1112954|NCT02504268|2196383|FG004|Overall Study|Lost to Follow-up|0
1112955|NCT02504268|2196384|FG005|Overall Study|Lost to Follow-up|0
1112956|NCT02504268|2196385|FG006|Overall Study|Lost to Follow-up|0
1112957|NCT02504268|2196386|FG007|Overall Study|Lost to Follow-up|0
1112958|NCT02504268|2196387|FG008|Overall Study|Lost to Follow-up|0
1112959|NCT02504268|2196379|FG000|Overall Study|Death|1
1112960|NCT02504268|2196380|FG001|Overall Study|Death|1
1112961|NCT02504268|2196381|FG002|Overall Study|Death|0
1112962|NCT02504268|2196382|FG003|Overall Study|Death|0
1112963|NCT02504268|2196383|FG004|Overall Study|Death|0
1112964|NCT02504268|2196384|FG005|Overall Study|Death|0
1112965|NCT02504268|2196385|FG006|Overall Study|Death|0
1112966|NCT02504268|2196386|FG007|Overall Study|Death|0
1112967|NCT02504268|2196387|FG008|Overall Study|Death|0
1112968|NCT02504268|2196379|FG000|Overall Study|Subject Request to Discontinue|11
1112969|NCT02504268|2196380|FG001|Overall Study|Subject Request to Discontinue|3
1112970|NCT02504268|2196381|FG002|Overall Study|Subject Request to Discontinue|6
1112971|NCT02504268|2196382|FG003|Overall Study|Subject Request to Discontinue|0
1112972|NCT02504268|2196383|FG004|Overall Study|Subject Request to Discontinue|0
1112973|NCT02504268|2196384|FG005|Overall Study|Subject Request to Discontinue|0
1112974|NCT02504268|2196385|FG006|Overall Study|Subject Request to Discontinue|0
1112975|NCT02504268|2196386|FG007|Overall Study|Subject Request to Discontinue|0
1112976|NCT02504268|2196387|FG008|Overall Study|Subject Request to Discontinue|0
1112977|NCT02504268|2196379|FG000|Overall Study|No Longer Meets Study Criteria|2
896658|NCT00705679|1868438|FG003|Overall Study|Adverse Event|0
896659|NCT00705679|1868439|FG004|Overall Study|Adverse Event|0
896660|NCT00705679|1868435|FG000|Overall Study|Death|0
896661|NCT00705679|1868436|FG001|Overall Study|Death|0
896662|NCT00705679|1868437|FG002|Overall Study|Death|3
896663|NCT00705679|1868438|FG003|Overall Study|Death|2
896664|NCT00705679|1868439|FG004|Overall Study|Death|1
896665|NCT00705679|1868435|FG000|Overall Study|Lost to Follow-up|32
896666|NCT00705679|1868436|FG001|Overall Study|Lost to Follow-up|60
896667|NCT00705679|1868437|FG002|Overall Study|Lost to Follow-up|44
896668|NCT00705679|1868438|FG003|Overall Study|Lost to Follow-up|30
896669|NCT00705679|1868439|FG004|Overall Study|Lost to Follow-up|35
896670|NCT00705679|1868435|FG000|Overall Study|Physician Decision|0
896671|NCT00705679|1868436|FG001|Overall Study|Physician Decision|1
896672|NCT00705679|1868437|FG002|Overall Study|Physician Decision|0
896673|NCT00705679|1868438|FG003|Overall Study|Physician Decision|1
896674|NCT00705679|1868439|FG004|Overall Study|Physician Decision|0
896675|NCT00705679|1868435|FG000|Overall Study|Withdrawal by Subject|32
896676|NCT00705679|1868436|FG001|Overall Study|Withdrawal by Subject|77
896677|NCT00705679|1868437|FG002|Overall Study|Withdrawal by Subject|68
896678|NCT00705679|1868438|FG003|Overall Study|Withdrawal by Subject|47
896679|NCT00705679|1868439|FG004|Overall Study|Withdrawal by Subject|33
896680|NCT00705718|1868458|FG000|Overall Study|Death|6
896681|NCT00705718|1868459|FG001|Overall Study|Death|6
896682|NCT00705718|1868458|FG000|Overall Study|Not due for Visit|0
896683|NCT00705718|1868459|FG001|Overall Study|Not due for Visit|12
896684|NCT00705718|1868458|FG000|Overall Study|Follow up not done|1
896685|NCT00705718|1868459|FG001|Overall Study|Follow up not done|4
896686|NCT00705757|1868468|FG000|Overall Study|Lack of Efficacy|5
896687|NCT00705757|1868469|FG001|Overall Study|Lack of Efficacy|1
896688|NCT00705757|1868470|FG002|Overall Study|Lack of Efficacy|3
896689|NCT00705757|1868468|FG000|Overall Study|Lost to Follow-up|7
896690|NCT00705757|1868469|FG001|Overall Study|Lost to Follow-up|6
896691|NCT00705757|1868470|FG002|Overall Study|Lost to Follow-up|6
896692|NCT00705757|1868468|FG000|Overall Study|Withdrawal by Subject|1
896693|NCT00705757|1868469|FG001|Overall Study|Withdrawal by Subject|1
896694|NCT00705757|1868470|FG002|Overall Study|Withdrawal by Subject|2
896695|NCT00705783|1868480|FG000|Conversion Phase|Sponsor Discontinued Study|54
896696|NCT00705783|1868481|FG001|Conversion Phase|Sponsor Discontinued Study|0
1112978|NCT02504268|2196380|FG001|Overall Study|No Longer Meets Study Criteria|3
1112979|NCT02504268|2196381|FG002|Overall Study|No Longer Meets Study Criteria|0
1112980|NCT02504268|2196382|FG003|Overall Study|No Longer Meets Study Criteria|0
1112981|NCT02504268|2196383|FG004|Overall Study|No Longer Meets Study Criteria|0
1112982|NCT02504268|2196384|FG005|Overall Study|No Longer Meets Study Criteria|0
1112983|NCT02504268|2196385|FG006|Overall Study|No Longer Meets Study Criteria|0
1112984|NCT02504268|2196386|FG007|Overall Study|No Longer Meets Study Criteria|0
1112985|NCT02504268|2196387|FG008|Overall Study|No Longer Meets Study Criteria|0
1112986|NCT02504268|2196379|FG000|Overall Study|Lack of Efficacy|11
1112987|NCT02504268|2196380|FG001|Overall Study|Lack of Efficacy|35
1112988|NCT02504268|2196381|FG002|Overall Study|Lack of Efficacy|9
1112989|NCT02504268|2196382|FG003|Overall Study|Lack of Efficacy|0
1112990|NCT02504268|2196383|FG004|Overall Study|Lack of Efficacy|0
1112991|NCT02504268|2196384|FG005|Overall Study|Lack of Efficacy|0
1112992|NCT02504268|2196385|FG006|Overall Study|Lack of Efficacy|0
1112993|NCT02504268|2196386|FG007|Overall Study|Lack of Efficacy|0
1112994|NCT02504268|2196387|FG008|Overall Study|Lack of Efficacy|0
1112995|NCT02504268|2196379|FG000|Overall Study|Poor/Non-Compliance|3
1112996|NCT02504268|2196380|FG001|Overall Study|Poor/Non-Compliance|2
1112997|NCT02504268|2196381|FG002|Overall Study|Poor/Non-Compliance|3
1112998|NCT02504268|2196382|FG003|Overall Study|Poor/Non-Compliance|0
1112999|NCT02504268|2196383|FG004|Overall Study|Poor/Non-Compliance|0
1113000|NCT02504268|2196384|FG005|Overall Study|Poor/Non-Compliance|0
1113001|NCT02504268|2196385|FG006|Overall Study|Poor/Non-Compliance|0
1113002|NCT02504268|2196386|FG007|Overall Study|Poor/Non-Compliance|0
1113003|NCT02504268|2196387|FG008|Overall Study|Poor/Non-Compliance|0
1113004|NCT02504268|2196379|FG000|Overall Study|Not Disclosed|1
1113005|NCT02504268|2196380|FG001|Overall Study|Not Disclosed|0
1113006|NCT02504268|2196381|FG002|Overall Study|Not Disclosed|2
1113007|NCT02504268|2196382|FG003|Overall Study|Not Disclosed|0
1113008|NCT02504268|2196383|FG004|Overall Study|Not Disclosed|0
1113009|NCT02504268|2196384|FG005|Overall Study|Not Disclosed|0
1113010|NCT02504268|2196385|FG006|Overall Study|Not Disclosed|0
1113011|NCT02504268|2196386|FG007|Overall Study|Not Disclosed|0
1113012|NCT02504268|2196387|FG008|Overall Study|Not Disclosed|0
1113013|NCT02504294|2196409|FG000|Overall Study|Adverse Event|15
1113014|NCT02504294|2196410|FG001|Overall Study|Adverse Event|12
1113015|NCT02504294|2196409|FG000|Overall Study|Withdrawal by Subject|7
1113016|NCT02504294|2196410|FG001|Overall Study|Withdrawal by Subject|1
1113017|NCT02504294|2196409|FG000|Overall Study|Protocol Violation|27
1113018|NCT02504294|2196410|FG001|Overall Study|Protocol Violation|26
1113019|NCT02504294|2196409|FG000|Overall Study|Physician Decision|1
1113020|NCT02504294|2196410|FG001|Overall Study|Physician Decision|2
1113021|NCT02504294|2196409|FG000|Overall Study|Lost to Follow-up|6
1113022|NCT02504294|2196410|FG001|Overall Study|Lost to Follow-up|7
1113023|NCT02504320|2196420|FG000|Treatment Period 1|Positive Drug Screen|0
1113024|NCT02504320|2196421|FG001|Treatment Period 1|Positive Drug Screen|0
1113025|NCT02504320|2196422|FG002|Treatment Period 1|Positive Drug Screen|1
1113026|NCT02504320|2196423|FG003|Treatment Period 1|Positive Drug Screen|0
1113027|NCT02504320|2196420|FG000|Treatment Period 2|Positive Drug Screen|0
1113028|NCT02504320|2196421|FG001|Treatment Period 2|Positive Drug Screen|1
1113029|NCT02504320|2196422|FG002|Treatment Period 2|Positive Drug Screen|0
1113030|NCT02504320|2196423|FG003|Treatment Period 2|Positive Drug Screen|0
1113031|NCT02504320|2196420|FG000|Treatment Period 3|Positive Drug Screen|0
1113032|NCT02504320|2196421|FG001|Treatment Period 3|Positive Drug Screen|0
1113033|NCT02504320|2196422|FG002|Treatment Period 3|Positive Drug Screen|0
1113034|NCT02504320|2196423|FG003|Treatment Period 3|Positive Drug Screen|1
1113035|NCT02504320|2196420|FG000|Treatment Period 3|Adverse Event|0
1113036|NCT02504320|2196421|FG001|Treatment Period 3|Adverse Event|0
1113037|NCT02504320|2196422|FG002|Treatment Period 3|Adverse Event|1
1113038|NCT02504320|2196423|FG003|Treatment Period 3|Adverse Event|0
1113039|NCT02504424|2196433|FG000|Overall Study|Withdrawal by Subject|2
1113040|NCT02504502|2196440|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4
1113041|NCT02504502|2196441|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7
1113042|NCT02504502|2196440|FG000|Crossover to Enhanced Report|Lost to Follow-up|5
1113043|NCT02504502|2196441|FG001|Crossover to Enhanced Report|Lost to Follow-up|0
1113044|NCT02504541|2196447|FG000|Overall Study|Adverse Event|4
1113045|NCT02504541|2196447|FG000|Overall Study|Withdrawal by Subject|4
1113046|NCT02504541|2196447|FG000|Overall Study|Lost to Follow-up|1
1113047|NCT02504541|2196447|FG000|Overall Study|Met Stopping Criteria|1
1113048|NCT02504541|2196447|FG000|Overall Study|Protocol Violation|2
1113049|NCT02504541|2196447|FG000|Overall Study|Termination by Sponsor|1
1113050|NCT02504541|2196447|FG000|Overall Study|Other|2
1113051|NCT02504541|2196447|FG000|Overall Study|Multiple|5
1113052|NCT02504671|2196480|FG000|Overall Study|Withdrawal by Subject|1
1113053|NCT02504671|2196481|FG001|Overall Study|Withdrawal by Subject|5
1113054|NCT02504671|2196482|FG002|Overall Study|Withdrawal by Subject|4
1113055|NCT02504671|2196483|FG003|Overall Study|Withdrawal by Subject|4
1113056|NCT02504671|2196484|FG004|Overall Study|Withdrawal by Subject|5
1113057|NCT02504671|2196485|FG005|Overall Study|Withdrawal by Subject|3
1113058|NCT02504671|2196480|FG000|Overall Study|Lack of Efficacy|1
1113059|NCT02504671|2196481|FG001|Overall Study|Lack of Efficacy|3
1113060|NCT02504671|2196482|FG002|Overall Study|Lack of Efficacy|1
1113061|NCT02504671|2196483|FG003|Overall Study|Lack of Efficacy|0
1113062|NCT02504671|2196484|FG004|Overall Study|Lack of Efficacy|4
1113063|NCT02504671|2196485|FG005|Overall Study|Lack of Efficacy|4
1113064|NCT02504671|2196480|FG000|Overall Study|Adverse Event|1
1113065|NCT02504671|2196481|FG001|Overall Study|Adverse Event|1
1113066|NCT02504671|2196482|FG002|Overall Study|Adverse Event|0
1113067|NCT02504671|2196483|FG003|Overall Study|Adverse Event|1
1113068|NCT02504671|2196484|FG004|Overall Study|Adverse Event|0
1113069|NCT02504671|2196485|FG005|Overall Study|Adverse Event|2
1113070|NCT02504671|2196480|FG000|Overall Study|Protocol Violation|2
1113071|NCT02504671|2196481|FG001|Overall Study|Protocol Violation|1
1113072|NCT02504671|2196482|FG002|Overall Study|Protocol Violation|0
1113073|NCT02504671|2196483|FG003|Overall Study|Protocol Violation|0
1113074|NCT02504671|2196484|FG004|Overall Study|Protocol Violation|0
1113075|NCT02504671|2196485|FG005|Overall Study|Protocol Violation|1
1113076|NCT02504671|2196480|FG000|Overall Study|Lost to Follow-up|0
1113077|NCT02504671|2196481|FG001|Overall Study|Lost to Follow-up|0
1113078|NCT02504671|2196482|FG002|Overall Study|Lost to Follow-up|2
1113079|NCT02504671|2196483|FG003|Overall Study|Lost to Follow-up|0
1113080|NCT02504671|2196484|FG004|Overall Study|Lost to Follow-up|0
1113081|NCT02504671|2196485|FG005|Overall Study|Lost to Follow-up|1
1113082|NCT02504671|2196480|FG000|Overall Study|Protocol defined stopping criteria|7
1113083|NCT02504671|2196481|FG001|Overall Study|Protocol defined stopping criteria|4
1113084|NCT02504671|2196482|FG002|Overall Study|Protocol defined stopping criteria|3
1113085|NCT02504671|2196483|FG003|Overall Study|Protocol defined stopping criteria|5
1113086|NCT02504671|2196484|FG004|Overall Study|Protocol defined stopping criteria|3
1113087|NCT02504671|2196485|FG005|Overall Study|Protocol defined stopping criteria|3
1113088|NCT02504827|2196517|FG000|Overall Study|Could not produce sputum|1
1113089|NCT02504892|2196521|FG000|Overall Study|Adverse event-pneumonitis|2
1113090|NCT02505217|2196536|FG000|Overall Study|Withdrawal by Subject|1
1113091|NCT02505217|2196537|FG001|Overall Study|Withdrawal by Subject|2
1113092|NCT02505334|2196549|FG000|Main Treatment Period|Adverse Event|3
1113093|NCT02505334|2196550|FG001|Main Treatment Period|Adverse Event|3
1113094|NCT02505334|2196549|FG000|Main Treatment Period|Lack of Efficacy|7
1113095|NCT02505334|2196550|FG001|Main Treatment Period|Lack of Efficacy|17
1113096|NCT02505334|2196549|FG000|Main Treatment Period|Protocol Violation|0
1113097|NCT02505334|2196550|FG001|Main Treatment Period|Protocol Violation|1
1113098|NCT02505334|2196549|FG000|Main Treatment Period|Withdrawal by Subject|1
1113099|NCT02505334|2196550|FG001|Main Treatment Period|Withdrawal by Subject|8
1113100|NCT02505334|2196549|FG000|Main Treatment Period|Unclassified|4
1113101|NCT02505334|2196550|FG001|Main Treatment Period|Unclassified|10
1113102|NCT02505334|2196549|FG000|Extension Treatment Period|Adverse Event|5
1113103|NCT02505334|2196550|FG001|Extension Treatment Period|Adverse Event|0
1113104|NCT02505334|2196549|FG000|Extension Treatment Period|Lack of Efficacy|4
1113105|NCT02505334|2196550|FG001|Extension Treatment Period|Lack of Efficacy|0
1113106|NCT02505334|2196549|FG000|Extension Treatment Period|Withdrawal by Subject|6
1113107|NCT02505334|2196550|FG001|Extension Treatment Period|Withdrawal by Subject|0
1113108|NCT02505334|2196549|FG000|Extension Treatment Period|Unclassified|3
1113109|NCT02505334|2196550|FG001|Extension Treatment Period|Unclassified|0
1113122|NCT02505542|2196573|FG000|Part A: Open-Label Period|Adverse Event|31
1113123|NCT02505542|2196574|FG001|Part A: Open-Label Period|Adverse Event|0
1113124|NCT02505542|2196575|FG002|Part A: Open-Label Period|Adverse Event|0
1113125|NCT02505542|2196576|FG003|Part A: Open-Label Period|Adverse Event|0
1113126|NCT02505542|2196573|FG000|Part A: Open-Label Period|Lack of Efficacy|5
1113127|NCT02505542|2196574|FG001|Part A: Open-Label Period|Lack of Efficacy|0
1113128|NCT02505542|2196575|FG002|Part A: Open-Label Period|Lack of Efficacy|0
1113129|NCT02505542|2196576|FG003|Part A: Open-Label Period|Lack of Efficacy|0
1113130|NCT02505542|2196573|FG000|Part A: Open-Label Period|Protocol Violation|1
1113131|NCT02505542|2196574|FG001|Part A: Open-Label Period|Protocol Violation|0
1113132|NCT02505542|2196575|FG002|Part A: Open-Label Period|Protocol Violation|0
1113133|NCT02505542|2196576|FG003|Part A: Open-Label Period|Protocol Violation|0
1113134|NCT02505542|2196573|FG000|Part A: Open-Label Period|Lost to Follow-up|5
1113135|NCT02505542|2196574|FG001|Part A: Open-Label Period|Lost to Follow-up|0
1113136|NCT02505542|2196575|FG002|Part A: Open-Label Period|Lost to Follow-up|0
1113137|NCT02505542|2196576|FG003|Part A: Open-Label Period|Lost to Follow-up|0
1113138|NCT02505542|2196573|FG000|Part A: Open-Label Period|Withdrawal by Subject|27
1113139|NCT02505542|2196574|FG001|Part A: Open-Label Period|Withdrawal by Subject|0
1113140|NCT02505542|2196575|FG002|Part A: Open-Label Period|Withdrawal by Subject|0
1113141|NCT02505542|2196576|FG003|Part A: Open-Label Period|Withdrawal by Subject|0
1113142|NCT02505542|2196573|FG000|Part A: Open-Label Period|New medical history available|1
1113143|NCT02505542|2196574|FG001|Part A: Open-Label Period|New medical history available|0
1113144|NCT02505542|2196575|FG002|Part A: Open-Label Period|New medical history available|0
1113145|NCT02505542|2196576|FG003|Part A: Open-Label Period|New medical history available|0
1113146|NCT02505542|2196573|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1
1113147|NCT02505542|2196574|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0
1113148|NCT02505542|2196575|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0
1113149|NCT02505542|2196576|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0
1113150|NCT02505542|2196573|FG000|Part A: Open-Label Period|Pregnancy|2
1113151|NCT02505542|2196574|FG001|Part A: Open-Label Period|Pregnancy|0
1113152|NCT02505542|2196575|FG002|Part A: Open-Label Period|Pregnancy|0
1113153|NCT02505542|2196576|FG003|Part A: Open-Label Period|Pregnancy|0
1113154|NCT02505542|2196573|FG000|Part A: Open-Label Period|Sponsor directive|1
1113155|NCT02505542|2196574|FG001|Part A: Open-Label Period|Sponsor directive|0
1113156|NCT02505542|2196575|FG002|Part A: Open-Label Period|Sponsor directive|0
1113157|NCT02505542|2196576|FG003|Part A: Open-Label Period|Sponsor directive|0
1113158|NCT02505542|2196573|FG000|Part A: Open-Label Period|Medical monitor decision|1
1113159|NCT02505542|2196574|FG001|Part A: Open-Label Period|Medical monitor decision|0
1113160|NCT02505542|2196575|FG002|Part A: Open-Label Period|Medical monitor decision|0
1113161|NCT02505542|2196576|FG003|Part A: Open-Label Period|Medical monitor decision|0
1113162|NCT02505542|2196573|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1
1113163|NCT02505542|2196574|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0
1113164|NCT02505542|2196575|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0
1113165|NCT02505542|2196576|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0
1113166|NCT02505542|2196573|FG000|Part A: Open-Label Period|Non-compliance|1
1113167|NCT02505542|2196574|FG001|Part A: Open-Label Period|Non-compliance|0
1113168|NCT02505542|2196575|FG002|Part A: Open-Label Period|Non-compliance|0
1113169|NCT02505542|2196576|FG003|Part A: Open-Label Period|Non-compliance|0
1113170|NCT02505542|2196573|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
1113171|NCT02505542|2196574|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
1113172|NCT02505542|2196575|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
1113173|NCT02505542|2196576|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
1113174|NCT02505542|2196573|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
1113175|NCT02505542|2196574|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
1113176|NCT02505542|2196575|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
1113177|NCT02505542|2196576|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
1113178|NCT02505542|2196573|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
1113179|NCT02505542|2196574|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
1113180|NCT02505542|2196575|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
1113181|NCT02505542|2196576|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
1113182|NCT02505542|2196573|FG000|Part B: Double-Blind Period|Adverse Event|0
1113183|NCT02505542|2196574|FG001|Part B: Double-Blind Period|Adverse Event|0
1113184|NCT02505542|2196575|FG002|Part B: Double-Blind Period|Adverse Event|1
1113185|NCT02505542|2196576|FG003|Part B: Double-Blind Period|Adverse Event|3
1113186|NCT02505542|2196573|FG000|Part B: Double-Blind Period|Lost to Follow-up|0
1113187|NCT02505542|2196574|FG001|Part B: Double-Blind Period|Lost to Follow-up|0
1113188|NCT02505542|2196575|FG002|Part B: Double-Blind Period|Lost to Follow-up|0
1113189|NCT02505542|2196576|FG003|Part B: Double-Blind Period|Lost to Follow-up|1
1113190|NCT02505542|2196573|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0
1113191|NCT02505542|2196574|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8
1113192|NCT02505542|2196575|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7
1113193|NCT02505542|2196576|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2
1113194|NCT02505542|2196573|FG000|Part B: Double-Blind Period|Planning pregnancy|0
1113195|NCT02505542|2196574|FG001|Part B: Double-Blind Period|Planning pregnancy|1
1113196|NCT02505542|2196575|FG002|Part B: Double-Blind Period|Planning pregnancy|0
1113197|NCT02505542|2196576|FG003|Part B: Double-Blind Period|Planning pregnancy|0
1113198|NCT02505542|2196573|FG000|Part B: Double-Blind Period|Week 94 missed|0
1113199|NCT02505542|2196574|FG001|Part B: Double-Blind Period|Week 94 missed|0
1113200|NCT02505542|2196575|FG002|Part B: Double-Blind Period|Week 94 missed|1
1113201|NCT02505542|2196576|FG003|Part B: Double-Blind Period|Week 94 missed|0
1113202|NCT02505542|2196573|FG000|Part B: Double-Blind Period|Patient was moved from the country|0
1113203|NCT02505542|2196574|FG001|Part B: Double-Blind Period|Patient was moved from the country|0
1113204|NCT02505542|2196575|FG002|Part B: Double-Blind Period|Patient was moved from the country|0
1113205|NCT02505542|2196576|FG003|Part B: Double-Blind Period|Patient was moved from the country|1
1113206|NCT02505542|2196573|FG000|Part B: Double-Blind Period|Lack of Efficacy|0
1113207|NCT02505542|2196574|FG001|Part B: Double-Blind Period|Lack of Efficacy|1
1113208|NCT02505542|2196575|FG002|Part B: Double-Blind Period|Lack of Efficacy|0
1113209|NCT02505542|2196576|FG003|Part B: Double-Blind Period|Lack of Efficacy|0
1113210|NCT02505542|2196573|FG000|Part B: Double-Blind Period|Miscalculation|0
1113211|NCT02505542|2196574|FG001|Part B: Double-Blind Period|Miscalculation|1
1113212|NCT02505542|2196575|FG002|Part B: Double-Blind Period|Miscalculation|0
1113213|NCT02505542|2196576|FG003|Part B: Double-Blind Period|Miscalculation|0
1113214|NCT02505542|2196573|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0
1113215|NCT02505542|2196574|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1
1113216|NCT02505542|2196575|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0
1113217|NCT02505542|2196576|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0
1113218|NCT02505867|2196604|FG000|Overall Study|Lack of Efficacy|6
1113219|NCT02505867|2196605|FG001|Overall Study|Lack of Efficacy|6
1113220|NCT02505945|2196622|FG000|Overall Study|Withdrawal by Subject|13
1113221|NCT02505945|2196623|FG001|Overall Study|Withdrawal by Subject|2
1113222|NCT02505945|2196622|FG000|Overall Study|Adverse Event|1
1113223|NCT02505945|2196623|FG001|Overall Study|Adverse Event|0
1113224|NCT02505945|2196622|FG000|Overall Study|Physician Decision|2
1113225|NCT02505945|2196623|FG001|Overall Study|Physician Decision|1
1113226|NCT02505945|2196622|FG000|Overall Study|Lost to Follow-up|6
1113227|NCT02505945|2196623|FG001|Overall Study|Lost to Follow-up|1
1113228|NCT02506036|2196631|FG000|First Intervention (4-6 Weeks)|Death|1
1113229|NCT02506036|2196632|FG001|First Intervention (4-6 Weeks)|Death|0
1113230|NCT02506036|2196631|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0
1113231|NCT02506036|2196632|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1
1113232|NCT02506036|2196631|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
1113233|NCT02506036|2196632|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
1113234|NCT02506257|2196655|FG000|Overall Study|Adverse Event|0
1113235|NCT02506257|2196656|FG001|Overall Study|Adverse Event|2
1113236|NCT02506257|2196657|FG002|Overall Study|Adverse Event|3
1113237|NCT02506257|2196658|FG003|Overall Study|Adverse Event|0
1113238|NCT02506257|2196655|FG000|Overall Study|Protocol Violation|0
1113239|NCT02506257|2196656|FG001|Overall Study|Protocol Violation|0
1113240|NCT02506257|2196657|FG002|Overall Study|Protocol Violation|1
1113241|NCT02506257|2196658|FG003|Overall Study|Protocol Violation|0
1113242|NCT02506816|2196741|FG000|Overall Study|Adverse Event|3
1113243|NCT02506881|2196762|FG000|First Intervention (Day 1)|Protocol Violation|0
1113244|NCT02506881|2196763|FG001|First Intervention (Day 1)|Protocol Violation|0
1113245|NCT02506881|2196764|FG002|First Intervention (Day 1)|Protocol Violation|1
1113246|NCT02506881|2196765|FG003|First Intervention (Day 1)|Protocol Violation|0
1113247|NCT02506881|2196762|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
1113248|NCT02506881|2196763|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
1113249|NCT02506881|2196764|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
1113250|NCT02506881|2196765|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
1113251|NCT02506881|2196762|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0
1113252|NCT02506881|2196763|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0
1113253|NCT02506881|2196764|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12
1113254|NCT02506881|2196765|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12
1113255|NCT02507219|2196792|FG000|Overall Study|Physician Decision|1
1113256|NCT02507219|2196793|FG001|Overall Study|Physician Decision|0
1113257|NCT02507219|2196794|FG002|Overall Study|Physician Decision|0
1113258|NCT02507219|2196795|FG003|Overall Study|Physician Decision|0
1113259|NCT02507219|2196796|FG004|Overall Study|Physician Decision|0
1113260|NCT02507219|2196797|FG005|Overall Study|Physician Decision|0
1113261|NCT02507219|2196792|FG000|Overall Study|Withdrawal by Subject|0
1113262|NCT02507219|2196793|FG001|Overall Study|Withdrawal by Subject|0
1113263|NCT02507219|2196794|FG002|Overall Study|Withdrawal by Subject|0
1113264|NCT02507219|2196795|FG003|Overall Study|Withdrawal by Subject|0
1113265|NCT02507219|2196796|FG004|Overall Study|Withdrawal by Subject|1
1113266|NCT02507219|2196797|FG005|Overall Study|Withdrawal by Subject|0
1113267|NCT02507297|2196807|FG000|Overall Study|Withdrawal by Subject|1
1113268|NCT02507297|2196808|FG001|Overall Study|Withdrawal by Subject|0
1113269|NCT02507297|2196807|FG000|Overall Study|Lost to Follow-up|0
1113270|NCT02507297|2196808|FG001|Overall Study|Lost to Follow-up|1
1113271|NCT02507349|2196816|FG000|Overall Study|Death|12
1113272|NCT02507349|2196817|FG001|Overall Study|Death|16
1113273|NCT02507349|2196816|FG000|Overall Study|Withdrawal by Subject|1
1113274|NCT02507349|2196817|FG001|Overall Study|Withdrawal by Subject|1
1113275|NCT02507349|2196816|FG000|Overall Study|Lost to Follow-up|174
1113276|NCT02507349|2196817|FG001|Overall Study|Lost to Follow-up|144
1113277|NCT02507375|2196825|FG000|Overall Study|Progressive Disease|4
1113278|NCT02507375|2196826|FG001|Overall Study|Progressive Disease|5
1113279|NCT02507375|2196825|FG000|Overall Study|Death|0
1113280|NCT02507375|2196826|FG001|Overall Study|Death|1
1113281|NCT02507375|2196825|FG000|Overall Study|Refused treatment|0
1113282|NCT02507375|2196826|FG001|Overall Study|Refused treatment|1
1113283|NCT02507375|2196825|FG000|Overall Study|Adverse Event|0
1113284|NCT02507375|2196826|FG001|Overall Study|Adverse Event|1
1113285|NCT02507752|2196846|FG000|Overall Study|Adverse Event|1
1113286|NCT02507752|2196846|FG000|Overall Study|Protocol Violation|6
1113287|NCT02507752|2196846|FG000|Overall Study|Lost to Follow-up|7
1113288|NCT02507752|2196846|FG000|Overall Study|Infusion reaction at first infusion|1
1113289|NCT02507752|2196846|FG000|Overall Study|Participant didn't perform visit Week 12|1
1113290|NCT02507752|2196846|FG000|Overall Study|Participant didn't perform visit Week 24|1
1113291|NCT02508116|2196865|FG000|Overall Study|Lost to Follow-up|2
1113292|NCT02508116|2196866|FG001|Overall Study|Lost to Follow-up|3
1113293|NCT02508116|2196865|FG000|Overall Study|Withdrawal by Subject|3
1113294|NCT02508116|2196866|FG001|Overall Study|Withdrawal by Subject|2
1113295|NCT02508116|2196865|FG000|Overall Study|Protocol Violation|1
1113296|NCT02508116|2196866|FG001|Overall Study|Protocol Violation|2
1113297|NCT02508116|2196865|FG000|Overall Study|Physician Decision|2
1113298|NCT02508116|2196866|FG001|Overall Study|Physician Decision|0
1113299|NCT02508194|2196874|FG000|Overall Study|Death|5
1113300|NCT02508194|2196875|FG001|Overall Study|Death|3
1113301|NCT02508194|2196874|FG000|Overall Study|Lost to Follow-up|25
1113302|NCT02508194|2196875|FG001|Overall Study|Lost to Follow-up|18
1113303|NCT02508194|2196874|FG000|Overall Study|Withdrawal by Subject|20
1113304|NCT02508194|2196875|FG001|Overall Study|Withdrawal by Subject|18
1113305|NCT02508194|2196874|FG000|Overall Study|Error in Randomization|1
1113306|NCT02508194|2196875|FG001|Overall Study|Error in Randomization|3
1113307|NCT02508194|2196874|FG000|Overall Study|Principal Investigator Decision|1
1113308|NCT02508194|2196875|FG001|Overall Study|Principal Investigator Decision|2
1113309|NCT02508428|2196914|FG000|Overall Study|Death|32
1113310|NCT02508428|2196915|FG001|Overall Study|Death|33
1113311|NCT02508428|2196914|FG000|Overall Study|Liner revised|3
1113312|NCT02508428|2196915|FG001|Overall Study|Liner revised|19
1113313|NCT02508428|2196914|FG000|Overall Study|Incomplete follow-up|17
1113314|NCT02508428|2196915|FG001|Overall Study|Incomplete follow-up|15
1113315|NCT02508532|2196937|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
1113316|NCT02508532|2196938|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
1113317|NCT02508532|2196939|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
1113318|NCT02508532|2196940|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
1113319|NCT02508532|2196941|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
1113320|NCT02508532|2196942|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
1113321|NCT02508532|2196943|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1
1113322|NCT02508532|2196944|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
1113323|NCT02508532|2196945|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
1113324|NCT02508532|2196937|FG000|Part 1 - Dose Determining Period|Not Evaluable|0
1113325|NCT02508532|2196938|FG001|Part 1 - Dose Determining Period|Not Evaluable|0
1113326|NCT02508532|2196939|FG002|Part 1 - Dose Determining Period|Not Evaluable|0
1113327|NCT02508532|2196940|FG003|Part 1 - Dose Determining Period|Not Evaluable|0
1113328|NCT02508532|2196941|FG004|Part 1 - Dose Determining Period|Not Evaluable|0
1113329|NCT02508532|2196942|FG005|Part 1 - Dose Determining Period|Not Evaluable|0
1113330|NCT02508532|2196943|FG006|Part 1 - Dose Determining Period|Not Evaluable|0
1113331|NCT02508532|2196944|FG007|Part 1 - Dose Determining Period|Not Evaluable|1
1113332|NCT02508532|2196945|FG008|Part 1 - Dose Determining Period|Not Evaluable|0
1113333|NCT02508532|2196937|FG000|Part 2 - Treatment|Disease Progression|0
1113334|NCT02508532|2196938|FG001|Part 2 - Treatment|Disease Progression|0
1113335|NCT02508532|2196939|FG002|Part 2 - Treatment|Disease Progression|0
1113336|NCT02508532|2196940|FG003|Part 2 - Treatment|Disease Progression|0
1113337|NCT02508532|2196941|FG004|Part 2 - Treatment|Disease Progression|0
1113338|NCT02508532|2196942|FG005|Part 2 - Treatment|Disease Progression|0
1113339|NCT02508532|2196943|FG006|Part 2 - Treatment|Disease Progression|0
1113340|NCT02508532|2196944|FG007|Part 2 - Treatment|Disease Progression|0
1113341|NCT02508532|2196945|FG008|Part 2 - Treatment|Disease Progression|118
1113342|NCT02508532|2196937|FG000|Part 2 - Treatment|Adverse Event|0
1113343|NCT02508532|2196938|FG001|Part 2 - Treatment|Adverse Event|0
1113344|NCT02508532|2196939|FG002|Part 2 - Treatment|Adverse Event|0
1113345|NCT02508532|2196940|FG003|Part 2 - Treatment|Adverse Event|0
1113346|NCT02508532|2196941|FG004|Part 2 - Treatment|Adverse Event|0
1113347|NCT02508532|2196942|FG005|Part 2 - Treatment|Adverse Event|0
1113348|NCT02508532|2196943|FG006|Part 2 - Treatment|Adverse Event|0
1113349|NCT02508532|2196944|FG007|Part 2 - Treatment|Adverse Event|0
1113350|NCT02508532|2196945|FG008|Part 2 - Treatment|Adverse Event|49
1113351|NCT02508532|2196937|FG000|Part 2 - Treatment|Physician Decision|0
1113352|NCT02508532|2196938|FG001|Part 2 - Treatment|Physician Decision|0
1113353|NCT02508532|2196939|FG002|Part 2 - Treatment|Physician Decision|0
1113354|NCT02508532|2196940|FG003|Part 2 - Treatment|Physician Decision|0
1113355|NCT02508532|2196941|FG004|Part 2 - Treatment|Physician Decision|0
1113356|NCT02508532|2196942|FG005|Part 2 - Treatment|Physician Decision|0
1113357|NCT02508532|2196943|FG006|Part 2 - Treatment|Physician Decision|0
1113358|NCT02508532|2196944|FG007|Part 2 - Treatment|Physician Decision|0
1113359|NCT02508532|2196945|FG008|Part 2 - Treatment|Physician Decision|12
1113360|NCT02508532|2196937|FG000|Part 2 - Treatment|Administrative|0
1113361|NCT02508532|2196938|FG001|Part 2 - Treatment|Administrative|0
1113362|NCT02508532|2196939|FG002|Part 2 - Treatment|Administrative|0
1113363|NCT02508532|2196940|FG003|Part 2 - Treatment|Administrative|0
1113364|NCT02508532|2196941|FG004|Part 2 - Treatment|Administrative|0
1113365|NCT02508532|2196942|FG005|Part 2 - Treatment|Administrative|0
1113366|NCT02508532|2196943|FG006|Part 2 - Treatment|Administrative|0
1113367|NCT02508532|2196944|FG007|Part 2 - Treatment|Administrative|0
1113368|NCT02508532|2196945|FG008|Part 2 - Treatment|Administrative|3
1113369|NCT02508532|2196937|FG000|Part 2 - Treatment|Sponsor Decision|0
1113370|NCT02508532|2196938|FG001|Part 2 - Treatment|Sponsor Decision|0
1113371|NCT02508532|2196939|FG002|Part 2 - Treatment|Sponsor Decision|0
1113372|NCT02508532|2196940|FG003|Part 2 - Treatment|Sponsor Decision|0
1113373|NCT02508532|2196941|FG004|Part 2 - Treatment|Sponsor Decision|0
1113374|NCT02508532|2196942|FG005|Part 2 - Treatment|Sponsor Decision|0
1113375|NCT02508532|2196943|FG006|Part 2 - Treatment|Sponsor Decision|0
1113376|NCT02508532|2196944|FG007|Part 2 - Treatment|Sponsor Decision|0
1113377|NCT02508532|2196945|FG008|Part 2 - Treatment|Sponsor Decision|28
1113378|NCT02508532|2196937|FG000|Part 2 - Treatment|Death|0
1113379|NCT02508532|2196938|FG001|Part 2 - Treatment|Death|0
1113380|NCT02508532|2196939|FG002|Part 2 - Treatment|Death|0
1113381|NCT02508532|2196940|FG003|Part 2 - Treatment|Death|0
1113382|NCT02508532|2196941|FG004|Part 2 - Treatment|Death|0
1113383|NCT02508532|2196942|FG005|Part 2 - Treatment|Death|0
1113384|NCT02508532|2196943|FG006|Part 2 - Treatment|Death|0
1113385|NCT02508532|2196944|FG007|Part 2 - Treatment|Death|0
1113386|NCT02508532|2196945|FG008|Part 2 - Treatment|Death|1
1113387|NCT02508532|2196937|FG000|Part 2 - Treatment|Withdrawal by Subject|0
1113388|NCT02508532|2196938|FG001|Part 2 - Treatment|Withdrawal by Subject|0
1113389|NCT02508532|2196939|FG002|Part 2 - Treatment|Withdrawal by Subject|0
1113390|NCT02508532|2196940|FG003|Part 2 - Treatment|Withdrawal by Subject|0
1113391|NCT02508532|2196941|FG004|Part 2 - Treatment|Withdrawal by Subject|0
1113392|NCT02508532|2196942|FG005|Part 2 - Treatment|Withdrawal by Subject|0
1113393|NCT02508532|2196943|FG006|Part 2 - Treatment|Withdrawal by Subject|0
1113394|NCT02508532|2196944|FG007|Part 2 - Treatment|Withdrawal by Subject|0
1113395|NCT02508532|2196945|FG008|Part 2 - Treatment|Withdrawal by Subject|6
1113396|NCT02508532|2196937|FG000|Part 1 and Part 2 End of Study|Disease Progression|2
1113397|NCT02508532|2196938|FG001|Part 1 and Part 2 End of Study|Disease Progression|0
1113398|NCT02508532|2196939|FG002|Part 1 and Part 2 End of Study|Disease Progression|0
1113399|NCT02508532|2196940|FG003|Part 1 and Part 2 End of Study|Disease Progression|0
1113400|NCT02508532|2196941|FG004|Part 1 and Part 2 End of Study|Disease Progression|0
1113401|NCT02508532|2196942|FG005|Part 1 and Part 2 End of Study|Disease Progression|0
1113402|NCT02508532|2196943|FG006|Part 1 and Part 2 End of Study|Disease Progression|0
1113403|NCT02508532|2196944|FG007|Part 1 and Part 2 End of Study|Disease Progression|1
1113404|NCT02508532|2196945|FG008|Part 1 and Part 2 End of Study|Disease Progression|6
1113405|NCT02508532|2196937|FG000|Part 1 and Part 2 End of Study|Adverse Event|1
1113406|NCT02508532|2196938|FG001|Part 1 and Part 2 End of Study|Adverse Event|0
1113407|NCT02508532|2196939|FG002|Part 1 and Part 2 End of Study|Adverse Event|1
1113408|NCT02508532|2196940|FG003|Part 1 and Part 2 End of Study|Adverse Event|0
1113409|NCT02508532|2196941|FG004|Part 1 and Part 2 End of Study|Adverse Event|0
1113410|NCT02508532|2196942|FG005|Part 1 and Part 2 End of Study|Adverse Event|0
1113411|NCT02508532|2196943|FG006|Part 1 and Part 2 End of Study|Adverse Event|0
1113412|NCT02508532|2196944|FG007|Part 1 and Part 2 End of Study|Adverse Event|0
1113413|NCT02508532|2196945|FG008|Part 1 and Part 2 End of Study|Adverse Event|2
1113414|NCT02508532|2196937|FG000|Part 1 and Part 2 End of Study|Death|0
1113415|NCT02508532|2196938|FG001|Part 1 and Part 2 End of Study|Death|4
1113416|NCT02508532|2196939|FG002|Part 1 and Part 2 End of Study|Death|2
1113417|NCT02508532|2196940|FG003|Part 1 and Part 2 End of Study|Death|4
1113418|NCT02508532|2196941|FG004|Part 1 and Part 2 End of Study|Death|3
1113419|NCT02508532|2196942|FG005|Part 1 and Part 2 End of Study|Death|0
1113420|NCT02508532|2196943|FG006|Part 1 and Part 2 End of Study|Death|0
1113421|NCT02508532|2196944|FG007|Part 1 and Part 2 End of Study|Death|1
1113422|NCT02508532|2196945|FG008|Part 1 and Part 2 End of Study|Death|111
1113423|NCT02508532|2196937|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1
1113424|NCT02508532|2196938|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1
1113425|NCT02508532|2196939|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1
1113426|NCT02508532|2196940|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0
1113427|NCT02508532|2196941|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0
1113428|NCT02508532|2196942|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0
1113429|NCT02508532|2196943|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0
1113430|NCT02508532|2196944|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0
1113431|NCT02508532|2196945|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6
1113432|NCT02508532|2196937|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
1113433|NCT02508532|2196938|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
1113434|NCT02508532|2196939|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
1113435|NCT02508532|2196940|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
1113436|NCT02508532|2196941|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
1113437|NCT02508532|2196942|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
1113438|NCT02508532|2196943|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
1113439|NCT02508532|2196944|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
1113440|NCT02508532|2196945|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15
1113441|NCT02508532|2196937|FG000|Part 1 and Part 2 End of Study|Physician Decision|0
1113442|NCT02508532|2196938|FG001|Part 1 and Part 2 End of Study|Physician Decision|0
1113443|NCT02508532|2196939|FG002|Part 1 and Part 2 End of Study|Physician Decision|1
1113444|NCT02508532|2196940|FG003|Part 1 and Part 2 End of Study|Physician Decision|0
1113445|NCT02508532|2196941|FG004|Part 1 and Part 2 End of Study|Physician Decision|1
1113446|NCT02508532|2196942|FG005|Part 1 and Part 2 End of Study|Physician Decision|0
1113447|NCT02508532|2196943|FG006|Part 1 and Part 2 End of Study|Physician Decision|0
1113448|NCT02508532|2196944|FG007|Part 1 and Part 2 End of Study|Physician Decision|0
1113449|NCT02508532|2196945|FG008|Part 1 and Part 2 End of Study|Physician Decision|8
1113450|NCT02508532|2196937|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0
1113451|NCT02508532|2196938|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0
1113452|NCT02508532|2196939|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0
1113453|NCT02508532|2196940|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0
1113454|NCT02508532|2196941|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0
1113455|NCT02508532|2196942|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0
1113456|NCT02508532|2196943|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0
1113457|NCT02508532|2196944|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0
1113458|NCT02508532|2196945|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1
1113459|NCT02508532|2196937|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2
1113460|NCT02508532|2196938|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1
1113461|NCT02508532|2196939|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1
1113462|NCT02508532|2196940|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2
1113463|NCT02508532|2196941|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2
1113464|NCT02508532|2196942|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0
1113465|NCT02508532|2196943|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0
1113466|NCT02508532|2196944|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1
1113467|NCT02508532|2196945|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|67
1113468|NCT02508532|2196937|FG000|Part 1 and Part 2 End of Study|Continuing in study|0
1113469|NCT02508532|2196938|FG001|Part 1 and Part 2 End of Study|Continuing in study|0
1113470|NCT02508532|2196939|FG002|Part 1 and Part 2 End of Study|Continuing in study|0
1113471|NCT02508532|2196940|FG003|Part 1 and Part 2 End of Study|Continuing in study|0
1113472|NCT02508532|2196941|FG004|Part 1 and Part 2 End of Study|Continuing in study|0
1113473|NCT02508532|2196942|FG005|Part 1 and Part 2 End of Study|Continuing in study|0
1113474|NCT02508532|2196943|FG006|Part 1 and Part 2 End of Study|Continuing in study|0
1113475|NCT02508532|2196944|FG007|Part 1 and Part 2 End of Study|Continuing in study|0
1113476|NCT02508532|2196945|FG008|Part 1 and Part 2 End of Study|Continuing in study|1
1113477|NCT02508649|2196982|FG000|Overall Study|Withdrawal by Subject|4
1113478|NCT02508649|2196983|FG001|Overall Study|Withdrawal by Subject|6
1113479|NCT02508649|2196984|FG002|Overall Study|Withdrawal by Subject|5
1113480|NCT02508649|2196985|FG003|Overall Study|Withdrawal by Subject|6
1113481|NCT02508649|2196982|FG000|Overall Study|Investigator withdrew the subject|1
1113482|NCT02508649|2196983|FG001|Overall Study|Investigator withdrew the subject|2
1113483|NCT02508649|2196984|FG002|Overall Study|Investigator withdrew the subject|1
1113484|NCT02508649|2196985|FG003|Overall Study|Investigator withdrew the subject|0
1113485|NCT02508649|2196982|FG000|Overall Study|Post randomization screening failure|12
1113486|NCT02508649|2196983|FG001|Overall Study|Post randomization screening failure|4
1113487|NCT02508649|2196984|FG002|Overall Study|Post randomization screening failure|9
1113488|NCT02508649|2196985|FG003|Overall Study|Post randomization screening failure|3
1113489|NCT02508649|2196982|FG000|Overall Study|Lost to Follow-up|1
1113490|NCT02508649|2196983|FG001|Overall Study|Lost to Follow-up|1
1113491|NCT02508649|2196984|FG002|Overall Study|Lost to Follow-up|0
1113492|NCT02508649|2196985|FG003|Overall Study|Lost to Follow-up|1
1113493|NCT02508701|2197002|FG000|Overall Study|Lost to Follow-up|9
1113494|NCT02508701|2197003|FG001|Overall Study|Lost to Follow-up|5
1113495|NCT02508701|2197004|FG002|Overall Study|Lost to Follow-up|5
1113496|NCT02508701|2197005|FG003|Overall Study|Lost to Follow-up|3
1113497|NCT02508935|2197019|FG000|Overall Study|Withdrawal by Subject|1
1113498|NCT02508935|2197019|FG000|Overall Study|Withdrawal by Caregiver|8
1113499|NCT02508935|2197019|FG000|Overall Study|Pain Score <4|1
1113500|NCT02508935|2197019|FG000|Overall Study|Emesis|3
1113501|NCT02508935|2197019|FG000|Overall Study|Adverse Event|3
1113502|NCT02508935|2197019|FG000|Overall Study|Protocol Violation|1
1113503|NCT02508935|2197019|FG000|Overall Study|Physician Decision|1
1113504|NCT02508935|2197019|FG000|Overall Study|Trial terminated by sponsor|5
1113505|NCT02509026|2197025|FG000|Induction Period (24 Weeks)|Adverse Event|5
1113506|NCT02509026|2197025|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5
1113507|NCT02509026|2197025|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6
1113508|NCT02509026|2197025|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1
1113509|NCT02509026|2197025|FG000|Induction Period (24 Weeks)|Other|2
1113510|NCT02509026|2197025|FG000|Induction Period (24 Weeks)|Protocol Violation|1
1113511|NCT02509026|2197025|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1
1113512|NCT02509026|2197025|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1
1113513|NCT02509026|2197025|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2
1113514|NCT02509026|2197025|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5
1113515|NCT02509026|2197025|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1
1113516|NCT02509026|2197025|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2
1113517|NCT02509026|2197025|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1
1113518|NCT02509078|2197074|FG000|Overall Study|Protocol Violation|1
1113519|NCT02509078|2197075|FG001|Overall Study|Protocol Violation|1
1113520|NCT02509117|2197093|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1113521|NCT02509117|2197094|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
1113522|NCT02509117|2197095|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1113523|NCT02509117|2197096|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1113524|NCT02509117|2197097|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1113525|NCT02509117|2197098|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1113526|NCT02509117|2197099|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1113527|NCT02509117|2197100|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1113528|NCT02509117|2197101|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1113529|NCT02509117|2197102|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1113530|NCT02509117|2197093|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1113531|NCT02509117|2197094|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1113532|NCT02509117|2197095|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1113533|NCT02509117|2197096|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1113534|NCT02509117|2197097|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1113535|NCT02509117|2197098|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1113536|NCT02509117|2197099|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1113537|NCT02509117|2197100|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1113538|NCT02509117|2197101|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1113539|NCT02509117|2197102|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
1113540|NCT02509117|2197093|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1113541|NCT02509117|2197094|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1113542|NCT02509117|2197095|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1113543|NCT02509117|2197096|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1113544|NCT02509117|2197097|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1113545|NCT02509117|2197098|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1113546|NCT02509117|2197099|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1113547|NCT02509117|2197100|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1113548|NCT02509117|2197101|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1113549|NCT02509117|2197102|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
1113550|NCT02509156|2197142|FG000|Randomized Phase|Death|1
1113551|NCT02509156|2197143|FG001|Randomized Phase|Death|0
1113552|NCT02509156|2197142|FG000|Randomized Phase|Withdrawal by Subject|1
1113553|NCT02509156|2197143|FG001|Randomized Phase|Withdrawal by Subject|1
1113554|NCT02510001|2197212|FG000|Overall Study|Early disease progression|0
1113555|NCT02510001|2197213|FG001|Overall Study|Early disease progression|0
1113556|NCT02510001|2197214|FG002|Overall Study|Early disease progression|0
1113557|NCT02510001|2197215|FG003|Overall Study|Early disease progression|1
1113558|NCT02510001|2197216|FG004|Overall Study|Early disease progression|1
1113559|NCT02510001|2197217|FG005|Overall Study|Early disease progression|1
1113560|NCT02510001|2197218|FG006|Overall Study|Early disease progression|0
1113561|NCT02510001|2197219|FG007|Overall Study|Early disease progression|0
1113562|NCT02510001|2197212|FG000|Overall Study|Adverse Event|0
1113563|NCT02510001|2197213|FG001|Overall Study|Adverse Event|0
1113564|NCT02510001|2197214|FG002|Overall Study|Adverse Event|0
1113565|NCT02510001|2197215|FG003|Overall Study|Adverse Event|1
1113566|NCT02510001|2197216|FG004|Overall Study|Adverse Event|2
1113567|NCT02510001|2197217|FG005|Overall Study|Adverse Event|1
1113568|NCT02510001|2197218|FG006|Overall Study|Adverse Event|2
1113569|NCT02510001|2197219|FG007|Overall Study|Adverse Event|5
1113570|NCT02510001|2197212|FG000|Overall Study|Physician Decision|0
1113571|NCT02510001|2197213|FG001|Overall Study|Physician Decision|0
1113572|NCT02510001|2197214|FG002|Overall Study|Physician Decision|0
1113573|NCT02510001|2197215|FG003|Overall Study|Physician Decision|0
1113574|NCT02510001|2197216|FG004|Overall Study|Physician Decision|1
1113575|NCT02510001|2197217|FG005|Overall Study|Physician Decision|0
1113576|NCT02510001|2197218|FG006|Overall Study|Physician Decision|0
1113577|NCT02510001|2197219|FG007|Overall Study|Physician Decision|0
1113578|NCT02510001|2197212|FG000|Overall Study|Withdrawal by Subject|0
1113579|NCT02510001|2197213|FG001|Overall Study|Withdrawal by Subject|0
1113580|NCT02510001|2197214|FG002|Overall Study|Withdrawal by Subject|0
1113581|NCT02510001|2197215|FG003|Overall Study|Withdrawal by Subject|0
1113582|NCT02510001|2197216|FG004|Overall Study|Withdrawal by Subject|0
1113583|NCT02510001|2197217|FG005|Overall Study|Withdrawal by Subject|0
1113584|NCT02510001|2197218|FG006|Overall Study|Withdrawal by Subject|0
1113585|NCT02510001|2197219|FG007|Overall Study|Withdrawal by Subject|2
1113586|NCT02510014|2197257|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1
1113587|NCT02510014|2197258|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1
1113588|NCT02510014|2197257|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
1113589|NCT02510014|2197258|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
1113590|NCT02510014|2197257|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
1113591|NCT02510014|2197258|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
1113592|NCT02510014|2197257|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0
1113593|NCT02510014|2197258|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1
1113594|NCT02510014|2197257|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
1113595|NCT02510014|2197258|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
1113596|NCT02510014|2197257|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
1113597|NCT02510014|2197258|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
896697|NCT00705783|1868482|FG002|Conversion Phase|Sponsor Discontinued Study|0
896698|NCT00705783|1868480|FG000|Conversion Phase|Lost to Follow-up|13
896699|NCT00705783|1868481|FG001|Conversion Phase|Lost to Follow-up|0
896700|NCT00705783|1868482|FG002|Conversion Phase|Lost to Follow-up|0
896701|NCT00705783|1868480|FG000|Conversion Phase|Met Withdrawal Criteria|4
896702|NCT00705783|1868481|FG001|Conversion Phase|Met Withdrawal Criteria|0
896703|NCT00705783|1868482|FG002|Conversion Phase|Met Withdrawal Criteria|0
896704|NCT00705783|1868480|FG000|Conversion Phase|Withdrawn by Investigator|4
896705|NCT00705783|1868481|FG001|Conversion Phase|Withdrawn by Investigator|0
896706|NCT00705783|1868482|FG002|Conversion Phase|Withdrawn by Investigator|0
896707|NCT00705783|1868480|FG000|Conversion Phase|Withdrew Consent|24
896708|NCT00705783|1868481|FG001|Conversion Phase|Withdrew Consent|0
896709|NCT00705783|1868482|FG002|Conversion Phase|Withdrew Consent|0
896710|NCT00705783|1868480|FG000|Conversion Phase|Protocol Deviation|2
896711|NCT00705783|1868481|FG001|Conversion Phase|Protocol Deviation|0
896712|NCT00705783|1868482|FG002|Conversion Phase|Protocol Deviation|0
896713|NCT00705783|1868480|FG000|Conversion Phase|Adverse Event|11
896714|NCT00705783|1868481|FG001|Conversion Phase|Adverse Event|0
896715|NCT00705783|1868482|FG002|Conversion Phase|Adverse Event|0
896716|NCT00705783|1868480|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13
896717|NCT00705783|1868481|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
896718|NCT00705783|1868482|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
896719|NCT00705783|1868480|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8
896720|NCT00705783|1868481|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
896721|NCT00705783|1868482|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
896722|NCT00705783|1868480|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42
896723|NCT00705783|1868481|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0
896724|NCT00705783|1868482|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0
896725|NCT00705783|1868480|FG000|Oral Stabilization Phase|Lost to Follow-up|7
896726|NCT00705783|1868481|FG001|Oral Stabilization Phase|Lost to Follow-up|0
896727|NCT00705783|1868482|FG002|Oral Stabilization Phase|Lost to Follow-up|0
896728|NCT00705783|1868480|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19
896729|NCT00705783|1868481|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
896730|NCT00705783|1868482|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
896731|NCT00705783|1868480|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12
896732|NCT00705783|1868481|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
896733|NCT00705783|1868482|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
896734|NCT00705783|1868480|FG000|Oral Stabilization Phase|Withdrew Consent|29
896735|NCT00705783|1868481|FG001|Oral Stabilization Phase|Withdrew Consent|0
896736|NCT00705783|1868482|FG002|Oral Stabilization Phase|Withdrew Consent|0
896737|NCT00705783|1868480|FG000|Oral Stabilization Phase|Adverse Event|14
896738|NCT00705783|1868481|FG001|Oral Stabilization Phase|Adverse Event|0
896739|NCT00705783|1868482|FG002|Oral Stabilization Phase|Adverse Event|0
896740|NCT00705783|1868480|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
896741|NCT00705783|1868481|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
896742|NCT00705783|1868482|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
896743|NCT00705783|1868480|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
896744|NCT00705783|1868481|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
896745|NCT00705783|1868482|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
896746|NCT00705783|1868480|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86
896747|NCT00705783|1868481|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0
896748|NCT00705783|1868482|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0
896749|NCT00705783|1868480|FG000|Depot Stabilization Phase|Lost to Follow-up|11
896750|NCT00705783|1868481|FG001|Depot Stabilization Phase|Lost to Follow-up|0
896751|NCT00705783|1868482|FG002|Depot Stabilization Phase|Lost to Follow-up|0
896752|NCT00705783|1868480|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8
896753|NCT00705783|1868481|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0
896754|NCT00705783|1868482|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0
1113598|NCT02510014|2197257|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
1113599|NCT02510014|2197258|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
1113600|NCT02510014|2197257|FG000|Run-In Period (Days -14 to Day -1)|Other|19
1113601|NCT02510014|2197258|FG001|Run-In Period (Days -14 to Day -1)|Other|1
1113602|NCT02510014|2197257|FG000|Treatment Period|Adverse Event|11
1113603|NCT02510014|2197258|FG001|Treatment Period|Adverse Event|4
1113604|NCT02510014|2197257|FG000|Treatment Period|Withdrawal symptoms|3
1113605|NCT02510014|2197258|FG001|Treatment Period|Withdrawal symptoms|0
1113606|NCT02510014|2197257|FG000|Treatment Period|Lost to Follow-up|80
1113607|NCT02510014|2197258|FG001|Treatment Period|Lost to Follow-up|19
1113608|NCT02510014|2197257|FG000|Treatment Period|Physician Decision|5
1113609|NCT02510014|2197258|FG001|Treatment Period|Physician Decision|0
1113610|NCT02510014|2197257|FG000|Treatment Period|Withdrawal by Subject|67
1113611|NCT02510014|2197258|FG001|Treatment Period|Withdrawal by Subject|24
1113612|NCT02510014|2197257|FG000|Treatment Period|Withdrawn by the investigator|7
1113613|NCT02510014|2197258|FG001|Treatment Period|Withdrawn by the investigator|1
1113614|NCT02510014|2197257|FG000|Treatment Period|Protocol Violation|4
1113615|NCT02510014|2197258|FG001|Treatment Period|Protocol Violation|4
1113616|NCT02510014|2197257|FG000|Treatment Period|Incarceration, pregnancy, misc|29
1113617|NCT02510014|2197258|FG001|Treatment Period|Incarceration, pregnancy, misc|5
1113618|NCT02510040|2197267|FG000|Overall Study|Deemed no longer eligible|18
1113619|NCT02510040|2197268|FG001|Overall Study|Deemed no longer eligible|3
1113620|NCT02510040|2197269|FG002|Overall Study|Deemed no longer eligible|1
1113621|NCT02510664|2197290|FG000|Overall Study|Transferred Care|9
1113622|NCT02510664|2197291|FG001|Overall Study|Transferred Care|9
1113623|NCT02510664|2197292|FG002|Overall Study|Transferred Care|0
1113624|NCT02510664|2197290|FG000|Overall Study|Provider Retired/No Time to Reschedule|10
1113625|NCT02510664|2197291|FG001|Overall Study|Provider Retired/No Time to Reschedule|10
1113626|NCT02510664|2197292|FG002|Overall Study|Provider Retired/No Time to Reschedule|0
1113627|NCT02510664|2197290|FG000|Overall Study|Time Constraints|1
1113628|NCT02510664|2197291|FG001|Overall Study|Time Constraints|1
1113629|NCT02510664|2197292|FG002|Overall Study|Time Constraints|0
1113630|NCT02510794|2197309|FG000|Overall Study|Adverse Event|0
1113631|NCT02510794|2197310|FG001|Overall Study|Adverse Event|1
1113632|NCT02510794|2197311|FG002|Overall Study|Adverse Event|0
1113633|NCT02510794|2197312|FG003|Overall Study|Adverse Event|0
1113634|NCT02510794|2197309|FG000|Overall Study|Death|1
1113635|NCT02510794|2197310|FG001|Overall Study|Death|2
1113636|NCT02510794|2197311|FG002|Overall Study|Death|1
1113637|NCT02510794|2197312|FG003|Overall Study|Death|1
1113638|NCT02510794|2197309|FG000|Overall Study|Lack of Efficacy|3
1113639|NCT02510794|2197310|FG001|Overall Study|Lack of Efficacy|1
1113640|NCT02510794|2197311|FG002|Overall Study|Lack of Efficacy|1
1113641|NCT02510794|2197312|FG003|Overall Study|Lack of Efficacy|0
1113642|NCT02510794|2197309|FG000|Overall Study|Participant moved out of the area|0
1113643|NCT02510794|2197310|FG001|Overall Study|Participant moved out of the area|0
1113644|NCT02510794|2197311|FG002|Overall Study|Participant moved out of the area|0
1113645|NCT02510794|2197312|FG003|Overall Study|Participant moved out of the area|1
1113646|NCT02510794|2197309|FG000|Overall Study|Physician Decision|3
1113647|NCT02510794|2197310|FG001|Overall Study|Physician Decision|0
1113648|NCT02510794|2197311|FG002|Overall Study|Physician Decision|0
1113649|NCT02510794|2197312|FG003|Overall Study|Physician Decision|0
1113650|NCT02510794|2197309|FG000|Overall Study|Protocol Violation|0
1113651|NCT02510794|2197310|FG001|Overall Study|Protocol Violation|0
1113652|NCT02510794|2197311|FG002|Overall Study|Protocol Violation|1
1113653|NCT02510794|2197312|FG003|Overall Study|Protocol Violation|0
1113654|NCT02510794|2197309|FG000|Overall Study|Withdrawal by Subject|1
1113655|NCT02510794|2197310|FG001|Overall Study|Withdrawal by Subject|2
1113656|NCT02510794|2197311|FG002|Overall Study|Withdrawal by Subject|4
1113657|NCT02510794|2197312|FG003|Overall Study|Withdrawal by Subject|3
1113658|NCT02510820|2197324|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0
1113659|NCT02510820|2197325|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
1113660|NCT02510820|2197324|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1113661|NCT02510820|2197325|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1113662|NCT02511106|2197334|FG000|Overall Study|Lost to Follow-up|1
1113663|NCT02511106|2197335|FG001|Overall Study|Lost to Follow-up|2
1113664|NCT02511106|2197334|FG000|Overall Study|Withdrawal by Subject|19
1113665|NCT02511106|2197335|FG001|Overall Study|Withdrawal by Subject|14
1113666|NCT02511106|2197334|FG000|Overall Study|Ongoing study at data cut-off|309
1113667|NCT02511106|2197335|FG001|Overall Study|Ongoing study at data cut-off|307
1113668|NCT02511106|2197334|FG000|Overall Study|Without specified reason|1
1113669|NCT02511106|2197335|FG001|Overall Study|Without specified reason|0
1113670|NCT02511106|2197334|FG000|Overall Study|Missing|1
1113671|NCT02511106|2197335|FG001|Overall Study|Missing|0
1113672|NCT02511431|2197372|FG000|Treatment|Lost to Follow-up|0
1113673|NCT02511431|2197373|FG001|Treatment|Lost to Follow-up|0
1113674|NCT02511431|2197374|FG002|Treatment|Lost to Follow-up|1
1113675|NCT02511431|2197375|FG003|Treatment|Lost to Follow-up|0
1113676|NCT02511431|2197376|FG004|Treatment|Lost to Follow-up|0
1113677|NCT02511431|2197377|FG005|Treatment|Lost to Follow-up|1
1113678|NCT02511678|2197428|FG000|Overall Study|Withdrawal by Subject|2
1113679|NCT02511678|2197428|FG000|Overall Study|Lost to Follow-up|4
1113680|NCT02511678|2197428|FG000|Overall Study|Death|19
1113681|NCT02511678|2197428|FG000|Overall Study|Adverse Event|1
1113682|NCT02511678|2197428|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5
1113683|NCT02511678|2197428|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1
1113684|NCT02511678|2197428|FG000|Overall Study|Required Radiofrequency Ablation|1
1113685|NCT02511678|2197428|FG000|Overall Study|Biopsy was Negative|1
1113686|NCT02511678|2197428|FG000|Overall Study|Protocol Violation|1
1113687|NCT02511678|2197428|FG000|Overall Study|Received Radiation Treatment|1
1113688|NCT02511782|2197452|FG000|Overall Study|Withdrawal by Subject|1
1113689|NCT02511782|2197453|FG001|Overall Study|Withdrawal by Subject|0
1113690|NCT02511782|2197454|FG002|Overall Study|Withdrawal by Subject|0
1113691|NCT02512042|2197464|FG000|Overall Study|Adverse Event|0
1113692|NCT02512042|2197465|FG001|Overall Study|Adverse Event|4
1113693|NCT02512042|2197464|FG000|Overall Study|Withdrawal by Subject|6
1113694|NCT02512042|2197465|FG001|Overall Study|Withdrawal by Subject|6
1113695|NCT02512042|2197464|FG000|Overall Study|Non-compliance with study drug|1
1113696|NCT02512042|2197465|FG001|Overall Study|Non-compliance with study drug|2
1113697|NCT02512042|2197464|FG000|Overall Study|Lost to Follow-up|5
1113698|NCT02512042|2197465|FG001|Overall Study|Lost to Follow-up|2
1113699|NCT02512042|2197464|FG000|Overall Study|Other|11
1113700|NCT02512042|2197465|FG001|Overall Study|Other|11
1113701|NCT02512068|2197473|FG000|Overall Study|Pretreatment Event/Adverse Event|8
1113702|NCT02512068|2197474|FG001|Overall Study|Pretreatment Event/Adverse Event|6
1113703|NCT02512068|2197473|FG000|Overall Study|Major Protocol Deviation|1
1113704|NCT02512068|2197474|FG001|Overall Study|Major Protocol Deviation|0
1113705|NCT02512068|2197473|FG000|Overall Study|Voluntary Withdrawal|0
1113706|NCT02512068|2197474|FG001|Overall Study|Voluntary Withdrawal|1
1113707|NCT02512068|2197473|FG000|Overall Study|Lack of Efficacy|0
1113708|NCT02512068|2197474|FG001|Overall Study|Lack of Efficacy|1
1113709|NCT02512068|2197473|FG000|Overall Study|Reason Not Specified|3
1113710|NCT02512068|2197474|FG001|Overall Study|Reason Not Specified|5
1113711|NCT02512302|2197502|FG000|Period 1|Adverse Event|0
1113712|NCT02512302|2197503|FG001|Period 1|Adverse Event|1
1113713|NCT02512302|2197504|FG002|Period 1|Adverse Event|0
1113714|NCT02512302|2197505|FG003|Period 1|Adverse Event|0
1113715|NCT02512302|2197506|FG004|Period 1|Adverse Event|0
1113716|NCT02512302|2197507|FG005|Period 1|Adverse Event|0
1113717|NCT02512302|2197508|FG006|Period 1|Adverse Event|0
1113718|NCT02512302|2197509|FG007|Period 1|Adverse Event|0
1113719|NCT02512302|2197510|FG008|Period 1|Adverse Event|0
1113720|NCT02512302|2197511|FG009|Period 1|Adverse Event|0
1113721|NCT02512302|2197502|FG000|Period 2|Adverse Event|0
1113722|NCT02512302|2197503|FG001|Period 2|Adverse Event|0
1113723|NCT02512302|2197504|FG002|Period 2|Adverse Event|0
1113724|NCT02512302|2197505|FG003|Period 2|Adverse Event|0
1113725|NCT02512302|2197506|FG004|Period 2|Adverse Event|0
1113726|NCT02512302|2197507|FG005|Period 2|Adverse Event|0
1113727|NCT02512302|2197508|FG006|Period 2|Adverse Event|0
1113728|NCT02512302|2197509|FG007|Period 2|Adverse Event|0
1113729|NCT02512302|2197510|FG008|Period 2|Adverse Event|0
1113730|NCT02512302|2197511|FG009|Period 2|Adverse Event|1
1113731|NCT02512302|2197502|FG000|Period 3|Lost to Follow-up|0
1113732|NCT02512302|2197503|FG001|Period 3|Lost to Follow-up|0
1113733|NCT02512302|2197504|FG002|Period 3|Lost to Follow-up|1
1113734|NCT02512302|2197505|FG003|Period 3|Lost to Follow-up|0
1113735|NCT02512302|2197506|FG004|Period 3|Lost to Follow-up|0
1113736|NCT02512302|2197507|FG005|Period 3|Lost to Follow-up|0
1113737|NCT02512302|2197508|FG006|Period 3|Lost to Follow-up|0
1113738|NCT02512302|2197509|FG007|Period 3|Lost to Follow-up|0
1113739|NCT02512302|2197510|FG008|Period 3|Lost to Follow-up|0
1113740|NCT02512302|2197511|FG009|Period 3|Lost to Follow-up|0
1113741|NCT02512302|2197502|FG000|Period 4|Adverse Event|0
1113742|NCT02512302|2197503|FG001|Period 4|Adverse Event|0
1113743|NCT02512302|2197504|FG002|Period 4|Adverse Event|0
1113744|NCT02512302|2197505|FG003|Period 4|Adverse Event|0
1113745|NCT02512302|2197506|FG004|Period 4|Adverse Event|0
1113746|NCT02512302|2197507|FG005|Period 4|Adverse Event|0
1113747|NCT02512302|2197508|FG006|Period 4|Adverse Event|1
1113748|NCT02512302|2197509|FG007|Period 4|Adverse Event|0
1113749|NCT02512302|2197510|FG008|Period 4|Adverse Event|0
1113750|NCT02512302|2197511|FG009|Period 4|Adverse Event|0
1113751|NCT02512861|2197619|FG000|Overall Study|Protocol Violation|3
1113752|NCT02512861|2197620|FG001|Overall Study|Protocol Violation|7
1113753|NCT02512861|2197619|FG000|Overall Study|Physician Decision|3
1113754|NCT02512861|2197620|FG001|Overall Study|Physician Decision|1
1113755|NCT02512861|2197619|FG000|Overall Study|Withdrawal by Subject|0
1113756|NCT02512861|2197620|FG001|Overall Study|Withdrawal by Subject|1
1113757|NCT02512965|2197642|FG000|Overall Study|Withdrawal by Subject|0
1113758|NCT02512965|2197643|FG001|Overall Study|Withdrawal by Subject|4
1113759|NCT02513160|2197673|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
1113760|NCT02513160|2197674|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1113761|NCT02513160|2197675|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1113762|NCT02513160|2197676|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1113763|NCT02513160|2197673|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
1113764|NCT02513160|2197674|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1113765|NCT02513160|2197675|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1113766|NCT02513160|2197676|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1113767|NCT02513160|2197673|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
1113768|NCT02513160|2197674|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1113769|NCT02513160|2197675|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1113770|NCT02513160|2197676|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1113771|NCT02513160|2197673|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4
1113772|NCT02513160|2197674|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1113773|NCT02513160|2197675|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1113774|NCT02513160|2197676|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1113775|NCT02513160|2197673|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
1113776|NCT02513160|2197674|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1113777|NCT02513160|2197675|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1113778|NCT02513160|2197676|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1113779|NCT02513160|2197673|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
1113780|NCT02513160|2197674|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1113781|NCT02513160|2197675|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1113782|NCT02513160|2197676|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1113783|NCT02513160|2197673|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
1113784|NCT02513160|2197674|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1113785|NCT02513160|2197675|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1113786|NCT02513160|2197676|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1113787|NCT02513160|2197673|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
1113788|NCT02513160|2197674|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
1113789|NCT02513160|2197675|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
1113790|NCT02513160|2197676|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
1113791|NCT02513160|2197673|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1
1113792|NCT02513160|2197674|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1113793|NCT02513160|2197675|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1113794|NCT02513160|2197676|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1113795|NCT02513160|2197673|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
1113796|NCT02513160|2197674|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1113797|NCT02513160|2197675|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1113798|NCT02513160|2197676|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1113799|NCT02513160|2197673|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
1113800|NCT02513160|2197674|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1113801|NCT02513160|2197675|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1113802|NCT02513160|2197676|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1113803|NCT02513160|2197673|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1113804|NCT02513160|2197674|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
1113805|NCT02513160|2197675|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1113806|NCT02513160|2197676|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1113807|NCT02513459|2197706|FG000|Overall Study|Adverse Event|7
1113808|NCT02513459|2197706|FG000|Overall Study|Withdrew consent|5
1113809|NCT02513459|2197706|FG000|Overall Study|Loss of efficacy|2
1113810|NCT02513459|2197706|FG000|Overall Study|Pregnancy|2
1113811|NCT02513459|2197706|FG000|Overall Study|Subject decision|2
1113812|NCT02513459|2197706|FG000|Overall Study|Lack of response|1
1113813|NCT02513459|2197706|FG000|Overall Study|Reproductive plans|1
1113814|NCT02513459|2197706|FG000|Overall Study|Surgery planned-- not done|1
1113815|NCT02513472|2197717|FG000|Overall Study|Radiological Disease Progression|45
1113816|NCT02513472|2197718|FG001|Overall Study|Radiological Disease Progression|56
1113817|NCT02513472|2197717|FG000|Overall Study|Clinical Disease Progression|5
1113818|NCT02513472|2197718|FG001|Overall Study|Clinical Disease Progression|12
1113819|NCT02513472|2197717|FG000|Overall Study|Adverse Event|7
1113820|NCT02513472|2197718|FG001|Overall Study|Adverse Event|11
1113821|NCT02513472|2197717|FG000|Overall Study|Withdrawal by Subject|0
1113822|NCT02513472|2197718|FG001|Overall Study|Withdrawal by Subject|4
1113823|NCT02513472|2197717|FG000|Overall Study|Subject Choice|2
1113824|NCT02513472|2197718|FG001|Overall Study|Subject Choice|6
1113825|NCT02513472|2197717|FG000|Overall Study|Treatment Completed as per Protocol|3
1113826|NCT02513472|2197718|FG001|Overall Study|Treatment Completed as per Protocol|1
1113827|NCT02513472|2197717|FG000|Overall Study|Other|3
1113828|NCT02513472|2197718|FG001|Overall Study|Other|3
1113829|NCT02513550|2197739|FG000|Double Blind Treatment Period|Withdrawal by Subject|11
1113830|NCT02513550|2197740|FG001|Double Blind Treatment Period|Withdrawal by Subject|11
1113831|NCT02513550|2197741|FG002|Double Blind Treatment Period|Withdrawal by Subject|25
1113832|NCT02513550|2197742|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
1113833|NCT02513550|2197743|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
1113834|NCT02513550|2197744|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
1113835|NCT02513550|2197739|FG000|Double Blind Treatment Period|Adverse Event|5
1113836|NCT02513550|2197740|FG001|Double Blind Treatment Period|Adverse Event|13
1113837|NCT02513550|2197741|FG002|Double Blind Treatment Period|Adverse Event|17
1113838|NCT02513550|2197742|FG003|Double Blind Treatment Period|Adverse Event|0
1113839|NCT02513550|2197743|FG004|Double Blind Treatment Period|Adverse Event|1
1113840|NCT02513550|2197744|FG005|Double Blind Treatment Period|Adverse Event|0
1113841|NCT02513550|2197739|FG000|Double Blind Treatment Period|Lost to Follow-up|9
1113842|NCT02513550|2197740|FG001|Double Blind Treatment Period|Lost to Follow-up|7
1113843|NCT02513550|2197741|FG002|Double Blind Treatment Period|Lost to Follow-up|11
1113844|NCT02513550|2197742|FG003|Double Blind Treatment Period|Lost to Follow-up|0
1113845|NCT02513550|2197743|FG004|Double Blind Treatment Period|Lost to Follow-up|0
1113846|NCT02513550|2197744|FG005|Double Blind Treatment Period|Lost to Follow-up|1
1113847|NCT02513550|2197739|FG000|Double Blind Treatment Period|Lack of Efficacy|4
1113848|NCT02513550|2197740|FG001|Double Blind Treatment Period|Lack of Efficacy|5
1113849|NCT02513550|2197741|FG002|Double Blind Treatment Period|Lack of Efficacy|6
1113850|NCT02513550|2197742|FG003|Double Blind Treatment Period|Lack of Efficacy|0
1113851|NCT02513550|2197743|FG004|Double Blind Treatment Period|Lack of Efficacy|0
1113852|NCT02513550|2197744|FG005|Double Blind Treatment Period|Lack of Efficacy|0
1113853|NCT02513550|2197739|FG000|Double Blind Treatment Period|Protocol Violation|1
1113854|NCT02513550|2197740|FG001|Double Blind Treatment Period|Protocol Violation|1
1113855|NCT02513550|2197741|FG002|Double Blind Treatment Period|Protocol Violation|4
1113856|NCT02513550|2197742|FG003|Double Blind Treatment Period|Protocol Violation|0
1113857|NCT02513550|2197743|FG004|Double Blind Treatment Period|Protocol Violation|0
1113858|NCT02513550|2197744|FG005|Double Blind Treatment Period|Protocol Violation|0
1113859|NCT02513550|2197739|FG000|Double Blind Treatment Period|Physician Decision|2
1113860|NCT02513550|2197740|FG001|Double Blind Treatment Period|Physician Decision|0
1113861|NCT02513550|2197741|FG002|Double Blind Treatment Period|Physician Decision|4
1113862|NCT02513550|2197742|FG003|Double Blind Treatment Period|Physician Decision|0
1113863|NCT02513550|2197743|FG004|Double Blind Treatment Period|Physician Decision|0
1113864|NCT02513550|2197744|FG005|Double Blind Treatment Period|Physician Decision|0
1113865|NCT02513550|2197739|FG000|Double Blind Treatment Period|Site terminated by sponsor|1
1113866|NCT02513550|2197740|FG001|Double Blind Treatment Period|Site terminated by sponsor|1
1113867|NCT02513550|2197741|FG002|Double Blind Treatment Period|Site terminated by sponsor|3
1113868|NCT02513550|2197742|FG003|Double Blind Treatment Period|Site terminated by sponsor|0
1113869|NCT02513550|2197743|FG004|Double Blind Treatment Period|Site terminated by sponsor|0
1113870|NCT02513550|2197744|FG005|Double Blind Treatment Period|Site terminated by sponsor|0
1113871|NCT02513550|2197739|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1113872|NCT02513550|2197740|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1113873|NCT02513550|2197741|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
1113874|NCT02513550|2197742|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1113875|NCT02513550|2197743|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1113876|NCT02513550|2197744|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1113877|NCT02513550|2197739|FG000|Double Blind Treatment Period|Due to personal business|2
1113878|NCT02513550|2197740|FG001|Double Blind Treatment Period|Due to personal business|0
1113879|NCT02513550|2197741|FG002|Double Blind Treatment Period|Due to personal business|1
1113880|NCT02513550|2197742|FG003|Double Blind Treatment Period|Due to personal business|0
1113881|NCT02513550|2197743|FG004|Double Blind Treatment Period|Due to personal business|0
1113882|NCT02513550|2197744|FG005|Double Blind Treatment Period|Due to personal business|0
1113883|NCT02513550|2197739|FG000|Double Blind Treatment Period|Death|1
1113884|NCT02513550|2197740|FG001|Double Blind Treatment Period|Death|0
1113885|NCT02513550|2197741|FG002|Double Blind Treatment Period|Death|2
1113886|NCT02513550|2197742|FG003|Double Blind Treatment Period|Death|0
1113887|NCT02513550|2197743|FG004|Double Blind Treatment Period|Death|0
1113888|NCT02513550|2197744|FG005|Double Blind Treatment Period|Death|0
1113889|NCT02513550|2197739|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12
1113890|NCT02513550|2197740|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20
1113891|NCT02513550|2197741|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26
1113892|NCT02513550|2197742|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0
1113893|NCT02513550|2197743|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0
1113894|NCT02513550|2197744|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0
1113895|NCT02513550|2197739|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
1113896|NCT02513550|2197740|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
1113897|NCT02513550|2197741|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
1113898|NCT02513550|2197742|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
1113899|NCT02513550|2197743|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
1113900|NCT02513550|2197744|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
1113901|NCT02513550|2197739|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4
1113902|NCT02513550|2197740|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2
1113903|NCT02513550|2197741|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7
1113904|NCT02513550|2197742|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0
1113905|NCT02513550|2197743|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0
1113906|NCT02513550|2197744|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0
1113907|NCT02513550|2197739|FG000|Post-Treatment Follow-up Period|Adverse Event|1
1113908|NCT02513550|2197740|FG001|Post-Treatment Follow-up Period|Adverse Event|1
1113909|NCT02513550|2197741|FG002|Post-Treatment Follow-up Period|Adverse Event|4
1113910|NCT02513550|2197742|FG003|Post-Treatment Follow-up Period|Adverse Event|0
1113911|NCT02513550|2197743|FG004|Post-Treatment Follow-up Period|Adverse Event|0
1113912|NCT02513550|2197744|FG005|Post-Treatment Follow-up Period|Adverse Event|0
1113913|NCT02513550|2197739|FG000|Post-Treatment Follow-up Period|Physician Decision|2
1113914|NCT02513550|2197740|FG001|Post-Treatment Follow-up Period|Physician Decision|0
1113915|NCT02513550|2197741|FG002|Post-Treatment Follow-up Period|Physician Decision|0
1113916|NCT02513550|2197742|FG003|Post-Treatment Follow-up Period|Physician Decision|0
1113917|NCT02513550|2197743|FG004|Post-Treatment Follow-up Period|Physician Decision|0
1113918|NCT02513550|2197744|FG005|Post-Treatment Follow-up Period|Physician Decision|0
1113919|NCT02513550|2197739|FG000|Post-Treatment Follow-up Period|Death|0
1113920|NCT02513550|2197740|FG001|Post-Treatment Follow-up Period|Death|0
1113921|NCT02513550|2197741|FG002|Post-Treatment Follow-up Period|Death|1
1113922|NCT02513550|2197742|FG003|Post-Treatment Follow-up Period|Death|0
1113923|NCT02513550|2197743|FG004|Post-Treatment Follow-up Period|Death|0
1113924|NCT02513550|2197744|FG005|Post-Treatment Follow-up Period|Death|0
1113925|NCT02513550|2197739|FG000|Post-Treatment Follow-up Period|Subject move out of town|0
1113926|NCT02513550|2197740|FG001|Post-Treatment Follow-up Period|Subject move out of town|0
1113927|NCT02513550|2197741|FG002|Post-Treatment Follow-up Period|Subject move out of town|1
1113928|NCT02513550|2197742|FG003|Post-Treatment Follow-up Period|Subject move out of town|0
1113929|NCT02513550|2197743|FG004|Post-Treatment Follow-up Period|Subject move out of town|0
1113930|NCT02513550|2197744|FG005|Post-Treatment Follow-up Period|Subject move out of town|0
1113931|NCT02513550|2197739|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1113932|NCT02513550|2197740|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1113933|NCT02513550|2197741|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
1113934|NCT02513550|2197742|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1113935|NCT02513550|2197743|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1113936|NCT02513550|2197744|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1113937|NCT02513550|2197739|FG000|Post-Treatment Follow-up Period|Labor Reasons|0
1113938|NCT02513550|2197740|FG001|Post-Treatment Follow-up Period|Labor Reasons|0
1113939|NCT02513550|2197741|FG002|Post-Treatment Follow-up Period|Labor Reasons|1
1113940|NCT02513550|2197742|FG003|Post-Treatment Follow-up Period|Labor Reasons|0
1113941|NCT02513550|2197743|FG004|Post-Treatment Follow-up Period|Labor Reasons|0
1113942|NCT02513550|2197744|FG005|Post-Treatment Follow-up Period|Labor Reasons|0
1113943|NCT02513732|2197774|FG000|Overall Study|Lost to Follow-up|11
1113944|NCT02513732|2197774|FG000|Overall Study|Death|9
1113945|NCT02513732|2197774|FG000|Overall Study|Changing hospital|2
1113946|NCT02513745|2197780|FG000|Overall Study|Criteria at time of surgery not met.|3
1113947|NCT02513745|2197781|FG001|Overall Study|Criteria at time of surgery not met.|3
1113948|NCT02513771|2197789|FG000|Overall Study|Lost to Follow-up|1
1113949|NCT02513771|2197790|FG001|Overall Study|Lost to Follow-up|1
1113950|NCT02513771|2197789|FG000|Overall Study|Not being able to get to clinic|1
1113951|NCT02513771|2197790|FG001|Overall Study|Not being able to get to clinic|0
1113952|NCT02513823|2197796|FG000|Overall Study|Lost to Follow-up|4
1113953|NCT02513823|2197796|FG000|Overall Study|Physician Decision|1
1113955|NCT02514122|2197842|FG000|Overall Study|Withdrawal by Subject|2
1113956|NCT02514122|2197843|FG001|Overall Study|Withdrawal by Subject|0
1113957|NCT02514174|2197849|FG000|Overall Study|Patient refused to continue medication|1
1113958|NCT02514174|2197849|FG000|Overall Study|Adverse Event|2
1113959|NCT02514174|2197849|FG000|Overall Study|Study closed by sponsor|9
1113960|NCT02514174|2197849|FG000|Overall Study|Progressive disease|11
1113961|NCT02514174|2197849|FG000|Overall Study|Treatment change|1
1113962|NCT02514174|2197849|FG000|Overall Study|Treated off study with Afatinib.|1
1113963|NCT02514239|2197863|FG000|Overall Study|Refused to continue trial medication|0
1113964|NCT02514239|2197864|FG001|Overall Study|Refused to continue trial medication|0
1113965|NCT02514239|2197865|FG002|Overall Study|Refused to continue trial medication|0
1113966|NCT02514239|2197866|FG003|Overall Study|Refused to continue trial medication|0
1113967|NCT02514239|2197867|FG004|Overall Study|Refused to continue trial medication|0
1113968|NCT02514239|2197868|FG005|Overall Study|Refused to continue trial medication|0
1113969|NCT02514239|2197869|FG006|Overall Study|Refused to continue trial medication|0
1113970|NCT02514239|2197870|FG007|Overall Study|Refused to continue trial medication|0
1113971|NCT02514239|2197871|FG008|Overall Study|Refused to continue trial medication|0
1113972|NCT02514239|2197872|FG009|Overall Study|Refused to continue trial medication|1
1113973|NCT02514239|2197863|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
1113974|NCT02514239|2197864|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
1113975|NCT02514239|2197865|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
1113976|NCT02514239|2197866|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
1113977|NCT02514239|2197867|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
1113978|NCT02514239|2197868|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
1113979|NCT02514239|2197869|FG006|Overall Study|Dose-limiting toxicity (DLT)|0
1113980|NCT02514239|2197870|FG007|Overall Study|Dose-limiting toxicity (DLT)|0
1113981|NCT02514239|2197871|FG008|Overall Study|Dose-limiting toxicity (DLT)|1
1113982|NCT02514239|2197872|FG009|Overall Study|Dose-limiting toxicity (DLT)|2
1113983|NCT02514239|2197863|FG000|Overall Study|Not treated|0
896755|NCT00705783|1868480|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9
896756|NCT00705783|1868481|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0
896757|NCT00705783|1868482|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0
896758|NCT00705783|1868480|FG000|Depot Stabilization Phase|Withdrew Consent|29
896759|NCT00705783|1868481|FG001|Depot Stabilization Phase|Withdrew Consent|0
896760|NCT00705783|1868482|FG002|Depot Stabilization Phase|Withdrew Consent|0
1113984|NCT02514239|2197864|FG001|Overall Study|Not treated|1
1113985|NCT02514239|2197865|FG002|Overall Study|Not treated|0
1113986|NCT02514239|2197866|FG003|Overall Study|Not treated|0
1113987|NCT02514239|2197867|FG004|Overall Study|Not treated|0
1113988|NCT02514239|2197868|FG005|Overall Study|Not treated|0
1113989|NCT02514239|2197869|FG006|Overall Study|Not treated|0
1113990|NCT02514239|2197870|FG007|Overall Study|Not treated|0
1113991|NCT02514239|2197871|FG008|Overall Study|Not treated|0
1113992|NCT02514239|2197872|FG009|Overall Study|Not treated|0
1113993|NCT02514239|2197863|FG000|Overall Study|Other Adverse Events|2
1113994|NCT02514239|2197864|FG001|Overall Study|Other Adverse Events|0
1113995|NCT02514239|2197865|FG002|Overall Study|Other Adverse Events|0
1113996|NCT02514239|2197866|FG003|Overall Study|Other Adverse Events|1
1113997|NCT02514239|2197867|FG004|Overall Study|Other Adverse Events|0
1113998|NCT02514239|2197868|FG005|Overall Study|Other Adverse Events|1
1113999|NCT02514239|2197869|FG006|Overall Study|Other Adverse Events|0
1114000|NCT02514239|2197870|FG007|Overall Study|Other Adverse Events|1
1114001|NCT02514239|2197871|FG008|Overall Study|Other Adverse Events|2
1114002|NCT02514239|2197872|FG009|Overall Study|Other Adverse Events|0
1114003|NCT02514239|2197863|FG000|Overall Study|Progressive disease|3
1114004|NCT02514239|2197864|FG001|Overall Study|Progressive disease|3
1114005|NCT02514239|2197865|FG002|Overall Study|Progressive disease|2
1114006|NCT02514239|2197866|FG003|Overall Study|Progressive disease|2
1114007|NCT02514239|2197867|FG004|Overall Study|Progressive disease|3
1114008|NCT02514239|2197868|FG005|Overall Study|Progressive disease|3
1114009|NCT02514239|2197869|FG006|Overall Study|Progressive disease|4
1114010|NCT02514239|2197870|FG007|Overall Study|Progressive disease|2
1114011|NCT02514239|2197871|FG008|Overall Study|Progressive disease|5
1114012|NCT02514239|2197872|FG009|Overall Study|Progressive disease|0
1114013|NCT02514473|2197914|FG000|Overall Study|Adverse Event|0
1114014|NCT02514473|2197915|FG001|Overall Study|Adverse Event|2
1114015|NCT02514473|2197914|FG000|Overall Study|Withdrawal by Subject|2
1114016|NCT02514473|2197915|FG001|Overall Study|Withdrawal by Subject|1
1114017|NCT02514473|2197914|FG000|Overall Study|Lost to Follow-up|0
1114018|NCT02514473|2197915|FG001|Overall Study|Lost to Follow-up|1
1114019|NCT02514473|2197914|FG000|Overall Study|Other|1
1114020|NCT02514473|2197915|FG001|Overall Study|Other|1
1114021|NCT02514551|2197924|FG000|Overall Study|Lost to Follow-up|0
1114022|NCT02514551|2197925|FG001|Overall Study|Lost to Follow-up|1
1114023|NCT02514551|2197924|FG000|Overall Study|Participant Never Treated|0
1114024|NCT02514551|2197925|FG001|Overall Study|Participant Never Treated|2
1114025|NCT02514577|2197934|FG000|Overall Study|Lost to Follow-up|6
1114026|NCT02514577|2197935|FG001|Overall Study|Lost to Follow-up|6
1114027|NCT02514577|2197934|FG000|Overall Study|Protocol Violation|1
1114028|NCT02514577|2197935|FG001|Overall Study|Protocol Violation|0
1114029|NCT02514577|2197934|FG000|Overall Study|Withdrawal by Subject|6
1114030|NCT02514577|2197935|FG001|Overall Study|Withdrawal by Subject|6
1114031|NCT02514577|2197934|FG000|Overall Study|Adverse Event|1
1114032|NCT02514577|2197935|FG001|Overall Study|Adverse Event|1
1114033|NCT02514746|2197943|FG000|Overall Study|Chronically Ill|1
1114034|NCT02514746|2197944|FG001|Overall Study|Chronically Ill|2
1114035|NCT02514746|2197943|FG000|Overall Study|Physician Decision|4
1114036|NCT02514746|2197944|FG001|Overall Study|Physician Decision|2
1114037|NCT02514746|2197943|FG000|Overall Study|Withdrawal by Subject|12
1114038|NCT02514746|2197944|FG001|Overall Study|Withdrawal by Subject|10
1114039|NCT02514746|2197943|FG000|Overall Study|Other|5
1114040|NCT02514746|2197944|FG001|Overall Study|Other|1
1114041|NCT02514772|2197954|FG000|Overall Study|Adverse Event|1
1114042|NCT02514772|2197955|FG001|Overall Study|Adverse Event|0
1114043|NCT02514772|2197954|FG000|Overall Study|Death|0
1114044|NCT02514772|2197955|FG001|Overall Study|Death|1
1114045|NCT02514772|2197954|FG000|Overall Study|Withdrawal by Subject|2
1114046|NCT02514772|2197955|FG001|Overall Study|Withdrawal by Subject|1
1114047|NCT02514824|2197965|FG000|Overall Study|Withdrawal by Subject|1
1114048|NCT02514824|2197966|FG001|Overall Study|Withdrawal by Subject|0
1114049|NCT02514824|2197967|FG002|Overall Study|Withdrawal by Subject|0
1114050|NCT02514824|2197968|FG003|Overall Study|Withdrawal by Subject|0
1114051|NCT02514824|2197965|FG000|Overall Study|Dose-Limiting Toxicity|0
1114052|NCT02514824|2197966|FG001|Overall Study|Dose-Limiting Toxicity|1
1114053|NCT02514824|2197967|FG002|Overall Study|Dose-Limiting Toxicity|0
1114054|NCT02514824|2197968|FG003|Overall Study|Dose-Limiting Toxicity|0
1114055|NCT02515045|2197986|FG000|Overall Study|Adverse Event|0
1114056|NCT02515045|2197987|FG001|Overall Study|Adverse Event|3
1114057|NCT02515045|2197988|FG002|Overall Study|Adverse Event|3
1114058|NCT02515045|2197986|FG000|Overall Study|Lost to Follow-up|0
1114059|NCT02515045|2197987|FG001|Overall Study|Lost to Follow-up|1
1114060|NCT02515045|2197988|FG002|Overall Study|Lost to Follow-up|1
1114061|NCT02515097|2198007|FG000|Overall Study|Lost to Follow-up|4
1114062|NCT02515097|2198008|FG001|Overall Study|Lost to Follow-up|2
1114063|NCT02515097|2198007|FG000|Overall Study|Withdrawal by Subject|1
1114064|NCT02515097|2198008|FG001|Overall Study|Withdrawal by Subject|3
1114065|NCT02515097|2198007|FG000|Overall Study|Adverse Event|2
1114066|NCT02515097|2198008|FG001|Overall Study|Adverse Event|1
1114067|NCT02515279|2198023|FG000|Overall Study|Adverse Event|7
1114068|NCT02515279|2198023|FG000|Overall Study|Lack of Efficacy|31
1114069|NCT02515279|2198023|FG000|Overall Study|Lost to Follow-up|9
1114070|NCT02515279|2198023|FG000|Overall Study|Withdrawal by Subject|18
1114071|NCT02515279|2198023|FG000|Overall Study|End-of-treatment visit not attended|17
1114072|NCT02515279|2198023|FG000|Overall Study|Other|22
1114073|NCT02515331|2198043|FG000|Overall Study|Withdrawal by Subject|0
1114074|NCT02515331|2198044|FG001|Overall Study|Withdrawal by Subject|0
1114075|NCT02515331|2198045|FG002|Overall Study|Withdrawal by Subject|1
1114076|NCT02515331|2198043|FG000|Overall Study|Protocol deviation|0
1114077|NCT02515331|2198044|FG001|Overall Study|Protocol deviation|0
1114078|NCT02515331|2198045|FG002|Overall Study|Protocol deviation|3
1114079|NCT02515331|2198043|FG000|Overall Study|Adverse Event|2
1114080|NCT02515331|2198044|FG001|Overall Study|Adverse Event|0
1114081|NCT02515331|2198045|FG002|Overall Study|Adverse Event|0
1114082|NCT02515630|2198055|FG000|Overall Study|Withdrawal by Subject|5
1114083|NCT02515630|2198055|FG000|Overall Study|Adverse Event|4
1114084|NCT02515630|2198055|FG000|Overall Study|Physician Decision|4
1114085|NCT02515630|2198055|FG000|Overall Study|Death|2
1114086|NCT02515630|2198055|FG000|Overall Study|Disease Progression|1
1114087|NCT02515669|2198075|FG000|228 Week Open-Label Phase|Other|0
1114088|NCT02515669|2198076|FG001|228 Week Open-Label Phase|Other|0
1114089|NCT02515669|2198077|FG002|228 Week Open-Label Phase|Other|1
1114090|NCT02515669|2198078|FG003|228 Week Open-Label Phase|Other|4
1114091|NCT02515669|2198075|FG000|228 Week Open-Label Phase|Lack of Efficacy|0
1114092|NCT02515669|2198076|FG001|228 Week Open-Label Phase|Lack of Efficacy|0
1114093|NCT02515669|2198077|FG002|228 Week Open-Label Phase|Lack of Efficacy|1
1114094|NCT02515669|2198078|FG003|228 Week Open-Label Phase|Lack of Efficacy|0
1114095|NCT02515669|2198075|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
1114096|NCT02515669|2198076|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
1114097|NCT02515669|2198077|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2
1114098|NCT02515669|2198078|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3
1114099|NCT02515669|2198075|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0
1114100|NCT02515669|2198076|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7
1114101|NCT02515669|2198077|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2
1114102|NCT02515669|2198078|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17
1114103|NCT02515669|2198075|FG000|228 Week Open-Label Phase|Missing|0
1114104|NCT02515669|2198076|FG001|228 Week Open-Label Phase|Missing|2
1114105|NCT02515669|2198077|FG002|228 Week Open-Label Phase|Missing|2
1114106|NCT02515669|2198078|FG003|228 Week Open-Label Phase|Missing|2
1114107|NCT02515942|2198141|FG000|Overall Study|Adverse Event|5
1114108|NCT02515942|2198142|FG001|Overall Study|Adverse Event|0
1114109|NCT02515942|2198143|FG002|Overall Study|Adverse Event|0
1114110|NCT02515942|2198141|FG000|Overall Study|Death|0
1114111|NCT02515942|2198142|FG001|Overall Study|Death|0
1114112|NCT02515942|2198143|FG002|Overall Study|Death|1
1114113|NCT02515942|2198141|FG000|Overall Study|Lack of Efficacy|0
1114114|NCT02515942|2198142|FG001|Overall Study|Lack of Efficacy|0
1114115|NCT02515942|2198143|FG002|Overall Study|Lack of Efficacy|1
1114116|NCT02515942|2198141|FG000|Overall Study|Lost to Follow-up|2
1114117|NCT02515942|2198142|FG001|Overall Study|Lost to Follow-up|0
1114118|NCT02515942|2198143|FG002|Overall Study|Lost to Follow-up|0
1114119|NCT02515942|2198141|FG000|Overall Study|Withdrawal by Subject|0
1114120|NCT02515942|2198142|FG001|Overall Study|Withdrawal by Subject|3
1114121|NCT02515942|2198143|FG002|Overall Study|Withdrawal by Subject|2
1114122|NCT02515994|2198155|FG000|Overall Study|Protocol Violation|3
1114123|NCT02515994|2198156|FG001|Overall Study|Protocol Violation|5
1114124|NCT02515994|2198155|FG000|Overall Study|No Longer Meets Eligibility Criteria|2
1114125|NCT02515994|2198156|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
1114126|NCT02515994|2198155|FG000|Overall Study|Adverse Event|3
1114127|NCT02515994|2198156|FG001|Overall Study|Adverse Event|1
1114128|NCT02515994|2198155|FG000|Overall Study|Withdrawal by Subject|2
1114129|NCT02515994|2198156|FG001|Overall Study|Withdrawal by Subject|0
1114130|NCT02516098|2198178|FG000|Period 1|Protocol Violation|1
1114131|NCT02516098|2198179|FG001|Period 1|Protocol Violation|0
1114132|NCT02516098|2198178|FG000|Washout After Period 1|Adverse Event|0
1114133|NCT02516098|2198179|FG001|Washout After Period 1|Adverse Event|1
1114134|NCT02516098|2198178|FG000|Period 2|Withdrawal by Subject|0
1114135|NCT02516098|2198179|FG001|Period 2|Withdrawal by Subject|1
1114136|NCT02516163|2198191|FG000|Overall Study|Withdrawal by Subject|1
1114137|NCT02516163|2198191|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11
1114138|NCT02516163|2198191|FG000|Overall Study|Unfit/delay in surgery|3
1114139|NCT02516163|2198191|FG000|Overall Study|Use of incorrect measurement technique|5
1114140|NCT02516163|2198191|FG000|Overall Study|Data not recorded|2
1114141|NCT02516163|2198191|FG000|Overall Study|MRI contraindication exclusion|6
1114142|NCT02516202|2198198|FG000|Overall Study|Withdrawal by Subject|1
1114143|NCT02516202|2198199|FG001|Overall Study|Withdrawal by Subject|0
1114144|NCT02516202|2198200|FG002|Overall Study|Withdrawal by Subject|1
1114145|NCT02516202|2198198|FG000|Overall Study|Lost to Follow-up|1
1114146|NCT02516202|2198199|FG001|Overall Study|Lost to Follow-up|1
1114147|NCT02516202|2198200|FG002|Overall Study|Lost to Follow-up|1
1114148|NCT02516202|2198198|FG000|Overall Study|Stopped Follow-up|0
1114149|NCT02516202|2198199|FG001|Overall Study|Stopped Follow-up|0
1114150|NCT02516202|2198200|FG002|Overall Study|Stopped Follow-up|1
1114163|NCT02516306|2198228|FG000|Period 2: Day 8 - 91|Protocol Violation|1
1114164|NCT02516306|2198229|FG001|Period 2: Day 8 - 91|Protocol Violation|2
1114165|NCT02516332|2198238|FG000|Overall Study|Withdrawal by Subject|2
1114166|NCT02516332|2198239|FG001|Overall Study|Withdrawal by Subject|1
1114167|NCT02516332|2198240|FG002|Overall Study|Withdrawal by Subject|2
1114168|NCT02516410|2198250|FG000|Overall Study|Adverse Event|0
1114169|NCT02516410|2198251|FG001|Overall Study|Adverse Event|1
1114170|NCT02516410|2198250|FG000|Overall Study|Withdrawal by Subject|0
1114171|NCT02516410|2198251|FG001|Overall Study|Withdrawal by Subject|1
1114172|NCT02516592|2198264|FG000|Overall Study|Patient withdrew consent|5
1114173|NCT02516592|2198265|FG001|Overall Study|Patient withdrew consent|2
1114174|NCT02516592|2198264|FG000|Overall Study|Protocol deviation|4
1114175|NCT02516592|2198265|FG001|Overall Study|Protocol deviation|4
1114176|NCT02516592|2198264|FG000|Overall Study|Lost to Follow-up|2
1114177|NCT02516592|2198265|FG001|Overall Study|Lost to Follow-up|3
1114178|NCT02516592|2198264|FG000|Overall Study|Patient/guardian decision|2
1114179|NCT02516592|2198265|FG001|Overall Study|Patient/guardian decision|1
1114180|NCT02516592|2198264|FG000|Overall Study|Adverse Event|1
1114181|NCT02516592|2198265|FG001|Overall Study|Adverse Event|2
1114182|NCT02516592|2198264|FG000|Overall Study|Abnormal test procedure result|1
1114183|NCT02516592|2198265|FG001|Overall Study|Abnormal test procedure result|0
1114184|NCT02516592|2198264|FG000|Overall Study|Death|1
1114185|NCT02516592|2198265|FG001|Overall Study|Death|1
1114186|NCT02516605|2198276|FG000|Overall Study|Protocol Violation|0
1114187|NCT02516605|2198277|FG001|Overall Study|Protocol Violation|0
1114188|NCT02516605|2198278|FG002|Overall Study|Protocol Violation|0
1114189|NCT02516605|2198279|FG003|Overall Study|Protocol Violation|0
1114190|NCT02516605|2198280|FG004|Overall Study|Protocol Violation|1
1114191|NCT02516605|2198276|FG000|Overall Study|Withdrawal by Subject|0
1114192|NCT02516605|2198277|FG001|Overall Study|Withdrawal by Subject|0
1114193|NCT02516605|2198278|FG002|Overall Study|Withdrawal by Subject|0
1114194|NCT02516605|2198279|FG003|Overall Study|Withdrawal by Subject|1
1114195|NCT02516605|2198280|FG004|Overall Study|Withdrawal by Subject|0
1114196|NCT02516982|2198300|FG000|Overall Study|Called in to antenatal appointment|32
1114197|NCT02516982|2198301|FG001|Overall Study|Called in to antenatal appointment|35
1114198|NCT02516982|2198302|FG002|Overall Study|Called in to antenatal appointment|0
1114199|NCT02516982|2198303|FG003|Overall Study|Called in to antenatal appointment|0
1114200|NCT02516982|2198300|FG000|Overall Study|Withdrawal by Subject|0
1114201|NCT02516982|2198301|FG001|Overall Study|Withdrawal by Subject|0
1114202|NCT02516982|2198302|FG002|Overall Study|Withdrawal by Subject|1
1114203|NCT02516982|2198303|FG003|Overall Study|Withdrawal by Subject|2
1114204|NCT02516982|2198300|FG000|Overall Study|Protocol Violation|0
1114205|NCT02516982|2198301|FG001|Overall Study|Protocol Violation|0
1114206|NCT02516982|2198302|FG002|Overall Study|Protocol Violation|1
1114207|NCT02516982|2198303|FG003|Overall Study|Protocol Violation|1
1114208|NCT02516982|2198300|FG000|Overall Study|Did not install the app|0
1114209|NCT02516982|2198301|FG001|Overall Study|Did not install the app|0
1114210|NCT02516982|2198302|FG002|Overall Study|Did not install the app|46
1114211|NCT02516982|2198303|FG003|Overall Study|Did not install the app|47
1114212|NCT02517268|2198329|FG000|Overall Study|Withdrawal by Subject|1
1114213|NCT02517268|2198330|FG001|Overall Study|Withdrawal by Subject|0
1114214|NCT02517463|2198338|FG000|Overall Study|Lost to Follow-up|5
1114215|NCT02517463|2198339|FG001|Overall Study|Lost to Follow-up|2
1114216|NCT02517515|2198347|FG000|Overall Study|Adverse Event|0
1114217|NCT02517515|2198348|FG001|Overall Study|Adverse Event|1
1114218|NCT02517515|2198347|FG000|Overall Study|Withdrew Consent|0
1114219|NCT02517515|2198348|FG001|Overall Study|Withdrew Consent|1
1114220|NCT02517515|2198347|FG000|Overall Study|Lost to Follow-up|1
1114221|NCT02517515|2198348|FG001|Overall Study|Lost to Follow-up|0
896761|NCT00705783|1868480|FG000|Depot Stabilization Phase|Adverse Event|17
896762|NCT00705783|1868481|FG001|Depot Stabilization Phase|Adverse Event|0
896763|NCT00705783|1868482|FG002|Depot Stabilization Phase|Adverse Event|0
896764|NCT00705783|1868480|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
896765|NCT00705783|1868481|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
896766|NCT00705783|1868482|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
896767|NCT00705783|1868480|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
896768|NCT00705783|1868481|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
896769|NCT00705783|1868482|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
896770|NCT00705783|1868480|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0
1114222|NCT02517515|2198347|FG000|Overall Study|Other|1
1114223|NCT02517515|2198348|FG001|Overall Study|Other|0
1114224|NCT02517528|2198355|FG000|Overall Study|Withdrawal by Subject|1
1114225|NCT02517541|2198359|FG000|Baseline Period (Own Product)|Protocol Violation|1
1114226|NCT02517541|2198359|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
1114227|NCT02517541|2198359|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
1114228|NCT02517541|2198359|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
1114229|NCT02517541|2198359|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
1114230|NCT02517541|2198359|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
1114231|NCT02517866|2198394|FG000|Overall Study|Pretreatment Event/Adverse Event|9
1114232|NCT02517866|2198395|FG001|Overall Study|Pretreatment Event/Adverse Event|2
1114233|NCT02517866|2198396|FG002|Overall Study|Pretreatment Event/Adverse Event|0
1114234|NCT02517866|2198394|FG000|Overall Study|Significant Protocol Deviation|4
1114235|NCT02517866|2198395|FG001|Overall Study|Significant Protocol Deviation|1
1114236|NCT02517866|2198396|FG002|Overall Study|Significant Protocol Deviation|0
1114237|NCT02517866|2198394|FG000|Overall Study|Lost to Follow-up|1
1114238|NCT02517866|2198395|FG001|Overall Study|Lost to Follow-up|0
1114239|NCT02517866|2198396|FG002|Overall Study|Lost to Follow-up|0
1114240|NCT02517866|2198394|FG000|Overall Study|Voluntary Withdrawal|2
1114241|NCT02517866|2198395|FG001|Overall Study|Voluntary Withdrawal|2
1114242|NCT02517866|2198396|FG002|Overall Study|Voluntary Withdrawal|0
1114243|NCT02517866|2198394|FG000|Overall Study|Investigator Decision|2
1114244|NCT02517866|2198395|FG001|Overall Study|Investigator Decision|1
1114245|NCT02517866|2198396|FG002|Overall Study|Investigator Decision|0
1114246|NCT02517866|2198394|FG000|Overall Study|Reason not specified|2
1114247|NCT02517866|2198395|FG001|Overall Study|Reason not specified|0
1114248|NCT02517866|2198396|FG002|Overall Study|Reason not specified|0
1114249|NCT02517905|2198408|FG000|Overall Study|Lost to Follow-up|4
1114250|NCT02517905|2198409|FG001|Overall Study|Lost to Follow-up|0
1114251|NCT02517905|2198408|FG000|Overall Study|Withdrawal by Subject|4
1114252|NCT02517905|2198409|FG001|Overall Study|Withdrawal by Subject|0
1114253|NCT02517905|2198408|FG000|Overall Study|Screen failure|2
1114254|NCT02517905|2198409|FG001|Overall Study|Screen failure|2
1114255|NCT02518048|2198424|FG000|Overall Study|Withdrawal by Subject|1
1114256|NCT02518113|2198433|FG000|Overall Study|Adverse Event|1
1114257|NCT02518113|2198434|FG001|Overall Study|Adverse Event|0
1114258|NCT02518113|2198435|FG002|Overall Study|Adverse Event|1
1114259|NCT02518113|2198436|FG003|Overall Study|Adverse Event|0
1114260|NCT02518113|2198433|FG000|Overall Study|Death|1
1114261|NCT02518113|2198434|FG001|Overall Study|Death|2
1114262|NCT02518113|2198435|FG002|Overall Study|Death|0
1114263|NCT02518113|2198436|FG003|Overall Study|Death|0
1114264|NCT02518113|2198433|FG000|Overall Study|Physician Decision|0
1114265|NCT02518113|2198434|FG001|Overall Study|Physician Decision|1
1114266|NCT02518113|2198435|FG002|Overall Study|Physician Decision|0
1114267|NCT02518113|2198436|FG003|Overall Study|Physician Decision|0
1114268|NCT02518113|2198433|FG000|Overall Study|Progressive Disease|1
1114269|NCT02518113|2198434|FG001|Overall Study|Progressive Disease|2
1114270|NCT02518113|2198435|FG002|Overall Study|Progressive Disease|3
1114271|NCT02518113|2198436|FG003|Overall Study|Progressive Disease|0
1114272|NCT02518464|2198483|FG000|Overall Study|Adverse Event|2
1114273|NCT02518490|2198487|FG000|Overall Study|Withdrawal by Subject|1
1114274|NCT02518490|2198488|FG001|Overall Study|Withdrawal by Subject|1
1114275|NCT02518620|2198497|FG000|Overall Study|Adverse Event|23
1114276|NCT02518620|2198498|FG001|Overall Study|Adverse Event|11
1114277|NCT02518620|2198497|FG000|Overall Study|Lack of Efficacy|2
1114278|NCT02518620|2198498|FG001|Overall Study|Lack of Efficacy|0
1114279|NCT02518620|2198497|FG000|Overall Study|Non-Compliance with Study Drug|1
1114280|NCT02518620|2198498|FG001|Overall Study|Non-Compliance with Study Drug|0
1114281|NCT02518620|2198497|FG000|Overall Study|Physician Decision|1
1114282|NCT02518620|2198498|FG001|Overall Study|Physician Decision|1
1114283|NCT02518620|2198497|FG000|Overall Study|Sponsor's Decision|0
1114284|NCT02518620|2198498|FG001|Overall Study|Sponsor's Decision|3
1114285|NCT02518620|2198497|FG000|Overall Study|Lost to Follow-up|1
1114286|NCT02518620|2198498|FG001|Overall Study|Lost to Follow-up|1
1114287|NCT02518620|2198497|FG000|Overall Study|Withdrawal by Subject|17
1114288|NCT02518620|2198498|FG001|Overall Study|Withdrawal by Subject|9
1114289|NCT02518620|2198497|FG000|Overall Study|Death|1
1114290|NCT02518620|2198498|FG001|Overall Study|Death|0
1114291|NCT02518620|2198497|FG000|Overall Study|Pregnancy Wish|3
1114292|NCT02518620|2198498|FG001|Overall Study|Pregnancy Wish|0
1114293|NCT02518620|2198497|FG000|Overall Study|Pregnancy|1
1114294|NCT02518620|2198498|FG001|Overall Study|Pregnancy|0
1114295|NCT02518620|2198497|FG000|Overall Study|Relocation|2
1114296|NCT02518620|2198498|FG001|Overall Study|Relocation|1
1114297|NCT02518685|2198508|FG000|Overall Study|Adverse Event|29
1114298|NCT02518685|2198509|FG001|Overall Study|Adverse Event|1
1114299|NCT02518685|2198508|FG000|Overall Study|Withdrawal by Subject|10
1114300|NCT02518685|2198509|FG001|Overall Study|Withdrawal by Subject|3
1114301|NCT02518685|2198508|FG000|Overall Study|relocation, study fatigue|7
1114302|NCT02518685|2198509|FG001|Overall Study|relocation, study fatigue|2
1114303|NCT02518685|2198508|FG000|Overall Study|Pregnancy|1
1114304|NCT02518685|2198509|FG001|Overall Study|Pregnancy|0
1114305|NCT02518685|2198508|FG000|Overall Study|Physician Decision|1
1114306|NCT02518685|2198509|FG001|Overall Study|Physician Decision|0
1114307|NCT02518685|2198508|FG000|Overall Study|Lost to Follow-up|1
1114308|NCT02518685|2198509|FG001|Overall Study|Lost to Follow-up|4
1114309|NCT02518919|2198519|FG000|Overall Study|Protocol Violation|1
1114310|NCT02518919|2198520|FG001|Overall Study|Protocol Violation|1
1114311|NCT02518919|2198521|FG002|Overall Study|Protocol Violation|2
1114312|NCT02518971|2198531|FG000|Overall Study|Lost to Follow-up|0
1114313|NCT02518971|2198532|FG001|Overall Study|Lost to Follow-up|1
1114314|NCT02518971|2198531|FG000|Overall Study|Physician Decision|6
1114315|NCT02518971|2198532|FG001|Overall Study|Physician Decision|6
1114316|NCT02518971|2198531|FG000|Overall Study|Protocol Violation|6
1114317|NCT02518971|2198532|FG001|Overall Study|Protocol Violation|4
896771|NCT00705783|1868481|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179
896772|NCT00705783|1868482|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58
896773|NCT00705783|1868480|FG000|Depot Maintenance Phase|Lost to Follow-up|0
896774|NCT00705783|1868481|FG001|Depot Maintenance Phase|Lost to Follow-up|5
896775|NCT00705783|1868482|FG002|Depot Maintenance Phase|Lost to Follow-up|3
896776|NCT00705783|1868480|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
896777|NCT00705783|1868481|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2
896778|NCT00705783|1868482|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2
896779|NCT00705783|1868480|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
896780|NCT00705783|1868481|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
896781|NCT00705783|1868482|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6
896782|NCT00705783|1868480|FG000|Depot Maintenance Phase|Withdrew Consent|0
896783|NCT00705783|1868481|FG001|Depot Maintenance Phase|Withdrew Consent|14
896784|NCT00705783|1868482|FG002|Depot Maintenance Phase|Withdrew Consent|4
896785|NCT00705783|1868480|FG000|Depot Maintenance Phase|Protocol Deviation|0
896786|NCT00705783|1868481|FG001|Depot Maintenance Phase|Protocol Deviation|2
896787|NCT00705783|1868482|FG002|Depot Maintenance Phase|Protocol Deviation|0
896788|NCT00705783|1868480|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
896789|NCT00705783|1868481|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
896790|NCT00705783|1868482|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
896791|NCT00705783|1868480|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
896792|NCT00705783|1868481|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
896793|NCT00705783|1868482|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
896794|NCT00705783|1868480|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
896795|NCT00705783|1868481|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
896796|NCT00705783|1868482|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
896797|NCT00705939|1868523|FG000|Overall Study|Protocol Violation|0
896798|NCT00705939|1868524|FG001|Overall Study|Protocol Violation|0
896799|NCT00705939|1868525|FG002|Overall Study|Protocol Violation|1
896800|NCT00705939|1868523|FG000|Overall Study|Withdrawal by Subject|0
896801|NCT00705939|1868524|FG001|Overall Study|Withdrawal by Subject|1
896802|NCT00705939|1868525|FG002|Overall Study|Withdrawal by Subject|3
896803|NCT00705939|1868523|FG000|Overall Study|Physician Decision|0
896804|NCT00705939|1868524|FG001|Overall Study|Physician Decision|1
896805|NCT00705939|1868525|FG002|Overall Study|Physician Decision|0
896806|NCT00706004|1868534|FG000|Overall Study|Did not meet eligibility criteria|2
896807|NCT00706030|1868543|FG000|Overall Study|Disease Progression|4
896808|NCT00706030|1868544|FG001|Overall Study|Disease Progression|6
896809|NCT00706030|1868545|FG002|Overall Study|Disease Progression|46
896810|NCT00706030|1868546|FG003|Overall Study|Disease Progression|12
896811|NCT00706030|1868543|FG000|Overall Study|Adverse Event|1
896812|NCT00706030|1868544|FG001|Overall Study|Adverse Event|0
896813|NCT00706030|1868545|FG002|Overall Study|Adverse Event|4
896814|NCT00706030|1868546|FG003|Overall Study|Adverse Event|2
896815|NCT00706030|1868543|FG000|Overall Study|Withdrawal by Subject|1
896816|NCT00706030|1868544|FG001|Overall Study|Withdrawal by Subject|0
896817|NCT00706030|1868545|FG002|Overall Study|Withdrawal by Subject|2
896818|NCT00706030|1868546|FG003|Overall Study|Withdrawal by Subject|0
896819|NCT00706030|1868543|FG000|Overall Study|Physician Decision|0
896820|NCT00706030|1868544|FG001|Overall Study|Physician Decision|0
896821|NCT00706030|1868545|FG002|Overall Study|Physician Decision|2
896822|NCT00706030|1868546|FG003|Overall Study|Physician Decision|0
896823|NCT00706030|1868543|FG000|Overall Study|Not recorded|0
896824|NCT00706030|1868544|FG001|Overall Study|Not recorded|0
896825|NCT00706030|1868545|FG002|Overall Study|Not recorded|2
896826|NCT00706030|1868546|FG003|Overall Study|Not recorded|0
896827|NCT00706030|1868543|FG000|Overall Study|Protocol Violation|0
896828|NCT00706030|1868544|FG001|Overall Study|Protocol Violation|0
896829|NCT00706030|1868545|FG002|Overall Study|Protocol Violation|1
896830|NCT00706030|1868546|FG003|Overall Study|Protocol Violation|1
896831|NCT00706030|1868543|FG000|Overall Study|Failed to return|0
896832|NCT00706030|1868544|FG001|Overall Study|Failed to return|0
896833|NCT00706030|1868545|FG002|Overall Study|Failed to return|1
896834|NCT00706030|1868546|FG003|Overall Study|Failed to return|0
896835|NCT00706030|1868543|FG000|Overall Study|Symptomatic Deterioration|0
896836|NCT00706030|1868544|FG001|Overall Study|Symptomatic Deterioration|0
896837|NCT00706030|1868545|FG002|Overall Study|Symptomatic Deterioration|1
896838|NCT00706030|1868546|FG003|Overall Study|Symptomatic Deterioration|0
896839|NCT00706030|1868543|FG000|Overall Study|No treatment received|0
896840|NCT00706030|1868544|FG001|Overall Study|No treatment received|0
896841|NCT00706030|1868545|FG002|Overall Study|No treatment received|0
1114318|NCT02518971|2198531|FG000|Overall Study|Withdrawal by Subject|4
1114319|NCT02518971|2198532|FG001|Overall Study|Withdrawal by Subject|5
1114320|NCT02518971|2198531|FG000|Overall Study|Side effects|1
1114321|NCT02518971|2198532|FG001|Overall Study|Side effects|0
1114322|NCT02518971|2198531|FG000|Overall Study|medication lost in mail|0
1114323|NCT02518971|2198532|FG001|Overall Study|medication lost in mail|1
1114324|NCT02518971|2198531|FG000|Overall Study|eligibility criteria no longer met|6
1114325|NCT02518971|2198532|FG001|Overall Study|eligibility criteria no longer met|3
1114326|NCT02519231|2198587|FG000|Overall Study|Lost to Follow-up|2
1114327|NCT02519231|2198588|FG001|Overall Study|Lost to Follow-up|5
1114328|NCT02519231|2198587|FG000|Overall Study|Withdrawal by Subject|0
1114329|NCT02519231|2198588|FG001|Overall Study|Withdrawal by Subject|1
1114330|NCT02519504|2198615|FG000|Overall Study|Protocol Violation|6
1114331|NCT02519504|2198616|FG001|Overall Study|Protocol Violation|5
1114332|NCT02519504|2198615|FG000|Overall Study|Ineligible for direct testing|12
1114333|NCT02519504|2198616|FG001|Overall Study|Ineligible for direct testing|12
1114334|NCT02519504|2198615|FG000|Overall Study|Did not participate in direct testing|95
1114335|NCT02519504|2198616|FG001|Overall Study|Did not participate in direct testing|86
1114336|NCT02519595|2198625|FG000|Overall Study|Protocol Violation|8
1114337|NCT02519595|2198626|FG001|Overall Study|Protocol Violation|22
1114338|NCT02519595|2198627|FG002|Overall Study|Protocol Violation|16
1114339|NCT02519842|2198650|FG000|Base Study: Cycle 1|Screening Failure|1
1114340|NCT02519842|2198651|FG001|Base Study: Cycle 1|Screening Failure|1
1114341|NCT02519842|2198652|FG002|Base Study: Cycle 1|Screening Failure|0
1114342|NCT02519842|2198650|FG000|Base Study: Cycle 1|Adverse Event|1
1114343|NCT02519842|2198651|FG001|Base Study: Cycle 1|Adverse Event|0
1114344|NCT02519842|2198652|FG002|Base Study: Cycle 1|Adverse Event|0
1114345|NCT02519842|2198650|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
1114346|NCT02519842|2198651|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
1114347|NCT02519842|2198652|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
1114348|NCT02519842|2198650|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0
1114349|NCT02519842|2198651|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1
1114350|NCT02519842|2198652|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0
1114351|NCT02519842|2198650|FG000|Optional Extension: Cycles 2-6|Physician Decision|0
1114352|NCT02519842|2198651|FG001|Optional Extension: Cycles 2-6|Physician Decision|0
1114353|NCT02519842|2198652|FG002|Optional Extension: Cycles 2-6|Physician Decision|5
1114354|NCT02519842|2198650|FG000|Optional Extension: Cycles 2-6|Adverse Event|0
1114355|NCT02519842|2198651|FG001|Optional Extension: Cycles 2-6|Adverse Event|0
1114356|NCT02519842|2198652|FG002|Optional Extension: Cycles 2-6|Adverse Event|1
1114357|NCT02519842|2198650|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
1114358|NCT02519842|2198651|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
1114359|NCT02519842|2198652|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
1114360|NCT02519842|2198650|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
1114361|NCT02519842|2198651|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
1114362|NCT02519842|2198652|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
1114363|NCT02519842|2198650|FG000|Optional Extension: Cycles 2-6|Death|0
1114364|NCT02519842|2198651|FG001|Optional Extension: Cycles 2-6|Death|0
1114365|NCT02519842|2198652|FG002|Optional Extension: Cycles 2-6|Death|1
1114366|NCT02519842|2198650|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
1114367|NCT02519842|2198651|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
1114368|NCT02519842|2198652|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
1114369|NCT02519842|2198650|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
1114370|NCT02519842|2198651|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
1114371|NCT02519842|2198652|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
1114372|NCT02519842|2198650|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
1114373|NCT02519842|2198651|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
1114374|NCT02519842|2198652|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
1114375|NCT02519842|2198650|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
1114376|NCT02519842|2198651|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
1114377|NCT02519842|2198652|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
1114378|NCT02519855|2198662|FG000|Overall Study|Adverse Event|0
1114379|NCT02519855|2198663|FG001|Overall Study|Adverse Event|1
1114380|NCT02519855|2198662|FG000|Overall Study|Lost to Follow-up|3
1114381|NCT02519855|2198663|FG001|Overall Study|Lost to Follow-up|3
1114382|NCT02520011|2198672|FG000|Overall Study|Adverse Event|0
1114383|NCT02520011|2198673|FG001|Overall Study|Adverse Event|1
1114384|NCT02520011|2198674|FG002|Overall Study|Adverse Event|2
1114385|NCT02520011|2198672|FG000|Overall Study|Death|0
1114386|NCT02520011|2198673|FG001|Overall Study|Death|8
1114387|NCT02520011|2198674|FG002|Overall Study|Death|1
1114388|NCT02520011|2198672|FG000|Overall Study|Lack of Efficacy|4
1114389|NCT02520011|2198673|FG001|Overall Study|Lack of Efficacy|26
1114390|NCT02520011|2198674|FG002|Overall Study|Lack of Efficacy|4
1114391|NCT02520011|2198672|FG000|Overall Study|Physician Decision|0
1114392|NCT02520011|2198673|FG001|Overall Study|Physician Decision|2
1114393|NCT02520011|2198674|FG002|Overall Study|Physician Decision|0
1114394|NCT02520011|2198672|FG000|Overall Study|Withdrawal by Subject|1
1114395|NCT02520011|2198673|FG001|Overall Study|Withdrawal by Subject|3
1114396|NCT02520011|2198674|FG002|Overall Study|Withdrawal by Subject|0
896842|NCT00706030|1868546|FG003|Overall Study|No treatment received|1
896843|NCT00706030|1868543|FG000|Overall Study|Death|0
896844|NCT00706030|1868544|FG001|Overall Study|Death|0
896845|NCT00706030|1868545|FG002|Overall Study|Death|1
896846|NCT00706030|1868546|FG003|Overall Study|Death|0
896847|NCT00706095|1868560|FG000|Overall Study|Progressive Disease|4
896848|NCT00706095|1868561|FG001|Overall Study|Progressive Disease|5
896849|NCT00706095|1868562|FG002|Overall Study|Progressive Disease|3
896850|NCT00706095|1868560|FG000|Overall Study|Clinical Progression|1
896851|NCT00706095|1868561|FG001|Overall Study|Clinical Progression|2
896852|NCT00706095|1868562|FG002|Overall Study|Clinical Progression|2
896853|NCT00706095|1868560|FG000|Overall Study|Withdrawal by Subject|1
896854|NCT00706095|1868561|FG001|Overall Study|Withdrawal by Subject|0
896855|NCT00706095|1868562|FG002|Overall Study|Withdrawal by Subject|0
896856|NCT00706134|1868599|FG000|Overall Study|Adverse Event|8
896857|NCT00706134|1868600|FG001|Overall Study|Adverse Event|7
896858|NCT00706134|1868601|FG002|Overall Study|Adverse Event|2
896859|NCT00706134|1868602|FG003|Overall Study|Adverse Event|3
896860|NCT00706134|1868599|FG000|Overall Study|Lost to Follow-up|0
896861|NCT00706134|1868600|FG001|Overall Study|Lost to Follow-up|1
896862|NCT00706134|1868601|FG002|Overall Study|Lost to Follow-up|0
896863|NCT00706134|1868602|FG003|Overall Study|Lost to Follow-up|0
896864|NCT00706134|1868599|FG000|Overall Study|Protocol Violation|0
896865|NCT00706134|1868600|FG001|Overall Study|Protocol Violation|6
896866|NCT00706134|1868601|FG002|Overall Study|Protocol Violation|0
896867|NCT00706134|1868602|FG003|Overall Study|Protocol Violation|3
896868|NCT00706134|1868599|FG000|Overall Study|Withdrawal by Subject|1
896869|NCT00706134|1868600|FG001|Overall Study|Withdrawal by Subject|2
896870|NCT00706134|1868601|FG002|Overall Study|Withdrawal by Subject|1
896871|NCT00706134|1868602|FG003|Overall Study|Withdrawal by Subject|0
896872|NCT00706134|1868599|FG000|Overall Study|Unsatisfactory therapeutic effect|9
896873|NCT00706134|1868600|FG001|Overall Study|Unsatisfactory therapeutic effect|3
896874|NCT00706134|1868601|FG002|Overall Study|Unsatisfactory therapeutic effect|3
1114397|NCT02520011|2198672|FG000|Overall Study|Protocol Deviation|0
1114398|NCT02520011|2198673|FG001|Overall Study|Protocol Deviation|1
1114399|NCT02520011|2198674|FG002|Overall Study|Protocol Deviation|0
1114400|NCT02520011|2198672|FG000|Overall Study|Patient went to hospice|0
1114401|NCT02520011|2198673|FG001|Overall Study|Patient went to hospice|1
1114402|NCT02520011|2198674|FG002|Overall Study|Patient went to hospice|0
1114403|NCT02520011|2198672|FG000|Overall Study|Progressive disease following response|0
1114404|NCT02520011|2198673|FG001|Overall Study|Progressive disease following response|4
1114405|NCT02520011|2198674|FG002|Overall Study|Progressive disease following response|2
1114406|NCT02520089|2198689|FG000|Overall Study|Lost to Follow-up|3
1114407|NCT02520089|2198690|FG001|Overall Study|Lost to Follow-up|4
1114408|NCT02520284|2198699|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1
1114409|NCT02520284|2198700|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3
1114410|NCT02520284|2198701|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0
1114411|NCT02520284|2198699|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
1114412|NCT02520284|2198700|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
1114413|NCT02520284|2198701|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
1114414|NCT02520284|2198699|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
1114415|NCT02520284|2198700|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
1114416|NCT02520284|2198701|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
1114417|NCT02520284|2198699|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
1114418|NCT02520284|2198700|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
1114419|NCT02520284|2198701|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
1114420|NCT02520284|2198699|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
1114421|NCT02520284|2198700|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
1114422|NCT02520284|2198701|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
1114423|NCT02520284|2198699|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
1114424|NCT02520284|2198700|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
1114425|NCT02520284|2198701|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
1114426|NCT02520284|2198699|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
1114427|NCT02520284|2198700|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
1114428|NCT02520284|2198701|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
1114429|NCT02520284|2198699|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
1114430|NCT02520284|2198700|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
1114431|NCT02520284|2198701|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
1114432|NCT02520284|2198699|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
1114433|NCT02520284|2198700|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
1114434|NCT02520284|2198701|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
1114435|NCT02520284|2198699|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
1114436|NCT02520284|2198700|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
896875|NCT00706134|1868602|FG003|Overall Study|Unsatisfactory therapeutic effect|5
896876|NCT00706134|1868599|FG000|Overall Study|Did not meet study criteria|2
896877|NCT00706134|1868600|FG001|Overall Study|Did not meet study criteria|0
1114437|NCT02520284|2198701|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
1114438|NCT02520284|2198699|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
1114439|NCT02520284|2198700|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
1114440|NCT02520284|2198701|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
1114441|NCT02520310|2198715|FG000|At 6 Months Clinical Follow-up|Death|1
1114442|NCT02520310|2198715|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
1114443|NCT02520310|2198715|FG000|AT 3 Year Clinical Follow-up|Death|2
1114444|NCT02520310|2198715|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
1114445|NCT02520310|2198715|FG000|AT 4 Year Clinical Follow-up|Death|1
1114446|NCT02520310|2198715|FG000|AT 4 Year Clinical Follow-up|missed visit|1
1114447|NCT02520388|2198723|FG000|Overall Study|Physician Decision|1
1114448|NCT02520388|2198724|FG001|Overall Study|Physician Decision|0
1114449|NCT02520388|2198723|FG000|Overall Study|Subject or parent/guardian request|0
1114450|NCT02520388|2198724|FG001|Overall Study|Subject or parent/guardian request|6
1114451|NCT02520388|2198723|FG000|Overall Study|Adverse Event|1
1114452|NCT02520388|2198724|FG001|Overall Study|Adverse Event|4
1114453|NCT02520388|2198723|FG000|Overall Study|Lost to Follow-up|3
1114454|NCT02520388|2198724|FG001|Overall Study|Lost to Follow-up|2
1114455|NCT02520388|2198723|FG000|Overall Study|Other (reason not defined)|4
1114456|NCT02520388|2198724|FG001|Overall Study|Other (reason not defined)|4
1114457|NCT02520531|2198755|FG000|Overall Study|Revision of study device components|2
1114458|NCT02520531|2198756|FG001|Overall Study|Revision of study device components|2
1114459|NCT02520531|2198755|FG000|Overall Study|Death|1
1114460|NCT02520531|2198756|FG001|Overall Study|Death|2
1114461|NCT02520531|2198755|FG000|Overall Study|Lost to Follow-up|1
1114462|NCT02520531|2198756|FG001|Overall Study|Lost to Follow-up|1
1114463|NCT02520531|2198755|FG000|Overall Study|Meet exclusion criterion|0
1114464|NCT02520531|2198756|FG001|Overall Study|Meet exclusion criterion|1
1114465|NCT02520531|2198755|FG000|Overall Study|Withdrawal by Subject|1
1114466|NCT02520531|2198756|FG001|Overall Study|Withdrawal by Subject|0
1114467|NCT02520531|2198755|FG000|Overall Study|Not study device|1
1114468|NCT02520531|2198756|FG001|Overall Study|Not study device|0
1114469|NCT02521376|2198788|FG000|Overall Study|Enrolled, But Not Treated|1
1114470|NCT02521376|2198789|FG001|Overall Study|Enrolled, But Not Treated|0
1114471|NCT02521376|2198790|FG002|Overall Study|Enrolled, But Not Treated|0
1114472|NCT02521376|2198791|FG003|Overall Study|Enrolled, But Not Treated|0
1114473|NCT02521792|2198829|FG000|Overall Study|Study Terminated|6
1114474|NCT02521870|2198841|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0
1114475|NCT02521870|2198842|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1
1114476|NCT02521870|2198843|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0
1114477|NCT02521870|2198844|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0
1114478|NCT02521870|2198845|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0
1114479|NCT02521870|2198846|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0
1114480|NCT02521870|2198847|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0
1114481|NCT02521870|2198848|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0
1114482|NCT02521870|2198849|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0
1114483|NCT02521870|2198850|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0
1114484|NCT02521870|2198851|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0
1114485|NCT02521870|2198852|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0
1114486|NCT02521870|2198841|FG000|Phase 1: Dose Escalation|Adverse Event|2
1114487|NCT02521870|2198842|FG001|Phase 1: Dose Escalation|Adverse Event|1
1114488|NCT02521870|2198843|FG002|Phase 1: Dose Escalation|Adverse Event|0
1114489|NCT02521870|2198844|FG003|Phase 1: Dose Escalation|Adverse Event|0
1114490|NCT02521870|2198845|FG004|Phase 1: Dose Escalation|Adverse Event|0
1114491|NCT02521870|2198846|FG005|Phase 1: Dose Escalation|Adverse Event|0
1114492|NCT02521870|2198847|FG006|Phase 1: Dose Escalation|Adverse Event|0
1114493|NCT02521870|2198848|FG007|Phase 1: Dose Escalation|Adverse Event|0
1114494|NCT02521870|2198849|FG008|Phase 1: Dose Escalation|Adverse Event|0
1114495|NCT02521870|2198850|FG009|Phase 1: Dose Escalation|Adverse Event|0
1114496|NCT02521870|2198851|FG010|Phase 1: Dose Escalation|Adverse Event|0
1114497|NCT02521870|2198852|FG011|Phase 1: Dose Escalation|Adverse Event|0
1114498|NCT02521870|2198841|FG000|Phase 1: Dose Escalation|Progressive Disease|3
1114499|NCT02521870|2198842|FG001|Phase 1: Dose Escalation|Progressive Disease|2
1114500|NCT02521870|2198843|FG002|Phase 1: Dose Escalation|Progressive Disease|4
1114501|NCT02521870|2198844|FG003|Phase 1: Dose Escalation|Progressive Disease|6
1114502|NCT02521870|2198845|FG004|Phase 1: Dose Escalation|Progressive Disease|0
1114503|NCT02521870|2198846|FG005|Phase 1: Dose Escalation|Progressive Disease|0
1114504|NCT02521870|2198847|FG006|Phase 1: Dose Escalation|Progressive Disease|0
1114505|NCT02521870|2198848|FG007|Phase 1: Dose Escalation|Progressive Disease|0
1114506|NCT02521870|2198849|FG008|Phase 1: Dose Escalation|Progressive Disease|0
1114507|NCT02521870|2198850|FG009|Phase 1: Dose Escalation|Progressive Disease|0
1114508|NCT02521870|2198851|FG010|Phase 1: Dose Escalation|Progressive Disease|0
1114509|NCT02521870|2198852|FG011|Phase 1: Dose Escalation|Progressive Disease|0
1114510|NCT02521870|2198841|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0
1114511|NCT02521870|2198842|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0
1114512|NCT02521870|2198843|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0
1114513|NCT02521870|2198844|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0
1114514|NCT02521870|2198845|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5
1114515|NCT02521870|2198846|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1
1114516|NCT02521870|2198847|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1
1114517|NCT02521870|2198848|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0
1114518|NCT02521870|2198849|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1
1114519|NCT02521870|2198850|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1
1114520|NCT02521870|2198851|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2
1114521|NCT02521870|2198852|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0
1114522|NCT02521870|2198841|FG000|Phase 2: Dose Expansion|Adverse Event|0
1114523|NCT02521870|2198842|FG001|Phase 2: Dose Expansion|Adverse Event|0
1114524|NCT02521870|2198843|FG002|Phase 2: Dose Expansion|Adverse Event|0
1114525|NCT02521870|2198844|FG003|Phase 2: Dose Expansion|Adverse Event|0
1114526|NCT02521870|2198845|FG004|Phase 2: Dose Expansion|Adverse Event|11
1114527|NCT02521870|2198846|FG005|Phase 2: Dose Expansion|Adverse Event|2
1114528|NCT02521870|2198847|FG006|Phase 2: Dose Expansion|Adverse Event|0
1114529|NCT02521870|2198848|FG007|Phase 2: Dose Expansion|Adverse Event|1
1114530|NCT02521870|2198849|FG008|Phase 2: Dose Expansion|Adverse Event|5
1114531|NCT02521870|2198850|FG009|Phase 2: Dose Expansion|Adverse Event|0
1114532|NCT02521870|2198851|FG010|Phase 2: Dose Expansion|Adverse Event|1
1114533|NCT02521870|2198852|FG011|Phase 2: Dose Expansion|Adverse Event|0
1114534|NCT02521870|2198841|FG000|Phase 2: Dose Expansion|Progressive Disease|0
1114535|NCT02521870|2198842|FG001|Phase 2: Dose Expansion|Progressive Disease|0
1114536|NCT02521870|2198843|FG002|Phase 2: Dose Expansion|Progressive Disease|0
1114537|NCT02521870|2198844|FG003|Phase 2: Dose Expansion|Progressive Disease|0
1114538|NCT02521870|2198845|FG004|Phase 2: Dose Expansion|Progressive Disease|22
1114539|NCT02521870|2198846|FG005|Phase 2: Dose Expansion|Progressive Disease|18
1114540|NCT02521870|2198847|FG006|Phase 2: Dose Expansion|Progressive Disease|17
1114541|NCT02521870|2198848|FG007|Phase 2: Dose Expansion|Progressive Disease|7
1114542|NCT02521870|2198849|FG008|Phase 2: Dose Expansion|Progressive Disease|5
1114543|NCT02521870|2198850|FG009|Phase 2: Dose Expansion|Progressive Disease|17
1114544|NCT02521870|2198851|FG010|Phase 2: Dose Expansion|Progressive Disease|17
1114545|NCT02521870|2198852|FG011|Phase 2: Dose Expansion|Progressive Disease|21
1114546|NCT02521870|2198841|FG000|Phase 2: Dose Expansion|Death|0
1114547|NCT02521870|2198842|FG001|Phase 2: Dose Expansion|Death|0
1114548|NCT02521870|2198843|FG002|Phase 2: Dose Expansion|Death|0
1114549|NCT02521870|2198844|FG003|Phase 2: Dose Expansion|Death|0
1114550|NCT02521870|2198845|FG004|Phase 2: Dose Expansion|Death|1
1114551|NCT02521870|2198846|FG005|Phase 2: Dose Expansion|Death|1
1114552|NCT02521870|2198847|FG006|Phase 2: Dose Expansion|Death|3
1114553|NCT02521870|2198848|FG007|Phase 2: Dose Expansion|Death|1
1114554|NCT02521870|2198849|FG008|Phase 2: Dose Expansion|Death|1
1114555|NCT02521870|2198850|FG009|Phase 2: Dose Expansion|Death|5
1114556|NCT02521870|2198851|FG010|Phase 2: Dose Expansion|Death|2
1114557|NCT02521870|2198852|FG011|Phase 2: Dose Expansion|Death|2
1114558|NCT02521870|2198841|FG000|Phase 2: Dose Expansion|Other|0
1114559|NCT02521870|2198842|FG001|Phase 2: Dose Expansion|Other|0
1114560|NCT02521870|2198843|FG002|Phase 2: Dose Expansion|Other|0
1114561|NCT02521870|2198844|FG003|Phase 2: Dose Expansion|Other|0
1114562|NCT02521870|2198845|FG004|Phase 2: Dose Expansion|Other|10
1114563|NCT02521870|2198846|FG005|Phase 2: Dose Expansion|Other|3
1114564|NCT02521870|2198847|FG006|Phase 2: Dose Expansion|Other|2
1114565|NCT02521870|2198848|FG007|Phase 2: Dose Expansion|Other|0
1114566|NCT02521870|2198849|FG008|Phase 2: Dose Expansion|Other|10
1114567|NCT02521870|2198850|FG009|Phase 2: Dose Expansion|Other|5
1114568|NCT02521870|2198851|FG010|Phase 2: Dose Expansion|Other|1
1114569|NCT02521870|2198852|FG011|Phase 2: Dose Expansion|Other|7
1114570|NCT02521870|2198841|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0
1114571|NCT02521870|2198842|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0
1114572|NCT02521870|2198843|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0
1114573|NCT02521870|2198844|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0
1114574|NCT02521870|2198845|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1
1114575|NCT02521870|2198846|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0
1114576|NCT02521870|2198847|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0
1114577|NCT02521870|2198848|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0
1114578|NCT02521870|2198849|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0
1114579|NCT02521870|2198850|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0
1114580|NCT02521870|2198851|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0
1114581|NCT02521870|2198852|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0
1114582|NCT02521870|2198841|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
1114583|NCT02521870|2198842|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
1114584|NCT02521870|2198843|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
1114585|NCT02521870|2198844|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
1114586|NCT02521870|2198845|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2
1114587|NCT02521870|2198846|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
1114588|NCT02521870|2198847|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
1114589|NCT02521870|2198848|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
1114590|NCT02521870|2198849|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
1114591|NCT02521870|2198850|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
1114592|NCT02521870|2198851|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
1114593|NCT02521870|2198852|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
1114594|NCT02521948|2198882|FG000|Overall Study|Adverse Event|2
1114595|NCT02521948|2198882|FG000|Overall Study|Death|4
1114596|NCT02521948|2198882|FG000|Overall Study|Lost to Follow-up|1
1114597|NCT02521948|2198882|FG000|Overall Study|Did not attend one or both follow-ups|6
1114598|NCT02522286|2198919|FG000|Overall Study|Withdrawal by Subject|3
1114599|NCT02522286|2198920|FG001|Overall Study|Withdrawal by Subject|0
1114600|NCT02522286|2198921|FG002|Overall Study|Withdrawal by Subject|0
1114601|NCT02522286|2198922|FG003|Overall Study|Withdrawal by Subject|3
1114602|NCT02522299|2198934|FG000|Overall Study|Adverse Event|2
1114603|NCT02522299|2198935|FG001|Overall Study|Adverse Event|0
1114604|NCT02522299|2198934|FG000|Overall Study|Physician Decision|0
1114605|NCT02522299|2198935|FG001|Overall Study|Physician Decision|1
1114606|NCT02522299|2198934|FG000|Overall Study|Withdrawal by Subject|2
1114607|NCT02522299|2198935|FG001|Overall Study|Withdrawal by Subject|0
1114608|NCT02522325|2198955|FG000|Overall Study|Adverse Event|0
1114609|NCT02522325|2198956|FG001|Overall Study|Adverse Event|1
1114610|NCT02522377|2198964|FG000|Overall Study|Withdrawal by Subject|1
1114611|NCT02522377|2198965|FG001|Overall Study|Withdrawal by Subject|0
1114612|NCT02522377|2198964|FG000|Overall Study|Remission Achieved|3
1114613|NCT02522377|2198965|FG001|Overall Study|Remission Achieved|0
1114614|NCT02522403|2198973|FG000|Overall Study|Lost to Follow-up|2
1114615|NCT02522403|2198974|FG001|Overall Study|Lost to Follow-up|2
1114616|NCT02522403|2198973|FG000|Overall Study|Withdrawal by Subject|2
1114617|NCT02522403|2198974|FG001|Overall Study|Withdrawal by Subject|4
1114618|NCT02522481|2198989|FG000|Overall Study|discontinued|1
1114619|NCT02522481|2198989|FG000|Overall Study|Not dosed|2
1114620|NCT02522494|2199002|FG000|Overall Study|Lost to Follow-up|6
1114621|NCT02522494|2199003|FG001|Overall Study|Lost to Follow-up|2
1114622|NCT02522494|2199002|FG000|Overall Study|Withdrawal by Subject|1
1114623|NCT02522494|2199003|FG001|Overall Study|Withdrawal by Subject|0
1114624|NCT02522494|2199002|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6
1114625|NCT02522494|2199003|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2
1114626|NCT02522494|2199002|FG000|Overall Study|Participant did not watch the video|1
1114627|NCT02522494|2199003|FG001|Overall Study|Participant did not watch the video|0
1114628|NCT02522494|2199002|FG000|Overall Study|Death|0
1114629|NCT02522494|2199003|FG001|Overall Study|Death|1
1114630|NCT02522624|2199011|FG000|Overall Study|Technical failure|1
1114631|NCT02522624|2199012|FG001|Overall Study|Technical failure|0
1114632|NCT02522728|2199029|FG000|Overall Study|Withdrawal by Subject|6
1114633|NCT02522728|2199030|FG001|Overall Study|Withdrawal by Subject|6
1114634|NCT02522728|2199029|FG000|Overall Study|Death|4
1114635|NCT02522728|2199030|FG001|Overall Study|Death|3
1114636|NCT02522728|2199029|FG000|Overall Study|Adverse Event|2
1114637|NCT02522728|2199030|FG001|Overall Study|Adverse Event|1
1114638|NCT02522728|2199029|FG000|Overall Study|Did not receive randomized study device|0
1114639|NCT02522728|2199030|FG001|Overall Study|Did not receive randomized study device|1
1114640|NCT02522767|2199038|FG000|Double-blind|Withdrawal by Subject|8
1114641|NCT02522767|2199039|FG001|Double-blind|Withdrawal by Subject|11
1114642|NCT02522767|2199038|FG000|Double-blind|Lost to Follow-up|1
1114643|NCT02522767|2199039|FG001|Double-blind|Lost to Follow-up|0
1114644|NCT02522767|2199038|FG000|Double-blind|Adverse Event|1
1114645|NCT02522767|2199039|FG001|Double-blind|Adverse Event|10
1114646|NCT02522767|2199038|FG000|Double-blind|Protocol Violation|0
1114647|NCT02522767|2199039|FG001|Double-blind|Protocol Violation|1
1114648|NCT02522767|2199038|FG000|Double-blind|Lack of Efficacy|0
1114649|NCT02522767|2199039|FG001|Double-blind|Lack of Efficacy|2
1114650|NCT02522767|2199038|FG000|Double-blind|Protocol Deviation|1
1114651|NCT02522767|2199039|FG001|Double-blind|Protocol Deviation|0
1114652|NCT02522767|2199038|FG000|Open-label|Withdrawal by Subject|2
1114653|NCT02522767|2199039|FG001|Open-label|Withdrawal by Subject|3
1114654|NCT02522767|2199038|FG000|Open-label|Lost to Follow-up|0
1114655|NCT02522767|2199039|FG001|Open-label|Lost to Follow-up|1
1114656|NCT02522767|2199038|FG000|Open-label|Adverse Event|2
1114657|NCT02522767|2199039|FG001|Open-label|Adverse Event|1
1114658|NCT02522767|2199038|FG000|Open-label|Lack of Efficacy|1
1114659|NCT02522767|2199039|FG001|Open-label|Lack of Efficacy|1
1114660|NCT02522767|2199038|FG000|Open-label|Protocol Violation|0
1114661|NCT02522767|2199039|FG001|Open-label|Protocol Violation|1
1114662|NCT02522780|2199049|FG000|Overall Study|Consent withdrawn by subject|5
1114663|NCT02522780|2199050|FG001|Overall Study|Consent withdrawn by subject|7
1114664|NCT02522780|2199049|FG000|Overall Study|Protocol deviation|1
1114665|NCT02522780|2199050|FG001|Overall Study|Protocol deviation|3
1114666|NCT02522780|2199049|FG000|Overall Study|Subject refused endoscopic procedure|0
1114667|NCT02522780|2199050|FG001|Overall Study|Subject refused endoscopic procedure|1
1114668|NCT02522780|2199049|FG000|Overall Study|Adverse event, non-fatal|11
1114669|NCT02522780|2199050|FG001|Overall Study|Adverse event, non-fatal|16
1114670|NCT02522884|2199066|FG000|Overall Study|Withdrawal by Subject|6
1114671|NCT02522884|2199066|FG000|Overall Study|Death|3
1114672|NCT02522884|2199066|FG000|Overall Study|Missed 12-month Follow-up|9
1114673|NCT02523599|2199102|FG000|Overall Study|Adverse Event|1
1114674|NCT02523599|2199103|FG001|Overall Study|Adverse Event|0
1114675|NCT02523599|2199102|FG000|Overall Study|Physician Decision|1
1114676|NCT02523599|2199103|FG001|Overall Study|Physician Decision|0
1114677|NCT02523599|2199102|FG000|Overall Study|Lost to Follow-up|4
1114678|NCT02523599|2199103|FG001|Overall Study|Lost to Follow-up|1
1114679|NCT02523599|2199102|FG000|Overall Study|Did not return for Day 30 visit|2
1114680|NCT02523599|2199103|FG001|Overall Study|Did not return for Day 30 visit|0
1114681|NCT02524145|2199152|FG000|Overall Study|Withdrawal by Subject|2
1114682|NCT02524145|2199153|FG001|Overall Study|Withdrawal by Subject|2
1114683|NCT02524145|2199154|FG002|Overall Study|Withdrawal by Subject|3
1114684|NCT02524158|2199164|FG000|12-weeks Assessment|Withdrawal by Subject|1
1114685|NCT02524158|2199165|FG001|12-weeks Assessment|Withdrawal by Subject|1
1114686|NCT02524158|2199164|FG000|12-weeks Assessment|Lost to Follow-up|18
1114687|NCT02524158|2199165|FG001|12-weeks Assessment|Lost to Follow-up|12
1114688|NCT02524158|2199164|FG000|6-month Assessment|Withdrawal by Subject|1
1114689|NCT02524158|2199165|FG001|6-month Assessment|Withdrawal by Subject|1
1114690|NCT02524158|2199164|FG000|6-month Assessment|Lost to Follow-up|21
1114691|NCT02524158|2199165|FG001|6-month Assessment|Lost to Follow-up|20
1114692|NCT02524288|2199174|FG000|Overall Study|Adverse Event|115
1114693|NCT02524288|2199174|FG000|Overall Study|Lost to Follow-up|216
1114694|NCT02524288|2199174|FG000|Overall Study|Non-Compliance With Protocol|32
1114695|NCT02524288|2199174|FG000|Overall Study|Non-Compliance With Study Drug|14
1114696|NCT02524288|2199174|FG000|Overall Study|Pregnancy Wish|6
1114697|NCT02524288|2199174|FG000|Overall Study|Protocol Violation|6
1114698|NCT02524288|2199174|FG000|Overall Study|Screen Failure|2
1114699|NCT02524288|2199174|FG000|Overall Study|Site Discontinued Study Participation|1
1114700|NCT02524288|2199174|FG000|Overall Study|Study Terminated By Sponsor|1417
1114701|NCT02524288|2199174|FG000|Overall Study|Subject Moved|32
1114702|NCT02524288|2199174|FG000|Overall Study|Withdrawal by Subject|76
1114703|NCT02524288|2199174|FG000|Overall Study|Pregnancy|22
1114704|NCT02524288|2199174|FG000|Overall Study|Physician Decision|2
1114705|NCT02524665|2199198|FG000|Overall Study|Lost to Follow-up|1
1114706|NCT02524730|2199203|FG000|Overall Study|Lost to Follow-up|5
1114707|NCT02524730|2199203|FG000|Overall Study|Withdrawal by Subject|18
1114708|NCT02524730|2199203|FG000|Overall Study|Death|10
1114709|NCT02524730|2199203|FG000|Overall Study|Adverse Event|8
1114710|NCT02524730|2199203|FG000|Overall Study|Protocol Violation|1
1114711|NCT02524730|2199203|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4
1114712|NCT02524847|2199211|FG000|Overall Study|Adverse Event|4
1114713|NCT02524847|2199211|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
1114714|NCT02524847|2199211|FG000|Overall Study|Condition no Longer Requires Treatment|4
1114715|NCT02524847|2199211|FG000|Overall Study|Death|1
1114716|NCT02524847|2199211|FG000|Overall Study|Reason not Specified|1
1114717|NCT02525094|2199254|FG000|Overall Study|Lost to Follow-up|2
1114718|NCT02525094|2199255|FG001|Overall Study|Lost to Follow-up|1
1114719|NCT02525094|2199254|FG000|Overall Study|Withdrawal by Subject|5
1114720|NCT02525094|2199255|FG001|Overall Study|Withdrawal by Subject|6
1114721|NCT02525094|2199254|FG000|Overall Study|Not Treated|1
1114722|NCT02525094|2199255|FG001|Overall Study|Not Treated|1
1114723|NCT02525133|2199264|FG000|Overall Study|Adverse Event|0
1114724|NCT02525133|2199265|FG001|Overall Study|Adverse Event|1
1114725|NCT02525133|2199264|FG000|Overall Study|Death|0
1114726|NCT02525133|2199265|FG001|Overall Study|Death|1
1114727|NCT02525133|2199264|FG000|Overall Study|did not meet randomization criteria|1
1114728|NCT02525133|2199265|FG001|Overall Study|did not meet randomization criteria|0
1114729|NCT02525133|2199264|FG000|Overall Study|Lost to Follow-up|5
1114730|NCT02525133|2199265|FG001|Overall Study|Lost to Follow-up|1
1114731|NCT02525133|2199264|FG000|Overall Study|randomized not enrolled|3
1114732|NCT02525133|2199265|FG001|Overall Study|randomized not enrolled|0
1114733|NCT02525133|2199264|FG000|Overall Study|Withdrawal by Subject|1
1114734|NCT02525133|2199265|FG001|Overall Study|Withdrawal by Subject|0
1114735|NCT02525471|2199277|FG000|Overall Study|Screen Failure|6
1114736|NCT02525471|2199277|FG000|Overall Study|Withdrawal by Subject|4
1114737|NCT02525471|2199277|FG000|Overall Study|Death|1
1114738|NCT02525588|2199323|FG000|Overall Study|Death|3
1114739|NCT02525588|2199324|FG001|Overall Study|Death|1
1114740|NCT02525588|2199323|FG000|Overall Study|Lost to Follow-up|2
1114741|NCT02525588|2199324|FG001|Overall Study|Lost to Follow-up|0
1114742|NCT02525588|2199323|FG000|Overall Study|Withdrawal by Subject|1
1114743|NCT02525588|2199324|FG001|Overall Study|Withdrawal by Subject|1
1114744|NCT02525588|2199323|FG000|Overall Study|Adverse Event|0
1114745|NCT02525588|2199324|FG001|Overall Study|Adverse Event|1
1114746|NCT02525627|2199332|FG000|Overall Study|Revision|1
1114747|NCT02525627|2199333|FG001|Overall Study|Revision|1
1114748|NCT02525627|2199332|FG000|Overall Study|Withdrawal by Subject|1
1114749|NCT02525627|2199333|FG001|Overall Study|Withdrawal by Subject|2
1114750|NCT02525627|2199332|FG000|Overall Study|Death|1
1114751|NCT02525627|2199333|FG001|Overall Study|Death|0
1114752|NCT02525627|2199332|FG000|Overall Study|Site terminated|11
1114753|NCT02525627|2199333|FG001|Overall Study|Site terminated|10
1114754|NCT02525744|2199352|FG000|Period 1|Physician Decision|0
1114755|NCT02525744|2199353|FG001|Period 1|Physician Decision|0
1114756|NCT02525744|2199354|FG002|Period 1|Physician Decision|1
1114757|NCT02525744|2199355|FG003|Period 1|Physician Decision|0
1114758|NCT02525744|2199352|FG000|Period 3|Adverse Event|0
1114759|NCT02525744|2199353|FG001|Period 3|Adverse Event|1
1114760|NCT02525744|2199354|FG002|Period 3|Adverse Event|0
1114761|NCT02525744|2199355|FG003|Period 3|Adverse Event|0
1114762|NCT02525744|2199352|FG000|Period 4|Withdrawal by Subject|1
1114763|NCT02525744|2199353|FG001|Period 4|Withdrawal by Subject|0
1114764|NCT02525744|2199354|FG002|Period 4|Withdrawal by Subject|0
1114765|NCT02525744|2199355|FG003|Period 4|Withdrawal by Subject|0
1114766|NCT02525744|2199352|FG000|Period 5|Physician Decision|1
1114767|NCT02525744|2199353|FG001|Period 5|Physician Decision|0
1114768|NCT02525744|2199354|FG002|Period 5|Physician Decision|0
1114769|NCT02525744|2199355|FG003|Period 5|Physician Decision|0
1114770|NCT02525874|2199376|FG000|Overall Study|Other|1
1114771|NCT02525874|2199376|FG000|Overall Study|Investigator Decision|1
1114772|NCT02525874|2199376|FG000|Overall Study|Consent withdrawn|22
1114773|NCT02525874|2199376|FG000|Overall Study|Non-compliance with study drug|3
1114774|NCT02525874|2199376|FG000|Overall Study|Adverse Event|17
1114775|NCT02525874|2199376|FG000|Overall Study|Lost to Follow-up|7
1114776|NCT02525874|2199376|FG000|Overall Study|Disease progression, defined by protocol|2
1114777|NCT02525874|2199376|FG000|Overall Study|Disease relapse|4
1114778|NCT02525874|2199376|FG000|Overall Study|Alternative Treatment for MS|2
1114779|NCT02525874|2199376|FG000|Overall Study|New lesions in Brain|1
1114780|NCT02526160|2199382|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0
1114781|NCT02526160|2199383|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1
1114782|NCT02526160|2199382|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0
1114783|NCT02526160|2199383|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1
1114784|NCT02526160|2199382|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3
1114785|NCT02526160|2199383|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3
896878|NCT00706134|1868601|FG002|Overall Study|Did not meet study criteria|0
896879|NCT00706134|1868602|FG003|Overall Study|Did not meet study criteria|0
896880|NCT00706238|1868612|FG000|Overall Study|Disease progression|4
896881|NCT00706238|1868612|FG000|Overall Study|Other|1
896882|NCT00706342|1868627|FG000|Overall Study|Adverse Event|3
896883|NCT00706342|1868627|FG000|Overall Study|Not responding to treatment|2
896884|NCT00706342|1868627|FG000|Overall Study|Withdrawn due to failure to respond|1
896885|NCT00706342|1868627|FG000|Overall Study|Death|1
896886|NCT00706342|1868627|FG000|Overall Study|Withdrew from the study on his own.|1
896887|NCT00706342|1868627|FG000|Overall Study|Investigator discretion|2
896888|NCT00706342|1868627|FG000|Overall Study|Non-responder Week 12|1
896889|NCT00706342|1868627|FG000|Overall Study|Ongoing|6
896890|NCT00706342|1868627|FG000|Overall Study|WIthdrawal of consent|1
896891|NCT00706355|1868635|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
896892|NCT00706355|1868636|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
896893|NCT00706355|1868637|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
896894|NCT00706355|1868638|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
896895|NCT00706355|1868635|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
896896|NCT00706355|1868636|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
896897|NCT00706355|1868637|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
896898|NCT00706355|1868638|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
896899|NCT00706355|1868635|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
896900|NCT00706355|1868636|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
896901|NCT00706355|1868637|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
896902|NCT00706355|1868638|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
896903|NCT00706355|1868635|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
896904|NCT00706355|1868636|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
896905|NCT00706355|1868637|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
896906|NCT00706355|1868638|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
896907|NCT00706355|1868635|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
896908|NCT00706355|1868636|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
896909|NCT00706355|1868637|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
896910|NCT00706355|1868638|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
896911|NCT00706355|1868635|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0
896912|NCT00706355|1868636|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0
896913|NCT00706355|1868637|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1
896914|NCT00706355|1868638|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0
896915|NCT00706355|1868635|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
896916|NCT00706355|1868636|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
896917|NCT00706355|1868637|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
896918|NCT00706355|1868638|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
1114786|NCT02526160|2199382|FG000|Open-Label Treatment Extension Period I|Death|0
1114787|NCT02526160|2199383|FG001|Open-Label Treatment Extension Period I|Death|1
1114788|NCT02526160|2199382|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3
1114789|NCT02526160|2199383|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1
1114790|NCT02526160|2199382|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0
1114791|NCT02526160|2199383|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1
1114792|NCT02526160|2199382|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0
1114793|NCT02526160|2199383|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1
1114794|NCT02526160|2199382|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1
1114795|NCT02526160|2199383|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0
1114796|NCT02526212|2199396|FG000|Overall Study|Incarceration|1
1114797|NCT02526212|2199397|FG001|Overall Study|Incarceration|0
1114798|NCT02526212|2199396|FG000|Overall Study|Lost to Follow-up|1
1114799|NCT02526212|2199397|FG001|Overall Study|Lost to Follow-up|0
1114800|NCT02526212|2199396|FG000|Overall Study|Death|0
1114801|NCT02526212|2199397|FG001|Overall Study|Death|1
1114802|NCT02526290|2199423|FG000|Overall Study|Adverse Event|3
1114803|NCT02526290|2199423|FG000|Overall Study|Withdrawal by Subject|4
1114804|NCT02526290|2199423|FG000|Overall Study|Physician Decision|1
1114805|NCT02526524|2199433|FG000|Overall Study|Withdrawal by Subject|3
1114806|NCT02526524|2199434|FG001|Overall Study|Withdrawal by Subject|3
1114807|NCT02526524|2199435|FG002|Overall Study|Withdrawal by Subject|6
1114808|NCT02526524|2199436|FG003|Overall Study|Withdrawal by Subject|1
1114809|NCT02526524|2199437|FG004|Overall Study|Withdrawal by Subject|9
1114810|NCT02526524|2199438|FG005|Overall Study|Withdrawal by Subject|5
1114811|NCT02526524|2199433|FG000|Overall Study|Adverse Event|3
1114812|NCT02526524|2199434|FG001|Overall Study|Adverse Event|2
1114813|NCT02526524|2199435|FG002|Overall Study|Adverse Event|4
1114814|NCT02526524|2199436|FG003|Overall Study|Adverse Event|2
1114815|NCT02526524|2199437|FG004|Overall Study|Adverse Event|6
1114816|NCT02526524|2199438|FG005|Overall Study|Adverse Event|8
1114817|NCT02526524|2199433|FG000|Overall Study|Lost to Follow-up|2
1114818|NCT02526524|2199434|FG001|Overall Study|Lost to Follow-up|3
1114819|NCT02526524|2199435|FG002|Overall Study|Lost to Follow-up|8
1114820|NCT02526524|2199436|FG003|Overall Study|Lost to Follow-up|1
1114821|NCT02526524|2199437|FG004|Overall Study|Lost to Follow-up|2
1114822|NCT02526524|2199438|FG005|Overall Study|Lost to Follow-up|5
1114823|NCT02526524|2199433|FG000|Overall Study|Protocol Violation|3
1114824|NCT02526524|2199434|FG001|Overall Study|Protocol Violation|1
1114825|NCT02526524|2199435|FG002|Overall Study|Protocol Violation|5
1114826|NCT02526524|2199436|FG003|Overall Study|Protocol Violation|3
1114827|NCT02526524|2199437|FG004|Overall Study|Protocol Violation|4
1114828|NCT02526524|2199438|FG005|Overall Study|Protocol Violation|3
1114829|NCT02526524|2199433|FG000|Overall Study|Loss of Glucose Control|0
1114830|NCT02526524|2199434|FG001|Overall Study|Loss of Glucose Control|0
1114831|NCT02526524|2199435|FG002|Overall Study|Loss of Glucose Control|3
1114832|NCT02526524|2199436|FG003|Overall Study|Loss of Glucose Control|0
1114833|NCT02526524|2199437|FG004|Overall Study|Loss of Glucose Control|2
1114834|NCT02526524|2199438|FG005|Overall Study|Loss of Glucose Control|0
1114835|NCT02526524|2199433|FG000|Overall Study|Physician Decision|0
1114836|NCT02526524|2199434|FG001|Overall Study|Physician Decision|0
1114837|NCT02526524|2199435|FG002|Overall Study|Physician Decision|0
1114838|NCT02526524|2199436|FG003|Overall Study|Physician Decision|0
1114839|NCT02526524|2199437|FG004|Overall Study|Physician Decision|1
1114840|NCT02526524|2199438|FG005|Overall Study|Physician Decision|0
1114841|NCT02526524|2199433|FG000|Overall Study|Sponsor Decision|1
1114842|NCT02526524|2199434|FG001|Overall Study|Sponsor Decision|0
1114843|NCT02526524|2199435|FG002|Overall Study|Sponsor Decision|0
1114844|NCT02526524|2199436|FG003|Overall Study|Sponsor Decision|0
1114845|NCT02526524|2199437|FG004|Overall Study|Sponsor Decision|0
1114846|NCT02526524|2199438|FG005|Overall Study|Sponsor Decision|0
1114847|NCT02526550|2199452|FG000|Overall Study|Lost to Follow-up|1
1114848|NCT02526693|2199491|FG000|Overall Study|Physician Decision|3
1114849|NCT02526693|2199492|FG001|Overall Study|Physician Decision|1
1114850|NCT02527148|2199504|FG000|Overall Study|Did not receive study intervention|1
1114851|NCT02527148|2199505|FG001|Overall Study|Did not receive study intervention|0
1114852|NCT02527161|2199513|FG000|Overall Study|Failed MRI|52
1114853|NCT02527161|2199513|FG000|Overall Study|Withdrawal by Subject|19
1114854|NCT02527161|2199513|FG000|Overall Study|Delay in or unfit for surgery|16
1114855|NCT02527161|2199513|FG000|Overall Study|MRI contraindication|6
1114856|NCT02527161|2199513|FG000|Overall Study|Consent violation|4
1114857|NCT02527161|2199513|FG000|Overall Study|Only Recruited to Part A|27
1114858|NCT02527161|2199513|FG000|Overall Study|Physician Decision|1
1114859|NCT02527161|2199513|FG000|Overall Study|Adverse Event|1
1114860|NCT02527161|2199513|FG000|Overall Study|Lost to Follow-up|6
1114861|NCT02527343|2199529|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1
1114862|NCT02527343|2199530|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0
1114863|NCT02527343|2199531|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0
1114864|NCT02527343|2199532|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0
1114865|NCT02527343|2199533|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0
1114866|NCT02527343|2199534|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0
1114867|NCT02527343|2199529|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1
1114868|NCT02527343|2199530|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
1114869|NCT02527343|2199531|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
1114870|NCT02527343|2199532|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
1114871|NCT02527343|2199533|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
1114872|NCT02527343|2199534|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
1114873|NCT02527343|2199529|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
1114874|NCT02527343|2199530|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4
896919|NCT00706355|1868635|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0
896920|NCT00706355|1868636|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0
1114875|NCT02527343|2199531|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
1114876|NCT02527343|2199532|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
1114877|NCT02527343|2199533|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
1114878|NCT02527343|2199534|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
1114879|NCT02527343|2199529|FG000|RT Period: Weeks 1 to 52|Other|4
1114880|NCT02527343|2199530|FG001|RT Period: Weeks 1 to 52|Other|3
1114881|NCT02527343|2199531|FG002|RT Period: Weeks 1 to 52|Other|0
1114882|NCT02527343|2199532|FG003|RT Period: Weeks 1 to 52|Other|0
1114883|NCT02527343|2199533|FG004|RT Period: Weeks 1 to 52|Other|0
1114884|NCT02527343|2199534|FG005|RT Period: Weeks 1 to 52|Other|0
1114885|NCT02527343|2199529|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
1114886|NCT02527343|2199530|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
1114887|NCT02527343|2199531|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1
1114888|NCT02527343|2199532|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
1114889|NCT02527343|2199533|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
1114890|NCT02527343|2199534|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
1114891|NCT02527343|2199529|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0
1114892|NCT02527343|2199530|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0
1114893|NCT02527343|2199531|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0
1114894|NCT02527343|2199532|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2
1114895|NCT02527343|2199533|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0
1114896|NCT02527343|2199534|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0
1114897|NCT02527343|2199529|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
1114898|NCT02527343|2199530|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
1114899|NCT02527343|2199531|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
1114900|NCT02527343|2199532|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
1114901|NCT02527343|2199533|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1
1114902|NCT02527343|2199534|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
1114903|NCT02527343|2199529|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
1114904|NCT02527343|2199530|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
1114905|NCT02527343|2199531|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
1114906|NCT02527343|2199532|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
1114907|NCT02527343|2199533|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3
1114908|NCT02527343|2199534|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1
1114909|NCT02527343|2199529|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
1114910|NCT02527343|2199530|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
1114911|NCT02527343|2199531|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
1114912|NCT02527343|2199532|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
1114913|NCT02527343|2199533|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2
1114914|NCT02527343|2199534|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1
1114915|NCT02527343|2199529|FG000|OLE Period-Year 1: Week 53 to 104|Other|0
1114916|NCT02527343|2199530|FG001|OLE Period-Year 1: Week 53 to 104|Other|0
1114917|NCT02527343|2199531|FG002|OLE Period-Year 1: Week 53 to 104|Other|0
1114918|NCT02527343|2199532|FG003|OLE Period-Year 1: Week 53 to 104|Other|0
1114919|NCT02527343|2199533|FG004|OLE Period-Year 1: Week 53 to 104|Other|5
1114920|NCT02527343|2199534|FG005|OLE Period-Year 1: Week 53 to 104|Other|7
1114921|NCT02527343|2199529|FG000|OLE Period-Year 2: Week 105 to 156|Other|0
1114922|NCT02527343|2199530|FG001|OLE Period-Year 2: Week 105 to 156|Other|0
1114923|NCT02527343|2199531|FG002|OLE Period-Year 2: Week 105 to 156|Other|0
1114924|NCT02527343|2199532|FG003|OLE Period-Year 2: Week 105 to 156|Other|0
1114925|NCT02527343|2199533|FG004|OLE Period-Year 2: Week 105 to 156|Other|1
1114926|NCT02527343|2199534|FG005|OLE Period-Year 2: Week 105 to 156|Other|2
1114927|NCT02527343|2199529|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
1114928|NCT02527343|2199530|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
1114929|NCT02527343|2199531|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
1114930|NCT02527343|2199532|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
1114931|NCT02527343|2199533|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1
1114932|NCT02527343|2199534|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
1114933|NCT02527343|2199529|FG000|PT Follow-up: Weeks 104 to 169|Other|0
1114934|NCT02527343|2199530|FG001|PT Follow-up: Weeks 104 to 169|Other|0
1114935|NCT02527343|2199531|FG002|PT Follow-up: Weeks 104 to 169|Other|0
1114936|NCT02527343|2199532|FG003|PT Follow-up: Weeks 104 to 169|Other|0
1114937|NCT02527343|2199533|FG004|PT Follow-up: Weeks 104 to 169|Other|0
1114938|NCT02527343|2199534|FG005|PT Follow-up: Weeks 104 to 169|Other|1
1114939|NCT02527421|2199551|FG000|Overall Study|Withdrawal by Subject|1
1114940|NCT02527421|2199552|FG001|Overall Study|Withdrawal by Subject|0
1114941|NCT02527434|2199561|FG000|Overall Study|Lost to Follow-up|2
1114942|NCT02527434|2199562|FG001|Overall Study|Lost to Follow-up|2
1114943|NCT02527434|2199563|FG002|Overall Study|Lost to Follow-up|0
1114944|NCT02527434|2199561|FG000|Overall Study|Death|19
1114945|NCT02527434|2199562|FG001|Overall Study|Death|6
1114946|NCT02527434|2199563|FG002|Overall Study|Death|17
1114947|NCT02527434|2199561|FG000|Overall Study|Withdrawal by Subject|5
1114948|NCT02527434|2199562|FG001|Overall Study|Withdrawal by Subject|3
1114949|NCT02527434|2199563|FG002|Overall Study|Withdrawal by Subject|3
1114950|NCT02527434|2199561|FG000|Overall Study|Reason Not Specified|1
1114951|NCT02527434|2199562|FG001|Overall Study|Reason Not Specified|0
1114952|NCT02527434|2199563|FG002|Overall Study|Reason Not Specified|0
1114953|NCT02527434|2199561|FG000|Overall Study|Site closure|1
1114954|NCT02527434|2199562|FG001|Overall Study|Site closure|0
1114955|NCT02527434|2199563|FG002|Overall Study|Site closure|0
1114956|NCT02528188|2199612|FG000|Overall Study|Adverse Event|23
1114957|NCT02528188|2199613|FG001|Overall Study|Adverse Event|22
1114958|NCT02528188|2199614|FG002|Overall Study|Adverse Event|8
1114959|NCT02528188|2199612|FG000|Overall Study|Protocol Violation|4
1114960|NCT02528188|2199613|FG001|Overall Study|Protocol Violation|6
1114961|NCT02528188|2199614|FG002|Overall Study|Protocol Violation|4
1114962|NCT02528188|2199612|FG000|Overall Study|Lack of Efficacy|19
1114963|NCT02528188|2199613|FG001|Overall Study|Lack of Efficacy|21
1114964|NCT02528188|2199614|FG002|Overall Study|Lack of Efficacy|22
1114965|NCT02528188|2199612|FG000|Overall Study|Withdrawal by Subject|97
1114966|NCT02528188|2199613|FG001|Overall Study|Withdrawal by Subject|104
1114967|NCT02528188|2199614|FG002|Overall Study|Withdrawal by Subject|100
1114968|NCT02528188|2199612|FG000|Overall Study|Lost to Follow-up|25
1114969|NCT02528188|2199613|FG001|Overall Study|Lost to Follow-up|21
1114970|NCT02528188|2199614|FG002|Overall Study|Lost to Follow-up|31
1114971|NCT02528188|2199612|FG000|Overall Study|Death|4
1114972|NCT02528188|2199613|FG001|Overall Study|Death|4
1114973|NCT02528188|2199614|FG002|Overall Study|Death|0
1114974|NCT02528188|2199612|FG000|Overall Study|Other|89
1114975|NCT02528188|2199613|FG001|Overall Study|Other|91
1114976|NCT02528188|2199614|FG002|Overall Study|Other|74
1114977|NCT02528188|2199612|FG000|Overall Study|Randomized but not treated|6
1114978|NCT02528188|2199613|FG001|Overall Study|Randomized but not treated|7
1114979|NCT02528188|2199614|FG002|Overall Study|Randomized but not treated|12
1114980|NCT02528214|2199624|FG000|Overall Study|Protocol Violation|0
1114981|NCT02528214|2199625|FG001|Overall Study|Protocol Violation|1
1114982|NCT02528214|2199624|FG000|Overall Study|Adverse Event|0
1114983|NCT02528214|2199625|FG001|Overall Study|Adverse Event|1
1114984|NCT02528214|2199624|FG000|Overall Study|Other than specified above|0
1114985|NCT02528214|2199625|FG001|Overall Study|Other than specified above|1
1114986|NCT02528305|2199672|FG000|Overall Study|Withdrawal by Subject|1
1114987|NCT02528305|2199672|FG000|Overall Study|Adverse Event|1
1114988|NCT02528305|2199672|FG000|Overall Study|Physician Decision|1
1114989|NCT02528331|2199699|FG000|Overall Study|Withdrawal by Subject|2
1114990|NCT02528357|2199722|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1114991|NCT02528357|2199723|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1
1114992|NCT02528357|2199724|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1114993|NCT02528357|2199725|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1114994|NCT02528357|2199726|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
896921|NCT00706355|1868637|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0
896922|NCT00706355|1868638|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2
896923|NCT00706355|1868635|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
1114995|NCT02528357|2199727|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1114996|NCT02528357|2199728|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1114997|NCT02528357|2199729|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1114998|NCT02528357|2199730|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1114999|NCT02528357|2199731|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1115000|NCT02528357|2199732|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1115001|NCT02528357|2199733|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1115002|NCT02528357|2199734|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1115003|NCT02528357|2199735|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1115004|NCT02528357|2199736|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1115005|NCT02528357|2199737|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1115006|NCT02528357|2199738|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1115007|NCT02528357|2199739|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1115008|NCT02528357|2199740|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
1115009|NCT02528357|2199722|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115010|NCT02528357|2199723|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115011|NCT02528357|2199724|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115012|NCT02528357|2199725|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
1115013|NCT02528357|2199726|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115014|NCT02528357|2199727|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2
1115015|NCT02528357|2199728|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115016|NCT02528357|2199729|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
1115017|NCT02528357|2199730|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115018|NCT02528357|2199731|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115019|NCT02528357|2199732|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115020|NCT02528357|2199733|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115021|NCT02528357|2199734|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115022|NCT02528357|2199735|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115023|NCT02528357|2199736|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115024|NCT02528357|2199737|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115025|NCT02528357|2199738|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115026|NCT02528357|2199739|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115027|NCT02528357|2199740|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
1115028|NCT02528357|2199722|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115029|NCT02528357|2199723|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115030|NCT02528357|2199724|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
1115031|NCT02528357|2199725|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115032|NCT02528357|2199726|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3
1115033|NCT02528357|2199727|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115034|NCT02528357|2199728|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
1115035|NCT02528357|2199729|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1
1115036|NCT02528357|2199730|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115037|NCT02528357|2199731|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115038|NCT02528357|2199732|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115039|NCT02528357|2199733|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115040|NCT02528357|2199734|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115041|NCT02528357|2199735|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115042|NCT02528357|2199736|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115043|NCT02528357|2199737|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115044|NCT02528357|2199738|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115045|NCT02528357|2199739|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115046|NCT02528357|2199740|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
1115047|NCT02528357|2199722|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115048|NCT02528357|2199723|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115049|NCT02528357|2199724|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115050|NCT02528357|2199725|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115051|NCT02528357|2199726|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1
1115052|NCT02528357|2199727|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115053|NCT02528357|2199728|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115054|NCT02528357|2199729|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115055|NCT02528357|2199730|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115056|NCT02528357|2199731|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115057|NCT02528357|2199732|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115058|NCT02528357|2199733|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115059|NCT02528357|2199734|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115060|NCT02528357|2199735|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115061|NCT02528357|2199736|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115062|NCT02528357|2199737|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115063|NCT02528357|2199738|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115064|NCT02528357|2199739|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115065|NCT02528357|2199740|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115066|NCT02528357|2199722|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115067|NCT02528357|2199723|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115068|NCT02528357|2199724|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115069|NCT02528357|2199725|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115070|NCT02528357|2199726|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115071|NCT02528357|2199727|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115072|NCT02528357|2199728|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115073|NCT02528357|2199729|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115074|NCT02528357|2199730|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115075|NCT02528357|2199731|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115076|NCT02528357|2199732|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115077|NCT02528357|2199733|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115078|NCT02528357|2199734|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115079|NCT02528357|2199735|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1
1115080|NCT02528357|2199736|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5
1115081|NCT02528357|2199737|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115082|NCT02528357|2199738|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115083|NCT02528357|2199739|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115084|NCT02528357|2199740|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
1115085|NCT02528357|2199722|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115086|NCT02528357|2199723|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115087|NCT02528357|2199724|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115088|NCT02528357|2199725|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115089|NCT02528357|2199726|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115090|NCT02528357|2199727|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115091|NCT02528357|2199728|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115092|NCT02528357|2199729|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115093|NCT02528357|2199730|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115094|NCT02528357|2199731|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115095|NCT02528357|2199732|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115096|NCT02528357|2199733|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115097|NCT02528357|2199734|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115098|NCT02528357|2199735|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1
1115099|NCT02528357|2199736|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115100|NCT02528357|2199737|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115101|NCT02528357|2199738|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115102|NCT02528357|2199739|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115103|NCT02528357|2199740|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
1115104|NCT02528357|2199722|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115105|NCT02528357|2199723|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115106|NCT02528357|2199724|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115107|NCT02528357|2199725|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115108|NCT02528357|2199726|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115109|NCT02528357|2199727|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115110|NCT02528357|2199728|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115111|NCT02528357|2199729|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115112|NCT02528357|2199730|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115113|NCT02528357|2199731|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115114|NCT02528357|2199732|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
1115115|NCT02528357|2199733|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115116|NCT02528357|2199734|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
1115117|NCT02528357|2199735|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
1115118|NCT02528357|2199736|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
1115119|NCT02528357|2199737|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115120|NCT02528357|2199738|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115121|NCT02528357|2199739|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115122|NCT02528357|2199740|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
1115123|NCT02528357|2199722|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115124|NCT02528357|2199723|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115125|NCT02528357|2199724|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115126|NCT02528357|2199725|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115127|NCT02528357|2199726|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115128|NCT02528357|2199727|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115129|NCT02528357|2199728|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115130|NCT02528357|2199729|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115131|NCT02528357|2199730|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
1115132|NCT02528357|2199731|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
1115133|NCT02528357|2199732|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115134|NCT02528357|2199733|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3
1115135|NCT02528357|2199734|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4
1115136|NCT02528357|2199735|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
1115137|NCT02528357|2199736|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
1115138|NCT02528357|2199737|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
896924|NCT00706355|1868636|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
896925|NCT00706355|1868637|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
896926|NCT00706355|1868638|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
896927|NCT00706381|1868654|FG000|Overall Study|Lost to Follow-up|0
896928|NCT00706381|1868655|FG001|Overall Study|Lost to Follow-up|1
896929|NCT00706381|1868656|FG002|Overall Study|Lost to Follow-up|1
896930|NCT00706381|1868657|FG003|Overall Study|Lost to Follow-up|0
896931|NCT00706433|1868687|FG000|Overall Study|Lost to Follow-up|3
1115139|NCT02528357|2199738|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115140|NCT02528357|2199739|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115141|NCT02528357|2199740|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115142|NCT02528357|2199722|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115143|NCT02528357|2199723|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115144|NCT02528357|2199724|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115145|NCT02528357|2199725|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115146|NCT02528357|2199726|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115147|NCT02528357|2199727|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115148|NCT02528357|2199728|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115149|NCT02528357|2199729|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115150|NCT02528357|2199730|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115151|NCT02528357|2199731|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115152|NCT02528357|2199732|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115153|NCT02528357|2199733|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115154|NCT02528357|2199734|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115155|NCT02528357|2199735|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115156|NCT02528357|2199736|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115157|NCT02528357|2199737|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115158|NCT02528357|2199738|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2
1115159|NCT02528357|2199739|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115160|NCT02528357|2199740|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
1115161|NCT02528357|2199722|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115162|NCT02528357|2199723|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115163|NCT02528357|2199724|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115164|NCT02528357|2199725|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115165|NCT02528357|2199726|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115166|NCT02528357|2199727|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115167|NCT02528357|2199728|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115168|NCT02528357|2199729|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115169|NCT02528357|2199730|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115170|NCT02528357|2199731|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115171|NCT02528357|2199732|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115172|NCT02528357|2199733|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115173|NCT02528357|2199734|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115174|NCT02528357|2199735|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115175|NCT02528357|2199736|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115176|NCT02528357|2199737|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
1115177|NCT02528357|2199738|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1
1115178|NCT02528357|2199739|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4
1115179|NCT02528357|2199740|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3
1115180|NCT02528643|2199804|FG000|Overall Study|Death|38
1115181|NCT02528643|2199805|FG001|Overall Study|Death|76
1115182|NCT02528643|2199804|FG000|Overall Study|Lost to Follow-up|0
1115183|NCT02528643|2199805|FG001|Overall Study|Lost to Follow-up|1
1115184|NCT02528643|2199804|FG000|Overall Study|Withdrawal by Subject|0
1115185|NCT02528643|2199805|FG001|Overall Study|Withdrawal by Subject|7
1115186|NCT02528643|2199804|FG000|Overall Study|Miscellaneous|0
1115187|NCT02528643|2199805|FG001|Overall Study|Miscellaneous|1
1115188|NCT02528643|2199804|FG000|Overall Study|No End of Study Information Available|1
1115189|NCT02528643|2199805|FG001|Overall Study|No End of Study Information Available|0
1115190|NCT02528942|2199825|FG000|Overall Study|Did not meet imaging criteria|9
1115191|NCT02528942|2199825|FG000|Overall Study|Lost to Follow-up|25
1115192|NCT02529137|2199838|FG000|Overall Study|Discontinuation for different reasons|8
1115193|NCT02529488|2199843|FG000|Overall Study|Adverse Event|1
1115194|NCT02529488|2199843|FG000|Overall Study|Death|3
1115195|NCT02529553|2199860|FG000|Overall Study|Progressive Disease|1
1115196|NCT02529553|2199861|FG001|Overall Study|Progressive Disease|0
1115197|NCT02529553|2199862|FG002|Overall Study|Progressive Disease|1
1115198|NCT02529553|2199863|FG003|Overall Study|Progressive Disease|3
1115199|NCT02529553|2199864|FG004|Overall Study|Progressive Disease|2
896932|NCT00706433|1868688|FG001|Overall Study|Lost to Follow-up|1
1115200|NCT02529553|2199865|FG005|Overall Study|Progressive Disease|3
1115201|NCT02529553|2199866|FG006|Overall Study|Progressive Disease|3
1115202|NCT02529553|2199867|FG007|Overall Study|Progressive Disease|5
1115203|NCT02529553|2199868|FG008|Overall Study|Progressive Disease|3
1115204|NCT02529553|2199860|FG000|Overall Study|Physician Decision|0
1115205|NCT02529553|2199861|FG001|Overall Study|Physician Decision|1
1115206|NCT02529553|2199862|FG002|Overall Study|Physician Decision|0
1115207|NCT02529553|2199863|FG003|Overall Study|Physician Decision|0
1115208|NCT02529553|2199864|FG004|Overall Study|Physician Decision|1
1115209|NCT02529553|2199865|FG005|Overall Study|Physician Decision|0
1115210|NCT02529553|2199866|FG006|Overall Study|Physician Decision|0
1115211|NCT02529553|2199867|FG007|Overall Study|Physician Decision|0
1115212|NCT02529553|2199868|FG008|Overall Study|Physician Decision|0
1115213|NCT02529553|2199860|FG000|Overall Study|Withdrawal by Subject|0
1115214|NCT02529553|2199861|FG001|Overall Study|Withdrawal by Subject|0
1115215|NCT02529553|2199862|FG002|Overall Study|Withdrawal by Subject|0
1115216|NCT02529553|2199863|FG003|Overall Study|Withdrawal by Subject|0
1115217|NCT02529553|2199864|FG004|Overall Study|Withdrawal by Subject|0
1115218|NCT02529553|2199865|FG005|Overall Study|Withdrawal by Subject|1
1115219|NCT02529553|2199866|FG006|Overall Study|Withdrawal by Subject|0
1115220|NCT02529553|2199867|FG007|Overall Study|Withdrawal by Subject|1
1115221|NCT02529553|2199868|FG008|Overall Study|Withdrawal by Subject|0
1115222|NCT02529995|2199891|FG000|Part A|Ongoing Study at Data Cut-off|14
1115223|NCT02529995|2199892|FG001|Part A|Ongoing Study at Data Cut-off|16
1115224|NCT02529995|2199891|FG000|Part A|Discontinued Study|1
1115225|NCT02529995|2199892|FG001|Part A|Discontinued Study|0
1115226|NCT02529995|2199891|FG000|Part B|Ongoing Study at Data Cut-off|0
1115227|NCT02529995|2199892|FG001|Part B|Ongoing Study at Data Cut-off|7
1115228|NCT02529995|2199891|FG000|Part B|Discontinued Study|6
1115229|NCT02529995|2199892|FG001|Part B|Discontinued Study|5
1115230|NCT02530125|2199898|FG000|Completed Treatment|Early termination of study|1
1115231|NCT02530125|2199898|FG000|Followed for Survival for 2 Years|Early termination of study|3
1115232|NCT02530242|2199913|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0
1115233|NCT02530242|2199914|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1
1115234|NCT02530385|2199942|FG000|Overall Study|Withdrawal by Subject|0
1115235|NCT02530385|2199943|FG001|Overall Study|Withdrawal by Subject|1
1115236|NCT02530619|2200033|FG000|Registered for Study|Withdrawal by Subject|2
1115237|NCT02530619|2200033|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2
1115238|NCT02530619|2200033|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2
1115239|NCT02530619|2200033|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4
1115240|NCT02530619|2200033|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2
1115241|NCT02530619|2200033|FG000|Follow-up Period (6 Months)|Death|4
1115242|NCT02530619|2200033|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2
1115243|NCT02530619|2200033|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5
1115244|NCT02530671|2200039|FG000|Overall Study|Lost to Follow-up|2
1115245|NCT02530671|2200040|FG001|Overall Study|Lost to Follow-up|0
1115246|NCT02530671|2200039|FG000|Overall Study|Withdrawal by Subject|1
1115247|NCT02530671|2200040|FG001|Overall Study|Withdrawal by Subject|0
1115248|NCT02530905|2200048|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
1115249|NCT02530905|2200049|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
1115250|NCT02530905|2200050|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1
1115251|NCT02530970|2200072|FG000|Overall Study|Adverse Event|8
1115252|NCT02530970|2200072|FG000|Overall Study|Lost to Follow-up|88
1115253|NCT02530970|2200072|FG000|Overall Study|Physician Decision|5
1115254|NCT02530970|2200072|FG000|Overall Study|Withdrawal by Subject|14
1115255|NCT02530970|2200072|FG000|Overall Study|Death|6
1115256|NCT02530970|2200072|FG000|Overall Study|Hospitalization|1
1115257|NCT02530970|2200072|FG000|Overall Study|Insurance|2
1115258|NCT02530970|2200072|FG000|Overall Study|Explant|2
1115259|NCT02530970|2200072|FG000|Overall Study|Change in Provider|5
1115260|NCT02530970|2200072|FG000|Overall Study|Relocation|3
1115261|NCT02531035|2200098|FG000|Overall Study|Death|0
1115262|NCT02531035|2200099|FG001|Overall Study|Death|1
1115263|NCT02531035|2200098|FG000|Overall Study|Protocol Violation|1
1115264|NCT02531035|2200099|FG001|Overall Study|Protocol Violation|1
1115265|NCT02531035|2200098|FG000|Overall Study|Noncompliance with study drug|8
1115266|NCT02531035|2200099|FG001|Overall Study|Noncompliance with study drug|3
1115267|NCT02531035|2200098|FG000|Overall Study|Physician Decision|1
1115268|NCT02531035|2200099|FG001|Overall Study|Physician Decision|0
1115269|NCT02531035|2200098|FG000|Overall Study|Adverse Event|16
1115270|NCT02531035|2200099|FG001|Overall Study|Adverse Event|45
1115271|NCT02531035|2200098|FG000|Overall Study|Other|3
1115272|NCT02531035|2200099|FG001|Overall Study|Other|2
1115273|NCT02531035|2200098|FG000|Overall Study|Withdrawal by Subject|42
1115274|NCT02531035|2200099|FG001|Overall Study|Withdrawal by Subject|32
1115275|NCT02531035|2200098|FG000|Overall Study|Lost to Follow-up|8
1115276|NCT02531035|2200099|FG001|Overall Study|Lost to Follow-up|10
1115277|NCT02531035|2200098|FG000|Overall Study|Randomized, not treated|2
1115278|NCT02531035|2200099|FG001|Overall Study|Randomized, not treated|1
1115279|NCT02531113|2200105|FG000|Induction Period: Week 0 to 12|Adverse Event|4
1115280|NCT02531113|2200105|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4
1115281|NCT02531113|2200105|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3
1115282|NCT02531113|2200105|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2
1115283|NCT02531113|2200105|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5
1115284|NCT02531113|2200105|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19
1115285|NCT02531113|2200105|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11
1115286|NCT02531113|2200105|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1
1115287|NCT02531373|2200127|FG000|Overall Study|Lack of Efficacy|0
1115288|NCT02531373|2200128|FG001|Overall Study|Lack of Efficacy|0
1115289|NCT02531373|2200129|FG002|Overall Study|Lack of Efficacy|0
1115290|NCT02531373|2200130|FG003|Overall Study|Lack of Efficacy|0
1115291|NCT02531373|2200131|FG004|Overall Study|Lack of Efficacy|3
1115292|NCT02531373|2200132|FG005|Overall Study|Lack of Efficacy|2
1115293|NCT02531373|2200133|FG006|Overall Study|Lack of Efficacy|4
1115294|NCT02531373|2200134|FG007|Overall Study|Lack of Efficacy|8
1115295|NCT02531373|2200135|FG008|Overall Study|Lack of Efficacy|5
1115296|NCT02531373|2200127|FG000|Overall Study|Lost to Follow-up|0
1115297|NCT02531373|2200128|FG001|Overall Study|Lost to Follow-up|0
1115298|NCT02531373|2200129|FG002|Overall Study|Lost to Follow-up|0
1115299|NCT02531373|2200130|FG003|Overall Study|Lost to Follow-up|0
1115300|NCT02531373|2200131|FG004|Overall Study|Lost to Follow-up|0
1115301|NCT02531373|2200132|FG005|Overall Study|Lost to Follow-up|2
1115302|NCT02531373|2200133|FG006|Overall Study|Lost to Follow-up|2
1115303|NCT02531373|2200134|FG007|Overall Study|Lost to Follow-up|0
1115304|NCT02531373|2200135|FG008|Overall Study|Lost to Follow-up|0
1115305|NCT02531373|2200127|FG000|Overall Study|Physician Decision|0
1115306|NCT02531373|2200128|FG001|Overall Study|Physician Decision|0
1115307|NCT02531373|2200129|FG002|Overall Study|Physician Decision|0
1115308|NCT02531373|2200130|FG003|Overall Study|Physician Decision|0
1115309|NCT02531373|2200131|FG004|Overall Study|Physician Decision|2
1115310|NCT02531373|2200132|FG005|Overall Study|Physician Decision|1
1115311|NCT02531373|2200133|FG006|Overall Study|Physician Decision|0
1115312|NCT02531373|2200134|FG007|Overall Study|Physician Decision|0
1115313|NCT02531373|2200135|FG008|Overall Study|Physician Decision|0
1115314|NCT02531373|2200127|FG000|Overall Study|Protocol Violation|0
1115315|NCT02531373|2200128|FG001|Overall Study|Protocol Violation|0
1115316|NCT02531373|2200129|FG002|Overall Study|Protocol Violation|0
1115317|NCT02531373|2200130|FG003|Overall Study|Protocol Violation|0
1115318|NCT02531373|2200131|FG004|Overall Study|Protocol Violation|0
1115319|NCT02531373|2200132|FG005|Overall Study|Protocol Violation|1
1115320|NCT02531373|2200133|FG006|Overall Study|Protocol Violation|1
1115321|NCT02531373|2200134|FG007|Overall Study|Protocol Violation|0
1115322|NCT02531373|2200135|FG008|Overall Study|Protocol Violation|1
1115323|NCT02531373|2200127|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1115324|NCT02531373|2200128|FG001|Overall Study|Withdrawal by Parent/Guardian|0
1115325|NCT02531373|2200129|FG002|Overall Study|Withdrawal by Parent/Guardian|0
1115326|NCT02531373|2200130|FG003|Overall Study|Withdrawal by Parent/Guardian|0
1115327|NCT02531373|2200131|FG004|Overall Study|Withdrawal by Parent/Guardian|0
1115328|NCT02531373|2200132|FG005|Overall Study|Withdrawal by Parent/Guardian|3
1115329|NCT02531373|2200133|FG006|Overall Study|Withdrawal by Parent/Guardian|4
1115330|NCT02531373|2200134|FG007|Overall Study|Withdrawal by Parent/Guardian|1
1115331|NCT02531373|2200135|FG008|Overall Study|Withdrawal by Parent/Guardian|3
1115332|NCT02531373|2200127|FG000|Overall Study|Withdrawal by Subject|0
1115333|NCT02531373|2200128|FG001|Overall Study|Withdrawal by Subject|0
1115334|NCT02531373|2200129|FG002|Overall Study|Withdrawal by Subject|0
1115335|NCT02531373|2200130|FG003|Overall Study|Withdrawal by Subject|0
1115336|NCT02531373|2200131|FG004|Overall Study|Withdrawal by Subject|3
1115337|NCT02531373|2200132|FG005|Overall Study|Withdrawal by Subject|0
1115338|NCT02531373|2200133|FG006|Overall Study|Withdrawal by Subject|0
1115339|NCT02531373|2200134|FG007|Overall Study|Withdrawal by Subject|0
1115340|NCT02531373|2200135|FG008|Overall Study|Withdrawal by Subject|0
1115341|NCT02531438|2200158|FG000|Overall Study|Adverse Event|7
1115342|NCT02531438|2200159|FG001|Overall Study|Adverse Event|9
1115343|NCT02531438|2200158|FG000|Overall Study|Lost to Follow-up|0
1115344|NCT02531438|2200159|FG001|Overall Study|Lost to Follow-up|3
1115345|NCT02531438|2200158|FG000|Overall Study|Withdrawal by Subject|7
1115346|NCT02531438|2200159|FG001|Overall Study|Withdrawal by Subject|8
1115347|NCT02531438|2200158|FG000|Overall Study|Physician Decision|0
1115348|NCT02531438|2200159|FG001|Overall Study|Physician Decision|1
1115349|NCT02531438|2200158|FG000|Overall Study|Death|6
1115350|NCT02531438|2200159|FG001|Overall Study|Death|3
1115351|NCT02531438|2200158|FG000|Overall Study|Randomized, but Not Treated|4
1115352|NCT02531438|2200159|FG001|Overall Study|Randomized, but Not Treated|0
1115353|NCT02531438|2200158|FG000|Overall Study|Missed EOT/PTE Visit|5
1115354|NCT02531438|2200159|FG001|Overall Study|Missed EOT/PTE Visit|2
1115355|NCT02531438|2200158|FG000|Overall Study|Randomized with Exclusion Criteria|1
1115356|NCT02531438|2200159|FG001|Overall Study|Randomized with Exclusion Criteria|0
1115357|NCT02531646|2200222|FG000|Overall Study|equip. image processing issue|5
1115358|NCT02531646|2200223|FG001|Overall Study|equip. image processing issue|1
1115359|NCT02531646|2200224|FG002|Overall Study|equip. image processing issue|0
1115360|NCT02531698|2200234|FG000|Overall Study|Adverse Event|2
1115361|NCT02531698|2200235|FG001|Overall Study|Adverse Event|1
1115362|NCT02531698|2200234|FG000|Overall Study|Withdrawal by Subject|6
1115363|NCT02531698|2200235|FG001|Overall Study|Withdrawal by Subject|1
1115364|NCT02531698|2200234|FG000|Overall Study|Protocol Violation|2
1115365|NCT02531698|2200235|FG001|Overall Study|Protocol Violation|0
1115366|NCT02531698|2200234|FG000|Overall Study|Lost to Follow-up|1
1115367|NCT02531698|2200235|FG001|Overall Study|Lost to Follow-up|0
1115368|NCT02531802|2200271|FG000|Received Vaccination 2|Medication interfering with study taken|0
1115369|NCT02531802|2200272|FG001|Received Vaccination 2|Medication interfering with study taken|0
1115370|NCT02531802|2200273|FG002|Received Vaccination 2|Medication interfering with study taken|1
1115371|NCT02531802|2200274|FG003|Received Vaccination 2|Medication interfering with study taken|0
1115372|NCT02531802|2200275|FG004|Received Vaccination 2|Medication interfering with study taken|0
1115373|NCT02531802|2200276|FG005|Received Vaccination 2|Medication interfering with study taken|0
1115374|NCT02531802|2200277|FG006|Received Vaccination 2|Medication interfering with study taken|0
1115375|NCT02531802|2200278|FG007|Received Vaccination 2|Medication interfering with study taken|0
1115376|NCT02531802|2200279|FG008|Received Vaccination 2|Medication interfering with study taken|0
1115377|NCT02531802|2200280|FG009|Received Vaccination 2|Medication interfering with study taken|1
1115378|NCT02531802|2200281|FG010|Received Vaccination 2|Medication interfering with study taken|1
1115379|NCT02531802|2200282|FG011|Received Vaccination 2|Medication interfering with study taken|0
1115380|NCT02531802|2200283|FG012|Received Vaccination 2|Medication interfering with study taken|1
1115381|NCT02531802|2200284|FG013|Received Vaccination 2|Medication interfering with study taken|0
1115382|NCT02531802|2200285|FG014|Received Vaccination 2|Medication interfering with study taken|0
1115383|NCT02531802|2200286|FG015|Received Vaccination 2|Medication interfering with study taken|0
1115384|NCT02531802|2200287|FG016|Received Vaccination 2|Medication interfering with study taken|0
1115385|NCT02531802|2200288|FG017|Received Vaccination 2|Medication interfering with study taken|0
1115386|NCT02531802|2200289|FG018|Received Vaccination 2|Medication interfering with study taken|1
1115387|NCT02531802|2200290|FG019|Received Vaccination 2|Medication interfering with study taken|0
1115388|NCT02531802|2200291|FG020|Received Vaccination 2|Medication interfering with study taken|0
1115389|NCT02531802|2200271|FG000|Received Vaccination 2|Physician Decision|0
1115390|NCT02531802|2200272|FG001|Received Vaccination 2|Physician Decision|0
1115391|NCT02531802|2200273|FG002|Received Vaccination 2|Physician Decision|0
1115392|NCT02531802|2200274|FG003|Received Vaccination 2|Physician Decision|0
1115393|NCT02531802|2200275|FG004|Received Vaccination 2|Physician Decision|0
1115394|NCT02531802|2200276|FG005|Received Vaccination 2|Physician Decision|1
1115395|NCT02531802|2200277|FG006|Received Vaccination 2|Physician Decision|0
1115396|NCT02531802|2200278|FG007|Received Vaccination 2|Physician Decision|0
1115397|NCT02531802|2200279|FG008|Received Vaccination 2|Physician Decision|0
1115398|NCT02531802|2200280|FG009|Received Vaccination 2|Physician Decision|2
1115399|NCT02531802|2200281|FG010|Received Vaccination 2|Physician Decision|0
1115400|NCT02531802|2200282|FG011|Received Vaccination 2|Physician Decision|0
1115401|NCT02531802|2200283|FG012|Received Vaccination 2|Physician Decision|0
1115402|NCT02531802|2200284|FG013|Received Vaccination 2|Physician Decision|1
1115403|NCT02531802|2200285|FG014|Received Vaccination 2|Physician Decision|0
1115404|NCT02531802|2200286|FG015|Received Vaccination 2|Physician Decision|0
1115405|NCT02531802|2200287|FG016|Received Vaccination 2|Physician Decision|0
1115406|NCT02531802|2200288|FG017|Received Vaccination 2|Physician Decision|1
1115407|NCT02531802|2200289|FG018|Received Vaccination 2|Physician Decision|0
1115408|NCT02531802|2200290|FG019|Received Vaccination 2|Physician Decision|0
1115409|NCT02531802|2200291|FG020|Received Vaccination 2|Physician Decision|0
1115410|NCT02531802|2200271|FG000|Received Vaccination 2|Adverse Event|0
1115411|NCT02531802|2200272|FG001|Received Vaccination 2|Adverse Event|0
1115412|NCT02531802|2200273|FG002|Received Vaccination 2|Adverse Event|0
1115413|NCT02531802|2200274|FG003|Received Vaccination 2|Adverse Event|0
1115414|NCT02531802|2200275|FG004|Received Vaccination 2|Adverse Event|0
1115415|NCT02531802|2200276|FG005|Received Vaccination 2|Adverse Event|2
1115416|NCT02531802|2200277|FG006|Received Vaccination 2|Adverse Event|0
1115417|NCT02531802|2200278|FG007|Received Vaccination 2|Adverse Event|0
1115418|NCT02531802|2200279|FG008|Received Vaccination 2|Adverse Event|0
1115419|NCT02531802|2200280|FG009|Received Vaccination 2|Adverse Event|0
1115420|NCT02531802|2200281|FG010|Received Vaccination 2|Adverse Event|0
1115421|NCT02531802|2200282|FG011|Received Vaccination 2|Adverse Event|0
1115422|NCT02531802|2200283|FG012|Received Vaccination 2|Adverse Event|0
1115423|NCT02531802|2200284|FG013|Received Vaccination 2|Adverse Event|0
1115424|NCT02531802|2200285|FG014|Received Vaccination 2|Adverse Event|0
1115425|NCT02531802|2200286|FG015|Received Vaccination 2|Adverse Event|0
1115426|NCT02531802|2200287|FG016|Received Vaccination 2|Adverse Event|0
1115427|NCT02531802|2200288|FG017|Received Vaccination 2|Adverse Event|2
1115428|NCT02531802|2200289|FG018|Received Vaccination 2|Adverse Event|1
1115429|NCT02531802|2200290|FG019|Received Vaccination 2|Adverse Event|0
1115430|NCT02531802|2200291|FG020|Received Vaccination 2|Adverse Event|1
1115431|NCT02531802|2200271|FG000|Received Vaccination 2|Withdrawal by Subject|0
1115432|NCT02531802|2200272|FG001|Received Vaccination 2|Withdrawal by Subject|0
1115433|NCT02531802|2200273|FG002|Received Vaccination 2|Withdrawal by Subject|0
1115434|NCT02531802|2200274|FG003|Received Vaccination 2|Withdrawal by Subject|0
1115435|NCT02531802|2200275|FG004|Received Vaccination 2|Withdrawal by Subject|0
1115436|NCT02531802|2200276|FG005|Received Vaccination 2|Withdrawal by Subject|0
1115437|NCT02531802|2200277|FG006|Received Vaccination 2|Withdrawal by Subject|0
1115438|NCT02531802|2200278|FG007|Received Vaccination 2|Withdrawal by Subject|0
1115439|NCT02531802|2200279|FG008|Received Vaccination 2|Withdrawal by Subject|0
1115440|NCT02531802|2200280|FG009|Received Vaccination 2|Withdrawal by Subject|0
1115441|NCT02531802|2200281|FG010|Received Vaccination 2|Withdrawal by Subject|1
1115442|NCT02531802|2200282|FG011|Received Vaccination 2|Withdrawal by Subject|0
1115443|NCT02531802|2200283|FG012|Received Vaccination 2|Withdrawal by Subject|1
1115444|NCT02531802|2200284|FG013|Received Vaccination 2|Withdrawal by Subject|1
1115445|NCT02531802|2200285|FG014|Received Vaccination 2|Withdrawal by Subject|1
1115446|NCT02531802|2200286|FG015|Received Vaccination 2|Withdrawal by Subject|0
1115447|NCT02531802|2200287|FG016|Received Vaccination 2|Withdrawal by Subject|0
1115448|NCT02531802|2200288|FG017|Received Vaccination 2|Withdrawal by Subject|1
1115449|NCT02531802|2200289|FG018|Received Vaccination 2|Withdrawal by Subject|1
1115450|NCT02531802|2200290|FG019|Received Vaccination 2|Withdrawal by Subject|1
1115451|NCT02531802|2200291|FG020|Received Vaccination 2|Withdrawal by Subject|0
1115452|NCT02532179|2200392|FG000|Overall Study|Lost to Follow-up|1
1115453|NCT02532179|2200392|FG000|Overall Study|Pregnancy|1
1115454|NCT02532179|2200392|FG000|Overall Study|Subject received depot steroid injection|1
1115455|NCT02532283|2200398|FG000|Overall Study|Adverse Event|0
1115456|NCT02532283|2200399|FG001|Overall Study|Adverse Event|1
1115457|NCT02532283|2200398|FG000|Overall Study|Death|1
1115458|NCT02532283|2200399|FG001|Overall Study|Death|0
1115459|NCT02532283|2200398|FG000|Overall Study|Lost to Follow-up|0
1115460|NCT02532283|2200399|FG001|Overall Study|Lost to Follow-up|1
1115461|NCT02532283|2200398|FG000|Overall Study|Withdrawal by Subject|8
1115462|NCT02532283|2200399|FG001|Overall Study|Withdrawal by Subject|3
1115463|NCT02532374|2200407|FG000|Overall Study|Withdrawal by Subject|1
1115464|NCT02532374|2200407|FG000|Overall Study|Physician Decision|1
1115465|NCT02532465|2200421|FG000|Overall Study|Protocol Violation|1
1115466|NCT02532465|2200422|FG001|Overall Study|Protocol Violation|0
1115467|NCT02532465|2200421|FG000|Overall Study|Lack of Efficacy|0
1115468|NCT02532465|2200422|FG001|Overall Study|Lack of Efficacy|1
1115469|NCT02532517|2200428|FG000|Overall Study|Did not complete 24-Month visit|4
1115470|NCT02532517|2200428|FG000|Overall Study|Failed Angiographic eligibility|1
1115471|NCT02532517|2200428|FG000|Overall Study|Lost to Follow-up|4
1115472|NCT02532517|2200428|FG000|Overall Study|Withdrawal by Subject|4
1115473|NCT02532517|2200428|FG000|Overall Study|Death|4
1115474|NCT02532543|2200436|FG000|Overall Study|Lost to Follow-up|0
1115475|NCT02532543|2200437|FG001|Overall Study|Lost to Follow-up|0
1115476|NCT02532543|2200438|FG002|Overall Study|Lost to Follow-up|1
1115477|NCT02532543|2200439|FG003|Overall Study|Lost to Follow-up|0
1115478|NCT02532647|2200462|FG000|Overall Study|Did not receive trial medication|1
1115479|NCT02532647|2200463|FG001|Overall Study|Did not receive trial medication|0
1115480|NCT02532647|2200464|FG002|Overall Study|Did not receive trial medication|1
1115481|NCT02532764|2200482|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1115482|NCT02532764|2200483|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1115483|NCT02532764|2200484|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1115484|NCT02532764|2200485|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1115485|NCT02532764|2200486|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1115486|NCT02532764|2200487|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1115487|NCT02532764|2200488|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1115488|NCT02532764|2200489|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
1115489|NCT02532764|2200490|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
1115490|NCT02532764|2200491|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
1115491|NCT02532855|2200520|FG000|Overall Study|Lost to Follow-up|4
1115492|NCT02532855|2200521|FG001|Overall Study|Lost to Follow-up|3
1115493|NCT02532855|2200520|FG000|Overall Study|Withdrawal by Subject|4
1115494|NCT02532855|2200521|FG001|Overall Study|Withdrawal by Subject|8
1115495|NCT02532972|2200536|FG000|Overall Study|Withdrawal by Subject|1
1115496|NCT02533180|2200580|FG000|Overall Study|Death|0
1115497|NCT02533180|2200581|FG001|Overall Study|Death|1
1115498|NCT02533180|2200580|FG000|Overall Study|Lost to Follow-up|0
1115499|NCT02533180|2200581|FG001|Overall Study|Lost to Follow-up|1
1115500|NCT02533180|2200580|FG000|Overall Study|Physician Decision|0
1115501|NCT02533180|2200581|FG001|Overall Study|Physician Decision|1
1115502|NCT02533180|2200580|FG000|Overall Study|Withdrawal by Subject|2
1115503|NCT02533180|2200581|FG001|Overall Study|Withdrawal by Subject|4
1115504|NCT02533180|2200580|FG000|Overall Study|Screen Failure|37
1115505|NCT02533180|2200581|FG001|Overall Study|Screen Failure|0
1115506|NCT02533180|2200580|FG000|Overall Study|Protocol Deviation|0
1115507|NCT02533180|2200581|FG001|Overall Study|Protocol Deviation|1
1115508|NCT02533180|2200580|FG000|Overall Study|On Study|0
1115509|NCT02533180|2200581|FG001|Overall Study|On Study|39
1115510|NCT02533258|2200586|FG000|Overall Study|Adverse Event|1
1115511|NCT02533258|2200586|FG000|Overall Study|Death|2
1115512|NCT02533258|2200586|FG000|Overall Study|Other|1
1115513|NCT02533258|2200586|FG000|Overall Study|Economic factor|1
1115514|NCT02533258|2200586|FG000|Overall Study|Progression of pleural effusion|1
1115515|NCT02533258|2200586|FG000|Overall Study|Lack of Efficacy|2
1115516|NCT02533375|2200590|FG000|Overall Study|Lack of Efficacy|3
1115517|NCT02533375|2200590|FG000|Overall Study|Adverse Event|2
1115518|NCT02533401|2200594|FG000|Overall Study|Adverse Event/Intercurrent Disease|3
1115519|NCT02533401|2200594|FG000|Overall Study|Death|5
1115520|NCT02533401|2200594|FG000|Overall Study|Insufficient Response/Progressed Disease|1
1115521|NCT02533401|2200594|FG000|Overall Study|Lost to Follow-up|1
1115522|NCT02533401|2200594|FG000|Overall Study|Violation of Selection Criteria|1
1115523|NCT02533453|2200605|FG000|Overall Study|Adverse Event|6
1115524|NCT02533453|2200605|FG000|Overall Study|Protocol Violation|1
1115525|NCT02533453|2200605|FG000|Overall Study|Withdrawal by Subject|2
1115526|NCT02533570|2200630|FG000|Overall Study|Adverse Event|0
1115527|NCT02533570|2200631|FG001|Overall Study|Adverse Event|1
1115528|NCT02533570|2200632|FG002|Overall Study|Adverse Event|1
1115529|NCT02533674|2200648|FG000|Dose Level I|Progressive disease|1
1115530|NCT02533674|2200649|FG001|Dose Level I|Progressive disease|0
1115531|NCT02533674|2200650|FG002|Dose Level I|Progressive disease|0
1115532|NCT02533674|2200651|FG003|Dose Level I|Progressive disease|0
1115533|NCT02533674|2200652|FG004|Dose Level I|Progressive disease|0
1115534|NCT02533674|2200653|FG005|Dose Level I|Progressive disease|0
1115535|NCT02533674|2200654|FG006|Dose Level I|Progressive disease|0
1115536|NCT02533674|2200655|FG007|Dose Level I|Progressive disease|0
1115537|NCT02533674|2200648|FG000|Dose Level I|Withdrawal by Subject|1
1115538|NCT02533674|2200649|FG001|Dose Level I|Withdrawal by Subject|0
1115539|NCT02533674|2200650|FG002|Dose Level I|Withdrawal by Subject|0
1115540|NCT02533674|2200651|FG003|Dose Level I|Withdrawal by Subject|0
1115541|NCT02533674|2200652|FG004|Dose Level I|Withdrawal by Subject|0
1115542|NCT02533674|2200653|FG005|Dose Level I|Withdrawal by Subject|0
1115543|NCT02533674|2200654|FG006|Dose Level I|Withdrawal by Subject|0
1115544|NCT02533674|2200655|FG007|Dose Level I|Withdrawal by Subject|0
1115545|NCT02533674|2200648|FG000|Dose Level I|Physician Decision|1
1115546|NCT02533674|2200649|FG001|Dose Level I|Physician Decision|0
1115547|NCT02533674|2200650|FG002|Dose Level I|Physician Decision|0
1115548|NCT02533674|2200651|FG003|Dose Level I|Physician Decision|0
1115549|NCT02533674|2200652|FG004|Dose Level I|Physician Decision|0
1115550|NCT02533674|2200653|FG005|Dose Level I|Physician Decision|0
1115551|NCT02533674|2200654|FG006|Dose Level I|Physician Decision|0
1115552|NCT02533674|2200655|FG007|Dose Level I|Physician Decision|0
1115553|NCT02533674|2200648|FG000|Dose Level I|Death|1
1115554|NCT02533674|2200649|FG001|Dose Level I|Death|0
1115555|NCT02533674|2200650|FG002|Dose Level I|Death|0
1115556|NCT02533674|2200651|FG003|Dose Level I|Death|0
1115557|NCT02533674|2200652|FG004|Dose Level I|Death|0
1115558|NCT02533674|2200653|FG005|Dose Level I|Death|0
1115559|NCT02533674|2200654|FG006|Dose Level I|Death|0
1115560|NCT02533674|2200655|FG007|Dose Level I|Death|0
1115561|NCT02533674|2200648|FG000|Dose Level I|Never Treated|1
1115562|NCT02533674|2200649|FG001|Dose Level I|Never Treated|0
1115563|NCT02533674|2200650|FG002|Dose Level I|Never Treated|0
1115564|NCT02533674|2200651|FG003|Dose Level I|Never Treated|0
1115565|NCT02533674|2200652|FG004|Dose Level I|Never Treated|0
1115566|NCT02533674|2200653|FG005|Dose Level I|Never Treated|0
1115567|NCT02533674|2200654|FG006|Dose Level I|Never Treated|0
1115568|NCT02533674|2200655|FG007|Dose Level I|Never Treated|0
1115569|NCT02533674|2200648|FG000|Dose Level II|Progressive disease|0
1115570|NCT02533674|2200649|FG001|Dose Level II|Progressive disease|3
1115571|NCT02533674|2200650|FG002|Dose Level II|Progressive disease|0
1115572|NCT02533674|2200651|FG003|Dose Level II|Progressive disease|0
1115573|NCT02533674|2200652|FG004|Dose Level II|Progressive disease|0
1115574|NCT02533674|2200653|FG005|Dose Level II|Progressive disease|0
1115575|NCT02533674|2200654|FG006|Dose Level II|Progressive disease|0
1115576|NCT02533674|2200655|FG007|Dose Level II|Progressive disease|0
1115577|NCT02533674|2200648|FG000|Dose Level II|Withdrawal by Subject|0
1115578|NCT02533674|2200649|FG001|Dose Level II|Withdrawal by Subject|1
1115579|NCT02533674|2200650|FG002|Dose Level II|Withdrawal by Subject|0
1115580|NCT02533674|2200651|FG003|Dose Level II|Withdrawal by Subject|0
1115581|NCT02533674|2200652|FG004|Dose Level II|Withdrawal by Subject|0
1115582|NCT02533674|2200653|FG005|Dose Level II|Withdrawal by Subject|0
1115583|NCT02533674|2200654|FG006|Dose Level II|Withdrawal by Subject|0
1115584|NCT02533674|2200655|FG007|Dose Level II|Withdrawal by Subject|0
1115585|NCT02533674|2200648|FG000|Dose Level II|Treatment-related AE|0
1115586|NCT02533674|2200649|FG001|Dose Level II|Treatment-related AE|1
1115587|NCT02533674|2200650|FG002|Dose Level II|Treatment-related AE|0
1115588|NCT02533674|2200651|FG003|Dose Level II|Treatment-related AE|0
1115589|NCT02533674|2200652|FG004|Dose Level II|Treatment-related AE|0
1115590|NCT02533674|2200653|FG005|Dose Level II|Treatment-related AE|0
1115591|NCT02533674|2200654|FG006|Dose Level II|Treatment-related AE|0
1115592|NCT02533674|2200655|FG007|Dose Level II|Treatment-related AE|0
1115593|NCT02533674|2200648|FG000|Dose Level II|Physician Decision|0
1115594|NCT02533674|2200649|FG001|Dose Level II|Physician Decision|1
1115595|NCT02533674|2200650|FG002|Dose Level II|Physician Decision|0
1115596|NCT02533674|2200651|FG003|Dose Level II|Physician Decision|0
1115597|NCT02533674|2200652|FG004|Dose Level II|Physician Decision|0
1115598|NCT02533674|2200653|FG005|Dose Level II|Physician Decision|0
1115599|NCT02533674|2200654|FG006|Dose Level II|Physician Decision|0
1115600|NCT02533674|2200655|FG007|Dose Level II|Physician Decision|0
1115601|NCT02533674|2200648|FG000|Dose Level II|Non-treatment-related AE|0
1115602|NCT02533674|2200649|FG001|Dose Level II|Non-treatment-related AE|1
1115603|NCT02533674|2200650|FG002|Dose Level II|Non-treatment-related AE|0
1115604|NCT02533674|2200651|FG003|Dose Level II|Non-treatment-related AE|0
1115605|NCT02533674|2200652|FG004|Dose Level II|Non-treatment-related AE|0
1115606|NCT02533674|2200653|FG005|Dose Level II|Non-treatment-related AE|0
1115607|NCT02533674|2200654|FG006|Dose Level II|Non-treatment-related AE|0
1115608|NCT02533674|2200655|FG007|Dose Level II|Non-treatment-related AE|0
1115609|NCT02533674|2200648|FG000|Dose Level III|Progressive disease|0
1115610|NCT02533674|2200649|FG001|Dose Level III|Progressive disease|0
1115611|NCT02533674|2200650|FG002|Dose Level III|Progressive disease|2
1115612|NCT02533674|2200651|FG003|Dose Level III|Progressive disease|0
1115613|NCT02533674|2200652|FG004|Dose Level III|Progressive disease|0
1115614|NCT02533674|2200653|FG005|Dose Level III|Progressive disease|0
1115615|NCT02533674|2200654|FG006|Dose Level III|Progressive disease|0
1115616|NCT02533674|2200655|FG007|Dose Level III|Progressive disease|0
1115617|NCT02533674|2200648|FG000|Dose Level III|Withdrawal by Subject|0
1115618|NCT02533674|2200649|FG001|Dose Level III|Withdrawal by Subject|0
1115619|NCT02533674|2200650|FG002|Dose Level III|Withdrawal by Subject|1
1115620|NCT02533674|2200651|FG003|Dose Level III|Withdrawal by Subject|0
1115621|NCT02533674|2200652|FG004|Dose Level III|Withdrawal by Subject|0
1115622|NCT02533674|2200653|FG005|Dose Level III|Withdrawal by Subject|0
1115623|NCT02533674|2200654|FG006|Dose Level III|Withdrawal by Subject|0
1115624|NCT02533674|2200655|FG007|Dose Level III|Withdrawal by Subject|0
1115625|NCT02533674|2200648|FG000|Dose Level III|Treatment-related AE|0
1115626|NCT02533674|2200649|FG001|Dose Level III|Treatment-related AE|0
1115627|NCT02533674|2200650|FG002|Dose Level III|Treatment-related AE|1
1115628|NCT02533674|2200651|FG003|Dose Level III|Treatment-related AE|0
1115629|NCT02533674|2200652|FG004|Dose Level III|Treatment-related AE|0
1115630|NCT02533674|2200653|FG005|Dose Level III|Treatment-related AE|0
1115631|NCT02533674|2200654|FG006|Dose Level III|Treatment-related AE|0
1115632|NCT02533674|2200655|FG007|Dose Level III|Treatment-related AE|0
1115633|NCT02533674|2200648|FG000|Dose Level IV|Progressive disease|0
1115634|NCT02533674|2200649|FG001|Dose Level IV|Progressive disease|0
1115635|NCT02533674|2200650|FG002|Dose Level IV|Progressive disease|0
1115636|NCT02533674|2200651|FG003|Dose Level IV|Progressive disease|3
1115637|NCT02533674|2200652|FG004|Dose Level IV|Progressive disease|0
1115638|NCT02533674|2200653|FG005|Dose Level IV|Progressive disease|0
1115639|NCT02533674|2200654|FG006|Dose Level IV|Progressive disease|0
1115640|NCT02533674|2200655|FG007|Dose Level IV|Progressive disease|0
1115641|NCT02533674|2200648|FG000|Dose Level IV|Withdrawal by Subject|0
1115642|NCT02533674|2200649|FG001|Dose Level IV|Withdrawal by Subject|0
1115643|NCT02533674|2200650|FG002|Dose Level IV|Withdrawal by Subject|0
1115644|NCT02533674|2200651|FG003|Dose Level IV|Withdrawal by Subject|1
1115645|NCT02533674|2200652|FG004|Dose Level IV|Withdrawal by Subject|0
1115646|NCT02533674|2200653|FG005|Dose Level IV|Withdrawal by Subject|0
1115647|NCT02533674|2200654|FG006|Dose Level IV|Withdrawal by Subject|0
1115648|NCT02533674|2200655|FG007|Dose Level IV|Withdrawal by Subject|0
1115649|NCT02533674|2200648|FG000|Dose Level IV|Physician Decision|0
1115650|NCT02533674|2200649|FG001|Dose Level IV|Physician Decision|0
1115651|NCT02533674|2200650|FG002|Dose Level IV|Physician Decision|0
1115652|NCT02533674|2200651|FG003|Dose Level IV|Physician Decision|1
1115653|NCT02533674|2200652|FG004|Dose Level IV|Physician Decision|0
1115654|NCT02533674|2200653|FG005|Dose Level IV|Physician Decision|0
1115655|NCT02533674|2200654|FG006|Dose Level IV|Physician Decision|0
1115656|NCT02533674|2200655|FG007|Dose Level IV|Physician Decision|0
1115657|NCT02533674|2200648|FG000|Dose Level V|Progressive disease|0
1115658|NCT02533674|2200649|FG001|Dose Level V|Progressive disease|0
1115659|NCT02533674|2200650|FG002|Dose Level V|Progressive disease|0
1115660|NCT02533674|2200651|FG003|Dose Level V|Progressive disease|0
1115661|NCT02533674|2200652|FG004|Dose Level V|Progressive disease|3
1115662|NCT02533674|2200653|FG005|Dose Level V|Progressive disease|0
1115663|NCT02533674|2200654|FG006|Dose Level V|Progressive disease|0
1115664|NCT02533674|2200655|FG007|Dose Level V|Progressive disease|0
1115665|NCT02533674|2200648|FG000|Dose Level V|Withdrawal by Subject|0
1115666|NCT02533674|2200649|FG001|Dose Level V|Withdrawal by Subject|0
1115667|NCT02533674|2200650|FG002|Dose Level V|Withdrawal by Subject|0
1115668|NCT02533674|2200651|FG003|Dose Level V|Withdrawal by Subject|0
1115669|NCT02533674|2200652|FG004|Dose Level V|Withdrawal by Subject|1
1115670|NCT02533674|2200653|FG005|Dose Level V|Withdrawal by Subject|0
1115671|NCT02533674|2200654|FG006|Dose Level V|Withdrawal by Subject|0
1115672|NCT02533674|2200655|FG007|Dose Level V|Withdrawal by Subject|0
1115673|NCT02533674|2200648|FG000|Dose Level V|Physician Decision|0
1115674|NCT02533674|2200649|FG001|Dose Level V|Physician Decision|0
1115675|NCT02533674|2200650|FG002|Dose Level V|Physician Decision|0
1115676|NCT02533674|2200651|FG003|Dose Level V|Physician Decision|0
1115677|NCT02533674|2200652|FG004|Dose Level V|Physician Decision|1
1115678|NCT02533674|2200653|FG005|Dose Level V|Physician Decision|0
1115679|NCT02533674|2200654|FG006|Dose Level V|Physician Decision|0
1115680|NCT02533674|2200655|FG007|Dose Level V|Physician Decision|0
1115681|NCT02533674|2200648|FG000|Dose Level VI|Progressive disease|0
1115682|NCT02533674|2200649|FG001|Dose Level VI|Progressive disease|0
1115683|NCT02533674|2200650|FG002|Dose Level VI|Progressive disease|0
1115684|NCT02533674|2200651|FG003|Dose Level VI|Progressive disease|0
1115685|NCT02533674|2200652|FG004|Dose Level VI|Progressive disease|0
1115686|NCT02533674|2200653|FG005|Dose Level VI|Progressive disease|7
1115687|NCT02533674|2200654|FG006|Dose Level VI|Progressive disease|0
1115688|NCT02533674|2200655|FG007|Dose Level VI|Progressive disease|0
1115689|NCT02533674|2200648|FG000|Dose Level VI|Withdrawal by Subject|0
1115690|NCT02533674|2200649|FG001|Dose Level VI|Withdrawal by Subject|0
1115691|NCT02533674|2200650|FG002|Dose Level VI|Withdrawal by Subject|0
1115692|NCT02533674|2200651|FG003|Dose Level VI|Withdrawal by Subject|0
1115693|NCT02533674|2200652|FG004|Dose Level VI|Withdrawal by Subject|0
896933|NCT00706433|1868689|FG002|Overall Study|Lost to Follow-up|6
896934|NCT00706433|1868690|FG003|Overall Study|Lost to Follow-up|0
896935|NCT00706433|1868687|FG000|Overall Study|Withdrawal by Subject|1
896936|NCT00706433|1868688|FG001|Overall Study|Withdrawal by Subject|2
896937|NCT00706433|1868689|FG002|Overall Study|Withdrawal by Subject|3
896938|NCT00706433|1868690|FG003|Overall Study|Withdrawal by Subject|1
896939|NCT00706433|1868687|FG000|Overall Study|Adverse Event|0
896940|NCT00706433|1868688|FG001|Overall Study|Adverse Event|0
896941|NCT00706433|1868689|FG002|Overall Study|Adverse Event|1
896942|NCT00706433|1868690|FG003|Overall Study|Adverse Event|0
896943|NCT00706433|1868687|FG000|Overall Study|Protocol Violation|1
896944|NCT00706433|1868688|FG001|Overall Study|Protocol Violation|0
896945|NCT00706433|1868689|FG002|Overall Study|Protocol Violation|0
896946|NCT00706433|1868690|FG003|Overall Study|Protocol Violation|0
1115694|NCT02533674|2200653|FG005|Dose Level VI|Withdrawal by Subject|1
1115695|NCT02533674|2200654|FG006|Dose Level VI|Withdrawal by Subject|0
896947|NCT00706433|1868687|FG000|Overall Study|new job|0
896948|NCT00706433|1868688|FG001|Overall Study|new job|0
896949|NCT00706433|1868689|FG002|Overall Study|new job|0
896950|NCT00706433|1868690|FG003|Overall Study|new job|1
896951|NCT00706511|1868733|FG000|Overall Study|Withdrawal by Subject|1
896952|NCT00706511|1868734|FG001|Overall Study|Withdrawal by Subject|0
896953|NCT00706511|1868735|FG002|Overall Study|Withdrawal by Subject|0
1115696|NCT02533674|2200655|FG007|Dose Level VI|Withdrawal by Subject|0
1115697|NCT02533674|2200648|FG000|Dose Level VI|Treatment-related AE|0
1115698|NCT02533674|2200649|FG001|Dose Level VI|Treatment-related AE|0
1115699|NCT02533674|2200650|FG002|Dose Level VI|Treatment-related AE|0
1115700|NCT02533674|2200651|FG003|Dose Level VI|Treatment-related AE|0
1115701|NCT02533674|2200652|FG004|Dose Level VI|Treatment-related AE|0
1115702|NCT02533674|2200653|FG005|Dose Level VI|Treatment-related AE|1
1115703|NCT02533674|2200654|FG006|Dose Level VI|Treatment-related AE|0
1115704|NCT02533674|2200655|FG007|Dose Level VI|Treatment-related AE|0
1115705|NCT02533674|2200648|FG000|Dose Level VII|Progressive disease|0
1115706|NCT02533674|2200649|FG001|Dose Level VII|Progressive disease|0
1115707|NCT02533674|2200650|FG002|Dose Level VII|Progressive disease|0
1115708|NCT02533674|2200651|FG003|Dose Level VII|Progressive disease|0
1115709|NCT02533674|2200652|FG004|Dose Level VII|Progressive disease|0
1115710|NCT02533674|2200653|FG005|Dose Level VII|Progressive disease|0
1115711|NCT02533674|2200654|FG006|Dose Level VII|Progressive disease|10
1115712|NCT02533674|2200655|FG007|Dose Level VII|Progressive disease|0
1115713|NCT02533674|2200648|FG000|Dose Level VII|Withdrawal by Subject|0
1115714|NCT02533674|2200649|FG001|Dose Level VII|Withdrawal by Subject|0
1115715|NCT02533674|2200650|FG002|Dose Level VII|Withdrawal by Subject|0
1115716|NCT02533674|2200651|FG003|Dose Level VII|Withdrawal by Subject|0
1115717|NCT02533674|2200652|FG004|Dose Level VII|Withdrawal by Subject|0
1115718|NCT02533674|2200653|FG005|Dose Level VII|Withdrawal by Subject|0
1115719|NCT02533674|2200654|FG006|Dose Level VII|Withdrawal by Subject|3
1115720|NCT02533674|2200655|FG007|Dose Level VII|Withdrawal by Subject|0
1115721|NCT02533674|2200648|FG000|Dose Level VII|Treatment-related AE|0
1115722|NCT02533674|2200649|FG001|Dose Level VII|Treatment-related AE|0
1115723|NCT02533674|2200650|FG002|Dose Level VII|Treatment-related AE|0
1115724|NCT02533674|2200651|FG003|Dose Level VII|Treatment-related AE|0
1115725|NCT02533674|2200652|FG004|Dose Level VII|Treatment-related AE|0
1115726|NCT02533674|2200653|FG005|Dose Level VII|Treatment-related AE|0
1115727|NCT02533674|2200654|FG006|Dose Level VII|Treatment-related AE|1
1115728|NCT02533674|2200655|FG007|Dose Level VII|Treatment-related AE|0
1115729|NCT02533674|2200648|FG000|Dose Level VII|Death|0
1115730|NCT02533674|2200649|FG001|Dose Level VII|Death|0
1115731|NCT02533674|2200650|FG002|Dose Level VII|Death|0
1115732|NCT02533674|2200651|FG003|Dose Level VII|Death|0
1115733|NCT02533674|2200652|FG004|Dose Level VII|Death|0
1115734|NCT02533674|2200653|FG005|Dose Level VII|Death|0
1115735|NCT02533674|2200654|FG006|Dose Level VII|Death|2
1115736|NCT02533674|2200655|FG007|Dose Level VII|Death|0
1115737|NCT02533674|2200648|FG000|Dose Level VIII|Progressive disease|0
1115738|NCT02533674|2200649|FG001|Dose Level VIII|Progressive disease|0
1115739|NCT02533674|2200650|FG002|Dose Level VIII|Progressive disease|0
1115740|NCT02533674|2200651|FG003|Dose Level VIII|Progressive disease|0
1115741|NCT02533674|2200652|FG004|Dose Level VIII|Progressive disease|0
1115742|NCT02533674|2200653|FG005|Dose Level VIII|Progressive disease|0
1115743|NCT02533674|2200654|FG006|Dose Level VIII|Progressive disease|0
1115744|NCT02533674|2200655|FG007|Dose Level VIII|Progressive disease|3
1115745|NCT02533674|2200648|FG000|Dose Level VIII|Withdrawal by Subject|0
1115746|NCT02533674|2200649|FG001|Dose Level VIII|Withdrawal by Subject|0
1115747|NCT02533674|2200650|FG002|Dose Level VIII|Withdrawal by Subject|0
1115748|NCT02533674|2200651|FG003|Dose Level VIII|Withdrawal by Subject|0
1115749|NCT02533674|2200652|FG004|Dose Level VIII|Withdrawal by Subject|0
1115750|NCT02533674|2200653|FG005|Dose Level VIII|Withdrawal by Subject|0
1115751|NCT02533674|2200654|FG006|Dose Level VIII|Withdrawal by Subject|0
1115752|NCT02533674|2200655|FG007|Dose Level VIII|Withdrawal by Subject|1
1115753|NCT02533674|2200648|FG000|Dose Level VIII|Treatment-related AE|0
1115754|NCT02533674|2200649|FG001|Dose Level VIII|Treatment-related AE|0
1115755|NCT02533674|2200650|FG002|Dose Level VIII|Treatment-related AE|0
1115756|NCT02533674|2200651|FG003|Dose Level VIII|Treatment-related AE|0
1115757|NCT02533674|2200652|FG004|Dose Level VIII|Treatment-related AE|0
1115758|NCT02533674|2200653|FG005|Dose Level VIII|Treatment-related AE|0
1115759|NCT02533674|2200654|FG006|Dose Level VIII|Treatment-related AE|0
1115760|NCT02533674|2200655|FG007|Dose Level VIII|Treatment-related AE|1
1115761|NCT02533674|2200648|FG000|Dose Level VIII|Never treated|0
1115762|NCT02533674|2200649|FG001|Dose Level VIII|Never treated|0
1115763|NCT02533674|2200650|FG002|Dose Level VIII|Never treated|0
1115764|NCT02533674|2200651|FG003|Dose Level VIII|Never treated|0
1115765|NCT02533674|2200652|FG004|Dose Level VIII|Never treated|0
1115766|NCT02533674|2200653|FG005|Dose Level VIII|Never treated|0
1115767|NCT02533674|2200654|FG006|Dose Level VIII|Never treated|0
1115768|NCT02533674|2200655|FG007|Dose Level VIII|Never treated|1
1115769|NCT02533999|2200702|FG000|Overall Study|Lost to Follow-up|3
1115770|NCT02533999|2200703|FG001|Overall Study|Lost to Follow-up|5
1115771|NCT02533999|2200702|FG000|Overall Study|Protocol Violation|3
1115772|NCT02533999|2200703|FG001|Overall Study|Protocol Violation|0
1115773|NCT02533999|2200702|FG000|Overall Study|Adverse Event|0
1115774|NCT02533999|2200703|FG001|Overall Study|Adverse Event|1
1115775|NCT02533999|2200702|FG000|Overall Study|Randomized but intervention not received|0
1115776|NCT02533999|2200703|FG001|Overall Study|Randomized but intervention not received|1
1115777|NCT02534324|2200727|FG000|Overall Study|Protocol Violation|4
1115778|NCT02534324|2200728|FG001|Overall Study|Protocol Violation|1
1115779|NCT02534324|2200727|FG000|Overall Study|Lost to Follow-up|20
1115780|NCT02534324|2200728|FG001|Overall Study|Lost to Follow-up|7
1115781|NCT02534324|2200727|FG000|Overall Study|Adverse Event|1
1115782|NCT02534324|2200728|FG001|Overall Study|Adverse Event|0
1115783|NCT02534350|2200736|FG000|Overall Study|Randomized But Not Treated|1
1115784|NCT02534350|2200737|FG001|Overall Study|Randomized But Not Treated|0
1115785|NCT02534350|2200736|FG000|Overall Study|Protocol Violation|1
1115786|NCT02534350|2200737|FG001|Overall Study|Protocol Violation|0
1115787|NCT02534350|2200736|FG000|Overall Study|Withdrew Consent|2
1115788|NCT02534350|2200737|FG001|Overall Study|Withdrew Consent|0
1115789|NCT02534493|2200743|FG000|Overall Study|Lost to Follow-up|1
1115790|NCT02534493|2200743|FG000|Overall Study|Withdrawal by Subject|1
1115791|NCT02534883|2200751|FG000|Overall Study|Early Termination|8
1115792|NCT02534883|2200752|FG001|Overall Study|Early Termination|3
1115793|NCT02534896|2200761|FG000|Overall Study|Adverse Event|2
1115794|NCT02534896|2200762|FG001|Overall Study|Adverse Event|1
1115795|NCT02534896|2200763|FG002|Overall Study|Adverse Event|1
1115796|NCT02534896|2200761|FG000|Overall Study|Insufficient therapeutic response|2
1115797|NCT02534896|2200762|FG001|Overall Study|Insufficient therapeutic response|0
1115798|NCT02534896|2200763|FG002|Overall Study|Insufficient therapeutic response|0
1115799|NCT02534935|2200774|FG000|Stage 1: 24 Months|Withdrawal by Subject|0
1115800|NCT02534935|2200775|FG001|Stage 1: 24 Months|Withdrawal by Subject|3
1115801|NCT02534935|2200776|FG002|Stage 1: 24 Months|Withdrawal by Subject|3
1115802|NCT02534935|2200774|FG000|Stage 1: 24 Months|No longer willing to participate in study|0
1115803|NCT02534935|2200775|FG001|Stage 1: 24 Months|No longer willing to participate in study|1
1115804|NCT02534935|2200776|FG002|Stage 1: 24 Months|No longer willing to participate in study|1
1115805|NCT02534935|2200774|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0
1115806|NCT02534935|2200775|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3
1115807|NCT02534935|2200776|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0
1115808|NCT02534935|2200774|FG000|Stage 1: 24 Months|Lost to Follow-up|0
1115809|NCT02534935|2200775|FG001|Stage 1: 24 Months|Lost to Follow-up|1
1115810|NCT02534935|2200776|FG002|Stage 1: 24 Months|Lost to Follow-up|1
1115811|NCT02534935|2200774|FG000|Stage 1: 24 Months|Adverse Event|0
1115812|NCT02534935|2200775|FG001|Stage 1: 24 Months|Adverse Event|2
1115813|NCT02534935|2200776|FG002|Stage 1: 24 Months|Adverse Event|0
1115814|NCT02534935|2200774|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0
1115815|NCT02534935|2200775|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4
1115816|NCT02534935|2200776|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0
1115817|NCT02534935|2200774|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
1115818|NCT02534935|2200775|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1
1115819|NCT02534935|2200776|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
1115820|NCT02535000|2200804|FG000|Overall Study|Cancellation of surgery.|1
1115821|NCT02535000|2200805|FG001|Overall Study|Cancellation of surgery.|2
1115822|NCT02535364|2200829|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
1115823|NCT02535364|2200829|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
1115824|NCT02535364|2200829|FG000|Part A Screening Through Leukapheresis|Disease progression|1
1115825|NCT02535364|2200829|FG000|Part B Screening|Study placed on clinical hold by FDA|7
1115826|NCT02535364|2200829|FG000|Part B Screening|Unable to manufacture JCAR015|3
1115827|NCT02535364|2200829|FG000|Part B Screening|Death|2
1115828|NCT02535364|2200829|FG000|Part B Screening|Physician Decision|1
1115829|NCT02535364|2200829|FG000|Part B Screening|Withdrawal by Subject|1
1115830|NCT02535364|2200829|FG000|Part B Screening|Adverse Event|1
1115831|NCT02535364|2200829|FG000|Part B Screening|Change in diagnosis, no longer eligible|2
1115832|NCT02535364|2200829|FG000|Study Treatment|Death|1
1115833|NCT02535364|2200829|FG000|Study Treatment|Study placed on clinical hold by FDA|1
1115834|NCT02535364|2200829|FG000|12-Month Follow-up Period|Disease progression|22
1115835|NCT02535364|2200829|FG000|12-Month Follow-up Period|Death|5
1115836|NCT02535364|2200829|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5
1115837|NCT02535364|2200829|FG000|12-Month Follow-up Period|Subject received alternative therapy|2
1115838|NCT02535364|2200829|FG000|12-Month Follow-up Period|Subject transferred to hospice|1
1115839|NCT02535416|2200842|FG000|Overall Study|Family bereavement overseas|1
1115840|NCT02535416|2200843|FG001|Overall Study|Family bereavement overseas|0
1115841|NCT02535416|2200844|FG002|Overall Study|Family bereavement overseas|0
1115842|NCT02535416|2200845|FG003|Overall Study|Family bereavement overseas|0
1115843|NCT02535416|2200846|FG004|Overall Study|Family bereavement overseas|0
1115844|NCT02535416|2200847|FG005|Overall Study|Family bereavement overseas|0
1115845|NCT02535416|2200848|FG006|Overall Study|Family bereavement overseas|0
1115846|NCT02535416|2200849|FG007|Overall Study|Family bereavement overseas|0
1115847|NCT02535416|2200850|FG008|Overall Study|Family bereavement overseas|0
1115848|NCT02535715|2200902|FG000|Overall Study|Withdrawal by Subject|0
1115849|NCT02535715|2200903|FG001|Overall Study|Withdrawal by Subject|0
1115850|NCT02535715|2200904|FG002|Overall Study|Withdrawal by Subject|1
1115851|NCT02535741|2200915|FG000|Overall Study|Adverse Event|3
1115852|NCT02535741|2200915|FG000|Overall Study|Withdrawal by Subject|9
1115853|NCT02535741|2200915|FG000|Overall Study|Lost to Follow-up|10
1115854|NCT02535741|2200915|FG000|Overall Study|Exclusion criteria: Bilateral implant|4
1115855|NCT02535741|2200915|FG000|Overall Study|Missing data|6
1115856|NCT02536313|2200980|FG000|Overall Study|Lack of Efficacy|0
1115857|NCT02536313|2200981|FG001|Overall Study|Lack of Efficacy|1
1115863|NCT02536378|2200995|FG000|Overall Study|Physician Decision|0
1115864|NCT02536378|2200996|FG001|Overall Study|Physician Decision|2
1115865|NCT02536378|2200995|FG000|Overall Study|Withdrawal by Subject|0
1115866|NCT02536378|2200996|FG001|Overall Study|Withdrawal by Subject|1
1115867|NCT02536378|2200995|FG000|Overall Study|Death|1
1115868|NCT02536378|2200996|FG001|Overall Study|Death|2
1115869|NCT02536378|2200995|FG000|Overall Study|Patient refused further follow up|6
1115870|NCT02536378|2200996|FG001|Overall Study|Patient refused further follow up|2
1115871|NCT02536404|2201006|FG000|Overall Study|Adverse Event|5
1115872|NCT02536404|2201007|FG001|Overall Study|Adverse Event|0
1115873|NCT02536404|2201006|FG000|Overall Study|Withdrawal by Subject|4
1115874|NCT02536404|2201007|FG001|Overall Study|Withdrawal by Subject|1
1115875|NCT02536404|2201006|FG000|Overall Study|Physician Decision|10
1115876|NCT02536404|2201007|FG001|Overall Study|Physician Decision|0
1115877|NCT02536404|2201006|FG000|Overall Study|Sponsor decision|1
1115878|NCT02536404|2201007|FG001|Overall Study|Sponsor decision|0
1115879|NCT02536508|2201016|FG000|Overall Study|Withdrawal by Subject|18
1115880|NCT02536508|2201017|FG001|Overall Study|Withdrawal by Subject|13
1115881|NCT02536508|2201018|FG002|Overall Study|Withdrawal by Subject|7
1115882|NCT02536508|2201016|FG000|Overall Study|Adverse Event|14
1115883|NCT02536508|2201017|FG001|Overall Study|Adverse Event|13
1115884|NCT02536508|2201018|FG002|Overall Study|Adverse Event|6
1115885|NCT02536508|2201016|FG000|Overall Study|Lost to Follow-up|12
1115886|NCT02536508|2201017|FG001|Overall Study|Lost to Follow-up|4
1115887|NCT02536508|2201018|FG002|Overall Study|Lost to Follow-up|0
1115888|NCT02536508|2201016|FG000|Overall Study|Lack of Efficacy|3
1115889|NCT02536508|2201017|FG001|Overall Study|Lack of Efficacy|5
1115890|NCT02536508|2201018|FG002|Overall Study|Lack of Efficacy|4
1115891|NCT02536508|2201016|FG000|Overall Study|Protocol Discontinuation Criteria|3
1115892|NCT02536508|2201017|FG001|Overall Study|Protocol Discontinuation Criteria|2
1115893|NCT02536508|2201018|FG002|Overall Study|Protocol Discontinuation Criteria|2
1115894|NCT02536508|2201016|FG000|Overall Study|Physician Decision|0
1115895|NCT02536508|2201017|FG001|Overall Study|Physician Decision|4
1115896|NCT02536508|2201018|FG002|Overall Study|Physician Decision|2
1115897|NCT02536508|2201016|FG000|Overall Study|Major Protocol Deviation|2
1115898|NCT02536508|2201017|FG001|Overall Study|Major Protocol Deviation|2
1115899|NCT02536508|2201018|FG002|Overall Study|Major Protocol Deviation|2
1115900|NCT02536508|2201016|FG000|Overall Study|Administrative Reasons|0
1115901|NCT02536508|2201017|FG001|Overall Study|Administrative Reasons|1
1115902|NCT02536508|2201018|FG002|Overall Study|Administrative Reasons|0
1115903|NCT02536664|2201028|FG000|Overall Study|Inadequate completion of documentation|2
1115904|NCT02536664|2201029|FG001|Overall Study|Inadequate completion of documentation|4
1115905|NCT02536664|2201028|FG000|Overall Study|Progression|13
1115906|NCT02536664|2201029|FG001|Overall Study|Progression|18
1115907|NCT02536664|2201028|FG000|Overall Study|Death due to lymphoma|2
1115908|NCT02536664|2201029|FG001|Overall Study|Death due to lymphoma|1
1115909|NCT02536664|2201028|FG000|Overall Study|Death due to other reason|3
1115910|NCT02536664|2201029|FG001|Overall Study|Death due to other reason|2
1115911|NCT02536664|2201028|FG000|Overall Study|Intolerability|8
1115912|NCT02536664|2201029|FG001|Overall Study|Intolerability|6
1115913|NCT02536664|2201028|FG000|Overall Study|Withdrawal by Subject|8
1115914|NCT02536664|2201029|FG001|Overall Study|Withdrawal by Subject|5
1115915|NCT02536664|2201028|FG000|Overall Study|Other|18
1115916|NCT02536664|2201029|FG001|Overall Study|Other|24
1115917|NCT02536664|2201028|FG000|Overall Study|Missing|53
1115918|NCT02536664|2201029|FG001|Overall Study|Missing|20
1115919|NCT02536781|2201037|FG000|Overall Study|Lost to Follow-up|2
1115920|NCT02536781|2201038|FG001|Overall Study|Lost to Follow-up|0
1115921|NCT02536794|2201044|FG000|Reached 1st Response Assessment|Adverse Event|2
1115922|NCT02536794|2201044|FG000|Reached 1st Response Assessment|Progressive Disease|2
1115923|NCT02536794|2201044|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1
1115924|NCT02536794|2201044|FG000|Reached 1st Response Assessment|Protocol Violation|1
1115925|NCT02536794|2201044|FG000|Continued Treatment After 1st Response|Progressive disease|7
1115926|NCT02536794|2201044|FG000|Continued Treatment After 1st Response|Adverse Event|1
1115927|NCT02536833|2201052|FG000|Overall Study|Discontinued Before Treatment|0
1115928|NCT02536833|2201053|FG001|Overall Study|Discontinued Before Treatment|0
1115929|NCT02536833|2201054|FG002|Overall Study|Discontinued Before Treatment|1
1115930|NCT02536833|2201055|FG003|Overall Study|Discontinued Before Treatment|2
1115931|NCT02536833|2201052|FG000|Overall Study|Adverse Event|1
1115932|NCT02536833|2201053|FG001|Overall Study|Adverse Event|3
1115933|NCT02536833|2201054|FG002|Overall Study|Adverse Event|4
1115934|NCT02536833|2201055|FG003|Overall Study|Adverse Event|1
1115935|NCT02536833|2201052|FG000|Overall Study|Lost to Follow-up|2
1115936|NCT02536833|2201053|FG001|Overall Study|Lost to Follow-up|1
1115937|NCT02536833|2201054|FG002|Overall Study|Lost to Follow-up|2
1115938|NCT02536833|2201055|FG003|Overall Study|Lost to Follow-up|2
1115939|NCT02536833|2201052|FG000|Overall Study|Physician Decision|0
1115940|NCT02536833|2201053|FG001|Overall Study|Physician Decision|0
1115941|NCT02536833|2201054|FG002|Overall Study|Physician Decision|0
1115942|NCT02536833|2201055|FG003|Overall Study|Physician Decision|1
1115943|NCT02536833|2201052|FG000|Overall Study|Site Terminated by Sponsor|2
1115944|NCT02536833|2201053|FG001|Overall Study|Site Terminated by Sponsor|2
1115945|NCT02536833|2201054|FG002|Overall Study|Site Terminated by Sponsor|2
1115946|NCT02536833|2201055|FG003|Overall Study|Site Terminated by Sponsor|2
1115947|NCT02536833|2201052|FG000|Overall Study|Subject Non-Compliance|0
1115948|NCT02536833|2201053|FG001|Overall Study|Subject Non-Compliance|1
1115949|NCT02536833|2201054|FG002|Overall Study|Subject Non-Compliance|1
1115950|NCT02536833|2201055|FG003|Overall Study|Subject Non-Compliance|0
1115951|NCT02536833|2201052|FG000|Overall Study|Withdrawal by Subject|4
1115952|NCT02536833|2201053|FG001|Overall Study|Withdrawal by Subject|3
1115953|NCT02536833|2201054|FG002|Overall Study|Withdrawal by Subject|5
1115954|NCT02536833|2201055|FG003|Overall Study|Withdrawal by Subject|11
1115955|NCT02536846|2201066|FG000|Overall Study|Withdrawal by Subject|1
1115956|NCT02536963|2201071|FG000|Overall Study|Withdrawal by Subject|18
1115957|NCT02536976|2201077|FG000|Overall Study|Physician Decision|0
1115958|NCT02536976|2201078|FG001|Overall Study|Physician Decision|1
1115959|NCT02537015|2201086|FG000|Overall Study|Adverse Event|3
1115960|NCT02537015|2201086|FG000|Overall Study|Withdrawal by Subject|2
1115961|NCT02537015|2201086|FG000|Overall Study|Other Miscellaneous Reasons|1
1115962|NCT02537431|2201090|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
1115963|NCT02537522|2201103|FG000|Phase I - Contralateral|Subject no longer eligible|15
1115964|NCT02537522|2201104|FG001|Phase I - Contralateral|Subject no longer eligible|7
1115965|NCT02537522|2201105|FG002|Phase I - Contralateral|Subject no longer eligible|0
1115966|NCT02537522|2201106|FG003|Phase I - Contralateral|Subject no longer eligible|0
1115967|NCT02537522|2201103|FG000|Phase I - Contralateral|Withdrawal by Subject|0
1115968|NCT02537522|2201104|FG001|Phase I - Contralateral|Withdrawal by Subject|1
1115969|NCT02537522|2201105|FG002|Phase I - Contralateral|Withdrawal by Subject|0
1115970|NCT02537522|2201106|FG003|Phase I - Contralateral|Withdrawal by Subject|0
1115971|NCT02537522|2201103|FG000|Phase I - Contralateral|incorrect randomization|0
1115972|NCT02537522|2201104|FG001|Phase I - Contralateral|incorrect randomization|1
1115973|NCT02537522|2201105|FG002|Phase I - Contralateral|incorrect randomization|0
1115974|NCT02537522|2201106|FG003|Phase I - Contralateral|incorrect randomization|0
1115975|NCT02537522|2201103|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0
1115976|NCT02537522|2201104|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1
1115977|NCT02537522|2201105|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0
1115978|NCT02537522|2201106|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0
1115979|NCT02537522|2201103|FG000|Phase II - Period 1 Bilateral|Adverse Event|0
1115980|NCT02537522|2201104|FG001|Phase II - Period 1 Bilateral|Adverse Event|0
1115981|NCT02537522|2201105|FG002|Phase II - Period 1 Bilateral|Adverse Event|0
1115982|NCT02537522|2201106|FG003|Phase II - Period 1 Bilateral|Adverse Event|1
1115983|NCT02537574|2201115|FG000|Overall Study|Adverse Event|1
1115984|NCT02537574|2201116|FG001|Overall Study|Adverse Event|3
1115985|NCT02537574|2201117|FG002|Overall Study|Adverse Event|2
1115986|NCT02537574|2201115|FG000|Overall Study|Lost to Follow-up|40
1115987|NCT02537574|2201116|FG001|Overall Study|Lost to Follow-up|51
1115988|NCT02537574|2201117|FG002|Overall Study|Lost to Follow-up|55
1115989|NCT02537574|2201115|FG000|Overall Study|Noncompliance with study drug|0
1115990|NCT02537574|2201116|FG001|Overall Study|Noncompliance with study drug|1
896954|NCT00706511|1868736|FG003|Overall Study|Withdrawal by Subject|0
896955|NCT00706628|1868776|FG000|Overall Study|Other Adverse Event|16
896956|NCT00706628|1868777|FG001|Overall Study|Other Adverse Event|5
896957|NCT00706628|1868778|FG002|Overall Study|Other Adverse Event|5
1115991|NCT02537574|2201117|FG002|Overall Study|Noncompliance with study drug|1
1115992|NCT02537574|2201115|FG000|Overall Study|Physician Decision|2
1115993|NCT02537574|2201116|FG001|Overall Study|Physician Decision|0
1115994|NCT02537574|2201117|FG002|Overall Study|Physician Decision|0
1115995|NCT02537574|2201115|FG000|Overall Study|Protocol Violation|4
1115996|NCT02537574|2201116|FG001|Overall Study|Protocol Violation|2
1115997|NCT02537574|2201117|FG002|Overall Study|Protocol Violation|3
1115998|NCT02537574|2201115|FG000|Overall Study|Withdrawal by Subject|37
1115999|NCT02537574|2201116|FG001|Overall Study|Withdrawal by Subject|27
1116000|NCT02537574|2201117|FG002|Overall Study|Withdrawal by Subject|29
1116001|NCT02537574|2201115|FG000|Overall Study|Lack of Efficacy|14
1116002|NCT02537574|2201116|FG001|Overall Study|Lack of Efficacy|16
1116003|NCT02537574|2201117|FG002|Overall Study|Lack of Efficacy|15
1116004|NCT02537574|2201115|FG000|Overall Study|Duplicate Patient|1
1116005|NCT02537574|2201116|FG001|Overall Study|Duplicate Patient|0
1116006|NCT02537574|2201117|FG002|Overall Study|Duplicate Patient|0
1116007|NCT02537574|2201115|FG000|Overall Study|Patient not Stable|0
1116008|NCT02537574|2201116|FG001|Overall Study|Patient not Stable|1
1116009|NCT02537574|2201117|FG002|Overall Study|Patient not Stable|0
1116010|NCT02537574|2201115|FG000|Overall Study|Incarceration|0
1116011|NCT02537574|2201116|FG001|Overall Study|Incarceration|1
1116012|NCT02537574|2201117|FG002|Overall Study|Incarceration|0
1116013|NCT02537574|2201115|FG000|Overall Study|Failed Naloxone Challenge|0
1116014|NCT02537574|2201116|FG001|Overall Study|Failed Naloxone Challenge|1
1116015|NCT02537574|2201117|FG002|Overall Study|Failed Naloxone Challenge|0
1116016|NCT02537574|2201115|FG000|Overall Study|Transportation Issues|0
1116017|NCT02537574|2201116|FG001|Overall Study|Transportation Issues|0
1116018|NCT02537574|2201117|FG002|Overall Study|Transportation Issues|1
1116019|NCT02537574|2201115|FG000|Overall Study|Subject did not want last Vivitrol Injec|0
1116020|NCT02537574|2201116|FG001|Overall Study|Subject did not want last Vivitrol Injec|0
1116021|NCT02537574|2201117|FG002|Overall Study|Subject did not want last Vivitrol Injec|1
1116022|NCT02537574|2201115|FG000|Overall Study|Noncompliance with Protocol|0
1116023|NCT02537574|2201116|FG001|Overall Study|Noncompliance with Protocol|0
1116024|NCT02537574|2201117|FG002|Overall Study|Noncompliance with Protocol|1
1116025|NCT02538029|2201164|FG000|Overall Study|unable to complete cognitive assessments|1
1116026|NCT02538029|2201165|FG001|Overall Study|unable to complete cognitive assessments|0
1116027|NCT02538029|2201166|FG002|Overall Study|unable to complete cognitive assessments|1
1116028|NCT02538094|2201187|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
1116029|NCT02538094|2201188|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
1116030|NCT02538094|2201187|FG000|Washout (4 Weeks)|Withdrawal by Subject|0
1116031|NCT02538094|2201188|FG001|Washout (4 Weeks)|Withdrawal by Subject|1
1116032|NCT02538107|2201194|FG000|Overall Study|Did not receive any Mircera dose|11
1116033|NCT02538107|2201194|FG000|Overall Study|Missing|5
1116034|NCT02538107|2201194|FG000|Overall Study|Necessity of dialysis|20
1116035|NCT02538107|2201194|FG000|Overall Study|Administration of other ESA|11
1116036|NCT02538107|2201194|FG000|Overall Study|No further treatment necessary|18
1116037|NCT02538107|2201194|FG000|Overall Study|Withdrawal by Subject|17
1116038|NCT02538107|2201194|FG000|Overall Study|Death|4
1116039|NCT02538107|2201194|FG000|Overall Study|Administrative reason|5
1116040|NCT02538107|2201194|FG000|Overall Study|Adverse Event|4
1116041|NCT02538107|2201194|FG000|Overall Study|Surgery|1
1116042|NCT02538107|2201194|FG000|Overall Study|Other|7
1116043|NCT02538107|2201194|FG000|Overall Study|Not recorded|7
1116044|NCT02538341|2201210|FG000|Overall Study|Lost to Follow-up|51
1116045|NCT02538341|2201211|FG001|Overall Study|Lost to Follow-up|46
1116046|NCT02538341|2201210|FG000|Overall Study|Withdrawal by Subject|3
1116047|NCT02538341|2201211|FG001|Overall Study|Withdrawal by Subject|1
1116048|NCT02538341|2201210|FG000|Overall Study|Death|2
1116049|NCT02538341|2201211|FG001|Overall Study|Death|0
1116050|NCT02538471|2201235|FG000|Overall Study|Progression of disease|2
1116051|NCT02538614|2201261|FG000|Overall Study|Progressive Disease|2
1116052|NCT02538666|2201270|FG000|Overall Study|Disease progression|1
1116053|NCT02538666|2201271|FG001|Overall Study|Disease progression|0
1116054|NCT02538666|2201272|FG002|Overall Study|Disease progression|0
1116055|NCT02538666|2201270|FG000|Overall Study|no longer meets study criteria|1
1116056|NCT02538666|2201271|FG001|Overall Study|no longer meets study criteria|0
1116057|NCT02538666|2201272|FG002|Overall Study|no longer meets study criteria|0
1116058|NCT02538666|2201270|FG000|Overall Study|Withdrew Consent|0
1116059|NCT02538666|2201271|FG001|Overall Study|Withdrew Consent|1
1116060|NCT02538666|2201272|FG002|Overall Study|Withdrew Consent|1
1116061|NCT02538900|2201306|FG000|Overall Study|Death|2
1116062|NCT02538900|2201307|FG001|Overall Study|Death|2
1116063|NCT02538900|2201308|FG002|Overall Study|Death|2
1116064|NCT02538900|2201306|FG000|Overall Study|Withdrawal by Subject|18
1116065|NCT02538900|2201307|FG001|Overall Study|Withdrawal by Subject|16
1116066|NCT02538900|2201308|FG002|Overall Study|Withdrawal by Subject|15
1116067|NCT02538965|2201316|FG000|Treatment Period|Other = Death due to disease progression|1
1116068|NCT02538965|2201316|FG000|Treatment Period|Adverse Event|2
1116069|NCT02538965|2201316|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
1116070|NCT02538965|2201316|FG000|Treatment Period|Treatment Failure|9
1116071|NCT02538965|2201316|FG000|Treatment Period|Disease Progression|1
1116072|NCT02538965|2201316|FG000|Treatment Period|Physician Decision|2
1116073|NCT02538965|2201316|FG000|Follow-Up Period|Other = Death due to disease progression|13
1116074|NCT02538965|2201316|FG000|Follow-Up Period|Withdrawal by Parent|4
1116075|NCT02539134|2201335|FG000|Overall Study|Lost to Follow-up|1
1116076|NCT02539134|2201336|FG001|Overall Study|Lost to Follow-up|0
1116077|NCT02539134|2201337|FG002|Overall Study|Lost to Follow-up|0
1116078|NCT02539134|2201338|FG003|Overall Study|Lost to Follow-up|0
1116079|NCT02539134|2201339|FG004|Overall Study|Lost to Follow-up|0
1116080|NCT02539134|2201340|FG005|Overall Study|Lost to Follow-up|0
1116081|NCT02539225|2201361|FG000|Part A|Adverse Event|13
1116082|NCT02539225|2201362|FG001|Part A|Adverse Event|4
1116083|NCT02539225|2201361|FG000|Part A|Withdrawal by Subject|2
1116084|NCT02539225|2201362|FG001|Part A|Withdrawal by Subject|4
1116085|NCT02539225|2201361|FG000|Part A|Physician Decision|4
1116086|NCT02539225|2201362|FG001|Part A|Physician Decision|7
1116087|NCT02539225|2201361|FG000|Part A|Did Not Receive study Drug|1
1116088|NCT02539225|2201362|FG001|Part A|Did Not Receive study Drug|1
1116089|NCT02539225|2201361|FG000|Pre Treatment for Part B|Progressive disease|1
1116090|NCT02539225|2201362|FG001|Pre Treatment for Part B|Progressive disease|1
1116091|NCT02539225|2201361|FG000|Pre Treatment for Part B|Adverse Event|1
1116092|NCT02539225|2201362|FG001|Pre Treatment for Part B|Adverse Event|1
1116093|NCT02539225|2201361|FG000|Pre Treatment for Part B|Withdrawal by Subject|1
1116094|NCT02539225|2201362|FG001|Pre Treatment for Part B|Withdrawal by Subject|0
1116095|NCT02539225|2201361|FG000|Pre Treatment for Part B|Physician Decision|2
1116096|NCT02539225|2201362|FG001|Pre Treatment for Part B|Physician Decision|0
1116097|NCT02539225|2201361|FG000|Part B|Adverse Event|4
1116098|NCT02539225|2201362|FG001|Part B|Adverse Event|4
1116099|NCT02539225|2201361|FG000|Part B|Withdrawal by Subject|0
1116100|NCT02539225|2201362|FG001|Part B|Withdrawal by Subject|3
1116101|NCT02539225|2201361|FG000|Part B|Physician Decision|0
1116102|NCT02539225|2201362|FG001|Part B|Physician Decision|9
1116103|NCT02539368|2201387|FG000|Overall Study|Death|4
1116104|NCT02539368|2201388|FG001|Overall Study|Death|2
1116105|NCT02539368|2201389|FG002|Overall Study|Death|1
1116106|NCT02539368|2201390|FG003|Overall Study|Death|0
1116107|NCT02539368|2201391|FG004|Overall Study|Death|0
1116108|NCT02539368|2201387|FG000|Overall Study|Withdrawal by Subject|44
1116109|NCT02539368|2201388|FG001|Overall Study|Withdrawal by Subject|35
1116110|NCT02539368|2201389|FG002|Overall Study|Withdrawal by Subject|9
1116111|NCT02539368|2201390|FG003|Overall Study|Withdrawal by Subject|1
1116112|NCT02539368|2201391|FG004|Overall Study|Withdrawal by Subject|3
1116113|NCT02539368|2201387|FG000|Overall Study|Physician Decision|49
1116114|NCT02539368|2201388|FG001|Overall Study|Physician Decision|15
1116115|NCT02539368|2201389|FG002|Overall Study|Physician Decision|7
1116116|NCT02539368|2201390|FG003|Overall Study|Physician Decision|0
1116117|NCT02539368|2201391|FG004|Overall Study|Physician Decision|2
1116118|NCT02539368|2201387|FG000|Overall Study|Lost to Follow-up|96
1116119|NCT02539368|2201388|FG001|Overall Study|Lost to Follow-up|21
1116120|NCT02539368|2201389|FG002|Overall Study|Lost to Follow-up|16
1116121|NCT02539368|2201390|FG003|Overall Study|Lost to Follow-up|4
1116122|NCT02539368|2201391|FG004|Overall Study|Lost to Follow-up|3
1116123|NCT02539368|2201387|FG000|Overall Study|Adverse Event|44
1116124|NCT02539368|2201388|FG001|Overall Study|Adverse Event|5
1116125|NCT02539368|2201389|FG002|Overall Study|Adverse Event|9
1116126|NCT02539368|2201390|FG003|Overall Study|Adverse Event|0
1116127|NCT02539368|2201391|FG004|Overall Study|Adverse Event|3
1116128|NCT02539368|2201387|FG000|Overall Study|Participant Non-compliant|13
1116129|NCT02539368|2201388|FG001|Overall Study|Participant Non-compliant|2
1116130|NCT02539368|2201389|FG002|Overall Study|Participant Non-compliant|1
1116131|NCT02539368|2201390|FG003|Overall Study|Participant Non-compliant|1
1116132|NCT02539368|2201391|FG004|Overall Study|Participant Non-compliant|0
1116133|NCT02539368|2201387|FG000|Overall Study|Other|145
1116134|NCT02539368|2201388|FG001|Overall Study|Other|18
1116135|NCT02539368|2201389|FG002|Overall Study|Other|24
1116136|NCT02539368|2201390|FG003|Overall Study|Other|1
1116137|NCT02539368|2201391|FG004|Overall Study|Other|3
1116138|NCT02539368|2201387|FG000|Overall Study|Missing|10
1116139|NCT02539368|2201388|FG001|Overall Study|Missing|3
1116140|NCT02539368|2201389|FG002|Overall Study|Missing|0
1116141|NCT02539368|2201390|FG003|Overall Study|Missing|0
1116142|NCT02539368|2201391|FG004|Overall Study|Missing|0
1116143|NCT02539797|2201433|FG000|Overall Study|Lost to Follow-up|0
1116144|NCT02539797|2201434|FG001|Overall Study|Lost to Follow-up|1
1116145|NCT02539797|2201435|FG002|Overall Study|Lost to Follow-up|0
1116146|NCT02540083|2201458|FG000|Overall Study|Withdrawal by Subject|16
1116147|NCT02540213|2201479|FG000|Overall Study|Death/adverse event|18
1116148|NCT02540213|2201479|FG000|Overall Study|Administrative reasons|3
1116149|NCT02540213|2201479|FG000|Overall Study|Kidney transplant|3
1116150|NCT02540213|2201479|FG000|Overall Study|Lack of Efficacy|6
1116151|NCT02540213|2201479|FG000|Overall Study|Consent withdrawn|7
1116152|NCT02540213|2201479|FG000|Overall Study|Enrolled but not treated|2
1116153|NCT02540265|2201495|FG000|Overall Study|Lost to Follow-up|0
1116154|NCT02540265|2201496|FG001|Overall Study|Lost to Follow-up|0
1116155|NCT02540265|2201497|FG002|Overall Study|Lost to Follow-up|1
1116156|NCT02540291|2201509|FG000|Overall Study|Death|7
1116157|NCT02540291|2201510|FG001|Overall Study|Death|7
1116158|NCT02540291|2201511|FG002|Overall Study|Death|5
896958|NCT00706628|1868779|FG003|Overall Study|Other Adverse Event|2
896959|NCT00706628|1868776|FG000|Overall Study|Non compliant with protocol|0
1116159|NCT02540291|2201512|FG003|Overall Study|Death|7
1116160|NCT02540291|2201509|FG000|Overall Study|Lost to Follow-up|0
1116161|NCT02540291|2201510|FG001|Overall Study|Lost to Follow-up|0
1116162|NCT02540291|2201511|FG002|Overall Study|Lost to Follow-up|1
1116163|NCT02540291|2201512|FG003|Overall Study|Lost to Follow-up|0
1116164|NCT02540291|2201509|FG000|Overall Study|Withdrawal Of Consent|0
1116165|NCT02540291|2201510|FG001|Overall Study|Withdrawal Of Consent|1
1116166|NCT02540291|2201511|FG002|Overall Study|Withdrawal Of Consent|0
1116167|NCT02540291|2201512|FG003|Overall Study|Withdrawal Of Consent|0
1116168|NCT02540291|2201509|FG000|Overall Study|Study Terminated By Sponsor|1
1116169|NCT02540291|2201510|FG001|Overall Study|Study Terminated By Sponsor|0
1116170|NCT02540291|2201511|FG002|Overall Study|Study Terminated By Sponsor|0
1116171|NCT02540291|2201512|FG003|Overall Study|Study Terminated By Sponsor|0
1116172|NCT02540291|2201509|FG000|Overall Study|Other|0
1116173|NCT02540291|2201510|FG001|Overall Study|Other|0
1116174|NCT02540291|2201511|FG002|Overall Study|Other|1
1116175|NCT02540291|2201512|FG003|Overall Study|Other|0
1116176|NCT02540356|2201526|FG000|Overall Study|Terminated due to disease progression|1
1116177|NCT02540356|2201527|FG001|Overall Study|Terminated due to disease progression|0
1116178|NCT02540538|2201544|FG000|Overall Study|Pregnancy|0
1116179|NCT02540538|2201545|FG001|Overall Study|Pregnancy|1
1116180|NCT02540538|2201546|FG002|Overall Study|Pregnancy|0
1116181|NCT02540668|2201564|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0
1116182|NCT02540668|2201565|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1
1116183|NCT02540850|2201584|FG000|Overall Study|Lost to Follow-up|69
1116184|NCT02540850|2201585|FG001|Overall Study|Lost to Follow-up|66
1116185|NCT02540850|2201586|FG002|Overall Study|Lost to Follow-up|34
1116186|NCT02540954|2201596|FG000|Overall Study|Physician Decision|3
1116187|NCT02540954|2201597|FG001|Overall Study|Physician Decision|1
1116188|NCT02540954|2201596|FG000|Overall Study|Withdrawal by Subject|6
1116189|NCT02540954|2201597|FG001|Overall Study|Withdrawal by Subject|5
1116190|NCT02540954|2201596|FG000|Overall Study|Lost to Follow-up|1
1116191|NCT02540954|2201597|FG001|Overall Study|Lost to Follow-up|1
1116192|NCT02540954|2201596|FG000|Overall Study|Adverse Event|4
1116193|NCT02540954|2201597|FG001|Overall Study|Adverse Event|2
1116194|NCT02540954|2201596|FG000|Overall Study|Death|0
1116195|NCT02540954|2201597|FG001|Overall Study|Death|3
1116196|NCT02540954|2201596|FG000|Overall Study|Treatment failure|1
1116197|NCT02540954|2201597|FG001|Overall Study|Treatment failure|0
1116198|NCT02540954|2201596|FG000|Overall Study|Other reason|4
1116199|NCT02540954|2201597|FG001|Overall Study|Other reason|2
1116200|NCT02540993|2201605|FG000|Overall Study|Lost to Follow-up|5
1116201|NCT02540993|2201606|FG001|Overall Study|Lost to Follow-up|3
1116202|NCT02540993|2201605|FG000|Overall Study|Withdrawal by Subject|4
1116203|NCT02540993|2201606|FG001|Overall Study|Withdrawal by Subject|6
1116204|NCT02540993|2201605|FG000|Overall Study|GCP violations|33
1116205|NCT02540993|2201606|FG001|Overall Study|GCP violations|27
1116206|NCT02541604|2201644|FG000|Overall Study|Death|6
1116207|NCT02541604|2201645|FG001|Overall Study|Death|5
1116208|NCT02541604|2201646|FG002|Overall Study|Death|7
1116209|NCT02541604|2201647|FG003|Overall Study|Death|2
1116210|NCT02541604|2201648|FG004|Overall Study|Death|9
1116211|NCT02541604|2201649|FG005|Overall Study|Death|8
1116212|NCT02541604|2201650|FG006|Overall Study|Death|9
1116213|NCT02541604|2201651|FG007|Overall Study|Death|9
1116214|NCT02541604|2201652|FG008|Overall Study|Death|3
1116215|NCT02541604|2201653|FG009|Overall Study|Death|4
1116216|NCT02541604|2201654|FG010|Overall Study|Death|2
1116217|NCT02541604|2201655|FG011|Overall Study|Death|3
1116218|NCT02541604|2201644|FG000|Overall Study|Lost to Follow-up|2
1116219|NCT02541604|2201645|FG001|Overall Study|Lost to Follow-up|0
1116220|NCT02541604|2201646|FG002|Overall Study|Lost to Follow-up|1
1116221|NCT02541604|2201647|FG003|Overall Study|Lost to Follow-up|0
1116222|NCT02541604|2201648|FG004|Overall Study|Lost to Follow-up|0
1116223|NCT02541604|2201649|FG005|Overall Study|Lost to Follow-up|1
1116224|NCT02541604|2201650|FG006|Overall Study|Lost to Follow-up|1
1116225|NCT02541604|2201651|FG007|Overall Study|Lost to Follow-up|0
1116226|NCT02541604|2201652|FG008|Overall Study|Lost to Follow-up|0
1116227|NCT02541604|2201653|FG009|Overall Study|Lost to Follow-up|0
1116228|NCT02541604|2201654|FG010|Overall Study|Lost to Follow-up|0
1116229|NCT02541604|2201655|FG011|Overall Study|Lost to Follow-up|0
1116230|NCT02541604|2201644|FG000|Overall Study|Withdrawal by Subject|2
1116231|NCT02541604|2201645|FG001|Overall Study|Withdrawal by Subject|0
1116232|NCT02541604|2201646|FG002|Overall Study|Withdrawal by Subject|1
1116233|NCT02541604|2201647|FG003|Overall Study|Withdrawal by Subject|0
1116234|NCT02541604|2201648|FG004|Overall Study|Withdrawal by Subject|1
1116235|NCT02541604|2201649|FG005|Overall Study|Withdrawal by Subject|1
1116236|NCT02541604|2201650|FG006|Overall Study|Withdrawal by Subject|0
1116237|NCT02541604|2201651|FG007|Overall Study|Withdrawal by Subject|0
1116238|NCT02541604|2201652|FG008|Overall Study|Withdrawal by Subject|1
1116239|NCT02541604|2201653|FG009|Overall Study|Withdrawal by Subject|0
1116240|NCT02541604|2201654|FG010|Overall Study|Withdrawal by Subject|0
1116241|NCT02541604|2201655|FG011|Overall Study|Withdrawal by Subject|0
1116242|NCT02541604|2201644|FG000|Overall Study|Study Terminated by Sponsor|1
1116243|NCT02541604|2201645|FG001|Overall Study|Study Terminated by Sponsor|4
1116244|NCT02541604|2201646|FG002|Overall Study|Study Terminated by Sponsor|2
1116245|NCT02541604|2201647|FG003|Overall Study|Study Terminated by Sponsor|1
1116246|NCT02541604|2201648|FG004|Overall Study|Study Terminated by Sponsor|0
1116247|NCT02541604|2201649|FG005|Overall Study|Study Terminated by Sponsor|0
1116248|NCT02541604|2201650|FG006|Overall Study|Study Terminated by Sponsor|0
1116249|NCT02541604|2201651|FG007|Overall Study|Study Terminated by Sponsor|0
1116250|NCT02541604|2201652|FG008|Overall Study|Study Terminated by Sponsor|0
1116251|NCT02541604|2201653|FG009|Overall Study|Study Terminated by Sponsor|0
1116252|NCT02541604|2201654|FG010|Overall Study|Study Terminated by Sponsor|0
1116253|NCT02541604|2201655|FG011|Overall Study|Study Terminated by Sponsor|0
1116254|NCT02541604|2201644|FG000|Overall Study|Medical condition may jeopardize safety|0
1116255|NCT02541604|2201645|FG001|Overall Study|Medical condition may jeopardize safety|0
1116256|NCT02541604|2201646|FG002|Overall Study|Medical condition may jeopardize safety|0
1116257|NCT02541604|2201647|FG003|Overall Study|Medical condition may jeopardize safety|0
1116258|NCT02541604|2201648|FG004|Overall Study|Medical condition may jeopardize safety|0
1116259|NCT02541604|2201649|FG005|Overall Study|Medical condition may jeopardize safety|0
1116260|NCT02541604|2201650|FG006|Overall Study|Medical condition may jeopardize safety|0
1116261|NCT02541604|2201651|FG007|Overall Study|Medical condition may jeopardize safety|1
1116262|NCT02541604|2201652|FG008|Overall Study|Medical condition may jeopardize safety|0
1116263|NCT02541604|2201653|FG009|Overall Study|Medical condition may jeopardize safety|0
1116264|NCT02541604|2201654|FG010|Overall Study|Medical condition may jeopardize safety|0
1116265|NCT02541604|2201655|FG011|Overall Study|Medical condition may jeopardize safety|0
1116266|NCT02541669|2201709|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0
1116267|NCT02541669|2201710|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0
1116268|NCT02541669|2201711|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1
1116269|NCT02541669|2201712|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0
1116270|NCT02541669|2201713|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1
1116271|NCT02541903|2201743|FG000|Overall Study|Death|1
1116272|NCT02542072|2201766|FG000|First Intervention (1 Month)|Adverse Event|1
1116273|NCT02542072|2201767|FG001|First Intervention (1 Month)|Adverse Event|1
1116274|NCT02542072|2201766|FG000|First Intervention (1 Month)|Lost to Follow-up|2
1116275|NCT02542072|2201767|FG001|First Intervention (1 Month)|Lost to Follow-up|0
1116276|NCT02542072|2201766|FG000|First Intervention (1 Month)|Lens discomfort|1
1116277|NCT02542072|2201767|FG001|First Intervention (1 Month)|Lens discomfort|2
1116278|NCT02542072|2201766|FG000|First Intervention (1 Month)|Protocol Violation|1
1116279|NCT02542072|2201767|FG001|First Intervention (1 Month)|Protocol Violation|0
1116280|NCT02542072|2201766|FG000|Second Intervention (1 Month)|Lost to Follow-up|1
1116281|NCT02542072|2201767|FG001|Second Intervention (1 Month)|Lost to Follow-up|0
1116282|NCT02542072|2201766|FG000|Second Intervention (1 Month)|Lens discomfort|1
1116283|NCT02542072|2201767|FG001|Second Intervention (1 Month)|Lens discomfort|0
896960|NCT00706628|1868777|FG001|Overall Study|Non compliant with protocol|1
896961|NCT00706628|1868778|FG002|Overall Study|Non compliant with protocol|0
896962|NCT00706628|1868779|FG003|Overall Study|Non compliant with protocol|0
896963|NCT00706628|1868776|FG000|Overall Study|Consent withdrawn|6
896964|NCT00706628|1868777|FG001|Overall Study|Consent withdrawn|1
896965|NCT00706628|1868778|FG002|Overall Study|Consent withdrawn|3
896966|NCT00706628|1868779|FG003|Overall Study|Consent withdrawn|0
896967|NCT00706628|1868776|FG000|Overall Study|Progressive disease|20
896968|NCT00706628|1868777|FG001|Overall Study|Progressive disease|13
896969|NCT00706628|1868778|FG002|Overall Study|Progressive disease|8
896970|NCT00706628|1868779|FG003|Overall Study|Progressive disease|1
896971|NCT00706628|1868776|FG000|Overall Study|Other than those stated above|4
896972|NCT00706628|1868777|FG001|Overall Study|Other than those stated above|0
896973|NCT00706628|1868778|FG002|Overall Study|Other than those stated above|0
896974|NCT00706628|1868779|FG003|Overall Study|Other than those stated above|0
896975|NCT00706628|1868776|FG000|Overall Study|Not treated|1
896976|NCT00706628|1868777|FG001|Overall Study|Not treated|1
896977|NCT00706628|1868778|FG002|Overall Study|Not treated|0
896978|NCT00706628|1868779|FG003|Overall Study|Not treated|0
896979|NCT00706641|1868792|FG000|Dasatinib Administration|Withdrawal by Subject|1
896980|NCT00706641|1868792|FG000|Dasatinib Administration|Ineligible after start of therapy|1
896981|NCT00706641|1868792|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1
896982|NCT00706654|1868799|FG000|Conversion Phase|Lost to Follow-up|4
896983|NCT00706654|1868800|FG001|Conversion Phase|Lost to Follow-up|0
896984|NCT00706654|1868801|FG002|Conversion Phase|Lost to Follow-up|0
896985|NCT00706654|1868802|FG003|Conversion Phase|Lost to Follow-up|0
896986|NCT00706654|1868799|FG000|Conversion Phase|Sponsor Discontinued Trial|8
896987|NCT00706654|1868800|FG001|Conversion Phase|Sponsor Discontinued Trial|0
896988|NCT00706654|1868801|FG002|Conversion Phase|Sponsor Discontinued Trial|0
896989|NCT00706654|1868802|FG003|Conversion Phase|Sponsor Discontinued Trial|0
896990|NCT00706654|1868799|FG000|Conversion Phase|Met Withdrawal Criteria|2
896991|NCT00706654|1868800|FG001|Conversion Phase|Met Withdrawal Criteria|0
896992|NCT00706654|1868801|FG002|Conversion Phase|Met Withdrawal Criteria|0
896993|NCT00706654|1868802|FG003|Conversion Phase|Met Withdrawal Criteria|0
896994|NCT00706654|1868799|FG000|Conversion Phase|Withdrawn by Investigator|14
896995|NCT00706654|1868800|FG001|Conversion Phase|Withdrawn by Investigator|0
896996|NCT00706654|1868801|FG002|Conversion Phase|Withdrawn by Investigator|0
896997|NCT00706654|1868802|FG003|Conversion Phase|Withdrawn by Investigator|0
896998|NCT00706654|1868799|FG000|Conversion Phase|Withdrew Consent|38
1116284|NCT02542267|2201806|FG000|Overall Study|Ongoing|31
1116285|NCT02542267|2201806|FG000|Overall Study|Withdrawal by Subject|8
1116286|NCT02542267|2201806|FG000|Overall Study|Physician Decision|5
1116287|NCT02542267|2201806|FG000|Overall Study|Lost to Follow-up|4
1116288|NCT02542267|2201806|FG000|Overall Study|Death|12
1116289|NCT02542267|2201806|FG000|Overall Study|Surgical Bypass of All Study Devices|12
1116290|NCT02542267|2201806|FG000|Overall Study|Other|5
1116291|NCT02542397|2201819|FG000|Overall Study|Death|2
1116292|NCT02542397|2201819|FG000|Overall Study|Physician Decision|6
1116293|NCT02542397|2201819|FG000|Overall Study|Withdrawal by Subject|6
1116294|NCT02542397|2201819|FG000|Overall Study|Lost to Follow-up|2
1116295|NCT02542605|2201851|FG000|Part B: Challenge Phase|Sponsor decision|1
1116296|NCT02542605|2201852|FG001|Part B: Challenge Phase|Sponsor decision|0
1116297|NCT02542605|2201853|FG002|Part B: Challenge Phase|Sponsor decision|0
1116298|NCT02542605|2201851|FG000|Part B: Randomization Phase|Withdrawal by Subject|0
1116299|NCT02542605|2201852|FG001|Part B: Randomization Phase|Withdrawal by Subject|0
1116300|NCT02542605|2201853|FG002|Part B: Randomization Phase|Withdrawal by Subject|1
1116301|NCT02542631|2201864|FG000|Overall Study|Adverse Event|1
1116302|NCT02542631|2201865|FG001|Overall Study|Adverse Event|1
1116303|NCT02542631|2201864|FG000|Overall Study|Sponsor Termination|1
1116304|NCT02542631|2201865|FG001|Overall Study|Sponsor Termination|0
1116305|NCT02542631|2201864|FG000|Overall Study|Withdrawal by Subject|11
1116306|NCT02542631|2201865|FG001|Overall Study|Withdrawal by Subject|16
1116307|NCT02542631|2201864|FG000|Overall Study|Protocol Violation|1
1116308|NCT02542631|2201865|FG001|Overall Study|Protocol Violation|1
1116309|NCT02542631|2201864|FG000|Overall Study|Physician Decision|6
1116310|NCT02542631|2201865|FG001|Overall Study|Physician Decision|4
1116311|NCT02542631|2201864|FG000|Overall Study|Lost to Follow-up|6
1116312|NCT02542631|2201865|FG001|Overall Study|Lost to Follow-up|5
1116313|NCT02542631|2201864|FG000|Overall Study|Death|1
1116314|NCT02542631|2201865|FG001|Overall Study|Death|2
1116315|NCT02542631|2201864|FG000|Overall Study|Other|2
1116316|NCT02542631|2201865|FG001|Overall Study|Other|1
1116317|NCT02542631|2201864|FG000|Overall Study|Used Prohibited Medication|2
1116318|NCT02542631|2201865|FG001|Overall Study|Used Prohibited Medication|1
1116319|NCT02542865|2201880|FG000|Overall Study|Identified as screen failure|1
1116320|NCT02542865|2201881|FG001|Overall Study|Identified as screen failure|0
1116321|NCT02542865|2201880|FG000|Overall Study|Withdrawal by Subject|16
1116322|NCT02542865|2201881|FG001|Overall Study|Withdrawal by Subject|0
1116323|NCT02542943|2201890|FG000|Overall Study|Lost to Follow-up|1
1116324|NCT02542943|2201891|FG001|Overall Study|Lost to Follow-up|0
1116325|NCT02542943|2201892|FG002|Overall Study|Lost to Follow-up|0
1116326|NCT02542943|2201890|FG000|Overall Study|Withdrawal by Subject|0
1116327|NCT02542943|2201891|FG001|Overall Study|Withdrawal by Subject|1
1116328|NCT02542943|2201892|FG002|Overall Study|Withdrawal by Subject|0
1116329|NCT02543203|2201903|FG000|Overall Study|Unpalatable Fragrance|2
1116330|NCT02543203|2201904|FG001|Overall Study|Unpalatable Fragrance|2
1116331|NCT02543203|2201903|FG000|Overall Study|Lost to Follow-up|1
1116332|NCT02543203|2201904|FG001|Overall Study|Lost to Follow-up|0
1116333|NCT02543203|2201903|FG000|Overall Study|Increased Irritability|1
1116334|NCT02543203|2201904|FG001|Overall Study|Increased Irritability|0
1116335|NCT02543203|2201903|FG000|Overall Study|Family|1
1116336|NCT02543203|2201904|FG001|Overall Study|Family|2
1116337|NCT02543203|2201903|FG000|Overall Study|Negative Behavior|1
896999|NCT00706654|1868800|FG001|Conversion Phase|Withdrew Consent|0
897000|NCT00706654|1868801|FG002|Conversion Phase|Withdrew Consent|0
897001|NCT00706654|1868802|FG003|Conversion Phase|Withdrew Consent|0
897002|NCT00706654|1868799|FG000|Conversion Phase|Adverse Event|18
897003|NCT00706654|1868800|FG001|Conversion Phase|Adverse Event|0
897004|NCT00706654|1868801|FG002|Conversion Phase|Adverse Event|0
897005|NCT00706654|1868802|FG003|Conversion Phase|Adverse Event|0
897006|NCT00706654|1868799|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9
897007|NCT00706654|1868800|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
897008|NCT00706654|1868801|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
897009|NCT00706654|1868802|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0
897010|NCT00706654|1868799|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2
897011|NCT00706654|1868800|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
897012|NCT00706654|1868801|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
897013|NCT00706654|1868802|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0
897014|NCT00706654|1868799|FG000|Oral Stabilization Phase|Lost to Follow-up|17
897015|NCT00706654|1868800|FG001|Oral Stabilization Phase|Lost to Follow-up|0
897016|NCT00706654|1868801|FG002|Oral Stabilization Phase|Lost to Follow-up|0
897017|NCT00706654|1868802|FG003|Oral Stabilization Phase|Lost to Follow-up|0
897018|NCT00706654|1868799|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19
897019|NCT00706654|1868800|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0
897020|NCT00706654|1868801|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0
897021|NCT00706654|1868802|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0
897022|NCT00706654|1868799|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15
897023|NCT00706654|1868800|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
897024|NCT00706654|1868801|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
897025|NCT00706654|1868802|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0
1018313|NCT01570283|2043159|FG002|Cohort 1: Dose Level 1|Death|0
1116338|NCT02543203|2201904|FG001|Overall Study|Negative Behavior|0
1116339|NCT02543203|2201903|FG000|Overall Study|Withdrawal by Subject|0
1116340|NCT02543203|2201904|FG001|Overall Study|Withdrawal by Subject|1
1116341|NCT02543294|2201918|FG000|Overall Study|Lost to Follow-up|3
1116342|NCT02543294|2201918|FG000|Overall Study|Physician Decision|2
1116343|NCT02543294|2201918|FG000|Overall Study|Withdrawal by Subject|7
1116344|NCT02543346|2201923|FG000|Second Priming Visit|Withdrawal by Subject|0
1116345|NCT02543346|2201924|FG001|Second Priming Visit|Withdrawal by Subject|2
1116346|NCT02543346|2201925|FG002|Second Priming Visit|Withdrawal by Subject|2
1116347|NCT02543346|2201926|FG003|Second Priming Visit|Withdrawal by Subject|2
1116348|NCT02543346|2201923|FG000|Second Priming Visit|Adverse Event|1
1116349|NCT02543346|2201924|FG001|Second Priming Visit|Adverse Event|0
1116350|NCT02543346|2201925|FG002|Second Priming Visit|Adverse Event|0
1116351|NCT02543346|2201926|FG003|Second Priming Visit|Adverse Event|0
1116352|NCT02543528|2201949|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0
1116353|NCT02543528|2201950|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0
1116354|NCT02543528|2201951|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0
1116355|NCT02543528|2201952|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0
1116356|NCT02543528|2201953|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2
1116357|NCT02543528|2201949|FG000|Adaptation Period|Lens Handling Difficultes|0
1116358|NCT02543528|2201950|FG001|Adaptation Period|Lens Handling Difficultes|0
1116359|NCT02543528|2201951|FG002|Adaptation Period|Lens Handling Difficultes|0
1116360|NCT02543528|2201952|FG003|Adaptation Period|Lens Handling Difficultes|0
1116361|NCT02543528|2201953|FG004|Adaptation Period|Lens Handling Difficultes|8
1116362|NCT02543528|2201949|FG000|Adaptation Period|Lost to Follow-up|0
1116363|NCT02543528|2201950|FG001|Adaptation Period|Lost to Follow-up|0
1116364|NCT02543528|2201951|FG002|Adaptation Period|Lost to Follow-up|0
1116365|NCT02543528|2201952|FG003|Adaptation Period|Lost to Follow-up|0
1116366|NCT02543528|2201953|FG004|Adaptation Period|Lost to Follow-up|14
1116367|NCT02543528|2201949|FG000|Adaptation Period|Adverse Event|0
1116368|NCT02543528|2201950|FG001|Adaptation Period|Adverse Event|0
1116369|NCT02543528|2201951|FG002|Adaptation Period|Adverse Event|0
1116370|NCT02543528|2201952|FG003|Adaptation Period|Adverse Event|0
1116371|NCT02543528|2201953|FG004|Adaptation Period|Adverse Event|2
1116372|NCT02543528|2201949|FG000|Extended Wear Period|Adverse Event|17
1116373|NCT02543528|2201950|FG001|Extended Wear Period|Adverse Event|11
1116374|NCT02543528|2201951|FG002|Extended Wear Period|Adverse Event|16
1116375|NCT02543528|2201952|FG003|Extended Wear Period|Adverse Event|3
1116376|NCT02543528|2201953|FG004|Extended Wear Period|Adverse Event|0
1116377|NCT02543528|2201949|FG000|Extended Wear Period|Missed too many scheduled visits|0
1116378|NCT02543528|2201950|FG001|Extended Wear Period|Missed too many scheduled visits|0
1116379|NCT02543528|2201951|FG002|Extended Wear Period|Missed too many scheduled visits|1
1116380|NCT02543528|2201952|FG003|Extended Wear Period|Missed too many scheduled visits|3
1116381|NCT02543528|2201953|FG004|Extended Wear Period|Missed too many scheduled visits|0
1116382|NCT02543528|2201949|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1
1116383|NCT02543528|2201950|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0
1116384|NCT02543528|2201951|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0
1116385|NCT02543528|2201952|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0
1116386|NCT02543528|2201953|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0
1116387|NCT02543528|2201949|FG000|Extended Wear Period|Lost to Follow-up|0
1116388|NCT02543528|2201950|FG001|Extended Wear Period|Lost to Follow-up|1
1116389|NCT02543528|2201951|FG002|Extended Wear Period|Lost to Follow-up|2
1116390|NCT02543528|2201952|FG003|Extended Wear Period|Lost to Follow-up|1
1116391|NCT02543528|2201953|FG004|Extended Wear Period|Lost to Follow-up|0
1116392|NCT02543528|2201949|FG000|Extended Wear Period|Withdrawal by Subject|10
1116393|NCT02543528|2201950|FG001|Extended Wear Period|Withdrawal by Subject|9
1116394|NCT02543528|2201951|FG002|Extended Wear Period|Withdrawal by Subject|4
1116395|NCT02543528|2201952|FG003|Extended Wear Period|Withdrawal by Subject|5
1116396|NCT02543528|2201953|FG004|Extended Wear Period|Withdrawal by Subject|0
1116397|NCT02543658|2201978|FG000|Overall Study|Lack of Efficacy|0
1116398|NCT02543658|2201979|FG001|Overall Study|Lack of Efficacy|4
1116399|NCT02543801|2202001|FG000|Overall Study|Protocol Violation|1
1116400|NCT02543801|2202002|FG001|Overall Study|Protocol Violation|2
1116401|NCT02543801|2202003|FG002|Overall Study|Protocol Violation|0
1116402|NCT02543801|2202004|FG003|Overall Study|Protocol Violation|0
1116403|NCT02543892|2202032|FG000|Received Vaccination 2|Withdrawal by Subject|1
1116404|NCT02543892|2202033|FG001|Received Vaccination 2|Withdrawal by Subject|0
1116405|NCT02543892|2202034|FG002|Received Vaccination 2|Withdrawal by Subject|0
1116406|NCT02543892|2202035|FG003|Received Vaccination 2|Withdrawal by Subject|0
1116407|NCT02543892|2202036|FG004|Received Vaccination 2|Withdrawal by Subject|0
1116408|NCT02543892|2202037|FG005|Received Vaccination 2|Withdrawal by Subject|0
1116409|NCT02543892|2202038|FG006|Received Vaccination 2|Withdrawal by Subject|0
1116410|NCT02543892|2202039|FG007|Received Vaccination 2|Withdrawal by Subject|1
1116411|NCT02543892|2202032|FG000|Received Vaccination 2|Physician Decision|0
1116412|NCT02543892|2202033|FG001|Received Vaccination 2|Physician Decision|0
1116413|NCT02543892|2202034|FG002|Received Vaccination 2|Physician Decision|0
1116414|NCT02543892|2202035|FG003|Received Vaccination 2|Physician Decision|0
1116415|NCT02543892|2202036|FG004|Received Vaccination 2|Physician Decision|0
1116416|NCT02543892|2202037|FG005|Received Vaccination 2|Physician Decision|1
1116417|NCT02543892|2202038|FG006|Received Vaccination 2|Physician Decision|0
1116418|NCT02543892|2202039|FG007|Received Vaccination 2|Physician Decision|0
1116419|NCT02543892|2202032|FG000|Received Vaccination 2|Adverse Event|0
1116420|NCT02543892|2202033|FG001|Received Vaccination 2|Adverse Event|1
1116421|NCT02543892|2202034|FG002|Received Vaccination 2|Adverse Event|0
1116422|NCT02543892|2202035|FG003|Received Vaccination 2|Adverse Event|0
1116423|NCT02543892|2202036|FG004|Received Vaccination 2|Adverse Event|0
1116424|NCT02543892|2202037|FG005|Received Vaccination 2|Adverse Event|0
1116425|NCT02543892|2202038|FG006|Received Vaccination 2|Adverse Event|0
1116426|NCT02543892|2202039|FG007|Received Vaccination 2|Adverse Event|0
1116427|NCT02543892|2202032|FG000|Had Immunology Data|Withdrawal by Subject|0
1116428|NCT02543892|2202033|FG001|Had Immunology Data|Withdrawal by Subject|0
1116429|NCT02543892|2202034|FG002|Had Immunology Data|Withdrawal by Subject|0
1116430|NCT02543892|2202035|FG003|Had Immunology Data|Withdrawal by Subject|0
1116431|NCT02543892|2202036|FG004|Had Immunology Data|Withdrawal by Subject|0
1116432|NCT02543892|2202037|FG005|Had Immunology Data|Withdrawal by Subject|0
1116433|NCT02543892|2202038|FG006|Had Immunology Data|Withdrawal by Subject|1
1116434|NCT02543892|2202039|FG007|Had Immunology Data|Withdrawal by Subject|0
1116435|NCT02543918|2202064|FG000|Overall Study|Never treated|0
1116436|NCT02543918|2202065|FG001|Overall Study|Never treated|1
1116437|NCT02543918|2202064|FG000|Overall Study|Lost to Follow-up|1
1116438|NCT02543918|2202065|FG001|Overall Study|Lost to Follow-up|1
1116439|NCT02543918|2202064|FG000|Overall Study|Withdrawal by Subject|1
1116440|NCT02543918|2202065|FG001|Overall Study|Withdrawal by Subject|1
1116441|NCT02543918|2202064|FG000|Overall Study|Adverse Event|1
1116442|NCT02543918|2202065|FG001|Overall Study|Adverse Event|1
1116443|NCT02544074|2202092|FG000|Overall Study|Withdrawal by Subject|0
1116444|NCT02544074|2202093|FG001|Overall Study|Withdrawal by Subject|1
1116445|NCT02544074|2202094|FG002|Overall Study|Withdrawal by Subject|0
1116446|NCT02544074|2202095|FG003|Overall Study|Withdrawal by Subject|0
1116447|NCT02544074|2202096|FG004|Overall Study|Withdrawal by Subject|0
1116448|NCT02544074|2202097|FG005|Overall Study|Withdrawal by Subject|0
1116449|NCT02544074|2202098|FG006|Overall Study|Withdrawal by Subject|0
1116450|NCT02544074|2202099|FG007|Overall Study|Withdrawal by Subject|0
1116451|NCT02544074|2202100|FG008|Overall Study|Withdrawal by Subject|0
1116452|NCT02544074|2202101|FG009|Overall Study|Withdrawal by Subject|0
1116453|NCT02544074|2202102|FG010|Overall Study|Withdrawal by Subject|0
1116454|NCT02544074|2202103|FG011|Overall Study|Withdrawal by Subject|0
1116455|NCT02544074|2202104|FG012|Overall Study|Withdrawal by Subject|0
1116456|NCT02544074|2202105|FG013|Overall Study|Withdrawal by Subject|0
1116457|NCT02544074|2202106|FG014|Overall Study|Withdrawal by Subject|0
1116458|NCT02544074|2202107|FG015|Overall Study|Withdrawal by Subject|0
1116459|NCT02544074|2202108|FG016|Overall Study|Withdrawal by Subject|0
1116460|NCT02544074|2202109|FG017|Overall Study|Withdrawal by Subject|0
1116461|NCT02544074|2202110|FG018|Overall Study|Withdrawal by Subject|0
1116462|NCT02544074|2202111|FG019|Overall Study|Withdrawal by Subject|0
1116463|NCT02544074|2202112|FG020|Overall Study|Withdrawal by Subject|0
1116464|NCT02544074|2202092|FG000|Overall Study|Tablet error|0
1116465|NCT02544074|2202093|FG001|Overall Study|Tablet error|0
1116466|NCT02544074|2202094|FG002|Overall Study|Tablet error|0
1116467|NCT02544074|2202095|FG003|Overall Study|Tablet error|0
1116468|NCT02544074|2202096|FG004|Overall Study|Tablet error|0
1116469|NCT02544074|2202097|FG005|Overall Study|Tablet error|1
1116470|NCT02544074|2202098|FG006|Overall Study|Tablet error|0
1116471|NCT02544074|2202099|FG007|Overall Study|Tablet error|0
1116472|NCT02544074|2202100|FG008|Overall Study|Tablet error|0
1116473|NCT02544074|2202101|FG009|Overall Study|Tablet error|1
1116474|NCT02544074|2202102|FG010|Overall Study|Tablet error|0
1116475|NCT02544074|2202103|FG011|Overall Study|Tablet error|0
1116476|NCT02544074|2202104|FG012|Overall Study|Tablet error|0
1116477|NCT02544074|2202105|FG013|Overall Study|Tablet error|0
1116478|NCT02544074|2202106|FG014|Overall Study|Tablet error|0
1116479|NCT02544074|2202107|FG015|Overall Study|Tablet error|0
1116480|NCT02544074|2202108|FG016|Overall Study|Tablet error|0
1116481|NCT02544074|2202109|FG017|Overall Study|Tablet error|0
1116482|NCT02544074|2202110|FG018|Overall Study|Tablet error|0
1116483|NCT02544074|2202111|FG019|Overall Study|Tablet error|0
1116484|NCT02544074|2202112|FG020|Overall Study|Tablet error|0
1116485|NCT02544113|2202148|FG000|Overall Study|Death|3
1116486|NCT02544113|2202149|FG001|Overall Study|Death|4
1116487|NCT02544152|2202157|FG000|Overall Study|Adverse Event|0
1116488|NCT02544152|2202158|FG001|Overall Study|Adverse Event|4
1116489|NCT02544152|2202157|FG000|Overall Study|Withdrawal by Subject|0
1116490|NCT02544152|2202158|FG001|Overall Study|Withdrawal by Subject|3
1116491|NCT02544152|2202157|FG000|Overall Study|Other|1
1116492|NCT02544152|2202158|FG001|Overall Study|Other|0
1116493|NCT02544217|2202170|FG000|Overall Study|Withdrawal by Subject|1
1116494|NCT02544217|2202171|FG001|Overall Study|Withdrawal by Subject|1
1116495|NCT02544217|2202172|FG002|Overall Study|Withdrawal by Subject|0
1116496|NCT02544217|2202173|FG003|Overall Study|Withdrawal by Subject|0
1116497|NCT02544217|2202174|FG004|Overall Study|Withdrawal by Subject|0
1116498|NCT02544217|2202175|FG005|Overall Study|Withdrawal by Subject|0
1116499|NCT02544321|2202244|FG000|Overall Study|Withdrawal by Subject|1
1116500|NCT02544321|2202245|FG001|Overall Study|Withdrawal by Subject|2
1116501|NCT02544321|2202244|FG000|Overall Study|Adverse Event|1
1116502|NCT02544321|2202245|FG001|Overall Study|Adverse Event|1
1116503|NCT02544321|2202244|FG000|Overall Study|Protocol Violation|0
1116504|NCT02544321|2202245|FG001|Overall Study|Protocol Violation|1
1116505|NCT02544451|2202263|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1
1116506|NCT02544451|2202264|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6
1116507|NCT02544451|2202265|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0
1116508|NCT02544451|2202266|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0
1116509|NCT02544451|2202263|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3
1116510|NCT02544451|2202264|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2
1116511|NCT02544451|2202265|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1
1116512|NCT02544451|2202266|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0
1116513|NCT02544451|2202263|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2
1116514|NCT02544451|2202264|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
1116515|NCT02544451|2202265|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
1116516|NCT02544451|2202266|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
1116517|NCT02544451|2202263|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4
1116518|NCT02544451|2202264|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0
1116519|NCT02544451|2202265|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0
1116520|NCT02544451|2202266|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0
1116521|NCT02544451|2202263|FG000|Treatment Period 1 (96 Weeks)|Other|4
1116522|NCT02544451|2202264|FG001|Treatment Period 1 (96 Weeks)|Other|4
1116523|NCT02544451|2202265|FG002|Treatment Period 1 (96 Weeks)|Other|0
1116524|NCT02544451|2202266|FG003|Treatment Period 1 (96 Weeks)|Other|0
1116525|NCT02544451|2202263|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
1116526|NCT02544451|2202264|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
1116527|NCT02544451|2202265|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
1116528|NCT02544451|2202266|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10
1116529|NCT02544633|2202293|FG000|Treatment Period|Patient Still on Treatment/Study|0
1116530|NCT02544633|2202294|FG001|Treatment Period|Patient Still on Treatment/Study|1
1116531|NCT02544633|2202295|FG002|Treatment Period|Patient Still on Treatment/Study|1
1116532|NCT02544633|2202296|FG003|Treatment Period|Patient Still on Treatment/Study|0
897026|NCT00706654|1868799|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21
897027|NCT00706654|1868800|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
897028|NCT00706654|1868801|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
897029|NCT00706654|1868802|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0
897030|NCT00706654|1868799|FG000|Oral Stabilization Phase|Withdrew consent|55
897031|NCT00706654|1868800|FG001|Oral Stabilization Phase|Withdrew consent|0
897032|NCT00706654|1868801|FG002|Oral Stabilization Phase|Withdrew consent|0
897033|NCT00706654|1868802|FG003|Oral Stabilization Phase|Withdrew consent|0
897034|NCT00706654|1868799|FG000|Oral Stabilization Phase|Protocol Deviation|2
897035|NCT00706654|1868800|FG001|Oral Stabilization Phase|Protocol Deviation|0
897036|NCT00706654|1868801|FG002|Oral Stabilization Phase|Protocol Deviation|0
897037|NCT00706654|1868802|FG003|Oral Stabilization Phase|Protocol Deviation|0
897038|NCT00706654|1868799|FG000|Oral Stabilization Phase|Adverse Event|21
897039|NCT00706654|1868800|FG001|Oral Stabilization Phase|Adverse Event|0
897040|NCT00706654|1868801|FG002|Oral Stabilization Phase|Adverse Event|0
897041|NCT00706654|1868802|FG003|Oral Stabilization Phase|Adverse Event|0
897042|NCT00706654|1868799|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
897043|NCT00706654|1868800|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
897044|NCT00706654|1868801|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
897045|NCT00706654|1868802|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
897046|NCT00706654|1868799|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
897047|NCT00706654|1868800|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
897048|NCT00706654|1868801|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
897049|NCT00706654|1868802|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
897050|NCT00706654|1868799|FG000|Depot Maintenance Phase|Lost to Follow-up|0
897051|NCT00706654|1868800|FG001|Depot Maintenance Phase|Lost to Follow-up|4
897052|NCT00706654|1868801|FG002|Depot Maintenance Phase|Lost to Follow-up|10
897053|NCT00706654|1868802|FG003|Depot Maintenance Phase|Lost to Follow-up|6
897054|NCT00706654|1868799|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
897055|NCT00706654|1868800|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4
897056|NCT00706654|1868801|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6
897057|NCT00706654|1868802|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5
897058|NCT00706654|1868799|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
897059|NCT00706654|1868800|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
897060|NCT00706654|1868801|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12
897061|NCT00706654|1868802|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8
897062|NCT00706654|1868799|FG000|Depot Maintenance Phase|Withdrew Consent|0
897063|NCT00706654|1868800|FG001|Depot Maintenance Phase|Withdrew Consent|21
897064|NCT00706654|1868801|FG002|Depot Maintenance Phase|Withdrew Consent|29
897065|NCT00706654|1868802|FG003|Depot Maintenance Phase|Withdrew Consent|14
897066|NCT00706654|1868799|FG000|Depot Maintenance Phase|Protocol Deviation|0
897067|NCT00706654|1868800|FG001|Depot Maintenance Phase|Protocol Deviation|2
1116533|NCT02544633|2202293|FG000|Treatment Period|Adverse Event|7
1116534|NCT02544633|2202294|FG001|Treatment Period|Adverse Event|4
1116535|NCT02544633|2202295|FG002|Treatment Period|Adverse Event|0
1116536|NCT02544633|2202296|FG003|Treatment Period|Adverse Event|5
1116537|NCT02544633|2202293|FG000|Treatment Period|Lack of Efficacy|17
1116538|NCT02544633|2202294|FG001|Treatment Period|Lack of Efficacy|11
1116539|NCT02544633|2202295|FG002|Treatment Period|Lack of Efficacy|5
1116540|NCT02544633|2202296|FG003|Treatment Period|Lack of Efficacy|5
1116541|NCT02544633|2202293|FG000|Treatment Period|Global Deterioration of Health|3
1116542|NCT02544633|2202294|FG001|Treatment Period|Global Deterioration of Health|3
1116543|NCT02544633|2202295|FG002|Treatment Period|Global Deterioration of Health|0
1116544|NCT02544633|2202296|FG003|Treatment Period|Global Deterioration of Health|1
1116545|NCT02544633|2202293|FG000|Treatment Period|Withdrawal by Subject|1
1116546|NCT02544633|2202294|FG001|Treatment Period|Withdrawal by Subject|0
1116547|NCT02544633|2202295|FG002|Treatment Period|Withdrawal by Subject|0
1116548|NCT02544633|2202296|FG003|Treatment Period|Withdrawal by Subject|0
1116549|NCT02544633|2202293|FG000|Treatment Period|Lost to Follow-up|0
1116550|NCT02544633|2202294|FG001|Treatment Period|Lost to Follow-up|1
1116551|NCT02544633|2202295|FG002|Treatment Period|Lost to Follow-up|0
1116552|NCT02544633|2202296|FG003|Treatment Period|Lost to Follow-up|0
1116553|NCT02544633|2202293|FG000|Treatment Period|Death|0
1116554|NCT02544633|2202294|FG001|Treatment Period|Death|0
1116555|NCT02544633|2202295|FG002|Treatment Period|Death|1
1116556|NCT02544633|2202296|FG003|Treatment Period|Death|0
1116557|NCT02544633|2202293|FG000|Treatment Period|Non-compliance|0
1116558|NCT02544633|2202294|FG001|Treatment Period|Non-compliance|0
1116559|NCT02544633|2202295|FG002|Treatment Period|Non-compliance|1
1116560|NCT02544633|2202296|FG003|Treatment Period|Non-compliance|0
1116561|NCT02544633|2202293|FG000|Treatment Period|Clinical Disease Progression|0
1116562|NCT02544633|2202294|FG001|Treatment Period|Clinical Disease Progression|0
1116563|NCT02544633|2202295|FG002|Treatment Period|Clinical Disease Progression|0
1116564|NCT02544633|2202296|FG003|Treatment Period|Clinical Disease Progression|1
1116565|NCT02544633|2202293|FG000|Survival Follow-up Period|Death|12
1116566|NCT02544633|2202294|FG001|Survival Follow-up Period|Death|14
1116567|NCT02544633|2202295|FG002|Survival Follow-up Period|Death|3
1116568|NCT02544633|2202296|FG003|Survival Follow-up Period|Death|9
1116569|NCT02544633|2202293|FG000|Survival Follow-up Period|Lost to Follow-up|0
1116570|NCT02544633|2202294|FG001|Survival Follow-up Period|Lost to Follow-up|1
1116571|NCT02544633|2202295|FG002|Survival Follow-up Period|Lost to Follow-up|1
1116572|NCT02544633|2202296|FG003|Survival Follow-up Period|Lost to Follow-up|0
1116573|NCT02544633|2202293|FG000|Survival Follow-up Period|Withdrawal by Subject|4
1116574|NCT02544633|2202294|FG001|Survival Follow-up Period|Withdrawal by Subject|0
1116575|NCT02544633|2202295|FG002|Survival Follow-up Period|Withdrawal by Subject|1
1116576|NCT02544633|2202296|FG003|Survival Follow-up Period|Withdrawal by Subject|0
1116577|NCT02544633|2202293|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12
1116578|NCT02544633|2202294|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4
1116579|NCT02544633|2202295|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2
1116580|NCT02544633|2202296|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3
1116581|NCT02544763|2202321|FG000|Overall Study|Adverse Event|8
1116582|NCT02544763|2202322|FG001|Overall Study|Adverse Event|8
1116583|NCT02544763|2202323|FG002|Overall Study|Adverse Event|0
1116584|NCT02544763|2202321|FG000|Overall Study|Withdrawn by parent/guardian|1
1116585|NCT02544763|2202322|FG001|Overall Study|Withdrawn by parent/guardian|1
1116586|NCT02544763|2202323|FG002|Overall Study|Withdrawn by parent/guardian|1
1116587|NCT02544763|2202321|FG000|Overall Study|Met withdrawal criteria|0
1116588|NCT02544763|2202322|FG001|Overall Study|Met withdrawal criteria|2
1116589|NCT02544763|2202323|FG002|Overall Study|Met withdrawal criteria|0
1116590|NCT02544763|2202321|FG000|Overall Study|Physician Decision|0
1116591|NCT02544763|2202322|FG001|Overall Study|Physician Decision|1
1116592|NCT02544763|2202323|FG002|Overall Study|Physician Decision|0
1116593|NCT02544763|2202321|FG000|Overall Study|Difficulties taking IMP|1
1116594|NCT02544763|2202322|FG001|Overall Study|Difficulties taking IMP|0
1116595|NCT02544763|2202323|FG002|Overall Study|Difficulties taking IMP|0
1116596|NCT02545075|2202342|FG000|Randomization|Lost to Follow-up|0
1116597|NCT02545075|2202343|FG001|Randomization|Lost to Follow-up|1
1116598|NCT02545075|2202342|FG000|Randomization|Withdrawal by Subject|0
1116599|NCT02545075|2202343|FG001|Randomization|Withdrawal by Subject|6
1116600|NCT02545075|2202342|FG000|Treatment|Disease progression|71
1116601|NCT02545075|2202343|FG001|Treatment|Disease progression|32
1116602|NCT02545075|2202342|FG000|Treatment|Participant dicontinued study treatment|7
1116603|NCT02545075|2202343|FG001|Treatment|Participant dicontinued study treatment|9
1116604|NCT02545075|2202342|FG000|Treatment|Withdrawal by Subject|1
1116605|NCT02545075|2202343|FG001|Treatment|Withdrawal by Subject|0
1116606|NCT02545075|2202342|FG000|Treatment|Adverse event not related to study drug|1
1116607|NCT02545075|2202343|FG001|Treatment|Adverse event not related to study drug|0
1116608|NCT02545075|2202342|FG000|Treatment|Death|1
1116609|NCT02545075|2202343|FG001|Treatment|Death|0
1116610|NCT02545075|2202342|FG000|Treatment|Participant drug toxicity|1
1116611|NCT02545075|2202343|FG001|Treatment|Participant drug toxicity|0
1116612|NCT02545075|2202342|FG000|Treatment|Completed treatment|40
1116613|NCT02545075|2202343|FG001|Treatment|Completed treatment|12
1116614|NCT02545270|2202356|FG000|Overall Study|technical difficulties|0
1116615|NCT02545270|2202357|FG001|Overall Study|technical difficulties|1
1116616|NCT02545270|2202358|FG002|Overall Study|technical difficulties|0
1116617|NCT02545270|2202356|FG000|Overall Study|Videos being too similar to other|0
1116618|NCT02545270|2202357|FG001|Overall Study|Videos being too similar to other|0
1116619|NCT02545270|2202358|FG002|Overall Study|Videos being too similar to other|2
1116630|NCT02545322|2202378|FG000|Overall Study|Withdrawal by Subject|3
1116631|NCT02545504|2202384|FG000|Overall Study|Death|174
1116632|NCT02545504|2202385|FG001|Overall Study|Death|168
1116633|NCT02545504|2202384|FG000|Overall Study|Unknown reason|30
1116634|NCT02545504|2202385|FG001|Overall Study|Unknown reason|32
1116635|NCT02545504|2202384|FG000|Overall Study|Withdrew consent|9
1116636|NCT02545504|2202385|FG001|Overall Study|Withdrew consent|11
1116637|NCT02545504|2202384|FG000|Overall Study|Investigator's discretion|3
1116638|NCT02545504|2202385|FG001|Overall Study|Investigator's discretion|1
1116639|NCT02545504|2202384|FG000|Overall Study|Lost to Follow-up|2
1116640|NCT02545504|2202385|FG001|Overall Study|Lost to Follow-up|2
1116641|NCT02545543|2202397|FG000|Overall Study|Lost to Follow-up|67
1116642|NCT02545543|2202398|FG001|Overall Study|Lost to Follow-up|25
1116643|NCT02545543|2202397|FG000|Overall Study|Physician Decision|3
1116644|NCT02545543|2202398|FG001|Overall Study|Physician Decision|0
1116645|NCT02545543|2202397|FG000|Overall Study|Withdrawal by Subject|9
1116646|NCT02545543|2202398|FG001|Overall Study|Withdrawal by Subject|8
1116647|NCT02545543|2202397|FG000|Overall Study|Noncomplaince|1
1116648|NCT02545543|2202398|FG001|Overall Study|Noncomplaince|0
1116649|NCT02545543|2202397|FG000|Overall Study|Enrolment of subject at >1 study site|1
1116650|NCT02545543|2202398|FG001|Overall Study|Enrolment of subject at >1 study site|1
1116654|NCT02545933|2202450|FG000|Overall Study|Adverse Event|3
1116655|NCT02545933|2202451|FG001|Overall Study|Adverse Event|0
1116656|NCT02545933|2202452|FG002|Overall Study|Adverse Event|0
897068|NCT00706654|1868801|FG002|Depot Maintenance Phase|Protocol Deviation|3
897069|NCT00706654|1868802|FG003|Depot Maintenance Phase|Protocol Deviation|1
897070|NCT00706654|1868799|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
897071|NCT00706654|1868800|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
897072|NCT00706654|1868801|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
897073|NCT00706654|1868802|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
897074|NCT00706654|1868799|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
897075|NCT00706654|1868800|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
897076|NCT00706654|1868801|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
897077|NCT00706654|1868802|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
897078|NCT00706654|1868799|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
897079|NCT00706654|1868800|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
897080|NCT00706654|1868801|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
897081|NCT00706654|1868802|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
897082|NCT00706706|1868812|FG000|Overall Study|Death|53
897083|NCT00706706|1868812|FG000|Overall Study|Lost to Follow-up|7
897084|NCT00706706|1868812|FG000|Overall Study|Study endpoint had reached|45
897085|NCT00706849|1868861|FG000|Treatment Period|Adverse Event|0
897086|NCT00706849|1868862|FG001|Treatment Period|Adverse Event|9
897087|NCT00706849|1868861|FG000|Treatment Period|Other|0
897088|NCT00706849|1868862|FG001|Treatment Period|Other|1
897089|NCT00706849|1868861|FG000|Follow-up Period|Withdrawal by Subject|0
897090|NCT00706849|1868862|FG001|Follow-up Period|Withdrawal by Subject|2
897091|NCT00706849|1868861|FG000|Follow-up Period|Protocol non-compliance|0
897092|NCT00706849|1868862|FG001|Follow-up Period|Protocol non-compliance|1
897093|NCT00706901|1868871|FG000|Overall Study|Lost to Follow-up|2
897094|NCT00706901|1868872|FG001|Overall Study|Lost to Follow-up|3
897095|NCT00706901|1868873|FG002|Overall Study|Lost to Follow-up|2
897096|NCT00706901|1868871|FG000|Overall Study|Withdrawal by Subject|4
897097|NCT00706901|1868872|FG001|Overall Study|Withdrawal by Subject|2
897098|NCT00706901|1868873|FG002|Overall Study|Withdrawal by Subject|5
1116657|NCT02545933|2202450|FG000|Overall Study|Withdrawal by Subject|2
1116658|NCT02545933|2202451|FG001|Overall Study|Withdrawal by Subject|3
1116659|NCT02545933|2202452|FG002|Overall Study|Withdrawal by Subject|3
1116660|NCT02545933|2202450|FG000|Overall Study|Protocol Violation|1
1116661|NCT02545933|2202451|FG001|Overall Study|Protocol Violation|0
1116662|NCT02545933|2202452|FG002|Overall Study|Protocol Violation|1
1116663|NCT02546193|2202462|FG000|Overall Study|Withdrawal by Subject|2
1116664|NCT02546193|2202463|FG001|Overall Study|Withdrawal by Subject|0
1116665|NCT02546193|2202464|FG002|Overall Study|Withdrawal by Subject|1
1116666|NCT02546193|2202465|FG003|Overall Study|Withdrawal by Subject|0
1116667|NCT02546193|2202462|FG000|Overall Study|Not eligible at time of induction|4
1116668|NCT02546193|2202463|FG001|Overall Study|Not eligible at time of induction|6
1116669|NCT02546193|2202464|FG002|Overall Study|Not eligible at time of induction|1
1116670|NCT02546193|2202465|FG003|Overall Study|Not eligible at time of induction|0
1116671|NCT02546323|2202473|FG000|Overall Study|Withdrawal by Subject|36
1116672|NCT02546323|2202474|FG001|Overall Study|Withdrawal by Subject|33
1116673|NCT02546323|2202473|FG000|Overall Study|Eligibility Criteria not Fulfilled|0
1116674|NCT02546323|2202474|FG001|Overall Study|Eligibility Criteria not Fulfilled|1
1116675|NCT02546323|2202473|FG000|Overall Study|Adverse Event|17
1116676|NCT02546323|2202474|FG001|Overall Study|Adverse Event|11
1116677|NCT02546323|2202473|FG000|Overall Study|Patient Specific Reasons|1
1116678|NCT02546323|2202474|FG001|Overall Study|Patient Specific Reasons|2
1116679|NCT02546323|2202473|FG000|Overall Study|Lost to Follow-up|2
1116680|NCT02546323|2202474|FG001|Overall Study|Lost to Follow-up|3
1116681|NCT02546323|2202473|FG000|Overall Study|Non-compliance with Study Drug|2
1116682|NCT02546323|2202474|FG001|Overall Study|Non-compliance with Study Drug|2
1116683|NCT02546323|2202473|FG000|Overall Study|Met Withdrawal Criteria|2
1116684|NCT02546323|2202474|FG001|Overall Study|Met Withdrawal Criteria|14
1116685|NCT02546362|2202480|FG000|4-week Treatment Period|Lost to Follow-up|1
1116686|NCT02546362|2202480|FG000|4-week Treatment Period|Change in medication|2
1116687|NCT02546362|2202480|FG000|12-week Treatment Period|Withdrawal by Subject|6
1116688|NCT02546362|2202480|FG000|12-week Treatment Period|Lost to Follow-up|2
1116689|NCT02546362|2202480|FG000|12-week Treatment Period|Change in medication|1
1116690|NCT02546609|2202518|FG000|Overall Study|Withdrawal by Subject|0
1116691|NCT02546609|2202519|FG001|Overall Study|Withdrawal by Subject|1
1116692|NCT02546609|2202520|FG002|Overall Study|Withdrawal by Subject|2
1116693|NCT02546609|2202518|FG000|Overall Study|Adverse Event|0
1116694|NCT02546609|2202519|FG001|Overall Study|Adverse Event|6
1116695|NCT02546609|2202520|FG002|Overall Study|Adverse Event|1
1116696|NCT02546609|2202518|FG000|Overall Study|Protocol Violation|0
1116697|NCT02546609|2202519|FG001|Overall Study|Protocol Violation|1
1116698|NCT02546609|2202520|FG002|Overall Study|Protocol Violation|1
1116699|NCT02546609|2202518|FG000|Overall Study|Lost to Follow-up|2
1116700|NCT02546609|2202519|FG001|Overall Study|Lost to Follow-up|3
1116701|NCT02546609|2202520|FG002|Overall Study|Lost to Follow-up|1
897099|NCT00706901|1868871|FG000|Overall Study|In Jail|1
897100|NCT00706901|1868872|FG001|Overall Study|In Jail|0
897101|NCT00706901|1868873|FG002|Overall Study|In Jail|1
897102|NCT00706901|1868871|FG000|Overall Study|Death|1
897103|NCT00706901|1868872|FG001|Overall Study|Death|0
897104|NCT00706901|1868873|FG002|Overall Study|Death|0
897105|NCT00706914|1868885|FG000|Overall Study|Lack of Efficacy|0
897106|NCT00706914|1868886|FG001|Overall Study|Lack of Efficacy|1
897107|NCT00706914|1868887|FG002|Overall Study|Lack of Efficacy|0
897108|NCT00706914|1868885|FG000|Overall Study|Lost to Follow-up|1
897109|NCT00706914|1868886|FG001|Overall Study|Lost to Follow-up|0
897110|NCT00706914|1868887|FG002|Overall Study|Lost to Follow-up|0
897111|NCT00706914|1868885|FG000|Overall Study|Adverse Event|2
897112|NCT00706914|1868886|FG001|Overall Study|Adverse Event|2
897113|NCT00706914|1868887|FG002|Overall Study|Adverse Event|0
897114|NCT00706914|1868885|FG000|Overall Study|Protocol Violation|3
897115|NCT00706914|1868886|FG001|Overall Study|Protocol Violation|1
897116|NCT00706914|1868887|FG002|Overall Study|Protocol Violation|1
897117|NCT00706966|1868895|FG000|Overall Study|Adverse Event|1
897118|NCT00706992|1868943|FG000|Overall Study|Study termination|5
897119|NCT00706992|1868944|FG001|Overall Study|Study termination|5
897120|NCT00706992|1868945|FG002|Overall Study|Study termination|6
897121|NCT00706992|1868946|FG003|Overall Study|Study termination|2
897122|NCT00706992|1868947|FG004|Overall Study|Study termination|3
897123|NCT00706992|1868948|FG005|Overall Study|Study termination|2
897124|NCT00706992|1868949|FG006|Overall Study|Study termination|3
897125|NCT00706992|1868943|FG000|Overall Study|Disease progression before treatment|0
897126|NCT00706992|1868944|FG001|Overall Study|Disease progression before treatment|0
897127|NCT00706992|1868945|FG002|Overall Study|Disease progression before treatment|0
897128|NCT00706992|1868946|FG003|Overall Study|Disease progression before treatment|0
897129|NCT00706992|1868947|FG004|Overall Study|Disease progression before treatment|1
897130|NCT00706992|1868948|FG005|Overall Study|Disease progression before treatment|0
897131|NCT00706992|1868949|FG006|Overall Study|Disease progression before treatment|0
897132|NCT00707031|1868968|FG000|Overall Study|Adverse Event|45
897133|NCT00707031|1868969|FG001|Overall Study|Adverse Event|45
897134|NCT00707031|1868968|FG000|Overall Study|Lack of Efficacy|19
897135|NCT00707031|1868969|FG001|Overall Study|Lack of Efficacy|6
897136|NCT00707031|1868968|FG000|Overall Study|Lost to Follow-up|2
897137|NCT00707031|1868969|FG001|Overall Study|Lost to Follow-up|1
897138|NCT00707031|1868968|FG000|Overall Study|Protocol Violation|1
897139|NCT00707031|1868969|FG001|Overall Study|Protocol Violation|0
897140|NCT00707031|1868968|FG000|Overall Study|Withdrawal by Subject|7
897141|NCT00707031|1868969|FG001|Overall Study|Withdrawal by Subject|8
897142|NCT00707031|1868968|FG000|Overall Study|Poor Compliance to Protocol|7
897143|NCT00707031|1868969|FG001|Overall Study|Poor Compliance to Protocol|13
1116702|NCT02546609|2202518|FG000|Overall Study|travel or work schedule restriction|0
1116703|NCT02546609|2202519|FG001|Overall Study|travel or work schedule restriction|0
1116704|NCT02546609|2202520|FG002|Overall Study|travel or work schedule restriction|2
1116705|NCT02546765|2202532|FG000|Overall Study|Withdrawal by Subject|0
1116706|NCT02546765|2202533|FG001|Overall Study|Withdrawal by Subject|1
1116707|NCT02546765|2202534|FG002|Overall Study|Withdrawal by Subject|0
1116708|NCT02546765|2202535|FG003|Overall Study|Withdrawal by Subject|0
1116709|NCT02546856|2202558|FG000|4 Months Evaluation|Death|2
1116710|NCT02546856|2202559|FG001|4 Months Evaluation|Death|3
1116711|NCT02546856|2202558|FG000|4 Months Evaluation|Withdrawal by Subject|2
1116712|NCT02546856|2202559|FG001|4 Months Evaluation|Withdrawal by Subject|3
1116713|NCT02546856|2202558|FG000|4 Months Evaluation|Lost to Follow-up|3
1116714|NCT02546856|2202559|FG001|4 Months Evaluation|Lost to Follow-up|3
1116715|NCT02546856|2202558|FG000|4 Months Evaluation|Physician Decision|3
1116716|NCT02546856|2202559|FG001|4 Months Evaluation|Physician Decision|0
1116717|NCT02546856|2202558|FG000|4 Months Evaluation|Working or living abroad|5
1116718|NCT02546856|2202559|FG001|4 Months Evaluation|Working or living abroad|1
1116719|NCT02546856|2202558|FG000|4 Months Evaluation|reasons not due to titration|4
1116720|NCT02546856|2202559|FG001|4 Months Evaluation|reasons not due to titration|1
1116721|NCT02546856|2202558|FG000|4 Months Evaluation|HF Unit not active in summer|1
1116722|NCT02546856|2202559|FG001|4 Months Evaluation|HF Unit not active in summer|0
1116723|NCT02546856|2202558|FG000|6 Months Evaluation|Death|1
1116724|NCT02546856|2202559|FG001|6 Months Evaluation|Death|1
1116725|NCT02546856|2202558|FG000|6 Months Evaluation|Lost to Follow-up|1
1116726|NCT02546856|2202559|FG001|6 Months Evaluation|Lost to Follow-up|1
1116727|NCT02546856|2202558|FG000|6 Months Evaluation|Working or living abroad|6
1116728|NCT02546856|2202559|FG001|6 Months Evaluation|Working or living abroad|4
1116729|NCT02546856|2202558|FG000|6 Months Evaluation|reasons not due to titration|0
1116730|NCT02546856|2202559|FG001|6 Months Evaluation|reasons not due to titration|1
1116759|NCT02547038|2202597|FG000|Overall Study|Lost to Follow-up|3
897144|NCT00707031|1868968|FG000|Overall Study|Familial or Personal Reasons|12
897145|NCT00707031|1868969|FG001|Overall Study|Familial or Personal Reasons|15
897146|NCT00707031|1868968|FG000|Overall Study|Serious Noncompliance|2
897147|NCT00707031|1868969|FG001|Overall Study|Serious Noncompliance|3
897148|NCT00707031|1868968|FG000|Overall Study|Sponsor Decision|9
897149|NCT00707031|1868969|FG001|Overall Study|Sponsor Decision|8
897150|NCT00707057|1868978|FG000|Overall Study|Withdrawal by Subject|8
897151|NCT00707057|1868979|FG001|Overall Study|Withdrawal by Subject|3
897152|NCT00707057|1868978|FG000|Overall Study|Dosed incorrectly|0
897153|NCT00707057|1868979|FG001|Overall Study|Dosed incorrectly|1
897154|NCT00707174|1868987|FG000|Overall Study|Adverse Event|1
897155|NCT00707174|1868988|FG001|Overall Study|Adverse Event|6
897156|NCT00707174|1868987|FG000|Overall Study|Withdrawal by Subject|4
897157|NCT00707174|1868988|FG001|Overall Study|Withdrawal by Subject|1
897158|NCT00707239|1868997|FG000|Overall Study|Adverse Event|5
897159|NCT00707239|1868998|FG001|Overall Study|Adverse Event|3
897160|NCT00707239|1868999|FG002|Overall Study|Adverse Event|2
897161|NCT00707239|1868997|FG000|Overall Study|Death|3
897162|NCT00707239|1868998|FG001|Overall Study|Death|1
897163|NCT00707239|1868999|FG002|Overall Study|Death|3
897164|NCT00707239|1868997|FG000|Overall Study|Physician Decision|1
897165|NCT00707239|1868998|FG001|Overall Study|Physician Decision|1
897166|NCT00707239|1868999|FG002|Overall Study|Physician Decision|2
1116760|NCT02547038|2202598|FG001|Overall Study|Lost to Follow-up|2
1116761|NCT02547220|2202615|FG000|Overall Study|Withdrawal by Subject|1
1116762|NCT02547220|2202616|FG001|Overall Study|Withdrawal by Subject|0
1116763|NCT02547220|2202615|FG000|Overall Study|Study terminated by sponsor|18
1116764|NCT02547220|2202616|FG001|Overall Study|Study terminated by sponsor|20
1116765|NCT02547233|2202624|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1
1116766|NCT02547233|2202625|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0
1116767|NCT02547233|2202624|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
1116768|NCT02547233|2202625|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
1116769|NCT02547233|2202624|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
1116770|NCT02547233|2202625|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
1116771|NCT02547233|2202624|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
1116772|NCT02547233|2202625|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
1116773|NCT02547233|2202624|FG000|12-month Follow-up|Withdrawal by Subject|10
1116774|NCT02547233|2202625|FG001|12-month Follow-up|Withdrawal by Subject|10
1116775|NCT02547233|2202624|FG000|12-month Follow-up|Lost to Follow-up|3
1116776|NCT02547233|2202625|FG001|12-month Follow-up|Lost to Follow-up|3
1116777|NCT02547233|2202624|FG000|12-month Follow-up|Lack of Efficacy|1
1116778|NCT02547233|2202625|FG001|12-month Follow-up|Lack of Efficacy|2
1116779|NCT02547233|2202624|FG000|12-month Follow-up|Protocol Violation|0
1116780|NCT02547233|2202625|FG001|12-month Follow-up|Protocol Violation|1
1116781|NCT02547233|2202624|FG000|12-month Follow-up|Other|0
1116782|NCT02547233|2202625|FG001|12-month Follow-up|Other|1
1116783|NCT02547363|2202635|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
1116784|NCT02547363|2202636|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
1116785|NCT02547363|2202635|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
1116786|NCT02547363|2202636|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
1116787|NCT02547363|2202635|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
1116788|NCT02547363|2202636|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
1116789|NCT02547363|2202635|FG000|3-day Treatment and 8-week Follow-up|Other|1
1116790|NCT02547363|2202636|FG001|3-day Treatment and 8-week Follow-up|Other|1
1116791|NCT02547363|2202635|FG000|12-month Follow-up|Withdrawal by Subject|4
1116792|NCT02547363|2202636|FG001|12-month Follow-up|Withdrawal by Subject|3
1116793|NCT02547363|2202635|FG000|12-month Follow-up|Lost to Follow-up|4
1116794|NCT02547363|2202636|FG001|12-month Follow-up|Lost to Follow-up|1
1116795|NCT02547363|2202635|FG000|12-month Follow-up|Lack of Efficacy|1
1116796|NCT02547363|2202636|FG001|12-month Follow-up|Lack of Efficacy|1
1116797|NCT02547363|2202635|FG000|12-month Follow-up|Other|1
1116798|NCT02547363|2202636|FG001|12-month Follow-up|Other|0
1116799|NCT02547428|2202646|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8
1116800|NCT02547428|2202647|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1
1116801|NCT02547428|2202646|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
1116802|NCT02547428|2202647|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
1116803|NCT02547428|2202646|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
1116804|NCT02547428|2202647|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
1116805|NCT02547428|2202646|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1
1116806|NCT02547428|2202647|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3
1116807|NCT02547428|2202646|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0
1116808|NCT02547428|2202647|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3
1116809|NCT02547428|2202646|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0
1116810|NCT02547428|2202647|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3
1116811|NCT02547428|2202646|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0
1116812|NCT02547428|2202647|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1
1116813|NCT02547428|2202646|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1
1116814|NCT02547428|2202647|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0
1116815|NCT02547454|2202660|FG000|Overall Study|Due to hemodialysis|53
1116816|NCT02547454|2202660|FG000|Overall Study|Due to transplantation|1
1116817|NCT02547454|2202660|FG000|Overall Study|Due to no further need to treat|4
1116818|NCT02547454|2202660|FG000|Overall Study|Death|38
1116819|NCT02547454|2202660|FG000|Overall Study|Lost to Follow-up|26
1116820|NCT02547454|2202660|FG000|Overall Study|Other|39
1116821|NCT02547454|2202660|FG000|Overall Study|No data|11
1116822|NCT02547649|2202676|FG000|Overall Study|Lost to Follow-up|3
1116823|NCT02547649|2202677|FG001|Overall Study|Lost to Follow-up|1
1116824|NCT02547649|2202678|FG002|Overall Study|Lost to Follow-up|1
1116825|NCT02547649|2202676|FG000|Overall Study|Not vaccinated|0
1116826|NCT02547649|2202677|FG001|Overall Study|Not vaccinated|0
1116827|NCT02547649|2202678|FG002|Overall Study|Not vaccinated|1
1116828|NCT02547649|2202676|FG000|Overall Study|Withdrawal by Subject|0
1116829|NCT02547649|2202677|FG001|Overall Study|Withdrawal by Subject|4
1116830|NCT02547649|2202678|FG002|Overall Study|Withdrawal by Subject|2
1116831|NCT02547766|2202691|FG000|Overall Study|Withdrawal by Subject|1
1116832|NCT02547922|2202707|FG000|Overall Study|Withdrawal by Subject|9
1116833|NCT02547922|2202708|FG001|Overall Study|Withdrawal by Subject|6
1116834|NCT02547922|2202709|FG002|Overall Study|Withdrawal by Subject|10
1116835|NCT02547922|2202707|FG000|Overall Study|Adverse Event|3
1116836|NCT02547922|2202708|FG001|Overall Study|Adverse Event|1
1116837|NCT02547922|2202709|FG002|Overall Study|Adverse Event|2
1116838|NCT02547922|2202707|FG000|Overall Study|Lost to Follow-up|1
1116839|NCT02547922|2202708|FG001|Overall Study|Lost to Follow-up|0
1116840|NCT02547922|2202709|FG002|Overall Study|Lost to Follow-up|0
1116841|NCT02547922|2202707|FG000|Overall Study|Lack of Efficacy|5
1116842|NCT02547922|2202708|FG001|Overall Study|Lack of Efficacy|7
1116843|NCT02547922|2202709|FG002|Overall Study|Lack of Efficacy|4
1116844|NCT02547922|2202707|FG000|Overall Study|Death|1
1116845|NCT02547922|2202708|FG001|Overall Study|Death|0
1116846|NCT02547922|2202709|FG002|Overall Study|Death|0
1116847|NCT02547922|2202707|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4
1116848|NCT02547922|2202708|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8
1116849|NCT02547922|2202709|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9
1116850|NCT02547922|2202707|FG000|Overall Study|TECHNICAL PROBLEMS|1
1116851|NCT02547922|2202708|FG001|Overall Study|TECHNICAL PROBLEMS|0
1116852|NCT02547922|2202709|FG002|Overall Study|TECHNICAL PROBLEMS|0
1116853|NCT02547922|2202707|FG000|Overall Study|PROGRESSIVE DISEASE|1
897167|NCT00707239|1868997|FG000|Overall Study|Protocol Violation|0
897168|NCT00707239|1868998|FG001|Overall Study|Protocol Violation|0
897169|NCT00707239|1868999|FG002|Overall Study|Protocol Violation|1
897170|NCT00707239|1868997|FG000|Overall Study|Lack of Efficacy|1
897171|NCT00707239|1868998|FG001|Overall Study|Lack of Efficacy|2
897172|NCT00707239|1868999|FG002|Overall Study|Lack of Efficacy|0
897173|NCT00707239|1868997|FG000|Overall Study|Randomized, but not treated|1
897174|NCT00707239|1868998|FG001|Overall Study|Randomized, but not treated|1
897175|NCT00707239|1868999|FG002|Overall Study|Randomized, but not treated|1
897176|NCT00707239|1868997|FG000|Overall Study|Other|8
897177|NCT00707239|1868998|FG001|Overall Study|Other|3
897178|NCT00707239|1868999|FG002|Overall Study|Other|5
897179|NCT00707486|1869023|FG000|Overall Study|Withdrawal by Subject|1
897180|NCT00707577|1869031|FG000|Overall Study|Withdrawal by Subject|3
897181|NCT00707577|1869032|FG001|Overall Study|Withdrawal by Subject|2
897182|NCT00707577|1869031|FG000|Overall Study|Lost to Follow-up|34
897183|NCT00707577|1869032|FG001|Overall Study|Lost to Follow-up|25
897184|NCT00707577|1869031|FG000|Overall Study|Left employment|13
897185|NCT00707577|1869032|FG001|Overall Study|Left employment|10
897186|NCT00707577|1869031|FG000|Overall Study|Pregnancy|4
897187|NCT00707577|1869032|FG001|Overall Study|Pregnancy|1
897188|NCT00707746|1869051|FG000|Treatment Period|Adverse Event|2
897189|NCT00707746|1869052|FG001|Treatment Period|Adverse Event|4
897190|NCT00707746|1869051|FG000|Treatment Period|Ineligibility|0
897191|NCT00707746|1869052|FG001|Treatment Period|Ineligibility|1
897192|NCT00707954|1869085|FG000|Overall Study|Physician Decision|0
897193|NCT00707954|1869086|FG001|Overall Study|Physician Decision|0
897194|NCT00707954|1869087|FG002|Overall Study|Physician Decision|0
897195|NCT00707954|1869088|FG003|Overall Study|Physician Decision|0
897196|NCT00707954|1869089|FG004|Overall Study|Physician Decision|1
897197|NCT00707980|1869114|FG000|Overall Study|Adverse Event|49
897198|NCT00707980|1869114|FG000|Overall Study|Lack of Efficacy|35
897199|NCT00707980|1869114|FG000|Overall Study|Non-Compliance with Study Drug|28
897200|NCT00707980|1869114|FG000|Overall Study|Protocol Deviations|19
897201|NCT00707980|1869114|FG000|Overall Study|Withdrawal of Consent|81
897202|NCT00707980|1869114|FG000|Overall Study|Lost to Follow-up|59
897203|NCT00707980|1869114|FG000|Overall Study|Other|39
897204|NCT00707993|1869120|FG000|Overall Study|Adverse Event|16
897205|NCT00707993|1869121|FG001|Overall Study|Adverse Event|20
897206|NCT00707993|1869120|FG000|Overall Study|Protocol Violation|4
897207|NCT00707993|1869121|FG001|Overall Study|Protocol Violation|7
897208|NCT00707993|1869120|FG000|Overall Study|Lost to Follow-up|0
897209|NCT00707993|1869121|FG001|Overall Study|Lost to Follow-up|4
897210|NCT00707993|1869120|FG000|Overall Study|Withdrawal by Subject|12
897211|NCT00707993|1869121|FG001|Overall Study|Withdrawal by Subject|16
897212|NCT00707993|1869120|FG000|Overall Study|Hyperglycemic Rescue|55
897213|NCT00707993|1869121|FG001|Overall Study|Hyperglycemic Rescue|47
897214|NCT00707993|1869120|FG000|Overall Study|Other|2
897215|NCT00707993|1869121|FG001|Overall Study|Other|0
897216|NCT00708032|1869138|FG000|Overall Study|Adverse Event|0
897217|NCT00708032|1869139|FG001|Overall Study|Adverse Event|2
897218|NCT00708032|1869138|FG000|Overall Study|Lost to Follow-up|1
897219|NCT00708032|1869139|FG001|Overall Study|Lost to Follow-up|2
897220|NCT00708032|1869138|FG000|Overall Study|Pregnancy|0
897221|NCT00708032|1869139|FG001|Overall Study|Pregnancy|1
897222|NCT00708032|1869138|FG000|Overall Study|Poor vision|0
897223|NCT00708032|1869139|FG001|Overall Study|Poor vision|6
897224|NCT00708032|1869138|FG000|Overall Study|Visit out of range at month 12|4
897225|NCT00708032|1869139|FG001|Overall Study|Visit out of range at month 12|1
897226|NCT00708032|1869138|FG000|Overall Study|Did not meet protocol criteria|1
897227|NCT00708032|1869139|FG001|Overall Study|Did not meet protocol criteria|2
897228|NCT00708032|1869138|FG000|Overall Study|Protocol Violation|4
897229|NCT00708032|1869139|FG001|Overall Study|Protocol Violation|1
897230|NCT00708032|1869138|FG000|Overall Study|Withdrawal by Subject|0
897231|NCT00708032|1869139|FG001|Overall Study|Withdrawal by Subject|1
897232|NCT00708097|1869179|FG000|Period 1|Protocol Violation|0
897233|NCT00708097|1869180|FG001|Period 1|Protocol Violation|1
897234|NCT00708097|1869181|FG002|Period 1|Protocol Violation|0
1116854|NCT02547922|2202708|FG001|Overall Study|PROGRESSIVE DISEASE|0
1116855|NCT02547922|2202709|FG002|Overall Study|PROGRESSIVE DISEASE|2
1116856|NCT02547922|2202707|FG000|Overall Study|Physician Decision|2
1116857|NCT02547922|2202708|FG001|Overall Study|Physician Decision|1
1116858|NCT02547922|2202709|FG002|Overall Study|Physician Decision|2
1116859|NCT02547922|2202707|FG000|Overall Study|Patients did not receive IP|1
1116860|NCT02547922|2202708|FG001|Overall Study|Patients did not receive IP|1
1116861|NCT02547922|2202709|FG002|Overall Study|Patients did not receive IP|0
1116862|NCT02547935|2202726|FG000|Overall Study|Other|0
1116863|NCT02547935|2202727|FG001|Overall Study|Other|1
1116864|NCT02547935|2202728|FG002|Overall Study|Other|0
1116865|NCT02547935|2202726|FG000|Overall Study|Withdrawal by Subject|2
1116866|NCT02547935|2202727|FG001|Overall Study|Withdrawal by Subject|3
1116867|NCT02547935|2202728|FG002|Overall Study|Withdrawal by Subject|4
1116868|NCT02547935|2202726|FG000|Overall Study|Screen Failure|2
1116869|NCT02547935|2202727|FG001|Overall Study|Screen Failure|0
1116870|NCT02547935|2202728|FG002|Overall Study|Screen Failure|0
1116871|NCT02547935|2202726|FG000|Overall Study|Physician Decision|0
1116872|NCT02547935|2202727|FG001|Overall Study|Physician Decision|1
1116873|NCT02547935|2202728|FG002|Overall Study|Physician Decision|0
1116874|NCT02547935|2202726|FG000|Overall Study|Lost to Follow-up|0
1116875|NCT02547935|2202727|FG001|Overall Study|Lost to Follow-up|2
1116876|NCT02547935|2202728|FG002|Overall Study|Lost to Follow-up|1
1116877|NCT02547935|2202726|FG000|Overall Study|Death|1
1116878|NCT02547935|2202727|FG001|Overall Study|Death|1
1116879|NCT02547935|2202728|FG002|Overall Study|Death|0
1116880|NCT02547974|2202742|FG000|Overall Study|Withdrawal by Subject|1
1116881|NCT02547974|2202743|FG001|Overall Study|Withdrawal by Subject|0
897235|NCT00708097|1869182|FG003|Period 1|Protocol Violation|2
897236|NCT00708097|1869183|FG004|Period 1|Protocol Violation|0
897237|NCT00708097|1869179|FG000|Period 1|Other Reason|0
897238|NCT00708097|1869180|FG001|Period 1|Other Reason|0
897239|NCT00708097|1869181|FG002|Period 1|Other Reason|0
897240|NCT00708097|1869182|FG003|Period 1|Other Reason|0
897241|NCT00708097|1869183|FG004|Period 1|Other Reason|1
897242|NCT00708097|1869179|FG000|Period 2|Protocol Violation|0
897243|NCT00708097|1869180|FG001|Period 2|Protocol Violation|1
897244|NCT00708097|1869181|FG002|Period 2|Protocol Violation|1
897245|NCT00708097|1869182|FG003|Period 2|Protocol Violation|1
897246|NCT00708097|1869183|FG004|Period 2|Protocol Violation|0
897247|NCT00708123|1869217|FG000|Period 1|Protocol Violation|0
897248|NCT00708123|1869218|FG001|Period 1|Protocol Violation|1
897249|NCT00708123|1869219|FG002|Period 1|Protocol Violation|0
897250|NCT00708123|1869220|FG003|Period 1|Protocol Violation|1
897251|NCT00708123|1869221|FG004|Period 1|Protocol Violation|0
897252|NCT00708123|1869217|FG000|Period 1|Adverse Event|0
897253|NCT00708123|1869218|FG001|Period 1|Adverse Event|0
897254|NCT00708123|1869219|FG002|Period 1|Adverse Event|1
897255|NCT00708123|1869220|FG003|Period 1|Adverse Event|0
897256|NCT00708123|1869221|FG004|Period 1|Adverse Event|0
897257|NCT00708123|1869217|FG000|Period 2|Protocol Violation|0
897258|NCT00708123|1869218|FG001|Period 2|Protocol Violation|0
897259|NCT00708123|1869219|FG002|Period 2|Protocol Violation|0
897260|NCT00708123|1869220|FG003|Period 2|Protocol Violation|1
897261|NCT00708123|1869221|FG004|Period 2|Protocol Violation|0
897262|NCT00708123|1869217|FG000|Period 2|Other Reason|1
897263|NCT00708123|1869218|FG001|Period 2|Other Reason|0
897264|NCT00708123|1869219|FG002|Period 2|Other Reason|0
897265|NCT00708123|1869220|FG003|Period 2|Other Reason|0
897266|NCT00708123|1869221|FG004|Period 2|Other Reason|0
897267|NCT00708123|1869217|FG000|Period 3|Lost to Follow-up|0
897268|NCT00708123|1869218|FG001|Period 3|Lost to Follow-up|0
897269|NCT00708123|1869219|FG002|Period 3|Lost to Follow-up|1
897270|NCT00708123|1869220|FG003|Period 3|Lost to Follow-up|1
897271|NCT00708123|1869221|FG004|Period 3|Lost to Follow-up|0
897272|NCT00708123|1869217|FG000|Period 4|Protocol Violation|0
897273|NCT00708123|1869218|FG001|Period 4|Protocol Violation|1
897274|NCT00708123|1869219|FG002|Period 4|Protocol Violation|0
897275|NCT00708123|1869220|FG003|Period 4|Protocol Violation|0
897276|NCT00708123|1869221|FG004|Period 4|Protocol Violation|0
897277|NCT00708162|1869239|FG000|Randomized Phase|Randomized but Not Treated|7
897278|NCT00708162|1869240|FG001|Randomized Phase|Randomized but Not Treated|5
897279|NCT00708162|1869239|FG000|Randomized Phase|Participant Noncompliance|40
897280|NCT00708162|1869240|FG001|Randomized Phase|Participant Noncompliance|32
897281|NCT00708162|1869239|FG000|Randomized Phase|Lost to Follow-up|34
897282|NCT00708162|1869240|FG001|Randomized Phase|Lost to Follow-up|34
897283|NCT00708162|1869239|FG000|Randomized Phase|Withdrew Consent|31
897284|NCT00708162|1869240|FG001|Randomized Phase|Withdrew Consent|22
897285|NCT00708162|1869239|FG000|Randomized Phase|Lack of Efficacy|14
897286|NCT00708162|1869240|FG001|Randomized Phase|Lack of Efficacy|19
897287|NCT00708162|1869239|FG000|Randomized Phase|Protocol Violation|10
897288|NCT00708162|1869240|FG001|Randomized Phase|Protocol Violation|11
897289|NCT00708162|1869239|FG000|Randomized Phase|Adverse Event|8
897290|NCT00708162|1869240|FG001|Randomized Phase|Adverse Event|12
897291|NCT00708162|1869239|FG000|Randomized Phase|Investigator's Discretion|7
897292|NCT00708162|1869240|FG001|Randomized Phase|Investigator's Discretion|10
897293|NCT00708162|1869239|FG000|Randomized Phase|Death|2
897294|NCT00708162|1869240|FG001|Randomized Phase|Death|9
1116882|NCT02547974|2202744|FG002|Overall Study|Withdrawal by Subject|0
1116883|NCT02547974|2202745|FG003|Overall Study|Withdrawal by Subject|0
1116884|NCT02547987|2202758|FG000|Overall Study|Withdrawal by Subject|1
1116885|NCT02547987|2202758|FG000|Overall Study|Adverse Event|2
1116886|NCT02548078|2202764|FG000|Overall Study|Serious adverse event/Adverse event|1
1116887|NCT02548078|2202765|FG001|Overall Study|Serious adverse event/Adverse event|0
1116888|NCT02548078|2202764|FG000|Overall Study|Moved from study area|3
1116889|NCT02548078|2202765|FG001|Overall Study|Moved from study area|3
1116890|NCT02548078|2202764|FG000|Overall Study|Lost to Follow-up|1
1116891|NCT02548078|2202765|FG001|Overall Study|Lost to Follow-up|3
1116892|NCT02548143|2202780|FG000|Overall Study|Adverse Event|1
1116893|NCT02548143|2202781|FG001|Overall Study|Adverse Event|0
1116894|NCT02548143|2202780|FG000|Overall Study|Withdrawal by Subject|0
1116895|NCT02548143|2202781|FG001|Overall Study|Withdrawal by Subject|1
1116896|NCT02548156|2202787|FG000|Washout Period 1|Lost to Follow-up|0
1116897|NCT02548156|2202788|FG001|Washout Period 1|Lost to Follow-up|0
1116898|NCT02548156|2202789|FG002|Washout Period 1|Lost to Follow-up|0
1116899|NCT02548156|2202790|FG003|Washout Period 1|Lost to Follow-up|0
1116900|NCT02548156|2202791|FG004|Washout Period 1|Lost to Follow-up|1
1116901|NCT02548156|2202792|FG005|Washout Period 1|Lost to Follow-up|0
1116902|NCT02548455|2202833|FG000|Overall Study|Withdrawal by Subject|27
1116903|NCT02548455|2202833|FG000|Overall Study|Death|26
1116904|NCT02548455|2202833|FG000|Overall Study|Lost to Follow-up|14
1116905|NCT02548455|2202833|FG000|Overall Study|Visit not completed|173
1116906|NCT02548585|2202844|FG000|Overall Study|Withdrawal by Subject|0
1116907|NCT02548585|2202845|FG001|Overall Study|Withdrawal by Subject|0
1116908|NCT02548585|2202846|FG002|Overall Study|Withdrawal by Subject|0
1116909|NCT02548585|2202847|FG003|Overall Study|Withdrawal by Subject|0
1116910|NCT02548585|2202848|FG004|Overall Study|Withdrawal by Subject|0
1116911|NCT02548585|2202849|FG005|Overall Study|Withdrawal by Subject|1
1116912|NCT02548585|2202850|FG006|Overall Study|Withdrawal by Subject|0
1116913|NCT02548585|2202844|FG000|Overall Study|Lost to Follow-up|1
1116914|NCT02548585|2202845|FG001|Overall Study|Lost to Follow-up|0
1116915|NCT02548585|2202846|FG002|Overall Study|Lost to Follow-up|0
1116916|NCT02548585|2202847|FG003|Overall Study|Lost to Follow-up|0
1116917|NCT02548585|2202848|FG004|Overall Study|Lost to Follow-up|0
1116918|NCT02548585|2202849|FG005|Overall Study|Lost to Follow-up|0
1116919|NCT02548585|2202850|FG006|Overall Study|Lost to Follow-up|0
1116920|NCT02548585|2202844|FG000|Overall Study|Other|1
1116921|NCT02548585|2202845|FG001|Overall Study|Other|0
1116922|NCT02548585|2202846|FG002|Overall Study|Other|0
1116923|NCT02548585|2202847|FG003|Overall Study|Other|2
1116924|NCT02548585|2202848|FG004|Overall Study|Other|3
1116925|NCT02548585|2202849|FG005|Overall Study|Other|0
1116926|NCT02548585|2202850|FG006|Overall Study|Other|1
1116927|NCT02548585|2202844|FG000|Overall Study|Randomized but not treated|0
1116928|NCT02548585|2202845|FG001|Overall Study|Randomized but not treated|0
1116929|NCT02548585|2202846|FG002|Overall Study|Randomized but not treated|0
1116930|NCT02548585|2202847|FG003|Overall Study|Randomized but not treated|0
1116931|NCT02548585|2202848|FG004|Overall Study|Randomized but not treated|0
1116932|NCT02548585|2202849|FG005|Overall Study|Randomized but not treated|1
1116933|NCT02548585|2202850|FG006|Overall Study|Randomized but not treated|0
1116934|NCT02548650|2202893|FG000|Triple Therapy|Adverse Event|1
1116935|NCT02548650|2202894|FG001|Triple Therapy|Adverse Event|0
1116936|NCT02548650|2202893|FG000|Triple Therapy|Withdrawal by Subject|0
1116937|NCT02548650|2202894|FG001|Triple Therapy|Withdrawal by Subject|4
1116938|NCT02548650|2202893|FG000|Double Therapy|Adverse Event|1
1116939|NCT02548650|2202894|FG001|Double Therapy|Adverse Event|1
1116940|NCT02548650|2202893|FG000|Double Therapy|Withdrawal by Subject|0
1116941|NCT02548650|2202894|FG001|Double Therapy|Withdrawal by Subject|1
1116942|NCT02548962|2202942|FG000|Overall Study|Withdrawal by Subject|1
1116943|NCT02548962|2202943|FG001|Overall Study|Withdrawal by Subject|0
1116944|NCT02549027|2202978|FG000|Washout After Period 4|Withdrawal by Subject|0
1116945|NCT02549027|2202979|FG001|Washout After Period 4|Withdrawal by Subject|1
1116946|NCT02549027|2202980|FG002|Washout After Period 4|Withdrawal by Subject|1
1116947|NCT02549027|2202981|FG003|Washout After Period 4|Withdrawal by Subject|1
1116948|NCT02549027|2202982|FG004|Washout After Period 4|Withdrawal by Subject|0
1116949|NCT02549027|2202983|FG005|Washout After Period 4|Withdrawal by Subject|0
1116950|NCT02549027|2202978|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1116951|NCT02549027|2202979|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1116952|NCT02549027|2202980|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1116953|NCT02549027|2202981|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1116954|NCT02549027|2202982|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2
1116955|NCT02549027|2202983|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1116966|NCT02549196|2203026|FG000|Overall Study|Protocol Violation|0
1116967|NCT02549196|2203027|FG001|Overall Study|Protocol Violation|0
1116968|NCT02549196|2203028|FG002|Overall Study|Protocol Violation|0
1116969|NCT02549196|2203029|FG003|Overall Study|Protocol Violation|1
1116970|NCT02549196|2203026|FG000|Overall Study|Withdrawal by Subject|1
1116971|NCT02549196|2203027|FG001|Overall Study|Withdrawal by Subject|0
1116972|NCT02549196|2203028|FG002|Overall Study|Withdrawal by Subject|1
1116973|NCT02549196|2203029|FG003|Overall Study|Withdrawal by Subject|0
1116974|NCT02549287|2203045|FG000|Overall Study|Lost to Follow-up|65
1116975|NCT02549287|2203046|FG001|Overall Study|Lost to Follow-up|26
1116976|NCT02549287|2203045|FG000|Overall Study|Withdrawal by Subject|15
1116977|NCT02549287|2203046|FG001|Overall Study|Withdrawal by Subject|6
1116978|NCT02549339|2203054|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2
1116979|NCT02549339|2203055|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0
1116980|NCT02549339|2203054|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
1116981|NCT02549339|2203055|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
1116982|NCT02549339|2203054|FG000|3-day Treatment and 8-week Follow-up|Other|1
1116983|NCT02549339|2203055|FG001|3-day Treatment and 8-week Follow-up|Other|0
1116984|NCT02549339|2203054|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
1116985|NCT02549339|2203055|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
1116986|NCT02549339|2203054|FG000|12-month Follow-up|Lack of Efficacy|0
1116987|NCT02549339|2203055|FG001|12-month Follow-up|Lack of Efficacy|2
1116988|NCT02549339|2203054|FG000|12-month Follow-up|Withdrawal by Subject|8
1116989|NCT02549339|2203055|FG001|12-month Follow-up|Withdrawal by Subject|3
1116990|NCT02549339|2203054|FG000|12-month Follow-up|Lost to Follow-up|1
1116991|NCT02549339|2203055|FG001|12-month Follow-up|Lost to Follow-up|3
1116992|NCT02549339|2203054|FG000|12-month Follow-up|Other|0
1116993|NCT02549339|2203055|FG001|12-month Follow-up|Other|3
1116994|NCT02549352|2203065|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
1116995|NCT02549352|2203066|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
1116996|NCT02549352|2203065|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
1116997|NCT02549352|2203066|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
1116998|NCT02549352|2203065|FG000|3-day Treatment and 8-week Follow-up|Other|0
1116999|NCT02549352|2203066|FG001|3-day Treatment and 8-week Follow-up|Other|2
1117000|NCT02549352|2203065|FG000|12-month Follow-up|Withdrawal by Subject|4
1117001|NCT02549352|2203066|FG001|12-month Follow-up|Withdrawal by Subject|5
1117002|NCT02549352|2203065|FG000|12-month Follow-up|Lost to Follow-up|3
1117003|NCT02549352|2203066|FG001|12-month Follow-up|Lost to Follow-up|2
1117004|NCT02549352|2203065|FG000|12-month Follow-up|Death|0
1117005|NCT02549352|2203066|FG001|12-month Follow-up|Death|1
1117006|NCT02549352|2203065|FG000|12-month Follow-up|Protocol Violation|0
1117007|NCT02549352|2203066|FG001|12-month Follow-up|Protocol Violation|1
1117008|NCT02549352|2203065|FG000|12-month Follow-up|Other|1
1117009|NCT02549352|2203066|FG001|12-month Follow-up|Other|3
1117010|NCT02549573|2203096|FG000|Overall Study|Withdrawal by Subject|0
1117011|NCT02549573|2203097|FG001|Overall Study|Withdrawal by Subject|2
1117012|NCT02549573|2203096|FG000|Overall Study|Protocol Violation|0
1117013|NCT02549573|2203097|FG001|Overall Study|Protocol Violation|1
1117014|NCT02549859|2203103|FG000|Long-term 60 Hz DBS|Study Closed|1
1117015|NCT02550106|2203111|FG000|Overall Study|Adverse Event|1
1117016|NCT02550106|2203111|FG000|Overall Study|Lack of Efficacy|3
1117017|NCT02550106|2203111|FG000|Overall Study|Protocol Violation|6
1117018|NCT02550106|2203111|FG000|Overall Study|Withdrawal by Subject|2
1117019|NCT02550288|2203139|FG000|Overall Study|Adverse Event|0
1117020|NCT02550288|2203140|FG001|Overall Study|Adverse Event|1
1117021|NCT02550288|2203141|FG002|Overall Study|Adverse Event|0
1117022|NCT02550288|2203142|FG003|Overall Study|Adverse Event|0
1117023|NCT02550288|2203143|FG004|Overall Study|Adverse Event|0
1117024|NCT02550288|2203139|FG000|Overall Study|Physician Decision|0
1117025|NCT02550288|2203140|FG001|Overall Study|Physician Decision|0
1117026|NCT02550288|2203141|FG002|Overall Study|Physician Decision|0
1117027|NCT02550288|2203142|FG003|Overall Study|Physician Decision|1
1117028|NCT02550288|2203143|FG004|Overall Study|Physician Decision|0
1117029|NCT02550288|2203139|FG000|Overall Study|Protocol Violation|2
1117030|NCT02550288|2203140|FG001|Overall Study|Protocol Violation|2
1117031|NCT02550288|2203141|FG002|Overall Study|Protocol Violation|1
1117032|NCT02550288|2203142|FG003|Overall Study|Protocol Violation|0
1117033|NCT02550288|2203143|FG004|Overall Study|Protocol Violation|3
1117034|NCT02550288|2203139|FG000|Overall Study|Participant moved|0
1117035|NCT02550288|2203140|FG001|Overall Study|Participant moved|0
1117036|NCT02550288|2203141|FG002|Overall Study|Participant moved|0
1117037|NCT02550288|2203142|FG003|Overall Study|Participant moved|1
1117038|NCT02550288|2203143|FG004|Overall Study|Participant moved|0
1117039|NCT02550288|2203139|FG000|Overall Study|Withdrawal by Subject|0
1117040|NCT02550288|2203140|FG001|Overall Study|Withdrawal by Subject|0
1117041|NCT02550288|2203141|FG002|Overall Study|Withdrawal by Subject|0
1117042|NCT02550288|2203142|FG003|Overall Study|Withdrawal by Subject|1
1117043|NCT02550288|2203143|FG004|Overall Study|Withdrawal by Subject|0
1117058|NCT02550795|2203185|FG000|Overall Study|Physician Decision|0
1117059|NCT02550795|2203186|FG001|Overall Study|Physician Decision|1
1117060|NCT02550795|2203187|FG002|Overall Study|Physician Decision|0
1117061|NCT02550873|2203197|FG000|Randomized Double Blind|Adverse Event|3
1117062|NCT02550873|2203198|FG001|Randomized Double Blind|Adverse Event|1
1117063|NCT02550873|2203199|FG002|Randomized Double Blind|Adverse Event|0
1117064|NCT02550873|2203197|FG000|Randomized Double Blind|Disease progression|1
1117065|NCT02550873|2203198|FG001|Randomized Double Blind|Disease progression|1
1117066|NCT02550873|2203199|FG002|Randomized Double Blind|Disease progression|0
1117067|NCT02550873|2203197|FG000|Open Label Extension|Study ongoing|0
1117068|NCT02550873|2203198|FG001|Open Label Extension|Study ongoing|0
1117069|NCT02550873|2203199|FG002|Open Label Extension|Study ongoing|111
1117070|NCT02550938|2203225|FG000|Overall Study|Lost to Follow-up|8
1117071|NCT02550938|2203226|FG001|Overall Study|Lost to Follow-up|7
1117072|NCT02550938|2203227|FG002|Overall Study|Lost to Follow-up|12
1117073|NCT02550938|2203228|FG003|Overall Study|Lost to Follow-up|11
1117074|NCT02551055|2203245|FG000|Overall Study|Death|2
1117075|NCT02551055|2203246|FG001|Overall Study|Death|4
1117076|NCT02551055|2203247|FG002|Overall Study|Death|2
1117077|NCT02551055|2203248|FG003|Overall Study|Death|2
1117078|NCT02551055|2203249|FG004|Overall Study|Death|2
1117079|NCT02551055|2203250|FG005|Overall Study|Death|1
1117080|NCT02551055|2203251|FG006|Overall Study|Death|2
1117081|NCT02551055|2203252|FG007|Overall Study|Death|0
1117082|NCT02551055|2203245|FG000|Overall Study|Study Terminated by Sponsor|1
1117083|NCT02551055|2203246|FG001|Overall Study|Study Terminated by Sponsor|1
1117084|NCT02551055|2203247|FG002|Overall Study|Study Terminated by Sponsor|0
1117085|NCT02551055|2203248|FG003|Overall Study|Study Terminated by Sponsor|2
1117086|NCT02551055|2203249|FG004|Overall Study|Study Terminated by Sponsor|2
1117087|NCT02551055|2203250|FG005|Overall Study|Study Terminated by Sponsor|0
1117088|NCT02551055|2203251|FG006|Overall Study|Study Terminated by Sponsor|0
1117089|NCT02551055|2203252|FG007|Overall Study|Study Terminated by Sponsor|0
1117090|NCT02551055|2203245|FG000|Overall Study|Withdrawal by Subject|1
1117091|NCT02551055|2203246|FG001|Overall Study|Withdrawal by Subject|1
1117092|NCT02551055|2203247|FG002|Overall Study|Withdrawal by Subject|0
1117093|NCT02551055|2203248|FG003|Overall Study|Withdrawal by Subject|1
1117094|NCT02551055|2203249|FG004|Overall Study|Withdrawal by Subject|2
1117095|NCT02551055|2203250|FG005|Overall Study|Withdrawal by Subject|0
1117096|NCT02551055|2203251|FG006|Overall Study|Withdrawal by Subject|0
1117097|NCT02551055|2203252|FG007|Overall Study|Withdrawal by Subject|0
1117098|NCT02551055|2203245|FG000|Overall Study|Reason not specified|0
1117099|NCT02551055|2203246|FG001|Overall Study|Reason not specified|0
1117100|NCT02551055|2203247|FG002|Overall Study|Reason not specified|0
1117101|NCT02551055|2203248|FG003|Overall Study|Reason not specified|0
1117102|NCT02551055|2203249|FG004|Overall Study|Reason not specified|1
1117103|NCT02551055|2203250|FG005|Overall Study|Reason not specified|0
1117104|NCT02551055|2203251|FG006|Overall Study|Reason not specified|1
1117105|NCT02551055|2203252|FG007|Overall Study|Reason not specified|0
1117106|NCT02551159|2203282|FG000|Overall Study|Death|352
1117107|NCT02551159|2203283|FG001|Overall Study|Death|174
1117108|NCT02551159|2203284|FG002|Overall Study|Death|161
1117109|NCT02551159|2203282|FG000|Overall Study|Withdrawal by Subject|8
1117110|NCT02551159|2203283|FG001|Overall Study|Withdrawal by Subject|5
1117111|NCT02551159|2203284|FG002|Overall Study|Withdrawal by Subject|16
1117112|NCT02551159|2203282|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53
1117113|NCT02551159|2203283|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25
1117114|NCT02551159|2203284|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29
1117115|NCT02551666|2203314|FG000|Overall Study|Withdrawal by Subject|1
1117116|NCT02551666|2203315|FG001|Overall Study|Withdrawal by Subject|3
1117117|NCT02551692|2203324|FG000|Overall Study|Lost to Follow-up|0
1117118|NCT02551692|2203325|FG001|Overall Study|Lost to Follow-up|1
1117119|NCT02551692|2203326|FG002|Overall Study|Lost to Follow-up|4
1117120|NCT02551692|2203324|FG000|Overall Study|Withdrawal by Subject|1
1117121|NCT02551692|2203325|FG001|Overall Study|Withdrawal by Subject|0
1117122|NCT02551692|2203326|FG002|Overall Study|Withdrawal by Subject|1
1117123|NCT02551731|2203338|FG000|Overall Study|Withdrawal by Subject|2
1117124|NCT02551874|2203394|FG000|Overall Study|Lost to Follow-up|0
1117125|NCT02551874|2203395|FG001|Overall Study|Lost to Follow-up|2
1117126|NCT02551874|2203394|FG000|Overall Study|Pregnancy|0
1117127|NCT02551874|2203395|FG001|Overall Study|Pregnancy|1
1117128|NCT02551874|2203394|FG000|Overall Study|Reason not reported|10
1117129|NCT02551874|2203395|FG001|Overall Study|Reason not reported|4
1117130|NCT02551874|2203394|FG000|Overall Study|Did not receive randomized treatment|0
1117131|NCT02551874|2203395|FG001|Overall Study|Did not receive randomized treatment|7
1117132|NCT02551874|2203394|FG000|Overall Study|Did not enter long-term study|18
1117133|NCT02551874|2203395|FG001|Overall Study|Did not enter long-term study|25
1117134|NCT02552121|2203422|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
1117135|NCT02552121|2203423|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1117136|NCT02552121|2203424|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1117137|NCT02552121|2203425|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1117138|NCT02552121|2203426|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1117139|NCT02552121|2203427|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1117140|NCT02552121|2203428|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1117141|NCT02552121|2203429|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1117142|NCT02552121|2203422|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
1117143|NCT02552121|2203423|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1117144|NCT02552121|2203424|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1117145|NCT02552121|2203425|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1117146|NCT02552121|2203426|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1117147|NCT02552121|2203427|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1117148|NCT02552121|2203428|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1117149|NCT02552121|2203429|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1117150|NCT02552121|2203422|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1117151|NCT02552121|2203423|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
1117152|NCT02552121|2203424|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1117153|NCT02552121|2203425|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1117154|NCT02552121|2203426|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1117155|NCT02552121|2203427|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1117156|NCT02552121|2203428|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1117157|NCT02552121|2203429|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1117158|NCT02552121|2203422|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
897295|NCT00708162|1869239|FG000|Randomized Phase|Pregnancy|3
897296|NCT00708162|1869240|FG001|Randomized Phase|Pregnancy|0
897297|NCT00708162|1869239|FG000|Open-Label Phase|Lost to Follow-up|10
897298|NCT00708162|1869240|FG001|Open-Label Phase|Lost to Follow-up|8
897299|NCT00708162|1869239|FG000|Open-Label Phase|Withdrew Consent|12
897300|NCT00708162|1869240|FG001|Open-Label Phase|Withdrew Consent|6
897301|NCT00708162|1869239|FG000|Open-Label Phase|Participant Noncompliance|7
897302|NCT00708162|1869240|FG001|Open-Label Phase|Participant Noncompliance|7
897303|NCT00708162|1869239|FG000|Open-Label Phase|Lack of Efficacy|7
897304|NCT00708162|1869240|FG001|Open-Label Phase|Lack of Efficacy|4
897305|NCT00708162|1869239|FG000|Open-Label Phase|Investigator's Discretion|3
897306|NCT00708162|1869240|FG001|Open-Label Phase|Investigator's Discretion|2
897307|NCT00708162|1869239|FG000|Open-Label Phase|Death|3
897308|NCT00708162|1869240|FG001|Open-Label Phase|Death|1
897309|NCT00708162|1869239|FG000|Open-Label Phase|Adverse Event|1
897310|NCT00708162|1869240|FG001|Open-Label Phase|Adverse Event|2
897311|NCT00708162|1869239|FG000|Open-Label Phase|Other|1
897312|NCT00708162|1869240|FG001|Open-Label Phase|Other|0
897313|NCT00708175|1869249|FG000|Overall Study|Adverse Event|4
897314|NCT00708175|1869250|FG001|Overall Study|Adverse Event|5
897315|NCT00708175|1869249|FG000|Overall Study|Protocol Violation|2
897316|NCT00708175|1869250|FG001|Overall Study|Protocol Violation|3
897317|NCT00708175|1869249|FG000|Overall Study|Lost to Follow-up|5
897318|NCT00708175|1869250|FG001|Overall Study|Lost to Follow-up|3
897319|NCT00708175|1869249|FG000|Overall Study|Withdrawal by Subject|5
897320|NCT00708175|1869250|FG001|Overall Study|Withdrawal by Subject|7
897321|NCT00708175|1869249|FG000|Overall Study|BMD loss >7%|2
897322|NCT00708175|1869250|FG001|Overall Study|BMD loss >7%|3
897323|NCT00708201|1869258|FG000|Overall Study|Adverse Event|4
897324|NCT00708201|1869259|FG001|Overall Study|Adverse Event|4
897325|NCT00708201|1869258|FG000|Overall Study|Withdrawal by Subject|1
897326|NCT00708201|1869259|FG001|Overall Study|Withdrawal by Subject|1
897327|NCT00708201|1869258|FG000|Overall Study|Lost to Follow-up|2
897328|NCT00708201|1869259|FG001|Overall Study|Lost to Follow-up|0
897329|NCT00708201|1869258|FG000|Overall Study|Protocol Violation|0
897330|NCT00708201|1869259|FG001|Overall Study|Protocol Violation|1
897331|NCT00708214|1869268|FG000|Overall Study|Other Adverse Event|3
897332|NCT00708214|1869269|FG001|Overall Study|Other Adverse Event|6
897333|NCT00708214|1869270|FG002|Overall Study|Other Adverse Event|2
897334|NCT00708214|1869268|FG000|Overall Study|Other|0
897335|NCT00708214|1869269|FG001|Overall Study|Other|1
897336|NCT00708214|1869270|FG002|Overall Study|Other|1
897337|NCT00708214|1869268|FG000|Overall Study|Progressive Disease|4
897338|NCT00708214|1869269|FG001|Overall Study|Progressive Disease|6
897339|NCT00708214|1869270|FG002|Overall Study|Progressive Disease|5
897340|NCT00708227|1869287|FG000|Overall Study|Physician Decision|0
897341|NCT00708227|1869288|FG001|Overall Study|Physician Decision|3
897342|NCT00708227|1869289|FG002|Overall Study|Physician Decision|1
897343|NCT00708227|1869290|FG003|Overall Study|Physician Decision|2
897344|NCT00708227|1869287|FG000|Overall Study|Withdrawal by Subject|1
897345|NCT00708227|1869288|FG001|Overall Study|Withdrawal by Subject|2
897346|NCT00708227|1869289|FG002|Overall Study|Withdrawal by Subject|0
1117159|NCT02552121|2203423|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
1117160|NCT02552121|2203424|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1117161|NCT02552121|2203425|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1117162|NCT02552121|2203426|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1117163|NCT02552121|2203427|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1117164|NCT02552121|2203428|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1117165|NCT02552121|2203429|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1117166|NCT02552121|2203422|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1117167|NCT02552121|2203423|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
1117168|NCT02552121|2203424|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1117169|NCT02552121|2203425|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1117170|NCT02552121|2203426|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1117171|NCT02552121|2203427|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1117172|NCT02552121|2203428|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1117173|NCT02552121|2203429|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1117174|NCT02552121|2203422|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1117175|NCT02552121|2203423|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
1117176|NCT02552121|2203424|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1117177|NCT02552121|2203425|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1117178|NCT02552121|2203426|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1117179|NCT02552121|2203427|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
897347|NCT00708227|1869290|FG003|Overall Study|Withdrawal by Subject|1
897348|NCT00708305|1869320|FG000|Period 1|Protocol Violation|1
897349|NCT00708305|1869321|FG001|Period 1|Protocol Violation|0
897350|NCT00708305|1869322|FG002|Period 1|Protocol Violation|1
897351|NCT00708305|1869323|FG003|Period 1|Protocol Violation|0
897352|NCT00708305|1869320|FG000|Period 1|Other Reason|0
897353|NCT00708305|1869321|FG001|Period 1|Other Reason|0
897354|NCT00708305|1869322|FG002|Period 1|Other Reason|0
897355|NCT00708305|1869323|FG003|Period 1|Other Reason|2
897356|NCT00708305|1869320|FG000|Period 2|Lost to Follow-up|0
897357|NCT00708305|1869321|FG001|Period 2|Lost to Follow-up|1
897358|NCT00708305|1869322|FG002|Period 2|Lost to Follow-up|0
897359|NCT00708305|1869323|FG003|Period 2|Lost to Follow-up|0
897360|NCT00708305|1869320|FG000|Period 2|Protocol Violation|0
897361|NCT00708305|1869321|FG001|Period 2|Protocol Violation|1
897362|NCT00708305|1869322|FG002|Period 2|Protocol Violation|0
897363|NCT00708305|1869323|FG003|Period 2|Protocol Violation|0
897364|NCT00708305|1869320|FG000|Period 2|Other Reason|1
897365|NCT00708305|1869321|FG001|Period 2|Other Reason|0
897366|NCT00708305|1869322|FG002|Period 2|Other Reason|0
897367|NCT00708305|1869323|FG003|Period 2|Other Reason|1
897368|NCT00708305|1869320|FG000|Period 3|Protocol Violation|0
897369|NCT00708305|1869321|FG001|Period 3|Protocol Violation|2
897370|NCT00708305|1869322|FG002|Period 3|Protocol Violation|0
897371|NCT00708305|1869323|FG003|Period 3|Protocol Violation|0
897372|NCT00708305|1869320|FG000|Period 3|Other Reason|1
897373|NCT00708305|1869321|FG001|Period 3|Other Reason|0
897374|NCT00708305|1869322|FG002|Period 3|Other Reason|0
897375|NCT00708305|1869323|FG003|Period 3|Other Reason|0
897376|NCT00708422|1869338|FG000|Overall Study|Adverse Event|3
897377|NCT00708422|1869339|FG001|Overall Study|Adverse Event|1
897378|NCT00708422|1869338|FG000|Overall Study|Withdrawal by Subject|1
897379|NCT00708422|1869339|FG001|Overall Study|Withdrawal by Subject|0
897380|NCT00708435|1869347|FG000|Overall Study|Death / Serious Adverse Event|10
897381|NCT00708435|1869348|FG001|Overall Study|Death / Serious Adverse Event|5
897382|NCT00708435|1869347|FG000|Overall Study|Lost to Follow-up|9
897383|NCT00708435|1869348|FG001|Overall Study|Lost to Follow-up|4
897384|NCT00708435|1869347|FG000|Overall Study|Withdrawal by Subject|3
897385|NCT00708435|1869348|FG001|Overall Study|Withdrawal by Subject|7
897386|NCT00708435|1869347|FG000|Overall Study|Adverse Event|1
897387|NCT00708435|1869348|FG001|Overall Study|Adverse Event|0
897388|NCT00708435|1869347|FG000|Overall Study|Protocol Violation|0
897389|NCT00708435|1869348|FG001|Overall Study|Protocol Violation|1
897390|NCT00708435|1869347|FG000|Overall Study|Intervention by primary care physician|1
897391|NCT00708435|1869348|FG001|Overall Study|Intervention by primary care physician|0
897392|NCT00708435|1869347|FG000|Overall Study|Refused hospitalization|1
897393|NCT00708435|1869348|FG001|Overall Study|Refused hospitalization|0
897394|NCT00708461|1869358|FG000|Overall Study|Lost to Follow-up|18
897395|NCT00708461|1869359|FG001|Overall Study|Lost to Follow-up|11
897396|NCT00708461|1869358|FG000|Overall Study|Withdrawal by Subject|8
897397|NCT00708461|1869359|FG001|Overall Study|Withdrawal by Subject|9
897398|NCT00708461|1869358|FG000|Overall Study|left workforce|115
897399|NCT00708461|1869359|FG001|Overall Study|left workforce|180
897400|NCT00708500|1869368|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
897401|NCT00708500|1869369|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
897402|NCT00708500|1869370|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
897403|NCT00708500|1869368|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
897404|NCT00708500|1869369|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
897405|NCT00708500|1869370|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
1117180|NCT02552121|2203428|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1117181|NCT02552121|2203429|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1117182|NCT02552121|2203422|FG000|Part 2: Cohort Expansion|Patient Choice|0
1117183|NCT02552121|2203423|FG001|Part 2: Cohort Expansion|Patient Choice|0
897406|NCT00708500|1869368|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
897407|NCT00708500|1869369|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
897408|NCT00708500|1869370|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
897409|NCT00708500|1869368|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
897410|NCT00708500|1869369|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
897411|NCT00708500|1869370|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
897412|NCT00708500|1869368|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
897413|NCT00708500|1869369|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
897414|NCT00708500|1869370|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
897415|NCT00708500|1869368|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
897416|NCT00708500|1869369|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
897417|NCT00708500|1869370|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
897418|NCT00708500|1869368|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
897419|NCT00708500|1869369|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
897420|NCT00708500|1869370|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
897421|NCT00708500|1869368|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
897422|NCT00708500|1869369|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
897423|NCT00708500|1869370|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
897424|NCT00708500|1869368|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
897425|NCT00708500|1869369|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
897426|NCT00708500|1869370|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
897427|NCT00708500|1869368|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
897428|NCT00708500|1869369|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
897429|NCT00708500|1869370|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
897430|NCT00708500|1869368|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
897431|NCT00708500|1869369|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
897432|NCT00708500|1869370|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
897433|NCT00708500|1869368|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
897434|NCT00708500|1869369|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
897435|NCT00708500|1869370|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
897436|NCT00708500|1869368|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
897437|NCT00708500|1869369|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
897438|NCT00708500|1869370|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
897439|NCT00708500|1869368|FG000|FOLLOWUP|Adverse Event|0
897440|NCT00708500|1869369|FG001|FOLLOWUP|Adverse Event|1
897441|NCT00708500|1869370|FG002|FOLLOWUP|Adverse Event|0
897442|NCT00708500|1869368|FG000|FOLLOWUP|Lost to Follow-up|1
897443|NCT00708500|1869369|FG001|FOLLOWUP|Lost to Follow-up|6
897444|NCT00708500|1869370|FG002|FOLLOWUP|Lost to Follow-up|4
897445|NCT00708500|1869368|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3
897446|NCT00708500|1869369|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4
897447|NCT00708500|1869370|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5
897448|NCT00708500|1869368|FG000|FOLLOWUP|Subject withdrew consent|31
897449|NCT00708500|1869369|FG001|FOLLOWUP|Subject withdrew consent|4
897450|NCT00708500|1869370|FG002|FOLLOWUP|Subject withdrew consent|5
897451|NCT00708500|1869368|FG000|FOLLOWUP|Non-compliance with protocol|5
897452|NCT00708500|1869369|FG001|FOLLOWUP|Non-compliance with protocol|0
897453|NCT00708500|1869370|FG002|FOLLOWUP|Non-compliance with protocol|1
897454|NCT00708552|1869391|FG000|Overall Study|Adverse Event|10
897455|NCT00708552|1869392|FG001|Overall Study|Adverse Event|3
897456|NCT00708552|1869393|FG002|Overall Study|Adverse Event|4
897457|NCT00708552|1869394|FG003|Overall Study|Adverse Event|6
897458|NCT00708552|1869391|FG000|Overall Study|Lack of Efficacy|0
897459|NCT00708552|1869392|FG001|Overall Study|Lack of Efficacy|4
897460|NCT00708552|1869393|FG002|Overall Study|Lack of Efficacy|1
897461|NCT00708552|1869394|FG003|Overall Study|Lack of Efficacy|0
897462|NCT00708552|1869391|FG000|Overall Study|Protocol Violation|0
897463|NCT00708552|1869392|FG001|Overall Study|Protocol Violation|0
897464|NCT00708552|1869393|FG002|Overall Study|Protocol Violation|2
897465|NCT00708552|1869394|FG003|Overall Study|Protocol Violation|4
897466|NCT00708552|1869391|FG000|Overall Study|Lost to Follow-up|4
897467|NCT00708552|1869392|FG001|Overall Study|Lost to Follow-up|2
897468|NCT00708552|1869393|FG002|Overall Study|Lost to Follow-up|0
897469|NCT00708552|1869394|FG003|Overall Study|Lost to Follow-up|1
897470|NCT00708552|1869391|FG000|Overall Study|Physician Decision|1
897471|NCT00708552|1869392|FG001|Overall Study|Physician Decision|2
897472|NCT00708552|1869393|FG002|Overall Study|Physician Decision|0
897473|NCT00708552|1869394|FG003|Overall Study|Physician Decision|0
897474|NCT00708552|1869391|FG000|Overall Study|Withdrawal by Subject|12
897475|NCT00708552|1869392|FG001|Overall Study|Withdrawal by Subject|7
897476|NCT00708552|1869393|FG002|Overall Study|Withdrawal by Subject|8
897477|NCT00708552|1869394|FG003|Overall Study|Withdrawal by Subject|10
897478|NCT00708643|1869410|FG000|Overall Study|Adverse Event|0
1117184|NCT02552121|2203424|FG002|Part 2: Cohort Expansion|Patient Choice|1
1117185|NCT02552121|2203425|FG003|Part 2: Cohort Expansion|Patient Choice|0
1117186|NCT02552121|2203426|FG004|Part 2: Cohort Expansion|Patient Choice|0
1117187|NCT02552121|2203427|FG005|Part 2: Cohort Expansion|Patient Choice|0
1117188|NCT02552121|2203428|FG006|Part 2: Cohort Expansion|Patient Choice|1
1117189|NCT02552121|2203429|FG007|Part 2: Cohort Expansion|Patient Choice|0
897479|NCT00708643|1869411|FG001|Overall Study|Adverse Event|1
897480|NCT00708682|1869417|FG000|Infant Series|Adverse Event|1
897481|NCT00708682|1869417|FG000|Infant Series|Lost to Follow-up|4
897482|NCT00708682|1869417|FG000|Infant Series|Protocol Violation|1
897483|NCT00708682|1869417|FG000|Infant Series|Parent/legal guardian request|6
897484|NCT00708682|1869417|FG000|Infant Series|Failed to return|2
897485|NCT00708682|1869417|FG000|Infant Series|Other|19
897486|NCT00708682|1869417|FG000|After Infant Series|Parent/Legal Guardian Request|1
897487|NCT00708682|1869417|FG000|Toddler Dose|Parent/Legal Guardian Request|1
897488|NCT00708682|1869417|FG000|Toddler Dose|Lost to Follow-up|3
897489|NCT00708682|1869417|FG000|Toddler Dose|Failed to Return|4
897490|NCT00708708|1869423|FG000|Overall Study|Another therapy instead of Enbrel|141
897491|NCT00708708|1869423|FG000|Overall Study|Lost to Follow-up|52
897492|NCT00708708|1869423|FG000|Overall Study|Withdrawal by Subject|51
897493|NCT00708708|1869423|FG000|Overall Study|Intolerance|42
897494|NCT00708708|1869423|FG000|Overall Study|Another therapy along with Enbrel|15
897495|NCT00708708|1869423|FG000|Overall Study|Other unspecified|11
897496|NCT00708708|1869423|FG000|Overall Study|Good effectiveness|9
897497|NCT00708708|1869423|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9
897498|NCT00708708|1869423|FG000|Overall Study|Administrative reasons|7
897499|NCT00708708|1869423|FG000|Overall Study|Lack of effectiveness|4
897500|NCT00708708|1869423|FG000|Overall Study|Lack of compliance|3
897501|NCT00708708|1869423|FG000|Overall Study|Pregnancy|3
897502|NCT00708708|1869423|FG000|Overall Study|Adverse Event|3
897503|NCT00708708|1869423|FG000|Overall Study|Missing values|392
897504|NCT00709059|1869475|FG000|Overall Study|Lost to Follow-up|34
897505|NCT00709059|1869475|FG000|Overall Study|Withdrawal by Subject|19
897506|NCT00709059|1869475|FG000|Overall Study|Physician Decision|7
897507|NCT00709059|1869475|FG000|Overall Study|Disease complication|3
897508|NCT00709059|1869475|FG000|Overall Study|Side effects|20
897509|NCT00709059|1869475|FG000|Overall Study|Serious side effects|11
897510|NCT00709098|1869482|FG000|Double-blind Period|Withdrawal of consent|3
897511|NCT00709098|1869483|FG001|Double-blind Period|Withdrawal of consent|3
897512|NCT00709098|1869484|FG002|Double-blind Period|Withdrawal of consent|0
897513|NCT00709098|1869482|FG000|Double-blind Period|Administrative reason|1
897514|NCT00709098|1869483|FG001|Double-blind Period|Administrative reason|3
897515|NCT00709098|1869484|FG002|Double-blind Period|Administrative reason|0
897516|NCT00709098|1869482|FG000|Double-blind Period|Death|1
897517|NCT00709098|1869483|FG001|Double-blind Period|Death|1
897518|NCT00709098|1869484|FG002|Double-blind Period|Death|0
897519|NCT00709098|1869482|FG000|Double-blind Period|Lost to Follow-up|1
897520|NCT00709098|1869483|FG001|Double-blind Period|Lost to Follow-up|1
897521|NCT00709098|1869484|FG002|Double-blind Period|Lost to Follow-up|0
897522|NCT00709098|1869482|FG000|Open-label Period|Withdrawal of consent|0
897523|NCT00709098|1869483|FG001|Open-label Period|Withdrawal of consent|0
897524|NCT00709098|1869484|FG002|Open-label Period|Withdrawal of consent|7
897525|NCT00709098|1869482|FG000|Open-label Period|Administrative reason|0
897526|NCT00709098|1869483|FG001|Open-label Period|Administrative reason|0
897527|NCT00709098|1869484|FG002|Open-label Period|Administrative reason|5
897528|NCT00709098|1869482|FG000|Open-label Period|Death|0
897529|NCT00709098|1869483|FG001|Open-label Period|Death|0
897530|NCT00709098|1869484|FG002|Open-label Period|Death|1
897531|NCT00709098|1869482|FG000|Open-label Period|Lost to Follow-up|0
897532|NCT00709098|1869483|FG001|Open-label Period|Lost to Follow-up|0
897533|NCT00709098|1869484|FG002|Open-label Period|Lost to Follow-up|1
897534|NCT00709111|1869493|FG000|Overall Study|Withdrawal by Subject|1
897535|NCT00709111|1869493|FG000|Overall Study|Unable to attend clinic visits|1
897536|NCT00709124|1869499|FG000|Overall Study|Death|3
897537|NCT00709124|1869500|FG001|Overall Study|Death|1
897538|NCT00709124|1869499|FG000|Overall Study|encephalopathy; can't do assessment|1
897539|NCT00709124|1869500|FG001|Overall Study|encephalopathy; can't do assessment|0
897540|NCT00709202|1869512|FG000|Overall Study|Withdrawal by Subject|6
897541|NCT00709202|1869513|FG001|Overall Study|Withdrawal by Subject|6
897542|NCT00709228|1869520|FG000|Overall Study|Not treated|14
897543|NCT00709228|1869520|FG000|Overall Study|Eligibility criteria not met|281
897544|NCT00709228|1869520|FG000|Overall Study|Adverse events|2
897545|NCT00709228|1869520|FG000|Overall Study|Discontinued treatment|14
897546|NCT00709228|1869520|FG000|Overall Study|Did not enter follow-up|4
897547|NCT00709228|1869520|FG000|Overall Study|Discontinued follow-up|5
897548|NCT00709228|1869520|FG000|Overall Study|Disease progression|1
897549|NCT00709228|1869520|FG000|Overall Study|Lost to Follow-up|6
897550|NCT00709228|1869520|FG000|Overall Study|Non-compliance|5
897551|NCT00709319|1869541|FG000|Overall Study|Death|4
897552|NCT00709319|1869541|FG000|Overall Study|Withdrawal by Subject|2
897553|NCT00709592|1869547|FG000|Overall Study|Unable to proceed to transplant|0
897554|NCT00709592|1869548|FG001|Overall Study|Unable to proceed to transplant|1
897555|NCT00709618|1869554|FG000|Overall Study|Withdrawal by Subject|4
897556|NCT00709618|1869554|FG000|Overall Study|Lost to Follow-up|1
1117190|NCT02552121|2203422|FG000|Part 2: Cohort Expansion|Disease Progression|0
1117191|NCT02552121|2203423|FG001|Part 2: Cohort Expansion|Disease Progression|0
1117192|NCT02552121|2203424|FG002|Part 2: Cohort Expansion|Disease Progression|3
1117193|NCT02552121|2203425|FG003|Part 2: Cohort Expansion|Disease Progression|2
1117194|NCT02552121|2203426|FG004|Part 2: Cohort Expansion|Disease Progression|1
1117195|NCT02552121|2203427|FG005|Part 2: Cohort Expansion|Disease Progression|4
1117196|NCT02552121|2203428|FG006|Part 2: Cohort Expansion|Disease Progression|0
1117197|NCT02552121|2203429|FG007|Part 2: Cohort Expansion|Disease Progression|3
1117198|NCT02552121|2203422|FG000|Part 2: Cohort Expansion|Adverse Event|0
1117199|NCT02552121|2203423|FG001|Part 2: Cohort Expansion|Adverse Event|0
1117200|NCT02552121|2203424|FG002|Part 2: Cohort Expansion|Adverse Event|6
1117201|NCT02552121|2203425|FG003|Part 2: Cohort Expansion|Adverse Event|1
1117202|NCT02552121|2203426|FG004|Part 2: Cohort Expansion|Adverse Event|0
1117203|NCT02552121|2203427|FG005|Part 2: Cohort Expansion|Adverse Event|0
897557|NCT00709618|1869554|FG000|Overall Study|Study Closed/Terminated|25
897558|NCT00709722|1869567|FG000|Overall Study|Adverse Event|1
897559|NCT00709735|1869573|FG000|Overall Study|Lost to Follow-up|1
897560|NCT00709735|1869574|FG001|Overall Study|Lost to Follow-up|1
897561|NCT00709735|1869573|FG000|Overall Study|Relapse into Opioid Abuse|0
897562|NCT00709735|1869574|FG001|Overall Study|Relapse into Opioid Abuse|1
897563|NCT00709735|1869573|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2
897564|NCT00709735|1869574|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0
897565|NCT00709761|1869580|FG000|Overall Study|Withdrawal by Subject|8
897566|NCT00709761|1869580|FG000|Overall Study|study closed/terminated|17
897567|NCT00709761|1869580|FG000|Overall Study|Lost to Follow-up|2
897568|NCT00709852|1869593|FG000|Period 1|Adverse Event|2
897569|NCT00709852|1869594|FG001|Period 1|Adverse Event|0
897570|NCT00709852|1869593|FG000|Period 1|Withdrawal by Subject|4
897571|NCT00709852|1869594|FG001|Period 1|Withdrawal by Subject|2
897572|NCT00709852|1869593|FG000|Period 1|Protocol Violation|1
897573|NCT00709852|1869594|FG001|Period 1|Protocol Violation|0
897574|NCT00709852|1869593|FG000|Period 1|Defective scanner|0
897575|NCT00709852|1869594|FG001|Period 1|Defective scanner|1
897576|NCT00709852|1869593|FG000|Period 1|Lost to Follow-up|1
897577|NCT00709852|1869594|FG001|Period 1|Lost to Follow-up|0
897578|NCT00709852|1869593|FG000|Period 2|Protocol Violation|4
897579|NCT00709852|1869594|FG001|Period 2|Protocol Violation|1
897580|NCT00709852|1869593|FG000|Period 2|Adverse Event|1
897581|NCT00709852|1869594|FG001|Period 2|Adverse Event|1
897582|NCT00709852|1869593|FG000|Period 2|Lost to Follow-up|1
897583|NCT00709852|1869594|FG001|Period 2|Lost to Follow-up|0
897584|NCT00709852|1869593|FG000|Period 2|No 72-hour follow-up|3
897585|NCT00709852|1869594|FG001|Period 2|No 72-hour follow-up|0
897586|NCT00709956|1869632|FG000|Overall Study|Withdrawal by Subject|1
897587|NCT00709956|1869633|FG001|Overall Study|Withdrawal by Subject|1
897588|NCT00709956|1869632|FG000|Overall Study|Inclusion/exclusion criteria violation|2
897589|NCT00709956|1869633|FG001|Overall Study|Inclusion/exclusion criteria violation|3
897590|NCT00709995|1869643|FG000|Overall Study|Adverse Event|4
897591|NCT00709995|1869644|FG001|Overall Study|Adverse Event|2
897592|NCT00709995|1869643|FG000|Overall Study|Withdrawal by Subject|1
897593|NCT00709995|1869644|FG001|Overall Study|Withdrawal by Subject|3
897594|NCT00710021|1869656|FG000|Overall Study|Lost to Follow-up|1
897595|NCT00710021|1869657|FG001|Overall Study|Lost to Follow-up|0
897596|NCT00710021|1869658|FG002|Overall Study|Lost to Follow-up|0
897597|NCT00710021|1869656|FG000|Overall Study|Subject's Decision|0
897598|NCT00710021|1869657|FG001|Overall Study|Subject's Decision|1
897599|NCT00710021|1869658|FG002|Overall Study|Subject's Decision|0
897600|NCT00710021|1869656|FG000|Overall Study|Subject misrandomized|0
897601|NCT00710021|1869657|FG001|Overall Study|Subject misrandomized|1
897602|NCT00710021|1869658|FG002|Overall Study|Subject misrandomized|1
897603|NCT00710021|1869656|FG000|Overall Study|Physician Decision|0
897604|NCT00710021|1869657|FG001|Overall Study|Physician Decision|1
897605|NCT00710021|1869658|FG002|Overall Study|Physician Decision|0
897606|NCT00710034|1869669|FG000|Completed 6 Weeks of Treatment|Adverse Event|5
897607|NCT00710034|1869670|FG001|Completed 6 Weeks of Treatment|Adverse Event|12
897608|NCT00710034|1869669|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12
897609|NCT00710034|1869670|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8
897610|NCT00710034|1869669|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15
897611|NCT00710034|1869670|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17
897612|NCT00710034|1869669|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2
897613|NCT00710034|1869670|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6
897614|NCT00710034|1869669|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
897615|NCT00710034|1869670|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
897616|NCT00710034|1869669|FG000|Completed 6 Weeks of Treatment|Physician Decision|1
897617|NCT00710034|1869670|FG001|Completed 6 Weeks of Treatment|Physician Decision|0
897618|NCT00710034|1869669|FG000|Completed 12 Weeks of Treatment|Adverse Event|0
897619|NCT00710034|1869670|FG001|Completed 12 Weeks of Treatment|Adverse Event|1
897620|NCT00710034|1869669|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0
897621|NCT00710034|1869670|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2
897622|NCT00710034|1869669|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5
1018314|NCT01570283|2043160|FG003|Cohort 1: Dose Level 1|Death|0
1117204|NCT02552121|2203428|FG006|Part 2: Cohort Expansion|Adverse Event|0
1117205|NCT02552121|2203429|FG007|Part 2: Cohort Expansion|Adverse Event|0
1117206|NCT02552121|2203422|FG000|Part 2: Cohort Expansion|Death|0
1117207|NCT02552121|2203423|FG001|Part 2: Cohort Expansion|Death|0
1117208|NCT02552121|2203424|FG002|Part 2: Cohort Expansion|Death|1
1117209|NCT02552121|2203425|FG003|Part 2: Cohort Expansion|Death|0
1117210|NCT02552121|2203426|FG004|Part 2: Cohort Expansion|Death|0
1117211|NCT02552121|2203427|FG005|Part 2: Cohort Expansion|Death|0
1117212|NCT02552121|2203428|FG006|Part 2: Cohort Expansion|Death|0
1117213|NCT02552121|2203429|FG007|Part 2: Cohort Expansion|Death|0
1117214|NCT02552147|2203461|FG000|First Intervention (7 Days)|Protocol Violation|1
1117215|NCT02552147|2203462|FG001|First Intervention (7 Days)|Protocol Violation|0
1117216|NCT02552147|2203461|FG000|Second Intervention (7 Days)|Protocol Violation|2
1117217|NCT02552147|2203462|FG001|Second Intervention (7 Days)|Protocol Violation|0
1117218|NCT02552212|2203470|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6
1117219|NCT02552212|2203471|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3
1117220|NCT02552212|2203472|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0
1117221|NCT02552212|2203470|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
1117222|NCT02552212|2203471|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
1117223|NCT02552212|2203472|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0
1117224|NCT02552212|2203470|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
1117225|NCT02552212|2203471|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
1117226|NCT02552212|2203472|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0
1117227|NCT02552212|2203470|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1
1117228|NCT02552212|2203471|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
1117229|NCT02552212|2203472|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
1117230|NCT02552212|2203470|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3
1117231|NCT02552212|2203471|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7
1117232|NCT02552212|2203472|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0
1117233|NCT02552212|2203470|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
1117234|NCT02552212|2203471|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
1117235|NCT02552212|2203472|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0
1117236|NCT02552212|2203470|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0
1117237|NCT02552212|2203471|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1
1117238|NCT02552212|2203472|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0
1117239|NCT02552212|2203470|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0
1117240|NCT02552212|2203471|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1
1117241|NCT02552212|2203472|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0
1117242|NCT02552212|2203470|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0
1117243|NCT02552212|2203471|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1
1117244|NCT02552212|2203472|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0
1117245|NCT02552212|2203470|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1
1117246|NCT02552212|2203471|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
1117247|NCT02552212|2203472|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
1117248|NCT02552212|2203470|FG000|SFE Period (Week 52 - 156)|Adverse Event|0
1117249|NCT02552212|2203471|FG001|SFE Period (Week 52 - 156)|Adverse Event|0
1117250|NCT02552212|2203472|FG002|SFE Period (Week 52 - 156)|Adverse Event|5
1117251|NCT02552212|2203470|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0
1117252|NCT02552212|2203471|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0
1117253|NCT02552212|2203472|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4
1117254|NCT02552212|2203470|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0
1117255|NCT02552212|2203471|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0
1117256|NCT02552212|2203472|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2
1117257|NCT02552212|2203470|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
1117258|NCT02552212|2203471|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
897623|NCT00710034|1869670|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5
897624|NCT00710034|1869669|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
897625|NCT00710034|1869670|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
897626|NCT00710034|1869669|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
897627|NCT00710034|1869670|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
897628|NCT00710385|1869686|FG000|Overall Study|Did not qualify|1
897629|NCT00710385|1869686|FG000|Overall Study|Withdrawal by Subject|1
897630|NCT00710385|1869686|FG000|Overall Study|Undisclosed back pain|1
897631|NCT00710385|1869686|FG000|Overall Study|Physician Decision|1
897632|NCT00710385|1869686|FG000|Overall Study|Undisclosed excessive methadone use|1
897633|NCT00710424|1869698|FG000|Overall Study|Adverse Event|30
897634|NCT00710424|1869699|FG001|Overall Study|Adverse Event|12
897635|NCT00710424|1869698|FG000|Overall Study|Lack of Efficacy|4
897636|NCT00710424|1869699|FG001|Overall Study|Lack of Efficacy|5
897637|NCT00710424|1869698|FG000|Overall Study|Withdrawal by Subject|5
897638|NCT00710424|1869699|FG001|Overall Study|Withdrawal by Subject|3
897639|NCT00710424|1869698|FG000|Overall Study|Lost to Follow-up|0
897640|NCT00710424|1869699|FG001|Overall Study|Lost to Follow-up|1
897641|NCT00710424|1869698|FG000|Overall Study|Refused medication, no side effects|1
897642|NCT00710424|1869699|FG001|Overall Study|Refused medication, no side effects|0
897643|NCT00710424|1869698|FG000|Overall Study|Non-compliance with stable analgesia|1
897644|NCT00710424|1869699|FG001|Overall Study|Non-compliance with stable analgesia|0
897645|NCT00710424|1869698|FG000|Overall Study|Did not meet entry criteria at visit 1|1
897646|NCT00710424|1869699|FG001|Overall Study|Did not meet entry criteria at visit 1|0
897647|NCT00710424|1869698|FG000|Overall Study|Subject thought medication changed|1
897648|NCT00710424|1869699|FG001|Overall Study|Subject thought medication changed|0
897649|NCT00710424|1869698|FG000|Overall Study|Ceased treatment due to travel|1
897650|NCT00710424|1869699|FG001|Overall Study|Ceased treatment due to travel|0
1117259|NCT02552212|2203472|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18
1117260|NCT02552212|2203470|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
1117261|NCT02552212|2203471|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
897651|NCT00710424|1869698|FG000|Overall Study|Subject preferred paracetamol|0
897652|NCT00710424|1869699|FG001|Overall Study|Subject preferred paracetamol|1
897653|NCT00710424|1869698|FG000|Overall Study|Felt good so stopped treatment|0
897654|NCT00710424|1869699|FG001|Overall Study|Felt good so stopped treatment|1
897655|NCT00710554|1869707|FG000|Overall Study|Adverse Event|24
897656|NCT00710554|1869708|FG001|Overall Study|Adverse Event|7
897657|NCT00710554|1869707|FG000|Overall Study|Withdrawal by Subject|7
897658|NCT00710554|1869708|FG001|Overall Study|Withdrawal by Subject|3
897659|NCT00710554|1869707|FG000|Overall Study|Lost to Follow-up|7
897660|NCT00710554|1869708|FG001|Overall Study|Lost to Follow-up|1
897661|NCT00710554|1869707|FG000|Overall Study|Lack of Efficacy|11
897662|NCT00710554|1869708|FG001|Overall Study|Lack of Efficacy|12
897663|NCT00710554|1869707|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0
897664|NCT00710554|1869708|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1
897665|NCT00710593|1869716|FG000|Overall Study|Incarceration|1
897666|NCT00710593|1869717|FG001|Overall Study|Incarceration|0
897667|NCT00710593|1869716|FG000|Overall Study|Unable to complete Wk 48 within window|2
897668|NCT00710593|1869717|FG001|Overall Study|Unable to complete Wk 48 within window|0
897669|NCT00710593|1869716|FG000|Overall Study|Lost to Follow-up|3
897670|NCT00710593|1869717|FG001|Overall Study|Lost to Follow-up|1
897671|NCT00710593|1869716|FG000|Overall Study|Moved out of area|1
897672|NCT00710593|1869717|FG001|Overall Study|Moved out of area|0
897673|NCT00710593|1869716|FG000|Overall Study|Failure to adhere or complete study eval|1
897674|NCT00710593|1869717|FG001|Overall Study|Failure to adhere or complete study eval|1
897675|NCT00710593|1869716|FG000|Overall Study|Protocol Violation|1
897676|NCT00710593|1869717|FG001|Overall Study|Protocol Violation|1
897677|NCT00710593|1869716|FG000|Overall Study|Prem disc vaccine, completed all visits|6
897678|NCT00710593|1869717|FG001|Overall Study|Prem disc vaccine, completed all visits|2
897679|NCT00710606|1869741|FG000|Overall Study|Adverse Event|0
897680|NCT00710606|1869742|FG001|Overall Study|Adverse Event|2
897681|NCT00710684|1869753|FG000|Overall Study|Adverse Event|11
897682|NCT00710684|1869754|FG001|Overall Study|Adverse Event|19
897683|NCT00710684|1869755|FG002|Overall Study|Adverse Event|16
897684|NCT00710684|1869753|FG000|Overall Study|Lack of Efficacy|4
897685|NCT00710684|1869754|FG001|Overall Study|Lack of Efficacy|3
897686|NCT00710684|1869755|FG002|Overall Study|Lack of Efficacy|5
897687|NCT00710684|1869753|FG000|Overall Study|Protocol Violation|5
897688|NCT00710684|1869754|FG001|Overall Study|Protocol Violation|5
897689|NCT00710684|1869755|FG002|Overall Study|Protocol Violation|5
897690|NCT00710684|1869753|FG000|Overall Study|Lost to Follow-up|4
897691|NCT00710684|1869754|FG001|Overall Study|Lost to Follow-up|6
897692|NCT00710684|1869755|FG002|Overall Study|Lost to Follow-up|7
897693|NCT00710684|1869753|FG000|Overall Study|Physician Decision|0
897694|NCT00710684|1869754|FG001|Overall Study|Physician Decision|2
897695|NCT00710684|1869755|FG002|Overall Study|Physician Decision|4
897696|NCT00710684|1869753|FG000|Overall Study|Withdrawal by Subject|24
897697|NCT00710684|1869754|FG001|Overall Study|Withdrawal by Subject|18
897698|NCT00710684|1869755|FG002|Overall Study|Withdrawal by Subject|11
897699|NCT00710684|1869753|FG000|Overall Study|Missing|1
897700|NCT00710684|1869754|FG001|Overall Study|Missing|0
897701|NCT00710684|1869755|FG002|Overall Study|Missing|0
897702|NCT00710684|1869753|FG000|Overall Study|Did not continue after week 24|25
897703|NCT00710684|1869754|FG001|Overall Study|Did not continue after week 24|21
897704|NCT00710684|1869755|FG002|Overall Study|Did not continue after week 24|16
897705|NCT00710749|1869769|FG000|First Intervention|Withdrawal by Subject|1
897706|NCT00710749|1869770|FG001|First Intervention|Withdrawal by Subject|0
897707|NCT00710762|1869780|FG000|Overall Study|Progressive disease|27
897708|NCT00710762|1869781|FG001|Overall Study|Progressive disease|30
897709|NCT00710762|1869780|FG000|Overall Study|Adverse Event other disease worsening|2
897710|NCT00710762|1869781|FG001|Overall Study|Adverse Event other disease worsening|1
897711|NCT00710762|1869780|FG000|Overall Study|Other Adverse Event|7
897712|NCT00710762|1869781|FG001|Overall Study|Other Adverse Event|7
897713|NCT00710762|1869780|FG000|Overall Study|Lost to Follow-up|1
897714|NCT00710762|1869781|FG001|Overall Study|Lost to Follow-up|0
897715|NCT00710762|1869780|FG000|Overall Study|Reason other than listed above|2
897716|NCT00710762|1869781|FG001|Overall Study|Reason other than listed above|2
897717|NCT00710866|1869807|FG000|Overall Study|Protocol Violation|5
897718|NCT00710866|1869808|FG001|Overall Study|Protocol Violation|4
897719|NCT00710866|1869807|FG000|Overall Study|Withdrawal by Subject|2
897720|NCT00710866|1869808|FG001|Overall Study|Withdrawal by Subject|1
897721|NCT00710866|1869807|FG000|Overall Study|Lost to Follow-up|1
1117262|NCT02552212|2203472|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1
1117263|NCT02552212|2203470|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0
1117264|NCT02552212|2203471|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0
1117265|NCT02552212|2203472|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1
1117266|NCT02552212|2203470|FG000|SFE Period (Week 52 - 156)|Investigator decision|0
1117267|NCT02552212|2203471|FG001|SFE Period (Week 52 - 156)|Investigator decision|0
1117268|NCT02552212|2203472|FG002|SFE Period (Week 52 - 156)|Investigator decision|1
1117269|NCT02552212|2203470|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
1117270|NCT02552212|2203471|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
1117271|NCT02552212|2203472|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1
1117272|NCT02552212|2203470|FG000|SFE Period (Week 52 - 156)|Compassionate access|0
1117273|NCT02552212|2203471|FG001|SFE Period (Week 52 - 156)|Compassionate access|0
1117274|NCT02552212|2203472|FG002|SFE Period (Week 52 - 156)|Compassionate access|2
1117275|NCT02552212|2203470|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
1117276|NCT02552212|2203471|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
1117277|NCT02552212|2203472|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1
1117278|NCT02552212|2203470|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0
1117279|NCT02552212|2203471|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0
1117280|NCT02552212|2203472|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1
1117281|NCT02552225|2203490|FG000|Overall Study|Withdrawal by Subject|1
897722|NCT00710866|1869808|FG001|Overall Study|Lost to Follow-up|0
897723|NCT00710866|1869807|FG000|Overall Study|Failed to meet eligibility|1
897724|NCT00710866|1869808|FG001|Overall Study|Failed to meet eligibility|1
897725|NCT00710879|1869816|FG000|Overall Study|Lost to Follow-up|2
897726|NCT00710879|1869817|FG001|Overall Study|Lost to Follow-up|1
897727|NCT00710879|1869816|FG000|Overall Study|Protocol Violation|0
897728|NCT00710879|1869817|FG001|Overall Study|Protocol Violation|3
897731|NCT00711009|1869863|FG000|Overall Study|Adverse Event/HIV-Related Event|4
897732|NCT00711009|1869864|FG001|Overall Study|Adverse Event/HIV-Related Event|5
897733|NCT00711009|1869863|FG000|Overall Study|Withdrawal by Subject|4
897734|NCT00711009|1869864|FG001|Overall Study|Withdrawal by Subject|2
897735|NCT00711009|1869863|FG000|Overall Study|Lost to Follow-up|3
897736|NCT00711009|1869864|FG001|Overall Study|Lost to Follow-up|9
897737|NCT00711009|1869863|FG000|Overall Study|Participant Noncompliant|0
897738|NCT00711009|1869864|FG001|Overall Study|Participant Noncompliant|1
897739|NCT00711009|1869863|FG000|Overall Study|Virologic Failure|2
897740|NCT00711009|1869864|FG001|Overall Study|Virologic Failure|1
897741|NCT00711009|1869863|FG000|Overall Study|Pregnancy|1
897742|NCT00711009|1869864|FG001|Overall Study|Pregnancy|0
897743|NCT00711009|1869863|FG000|Overall Study|Site closing|0
897744|NCT00711009|1869864|FG001|Overall Study|Site closing|1
897745|NCT00711009|1869863|FG000|Overall Study|Dose adjustment|1
897746|NCT00711009|1869864|FG001|Overall Study|Dose adjustment|0
897747|NCT00711100|1869874|FG000|Overall Study|Lack of Efficacy|5
897748|NCT00711100|1869874|FG000|Overall Study|Withdrawal by Subject|8
897749|NCT00711113|1869890|FG000|Overall Study|Lost to Follow-up|9
897750|NCT00711113|1869890|FG000|Overall Study|Implant lost|2
897751|NCT00711191|1869897|FG000|Overall Study|Adverse Event|1
897752|NCT00711191|1869898|FG001|Overall Study|Adverse Event|1
897753|NCT00711191|1869899|FG002|Overall Study|Adverse Event|2
897754|NCT00711191|1869897|FG000|Overall Study|Objective progression or relapse|2
897755|NCT00711191|1869898|FG001|Overall Study|Objective progression or relapse|3
897756|NCT00711191|1869899|FG002|Overall Study|Objective progression or relapse|7
897757|NCT00711191|1869897|FG000|Overall Study|Withdrawal by Subject|0
897758|NCT00711191|1869898|FG001|Overall Study|Withdrawal by Subject|1
897759|NCT00711191|1869899|FG002|Overall Study|Withdrawal by Subject|3
897760|NCT00711243|1869916|FG000|Registed and Started Treatment|Withdrawal by Subject|0
897761|NCT00711243|1869917|FG001|Registed and Started Treatment|Withdrawal by Subject|0
897762|NCT00711243|1869918|FG002|Registed and Started Treatment|Withdrawal by Subject|0
897763|NCT00711243|1869919|FG003|Registed and Started Treatment|Withdrawal by Subject|0
897764|NCT00711243|1869920|FG004|Registed and Started Treatment|Withdrawal by Subject|0
897765|NCT00711243|1869921|FG005|Registed and Started Treatment|Withdrawal by Subject|1
897766|NCT00711243|1869916|FG000|Reached First Response/4 Cycles|Death|0
897767|NCT00711243|1869917|FG001|Reached First Response/4 Cycles|Death|0
897768|NCT00711243|1869918|FG002|Reached First Response/4 Cycles|Death|0
897769|NCT00711243|1869919|FG003|Reached First Response/4 Cycles|Death|0
897770|NCT00711243|1869920|FG004|Reached First Response/4 Cycles|Death|0
897771|NCT00711243|1869921|FG005|Reached First Response/4 Cycles|Death|2
897772|NCT00711243|1869916|FG000|Reached First Response/4 Cycles|Progressive disease|0
897773|NCT00711243|1869917|FG001|Reached First Response/4 Cycles|Progressive disease|0
897774|NCT00711243|1869918|FG002|Reached First Response/4 Cycles|Progressive disease|0
897775|NCT00711243|1869919|FG003|Reached First Response/4 Cycles|Progressive disease|1
897776|NCT00711243|1869920|FG004|Reached First Response/4 Cycles|Progressive disease|0
897777|NCT00711243|1869921|FG005|Reached First Response/4 Cycles|Progressive disease|0
1018315|NCT01570283|2043161|FG004|Cohort 1: Dose Level 1|Death|0
1117282|NCT02552225|2203491|FG001|Overall Study|Withdrawal by Subject|0
1162069|NCT03382821|2284074|FG000|Overall Study|Did not receive allocated intervention.|0
1162070|NCT03382821|2284075|FG001|Overall Study|Did not receive allocated intervention.|3
897778|NCT00711243|1869916|FG000|Treated Cycle 5 After First Response|Progressive disease|1
897779|NCT00711243|1869917|FG001|Treated Cycle 5 After First Response|Progressive disease|2
897780|NCT00711243|1869918|FG002|Treated Cycle 5 After First Response|Progressive disease|0
897781|NCT00711243|1869919|FG003|Treated Cycle 5 After First Response|Progressive disease|0
897782|NCT00711243|1869920|FG004|Treated Cycle 5 After First Response|Progressive disease|1
897783|NCT00711243|1869921|FG005|Treated Cycle 5 After First Response|Progressive disease|1
897784|NCT00711243|1869916|FG000|Treated Cycle 5 After First Response|Death|0
897785|NCT00711243|1869917|FG001|Treated Cycle 5 After First Response|Death|0
897786|NCT00711243|1869918|FG002|Treated Cycle 5 After First Response|Death|0
897787|NCT00711243|1869919|FG003|Treated Cycle 5 After First Response|Death|0
897788|NCT00711243|1869920|FG004|Treated Cycle 5 After First Response|Death|0
897789|NCT00711243|1869921|FG005|Treated Cycle 5 After First Response|Death|2
897790|NCT00711243|1869916|FG000|Treated Cycle 5 After First Response|Decline in performance status|0
897791|NCT00711243|1869917|FG001|Treated Cycle 5 After First Response|Decline in performance status|0
897792|NCT00711243|1869918|FG002|Treated Cycle 5 After First Response|Decline in performance status|0
897793|NCT00711243|1869919|FG003|Treated Cycle 5 After First Response|Decline in performance status|0
897794|NCT00711243|1869920|FG004|Treated Cycle 5 After First Response|Decline in performance status|0
897795|NCT00711243|1869921|FG005|Treated Cycle 5 After First Response|Decline in performance status|1
897796|NCT00711243|1869916|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0
897797|NCT00711243|1869917|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0
897798|NCT00711243|1869918|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0
897799|NCT00711243|1869919|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0
897800|NCT00711243|1869920|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0
897801|NCT00711243|1869921|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2
897802|NCT00711412|1869964|FG000|Induction Treatment|Death|2
897803|NCT00711412|1869964|FG000|Induction Treatment|Adverse Event|1
897804|NCT00711412|1869964|FG000|Induction Treatment|Other|1
897805|NCT00711412|1869964|FG000|Evaluated for Combination Treatment|Adverse Event|2
897806|NCT00711412|1869964|FG000|Evaluated for Combination Treatment|Death|1
897807|NCT00711412|1869964|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1
897808|NCT00711412|1869964|FG000|Evaluated for Combination Treatment|Progressive disease|2
897809|NCT00711412|1869964|FG000|Combination Treatment|Progressive Disease|1
897810|NCT00711412|1869964|FG000|Evaluation for Response and Surgery|Progressive Disease|2
897811|NCT00711412|1869964|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2
897812|NCT00711412|1869964|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1
897813|NCT00711412|1869964|FG000|Evaluation for Response and Surgery|Death|1
897814|NCT00711412|1869964|FG000|Survival Follow up Until Death|Other|12
897815|NCT00711425|1869969|FG000|Overall Study|Protocol Violation|1
897816|NCT00711425|1869969|FG000|Overall Study|Death|2
897817|NCT00711425|1869969|FG000|Overall Study|Lost to Follow-up|1
897818|NCT00711477|1869985|FG000|Overall Study|Adverse Event|3
897819|NCT00711477|1869986|FG001|Overall Study|Adverse Event|1
897820|NCT00711477|1869985|FG000|Overall Study|Lost to Follow-up|0
897821|NCT00711477|1869986|FG001|Overall Study|Lost to Follow-up|1
897822|NCT00711477|1869985|FG000|Overall Study|Noncompliance|0
897823|NCT00711477|1869986|FG001|Overall Study|Noncompliance|1
897824|NCT00711516|1870001|FG000|Overall Study|Adverse Event|1
897825|NCT00711516|1870002|FG001|Overall Study|Adverse Event|1
897826|NCT00711516|1870001|FG000|Overall Study|Withdrawal by Subject|0
897827|NCT00711516|1870002|FG001|Overall Study|Withdrawal by Subject|1
897828|NCT00711516|1870001|FG000|Overall Study|Protocol Violation|0
897829|NCT00711516|1870002|FG001|Overall Study|Protocol Violation|1
897830|NCT00711529|1870010|FG000|Overall Study|Protocol Violation|2
897831|NCT00711529|1870011|FG001|Overall Study|Protocol Violation|0
897832|NCT00711529|1870010|FG000|Overall Study|Withdrawal by Subject|2
897833|NCT00711529|1870011|FG001|Overall Study|Withdrawal by Subject|6
897834|NCT00711555|1870017|FG000|Overall Study|Adverse Event|3
897835|NCT00711594|1870024|FG000|Overall Study|Progressive disease|2
897836|NCT00711594|1870025|FG001|Overall Study|Progressive disease|2
897837|NCT00711594|1870026|FG002|Overall Study|Progressive disease|6
897838|NCT00711594|1870027|FG003|Overall Study|Progressive disease|44
897839|NCT00711594|1870024|FG000|Overall Study|Other Adverse Event|1
897840|NCT00711594|1870025|FG001|Overall Study|Other Adverse Event|0
897841|NCT00711594|1870026|FG002|Overall Study|Other Adverse Event|0
897842|NCT00711594|1870027|FG003|Overall Study|Other Adverse Event|16
897843|NCT00711594|1870024|FG000|Overall Study|Withdrawal by Subject|0
897844|NCT00711594|1870025|FG001|Overall Study|Withdrawal by Subject|1
897845|NCT00711594|1870026|FG002|Overall Study|Withdrawal by Subject|0
897846|NCT00711594|1870027|FG003|Overall Study|Withdrawal by Subject|2
897847|NCT00711646|1870041|FG000|Overall Study|Adverse Event|6
897848|NCT00711646|1870042|FG001|Overall Study|Adverse Event|1
1117283|NCT02552238|2203497|FG000|Overall Study|Withdrawal by Subject|2
1117284|NCT02552238|2203497|FG000|Overall Study|Adverse Event|2
1117285|NCT02552303|2203512|FG000|Allocation|Withdrawal by Subject|2
1117286|NCT02552303|2203513|FG001|Allocation|Withdrawal by Subject|1
1117287|NCT02552303|2203514|FG002|Allocation|Withdrawal by Subject|1
1117288|NCT02552303|2203515|FG003|Allocation|Withdrawal by Subject|1
1117289|NCT02552303|2203512|FG000|Allocation|ineligible|1
897849|NCT00711646|1870041|FG000|Overall Study|Withdrawal by Subject|4
897850|NCT00711646|1870042|FG001|Overall Study|Withdrawal by Subject|0
897851|NCT00711646|1870041|FG000|Overall Study|Protocol Violation|0
897852|NCT00711646|1870042|FG001|Overall Study|Protocol Violation|1
897853|NCT00711646|1870041|FG000|Overall Study|Lost to Follow-up|1
897854|NCT00711646|1870042|FG001|Overall Study|Lost to Follow-up|0
897855|NCT00711646|1870041|FG000|Overall Study|administrative decision|0
897856|NCT00711646|1870042|FG001|Overall Study|administrative decision|1
897857|NCT00711646|1870041|FG000|Overall Study|patient non-compliance|1
897858|NCT00711646|1870042|FG001|Overall Study|patient non-compliance|0
897859|NCT00711802|1870067|FG000|Overall Study|Not treated (no further detail)|2
897860|NCT00711802|1870068|FG001|Overall Study|Not treated (no further detail)|1
897861|NCT00711802|1870069|FG002|Overall Study|Not treated (no further detail)|2
897862|NCT00711802|1870070|FG003|Overall Study|Not treated (no further detail)|0
897863|NCT00711802|1870071|FG004|Overall Study|Not treated (no further detail)|2
897864|NCT00711802|1870072|FG005|Overall Study|Not treated (no further detail)|0
897865|NCT00711802|1870073|FG006|Overall Study|Not treated (no further detail)|0
897866|NCT00711802|1870074|FG007|Overall Study|Not treated (no further detail)|0
897867|NCT00711802|1870067|FG000|Overall Study|Adverse Event|0
897868|NCT00711802|1870068|FG001|Overall Study|Adverse Event|0
897869|NCT00711802|1870069|FG002|Overall Study|Adverse Event|0
897870|NCT00711802|1870070|FG003|Overall Study|Adverse Event|0
897871|NCT00711802|1870071|FG004|Overall Study|Adverse Event|1
897872|NCT00711802|1870072|FG005|Overall Study|Adverse Event|1
897873|NCT00711802|1870073|FG006|Overall Study|Adverse Event|0
897874|NCT00711802|1870074|FG007|Overall Study|Adverse Event|0
897875|NCT00711802|1870067|FG000|Overall Study|Microbiological failure|0
897876|NCT00711802|1870068|FG001|Overall Study|Microbiological failure|1
897877|NCT00711802|1870069|FG002|Overall Study|Microbiological failure|0
897878|NCT00711802|1870070|FG003|Overall Study|Microbiological failure|0
897879|NCT00711802|1870071|FG004|Overall Study|Microbiological failure|0
897880|NCT00711802|1870072|FG005|Overall Study|Microbiological failure|1
897881|NCT00711802|1870073|FG006|Overall Study|Microbiological failure|0
897882|NCT00711802|1870074|FG007|Overall Study|Microbiological failure|0
897883|NCT00711802|1870067|FG000|Overall Study|Protocol Violation|0
897884|NCT00711802|1870068|FG001|Overall Study|Protocol Violation|0
897885|NCT00711802|1870069|FG002|Overall Study|Protocol Violation|0
897886|NCT00711802|1870070|FG003|Overall Study|Protocol Violation|1
897887|NCT00711802|1870071|FG004|Overall Study|Protocol Violation|0
897888|NCT00711802|1870072|FG005|Overall Study|Protocol Violation|0
897889|NCT00711802|1870073|FG006|Overall Study|Protocol Violation|0
897890|NCT00711802|1870074|FG007|Overall Study|Protocol Violation|0
897891|NCT00711802|1870067|FG000|Overall Study|Physician Decision|0
897892|NCT00711802|1870068|FG001|Overall Study|Physician Decision|2
897893|NCT00711802|1870069|FG002|Overall Study|Physician Decision|0
897894|NCT00711802|1870070|FG003|Overall Study|Physician Decision|0
897895|NCT00711802|1870071|FG004|Overall Study|Physician Decision|0
897896|NCT00711802|1870072|FG005|Overall Study|Physician Decision|0
897897|NCT00711802|1870073|FG006|Overall Study|Physician Decision|0
897898|NCT00711802|1870074|FG007|Overall Study|Physician Decision|0
897899|NCT00711802|1870067|FG000|Overall Study|Withdrawal by Subject|0
897900|NCT00711802|1870068|FG001|Overall Study|Withdrawal by Subject|1
897901|NCT00711802|1870069|FG002|Overall Study|Withdrawal by Subject|0
897902|NCT00711802|1870070|FG003|Overall Study|Withdrawal by Subject|1
897903|NCT00711802|1870071|FG004|Overall Study|Withdrawal by Subject|0
897904|NCT00711802|1870072|FG005|Overall Study|Withdrawal by Subject|0
897905|NCT00711802|1870073|FG006|Overall Study|Withdrawal by Subject|0
897906|NCT00711802|1870074|FG007|Overall Study|Withdrawal by Subject|0
897907|NCT00711802|1870067|FG000|Overall Study|Lost to Follow-up|0
897908|NCT00711802|1870068|FG001|Overall Study|Lost to Follow-up|0
897909|NCT00711802|1870069|FG002|Overall Study|Lost to Follow-up|3
897910|NCT00711802|1870070|FG003|Overall Study|Lost to Follow-up|1
897911|NCT00711802|1870071|FG004|Overall Study|Lost to Follow-up|10
897912|NCT00711802|1870072|FG005|Overall Study|Lost to Follow-up|6
897913|NCT00711802|1870073|FG006|Overall Study|Lost to Follow-up|4
897914|NCT00711802|1870074|FG007|Overall Study|Lost to Follow-up|2
897915|NCT00711802|1870067|FG000|Overall Study|Reason not reported|0
897916|NCT00711802|1870068|FG001|Overall Study|Reason not reported|1
897917|NCT00711802|1870069|FG002|Overall Study|Reason not reported|1
897918|NCT00711802|1870070|FG003|Overall Study|Reason not reported|0
897919|NCT00711802|1870071|FG004|Overall Study|Reason not reported|1
897920|NCT00711802|1870072|FG005|Overall Study|Reason not reported|0
897921|NCT00711802|1870073|FG006|Overall Study|Reason not reported|1
897922|NCT00711802|1870074|FG007|Overall Study|Reason not reported|0
897923|NCT00711880|1870110|FG000|Overall Study|Adverse Event|11
897924|NCT00711880|1870111|FG001|Overall Study|Adverse Event|2
897925|NCT00711880|1870110|FG000|Overall Study|Patient non-compliance|1
897926|NCT00711880|1870111|FG001|Overall Study|Patient non-compliance|0
1117290|NCT02552303|2203513|FG001|Allocation|ineligible|1
1117291|NCT02552303|2203514|FG002|Allocation|ineligible|0
1117292|NCT02552303|2203515|FG003|Allocation|ineligible|0
1117293|NCT02552303|2203512|FG000|Follow-Up|Lost to Follow-up|0
1117294|NCT02552303|2203513|FG001|Follow-Up|Lost to Follow-up|0
1117295|NCT02552303|2203514|FG002|Follow-Up|Lost to Follow-up|1
1117296|NCT02552303|2203515|FG003|Follow-Up|Lost to Follow-up|0
1117297|NCT02552303|2203512|FG000|Follow-Up|ineligible|0
1117298|NCT02552303|2203513|FG001|Follow-Up|ineligible|2
1117299|NCT02552303|2203514|FG002|Follow-Up|ineligible|0
1117300|NCT02552303|2203515|FG003|Follow-Up|ineligible|0
1117301|NCT02552316|2203525|FG000|Overall Study|Withdrawal by Subject|1
1117302|NCT02552316|2203525|FG000|Overall Study|Withdrawal due to non-compliance|1
1117303|NCT02552355|2203577|FG000|Overall Study|Adverse Event|0
1117304|NCT02552355|2203578|FG001|Overall Study|Adverse Event|2
1117305|NCT02552355|2203579|FG002|Overall Study|Adverse Event|2
1117306|NCT02552355|2203580|FG003|Overall Study|Adverse Event|0
1117307|NCT02552355|2203577|FG000|Overall Study|Withdrawal by Subject|0
1117308|NCT02552355|2203578|FG001|Overall Study|Withdrawal by Subject|0
1117309|NCT02552355|2203579|FG002|Overall Study|Withdrawal by Subject|0
1117310|NCT02552355|2203580|FG003|Overall Study|Withdrawal by Subject|1
1117311|NCT02552732|2203595|FG000|Overall Study|Lost to Follow-up|2
1117312|NCT02552732|2203595|FG000|Overall Study|Physician Decision|1
1117313|NCT02552732|2203595|FG000|Overall Study|Day 1 SpO2 > 96%|1
1117314|NCT02552732|2203595|FG000|Overall Study|Withdrawal by Subject|6
1117315|NCT02552888|2203611|FG000|Overall Study|Lost to Follow-up|1
1117316|NCT02552888|2203612|FG001|Overall Study|Lost to Follow-up|1
1117317|NCT02552966|2203622|FG000|Overall Study|Lost to Follow-up|2
1117318|NCT02552966|2203622|FG000|Overall Study|Withdrawal by Subject|3
1117319|NCT02553317|2203632|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
1117320|NCT02553317|2203633|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
1117321|NCT02553317|2203632|FG000|Overall Treatment Period + Follow-up|Physician Decision|2
1117322|NCT02553317|2203633|FG001|Overall Treatment Period + Follow-up|Physician Decision|4
1117323|NCT02553317|2203632|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
1117324|NCT02553317|2203633|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
1117325|NCT02553317|2203632|FG000|Overall Treatment Period + Follow-up|Death|1
1117326|NCT02553317|2203633|FG001|Overall Treatment Period + Follow-up|Death|3
1117327|NCT02553317|2203632|FG000|Overall Treatment Period + Follow-up|Adverse Event|6
1117328|NCT02553317|2203633|FG001|Overall Treatment Period + Follow-up|Adverse Event|5
1117329|NCT02553317|2203632|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
1117330|NCT02553317|2203633|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
1117331|NCT02553317|2203632|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0
1117332|NCT02553317|2203633|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1
1117333|NCT02553317|2203632|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
1117334|NCT02553317|2203633|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
1117335|NCT02553317|2203632|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0
1117336|NCT02553317|2203633|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1
1117337|NCT02553317|2203632|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
1117338|NCT02553317|2203633|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
1117339|NCT02553330|2203643|FG000|Overall Study|Study Terminated by Sponsor|2
1117340|NCT02553330|2203644|FG001|Overall Study|Study Terminated by Sponsor|13
1117341|NCT02553330|2203645|FG002|Overall Study|Study Terminated by Sponsor|12
1117342|NCT02553330|2203643|FG000|Overall Study|Withdrawal by Subject|3
1117343|NCT02553330|2203644|FG001|Overall Study|Withdrawal by Subject|19
1117344|NCT02553330|2203645|FG002|Overall Study|Withdrawal by Subject|21
1117345|NCT02553330|2203643|FG000|Overall Study|Other|0
1117346|NCT02553330|2203644|FG001|Overall Study|Other|1
1117347|NCT02553330|2203645|FG002|Overall Study|Other|0
1117348|NCT02553330|2203643|FG000|Overall Study|Non compliance to study treatment|0
1117349|NCT02553330|2203644|FG001|Overall Study|Non compliance to study treatment|1
1117350|NCT02553330|2203645|FG002|Overall Study|Non compliance to study treatment|0
1117351|NCT02553330|2203643|FG000|Overall Study|Adverse Event|0
1117352|NCT02553330|2203644|FG001|Overall Study|Adverse Event|1
1117353|NCT02553330|2203645|FG002|Overall Study|Adverse Event|0
1117354|NCT02553330|2203643|FG000|Overall Study|Lost to Follow-up|0
1117355|NCT02553330|2203644|FG001|Overall Study|Lost to Follow-up|4
1117356|NCT02553330|2203645|FG002|Overall Study|Lost to Follow-up|4
1117357|NCT02553421|2203666|FG000|Overall Study|Lost to Follow-up|21
1117358|NCT02553421|2203667|FG001|Overall Study|Lost to Follow-up|1
1117359|NCT02553421|2203666|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5
897927|NCT00711880|1870110|FG000|Overall Study|Lack of Efficacy|1
897928|NCT00711880|1870111|FG001|Overall Study|Lack of Efficacy|5
897929|NCT00711958|1870119|FG000|Overall Study|Withdrawal by Subject|6
897930|NCT00711958|1870120|FG001|Overall Study|Withdrawal by Subject|8
897931|NCT00711958|1870119|FG000|Overall Study|Lack of Efficacy|3
1117360|NCT02553421|2203667|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0
1117361|NCT02553421|2203666|FG000|Overall Study|Improper Device Placement|3
1117362|NCT02553421|2203667|FG001|Overall Study|Improper Device Placement|0
1117363|NCT02553499|2203688|FG000|Overall Study|Adverse Event|0
1117364|NCT02553499|2203689|FG001|Overall Study|Adverse Event|0
1117365|NCT02553499|2203690|FG002|Overall Study|Adverse Event|0
1117366|NCT02553499|2203691|FG003|Overall Study|Adverse Event|0
1117367|NCT02553499|2203692|FG004|Overall Study|Adverse Event|0
1117368|NCT02553499|2203693|FG005|Overall Study|Adverse Event|0
1117369|NCT02553499|2203694|FG006|Overall Study|Adverse Event|1
1117370|NCT02553499|2203695|FG007|Overall Study|Adverse Event|1
1117371|NCT02553499|2203696|FG008|Overall Study|Adverse Event|0
1117372|NCT02553499|2203697|FG009|Overall Study|Adverse Event|0
897932|NCT00711958|1870120|FG001|Overall Study|Lack of Efficacy|1
897933|NCT00711958|1870119|FG000|Overall Study|Clinical deterioration|1
897934|NCT00711958|1870120|FG001|Overall Study|Clinical deterioration|0
897935|NCT00711958|1870119|FG000|Overall Study|Adverse Event|9
897936|NCT00711958|1870120|FG001|Overall Study|Adverse Event|7
897937|NCT00711958|1870119|FG000|Overall Study|Protocol Violation|1
897938|NCT00711958|1870120|FG001|Overall Study|Protocol Violation|0
897939|NCT00711958|1870119|FG000|Overall Study|Lost to Follow-up|2
897940|NCT00711958|1870120|FG001|Overall Study|Lost to Follow-up|2
897941|NCT00711958|1870119|FG000|Overall Study|Death|10
897942|NCT00711958|1870120|FG001|Overall Study|Death|5
897943|NCT00711958|1870119|FG000|Overall Study|Progression of disease|1
897944|NCT00711958|1870120|FG001|Overall Study|Progression of disease|0
897945|NCT00711971|1870129|FG000|Overall Study|Lost to Follow-up|3
897946|NCT00711971|1870130|FG001|Overall Study|Lost to Follow-up|4
897947|NCT00711971|1870131|FG002|Overall Study|Lost to Follow-up|1
897948|NCT00712010|1870154|FG000|Washout (7 Days)|Withdrawal by Subject|1
897949|NCT00712166|1870185|FG000|Overall Study|Noncompliance|0
897950|NCT00712166|1870186|FG001|Overall Study|Noncompliance|1
897951|NCT00712270|1870218|FG000|Overall Study|Withdrawal by Subject|11
897952|NCT00712270|1870218|FG000|Overall Study|Screen Failure|3
897953|NCT00712335|1870272|FG000|Overall Study|Withdrawal by Subject|0
897954|NCT00712335|1870273|FG001|Overall Study|Withdrawal by Subject|7
897955|NCT00712335|1870274|FG002|Overall Study|Withdrawal by Subject|2
897956|NCT00712335|1870275|FG003|Overall Study|Withdrawal by Subject|3
897957|NCT00712335|1870276|FG004|Overall Study|Withdrawal by Subject|0
897958|NCT00712335|1870272|FG000|Overall Study|Lost to Follow-up|2
897959|NCT00712335|1870273|FG001|Overall Study|Lost to Follow-up|5
897960|NCT00712335|1870274|FG002|Overall Study|Lost to Follow-up|0
897961|NCT00712335|1870275|FG003|Overall Study|Lost to Follow-up|1
897962|NCT00712335|1870276|FG004|Overall Study|Lost to Follow-up|0
897963|NCT00712335|1870272|FG000|Overall Study|Protocol Violation|1
897964|NCT00712335|1870273|FG001|Overall Study|Protocol Violation|2
897965|NCT00712335|1870274|FG002|Overall Study|Protocol Violation|1
897966|NCT00712335|1870275|FG003|Overall Study|Protocol Violation|0
897967|NCT00712335|1870276|FG004|Overall Study|Protocol Violation|0
897968|NCT00712335|1870272|FG000|Overall Study|Lack of Efficacy|0
897969|NCT00712335|1870273|FG001|Overall Study|Lack of Efficacy|0
897970|NCT00712335|1870274|FG002|Overall Study|Lack of Efficacy|1
897971|NCT00712335|1870275|FG003|Overall Study|Lack of Efficacy|1
897972|NCT00712335|1870276|FG004|Overall Study|Lack of Efficacy|0
897973|NCT00712335|1870272|FG000|Overall Study|Other Reason|0
897974|NCT00712335|1870273|FG001|Overall Study|Other Reason|3
897975|NCT00712335|1870274|FG002|Overall Study|Other Reason|1
897976|NCT00712335|1870275|FG003|Overall Study|Other Reason|0
897977|NCT00712335|1870276|FG004|Overall Study|Other Reason|0
897978|NCT00712348|1870288|FG000|Overall Study|Withdrawal by Subject|1
897979|NCT00712543|1870307|FG000|Day 8-14|Lost to Follow-up|0
897980|NCT00712543|1870308|FG001|Day 8-14|Lost to Follow-up|2
897981|NCT00712673|1870317|FG000|Overall Study|Adverse Event|3
897982|NCT00712673|1870318|FG001|Overall Study|Adverse Event|3
897983|NCT00712673|1870319|FG002|Overall Study|Adverse Event|21
897984|NCT00712673|1870320|FG003|Overall Study|Adverse Event|26
897985|NCT00712673|1870317|FG000|Overall Study|Lack of Efficacy|2
897986|NCT00712673|1870318|FG001|Overall Study|Lack of Efficacy|8
897987|NCT00712673|1870319|FG002|Overall Study|Lack of Efficacy|8
897988|NCT00712673|1870320|FG003|Overall Study|Lack of Efficacy|6
897989|NCT00712673|1870317|FG000|Overall Study|Poor Compliance to Protocol|3
897990|NCT00712673|1870318|FG001|Overall Study|Poor Compliance to Protocol|3
897991|NCT00712673|1870319|FG002|Overall Study|Poor Compliance to Protocol|4
897992|NCT00712673|1870320|FG003|Overall Study|Poor Compliance to Protocol|16
897993|NCT00712673|1870317|FG000|Overall Study|Lost to Follow-up|1
897994|NCT00712673|1870318|FG001|Overall Study|Lost to Follow-up|0
897995|NCT00712673|1870319|FG002|Overall Study|Lost to Follow-up|2
897996|NCT00712673|1870320|FG003|Overall Study|Lost to Follow-up|0
897997|NCT00712673|1870317|FG000|Overall Study|Withdrawal by Subject|6
897998|NCT00712673|1870318|FG001|Overall Study|Withdrawal by Subject|7
897999|NCT00712673|1870319|FG002|Overall Study|Withdrawal by Subject|15
898000|NCT00712673|1870320|FG003|Overall Study|Withdrawal by Subject|20
898001|NCT00712673|1870317|FG000|Overall Study|Familial and Personal Reasons|5
898002|NCT00712673|1870318|FG001|Overall Study|Familial and Personal Reasons|0
898003|NCT00712673|1870319|FG002|Overall Study|Familial and Personal Reasons|5
898004|NCT00712673|1870320|FG003|Overall Study|Familial and Personal Reasons|2
898005|NCT00712673|1870317|FG000|Overall Study|Investigator's Decision|1
898006|NCT00712673|1870318|FG001|Overall Study|Investigator's Decision|0
898007|NCT00712673|1870319|FG002|Overall Study|Investigator's Decision|0
1117373|NCT02553499|2203698|FG010|Overall Study|Adverse Event|0
1117374|NCT02553499|2203699|FG011|Overall Study|Adverse Event|0
1117375|NCT02553499|2203700|FG012|Overall Study|Adverse Event|0
1117376|NCT02553499|2203701|FG013|Overall Study|Adverse Event|1
1117377|NCT02553499|2203688|FG000|Overall Study|Death|0
1117378|NCT02553499|2203689|FG001|Overall Study|Death|1
1117379|NCT02553499|2203690|FG002|Overall Study|Death|1
1117380|NCT02553499|2203691|FG003|Overall Study|Death|0
1117381|NCT02553499|2203692|FG004|Overall Study|Death|1
1117382|NCT02553499|2203693|FG005|Overall Study|Death|2
1117383|NCT02553499|2203694|FG006|Overall Study|Death|0
1117384|NCT02553499|2203695|FG007|Overall Study|Death|0
1117385|NCT02553499|2203696|FG008|Overall Study|Death|0
1117386|NCT02553499|2203697|FG009|Overall Study|Death|0
1117387|NCT02553499|2203698|FG010|Overall Study|Death|1
1117388|NCT02553499|2203699|FG011|Overall Study|Death|0
1117389|NCT02553499|2203700|FG012|Overall Study|Death|0
1117390|NCT02553499|2203701|FG013|Overall Study|Death|0
1117391|NCT02553499|2203688|FG000|Overall Study|Lost to Follow-up|0
1117392|NCT02553499|2203689|FG001|Overall Study|Lost to Follow-up|0
1117393|NCT02553499|2203690|FG002|Overall Study|Lost to Follow-up|0
1117394|NCT02553499|2203691|FG003|Overall Study|Lost to Follow-up|0
1117395|NCT02553499|2203692|FG004|Overall Study|Lost to Follow-up|0
1117396|NCT02553499|2203693|FG005|Overall Study|Lost to Follow-up|0
1117397|NCT02553499|2203694|FG006|Overall Study|Lost to Follow-up|1
1117398|NCT02553499|2203695|FG007|Overall Study|Lost to Follow-up|0
1117399|NCT02553499|2203696|FG008|Overall Study|Lost to Follow-up|0
1117400|NCT02553499|2203697|FG009|Overall Study|Lost to Follow-up|0
1117401|NCT02553499|2203698|FG010|Overall Study|Lost to Follow-up|0
1117402|NCT02553499|2203699|FG011|Overall Study|Lost to Follow-up|0
1117403|NCT02553499|2203700|FG012|Overall Study|Lost to Follow-up|0
1117404|NCT02553499|2203701|FG013|Overall Study|Lost to Follow-up|0
1117405|NCT02553499|2203688|FG000|Overall Study|Physician Decision|0
1117406|NCT02553499|2203689|FG001|Overall Study|Physician Decision|1
1117407|NCT02553499|2203690|FG002|Overall Study|Physician Decision|1
898008|NCT00712673|1870320|FG003|Overall Study|Investigator's Decision|0
898009|NCT00712673|1870317|FG000|Overall Study|Protocol Violation|0
898010|NCT00712673|1870318|FG001|Overall Study|Protocol Violation|0
898011|NCT00712673|1870319|FG002|Overall Study|Protocol Violation|2
898012|NCT00712673|1870320|FG003|Overall Study|Protocol Violation|0
898013|NCT00712712|1870339|FG000|Overall Study|Protocol Violation|11
898014|NCT00712712|1870339|FG000|Overall Study|Radiofrequency not done|3
898015|NCT00712712|1870339|FG000|Overall Study|Death|8
898016|NCT00712712|1870339|FG000|Overall Study|Withdrawal by Subject|1
898017|NCT00712725|1870351|FG000|Overall Study|Adverse Event|1
898018|NCT00712725|1870352|FG001|Overall Study|Adverse Event|0
898019|NCT00712725|1870353|FG002|Overall Study|Adverse Event|0
898020|NCT00712725|1870354|FG003|Overall Study|Adverse Event|1
898021|NCT00712725|1870355|FG004|Overall Study|Adverse Event|0
898022|NCT00712725|1870356|FG005|Overall Study|Adverse Event|0
898023|NCT00712725|1870357|FG006|Overall Study|Adverse Event|0
898024|NCT00712725|1870358|FG007|Overall Study|Adverse Event|0
898025|NCT00712725|1870351|FG000|Overall Study|Lost to Follow-up|3
898026|NCT00712725|1870352|FG001|Overall Study|Lost to Follow-up|2
898027|NCT00712725|1870353|FG002|Overall Study|Lost to Follow-up|1
898028|NCT00712725|1870354|FG003|Overall Study|Lost to Follow-up|1
898029|NCT00712725|1870355|FG004|Overall Study|Lost to Follow-up|2
898030|NCT00712725|1870356|FG005|Overall Study|Lost to Follow-up|2
898031|NCT00712725|1870357|FG006|Overall Study|Lost to Follow-up|3
898032|NCT00712725|1870358|FG007|Overall Study|Lost to Follow-up|1
898033|NCT00712725|1870351|FG000|Overall Study|Physician Decision|2
898034|NCT00712725|1870352|FG001|Overall Study|Physician Decision|0
898035|NCT00712725|1870353|FG002|Overall Study|Physician Decision|0
898036|NCT00712725|1870354|FG003|Overall Study|Physician Decision|0
898037|NCT00712725|1870355|FG004|Overall Study|Physician Decision|1
898038|NCT00712725|1870356|FG005|Overall Study|Physician Decision|0
898039|NCT00712725|1870357|FG006|Overall Study|Physician Decision|2
898040|NCT00712725|1870358|FG007|Overall Study|Physician Decision|0
898041|NCT00712725|1870351|FG000|Overall Study|Pregnancy|0
898042|NCT00712725|1870352|FG001|Overall Study|Pregnancy|1
898043|NCT00712725|1870353|FG002|Overall Study|Pregnancy|0
898044|NCT00712725|1870354|FG003|Overall Study|Pregnancy|0
898045|NCT00712725|1870355|FG004|Overall Study|Pregnancy|1
898046|NCT00712725|1870356|FG005|Overall Study|Pregnancy|0
898047|NCT00712725|1870357|FG006|Overall Study|Pregnancy|2
898048|NCT00712725|1870358|FG007|Overall Study|Pregnancy|0
898049|NCT00712725|1870351|FG000|Overall Study|Protocol Violation|2
898050|NCT00712725|1870352|FG001|Overall Study|Protocol Violation|0
898051|NCT00712725|1870353|FG002|Overall Study|Protocol Violation|1
898052|NCT00712725|1870354|FG003|Overall Study|Protocol Violation|3
898053|NCT00712725|1870355|FG004|Overall Study|Protocol Violation|2
898054|NCT00712725|1870356|FG005|Overall Study|Protocol Violation|0
898055|NCT00712725|1870357|FG006|Overall Study|Protocol Violation|1
898056|NCT00712725|1870358|FG007|Overall Study|Protocol Violation|1
898057|NCT00712725|1870351|FG000|Overall Study|Withdrawal by Subject|2
898058|NCT00712725|1870352|FG001|Overall Study|Withdrawal by Subject|1
898059|NCT00712725|1870353|FG002|Overall Study|Withdrawal by Subject|1
898060|NCT00712725|1870354|FG003|Overall Study|Withdrawal by Subject|2
898061|NCT00712725|1870355|FG004|Overall Study|Withdrawal by Subject|1
898062|NCT00712725|1870356|FG005|Overall Study|Withdrawal by Subject|1
1117408|NCT02553499|2203691|FG003|Overall Study|Physician Decision|0
1117409|NCT02553499|2203692|FG004|Overall Study|Physician Decision|1
1117410|NCT02553499|2203693|FG005|Overall Study|Physician Decision|0
1117411|NCT02553499|2203694|FG006|Overall Study|Physician Decision|0
1117412|NCT02553499|2203695|FG007|Overall Study|Physician Decision|1
1117413|NCT02553499|2203696|FG008|Overall Study|Physician Decision|1
1117414|NCT02553499|2203697|FG009|Overall Study|Physician Decision|2
1117415|NCT02553499|2203698|FG010|Overall Study|Physician Decision|1
1117416|NCT02553499|2203699|FG011|Overall Study|Physician Decision|3
1117417|NCT02553499|2203700|FG012|Overall Study|Physician Decision|1
1117418|NCT02553499|2203701|FG013|Overall Study|Physician Decision|0
1117419|NCT02553499|2203688|FG000|Overall Study|Progressive Disease|0
1117420|NCT02553499|2203689|FG001|Overall Study|Progressive Disease|0
1117421|NCT02553499|2203690|FG002|Overall Study|Progressive Disease|0
1117422|NCT02553499|2203691|FG003|Overall Study|Progressive Disease|2
1117423|NCT02553499|2203692|FG004|Overall Study|Progressive Disease|1
1117424|NCT02553499|2203693|FG005|Overall Study|Progressive Disease|1
1117425|NCT02553499|2203694|FG006|Overall Study|Progressive Disease|1
1117426|NCT02553499|2203695|FG007|Overall Study|Progressive Disease|0
1117427|NCT02553499|2203696|FG008|Overall Study|Progressive Disease|0
1117428|NCT02553499|2203697|FG009|Overall Study|Progressive Disease|1
1117429|NCT02553499|2203698|FG010|Overall Study|Progressive Disease|0
1117430|NCT02553499|2203699|FG011|Overall Study|Progressive Disease|0
1117431|NCT02553499|2203700|FG012|Overall Study|Progressive Disease|2
1117432|NCT02553499|2203701|FG013|Overall Study|Progressive Disease|1
1117433|NCT02553499|2203688|FG000|Overall Study|Study Terminated by Sponsor|0
898063|NCT00712725|1870357|FG006|Overall Study|Withdrawal by Subject|1
898064|NCT00712725|1870358|FG007|Overall Study|Withdrawal by Subject|2
898065|NCT00712725|1870351|FG000|Overall Study|Lack of Qualifying Event|16
898066|NCT00712725|1870352|FG001|Overall Study|Lack of Qualifying Event|2
898067|NCT00712725|1870353|FG002|Overall Study|Lack of Qualifying Event|6
898068|NCT00712725|1870354|FG003|Overall Study|Lack of Qualifying Event|8
898069|NCT00712725|1870355|FG004|Overall Study|Lack of Qualifying Event|11
898070|NCT00712725|1870356|FG005|Overall Study|Lack of Qualifying Event|13
898071|NCT00712725|1870357|FG006|Overall Study|Lack of Qualifying Event|11
898072|NCT00712725|1870358|FG007|Overall Study|Lack of Qualifying Event|6
898073|NCT00712725|1870351|FG000|Overall Study|Protocol Specified Criteria|3
898074|NCT00712725|1870352|FG001|Overall Study|Protocol Specified Criteria|0
898075|NCT00712725|1870353|FG002|Overall Study|Protocol Specified Criteria|1
898076|NCT00712725|1870354|FG003|Overall Study|Protocol Specified Criteria|2
898077|NCT00712725|1870355|FG004|Overall Study|Protocol Specified Criteria|1
898078|NCT00712725|1870356|FG005|Overall Study|Protocol Specified Criteria|0
898079|NCT00712725|1870357|FG006|Overall Study|Protocol Specified Criteria|2
898080|NCT00712725|1870358|FG007|Overall Study|Protocol Specified Criteria|1
898081|NCT00712920|1870379|FG000|Overall Study|Adverse Event|3
898082|NCT00712920|1870380|FG001|Overall Study|Adverse Event|4
898083|NCT00712920|1870381|FG002|Overall Study|Adverse Event|7
898084|NCT00712920|1870379|FG000|Overall Study|Withdrawal by Subject|4
898085|NCT00712920|1870380|FG001|Overall Study|Withdrawal by Subject|2
898086|NCT00712920|1870381|FG002|Overall Study|Withdrawal by Subject|1
898087|NCT00712920|1870379|FG000|Overall Study|Lost to Follow-up|1
898088|NCT00712920|1870380|FG001|Overall Study|Lost to Follow-up|4
898089|NCT00712920|1870381|FG002|Overall Study|Lost to Follow-up|0
898090|NCT00712920|1870379|FG000|Overall Study|Lack of Efficacy|1
898091|NCT00712920|1870380|FG001|Overall Study|Lack of Efficacy|0
898092|NCT00712920|1870381|FG002|Overall Study|Lack of Efficacy|1
898093|NCT00712920|1870379|FG000|Overall Study|Other|5
898094|NCT00712920|1870380|FG001|Overall Study|Other|7
898095|NCT00712920|1870381|FG002|Overall Study|Other|3
898096|NCT00712920|1870379|FG000|Overall Study|Non-compliance|3
898097|NCT00712920|1870380|FG001|Overall Study|Non-compliance|0
898098|NCT00712920|1870381|FG002|Overall Study|Non-compliance|0
898099|NCT00712959|1870399|FG000|Overall Study|Protocol Violation|3
898100|NCT00712959|1870400|FG001|Overall Study|Protocol Violation|1
898101|NCT00712959|1870399|FG000|Overall Study|Lost to Follow-up|13
898102|NCT00712959|1870400|FG001|Overall Study|Lost to Follow-up|2
898103|NCT00712959|1870399|FG000|Overall Study|Withdrawal by Subject|3
898104|NCT00712959|1870400|FG001|Overall Study|Withdrawal by Subject|0
898105|NCT00712985|1870406|FG000|Overall Study|1 withdrew prior to start of drug|1
898106|NCT00712985|1870406|FG000|Overall Study|1 patient moved out of state|1
898107|NCT00712985|1870406|FG000|Overall Study|Lack of Efficacy|3
898108|NCT00713206|1870412|FG000|Overall Study|Lost to Follow-up|4
898109|NCT00713206|1870413|FG001|Overall Study|Lost to Follow-up|4
898110|NCT00713206|1870412|FG000|Overall Study|Death|1
898111|NCT00713206|1870413|FG001|Overall Study|Death|0
898112|NCT00713219|1870419|FG000|Overall Study|Death|1
898113|NCT00713219|1870419|FG000|Overall Study|Protocol Violation|1
898114|NCT00713310|1870429|FG000|Overall Study|Adverse Event|5
898115|NCT00713310|1870430|FG001|Overall Study|Adverse Event|2
898116|NCT00713310|1870429|FG000|Overall Study|Lack of Efficacy|0
898117|NCT00713310|1870430|FG001|Overall Study|Lack of Efficacy|2
898118|NCT00713310|1870429|FG000|Overall Study|Withdrawal by Subject|0
898119|NCT00713310|1870430|FG001|Overall Study|Withdrawal by Subject|2
898120|NCT00713323|1870436|FG000|Overall Study|Adverse Event|75
898121|NCT00713323|1870436|FG000|Overall Study|Withdrawal by Subject|15
898122|NCT00713323|1870436|FG000|Overall Study|Lost to Follow-up|11
1117434|NCT02553499|2203689|FG001|Overall Study|Study Terminated by Sponsor|0
1117435|NCT02553499|2203690|FG002|Overall Study|Study Terminated by Sponsor|0
1117436|NCT02553499|2203691|FG003|Overall Study|Study Terminated by Sponsor|0
1117437|NCT02553499|2203692|FG004|Overall Study|Study Terminated by Sponsor|0
1117438|NCT02553499|2203693|FG005|Overall Study|Study Terminated by Sponsor|0
1117439|NCT02553499|2203694|FG006|Overall Study|Study Terminated by Sponsor|0
1117440|NCT02553499|2203695|FG007|Overall Study|Study Terminated by Sponsor|0
1117441|NCT02553499|2203696|FG008|Overall Study|Study Terminated by Sponsor|1
1117442|NCT02553499|2203697|FG009|Overall Study|Study Terminated by Sponsor|0
1117443|NCT02553499|2203698|FG010|Overall Study|Study Terminated by Sponsor|0
1117444|NCT02553499|2203699|FG011|Overall Study|Study Terminated by Sponsor|0
898123|NCT00713323|1870436|FG000|Overall Study|Lack of Efficacy|36
898124|NCT00713323|1870436|FG000|Overall Study|Low creatine clearance at screening|1
898125|NCT00713323|1870436|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1
898126|NCT00713323|1870436|FG000|Overall Study|Surgery cured allodynic pain|1
898127|NCT00713323|1870436|FG000|Overall Study|Pain free|1
898128|NCT00713323|1870436|FG000|Overall Study|Non-compliance|1
898129|NCT00713323|1870436|FG000|Overall Study|Pain resolved|1
898130|NCT00713323|1870436|FG000|Overall Study|Subject travelling to USA|1
898131|NCT00713323|1870436|FG000|Overall Study|Subject travelling to Dominica Republic|1
898132|NCT00713323|1870436|FG000|Overall Study|Treatment that may interact with Sativex|1
898133|NCT00713349|1870440|FG000|Overall Study|Protocol Violation|1
898134|NCT00713544|1870465|FG000|Overall Study|Adverse Event|5
898135|NCT00713544|1870466|FG001|Overall Study|Adverse Event|3
898136|NCT00713544|1870467|FG002|Overall Study|Adverse Event|7
898137|NCT00713544|1870468|FG003|Overall Study|Adverse Event|7
898138|NCT00713544|1870469|FG004|Overall Study|Adverse Event|3
898139|NCT00713544|1870470|FG005|Overall Study|Adverse Event|5
898140|NCT00713544|1870465|FG000|Overall Study|Withdrawal by Subject|2
898141|NCT00713544|1870466|FG001|Overall Study|Withdrawal by Subject|0
898142|NCT00713544|1870467|FG002|Overall Study|Withdrawal by Subject|3
898143|NCT00713544|1870468|FG003|Overall Study|Withdrawal by Subject|2
898144|NCT00713544|1870469|FG004|Overall Study|Withdrawal by Subject|3
898145|NCT00713544|1870470|FG005|Overall Study|Withdrawal by Subject|1
898146|NCT00713544|1870465|FG000|Overall Study|Protocol Violation|0
898147|NCT00713544|1870466|FG001|Overall Study|Protocol Violation|0
898148|NCT00713544|1870467|FG002|Overall Study|Protocol Violation|0
898149|NCT00713544|1870468|FG003|Overall Study|Protocol Violation|0
898150|NCT00713544|1870469|FG004|Overall Study|Protocol Violation|0
898151|NCT00713544|1870470|FG005|Overall Study|Protocol Violation|1
898152|NCT00713544|1870465|FG000|Overall Study|Physician Decision|0
898153|NCT00713544|1870466|FG001|Overall Study|Physician Decision|0
898154|NCT00713544|1870467|FG002|Overall Study|Physician Decision|0
898155|NCT00713544|1870468|FG003|Overall Study|Physician Decision|0
898156|NCT00713544|1870469|FG004|Overall Study|Physician Decision|0
898157|NCT00713544|1870470|FG005|Overall Study|Physician Decision|2
898158|NCT00713544|1870465|FG000|Overall Study|Lack of Efficacy|0
898159|NCT00713544|1870466|FG001|Overall Study|Lack of Efficacy|1
898160|NCT00713544|1870467|FG002|Overall Study|Lack of Efficacy|0
898161|NCT00713544|1870468|FG003|Overall Study|Lack of Efficacy|1
898162|NCT00713544|1870469|FG004|Overall Study|Lack of Efficacy|1
898163|NCT00713544|1870470|FG005|Overall Study|Lack of Efficacy|0
898164|NCT00713544|1870465|FG000|Overall Study|Lost to Follow-up|0
898165|NCT00713544|1870466|FG001|Overall Study|Lost to Follow-up|0
898166|NCT00713544|1870467|FG002|Overall Study|Lost to Follow-up|1
898167|NCT00713544|1870468|FG003|Overall Study|Lost to Follow-up|0
898168|NCT00713544|1870469|FG004|Overall Study|Lost to Follow-up|0
898169|NCT00713544|1870470|FG005|Overall Study|Lost to Follow-up|0
898170|NCT00713544|1870465|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0
898171|NCT00713544|1870466|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1
898172|NCT00713544|1870467|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0
898173|NCT00713544|1870468|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0
898174|NCT00713544|1870469|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0
898175|NCT00713544|1870470|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0
898176|NCT00713544|1870465|FG000|Overall Study|Incorrect enrollment|0
898177|NCT00713544|1870466|FG001|Overall Study|Incorrect enrollment|1
898178|NCT00713544|1870467|FG002|Overall Study|Incorrect enrollment|0
898179|NCT00713544|1870468|FG003|Overall Study|Incorrect enrollment|0
898180|NCT00713544|1870469|FG004|Overall Study|Incorrect enrollment|0
898181|NCT00713544|1870470|FG005|Overall Study|Incorrect enrollment|0
898182|NCT00713544|1870465|FG000|Overall Study|Hepatotoxicity - not an AE|0
898183|NCT00713544|1870466|FG001|Overall Study|Hepatotoxicity - not an AE|0
898184|NCT00713544|1870467|FG002|Overall Study|Hepatotoxicity - not an AE|0
898185|NCT00713544|1870468|FG003|Overall Study|Hepatotoxicity - not an AE|0
898186|NCT00713544|1870469|FG004|Overall Study|Hepatotoxicity - not an AE|1
898187|NCT00713544|1870470|FG005|Overall Study|Hepatotoxicity - not an AE|0
898188|NCT00713609|1870499|FG000|Overall Study|Adverse Event|2
898189|NCT00713609|1870500|FG001|Overall Study|Adverse Event|0
898190|NCT00713609|1870501|FG002|Overall Study|Adverse Event|2
898191|NCT00713609|1870502|FG003|Overall Study|Adverse Event|2
1117445|NCT02553499|2203700|FG012|Overall Study|Study Terminated by Sponsor|0
1117446|NCT02553499|2203701|FG013|Overall Study|Study Terminated by Sponsor|0
1117447|NCT02553499|2203688|FG000|Overall Study|Withdrawal by Subject|2
1117448|NCT02553499|2203689|FG001|Overall Study|Withdrawal by Subject|0
1117449|NCT02553499|2203690|FG002|Overall Study|Withdrawal by Subject|0
1117450|NCT02553499|2203691|FG003|Overall Study|Withdrawal by Subject|0
1117451|NCT02553499|2203692|FG004|Overall Study|Withdrawal by Subject|0
1117452|NCT02553499|2203693|FG005|Overall Study|Withdrawal by Subject|0
1117453|NCT02553499|2203694|FG006|Overall Study|Withdrawal by Subject|0
1117454|NCT02553499|2203695|FG007|Overall Study|Withdrawal by Subject|1
1117455|NCT02553499|2203696|FG008|Overall Study|Withdrawal by Subject|1
1117456|NCT02553499|2203697|FG009|Overall Study|Withdrawal by Subject|0
898192|NCT00713609|1870503|FG004|Overall Study|Adverse Event|3
898193|NCT00713609|1870504|FG005|Overall Study|Adverse Event|1
898194|NCT00713609|1870499|FG000|Overall Study|Lost to Follow-up|5
898195|NCT00713609|1870500|FG001|Overall Study|Lost to Follow-up|7
898196|NCT00713609|1870501|FG002|Overall Study|Lost to Follow-up|5
898197|NCT00713609|1870502|FG003|Overall Study|Lost to Follow-up|5
898198|NCT00713609|1870503|FG004|Overall Study|Lost to Follow-up|7
898199|NCT00713609|1870504|FG005|Overall Study|Lost to Follow-up|0
898200|NCT00713609|1870499|FG000|Overall Study|Lack of Efficacy|1
898201|NCT00713609|1870500|FG001|Overall Study|Lack of Efficacy|3
898202|NCT00713609|1870501|FG002|Overall Study|Lack of Efficacy|0
898203|NCT00713609|1870502|FG003|Overall Study|Lack of Efficacy|0
898204|NCT00713609|1870503|FG004|Overall Study|Lack of Efficacy|1
898205|NCT00713609|1870504|FG005|Overall Study|Lack of Efficacy|0
898206|NCT00713609|1870499|FG000|Overall Study|Non-Compliance with Study Treatment|1
898207|NCT00713609|1870500|FG001|Overall Study|Non-Compliance with Study Treatment|1
898208|NCT00713609|1870501|FG002|Overall Study|Non-Compliance with Study Treatment|2
898209|NCT00713609|1870502|FG003|Overall Study|Non-Compliance with Study Treatment|0
898210|NCT00713609|1870503|FG004|Overall Study|Non-Compliance with Study Treatment|1
898211|NCT00713609|1870504|FG005|Overall Study|Non-Compliance with Study Treatment|0
898212|NCT00713609|1870499|FG000|Overall Study|Withdrawal by Subject|6
898213|NCT00713609|1870500|FG001|Overall Study|Withdrawal by Subject|1
898214|NCT00713609|1870501|FG002|Overall Study|Withdrawal by Subject|5
898215|NCT00713609|1870502|FG003|Overall Study|Withdrawal by Subject|1
898216|NCT00713609|1870503|FG004|Overall Study|Withdrawal by Subject|5
898217|NCT00713609|1870504|FG005|Overall Study|Withdrawal by Subject|7
898218|NCT00713609|1870499|FG000|Overall Study|Protocol Violation|6
898219|NCT00713609|1870500|FG001|Overall Study|Protocol Violation|3
898220|NCT00713609|1870501|FG002|Overall Study|Protocol Violation|1
898221|NCT00713609|1870502|FG003|Overall Study|Protocol Violation|1
898222|NCT00713609|1870503|FG004|Overall Study|Protocol Violation|2
898223|NCT00713609|1870504|FG005|Overall Study|Protocol Violation|0
898224|NCT00713648|1870518|FG000|Overall Study|Adverse Event|1
898225|NCT00713648|1870518|FG000|Overall Study|Unclassified|2
898226|NCT00713648|1870518|FG000|Overall Study|According to Protocol|2
898227|NCT00713648|1870518|FG000|Overall Study|Development of antibodies|3
898228|NCT00713700|1870539|FG000|Overall Study|Lost to Follow-up|3
898229|NCT00713700|1870539|FG000|Overall Study|Withdrawal by Subject|1
898230|NCT00713830|1870554|FG000|Overall Study|Adverse Event|23
898231|NCT00713830|1870555|FG001|Overall Study|Adverse Event|71
898232|NCT00713830|1870554|FG000|Overall Study|Lack of Efficacy|24
898233|NCT00713830|1870555|FG001|Overall Study|Lack of Efficacy|16
898234|NCT00713830|1870554|FG000|Overall Study|Lost to Follow-up|2
898235|NCT00713830|1870555|FG001|Overall Study|Lost to Follow-up|9
898236|NCT00713830|1870554|FG000|Overall Study|Withdrawal by Subject|13
898237|NCT00713830|1870555|FG001|Overall Study|Withdrawal by Subject|23
898238|NCT00713830|1870554|FG000|Overall Study|Poor Compliance to Protocol|7
898239|NCT00713830|1870555|FG001|Overall Study|Poor Compliance to Protocol|14
898240|NCT00713830|1870554|FG000|Overall Study|Familial and Personal Reasons|9
898241|NCT00713830|1870555|FG001|Overall Study|Familial and Personal Reasons|34
898242|NCT00713830|1870554|FG000|Overall Study|Sponsor Decision|4
898243|NCT00713830|1870555|FG001|Overall Study|Sponsor Decision|10
898244|NCT00714051|1870563|FG000|Overall Study|Withdrawal by Subject|1
898245|NCT00714051|1870564|FG001|Overall Study|Withdrawal by Subject|0
898246|NCT00714051|1870563|FG000|Overall Study|Death|0
898247|NCT00714051|1870564|FG001|Overall Study|Death|1
898248|NCT00714168|1870572|FG000|Overall Study|Pregnancy|5
898249|NCT00714168|1870573|FG001|Overall Study|Pregnancy|4
898250|NCT00714168|1870572|FG000|Overall Study|Lost to Follow-up|32
898251|NCT00714168|1870573|FG001|Overall Study|Lost to Follow-up|50
898252|NCT00714168|1870572|FG000|Overall Study|Relocation|4
898253|NCT00714168|1870573|FG001|Overall Study|Relocation|3
898254|NCT00714168|1870572|FG000|Overall Study|Non-study medical condition|3
898255|NCT00714168|1870573|FG001|Overall Study|Non-study medical condition|2
898256|NCT00714259|1870601|FG000|Overall Study|Death|2
898257|NCT00714285|1870618|FG000|Overall Study|Lost to Follow-up|0
898258|NCT00714285|1870619|FG001|Overall Study|Lost to Follow-up|2
898259|NCT00714285|1870620|FG002|Overall Study|Lost to Follow-up|0
898260|NCT00714285|1870621|FG003|Overall Study|Lost to Follow-up|1
898261|NCT00714285|1870618|FG000|Overall Study|Migrated/moved from study area|0
898262|NCT00714285|1870619|FG001|Overall Study|Migrated/moved from study area|1
898263|NCT00714285|1870620|FG002|Overall Study|Migrated/moved from study area|0
898264|NCT00714285|1870621|FG003|Overall Study|Migrated/moved from study area|0
898265|NCT00714415|1870648|FG000|Overall Study|Lack of Efficacy|1
898266|NCT00714415|1870649|FG001|Overall Study|Lack of Efficacy|0
898267|NCT00714415|1870648|FG000|Overall Study|Death|1
1117457|NCT02553499|2203698|FG010|Overall Study|Withdrawal by Subject|1
1117458|NCT02553499|2203699|FG011|Overall Study|Withdrawal by Subject|0
1117459|NCT02553499|2203700|FG012|Overall Study|Withdrawal by Subject|0
1117460|NCT02553499|2203701|FG013|Overall Study|Withdrawal by Subject|0
1117461|NCT02553538|2203738|FG000|Overall Study|Could Not Reach by Telephone|133
1117462|NCT02553538|2203739|FG001|Overall Study|Could Not Reach by Telephone|0
1117463|NCT02553538|2203738|FG000|Overall Study|Died or Left Network|54
1117464|NCT02553538|2203739|FG001|Overall Study|Died or Left Network|56
1117465|NCT02553629|2203747|FG000|Overall Study|Logistic reasons|3
1117466|NCT02553629|2203748|FG001|Overall Study|Logistic reasons|6
1117467|NCT02553772|2203765|FG000|Overall Study|Adverse Event|2
1117468|NCT02553772|2203766|FG001|Overall Study|Adverse Event|3
1117469|NCT02553772|2203765|FG000|Overall Study|Lost to Follow-up|2
1117470|NCT02553772|2203766|FG001|Overall Study|Lost to Follow-up|1
1117471|NCT02553772|2203765|FG000|Overall Study|Withdrawal of Consent|1
1117472|NCT02553772|2203766|FG001|Overall Study|Withdrawal of Consent|1
1117473|NCT02553772|2203765|FG000|Overall Study|Lack of Efficacy|1
1117474|NCT02553772|2203766|FG001|Overall Study|Lack of Efficacy|0
1117475|NCT02553772|2203765|FG000|Overall Study|Other Miscellaneous Reasons|0
1117476|NCT02553772|2203766|FG001|Overall Study|Other Miscellaneous Reasons|1
1117477|NCT02553928|2203795|FG000|Overall Study|Adverse Event|2
1117478|NCT02553928|2203796|FG001|Overall Study|Adverse Event|1
1117479|NCT02553928|2203795|FG000|Overall Study|Lost to Follow-up|0
1117480|NCT02553928|2203796|FG001|Overall Study|Lost to Follow-up|1
1117481|NCT02553928|2203795|FG000|Overall Study|Administrative reason(s)|0
1117482|NCT02553928|2203796|FG001|Overall Study|Administrative reason(s)|1
1117483|NCT02554019|2203806|FG000|Overall Study|Withdrawal by Subject|1
1117484|NCT02554019|2203807|FG001|Overall Study|Withdrawal by Subject|0
1117485|NCT02554019|2203808|FG002|Overall Study|Withdrawal by Subject|2
1117486|NCT02554019|2203806|FG000|Overall Study|Adverse Event|1
1117487|NCT02554019|2203807|FG001|Overall Study|Adverse Event|0
1117488|NCT02554019|2203808|FG002|Overall Study|Adverse Event|0
1117489|NCT02554279|2203818|FG000|Overall Study|Adverse Event|2
1117490|NCT02554279|2203819|FG001|Overall Study|Adverse Event|5
1117491|NCT02554279|2203818|FG000|Overall Study|Lost to Follow-up|3
1117492|NCT02554279|2203819|FG001|Overall Study|Lost to Follow-up|2
1117493|NCT02554279|2203818|FG000|Overall Study|Withdrawal by Subject|6
1117494|NCT02554279|2203819|FG001|Overall Study|Withdrawal by Subject|4
1117495|NCT02554279|2203818|FG000|Overall Study|Protocol Violation|2
1117496|NCT02554279|2203819|FG001|Overall Study|Protocol Violation|1
1117497|NCT02554279|2203818|FG000|Overall Study|Other reason|19
1117498|NCT02554279|2203819|FG001|Overall Study|Other reason|6
1117499|NCT02554474|2203844|FG000|Overall Study|Protocol Violation|1
1117500|NCT02554474|2203845|FG001|Overall Study|Protocol Violation|1
1117501|NCT02554474|2203844|FG000|Overall Study|Health issue not related to the study|1
1117502|NCT02554474|2203845|FG001|Overall Study|Health issue not related to the study|0
1117503|NCT02554474|2203844|FG000|Overall Study|Withdrawal by Subject|1
1117504|NCT02554474|2203845|FG001|Overall Study|Withdrawal by Subject|1
1117505|NCT02554513|2203851|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0
1117506|NCT02554513|2203852|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1
1117507|NCT02554682|2203878|FG000|Overall Study|Lost to Follow-up|11
1117508|NCT02554682|2203879|FG001|Overall Study|Lost to Follow-up|9
1117509|NCT02554682|2203880|FG002|Overall Study|Lost to Follow-up|4
1117510|NCT02554682|2203881|FG003|Overall Study|Lost to Follow-up|3
1117511|NCT02554682|2203882|FG004|Overall Study|Lost to Follow-up|2
1117512|NCT02554682|2203883|FG005|Overall Study|Lost to Follow-up|1
1117513|NCT02554682|2203884|FG006|Overall Study|Lost to Follow-up|6
1117514|NCT02554682|2203885|FG007|Overall Study|Lost to Follow-up|6
1117515|NCT02554682|2203886|FG008|Overall Study|Lost to Follow-up|2
1117516|NCT02554682|2203887|FG009|Overall Study|Lost to Follow-up|2
1117517|NCT02554682|2203878|FG000|Overall Study|Withdrawal by Subject|2
1117518|NCT02554682|2203879|FG001|Overall Study|Withdrawal by Subject|1
1117519|NCT02554682|2203880|FG002|Overall Study|Withdrawal by Subject|0
1117520|NCT02554682|2203881|FG003|Overall Study|Withdrawal by Subject|0
1117521|NCT02554682|2203882|FG004|Overall Study|Withdrawal by Subject|0
1117522|NCT02554682|2203883|FG005|Overall Study|Withdrawal by Subject|0
1117523|NCT02554682|2203884|FG006|Overall Study|Withdrawal by Subject|0
1117524|NCT02554682|2203885|FG007|Overall Study|Withdrawal by Subject|0
1117525|NCT02554682|2203886|FG008|Overall Study|Withdrawal by Subject|0
1117526|NCT02554682|2203887|FG009|Overall Study|Withdrawal by Subject|0
1117527|NCT02554682|2203878|FG000|Overall Study|Physician Decision|2
1117528|NCT02554682|2203879|FG001|Overall Study|Physician Decision|2
1117529|NCT02554682|2203880|FG002|Overall Study|Physician Decision|0
1117530|NCT02554682|2203881|FG003|Overall Study|Physician Decision|0
1117531|NCT02554682|2203882|FG004|Overall Study|Physician Decision|0
1117532|NCT02554682|2203883|FG005|Overall Study|Physician Decision|0
1117533|NCT02554682|2203884|FG006|Overall Study|Physician Decision|0
1117534|NCT02554682|2203885|FG007|Overall Study|Physician Decision|0
1117535|NCT02554682|2203886|FG008|Overall Study|Physician Decision|0
1117536|NCT02554682|2203887|FG009|Overall Study|Physician Decision|0
1117537|NCT02554721|2203917|FG000|Overall Study|Adverse Event|1
1117538|NCT02554721|2203918|FG001|Overall Study|Adverse Event|0
1117539|NCT02554721|2203919|FG002|Overall Study|Adverse Event|0
1117540|NCT02554721|2203920|FG003|Overall Study|Adverse Event|0
1117541|NCT02554721|2203921|FG004|Overall Study|Adverse Event|1
1117542|NCT02554721|2203917|FG000|Overall Study|Noncompliance|0
1117543|NCT02554721|2203918|FG001|Overall Study|Noncompliance|0
1117544|NCT02554721|2203919|FG002|Overall Study|Noncompliance|0
1117545|NCT02554721|2203920|FG003|Overall Study|Noncompliance|0
1117546|NCT02554721|2203921|FG004|Overall Study|Noncompliance|1
1117547|NCT02554786|2203945|FG000|Overall Study|Subject/guardian decision|29
898268|NCT00714415|1870649|FG001|Overall Study|Death|0
898269|NCT00714493|1870655|FG000|Overall Study|Adverse Event|11
898270|NCT00714493|1870655|FG000|Overall Study|Death|3
898271|NCT00714493|1870655|FG000|Overall Study|Lack of Efficacy|10
1117548|NCT02554786|2203946|FG001|Overall Study|Subject/guardian decision|17
1117549|NCT02554786|2203947|FG002|Overall Study|Subject/guardian decision|18
1117550|NCT02554786|2203948|FG003|Overall Study|Subject/guardian decision|30
1117551|NCT02554786|2203949|FG004|Overall Study|Subject/guardian decision|20
1117552|NCT02554786|2203945|FG000|Overall Study|Lost to Follow-up|4
1117553|NCT02554786|2203946|FG001|Overall Study|Lost to Follow-up|3
1117554|NCT02554786|2203947|FG002|Overall Study|Lost to Follow-up|4
1117555|NCT02554786|2203948|FG003|Overall Study|Lost to Follow-up|2
1117556|NCT02554786|2203949|FG004|Overall Study|Lost to Follow-up|2
1117557|NCT02554786|2203945|FG000|Overall Study|Protocol deviation|1
1117558|NCT02554786|2203946|FG001|Overall Study|Protocol deviation|3
1117559|NCT02554786|2203947|FG002|Overall Study|Protocol deviation|3
1117560|NCT02554786|2203948|FG003|Overall Study|Protocol deviation|4
1117561|NCT02554786|2203949|FG004|Overall Study|Protocol deviation|2
1117562|NCT02554786|2203945|FG000|Overall Study|Technical problems|1
1117563|NCT02554786|2203946|FG001|Overall Study|Technical problems|1
1117564|NCT02554786|2203947|FG002|Overall Study|Technical problems|0
1117565|NCT02554786|2203948|FG003|Overall Study|Technical problems|2
1117566|NCT02554786|2203949|FG004|Overall Study|Technical problems|1
1117567|NCT02554786|2203945|FG000|Overall Study|Adverse Event|0
1117568|NCT02554786|2203946|FG001|Overall Study|Adverse Event|0
1117569|NCT02554786|2203947|FG002|Overall Study|Adverse Event|0
1117570|NCT02554786|2203948|FG003|Overall Study|Adverse Event|0
1117571|NCT02554786|2203949|FG004|Overall Study|Adverse Event|2
1117572|NCT02554786|2203945|FG000|Overall Study|Death|0
1117573|NCT02554786|2203946|FG001|Overall Study|Death|0
1117574|NCT02554786|2203947|FG002|Overall Study|Death|0
1117575|NCT02554786|2203948|FG003|Overall Study|Death|1
1117576|NCT02554786|2203949|FG004|Overall Study|Death|0
1117577|NCT02554786|2203945|FG000|Overall Study|Non-compliance with study treatment|0
1117578|NCT02554786|2203946|FG001|Overall Study|Non-compliance with study treatment|1
1117579|NCT02554786|2203947|FG002|Overall Study|Non-compliance with study treatment|1
1117580|NCT02554786|2203948|FG003|Overall Study|Non-compliance with study treatment|0
1117581|NCT02554786|2203949|FG004|Overall Study|Non-compliance with study treatment|1
1117582|NCT02554786|2203945|FG000|Overall Study|Physician Decision|0
1117583|NCT02554786|2203946|FG001|Overall Study|Physician Decision|1
1117584|NCT02554786|2203947|FG002|Overall Study|Physician Decision|4
1117585|NCT02554786|2203948|FG003|Overall Study|Physician Decision|1
1117586|NCT02554786|2203949|FG004|Overall Study|Physician Decision|1
1117587|NCT02554786|2203945|FG000|Overall Study|Pregnancy|0
1117588|NCT02554786|2203946|FG001|Overall Study|Pregnancy|0
1117589|NCT02554786|2203947|FG002|Overall Study|Pregnancy|0
1117590|NCT02554786|2203948|FG003|Overall Study|Pregnancy|1
1117591|NCT02554786|2203949|FG004|Overall Study|Pregnancy|1
1117592|NCT02554877|2203978|FG000|Overall Study|Adverse Event|2
1117593|NCT02554877|2203979|FG001|Overall Study|Adverse Event|0
1117594|NCT02554877|2203980|FG002|Overall Study|Adverse Event|0
1117595|NCT02554877|2203981|FG003|Overall Study|Adverse Event|1
1117596|NCT02554877|2203978|FG000|Overall Study|Lost to Follow-up|1
1117597|NCT02554877|2203979|FG001|Overall Study|Lost to Follow-up|1
1117598|NCT02554877|2203980|FG002|Overall Study|Lost to Follow-up|1
1117599|NCT02554877|2203981|FG003|Overall Study|Lost to Follow-up|2
1117600|NCT02554877|2203978|FG000|Overall Study|Did not meet entrance criteria|0
1117601|NCT02554877|2203979|FG001|Overall Study|Did not meet entrance criteria|0
1117602|NCT02554877|2203980|FG002|Overall Study|Did not meet entrance criteria|1
1117603|NCT02554877|2203981|FG003|Overall Study|Did not meet entrance criteria|0
1117604|NCT02554877|2203978|FG000|Overall Study|No longer met eligibility criteria|1
1117605|NCT02554877|2203979|FG001|Overall Study|No longer met eligibility criteria|0
1117606|NCT02554877|2203980|FG002|Overall Study|No longer met eligibility criteria|1
1117607|NCT02554877|2203981|FG003|Overall Study|No longer met eligibility criteria|1
1117608|NCT02554877|2203978|FG000|Overall Study|Protocol Violation|3
1117609|NCT02554877|2203979|FG001|Overall Study|Protocol Violation|1
1117610|NCT02554877|2203980|FG002|Overall Study|Protocol Violation|1
1117611|NCT02554877|2203981|FG003|Overall Study|Protocol Violation|0
1117612|NCT02554877|2203978|FG000|Overall Study|Other|1
1117613|NCT02554877|2203979|FG001|Overall Study|Other|3
1117614|NCT02554877|2203980|FG002|Overall Study|Other|0
1117615|NCT02554877|2203981|FG003|Overall Study|Other|3
1117616|NCT02554877|2203978|FG000|Overall Study|Insufficient clinical response|4
1117617|NCT02554877|2203979|FG001|Overall Study|Insufficient clinical response|0
1117618|NCT02554877|2203980|FG002|Overall Study|Insufficient clinical response|0
1117619|NCT02554877|2203981|FG003|Overall Study|Insufficient clinical response|0
1117620|NCT02554877|2203978|FG000|Overall Study|No longer willing to participate|0
1117621|NCT02554877|2203979|FG001|Overall Study|No longer willing to participate|2
1117622|NCT02554877|2203980|FG002|Overall Study|No longer willing to participate|2
1117623|NCT02554877|2203981|FG003|Overall Study|No longer willing to participate|0
1117624|NCT02554890|2203993|FG000|Double-blind|Adverse Event|45
1117625|NCT02554890|2203994|FG001|Double-blind|Adverse Event|51
1117626|NCT02554890|2203993|FG000|Double-blind|Death|6
1117627|NCT02554890|2203994|FG001|Double-blind|Death|4
1117628|NCT02554890|2203993|FG000|Double-blind|Protocol Violation|1
1117629|NCT02554890|2203994|FG001|Double-blind|Protocol Violation|1
1117630|NCT02554890|2203993|FG000|Double-blind|Physician Decision|4
1117631|NCT02554890|2203994|FG001|Double-blind|Physician Decision|3
1117632|NCT02554890|2203993|FG000|Double-blind|Subject/Guardian decision|21
1117633|NCT02554890|2203994|FG001|Double-blind|Subject/Guardian decision|16
1117634|NCT02554890|2203993|FG000|Double-blind|Lost to Follow-up|7
1117635|NCT02554890|2203994|FG001|Double-blind|Lost to Follow-up|5
1117636|NCT02554890|2203993|FG000|Double-blind|Technical problems|1
1117637|NCT02554890|2203994|FG001|Double-blind|Technical problems|0
1117638|NCT02554890|2203993|FG000|Double-blind|Withdrawal by Subject|5
1117639|NCT02554890|2203994|FG001|Double-blind|Withdrawal by Subject|6
1117640|NCT02554890|2203993|FG000|Double-blind|Noncompliance with study treatment|6
1117641|NCT02554890|2203994|FG001|Double-blind|Noncompliance with study treatment|5
1117642|NCT02554890|2203993|FG000|Open-label|Adverse Event|0
1117643|NCT02554890|2203994|FG001|Open-label|Adverse Event|30
1117644|NCT02554890|2203993|FG000|Open-label|Death|0
1117645|NCT02554890|2203994|FG001|Open-label|Death|1
1117646|NCT02554890|2203993|FG000|Open-label|Physician Decision|0
1117647|NCT02554890|2203994|FG001|Open-label|Physician Decision|1
1117648|NCT02554890|2203993|FG000|Open-label|Subject/Guardian decision|0
1117649|NCT02554890|2203994|FG001|Open-label|Subject/Guardian decision|11
1117650|NCT02554890|2203993|FG000|Open-label|Lost to Follow-up|0
1117651|NCT02554890|2203994|FG001|Open-label|Lost to Follow-up|7
1117652|NCT02554890|2203993|FG000|Open-label|Technical problems|0
1117653|NCT02554890|2203994|FG001|Open-label|Technical problems|1
1117654|NCT02554890|2203993|FG000|Open-label|Withdrawal by Subject|0
1117655|NCT02554890|2203994|FG001|Open-label|Withdrawal by Subject|1
1117656|NCT02554903|2204004|FG000|Overall Study|Death|1
1117657|NCT02554903|2204005|FG001|Overall Study|Death|1
1117658|NCT02554903|2204004|FG000|Overall Study|Physician Decision|2
1117659|NCT02554903|2204005|FG001|Overall Study|Physician Decision|2
1117660|NCT02554903|2204004|FG000|Overall Study|Heart Transplant|1
1117661|NCT02554903|2204005|FG001|Overall Study|Heart Transplant|2
1117662|NCT02554929|2204014|FG000|Overall Study|Lost to Follow-up|4
1117663|NCT02554929|2204015|FG001|Overall Study|Lost to Follow-up|4
1117664|NCT02554929|2204014|FG000|Overall Study|Withdrawal by Subject|2
1117665|NCT02554929|2204015|FG001|Overall Study|Withdrawal by Subject|8
1117666|NCT02554981|2204021|FG000|Overall Study|Adverse Event|1
1117667|NCT02554981|2204021|FG000|Overall Study|Administrative Reasons|1
1117668|NCT02554981|2204021|FG000|Overall Study|Other Miscellaneous Reasons|3
1117669|NCT02555215|2204036|FG000|Overall Study|Other|1
1117670|NCT02555215|2204036|FG000|Overall Study|Investigator Decision|2
1117671|NCT02555371|2204066|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
1117672|NCT02555371|2204067|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
1117673|NCT02555371|2204068|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
1117674|NCT02555371|2204069|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
1117675|NCT02555371|2204070|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
1117676|NCT02555371|2204066|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
1117677|NCT02555371|2204067|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
1117678|NCT02555371|2204068|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
1117679|NCT02555371|2204069|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
1117680|NCT02555371|2204070|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
1117681|NCT02555371|2204066|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
1117682|NCT02555371|2204067|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
1117683|NCT02555371|2204068|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
1117684|NCT02555371|2204069|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
1117685|NCT02555371|2204070|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
1117686|NCT02555371|2204066|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
1117687|NCT02555371|2204067|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
1117688|NCT02555371|2204068|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
1117689|NCT02555371|2204069|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
1117690|NCT02555371|2204070|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
1117691|NCT02555371|2204066|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
1117692|NCT02555371|2204067|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
1117693|NCT02555371|2204068|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
1117694|NCT02555371|2204069|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
1117695|NCT02555371|2204070|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
1117696|NCT02555371|2204066|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
1117697|NCT02555371|2204067|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
1117698|NCT02555371|2204068|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
1117699|NCT02555371|2204069|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
1117700|NCT02555371|2204070|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
1117701|NCT02555371|2204066|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
1117702|NCT02555371|2204067|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
1117703|NCT02555371|2204068|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
1117704|NCT02555371|2204069|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
1117705|NCT02555371|2204070|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
1117706|NCT02555371|2204066|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
1117707|NCT02555371|2204067|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
1117708|NCT02555371|2204068|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
1117709|NCT02555371|2204069|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
1117710|NCT02555371|2204070|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
1117711|NCT02555371|2204066|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0
1117712|NCT02555371|2204067|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2
1117713|NCT02555371|2204068|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1
1117714|NCT02555371|2204069|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0
1117715|NCT02555371|2204070|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0
1117716|NCT02555371|2204066|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
1117717|NCT02555371|2204067|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
1117718|NCT02555371|2204068|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
1117719|NCT02555371|2204069|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
1117720|NCT02555371|2204070|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
1117721|NCT02555371|2204066|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
1117722|NCT02555371|2204067|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
1117723|NCT02555371|2204068|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
1117724|NCT02555371|2204069|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
1117725|NCT02555371|2204070|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
1117726|NCT02555371|2204066|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
1117727|NCT02555371|2204067|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
1117728|NCT02555371|2204068|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
1117729|NCT02555371|2204069|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
1117730|NCT02555371|2204070|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
1117731|NCT02555371|2204066|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
1117732|NCT02555371|2204067|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
1117733|NCT02555371|2204068|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
1117734|NCT02555371|2204069|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
1117735|NCT02555371|2204070|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
1117736|NCT02555371|2204066|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
1117737|NCT02555371|2204067|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
1117738|NCT02555371|2204068|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
1117739|NCT02555371|2204069|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
1117740|NCT02555371|2204070|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
1117741|NCT02555618|2204085|FG000|Overall Study|Sponsor's Circumstances|1
1117742|NCT02555618|2204086|FG001|Overall Study|Sponsor's Circumstances|0
1117749|NCT02555683|2204108|FG000|Overall Study|Physician Decision|1
1117750|NCT02555683|2204109|FG001|Overall Study|Physician Decision|0
1117751|NCT02555683|2204110|FG002|Overall Study|Physician Decision|2
1117752|NCT02555683|2204108|FG000|Overall Study|Lost to Follow-up|2
1117753|NCT02555683|2204109|FG001|Overall Study|Lost to Follow-up|1
1117754|NCT02555683|2204110|FG002|Overall Study|Lost to Follow-up|2
1117755|NCT02555683|2204108|FG000|Overall Study|Technical Problems|1
1117756|NCT02555683|2204109|FG001|Overall Study|Technical Problems|1
1117757|NCT02555683|2204110|FG002|Overall Study|Technical Problems|0
1117758|NCT02555683|2204108|FG000|Overall Study|Protocol deviation|0
1117759|NCT02555683|2204109|FG001|Overall Study|Protocol deviation|1
1117760|NCT02555683|2204110|FG002|Overall Study|Protocol deviation|0
1117761|NCT02555683|2204108|FG000|Overall Study|Lack of Efficacy|2
1117762|NCT02555683|2204109|FG001|Overall Study|Lack of Efficacy|0
1117763|NCT02555683|2204110|FG002|Overall Study|Lack of Efficacy|0
1117764|NCT02555683|2204108|FG000|Overall Study|Death|0
1117765|NCT02555683|2204109|FG001|Overall Study|Death|1
1117766|NCT02555683|2204110|FG002|Overall Study|Death|2
1117767|NCT02555683|2204108|FG000|Overall Study|Adverse Event|1
1117768|NCT02555683|2204109|FG001|Overall Study|Adverse Event|0
1117769|NCT02555683|2204110|FG002|Overall Study|Adverse Event|1
1117770|NCT02555683|2204108|FG000|Overall Study|Subject/guardian decision|12
1117771|NCT02555683|2204109|FG001|Overall Study|Subject/guardian decision|12
1117772|NCT02555683|2204110|FG002|Overall Study|Subject/guardian decision|22
1117773|NCT02555683|2204108|FG000|Overall Study|Death post Treatment/safety period|0
1117774|NCT02555683|2204109|FG001|Overall Study|Death post Treatment/safety period|1
1117775|NCT02555683|2204110|FG002|Overall Study|Death post Treatment/safety period|0
1117776|NCT02555722|2204120|FG000|Week 2|Adverse Event|0
1117777|NCT02555722|2204121|FG001|Week 2|Adverse Event|1
1117778|NCT02555722|2204120|FG000|Week 2|Withdrawal by Subject|1
1117779|NCT02555722|2204121|FG001|Week 2|Withdrawal by Subject|0
1117780|NCT02555722|2204120|FG000|Month 1|Lens Discomfort|1
1117781|NCT02555722|2204121|FG001|Month 1|Lens Discomfort|0
1117782|NCT02555722|2204120|FG000|Month 2|Withdrawal by Subject|3
1117783|NCT02555722|2204121|FG001|Month 2|Withdrawal by Subject|0
1117784|NCT02555722|2204120|FG000|Month 2|Lost to Follow-up|1
1117785|NCT02555722|2204121|FG001|Month 2|Lost to Follow-up|0
1117786|NCT02555878|2204152|FG000|Overall Study|Lost to Follow-up|2
1117787|NCT02555878|2204153|FG001|Overall Study|Lost to Follow-up|3
1117788|NCT02555878|2204152|FG000|Overall Study|Withdrawal by Subject|48
1117789|NCT02555878|2204153|FG001|Overall Study|Withdrawal by Subject|48
1117790|NCT02555878|2204152|FG000|Overall Study|Adverse Event|12
1117791|NCT02555878|2204153|FG001|Overall Study|Adverse Event|8
1117792|NCT02555878|2204152|FG000|Overall Study|Death|74
1117793|NCT02555878|2204153|FG001|Overall Study|Death|59
1117794|NCT02555878|2204152|FG000|Overall Study|Protocol Violation|1
1117795|NCT02555878|2204153|FG001|Overall Study|Protocol Violation|2
1117796|NCT02555878|2204152|FG000|Overall Study|Physician Decision|12
1117797|NCT02555878|2204153|FG001|Overall Study|Physician Decision|13
1117798|NCT02555878|2204152|FG000|Overall Study|Other|17
1117799|NCT02555878|2204153|FG001|Overall Study|Other|17
1117800|NCT02556138|2204178|FG000|Overall Study|Withdrawal by Subject|1
1117801|NCT02556177|2204184|FG000|Overall Study|Subjects did not complete all 4 visits|283
1117802|NCT02556177|2204185|FG001|Overall Study|Subjects did not complete all 4 visits|61
1117803|NCT02556203|2204193|FG000|Overall Study|Withdrawal by Subject|21
1117804|NCT02556203|2204194|FG001|Overall Study|Withdrawal by Subject|21
1117805|NCT02556203|2204193|FG000|Overall Study|Lost to Follow-up|5
1117806|NCT02556203|2204194|FG001|Overall Study|Lost to Follow-up|5
1117807|NCT02556203|2204193|FG000|Overall Study|Adverse Event|1
1117808|NCT02556203|2204194|FG001|Overall Study|Adverse Event|0
1117809|NCT02556255|2204200|FG000|Overall Study|Lost to Follow-up|4
1117810|NCT02556307|2204204|FG000|Overall Study|Premature treatment interruption|11
1117811|NCT02556307|2204204|FG000|Overall Study|Lost to Follow-up|36
1117812|NCT02556307|2204204|FG000|Overall Study|Change to triple therapy|4
1117813|NCT02556307|2204204|FG000|Overall Study|Enrolled but not treated|2
1117814|NCT02556632|2204254|FG000|Overall Study|Lost to Follow-up|1
1117815|NCT02556632|2204255|FG001|Overall Study|Lost to Follow-up|0
1117816|NCT02556632|2204256|FG002|Overall Study|Lost to Follow-up|0
1117817|NCT02556632|2204254|FG000|Overall Study|Disliked Intervention|1
1117818|NCT02556632|2204255|FG001|Overall Study|Disliked Intervention|1
1117819|NCT02556632|2204256|FG002|Overall Study|Disliked Intervention|1
1117820|NCT02556632|2204254|FG000|Overall Study|No Reason|1
1117821|NCT02556632|2204255|FG001|Overall Study|No Reason|0
1117822|NCT02556632|2204256|FG002|Overall Study|No Reason|1
1117823|NCT02556632|2204254|FG000|Overall Study|Personal Issues|0
1117824|NCT02556632|2204255|FG001|Overall Study|Personal Issues|1
1117825|NCT02556632|2204256|FG002|Overall Study|Personal Issues|1
1117826|NCT02556632|2204254|FG000|Overall Study|Changed Mind|0
1117827|NCT02556632|2204255|FG001|Overall Study|Changed Mind|1
1117828|NCT02556632|2204256|FG002|Overall Study|Changed Mind|0
1117829|NCT02556632|2204254|FG000|Overall Study|Withdrew (Unrelated Medical)|1
1117830|NCT02556632|2204255|FG001|Overall Study|Withdrew (Unrelated Medical)|0
1117831|NCT02556632|2204256|FG002|Overall Study|Withdrew (Unrelated Medical)|0
1117832|NCT02556632|2204254|FG000|Overall Study|Unrelated Adverse Event|1
1117833|NCT02556632|2204255|FG001|Overall Study|Unrelated Adverse Event|0
1117834|NCT02556632|2204256|FG002|Overall Study|Unrelated Adverse Event|3
1117835|NCT02556632|2204254|FG000|Overall Study|Related Adverse Event|0
1117836|NCT02556632|2204255|FG001|Overall Study|Related Adverse Event|1
1117837|NCT02556632|2204256|FG002|Overall Study|Related Adverse Event|0
1117838|NCT02556632|2204254|FG000|Overall Study|Possibly Related Adverse Event|0
1117839|NCT02556632|2204255|FG001|Overall Study|Possibly Related Adverse Event|0
1117840|NCT02556632|2204256|FG002|Overall Study|Possibly Related Adverse Event|1
1117841|NCT02556632|2204254|FG000|Overall Study|Did Not Start RT|0
1117842|NCT02556632|2204255|FG001|Overall Study|Did Not Start RT|1
1117843|NCT02556632|2204256|FG002|Overall Study|Did Not Start RT|0
1117844|NCT02556632|2204254|FG000|Overall Study|Ineligible|0
1117845|NCT02556632|2204255|FG001|Overall Study|Ineligible|1
1117846|NCT02556632|2204256|FG002|Overall Study|Ineligible|0
1117847|NCT02556632|2204254|FG000|Overall Study|Disliked Study Procedures|0
1117848|NCT02556632|2204255|FG001|Overall Study|Disliked Study Procedures|0
1117849|NCT02556632|2204256|FG002|Overall Study|Disliked Study Procedures|1
1117850|NCT02556632|2204254|FG000|Overall Study|Treatment or Change Delay|0
1117851|NCT02556632|2204255|FG001|Overall Study|Treatment or Change Delay|0
1117852|NCT02556632|2204256|FG002|Overall Study|Treatment or Change Delay|1
1117853|NCT02556801|2204300|FG000|Overall Study|Lost to Follow-up|1
1117854|NCT02556801|2204301|FG001|Overall Study|Lost to Follow-up|0
1117855|NCT02556801|2204302|FG002|Overall Study|Lost to Follow-up|2
1117856|NCT02556801|2204303|FG003|Overall Study|Lost to Follow-up|0
1117857|NCT02556801|2204300|FG000|Overall Study|Withdrawal by Subject|1
1117858|NCT02556801|2204301|FG001|Overall Study|Withdrawal by Subject|1
1117859|NCT02556801|2204302|FG002|Overall Study|Withdrawal by Subject|1
1117860|NCT02556801|2204303|FG003|Overall Study|Withdrawal by Subject|0
1117861|NCT02556801|2204300|FG000|Overall Study|Protocol Violation|0
1117862|NCT02556801|2204301|FG001|Overall Study|Protocol Violation|3
1117863|NCT02556801|2204302|FG002|Overall Study|Protocol Violation|1
1117864|NCT02556801|2204303|FG003|Overall Study|Protocol Violation|1
1117865|NCT02556801|2204300|FG000|Overall Study|Adverse Event|0
1117866|NCT02556801|2204301|FG001|Overall Study|Adverse Event|2
1117867|NCT02556801|2204302|FG002|Overall Study|Adverse Event|0
1117868|NCT02556801|2204303|FG003|Overall Study|Adverse Event|3
1117869|NCT02556801|2204300|FG000|Overall Study|Pregnancy|0
1117870|NCT02556801|2204301|FG001|Overall Study|Pregnancy|1
1117871|NCT02556801|2204302|FG002|Overall Study|Pregnancy|0
1117872|NCT02556801|2204303|FG003|Overall Study|Pregnancy|0
1117873|NCT02556801|2204300|FG000|Overall Study|Personal reasons patient|0
1117874|NCT02556801|2204301|FG001|Overall Study|Personal reasons patient|0
1117875|NCT02556801|2204302|FG002|Overall Study|Personal reasons patient|0
1117876|NCT02556801|2204303|FG003|Overall Study|Personal reasons patient|1
1117877|NCT02556918|2204315|FG000|Overall Study|Protocol Violation|5
1117878|NCT02556918|2204316|FG001|Overall Study|Protocol Violation|6
1117879|NCT02556918|2204315|FG000|Overall Study|Withdrawal by Subject|4
1117880|NCT02556918|2204316|FG001|Overall Study|Withdrawal by Subject|4
1117881|NCT02557100|2204335|FG000|Single Blind Treatment Period|Lost to Follow-up|0
1117882|NCT02557100|2204336|FG001|Single Blind Treatment Period|Lost to Follow-up|1
1117883|NCT02557100|2204337|FG002|Single Blind Treatment Period|Lost to Follow-up|0
1117884|NCT02557100|2204335|FG000|Single Blind Treatment Period|Death|0
1117885|NCT02557100|2204336|FG001|Single Blind Treatment Period|Death|1
1117886|NCT02557100|2204337|FG002|Single Blind Treatment Period|Death|0
1117887|NCT02557100|2204335|FG000|Single Blind Treatment Period|Request to Discontinue|0
1117888|NCT02557100|2204336|FG001|Single Blind Treatment Period|Request to Discontinue|1
1117889|NCT02557100|2204337|FG002|Single Blind Treatment Period|Request to Discontinue|0
1117890|NCT02557100|2204335|FG000|Single Blind Treatment Period|Adverse Event|0
1117891|NCT02557100|2204336|FG001|Single Blind Treatment Period|Adverse Event|1
1117892|NCT02557100|2204337|FG002|Single Blind Treatment Period|Adverse Event|0
1117893|NCT02557100|2204335|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40
1117894|NCT02557100|2204336|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36
1117895|NCT02557100|2204337|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0
1117896|NCT02557100|2204335|FG000|Cumulative Abatacept Period|Other Reasons|0
1117897|NCT02557100|2204336|FG001|Cumulative Abatacept Period|Other Reasons|0
1117898|NCT02557100|2204337|FG002|Cumulative Abatacept Period|Other Reasons|1
1117899|NCT02557100|2204335|FG000|Cumulative Abatacept Period|Lost to Follow-up|0
1117900|NCT02557100|2204336|FG001|Cumulative Abatacept Period|Lost to Follow-up|0
1117901|NCT02557100|2204337|FG002|Cumulative Abatacept Period|Lost to Follow-up|2
1117902|NCT02557100|2204335|FG000|Cumulative Abatacept Period|Request to Discontinue|0
1117903|NCT02557100|2204336|FG001|Cumulative Abatacept Period|Request to Discontinue|0
1117904|NCT02557100|2204337|FG002|Cumulative Abatacept Period|Request to Discontinue|1
1117914|NCT02557399|2204378|FG000|Overall Study|Adverse Event|6
1117915|NCT02557399|2204379|FG001|Overall Study|Adverse Event|5
1117916|NCT02557399|2204378|FG000|Overall Study|Protocol Violation|0
1117917|NCT02557399|2204379|FG001|Overall Study|Protocol Violation|1
1117918|NCT02557399|2204378|FG000|Overall Study|Protocol-defined stopping criteria|0
1117919|NCT02557399|2204379|FG001|Overall Study|Protocol-defined stopping criteria|1
1117920|NCT02557399|2204378|FG000|Overall Study|Withdrawal by Subject|1
1117921|NCT02557399|2204379|FG001|Overall Study|Withdrawal by Subject|1
1117922|NCT02557516|2204392|FG000|Overall Study|Adverse Event|1
1117923|NCT02557516|2204393|FG001|Overall Study|Adverse Event|0
1117924|NCT02557516|2204394|FG002|Overall Study|Adverse Event|2
1117925|NCT02557516|2204395|FG003|Overall Study|Adverse Event|1
1117926|NCT02557516|2204392|FG000|Overall Study|Disease progression|0
1117927|NCT02557516|2204393|FG001|Overall Study|Disease progression|2
1117928|NCT02557516|2204394|FG002|Overall Study|Disease progression|0
1117929|NCT02557516|2204395|FG003|Overall Study|Disease progression|0
1117930|NCT02557516|2204392|FG000|Overall Study|Physician Decision|0
1117931|NCT02557516|2204393|FG001|Overall Study|Physician Decision|2
1117932|NCT02557516|2204394|FG002|Overall Study|Physician Decision|0
1117933|NCT02557516|2204395|FG003|Overall Study|Physician Decision|0
1117934|NCT02557516|2204392|FG000|Overall Study|Sponsor decision|0
1117935|NCT02557516|2204393|FG001|Overall Study|Sponsor decision|1
1117936|NCT02557516|2204394|FG002|Overall Study|Sponsor decision|2
1117937|NCT02557516|2204395|FG003|Overall Study|Sponsor decision|8
1117938|NCT02557646|2204419|FG000|Overall Study|Adverse Event|40
1117939|NCT02557646|2204419|FG000|Overall Study|Death|1
1117940|NCT02557646|2204419|FG000|Overall Study|Lack of Efficacy|186
1117941|NCT02557646|2204419|FG000|Overall Study|Withdrawal by Subject|18
1117942|NCT02557646|2204419|FG000|Overall Study|Lost to Follow-up|17
1117943|NCT02557646|2204419|FG000|Overall Study|Other|14
1117944|NCT02558231|2204434|FG000|Overall Study|Death|4
1117945|NCT02558231|2204435|FG001|Overall Study|Death|12
1117946|NCT02558231|2204434|FG000|Overall Study|Lost to Follow-up|7
1117947|NCT02558231|2204435|FG001|Overall Study|Lost to Follow-up|4
1117948|NCT02558231|2204434|FG000|Overall Study|Withdrawal by Subject|7
1117949|NCT02558231|2204435|FG001|Overall Study|Withdrawal by Subject|4
1117950|NCT02558231|2204434|FG000|Overall Study|Physician Decision|7
1117951|NCT02558231|2204435|FG001|Overall Study|Physician Decision|5
1117952|NCT02558231|2204434|FG000|Overall Study|Sponsor Decision|0
1117953|NCT02558231|2204435|FG001|Overall Study|Sponsor Decision|1
1117954|NCT02558296|2204443|FG000|Completed the Study Through Week 24|Adverse Event|9
1117955|NCT02558296|2204444|FG001|Completed the Study Through Week 24|Adverse Event|3
1117956|NCT02558296|2204443|FG000|Completed the Study Through Week 24|Death|7
1117957|NCT02558296|2204444|FG001|Completed the Study Through Week 24|Death|7
1117958|NCT02558296|2204443|FG000|Completed the Study Through Week 24|Lost to Follow-up|8
1117959|NCT02558296|2204444|FG001|Completed the Study Through Week 24|Lost to Follow-up|1
1117960|NCT02558296|2204443|FG000|Completed the Study Through Week 24|Physician Decision|1
1117961|NCT02558296|2204444|FG001|Completed the Study Through Week 24|Physician Decision|0
1117962|NCT02558296|2204443|FG000|Completed the Study Through Week 24|Protocol Violation|1
1117963|NCT02558296|2204444|FG001|Completed the Study Through Week 24|Protocol Violation|1
1117964|NCT02558296|2204443|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17
1117965|NCT02558296|2204444|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13
1117966|NCT02558296|2204443|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1
1117967|NCT02558296|2204444|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0
1117968|NCT02558296|2204443|FG000|Completed the Study|Adverse Event|14
1117969|NCT02558296|2204444|FG001|Completed the Study|Adverse Event|5
1117970|NCT02558296|2204443|FG000|Completed the Study|Death|39
1117971|NCT02558296|2204444|FG001|Completed the Study|Death|25
1117972|NCT02558296|2204443|FG000|Completed the Study|Lost to Follow-up|31
1117973|NCT02558296|2204444|FG001|Completed the Study|Lost to Follow-up|23
1117974|NCT02558296|2204443|FG000|Completed the Study|Physician Decision|6
1117975|NCT02558296|2204444|FG001|Completed the Study|Physician Decision|0
1117976|NCT02558296|2204443|FG000|Completed the Study|Protocol Violation|2
1117977|NCT02558296|2204444|FG001|Completed the Study|Protocol Violation|1
1117978|NCT02558296|2204443|FG000|Completed the Study|Withdrawal by Subject|53
1117979|NCT02558296|2204444|FG001|Completed the Study|Withdrawal by Subject|31
1117980|NCT02558296|2204443|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1
1117981|NCT02558296|2204444|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0
1117982|NCT02558400|2204466|FG000|Overall Study|Adverse Event|47
1117983|NCT02558400|2204467|FG001|Overall Study|Adverse Event|53
1117984|NCT02558400|2204468|FG002|Overall Study|Adverse Event|4
1117985|NCT02558400|2204466|FG000|Overall Study|Withdrawal by Subject|13
1117986|NCT02558400|2204467|FG001|Overall Study|Withdrawal by Subject|9
1117987|NCT02558400|2204468|FG002|Overall Study|Withdrawal by Subject|8
1117988|NCT02558400|2204466|FG000|Overall Study|Non-Compliant|0
1117989|NCT02558400|2204467|FG001|Overall Study|Non-Compliant|1
1117990|NCT02558400|2204468|FG002|Overall Study|Non-Compliant|3
1117991|NCT02558400|2204466|FG000|Overall Study|Lost to Follow-up|5
1117992|NCT02558400|2204467|FG001|Overall Study|Lost to Follow-up|5
1117993|NCT02558400|2204468|FG002|Overall Study|Lost to Follow-up|4
1117994|NCT02558400|2204466|FG000|Overall Study|Lack of Efficacy|0
1117995|NCT02558400|2204467|FG001|Overall Study|Lack of Efficacy|13
1117996|NCT02558400|2204468|FG002|Overall Study|Lack of Efficacy|1
1117997|NCT02558400|2204466|FG000|Overall Study|Disallowed Concurrent Medication|6
1117998|NCT02558400|2204467|FG001|Overall Study|Disallowed Concurrent Medication|7
1117999|NCT02558400|2204468|FG002|Overall Study|Disallowed Concurrent Medication|5
1118000|NCT02558400|2204466|FG000|Overall Study|Physician Decision|2
1118001|NCT02558400|2204467|FG001|Overall Study|Physician Decision|2
1118002|NCT02558400|2204468|FG002|Overall Study|Physician Decision|0
1118003|NCT02558400|2204466|FG000|Overall Study|Protocol Violation|6
1118004|NCT02558400|2204467|FG001|Overall Study|Protocol Violation|3
1118005|NCT02558400|2204468|FG002|Overall Study|Protocol Violation|8
1118006|NCT02558400|2204466|FG000|Overall Study|Death|0
1118007|NCT02558400|2204467|FG001|Overall Study|Death|1
1118008|NCT02558400|2204468|FG002|Overall Study|Death|0
1118009|NCT02558400|2204466|FG000|Overall Study|Ineligible for the study|0
1118010|NCT02558400|2204467|FG001|Overall Study|Ineligible for the study|2
1118011|NCT02558400|2204468|FG002|Overall Study|Ineligible for the study|0
1118012|NCT02558790|2204479|FG000|Overall Study|Lost to Follow-up|2
1118013|NCT02558790|2204479|FG000|Overall Study|Physician Decision|1
1118014|NCT02558790|2204479|FG000|Overall Study|Withdrawal by Subject|1
1118015|NCT02558790|2204479|FG000|Overall Study|Screen Fail|3
1118016|NCT02559115|2204525|FG000|Overall Study|Withdrawal by Subject|3
1118017|NCT02559206|2204537|FG000|Overall Study|Adverse Event|0
1118018|NCT02559206|2204538|FG001|Overall Study|Adverse Event|4
1118019|NCT02559206|2204539|FG002|Overall Study|Adverse Event|1
1118020|NCT02559206|2204540|FG003|Overall Study|Adverse Event|5
1118021|NCT02559206|2204541|FG004|Overall Study|Adverse Event|3
1118022|NCT02559206|2204542|FG005|Overall Study|Adverse Event|0
1118023|NCT02559206|2204543|FG006|Overall Study|Adverse Event|1
1118024|NCT02559206|2204544|FG007|Overall Study|Adverse Event|0
1118025|NCT02559206|2204537|FG000|Overall Study|Protocol Violation|1
1118026|NCT02559206|2204538|FG001|Overall Study|Protocol Violation|0
1118027|NCT02559206|2204539|FG002|Overall Study|Protocol Violation|1
1118028|NCT02559206|2204540|FG003|Overall Study|Protocol Violation|0
1118029|NCT02559206|2204541|FG004|Overall Study|Protocol Violation|0
1118030|NCT02559206|2204542|FG005|Overall Study|Protocol Violation|2
1118031|NCT02559206|2204543|FG006|Overall Study|Protocol Violation|0
1118032|NCT02559206|2204544|FG007|Overall Study|Protocol Violation|0
1118033|NCT02559206|2204537|FG000|Overall Study|Withdrawal by Subject|3
1118034|NCT02559206|2204538|FG001|Overall Study|Withdrawal by Subject|3
1118035|NCT02559206|2204539|FG002|Overall Study|Withdrawal by Subject|1
1118036|NCT02559206|2204540|FG003|Overall Study|Withdrawal by Subject|3
1118037|NCT02559206|2204541|FG004|Overall Study|Withdrawal by Subject|5
1118038|NCT02559206|2204542|FG005|Overall Study|Withdrawal by Subject|4
1118039|NCT02559206|2204543|FG006|Overall Study|Withdrawal by Subject|1
1118040|NCT02559206|2204544|FG007|Overall Study|Withdrawal by Subject|2
1118041|NCT02559206|2204537|FG000|Overall Study|Lost to Follow-up|3
1118042|NCT02559206|2204538|FG001|Overall Study|Lost to Follow-up|5
1118043|NCT02559206|2204539|FG002|Overall Study|Lost to Follow-up|3
1118044|NCT02559206|2204540|FG003|Overall Study|Lost to Follow-up|3
1118045|NCT02559206|2204541|FG004|Overall Study|Lost to Follow-up|2
1118046|NCT02559206|2204542|FG005|Overall Study|Lost to Follow-up|5
1118047|NCT02559206|2204543|FG006|Overall Study|Lost to Follow-up|1
1118048|NCT02559206|2204544|FG007|Overall Study|Lost to Follow-up|4
1118049|NCT02559206|2204537|FG000|Overall Study|Lack of Efficacy|1
1118050|NCT02559206|2204538|FG001|Overall Study|Lack of Efficacy|0
1118051|NCT02559206|2204539|FG002|Overall Study|Lack of Efficacy|3
1118052|NCT02559206|2204540|FG003|Overall Study|Lack of Efficacy|2
1118053|NCT02559206|2204541|FG004|Overall Study|Lack of Efficacy|2
1118054|NCT02559206|2204542|FG005|Overall Study|Lack of Efficacy|3
1118055|NCT02559206|2204543|FG006|Overall Study|Lack of Efficacy|3
1118056|NCT02559206|2204544|FG007|Overall Study|Lack of Efficacy|3
1118057|NCT02559206|2204537|FG000|Overall Study|Other Not Specified|0
1118058|NCT02559206|2204538|FG001|Overall Study|Other Not Specified|0
1118059|NCT02559206|2204539|FG002|Overall Study|Other Not Specified|0
1118060|NCT02559206|2204540|FG003|Overall Study|Other Not Specified|1
1118061|NCT02559206|2204541|FG004|Overall Study|Other Not Specified|0
1118062|NCT02559206|2204542|FG005|Overall Study|Other Not Specified|0
1118063|NCT02559206|2204543|FG006|Overall Study|Other Not Specified|0
1118064|NCT02559206|2204544|FG007|Overall Study|Other Not Specified|0
1118065|NCT02559310|2204564|FG000|Overall Study|Death|4
1118066|NCT02559310|2204565|FG001|Overall Study|Death|3
1118067|NCT02559310|2204564|FG000|Overall Study|Lost to Follow-up|5
1118068|NCT02559310|2204565|FG001|Overall Study|Lost to Follow-up|3
1118069|NCT02559310|2204564|FG000|Overall Study|Physician Decision|2
1118070|NCT02559310|2204565|FG001|Overall Study|Physician Decision|1
1118071|NCT02559310|2204564|FG000|Overall Study|Withdrawal by Subject|13
1118072|NCT02559310|2204565|FG001|Overall Study|Withdrawal by Subject|9
1118073|NCT02559310|2204564|FG000|Overall Study|Sponsor Decision|0
1118074|NCT02559310|2204565|FG001|Overall Study|Sponsor Decision|1
1118075|NCT02559310|2204564|FG000|Overall Study|Randomized but not treated|3
1118076|NCT02559310|2204565|FG001|Overall Study|Randomized but not treated|2
1118077|NCT02559414|2204574|FG000|Overall Study|Lost to Follow-up|0
1118078|NCT02559414|2204575|FG001|Overall Study|Lost to Follow-up|1
1118079|NCT02559414|2204576|FG002|Overall Study|Lost to Follow-up|0
1118080|NCT02559414|2204574|FG000|Overall Study|Withdrawal by Subject|1
1118081|NCT02559414|2204575|FG001|Overall Study|Withdrawal by Subject|0
1118082|NCT02559414|2204576|FG002|Overall Study|Withdrawal by Subject|1
1118083|NCT02559414|2204574|FG000|Overall Study|Other|0
1118084|NCT02559414|2204575|FG001|Overall Study|Other|1
1118085|NCT02559414|2204576|FG002|Overall Study|Other|1
1118086|NCT02559505|2204601|FG000|Overall Study|Lost to Follow-up|23
1118087|NCT02559505|2204602|FG001|Overall Study|Lost to Follow-up|20
1118088|NCT02559505|2204601|FG000|Overall Study|Withdrawal by Subject|4
1118089|NCT02559505|2204602|FG001|Overall Study|Withdrawal by Subject|2
1118090|NCT02559570|2204625|FG000|Overall Study|Adverse Event|0
1118091|NCT02559570|2204626|FG001|Overall Study|Adverse Event|2
1118092|NCT02559570|2204627|FG002|Overall Study|Adverse Event|0
1118093|NCT02559570|2204628|FG003|Overall Study|Adverse Event|1
1118094|NCT02559570|2204629|FG004|Overall Study|Adverse Event|0
1118095|NCT02559570|2204625|FG000|Overall Study|Withdrawal of Consent|0
1118096|NCT02559570|2204626|FG001|Overall Study|Withdrawal of Consent|0
1118097|NCT02559570|2204627|FG002|Overall Study|Withdrawal of Consent|1
1118098|NCT02559570|2204628|FG003|Overall Study|Withdrawal of Consent|2
1118099|NCT02559570|2204629|FG004|Overall Study|Withdrawal of Consent|1
1118100|NCT02559570|2204625|FG000|Overall Study|Lost to Follow-up|1
1118101|NCT02559570|2204626|FG001|Overall Study|Lost to Follow-up|0
1118102|NCT02559570|2204627|FG002|Overall Study|Lost to Follow-up|0
1118103|NCT02559570|2204628|FG003|Overall Study|Lost to Follow-up|0
1118104|NCT02559570|2204629|FG004|Overall Study|Lost to Follow-up|0
1118105|NCT02559570|2204625|FG000|Overall Study|Protocol Violation|1
1118106|NCT02559570|2204626|FG001|Overall Study|Protocol Violation|0
1118107|NCT02559570|2204627|FG002|Overall Study|Protocol Violation|0
1118108|NCT02559570|2204628|FG003|Overall Study|Protocol Violation|0
1118109|NCT02559570|2204629|FG004|Overall Study|Protocol Violation|1
1118110|NCT02559570|2204625|FG000|Overall Study|Other Miscellaneous Reasons|0
1118111|NCT02559570|2204626|FG001|Overall Study|Other Miscellaneous Reasons|0
1118112|NCT02559570|2204627|FG002|Overall Study|Other Miscellaneous Reasons|1
1118113|NCT02559570|2204628|FG003|Overall Study|Other Miscellaneous Reasons|0
1118114|NCT02559570|2204629|FG004|Overall Study|Other Miscellaneous Reasons|0
1118115|NCT02559622|2204644|FG000|Overall Study|Progressive disease|0
1118116|NCT02559622|2204645|FG001|Overall Study|Progressive disease|1
1118117|NCT02559622|2204646|FG002|Overall Study|Progressive disease|0
1118118|NCT02559622|2204647|FG003|Overall Study|Progressive disease|0
1118119|NCT02559622|2204644|FG000|Overall Study|Adverse Event|0
1118120|NCT02559622|2204645|FG001|Overall Study|Adverse Event|2
1118121|NCT02559622|2204646|FG002|Overall Study|Adverse Event|2
1118122|NCT02559622|2204647|FG003|Overall Study|Adverse Event|2
1118123|NCT02559622|2204644|FG000|Overall Study|Patient/guardian decision|1
1118124|NCT02559622|2204645|FG001|Overall Study|Patient/guardian decision|2
1118125|NCT02559622|2204646|FG002|Overall Study|Patient/guardian decision|0
1118126|NCT02559622|2204647|FG003|Overall Study|Patient/guardian decision|1
1118127|NCT02559687|2204661|FG000|Overall Study|Death|103
1118128|NCT02559687|2204661|FG000|Overall Study|Withdrawal by Subject|4
1118129|NCT02559687|2204661|FG000|Overall Study|Ongoing Follow-Up|14
1118130|NCT02559713|2204665|FG000|Overall Study|Pretreatment Event/ Adverse Event|1
1118131|NCT02559817|2204674|FG000|Treatment Period|Adverse Event|1
1118132|NCT02559817|2204675|FG001|Treatment Period|Adverse Event|0
1118133|NCT02559817|2204676|FG002|Treatment Period|Adverse Event|1
1118134|NCT02559817|2204677|FG003|Treatment Period|Adverse Event|0
1118135|NCT02559817|2204678|FG004|Treatment Period|Adverse Event|0
1118136|NCT02559817|2204674|FG000|Treatment Period|Lack of Efficacy|0
1118137|NCT02559817|2204675|FG001|Treatment Period|Lack of Efficacy|1
1118138|NCT02559817|2204676|FG002|Treatment Period|Lack of Efficacy|0
1118139|NCT02559817|2204677|FG003|Treatment Period|Lack of Efficacy|0
1118140|NCT02559817|2204678|FG004|Treatment Period|Lack of Efficacy|0
1118141|NCT02559817|2204674|FG000|Treatment Period|Lost to Follow-up|0
1118142|NCT02559817|2204675|FG001|Treatment Period|Lost to Follow-up|1
1118143|NCT02559817|2204676|FG002|Treatment Period|Lost to Follow-up|0
1118144|NCT02559817|2204677|FG003|Treatment Period|Lost to Follow-up|1
1118145|NCT02559817|2204678|FG004|Treatment Period|Lost to Follow-up|0
1118146|NCT02559817|2204674|FG000|Treatment Period|Non-Compliance With Study Drug|0
1118147|NCT02559817|2204675|FG001|Treatment Period|Non-Compliance With Study Drug|0
1118148|NCT02559817|2204676|FG002|Treatment Period|Non-Compliance With Study Drug|1
1118149|NCT02559817|2204677|FG003|Treatment Period|Non-Compliance With Study Drug|0
1118150|NCT02559817|2204678|FG004|Treatment Period|Non-Compliance With Study Drug|0
1118151|NCT02559817|2204674|FG000|Treatment Period|Protocol Violation|0
1118152|NCT02559817|2204675|FG001|Treatment Period|Protocol Violation|0
1118153|NCT02559817|2204676|FG002|Treatment Period|Protocol Violation|0
1118154|NCT02559817|2204677|FG003|Treatment Period|Protocol Violation|1
1118155|NCT02559817|2204678|FG004|Treatment Period|Protocol Violation|0
1118156|NCT02559895|2204694|FG000|Overall Study|Adverse Event|3
1118157|NCT02559895|2204695|FG001|Overall Study|Adverse Event|3
1118158|NCT02559895|2204696|FG002|Overall Study|Adverse Event|2
1118159|NCT02559895|2204697|FG003|Overall Study|Adverse Event|1
1118160|NCT02559895|2204694|FG000|Overall Study|Lack of Efficacy|2
1118161|NCT02559895|2204695|FG001|Overall Study|Lack of Efficacy|3
1118162|NCT02559895|2204696|FG002|Overall Study|Lack of Efficacy|2
1118163|NCT02559895|2204697|FG003|Overall Study|Lack of Efficacy|8
1118164|NCT02559895|2204694|FG000|Overall Study|Lost to Follow-up|22
1118165|NCT02559895|2204695|FG001|Overall Study|Lost to Follow-up|16
1118166|NCT02559895|2204696|FG002|Overall Study|Lost to Follow-up|12
1118167|NCT02559895|2204697|FG003|Overall Study|Lost to Follow-up|17
1118168|NCT02559895|2204694|FG000|Overall Study|Physician Decision|1
1118169|NCT02559895|2204695|FG001|Overall Study|Physician Decision|1
1118170|NCT02559895|2204696|FG002|Overall Study|Physician Decision|3
1118171|NCT02559895|2204697|FG003|Overall Study|Physician Decision|0
1118172|NCT02559895|2204694|FG000|Overall Study|Withdrawal by Subject|16
1118173|NCT02559895|2204695|FG001|Overall Study|Withdrawal by Subject|9
1118174|NCT02559895|2204696|FG002|Overall Study|Withdrawal by Subject|20
1118175|NCT02559895|2204697|FG003|Overall Study|Withdrawal by Subject|9
1118176|NCT02559895|2204694|FG000|Overall Study|Study Burden|10
1118177|NCT02559895|2204695|FG001|Overall Study|Study Burden|16
1118178|NCT02559895|2204696|FG002|Overall Study|Study Burden|12
1118179|NCT02559895|2204697|FG003|Overall Study|Study Burden|22
1118180|NCT02559895|2204694|FG000|Overall Study|Other|1
1118181|NCT02559895|2204695|FG001|Overall Study|Other|5
1118182|NCT02559895|2204696|FG002|Overall Study|Other|3
1118183|NCT02559895|2204697|FG003|Overall Study|Other|3
1118184|NCT02560012|2204707|FG000|Overall Study|Study Terminated|2
1118185|NCT02560025|2204711|FG000|Overall Study|Ineligible after consent/ registration|3
1118186|NCT02560389|2204748|FG000|Overall Study|Lost to Follow-up|1
1118187|NCT02560389|2204749|FG001|Overall Study|Lost to Follow-up|2
1118188|NCT02560389|2204750|FG002|Overall Study|Lost to Follow-up|2
1118189|NCT02560389|2204748|FG000|Overall Study|Tested positive for illicit substance|0
1118190|NCT02560389|2204749|FG001|Overall Study|Tested positive for illicit substance|1
1118191|NCT02560389|2204750|FG002|Overall Study|Tested positive for illicit substance|0
1118192|NCT02560558|2204769|FG000|Overall Study|Adverse Event|1
1118193|NCT02560558|2204770|FG001|Overall Study|Adverse Event|0
1118194|NCT02560558|2204769|FG000|Overall Study|Death|0
1118195|NCT02560558|2204770|FG001|Overall Study|Death|2
1118196|NCT02560558|2204769|FG000|Overall Study|Lost to Follow-up|0
1118197|NCT02560558|2204770|FG001|Overall Study|Lost to Follow-up|4
1118198|NCT02560558|2204769|FG000|Overall Study|Protocol Violation|3
1118199|NCT02560558|2204770|FG001|Overall Study|Protocol Violation|0
1118200|NCT02560558|2204769|FG000|Overall Study|Withdrawal by Subject|3
1118201|NCT02560558|2204770|FG001|Overall Study|Withdrawal by Subject|0
1118202|NCT02561000|2204829|FG000|Overall Study|Withdrawal by Subject|2
1118203|NCT02561000|2204830|FG001|Overall Study|Withdrawal by Subject|3
1118204|NCT02561000|2204831|FG002|Overall Study|Withdrawal by Subject|0
1118205|NCT02561000|2204829|FG000|Overall Study|Adverse Event|0
1118206|NCT02561000|2204830|FG001|Overall Study|Adverse Event|1
1118207|NCT02561000|2204831|FG002|Overall Study|Adverse Event|0
1118208|NCT02561078|2204841|FG000|Overall Study|Adverse Event|5
1118209|NCT02561078|2204842|FG001|Overall Study|Adverse Event|2
1118210|NCT02561078|2204841|FG000|Overall Study|Death|2
1118211|NCT02561078|2204842|FG001|Overall Study|Death|1
1118212|NCT02561078|2204841|FG000|Overall Study|Lost to Follow-up|2
1118213|NCT02561078|2204842|FG001|Overall Study|Lost to Follow-up|6
1118214|NCT02561078|2204841|FG000|Overall Study|Non-Compliance with Study Drug|6
1118215|NCT02561078|2204842|FG001|Overall Study|Non-Compliance with Study Drug|3
1118216|NCT02561078|2204841|FG000|Overall Study|Physician Decision|2
1118217|NCT02561078|2204842|FG001|Overall Study|Physician Decision|3
1118218|NCT02561078|2204841|FG000|Overall Study|Withdrawal by Subject|13
1118219|NCT02561078|2204842|FG001|Overall Study|Withdrawal by Subject|10
1118220|NCT02561156|2204870|FG000|Part 2|Adverse Event|0
1118221|NCT02561156|2204871|FG001|Part 2|Adverse Event|0
1118222|NCT02561156|2204872|FG002|Part 2|Adverse Event|0
1118223|NCT02561156|2204873|FG003|Part 2|Adverse Event|0
1118224|NCT02561156|2204874|FG004|Part 2|Adverse Event|0
1118225|NCT02561156|2204875|FG005|Part 2|Adverse Event|0
1118226|NCT02561156|2204876|FG006|Part 2|Adverse Event|0
1118227|NCT02561156|2204877|FG007|Part 2|Adverse Event|0
1118228|NCT02561156|2204878|FG008|Part 2|Adverse Event|0
1118229|NCT02561156|2204879|FG009|Part 2|Adverse Event|0
1118230|NCT02561156|2204880|FG010|Part 2|Adverse Event|0
1118231|NCT02561156|2204881|FG011|Part 2|Adverse Event|1
1118232|NCT02561156|2204882|FG012|Part 2|Adverse Event|0
1118233|NCT02561195|2204932|FG000|Vaccination 1 to 3|Adverse Event|4
1118234|NCT02561195|2204933|FG001|Vaccination 1 to 3|Adverse Event|5
1118235|NCT02561195|2204934|FG002|Vaccination 1 to 3|Adverse Event|0
1118236|NCT02561195|2204935|FG003|Vaccination 1 to 3|Adverse Event|3
1118237|NCT02561195|2204936|FG004|Vaccination 1 to 3|Adverse Event|4
1118238|NCT02561195|2204937|FG005|Vaccination 1 to 3|Adverse Event|0
1118239|NCT02561195|2204938|FG006|Vaccination 1 to 3|Adverse Event|0
1118240|NCT02561195|2204939|FG007|Vaccination 1 to 3|Adverse Event|0
1118241|NCT02561195|2204940|FG008|Vaccination 1 to 3|Adverse Event|0
1118242|NCT02561195|2204941|FG009|Vaccination 1 to 3|Adverse Event|0
1118243|NCT02561195|2204942|FG010|Vaccination 1 to 3|Adverse Event|0
1118244|NCT02561195|2204943|FG011|Vaccination 1 to 3|Adverse Event|0
1118245|NCT02561195|2204944|FG012|Vaccination 1 to 3|Adverse Event|0
1118246|NCT02561195|2204945|FG013|Vaccination 1 to 3|Adverse Event|0
1118247|NCT02561195|2204932|FG000|Vaccination 1 to 3|Lost to Follow-up|3
1118248|NCT02561195|2204933|FG001|Vaccination 1 to 3|Lost to Follow-up|4
1118249|NCT02561195|2204934|FG002|Vaccination 1 to 3|Lost to Follow-up|0
1118250|NCT02561195|2204935|FG003|Vaccination 1 to 3|Lost to Follow-up|2
1118251|NCT02561195|2204936|FG004|Vaccination 1 to 3|Lost to Follow-up|3
1118252|NCT02561195|2204937|FG005|Vaccination 1 to 3|Lost to Follow-up|3
1118253|NCT02561195|2204938|FG006|Vaccination 1 to 3|Lost to Follow-up|0
1118254|NCT02561195|2204939|FG007|Vaccination 1 to 3|Lost to Follow-up|0
1118255|NCT02561195|2204940|FG008|Vaccination 1 to 3|Lost to Follow-up|0
1118256|NCT02561195|2204941|FG009|Vaccination 1 to 3|Lost to Follow-up|0
1118257|NCT02561195|2204942|FG010|Vaccination 1 to 3|Lost to Follow-up|0
1118258|NCT02561195|2204943|FG011|Vaccination 1 to 3|Lost to Follow-up|0
1118259|NCT02561195|2204944|FG012|Vaccination 1 to 3|Lost to Follow-up|0
1118260|NCT02561195|2204945|FG013|Vaccination 1 to 3|Lost to Follow-up|0
1118261|NCT02561195|2204932|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0
1118262|NCT02561195|2204933|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1
1118263|NCT02561195|2204934|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0
1118264|NCT02561195|2204935|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4
1118265|NCT02561195|2204936|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4
1118266|NCT02561195|2204937|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1
1118267|NCT02561195|2204938|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0
1118268|NCT02561195|2204939|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0
1118269|NCT02561195|2204940|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0
1118270|NCT02561195|2204941|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0
1118271|NCT02561195|2204942|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0
1118272|NCT02561195|2204943|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0
1118273|NCT02561195|2204944|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0
1118274|NCT02561195|2204945|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0
1118275|NCT02561195|2204932|FG000|Vaccination 1 to 3|No longer willing to participate|2
1118276|NCT02561195|2204933|FG001|Vaccination 1 to 3|No longer willing to participate|4
1118277|NCT02561195|2204934|FG002|Vaccination 1 to 3|No longer willing to participate|0
1118278|NCT02561195|2204935|FG003|Vaccination 1 to 3|No longer willing to participate|4
1118279|NCT02561195|2204936|FG004|Vaccination 1 to 3|No longer willing to participate|1
1118280|NCT02561195|2204937|FG005|Vaccination 1 to 3|No longer willing to participate|3
1118281|NCT02561195|2204938|FG006|Vaccination 1 to 3|No longer willing to participate|0
1118282|NCT02561195|2204939|FG007|Vaccination 1 to 3|No longer willing to participate|0
1118283|NCT02561195|2204940|FG008|Vaccination 1 to 3|No longer willing to participate|0
1118284|NCT02561195|2204941|FG009|Vaccination 1 to 3|No longer willing to participate|0
1118285|NCT02561195|2204942|FG010|Vaccination 1 to 3|No longer willing to participate|0
1118286|NCT02561195|2204943|FG011|Vaccination 1 to 3|No longer willing to participate|0
1118287|NCT02561195|2204944|FG012|Vaccination 1 to 3|No longer willing to participate|0
1118288|NCT02561195|2204945|FG013|Vaccination 1 to 3|No longer willing to participate|0
1118289|NCT02561195|2204932|FG000|Vaccination 1 to 3|Other|7
1118290|NCT02561195|2204933|FG001|Vaccination 1 to 3|Other|3
1118291|NCT02561195|2204934|FG002|Vaccination 1 to 3|Other|1
1118292|NCT02561195|2204935|FG003|Vaccination 1 to 3|Other|7
1118293|NCT02561195|2204936|FG004|Vaccination 1 to 3|Other|5
1118294|NCT02561195|2204937|FG005|Vaccination 1 to 3|Other|1
1118295|NCT02561195|2204938|FG006|Vaccination 1 to 3|Other|0
1118296|NCT02561195|2204939|FG007|Vaccination 1 to 3|Other|0
1118297|NCT02561195|2204940|FG008|Vaccination 1 to 3|Other|0
1118298|NCT02561195|2204941|FG009|Vaccination 1 to 3|Other|0
1118299|NCT02561195|2204942|FG010|Vaccination 1 to 3|Other|0
1118300|NCT02561195|2204943|FG011|Vaccination 1 to 3|Other|0
1118301|NCT02561195|2204944|FG012|Vaccination 1 to 3|Other|0
1118302|NCT02561195|2204945|FG013|Vaccination 1 to 3|Other|0
1118303|NCT02561195|2204932|FG000|Vaccination 1 to 3|Protocol Violation|1
1118304|NCT02561195|2204933|FG001|Vaccination 1 to 3|Protocol Violation|0
1118305|NCT02561195|2204934|FG002|Vaccination 1 to 3|Protocol Violation|1
1118306|NCT02561195|2204935|FG003|Vaccination 1 to 3|Protocol Violation|2
1118307|NCT02561195|2204936|FG004|Vaccination 1 to 3|Protocol Violation|5
1118308|NCT02561195|2204937|FG005|Vaccination 1 to 3|Protocol Violation|2
1118309|NCT02561195|2204938|FG006|Vaccination 1 to 3|Protocol Violation|0
1118310|NCT02561195|2204939|FG007|Vaccination 1 to 3|Protocol Violation|0
1118311|NCT02561195|2204940|FG008|Vaccination 1 to 3|Protocol Violation|0
1118312|NCT02561195|2204941|FG009|Vaccination 1 to 3|Protocol Violation|0
1118313|NCT02561195|2204942|FG010|Vaccination 1 to 3|Protocol Violation|0
1118314|NCT02561195|2204943|FG011|Vaccination 1 to 3|Protocol Violation|0
1118315|NCT02561195|2204944|FG012|Vaccination 1 to 3|Protocol Violation|0
1118316|NCT02561195|2204945|FG013|Vaccination 1 to 3|Protocol Violation|0
1118317|NCT02561195|2204932|FG000|Vaccination 1 to 3|Death|2
1118318|NCT02561195|2204933|FG001|Vaccination 1 to 3|Death|1
1118319|NCT02561195|2204934|FG002|Vaccination 1 to 3|Death|0
1118320|NCT02561195|2204935|FG003|Vaccination 1 to 3|Death|2
1118321|NCT02561195|2204936|FG004|Vaccination 1 to 3|Death|0
1118322|NCT02561195|2204937|FG005|Vaccination 1 to 3|Death|0
1118323|NCT02561195|2204938|FG006|Vaccination 1 to 3|Death|0
1118324|NCT02561195|2204939|FG007|Vaccination 1 to 3|Death|0
1118325|NCT02561195|2204940|FG008|Vaccination 1 to 3|Death|0
1118326|NCT02561195|2204941|FG009|Vaccination 1 to 3|Death|0
1118327|NCT02561195|2204942|FG010|Vaccination 1 to 3|Death|0
1118328|NCT02561195|2204943|FG011|Vaccination 1 to 3|Death|0
1118329|NCT02561195|2204944|FG012|Vaccination 1 to 3|Death|0
1118330|NCT02561195|2204945|FG013|Vaccination 1 to 3|Death|0
1118331|NCT02561195|2204932|FG000|Vaccination 1 to 3|Withdrawal by Subject|3
1118332|NCT02561195|2204933|FG001|Vaccination 1 to 3|Withdrawal by Subject|4
1118333|NCT02561195|2204934|FG002|Vaccination 1 to 3|Withdrawal by Subject|4
1118334|NCT02561195|2204935|FG003|Vaccination 1 to 3|Withdrawal by Subject|2
1118335|NCT02561195|2204936|FG004|Vaccination 1 to 3|Withdrawal by Subject|6
1118336|NCT02561195|2204937|FG005|Vaccination 1 to 3|Withdrawal by Subject|0
1118337|NCT02561195|2204938|FG006|Vaccination 1 to 3|Withdrawal by Subject|0
1118338|NCT02561195|2204939|FG007|Vaccination 1 to 3|Withdrawal by Subject|0
1118339|NCT02561195|2204940|FG008|Vaccination 1 to 3|Withdrawal by Subject|0
1118340|NCT02561195|2204941|FG009|Vaccination 1 to 3|Withdrawal by Subject|0
1118341|NCT02561195|2204942|FG010|Vaccination 1 to 3|Withdrawal by Subject|0
1118342|NCT02561195|2204943|FG011|Vaccination 1 to 3|Withdrawal by Subject|0
1118343|NCT02561195|2204944|FG012|Vaccination 1 to 3|Withdrawal by Subject|0
1118344|NCT02561195|2204945|FG013|Vaccination 1 to 3|Withdrawal by Subject|0
1118345|NCT02561195|2204932|FG000|Vaccination 1 to 3|Randomized but not treated|1
1118346|NCT02561195|2204933|FG001|Vaccination 1 to 3|Randomized but not treated|0
1118347|NCT02561195|2204934|FG002|Vaccination 1 to 3|Randomized but not treated|0
1118348|NCT02561195|2204935|FG003|Vaccination 1 to 3|Randomized but not treated|0
1118349|NCT02561195|2204936|FG004|Vaccination 1 to 3|Randomized but not treated|0
1118350|NCT02561195|2204937|FG005|Vaccination 1 to 3|Randomized but not treated|0
1118351|NCT02561195|2204938|FG006|Vaccination 1 to 3|Randomized but not treated|0
1118352|NCT02561195|2204939|FG007|Vaccination 1 to 3|Randomized but not treated|0
1118353|NCT02561195|2204940|FG008|Vaccination 1 to 3|Randomized but not treated|0
1118354|NCT02561195|2204941|FG009|Vaccination 1 to 3|Randomized but not treated|0
1118355|NCT02561195|2204942|FG010|Vaccination 1 to 3|Randomized but not treated|0
1118356|NCT02561195|2204943|FG011|Vaccination 1 to 3|Randomized but not treated|0
1118357|NCT02561195|2204944|FG012|Vaccination 1 to 3|Randomized but not treated|0
1118358|NCT02561195|2204945|FG013|Vaccination 1 to 3|Randomized but not treated|0
1118359|NCT02561195|2204932|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0
1118360|NCT02561195|2204933|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0
1118361|NCT02561195|2204934|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0
1118362|NCT02561195|2204935|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0
1118363|NCT02561195|2204936|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0
1118364|NCT02561195|2204937|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0
1118365|NCT02561195|2204938|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0
1118366|NCT02561195|2204939|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0
1118367|NCT02561195|2204940|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3
1118368|NCT02561195|2204941|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1
1118369|NCT02561195|2204942|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2
1118370|NCT02561195|2204943|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2
1118371|NCT02561195|2204944|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3
1118372|NCT02561195|2204945|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0
1118373|NCT02561195|2204932|FG000|Extension Stage (Vaccination 4)|Adverse Event|0
1118374|NCT02561195|2204933|FG001|Extension Stage (Vaccination 4)|Adverse Event|0
1118375|NCT02561195|2204934|FG002|Extension Stage (Vaccination 4)|Adverse Event|0
1118376|NCT02561195|2204935|FG003|Extension Stage (Vaccination 4)|Adverse Event|0
1118377|NCT02561195|2204936|FG004|Extension Stage (Vaccination 4)|Adverse Event|0
1118378|NCT02561195|2204937|FG005|Extension Stage (Vaccination 4)|Adverse Event|0
1118379|NCT02561195|2204938|FG006|Extension Stage (Vaccination 4)|Adverse Event|0
1118380|NCT02561195|2204939|FG007|Extension Stage (Vaccination 4)|Adverse Event|0
1118381|NCT02561195|2204940|FG008|Extension Stage (Vaccination 4)|Adverse Event|0
1118382|NCT02561195|2204941|FG009|Extension Stage (Vaccination 4)|Adverse Event|0
1118383|NCT02561195|2204942|FG010|Extension Stage (Vaccination 4)|Adverse Event|0
1118384|NCT02561195|2204943|FG011|Extension Stage (Vaccination 4)|Adverse Event|0
1118385|NCT02561195|2204944|FG012|Extension Stage (Vaccination 4)|Adverse Event|0
1118386|NCT02561195|2204945|FG013|Extension Stage (Vaccination 4)|Adverse Event|2
1118387|NCT02561195|2204932|FG000|Extension Stage (Vaccination 4)|Death|0
1118388|NCT02561195|2204933|FG001|Extension Stage (Vaccination 4)|Death|0
1118389|NCT02561195|2204934|FG002|Extension Stage (Vaccination 4)|Death|0
1118390|NCT02561195|2204935|FG003|Extension Stage (Vaccination 4)|Death|0
1118391|NCT02561195|2204936|FG004|Extension Stage (Vaccination 4)|Death|0
1118392|NCT02561195|2204937|FG005|Extension Stage (Vaccination 4)|Death|0
1118393|NCT02561195|2204938|FG006|Extension Stage (Vaccination 4)|Death|0
1118394|NCT02561195|2204939|FG007|Extension Stage (Vaccination 4)|Death|0
1118395|NCT02561195|2204940|FG008|Extension Stage (Vaccination 4)|Death|0
1118396|NCT02561195|2204941|FG009|Extension Stage (Vaccination 4)|Death|1
1118397|NCT02561195|2204942|FG010|Extension Stage (Vaccination 4)|Death|0
1118398|NCT02561195|2204943|FG011|Extension Stage (Vaccination 4)|Death|0
1118399|NCT02561195|2204944|FG012|Extension Stage (Vaccination 4)|Death|0
1118400|NCT02561195|2204945|FG013|Extension Stage (Vaccination 4)|Death|0
1118401|NCT02561195|2204932|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0
1118402|NCT02561195|2204933|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0
1118403|NCT02561195|2204934|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0
1118404|NCT02561195|2204935|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0
1118405|NCT02561195|2204936|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0
1118406|NCT02561195|2204937|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0
1118407|NCT02561195|2204938|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1
1118408|NCT02561195|2204939|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1
1118409|NCT02561195|2204940|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0
1118410|NCT02561195|2204941|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0
1118411|NCT02561195|2204942|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2
1118412|NCT02561195|2204943|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1
1118413|NCT02561195|2204944|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2
1118414|NCT02561195|2204945|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1
1118415|NCT02561195|2204932|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
1118416|NCT02561195|2204933|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
1118417|NCT02561195|2204934|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
1118418|NCT02561195|2204935|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
1118419|NCT02561195|2204936|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
1118420|NCT02561195|2204937|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
1118421|NCT02561195|2204938|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
1118422|NCT02561195|2204939|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
1118423|NCT02561195|2204940|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
1118424|NCT02561195|2204941|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
1118425|NCT02561195|2204942|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
1118426|NCT02561195|2204943|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
1118427|NCT02561195|2204944|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
1118428|NCT02561195|2204945|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
1118429|NCT02561195|2204932|FG000|Extension Stage (Vaccination 4)|Other|0
1118430|NCT02561195|2204933|FG001|Extension Stage (Vaccination 4)|Other|0
1118431|NCT02561195|2204934|FG002|Extension Stage (Vaccination 4)|Other|0
1118432|NCT02561195|2204935|FG003|Extension Stage (Vaccination 4)|Other|0
1118433|NCT02561195|2204936|FG004|Extension Stage (Vaccination 4)|Other|0
1118434|NCT02561195|2204937|FG005|Extension Stage (Vaccination 4)|Other|0
1118435|NCT02561195|2204938|FG006|Extension Stage (Vaccination 4)|Other|0
1118436|NCT02561195|2204939|FG007|Extension Stage (Vaccination 4)|Other|0
1118437|NCT02561195|2204940|FG008|Extension Stage (Vaccination 4)|Other|0
1118438|NCT02561195|2204941|FG009|Extension Stage (Vaccination 4)|Other|0
1118439|NCT02561195|2204942|FG010|Extension Stage (Vaccination 4)|Other|2
1118440|NCT02561195|2204943|FG011|Extension Stage (Vaccination 4)|Other|2
1118441|NCT02561195|2204944|FG012|Extension Stage (Vaccination 4)|Other|1
1118442|NCT02561195|2204945|FG013|Extension Stage (Vaccination 4)|Other|0
1118443|NCT02561195|2204932|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0
1118444|NCT02561195|2204933|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0
1118445|NCT02561195|2204934|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0
1118446|NCT02561195|2204935|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0
1118447|NCT02561195|2204936|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0
1118448|NCT02561195|2204937|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0
1118449|NCT02561195|2204938|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1
1118450|NCT02561195|2204939|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0
1118451|NCT02561195|2204940|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0
1118452|NCT02561195|2204941|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0
1118453|NCT02561195|2204942|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2
1118454|NCT02561195|2204943|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1
1118455|NCT02561195|2204944|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0
1118456|NCT02561195|2204945|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1
1118457|NCT02561247|2204986|FG000|Overall Study|Protocol Violation|1
1118458|NCT02561247|2204986|FG000|Overall Study|Withdrawal by Subject|1
1118459|NCT02561247|2204986|FG000|Overall Study|Two filter changes required within the first 24 hours.|4
1118460|NCT02561273|2204992|FG000|Overall Study|Protocol Violation|1
1118461|NCT02561273|2204993|FG001|Overall Study|Protocol Violation|0
1118462|NCT02561299|2205003|FG000|Overall Study|Death|2
1118463|NCT02561299|2205004|FG001|Overall Study|Death|4
1118464|NCT02561299|2205003|FG000|Overall Study|Lost to Follow-up|1
1118465|NCT02561299|2205004|FG001|Overall Study|Lost to Follow-up|0
1118466|NCT02561299|2205003|FG000|Overall Study|Withdrawal by Subject|2
1118467|NCT02561299|2205004|FG001|Overall Study|Withdrawal by Subject|2
1118468|NCT02561455|2205037|FG000|Overall Study|Participant Transitioned to Commercial Drug|1
1118469|NCT02561455|2205038|FG001|Overall Study|Participant Transitioned to Commercial Drug|1
1118470|NCT02561455|2205039|FG002|Overall Study|Participant Transitioned to Commercial Drug|2
1118471|NCT02561455|2205040|FG003|Overall Study|Participant Transitioned to Commercial Drug|1
1118472|NCT02561455|2205037|FG000|Overall Study|Withdrawal by Subject|1
1118473|NCT02561455|2205038|FG001|Overall Study|Withdrawal by Subject|0
1118474|NCT02561455|2205039|FG002|Overall Study|Withdrawal by Subject|1
1118475|NCT02561455|2205040|FG003|Overall Study|Withdrawal by Subject|0
1118476|NCT02561455|2205037|FG000|Overall Study|Disease Progression|0
1118477|NCT02561455|2205038|FG001|Overall Study|Disease Progression|1
1118478|NCT02561455|2205039|FG002|Overall Study|Disease Progression|0
1118479|NCT02561455|2205040|FG003|Overall Study|Disease Progression|0
1118480|NCT02561572|2205064|FG000|Overall Study|Inadequate time before surgery|2
1118481|NCT02561572|2205065|FG001|Overall Study|Inadequate time before surgery|1
1118482|NCT02561572|2205064|FG000|Overall Study|Protocol Violation|0
1118483|NCT02561572|2205065|FG001|Overall Study|Protocol Violation|1
1118484|NCT02561806|2205093|FG000|Induction Period|Adverse Event|0
1118485|NCT02561806|2205094|FG001|Induction Period|Adverse Event|2
1118486|NCT02561806|2205093|FG000|Induction Period|Lack of Efficacy|1
1118487|NCT02561806|2205094|FG001|Induction Period|Lack of Efficacy|0
1118488|NCT02561806|2205093|FG000|Induction Period|Withdrawal by Subject|0
1118489|NCT02561806|2205094|FG001|Induction Period|Withdrawal by Subject|2
1118490|NCT02561806|2205093|FG000|Induction Period|Site staff became unblinded|1
1118491|NCT02561806|2205094|FG001|Induction Period|Site staff became unblinded|0
1118492|NCT02561806|2205093|FG000|Induction Period|Randomized but not treated|0
1118493|NCT02561806|2205094|FG001|Induction Period|Randomized but not treated|1
1118494|NCT02561806|2205093|FG000|Maintenance Period|Adverse Event|2
1118495|NCT02561806|2205094|FG001|Maintenance Period|Adverse Event|1
1118496|NCT02561806|2205093|FG000|Maintenance Period|Lack of Efficacy|3
1118497|NCT02561806|2205094|FG001|Maintenance Period|Lack of Efficacy|1
1118498|NCT02561806|2205093|FG000|Maintenance Period|Lost to Follow-up|2
1118499|NCT02561806|2205094|FG001|Maintenance Period|Lost to Follow-up|2
1118500|NCT02561806|2205093|FG000|Maintenance Period|Protocol Violation|1
1118501|NCT02561806|2205094|FG001|Maintenance Period|Protocol Violation|0
1118502|NCT02561806|2205093|FG000|Maintenance Period|Withdrawal by Subject|5
1118503|NCT02561806|2205094|FG001|Maintenance Period|Withdrawal by Subject|3
1118504|NCT02561806|2205093|FG000|Maintenance Period|Site staff became unblinded|0
1118505|NCT02561806|2205094|FG001|Maintenance Period|Site staff became unblinded|1
1118506|NCT02561806|2205093|FG000|Post-Treatment Follow-up|Lost to Follow-up|1
1118507|NCT02561806|2205094|FG001|Post-Treatment Follow-up|Lost to Follow-up|1
1118508|NCT02561806|2205093|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1
1118509|NCT02561806|2205094|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0
1118510|NCT02561832|2205117|FG000|Overall Study|Withdrawal by Subject|1
1118511|NCT02561832|2205118|FG001|Overall Study|Withdrawal by Subject|1
1118512|NCT02561832|2205117|FG000|Overall Study|Adverse Event|3
1118513|NCT02561832|2205118|FG001|Overall Study|Adverse Event|0
1118514|NCT02561832|2205117|FG000|Overall Study|Disease progression|3
1118515|NCT02561832|2205118|FG001|Overall Study|Disease progression|3
1118553|NCT02562482|2205193|FG000|Overall Study|Enrolled, but did not receive product|4
1118554|NCT02562482|2205194|FG001|Overall Study|Enrolled, but did not receive product|0
1118555|NCT02562482|2205193|FG000|Overall Study|Lost to Follow-up|9
1118556|NCT02562482|2205194|FG001|Overall Study|Lost to Follow-up|6
1118557|NCT02562482|2205193|FG000|Overall Study|Moved from area|2
1118558|NCT02562482|2205194|FG001|Overall Study|Moved from area|3
1118559|NCT02562482|2205193|FG000|Overall Study|Withdrawal by Subject|5
1118560|NCT02562482|2205194|FG001|Overall Study|Withdrawal by Subject|3
1118561|NCT02562482|2205193|FG000|Overall Study|Physician Decision|1
1118562|NCT02562482|2205194|FG001|Overall Study|Physician Decision|3
1118563|NCT02562482|2205193|FG000|Overall Study|Illness/Injury unrelated to product|0
1118564|NCT02562482|2205194|FG001|Overall Study|Illness/Injury unrelated to product|1
1118565|NCT02563028|2205256|FG000|Overall Study|Lack of equipment|1
1118566|NCT02563028|2205256|FG000|Overall Study|Unable to elicit VEP post induction|1
1118567|NCT02563067|2205263|FG000|Overall Study|Subject/guardian decision|14
1118568|NCT02563067|2205264|FG001|Overall Study|Subject/guardian decision|20
1118569|NCT02563067|2205265|FG002|Overall Study|Subject/guardian decision|16
1118570|NCT02563067|2205263|FG000|Overall Study|Physician Decision|0
1118571|NCT02563067|2205264|FG001|Overall Study|Physician Decision|1
1118572|NCT02563067|2205265|FG002|Overall Study|Physician Decision|3
1118573|NCT02563067|2205263|FG000|Overall Study|Lost to Follow-up|1
1118574|NCT02563067|2205264|FG001|Overall Study|Lost to Follow-up|2
1118575|NCT02563067|2205265|FG002|Overall Study|Lost to Follow-up|0
1118576|NCT02563067|2205263|FG000|Overall Study|Technical problems|0
1118577|NCT02563067|2205264|FG001|Overall Study|Technical problems|1
1118578|NCT02563067|2205265|FG002|Overall Study|Technical problems|0
1118579|NCT02563067|2205263|FG000|Overall Study|Lack of Efficacy|1
1118580|NCT02563067|2205264|FG001|Overall Study|Lack of Efficacy|0
1118581|NCT02563067|2205265|FG002|Overall Study|Lack of Efficacy|0
1118582|NCT02563067|2205263|FG000|Overall Study|Death|0
1118583|NCT02563067|2205264|FG001|Overall Study|Death|1
1118584|NCT02563067|2205265|FG002|Overall Study|Death|1
1118585|NCT02563067|2205263|FG000|Overall Study|Adverse Event|2
1118586|NCT02563067|2205264|FG001|Overall Study|Adverse Event|1
1118587|NCT02563067|2205265|FG002|Overall Study|Adverse Event|0
1118588|NCT02563067|2205263|FG000|Overall Study|Death post Treatment/safety period|1
1118589|NCT02563067|2205264|FG001|Overall Study|Death post Treatment/safety period|0
1118590|NCT02563067|2205265|FG002|Overall Study|Death post Treatment/safety period|0
1118591|NCT02563106|2205293|FG000|Overall Study|Withdrawal by Subject|7
1118592|NCT02563106|2205294|FG001|Overall Study|Withdrawal by Subject|8
1118593|NCT02563106|2205293|FG000|Overall Study|Adverse Event|17
1118594|NCT02563106|2205294|FG001|Overall Study|Adverse Event|15
1118595|NCT02563106|2205293|FG000|Overall Study|Protocol Violation|1
1118596|NCT02563106|2205294|FG001|Overall Study|Protocol Violation|0
1118597|NCT02563106|2205293|FG000|Overall Study|Use of non-permitted concurrent therapy|1
1118598|NCT02563106|2205294|FG001|Overall Study|Use of non-permitted concurrent therapy|2
1118599|NCT02563106|2205293|FG000|Overall Study|Lost to Follow-up|3
1118600|NCT02563106|2205294|FG001|Overall Study|Lost to Follow-up|2
1118601|NCT02563106|2205293|FG000|Overall Study|Physician Decision|3
1118602|NCT02563106|2205294|FG001|Overall Study|Physician Decision|1
1118603|NCT02563106|2205293|FG000|Overall Study|Other reason - not specified|2
1118604|NCT02563106|2205294|FG001|Overall Study|Other reason - not specified|1
1118605|NCT02563548|2205323|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
1118606|NCT02563548|2205324|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
1118607|NCT02563548|2205325|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
1118608|NCT02563548|2205326|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
1118609|NCT02563548|2205327|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
1118610|NCT02563548|2205328|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
1118611|NCT02563548|2205323|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
1118612|NCT02563548|2205324|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
1118613|NCT02563548|2205325|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
1118614|NCT02563548|2205326|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
1118615|NCT02563548|2205327|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
1118616|NCT02563548|2205328|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
1118617|NCT02563548|2205323|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
1118618|NCT02563548|2205324|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
1118619|NCT02563548|2205325|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
1118620|NCT02563548|2205326|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
1118621|NCT02563548|2205327|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
1118622|NCT02563548|2205328|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
1118623|NCT02563548|2205323|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
1118624|NCT02563548|2205324|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
1118625|NCT02563548|2205325|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
1118626|NCT02563548|2205326|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
1118627|NCT02563548|2205327|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
1118628|NCT02563548|2205328|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
1118629|NCT02563548|2205323|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
1118630|NCT02563548|2205324|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
1118631|NCT02563548|2205325|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
1118632|NCT02563548|2205326|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
1118633|NCT02563548|2205327|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
1118634|NCT02563548|2205328|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
1118635|NCT02563548|2205323|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
1118636|NCT02563548|2205324|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
1118637|NCT02563548|2205325|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
1118638|NCT02563548|2205326|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
1118639|NCT02563548|2205327|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
1118640|NCT02563548|2205328|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
1118641|NCT02563548|2205323|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
1118642|NCT02563548|2205324|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
1118643|NCT02563548|2205325|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
1118644|NCT02563548|2205326|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
1118645|NCT02563548|2205327|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
1118646|NCT02563548|2205328|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
1118647|NCT02563548|2205323|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
1118648|NCT02563548|2205324|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
1118649|NCT02563548|2205325|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
1118650|NCT02563548|2205326|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
1118651|NCT02563548|2205327|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
1118652|NCT02563548|2205328|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
1118653|NCT02563548|2205323|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
1118654|NCT02563548|2205324|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
1118655|NCT02563548|2205325|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
1118656|NCT02563548|2205326|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
1118657|NCT02563548|2205327|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
1118658|NCT02563548|2205328|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
1118659|NCT02563548|2205323|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
1118660|NCT02563548|2205324|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
1118661|NCT02563548|2205325|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
1118662|NCT02563548|2205326|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
1118663|NCT02563548|2205327|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
1118664|NCT02563548|2205328|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
1118665|NCT02563548|2205323|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
1118666|NCT02563548|2205324|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
1118667|NCT02563548|2205325|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
1118668|NCT02563548|2205326|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
1118669|NCT02563548|2205327|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
1118670|NCT02563548|2205328|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
1118671|NCT02563548|2205323|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
1118672|NCT02563548|2205324|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
1118673|NCT02563548|2205325|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
1118674|NCT02563548|2205326|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
1118675|NCT02563548|2205327|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
1118676|NCT02563548|2205328|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
1118677|NCT02563561|2205351|FG000|Overall Study|Histology Other than Ta, G1-G2|3
1118678|NCT02563561|2205352|FG001|Overall Study|Histology Other than Ta, G1-G2|6
1118679|NCT02563561|2205353|FG002|Overall Study|Histology Other than Ta, G1-G2|6
1118680|NCT02563561|2205351|FG000|Overall Study|Withdrew of Consent|1
1118681|NCT02563561|2205352|FG001|Overall Study|Withdrew of Consent|1
1118682|NCT02563561|2205353|FG002|Overall Study|Withdrew of Consent|2
1118683|NCT02563561|2205351|FG000|Overall Study|Lost to Follow-up|1
1118684|NCT02563561|2205352|FG001|Overall Study|Lost to Follow-up|1
1118685|NCT02563561|2205353|FG002|Overall Study|Lost to Follow-up|0
1118686|NCT02563561|2205351|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4
1118687|NCT02563561|2205352|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2
1118688|NCT02563561|2205353|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1
1118689|NCT02563561|2205351|FG000|Overall Study|Investigator Decision|3
1118690|NCT02563561|2205352|FG001|Overall Study|Investigator Decision|4
1118691|NCT02563561|2205353|FG002|Overall Study|Investigator Decision|2
1118692|NCT02563561|2205351|FG000|Overall Study|Sponsor Decision|5
1118693|NCT02563561|2205352|FG001|Overall Study|Sponsor Decision|2
1118694|NCT02563561|2205353|FG002|Overall Study|Sponsor Decision|4
1118695|NCT02563561|2205351|FG000|Overall Study|Other|1
1118696|NCT02563561|2205352|FG001|Overall Study|Other|5
1118697|NCT02563561|2205353|FG002|Overall Study|Other|2
1118698|NCT02563899|2205389|FG000|Overall Study|Protocol Violation|1
1118699|NCT02563899|2205390|FG001|Overall Study|Protocol Violation|0
1118700|NCT02563899|2205391|FG002|Overall Study|Protocol Violation|0
1118701|NCT02563899|2205392|FG003|Overall Study|Protocol Violation|0
1118702|NCT02563899|2205389|FG000|Overall Study|Withdrawal by Subject|0
1118703|NCT02563899|2205390|FG001|Overall Study|Withdrawal by Subject|0
1118704|NCT02563899|2205391|FG002|Overall Study|Withdrawal by Subject|1
1118705|NCT02563899|2205392|FG003|Overall Study|Withdrawal by Subject|0
1118706|NCT02564042|2205440|FG000|Overall Study|Adverse Event|4
1118707|NCT02564042|2205441|FG001|Overall Study|Adverse Event|4
1118708|NCT02564042|2205442|FG002|Overall Study|Adverse Event|3
1118709|NCT02564042|2205443|FG003|Overall Study|Adverse Event|0
1118710|NCT02564042|2205444|FG004|Overall Study|Adverse Event|0
1118711|NCT02564042|2205445|FG005|Overall Study|Adverse Event|1
1118712|NCT02564042|2205440|FG000|Overall Study|Lost to Follow-up|1
1118713|NCT02564042|2205441|FG001|Overall Study|Lost to Follow-up|1
1118714|NCT02564042|2205442|FG002|Overall Study|Lost to Follow-up|1
1118715|NCT02564042|2205443|FG003|Overall Study|Lost to Follow-up|0
1118716|NCT02564042|2205444|FG004|Overall Study|Lost to Follow-up|1
1118717|NCT02564042|2205445|FG005|Overall Study|Lost to Follow-up|1
1118718|NCT02564042|2205440|FG000|Overall Study|Physician Decision|1
1118719|NCT02564042|2205441|FG001|Overall Study|Physician Decision|0
1118720|NCT02564042|2205442|FG002|Overall Study|Physician Decision|0
1118721|NCT02564042|2205443|FG003|Overall Study|Physician Decision|1
1118722|NCT02564042|2205444|FG004|Overall Study|Physician Decision|0
1118723|NCT02564042|2205445|FG005|Overall Study|Physician Decision|0
1118724|NCT02564042|2205440|FG000|Overall Study|Withdrawal by Subject|5
1118725|NCT02564042|2205441|FG001|Overall Study|Withdrawal by Subject|3
1118726|NCT02564042|2205442|FG002|Overall Study|Withdrawal by Subject|2
1118727|NCT02564042|2205443|FG003|Overall Study|Withdrawal by Subject|2
1118728|NCT02564042|2205444|FG004|Overall Study|Withdrawal by Subject|10
1118729|NCT02564042|2205445|FG005|Overall Study|Withdrawal by Subject|12
1118730|NCT02564055|2205465|FG000|Overall Study|Adverse Event|1
1118731|NCT02564055|2205466|FG001|Overall Study|Adverse Event|0
1118732|NCT02564055|2205467|FG002|Overall Study|Adverse Event|4
1118733|NCT02564055|2205468|FG003|Overall Study|Adverse Event|1
1118734|NCT02564055|2205469|FG004|Overall Study|Adverse Event|4
1118735|NCT02564055|2205470|FG005|Overall Study|Adverse Event|1
1118736|NCT02564055|2205465|FG000|Overall Study|Protocol Violation|1
1118737|NCT02564055|2205466|FG001|Overall Study|Protocol Violation|0
1118738|NCT02564055|2205467|FG002|Overall Study|Protocol Violation|0
1118739|NCT02564055|2205468|FG003|Overall Study|Protocol Violation|0
1118740|NCT02564055|2205469|FG004|Overall Study|Protocol Violation|0
1118741|NCT02564055|2205470|FG005|Overall Study|Protocol Violation|0
1118742|NCT02564055|2205465|FG000|Overall Study|Reached stopping criteria|0
1118743|NCT02564055|2205466|FG001|Overall Study|Reached stopping criteria|0
1118744|NCT02564055|2205467|FG002|Overall Study|Reached stopping criteria|0
1118745|NCT02564055|2205468|FG003|Overall Study|Reached stopping criteria|0
1118746|NCT02564055|2205469|FG004|Overall Study|Reached stopping criteria|0
1118747|NCT02564055|2205470|FG005|Overall Study|Reached stopping criteria|1
1118748|NCT02564055|2205465|FG000|Overall Study|Lost to Follow-up|0
1118749|NCT02564055|2205466|FG001|Overall Study|Lost to Follow-up|1
1118750|NCT02564055|2205467|FG002|Overall Study|Lost to Follow-up|4
1118751|NCT02564055|2205468|FG003|Overall Study|Lost to Follow-up|2
1118752|NCT02564055|2205469|FG004|Overall Study|Lost to Follow-up|1
1118753|NCT02564055|2205470|FG005|Overall Study|Lost to Follow-up|0
1118754|NCT02564055|2205465|FG000|Overall Study|Physician Decision|0
1118755|NCT02564055|2205466|FG001|Overall Study|Physician Decision|0
1118756|NCT02564055|2205467|FG002|Overall Study|Physician Decision|1
1118757|NCT02564055|2205468|FG003|Overall Study|Physician Decision|0
1118758|NCT02564055|2205469|FG004|Overall Study|Physician Decision|0
1118759|NCT02564055|2205470|FG005|Overall Study|Physician Decision|0
1118760|NCT02564055|2205465|FG000|Overall Study|Withdrawal by Subject|4
1118761|NCT02564055|2205466|FG001|Overall Study|Withdrawal by Subject|4
1118762|NCT02564055|2205467|FG002|Overall Study|Withdrawal by Subject|3
1118763|NCT02564055|2205468|FG003|Overall Study|Withdrawal by Subject|3
1118764|NCT02564055|2205469|FG004|Overall Study|Withdrawal by Subject|10
1118765|NCT02564055|2205470|FG005|Overall Study|Withdrawal by Subject|10
1118766|NCT02564120|2205489|FG000|Overall Study|Did not return release forms|160
1118767|NCT02564120|2205489|FG000|Overall Study|Death|58
1118768|NCT02564120|2205489|FG000|Overall Study|Withdrawal by Subject|204
1118769|NCT02564120|2205489|FG000|Overall Study|Other medical condition|24
1118770|NCT02564198|2205506|FG000|Overall Study|Withdrawal by Subject|2
1118771|NCT02564198|2205507|FG001|Overall Study|Withdrawal by Subject|4
1118772|NCT02564198|2205508|FG002|Overall Study|Withdrawal by Subject|0
1118773|NCT02564198|2205506|FG000|Overall Study|Adverse Event|0
1118774|NCT02564198|2205507|FG001|Overall Study|Adverse Event|1
1118775|NCT02564198|2205508|FG002|Overall Study|Adverse Event|0
1118776|NCT02564211|2205518|FG000|Overall Study|Adverse Event|4
1118785|NCT02564471|2205550|FG000|Overall Study|Adverse Event|1
1118786|NCT02564471|2205551|FG001|Overall Study|Adverse Event|0
1118787|NCT02564471|2205552|FG002|Overall Study|Adverse Event|0
1118788|NCT02564471|2205553|FG003|Overall Study|Adverse Event|0
1118789|NCT02564471|2205550|FG000|Overall Study|Withdrawal by Subject|2
1118790|NCT02564471|2205551|FG001|Overall Study|Withdrawal by Subject|1
1118791|NCT02564471|2205552|FG002|Overall Study|Withdrawal by Subject|3
1118792|NCT02564471|2205553|FG003|Overall Study|Withdrawal by Subject|0
1118793|NCT02564471|2205550|FG000|Overall Study|Lost to Follow-up|0
1118794|NCT02564471|2205551|FG001|Overall Study|Lost to Follow-up|2
1118795|NCT02564471|2205552|FG002|Overall Study|Lost to Follow-up|0
1118796|NCT02564471|2205553|FG003|Overall Study|Lost to Follow-up|0
1118797|NCT02564718|2205574|FG000|Overall Study|Withdrew from treatment|0
1118798|NCT02564718|2205575|FG001|Overall Study|Withdrew from treatment|1
1118799|NCT02564887|2205583|FG000|Overall Study|Lost to Follow-up|6
1118800|NCT02564887|2205584|FG001|Overall Study|Lost to Follow-up|0
1118801|NCT02564900|2205607|FG000|Dose Escalation|Progressive disease per RECIST|2
1118802|NCT02564900|2205608|FG001|Dose Escalation|Progressive disease per RECIST|3
1118803|NCT02564900|2205609|FG002|Dose Escalation|Progressive disease per RECIST|3
1118804|NCT02564900|2205610|FG003|Dose Escalation|Progressive disease per RECIST|3
1118805|NCT02564900|2205611|FG004|Dose Escalation|Progressive disease per RECIST|3
1118806|NCT02564900|2205612|FG005|Dose Escalation|Progressive disease per RECIST|1
1118807|NCT02564900|2205613|FG006|Dose Escalation|Progressive disease per RECIST|0
1118808|NCT02564900|2205614|FG007|Dose Escalation|Progressive disease per RECIST|0
1118809|NCT02564900|2205615|FG008|Dose Escalation|Progressive disease per RECIST|0
1118810|NCT02564900|2205616|FG009|Dose Escalation|Progressive disease per RECIST|0
1118811|NCT02564900|2205617|FG010|Dose Escalation|Progressive disease per RECIST|0
1118812|NCT02564900|2205618|FG011|Dose Escalation|Progressive disease per RECIST|0
1118813|NCT02564900|2205619|FG012|Dose Escalation|Progressive disease per RECIST|0
1118814|NCT02564900|2205620|FG013|Dose Escalation|Progressive disease per RECIST|0
1118815|NCT02564900|2205621|FG014|Dose Escalation|Progressive disease per RECIST|0
1118816|NCT02564900|2205607|FG000|Dose Escalation|Ongoing|1
1118817|NCT02564900|2205608|FG001|Dose Escalation|Ongoing|0
1118818|NCT02564900|2205609|FG002|Dose Escalation|Ongoing|0
1118819|NCT02564900|2205610|FG003|Dose Escalation|Ongoing|2
1118820|NCT02564900|2205611|FG004|Dose Escalation|Ongoing|2
1118821|NCT02564900|2205612|FG005|Dose Escalation|Ongoing|2
1118822|NCT02564900|2205613|FG006|Dose Escalation|Ongoing|0
1118823|NCT02564900|2205614|FG007|Dose Escalation|Ongoing|0
1118824|NCT02564900|2205615|FG008|Dose Escalation|Ongoing|0
1118825|NCT02564900|2205616|FG009|Dose Escalation|Ongoing|0
1118826|NCT02564900|2205617|FG010|Dose Escalation|Ongoing|0
1118827|NCT02564900|2205618|FG011|Dose Escalation|Ongoing|0
1118828|NCT02564900|2205619|FG012|Dose Escalation|Ongoing|0
1118829|NCT02564900|2205620|FG013|Dose Escalation|Ongoing|0
898272|NCT00714493|1870655|FG000|Overall Study|Lost to Follow-up|3
898273|NCT00714493|1870655|FG000|Overall Study|Protocol Violation|12
898274|NCT00714493|1870655|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
898275|NCT00714493|1870655|FG000|Overall Study|OTHER|2
898276|NCT00714688|1870687|FG000|Overall Study|Lack of Efficacy|14
898277|NCT00714688|1870688|FG001|Overall Study|Lack of Efficacy|1
1118830|NCT02564900|2205621|FG014|Dose Escalation|Ongoing|0
1118831|NCT02564900|2205607|FG000|Dose Escalation|Adverse Event|0
1118832|NCT02564900|2205608|FG001|Dose Escalation|Adverse Event|0
1118833|NCT02564900|2205609|FG002|Dose Escalation|Adverse Event|0
1118834|NCT02564900|2205610|FG003|Dose Escalation|Adverse Event|1
1118835|NCT02564900|2205611|FG004|Dose Escalation|Adverse Event|1
1118836|NCT02564900|2205612|FG005|Dose Escalation|Adverse Event|3
1118837|NCT02564900|2205613|FG006|Dose Escalation|Adverse Event|0
1118838|NCT02564900|2205614|FG007|Dose Escalation|Adverse Event|0
1118839|NCT02564900|2205615|FG008|Dose Escalation|Adverse Event|0
1118840|NCT02564900|2205616|FG009|Dose Escalation|Adverse Event|0
1118841|NCT02564900|2205617|FG010|Dose Escalation|Adverse Event|0
1118842|NCT02564900|2205618|FG011|Dose Escalation|Adverse Event|0
1118843|NCT02564900|2205619|FG012|Dose Escalation|Adverse Event|0
1118844|NCT02564900|2205620|FG013|Dose Escalation|Adverse Event|0
1118845|NCT02564900|2205621|FG014|Dose Escalation|Adverse Event|0
1118846|NCT02564900|2205607|FG000|Dose Expansion|Progressive disease per RECIST|0
1118847|NCT02564900|2205608|FG001|Dose Expansion|Progressive disease per RECIST|0
1118848|NCT02564900|2205609|FG002|Dose Expansion|Progressive disease per RECIST|0
1118849|NCT02564900|2205610|FG003|Dose Expansion|Progressive disease per RECIST|0
1118850|NCT02564900|2205611|FG004|Dose Expansion|Progressive disease per RECIST|0
1118851|NCT02564900|2205612|FG005|Dose Expansion|Progressive disease per RECIST|0
1118852|NCT02564900|2205613|FG006|Dose Expansion|Progressive disease per RECIST|19
1118853|NCT02564900|2205614|FG007|Dose Expansion|Progressive disease per RECIST|17
1118854|NCT02564900|2205615|FG008|Dose Expansion|Progressive disease per RECIST|8
1118855|NCT02564900|2205616|FG009|Dose Expansion|Progressive disease per RECIST|16
1118856|NCT02564900|2205617|FG010|Dose Expansion|Progressive disease per RECIST|13
1118857|NCT02564900|2205618|FG011|Dose Expansion|Progressive disease per RECIST|19
1118858|NCT02564900|2205619|FG012|Dose Expansion|Progressive disease per RECIST|10
1118859|NCT02564900|2205620|FG013|Dose Expansion|Progressive disease per RECIST|13
1118860|NCT02564900|2205621|FG014|Dose Expansion|Progressive disease per RECIST|11
1118861|NCT02564900|2205607|FG000|Dose Expansion|Clinical progression|0
1118862|NCT02564900|2205608|FG001|Dose Expansion|Clinical progression|0
1118863|NCT02564900|2205609|FG002|Dose Expansion|Clinical progression|0
1118864|NCT02564900|2205610|FG003|Dose Expansion|Clinical progression|0
1118865|NCT02564900|2205611|FG004|Dose Expansion|Clinical progression|0
1118866|NCT02564900|2205612|FG005|Dose Expansion|Clinical progression|0
1118867|NCT02564900|2205613|FG006|Dose Expansion|Clinical progression|5
1118868|NCT02564900|2205614|FG007|Dose Expansion|Clinical progression|12
1118869|NCT02564900|2205615|FG008|Dose Expansion|Clinical progression|0
1118870|NCT02564900|2205616|FG009|Dose Expansion|Clinical progression|3
1118871|NCT02564900|2205617|FG010|Dose Expansion|Clinical progression|2
1118872|NCT02564900|2205618|FG011|Dose Expansion|Clinical progression|0
1118873|NCT02564900|2205619|FG012|Dose Expansion|Clinical progression|1
1118874|NCT02564900|2205620|FG013|Dose Expansion|Clinical progression|3
1118875|NCT02564900|2205621|FG014|Dose Expansion|Clinical progression|1
1118876|NCT02564900|2205607|FG000|Dose Expansion|Adverse Event|0
1118877|NCT02564900|2205608|FG001|Dose Expansion|Adverse Event|0
1118878|NCT02564900|2205609|FG002|Dose Expansion|Adverse Event|0
1118879|NCT02564900|2205610|FG003|Dose Expansion|Adverse Event|0
1118880|NCT02564900|2205611|FG004|Dose Expansion|Adverse Event|0
1118881|NCT02564900|2205612|FG005|Dose Expansion|Adverse Event|0
1118882|NCT02564900|2205613|FG006|Dose Expansion|Adverse Event|9
1118883|NCT02564900|2205614|FG007|Dose Expansion|Adverse Event|22
1118884|NCT02564900|2205615|FG008|Dose Expansion|Adverse Event|0
1118885|NCT02564900|2205616|FG009|Dose Expansion|Adverse Event|11
1118886|NCT02564900|2205617|FG010|Dose Expansion|Adverse Event|0
1118887|NCT02564900|2205618|FG011|Dose Expansion|Adverse Event|5
1118888|NCT02564900|2205619|FG012|Dose Expansion|Adverse Event|2
1118889|NCT02564900|2205620|FG013|Dose Expansion|Adverse Event|2
1118890|NCT02564900|2205621|FG014|Dose Expansion|Adverse Event|1
1118891|NCT02564900|2205607|FG000|Dose Expansion|Ongoing|0
1118892|NCT02564900|2205608|FG001|Dose Expansion|Ongoing|0
1118893|NCT02564900|2205609|FG002|Dose Expansion|Ongoing|0
1118894|NCT02564900|2205610|FG003|Dose Expansion|Ongoing|0
1118895|NCT02564900|2205611|FG004|Dose Expansion|Ongoing|0
1118896|NCT02564900|2205612|FG005|Dose Expansion|Ongoing|0
1118897|NCT02564900|2205613|FG006|Dose Expansion|Ongoing|9
1118898|NCT02564900|2205614|FG007|Dose Expansion|Ongoing|10
1118899|NCT02564900|2205615|FG008|Dose Expansion|Ongoing|11
1118900|NCT02564900|2205616|FG009|Dose Expansion|Ongoing|3
1118901|NCT02564900|2205617|FG010|Dose Expansion|Ongoing|0
1118902|NCT02564900|2205618|FG011|Dose Expansion|Ongoing|0
1118903|NCT02564900|2205619|FG012|Dose Expansion|Ongoing|4
1118904|NCT02564900|2205620|FG013|Dose Expansion|Ongoing|0
1118905|NCT02564900|2205621|FG014|Dose Expansion|Ongoing|6
1118906|NCT02564900|2205607|FG000|Dose Expansion|Death|0
1118907|NCT02564900|2205608|FG001|Dose Expansion|Death|0
1118908|NCT02564900|2205609|FG002|Dose Expansion|Death|0
1118909|NCT02564900|2205610|FG003|Dose Expansion|Death|0
1118910|NCT02564900|2205611|FG004|Dose Expansion|Death|0
1118911|NCT02564900|2205612|FG005|Dose Expansion|Death|0
1118912|NCT02564900|2205613|FG006|Dose Expansion|Death|1
1118913|NCT02564900|2205614|FG007|Dose Expansion|Death|0
1118914|NCT02564900|2205615|FG008|Dose Expansion|Death|0
1118915|NCT02564900|2205616|FG009|Dose Expansion|Death|0
1118916|NCT02564900|2205617|FG010|Dose Expansion|Death|1
1118917|NCT02564900|2205618|FG011|Dose Expansion|Death|0
1118918|NCT02564900|2205619|FG012|Dose Expansion|Death|1
1118919|NCT02564900|2205620|FG013|Dose Expansion|Death|1
1118920|NCT02564900|2205621|FG014|Dose Expansion|Death|0
1118921|NCT02564900|2205607|FG000|Dose Expansion|Withdrawal by Subject|0
1118922|NCT02564900|2205608|FG001|Dose Expansion|Withdrawal by Subject|0
898278|NCT00714688|1870689|FG002|Overall Study|Lack of Efficacy|4
898279|NCT00714688|1870687|FG000|Overall Study|Withdrawal by Subject|4
898280|NCT00714688|1870688|FG001|Overall Study|Withdrawal by Subject|3
898281|NCT00714688|1870689|FG002|Overall Study|Withdrawal by Subject|3
898282|NCT00714688|1870687|FG000|Overall Study|Lost to Follow-up|5
898283|NCT00714688|1870688|FG001|Overall Study|Lost to Follow-up|2
898284|NCT00714688|1870689|FG002|Overall Study|Lost to Follow-up|0
898285|NCT00714688|1870687|FG000|Overall Study|Adverse Event|2
898286|NCT00714688|1870688|FG001|Overall Study|Adverse Event|15
898287|NCT00714688|1870689|FG002|Overall Study|Adverse Event|19
898288|NCT00714688|1870687|FG000|Overall Study|Subject Non-compliant|3
898289|NCT00714688|1870688|FG001|Overall Study|Subject Non-compliant|5
898290|NCT00714688|1870689|FG002|Overall Study|Subject Non-compliant|5
898291|NCT00714688|1870687|FG000|Overall Study|Ineligible to Continue the Study|0
898292|NCT00714688|1870688|FG001|Overall Study|Ineligible to Continue the Study|1
898293|NCT00714688|1870689|FG002|Overall Study|Ineligible to Continue the Study|1
898294|NCT00714688|1870687|FG000|Overall Study|Sponsor's Decision|0
898295|NCT00714688|1870688|FG001|Overall Study|Sponsor's Decision|2
898296|NCT00714688|1870689|FG002|Overall Study|Sponsor's Decision|0
898297|NCT00714688|1870687|FG000|Overall Study|Other|1
898298|NCT00714688|1870688|FG001|Overall Study|Other|6
898299|NCT00714688|1870689|FG002|Overall Study|Other|5
898300|NCT00714714|1870697|FG000|Overall Study|Adverse Event|1
898301|NCT00714870|1870718|FG000|Overall Study|Lost to Follow-up|22
898302|NCT00714870|1870719|FG001|Overall Study|Lost to Follow-up|5
898303|NCT00714870|1870718|FG000|Overall Study|patient unable to come b/c back pain|1
898304|NCT00714870|1870719|FG001|Overall Study|patient unable to come b/c back pain|0
898305|NCT00714870|1870718|FG000|Overall Study|did not attend minimum of 4 sessions|4
898306|NCT00714870|1870719|FG001|Overall Study|did not attend minimum of 4 sessions|0
898307|NCT00715026|1870725|FG000|Overall Study|Withdrawal by Subject|5
898308|NCT00715026|1870725|FG000|Overall Study|Lost to Follow-up|3
898309|NCT00715026|1870725|FG000|Overall Study|Protocol Violation|1
898310|NCT00715026|1870725|FG000|Overall Study|Surgery done on non-study consented hip|1
898311|NCT00715078|1870732|FG000|Overall Study|Death|29
898312|NCT00715078|1870733|FG001|Overall Study|Death|36
898313|NCT00715078|1870734|FG002|Overall Study|Death|36
1118923|NCT02564900|2205609|FG002|Dose Expansion|Withdrawal by Subject|0
1118924|NCT02564900|2205610|FG003|Dose Expansion|Withdrawal by Subject|0
1118925|NCT02564900|2205611|FG004|Dose Expansion|Withdrawal by Subject|0
1118926|NCT02564900|2205612|FG005|Dose Expansion|Withdrawal by Subject|0
1118927|NCT02564900|2205613|FG006|Dose Expansion|Withdrawal by Subject|4
1118928|NCT02564900|2205614|FG007|Dose Expansion|Withdrawal by Subject|0
1118929|NCT02564900|2205615|FG008|Dose Expansion|Withdrawal by Subject|0
1118930|NCT02564900|2205616|FG009|Dose Expansion|Withdrawal by Subject|0
1118931|NCT02564900|2205617|FG010|Dose Expansion|Withdrawal by Subject|1
1118932|NCT02564900|2205618|FG011|Dose Expansion|Withdrawal by Subject|0
1118933|NCT02564900|2205619|FG012|Dose Expansion|Withdrawal by Subject|0
1118934|NCT02564900|2205620|FG013|Dose Expansion|Withdrawal by Subject|1
1118935|NCT02564900|2205621|FG014|Dose Expansion|Withdrawal by Subject|1
1118936|NCT02564900|2205607|FG000|Dose Expansion|Other|0
1118937|NCT02564900|2205608|FG001|Dose Expansion|Other|0
1118938|NCT02564900|2205609|FG002|Dose Expansion|Other|0
1118939|NCT02564900|2205610|FG003|Dose Expansion|Other|0
1118940|NCT02564900|2205611|FG004|Dose Expansion|Other|0
898314|NCT00715078|1870732|FG000|Overall Study|Withdrawal by Subject|1
898315|NCT00715078|1870733|FG001|Overall Study|Withdrawal by Subject|0
898316|NCT00715078|1870734|FG002|Overall Study|Withdrawal by Subject|1
898317|NCT00715078|1870732|FG000|Overall Study|Unable to start due to disease prog.|0
898318|NCT00715078|1870733|FG001|Overall Study|Unable to start due to disease prog.|0
1118941|NCT02564900|2205612|FG005|Dose Expansion|Other|0
1118942|NCT02564900|2205613|FG006|Dose Expansion|Other|1
1118943|NCT02564900|2205614|FG007|Dose Expansion|Other|0
1118944|NCT02564900|2205615|FG008|Dose Expansion|Other|1
1118945|NCT02564900|2205616|FG009|Dose Expansion|Other|0
1118946|NCT02564900|2205617|FG010|Dose Expansion|Other|0
1118947|NCT02564900|2205618|FG011|Dose Expansion|Other|0
1118948|NCT02564900|2205619|FG012|Dose Expansion|Other|0
1118949|NCT02564900|2205620|FG013|Dose Expansion|Other|0
1118950|NCT02564900|2205621|FG014|Dose Expansion|Other|1
1118951|NCT02564900|2205607|FG000|Dose Expansion|Did not receive treatment|0
1118952|NCT02564900|2205608|FG001|Dose Expansion|Did not receive treatment|0
1118953|NCT02564900|2205609|FG002|Dose Expansion|Did not receive treatment|0
1118954|NCT02564900|2205610|FG003|Dose Expansion|Did not receive treatment|0
1118955|NCT02564900|2205611|FG004|Dose Expansion|Did not receive treatment|0
1118956|NCT02564900|2205612|FG005|Dose Expansion|Did not receive treatment|0
1118957|NCT02564900|2205613|FG006|Dose Expansion|Did not receive treatment|1
1118958|NCT02564900|2205614|FG007|Dose Expansion|Did not receive treatment|1
1118959|NCT02564900|2205615|FG008|Dose Expansion|Did not receive treatment|0
1118960|NCT02564900|2205616|FG009|Dose Expansion|Did not receive treatment|0
1118961|NCT02564900|2205617|FG010|Dose Expansion|Did not receive treatment|0
1118962|NCT02564900|2205618|FG011|Dose Expansion|Did not receive treatment|0
1118963|NCT02564900|2205619|FG012|Dose Expansion|Did not receive treatment|0
1118964|NCT02564900|2205620|FG013|Dose Expansion|Did not receive treatment|0
1118965|NCT02564900|2205621|FG014|Dose Expansion|Did not receive treatment|1
1118966|NCT02564952|2205671|FG000|Overall Study|Adverse Event|6
1118967|NCT02564952|2205671|FG000|Overall Study|Lost to Follow-up|1
1118968|NCT02564952|2205671|FG000|Overall Study|Participant Withdrawn by Investigator|1
1118969|NCT02564952|2205671|FG000|Overall Study|Withdrawal by Subject|1
1118970|NCT02564952|2205671|FG000|Overall Study|Low Efficacy|1
1118971|NCT02564952|2205671|FG000|Overall Study|Participant Met Withdrawal Criteria|1
1118972|NCT02565108|2205677|FG000|Overall Study|Adverse Event|1
1118973|NCT02565108|2205678|FG001|Overall Study|Adverse Event|0
1118974|NCT02565108|2205677|FG000|Overall Study|Withdrew Consent|1
1118975|NCT02565108|2205678|FG001|Overall Study|Withdrew Consent|0
1118976|NCT02565147|2205686|FG000|Overall Study|Withdrawal by Subject|5
1118977|NCT02565147|2205687|FG001|Overall Study|Withdrawal by Subject|1
1118978|NCT02565147|2205686|FG000|Overall Study|Lost to Follow-up|0
1118979|NCT02565147|2205687|FG001|Overall Study|Lost to Follow-up|1
1118980|NCT02565147|2205686|FG000|Overall Study|Death|1
1118981|NCT02565147|2205687|FG001|Overall Study|Death|1
1118982|NCT02565186|2205695|FG000|Overall Study|Adverse Event|113
1118983|NCT02565186|2205696|FG001|Overall Study|Adverse Event|148
1118984|NCT02565186|2205695|FG000|Overall Study|Lost to Follow-up|102
1118985|NCT02565186|2205696|FG001|Overall Study|Lost to Follow-up|93
1118986|NCT02565186|2205695|FG000|Overall Study|Non-Compliance|57
1118987|NCT02565186|2205696|FG001|Overall Study|Non-Compliance|55
1118988|NCT02565186|2205695|FG000|Overall Study|Withdrawal by Subject|229
1118989|NCT02565186|2205696|FG001|Overall Study|Withdrawal by Subject|214
1118990|NCT02565186|2205695|FG000|Overall Study|Physician Decision|18
1118991|NCT02565186|2205696|FG001|Overall Study|Physician Decision|16
1118992|NCT02565186|2205695|FG000|Overall Study|Sponsor Request|5
1118993|NCT02565186|2205696|FG001|Overall Study|Sponsor Request|9
1118994|NCT02565186|2205695|FG000|Overall Study|Missing|1
1118995|NCT02565186|2205696|FG001|Overall Study|Missing|0
1118996|NCT02565186|2205695|FG000|Overall Study|Did Not Receive Study Drug|55
1118997|NCT02565186|2205696|FG001|Overall Study|Did Not Receive Study Drug|86
1118998|NCT02565381|2205705|FG000|Overall Study|Lost to Follow-up|1
1118999|NCT02565381|2205706|FG001|Overall Study|Lost to Follow-up|0
1119000|NCT02565381|2205707|FG002|Overall Study|Lost to Follow-up|1
1119001|NCT02565511|2205728|FG000|Overall Study|Study terminated by Sponsor|35
1119002|NCT02565511|2205729|FG001|Overall Study|Study terminated by Sponsor|22
1119003|NCT02565511|2205730|FG002|Overall Study|Study terminated by Sponsor|235
1119004|NCT02565511|2205731|FG003|Overall Study|Study terminated by Sponsor|156
1119005|NCT02565511|2205728|FG000|Overall Study|Withdrawal by Subject|3
1119006|NCT02565511|2205729|FG001|Overall Study|Withdrawal by Subject|0
1119007|NCT02565511|2205730|FG002|Overall Study|Withdrawal by Subject|12
1119008|NCT02565511|2205731|FG003|Overall Study|Withdrawal by Subject|5
1119009|NCT02565511|2205728|FG000|Overall Study|Adverse Event|0
1119010|NCT02565511|2205729|FG001|Overall Study|Adverse Event|0
1119011|NCT02565511|2205730|FG002|Overall Study|Adverse Event|1
1119012|NCT02565511|2205731|FG003|Overall Study|Adverse Event|1
1119013|NCT02565511|2205728|FG000|Overall Study|Lost to Follow-up|4
1119014|NCT02565511|2205729|FG001|Overall Study|Lost to Follow-up|1
1119015|NCT02565511|2205730|FG002|Overall Study|Lost to Follow-up|0
1119016|NCT02565511|2205731|FG003|Overall Study|Lost to Follow-up|1
1119017|NCT02565511|2205728|FG000|Overall Study|Physician Decision|0
1119018|NCT02565511|2205729|FG001|Overall Study|Physician Decision|0
1119019|NCT02565511|2205730|FG002|Overall Study|Physician Decision|0
1119020|NCT02565511|2205731|FG003|Overall Study|Physician Decision|1
1119021|NCT02565511|2205728|FG000|Overall Study|Protocol deviation|0
1119022|NCT02565511|2205729|FG001|Overall Study|Protocol deviation|0
1119023|NCT02565511|2205730|FG002|Overall Study|Protocol deviation|3
1119024|NCT02565511|2205731|FG003|Overall Study|Protocol deviation|0
1119025|NCT02565576|2205743|FG000|Overall Study|abnormal lab value|2
1119026|NCT02565576|2205744|FG001|Overall Study|abnormal lab value|0
1119027|NCT02565576|2205743|FG000|Overall Study|subject / guardian decision|1
1119028|NCT02565576|2205744|FG001|Overall Study|subject / guardian decision|3
1119029|NCT02565576|2205743|FG000|Overall Study|Lost to Follow-up|1
1119030|NCT02565576|2205744|FG001|Overall Study|Lost to Follow-up|0
1119031|NCT02565576|2205743|FG000|Overall Study|Death|0
1119032|NCT02565576|2205744|FG001|Overall Study|Death|2
1119033|NCT02565576|2205743|FG000|Overall Study|Adverse Event|1
1119034|NCT02565576|2205744|FG001|Overall Study|Adverse Event|0
1119035|NCT02565615|2205755|FG000|Overall Study|Death|0
1119036|NCT02565615|2205756|FG001|Overall Study|Death|1
1119037|NCT02565615|2205757|FG002|Overall Study|Death|0
1119038|NCT02565615|2205758|FG003|Overall Study|Death|0
1119039|NCT02565615|2205759|FG004|Overall Study|Death|4
1119040|NCT02565615|2205755|FG000|Overall Study|Not willing to participate in study|2
1119041|NCT02565615|2205756|FG001|Overall Study|Not willing to participate in study|21
1119042|NCT02565615|2205757|FG002|Overall Study|Not willing to participate in study|0
1119043|NCT02565615|2205758|FG003|Overall Study|Not willing to participate in study|1
1119044|NCT02565615|2205759|FG004|Overall Study|Not willing to participate in study|169
1119045|NCT02565615|2205755|FG000|Overall Study|Lost to Follow-up|0
1119046|NCT02565615|2205756|FG001|Overall Study|Lost to Follow-up|4
1119047|NCT02565615|2205757|FG002|Overall Study|Lost to Follow-up|0
1119048|NCT02565615|2205758|FG003|Overall Study|Lost to Follow-up|1
1119049|NCT02565615|2205759|FG004|Overall Study|Lost to Follow-up|765
1119050|NCT02565615|2205755|FG000|Overall Study|Not meeting eligibility criteria|0
1119051|NCT02565615|2205756|FG001|Overall Study|Not meeting eligibility criteria|7
1119052|NCT02565615|2205757|FG002|Overall Study|Not meeting eligibility criteria|0
1119053|NCT02565615|2205758|FG003|Overall Study|Not meeting eligibility criteria|0
1119054|NCT02565615|2205759|FG004|Overall Study|Not meeting eligibility criteria|25
1119055|NCT02565615|2205755|FG000|Overall Study|Reason not defined|0
1119056|NCT02565615|2205756|FG001|Overall Study|Reason not defined|2
1119057|NCT02565615|2205757|FG002|Overall Study|Reason not defined|0
1119058|NCT02565615|2205758|FG003|Overall Study|Reason not defined|1
1119059|NCT02565615|2205759|FG004|Overall Study|Reason not defined|62
1119060|NCT02565615|2205755|FG000|Overall Study|Adverse Event|1
1119061|NCT02565615|2205756|FG001|Overall Study|Adverse Event|1
1119062|NCT02565615|2205757|FG002|Overall Study|Adverse Event|0
1119063|NCT02565615|2205758|FG003|Overall Study|Adverse Event|0
1119064|NCT02565615|2205759|FG004|Overall Study|Adverse Event|9
1119065|NCT02565615|2205755|FG000|Overall Study|Untreated|0
1119066|NCT02565615|2205756|FG001|Overall Study|Untreated|0
1119067|NCT02565615|2205757|FG002|Overall Study|Untreated|0
1119068|NCT02565615|2205758|FG003|Overall Study|Untreated|0
1119069|NCT02565615|2205759|FG004|Overall Study|Untreated|567
1119070|NCT02565706|2205784|FG000|Overall Study|Withdrawal by Subject|5
1119071|NCT02565706|2205785|FG001|Overall Study|Withdrawal by Subject|7
1119072|NCT02565706|2205786|FG002|Overall Study|Withdrawal by Subject|7
1119073|NCT02565706|2205787|FG003|Overall Study|Withdrawal by Subject|11
1119074|NCT02565706|2205784|FG000|Overall Study|Lost to Follow-up|72
1119075|NCT02565706|2205785|FG001|Overall Study|Lost to Follow-up|75
1119076|NCT02565706|2205786|FG002|Overall Study|Lost to Follow-up|82
1119077|NCT02565706|2205787|FG003|Overall Study|Lost to Follow-up|74
1119078|NCT02565784|2205802|FG000|First Treatment|Adverse Event|1
1119079|NCT02565784|2205802|FG000|First Treatment|Withdrawal by Subject|1
1119080|NCT02565784|2205802|FG000|Second Treatment|Withdrawal by Subject|2
1119081|NCT02565810|2205810|FG000|Overall Study|Withdrawal by Subject|1
1119082|NCT02565914|2205833|FG000|Overall Study|Adverse Event|17
1119083|NCT02565914|2205833|FG000|Overall Study|Withdrawal of consent (not due to AE)|25
1119084|NCT02565914|2205833|FG000|Overall Study|Lost to Follow-up|12
1119085|NCT02565914|2205833|FG000|Overall Study|Death (not treatment emergent)|1
1119086|NCT02565914|2205833|FG000|Overall Study|Other noncompliance|6
1119087|NCT02565914|2205833|FG000|Overall Study|Physician Decision|6
1119088|NCT02565914|2205833|FG000|Overall Study|Parent study termination by sponsor|1
1119089|NCT02565914|2205833|FG000|Overall Study|Commercial drug available|5
1119090|NCT02565914|2205833|FG000|Overall Study|Other|18
1119091|NCT02565914|2205833|FG000|Overall Study|Enrolled, but did not receive study drug|2
1119092|NCT02566005|2205847|FG000|Overall Study|vaginal bleeding|0
1119093|NCT02566005|2205848|FG001|Overall Study|vaginal bleeding|1
1119094|NCT02566005|2205847|FG000|Overall Study|received foley|8
1119095|NCT02566005|2205848|FG001|Overall Study|received foley|0
1119096|NCT02566005|2205847|FG000|Overall Study|did not receive foley|0
1119097|NCT02566005|2205848|FG001|Overall Study|did not receive foley|1
1119098|NCT02566005|2205847|FG000|Overall Study|labor after randomization|0
1119099|NCT02566005|2205848|FG001|Overall Study|labor after randomization|4
1119100|NCT02566031|2205856|FG000|Overall Study|Patient/guardian decision|14
1119101|NCT02566031|2205857|FG001|Overall Study|Patient/guardian decision|7
1119102|NCT02566031|2205856|FG000|Overall Study|Protocol deviation|2
1119103|NCT02566031|2205857|FG001|Overall Study|Protocol deviation|3
1119104|NCT02566031|2205856|FG000|Overall Study|Adverse Event|3
1119105|NCT02566031|2205857|FG001|Overall Study|Adverse Event|1
1119106|NCT02566031|2205856|FG000|Overall Study|Lost to Follow-up|1
1119107|NCT02566031|2205857|FG001|Overall Study|Lost to Follow-up|1
1119108|NCT02566109|2205891|FG000|Overall Study|Withdrawal by Subject|1
1119109|NCT02566525|2205942|FG000|Overall Study|Protocol Violation|3
1119110|NCT02566525|2205943|FG001|Overall Study|Protocol Violation|5
1119111|NCT02566577|2205953|FG000|Overall Study|Withdrawal by Subject|1
1119112|NCT02566577|2205954|FG001|Overall Study|Withdrawal by Subject|1
1119113|NCT02566577|2205953|FG000|Overall Study|Equipment failure|1
1119114|NCT02566577|2205954|FG001|Overall Study|Equipment failure|1
1119115|NCT02566577|2205953|FG000|Overall Study|Physical limitation|1
1119116|NCT02566577|2205954|FG001|Overall Study|Physical limitation|0
1119117|NCT02566759|2205988|FG000|All Parts|Withdrawal by Subject|0
1119118|NCT02566759|2205989|FG001|All Parts|Withdrawal by Subject|1
1119119|NCT02566759|2205990|FG002|All Parts|Withdrawal by Subject|0
1119120|NCT02566759|2205991|FG003|All Parts|Withdrawal by Subject|0
1119121|NCT02566759|2205992|FG004|All Parts|Withdrawal by Subject|0
1119122|NCT02566759|2205993|FG005|All Parts|Withdrawal by Subject|0
1119123|NCT02566759|2205994|FG006|All Parts|Withdrawal by Subject|0
1119124|NCT02566759|2205995|FG007|All Parts|Withdrawal by Subject|0
1119125|NCT02566759|2205996|FG008|All Parts|Withdrawal by Subject|0
1119126|NCT02566759|2205997|FG009|All Parts|Withdrawal by Subject|0
1119127|NCT02566759|2205998|FG010|All Parts|Withdrawal by Subject|0
1119128|NCT02566759|2205999|FG011|All Parts|Withdrawal by Subject|0
1119129|NCT02566759|2206000|FG012|All Parts|Withdrawal by Subject|0
1119130|NCT02566759|2206001|FG013|All Parts|Withdrawal by Subject|0
1119131|NCT02566759|2206002|FG014|All Parts|Withdrawal by Subject|0
1119132|NCT02566759|2206003|FG015|All Parts|Withdrawal by Subject|0
1119133|NCT02566759|2206004|FG016|All Parts|Withdrawal by Subject|0
1119134|NCT02566759|2205988|FG000|All Parts|Adverse Event|0
1119135|NCT02566759|2205989|FG001|All Parts|Adverse Event|0
1119136|NCT02566759|2205990|FG002|All Parts|Adverse Event|0
1119137|NCT02566759|2205991|FG003|All Parts|Adverse Event|0
1119138|NCT02566759|2205992|FG004|All Parts|Adverse Event|0
1119139|NCT02566759|2205993|FG005|All Parts|Adverse Event|0
1119140|NCT02566759|2205994|FG006|All Parts|Adverse Event|0
1119141|NCT02566759|2205995|FG007|All Parts|Adverse Event|0
1119142|NCT02566759|2205996|FG008|All Parts|Adverse Event|0
1119143|NCT02566759|2205997|FG009|All Parts|Adverse Event|0
1119144|NCT02566759|2205998|FG010|All Parts|Adverse Event|0
1119145|NCT02566759|2205999|FG011|All Parts|Adverse Event|0
1119146|NCT02566759|2206000|FG012|All Parts|Adverse Event|1
1119147|NCT02566759|2206001|FG013|All Parts|Adverse Event|3
1119148|NCT02566759|2206002|FG014|All Parts|Adverse Event|0
1119149|NCT02566759|2206003|FG015|All Parts|Adverse Event|0
1119150|NCT02566759|2206004|FG016|All Parts|Adverse Event|0
1119151|NCT02566759|2205988|FG000|All Parts|Other|0
1119152|NCT02566759|2205989|FG001|All Parts|Other|0
1119153|NCT02566759|2205990|FG002|All Parts|Other|0
1119154|NCT02566759|2205991|FG003|All Parts|Other|0
1119155|NCT02566759|2205992|FG004|All Parts|Other|0
1119156|NCT02566759|2205993|FG005|All Parts|Other|0
1119157|NCT02566759|2205994|FG006|All Parts|Other|0
1119158|NCT02566759|2205995|FG007|All Parts|Other|0
1119159|NCT02566759|2205996|FG008|All Parts|Other|0
1119160|NCT02566759|2205997|FG009|All Parts|Other|0
1119161|NCT02566759|2205998|FG010|All Parts|Other|0
1119162|NCT02566759|2205999|FG011|All Parts|Other|0
1119163|NCT02566759|2206000|FG012|All Parts|Other|0
1119164|NCT02566759|2206001|FG013|All Parts|Other|2
1119165|NCT02566759|2206002|FG014|All Parts|Other|0
1119166|NCT02566759|2206003|FG015|All Parts|Other|0
1119167|NCT02566759|2206004|FG016|All Parts|Other|0
1119168|NCT02566759|2205988|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119169|NCT02566759|2205989|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119170|NCT02566759|2205990|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119171|NCT02566759|2205991|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119172|NCT02566759|2205992|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119173|NCT02566759|2205993|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119174|NCT02566759|2205994|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119175|NCT02566759|2205995|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119176|NCT02566759|2205996|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119177|NCT02566759|2205997|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119178|NCT02566759|2205998|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119179|NCT02566759|2205999|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119180|NCT02566759|2206000|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119181|NCT02566759|2206001|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119182|NCT02566759|2206002|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119183|NCT02566759|2206003|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1119184|NCT02566759|2206004|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
1119185|NCT02566785|2206065|FG000|Overall Study|Lost to Follow-up|0
1119186|NCT02566785|2206066|FG001|Overall Study|Lost to Follow-up|2
1119187|NCT02566785|2206065|FG000|Overall Study|Worsening condition|1
1119188|NCT02566785|2206066|FG001|Overall Study|Worsening condition|1
1119189|NCT02566902|2206082|FG000|Overall Study|Protocol Violation|2
1119190|NCT02566902|2206083|FG001|Overall Study|Protocol Violation|1
1119191|NCT02566993|2206091|FG000|Overall Study|Randomized but not treated|5
1119192|NCT02566993|2206092|FG001|Overall Study|Randomized but not treated|16
1119193|NCT02566993|2206091|FG000|Overall Study|Progressive disease|213
1119194|NCT02566993|2206092|FG001|Overall Study|Progressive disease|152
1119195|NCT02566993|2206091|FG000|Overall Study|Withdrawal by Subject|12
1119196|NCT02566993|2206092|FG001|Overall Study|Withdrawal by Subject|28
1119197|NCT02566993|2206091|FG000|Overall Study|Death|17
1119198|NCT02566993|2206092|FG001|Overall Study|Death|23
1119199|NCT02566993|2206091|FG000|Overall Study|Physician Decision|10
1119200|NCT02566993|2206092|FG001|Overall Study|Physician Decision|17
1119201|NCT02566993|2206091|FG000|Overall Study|Study drug-related adverse event|20
1119202|NCT02566993|2206092|FG001|Overall Study|Study drug-related adverse event|41
1119203|NCT02566993|2206091|FG000|Overall Study|Non study drug-related adverse event|9
1119204|NCT02566993|2206092|FG001|Overall Study|Non study drug-related adverse event|9
1119205|NCT02566993|2206091|FG000|Overall Study|Symptomatic deterioration|9
1119206|NCT02566993|2206092|FG001|Overall Study|Symptomatic deterioration|16
1119207|NCT02566993|2206091|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9
1119208|NCT02566993|2206092|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1
1119209|NCT02566993|2206091|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1
1119210|NCT02566993|2206092|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1
1119211|NCT02566993|2206091|FG000|Overall Study|Screening failure|2
1119212|NCT02566993|2206092|FG001|Overall Study|Screening failure|0
1119213|NCT02566993|2206091|FG000|Overall Study|Lost to Follow-up|0
1119214|NCT02566993|2206092|FG001|Overall Study|Lost to Follow-up|1
1119215|NCT02566993|2206091|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0
1119216|NCT02566993|2206092|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1
1119217|NCT02567188|2206100|FG000|Overall Study|Death|10
1119218|NCT02567188|2206100|FG000|Overall Study|Terminated Mircera Treatment|9
1119219|NCT02567188|2206100|FG000|Overall Study|Lost to Follow-up|5
1119220|NCT02567188|2206100|FG000|Overall Study|Adverse Event|1
1119221|NCT02567188|2206100|FG000|Overall Study|Withdrawal by Subject|1
1119222|NCT02567188|2206100|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1
1119223|NCT02567188|2206100|FG000|Overall Study|Moved and Changed Clinic|1
1119224|NCT02567188|2206100|FG000|Overall Study|Started Hemodialysis|2
1119225|NCT02567188|2206100|FG000|Overall Study|Protocol Violation|5
1119226|NCT02567227|2206107|FG000|9 Weeks|Adverse Event|5
1119227|NCT02567227|2206108|FG001|9 Weeks|Adverse Event|5
1119228|NCT02567227|2206107|FG000|9 Weeks|Withdrawal by Subject|18
1119229|NCT02567227|2206108|FG001|9 Weeks|Withdrawal by Subject|8
1119230|NCT02567227|2206107|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11
1119231|NCT02567227|2206108|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11
1119232|NCT02567227|2206107|FG000|6 Month|Death|2
1119233|NCT02567227|2206108|FG001|6 Month|Death|0
1119234|NCT02567227|2206107|FG000|6 Month|Lost to Follow-up|43
1119235|NCT02567227|2206108|FG001|6 Month|Lost to Follow-up|40
1119236|NCT02567227|2206107|FG000|12 Months|Lost to Follow-up|31
1119237|NCT02567227|2206108|FG001|12 Months|Lost to Follow-up|32
1119238|NCT02567227|2206107|FG000|12 Months|Death|0
1119239|NCT02567227|2206108|FG001|12 Months|Death|2
1119240|NCT02567266|2206117|FG000|Overall Study|Withdrawal by Subject|10
1119241|NCT02567266|2206118|FG001|Overall Study|Withdrawal by Subject|7
1119242|NCT02567266|2206119|FG002|Overall Study|Withdrawal by Subject|6
1119243|NCT02567266|2206117|FG000|Overall Study|Lost to Follow-up|13
1119244|NCT02567266|2206118|FG001|Overall Study|Lost to Follow-up|8
1119245|NCT02567266|2206119|FG002|Overall Study|Lost to Follow-up|10
1119246|NCT02567552|2206129|FG000|Overall Study|Adverse Event|0
1119247|NCT02567552|2206130|FG001|Overall Study|Adverse Event|1
1119248|NCT02567656|2206142|FG000|Overall Study|Premature discontinuation due to PD|1
1119249|NCT02567656|2206143|FG001|Overall Study|Premature discontinuation due to PD|1
1119250|NCT02567656|2206144|FG002|Overall Study|Premature discontinuation due to PD|2
1119251|NCT02567656|2206145|FG003|Overall Study|Premature discontinuation due to PD|0
1119252|NCT02567656|2206146|FG004|Overall Study|Premature discontinuation due to PD|0
1119253|NCT02567656|2206147|FG005|Overall Study|Premature discontinuation due to PD|0
1119254|NCT02567708|2206161|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
1119255|NCT02567708|2206162|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
1119256|NCT02567708|2206161|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
1119257|NCT02567708|2206162|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
898319|NCT00715078|1870734|FG002|Overall Study|Unable to start due to disease prog.|1
898320|NCT00715117|1870791|FG000|Overall Study|Crohn's flare and rescue with steroids|0
898321|NCT00715117|1870792|FG001|Overall Study|Crohn's flare and rescue with steroids|1
898322|NCT00715208|1870805|FG000|Overall Study|Withdrawal by Subject|1
898323|NCT00715208|1870806|FG001|Overall Study|Withdrawal by Subject|1
898324|NCT00715208|1870805|FG000|Overall Study|Adverse Event|0
898325|NCT00715208|1870806|FG001|Overall Study|Adverse Event|6
898326|NCT00715208|1870805|FG000|Overall Study|Lack of Efficacy|0
898327|NCT00715208|1870806|FG001|Overall Study|Lack of Efficacy|2
898328|NCT00715299|1870812|FG000|Overall Study|Withdrawal by Subject|1
898329|NCT00715299|1870812|FG000|Overall Study|Adverse Event|3
898330|NCT00715299|1870812|FG000|Overall Study|failed the pre-screen exercise test|2
898331|NCT00715403|1870827|FG000|Overall Study|Progressive disease|0
898332|NCT00715403|1870828|FG001|Overall Study|Progressive disease|1
898333|NCT00715403|1870829|FG002|Overall Study|Progressive disease|3
898334|NCT00715403|1870830|FG003|Overall Study|Progressive disease|9
898335|NCT00715403|1870831|FG004|Overall Study|Progressive disease|5
898336|NCT00715403|1870832|FG005|Overall Study|Progressive disease|14
898337|NCT00715403|1870833|FG006|Overall Study|Progressive disease|1
1119258|NCT02567708|2206161|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
1119259|NCT02567708|2206162|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
1119260|NCT02567708|2206161|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
1119261|NCT02567708|2206162|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
1119262|NCT02568046|2206178|FG000|Overall Study|Adverse Event|0
1119263|NCT02568046|2206179|FG001|Overall Study|Adverse Event|1
1119264|NCT02568046|2206178|FG000|Overall Study|Death|2
1119265|NCT02568046|2206179|FG001|Overall Study|Death|0
1119266|NCT02568046|2206178|FG000|Overall Study|Progressive Disease|1
1119267|NCT02568046|2206179|FG001|Overall Study|Progressive Disease|0
1119268|NCT02568046|2206178|FG000|Overall Study|Withdrawal by Subject|2
1119269|NCT02568046|2206179|FG001|Overall Study|Withdrawal by Subject|1
1119270|NCT02568046|2206178|FG000|Overall Study|Other Events|0
1119271|NCT02568046|2206179|FG001|Overall Study|Other Events|1
1119272|NCT02568072|2206185|FG000|Overall Study|Unavailable for appointment|23
1119273|NCT02568072|2206185|FG000|Overall Study|Unable to contact|3
1119274|NCT02568072|2206185|FG000|Overall Study|Diagnosis of Long QT Syndrome|1
1119275|NCT02568072|2206185|FG000|Overall Study|Withdrawal by Subject|1
1119276|NCT02568072|2206185|FG000|Overall Study|Sustained injury, marathon not run|24
1119277|NCT02568254|2206190|FG000|Period 2|Adverse Event|0
1119278|NCT02568254|2206191|FG001|Period 2|Adverse Event|0
1119279|NCT02568254|2206192|FG002|Period 2|Adverse Event|1
1119280|NCT02568254|2206193|FG003|Period 2|Adverse Event|0
1119281|NCT02568254|2206194|FG004|Period 2|Adverse Event|0
1119282|NCT02568254|2206195|FG005|Period 2|Adverse Event|0
1119283|NCT02568254|2206190|FG000|Period 3|Unstatisfactory Lens fitting|0
1119284|NCT02568254|2206191|FG001|Period 3|Unstatisfactory Lens fitting|0
1119285|NCT02568254|2206192|FG002|Period 3|Unstatisfactory Lens fitting|0
1119286|NCT02568254|2206193|FG003|Period 3|Unstatisfactory Lens fitting|0
1119287|NCT02568254|2206194|FG004|Period 3|Unstatisfactory Lens fitting|1
1119288|NCT02568254|2206195|FG005|Period 3|Unstatisfactory Lens fitting|0
1119289|NCT02568384|2206207|FG000|Overall Study|Mobile devices incompatible with App|2
1119290|NCT02568397|2206211|FG000|Period 2|Withdrawal by Subject|0
1119291|NCT02568397|2206212|FG001|Period 2|Withdrawal by Subject|1
1119292|NCT02568397|2206211|FG000|Period 2|Physician Decision|0
1119293|NCT02568397|2206212|FG001|Period 2|Physician Decision|1
1119294|NCT02568475|2206229|FG000|Overall Study|Lost to Follow-up|40
1119295|NCT02568475|2206230|FG001|Overall Study|Lost to Follow-up|39
1119296|NCT02568475|2206229|FG000|Overall Study|Withdrawal by Subject|2
1119297|NCT02568475|2206230|FG001|Overall Study|Withdrawal by Subject|0
1119298|NCT02568475|2206229|FG000|Overall Study|Discharged home|4
1119299|NCT02568475|2206230|FG001|Overall Study|Discharged home|4
1119300|NCT02568475|2206229|FG000|Overall Study|Short-term: Discharge location unknown|4
1119301|NCT02568475|2206230|FG001|Overall Study|Short-term: Discharge location unknown|0
1119302|NCT02568475|2206229|FG000|Overall Study|Transferred to another facility|1
1119303|NCT02568475|2206230|FG001|Overall Study|Transferred to another facility|0
1119304|NCT02568683|2206249|FG000|Overall Study|Death|0
1119305|NCT02568683|2206250|FG001|Overall Study|Death|2
1119306|NCT02568683|2206249|FG000|Overall Study|Withdrew Consent|1
1119307|NCT02568683|2206250|FG001|Overall Study|Withdrew Consent|0
1119308|NCT02568683|2206249|FG000|Overall Study|Study Terminated By Sponsor|5
1119309|NCT02568683|2206250|FG001|Overall Study|Study Terminated By Sponsor|2
1119310|NCT02569398|2206278|FG000|Overall Study|Adverse Event|0
1119311|NCT02569398|2206279|FG001|Overall Study|Adverse Event|1
1119312|NCT02569398|2206280|FG002|Overall Study|Adverse Event|6
1119313|NCT02569398|2206278|FG000|Overall Study|Withdrawal by Subject|43
1119314|NCT02569398|2206279|FG001|Overall Study|Withdrawal by Subject|43
1119315|NCT02569398|2206280|FG002|Overall Study|Withdrawal by Subject|30
1119316|NCT02569398|2206278|FG000|Overall Study|Study terminated by sponsor|130
1119317|NCT02569398|2206279|FG001|Overall Study|Study terminated by sponsor|131
1119318|NCT02569398|2206280|FG002|Overall Study|Study terminated by sponsor|134
1119319|NCT02569398|2206278|FG000|Overall Study|Other|12
1119320|NCT02569398|2206279|FG001|Overall Study|Other|14
1119321|NCT02569398|2206280|FG002|Overall Study|Other|13
1119322|NCT02569437|2206299|FG000|Overall Study|Lost to Follow-up|12
1119323|NCT02569437|2206300|FG001|Overall Study|Lost to Follow-up|14
1119324|NCT02569476|2206306|FG000|Overall Study|Roll over to Long-Term Extension Study|73
1119325|NCT02569476|2206306|FG000|Overall Study|Death|33
1119326|NCT02569476|2206306|FG000|Overall Study|Withdrawal by Subject|9
1119327|NCT02569476|2206306|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1
1119328|NCT02569476|2206306|FG000|Overall Study|Palliative care|1
1119329|NCT02569476|2206306|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1
1119330|NCT02569476|2206306|FG000|Overall Study|Transitioned to Long Term Extension Study|1
1119331|NCT02569801|2206391|FG000|Overall Study|Withdrawal by Subject|9
1119332|NCT02569801|2206392|FG001|Overall Study|Withdrawal by Subject|9
1119333|NCT02569801|2206391|FG000|Overall Study|Sponsor Decision|13
1119334|NCT02569801|2206392|FG001|Overall Study|Sponsor Decision|14
1119335|NCT02569801|2206391|FG000|Overall Study|Progressive Disease|2
1119336|NCT02569801|2206392|FG001|Overall Study|Progressive Disease|7
1119337|NCT02569801|2206391|FG000|Overall Study|Lost to Follow-up|0
1119338|NCT02569801|2206392|FG001|Overall Study|Lost to Follow-up|1
1119339|NCT02569801|2206391|FG000|Overall Study|Death|12
1119340|NCT02569801|2206392|FG001|Overall Study|Death|4
1119341|NCT02569853|2206400|FG000|Overall Study|Adverse Event|2
1119342|NCT02569853|2206401|FG001|Overall Study|Adverse Event|0
1119343|NCT02569853|2206400|FG000|Overall Study|Withdrawal by Subject|3
1119344|NCT02569853|2206401|FG001|Overall Study|Withdrawal by Subject|2
1119345|NCT02569853|2206400|FG000|Overall Study|Lost to Follow-up|3
1119346|NCT02569853|2206401|FG001|Overall Study|Lost to Follow-up|3
1119347|NCT02569853|2206400|FG000|Overall Study|Protocol Violation|1
1119348|NCT02569853|2206401|FG001|Overall Study|Protocol Violation|1
1119349|NCT02569853|2206400|FG000|Overall Study|Did not experience migraine attack|10
1119350|NCT02569853|2206401|FG001|Overall Study|Did not experience migraine attack|7
1119351|NCT02569853|2206400|FG000|Overall Study|Physician Decision|1
1119352|NCT02569853|2206401|FG001|Overall Study|Physician Decision|1
1119353|NCT02569996|2206416|FG000|Overall Study|Adverse Event|6
1119354|NCT02569996|2206416|FG000|Overall Study|Physician Decision|3
1119355|NCT02569996|2206416|FG000|Overall Study|Progression of the disease|18
1119356|NCT02569996|2206416|FG000|Overall Study|New anti-lymphoma treatment|1
1119357|NCT02569996|2206416|FG000|Overall Study|Non-compliance|9
1119358|NCT02569996|2206416|FG000|Overall Study|Withdrawal by Subject|5
1119359|NCT02569996|2206416|FG000|Overall Study|Lost to Follow-up|5
1119360|NCT02569996|2206416|FG000|Overall Study|Complete remission|7
1119361|NCT02569996|2206416|FG000|Overall Study|Unknown reason|1
1119362|NCT02570074|2206431|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
1119363|NCT02570074|2206432|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
1119364|NCT02570126|2206452|FG000|Overall Study|Lost to Follow-up|2
1119365|NCT02570126|2206453|FG001|Overall Study|Lost to Follow-up|0
1119366|NCT02570126|2206452|FG000|Overall Study|Unable To Arrange Visit 3|1
1119367|NCT02570126|2206453|FG001|Overall Study|Unable To Arrange Visit 3|0
1119368|NCT02570126|2206452|FG000|Overall Study|Violation Of Procedures GSK|0
1119369|NCT02570126|2206453|FG001|Overall Study|Violation Of Procedures GSK|1
1119370|NCT02570126|2206452|FG000|Overall Study|Protocol Violation|0
1119371|NCT02570126|2206453|FG001|Overall Study|Protocol Violation|1
1119372|NCT02570126|2206452|FG000|Overall Study|Withdrawal by Subject|3
1119373|NCT02570126|2206453|FG001|Overall Study|Withdrawal by Subject|7
1119374|NCT02570152|2206468|FG000|Overall Study|Protocol Violation|2
1119375|NCT02570152|2206468|FG000|Overall Study|Migrated/moved from study area|13
1119376|NCT02570165|2206479|FG000|Overall Study|Adverse Event|1
1119377|NCT02570165|2206480|FG001|Overall Study|Adverse Event|0
1119378|NCT02570165|2206481|FG002|Overall Study|Adverse Event|2
1119379|NCT02570165|2206482|FG003|Overall Study|Adverse Event|0
1119380|NCT02570165|2206483|FG004|Overall Study|Adverse Event|0
1119381|NCT02570165|2206484|FG005|Overall Study|Adverse Event|0
1119382|NCT02570165|2206485|FG006|Overall Study|Adverse Event|0
1119383|NCT02570165|2206479|FG000|Overall Study|Lack of Efficacy|0
1119384|NCT02570165|2206480|FG001|Overall Study|Lack of Efficacy|1
1119385|NCT02570165|2206481|FG002|Overall Study|Lack of Efficacy|0
1119386|NCT02570165|2206482|FG003|Overall Study|Lack of Efficacy|0
1119387|NCT02570165|2206483|FG004|Overall Study|Lack of Efficacy|4
1119388|NCT02570165|2206484|FG005|Overall Study|Lack of Efficacy|0
1119389|NCT02570165|2206485|FG006|Overall Study|Lack of Efficacy|0
1119390|NCT02570165|2206479|FG000|Overall Study|Par. Reached Stopping Criteria|1
1119391|NCT02570165|2206480|FG001|Overall Study|Par. Reached Stopping Criteria|1
1119392|NCT02570165|2206481|FG002|Overall Study|Par. Reached Stopping Criteria|0
1119393|NCT02570165|2206482|FG003|Overall Study|Par. Reached Stopping Criteria|2
1119394|NCT02570165|2206483|FG004|Overall Study|Par. Reached Stopping Criteria|1
1119395|NCT02570165|2206484|FG005|Overall Study|Par. Reached Stopping Criteria|1
1119396|NCT02570165|2206485|FG006|Overall Study|Par. Reached Stopping Criteria|0
1119397|NCT02570165|2206479|FG000|Overall Study|Lost to Follow-up|0
1119398|NCT02570165|2206480|FG001|Overall Study|Lost to Follow-up|0
1119399|NCT02570165|2206481|FG002|Overall Study|Lost to Follow-up|1
1119400|NCT02570165|2206482|FG003|Overall Study|Lost to Follow-up|1
1119401|NCT02570165|2206483|FG004|Overall Study|Lost to Follow-up|0
1119402|NCT02570165|2206484|FG005|Overall Study|Lost to Follow-up|0
1119403|NCT02570165|2206485|FG006|Overall Study|Lost to Follow-up|0
1119404|NCT02570165|2206479|FG000|Overall Study|Physician Decision|0
1119405|NCT02570165|2206480|FG001|Overall Study|Physician Decision|1
1119406|NCT02570165|2206481|FG002|Overall Study|Physician Decision|0
1119407|NCT02570165|2206482|FG003|Overall Study|Physician Decision|0
1119408|NCT02570165|2206483|FG004|Overall Study|Physician Decision|0
1119409|NCT02570165|2206484|FG005|Overall Study|Physician Decision|0
1119410|NCT02570165|2206485|FG006|Overall Study|Physician Decision|0
1119411|NCT02570165|2206479|FG000|Overall Study|Withdrawal by Subject|0
1119412|NCT02570165|2206480|FG001|Overall Study|Withdrawal by Subject|0
1119413|NCT02570165|2206481|FG002|Overall Study|Withdrawal by Subject|0
1119414|NCT02570165|2206482|FG003|Overall Study|Withdrawal by Subject|2
1119415|NCT02570165|2206483|FG004|Overall Study|Withdrawal by Subject|1
1119416|NCT02570165|2206484|FG005|Overall Study|Withdrawal by Subject|0
1119417|NCT02570165|2206485|FG006|Overall Study|Withdrawal by Subject|0
1119418|NCT02570165|2206479|FG000|Overall Study|Par. did not Meet Continuation Criteria|0
1119419|NCT02570165|2206480|FG001|Overall Study|Par. did not Meet Continuation Criteria|0
1119420|NCT02570165|2206481|FG002|Overall Study|Par. did not Meet Continuation Criteria|0
1119421|NCT02570165|2206482|FG003|Overall Study|Par. did not Meet Continuation Criteria|0
1119422|NCT02570165|2206483|FG004|Overall Study|Par. did not Meet Continuation Criteria|0
1119423|NCT02570165|2206484|FG005|Overall Study|Par. did not Meet Continuation Criteria|1
1119424|NCT02570165|2206485|FG006|Overall Study|Par. did not Meet Continuation Criteria|0
1119425|NCT02570165|2206479|FG000|Overall Study|Withdrawal Request by GSK|0
1119426|NCT02570165|2206480|FG001|Overall Study|Withdrawal Request by GSK|0
1119427|NCT02570165|2206481|FG002|Overall Study|Withdrawal Request by GSK|2
1119428|NCT02570165|2206482|FG003|Overall Study|Withdrawal Request by GSK|0
1119429|NCT02570165|2206483|FG004|Overall Study|Withdrawal Request by GSK|0
1119430|NCT02570165|2206484|FG005|Overall Study|Withdrawal Request by GSK|0
1119431|NCT02570165|2206485|FG006|Overall Study|Withdrawal Request by GSK|0
1119432|NCT02570308|2206515|FG000|Overall Study|Death|1
1119433|NCT02570308|2206516|FG001|Overall Study|Death|5
1119434|NCT02570308|2206517|FG002|Overall Study|Death|4
1119435|NCT02570308|2206518|FG003|Overall Study|Death|4
1119436|NCT02570308|2206519|FG004|Overall Study|Death|69
1119437|NCT02570308|2206515|FG000|Overall Study|Lost to Follow-up|0
1119438|NCT02570308|2206516|FG001|Overall Study|Lost to Follow-up|0
1119439|NCT02570308|2206517|FG002|Overall Study|Lost to Follow-up|0
1119440|NCT02570308|2206518|FG003|Overall Study|Lost to Follow-up|0
1119441|NCT02570308|2206519|FG004|Overall Study|Lost to Follow-up|2
1119442|NCT02570308|2206515|FG000|Overall Study|Withdrawal by Subject|0
1119443|NCT02570308|2206516|FG001|Overall Study|Withdrawal by Subject|0
1119444|NCT02570308|2206517|FG002|Overall Study|Withdrawal by Subject|0
1119445|NCT02570308|2206518|FG003|Overall Study|Withdrawal by Subject|0
1119446|NCT02570308|2206519|FG004|Overall Study|Withdrawal by Subject|1
1119447|NCT02570308|2206515|FG000|Overall Study|Other|0
1119448|NCT02570308|2206516|FG001|Overall Study|Other|0
1119449|NCT02570308|2206517|FG002|Overall Study|Other|0
1119450|NCT02570308|2206518|FG003|Overall Study|Other|0
1119451|NCT02570308|2206519|FG004|Overall Study|Other|2
1119452|NCT02570711|2206551|FG000|Overall Study|Death|1
1119453|NCT02570711|2206552|FG001|Overall Study|Death|0
1119454|NCT02570711|2206551|FG000|Overall Study|Early Termination of Study by Sponsor|0
1119455|NCT02570711|2206552|FG001|Overall Study|Early Termination of Study by Sponsor|2
1119456|NCT02570750|2206560|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
1119457|NCT02570750|2206561|FG001|Overall Study|Inclusion/exclusion criteria deviation|0
1119458|NCT02570750|2206560|FG000|Overall Study|Protocol deviation|4
1119459|NCT02570750|2206561|FG001|Overall Study|Protocol deviation|2
1119460|NCT02570750|2206560|FG000|Overall Study|Withdrawal by Subject|5
1119461|NCT02570750|2206561|FG001|Overall Study|Withdrawal by Subject|0
1119462|NCT02570750|2206560|FG000|Overall Study|Lost to Follow-up|2
1119463|NCT02570750|2206561|FG001|Overall Study|Lost to Follow-up|2
1119464|NCT02570750|2206560|FG000|Overall Study|Adverse Event|2
1119465|NCT02570750|2206561|FG001|Overall Study|Adverse Event|1
1119466|NCT02571049|2206567|FG000|Screening|Did not meet entry criteria|2
1119467|NCT02571049|2206568|FG001|Screening|Did not meet entry criteria|2
1119468|NCT02571049|2206567|FG000|Randomization|No migraine attack|0
1119469|NCT02571049|2206568|FG001|Randomization|No migraine attack|1
1119470|NCT02571049|2206567|FG000|Randomization|Adverse Event|0
1119471|NCT02571049|2206568|FG001|Randomization|Adverse Event|1
1119472|NCT02571075|2206576|FG000|Overall Study|Lost to Follow-up|20
1119473|NCT02571075|2206577|FG001|Overall Study|Lost to Follow-up|24
1119474|NCT02571244|2206607|FG000|Overall Study|Lost to Follow-up|0
1119475|NCT02571244|2206608|FG001|Overall Study|Lost to Follow-up|1
1119476|NCT02571244|2206607|FG000|Overall Study|Unable to reach out post discharge|3
1119477|NCT02571244|2206608|FG001|Overall Study|Unable to reach out post discharge|0
1119478|NCT02571452|2206628|FG000|Overall Study Treatment|Protocol Violation|0
1119479|NCT02571452|2206629|FG001|Overall Study Treatment|Protocol Violation|1
1119480|NCT02571452|2206628|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4
1119481|NCT02571452|2206629|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0
1119482|NCT02571452|2206628|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1
1119483|NCT02571452|2206629|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0
1119484|NCT02571777|2206645|FG000|Overall Study|Subject/guardian decision|34
1119485|NCT02571777|2206646|FG001|Overall Study|Subject/guardian decision|26
1119486|NCT02571777|2206647|FG002|Overall Study|Subject/guardian decision|26
1119487|NCT02571777|2206648|FG003|Overall Study|Subject/guardian decision|25
1119488|NCT02571777|2206649|FG004|Overall Study|Subject/guardian decision|27
1119489|NCT02571777|2206645|FG000|Overall Study|Protocol Deviation|2
1119490|NCT02571777|2206646|FG001|Overall Study|Protocol Deviation|3
1119491|NCT02571777|2206647|FG002|Overall Study|Protocol Deviation|4
1119492|NCT02571777|2206648|FG003|Overall Study|Protocol Deviation|8
1119493|NCT02571777|2206649|FG004|Overall Study|Protocol Deviation|4
1119494|NCT02571777|2206645|FG000|Overall Study|Death|1
1119495|NCT02571777|2206646|FG001|Overall Study|Death|1
1119496|NCT02571777|2206647|FG002|Overall Study|Death|4
1119497|NCT02571777|2206648|FG003|Overall Study|Death|0
1119498|NCT02571777|2206649|FG004|Overall Study|Death|0
1119499|NCT02571777|2206645|FG000|Overall Study|Lost to Follow-up|1
1119500|NCT02571777|2206646|FG001|Overall Study|Lost to Follow-up|1
1119501|NCT02571777|2206647|FG002|Overall Study|Lost to Follow-up|2
1119502|NCT02571777|2206648|FG003|Overall Study|Lost to Follow-up|0
1119503|NCT02571777|2206649|FG004|Overall Study|Lost to Follow-up|1
1119504|NCT02571777|2206645|FG000|Overall Study|Physician Decision|1
1119505|NCT02571777|2206646|FG001|Overall Study|Physician Decision|7
1119506|NCT02571777|2206647|FG002|Overall Study|Physician Decision|5
1119507|NCT02571777|2206648|FG003|Overall Study|Physician Decision|2
1119508|NCT02571777|2206649|FG004|Overall Study|Physician Decision|4
1119509|NCT02571777|2206645|FG000|Overall Study|Pregnancy|0
1119510|NCT02571777|2206646|FG001|Overall Study|Pregnancy|0
1119511|NCT02571777|2206647|FG002|Overall Study|Pregnancy|0
1119512|NCT02571777|2206648|FG003|Overall Study|Pregnancy|2
1119513|NCT02571777|2206649|FG004|Overall Study|Pregnancy|0
1119514|NCT02571972|2206661|FG000|Overall Study|Protocol Violation|2
1119515|NCT02571972|2206661|FG000|Overall Study|Withdrawal by Subject|2
1119516|NCT02572076|2206665|FG000|Overall Study|Protocol Violation|1
1119517|NCT02572167|2206672|FG000|Overall Study|In follow up|6
1119518|NCT02572167|2206673|FG001|Overall Study|In follow up|48
1119519|NCT02572167|2206674|FG002|Overall Study|In follow up|27
1119520|NCT02572167|2206672|FG000|Overall Study|Withdrawal by Subject|0
1119521|NCT02572167|2206673|FG001|Overall Study|Withdrawal by Subject|3
1119522|NCT02572167|2206674|FG002|Overall Study|Withdrawal by Subject|1
1119523|NCT02572167|2206672|FG000|Overall Study|Lost to Follow-up|0
1119524|NCT02572167|2206673|FG001|Overall Study|Lost to Follow-up|2
1119525|NCT02572167|2206674|FG002|Overall Study|Lost to Follow-up|1
1119526|NCT02572167|2206672|FG000|Overall Study|Death|0
1119527|NCT02572167|2206673|FG001|Overall Study|Death|3
1119528|NCT02572167|2206674|FG002|Overall Study|Death|1
1119529|NCT02572167|2206672|FG000|Overall Study|Did not meet inclusion criteria|0
1119530|NCT02572167|2206673|FG001|Overall Study|Did not meet inclusion criteria|0
1119531|NCT02572167|2206674|FG002|Overall Study|Did not meet inclusion criteria|1
1119532|NCT02572388|2206686|FG000|Overall Study|Withdrawal by Subject|1
1119533|NCT02572388|2206687|FG001|Overall Study|Withdrawal by Subject|1
1119534|NCT02572388|2206688|FG002|Overall Study|Withdrawal by Subject|2
1119535|NCT02572388|2206689|FG003|Overall Study|Withdrawal by Subject|2
1119536|NCT02572401|2206703|FG000|Overall Study|Lost to Follow-up|5
1119537|NCT02572401|2206704|FG001|Overall Study|Lost to Follow-up|8
1119538|NCT02572401|2206705|FG002|Overall Study|Lost to Follow-up|9
1119539|NCT02572401|2206706|FG003|Overall Study|Lost to Follow-up|9
1119540|NCT02572401|2206703|FG000|Overall Study|Death|0
1119541|NCT02572401|2206704|FG001|Overall Study|Death|0
1119542|NCT02572401|2206705|FG002|Overall Study|Death|0
1119543|NCT02572401|2206706|FG003|Overall Study|Death|1
1119544|NCT02572817|2206755|FG000|Overall Study|Death|6
1119545|NCT02572817|2206756|FG001|Overall Study|Death|3
1119546|NCT02572817|2206755|FG000|Overall Study|Lost to Follow-up|3
1119547|NCT02572817|2206756|FG001|Overall Study|Lost to Follow-up|3
1119548|NCT02573012|2206764|FG000|Overall Study|Adverse Event|5
1119549|NCT02573012|2206765|FG001|Overall Study|Adverse Event|5
1119550|NCT02573012|2206764|FG000|Overall Study|Lack of Efficacy|5
1119551|NCT02573012|2206765|FG001|Overall Study|Lack of Efficacy|4
1119552|NCT02573012|2206764|FG000|Overall Study|Non-compliance|1
1119553|NCT02573012|2206765|FG001|Overall Study|Non-compliance|2
1119554|NCT02573012|2206764|FG000|Overall Study|Withdrawal by Subject|2
1119555|NCT02573012|2206765|FG001|Overall Study|Withdrawal by Subject|2
1119556|NCT02573012|2206764|FG000|Overall Study|Study Ended per Protocol|1
1119557|NCT02573012|2206765|FG001|Overall Study|Study Ended per Protocol|0
1119558|NCT02573012|2206764|FG000|Overall Study|Physician Decision|1
1119559|NCT02573012|2206765|FG001|Overall Study|Physician Decision|2
1119560|NCT02573155|2206773|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0
1119561|NCT02573155|2206774|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1
1119562|NCT02573155|2206773|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
1119563|NCT02573155|2206774|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
1119564|NCT02573155|2206773|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0
1119565|NCT02573155|2206774|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3
1119566|NCT02573155|2206773|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
1119567|NCT02573155|2206774|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
1119568|NCT02573155|2206773|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0
1119569|NCT02573155|2206774|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2
1119570|NCT02573155|2206773|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
1119571|NCT02573155|2206774|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
1119572|NCT02573155|2206773|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0
1119573|NCT02573155|2206774|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1
1119574|NCT02573155|2206773|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0
1119575|NCT02573155|2206774|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1
1119576|NCT02573246|2206824|FG000|Overall Study|Lost to Follow-up|2
1119577|NCT02573246|2206825|FG001|Overall Study|Lost to Follow-up|0
1119578|NCT02573246|2206826|FG002|Overall Study|Lost to Follow-up|0
1119579|NCT02573246|2206827|FG003|Overall Study|Lost to Follow-up|0
1119580|NCT02573246|2206828|FG004|Overall Study|Lost to Follow-up|1
1119581|NCT02573246|2206824|FG000|Overall Study|Withdrawal by Subject|0
1119582|NCT02573246|2206825|FG001|Overall Study|Withdrawal by Subject|0
1119583|NCT02573246|2206826|FG002|Overall Study|Withdrawal by Subject|0
1119584|NCT02573246|2206827|FG003|Overall Study|Withdrawal by Subject|0
1119585|NCT02573246|2206828|FG004|Overall Study|Withdrawal by Subject|1
1119586|NCT02573246|2206824|FG000|Overall Study|Physician Decision|1
1119587|NCT02573246|2206825|FG001|Overall Study|Physician Decision|1
1119588|NCT02573246|2206826|FG002|Overall Study|Physician Decision|3
1119589|NCT02573246|2206827|FG003|Overall Study|Physician Decision|2
1119590|NCT02573246|2206828|FG004|Overall Study|Physician Decision|2
1119591|NCT02573311|2206847|FG000|Disposition for Part 1|Withdrawal by Subject|7
1119592|NCT02573311|2206848|FG001|Disposition for Part 1|Withdrawal by Subject|3
1119593|NCT02573311|2206847|FG000|Disposition for Part 2|Physician Decision|25
1119594|NCT02573311|2206848|FG001|Disposition for Part 2|Physician Decision|7
1119595|NCT02573311|2206847|FG000|Disposition for Part 2|Adverse Event|36
1119596|NCT02573311|2206848|FG001|Disposition for Part 2|Adverse Event|5
1119597|NCT02573311|2206847|FG000|Disposition for Part 2|Lost to Follow-up|76
1119598|NCT02573311|2206848|FG001|Disposition for Part 2|Lost to Follow-up|7
1119599|NCT02573311|2206847|FG000|Disposition for Part 2|Withdrawal by Subject|60
1119600|NCT02573311|2206848|FG001|Disposition for Part 2|Withdrawal by Subject|3
1119601|NCT02573311|2206847|FG000|Disposition for Part 2|Investigator decision|0
1119602|NCT02573311|2206848|FG001|Disposition for Part 2|Investigator decision|1
1119603|NCT02573311|2206847|FG000|Disposition for Part 2|Other than specified above|13
1119604|NCT02573311|2206848|FG001|Disposition for Part 2|Other than specified above|3
1119605|NCT02573350|2206856|FG000|Overall Study|Lost to Follow-up|2
1119606|NCT02573350|2206857|FG001|Overall Study|Lost to Follow-up|1
1119607|NCT02573350|2206856|FG000|Overall Study|Adverse Event|3
1119608|NCT02573350|2206857|FG001|Overall Study|Adverse Event|4
1119609|NCT02573350|2206856|FG000|Overall Study|Subject met Withdrawal Criteria|1
1119610|NCT02573350|2206857|FG001|Overall Study|Subject met Withdrawal Criteria|1
1119611|NCT02573350|2206856|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3
1119612|NCT02573350|2206857|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1
1119613|NCT02573350|2206856|FG000|Overall Study|Subject withdrew consent to participate|6
1119614|NCT02573350|2206857|FG001|Overall Study|Subject withdrew consent to participate|1
1119615|NCT02573350|2206856|FG000|Overall Study|Protocol Deviation|1
1119616|NCT02573350|2206857|FG001|Overall Study|Protocol Deviation|1
1119617|NCT02573467|2206879|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0
1119618|NCT02573467|2206880|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0
1119619|NCT02573467|2206881|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1
1119620|NCT02573467|2206882|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0
1119621|NCT02573467|2206879|FG000|Double-blind Treatment Epoch|Adverse Event|1
1119622|NCT02573467|2206880|FG001|Double-blind Treatment Epoch|Adverse Event|0
1119623|NCT02573467|2206881|FG002|Double-blind Treatment Epoch|Adverse Event|1
1119624|NCT02573467|2206882|FG003|Double-blind Treatment Epoch|Adverse Event|0
1119625|NCT02573467|2206879|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2
1119626|NCT02573467|2206880|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1
1119627|NCT02573467|2206881|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1
1119628|NCT02573467|2206882|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0
1119629|NCT02573467|2206879|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50
1119630|NCT02573467|2206880|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51
1119631|NCT02573467|2206881|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48
1119632|NCT02573467|2206882|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55
1119633|NCT02573467|2206879|FG000|Post-treatment Follow up Epoch|Death|1
1119634|NCT02573467|2206880|FG001|Post-treatment Follow up Epoch|Death|1
1119635|NCT02573467|2206881|FG002|Post-treatment Follow up Epoch|Death|0
1119636|NCT02573467|2206882|FG003|Post-treatment Follow up Epoch|Death|1
1119637|NCT02573467|2206879|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5
1119638|NCT02573467|2206880|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4
1119639|NCT02573467|2206881|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9
1119640|NCT02573467|2206882|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2
1119641|NCT02573467|2206879|FG000|Post-treatment Follow up Epoch|Technical problems|0
1119642|NCT02573467|2206880|FG001|Post-treatment Follow up Epoch|Technical problems|0
1119643|NCT02573467|2206881|FG002|Post-treatment Follow up Epoch|Technical problems|1
1119644|NCT02573467|2206882|FG003|Post-treatment Follow up Epoch|Technical problems|0
1119645|NCT02573493|2206897|FG000|Overall Study|Determined to not be eligible after enrollment|0
1119646|NCT02573493|2206898|FG001|Overall Study|Determined to not be eligible after enrollment|0
1119647|NCT02573493|2206899|FG002|Overall Study|Determined to not be eligible after enrollment|0
1119648|NCT02573493|2206900|FG003|Overall Study|Determined to not be eligible after enrollment|1
1119649|NCT02573870|2206944|FG000|Overall Study|Adverse Event|0
1119650|NCT02573870|2206945|FG001|Overall Study|Adverse Event|2
1119651|NCT02573870|2206944|FG000|Overall Study|Lack of Efficacy|0
1119652|NCT02573870|2206945|FG001|Overall Study|Lack of Efficacy|1
1119653|NCT02573870|2206944|FG000|Overall Study|Other: Reached defined stopping criteria|0
1119654|NCT02573870|2206945|FG001|Overall Study|Other: Reached defined stopping criteria|1
1119655|NCT02573870|2206944|FG000|Overall Study|Lost to Follow-up|0
1119656|NCT02573870|2206945|FG001|Overall Study|Lost to Follow-up|1
1119657|NCT02573870|2206944|FG000|Overall Study|Other: Fail to Meet Visit|0
1119658|NCT02573870|2206945|FG001|Overall Study|Other: Fail to Meet Visit|2
1119659|NCT02573883|2206953|FG000|Six Month Follow Up|Lost to Follow-up|1
1119660|NCT02573883|2206954|FG001|Six Month Follow Up|Lost to Follow-up|0
1119661|NCT02573883|2206955|FG002|Six Month Follow Up|Lost to Follow-up|0
1119662|NCT02573883|2206956|FG003|Six Month Follow Up|Lost to Follow-up|0
1119663|NCT02573883|2206953|FG000|One Year Follow Up|Lost to Follow-up|2
1119664|NCT02573883|2206954|FG001|One Year Follow Up|Lost to Follow-up|1
1119665|NCT02573883|2206955|FG002|One Year Follow Up|Lost to Follow-up|0
1119666|NCT02573883|2206956|FG003|One Year Follow Up|Lost to Follow-up|0
1119667|NCT02573948|2206971|FG000|Longitudinal Cohort|Death|9
1119668|NCT02573948|2206971|FG000|Longitudinal Cohort|Lost to Follow-up|22
1119669|NCT02573948|2206971|FG000|Longitudinal Cohort|Incarcerated|25
1119670|NCT02574078|2206991|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0
1119671|NCT02574078|2206992|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0
1119672|NCT02574078|2206993|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0
1119673|NCT02574078|2206994|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0
1119674|NCT02574078|2206995|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0
1119675|NCT02574078|2206996|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1
1119676|NCT02574078|2206997|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2
1119677|NCT02574078|2206998|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0
1119678|NCT02574078|2206999|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1
1119679|NCT02574078|2207000|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0
1119680|NCT02574078|2207001|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0
1119681|NCT02574078|2207002|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0
1119682|NCT02574078|2207003|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0
1119683|NCT02574078|2206991|FG000|Pre-Treatment Period|Participant withdrew consent|0
898338|NCT00715403|1870827|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
898339|NCT00715403|1870828|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
898340|NCT00715403|1870829|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
898341|NCT00715403|1870830|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
898342|NCT00715403|1870831|FG004|Overall Study|Dose limiting Toxicity (DLT)|0
898343|NCT00715403|1870832|FG005|Overall Study|Dose limiting Toxicity (DLT)|1
898344|NCT00715403|1870833|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
898345|NCT00715403|1870827|FG000|Overall Study|Other Adverse Event than DLT|1
898346|NCT00715403|1870828|FG001|Overall Study|Other Adverse Event than DLT|0
898347|NCT00715403|1870829|FG002|Overall Study|Other Adverse Event than DLT|0
898348|NCT00715403|1870830|FG003|Overall Study|Other Adverse Event than DLT|0
898349|NCT00715403|1870831|FG004|Overall Study|Other Adverse Event than DLT|0
898350|NCT00715403|1870832|FG005|Overall Study|Other Adverse Event than DLT|2
898351|NCT00715403|1870833|FG006|Overall Study|Other Adverse Event than DLT|0
898352|NCT00715403|1870827|FG000|Overall Study|Protocol Violation|0
898353|NCT00715403|1870828|FG001|Overall Study|Protocol Violation|0
898354|NCT00715403|1870829|FG002|Overall Study|Protocol Violation|0
898355|NCT00715403|1870830|FG003|Overall Study|Protocol Violation|0
898356|NCT00715403|1870831|FG004|Overall Study|Protocol Violation|0
898357|NCT00715403|1870832|FG005|Overall Study|Protocol Violation|1
898358|NCT00715403|1870833|FG006|Overall Study|Protocol Violation|0
898359|NCT00715403|1870827|FG000|Overall Study|Other reason not defined above|0
898360|NCT00715403|1870828|FG001|Overall Study|Other reason not defined above|0
898361|NCT00715403|1870829|FG002|Overall Study|Other reason not defined above|1
898362|NCT00715403|1870830|FG003|Overall Study|Other reason not defined above|0
898363|NCT00715403|1870831|FG004|Overall Study|Other reason not defined above|1
898364|NCT00715403|1870832|FG005|Overall Study|Other reason not defined above|1
898365|NCT00715403|1870833|FG006|Overall Study|Other reason not defined above|0
898366|NCT00715429|1870851|FG000|Overall Study|Did not complete the study diary|0
898367|NCT00715429|1870852|FG001|Overall Study|Did not complete the study diary|1
898368|NCT00715520|1870861|FG000|Overall Study|Screen failure|8
898369|NCT00715520|1870862|FG001|Overall Study|Screen failure|1
898370|NCT00715520|1870863|FG002|Overall Study|Screen failure|1
898371|NCT00715520|1870861|FG000|Overall Study|Withdrawal by Subject|2
898372|NCT00715520|1870862|FG001|Overall Study|Withdrawal by Subject|0
898373|NCT00715520|1870863|FG002|Overall Study|Withdrawal by Subject|1
898374|NCT00715559|1870871|FG000|Overall Study|medication not tolerated - nausea|1
898375|NCT00715624|1870877|FG000|Overall Study|Adverse Event|12
898376|NCT00715624|1870878|FG001|Overall Study|Adverse Event|37
898377|NCT00715624|1870877|FG000|Overall Study|Lack of Efficacy|11
898378|NCT00715624|1870878|FG001|Overall Study|Lack of Efficacy|11
898379|NCT00715624|1870877|FG000|Overall Study|Lost to Follow-up|1
898380|NCT00715624|1870878|FG001|Overall Study|Lost to Follow-up|2
898381|NCT00715624|1870877|FG000|Overall Study|Protocol Violation|1
898382|NCT00715624|1870878|FG001|Overall Study|Protocol Violation|0
898383|NCT00715624|1870877|FG000|Overall Study|Withdrawal by Subject|11
898384|NCT00715624|1870878|FG001|Overall Study|Withdrawal by Subject|25
898385|NCT00715624|1870877|FG000|Overall Study|Familial and personal reasons|10
898386|NCT00715624|1870878|FG001|Overall Study|Familial and personal reasons|22
898387|NCT00715624|1870877|FG000|Overall Study|Poor compliance|6
898388|NCT00715624|1870878|FG001|Overall Study|Poor compliance|13
898389|NCT00715624|1870877|FG000|Overall Study|Sponsor decision|0
898390|NCT00715624|1870878|FG001|Overall Study|Sponsor decision|4
898391|NCT00715624|1870877|FG000|Overall Study|Incorrect randomization (not treated)|0
898392|NCT00715624|1870878|FG001|Overall Study|Incorrect randomization (not treated)|1
898393|NCT00715624|1870877|FG000|Overall Study|Other|0
898394|NCT00715624|1870878|FG001|Overall Study|Other|1
898395|NCT00715676|1870896|FG000|Overall Study|Adverse Event|3
898396|NCT00715676|1870897|FG001|Overall Study|Adverse Event|5
898397|NCT00715676|1870898|FG002|Overall Study|Adverse Event|21
898398|NCT00715676|1870896|FG000|Overall Study|Withdrawal by Subject|1
1119684|NCT02574078|2206992|FG001|Pre-Treatment Period|Participant withdrew consent|0
1119685|NCT02574078|2206993|FG002|Pre-Treatment Period|Participant withdrew consent|0
1119686|NCT02574078|2206994|FG003|Pre-Treatment Period|Participant withdrew consent|0
1119687|NCT02574078|2206995|FG004|Pre-Treatment Period|Participant withdrew consent|0
1119688|NCT02574078|2206996|FG005|Pre-Treatment Period|Participant withdrew consent|0
1119689|NCT02574078|2206997|FG006|Pre-Treatment Period|Participant withdrew consent|0
1119690|NCT02574078|2206998|FG007|Pre-Treatment Period|Participant withdrew consent|3
1119691|NCT02574078|2206999|FG008|Pre-Treatment Period|Participant withdrew consent|0
1119692|NCT02574078|2207000|FG009|Pre-Treatment Period|Participant withdrew consent|0
1119693|NCT02574078|2207001|FG010|Pre-Treatment Period|Participant withdrew consent|2
1119694|NCT02574078|2207002|FG011|Pre-Treatment Period|Participant withdrew consent|0
1119695|NCT02574078|2207003|FG012|Pre-Treatment Period|Participant withdrew consent|0
1119696|NCT02574078|2206991|FG000|Pre-Treatment Period|Other reasons|0
1119697|NCT02574078|2206992|FG001|Pre-Treatment Period|Other reasons|0
1119698|NCT02574078|2206993|FG002|Pre-Treatment Period|Other reasons|0
1119699|NCT02574078|2206994|FG003|Pre-Treatment Period|Other reasons|0
1119700|NCT02574078|2206995|FG004|Pre-Treatment Period|Other reasons|0
1119701|NCT02574078|2206996|FG005|Pre-Treatment Period|Other reasons|0
1119702|NCT02574078|2206997|FG006|Pre-Treatment Period|Other reasons|2
1119703|NCT02574078|2206998|FG007|Pre-Treatment Period|Other reasons|0
1119704|NCT02574078|2206999|FG008|Pre-Treatment Period|Other reasons|0
1119705|NCT02574078|2207000|FG009|Pre-Treatment Period|Other reasons|0
1119706|NCT02574078|2207001|FG010|Pre-Treatment Period|Other reasons|2
1119707|NCT02574078|2207002|FG011|Pre-Treatment Period|Other reasons|0
1119708|NCT02574078|2207003|FG012|Pre-Treatment Period|Other reasons|0
1119709|NCT02574078|2206991|FG000|Pre-Treatment Period|Poor/non-compliance|0
1119710|NCT02574078|2206992|FG001|Pre-Treatment Period|Poor/non-compliance|0
1119711|NCT02574078|2206993|FG002|Pre-Treatment Period|Poor/non-compliance|0
1119712|NCT02574078|2206994|FG003|Pre-Treatment Period|Poor/non-compliance|0
1119713|NCT02574078|2206995|FG004|Pre-Treatment Period|Poor/non-compliance|0
1119714|NCT02574078|2206996|FG005|Pre-Treatment Period|Poor/non-compliance|0
1119715|NCT02574078|2206997|FG006|Pre-Treatment Period|Poor/non-compliance|0
1119716|NCT02574078|2206998|FG007|Pre-Treatment Period|Poor/non-compliance|0
1119717|NCT02574078|2206999|FG008|Pre-Treatment Period|Poor/non-compliance|0
1119718|NCT02574078|2207000|FG009|Pre-Treatment Period|Poor/non-compliance|0
1119719|NCT02574078|2207001|FG010|Pre-Treatment Period|Poor/non-compliance|0
1119720|NCT02574078|2207002|FG011|Pre-Treatment Period|Poor/non-compliance|1
1119721|NCT02574078|2207003|FG012|Pre-Treatment Period|Poor/non-compliance|0
1119722|NCT02574078|2206991|FG000|Treatment Period|Disease progression|6
1119723|NCT02574078|2206992|FG001|Treatment Period|Disease progression|4
1119724|NCT02574078|2206993|FG002|Treatment Period|Disease progression|7
1119725|NCT02574078|2206994|FG003|Treatment Period|Disease progression|18
1119726|NCT02574078|2206995|FG004|Treatment Period|Disease progression|16
1119727|NCT02574078|2206996|FG005|Treatment Period|Disease progression|26
1119728|NCT02574078|2206997|FG006|Treatment Period|Disease progression|5
1119729|NCT02574078|2206998|FG007|Treatment Period|Disease progression|9
1119730|NCT02574078|2206999|FG008|Treatment Period|Disease progression|8
1119731|NCT02574078|2207000|FG009|Treatment Period|Disease progression|5
1119732|NCT02574078|2207001|FG010|Treatment Period|Disease progression|20
1119733|NCT02574078|2207002|FG011|Treatment Period|Disease progression|29
1119734|NCT02574078|2207003|FG012|Treatment Period|Disease progression|2
1119735|NCT02574078|2206991|FG000|Treatment Period|Study drug toxicity|1
1119736|NCT02574078|2206992|FG001|Treatment Period|Study drug toxicity|1
1119737|NCT02574078|2206993|FG002|Treatment Period|Study drug toxicity|0
1119738|NCT02574078|2206994|FG003|Treatment Period|Study drug toxicity|5
1119739|NCT02574078|2206995|FG004|Treatment Period|Study drug toxicity|3
1119740|NCT02574078|2206996|FG005|Treatment Period|Study drug toxicity|1
1119741|NCT02574078|2206997|FG006|Treatment Period|Study drug toxicity|2
1119742|NCT02574078|2206998|FG007|Treatment Period|Study drug toxicity|0
1119743|NCT02574078|2206999|FG008|Treatment Period|Study drug toxicity|2
1119744|NCT02574078|2207000|FG009|Treatment Period|Study drug toxicity|1
1119745|NCT02574078|2207001|FG010|Treatment Period|Study drug toxicity|16
1119746|NCT02574078|2207002|FG011|Treatment Period|Study drug toxicity|2
1119747|NCT02574078|2207003|FG012|Treatment Period|Study drug toxicity|4
1119748|NCT02574078|2206991|FG000|Treatment Period|Death|2
1119749|NCT02574078|2206992|FG001|Treatment Period|Death|0
1119750|NCT02574078|2206993|FG002|Treatment Period|Death|0
1119751|NCT02574078|2206994|FG003|Treatment Period|Death|0
1119752|NCT02574078|2206995|FG004|Treatment Period|Death|1
1119753|NCT02574078|2206996|FG005|Treatment Period|Death|1
1119754|NCT02574078|2206997|FG006|Treatment Period|Death|1
1119755|NCT02574078|2206998|FG007|Treatment Period|Death|1
1119756|NCT02574078|2206999|FG008|Treatment Period|Death|7
1119757|NCT02574078|2207000|FG009|Treatment Period|Death|1
1119758|NCT02574078|2207001|FG010|Treatment Period|Death|0
1119759|NCT02574078|2207002|FG011|Treatment Period|Death|2
1119760|NCT02574078|2207003|FG012|Treatment Period|Death|1
1119761|NCT02574078|2206991|FG000|Treatment Period|Adverse event unrelated to drug|0
1119762|NCT02574078|2206992|FG001|Treatment Period|Adverse event unrelated to drug|0
1119763|NCT02574078|2206993|FG002|Treatment Period|Adverse event unrelated to drug|1
1119764|NCT02574078|2206994|FG003|Treatment Period|Adverse event unrelated to drug|0
1119765|NCT02574078|2206995|FG004|Treatment Period|Adverse event unrelated to drug|2
1119766|NCT02574078|2206996|FG005|Treatment Period|Adverse event unrelated to drug|3
1119767|NCT02574078|2206997|FG006|Treatment Period|Adverse event unrelated to drug|0
1119768|NCT02574078|2206998|FG007|Treatment Period|Adverse event unrelated to drug|0
1119769|NCT02574078|2206999|FG008|Treatment Period|Adverse event unrelated to drug|1
1119770|NCT02574078|2207000|FG009|Treatment Period|Adverse event unrelated to drug|2
1119771|NCT02574078|2207001|FG010|Treatment Period|Adverse event unrelated to drug|4
1119772|NCT02574078|2207002|FG011|Treatment Period|Adverse event unrelated to drug|1
1119773|NCT02574078|2207003|FG012|Treatment Period|Adverse event unrelated to drug|0
1119774|NCT02574078|2206991|FG000|Treatment Period|Administrative reason by Sponsor|0
1119775|NCT02574078|2206992|FG001|Treatment Period|Administrative reason by Sponsor|1
1119776|NCT02574078|2206993|FG002|Treatment Period|Administrative reason by Sponsor|0
1119777|NCT02574078|2206994|FG003|Treatment Period|Administrative reason by Sponsor|0
1119778|NCT02574078|2206995|FG004|Treatment Period|Administrative reason by Sponsor|0
1119779|NCT02574078|2206996|FG005|Treatment Period|Administrative reason by Sponsor|0
1119780|NCT02574078|2206997|FG006|Treatment Period|Administrative reason by Sponsor|1
1119781|NCT02574078|2206998|FG007|Treatment Period|Administrative reason by Sponsor|0
1119782|NCT02574078|2206999|FG008|Treatment Period|Administrative reason by Sponsor|0
1119783|NCT02574078|2207000|FG009|Treatment Period|Administrative reason by Sponsor|0
1119784|NCT02574078|2207001|FG010|Treatment Period|Administrative reason by Sponsor|0
1119785|NCT02574078|2207002|FG011|Treatment Period|Administrative reason by Sponsor|0
1119786|NCT02574078|2207003|FG012|Treatment Period|Administrative reason by Sponsor|3
1119787|NCT02574078|2206991|FG000|Treatment Period|Other reasons|1
1119788|NCT02574078|2206992|FG001|Treatment Period|Other reasons|0
1119789|NCT02574078|2206993|FG002|Treatment Period|Other reasons|1
1119790|NCT02574078|2206994|FG003|Treatment Period|Other reasons|3
1119791|NCT02574078|2206995|FG004|Treatment Period|Other reasons|3
1119792|NCT02574078|2206996|FG005|Treatment Period|Other reasons|1
1119793|NCT02574078|2206997|FG006|Treatment Period|Other reasons|2
1119794|NCT02574078|2206998|FG007|Treatment Period|Other reasons|1
1119795|NCT02574078|2206999|FG008|Treatment Period|Other reasons|3
1119796|NCT02574078|2207000|FG009|Treatment Period|Other reasons|1
1119797|NCT02574078|2207001|FG010|Treatment Period|Other reasons|1
1119798|NCT02574078|2207002|FG011|Treatment Period|Other reasons|3
1119799|NCT02574078|2207003|FG012|Treatment Period|Other reasons|1
1119800|NCT02574078|2206991|FG000|Treatment Period|Participant request to stop drug|0
1119801|NCT02574078|2206992|FG001|Treatment Period|Participant request to stop drug|0
1119802|NCT02574078|2206993|FG002|Treatment Period|Participant request to stop drug|0
1119803|NCT02574078|2206994|FG003|Treatment Period|Participant request to stop drug|2
1119804|NCT02574078|2206995|FG004|Treatment Period|Participant request to stop drug|4
1119805|NCT02574078|2206996|FG005|Treatment Period|Participant request to stop drug|0
1119806|NCT02574078|2206997|FG006|Treatment Period|Participant request to stop drug|1
1119807|NCT02574078|2206998|FG007|Treatment Period|Participant request to stop drug|0
1119808|NCT02574078|2206999|FG008|Treatment Period|Participant request to stop drug|3
1119809|NCT02574078|2207000|FG009|Treatment Period|Participant request to stop drug|2
1119810|NCT02574078|2207001|FG010|Treatment Period|Participant request to stop drug|2
1119811|NCT02574078|2207002|FG011|Treatment Period|Participant request to stop drug|4
1119812|NCT02574078|2207003|FG012|Treatment Period|Participant request to stop drug|1
1119813|NCT02574078|2206991|FG000|Treatment Period|Participant withdrew consent|0
1119814|NCT02574078|2206992|FG001|Treatment Period|Participant withdrew consent|0
1119815|NCT02574078|2206993|FG002|Treatment Period|Participant withdrew consent|0
1119816|NCT02574078|2206994|FG003|Treatment Period|Participant withdrew consent|0
1119817|NCT02574078|2206995|FG004|Treatment Period|Participant withdrew consent|1
1119818|NCT02574078|2206996|FG005|Treatment Period|Participant withdrew consent|1
1119819|NCT02574078|2206997|FG006|Treatment Period|Participant withdrew consent|0
1119820|NCT02574078|2206998|FG007|Treatment Period|Participant withdrew consent|1
1119821|NCT02574078|2206999|FG008|Treatment Period|Participant withdrew consent|0
1119822|NCT02574078|2207000|FG009|Treatment Period|Participant withdrew consent|2
1119823|NCT02574078|2207001|FG010|Treatment Period|Participant withdrew consent|1
1119824|NCT02574078|2207002|FG011|Treatment Period|Participant withdrew consent|4
1119825|NCT02574078|2207003|FG012|Treatment Period|Participant withdrew consent|1
1119826|NCT02574078|2206991|FG000|Treatment Period|Participant no longer meets criteria|0
1119827|NCT02574078|2206992|FG001|Treatment Period|Participant no longer meets criteria|0
1119828|NCT02574078|2206993|FG002|Treatment Period|Participant no longer meets criteria|0
1119829|NCT02574078|2206994|FG003|Treatment Period|Participant no longer meets criteria|0
1119830|NCT02574078|2206995|FG004|Treatment Period|Participant no longer meets criteria|1
898399|NCT00715676|1870897|FG001|Overall Study|Withdrawal by Subject|3
898400|NCT00715676|1870898|FG002|Overall Study|Withdrawal by Subject|8
898401|NCT00715676|1870896|FG000|Overall Study|Lost to Follow-up|1
898402|NCT00715676|1870897|FG001|Overall Study|Lost to Follow-up|2
898403|NCT00715676|1870898|FG002|Overall Study|Lost to Follow-up|1
898404|NCT00715676|1870896|FG000|Overall Study|Terminated by Sponsor|1
898405|NCT00715676|1870897|FG001|Overall Study|Terminated by Sponsor|0
898406|NCT00715676|1870898|FG002|Overall Study|Terminated by Sponsor|0
898407|NCT00715676|1870896|FG000|Overall Study|Did Not Meet Entry Criteria|0
898408|NCT00715676|1870897|FG001|Overall Study|Did Not Meet Entry Criteria|0
898409|NCT00715676|1870898|FG002|Overall Study|Did Not Meet Entry Criteria|1
898410|NCT00715676|1870896|FG000|Overall Study|Use of Exclusionary Medication|0
1119831|NCT02574078|2206996|FG005|Treatment Period|Participant no longer meets criteria|0
1119832|NCT02574078|2206997|FG006|Treatment Period|Participant no longer meets criteria|0
1119833|NCT02574078|2206998|FG007|Treatment Period|Participant no longer meets criteria|0
1119834|NCT02574078|2206999|FG008|Treatment Period|Participant no longer meets criteria|0
1119835|NCT02574078|2207000|FG009|Treatment Period|Participant no longer meets criteria|1
1119836|NCT02574078|2207001|FG010|Treatment Period|Participant no longer meets criteria|1
1119837|NCT02574078|2207002|FG011|Treatment Period|Participant no longer meets criteria|1
1119838|NCT02574078|2207003|FG012|Treatment Period|Participant no longer meets criteria|0
1119839|NCT02574078|2206991|FG000|Treatment Period|Lost to Follow-up|0
1119840|NCT02574078|2206992|FG001|Treatment Period|Lost to Follow-up|0
1119841|NCT02574078|2206993|FG002|Treatment Period|Lost to Follow-up|0
1119842|NCT02574078|2206994|FG003|Treatment Period|Lost to Follow-up|0
1119843|NCT02574078|2206995|FG004|Treatment Period|Lost to Follow-up|0
1119844|NCT02574078|2206996|FG005|Treatment Period|Lost to Follow-up|0
1119845|NCT02574078|2206997|FG006|Treatment Period|Lost to Follow-up|0
1119846|NCT02574078|2206998|FG007|Treatment Period|Lost to Follow-up|0
1119847|NCT02574078|2206999|FG008|Treatment Period|Lost to Follow-up|0
1119848|NCT02574078|2207000|FG009|Treatment Period|Lost to Follow-up|1
1119849|NCT02574078|2207001|FG010|Treatment Period|Lost to Follow-up|0
1119850|NCT02574078|2207002|FG011|Treatment Period|Lost to Follow-up|1
1119851|NCT02574078|2207003|FG012|Treatment Period|Lost to Follow-up|0
1119852|NCT02574078|2206991|FG000|Treatment Period|Maximum clinical benefit|0
1119853|NCT02574078|2206992|FG001|Treatment Period|Maximum clinical benefit|0
1119854|NCT02574078|2206993|FG002|Treatment Period|Maximum clinical benefit|0
1119855|NCT02574078|2206994|FG003|Treatment Period|Maximum clinical benefit|0
1119856|NCT02574078|2206995|FG004|Treatment Period|Maximum clinical benefit|0
1119857|NCT02574078|2206996|FG005|Treatment Period|Maximum clinical benefit|0
1119858|NCT02574078|2206997|FG006|Treatment Period|Maximum clinical benefit|0
1119859|NCT02574078|2206998|FG007|Treatment Period|Maximum clinical benefit|0
1119860|NCT02574078|2206999|FG008|Treatment Period|Maximum clinical benefit|0
1119861|NCT02574078|2207000|FG009|Treatment Period|Maximum clinical benefit|1
1119862|NCT02574078|2207001|FG010|Treatment Period|Maximum clinical benefit|0
1119863|NCT02574078|2207002|FG011|Treatment Period|Maximum clinical benefit|0
1119864|NCT02574078|2207003|FG012|Treatment Period|Maximum clinical benefit|0
1119865|NCT02574247|2207037|FG000|Overall Study|Withdrawal by Subject|1
1119866|NCT02574247|2207038|FG001|Overall Study|Withdrawal by Subject|0
1119867|NCT02574247|2207039|FG002|Overall Study|Withdrawal by Subject|0
1119868|NCT02574247|2207037|FG000|Overall Study|Did not meet inclusion criteria|4
1119869|NCT02574247|2207038|FG001|Overall Study|Did not meet inclusion criteria|3
1119870|NCT02574247|2207039|FG002|Overall Study|Did not meet inclusion criteria|5
1119871|NCT02574260|2207049|FG000|Overall Study|Disease Progression|1
1119872|NCT02574312|2207055|FG000|3 Months Follow-up|Withdrawal by Subject|1
1119873|NCT02574312|2207056|FG001|3 Months Follow-up|Withdrawal by Subject|0
1119880|NCT02574520|2207075|FG000|Overall Study|Not dosed|2
1119881|NCT02574520|2207076|FG001|Overall Study|Not dosed|0
1119882|NCT02574520|2207077|FG002|Overall Study|Not dosed|5
1119883|NCT02574520|2207078|FG003|Overall Study|Not dosed|4
1119884|NCT02574520|2207075|FG000|Overall Study|Adverse Event|0
1119885|NCT02574520|2207076|FG001|Overall Study|Adverse Event|0
1119886|NCT02574520|2207077|FG002|Overall Study|Adverse Event|0
1119887|NCT02574520|2207078|FG003|Overall Study|Adverse Event|1
1119888|NCT02574520|2207075|FG000|Overall Study|Withdrawal by Subject|0
1119889|NCT02574520|2207076|FG001|Overall Study|Withdrawal by Subject|0
1119890|NCT02574520|2207077|FG002|Overall Study|Withdrawal by Subject|0
1119891|NCT02574520|2207078|FG003|Overall Study|Withdrawal by Subject|1
1119892|NCT02574520|2207075|FG000|Overall Study|Other|0
1119893|NCT02574520|2207076|FG001|Overall Study|Other|0
1119894|NCT02574520|2207077|FG002|Overall Study|Other|0
1119895|NCT02574520|2207078|FG003|Overall Study|Other|2
1119896|NCT02574637|2207102|FG000|Double-blind Period|Adverse Event|1
1119897|NCT02574637|2207103|FG001|Double-blind Period|Adverse Event|0
1119898|NCT02574637|2207104|FG002|Double-blind Period|Adverse Event|0
1119899|NCT02574637|2207105|FG003|Double-blind Period|Adverse Event|0
1119900|NCT02574637|2207106|FG004|Double-blind Period|Adverse Event|0
1119901|NCT02574637|2207107|FG005|Double-blind Period|Adverse Event|0
1119902|NCT02574637|2207108|FG006|Double-blind Period|Adverse Event|0
1119903|NCT02574637|2207109|FG007|Double-blind Period|Adverse Event|0
1119904|NCT02574637|2207110|FG008|Double-blind Period|Adverse Event|0
1119905|NCT02574637|2207111|FG009|Double-blind Period|Adverse Event|0
1119906|NCT02574637|2207102|FG000|Double-blind Period|Lack of Efficacy|0
1119907|NCT02574637|2207103|FG001|Double-blind Period|Lack of Efficacy|0
1119908|NCT02574637|2207104|FG002|Double-blind Period|Lack of Efficacy|2
1119909|NCT02574637|2207105|FG003|Double-blind Period|Lack of Efficacy|0
1119910|NCT02574637|2207106|FG004|Double-blind Period|Lack of Efficacy|0
1119911|NCT02574637|2207107|FG005|Double-blind Period|Lack of Efficacy|0
1119912|NCT02574637|2207108|FG006|Double-blind Period|Lack of Efficacy|0
1119913|NCT02574637|2207109|FG007|Double-blind Period|Lack of Efficacy|0
1119914|NCT02574637|2207110|FG008|Double-blind Period|Lack of Efficacy|0
1119915|NCT02574637|2207111|FG009|Double-blind Period|Lack of Efficacy|0
1119916|NCT02574637|2207102|FG000|Double-blind Period|Protocol Deviation|1
1119917|NCT02574637|2207103|FG001|Double-blind Period|Protocol Deviation|0
1119918|NCT02574637|2207104|FG002|Double-blind Period|Protocol Deviation|0
1119919|NCT02574637|2207105|FG003|Double-blind Period|Protocol Deviation|0
1119920|NCT02574637|2207106|FG004|Double-blind Period|Protocol Deviation|0
1119921|NCT02574637|2207107|FG005|Double-blind Period|Protocol Deviation|0
1119922|NCT02574637|2207108|FG006|Double-blind Period|Protocol Deviation|0
1119923|NCT02574637|2207109|FG007|Double-blind Period|Protocol Deviation|0
1119924|NCT02574637|2207110|FG008|Double-blind Period|Protocol Deviation|0
1119925|NCT02574637|2207111|FG009|Double-blind Period|Protocol Deviation|0
1119926|NCT02574637|2207102|FG000|Double-blind Period|Non-Compliance With Study Drug|0
1119927|NCT02574637|2207103|FG001|Double-blind Period|Non-Compliance With Study Drug|0
1119928|NCT02574637|2207104|FG002|Double-blind Period|Non-Compliance With Study Drug|0
1119929|NCT02574637|2207105|FG003|Double-blind Period|Non-Compliance With Study Drug|1
1119930|NCT02574637|2207106|FG004|Double-blind Period|Non-Compliance With Study Drug|0
1119931|NCT02574637|2207107|FG005|Double-blind Period|Non-Compliance With Study Drug|0
1119932|NCT02574637|2207108|FG006|Double-blind Period|Non-Compliance With Study Drug|0
1119933|NCT02574637|2207109|FG007|Double-blind Period|Non-Compliance With Study Drug|0
1119934|NCT02574637|2207110|FG008|Double-blind Period|Non-Compliance With Study Drug|0
1119935|NCT02574637|2207111|FG009|Double-blind Period|Non-Compliance With Study Drug|0
1119936|NCT02574637|2207102|FG000|Double-blind Period|Study Terminated By Sponsor|1
1119937|NCT02574637|2207103|FG001|Double-blind Period|Study Terminated By Sponsor|1
1119938|NCT02574637|2207104|FG002|Double-blind Period|Study Terminated By Sponsor|5
1119939|NCT02574637|2207105|FG003|Double-blind Period|Study Terminated By Sponsor|2
1119940|NCT02574637|2207106|FG004|Double-blind Period|Study Terminated By Sponsor|2
1119941|NCT02574637|2207107|FG005|Double-blind Period|Study Terminated By Sponsor|0
1119942|NCT02574637|2207108|FG006|Double-blind Period|Study Terminated By Sponsor|0
1119943|NCT02574637|2207109|FG007|Double-blind Period|Study Terminated By Sponsor|0
1119944|NCT02574637|2207110|FG008|Double-blind Period|Study Terminated By Sponsor|0
1119945|NCT02574637|2207111|FG009|Double-blind Period|Study Terminated By Sponsor|0
1119946|NCT02574637|2207102|FG000|Double-blind Period|Reason Not Specified|0
1119947|NCT02574637|2207103|FG001|Double-blind Period|Reason Not Specified|0
1119948|NCT02574637|2207104|FG002|Double-blind Period|Reason Not Specified|0
1119949|NCT02574637|2207105|FG003|Double-blind Period|Reason Not Specified|1
1119950|NCT02574637|2207106|FG004|Double-blind Period|Reason Not Specified|0
1119951|NCT02574637|2207107|FG005|Double-blind Period|Reason Not Specified|0
1119952|NCT02574637|2207108|FG006|Double-blind Period|Reason Not Specified|0
1119953|NCT02574637|2207109|FG007|Double-blind Period|Reason Not Specified|0
1119954|NCT02574637|2207110|FG008|Double-blind Period|Reason Not Specified|0
1119955|NCT02574637|2207111|FG009|Double-blind Period|Reason Not Specified|0
1119956|NCT02574637|2207102|FG000|Open-label (OL) Period|Adverse Event|0
1119957|NCT02574637|2207103|FG001|Open-label (OL) Period|Adverse Event|0
1119958|NCT02574637|2207104|FG002|Open-label (OL) Period|Adverse Event|0
1119959|NCT02574637|2207105|FG003|Open-label (OL) Period|Adverse Event|0
1119960|NCT02574637|2207106|FG004|Open-label (OL) Period|Adverse Event|0
1119961|NCT02574637|2207107|FG005|Open-label (OL) Period|Adverse Event|0
1119962|NCT02574637|2207108|FG006|Open-label (OL) Period|Adverse Event|0
1119963|NCT02574637|2207109|FG007|Open-label (OL) Period|Adverse Event|0
1119964|NCT02574637|2207110|FG008|Open-label (OL) Period|Adverse Event|1
1119965|NCT02574637|2207111|FG009|Open-label (OL) Period|Adverse Event|0
1119966|NCT02574637|2207102|FG000|Open-label (OL) Period|Withdrawal by Subject|0
1119967|NCT02574637|2207103|FG001|Open-label (OL) Period|Withdrawal by Subject|0
1119968|NCT02574637|2207104|FG002|Open-label (OL) Period|Withdrawal by Subject|0
1119969|NCT02574637|2207105|FG003|Open-label (OL) Period|Withdrawal by Subject|0
1119970|NCT02574637|2207106|FG004|Open-label (OL) Period|Withdrawal by Subject|0
1119971|NCT02574637|2207107|FG005|Open-label (OL) Period|Withdrawal by Subject|1
1119972|NCT02574637|2207108|FG006|Open-label (OL) Period|Withdrawal by Subject|0
1119973|NCT02574637|2207109|FG007|Open-label (OL) Period|Withdrawal by Subject|0
1119974|NCT02574637|2207110|FG008|Open-label (OL) Period|Withdrawal by Subject|0
1119975|NCT02574637|2207111|FG009|Open-label (OL) Period|Withdrawal by Subject|1
1119976|NCT02574637|2207102|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0
1119977|NCT02574637|2207103|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0
1119978|NCT02574637|2207104|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0
1119979|NCT02574637|2207105|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0
1119980|NCT02574637|2207106|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0
1119981|NCT02574637|2207107|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1
1119982|NCT02574637|2207108|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2
1119983|NCT02574637|2207109|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1
1119984|NCT02574637|2207110|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1
1119985|NCT02574637|2207111|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0
1119986|NCT02574845|2207142|FG000|Overall Study|Consent withdrawn further participation|0
1119987|NCT02574845|2207143|FG001|Overall Study|Consent withdrawn further participation|0
1119988|NCT02574845|2207144|FG002|Overall Study|Consent withdrawn further participation|0
1119989|NCT02574845|2207145|FG003|Overall Study|Consent withdrawn further participation|0
1119990|NCT02574845|2207146|FG004|Overall Study|Consent withdrawn further participation|1
1119991|NCT02574845|2207147|FG005|Overall Study|Consent withdrawn further participation|0
1119992|NCT02574845|2207142|FG000|Overall Study|Adverse Event|0
898411|NCT00715676|1870897|FG001|Overall Study|Use of Exclusionary Medication|0
898412|NCT00715676|1870898|FG002|Overall Study|Use of Exclusionary Medication|1
898413|NCT00715676|1870896|FG000|Overall Study|Elevated Blood Glucose|0
898414|NCT00715676|1870897|FG001|Overall Study|Elevated Blood Glucose|1
898415|NCT00715676|1870898|FG002|Overall Study|Elevated Blood Glucose|0
898416|NCT00715793|1870938|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
898417|NCT00715793|1870939|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
898418|NCT00715793|1870938|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
898419|NCT00715793|1870939|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
898420|NCT00715910|1870959|FG000|Booster and ESFU Phase|Lost to Follow-up|0
898421|NCT00715910|1870960|FG001|Booster and ESFU Phase|Lost to Follow-up|0
898422|NCT00715910|1870961|FG002|Booster and ESFU Phase|Lost to Follow-up|0
898423|NCT00715910|1870962|FG003|Booster and ESFU Phase|Lost to Follow-up|6
1119993|NCT02574845|2207143|FG001|Overall Study|Adverse Event|1
1119994|NCT02574845|2207144|FG002|Overall Study|Adverse Event|0
1119995|NCT02574845|2207145|FG003|Overall Study|Adverse Event|0
1119996|NCT02574845|2207146|FG004|Overall Study|Adverse Event|0
1119997|NCT02574845|2207147|FG005|Overall Study|Adverse Event|1
1119998|NCT02575079|2207167|FG000|Overall Study|Death|3
1119999|NCT02575079|2207168|FG001|Overall Study|Death|0
1120000|NCT02575079|2207167|FG000|Overall Study|Withdrawal by Subject|3
1120001|NCT02575079|2207168|FG001|Overall Study|Withdrawal by Subject|0
1120002|NCT02575807|2207182|FG000|Overall Study|Death|8
1120003|NCT02575807|2207183|FG001|Overall Study|Death|3
1120004|NCT02575807|2207184|FG002|Overall Study|Death|7
1120005|NCT02575807|2207185|FG003|Overall Study|Death|0
1120006|NCT02575807|2207186|FG004|Overall Study|Death|1
1120007|NCT02575807|2207182|FG000|Overall Study|Study terminated by Sponsor|0
1120008|NCT02575807|2207183|FG001|Overall Study|Study terminated by Sponsor|1
1120009|NCT02575807|2207184|FG002|Overall Study|Study terminated by Sponsor|7
1120010|NCT02575807|2207185|FG003|Overall Study|Study terminated by Sponsor|0
1120011|NCT02575807|2207186|FG004|Overall Study|Study terminated by Sponsor|1
1120012|NCT02575807|2207182|FG000|Overall Study|Terminated due to FDA clinical hold|1
1120013|NCT02575807|2207183|FG001|Overall Study|Terminated due to FDA clinical hold|0
1120014|NCT02575807|2207184|FG002|Overall Study|Terminated due to FDA clinical hold|0
1120015|NCT02575807|2207185|FG003|Overall Study|Terminated due to FDA clinical hold|0
1120016|NCT02575807|2207186|FG004|Overall Study|Terminated due to FDA clinical hold|0
1120017|NCT02575807|2207182|FG000|Overall Study|Terminated due to physician decision|0
1120018|NCT02575807|2207183|FG001|Overall Study|Terminated due to physician decision|0
1120019|NCT02575807|2207184|FG002|Overall Study|Terminated due to physician decision|1
1120020|NCT02575807|2207185|FG003|Overall Study|Terminated due to physician decision|0
1120021|NCT02575807|2207186|FG004|Overall Study|Terminated due to physician decision|0
1120022|NCT02575807|2207182|FG000|Overall Study|Subject ineligible - medical implant|0
1120023|NCT02575807|2207183|FG001|Overall Study|Subject ineligible - medical implant|0
1120024|NCT02575807|2207184|FG002|Overall Study|Subject ineligible - medical implant|0
1120025|NCT02575807|2207185|FG003|Overall Study|Subject ineligible - medical implant|1
1120026|NCT02575807|2207186|FG004|Overall Study|Subject ineligible - medical implant|0
1120027|NCT02575807|2207182|FG000|Overall Study|Withdrawal by Subject|0
1120028|NCT02575807|2207183|FG001|Overall Study|Withdrawal by Subject|0
1120029|NCT02575807|2207184|FG002|Overall Study|Withdrawal by Subject|1
1120030|NCT02575807|2207185|FG003|Overall Study|Withdrawal by Subject|1
1120031|NCT02575807|2207186|FG004|Overall Study|Withdrawal by Subject|2
1120032|NCT02575833|2207202|FG000|Overall Study|Withdrawal by Subject|0
1120033|NCT02575833|2207203|FG001|Overall Study|Withdrawal by Subject|1
1120034|NCT02575833|2207202|FG000|Overall Study|Lost to Follow-up|1
1120035|NCT02575833|2207203|FG001|Overall Study|Lost to Follow-up|0
1120036|NCT02575911|2207209|FG000|Overall Study|Lost to Follow-up|1
1120037|NCT02575950|2207221|FG000|Overall Study|Withdrawal by Subject|0
1120038|NCT02575950|2207222|FG001|Overall Study|Withdrawal by Subject|0
1120039|NCT02575950|2207223|FG002|Overall Study|Withdrawal by Subject|0
1120040|NCT02575950|2207224|FG003|Overall Study|Withdrawal by Subject|2
1120041|NCT02575950|2207221|FG000|Overall Study|Lost to Follow-up|0
1120042|NCT02575950|2207222|FG001|Overall Study|Lost to Follow-up|1
1120043|NCT02575950|2207223|FG002|Overall Study|Lost to Follow-up|0
1120044|NCT02575950|2207224|FG003|Overall Study|Lost to Follow-up|3
1120045|NCT02576054|2207236|FG000|Overall Study|Withdrawal by Subject|1
1120046|NCT02576067|2207244|FG000|Overall Study|Death|0
1120047|NCT02576067|2207245|FG001|Overall Study|Death|1
1120048|NCT02576067|2207244|FG000|Overall Study|Lack of Efficacy|1
1120049|NCT02576067|2207245|FG001|Overall Study|Lack of Efficacy|0
1120050|NCT02576067|2207244|FG000|Overall Study|Lost to Follow-up|11
1120051|NCT02576067|2207245|FG001|Overall Study|Lost to Follow-up|0
1120052|NCT02576067|2207244|FG000|Overall Study|Withdrawal by Subject|11
1120053|NCT02576067|2207245|FG001|Overall Study|Withdrawal by Subject|2
1120054|NCT02576067|2207244|FG000|Overall Study|study closure of main CIRT trial)|0
1120055|NCT02576067|2207245|FG001|Overall Study|study closure of main CIRT trial)|8
1120056|NCT02576067|2207244|FG000|Overall Study|not randomized, failed run-in|7
1120057|NCT02576067|2207245|FG001|Overall Study|not randomized, failed run-in|0
1120058|NCT02576067|2207244|FG000|Overall Study|screen failure/ re-enrolled|0
1120059|NCT02576067|2207245|FG001|Overall Study|screen failure/ re-enrolled|25
1120060|NCT02576067|2207244|FG000|Overall Study|Physician Decision|4
1120061|NCT02576067|2207245|FG001|Overall Study|Physician Decision|0
1120062|NCT02576145|2207253|FG000|Overall Study|Adverse Event|1
1120063|NCT02576145|2207254|FG001|Overall Study|Adverse Event|0
1120064|NCT02576145|2207253|FG000|Overall Study|Withdrawal by Subject|1
1120065|NCT02576145|2207254|FG001|Overall Study|Withdrawal by Subject|0
1120066|NCT02576145|2207253|FG000|Overall Study|Acute rejection|1
1120067|NCT02576145|2207254|FG001|Overall Study|Acute rejection|0
1120068|NCT02576145|2207253|FG000|Overall Study|Tetanus Titers Decreased|0
1120069|NCT02576145|2207254|FG001|Overall Study|Tetanus Titers Decreased|1
1120070|NCT02576509|2207271|FG000|Pre-Treatment Period|Participant request to stop therapy|0
1120071|NCT02576509|2207272|FG001|Pre-Treatment Period|Participant request to stop therapy|2
1120072|NCT02576509|2207271|FG000|Pre-Treatment Period|Participant withdrew consent|1
1120073|NCT02576509|2207272|FG001|Pre-Treatment Period|Participant withdrew consent|5
1120074|NCT02576509|2207271|FG000|Pre-Treatment Period|Participant no longer meets criteria|3
1120075|NCT02576509|2207272|FG001|Pre-Treatment Period|Participant no longer meets criteria|2
1120076|NCT02576509|2207271|FG000|Treatment Period|Disease progression|245
1120077|NCT02576509|2207272|FG001|Treatment Period|Disease progression|240
1120078|NCT02576509|2207271|FG000|Treatment Period|Study drug toxicity|32
1120079|NCT02576509|2207272|FG001|Treatment Period|Study drug toxicity|41
1120080|NCT02576509|2207271|FG000|Treatment Period|Death|1
1120081|NCT02576509|2207272|FG001|Treatment Period|Death|1
1120082|NCT02576509|2207271|FG000|Treatment Period|Adverse event unrelated to study drug|37
1120083|NCT02576509|2207272|FG001|Treatment Period|Adverse event unrelated to study drug|40
1120084|NCT02576509|2207271|FG000|Treatment Period|Participant request to stop treatment|8
1120085|NCT02576509|2207272|FG001|Treatment Period|Participant request to stop treatment|17
1120086|NCT02576509|2207271|FG000|Treatment Period|Participant withdrew consent|2
1120087|NCT02576509|2207272|FG001|Treatment Period|Participant withdrew consent|7
1120088|NCT02576509|2207271|FG000|Treatment Period|Lost to Follow-up|0
1120089|NCT02576509|2207272|FG001|Treatment Period|Lost to Follow-up|1
1120090|NCT02576509|2207271|FG000|Treatment Period|Maximum clinical benefit|1
1120091|NCT02576509|2207272|FG001|Treatment Period|Maximum clinical benefit|0
1120092|NCT02576509|2207271|FG000|Treatment Period|Poor/non-compliance|0
1120093|NCT02576509|2207272|FG001|Treatment Period|Poor/non-compliance|1
1120094|NCT02576509|2207271|FG000|Treatment Period|Participant no longer meets criteria|1
1120095|NCT02576509|2207272|FG001|Treatment Period|Participant no longer meets criteria|0
1120096|NCT02576509|2207271|FG000|Treatment Period|Other reason|2
1120097|NCT02576509|2207272|FG001|Treatment Period|Other reason|7
1120098|NCT02576509|2207271|FG000|Follow-up Period|Death|41
1120099|NCT02576509|2207272|FG001|Follow-up Period|Death|35
1120100|NCT02576509|2207271|FG000|Follow-up Period|Participant withdrew consent|7
1120101|NCT02576509|2207272|FG001|Follow-up Period|Participant withdrew consent|14
1120102|NCT02576509|2207271|FG000|Follow-up Period|Lost to Follow-up|0
1120103|NCT02576509|2207272|FG001|Follow-up Period|Lost to Follow-up|1
1120104|NCT02576509|2207271|FG000|Follow-up Period|Other reason|1
1120105|NCT02576509|2207272|FG001|Follow-up Period|Other reason|2
1120106|NCT02576535|2207278|FG000|Overall Study|Withdrawal by Subject|2
1120107|NCT02576587|2207284|FG000|Baseline|Equipment failure|0
1120108|NCT02576587|2207285|FG001|Baseline|Equipment failure|1
1120109|NCT02576587|2207284|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25
1120110|NCT02576587|2207285|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0
1120111|NCT02576587|2207284|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
1120112|NCT02576587|2207285|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
1120113|NCT02576587|2207284|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0
1120114|NCT02576587|2207285|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155
1120115|NCT02576639|2207298|FG000|Overall Study|Withdrawal by Subject|1
1120116|NCT02576639|2207299|FG001|Overall Study|Withdrawal by Subject|2
1120117|NCT02576639|2207300|FG002|Overall Study|Withdrawal by Subject|1
1120118|NCT02576639|2207301|FG003|Overall Study|Withdrawal by Subject|0
1120119|NCT02576639|2207302|FG004|Overall Study|Withdrawal by Subject|1
1120120|NCT02576639|2207298|FG000|Overall Study|Adverse Event|1
1120121|NCT02576639|2207299|FG001|Overall Study|Adverse Event|0
1120122|NCT02576639|2207300|FG002|Overall Study|Adverse Event|1
1120123|NCT02576639|2207301|FG003|Overall Study|Adverse Event|1
1120124|NCT02576639|2207302|FG004|Overall Study|Adverse Event|2
1120125|NCT02576639|2207298|FG000|Overall Study|Physician Decision|0
1120126|NCT02576639|2207299|FG001|Overall Study|Physician Decision|0
1120127|NCT02576639|2207300|FG002|Overall Study|Physician Decision|0
1120128|NCT02576639|2207301|FG003|Overall Study|Physician Decision|0
1120129|NCT02576639|2207302|FG004|Overall Study|Physician Decision|1
1120130|NCT02576652|2207318|FG000|Overall Study|Withdrawal by Subject|2
1120131|NCT02576678|2207325|FG000|Overall Study|Adverse Event|0
1120132|NCT02576678|2207326|FG001|Overall Study|Adverse Event|0
1120133|NCT02576678|2207327|FG002|Overall Study|Adverse Event|2
1120134|NCT02576678|2207325|FG000|Overall Study|Withdrawal by Subject|3
1120135|NCT02576678|2207326|FG001|Overall Study|Withdrawal by Subject|1
1120136|NCT02576678|2207327|FG002|Overall Study|Withdrawal by Subject|2
1120137|NCT02576678|2207325|FG000|Overall Study|Lost to Follow-up|0
1120138|NCT02576678|2207326|FG001|Overall Study|Lost to Follow-up|0
1120139|NCT02576678|2207327|FG002|Overall Study|Lost to Follow-up|1
1120140|NCT02576678|2207325|FG000|Overall Study|Miscellaneous|2
1120141|NCT02576678|2207326|FG001|Overall Study|Miscellaneous|0
1120142|NCT02576678|2207327|FG002|Overall Study|Miscellaneous|0
1120143|NCT02576938|2207348|FG000|Overall Study|Adverse Event|5
1120144|NCT02576938|2207349|FG001|Overall Study|Adverse Event|3
1120145|NCT02576938|2207350|FG002|Overall Study|Adverse Event|6
1120146|NCT02576938|2207348|FG000|Overall Study|Protocol Violation|1
1120147|NCT02576938|2207349|FG001|Overall Study|Protocol Violation|1
1120148|NCT02576938|2207350|FG002|Overall Study|Protocol Violation|1
1120149|NCT02576938|2207348|FG000|Overall Study|Withdrawal by Subject|3
1120150|NCT02576938|2207349|FG001|Overall Study|Withdrawal by Subject|2
1120151|NCT02576938|2207350|FG002|Overall Study|Withdrawal by Subject|4
1120152|NCT02576938|2207348|FG000|Overall Study|Lack of Efficacy|9
1120153|NCT02576938|2207349|FG001|Overall Study|Lack of Efficacy|4
1120154|NCT02576938|2207350|FG002|Overall Study|Lack of Efficacy|0
1120155|NCT02576938|2207348|FG000|Overall Study|Lost to Follow-up|2
1120156|NCT02576938|2207349|FG001|Overall Study|Lost to Follow-up|0
1120157|NCT02576938|2207350|FG002|Overall Study|Lost to Follow-up|1
1120158|NCT02576938|2207348|FG000|Overall Study|Physician Decision|0
1120159|NCT02576938|2207349|FG001|Overall Study|Physician Decision|1
1120160|NCT02576938|2207350|FG002|Overall Study|Physician Decision|0
1120161|NCT02576938|2207348|FG000|Overall Study|Met Exclusion Criteria|0
1120162|NCT02576938|2207349|FG001|Overall Study|Met Exclusion Criteria|1
1120163|NCT02576938|2207350|FG002|Overall Study|Met Exclusion Criteria|0
1120164|NCT02576951|2207364|FG000|Overall Study|Lost to Follow-up|0
1120165|NCT02576951|2207365|FG001|Overall Study|Lost to Follow-up|0
1120166|NCT02576951|2207366|FG002|Overall Study|Lost to Follow-up|2
1120167|NCT02576951|2207367|FG003|Overall Study|Lost to Follow-up|2
1120168|NCT02576951|2207364|FG000|Overall Study|Withdrawal by Subject|1
1120169|NCT02576951|2207365|FG001|Overall Study|Withdrawal by Subject|0
1120170|NCT02576951|2207366|FG002|Overall Study|Withdrawal by Subject|0
1120171|NCT02576951|2207367|FG003|Overall Study|Withdrawal by Subject|2
1120172|NCT02576951|2207364|FG000|Overall Study|Protocol Violation|0
1120173|NCT02576951|2207365|FG001|Overall Study|Protocol Violation|0
1120174|NCT02576951|2207366|FG002|Overall Study|Protocol Violation|0
1120175|NCT02576951|2207367|FG003|Overall Study|Protocol Violation|1
1120176|NCT02576977|2207381|FG000|Overall Study|Adverse Event|13
1120177|NCT02576977|2207382|FG001|Overall Study|Adverse Event|2
1120178|NCT02576977|2207381|FG000|Overall Study|Death|73
1120179|NCT02576977|2207382|FG001|Overall Study|Death|60
1120180|NCT02576977|2207381|FG000|Overall Study|Screen failure|1
1120181|NCT02576977|2207382|FG001|Overall Study|Screen failure|0
1120182|NCT02576977|2207381|FG000|Overall Study|Study Terminated at Selected Sites|27
1120183|NCT02576977|2207382|FG001|Overall Study|Study Terminated at Selected Sites|50
1120184|NCT02576977|2207381|FG000|Overall Study|Withdrawal by Subject|11
1120185|NCT02576977|2207382|FG001|Overall Study|Withdrawal by Subject|11
1120186|NCT02576977|2207381|FG000|Overall Study|Final Disposition Unknown|0
1120187|NCT02576977|2207382|FG001|Overall Study|Final Disposition Unknown|1
1120188|NCT02576977|2207381|FG000|Overall Study|Lost to Follow-up|1
1120189|NCT02576977|2207382|FG001|Overall Study|Lost to Follow-up|0
1120190|NCT02576977|2207381|FG000|Overall Study|Progressive Disease|0
1120191|NCT02576977|2207382|FG001|Overall Study|Progressive Disease|1
1120192|NCT02576990|2207390|FG000|Overall Study|Death|29
1120193|NCT02576990|2207391|FG001|Overall Study|Death|18
1120194|NCT02576990|2207390|FG000|Overall Study|Physician Decision|1
1120195|NCT02576990|2207391|FG001|Overall Study|Physician Decision|0
1120196|NCT02576990|2207390|FG000|Overall Study|Screen failure|2
1120197|NCT02576990|2207391|FG001|Overall Study|Screen failure|0
1120198|NCT02576990|2207390|FG000|Overall Study|Sponsor's decision|24
1120199|NCT02576990|2207391|FG001|Overall Study|Sponsor's decision|4
1120200|NCT02576990|2207390|FG000|Overall Study|Withdrawal by Subject|0
1120201|NCT02576990|2207391|FG001|Overall Study|Withdrawal by Subject|2
1120202|NCT02577003|2207399|FG000|Overall Study|Adverse Event|2
1120203|NCT02577003|2207400|FG001|Overall Study|Adverse Event|4
1120204|NCT02577003|2207399|FG000|Overall Study|Withdrawal by Subject|0
1120205|NCT02577003|2207400|FG001|Overall Study|Withdrawal by Subject|1
1120206|NCT02577016|2207408|FG000|Overall Study|Adverse Event|2
1120207|NCT02577016|2207409|FG001|Overall Study|Adverse Event|1
1120208|NCT02577016|2207408|FG000|Overall Study|Physician Decision|0
1120209|NCT02577016|2207409|FG001|Overall Study|Physician Decision|1
1120210|NCT02577029|2207423|FG000|Overall Study|Adverse Event|1
1120211|NCT02577029|2207424|FG001|Overall Study|Adverse Event|0
1120212|NCT02577029|2207425|FG002|Overall Study|Adverse Event|2
1120213|NCT02577029|2207426|FG003|Overall Study|Adverse Event|0
1120214|NCT02577029|2207427|FG004|Overall Study|Adverse Event|1
1120215|NCT02577029|2207428|FG005|Overall Study|Adverse Event|0
1120216|NCT02577029|2207429|FG006|Overall Study|Adverse Event|0
1120217|NCT02577029|2207430|FG007|Overall Study|Adverse Event|0
1120218|NCT02577029|2207423|FG000|Overall Study|Withdrawal by Subject|0
1120219|NCT02577029|2207424|FG001|Overall Study|Withdrawal by Subject|0
1120220|NCT02577029|2207425|FG002|Overall Study|Withdrawal by Subject|0
1120221|NCT02577029|2207426|FG003|Overall Study|Withdrawal by Subject|0
1120222|NCT02577029|2207427|FG004|Overall Study|Withdrawal by Subject|0
1120223|NCT02577029|2207428|FG005|Overall Study|Withdrawal by Subject|1
1120224|NCT02577029|2207429|FG006|Overall Study|Withdrawal by Subject|0
1120225|NCT02577029|2207430|FG007|Overall Study|Withdrawal by Subject|0
1120226|NCT02577029|2207423|FG000|Overall Study|Sponsor Termination of the Study|9
1120227|NCT02577029|2207424|FG001|Overall Study|Sponsor Termination of the Study|2
1120228|NCT02577029|2207425|FG002|Overall Study|Sponsor Termination of the Study|5
1120229|NCT02577029|2207426|FG003|Overall Study|Sponsor Termination of the Study|12
1120230|NCT02577029|2207427|FG004|Overall Study|Sponsor Termination of the Study|10
1120231|NCT02577029|2207428|FG005|Overall Study|Sponsor Termination of the Study|12
1120232|NCT02577029|2207429|FG006|Overall Study|Sponsor Termination of the Study|12
1120233|NCT02577029|2207430|FG007|Overall Study|Sponsor Termination of the Study|12
1120234|NCT02577107|2207460|FG000|Overall Study|Protocol deviation|0
1120235|NCT02577107|2207461|FG001|Overall Study|Protocol deviation|1
1120236|NCT02577146|2207467|FG000|Overall Study|Lost to Follow-up|8
1120237|NCT02577146|2207467|FG000|Overall Study|Physician Decision|3
1120238|NCT02577146|2207467|FG000|Overall Study|Screen Failure|17
1120239|NCT02577315|2207473|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1120240|NCT02577315|2207474|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1120249|NCT02577718|2207545|FG000|Overall Study|Death|6
1120250|NCT02577718|2207545|FG000|Overall Study|Withdrawal by Subject|2
1120251|NCT02577887|2207560|FG000|Overall Study|Death|93
1120252|NCT02577887|2207560|FG000|Overall Study|Protocol Violation|125
1120253|NCT02577887|2207560|FG000|Overall Study|Withdrawal by Subject|80
1120254|NCT02578186|2207599|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
1120255|NCT02578186|2207600|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
1120256|NCT02578186|2207599|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1
1120257|NCT02578186|2207600|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1
1120258|NCT02578316|2207614|FG000|Extension Phase|Progression of disease|6
1120259|NCT02578680|2207624|FG000|Overall Study|Death|124
1120260|NCT02578680|2207625|FG001|Overall Study|Death|104
1120261|NCT02578680|2207624|FG000|Overall Study|Protocol Violation|1
1120262|NCT02578680|2207625|FG001|Overall Study|Protocol Violation|1
1120263|NCT02578680|2207624|FG000|Overall Study|Withdrawal by Parent/Guardian|1
1120264|NCT02578680|2207625|FG001|Overall Study|Withdrawal by Parent/Guardian|0
1120265|NCT02578680|2207624|FG000|Overall Study|Withdrawal by Subject|8
1120266|NCT02578680|2207625|FG001|Overall Study|Withdrawal by Subject|5
1120267|NCT02578680|2207624|FG000|Overall Study|Ongoing in Study|276
1120268|NCT02578680|2207625|FG001|Overall Study|Ongoing in Study|96
1120269|NCT02578706|2207634|FG000|Overall Study|Withdrawal by Subject|1
1120270|NCT02578706|2207635|FG001|Overall Study|Withdrawal by Subject|0
1120271|NCT02578706|2207636|FG002|Overall Study|Withdrawal by Subject|0
1120272|NCT02578706|2207634|FG000|Overall Study|Lost to Follow-up|0
1120273|NCT02578706|2207635|FG001|Overall Study|Lost to Follow-up|4
1120274|NCT02578706|2207636|FG002|Overall Study|Lost to Follow-up|0
1120275|NCT02578706|2207634|FG000|Overall Study|Physician Decision|0
1120276|NCT02578706|2207635|FG001|Overall Study|Physician Decision|1
1120277|NCT02578706|2207636|FG002|Overall Study|Physician Decision|0
1120278|NCT02578862|2207660|FG000|Overall Study|Withdrawal by Subject|0
1120279|NCT02578862|2207661|FG001|Overall Study|Withdrawal by Subject|1
1120280|NCT02578862|2207660|FG000|Overall Study|Unplanned unilateral procedure|0
1120281|NCT02578862|2207661|FG001|Overall Study|Unplanned unilateral procedure|1
1120282|NCT02578940|2207676|FG000|Overall Study|Screening failure|5
1120283|NCT02578940|2207676|FG000|Overall Study|Lost to Follow-up|1
1120284|NCT02578992|2207684|FG000|Overall Study|equipment not available or malfunction|3
1120285|NCT02578992|2207685|FG001|Overall Study|equipment not available or malfunction|3
1120286|NCT02579382|2207728|FG000|Main Study Phase|Lost to Follow-up|0
1120287|NCT02579382|2207729|FG001|Main Study Phase|Lost to Follow-up|0
1120288|NCT02579382|2207730|FG002|Main Study Phase|Lost to Follow-up|2
1120289|NCT02579382|2207731|FG003|Main Study Phase|Lost to Follow-up|0
1120290|NCT02579382|2207728|FG000|Main Study Phase|Withdrew Consent|0
1120291|NCT02579382|2207729|FG001|Main Study Phase|Withdrew Consent|0
1120292|NCT02579382|2207730|FG002|Main Study Phase|Withdrew Consent|0
1120293|NCT02579382|2207731|FG003|Main Study Phase|Withdrew Consent|2
1120294|NCT02579382|2207728|FG000|Main Study Phase|Lack of Efficacy|0
1120295|NCT02579382|2207729|FG001|Main Study Phase|Lack of Efficacy|0
1120296|NCT02579382|2207730|FG002|Main Study Phase|Lack of Efficacy|0
1120297|NCT02579382|2207731|FG003|Main Study Phase|Lack of Efficacy|1
1120298|NCT02579382|2207728|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
1120299|NCT02579382|2207729|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
1162075|NCT03382899|2284097|FG000|Overall Study|Ineligibility Determined|0
1120300|NCT02579382|2207730|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
1120301|NCT02579382|2207731|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
1120302|NCT02579382|2207728|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1
1120303|NCT02579382|2207729|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
1120304|NCT02579382|2207730|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2
1120305|NCT02579382|2207731|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
1120306|NCT02579382|2207728|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
1120307|NCT02579382|2207729|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
1120308|NCT02579382|2207730|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
1120309|NCT02579382|2207731|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
1120310|NCT02579382|2207728|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
1120311|NCT02579382|2207729|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
1120312|NCT02579382|2207730|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
1120313|NCT02579382|2207731|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
1120314|NCT02579382|2207728|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
1120315|NCT02579382|2207729|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
1120316|NCT02579382|2207730|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
1120317|NCT02579382|2207731|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
1120318|NCT02579382|2207728|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
1120319|NCT02579382|2207729|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
1120320|NCT02579382|2207730|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
1120321|NCT02579382|2207731|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
1120322|NCT02579603|2207768|FG000|Overall Study|Not treated|1
1120323|NCT02579603|2207769|FG001|Overall Study|Not treated|0
1120324|NCT02579603|2207768|FG000|Overall Study|Adverse Event|2
1120325|NCT02579603|2207769|FG001|Overall Study|Adverse Event|2
1120326|NCT02579603|2207768|FG000|Overall Study|Other than stated|1
1120327|NCT02579603|2207769|FG001|Overall Study|Other than stated|0
1120328|NCT02579616|2207776|FG000|Overall Study|Participants did not receive treatment|3
1120329|NCT02579629|2207783|FG000|Overall Study|Withdrawal by Subject|0
1120330|NCT02579629|2207784|FG001|Overall Study|Withdrawal by Subject|1
1120331|NCT02579629|2207785|FG002|Overall Study|Withdrawal by Subject|0
1120332|NCT02579629|2207783|FG000|Overall Study|Screen Failure|2
1120333|NCT02579629|2207784|FG001|Overall Study|Screen Failure|0
1120334|NCT02579629|2207785|FG002|Overall Study|Screen Failure|2
1120335|NCT02579759|2207796|FG000|Overall Study|Protocol Violation|2
1120336|NCT02579759|2207797|FG001|Overall Study|Protocol Violation|0
1120337|NCT02579759|2207798|FG002|Overall Study|Protocol Violation|0
1120338|NCT02579759|2207796|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0
1120339|NCT02579759|2207797|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1
1120340|NCT02579759|2207798|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0
1120341|NCT02579759|2207796|FG000|Overall Study|BfArM hold|13
1120342|NCT02579759|2207797|FG001|Overall Study|BfArM hold|12
1120343|NCT02579759|2207798|FG002|Overall Study|BfArM hold|12
1120344|NCT02579759|2207796|FG000|Overall Study|Sponsor stopped Dose 2|0
1120345|NCT02579759|2207797|FG001|Overall Study|Sponsor stopped Dose 2|41
898424|NCT00715910|1870963|FG004|Booster and ESFU Phase|Lost to Follow-up|1
898425|NCT00715910|1870964|FG005|Booster and ESFU Phase|Lost to Follow-up|13
898426|NCT00715910|1870959|FG000|Booster and ESFU Phase|Other|0
1120346|NCT02579759|2207798|FG002|Overall Study|Sponsor stopped Dose 2|0
1120347|NCT02579759|2207796|FG000|Overall Study|Non compliance|0
1120348|NCT02579759|2207797|FG001|Overall Study|Non compliance|1
1120349|NCT02579759|2207798|FG002|Overall Study|Non compliance|0
1120350|NCT02579759|2207796|FG000|Overall Study|Pregnancy|0
1120351|NCT02579759|2207797|FG001|Overall Study|Pregnancy|1
1120352|NCT02579759|2207798|FG002|Overall Study|Pregnancy|0
1120353|NCT02579759|2207796|FG000|Overall Study|Inclusion/exclusion criteria|0
1120354|NCT02579759|2207797|FG001|Overall Study|Inclusion/exclusion criteria|0
1120355|NCT02579759|2207798|FG002|Overall Study|Inclusion/exclusion criteria|1
1120356|NCT02579759|2207796|FG000|Overall Study|Adverse Event|4
1120357|NCT02579759|2207797|FG001|Overall Study|Adverse Event|3
1120358|NCT02579759|2207798|FG002|Overall Study|Adverse Event|1
1120359|NCT02579759|2207796|FG000|Overall Study|Withdrawal by Subject|3
1120360|NCT02579759|2207797|FG001|Overall Study|Withdrawal by Subject|3
1120361|NCT02579759|2207798|FG002|Overall Study|Withdrawal by Subject|5
1120362|NCT02579759|2207796|FG000|Overall Study|Lost to Follow-up|2
1120363|NCT02579759|2207797|FG001|Overall Study|Lost to Follow-up|2
1120364|NCT02579759|2207798|FG002|Overall Study|Lost to Follow-up|2
1120365|NCT02579772|2207808|FG000|Overall Study|Withdrawal by Subject|0
1120366|NCT02579772|2207809|FG001|Overall Study|Withdrawal by Subject|1
898427|NCT00715910|1870960|FG001|Booster and ESFU Phase|Other|0
898428|NCT00715910|1870961|FG002|Booster and ESFU Phase|Other|0
898429|NCT00715910|1870962|FG003|Booster and ESFU Phase|Other|5
898430|NCT00715910|1870963|FG004|Booster and ESFU Phase|Other|1
898431|NCT00715910|1870964|FG005|Booster and ESFU Phase|Other|0
898432|NCT00715949|1870980|FG000|Overall Study|could not finish first test|4
898433|NCT00716092|1871006|FG000|Overall Study|Other incl. Lack of Efficacy|2
898434|NCT00716092|1871007|FG001|Overall Study|Other incl. Lack of Efficacy|1
898435|NCT00716092|1871008|FG002|Overall Study|Other incl. Lack of Efficacy|0
898436|NCT00716144|1871020|FG000|Overall Study|Withdrawal by Subject|4
898437|NCT00716144|1871021|FG001|Overall Study|Withdrawal by Subject|2
1120367|NCT02579772|2207808|FG000|Overall Study|Usage of additional antioxidants|1
1120368|NCT02579772|2207809|FG001|Overall Study|Usage of additional antioxidants|0
1120369|NCT02579772|2207808|FG000|Overall Study|flu-like illness, orthopedic trauma|1
1120370|NCT02579772|2207809|FG001|Overall Study|flu-like illness, orthopedic trauma|1
1120371|NCT02579863|2207821|FG000|Overall Study|Final Disposition Unknown|2
1120372|NCT02579863|2207822|FG001|Overall Study|Final Disposition Unknown|1
1120373|NCT02579863|2207821|FG000|Overall Study|Adverse Event|18
1120374|NCT02579863|2207822|FG001|Overall Study|Adverse Event|11
1120375|NCT02579863|2207821|FG000|Overall Study|Death|31
1120376|NCT02579863|2207822|FG001|Overall Study|Death|29
1120377|NCT02579863|2207821|FG000|Overall Study|Lost to Follow-up|2
1120378|NCT02579863|2207822|FG001|Overall Study|Lost to Follow-up|1
1120379|NCT02579863|2207821|FG000|Overall Study|Physician Decision|1
1120380|NCT02579863|2207822|FG001|Overall Study|Physician Decision|2
1120381|NCT02579863|2207821|FG000|Overall Study|Screen Failure|0
1120382|NCT02579863|2207822|FG001|Overall Study|Screen Failure|2
1120383|NCT02579863|2207821|FG000|Overall Study|Study Terminated at Selected Sites|82
1120384|NCT02579863|2207822|FG001|Overall Study|Study Terminated at Selected Sites|88
1120385|NCT02579863|2207821|FG000|Overall Study|Withdrawal by Subject|20
1120386|NCT02579863|2207822|FG001|Overall Study|Withdrawal by Subject|20
1120387|NCT02579928|2207848|FG000|Overall Study|Withdrawal by Subject|1
1120388|NCT02579928|2207849|FG001|Overall Study|Withdrawal by Subject|0
1120389|NCT02580058|2207858|FG000|Overall Study|Lost to Follow-up|4
1120390|NCT02580058|2207859|FG001|Overall Study|Lost to Follow-up|5
1120391|NCT02580058|2207860|FG002|Overall Study|Lost to Follow-up|4
1120392|NCT02580058|2207858|FG000|Overall Study|Ongoing|51
1120393|NCT02580058|2207859|FG001|Overall Study|Ongoing|55
1120394|NCT02580058|2207860|FG002|Overall Study|Ongoing|46
1120395|NCT02580058|2207858|FG000|Overall Study|Withdrawal by Subject|24
1120396|NCT02580058|2207859|FG001|Overall Study|Withdrawal by Subject|26
1120397|NCT02580058|2207860|FG002|Overall Study|Withdrawal by Subject|36
1120398|NCT02580240|2207890|FG000|Overall Study|Physician Decision|2
1120399|NCT02580240|2207891|FG001|Overall Study|Physician Decision|0
1120400|NCT02580357|2207904|FG000|Overall Study|Lost to Follow-up|2
1120401|NCT02580357|2207905|FG001|Overall Study|Lost to Follow-up|0
1120402|NCT02580357|2207906|FG002|Overall Study|Lost to Follow-up|0
1120403|NCT02580357|2207904|FG000|Overall Study|Protocol Violation|1
1120404|NCT02580357|2207905|FG001|Overall Study|Protocol Violation|0
1120405|NCT02580357|2207906|FG002|Overall Study|Protocol Violation|0
1120406|NCT02580591|2207918|FG000|Overall Study|Adverse Event|0
1120407|NCT02580591|2207919|FG001|Overall Study|Adverse Event|1
1120408|NCT02580591|2207920|FG002|Overall Study|Adverse Event|2
1120409|NCT02580591|2207921|FG003|Overall Study|Adverse Event|5
1120410|NCT02580591|2207918|FG000|Overall Study|Protocol Violation|3
1120411|NCT02580591|2207919|FG001|Overall Study|Protocol Violation|2
1120412|NCT02580591|2207920|FG002|Overall Study|Protocol Violation|1
1120413|NCT02580591|2207921|FG003|Overall Study|Protocol Violation|1
1120414|NCT02580591|2207918|FG000|Overall Study|Lost to Follow-up|5
1120415|NCT02580591|2207919|FG001|Overall Study|Lost to Follow-up|3
1120416|NCT02580591|2207920|FG002|Overall Study|Lost to Follow-up|3
1120417|NCT02580591|2207921|FG003|Overall Study|Lost to Follow-up|1
1120418|NCT02580591|2207918|FG000|Overall Study|Withdrawal by Subject|6
1120419|NCT02580591|2207919|FG001|Overall Study|Withdrawal by Subject|1
1120420|NCT02580591|2207920|FG002|Overall Study|Withdrawal by Subject|2
1120421|NCT02580591|2207921|FG003|Overall Study|Withdrawal by Subject|3
1120422|NCT02580591|2207918|FG000|Overall Study|Not treated|1
1120423|NCT02580591|2207919|FG001|Overall Study|Not treated|1
1120424|NCT02580591|2207920|FG002|Overall Study|Not treated|0
1120425|NCT02580591|2207921|FG003|Overall Study|Not treated|0
1120426|NCT02580591|2207918|FG000|Overall Study|Other than specified|3
1120427|NCT02580591|2207919|FG001|Overall Study|Other than specified|2
1120428|NCT02580591|2207920|FG002|Overall Study|Other than specified|5
1120429|NCT02580591|2207921|FG003|Overall Study|Other than specified|2
1120430|NCT02580877|2207937|FG000|Overall Study|Withdrawal by Subject|1
1120431|NCT02580877|2207938|FG001|Overall Study|Withdrawal by Subject|3
1120432|NCT02580877|2207937|FG000|Overall Study|Adverse Event|0
1120433|NCT02580877|2207938|FG001|Overall Study|Adverse Event|1
1120434|NCT02581163|2207958|FG000|Overall Study|Failure to return|15
1120435|NCT02581163|2207958|FG000|Overall Study|Insufficient virological response|3
1120436|NCT02581163|2207958|FG000|Overall Study|Withdrew consent|1
1120437|NCT02581163|2207958|FG000|Overall Study|Death|1
1120438|NCT02581163|2207958|FG000|Overall Study|Other, not specified|9
1120439|NCT02581189|2207965|FG000|Overall Study|Failure to return|36
1120440|NCT02581189|2207965|FG000|Overall Study|Withdrew consent|5
1120441|NCT02581189|2207965|FG000|Overall Study|Death|3
1120442|NCT02581189|2207965|FG000|Overall Study|Insufficient virological response|2
1120443|NCT02581189|2207965|FG000|Overall Study|Other, not specified|7
1120444|NCT02581202|2207972|FG000|Overall Study|Lack of Efficacy|2
1120445|NCT02581202|2207972|FG000|Overall Study|Withdrawal by Subject|4
1120446|NCT02581202|2207972|FG000|Overall Study|Lost to Follow-up|5
1120447|NCT02581202|2207972|FG000|Overall Study|Pregnancy|3
1120448|NCT02581345|2207979|FG000|Part 1: up to Week 16|Adverse Event|3
1120449|NCT02581345|2207980|FG001|Part 1: up to Week 16|Adverse Event|8
1120450|NCT02581345|2207981|FG002|Part 1: up to Week 16|Adverse Event|0
1120451|NCT02581345|2207982|FG003|Part 1: up to Week 16|Adverse Event|0
1120452|NCT02581345|2207979|FG000|Part 1: up to Week 16|Physician Decision|2
1120453|NCT02581345|2207980|FG001|Part 1: up to Week 16|Physician Decision|4
1120454|NCT02581345|2207981|FG002|Part 1: up to Week 16|Physician Decision|0
1120455|NCT02581345|2207982|FG003|Part 1: up to Week 16|Physician Decision|0
1120456|NCT02581345|2207979|FG000|Part 1: up to Week 16|Withdrawal by Subject|4
1120457|NCT02581345|2207980|FG001|Part 1: up to Week 16|Withdrawal by Subject|7
1120458|NCT02581345|2207981|FG002|Part 1: up to Week 16|Withdrawal by Subject|0
1120459|NCT02581345|2207982|FG003|Part 1: up to Week 16|Withdrawal by Subject|0
1120460|NCT02581345|2207979|FG000|Part 1: up to Week 16|Lost to Follow-up|2
1120461|NCT02581345|2207980|FG001|Part 1: up to Week 16|Lost to Follow-up|0
1120462|NCT02581345|2207981|FG002|Part 1: up to Week 16|Lost to Follow-up|0
1120463|NCT02581345|2207982|FG003|Part 1: up to Week 16|Lost to Follow-up|0
1120464|NCT02581345|2207979|FG000|Part 1: up to Week 16|Unspecified Reason|3
1120465|NCT02581345|2207980|FG001|Part 1: up to Week 16|Unspecified Reason|3
1120466|NCT02581345|2207981|FG002|Part 1: up to Week 16|Unspecified Reason|0
1120467|NCT02581345|2207982|FG003|Part 1: up to Week 16|Unspecified Reason|0
1120468|NCT02581345|2207979|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1
1120469|NCT02581345|2207980|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1
1120470|NCT02581345|2207981|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0
1120471|NCT02581345|2207982|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0
1120472|NCT02581345|2207979|FG000|Part 2: Week 17 to Week 47|Adverse Event|5
1120473|NCT02581345|2207980|FG001|Part 2: Week 17 to Week 47|Adverse Event|0
1120474|NCT02581345|2207981|FG002|Part 2: Week 17 to Week 47|Adverse Event|2
1120475|NCT02581345|2207982|FG003|Part 2: Week 17 to Week 47|Adverse Event|2
1120476|NCT02581345|2207979|FG000|Part 2: Week 17 to Week 47|Physician Decision|3
1120477|NCT02581345|2207980|FG001|Part 2: Week 17 to Week 47|Physician Decision|0
1120478|NCT02581345|2207981|FG002|Part 2: Week 17 to Week 47|Physician Decision|2
1120479|NCT02581345|2207982|FG003|Part 2: Week 17 to Week 47|Physician Decision|1
1120480|NCT02581345|2207979|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
1120481|NCT02581345|2207980|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
1120482|NCT02581345|2207981|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
1120483|NCT02581345|2207982|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
1120484|NCT02581345|2207979|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
1120485|NCT02581345|2207980|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
1120486|NCT02581345|2207981|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
1120487|NCT02581345|2207982|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
1120488|NCT02581345|2207979|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2
1120489|NCT02581345|2207980|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0
1120490|NCT02581345|2207981|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0
1120491|NCT02581345|2207982|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1
1120492|NCT02581345|2207979|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2
1120493|NCT02581345|2207980|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0
1120494|NCT02581345|2207981|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1
1120495|NCT02581345|2207982|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1
1120496|NCT02581410|2208010|FG000|Vaccination Phase|Adverse Event|2
1120497|NCT02581410|2208011|FG001|Vaccination Phase|Adverse Event|1
1120498|NCT02581410|2208010|FG000|Vaccination Phase|Withdrawal by Subject|0
1120499|NCT02581410|2208011|FG001|Vaccination Phase|Withdrawal by Subject|1
1120500|NCT02581410|2208010|FG000|Vaccination Phase|Migrated/moved from study area|0
1120501|NCT02581410|2208011|FG001|Vaccination Phase|Migrated/moved from study area|1
1120502|NCT02581410|2208010|FG000|End of Study Phase|Adverse Event|4
1120503|NCT02581410|2208011|FG001|End of Study Phase|Adverse Event|3
1120504|NCT02581410|2208010|FG000|End of Study Phase|Withdrawal by Subject|1
1120505|NCT02581410|2208011|FG001|End of Study Phase|Withdrawal by Subject|2
1120506|NCT02581410|2208010|FG000|End of Study Phase|Migrated/moved from study area|0
1120507|NCT02581410|2208011|FG001|End of Study Phase|Migrated/moved from study area|3
1120508|NCT02581410|2208010|FG000|End of Study Phase|Lost to Follow-up|0
1120509|NCT02581410|2208011|FG001|End of Study Phase|Lost to Follow-up|2
1120510|NCT02581410|2208010|FG000|End of Study Phase|Other-transfer of subject not completed|0
1120511|NCT02581410|2208011|FG001|End of Study Phase|Other-transfer of subject not completed|1
1120512|NCT02581488|2208029|FG000|Overall Study|Adverse Event|6
1120513|NCT02581488|2208030|FG001|Overall Study|Adverse Event|7
1120514|NCT02581488|2208029|FG000|Overall Study|Lost to Follow-up|1
1120515|NCT02581488|2208030|FG001|Overall Study|Lost to Follow-up|0
1120516|NCT02581488|2208029|FG000|Overall Study|Withdrawal by Subject|1
1120517|NCT02581488|2208030|FG001|Overall Study|Withdrawal by Subject|0
1120518|NCT02581488|2208029|FG000|Overall Study|Non-Compliance|1
1120519|NCT02581488|2208030|FG001|Overall Study|Non-Compliance|0
1120520|NCT02581488|2208029|FG000|Overall Study|Protocol Violation|0
898438|NCT00716144|1871022|FG002|Overall Study|Withdrawal by Subject|6
898439|NCT00716144|1871023|FG003|Overall Study|Withdrawal by Subject|6
898440|NCT00716144|1871020|FG000|Overall Study|Lost to Follow-up|2
898441|NCT00716144|1871021|FG001|Overall Study|Lost to Follow-up|2
898442|NCT00716144|1871022|FG002|Overall Study|Lost to Follow-up|1
898443|NCT00716144|1871023|FG003|Overall Study|Lost to Follow-up|2
898444|NCT00716144|1871020|FG000|Overall Study|Adverse Event|0
898445|NCT00716144|1871021|FG001|Overall Study|Adverse Event|0
898446|NCT00716144|1871022|FG002|Overall Study|Adverse Event|0
898447|NCT00716144|1871023|FG003|Overall Study|Adverse Event|2
898448|NCT00716144|1871020|FG000|Overall Study|Non-compliance|1
898449|NCT00716144|1871021|FG001|Overall Study|Non-compliance|0
1120521|NCT02581488|2208030|FG001|Overall Study|Protocol Violation|4
1120522|NCT02581891|2208058|FG000|Overall Study|Adverse Event|4
1120523|NCT02581891|2208059|FG001|Overall Study|Adverse Event|6
1120524|NCT02581891|2208058|FG000|Overall Study|Death|3
1120525|NCT02581891|2208059|FG001|Overall Study|Death|4
1120526|NCT02581891|2208058|FG000|Overall Study|Lost to Follow-up|1
1120527|NCT02581891|2208059|FG001|Overall Study|Lost to Follow-up|2
1120528|NCT02581891|2208058|FG000|Overall Study|Physician Decision|0
1120529|NCT02581891|2208059|FG001|Overall Study|Physician Decision|1
1120530|NCT02581891|2208058|FG000|Overall Study|Withdrawal by Subject|4
1120531|NCT02581891|2208059|FG001|Overall Study|Withdrawal by Subject|5
1120532|NCT02581891|2208058|FG000|Overall Study|Other Reasons|3
1120533|NCT02581891|2208059|FG001|Overall Study|Other Reasons|1
1120534|NCT02581891|2208058|FG000|Overall Study|Discontinued during followup|1
1120535|NCT02581891|2208059|FG001|Overall Study|Discontinued during followup|0
1120538|NCT02581995|2208070|FG000|Overall Study|Unspecified other|3
1120539|NCT02581995|2208070|FG000|Overall Study|Adverse Event|6
1120540|NCT02581995|2208070|FG000|Overall Study|Lost to Follow-up|5
1120541|NCT02581995|2208070|FG000|Overall Study|Withdrawal by participant|12
1120542|NCT02581995|2208070|FG000|Overall Study|Physician Decision|1
1120543|NCT02581995|2208070|FG000|Overall Study|Death|4
1120544|NCT02582242|2208090|FG000|Overall Study|Adverse Event|4
1120545|NCT02582242|2208091|FG001|Overall Study|Adverse Event|3
1120546|NCT02582242|2208090|FG000|Overall Study|Protocol Violation|3
1120547|NCT02582242|2208091|FG001|Overall Study|Protocol Violation|1
1120548|NCT02582242|2208090|FG000|Overall Study|Lost to Follow-up|0
1120549|NCT02582242|2208091|FG001|Overall Study|Lost to Follow-up|1
1120550|NCT02582242|2208090|FG000|Overall Study|Withdrawal by Subject|11
1120551|NCT02582242|2208091|FG001|Overall Study|Withdrawal by Subject|11
1120552|NCT02582242|2208090|FG000|Overall Study|Unclassified|2
1120553|NCT02582242|2208091|FG001|Overall Study|Unclassified|1
1120554|NCT02582255|2208099|FG000|Overall Study|Protocol Violation|0
1120555|NCT02582255|2208100|FG001|Overall Study|Protocol Violation|3
1120556|NCT02582515|2208109|FG000|Overall Study|Withdrawal by Subject|0
1120557|NCT02582515|2208110|FG001|Overall Study|Withdrawal by Subject|1
1120558|NCT02582632|2208116|FG000|Overall Study|Other|1
1120559|NCT02582658|2208120|FG000|Overall Study|Failure to Return|10
1120560|NCT02582658|2208120|FG000|Overall Study|Insufficient Virological Response|2
1120561|NCT02582658|2208120|FG000|Overall Study|Withdrawn Consent|1
1120562|NCT02582658|2208120|FG000|Overall Study|Death|1
1120563|NCT02582658|2208120|FG000|Overall Study|Not further specified|11
1120564|NCT02582671|2208124|FG000|Overall Study|Failure to return|1
1120565|NCT02582671|2208124|FG000|Overall Study|Other, not specified|1
1120566|NCT02582684|2208129|FG000|Overall Study|Unable to contact subject/parent|4
1120567|NCT02582684|2208129|FG000|Overall Study|Subject not able to get to clinic|10
1120568|NCT02582684|2208129|FG000|Overall Study|Subject withdrew consent|1
1120569|NCT02582684|2208129|FG000|Overall Study|Found to be ineligible after enrollment|2
1120570|NCT02582814|2208135|FG000|Overall Study|Study-specific withdrawal criteria|1
1120571|NCT02582814|2208136|FG001|Overall Study|Study-specific withdrawal criteria|0
1120572|NCT02582814|2208135|FG000|Overall Study|Withdrawal by Subject|4
1120573|NCT02582814|2208136|FG001|Overall Study|Withdrawal by Subject|3
1120574|NCT02582814|2208135|FG000|Overall Study|Adverse Event|4
1120575|NCT02582814|2208136|FG001|Overall Study|Adverse Event|4
1120576|NCT02582866|2208157|FG000|Overall Study|Death|1
1120577|NCT02582866|2208157|FG000|Overall Study|Lack of Efficacy|2
1120578|NCT02582866|2208157|FG000|Overall Study|Lost to Follow-up|2
1120579|NCT02582866|2208157|FG000|Overall Study|Withdrawal by Subject|7
1120580|NCT02582866|2208157|FG000|Overall Study|Investigator decision|5
1120581|NCT02582866|2208157|FG000|Overall Study|Participant wants to get pregnant|1
1120582|NCT02582866|2208157|FG000|Overall Study|Pregnancy|2
1120583|NCT02582866|2208157|FG000|Overall Study|Sponsor decision|1
1120584|NCT02582866|2208157|FG000|Overall Study|Withdrawal due to personal reasons|1
1120585|NCT02582983|2208165|FG000|Overall Study|Death|3
1120586|NCT02582983|2208165|FG000|Overall Study|Withdrawal by Subject|2
1120587|NCT02582983|2208165|FG000|Overall Study|Adverse Event|1
1120594|NCT02583256|2208193|FG000|Overall Study|Withdrawal by Subject|0
1120595|NCT02583256|2208194|FG001|Overall Study|Withdrawal by Subject|1
1120596|NCT02583256|2208195|FG002|Overall Study|Withdrawal by Subject|1
1120597|NCT02583256|2208196|FG003|Overall Study|Withdrawal by Subject|0
1120598|NCT02583256|2208193|FG000|Overall Study|Lost to Follow-up|1
1120599|NCT02583256|2208194|FG001|Overall Study|Lost to Follow-up|1
1120600|NCT02583256|2208195|FG002|Overall Study|Lost to Follow-up|0
1120601|NCT02583256|2208196|FG003|Overall Study|Lost to Follow-up|1
1120602|NCT02583256|2208193|FG000|Overall Study|Administrative/Other|2
1120603|NCT02583256|2208194|FG001|Overall Study|Administrative/Other|0
1120604|NCT02583256|2208195|FG002|Overall Study|Administrative/Other|1
1120605|NCT02583256|2208196|FG003|Overall Study|Administrative/Other|2
1120611|NCT02583399|2208239|FG000|Overall Study|Able to be discharged|3
1120612|NCT02583399|2208239|FG000|Overall Study|Wanted to use a restricted medication|3
1120613|NCT02583425|2208243|FG000|Screening|Did not meet entry criteria|12
1120614|NCT02583425|2208243|FG000|Baseline|Did not meet continued criteria|5
1120615|NCT02583425|2208243|FG000|Treatment Period|Adverse Event|1
1120616|NCT02583477|2208250|FG000|Overall Study|Adverse Event|0
1120617|NCT02583477|2208251|FG001|Overall Study|Adverse Event|2
1120618|NCT02583477|2208250|FG000|Overall Study|Death|1
1120619|NCT02583477|2208251|FG001|Overall Study|Death|16
1120620|NCT02583477|2208250|FG000|Overall Study|Study terminated|2
1120621|NCT02583477|2208251|FG001|Overall Study|Study terminated|2
1120622|NCT02583711|2208261|FG000|Overall Study|Withdrawal by Subject|0
1120623|NCT02583711|2208262|FG001|Overall Study|Withdrawal by Subject|10
1120624|NCT02583711|2208263|FG002|Overall Study|Withdrawal by Subject|0
1120625|NCT02584257|2208277|FG000|Period 1|Withdrawal by Subject|0
1120626|NCT02584257|2208278|FG001|Period 1|Withdrawal by Subject|0
1120627|NCT02584257|2208279|FG002|Period 1|Withdrawal by Subject|0
1120628|NCT02584257|2208280|FG003|Period 1|Withdrawal by Subject|0
1120629|NCT02584257|2208281|FG004|Period 1|Withdrawal by Subject|0
1120630|NCT02584257|2208282|FG005|Period 1|Withdrawal by Subject|0
1120631|NCT02584257|2208283|FG006|Period 1|Withdrawal by Subject|1
1120632|NCT02584257|2208284|FG007|Period 1|Withdrawal by Subject|0
1120633|NCT02584257|2208285|FG008|Period 1|Withdrawal by Subject|0
1120634|NCT02584257|2208277|FG000|Period 2|Physician Decision|1
1120635|NCT02584257|2208278|FG001|Period 2|Physician Decision|0
1120636|NCT02584257|2208279|FG002|Period 2|Physician Decision|0
1120637|NCT02584257|2208280|FG003|Period 2|Physician Decision|0
1120638|NCT02584257|2208281|FG004|Period 2|Physician Decision|0
1120639|NCT02584257|2208282|FG005|Period 2|Physician Decision|0
1120640|NCT02584257|2208283|FG006|Period 2|Physician Decision|0
1120641|NCT02584257|2208284|FG007|Period 2|Physician Decision|0
1120642|NCT02584257|2208285|FG008|Period 2|Physician Decision|0
1120643|NCT02584257|2208277|FG000|Period 2|Adverse Event|0
1120644|NCT02584257|2208278|FG001|Period 2|Adverse Event|1
1120645|NCT02584257|2208279|FG002|Period 2|Adverse Event|0
1120646|NCT02584257|2208280|FG003|Period 2|Adverse Event|0
1120647|NCT02584257|2208281|FG004|Period 2|Adverse Event|0
1120648|NCT02584257|2208282|FG005|Period 2|Adverse Event|0
1120649|NCT02584257|2208283|FG006|Period 2|Adverse Event|0
1120650|NCT02584257|2208284|FG007|Period 2|Adverse Event|0
1120651|NCT02584257|2208285|FG008|Period 2|Adverse Event|0
1120652|NCT02584452|2208299|FG000|Overall Study|Physician Decision|1
1120653|NCT02584452|2208300|FG001|Overall Study|Physician Decision|1
1120654|NCT02584452|2208299|FG000|Overall Study|Lost to Follow-up|1
1120655|NCT02584452|2208300|FG001|Overall Study|Lost to Follow-up|1
1120656|NCT02584504|2208310|FG000|Double-blind Treatment|Participant withdrew consent|0
1120657|NCT02584504|2208311|FG001|Double-blind Treatment|Participant withdrew consent|0
1120658|NCT02584504|2208312|FG002|Double-blind Treatment|Participant withdrew consent|1
1120659|NCT02584504|2208310|FG000|Double-blind Treatment|Adverse Event|0
1120660|NCT02584504|2208311|FG001|Double-blind Treatment|Adverse Event|1
1120661|NCT02584504|2208312|FG002|Double-blind Treatment|Adverse Event|0
1120662|NCT02584504|2208310|FG000|Double-blind Treatment|Family Matter|0
1120663|NCT02584504|2208311|FG001|Double-blind Treatment|Family Matter|1
1120664|NCT02584504|2208312|FG002|Double-blind Treatment|Family Matter|0
1120665|NCT02584504|2208310|FG000|Open-label Treatment|Participant withdrew consent|0
1120666|NCT02584504|2208311|FG001|Open-label Treatment|Participant withdrew consent|0
1120667|NCT02584504|2208312|FG002|Open-label Treatment|Participant withdrew consent|4
1120668|NCT02584504|2208310|FG000|Open-label Treatment|Adverse Event|2
1120669|NCT02584504|2208311|FG001|Open-label Treatment|Adverse Event|2
1120670|NCT02584504|2208312|FG002|Open-label Treatment|Adverse Event|3
1120671|NCT02584504|2208310|FG000|Open-label Treatment|Physician Decision|0
1120672|NCT02584504|2208311|FG001|Open-label Treatment|Physician Decision|1
1120673|NCT02584504|2208312|FG002|Open-label Treatment|Physician Decision|0
1120674|NCT02584504|2208310|FG000|Open-label Treatment|Entered but not treated|0
1120675|NCT02584504|2208311|FG001|Open-label Treatment|Entered but not treated|1
1120676|NCT02584504|2208312|FG002|Open-label Treatment|Entered but not treated|1
1120677|NCT02584660|2208330|FG000|Overall Study|Adverse Event|4
1120678|NCT02584660|2208331|FG001|Overall Study|Adverse Event|0
1120679|NCT02584660|2208330|FG000|Overall Study|Lost to Follow-up|3
1120680|NCT02584660|2208331|FG001|Overall Study|Lost to Follow-up|4
1120681|NCT02584660|2208330|FG000|Overall Study|Protocol Violation|0
1120682|NCT02584660|2208331|FG001|Overall Study|Protocol Violation|1
1120683|NCT02584660|2208330|FG000|Overall Study|Withdrawal by Subject|0
1120684|NCT02584660|2208331|FG001|Overall Study|Withdrawal by Subject|2
1120685|NCT02584660|2208330|FG000|Overall Study|Other|0
1120686|NCT02584660|2208331|FG001|Overall Study|Other|1
1120687|NCT02584855|2208373|FG000|Open-Label Treatment Period|Lack of Efficacy|61
1120688|NCT02584855|2208374|FG001|Open-Label Treatment Period|Lack of Efficacy|0
1120689|NCT02584855|2208375|FG002|Open-Label Treatment Period|Lack of Efficacy|0
1120690|NCT02584855|2208376|FG003|Open-Label Treatment Period|Lack of Efficacy|0
1120691|NCT02584855|2208377|FG004|Open-Label Treatment Period|Lack of Efficacy|0
1120692|NCT02584855|2208378|FG005|Open-Label Treatment Period|Lack of Efficacy|0
1120693|NCT02584855|2208373|FG000|Open-Label Treatment Period|Withdrawal by Subject|21
1120694|NCT02584855|2208374|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
1120695|NCT02584855|2208375|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
1120696|NCT02584855|2208376|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
1120697|NCT02584855|2208377|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
1120698|NCT02584855|2208378|FG005|Open-Label Treatment Period|Withdrawal by Subject|0
1120699|NCT02584855|2208373|FG000|Open-Label Treatment Period|Adverse Event|14
1120700|NCT02584855|2208374|FG001|Open-Label Treatment Period|Adverse Event|0
1120701|NCT02584855|2208375|FG002|Open-Label Treatment Period|Adverse Event|0
1120702|NCT02584855|2208376|FG003|Open-Label Treatment Period|Adverse Event|0
1120703|NCT02584855|2208377|FG004|Open-Label Treatment Period|Adverse Event|0
1120704|NCT02584855|2208378|FG005|Open-Label Treatment Period|Adverse Event|0
1120705|NCT02584855|2208373|FG000|Open-Label Treatment Period|Death|2
1120706|NCT02584855|2208374|FG001|Open-Label Treatment Period|Death|0
1120707|NCT02584855|2208375|FG002|Open-Label Treatment Period|Death|0
1120708|NCT02584855|2208376|FG003|Open-Label Treatment Period|Death|0
1120709|NCT02584855|2208377|FG004|Open-Label Treatment Period|Death|0
898450|NCT00716144|1871022|FG002|Overall Study|Non-compliance|0
898451|NCT00716144|1871023|FG003|Overall Study|Non-compliance|0
898452|NCT00716144|1871020|FG000|Overall Study|Protocol Violation|2
898453|NCT00716144|1871021|FG001|Overall Study|Protocol Violation|0
898454|NCT00716144|1871022|FG002|Overall Study|Protocol Violation|1
898455|NCT00716144|1871023|FG003|Overall Study|Protocol Violation|0
898456|NCT00716144|1871020|FG000|Overall Study|Physician Decision|0
1120710|NCT02584855|2208378|FG005|Open-Label Treatment Period|Death|0
1120711|NCT02584855|2208373|FG000|Open-Label Treatment Period|Lost to Follow-up|1
1120712|NCT02584855|2208374|FG001|Open-Label Treatment Period|Lost to Follow-up|0
1120713|NCT02584855|2208375|FG002|Open-Label Treatment Period|Lost to Follow-up|0
1120714|NCT02584855|2208376|FG003|Open-Label Treatment Period|Lost to Follow-up|0
1120715|NCT02584855|2208377|FG004|Open-Label Treatment Period|Lost to Follow-up|0
1120716|NCT02584855|2208378|FG005|Open-Label Treatment Period|Lost to Follow-up|0
1120717|NCT02584855|2208373|FG000|Open-Label Treatment Period|Protocol Violation|1
1120718|NCT02584855|2208374|FG001|Open-Label Treatment Period|Protocol Violation|0
1120719|NCT02584855|2208375|FG002|Open-Label Treatment Period|Protocol Violation|0
1120720|NCT02584855|2208376|FG003|Open-Label Treatment Period|Protocol Violation|0
1120721|NCT02584855|2208377|FG004|Open-Label Treatment Period|Protocol Violation|0
1120722|NCT02584855|2208378|FG005|Open-Label Treatment Period|Protocol Violation|0
1120723|NCT02584855|2208373|FG000|Open-Label Treatment Period|No PI Available|2
1120724|NCT02584855|2208374|FG001|Open-Label Treatment Period|No PI Available|0
1120725|NCT02584855|2208375|FG002|Open-Label Treatment Period|No PI Available|0
1120726|NCT02584855|2208376|FG003|Open-Label Treatment Period|No PI Available|0
1120727|NCT02584855|2208377|FG004|Open-Label Treatment Period|No PI Available|0
1120728|NCT02584855|2208378|FG005|Open-Label Treatment Period|No PI Available|0
1120729|NCT02584855|2208373|FG000|Open-Label Treatment Period|Sponsor Decision|1
1120730|NCT02584855|2208374|FG001|Open-Label Treatment Period|Sponsor Decision|0
1120731|NCT02584855|2208375|FG002|Open-Label Treatment Period|Sponsor Decision|0
1120732|NCT02584855|2208376|FG003|Open-Label Treatment Period|Sponsor Decision|0
1120733|NCT02584855|2208377|FG004|Open-Label Treatment Period|Sponsor Decision|0
1120734|NCT02584855|2208378|FG005|Open-Label Treatment Period|Sponsor Decision|0
1120735|NCT02584855|2208373|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0
1120736|NCT02584855|2208374|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0
1120737|NCT02584855|2208375|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2
1120738|NCT02584855|2208376|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0
1120739|NCT02584855|2208377|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0
1120740|NCT02584855|2208378|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0
1120741|NCT02584855|2208373|FG000|Double-Blind Withdrawal Period|Adverse Event|0
1120742|NCT02584855|2208374|FG001|Double-Blind Withdrawal Period|Adverse Event|4
1120743|NCT02584855|2208375|FG002|Double-Blind Withdrawal Period|Adverse Event|0
1120744|NCT02584855|2208376|FG003|Double-Blind Withdrawal Period|Adverse Event|1
1120745|NCT02584855|2208377|FG004|Double-Blind Withdrawal Period|Adverse Event|0
1120746|NCT02584855|2208378|FG005|Double-Blind Withdrawal Period|Adverse Event|0
1120747|NCT02584855|2208373|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0
1120748|NCT02584855|2208374|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10
1120749|NCT02584855|2208375|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0
1120750|NCT02584855|2208376|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0
1120751|NCT02584855|2208377|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0
1120752|NCT02584855|2208378|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0
1120753|NCT02584855|2208373|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
1120754|NCT02584855|2208374|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
1120755|NCT02584855|2208375|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
1120756|NCT02584855|2208376|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
1120757|NCT02584855|2208377|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
1120758|NCT02584855|2208378|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
1120759|NCT02584855|2208373|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0
1120760|NCT02584855|2208374|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0
1120761|NCT02584855|2208375|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0
1120762|NCT02584855|2208376|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0
1120763|NCT02584855|2208377|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7
1120764|NCT02584855|2208378|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0
1120765|NCT02584855|2208373|FG000|Post Treatment Follow-up Period|Protocol Violation|0
1120766|NCT02584855|2208374|FG001|Post Treatment Follow-up Period|Protocol Violation|0
1120767|NCT02584855|2208375|FG002|Post Treatment Follow-up Period|Protocol Violation|0
1120768|NCT02584855|2208376|FG003|Post Treatment Follow-up Period|Protocol Violation|0
1120769|NCT02584855|2208377|FG004|Post Treatment Follow-up Period|Protocol Violation|1
1120770|NCT02584855|2208378|FG005|Post Treatment Follow-up Period|Protocol Violation|0
1120771|NCT02584959|2208403|FG000|Period 1|Withdrawn from study|3
1120772|NCT02584959|2208404|FG001|Period 1|Withdrawn from study|4
1120773|NCT02584959|2208405|FG002|Period 1|Withdrawn from study|0
1120774|NCT02584959|2208403|FG000|Period 2|Withdrawn from study|6
1120775|NCT02584959|2208404|FG001|Period 2|Withdrawn from study|1
1120776|NCT02584959|2208405|FG002|Period 2|Withdrawn from study|2
1120781|NCT02585713|2208460|FG000|Overall Study|Withdrew prior to treatment|2
1120782|NCT02585713|2208461|FG001|Overall Study|Withdrew prior to treatment|7
1120783|NCT02585713|2208460|FG000|Overall Study|Other|3
1120784|NCT02585713|2208461|FG001|Overall Study|Other|1
1120785|NCT02585778|2208471|FG000|Overall Study|Adverse Event|17
1120786|NCT02585778|2208472|FG001|Overall Study|Adverse Event|4
1120787|NCT02585778|2208471|FG000|Overall Study|Participant did not wish to continue|9
1120788|NCT02585778|2208472|FG001|Overall Study|Participant did not wish to continue|4
1120789|NCT02585778|2208471|FG000|Overall Study|Poor compliance to study protocol|0
1120790|NCT02585778|2208472|FG001|Overall Study|Poor compliance to study protocol|2
1120791|NCT02585778|2208471|FG000|Overall Study|Death|0
1120792|NCT02585778|2208472|FG001|Overall Study|Death|1
1120793|NCT02585778|2208471|FG000|Overall Study|Randomized but not treated|1
1120794|NCT02585778|2208472|FG001|Overall Study|Randomized but not treated|2
1120795|NCT02585778|2208471|FG000|Overall Study|Other than specified above|6
1120796|NCT02585778|2208472|FG001|Overall Study|Other than specified above|2
1120797|NCT02585830|2208482|FG000|Overall Study|Withdrawal by Subject|3
1120798|NCT02585934|2208509|FG000|Overall Study|Lost to Follow-up|2
1120799|NCT02585934|2208510|FG001|Overall Study|Lost to Follow-up|2
1120800|NCT02585934|2208509|FG000|Overall Study|Protocol Violation|14
1120801|NCT02585934|2208510|FG001|Overall Study|Protocol Violation|11
1120802|NCT02585934|2208509|FG000|Overall Study|Adverse Event|21
1120803|NCT02585934|2208510|FG001|Overall Study|Adverse Event|22
1120804|NCT02585934|2208509|FG000|Overall Study|Physician Decision|3
1120805|NCT02585934|2208510|FG001|Overall Study|Physician Decision|2
1120806|NCT02585934|2208509|FG000|Overall Study|Withdrawal by Subject|7
1120807|NCT02585934|2208510|FG001|Overall Study|Withdrawal by Subject|21
1120808|NCT02585934|2208509|FG000|Overall Study|Lack of Efficacy|2
1120809|NCT02585934|2208510|FG001|Overall Study|Lack of Efficacy|1
1120810|NCT02585934|2208509|FG000|Overall Study|Death|2
1120811|NCT02585934|2208510|FG001|Overall Study|Death|0
1120812|NCT02585934|2208509|FG000|Overall Study|Caregiver Withdrew Consent|7
1120813|NCT02585934|2208510|FG001|Overall Study|Caregiver Withdrew Consent|7
1120814|NCT02585934|2208509|FG000|Overall Study|Sponsor Termination|1
1120815|NCT02585934|2208510|FG001|Overall Study|Sponsor Termination|2
1120816|NCT02585934|2208509|FG000|Overall Study|Another Reason|10
1120817|NCT02585934|2208510|FG001|Overall Study|Another Reason|5
1120818|NCT02585960|2208524|FG000|PK/Safety Assessment Period|Physician Decision|0
1120819|NCT02585960|2208525|FG001|PK/Safety Assessment Period|Physician Decision|1
1120820|NCT02585960|2208526|FG002|PK/Safety Assessment Period|Physician Decision|0
1120821|NCT02585960|2208524|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1
1120822|NCT02585960|2208525|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2
1120823|NCT02585960|2208526|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5
1162076|NCT03382899|2284098|FG001|Overall Study|Ineligibility Determined|1
1120824|NCT02585960|2208524|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0
1120825|NCT02585960|2208525|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2
1120826|NCT02585960|2208526|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0
1120827|NCT02585960|2208524|FG000|PK/Safety Assessment Period|Other|4
1120828|NCT02585960|2208525|FG001|PK/Safety Assessment Period|Other|4
1120829|NCT02585960|2208526|FG002|PK/Safety Assessment Period|Other|0
1120830|NCT02585960|2208524|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0
1120831|NCT02585960|2208525|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1
1120832|NCT02585960|2208526|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0
1120833|NCT02585960|2208524|FG000|PK/Safety Assessment Period|Screen Failure|0
1120834|NCT02585960|2208525|FG001|PK/Safety Assessment Period|Screen Failure|0
1120835|NCT02585960|2208526|FG002|PK/Safety Assessment Period|Screen Failure|1
1120836|NCT02585960|2208524|FG000|Prophylactic Treatment Period|Major protocol deviation|0
1120837|NCT02585960|2208525|FG001|Prophylactic Treatment Period|Major protocol deviation|4
1120838|NCT02585960|2208526|FG002|Prophylactic Treatment Period|Major protocol deviation|0
1120839|NCT02585960|2208524|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
1120840|NCT02585960|2208525|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
1120841|NCT02585960|2208526|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
1120842|NCT02585999|2208537|FG000|Overall Study|Lost to Follow-up|1
1120843|NCT02585999|2208537|FG000|Overall Study|Protocol Violation|1
1120844|NCT02586012|2208542|FG000|Overall Study|Withdrawal by Subject|1
1120845|NCT02586012|2208543|FG001|Overall Study|Withdrawal by Subject|1
1120846|NCT02586012|2208544|FG002|Overall Study|Withdrawal by Subject|0
1120847|NCT02586012|2208545|FG003|Overall Study|Withdrawal by Subject|1
1120848|NCT02586012|2208546|FG004|Overall Study|Withdrawal by Subject|0
1120849|NCT02586012|2208547|FG005|Overall Study|Withdrawal by Subject|2
1120850|NCT02586012|2208542|FG000|Overall Study|Protocol Violation|0
1120851|NCT02586012|2208543|FG001|Overall Study|Protocol Violation|0
1120852|NCT02586012|2208544|FG002|Overall Study|Protocol Violation|0
1120853|NCT02586012|2208545|FG003|Overall Study|Protocol Violation|0
1120854|NCT02586012|2208546|FG004|Overall Study|Protocol Violation|0
1120855|NCT02586012|2208547|FG005|Overall Study|Protocol Violation|1
1120856|NCT02586012|2208542|FG000|Overall Study|study terminated|0
1120857|NCT02586012|2208543|FG001|Overall Study|study terminated|2
1120858|NCT02586012|2208544|FG002|Overall Study|study terminated|1
1120859|NCT02586012|2208545|FG003|Overall Study|study terminated|1
1120860|NCT02586012|2208546|FG004|Overall Study|study terminated|1
1120861|NCT02586012|2208547|FG005|Overall Study|study terminated|0
1120884|NCT02586064|2208567|FG000|Overall Study|Other Obligations|6
1120885|NCT02586064|2208568|FG001|Overall Study|Other Obligations|6
1120886|NCT02586064|2208567|FG000|Overall Study|Other|3
1120887|NCT02586064|2208568|FG001|Overall Study|Other|7
1120888|NCT02586064|2208567|FG000|Overall Study|Never Started|3
1120889|NCT02586064|2208568|FG001|Overall Study|Never Started|3
1120890|NCT02586064|2208567|FG000|Overall Study|Lost Interest|1
1120891|NCT02586064|2208568|FG001|Overall Study|Lost Interest|4
1120892|NCT02586064|2208567|FG000|Overall Study|Miscellaneous Life Issues|0
1120893|NCT02586064|2208568|FG001|Overall Study|Miscellaneous Life Issues|5
1120894|NCT02586064|2208567|FG000|Overall Study|Infrequent Attendance|2
1120895|NCT02586064|2208568|FG001|Overall Study|Infrequent Attendance|1
1120896|NCT02586064|2208567|FG000|Overall Study|Timed Out|2
1120897|NCT02586064|2208568|FG001|Overall Study|Timed Out|0
1120898|NCT02586064|2208567|FG000|Overall Study|AUD relapse|0
1120899|NCT02586064|2208568|FG001|Overall Study|AUD relapse|2
1120900|NCT02586064|2208567|FG000|Overall Study|Legal Issue|1
1120901|NCT02586064|2208568|FG001|Overall Study|Legal Issue|0
1120902|NCT02586077|2208577|FG000|Overall Study|Withdrawal by Subject|1
1120903|NCT02586077|2208577|FG000|Overall Study|Physician Decision|4
1120904|NCT02586077|2208577|FG000|Overall Study|Lost to Follow-up|3
1120905|NCT02586155|2208584|FG000|Overall Study|Adverse Event|2
1120906|NCT02586155|2208585|FG001|Overall Study|Adverse Event|3
1120907|NCT02586155|2208584|FG000|Overall Study|Withdrawal by Subject|31
1120908|NCT02586155|2208585|FG001|Overall Study|Withdrawal by Subject|24
1120909|NCT02586155|2208584|FG000|Overall Study|Lost to Follow-up|7
1120910|NCT02586155|2208585|FG001|Overall Study|Lost to Follow-up|13
1120911|NCT02586155|2208584|FG000|Overall Study|Death|61
1120912|NCT02586155|2208585|FG001|Overall Study|Death|72
1120913|NCT02586155|2208584|FG000|Overall Study|Other reasons|26
1120914|NCT02586155|2208585|FG001|Overall Study|Other reasons|15
1120915|NCT02586207|2208591|FG000|Overall Study|Physician Decision|1
1120916|NCT02586207|2208591|FG000|Overall Study|Withdrawal by Subject|1
1120917|NCT02586233|2208602|FG000|Overall Study|Randomized but did not receive treatment|0
1120918|NCT02586233|2208603|FG001|Overall Study|Randomized but did not receive treatment|1
1120919|NCT02586233|2208604|FG002|Overall Study|Randomized but did not receive treatment|0
1120920|NCT02586233|2208605|FG003|Overall Study|Randomized but did not receive treatment|0
1120921|NCT02586233|2208606|FG004|Overall Study|Randomized but did not receive treatment|0
1120922|NCT02586233|2208607|FG005|Overall Study|Randomized but did not receive treatment|2
1120923|NCT02586233|2208608|FG006|Overall Study|Randomized but did not receive treatment|2
1120924|NCT02586233|2208602|FG000|Overall Study|Death|0
1120925|NCT02586233|2208603|FG001|Overall Study|Death|1
1120926|NCT02586233|2208604|FG002|Overall Study|Death|0
1120927|NCT02586233|2208605|FG003|Overall Study|Death|0
1120928|NCT02586233|2208606|FG004|Overall Study|Death|2
1120929|NCT02586233|2208607|FG005|Overall Study|Death|0
1120930|NCT02586233|2208608|FG006|Overall Study|Death|0
1120931|NCT02586415|2208630|FG000|Overall Study|Death|13
1120932|NCT02586415|2208631|FG001|Overall Study|Death|23
1120933|NCT02586415|2208630|FG000|Overall Study|Lost to Follow-up|1
1120934|NCT02586415|2208631|FG001|Overall Study|Lost to Follow-up|2
1120935|NCT02586493|2208638|FG000|Overall Study|Adverse Event|4
1120936|NCT02586493|2208638|FG000|Overall Study|Protocol Violation|6
1120937|NCT02586493|2208638|FG000|Overall Study|Lost to Follow-up|1
1120938|NCT02586493|2208638|FG000|Overall Study|Withdrawal by Subject|1
1120939|NCT02586506|2208642|FG000|Overall Study|Protocol Violation|6
1120940|NCT02586506|2208642|FG000|Overall Study|Lost to Follow-up|1
1120941|NCT02586506|2208642|FG000|Overall Study|Other Reason|2
1120942|NCT02586727|2208652|FG000|Overall Study|Lost to Follow-up|1
1120943|NCT02586727|2208653|FG001|Overall Study|Lost to Follow-up|0
1120944|NCT02586805|2208663|FG000|Overall Study|Withdrawal by Subject|3
1120945|NCT02586805|2208664|FG001|Overall Study|Withdrawal by Subject|1
1120946|NCT02586805|2208665|FG002|Overall Study|Withdrawal by Subject|1
1120947|NCT02586805|2208666|FG003|Overall Study|Withdrawal by Subject|2
1120948|NCT02586805|2208663|FG000|Overall Study|Adverse Event|2
1120949|NCT02586805|2208664|FG001|Overall Study|Adverse Event|0
1120950|NCT02586805|2208665|FG002|Overall Study|Adverse Event|1
1120951|NCT02586805|2208666|FG003|Overall Study|Adverse Event|0
1120952|NCT02586805|2208663|FG000|Overall Study|Lost to Follow-up|0
1120953|NCT02586805|2208664|FG001|Overall Study|Lost to Follow-up|0
1120954|NCT02586805|2208665|FG002|Overall Study|Lost to Follow-up|1
1120955|NCT02586805|2208666|FG003|Overall Study|Lost to Follow-up|0
1120956|NCT02586805|2208663|FG000|Overall Study|Physician Decision|1
1120957|NCT02586805|2208664|FG001|Overall Study|Physician Decision|0
1120958|NCT02586805|2208665|FG002|Overall Study|Physician Decision|0
1120959|NCT02586805|2208666|FG003|Overall Study|Physician Decision|0
1120960|NCT02587065|2208709|FG000|Overall Study|Adverse Event|14
1120961|NCT02587065|2208709|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5
1120962|NCT02587065|2208709|FG000|Overall Study|Non-adherence to the Protocol|3
1120963|NCT02587065|2208709|FG000|Overall Study|Discontinuation of Study Medication|2
1120964|NCT02587065|2208709|FG000|Overall Study|Reason not Specified|3
1120965|NCT02587143|2208724|FG000|Overall Study|Adverse Event|1
1120966|NCT02587143|2208725|FG001|Overall Study|Adverse Event|0
1120967|NCT02587221|2208733|FG000|Overall Study|Adverse Event|3
1120968|NCT02587221|2208734|FG001|Overall Study|Adverse Event|3
1120969|NCT02587221|2208733|FG000|Overall Study|Death|33
1120970|NCT02587221|2208734|FG001|Overall Study|Death|34
1120971|NCT02587221|2208733|FG000|Overall Study|Withdrawal by Subject|66
1120972|NCT02587221|2208734|FG001|Overall Study|Withdrawal by Subject|61
1120973|NCT02587221|2208733|FG000|Overall Study|Lost to Follow-up|21
1120974|NCT02587221|2208734|FG001|Overall Study|Lost to Follow-up|19
1120975|NCT02587221|2208733|FG000|Overall Study|Protocol Violation|6
1120976|NCT02587221|2208734|FG001|Overall Study|Protocol Violation|5
1120977|NCT02587221|2208733|FG000|Overall Study|Other Reason or Unspecified|2
1120978|NCT02587221|2208734|FG001|Overall Study|Other Reason or Unspecified|1
1120979|NCT02587234|2208742|FG000|Overall Study|Withdrawal by Subject|1
1120980|NCT02587234|2208743|FG001|Overall Study|Withdrawal by Subject|1
1120981|NCT02587234|2208742|FG000|Overall Study|Lost to Follow-up|0
1120982|NCT02587234|2208743|FG001|Overall Study|Lost to Follow-up|2
1120983|NCT02587520|2208776|FG000|Overall Study|Protocol Violation|2
1120984|NCT02587520|2208777|FG001|Overall Study|Protocol Violation|0
1120985|NCT02587520|2208778|FG002|Overall Study|Protocol Violation|0
1120986|NCT02587520|2208779|FG003|Overall Study|Protocol Violation|2
1120987|NCT02587520|2208780|FG004|Overall Study|Protocol Violation|0
1120988|NCT02587520|2208781|FG005|Overall Study|Protocol Violation|1
1120989|NCT02587520|2208782|FG006|Overall Study|Protocol Violation|1
1120990|NCT02587520|2208783|FG007|Overall Study|Protocol Violation|1
1120991|NCT02587520|2208784|FG008|Overall Study|Protocol Violation|3
1120992|NCT02587520|2208785|FG009|Overall Study|Protocol Violation|3
1120993|NCT02587520|2208786|FG010|Overall Study|Protocol Violation|1
1120994|NCT02587520|2208787|FG011|Overall Study|Protocol Violation|2
1120995|NCT02587520|2208788|FG012|Overall Study|Protocol Violation|0
1120996|NCT02587520|2208789|FG013|Overall Study|Protocol Violation|0
1120997|NCT02587520|2208790|FG014|Overall Study|Protocol Violation|0
1120998|NCT02587520|2208791|FG015|Overall Study|Protocol Violation|0
1120999|NCT02587520|2208792|FG016|Overall Study|Protocol Violation|0
1121000|NCT02587520|2208793|FG017|Overall Study|Protocol Violation|0
1121001|NCT02587520|2208776|FG000|Overall Study|Adverse Event|0
1121002|NCT02587520|2208777|FG001|Overall Study|Adverse Event|0
1121003|NCT02587520|2208778|FG002|Overall Study|Adverse Event|0
1121004|NCT02587520|2208779|FG003|Overall Study|Adverse Event|0
1121005|NCT02587520|2208780|FG004|Overall Study|Adverse Event|0
1121006|NCT02587520|2208781|FG005|Overall Study|Adverse Event|0
1121007|NCT02587520|2208782|FG006|Overall Study|Adverse Event|0
1121008|NCT02587520|2208783|FG007|Overall Study|Adverse Event|0
1121009|NCT02587520|2208784|FG008|Overall Study|Adverse Event|0
1121010|NCT02587520|2208785|FG009|Overall Study|Adverse Event|0
1121011|NCT02587520|2208786|FG010|Overall Study|Adverse Event|0
1121012|NCT02587520|2208787|FG011|Overall Study|Adverse Event|1
1121013|NCT02587520|2208788|FG012|Overall Study|Adverse Event|0
1121014|NCT02587520|2208789|FG013|Overall Study|Adverse Event|0
1121015|NCT02587520|2208790|FG014|Overall Study|Adverse Event|0
1121016|NCT02587520|2208791|FG015|Overall Study|Adverse Event|0
1121017|NCT02587520|2208792|FG016|Overall Study|Adverse Event|0
1121018|NCT02587520|2208793|FG017|Overall Study|Adverse Event|0
1121019|NCT02587520|2208776|FG000|Overall Study|Withdrawal by Subject|0
1121020|NCT02587520|2208777|FG001|Overall Study|Withdrawal by Subject|0
1121021|NCT02587520|2208778|FG002|Overall Study|Withdrawal by Subject|1
1121022|NCT02587520|2208779|FG003|Overall Study|Withdrawal by Subject|1
1121023|NCT02587520|2208780|FG004|Overall Study|Withdrawal by Subject|0
1121024|NCT02587520|2208781|FG005|Overall Study|Withdrawal by Subject|1
1121025|NCT02587520|2208782|FG006|Overall Study|Withdrawal by Subject|1
1121026|NCT02587520|2208783|FG007|Overall Study|Withdrawal by Subject|0
1121027|NCT02587520|2208784|FG008|Overall Study|Withdrawal by Subject|0
1121028|NCT02587520|2208785|FG009|Overall Study|Withdrawal by Subject|0
1121029|NCT02587520|2208786|FG010|Overall Study|Withdrawal by Subject|0
1121030|NCT02587520|2208787|FG011|Overall Study|Withdrawal by Subject|0
1121031|NCT02587520|2208788|FG012|Overall Study|Withdrawal by Subject|0
1121032|NCT02587520|2208789|FG013|Overall Study|Withdrawal by Subject|1
1121033|NCT02587520|2208790|FG014|Overall Study|Withdrawal by Subject|0
1121034|NCT02587520|2208791|FG015|Overall Study|Withdrawal by Subject|0
1121035|NCT02587520|2208792|FG016|Overall Study|Withdrawal by Subject|0
1121036|NCT02587520|2208793|FG017|Overall Study|Withdrawal by Subject|0
1121037|NCT02587520|2208776|FG000|Overall Study|Lost to Follow-up|0
1121038|NCT02587520|2208777|FG001|Overall Study|Lost to Follow-up|2
1121039|NCT02587520|2208778|FG002|Overall Study|Lost to Follow-up|0
1121040|NCT02587520|2208779|FG003|Overall Study|Lost to Follow-up|2
1121041|NCT02587520|2208780|FG004|Overall Study|Lost to Follow-up|0
1121042|NCT02587520|2208781|FG005|Overall Study|Lost to Follow-up|1
1121043|NCT02587520|2208782|FG006|Overall Study|Lost to Follow-up|1
1121044|NCT02587520|2208783|FG007|Overall Study|Lost to Follow-up|1
1121045|NCT02587520|2208784|FG008|Overall Study|Lost to Follow-up|0
1121046|NCT02587520|2208785|FG009|Overall Study|Lost to Follow-up|2
1121047|NCT02587520|2208786|FG010|Overall Study|Lost to Follow-up|2
1121048|NCT02587520|2208787|FG011|Overall Study|Lost to Follow-up|1
1121049|NCT02587520|2208788|FG012|Overall Study|Lost to Follow-up|0
1121050|NCT02587520|2208789|FG013|Overall Study|Lost to Follow-up|0
1121051|NCT02587520|2208790|FG014|Overall Study|Lost to Follow-up|0
1121052|NCT02587520|2208791|FG015|Overall Study|Lost to Follow-up|0
1121053|NCT02587520|2208792|FG016|Overall Study|Lost to Follow-up|0
1121054|NCT02587520|2208793|FG017|Overall Study|Lost to Follow-up|0
1121055|NCT02587819|2208831|FG000|Overall Study|Adverse Event|1
1121056|NCT02587819|2208831|FG000|Overall Study|Lost to Follow-up|1
1121057|NCT02587962|2208841|FG000|Overall Study|Adverse Event|0
1121058|NCT02587962|2208842|FG001|Overall Study|Adverse Event|0
1121059|NCT02587962|2208843|FG002|Overall Study|Adverse Event|1
1121060|NCT02587962|2208844|FG003|Overall Study|Adverse Event|0
1121061|NCT02587962|2208845|FG004|Overall Study|Adverse Event|0
1121062|NCT02587962|2208841|FG000|Overall Study|Withdrawal by Subject|0
1121063|NCT02587962|2208842|FG001|Overall Study|Withdrawal by Subject|0
1121064|NCT02587962|2208843|FG002|Overall Study|Withdrawal by Subject|1
1121065|NCT02587962|2208844|FG003|Overall Study|Withdrawal by Subject|1
1121066|NCT02587962|2208845|FG004|Overall Study|Withdrawal by Subject|4
1121067|NCT02587962|2208841|FG000|Overall Study|Radiological progression|2
1121068|NCT02587962|2208842|FG001|Overall Study|Radiological progression|2
1121069|NCT02587962|2208843|FG002|Overall Study|Radiological progression|2
1121070|NCT02587962|2208844|FG003|Overall Study|Radiological progression|5
1121071|NCT02587962|2208845|FG004|Overall Study|Radiological progression|10
1121072|NCT02587962|2208841|FG000|Overall Study|Clinical progression|0
1121073|NCT02587962|2208842|FG001|Overall Study|Clinical progression|1
1121074|NCT02587962|2208843|FG002|Overall Study|Clinical progression|2
1121075|NCT02587962|2208844|FG003|Overall Study|Clinical progression|0
1121076|NCT02587962|2208845|FG004|Overall Study|Clinical progression|1
1121077|NCT02588261|2208907|FG000|Overall Study|Study Terminated by Sponsor|157
1121078|NCT02588261|2208908|FG001|Overall Study|Study Terminated by Sponsor|142
1121079|NCT02588261|2208907|FG000|Overall Study|Protocol Deviation|1
1121080|NCT02588261|2208908|FG001|Overall Study|Protocol Deviation|0
1121081|NCT02588261|2208907|FG000|Overall Study|Death|1
1121082|NCT02588261|2208908|FG001|Overall Study|Death|2
1121083|NCT02588261|2208907|FG000|Overall Study|Withdrawal by Subject|12
1121084|NCT02588261|2208908|FG001|Overall Study|Withdrawal by Subject|8
1121085|NCT02588261|2208907|FG000|Overall Study|Noncompliance with Study Drug|0
1121086|NCT02588261|2208908|FG001|Overall Study|Noncompliance with Study Drug|1
1121087|NCT02588261|2208907|FG000|Overall Study|Miscellaneous|5
1121088|NCT02588261|2208908|FG001|Overall Study|Miscellaneous|4
1121089|NCT02588261|2208907|FG000|Overall Study|Progressive Disease|61
1121090|NCT02588261|2208908|FG001|Overall Study|Progressive Disease|82
1121091|NCT02588261|2208907|FG000|Overall Study|Adverse Event|29
1121092|NCT02588261|2208908|FG001|Overall Study|Adverse Event|24
1121093|NCT02588261|2208907|FG000|Overall Study|Lost to Follow-up|1
1121094|NCT02588261|2208908|FG001|Overall Study|Lost to Follow-up|0
1121095|NCT02588339|2208914|FG000|Overall Study|Withdrawal by Subject|1
1121096|NCT02588339|2208914|FG000|Overall Study|GVHD Progression prior to treatment|2
1121097|NCT02588612|2208947|FG000|Overall Study|Physician Decision|1
1121098|NCT02588612|2208947|FG000|Overall Study|Leukapheresis did not yield enough cells|1
1121099|NCT02588612|2208947|FG000|Overall Study|Failed eligibility prior to chemotherapy|2
1121100|NCT02588612|2208947|FG000|Overall Study|Death prior to T-cell infusion|1
1121101|NCT02588664|2208953|FG000|Overall Study|Death|56
1121102|NCT02588664|2208954|FG001|Overall Study|Death|55
1121103|NCT02588664|2208953|FG000|Overall Study|Lost to Follow-up|1305
1121104|NCT02588664|2208954|FG001|Overall Study|Lost to Follow-up|990
1121105|NCT02588833|2208962|FG000|Part 1|Withdrawal by Subject|1
1121106|NCT02588833|2208963|FG001|Part 1|Withdrawal by Subject|0
1121107|NCT02588833|2208962|FG000|Part 2A|Physician Decision|0
1121108|NCT02588833|2208963|FG001|Part 2A|Physician Decision|1
1121109|NCT02588833|2208962|FG000|Part 2A|Withdrawal by Subject|0
1121110|NCT02588833|2208963|FG001|Part 2A|Withdrawal by Subject|1
1121111|NCT02588833|2208962|FG000|Part 2B|Adverse Event|0
1121112|NCT02588833|2208963|FG001|Part 2B|Adverse Event|1
1121113|NCT02588833|2208962|FG000|Part 2C|Adverse Event|0
1121114|NCT02588833|2208963|FG001|Part 2C|Adverse Event|1
1121115|NCT02588833|2208962|FG000|Part 2C|Withdrawal by Subject|0
1121116|NCT02588833|2208963|FG001|Part 2C|Withdrawal by Subject|1
1121117|NCT02588833|2208962|FG000|Part 3 (Safety Follow-up)|Other|0
1121118|NCT02588833|2208963|FG001|Part 3 (Safety Follow-up)|Other|2
1121119|NCT02589405|2209003|FG000|Overall Study|Adverse Event|3
1121120|NCT02589405|2209003|FG000|Overall Study|Withdrawal by Subject|1
1121121|NCT02589626|2209009|FG000|Overall Study|Other than the reason specified|1
1121122|NCT02589626|2209010|FG001|Overall Study|Other than the reason specified|0
1121123|NCT02589626|2209009|FG000|Overall Study|Withdrawal by Subject|1
1121124|NCT02589626|2209010|FG001|Overall Study|Withdrawal by Subject|1
1121125|NCT02589626|2209009|FG000|Overall Study|Adverse Event|1
1121126|NCT02589626|2209010|FG001|Overall Study|Adverse Event|1
1121127|NCT02589639|2209019|FG000|Overall Study|Lost to Follow-up|1
1121128|NCT02589639|2209020|FG001|Overall Study|Lost to Follow-up|0
1121129|NCT02589639|2209021|FG002|Overall Study|Lost to Follow-up|0
1121130|NCT02589639|2209019|FG000|Overall Study|Protocol Violation|1
1121131|NCT02589639|2209020|FG001|Overall Study|Protocol Violation|0
1121132|NCT02589639|2209021|FG002|Overall Study|Protocol Violation|0
1121133|NCT02589639|2209019|FG000|Overall Study|Patient withdrawal, not due to AE|3
1121134|NCT02589639|2209020|FG001|Overall Study|Patient withdrawal, not due to AE|0
1121135|NCT02589639|2209021|FG002|Overall Study|Patient withdrawal, not due to AE|0
1121136|NCT02589639|2209019|FG000|Overall Study|Adverse Event|4
1121137|NCT02589639|2209020|FG001|Overall Study|Adverse Event|5
1121138|NCT02589639|2209021|FG002|Overall Study|Adverse Event|3
1121139|NCT02589639|2209019|FG000|Overall Study|Other reason than specified above|1
1121140|NCT02589639|2209020|FG001|Overall Study|Other reason than specified above|2
1121141|NCT02589639|2209021|FG002|Overall Study|Other reason than specified above|1
1121142|NCT02589639|2209019|FG000|Overall Study|Not Treated|0
1121143|NCT02589639|2209020|FG001|Overall Study|Not Treated|3
1121144|NCT02589639|2209021|FG002|Overall Study|Not Treated|0
1121145|NCT02589665|2209033|FG000|Induction Period|Did not receive drug|0
1121146|NCT02589665|2209034|FG001|Induction Period|Did not receive drug|0
1121147|NCT02589665|2209035|FG002|Induction Period|Did not receive drug|0
1121148|NCT02589665|2209036|FG003|Induction Period|Did not receive drug|1
1121149|NCT02589665|2209037|FG004|Induction Period|Did not receive drug|0
1121150|NCT02589665|2209038|FG005|Induction Period|Did not receive drug|0
1121151|NCT02589665|2209039|FG006|Induction Period|Did not receive drug|0
1121152|NCT02589665|2209040|FG007|Induction Period|Did not receive drug|0
1121153|NCT02589665|2209041|FG008|Induction Period|Did not receive drug|0
1121154|NCT02589665|2209042|FG009|Induction Period|Did not receive drug|0
1121155|NCT02589665|2209033|FG000|Induction Period|Adverse Event|3
1121156|NCT02589665|2209034|FG001|Induction Period|Adverse Event|0
1121157|NCT02589665|2209035|FG002|Induction Period|Adverse Event|2
1121158|NCT02589665|2209036|FG003|Induction Period|Adverse Event|2
1121159|NCT02589665|2209037|FG004|Induction Period|Adverse Event|0
1121160|NCT02589665|2209038|FG005|Induction Period|Adverse Event|0
1121161|NCT02589665|2209039|FG006|Induction Period|Adverse Event|0
1121162|NCT02589665|2209040|FG007|Induction Period|Adverse Event|0
1121163|NCT02589665|2209041|FG008|Induction Period|Adverse Event|0
1121164|NCT02589665|2209042|FG009|Induction Period|Adverse Event|0
1121165|NCT02589665|2209033|FG000|Induction Period|Withdrawal by Subject|0
1121166|NCT02589665|2209034|FG001|Induction Period|Withdrawal by Subject|1
1121167|NCT02589665|2209035|FG002|Induction Period|Withdrawal by Subject|0
1121168|NCT02589665|2209036|FG003|Induction Period|Withdrawal by Subject|1
1121169|NCT02589665|2209037|FG004|Induction Period|Withdrawal by Subject|0
1121170|NCT02589665|2209038|FG005|Induction Period|Withdrawal by Subject|0
1121171|NCT02589665|2209039|FG006|Induction Period|Withdrawal by Subject|0
1121172|NCT02589665|2209040|FG007|Induction Period|Withdrawal by Subject|0
1121173|NCT02589665|2209041|FG008|Induction Period|Withdrawal by Subject|0
1121174|NCT02589665|2209042|FG009|Induction Period|Withdrawal by Subject|0
1121175|NCT02589665|2209033|FG000|Induction Period|Protocol Violation|0
1121176|NCT02589665|2209034|FG001|Induction Period|Protocol Violation|1
1121177|NCT02589665|2209035|FG002|Induction Period|Protocol Violation|0
1121178|NCT02589665|2209036|FG003|Induction Period|Protocol Violation|0
1121179|NCT02589665|2209037|FG004|Induction Period|Protocol Violation|0
1121180|NCT02589665|2209038|FG005|Induction Period|Protocol Violation|0
1121181|NCT02589665|2209039|FG006|Induction Period|Protocol Violation|0
1121182|NCT02589665|2209040|FG007|Induction Period|Protocol Violation|0
1121183|NCT02589665|2209041|FG008|Induction Period|Protocol Violation|0
1121184|NCT02589665|2209042|FG009|Induction Period|Protocol Violation|0
1121185|NCT02589665|2209033|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
1121186|NCT02589665|2209034|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
1121187|NCT02589665|2209035|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
1121188|NCT02589665|2209036|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
1121189|NCT02589665|2209037|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
1121190|NCT02589665|2209038|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
1121191|NCT02589665|2209039|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
1121192|NCT02589665|2209040|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
1121193|NCT02589665|2209041|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
1121194|NCT02589665|2209042|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
1121195|NCT02589665|2209033|FG000|Maintenance Period|Withdrawal by Subject|0
1121196|NCT02589665|2209034|FG001|Maintenance Period|Withdrawal by Subject|0
1121197|NCT02589665|2209035|FG002|Maintenance Period|Withdrawal by Subject|0
1121198|NCT02589665|2209036|FG003|Maintenance Period|Withdrawal by Subject|0
1121199|NCT02589665|2209037|FG004|Maintenance Period|Withdrawal by Subject|4
1121200|NCT02589665|2209038|FG005|Maintenance Period|Withdrawal by Subject|2
1121201|NCT02589665|2209039|FG006|Maintenance Period|Withdrawal by Subject|4
1121202|NCT02589665|2209040|FG007|Maintenance Period|Withdrawal by Subject|0
1121203|NCT02589665|2209041|FG008|Maintenance Period|Withdrawal by Subject|0
1121204|NCT02589665|2209042|FG009|Maintenance Period|Withdrawal by Subject|0
1121205|NCT02589665|2209033|FG000|Maintenance Period|Lack of Efficacy|0
1121206|NCT02589665|2209034|FG001|Maintenance Period|Lack of Efficacy|0
1121207|NCT02589665|2209035|FG002|Maintenance Period|Lack of Efficacy|0
1121208|NCT02589665|2209036|FG003|Maintenance Period|Lack of Efficacy|0
1121209|NCT02589665|2209037|FG004|Maintenance Period|Lack of Efficacy|2
1121210|NCT02589665|2209038|FG005|Maintenance Period|Lack of Efficacy|1
1121211|NCT02589665|2209039|FG006|Maintenance Period|Lack of Efficacy|0
1121212|NCT02589665|2209040|FG007|Maintenance Period|Lack of Efficacy|0
1121213|NCT02589665|2209041|FG008|Maintenance Period|Lack of Efficacy|0
1121214|NCT02589665|2209042|FG009|Maintenance Period|Lack of Efficacy|0
1121215|NCT02589665|2209033|FG000|Maintenance Period|Adverse Event|0
1121216|NCT02589665|2209034|FG001|Maintenance Period|Adverse Event|0
1121217|NCT02589665|2209035|FG002|Maintenance Period|Adverse Event|0
1121218|NCT02589665|2209036|FG003|Maintenance Period|Adverse Event|0
1121219|NCT02589665|2209037|FG004|Maintenance Period|Adverse Event|0
1121220|NCT02589665|2209038|FG005|Maintenance Period|Adverse Event|0
1121221|NCT02589665|2209039|FG006|Maintenance Period|Adverse Event|2
1121222|NCT02589665|2209040|FG007|Maintenance Period|Adverse Event|0
1121223|NCT02589665|2209041|FG008|Maintenance Period|Adverse Event|0
1121224|NCT02589665|2209042|FG009|Maintenance Period|Adverse Event|0
1121225|NCT02589665|2209033|FG000|Maintenance Period|Lost to Follow-up|0
1121226|NCT02589665|2209034|FG001|Maintenance Period|Lost to Follow-up|0
1121227|NCT02589665|2209035|FG002|Maintenance Period|Lost to Follow-up|0
1121228|NCT02589665|2209036|FG003|Maintenance Period|Lost to Follow-up|0
1121229|NCT02589665|2209037|FG004|Maintenance Period|Lost to Follow-up|0
1121230|NCT02589665|2209038|FG005|Maintenance Period|Lost to Follow-up|1
1121231|NCT02589665|2209039|FG006|Maintenance Period|Lost to Follow-up|0
1121232|NCT02589665|2209040|FG007|Maintenance Period|Lost to Follow-up|0
1121233|NCT02589665|2209041|FG008|Maintenance Period|Lost to Follow-up|0
1121234|NCT02589665|2209042|FG009|Maintenance Period|Lost to Follow-up|0
1121235|NCT02589665|2209033|FG000|Maintenance Period|Physician Decision|0
1121236|NCT02589665|2209034|FG001|Maintenance Period|Physician Decision|0
1121237|NCT02589665|2209035|FG002|Maintenance Period|Physician Decision|0
1121238|NCT02589665|2209036|FG003|Maintenance Period|Physician Decision|0
1121239|NCT02589665|2209037|FG004|Maintenance Period|Physician Decision|0
1121240|NCT02589665|2209038|FG005|Maintenance Period|Physician Decision|1
1121241|NCT02589665|2209039|FG006|Maintenance Period|Physician Decision|0
1121242|NCT02589665|2209040|FG007|Maintenance Period|Physician Decision|0
1121243|NCT02589665|2209041|FG008|Maintenance Period|Physician Decision|0
1121244|NCT02589665|2209042|FG009|Maintenance Period|Physician Decision|0
1121245|NCT02589665|2209033|FG000|Maintenance Period|Reason Not Collected|0
1121246|NCT02589665|2209034|FG001|Maintenance Period|Reason Not Collected|0
1121247|NCT02589665|2209035|FG002|Maintenance Period|Reason Not Collected|0
1121248|NCT02589665|2209036|FG003|Maintenance Period|Reason Not Collected|0
1121249|NCT02589665|2209037|FG004|Maintenance Period|Reason Not Collected|0
1121250|NCT02589665|2209038|FG005|Maintenance Period|Reason Not Collected|1
1121251|NCT02589665|2209039|FG006|Maintenance Period|Reason Not Collected|1
1121252|NCT02589665|2209040|FG007|Maintenance Period|Reason Not Collected|0
1121253|NCT02589665|2209041|FG008|Maintenance Period|Reason Not Collected|0
1121254|NCT02589665|2209042|FG009|Maintenance Period|Reason Not Collected|0
1121255|NCT02589665|2209033|FG000|Induction Extension Period|Adverse Event|0
1121256|NCT02589665|2209034|FG001|Induction Extension Period|Adverse Event|0
1121257|NCT02589665|2209035|FG002|Induction Extension Period|Adverse Event|0
1121258|NCT02589665|2209036|FG003|Induction Extension Period|Adverse Event|0
1121259|NCT02589665|2209037|FG004|Induction Extension Period|Adverse Event|0
1121260|NCT02589665|2209038|FG005|Induction Extension Period|Adverse Event|0
1121261|NCT02589665|2209039|FG006|Induction Extension Period|Adverse Event|0
1121262|NCT02589665|2209040|FG007|Induction Extension Period|Adverse Event|0
1121263|NCT02589665|2209041|FG008|Induction Extension Period|Adverse Event|4
1121264|NCT02589665|2209042|FG009|Induction Extension Period|Adverse Event|0
1121265|NCT02589665|2209033|FG000|Induction Extension Period|Lack of Efficacy|0
1121266|NCT02589665|2209034|FG001|Induction Extension Period|Lack of Efficacy|0
1121267|NCT02589665|2209035|FG002|Induction Extension Period|Lack of Efficacy|0
1121268|NCT02589665|2209036|FG003|Induction Extension Period|Lack of Efficacy|0
1121269|NCT02589665|2209037|FG004|Induction Extension Period|Lack of Efficacy|0
1121270|NCT02589665|2209038|FG005|Induction Extension Period|Lack of Efficacy|0
1121271|NCT02589665|2209039|FG006|Induction Extension Period|Lack of Efficacy|0
1121272|NCT02589665|2209040|FG007|Induction Extension Period|Lack of Efficacy|0
1121273|NCT02589665|2209041|FG008|Induction Extension Period|Lack of Efficacy|3
1121274|NCT02589665|2209042|FG009|Induction Extension Period|Lack of Efficacy|0
1121275|NCT02589665|2209033|FG000|Induction Extension Period|Withdrawal by Subject|0
1121276|NCT02589665|2209034|FG001|Induction Extension Period|Withdrawal by Subject|0
1121277|NCT02589665|2209035|FG002|Induction Extension Period|Withdrawal by Subject|0
1121278|NCT02589665|2209036|FG003|Induction Extension Period|Withdrawal by Subject|0
1121279|NCT02589665|2209037|FG004|Induction Extension Period|Withdrawal by Subject|0
1121280|NCT02589665|2209038|FG005|Induction Extension Period|Withdrawal by Subject|0
1121281|NCT02589665|2209039|FG006|Induction Extension Period|Withdrawal by Subject|0
1121282|NCT02589665|2209040|FG007|Induction Extension Period|Withdrawal by Subject|2
1121283|NCT02589665|2209041|FG008|Induction Extension Period|Withdrawal by Subject|3
1121284|NCT02589665|2209042|FG009|Induction Extension Period|Withdrawal by Subject|0
1121285|NCT02589665|2209033|FG000|Induction Extension Period|Physician Decision|0
1121286|NCT02589665|2209034|FG001|Induction Extension Period|Physician Decision|0
1121287|NCT02589665|2209035|FG002|Induction Extension Period|Physician Decision|0
1121288|NCT02589665|2209036|FG003|Induction Extension Period|Physician Decision|0
1121289|NCT02589665|2209037|FG004|Induction Extension Period|Physician Decision|0
1121290|NCT02589665|2209038|FG005|Induction Extension Period|Physician Decision|0
1121291|NCT02589665|2209039|FG006|Induction Extension Period|Physician Decision|0
1121292|NCT02589665|2209040|FG007|Induction Extension Period|Physician Decision|0
1121293|NCT02589665|2209041|FG008|Induction Extension Period|Physician Decision|1
1121294|NCT02589665|2209042|FG009|Induction Extension Period|Physician Decision|0
1121295|NCT02589665|2209033|FG000|Induction Extension Period|Reason Not Collected|0
1121296|NCT02589665|2209034|FG001|Induction Extension Period|Reason Not Collected|0
1121297|NCT02589665|2209035|FG002|Induction Extension Period|Reason Not Collected|0
1121298|NCT02589665|2209036|FG003|Induction Extension Period|Reason Not Collected|0
1121299|NCT02589665|2209037|FG004|Induction Extension Period|Reason Not Collected|0
1121300|NCT02589665|2209038|FG005|Induction Extension Period|Reason Not Collected|0
1121301|NCT02589665|2209039|FG006|Induction Extension Period|Reason Not Collected|0
1121302|NCT02589665|2209040|FG007|Induction Extension Period|Reason Not Collected|0
1121303|NCT02589665|2209041|FG008|Induction Extension Period|Reason Not Collected|1
1121304|NCT02589665|2209042|FG009|Induction Extension Period|Reason Not Collected|0
1121305|NCT02589665|2209033|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
1121306|NCT02589665|2209034|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
1121307|NCT02589665|2209035|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
1121308|NCT02589665|2209036|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
1121309|NCT02589665|2209037|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
1121310|NCT02589665|2209038|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
1121311|NCT02589665|2209039|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
1121312|NCT02589665|2209040|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
1121313|NCT02589665|2209041|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
1121314|NCT02589665|2209042|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
1121315|NCT02589665|2209033|FG000|Maintenance Extension Period|Withdrawal by Subject|0
1121316|NCT02589665|2209034|FG001|Maintenance Extension Period|Withdrawal by Subject|0
1121317|NCT02589665|2209035|FG002|Maintenance Extension Period|Withdrawal by Subject|0
1121318|NCT02589665|2209036|FG003|Maintenance Extension Period|Withdrawal by Subject|0
1121319|NCT02589665|2209037|FG004|Maintenance Extension Period|Withdrawal by Subject|0
1121320|NCT02589665|2209038|FG005|Maintenance Extension Period|Withdrawal by Subject|0
1121321|NCT02589665|2209039|FG006|Maintenance Extension Period|Withdrawal by Subject|0
1121322|NCT02589665|2209040|FG007|Maintenance Extension Period|Withdrawal by Subject|0
1121323|NCT02589665|2209041|FG008|Maintenance Extension Period|Withdrawal by Subject|0
1121324|NCT02589665|2209042|FG009|Maintenance Extension Period|Withdrawal by Subject|4
1121325|NCT02589665|2209033|FG000|Maintenance Extension Period|Lack of Efficacy|0
1121326|NCT02589665|2209034|FG001|Maintenance Extension Period|Lack of Efficacy|0
1121327|NCT02589665|2209035|FG002|Maintenance Extension Period|Lack of Efficacy|0
1121328|NCT02589665|2209036|FG003|Maintenance Extension Period|Lack of Efficacy|0
1121329|NCT02589665|2209037|FG004|Maintenance Extension Period|Lack of Efficacy|0
1121330|NCT02589665|2209038|FG005|Maintenance Extension Period|Lack of Efficacy|0
1121331|NCT02589665|2209039|FG006|Maintenance Extension Period|Lack of Efficacy|0
1121332|NCT02589665|2209040|FG007|Maintenance Extension Period|Lack of Efficacy|0
1121333|NCT02589665|2209041|FG008|Maintenance Extension Period|Lack of Efficacy|0
1121334|NCT02589665|2209042|FG009|Maintenance Extension Period|Lack of Efficacy|4
1121335|NCT02589665|2209033|FG000|Maintenance Extension Period|Adverse Event|0
1121336|NCT02589665|2209034|FG001|Maintenance Extension Period|Adverse Event|0
1121337|NCT02589665|2209035|FG002|Maintenance Extension Period|Adverse Event|0
1121338|NCT02589665|2209036|FG003|Maintenance Extension Period|Adverse Event|0
1121339|NCT02589665|2209037|FG004|Maintenance Extension Period|Adverse Event|0
1121340|NCT02589665|2209038|FG005|Maintenance Extension Period|Adverse Event|0
1121341|NCT02589665|2209039|FG006|Maintenance Extension Period|Adverse Event|0
1121342|NCT02589665|2209040|FG007|Maintenance Extension Period|Adverse Event|0
1121343|NCT02589665|2209041|FG008|Maintenance Extension Period|Adverse Event|0
1121344|NCT02589665|2209042|FG009|Maintenance Extension Period|Adverse Event|2
1121345|NCT02589665|2209033|FG000|Maintenance Extension Period|Non-responder|0
1121346|NCT02589665|2209034|FG001|Maintenance Extension Period|Non-responder|0
1121347|NCT02589665|2209035|FG002|Maintenance Extension Period|Non-responder|0
1121348|NCT02589665|2209036|FG003|Maintenance Extension Period|Non-responder|0
1121349|NCT02589665|2209037|FG004|Maintenance Extension Period|Non-responder|0
1121350|NCT02589665|2209038|FG005|Maintenance Extension Period|Non-responder|0
1121351|NCT02589665|2209039|FG006|Maintenance Extension Period|Non-responder|0
1121352|NCT02589665|2209040|FG007|Maintenance Extension Period|Non-responder|0
1121353|NCT02589665|2209041|FG008|Maintenance Extension Period|Non-responder|0
1121354|NCT02589665|2209042|FG009|Maintenance Extension Period|Non-responder|1
1121355|NCT02590003|2209095|FG000|Overall Study|Death|1
1121356|NCT02590003|2209096|FG001|Overall Study|Death|2
1121357|NCT02590354|2209102|FG000|Phase 1|Active hepatitis B or C infection|1
1121358|NCT02590354|2209102|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1
1121359|NCT02590354|2209102|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75
1121360|NCT02590354|2209102|FG000|Phase 1|Subject does not want to participate|20
1121361|NCT02590354|2209102|FG000|Phase 1|Lost to Follow-up|1
1121362|NCT02590354|2209102|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2
1121363|NCT02590406|2209109|FG000|Overall Study|Adverse Event|1
1121364|NCT02590406|2209110|FG001|Overall Study|Adverse Event|0
1121365|NCT02590406|2209109|FG000|Overall Study|Saturometer malfunction|0
1121366|NCT02590406|2209110|FG001|Overall Study|Saturometer malfunction|1
1121367|NCT02590432|2209118|FG000|Open-label Treatment Period|Adverse Event|97
1121368|NCT02590432|2209119|FG001|Open-label Treatment Period|Adverse Event|79
1121369|NCT02590432|2209120|FG002|Open-label Treatment Period|Adverse Event|0
1121370|NCT02590432|2209121|FG003|Open-label Treatment Period|Adverse Event|0
1121371|NCT02590432|2209122|FG004|Open-label Treatment Period|Adverse Event|0
1121372|NCT02590432|2209123|FG005|Open-label Treatment Period|Adverse Event|0
1121373|NCT02590432|2209124|FG006|Open-label Treatment Period|Adverse Event|0
1121374|NCT02590432|2209125|FG007|Open-label Treatment Period|Adverse Event|0
1121375|NCT02590432|2209126|FG008|Open-label Treatment Period|Adverse Event|0
1121376|NCT02590432|2209118|FG000|Open-label Treatment Period|Lack of Efficacy|14
1121377|NCT02590432|2209119|FG001|Open-label Treatment Period|Lack of Efficacy|5
1121378|NCT02590432|2209120|FG002|Open-label Treatment Period|Lack of Efficacy|0
1121379|NCT02590432|2209121|FG003|Open-label Treatment Period|Lack of Efficacy|0
1121380|NCT02590432|2209122|FG004|Open-label Treatment Period|Lack of Efficacy|0
1121381|NCT02590432|2209123|FG005|Open-label Treatment Period|Lack of Efficacy|0
1121382|NCT02590432|2209124|FG006|Open-label Treatment Period|Lack of Efficacy|0
1121383|NCT02590432|2209125|FG007|Open-label Treatment Period|Lack of Efficacy|0
1121384|NCT02590432|2209126|FG008|Open-label Treatment Period|Lack of Efficacy|0
1121385|NCT02590432|2209118|FG000|Open-label Treatment Period|Withdrawal of Consent|43
1121386|NCT02590432|2209119|FG001|Open-label Treatment Period|Withdrawal of Consent|28
1121387|NCT02590432|2209120|FG002|Open-label Treatment Period|Withdrawal of Consent|0
1121388|NCT02590432|2209121|FG003|Open-label Treatment Period|Withdrawal of Consent|0
1121389|NCT02590432|2209122|FG004|Open-label Treatment Period|Withdrawal of Consent|0
1121390|NCT02590432|2209123|FG005|Open-label Treatment Period|Withdrawal of Consent|0
1121391|NCT02590432|2209124|FG006|Open-label Treatment Period|Withdrawal of Consent|0
1121392|NCT02590432|2209125|FG007|Open-label Treatment Period|Withdrawal of Consent|0
1121393|NCT02590432|2209126|FG008|Open-label Treatment Period|Withdrawal of Consent|0
1121394|NCT02590432|2209118|FG000|Open-label Treatment Period|Lost to Follow-up|51
1121395|NCT02590432|2209119|FG001|Open-label Treatment Period|Lost to Follow-up|29
1121396|NCT02590432|2209120|FG002|Open-label Treatment Period|Lost to Follow-up|0
1121397|NCT02590432|2209121|FG003|Open-label Treatment Period|Lost to Follow-up|0
1121398|NCT02590432|2209122|FG004|Open-label Treatment Period|Lost to Follow-up|0
1121399|NCT02590432|2209123|FG005|Open-label Treatment Period|Lost to Follow-up|0
1121400|NCT02590432|2209124|FG006|Open-label Treatment Period|Lost to Follow-up|0
1121401|NCT02590432|2209125|FG007|Open-label Treatment Period|Lost to Follow-up|0
1121402|NCT02590432|2209126|FG008|Open-label Treatment Period|Lost to Follow-up|0
1121403|NCT02590432|2209118|FG000|Open-label Treatment Period|Protocol Violation|10
1121404|NCT02590432|2209119|FG001|Open-label Treatment Period|Protocol Violation|4
1121405|NCT02590432|2209120|FG002|Open-label Treatment Period|Protocol Violation|0
1121406|NCT02590432|2209121|FG003|Open-label Treatment Period|Protocol Violation|0
1121407|NCT02590432|2209122|FG004|Open-label Treatment Period|Protocol Violation|0
1121408|NCT02590432|2209123|FG005|Open-label Treatment Period|Protocol Violation|0
1121409|NCT02590432|2209124|FG006|Open-label Treatment Period|Protocol Violation|0
1121410|NCT02590432|2209125|FG007|Open-label Treatment Period|Protocol Violation|0
1121411|NCT02590432|2209126|FG008|Open-label Treatment Period|Protocol Violation|0
1121412|NCT02590432|2209118|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7
1121413|NCT02590432|2209119|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1
1121414|NCT02590432|2209120|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0
1121415|NCT02590432|2209121|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0
1121416|NCT02590432|2209122|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0
1121417|NCT02590432|2209123|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0
1121418|NCT02590432|2209124|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0
1121419|NCT02590432|2209125|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0
1121420|NCT02590432|2209126|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0
1121421|NCT02590432|2209118|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10
1121422|NCT02590432|2209119|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6
1121423|NCT02590432|2209120|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0
1121424|NCT02590432|2209121|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0
1121425|NCT02590432|2209122|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0
1121426|NCT02590432|2209123|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0
1121427|NCT02590432|2209124|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0
1121428|NCT02590432|2209125|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0
1121429|NCT02590432|2209126|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0
1121430|NCT02590432|2209118|FG000|Double-blind Treatment Period|Adverse Event|0
1121431|NCT02590432|2209119|FG001|Double-blind Treatment Period|Adverse Event|0
1121432|NCT02590432|2209120|FG002|Double-blind Treatment Period|Adverse Event|14
1121433|NCT02590432|2209121|FG003|Double-blind Treatment Period|Adverse Event|12
1121434|NCT02590432|2209122|FG004|Double-blind Treatment Period|Adverse Event|6
1121435|NCT02590432|2209123|FG005|Double-blind Treatment Period|Adverse Event|22
1121436|NCT02590432|2209124|FG006|Double-blind Treatment Period|Adverse Event|20
1121437|NCT02590432|2209125|FG007|Double-blind Treatment Period|Adverse Event|0
1121438|NCT02590432|2209126|FG008|Double-blind Treatment Period|Adverse Event|0
1121439|NCT02590432|2209118|FG000|Double-blind Treatment Period|Lack of Efficacy|0
1121440|NCT02590432|2209119|FG001|Double-blind Treatment Period|Lack of Efficacy|0
1121441|NCT02590432|2209120|FG002|Double-blind Treatment Period|Lack of Efficacy|1
1121442|NCT02590432|2209121|FG003|Double-blind Treatment Period|Lack of Efficacy|0
1121443|NCT02590432|2209122|FG004|Double-blind Treatment Period|Lack of Efficacy|0
1121444|NCT02590432|2209123|FG005|Double-blind Treatment Period|Lack of Efficacy|0
1121445|NCT02590432|2209124|FG006|Double-blind Treatment Period|Lack of Efficacy|0
1121446|NCT02590432|2209125|FG007|Double-blind Treatment Period|Lack of Efficacy|0
1121447|NCT02590432|2209126|FG008|Double-blind Treatment Period|Lack of Efficacy|0
1121448|NCT02590432|2209118|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
1121449|NCT02590432|2209119|FG001|Double-blind Treatment Period|Withdrawal of Consent|0
1121450|NCT02590432|2209120|FG002|Double-blind Treatment Period|Withdrawal of Consent|1
1121451|NCT02590432|2209121|FG003|Double-blind Treatment Period|Withdrawal of Consent|3
1121452|NCT02590432|2209122|FG004|Double-blind Treatment Period|Withdrawal of Consent|3
1121453|NCT02590432|2209123|FG005|Double-blind Treatment Period|Withdrawal of Consent|1
1121454|NCT02590432|2209124|FG006|Double-blind Treatment Period|Withdrawal of Consent|1
1121455|NCT02590432|2209125|FG007|Double-blind Treatment Period|Withdrawal of Consent|0
1121456|NCT02590432|2209126|FG008|Double-blind Treatment Period|Withdrawal of Consent|0
1121457|NCT02590432|2209118|FG000|Double-blind Treatment Period|Lost to Follow-up|0
1121458|NCT02590432|2209119|FG001|Double-blind Treatment Period|Lost to Follow-up|0
1121459|NCT02590432|2209120|FG002|Double-blind Treatment Period|Lost to Follow-up|1
1121460|NCT02590432|2209121|FG003|Double-blind Treatment Period|Lost to Follow-up|0
1121461|NCT02590432|2209122|FG004|Double-blind Treatment Period|Lost to Follow-up|0
1121462|NCT02590432|2209123|FG005|Double-blind Treatment Period|Lost to Follow-up|2
1121463|NCT02590432|2209124|FG006|Double-blind Treatment Period|Lost to Follow-up|0
1121464|NCT02590432|2209125|FG007|Double-blind Treatment Period|Lost to Follow-up|0
1121465|NCT02590432|2209126|FG008|Double-blind Treatment Period|Lost to Follow-up|0
1121466|NCT02590432|2209118|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0
1121467|NCT02590432|2209119|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0
1121468|NCT02590432|2209120|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0
1121469|NCT02590432|2209121|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0
1121470|NCT02590432|2209122|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0
1121471|NCT02590432|2209123|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1
1121472|NCT02590432|2209124|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0
1121473|NCT02590432|2209125|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0
1121474|NCT02590432|2209126|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0
1121475|NCT02590432|2209118|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0
1121476|NCT02590432|2209119|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0
1121477|NCT02590432|2209120|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0
1121478|NCT02590432|2209121|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0
1121479|NCT02590432|2209122|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0
1121480|NCT02590432|2209123|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0
1121481|NCT02590432|2209124|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0
1121482|NCT02590432|2209125|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12
1121483|NCT02590432|2209126|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15
1121484|NCT02590432|2209118|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1121485|NCT02590432|2209119|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1121486|NCT02590432|2209120|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1121487|NCT02590432|2209121|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1121488|NCT02590432|2209122|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1121489|NCT02590432|2209123|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1121490|NCT02590432|2209124|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1121491|NCT02590432|2209125|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
1121492|NCT02590432|2209126|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1121493|NCT02590432|2209118|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1121494|NCT02590432|2209119|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1121495|NCT02590432|2209120|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1121496|NCT02590432|2209121|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1121497|NCT02590432|2209122|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1121498|NCT02590432|2209123|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1121499|NCT02590432|2209124|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1121500|NCT02590432|2209125|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
1121501|NCT02590432|2209126|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
1121502|NCT02590432|2209118|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1121503|NCT02590432|2209119|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1121504|NCT02590432|2209120|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1121505|NCT02590432|2209121|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1121506|NCT02590432|2209122|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1121507|NCT02590432|2209123|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1121508|NCT02590432|2209124|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1121509|NCT02590432|2209125|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1121510|NCT02590432|2209126|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
1121511|NCT02590432|2209118|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1121512|NCT02590432|2209119|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1121513|NCT02590432|2209120|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1121514|NCT02590432|2209121|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1121515|NCT02590432|2209122|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1121516|NCT02590432|2209123|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1121517|NCT02590432|2209124|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1121518|NCT02590432|2209125|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1121519|NCT02590432|2209126|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1
1121520|NCT02590432|2209118|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1121521|NCT02590432|2209119|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1121522|NCT02590432|2209120|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1121523|NCT02590432|2209121|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1162077|NCT03382899|2284097|FG000|Overall Study|Lost to Follow-up|0
898457|NCT00716144|1871021|FG001|Overall Study|Physician Decision|1
898458|NCT00716144|1871022|FG002|Overall Study|Physician Decision|2
898459|NCT00716144|1871023|FG003|Overall Study|Physician Decision|2
898460|NCT00716144|1871020|FG000|Overall Study|Intercurrent illness|0
898461|NCT00716144|1871021|FG001|Overall Study|Intercurrent illness|0
1121524|NCT02590432|2209122|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1121525|NCT02590432|2209123|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1121526|NCT02590432|2209124|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1121527|NCT02590432|2209125|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
1121528|NCT02590432|2209126|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1121529|NCT02590432|2209118|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1121530|NCT02590432|2209119|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1121531|NCT02590432|2209120|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1121532|NCT02590432|2209121|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1121533|NCT02590432|2209122|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1121534|NCT02590432|2209123|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1121535|NCT02590432|2209124|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1121536|NCT02590432|2209125|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
1121537|NCT02590432|2209126|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1121538|NCT02590562|2209138|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6
1121539|NCT02590588|2209148|FG000|Overall Study|Adverse Event|1
1121540|NCT02590939|2209154|FG000|Overall Study|Withdrawal by Subject|3
1121541|NCT02590939|2209155|FG001|Overall Study|Withdrawal by Subject|1
1121542|NCT02590939|2209154|FG000|Overall Study|Failed the nociceptive test|2
1121543|NCT02590939|2209155|FG001|Overall Study|Failed the nociceptive test|1
1121544|NCT02591238|2209169|FG000|Overall Study|Pregnancy|1
1121545|NCT02591238|2209170|FG001|Overall Study|Pregnancy|0
1121546|NCT02591238|2209171|FG002|Overall Study|Pregnancy|0
1121547|NCT02591238|2209172|FG003|Overall Study|Pregnancy|0
1121548|NCT02591238|2209169|FG000|Overall Study|Withdrawal by Subject|0
1121549|NCT02591238|2209170|FG001|Overall Study|Withdrawal by Subject|0
1121550|NCT02591238|2209171|FG002|Overall Study|Withdrawal by Subject|0
1121551|NCT02591238|2209172|FG003|Overall Study|Withdrawal by Subject|1
1121552|NCT02591238|2209169|FG000|Overall Study|influenza|0
1121553|NCT02591238|2209170|FG001|Overall Study|influenza|0
1121554|NCT02591238|2209171|FG002|Overall Study|influenza|0
1121555|NCT02591238|2209172|FG003|Overall Study|influenza|1
1121556|NCT02591238|2209169|FG000|Overall Study|personal circumstances|0
1121557|NCT02591238|2209170|FG001|Overall Study|personal circumstances|0
1121558|NCT02591238|2209171|FG002|Overall Study|personal circumstances|0
1121559|NCT02591238|2209172|FG003|Overall Study|personal circumstances|1
1121560|NCT02591238|2209169|FG000|Overall Study|personal circumstances|0
1121561|NCT02591238|2209170|FG001|Overall Study|personal circumstances|1
1121562|NCT02591238|2209171|FG002|Overall Study|personal circumstances|0
1121563|NCT02591238|2209172|FG003|Overall Study|personal circumstances|0
1121564|NCT02591290|2209182|FG000|Overall Study|Withdrawal by Subject|2
1121565|NCT02592018|2209205|FG000|Overall Study|Adverse Event|1
1121566|NCT02592018|2209205|FG000|Overall Study|Lost to Follow-up|1
1121567|NCT02592434|2209218|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12
1121568|NCT02592434|2209219|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0
1121569|NCT02592434|2209220|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0
1121570|NCT02592434|2209218|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
1121571|NCT02592434|2209219|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
1121572|NCT02592434|2209220|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
1121573|NCT02592434|2209218|FG000|Open-Label Phase (18 Weeks)|Other|3
1121574|NCT02592434|2209219|FG001|Open-Label Phase (18 Weeks)|Other|0
1121575|NCT02592434|2209220|FG002|Open-Label Phase (18 Weeks)|Other|0
1121576|NCT02592434|2209218|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4
1121577|NCT02592434|2209219|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0
1121578|NCT02592434|2209220|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0
1121579|NCT02592434|2209218|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0
1121580|NCT02592434|2209219|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2
1121581|NCT02592434|2209220|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2
1121582|NCT02592434|2209218|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
1121583|NCT02592434|2209219|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
1121584|NCT02592434|2209220|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
1121585|NCT02592434|2209218|FG000|Double Blind Phase (26 Weeks)|Other|0
1121586|NCT02592434|2209219|FG001|Double Blind Phase (26 Weeks)|Other|1
1121587|NCT02592434|2209220|FG002|Double Blind Phase (26 Weeks)|Other|0
1121588|NCT02592434|2209218|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0
1121589|NCT02592434|2209219|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0
1121590|NCT02592434|2209220|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1
1121591|NCT02592434|2209218|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
1121592|NCT02592434|2209219|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
1121593|NCT02592434|2209220|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
1121594|NCT02592434|2209218|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
1121595|NCT02592434|2209219|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
1121596|NCT02592434|2209220|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
1121597|NCT02592447|2209230|FG000|Overall Study|Lost to Follow-up|1
1121598|NCT02592447|2209231|FG001|Overall Study|Lost to Follow-up|0
1121599|NCT02592447|2209230|FG000|Overall Study|Ineligible after randomization|1
1121600|NCT02592447|2209231|FG001|Overall Study|Ineligible after randomization|0
1121601|NCT02592447|2209230|FG000|Overall Study|Withdrawal by Subject|0
1121602|NCT02592447|2209231|FG001|Overall Study|Withdrawal by Subject|1
1121603|NCT02592798|2209278|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1
1121604|NCT02592798|2209279|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0
1121605|NCT02592798|2209278|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0
1121606|NCT02592798|2209279|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1
1121607|NCT02592798|2209278|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1
1121608|NCT02592798|2209279|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3
1121609|NCT02592798|2209278|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1
1121610|NCT02592798|2209279|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2
1121611|NCT02592798|2209278|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3
1121612|NCT02592798|2209279|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2
1121613|NCT02592798|2209278|FG000|Double-Blind Period 2 (DB2)|Other reasons|1
1121614|NCT02592798|2209279|FG001|Double-Blind Period 2 (DB2)|Other reasons|0
1121615|NCT02592798|2209278|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1
1121616|NCT02592798|2209279|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0
1121617|NCT02592798|2209278|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1
1121618|NCT02592798|2209279|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0
1121619|NCT02592798|2209278|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1
1121620|NCT02592798|2209279|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2
898462|NCT00716144|1871022|FG002|Overall Study|Intercurrent illness|1
898463|NCT00716144|1871023|FG003|Overall Study|Intercurrent illness|0
898464|NCT00716144|1871020|FG000|Overall Study|Withdrew consent, allowed use of data|0
898465|NCT00716144|1871021|FG001|Overall Study|Withdrew consent, allowed use of data|0
898466|NCT00716144|1871022|FG002|Overall Study|Withdrew consent, allowed use of data|1
1121621|NCT02592798|2209278|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1
1121622|NCT02592798|2209279|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0
1121623|NCT02592798|2209278|FG000|Transition From DB2 to OLE|Other reasons|1
1121624|NCT02592798|2209279|FG001|Transition From DB2 to OLE|Other reasons|0
1121625|NCT02592798|2209278|FG000|Open Label Period (OLE)|Other reasons|0
1121626|NCT02592798|2209279|FG001|Open Label Period (OLE)|Other reasons|2
1121627|NCT02592798|2209278|FG000|Open Label Period (OLE)|Participant request to discontinue|1
1121628|NCT02592798|2209279|FG001|Open Label Period (OLE)|Participant request to discontinue|0
1121629|NCT02592798|2209278|FG000|Open Label Period (OLE)|Lost to Follow-up|0
1121630|NCT02592798|2209279|FG001|Open Label Period (OLE)|Lost to Follow-up|1
1121631|NCT02592798|2209278|FG000|Open Label Period (OLE)|Lack of Efficacy|3
1121632|NCT02592798|2209279|FG001|Open Label Period (OLE)|Lack of Efficacy|5
1121633|NCT02592798|2209278|FG000|Open Label Period (OLE)|Adverse Event|0
1121634|NCT02592798|2209279|FG001|Open Label Period (OLE)|Adverse Event|1
1121635|NCT02592876|2209294|FG000|Overall Study|Withdrawal by Subject|3
1121636|NCT02592876|2209295|FG001|Overall Study|Withdrawal by Subject|3
1121637|NCT02592876|2209294|FG000|Overall Study|Study Termination by Sponsor|32
1121638|NCT02592876|2209295|FG001|Overall Study|Study Termination by Sponsor|27
1121639|NCT02592876|2209294|FG000|Overall Study|Lost to Follow-up|0
1121640|NCT02592876|2209295|FG001|Overall Study|Lost to Follow-up|1
1121641|NCT02592876|2209294|FG000|Overall Study|Death|6
1121642|NCT02592876|2209295|FG001|Overall Study|Death|9
1121643|NCT02593097|2209326|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
1121644|NCT02593097|2209327|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2
1121645|NCT02593097|2209326|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
1121646|NCT02593097|2209327|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2
1121647|NCT02593097|2209326|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1
1121648|NCT02593097|2209327|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1
1121649|NCT02593097|2209326|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1
1121650|NCT02593097|2209327|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0
1121651|NCT02593097|2209326|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
1121652|NCT02593097|2209327|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
1121653|NCT02593149|2209335|FG000|Run-In|Didn't use CVC for at least 21 days|36
1121654|NCT02593149|2209336|FG001|Run-In|Didn't use CVC for at least 21 days|38
1121655|NCT02593149|2209335|FG000|Intervention|Didn't use CVC for at least 21 day|116
1121656|NCT02593149|2209336|FG001|Intervention|Didn't use CVC for at least 21 day|115
1121657|NCT02593305|2209345|FG000|Post 1|Comparison only group. No intervention.|0
1121658|NCT02593305|2209346|FG001|Post 1|Comparison only group. No intervention.|0
1121659|NCT02593305|2209347|FG002|Post 1|Comparison only group. No intervention.|10
1121660|NCT02593318|2209358|FG000|Overall Study|Withdrawal by Subject|1
1121661|NCT02593318|2209359|FG001|Overall Study|Withdrawal by Subject|1
1121662|NCT02593539|2209380|FG000|Overall Study|Adverse Event|1
1121663|NCT02593825|2209398|FG000|Intervention|Lost to Follow-up|10
1121664|NCT02593825|2209399|FG001|Intervention|Lost to Follow-up|12
1121665|NCT02593864|2209407|FG000|Overall Study|Withdrawal by Subject|3
1121666|NCT02593864|2209407|FG000|Overall Study|Lost to Follow-up|3
1121667|NCT02594098|2209422|FG000|Overall Study|Lack of Efficacy|17
1121668|NCT02594098|2209423|FG001|Overall Study|Lack of Efficacy|6
1121669|NCT02594098|2209422|FG000|Overall Study|Withdrawal by Subject|1
1121670|NCT02594098|2209423|FG001|Overall Study|Withdrawal by Subject|3
1121671|NCT02594098|2209422|FG000|Overall Study|Terminated participation|6
1121672|NCT02594098|2209423|FG001|Overall Study|Terminated participation|2
1121673|NCT02594098|2209422|FG000|Overall Study|Seek alternative treatment|2
1121674|NCT02594098|2209423|FG001|Overall Study|Seek alternative treatment|1
1121675|NCT02594098|2209422|FG000|Overall Study|Other|0
1121676|NCT02594098|2209423|FG001|Overall Study|Other|1
1121677|NCT02594163|2209442|FG000|Treatment Period|Progressive disease|2
1121678|NCT02594163|2209443|FG001|Treatment Period|Progressive disease|3
1121679|NCT02594163|2209442|FG000|Treatment Period|Adverse Event|1
1121680|NCT02594163|2209443|FG001|Treatment Period|Adverse Event|5
1121681|NCT02594163|2209442|FG000|Treatment Period|Physician Decision|1
1121682|NCT02594163|2209443|FG001|Treatment Period|Physician Decision|3
1121683|NCT02594163|2209442|FG000|Treatment Period|Study termination by sponsor|2
1121684|NCT02594163|2209443|FG001|Treatment Period|Study termination by sponsor|1
1121685|NCT02594163|2209442|FG000|Treatment Period|Other, Non-AE|1
1121686|NCT02594163|2209443|FG001|Treatment Period|Other, Non-AE|0
1121687|NCT02594163|2209442|FG000|Follow-up Period|Withdrawal by Subject|0
1121688|NCT02594163|2209443|FG001|Follow-up Period|Withdrawal by Subject|1
1121689|NCT02594163|2209442|FG000|Follow-up Period|Study Termination by Sponsor|6
1121690|NCT02594163|2209443|FG001|Follow-up Period|Study Termination by Sponsor|4
1121691|NCT02594163|2209442|FG000|Follow-up Period|Lost to Follow-up|1
1121692|NCT02594163|2209443|FG001|Follow-up Period|Lost to Follow-up|0
1121693|NCT02594163|2209442|FG000|Follow-up Period|Death|2
1121694|NCT02594163|2209443|FG001|Follow-up Period|Death|5
1121695|NCT02594163|2209442|FG000|Follow-up Period|Adverse Event|0
1121696|NCT02594163|2209443|FG001|Follow-up Period|Adverse Event|1
1121697|NCT02594163|2209442|FG000|Follow-up Period|Progressive Disease|2
1121698|NCT02594163|2209443|FG001|Follow-up Period|Progressive Disease|0
1121699|NCT02594163|2209442|FG000|Follow-up Period|Physician Decision|0
1121700|NCT02594163|2209443|FG001|Follow-up Period|Physician Decision|1
1121701|NCT02595008|2209479|FG000|Overall Study|Enrolled In Error|1
1121702|NCT02595008|2209480|FG001|Overall Study|Enrolled In Error|0
1121703|NCT02595073|2209488|FG000|Overall Study|Progressive Disease|0
1121704|NCT02595073|2209489|FG001|Overall Study|Progressive Disease|1
1121705|NCT02595073|2209488|FG000|Overall Study|Protocol Violation|2
1121706|NCT02595073|2209489|FG001|Overall Study|Protocol Violation|0
1121710|NCT02595398|2209501|FG000|Overall Study|Non-compliance|1
1121711|NCT02595398|2209502|FG001|Overall Study|Non-compliance|0
1121712|NCT02595398|2209501|FG000|Overall Study|Withdrawal by Subject|2
1121713|NCT02595398|2209502|FG001|Overall Study|Withdrawal by Subject|1
1121714|NCT02595398|2209501|FG000|Overall Study|Lost to Follow-up|1
1121715|NCT02595398|2209502|FG001|Overall Study|Lost to Follow-up|0
1121716|NCT02595437|2209508|FG000|Triferic Via IV|Withdrawal by Subject|1
1121717|NCT02595450|2209520|FG000|Overall Study|Unspecified (only completed 1 cycle)|73
1121718|NCT02595450|2209520|FG000|Overall Study|Enrolled, but not treated|8
1121719|NCT02595502|2209524|FG000|Period 1|Adverse Event|0
1121720|NCT02595502|2209525|FG001|Period 1|Adverse Event|1
1121721|NCT02595502|2209524|FG000|Period 1|Withdrawal by Subject|1
1121722|NCT02595502|2209525|FG001|Period 1|Withdrawal by Subject|0
1121723|NCT02595502|2209524|FG000|Period 1|Lost to Follow-up|0
1121724|NCT02595502|2209525|FG001|Period 1|Lost to Follow-up|1
1121725|NCT02595502|2209524|FG000|Period 2|Adverse Event|1
1121726|NCT02595502|2209525|FG001|Period 2|Adverse Event|1
1121727|NCT02595502|2209524|FG000|Period 2|Received incorrect lens at Period 1|0
1121728|NCT02595502|2209525|FG001|Period 2|Received incorrect lens at Period 1|1
1121729|NCT02595502|2209524|FG000|Period 3|Protocol Violation|0
1121730|NCT02595502|2209525|FG001|Period 3|Protocol Violation|1
1121731|NCT02595502|2209524|FG000|Period 3|Lost to Follow-up|1
1121732|NCT02595502|2209525|FG001|Period 3|Lost to Follow-up|0
1121733|NCT02595502|2209524|FG000|Period 3|Received Incorrect Treatment at period 3|0
1121734|NCT02595502|2209525|FG001|Period 3|Received Incorrect Treatment at period 3|1
1121735|NCT02595528|2209535|FG000|Overall Study|Withdrawal by Subject|1
1121736|NCT02595528|2209536|FG001|Overall Study|Withdrawal by Subject|2
1121737|NCT02595528|2209537|FG002|Overall Study|Withdrawal by Subject|1
1121738|NCT02595528|2209538|FG003|Overall Study|Withdrawal by Subject|3
1121739|NCT02595528|2209535|FG000|Overall Study|Lost to Follow-up|1
1121740|NCT02595528|2209536|FG001|Overall Study|Lost to Follow-up|1
1121741|NCT02595528|2209537|FG002|Overall Study|Lost to Follow-up|0
1121742|NCT02595528|2209538|FG003|Overall Study|Lost to Follow-up|1
1121743|NCT02595723|2209564|FG000|First Washout (21 Days)|Withdrawal by Subject|1
1121744|NCT02595723|2209565|FG001|First Washout (21 Days)|Withdrawal by Subject|0
1121745|NCT02595723|2209566|FG002|First Washout (21 Days)|Withdrawal by Subject|0
1121746|NCT02595723|2209564|FG000|First Washout (21 Days)|Lost to Follow-up|1
1121747|NCT02595723|2209565|FG001|First Washout (21 Days)|Lost to Follow-up|0
1121748|NCT02595723|2209566|FG002|First Washout (21 Days)|Lost to Follow-up|0
1121749|NCT02595749|2209576|FG000|Overall Study|Withdrawal by Subject|12
1121750|NCT02595749|2209577|FG001|Overall Study|Withdrawal by Subject|7
1121751|NCT02595970|2209583|FG000|Overall Study|Withdrawal by Subject|2
1121752|NCT02595970|2209583|FG000|Overall Study|Physician Decision|2
1121753|NCT02595970|2209583|FG000|Overall Study|Protocol Violation|4
1121754|NCT02595970|2209583|FG000|Overall Study|Adverse Event|5
1121755|NCT02595970|2209583|FG000|Overall Study|Lack of Efficacy|7
1121756|NCT02596009|2209592|FG000|Overall Study|Administrative problems|0
1121757|NCT02596009|2209593|FG001|Overall Study|Administrative problems|1
1121758|NCT02596009|2209594|FG002|Overall Study|Administrative problems|0
1121759|NCT02596009|2209595|FG003|Overall Study|Administrative problems|0
1121760|NCT02596009|2209596|FG004|Overall Study|Administrative problems|0
1121761|NCT02596009|2209597|FG005|Overall Study|Administrative problems|0
1121762|NCT02596035|2209615|FG000|Overall Study|Disease Progression|62
1121763|NCT02596035|2209616|FG001|Overall Study|Disease Progression|32
1121764|NCT02596035|2209617|FG002|Overall Study|Disease Progression|1
1121765|NCT02596035|2209615|FG000|Overall Study|Study Drug Toxicity|11
1121766|NCT02596035|2209616|FG001|Overall Study|Study Drug Toxicity|3
1121767|NCT02596035|2209617|FG002|Overall Study|Study Drug Toxicity|0
1121768|NCT02596035|2209615|FG000|Overall Study|Adverse Event|6
1121769|NCT02596035|2209616|FG001|Overall Study|Adverse Event|2
1121770|NCT02596035|2209617|FG002|Overall Study|Adverse Event|0
1121771|NCT02596035|2209615|FG000|Overall Study|Withdrawal by Subject|4
1121772|NCT02596035|2209616|FG001|Overall Study|Withdrawal by Subject|2
1121773|NCT02596035|2209617|FG002|Overall Study|Withdrawal by Subject|0
1121774|NCT02596035|2209615|FG000|Overall Study|Poor/Non-Compliance|0
1121775|NCT02596035|2209616|FG001|Overall Study|Poor/Non-Compliance|1
1121776|NCT02596035|2209617|FG002|Overall Study|Poor/Non-Compliance|0
1121777|NCT02596035|2209615|FG000|Overall Study|Other Reasons|3
1121778|NCT02596035|2209616|FG001|Overall Study|Other Reasons|4
1121779|NCT02596035|2209617|FG002|Overall Study|Other Reasons|0
1121780|NCT02596230|2209629|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714
1121781|NCT02596230|2209630|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228
1121782|NCT02596230|2209631|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0
1121783|NCT02596230|2209632|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846
1121784|NCT02596230|2209633|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0
1121785|NCT02596230|2209629|FG000|Objective 2, One Year|Lost to Follow-up|0
1121786|NCT02596230|2209630|FG001|Objective 2, One Year|Lost to Follow-up|41
1121787|NCT02596230|2209631|FG002|Objective 2, One Year|Lost to Follow-up|41
1121788|NCT02596230|2209632|FG003|Objective 2, One Year|Lost to Follow-up|32
1121789|NCT02596230|2209633|FG004|Objective 2, One Year|Lost to Follow-up|46
1121790|NCT02596230|2209629|FG000|Objective 2, One Year|Withdrawal by Subject|0
1121791|NCT02596230|2209630|FG001|Objective 2, One Year|Withdrawal by Subject|11
1121792|NCT02596230|2209631|FG002|Objective 2, One Year|Withdrawal by Subject|14
1121793|NCT02596230|2209632|FG003|Objective 2, One Year|Withdrawal by Subject|5
1121794|NCT02596230|2209633|FG004|Objective 2, One Year|Withdrawal by Subject|2
1121795|NCT02596230|2209629|FG000|Objective 2, One Year|Adverse drug reaction|0
1121796|NCT02596230|2209630|FG001|Objective 2, One Year|Adverse drug reaction|1
1121797|NCT02596230|2209631|FG002|Objective 2, One Year|Adverse drug reaction|0
1121798|NCT02596230|2209632|FG003|Objective 2, One Year|Adverse drug reaction|0
1121799|NCT02596230|2209633|FG004|Objective 2, One Year|Adverse drug reaction|0
1121800|NCT02596230|2209629|FG000|Objective 2, One Year|Death|0
1121801|NCT02596230|2209630|FG001|Objective 2, One Year|Death|12
1121802|NCT02596230|2209631|FG002|Objective 2, One Year|Death|41
1121803|NCT02596230|2209632|FG003|Objective 2, One Year|Death|21
1121804|NCT02596230|2209633|FG004|Objective 2, One Year|Death|30
1121805|NCT02596230|2209629|FG000|Objective 2, One Year|Other|0
1121806|NCT02596230|2209630|FG001|Objective 2, One Year|Other|3
1121807|NCT02596230|2209631|FG002|Objective 2, One Year|Other|2
1121808|NCT02596230|2209632|FG003|Objective 2, One Year|Other|0
1121809|NCT02596230|2209633|FG004|Objective 2, One Year|Other|0
1121810|NCT02596620|2209666|FG000|Overall Study|Lost to Follow-up|1
1121811|NCT02596620|2209667|FG001|Overall Study|Lost to Follow-up|1
1121812|NCT02596711|2209676|FG000|Overall Study|Lost to Follow-up|1
1121813|NCT02596711|2209677|FG001|Overall Study|Lost to Follow-up|2
1121814|NCT02596711|2209678|FG002|Overall Study|Lost to Follow-up|3
1121815|NCT02596854|2209696|FG000|Overall Study|Withdrawn|8
1121816|NCT02596893|2209709|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
1121817|NCT02596893|2209710|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
1121818|NCT02596893|2209711|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
1121819|NCT02596893|2209712|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
1121820|NCT02596893|2209709|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
1121821|NCT02596893|2209710|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
1121822|NCT02596893|2209711|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
1121823|NCT02596893|2209712|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
1121824|NCT02596893|2209709|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
1121825|NCT02596893|2209710|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
1121826|NCT02596893|2209711|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
1121827|NCT02596893|2209712|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
1121828|NCT02596893|2209709|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
1121829|NCT02596893|2209710|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
1121830|NCT02596893|2209711|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
1121831|NCT02596893|2209712|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
1121832|NCT02596893|2209709|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
1121833|NCT02596893|2209710|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
1121834|NCT02596893|2209711|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
1121835|NCT02596893|2209712|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
1121836|NCT02596893|2209709|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
1121837|NCT02596893|2209710|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
1121838|NCT02596893|2209711|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
1121839|NCT02596893|2209712|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
1121840|NCT02596893|2209709|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
1121841|NCT02596893|2209710|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
1121842|NCT02596893|2209711|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
1121843|NCT02596893|2209712|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
1121844|NCT02596893|2209709|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
1121845|NCT02596893|2209710|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
1121846|NCT02596893|2209711|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
1121847|NCT02596893|2209712|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
1121848|NCT02596893|2209709|FG000|Overall Double-Blind Period Weeks 0-52|Death|0
1121849|NCT02596893|2209710|FG001|Overall Double-Blind Period Weeks 0-52|Death|0
1121850|NCT02596893|2209711|FG002|Overall Double-Blind Period Weeks 0-52|Death|1
1121851|NCT02596893|2209712|FG003|Overall Double-Blind Period Weeks 0-52|Death|0
1121852|NCT02596893|2209709|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
1121853|NCT02596893|2209710|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
1121854|NCT02596893|2209711|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
1121855|NCT02596893|2209712|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
1121856|NCT02596893|2209709|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66
1121857|NCT02596893|2209710|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76
1121858|NCT02596893|2209711|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69
1121859|NCT02596893|2209712|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70
1121860|NCT02596945|2209731|FG000|Overall Study|No documentation of study drug dosing|3
1121861|NCT02596945|2209731|FG000|Overall Study|Other|32
1121862|NCT02596945|2209731|FG000|Overall Study|Change to hemodialysis|15
1121863|NCT02596945|2209731|FG000|Overall Study|Other Erythropoietin stimulating agent|4
1121864|NCT02596945|2209731|FG000|Overall Study|Withdrawal by Subject|1
1121865|NCT02596945|2209731|FG000|Overall Study|Missing|1
1121866|NCT02596958|2209735|FG000|Overall Study|Serious Adverse Drug Reactions|44
1121867|NCT02596958|2209735|FG000|Overall Study|Cancer Progression|441
1121868|NCT02596958|2209735|FG000|Overall Study|Death From Cancer|112
1121869|NCT02596958|2209735|FG000|Overall Study|Death From Other Cause|33
1121870|NCT02596958|2209735|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61
1121871|NCT02596958|2209735|FG000|Overall Study|Administrative Reasons/Other|231
1121872|NCT02596958|2209735|FG000|Overall Study|Lost to Follow-up|33
1121873|NCT02596958|2209735|FG000|Overall Study|Missing|32
1121874|NCT02596958|2209735|FG000|Overall Study|Excluded Due to Second Line Treatment|9
1121875|NCT02596971|2209742|FG000|Overall Study|Death|5
1121876|NCT02596971|2209743|FG001|Overall Study|Death|1
1121877|NCT02596971|2209744|FG002|Overall Study|Death|5
1121878|NCT02596971|2209742|FG000|Overall Study|Withdrawal by Subject|5
1121879|NCT02596971|2209743|FG001|Overall Study|Withdrawal by Subject|1
1121880|NCT02596971|2209744|FG002|Overall Study|Withdrawal by Subject|4
1121881|NCT02597049|2209758|FG000|Overall Study|Lost to Follow-up|0
1121882|NCT02597049|2209759|FG001|Overall Study|Lost to Follow-up|3
1121883|NCT02597049|2209760|FG002|Overall Study|Lost to Follow-up|2
1121884|NCT02597049|2209758|FG000|Overall Study|Withdrawal by Subject|2
1121885|NCT02597049|2209759|FG001|Overall Study|Withdrawal by Subject|2
1121886|NCT02597049|2209760|FG002|Overall Study|Withdrawal by Subject|1
1121887|NCT02597049|2209758|FG000|Overall Study|Adverse Event|2
1121888|NCT02597049|2209759|FG001|Overall Study|Adverse Event|0
1121889|NCT02597049|2209760|FG002|Overall Study|Adverse Event|0
1121890|NCT02597049|2209758|FG000|Overall Study|Death|2
1121891|NCT02597049|2209759|FG001|Overall Study|Death|0
1121892|NCT02597049|2209760|FG002|Overall Study|Death|0
1121893|NCT02597049|2209758|FG000|Overall Study|Noncompliant with Study Visits|1
1121894|NCT02597049|2209759|FG001|Overall Study|Noncompliant with Study Visits|0
1121895|NCT02597049|2209760|FG002|Overall Study|Noncompliant with Study Visits|0
1121896|NCT02597062|2209768|FG000|Overall Study|Ineligible|1
1121897|NCT02597452|2209835|FG000|Overall Study|testing incomplete|30
1121898|NCT02597478|2209841|FG000|Overall Study|Withdrawal by Subject|2
1121899|NCT02597478|2209842|FG001|Overall Study|Withdrawal by Subject|0
1121900|NCT02597478|2209841|FG000|Overall Study|Change of opioid dose|1
1121901|NCT02597478|2209842|FG001|Overall Study|Change of opioid dose|0
1121902|NCT02597478|2209841|FG000|Overall Study|Insufficient exertional dyspnea|0
1121903|NCT02597478|2209842|FG001|Overall Study|Insufficient exertional dyspnea|1
1121904|NCT02597712|2209888|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2
1121905|NCT02597712|2209889|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0
1121906|NCT02597712|2209888|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1
1121907|NCT02597712|2209889|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0
1121908|NCT02597712|2209888|FG000|Overall Study|Recurrent metastatic prostate cancer|0
1121909|NCT02597712|2209889|FG001|Overall Study|Recurrent metastatic prostate cancer|1
1121910|NCT02597855|2209897|FG000|Overall Study|Lost to Follow-up|2
1121911|NCT02597855|2209898|FG001|Overall Study|Lost to Follow-up|1
1121912|NCT02597920|2209916|FG000|Overall Study|Worsening of other pre-existing disease|0
1121913|NCT02597920|2209917|FG001|Overall Study|Worsening of other pre-existing disease|1
1121914|NCT02597920|2209918|FG002|Overall Study|Worsening of other pre-existing disease|0
1121915|NCT02597920|2209916|FG000|Overall Study|Other adverse event|20
1121916|NCT02597920|2209917|FG001|Overall Study|Other adverse event|30
1121917|NCT02597920|2209918|FG002|Overall Study|Other adverse event|0
1121918|NCT02597920|2209916|FG000|Overall Study|Lost to Follow-up|7
1121919|NCT02597920|2209917|FG001|Overall Study|Lost to Follow-up|9
1121920|NCT02597920|2209918|FG002|Overall Study|Lost to Follow-up|0
1121921|NCT02597920|2209916|FG000|Overall Study|Refuse to continue in the study|3
1121922|NCT02597920|2209917|FG001|Overall Study|Refuse to continue in the study|13
1121923|NCT02597920|2209918|FG002|Overall Study|Refuse to continue in the study|1
1121924|NCT02597920|2209916|FG000|Overall Study|Other than specified|10
1121925|NCT02597920|2209917|FG001|Overall Study|Other than specified|31
1121926|NCT02597920|2209918|FG002|Overall Study|Other than specified|5
1121927|NCT02597920|2209916|FG000|Overall Study|Other|1
1121928|NCT02597920|2209917|FG001|Overall Study|Other|0
1121929|NCT02597920|2209918|FG002|Overall Study|Other|0
1121930|NCT02597933|2209930|FG000|Overall Study|Withdrawal by Subject|7
1121931|NCT02597933|2209931|FG001|Overall Study|Withdrawal by Subject|5
1121932|NCT02597933|2209930|FG000|Overall Study|Protocol Violation|2
1121933|NCT02597933|2209931|FG001|Overall Study|Protocol Violation|2
1121934|NCT02597933|2209930|FG000|Overall Study|Adverse Event|20
1121935|NCT02597933|2209931|FG001|Overall Study|Adverse Event|28
1121936|NCT02597933|2209930|FG000|Overall Study|Not treated|2
1121937|NCT02597933|2209931|FG001|Overall Study|Not treated|2
1121938|NCT02597933|2209930|FG000|Overall Study|Other than stated above|7
1121939|NCT02597933|2209931|FG001|Overall Study|Other than stated above|14
1121940|NCT02597946|2209937|FG000|Overall Study|Withdrawal by Subject|1
1121941|NCT02597946|2209937|FG000|Overall Study|Progressive disease|16
1121942|NCT02597946|2209937|FG000|Overall Study|Other than above|1
1121943|NCT02598076|2209943|FG000|Overall Study|Lost to Follow-up|2
1121944|NCT02598076|2209944|FG001|Overall Study|Lost to Follow-up|3
1121945|NCT02598128|2209966|FG000|Period A: Days -7 to -1|Adverse Event|1
1121946|NCT02598128|2209967|FG001|Period A: Days -7 to -1|Adverse Event|0
1121947|NCT02598128|2209968|FG002|Period A: Days -7 to -1|Adverse Event|0
1121948|NCT02598128|2209969|FG003|Period A: Days -7 to -1|Adverse Event|0
1121949|NCT02598193|2209981|FG000|Overall Study|Adverse Event|13
1121950|NCT02598193|2209981|FG000|Overall Study|Withdrawal by Subject|1
1121951|NCT02598193|2209981|FG000|Overall Study|Listed in active lung transplant list|1
1121952|NCT02598193|2209981|FG000|Overall Study|Does not want to take Nintedanib|1
1121953|NCT02598297|2209987|FG000|Overall Study|Study terminated by Sponsor|21
1121954|NCT02598297|2209988|FG001|Overall Study|Study terminated by Sponsor|23
1121955|NCT02598297|2209987|FG000|Overall Study|Adverse Event|1
1121956|NCT02598297|2209988|FG001|Overall Study|Adverse Event|1
1121957|NCT02598297|2209987|FG000|Overall Study|Physician Decision|1
1121958|NCT02598297|2209988|FG001|Overall Study|Physician Decision|0
1121959|NCT02598297|2209987|FG000|Overall Study|Subject/guardian decision|1
1121960|NCT02598297|2209988|FG001|Overall Study|Subject/guardian decision|0
1121961|NCT02598297|2209987|FG000|Overall Study|Followed for survival|1
1121962|NCT02598297|2209988|FG001|Overall Study|Followed for survival|0
1121963|NCT02598934|2210005|FG000|Overall Study|Adverse Event|11
1121964|NCT02598934|2210006|FG001|Overall Study|Adverse Event|13
1121965|NCT02598934|2210005|FG000|Overall Study|Failure to Return|3
1121966|NCT02598934|2210006|FG001|Overall Study|Failure to Return|3
1121967|NCT02598934|2210005|FG000|Overall Study|Withdrawal by Subject|2
1121968|NCT02598934|2210006|FG001|Overall Study|Withdrawal by Subject|3
1121969|NCT02598934|2210005|FG000|Overall Study|Administrative|2
1121970|NCT02598934|2210006|FG001|Overall Study|Administrative|1
1121971|NCT02598934|2210005|FG000|Overall Study|Protocol Violation|1
1121972|NCT02598934|2210006|FG001|Overall Study|Protocol Violation|2
1121973|NCT02599129|2210014|FG000|Overall Study|Lack of Efficacy|2
1121974|NCT02599129|2210015|FG001|Overall Study|Lack of Efficacy|2
1121975|NCT02599129|2210014|FG000|Overall Study|Lost to Follow-up|1
1121976|NCT02599129|2210015|FG001|Overall Study|Lost to Follow-up|0
1121977|NCT02599129|2210014|FG000|Overall Study|Withdrawal by Subject|2
1121978|NCT02599129|2210015|FG001|Overall Study|Withdrawal by Subject|1
1121979|NCT02599402|2210027|FG000|Overall Study|Disease progression|153
1121980|NCT02599402|2210027|FG000|Overall Study|Study drug toxicity|201
1121981|NCT02599402|2210027|FG000|Overall Study|Death|26
1121982|NCT02599402|2210027|FG000|Overall Study|Adverse Event unrelated to study drug|23
1121983|NCT02599402|2210027|FG000|Overall Study|Participant request to discontinue study treatment|13
1121984|NCT02599402|2210027|FG000|Overall Study|Participant withdrew consent|5
1121985|NCT02599402|2210027|FG000|Overall Study|Lost to Follow-up|1
1121986|NCT02599402|2210027|FG000|Overall Study|Maximum Clinical Benefit|7
1121987|NCT02599402|2210027|FG000|Overall Study|Poor/non-compliance|1
1121988|NCT02599402|2210027|FG000|Overall Study|Pregnancy|1
1162078|NCT03382899|2284098|FG001|Overall Study|Lost to Follow-up|1
1121989|NCT02599402|2210027|FG000|Overall Study|Participant no longer met study criteria|7
1121990|NCT02599402|2210027|FG000|Overall Study|Other Reasons|95
1121991|NCT02599688|2210078|FG000|Overall Study|Lack of Efficacy|1
1121992|NCT02599688|2210078|FG000|Overall Study|Withdrawal by Subject|1
1121993|NCT02599688|2210078|FG000|Overall Study|Termination by Sponsor|2
1121994|NCT02599961|2210090|FG000|Overall Study|Withdrawal by Subject|1
1121995|NCT02599961|2210090|FG000|Overall Study|Subject Non-Compliance|2
1121996|NCT02599961|2210090|FG000|Overall Study|Discontinuation of Study by Sponsor|9
1121997|NCT02599961|2210090|FG000|Overall Study|Other, Not Specified|3
1121998|NCT02600351|2210102|FG000|Overall Study|Lack of Efficacy|3
1121999|NCT02600351|2210103|FG001|Overall Study|Lack of Efficacy|0
1122000|NCT02600351|2210104|FG002|Overall Study|Lack of Efficacy|5
1122001|NCT02600351|2210105|FG003|Overall Study|Lack of Efficacy|2
1122002|NCT02600351|2210102|FG000|Overall Study|Lost to Follow-up|1
1122003|NCT02600351|2210103|FG001|Overall Study|Lost to Follow-up|0
1122004|NCT02600351|2210104|FG002|Overall Study|Lost to Follow-up|0
1122005|NCT02600351|2210105|FG003|Overall Study|Lost to Follow-up|0
1122006|NCT02600351|2210102|FG000|Overall Study|Randomized but Not Treated|1
1122007|NCT02600351|2210103|FG001|Overall Study|Randomized but Not Treated|0
1122008|NCT02600351|2210104|FG002|Overall Study|Randomized but Not Treated|1
1122009|NCT02600351|2210105|FG003|Overall Study|Randomized but Not Treated|3
1122010|NCT02600559|2210133|FG000|Overall Study|Withdrawal by Subject|3
1122011|NCT02600559|2210133|FG000|Overall Study|Lost to Follow-up|20
898467|NCT00716144|1871023|FG003|Overall Study|Withdrew consent, allowed use of data|0
898468|NCT00716144|1871020|FG000|Overall Study|Adverse event: left foot pain|0
898469|NCT00716144|1871021|FG001|Overall Study|Adverse event: left foot pain|1
898470|NCT00716144|1871022|FG002|Overall Study|Adverse event: left foot pain|0
898471|NCT00716144|1871023|FG003|Overall Study|Adverse event: left foot pain|0
898472|NCT00716144|1871020|FG000|Overall Study|Clinical Depression|0
898473|NCT00716144|1871021|FG001|Overall Study|Clinical Depression|1
898474|NCT00716144|1871022|FG002|Overall Study|Clinical Depression|0
1122012|NCT02600819|2210171|FG000|GEN Phase|Adverse Event|2
1122013|NCT02600819|2210172|FG001|GEN Phase|Adverse Event|0
1122014|NCT02600819|2210171|FG000|GEN Phase|Death|2
1122015|NCT02600819|2210172|FG001|GEN Phase|Death|0
1122016|NCT02600819|2210171|FG000|GEN Phase|Investigator's Discretion|4
1122017|NCT02600819|2210172|FG001|GEN Phase|Investigator's Discretion|0
1122018|NCT02600819|2210171|FG000|GEN Phase|Non-Compliance with Study Drug|1
1122019|NCT02600819|2210172|FG001|GEN Phase|Non-Compliance with Study Drug|0
1122020|NCT02600819|2210171|FG000|GEN Phase|Withdrew Consent|5
1122021|NCT02600819|2210172|FG001|GEN Phase|Withdrew Consent|0
1122022|NCT02600819|2210171|FG000|GEN Phase|Lost to Follow-up|2
1122023|NCT02600819|2210172|FG001|GEN Phase|Lost to Follow-up|0
1122024|NCT02600845|2210178|FG000|Overall Study|Reason Not Specified|3
1122025|NCT02600845|2210178|FG000|Overall Study|Non-compliance with Study Procedures|10
1122026|NCT02600845|2210178|FG000|Overall Study|Consent Withdrawal|5
1122027|NCT02600871|2210184|FG000|Overall Study|Lost to Follow-up|13
1122028|NCT02600871|2210185|FG001|Overall Study|Lost to Follow-up|10
1122038|NCT02601001|2210199|FG000|Dosing Period 2|Adverse Event|0
1122039|NCT02601001|2210200|FG001|Dosing Period 2|Adverse Event|0
1122040|NCT02601001|2210201|FG002|Dosing Period 2|Adverse Event|0
1122041|NCT02601001|2210202|FG003|Dosing Period 2|Adverse Event|0
1122042|NCT02601001|2210203|FG004|Dosing Period 2|Adverse Event|0
1122043|NCT02601001|2210204|FG005|Dosing Period 2|Adverse Event|0
1122044|NCT02601001|2210205|FG006|Dosing Period 2|Adverse Event|1
1122045|NCT02601027|2210228|FG000|Registration to Surgery|Withdrawal by Subject|20
1122046|NCT02601027|2210229|FG001|Registration to Surgery|Withdrawal by Subject|10
1122065|NCT02601300|2210279|FG000|Induction Phase|Lack of Efficacy|2
1122066|NCT02601300|2210279|FG000|Induction Phase|Protocol Violation|1
1122067|NCT02601300|2210279|FG000|Extension Phase|Withdrawal by Subject|3
1122068|NCT02601300|2210279|FG000|Extension Phase|Adverse Event|4
1122069|NCT02601300|2210279|FG000|Extension Phase|Lack of Efficacy|10
1122070|NCT02601313|2210288|FG000|Overall Study|Death|2
1122071|NCT02601313|2210289|FG001|Overall Study|Death|16
1122072|NCT02601313|2210290|FG002|Overall Study|Death|4
1122073|NCT02601313|2210288|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0
1122074|NCT02601313|2210289|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5
1122075|NCT02601313|2210290|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2
1122076|NCT02601313|2210288|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0
1122077|NCT02601313|2210289|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1
1122078|NCT02601313|2210290|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1
1122079|NCT02601313|2210288|FG000|Overall Study|Still on study|0
1122080|NCT02601313|2210289|FG001|Overall Study|Still on study|52
1122081|NCT02601313|2210290|FG002|Overall Study|Still on study|10
1122082|NCT02601313|2210288|FG000|Overall Study|Enrolled, did not initiate AC|4
1122083|NCT02601313|2210289|FG001|Overall Study|Enrolled, did not initiate AC|0
1122084|NCT02601313|2210290|FG002|Overall Study|Enrolled, did not initiate AC|0
1122085|NCT02601469|2210300|FG000|Overall Study|Enrolled in Error|1
1122086|NCT02601469|2210301|FG001|Overall Study|Enrolled in Error|0
1122087|NCT02601560|2210315|FG000|Overall Study|Other|0
1122088|NCT02601560|2210316|FG001|Overall Study|Other|0
1122089|NCT02601560|2210317|FG002|Overall Study|Other|0
1122090|NCT02601560|2210318|FG003|Overall Study|Other|0
1122091|NCT02601560|2210319|FG004|Overall Study|Other|0
1122092|NCT02601560|2210320|FG005|Overall Study|Other|0
1122093|NCT02601560|2210321|FG006|Overall Study|Other|1
1122094|NCT02601560|2210322|FG007|Overall Study|Other|0
1122095|NCT02601573|2210352|FG000|Overall Study|Lost to Follow-up|0
1122096|NCT02601573|2210353|FG001|Overall Study|Lost to Follow-up|3
1122097|NCT02601573|2210354|FG002|Overall Study|Lost to Follow-up|1
1122098|NCT02601573|2210355|FG003|Overall Study|Lost to Follow-up|0
1122099|NCT02601573|2210356|FG004|Overall Study|Lost to Follow-up|2
1122100|NCT02601573|2210352|FG000|Overall Study|Withdrawal by Subject|0
1122101|NCT02601573|2210353|FG001|Overall Study|Withdrawal by Subject|1
1122102|NCT02601573|2210354|FG002|Overall Study|Withdrawal by Subject|0
1122103|NCT02601573|2210355|FG003|Overall Study|Withdrawal by Subject|1
1122104|NCT02601573|2210356|FG004|Overall Study|Withdrawal by Subject|0
1122105|NCT02601625|2210372|FG000|Overall Study|Lost to Follow-up|0
1122106|NCT02601625|2210373|FG001|Overall Study|Lost to Follow-up|0
1122107|NCT02601625|2210374|FG002|Overall Study|Lost to Follow-up|1
1122108|NCT02601625|2210375|FG003|Overall Study|Lost to Follow-up|1
1122109|NCT02601820|2210399|FG000|Early On-Treatment (T2)|Missing T2 Record|51
1122110|NCT02601820|2210399|FG000|Late On-Treatment (T3)|missing T3 Record|49
1122111|NCT02601820|2210399|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3
1122112|NCT02601820|2210399|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88
1122113|NCT02602080|2210435|FG000|Overall Study|Protocol Violation|6
1122114|NCT02602080|2210436|FG001|Overall Study|Protocol Violation|1
1122115|NCT02602080|2210437|FG002|Overall Study|Protocol Violation|3
1122116|NCT02603107|2210466|FG000|Randomized Phase|Withdrew consent|8
1122117|NCT02603107|2210467|FG001|Randomized Phase|Withdrew consent|15
1122118|NCT02603107|2210466|FG000|Randomized Phase|Lost to Follow-up|1
1122119|NCT02603107|2210467|FG001|Randomized Phase|Lost to Follow-up|3
1122120|NCT02603107|2210466|FG000|Randomized Phase|Adverse Event|2
1122121|NCT02603107|2210467|FG001|Randomized Phase|Adverse Event|0
1122122|NCT02603107|2210466|FG000|Randomized Phase|Death|1
1122123|NCT02603107|2210467|FG001|Randomized Phase|Death|1
1122124|NCT02603107|2210466|FG000|Randomized Phase|Non-compliance with study drug|1
1122125|NCT02603107|2210467|FG001|Randomized Phase|Non-compliance with study drug|1
1122126|NCT02603107|2210466|FG000|Randomized Phase|Investigator's discretion|0
1122127|NCT02603107|2210467|FG001|Randomized Phase|Investigator's discretion|1
1122128|NCT02603107|2210466|FG000|Randomized Phase|Lack of Efficacy|1
1122129|NCT02603107|2210467|FG001|Randomized Phase|Lack of Efficacy|0
1122130|NCT02603107|2210466|FG000|Randomized Phase|Protocol Violation|1
1122131|NCT02603107|2210467|FG001|Randomized Phase|Protocol Violation|0
1122132|NCT02603107|2210466|FG000|Optional Extension Phase|Lost to Follow-up|3
1122133|NCT02603107|2210467|FG001|Optional Extension Phase|Lost to Follow-up|3
1122134|NCT02603107|2210466|FG000|Optional Extension Phase|Withdrew consent|3
1122135|NCT02603107|2210467|FG001|Optional Extension Phase|Withdrew consent|2
1122136|NCT02603107|2210466|FG000|Optional Extension Phase|Investigator's discretion|2
1122137|NCT02603107|2210467|FG001|Optional Extension Phase|Investigator's discretion|2
1122138|NCT02603107|2210466|FG000|Optional Extension Phase|Pregnancy|0
1122139|NCT02603107|2210467|FG001|Optional Extension Phase|Pregnancy|3
1122140|NCT02603107|2210466|FG000|Optional Extension Phase|Adverse Event|0
1122141|NCT02603107|2210467|FG001|Optional Extension Phase|Adverse Event|2
1122142|NCT02603107|2210466|FG000|Optional Extension Phase|Not treated in extension phase|0
1122143|NCT02603107|2210467|FG001|Optional Extension Phase|Not treated in extension phase|1
1122144|NCT02603107|2210466|FG000|Optional Extension Phase|Protocol Violation|1
1122145|NCT02603107|2210467|FG001|Optional Extension Phase|Protocol Violation|0
1122146|NCT02603120|2210477|FG000|Double-Blind Treatment Phase|Withdrew consent|4
1122147|NCT02603120|2210478|FG001|Double-Blind Treatment Phase|Withdrew consent|8
1122148|NCT02603120|2210477|FG000|Double-Blind Treatment Phase|Adverse Event|3
1122149|NCT02603120|2210478|FG001|Double-Blind Treatment Phase|Adverse Event|3
1122150|NCT02603120|2210477|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
1122151|NCT02603120|2210478|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
1122152|NCT02603120|2210477|FG000|Double-Blind Treatment Phase|Death|2
1122153|NCT02603120|2210478|FG001|Double-Blind Treatment Phase|Death|0
1122154|NCT02603120|2210477|FG000|Double-Blind Treatment Phase|Investigator's discretion|2
1122155|NCT02603120|2210478|FG001|Double-Blind Treatment Phase|Investigator's discretion|0
1122156|NCT02603120|2210477|FG000|Double-Blind Treatment Phase|Pregnancy|1
1122157|NCT02603120|2210478|FG001|Double-Blind Treatment Phase|Pregnancy|1
1122158|NCT02603120|2210477|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1
1122159|NCT02603120|2210478|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0
1122160|NCT02603120|2210477|FG000|Double-Blind Treatment Phase|Did not receive study drug|2
1122161|NCT02603120|2210478|FG001|Double-Blind Treatment Phase|Did not receive study drug|2
1122162|NCT02603120|2210477|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3
1122163|NCT02603120|2210478|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4
1122164|NCT02603120|2210477|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1
1122165|NCT02603120|2210478|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2
1122166|NCT02603120|2210477|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1
1122167|NCT02603120|2210478|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2
1122168|NCT02603120|2210477|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0
1122169|NCT02603120|2210478|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1
1122170|NCT02603120|2210477|FG000|OL Extension B/F/TAF Treatment Phase|Death|0
1122171|NCT02603120|2210478|FG001|OL Extension B/F/TAF Treatment Phase|Death|1
1122172|NCT02603120|2210477|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0
1122173|NCT02603120|2210478|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1
1122174|NCT02603393|2210524|FG000|Overall Study|Patient/guardian decision|32
1122175|NCT02603393|2210525|FG001|Overall Study|Patient/guardian decision|18
1122176|NCT02603393|2210524|FG000|Overall Study|Adverse Event|17
1122177|NCT02603393|2210525|FG001|Overall Study|Adverse Event|15
1122178|NCT02603393|2210524|FG000|Overall Study|Technical problems|4
1122179|NCT02603393|2210525|FG001|Overall Study|Technical problems|7
1122180|NCT02603393|2210524|FG000|Overall Study|Lack of Efficacy|7
1122181|NCT02603393|2210525|FG001|Overall Study|Lack of Efficacy|2
1122182|NCT02603393|2210524|FG000|Overall Study|Death|3
1122183|NCT02603393|2210525|FG001|Overall Study|Death|4
1122184|NCT02603393|2210524|FG000|Overall Study|Physician Decision|3
1122185|NCT02603393|2210525|FG001|Overall Study|Physician Decision|3
1122186|NCT02603393|2210524|FG000|Overall Study|Protocol deviation|2
1122187|NCT02603393|2210525|FG001|Overall Study|Protocol deviation|3
1122188|NCT02603393|2210524|FG000|Overall Study|Lost to Follow-up|1
1122189|NCT02603393|2210525|FG001|Overall Study|Lost to Follow-up|2
1122190|NCT02603393|2210524|FG000|Overall Study|Non-compliance with study treatment|1
1122191|NCT02603393|2210525|FG001|Overall Study|Non-compliance with study treatment|0
1122192|NCT02603393|2210524|FG000|Overall Study|Sponsor decision|1
1122193|NCT02603393|2210525|FG001|Overall Study|Sponsor decision|0
1122194|NCT02603419|2210537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
1122195|NCT02603419|2210538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
1122196|NCT02603419|2210539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
1122197|NCT02603419|2210540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
1122198|NCT02603419|2210541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
1122199|NCT02603419|2210542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
1122200|NCT02603419|2210537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
1122201|NCT02603419|2210538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
1122202|NCT02603419|2210539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
1122203|NCT02603419|2210540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
1122204|NCT02603419|2210541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
1122205|NCT02603419|2210542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
1122206|NCT02603419|2210537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
1122207|NCT02603419|2210538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
1122208|NCT02603419|2210539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
1122209|NCT02603419|2210540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
1122210|NCT02603419|2210541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
1122211|NCT02603419|2210542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
1122212|NCT02603419|2210537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
1122213|NCT02603419|2210538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
1122214|NCT02603419|2210539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
1122215|NCT02603419|2210540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
1122216|NCT02603419|2210541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
1122217|NCT02603419|2210542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
1122218|NCT02603419|2210537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
1122219|NCT02603419|2210538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
1122220|NCT02603419|2210539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
1122221|NCT02603419|2210540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
1122222|NCT02603419|2210541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
1122223|NCT02603419|2210542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
1122224|NCT02603419|2210537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
1122225|NCT02603419|2210538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
1122226|NCT02603419|2210539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
1122227|NCT02603419|2210540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
1122228|NCT02603419|2210541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
1122229|NCT02603419|2210542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
1122230|NCT02603419|2210537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
1122231|NCT02603419|2210538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
1122232|NCT02603419|2210539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
1122233|NCT02603419|2210540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
1122234|NCT02603419|2210541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
1122235|NCT02603419|2210542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
1122236|NCT02603419|2210537|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
1122237|NCT02603419|2210538|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
1122238|NCT02603419|2210539|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
1122239|NCT02603419|2210540|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
1122240|NCT02603419|2210541|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
1122241|NCT02603419|2210542|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
1122242|NCT02603419|2210537|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0
1122243|NCT02603419|2210538|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0
1122244|NCT02603419|2210539|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0
1122245|NCT02603419|2210540|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0
1122246|NCT02603419|2210541|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0
1122247|NCT02603419|2210542|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1
1122248|NCT02603419|2210537|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
1122249|NCT02603419|2210538|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
1122250|NCT02603419|2210539|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
1122251|NCT02603419|2210540|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
1122252|NCT02603419|2210541|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
1122253|NCT02603419|2210542|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
1122270|NCT02603809|2210576|FG000|Overall Study|Withdrawal by Subject|4
1122271|NCT02603809|2210577|FG001|Overall Study|Withdrawal by Subject|1
1122272|NCT02603809|2210578|FG002|Overall Study|Withdrawal by Subject|2
1122273|NCT02603809|2210579|FG003|Overall Study|Withdrawal by Subject|3
1122274|NCT02603809|2210580|FG004|Overall Study|Withdrawal by Subject|3
1122275|NCT02603809|2210581|FG005|Overall Study|Withdrawal by Subject|4
1122276|NCT02603809|2210576|FG000|Overall Study|Lost to Follow-up|2
1122277|NCT02603809|2210577|FG001|Overall Study|Lost to Follow-up|3
1122278|NCT02603809|2210578|FG002|Overall Study|Lost to Follow-up|1
1122279|NCT02603809|2210579|FG003|Overall Study|Lost to Follow-up|4
1122280|NCT02603809|2210580|FG004|Overall Study|Lost to Follow-up|2
1122281|NCT02603809|2210581|FG005|Overall Study|Lost to Follow-up|2
1122282|NCT02603809|2210576|FG000|Overall Study|Pre-specified discontinuation criteria|3
1122283|NCT02603809|2210577|FG001|Overall Study|Pre-specified discontinuation criteria|3
1122284|NCT02603809|2210578|FG002|Overall Study|Pre-specified discontinuation criteria|2
1122285|NCT02603809|2210579|FG003|Overall Study|Pre-specified discontinuation criteria|2
1122286|NCT02603809|2210580|FG004|Overall Study|Pre-specified discontinuation criteria|3
1122287|NCT02603809|2210581|FG005|Overall Study|Pre-specified discontinuation criteria|1
1122288|NCT02603809|2210576|FG000|Overall Study|Physician Decision|0
1122289|NCT02603809|2210577|FG001|Overall Study|Physician Decision|0
1122290|NCT02603809|2210578|FG002|Overall Study|Physician Decision|0
1122291|NCT02603809|2210579|FG003|Overall Study|Physician Decision|1
1122292|NCT02603809|2210580|FG004|Overall Study|Physician Decision|2
1122293|NCT02603809|2210581|FG005|Overall Study|Physician Decision|1
1122294|NCT02603809|2210576|FG000|Overall Study|Adverse Event|3
1122295|NCT02603809|2210577|FG001|Overall Study|Adverse Event|0
1122296|NCT02603809|2210578|FG002|Overall Study|Adverse Event|2
1122297|NCT02603809|2210579|FG003|Overall Study|Adverse Event|2
1122298|NCT02603809|2210580|FG004|Overall Study|Adverse Event|1
1122299|NCT02603809|2210581|FG005|Overall Study|Adverse Event|1
1122300|NCT02603809|2210576|FG000|Overall Study|Lack of Efficacy|0
1122301|NCT02603809|2210577|FG001|Overall Study|Lack of Efficacy|1
1122302|NCT02603809|2210578|FG002|Overall Study|Lack of Efficacy|0
1122303|NCT02603809|2210579|FG003|Overall Study|Lack of Efficacy|0
1122304|NCT02603809|2210580|FG004|Overall Study|Lack of Efficacy|0
1122305|NCT02603809|2210581|FG005|Overall Study|Lack of Efficacy|1
1122306|NCT02603887|2210597|FG000|Overall Study|FDA Guidance|1
1122307|NCT02603887|2210597|FG000|Overall Study|Adverse Event|4
1122308|NCT02603887|2210597|FG000|Overall Study|Disease progression|1
1122309|NCT02603952|2210610|FG000|Overall Study|Withdrawal by Subject|1
1122310|NCT02603952|2210611|FG001|Overall Study|Withdrawal by Subject|0
1122311|NCT02603952|2210612|FG002|Overall Study|Withdrawal by Subject|0
1122312|NCT02603952|2210613|FG003|Overall Study|Withdrawal by Subject|0
1122313|NCT02603952|2210610|FG000|Overall Study|Received oseltamivir by error|0
1122314|NCT02603952|2210611|FG001|Overall Study|Received oseltamivir by error|0
1122315|NCT02603952|2210612|FG002|Overall Study|Received oseltamivir by error|0
1122316|NCT02603952|2210613|FG003|Overall Study|Received oseltamivir by error|1
1122317|NCT02604017|2210628|FG000|Overall Study|Withdrew Consent|0
1122318|NCT02604017|2210629|FG001|Overall Study|Withdrew Consent|2
1122319|NCT02604017|2210628|FG000|Overall Study|Lost to Follow-up|5
1122320|NCT02604017|2210629|FG001|Overall Study|Lost to Follow-up|6
1122321|NCT02604017|2210628|FG000|Overall Study|Other|1
1122322|NCT02604017|2210629|FG001|Overall Study|Other|0
1122323|NCT02604160|2210637|FG000|Overall Study|Protocol Violation|0
1122324|NCT02604160|2210638|FG001|Overall Study|Protocol Violation|1
1122325|NCT02604160|2210637|FG000|Overall Study|Physician Decision|0
1122326|NCT02604160|2210638|FG001|Overall Study|Physician Decision|1
1122327|NCT02604199|2210663|FG000|Overall Study|Pregnancy|0
1122328|NCT02604199|2210664|FG001|Overall Study|Pregnancy|0
1122329|NCT02604199|2210665|FG002|Overall Study|Pregnancy|0
1122330|NCT02604199|2210666|FG003|Overall Study|Pregnancy|1
1122331|NCT02604199|2210663|FG000|Overall Study|Study terminated by sponsor|0
1122332|NCT02604199|2210664|FG001|Overall Study|Study terminated by sponsor|2
1122333|NCT02604199|2210665|FG002|Overall Study|Study terminated by sponsor|0
1122334|NCT02604199|2210666|FG003|Overall Study|Study terminated by sponsor|2
1122335|NCT02604199|2210663|FG000|Overall Study|Withdrawal by Subject|0
1122336|NCT02604199|2210664|FG001|Overall Study|Withdrawal by Subject|1
1122337|NCT02604199|2210665|FG002|Overall Study|Withdrawal by Subject|0
1122338|NCT02604199|2210666|FG003|Overall Study|Withdrawal by Subject|0
1122339|NCT02604264|2210703|FG000|Intervention|Didn't use CVC for at least 21 days|200
1122340|NCT02604264|2210704|FG001|Intervention|Didn't use CVC for at least 21 days|242
1122341|NCT02604342|2210712|FG000|Overall Study|Death|32
1122342|NCT02604342|2210713|FG001|Overall Study|Death|16
1122343|NCT02604342|2210712|FG000|Overall Study|Progression of disease|1
1122344|NCT02604342|2210713|FG001|Overall Study|Progression of disease|0
1122345|NCT02604342|2210712|FG000|Overall Study|Withdrawal by Subject|5
1122346|NCT02604342|2210713|FG001|Overall Study|Withdrawal by Subject|6
1122347|NCT02604342|2210712|FG000|Overall Study|Other|1
1122348|NCT02604342|2210713|FG001|Overall Study|Other|0
1122349|NCT02604342|2210712|FG000|Overall Study|Study Termination by Sponsor|1
1122350|NCT02604342|2210713|FG001|Overall Study|Study Termination by Sponsor|0
1122351|NCT02604342|2210712|FG000|Overall Study|Lost to Follow-up|1
1122352|NCT02604342|2210713|FG001|Overall Study|Lost to Follow-up|1
1122353|NCT02604342|2210712|FG000|Overall Study|Physician Decision|2
1122354|NCT02604342|2210713|FG001|Overall Study|Physician Decision|0
1122355|NCT02604407|2210722|FG000|Overall Study|Adverse Event|0
1122356|NCT02604407|2210723|FG001|Overall Study|Adverse Event|7
1122357|NCT02604407|2210724|FG002|Overall Study|Adverse Event|5
1122358|NCT02604407|2210722|FG000|Overall Study|Protocol Violation|2
1122359|NCT02604407|2210723|FG001|Overall Study|Protocol Violation|0
1122360|NCT02604407|2210724|FG002|Overall Study|Protocol Violation|0
1122361|NCT02604407|2210722|FG000|Overall Study|Withdrawal by Subject|3
1122362|NCT02604407|2210723|FG001|Overall Study|Withdrawal by Subject|3
1122363|NCT02604407|2210724|FG002|Overall Study|Withdrawal by Subject|5
1122364|NCT02604407|2210722|FG000|Overall Study|Lost to Follow-up|2
1122365|NCT02604407|2210723|FG001|Overall Study|Lost to Follow-up|1
1122366|NCT02604407|2210724|FG002|Overall Study|Lost to Follow-up|2
1122367|NCT02604407|2210722|FG000|Overall Study|Lack of Efficacy|1
1122368|NCT02604407|2210723|FG001|Overall Study|Lack of Efficacy|0
1122369|NCT02604407|2210724|FG002|Overall Study|Lack of Efficacy|0
1122370|NCT02604407|2210722|FG000|Overall Study|Other|3
1122371|NCT02604407|2210723|FG001|Overall Study|Other|1
1122372|NCT02604407|2210724|FG002|Overall Study|Other|4
1122395|NCT02604550|2210743|FG000|Overall Study|Lost to Follow-up|7
1122396|NCT02604550|2210744|FG001|Overall Study|Lost to Follow-up|6
1122397|NCT02604550|2210743|FG000|Overall Study|Withdrawal by Subject|0
1122398|NCT02604550|2210744|FG001|Overall Study|Withdrawal by Subject|1
1122399|NCT02604550|2210743|FG000|Overall Study|Incomplete data using paper journal|18
1122400|NCT02604550|2210744|FG001|Overall Study|Incomplete data using paper journal|19
1122401|NCT02604589|2210753|FG000|Overall Study|catheter dislodgement|0
1122402|NCT02604589|2210754|FG001|Overall Study|catheter dislodgement|0
1122403|NCT02604589|2210755|FG002|Overall Study|catheter dislodgement|1
1122404|NCT02605122|2210771|FG000|Overall Study|Withdrawal by Subject|4
1122405|NCT02605122|2210772|FG001|Overall Study|Withdrawal by Subject|1
1122406|NCT02605122|2210771|FG000|Overall Study|Lost to Follow-up|1
1122407|NCT02605122|2210772|FG001|Overall Study|Lost to Follow-up|1
1122408|NCT02605174|2210782|FG000|Overall Study|Adverse Event|0
1122409|NCT02605174|2210783|FG001|Overall Study|Adverse Event|0
1122410|NCT02605174|2210784|FG002|Overall Study|Adverse Event|1
1122411|NCT02605174|2210785|FG003|Overall Study|Adverse Event|0
1122412|NCT02605174|2210786|FG004|Overall Study|Adverse Event|4
1122413|NCT02605174|2210787|FG005|Overall Study|Adverse Event|0
1122414|NCT02605174|2210788|FG006|Overall Study|Adverse Event|0
1122415|NCT02605174|2210782|FG000|Overall Study|Lost to Follow-up|20
1122416|NCT02605174|2210783|FG001|Overall Study|Lost to Follow-up|7
1122417|NCT02605174|2210784|FG002|Overall Study|Lost to Follow-up|27
1122418|NCT02605174|2210785|FG003|Overall Study|Lost to Follow-up|10
1122419|NCT02605174|2210786|FG004|Overall Study|Lost to Follow-up|20
1122420|NCT02605174|2210787|FG005|Overall Study|Lost to Follow-up|10
1122421|NCT02605174|2210788|FG006|Overall Study|Lost to Follow-up|29
1122422|NCT02605174|2210782|FG000|Overall Study|Protocol Violation|10
1122423|NCT02605174|2210783|FG001|Overall Study|Protocol Violation|4
1122424|NCT02605174|2210784|FG002|Overall Study|Protocol Violation|14
1122425|NCT02605174|2210785|FG003|Overall Study|Protocol Violation|6
1122426|NCT02605174|2210786|FG004|Overall Study|Protocol Violation|7
1122427|NCT02605174|2210787|FG005|Overall Study|Protocol Violation|7
1122428|NCT02605174|2210788|FG006|Overall Study|Protocol Violation|12
1122429|NCT02605174|2210782|FG000|Overall Study|Pregnancy|1
1122430|NCT02605174|2210783|FG001|Overall Study|Pregnancy|0
1122431|NCT02605174|2210784|FG002|Overall Study|Pregnancy|0
1122432|NCT02605174|2210785|FG003|Overall Study|Pregnancy|2
1122433|NCT02605174|2210786|FG004|Overall Study|Pregnancy|0
1122434|NCT02605174|2210787|FG005|Overall Study|Pregnancy|0
1122435|NCT02605174|2210788|FG006|Overall Study|Pregnancy|0
1122436|NCT02605174|2210782|FG000|Overall Study|Withdrawal by Subject|9
1122437|NCT02605174|2210783|FG001|Overall Study|Withdrawal by Subject|6
1122438|NCT02605174|2210784|FG002|Overall Study|Withdrawal by Subject|14
1122439|NCT02605174|2210785|FG003|Overall Study|Withdrawal by Subject|11
1122440|NCT02605174|2210786|FG004|Overall Study|Withdrawal by Subject|6
1122441|NCT02605174|2210787|FG005|Overall Study|Withdrawal by Subject|4
1122442|NCT02605174|2210788|FG006|Overall Study|Withdrawal by Subject|15
1122443|NCT02605174|2210782|FG000|Overall Study|Physician Decision|2
1122444|NCT02605174|2210783|FG001|Overall Study|Physician Decision|0
1122445|NCT02605174|2210784|FG002|Overall Study|Physician Decision|0
1122446|NCT02605174|2210785|FG003|Overall Study|Physician Decision|0
1122447|NCT02605174|2210786|FG004|Overall Study|Physician Decision|0
1122448|NCT02605174|2210787|FG005|Overall Study|Physician Decision|0
1122449|NCT02605174|2210788|FG006|Overall Study|Physician Decision|3
1122450|NCT02605174|2210782|FG000|Overall Study|Randomization Failure|22
1122451|NCT02605174|2210783|FG001|Overall Study|Randomization Failure|6
1122452|NCT02605174|2210784|FG002|Overall Study|Randomization Failure|20
1122453|NCT02605174|2210785|FG003|Overall Study|Randomization Failure|7
1122454|NCT02605174|2210786|FG004|Overall Study|Randomization Failure|16
1122455|NCT02605174|2210787|FG005|Overall Study|Randomization Failure|11
1122456|NCT02605174|2210788|FG006|Overall Study|Randomization Failure|30
1122457|NCT02605447|2210847|FG000|Overall Study|Death|66
1122458|NCT02605447|2210847|FG000|Overall Study|Physician Decision|1
1122459|NCT02605447|2210847|FG000|Overall Study|Lost to Follow-up|24
1122460|NCT02605447|2210847|FG000|Overall Study|Withdrawal by Subject|10
1122461|NCT02605447|2210847|FG000|Overall Study|Not disclosed|1
1122462|NCT02605837|2210863|FG000|Overall Study|Adverse Event|3
1122463|NCT02605837|2210864|FG001|Overall Study|Adverse Event|1
1122464|NCT02605837|2210863|FG000|Overall Study|Non-Compliance with Study Drug|0
1122465|NCT02605837|2210864|FG001|Overall Study|Non-Compliance with Study Drug|1
1122466|NCT02605837|2210863|FG000|Overall Study|Withdrawal by Subject|8
1122467|NCT02605837|2210864|FG001|Overall Study|Withdrawal by Subject|8
1122468|NCT02605837|2210863|FG000|Overall Study|Physician Decision|0
1122469|NCT02605837|2210864|FG001|Overall Study|Physician Decision|1
1122470|NCT02605928|2210893|FG000|Overall Study|Model tuning phase|28
1122471|NCT02605928|2210893|FG000|Overall Study|Lack of Efficacy|5
1122472|NCT02605954|2210899|FG000|Overall Study|Adverse Event|5
1122473|NCT02605954|2210900|FG001|Overall Study|Adverse Event|1
1122474|NCT02605954|2210899|FG000|Overall Study|Investigator's Discretion|1
1122475|NCT02605954|2210900|FG001|Overall Study|Investigator's Discretion|0
1122476|NCT02605954|2210899|FG000|Overall Study|Non-Compliance with Study Drug|1
1122477|NCT02605954|2210900|FG001|Overall Study|Non-Compliance with Study Drug|0
1122478|NCT02605954|2210899|FG000|Overall Study|Withdrew Consent|2
1122479|NCT02605954|2210900|FG001|Overall Study|Withdrew Consent|2
1122480|NCT02605954|2210899|FG000|Overall Study|Lost to Follow-up|3
1122481|NCT02605954|2210900|FG001|Overall Study|Lost to Follow-up|0
1122482|NCT02605954|2210899|FG000|Overall Study|Randomized but not treated|0
1122483|NCT02605954|2210900|FG001|Overall Study|Randomized but not treated|1
1122484|NCT02605967|2210911|FG000|Overall Study : Prior to Cross Over|subject / guardian decision|1
1122485|NCT02605967|2210912|FG001|Overall Study : Prior to Cross Over|subject / guardian decision|2
1122486|NCT02605967|2210913|FG002|Overall Study : Prior to Cross Over|subject / guardian decision|0
1122487|NCT02605967|2210911|FG000|Overall Study : Prior to Cross Over|Physician Decision|1
1122488|NCT02605967|2210912|FG001|Overall Study : Prior to Cross Over|Physician Decision|1
1122489|NCT02605967|2210913|FG002|Overall Study : Prior to Cross Over|Physician Decision|0
1122490|NCT02605967|2210911|FG000|Overall Study : Prior to Cross Over|Death|4
1122491|NCT02605967|2210912|FG001|Overall Study : Prior to Cross Over|Death|2
1122492|NCT02605967|2210913|FG002|Overall Study : Prior to Cross Over|Death|0
1122493|NCT02605967|2210911|FG000|Overall Study : Prior to Cross Over|Adverse Event|1
1122494|NCT02605967|2210912|FG001|Overall Study : Prior to Cross Over|Adverse Event|0
1122495|NCT02605967|2210913|FG002|Overall Study : Prior to Cross Over|Adverse Event|0
1122496|NCT02605967|2210911|FG000|Overall Study : Prior to Cross Over|treatment ongoing|16
1122497|NCT02605967|2210912|FG001|Overall Study : Prior to Cross Over|treatment ongoing|3
1122498|NCT02605967|2210913|FG002|Overall Study : Prior to Cross Over|treatment ongoing|0
1122499|NCT02605967|2210911|FG000|Overall Study : Prior to Cross Over|progressive disease|59
1122500|NCT02605967|2210912|FG001|Overall Study : Prior to Cross Over|progressive disease|32
1122501|NCT02605967|2210913|FG002|Overall Study : Prior to Cross Over|progressive disease|0
1122502|NCT02605967|2210911|FG000|After Cross Over|subject / guardian decision|1
1122503|NCT02605967|2210912|FG001|After Cross Over|subject / guardian decision|0
1122504|NCT02605967|2210913|FG002|After Cross Over|subject / guardian decision|1
1122505|NCT02605967|2210911|FG000|After Cross Over|Physician Decision|1
1122506|NCT02605967|2210912|FG001|After Cross Over|Physician Decision|0
1122507|NCT02605967|2210913|FG002|After Cross Over|Physician Decision|2
1122508|NCT02605967|2210911|FG000|After Cross Over|Death|4
1122509|NCT02605967|2210912|FG001|After Cross Over|Death|0
1122510|NCT02605967|2210913|FG002|After Cross Over|Death|2
1122511|NCT02605967|2210911|FG000|After Cross Over|Adverse Event|1
1122512|NCT02605967|2210912|FG001|After Cross Over|Adverse Event|0
1122513|NCT02605967|2210913|FG002|After Cross Over|Adverse Event|1
1122514|NCT02605967|2210911|FG000|After Cross Over|treatment ongoing|16
1122515|NCT02605967|2210912|FG001|After Cross Over|treatment ongoing|0
1122516|NCT02605967|2210913|FG002|After Cross Over|treatment ongoing|3
1122517|NCT02605967|2210911|FG000|After Cross Over|progressive disease|59
1122518|NCT02605967|2210912|FG001|After Cross Over|progressive disease|0
1122519|NCT02605967|2210913|FG002|After Cross Over|progressive disease|16
1122520|NCT02606253|2210942|FG000|Overall Study|Adverse Event|2
1122521|NCT02606253|2210943|FG001|Overall Study|Adverse Event|0
1122522|NCT02606253|2210944|FG002|Overall Study|Adverse Event|0
1122523|NCT02606253|2210942|FG000|Overall Study|Protocol Violation|2
1122524|NCT02606253|2210943|FG001|Overall Study|Protocol Violation|1
1122525|NCT02606253|2210944|FG002|Overall Study|Protocol Violation|0
1122526|NCT02606253|2210942|FG000|Overall Study|Physician Decision|1
1122527|NCT02606253|2210943|FG001|Overall Study|Physician Decision|1
1122528|NCT02606253|2210944|FG002|Overall Study|Physician Decision|0
1122529|NCT02606643|2210974|FG000|Overall Study|did not meet inclusion criteria|1
1122530|NCT02606643|2210975|FG001|Overall Study|did not meet inclusion criteria|3
1122531|NCT02606877|2211003|FG000|Overall Study|Adverse Event|3
1122532|NCT02606877|2211004|FG001|Overall Study|Adverse Event|0
1122533|NCT02606877|2211003|FG000|Overall Study|Non-compliance with protocol|0
1122534|NCT02606877|2211004|FG001|Overall Study|Non-compliance with protocol|1
1122535|NCT02606877|2211003|FG000|Overall Study|Other than listed above|1
1122536|NCT02606877|2211004|FG001|Overall Study|Other than listed above|0
1122537|NCT02607228|2211042|FG000|Overall Study|Progressive Disease|4
1122538|NCT02607228|2211043|FG001|Overall Study|Progressive Disease|3
1122539|NCT02607228|2211044|FG002|Overall Study|Progressive Disease|1
1122540|NCT02607228|2211045|FG003|Overall Study|Progressive Disease|5
1122541|NCT02607228|2211046|FG004|Overall Study|Progressive Disease|4
1122542|NCT02607228|2211047|FG005|Overall Study|Progressive Disease|3
1122543|NCT02607228|2211048|FG006|Overall Study|Progressive Disease|1
1122544|NCT02607228|2211042|FG000|Overall Study|Adverse Event|1
1122545|NCT02607228|2211043|FG001|Overall Study|Adverse Event|0
1122546|NCT02607228|2211044|FG002|Overall Study|Adverse Event|1
1122547|NCT02607228|2211045|FG003|Overall Study|Adverse Event|0
1122548|NCT02607228|2211046|FG004|Overall Study|Adverse Event|1
1122549|NCT02607228|2211047|FG005|Overall Study|Adverse Event|1
1122550|NCT02607228|2211048|FG006|Overall Study|Adverse Event|1
1122551|NCT02607228|2211042|FG000|Overall Study|Investigator's Discretion|0
1122552|NCT02607228|2211043|FG001|Overall Study|Investigator's Discretion|0
1122553|NCT02607228|2211044|FG002|Overall Study|Investigator's Discretion|1
1122554|NCT02607228|2211045|FG003|Overall Study|Investigator's Discretion|0
1122555|NCT02607228|2211046|FG004|Overall Study|Investigator's Discretion|0
1122556|NCT02607228|2211047|FG005|Overall Study|Investigator's Discretion|1
1122557|NCT02607228|2211048|FG006|Overall Study|Investigator's Discretion|0
1122558|NCT02607228|2211042|FG000|Overall Study|Withdrew Consent|0
1122559|NCT02607228|2211043|FG001|Overall Study|Withdrew Consent|1
1122560|NCT02607228|2211044|FG002|Overall Study|Withdrew Consent|0
1122561|NCT02607228|2211045|FG003|Overall Study|Withdrew Consent|0
1122562|NCT02607228|2211046|FG004|Overall Study|Withdrew Consent|0
1122563|NCT02607228|2211047|FG005|Overall Study|Withdrew Consent|1
1122564|NCT02607228|2211048|FG006|Overall Study|Withdrew Consent|0
1122565|NCT02607228|2211042|FG000|Overall Study|Study Terminated by Sponsor|0
1122566|NCT02607228|2211043|FG001|Overall Study|Study Terminated by Sponsor|0
1122567|NCT02607228|2211044|FG002|Overall Study|Study Terminated by Sponsor|0
1122568|NCT02607228|2211045|FG003|Overall Study|Study Terminated by Sponsor|1
1122569|NCT02607228|2211046|FG004|Overall Study|Study Terminated by Sponsor|0
1122570|NCT02607228|2211047|FG005|Overall Study|Study Terminated by Sponsor|0
1122571|NCT02607228|2211048|FG006|Overall Study|Study Terminated by Sponsor|0
1122572|NCT02607280|2211086|FG000|Overall Study|Adverse Event|4
1122573|NCT02607280|2211087|FG001|Overall Study|Adverse Event|0
1122574|NCT02607280|2211086|FG000|Overall Study|Decrease in CrCl <15|0
1122575|NCT02607280|2211087|FG001|Overall Study|Decrease in CrCl <15|1
1122576|NCT02607306|2211096|FG000|Overall Study|Adverse Event|8
1122577|NCT02607306|2211097|FG001|Overall Study|Adverse Event|6
1122578|NCT02607306|2211098|FG002|Overall Study|Adverse Event|6
1122579|NCT02607306|2211096|FG000|Overall Study|Unclassified|1
1122580|NCT02607306|2211097|FG001|Overall Study|Unclassified|4
1122581|NCT02607306|2211098|FG002|Overall Study|Unclassified|0
1122582|NCT02607306|2211096|FG000|Overall Study|Withdrawal by Subject|8
1122583|NCT02607306|2211097|FG001|Overall Study|Withdrawal by Subject|10
1122584|NCT02607306|2211098|FG002|Overall Study|Withdrawal by Subject|2
1122585|NCT02607306|2211096|FG000|Overall Study|Lack of Efficacy|0
1122586|NCT02607306|2211097|FG001|Overall Study|Lack of Efficacy|1
1122587|NCT02607306|2211098|FG002|Overall Study|Lack of Efficacy|1
1122588|NCT02607306|2211096|FG000|Overall Study|Protocol Violation|4
1122589|NCT02607306|2211097|FG001|Overall Study|Protocol Violation|2
1122590|NCT02607306|2211098|FG002|Overall Study|Protocol Violation|1
1122591|NCT02607735|2211118|FG000|Primary Study|Randomized but Never Treated|1
1122592|NCT02607735|2211119|FG001|Primary Study|Randomized but Never Treated|0
1122593|NCT02607735|2211120|FG002|Primary Study|Randomized but Never Treated|0
1122594|NCT02607735|2211118|FG000|Primary Study|Lost to Follow-up|4
1122595|NCT02607735|2211119|FG001|Primary Study|Lost to Follow-up|0
1122596|NCT02607735|2211120|FG002|Primary Study|Lost to Follow-up|0
1122597|NCT02607735|2211118|FG000|Primary Study|Withdrew Consent|2
1122598|NCT02607735|2211119|FG001|Primary Study|Withdrew Consent|0
1122599|NCT02607735|2211120|FG002|Primary Study|Withdrew Consent|0
1122600|NCT02607735|2211118|FG000|Deferred Treatment Substudy|Lost to Follow-up|0
1122601|NCT02607735|2211119|FG001|Deferred Treatment Substudy|Lost to Follow-up|0
1122602|NCT02607735|2211120|FG002|Deferred Treatment Substudy|Lost to Follow-up|4
1122603|NCT02607735|2211118|FG000|Deferred Treatment Substudy|Withdrew Consent|0
1122604|NCT02607735|2211119|FG001|Deferred Treatment Substudy|Withdrew Consent|0
1122605|NCT02607735|2211120|FG002|Deferred Treatment Substudy|Withdrew Consent|1
1122606|NCT02607800|2211130|FG000|Overall Study|Lost to Follow-up|7
1122607|NCT02607800|2211131|FG001|Overall Study|Lost to Follow-up|10
1122608|NCT02607800|2211130|FG000|Overall Study|Withdrew Consent|2
1122609|NCT02607800|2211131|FG001|Overall Study|Withdrew Consent|0
1122610|NCT02607800|2211130|FG000|Overall Study|Randomized/Enrolled but Not Treated|1
1122611|NCT02607800|2211131|FG001|Overall Study|Randomized/Enrolled but Not Treated|1
1122612|NCT02607930|2211157|FG000|Double-Blinded Phase|Randomized and Never Treated|2
1122613|NCT02607930|2211158|FG001|Double-Blinded Phase|Randomized and Never Treated|0
1122614|NCT02607930|2211157|FG000|Double-Blinded Phase|Adverse Event|0
1122615|NCT02607930|2211158|FG001|Double-Blinded Phase|Adverse Event|4
1122616|NCT02607930|2211157|FG000|Double-Blinded Phase|Death|2
1122617|NCT02607930|2211158|FG001|Double-Blinded Phase|Death|1
1122618|NCT02607930|2211157|FG000|Double-Blinded Phase|Investigator's Discretion|6
1122619|NCT02607930|2211158|FG001|Double-Blinded Phase|Investigator's Discretion|3
1122620|NCT02607930|2211157|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|3
1122621|NCT02607930|2211158|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|5
1122622|NCT02607930|2211157|FG000|Double-Blinded Phase|Protocol Violation|2
1122623|NCT02607930|2211158|FG001|Double-Blinded Phase|Protocol Violation|3
1122624|NCT02607930|2211157|FG000|Double-Blinded Phase|Withdrew Consent|14
1122625|NCT02607930|2211158|FG001|Double-Blinded Phase|Withdrew Consent|18
1122626|NCT02607930|2211157|FG000|Double-Blinded Phase|Lost to Follow-up|25
1122627|NCT02607930|2211158|FG001|Double-Blinded Phase|Lost to Follow-up|19
1122628|NCT02607930|2211157|FG000|Open-Label Extension Phase|Still in Study up to Data Cut Date for OL Week 48|237
1122629|NCT02607930|2211158|FG001|Open-Label Extension Phase|Still in Study up to Data Cut Date for OL Week 48|240
1122630|NCT02607930|2211157|FG000|Open-Label Extension Phase|Adverse Event|2
1122631|NCT02607930|2211158|FG001|Open-Label Extension Phase|Adverse Event|0
1122632|NCT02607930|2211157|FG000|Open-Label Extension Phase|Death|1
1122633|NCT02607930|2211158|FG001|Open-Label Extension Phase|Death|1
1122634|NCT02607930|2211157|FG000|Open-Label Extension Phase|Investigator's Discretion|0
1122635|NCT02607930|2211158|FG001|Open-Label Extension Phase|Investigator's Discretion|1
1122636|NCT02607930|2211157|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|1
1122637|NCT02607930|2211158|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0
1122638|NCT02607930|2211157|FG000|Open-Label Extension Phase|Protocol Violation|1
1122639|NCT02607930|2211158|FG001|Open-Label Extension Phase|Protocol Violation|1
1122640|NCT02607930|2211157|FG000|Open-Label Extension Phase|Withdrew Consent|4
1122641|NCT02607930|2211158|FG001|Open-Label Extension Phase|Withdrew Consent|6
1122642|NCT02607930|2211157|FG000|Open-Label Extension Phase|Lost to Follow-up|6
1122643|NCT02607930|2211158|FG001|Open-Label Extension Phase|Lost to Follow-up|5
1122644|NCT02607956|2211168|FG000|Double-Blinded Phase|Randomized and Never Treated|7
1122645|NCT02607956|2211169|FG001|Double-Blinded Phase|Randomized and Never Treated|5
1122646|NCT02607956|2211168|FG000|Double-Blinded Phase|Adverse Event|4
1122647|NCT02607956|2211169|FG001|Double-Blinded Phase|Adverse Event|3
1122648|NCT02607956|2211168|FG000|Double-Blinded Phase|Death|4
1122649|NCT02607956|2211169|FG001|Double-Blinded Phase|Death|4
1122650|NCT02607956|2211168|FG000|Double-Blinded Phase|Investigator's Discretion|7
1122651|NCT02607956|2211169|FG001|Double-Blinded Phase|Investigator's Discretion|2
1122652|NCT02607956|2211168|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0
1122653|NCT02607956|2211169|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3
1122654|NCT02607956|2211168|FG000|Double-Blinded Phase|Protocol Violation|3
1122655|NCT02607956|2211169|FG001|Double-Blinded Phase|Protocol Violation|1
1122656|NCT02607956|2211168|FG000|Double-Blinded Phase|Withdrew Consent|17
1122657|NCT02607956|2211169|FG001|Double-Blinded Phase|Withdrew Consent|19
1122658|NCT02607956|2211168|FG000|Double-Blinded Phase|Lost to Follow-up|19
1122659|NCT02607956|2211169|FG001|Double-Blinded Phase|Lost to Follow-up|16
1122660|NCT02607956|2211168|FG000|Open-Label Extension Phase|Still in Study up to Data Cut Date For OL Week 48|244
1122661|NCT02607956|2211169|FG001|Open-Label Extension Phase|Still in Study up to Data Cut Date For OL Week 48|254
1122662|NCT02607956|2211168|FG000|Open-Label Extension Phase|Investigator's Discretion|0
1122663|NCT02607956|2211169|FG001|Open-Label Extension Phase|Investigator's Discretion|1
1122664|NCT02607956|2211168|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|1
1122665|NCT02607956|2211169|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0
1122666|NCT02607956|2211168|FG000|Open-Label Extension Phase|Withdrew Consent|6
1122667|NCT02607956|2211169|FG001|Open-Label Extension Phase|Withdrew Consent|5
1122668|NCT02607956|2211168|FG000|Open-Label Extension Phase|Lost to Follow-up|3
1122669|NCT02607956|2211169|FG001|Open-Label Extension Phase|Lost to Follow-up|5
1122670|NCT02608099|2211179|FG000|Overall Study|Ablation procedure not initiated|3
1122671|NCT02608099|2211180|FG001|Overall Study|Ablation procedure not initiated|2
1122672|NCT02608450|2211210|FG000|Overall Study|Lost to Follow-up|39
1122673|NCT02608450|2211211|FG001|Overall Study|Lost to Follow-up|32
1122674|NCT02608450|2211210|FG000|Overall Study|Withdrawal by Subject|21
1122675|NCT02608450|2211211|FG001|Overall Study|Withdrawal by Subject|15
1122676|NCT02608450|2211210|FG000|Overall Study|Adverse Event|3
1122677|NCT02608450|2211211|FG001|Overall Study|Adverse Event|6
1122678|NCT02608450|2211210|FG000|Overall Study|Withdrawal by parent|2
1122679|NCT02608450|2211211|FG001|Overall Study|Withdrawal by parent|3
1122680|NCT02608450|2211210|FG000|Overall Study|Lack of Efficacy|0
1122681|NCT02608450|2211211|FG001|Overall Study|Lack of Efficacy|3
1122682|NCT02608450|2211210|FG000|Overall Study|Noncompliance with study drug|0
1122683|NCT02608450|2211211|FG001|Overall Study|Noncompliance with study drug|2
1122684|NCT02608450|2211210|FG000|Overall Study|Physician Decision|0
1122685|NCT02608450|2211211|FG001|Overall Study|Physician Decision|1
1122686|NCT02608450|2211210|FG000|Overall Study|Pregnancy|0
1122687|NCT02608450|2211211|FG001|Overall Study|Pregnancy|1
1122688|NCT02608450|2211210|FG000|Overall Study|Progressive disease|1
1122689|NCT02608450|2211211|FG001|Overall Study|Progressive disease|0
1122690|NCT02608450|2211210|FG000|Overall Study|Multiple reasons|0
1122691|NCT02608450|2211211|FG001|Overall Study|Multiple reasons|2
1122692|NCT02608476|2211233|FG000|Overall Study|Withdrawal by Subject|30
1122693|NCT02608476|2211234|FG001|Overall Study|Withdrawal by Subject|37
1122694|NCT02608476|2211233|FG000|Overall Study|Lost to Follow-up|24
1122695|NCT02608476|2211234|FG001|Overall Study|Lost to Follow-up|24
1122696|NCT02608476|2211233|FG000|Overall Study|Adverse Event|2
1122697|NCT02608476|2211234|FG001|Overall Study|Adverse Event|8
1122698|NCT02608476|2211233|FG000|Overall Study|Withdrawal by Parent/Guardian|5
1122699|NCT02608476|2211234|FG001|Overall Study|Withdrawal by Parent/Guardian|4
1122700|NCT02608476|2211233|FG000|Overall Study|Noncompliance with treatment|1
1122701|NCT02608476|2211234|FG001|Overall Study|Noncompliance with treatment|5
1122702|NCT02608476|2211233|FG000|Overall Study|Lack of Efficacy|3
1122703|NCT02608476|2211234|FG001|Overall Study|Lack of Efficacy|1
1122704|NCT02608476|2211233|FG000|Overall Study|Other|0
1122705|NCT02608476|2211234|FG001|Overall Study|Other|1
1122706|NCT02608476|2211233|FG000|Overall Study|Physician Decision|1
1122707|NCT02608476|2211234|FG001|Overall Study|Physician Decision|0
1122708|NCT02608476|2211233|FG000|Overall Study|Pregnancy|0
1122709|NCT02608476|2211234|FG001|Overall Study|Pregnancy|1
1122710|NCT02608476|2211233|FG000|Overall Study|Progressive disease|1
1122711|NCT02608476|2211234|FG001|Overall Study|Progressive disease|0
1122712|NCT02608684|2211249|FG000|Overall Study|Physician Decision|2
1122713|NCT02608684|2211249|FG000|Overall Study|Withdrawal by Subject|1
1122714|NCT02608879|2211256|FG000|Overall Study|Lost to Follow-up|1
1122715|NCT02608879|2211257|FG001|Overall Study|Lost to Follow-up|0
1122716|NCT02608879|2211258|FG002|Overall Study|Lost to Follow-up|0
1122717|NCT02608879|2211256|FG000|Overall Study|Did not meet continuation criteria|0
1122718|NCT02608879|2211257|FG001|Overall Study|Did not meet continuation criteria|0
1122719|NCT02608879|2211258|FG002|Overall Study|Did not meet continuation criteria|3
1122720|NCT02608892|2211268|FG000|Overall Study|Lost to Follow-up|1
1122721|NCT02608892|2211269|FG001|Overall Study|Lost to Follow-up|0
1122722|NCT02609178|2211296|FG000|First Crown|Withdrawal by Subject|0
1122723|NCT02609178|2211297|FG001|First Crown|Withdrawal by Subject|0
1122724|NCT02609178|2211298|FG002|First Crown|Withdrawal by Subject|1
1122725|NCT02609178|2211299|FG003|First Crown|Withdrawal by Subject|1
1122726|NCT02609178|2211300|FG004|First Crown|Withdrawal by Subject|0
1122727|NCT02609178|2211301|FG005|First Crown|Withdrawal by Subject|0
1122728|NCT02609399|2211323|FG000|Influenza Season 2015-2016|Lost to Follow-up|3
1122729|NCT02609399|2211324|FG001|Influenza Season 2015-2016|Lost to Follow-up|2
1122730|NCT02609399|2211323|FG000|Influenza Season 2016-2017|Lost to Follow-up|8
1122731|NCT02609399|2211324|FG001|Influenza Season 2016-2017|Lost to Follow-up|5
1122732|NCT02609399|2211323|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1
1122733|NCT02609399|2211324|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0
1122738|NCT02609607|2211341|FG000|Overall Study|Lost to Follow-up|0
1122739|NCT02609607|2211342|FG001|Overall Study|Lost to Follow-up|1
1122740|NCT02609633|2211350|FG000|Overall Study|Consent Withdrawn|0
1122741|NCT02609633|2211351|FG001|Overall Study|Consent Withdrawn|1
1122742|NCT02609633|2211350|FG000|Overall Study|Protocol Deviation|1
1122743|NCT02609633|2211351|FG001|Overall Study|Protocol Deviation|0
1122744|NCT02609633|2211350|FG000|Overall Study|Non-Compliant with Study Procedures|2
1122745|NCT02609633|2211351|FG001|Overall Study|Non-Compliant with Study Procedures|0
1122746|NCT02609633|2211350|FG000|Overall Study|Reason not Specified|2
1122747|NCT02609633|2211351|FG001|Overall Study|Reason not Specified|1
1122748|NCT02609659|2211358|FG000|Overall Study|Adverse Event|1
1122749|NCT02609659|2211358|FG000|Overall Study|Lost to Follow-up|6
1122750|NCT02609659|2211358|FG000|Overall Study|Other|1
1122751|NCT02609672|2211364|FG000|Overall Study|Lost to Follow-up|3
1122752|NCT02609672|2211365|FG001|Overall Study|Lost to Follow-up|1
1122753|NCT02609984|2211381|FG000|Overall Study|Death|29
1122754|NCT02609984|2211382|FG001|Overall Study|Death|26
1122755|NCT02609984|2211381|FG000|Overall Study|Participation Discontinued by Sponsor|12
1122756|NCT02609984|2211382|FG001|Overall Study|Participation Discontinued by Sponsor|10
1122757|NCT02609984|2211381|FG000|Overall Study|Lost to Follow-up|1
1122758|NCT02609984|2211382|FG001|Overall Study|Lost to Follow-up|2
1122759|NCT02609984|2211381|FG000|Overall Study|Withdrawal by Subject|0
1122760|NCT02609984|2211382|FG001|Overall Study|Withdrawal by Subject|1
1122761|NCT02609984|2211381|FG000|Overall Study|Disease Progression|2
1122762|NCT02609984|2211382|FG001|Overall Study|Disease Progression|0
1122763|NCT02610140|2211390|FG000|Randomization and Treatment Period|Radiological progression|23
1122764|NCT02610140|2211391|FG001|Randomization and Treatment Period|Radiological progression|15
1122765|NCT02610140|2211390|FG000|Randomization and Treatment Period|Progressive disease - radiological|54
1122766|NCT02610140|2211391|FG001|Randomization and Treatment Period|Progressive disease - radiological|23
1122767|NCT02610140|2211390|FG000|Randomization and Treatment Period|Protocol Violation|1
1122768|NCT02610140|2211391|FG001|Randomization and Treatment Period|Protocol Violation|0
1122769|NCT02610140|2211390|FG000|Randomization and Treatment Period|Physician Decision|0
1122770|NCT02610140|2211391|FG001|Randomization and Treatment Period|Physician Decision|1
1122771|NCT02610140|2211390|FG000|Randomization and Treatment Period|Lack of Efficacy|1
1122772|NCT02610140|2211391|FG001|Randomization and Treatment Period|Lack of Efficacy|0
1122773|NCT02610140|2211390|FG000|Randomization and Treatment Period|Death|7
1122774|NCT02610140|2211391|FG001|Randomization and Treatment Period|Death|1
1122775|NCT02610140|2211390|FG000|Randomization and Treatment Period|Withdrawal by Subject|12
1122776|NCT02610140|2211391|FG001|Randomization and Treatment Period|Withdrawal by Subject|12
1122777|NCT02610140|2211390|FG000|Randomization and Treatment Period|Adverse Event|44
1122778|NCT02610140|2211391|FG001|Randomization and Treatment Period|Adverse Event|13
1122779|NCT02610140|2211390|FG000|Randomization and Treatment Period|Progressive disease - clinical|12
1122780|NCT02610140|2211391|FG001|Randomization and Treatment Period|Progressive disease - clinical|5
1122781|NCT02610140|2211390|FG000|Randomization and Treatment Period|Ongoing but not completed|9
1122782|NCT02610140|2211391|FG001|Randomization and Treatment Period|Ongoing but not completed|2
1122783|NCT02610140|2211390|FG000|Randomization and Treatment Period|Not treated|3
1122784|NCT02610140|2211391|FG001|Randomization and Treatment Period|Not treated|10
1122785|NCT02610140|2211390|FG000|Safety Follow-up|Other|0
1122786|NCT02610140|2211391|FG001|Safety Follow-up|Other|2
1122787|NCT02610140|2211390|FG000|Safety Follow-up|Lost to Follow-up|1
1122788|NCT02610140|2211391|FG001|Safety Follow-up|Lost to Follow-up|0
1122789|NCT02610140|2211390|FG000|Safety Follow-up|No follow-up|5
1122790|NCT02610140|2211391|FG001|Safety Follow-up|No follow-up|3
1122791|NCT02610140|2211390|FG000|Safety Follow-up|Death|12
1122792|NCT02610140|2211391|FG001|Safety Follow-up|Death|2
1122793|NCT02610140|2211390|FG000|Safety Follow-up|Deterioration of general conditions|15
1122794|NCT02610140|2211391|FG001|Safety Follow-up|Deterioration of general conditions|5
1122795|NCT02610140|2211390|FG000|Safety Follow-up|Withdrawal by Subject|12
1122796|NCT02610140|2211391|FG001|Safety Follow-up|Withdrawal by Subject|12
1122797|NCT02610140|2211390|FG000|Active Follow-up|Progressive disease - radiological|30
1122798|NCT02610140|2211391|FG001|Active Follow-up|Progressive disease - radiological|22
1122799|NCT02610140|2211390|FG000|Active Follow-up|Death|8
1122800|NCT02610140|2211391|FG001|Active Follow-up|Death|1
1122801|NCT02610140|2211390|FG000|Active Follow-up|Withdrawal by Subject|4
1122802|NCT02610140|2211391|FG001|Active Follow-up|Withdrawal by Subject|0
1122803|NCT02610140|2211390|FG000|Active Follow-up|Progressive disease - clinical|1
1122804|NCT02610140|2211391|FG001|Active Follow-up|Progressive disease - clinical|2
1122805|NCT02610140|2211390|FG000|Active Follow-up|Deterioration of general conditions|1
1122806|NCT02610140|2211391|FG001|Active Follow-up|Deterioration of general conditions|0
1122807|NCT02610140|2211390|FG000|Active Follow-up|Ongoing but not completed|4
1122808|NCT02610140|2211391|FG001|Active Follow-up|Ongoing but not completed|1
1122809|NCT02610140|2211390|FG000|Long-term Follow-up|Death|86
1122810|NCT02610140|2211391|FG001|Long-term Follow-up|Death|44
1122811|NCT02610140|2211390|FG000|Long-term Follow-up|Withdrawal by Subject|6
1122812|NCT02610140|2211391|FG001|Long-term Follow-up|Withdrawal by Subject|3
1122813|NCT02610140|2211390|FG000|Long-term Follow-up|Lost to Follow-up|1
1122814|NCT02610140|2211391|FG001|Long-term Follow-up|Lost to Follow-up|2
1122815|NCT02610140|2211390|FG000|Long-term Follow-up|Ongoing but not completed|30
1122816|NCT02610140|2211391|FG001|Long-term Follow-up|Ongoing but not completed|17
1122817|NCT02610192|2211397|FG000|Overall Study|Received other treatment|8
1122818|NCT02610192|2211397|FG000|Overall Study|Physician Decision|1
1122819|NCT02610231|2211401|FG000|Overall Study|Withdrawal by Subject|27
1122820|NCT02610231|2211401|FG000|Overall Study|Adverse Event|20
1122821|NCT02610231|2211401|FG000|Overall Study|Death|5
1122822|NCT02610231|2211401|FG000|Overall Study|Surgery|2
1122823|NCT02610231|2211401|FG000|Overall Study|Physician Decision|1
1122824|NCT02610231|2211401|FG000|Overall Study|Non Compliance|2
1122825|NCT02610231|2211401|FG000|Overall Study|Other|3
1122826|NCT02610725|2211417|FG000|Overall Study|Lost to Follow-up|197
1122827|NCT02610725|2211417|FG000|Overall Study|self-reported contraindication|9
1122828|NCT02610777|2211423|FG000|Overall Study|Ongoing in Follow-up|14
1122829|NCT02610777|2211424|FG001|Overall Study|Ongoing in Follow-up|12
1122830|NCT02610777|2211423|FG000|Overall Study|Withdrawal by Subject|1
1122831|NCT02610777|2211424|FG001|Overall Study|Withdrawal by Subject|2
1122832|NCT02610777|2211423|FG000|Overall Study|Other|0
1122833|NCT02610777|2211424|FG001|Overall Study|Other|1
1122834|NCT02610777|2211423|FG000|Overall Study|Ongoing on Treatment|6
1122835|NCT02610777|2211424|FG001|Overall Study|Ongoing on Treatment|7
1122836|NCT02610816|2211432|FG000|Phase 1|Withdrawal by Subject|2
1122837|NCT02610816|2211433|FG001|Phase 1|Withdrawal by Subject|6
1122838|NCT02610816|2211434|FG002|Phase 1|Withdrawal by Subject|0
1122839|NCT02610816|2211435|FG003|Phase 1|Withdrawal by Subject|0
1122840|NCT02610816|2211432|FG000|Phase 1|Lost to Follow-up|2
1122841|NCT02610816|2211433|FG001|Phase 1|Lost to Follow-up|1
1122842|NCT02610816|2211434|FG002|Phase 1|Lost to Follow-up|0
1122843|NCT02610816|2211435|FG003|Phase 1|Lost to Follow-up|0
1122844|NCT02610816|2211432|FG000|Phase 1|Physician Decision|0
1122845|NCT02610816|2211433|FG001|Phase 1|Physician Decision|1
1122846|NCT02610816|2211434|FG002|Phase 1|Physician Decision|0
1122847|NCT02610816|2211435|FG003|Phase 1|Physician Decision|0
1122848|NCT02610816|2211432|FG000|Phase 2|Withdrawal by Subject|0
1122849|NCT02610816|2211433|FG001|Phase 2|Withdrawal by Subject|0
1122850|NCT02610816|2211434|FG002|Phase 2|Withdrawal by Subject|9
1122851|NCT02610816|2211435|FG003|Phase 2|Withdrawal by Subject|3
1122852|NCT02610816|2211432|FG000|Phase 2|Lost to Follow-up|0
1122853|NCT02610816|2211433|FG001|Phase 2|Lost to Follow-up|0
1122854|NCT02610816|2211434|FG002|Phase 2|Lost to Follow-up|2
1122855|NCT02610816|2211435|FG003|Phase 2|Lost to Follow-up|0
1122856|NCT02610816|2211432|FG000|Phase 2|Physician Decision|0
1122857|NCT02610816|2211433|FG001|Phase 2|Physician Decision|0
1122858|NCT02610816|2211434|FG002|Phase 2|Physician Decision|0
1122859|NCT02610816|2211435|FG003|Phase 2|Physician Decision|2
1122860|NCT02610816|2211432|FG000|Phase 2|Pregnancy|0
1122861|NCT02610816|2211433|FG001|Phase 2|Pregnancy|0
1122862|NCT02610816|2211434|FG002|Phase 2|Pregnancy|0
1122863|NCT02610816|2211435|FG003|Phase 2|Pregnancy|1
1122864|NCT02610842|2211445|FG000|Overall Study|Lost to Follow-up|5
1122865|NCT02611362|2211501|FG000|Overall Study|Withdrawal by Subject|7
1122866|NCT02611362|2211502|FG001|Overall Study|Withdrawal by Subject|2
1122867|NCT02611362|2211501|FG000|Overall Study|Lost to Follow-up|2
1122868|NCT02611362|2211502|FG001|Overall Study|Lost to Follow-up|4
1122869|NCT02611479|2211509|FG000|Baseline Enrollment|Exited study|13
1122870|NCT02611479|2211509|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
1122871|NCT02611479|2211509|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
1122872|NCT02611479|2211509|FG000|Data Cleaning|No baseline function or pain metrics|2
1122873|NCT02611752|2211515|FG000|Overall Study|Adverse Event|0
1122874|NCT02611752|2211516|FG001|Overall Study|Adverse Event|1
1122875|NCT02611778|2211546|FG000|Overall Study|Withdrawal by Subject|2
1122876|NCT02611778|2211547|FG001|Overall Study|Withdrawal by Subject|8
1122877|NCT02611778|2211546|FG000|Overall Study|Adverse Event|1
1122878|NCT02611778|2211547|FG001|Overall Study|Adverse Event|2
1122879|NCT02611778|2211546|FG000|Overall Study|Death|2
1122880|NCT02611778|2211547|FG001|Overall Study|Death|1
1122881|NCT02611778|2211546|FG000|Overall Study|Protocol Violation|1
1122882|NCT02611778|2211547|FG001|Overall Study|Protocol Violation|0
1122883|NCT02611778|2211546|FG000|Overall Study|Lost to Follow-up|3
1122884|NCT02611778|2211547|FG001|Overall Study|Lost to Follow-up|1
1122885|NCT02611778|2211546|FG000|Overall Study|Need for alternative treatment|1
1122886|NCT02611778|2211547|FG001|Overall Study|Need for alternative treatment|0
1122887|NCT02611778|2211546|FG000|Overall Study|Other Reason|2
1122888|NCT02611778|2211547|FG001|Overall Study|Other Reason|1
898475|NCT00716144|1871023|FG003|Overall Study|Clinical Depression|0
898476|NCT00716274|1871036|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2
898477|NCT00716274|1871037|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0
898478|NCT00716274|1871038|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0
898479|NCT00716274|1871039|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0
898480|NCT00716274|1871040|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0
898481|NCT00716274|1871041|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1122889|NCT02611817|2211557|FG000|Open-label Induction Phase|Reason not Specified|9
1122890|NCT02611817|2211558|FG001|Open-label Induction Phase|Reason not Specified|0
1122891|NCT02611817|2211559|FG002|Open-label Induction Phase|Reason not Specified|0
1122892|NCT02611817|2211557|FG000|Open-label Induction Phase|Lack of Efficacy|8
1122893|NCT02611817|2211558|FG001|Open-label Induction Phase|Lack of Efficacy|0
1122894|NCT02611817|2211559|FG002|Open-label Induction Phase|Lack of Efficacy|0
1122895|NCT02611817|2211557|FG000|Open-label Induction Phase|Pregnancy|1
1122896|NCT02611817|2211558|FG001|Open-label Induction Phase|Pregnancy|0
1122897|NCT02611817|2211559|FG002|Open-label Induction Phase|Pregnancy|0
1122898|NCT02611817|2211557|FG000|Open-label Induction Phase|Withdrawal by Subject|9
1122899|NCT02611817|2211558|FG001|Open-label Induction Phase|Withdrawal by Subject|0
1122900|NCT02611817|2211559|FG002|Open-label Induction Phase|Withdrawal by Subject|0
1122901|NCT02611817|2211557|FG000|Open-label Induction Phase|Lost to Follow-up|2
1122902|NCT02611817|2211558|FG001|Open-label Induction Phase|Lost to Follow-up|0
1122903|NCT02611817|2211559|FG002|Open-label Induction Phase|Lost to Follow-up|0
1122904|NCT02611817|2211557|FG000|Open-label Induction Phase|Protocol Violation|5
1122905|NCT02611817|2211558|FG001|Open-label Induction Phase|Protocol Violation|0
1122906|NCT02611817|2211559|FG002|Open-label Induction Phase|Protocol Violation|0
1122907|NCT02611817|2211557|FG000|Open-label Induction Phase|Adverse Event|16
1122908|NCT02611817|2211558|FG001|Open-label Induction Phase|Adverse Event|0
1122909|NCT02611817|2211559|FG002|Open-label Induction Phase|Adverse Event|0
1122910|NCT02611817|2211557|FG000|Double-blind Maintenance Phase|Adverse Event|0
1122911|NCT02611817|2211558|FG001|Double-blind Maintenance Phase|Adverse Event|12
1122912|NCT02611817|2211559|FG002|Double-blind Maintenance Phase|Adverse Event|11
1122913|NCT02611817|2211557|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0
1122914|NCT02611817|2211558|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1
1122915|NCT02611817|2211559|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0
1122916|NCT02611817|2211557|FG000|Double-blind Maintenance Phase|Reason not Specified|0
1122917|NCT02611817|2211558|FG001|Double-blind Maintenance Phase|Reason not Specified|1
1122918|NCT02611817|2211559|FG002|Double-blind Maintenance Phase|Reason not Specified|2
1122919|NCT02611817|2211557|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0
1122920|NCT02611817|2211558|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43
1122921|NCT02611817|2211559|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78
1122922|NCT02611817|2211557|FG000|Double-blind Maintenance Phase|Pregnancy|0
1122923|NCT02611817|2211558|FG001|Double-blind Maintenance Phase|Pregnancy|0
1122924|NCT02611817|2211559|FG002|Double-blind Maintenance Phase|Pregnancy|1
1122925|NCT02611817|2211557|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0
1122926|NCT02611817|2211558|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5
1122927|NCT02611817|2211559|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14
1122928|NCT02611817|2211557|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0
1122929|NCT02611817|2211558|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0
1122930|NCT02611817|2211559|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1
1122931|NCT02611830|2211570|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9
1122932|NCT02611830|2211571|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0
1122933|NCT02611830|2211572|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0
1122934|NCT02611830|2211573|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0
1122935|NCT02611830|2211570|FG000|OL Induction Phase|Significant Protocol Deviation|4
1122936|NCT02611830|2211571|FG001|OL Induction Phase|Significant Protocol Deviation|0
1122937|NCT02611830|2211572|FG002|OL Induction Phase|Significant Protocol Deviation|0
1122938|NCT02611830|2211573|FG003|OL Induction Phase|Significant Protocol Deviation|0
1122939|NCT02611830|2211570|FG000|OL Induction Phase|Voluntary Withdrawal|5
1122940|NCT02611830|2211571|FG001|OL Induction Phase|Voluntary Withdrawal|0
1122941|NCT02611830|2211572|FG002|OL Induction Phase|Voluntary Withdrawal|0
1122942|NCT02611830|2211573|FG003|OL Induction Phase|Voluntary Withdrawal|0
1122943|NCT02611830|2211570|FG000|OL Induction Phase|Lack of Efficacy|9
1122944|NCT02611830|2211571|FG001|OL Induction Phase|Lack of Efficacy|0
1122945|NCT02611830|2211572|FG002|OL Induction Phase|Lack of Efficacy|0
1122946|NCT02611830|2211573|FG003|OL Induction Phase|Lack of Efficacy|0
1122947|NCT02611830|2211570|FG000|OL Induction Phase|Reason not specified|3
1122948|NCT02611830|2211571|FG001|OL Induction Phase|Reason not specified|0
1122949|NCT02611830|2211572|FG002|OL Induction Phase|Reason not specified|0
1122950|NCT02611830|2211573|FG003|OL Induction Phase|Reason not specified|0
1122951|NCT02611830|2211570|FG000|Maintenance Phase|Lack of Efficacy|0
1122952|NCT02611830|2211571|FG001|Maintenance Phase|Lack of Efficacy|29
1122953|NCT02611830|2211572|FG002|Maintenance Phase|Lack of Efficacy|18
1122954|NCT02611830|2211573|FG003|Maintenance Phase|Lack of Efficacy|6
1122955|NCT02611830|2211570|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0
1122956|NCT02611830|2211571|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5
1122957|NCT02611830|2211572|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5
1122958|NCT02611830|2211573|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2
1122959|NCT02611830|2211570|FG000|Maintenance Phase|Significant Protocol Deviation|0
1122960|NCT02611830|2211571|FG001|Maintenance Phase|Significant Protocol Deviation|0
1122961|NCT02611830|2211572|FG002|Maintenance Phase|Significant Protocol Deviation|1
1122962|NCT02611830|2211573|FG003|Maintenance Phase|Significant Protocol Deviation|1
1122963|NCT02611830|2211570|FG000|Maintenance Phase|Lost to Follow-up|0
1122964|NCT02611830|2211571|FG001|Maintenance Phase|Lost to Follow-up|0
1122965|NCT02611830|2211572|FG002|Maintenance Phase|Lost to Follow-up|0
1122966|NCT02611830|2211573|FG003|Maintenance Phase|Lost to Follow-up|1
1122967|NCT02611830|2211570|FG000|Maintenance Phase|Voluntary Withdrawal|0
1122968|NCT02611830|2211571|FG001|Maintenance Phase|Voluntary Withdrawal|1
1122969|NCT02611830|2211572|FG002|Maintenance Phase|Voluntary Withdrawal|2
1122970|NCT02611830|2211573|FG003|Maintenance Phase|Voluntary Withdrawal|5
1122971|NCT02611830|2211570|FG000|Maintenance Phase|Pregnancy|0
1122972|NCT02611830|2211571|FG001|Maintenance Phase|Pregnancy|0
1122973|NCT02611830|2211572|FG002|Maintenance Phase|Pregnancy|1
1122974|NCT02611830|2211573|FG003|Maintenance Phase|Pregnancy|0
1122975|NCT02611830|2211570|FG000|Maintenance Phase|Reason not specified|0
1122976|NCT02611830|2211571|FG001|Maintenance Phase|Reason not specified|1
1122977|NCT02611830|2211572|FG002|Maintenance Phase|Reason not specified|4
1122978|NCT02611830|2211573|FG003|Maintenance Phase|Reason not specified|0
1122979|NCT02611882|2211585|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33
1122980|NCT02611882|2211586|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0
1122981|NCT02611882|2211587|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0
1122982|NCT02612064|2211596|FG000|Overall Study|Withdrawal by Subject|1
1122983|NCT02612064|2211597|FG001|Overall Study|Withdrawal by Subject|1
1122984|NCT02612064|2211596|FG000|Overall Study|Other|0
1122985|NCT02612064|2211597|FG001|Overall Study|Other|2
1122986|NCT02612077|2211603|FG000|Overall Study|Adverse Event|3
1122987|NCT02612077|2211603|FG000|Overall Study|Withdrawal by Subject|9
1122988|NCT02612077|2211603|FG000|Overall Study|Protocol Violation|28
1122989|NCT02612077|2211603|FG000|Overall Study|Lost to Follow-up|20
1122990|NCT02612077|2211603|FG000|Overall Study|Death|377
1122991|NCT02612077|2211603|FG000|Overall Study|Moved or Changed Medical Team|23
1122992|NCT02612077|2211603|FG000|Overall Study|Enrollment in a Clinical Trial|1
1122993|NCT02612077|2211603|FG000|Overall Study|Disease Progression|3
1122994|NCT02612077|2211603|FG000|Overall Study|Unknown reason|2
1122995|NCT02612155|2211612|FG000|Overall Study|Death|1
1122996|NCT02612155|2211613|FG001|Overall Study|Death|1
1122997|NCT02612155|2211612|FG000|Overall Study|Lost to Follow-up|2
1122998|NCT02612155|2211613|FG001|Overall Study|Lost to Follow-up|2
1122999|NCT02612194|2211622|FG000|Overall Study|Death|5
1123000|NCT02612194|2211623|FG001|Overall Study|Death|0
1123001|NCT02612194|2211624|FG002|Overall Study|Death|2
1123002|NCT02612194|2211622|FG000|Overall Study|Early Study Termination|1
1123003|NCT02612194|2211623|FG001|Overall Study|Early Study Termination|0
1123004|NCT02612194|2211624|FG002|Overall Study|Early Study Termination|0
1123005|NCT02612428|2211633|FG000|VTL-308|Death|14
1123006|NCT02612428|2211634|FG001|VTL-308|Death|16
1123007|NCT02612428|2211633|FG000|VTL-308|Withdrawal by Subject|0
1123008|NCT02612428|2211634|FG001|VTL-308|Withdrawal by Subject|1
1123009|NCT02612428|2211633|FG000|VTL-308E|Death|9
1123010|NCT02612428|2211634|FG001|VTL-308E|Death|7
1123011|NCT02612428|2211633|FG000|VTL-308E|Lost to Follow-up|2
1123012|NCT02612428|2211634|FG001|VTL-308E|Lost to Follow-up|0
1123013|NCT02612610|2211644|FG000|Overall Study|Withdrawal by Subject|1
1123014|NCT02612610|2211645|FG001|Overall Study|Withdrawal by Subject|1
1123015|NCT02612610|2211646|FG002|Overall Study|Withdrawal by Subject|0
1123016|NCT02612610|2211647|FG003|Overall Study|Withdrawal by Subject|2
1123017|NCT02612610|2211644|FG000|Overall Study|Adverse Event|2
1123018|NCT02612610|2211645|FG001|Overall Study|Adverse Event|2
1123019|NCT02612610|2211646|FG002|Overall Study|Adverse Event|3
1123020|NCT02612610|2211647|FG003|Overall Study|Adverse Event|10
1123021|NCT02612610|2211644|FG000|Overall Study|Lost to Follow-up|0
1123022|NCT02612610|2211645|FG001|Overall Study|Lost to Follow-up|1
1123023|NCT02612610|2211646|FG002|Overall Study|Lost to Follow-up|0
1123024|NCT02612610|2211647|FG003|Overall Study|Lost to Follow-up|0
1123025|NCT02612610|2211644|FG000|Overall Study|Protocol Violation|0
1123026|NCT02612610|2211645|FG001|Overall Study|Protocol Violation|1
1123027|NCT02612610|2211646|FG002|Overall Study|Protocol Violation|1
1123028|NCT02612610|2211647|FG003|Overall Study|Protocol Violation|0
1123029|NCT02612610|2211644|FG000|Overall Study|Lack of Efficacy|1
1123030|NCT02612610|2211645|FG001|Overall Study|Lack of Efficacy|2
1123031|NCT02612610|2211646|FG002|Overall Study|Lack of Efficacy|0
1123032|NCT02612610|2211647|FG003|Overall Study|Lack of Efficacy|1
1123033|NCT02612610|2211644|FG000|Overall Study|Physician Decision|0
1123034|NCT02612610|2211645|FG001|Overall Study|Physician Decision|1
1123035|NCT02612610|2211646|FG002|Overall Study|Physician Decision|0
1123036|NCT02612610|2211647|FG003|Overall Study|Physician Decision|0
1123037|NCT02612610|2211644|FG000|Overall Study|Noncompliance|1
1123038|NCT02612610|2211645|FG001|Overall Study|Noncompliance|0
1123039|NCT02612610|2211646|FG002|Overall Study|Noncompliance|0
1123040|NCT02612610|2211647|FG003|Overall Study|Noncompliance|0
1123041|NCT02612610|2211644|FG000|Overall Study|Cough Improvement|0
1123042|NCT02612610|2211645|FG001|Overall Study|Cough Improvement|0
1123043|NCT02612610|2211646|FG002|Overall Study|Cough Improvement|1
1123044|NCT02612610|2211647|FG003|Overall Study|Cough Improvement|0
1123045|NCT02612623|2211661|FG000|Overall Study|Withdrawal by Subject|0
1123046|NCT02612623|2211662|FG001|Overall Study|Withdrawal by Subject|1
1123047|NCT02612623|2211663|FG002|Overall Study|Withdrawal by Subject|0
1123048|NCT02612623|2211664|FG003|Overall Study|Withdrawal by Subject|0
1123049|NCT02612623|2211661|FG000|Overall Study|Adverse Event|1
1123050|NCT02612623|2211662|FG001|Overall Study|Adverse Event|0
1123051|NCT02612623|2211663|FG002|Overall Study|Adverse Event|1
1123052|NCT02612623|2211664|FG003|Overall Study|Adverse Event|0
1123053|NCT02612727|2211687|FG000|Overall Study|Parent request|4
1123054|NCT02612727|2211688|FG001|Overall Study|Parent request|1
1123055|NCT02612727|2211687|FG000|Overall Study|Needed treatment incompatible with PT|1
1123056|NCT02612727|2211688|FG001|Overall Study|Needed treatment incompatible with PT|1
1123057|NCT02612727|2211687|FG000|Overall Study|Direct hyperbilirubinemia|0
1123058|NCT02612727|2211688|FG001|Overall Study|Direct hyperbilirubinemia|2
1123059|NCT02612779|2211696|FG000|Overall Study|Administrative reason by sponsor|4
1123060|NCT02612779|2211697|FG001|Overall Study|Administrative reason by sponsor|1
1123061|NCT02612779|2211696|FG000|Overall Study|No longer meet study criteria|0
1123062|NCT02612779|2211697|FG001|Overall Study|No longer meet study criteria|1
1123063|NCT02612779|2211696|FG000|Overall Study|Disease progression|29
1123064|NCT02612779|2211697|FG001|Overall Study|Disease progression|2
1123065|NCT02612779|2211696|FG000|Overall Study|Study drug toxicity|10
1123066|NCT02612779|2211697|FG001|Overall Study|Study drug toxicity|1
1123067|NCT02612779|2211696|FG000|Overall Study|Death|1
1123068|NCT02612779|2211697|FG001|Overall Study|Death|0
1123069|NCT02612779|2211696|FG000|Overall Study|Adverse event unrelated to study drug|5
1123070|NCT02612779|2211697|FG001|Overall Study|Adverse event unrelated to study drug|0
1123071|NCT02612779|2211696|FG000|Overall Study|Participant withdrew consent|4
1123072|NCT02612779|2211697|FG001|Overall Study|Participant withdrew consent|0
1123073|NCT02612779|2211696|FG000|Overall Study|Lost to Follow-up|1
1123074|NCT02612779|2211697|FG001|Overall Study|Lost to Follow-up|0
1123075|NCT02612779|2211696|FG000|Overall Study|Maximum clinical benefit|10
1123076|NCT02612779|2211697|FG001|Overall Study|Maximum clinical benefit|1
1123077|NCT02612779|2211696|FG000|Overall Study|Other reasons|4
1123078|NCT02612779|2211697|FG001|Overall Study|Other reasons|0
1123079|NCT02612909|2211722|FG000|Phase 2|Withdrawal by Subject|2
1123080|NCT02612909|2211723|FG001|Phase 2|Withdrawal by Subject|5
1123081|NCT02612909|2211724|FG002|Phase 2|Withdrawal by Subject|0
1123082|NCT02612909|2211725|FG003|Phase 2|Withdrawal by Subject|0
1123083|NCT02612909|2211726|FG004|Phase 2|Withdrawal by Subject|0
1123084|NCT02612909|2211722|FG000|Phase 2|Pregnancy|0
1123085|NCT02612909|2211723|FG001|Phase 2|Pregnancy|0
1123086|NCT02612909|2211724|FG002|Phase 2|Pregnancy|1
1123087|NCT02612909|2211725|FG003|Phase 2|Pregnancy|0
1123088|NCT02612909|2211726|FG004|Phase 2|Pregnancy|0
1123089|NCT02612909|2211722|FG000|Phase 3|Withdrawal by Subject|0
1123090|NCT02612909|2211723|FG001|Phase 3|Withdrawal by Subject|0
1123091|NCT02612909|2211724|FG002|Phase 3|Withdrawal by Subject|0
1123092|NCT02612909|2211725|FG003|Phase 3|Withdrawal by Subject|1
1123093|NCT02612909|2211726|FG004|Phase 3|Withdrawal by Subject|0
1123094|NCT02613169|2211751|FG000|Overall Study|Withdrawal by Subject|4
1123095|NCT02613169|2211752|FG001|Overall Study|Withdrawal by Subject|1
1123096|NCT02613169|2211751|FG000|Overall Study|Lost to Follow-up|0
1123097|NCT02613169|2211752|FG001|Overall Study|Lost to Follow-up|5
1123098|NCT02613169|2211751|FG000|Overall Study|HIV|0
1123099|NCT02613169|2211752|FG001|Overall Study|HIV|2
1123100|NCT02613169|2211751|FG000|Overall Study|No TB infection endpoint|14
1123101|NCT02613169|2211752|FG001|Overall Study|No TB infection endpoint|9
1123102|NCT02613182|2211758|FG000|Overall Study|Death|6
1123103|NCT02613182|2211758|FG000|Overall Study|Physician Decision|1
1123104|NCT02613182|2211758|FG000|Overall Study|Study Terminated by Sponsor|21
1123105|NCT02613182|2211758|FG000|Overall Study|Withdrawal by Subject|6
1123106|NCT02613208|2211762|FG000|Overall Study|Withdrawal by Subject|1
1123107|NCT02613208|2211762|FG000|Overall Study|Change of address|2
1123108|NCT02613208|2211762|FG000|Overall Study|Physician Decision|2
1123109|NCT02613208|2211762|FG000|Overall Study|Lost to Follow-up|5
1123110|NCT02613208|2211762|FG000|Overall Study|Death|37
1123111|NCT02613221|2211766|FG000|Overall Study|Lack of efficacy (exacerbation)|50
1123112|NCT02613221|2211766|FG000|Overall Study|Adverse Event|2
1123113|NCT02613221|2211766|FG000|Overall Study|Voluntary Discontinuation|1
1123114|NCT02613221|2211766|FG000|Overall Study|Delayed Treatment|1
1123115|NCT02613221|2211766|FG000|Overall Study|Enrolled but Not Treated|1
1123116|NCT02613364|2211777|FG000|Overall Study|Other|19
1123117|NCT02613364|2211778|FG001|Overall Study|Other|29
1123118|NCT02613364|2211779|FG002|Overall Study|Other|17
1123119|NCT02613364|2211777|FG000|Overall Study|Too time consuming|21
1123120|NCT02613364|2211778|FG001|Overall Study|Too time consuming|26
1123121|NCT02613364|2211779|FG002|Overall Study|Too time consuming|26
1123122|NCT02613364|2211777|FG000|Overall Study|Withdrawal by Subject|13
1123123|NCT02613364|2211778|FG001|Overall Study|Withdrawal by Subject|18
1123124|NCT02613364|2211779|FG002|Overall Study|Withdrawal by Subject|17
1123125|NCT02613364|2211777|FG000|Overall Study|Medical|12
1123126|NCT02613364|2211778|FG001|Overall Study|Medical|13
1123127|NCT02613364|2211779|FG002|Overall Study|Medical|9
1123128|NCT02613364|2211777|FG000|Overall Study|Disliked Study Procedure|1
1123129|NCT02613364|2211778|FG001|Overall Study|Disliked Study Procedure|1
1123130|NCT02613364|2211779|FG002|Overall Study|Disliked Study Procedure|4
1123131|NCT02613364|2211777|FG000|Overall Study|Disliked Intervention|0
1123132|NCT02613364|2211778|FG001|Overall Study|Disliked Intervention|3
1123133|NCT02613364|2211779|FG002|Overall Study|Disliked Intervention|3
1123134|NCT02613403|2211791|FG000|Overall Study|Lost to Follow-up|0
1123135|NCT02613403|2211792|FG001|Overall Study|Lost to Follow-up|1
1123136|NCT02613403|2211793|FG002|Overall Study|Lost to Follow-up|0
1123137|NCT02613403|2211794|FG003|Overall Study|Lost to Follow-up|0
1123138|NCT02613403|2211795|FG004|Overall Study|Lost to Follow-up|0
1123139|NCT02613403|2211791|FG000|Overall Study|Withdrawal by Subject|2
1123140|NCT02613403|2211792|FG001|Overall Study|Withdrawal by Subject|0
1123141|NCT02613403|2211793|FG002|Overall Study|Withdrawal by Subject|0
1123142|NCT02613403|2211794|FG003|Overall Study|Withdrawal by Subject|0
1123143|NCT02613403|2211795|FG004|Overall Study|Withdrawal by Subject|0
1123144|NCT02613481|2211805|FG000|Overall Study|Lost to Follow-up|7
1123145|NCT02613481|2211805|FG000|Overall Study|Withdrawal by Subject|2
1123146|NCT02613507|2211811|FG000|Overall Study|Disease Progression|237
1123147|NCT02613507|2211812|FG001|Overall Study|Disease Progression|109
1123148|NCT02613507|2211811|FG000|Overall Study|Study Drug Toxicity|15
1123149|NCT02613507|2211812|FG001|Overall Study|Study Drug Toxicity|14
1123150|NCT02613507|2211811|FG000|Overall Study|Death|3
1123151|NCT02613507|2211812|FG001|Overall Study|Death|0
1123152|NCT02613507|2211811|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17
1123153|NCT02613507|2211812|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
1123154|NCT02613507|2211811|FG000|Overall Study|Request to Discontinue Study Treatment|8
1123155|NCT02613507|2211812|FG001|Overall Study|Request to Discontinue Study Treatment|17
1123156|NCT02613507|2211811|FG000|Overall Study|Participant Withdrew Consent|0
1123157|NCT02613507|2211812|FG001|Overall Study|Participant Withdrew Consent|2
1123158|NCT02613507|2211811|FG000|Overall Study|Lost to Follow-up|1
1123159|NCT02613507|2211812|FG001|Overall Study|Lost to Follow-up|0
1123160|NCT02613507|2211811|FG000|Overall Study|Maximum Clinical Benefit|4
1123161|NCT02613507|2211812|FG001|Overall Study|Maximum Clinical Benefit|10
1123162|NCT02613507|2211811|FG000|Overall Study|Brain Radiotherapy Activity Limited|1
1123163|NCT02613507|2211812|FG001|Overall Study|Brain Radiotherapy Activity Limited|0
1123164|NCT02613507|2211811|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
898482|NCT00716274|1871036|FG000|Study Period II (16-Weeks)|Protocol Violation|0
898483|NCT00716274|1871037|FG001|Study Period II (16-Weeks)|Protocol Violation|3
898484|NCT00716274|1871038|FG002|Study Period II (16-Weeks)|Protocol Violation|0
898485|NCT00716274|1871039|FG003|Study Period II (16-Weeks)|Protocol Violation|0
898486|NCT00716274|1871040|FG004|Study Period II (16-Weeks)|Protocol Violation|0
898487|NCT00716274|1871041|FG005|Study Period II (16-Weeks)|Protocol Violation|1
898488|NCT00716274|1871036|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1
898489|NCT00716274|1871037|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0
898490|NCT00716274|1871038|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0
898491|NCT00716274|1871039|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0
1123165|NCT02613507|2211812|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
1123166|NCT02613507|2211811|FG000|Overall Study|Randomized but not Treated|1
1123167|NCT02613507|2211812|FG001|Overall Study|Randomized but not Treated|10
1123168|NCT02613572|2211821|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1
1123169|NCT02613572|2211822|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
1123170|NCT02613572|2211823|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
1123171|NCT02613572|2211821|FG000|Phase II: Double-Blind Rand Plac Control|Death|0
1123172|NCT02613572|2211822|FG001|Phase II: Double-Blind Rand Plac Control|Death|1
1123173|NCT02613572|2211823|FG002|Phase II: Double-Blind Rand Plac Control|Death|0
1123174|NCT02613871|2211835|FG000|Overall Study|Death|2
1123175|NCT02613871|2211835|FG000|Overall Study|Withdrew Consent|1
1123176|NCT02613884|2211839|FG000|Overall Study|Death|1
1123177|NCT02613884|2211839|FG000|Overall Study|Lost to Follow-up|1
1123178|NCT02613910|2211858|FG000|Overall Study|Termination of study|1
1123199|NCT02614079|2211877|FG000|Overall Study|Withdrawal by Subject|1
1123200|NCT02614131|2211888|FG000|Overall Study|Withdrawal by Subject|1
1123201|NCT02614131|2211889|FG001|Overall Study|Withdrawal by Subject|0
1123202|NCT02614131|2211890|FG002|Overall Study|Withdrawal by Subject|0
1123203|NCT02614131|2211891|FG003|Overall Study|Withdrawal by Subject|0
1123204|NCT02614131|2211892|FG004|Overall Study|Withdrawal by Subject|0
1123205|NCT02614131|2211893|FG005|Overall Study|Withdrawal by Subject|0
1123206|NCT02614131|2211894|FG006|Overall Study|Withdrawal by Subject|0
1123207|NCT02614131|2211888|FG000|Overall Study|Adverse Event|0
1123208|NCT02614131|2211889|FG001|Overall Study|Adverse Event|0
1123209|NCT02614131|2211890|FG002|Overall Study|Adverse Event|0
1123210|NCT02614131|2211891|FG003|Overall Study|Adverse Event|0
1123211|NCT02614131|2211892|FG004|Overall Study|Adverse Event|0
1123212|NCT02614131|2211893|FG005|Overall Study|Adverse Event|0
1123213|NCT02614131|2211894|FG006|Overall Study|Adverse Event|1
1123214|NCT02614183|2211919|FG000|Double Blind Treatment Phase|Adverse Event|10
1123215|NCT02614183|2211920|FG001|Double Blind Treatment Phase|Adverse Event|9
1123216|NCT02614183|2211921|FG002|Double Blind Treatment Phase|Adverse Event|7
1123217|NCT02614183|2211919|FG000|Double Blind Treatment Phase|Lack of Efficacy|10
1123218|NCT02614183|2211920|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
1123219|NCT02614183|2211921|FG002|Double Blind Treatment Phase|Lack of Efficacy|2
1123220|NCT02614183|2211919|FG000|Double Blind Treatment Phase|Lost to Follow-up|18
1123221|NCT02614183|2211920|FG001|Double Blind Treatment Phase|Lost to Follow-up|9
1123222|NCT02614183|2211921|FG002|Double Blind Treatment Phase|Lost to Follow-up|5
1123223|NCT02614183|2211919|FG000|Double Blind Treatment Phase|Physician Decision|7
1123224|NCT02614183|2211920|FG001|Double Blind Treatment Phase|Physician Decision|3
1123225|NCT02614183|2211921|FG002|Double Blind Treatment Phase|Physician Decision|2
1123226|NCT02614183|2211919|FG000|Double Blind Treatment Phase|Pregnancy|2
1123227|NCT02614183|2211920|FG001|Double Blind Treatment Phase|Pregnancy|1
1123228|NCT02614183|2211921|FG002|Double Blind Treatment Phase|Pregnancy|3
1123229|NCT02614183|2211919|FG000|Double Blind Treatment Phase|Protocol Violation|2
1123230|NCT02614183|2211920|FG001|Double Blind Treatment Phase|Protocol Violation|2
1123231|NCT02614183|2211921|FG002|Double Blind Treatment Phase|Protocol Violation|2
1123232|NCT02614183|2211919|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33
1123233|NCT02614183|2211920|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
1123234|NCT02614183|2211921|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16
1123235|NCT02614183|2211919|FG000|Double Blind Treatment Phase|Did not receive study drug|1
1123236|NCT02614183|2211920|FG001|Double Blind Treatment Phase|Did not receive study drug|1
1123237|NCT02614183|2211921|FG002|Double Blind Treatment Phase|Did not receive study drug|2
1123238|NCT02614183|2211919|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5
1123239|NCT02614183|2211920|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
1123240|NCT02614183|2211921|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5
1123241|NCT02614183|2211919|FG000|Post Treatment Follow-up Phase|Physician Decision|5
1123242|NCT02614183|2211920|FG001|Post Treatment Follow-up Phase|Physician Decision|1
1123243|NCT02614183|2211921|FG002|Post Treatment Follow-up Phase|Physician Decision|2
1123244|NCT02614183|2211919|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
1123245|NCT02614183|2211920|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
1123246|NCT02614183|2211921|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
1123247|NCT02614183|2211919|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7
1123248|NCT02614183|2211920|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2
1123249|NCT02614183|2211921|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
1123250|NCT02614196|2211941|FG000|Double Blind Treatment Phase|Adverse Event|8
1123251|NCT02614196|2211942|FG001|Double Blind Treatment Phase|Adverse Event|5
1123252|NCT02614196|2211943|FG002|Double Blind Treatment Phase|Adverse Event|9
1123253|NCT02614196|2211944|FG003|Double Blind Treatment Phase|Adverse Event|0
1123254|NCT02614196|2211945|FG004|Double Blind Treatment Phase|Adverse Event|0
1123255|NCT02614196|2211946|FG005|Double Blind Treatment Phase|Adverse Event|0
1123256|NCT02614196|2211941|FG000|Double Blind Treatment Phase|Lack of Efficacy|6
1123257|NCT02614196|2211942|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
1123258|NCT02614196|2211943|FG002|Double Blind Treatment Phase|Lack of Efficacy|1
1123259|NCT02614196|2211944|FG003|Double Blind Treatment Phase|Lack of Efficacy|0
1123260|NCT02614196|2211945|FG004|Double Blind Treatment Phase|Lack of Efficacy|0
1123261|NCT02614196|2211946|FG005|Double Blind Treatment Phase|Lack of Efficacy|0
1123262|NCT02614196|2211941|FG000|Double Blind Treatment Phase|Lost to Follow-up|10
1123263|NCT02614196|2211942|FG001|Double Blind Treatment Phase|Lost to Follow-up|7
1123264|NCT02614196|2211943|FG002|Double Blind Treatment Phase|Lost to Follow-up|1
1123265|NCT02614196|2211944|FG003|Double Blind Treatment Phase|Lost to Follow-up|0
1123266|NCT02614196|2211945|FG004|Double Blind Treatment Phase|Lost to Follow-up|0
1123267|NCT02614196|2211946|FG005|Double Blind Treatment Phase|Lost to Follow-up|0
1123268|NCT02614196|2211941|FG000|Double Blind Treatment Phase|Physician Decision|4
1123269|NCT02614196|2211942|FG001|Double Blind Treatment Phase|Physician Decision|0
1123270|NCT02614196|2211943|FG002|Double Blind Treatment Phase|Physician Decision|2
1123271|NCT02614196|2211944|FG003|Double Blind Treatment Phase|Physician Decision|0
1123272|NCT02614196|2211945|FG004|Double Blind Treatment Phase|Physician Decision|0
1123273|NCT02614196|2211946|FG005|Double Blind Treatment Phase|Physician Decision|0
1123274|NCT02614196|2211941|FG000|Double Blind Treatment Phase|Pregnancy|1
1123275|NCT02614196|2211942|FG001|Double Blind Treatment Phase|Pregnancy|2
1123276|NCT02614196|2211943|FG002|Double Blind Treatment Phase|Pregnancy|0
1123277|NCT02614196|2211944|FG003|Double Blind Treatment Phase|Pregnancy|0
1123278|NCT02614196|2211945|FG004|Double Blind Treatment Phase|Pregnancy|0
1123279|NCT02614196|2211946|FG005|Double Blind Treatment Phase|Pregnancy|0
1123280|NCT02614196|2211941|FG000|Double Blind Treatment Phase|Protocol Violation|5
1123281|NCT02614196|2211942|FG001|Double Blind Treatment Phase|Protocol Violation|2
1123282|NCT02614196|2211943|FG002|Double Blind Treatment Phase|Protocol Violation|1
1123283|NCT02614196|2211944|FG003|Double Blind Treatment Phase|Protocol Violation|0
1123284|NCT02614196|2211945|FG004|Double Blind Treatment Phase|Protocol Violation|1
1123285|NCT02614196|2211946|FG005|Double Blind Treatment Phase|Protocol Violation|0
1123286|NCT02614196|2211941|FG000|Double Blind Treatment Phase|Terminated by sponsor|1
1123287|NCT02614196|2211942|FG001|Double Blind Treatment Phase|Terminated by sponsor|0
1123288|NCT02614196|2211943|FG002|Double Blind Treatment Phase|Terminated by sponsor|0
1123289|NCT02614196|2211944|FG003|Double Blind Treatment Phase|Terminated by sponsor|0
1123290|NCT02614196|2211945|FG004|Double Blind Treatment Phase|Terminated by sponsor|0
1123291|NCT02614196|2211946|FG005|Double Blind Treatment Phase|Terminated by sponsor|0
1123292|NCT02614196|2211941|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39
1123293|NCT02614196|2211942|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
1123294|NCT02614196|2211943|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14
1123295|NCT02614196|2211944|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4
1123296|NCT02614196|2211945|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0
1123297|NCT02614196|2211946|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0
1123298|NCT02614196|2211941|FG000|Double Blind Treatment Phase|Did not receive study drug|2
1123299|NCT02614196|2211942|FG001|Double Blind Treatment Phase|Did not receive study drug|2
1123300|NCT02614196|2211943|FG002|Double Blind Treatment Phase|Did not receive study drug|3
1123301|NCT02614196|2211944|FG003|Double Blind Treatment Phase|Did not receive study drug|0
1123302|NCT02614196|2211945|FG004|Double Blind Treatment Phase|Did not receive study drug|0
1123303|NCT02614196|2211946|FG005|Double Blind Treatment Phase|Did not receive study drug|0
1123304|NCT02614196|2211941|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8
1123305|NCT02614196|2211942|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
1123306|NCT02614196|2211943|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3
1123307|NCT02614196|2211944|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0
1123308|NCT02614196|2211945|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1
1123309|NCT02614196|2211946|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0
1123310|NCT02614196|2211941|FG000|Post Treatment Follow-up Phase|Pregnancy|2
1123311|NCT02614196|2211942|FG001|Post Treatment Follow-up Phase|Pregnancy|0
1123312|NCT02614196|2211943|FG002|Post Treatment Follow-up Phase|Pregnancy|0
1123313|NCT02614196|2211944|FG003|Post Treatment Follow-up Phase|Pregnancy|0
1123314|NCT02614196|2211945|FG004|Post Treatment Follow-up Phase|Pregnancy|0
1123315|NCT02614196|2211946|FG005|Post Treatment Follow-up Phase|Pregnancy|0
1123316|NCT02614196|2211941|FG000|Post Treatment Follow-up Phase|Protocol Violation|0
1123317|NCT02614196|2211942|FG001|Post Treatment Follow-up Phase|Protocol Violation|1
1123318|NCT02614196|2211943|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
1123319|NCT02614196|2211944|FG003|Post Treatment Follow-up Phase|Protocol Violation|0
1123320|NCT02614196|2211945|FG004|Post Treatment Follow-up Phase|Protocol Violation|1
1123321|NCT02614196|2211946|FG005|Post Treatment Follow-up Phase|Protocol Violation|0
1123322|NCT02614196|2211941|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10
1123323|NCT02614196|2211942|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
1123324|NCT02614196|2211943|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
1123325|NCT02614196|2211944|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1
1123326|NCT02614196|2211945|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0
1123327|NCT02614196|2211946|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0
1123328|NCT02614261|2211986|FG000|Overall Study|Adverse Event|6
1123329|NCT02614261|2211987|FG001|Overall Study|Adverse Event|3
1123330|NCT02614261|2211988|FG002|Overall Study|Adverse Event|2
1123331|NCT02614261|2211986|FG000|Overall Study|Lack of Efficacy|4
1123332|NCT02614261|2211987|FG001|Overall Study|Lack of Efficacy|0
1123333|NCT02614261|2211988|FG002|Overall Study|Lack of Efficacy|0
1123334|NCT02614261|2211986|FG000|Overall Study|Lost to Follow-up|10
1123335|NCT02614261|2211987|FG001|Overall Study|Lost to Follow-up|4
1123336|NCT02614261|2211988|FG002|Overall Study|Lost to Follow-up|1
1123337|NCT02614261|2211986|FG000|Overall Study|Physician Decision|2
1123338|NCT02614261|2211987|FG001|Overall Study|Physician Decision|1
1123339|NCT02614261|2211988|FG002|Overall Study|Physician Decision|1
1123340|NCT02614261|2211986|FG000|Overall Study|Pregnancy|2
1123341|NCT02614261|2211987|FG001|Overall Study|Pregnancy|2
1123342|NCT02614261|2211988|FG002|Overall Study|Pregnancy|0
1123343|NCT02614261|2211986|FG000|Overall Study|Protocol Violation|6
1123344|NCT02614261|2211987|FG001|Overall Study|Protocol Violation|1
1123345|NCT02614261|2211988|FG002|Overall Study|Protocol Violation|0
1123346|NCT02614261|2211986|FG000|Overall Study|Withdrawal by Subject|19
1123347|NCT02614261|2211987|FG001|Overall Study|Withdrawal by Subject|4
1123348|NCT02614261|2211988|FG002|Overall Study|Withdrawal by Subject|7
1123349|NCT02614287|2212010|FG000|Open Label (OL) Treatment Phase|Adverse Event|7
1123350|NCT02614287|2212011|FG001|Open Label (OL) Treatment Phase|Adverse Event|6
1123351|NCT02614287|2212010|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13
1123352|NCT02614287|2212011|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5
1123353|NCT02614287|2212010|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7
1123354|NCT02614287|2212011|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4
1123355|NCT02614287|2212010|FG000|Open Label (OL) Treatment Phase|Physician Decision|1
1123356|NCT02614287|2212011|FG001|Open Label (OL) Treatment Phase|Physician Decision|0
1123357|NCT02614287|2212010|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
1123358|NCT02614287|2212011|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
1123359|NCT02614287|2212010|FG000|Post Treatment Follow-up Phase|Adverse Event|1
1123360|NCT02614287|2212011|FG001|Post Treatment Follow-up Phase|Adverse Event|0
1123361|NCT02614287|2212010|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2
1123362|NCT02614287|2212011|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2
1123363|NCT02614287|2212010|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6
1123364|NCT02614287|2212011|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3
1123365|NCT02614560|2212045|FG000|Overall Study|Death|6
1123366|NCT02614560|2212046|FG001|Overall Study|Death|2
1123367|NCT02614703|2212067|FG000|Overall Study|Withdrawal by Subject|7
1123368|NCT02614703|2212068|FG001|Overall Study|Withdrawal by Subject|1
1123369|NCT02614729|2212076|FG000|Overall Study|Withdrawal by Subject|1
1123370|NCT02614729|2212077|FG001|Overall Study|Withdrawal by Subject|0
1123371|NCT02614794|2212087|FG000|Overall Study|On treatment|118
1123372|NCT02614794|2212088|FG001|Overall Study|On treatment|27
1123373|NCT02614794|2212087|FG000|Overall Study|In long term follow up|148
1123374|NCT02614794|2212088|FG001|Overall Study|In long term follow up|85
1123375|NCT02614794|2212087|FG000|Overall Study|Death|126
1123376|NCT02614794|2212088|FG001|Overall Study|Death|84
1123377|NCT02614794|2212087|FG000|Overall Study|Withdrawal by Subject|16
1123378|NCT02614794|2212088|FG001|Overall Study|Withdrawal by Subject|5
1123379|NCT02614794|2212087|FG000|Overall Study|Lost to Follow-up|2
1123380|NCT02614794|2212088|FG001|Overall Study|Lost to Follow-up|0
1123381|NCT02614794|2212087|FG000|Overall Study|Physician Decision|0
1123382|NCT02614794|2212088|FG001|Overall Study|Physician Decision|1
1123383|NCT02615145|2212107|FG000|Overall Study|Did Not Start Treatment|0
1123384|NCT02615145|2212108|FG001|Overall Study|Did Not Start Treatment|0
1123385|NCT02615145|2212109|FG002|Overall Study|Did Not Start Treatment|1
1123386|NCT02615145|2212110|FG003|Overall Study|Did Not Start Treatment|1
1123387|NCT02615145|2212107|FG000|Overall Study|Failure to Return|20
1123388|NCT02615145|2212108|FG001|Overall Study|Failure to Return|10
1123389|NCT02615145|2212109|FG002|Overall Study|Failure to Return|7
1123390|NCT02615145|2212110|FG003|Overall Study|Failure to Return|0
1123391|NCT02615145|2212107|FG000|Overall Study|Death|2
1123392|NCT02615145|2212108|FG001|Overall Study|Death|3
1123393|NCT02615145|2212109|FG002|Overall Study|Death|0
1123394|NCT02615145|2212110|FG003|Overall Study|Death|0
1123395|NCT02615145|2212107|FG000|Overall Study|Other, Not Specified|5
1123396|NCT02615145|2212108|FG001|Overall Study|Other, Not Specified|2
1123397|NCT02615145|2212109|FG002|Overall Study|Other, Not Specified|0
1123398|NCT02615145|2212110|FG003|Overall Study|Other, Not Specified|0
1123399|NCT02615171|2212151|FG000|Overall Study|Lost to Follow-up|2
1123400|NCT02615171|2212152|FG001|Overall Study|Lost to Follow-up|1
1123401|NCT02615249|2212158|FG000|Overall Study|Withdrawal by Subject|1
1123402|NCT02615470|2212165|FG000|Overall Study|Lost to Follow-up|21
1123403|NCT02615470|2212166|FG001|Overall Study|Lost to Follow-up|32
1123404|NCT02615509|2212172|FG000|Overall Study|Lost to Follow-up|134
1123405|NCT02615509|2212172|FG000|Overall Study|Death|4
1123406|NCT02615509|2212172|FG000|Overall Study|Withdrawal by Subject|8
1123407|NCT02616029|2212205|FG000|Overall Study|Adverse Event|1
1123408|NCT02616029|2212206|FG001|Overall Study|Adverse Event|0
1123409|NCT02616029|2212205|FG000|Overall Study|Death|0
1123410|NCT02616029|2212206|FG001|Overall Study|Death|1
1123411|NCT02616029|2212205|FG000|Overall Study|Protocol Violation|1
1123412|NCT02616029|2212206|FG001|Overall Study|Protocol Violation|0
1123413|NCT02616029|2212205|FG000|Overall Study|Withdrew Consent|1
1123414|NCT02616029|2212206|FG001|Overall Study|Withdrew Consent|0
1123415|NCT02616029|2212205|FG000|Overall Study|Enrolled and Never Treated|1
1123416|NCT02616029|2212206|FG001|Overall Study|Enrolled and Never Treated|1
1123417|NCT02616146|2212214|FG000|Overall Study|Adverse Event|64
1123418|NCT02616146|2212215|FG001|Overall Study|Adverse Event|24
1123419|NCT02616146|2212214|FG000|Overall Study|Lost to Follow-up|23
1123420|NCT02616146|2212215|FG001|Overall Study|Lost to Follow-up|13
1123421|NCT02616146|2212214|FG000|Overall Study|Non-compliance with study protocol|2
1123422|NCT02616146|2212215|FG001|Overall Study|Non-compliance with study protocol|0
1123423|NCT02616146|2212214|FG000|Overall Study|Non-compliance with study drug|4
1123424|NCT02616146|2212215|FG001|Overall Study|Non-compliance with study drug|2
1123425|NCT02616146|2212214|FG000|Overall Study|Pregnancy|2
1123426|NCT02616146|2212215|FG001|Overall Study|Pregnancy|2
1123427|NCT02616146|2212214|FG000|Overall Study|Pregnancy wish|3
1123428|NCT02616146|2212215|FG001|Overall Study|Pregnancy wish|0
1123429|NCT02616146|2212214|FG000|Overall Study|Protocol Violation|6
1123430|NCT02616146|2212215|FG001|Overall Study|Protocol Violation|3
1123431|NCT02616146|2212214|FG000|Overall Study|Study terminated by sponsor|1372
1123432|NCT02616146|2212215|FG001|Overall Study|Study terminated by sponsor|432
1123433|NCT02616146|2212214|FG000|Overall Study|Participant moved|4
1123434|NCT02616146|2212215|FG001|Overall Study|Participant moved|3
1123435|NCT02616146|2212214|FG000|Overall Study|Withdrawal by Subject|30
1123436|NCT02616146|2212215|FG001|Overall Study|Withdrawal by Subject|24
1123437|NCT02616146|2212214|FG000|Overall Study|Physician Decision|2
1123438|NCT02616146|2212215|FG001|Overall Study|Physician Decision|1
1123439|NCT02616380|2212230|FG000|Overall Study|Lost to Follow-up|1
1123440|NCT02616380|2212230|FG000|Overall Study|Other|2
1123441|NCT02616393|2212237|FG000|Overall Study|Death|5
1123442|NCT02616393|2212238|FG001|Overall Study|Death|12
1123443|NCT02616393|2212239|FG002|Overall Study|Death|1
1123444|NCT02616393|2212237|FG000|Overall Study|Termination by Sponsor|4
1123445|NCT02616393|2212238|FG001|Overall Study|Termination by Sponsor|5
1123446|NCT02616393|2212239|FG002|Overall Study|Termination by Sponsor|2
1123447|NCT02616393|2212237|FG000|Overall Study|Other|3
1123448|NCT02616393|2212238|FG001|Overall Study|Other|0
1123449|NCT02616393|2212239|FG002|Overall Study|Other|0
1123450|NCT02616393|2212237|FG000|Overall Study|Withdrawal by Subject|1
1123451|NCT02616393|2212238|FG001|Overall Study|Withdrawal by Subject|1
1123452|NCT02616393|2212239|FG002|Overall Study|Withdrawal by Subject|0
1123453|NCT02616393|2212237|FG000|Overall Study|Lost to Follow-up|0
1123454|NCT02616393|2212238|FG001|Overall Study|Lost to Follow-up|2
1123455|NCT02616393|2212239|FG002|Overall Study|Lost to Follow-up|0
1123456|NCT02616601|2212282|FG000|Overall Study|Withdrawal by Subject|4
1123457|NCT02616601|2212283|FG001|Overall Study|Withdrawal by Subject|4
1123458|NCT02616601|2212284|FG002|Overall Study|Withdrawal by Subject|3
1123459|NCT02616601|2212282|FG000|Overall Study|Adverse Event|2
1123460|NCT02616601|2212283|FG001|Overall Study|Adverse Event|0
1123461|NCT02616601|2212284|FG002|Overall Study|Adverse Event|2
1123462|NCT02616601|2212282|FG000|Overall Study|Death|1
1123463|NCT02616601|2212283|FG001|Overall Study|Death|0
1123464|NCT02616601|2212284|FG002|Overall Study|Death|0
1123465|NCT02616601|2212282|FG000|Overall Study|Lost to Follow-up|1
1123466|NCT02616601|2212283|FG001|Overall Study|Lost to Follow-up|0
1123467|NCT02616601|2212284|FG002|Overall Study|Lost to Follow-up|1
1123468|NCT02616601|2212282|FG000|Overall Study|Non-Compliance with Test Article|1
1123469|NCT02616601|2212283|FG001|Overall Study|Non-Compliance with Test Article|0
1123470|NCT02616601|2212284|FG002|Overall Study|Non-Compliance with Test Article|1
1123471|NCT02616614|2212295|FG000|Overall Study|Withdrawal by Subject|10
1123472|NCT02616614|2212296|FG001|Overall Study|Withdrawal by Subject|5
1123473|NCT02616614|2212297|FG002|Overall Study|Withdrawal by Subject|6
1123474|NCT02616614|2212295|FG000|Overall Study|Physician Decision|2
1123475|NCT02616614|2212296|FG001|Overall Study|Physician Decision|1
1123476|NCT02616614|2212297|FG002|Overall Study|Physician Decision|0
1123477|NCT02616614|2212295|FG000|Overall Study|Adverse Event|1
1123478|NCT02616614|2212296|FG001|Overall Study|Adverse Event|4
1123479|NCT02616614|2212297|FG002|Overall Study|Adverse Event|1
1123480|NCT02616614|2212295|FG000|Overall Study|Protocol Violation|0
1123481|NCT02616614|2212296|FG001|Overall Study|Protocol Violation|3
1123482|NCT02616614|2212297|FG002|Overall Study|Protocol Violation|1
1123483|NCT02616614|2212295|FG000|Overall Study|Prohibited Medication|12
1123484|NCT02616614|2212296|FG001|Overall Study|Prohibited Medication|9
1123485|NCT02616614|2212297|FG002|Overall Study|Prohibited Medication|5
1123486|NCT02616614|2212295|FG000|Overall Study|More than 3 applications missed|6
1123487|NCT02616614|2212296|FG001|Overall Study|More than 3 applications missed|8
1123488|NCT02616614|2212297|FG002|Overall Study|More than 3 applications missed|1
1123489|NCT02616614|2212295|FG000|Overall Study|Lost to Follow-up|31
1123490|NCT02616614|2212296|FG001|Overall Study|Lost to Follow-up|28
1123491|NCT02616614|2212297|FG002|Overall Study|Lost to Follow-up|13
1123492|NCT02616614|2212295|FG000|Overall Study|Pregnancy|2
1123493|NCT02616614|2212296|FG001|Overall Study|Pregnancy|0
1123494|NCT02616614|2212297|FG002|Overall Study|Pregnancy|1
1123495|NCT02616614|2212295|FG000|Overall Study|Other|1
1123496|NCT02616614|2212296|FG001|Overall Study|Other|2
1123497|NCT02616614|2212297|FG002|Overall Study|Other|1
1123498|NCT02616783|2212308|FG000|Overall Study|Randomized but Not Treated|1
1123499|NCT02616783|2212309|FG001|Overall Study|Randomized but Not Treated|0
1123500|NCT02616783|2212308|FG000|Overall Study|Adverse Event|1
1123501|NCT02616783|2212309|FG001|Overall Study|Adverse Event|0
1123502|NCT02616783|2212308|FG000|Overall Study|Death|1
1123503|NCT02616783|2212309|FG001|Overall Study|Death|0
1123504|NCT02616783|2212308|FG000|Overall Study|Non-Compliance with Study Drug|1
1123505|NCT02616783|2212309|FG001|Overall Study|Non-Compliance with Study Drug|0
1123506|NCT02616783|2212308|FG000|Overall Study|Protocol Violation|1
1123507|NCT02616783|2212309|FG001|Overall Study|Protocol Violation|1
1123508|NCT02616783|2212308|FG000|Overall Study|Withdrew Consent|1
1123509|NCT02616783|2212309|FG001|Overall Study|Withdrew Consent|1
1123510|NCT02616900|2212315|FG000|Overall Study|Lack of Efficacy|7
1123511|NCT02616900|2212315|FG000|Overall Study|Lost to Follow-up|2
1123512|NCT02616900|2212315|FG000|Overall Study|Protocol Violation|5
1123513|NCT02616900|2212315|FG000|Overall Study|Withdrawal by Subject|3
1123514|NCT02616900|2212315|FG000|Overall Study|Incomplete data|6
1123515|NCT02617589|2212321|FG000|All Randomized|Request to discontinue study treatment|1
1123516|NCT02617589|2212322|FG001|All Randomized|Request to discontinue study treatment|3
1123517|NCT02617589|2212321|FG000|All Randomized|Participant Withdrew Consent|1
1123518|NCT02617589|2212322|FG001|All Randomized|Participant Withdrew Consent|2
1123519|NCT02617589|2212321|FG000|Treatment Period|Other Reasons|2
1123520|NCT02617589|2212322|FG001|Treatment Period|Other Reasons|2
1123521|NCT02617589|2212321|FG000|Treatment Period|Not reported|1
1123522|NCT02617589|2212322|FG001|Treatment Period|Not reported|0
1123523|NCT02617589|2212321|FG000|Treatment Period|Poor/Non compliance|1
1123524|NCT02617589|2212322|FG001|Treatment Period|Poor/Non compliance|1
898492|NCT00716274|1871040|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0
898493|NCT00716274|1871041|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0
898494|NCT00716274|1871036|FG000|Study Period II (16-Weeks)|Physician Decision|3
898495|NCT00716274|1871037|FG001|Study Period II (16-Weeks)|Physician Decision|1
898496|NCT00716274|1871038|FG002|Study Period II (16-Weeks)|Physician Decision|0
898497|NCT00716274|1871039|FG003|Study Period II (16-Weeks)|Physician Decision|0
898498|NCT00716274|1871040|FG004|Study Period II (16-Weeks)|Physician Decision|0
898499|NCT00716274|1871041|FG005|Study Period II (16-Weeks)|Physician Decision|1
898500|NCT00716274|1871036|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
898501|NCT00716274|1871037|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
898502|NCT00716274|1871038|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
898503|NCT00716274|1871039|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
898504|NCT00716274|1871040|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
898505|NCT00716274|1871041|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
898506|NCT00716274|1871036|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0
898507|NCT00716274|1871037|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2
898508|NCT00716274|1871038|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0
898509|NCT00716274|1871039|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0
898510|NCT00716274|1871040|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0
898511|NCT00716274|1871041|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0
898512|NCT00716274|1871036|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0
898513|NCT00716274|1871037|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0
898514|NCT00716274|1871038|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2
898515|NCT00716274|1871039|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0
898516|NCT00716274|1871040|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0
898517|NCT00716274|1871041|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0
898518|NCT00716274|1871036|FG000|Study Period III (16-Weeks)|Physician Decision|0
898519|NCT00716274|1871037|FG001|Study Period III (16-Weeks)|Physician Decision|0
898520|NCT00716274|1871038|FG002|Study Period III (16-Weeks)|Physician Decision|0
898521|NCT00716274|1871039|FG003|Study Period III (16-Weeks)|Physician Decision|0
1123525|NCT02617589|2212321|FG000|Treatment Period|Maximum Clinical Benefit|0
1123526|NCT02617589|2212322|FG001|Treatment Period|Maximum Clinical Benefit|2
1123527|NCT02617589|2212321|FG000|Treatment Period|Participant Withdrew Consent|2
1123528|NCT02617589|2212322|FG001|Treatment Period|Participant Withdrew Consent|6
1123529|NCT02617589|2212321|FG000|Treatment Period|Participant Request to discontinue|12
1123530|NCT02617589|2212322|FG001|Treatment Period|Participant Request to discontinue|20
1123531|NCT02617589|2212321|FG000|Treatment Period|Adverse event unrelated to study drug|15
1123532|NCT02617589|2212322|FG001|Treatment Period|Adverse event unrelated to study drug|9
1123533|NCT02617589|2212321|FG000|Treatment Period|Death|1
1123534|NCT02617589|2212322|FG001|Treatment Period|Death|1
1123535|NCT02617589|2212321|FG000|Treatment Period|Study Drug Toxicity|26
1123536|NCT02617589|2212322|FG001|Treatment Period|Study Drug Toxicity|20
1123537|NCT02617589|2212321|FG000|Treatment Period|Disease Progression|214
1123538|NCT02617589|2212322|FG001|Treatment Period|Disease Progression|137
1123539|NCT02617589|2212321|FG000|Treatment Period|Completed Treatment|0
1123540|NCT02617589|2212322|FG001|Treatment Period|Completed Treatment|76
1123541|NCT02617628|2212330|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62
1123542|NCT02617628|2212331|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61
1123543|NCT02618382|2212419|FG000|Overall Study|Physician Decision|1
1123544|NCT02618382|2212419|FG000|Overall Study|Withdrawal by Subject|1
1123545|NCT02618382|2212419|FG000|Overall Study|Protocol Violation|1
1123546|NCT02618616|2212429|FG000|Overall Study|Lack of Efficacy|4
1123547|NCT02618616|2212430|FG001|Overall Study|Lack of Efficacy|0
1123548|NCT02618616|2212429|FG000|Overall Study|Pregnancy|0
1123549|NCT02618616|2212430|FG001|Overall Study|Pregnancy|1
1123550|NCT02618616|2212429|FG000|Overall Study|Adverse Event|8
1123551|NCT02618616|2212430|FG001|Overall Study|Adverse Event|0
1123552|NCT02618616|2212429|FG000|Overall Study|Failure to comply with dosing/evaluation|1
1123553|NCT02618616|2212430|FG001|Overall Study|Failure to comply with dosing/evaluation|0
1123554|NCT02618616|2212429|FG000|Overall Study|Consent withdrawn by subject|8
1123555|NCT02618616|2212430|FG001|Overall Study|Consent withdrawn by subject|5
1123556|NCT02618616|2212429|FG000|Overall Study|Lost to Follow-up|0
1123557|NCT02618616|2212430|FG001|Overall Study|Lost to Follow-up|1
1123558|NCT02618759|2212463|FG000|Overall Study|Lost to Follow-up|0
1123559|NCT02618759|2212464|FG001|Overall Study|Lost to Follow-up|1
1123560|NCT02618759|2212463|FG000|Overall Study|Withdrawal by Subject|1
1123561|NCT02618759|2212464|FG001|Overall Study|Withdrawal by Subject|0
1123562|NCT02618759|2212463|FG000|Overall Study|Other Reasons|1
1123563|NCT02618759|2212464|FG001|Overall Study|Other Reasons|4
1123564|NCT02618928|2212490|FG000|Overall Study|Failure to Return|28
1123565|NCT02618928|2212490|FG000|Overall Study|Insufficient Virological Response|1
1123566|NCT02618928|2212490|FG000|Overall Study|Withdrawal by Subject|2
1123567|NCT02618928|2212490|FG000|Overall Study|Death|3
1123568|NCT02618928|2212490|FG000|Overall Study|Other|11
1123569|NCT02618928|2212490|FG000|Overall Study|Missing|6
1123570|NCT02618928|2212490|FG000|Overall Study|Treatment Never Started|7
1123571|NCT02618967|2212505|FG000|Overall Study|Lost to Follow-up|0
1123572|NCT02618967|2212506|FG001|Overall Study|Lost to Follow-up|0
1123573|NCT02618967|2212507|FG002|Overall Study|Lost to Follow-up|1
1123574|NCT02618967|2212508|FG003|Overall Study|Lost to Follow-up|0
1123575|NCT02618967|2212509|FG004|Overall Study|Lost to Follow-up|2
1123576|NCT02618967|2212510|FG005|Overall Study|Lost to Follow-up|0
1123577|NCT02618967|2212511|FG006|Overall Study|Lost to Follow-up|0
1123578|NCT02618967|2212512|FG007|Overall Study|Lost to Follow-up|0
1123579|NCT02618967|2212505|FG000|Overall Study|Withdrawal by Subject|1
1123580|NCT02618967|2212506|FG001|Overall Study|Withdrawal by Subject|0
1123581|NCT02618967|2212507|FG002|Overall Study|Withdrawal by Subject|0
1123582|NCT02618967|2212508|FG003|Overall Study|Withdrawal by Subject|0
1123583|NCT02618967|2212509|FG004|Overall Study|Withdrawal by Subject|0
1123584|NCT02618967|2212510|FG005|Overall Study|Withdrawal by Subject|0
1123585|NCT02618967|2212511|FG006|Overall Study|Withdrawal by Subject|0
1123586|NCT02618967|2212512|FG007|Overall Study|Withdrawal by Subject|0
1123587|NCT02619175|2212532|FG000|Overall Study|Withdrawal by Subject|1
1123588|NCT02619175|2212533|FG001|Overall Study|Withdrawal by Subject|0
1123589|NCT02619175|2212532|FG000|Overall Study|foot pain|1
1123590|NCT02619175|2212533|FG001|Overall Study|foot pain|0
1123591|NCT02619617|2212591|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
1123592|NCT02619617|2212592|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
1123593|NCT02619617|2212591|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0
1123594|NCT02619617|2212592|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3
1123595|NCT02620020|2212613|FG000|Overall Study|Adverse Event|8
1123596|NCT02620020|2212614|FG001|Overall Study|Adverse Event|4
1123597|NCT02620020|2212615|FG002|Overall Study|Adverse Event|3
1123598|NCT02620020|2212616|FG003|Overall Study|Adverse Event|5
1123599|NCT02620020|2212613|FG000|Overall Study|Lost to Follow-up|4
1123600|NCT02620020|2212614|FG001|Overall Study|Lost to Follow-up|8
1123601|NCT02620020|2212615|FG002|Overall Study|Lost to Follow-up|1
1123602|NCT02620020|2212616|FG003|Overall Study|Lost to Follow-up|4
1123603|NCT02620020|2212613|FG000|Overall Study|Physician Decision|7
1123604|NCT02620020|2212614|FG001|Overall Study|Physician Decision|4
1123605|NCT02620020|2212615|FG002|Overall Study|Physician Decision|3
1123606|NCT02620020|2212616|FG003|Overall Study|Physician Decision|4
1123607|NCT02620020|2212613|FG000|Overall Study|Protocol Violation|5
1123608|NCT02620020|2212614|FG001|Overall Study|Protocol Violation|2
1123609|NCT02620020|2212615|FG002|Overall Study|Protocol Violation|1
1123610|NCT02620020|2212616|FG003|Overall Study|Protocol Violation|1
1123611|NCT02620020|2212613|FG000|Overall Study|Withdrawal by Subject|20
1123612|NCT02620020|2212614|FG001|Overall Study|Withdrawal by Subject|16
1123613|NCT02620020|2212615|FG002|Overall Study|Withdrawal by Subject|17
1123614|NCT02620020|2212616|FG003|Overall Study|Withdrawal by Subject|12
1123615|NCT02620020|2212613|FG000|Overall Study|Death|0
1123616|NCT02620020|2212614|FG001|Overall Study|Death|1
1123617|NCT02620020|2212615|FG002|Overall Study|Death|0
1123618|NCT02620020|2212616|FG003|Overall Study|Death|0
1123619|NCT02620384|2212628|FG000|Overall Study|Adverse Event|2
1123620|NCT02620384|2212629|FG001|Overall Study|Adverse Event|1
1123621|NCT02620384|2212628|FG000|Overall Study|Discharged prior to 2nd dose|2
1123622|NCT02620384|2212629|FG001|Overall Study|Discharged prior to 2nd dose|5
1123623|NCT02620384|2212628|FG000|Overall Study|Drug shortage prevented 2nd dose|0
1123624|NCT02620384|2212629|FG001|Overall Study|Drug shortage prevented 2nd dose|1
1123625|NCT02620787|2212652|FG000|Overall Study|Adverse Event|1
1123626|NCT02620787|2212653|FG001|Overall Study|Adverse Event|0
1123627|NCT02620787|2212652|FG000|Overall Study|Eligibility Criteria Not Met|1
1123628|NCT02620787|2212653|FG001|Overall Study|Eligibility Criteria Not Met|0
1123629|NCT02621034|2212684|FG000|Overall Study|Lost to Follow-up|3
1123630|NCT02621034|2212685|FG001|Overall Study|Lost to Follow-up|2
1123631|NCT02621034|2212686|FG002|Overall Study|Lost to Follow-up|5
1123632|NCT02621047|2212699|FG000|Overall Study|Adverse Event|0
1123633|NCT02621047|2212700|FG001|Overall Study|Adverse Event|0
1123634|NCT02621047|2212701|FG002|Overall Study|Adverse Event|1
1123635|NCT02621073|2212721|FG000|Overall Study|Lost to Follow-up|0
1123636|NCT02621073|2212722|FG001|Overall Study|Lost to Follow-up|1
1123637|NCT02621073|2212721|FG000|Overall Study|Physician Decision|3
1123638|NCT02621073|2212722|FG001|Overall Study|Physician Decision|2
1123641|NCT02621606|2212744|FG000|Overall Study|Withdrawal by Subject|0
1123642|NCT02621606|2212745|FG001|Overall Study|Withdrawal by Subject|1
1123643|NCT02621606|2212746|FG002|Overall Study|Withdrawal by Subject|0
1123644|NCT02621931|2212775|FG000|Overall Study|Death|0
1123645|NCT02621931|2212776|FG001|Overall Study|Death|1
1123646|NCT02621931|2212777|FG002|Overall Study|Death|0
1123647|NCT02621931|2212775|FG000|Overall Study|Adverse Event|8
1123648|NCT02621931|2212776|FG001|Overall Study|Adverse Event|5
1123649|NCT02621931|2212777|FG002|Overall Study|Adverse Event|7
1123650|NCT02621931|2212775|FG000|Overall Study|Withdrawal by Subject|12
1123651|NCT02621931|2212776|FG001|Overall Study|Withdrawal by Subject|10
1123652|NCT02621931|2212777|FG002|Overall Study|Withdrawal by Subject|11
1123653|NCT02621931|2212775|FG000|Overall Study|Protocol Violation|2
1123654|NCT02621931|2212776|FG001|Overall Study|Protocol Violation|2
1123655|NCT02621931|2212777|FG002|Overall Study|Protocol Violation|2
1123656|NCT02621931|2212775|FG000|Overall Study|Pregnancy|2
1123657|NCT02621931|2212776|FG001|Overall Study|Pregnancy|0
1123658|NCT02621931|2212777|FG002|Overall Study|Pregnancy|0
1123659|NCT02621931|2212775|FG000|Overall Study|Noncompliance to study procedures|0
1123660|NCT02621931|2212776|FG001|Overall Study|Noncompliance to study procedures|1
1123661|NCT02621931|2212777|FG002|Overall Study|Noncompliance to study procedures|2
1123662|NCT02621931|2212775|FG000|Overall Study|Lost to Follow-up|8
1123663|NCT02621931|2212776|FG001|Overall Study|Lost to Follow-up|7
1123664|NCT02621931|2212777|FG002|Overall Study|Lost to Follow-up|10
1123665|NCT02621931|2212775|FG000|Overall Study|Lack of Efficacy|0
1123666|NCT02621931|2212776|FG001|Overall Study|Lack of Efficacy|0
1123667|NCT02621931|2212777|FG002|Overall Study|Lack of Efficacy|1
1123668|NCT02621931|2212775|FG000|Overall Study|Other|1
1123669|NCT02621931|2212776|FG001|Overall Study|Other|1
1123670|NCT02621931|2212777|FG002|Overall Study|Other|3
1123671|NCT02622074|2212802|FG000|Overall Study|Death|4
1123672|NCT02622074|2212803|FG001|Overall Study|Death|0
1123673|NCT02622074|2212804|FG002|Overall Study|Death|0
1123674|NCT02622074|2212805|FG003|Overall Study|Death|1
1123675|NCT02622074|2212806|FG004|Overall Study|Death|1
1123676|NCT02622074|2212807|FG005|Overall Study|Death|0
1123677|NCT02622074|2212802|FG000|Overall Study|Withdrawal by Subject|0
1123678|NCT02622074|2212803|FG001|Overall Study|Withdrawal by Subject|1
1123679|NCT02622074|2212804|FG002|Overall Study|Withdrawal by Subject|0
1123680|NCT02622074|2212805|FG003|Overall Study|Withdrawal by Subject|0
1123681|NCT02622074|2212806|FG004|Overall Study|Withdrawal by Subject|0
1123682|NCT02622074|2212807|FG005|Overall Study|Withdrawal by Subject|0
1123683|NCT02622113|2212823|FG000|Overall Study|Adverse Event|4
1123684|NCT02622113|2212824|FG001|Overall Study|Adverse Event|4
1123685|NCT02622113|2212823|FG000|Overall Study|Physician Decision|0
1123686|NCT02622113|2212824|FG001|Overall Study|Physician Decision|1
1123687|NCT02622113|2212823|FG000|Overall Study|Withdrawal by Subject|0
1123688|NCT02622113|2212824|FG001|Overall Study|Withdrawal by Subject|2
1123689|NCT02622113|2212823|FG000|Overall Study|Stopping Criteria|1
1123690|NCT02622113|2212824|FG001|Overall Study|Stopping Criteria|3
1123691|NCT02622321|2212858|FG000|Overall Study|Withdrawal by Subject|2
1123692|NCT02622321|2212859|FG001|Overall Study|Withdrawal by Subject|0
1123693|NCT02622321|2212860|FG002|Overall Study|Withdrawal by Subject|0
1123694|NCT02622321|2212861|FG003|Overall Study|Withdrawal by Subject|0
1123695|NCT02622321|2212858|FG000|Overall Study|Death|0
1123696|NCT02622321|2212859|FG001|Overall Study|Death|0
1123697|NCT02622321|2212860|FG002|Overall Study|Death|1
1123698|NCT02622321|2212861|FG003|Overall Study|Death|0
1123699|NCT02622321|2212858|FG000|Overall Study|Physician Decision|1
1123700|NCT02622321|2212859|FG001|Overall Study|Physician Decision|0
1123701|NCT02622321|2212860|FG002|Overall Study|Physician Decision|0
1123702|NCT02622321|2212861|FG003|Overall Study|Physician Decision|0
1123703|NCT02622568|2212887|FG000|Overall Study|Lost to Follow-up|5
1123704|NCT02622568|2212888|FG001|Overall Study|Lost to Follow-up|5
1123705|NCT02622724|2212896|FG000|Overall Study|Death|51
1123706|NCT02622724|2212897|FG001|Overall Study|Death|53
1123707|NCT02622724|2212896|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4
1123708|NCT02622724|2212897|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7
1123709|NCT02622724|2212896|FG000|Overall Study|Early termination of study|38
1123710|NCT02622724|2212897|FG001|Overall Study|Early termination of study|43
1123711|NCT02623322|2212933|FG000|Overall Study|Lost to Follow-up|2
1123712|NCT02623322|2212934|FG001|Overall Study|Lost to Follow-up|1
1123713|NCT02623322|2212935|FG002|Overall Study|Lost to Follow-up|0
1123714|NCT02623335|2212947|FG000|Overall Study|Death|8
1123715|NCT02623335|2212948|FG001|Overall Study|Death|7
1123716|NCT02623335|2212947|FG000|Overall Study|Lost to Follow-up|15
1123717|NCT02623335|2212948|FG001|Overall Study|Lost to Follow-up|23
1123718|NCT02623335|2212947|FG000|Overall Study|Withdrawal by Subject|2
1123719|NCT02623335|2212948|FG001|Overall Study|Withdrawal by Subject|5
1123720|NCT02623335|2212947|FG000|Overall Study|Protocol Violation|2
1123721|NCT02623335|2212948|FG001|Overall Study|Protocol Violation|1
1123722|NCT02623361|2212965|FG000|Overall Study|Protocol Violation|0
1123723|NCT02623361|2212966|FG001|Overall Study|Protocol Violation|1
1123724|NCT02623361|2212965|FG000|Overall Study|Withdrawal by Subject|0
1123725|NCT02623361|2212966|FG001|Overall Study|Withdrawal by Subject|1
1123726|NCT02623725|2212974|FG000|Overall Study|Non compliance with protocol|9
1123727|NCT02623725|2212975|FG001|Overall Study|Non compliance with protocol|3
1123728|NCT02623725|2212974|FG000|Overall Study|Serious adverse event|0
1123729|NCT02623725|2212975|FG001|Overall Study|Serious adverse event|2
1123730|NCT02623725|2212974|FG000|Overall Study|Withdrawal by Subject|7
1123731|NCT02623725|2212975|FG001|Overall Study|Withdrawal by Subject|1
1123732|NCT02623829|2212994|FG000|Overall Study|Lost to Follow-up|1
1123733|NCT02623829|2212995|FG001|Overall Study|Lost to Follow-up|1
1123734|NCT02624050|2213012|FG000|Overall Study|Physician Decision|4
1123735|NCT02624050|2213013|FG001|Overall Study|Physician Decision|0
1123736|NCT02624050|2213012|FG000|Overall Study|Protocol Violation|2
1123737|NCT02624050|2213013|FG001|Overall Study|Protocol Violation|0
1123738|NCT02624284|2213031|FG000|Overall Study|Withdrawal by Subject|3
1123739|NCT02624284|2213032|FG001|Overall Study|Withdrawal by Subject|6
1123740|NCT02624284|2213033|FG002|Overall Study|Withdrawal by Subject|3
1123741|NCT02624284|2213031|FG000|Overall Study|Protocol Violation|9
1123742|NCT02624284|2213032|FG001|Overall Study|Protocol Violation|10
1123743|NCT02624284|2213033|FG002|Overall Study|Protocol Violation|7
1123744|NCT02624284|2213031|FG000|Overall Study|Revealed exclusionary condition|2
1123745|NCT02624284|2213032|FG001|Overall Study|Revealed exclusionary condition|2
1123746|NCT02624284|2213033|FG002|Overall Study|Revealed exclusionary condition|0
1123747|NCT02624284|2213031|FG000|Overall Study|Adverse Event|0
1123748|NCT02624284|2213032|FG001|Overall Study|Adverse Event|0
1123749|NCT02624284|2213033|FG002|Overall Study|Adverse Event|1
1123750|NCT02624492|2213048|FG000|Overall Study|Adverse Event|2
1123751|NCT02624492|2213049|FG001|Overall Study|Adverse Event|2
1123752|NCT02624492|2213050|FG002|Overall Study|Adverse Event|2
1123753|NCT02624492|2213048|FG000|Overall Study|Progressive disease|0
1123754|NCT02624492|2213049|FG001|Overall Study|Progressive disease|2
1123755|NCT02624492|2213050|FG002|Overall Study|Progressive disease|3
1123756|NCT02624687|2213060|FG000|Overall Study|Withdrawal by Subject|1
1123757|NCT02624687|2213061|FG001|Overall Study|Withdrawal by Subject|1
1123758|NCT02624687|2213060|FG000|Overall Study|medical leave from work|0
1123759|NCT02624687|2213061|FG001|Overall Study|medical leave from work|1
1123760|NCT02624713|2213080|FG000|Overall Study|Lost to Follow-up|14
1123761|NCT02624713|2213081|FG001|Overall Study|Lost to Follow-up|0
1123762|NCT02624791|2213088|FG000|Overall Study|Withdrawal by Subject|2
1123763|NCT02624791|2213089|FG001|Overall Study|Withdrawal by Subject|0
1123764|NCT02624791|2213090|FG002|Overall Study|Withdrawal by Subject|0
1123765|NCT02624791|2213091|FG003|Overall Study|Withdrawal by Subject|0
1123766|NCT02624791|2213092|FG004|Overall Study|Withdrawal by Subject|0
1123767|NCT02624791|2213093|FG005|Overall Study|Withdrawal by Subject|0
1123768|NCT02624986|2213118|FG000|Overall Study|Death|0
1123769|NCT02624986|2213119|FG001|Overall Study|Death|1
1123770|NCT02624986|2213120|FG002|Overall Study|Death|2
1123771|NCT02624986|2213121|FG003|Overall Study|Death|2
1123772|NCT02624986|2213122|FG004|Overall Study|Death|2
1123773|NCT02624986|2213123|FG005|Overall Study|Death|0
1123774|NCT02624986|2213124|FG006|Overall Study|Death|0
1123775|NCT02624986|2213125|FG007|Overall Study|Death|1
1123776|NCT02624986|2213118|FG000|Overall Study|Study Terminated by Sponsor|1
1123777|NCT02624986|2213119|FG001|Overall Study|Study Terminated by Sponsor|1
1123778|NCT02624986|2213120|FG002|Overall Study|Study Terminated by Sponsor|0
1123779|NCT02624986|2213121|FG003|Overall Study|Study Terminated by Sponsor|1
1123780|NCT02624986|2213122|FG004|Overall Study|Study Terminated by Sponsor|2
1123781|NCT02624986|2213123|FG005|Overall Study|Study Terminated by Sponsor|2
1123782|NCT02624986|2213124|FG006|Overall Study|Study Terminated by Sponsor|4
1123783|NCT02624986|2213125|FG007|Overall Study|Study Terminated by Sponsor|3
1123784|NCT02624986|2213118|FG000|Overall Study|Progressive Disease|0
1123785|NCT02624986|2213119|FG001|Overall Study|Progressive Disease|1
1123786|NCT02624986|2213120|FG002|Overall Study|Progressive Disease|0
1123787|NCT02624986|2213121|FG003|Overall Study|Progressive Disease|0
1123788|NCT02624986|2213122|FG004|Overall Study|Progressive Disease|0
1123789|NCT02624986|2213123|FG005|Overall Study|Progressive Disease|0
1123790|NCT02624986|2213124|FG006|Overall Study|Progressive Disease|0
1123791|NCT02624986|2213125|FG007|Overall Study|Progressive Disease|0
1123792|NCT02624986|2213118|FG000|Overall Study|Protocol Violation|1
1123793|NCT02624986|2213119|FG001|Overall Study|Protocol Violation|0
1123794|NCT02624986|2213120|FG002|Overall Study|Protocol Violation|0
1123795|NCT02624986|2213121|FG003|Overall Study|Protocol Violation|0
1123796|NCT02624986|2213122|FG004|Overall Study|Protocol Violation|0
1123797|NCT02624986|2213123|FG005|Overall Study|Protocol Violation|0
1123798|NCT02624986|2213124|FG006|Overall Study|Protocol Violation|0
1123799|NCT02624986|2213125|FG007|Overall Study|Protocol Violation|0
1123800|NCT02624986|2213118|FG000|Overall Study|Withdrawal by Subject|0
1123801|NCT02624986|2213119|FG001|Overall Study|Withdrawal by Subject|0
1123802|NCT02624986|2213120|FG002|Overall Study|Withdrawal by Subject|0
1123803|NCT02624986|2213121|FG003|Overall Study|Withdrawal by Subject|0
1123804|NCT02624986|2213122|FG004|Overall Study|Withdrawal by Subject|0
1123805|NCT02624986|2213123|FG005|Overall Study|Withdrawal by Subject|0
1123806|NCT02624986|2213124|FG006|Overall Study|Withdrawal by Subject|0
1123807|NCT02624986|2213125|FG007|Overall Study|Withdrawal by Subject|1
1123808|NCT02625220|2213181|FG000|Overall Study|Adverse Event|2
1123809|NCT02625220|2213181|FG000|Overall Study|Lost to Follow-up|2
1123810|NCT02625220|2213181|FG000|Overall Study|Protocol Violation|1
1123811|NCT02625220|2213181|FG000|Overall Study|Study discontinued at site|2
1123812|NCT02625233|2213187|FG000|Overall Study|Adverse Event|2
1123813|NCT02625233|2213188|FG001|Overall Study|Adverse Event|0
1123814|NCT02625259|2213199|FG000|First Intervention (Day 1)|Other|0
1123815|NCT02625259|2213200|FG001|First Intervention (Day 1)|Other|0
1123816|NCT02625259|2213201|FG002|First Intervention (Day 1)|Other|1
1123817|NCT02625259|2213202|FG003|First Intervention (Day 1)|Other|0
1123818|NCT02625259|2213203|FG004|First Intervention (Day 1)|Other|0
1123819|NCT02625259|2213199|FG000|First Intervention (Day 1)|Adverse Event|2
1123820|NCT02625259|2213200|FG001|First Intervention (Day 1)|Adverse Event|1
1123821|NCT02625259|2213201|FG002|First Intervention (Day 1)|Adverse Event|0
1123822|NCT02625259|2213202|FG003|First Intervention (Day 1)|Adverse Event|0
1123823|NCT02625259|2213203|FG004|First Intervention (Day 1)|Adverse Event|0
1123824|NCT02625259|2213199|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
1123825|NCT02625259|2213200|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
1123826|NCT02625259|2213201|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
1123827|NCT02625259|2213202|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
1123828|NCT02625259|2213203|FG004|First Intervention (Day 1)|Withdrawal by Subject|0
1123829|NCT02625324|2213229|FG000|30-Day Follow-up for Primary Endpoint|Death|1
1123830|NCT02625324|2213229|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
1123831|NCT02625324|2213229|FG000|6-Month Follow-up Subject Accountability|Death|5
1123832|NCT02625324|2213229|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
1123833|NCT02625324|2213229|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
1123834|NCT02625324|2213229|FG000|12-Month Follow-up Secondary Endpoint|Death|4
1123835|NCT02625324|2213229|FG000|24-Month Follow-up Secondary Endpoint|Death|2
1123836|NCT02625324|2213229|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
1123837|NCT02625324|2213229|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
1123838|NCT02625324|2213229|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28
1123839|NCT02625610|2213267|FG000|Overall Study|Ongoing|34
1123840|NCT02625610|2213268|FG001|Overall Study|Ongoing|54
1123841|NCT02625623|2213276|FG000|Overall Study|Participants randomized but not treated|9
1123842|NCT02625623|2213277|FG001|Overall Study|Participants randomized but not treated|1
1123843|NCT02625909|2213291|FG000|Overall Study|Death|2
1123844|NCT02625909|2213292|FG001|Overall Study|Death|0
1123845|NCT02625909|2213291|FG000|Overall Study|Lost to Follow-up|3
1123846|NCT02625909|2213292|FG001|Overall Study|Lost to Follow-up|5
1123847|NCT02625909|2213291|FG000|Overall Study|Lack of Efficacy|9
1123848|NCT02625909|2213292|FG001|Overall Study|Lack of Efficacy|2
1123849|NCT02625909|2213291|FG000|Overall Study|Reinfection|3
1123850|NCT02625909|2213292|FG001|Overall Study|Reinfection|2
1123851|NCT02625922|2213300|FG000|Overall Study|Non-availability of IMP|1
1123852|NCT02625922|2213301|FG001|Overall Study|Non-availability of IMP|1
1123853|NCT02625922|2213300|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1
1123854|NCT02625922|2213301|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1
1123855|NCT02625974|2213312|FG000|Overall Study|Adverse Event|12
1123856|NCT02625974|2213313|FG001|Overall Study|Adverse Event|2
1123857|NCT02625974|2213312|FG000|Overall Study|Withdrawal by Subject|3
1123858|NCT02625974|2213313|FG001|Overall Study|Withdrawal by Subject|1
1123859|NCT02625974|2213312|FG000|Overall Study|positive parasitemia|1
1123860|NCT02625974|2213313|FG001|Overall Study|positive parasitemia|0
1123861|NCT02625974|2213312|FG000|Overall Study|non-compliance with study drug|0
1123862|NCT02625974|2213313|FG001|Overall Study|non-compliance with study drug|2
1123863|NCT02625974|2213312|FG000|Overall Study|Protocol Violation|0
1123864|NCT02625974|2213313|FG001|Overall Study|Protocol Violation|1
1123865|NCT02626000|2213355|FG000|Overall Study|Decision by Sponsor|1
1123866|NCT02626000|2213355|FG000|Overall Study|Death|29
1123867|NCT02626026|2213366|FG000|Overall Study|Randomized but Never Treated|0
1123868|NCT02626026|2213367|FG001|Overall Study|Randomized but Never Treated|0
1123869|NCT02626026|2213368|FG002|Overall Study|Randomized but Never Treated|0
1123870|NCT02626026|2213369|FG003|Overall Study|Randomized but Never Treated|0
1123871|NCT02626026|2213370|FG004|Overall Study|Randomized but Never Treated|1
1123872|NCT02626026|2213371|FG005|Overall Study|Randomized but Never Treated|0
1123873|NCT02626182|2213412|FG000|Overall Study|Adverse Event|2
1123874|NCT02626182|2213413|FG001|Overall Study|Adverse Event|0
1123875|NCT02626780|2213439|FG000|Overall Study|Withdrawal by Subject|3
1123876|NCT02626819|2213445|FG000|Overall Study|Lost to Follow-up|3
1123877|NCT02626819|2213446|FG001|Overall Study|Lost to Follow-up|2
1123878|NCT02626819|2213445|FG000|Overall Study|Withdrawal by Subject|1
1123879|NCT02626819|2213446|FG001|Overall Study|Withdrawal by Subject|0
1123880|NCT02626819|2213445|FG000|Overall Study|Diagnosed w/ catastrophic illness|0
1123881|NCT02626819|2213446|FG001|Overall Study|Diagnosed w/ catastrophic illness|1
1123882|NCT02627144|2213483|FG000|Overall Study|Serious adverse event|32
1123883|NCT02627144|2213483|FG000|Overall Study|Cancer progression|171
1123884|NCT02627144|2213483|FG000|Overall Study|Death from cancer|20
1123885|NCT02627144|2213483|FG000|Overall Study|Death from other cause|8
1123886|NCT02627144|2213483|FG000|Overall Study|Refusal of treatment / poor cooperation|38
1123887|NCT02627144|2213483|FG000|Overall Study|Administrative reasons|65
1123888|NCT02627144|2213483|FG000|Overall Study|Lost to Follow-up|8
1123889|NCT02627144|2213483|FG000|Overall Study|Enrolled, not treated|6
1123890|NCT02627144|2213483|FG000|Overall Study|Other|17
1123891|NCT02627495|2213487|FG000|Overall Study|Withdrawal by Subject|4
1123892|NCT02627677|2213494|FG000|Overall Study|Adverse event (not progressive disease)|1
1123893|NCT02627677|2213495|FG001|Overall Study|Adverse event (not progressive disease)|4
1123894|NCT02627677|2213496|FG002|Overall Study|Adverse event (not progressive disease)|1
1123895|NCT02627677|2213494|FG000|Overall Study|Progressive disease|1
1123896|NCT02627677|2213495|FG001|Overall Study|Progressive disease|3
1123897|NCT02627677|2213496|FG002|Overall Study|Progressive disease|0
1123898|NCT02627677|2213494|FG000|Overall Study|Lack of Efficacy|1
1123899|NCT02627677|2213495|FG001|Overall Study|Lack of Efficacy|2
1123900|NCT02627677|2213496|FG002|Overall Study|Lack of Efficacy|0
1123901|NCT02627677|2213494|FG000|Overall Study|Lost to Follow-up|0
1123902|NCT02627677|2213495|FG001|Overall Study|Lost to Follow-up|0
1123903|NCT02627677|2213496|FG002|Overall Study|Lost to Follow-up|1
1123904|NCT02627677|2213494|FG000|Overall Study|Pregnancy|0
1123905|NCT02627677|2213495|FG001|Overall Study|Pregnancy|1
1123906|NCT02627677|2213496|FG002|Overall Study|Pregnancy|0
1123907|NCT02627677|2213494|FG000|Overall Study|Study Terminated by Sponsor|5
1123908|NCT02627677|2213495|FG001|Overall Study|Study Terminated by Sponsor|10
1123909|NCT02627677|2213496|FG002|Overall Study|Study Terminated by Sponsor|6
1123910|NCT02627677|2213494|FG000|Overall Study|Physician Decision|0
1123911|NCT02627677|2213495|FG001|Overall Study|Physician Decision|0
1123912|NCT02627677|2213496|FG002|Overall Study|Physician Decision|2
1123913|NCT02627677|2213494|FG000|Overall Study|Withdrawal by Subject|2
1123914|NCT02627677|2213495|FG001|Overall Study|Withdrawal by Subject|1
1123915|NCT02627677|2213496|FG002|Overall Study|Withdrawal by Subject|1
1123916|NCT02627677|2213494|FG000|Overall Study|Reason not Specified|0
1123917|NCT02627677|2213495|FG001|Overall Study|Reason not Specified|0
1123918|NCT02627677|2213496|FG002|Overall Study|Reason not Specified|1
1123919|NCT02627677|2213494|FG000|Overall Study|Randomized but not Treated|1
1123920|NCT02627677|2213495|FG001|Overall Study|Randomized but not Treated|0
1123921|NCT02627677|2213496|FG002|Overall Study|Randomized but not Treated|0
1123922|NCT02628028|2213536|FG000|Dosing Period|Withdrawal by Subject|0
1123923|NCT02628028|2213537|FG001|Dosing Period|Withdrawal by Subject|0
1123924|NCT02628028|2213538|FG002|Dosing Period|Withdrawal by Subject|1
1123925|NCT02628028|2213539|FG003|Dosing Period|Withdrawal by Subject|0
1123926|NCT02628028|2213540|FG004|Dosing Period|Withdrawal by Subject|2
1123927|NCT02628028|2213541|FG005|Dosing Period|Withdrawal by Subject|4
1123928|NCT02628028|2213542|FG006|Dosing Period|Withdrawal by Subject|1
1123929|NCT02628028|2213543|FG007|Dosing Period|Withdrawal by Subject|1
1123930|NCT02628028|2213536|FG000|Dosing Period|Adverse Event|0
1123931|NCT02628028|2213537|FG001|Dosing Period|Adverse Event|0
1123932|NCT02628028|2213538|FG002|Dosing Period|Adverse Event|0
1123933|NCT02628028|2213539|FG003|Dosing Period|Adverse Event|0
1123934|NCT02628028|2213540|FG004|Dosing Period|Adverse Event|2
1123935|NCT02628028|2213541|FG005|Dosing Period|Adverse Event|1
1123936|NCT02628028|2213542|FG006|Dosing Period|Adverse Event|3
1123937|NCT02628028|2213543|FG007|Dosing Period|Adverse Event|2
1123938|NCT02628028|2213536|FG000|Dosing Period|Death|0
1123939|NCT02628028|2213537|FG001|Dosing Period|Death|0
1123940|NCT02628028|2213538|FG002|Dosing Period|Death|0
1123941|NCT02628028|2213539|FG003|Dosing Period|Death|0
1123942|NCT02628028|2213540|FG004|Dosing Period|Death|0
1123943|NCT02628028|2213541|FG005|Dosing Period|Death|0
1123944|NCT02628028|2213542|FG006|Dosing Period|Death|0
1123945|NCT02628028|2213543|FG007|Dosing Period|Death|1
1123946|NCT02628028|2213536|FG000|Dosing Period|Lack of Efficacy|0
1123947|NCT02628028|2213537|FG001|Dosing Period|Lack of Efficacy|0
1123948|NCT02628028|2213538|FG002|Dosing Period|Lack of Efficacy|0
1123949|NCT02628028|2213539|FG003|Dosing Period|Lack of Efficacy|0
1123950|NCT02628028|2213540|FG004|Dosing Period|Lack of Efficacy|3
1123951|NCT02628028|2213541|FG005|Dosing Period|Lack of Efficacy|0
1123952|NCT02628028|2213542|FG006|Dosing Period|Lack of Efficacy|1
1123953|NCT02628028|2213543|FG007|Dosing Period|Lack of Efficacy|0
1123954|NCT02628028|2213536|FG000|Dosing Period|Study Terminated by Sponsor|0
1123955|NCT02628028|2213537|FG001|Dosing Period|Study Terminated by Sponsor|0
1123956|NCT02628028|2213538|FG002|Dosing Period|Study Terminated by Sponsor|0
1123957|NCT02628028|2213539|FG003|Dosing Period|Study Terminated by Sponsor|0
1123958|NCT02628028|2213540|FG004|Dosing Period|Study Terminated by Sponsor|7
1123959|NCT02628028|2213541|FG005|Dosing Period|Study Terminated by Sponsor|6
1123960|NCT02628028|2213542|FG006|Dosing Period|Study Terminated by Sponsor|7
1123961|NCT02628028|2213543|FG007|Dosing Period|Study Terminated by Sponsor|7
1123962|NCT02628028|2213536|FG000|Dosing Period|Physician Decision|0
1123963|NCT02628028|2213537|FG001|Dosing Period|Physician Decision|0
1123964|NCT02628028|2213538|FG002|Dosing Period|Physician Decision|0
1123965|NCT02628028|2213539|FG003|Dosing Period|Physician Decision|0
1123966|NCT02628028|2213540|FG004|Dosing Period|Physician Decision|0
1123967|NCT02628028|2213541|FG005|Dosing Period|Physician Decision|1
1123968|NCT02628028|2213542|FG006|Dosing Period|Physician Decision|0
1123969|NCT02628028|2213543|FG007|Dosing Period|Physician Decision|0
1123970|NCT02628028|2213536|FG000|Dosing Period|Site Terminated by Sponsor|0
1123971|NCT02628028|2213537|FG001|Dosing Period|Site Terminated by Sponsor|0
1123972|NCT02628028|2213538|FG002|Dosing Period|Site Terminated by Sponsor|0
1123973|NCT02628028|2213539|FG003|Dosing Period|Site Terminated by Sponsor|0
1123974|NCT02628028|2213540|FG004|Dosing Period|Site Terminated by Sponsor|0
1123975|NCT02628028|2213541|FG005|Dosing Period|Site Terminated by Sponsor|1
1123976|NCT02628028|2213542|FG006|Dosing Period|Site Terminated by Sponsor|1
1123977|NCT02628028|2213543|FG007|Dosing Period|Site Terminated by Sponsor|0
1123978|NCT02628028|2213536|FG000|Dosing Period|Lost to Follow-up|0
1123979|NCT02628028|2213537|FG001|Dosing Period|Lost to Follow-up|0
1123980|NCT02628028|2213538|FG002|Dosing Period|Lost to Follow-up|0
1123981|NCT02628028|2213539|FG003|Dosing Period|Lost to Follow-up|0
1123982|NCT02628028|2213540|FG004|Dosing Period|Lost to Follow-up|0
1123983|NCT02628028|2213541|FG005|Dosing Period|Lost to Follow-up|0
1123984|NCT02628028|2213542|FG006|Dosing Period|Lost to Follow-up|1
1123985|NCT02628028|2213543|FG007|Dosing Period|Lost to Follow-up|0
1123986|NCT02628028|2213536|FG000|Dosing Period|Other|0
1123987|NCT02628028|2213537|FG001|Dosing Period|Other|0
1123988|NCT02628028|2213538|FG002|Dosing Period|Other|0
1123989|NCT02628028|2213539|FG003|Dosing Period|Other|0
1123990|NCT02628028|2213540|FG004|Dosing Period|Other|2
1123991|NCT02628028|2213541|FG005|Dosing Period|Other|1
1123992|NCT02628028|2213542|FG006|Dosing Period|Other|2
1123993|NCT02628028|2213543|FG007|Dosing Period|Other|4
1123994|NCT02628028|2213536|FG000|Long-term Extension (LTE) Period|Adverse Event|0
1123995|NCT02628028|2213537|FG001|Long-term Extension (LTE) Period|Adverse Event|0
1123996|NCT02628028|2213538|FG002|Long-term Extension (LTE) Period|Adverse Event|0
1123997|NCT02628028|2213539|FG003|Long-term Extension (LTE) Period|Adverse Event|0
1123998|NCT02628028|2213540|FG004|Long-term Extension (LTE) Period|Adverse Event|0
1123999|NCT02628028|2213541|FG005|Long-term Extension (LTE) Period|Adverse Event|1
1124000|NCT02628028|2213542|FG006|Long-term Extension (LTE) Period|Adverse Event|0
1124001|NCT02628028|2213543|FG007|Long-term Extension (LTE) Period|Adverse Event|3
1124002|NCT02628028|2213536|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0
1124003|NCT02628028|2213537|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0
1124004|NCT02628028|2213538|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0
1124005|NCT02628028|2213539|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0
1124006|NCT02628028|2213540|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0
1124007|NCT02628028|2213541|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2
1124008|NCT02628028|2213542|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0
1124009|NCT02628028|2213543|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1
1124010|NCT02628028|2213536|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
1124011|NCT02628028|2213537|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
1124012|NCT02628028|2213538|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
1124013|NCT02628028|2213539|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
1124014|NCT02628028|2213540|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
1124015|NCT02628028|2213541|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
1124016|NCT02628028|2213542|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
1124017|NCT02628028|2213543|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
1124018|NCT02628028|2213536|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0
1124019|NCT02628028|2213537|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0
1124020|NCT02628028|2213538|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0
1124021|NCT02628028|2213539|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0
1124022|NCT02628028|2213540|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0
1124023|NCT02628028|2213541|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2
1124024|NCT02628028|2213542|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3
1124025|NCT02628028|2213543|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3
1124026|NCT02628028|2213536|FG000|Long-term Extension (LTE) Period|Other|0
1124027|NCT02628028|2213537|FG001|Long-term Extension (LTE) Period|Other|0
1124028|NCT02628028|2213538|FG002|Long-term Extension (LTE) Period|Other|0
1124029|NCT02628028|2213539|FG003|Long-term Extension (LTE) Period|Other|0
1124030|NCT02628028|2213540|FG004|Long-term Extension (LTE) Period|Other|0
1124031|NCT02628028|2213541|FG005|Long-term Extension (LTE) Period|Other|3
1124032|NCT02628028|2213542|FG006|Long-term Extension (LTE) Period|Other|4
1124033|NCT02628028|2213543|FG007|Long-term Extension (LTE) Period|Other|3
1124034|NCT02628418|2213593|FG000|Overall Study|Lost to Follow-up|1
1124035|NCT02628418|2213594|FG001|Overall Study|Lost to Follow-up|2
1124036|NCT02628444|2213609|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1
1124037|NCT02628444|2213610|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
1124038|NCT02628444|2213611|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
1124039|NCT02628444|2213612|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
1124040|NCT02628444|2213613|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
1124041|NCT02628444|2213614|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
1124042|NCT02628444|2213615|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
1124043|NCT02628444|2213616|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
1124044|NCT02628444|2213617|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
1124045|NCT02628444|2213609|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
1124046|NCT02628444|2213610|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4
1124047|NCT02628444|2213611|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3
1124048|NCT02628444|2213612|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
1124049|NCT02628444|2213613|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
1124050|NCT02628444|2213614|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
1124051|NCT02628444|2213615|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
1124052|NCT02628444|2213616|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
1124053|NCT02628444|2213617|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
1124054|NCT02628444|2213609|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21
1124055|NCT02628444|2213610|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16
1124056|NCT02628444|2213611|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25
1124057|NCT02628444|2213612|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
1124058|NCT02628444|2213613|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
1124059|NCT02628444|2213614|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
1124060|NCT02628444|2213615|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
1124061|NCT02628444|2213616|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
1124062|NCT02628444|2213617|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
1124063|NCT02628444|2213609|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
1124064|NCT02628444|2213610|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16
1124065|NCT02628444|2213611|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
1124066|NCT02628444|2213612|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
1124067|NCT02628444|2213613|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
1124068|NCT02628444|2213614|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
1124069|NCT02628444|2213615|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
1124070|NCT02628444|2213616|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
1124071|NCT02628444|2213617|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
1124072|NCT02628444|2213609|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
1124073|NCT02628444|2213610|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3
1124074|NCT02628444|2213611|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
898522|NCT00716274|1871040|FG004|Study Period III (16-Weeks)|Physician Decision|1
898523|NCT00716274|1871041|FG005|Study Period III (16-Weeks)|Physician Decision|0
898524|NCT00716274|1871036|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0
898525|NCT00716274|1871037|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0
898526|NCT00716274|1871038|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0
898527|NCT00716274|1871039|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1
898528|NCT00716274|1871040|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1
898529|NCT00716274|1871041|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0
898530|NCT00716274|1871036|FG000|Study Period III (16-Weeks)|Adverse Event|0
898531|NCT00716274|1871037|FG001|Study Period III (16-Weeks)|Adverse Event|0
898532|NCT00716274|1871038|FG002|Study Period III (16-Weeks)|Adverse Event|0
898533|NCT00716274|1871039|FG003|Study Period III (16-Weeks)|Adverse Event|0
898534|NCT00716274|1871040|FG004|Study Period III (16-Weeks)|Adverse Event|1
898535|NCT00716274|1871041|FG005|Study Period III (16-Weeks)|Adverse Event|0
898536|NCT00716417|1871068|FG000|Overall Study|Adverse Event|0
898537|NCT00716417|1871069|FG001|Overall Study|Adverse Event|0
898538|NCT00716417|1871070|FG002|Overall Study|Adverse Event|2
1124075|NCT02628444|2213612|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
1124076|NCT02628444|2213613|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
1124077|NCT02628444|2213614|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
1124078|NCT02628444|2213615|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
1124079|NCT02628444|2213616|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
1124080|NCT02628444|2213617|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
1124081|NCT02628444|2213609|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
1124082|NCT02628444|2213610|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
1124083|NCT02628444|2213611|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
1124084|NCT02628444|2213612|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1
1124085|NCT02628444|2213613|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
1124086|NCT02628444|2213614|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
1124087|NCT02628444|2213615|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
1124088|NCT02628444|2213616|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
1124089|NCT02628444|2213617|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
1124090|NCT02628444|2213609|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
1124091|NCT02628444|2213610|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
1124092|NCT02628444|2213611|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
1124093|NCT02628444|2213612|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
1124094|NCT02628444|2213613|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
1124095|NCT02628444|2213614|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
1124096|NCT02628444|2213615|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81
1124097|NCT02628444|2213616|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84
1124098|NCT02628444|2213617|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85
1124099|NCT02628444|2213609|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
1124100|NCT02628444|2213610|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
1124101|NCT02628444|2213611|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
1124102|NCT02628444|2213612|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5
1124103|NCT02628444|2213613|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6
1124104|NCT02628444|2213614|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10
1124105|NCT02628444|2213615|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12
1124106|NCT02628444|2213616|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11
1124107|NCT02628444|2213617|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9
1124108|NCT02628444|2213609|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
1124109|NCT02628444|2213610|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
1124110|NCT02628444|2213611|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
1124111|NCT02628444|2213612|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
1124112|NCT02628444|2213613|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
1124113|NCT02628444|2213614|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
1124114|NCT02628444|2213615|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
1124115|NCT02628444|2213616|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2
1124116|NCT02628444|2213617|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
1124117|NCT02628444|2213609|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
1124118|NCT02628444|2213610|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
1124119|NCT02628444|2213611|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
1124120|NCT02628444|2213612|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
1124121|NCT02628444|2213613|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
1124122|NCT02628444|2213614|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
1124123|NCT02628444|2213615|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3
1124124|NCT02628444|2213616|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
1124125|NCT02628444|2213617|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
1124126|NCT02628600|2213644|FG000|Overall Study|Death|2
1124127|NCT02628600|2213645|FG001|Overall Study|Death|1
1124128|NCT02628600|2213644|FG000|Overall Study|Adverse Event|3
1124129|NCT02628600|2213645|FG001|Overall Study|Adverse Event|20
1124130|NCT02628600|2213644|FG000|Overall Study|Protocol Violation|0
1124131|NCT02628600|2213645|FG001|Overall Study|Protocol Violation|1
1124132|NCT02628600|2213644|FG000|Overall Study|Lack of Efficacy|2
1124133|NCT02628600|2213645|FG001|Overall Study|Lack of Efficacy|0
1124134|NCT02628600|2213644|FG000|Overall Study|Withdrawal by Subject|13
1124135|NCT02628600|2213645|FG001|Overall Study|Withdrawal by Subject|8
1124136|NCT02628600|2213644|FG000|Overall Study|Lost to Follow-up|1
1124137|NCT02628600|2213645|FG001|Overall Study|Lost to Follow-up|0
1124138|NCT02628600|2213644|FG000|Overall Study|Physician Decision|2
1124139|NCT02628600|2213645|FG001|Overall Study|Physician Decision|2
1124140|NCT02628600|2213644|FG000|Overall Study|Other not specified|1
898539|NCT00716417|1871071|FG003|Overall Study|Adverse Event|1
898540|NCT00716417|1871072|FG004|Overall Study|Adverse Event|0
898541|NCT00716417|1871073|FG005|Overall Study|Adverse Event|0
898542|NCT00716417|1871074|FG006|Overall Study|Adverse Event|3
898543|NCT00716417|1871075|FG007|Overall Study|Adverse Event|1
1124141|NCT02628600|2213645|FG001|Overall Study|Other not specified|0
1124142|NCT02628743|2213651|FG000|Overall Study|Other|3
1124143|NCT02628743|2213651|FG000|Overall Study|Withdrawal by Subject|50
1124144|NCT02628743|2213651|FG000|Overall Study|Study Terminated by Sponsor|76
1124145|NCT02628743|2213651|FG000|Overall Study|Physician Decision|2
1124146|NCT02628769|2213655|FG000|First Intervention|Adverse Event|1
1124147|NCT02628769|2213656|FG001|First Intervention|Adverse Event|0
1124148|NCT02628769|2213655|FG000|First Intervention|Withdrawal by Subject|0
1124149|NCT02628769|2213656|FG001|First Intervention|Withdrawal by Subject|1
1124150|NCT02628769|2213655|FG000|Second Intervention|Adverse Event|2
898544|NCT00716417|1871076|FG008|Overall Study|Adverse Event|0
898545|NCT00716417|1871077|FG009|Overall Study|Adverse Event|3
898546|NCT00716417|1871068|FG000|Overall Study|Withdrawal by Subject|0
898547|NCT00716417|1871069|FG001|Overall Study|Withdrawal by Subject|1
898548|NCT00716417|1871070|FG002|Overall Study|Withdrawal by Subject|0
898549|NCT00716417|1871071|FG003|Overall Study|Withdrawal by Subject|2
898550|NCT00716417|1871072|FG004|Overall Study|Withdrawal by Subject|0
898551|NCT00716417|1871073|FG005|Overall Study|Withdrawal by Subject|0
898552|NCT00716417|1871074|FG006|Overall Study|Withdrawal by Subject|1
898553|NCT00716417|1871075|FG007|Overall Study|Withdrawal by Subject|0
898554|NCT00716417|1871076|FG008|Overall Study|Withdrawal by Subject|0
898555|NCT00716417|1871077|FG009|Overall Study|Withdrawal by Subject|0
898556|NCT00716417|1871068|FG000|Overall Study|Progressive disease|3
1124151|NCT02628769|2213656|FG001|Second Intervention|Adverse Event|0
1124152|NCT02628769|2213655|FG000|Second Intervention|Physician Decision|0
1124153|NCT02628769|2213656|FG001|Second Intervention|Physician Decision|1
1124154|NCT02628873|2213664|FG000|Break (1 Hour)|Withdrawal by Subject|0
1124155|NCT02628873|2213665|FG001|Break (1 Hour)|Withdrawal by Subject|1
1124156|NCT02628873|2213664|FG000|Second Test (1 Hour)|Physician Decision|1
1124157|NCT02628873|2213665|FG001|Second Test (1 Hour)|Physician Decision|0
1124158|NCT02628938|2213674|FG000|Overall Study|Did not attend the follow up recall|2
1124159|NCT02628938|2213675|FG001|Overall Study|Did not attend the follow up recall|2
1124160|NCT02628938|2213676|FG002|Overall Study|Did not attend the follow up recall|1
1124161|NCT02628938|2213674|FG000|Overall Study|Failure to comply with the instructions|3
1124162|NCT02628938|2213675|FG001|Overall Study|Failure to comply with the instructions|0
1124163|NCT02628938|2213676|FG002|Overall Study|Failure to comply with the instructions|3
1124164|NCT02629133|2213699|FG000|Overall Study|Lost to Follow-up|3
1124165|NCT02629133|2213700|FG001|Overall Study|Lost to Follow-up|1
1124166|NCT02629133|2213699|FG000|Overall Study|Withdrawal by Subject|1
1124167|NCT02629133|2213700|FG001|Overall Study|Withdrawal by Subject|1
1124183|NCT02629822|2213731|FG000|Base Study|Lost to Follow-up|2
1124184|NCT02629822|2213731|FG000|Base Study|Non-Compliance With Study Drug|1
1124185|NCT02629822|2213731|FG000|Extension Study|Adverse Event|1
1124186|NCT02629822|2213731|FG000|Extension Study|Lost to Follow-up|1
1124187|NCT02629861|2213739|FG000|Overall Study|Adverse Event|7
1124188|NCT02629861|2213740|FG001|Overall Study|Adverse Event|5
1124189|NCT02629861|2213741|FG002|Overall Study|Adverse Event|4
1124190|NCT02629861|2213739|FG000|Overall Study|Withdrawal by Subject|5
1124191|NCT02629861|2213740|FG001|Overall Study|Withdrawal by Subject|8
1124192|NCT02629861|2213741|FG002|Overall Study|Withdrawal by Subject|13
1124193|NCT02629861|2213739|FG000|Overall Study|Protocol Violation|2
1124194|NCT02629861|2213740|FG001|Overall Study|Protocol Violation|3
1124195|NCT02629861|2213741|FG002|Overall Study|Protocol Violation|7
1124196|NCT02629861|2213739|FG000|Overall Study|Lost to Follow-up|12
1124197|NCT02629861|2213740|FG001|Overall Study|Lost to Follow-up|9
1124198|NCT02629861|2213741|FG002|Overall Study|Lost to Follow-up|4
1124199|NCT02629861|2213739|FG000|Overall Study|Other|1
1124200|NCT02629861|2213740|FG001|Overall Study|Other|1
1124201|NCT02629861|2213741|FG002|Overall Study|Other|0
1124202|NCT02629861|2213739|FG000|Overall Study|Pregnancy|2
1124203|NCT02629861|2213740|FG001|Overall Study|Pregnancy|1
1124204|NCT02629861|2213741|FG002|Overall Study|Pregnancy|0
1124205|NCT02629965|2213749|FG000|Period 1|Adverse Event|1
1124206|NCT02629965|2213750|FG001|Period 1|Adverse Event|0
1124207|NCT02629965|2213749|FG000|Period 1|Unexpected worsening of disease|2
1124208|NCT02629965|2213750|FG001|Period 1|Unexpected worsening of disease|0
1124209|NCT02629965|2213749|FG000|Period 1|Other than listed above|1
898557|NCT00716417|1871069|FG001|Overall Study|Progressive disease|5
1124210|NCT02629965|2213750|FG001|Period 1|Other than listed above|2
1124211|NCT02629965|2213749|FG000|Period 2|Adverse Event|1
1124212|NCT02629965|2213750|FG001|Period 2|Adverse Event|0
1124213|NCT02630186|2213787|FG000|Overall Study|Withdrawal by Subject|1
1124214|NCT02630251|2213795|FG000|Overall Study|Physician Decision|0
1124215|NCT02630251|2213796|FG001|Overall Study|Physician Decision|0
1124216|NCT02630251|2213797|FG002|Overall Study|Physician Decision|1
1124217|NCT02630251|2213798|FG003|Overall Study|Physician Decision|0
1124218|NCT02630459|2213821|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
1124219|NCT02630459|2213822|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1
1124220|NCT02630459|2213823|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
1124221|NCT02630459|2213824|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2
1124222|NCT02630459|2213825|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
1124223|NCT02630459|2213826|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
1162079|NCT03382899|2284097|FG000|Overall Study|Sponsor's decision|31
898558|NCT00716417|1871070|FG002|Overall Study|Progressive disease|3
898559|NCT00716417|1871071|FG003|Overall Study|Progressive disease|8
898560|NCT00716417|1871072|FG004|Overall Study|Progressive disease|0
898561|NCT00716417|1871073|FG005|Overall Study|Progressive disease|3
898562|NCT00716417|1871074|FG006|Overall Study|Progressive disease|3
898563|NCT00716417|1871075|FG007|Overall Study|Progressive disease|1
898564|NCT00716417|1871076|FG008|Overall Study|Progressive disease|5
898565|NCT00716417|1871077|FG009|Overall Study|Progressive disease|0
898566|NCT00716417|1871068|FG000|Overall Study|Dose limiting toxicity (DLT)|0
898567|NCT00716417|1871069|FG001|Overall Study|Dose limiting toxicity (DLT)|0
898568|NCT00716417|1871070|FG002|Overall Study|Dose limiting toxicity (DLT)|0
898569|NCT00716417|1871071|FG003|Overall Study|Dose limiting toxicity (DLT)|0
898570|NCT00716417|1871072|FG004|Overall Study|Dose limiting toxicity (DLT)|1
898571|NCT00716417|1871073|FG005|Overall Study|Dose limiting toxicity (DLT)|0
898572|NCT00716417|1871074|FG006|Overall Study|Dose limiting toxicity (DLT)|0
898573|NCT00716417|1871075|FG007|Overall Study|Dose limiting toxicity (DLT)|0
898574|NCT00716417|1871076|FG008|Overall Study|Dose limiting toxicity (DLT)|0
898575|NCT00716417|1871077|FG009|Overall Study|Dose limiting toxicity (DLT)|0
898576|NCT00716417|1871068|FG000|Overall Study|On patient request due to toxicities|0
898577|NCT00716417|1871069|FG001|Overall Study|On patient request due to toxicities|0
898578|NCT00716417|1871070|FG002|Overall Study|On patient request due to toxicities|0
898579|NCT00716417|1871071|FG003|Overall Study|On patient request due to toxicities|0
898580|NCT00716417|1871072|FG004|Overall Study|On patient request due to toxicities|0
898581|NCT00716417|1871073|FG005|Overall Study|On patient request due to toxicities|0
898582|NCT00716417|1871074|FG006|Overall Study|On patient request due to toxicities|0
898583|NCT00716417|1871075|FG007|Overall Study|On patient request due to toxicities|1
898584|NCT00716417|1871076|FG008|Overall Study|On patient request due to toxicities|0
898585|NCT00716417|1871077|FG009|Overall Study|On patient request due to toxicities|0
898586|NCT00716456|1871109|FG000|Overall Study|Adverse Event|0
898587|NCT00716456|1871110|FG001|Overall Study|Adverse Event|2
898588|NCT00716456|1871111|FG002|Overall Study|Adverse Event|0
898589|NCT00716482|1871119|FG000|Overall Study|Lost to Follow-up|6
898590|NCT00716482|1871119|FG000|Overall Study|Inadequate acquisition or analysis|50
898591|NCT00716482|1871119|FG000|Overall Study|no pathology obtained|10
898592|NCT00716482|1871119|FG000|Overall Study|technical/machine error|28
898593|NCT00716482|1871119|FG000|Overall Study|inclusion/exclusion criteria not met|25
898594|NCT00716625|1871134|FG000|Overall Study|Safety was not Assessable|1
898595|NCT00716859|1871192|FG000|Overall Study|Adverse Event|4
898596|NCT00716859|1871193|FG001|Overall Study|Adverse Event|1
898597|NCT00716859|1871192|FG000|Overall Study|Lack of Efficacy|3
898598|NCT00716859|1871193|FG001|Overall Study|Lack of Efficacy|0
898599|NCT00716859|1871192|FG000|Overall Study|Withdrawal by Subject|1
898600|NCT00716859|1871193|FG001|Overall Study|Withdrawal by Subject|3
898601|NCT00716859|1871192|FG000|Overall Study|Not treated|1
898602|NCT00716859|1871193|FG001|Overall Study|Not treated|1
898603|NCT00716976|1871214|FG000|Overall Study|Adverse Event|2
898604|NCT00716976|1871215|FG001|Overall Study|Adverse Event|0
898605|NCT00716976|1871214|FG000|Overall Study|Death|1
898606|NCT00716976|1871215|FG001|Overall Study|Death|0
898607|NCT00716976|1871214|FG000|Overall Study|Physician Decision|2
898608|NCT00716976|1871215|FG001|Overall Study|Physician Decision|2
898609|NCT00716976|1871214|FG000|Overall Study|Withdrawal by Subject|5
898610|NCT00716976|1871215|FG001|Overall Study|Withdrawal by Subject|1
898611|NCT00716976|1871214|FG000|Overall Study|Premature discontinuation cisplatin|5
898612|NCT00716976|1871215|FG001|Overall Study|Premature discontinuation cisplatin|4
898613|NCT00716976|1871214|FG000|Overall Study|Radiation during protocol|1
898614|NCT00716976|1871215|FG001|Overall Study|Radiation during protocol|0
898615|NCT00716976|1871214|FG000|Overall Study|Ineligibles|4
898616|NCT00716976|1871215|FG001|Overall Study|Ineligibles|2
898617|NCT00717067|1871244|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
898618|NCT00717067|1871245|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
898619|NCT00717067|1871246|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
898620|NCT00717067|1871247|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
898621|NCT00717067|1871248|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
898622|NCT00717093|1871272|FG000|Overall Study|Adverse Event|19
1124224|NCT02630459|2213827|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
1124225|NCT02630459|2213828|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
1124226|NCT02630459|2213821|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
1124227|NCT02630459|2213822|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
1124228|NCT02630459|2213823|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1
1124229|NCT02630459|2213824|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
1124230|NCT02630459|2213825|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
1124231|NCT02630459|2213826|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
1124232|NCT02630459|2213827|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
1124233|NCT02630459|2213828|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
1124234|NCT02630459|2213821|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2
1124235|NCT02630459|2213822|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
1124236|NCT02630459|2213823|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4
1124237|NCT02630459|2213824|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
1124238|NCT02630459|2213825|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
1124239|NCT02630459|2213826|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
1124240|NCT02630459|2213827|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
1124241|NCT02630459|2213828|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
1124242|NCT02630459|2213821|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1
1124243|NCT02630459|2213822|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
1124244|NCT02630459|2213823|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
1124245|NCT02630459|2213824|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
1124246|NCT02630459|2213825|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
1124247|NCT02630459|2213826|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
1124248|NCT02630459|2213827|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
1124249|NCT02630459|2213828|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
1124250|NCT02630459|2213821|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
1124251|NCT02630459|2213822|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
1124252|NCT02630459|2213823|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
1124253|NCT02630459|2213824|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
1124254|NCT02630459|2213825|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4
1124255|NCT02630459|2213826|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1
1124256|NCT02630459|2213827|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
1124257|NCT02630459|2213828|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
1124258|NCT02630459|2213821|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0
1124259|NCT02630459|2213822|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0
1124260|NCT02630459|2213823|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0
1124261|NCT02630459|2213824|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0
1124262|NCT02630459|2213825|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24
1124263|NCT02630459|2213826|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3
1124264|NCT02630459|2213827|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0
1124265|NCT02630459|2213828|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0
1124266|NCT02630459|2213821|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
1124267|NCT02630459|2213822|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
1124268|NCT02630459|2213823|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
1124269|NCT02630459|2213824|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
1124270|NCT02630459|2213825|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1
1124271|NCT02630459|2213826|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
1124272|NCT02630459|2213827|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
1124273|NCT02630459|2213828|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
1124274|NCT02630563|2213853|FG000|Overall Study|Administrative|1
1124275|NCT02630693|2213860|FG000|Overall Study|No receive treatment|0
1124276|NCT02630693|2213861|FG001|Overall Study|No receive treatment|1
1124277|NCT02630706|2213870|FG000|Overall Study|Adverse Event|2
1124278|NCT02630706|2213871|FG001|Overall Study|Adverse Event|1
1124279|NCT02630706|2213872|FG002|Overall Study|Adverse Event|1
1124280|NCT02630706|2213870|FG000|Overall Study|Lost to Follow-up|0
1124281|NCT02630706|2213871|FG001|Overall Study|Lost to Follow-up|1
1124282|NCT02630706|2213872|FG002|Overall Study|Lost to Follow-up|2
1124283|NCT02630706|2213870|FG000|Overall Study|Physician Decision|1
1124284|NCT02630706|2213871|FG001|Overall Study|Physician Decision|1
1124285|NCT02630706|2213872|FG002|Overall Study|Physician Decision|0
1124286|NCT02630706|2213870|FG000|Overall Study|Pregnancy|0
1124287|NCT02630706|2213871|FG001|Overall Study|Pregnancy|1
1124288|NCT02630706|2213872|FG002|Overall Study|Pregnancy|0
1124289|NCT02630706|2213870|FG000|Overall Study|Withdrawal by Subject|4
1124290|NCT02630706|2213871|FG001|Overall Study|Withdrawal by Subject|5
1124291|NCT02630706|2213872|FG002|Overall Study|Withdrawal by Subject|7
1124292|NCT02630966|2213900|FG000|Overall Study|Adverse Event|1
1124293|NCT02630966|2213901|FG001|Overall Study|Adverse Event|3
1124294|NCT02630966|2213900|FG000|Overall Study|Significant Protocol Deviation|0
1124295|NCT02630966|2213901|FG001|Overall Study|Significant Protocol Deviation|2
1124296|NCT02630966|2213900|FG000|Overall Study|Voluntary Withdrawal|1
1124297|NCT02630966|2213901|FG001|Overall Study|Voluntary Withdrawal|1
1124298|NCT02630966|2213900|FG000|Overall Study|Lack of Efficacy|0
1124299|NCT02630966|2213901|FG001|Overall Study|Lack of Efficacy|2
1124312|NCT02631538|2213942|FG000|Treatment Period (Up to Week 52)|Adverse Event|1
1124313|NCT02631538|2213943|FG001|Treatment Period (Up to Week 52)|Adverse Event|5
1124314|NCT02631538|2213944|FG002|Treatment Period (Up to Week 52)|Adverse Event|2
1124315|NCT02631538|2213945|FG003|Treatment Period (Up to Week 52)|Adverse Event|2
1124316|NCT02631538|2213942|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
1124317|NCT02631538|2213943|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
1124318|NCT02631538|2213944|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2
1124319|NCT02631538|2213945|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5
1124320|NCT02631538|2213942|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1
1124321|NCT02631538|2213943|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1
1124322|NCT02631538|2213944|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0
1124323|NCT02631538|2213945|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0
1124324|NCT02631538|2213942|FG000|Treatment Period (Up to Week 52)|Physician Decision|1
1124325|NCT02631538|2213943|FG001|Treatment Period (Up to Week 52)|Physician Decision|0
1124326|NCT02631538|2213944|FG002|Treatment Period (Up to Week 52)|Physician Decision|0
1124327|NCT02631538|2213945|FG003|Treatment Period (Up to Week 52)|Physician Decision|1
1124328|NCT02631538|2213942|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0
1124329|NCT02631538|2213943|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0
1124330|NCT02631538|2213944|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1
1124331|NCT02631538|2213945|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0
1124332|NCT02631538|2213942|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
1124333|NCT02631538|2213943|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
1124334|NCT02631538|2213944|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
1124335|NCT02631538|2213945|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
1124336|NCT02631551|2213959|FG000|Overall Study|Adverse Event|1
1124337|NCT02631551|2213960|FG001|Overall Study|Adverse Event|2
1124338|NCT02631551|2213961|FG002|Overall Study|Adverse Event|4
1124339|NCT02631551|2213962|FG003|Overall Study|Adverse Event|0
1124340|NCT02631551|2213959|FG000|Overall Study|Lack of Efficacy|0
1124341|NCT02631551|2213960|FG001|Overall Study|Lack of Efficacy|0
1124342|NCT02631551|2213961|FG002|Overall Study|Lack of Efficacy|1
1124343|NCT02631551|2213962|FG003|Overall Study|Lack of Efficacy|0
1124344|NCT02631551|2213959|FG000|Overall Study|Lost to Follow-up|1
1124345|NCT02631551|2213960|FG001|Overall Study|Lost to Follow-up|2
1124346|NCT02631551|2213961|FG002|Overall Study|Lost to Follow-up|0
1124347|NCT02631551|2213962|FG003|Overall Study|Lost to Follow-up|3
1124348|NCT02631551|2213959|FG000|Overall Study|Withdrawal by Subject|2
1124349|NCT02631551|2213960|FG001|Overall Study|Withdrawal by Subject|2
1124350|NCT02631551|2213961|FG002|Overall Study|Withdrawal by Subject|0
1124351|NCT02631551|2213962|FG003|Overall Study|Withdrawal by Subject|5
1124352|NCT02631551|2213959|FG000|Overall Study|Protocol deviation|3
1124353|NCT02631551|2213960|FG001|Overall Study|Protocol deviation|6
1124354|NCT02631551|2213961|FG002|Overall Study|Protocol deviation|3
1124355|NCT02631551|2213962|FG003|Overall Study|Protocol deviation|0
1124356|NCT02631551|2213959|FG000|Overall Study|Non-compliance with study procedures|0
1124357|NCT02631551|2213960|FG001|Overall Study|Non-compliance with study procedures|0
1124358|NCT02631551|2213961|FG002|Overall Study|Non-compliance with study procedures|1
1124359|NCT02631551|2213962|FG003|Overall Study|Non-compliance with study procedures|1
1124360|NCT02631551|2213959|FG000|Overall Study|Non-compliance with study drug|1
1124361|NCT02631551|2213960|FG001|Overall Study|Non-compliance with study drug|0
1124362|NCT02631551|2213961|FG002|Overall Study|Non-compliance with study drug|0
1124363|NCT02631551|2213962|FG003|Overall Study|Non-compliance with study drug|0
1124364|NCT02631551|2213959|FG000|Overall Study|Other, specific reasons not collected|5
1124365|NCT02631551|2213960|FG001|Overall Study|Other, specific reasons not collected|7
1124366|NCT02631551|2213961|FG002|Overall Study|Other, specific reasons not collected|2
1124367|NCT02631551|2213962|FG003|Overall Study|Other, specific reasons not collected|2
1124368|NCT02631746|2213985|FG000|Overall Study|Lack of Efficacy|3
1124369|NCT02631850|2214011|FG000|Treatment Period|Lost to Follow-up|0
1124370|NCT02631850|2214012|FG001|Treatment Period|Lost to Follow-up|1
1124371|NCT02631850|2214013|FG002|Treatment Period|Lost to Follow-up|0
1124372|NCT02631850|2214014|FG003|Treatment Period|Lost to Follow-up|0
1124373|NCT02631850|2214011|FG000|Treatment Period|Protocol Violation|1
1124374|NCT02631850|2214012|FG001|Treatment Period|Protocol Violation|0
1124375|NCT02631850|2214013|FG002|Treatment Period|Protocol Violation|0
1124376|NCT02631850|2214014|FG003|Treatment Period|Protocol Violation|0
1124377|NCT02631850|2214011|FG000|Treatment Period|Withdrawal by Subject|0
1124378|NCT02631850|2214012|FG001|Treatment Period|Withdrawal by Subject|5
1124379|NCT02631850|2214013|FG002|Treatment Period|Withdrawal by Subject|2
1124380|NCT02631850|2214014|FG003|Treatment Period|Withdrawal by Subject|2
1124381|NCT02631850|2214011|FG000|Treatment Period|Adverse Event|1
1124382|NCT02631850|2214012|FG001|Treatment Period|Adverse Event|0
1124383|NCT02631850|2214013|FG002|Treatment Period|Adverse Event|2
1124384|NCT02631850|2214014|FG003|Treatment Period|Adverse Event|3
1124385|NCT02631850|2214011|FG000|Treatment Period|Family medical issue|1
1124386|NCT02631850|2214012|FG001|Treatment Period|Family medical issue|0
1124387|NCT02631850|2214013|FG002|Treatment Period|Family medical issue|0
1124388|NCT02631850|2214014|FG003|Treatment Period|Family medical issue|0
1124389|NCT02631850|2214011|FG000|6 Month Follow up|Lost to Follow-up|5
1124390|NCT02631850|2214012|FG001|6 Month Follow up|Lost to Follow-up|8
1124391|NCT02631850|2214013|FG002|6 Month Follow up|Lost to Follow-up|3
1124392|NCT02631850|2214014|FG003|6 Month Follow up|Lost to Follow-up|5
1124393|NCT02631850|2214011|FG000|6 Month Follow up|Withdrawal by Subject|1
1124394|NCT02631850|2214012|FG001|6 Month Follow up|Withdrawal by Subject|0
1124395|NCT02631850|2214013|FG002|6 Month Follow up|Withdrawal by Subject|0
1124396|NCT02631850|2214014|FG003|6 Month Follow up|Withdrawal by Subject|2
1124397|NCT02631850|2214011|FG000|6 Month Follow up|Adverse Event|1
1124398|NCT02631850|2214012|FG001|6 Month Follow up|Adverse Event|4
1124399|NCT02631850|2214013|FG002|6 Month Follow up|Adverse Event|1
1124400|NCT02631850|2214014|FG003|6 Month Follow up|Adverse Event|3
1124401|NCT02631850|2214011|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0
1124402|NCT02631850|2214012|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
1124403|NCT02631850|2214013|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2
1124404|NCT02631850|2214014|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
1124405|NCT02631876|2214027|FG000|Overall Study|Death|96
1124406|NCT02631876|2214028|FG001|Overall Study|Death|50
1124407|NCT02631876|2214027|FG000|Overall Study|Investigator's discretion|1
1124408|NCT02631876|2214028|FG001|Overall Study|Investigator's discretion|0
1124409|NCT02631876|2214027|FG000|Overall Study|Lost to Follow-up|2
1124410|NCT02631876|2214028|FG001|Overall Study|Lost to Follow-up|0
1124411|NCT02631876|2214027|FG000|Overall Study|Withdrawal by Subject|16
1124412|NCT02631876|2214028|FG001|Overall Study|Withdrawal by Subject|9
1124413|NCT02631876|2214027|FG000|Overall Study|Other than specified|4
1124414|NCT02631876|2214028|FG001|Overall Study|Other than specified|4
1124415|NCT02632110|2214049|FG000|Overall Study|Withdrawal by Subject|1
1124416|NCT02632110|2214050|FG001|Overall Study|Withdrawal by Subject|1
1124417|NCT02632110|2214051|FG002|Overall Study|Withdrawal by Subject|0
1124418|NCT02632110|2214052|FG003|Overall Study|Withdrawal by Subject|0
1124419|NCT02632110|2214053|FG004|Overall Study|Withdrawal by Subject|1
1124420|NCT02632110|2214054|FG005|Overall Study|Withdrawal by Subject|1
1124421|NCT02632110|2214055|FG006|Overall Study|Withdrawal by Subject|3
1124422|NCT02632110|2214056|FG007|Overall Study|Withdrawal by Subject|3
1124423|NCT02632110|2214057|FG008|Overall Study|Withdrawal by Subject|1
1124424|NCT02632110|2214058|FG009|Overall Study|Withdrawal by Subject|1
1124425|NCT02632552|2214133|FG000|Overall Study|Lost to Follow-up|14
1124426|NCT02632552|2214134|FG001|Overall Study|Lost to Follow-up|8
1124427|NCT02632552|2214133|FG000|Overall Study|Withdrawal by Subject|2
1124428|NCT02632552|2214134|FG001|Overall Study|Withdrawal by Subject|0
1124429|NCT02632552|2214133|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7
1124430|NCT02632552|2214134|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2
1124431|NCT02632747|2214143|FG000|Wash-out Period|Adverse Event|1
1124432|NCT02632747|2214144|FG001|Wash-out Period|Adverse Event|0
1124433|NCT02632786|2214152|FG000|Overall Study|Adverse Event|2
1124434|NCT02632786|2214153|FG001|Overall Study|Adverse Event|1
1124435|NCT02632786|2214152|FG000|Overall Study|Death|3
1124436|NCT02632786|2214153|FG001|Overall Study|Death|2
1124437|NCT02632786|2214152|FG000|Overall Study|Physician Decision|5
1124438|NCT02632786|2214153|FG001|Overall Study|Physician Decision|4
1124439|NCT02632786|2214152|FG000|Overall Study|Withdrawal by Subject|1
1124440|NCT02632786|2214153|FG001|Overall Study|Withdrawal by Subject|0
1124441|NCT02632838|2214171|FG000|Overall Study|Withdrawal by Subject|3
1124442|NCT02632838|2214172|FG001|Overall Study|Withdrawal by Subject|0
1124443|NCT02632838|2214171|FG000|Overall Study|Lost to Follow-up|0
1124444|NCT02632838|2214172|FG001|Overall Study|Lost to Follow-up|2
1124445|NCT02633020|2214184|FG000|Overall Study|Adverse Event|1
1124446|NCT02633020|2214185|FG001|Overall Study|Adverse Event|0
1124447|NCT02633046|2214191|FG000|Overall Study|Adverse Event|8
1124448|NCT02633046|2214191|FG000|Overall Study|Physician Decision|7
1124449|NCT02633046|2214191|FG000|Overall Study|Withdrawal by Subject|8
1124450|NCT02633046|2214191|FG000|Overall Study|Increased proteinuria|2
1124451|NCT02633046|2214191|FG000|Overall Study|Participant decided not to continue with open label extension|1
1124452|NCT02633046|2214191|FG000|Overall Study|Mutual decision patient and physician|1
1124453|NCT02633215|2214197|FG000|Overall Study|Lost to Follow-up|2
1124454|NCT02633215|2214198|FG001|Overall Study|Lost to Follow-up|3
1124455|NCT02633306|2214210|FG000|Overall Study|Withdrawal by Subject|3
1124456|NCT02633501|2214244|FG000|Overall Study|Adverse Event|0
1124457|NCT02633501|2214245|FG001|Overall Study|Adverse Event|0
1124458|NCT02633501|2214246|FG002|Overall Study|Adverse Event|1
1124459|NCT02633501|2214247|FG003|Overall Study|Adverse Event|0
1124460|NCT02633501|2214248|FG004|Overall Study|Adverse Event|1
1124461|NCT02633501|2214249|FG005|Overall Study|Adverse Event|1
1124462|NCT02633501|2214244|FG000|Overall Study|Withdrawal by Subject|2
1124463|NCT02633501|2214245|FG001|Overall Study|Withdrawal by Subject|1
1124464|NCT02633501|2214246|FG002|Overall Study|Withdrawal by Subject|2
1124465|NCT02633501|2214247|FG003|Overall Study|Withdrawal by Subject|2
1124466|NCT02633501|2214248|FG004|Overall Study|Withdrawal by Subject|1
1124467|NCT02633501|2214249|FG005|Overall Study|Withdrawal by Subject|3
1124468|NCT02633501|2214244|FG000|Overall Study|Various other reasons|0
1124469|NCT02633501|2214245|FG001|Overall Study|Various other reasons|2
1124470|NCT02633501|2214246|FG002|Overall Study|Various other reasons|4
1124471|NCT02633501|2214247|FG003|Overall Study|Various other reasons|1
1124472|NCT02633501|2214248|FG004|Overall Study|Various other reasons|7
1124473|NCT02633501|2214249|FG005|Overall Study|Various other reasons|11
1124474|NCT02633501|2214244|FG000|Overall Study|Lost to Follow-up|0
1124475|NCT02633501|2214245|FG001|Overall Study|Lost to Follow-up|0
1124476|NCT02633501|2214246|FG002|Overall Study|Lost to Follow-up|0
1124477|NCT02633501|2214247|FG003|Overall Study|Lost to Follow-up|1
1124478|NCT02633501|2214248|FG004|Overall Study|Lost to Follow-up|2
1124479|NCT02633501|2214249|FG005|Overall Study|Lost to Follow-up|0
1124480|NCT02633527|2214273|FG000|Overall Study|Failed to meet eligibility|0
1124481|NCT02633527|2214274|FG001|Overall Study|Failed to meet eligibility|1
1124482|NCT02633527|2214275|FG002|Overall Study|Failed to meet eligibility|1
1124483|NCT02633527|2214276|FG003|Overall Study|Failed to meet eligibility|0
1124484|NCT02633527|2214277|FG004|Overall Study|Failed to meet eligibility|1
1124485|NCT02633527|2214273|FG000|Overall Study|Adverse Event|0
1124486|NCT02633527|2214274|FG001|Overall Study|Adverse Event|4
1124487|NCT02633527|2214275|FG002|Overall Study|Adverse Event|3
1124488|NCT02633527|2214276|FG003|Overall Study|Adverse Event|1
1124489|NCT02633527|2214277|FG004|Overall Study|Adverse Event|5
1124490|NCT02633527|2214273|FG000|Overall Study|Lost to Follow-up|1
1124491|NCT02633527|2214274|FG001|Overall Study|Lost to Follow-up|2
1124492|NCT02633527|2214275|FG002|Overall Study|Lost to Follow-up|5
1124493|NCT02633527|2214276|FG003|Overall Study|Lost to Follow-up|5
1124494|NCT02633527|2214277|FG004|Overall Study|Lost to Follow-up|4
1124495|NCT02633527|2214273|FG000|Overall Study|Withdrawal by Subject|0
1124496|NCT02633527|2214274|FG001|Overall Study|Withdrawal by Subject|3
1124497|NCT02633527|2214275|FG002|Overall Study|Withdrawal by Subject|5
1124498|NCT02633527|2214276|FG003|Overall Study|Withdrawal by Subject|4
1124499|NCT02633527|2214277|FG004|Overall Study|Withdrawal by Subject|4
1124500|NCT02633527|2214273|FG000|Overall Study|Protocol Violation|0
1124501|NCT02633527|2214274|FG001|Overall Study|Protocol Violation|1
1124502|NCT02633527|2214275|FG002|Overall Study|Protocol Violation|1
1124503|NCT02633527|2214276|FG003|Overall Study|Protocol Violation|1
1124504|NCT02633527|2214277|FG004|Overall Study|Protocol Violation|1
1124505|NCT02633527|2214273|FG000|Overall Study|Physician Decision|0
1124506|NCT02633527|2214274|FG001|Overall Study|Physician Decision|0
1124507|NCT02633527|2214275|FG002|Overall Study|Physician Decision|0
1124508|NCT02633527|2214276|FG003|Overall Study|Physician Decision|0
1124509|NCT02633527|2214277|FG004|Overall Study|Physician Decision|1
1124510|NCT02633527|2214273|FG000|Overall Study|Administrative reason|1
1124511|NCT02633527|2214274|FG001|Overall Study|Administrative reason|0
1124512|NCT02633527|2214275|FG002|Overall Study|Administrative reason|0
1124513|NCT02633527|2214276|FG003|Overall Study|Administrative reason|1
1124514|NCT02633527|2214277|FG004|Overall Study|Administrative reason|0
1124515|NCT02633527|2214273|FG000|Overall Study|Multiple reasons|1
1124516|NCT02633527|2214274|FG001|Overall Study|Multiple reasons|0
1124517|NCT02633527|2214275|FG002|Overall Study|Multiple reasons|2
1124518|NCT02633527|2214276|FG003|Overall Study|Multiple reasons|2
1124519|NCT02633527|2214277|FG004|Overall Study|Multiple reasons|1
1124520|NCT02633787|2214298|FG000|Overall Study|Withdrawal by Subject|1
1124521|NCT02633800|2214304|FG000|Overall Study|Death|3
1124522|NCT02633800|2214305|FG001|Overall Study|Death|3
1124523|NCT02633800|2214304|FG000|Overall Study|Reason not provided|1
1124524|NCT02633800|2214305|FG001|Overall Study|Reason not provided|0
1124525|NCT02633800|2214304|FG000|Overall Study|Radiologic(al) progression|23
1124526|NCT02633800|2214305|FG001|Overall Study|Radiologic(al) progression|23
1124527|NCT02633800|2214304|FG000|Overall Study|Clinical progression|3
1124528|NCT02633800|2214305|FG001|Overall Study|Clinical progression|6
1124529|NCT02633800|2214304|FG000|Overall Study|Study terminated by sponsor|6
1124530|NCT02633800|2214305|FG001|Overall Study|Study terminated by sponsor|5
1124531|NCT02633800|2214304|FG000|Overall Study|Adverse event, non-fatal|7
1124532|NCT02633800|2214305|FG001|Overall Study|Adverse event, non-fatal|2
1124533|NCT02633800|2214304|FG000|Overall Study|Withdrawal by Subject|0
1124534|NCT02633800|2214305|FG001|Overall Study|Withdrawal by Subject|3
1124535|NCT02633800|2214304|FG000|Overall Study|Patient Request|1
1124536|NCT02633800|2214305|FG001|Overall Study|Patient Request|1
1124537|NCT02634151|2214347|FG000|Overall Study|Withdrawal by Subject|1
1124538|NCT02634151|2214348|FG001|Overall Study|Withdrawal by Subject|0
1124539|NCT02634151|2214347|FG000|Overall Study|Non-Compliance|0
1124540|NCT02634151|2214348|FG001|Overall Study|Non-Compliance|1
1124541|NCT02634151|2214347|FG000|Overall Study|Other|0
1124542|NCT02634151|2214348|FG001|Overall Study|Other|1
1124543|NCT02634320|2214363|FG000|Overall Study|Adverse Event|2
1124544|NCT02634320|2214363|FG000|Overall Study|Lost to Follow-up|3
1124545|NCT02634320|2214363|FG000|Overall Study|Moved out of area|2
1124546|NCT02634320|2214363|FG000|Overall Study|Out of window for study visits|1
1124547|NCT02634320|2214363|FG000|Overall Study|Protocol Violation|1
1124548|NCT02634320|2214363|FG000|Overall Study|Withdrawal by Subject|5
1124549|NCT02634320|2214363|FG000|Overall Study|Lack of Efficacy|2
1124550|NCT02634333|2214369|FG000|Overall Study|Completed out of Window|3
1124551|NCT02634333|2214370|FG001|Overall Study|Completed out of Window|2
1124552|NCT02634333|2214369|FG000|Overall Study|Missed Visit|5
1124553|NCT02634333|2214370|FG001|Overall Study|Missed Visit|2
1124554|NCT02634333|2214369|FG000|Overall Study|Lost to Follow-up|12
1124555|NCT02634333|2214370|FG001|Overall Study|Lost to Follow-up|7
1124556|NCT02634333|2214369|FG000|Overall Study|Withdrawal by Subject|9
1124557|NCT02634333|2214370|FG001|Overall Study|Withdrawal by Subject|13
1124558|NCT02634333|2214369|FG000|Overall Study|Death|11
1124559|NCT02634333|2214370|FG001|Overall Study|Death|8
1124560|NCT02634346|2214380|FG000|Overall Study|Withdrawal by Subject|8
1124561|NCT02634346|2214381|FG001|Overall Study|Withdrawal by Subject|9
1124562|NCT02634346|2214382|FG002|Overall Study|Withdrawal by Subject|8
1124563|NCT02634346|2214380|FG000|Overall Study|Adverse Event|2
1124564|NCT02634346|2214381|FG001|Overall Study|Adverse Event|2
1124565|NCT02634346|2214382|FG002|Overall Study|Adverse Event|7
1124566|NCT02634346|2214380|FG000|Overall Study|Lack of Efficacy|1
1124567|NCT02634346|2214381|FG001|Overall Study|Lack of Efficacy|2
1124568|NCT02634346|2214382|FG002|Overall Study|Lack of Efficacy|8
1124569|NCT02634346|2214380|FG000|Overall Study|Lost to Follow-up|1
1124570|NCT02634346|2214381|FG001|Overall Study|Lost to Follow-up|0
1124571|NCT02634346|2214382|FG002|Overall Study|Lost to Follow-up|0
1124572|NCT02634346|2214380|FG000|Overall Study|Protocol Violation|0
1124573|NCT02634346|2214381|FG001|Overall Study|Protocol Violation|1
1124574|NCT02634346|2214382|FG002|Overall Study|Protocol Violation|0
1124575|NCT02634580|2214394|FG000|Double-blind Treatment Period|Subject Request|1
1124576|NCT02634580|2214395|FG001|Double-blind Treatment Period|Subject Request|0
1124577|NCT02634580|2214396|FG002|Double-blind Treatment Period|Subject Request|1
1124578|NCT02634580|2214397|FG003|Double-blind Treatment Period|Subject Request|1
1124579|NCT02634580|2214394|FG000|Open-label Extension Period|Withdrawal by Subject|0
1124580|NCT02634580|2214395|FG001|Open-label Extension Period|Withdrawal by Subject|1
1124581|NCT02634580|2214396|FG002|Open-label Extension Period|Withdrawal by Subject|0
1124582|NCT02634580|2214397|FG003|Open-label Extension Period|Withdrawal by Subject|1
1124583|NCT02634788|2214427|FG000|Overall Study|Adverse Event|0
1124584|NCT02634788|2214428|FG001|Overall Study|Adverse Event|8
1124585|NCT02634788|2214429|FG002|Overall Study|Adverse Event|3
1124586|NCT02634788|2214430|FG003|Overall Study|Adverse Event|1
1124587|NCT02634788|2214427|FG000|Overall Study|Lack of Efficacy|4
1124588|NCT02634788|2214428|FG001|Overall Study|Lack of Efficacy|0
1124589|NCT02634788|2214429|FG002|Overall Study|Lack of Efficacy|1
1124590|NCT02634788|2214430|FG003|Overall Study|Lack of Efficacy|4
1124591|NCT02634788|2214427|FG000|Overall Study|Lost to Follow-up|0
1124592|NCT02634788|2214428|FG001|Overall Study|Lost to Follow-up|1
1124593|NCT02634788|2214429|FG002|Overall Study|Lost to Follow-up|0
1124594|NCT02634788|2214430|FG003|Overall Study|Lost to Follow-up|0
1124595|NCT02634788|2214427|FG000|Overall Study|Withdrawal by Subject|0
1124596|NCT02634788|2214428|FG001|Overall Study|Withdrawal by Subject|1
1124597|NCT02634788|2214429|FG002|Overall Study|Withdrawal by Subject|1
1124598|NCT02634788|2214430|FG003|Overall Study|Withdrawal by Subject|0
1124599|NCT02634801|2214443|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2
1124600|NCT02634801|2214444|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20
1124601|NCT02634801|2214445|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0
1124602|NCT02634801|2214443|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
1124603|NCT02634801|2214444|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
1124604|NCT02634801|2214445|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
1124605|NCT02634801|2214443|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
1124606|NCT02634801|2214444|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
1124607|NCT02634801|2214445|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
1124608|NCT02634801|2214443|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
1124609|NCT02634801|2214444|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
1124610|NCT02634801|2214445|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
1124611|NCT02634801|2214443|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
1124612|NCT02634801|2214444|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
1124613|NCT02634801|2214445|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
1124614|NCT02634801|2214443|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0
1124615|NCT02634801|2214444|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0
1124616|NCT02634801|2214445|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1
1124617|NCT02634801|2214443|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
1124618|NCT02634801|2214444|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
1124619|NCT02634801|2214445|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
1162080|NCT03382899|2284098|FG001|Overall Study|Sponsor's decision|28
1124620|NCT02634801|2214443|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
1124621|NCT02634801|2214444|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
1124622|NCT02634801|2214445|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
1124623|NCT02634801|2214443|FG000|Extension Period (Weeks 24 to 36)|Missing|1
1124624|NCT02634801|2214444|FG001|Extension Period (Weeks 24 to 36)|Missing|0
1124625|NCT02634801|2214445|FG002|Extension Period (Weeks 24 to 36)|Missing|0
1124626|NCT02634801|2214443|FG000|Follow-up Period|Lost to Follow-up|3
1124627|NCT02634801|2214444|FG001|Follow-up Period|Lost to Follow-up|1
1124628|NCT02634801|2214445|FG002|Follow-up Period|Lost to Follow-up|2
1124629|NCT02634801|2214443|FG000|Follow-up Period|Physician Decision|0
1124630|NCT02634801|2214444|FG001|Follow-up Period|Physician Decision|0
1124631|NCT02634801|2214445|FG002|Follow-up Period|Physician Decision|1
1124632|NCT02634801|2214443|FG000|Follow-up Period|Withdrawal by Subject|1
1124633|NCT02634801|2214444|FG001|Follow-up Period|Withdrawal by Subject|2
1124634|NCT02634801|2214445|FG002|Follow-up Period|Withdrawal by Subject|5
1124635|NCT02634801|2214443|FG000|Follow-up Period|Adverse Event|1
1124636|NCT02634801|2214444|FG001|Follow-up Period|Adverse Event|5
1124637|NCT02634801|2214445|FG002|Follow-up Period|Adverse Event|0
1124638|NCT02634983|2214470|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
1124639|NCT02634983|2214471|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
1124640|NCT02635204|2214488|FG000|Overall Study|Adverse Event|1
1124641|NCT02635204|2214489|FG001|Overall Study|Adverse Event|0
1124642|NCT02635204|2214488|FG000|Overall Study|Lost to Follow-up|1
1124643|NCT02635204|2214489|FG001|Overall Study|Lost to Follow-up|1
1124644|NCT02635347|2214497|FG000|Overall Study|Failed screening|20
1124645|NCT02635347|2214498|FG001|Overall Study|Failed screening|7
1124646|NCT02635386|2214510|FG000|Overall Study|Pregnancy|2
1124647|NCT02635386|2214511|FG001|Overall Study|Pregnancy|0
1124648|NCT02635386|2214512|FG002|Overall Study|Pregnancy|0
1124649|NCT02635386|2214513|FG003|Overall Study|Pregnancy|0
1124650|NCT02635386|2214514|FG004|Overall Study|Pregnancy|2
1124651|NCT02635386|2214510|FG000|Overall Study|Withdrawal by Subject|1
1124652|NCT02635386|2214511|FG001|Overall Study|Withdrawal by Subject|1
1124653|NCT02635386|2214512|FG002|Overall Study|Withdrawal by Subject|0
1124654|NCT02635386|2214513|FG003|Overall Study|Withdrawal by Subject|1
1124655|NCT02635386|2214514|FG004|Overall Study|Withdrawal by Subject|0
1124656|NCT02635386|2214510|FG000|Overall Study|Physician Decision|0
1124657|NCT02635386|2214511|FG001|Overall Study|Physician Decision|1
1124658|NCT02635386|2214512|FG002|Overall Study|Physician Decision|0
1124659|NCT02635386|2214513|FG003|Overall Study|Physician Decision|0
1124660|NCT02635386|2214514|FG004|Overall Study|Physician Decision|0
1124661|NCT02635386|2214510|FG000|Overall Study|Moved Out of State|0
1124662|NCT02635386|2214511|FG001|Overall Study|Moved Out of State|1
1124663|NCT02635386|2214512|FG002|Overall Study|Moved Out of State|0
1124664|NCT02635386|2214513|FG003|Overall Study|Moved Out of State|0
1124665|NCT02635386|2214514|FG004|Overall Study|Moved Out of State|0
1124666|NCT02635386|2214510|FG000|Overall Study|Noncompliant|0
1124667|NCT02635386|2214511|FG001|Overall Study|Noncompliant|2
1124668|NCT02635386|2214512|FG002|Overall Study|Noncompliant|1
1124669|NCT02635386|2214513|FG003|Overall Study|Noncompliant|1
1124670|NCT02635386|2214514|FG004|Overall Study|Noncompliant|1
1124671|NCT02635386|2214510|FG000|Overall Study|side effects|0
1124672|NCT02635386|2214511|FG001|Overall Study|side effects|0
1124673|NCT02635386|2214512|FG002|Overall Study|side effects|1
1124674|NCT02635386|2214513|FG003|Overall Study|side effects|4
1124675|NCT02635386|2214514|FG004|Overall Study|side effects|6
1124676|NCT02635386|2214510|FG000|Overall Study|needed other major surgery|0
1124677|NCT02635386|2214511|FG001|Overall Study|needed other major surgery|1
1124678|NCT02635386|2214512|FG002|Overall Study|needed other major surgery|0
1124679|NCT02635386|2214513|FG003|Overall Study|needed other major surgery|0
1124680|NCT02635386|2214514|FG004|Overall Study|needed other major surgery|0
1124681|NCT02635386|2214510|FG000|Overall Study|Other medical problems not drug related|0
1124682|NCT02635386|2214511|FG001|Overall Study|Other medical problems not drug related|0
1124683|NCT02635386|2214512|FG002|Overall Study|Other medical problems not drug related|0
1124684|NCT02635386|2214513|FG003|Overall Study|Other medical problems not drug related|1
1124685|NCT02635386|2214514|FG004|Overall Study|Other medical problems not drug related|0
1124686|NCT02635646|2214551|FG000|Overall Study|Lost to Follow-up|24
1124687|NCT02635646|2214552|FG001|Overall Study|Lost to Follow-up|25
1124688|NCT02635646|2214551|FG000|Overall Study|Pregnancy|1
1124689|NCT02635646|2214552|FG001|Overall Study|Pregnancy|1
1124690|NCT02635724|2214567|FG000|Overall Study|Withdrawal by Subject|0
1124691|NCT02635724|2214568|FG001|Overall Study|Withdrawal by Subject|1
1124692|NCT02635724|2214569|FG002|Overall Study|Withdrawal by Subject|0
1124693|NCT02635737|2214577|FG000|Overall Study|Protocol Violation|1
1124694|NCT02635984|2214591|FG000|Overall Study|Lost to Follow-up|2
1124695|NCT02635984|2214592|FG001|Overall Study|Lost to Follow-up|4
1124696|NCT02635984|2214591|FG000|Overall Study|Study Arm Closed|1
1124697|NCT02635984|2214592|FG001|Overall Study|Study Arm Closed|0
1124698|NCT02636361|2214604|FG000|Period 4|Physician Decision|0
1124699|NCT02636361|2214605|FG001|Period 4|Physician Decision|0
1124700|NCT02636361|2214606|FG002|Period 4|Physician Decision|0
1124701|NCT02636361|2214607|FG003|Period 4|Physician Decision|1
1124702|NCT02636361|2214608|FG004|Period 4|Physician Decision|0
1124703|NCT02636595|2214622|FG000|Overall Study|Lost to Follow-up|1
1124704|NCT02636595|2214622|FG000|Overall Study|Other|1
1124705|NCT02636608|2214626|FG000|Overall Study|Failure to Return|4
1124706|NCT02636608|2214626|FG000|Overall Study|Insufficient Virological Response|1
1124707|NCT02636608|2214626|FG000|Overall Study|Death|3
1124708|NCT02636608|2214626|FG000|Overall Study|Other|2
1124709|NCT02636608|2214626|FG000|Overall Study|Did Not Receive Treatment|1
1124710|NCT02636699|2214635|FG000|Overall Study|Adverse Event|4
1124711|NCT02636699|2214636|FG001|Overall Study|Adverse Event|0
1124712|NCT02636699|2214635|FG000|Overall Study|Lost to Follow-up|3
1124713|NCT02636699|2214636|FG001|Overall Study|Lost to Follow-up|3
1124714|NCT02636699|2214635|FG000|Overall Study|Non-compliance with the investigational product (IP)|2
1124715|NCT02636699|2214636|FG001|Overall Study|Non-compliance with the investigational product (IP)|0
1124716|NCT02636699|2214635|FG000|Overall Study|Physician Decision|0
1124717|NCT02636699|2214636|FG001|Overall Study|Physician Decision|1
1124718|NCT02636699|2214635|FG000|Overall Study|Withdrawal by Subject|13
1124719|NCT02636699|2214636|FG001|Overall Study|Withdrawal by Subject|6
1124720|NCT02636699|2214635|FG000|Overall Study|Other|3
1124721|NCT02636699|2214636|FG001|Overall Study|Other|1
1124722|NCT02636725|2214647|FG000|Baseline|Adverse Event|1
1124723|NCT02636725|2214647|FG000|Baseline|Lack of Efficacy|2
1124724|NCT02636868|2214654|FG000|Overall Study|Death|0
1124725|NCT02636868|2214655|FG001|Overall Study|Death|1
1124726|NCT02636868|2214656|FG002|Overall Study|Death|2
1124727|NCT02636907|2214664|FG000|Autoinjector Assessment Period|Adverse Event|2
1124728|NCT02636907|2214664|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2
1124729|NCT02636907|2214664|FG000|Extension Phase|Adverse Event|2
1124730|NCT02636907|2214664|FG000|Extension Phase|Withdrawal by Subject|4
1124731|NCT02636907|2214664|FG000|Extension Phase|Physician Decision|1
1124732|NCT02636907|2214664|FG000|Extension Phase|Lost to Follow-up|2
1124733|NCT02636907|2214664|FG000|Extension Phase|Lack of Efficacy|1
1124734|NCT02637037|2214670|FG000|Overall Study|Positive drug screen at admission|1
1124735|NCT02637037|2214671|FG001|Overall Study|Positive drug screen at admission|0
1124736|NCT02637037|2214670|FG000|Overall Study|Withdrawal by Subject|2
1124737|NCT02637037|2214671|FG001|Overall Study|Withdrawal by Subject|1
1124738|NCT02637037|2214670|FG000|Overall Study|Adverse Event|1
1124739|NCT02637037|2214671|FG001|Overall Study|Adverse Event|0
1124740|NCT02637063|2214692|FG000|Overall Study|Lost to Follow-up|3
1124741|NCT02637063|2214693|FG001|Overall Study|Lost to Follow-up|2
1124742|NCT02637063|2214694|FG002|Overall Study|Lost to Follow-up|3
1124743|NCT02637063|2214692|FG000|Overall Study|Withdrawal by Subject|2
1124744|NCT02637063|2214693|FG001|Overall Study|Withdrawal by Subject|2
1124745|NCT02637063|2214694|FG002|Overall Study|Withdrawal by Subject|3
1124746|NCT02637076|2214704|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
1124747|NCT02637076|2214705|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
1124748|NCT02637076|2214704|FG000|Overall Study|Withdrawal by Subject|0
1124749|NCT02637076|2214705|FG001|Overall Study|Withdrawal by Subject|4
1124750|NCT02637141|2214714|FG000|Overall Study|Adverse Event|1
1124751|NCT02637141|2214715|FG001|Overall Study|Adverse Event|1
1124752|NCT02637141|2214716|FG002|Overall Study|Adverse Event|0
1124753|NCT02637141|2214714|FG000|Overall Study|Withdrawal by Subject|1
1124754|NCT02637141|2214715|FG001|Overall Study|Withdrawal by Subject|1
1124755|NCT02637141|2214716|FG002|Overall Study|Withdrawal by Subject|1
1124756|NCT02637232|2214724|FG000|Overall Study|Lost to Follow-up|42
1124757|NCT02637232|2214724|FG000|Overall Study|Adverse Event|11
1124758|NCT02637232|2214724|FG000|Overall Study|patient 's decision|2
1124759|NCT02637323|2214730|FG000|Overall Study|Lost to Follow-up|2
1124760|NCT02637323|2214731|FG001|Overall Study|Lost to Follow-up|0
1124761|NCT02637323|2214730|FG000|Overall Study|Protocol Violation|0
1124762|NCT02637323|2214731|FG001|Overall Study|Protocol Violation|1
1124763|NCT02637557|2214751|FG000|Overall Study|Adverse Event|3
1124764|NCT02637557|2214752|FG001|Overall Study|Adverse Event|1
1124765|NCT02637557|2214753|FG002|Overall Study|Adverse Event|3
1124766|NCT02637557|2214754|FG003|Overall Study|Adverse Event|3
1124767|NCT02637557|2214751|FG000|Overall Study|Lost to Follow-up|1
1124768|NCT02637557|2214752|FG001|Overall Study|Lost to Follow-up|1
1124769|NCT02637557|2214753|FG002|Overall Study|Lost to Follow-up|0
1124770|NCT02637557|2214754|FG003|Overall Study|Lost to Follow-up|1
1124771|NCT02637557|2214751|FG000|Overall Study|Physician Decision|1
1124772|NCT02637557|2214752|FG001|Overall Study|Physician Decision|0
1124773|NCT02637557|2214753|FG002|Overall Study|Physician Decision|0
1124774|NCT02637557|2214754|FG003|Overall Study|Physician Decision|0
1124775|NCT02637557|2214751|FG000|Overall Study|Protocol Violation|2
1124776|NCT02637557|2214752|FG001|Overall Study|Protocol Violation|0
1124777|NCT02637557|2214753|FG002|Overall Study|Protocol Violation|2
1124778|NCT02637557|2214754|FG003|Overall Study|Protocol Violation|1
1124779|NCT02637557|2214751|FG000|Overall Study|Withdrawal by Subject|1
1124780|NCT02637557|2214752|FG001|Overall Study|Withdrawal by Subject|3
1124781|NCT02637557|2214753|FG002|Overall Study|Withdrawal by Subject|4
1124782|NCT02637557|2214754|FG003|Overall Study|Withdrawal by Subject|2
1124783|NCT02637856|2214786|FG000|Main Study (Baseline to Week 100)|Adverse Event|9
898623|NCT00717093|1871273|FG001|Overall Study|Adverse Event|9
898624|NCT00717093|1871272|FG000|Overall Study|Lack of Efficacy|3
898625|NCT00717093|1871273|FG001|Overall Study|Lack of Efficacy|13
898626|NCT00717093|1871272|FG000|Overall Study|Lost to Follow-up|9
898627|NCT00717093|1871273|FG001|Overall Study|Lost to Follow-up|6
898628|NCT00717093|1871272|FG000|Overall Study|Withdrawal by Subject|12
898629|NCT00717093|1871273|FG001|Overall Study|Withdrawal by Subject|19
898630|NCT00717093|1871272|FG000|Overall Study|Other|0
898631|NCT00717093|1871273|FG001|Overall Study|Other|1
898632|NCT00717093|1871272|FG000|Overall Study|Randomized but not treated|1
898633|NCT00717093|1871273|FG001|Overall Study|Randomized but not treated|0
898634|NCT00717197|1871279|FG000|Overall Study|Unable to purchase study drug|5
898635|NCT00717197|1871279|FG000|Overall Study|Tumor Progression|1
898636|NCT00717197|1871279|FG000|Overall Study|Physician Decision|1
898637|NCT00717236|1871285|FG000|Double-Blind Period|Adverse Event|33
898638|NCT00717236|1871286|FG001|Double-Blind Period|Adverse Event|6
898639|NCT00717236|1871285|FG000|Double-Blind Period|Lack of Efficacy|6
898640|NCT00717236|1871286|FG001|Double-Blind Period|Lack of Efficacy|6
898641|NCT00717236|1871285|FG000|Double-Blind Period|Lost to Follow-up|3
898642|NCT00717236|1871286|FG001|Double-Blind Period|Lost to Follow-up|5
898643|NCT00717236|1871285|FG000|Double-Blind Period|Withdrawal by Subject|10
898644|NCT00717236|1871286|FG001|Double-Blind Period|Withdrawal by Subject|2
898645|NCT00717236|1871285|FG000|Double-Blind Period|Loss of efficacy|3
898646|NCT00717236|1871286|FG001|Double-Blind Period|Loss of efficacy|0
898647|NCT00717236|1871285|FG000|Double-Blind Period|Other: Death|1
898648|NCT00717236|1871286|FG001|Double-Blind Period|Other: Death|0
898649|NCT00717236|1871285|FG000|Double-Blind Period|Other: Pregnancy|1
898650|NCT00717236|1871286|FG001|Double-Blind Period|Other: Pregnancy|0
898651|NCT00717236|1871285|FG000|Double-Blind Period|Other: Protocol Violation|2
898652|NCT00717236|1871286|FG001|Double-Blind Period|Other: Protocol Violation|0
898653|NCT00717236|1871285|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
898654|NCT00717236|1871286|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
898655|NCT00717236|1871285|FG000|Double-Blind Period|Other: Site withdrew|2
898656|NCT00717236|1871286|FG001|Double-Blind Period|Other: Site withdrew|0
898657|NCT00717236|1871285|FG000|Double-Blind Period|Other: Screening failure|1
898658|NCT00717236|1871286|FG001|Double-Blind Period|Other: Screening failure|0
898659|NCT00717236|1871285|FG000|Double-Blind Period|Other: subject withdrew consent|1
898660|NCT00717236|1871286|FG001|Double-Blind Period|Other: subject withdrew consent|1
898661|NCT00717236|1871285|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2
898662|NCT00717236|1871286|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1
898663|NCT00717236|1871285|FG000|Double-Blind Period|Other: History of adenoid grown|1
898664|NCT00717236|1871286|FG001|Double-Blind Period|Other: History of adenoid grown|0
898665|NCT00717236|1871285|FG000|Double-Blind Period|Other: History of cancer|1
898666|NCT00717236|1871286|FG001|Double-Blind Period|Other: History of cancer|0
898667|NCT00717236|1871285|FG000|Double-Blind Period|Other: Sponsor request|1
898668|NCT00717236|1871286|FG001|Double-Blind Period|Other: Sponsor request|0
898669|NCT00717236|1871285|FG000|Double-Blind Period|Other: Inappropriate randomization|1
898670|NCT00717236|1871286|FG001|Double-Blind Period|Other: Inappropriate randomization|0
898671|NCT00717236|1871285|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
898672|NCT00717236|1871286|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
898673|NCT00717236|1871285|FG000|Double-Blind Period|Other: Subject moved|1
898674|NCT00717236|1871286|FG001|Double-Blind Period|Other: Subject moved|1
898675|NCT00717236|1871285|FG000|Double-Blind Period|Other: Stopped taking DMARD|1
898676|NCT00717236|1871286|FG001|Double-Blind Period|Other: Stopped taking DMARD|0
898677|NCT00717236|1871285|FG000|Double-Blind Period|Other: Prohibited medication taken|2
898678|NCT00717236|1871286|FG001|Double-Blind Period|Other: Prohibited medication taken|2
898679|NCT00717236|1871285|FG000|Double-Blind Period|Other: Transportation problems|0
898680|NCT00717236|1871286|FG001|Double-Blind Period|Other: Transportation problems|1
898681|NCT00717236|1871285|FG000|Double-Blind Period|Other: Investigator Decision|0
898682|NCT00717236|1871286|FG001|Double-Blind Period|Other: Investigator Decision|1
898683|NCT00717236|1871285|FG000|Open-Label Period|Adverse Event|29
898684|NCT00717236|1871286|FG001|Open-Label Period|Adverse Event|4
898685|NCT00717236|1871285|FG000|Open-Label Period|Lack of Efficacy|30
898686|NCT00717236|1871286|FG001|Open-Label Period|Lack of Efficacy|8
898687|NCT00717236|1871285|FG000|Open-Label Period|Lost to Follow-up|28
898688|NCT00717236|1871286|FG001|Open-Label Period|Lost to Follow-up|4
898689|NCT00717236|1871285|FG000|Open-Label Period|Withdrawal by Subject|20
898690|NCT00717236|1871286|FG001|Open-Label Period|Withdrawal by Subject|2
898691|NCT00717236|1871285|FG000|Open-Label Period|Loss of Efficacy|6
898692|NCT00717236|1871286|FG001|Open-Label Period|Loss of Efficacy|1
898693|NCT00717236|1871285|FG000|Open-Label Period|Other: Peripheral Neuropathy|0
898694|NCT00717236|1871286|FG001|Open-Label Period|Other: Peripheral Neuropathy|1
898695|NCT00717236|1871285|FG000|Open-Label Period|Other: Lack of Compliance|1
898696|NCT00717236|1871286|FG001|Open-Label Period|Other: Lack of Compliance|1
898697|NCT00717236|1871285|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1
898698|NCT00717236|1871286|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0
898699|NCT00717236|1871285|FG000|Open-Label Period|Other: Moved|1
898700|NCT00717236|1871286|FG001|Open-Label Period|Other: Moved|0
898701|NCT00717236|1871285|FG000|Open-Label Period|Other: Investigator Decision|1
898702|NCT00717236|1871286|FG001|Open-Label Period|Other: Investigator Decision|0
898703|NCT00717236|1871285|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1
898704|NCT00717236|1871286|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0
898705|NCT00717236|1871285|FG000|Open-Label Period|Other: Sponsor Request|3
898706|NCT00717236|1871286|FG001|Open-Label Period|Other: Sponsor Request|0
898707|NCT00717236|1871285|FG000|Open-Label Period|Other: Cataract Surgery|1
898708|NCT00717236|1871286|FG001|Open-Label Period|Other: Cataract Surgery|0
898709|NCT00717236|1871285|FG000|Open-Label Period|Other: Administration of Golimumab|1
898710|NCT00717236|1871286|FG001|Open-Label Period|Other: Administration of Golimumab|0
898711|NCT00717236|1871285|FG000|Open-Label Period|Other: Completion Accidently Performed|1
898712|NCT00717236|1871286|FG001|Open-Label Period|Other: Completion Accidently Performed|0
898713|NCT00717236|1871285|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1
898714|NCT00717236|1871286|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0
898715|NCT00717249|1871296|FG000|Overall Study|Lens Discomfort|4
898716|NCT00717249|1871297|FG001|Overall Study|Lens Discomfort|1
898717|NCT00717249|1871296|FG000|Overall Study|Unsatisfactory visual Response|0
898718|NCT00717249|1871297|FG001|Overall Study|Unsatisfactory visual Response|2
898719|NCT00717249|1871296|FG000|Overall Study|Adverse Event|4
898720|NCT00717249|1871297|FG001|Overall Study|Adverse Event|2
898721|NCT00717249|1871296|FG000|Overall Study|Lost to Follow-up|2
898722|NCT00717249|1871297|FG001|Overall Study|Lost to Follow-up|0
898723|NCT00717249|1871296|FG000|Overall Study|Withdrawal by Subject|1
898724|NCT00717249|1871297|FG001|Overall Study|Withdrawal by Subject|2
898725|NCT00717249|1871296|FG000|Overall Study|Pregnancy|6
898726|NCT00717249|1871297|FG001|Overall Study|Pregnancy|3
898727|NCT00717249|1871296|FG000|Overall Study|Protocol Violation|0
898728|NCT00717249|1871297|FG001|Overall Study|Protocol Violation|2
898729|NCT00717249|1871296|FG000|Overall Study|Subject became Ineligible|1
898730|NCT00717249|1871297|FG001|Overall Study|Subject became Ineligible|1
898731|NCT00717249|1871296|FG000|Overall Study|Unsatisfactory Physiological Response|0
898732|NCT00717249|1871297|FG001|Overall Study|Unsatisfactory Physiological Response|1
898733|NCT00717249|1871296|FG000|Overall Study|Gastric Surgery|0
898734|NCT00717249|1871297|FG001|Overall Study|Gastric Surgery|1
898735|NCT00717249|1871296|FG000|Overall Study|Diagnosed with Diabetes|1
898736|NCT00717249|1871297|FG001|Overall Study|Diagnosed with Diabetes|0
898737|NCT00717249|1871296|FG000|Overall Study|Diagnosed with Multiple Scletosis|1
898738|NCT00717249|1871297|FG001|Overall Study|Diagnosed with Multiple Scletosis|0
898739|NCT00717249|1871296|FG000|Overall Study|Subject relocated|1
898740|NCT00717249|1871297|FG001|Overall Study|Subject relocated|0
898741|NCT00717249|1871296|FG000|Overall Study|Headaches|1
898742|NCT00717249|1871297|FG001|Overall Study|Headaches|0
898743|NCT00717314|1871324|FG000|Overall Study|Adverse Event|3
898744|NCT00717314|1871325|FG001|Overall Study|Adverse Event|2
898745|NCT00717314|1871324|FG000|Overall Study|Protocol Violation|1
898746|NCT00717314|1871325|FG001|Overall Study|Protocol Violation|0
898747|NCT00717314|1871324|FG000|Overall Study|Lost to Follow-up|1
898748|NCT00717314|1871325|FG001|Overall Study|Lost to Follow-up|5
898749|NCT00717314|1871324|FG000|Overall Study|Withdrawal by Subject|1
898750|NCT00717314|1871325|FG001|Overall Study|Withdrawal by Subject|3
898751|NCT00717366|1871333|FG000|Core Study Period (20 Weeks)|Renal transplant|4
898752|NCT00717366|1871334|FG001|Core Study Period (20 Weeks)|Renal transplant|9
898753|NCT00717366|1871333|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0
898754|NCT00717366|1871334|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2
898755|NCT00717366|1871333|FG000|Core Study Period (20 Weeks)|Death|0
898756|NCT00717366|1871334|FG001|Core Study Period (20 Weeks)|Death|1
898757|NCT00717366|1871333|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
898758|NCT00717366|1871334|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
898759|NCT00717366|1871333|FG000|Extension Period (52 Weeks)|Renal transplant|3
898760|NCT00717366|1871334|FG001|Extension Period (52 Weeks)|Renal transplant|13
898761|NCT00717366|1871333|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0
898762|NCT00717366|1871334|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2
898763|NCT00717366|1871333|FG000|Extension Period (52 Weeks)|Withdrew consent|1
898764|NCT00717366|1871334|FG001|Extension Period (52 Weeks)|Withdrew consent|1
898765|NCT00717522|1871355|FG000|Overall Study|Disease Progression|5
898766|NCT00717522|1871355|FG000|Overall Study|Adverse Event|1
898767|NCT00717522|1871355|FG000|Overall Study|Death|1
898768|NCT00717756|1871372|FG000|Overall Study|Withdrawal by Subject|1
898769|NCT00717769|1871379|FG000|Overall Study|Adverse Event|9
898770|NCT00717769|1871380|FG001|Overall Study|Adverse Event|6
898771|NCT00717769|1871381|FG002|Overall Study|Adverse Event|1
898772|NCT00717769|1871379|FG000|Overall Study|Lack of compliance|0
898773|NCT00717769|1871380|FG001|Overall Study|Lack of compliance|2
898774|NCT00717769|1871381|FG002|Overall Study|Lack of compliance|0
898775|NCT00717769|1871379|FG000|Overall Study|Lost to Follow-up|3
898776|NCT00717769|1871380|FG001|Overall Study|Lost to Follow-up|4
898777|NCT00717769|1871381|FG002|Overall Study|Lost to Follow-up|0
898778|NCT00717769|1871379|FG000|Overall Study|Lack of Efficacy|1
898779|NCT00717769|1871380|FG001|Overall Study|Lack of Efficacy|2
898780|NCT00717769|1871381|FG002|Overall Study|Lack of Efficacy|0
898781|NCT00717769|1871379|FG000|Overall Study|Protocol Violation|0
898782|NCT00717769|1871380|FG001|Overall Study|Protocol Violation|2
898783|NCT00717769|1871381|FG002|Overall Study|Protocol Violation|0
898784|NCT00717769|1871379|FG000|Overall Study|Sponsor decision|1
898785|NCT00717769|1871380|FG001|Overall Study|Sponsor decision|0
898786|NCT00717769|1871381|FG002|Overall Study|Sponsor decision|10
898787|NCT00717769|1871379|FG000|Overall Study|Withdrew consent|2
898788|NCT00717769|1871380|FG001|Overall Study|Withdrew consent|2
898789|NCT00717769|1871381|FG002|Overall Study|Withdrew consent|0
898790|NCT00717860|1871393|FG000|Overall Study|Clinical adverse experience|5
898791|NCT00717860|1871394|FG001|Overall Study|Clinical adverse experience|9
898792|NCT00717860|1871393|FG000|Overall Study|Laboratory adverse experience|2
898793|NCT00717860|1871394|FG001|Overall Study|Laboratory adverse experience|2
898794|NCT00717860|1871393|FG000|Overall Study|Lack of Efficacy|7
898795|NCT00717860|1871394|FG001|Overall Study|Lack of Efficacy|13
898796|NCT00717860|1871393|FG000|Overall Study|Discontinued for other reason|6
898797|NCT00717860|1871394|FG001|Overall Study|Discontinued for other reason|1
898798|NCT00717860|1871393|FG000|Overall Study|Withdrew consent|7
898799|NCT00717860|1871394|FG001|Overall Study|Withdrew consent|3
898800|NCT00717886|1871409|FG000|Overall Study|Withdrawal by Subject|3
898801|NCT00717886|1871409|FG000|Overall Study|Treatment Failure|1
898802|NCT00718042|1871437|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
898803|NCT00718042|1871438|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
898804|NCT00718042|1871439|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
898805|NCT00718042|1871440|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
898806|NCT00718042|1871441|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
898807|NCT00718042|1871442|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
898808|NCT00718042|1871437|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64
898809|NCT00718042|1871438|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0
898810|NCT00718042|1871439|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0
898811|NCT00718042|1871440|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0
898812|NCT00718042|1871441|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36
898813|NCT00718042|1871442|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0
898814|NCT00718042|1871437|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0
898815|NCT00718042|1871438|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1
898816|NCT00718042|1871439|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1
898817|NCT00718042|1871440|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0
898818|NCT00718042|1871441|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0
898819|NCT00718042|1871442|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0
898820|NCT00718042|1871437|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
898821|NCT00718042|1871438|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
898822|NCT00718042|1871439|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
898823|NCT00718042|1871440|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
898824|NCT00718042|1871441|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
898825|NCT00718042|1871442|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
898826|NCT00718042|1871437|FG000|Donor Follow-up|Lost to Follow-up|13
898827|NCT00718042|1871438|FG001|Donor Follow-up|Lost to Follow-up|0
898828|NCT00718042|1871439|FG002|Donor Follow-up|Lost to Follow-up|0
898829|NCT00718042|1871440|FG003|Donor Follow-up|Lost to Follow-up|0
898830|NCT00718042|1871441|FG004|Donor Follow-up|Lost to Follow-up|19
898831|NCT00718042|1871442|FG005|Donor Follow-up|Lost to Follow-up|0
898832|NCT00718081|1871457|FG000|Overall Study|Adverse Event|0
898833|NCT00718081|1871458|FG001|Overall Study|Adverse Event|1
898834|NCT00718081|1871459|FG002|Overall Study|Adverse Event|0
898835|NCT00718081|1871457|FG000|Overall Study|Lack of Efficacy|7
898836|NCT00718081|1871458|FG001|Overall Study|Lack of Efficacy|3
898837|NCT00718081|1871459|FG002|Overall Study|Lack of Efficacy|21
898838|NCT00718159|1871492|FG000|Overall Study|Progressive Disease|3
898839|NCT00718159|1871493|FG001|Overall Study|Progressive Disease|3
898840|NCT00718159|1871494|FG002|Overall Study|Progressive Disease|2
898841|NCT00718159|1871495|FG003|Overall Study|Progressive Disease|0
898842|NCT00718159|1871496|FG004|Overall Study|Progressive Disease|6
898843|NCT00718159|1871497|FG005|Overall Study|Progressive Disease|0
898844|NCT00718159|1871498|FG006|Overall Study|Progressive Disease|0
898845|NCT00718159|1871492|FG000|Overall Study|Death due to Adverse Event|0
898846|NCT00718159|1871493|FG001|Overall Study|Death due to Adverse Event|0
898847|NCT00718159|1871494|FG002|Overall Study|Death due to Adverse Event|0
898848|NCT00718159|1871495|FG003|Overall Study|Death due to Adverse Event|2
898849|NCT00718159|1871496|FG004|Overall Study|Death due to Adverse Event|2
898850|NCT00718159|1871497|FG005|Overall Study|Death due to Adverse Event|0
898851|NCT00718159|1871498|FG006|Overall Study|Death due to Adverse Event|0
898852|NCT00718159|1871492|FG000|Overall Study|Death due to Study Drug Toxicity|0
1124784|NCT02637856|2214787|FG001|Main Study (Baseline to Week 100)|Adverse Event|0
1124785|NCT02637856|2214786|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5
1124786|NCT02637856|2214787|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0
1124787|NCT02637856|2214786|FG000|Main Study (Baseline to Week 100)|Physician Decision|2
1124788|NCT02637856|2214787|FG001|Main Study (Baseline to Week 100)|Physician Decision|0
1124789|NCT02637856|2214786|FG000|Main Study (Baseline to Week 100)|Pregnancy|7
1124790|NCT02637856|2214787|FG001|Main Study (Baseline to Week 100)|Pregnancy|0
1124791|NCT02637856|2214786|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
1124792|NCT02637856|2214787|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
1124793|NCT02637856|2214786|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2
1124794|NCT02637856|2214787|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0
1124795|NCT02637856|2214786|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
1124796|NCT02637856|2214787|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
1124797|NCT02637856|2214786|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1
1124798|NCT02637856|2214787|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0
1124799|NCT02637856|2214786|FG000|Main Study (Baseline to Week 100)|Incarceration|1
1124800|NCT02637856|2214787|FG001|Main Study (Baseline to Week 100)|Incarceration|0
1124801|NCT02637856|2214786|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
1124802|NCT02637856|2214787|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
1124803|NCT02637856|2214786|FG000|Main Study (Baseline to Week 100)|Site Closing|6
1124804|NCT02637856|2214787|FG001|Main Study (Baseline to Week 100)|Site Closing|0
1124805|NCT02637856|2214786|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
1124806|NCT02637856|2214787|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
1124807|NCT02637856|2214786|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
1124808|NCT02637856|2214787|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
1124809|NCT02637895|2214795|FG000|Overall Study|Lost to Follow-up|4
1124810|NCT02637895|2214796|FG001|Overall Study|Lost to Follow-up|0
1124811|NCT02637895|2214795|FG000|Overall Study|Protocol Violation|0
1124812|NCT02637895|2214796|FG001|Overall Study|Protocol Violation|1
1124813|NCT02637895|2214795|FG000|Overall Study|Lack of Efficacy|1
1124814|NCT02637895|2214796|FG001|Overall Study|Lack of Efficacy|0
1124815|NCT02637895|2214795|FG000|Overall Study|Withdrawal by Subject|1
1124816|NCT02637895|2214796|FG001|Overall Study|Withdrawal by Subject|1
1124817|NCT02637895|2214795|FG000|Overall Study|Abnormal baseline lab|0
1124818|NCT02637895|2214796|FG001|Overall Study|Abnormal baseline lab|1
1124819|NCT02638012|2214816|FG000|Overall Study|Lost to Follow-up|1
1124820|NCT02638103|2214833|FG000|Overall Study|Adverse Event|13
1124821|NCT02638103|2214834|FG001|Overall Study|Adverse Event|12
1124822|NCT02638103|2214835|FG002|Overall Study|Adverse Event|19
1124823|NCT02638103|2214836|FG003|Overall Study|Adverse Event|12
1124824|NCT02638103|2214833|FG000|Overall Study|Withdrawal by Subject|43
1124825|NCT02638103|2214834|FG001|Overall Study|Withdrawal by Subject|53
1124826|NCT02638103|2214835|FG002|Overall Study|Withdrawal by Subject|30
1124827|NCT02638103|2214836|FG003|Overall Study|Withdrawal by Subject|61
1124828|NCT02638103|2214833|FG000|Overall Study|Protocol Violation|1
1124829|NCT02638103|2214834|FG001|Overall Study|Protocol Violation|2
1124830|NCT02638103|2214835|FG002|Overall Study|Protocol Violation|1
1124831|NCT02638103|2214836|FG003|Overall Study|Protocol Violation|4
1124832|NCT02638103|2214833|FG000|Overall Study|Pregnancy|2
1124833|NCT02638103|2214834|FG001|Overall Study|Pregnancy|3
1124834|NCT02638103|2214835|FG002|Overall Study|Pregnancy|0
1124835|NCT02638103|2214836|FG003|Overall Study|Pregnancy|1
1124836|NCT02638103|2214833|FG000|Overall Study|Non-compliance to Study Procedures|2
1124837|NCT02638103|2214834|FG001|Overall Study|Non-compliance to Study Procedures|1
1124838|NCT02638103|2214835|FG002|Overall Study|Non-compliance to Study Procedures|1
1124839|NCT02638103|2214836|FG003|Overall Study|Non-compliance to Study Procedures|1
1124840|NCT02638103|2214833|FG000|Overall Study|Lost to Follow-up|26
1124841|NCT02638103|2214834|FG001|Overall Study|Lost to Follow-up|33
1124842|NCT02638103|2214835|FG002|Overall Study|Lost to Follow-up|20
1124843|NCT02638103|2214836|FG003|Overall Study|Lost to Follow-up|37
1124844|NCT02638103|2214833|FG000|Overall Study|Lack of Efficacy|14
1124845|NCT02638103|2214834|FG001|Overall Study|Lack of Efficacy|10
1124846|NCT02638103|2214835|FG002|Overall Study|Lack of Efficacy|12
1124847|NCT02638103|2214836|FG003|Overall Study|Lack of Efficacy|22
1124848|NCT02638103|2214833|FG000|Overall Study|Other than specified|5
1124849|NCT02638103|2214834|FG001|Overall Study|Other than specified|4
1124850|NCT02638103|2214835|FG002|Overall Study|Other than specified|2
1124851|NCT02638103|2214836|FG003|Overall Study|Other than specified|4
1124852|NCT02638259|2214876|FG000|Treatment Period 1|Adverse Event|1
1124853|NCT02638259|2214877|FG001|Treatment Period 1|Adverse Event|5
1124854|NCT02638259|2214876|FG000|Treatment Period 1|Death|0
1124855|NCT02638259|2214877|FG001|Treatment Period 1|Death|1
1124856|NCT02638259|2214876|FG000|Treatment Period 1|Lack of Efficacy|0
1124857|NCT02638259|2214877|FG001|Treatment Period 1|Lack of Efficacy|1
1124858|NCT02638259|2214876|FG000|Treatment Period 1|Protocol Violation|0
1124859|NCT02638259|2214877|FG001|Treatment Period 1|Protocol Violation|3
1124860|NCT02638259|2214876|FG000|Treatment Period 1|Withdrawal by Subject|4
1124861|NCT02638259|2214877|FG001|Treatment Period 1|Withdrawal by Subject|6
1124862|NCT02638259|2214876|FG000|Treatment Period 1|Withdrawn per sponsor decision|0
1124863|NCT02638259|2214877|FG001|Treatment Period 1|Withdrawn per sponsor decision|2
1124864|NCT02638259|2214876|FG000|Treatment Period 2|Adverse Event|5
1124865|NCT02638259|2214877|FG001|Treatment Period 2|Adverse Event|4
1124866|NCT02638259|2214876|FG000|Treatment Period 2|Withdrawal by Subject|1
1124867|NCT02638259|2214877|FG001|Treatment Period 2|Withdrawal by Subject|7
1124868|NCT02638337|2214889|FG000|Overall Study|Adverse Event|6
1124869|NCT02638337|2214890|FG001|Overall Study|Adverse Event|10
1124870|NCT02638337|2214889|FG000|Overall Study|Protocol Violation|3
1124871|NCT02638337|2214890|FG001|Overall Study|Protocol Violation|0
1124872|NCT02638337|2214889|FG000|Overall Study|Withdrawal by Subject|13
1124873|NCT02638337|2214890|FG001|Overall Study|Withdrawal by Subject|16
1124874|NCT02638337|2214889|FG000|Overall Study|Lost to Follow-up|7
1124875|NCT02638337|2214890|FG001|Overall Study|Lost to Follow-up|7
1124876|NCT02638337|2214889|FG000|Overall Study|Other - Miscellaneous|4
1124877|NCT02638337|2214890|FG001|Overall Study|Other - Miscellaneous|3
1124878|NCT02638493|2214899|FG000|Overall Study|Inability to provide semen samples|2
1124879|NCT02638493|2214900|FG001|Overall Study|Inability to provide semen samples|0
1124880|NCT02638493|2214901|FG002|Overall Study|Inability to provide semen samples|0
1124881|NCT02638623|2214922|FG000|Overall Study|Surgery timing|5
1124882|NCT02638623|2214923|FG001|Overall Study|Surgery timing|6
1124883|NCT02638623|2214922|FG000|Overall Study|Not given intervention|2
1124884|NCT02638623|2214923|FG001|Overall Study|Not given intervention|0
1124885|NCT02638948|2214933|FG000|Overall Study|Withdrawal by Subject|4
1124886|NCT02638948|2214934|FG001|Overall Study|Withdrawal by Subject|5
1124887|NCT02638948|2214935|FG002|Overall Study|Withdrawal by Subject|3
1124888|NCT02638948|2214936|FG003|Overall Study|Withdrawal by Subject|1
1124889|NCT02638948|2214933|FG000|Overall Study|Administrative Reason by Sponsor|0
1124890|NCT02638948|2214934|FG001|Overall Study|Administrative Reason by Sponsor|1
1124891|NCT02638948|2214935|FG002|Overall Study|Administrative Reason by Sponsor|0
1124892|NCT02638948|2214936|FG003|Overall Study|Administrative Reason by Sponsor|4
1124893|NCT02638948|2214933|FG000|Overall Study|Adverse Event|0
1124894|NCT02638948|2214934|FG001|Overall Study|Adverse Event|0
1124895|NCT02638948|2214935|FG002|Overall Study|Adverse Event|1
1124896|NCT02638948|2214936|FG003|Overall Study|Adverse Event|1
1124897|NCT02638948|2214933|FG000|Overall Study|Lack of Efficacy|1
1124898|NCT02638948|2214934|FG001|Overall Study|Lack of Efficacy|1
1124899|NCT02638948|2214935|FG002|Overall Study|Lack of Efficacy|0
1124900|NCT02638948|2214936|FG003|Overall Study|Lack of Efficacy|0
1124901|NCT02638948|2214933|FG000|Overall Study|Lost to Follow-up|0
1124902|NCT02638948|2214934|FG001|Overall Study|Lost to Follow-up|0
1124903|NCT02638948|2214935|FG002|Overall Study|Lost to Follow-up|1
1124904|NCT02638948|2214936|FG003|Overall Study|Lost to Follow-up|1
1124905|NCT02638948|2214933|FG000|Overall Study|Poor/Non-Compliance|0
1124906|NCT02638948|2214934|FG001|Overall Study|Poor/Non-Compliance|2
1124907|NCT02638948|2214935|FG002|Overall Study|Poor/Non-Compliance|1
1124908|NCT02638948|2214936|FG003|Overall Study|Poor/Non-Compliance|0
1124909|NCT02638948|2214933|FG000|Overall Study|Participant no longer met study criteria|0
1124910|NCT02638948|2214934|FG001|Overall Study|Participant no longer met study criteria|1
1124911|NCT02638948|2214935|FG002|Overall Study|Participant no longer met study criteria|0
1124912|NCT02638948|2214936|FG003|Overall Study|Participant no longer met study criteria|0
1124913|NCT02638948|2214933|FG000|Overall Study|Other than specified above|4
1124914|NCT02638948|2214934|FG001|Overall Study|Other than specified above|1
1124915|NCT02638948|2214935|FG002|Overall Study|Other than specified above|1
1124916|NCT02638948|2214936|FG003|Overall Study|Other than specified above|1
1124917|NCT02639052|2214958|FG000|Overall Study|Lost to Follow-up|1
1124918|NCT02639247|2214975|FG000|Overall Study|Lost to Follow-up|2
1124919|NCT02639247|2214976|FG001|Overall Study|Lost to Follow-up|1
1124920|NCT02639247|2214975|FG000|Overall Study|Death|2
1124921|NCT02639247|2214976|FG001|Overall Study|Death|0
1124922|NCT02639247|2214975|FG000|Overall Study|Withdrew Consent|0
1124923|NCT02639247|2214976|FG001|Overall Study|Withdrew Consent|1
1124924|NCT02639247|2214975|FG000|Overall Study|Protocol Violation|1
1124925|NCT02639247|2214976|FG001|Overall Study|Protocol Violation|0
1124926|NCT02639338|2214993|FG000|Overall Study|Lost to Follow-up|2
1124927|NCT02639338|2214994|FG001|Overall Study|Lost to Follow-up|2
1124928|NCT02639338|2214993|FG000|Overall Study|Withdrew Consent|1
1124929|NCT02639338|2214994|FG001|Overall Study|Withdrew Consent|2
1124930|NCT02639338|2214993|FG000|Overall Study|Death|1
1124931|NCT02639338|2214994|FG001|Overall Study|Death|0
1124932|NCT02639338|2214993|FG000|Overall Study|Randomized but Not Treated|0
1124933|NCT02639338|2214994|FG001|Overall Study|Randomized but Not Treated|1
1124934|NCT02639559|2215038|FG000|Overall Study|Mobilization failure|0
1124935|NCT02639559|2215039|FG001|Overall Study|Mobilization failure|3
1124936|NCT02639559|2215038|FG000|Overall Study|Issues with vascular acess|1
1124937|NCT02639559|2215039|FG001|Overall Study|Issues with vascular acess|0
1124938|NCT02640053|2215083|FG000|Overall Study|Withdrawal by Subject|2
1124939|NCT02640053|2215084|FG001|Overall Study|Withdrawal by Subject|1
1124940|NCT02640053|2215083|FG000|Overall Study|Adverse Event|1
1124941|NCT02640053|2215084|FG001|Overall Study|Adverse Event|1
1124942|NCT02640053|2215083|FG000|Overall Study|Alternative Therapy|1
1124943|NCT02640053|2215084|FG001|Overall Study|Alternative Therapy|1
1124944|NCT02640053|2215083|FG000|Overall Study|Chemo regimen changed after 1st Rx|0
1124945|NCT02640053|2215084|FG001|Overall Study|Chemo regimen changed after 1st Rx|1
1124946|NCT02640157|2215093|FG000|Overall Study|Adverse Event|2
1124947|NCT02640157|2215094|FG001|Overall Study|Adverse Event|2
1124948|NCT02640157|2215095|FG002|Overall Study|Adverse Event|1
1124949|NCT02640157|2215093|FG000|Overall Study|Withdrew consent|2
1124950|NCT02640157|2215094|FG001|Overall Study|Withdrew consent|0
1124951|NCT02640157|2215095|FG002|Overall Study|Withdrew consent|2
1124952|NCT02640157|2215093|FG000|Overall Study|Lost to Follow-up|9
1124953|NCT02640157|2215094|FG001|Overall Study|Lost to Follow-up|2
1124954|NCT02640157|2215095|FG002|Overall Study|Lost to Follow-up|7
1124955|NCT02640157|2215093|FG000|Overall Study|Randomized in error; did not receive Tx|0
1162081|NCT03382899|2284097|FG000|Overall Study|Withdrawal by Subject|0
1124956|NCT02640157|2215094|FG001|Overall Study|Randomized in error; did not receive Tx|1
1124957|NCT02640157|2215095|FG002|Overall Study|Randomized in error; did not receive Tx|0
1124958|NCT02640235|2215106|FG000|Overall Study|Withdrawal by Subject|7
1124959|NCT02640235|2215107|FG001|Overall Study|Withdrawal by Subject|6
1124960|NCT02640235|2215106|FG000|Overall Study|Lost to Follow-up|4
1124961|NCT02640235|2215107|FG001|Overall Study|Lost to Follow-up|3
1124962|NCT02640235|2215106|FG000|Overall Study|Death|2
1124963|NCT02640235|2215107|FG001|Overall Study|Death|3
1124964|NCT02640235|2215106|FG000|Overall Study|Other|1
1124965|NCT02640235|2215107|FG001|Overall Study|Other|2
1124966|NCT02640404|2215115|FG000|Overall Study|Protocol Violation|1
1124967|NCT02640404|2215116|FG001|Overall Study|Protocol Violation|0
1124968|NCT02640404|2215115|FG000|Overall Study|Withdrawal by Subject|1
1124969|NCT02640404|2215116|FG001|Overall Study|Withdrawal by Subject|0
1124970|NCT02640482|2215124|FG000|Overall Study|Lost to Follow-up|3
1124971|NCT02640482|2215125|FG001|Overall Study|Lost to Follow-up|0
1124972|NCT02640547|2215131|FG000|Overall Study|Failure to Return|1
1124973|NCT02640547|2215131|FG000|Overall Study|Withdrawal by Subject|1
1124974|NCT02640547|2215131|FG000|Overall Study|Death|6
1124975|NCT02640547|2215131|FG000|Overall Study|Miscellaneous|3
1124976|NCT02640612|2215146|FG000|Overall Study|Adverse Event|6
1124977|NCT02640612|2215147|FG001|Overall Study|Adverse Event|7
1124978|NCT02640612|2215148|FG002|Overall Study|Adverse Event|2
1124979|NCT02640612|2215146|FG000|Overall Study|Death|1
1124980|NCT02640612|2215147|FG001|Overall Study|Death|0
1124981|NCT02640612|2215148|FG002|Overall Study|Death|0
1124982|NCT02640612|2215146|FG000|Overall Study|Withdrawal by Subject|10
1124983|NCT02640612|2215147|FG001|Overall Study|Withdrawal by Subject|3
1124984|NCT02640612|2215148|FG002|Overall Study|Withdrawal by Subject|3
1124985|NCT02640612|2215146|FG000|Overall Study|Lost to Follow-up|4
1124986|NCT02640612|2215147|FG001|Overall Study|Lost to Follow-up|1
1124987|NCT02640612|2215148|FG002|Overall Study|Lost to Follow-up|1
1124988|NCT02640612|2215146|FG000|Overall Study|Protocol Violation|0
1124989|NCT02640612|2215147|FG001|Overall Study|Protocol Violation|2
1124990|NCT02640612|2215148|FG002|Overall Study|Protocol Violation|0
1124991|NCT02640612|2215146|FG000|Overall Study|Lack of Efficacy|1
1124992|NCT02640612|2215147|FG001|Overall Study|Lack of Efficacy|1
1124993|NCT02640612|2215148|FG002|Overall Study|Lack of Efficacy|0
1124995|NCT02640755|2215172|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
1124996|NCT02640755|2215173|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
1124997|NCT02640755|2215172|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
1124998|NCT02640755|2215173|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
1124999|NCT02640755|2215172|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
1125000|NCT02640755|2215173|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
1125001|NCT02641080|2215204|FG000|Overall Study|Physician Decision|2
1125002|NCT02641080|2215205|FG001|Overall Study|Physician Decision|0
1125003|NCT02641080|2215204|FG000|Overall Study|Withdrawal by Subject|0
1125004|NCT02641080|2215205|FG001|Overall Study|Withdrawal by Subject|1
1125005|NCT02641080|2215204|FG000|Overall Study|Rehab Center denied use of pumps|0
1125006|NCT02641080|2215205|FG001|Overall Study|Rehab Center denied use of pumps|3
1125007|NCT02641080|2215204|FG000|Overall Study|Lost to Follow-up|0
1125008|NCT02641080|2215205|FG001|Overall Study|Lost to Follow-up|3
1125009|NCT02641379|2215243|FG000|Overall Study|Exclusion criterion during screening|1
1125010|NCT02641379|2215244|FG001|Overall Study|Exclusion criterion during screening|0
1125011|NCT02641379|2215245|FG002|Overall Study|Exclusion criterion during screening|0
1125012|NCT02641379|2215246|FG003|Overall Study|Exclusion criterion during screening|1
1125013|NCT02641379|2215247|FG004|Overall Study|Exclusion criterion during screening|2
1125014|NCT02641379|2215248|FG005|Overall Study|Exclusion criterion during screening|0
1125015|NCT02641379|2215249|FG006|Overall Study|Exclusion criterion during screening|0
1125016|NCT02641379|2215250|FG007|Overall Study|Exclusion criterion during screening|0
1125017|NCT02641379|2215251|FG008|Overall Study|Exclusion criterion during screening|0
1125018|NCT02641379|2215252|FG009|Overall Study|Exclusion criterion during screening|0
1125019|NCT02641379|2215253|FG010|Overall Study|Exclusion criterion during screening|0
1125020|NCT02641379|2215243|FG000|Overall Study|Withdrawal of informed consent|0
1125021|NCT02641379|2215244|FG001|Overall Study|Withdrawal of informed consent|1
1125022|NCT02641379|2215245|FG002|Overall Study|Withdrawal of informed consent|0
1125023|NCT02641379|2215246|FG003|Overall Study|Withdrawal of informed consent|0
1125024|NCT02641379|2215247|FG004|Overall Study|Withdrawal of informed consent|0
1125025|NCT02641379|2215248|FG005|Overall Study|Withdrawal of informed consent|0
1125026|NCT02641379|2215249|FG006|Overall Study|Withdrawal of informed consent|0
1125027|NCT02641379|2215250|FG007|Overall Study|Withdrawal of informed consent|1
1125028|NCT02641379|2215251|FG008|Overall Study|Withdrawal of informed consent|0
1125029|NCT02641379|2215252|FG009|Overall Study|Withdrawal of informed consent|0
1125030|NCT02641379|2215253|FG010|Overall Study|Withdrawal of informed consent|0
1125031|NCT02641379|2215243|FG000|Overall Study|Adverse Event|7
1125032|NCT02641379|2215244|FG001|Overall Study|Adverse Event|8
1125033|NCT02641379|2215245|FG002|Overall Study|Adverse Event|2
1125034|NCT02641379|2215246|FG003|Overall Study|Adverse Event|2
1125035|NCT02641379|2215247|FG004|Overall Study|Adverse Event|5
1125036|NCT02641379|2215248|FG005|Overall Study|Adverse Event|1
1125037|NCT02641379|2215249|FG006|Overall Study|Adverse Event|5
1125038|NCT02641379|2215250|FG007|Overall Study|Adverse Event|0
1125039|NCT02641379|2215251|FG008|Overall Study|Adverse Event|1
1125040|NCT02641379|2215252|FG009|Overall Study|Adverse Event|1
1125041|NCT02641379|2215253|FG010|Overall Study|Adverse Event|5
1125042|NCT02641379|2215243|FG000|Overall Study|Lack of Efficacy|0
1125043|NCT02641379|2215244|FG001|Overall Study|Lack of Efficacy|0
1125044|NCT02641379|2215245|FG002|Overall Study|Lack of Efficacy|2
1125045|NCT02641379|2215246|FG003|Overall Study|Lack of Efficacy|0
1125046|NCT02641379|2215247|FG004|Overall Study|Lack of Efficacy|0
1125047|NCT02641379|2215248|FG005|Overall Study|Lack of Efficacy|2
1125048|NCT02641379|2215249|FG006|Overall Study|Lack of Efficacy|0
1125049|NCT02641379|2215250|FG007|Overall Study|Lack of Efficacy|5
1125050|NCT02641379|2215251|FG008|Overall Study|Lack of Efficacy|0
1125051|NCT02641379|2215252|FG009|Overall Study|Lack of Efficacy|0
1125052|NCT02641379|2215253|FG010|Overall Study|Lack of Efficacy|0
1125053|NCT02641379|2215243|FG000|Overall Study|Participant unable to attend study visit|4
1125054|NCT02641379|2215244|FG001|Overall Study|Participant unable to attend study visit|10
1125055|NCT02641379|2215245|FG002|Overall Study|Participant unable to attend study visit|1
1125056|NCT02641379|2215246|FG003|Overall Study|Participant unable to attend study visit|2
1125057|NCT02641379|2215247|FG004|Overall Study|Participant unable to attend study visit|5
1125058|NCT02641379|2215248|FG005|Overall Study|Participant unable to attend study visit|1
1125059|NCT02641379|2215249|FG006|Overall Study|Participant unable to attend study visit|1
1125060|NCT02641379|2215250|FG007|Overall Study|Participant unable to attend study visit|1
1125061|NCT02641379|2215251|FG008|Overall Study|Participant unable to attend study visit|0
1125062|NCT02641379|2215252|FG009|Overall Study|Participant unable to attend study visit|2
1125063|NCT02641379|2215253|FG010|Overall Study|Participant unable to attend study visit|0
1125064|NCT02641379|2215243|FG000|Overall Study|Participant's compliance|0
1125065|NCT02641379|2215244|FG001|Overall Study|Participant's compliance|1
1125066|NCT02641379|2215245|FG002|Overall Study|Participant's compliance|0
1125067|NCT02641379|2215246|FG003|Overall Study|Participant's compliance|1
1125068|NCT02641379|2215247|FG004|Overall Study|Participant's compliance|0
1125069|NCT02641379|2215248|FG005|Overall Study|Participant's compliance|2
1125070|NCT02641379|2215249|FG006|Overall Study|Participant's compliance|0
898853|NCT00718159|1871493|FG001|Overall Study|Death due to Study Drug Toxicity|0
898854|NCT00718159|1871494|FG002|Overall Study|Death due to Study Drug Toxicity|1
898855|NCT00718159|1871495|FG003|Overall Study|Death due to Study Drug Toxicity|2
898856|NCT00718159|1871496|FG004|Overall Study|Death due to Study Drug Toxicity|0
898857|NCT00718159|1871497|FG005|Overall Study|Death due to Study Drug Toxicity|0
898858|NCT00718159|1871498|FG006|Overall Study|Death due to Study Drug Toxicity|0
898859|NCT00718159|1871492|FG000|Overall Study|Investigator Decision|0
898860|NCT00718159|1871493|FG001|Overall Study|Investigator Decision|0
898861|NCT00718159|1871494|FG002|Overall Study|Investigator Decision|0
898862|NCT00718159|1871495|FG003|Overall Study|Investigator Decision|0
898863|NCT00718159|1871496|FG004|Overall Study|Investigator Decision|0
898864|NCT00718159|1871497|FG005|Overall Study|Investigator Decision|1
898865|NCT00718159|1871498|FG006|Overall Study|Investigator Decision|1
898866|NCT00718237|1871516|FG000|Overall Study|Adverse Event|1
898867|NCT00718237|1871517|FG001|Overall Study|Adverse Event|3
898868|NCT00718237|1871516|FG000|Overall Study|Lost to Follow-up|2
898869|NCT00718237|1871517|FG001|Overall Study|Lost to Follow-up|2
898870|NCT00718237|1871516|FG000|Overall Study|Physician Decision|1
898871|NCT00718237|1871517|FG001|Overall Study|Physician Decision|0
898872|NCT00718237|1871516|FG000|Overall Study|Withdrawal by Subject|9
898873|NCT00718237|1871517|FG001|Overall Study|Withdrawal by Subject|10
898874|NCT00718315|1871539|FG000|Overall Study|Adverse Event|1
898875|NCT00718315|1871540|FG001|Overall Study|Adverse Event|2
898876|NCT00718315|1871541|FG002|Overall Study|Adverse Event|3
898877|NCT00718315|1871539|FG000|Overall Study|Death|6
898878|NCT00718315|1871540|FG001|Overall Study|Death|6
898879|NCT00718315|1871541|FG002|Overall Study|Death|5
898880|NCT00718315|1871539|FG000|Overall Study|Lost to Follow-up|2
898881|NCT00718315|1871540|FG001|Overall Study|Lost to Follow-up|3
898882|NCT00718315|1871541|FG002|Overall Study|Lost to Follow-up|4
898883|NCT00718315|1871539|FG000|Overall Study|Protocol Violation|5
898884|NCT00718315|1871540|FG001|Overall Study|Protocol Violation|5
898885|NCT00718315|1871541|FG002|Overall Study|Protocol Violation|3
898886|NCT00718315|1871539|FG000|Overall Study|Erlotinib dose decreased|4
898887|NCT00718315|1871540|FG001|Overall Study|Erlotinib dose decreased|3
898888|NCT00718315|1871541|FG002|Overall Study|Erlotinib dose decreased|1
1125071|NCT02641379|2215250|FG007|Overall Study|Participant's compliance|0
1125072|NCT02641379|2215251|FG008|Overall Study|Participant's compliance|1
1125073|NCT02641379|2215252|FG009|Overall Study|Participant's compliance|1
1125074|NCT02641379|2215253|FG010|Overall Study|Participant's compliance|1
1125075|NCT02641379|2215243|FG000|Overall Study|Participant cannot be reached|4
1125076|NCT02641379|2215244|FG001|Overall Study|Participant cannot be reached|4
1125077|NCT02641379|2215245|FG002|Overall Study|Participant cannot be reached|0
1125078|NCT02641379|2215246|FG003|Overall Study|Participant cannot be reached|8
1125079|NCT02641379|2215247|FG004|Overall Study|Participant cannot be reached|2
1125080|NCT02641379|2215248|FG005|Overall Study|Participant cannot be reached|1
1125081|NCT02641379|2215249|FG006|Overall Study|Participant cannot be reached|0
1125082|NCT02641379|2215250|FG007|Overall Study|Participant cannot be reached|1
1125083|NCT02641379|2215251|FG008|Overall Study|Participant cannot be reached|0
1125084|NCT02641379|2215252|FG009|Overall Study|Participant cannot be reached|2
1125085|NCT02641379|2215253|FG010|Overall Study|Participant cannot be reached|1
1125086|NCT02641379|2215243|FG000|Overall Study|PCR positive at Week 24|15
1125087|NCT02641379|2215244|FG001|Overall Study|PCR positive at Week 24|21
1125088|NCT02641379|2215245|FG002|Overall Study|PCR positive at Week 24|62
1125089|NCT02641379|2215246|FG003|Overall Study|PCR positive at Week 24|0
1125090|NCT02641379|2215247|FG004|Overall Study|PCR positive at Week 24|0
1125091|NCT02641379|2215248|FG005|Overall Study|PCR positive at Week 24|6
1125092|NCT02641379|2215249|FG006|Overall Study|PCR positive at Week 24|3
1125093|NCT02641379|2215250|FG007|Overall Study|PCR positive at Week 24|8
1125094|NCT02641379|2215251|FG008|Overall Study|PCR positive at Week 24|0
1125095|NCT02641379|2215252|FG009|Overall Study|PCR positive at Week 24|1
1125096|NCT02641379|2215253|FG010|Overall Study|PCR positive at Week 24|0
1125097|NCT02641379|2215243|FG000|Overall Study|PCR positive at follow up 2|1
1125098|NCT02641379|2215244|FG001|Overall Study|PCR positive at follow up 2|0
1125099|NCT02641379|2215245|FG002|Overall Study|PCR positive at follow up 2|0
1125100|NCT02641379|2215246|FG003|Overall Study|PCR positive at follow up 2|0
1125101|NCT02641379|2215247|FG004|Overall Study|PCR positive at follow up 2|0
1125102|NCT02641379|2215248|FG005|Overall Study|PCR positive at follow up 2|0
1125103|NCT02641379|2215249|FG006|Overall Study|PCR positive at follow up 2|0
1125104|NCT02641379|2215250|FG007|Overall Study|PCR positive at follow up 2|0
1125105|NCT02641379|2215251|FG008|Overall Study|PCR positive at follow up 2|0
1125106|NCT02641379|2215252|FG009|Overall Study|PCR positive at follow up 2|0
1125107|NCT02641379|2215253|FG010|Overall Study|PCR positive at follow up 2|0
1125108|NCT02641379|2215243|FG000|Overall Study|Participant showed relapse|1
1125109|NCT02641379|2215244|FG001|Overall Study|Participant showed relapse|0
1125110|NCT02641379|2215245|FG002|Overall Study|Participant showed relapse|0
1125111|NCT02641379|2215246|FG003|Overall Study|Participant showed relapse|0
1125112|NCT02641379|2215247|FG004|Overall Study|Participant showed relapse|0
1125113|NCT02641379|2215248|FG005|Overall Study|Participant showed relapse|0
1125114|NCT02641379|2215249|FG006|Overall Study|Participant showed relapse|1
1125115|NCT02641379|2215250|FG007|Overall Study|Participant showed relapse|0
1125116|NCT02641379|2215251|FG008|Overall Study|Participant showed relapse|0
1125117|NCT02641379|2215252|FG009|Overall Study|Participant showed relapse|0
1125118|NCT02641379|2215253|FG010|Overall Study|Participant showed relapse|0
1125119|NCT02641379|2215243|FG000|Overall Study|Participant stopped study/treatment|1
1125120|NCT02641379|2215244|FG001|Overall Study|Participant stopped study/treatment|3
1125121|NCT02641379|2215245|FG002|Overall Study|Participant stopped study/treatment|1
1125122|NCT02641379|2215246|FG003|Overall Study|Participant stopped study/treatment|0
1125123|NCT02641379|2215247|FG004|Overall Study|Participant stopped study/treatment|0
1125124|NCT02641379|2215248|FG005|Overall Study|Participant stopped study/treatment|1
1125125|NCT02641379|2215249|FG006|Overall Study|Participant stopped study/treatment|2
1125126|NCT02641379|2215250|FG007|Overall Study|Participant stopped study/treatment|0
1125127|NCT02641379|2215251|FG008|Overall Study|Participant stopped study/treatment|1
1125128|NCT02641379|2215252|FG009|Overall Study|Participant stopped study/treatment|0
1125129|NCT02641379|2215253|FG010|Overall Study|Participant stopped study/treatment|0
1125130|NCT02641379|2215243|FG000|Overall Study|Therapy stopped due to misunderstanding|1
1125131|NCT02641379|2215244|FG001|Overall Study|Therapy stopped due to misunderstanding|0
1125132|NCT02641379|2215245|FG002|Overall Study|Therapy stopped due to misunderstanding|0
1125133|NCT02641379|2215246|FG003|Overall Study|Therapy stopped due to misunderstanding|0
1125134|NCT02641379|2215247|FG004|Overall Study|Therapy stopped due to misunderstanding|0
1125135|NCT02641379|2215248|FG005|Overall Study|Therapy stopped due to misunderstanding|0
1125136|NCT02641379|2215249|FG006|Overall Study|Therapy stopped due to misunderstanding|0
1125137|NCT02641379|2215250|FG007|Overall Study|Therapy stopped due to misunderstanding|0
1125138|NCT02641379|2215251|FG008|Overall Study|Therapy stopped due to misunderstanding|0
1125139|NCT02641379|2215252|FG009|Overall Study|Therapy stopped due to misunderstanding|0
1125140|NCT02641379|2215253|FG010|Overall Study|Therapy stopped due to misunderstanding|0
1125141|NCT02641379|2215243|FG000|Overall Study|Financial problems|0
1125142|NCT02641379|2215244|FG001|Overall Study|Financial problems|1
1125143|NCT02641379|2215245|FG002|Overall Study|Financial problems|0
1125144|NCT02641379|2215246|FG003|Overall Study|Financial problems|0
1125145|NCT02641379|2215247|FG004|Overall Study|Financial problems|0
1125146|NCT02641379|2215248|FG005|Overall Study|Financial problems|0
1125147|NCT02641379|2215249|FG006|Overall Study|Financial problems|0
1125148|NCT02641379|2215250|FG007|Overall Study|Financial problems|0
1125149|NCT02641379|2215251|FG008|Overall Study|Financial problems|0
1125150|NCT02641379|2215252|FG009|Overall Study|Financial problems|0
1125151|NCT02641379|2215253|FG010|Overall Study|Financial problems|0
1125152|NCT02641379|2215243|FG000|Overall Study|PCR positive at Week 68|0
1125153|NCT02641379|2215244|FG001|Overall Study|PCR positive at Week 68|1
1125154|NCT02641379|2215245|FG002|Overall Study|PCR positive at Week 68|0
1125155|NCT02641379|2215246|FG003|Overall Study|PCR positive at Week 68|0
1125156|NCT02641379|2215247|FG004|Overall Study|PCR positive at Week 68|0
898889|NCT00718315|1871539|FG000|Overall Study|Use of Minocyclin|1
898890|NCT00718315|1871540|FG001|Overall Study|Use of Minocyclin|1
898891|NCT00718315|1871541|FG002|Overall Study|Use of Minocyclin|1
898892|NCT00718315|1871539|FG000|Overall Study|Disease progression|0
898893|NCT00718315|1871540|FG001|Overall Study|Disease progression|1
898894|NCT00718315|1871541|FG002|Overall Study|Disease progression|1
1125157|NCT02641379|2215248|FG005|Overall Study|PCR positive at Week 68|0
1125158|NCT02641379|2215249|FG006|Overall Study|PCR positive at Week 68|0
1125159|NCT02641379|2215250|FG007|Overall Study|PCR positive at Week 68|0
1125160|NCT02641379|2215251|FG008|Overall Study|PCR positive at Week 68|0
1125161|NCT02641379|2215252|FG009|Overall Study|PCR positive at Week 68|0
1125162|NCT02641379|2215253|FG010|Overall Study|PCR positive at Week 68|0
1125163|NCT02641379|2215243|FG000|Overall Study|PCR positive at Week 48|0
1125164|NCT02641379|2215244|FG001|Overall Study|PCR positive at Week 48|1
1125165|NCT02641379|2215245|FG002|Overall Study|PCR positive at Week 48|0
1125166|NCT02641379|2215246|FG003|Overall Study|PCR positive at Week 48|0
1125167|NCT02641379|2215247|FG004|Overall Study|PCR positive at Week 48|0
1125168|NCT02641379|2215248|FG005|Overall Study|PCR positive at Week 48|0
1125169|NCT02641379|2215249|FG006|Overall Study|PCR positive at Week 48|0
1125170|NCT02641379|2215250|FG007|Overall Study|PCR positive at Week 48|0
1125171|NCT02641379|2215251|FG008|Overall Study|PCR positive at Week 48|0
1125172|NCT02641379|2215252|FG009|Overall Study|PCR positive at Week 48|0
1125173|NCT02641379|2215253|FG010|Overall Study|PCR positive at Week 48|0
1125174|NCT02641379|2215243|FG000|Overall Study|PCR not performed at Week 12|0
1125175|NCT02641379|2215244|FG001|Overall Study|PCR not performed at Week 12|0
1125176|NCT02641379|2215245|FG002|Overall Study|PCR not performed at Week 12|1
1125177|NCT02641379|2215246|FG003|Overall Study|PCR not performed at Week 12|0
1125178|NCT02641379|2215247|FG004|Overall Study|PCR not performed at Week 12|0
1125179|NCT02641379|2215248|FG005|Overall Study|PCR not performed at Week 12|0
1125180|NCT02641379|2215249|FG006|Overall Study|PCR not performed at Week 12|0
1125181|NCT02641379|2215250|FG007|Overall Study|PCR not performed at Week 12|0
1125182|NCT02641379|2215251|FG008|Overall Study|PCR not performed at Week 12|0
898895|NCT00718315|1871539|FG000|Overall Study|Other|0
898896|NCT00718315|1871540|FG001|Overall Study|Other|0
898897|NCT00718315|1871541|FG002|Overall Study|Other|1
898898|NCT00718315|1871539|FG000|Overall Study|Use of ATB and Corticoids|0
898899|NCT00718315|1871540|FG001|Overall Study|Use of ATB and Corticoids|1
898900|NCT00718315|1871541|FG002|Overall Study|Use of ATB and Corticoids|2
898901|NCT00718328|1871551|FG000|Overall Study|Lost to Follow-up|1
898902|NCT00718328|1871552|FG001|Overall Study|Lost to Follow-up|0
898903|NCT00718419|1871560|FG000|Overall Study|Adverse Event|2
898904|NCT00718419|1871561|FG001|Overall Study|Adverse Event|1
898905|NCT00718419|1871560|FG000|Overall Study|Physician Decision|1
898906|NCT00718419|1871561|FG001|Overall Study|Physician Decision|6
898907|NCT00718419|1871560|FG000|Overall Study|Sponsor decision|0
898908|NCT00718419|1871561|FG001|Overall Study|Sponsor decision|1
898909|NCT00718419|1871560|FG000|Overall Study|Withdrawal by Subject|0
898910|NCT00718419|1871561|FG001|Overall Study|Withdrawal by Subject|5
898911|NCT00718419|1871560|FG000|Overall Study|Progressive Disease|7
898912|NCT00718419|1871561|FG001|Overall Study|Progressive Disease|25
898913|NCT00718419|1871560|FG000|Overall Study|Death Due to Progressive Disease|2
898914|NCT00718419|1871561|FG001|Overall Study|Death Due to Progressive Disease|0
898915|NCT00718419|1871560|FG000|Overall Study|Death Due to Study Drug Related|0
898916|NCT00718419|1871561|FG001|Overall Study|Death Due to Study Drug Related|1
898917|NCT00718419|1871560|FG000|Overall Study|Death Due to Adverse Events|1
898918|NCT00718419|1871561|FG001|Overall Study|Death Due to Adverse Events|0
898919|NCT00718510|1871569|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
898920|NCT00718510|1871570|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
898921|NCT00718510|1871569|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
898922|NCT00718510|1871570|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
898923|NCT00718523|1871578|FG000|Overall Study|Withdrawal by Subject|5
898924|NCT00718523|1871579|FG001|Overall Study|Withdrawal by Subject|7
898925|NCT00718523|1871578|FG000|Overall Study|Death|13
898926|NCT00718523|1871579|FG001|Overall Study|Death|17
898927|NCT00718549|1871585|FG000|Induction Phase|Disease Progression|1
898928|NCT00718549|1871586|FG001|Induction Phase|Disease Progression|0
898929|NCT00718549|1871587|FG002|Induction Phase|Disease Progression|0
898930|NCT00718549|1871585|FG000|Induction Phase|Eligibility Criteria Violation|2
898931|NCT00718549|1871586|FG001|Induction Phase|Eligibility Criteria Violation|0
1018316|NCT01570283|2043162|FG005|Cohort 1: Dose Level 1|Death|0
1125183|NCT02641379|2215252|FG009|Overall Study|PCR not performed at Week 12|0
1125184|NCT02641379|2215253|FG010|Overall Study|PCR not performed at Week 12|0
1125185|NCT02641379|2215243|FG000|Overall Study|No PCR at baseline|0
1125186|NCT02641379|2215244|FG001|Overall Study|No PCR at baseline|0
1125187|NCT02641379|2215245|FG002|Overall Study|No PCR at baseline|1
1125188|NCT02641379|2215246|FG003|Overall Study|No PCR at baseline|0
1125189|NCT02641379|2215247|FG004|Overall Study|No PCR at baseline|0
1125190|NCT02641379|2215248|FG005|Overall Study|No PCR at baseline|0
1125191|NCT02641379|2215249|FG006|Overall Study|No PCR at baseline|0
1125192|NCT02641379|2215250|FG007|Overall Study|No PCR at baseline|0
1125193|NCT02641379|2215251|FG008|Overall Study|No PCR at baseline|0
1125194|NCT02641379|2215252|FG009|Overall Study|No PCR at baseline|0
1125195|NCT02641379|2215253|FG010|Overall Study|No PCR at baseline|0
1125196|NCT02641379|2215243|FG000|Overall Study|PCR positive at Week 28|0
1125197|NCT02641379|2215244|FG001|Overall Study|PCR positive at Week 28|0
1125198|NCT02641379|2215245|FG002|Overall Study|PCR positive at Week 28|1
1125199|NCT02641379|2215246|FG003|Overall Study|PCR positive at Week 28|0
1125200|NCT02641379|2215247|FG004|Overall Study|PCR positive at Week 28|0
1125201|NCT02641379|2215248|FG005|Overall Study|PCR positive at Week 28|0
1125202|NCT02641379|2215249|FG006|Overall Study|PCR positive at Week 28|0
1125203|NCT02641379|2215250|FG007|Overall Study|PCR positive at Week 28|0
1125204|NCT02641379|2215251|FG008|Overall Study|PCR positive at Week 28|0
1125205|NCT02641379|2215252|FG009|Overall Study|PCR positive at Week 28|0
1125206|NCT02641379|2215253|FG010|Overall Study|PCR positive at Week 28|0
1125207|NCT02641379|2215243|FG000|Overall Study|PCR sample for Week 4 not drawn|0
1125208|NCT02641379|2215244|FG001|Overall Study|PCR sample for Week 4 not drawn|0
1125209|NCT02641379|2215245|FG002|Overall Study|PCR sample for Week 4 not drawn|0
1125210|NCT02641379|2215246|FG003|Overall Study|PCR sample for Week 4 not drawn|1
1125211|NCT02641379|2215247|FG004|Overall Study|PCR sample for Week 4 not drawn|0
1125212|NCT02641379|2215248|FG005|Overall Study|PCR sample for Week 4 not drawn|0
1125213|NCT02641379|2215249|FG006|Overall Study|PCR sample for Week 4 not drawn|0
1125214|NCT02641379|2215250|FG007|Overall Study|PCR sample for Week 4 not drawn|0
1125215|NCT02641379|2215251|FG008|Overall Study|PCR sample for Week 4 not drawn|0
1125216|NCT02641379|2215252|FG009|Overall Study|PCR sample for Week 4 not drawn|0
1125217|NCT02641379|2215253|FG010|Overall Study|PCR sample for Week 4 not drawn|0
1125218|NCT02641379|2215243|FG000|Overall Study|Inclusion criteria not fulfilled|0
1125219|NCT02641379|2215244|FG001|Overall Study|Inclusion criteria not fulfilled|0
1125220|NCT02641379|2215245|FG002|Overall Study|Inclusion criteria not fulfilled|0
1125221|NCT02641379|2215246|FG003|Overall Study|Inclusion criteria not fulfilled|1
1125222|NCT02641379|2215247|FG004|Overall Study|Inclusion criteria not fulfilled|0
1125223|NCT02641379|2215248|FG005|Overall Study|Inclusion criteria not fulfilled|0
1125224|NCT02641379|2215249|FG006|Overall Study|Inclusion criteria not fulfilled|0
1125225|NCT02641379|2215250|FG007|Overall Study|Inclusion criteria not fulfilled|0
1125226|NCT02641379|2215251|FG008|Overall Study|Inclusion criteria not fulfilled|0
1125227|NCT02641379|2215252|FG009|Overall Study|Inclusion criteria not fulfilled|0
1125228|NCT02641379|2215253|FG010|Overall Study|Inclusion criteria not fulfilled|0
1125229|NCT02641379|2215243|FG000|Overall Study|Baseline viral load unavailable|0
1125230|NCT02641379|2215244|FG001|Overall Study|Baseline viral load unavailable|0
1125231|NCT02641379|2215245|FG002|Overall Study|Baseline viral load unavailable|0
1125232|NCT02641379|2215246|FG003|Overall Study|Baseline viral load unavailable|1
1125233|NCT02641379|2215247|FG004|Overall Study|Baseline viral load unavailable|0
1125234|NCT02641379|2215248|FG005|Overall Study|Baseline viral load unavailable|0
1125235|NCT02641379|2215249|FG006|Overall Study|Baseline viral load unavailable|0
1125236|NCT02641379|2215250|FG007|Overall Study|Baseline viral load unavailable|0
1125237|NCT02641379|2215251|FG008|Overall Study|Baseline viral load unavailable|0
1125238|NCT02641379|2215252|FG009|Overall Study|Baseline viral load unavailable|0
1125239|NCT02641379|2215253|FG010|Overall Study|Baseline viral load unavailable|0
1125240|NCT02641379|2215243|FG000|Overall Study|Blood could not be drawn|0
1125241|NCT02641379|2215244|FG001|Overall Study|Blood could not be drawn|0
1125242|NCT02641379|2215245|FG002|Overall Study|Blood could not be drawn|0
1125243|NCT02641379|2215246|FG003|Overall Study|Blood could not be drawn|0
1125244|NCT02641379|2215247|FG004|Overall Study|Blood could not be drawn|1
1125245|NCT02641379|2215248|FG005|Overall Study|Blood could not be drawn|0
1125246|NCT02641379|2215249|FG006|Overall Study|Blood could not be drawn|0
1125247|NCT02641379|2215250|FG007|Overall Study|Blood could not be drawn|0
1125248|NCT02641379|2215251|FG008|Overall Study|Blood could not be drawn|0
1125249|NCT02641379|2215252|FG009|Overall Study|Blood could not be drawn|0
1125250|NCT02641379|2215253|FG010|Overall Study|Blood could not be drawn|0
1125251|NCT02641379|2215243|FG000|Overall Study|Protocol Violation|0
1125252|NCT02641379|2215244|FG001|Overall Study|Protocol Violation|0
1125253|NCT02641379|2215245|FG002|Overall Study|Protocol Violation|0
1125254|NCT02641379|2215246|FG003|Overall Study|Protocol Violation|0
1125255|NCT02641379|2215247|FG004|Overall Study|Protocol Violation|2
1125256|NCT02641379|2215248|FG005|Overall Study|Protocol Violation|0
1125257|NCT02641379|2215249|FG006|Overall Study|Protocol Violation|0
1125258|NCT02641379|2215250|FG007|Overall Study|Protocol Violation|0
1125259|NCT02641379|2215251|FG008|Overall Study|Protocol Violation|1
1125260|NCT02641379|2215252|FG009|Overall Study|Protocol Violation|0
1125261|NCT02641379|2215253|FG010|Overall Study|Protocol Violation|0
1125262|NCT02641379|2215243|FG000|Overall Study|Participation in sili rescue study|0
1125263|NCT02641379|2215244|FG001|Overall Study|Participation in sili rescue study|0
1125264|NCT02641379|2215245|FG002|Overall Study|Participation in sili rescue study|0
1125265|NCT02641379|2215246|FG003|Overall Study|Participation in sili rescue study|0
1125266|NCT02641379|2215247|FG004|Overall Study|Participation in sili rescue study|0
1125267|NCT02641379|2215248|FG005|Overall Study|Participation in sili rescue study|1
1125268|NCT02641379|2215249|FG006|Overall Study|Participation in sili rescue study|0
1125269|NCT02641379|2215250|FG007|Overall Study|Participation in sili rescue study|0
1125270|NCT02641379|2215251|FG008|Overall Study|Participation in sili rescue study|0
1125271|NCT02641379|2215252|FG009|Overall Study|Participation in sili rescue study|0
1125272|NCT02641379|2215253|FG010|Overall Study|Participation in sili rescue study|0
1125273|NCT02641379|2215243|FG000|Overall Study|Lost to Follow-up|0
1125274|NCT02641379|2215244|FG001|Overall Study|Lost to Follow-up|0
1125275|NCT02641379|2215245|FG002|Overall Study|Lost to Follow-up|0
1125276|NCT02641379|2215246|FG003|Overall Study|Lost to Follow-up|0
1125277|NCT02641379|2215247|FG004|Overall Study|Lost to Follow-up|0
1125278|NCT02641379|2215248|FG005|Overall Study|Lost to Follow-up|0
1125279|NCT02641379|2215249|FG006|Overall Study|Lost to Follow-up|0
1125280|NCT02641379|2215250|FG007|Overall Study|Lost to Follow-up|0
1125281|NCT02641379|2215251|FG008|Overall Study|Lost to Follow-up|1
1125282|NCT02641379|2215252|FG009|Overall Study|Lost to Follow-up|0
1125283|NCT02641379|2215253|FG010|Overall Study|Lost to Follow-up|0
1125284|NCT02641379|2215243|FG000|Overall Study|Source data not found|0
1125285|NCT02641379|2215244|FG001|Overall Study|Source data not found|0
1125286|NCT02641379|2215245|FG002|Overall Study|Source data not found|0
1125287|NCT02641379|2215246|FG003|Overall Study|Source data not found|0
1125288|NCT02641379|2215247|FG004|Overall Study|Source data not found|0
1125289|NCT02641379|2215248|FG005|Overall Study|Source data not found|1
1125290|NCT02641379|2215249|FG006|Overall Study|Source data not found|0
1125291|NCT02641379|2215250|FG007|Overall Study|Source data not found|0
1125292|NCT02641379|2215251|FG008|Overall Study|Source data not found|0
1125293|NCT02641379|2215252|FG009|Overall Study|Source data not found|0
1125294|NCT02641379|2215253|FG010|Overall Study|Source data not found|0
1125295|NCT02641379|2215243|FG000|Overall Study|Participant showed weight reduction|0
1125296|NCT02641379|2215244|FG001|Overall Study|Participant showed weight reduction|0
1125297|NCT02641379|2215245|FG002|Overall Study|Participant showed weight reduction|0
1125298|NCT02641379|2215246|FG003|Overall Study|Participant showed weight reduction|0
1125299|NCT02641379|2215247|FG004|Overall Study|Participant showed weight reduction|0
1125300|NCT02641379|2215248|FG005|Overall Study|Participant showed weight reduction|0
1125301|NCT02641379|2215249|FG006|Overall Study|Participant showed weight reduction|0
1125302|NCT02641379|2215250|FG007|Overall Study|Participant showed weight reduction|1
1125303|NCT02641379|2215251|FG008|Overall Study|Participant showed weight reduction|0
1125304|NCT02641379|2215252|FG009|Overall Study|Participant showed weight reduction|0
1125305|NCT02641379|2215253|FG010|Overall Study|Participant showed weight reduction|0
1125306|NCT02641379|2215243|FG000|Overall Study|Non-response Week 12|0
1125307|NCT02641379|2215244|FG001|Overall Study|Non-response Week 12|0
1125308|NCT02641379|2215245|FG002|Overall Study|Non-response Week 12|0
1125309|NCT02641379|2215246|FG003|Overall Study|Non-response Week 12|0
1125310|NCT02641379|2215247|FG004|Overall Study|Non-response Week 12|0
1125311|NCT02641379|2215248|FG005|Overall Study|Non-response Week 12|0
1125312|NCT02641379|2215249|FG006|Overall Study|Non-response Week 12|0
1125313|NCT02641379|2215250|FG007|Overall Study|Non-response Week 12|1
1125314|NCT02641379|2215251|FG008|Overall Study|Non-response Week 12|0
1125315|NCT02641379|2215252|FG009|Overall Study|Non-response Week 12|0
1125316|NCT02641379|2215253|FG010|Overall Study|Non-response Week 12|0
1125317|NCT02641379|2215243|FG000|Overall Study|No 2 Log drop at Week 12|0
1125318|NCT02641379|2215244|FG001|Overall Study|No 2 Log drop at Week 12|0
1125319|NCT02641379|2215245|FG002|Overall Study|No 2 Log drop at Week 12|0
1125320|NCT02641379|2215246|FG003|Overall Study|No 2 Log drop at Week 12|0
1125321|NCT02641379|2215247|FG004|Overall Study|No 2 Log drop at Week 12|0
1125322|NCT02641379|2215248|FG005|Overall Study|No 2 Log drop at Week 12|0
1125323|NCT02641379|2215249|FG006|Overall Study|No 2 Log drop at Week 12|0
1125324|NCT02641379|2215250|FG007|Overall Study|No 2 Log drop at Week 12|0
1125325|NCT02641379|2215251|FG008|Overall Study|No 2 Log drop at Week 12|0
1125326|NCT02641379|2215252|FG009|Overall Study|No 2 Log drop at Week 12|0
1125327|NCT02641379|2215253|FG010|Overall Study|No 2 Log drop at Week 12|1
1125328|NCT02641379|2215243|FG000|Overall Study|Negative PCR result|0
1125329|NCT02641379|2215244|FG001|Overall Study|Negative PCR result|0
1125330|NCT02641379|2215245|FG002|Overall Study|Negative PCR result|0
1125331|NCT02641379|2215246|FG003|Overall Study|Negative PCR result|0
1125332|NCT02641379|2215247|FG004|Overall Study|Negative PCR result|0
1125333|NCT02641379|2215248|FG005|Overall Study|Negative PCR result|0
898932|NCT00718549|1871587|FG002|Induction Phase|Eligibility Criteria Violation|0
898933|NCT00718549|1871585|FG000|Induction Phase|Early Termination - No Additional Info|59
898934|NCT00718549|1871586|FG001|Induction Phase|Early Termination - No Additional Info|0
898935|NCT00718549|1871587|FG002|Induction Phase|Early Termination - No Additional Info|0
898936|NCT00718549|1871585|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
898937|NCT00718549|1871586|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
898938|NCT00718549|1871587|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
898939|NCT00718549|1871585|FG000|Maintenance/ Observation Phase|Death|0
1125334|NCT02641379|2215249|FG006|Overall Study|Negative PCR result|0
1125335|NCT02641379|2215250|FG007|Overall Study|Negative PCR result|0
1125336|NCT02641379|2215251|FG008|Overall Study|Negative PCR result|0
1125337|NCT02641379|2215252|FG009|Overall Study|Negative PCR result|1
1125338|NCT02641379|2215253|FG010|Overall Study|Negative PCR result|0
1125339|NCT02641379|2215243|FG000|Overall Study|Participant's PCR high|0
1125340|NCT02641379|2215244|FG001|Overall Study|Participant's PCR high|0
1125341|NCT02641379|2215245|FG002|Overall Study|Participant's PCR high|0
1125342|NCT02641379|2215246|FG003|Overall Study|Participant's PCR high|0
1125343|NCT02641379|2215247|FG004|Overall Study|Participant's PCR high|0
1125344|NCT02641379|2215248|FG005|Overall Study|Participant's PCR high|0
1125345|NCT02641379|2215249|FG006|Overall Study|Participant's PCR high|0
1125346|NCT02641379|2215250|FG007|Overall Study|Participant's PCR high|1
1125347|NCT02641379|2215251|FG008|Overall Study|Participant's PCR high|0
1125348|NCT02641379|2215252|FG009|Overall Study|Participant's PCR high|0
1125349|NCT02641379|2215253|FG010|Overall Study|Participant's PCR high|0
1125350|NCT02641379|2215243|FG000|Overall Study|Participant treated after Week 24|0
1125351|NCT02641379|2215244|FG001|Overall Study|Participant treated after Week 24|0
1125352|NCT02641379|2215245|FG002|Overall Study|Participant treated after Week 24|0
1125353|NCT02641379|2215246|FG003|Overall Study|Participant treated after Week 24|0
1125354|NCT02641379|2215247|FG004|Overall Study|Participant treated after Week 24|0
1125355|NCT02641379|2215248|FG005|Overall Study|Participant treated after Week 24|0
1125356|NCT02641379|2215249|FG006|Overall Study|Participant treated after Week 24|0
1125357|NCT02641379|2215250|FG007|Overall Study|Participant treated after Week 24|0
1125358|NCT02641379|2215251|FG008|Overall Study|Participant treated after Week 24|1
1125359|NCT02641379|2215252|FG009|Overall Study|Participant treated after Week 24|0
1125360|NCT02641379|2215253|FG010|Overall Study|Participant treated after Week 24|0
1125361|NCT02641379|2215243|FG000|Overall Study|Missing PCR result at Week 8|0
1125362|NCT02641379|2215244|FG001|Overall Study|Missing PCR result at Week 8|0
1125363|NCT02641379|2215245|FG002|Overall Study|Missing PCR result at Week 8|0
1125364|NCT02641379|2215246|FG003|Overall Study|Missing PCR result at Week 8|0
1125365|NCT02641379|2215247|FG004|Overall Study|Missing PCR result at Week 8|0
1125366|NCT02641379|2215248|FG005|Overall Study|Missing PCR result at Week 8|0
1125367|NCT02641379|2215249|FG006|Overall Study|Missing PCR result at Week 8|0
1125368|NCT02641379|2215250|FG007|Overall Study|Missing PCR result at Week 8|0
1125369|NCT02641379|2215251|FG008|Overall Study|Missing PCR result at Week 8|0
1125370|NCT02641379|2215252|FG009|Overall Study|Missing PCR result at Week 8|1
1125371|NCT02641379|2215253|FG010|Overall Study|Missing PCR result at Week 8|0
1125372|NCT02641379|2215243|FG000|Overall Study|PCR positive|0
1125373|NCT02641379|2215244|FG001|Overall Study|PCR positive|0
1125374|NCT02641379|2215245|FG002|Overall Study|PCR positive|0
1125375|NCT02641379|2215246|FG003|Overall Study|PCR positive|0
1125376|NCT02641379|2215247|FG004|Overall Study|PCR positive|0
1125377|NCT02641379|2215248|FG005|Overall Study|PCR positive|0
1125378|NCT02641379|2215249|FG006|Overall Study|PCR positive|1
1125379|NCT02641379|2215250|FG007|Overall Study|PCR positive|0
1125380|NCT02641379|2215251|FG008|Overall Study|PCR positive|0
1125381|NCT02641379|2215252|FG009|Overall Study|PCR positive|0
1125382|NCT02641379|2215253|FG010|Overall Study|PCR positive|0
1125383|NCT02641392|2215285|FG000|Overall Study|Lost to Follow-up|0
1125384|NCT02641392|2215286|FG001|Overall Study|Lost to Follow-up|0
1125385|NCT02641392|2215287|FG002|Overall Study|Lost to Follow-up|2
1125386|NCT02641392|2215285|FG000|Overall Study|Withdrawal by Subject|0
1125387|NCT02641392|2215286|FG001|Overall Study|Withdrawal by Subject|0
1125388|NCT02641392|2215287|FG002|Overall Study|Withdrawal by Subject|17
1125389|NCT02641392|2215285|FG000|Overall Study|Adverse Event|0
1125390|NCT02641392|2215286|FG001|Overall Study|Adverse Event|1
1125391|NCT02641392|2215287|FG002|Overall Study|Adverse Event|25
1125392|NCT02641392|2215285|FG000|Overall Study|Study Terminated by Sponsor|4
1125393|NCT02641392|2215286|FG001|Overall Study|Study Terminated by Sponsor|12
898940|NCT00718549|1871586|FG001|Maintenance/ Observation Phase|Death|1
898941|NCT00718549|1871587|FG002|Maintenance/ Observation Phase|Death|2
898942|NCT00718549|1871585|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0
898943|NCT00718549|1871586|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4
898944|NCT00718549|1871587|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4
898945|NCT00718549|1871585|FG000|Maintenance/ Observation Phase|Progression|0
898946|NCT00718549|1871586|FG001|Maintenance/ Observation Phase|Progression|5
898947|NCT00718549|1871587|FG002|Maintenance/ Observation Phase|Progression|14
898948|NCT00718549|1871585|FG000|Maintenance/ Observation Phase|Relapse|0
898949|NCT00718549|1871586|FG001|Maintenance/ Observation Phase|Relapse|3
898950|NCT00718549|1871587|FG002|Maintenance/ Observation Phase|Relapse|2
898951|NCT00718666|1871603|FG000|Booster Phase Year 5|No active participation request|0
898952|NCT00718666|1871604|FG001|Booster Phase Year 5|No active participation request|0
898953|NCT00718666|1871605|FG002|Booster Phase Year 5|No active participation request|1
898954|NCT00718666|1871603|FG000|Booster Phase Year 5|Declined v-4 serology|1
898955|NCT00718666|1871604|FG001|Booster Phase Year 5|Declined v-4 serology|0
898956|NCT00718666|1871605|FG002|Booster Phase Year 5|Declined v-4 serology|0
1125394|NCT02641392|2215287|FG002|Overall Study|Study Terminated by Sponsor|144
1125395|NCT02641392|2215285|FG000|Overall Study|Lack of Efficacy|0
1125396|NCT02641392|2215286|FG001|Overall Study|Lack of Efficacy|0
1125397|NCT02641392|2215287|FG002|Overall Study|Lack of Efficacy|101
1125398|NCT02641392|2215285|FG000|Overall Study|Miscellaneous|0
1125399|NCT02641392|2215286|FG001|Overall Study|Miscellaneous|0
1125400|NCT02641392|2215287|FG002|Overall Study|Miscellaneous|3
1125401|NCT02641392|2215285|FG000|Overall Study|Death|0
1125402|NCT02641392|2215286|FG001|Overall Study|Death|0
1125403|NCT02641392|2215287|FG002|Overall Study|Death|1
1125404|NCT02641587|2215319|FG000|Confinement Period|Adverse Event|1
1125405|NCT02641587|2215320|FG001|Confinement Period|Adverse Event|0
1125406|NCT02641587|2215319|FG000|Confinement Period|Withdrawal by Subject|2
1125407|NCT02641587|2215320|FG001|Confinement Period|Withdrawal by Subject|1
1125408|NCT02641587|2215319|FG000|Ambulatory Period|Withdrawal by Subject|1
1125409|NCT02641587|2215320|FG001|Ambulatory Period|Withdrawal by Subject|0
1125410|NCT02641730|2215346|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
1125411|NCT02641730|2215347|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
1125412|NCT02641730|2215348|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
1125413|NCT02641730|2215349|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
1125414|NCT02641730|2215350|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
1125415|NCT02641730|2215346|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
1125416|NCT02641730|2215347|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1
1125417|NCT02641730|2215348|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1
1125418|NCT02641730|2215349|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5
1125419|NCT02641730|2215350|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4
1125420|NCT02641730|2215346|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
1125421|NCT02641730|2215347|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
1125422|NCT02641730|2215348|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
1125423|NCT02641730|2215349|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
1125424|NCT02641730|2215350|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
1125425|NCT02641730|2215346|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
1125426|NCT02641730|2215347|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0
1125427|NCT02641730|2215348|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
1125428|NCT02641730|2215349|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1
1125429|NCT02641730|2215350|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1
1125430|NCT02641730|2215346|FG000|After Controlled Period (Week 16 - 52)|Other|0
1125431|NCT02641730|2215347|FG001|After Controlled Period (Week 16 - 52)|Other|1
1125432|NCT02641730|2215348|FG002|After Controlled Period (Week 16 - 52)|Other|1
1125433|NCT02641730|2215349|FG003|After Controlled Period (Week 16 - 52)|Other|0
1125434|NCT02641730|2215350|FG004|After Controlled Period (Week 16 - 52)|Other|1
1125435|NCT02641730|2215346|FG000|Observational Period (Week 60 - Week 84)|Other|0
1125436|NCT02641730|2215347|FG001|Observational Period (Week 60 - Week 84)|Other|0
1125437|NCT02641730|2215348|FG002|Observational Period (Week 60 - Week 84)|Other|0
1125438|NCT02641730|2215349|FG003|Observational Period (Week 60 - Week 84)|Other|0
1125439|NCT02641730|2215350|FG004|Observational Period (Week 60 - Week 84)|Other|1
1125445|NCT02642159|2215393|FG000|Overall Study|Randomized but not treated|1
1125446|NCT02642159|2215394|FG001|Overall Study|Randomized but not treated|0
1125447|NCT02642159|2215393|FG000|Overall Study|Adverse Event|10
1125448|NCT02642159|2215394|FG001|Overall Study|Adverse Event|4
1125449|NCT02642159|2215393|FG000|Overall Study|Withdrawal by Subject|9
1125450|NCT02642159|2215394|FG001|Overall Study|Withdrawal by Subject|1
1125451|NCT02642159|2215393|FG000|Overall Study|Poor compliance to study protocol|1
1125452|NCT02642159|2215394|FG001|Overall Study|Poor compliance to study protocol|0
1125453|NCT02642159|2215393|FG000|Overall Study|Other than specified above|10
1125454|NCT02642159|2215394|FG001|Overall Study|Other than specified above|3
1125455|NCT02642432|2215419|FG000|Overall Study|Adverse Event|2
1125456|NCT02642432|2215419|FG000|Overall Study|Withdrew Consent|1
1125457|NCT02642432|2215419|FG000|Overall Study|Lost to Follow-up|2
1125458|NCT02642432|2215419|FG000|Overall Study|Other|3
1125459|NCT02642614|2215440|FG000|Overall Study|Adverse Event|1
1125460|NCT02642614|2215441|FG001|Overall Study|Adverse Event|1
1125461|NCT02642614|2215442|FG002|Overall Study|Adverse Event|2
1125462|NCT02642614|2215443|FG003|Overall Study|Adverse Event|2
898957|NCT00718666|1871603|FG000|Booster Phase Year 5|Withdrawal by Subject|0
898958|NCT00718666|1871604|FG001|Booster Phase Year 5|Withdrawal by Subject|0
898959|NCT00718666|1871605|FG002|Booster Phase Year 5|Withdrawal by Subject|1
898960|NCT00718666|1871603|FG000|Booster Phase Year 5|Lost to Follow-up|1
898961|NCT00718666|1871604|FG001|Booster Phase Year 5|Lost to Follow-up|0
898962|NCT00718666|1871605|FG002|Booster Phase Year 5|Lost to Follow-up|4
898963|NCT00718718|1871630|FG000|Prior to Week 12|Adverse Event|0
898964|NCT00718718|1871631|FG001|Prior to Week 12|Adverse Event|0
898965|NCT00718718|1871632|FG002|Prior to Week 12|Adverse Event|0
898966|NCT00718718|1871633|FG003|Prior to Week 12|Adverse Event|0
1125463|NCT02642614|2215440|FG000|Overall Study|Lost to Follow-up|1
1125464|NCT02642614|2215441|FG001|Overall Study|Lost to Follow-up|0
1125465|NCT02642614|2215442|FG002|Overall Study|Lost to Follow-up|0
1125466|NCT02642614|2215443|FG003|Overall Study|Lost to Follow-up|0
1125467|NCT02642614|2215440|FG000|Overall Study|Withdrawal by Subject|1
1125468|NCT02642614|2215441|FG001|Overall Study|Withdrawal by Subject|1
1125469|NCT02642614|2215442|FG002|Overall Study|Withdrawal by Subject|0
1125470|NCT02642614|2215443|FG003|Overall Study|Withdrawal by Subject|0
1125471|NCT02642653|2215463|FG000|Overall Study|Adverse Event|2
1125472|NCT02642653|2215464|FG001|Overall Study|Adverse Event|0
1125473|NCT02642679|2215470|FG000|Overall Study|Withdrawal by Subject|1
1125474|NCT02642679|2215470|FG000|Overall Study|Physician Decision|1
1125475|NCT02642679|2215470|FG000|Overall Study|Physician Decision|1
1125478|NCT02643082|2215508|FG000|Period 1|Adverse Event|1
1125479|NCT02643082|2215509|FG001|Period 1|Adverse Event|0
1125480|NCT02643251|2215536|FG000|Overall Study|Adverse Event|3
1125481|NCT02643251|2215537|FG001|Overall Study|Adverse Event|1
1125482|NCT02643251|2215536|FG000|Overall Study|Withdrawal by Subject|2
1125483|NCT02643251|2215537|FG001|Overall Study|Withdrawal by Subject|0
1125484|NCT02643251|2215536|FG000|Overall Study|Lost to Follow-up|4
1125485|NCT02643251|2215537|FG001|Overall Study|Lost to Follow-up|1
1125486|NCT02643251|2215536|FG000|Overall Study|Protocol Violation|1
1125487|NCT02643251|2215537|FG001|Overall Study|Protocol Violation|0
1125488|NCT02643251|2215536|FG000|Overall Study|PI Decision to terminate patient|1
1125489|NCT02643251|2215537|FG001|Overall Study|PI Decision to terminate patient|0
1125490|NCT02643355|2215545|FG000|Overall Study|Withdrawal by Subject|1
1125491|NCT02643355|2215546|FG001|Overall Study|Withdrawal by Subject|3
1125492|NCT02643355|2215545|FG000|Overall Study|Protocol Violation|0
1125493|NCT02643355|2215546|FG001|Overall Study|Protocol Violation|2
1125494|NCT02643394|2215554|FG000|Overall Study|Protocol Violation|4
1125495|NCT02643394|2215555|FG001|Overall Study|Protocol Violation|5
1125496|NCT02643472|2215573|FG000|Overall Study|Death|2
1125497|NCT02643472|2215574|FG001|Overall Study|Death|5
1125498|NCT02643472|2215573|FG000|Overall Study|Withdrawal by Subject|3
1125499|NCT02643472|2215574|FG001|Overall Study|Withdrawal by Subject|2
1125500|NCT02643472|2215573|FG000|Overall Study|Protocol Violation|0
1125501|NCT02643472|2215574|FG001|Overall Study|Protocol Violation|1
1125502|NCT02643472|2215573|FG000|Overall Study|Lost to Follow-up|22
1125503|NCT02643472|2215574|FG001|Overall Study|Lost to Follow-up|26
1125504|NCT02643628|2215594|FG000|Overall Study|Lost to Follow-up|1
1125505|NCT02643628|2215595|FG001|Overall Study|Lost to Follow-up|4
1125506|NCT02643628|2215594|FG000|Overall Study|Withdrawal by Subject|0
1125507|NCT02643628|2215595|FG001|Overall Study|Withdrawal by Subject|1
1125508|NCT02643628|2215594|FG000|Overall Study|Relocated out of state|0
1125509|NCT02643628|2215595|FG001|Overall Study|Relocated out of state|1
1125510|NCT02643693|2215603|FG000|Overall Study|Physician Decision|0
1125511|NCT02643693|2215604|FG001|Overall Study|Physician Decision|1
1125512|NCT02643693|2215605|FG002|Overall Study|Physician Decision|0
1125513|NCT02643693|2215606|FG003|Overall Study|Physician Decision|0
1125514|NCT02643693|2215607|FG004|Overall Study|Physician Decision|0
1125515|NCT02643693|2215608|FG005|Overall Study|Physician Decision|0
1125516|NCT02643693|2215603|FG000|Overall Study|Withdrawal by Subject|0
1125517|NCT02643693|2215604|FG001|Overall Study|Withdrawal by Subject|1
1125518|NCT02643693|2215605|FG002|Overall Study|Withdrawal by Subject|0
1125519|NCT02643693|2215606|FG003|Overall Study|Withdrawal by Subject|0
1125520|NCT02643693|2215607|FG004|Overall Study|Withdrawal by Subject|0
1125521|NCT02643693|2215608|FG005|Overall Study|Withdrawal by Subject|0
1125522|NCT02643693|2215603|FG000|Overall Study|Protocol Adherence Issues|2
1125523|NCT02643693|2215604|FG001|Overall Study|Protocol Adherence Issues|0
1125524|NCT02643693|2215605|FG002|Overall Study|Protocol Adherence Issues|1
1125525|NCT02643693|2215606|FG003|Overall Study|Protocol Adherence Issues|0
1125526|NCT02643693|2215607|FG004|Overall Study|Protocol Adherence Issues|0
1125527|NCT02643693|2215608|FG005|Overall Study|Protocol Adherence Issues|1
1125528|NCT02644096|2215645|FG000|Overall Study|Withdrawal by Subject|28
1125529|NCT02644096|2215646|FG001|Overall Study|Withdrawal by Subject|25
1125530|NCT02644109|2215654|FG000|Overall Study|Adverse Event|0
1125531|NCT02644109|2215655|FG001|Overall Study|Adverse Event|4
1125532|NCT02644122|2215661|FG000|Overall Study|Withdrawal by Subject|1
1125533|NCT02644343|2215683|FG000|Overall Study|Withdrawal by Subject|1
1125534|NCT02644356|2215687|FG000|Overall Study|Withdrawal by Subject|2
1125535|NCT02644668|2215694|FG000|Overall Study|Adverse Event|2
1125536|NCT02644668|2215695|FG001|Overall Study|Adverse Event|0
1125537|NCT02644668|2215696|FG002|Overall Study|Adverse Event|1
1125538|NCT02644668|2215694|FG000|Overall Study|Protocol Violation|0
1125539|NCT02644668|2215695|FG001|Overall Study|Protocol Violation|0
1125540|NCT02644668|2215696|FG002|Overall Study|Protocol Violation|1
1125541|NCT02644668|2215694|FG000|Overall Study|Withdrawal by Subject|0
1125542|NCT02644668|2215695|FG001|Overall Study|Withdrawal by Subject|0
1125543|NCT02644668|2215696|FG002|Overall Study|Withdrawal by Subject|1
1125544|NCT02645409|2215764|FG000|Overall Study|Withdrawal by Subject|3
1125545|NCT02645409|2215765|FG001|Overall Study|Withdrawal by Subject|0
1125546|NCT02645409|2215764|FG000|Overall Study|Physician Decision|1
1125547|NCT02645409|2215765|FG001|Overall Study|Physician Decision|0
1125548|NCT02646124|2215786|FG000|Overall Study|Lost to Follow-up|0
1125549|NCT02646124|2215787|FG001|Overall Study|Lost to Follow-up|2
1125550|NCT02646332|2215795|FG000|Overall Study|Lost to Follow-up|0
1125551|NCT02646332|2215796|FG001|Overall Study|Lost to Follow-up|3
1125552|NCT02646423|2215813|FG000|Overall Study|Adverse Event|5
1125553|NCT02646423|2215814|FG001|Overall Study|Adverse Event|7
1125554|NCT02646423|2215813|FG000|Overall Study|Ineligible|2
1125555|NCT02646423|2215814|FG001|Overall Study|Ineligible|1
1125556|NCT02646566|2215832|FG000|Overall Study|Lost to Follow-up|5
1125557|NCT02646566|2215833|FG001|Overall Study|Lost to Follow-up|4
1125558|NCT02646566|2215834|FG002|Overall Study|Lost to Follow-up|5
898967|NCT00718718|1871634|FG004|Prior to Week 12|Adverse Event|0
898968|NCT00718718|1871635|FG005|Prior to Week 12|Adverse Event|0
898969|NCT00718718|1871636|FG006|Prior to Week 12|Adverse Event|0
898970|NCT00718718|1871637|FG007|Prior to Week 12|Adverse Event|1
898971|NCT00718718|1871638|FG008|Prior to Week 12|Adverse Event|1
898972|NCT00718718|1871639|FG009|Prior to Week 12|Adverse Event|0
898973|NCT00718718|1871630|FG000|Prior to Week 12|Withdrawal by Subject|0
898974|NCT00718718|1871631|FG001|Prior to Week 12|Withdrawal by Subject|0
898975|NCT00718718|1871632|FG002|Prior to Week 12|Withdrawal by Subject|0
898976|NCT00718718|1871633|FG003|Prior to Week 12|Withdrawal by Subject|0
898977|NCT00718718|1871634|FG004|Prior to Week 12|Withdrawal by Subject|3
898978|NCT00718718|1871635|FG005|Prior to Week 12|Withdrawal by Subject|0
898979|NCT00718718|1871636|FG006|Prior to Week 12|Withdrawal by Subject|1
898980|NCT00718718|1871637|FG007|Prior to Week 12|Withdrawal by Subject|1
898981|NCT00718718|1871638|FG008|Prior to Week 12|Withdrawal by Subject|1
898982|NCT00718718|1871639|FG009|Prior to Week 12|Withdrawal by Subject|0
898983|NCT00718718|1871630|FG000|Prior to Week 12|Other|1
898984|NCT00718718|1871631|FG001|Prior to Week 12|Other|0
898985|NCT00718718|1871632|FG002|Prior to Week 12|Other|1
898986|NCT00718718|1871633|FG003|Prior to Week 12|Other|0
1125559|NCT02646566|2215832|FG000|Overall Study|Treatment failure|1
1125560|NCT02646566|2215833|FG001|Overall Study|Treatment failure|0
1125561|NCT02646566|2215834|FG002|Overall Study|Treatment failure|0
1125562|NCT02646618|2215844|FG000|Overall Study|Lost to Follow-up|10
1125563|NCT02646618|2215845|FG001|Overall Study|Lost to Follow-up|14
1125564|NCT02646891|2215889|FG000|Overall Study|Adverse Event|0
1125565|NCT02646891|2215890|FG001|Overall Study|Adverse Event|1
1125566|NCT02646891|2215891|FG002|Overall Study|Adverse Event|0
1125567|NCT02646891|2215892|FG003|Overall Study|Adverse Event|0
1125568|NCT02646891|2215893|FG004|Overall Study|Adverse Event|0
1125569|NCT02646891|2215894|FG005|Overall Study|Adverse Event|0
898987|NCT00718718|1871634|FG004|Prior to Week 12|Other|0
898988|NCT00718718|1871635|FG005|Prior to Week 12|Other|0
898989|NCT00718718|1871636|FG006|Prior to Week 12|Other|0
898990|NCT00718718|1871637|FG007|Prior to Week 12|Other|0
898991|NCT00718718|1871638|FG008|Prior to Week 12|Other|0
898992|NCT00718718|1871639|FG009|Prior to Week 12|Other|0
898993|NCT00718718|1871630|FG000|Week 12 to End of Study|Adverse Event|0
898994|NCT00718718|1871631|FG001|Week 12 to End of Study|Adverse Event|0
898995|NCT00718718|1871632|FG002|Week 12 to End of Study|Adverse Event|0
898996|NCT00718718|1871633|FG003|Week 12 to End of Study|Adverse Event|0
898997|NCT00718718|1871634|FG004|Week 12 to End of Study|Adverse Event|0
898998|NCT00718718|1871635|FG005|Week 12 to End of Study|Adverse Event|0
898999|NCT00718718|1871636|FG006|Week 12 to End of Study|Adverse Event|0
899000|NCT00718718|1871637|FG007|Week 12 to End of Study|Adverse Event|1
899001|NCT00718718|1871638|FG008|Week 12 to End of Study|Adverse Event|0
899002|NCT00718718|1871639|FG009|Week 12 to End of Study|Adverse Event|0
899003|NCT00718718|1871630|FG000|Week 12 to End of Study|Death|0
899004|NCT00718718|1871631|FG001|Week 12 to End of Study|Death|0
899005|NCT00718718|1871632|FG002|Week 12 to End of Study|Death|0
899006|NCT00718718|1871633|FG003|Week 12 to End of Study|Death|0
899007|NCT00718718|1871634|FG004|Week 12 to End of Study|Death|0
899008|NCT00718718|1871635|FG005|Week 12 to End of Study|Death|1
899009|NCT00718718|1871636|FG006|Week 12 to End of Study|Death|0
899010|NCT00718718|1871637|FG007|Week 12 to End of Study|Death|0
899011|NCT00718718|1871638|FG008|Week 12 to End of Study|Death|0
899012|NCT00718718|1871639|FG009|Week 12 to End of Study|Death|0
899013|NCT00718718|1871630|FG000|Week 12 to End of Study|Withdrawal by Subject|0
899014|NCT00718718|1871631|FG001|Week 12 to End of Study|Withdrawal by Subject|0
899015|NCT00718718|1871632|FG002|Week 12 to End of Study|Withdrawal by Subject|0
899016|NCT00718718|1871633|FG003|Week 12 to End of Study|Withdrawal by Subject|0
899017|NCT00718718|1871634|FG004|Week 12 to End of Study|Withdrawal by Subject|0
899018|NCT00718718|1871635|FG005|Week 12 to End of Study|Withdrawal by Subject|2
899019|NCT00718718|1871636|FG006|Week 12 to End of Study|Withdrawal by Subject|1
899020|NCT00718718|1871637|FG007|Week 12 to End of Study|Withdrawal by Subject|0
899021|NCT00718718|1871638|FG008|Week 12 to End of Study|Withdrawal by Subject|0
899022|NCT00718718|1871639|FG009|Week 12 to End of Study|Withdrawal by Subject|0
899023|NCT00718718|1871630|FG000|Week 12 to End of Study|Lost to Follow-up|0
899024|NCT00718718|1871631|FG001|Week 12 to End of Study|Lost to Follow-up|0
899025|NCT00718718|1871632|FG002|Week 12 to End of Study|Lost to Follow-up|0
1125570|NCT02646891|2215895|FG006|Overall Study|Adverse Event|0
1125571|NCT02646891|2215896|FG007|Overall Study|Adverse Event|0
1125572|NCT02646891|2215897|FG008|Overall Study|Adverse Event|0
1125573|NCT02646891|2215898|FG009|Overall Study|Adverse Event|0
1125574|NCT02646891|2215889|FG000|Overall Study|Lost to Follow-up|0
1125575|NCT02646891|2215890|FG001|Overall Study|Lost to Follow-up|0
1125576|NCT02646891|2215891|FG002|Overall Study|Lost to Follow-up|0
1125577|NCT02646891|2215892|FG003|Overall Study|Lost to Follow-up|0
1125578|NCT02646891|2215893|FG004|Overall Study|Lost to Follow-up|0
1125579|NCT02646891|2215894|FG005|Overall Study|Lost to Follow-up|0
1125580|NCT02646891|2215895|FG006|Overall Study|Lost to Follow-up|2
1125581|NCT02646891|2215896|FG007|Overall Study|Lost to Follow-up|2
1125582|NCT02646891|2215897|FG008|Overall Study|Lost to Follow-up|2
1125583|NCT02646891|2215898|FG009|Overall Study|Lost to Follow-up|2
1125584|NCT02646891|2215889|FG000|Overall Study|Protocol Violation|0
1125585|NCT02646891|2215890|FG001|Overall Study|Protocol Violation|0
1125586|NCT02646891|2215891|FG002|Overall Study|Protocol Violation|0
1125587|NCT02646891|2215892|FG003|Overall Study|Protocol Violation|0
1125588|NCT02646891|2215893|FG004|Overall Study|Protocol Violation|0
1125589|NCT02646891|2215894|FG005|Overall Study|Protocol Violation|0
1125590|NCT02646891|2215895|FG006|Overall Study|Protocol Violation|1
1125591|NCT02646891|2215896|FG007|Overall Study|Protocol Violation|1
1125592|NCT02646891|2215897|FG008|Overall Study|Protocol Violation|0
1125593|NCT02646891|2215898|FG009|Overall Study|Protocol Violation|0
1125594|NCT02646891|2215889|FG000|Overall Study|Withdrawal by Subject|2
1125595|NCT02646891|2215890|FG001|Overall Study|Withdrawal by Subject|0
1125596|NCT02646891|2215891|FG002|Overall Study|Withdrawal by Subject|1
1125597|NCT02646891|2215892|FG003|Overall Study|Withdrawal by Subject|0
1125598|NCT02646891|2215893|FG004|Overall Study|Withdrawal by Subject|0
1125599|NCT02646891|2215894|FG005|Overall Study|Withdrawal by Subject|0
1125600|NCT02646891|2215895|FG006|Overall Study|Withdrawal by Subject|5
1125601|NCT02646891|2215896|FG007|Overall Study|Withdrawal by Subject|9
1125602|NCT02646891|2215897|FG008|Overall Study|Withdrawal by Subject|7
1125603|NCT02646891|2215898|FG009|Overall Study|Withdrawal by Subject|3
1125604|NCT02646891|2215889|FG000|Overall Study|Death|0
1125605|NCT02646891|2215890|FG001|Overall Study|Death|0
1125606|NCT02646891|2215891|FG002|Overall Study|Death|0
1125607|NCT02646891|2215892|FG003|Overall Study|Death|0
1125608|NCT02646891|2215893|FG004|Overall Study|Death|0
1125609|NCT02646891|2215894|FG005|Overall Study|Death|0
1125610|NCT02646891|2215895|FG006|Overall Study|Death|1
1125611|NCT02646891|2215896|FG007|Overall Study|Death|1
1125612|NCT02646891|2215897|FG008|Overall Study|Death|1
1125613|NCT02646891|2215898|FG009|Overall Study|Death|0
1125614|NCT02647320|2216006|FG000|Overall Study|Adverse Event|0
1125615|NCT02647320|2216007|FG001|Overall Study|Adverse Event|1
1125616|NCT02647320|2216008|FG002|Overall Study|Adverse Event|3
1125617|NCT02647320|2216009|FG003|Overall Study|Adverse Event|2
899026|NCT00718718|1871633|FG003|Week 12 to End of Study|Lost to Follow-up|0
899027|NCT00718718|1871634|FG004|Week 12 to End of Study|Lost to Follow-up|0
899028|NCT00718718|1871635|FG005|Week 12 to End of Study|Lost to Follow-up|0
899029|NCT00718718|1871636|FG006|Week 12 to End of Study|Lost to Follow-up|0
899030|NCT00718718|1871637|FG007|Week 12 to End of Study|Lost to Follow-up|0
899031|NCT00718718|1871638|FG008|Week 12 to End of Study|Lost to Follow-up|1
899032|NCT00718718|1871639|FG009|Week 12 to End of Study|Lost to Follow-up|0
899033|NCT00718718|1871630|FG000|Week 12 to End of Study|Other|0
899034|NCT00718718|1871631|FG001|Week 12 to End of Study|Other|1
899035|NCT00718718|1871632|FG002|Week 12 to End of Study|Other|0
899036|NCT00718718|1871633|FG003|Week 12 to End of Study|Other|1
899037|NCT00718718|1871634|FG004|Week 12 to End of Study|Other|0
899038|NCT00718718|1871635|FG005|Week 12 to End of Study|Other|0
899039|NCT00718718|1871636|FG006|Week 12 to End of Study|Other|1
899040|NCT00718718|1871637|FG007|Week 12 to End of Study|Other|0
899041|NCT00718718|1871638|FG008|Week 12 to End of Study|Other|0
899042|NCT00718718|1871639|FG009|Week 12 to End of Study|Other|0
899043|NCT00718770|1871665|FG000|Overall Study|Adverse Event|1
1125618|NCT02647320|2216010|FG004|Overall Study|Adverse Event|1
1125619|NCT02647320|2216006|FG000|Overall Study|Protocol Violation|0
1125620|NCT02647320|2216007|FG001|Overall Study|Protocol Violation|0
1125621|NCT02647320|2216008|FG002|Overall Study|Protocol Violation|3
1125622|NCT02647320|2216009|FG003|Overall Study|Protocol Violation|0
1125623|NCT02647320|2216010|FG004|Overall Study|Protocol Violation|0
1125624|NCT02647320|2216006|FG000|Overall Study|Withdrawal by Subject|7
1125625|NCT02647320|2216007|FG001|Overall Study|Withdrawal by Subject|4
1125626|NCT02647320|2216008|FG002|Overall Study|Withdrawal by Subject|2
1125627|NCT02647320|2216009|FG003|Overall Study|Withdrawal by Subject|2
1125628|NCT02647320|2216010|FG004|Overall Study|Withdrawal by Subject|7
1125629|NCT02647320|2216006|FG000|Overall Study|Persistent hyperglycemia|0
1125630|NCT02647320|2216007|FG001|Overall Study|Persistent hyperglycemia|1
1125631|NCT02647320|2216008|FG002|Overall Study|Persistent hyperglycemia|1
1125632|NCT02647320|2216009|FG003|Overall Study|Persistent hyperglycemia|1
1125633|NCT02647320|2216010|FG004|Overall Study|Persistent hyperglycemia|1
1125634|NCT02647320|2216006|FG000|Overall Study|Study terminated by sponsor|1
1125635|NCT02647320|2216007|FG001|Overall Study|Study terminated by sponsor|1
1125636|NCT02647320|2216008|FG002|Overall Study|Study terminated by sponsor|1
1125637|NCT02647320|2216009|FG003|Overall Study|Study terminated by sponsor|1
1125638|NCT02647320|2216010|FG004|Overall Study|Study terminated by sponsor|2
1125639|NCT02647320|2216006|FG000|Overall Study|Reason not provided|0
1125640|NCT02647320|2216007|FG001|Overall Study|Reason not provided|0
1125641|NCT02647320|2216008|FG002|Overall Study|Reason not provided|1
1125642|NCT02647320|2216009|FG003|Overall Study|Reason not provided|0
1125643|NCT02647320|2216010|FG004|Overall Study|Reason not provided|2
1125644|NCT02647320|2216006|FG000|Overall Study|Lost to Follow-up|1
1125645|NCT02647320|2216007|FG001|Overall Study|Lost to Follow-up|1
1125646|NCT02647320|2216008|FG002|Overall Study|Lost to Follow-up|0
1125647|NCT02647320|2216009|FG003|Overall Study|Lost to Follow-up|0
1125648|NCT02647320|2216010|FG004|Overall Study|Lost to Follow-up|0
1125649|NCT02647320|2216006|FG000|Overall Study|Develop anemia|1
1125650|NCT02647320|2216007|FG001|Overall Study|Develop anemia|0
1125651|NCT02647320|2216008|FG002|Overall Study|Develop anemia|0
1125652|NCT02647320|2216009|FG003|Overall Study|Develop anemia|0
1125653|NCT02647320|2216010|FG004|Overall Study|Develop anemia|0
1125654|NCT02647320|2216006|FG000|Overall Study|Lack of Efficacy|0
1125655|NCT02647320|2216007|FG001|Overall Study|Lack of Efficacy|0
1125656|NCT02647320|2216008|FG002|Overall Study|Lack of Efficacy|0
1125657|NCT02647320|2216009|FG003|Overall Study|Lack of Efficacy|1
1125658|NCT02647320|2216010|FG004|Overall Study|Lack of Efficacy|0
1125659|NCT02647320|2216006|FG000|Overall Study|Disposition Missing Due to Fire at Site|2
1125660|NCT02647320|2216007|FG001|Overall Study|Disposition Missing Due to Fire at Site|3
1125661|NCT02647320|2216008|FG002|Overall Study|Disposition Missing Due to Fire at Site|4
1125662|NCT02647320|2216009|FG003|Overall Study|Disposition Missing Due to Fire at Site|3
1125663|NCT02647320|2216010|FG004|Overall Study|Disposition Missing Due to Fire at Site|4
1125664|NCT02647645|2216030|FG000|Overall Study|Lost to Follow-up|2
1125665|NCT02647645|2216031|FG001|Overall Study|Lost to Follow-up|1
1125666|NCT02647658|2216039|FG000|Overall Study|Consent refusal|15
1125667|NCT02647658|2216040|FG001|Overall Study|Consent refusal|24
1125668|NCT02647788|2216048|FG000|Overall Study|Lost to Follow-up|13
1125669|NCT02647788|2216049|FG001|Overall Study|Lost to Follow-up|11
1125670|NCT02647788|2216048|FG000|Overall Study|Did not want opiate|0
1125671|NCT02647788|2216049|FG001|Overall Study|Did not want opiate|1
1125672|NCT02647788|2216048|FG000|Overall Study|Withdrawal by Subject|1
1125673|NCT02647788|2216049|FG001|Overall Study|Withdrawal by Subject|0
1125674|NCT02647788|2216048|FG000|Overall Study|Felt itchy with assigned medication|1
1125675|NCT02647788|2216049|FG001|Overall Study|Felt itchy with assigned medication|0
1125676|NCT02647788|2216048|FG000|Overall Study|Felt nauseous with assigned medication|1
1125677|NCT02647788|2216049|FG001|Overall Study|Felt nauseous with assigned medication|1
1125678|NCT02647866|2216060|FG000|Overall Study|Adverse Event|0
899044|NCT00718770|1871665|FG000|Overall Study|Lack of Efficacy|1
899045|NCT00718770|1871665|FG000|Overall Study|Lack of Efficacy|1
899046|NCT00718770|1871665|FG000|Overall Study|Adverse Event|1
899047|NCT00718770|1871665|FG000|Overall Study|Lack of Efficacy|1
899048|NCT00718770|1871665|FG000|Overall Study|Adverse Event|1
899049|NCT00718770|1871665|FG000|Overall Study|Lack of Efficacy|1
899050|NCT00718770|1871665|FG000|Overall Study|Adverse Event|1
899051|NCT00718809|1871671|FG000|Overall Study|Disease progression|9
899052|NCT00718809|1871672|FG001|Overall Study|Disease progression|7
899053|NCT00718809|1871671|FG000|Overall Study|Adverse Event|1
899054|NCT00718809|1871672|FG001|Overall Study|Adverse Event|1
899055|NCT00718809|1871671|FG000|Overall Study|Withdrawal by Subject|0
899056|NCT00718809|1871672|FG001|Overall Study|Withdrawal by Subject|1
899057|NCT00718809|1871671|FG000|Overall Study|Lost to Follow-up|1
899058|NCT00718809|1871672|FG001|Overall Study|Lost to Follow-up|0
899059|NCT00718809|1871671|FG000|Overall Study|Noncompliance|1
899060|NCT00718809|1871672|FG001|Overall Study|Noncompliance|0
899061|NCT00718861|1871680|FG000|Overall Study|Withdrawal by Subject|15
899062|NCT00718861|1871681|FG001|Overall Study|Withdrawal by Subject|10
899063|NCT00718861|1871680|FG000|Overall Study|Adverse Event|2
899064|NCT00718861|1871681|FG001|Overall Study|Adverse Event|1
899065|NCT00718861|1871680|FG000|Overall Study|Lost to Follow-up|2
899066|NCT00718861|1871681|FG001|Overall Study|Lost to Follow-up|1
899067|NCT00718861|1871680|FG000|Overall Study|Administrative Problems|1
899068|NCT00718861|1871681|FG001|Overall Study|Administrative Problems|1
899069|NCT00718861|1871680|FG000|Overall Study|Death|1
899070|NCT00718861|1871681|FG001|Overall Study|Death|5
899071|NCT00718887|1871689|FG000|Overall Study|Withdrawal by Subject|3
899072|NCT00718887|1871690|FG001|Overall Study|Withdrawal by Subject|2
899073|NCT00718887|1871689|FG000|Overall Study|Not identified|2
899074|NCT00718887|1871690|FG001|Overall Study|Not identified|7
899075|NCT00719043|1871709|FG000|Overall Study|Adverse Event|5
899076|NCT00719043|1871710|FG001|Overall Study|Adverse Event|1
899077|NCT00719043|1871711|FG002|Overall Study|Adverse Event|2
899078|NCT00719043|1871712|FG003|Overall Study|Adverse Event|2
899079|NCT00719043|1871713|FG004|Overall Study|Adverse Event|1
899080|NCT00719043|1871714|FG005|Overall Study|Adverse Event|4
899081|NCT00719043|1871715|FG006|Overall Study|Adverse Event|4
899082|NCT00719043|1871709|FG000|Overall Study|Lost to Follow-up|14
899083|NCT00719043|1871710|FG001|Overall Study|Lost to Follow-up|10
899084|NCT00719043|1871711|FG002|Overall Study|Lost to Follow-up|8
899085|NCT00719043|1871712|FG003|Overall Study|Lost to Follow-up|9
899086|NCT00719043|1871713|FG004|Overall Study|Lost to Follow-up|10
899087|NCT00719043|1871714|FG005|Overall Study|Lost to Follow-up|9
899088|NCT00719043|1871715|FG006|Overall Study|Lost to Follow-up|9
1125679|NCT02647866|2216061|FG001|Overall Study|Adverse Event|0
1125680|NCT02647866|2216062|FG002|Overall Study|Adverse Event|2
1125681|NCT02647866|2216063|FG003|Overall Study|Adverse Event|2
1125682|NCT02647866|2216064|FG004|Overall Study|Adverse Event|1
1125683|NCT02647866|2216060|FG000|Overall Study|Disease Worsening|3
1125684|NCT02647866|2216061|FG001|Overall Study|Disease Worsening|1
1125685|NCT02647866|2216062|FG002|Overall Study|Disease Worsening|0
1125686|NCT02647866|2216063|FG003|Overall Study|Disease Worsening|0
1125687|NCT02647866|2216064|FG004|Overall Study|Disease Worsening|1
1125688|NCT02647866|2216060|FG000|Overall Study|Withdrawal by Subject|1
1125689|NCT02647866|2216061|FG001|Overall Study|Withdrawal by Subject|1
1125690|NCT02647866|2216062|FG002|Overall Study|Withdrawal by Subject|2
1125691|NCT02647866|2216063|FG003|Overall Study|Withdrawal by Subject|4
1125692|NCT02647866|2216064|FG004|Overall Study|Withdrawal by Subject|4
1125693|NCT02647866|2216060|FG000|Overall Study|Physician Decision|0
1125694|NCT02647866|2216061|FG001|Overall Study|Physician Decision|1
1125695|NCT02647866|2216062|FG002|Overall Study|Physician Decision|1
1125696|NCT02647866|2216063|FG003|Overall Study|Physician Decision|0
1125697|NCT02647866|2216064|FG004|Overall Study|Physician Decision|2
1125698|NCT02647866|2216060|FG000|Overall Study|Death|0
1125699|NCT02647866|2216061|FG001|Overall Study|Death|1
1125700|NCT02647866|2216062|FG002|Overall Study|Death|0
1125701|NCT02647866|2216063|FG003|Overall Study|Death|0
1125702|NCT02647866|2216064|FG004|Overall Study|Death|0
1125703|NCT02647866|2216060|FG000|Overall Study|Subject moved to different country|1
1125704|NCT02647866|2216061|FG001|Overall Study|Subject moved to different country|0
1125705|NCT02647866|2216062|FG002|Overall Study|Subject moved to different country|0
1125706|NCT02647866|2216063|FG003|Overall Study|Subject moved to different country|0
1125707|NCT02647866|2216064|FG004|Overall Study|Subject moved to different country|0
1125708|NCT02647905|2216084|FG000|Overall Study|Lost to Follow-up|1
1125709|NCT02647905|2216084|FG000|Overall Study|Withdrawal by Subject|2
1125710|NCT02647944|2216090|FG000|Overall Study|Withdrawal by Subject|0
1125711|NCT02647944|2216091|FG001|Overall Study|Withdrawal by Subject|3
1125712|NCT02647944|2216090|FG000|Overall Study|Adverse Event|2
1125713|NCT02647944|2216091|FG001|Overall Study|Adverse Event|0
1125714|NCT02648204|2216114|FG000|Overall Study|Withdrawal by Subject|12
1125715|NCT02648204|2216115|FG001|Overall Study|Withdrawal by Subject|8
1125716|NCT02648204|2216116|FG002|Overall Study|Withdrawal by Subject|2
1125717|NCT02648204|2216117|FG003|Overall Study|Withdrawal by Subject|6
1125718|NCT02648204|2216114|FG000|Overall Study|Lost to Follow-up|5
1125719|NCT02648204|2216115|FG001|Overall Study|Lost to Follow-up|8
1125720|NCT02648204|2216116|FG002|Overall Study|Lost to Follow-up|4
1125721|NCT02648204|2216117|FG003|Overall Study|Lost to Follow-up|6
1125722|NCT02648204|2216114|FG000|Overall Study|Missing follow-up information|4
1125723|NCT02648204|2216115|FG001|Overall Study|Missing follow-up information|4
1125724|NCT02648204|2216116|FG002|Overall Study|Missing follow-up information|4
1125725|NCT02648204|2216117|FG003|Overall Study|Missing follow-up information|2
1125726|NCT02648204|2216114|FG000|Overall Study|Death|1
1125727|NCT02648204|2216115|FG001|Overall Study|Death|1
1125728|NCT02648204|2216116|FG002|Overall Study|Death|2
1125729|NCT02648204|2216117|FG003|Overall Study|Death|2
1125730|NCT02648204|2216114|FG000|Overall Study|Adverse Event|0
1125731|NCT02648204|2216115|FG001|Overall Study|Adverse Event|0
1125732|NCT02648204|2216116|FG002|Overall Study|Adverse Event|1
1125733|NCT02648204|2216117|FG003|Overall Study|Adverse Event|0
1125734|NCT02648217|2216129|FG000|Overall Study|Adverse Event|0
1125735|NCT02648217|2216130|FG001|Overall Study|Adverse Event|1
1125736|NCT02648217|2216129|FG000|Overall Study|Lost to Follow-up|1
1125737|NCT02648217|2216130|FG001|Overall Study|Lost to Follow-up|1
1125738|NCT02648217|2216129|FG000|Overall Study|Withdrawal by Subject|4
1125739|NCT02648217|2216130|FG001|Overall Study|Withdrawal by Subject|3
1125740|NCT02648217|2216129|FG000|Overall Study|Unclassified|5
1125741|NCT02648217|2216130|FG001|Overall Study|Unclassified|0
1125742|NCT02648438|2216143|FG000|Overall Study|Eligibility criteria not fulfilled|0
1125743|NCT02648438|2216144|FG001|Overall Study|Eligibility criteria not fulfilled|2
1125744|NCT02648438|2216145|FG002|Overall Study|Eligibility criteria not fulfilled|0
1125745|NCT02648438|2216143|FG000|Overall Study|Protocol Violation|2
1125746|NCT02648438|2216144|FG001|Overall Study|Protocol Violation|0
1125747|NCT02648438|2216145|FG002|Overall Study|Protocol Violation|0
1125748|NCT02648438|2216143|FG000|Overall Study|Withdrawal by Subject|1
1125749|NCT02648438|2216144|FG001|Overall Study|Withdrawal by Subject|1
1125750|NCT02648438|2216145|FG002|Overall Study|Withdrawal by Subject|0
899089|NCT00719043|1871709|FG000|Overall Study|Protocol Violation|0
899090|NCT00719043|1871710|FG001|Overall Study|Protocol Violation|0
899091|NCT00719043|1871711|FG002|Overall Study|Protocol Violation|0
899092|NCT00719043|1871712|FG003|Overall Study|Protocol Violation|0
899093|NCT00719043|1871713|FG004|Overall Study|Protocol Violation|0
899094|NCT00719043|1871714|FG005|Overall Study|Protocol Violation|1
899095|NCT00719043|1871715|FG006|Overall Study|Protocol Violation|0
899096|NCT00719043|1871709|FG000|Overall Study|Other|1
899097|NCT00719043|1871710|FG001|Overall Study|Other|0
899098|NCT00719043|1871711|FG002|Overall Study|Other|1
899099|NCT00719043|1871712|FG003|Overall Study|Other|2
899100|NCT00719043|1871713|FG004|Overall Study|Other|0
1125751|NCT02648698|2216167|FG000|Overall Study|Protocol Violation|1
1125752|NCT02648698|2216168|FG001|Overall Study|Protocol Violation|5
1125753|NCT02648932|2216185|FG000|Overall Study|No transplant|3
1125754|NCT02648932|2216186|FG001|Overall Study|No transplant|1
1125755|NCT02649218|2216239|FG000|Overall Study|Adverse Event|8
1125756|NCT02649218|2216239|FG000|Overall Study|Lack of Efficacy|8
1125757|NCT02649218|2216239|FG000|Overall Study|Pregnancy|3
1125758|NCT02649218|2216239|FG000|Overall Study|Protocol Violation|3
1125759|NCT02649218|2216239|FG000|Overall Study|Physician Decision|1
1125760|NCT02649218|2216239|FG000|Overall Study|Withdrawal by Subject|2
1125761|NCT02649231|2216248|FG000|Overall Study|Adverse Event|0
1125762|NCT02649231|2216249|FG001|Overall Study|Adverse Event|0
1125763|NCT02649231|2216250|FG002|Overall Study|Adverse Event|0
1125764|NCT02649231|2216251|FG003|Overall Study|Adverse Event|1
1125765|NCT02649231|2216248|FG000|Overall Study|Lost to Follow-up|2
1125766|NCT02649231|2216249|FG001|Overall Study|Lost to Follow-up|1
1125767|NCT02649231|2216250|FG002|Overall Study|Lost to Follow-up|1
1125768|NCT02649231|2216251|FG003|Overall Study|Lost to Follow-up|0
1125769|NCT02649231|2216248|FG000|Overall Study|Withdrawal by Subject|0
1125770|NCT02649231|2216249|FG001|Overall Study|Withdrawal by Subject|1
1125771|NCT02649231|2216250|FG002|Overall Study|Withdrawal by Subject|0
1125772|NCT02649231|2216251|FG003|Overall Study|Withdrawal by Subject|1
1125773|NCT02649231|2216248|FG000|Overall Study|Protocol Violation|2
1125774|NCT02649231|2216249|FG001|Overall Study|Protocol Violation|1
1125775|NCT02649231|2216250|FG002|Overall Study|Protocol Violation|1
1125776|NCT02649231|2216251|FG003|Overall Study|Protocol Violation|0
1125777|NCT02649439|2216272|FG000|Overall Study|Switched to alternative treatment|6
1125778|NCT02649439|2216273|FG001|Overall Study|Switched to alternative treatment|4
1125779|NCT02649439|2216272|FG000|Overall Study|Patient decision|1
1125780|NCT02649439|2216273|FG001|Overall Study|Patient decision|0
1125781|NCT02649439|2216272|FG000|Overall Study|Patient going out of country|1
1125782|NCT02649439|2216273|FG001|Overall Study|Patient going out of country|0
1125783|NCT02649439|2216272|FG000|Overall Study|To start finasteride|1
1125784|NCT02649439|2216273|FG001|Overall Study|To start finasteride|0
1125785|NCT02649439|2216272|FG000|Overall Study|Physician Decision|1
1125786|NCT02649439|2216273|FG001|Overall Study|Physician Decision|0
1125787|NCT02649439|2216272|FG000|Overall Study|Disease progression on study|12
1125788|NCT02649439|2216273|FG001|Overall Study|Disease progression on study|13
1125789|NCT02649439|2216272|FG000|Overall Study|Refused further treatment|1
1125790|NCT02649439|2216273|FG001|Overall Study|Refused further treatment|0
1125791|NCT02649439|2216272|FG000|Overall Study|Refused further follow up|2
1125792|NCT02649439|2216273|FG001|Overall Study|Refused further follow up|7
1125793|NCT02649439|2216272|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1
1125794|NCT02649439|2216273|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0
1125795|NCT02649439|2216272|FG000|Overall Study|No treatment, per protocol|1
1125796|NCT02649439|2216273|FG001|Overall Study|No treatment, per protocol|0
1125797|NCT02649439|2216272|FG000|Overall Study|PSA DT makes ineligible|0
1125798|NCT02649439|2216273|FG001|Overall Study|PSA DT makes ineligible|1
1125799|NCT02649439|2216272|FG000|Overall Study|Rising PSA No Mets|0
1125800|NCT02649439|2216273|FG001|Overall Study|Rising PSA No Mets|1
1125801|NCT02649439|2216272|FG000|Overall Study|Rising PSA|0
1125802|NCT02649439|2216273|FG001|Overall Study|Rising PSA|1
1125803|NCT02649439|2216272|FG000|Overall Study|Signed follow up protocol|0
1125804|NCT02649439|2216273|FG001|Overall Study|Signed follow up protocol|1
1125805|NCT02649634|2216340|FG000|Overall Study|Withdrawal by Subject|3
1125806|NCT02649634|2216341|FG001|Overall Study|Withdrawal by Subject|5
1125807|NCT02649634|2216340|FG000|Overall Study|Lost to Follow-up|0
1125808|NCT02649634|2216341|FG001|Overall Study|Lost to Follow-up|1
1125809|NCT02649894|2216355|FG000|Overall Study|Adverse Event|1
1125810|NCT02649894|2216356|FG001|Overall Study|Adverse Event|0
1125811|NCT02649894|2216355|FG000|Overall Study|Physician Decision|0
1125812|NCT02649894|2216356|FG001|Overall Study|Physician Decision|1
1125813|NCT02649894|2216355|FG000|Overall Study|Withdrawal by Subject|5
1125814|NCT02649894|2216356|FG001|Overall Study|Withdrawal by Subject|2
1125815|NCT02649894|2216355|FG000|Overall Study|Lost to Follow-up|2
1125816|NCT02649894|2216356|FG001|Overall Study|Lost to Follow-up|1
1125817|NCT02649894|2216355|FG000|Overall Study|Death|30
1125818|NCT02649894|2216356|FG001|Overall Study|Death|7
1125819|NCT02649894|2216355|FG000|Overall Study|Other, not specified|6
1125820|NCT02649894|2216356|FG001|Overall Study|Other, not specified|0
1125833|NCT02650128|2216371|FG000|Overall Study|Death|2
1125834|NCT02650284|2216401|FG000|Overall Study|Lost to Follow-up|3
1125835|NCT02650284|2216402|FG001|Overall Study|Lost to Follow-up|3
1125836|NCT02650284|2216401|FG000|Overall Study|Consent incorrectly taken|0
1125837|NCT02650284|2216402|FG001|Overall Study|Consent incorrectly taken|1
1125838|NCT02650466|2216417|FG000|Overall Study|Physician Decision|1
1125839|NCT02650466|2216417|FG000|Overall Study|Withdrawal by Subject|5
1125840|NCT02650466|2216417|FG000|Overall Study|Lost to Follow-up|1
1125841|NCT02650895|2216438|FG000|Overall Study|Withdrawal by Subject|0
1125842|NCT02650895|2216439|FG001|Overall Study|Withdrawal by Subject|1
1125843|NCT02650895|2216440|FG002|Overall Study|Withdrawal by Subject|0
1125844|NCT02650895|2216441|FG003|Overall Study|Withdrawal by Subject|0
1125845|NCT02650895|2216442|FG004|Overall Study|Withdrawal by Subject|0
1125846|NCT02650895|2216443|FG005|Overall Study|Withdrawal by Subject|0
1125847|NCT02650921|2216462|FG000|Overall Study|Withdrawal by Subject|4
1125848|NCT02650921|2216462|FG000|Overall Study|Lost to Follow-up|2
1125849|NCT02650921|2216462|FG000|Overall Study|Adverse Event|1
1125850|NCT02650921|2216462|FG000|Overall Study|Due to Medical Condition|1
1125851|NCT02651116|2216478|FG000|Overall Study|Adverse Event|0
1125852|NCT02651116|2216479|FG001|Overall Study|Adverse Event|1
1125853|NCT02651116|2216478|FG000|Overall Study|No Longer Willing To Participate In Study|1
1125854|NCT02651116|2216479|FG001|Overall Study|No Longer Willing To Participate In Study|0
1125855|NCT02651155|2216487|FG000|Overall Study|Pretreatment Event/Adverse Event|1
1125856|NCT02651155|2216488|FG001|Overall Study|Pretreatment Event/Adverse Event|2
1125857|NCT02651155|2216487|FG000|Overall Study|Voluntary Withdrawal|5
1125858|NCT02651155|2216488|FG001|Overall Study|Voluntary Withdrawal|0
1125859|NCT02651194|2216494|FG000|Overall Study|Lost to Follow-up|3
1125860|NCT02651194|2216494|FG000|Overall Study|Other|2
1125861|NCT02651220|2216501|FG000|Overall Study|Adverse Event|1
1125862|NCT02651220|2216502|FG001|Overall Study|Adverse Event|5
1125863|NCT02651220|2216503|FG002|Overall Study|Adverse Event|1
1125864|NCT02651220|2216501|FG000|Overall Study|Lost to Follow-up|8
1125865|NCT02651220|2216502|FG001|Overall Study|Lost to Follow-up|14
1125866|NCT02651220|2216503|FG002|Overall Study|Lost to Follow-up|14
1125867|NCT02651220|2216501|FG000|Overall Study|Non-Compliance with Study Drug|4
1125868|NCT02651220|2216502|FG001|Overall Study|Non-Compliance with Study Drug|0
1125869|NCT02651220|2216503|FG002|Overall Study|Non-Compliance with Study Drug|1
1125870|NCT02651220|2216501|FG000|Overall Study|Pregnancy|1
1125871|NCT02651220|2216502|FG001|Overall Study|Pregnancy|0
1125872|NCT02651220|2216503|FG002|Overall Study|Pregnancy|1
1125873|NCT02651220|2216501|FG000|Overall Study|Protocol Violation|0
1125874|NCT02651220|2216502|FG001|Overall Study|Protocol Violation|0
1125875|NCT02651220|2216503|FG002|Overall Study|Protocol Violation|1
1125876|NCT02651220|2216501|FG000|Overall Study|Withdrawal by Subject|5
1125877|NCT02651220|2216502|FG001|Overall Study|Withdrawal by Subject|6
1125878|NCT02651220|2216503|FG002|Overall Study|Withdrawal by Subject|8
1125879|NCT02651220|2216501|FG000|Overall Study|Miscellaneous|4
1125880|NCT02651220|2216502|FG001|Overall Study|Miscellaneous|1
1125881|NCT02651220|2216503|FG002|Overall Study|Miscellaneous|2
1125882|NCT02651220|2216501|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1125883|NCT02651220|2216502|FG001|Overall Study|Withdrawal by Parent/Guardian|1
1125884|NCT02651220|2216503|FG002|Overall Study|Withdrawal by Parent/Guardian|1
1125885|NCT02651467|2216552|FG000|Overall Study|Withdrawal by Subject|0
1125886|NCT02651467|2216553|FG001|Overall Study|Withdrawal by Subject|0
1125887|NCT02651467|2216554|FG002|Overall Study|Withdrawal by Subject|2
1125888|NCT02651467|2216552|FG000|Overall Study|Other (Not specified)|1
1125889|NCT02651467|2216553|FG001|Overall Study|Other (Not specified)|0
1125890|NCT02651467|2216554|FG002|Overall Study|Other (Not specified)|2
1125891|NCT02651688|2216587|FG000|Overall Study|Non-compliance|0
1125892|NCT02651688|2216588|FG001|Overall Study|Non-compliance|0
1125893|NCT02651688|2216589|FG002|Overall Study|Non-compliance|1
1125894|NCT02651688|2216587|FG000|Overall Study|Principal Investigator (PI) decision|0
1125895|NCT02651688|2216588|FG001|Overall Study|Principal Investigator (PI) decision|2
1125896|NCT02651688|2216589|FG002|Overall Study|Principal Investigator (PI) decision|0
1125897|NCT02651688|2216587|FG000|Overall Study|Lost to Follow-up|1
1125898|NCT02651688|2216588|FG001|Overall Study|Lost to Follow-up|3
1125899|NCT02651688|2216589|FG002|Overall Study|Lost to Follow-up|0
1125900|NCT02651688|2216587|FG000|Overall Study|Withdrawal by Subject|1
1125901|NCT02651688|2216588|FG001|Overall Study|Withdrawal by Subject|0
1125902|NCT02651688|2216589|FG002|Overall Study|Withdrawal by Subject|2
1125903|NCT02651922|2216597|FG000|Overall Study|due to exclusion criteria|2
1125904|NCT02651987|2216603|FG000|Overall Study|Adverse Event|2
1125905|NCT02651987|2216604|FG001|Overall Study|Adverse Event|2
1125906|NCT02651987|2216603|FG000|Overall Study|Consent Withdrawn|2
1125907|NCT02651987|2216604|FG001|Overall Study|Consent Withdrawn|0
1125908|NCT02651987|2216603|FG000|Overall Study|Local PD|0
1125909|NCT02651987|2216604|FG001|Overall Study|Local PD|2
1125910|NCT02651987|2216603|FG000|Overall Study|Investigator Decision|1
1125911|NCT02651987|2216604|FG001|Overall Study|Investigator Decision|1
1125912|NCT02652156|2216616|FG000|Overall Study|Physician Decision|1
1125913|NCT02652156|2216617|FG001|Overall Study|Physician Decision|0
1125914|NCT02652156|2216618|FG002|Overall Study|Physician Decision|0
1125915|NCT02652260|2216642|FG000|Overall Study|Pregnancy|0
1125916|NCT02652260|2216643|FG001|Overall Study|Pregnancy|1
1125917|NCT02652260|2216642|FG000|Overall Study|Withdrawal by Subject|0
1125918|NCT02652260|2216643|FG001|Overall Study|Withdrawal by Subject|1
1125919|NCT02652442|2216688|FG000|Centrifugation - Distance|Lost to Follow-up|1
1125920|NCT02652624|2216710|FG000|Randomized Phase|Pregnancy|3
1125921|NCT02652624|2216711|FG001|Randomized Phase|Pregnancy|1
1125922|NCT02652624|2216710|FG000|Randomized Phase|Investigator's Discretion|0
1125923|NCT02652624|2216711|FG001|Randomized Phase|Investigator's Discretion|2
1125924|NCT02652624|2216710|FG000|Randomized Phase|Death|0
1125925|NCT02652624|2216711|FG001|Randomized Phase|Death|1
1125926|NCT02652624|2216710|FG000|Randomized Phase|Lost to Follow-up|0
1125927|NCT02652624|2216711|FG001|Randomized Phase|Lost to Follow-up|1
1125928|NCT02652624|2216710|FG000|Extension Phase|Lost to Follow-up|3
1125929|NCT02652624|2216711|FG001|Extension Phase|Lost to Follow-up|1
1125930|NCT02652624|2216710|FG000|Extension Phase|Pregnancy|1
1125931|NCT02652624|2216711|FG001|Extension Phase|Pregnancy|1
1125932|NCT02652624|2216710|FG000|Extension Phase|Adverse Event|0
1125933|NCT02652624|2216711|FG001|Extension Phase|Adverse Event|1
1125934|NCT02652624|2216710|FG000|Extension Phase|Withdrew Consent|0
1125935|NCT02652624|2216711|FG001|Extension Phase|Withdrew Consent|1
1125936|NCT02652767|2216719|FG000|Overall Study|Death|2
1125937|NCT02652767|2216719|FG000|Overall Study|Lost to Follow-up|1
1125938|NCT02652767|2216719|FG000|Overall Study|Withdrawal by Subject|1
1125949|NCT02653170|2216758|FG000|Overall Study|Withdrawal by Subject|3
1125950|NCT02653170|2216759|FG001|Overall Study|Withdrawal by Subject|8
1125951|NCT02653170|2216760|FG002|Overall Study|Withdrawal by Subject|3
1125952|NCT02653170|2216758|FG000|Overall Study|withdrawn by study team|2
1125953|NCT02653170|2216759|FG001|Overall Study|withdrawn by study team|4
1125954|NCT02653170|2216760|FG002|Overall Study|withdrawn by study team|5
1125955|NCT02653170|2216758|FG000|Overall Study|Lost to Follow-up|12
1125956|NCT02653170|2216759|FG001|Overall Study|Lost to Follow-up|4
1125957|NCT02653170|2216760|FG002|Overall Study|Lost to Follow-up|10
1125958|NCT02653300|2216777|FG000|Overall Study|Withdrawal by Subject|2
1125959|NCT02653326|2216783|FG000|Overall Study|Lost to Follow-up|10
1125960|NCT02653326|2216784|FG001|Overall Study|Lost to Follow-up|7
1125961|NCT02653625|2216878|FG000|Overall Study|Adverse Event|1
1125962|NCT02653625|2216878|FG000|Overall Study|Non-compliance with Study Drug|1
1125963|NCT02653625|2216878|FG000|Overall Study|Protocol Violation|1
1125964|NCT02653625|2216878|FG000|Overall Study|Suspected Drug Induced Liver Injury|1
1125965|NCT02653664|2216885|FG000|Post-Treatment|Withdrawal by Subject|6
1125966|NCT02653664|2216886|FG001|Post-Treatment|Withdrawal by Subject|5
1125967|NCT02653664|2216887|FG002|Post-Treatment|Withdrawal by Subject|7
1125968|NCT02653664|2216885|FG000|Post-Treatment|Lost to Follow-up|8
1125969|NCT02653664|2216886|FG001|Post-Treatment|Lost to Follow-up|1
1125970|NCT02653664|2216887|FG002|Post-Treatment|Lost to Follow-up|7
1125971|NCT02653664|2216885|FG000|3 Month Follow-Up|Withdrawal by Subject|9
1125972|NCT02653664|2216886|FG001|3 Month Follow-Up|Withdrawal by Subject|5
1125973|NCT02653664|2216887|FG002|3 Month Follow-Up|Withdrawal by Subject|9
1125974|NCT02653664|2216885|FG000|3 Month Follow-Up|Lost to Follow-up|9
1125975|NCT02653664|2216886|FG001|3 Month Follow-Up|Lost to Follow-up|8
1125976|NCT02653664|2216887|FG002|3 Month Follow-Up|Lost to Follow-up|16
1125977|NCT02653664|2216885|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
1125978|NCT02653664|2216886|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
1125979|NCT02653664|2216887|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
1125980|NCT02653664|2216885|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3
1125981|NCT02653664|2216886|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
1125982|NCT02653664|2216887|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
1125983|NCT02653664|2216885|FG000|6 Month Follow-Up|Withdrawal by Subject|13
1125984|NCT02653664|2216886|FG001|6 Month Follow-Up|Withdrawal by Subject|7
1125985|NCT02653664|2216887|FG002|6 Month Follow-Up|Withdrawal by Subject|14
1125986|NCT02653664|2216885|FG000|6 Month Follow-Up|Lost to Follow-up|10
1125987|NCT02653664|2216886|FG001|6 Month Follow-Up|Lost to Follow-up|11
1125988|NCT02653664|2216887|FG002|6 Month Follow-Up|Lost to Follow-up|9
1125989|NCT02653664|2216885|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
1125990|NCT02653664|2216886|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
1125991|NCT02653664|2216887|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
1125992|NCT02653664|2216885|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0
1125993|NCT02653664|2216886|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1
1125994|NCT02653664|2216887|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0
1125995|NCT02654002|2216930|FG000|Overall Study|Adverse Event|0
1125996|NCT02654002|2216931|FG001|Overall Study|Adverse Event|0
1125997|NCT02654002|2216932|FG002|Overall Study|Adverse Event|0
1125998|NCT02654002|2216933|FG003|Overall Study|Adverse Event|0
1125999|NCT02654002|2216934|FG004|Overall Study|Adverse Event|0
1126000|NCT02654002|2216935|FG005|Overall Study|Adverse Event|0
1126001|NCT02654002|2216936|FG006|Overall Study|Adverse Event|1
1126002|NCT02654002|2216937|FG007|Overall Study|Adverse Event|0
1126003|NCT02654002|2216938|FG008|Overall Study|Adverse Event|0
1126004|NCT02654002|2216930|FG000|Overall Study|Withdrew Consent|0
1126005|NCT02654002|2216931|FG001|Overall Study|Withdrew Consent|0
1126006|NCT02654002|2216932|FG002|Overall Study|Withdrew Consent|0
1126007|NCT02654002|2216933|FG003|Overall Study|Withdrew Consent|0
1126008|NCT02654002|2216934|FG004|Overall Study|Withdrew Consent|0
1126009|NCT02654002|2216935|FG005|Overall Study|Withdrew Consent|1
1126010|NCT02654002|2216936|FG006|Overall Study|Withdrew Consent|0
1126011|NCT02654002|2216937|FG007|Overall Study|Withdrew Consent|1
1126012|NCT02654002|2216938|FG008|Overall Study|Withdrew Consent|0
1126013|NCT02654054|2216976|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
1126014|NCT02654054|2216977|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
1126015|NCT02654054|2216978|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
1126016|NCT02654054|2216976|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
1126017|NCT02654054|2216977|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1126018|NCT02654054|2216978|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13
1126019|NCT02654054|2216976|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
1126020|NCT02654054|2216977|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
1126021|NCT02654054|2216978|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
1126022|NCT02654054|2216976|FG000|Post-Treatment Follow-Up Period|Other|1
1126023|NCT02654054|2216977|FG001|Post-Treatment Follow-Up Period|Other|0
1126024|NCT02654054|2216978|FG002|Post-Treatment Follow-Up Period|Other|4
1126025|NCT02654054|2216976|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
1126026|NCT02654054|2216977|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
1126027|NCT02654054|2216978|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4
1126050|NCT02654145|2216997|FG000|Overall Study|Lack of Efficacy|1
1126051|NCT02654145|2216997|FG000|Overall Study|Protocol Violation|1
1126052|NCT02654145|2216997|FG000|Overall Study|Withdrawal by Subject|5
1126053|NCT02654717|2217040|FG000|Overall Study|Adverse Event|2
1126054|NCT02654717|2217041|FG001|Overall Study|Adverse Event|2
1126055|NCT02654717|2217040|FG000|Overall Study|Protocol Violation|1
1126056|NCT02654717|2217041|FG001|Overall Study|Protocol Violation|2
1126057|NCT02654717|2217040|FG000|Overall Study|Withdrawal by Subject|0
1126058|NCT02654717|2217041|FG001|Overall Study|Withdrawal by Subject|1
1126059|NCT02654717|2217040|FG000|Overall Study|Non-permitted medication|3
1126060|NCT02654717|2217041|FG001|Overall Study|Non-permitted medication|0
1126061|NCT02654977|2217098|FG000|Overall Study|Death|1
1126062|NCT02654977|2217098|FG000|Overall Study|Lost to Follow-up|1
1126063|NCT02654977|2217098|FG000|Overall Study|Adverse Event|1
1126064|NCT02654977|2217098|FG000|Overall Study|Withdrawal by Subject|1
1126065|NCT02654977|2217098|FG000|Overall Study|Lack of Efficacy|3
1126076|NCT02655224|2217114|FG000|Overall Study|Adverse Event|1
1126077|NCT02655224|2217115|FG001|Overall Study|Adverse Event|1
1126078|NCT02655237|2217123|FG000|Overall Study|Adverse Event|10
1126079|NCT02655237|2217124|FG001|Overall Study|Adverse Event|7
1126080|NCT02655237|2217123|FG000|Overall Study|Protocol Deviation|2
1126081|NCT02655237|2217124|FG001|Overall Study|Protocol Deviation|0
1126082|NCT02655237|2217123|FG000|Overall Study|Withdrawal by Participant|1
1126083|NCT02655237|2217124|FG001|Overall Study|Withdrawal by Participant|2
1126084|NCT02655237|2217123|FG000|Overall Study|Lack of Efficacy|0
1126085|NCT02655237|2217124|FG001|Overall Study|Lack of Efficacy|1
1126086|NCT02655237|2217123|FG000|Overall Study|Recovery Leading to Surgery|2
1126087|NCT02655237|2217124|FG001|Overall Study|Recovery Leading to Surgery|1
1126088|NCT02655237|2217123|FG000|Overall Study|Reduction of Hemoglobin Concentration|1
1126089|NCT02655237|2217124|FG001|Overall Study|Reduction of Hemoglobin Concentration|0
1126090|NCT02655237|2217123|FG000|Overall Study|Randomized but Not Treated|1
1126091|NCT02655237|2217124|FG001|Overall Study|Randomized but Not Treated|0
1126092|NCT02655419|2217141|FG000|Overall Study|Enrolled but not treated|1
1126093|NCT02655419|2217142|FG001|Overall Study|Enrolled but not treated|5
1126094|NCT02655419|2217141|FG000|Overall Study|Withdrawal by Subject|4
1126095|NCT02655419|2217142|FG001|Overall Study|Withdrawal by Subject|1
1126096|NCT02655419|2217141|FG000|Overall Study|Other|0
1126097|NCT02655419|2217142|FG001|Overall Study|Other|1
899101|NCT00719043|1871714|FG005|Overall Study|Other|2
899102|NCT00719043|1871715|FG006|Overall Study|Other|1
899103|NCT00719043|1871709|FG000|Overall Study|Withdrawal by Subject|12
899104|NCT00719043|1871710|FG001|Overall Study|Withdrawal by Subject|14
899105|NCT00719043|1871711|FG002|Overall Study|Withdrawal by Subject|9
899106|NCT00719043|1871712|FG003|Overall Study|Withdrawal by Subject|10
899107|NCT00719043|1871713|FG004|Overall Study|Withdrawal by Subject|16
899108|NCT00719043|1871714|FG005|Overall Study|Withdrawal by Subject|18
899109|NCT00719043|1871715|FG006|Overall Study|Withdrawal by Subject|14
899110|NCT00719212|1871765|FG000|Overall Study|Death|41
899111|NCT00719212|1871765|FG000|Overall Study|Lost to Follow-up|2
899112|NCT00719212|1871765|FG000|Overall Study|Withdrawal by Subject|1
899113|NCT00719264|1871771|FG000|Overall Study|Adverse Event|41
899114|NCT00719264|1871772|FG001|Overall Study|Adverse Event|49
899115|NCT00719264|1871771|FG000|Overall Study|Death|13
899116|NCT00719264|1871772|FG001|Overall Study|Death|10
899117|NCT00719264|1871771|FG000|Overall Study|Administrative Problems|6
1126098|NCT02655666|2217180|FG000|Overall Study|Sponsor stopped this clinical research.|12
1126099|NCT02655679|2217189|FG000|Overall Study|Adverse Event|0
1126100|NCT02655679|2217190|FG001|Overall Study|Adverse Event|1
1126101|NCT02655679|2217191|FG002|Overall Study|Adverse Event|0
1126102|NCT02655679|2217192|FG003|Overall Study|Adverse Event|0
1126103|NCT02655679|2217193|FG004|Overall Study|Adverse Event|0
1126104|NCT02655679|2217189|FG000|Overall Study|Withdrawal by Subject|1
1126105|NCT02655679|2217190|FG001|Overall Study|Withdrawal by Subject|1
1126106|NCT02655679|2217191|FG002|Overall Study|Withdrawal by Subject|0
1126107|NCT02655679|2217192|FG003|Overall Study|Withdrawal by Subject|3
1126108|NCT02655679|2217193|FG004|Overall Study|Withdrawal by Subject|1
1126109|NCT02655679|2217189|FG000|Overall Study|Inability to Comply with the Protocol|1
1126110|NCT02655679|2217190|FG001|Overall Study|Inability to Comply with the Protocol|0
1126111|NCT02655679|2217191|FG002|Overall Study|Inability to Comply with the Protocol|0
1126112|NCT02655679|2217192|FG003|Overall Study|Inability to Comply with the Protocol|0
1126113|NCT02655679|2217193|FG004|Overall Study|Inability to Comply with the Protocol|0
1126114|NCT02655679|2217189|FG000|Overall Study|Lost to Follow-up|0
1126115|NCT02655679|2217190|FG001|Overall Study|Lost to Follow-up|1
1126116|NCT02655679|2217191|FG002|Overall Study|Lost to Follow-up|1
1126117|NCT02655679|2217192|FG003|Overall Study|Lost to Follow-up|1
1126118|NCT02655679|2217193|FG004|Overall Study|Lost to Follow-up|0
1126119|NCT02655679|2217189|FG000|Overall Study|Other Miscellaneous Reasons|1
1126120|NCT02655679|2217190|FG001|Overall Study|Other Miscellaneous Reasons|0
1126121|NCT02655679|2217191|FG002|Overall Study|Other Miscellaneous Reasons|0
1126122|NCT02655679|2217192|FG003|Overall Study|Other Miscellaneous Reasons|0
1126123|NCT02655679|2217193|FG004|Overall Study|Other Miscellaneous Reasons|0
1126124|NCT02655887|2217206|FG000|Overall Study|Lost to Follow-up|3
1126125|NCT02655887|2217206|FG000|Overall Study|Death|4
1126126|NCT02655887|2217206|FG000|Overall Study|Withdrawal by Subject|3
1126127|NCT02655887|2217206|FG000|Overall Study|Missed 12-month follow-up visit|4
1126128|NCT02656173|2217228|FG000|Overall Study|Deviation from the Eligible Criteria|3
1126129|NCT02656173|2217229|FG001|Overall Study|Deviation from the Eligible Criteria|2
1126130|NCT02656173|2217228|FG000|Overall Study|Adverse Event|7
1126131|NCT02656173|2217229|FG001|Overall Study|Adverse Event|5
1126132|NCT02656173|2217228|FG000|Overall Study|Withdrawal by Subject|1
1126133|NCT02656173|2217229|FG001|Overall Study|Withdrawal by Subject|3
1126134|NCT02656173|2217228|FG000|Overall Study|Protocol Violation|0
1126135|NCT02656173|2217229|FG001|Overall Study|Protocol Violation|1
1126136|NCT02656173|2217228|FG000|Overall Study|Miscellaneous|2
1126137|NCT02656173|2217229|FG001|Overall Study|Miscellaneous|0
1126138|NCT02656290|2217237|FG000|Overall Study|Subjects Remain On Study|26
1126139|NCT02656329|2217243|FG000|Overall Study|Lost to Follow-up|2
1126140|NCT02656329|2217244|FG001|Overall Study|Lost to Follow-up|3
1126141|NCT02656329|2217243|FG000|Overall Study|Withdrawal by Subject|7
1126142|NCT02656329|2217244|FG001|Overall Study|Withdrawal by Subject|6
1126143|NCT02656329|2217243|FG000|Overall Study|Study termination by Sponsor|150
1126144|NCT02656329|2217244|FG001|Overall Study|Study termination by Sponsor|142
1126145|NCT02656329|2217243|FG000|Overall Study|Other than specified above|5
1126146|NCT02656329|2217244|FG001|Overall Study|Other than specified above|6
1126147|NCT02656680|2217291|FG000|Overall Study|Lost to Follow-up|0
1126148|NCT02656680|2217292|FG001|Overall Study|Lost to Follow-up|1
1126149|NCT02656693|2217303|FG000|Overall Study|Pregnancy|1
1126150|NCT02656693|2217304|FG001|Overall Study|Pregnancy|1
1126151|NCT02656693|2217305|FG002|Overall Study|Pregnancy|1
1126152|NCT02656693|2217303|FG000|Overall Study|Bariatric surgery|0
1126153|NCT02656693|2217304|FG001|Overall Study|Bariatric surgery|1
1126154|NCT02656693|2217305|FG002|Overall Study|Bariatric surgery|2
1126155|NCT02657031|2217330|FG000|Overall Study|Adverse Event|1
1126156|NCT02657031|2217331|FG001|Overall Study|Adverse Event|2
1126157|NCT02657369|2217353|FG000|Overall Study|Death|27
1126158|NCT02657369|2217353|FG000|Overall Study|Study terminated by sponsor|7
1126159|NCT02657408|2217359|FG000|Overall Study|Adverse Event|3
1126160|NCT02657408|2217360|FG001|Overall Study|Adverse Event|7
1126161|NCT02657889|2217401|FG000|Overall Study|Death|5
1126162|NCT02657889|2217402|FG001|Overall Study|Death|2
1126163|NCT02657889|2217403|FG002|Overall Study|Death|20
1126164|NCT02657889|2217404|FG003|Overall Study|Death|34
1126165|NCT02657889|2217401|FG000|Overall Study|Lost to Follow-up|2
1126166|NCT02657889|2217402|FG001|Overall Study|Lost to Follow-up|0
1126167|NCT02657889|2217403|FG002|Overall Study|Lost to Follow-up|1
1126168|NCT02657889|2217404|FG003|Overall Study|Lost to Follow-up|2
1126169|NCT02657889|2217401|FG000|Overall Study|Withdrawal by Subject|0
1126170|NCT02657889|2217402|FG001|Overall Study|Withdrawal by Subject|0
1126171|NCT02657889|2217403|FG002|Overall Study|Withdrawal by Subject|8
1126172|NCT02657889|2217404|FG003|Overall Study|Withdrawal by Subject|0
1126173|NCT02657889|2217401|FG000|Overall Study|Ongoing in Study|0
1126174|NCT02657889|2217402|FG001|Overall Study|Ongoing in Study|5
1126175|NCT02657889|2217403|FG002|Overall Study|Ongoing in Study|24
1126176|NCT02657889|2217404|FG003|Overall Study|Ongoing in Study|19
1126177|NCT02658019|2217435|FG000|Overall Study|Adverse Event|1
1126178|NCT02658084|2217441|FG000|Overall Study|Withdrawal by Subject|1
1126179|NCT02658084|2217442|FG001|Overall Study|Withdrawal by Subject|0
1126180|NCT02658084|2217441|FG000|Overall Study|Study Termination|1
1126181|NCT02658084|2217442|FG001|Overall Study|Study Termination|0
1126182|NCT02658149|2217449|FG000|Overall Study|Physician Decision|1
1126183|NCT02658149|2217450|FG001|Overall Study|Physician Decision|0
1126184|NCT02658175|2217459|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1
1126185|NCT02658175|2217460|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
1126186|NCT02658175|2217461|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
1126187|NCT02658175|2217459|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6
1126188|NCT02658175|2217460|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2
1126189|NCT02658175|2217461|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0
1126190|NCT02658175|2217459|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8
1126191|NCT02658175|2217460|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5
1126192|NCT02658175|2217461|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0
1126193|NCT02658175|2217459|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1
1126194|NCT02658175|2217460|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
1126195|NCT02658175|2217461|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
1126196|NCT02658175|2217459|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4
1126197|NCT02658175|2217460|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0
1126198|NCT02658175|2217461|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1
1126199|NCT02658175|2217459|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7
1126200|NCT02658175|2217460|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
1126201|NCT02658175|2217461|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
1126202|NCT02658175|2217459|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1
1126203|NCT02658175|2217460|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0
1126204|NCT02658175|2217461|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1
1126205|NCT02658175|2217459|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8
1126206|NCT02658175|2217460|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2
1126207|NCT02658175|2217461|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0
1126208|NCT02658175|2217459|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
1126209|NCT02658175|2217460|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
1126210|NCT02658175|2217461|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1
1126211|NCT02658175|2217459|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1
1126212|NCT02658175|2217460|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
1126213|NCT02658175|2217461|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
1126214|NCT02658448|2217478|FG000|Overall Study|Lost to Follow-up|1
1126215|NCT02658487|2217497|FG000|Overall Study|Death|2
1126216|NCT02658487|2217497|FG000|Overall Study|Disease progression|10
1126217|NCT02658487|2217497|FG000|Overall Study|Alternative therapy|1
1126218|NCT02658487|2217497|FG000|Overall Study|Adverse Event|1
1126219|NCT02658487|2217497|FG000|Overall Study|Treatment Failure, circulating blasts|1
1126220|NCT02658487|2217497|FG000|Overall Study|Refractory AML|1
1126221|NCT02658630|2217502|FG000|Overall Study|Withdrawal by Subject|4
1126222|NCT02658734|2217506|FG000|Overall Study|Adverse Event|2
1126223|NCT02658734|2217506|FG000|Overall Study|Death|4
1126224|NCT02658734|2217506|FG000|Overall Study|Lost to Follow-up|7
1126225|NCT02658734|2217506|FG000|Overall Study|Withdrawal of Consent|16
1126226|NCT02658734|2217506|FG000|Overall Study|Disease Progression|28
1126227|NCT02659020|2217535|FG000|Overall Study|Adverse Event|1
1126228|NCT02659020|2217536|FG001|Overall Study|Adverse Event|0
1126229|NCT02659020|2217537|FG002|Overall Study|Adverse Event|0
1126230|NCT02659020|2217538|FG003|Overall Study|Adverse Event|6
1126231|NCT02659020|2217539|FG004|Overall Study|Adverse Event|3
1126232|NCT02659020|2217540|FG005|Overall Study|Adverse Event|4
1126233|NCT02659020|2217541|FG006|Overall Study|Adverse Event|4
1126234|NCT02659020|2217535|FG000|Overall Study|Lost to Follow-up|1
1126235|NCT02659020|2217536|FG001|Overall Study|Lost to Follow-up|2
1126236|NCT02659020|2217537|FG002|Overall Study|Lost to Follow-up|1
1126237|NCT02659020|2217538|FG003|Overall Study|Lost to Follow-up|4
1126238|NCT02659020|2217539|FG004|Overall Study|Lost to Follow-up|1
1126239|NCT02659020|2217540|FG005|Overall Study|Lost to Follow-up|5
1126240|NCT02659020|2217541|FG006|Overall Study|Lost to Follow-up|0
1126241|NCT02659020|2217535|FG000|Overall Study|Physician Decision|0
1126242|NCT02659020|2217536|FG001|Overall Study|Physician Decision|0
1126243|NCT02659020|2217537|FG002|Overall Study|Physician Decision|1
1126244|NCT02659020|2217538|FG003|Overall Study|Physician Decision|1
1126245|NCT02659020|2217539|FG004|Overall Study|Physician Decision|6
1126246|NCT02659020|2217540|FG005|Overall Study|Physician Decision|3
1126247|NCT02659020|2217541|FG006|Overall Study|Physician Decision|1
1126248|NCT02659020|2217535|FG000|Overall Study|Withdrawal by Subject|2
1126249|NCT02659020|2217536|FG001|Overall Study|Withdrawal by Subject|3
1126250|NCT02659020|2217537|FG002|Overall Study|Withdrawal by Subject|1
1126251|NCT02659020|2217538|FG003|Overall Study|Withdrawal by Subject|4
1126252|NCT02659020|2217539|FG004|Overall Study|Withdrawal by Subject|4
1126253|NCT02659020|2217540|FG005|Overall Study|Withdrawal by Subject|9
1126254|NCT02659020|2217541|FG006|Overall Study|Withdrawal by Subject|3
1126255|NCT02659020|2217535|FG000|Overall Study|Progressive Disease|2
1126256|NCT02659020|2217536|FG001|Overall Study|Progressive Disease|2
1126257|NCT02659020|2217537|FG002|Overall Study|Progressive Disease|2
1126258|NCT02659020|2217538|FG003|Overall Study|Progressive Disease|15
1126259|NCT02659020|2217539|FG004|Overall Study|Progressive Disease|6
1126260|NCT02659020|2217540|FG005|Overall Study|Progressive Disease|7
1126261|NCT02659020|2217541|FG006|Overall Study|Progressive Disease|6
1126262|NCT02659020|2217535|FG000|Overall Study|On Treatment|0
1126263|NCT02659020|2217536|FG001|Overall Study|On Treatment|0
1126264|NCT02659020|2217537|FG002|Overall Study|On Treatment|0
1126265|NCT02659020|2217538|FG003|Overall Study|On Treatment|0
1126266|NCT02659020|2217539|FG004|Overall Study|On Treatment|0
1126267|NCT02659020|2217540|FG005|Overall Study|On Treatment|0
1126268|NCT02659020|2217541|FG006|Overall Study|On Treatment|1
1126269|NCT02659059|2217566|FG000|Overall Study|Completed|1
1126270|NCT02659059|2217567|FG001|Overall Study|Completed|0
899118|NCT00719264|1871772|FG001|Overall Study|Administrative Problems|4
899119|NCT00719264|1871771|FG000|Overall Study|Lost to Follow-up|1
899120|NCT00719264|1871772|FG001|Overall Study|Lost to Follow-up|1
899121|NCT00719264|1871771|FG000|Overall Study|Withdrawal by Subject|12
899122|NCT00719264|1871772|FG001|Overall Study|Withdrawal by Subject|7
899123|NCT00719264|1871771|FG000|Overall Study|Protocol Deviation|1
899124|NCT00719264|1871772|FG001|Overall Study|Protocol Deviation|3
899125|NCT00719264|1871771|FG000|Overall Study|New Cancer Therapy|4
899126|NCT00719264|1871772|FG001|Overall Study|New Cancer Therapy|2
899127|NCT00719264|1871771|FG000|Overall Study|Disease Progression|104
899128|NCT00719264|1871772|FG001|Overall Study|Disease Progression|107
899129|NCT00719355|1871796|FG000|Overall Study|Death|0
899130|NCT00719355|1871797|FG001|Overall Study|Death|1
899131|NCT00719355|1871796|FG000|Overall Study|Medical|14
899132|NCT00719355|1871797|FG001|Overall Study|Medical|5
899133|NCT00719355|1871796|FG000|Overall Study|Compliance|4
899134|NCT00719355|1871797|FG001|Overall Study|Compliance|6
899135|NCT00719355|1871796|FG000|Overall Study|Moved|0
899136|NCT00719355|1871797|FG001|Overall Study|Moved|1
899137|NCT00719472|1871803|FG000|Enrolled in Study|Physician decision to withdraw patient|1
899138|NCT00719472|1871803|FG000|Enrolled in Study|Subject decision to withdraw|8
899139|NCT00719472|1871803|FG000|Enrolled in Study|Various Reasons|17
899140|NCT00719472|1871803|FG000|Received Cycle 1 Treatment|Adverse Event|8
899141|NCT00719472|1871803|FG000|Received Cycle 1 Treatment|Death|5
899142|NCT00719472|1871803|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
899143|NCT00719472|1871803|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
899144|NCT00719472|1871803|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9
899145|NCT00719472|1871803|FG000|Received Cycle 1 Treatment|Various Reasons|13
899146|NCT00719472|1871803|FG000|Received Cycle 2 Treatment|Adverse Event|12
899147|NCT00719472|1871803|FG000|Received Cycle 2 Treatment|Death|6
899148|NCT00719472|1871803|FG000|Received Cycle 2 Treatment|Disease progression|3
1126271|NCT02659059|2217566|FG000|Overall Study|Other reasons|8
1126272|NCT02659059|2217567|FG001|Overall Study|Other reasons|2
1126273|NCT02659059|2217566|FG000|Overall Study|Disease Progression|120
1126274|NCT02659059|2217567|FG001|Overall Study|Disease Progression|16
1126275|NCT02659059|2217566|FG000|Overall Study|Study Drug toxicity|37
1126276|NCT02659059|2217567|FG001|Overall Study|Study Drug toxicity|9
1126277|NCT02659059|2217566|FG000|Overall Study|Death|2
1126278|NCT02659059|2217567|FG001|Overall Study|Death|1
1126279|NCT02659059|2217566|FG000|Overall Study|Adverse Event unrelated to Study drug|22
1126280|NCT02659059|2217567|FG001|Overall Study|Adverse Event unrelated to Study drug|4
1126281|NCT02659059|2217566|FG000|Overall Study|Participant request to discontinue study treatment|5
1126282|NCT02659059|2217567|FG001|Overall Study|Participant request to discontinue study treatment|0
1126283|NCT02659059|2217566|FG000|Overall Study|Participant withdrew consent|4
1126284|NCT02659059|2217567|FG001|Overall Study|Participant withdrew consent|0
1126285|NCT02659059|2217566|FG000|Overall Study|Lost to Follow-up|1
1126286|NCT02659059|2217567|FG001|Overall Study|Lost to Follow-up|0
1126287|NCT02659098|2217574|FG000|Overall Study|Withdrawal by Subject|7
1126288|NCT02659150|2217578|FG000|Subject Enrollment|Physician Decision|3
1126289|NCT02659150|2217578|FG000|Subject Enrollment|Withdrawal by Subject|2
1126290|NCT02659150|2217578|FG000|Baseline Imaging|Withdrawal by Subject|1
1126291|NCT02659150|2217578|FG000|Baseline Imaging|Physician Decision|1
1126292|NCT02659150|2217578|FG000|Study Drug Dosing|Adverse Event|1
1126293|NCT02659540|2217594|FG000|Overall Study|Adverse Event|3
1126294|NCT02659540|2217595|FG001|Overall Study|Adverse Event|2
1126295|NCT02659540|2217594|FG000|Overall Study|Death|1
1126296|NCT02659540|2217595|FG001|Overall Study|Death|0
1126297|NCT02659540|2217594|FG000|Overall Study|Progressive disease|2
1126298|NCT02659540|2217595|FG001|Overall Study|Progressive disease|6
1126299|NCT02659943|2217662|FG000|Overall Study|Switched to alternative treatment|1
1126300|NCT02659943|2217663|FG001|Overall Study|Switched to alternative treatment|1
1126301|NCT02659943|2217664|FG002|Overall Study|Switched to alternative treatment|0
1126302|NCT02659943|2217665|FG003|Overall Study|Switched to alternative treatment|2
1126303|NCT02659943|2217666|FG004|Overall Study|Switched to alternative treatment|1
1126304|NCT02659943|2217667|FG005|Overall Study|Switched to alternative treatment|0
1126305|NCT02659943|2217668|FG006|Overall Study|Switched to alternative treatment|1
1126306|NCT02659943|2217662|FG000|Overall Study|Disease progression on study|0
1126307|NCT02659943|2217663|FG001|Overall Study|Disease progression on study|1
1126308|NCT02659943|2217664|FG002|Overall Study|Disease progression on study|1
1126309|NCT02659943|2217665|FG003|Overall Study|Disease progression on study|1
1126310|NCT02659943|2217666|FG004|Overall Study|Disease progression on study|1
1126311|NCT02659943|2217667|FG005|Overall Study|Disease progression on study|4
1126312|NCT02659943|2217668|FG006|Overall Study|Disease progression on study|0
1126313|NCT02659943|2217662|FG000|Overall Study|Patient's condition per principal investigator|0
1126314|NCT02659943|2217663|FG001|Overall Study|Patient's condition per principal investigator|0
1126315|NCT02659943|2217664|FG002|Overall Study|Patient's condition per principal investigator|0
1126316|NCT02659943|2217665|FG003|Overall Study|Patient's condition per principal investigator|0
1126317|NCT02659943|2217666|FG004|Overall Study|Patient's condition per principal investigator|0
1126318|NCT02659943|2217667|FG005|Overall Study|Patient's condition per principal investigator|1
1126319|NCT02659943|2217668|FG006|Overall Study|Patient's condition per principal investigator|0
1126320|NCT02659943|2217662|FG000|Overall Study|Ineligible|0
1126321|NCT02659943|2217663|FG001|Overall Study|Ineligible|0
1126322|NCT02659943|2217664|FG002|Overall Study|Ineligible|0
1126323|NCT02659943|2217665|FG003|Overall Study|Ineligible|0
1126324|NCT02659943|2217666|FG004|Overall Study|Ineligible|0
1126325|NCT02659943|2217667|FG005|Overall Study|Ineligible|0
1126326|NCT02659943|2217668|FG006|Overall Study|Ineligible|1
1126327|NCT02659943|2217662|FG000|Overall Study|No longer meets eligibility|0
1126328|NCT02659943|2217663|FG001|Overall Study|No longer meets eligibility|0
1126329|NCT02659943|2217664|FG002|Overall Study|No longer meets eligibility|0
1126330|NCT02659943|2217665|FG003|Overall Study|No longer meets eligibility|0
1126331|NCT02659943|2217666|FG004|Overall Study|No longer meets eligibility|0
1126332|NCT02659943|2217667|FG005|Overall Study|No longer meets eligibility|0
1126333|NCT02659943|2217668|FG006|Overall Study|No longer meets eligibility|1
1126334|NCT02659943|2217662|FG000|Overall Study|No treatment, per protocol|0
1126335|NCT02659943|2217663|FG001|Overall Study|No treatment, per protocol|0
1126336|NCT02659943|2217664|FG002|Overall Study|No treatment, per protocol|0
1126337|NCT02659943|2217665|FG003|Overall Study|No treatment, per protocol|0
1126338|NCT02659943|2217666|FG004|Overall Study|No treatment, per protocol|0
1126339|NCT02659943|2217667|FG005|Overall Study|No treatment, per protocol|0
1126340|NCT02659943|2217668|FG006|Overall Study|No treatment, per protocol|3
1126341|NCT02660138|2217696|FG000|Overall Study|Adverse Event|0
1126342|NCT02660138|2217697|FG001|Overall Study|Adverse Event|3
1126343|NCT02660138|2217698|FG002|Overall Study|Adverse Event|2
1126344|NCT02660138|2217696|FG000|Overall Study|Lack of Efficacy|1
1126345|NCT02660138|2217697|FG001|Overall Study|Lack of Efficacy|2
1126346|NCT02660138|2217698|FG002|Overall Study|Lack of Efficacy|1
1126347|NCT02660138|2217696|FG000|Overall Study|Withdrawal by Subject|7
1126348|NCT02660138|2217697|FG001|Overall Study|Withdrawal by Subject|6
1126349|NCT02660138|2217698|FG002|Overall Study|Withdrawal by Subject|6
1126350|NCT02660138|2217696|FG000|Overall Study|Lost to Follow-up|4
1126351|NCT02660138|2217697|FG001|Overall Study|Lost to Follow-up|4
1126352|NCT02660138|2217698|FG002|Overall Study|Lost to Follow-up|1
1126353|NCT02660138|2217696|FG000|Overall Study|Sponsor Decision to Terminate Study|57
1126354|NCT02660138|2217697|FG001|Overall Study|Sponsor Decision to Terminate Study|57
1126355|NCT02660138|2217698|FG002|Overall Study|Sponsor Decision to Terminate Study|62
1126356|NCT02660138|2217696|FG000|Overall Study|Other|1
1126357|NCT02660138|2217697|FG001|Overall Study|Other|1
1126358|NCT02660138|2217698|FG002|Overall Study|Other|0
1126359|NCT02660138|2217696|FG000|Overall Study|Not treated|0
1126360|NCT02660138|2217697|FG001|Overall Study|Not treated|1
1126361|NCT02660138|2217698|FG002|Overall Study|Not treated|0
1126362|NCT02660229|2217711|FG000|Overall Study|Adverse Event|2
1126363|NCT02660229|2217712|FG001|Overall Study|Adverse Event|0
1126364|NCT02660229|2217711|FG000|Overall Study|Withdrawal by Subject|0
1126365|NCT02660229|2217712|FG001|Overall Study|Withdrawal by Subject|1
1126366|NCT02660242|2217718|FG000|Glucose Tabs|Lost to Follow-up|1
1126367|NCT02660242|2217718|FG000|Glucagon Injection|Lost to Follow-up|1
1126368|NCT02660359|2217734|FG000|Overall Study|Protocol Deviation|0
1126369|NCT02660359|2217735|FG001|Overall Study|Protocol Deviation|0
1126370|NCT02660359|2217736|FG002|Overall Study|Protocol Deviation|1
1126371|NCT02660359|2217734|FG000|Overall Study|Sponsor Decision to Terminate Study|73
1126372|NCT02660359|2217735|FG001|Overall Study|Sponsor Decision to Terminate Study|75
1126373|NCT02660359|2217736|FG002|Overall Study|Sponsor Decision to Terminate Study|71
1126374|NCT02660359|2217734|FG000|Overall Study|Lack of Efficacy|1
1126375|NCT02660359|2217735|FG001|Overall Study|Lack of Efficacy|1
1126376|NCT02660359|2217736|FG002|Overall Study|Lack of Efficacy|1
1126377|NCT02660359|2217734|FG000|Overall Study|Adverse Event|0
1126378|NCT02660359|2217735|FG001|Overall Study|Adverse Event|1
1126379|NCT02660359|2217736|FG002|Overall Study|Adverse Event|0
1126380|NCT02660359|2217734|FG000|Overall Study|Other|2
1126381|NCT02660359|2217735|FG001|Overall Study|Other|1
1126382|NCT02660359|2217736|FG002|Overall Study|Other|3
899149|NCT00719472|1871803|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3
899150|NCT00719472|1871803|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
899151|NCT00719472|1871803|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6
899152|NCT00719472|1871803|FG000|Received Cycle 2 Treatment|Various Reasons|25
899153|NCT00719537|1871809|FG000|Overall Study|Withdrawal by Subject|1
899154|NCT00719537|1871810|FG001|Overall Study|Withdrawal by Subject|0
899155|NCT00719537|1871809|FG000|Overall Study|Lost to Follow-up|0
899156|NCT00719537|1871810|FG001|Overall Study|Lost to Follow-up|1
899157|NCT00719563|1871818|FG000|Overall Study|Adverse Event|16
899158|NCT00719563|1871819|FG001|Overall Study|Adverse Event|13
899159|NCT00719563|1871818|FG000|Overall Study|Medical condition changed|3
899160|NCT00719563|1871819|FG001|Overall Study|Medical condition changed|5
899161|NCT00719563|1871818|FG000|Overall Study|Lack of Efficacy|3
899162|NCT00719563|1871819|FG001|Overall Study|Lack of Efficacy|7
899163|NCT00719563|1871818|FG000|Overall Study|Personal reasons|6
899164|NCT00719563|1871819|FG001|Overall Study|Personal reasons|7
899165|NCT00719563|1871818|FG000|Overall Study|Unknown reasons|4
899166|NCT00719563|1871819|FG001|Overall Study|Unknown reasons|6
899167|NCT00719563|1871818|FG000|Overall Study|Noncompliant|1
899168|NCT00719563|1871819|FG001|Overall Study|Noncompliant|1
899169|NCT00719563|1871818|FG000|Overall Study|Lost to Follow-up|5
899170|NCT00719563|1871819|FG001|Overall Study|Lost to Follow-up|3
899171|NCT00719680|1871850|FG000|Overall Study|Adverse Event|1
899172|NCT00719680|1871850|FG000|Overall Study|Lost to Follow-up|1
899173|NCT00719680|1871850|FG000|Overall Study|Withdrawal by Subject|3
899174|NCT00719706|1871856|FG000|Overall Study|Adverse Event|5
899175|NCT00719706|1871857|FG001|Overall Study|Adverse Event|4
899176|NCT00719706|1871856|FG000|Overall Study|Withdrawal by Subject|1
899177|NCT00719706|1871857|FG001|Overall Study|Withdrawal by Subject|2
899178|NCT00719706|1871856|FG000|Overall Study|Protocol Violation|3
899179|NCT00719706|1871857|FG001|Overall Study|Protocol Violation|0
899180|NCT00719732|1871863|FG000|Overall Study|Lost to Follow-up|20
899181|NCT00719732|1871863|FG000|Overall Study|Unilateral (not bilateral) implantation|1
899182|NCT00719732|1871863|FG000|Overall Study|Illness not associated with device|1
899183|NCT00719810|1871870|FG000|Overall Study|Adverse Event|0
899184|NCT00719810|1871871|FG001|Overall Study|Adverse Event|2
899185|NCT00719810|1871872|FG002|Overall Study|Adverse Event|3
899186|NCT00719810|1871870|FG000|Overall Study|Lost to Follow-up|2
899187|NCT00719810|1871871|FG001|Overall Study|Lost to Follow-up|0
899188|NCT00719810|1871872|FG002|Overall Study|Lost to Follow-up|3
899189|NCT00719810|1871870|FG000|Overall Study|Physician Decision|0
899190|NCT00719810|1871871|FG001|Overall Study|Physician Decision|1
899191|NCT00719810|1871872|FG002|Overall Study|Physician Decision|0
899192|NCT00719810|1871870|FG000|Overall Study|Withdrawal by Subject|1
899193|NCT00719810|1871871|FG001|Overall Study|Withdrawal by Subject|1
899194|NCT00719810|1871872|FG002|Overall Study|Withdrawal by Subject|2
899195|NCT00719849|1871882|FG000|Overall Study|Death|0
899196|NCT00719849|1871883|FG001|Overall Study|Death|1
899197|NCT00719862|1871891|FG000|Overall Study|Adverse Event|1
899198|NCT00719862|1871892|FG001|Overall Study|Adverse Event|2
899199|NCT00719862|1871891|FG000|Overall Study|Lack of Efficacy|3
899200|NCT00719862|1871892|FG001|Overall Study|Lack of Efficacy|0
899201|NCT00719862|1871891|FG000|Overall Study|Non-Compliance|1
899202|NCT00719862|1871892|FG001|Overall Study|Non-Compliance|0
899203|NCT00719862|1871891|FG000|Overall Study|Withdrawal by Subject|1
899204|NCT00719862|1871892|FG001|Overall Study|Withdrawal by Subject|0
899205|NCT00719862|1871891|FG000|Overall Study|Lost to Follow-up|0
899206|NCT00719862|1871892|FG001|Overall Study|Lost to Follow-up|1
899207|NCT00719862|1871891|FG000|Overall Study|Other|2
899208|NCT00719862|1871892|FG001|Overall Study|Other|3
1126383|NCT02660359|2217734|FG000|Overall Study|Withdrawal by Subject|7
1126384|NCT02660359|2217735|FG001|Overall Study|Withdrawal by Subject|5
1126385|NCT02660359|2217736|FG002|Overall Study|Withdrawal by Subject|8
1126386|NCT02660359|2217734|FG000|Overall Study|Lost to Follow-up|3
1126387|NCT02660359|2217735|FG001|Overall Study|Lost to Follow-up|3
1126388|NCT02660359|2217736|FG002|Overall Study|Lost to Follow-up|0
1126389|NCT02660489|2217746|FG000|Overall Study|Lost to Follow-up|1
1126390|NCT02660489|2217747|FG001|Overall Study|Lost to Follow-up|1
1126391|NCT02660489|2217746|FG000|Overall Study|Adverse Event|1
1126392|NCT02660489|2217747|FG001|Overall Study|Adverse Event|3
1126393|NCT02660489|2217746|FG000|Overall Study|no rhinovirus infection|4
1126394|NCT02660489|2217747|FG001|Overall Study|no rhinovirus infection|4
1126395|NCT02660580|2217755|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
1126396|NCT02660580|2217756|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
1126397|NCT02660580|2217757|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
1126398|NCT02660580|2217758|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
1126399|NCT02660580|2217759|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
1126400|NCT02660580|2217755|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
1126401|NCT02660580|2217756|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
1126402|NCT02660580|2217757|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
1126403|NCT02660580|2217758|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
1126404|NCT02660580|2217759|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
1126405|NCT02660580|2217755|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1
1126406|NCT02660580|2217756|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0
1126407|NCT02660580|2217757|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0
1126408|NCT02660580|2217758|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0
1126409|NCT02660580|2217759|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0
1126410|NCT02660580|2217755|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
1126411|NCT02660580|2217756|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
1126412|NCT02660580|2217757|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
1126413|NCT02660580|2217758|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
1126414|NCT02660580|2217759|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
1126415|NCT02660580|2217755|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2
1126416|NCT02660580|2217756|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9
1126417|NCT02660580|2217757|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0
1126418|NCT02660580|2217758|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0
1126419|NCT02660580|2217759|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0
1126420|NCT02660580|2217755|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
1126421|NCT02660580|2217756|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
1126422|NCT02660580|2217757|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
1126423|NCT02660580|2217758|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
1126424|NCT02660580|2217759|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
1126425|NCT02660580|2217755|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
1126426|NCT02660580|2217756|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
1126427|NCT02660580|2217757|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
1126428|NCT02660580|2217758|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
1126429|NCT02660580|2217759|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
1126430|NCT02660580|2217755|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
1126431|NCT02660580|2217756|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
1126432|NCT02660580|2217757|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
1126433|NCT02660580|2217758|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
1126434|NCT02660580|2217759|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
1126435|NCT02660580|2217755|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
1126436|NCT02660580|2217756|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
1126437|NCT02660580|2217757|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
1126438|NCT02660580|2217758|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
1126439|NCT02660580|2217759|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
1126440|NCT02660580|2217755|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
1126441|NCT02660580|2217756|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
1126442|NCT02660580|2217757|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
1162082|NCT03382899|2284098|FG001|Overall Study|Withdrawal by Subject|5
899209|NCT00719901|1871898|FG000|Overall Study|Adverse Event|5
899210|NCT00719901|1871898|FG000|Overall Study|Withdrawal by Subject|1
899211|NCT00719901|1871898|FG000|Overall Study|Alternate Treatment|1
899212|NCT00719901|1871898|FG000|Overall Study|Disease Progression|3
899213|NCT00719901|1871898|FG000|Overall Study|Availability of Study Drug|1
899214|NCT00719953|1871902|FG000|Overall Study|Adverse Event|4
899215|NCT00720057|1871908|FG000|Overall Study|Lost to Follow-up|0
899216|NCT00720057|1871909|FG001|Overall Study|Lost to Follow-up|2
899217|NCT00720057|1871908|FG000|Overall Study|Protocol Violation|1
899218|NCT00720057|1871909|FG001|Overall Study|Protocol Violation|0
899219|NCT00720057|1871908|FG000|Overall Study|Withdrawal by Subject|0
899220|NCT00720057|1871909|FG001|Overall Study|Withdrawal by Subject|1
1126443|NCT02660580|2217758|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
1126444|NCT02660580|2217759|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
1126445|NCT02660580|2217755|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
1126446|NCT02660580|2217756|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
1126447|NCT02660580|2217757|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
1126448|NCT02660580|2217758|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
1126449|NCT02660580|2217759|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
1126450|NCT02660580|2217755|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
1126451|NCT02660580|2217756|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
1126452|NCT02660580|2217757|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
1126453|NCT02660580|2217758|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
1126454|NCT02660580|2217759|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
1126455|NCT02660580|2217755|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
1126456|NCT02660580|2217756|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
1126457|NCT02660580|2217757|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
1126458|NCT02660580|2217758|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
1126459|NCT02660580|2217759|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
1126464|NCT02660944|2217817|FG000|Overall Study|Adverse Event|3
1126465|NCT02660944|2217818|FG001|Overall Study|Adverse Event|4
1126466|NCT02660944|2217817|FG000|Overall Study|Physician Decision|3
1126467|NCT02660944|2217818|FG001|Overall Study|Physician Decision|1
1126468|NCT02660944|2217817|FG000|Overall Study|Withdrawal by Subject|5
1126469|NCT02660944|2217818|FG001|Overall Study|Withdrawal by Subject|3
1126470|NCT02660944|2217817|FG000|Overall Study|Lost to Follow-up|4
1126471|NCT02660944|2217818|FG001|Overall Study|Lost to Follow-up|1
1126472|NCT02660944|2217817|FG000|Overall Study|Subject schedule|0
1126473|NCT02660944|2217818|FG001|Overall Study|Subject schedule|1
1126474|NCT02660944|2217817|FG000|Overall Study|Exclusion criteria met|2
1126475|NCT02660944|2217818|FG001|Overall Study|Exclusion criteria met|0
1126476|NCT02660983|2217826|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
1126477|NCT02660983|2217827|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
1126478|NCT02660983|2217826|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
1126479|NCT02660983|2217827|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
1126480|NCT02660983|2217826|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
1126481|NCT02660983|2217827|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
1126482|NCT02660983|2217826|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
1126483|NCT02660983|2217827|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
1126484|NCT02660983|2217826|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
1126485|NCT02660983|2217827|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
1126486|NCT02660983|2217826|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1
1126487|NCT02660983|2217827|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3
1126488|NCT02660983|2217826|FG000|Open Label Extension Phase (24 Weeks)|Other|0
1126489|NCT02660983|2217827|FG001|Open Label Extension Phase (24 Weeks)|Other|1
1126490|NCT02661061|2217836|FG000|Overall Study|Lack of Efficacy|1
1126491|NCT02661061|2217837|FG001|Overall Study|Lack of Efficacy|1
1126492|NCT02661061|2217836|FG000|Overall Study|Withdrawal by Subject|1
1126493|NCT02661061|2217837|FG001|Overall Study|Withdrawal by Subject|1
1126494|NCT02661178|2217867|FG000|Part 1|Protocol Violation|1
1126495|NCT02661178|2217868|FG001|Part 1|Protocol Violation|0
1126496|NCT02661178|2217869|FG002|Part 1|Protocol Violation|0
1126497|NCT02661178|2217870|FG003|Part 1|Protocol Violation|0
1126498|NCT02661178|2217871|FG004|Part 1|Protocol Violation|0
1126499|NCT02661178|2217872|FG005|Part 1|Protocol Violation|0
1126500|NCT02661178|2217873|FG006|Part 1|Protocol Violation|0
1126501|NCT02661178|2217874|FG007|Part 1|Protocol Violation|0
1126502|NCT02661178|2217875|FG008|Part 1|Protocol Violation|0
1126503|NCT02661178|2217876|FG009|Part 1|Protocol Violation|0
1126504|NCT02661178|2217877|FG010|Part 1|Protocol Violation|0
1126505|NCT02661178|2217878|FG011|Part 1|Protocol Violation|0
1126506|NCT02661178|2217879|FG012|Part 1|Protocol Violation|0
1126507|NCT02661178|2217880|FG013|Part 1|Protocol Violation|0
1126508|NCT02661178|2217881|FG014|Part 1|Protocol Violation|0
1126509|NCT02661217|2217933|FG000|Overall Study|Physician Decision|12
1126510|NCT02661217|2217934|FG001|Overall Study|Physician Decision|15
1126511|NCT02661217|2217933|FG000|Overall Study|Lost to Follow-up|1
1126512|NCT02661217|2217934|FG001|Overall Study|Lost to Follow-up|4
1126513|NCT02661217|2217933|FG000|Overall Study|Protocol Deviation|0
1126514|NCT02661217|2217934|FG001|Overall Study|Protocol Deviation|4
1126515|NCT02661217|2217933|FG000|Overall Study|Non-compliance with study treatment|5
1126516|NCT02661217|2217934|FG001|Overall Study|Non-compliance with study treatment|5
1126517|NCT02661217|2217933|FG000|Overall Study|Death|21
1126518|NCT02661217|2217934|FG001|Overall Study|Death|15
1126519|NCT02661217|2217933|FG000|Overall Study|Adverse Event|10
1126520|NCT02661217|2217934|FG001|Overall Study|Adverse Event|8
1126521|NCT02661217|2217933|FG000|Overall Study|Withdrawal by Subject|15
1126522|NCT02661217|2217934|FG001|Overall Study|Withdrawal by Subject|19
1126523|NCT02661217|2217933|FG000|Overall Study|Did not enter follow-up epoch|7
1126524|NCT02661217|2217934|FG001|Overall Study|Did not enter follow-up epoch|10
1126525|NCT02661217|2217933|FG000|Overall Study|Death - no study drug received|1
1126526|NCT02661217|2217934|FG001|Overall Study|Death - no study drug received|2
1126527|NCT02661217|2217933|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3
1126528|NCT02661217|2217934|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1
1126529|NCT02661490|2217952|FG000|Overall Study|Lost to Follow-up|0
1126530|NCT02661490|2217953|FG001|Overall Study|Lost to Follow-up|1
1126531|NCT02661490|2217954|FG002|Overall Study|Lost to Follow-up|0
1126532|NCT02661490|2217955|FG003|Overall Study|Lost to Follow-up|0
1126533|NCT02661490|2217956|FG004|Overall Study|Lost to Follow-up|2
1126534|NCT02661490|2217952|FG000|Overall Study|Withdrawal by Subject|2
1126535|NCT02661490|2217953|FG001|Overall Study|Withdrawal by Subject|0
1126536|NCT02661490|2217954|FG002|Overall Study|Withdrawal by Subject|2
1126537|NCT02661490|2217955|FG003|Overall Study|Withdrawal by Subject|0
1126538|NCT02661490|2217956|FG004|Overall Study|Withdrawal by Subject|0
1126539|NCT02661490|2217952|FG000|Overall Study|Death|1
1126540|NCT02661490|2217953|FG001|Overall Study|Death|1
1126541|NCT02661490|2217954|FG002|Overall Study|Death|0
1126542|NCT02661490|2217955|FG003|Overall Study|Death|1
1126543|NCT02661490|2217956|FG004|Overall Study|Death|0
1126544|NCT02661490|2217952|FG000|Overall Study|Reason not Specified|0
1126545|NCT02661490|2217953|FG001|Overall Study|Reason not Specified|0
1126546|NCT02661490|2217954|FG002|Overall Study|Reason not Specified|0
1126547|NCT02661490|2217955|FG003|Overall Study|Reason not Specified|0
1126548|NCT02661490|2217956|FG004|Overall Study|Reason not Specified|1
1126549|NCT02661594|2217972|FG000|Overall Study|Protocol Violation|1
1126550|NCT02661594|2217973|FG001|Overall Study|Protocol Violation|0
1126551|NCT02661594|2217974|FG002|Overall Study|Protocol Violation|1
1126552|NCT02661594|2217975|FG003|Overall Study|Protocol Violation|0
1126553|NCT02661815|2217993|FG000|Overall Study|Withdrawal by Subject|1
1126554|NCT02661815|2217994|FG001|Overall Study|Withdrawal by Subject|0
1126555|NCT02661815|2217995|FG002|Overall Study|Withdrawal by Subject|0
1126556|NCT02661815|2217996|FG003|Overall Study|Withdrawal by Subject|0
1126557|NCT02662556|2218053|FG000|Overall Study|Adverse Event|4
1126558|NCT02662556|2218053|FG000|Overall Study|Lack of Efficacy|4
1126559|NCT02662569|2218062|FG000|Overall Study|Withdrawal by Subject|6
1126560|NCT02662569|2218063|FG001|Overall Study|Withdrawal by Subject|1
1126561|NCT02662569|2218064|FG002|Overall Study|Withdrawal by Subject|6
1126562|NCT02662569|2218065|FG003|Overall Study|Withdrawal by Subject|4
1126563|NCT02662569|2218062|FG000|Overall Study|Lost to Follow-up|1
1126564|NCT02662569|2218063|FG001|Overall Study|Lost to Follow-up|0
1126565|NCT02662569|2218064|FG002|Overall Study|Lost to Follow-up|0
1126566|NCT02662569|2218065|FG003|Overall Study|Lost to Follow-up|0
1126567|NCT02662582|2218077|FG000|Treatment Period 1 (14 Days)|Adverse Event|3
1126568|NCT02662582|2218078|FG001|Treatment Period 1 (14 Days)|Adverse Event|2
1126569|NCT02662582|2218077|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0
1126570|NCT02662582|2218078|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1
1126571|NCT02662582|2218077|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1
1126572|NCT02662582|2218078|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0
1126573|NCT02662582|2218077|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1126574|NCT02662582|2218078|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1126575|NCT02662764|2218089|FG000|Overall Study|Adverse Event|6
1126576|NCT02662764|2218089|FG000|Overall Study|Lack of Efficacy|8
1126577|NCT02662764|2218089|FG000|Overall Study|Protocol Violation|1
1126578|NCT02662764|2218089|FG000|Overall Study|Withdrawal by Subject|5
1126579|NCT02662764|2218089|FG000|Overall Study|Device failure|4
1126580|NCT02662764|2218089|FG000|Overall Study|Patient changed treatment|1
1126581|NCT02662764|2218089|FG000|Overall Study|Patient discharged prior to 24 hrs|5
1126582|NCT02663128|2218100|FG000|Period 2|Physician Decision|0
1126583|NCT02663128|2218101|FG001|Period 2|Physician Decision|0
1126584|NCT02663128|2218102|FG002|Period 2|Physician Decision|0
1126585|NCT02663128|2218103|FG003|Period 2|Physician Decision|0
1126586|NCT02663128|2218104|FG004|Period 2|Physician Decision|1
1126587|NCT02663128|2218105|FG005|Period 2|Physician Decision|0
1126588|NCT02663453|2218120|FG000|Overall Study|Death|4
1126589|NCT02663453|2218121|FG001|Overall Study|Death|4
1126590|NCT02663453|2218120|FG000|Overall Study|Withdrawal by Subject|1
1126591|NCT02663453|2218121|FG001|Overall Study|Withdrawal by Subject|0
1126604|NCT02663674|2218147|FG000|Overall Study|Lost to Follow-up|5
1126605|NCT02663674|2218148|FG001|Overall Study|Lost to Follow-up|4
1126606|NCT02663674|2218147|FG000|Overall Study|Withdrawal by Subject|1
1126607|NCT02663674|2218148|FG001|Overall Study|Withdrawal by Subject|4
1126608|NCT02663674|2218147|FG000|Overall Study|Physician Decision|1
1126609|NCT02663674|2218148|FG001|Overall Study|Physician Decision|1
1126610|NCT02663674|2218147|FG000|Overall Study|Other Event (Health Related)|0
1126611|NCT02663674|2218148|FG001|Overall Study|Other Event (Health Related)|1
1126612|NCT02663687|2218159|FG000|Overall Study|Adverse Event|1
1126613|NCT02663687|2218160|FG001|Overall Study|Adverse Event|0
1126614|NCT02663687|2218161|FG002|Overall Study|Adverse Event|0
1126615|NCT02663687|2218162|FG003|Overall Study|Adverse Event|0
1126616|NCT02663687|2218163|FG004|Overall Study|Adverse Event|0
1126617|NCT02663687|2218159|FG000|Overall Study|Other|1
1126618|NCT02663687|2218160|FG001|Overall Study|Other|0
1126619|NCT02663687|2218161|FG002|Overall Study|Other|1
1126620|NCT02663687|2218162|FG003|Overall Study|Other|0
1126621|NCT02663687|2218163|FG004|Overall Study|Other|0
1126622|NCT02663817|2218188|FG000|Overall Study|Screen failure|2
1126623|NCT02663882|2218196|FG000|Overall Study|Lost to Follow-up|4
1126624|NCT02663882|2218197|FG001|Overall Study|Lost to Follow-up|2
1126625|NCT02663895|2218203|FG000|Overall Study|Adverse Event|3
1126626|NCT02663895|2218203|FG000|Overall Study|Physician Decision|2
1126627|NCT02663895|2218203|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1
1126628|NCT02663895|2218203|FG000|Overall Study|Withdrawal by Subject|1
1126629|NCT02664272|2218226|FG000|Overall Study|Fluoroscopic images not made available|2
1126630|NCT02664415|2218245|FG000|Overall Study|Adverse Event|1
1126631|NCT02664415|2218246|FG001|Overall Study|Adverse Event|0
1126632|NCT02665052|2218308|FG000|Overall Study|Lost to Follow-up|1
1126633|NCT02665052|2218309|FG001|Overall Study|Lost to Follow-up|0
1126634|NCT02665052|2218310|FG002|Overall Study|Lost to Follow-up|0
1126635|NCT02665052|2218311|FG003|Overall Study|Lost to Follow-up|0
1126636|NCT02665052|2218308|FG000|Overall Study|Withdrawal by Subject|1
1126637|NCT02665052|2218309|FG001|Overall Study|Withdrawal by Subject|1
1126638|NCT02665052|2218310|FG002|Overall Study|Withdrawal by Subject|0
1126639|NCT02665052|2218311|FG003|Overall Study|Withdrawal by Subject|5
1126640|NCT02665052|2218308|FG000|Overall Study|Adverse Event|1
1126641|NCT02665052|2218309|FG001|Overall Study|Adverse Event|1
1126642|NCT02665052|2218310|FG002|Overall Study|Adverse Event|0
1126643|NCT02665052|2218311|FG003|Overall Study|Adverse Event|0
1126644|NCT02665286|2218355|FG000|Overall Study|Lost to Follow-up|3
1126645|NCT02665286|2218356|FG001|Overall Study|Lost to Follow-up|2
1126646|NCT02665286|2218357|FG002|Overall Study|Lost to Follow-up|1
1126647|NCT02665455|2218374|FG000|Overall Study|Withdrawal by Subject|6
1126648|NCT02665455|2218374|FG000|Overall Study|Lost to Follow-up|1
1126649|NCT02665455|2218374|FG000|Overall Study|Adverse Event|1
1126650|NCT02665455|2218374|FG000|Overall Study|Protocol Violation|1
1126651|NCT02666222|2218422|FG000|Overall Study|Death|2
1126652|NCT02666430|2218441|FG000|Period 1|Lost to Follow-up|1
1126653|NCT02666430|2218442|FG001|Period 1|Lost to Follow-up|0
1126654|NCT02666430|2218441|FG000|Period 1|Adverse Event|0
1126655|NCT02666430|2218442|FG001|Period 1|Adverse Event|1
1126656|NCT02666430|2218441|FG000|Period 2|Withdrawal by Subject|1
1126657|NCT02666430|2218442|FG001|Period 2|Withdrawal by Subject|4
1126658|NCT02666430|2218441|FG000|Period 3|Lost to Follow-up|1
1126659|NCT02666430|2218442|FG001|Period 3|Lost to Follow-up|0
1126660|NCT02666664|2218471|FG000|Overall Study|Physician Decision|0
1126661|NCT02666664|2218472|FG001|Overall Study|Physician Decision|1
1126662|NCT02666664|2218471|FG000|Overall Study|Protocol Violation|0
1126663|NCT02666664|2218472|FG001|Overall Study|Protocol Violation|2
1126664|NCT02666664|2218471|FG000|Overall Study|Other|0
1126665|NCT02666664|2218472|FG001|Overall Study|Other|1
1126666|NCT02666664|2218471|FG000|Overall Study|Adverse Event|12
1126667|NCT02666664|2218472|FG001|Overall Study|Adverse Event|37
1126668|NCT02666664|2218471|FG000|Overall Study|Withdrawal by participant|23
1126669|NCT02666664|2218472|FG001|Overall Study|Withdrawal by participant|40
1126670|NCT02666664|2218471|FG000|Overall Study|Sponsor decision|0
1126671|NCT02666664|2218472|FG001|Overall Study|Sponsor decision|1
1126672|NCT02666664|2218471|FG000|Overall Study|Lost to Follow-up|1
1126673|NCT02666664|2218472|FG001|Overall Study|Lost to Follow-up|2
1126674|NCT02667236|2218530|FG000|Overall Study|Adverse Event|1
1126675|NCT02667236|2218531|FG001|Overall Study|Adverse Event|1
1126676|NCT02667236|2218530|FG000|Overall Study|Withdrawal by Subject|2
1126677|NCT02667236|2218531|FG001|Overall Study|Withdrawal by Subject|0
1126678|NCT02667275|2218539|FG000|Overall Study|Protocol Violation|11
1126679|NCT02667275|2218540|FG001|Overall Study|Protocol Violation|7
1126680|NCT02667275|2218539|FG000|Overall Study|Lost to Follow-up|0
1126681|NCT02667275|2218540|FG001|Overall Study|Lost to Follow-up|2
1126682|NCT02667275|2218539|FG000|Overall Study|Withdrawal by Subject|0
1126683|NCT02667275|2218540|FG001|Overall Study|Withdrawal by Subject|5
1126684|NCT02667275|2218539|FG000|Overall Study|Discontinued early without completing|0
899221|NCT00720096|1871917|FG000|Overall Study|Withdrawal by Subject|0
899222|NCT00720096|1871918|FG001|Overall Study|Withdrawal by Subject|2
899223|NCT00720109|1871924|FG000|Induction Period|Did not meet eligibility criteria|3
1090779|NCT02248818|2158526|FG008|Screening|Withdrawal by Subject|6
1090780|NCT02248818|2158518|FG000|Screening|Lost to Follow-up|0
1090781|NCT02248818|2158519|FG001|Screening|Lost to Follow-up|0
1090782|NCT02248818|2158520|FG002|Screening|Lost to Follow-up|0
1126685|NCT02667275|2218540|FG001|Overall Study|Discontinued early without completing|1
1126686|NCT02667288|2218546|FG000|Overall Study|Protocol Violation|5
1126687|NCT02667288|2218546|FG000|Overall Study|Lost to Follow-up|3
1126688|NCT02667288|2218546|FG000|Overall Study|Withdrawal by Subject|5
1126689|NCT02667301|2218550|FG000|Overall Study|Adverse Event|1
1126690|NCT02667301|2218550|FG000|Overall Study|Lack of Efficacy|1
1126691|NCT02667626|2218572|FG000|Overall Study|Withdrawal by Subject|0
1126692|NCT02667626|2218573|FG001|Overall Study|Withdrawal by Subject|1
1126693|NCT02667912|2218607|FG000|Overall Study|Death|3
1126694|NCT02667912|2218608|FG001|Overall Study|Death|1
1126695|NCT02667912|2218607|FG000|Overall Study|Withdrawal by Subject|1
1126696|NCT02667912|2218608|FG001|Overall Study|Withdrawal by Subject|2
1126697|NCT02667912|2218607|FG000|Overall Study|Withdrawal by Subject|1
1126698|NCT02667912|2218608|FG001|Overall Study|Withdrawal by Subject|0
1126699|NCT02668185|2218632|FG000|First Intervention (4 Weeks)|Physician Decision|2
1126700|NCT02668185|2218633|FG001|First Intervention (4 Weeks)|Physician Decision|0
1126701|NCT02668185|2218632|FG000|Washout Period (2 Weeks)|Adverse Event|1
1126702|NCT02668185|2218633|FG001|Washout Period (2 Weeks)|Adverse Event|0
1126703|NCT02668185|2218632|FG000|Washout Period (2 Weeks)|Physician Decision|0
1126704|NCT02668185|2218633|FG001|Washout Period (2 Weeks)|Physician Decision|2
1126705|NCT02668185|2218632|FG000|Second Intervention (4 Weeks)|Physician Decision|1
1126706|NCT02668185|2218633|FG001|Second Intervention (4 Weeks)|Physician Decision|3
1126707|NCT02668302|2218646|FG000|Overall Study|Withdrawal by Subject|1
1126708|NCT02668302|2218647|FG001|Overall Study|Withdrawal by Subject|0
1126709|NCT02668393|2218655|FG000|Overall Study|Progressive disease|6
1126710|NCT02668393|2218656|FG001|Overall Study|Progressive disease|3
1126711|NCT02668393|2218655|FG000|Overall Study|Adverse Event|0
1126712|NCT02668393|2218656|FG001|Overall Study|Adverse Event|2
1126713|NCT02668393|2218655|FG000|Overall Study|Withdrawal from the trial|0
1126714|NCT02668393|2218656|FG001|Overall Study|Withdrawal from the trial|1
1126715|NCT02668393|2218655|FG000|Overall Study|Lack of benefit and side effects|1
1126716|NCT02668393|2218656|FG001|Overall Study|Lack of benefit and side effects|0
1126717|NCT02668640|2218672|FG000|Overall Study|Lost to Follow-up|13
1126718|NCT02668640|2218672|FG000|Overall Study|Other, not specified|1
1126719|NCT02668692|2218678|FG000|Overall Study|Adverse Event|1
1126720|NCT02668692|2218679|FG001|Overall Study|Adverse Event|0
1126721|NCT02668783|2218687|FG000|Overall Study|Pregnancy|0
1126722|NCT02668783|2218688|FG001|Overall Study|Pregnancy|1
1126723|NCT02668783|2218687|FG000|Overall Study|Protocol Violation|2
1126724|NCT02668783|2218688|FG001|Overall Study|Protocol Violation|1
1126725|NCT02668783|2218687|FG000|Overall Study|Study terminated by sponsor|9
1126726|NCT02668783|2218688|FG001|Overall Study|Study terminated by sponsor|10
1126727|NCT02668783|2218687|FG000|Overall Study|Subject moved|1
1126728|NCT02668783|2218688|FG001|Overall Study|Subject moved|0
1126729|NCT02668783|2218687|FG000|Overall Study|Withdrawal by Subject|1
1126730|NCT02668783|2218688|FG001|Overall Study|Withdrawal by Subject|0
1126731|NCT02668822|2218696|FG000|Overall Study|Protocol Violation|2
1126732|NCT02668822|2218697|FG001|Overall Study|Protocol Violation|0
1126733|NCT02668822|2218696|FG000|Overall Study|Study Terminated by Sponsor|7
1126734|NCT02668822|2218697|FG001|Overall Study|Study Terminated by Sponsor|9
1126735|NCT02669043|2218757|FG000|Overall Study|Didn't meet I/E criteria|4
1126736|NCT02669082|2218761|FG000|Overall Study|Adverse Event|1
1126737|NCT02669095|2218767|FG000|Overall Study|Adverse Event|1
1126738|NCT02669095|2218768|FG001|Overall Study|Adverse Event|0
1126739|NCT02669095|2218767|FG000|Overall Study|Unsatisfactory Lens Fitting|0
1126740|NCT02669095|2218768|FG001|Overall Study|Unsatisfactory Lens Fitting|1
1126741|NCT02669095|2218767|FG000|Overall Study|Torn Lens|0
1126742|NCT02669095|2218768|FG001|Overall Study|Torn Lens|1
1126743|NCT02669095|2218767|FG000|Overall Study|Visit 5 assessments not completed|0
1126744|NCT02669095|2218768|FG001|Overall Study|Visit 5 assessments not completed|1
1126745|NCT02669121|2218776|FG000|Overall Study|Adverse Event|4
1126746|NCT02669121|2218777|FG001|Overall Study|Adverse Event|5
1126747|NCT02669121|2218776|FG000|Overall Study|Lost to Follow-up|15
1126748|NCT02669121|2218777|FG001|Overall Study|Lost to Follow-up|27
1126749|NCT02669121|2218776|FG000|Overall Study|Withdrawal by Subject|132
1126750|NCT02669121|2218777|FG001|Overall Study|Withdrawal by Subject|140
1126751|NCT02669121|2218776|FG000|Overall Study|Pregnancy|0
1126752|NCT02669121|2218777|FG001|Overall Study|Pregnancy|1
1126753|NCT02669121|2218776|FG000|Overall Study|Discharged from US Military Active Service|117
1126754|NCT02669121|2218777|FG001|Overall Study|Discharged from US Military Active Service|91
1126755|NCT02669121|2218776|FG000|Overall Study|Reason not Specified|22
1126756|NCT02669121|2218777|FG001|Overall Study|Reason not Specified|18
1126757|NCT02669407|2218818|FG000|Overall Study|Physician Decision|3
1126758|NCT02669433|2218825|FG000|Overall Study|Protocol Violation|0
1126759|NCT02669433|2218826|FG001|Overall Study|Protocol Violation|4
1126760|NCT02669433|2218827|FG002|Overall Study|Protocol Violation|1
1126761|NCT02669433|2218825|FG000|Overall Study|Disease Progression|1
1126762|NCT02669433|2218826|FG001|Overall Study|Disease Progression|0
1126763|NCT02669433|2218827|FG002|Overall Study|Disease Progression|0
1126764|NCT02669433|2218825|FG000|Overall Study|Physician Decision|1
1126765|NCT02669433|2218826|FG001|Overall Study|Physician Decision|1
1126766|NCT02669433|2218827|FG002|Overall Study|Physician Decision|0
1126767|NCT02669433|2218825|FG000|Overall Study|Adverse Event|6
1126768|NCT02669433|2218826|FG001|Overall Study|Adverse Event|7
1126769|NCT02669433|2218827|FG002|Overall Study|Adverse Event|10
1126770|NCT02669433|2218825|FG000|Overall Study|Sponsor Termination|1
1126771|NCT02669433|2218826|FG001|Overall Study|Sponsor Termination|0
1126772|NCT02669433|2218827|FG002|Overall Study|Sponsor Termination|1
1126773|NCT02669433|2218825|FG000|Overall Study|Withdrawal by Subject|5
1126774|NCT02669433|2218826|FG001|Overall Study|Withdrawal by Subject|1
1126775|NCT02669433|2218827|FG002|Overall Study|Withdrawal by Subject|0
1126776|NCT02669433|2218825|FG000|Overall Study|Withdrawal by Caregiver|1
1126777|NCT02669433|2218826|FG001|Overall Study|Withdrawal by Caregiver|0
1126778|NCT02669433|2218827|FG002|Overall Study|Withdrawal by Caregiver|2
1126779|NCT02669433|2218825|FG000|Overall Study|Death|0
1126780|NCT02669433|2218826|FG001|Overall Study|Death|1
1126781|NCT02669433|2218827|FG002|Overall Study|Death|1
1126782|NCT02669667|2218846|FG000|Overall Study|Lost to Follow-up|0
1126783|NCT02669667|2218847|FG001|Overall Study|Lost to Follow-up|0
1126784|NCT02669667|2218848|FG002|Overall Study|Lost to Follow-up|0
1126785|NCT02669667|2218849|FG003|Overall Study|Lost to Follow-up|0
1126786|NCT02669667|2218850|FG004|Overall Study|Lost to Follow-up|0
1126787|NCT02669667|2218851|FG005|Overall Study|Lost to Follow-up|1
1126788|NCT02669667|2218852|FG006|Overall Study|Lost to Follow-up|0
1126789|NCT02669758|2218874|FG000|Overall Study|Withdrawal by Subject|43
1126790|NCT02669758|2218874|FG000|Overall Study|Lost to Follow-up|19
1126791|NCT02669758|2218874|FG000|Overall Study|Adverse Event|16
1126792|NCT02669758|2218874|FG000|Overall Study|Non-Compliance with Study Drug|8
1126793|NCT02669758|2218874|FG000|Overall Study|Lack of Efficacy|5
1126794|NCT02669758|2218874|FG000|Overall Study|Pregnancy|1
1126795|NCT02669758|2218874|FG000|Overall Study|Study noncompliance|1
1126796|NCT02669758|2218874|FG000|Overall Study|Protocol Violation|1
1126797|NCT02669849|2218890|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
1126798|NCT02669849|2218891|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0
1126799|NCT02669849|2218892|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3
1126800|NCT02669849|2218890|FG000|Overall Study|Lost to Follow-up|1
1126801|NCT02669849|2218891|FG001|Overall Study|Lost to Follow-up|0
1126802|NCT02669849|2218892|FG002|Overall Study|Lost to Follow-up|3
1126803|NCT02669849|2218890|FG000|Overall Study|Death|1
1126804|NCT02669849|2218891|FG001|Overall Study|Death|1
1126805|NCT02669849|2218892|FG002|Overall Study|Death|2
1126806|NCT02669849|2218890|FG000|Overall Study|Study terminated by sponsor|16
1126807|NCT02669849|2218891|FG001|Overall Study|Study terminated by sponsor|1
1126808|NCT02669849|2218892|FG002|Overall Study|Study terminated by sponsor|14
1126809|NCT02669849|2218890|FG000|Overall Study|Other|0
1126810|NCT02669849|2218891|FG001|Overall Study|Other|0
1126811|NCT02669849|2218892|FG002|Overall Study|Other|2
1126812|NCT02669862|2218903|FG000|Overall Study|Lost to Follow-up|0
1126813|NCT02669862|2218904|FG001|Overall Study|Lost to Follow-up|2
1126814|NCT02669862|2218905|FG002|Overall Study|Lost to Follow-up|1
1126815|NCT02669862|2218903|FG000|Overall Study|Withdrawal by Subject|2
1126816|NCT02669862|2218904|FG001|Overall Study|Withdrawal by Subject|2
1126817|NCT02669862|2218905|FG002|Overall Study|Withdrawal by Subject|3
1126818|NCT02669862|2218903|FG000|Overall Study|moved|0
1126819|NCT02669862|2218904|FG001|Overall Study|moved|1
1126820|NCT02669862|2218905|FG002|Overall Study|moved|0
1126821|NCT02669862|2218903|FG000|Overall Study|Protocol Violation|0
1126822|NCT02669862|2218904|FG001|Overall Study|Protocol Violation|0
1126823|NCT02669862|2218905|FG002|Overall Study|Protocol Violation|1
1126824|NCT02669940|2218931|FG000|Overall Study|Failure to return|0
1126825|NCT02669940|2218932|FG001|Overall Study|Failure to return|3
1126826|NCT02669940|2218931|FG000|Overall Study|Insufficient follow-up data|1
1126827|NCT02669940|2218932|FG001|Overall Study|Insufficient follow-up data|0
1126828|NCT02670083|2218947|FG000|Overall Study|Adverse Event|16
1126829|NCT02670083|2218948|FG001|Overall Study|Adverse Event|13
1126830|NCT02670083|2218947|FG000|Overall Study|Death|4
1126831|NCT02670083|2218948|FG001|Overall Study|Death|6
1126832|NCT02670083|2218947|FG000|Overall Study|Lost to Follow-up|2
1126833|NCT02670083|2218948|FG001|Overall Study|Lost to Follow-up|2
1126834|NCT02670083|2218947|FG000|Overall Study|Multiple Reasons|9
1126835|NCT02670083|2218948|FG001|Overall Study|Multiple Reasons|9
1126836|NCT02670083|2218947|FG000|Overall Study|Physician Decision|0
1126837|NCT02670083|2218948|FG001|Overall Study|Physician Decision|2
899224|NCT00720109|1871925|FG001|Induction Period|Did not meet eligibility criteria|0
899225|NCT00720109|1871926|FG002|Induction Period|Did not meet eligibility criteria|0
899226|NCT00720109|1871924|FG000|Induction Period|Bone Marrow Transplant|2
899227|NCT00720109|1871925|FG001|Induction Period|Bone Marrow Transplant|0
899228|NCT00720109|1871926|FG002|Induction Period|Bone Marrow Transplant|0
899229|NCT00720109|1871924|FG000|Induction Period|Physician Decision|1
899230|NCT00720109|1871925|FG001|Induction Period|Physician Decision|0
899231|NCT00720109|1871926|FG002|Induction Period|Physician Decision|0
899232|NCT00720109|1871924|FG000|Risk Stratification Period|Adverse Event|0
899233|NCT00720109|1871925|FG001|Risk Stratification Period|Adverse Event|1
1126838|NCT02670083|2218947|FG000|Overall Study|Study Terminated By Sponsor|257
1126839|NCT02670083|2218948|FG001|Overall Study|Study Terminated By Sponsor|254
1126840|NCT02670083|2218947|FG000|Overall Study|Symptomatic Deterioration|0
1126841|NCT02670083|2218948|FG001|Overall Study|Symptomatic Deterioration|2
1126842|NCT02670083|2218947|FG000|Overall Study|Withdrawal by Subject|32
1126843|NCT02670083|2218948|FG001|Overall Study|Withdrawal by Subject|31
1162083|NCT03382912|2284106|FG000|Overall Study|Physician Decision|0
1126844|NCT02670083|2218947|FG000|Overall Study|Non-Compliance With Study Drug|1
1126845|NCT02670083|2218948|FG001|Overall Study|Non-Compliance With Study Drug|0
1126846|NCT02670122|2218955|FG000|Overall Study|Lost to Follow-up|4
1126847|NCT02670330|2218968|FG000|Overall Study|Protocol Deviation|1
1126848|NCT02670330|2218969|FG001|Overall Study|Protocol Deviation|0
1126849|NCT02670330|2218968|FG000|Overall Study|Study Terminated By Sponsor|36
1126850|NCT02670330|2218969|FG001|Overall Study|Study Terminated By Sponsor|43
1126851|NCT02670330|2218968|FG000|Overall Study|Adverse Event|1
1126852|NCT02670330|2218969|FG001|Overall Study|Adverse Event|3
1126853|NCT02670330|2218968|FG000|Overall Study|Withdrawal by Subject|34
1126854|NCT02670330|2218969|FG001|Overall Study|Withdrawal by Subject|29
1126855|NCT02670330|2218968|FG000|Overall Study|Lost to Follow-up|3
1126856|NCT02670330|2218969|FG001|Overall Study|Lost to Follow-up|2
1126857|NCT02670382|2218979|FG000|Placebo lead-in Phase|Withdrawal by Subject|2
1126858|NCT02670382|2218980|FG001|Placebo lead-in Phase|Withdrawal by Subject|1
1126859|NCT02670473|2218988|FG000|Overall Study|Withdrawal by Subject|1
1126860|NCT02670538|2219004|FG000|Overall Study|Withdrawal of Consent|8
1126861|NCT02670538|2219005|FG001|Overall Study|Withdrawal of Consent|6
1126862|NCT02670538|2219006|FG002|Overall Study|Withdrawal of Consent|5
1126863|NCT02670538|2219004|FG000|Overall Study|Lost to Follow-up|8
1126864|NCT02670538|2219005|FG001|Overall Study|Lost to Follow-up|12
1126865|NCT02670538|2219006|FG002|Overall Study|Lost to Follow-up|7
1126866|NCT02670538|2219004|FG000|Overall Study|Adverse Event|5
1126867|NCT02670538|2219005|FG001|Overall Study|Adverse Event|5
1126868|NCT02670538|2219006|FG002|Overall Study|Adverse Event|11
1126869|NCT02670538|2219004|FG000|Overall Study|Lack of Efficacy|7
1126870|NCT02670538|2219005|FG001|Overall Study|Lack of Efficacy|1
1126871|NCT02670538|2219006|FG002|Overall Study|Lack of Efficacy|2
1126872|NCT02670538|2219004|FG000|Overall Study|Protocol Violation|3
1126873|NCT02670538|2219005|FG001|Overall Study|Protocol Violation|4
1126874|NCT02670538|2219006|FG002|Overall Study|Protocol Violation|1
1126875|NCT02670538|2219004|FG000|Overall Study|Noncompliance with Study Drug|1
1126876|NCT02670538|2219005|FG001|Overall Study|Noncompliance with Study Drug|3
1126877|NCT02670538|2219006|FG002|Overall Study|Noncompliance with Study Drug|2
1126878|NCT02670538|2219004|FG000|Overall Study|Other Miscellaneous Reasons|0
1126879|NCT02670538|2219005|FG001|Overall Study|Other Miscellaneous Reasons|1
1126880|NCT02670538|2219006|FG002|Overall Study|Other Miscellaneous Reasons|2
1126881|NCT02670551|2219017|FG000|Overall Study|Adverse Event|4
1126882|NCT02670551|2219018|FG001|Overall Study|Adverse Event|7
1126883|NCT02670551|2219019|FG002|Overall Study|Adverse Event|9
1126884|NCT02670551|2219017|FG000|Overall Study|Lack of Efficacy|2
1126885|NCT02670551|2219018|FG001|Overall Study|Lack of Efficacy|0
1126886|NCT02670551|2219019|FG002|Overall Study|Lack of Efficacy|3
1126887|NCT02670551|2219017|FG000|Overall Study|Withdrawal of Consent|6
1126888|NCT02670551|2219018|FG001|Overall Study|Withdrawal of Consent|3
1126889|NCT02670551|2219019|FG002|Overall Study|Withdrawal of Consent|8
1126890|NCT02670551|2219017|FG000|Overall Study|Lost to Follow-up|5
1126891|NCT02670551|2219018|FG001|Overall Study|Lost to Follow-up|7
1126892|NCT02670551|2219019|FG002|Overall Study|Lost to Follow-up|6
1126893|NCT02670551|2219017|FG000|Overall Study|Protocol Violation|1
1126894|NCT02670551|2219018|FG001|Overall Study|Protocol Violation|0
1126895|NCT02670551|2219019|FG002|Overall Study|Protocol Violation|0
1126896|NCT02670551|2219017|FG000|Overall Study|Noncompliance with study drug|3
1126897|NCT02670551|2219018|FG001|Overall Study|Noncompliance with study drug|3
1126898|NCT02670551|2219019|FG002|Overall Study|Noncompliance with study drug|2
1126899|NCT02670551|2219017|FG000|Overall Study|Other Miscellaneous Reasons|2
1126900|NCT02670551|2219018|FG001|Overall Study|Other Miscellaneous Reasons|3
1126901|NCT02670551|2219019|FG002|Overall Study|Other Miscellaneous Reasons|3
1126902|NCT02670551|2219017|FG000|Overall Study|Did Not Receive Treatment|5
1126903|NCT02670551|2219018|FG001|Overall Study|Did Not Receive Treatment|3
1126904|NCT02670551|2219019|FG002|Overall Study|Did Not Receive Treatment|0
1126905|NCT02670915|2219048|FG000|Overall Study|Withdrawal by Subject|0
1126906|NCT02670915|2219049|FG001|Overall Study|Withdrawal by Subject|1
1126907|NCT02670915|2219050|FG002|Overall Study|Withdrawal by Subject|4
1126908|NCT02670915|2219048|FG000|Overall Study|Withdrawal by parent/guardian|4
1126909|NCT02670915|2219049|FG001|Overall Study|Withdrawal by parent/guardian|4
1126910|NCT02670915|2219050|FG002|Overall Study|Withdrawal by parent/guardian|1
1126911|NCT02670915|2219048|FG000|Overall Study|Unclassified|0
1126912|NCT02670915|2219049|FG001|Overall Study|Unclassified|3
1126913|NCT02670915|2219050|FG002|Overall Study|Unclassified|0
1126914|NCT02670928|2219060|FG000|Overall Study|Adverse Event|3
1126915|NCT02670928|2219061|FG001|Overall Study|Adverse Event|1
1126916|NCT02670928|2219060|FG000|Overall Study|Withdrawal by Subject|4
1126917|NCT02670928|2219061|FG001|Overall Study|Withdrawal by Subject|0
1126918|NCT02670928|2219060|FG000|Overall Study|Lost to Follow-up|1
1126919|NCT02670928|2219061|FG001|Overall Study|Lost to Follow-up|0
1126920|NCT02670928|2219060|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2
1126921|NCT02670928|2219061|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0
1126922|NCT02671266|2219073|FG000|Overall Study|Withdrawal by Subject|1
1126923|NCT02671266|2219074|FG001|Overall Study|Withdrawal by Subject|1
1126924|NCT02671422|2219080|FG000|Overall Study|Lost to Follow-up|1
1126925|NCT02671422|2219080|FG000|Overall Study|Adverse Event|68
1126926|NCT02671422|2219080|FG000|Overall Study|Lack of Efficacy|1
1126927|NCT02671422|2219080|FG000|Overall Study|Lost to Follow-up|4
1126928|NCT02671422|2219080|FG000|Overall Study|Withdrawal by Subject|7
1126929|NCT02671422|2219080|FG000|Overall Study|Progressive Disease|156
1126930|NCT02671422|2219080|FG000|Overall Study|Worsening of Disease|4
1126931|NCT02671422|2219080|FG000|Overall Study|Sponsor decision|5
1126932|NCT02671422|2219080|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8
1126933|NCT02671422|2219080|FG000|Overall Study|Not treated with Vargatef®|3
1126934|NCT02671422|2219080|FG000|Overall Study|Other not defined above|3
1126935|NCT02671500|2219084|FG000|Overall Study|Lack of Efficacy|12
1126936|NCT02671500|2219084|FG000|Overall Study|Lost to Follow-up|2
1126937|NCT02671760|2219092|FG000|Overall Study|Lost to Follow-up|0
1126938|NCT02671760|2219093|FG001|Overall Study|Lost to Follow-up|1
1126939|NCT02671760|2219094|FG002|Overall Study|Lost to Follow-up|0
1126940|NCT02672423|2219127|FG000|Period 1|Adverse Event|0
1126941|NCT02672423|2219128|FG001|Period 1|Adverse Event|0
1126942|NCT02672423|2219129|FG002|Period 1|Adverse Event|0
1126943|NCT02672423|2219130|FG003|Period 1|Adverse Event|0
1126944|NCT02672423|2219131|FG004|Period 1|Adverse Event|1
1126945|NCT02672423|2219132|FG005|Period 1|Adverse Event|0
1126946|NCT02672423|2219133|FG006|Period 1|Adverse Event|0
1126947|NCT02672423|2219134|FG007|Period 1|Adverse Event|0
1126948|NCT02672423|2219135|FG008|Period 1|Adverse Event|0
1126949|NCT02672423|2219136|FG009|Period 1|Adverse Event|0
1126950|NCT02672423|2219127|FG000|Period 2|Withdrawal by Subject|0
1126951|NCT02672423|2219128|FG001|Period 2|Withdrawal by Subject|0
1126952|NCT02672423|2219129|FG002|Period 2|Withdrawal by Subject|1
1126953|NCT02672423|2219130|FG003|Period 2|Withdrawal by Subject|0
1126954|NCT02672423|2219131|FG004|Period 2|Withdrawal by Subject|0
1126955|NCT02672423|2219132|FG005|Period 2|Withdrawal by Subject|0
1126956|NCT02672423|2219133|FG006|Period 2|Withdrawal by Subject|0
1126957|NCT02672423|2219134|FG007|Period 2|Withdrawal by Subject|0
1126958|NCT02672423|2219135|FG008|Period 2|Withdrawal by Subject|0
1126959|NCT02672423|2219136|FG009|Period 2|Withdrawal by Subject|0
1126960|NCT02672423|2219127|FG000|Period 3|Withdrawal by Subject|0
1126961|NCT02672423|2219128|FG001|Period 3|Withdrawal by Subject|0
1126962|NCT02672423|2219129|FG002|Period 3|Withdrawal by Subject|0
1126963|NCT02672423|2219130|FG003|Period 3|Withdrawal by Subject|0
899234|NCT00720109|1871926|FG002|Risk Stratification Period|Adverse Event|0
899235|NCT00720109|1871924|FG000|Risk Stratification Period|Physician Decision|0
899236|NCT00720109|1871925|FG001|Risk Stratification Period|Physician Decision|2
899237|NCT00720109|1871926|FG002|Risk Stratification Period|Physician Decision|1
899238|NCT00720109|1871924|FG000|Risk Stratification Period|Bone marrow transplant|0
899239|NCT00720109|1871925|FG001|Risk Stratification Period|Bone marrow transplant|9
899240|NCT00720109|1871926|FG002|Risk Stratification Period|Bone marrow transplant|7
899241|NCT00720109|1871924|FG000|Risk Stratification Period|Disease progression or relapse|0
899242|NCT00720109|1871925|FG001|Risk Stratification Period|Disease progression or relapse|2
899243|NCT00720109|1871926|FG002|Risk Stratification Period|Disease progression or relapse|0
899244|NCT00720109|1871924|FG000|Risk Stratification Period|Development of second malignant neoplasm|0
899245|NCT00720109|1871925|FG001|Risk Stratification Period|Development of second malignant neoplasm|1
899246|NCT00720109|1871926|FG002|Risk Stratification Period|Development of second malignant neoplasm|0
899247|NCT00720122|1871935|FG000|Overall Study|Lost to Follow-up|1
899248|NCT00720122|1871935|FG000|Overall Study|Physician Decision|1
899249|NCT00720122|1871935|FG000|Overall Study|Withdrawal by Subject|7
899250|NCT00720213|1871939|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7
899251|NCT00720213|1871940|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0
899252|NCT00720213|1871941|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0
899253|NCT00720226|1871951|FG000|Overall Study|Withdrawal by Subject|7
899254|NCT00720226|1871952|FG001|Overall Study|Withdrawal by Subject|4
899255|NCT00720278|1871961|FG000|Overall Study|Adverse Event|5
899256|NCT00720278|1871962|FG001|Overall Study|Adverse Event|3
899257|NCT00720278|1871963|FG002|Overall Study|Adverse Event|4
899258|NCT00720278|1871961|FG000|Overall Study|Withdrawal by Subject|0
899259|NCT00720278|1871962|FG001|Overall Study|Withdrawal by Subject|1
899260|NCT00720278|1871963|FG002|Overall Study|Withdrawal by Subject|0
899261|NCT00720278|1871961|FG000|Overall Study|Lost to Follow-up|0
899262|NCT00720278|1871962|FG001|Overall Study|Lost to Follow-up|0
899263|NCT00720278|1871963|FG002|Overall Study|Lost to Follow-up|1
899264|NCT00720278|1871961|FG000|Overall Study|Non-compliance|1
899265|NCT00720278|1871962|FG001|Overall Study|Non-compliance|0
899266|NCT00720278|1871963|FG002|Overall Study|Non-compliance|0
899267|NCT00720278|1871961|FG000|Overall Study|eligibility criteria violation|1
899268|NCT00720278|1871962|FG001|Overall Study|eligibility criteria violation|0
899269|NCT00720278|1871963|FG002|Overall Study|eligibility criteria violation|1
899270|NCT00720356|1871984|FG000|Registration to Study|Determined to have methylated MGMT|67
899271|NCT00720356|1871984|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1
899272|NCT00720356|1871984|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
899273|NCT00720356|1871984|FG000|Went on to be Treated Cycle 3|Adverse Event|1
899274|NCT00720356|1871984|FG000|Went on to be Treated Cycle 3|Physician Decision|1
899275|NCT00720356|1871984|FG000|Follow up Until Death|Withdrawal by Subject|1
899276|NCT00720356|1871984|FG000|Follow up Until Death|Alive at last data collection|4
1126964|NCT02672423|2219131|FG004|Period 3|Withdrawal by Subject|0
1126965|NCT02672423|2219132|FG005|Period 3|Withdrawal by Subject|0
1126966|NCT02672423|2219133|FG006|Period 3|Withdrawal by Subject|0
1126967|NCT02672423|2219134|FG007|Period 3|Withdrawal by Subject|1
1126968|NCT02672423|2219135|FG008|Period 3|Withdrawal by Subject|0
1126969|NCT02672423|2219136|FG009|Period 3|Withdrawal by Subject|0
1126970|NCT02672423|2219127|FG000|Period 3|Physician Decision|0
1126971|NCT02672423|2219128|FG001|Period 3|Physician Decision|0
1126972|NCT02672423|2219129|FG002|Period 3|Physician Decision|0
1126973|NCT02672423|2219130|FG003|Period 3|Physician Decision|0
1126974|NCT02672423|2219131|FG004|Period 3|Physician Decision|0
1126975|NCT02672423|2219132|FG005|Period 3|Physician Decision|1
1126976|NCT02672423|2219133|FG006|Period 3|Physician Decision|0
1126977|NCT02672423|2219134|FG007|Period 3|Physician Decision|0
1126978|NCT02672423|2219135|FG008|Period 3|Physician Decision|0
1126979|NCT02672423|2219136|FG009|Period 3|Physician Decision|0
1126980|NCT02672553|2219168|FG000|Overall Study|Death|3
1126981|NCT02672553|2219169|FG001|Overall Study|Death|5
1126982|NCT02672553|2219168|FG000|Overall Study|Valve Explant|1
1126983|NCT02672553|2219169|FG001|Overall Study|Valve Explant|0
1126984|NCT02672553|2219168|FG000|Overall Study|Conversion to Commercial Valve|3
1126985|NCT02672553|2219169|FG001|Overall Study|Conversion to Commercial Valve|0
1126986|NCT02672553|2219168|FG000|Overall Study|Withdrawal by Subject|3
1126987|NCT02672553|2219169|FG001|Overall Study|Withdrawal by Subject|3
1126988|NCT02672553|2219168|FG000|Overall Study|Intraoperative screen failure|2
1126989|NCT02672553|2219169|FG001|Overall Study|Intraoperative screen failure|0
1126990|NCT02672852|2219178|FG000|Part A1|Disease Worsening|1
1126991|NCT02672852|2219179|FG001|Part A1|Disease Worsening|0
1126992|NCT02672852|2219180|FG002|Part A1|Disease Worsening|0
1126993|NCT02672852|2219181|FG003|Part A1|Disease Worsening|0
1126994|NCT02672852|2219182|FG004|Part A1|Disease Worsening|0
1126995|NCT02672852|2219183|FG005|Part A1|Disease Worsening|0
1126996|NCT02672852|2219184|FG006|Part A1|Disease Worsening|0
1126997|NCT02672852|2219178|FG000|Part A1|Adverse Event|0
1126998|NCT02672852|2219179|FG001|Part A1|Adverse Event|1
1126999|NCT02672852|2219180|FG002|Part A1|Adverse Event|0
1127000|NCT02672852|2219181|FG003|Part A1|Adverse Event|0
1127001|NCT02672852|2219182|FG004|Part A1|Adverse Event|0
1127002|NCT02672852|2219183|FG005|Part A1|Adverse Event|0
1127003|NCT02672852|2219184|FG006|Part A1|Adverse Event|0
1127004|NCT02672852|2219178|FG000|Part A1|Lost to Follow-up|1
1127005|NCT02672852|2219179|FG001|Part A1|Lost to Follow-up|2
1127006|NCT02672852|2219180|FG002|Part A1|Lost to Follow-up|0
1127007|NCT02672852|2219181|FG003|Part A1|Lost to Follow-up|0
1127008|NCT02672852|2219182|FG004|Part A1|Lost to Follow-up|0
1127009|NCT02672852|2219183|FG005|Part A1|Lost to Follow-up|0
1127010|NCT02672852|2219184|FG006|Part A1|Lost to Follow-up|0
1127011|NCT02672852|2219178|FG000|Part A1|Withdrawal by Subject|1
1127012|NCT02672852|2219179|FG001|Part A1|Withdrawal by Subject|1
1127013|NCT02672852|2219180|FG002|Part A1|Withdrawal by Subject|0
1127014|NCT02672852|2219181|FG003|Part A1|Withdrawal by Subject|0
1127015|NCT02672852|2219182|FG004|Part A1|Withdrawal by Subject|0
1127016|NCT02672852|2219183|FG005|Part A1|Withdrawal by Subject|0
1127017|NCT02672852|2219184|FG006|Part A1|Withdrawal by Subject|0
1127018|NCT02672852|2219178|FG000|Part A2|Disease worsening|0
1127019|NCT02672852|2219179|FG001|Part A2|Disease worsening|0
1127020|NCT02672852|2219180|FG002|Part A2|Disease worsening|1
1127021|NCT02672852|2219181|FG003|Part A2|Disease worsening|0
1127022|NCT02672852|2219182|FG004|Part A2|Disease worsening|0
1127023|NCT02672852|2219183|FG005|Part A2|Disease worsening|0
1127024|NCT02672852|2219184|FG006|Part A2|Disease worsening|0
1127025|NCT02672852|2219178|FG000|Part A2|Adverse Event|0
1127026|NCT02672852|2219179|FG001|Part A2|Adverse Event|0
1127027|NCT02672852|2219180|FG002|Part A2|Adverse Event|3
1127028|NCT02672852|2219181|FG003|Part A2|Adverse Event|0
1127029|NCT02672852|2219182|FG004|Part A2|Adverse Event|0
1127030|NCT02672852|2219183|FG005|Part A2|Adverse Event|0
1127031|NCT02672852|2219184|FG006|Part A2|Adverse Event|0
1127032|NCT02672852|2219178|FG000|Part A2|Lost to Follow-up|0
1127033|NCT02672852|2219179|FG001|Part A2|Lost to Follow-up|0
1127034|NCT02672852|2219180|FG002|Part A2|Lost to Follow-up|2
1127035|NCT02672852|2219181|FG003|Part A2|Lost to Follow-up|0
1127036|NCT02672852|2219182|FG004|Part A2|Lost to Follow-up|0
1127037|NCT02672852|2219183|FG005|Part A2|Lost to Follow-up|0
1127038|NCT02672852|2219184|FG006|Part A2|Lost to Follow-up|0
1127039|NCT02672852|2219178|FG000|Part A2|Withdrawal by Subject|0
899277|NCT00720382|1872001|FG000|Overall Study|Adverse Event|54
899278|NCT00720382|1872002|FG001|Overall Study|Adverse Event|17
899279|NCT00720382|1872001|FG000|Overall Study|Lack of Efficacy|18
899280|NCT00720382|1872002|FG001|Overall Study|Lack of Efficacy|7
899281|NCT00720382|1872001|FG000|Overall Study|Non-Compliance|15
899282|NCT00720382|1872002|FG001|Overall Study|Non-Compliance|5
899283|NCT00720382|1872001|FG000|Overall Study|Withdrawal by Subject|47
899284|NCT00720382|1872002|FG001|Overall Study|Withdrawal by Subject|11
899285|NCT00720382|1872001|FG000|Overall Study|Lost to Follow-up|28
899286|NCT00720382|1872002|FG001|Overall Study|Lost to Follow-up|14
899287|NCT00720382|1872001|FG000|Overall Study|administrative|14
899288|NCT00720382|1872002|FG001|Overall Study|administrative|5
899289|NCT00720434|1872012|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
1127040|NCT02672852|2219179|FG001|Part A2|Withdrawal by Subject|0
1127041|NCT02672852|2219180|FG002|Part A2|Withdrawal by Subject|1
1127042|NCT02672852|2219181|FG003|Part A2|Withdrawal by Subject|0
1127043|NCT02672852|2219182|FG004|Part A2|Withdrawal by Subject|0
1127044|NCT02672852|2219183|FG005|Part A2|Withdrawal by Subject|0
1127045|NCT02672852|2219184|FG006|Part A2|Withdrawal by Subject|0
1127046|NCT02672852|2219178|FG000|Part A2|Other|0
1127047|NCT02672852|2219179|FG001|Part A2|Other|0
1127048|NCT02672852|2219180|FG002|Part A2|Other|3
1127049|NCT02672852|2219181|FG003|Part A2|Other|0
1127050|NCT02672852|2219182|FG004|Part A2|Other|0
1127051|NCT02672852|2219183|FG005|Part A2|Other|0
899290|NCT00720434|1872013|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
899291|NCT00720434|1872014|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
899292|NCT00720434|1872015|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
899293|NCT00720434|1872012|FG000|Open-Label Period (Week 5-72)|Adverse Event|0
899294|NCT00720434|1872013|FG001|Open-Label Period (Week 5-72)|Adverse Event|0
899295|NCT00720434|1872014|FG002|Open-Label Period (Week 5-72)|Adverse Event|0
899296|NCT00720434|1872015|FG003|Open-Label Period (Week 5-72)|Adverse Event|2
899297|NCT00720434|1872012|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1
899298|NCT00720434|1872013|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0
899299|NCT00720434|1872014|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0
899300|NCT00720434|1872015|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0
899301|NCT00720434|1872012|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
899302|NCT00720434|1872013|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
899303|NCT00720434|1872014|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
899304|NCT00720434|1872015|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
899305|NCT00720434|1872012|FG000|Open-Label Period (Week 5-72)|Other|4
899306|NCT00720434|1872013|FG001|Open-Label Period (Week 5-72)|Other|3
899307|NCT00720434|1872014|FG002|Open-Label Period (Week 5-72)|Other|3
899308|NCT00720434|1872015|FG003|Open-Label Period (Week 5-72)|Other|2
899309|NCT00720499|1872035|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2
899310|NCT00720499|1872036|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
899311|NCT00720499|1872035|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1
899312|NCT00720499|1872036|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2
899313|NCT00720499|1872035|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2
899314|NCT00720499|1872036|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3
899315|NCT00720759|1872053|FG000|Overall Study|Lost to Follow-up|0
899316|NCT00720759|1872054|FG001|Overall Study|Lost to Follow-up|1
899317|NCT00720759|1872055|FG002|Overall Study|Lost to Follow-up|1
899318|NCT00720759|1872056|FG003|Overall Study|Lost to Follow-up|0
899319|NCT00720798|1872066|FG000|Overall Study|Adverse Event|304
899320|NCT00720798|1872066|FG000|Overall Study|Death|39
899321|NCT00720798|1872066|FG000|Overall Study|Insufficient Therapeutic Response|129
899322|NCT00720798|1872066|FG000|Overall Study|Protocol Violation|4
899323|NCT00720798|1872066|FG000|Overall Study|Refused Treatment|151
899324|NCT00720798|1872066|FG000|Overall Study|Failure to Return|46
899325|NCT00720798|1872066|FG000|Overall Study|Reason not Specified|83
899326|NCT00720876|1872070|FG000|Overall Study|found to be ineligible after starting tx|2
899327|NCT00720941|1872076|FG000|Overall Study|Death|334
899328|NCT00720941|1872077|FG001|Overall Study|Death|335
899329|NCT00720941|1872076|FG000|Overall Study|Protocol Violation|0
899330|NCT00720941|1872077|FG001|Overall Study|Protocol Violation|2
899331|NCT00720941|1872076|FG000|Overall Study|Lost to Follow-up|17
899332|NCT00720941|1872077|FG001|Overall Study|Lost to Follow-up|15
899333|NCT00720941|1872076|FG000|Overall Study|Physician Decision|1
899334|NCT00720941|1872077|FG001|Overall Study|Physician Decision|5
899335|NCT00720941|1872076|FG000|Overall Study|Withdrawal by Subject|27
899336|NCT00720941|1872077|FG001|Overall Study|Withdrawal by Subject|35
899337|NCT00720941|1872076|FG000|Overall Study|Ongoing|34
899338|NCT00720941|1872077|FG001|Overall Study|Ongoing|23
899339|NCT00721110|1872087|FG000|Overall Study|Ultram use|1
899340|NCT00721110|1872088|FG001|Overall Study|Ultram use|0
899341|NCT00721110|1872089|FG002|Overall Study|Ultram use|0
899342|NCT00721110|1872090|FG003|Overall Study|Ultram use|0
899343|NCT00721110|1872087|FG000|Overall Study|vertical incision|0
899344|NCT00721110|1872088|FG001|Overall Study|vertical incision|0
899345|NCT00721110|1872089|FG002|Overall Study|vertical incision|1
899346|NCT00721110|1872090|FG003|Overall Study|vertical incision|0
899347|NCT00721123|1872100|FG000|Overall Study|Adverse Event|96
899348|NCT00721123|1872100|FG000|Overall Study|Death|10
899349|NCT00721123|1872100|FG000|Overall Study|Insufficient Therapeutic Response|21
899350|NCT00721123|1872100|FG000|Overall Study|Protocol Violation|1
899351|NCT00721123|1872100|FG000|Overall Study|Refused Treatment|41
899352|NCT00721123|1872100|FG000|Overall Study|Failure to Return|9
899353|NCT00721123|1872100|FG000|Overall Study|Withdrawal by Subject|5
899354|NCT00721149|1872141|FG000|Overall Study|Physician Decision|1
899355|NCT00721214|1872162|FG000|Overall Study|Chose another center for transplant|1
899356|NCT00721214|1872162|FG000|Overall Study|Death|3
899357|NCT00721227|1872168|FG000|Overall Study|Lost to Follow-up|3
899358|NCT00721227|1872169|FG001|Overall Study|Lost to Follow-up|0
899359|NCT00721227|1872168|FG000|Overall Study|Noncompliance with scheduled visits.|1
899360|NCT00721227|1872169|FG001|Overall Study|Noncompliance with scheduled visits.|0
899361|NCT00721279|1872187|FG000|Overall Study|Lack of Efficacy|6
899362|NCT00721279|1872188|FG001|Overall Study|Lack of Efficacy|3
899363|NCT00721279|1872187|FG000|Overall Study|Tolerability insufficient|5
899364|NCT00721279|1872188|FG001|Overall Study|Tolerability insufficient|2
1127052|NCT02672852|2219184|FG006|Part A2|Other|0
1127053|NCT02672852|2219178|FG000|Part A2|Not entered in Part B|0
1127054|NCT02672852|2219179|FG001|Part A2|Not entered in Part B|0
1127055|NCT02672852|2219180|FG002|Part A2|Not entered in Part B|0
1127056|NCT02672852|2219181|FG003|Part A2|Not entered in Part B|4
1127057|NCT02672852|2219182|FG004|Part A2|Not entered in Part B|0
1127058|NCT02672852|2219183|FG005|Part A2|Not entered in Part B|0
1127059|NCT02672852|2219184|FG006|Part A2|Not entered in Part B|0
1127060|NCT02672852|2219178|FG000|Part B|Disease worsening|0
1127061|NCT02672852|2219179|FG001|Part B|Disease worsening|0
1127062|NCT02672852|2219180|FG002|Part B|Disease worsening|0
1127063|NCT02672852|2219181|FG003|Part B|Disease worsening|0
1127064|NCT02672852|2219182|FG004|Part B|Disease worsening|1
1127065|NCT02672852|2219183|FG005|Part B|Disease worsening|0
1127066|NCT02672852|2219184|FG006|Part B|Disease worsening|1
1127067|NCT02672852|2219178|FG000|Part B|Worsening pre-existing condition|0
1127068|NCT02672852|2219179|FG001|Part B|Worsening pre-existing condition|0
1127069|NCT02672852|2219180|FG002|Part B|Worsening pre-existing condition|0
1127070|NCT02672852|2219181|FG003|Part B|Worsening pre-existing condition|0
1127071|NCT02672852|2219182|FG004|Part B|Worsening pre-existing condition|0
1127072|NCT02672852|2219183|FG005|Part B|Worsening pre-existing condition|1
1127073|NCT02672852|2219184|FG006|Part B|Worsening pre-existing condition|0
1127074|NCT02672852|2219178|FG000|Part B|Other adverse event|0
1127075|NCT02672852|2219179|FG001|Part B|Other adverse event|0
1127076|NCT02672852|2219180|FG002|Part B|Other adverse event|0
899365|NCT00721279|1872187|FG000|Overall Study|Withdrawal by Subject|13
899366|NCT00721279|1872188|FG001|Overall Study|Withdrawal by Subject|3
899367|NCT00721279|1872187|FG000|Overall Study|Other|12
899368|NCT00721279|1872188|FG001|Overall Study|Other|16
899369|NCT00721396|1872210|FG000|Overall Study|Adverse Event|4
899370|NCT00721396|1872211|FG001|Overall Study|Adverse Event|7
899371|NCT00721396|1872212|FG002|Overall Study|Adverse Event|2
899372|NCT00721396|1872213|FG003|Overall Study|Adverse Event|0
899373|NCT00721396|1872210|FG000|Overall Study|Withdrawal by Subject|12
899374|NCT00721396|1872211|FG001|Overall Study|Withdrawal by Subject|15
899375|NCT00721396|1872212|FG002|Overall Study|Withdrawal by Subject|3
899376|NCT00721396|1872213|FG003|Overall Study|Withdrawal by Subject|7
899377|NCT00721396|1872210|FG000|Overall Study|Lost to Follow-up|7
899378|NCT00721396|1872211|FG001|Overall Study|Lost to Follow-up|9
899379|NCT00721396|1872212|FG002|Overall Study|Lost to Follow-up|3
899380|NCT00721396|1872213|FG003|Overall Study|Lost to Follow-up|3
899381|NCT00721396|1872210|FG000|Overall Study|Protocol Violation|4
899382|NCT00721396|1872211|FG001|Overall Study|Protocol Violation|3
899383|NCT00721396|1872212|FG002|Overall Study|Protocol Violation|1
899384|NCT00721396|1872213|FG003|Overall Study|Protocol Violation|0
899385|NCT00721396|1872210|FG000|Overall Study|Inappropriate enrollment|0
899386|NCT00721396|1872211|FG001|Overall Study|Inappropriate enrollment|2
899387|NCT00721396|1872212|FG002|Overall Study|Inappropriate enrollment|0
899388|NCT00721396|1872213|FG003|Overall Study|Inappropriate enrollment|0
899389|NCT00721396|1872210|FG000|Overall Study|Administrative reason|3
899390|NCT00721396|1872211|FG001|Overall Study|Administrative reason|0
899391|NCT00721396|1872212|FG002|Overall Study|Administrative reason|1
899392|NCT00721396|1872213|FG003|Overall Study|Administrative reason|0
899393|NCT00721409|1872231|FG000|Overall Study|Global deterioration of health status|2
899394|NCT00721409|1872232|FG001|Overall Study|Global deterioration of health status|6
899395|NCT00721409|1872233|FG002|Overall Study|Global deterioration of health status|3
899396|NCT00721409|1872231|FG000|Overall Study|Death|0
899397|NCT00721409|1872232|FG001|Overall Study|Death|1
899398|NCT00721409|1872233|FG002|Overall Study|Death|0
899399|NCT00721409|1872231|FG000|Overall Study|Randomized not Treated|0
899400|NCT00721409|1872232|FG001|Overall Study|Randomized not Treated|1
899401|NCT00721409|1872233|FG002|Overall Study|Randomized not Treated|4
899402|NCT00721409|1872231|FG000|Overall Study|Reason not specified|1
899403|NCT00721409|1872232|FG001|Overall Study|Reason not specified|0
899404|NCT00721409|1872233|FG002|Overall Study|Reason not specified|2
899405|NCT00721409|1872231|FG000|Overall Study|Adverse Event|0
899406|NCT00721409|1872232|FG001|Overall Study|Adverse Event|13
899407|NCT00721409|1872233|FG002|Overall Study|Adverse Event|2
899408|NCT00721409|1872231|FG000|Overall Study|Lost to Follow-up|0
899409|NCT00721409|1872232|FG001|Overall Study|Lost to Follow-up|0
899410|NCT00721409|1872233|FG002|Overall Study|Lost to Follow-up|1
899411|NCT00721409|1872231|FG000|Overall Study|Withdrawal by Subject|1
899412|NCT00721409|1872232|FG001|Overall Study|Withdrawal by Subject|6
899413|NCT00721409|1872233|FG002|Overall Study|Withdrawal by Subject|5
899414|NCT00721409|1872231|FG000|Overall Study|Objective progression or relapse|8
899415|NCT00721409|1872232|FG001|Overall Study|Objective progression or relapse|55
899416|NCT00721409|1872233|FG002|Overall Study|Objective progression or relapse|62
899417|NCT00721578|1872280|FG000|Overall Study|Death|1
899418|NCT00721578|1872281|FG001|Overall Study|Death|1
899419|NCT00721578|1872280|FG000|Overall Study|Withdrawal by Subject|1
899420|NCT00721578|1872281|FG001|Overall Study|Withdrawal by Subject|1
899421|NCT00721630|1872292|FG000|Overall Study|Participant found to be ineligible|1
899422|NCT00721734|1872301|FG000|Overall Study|Progressive Disease|3
899423|NCT00721734|1872302|FG001|Overall Study|Progressive Disease|10
899424|NCT00721734|1872303|FG002|Overall Study|Progressive Disease|4
899425|NCT00721734|1872304|FG003|Overall Study|Progressive Disease|5
1127077|NCT02672852|2219181|FG003|Part B|Other adverse event|0
1127078|NCT02672852|2219182|FG004|Part B|Other adverse event|3
1127079|NCT02672852|2219183|FG005|Part B|Other adverse event|5
1127080|NCT02672852|2219184|FG006|Part B|Other adverse event|1
1127081|NCT02672852|2219178|FG000|Part B|Lost to Follow-up|0
1127082|NCT02672852|2219179|FG001|Part B|Lost to Follow-up|0
1127083|NCT02672852|2219180|FG002|Part B|Lost to Follow-up|0
1127084|NCT02672852|2219181|FG003|Part B|Lost to Follow-up|0
1127085|NCT02672852|2219182|FG004|Part B|Lost to Follow-up|3
1127086|NCT02672852|2219183|FG005|Part B|Lost to Follow-up|4
1127087|NCT02672852|2219184|FG006|Part B|Lost to Follow-up|1
1127088|NCT02672852|2219178|FG000|Part B|Withdrawal by Subject|0
1127089|NCT02672852|2219179|FG001|Part B|Withdrawal by Subject|0
1127090|NCT02672852|2219180|FG002|Part B|Withdrawal by Subject|0
1127091|NCT02672852|2219181|FG003|Part B|Withdrawal by Subject|0
1127092|NCT02672852|2219182|FG004|Part B|Withdrawal by Subject|5
1127093|NCT02672852|2219183|FG005|Part B|Withdrawal by Subject|0
1127094|NCT02672852|2219184|FG006|Part B|Withdrawal by Subject|7
1127095|NCT02672852|2219178|FG000|Part B|Other|0
1127096|NCT02672852|2219179|FG001|Part B|Other|0
1127097|NCT02672852|2219180|FG002|Part B|Other|0
1127098|NCT02672852|2219181|FG003|Part B|Other|0
1127099|NCT02672852|2219182|FG004|Part B|Other|4
1127100|NCT02672852|2219183|FG005|Part B|Other|1
1127101|NCT02672852|2219184|FG006|Part B|Other|2
1127102|NCT02673489|2219225|FG000|Treatment Period|Lost to Follow-up|3
1127103|NCT02673489|2219226|FG001|Treatment Period|Lost to Follow-up|0
1127104|NCT02673489|2219225|FG000|Treatment Period|Participant request to discontinue|1
1127105|NCT02673489|2219226|FG001|Treatment Period|Participant request to discontinue|1
1127106|NCT02673489|2219225|FG000|Treatment Period|Participant moved to another province|1
1127107|NCT02673489|2219226|FG001|Treatment Period|Participant moved to another province|0
899426|NCT00721734|1872305|FG004|Overall Study|Progressive Disease|2
899427|NCT00721734|1872301|FG000|Overall Study|Adverse Event|3
899428|NCT00721734|1872302|FG001|Overall Study|Adverse Event|1
899429|NCT00721734|1872303|FG002|Overall Study|Adverse Event|4
899430|NCT00721734|1872304|FG003|Overall Study|Adverse Event|0
899431|NCT00721734|1872305|FG004|Overall Study|Adverse Event|3
899432|NCT00721734|1872301|FG000|Overall Study|Withdrawal by Subject|2
899433|NCT00721734|1872302|FG001|Overall Study|Withdrawal by Subject|1
899434|NCT00721734|1872303|FG002|Overall Study|Withdrawal by Subject|0
899435|NCT00721734|1872304|FG003|Overall Study|Withdrawal by Subject|0
899436|NCT00721734|1872305|FG004|Overall Study|Withdrawal by Subject|1
899437|NCT00721734|1872301|FG000|Overall Study|Other|0
899438|NCT00721734|1872302|FG001|Overall Study|Other|0
899439|NCT00721734|1872303|FG002|Overall Study|Other|0
899440|NCT00721734|1872304|FG003|Overall Study|Other|1
899441|NCT00721734|1872305|FG004|Overall Study|Other|0
899442|NCT00721799|1872317|FG000|Overall Study|Withdrawal by Subject|7
899443|NCT00721799|1872317|FG000|Overall Study|withdraw by subject after scan 1|1
899444|NCT00721955|1872324|FG000|Overall Study|Adverse Event|0
899445|NCT00721955|1872325|FG001|Overall Study|Adverse Event|0
899446|NCT00721955|1872326|FG002|Overall Study|Adverse Event|2
899447|NCT00721968|1872336|FG000|Overall Study|Lost to Follow-up|2
899448|NCT00721968|1872337|FG001|Overall Study|Lost to Follow-up|0
899449|NCT00722137|1872387|FG000|Overall Study|Overt Disease Progression|5
899450|NCT00722137|1872388|FG001|Overall Study|Overt Disease Progression|4
899451|NCT00722137|1872387|FG000|Overall Study|Adverse Event|17
899452|NCT00722137|1872388|FG001|Overall Study|Adverse Event|21
899453|NCT00722137|1872387|FG000|Overall Study|Death|12
899454|NCT00722137|1872388|FG001|Overall Study|Death|7
899455|NCT00722137|1872387|FG000|Overall Study|Withdrawal by Subject|6
899456|NCT00722137|1872388|FG001|Overall Study|Withdrawal by Subject|9
899457|NCT00722137|1872387|FG000|Overall Study|Other Reason Unknown|3
899458|NCT00722137|1872388|FG001|Overall Study|Other Reason Unknown|4
899459|NCT00722137|1872387|FG000|Overall Study|Randomized But Not Treated|2
899460|NCT00722137|1872388|FG001|Overall Study|Randomized But Not Treated|3
899461|NCT00722371|1872401|FG000|Overall Study|Adverse Event|6
899462|NCT00722371|1872402|FG001|Overall Study|Adverse Event|13
899463|NCT00722371|1872403|FG002|Overall Study|Adverse Event|9
899464|NCT00722371|1872404|FG003|Overall Study|Adverse Event|10
899465|NCT00722371|1872405|FG004|Overall Study|Adverse Event|6
899466|NCT00722371|1872406|FG005|Overall Study|Adverse Event|8
899467|NCT00722371|1872407|FG006|Overall Study|Adverse Event|4
899468|NCT00722371|1872401|FG000|Overall Study|Contraindication|0
899469|NCT00722371|1872402|FG001|Overall Study|Contraindication|0
899470|NCT00722371|1872403|FG002|Overall Study|Contraindication|1
899471|NCT00722371|1872404|FG003|Overall Study|Contraindication|0
899472|NCT00722371|1872405|FG004|Overall Study|Contraindication|0
899473|NCT00722371|1872406|FG005|Overall Study|Contraindication|0
899474|NCT00722371|1872407|FG006|Overall Study|Contraindication|0
899475|NCT00722371|1872401|FG000|Overall Study|Creatinine / Creatinine clearance|2
899476|NCT00722371|1872402|FG001|Overall Study|Creatinine / Creatinine clearance|1
899477|NCT00722371|1872403|FG002|Overall Study|Creatinine / Creatinine clearance|2
899478|NCT00722371|1872404|FG003|Overall Study|Creatinine / Creatinine clearance|3
899479|NCT00722371|1872405|FG004|Overall Study|Creatinine / Creatinine clearance|2
899480|NCT00722371|1872406|FG005|Overall Study|Creatinine / Creatinine clearance|1
899481|NCT00722371|1872407|FG006|Overall Study|Creatinine / Creatinine clearance|1
1127108|NCT02673489|2219225|FG000|Treatment Period|Participant was incarcerated|0
1127109|NCT02673489|2219226|FG001|Treatment Period|Participant was incarcerated|1
1127110|NCT02673489|2219225|FG000|Treatment Period|Adverse Event|0
1127111|NCT02673489|2219226|FG001|Treatment Period|Adverse Event|1
1127112|NCT02673489|2219225|FG000|Follow Up Period|Unable to return for week 24 follow-up|0
1127113|NCT02673489|2219226|FG001|Follow Up Period|Unable to return for week 24 follow-up|1
1127114|NCT02673489|2219225|FG000|Follow Up Period|Unable to return for follow-up|0
1127115|NCT02673489|2219226|FG001|Follow Up Period|Unable to return for follow-up|1
1127116|NCT02673515|2219235|FG000|Overall Study|Lack of motivation|2
1127117|NCT02673515|2219236|FG001|Overall Study|Lack of motivation|1
1127118|NCT02673619|2219255|FG000|Overall Study|Lost to Follow-up|1
1127119|NCT02673619|2219256|FG001|Overall Study|Lost to Follow-up|0
1127120|NCT02673619|2219257|FG002|Overall Study|Lost to Follow-up|0
1127121|NCT02673619|2219258|FG003|Overall Study|Lost to Follow-up|0
1127122|NCT02673619|2219255|FG000|Overall Study|Withdrawal by Subject|1
1127123|NCT02673619|2219256|FG001|Overall Study|Withdrawal by Subject|1
1127124|NCT02673619|2219257|FG002|Overall Study|Withdrawal by Subject|1
1127125|NCT02673619|2219258|FG003|Overall Study|Withdrawal by Subject|0
1127126|NCT02673619|2219255|FG000|Overall Study|Adverse Event|0
1127127|NCT02673619|2219256|FG001|Overall Study|Adverse Event|0
1127128|NCT02673619|2219257|FG002|Overall Study|Adverse Event|1
1127129|NCT02673619|2219258|FG003|Overall Study|Adverse Event|0
1127130|NCT02673619|2219255|FG000|Overall Study|Lack of Efficacy|0
1127131|NCT02673619|2219256|FG001|Overall Study|Lack of Efficacy|0
1127132|NCT02673619|2219257|FG002|Overall Study|Lack of Efficacy|1
1127133|NCT02673619|2219258|FG003|Overall Study|Lack of Efficacy|0
1127134|NCT02674061|2219287|FG000|Overall Study|Death|204
1127135|NCT02674061|2219288|FG001|Overall Study|Death|69
1127136|NCT02674061|2219287|FG000|Overall Study|Lost to Follow-up|1
1127137|NCT02674061|2219288|FG001|Overall Study|Lost to Follow-up|0
1127138|NCT02674061|2219287|FG000|Overall Study|Withdrawal by Subject|9
1127139|NCT02674061|2219288|FG001|Overall Study|Withdrawal by Subject|2
1127140|NCT02674061|2219287|FG000|Overall Study|Ongoing in Study|71
899482|NCT00722371|1872401|FG000|Overall Study|Excluded medication|0
899483|NCT00722371|1872402|FG001|Overall Study|Excluded medication|1
899484|NCT00722371|1872403|FG002|Overall Study|Excluded medication|1
899485|NCT00722371|1872404|FG003|Overall Study|Excluded medication|0
899486|NCT00722371|1872405|FG004|Overall Study|Excluded medication|0
899487|NCT00722371|1872406|FG005|Overall Study|Excluded medication|0
899488|NCT00722371|1872407|FG006|Overall Study|Excluded medication|1
899489|NCT00722371|1872401|FG000|Overall Study|Hyperglycemia|2
899490|NCT00722371|1872402|FG001|Overall Study|Hyperglycemia|6
899491|NCT00722371|1872403|FG002|Overall Study|Hyperglycemia|4
899492|NCT00722371|1872404|FG003|Overall Study|Hyperglycemia|2
899493|NCT00722371|1872405|FG004|Overall Study|Hyperglycemia|5
899494|NCT00722371|1872406|FG005|Overall Study|Hyperglycemia|1
899495|NCT00722371|1872407|FG006|Overall Study|Hyperglycemia|1
899496|NCT00722371|1872401|FG000|Overall Study|Hypoglycemia|1
899497|NCT00722371|1872402|FG001|Overall Study|Hypoglycemia|0
899498|NCT00722371|1872403|FG002|Overall Study|Hypoglycemia|0
899499|NCT00722371|1872404|FG003|Overall Study|Hypoglycemia|0
899500|NCT00722371|1872405|FG004|Overall Study|Hypoglycemia|0
899501|NCT00722371|1872406|FG005|Overall Study|Hypoglycemia|0
899502|NCT00722371|1872407|FG006|Overall Study|Hypoglycemia|0
899503|NCT00722371|1872401|FG000|Overall Study|Lack of Efficacy|4
899504|NCT00722371|1872402|FG001|Overall Study|Lack of Efficacy|6
899505|NCT00722371|1872403|FG002|Overall Study|Lack of Efficacy|6
899506|NCT00722371|1872404|FG003|Overall Study|Lack of Efficacy|6
899507|NCT00722371|1872405|FG004|Overall Study|Lack of Efficacy|2
899508|NCT00722371|1872406|FG005|Overall Study|Lack of Efficacy|3
899509|NCT00722371|1872407|FG006|Overall Study|Lack of Efficacy|0
899510|NCT00722371|1872401|FG000|Overall Study|Lost to Follow-up|11
899511|NCT00722371|1872402|FG001|Overall Study|Lost to Follow-up|14
899512|NCT00722371|1872403|FG002|Overall Study|Lost to Follow-up|21
899513|NCT00722371|1872404|FG003|Overall Study|Lost to Follow-up|13
899514|NCT00722371|1872405|FG004|Overall Study|Lost to Follow-up|8
899515|NCT00722371|1872406|FG005|Overall Study|Lost to Follow-up|16
899516|NCT00722371|1872407|FG006|Overall Study|Lost to Follow-up|13
899517|NCT00722371|1872401|FG000|Overall Study|Physician Decision|5
899518|NCT00722371|1872402|FG001|Overall Study|Physician Decision|2
899519|NCT00722371|1872403|FG002|Overall Study|Physician Decision|2
899520|NCT00722371|1872404|FG003|Overall Study|Physician Decision|5
899521|NCT00722371|1872405|FG004|Overall Study|Physician Decision|2
899522|NCT00722371|1872406|FG005|Overall Study|Physician Decision|3
899523|NCT00722371|1872407|FG006|Overall Study|Physician Decision|4
899524|NCT00722371|1872401|FG000|Overall Study|Pregnancy|1
899525|NCT00722371|1872402|FG001|Overall Study|Pregnancy|1
899526|NCT00722371|1872403|FG002|Overall Study|Pregnancy|0
899527|NCT00722371|1872404|FG003|Overall Study|Pregnancy|0
899528|NCT00722371|1872405|FG004|Overall Study|Pregnancy|0
899529|NCT00722371|1872406|FG005|Overall Study|Pregnancy|1
899530|NCT00722371|1872407|FG006|Overall Study|Pregnancy|0
899531|NCT00722371|1872401|FG000|Overall Study|Protocol Violation|6
899532|NCT00722371|1872402|FG001|Overall Study|Protocol Violation|1
899533|NCT00722371|1872403|FG002|Overall Study|Protocol Violation|0
1127141|NCT02674061|2219288|FG001|Overall Study|Ongoing in Study|20
1127142|NCT02674334|2219296|FG000|Overall Study|Lost to Follow-up|5
1127143|NCT02674334|2219297|FG001|Overall Study|Lost to Follow-up|3
1127144|NCT02674334|2219296|FG000|Overall Study|participant difficulty breathing|1
1127145|NCT02674334|2219297|FG001|Overall Study|participant difficulty breathing|0
1127146|NCT02674334|2219296|FG000|Overall Study|NIRS not recording|1
1127147|NCT02674334|2219297|FG001|Overall Study|NIRS not recording|0
1127148|NCT02674386|2219306|FG000|Overall Study|Lost to Follow-up|0
1127149|NCT02674386|2219307|FG001|Overall Study|Lost to Follow-up|1
1127150|NCT02674386|2219308|FG002|Overall Study|Lost to Follow-up|1
1127151|NCT02674386|2219306|FG000|Overall Study|Withdrawal by Subject|0
1127152|NCT02674386|2219307|FG001|Overall Study|Withdrawal by Subject|4
1127153|NCT02674386|2219308|FG002|Overall Study|Withdrawal by Subject|0
1127154|NCT02674386|2219306|FG000|Overall Study|Other|0
1127155|NCT02674386|2219307|FG001|Overall Study|Other|1
1127156|NCT02674386|2219308|FG002|Overall Study|Other|0
1127157|NCT02674386|2219306|FG000|Overall Study|Enrolled but not evaluated|0
1127158|NCT02674386|2219307|FG001|Overall Study|Enrolled but not evaluated|4
1127159|NCT02674386|2219308|FG002|Overall Study|Enrolled but not evaluated|0
1127160|NCT02674399|2219323|FG000|Overall Study|Lost to Follow-up|2
1127161|NCT02674399|2219324|FG001|Overall Study|Lost to Follow-up|0
1127162|NCT02674477|2219340|FG000|Overall Study|Protocol Violation|8
1127163|NCT02674477|2219341|FG001|Overall Study|Protocol Violation|2
1127164|NCT02674568|2219347|FG000|Overall Study|Withdrawal by Subject|5
1127165|NCT02674568|2219347|FG000|Overall Study|Death|303
1127166|NCT02674568|2219347|FG000|Overall Study|Physician Decision|2
1127167|NCT02674568|2219347|FG000|Overall Study|Lost to Follow-up|9
1127168|NCT02674568|2219347|FG000|Overall Study|Other, Not Specified|20
1127169|NCT02674633|2219358|FG000|Overall Study|Lost to Follow-up|3
1127170|NCT02674633|2219359|FG001|Overall Study|Lost to Follow-up|2
1127171|NCT02674633|2219358|FG000|Overall Study|Physician Decision|1
1127172|NCT02674633|2219359|FG001|Overall Study|Physician Decision|0
1127173|NCT02674633|2219358|FG000|Overall Study|Withdrawal by Parent/Guardian|1
1127174|NCT02674633|2219359|FG001|Overall Study|Withdrawal by Parent/Guardian|2
1127175|NCT02674685|2219374|FG000|Overall Study|Protocol Violation|4
1127176|NCT02674854|2219381|FG000|Overall Study|Adverse Event|17
1127177|NCT02674854|2219382|FG001|Overall Study|Adverse Event|15
899534|NCT00722371|1872404|FG003|Overall Study|Protocol Violation|1
899535|NCT00722371|1872405|FG004|Overall Study|Protocol Violation|4
899536|NCT00722371|1872406|FG005|Overall Study|Protocol Violation|2
899537|NCT00722371|1872407|FG006|Overall Study|Protocol Violation|1
899538|NCT00722371|1872401|FG000|Overall Study|Withdrawal by Subject|18
899539|NCT00722371|1872402|FG001|Overall Study|Withdrawal by Subject|27
899540|NCT00722371|1872403|FG002|Overall Study|Withdrawal by Subject|19
899541|NCT00722371|1872404|FG003|Overall Study|Withdrawal by Subject|23
899542|NCT00722371|1872405|FG004|Overall Study|Withdrawal by Subject|19
899543|NCT00722371|1872406|FG005|Overall Study|Withdrawal by Subject|18
899544|NCT00722371|1872407|FG006|Overall Study|Withdrawal by Subject|26
899545|NCT00722423|1872425|FG000|Overall Study|Protocol Violation|0
899546|NCT00722423|1872426|FG001|Overall Study|Protocol Violation|1
899547|NCT00722761|1872475|FG000|Overall Study|Lost to Follow-up|1
899548|NCT00722761|1872476|FG001|Overall Study|Lost to Follow-up|4
899549|NCT00722761|1872475|FG000|Overall Study|Withdrawal by Subject|5
899550|NCT00722761|1872476|FG001|Overall Study|Withdrawal by Subject|2
899551|NCT00722800|1872484|FG000|Overall Study|Withdrawal by Subject|1
899552|NCT00722800|1872485|FG001|Overall Study|Withdrawal by Subject|0
899553|NCT00722800|1872484|FG000|Overall Study|Physician Decision|1
899554|NCT00722800|1872485|FG001|Overall Study|Physician Decision|0
899555|NCT00723008|1872497|FG000|Enrollment|Lost to Follow-up|1
899556|NCT00723008|1872498|FG001|Enrollment|Lost to Follow-up|0
899557|NCT00723008|1872497|FG000|4-Week Double Blinded|Lack of Efficacy|0
899558|NCT00723008|1872498|FG001|4-Week Double Blinded|Lack of Efficacy|1
899559|NCT00723008|1872497|FG000|4-Week Double Blinded|Withdrawal by Subject|1
899560|NCT00723008|1872498|FG001|4-Week Double Blinded|Withdrawal by Subject|1
899561|NCT00723008|1872497|FG000|4-Week Double Blinded|Lost to Follow-up|4
899562|NCT00723008|1872498|FG001|4-Week Double Blinded|Lost to Follow-up|3
899563|NCT00723008|1872497|FG000|4-Week Unblinded Treatment|Adverse Event|1
899564|NCT00723008|1872498|FG001|4-Week Unblinded Treatment|Adverse Event|0
899565|NCT00723008|1872497|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0
899566|NCT00723008|1872498|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1
899567|NCT00723021|1872512|FG000|Intervention Period 4|Adverse Event|0
899568|NCT00723021|1872513|FG001|Intervention Period 4|Adverse Event|0
899569|NCT00723021|1872514|FG002|Intervention Period 4|Adverse Event|0
899570|NCT00723021|1872515|FG003|Intervention Period 4|Adverse Event|0
899571|NCT00723021|1872516|FG004|Intervention Period 4|Adverse Event|1
899572|NCT00723125|1872551|FG000|Overall Study|Met Dx|1
899573|NCT00723125|1872552|FG001|Overall Study|Met Dx|0
899574|NCT00723125|1872551|FG000|Overall Study|Withdrawal by Subject|15
899575|NCT00723125|1872552|FG001|Overall Study|Withdrawal by Subject|6
899576|NCT00723125|1872551|FG000|Overall Study|Adverse Event|2
899577|NCT00723125|1872552|FG001|Overall Study|Adverse Event|0
899578|NCT00723190|1872577|FG000|Overall Study|Withdrawal by Subject|45
899579|NCT00723190|1872577|FG000|Overall Study|Lost to Follow-up|37
899580|NCT00723190|1872577|FG000|Overall Study|Adverse Event|18
899581|NCT00723190|1872577|FG000|Overall Study|Lack of Efficacy|16
1127178|NCT02674854|2219383|FG002|Overall Study|Adverse Event|5
1127179|NCT02674854|2219381|FG000|Overall Study|Withdrawal by Subject|1
1127180|NCT02674854|2219382|FG001|Overall Study|Withdrawal by Subject|5
1127181|NCT02674854|2219383|FG002|Overall Study|Withdrawal by Subject|4
1127182|NCT02674854|2219381|FG000|Overall Study|No-compliant subject|1
1127183|NCT02674854|2219382|FG001|Overall Study|No-compliant subject|0
1127184|NCT02674854|2219383|FG002|Overall Study|No-compliant subject|1
1127185|NCT02674854|2219381|FG000|Overall Study|Lost to Follow-up|1
1127186|NCT02674854|2219382|FG001|Overall Study|Lost to Follow-up|0
1127187|NCT02674854|2219383|FG002|Overall Study|Lost to Follow-up|2
1127188|NCT02674854|2219381|FG000|Overall Study|Lack of Efficacy|0
1127189|NCT02674854|2219382|FG001|Overall Study|Lack of Efficacy|3
1127190|NCT02674854|2219383|FG002|Overall Study|Lack of Efficacy|0
1127191|NCT02674854|2219381|FG000|Overall Study|Disallowed Concurrent Medication|2
1127192|NCT02674854|2219382|FG001|Overall Study|Disallowed Concurrent Medication|2
1127193|NCT02674854|2219383|FG002|Overall Study|Disallowed Concurrent Medication|0
1127194|NCT02674854|2219381|FG000|Overall Study|Protocol Violation|1
1127195|NCT02674854|2219382|FG001|Overall Study|Protocol Violation|1
1127196|NCT02674854|2219383|FG002|Overall Study|Protocol Violation|2
1127197|NCT02674854|2219381|FG000|Overall Study|Death|0
1127198|NCT02674854|2219382|FG001|Overall Study|Death|1
1127199|NCT02674854|2219383|FG002|Overall Study|Death|0
1127200|NCT02674854|2219381|FG000|Overall Study|Subject missed V6.2|1
1127201|NCT02674854|2219382|FG001|Overall Study|Subject missed V6.2|0
1127202|NCT02674854|2219383|FG002|Overall Study|Subject missed V6.2|0
1127203|NCT02675075|2219393|FG000|Overall Study|Lost to Follow-up|3
1127204|NCT02675075|2219394|FG001|Overall Study|Lost to Follow-up|0
1127205|NCT02675231|2219405|FG000|Overall Study|Withdrawal by Subject|1
1127206|NCT02675231|2219406|FG001|Overall Study|Withdrawal by Subject|3
1127207|NCT02675231|2219407|FG002|Overall Study|Withdrawal by Subject|1
1127208|NCT02675231|2219405|FG000|Overall Study|Lost to Follow-up|2
1127209|NCT02675231|2219406|FG001|Overall Study|Lost to Follow-up|2
1127210|NCT02675231|2219407|FG002|Overall Study|Lost to Follow-up|2
1127211|NCT02675231|2219405|FG000|Overall Study|On study treatment/follow up|23
1127212|NCT02675231|2219406|FG001|Overall Study|On study treatment/follow up|31
1127213|NCT02675231|2219407|FG002|Overall Study|On study treatment/follow up|23
1127214|NCT02675426|2219419|FG000|Overall Study|Adverse Event|6
1127215|NCT02675426|2219420|FG001|Overall Study|Adverse Event|2
1127216|NCT02675426|2219421|FG002|Overall Study|Adverse Event|9
1127217|NCT02675426|2219419|FG000|Overall Study|Withdrawal by Subject|3
1127218|NCT02675426|2219420|FG001|Overall Study|Withdrawal by Subject|5
1127219|NCT02675426|2219421|FG002|Overall Study|Withdrawal by Subject|5
1127220|NCT02675426|2219419|FG000|Overall Study|Lost to Follow-up|1
1127221|NCT02675426|2219420|FG001|Overall Study|Lost to Follow-up|0
1127222|NCT02675426|2219421|FG002|Overall Study|Lost to Follow-up|2
1127223|NCT02675426|2219419|FG000|Overall Study|Other|3
1127224|NCT02675426|2219420|FG001|Overall Study|Other|1
1127225|NCT02675426|2219421|FG002|Overall Study|Other|2
899582|NCT00723190|1872577|FG000|Overall Study|Protocol Violation|15
899583|NCT00723190|1872577|FG000|Overall Study|Other-Premature Discontinuation|9
899584|NCT00723190|1872577|FG000|Overall Study|Other-Not included in safety population|2
899585|NCT00723203|1872581|FG000|Overall Study|Withdrawal by Subject|3
899586|NCT00723229|1872587|FG000|First Intervention|Lost to Follow-up|7
899587|NCT00723229|1872588|FG001|First Intervention|Lost to Follow-up|3
899588|NCT00723255|1872594|FG000|Overall Study|Ineligible: Inadequate pathology|1
899589|NCT00723255|1872594|FG000|Overall Study|Ineligible: Second primary|1
899590|NCT00723255|1872594|FG000|Overall Study|Ineligible: Wrong Primary|2
899591|NCT00723294|1872610|FG000|Overall Study|Lobular histology|2
899592|NCT00723294|1872610|FG000|Overall Study|>25% intraductal component|1
899593|NCT00723294|1872610|FG000|Overall Study|No MRI tumor enhancement|1
899594|NCT00723294|1872610|FG000|Overall Study|1.0-Tesla MRI|1
899595|NCT00723294|1872610|FG000|Overall Study|No cryoabalation|2
899596|NCT00723294|1872610|FG000|Overall Study|Did not undergo surgery|1
899597|NCT00723294|1872610|FG000|Overall Study|Treated prior to registration|1
899598|NCT00723294|1872610|FG000|Overall Study|Treated by non-credentialed surgeon|1
899599|NCT00723294|1872610|FG000|Overall Study|Benign lesion|1
899600|NCT00723294|1872610|FG000|Overall Study|Withdrawal by Subject|1
899601|NCT00723294|1872610|FG000|Overall Study|No treatment due to probe failure|1
899602|NCT00723398|1872619|FG000|Overall Study|Withdrawal by Subject|2
899603|NCT00723398|1872620|FG001|Overall Study|Withdrawal by Subject|6
899604|NCT00723398|1872621|FG002|Overall Study|Withdrawal by Subject|4
899605|NCT00723398|1872622|FG003|Overall Study|Withdrawal by Subject|4
899606|NCT00723398|1872623|FG004|Overall Study|Withdrawal by Subject|4
899607|NCT00723398|1872619|FG000|Overall Study|Protocol Violation|2
899608|NCT00723398|1872620|FG001|Overall Study|Protocol Violation|1
899609|NCT00723398|1872621|FG002|Overall Study|Protocol Violation|5
899610|NCT00723398|1872622|FG003|Overall Study|Protocol Violation|0
899611|NCT00723398|1872623|FG004|Overall Study|Protocol Violation|0
899612|NCT00723398|1872619|FG000|Overall Study|Physician Decision|2
899613|NCT00723398|1872620|FG001|Overall Study|Physician Decision|2
899614|NCT00723398|1872621|FG002|Overall Study|Physician Decision|5
899615|NCT00723398|1872622|FG003|Overall Study|Physician Decision|0
899616|NCT00723398|1872623|FG004|Overall Study|Physician Decision|1
899617|NCT00723398|1872619|FG000|Overall Study|Adverse Event|0
1127226|NCT02675517|2219429|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8
1127227|NCT02675517|2219429|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151
1127228|NCT02675634|2219442|FG000|Test Period 1|Adverse Event|0
1127229|NCT02675634|2219443|FG001|Test Period 1|Adverse Event|1
1127230|NCT02675634|2219444|FG002|Test Period 1|Adverse Event|0
1127231|NCT02675634|2219445|FG003|Test Period 1|Adverse Event|1
1127232|NCT02675634|2219446|FG004|Test Period 1|Adverse Event|0
1127233|NCT02675634|2219447|FG005|Test Period 1|Adverse Event|0
1127234|NCT02675634|2219442|FG000|Test Period 1|Device deficiency that did not lead to A|0
1127235|NCT02675634|2219443|FG001|Test Period 1|Device deficiency that did not lead to A|0
1127236|NCT02675634|2219444|FG002|Test Period 1|Device deficiency that did not lead to A|1
1127237|NCT02675634|2219445|FG003|Test Period 1|Device deficiency that did not lead to A|0
1127238|NCT02675634|2219446|FG004|Test Period 1|Device deficiency that did not lead to A|0
1127239|NCT02675634|2219447|FG005|Test Period 1|Device deficiency that did not lead to A|0
1127240|NCT02675634|2219442|FG000|Test Period 2|Lack of Efficacy|1
1127241|NCT02675634|2219443|FG001|Test Period 2|Lack of Efficacy|0
1127242|NCT02675634|2219444|FG002|Test Period 2|Lack of Efficacy|0
1127243|NCT02675634|2219445|FG003|Test Period 2|Lack of Efficacy|0
1127244|NCT02675634|2219446|FG004|Test Period 2|Lack of Efficacy|0
1127245|NCT02675634|2219447|FG005|Test Period 2|Lack of Efficacy|0
1127246|NCT02675634|2219442|FG000|Test Period 2|Adverse Event|0
1127247|NCT02675634|2219443|FG001|Test Period 2|Adverse Event|0
1127248|NCT02675634|2219444|FG002|Test Period 2|Adverse Event|0
1127249|NCT02675634|2219445|FG003|Test Period 2|Adverse Event|0
1127250|NCT02675634|2219446|FG004|Test Period 2|Adverse Event|0
1127251|NCT02675634|2219447|FG005|Test Period 2|Adverse Event|1
1127253|NCT02675907|2219470|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
1127254|NCT02675907|2219471|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
1127255|NCT02675907|2219470|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
1127256|NCT02675907|2219471|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
1127257|NCT02675907|2219470|FG000|Study Overall|Lack of Efficacy|1
1127258|NCT02675907|2219471|FG001|Study Overall|Lack of Efficacy|0
1127259|NCT02675907|2219470|FG000|Study Overall|Withdrawal by Subject|2
899618|NCT00723398|1872620|FG001|Overall Study|Adverse Event|5
899619|NCT00723398|1872621|FG002|Overall Study|Adverse Event|3
899620|NCT00723398|1872622|FG003|Overall Study|Adverse Event|1
899621|NCT00723398|1872623|FG004|Overall Study|Adverse Event|4
899622|NCT00723398|1872619|FG000|Overall Study|Lost to Follow-up|0
899623|NCT00723398|1872620|FG001|Overall Study|Lost to Follow-up|1
899624|NCT00723398|1872621|FG002|Overall Study|Lost to Follow-up|0
899625|NCT00723398|1872622|FG003|Overall Study|Lost to Follow-up|0
899626|NCT00723398|1872623|FG004|Overall Study|Lost to Follow-up|0
899627|NCT00723450|1872637|FG000|Open-Label Phase|Adverse Event|26
899628|NCT00723450|1872638|FG001|Open-Label Phase|Adverse Event|0
899629|NCT00723450|1872639|FG002|Open-Label Phase|Adverse Event|0
899630|NCT00723450|1872637|FG000|Open-Label Phase|Lack of Efficacy|18
899631|NCT00723450|1872638|FG001|Open-Label Phase|Lack of Efficacy|0
899632|NCT00723450|1872639|FG002|Open-Label Phase|Lack of Efficacy|0
899633|NCT00723450|1872637|FG000|Open-Label Phase|Protocol Violation|35
899634|NCT00723450|1872638|FG001|Open-Label Phase|Protocol Violation|0
899635|NCT00723450|1872639|FG002|Open-Label Phase|Protocol Violation|0
899636|NCT00723450|1872637|FG000|Open-Label Phase|Lost to Follow-up|7
899637|NCT00723450|1872638|FG001|Open-Label Phase|Lost to Follow-up|0
899638|NCT00723450|1872639|FG002|Open-Label Phase|Lost to Follow-up|0
899639|NCT00723450|1872637|FG000|Open-Label Phase|Physician Decision|2
899640|NCT00723450|1872638|FG001|Open-Label Phase|Physician Decision|0
899641|NCT00723450|1872639|FG002|Open-Label Phase|Physician Decision|0
899642|NCT00723450|1872637|FG000|Open-Label Phase|Withdrawal by Subject|37
899643|NCT00723450|1872638|FG001|Open-Label Phase|Withdrawal by Subject|0
899644|NCT00723450|1872639|FG002|Open-Label Phase|Withdrawal by Subject|0
899645|NCT00723450|1872637|FG000|Randomized Phase|Adverse Event|0
899646|NCT00723450|1872638|FG001|Randomized Phase|Adverse Event|26
899647|NCT00723450|1872639|FG002|Randomized Phase|Adverse Event|17
899648|NCT00723450|1872637|FG000|Randomized Phase|Lack of Efficacy|0
899649|NCT00723450|1872638|FG001|Randomized Phase|Lack of Efficacy|11
899650|NCT00723450|1872639|FG002|Randomized Phase|Lack of Efficacy|11
899651|NCT00723450|1872637|FG000|Randomized Phase|Protocol Violation|0
899652|NCT00723450|1872638|FG001|Randomized Phase|Protocol Violation|9
899653|NCT00723450|1872639|FG002|Randomized Phase|Protocol Violation|13
899654|NCT00723450|1872637|FG000|Randomized Phase|Lost to Follow-up|0
899655|NCT00723450|1872638|FG001|Randomized Phase|Lost to Follow-up|2
899656|NCT00723450|1872639|FG002|Randomized Phase|Lost to Follow-up|3
899657|NCT00723450|1872637|FG000|Randomized Phase|Physician Decision|0
899658|NCT00723450|1872638|FG001|Randomized Phase|Physician Decision|3
899659|NCT00723450|1872639|FG002|Randomized Phase|Physician Decision|1
899660|NCT00723450|1872637|FG000|Randomized Phase|Withdrawal by Subject|0
899661|NCT00723450|1872638|FG001|Randomized Phase|Withdrawal by Subject|14
899662|NCT00723450|1872639|FG002|Randomized Phase|Withdrawal by Subject|22
899663|NCT00723489|1872652|FG000|Overall Study|Physician Decision|0
899664|NCT00723489|1872653|FG001|Overall Study|Physician Decision|1
899665|NCT00723489|1872654|FG002|Overall Study|Physician Decision|0
899666|NCT00723489|1872655|FG003|Overall Study|Physician Decision|0
899667|NCT00723489|1872652|FG000|Overall Study|Pregnancy|0
899668|NCT00723489|1872653|FG001|Overall Study|Pregnancy|0
899669|NCT00723489|1872654|FG002|Overall Study|Pregnancy|0
899670|NCT00723489|1872655|FG003|Overall Study|Pregnancy|1
899671|NCT00723489|1872652|FG000|Overall Study|Withdrawal by Subject|0
899672|NCT00723489|1872653|FG001|Overall Study|Withdrawal by Subject|0
899673|NCT00723489|1872654|FG002|Overall Study|Withdrawal by Subject|0
899674|NCT00723489|1872655|FG003|Overall Study|Withdrawal by Subject|1
899675|NCT00723489|1872652|FG000|Overall Study|Seropositive at baseline|1
899676|NCT00723489|1872653|FG001|Overall Study|Seropositive at baseline|0
899677|NCT00723489|1872654|FG002|Overall Study|Seropositive at baseline|0
899678|NCT00723489|1872655|FG003|Overall Study|Seropositive at baseline|0
899679|NCT00723489|1872652|FG000|Overall Study|Prohibited Medication|0
899680|NCT00723489|1872653|FG001|Overall Study|Prohibited Medication|0
899681|NCT00723489|1872654|FG002|Overall Study|Prohibited Medication|0
899682|NCT00723489|1872655|FG003|Overall Study|Prohibited Medication|1
899683|NCT00723489|1872652|FG000|Overall Study|Samples Collected Out of Window|0
899684|NCT00723489|1872653|FG001|Overall Study|Samples Collected Out of Window|3
899685|NCT00723489|1872654|FG002|Overall Study|Samples Collected Out of Window|0
899686|NCT00723489|1872655|FG003|Overall Study|Samples Collected Out of Window|0
899687|NCT00723528|1872668|FG000|Period 1: Controlled Period (CP)|Adverse Event|0
899688|NCT00723528|1872669|FG001|Period 1: Controlled Period (CP)|Adverse Event|0
899689|NCT00723528|1872670|FG002|Period 1: Controlled Period (CP)|Adverse Event|1
899690|NCT00723528|1872671|FG003|Period 1: Controlled Period (CP)|Adverse Event|0
899691|NCT00723528|1872672|FG004|Period 1: Controlled Period (CP)|Adverse Event|0
899692|NCT00723528|1872673|FG005|Period 1: Controlled Period (CP)|Adverse Event|0
899693|NCT00723528|1872674|FG006|Period 1: Controlled Period (CP)|Adverse Event|0
899694|NCT00723528|1872668|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
899695|NCT00723528|1872669|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
899696|NCT00723528|1872670|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
899697|NCT00723528|1872671|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
899698|NCT00723528|1872672|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
899699|NCT00723528|1872673|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
899700|NCT00723528|1872674|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
899701|NCT00723528|1872668|FG000|Period 1: Controlled Period (CP)|Physician Decision|0
899702|NCT00723528|1872669|FG001|Period 1: Controlled Period (CP)|Physician Decision|0
899703|NCT00723528|1872670|FG002|Period 1: Controlled Period (CP)|Physician Decision|1
899704|NCT00723528|1872671|FG003|Period 1: Controlled Period (CP)|Physician Decision|0
899705|NCT00723528|1872672|FG004|Period 1: Controlled Period (CP)|Physician Decision|0
899706|NCT00723528|1872673|FG005|Period 1: Controlled Period (CP)|Physician Decision|0
899707|NCT00723528|1872674|FG006|Period 1: Controlled Period (CP)|Physician Decision|0
899708|NCT00723528|1872668|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
899709|NCT00723528|1872669|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
899710|NCT00723528|1872670|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
899711|NCT00723528|1872671|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
899712|NCT00723528|1872672|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
899713|NCT00723528|1872673|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
899714|NCT00723528|1872674|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
899715|NCT00723528|1872668|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
899716|NCT00723528|1872669|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
899717|NCT00723528|1872670|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
899718|NCT00723528|1872671|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
899719|NCT00723528|1872672|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
899720|NCT00723528|1872673|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
899721|NCT00723528|1872674|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
899722|NCT00723528|1872668|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0
899723|NCT00723528|1872669|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0
899724|NCT00723528|1872670|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0
899725|NCT00723528|1872671|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1
899726|NCT00723528|1872672|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0
899727|NCT00723528|1872673|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1
899728|NCT00723528|1872674|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1
899729|NCT00723528|1872668|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0
899730|NCT00723528|1872669|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0
899731|NCT00723528|1872670|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0
899732|NCT00723528|1872671|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0
899733|NCT00723528|1872672|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0
899734|NCT00723528|1872673|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1
899735|NCT00723528|1872674|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0
899736|NCT00723528|1872668|FG000|Period 2: After Controlled Period|Other|0
899737|NCT00723528|1872669|FG001|Period 2: After Controlled Period|Other|0
899738|NCT00723528|1872670|FG002|Period 2: After Controlled Period|Other|0
1127260|NCT02675907|2219471|FG001|Study Overall|Withdrawal by Subject|2
1127261|NCT02675907|2219470|FG000|Study Overall|Lost to Follow-up|0
1127262|NCT02675907|2219471|FG001|Study Overall|Lost to Follow-up|2
1127263|NCT02675998|2219481|FG000|8-Week Treatment Period|Adverse Event|6
1127264|NCT02675998|2219482|FG001|8-Week Treatment Period|Adverse Event|5
1127265|NCT02675998|2219483|FG002|8-Week Treatment Period|Adverse Event|6
1127266|NCT02675998|2219484|FG003|8-Week Treatment Period|Adverse Event|0
1127267|NCT02675998|2219481|FG000|8-Week Treatment Period|Withdrawal by Subject|3
1127268|NCT02675998|2219482|FG001|8-Week Treatment Period|Withdrawal by Subject|3
1127269|NCT02675998|2219483|FG002|8-Week Treatment Period|Withdrawal by Subject|3
1127270|NCT02675998|2219484|FG003|8-Week Treatment Period|Withdrawal by Subject|0
1127271|NCT02675998|2219481|FG000|8-Week Treatment Period|Lack of Efficacy|2
1127272|NCT02675998|2219482|FG001|8-Week Treatment Period|Lack of Efficacy|5
1127273|NCT02675998|2219483|FG002|8-Week Treatment Period|Lack of Efficacy|3
1127274|NCT02675998|2219484|FG003|8-Week Treatment Period|Lack of Efficacy|0
1127275|NCT02675998|2219481|FG000|8-Week Treatment Period|Physician Decision|1
1127276|NCT02675998|2219482|FG001|8-Week Treatment Period|Physician Decision|0
1127277|NCT02675998|2219483|FG002|8-Week Treatment Period|Physician Decision|2
1127278|NCT02675998|2219484|FG003|8-Week Treatment Period|Physician Decision|0
1127279|NCT02675998|2219481|FG000|8-Week Treatment Period|GI side Effects|1
1127280|NCT02675998|2219482|FG001|8-Week Treatment Period|GI side Effects|4
1127281|NCT02675998|2219483|FG002|8-Week Treatment Period|GI side Effects|2
1127282|NCT02675998|2219484|FG003|8-Week Treatment Period|GI side Effects|0
1127283|NCT02675998|2219481|FG000|8-Week Treatment Period|Protocol Violation|1
1127284|NCT02675998|2219482|FG001|8-Week Treatment Period|Protocol Violation|1
1127285|NCT02675998|2219483|FG002|8-Week Treatment Period|Protocol Violation|1
1127286|NCT02675998|2219484|FG003|8-Week Treatment Period|Protocol Violation|0
1127287|NCT02675998|2219481|FG000|8-Week Treatment Period|Other|3
1127288|NCT02675998|2219482|FG001|8-Week Treatment Period|Other|1
1127289|NCT02675998|2219483|FG002|8-Week Treatment Period|Other|2
1127290|NCT02675998|2219484|FG003|8-Week Treatment Period|Other|0
1127291|NCT02675998|2219481|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0
1127292|NCT02675998|2219482|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
1127293|NCT02675998|2219483|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
1127294|NCT02675998|2219484|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3
1127295|NCT02675998|2219481|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0
1127296|NCT02675998|2219482|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0
1127297|NCT02675998|2219483|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1
1127298|NCT02675998|2219484|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3
1127299|NCT02675998|2219481|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0
1127300|NCT02675998|2219482|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0
899739|NCT00723528|1872671|FG003|Period 2: After Controlled Period|Other|0
899740|NCT00723528|1872672|FG004|Period 2: After Controlled Period|Other|1
899741|NCT00723528|1872673|FG005|Period 2: After Controlled Period|Other|4
899742|NCT00723528|1872674|FG006|Period 2: After Controlled Period|Other|0
899743|NCT00723528|1872668|FG000|Period 2: After Controlled Period|Adverse Event|0
899744|NCT00723528|1872669|FG001|Period 2: After Controlled Period|Adverse Event|0
899745|NCT00723528|1872670|FG002|Period 2: After Controlled Period|Adverse Event|0
899746|NCT00723528|1872671|FG003|Period 2: After Controlled Period|Adverse Event|0
899747|NCT00723528|1872672|FG004|Period 2: After Controlled Period|Adverse Event|1
899748|NCT00723528|1872673|FG005|Period 2: After Controlled Period|Adverse Event|0
899749|NCT00723528|1872674|FG006|Period 2: After Controlled Period|Adverse Event|1
899750|NCT00723528|1872668|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
899751|NCT00723528|1872669|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
899752|NCT00723528|1872670|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
899753|NCT00723528|1872671|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
899754|NCT00723528|1872672|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
899755|NCT00723528|1872673|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
899756|NCT00723528|1872674|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
899757|NCT00723528|1872668|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
899758|NCT00723528|1872669|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
899759|NCT00723528|1872670|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
899760|NCT00723528|1872671|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
899761|NCT00723528|1872672|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
899762|NCT00723528|1872673|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
899763|NCT00723528|1872674|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
899764|NCT00723554|1872690|FG000|Overall Study|Adverse Event|12
899765|NCT00723554|1872690|FG000|Overall Study|Investigator's judgement|5
899766|NCT00723554|1872690|FG000|Overall Study|Inhaled medication other than iloprost|4
899767|NCT00723554|1872690|FG000|Overall Study|Withdrawal of consent|3
899768|NCT00723554|1872690|FG000|Overall Study|Other|3
899769|NCT00723554|1872690|FG000|Overall Study|Lost to Follow-up|1
899770|NCT00723554|1872690|FG000|Overall Study|Non-compliance|1
899771|NCT00723606|1872702|FG000|Overall Study|Adverse Event|2
1127301|NCT02675998|2219483|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0
1127302|NCT02675998|2219484|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1
1127303|NCT02675998|2219481|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1
1127304|NCT02675998|2219482|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0
1127305|NCT02675998|2219483|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0
1127306|NCT02675998|2219484|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0
1127307|NCT02675998|2219481|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
1127308|NCT02675998|2219482|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
1127309|NCT02675998|2219483|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
1127310|NCT02675998|2219484|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1
1127311|NCT02676466|2219515|FG000|Overall Study|Death|0
1127312|NCT02676466|2219516|FG001|Overall Study|Death|2
1127313|NCT02676466|2219517|FG002|Overall Study|Death|1
1127314|NCT02676466|2219518|FG003|Overall Study|Death|0
1127315|NCT02676466|2219519|FG004|Overall Study|Death|0
1127316|NCT02676466|2219520|FG005|Overall Study|Death|0
1127317|NCT02676466|2219521|FG006|Overall Study|Death|0
1127318|NCT02676466|2219522|FG007|Overall Study|Death|0
1127319|NCT02676466|2219515|FG000|Overall Study|Withdrawal by Subject|4
1127320|NCT02676466|2219516|FG001|Overall Study|Withdrawal by Subject|3
1127321|NCT02676466|2219517|FG002|Overall Study|Withdrawal by Subject|1
1127322|NCT02676466|2219518|FG003|Overall Study|Withdrawal by Subject|0
1127323|NCT02676466|2219519|FG004|Overall Study|Withdrawal by Subject|3
1127324|NCT02676466|2219520|FG005|Overall Study|Withdrawal by Subject|1
1127325|NCT02676466|2219521|FG006|Overall Study|Withdrawal by Subject|1
1127326|NCT02676466|2219522|FG007|Overall Study|Withdrawal by Subject|1
1127327|NCT02676882|2219565|FG000|Overall Study|Adverse Event|1
1127328|NCT02676882|2219566|FG001|Overall Study|Adverse Event|0
1127329|NCT02676882|2219565|FG000|Overall Study|Lost to Follow-up|1
1127330|NCT02676882|2219566|FG001|Overall Study|Lost to Follow-up|0
1127331|NCT02676882|2219565|FG000|Overall Study|Withdrawal by Subject|1
1127332|NCT02676882|2219566|FG001|Overall Study|Withdrawal by Subject|2
1127333|NCT02676895|2219575|FG000|Overall Study|Administrative reason|1
1127334|NCT02676895|2219576|FG001|Overall Study|Administrative reason|0
1127335|NCT02676895|2219577|FG002|Overall Study|Administrative reason|0
899772|NCT00723606|1872703|FG001|Overall Study|Adverse Event|5
899773|NCT00723606|1872702|FG000|Overall Study|Other|2
899774|NCT00723606|1872703|FG001|Overall Study|Other|0
899775|NCT00723606|1872702|FG000|Overall Study|Withdrawal by Subject|0
899776|NCT00723606|1872703|FG001|Overall Study|Withdrawal by Subject|2
899777|NCT00723697|1872717|FG000|Overall Study|Physician questionnaires not received|2
899778|NCT00723697|1872717|FG000|Overall Study|Missing Informed Consent Form|10
899779|NCT00723697|1872717|FG000|Overall Study|Other exclusion criteria applied|6
899780|NCT00723710|1872724|FG000|Overall Study|Disease progression|48
899781|NCT00723710|1872724|FG000|Overall Study|Adverse Event|88
899782|NCT00723710|1872724|FG000|Overall Study|Withdrawal by Subject|36
899783|NCT00723710|1872724|FG000|Overall Study|Physician Decision|2
899784|NCT00723801|1872744|FG000|Overall Study|Lost to Follow-up|1
899785|NCT00723801|1872745|FG001|Overall Study|Lost to Follow-up|2
899786|NCT00723801|1872744|FG000|Overall Study|Protocol Violation|2
899787|NCT00723801|1872745|FG001|Overall Study|Protocol Violation|1
899788|NCT00723840|1872755|FG000|Overall Study|Lost to Follow-up|2
899789|NCT00723840|1872755|FG000|Overall Study|Failure to return|18
899790|NCT00723840|1872755|FG000|Overall Study|Withdrawal by Subject|55
899791|NCT00723840|1872755|FG000|Overall Study|Serious Adverse Events|3
899792|NCT00723840|1872755|FG000|Overall Study|Other Medical Event|2
899793|NCT00723840|1872755|FG000|Overall Study|Unspecified reason|2
899794|NCT00723892|1872768|FG000|Overall Study|Participant not tracked|33
899795|NCT00723892|1872769|FG001|Overall Study|Participant not tracked|35
899796|NCT00723892|1872768|FG000|Overall Study|Virological criterion|24
899797|NCT00723892|1872769|FG001|Overall Study|Virological criterion|9
899798|NCT00723892|1872768|FG000|Overall Study|Withdrawal by Subject|6
899799|NCT00723892|1872769|FG001|Overall Study|Withdrawal by Subject|9
899800|NCT00723892|1872768|FG000|Overall Study|End planned|11
899801|NCT00723892|1872769|FG001|Overall Study|End planned|7
899802|NCT00723892|1872768|FG000|Overall Study|Bad tolerance|5
899803|NCT00723892|1872769|FG001|Overall Study|Bad tolerance|5
899804|NCT00723892|1872768|FG000|Overall Study|Multiple reasons|17
899805|NCT00723892|1872769|FG001|Overall Study|Multiple reasons|12
899806|NCT00723892|1872768|FG000|Overall Study|Other|6
899807|NCT00723892|1872769|FG001|Overall Study|Other|3
899808|NCT00723892|1872768|FG000|Overall Study|Study end|1
899809|NCT00723892|1872769|FG001|Overall Study|Study end|3
899810|NCT00723892|1872768|FG000|Overall Study|Weight loss|1
899811|NCT00723892|1872769|FG001|Overall Study|Weight loss|3
899812|NCT00723892|1872768|FG000|Overall Study|Alcohol abuse|0
899813|NCT00723892|1872769|FG001|Overall Study|Alcohol abuse|1
899814|NCT00723892|1872768|FG000|Overall Study|Intercurrent infection|2
899815|NCT00723892|1872769|FG001|Overall Study|Intercurrent infection|0
899816|NCT00723892|1872768|FG000|Overall Study|Drug addiction|1
899817|NCT00723892|1872769|FG001|Overall Study|Drug addiction|0
899818|NCT00723944|1872781|FG000|Permanent Prosthesis Placement|Adverse Event|1
899819|NCT00723944|1872782|FG001|Permanent Prosthesis Placement|Adverse Event|7
899820|NCT00723944|1872781|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2
1127336|NCT02676895|2219575|FG000|Overall Study|Protocol Violation|1
1127337|NCT02676895|2219576|FG001|Overall Study|Protocol Violation|0
1127338|NCT02676895|2219577|FG002|Overall Study|Protocol Violation|0
1127339|NCT02676895|2219575|FG000|Overall Study|Adverse Event|0
1127340|NCT02676895|2219576|FG001|Overall Study|Adverse Event|3
1127341|NCT02676895|2219577|FG002|Overall Study|Adverse Event|1
1127342|NCT02676895|2219575|FG000|Overall Study|Lost to Follow-up|0
1127343|NCT02676895|2219576|FG001|Overall Study|Lost to Follow-up|0
1127344|NCT02676895|2219577|FG002|Overall Study|Lost to Follow-up|1
1127345|NCT02676895|2219575|FG000|Overall Study|Withdrawal by Subject|0
1127346|NCT02676895|2219576|FG001|Overall Study|Withdrawal by Subject|0
1127347|NCT02676895|2219577|FG002|Overall Study|Withdrawal by Subject|1
1127348|NCT02677220|2219646|FG000|Overall Study|Adverse Event|1
1127349|NCT02677324|2219651|FG000|Overall Study|Disease Progression|6
1127350|NCT02677324|2219651|FG000|Overall Study|Inability to Swallow pills|1
1127351|NCT02677324|2219651|FG000|Overall Study|Non-compliance|1
1127352|NCT02677324|2219651|FG000|Overall Study|Lack of Efficacy|1
1127353|NCT02677324|2219651|FG000|Overall Study|Medical insurance coverage|1
1127354|NCT02677324|2219651|FG000|Overall Study|Adverse Event|1
1127355|NCT02677324|2219651|FG000|Overall Study|IgM Myeloma diagnosis|1
1127356|NCT02677714|2219710|FG000|Overall Study|Withdrawal by Subject|2
1127357|NCT02677714|2219711|FG001|Overall Study|Withdrawal by Subject|0
1127358|NCT02677844|2219755|FG000|Period 3|Withdrawal by Subject|0
1127359|NCT02677844|2219756|FG001|Period 3|Withdrawal by Subject|0
1127360|NCT02677844|2219757|FG002|Period 3|Withdrawal by Subject|0
1127361|NCT02677844|2219758|FG003|Period 3|Withdrawal by Subject|1
1127362|NCT02677844|2219759|FG004|Period 3|Withdrawal by Subject|0
899821|NCT00723944|1872782|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2
899822|NCT00723944|1872781|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1
899823|NCT00723944|1872782|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4
899824|NCT00723957|1872790|FG000|Overall Study|Adverse event unrelated to study drug|1
899825|NCT00723957|1872791|FG001|Overall Study|Adverse event unrelated to study drug|4
899826|NCT00723957|1872790|FG000|Overall Study|Death|3
899827|NCT00723957|1872791|FG001|Overall Study|Death|4
899828|NCT00723957|1872790|FG000|Overall Study|Disease progression|27
899829|NCT00723957|1872791|FG001|Overall Study|Disease progression|25
899830|NCT00723957|1872790|FG000|Overall Study|Maximum clinical benefit|4
899831|NCT00723957|1872791|FG001|Overall Study|Maximum clinical benefit|5
899832|NCT00723957|1872790|FG000|Overall Study|Investigator decision|1
899833|NCT00723957|1872791|FG001|Overall Study|Investigator decision|1
899834|NCT00723957|1872790|FG000|Overall Study|Study drug toxicity|4
899835|NCT00723957|1872791|FG001|Overall Study|Study drug toxicity|6
899836|NCT00723957|1872790|FG000|Overall Study|Withdrawal by Subject|7
899837|NCT00723957|1872791|FG001|Overall Study|Withdrawal by Subject|5
899838|NCT00723957|1872790|FG000|Overall Study|Reason not analyzed|1
899839|NCT00723957|1872791|FG001|Overall Study|Reason not analyzed|0
899840|NCT00723957|1872790|FG000|Overall Study|Never received treatment|3
899841|NCT00723957|1872791|FG001|Overall Study|Never received treatment|3
899842|NCT00724061|1872801|FG000|Dose Escalation Phase|Adverse Event|2
899843|NCT00724061|1872801|FG000|Dose Escalation Phase|Disease Progression|3
899844|NCT00724126|1872807|FG000|Overall Study|Adverse Event|2
899845|NCT00724126|1872808|FG001|Overall Study|Adverse Event|0
899846|NCT00724126|1872807|FG000|Overall Study|Withdrawal by Subject|8
899847|NCT00724126|1872808|FG001|Overall Study|Withdrawal by Subject|6
899848|NCT00724126|1872807|FG000|Overall Study|Lost to Follow-up|6
899849|NCT00724126|1872808|FG001|Overall Study|Lost to Follow-up|6
899850|NCT00724126|1872807|FG000|Overall Study|Noncompliance|2
899851|NCT00724126|1872808|FG001|Overall Study|Noncompliance|1
899852|NCT00724126|1872807|FG000|Overall Study|Subject randomized although ineligible|1
899853|NCT00724126|1872808|FG001|Overall Study|Subject randomized although ineligible|1
899854|NCT00724126|1872807|FG000|Overall Study|Subject had to leave vicinity of site|0
899855|NCT00724126|1872808|FG001|Overall Study|Subject had to leave vicinity of site|1
899856|NCT00724152|1872819|FG000|Two-arm Study Period|Withdrawal by Subject|3
899857|NCT00724152|1872820|FG001|Two-arm Study Period|Withdrawal by Subject|2
899858|NCT00724152|1872821|FG002|Two-arm Study Period|Withdrawal by Subject|0
899859|NCT00724152|1872819|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
899860|NCT00724152|1872820|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
899861|NCT00724152|1872821|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
899862|NCT00724243|1872831|FG000|Overall Study|Lack of Efficacy|10
899863|NCT00724243|1872831|FG000|Overall Study|Adverse Event|5
899864|NCT00724373|1872848|FG000|Overall Study|Adverse Event|41
899865|NCT00724373|1872848|FG000|Overall Study|Lack of Efficacy|82
899866|NCT00724373|1872848|FG000|Overall Study|Lost to Follow-up|7
899867|NCT00724373|1872848|FG000|Overall Study|Non-compliance|2
899868|NCT00724373|1872848|FG000|Overall Study|HCV RNA negative after 4 weeks|9
899869|NCT00724373|1872848|FG000|Overall Study|Participant moved away|1
899870|NCT00724373|1872848|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
899871|NCT00724373|1872848|FG000|Overall Study|Only to have 24 week regimen|1
899872|NCT00724373|1872848|FG000|Overall Study|Viral Relapse|1
899873|NCT00724373|1872848|FG000|Overall Study|Acute HCV infection|1
899874|NCT00724373|1872848|FG000|Overall Study|Drug Relapse|1
899875|NCT00724373|1872848|FG000|Overall Study|Tolerability|23
1127363|NCT02677844|2219760|FG005|Period 3|Withdrawal by Subject|0
1127364|NCT02677844|2219761|FG006|Period 3|Withdrawal by Subject|0
899876|NCT00724451|1872852|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7
899877|NCT00724451|1872852|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3
899878|NCT00724451|1872852|FG000|Overall Study|Not Eligible for Treatment|431
899879|NCT00724451|1872852|FG000|Overall Study|Participant Refused Treatment|89
899880|NCT00724451|1872852|FG000|Overall Study|Never Started Treatment|89
899881|NCT00724451|1872852|FG000|Overall Study|Unknown; No Data Sources Available|9
899882|NCT00724451|1872852|FG000|Overall Study|Physician Decision|116
899883|NCT00724451|1872852|FG000|Overall Study|Withdrawal by Subject|45
899884|NCT00724451|1872852|FG000|Overall Study|Investigator + Participant Decision|13
899885|NCT00724503|1872867|FG000|Overall Study|Lost to Follow-up|4
899886|NCT00724503|1872868|FG001|Overall Study|Lost to Follow-up|8
899887|NCT00724503|1872867|FG000|Overall Study|Withdrawal by Subject|11
899888|NCT00724503|1872868|FG001|Overall Study|Withdrawal by Subject|23
899889|NCT00724503|1872867|FG000|Overall Study|Death|190
899890|NCT00724503|1872868|FG001|Overall Study|Death|182
899891|NCT00724503|1872867|FG000|Overall Study|Adverse Event|1
899892|NCT00724503|1872868|FG001|Overall Study|Adverse Event|0
899893|NCT00724503|1872867|FG000|Overall Study|Not otherwise specified|4
899894|NCT00724503|1872868|FG001|Overall Study|Not otherwise specified|7
899895|NCT00724698|1872913|FG000|Overall Study|Adverse Event|9
899896|NCT00724698|1872913|FG000|Overall Study|Failure of Therapy|4
899897|NCT00724698|1872913|FG000|Overall Study|Poor Compliance|16
899898|NCT00724698|1872913|FG000|Overall Study|Lost to Follow-up|36
899899|NCT00724698|1872913|FG000|Overall Study|No Info|25
899900|NCT00724711|1872918|FG000|Overall Study|Adverse Event|7
899901|NCT00724711|1872919|FG001|Overall Study|Adverse Event|3
899902|NCT00724711|1872918|FG000|Overall Study|Pregnancy|0
899903|NCT00724711|1872919|FG001|Overall Study|Pregnancy|1
899904|NCT00724711|1872918|FG000|Overall Study|Lack of Efficacy|0
899905|NCT00724711|1872919|FG001|Overall Study|Lack of Efficacy|1
899906|NCT00724711|1872918|FG000|Overall Study|Physician Decision|0
899907|NCT00724711|1872919|FG001|Overall Study|Physician Decision|3
899908|NCT00724711|1872918|FG000|Overall Study|Withdrawal by Subject|5
899909|NCT00724711|1872919|FG001|Overall Study|Withdrawal by Subject|4
899910|NCT00724711|1872918|FG000|Overall Study|Lost to Follow-up|4
899911|NCT00724711|1872919|FG001|Overall Study|Lost to Follow-up|5
899912|NCT00724711|1872918|FG000|Overall Study|Protocol Violation|1
899913|NCT00724711|1872919|FG001|Overall Study|Protocol Violation|0
899914|NCT00724815|1872936|FG000|Overall Study|Randomized, not treated|31
899915|NCT00724815|1872937|FG001|Overall Study|Randomized, not treated|30
899916|NCT00724815|1872936|FG000|Overall Study|Adverse Event|5
899917|NCT00724815|1872937|FG001|Overall Study|Adverse Event|3
899918|NCT00724815|1872936|FG000|Overall Study|Lost to Follow-up|4
899919|NCT00724815|1872937|FG001|Overall Study|Lost to Follow-up|1
899920|NCT00724815|1872936|FG000|Overall Study|Other Various|3
899921|NCT00724815|1872937|FG001|Overall Study|Other Various|5
899922|NCT00724854|1872945|FG000|Overall Study|Lack of Efficacy|187
899923|NCT00724854|1872946|FG001|Overall Study|Lack of Efficacy|13
899924|NCT00724854|1872945|FG000|Overall Study|Lost to Follow-up|87
899925|NCT00724854|1872946|FG001|Overall Study|Lost to Follow-up|10
899926|NCT00724854|1872945|FG000|Overall Study|Adverse Event|62
899927|NCT00724854|1872946|FG001|Overall Study|Adverse Event|4
899928|NCT00724854|1872945|FG000|Overall Study|Other|42
899929|NCT00724854|1872946|FG001|Overall Study|Other|3
899930|NCT00724854|1872945|FG000|Overall Study|Death|11
899931|NCT00724854|1872946|FG001|Overall Study|Death|0
899932|NCT00724854|1872945|FG000|Overall Study|Change of treatment|7
899933|NCT00724854|1872946|FG001|Overall Study|Change of treatment|0
899934|NCT00724854|1872945|FG000|Overall Study|Withdrawal by Subject|5
899935|NCT00724854|1872946|FG001|Overall Study|Withdrawal by Subject|0
899936|NCT00724854|1872945|FG000|Overall Study|Adverse event + lack of efficacy|2
899937|NCT00724854|1872946|FG001|Overall Study|Adverse event + lack of efficacy|1
899938|NCT00724867|1872953|FG000|Overall Study|Adverse Event|25
899939|NCT00724867|1872953|FG000|Overall Study|Lack of Efficacy|14
899940|NCT00724867|1872953|FG000|Overall Study|Lost to Follow-up|12
899941|NCT00724867|1872953|FG000|Overall Study|Non-compliance with study drug|6
899942|NCT00724867|1872953|FG000|Overall Study|Physician Decision|17
899943|NCT00724867|1872953|FG000|Overall Study|Protocol Violation|1
899944|NCT00724867|1872953|FG000|Overall Study|Withdrawal by Subject|31
899945|NCT00724867|1872953|FG000|Overall Study|Sponsor decision to end study|14
899946|NCT00724867|1872953|FG000|Overall Study|Subject incarcerated|1
899947|NCT00724867|1872953|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4
899948|NCT00724867|1872953|FG000|Overall Study|Subject moved out of state|1
899949|NCT00724867|1872953|FG000|Overall Study|Elected to exit due to site closure|2
899950|NCT00724893|1872962|FG000|Overall Study|Adverse Event|76
899951|NCT00724893|1872963|FG001|Overall Study|Adverse Event|142
899952|NCT00724893|1872962|FG000|Overall Study|Withdrawal by Subject|0
899953|NCT00724893|1872963|FG001|Overall Study|Withdrawal by Subject|1
899954|NCT00724893|1872962|FG000|Overall Study|Lack of virologic response|94
1127381|NCT02678000|2219794|FG000|PART 2|Adverse Event|0
1127382|NCT02678000|2219795|FG001|PART 2|Adverse Event|0
1127383|NCT02678000|2219796|FG002|PART 2|Adverse Event|2
1127384|NCT02678000|2219797|FG003|PART 2|Adverse Event|1
1127385|NCT02678000|2219798|FG004|PART 2|Adverse Event|0
1127386|NCT02678000|2219794|FG000|PART 2|Withdrawal by Subject|0
1127387|NCT02678000|2219795|FG001|PART 2|Withdrawal by Subject|0
1127388|NCT02678000|2219796|FG002|PART 2|Withdrawal by Subject|1
1127389|NCT02678000|2219797|FG003|PART 2|Withdrawal by Subject|0
1127390|NCT02678000|2219798|FG004|PART 2|Withdrawal by Subject|0
1127391|NCT02678247|2219834|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0
1127392|NCT02678247|2219835|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2
1127393|NCT02678247|2219834|FG000|First Intervention (7 Weeks)|Adverse Event|1
1127394|NCT02678247|2219835|FG001|First Intervention (7 Weeks)|Adverse Event|2
1127395|NCT02678247|2219834|FG000|First Intervention (7 Weeks)|Physician Decision|1
1127396|NCT02678247|2219835|FG001|First Intervention (7 Weeks)|Physician Decision|0
1127397|NCT02678247|2219834|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1
1127398|NCT02678247|2219835|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1
1127399|NCT02678247|2219834|FG000|Second Intervention (7 Weeks)|Adverse Event|2
1127400|NCT02678247|2219835|FG001|Second Intervention (7 Weeks)|Adverse Event|1
1127401|NCT02678247|2219834|FG000|Second Intervention (7 Weeks)|Physician Decision|1
1127402|NCT02678247|2219835|FG001|Second Intervention (7 Weeks)|Physician Decision|0
1162084|NCT03382912|2284107|FG001|Overall Study|Physician Decision|1
899955|NCT00724893|1872963|FG001|Overall Study|Lack of virologic response|202
899956|NCT00724893|1872962|FG000|Overall Study|Reason not specified|193
899957|NCT00724893|1872963|FG001|Overall Study|Reason not specified|7
899958|NCT00724893|1872962|FG000|Overall Study|Patient choice|0
899959|NCT00724893|1872963|FG001|Overall Study|Patient choice|26
899960|NCT00724893|1872962|FG000|Overall Study|Geographic reasons|0
899961|NCT00724893|1872963|FG001|Overall Study|Geographic reasons|11
899962|NCT00724893|1872962|FG000|Overall Study|Incarceration|0
899963|NCT00724893|1872963|FG001|Overall Study|Incarceration|9
899964|NCT00724893|1872962|FG000|Overall Study|Substance abuse|0
899965|NCT00724893|1872963|FG001|Overall Study|Substance abuse|3
899966|NCT00724893|1872962|FG000|Overall Study|Financial reasons|0
899967|NCT00724893|1872963|FG001|Overall Study|Financial reasons|2
899968|NCT00724893|1872962|FG000|Overall Study|Assigned shorter treatment|0
899969|NCT00724893|1872963|FG001|Overall Study|Assigned shorter treatment|2
899970|NCT00724893|1872962|FG000|Overall Study|Lost to Follow-up|0
899971|NCT00724893|1872963|FG001|Overall Study|Lost to Follow-up|52
899972|NCT00724893|1872962|FG000|Overall Study|Unknown, missing data|1
899973|NCT00724893|1872963|FG001|Overall Study|Unknown, missing data|1
899974|NCT00724932|1872986|FG000|Overall Study|Lost to Follow-up|1
899975|NCT00724932|1872987|FG001|Overall Study|Lost to Follow-up|0
899976|NCT00724932|1872986|FG000|Overall Study|Not treated|4
899977|NCT00724932|1872987|FG001|Overall Study|Not treated|3
899978|NCT00724945|1872995|FG000|Period 1|non-compliance|1
899979|NCT00724945|1872996|FG001|Period 1|non-compliance|0
899980|NCT00724945|1872995|FG000|Period 1|Adverse Event|1
899981|NCT00724945|1872996|FG001|Period 1|Adverse Event|1
899982|NCT00724945|1872995|FG000|Period 1|Lost to Follow-up|1
899983|NCT00724945|1872996|FG001|Period 1|Lost to Follow-up|0
899984|NCT00724945|1872995|FG000|Period 2|lens comfort issue|3
899985|NCT00724945|1872996|FG001|Period 2|lens comfort issue|0
899986|NCT00724945|1872995|FG000|Period 2|lens physiology issue|1
899987|NCT00724945|1872996|FG001|Period 2|lens physiology issue|0
899988|NCT00724958|1873002|FG000|Overall Study|Adverse Event|28
899989|NCT00724958|1873002|FG000|Overall Study|Loss of Response|40
899990|NCT00724958|1873002|FG000|Overall Study|No Response|18
899991|NCT00724958|1873002|FG000|Overall Study|Remission|7
899992|NCT00724958|1873002|FG000|Overall Study|Other Reason|76
899993|NCT00724958|1873002|FG000|Overall Study|No documentation for end of therapy|13
899994|NCT00724971|1873006|FG000|Overall Study|Adverse Event|5
899995|NCT00724971|1873006|FG000|Overall Study|Withdrawal by Subject|1
899996|NCT00725010|1873035|FG000|Overall Study|Toxicity|9
899997|NCT00725010|1873035|FG000|Overall Study|Tumor Progression|7
899998|NCT00725010|1873035|FG000|Overall Study|Withdrawal by Subject|2
899999|NCT00725010|1873035|FG000|Overall Study|Death|1
900000|NCT00725010|1873035|FG000|Overall Study|Lost to Follow-up|1
900001|NCT00725010|1873035|FG000|Overall Study|Hepatopathy probably not Temodal-related|1
900002|NCT00725010|1873035|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1
900003|NCT00725010|1873035|FG000|Overall Study|No further documentation|1
900004|NCT00725010|1873035|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2
1127403|NCT02678286|2219848|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
1127404|NCT02678286|2219849|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
1127405|NCT02678286|2219848|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
1127406|NCT02678286|2219849|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
1127407|NCT02678286|2219848|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
1127408|NCT02678286|2219849|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
1127409|NCT02678286|2219848|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
1127410|NCT02678286|2219849|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
1127411|NCT02678286|2219848|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
1127412|NCT02678286|2219849|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
1127413|NCT02678390|2219857|FG000|AE (1 Day)|Withdrawal by Subject|0
1127414|NCT02678390|2219858|FG001|AE (1 Day)|Withdrawal by Subject|1
900005|NCT00725075|1873053|FG000|Overall Study|Use of Excluded Medication|0
900006|NCT00725075|1873054|FG001|Overall Study|Use of Excluded Medication|1
900007|NCT00725075|1873055|FG002|Overall Study|Use of Excluded Medication|0
900008|NCT00725075|1873053|FG000|Overall Study|Protocol Violation|0
900009|NCT00725075|1873054|FG001|Overall Study|Protocol Violation|0
900010|NCT00725075|1873055|FG002|Overall Study|Protocol Violation|1
900011|NCT00725075|1873053|FG000|Overall Study|Lost to Follow-up|1
900012|NCT00725075|1873054|FG001|Overall Study|Lost to Follow-up|0
900013|NCT00725075|1873055|FG002|Overall Study|Lost to Follow-up|0
900014|NCT00725075|1873053|FG000|Overall Study|Withdrawal by Subject|4
900015|NCT00725075|1873054|FG001|Overall Study|Withdrawal by Subject|5
900016|NCT00725075|1873055|FG002|Overall Study|Withdrawal by Subject|4
900017|NCT00725075|1873053|FG000|Overall Study|Adverse Event|2
900018|NCT00725075|1873054|FG001|Overall Study|Adverse Event|1
900019|NCT00725075|1873055|FG002|Overall Study|Adverse Event|1
900020|NCT00725075|1873053|FG000|Overall Study|Worsening of Disease|2
900021|NCT00725075|1873054|FG001|Overall Study|Worsening of Disease|1
900022|NCT00725075|1873055|FG002|Overall Study|Worsening of Disease|2
900023|NCT00725075|1873053|FG000|Overall Study|Inclusion/Exclusion Criteria|1
900024|NCT00725075|1873054|FG001|Overall Study|Inclusion/Exclusion Criteria|0
900025|NCT00725075|1873055|FG002|Overall Study|Inclusion/Exclusion Criteria|1
900026|NCT00725075|1873053|FG000|Overall Study|Other|1
900027|NCT00725075|1873054|FG001|Overall Study|Other|0
900028|NCT00725075|1873055|FG002|Overall Study|Other|0
900029|NCT00725101|1873063|FG000|Overall Study|Death|3
900030|NCT00725101|1873063|FG000|Overall Study|Lost to Follow-up|353
900031|NCT00725101|1873063|FG000|Overall Study|Protocol Violation|1
900032|NCT00725101|1873063|FG000|Overall Study|Withdrawal by Subject|127
900033|NCT00725101|1873063|FG000|Overall Study|not specified/no reason given|11
900034|NCT00725205|1873074|FG000|Overall Study|Adverse Event|22
900035|NCT00725205|1873074|FG000|Overall Study|Investigator Discontinued|1
900036|NCT00725205|1873074|FG000|Overall Study|Non-compliance With Protocol|14
900037|NCT00725205|1873074|FG000|Overall Study|Other|8
900038|NCT00725205|1873074|FG000|Overall Study|Protocol Defined Clinical Event|1
900039|NCT00725205|1873074|FG000|Overall Study|Treatment Failure|41
900040|NCT00725283|1873087|FG000|Overall Study|Missing Code|3
900041|NCT00725283|1873087|FG000|Overall Study|Death|5
900042|NCT00725283|1873087|FG000|Overall Study|Other|6
900043|NCT00725283|1873087|FG000|Overall Study|Withdrawal by Subject|10
900044|NCT00725296|1873091|FG000|Overall Study|Adverse Event|11
900045|NCT00725296|1873091|FG000|Overall Study|Lack of Efficacy|7
900046|NCT00725296|1873091|FG000|Overall Study|Withdrawal by Subject|3
900047|NCT00725296|1873091|FG000|Overall Study|Non-Compliance|2
900048|NCT00725296|1873091|FG000|Overall Study|Lost to Follow-up|1
900049|NCT00725296|1873091|FG000|Overall Study|Other|38
900050|NCT00725322|1873098|FG000|Washout (28 Days)|Withdrawal by Subject|2
900051|NCT00725322|1873099|FG001|Washout (28 Days)|Withdrawal by Subject|0
900052|NCT00725322|1873098|FG000|Washout (28 Days)|Protocol Violation|0
900053|NCT00725322|1873099|FG001|Washout (28 Days)|Protocol Violation|1
900054|NCT00725452|1873109|FG000|Overall Study|Adverse Event|3
900055|NCT00725452|1873109|FG000|Overall Study|Lack of Efficacy|2
900056|NCT00725452|1873109|FG000|Overall Study|Reason not specified|1
900057|NCT00725452|1873109|FG000|Overall Study|Physician Decision|1
900058|NCT00725452|1873109|FG000|Overall Study|Withdrawal by Subject|3
900059|NCT00725452|1873109|FG000|Overall Study|Lost to Follow-up|1
900060|NCT00725491|1873115|FG000|Overall Study|Adverse Event|3
900061|NCT00725491|1873116|FG001|Overall Study|Adverse Event|2
900062|NCT00725491|1873115|FG000|Overall Study|Pregnancy|0
900063|NCT00725491|1873116|FG001|Overall Study|Pregnancy|3
900064|NCT00725491|1873115|FG000|Overall Study|Risk for hyperstimulation|2
900065|NCT00725491|1873116|FG001|Overall Study|Risk for hyperstimulation|9
900066|NCT00725491|1873115|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1
900067|NCT00725491|1873116|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1
900068|NCT00725491|1873115|FG000|Overall Study|Fertilization failure|0
900069|NCT00725491|1873116|FG001|Overall Study|Fertilization failure|1
900070|NCT00725491|1873115|FG000|Overall Study|No/too few embryos/ bad quality embryos|3
900071|NCT00725491|1873116|FG001|Overall Study|No/too few embryos/ bad quality embryos|2
900072|NCT00725543|1873136|FG000|Overall Study|Adverse Event|10
900073|NCT00725543|1873136|FG000|Overall Study|Lack of Efficacy|3
900074|NCT00725543|1873136|FG000|Overall Study|Withdrawal by Subject|10
1127415|NCT02678416|2219866|FG000|Part 1|Withdrawal by Subject|1
1127416|NCT02678416|2219866|FG000|Part 2|Adverse Event|2
1127417|NCT02678416|2219866|FG000|Part 2|Withdrawal by Subject|1
1127418|NCT02678676|2219895|FG000|Overall Study|Death|619
1127419|NCT02678676|2219896|FG001|Overall Study|Death|649
1127420|NCT02678676|2219895|FG000|Overall Study|Withdrawal by Subject|13
1127421|NCT02678676|2219896|FG001|Overall Study|Withdrawal by Subject|5
1127422|NCT02678676|2219895|FG000|Overall Study|Lost to Follow-up|171
1127423|NCT02678676|2219896|FG001|Overall Study|Lost to Follow-up|151
1127424|NCT02678676|2219895|FG000|Overall Study|Unconfirmed for lost to follow-up|85
1127425|NCT02678676|2219896|FG001|Overall Study|Unconfirmed for lost to follow-up|67
1127426|NCT02678923|2219904|FG000|Overall Study|Protocol Deviation (Not Dosed)|1
1127427|NCT02678923|2219905|FG001|Overall Study|Protocol Deviation (Not Dosed)|3
1127428|NCT02678923|2219904|FG000|Overall Study|Withdrawal by Subject|3
1127429|NCT02678923|2219905|FG001|Overall Study|Withdrawal by Subject|2
1127430|NCT02678923|2219904|FG000|Overall Study|Lost to Follow-up|1
1127431|NCT02678923|2219905|FG001|Overall Study|Lost to Follow-up|0
1127432|NCT02678923|2219904|FG000|Overall Study|Did Not Return for Study Visits|1
1127433|NCT02678923|2219905|FG001|Overall Study|Did Not Return for Study Visits|0
1127434|NCT02679079|2219914|FG000|Overall Study|Adverse Event|2
1127435|NCT02679079|2219915|FG001|Overall Study|Adverse Event|0
1127436|NCT02679079|2219916|FG002|Overall Study|Adverse Event|2
1127437|NCT02679079|2219914|FG000|Overall Study|Protocol Violation|0
1127438|NCT02679079|2219915|FG001|Overall Study|Protocol Violation|1
1127439|NCT02679079|2219916|FG002|Overall Study|Protocol Violation|0
1127440|NCT02679079|2219914|FG000|Overall Study|Withdrawal by Subject|2
1127441|NCT02679079|2219915|FG001|Overall Study|Withdrawal by Subject|1
1127442|NCT02679079|2219916|FG002|Overall Study|Withdrawal by Subject|0
1127443|NCT02679222|2219924|FG000|Overall Study|No time for project|1
1127444|NCT02679235|2219936|FG000|Overall Study|Withdrawal by Subject|3
1127445|NCT02679235|2219936|FG000|Overall Study|Adverse Event|1
1127446|NCT02679274|2219942|FG000|Overall Study|Withdrawal by Subject|1
1127447|NCT02679274|2219943|FG001|Overall Study|Withdrawal by Subject|0
1127448|NCT02679287|2219951|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2
1127449|NCT02679287|2219952|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1
1127450|NCT02679287|2219951|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2
1127451|NCT02679287|2219952|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3
1127452|NCT02679287|2219951|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0
1127453|NCT02679287|2219952|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1
1127454|NCT02679287|2219951|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0
1127455|NCT02679287|2219952|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1
1127456|NCT02679287|2219951|FG000|Period 2|Work/Scheduling Conflict|1
1127457|NCT02679287|2219952|FG001|Period 2|Work/Scheduling Conflict|0
1127458|NCT02679287|2219951|FG000|Period 2|Disliked Mobile System|2
1127459|NCT02679287|2219952|FG001|Period 2|Disliked Mobile System|0
1127460|NCT02679287|2219951|FG000|Period 3|Work/Scheduling Conflict|0
1127461|NCT02679287|2219952|FG001|Period 3|Work/Scheduling Conflict|1
1127462|NCT02679573|2219970|FG000|Overall Study|Adverse Event|13
1127463|NCT02679573|2219971|FG001|Overall Study|Adverse Event|6
1127464|NCT02679573|2219970|FG000|Overall Study|Lack of Efficacy|12
1127465|NCT02679573|2219971|FG001|Overall Study|Lack of Efficacy|15
1127466|NCT02679573|2219970|FG000|Overall Study|Could not complete required study visits|6
1127467|NCT02679573|2219971|FG001|Overall Study|Could not complete required study visits|2
1127468|NCT02679573|2219970|FG000|Overall Study|Withdrawal by Subject|2
1127469|NCT02679573|2219971|FG001|Overall Study|Withdrawal by Subject|9
1127470|NCT02679573|2219970|FG000|Overall Study|Death|2
1127471|NCT02679573|2219971|FG001|Overall Study|Death|0
1127472|NCT02679573|2219970|FG000|Overall Study|Physician Decision|2
1127473|NCT02679573|2219971|FG001|Overall Study|Physician Decision|4
1127474|NCT02679573|2219970|FG000|Overall Study|Lost to Follow-up|0
1127475|NCT02679573|2219971|FG001|Overall Study|Lost to Follow-up|3
1127476|NCT02679729|2219992|FG000|Overall Study|Lost to Follow-up|0
1127477|NCT02679729|2219993|FG001|Overall Study|Lost to Follow-up|1
1127478|NCT02679729|2219994|FG002|Overall Study|Lost to Follow-up|0
1127479|NCT02679729|2219995|FG003|Overall Study|Lost to Follow-up|0
1127480|NCT02679729|2219996|FG004|Overall Study|Lost to Follow-up|1
1127481|NCT02679729|2219997|FG005|Overall Study|Lost to Follow-up|0
1127482|NCT02679729|2219998|FG006|Overall Study|Lost to Follow-up|0
1127483|NCT02679729|2219999|FG007|Overall Study|Lost to Follow-up|0
1127484|NCT02679729|2220000|FG008|Overall Study|Lost to Follow-up|0
1127485|NCT02679729|2219992|FG000|Overall Study|Participant decision|0
1127486|NCT02679729|2219993|FG001|Overall Study|Participant decision|1
1127487|NCT02679729|2219994|FG002|Overall Study|Participant decision|0
1127488|NCT02679729|2219995|FG003|Overall Study|Participant decision|0
1127489|NCT02679729|2219996|FG004|Overall Study|Participant decision|0
1127490|NCT02679729|2219997|FG005|Overall Study|Participant decision|0
1127491|NCT02679729|2219998|FG006|Overall Study|Participant decision|1
1127492|NCT02679729|2219999|FG007|Overall Study|Participant decision|0
1127493|NCT02679729|2220000|FG008|Overall Study|Participant decision|0
1127494|NCT02679755|2220034|FG000|Overall Study|Death|0
1127495|NCT02679755|2220035|FG001|Overall Study|Death|3
1127496|NCT02679755|2220034|FG000|Overall Study|Global deterioration of health status|1
1127497|NCT02679755|2220035|FG001|Overall Study|Global deterioration of health status|8
1127498|NCT02679755|2220034|FG000|Overall Study|Lost to Follow-up|1
1127499|NCT02679755|2220035|FG001|Overall Study|Lost to Follow-up|0
1127500|NCT02679755|2220034|FG000|Overall Study|Objective progression or relapse|24
1127501|NCT02679755|2220035|FG001|Overall Study|Objective progression or relapse|83
1127502|NCT02679755|2220034|FG000|Overall Study|Not defined|0
1127503|NCT02679755|2220035|FG001|Overall Study|Not defined|2
1127504|NCT02679755|2220034|FG000|Overall Study|Withdrawal by participant|6
1127505|NCT02679755|2220035|FG001|Overall Study|Withdrawal by participant|3
1127506|NCT02679755|2220034|FG000|Overall Study|Adverse Event|1
1127507|NCT02679755|2220035|FG001|Overall Study|Adverse Event|4
1127508|NCT02679755|2220034|FG000|Overall Study|Adverse events not related to study drug|1
1127509|NCT02679755|2220035|FG001|Overall Study|Adverse events not related to study drug|2
1127510|NCT02680002|2220069|FG000|Overall Study|Lost to Follow-up|5
1127511|NCT02680002|2220070|FG001|Overall Study|Lost to Follow-up|1
1127512|NCT02680002|2220071|FG002|Overall Study|Lost to Follow-up|4
1127513|NCT02680002|2220072|FG003|Overall Study|Lost to Follow-up|2
1127514|NCT02680002|2220073|FG004|Overall Study|Lost to Follow-up|0
1127515|NCT02680002|2220074|FG005|Overall Study|Lost to Follow-up|2
1127516|NCT02680002|2220069|FG000|Overall Study|Physician Decision|5
1127517|NCT02680002|2220070|FG001|Overall Study|Physician Decision|1
1127518|NCT02680002|2220071|FG002|Overall Study|Physician Decision|1
1127519|NCT02680002|2220072|FG003|Overall Study|Physician Decision|1
1127520|NCT02680002|2220073|FG004|Overall Study|Physician Decision|1
1127521|NCT02680002|2220074|FG005|Overall Study|Physician Decision|1
1127522|NCT02680002|2220069|FG000|Overall Study|Protocol Violation|1
1127523|NCT02680002|2220070|FG001|Overall Study|Protocol Violation|0
1127524|NCT02680002|2220071|FG002|Overall Study|Protocol Violation|1
1127525|NCT02680002|2220072|FG003|Overall Study|Protocol Violation|0
1127526|NCT02680002|2220073|FG004|Overall Study|Protocol Violation|1
1127527|NCT02680002|2220074|FG005|Overall Study|Protocol Violation|2
1127528|NCT02680002|2220069|FG000|Overall Study|Withdrawal by Subject|0
1127529|NCT02680002|2220070|FG001|Overall Study|Withdrawal by Subject|0
1127530|NCT02680002|2220071|FG002|Overall Study|Withdrawal by Subject|1
1127531|NCT02680002|2220072|FG003|Overall Study|Withdrawal by Subject|0
1127532|NCT02680002|2220073|FG004|Overall Study|Withdrawal by Subject|2
1127533|NCT02680002|2220074|FG005|Overall Study|Withdrawal by Subject|2
1127534|NCT02680002|2220069|FG000|Overall Study|Missed Visit 8 (Day 201)|2
1127535|NCT02680002|2220070|FG001|Overall Study|Missed Visit 8 (Day 201)|1
1127536|NCT02680002|2220071|FG002|Overall Study|Missed Visit 8 (Day 201)|3
1127537|NCT02680002|2220072|FG003|Overall Study|Missed Visit 8 (Day 201)|1
1127538|NCT02680002|2220073|FG004|Overall Study|Missed Visit 8 (Day 201)|5
1127539|NCT02680002|2220074|FG005|Overall Study|Missed Visit 8 (Day 201)|0
1127540|NCT02680002|2220069|FG000|Overall Study|Other|0
1127541|NCT02680002|2220070|FG001|Overall Study|Other|1
1127542|NCT02680002|2220071|FG002|Overall Study|Other|0
1127543|NCT02680002|2220072|FG003|Overall Study|Other|0
1127544|NCT02680002|2220073|FG004|Overall Study|Other|1
1127545|NCT02680002|2220074|FG005|Overall Study|Other|0
1127546|NCT02680002|2220069|FG000|Overall Study|Adverse Event|0
1127547|NCT02680002|2220070|FG001|Overall Study|Adverse Event|0
1127548|NCT02680002|2220071|FG002|Overall Study|Adverse Event|0
1127549|NCT02680002|2220072|FG003|Overall Study|Adverse Event|0
1127550|NCT02680002|2220073|FG004|Overall Study|Adverse Event|1
1127551|NCT02680002|2220074|FG005|Overall Study|Adverse Event|2
1127552|NCT02680041|2220091|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
1127553|NCT02680041|2220091|FG000|Overall Study|Lost to Follow-up|2
1127554|NCT02680639|2220148|FG000|Screening Period|Screen Failure|7
1127555|NCT02680639|2220149|FG001|Screening Period|Screen Failure|0
1127556|NCT02680639|2220150|FG002|Screening Period|Screen Failure|0
1127557|NCT02680665|2220160|FG000|Overall Study|No visit after the first prescription|5
1127558|NCT02680756|2220166|FG000|Overall Study|Adverse Event|10
1127559|NCT02680756|2220167|FG001|Overall Study|Adverse Event|2
1127560|NCT02680756|2220166|FG000|Overall Study|Lost to Follow-up|7
1127561|NCT02680756|2220167|FG001|Overall Study|Lost to Follow-up|6
1127562|NCT02680756|2220166|FG000|Overall Study|Withdrawal by Subject|5
1127563|NCT02680756|2220167|FG001|Overall Study|Withdrawal by Subject|5
1127564|NCT02680756|2220166|FG000|Overall Study|Physician Decision|4
1127565|NCT02680756|2220167|FG001|Overall Study|Physician Decision|1
1127566|NCT02680756|2220166|FG000|Overall Study|Hb ≤7.5 g/dL|0
1127567|NCT02680756|2220167|FG001|Overall Study|Hb ≤7.5 g/dL|2
1127568|NCT02680756|2220166|FG000|Overall Study|Blood transfusion for any reason|0
1127569|NCT02680756|2220167|FG001|Overall Study|Blood transfusion for any reason|1
1127570|NCT02680756|2220166|FG000|Overall Study|Death|1
1127571|NCT02680756|2220167|FG001|Overall Study|Death|0
1127572|NCT02680756|2220166|FG000|Overall Study|Protocol Violation|1
1127573|NCT02680756|2220167|FG001|Overall Study|Protocol Violation|0
1127574|NCT02680756|2220166|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1
1127575|NCT02680756|2220167|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0
1127576|NCT02680756|2220166|FG000|Overall Study|None of above or not recorded|3
1127577|NCT02680756|2220167|FG001|Overall Study|None of above or not recorded|2
1127578|NCT02680834|2220175|FG000|Overall Study|Physician Decision|5
1127579|NCT02680834|2220176|FG001|Overall Study|Physician Decision|2
1127580|NCT02680834|2220175|FG000|Overall Study|Withdrawal by Subject|6
1127581|NCT02680834|2220176|FG001|Overall Study|Withdrawal by Subject|0
1127582|NCT02680834|2220175|FG000|Overall Study|Lost to Follow-up|0
1127583|NCT02680834|2220176|FG001|Overall Study|Lost to Follow-up|1
1127584|NCT02680847|2220185|FG000|Overall Study|Other|2
1127585|NCT02680847|2220186|FG001|Overall Study|Other|0
1127586|NCT02680847|2220187|FG002|Overall Study|Other|0
1127587|NCT02680847|2220185|FG000|Overall Study|No longer met eligibility criteria|2
1127588|NCT02680847|2220186|FG001|Overall Study|No longer met eligibility criteria|2
1127589|NCT02680847|2220187|FG002|Overall Study|No longer met eligibility criteria|0
1127590|NCT02680847|2220185|FG000|Overall Study|Unwilling to participate in study|1
1127591|NCT02680847|2220186|FG001|Overall Study|Unwilling to participate in study|1
1127592|NCT02680847|2220187|FG002|Overall Study|Unwilling to participate in study|0
1127593|NCT02680847|2220185|FG000|Overall Study|Lack of Efficacy|0
1127594|NCT02680847|2220186|FG001|Overall Study|Lack of Efficacy|0
1127595|NCT02680847|2220187|FG002|Overall Study|Lack of Efficacy|2
1127596|NCT02680847|2220185|FG000|Overall Study|Adverse Event|0
1127597|NCT02680847|2220186|FG001|Overall Study|Adverse Event|0
1127598|NCT02680847|2220187|FG002|Overall Study|Adverse Event|1
1127599|NCT02681094|2220198|FG000|1 -Modified Enrolled Participants Set|Participant decision|7
1127600|NCT02681094|2220199|FG001|1 -Modified Enrolled Participants Set|Participant decision|10
1127601|NCT02681094|2220200|FG002|1 -Modified Enrolled Participants Set|Participant decision|9
1127602|NCT02681094|2220198|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10
1127603|NCT02681094|2220199|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4
1127604|NCT02681094|2220200|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1
1127605|NCT02681094|2220198|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
1127606|NCT02681094|2220199|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
1127607|NCT02681094|2220200|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
1127608|NCT02681094|2220198|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
1127609|NCT02681094|2220199|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
1127610|NCT02681094|2220200|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
1127611|NCT02681094|2220198|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
1127612|NCT02681094|2220199|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
1127613|NCT02681094|2220200|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
1127614|NCT02681094|2220198|FG000|1 -Modified Enrolled Participants Set|Other|6
1127615|NCT02681094|2220199|FG001|1 -Modified Enrolled Participants Set|Other|6
1127616|NCT02681094|2220200|FG002|1 -Modified Enrolled Participants Set|Other|7
1127617|NCT02681094|2220198|FG000|1 -Modified Enrolled Participants Set|No treatment given|0
1127618|NCT02681094|2220199|FG001|1 -Modified Enrolled Participants Set|No treatment given|1
1127619|NCT02681094|2220200|FG002|1 -Modified Enrolled Participants Set|No treatment given|1
1127620|NCT02681094|2220198|FG000|2 - Enrolled Participants Set|Participant decision|7
1127621|NCT02681094|2220199|FG001|2 - Enrolled Participants Set|Participant decision|10
1127622|NCT02681094|2220200|FG002|2 - Enrolled Participants Set|Participant decision|9
1127623|NCT02681094|2220198|FG000|2 - Enrolled Participants Set|Adverse Event|10
1127624|NCT02681094|2220199|FG001|2 - Enrolled Participants Set|Adverse Event|4
1127625|NCT02681094|2220200|FG002|2 - Enrolled Participants Set|Adverse Event|1
1127626|NCT02681094|2220198|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
1127627|NCT02681094|2220199|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
1127628|NCT02681094|2220200|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
1127629|NCT02681094|2220198|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1
1127630|NCT02681094|2220199|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5
1127631|NCT02681094|2220200|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14
1127632|NCT02681094|2220198|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
1127633|NCT02681094|2220199|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
1127634|NCT02681094|2220200|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
1127635|NCT02681094|2220198|FG000|2 - Enrolled Participants Set|Other|6
1127636|NCT02681094|2220199|FG001|2 - Enrolled Participants Set|Other|6
1127637|NCT02681094|2220200|FG002|2 - Enrolled Participants Set|Other|7
1127638|NCT02681094|2220198|FG000|2 - Enrolled Participants Set|No treatment given|0
1127639|NCT02681094|2220199|FG001|2 - Enrolled Participants Set|No treatment given|1
1127640|NCT02681094|2220200|FG002|2 - Enrolled Participants Set|No treatment given|1
1127641|NCT02681510|2220222|FG000|Overall Study|Withdrawal by Subject|1
1127642|NCT02681510|2220222|FG000|Overall Study|Lost to Follow-up|9
1127643|NCT02681523|2220226|FG000|Overall Study|Adverse Event|1
1127644|NCT02681523|2220226|FG000|Overall Study|Patient Non-compliance|1
1127645|NCT02682264|2220281|FG000|Overall Study|Withdrawal by Subject|56
1127646|NCT02682264|2220282|FG001|Overall Study|Withdrawal by Subject|45
1127647|NCT02682264|2220281|FG000|Overall Study|Lost to Follow-up|49
1127648|NCT02682264|2220282|FG001|Overall Study|Lost to Follow-up|41
1127649|NCT02682264|2220281|FG000|Overall Study|Lack of Efficacy|14
1127650|NCT02682264|2220282|FG001|Overall Study|Lack of Efficacy|16
1127651|NCT02682264|2220281|FG000|Overall Study|Withdrawal by Parent|6
1127652|NCT02682264|2220282|FG001|Overall Study|Withdrawal by Parent|7
1127653|NCT02682264|2220281|FG000|Overall Study|Adverse Event|9
1127654|NCT02682264|2220282|FG001|Overall Study|Adverse Event|0
1127655|NCT02682264|2220281|FG000|Overall Study|Noncompliance with study drug|1
1127656|NCT02682264|2220282|FG001|Overall Study|Noncompliance with study drug|4
1127657|NCT02682264|2220281|FG000|Overall Study|Pregnancy|1
1127658|NCT02682264|2220282|FG001|Overall Study|Pregnancy|2
1127659|NCT02682264|2220281|FG000|Overall Study|Recovery|1
1127660|NCT02682264|2220282|FG001|Overall Study|Recovery|2
1127661|NCT02682264|2220281|FG000|Overall Study|Progressive Disease|1
1127662|NCT02682264|2220282|FG001|Overall Study|Progressive Disease|0
1127663|NCT02682264|2220281|FG000|Overall Study|Technical Problems|0
1127664|NCT02682264|2220282|FG001|Overall Study|Technical Problems|1
1127665|NCT02682264|2220281|FG000|Overall Study|Moved abroad and unable to continue|0
1127666|NCT02682264|2220282|FG001|Overall Study|Moved abroad and unable to continue|3
1127667|NCT02682264|2220281|FG000|Overall Study|Stopped test article application|0
1127668|NCT02682264|2220282|FG001|Overall Study|Stopped test article application|1
1127669|NCT02682602|2220333|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1
1127670|NCT02682602|2220334|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0
1127671|NCT02682602|2220333|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
1127672|NCT02682602|2220334|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
1127673|NCT02682784|2220348|FG000|Overall Study|Withdrawal by Subject|0
1127674|NCT02682784|2220349|FG001|Overall Study|Withdrawal by Subject|2
1127675|NCT02682784|2220350|FG002|Overall Study|Withdrawal by Subject|1
1127676|NCT02682784|2220351|FG003|Overall Study|Withdrawal by Subject|2
1127677|NCT02682784|2220348|FG000|Overall Study|Physician Decision|1
1127678|NCT02682784|2220349|FG001|Overall Study|Physician Decision|0
1127679|NCT02682784|2220350|FG002|Overall Study|Physician Decision|1
1127680|NCT02682784|2220351|FG003|Overall Study|Physician Decision|1
1127681|NCT02682823|2220366|FG000|Overall Study|Withdrawal by Subject|0
1127682|NCT02682823|2220367|FG001|Overall Study|Withdrawal by Subject|0
1127683|NCT02682823|2220368|FG002|Overall Study|Withdrawal by Subject|1
1127684|NCT02682823|2220369|FG003|Overall Study|Withdrawal by Subject|0
1127685|NCT02682823|2220370|FG004|Overall Study|Withdrawal by Subject|1
1127686|NCT02682823|2220366|FG000|Overall Study|Protocol Deviation|0
1127687|NCT02682823|2220367|FG001|Overall Study|Protocol Deviation|1
1127688|NCT02682823|2220368|FG002|Overall Study|Protocol Deviation|0
1127689|NCT02682823|2220369|FG003|Overall Study|Protocol Deviation|0
1127690|NCT02682823|2220370|FG004|Overall Study|Protocol Deviation|0
1127691|NCT02682823|2220366|FG000|Overall Study|Adverse Event|0
1127692|NCT02682823|2220367|FG001|Overall Study|Adverse Event|0
1127693|NCT02682823|2220368|FG002|Overall Study|Adverse Event|0
1127694|NCT02682823|2220369|FG003|Overall Study|Adverse Event|1
1127695|NCT02682823|2220370|FG004|Overall Study|Adverse Event|0
1127696|NCT02683109|2220388|FG000|Overall Study|Adverse Event|1
1127697|NCT02683109|2220389|FG001|Overall Study|Adverse Event|0
1127698|NCT02683187|2220405|FG000|Overall Study|Failed IV access|3
1127699|NCT02683187|2220405|FG000|Overall Study|Withdrawal by Subject|5
1127700|NCT02683525|2220430|FG000|Overall Study|Lost to Follow-up|1
1127701|NCT02683525|2220430|FG000|Overall Study|Physician Decision|1
1127702|NCT02683525|2220430|FG000|Overall Study|Disease Progression|6
1127703|NCT02683668|2220449|FG000|Period 2|Withdrawal by Subject|0
1127704|NCT02683668|2220450|FG001|Period 2|Withdrawal by Subject|1
1127705|NCT02683668|2220451|FG002|Period 2|Withdrawal by Subject|0
1127706|NCT02683746|2220468|FG000|Overall Study|Adverse Event|3
1127707|NCT02683746|2220469|FG001|Overall Study|Adverse Event|2
1127708|NCT02683746|2220468|FG000|Overall Study|Lost to Follow-up|5
900075|NCT00725543|1873136|FG000|Overall Study|Physician Decision|5
900076|NCT00725543|1873136|FG000|Overall Study|Lost to Follow-up|4
900077|NCT00725543|1873136|FG000|Overall Study|Non-compliance|2
900078|NCT00725543|1873136|FG000|Overall Study|Other|119
900079|NCT00725608|1873140|FG000|Overall Study|Lost to Follow-up|60
900080|NCT00725608|1873140|FG000|Overall Study|Adverse Event|14
900081|NCT00725608|1873140|FG000|Overall Study|Individual reasons|86
900082|NCT00725608|1873140|FG000|Overall Study|Other|7
900083|NCT00725621|1873144|FG000|Overall Study|Adverse Event|25
900084|NCT00725621|1873144|FG000|Overall Study|Lack of Efficacy|46
1127709|NCT02683746|2220469|FG001|Overall Study|Lost to Follow-up|6
1127710|NCT02683746|2220468|FG000|Overall Study|Withdrawal by Subject|6
1127711|NCT02683746|2220469|FG001|Overall Study|Withdrawal by Subject|5
1127712|NCT02683746|2220468|FG000|Overall Study|Physician Decision|2
1127713|NCT02683746|2220469|FG001|Overall Study|Physician Decision|1
1127714|NCT02683785|2220488|FG000|Overall Study|Withdrawal by Subject|1
1127715|NCT02683785|2220489|FG001|Overall Study|Withdrawal by Subject|1
1127716|NCT02683785|2220488|FG000|Overall Study|Lost to Follow-up|0
1127717|NCT02683785|2220489|FG001|Overall Study|Lost to Follow-up|1
1127718|NCT02683785|2220488|FG000|Overall Study|Adverse Event|0
1127719|NCT02683785|2220489|FG001|Overall Study|Adverse Event|2
1127720|NCT02683876|2220499|FG000|Overall Study|samples damaged during shipping|2
1127721|NCT02683876|2220500|FG001|Overall Study|samples damaged during shipping|0
1127722|NCT02683941|2220519|FG000|Double-blind Phase|Adverse Event|0
1127723|NCT02683941|2220520|FG001|Double-blind Phase|Adverse Event|1
1127724|NCT02683941|2220519|FG000|Double-blind Phase|Withdrawal by Subject|4
1127725|NCT02683941|2220520|FG001|Double-blind Phase|Withdrawal by Subject|2
1127726|NCT02683941|2220519|FG000|Double-blind Phase|Lost to Follow-up|1
1127727|NCT02683941|2220520|FG001|Double-blind Phase|Lost to Follow-up|0
1127728|NCT02683941|2220519|FG000|Double-blind Phase|Disease Progression|5
1127729|NCT02683941|2220520|FG001|Double-blind Phase|Disease Progression|2
1127730|NCT02683941|2220519|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
1127731|NCT02683941|2220520|FG001|Open-label Treatment Phase|Withdrawal by Subject|2
1127732|NCT02683941|2220519|FG000|Open-label Treatment Phase|Disease Progression|1
1127733|NCT02683941|2220520|FG001|Open-label Treatment Phase|Disease Progression|2
1127734|NCT02683941|2220519|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18
1127735|NCT02683941|2220520|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9
1127736|NCT02683941|2220519|FG000|Open-label Treatment Phase|Other|1
1127737|NCT02683941|2220520|FG001|Open-label Treatment Phase|Other|0
1127738|NCT02683941|2220519|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3
1127739|NCT02683941|2220520|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3
1127740|NCT02683941|2220519|FG000|Open-label Follow-up Phase|Lost to Follow-up|1
1127741|NCT02683941|2220520|FG001|Open-label Follow-up Phase|Lost to Follow-up|0
1127742|NCT02683941|2220519|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6
1127743|NCT02683941|2220520|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4
1127744|NCT02683941|2220519|FG000|Open-label Follow-up Phase|Other|8
1127745|NCT02683941|2220520|FG001|Open-label Follow-up Phase|Other|1
1127746|NCT02684097|2220541|FG000|Overall Study|Lack of Efficacy|13
1127747|NCT02684097|2220542|FG001|Overall Study|Lack of Efficacy|6
1127748|NCT02684279|2220567|FG000|Overall Study|Adverse Event|87
1127749|NCT02684279|2220567|FG000|Overall Study|Lack of Efficacy|4
1127750|NCT02684279|2220567|FG000|Overall Study|Lost to Follow-up|61
1127751|NCT02684279|2220567|FG000|Overall Study|Protocol Violation|6
1127752|NCT02684279|2220567|FG000|Overall Study|Pregnancy|8
1127753|NCT02684279|2220567|FG000|Overall Study|Withdrawal by Subject|92
1127754|NCT02684279|2220567|FG000|Overall Study|non-compliance with study drug|9
1127755|NCT02684279|2220567|FG000|Overall Study|non compliance with study visits|2
1127756|NCT02684279|2220567|FG000|Overall Study|subject to have surgery|1
1127757|NCT02684279|2220567|FG000|Overall Study|family emergency|1
1127758|NCT02684279|2220567|FG000|Overall Study|Site closures|7
1127759|NCT02684279|2220567|FG000|Overall Study|Physician Decision|1
1127760|NCT02684344|2220573|FG000|Overall Study|Withdrawal by Subject|0
1127761|NCT02684344|2220574|FG001|Overall Study|Withdrawal by Subject|1
1127762|NCT02684357|2220583|FG000|Part A|Adverse Event (Worsening of Disease)|1
1127763|NCT02684357|2220584|FG001|Part A|Adverse Event (Worsening of Disease)|0
1127764|NCT02684357|2220585|FG002|Part A|Adverse Event (Worsening of Disease)|0
1127765|NCT02684357|2220586|FG003|Part A|Adverse Event (Worsening of Disease)|0
1127766|NCT02684357|2220587|FG004|Part A|Adverse Event (Worsening of Disease)|0
1127767|NCT02684357|2220588|FG005|Part A|Adverse Event (Worsening of Disease)|0
1127768|NCT02684357|2220583|FG000|Part A|Lost to Follow-up|0
1127769|NCT02684357|2220584|FG001|Part A|Lost to Follow-up|2
1127770|NCT02684357|2220585|FG002|Part A|Lost to Follow-up|2
1127771|NCT02684357|2220586|FG003|Part A|Lost to Follow-up|0
1127772|NCT02684357|2220587|FG004|Part A|Lost to Follow-up|0
1127773|NCT02684357|2220588|FG005|Part A|Lost to Follow-up|0
1127774|NCT02684357|2220583|FG000|Part A|Withdrawal by Subject|3
1127775|NCT02684357|2220584|FG001|Part A|Withdrawal by Subject|0
1127776|NCT02684357|2220585|FG002|Part A|Withdrawal by Subject|0
1127777|NCT02684357|2220586|FG003|Part A|Withdrawal by Subject|0
1127778|NCT02684357|2220587|FG004|Part A|Withdrawal by Subject|0
1127779|NCT02684357|2220588|FG005|Part A|Withdrawal by Subject|0
1127780|NCT02684357|2220583|FG000|Part A|Other|0
1127781|NCT02684357|2220584|FG001|Part A|Other|1
1127782|NCT02684357|2220585|FG002|Part A|Other|0
1127783|NCT02684357|2220586|FG003|Part A|Other|0
1127784|NCT02684357|2220587|FG004|Part A|Other|0
1127785|NCT02684357|2220588|FG005|Part A|Other|0
1127786|NCT02684357|2220583|FG000|Part B|Adverse Event (Other)|0
1127787|NCT02684357|2220584|FG001|Part B|Adverse Event (Other)|0
1127788|NCT02684357|2220585|FG002|Part B|Adverse Event (Other)|0
1127789|NCT02684357|2220586|FG003|Part B|Adverse Event (Other)|1
1127790|NCT02684357|2220587|FG004|Part B|Adverse Event (Other)|1
1127791|NCT02684357|2220588|FG005|Part B|Adverse Event (Other)|1
1127792|NCT02684357|2220583|FG000|Part B|Lost to Follow-up|0
1127793|NCT02684357|2220584|FG001|Part B|Lost to Follow-up|0
1127794|NCT02684357|2220585|FG002|Part B|Lost to Follow-up|0
1127795|NCT02684357|2220586|FG003|Part B|Lost to Follow-up|1
1127796|NCT02684357|2220587|FG004|Part B|Lost to Follow-up|1
1127797|NCT02684357|2220588|FG005|Part B|Lost to Follow-up|7
1127798|NCT02684357|2220583|FG000|Part B|Withdrawal by Subject|0
1127799|NCT02684357|2220584|FG001|Part B|Withdrawal by Subject|0
1127800|NCT02684357|2220585|FG002|Part B|Withdrawal by Subject|0
1127801|NCT02684357|2220586|FG003|Part B|Withdrawal by Subject|0
1127802|NCT02684357|2220587|FG004|Part B|Withdrawal by Subject|2
1127803|NCT02684357|2220588|FG005|Part B|Withdrawal by Subject|4
1127804|NCT02684357|2220583|FG000|Part B|Other|0
1127805|NCT02684357|2220584|FG001|Part B|Other|0
1127806|NCT02684357|2220585|FG002|Part B|Other|0
1127807|NCT02684357|2220586|FG003|Part B|Other|1
1127808|NCT02684357|2220587|FG004|Part B|Other|0
1127809|NCT02684357|2220588|FG005|Part B|Other|1
1127810|NCT02684370|2220604|FG000|Part A|Adverse Event|2
1127811|NCT02684370|2220605|FG001|Part A|Adverse Event|0
1127812|NCT02684370|2220606|FG002|Part A|Adverse Event|1
1127813|NCT02684370|2220607|FG003|Part A|Adverse Event|0
1127814|NCT02684370|2220608|FG004|Part A|Adverse Event|0
1127815|NCT02684370|2220609|FG005|Part A|Adverse Event|0
1127816|NCT02684370|2220604|FG000|Part A|Lost to Follow-up|1
1127817|NCT02684370|2220605|FG001|Part A|Lost to Follow-up|1
1127818|NCT02684370|2220606|FG002|Part A|Lost to Follow-up|0
1127819|NCT02684370|2220607|FG003|Part A|Lost to Follow-up|0
1127820|NCT02684370|2220608|FG004|Part A|Lost to Follow-up|0
1127821|NCT02684370|2220609|FG005|Part A|Lost to Follow-up|0
1127822|NCT02684370|2220604|FG000|Part A|Subject Withdrawal|1
1127823|NCT02684370|2220605|FG001|Part A|Subject Withdrawal|0
1127824|NCT02684370|2220606|FG002|Part A|Subject Withdrawal|3
1127825|NCT02684370|2220607|FG003|Part A|Subject Withdrawal|0
1127826|NCT02684370|2220608|FG004|Part A|Subject Withdrawal|0
1127827|NCT02684370|2220609|FG005|Part A|Subject Withdrawal|0
1127828|NCT02684370|2220604|FG000|Part A|Other|0
1127829|NCT02684370|2220605|FG001|Part A|Other|0
1127830|NCT02684370|2220606|FG002|Part A|Other|1
1127831|NCT02684370|2220607|FG003|Part A|Other|0
1127832|NCT02684370|2220608|FG004|Part A|Other|0
1127833|NCT02684370|2220609|FG005|Part A|Other|0
1127834|NCT02684370|2220604|FG000|Part B|Adverse Event|0
1127835|NCT02684370|2220605|FG001|Part B|Adverse Event|0
1127836|NCT02684370|2220606|FG002|Part B|Adverse Event|0
1127837|NCT02684370|2220607|FG003|Part B|Adverse Event|0
1127838|NCT02684370|2220608|FG004|Part B|Adverse Event|2
1127839|NCT02684370|2220609|FG005|Part B|Adverse Event|1
1127840|NCT02684370|2220604|FG000|Part B|Lost to Follow-up|0
1127841|NCT02684370|2220605|FG001|Part B|Lost to Follow-up|0
1127842|NCT02684370|2220606|FG002|Part B|Lost to Follow-up|0
1127843|NCT02684370|2220607|FG003|Part B|Lost to Follow-up|1
1127844|NCT02684370|2220608|FG004|Part B|Lost to Follow-up|2
1127845|NCT02684370|2220609|FG005|Part B|Lost to Follow-up|5
1127846|NCT02684370|2220604|FG000|Part B|Subject Withdrawal|0
1127847|NCT02684370|2220605|FG001|Part B|Subject Withdrawal|0
1127848|NCT02684370|2220606|FG002|Part B|Subject Withdrawal|0
1127849|NCT02684370|2220607|FG003|Part B|Subject Withdrawal|1
1127850|NCT02684370|2220608|FG004|Part B|Subject Withdrawal|1
1127851|NCT02684370|2220609|FG005|Part B|Subject Withdrawal|2
1127852|NCT02684617|2220673|FG000|Overall Study|Adverse Event|1
1127853|NCT02684617|2220674|FG001|Overall Study|Adverse Event|0
1127854|NCT02684617|2220675|FG002|Overall Study|Adverse Event|1
1127855|NCT02684617|2220673|FG000|Overall Study|Death|8
1127856|NCT02684617|2220674|FG001|Overall Study|Death|16
1127857|NCT02684617|2220675|FG002|Overall Study|Death|28
1127858|NCT02684617|2220673|FG000|Overall Study|Withdrawal by Subject|2
1127859|NCT02684617|2220674|FG001|Overall Study|Withdrawal by Subject|0
1127860|NCT02684617|2220675|FG002|Overall Study|Withdrawal by Subject|4
1127861|NCT02684617|2220673|FG000|Overall Study|Screen Failure|1
1127862|NCT02684617|2220674|FG001|Overall Study|Screen Failure|0
1127863|NCT02684617|2220675|FG002|Overall Study|Screen Failure|2
1127864|NCT02684617|2220673|FG000|Overall Study|Study Terminated by Sponsor|6
1127865|NCT02684617|2220674|FG001|Overall Study|Study Terminated by Sponsor|1
1127866|NCT02684617|2220675|FG002|Overall Study|Study Terminated by Sponsor|5
1127867|NCT02684981|2220724|FG000|Overall Study|Permanently discontinued the treatment|157
1127868|NCT02684981|2220725|FG001|Overall Study|Permanently discontinued the treatment|161
1127869|NCT02684981|2220726|FG002|Overall Study|Permanently discontinued the treatment|110
1127870|NCT02684981|2220724|FG000|Overall Study|Other|83
1127871|NCT02684981|2220725|FG001|Overall Study|Other|49
1127872|NCT02684981|2220726|FG002|Overall Study|Other|17
1127873|NCT02685033|2220746|FG000|Overall Study|Withdrawal of Consent|0
1127874|NCT02685033|2220747|FG001|Overall Study|Withdrawal of Consent|1
1127875|NCT02685033|2220746|FG000|Overall Study|Lost to Follow-up|2
1127876|NCT02685033|2220747|FG001|Overall Study|Lost to Follow-up|1
1127877|NCT02685033|2220746|FG000|Overall Study|Adverse Event|1
1127878|NCT02685033|2220747|FG001|Overall Study|Adverse Event|0
1127879|NCT02685072|2220755|FG000|Treatment Period|Lost to Follow-up|12
1127880|NCT02685072|2220756|FG001|Treatment Period|Lost to Follow-up|6
1127881|NCT02685072|2220755|FG000|Treatment Period|Withdrawal by Subject|1
1127882|NCT02685072|2220756|FG001|Treatment Period|Withdrawal by Subject|3
1127883|NCT02685072|2220755|FG000|1-Month Follow-Up|Withdrawal by Subject|1
1127884|NCT02685072|2220756|FG001|1-Month Follow-Up|Withdrawal by Subject|0
1127885|NCT02685488|2220785|FG000|Overall Study|Withdrawal by Subject|0
1127886|NCT02685488|2220786|FG001|Overall Study|Withdrawal by Subject|1
1127887|NCT02685826|2220804|FG000|Overall Study|Adverse Event|2
1127888|NCT02685826|2220805|FG001|Overall Study|Adverse Event|0
1127889|NCT02685826|2220806|FG002|Overall Study|Adverse Event|1
1127890|NCT02685826|2220804|FG000|Overall Study|Progressive Disease|2
1127891|NCT02685826|2220805|FG001|Overall Study|Progressive Disease|1
1127892|NCT02685826|2220806|FG002|Overall Study|Progressive Disease|0
1127893|NCT02685826|2220804|FG000|Overall Study|Withdrawal by Subject|2
1127894|NCT02685826|2220805|FG001|Overall Study|Withdrawal by Subject|0
1127895|NCT02685826|2220806|FG002|Overall Study|Withdrawal by Subject|0
1127896|NCT02685826|2220804|FG000|Overall Study|Full Clinical Hold by FDA|19
1127897|NCT02685826|2220805|FG001|Overall Study|Full Clinical Hold by FDA|9
1127898|NCT02685826|2220806|FG002|Overall Study|Full Clinical Hold by FDA|20
1127899|NCT02685995|2220827|FG000|Overall Study|Insertion of immediately puncturable graft.|1
1127900|NCT02685995|2220828|FG001|Overall Study|Insertion of immediately puncturable graft.|1
1127901|NCT02686034|2220836|FG000|Run-In Period 1|Eligibility|12
1127902|NCT02686034|2220837|FG001|Run-In Period 1|Eligibility|10
1127903|NCT02686034|2220836|FG000|Run-In Period 1|Withdrawal by Subject|4
1127904|NCT02686034|2220837|FG001|Run-In Period 1|Withdrawal by Subject|3
1127905|NCT02686034|2220836|FG000|Run-In Period 1|Lost to Follow-up|4
1127906|NCT02686034|2220837|FG001|Run-In Period 1|Lost to Follow-up|4
1127907|NCT02686034|2220836|FG000|Randomized Controlled Period 2|Lost to Follow-up|1
1127908|NCT02686034|2220837|FG001|Randomized Controlled Period 2|Lost to Follow-up|2
1127909|NCT02686034|2220836|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3
1127910|NCT02686034|2220837|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0
1127911|NCT02686034|2220836|FG000|Randomized Controlled Period 2|Adverse Event|0
1127912|NCT02686034|2220837|FG001|Randomized Controlled Period 2|Adverse Event|2
1127913|NCT02686034|2220836|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
1127914|NCT02686034|2220837|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
1127915|NCT02686034|2220836|FG000|Open Label Period 3|Lost to Follow-up|0
1127916|NCT02686034|2220837|FG001|Open Label Period 3|Lost to Follow-up|1
1127917|NCT02686164|2220852|FG000|Overall Study|Adverse Event|1
1127918|NCT02686164|2220852|FG000|Overall Study|Withdrawal of consent|1
1127919|NCT02686164|2220852|FG000|Overall Study|Clinical progression|1
1127920|NCT02687035|2220868|FG000|Overall Study|Withdrawal by Subject|1
1127921|NCT02687035|2220868|FG000|Overall Study|Death|87
1127922|NCT02687035|2220868|FG000|Overall Study|Lost to Follow-up|1
1127923|NCT02687035|2220868|FG000|Overall Study|Missed Visit|87
1127924|NCT02687035|2220868|FG000|Overall Study|Did not receive Study Device|8
1127925|NCT02687191|2220889|FG000|Overall Study|Death|0
1127926|NCT02687191|2220890|FG001|Overall Study|Death|1
1127927|NCT02687191|2220891|FG002|Overall Study|Death|1
1127928|NCT02687191|2220892|FG003|Overall Study|Death|0
1127929|NCT02687191|2220893|FG004|Overall Study|Death|1
1127930|NCT02687191|2220894|FG005|Overall Study|Death|1
1127931|NCT02687191|2220889|FG000|Overall Study|Withdrawal by Subject|0
1127932|NCT02687191|2220890|FG001|Overall Study|Withdrawal by Subject|0
1127933|NCT02687191|2220891|FG002|Overall Study|Withdrawal by Subject|0
1127934|NCT02687191|2220892|FG003|Overall Study|Withdrawal by Subject|1
1127935|NCT02687191|2220893|FG004|Overall Study|Withdrawal by Subject|0
1127936|NCT02687191|2220894|FG005|Overall Study|Withdrawal by Subject|0
1127937|NCT02687451|2220932|FG000|Overall Study|Withdrawal by Subject|1
1127938|NCT02687451|2220933|FG001|Overall Study|Withdrawal by Subject|0
1127939|NCT02687451|2220934|FG002|Overall Study|Withdrawal by Subject|0
1127940|NCT02687451|2220935|FG003|Overall Study|Withdrawal by Subject|0
1127941|NCT02687451|2220936|FG004|Overall Study|Withdrawal by Subject|0
1127942|NCT02687451|2220937|FG005|Overall Study|Withdrawal by Subject|1
1127943|NCT02687542|2220967|FG000|Overall Study|Medication error without associated AEs|0
1127944|NCT02687542|2220968|FG001|Overall Study|Medication error without associated AEs|0
1127945|NCT02687542|2220969|FG002|Overall Study|Medication error without associated AEs|0
1127946|NCT02687542|2220970|FG003|Overall Study|Medication error without associated AEs|0
1127947|NCT02687542|2220971|FG004|Overall Study|Medication error without associated AEs|1
1127948|NCT02687542|2220967|FG000|Overall Study|Lost to Follow-up|0
1127949|NCT02687542|2220968|FG001|Overall Study|Lost to Follow-up|0
1127950|NCT02687542|2220969|FG002|Overall Study|Lost to Follow-up|0
1127951|NCT02687542|2220970|FG003|Overall Study|Lost to Follow-up|0
1127952|NCT02687542|2220971|FG004|Overall Study|Lost to Follow-up|1
1127953|NCT02687542|2220967|FG000|Overall Study|Protocol Violation|0
1127954|NCT02687542|2220968|FG001|Overall Study|Protocol Violation|1
1127955|NCT02687542|2220969|FG002|Overall Study|Protocol Violation|0
1127956|NCT02687542|2220970|FG003|Overall Study|Protocol Violation|0
1127957|NCT02687542|2220971|FG004|Overall Study|Protocol Violation|0
1127958|NCT02687542|2220967|FG000|Overall Study|Other|5
1127959|NCT02687542|2220968|FG001|Overall Study|Other|9
1127960|NCT02687542|2220969|FG002|Overall Study|Other|10
1127961|NCT02687542|2220970|FG003|Overall Study|Other|6
1127962|NCT02687542|2220971|FG004|Overall Study|Other|5
1127963|NCT02687542|2220967|FG000|Overall Study|Adverse Event|3
1127964|NCT02687542|2220968|FG001|Overall Study|Adverse Event|1
1127965|NCT02687542|2220969|FG002|Overall Study|Adverse Event|3
1127966|NCT02687542|2220970|FG003|Overall Study|Adverse Event|2
1127967|NCT02687542|2220971|FG004|Overall Study|Adverse Event|9
1127968|NCT02687542|2220967|FG000|Overall Study|Withdrawal by Subject|0
1127969|NCT02687542|2220968|FG001|Overall Study|Withdrawal by Subject|1
1127970|NCT02687542|2220969|FG002|Overall Study|Withdrawal by Subject|1
1127971|NCT02687542|2220970|FG003|Overall Study|Withdrawal by Subject|2
1127972|NCT02687542|2220971|FG004|Overall Study|Withdrawal by Subject|4
1127973|NCT02687711|2220983|FG000|Overall Study|Adverse Event|89
1127974|NCT02687711|2220983|FG000|Overall Study|Lack of Efficacy|70
1127975|NCT02687711|2220983|FG000|Overall Study|Lost to Follow-up|20
1127976|NCT02687711|2220983|FG000|Overall Study|Consent withdrawn|15
1127977|NCT02687711|2220983|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1
1127978|NCT02687711|2220983|FG000|Overall Study|Too expensive|4
1127979|NCT02687711|2220983|FG000|Overall Study|Participant moved abroad|1
1127980|NCT02687711|2220983|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1
1127981|NCT02687711|2220983|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1
1127982|NCT02687711|2220983|FG000|Overall Study|Disliked taste|1
1127983|NCT02687711|2220983|FG000|Overall Study|Low mood|1
1127984|NCT02687711|2220983|FG000|Overall Study|Side effects|1
1127985|NCT02687711|2220983|FG000|Overall Study|Change of Hospital|1
1127986|NCT02687711|2220983|FG000|Overall Study|Liver Encephalopathy|1
1127987|NCT02687711|2220983|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1
1127988|NCT02687711|2220983|FG000|Overall Study|Withdrawn due to intake interruption|1
1127989|NCT02687711|2220983|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1
1127990|NCT02687711|2220983|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1
1127991|NCT02687711|2220983|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1
1127992|NCT02687815|2220989|FG000|Overall Study|Lost to Follow-up|2
1127993|NCT02687815|2220990|FG001|Overall Study|Lost to Follow-up|4
1127994|NCT02687815|2220989|FG000|Overall Study|Withdrawal by Subject|2
1127995|NCT02687815|2220990|FG001|Overall Study|Withdrawal by Subject|4
1127996|NCT02687919|2220998|FG000|Overall Study|Withdrawal by Subject|6
1127997|NCT02687919|2220999|FG001|Overall Study|Withdrawal by Subject|6
1127998|NCT02687919|2220998|FG000|Overall Study|Protocol Violation|2
1127999|NCT02687919|2220999|FG001|Overall Study|Protocol Violation|0
1128000|NCT02688153|2221007|FG000|Overall Study|Death|7
1128001|NCT02688153|2221008|FG001|Overall Study|Death|5
1128002|NCT02688153|2221007|FG000|Overall Study|Withdrawal by Subject|4
1128003|NCT02688153|2221008|FG001|Overall Study|Withdrawal by Subject|2
1128004|NCT02688153|2221007|FG000|Overall Study|Valve Explant|1
1128005|NCT02688153|2221008|FG001|Overall Study|Valve Explant|0
1128006|NCT02688153|2221007|FG000|Overall Study|Conversion to Commercial Valve|3
1128007|NCT02688153|2221008|FG001|Overall Study|Conversion to Commercial Valve|0
1128008|NCT02688192|2221017|FG000|Overall Study|Lost to Follow-up|11
1128009|NCT02688192|2221018|FG001|Overall Study|Lost to Follow-up|5
1128010|NCT02688192|2221017|FG000|Overall Study|Physician Decision|1
1128011|NCT02688192|2221018|FG001|Overall Study|Physician Decision|0
1128012|NCT02688387|2221038|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128013|NCT02688387|2221039|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128014|NCT02688387|2221040|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
1128015|NCT02688387|2221041|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128016|NCT02688387|2221042|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128017|NCT02688387|2221043|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128018|NCT02688387|2221044|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128019|NCT02688387|2221045|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128020|NCT02688387|2221046|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128021|NCT02688387|2221047|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128022|NCT02688387|2221048|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128023|NCT02688387|2221049|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128024|NCT02688387|2221050|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128025|NCT02688387|2221051|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128026|NCT02688387|2221052|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128027|NCT02688387|2221053|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128028|NCT02688387|2221054|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128029|NCT02688387|2221055|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128030|NCT02688387|2221056|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128031|NCT02688387|2221057|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128032|NCT02688387|2221058|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128033|NCT02688387|2221059|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1128034|NCT02688387|2221038|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128035|NCT02688387|2221039|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128036|NCT02688387|2221040|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128037|NCT02688387|2221041|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
1128038|NCT02688387|2221042|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128039|NCT02688387|2221043|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128040|NCT02688387|2221044|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128041|NCT02688387|2221045|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128042|NCT02688387|2221046|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128043|NCT02688387|2221047|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128044|NCT02688387|2221048|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128045|NCT02688387|2221049|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128046|NCT02688387|2221050|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128047|NCT02688387|2221051|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128048|NCT02688387|2221052|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128049|NCT02688387|2221053|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128050|NCT02688387|2221054|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128051|NCT02688387|2221055|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128052|NCT02688387|2221056|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128053|NCT02688387|2221057|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128054|NCT02688387|2221058|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128055|NCT02688387|2221059|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128056|NCT02688387|2221038|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128057|NCT02688387|2221039|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
1128058|NCT02688387|2221040|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128059|NCT02688387|2221041|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128060|NCT02688387|2221042|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128061|NCT02688387|2221043|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128062|NCT02688387|2221044|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128063|NCT02688387|2221045|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128064|NCT02688387|2221046|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128065|NCT02688387|2221047|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128066|NCT02688387|2221048|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128067|NCT02688387|2221049|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128068|NCT02688387|2221050|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128069|NCT02688387|2221051|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128070|NCT02688387|2221052|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128071|NCT02688387|2221053|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128072|NCT02688387|2221054|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128073|NCT02688387|2221055|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128074|NCT02688387|2221056|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128075|NCT02688387|2221057|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128076|NCT02688387|2221058|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128077|NCT02688387|2221059|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1128078|NCT02688387|2221038|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128079|NCT02688387|2221039|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128080|NCT02688387|2221040|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
1128081|NCT02688387|2221041|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128082|NCT02688387|2221042|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
1128083|NCT02688387|2221043|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128084|NCT02688387|2221044|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128085|NCT02688387|2221045|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128086|NCT02688387|2221046|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128087|NCT02688387|2221047|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128088|NCT02688387|2221048|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128089|NCT02688387|2221049|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128090|NCT02688387|2221050|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128091|NCT02688387|2221051|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128092|NCT02688387|2221052|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128093|NCT02688387|2221053|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128094|NCT02688387|2221054|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128095|NCT02688387|2221055|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128096|NCT02688387|2221056|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128097|NCT02688387|2221057|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128098|NCT02688387|2221058|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128099|NCT02688387|2221059|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1128100|NCT02688387|2221038|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
1128101|NCT02688387|2221039|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128102|NCT02688387|2221040|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128103|NCT02688387|2221041|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128104|NCT02688387|2221042|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128105|NCT02688387|2221043|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128106|NCT02688387|2221044|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128107|NCT02688387|2221045|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128108|NCT02688387|2221046|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128109|NCT02688387|2221047|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128110|NCT02688387|2221048|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128111|NCT02688387|2221049|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128112|NCT02688387|2221050|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128113|NCT02688387|2221051|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128114|NCT02688387|2221052|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128115|NCT02688387|2221053|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128116|NCT02688387|2221054|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128117|NCT02688387|2221055|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128118|NCT02688387|2221056|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128119|NCT02688387|2221057|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128120|NCT02688387|2221058|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128121|NCT02688387|2221059|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1128122|NCT02688387|2221038|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128123|NCT02688387|2221039|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128124|NCT02688387|2221040|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128125|NCT02688387|2221041|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128126|NCT02688387|2221042|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128127|NCT02688387|2221043|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128128|NCT02688387|2221044|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128129|NCT02688387|2221045|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128130|NCT02688387|2221046|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128131|NCT02688387|2221047|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128132|NCT02688387|2221048|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
1128133|NCT02688387|2221049|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128134|NCT02688387|2221050|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128135|NCT02688387|2221051|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128136|NCT02688387|2221052|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128137|NCT02688387|2221053|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128138|NCT02688387|2221054|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128139|NCT02688387|2221055|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128140|NCT02688387|2221056|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128141|NCT02688387|2221057|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128142|NCT02688387|2221058|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128143|NCT02688387|2221059|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1128144|NCT02688387|2221038|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128145|NCT02688387|2221039|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128146|NCT02688387|2221040|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128147|NCT02688387|2221041|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128148|NCT02688387|2221042|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128149|NCT02688387|2221043|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128150|NCT02688387|2221044|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128151|NCT02688387|2221045|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128152|NCT02688387|2221046|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128153|NCT02688387|2221047|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128154|NCT02688387|2221048|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128155|NCT02688387|2221049|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128156|NCT02688387|2221050|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128157|NCT02688387|2221051|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128158|NCT02688387|2221052|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
1128159|NCT02688387|2221053|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128160|NCT02688387|2221054|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128161|NCT02688387|2221055|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128162|NCT02688387|2221056|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128163|NCT02688387|2221057|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128164|NCT02688387|2221058|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128165|NCT02688387|2221059|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1128166|NCT02688387|2221038|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128167|NCT02688387|2221039|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128168|NCT02688387|2221040|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128169|NCT02688387|2221041|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128170|NCT02688387|2221042|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128171|NCT02688387|2221043|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128172|NCT02688387|2221044|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128173|NCT02688387|2221045|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128174|NCT02688387|2221046|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128175|NCT02688387|2221047|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128176|NCT02688387|2221048|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128177|NCT02688387|2221049|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128178|NCT02688387|2221050|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128179|NCT02688387|2221051|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128180|NCT02688387|2221052|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128181|NCT02688387|2221053|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128182|NCT02688387|2221054|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128183|NCT02688387|2221055|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128184|NCT02688387|2221056|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128185|NCT02688387|2221057|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128186|NCT02688387|2221058|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
1128187|NCT02688387|2221059|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1128188|NCT02688387|2221038|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128189|NCT02688387|2221039|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128190|NCT02688387|2221040|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128191|NCT02688387|2221041|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128192|NCT02688387|2221042|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128193|NCT02688387|2221043|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128194|NCT02688387|2221044|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128195|NCT02688387|2221045|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128196|NCT02688387|2221046|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128197|NCT02688387|2221047|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128198|NCT02688387|2221048|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128199|NCT02688387|2221049|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128200|NCT02688387|2221050|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128201|NCT02688387|2221051|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128202|NCT02688387|2221052|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128203|NCT02688387|2221053|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128204|NCT02688387|2221054|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128205|NCT02688387|2221055|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128206|NCT02688387|2221056|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
1128207|NCT02688387|2221057|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128208|NCT02688387|2221058|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
1128209|NCT02688387|2221059|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1128210|NCT02688387|2221038|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128211|NCT02688387|2221039|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128212|NCT02688387|2221040|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128213|NCT02688387|2221041|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128214|NCT02688387|2221042|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128215|NCT02688387|2221043|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128216|NCT02688387|2221044|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128217|NCT02688387|2221045|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128218|NCT02688387|2221046|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128219|NCT02688387|2221047|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128220|NCT02688387|2221048|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128221|NCT02688387|2221049|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128222|NCT02688387|2221050|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128223|NCT02688387|2221051|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128224|NCT02688387|2221052|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128225|NCT02688387|2221053|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128226|NCT02688387|2221054|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128227|NCT02688387|2221055|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128228|NCT02688387|2221056|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128229|NCT02688387|2221057|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
1128230|NCT02688387|2221058|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128231|NCT02688387|2221059|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1128232|NCT02688621|2221116|FG000|Overall Study|Pregnancy|1
1128233|NCT02688621|2221117|FG001|Overall Study|Pregnancy|3
1128234|NCT02688621|2221116|FG000|Overall Study|Lost to Follow-up|38
1128235|NCT02688621|2221117|FG001|Overall Study|Lost to Follow-up|15
1128236|NCT02688621|2221116|FG000|Overall Study|Withdrawal by Subject|1
1128237|NCT02688621|2221117|FG001|Overall Study|Withdrawal by Subject|0
1128238|NCT02688933|2221152|FG000|Overall Study|Adverse Event|3
1128239|NCT02688933|2221153|FG001|Overall Study|Adverse Event|1
1128240|NCT02688933|2221152|FG000|Overall Study|Lack of Efficacy|2
1128241|NCT02688933|2221153|FG001|Overall Study|Lack of Efficacy|2
1128242|NCT02688933|2221152|FG000|Overall Study|Poor compliance to protocol|7
1128243|NCT02688933|2221153|FG001|Overall Study|Poor compliance to protocol|4
1128244|NCT02688933|2221152|FG000|Overall Study|Hypoglycemia|2
1128245|NCT02688933|2221153|FG001|Overall Study|Hypoglycemia|0
1128246|NCT02688933|2221152|FG000|Overall Study|Other than Specified|14
1128247|NCT02688933|2221153|FG001|Overall Study|Other than Specified|25
1128248|NCT02688933|2221152|FG000|Overall Study|Lost to Follow-up|1
1128249|NCT02688933|2221153|FG001|Overall Study|Lost to Follow-up|5
1128250|NCT02689076|2221179|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172
1128251|NCT02689076|2221180|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213
1128252|NCT02689076|2221181|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0
1128253|NCT02689076|2221179|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3
1162085|NCT03382912|2284106|FG000|Overall Study|Sponsor Decision|6
900085|NCT00725621|1873144|FG000|Overall Study|Withdrawal by Subject|57
900086|NCT00725621|1873144|FG000|Overall Study|Physician Decision|19
900087|NCT00725621|1873144|FG000|Overall Study|Lost to Follow-up|52
900088|NCT00725621|1873144|FG000|Overall Study|Non-compliance|8
900089|NCT00725621|1873144|FG000|Overall Study|Continued treatment by other physician|6
900090|NCT00725621|1873144|FG000|Overall Study|Switched to other study|1
900091|NCT00725621|1873144|FG000|Overall Study|Switched to other drug|1
1128254|NCT02689076|2221180|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1
1128255|NCT02689076|2221181|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0
1128256|NCT02689076|2221179|FG000|Overall Study|Did not have an HIE match|2
1128257|NCT02689076|2221180|FG001|Overall Study|Did not have an HIE match|0
1128258|NCT02689076|2221181|FG002|Overall Study|Did not have an HIE match|0
1128259|NCT02689076|2221179|FG000|Overall Study|Death during non-VA encounter|2
1128260|NCT02689076|2221180|FG001|Overall Study|Death during non-VA encounter|5
1128261|NCT02689076|2221181|FG002|Overall Study|Death during non-VA encounter|0
1128262|NCT02689076|2221179|FG000|Overall Study|Provider declined to participate after participant assignment|1
1128263|NCT02689076|2221180|FG001|Overall Study|Provider declined to participate after participant assignment|1
1128264|NCT02689076|2221181|FG002|Overall Study|Provider declined to participate after participant assignment|0
1128265|NCT02689076|2221179|FG000|Overall Study|Participant no longer active in VA system|1
1128266|NCT02689076|2221180|FG001|Overall Study|Participant no longer active in VA system|0
1128267|NCT02689076|2221181|FG002|Overall Study|Participant no longer active in VA system|0
1128268|NCT02689076|2221179|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
1128269|NCT02689076|2221180|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2
1128270|NCT02689076|2221181|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
1128271|NCT02689206|2221198|FG000|Overall Study|Adverse Event|0
1128272|NCT02689206|2221199|FG001|Overall Study|Adverse Event|0
1128273|NCT02689206|2221200|FG002|Overall Study|Adverse Event|1
1128274|NCT02689206|2221201|FG003|Overall Study|Adverse Event|0
1128275|NCT02689206|2221202|FG004|Overall Study|Adverse Event|2
1128276|NCT02689206|2221198|FG000|Overall Study|Protocol Violation|1
1128277|NCT02689206|2221199|FG001|Overall Study|Protocol Violation|0
1128278|NCT02689206|2221200|FG002|Overall Study|Protocol Violation|0
1128279|NCT02689206|2221201|FG003|Overall Study|Protocol Violation|1
1128280|NCT02689206|2221202|FG004|Overall Study|Protocol Violation|2
1128281|NCT02689206|2221198|FG000|Overall Study|Other: Reached stopping criteria|0
1128282|NCT02689206|2221199|FG001|Overall Study|Other: Reached stopping criteria|1
1128283|NCT02689206|2221200|FG002|Overall Study|Other: Reached stopping criteria|2
1128284|NCT02689206|2221201|FG003|Overall Study|Other: Reached stopping criteria|3
1128285|NCT02689206|2221202|FG004|Overall Study|Other: Reached stopping criteria|4
1128286|NCT02689206|2221198|FG000|Overall Study|Physician Decision|1
1128287|NCT02689206|2221199|FG001|Overall Study|Physician Decision|0
1128288|NCT02689206|2221200|FG002|Overall Study|Physician Decision|0
1128289|NCT02689206|2221201|FG003|Overall Study|Physician Decision|0
1128290|NCT02689206|2221202|FG004|Overall Study|Physician Decision|0
1128291|NCT02689206|2221198|FG000|Overall Study|Withdrawal by Subject|1
1128292|NCT02689206|2221199|FG001|Overall Study|Withdrawal by Subject|0
1128293|NCT02689206|2221200|FG002|Overall Study|Withdrawal by Subject|1
1128294|NCT02689206|2221201|FG003|Overall Study|Withdrawal by Subject|0
1128295|NCT02689206|2221202|FG004|Overall Study|Withdrawal by Subject|0
1128296|NCT02689219|2221220|FG000|Overall Study|Death|1
1128297|NCT02689219|2221221|FG001|Overall Study|Death|1
1128298|NCT02689219|2221220|FG000|Overall Study|Disease Progression|10
1128299|NCT02689219|2221221|FG001|Overall Study|Disease Progression|6
1128300|NCT02689492|2221227|FG000|Overall Study|Lost to Follow-up|61
1128301|NCT02689492|2221227|FG000|Overall Study|Withdrawal by Subject|11
1128302|NCT02689492|2221227|FG000|Overall Study|Death|9
1128303|NCT02689492|2221227|FG000|Overall Study|Physician Decision|2
1128304|NCT02689492|2221227|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1
1128305|NCT02689492|2221227|FG000|Overall Study|Withdrawal/ Physician's Decision|1
1128306|NCT02689492|2221227|FG000|Overall Study|Other than listed|1
1128307|NCT02689804|2221236|FG000|Overall Study|Withdrawal by Subject|2
1128308|NCT02689804|2221237|FG001|Overall Study|Withdrawal by Subject|0
1128309|NCT02690194|2221297|FG000|Overall Study|Withdrawal by Subject|1
1128310|NCT02690194|2221298|FG001|Overall Study|Withdrawal by Subject|4
1128311|NCT02690194|2221299|FG002|Overall Study|Withdrawal by Subject|0
1128312|NCT02690207|2221307|FG000|Overall Study|Lost to Follow-up|48
1128313|NCT02690207|2221307|FG000|Overall Study|Withdrawal by Subject|46
1128314|NCT02690207|2221307|FG000|Overall Study|Protocol Violation|2
1128315|NCT02690207|2221307|FG000|Overall Study|Serious adverse event|110
1128316|NCT02690207|2221307|FG000|Overall Study|Non-serious Adverse Event|18
1128317|NCT02690207|2221307|FG000|Overall Study|Migrated/moved from study area|5
1128318|NCT02690207|2221307|FG000|Overall Study|Suspected HZ Episode|1
1128319|NCT02690207|2221307|FG000|Overall Study|Other reasons for withdrawal|23
900092|NCT00725621|1873144|FG000|Overall Study|Prepared for elective surgery|1
900093|NCT00725621|1873144|FG000|Overall Study|Reason not specified|55
900094|NCT00725712|1873154|FG000|Overall Study|Withdrawal by Subject|2
1128320|NCT02690649|2221317|FG000|Overall Study|Withdrawal by Subject|1
1128321|NCT02690649|2221318|FG001|Overall Study|Withdrawal by Subject|1
1128322|NCT02690649|2221317|FG000|Overall Study|Protocol Violation|0
1128323|NCT02690649|2221318|FG001|Overall Study|Protocol Violation|3
1128324|NCT02690701|2221328|FG000|Treatment Period 1|Adverse Event|2
1128325|NCT02690701|2221329|FG001|Treatment Period 1|Adverse Event|2
1128326|NCT02690701|2221328|FG000|Treatment Period 1|Withdrawal by Subject|0
1128327|NCT02690701|2221329|FG001|Treatment Period 1|Withdrawal by Subject|1
1128328|NCT02690701|2221328|FG000|Treatment Period 2|Adverse Event|2
1128329|NCT02690701|2221329|FG001|Treatment Period 2|Adverse Event|0
1128330|NCT02690701|2221328|FG000|Treatment Period 2|Lack of Efficacy|1
1128331|NCT02690701|2221329|FG001|Treatment Period 2|Lack of Efficacy|0
1128332|NCT02690701|2221328|FG000|Treatment Period 2|Lost to Follow-up|0
1128333|NCT02690701|2221329|FG001|Treatment Period 2|Lost to Follow-up|2
1128334|NCT02690701|2221328|FG000|Treatment Period 2|Withdrawal by Subject|0
1128335|NCT02690701|2221329|FG001|Treatment Period 2|Withdrawal by Subject|2
1128336|NCT02690701|2221328|FG000|Treatment Period 2|Protocol Violation|0
1128337|NCT02690701|2221329|FG001|Treatment Period 2|Protocol Violation|1
1128338|NCT02690714|2221336|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1
1128339|NCT02690714|2221336|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1
1128340|NCT02690727|2221344|FG000|Overall Study|Adverse Event|2
1128341|NCT02690727|2221345|FG001|Overall Study|Adverse Event|2
1128342|NCT02690974|2221371|FG000|Overall Study|Adverse Event|16
1128343|NCT02690974|2221371|FG000|Overall Study|Death|9
1128344|NCT02690974|2221371|FG000|Overall Study|Subject/guardian decision|4
1128345|NCT02690974|2221371|FG000|Overall Study|Lost to Follow-up|3
1128346|NCT02690974|2221371|FG000|Overall Study|Withdrawal of Informed Consent|3
1128347|NCT02690974|2221371|FG000|Overall Study|Physician Decision|2
1128348|NCT02690974|2221371|FG000|Overall Study|Non-compliance with study treatment|1
1128349|NCT02690974|2221371|FG000|Overall Study|Protocol-defined stopping criteria|1
1128350|NCT02690974|2221371|FG000|Overall Study|Protocol Deviation|1
1128351|NCT02691013|2221377|FG000|Overall Study|Withdrawal by Subject|3
1128352|NCT02691013|2221378|FG001|Overall Study|Withdrawal by Subject|0
1128353|NCT02691247|2221398|FG000|Overall Study|Withdrawal by Subject|1
1128354|NCT02691247|2221399|FG001|Overall Study|Withdrawal by Subject|2
1128355|NCT02691247|2221400|FG002|Overall Study|Withdrawal by Subject|2
1128356|NCT02691247|2221398|FG000|Overall Study|Lost to Follow-up|2
1128357|NCT02691247|2221399|FG001|Overall Study|Lost to Follow-up|0
1128358|NCT02691247|2221400|FG002|Overall Study|Lost to Follow-up|1
1128359|NCT02691455|2221440|FG000|Overall Study|Withdrawal by Subject|1
1128360|NCT02691455|2221441|FG001|Overall Study|Withdrawal by Subject|2
1128361|NCT02691455|2221440|FG000|Overall Study|Lost to Follow-up|15
1128362|NCT02691455|2221441|FG001|Overall Study|Lost to Follow-up|15
1128363|NCT02691468|2221449|FG000|Overall Study|Bronchial blocker use|2
1128364|NCT02691468|2221450|FG001|Overall Study|Bronchial blocker use|1
1128365|NCT02691468|2221449|FG000|Overall Study|Lost to Follow-up|2
1128366|NCT02691468|2221450|FG001|Overall Study|Lost to Follow-up|1
1128367|NCT02691468|2221449|FG000|Overall Study|Failure to advance FOB|2
1128368|NCT02691468|2221450|FG001|Overall Study|Failure to advance FOB|0
1128369|NCT02691494|2221459|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
1128370|NCT02691494|2221460|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
1128371|NCT02691494|2221461|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
1128372|NCT02691494|2221459|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2
1128373|NCT02691494|2221460|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3
1128374|NCT02691494|2221461|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
1128375|NCT02691494|2221459|FG000|Post-Treatment Follow-Up Period|Other|2
1128376|NCT02691494|2221460|FG001|Post-Treatment Follow-Up Period|Other|1
1128377|NCT02691494|2221461|FG002|Post-Treatment Follow-Up Period|Other|1
1128378|NCT02691494|2221459|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
1128379|NCT02691494|2221460|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
1128380|NCT02691494|2221461|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3
1128381|NCT02691494|2221459|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
1128382|NCT02691494|2221460|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1
1128383|NCT02691494|2221461|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
1128384|NCT02691507|2221471|FG000|Overall Study|Missed Visit 3|0
1128385|NCT02691507|2221472|FG001|Overall Study|Missed Visit 3|1
1128386|NCT02691572|2221480|FG000|Overall Study|Withdrawal by Subject|1
1128387|NCT02691572|2221481|FG001|Overall Study|Withdrawal by Subject|0
1128388|NCT02691572|2221480|FG000|Overall Study|Protocol Violation|0
1128389|NCT02691572|2221481|FG001|Overall Study|Protocol Violation|1
1128390|NCT02691702|2221498|FG000|Overall Study|Adverse Event|1
1128391|NCT02691702|2221499|FG001|Overall Study|Adverse Event|0
1128392|NCT02691702|2221500|FG002|Overall Study|Adverse Event|0
1128393|NCT02691702|2221501|FG003|Overall Study|Adverse Event|0
1128394|NCT02691702|2221502|FG004|Overall Study|Adverse Event|0
1128395|NCT02691702|2221503|FG005|Overall Study|Adverse Event|0
1128396|NCT02691702|2221504|FG006|Overall Study|Adverse Event|0
1128397|NCT02691702|2221505|FG007|Overall Study|Adverse Event|0
1128398|NCT02691702|2221506|FG008|Overall Study|Adverse Event|1
1128399|NCT02691702|2221507|FG009|Overall Study|Adverse Event|0
1128400|NCT02691702|2221508|FG010|Overall Study|Adverse Event|1
1128401|NCT02691702|2221498|FG000|Overall Study|Lost to Follow-up|0
1128402|NCT02691702|2221499|FG001|Overall Study|Lost to Follow-up|0
1128403|NCT02691702|2221500|FG002|Overall Study|Lost to Follow-up|1
1128404|NCT02691702|2221501|FG003|Overall Study|Lost to Follow-up|0
1128405|NCT02691702|2221502|FG004|Overall Study|Lost to Follow-up|0
1128406|NCT02691702|2221503|FG005|Overall Study|Lost to Follow-up|2
1128407|NCT02691702|2221504|FG006|Overall Study|Lost to Follow-up|0
1128408|NCT02691702|2221505|FG007|Overall Study|Lost to Follow-up|0
1128409|NCT02691702|2221506|FG008|Overall Study|Lost to Follow-up|0
1128410|NCT02691702|2221507|FG009|Overall Study|Lost to Follow-up|0
1128411|NCT02691702|2221508|FG010|Overall Study|Lost to Follow-up|1
1128412|NCT02691702|2221498|FG000|Overall Study|Withdrawal by Subject|1
1128413|NCT02691702|2221499|FG001|Overall Study|Withdrawal by Subject|1
1128414|NCT02691702|2221500|FG002|Overall Study|Withdrawal by Subject|0
1128415|NCT02691702|2221501|FG003|Overall Study|Withdrawal by Subject|0
1128416|NCT02691702|2221502|FG004|Overall Study|Withdrawal by Subject|0
1128417|NCT02691702|2221503|FG005|Overall Study|Withdrawal by Subject|1
1128418|NCT02691702|2221504|FG006|Overall Study|Withdrawal by Subject|2
1128419|NCT02691702|2221505|FG007|Overall Study|Withdrawal by Subject|0
1128420|NCT02691702|2221506|FG008|Overall Study|Withdrawal by Subject|0
1128421|NCT02691702|2221507|FG009|Overall Study|Withdrawal by Subject|0
1128422|NCT02691702|2221508|FG010|Overall Study|Withdrawal by Subject|0
1128423|NCT02691702|2221498|FG000|Overall Study|Other|0
1128424|NCT02691702|2221499|FG001|Overall Study|Other|0
1128425|NCT02691702|2221500|FG002|Overall Study|Other|0
1128426|NCT02691702|2221501|FG003|Overall Study|Other|0
1128427|NCT02691702|2221502|FG004|Overall Study|Other|0
1128428|NCT02691702|2221503|FG005|Overall Study|Other|0
1128429|NCT02691702|2221504|FG006|Overall Study|Other|1
1128430|NCT02691702|2221505|FG007|Overall Study|Other|0
1128431|NCT02691702|2221506|FG008|Overall Study|Other|1
1128432|NCT02691702|2221507|FG009|Overall Study|Other|0
1128433|NCT02691702|2221508|FG010|Overall Study|Other|0
1128434|NCT02691702|2221498|FG000|Overall Study|Protocol Violation|0
1128435|NCT02691702|2221499|FG001|Overall Study|Protocol Violation|0
1128436|NCT02691702|2221500|FG002|Overall Study|Protocol Violation|0
1128437|NCT02691702|2221501|FG003|Overall Study|Protocol Violation|0
1128438|NCT02691702|2221502|FG004|Overall Study|Protocol Violation|0
1128439|NCT02691702|2221503|FG005|Overall Study|Protocol Violation|0
1128440|NCT02691702|2221504|FG006|Overall Study|Protocol Violation|0
1128441|NCT02691702|2221505|FG007|Overall Study|Protocol Violation|0
1128442|NCT02691702|2221506|FG008|Overall Study|Protocol Violation|0
1128443|NCT02691702|2221507|FG009|Overall Study|Protocol Violation|2
1128444|NCT02691702|2221508|FG010|Overall Study|Protocol Violation|0
1128445|NCT02691741|2221542|FG000|Overall Study|Adverse Event|0
1128446|NCT02691741|2221543|FG001|Overall Study|Adverse Event|2
1128447|NCT02691741|2221542|FG000|Overall Study|Lost to Follow-up|1
1128448|NCT02691741|2221543|FG001|Overall Study|Lost to Follow-up|0
1128449|NCT02691741|2221542|FG000|Overall Study|Physician Decision|0
1128450|NCT02691741|2221543|FG001|Overall Study|Physician Decision|1
1128451|NCT02691741|2221542|FG000|Overall Study|Withdrawal by Subject|0
1128452|NCT02691741|2221543|FG001|Overall Study|Withdrawal by Subject|4
1128453|NCT02691936|2221556|FG000|Overall Study|Withdrawal by Subject|2
1128454|NCT02691936|2221557|FG001|Overall Study|Withdrawal by Subject|5
1128455|NCT02692040|2221585|FG000|Overall Study|Protocol Violation|0
1128456|NCT02692040|2221586|FG001|Overall Study|Protocol Violation|0
1128457|NCT02692040|2221587|FG002|Overall Study|Protocol Violation|0
1128458|NCT02692040|2221588|FG003|Overall Study|Protocol Violation|0
1128459|NCT02692040|2221589|FG004|Overall Study|Protocol Violation|0
1128460|NCT02692040|2221590|FG005|Overall Study|Protocol Violation|0
1128461|NCT02692040|2221591|FG006|Overall Study|Protocol Violation|0
1128462|NCT02692040|2221592|FG007|Overall Study|Protocol Violation|0
1128463|NCT02692040|2221593|FG008|Overall Study|Protocol Violation|0
1128464|NCT02692040|2221594|FG009|Overall Study|Protocol Violation|0
1128465|NCT02692040|2221595|FG010|Overall Study|Protocol Violation|0
1128466|NCT02692040|2221596|FG011|Overall Study|Protocol Violation|0
1128467|NCT02692040|2221597|FG012|Overall Study|Protocol Violation|1
1128468|NCT02692040|2221598|FG013|Overall Study|Protocol Violation|0
1128469|NCT02692040|2221599|FG014|Overall Study|Protocol Violation|0
1128470|NCT02692040|2221600|FG015|Overall Study|Protocol Violation|0
1128471|NCT02692040|2221601|FG016|Overall Study|Protocol Violation|0
1128472|NCT02692040|2221585|FG000|Overall Study|Adverse Event|0
1128473|NCT02692040|2221586|FG001|Overall Study|Adverse Event|0
1128474|NCT02692040|2221587|FG002|Overall Study|Adverse Event|0
1128475|NCT02692040|2221588|FG003|Overall Study|Adverse Event|0
1128476|NCT02692040|2221589|FG004|Overall Study|Adverse Event|0
1128477|NCT02692040|2221590|FG005|Overall Study|Adverse Event|0
1128478|NCT02692040|2221591|FG006|Overall Study|Adverse Event|0
1128479|NCT02692040|2221592|FG007|Overall Study|Adverse Event|0
1128480|NCT02692040|2221593|FG008|Overall Study|Adverse Event|0
1128481|NCT02692040|2221594|FG009|Overall Study|Adverse Event|0
1128482|NCT02692040|2221595|FG010|Overall Study|Adverse Event|0
1128483|NCT02692040|2221596|FG011|Overall Study|Adverse Event|0
1128484|NCT02692040|2221597|FG012|Overall Study|Adverse Event|0
1128485|NCT02692040|2221598|FG013|Overall Study|Adverse Event|3
1128486|NCT02692040|2221599|FG014|Overall Study|Adverse Event|1
1128487|NCT02692040|2221600|FG015|Overall Study|Adverse Event|1
1128488|NCT02692040|2221601|FG016|Overall Study|Adverse Event|0
1128489|NCT02692235|2221686|FG000|Overall Study|Withdrawal by Subject|2
1128490|NCT02692235|2221687|FG001|Overall Study|Withdrawal by Subject|1
1128491|NCT02692235|2221686|FG000|Overall Study|Adverse Event|1
1128492|NCT02692235|2221687|FG001|Overall Study|Adverse Event|2
1128493|NCT02692417|2221704|FG000|Overall Study|Withdrawal by Subject|5
1128494|NCT02692417|2221705|FG001|Overall Study|Withdrawal by Subject|1
1128495|NCT02692417|2221704|FG000|Overall Study|Adverse Event|1
1128496|NCT02692417|2221705|FG001|Overall Study|Adverse Event|0
1128497|NCT02692482|2221713|FG000|Overall Study|Death|2
1128498|NCT02692482|2221714|FG001|Overall Study|Death|2
1128499|NCT02692482|2221713|FG000|Overall Study|Withdrawal by Subject|1
1128500|NCT02692482|2221714|FG001|Overall Study|Withdrawal by Subject|2
1128501|NCT02692560|2221736|FG000|Overall Study|Withdrawal by Subject|0
1128502|NCT02692560|2221737|FG001|Overall Study|Withdrawal by Subject|6
1128503|NCT02692586|2221743|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1
1128504|NCT02692586|2221743|FG000|Overall Study|Received adjunctive thrombolytics|2
1128505|NCT02692703|2221747|FG000|Overall Study|Lost to Follow-up|1
1128506|NCT02692703|2221747|FG000|Overall Study|Other|1
1128507|NCT02692716|2221753|FG000|Overall Study|Lost to Follow-up|2
1128508|NCT02692716|2221754|FG001|Overall Study|Lost to Follow-up|5
1128509|NCT02692716|2221753|FG000|Overall Study|Withdrawal by Subject|3
1128510|NCT02692716|2221754|FG001|Overall Study|Withdrawal by Subject|1
1128511|NCT02693106|2221774|FG000|Overall Study|No time|3
1128512|NCT02693119|2221786|FG000|Open-Label Period|Withdrawal by Subject|0
1128513|NCT02693119|2221787|FG001|Open-Label Period|Withdrawal by Subject|1
1128514|NCT02693418|2221848|FG000|Overall Study|Lost to Follow-up|1
1128515|NCT02693418|2221849|FG001|Overall Study|Lost to Follow-up|2
1128516|NCT02693418|2221850|FG002|Overall Study|Lost to Follow-up|0
1128517|NCT02693418|2221851|FG003|Overall Study|Lost to Follow-up|0
1128518|NCT02693418|2221852|FG004|Overall Study|Lost to Follow-up|0
1128519|NCT02693418|2221848|FG000|Overall Study|Menses during study period|0
1128520|NCT02693418|2221849|FG001|Overall Study|Menses during study period|0
1128521|NCT02693418|2221850|FG002|Overall Study|Menses during study period|2
1128522|NCT02693418|2221851|FG003|Overall Study|Menses during study period|0
1128523|NCT02693418|2221852|FG004|Overall Study|Menses during study period|0
1128524|NCT02693691|2221864|FG000|Primary Endpoint Analysis (First 12M)|Death|30
1128525|NCT02693691|2221864|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12
1128526|NCT02693691|2221864|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7
1128527|NCT02693691|2221864|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1
1128528|NCT02693691|2221864|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12
1128529|NCT02693691|2221864|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11
1128530|NCT02693691|2221864|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1
1128531|NCT02693834|2221885|FG000|Baseline Measurement|Withdrawal by Subject|1
1128532|NCT02693834|2221886|FG001|Baseline Measurement|Withdrawal by Subject|0
1128533|NCT02693834|2221885|FG000|Baseline Measurement|Adverse Event|1
1128534|NCT02693834|2221886|FG001|Baseline Measurement|Adverse Event|0
1128535|NCT02693834|2221885|FG000|Week 2 Practice|Adverse Event|0
1128536|NCT02693834|2221886|FG001|Week 2 Practice|Adverse Event|1
1128537|NCT02694185|2221907|FG000|Overall Study|Withdrawal by Subject|45
1128538|NCT02694185|2221908|FG001|Overall Study|Withdrawal by Subject|0
1128539|NCT02694328|2221924|FG000|Overall Study|Adverse Event|27
1128540|NCT02694328|2221925|FG001|Overall Study|Adverse Event|33
1128541|NCT02694328|2221924|FG000|Overall Study|Withdrawal by Subject|27
1128542|NCT02694328|2221925|FG001|Overall Study|Withdrawal by Subject|23
1128543|NCT02694328|2221924|FG000|Overall Study|Lost to Follow-up|26
1128544|NCT02694328|2221925|FG001|Overall Study|Lost to Follow-up|22
1128545|NCT02694328|2221924|FG000|Overall Study|Noncompliant with study drug|11
1128546|NCT02694328|2221925|FG001|Overall Study|Noncompliant with study drug|8
1128547|NCT02694328|2221924|FG000|Overall Study|Incarceration|1
1128548|NCT02694328|2221925|FG001|Overall Study|Incarceration|1
1128549|NCT02694328|2221924|FG000|Overall Study|Lack of Efficacy|1
1128550|NCT02694328|2221925|FG001|Overall Study|Lack of Efficacy|2
1128551|NCT02694328|2221924|FG000|Overall Study|Pregnancy|1
1128552|NCT02694328|2221925|FG001|Overall Study|Pregnancy|1
1128553|NCT02694328|2221924|FG000|Overall Study|Protocol Violation|6
1128554|NCT02694328|2221925|FG001|Overall Study|Protocol Violation|5
1128555|NCT02694328|2221924|FG000|Overall Study|Abnormal Laboratory Value|0
1128556|NCT02694328|2221925|FG001|Overall Study|Abnormal Laboratory Value|3
1128557|NCT02694523|2221937|FG000|Part A|Adverse Event|7
1128558|NCT02694523|2221938|FG001|Part A|Adverse Event|3
1128559|NCT02694523|2221939|FG002|Part A|Adverse Event|0
1128560|NCT02694523|2221940|FG003|Part A|Adverse Event|0
1128561|NCT02694523|2221941|FG004|Part A|Adverse Event|0
1128562|NCT02694523|2221942|FG005|Part A|Adverse Event|0
1128563|NCT02694523|2221943|FG006|Part A|Adverse Event|0
1128564|NCT02694523|2221937|FG000|Part A|Protocol Violation|1
1128565|NCT02694523|2221938|FG001|Part A|Protocol Violation|0
1128566|NCT02694523|2221939|FG002|Part A|Protocol Violation|0
1128567|NCT02694523|2221940|FG003|Part A|Protocol Violation|0
1128568|NCT02694523|2221941|FG004|Part A|Protocol Violation|0
1128569|NCT02694523|2221942|FG005|Part A|Protocol Violation|0
1128570|NCT02694523|2221943|FG006|Part A|Protocol Violation|0
1128571|NCT02694523|2221937|FG000|Part A|Lost to Follow-up|1
1128572|NCT02694523|2221938|FG001|Part A|Lost to Follow-up|2
1128573|NCT02694523|2221939|FG002|Part A|Lost to Follow-up|0
1128574|NCT02694523|2221940|FG003|Part A|Lost to Follow-up|0
1128575|NCT02694523|2221941|FG004|Part A|Lost to Follow-up|0
1128576|NCT02694523|2221942|FG005|Part A|Lost to Follow-up|0
1128577|NCT02694523|2221943|FG006|Part A|Lost to Follow-up|0
1128578|NCT02694523|2221937|FG000|Part A|Withdrawal by Subject|3
1128579|NCT02694523|2221938|FG001|Part A|Withdrawal by Subject|1
1128580|NCT02694523|2221939|FG002|Part A|Withdrawal by Subject|0
1128581|NCT02694523|2221940|FG003|Part A|Withdrawal by Subject|0
1128582|NCT02694523|2221941|FG004|Part A|Withdrawal by Subject|0
1128583|NCT02694523|2221942|FG005|Part A|Withdrawal by Subject|0
1128584|NCT02694523|2221943|FG006|Part A|Withdrawal by Subject|0
1128585|NCT02694523|2221937|FG000|Part A|Other|1
1128586|NCT02694523|2221938|FG001|Part A|Other|1
1128587|NCT02694523|2221939|FG002|Part A|Other|0
1128588|NCT02694523|2221940|FG003|Part A|Other|0
1128589|NCT02694523|2221941|FG004|Part A|Other|0
1128590|NCT02694523|2221942|FG005|Part A|Other|0
1128591|NCT02694523|2221943|FG006|Part A|Other|0
1128592|NCT02694523|2221937|FG000|Part B|Adverse Event|0
1128593|NCT02694523|2221938|FG001|Part B|Adverse Event|0
1128594|NCT02694523|2221939|FG002|Part B|Adverse Event|7
1128595|NCT02694523|2221940|FG003|Part B|Adverse Event|1
1128596|NCT02694523|2221941|FG004|Part B|Adverse Event|1
1128597|NCT02694523|2221942|FG005|Part B|Adverse Event|2
1128598|NCT02694523|2221943|FG006|Part B|Adverse Event|0
1128599|NCT02694523|2221937|FG000|Part B|Protocol Violation|0
1128600|NCT02694523|2221938|FG001|Part B|Protocol Violation|0
1128601|NCT02694523|2221939|FG002|Part B|Protocol Violation|1
1128602|NCT02694523|2221940|FG003|Part B|Protocol Violation|0
1128603|NCT02694523|2221941|FG004|Part B|Protocol Violation|0
1128604|NCT02694523|2221942|FG005|Part B|Protocol Violation|0
1128605|NCT02694523|2221943|FG006|Part B|Protocol Violation|0
1128606|NCT02694523|2221937|FG000|Part B|Lost to Follow-up|0
1128607|NCT02694523|2221938|FG001|Part B|Lost to Follow-up|0
1128608|NCT02694523|2221939|FG002|Part B|Lost to Follow-up|2
1128609|NCT02694523|2221940|FG003|Part B|Lost to Follow-up|3
1128610|NCT02694523|2221941|FG004|Part B|Lost to Follow-up|2
1128611|NCT02694523|2221942|FG005|Part B|Lost to Follow-up|0
1128612|NCT02694523|2221943|FG006|Part B|Lost to Follow-up|1
1128613|NCT02694523|2221937|FG000|Part B|Withdrawal by Subject|0
1128614|NCT02694523|2221938|FG001|Part B|Withdrawal by Subject|0
1128615|NCT02694523|2221939|FG002|Part B|Withdrawal by Subject|9
1128616|NCT02694523|2221940|FG003|Part B|Withdrawal by Subject|0
1128617|NCT02694523|2221941|FG004|Part B|Withdrawal by Subject|1
1128618|NCT02694523|2221942|FG005|Part B|Withdrawal by Subject|3
1128619|NCT02694523|2221943|FG006|Part B|Withdrawal by Subject|0
1128620|NCT02694523|2221937|FG000|Part B|Other|0
1128621|NCT02694523|2221938|FG001|Part B|Other|0
1128622|NCT02694523|2221939|FG002|Part B|Other|1
1128623|NCT02694523|2221940|FG003|Part B|Other|0
1128624|NCT02694523|2221941|FG004|Part B|Other|0
1128625|NCT02694523|2221942|FG005|Part B|Other|0
1128626|NCT02694523|2221943|FG006|Part B|Other|1
1128627|NCT02694536|2221955|FG000|Overall Study|Progressive Disease|40
1128628|NCT02694536|2221955|FG000|Overall Study|Lost to Follow-up|1
1128629|NCT02694536|2221955|FG000|Overall Study|Study Drug-Related Adverse Event|1
1128630|NCT02694536|2221955|FG000|Overall Study|Withdrawal by Subject|8
1128631|NCT02694536|2221955|FG000|Overall Study|Death|8
1128632|NCT02694536|2221955|FG000|Overall Study|Other|22
1128633|NCT02694549|2221959|FG000|Overall Study|screen failures|2
1128634|NCT02694562|2221963|FG000|Overall Study|Death|8
1128635|NCT02694562|2221963|FG000|Overall Study|Protocol Violation|4
1128636|NCT02694562|2221963|FG000|Overall Study|Lost to Follow-up|3
1128637|NCT02694562|2221963|FG000|Overall Study|Screen Failure|2
1128638|NCT02694562|2221963|FG000|Overall Study|Physician Decision|1
1128639|NCT02694718|2221971|FG000|Overall Study|Death|1
1128640|NCT02694718|2221971|FG000|Overall Study|Withdrawal by Subject|1
1128641|NCT02694744|2221977|FG000|Overall Study|Adverse Event|2
1128642|NCT02694744|2221978|FG001|Overall Study|Adverse Event|1
1128643|NCT02694744|2221977|FG000|Overall Study|Withdrawal by Subject|2
1128644|NCT02694744|2221978|FG001|Overall Study|Withdrawal by Subject|1
1128645|NCT02694744|2221977|FG000|Overall Study|Physician Decision|1
1128646|NCT02694744|2221978|FG001|Overall Study|Physician Decision|2
1128647|NCT02694744|2221977|FG000|Overall Study|Lost to Follow-up|1
1128648|NCT02694744|2221978|FG001|Overall Study|Lost to Follow-up|0
1128649|NCT02694744|2221977|FG000|Overall Study|Taking potassium supplement: exclusion 6|0
1128650|NCT02694744|2221978|FG001|Overall Study|Taking potassium supplement: exclusion 6|1
1128651|NCT02694978|2221997|FG000|Overall Study|Adverse Event|10
1128652|NCT02694978|2221998|FG001|Overall Study|Adverse Event|9
1128653|NCT02694978|2221997|FG000|Overall Study|Withdrawal by Subject|22
1128654|NCT02694978|2221998|FG001|Overall Study|Withdrawal by Subject|19
1128655|NCT02694978|2221997|FG000|Overall Study|Lost to Follow-up|14
1128656|NCT02694978|2221998|FG001|Overall Study|Lost to Follow-up|17
1128657|NCT02694978|2221997|FG000|Overall Study|Death|4
1128658|NCT02694978|2221998|FG001|Overall Study|Death|1
1128659|NCT02694978|2221997|FG000|Overall Study|Other-Decision of Participant|6
1128660|NCT02694978|2221998|FG001|Overall Study|Other-Decision of Participant|1
1128661|NCT02694978|2221997|FG000|Overall Study|Other-Investigator's decision|1
1128662|NCT02694978|2221998|FG001|Overall Study|Other-Investigator's decision|0
1128663|NCT02694978|2221997|FG000|Overall Study|Other-Unable to be reached|0
1128664|NCT02694978|2221998|FG001|Overall Study|Other-Unable to be reached|1
1128665|NCT02694978|2221997|FG000|Overall Study|Other-Protocol noncompliant|2
1128666|NCT02694978|2221998|FG001|Overall Study|Other-Protocol noncompliant|1
1128667|NCT02694978|2221997|FG000|Overall Study|Other-Personal reasons|3
1128668|NCT02694978|2221998|FG001|Overall Study|Other-Personal reasons|3
1128669|NCT02694978|2221997|FG000|Overall Study|Other-Withdrew prior to dosing|9
1128670|NCT02694978|2221998|FG001|Overall Study|Other-Withdrew prior to dosing|8
1128671|NCT02695329|2222010|FG000|Overall Study|Adverse Event|1
1128672|NCT02695329|2222011|FG001|Overall Study|Adverse Event|0
1128673|NCT02695329|2222010|FG000|Overall Study|Poor X-ray quality for measurement|4
1128674|NCT02695329|2222011|FG001|Overall Study|Poor X-ray quality for measurement|5
1128675|NCT02695420|2222021|FG000|Overall Study|Death|0
1128676|NCT02695420|2222022|FG001|Overall Study|Death|1
1128677|NCT02695420|2222023|FG002|Overall Study|Death|0
1128678|NCT02695420|2222024|FG003|Overall Study|Death|0
1128679|NCT02695524|2222043|FG000|Overall Study|Lost to Follow-up|3
1128680|NCT02695524|2222044|FG001|Overall Study|Lost to Follow-up|2
1128681|NCT02695524|2222043|FG000|Overall Study|Death|0
1128682|NCT02695524|2222044|FG001|Overall Study|Death|1
1128683|NCT02695537|2222050|FG000|Overall Study|Adverse Event|3
1128684|NCT02695537|2222050|FG000|Overall Study|Lack of Efficacy|28
1128685|NCT02695537|2222050|FG000|Overall Study|Withdrawal by Subject|4
1128686|NCT02695537|2222050|FG000|Overall Study|Protocol Violation|3
1128687|NCT02695628|2222054|FG000|Overall Study|Withdrawal by Subject|1
1128688|NCT02695719|2222060|FG000|Overall Study|Pretreatment Event/Adverse Event|2
1128689|NCT02695719|2222061|FG001|Overall Study|Pretreatment Event/Adverse Event|9
1128690|NCT02695719|2222060|FG000|Overall Study|Significant Protocol Deviation|0
1128691|NCT02695719|2222061|FG001|Overall Study|Significant Protocol Deviation|1
1128692|NCT02695719|2222060|FG000|Overall Study|Voluntary Withdrawal|1
1128693|NCT02695719|2222061|FG001|Overall Study|Voluntary Withdrawal|0
1128694|NCT02696031|2222070|FG000|Week 24|Adverse Event|2
1128695|NCT02696031|2222071|FG001|Week 24|Adverse Event|4
1128696|NCT02696031|2222072|FG002|Week 24|Adverse Event|2
1128697|NCT02696031|2222070|FG000|Week 24|Lack of Efficacy|2
1128698|NCT02696031|2222071|FG001|Week 24|Lack of Efficacy|1
1128699|NCT02696031|2222072|FG002|Week 24|Lack of Efficacy|2
1128700|NCT02696031|2222070|FG000|Week 24|Lost to Follow-up|0
1128701|NCT02696031|2222071|FG001|Week 24|Lost to Follow-up|1
1128702|NCT02696031|2222072|FG002|Week 24|Lost to Follow-up|1
1128703|NCT02696031|2222070|FG000|Week 24|Physician Decision|1
1128704|NCT02696031|2222071|FG001|Week 24|Physician Decision|0
1128705|NCT02696031|2222072|FG002|Week 24|Physician Decision|1
1128706|NCT02696031|2222070|FG000|Week 24|Protocol Violation|1
1128707|NCT02696031|2222071|FG001|Week 24|Protocol Violation|0
1128708|NCT02696031|2222072|FG002|Week 24|Protocol Violation|0
1128709|NCT02696031|2222070|FG000|Week 24|Withdrawal by Subject|4
1128710|NCT02696031|2222071|FG001|Week 24|Withdrawal by Subject|1
1128711|NCT02696031|2222072|FG002|Week 24|Withdrawal by Subject|5
1128712|NCT02696031|2222070|FG000|Week 52|Adverse Event|4
1128713|NCT02696031|2222071|FG001|Week 52|Adverse Event|5
1128714|NCT02696031|2222072|FG002|Week 52|Adverse Event|3
1128715|NCT02696031|2222070|FG000|Week 52|Lack of Efficacy|10
1128716|NCT02696031|2222071|FG001|Week 52|Lack of Efficacy|7
1128717|NCT02696031|2222072|FG002|Week 52|Lack of Efficacy|11
1128718|NCT02696031|2222070|FG000|Week 52|Lost to Follow-up|1
1128719|NCT02696031|2222071|FG001|Week 52|Lost to Follow-up|1
1128720|NCT02696031|2222072|FG002|Week 52|Lost to Follow-up|1
1128721|NCT02696031|2222070|FG000|Week 52|Physician Decision|1
1128722|NCT02696031|2222071|FG001|Week 52|Physician Decision|1
1128723|NCT02696031|2222072|FG002|Week 52|Physician Decision|2
1128724|NCT02696031|2222070|FG000|Week 52|Pregnancy|0
1128725|NCT02696031|2222071|FG001|Week 52|Pregnancy|2
1128726|NCT02696031|2222072|FG002|Week 52|Pregnancy|0
1128727|NCT02696031|2222070|FG000|Week 52|Protocol Violation|1
1128728|NCT02696031|2222071|FG001|Week 52|Protocol Violation|0
1128729|NCT02696031|2222072|FG002|Week 52|Protocol Violation|0
1128730|NCT02696031|2222070|FG000|Week 52|Withdrawal by Subject|12
1128731|NCT02696031|2222071|FG001|Week 52|Withdrawal by Subject|3
1128732|NCT02696031|2222072|FG002|Week 52|Withdrawal by Subject|9
1128733|NCT02696317|2222117|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2
1128734|NCT02696317|2222118|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4
1128735|NCT02696317|2222117|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1
1128736|NCT02696317|2222118|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0
1128737|NCT02696434|2222128|FG000|Overall Study|Adverse Event|3
1128738|NCT02696434|2222129|FG001|Overall Study|Adverse Event|1
1128739|NCT02696434|2222128|FG000|Overall Study|Lost to Follow-up|5
1128740|NCT02696434|2222129|FG001|Overall Study|Lost to Follow-up|4
1128741|NCT02696434|2222128|FG000|Overall Study|Withdrawal by Subject|14
1128742|NCT02696434|2222129|FG001|Overall Study|Withdrawal by Subject|12
1128743|NCT02696434|2222128|FG000|Overall Study|Physician Decision|0
1128744|NCT02696434|2222129|FG001|Overall Study|Physician Decision|1
1128745|NCT02696785|2222143|FG000|Blinded Treatment Period|Adverse Event|0
1128746|NCT02696785|2222144|FG001|Blinded Treatment Period|Adverse Event|1
1128747|NCT02696785|2222145|FG002|Blinded Treatment Period|Adverse Event|3
1128748|NCT02696785|2222146|FG003|Blinded Treatment Period|Adverse Event|0
1128749|NCT02696785|2222143|FG000|Blinded Treatment Period|Withdrawal by Subject|0
1128750|NCT02696785|2222144|FG001|Blinded Treatment Period|Withdrawal by Subject|1
1128751|NCT02696785|2222145|FG002|Blinded Treatment Period|Withdrawal by Subject|1
1128752|NCT02696785|2222146|FG003|Blinded Treatment Period|Withdrawal by Subject|2
1128753|NCT02696785|2222143|FG000|Blinded Treatment Period|Lack of Efficacy|0
1128754|NCT02696785|2222144|FG001|Blinded Treatment Period|Lack of Efficacy|0
1128755|NCT02696785|2222145|FG002|Blinded Treatment Period|Lack of Efficacy|0
1128756|NCT02696785|2222146|FG003|Blinded Treatment Period|Lack of Efficacy|1
1128757|NCT02696785|2222143|FG000|Blinded Treatment Period|Screen Failure|1
1128758|NCT02696785|2222144|FG001|Blinded Treatment Period|Screen Failure|0
1128759|NCT02696785|2222145|FG002|Blinded Treatment Period|Screen Failure|0
1128760|NCT02696785|2222146|FG003|Blinded Treatment Period|Screen Failure|0
1128761|NCT02696785|2222143|FG000|Washout Period|Withdrawal by Subject|0
1128762|NCT02696785|2222144|FG001|Washout Period|Withdrawal by Subject|1
1128763|NCT02696785|2222145|FG002|Washout Period|Withdrawal by Subject|0
1128764|NCT02696785|2222146|FG003|Washout Period|Withdrawal by Subject|0
1128765|NCT02696785|2222143|FG000|Washout Period|Lack of Efficacy|0
1128766|NCT02696785|2222144|FG001|Washout Period|Lack of Efficacy|1
1128767|NCT02696785|2222145|FG002|Washout Period|Lack of Efficacy|0
1128768|NCT02696785|2222146|FG003|Washout Period|Lack of Efficacy|0
1128769|NCT02696785|2222143|FG000|Extended Treatment Period|Adverse Event|2
1128770|NCT02696785|2222144|FG001|Extended Treatment Period|Adverse Event|3
1128771|NCT02696785|2222145|FG002|Extended Treatment Period|Adverse Event|2
1128772|NCT02696785|2222146|FG003|Extended Treatment Period|Adverse Event|1
1128773|NCT02696785|2222143|FG000|Extended Treatment Period|Lack of Efficacy|0
1128774|NCT02696785|2222144|FG001|Extended Treatment Period|Lack of Efficacy|1
1128775|NCT02696785|2222145|FG002|Extended Treatment Period|Lack of Efficacy|0
1128776|NCT02696785|2222146|FG003|Extended Treatment Period|Lack of Efficacy|0
1128777|NCT02696785|2222143|FG000|Extended Treatment Period|Withdrawal by Subject|1
1128778|NCT02696785|2222144|FG001|Extended Treatment Period|Withdrawal by Subject|2
1128779|NCT02696785|2222145|FG002|Extended Treatment Period|Withdrawal by Subject|3
1128780|NCT02696785|2222146|FG003|Extended Treatment Period|Withdrawal by Subject|5
1128781|NCT02696785|2222143|FG000|Follow-up Period|Adverse Event|0
1128782|NCT02696785|2222144|FG001|Follow-up Period|Adverse Event|0
1128783|NCT02696785|2222145|FG002|Follow-up Period|Adverse Event|8
1128784|NCT02696785|2222146|FG003|Follow-up Period|Adverse Event|2
1128785|NCT02696785|2222143|FG000|Follow-up Period|Lost to Follow-up|0
1128786|NCT02696785|2222144|FG001|Follow-up Period|Lost to Follow-up|0
1128787|NCT02696785|2222145|FG002|Follow-up Period|Lost to Follow-up|0
1128788|NCT02696785|2222146|FG003|Follow-up Period|Lost to Follow-up|1
1128789|NCT02696785|2222143|FG000|Follow-up Period|Lack of Efficacy|0
1128790|NCT02696785|2222144|FG001|Follow-up Period|Lack of Efficacy|0
1128791|NCT02696785|2222145|FG002|Follow-up Period|Lack of Efficacy|0
1128792|NCT02696785|2222146|FG003|Follow-up Period|Lack of Efficacy|1
1128793|NCT02696785|2222143|FG000|Follow-up Period|Withdrawal by Subject|1
1128794|NCT02696785|2222144|FG001|Follow-up Period|Withdrawal by Subject|0
1128795|NCT02696785|2222145|FG002|Follow-up Period|Withdrawal by Subject|5
1128796|NCT02696785|2222146|FG003|Follow-up Period|Withdrawal by Subject|4
1128797|NCT02696798|2222177|FG000|Blinded Treatment Dosing Period|Adverse Event|2
1128798|NCT02696798|2222178|FG001|Blinded Treatment Dosing Period|Adverse Event|9
1128799|NCT02696798|2222179|FG002|Blinded Treatment Dosing Period|Adverse Event|2
1128800|NCT02696798|2222177|FG000|Blinded Treatment Dosing Period|Death|0
1128801|NCT02696798|2222178|FG001|Blinded Treatment Dosing Period|Death|0
1128802|NCT02696798|2222179|FG002|Blinded Treatment Dosing Period|Death|1
1128803|NCT02696798|2222177|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2
1128804|NCT02696798|2222178|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1
1128805|NCT02696798|2222179|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1
1128806|NCT02696798|2222177|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0
1128807|NCT02696798|2222178|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1
1128808|NCT02696798|2222179|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0
1128809|NCT02696798|2222177|FG000|Blinded Treatment Dosing Period|Physician Decision|0
1128810|NCT02696798|2222178|FG001|Blinded Treatment Dosing Period|Physician Decision|1
1128811|NCT02696798|2222179|FG002|Blinded Treatment Dosing Period|Physician Decision|0
1128812|NCT02696798|2222177|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7
1128813|NCT02696798|2222178|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3
1128814|NCT02696798|2222179|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4
1128815|NCT02696798|2222177|FG000|Extended Treatment Period|Adverse Event|1
1128816|NCT02696798|2222178|FG001|Extended Treatment Period|Adverse Event|4
1128817|NCT02696798|2222179|FG002|Extended Treatment Period|Adverse Event|5
1128818|NCT02696798|2222177|FG000|Extended Treatment Period|Lack of Efficacy|7
1128819|NCT02696798|2222178|FG001|Extended Treatment Period|Lack of Efficacy|2
1128820|NCT02696798|2222179|FG002|Extended Treatment Period|Lack of Efficacy|2
1128821|NCT02696798|2222177|FG000|Extended Treatment Period|Lost to Follow-up|1
1128822|NCT02696798|2222178|FG001|Extended Treatment Period|Lost to Follow-up|0
1128823|NCT02696798|2222179|FG002|Extended Treatment Period|Lost to Follow-up|0
1128824|NCT02696798|2222177|FG000|Extended Treatment Period|Physician Decision|0
1128825|NCT02696798|2222178|FG001|Extended Treatment Period|Physician Decision|1
1128826|NCT02696798|2222179|FG002|Extended Treatment Period|Physician Decision|0
1128827|NCT02696798|2222177|FG000|Extended Treatment Period|Withdrawal by Subject|3
1128828|NCT02696798|2222178|FG001|Extended Treatment Period|Withdrawal by Subject|2
1128829|NCT02696798|2222179|FG002|Extended Treatment Period|Withdrawal by Subject|3
1128830|NCT02696798|2222177|FG000|Post-treatment Follow-up Period|Adverse Event|2
1128831|NCT02696798|2222178|FG001|Post-treatment Follow-up Period|Adverse Event|12
1128832|NCT02696798|2222179|FG002|Post-treatment Follow-up Period|Adverse Event|6
1128833|NCT02696798|2222177|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0
1128834|NCT02696798|2222178|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1
1128835|NCT02696798|2222179|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1
1128836|NCT02696798|2222177|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1
1128837|NCT02696798|2222178|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2
1128838|NCT02696798|2222179|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0
1128839|NCT02696798|2222177|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2
1128840|NCT02696798|2222178|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8
1128841|NCT02696798|2222179|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12
1128842|NCT02696798|2222177|FG000|Post-treatment Follow-up Period|Physician Decision|0
1128843|NCT02696798|2222178|FG001|Post-treatment Follow-up Period|Physician Decision|2
1128844|NCT02696798|2222179|FG002|Post-treatment Follow-up Period|Physician Decision|0
1128845|NCT02696798|2222177|FG000|Post-treatment Follow-up Period|No progressive improvement|0
1128846|NCT02696798|2222178|FG001|Post-treatment Follow-up Period|No progressive improvement|1
1128847|NCT02696798|2222179|FG002|Post-treatment Follow-up Period|No progressive improvement|0
1128848|NCT02696850|2222203|FG000|Overall Study|Withdrawal by Subject|3
1128849|NCT02696850|2222204|FG001|Overall Study|Withdrawal by Subject|3
1128850|NCT02696850|2222203|FG000|Overall Study|Lost to Follow-up|8
1128851|NCT02696850|2222204|FG001|Overall Study|Lost to Follow-up|5
1128852|NCT02696902|2222213|FG000|Overall Study|Lost to Follow-up|0
1128853|NCT02696902|2222214|FG001|Overall Study|Lost to Follow-up|1
1128854|NCT02696902|2222215|FG002|Overall Study|Lost to Follow-up|1
1128855|NCT02696902|2222213|FG000|Overall Study|Withdrawal by Subject|0
1128856|NCT02696902|2222214|FG001|Overall Study|Withdrawal by Subject|0
1128857|NCT02696902|2222215|FG002|Overall Study|Withdrawal by Subject|1
1128858|NCT02696902|2222213|FG000|Overall Study|Death|19
1128859|NCT02696902|2222214|FG001|Overall Study|Death|3
1128860|NCT02696902|2222215|FG002|Overall Study|Death|24
1128861|NCT02696902|2222213|FG000|Overall Study|Participant not fit post-randomization|0
1128862|NCT02696902|2222214|FG001|Overall Study|Participant not fit post-randomization|0
1128863|NCT02696902|2222215|FG002|Overall Study|Participant not fit post-randomization|1
1128864|NCT02696902|2222213|FG000|Overall Study|Participant not eligible (negative PCR)|0
1128865|NCT02696902|2222214|FG001|Overall Study|Participant not eligible (negative PCR)|0
1128866|NCT02696902|2222215|FG002|Overall Study|Participant not eligible (negative PCR)|1
1128867|NCT02696902|2222213|FG000|Overall Study|Principal investigator's decision|1
1128868|NCT02696902|2222214|FG001|Overall Study|Principal investigator's decision|0
1128869|NCT02696902|2222215|FG002|Overall Study|Principal investigator's decision|0
1128870|NCT02696902|2222213|FG000|Overall Study|Sponsor's decision|1
1128871|NCT02696902|2222214|FG001|Overall Study|Sponsor's decision|0
1128872|NCT02696902|2222215|FG002|Overall Study|Sponsor's decision|0
1128873|NCT02696902|2222213|FG000|Overall Study|Transferred to other hospital|1
1128874|NCT02696902|2222214|FG001|Overall Study|Transferred to other hospital|0
1128875|NCT02696902|2222215|FG002|Overall Study|Transferred to other hospital|0
1128876|NCT02697435|2222294|FG000|Overall Study|Withdrawal by Subject|1
1128877|NCT02697435|2222295|FG001|Overall Study|Withdrawal by Subject|0
1128878|NCT02697435|2222294|FG000|Overall Study|Physician Decision|0
1128879|NCT02697435|2222295|FG001|Overall Study|Physician Decision|4
1128880|NCT02697591|2222312|FG000|Overall Study|Lost to Follow-up|0
1128881|NCT02697591|2222313|FG001|Overall Study|Lost to Follow-up|0
1128882|NCT02697591|2222314|FG002|Overall Study|Lost to Follow-up|0
1128883|NCT02697591|2222315|FG003|Overall Study|Lost to Follow-up|0
1128884|NCT02697591|2222316|FG004|Overall Study|Lost to Follow-up|0
1128885|NCT02697591|2222317|FG005|Overall Study|Lost to Follow-up|1
1128886|NCT02697591|2222318|FG006|Overall Study|Lost to Follow-up|1
1128887|NCT02697591|2222319|FG007|Overall Study|Lost to Follow-up|0
1128888|NCT02697591|2222320|FG008|Overall Study|Lost to Follow-up|0
1128889|NCT02697591|2222321|FG009|Overall Study|Lost to Follow-up|1
1128890|NCT02697591|2222312|FG000|Overall Study|Withdrawal by Subject|1
1128891|NCT02697591|2222313|FG001|Overall Study|Withdrawal by Subject|1
1128892|NCT02697591|2222314|FG002|Overall Study|Withdrawal by Subject|2
1128893|NCT02697591|2222315|FG003|Overall Study|Withdrawal by Subject|1
1128894|NCT02697591|2222316|FG004|Overall Study|Withdrawal by Subject|7
1128895|NCT02697591|2222317|FG005|Overall Study|Withdrawal by Subject|6
1128896|NCT02697591|2222318|FG006|Overall Study|Withdrawal by Subject|9
1128897|NCT02697591|2222319|FG007|Overall Study|Withdrawal by Subject|1
1128898|NCT02697591|2222320|FG008|Overall Study|Withdrawal by Subject|6
1128899|NCT02697591|2222321|FG009|Overall Study|Withdrawal by Subject|10
1128900|NCT02697591|2222312|FG000|Overall Study|Physician Decision|1
1128901|NCT02697591|2222313|FG001|Overall Study|Physician Decision|0
1128902|NCT02697591|2222314|FG002|Overall Study|Physician Decision|0
1128903|NCT02697591|2222315|FG003|Overall Study|Physician Decision|0
1128904|NCT02697591|2222316|FG004|Overall Study|Physician Decision|1
1128905|NCT02697591|2222317|FG005|Overall Study|Physician Decision|2
1128906|NCT02697591|2222318|FG006|Overall Study|Physician Decision|0
1128907|NCT02697591|2222319|FG007|Overall Study|Physician Decision|0
1128908|NCT02697591|2222320|FG008|Overall Study|Physician Decision|1
1128909|NCT02697591|2222321|FG009|Overall Study|Physician Decision|1
1128910|NCT02697591|2222312|FG000|Overall Study|Death|2
1128911|NCT02697591|2222313|FG001|Overall Study|Death|3
1128912|NCT02697591|2222314|FG002|Overall Study|Death|1
1128913|NCT02697591|2222315|FG003|Overall Study|Death|1
1128914|NCT02697591|2222316|FG004|Overall Study|Death|4
1128915|NCT02697591|2222317|FG005|Overall Study|Death|5
1128916|NCT02697591|2222318|FG006|Overall Study|Death|3
1128917|NCT02697591|2222319|FG007|Overall Study|Death|1
1128918|NCT02697591|2222320|FG008|Overall Study|Death|1
1128919|NCT02697591|2222321|FG009|Overall Study|Death|5
900095|NCT00725712|1873155|FG001|Overall Study|Withdrawal by Subject|1
900096|NCT00725712|1873154|FG000|Overall Study|Protocol Violation|1
900097|NCT00725712|1873155|FG001|Overall Study|Protocol Violation|0
900098|NCT00725712|1873154|FG000|Overall Study|Progressive disease|37
900099|NCT00725712|1873155|FG001|Overall Study|Progressive disease|16
900100|NCT00725712|1873154|FG000|Overall Study|Clinical progression not based on RECIST|0
900101|NCT00725712|1873155|FG001|Overall Study|Clinical progression not based on RECIST|3
900102|NCT00725712|1873154|FG000|Overall Study|Adverse Event|5
900103|NCT00725712|1873155|FG001|Overall Study|Adverse Event|5
900104|NCT00725712|1873154|FG000|Overall Study|Death|2
900105|NCT00725712|1873155|FG001|Overall Study|Death|0
900106|NCT00725712|1873154|FG000|Overall Study|Other: Death|1
900107|NCT00725712|1873155|FG001|Overall Study|Other: Death|0
900108|NCT00725712|1873154|FG000|Overall Study|Hospitalized, unable to continue|0
900109|NCT00725712|1873155|FG001|Overall Study|Hospitalized, unable to continue|1
900110|NCT00725725|1873168|FG000|Overall Study|Adverse Event|1
1128920|NCT02697591|2222312|FG000|Overall Study|Reason not Specified|0
1128921|NCT02697591|2222313|FG001|Overall Study|Reason not Specified|0
1128922|NCT02697591|2222314|FG002|Overall Study|Reason not Specified|0
1128923|NCT02697591|2222315|FG003|Overall Study|Reason not Specified|1
1128924|NCT02697591|2222316|FG004|Overall Study|Reason not Specified|1
1128925|NCT02697591|2222317|FG005|Overall Study|Reason not Specified|2
1128926|NCT02697591|2222318|FG006|Overall Study|Reason not Specified|3
1128927|NCT02697591|2222319|FG007|Overall Study|Reason not Specified|1
1128928|NCT02697591|2222320|FG008|Overall Study|Reason not Specified|1
1128929|NCT02697591|2222321|FG009|Overall Study|Reason not Specified|3
1128930|NCT02697617|2222344|FG000|Overall Study|Withdrawal by Subject|0
1128931|NCT02697617|2222345|FG001|Overall Study|Withdrawal by Subject|2
1128932|NCT02697617|2222344|FG000|Overall Study|Pregnancy|1
1128933|NCT02697617|2222345|FG001|Overall Study|Pregnancy|0
1128934|NCT02697734|2222357|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4
1128935|NCT02697734|2222358|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0
1128936|NCT02697734|2222357|FG000|Core Phase - up to Week 48|Adverse Event|1
1128937|NCT02697734|2222358|FG001|Core Phase - up to Week 48|Adverse Event|2
1128938|NCT02697734|2222357|FG000|Core Phase - up to Week 48|Physician Decision|1
1128939|NCT02697734|2222358|FG001|Core Phase - up to Week 48|Physician Decision|0
1128940|NCT02697734|2222357|FG000|Optional Extension Phase|Adverse Event|5
1128941|NCT02697734|2222358|FG001|Optional Extension Phase|Adverse Event|1
1128942|NCT02697734|2222357|FG000|Optional Extension Phase|Physician Decision|0
1128943|NCT02697734|2222358|FG001|Optional Extension Phase|Physician Decision|1
1128944|NCT02697916|2222396|FG000|Overall Study|Death|357
1128945|NCT02697916|2222397|FG001|Overall Study|Death|315
1128946|NCT02697916|2222396|FG000|Overall Study|Withdrawal by Subject|221
1128947|NCT02697916|2222397|FG001|Overall Study|Withdrawal by Subject|393
1128948|NCT02698176|2222410|FG000|Overall Study|Progressive disease|4
1128949|NCT02698176|2222411|FG001|Overall Study|Progressive disease|3
1128950|NCT02698176|2222412|FG002|Overall Study|Progressive disease|1
1128951|NCT02698176|2222413|FG003|Overall Study|Progressive disease|0
1128952|NCT02698176|2222410|FG000|Overall Study|Adverse Event|2
1128953|NCT02698176|2222411|FG001|Overall Study|Adverse Event|0
1128954|NCT02698176|2222412|FG002|Overall Study|Adverse Event|0
1128955|NCT02698176|2222413|FG003|Overall Study|Adverse Event|0
1128956|NCT02698176|2222410|FG000|Overall Study|Clinical progression|3
1128957|NCT02698176|2222411|FG001|Overall Study|Clinical progression|0
1128958|NCT02698176|2222412|FG002|Overall Study|Clinical progression|0
1128959|NCT02698176|2222413|FG003|Overall Study|Clinical progression|0
1128960|NCT02698189|2222426|FG000|Overall Study|Progressive disease|3
1128961|NCT02698189|2222427|FG001|Overall Study|Progressive disease|5
1128962|NCT02698189|2222426|FG000|Overall Study|Still ongoing in the study|0
1128963|NCT02698189|2222427|FG001|Overall Study|Still ongoing in the study|1
1128964|NCT02698241|2222444|FG000|Overall Study|Inclusion/exclusion criteria not met|4
1128965|NCT02698241|2222444|FG000|Overall Study|Screening not met|7
1128966|NCT02698241|2222444|FG000|Overall Study|Withdrawal by Subject|7
1128967|NCT02698241|2222444|FG000|Overall Study|Physician Decision|2
1128968|NCT02698241|2222444|FG000|Overall Study|Subject underwent system modification|2
1128969|NCT02698241|2222444|FG000|Overall Study|Lost to Follow-up|3
1128970|NCT02698241|2222444|FG000|Overall Study|Subject on inodrip not safe to continue|6
1128971|NCT02698241|2222444|FG000|Overall Study|geographic and licensing issue|1
1128972|NCT02698241|2222444|FG000|Overall Study|Death|2
1128973|NCT02698371|2222448|FG000|All Participants Flow|Lost to Follow-up|3
1128974|NCT02698371|2222448|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
1128975|NCT02698371|2222448|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
1128976|NCT02698371|2222448|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
1128977|NCT02698371|2222448|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
1128978|NCT02698371|2222448|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
1128979|NCT02698371|2222448|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
1128980|NCT02698410|2222464|FG000|Overall Study|Adverse Event|2
1128981|NCT02698410|2222464|FG000|Overall Study|Withdrawal by Subject|1
1128982|NCT02698410|2222464|FG000|Overall Study|Other|1
1128983|NCT02698423|2222470|FG000|Overall Study|Lost to Follow-up|19
1128984|NCT02698423|2222471|FG001|Overall Study|Lost to Follow-up|24
1128985|NCT02698436|2222481|FG000|Overall Study|Adverse Event|1
1128986|NCT02698436|2222482|FG001|Overall Study|Adverse Event|0
1128987|NCT02698436|2222481|FG000|Overall Study|Withdrawal by Subject|3
1128988|NCT02698436|2222482|FG001|Overall Study|Withdrawal by Subject|3
1128989|NCT02698436|2222481|FG000|Overall Study|Lost to Follow-up|2
1128990|NCT02698436|2222482|FG001|Overall Study|Lost to Follow-up|4
1128991|NCT02698436|2222481|FG000|Overall Study|Non-compliance with study regimen|1
1128992|NCT02698436|2222482|FG001|Overall Study|Non-compliance with study regimen|0
1128993|NCT02698475|2222488|FG000|Main Study Period|Lack of Efficacy|1
1128994|NCT02698475|2222488|FG000|Main Study Period|Protocol Violation|2
1128995|NCT02698475|2222488|FG000|Long-Term Extension Period|Lost to Follow-up|1
1128996|NCT02698475|2222488|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1
1128997|NCT02698475|2222488|FG000|Long-Term Extension Period|Withdrawal by Subject|3
1128998|NCT02698475|2222488|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22
1128999|NCT02698475|2222488|FG000|Long-Term Extension Period|Other|1
1129000|NCT02698787|2222512|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0
1129001|NCT02698787|2222513|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1
1129002|NCT02699099|2222530|FG000|Overall Study|Adverse Event|1
1129003|NCT02699099|2222531|FG001|Overall Study|Adverse Event|0
1129004|NCT02699099|2222532|FG002|Overall Study|Adverse Event|2
1129005|NCT02699099|2222530|FG000|Overall Study|Lost to Follow-up|0
1129006|NCT02699099|2222531|FG001|Overall Study|Lost to Follow-up|1
1129007|NCT02699099|2222532|FG002|Overall Study|Lost to Follow-up|0
1129008|NCT02699099|2222530|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7
1129009|NCT02699099|2222531|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
1129010|NCT02699099|2222532|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4
1129011|NCT02699125|2222542|FG000|Placebo|Lost to Follow-up|2
1129012|NCT02699125|2222543|FG001|Placebo|Lost to Follow-up|0
1129013|NCT02699125|2222542|FG000|Placebo|Protocol Violation|1
1129014|NCT02699125|2222543|FG001|Placebo|Protocol Violation|0
1129015|NCT02699125|2222542|FG000|Placebo|Withdrawal by Subject|0
1129016|NCT02699125|2222543|FG001|Placebo|Withdrawal by Subject|4
1129017|NCT02699125|2222542|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7
1129018|NCT02699125|2222543|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
1129019|NCT02699450|2222556|FG000|Overall Study|Death|2
1129020|NCT02699450|2222557|FG001|Overall Study|Death|1
1129021|NCT02699450|2222558|FG002|Overall Study|Death|2
1129022|NCT02699450|2222556|FG000|Overall Study|Met Criteria for Study Exit|0
1129023|NCT02699450|2222557|FG001|Overall Study|Met Criteria for Study Exit|0
1129024|NCT02699450|2222558|FG002|Overall Study|Met Criteria for Study Exit|1
1129025|NCT02699450|2222556|FG000|Overall Study|Protocol Violation|4
1129026|NCT02699450|2222557|FG001|Overall Study|Protocol Violation|3
1129027|NCT02699450|2222558|FG002|Overall Study|Protocol Violation|5
1129028|NCT02699450|2222556|FG000|Overall Study|Lost to Follow-up|3
1129029|NCT02699450|2222557|FG001|Overall Study|Lost to Follow-up|0
1129030|NCT02699450|2222558|FG002|Overall Study|Lost to Follow-up|5
1129031|NCT02699450|2222556|FG000|Overall Study|Physician Decision|2
1129032|NCT02699450|2222557|FG001|Overall Study|Physician Decision|0
1129033|NCT02699450|2222558|FG002|Overall Study|Physician Decision|0
1129034|NCT02699450|2222556|FG000|Overall Study|Withdrawal by Subject|3
1129035|NCT02699450|2222557|FG001|Overall Study|Withdrawal by Subject|1
1129036|NCT02699450|2222558|FG002|Overall Study|Withdrawal by Subject|2
1129037|NCT02699450|2222556|FG000|Overall Study|Adverse Event|1
1129038|NCT02699450|2222557|FG001|Overall Study|Adverse Event|0
1129039|NCT02699450|2222558|FG002|Overall Study|Adverse Event|0
1129040|NCT02699463|2222569|FG000|Overall Study|Lost to Follow-up|11
1129041|NCT02699463|2222570|FG001|Overall Study|Lost to Follow-up|8
1129042|NCT02699463|2222569|FG000|Overall Study|Withdrawal by Subject|4
1129043|NCT02699463|2222570|FG001|Overall Study|Withdrawal by Subject|1
1129044|NCT02699593|2222576|FG000|Period 1|Unsatisfactory Visual Response|0
1129045|NCT02699593|2222577|FG001|Period 1|Unsatisfactory Visual Response|1
1129046|NCT02699593|2222576|FG000|Period 1|Torn Contact Len|4
1129047|NCT02699593|2222577|FG001|Period 1|Torn Contact Len|3
1129048|NCT02699593|2222576|FG000|Period 1|Protocol Violation|0
1129049|NCT02699593|2222577|FG001|Period 1|Protocol Violation|1
1129050|NCT02699593|2222576|FG000|Period 1|Withdrawal by Subject|0
1129051|NCT02699593|2222577|FG001|Period 1|Withdrawal by Subject|1
1129052|NCT02699593|2222576|FG000|Period 1|Adverse Event|1
1129053|NCT02699593|2222577|FG001|Period 1|Adverse Event|1
1129054|NCT02699593|2222576|FG000|Period 2|Adverse Event|1
1129055|NCT02699593|2222577|FG001|Period 2|Adverse Event|1
1129056|NCT02699593|2222576|FG000|Period 2|Lost Contact Lens|0
1129057|NCT02699593|2222577|FG001|Period 2|Lost Contact Lens|1
1129058|NCT02699593|2222576|FG000|Period 2|Torn Contact Lens|1
1129059|NCT02699593|2222577|FG001|Period 2|Torn Contact Lens|0
1129060|NCT02699684|2222590|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
1129061|NCT02699684|2222591|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0
1129062|NCT02699749|2222612|FG000|Overall Study|Other|0
1129063|NCT02699749|2222613|FG001|Overall Study|Other|0
1129064|NCT02699749|2222614|FG002|Overall Study|Other|2
1129065|NCT02699749|2222615|FG003|Overall Study|Other|0
1129066|NCT02699749|2222616|FG004|Overall Study|Other|0
1129067|NCT02699749|2222617|FG005|Overall Study|Other|1
1129068|NCT02699749|2222618|FG006|Overall Study|Other|1
1129069|NCT02699749|2222619|FG007|Overall Study|Other|0
1129070|NCT02699749|2222620|FG008|Overall Study|Other|0
1129071|NCT02699749|2222621|FG009|Overall Study|Other|0
1129072|NCT02699749|2222622|FG010|Overall Study|Other|1
1129073|NCT02699749|2222623|FG011|Overall Study|Other|0
1129074|NCT02699749|2222624|FG012|Overall Study|Other|0
1129075|NCT02699749|2222625|FG013|Overall Study|Other|0
1129076|NCT02699749|2222612|FG000|Overall Study|Progressive Disease|3
1129077|NCT02699749|2222613|FG001|Overall Study|Progressive Disease|3
1129078|NCT02699749|2222614|FG002|Overall Study|Progressive Disease|14
1129079|NCT02699749|2222615|FG003|Overall Study|Progressive Disease|3
1129080|NCT02699749|2222616|FG004|Overall Study|Progressive Disease|3
1129081|NCT02699749|2222617|FG005|Overall Study|Progressive Disease|7
1129082|NCT02699749|2222618|FG006|Overall Study|Progressive Disease|5
1129083|NCT02699749|2222619|FG007|Overall Study|Progressive Disease|5
1129084|NCT02699749|2222620|FG008|Overall Study|Progressive Disease|6
1129085|NCT02699749|2222621|FG009|Overall Study|Progressive Disease|6
1129086|NCT02699749|2222622|FG010|Overall Study|Progressive Disease|5
1129087|NCT02699749|2222623|FG011|Overall Study|Progressive Disease|4
1129088|NCT02699749|2222624|FG012|Overall Study|Progressive Disease|3
1129089|NCT02699749|2222625|FG013|Overall Study|Progressive Disease|5
1129090|NCT02699749|2222612|FG000|Overall Study|Death|0
1129091|NCT02699749|2222613|FG001|Overall Study|Death|0
1129092|NCT02699749|2222614|FG002|Overall Study|Death|0
1129093|NCT02699749|2222615|FG003|Overall Study|Death|0
1129094|NCT02699749|2222616|FG004|Overall Study|Death|0
1129095|NCT02699749|2222617|FG005|Overall Study|Death|0
1129096|NCT02699749|2222618|FG006|Overall Study|Death|0
1129097|NCT02699749|2222619|FG007|Overall Study|Death|0
1129098|NCT02699749|2222620|FG008|Overall Study|Death|0
1129099|NCT02699749|2222621|FG009|Overall Study|Death|0
1129100|NCT02699749|2222622|FG010|Overall Study|Death|0
1129101|NCT02699749|2222623|FG011|Overall Study|Death|0
1129102|NCT02699749|2222624|FG012|Overall Study|Death|0
1129103|NCT02699749|2222625|FG013|Overall Study|Death|1
1129104|NCT02699749|2222612|FG000|Overall Study|Lost to Follow-up|0
1129105|NCT02699749|2222613|FG001|Overall Study|Lost to Follow-up|0
1129106|NCT02699749|2222614|FG002|Overall Study|Lost to Follow-up|0
1129107|NCT02699749|2222615|FG003|Overall Study|Lost to Follow-up|0
1129108|NCT02699749|2222616|FG004|Overall Study|Lost to Follow-up|0
1129109|NCT02699749|2222617|FG005|Overall Study|Lost to Follow-up|1
1129110|NCT02699749|2222618|FG006|Overall Study|Lost to Follow-up|0
1129111|NCT02699749|2222619|FG007|Overall Study|Lost to Follow-up|1
1129112|NCT02699749|2222620|FG008|Overall Study|Lost to Follow-up|0
1129113|NCT02699749|2222621|FG009|Overall Study|Lost to Follow-up|0
1129114|NCT02699749|2222622|FG010|Overall Study|Lost to Follow-up|0
1129115|NCT02699749|2222623|FG011|Overall Study|Lost to Follow-up|0
1129116|NCT02699749|2222624|FG012|Overall Study|Lost to Follow-up|0
1129117|NCT02699749|2222625|FG013|Overall Study|Lost to Follow-up|0
1129118|NCT02699866|2222655|FG000|Overall Study|Withdrawal by Subject|3
1129119|NCT02699866|2222655|FG000|Overall Study|Physician Decision|2
1129120|NCT02699866|2222655|FG000|Overall Study|Adverse Event|3
1129121|NCT02699892|2222659|FG000|Overall Study|Other|36
1129122|NCT02699983|2222670|FG000|Overall Study|Withdrawal by Subject|1
1129123|NCT02699983|2222671|FG001|Overall Study|Withdrawal by Subject|0
1129124|NCT02699996|2222683|FG000|Overall Study|Withdrawal by Subject|5
1129125|NCT02699996|2222684|FG001|Overall Study|Withdrawal by Subject|2
1129126|NCT02700412|2222705|FG000|Overall Study|Adverse Event|6
1129127|NCT02700412|2222705|FG000|Overall Study|Death|1
1129128|NCT02700412|2222705|FG000|Overall Study|Lack of Efficacy|19
1129129|NCT02700412|2222705|FG000|Overall Study|Protocol Violation|5
1129130|NCT02700412|2222705|FG000|Overall Study|Withdrawal by Subject|2
1129131|NCT02700815|2222722|FG000|Overall Study|Adverse Event|0
1129132|NCT02700815|2222723|FG001|Overall Study|Adverse Event|6
1129133|NCT02700815|2222724|FG002|Overall Study|Adverse Event|2
1129134|NCT02700815|2222725|FG003|Overall Study|Adverse Event|3
1129135|NCT02700815|2222722|FG000|Overall Study|Lack of Efficacy|0
1129136|NCT02700815|2222723|FG001|Overall Study|Lack of Efficacy|0
1129137|NCT02700815|2222724|FG002|Overall Study|Lack of Efficacy|1
1129138|NCT02700815|2222725|FG003|Overall Study|Lack of Efficacy|2
1129139|NCT02700815|2222722|FG000|Overall Study|Lost to Follow-up|1
1129140|NCT02700815|2222723|FG001|Overall Study|Lost to Follow-up|0
1129141|NCT02700815|2222724|FG002|Overall Study|Lost to Follow-up|0
1129142|NCT02700815|2222725|FG003|Overall Study|Lost to Follow-up|1
1129143|NCT02700815|2222722|FG000|Overall Study|Refusal to continue medication|0
1129144|NCT02700815|2222723|FG001|Overall Study|Refusal to continue medication|1
1129145|NCT02700815|2222724|FG002|Overall Study|Refusal to continue medication|0
1129146|NCT02700815|2222725|FG003|Overall Study|Refusal to continue medication|1
1129147|NCT02700815|2222722|FG000|Overall Study|Withdrawal by Subject|0
1129148|NCT02700815|2222723|FG001|Overall Study|Withdrawal by Subject|0
1129149|NCT02700815|2222724|FG002|Overall Study|Withdrawal by Subject|1
1129150|NCT02700815|2222725|FG003|Overall Study|Withdrawal by Subject|0
1129151|NCT02700919|2222738|FG000|Overall Study|Physician Decision|1
1129152|NCT02700919|2222739|FG001|Overall Study|Physician Decision|0
1129153|NCT02700919|2222740|FG002|Overall Study|Physician Decision|0
1129154|NCT02700919|2222738|FG000|Overall Study|Protocol Violation|1
1129155|NCT02700919|2222739|FG001|Overall Study|Protocol Violation|0
1129156|NCT02700919|2222740|FG002|Overall Study|Protocol Violation|0
1129157|NCT02700919|2222738|FG000|Overall Study|Adverse Event|1
1129158|NCT02700919|2222739|FG001|Overall Study|Adverse Event|3
1129159|NCT02700919|2222740|FG002|Overall Study|Adverse Event|1
1129160|NCT02700919|2222738|FG000|Overall Study|Withdrawal by Subject|5
1129161|NCT02700919|2222739|FG001|Overall Study|Withdrawal by Subject|8
1129162|NCT02700919|2222740|FG002|Overall Study|Withdrawal by Subject|2
1129163|NCT02700919|2222738|FG000|Overall Study|Lost to Follow-up|2
1129164|NCT02700919|2222739|FG001|Overall Study|Lost to Follow-up|0
1129165|NCT02700919|2222740|FG002|Overall Study|Lost to Follow-up|0
1129166|NCT02700919|2222738|FG000|Overall Study|Other|2
1129167|NCT02700919|2222739|FG001|Overall Study|Other|1
1129168|NCT02700919|2222740|FG002|Overall Study|Other|1
1129169|NCT02700984|2222759|FG000|Overall Study|Death|2
1129170|NCT02700984|2222760|FG001|Overall Study|Death|1
1129171|NCT02700984|2222759|FG000|Overall Study|Lost to Follow-up|2
1129172|NCT02700984|2222760|FG001|Overall Study|Lost to Follow-up|1
1129173|NCT02700984|2222759|FG000|Overall Study|Physician Decision|0
1129174|NCT02700984|2222760|FG001|Overall Study|Physician Decision|1
1129175|NCT02700984|2222759|FG000|Overall Study|Withdrawal by Subject|8
1129176|NCT02700984|2222760|FG001|Overall Study|Withdrawal by Subject|9
1129177|NCT02700984|2222759|FG000|Overall Study|Reason not specified|3
1129178|NCT02700984|2222760|FG001|Overall Study|Reason not specified|2
1129179|NCT02700997|2222776|FG000|Overall Study|Did not undergo CT imaging|1
1129180|NCT02700997|2222776|FG000|Overall Study|No CT measurement - pelvic calcification|1
1129181|NCT02701192|2222819|FG000|Overall Study|Protocol Violation|2
1129182|NCT02701192|2222819|FG000|Overall Study|Lost to Follow-up|4
1129193|NCT02701296|2222873|FG000|Overall Study|Incomplete Data|0
1129194|NCT02701296|2222874|FG001|Overall Study|Incomplete Data|2
1129195|NCT02701361|2222883|FG000|Overall Study|Lost to Follow-up|5
1129196|NCT02701361|2222884|FG001|Overall Study|Lost to Follow-up|2
1129197|NCT02701361|2222885|FG002|Overall Study|Lost to Follow-up|1
1129198|NCT02701361|2222883|FG000|Overall Study|Withdrawal by Subject|4
1129199|NCT02701361|2222884|FG001|Overall Study|Withdrawal by Subject|0
1129200|NCT02701361|2222885|FG002|Overall Study|Withdrawal by Subject|0
1129201|NCT02701361|2222883|FG000|Overall Study|timed out in rehab center|0
1129202|NCT02701361|2222884|FG001|Overall Study|timed out in rehab center|1
1129203|NCT02701361|2222885|FG002|Overall Study|timed out in rehab center|0
1129204|NCT02701361|2222883|FG000|Overall Study|incarceration|0
1129205|NCT02701361|2222884|FG001|Overall Study|incarceration|0
1129206|NCT02701361|2222885|FG002|Overall Study|incarceration|1
1129207|NCT02701413|2222912|FG000|Overall Study|Withdrawal by Subject|7
1129208|NCT02701413|2222913|FG001|Overall Study|Withdrawal by Subject|11
1129209|NCT02701634|2222941|FG000|Overall Study|Adverse Event|2
1129210|NCT02701634|2222942|FG001|Overall Study|Adverse Event|3
1129211|NCT02701634|2222941|FG000|Overall Study|Death|1
1129212|NCT02701634|2222942|FG001|Overall Study|Death|0
1129213|NCT02701634|2222941|FG000|Overall Study|Investigator's Discretion|7
1129214|NCT02701634|2222942|FG001|Overall Study|Investigator's Discretion|4
1129215|NCT02701634|2222941|FG000|Overall Study|Study terminated by Sponsor|15
1129216|NCT02701634|2222942|FG001|Overall Study|Study terminated by Sponsor|17
1129217|NCT02701634|2222941|FG000|Overall Study|Withdrew Consent|6
1129218|NCT02701634|2222942|FG001|Overall Study|Withdrew Consent|7
1129219|NCT02701634|2222941|FG000|Overall Study|Randomized but not treated|1
1129220|NCT02701634|2222942|FG001|Overall Study|Randomized but not treated|0
1129221|NCT02701764|2222970|FG000|Overall Study|Lost to Follow-up|0
1129222|NCT02701764|2222971|FG001|Overall Study|Lost to Follow-up|1
1129229|NCT02701985|2223006|FG000|Overall Study|Withdrawal by Subject|1
1129230|NCT02701985|2223007|FG001|Overall Study|Withdrawal by Subject|1
1129231|NCT02701985|2223006|FG000|Overall Study|Lost to Follow-up|1
1129232|NCT02701985|2223007|FG001|Overall Study|Lost to Follow-up|0
1129233|NCT02701985|2223006|FG000|Overall Study|Death|1
1129234|NCT02701985|2223007|FG001|Overall Study|Death|0
1129235|NCT02701985|2223006|FG000|Overall Study|Adverse Event|0
1129236|NCT02701985|2223007|FG001|Overall Study|Adverse Event|5
1129237|NCT02702011|2223018|FG000|Overall Study|Withdrawal by Subject|0
1129238|NCT02702011|2223019|FG001|Overall Study|Withdrawal by Subject|1
1129239|NCT02702011|2223020|FG002|Overall Study|Withdrawal by Subject|0
1129240|NCT02702011|2223021|FG003|Overall Study|Withdrawal by Subject|0
1129241|NCT02702193|2223033|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1
1129242|NCT02702193|2223034|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0
1129243|NCT02702193|2223033|FG000|4 Month Follow up|Withdrawal by Subject|1
1129244|NCT02702193|2223034|FG001|4 Month Follow up|Withdrawal by Subject|0
1129245|NCT02702193|2223033|FG000|4 Month Follow up|Lost to Follow-up|17
1129246|NCT02702193|2223034|FG001|4 Month Follow up|Lost to Follow-up|18
1129247|NCT02702193|2223033|FG000|8 Month Follow up|Withdrawal by Subject|1
1129248|NCT02702193|2223034|FG001|8 Month Follow up|Withdrawal by Subject|0
1129249|NCT02702193|2223033|FG000|8 Month Follow up|Lost to Follow-up|14
1129250|NCT02702193|2223034|FG001|8 Month Follow up|Lost to Follow-up|18
1129251|NCT02702193|2223033|FG000|12 Month Follow up|Withdrawal by Subject|1
1129252|NCT02702193|2223034|FG001|12 Month Follow up|Withdrawal by Subject|0
1129253|NCT02702193|2223033|FG000|12 Month Follow up|Lost to Follow-up|16
1129254|NCT02702193|2223034|FG001|12 Month Follow up|Lost to Follow-up|18
1129255|NCT02702388|2223042|FG000|Overall Study|Disease Progression|18
1129256|NCT02702388|2223043|FG001|Overall Study|Disease Progression|25
1129257|NCT02702388|2223042|FG000|Overall Study|Withdrawal by Subject|9
1129258|NCT02702388|2223043|FG001|Overall Study|Withdrawal by Subject|7
1129259|NCT02702388|2223042|FG000|Overall Study|Adverse Event|11
1129260|NCT02702388|2223043|FG001|Overall Study|Adverse Event|15
1129261|NCT02702388|2223042|FG000|Overall Study|Other|2
1129262|NCT02702388|2223043|FG001|Overall Study|Other|4
1129263|NCT02702401|2223060|FG000|Overall Study|Death|180
1129264|NCT02702401|2223061|FG001|Overall Study|Death|101
1129265|NCT02702401|2223060|FG000|Overall Study|Withdrawal by Subject|4
1129266|NCT02702401|2223061|FG001|Overall Study|Withdrawal by Subject|0
1129267|NCT02702401|2223060|FG000|Overall Study|Ongoing in study|94
1129268|NCT02702401|2223061|FG001|Overall Study|Ongoing in study|34
1129269|NCT02702518|2223069|FG000|Overall Study|Lost to Follow-up|3
1129270|NCT02702518|2223070|FG001|Overall Study|Lost to Follow-up|4
1129271|NCT02702609|2223078|FG000|Overall Study|Lost to Follow-up|8
1129272|NCT02702609|2223079|FG001|Overall Study|Lost to Follow-up|4
1129273|NCT02702609|2223078|FG000|Overall Study|Physician Decision|1
1129274|NCT02702609|2223079|FG001|Overall Study|Physician Decision|0
1129275|NCT02703259|2223105|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1
1129276|NCT02703259|2223106|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4
1129277|NCT02703259|2223105|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
1129278|NCT02703259|2223106|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
1129279|NCT02703259|2223105|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10
1129280|NCT02703259|2223106|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10
1129281|NCT02703311|2223112|FG000|Overall Study|Death|5
1129282|NCT02703311|2223112|FG000|Overall Study|Withdrawal by Subject|3
1129283|NCT02703324|2223116|FG000|Period Two|Withdrawal by Subject|0
1129284|NCT02703324|2223117|FG001|Period Two|Withdrawal by Subject|0
1129285|NCT02703324|2223118|FG002|Period Two|Withdrawal by Subject|1
1129286|NCT02703324|2223119|FG003|Period Two|Withdrawal by Subject|0
1129287|NCT02703324|2223120|FG004|Period Two|Withdrawal by Subject|0
1129288|NCT02703324|2223121|FG005|Period Two|Withdrawal by Subject|0
1129289|NCT02703337|2223130|FG000|Period One (Part A)|Withdrawal by Subject|0
1129290|NCT02703337|2223131|FG001|Period One (Part A)|Withdrawal by Subject|0
1129291|NCT02703337|2223132|FG002|Period One (Part A)|Withdrawal by Subject|0
1129292|NCT02703337|2223133|FG003|Period One (Part A)|Withdrawal by Subject|0
1129293|NCT02703337|2223134|FG004|Period One (Part A)|Withdrawal by Subject|1
1129294|NCT02703337|2223135|FG005|Period One (Part A)|Withdrawal by Subject|0
1129295|NCT02703337|2223136|FG006|Period One (Part A)|Withdrawal by Subject|0
1129296|NCT02703337|2223137|FG007|Period One (Part A)|Withdrawal by Subject|0
1129297|NCT02703454|2223182|FG000|Overall Study|Not treated|1
1129298|NCT02703454|2223183|FG001|Overall Study|Not treated|3
1129299|NCT02703454|2223182|FG000|Overall Study|Withdrawal by Subject|4
1129300|NCT02703454|2223183|FG001|Overall Study|Withdrawal by Subject|3
1129301|NCT02703454|2223182|FG000|Overall Study|Lost to Follow-up|1
1129302|NCT02703454|2223183|FG001|Overall Study|Lost to Follow-up|2
1129303|NCT02703454|2223182|FG000|Overall Study|Study discontinuation|5
1129304|NCT02703454|2223183|FG001|Overall Study|Study discontinuation|8
1129305|NCT02703532|2223210|FG000|Overall Study|Withdrawal by Subject|0
1129306|NCT02703532|2223211|FG001|Overall Study|Withdrawal by Subject|1
1129307|NCT02703532|2223212|FG002|Overall Study|Withdrawal by Subject|0
1129308|NCT02703532|2223213|FG003|Overall Study|Withdrawal by Subject|1
1129309|NCT02703532|2223210|FG000|Overall Study|Lost to Follow-up|2
1129310|NCT02703532|2223211|FG001|Overall Study|Lost to Follow-up|0
1129311|NCT02703532|2223212|FG002|Overall Study|Lost to Follow-up|2
1129312|NCT02703532|2223213|FG003|Overall Study|Lost to Follow-up|0
1129313|NCT02703636|2223223|FG000|Overall Study|Adverse Event|14
1129314|NCT02703636|2223223|FG000|Overall Study|Study stopped by sponsor|1
1129315|NCT02703636|2223223|FG000|Overall Study|Withdrawal by Subject|1
1129316|NCT02704091|2223270|FG000|Overall Study|Adverse Event|4
1129317|NCT02704091|2223271|FG001|Overall Study|Adverse Event|3
1129318|NCT02704091|2223270|FG000|Overall Study|Protocol Violation|5
1129319|NCT02704091|2223271|FG001|Overall Study|Protocol Violation|3
1129320|NCT02704091|2223270|FG000|Overall Study|Consent withdrawn|4
1129321|NCT02704091|2223271|FG001|Overall Study|Consent withdrawn|4
1129322|NCT02704091|2223270|FG000|Overall Study|Lost to Follow-up|13
1129323|NCT02704091|2223271|FG001|Overall Study|Lost to Follow-up|5
1129324|NCT02704091|2223270|FG000|Overall Study|Other|2
1129325|NCT02704091|2223271|FG001|Overall Study|Other|8
1129326|NCT02704143|2223285|FG000|Overall Study|disease progression|10
1129327|NCT02704689|2223298|FG000|Overall Study|Physician Decision|1
1129328|NCT02704689|2223298|FG000|Overall Study|Study device not implanted|2
1129329|NCT02705105|2223339|FG000|Treatment|Objective Disease Progression|1
1129330|NCT02705105|2223340|FG001|Treatment|Objective Disease Progression|50
1129331|NCT02705105|2223339|FG000|Treatment|Withdrawal by Subject|3
1129332|NCT02705105|2223340|FG001|Treatment|Withdrawal by Subject|5
1129333|NCT02705105|2223339|FG000|Treatment|Adverse Event|0
1129334|NCT02705105|2223340|FG001|Treatment|Adverse Event|17
1129335|NCT02705105|2223339|FG000|Treatment|Clinical Disease Progression|0
1129336|NCT02705105|2223340|FG001|Treatment|Clinical Disease Progression|32
1129337|NCT02705105|2223339|FG000|Treatment|Physician Decision|0
1129338|NCT02705105|2223340|FG001|Treatment|Physician Decision|3
1129339|NCT02705105|2223339|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0
1129340|NCT02705105|2223340|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2
1129341|NCT02705105|2223339|FG000|Follow-Up|Death|3
1129342|NCT02705105|2223340|FG001|Follow-Up|Death|68
1129343|NCT02705105|2223339|FG000|Follow-Up|Withdrawal by Subject|1
1129344|NCT02705105|2223340|FG001|Follow-Up|Withdrawal by Subject|14
1129345|NCT02705105|2223339|FG000|Follow-Up|Study Terminated|0
1129346|NCT02705105|2223340|FG001|Follow-Up|Study Terminated|26
1129347|NCT02705105|2223339|FG000|Follow-Up|Discontinued per Amendment 3|0
1129348|NCT02705105|2223340|FG001|Follow-Up|Discontinued per Amendment 3|2
1129349|NCT02705586|2223376|FG000|Overall Study|Health Issues|2
1129350|NCT02705586|2223376|FG000|Overall Study|Transportation Difficulties|5
1129351|NCT02705586|2223376|FG000|Overall Study|Vacation/Planned Absence|1
1129352|NCT02705625|2223383|FG000|Overall Study|Protocol Violation|1
1129353|NCT02705625|2223384|FG001|Overall Study|Protocol Violation|0
1129354|NCT02705625|2223385|FG002|Overall Study|Protocol Violation|0
1129355|NCT02705625|2223383|FG000|Overall Study|Adverse Event|6
1129356|NCT02705625|2223384|FG001|Overall Study|Adverse Event|5
1129357|NCT02705625|2223385|FG002|Overall Study|Adverse Event|2
1129358|NCT02705625|2223383|FG000|Overall Study|Death|0
1129359|NCT02705625|2223384|FG001|Overall Study|Death|0
1129360|NCT02705625|2223385|FG002|Overall Study|Death|1
1129361|NCT02705625|2223383|FG000|Overall Study|Withdrawal by Subject|1
1129362|NCT02705625|2223384|FG001|Overall Study|Withdrawal by Subject|4
1129363|NCT02705625|2223385|FG002|Overall Study|Withdrawal by Subject|5
1129364|NCT02705625|2223383|FG000|Overall Study|Lost to Follow-up|0
1129365|NCT02705625|2223384|FG001|Overall Study|Lost to Follow-up|0
1129366|NCT02705625|2223385|FG002|Overall Study|Lost to Follow-up|1
1129367|NCT02705625|2223383|FG000|Overall Study|Non-compliance|0
1129368|NCT02705625|2223384|FG001|Overall Study|Non-compliance|1
1129369|NCT02705625|2223385|FG002|Overall Study|Non-compliance|1
1129370|NCT02705625|2223383|FG000|Overall Study|Overdosing|0
1129371|NCT02705625|2223384|FG001|Overall Study|Overdosing|0
1129372|NCT02705625|2223385|FG002|Overall Study|Overdosing|1
1129373|NCT02705716|2223395|FG000|Overall Study|Adverse Event|0
1129374|NCT02705716|2223396|FG001|Overall Study|Adverse Event|1
1129375|NCT02705716|2223395|FG000|Overall Study|Protocol Violation|3
1129376|NCT02705716|2223396|FG001|Overall Study|Protocol Violation|0
1129377|NCT02705716|2223395|FG000|Overall Study|Withdrawal of Consent|1
1129378|NCT02705716|2223396|FG001|Overall Study|Withdrawal of Consent|1
1129379|NCT02706327|2223429|FG000|Overall Study|Lost to Follow-up|1
1129380|NCT02706327|2223430|FG001|Overall Study|Lost to Follow-up|1
1129381|NCT02706327|2223431|FG002|Overall Study|Lost to Follow-up|2
1129382|NCT02706483|2223439|FG000|Overall Study|Adverse Event|97
1129383|NCT02706483|2223439|FG000|Overall Study|Death|1
1129384|NCT02706483|2223439|FG000|Overall Study|Lack of Efficacy|39
1129385|NCT02706483|2223439|FG000|Overall Study|Lost to Follow-up|101
1129386|NCT02706483|2223439|FG000|Overall Study|Non-compliance with study drug|15
1129387|NCT02706483|2223439|FG000|Overall Study|Physician Decision|6
1129388|NCT02706483|2223439|FG000|Overall Study|Pregnancy|6
1129389|NCT02706483|2223439|FG000|Overall Study|Protocol Violation|18
1129390|NCT02706483|2223439|FG000|Overall Study|Withdrawal by Subject|136
1129391|NCT02706483|2223439|FG000|Overall Study|Non-compliance with visits|6
1129392|NCT02706483|2223439|FG000|Overall Study|Site closure|4
1129393|NCT02706483|2223439|FG000|Overall Study|Subject moved|1
1129394|NCT02706717|2223445|FG000|Overall Study|Withdrawal by Subject|1
1129395|NCT02706717|2223446|FG001|Overall Study|Withdrawal by Subject|8
1129396|NCT02706717|2223445|FG000|Overall Study|Lost to Follow-up|0
1129397|NCT02706717|2223446|FG001|Overall Study|Lost to Follow-up|1
1129398|NCT02706717|2223445|FG000|Overall Study|Physician Decision|0
1129399|NCT02706717|2223446|FG001|Overall Study|Physician Decision|1
1129400|NCT02706717|2223445|FG000|Overall Study|Death|0
1129401|NCT02706717|2223446|FG001|Overall Study|Death|1
1129402|NCT02706834|2223463|FG000|Overall Study|Pretreatment Event/Adverse Event|0
1129403|NCT02706834|2223464|FG001|Overall Study|Pretreatment Event/Adverse Event|1
1129404|NCT02706834|2223465|FG002|Overall Study|Pretreatment Event/Adverse Event|0
1129405|NCT02706834|2223466|FG003|Overall Study|Pretreatment Event/Adverse Event|0
1129406|NCT02706834|2223467|FG004|Overall Study|Pretreatment Event/Adverse Event|0
1129407|NCT02706834|2223468|FG005|Overall Study|Pretreatment Event/Adverse Event|0
1129408|NCT02706834|2223469|FG006|Overall Study|Pretreatment Event/Adverse Event|0
1129409|NCT02706834|2223470|FG007|Overall Study|Pretreatment Event/Adverse Event|0
1129410|NCT02706834|2223471|FG008|Overall Study|Pretreatment Event/Adverse Event|0
1129411|NCT02706834|2223472|FG009|Overall Study|Pretreatment Event/Adverse Event|0
1129412|NCT02706834|2223473|FG010|Overall Study|Pretreatment Event/Adverse Event|1
1129413|NCT02706834|2223463|FG000|Overall Study|Lost to Follow-up|0
1129414|NCT02706834|2223464|FG001|Overall Study|Lost to Follow-up|0
1129415|NCT02706834|2223465|FG002|Overall Study|Lost to Follow-up|1
1129416|NCT02706834|2223466|FG003|Overall Study|Lost to Follow-up|0
1129417|NCT02706834|2223467|FG004|Overall Study|Lost to Follow-up|0
1129418|NCT02706834|2223468|FG005|Overall Study|Lost to Follow-up|0
1129419|NCT02706834|2223469|FG006|Overall Study|Lost to Follow-up|0
1129420|NCT02706834|2223470|FG007|Overall Study|Lost to Follow-up|0
1129421|NCT02706834|2223471|FG008|Overall Study|Lost to Follow-up|0
1129422|NCT02706834|2223472|FG009|Overall Study|Lost to Follow-up|0
1129423|NCT02706834|2223473|FG010|Overall Study|Lost to Follow-up|0
1129424|NCT02706834|2223463|FG000|Overall Study|Voluntary Withdrawal|1
1129425|NCT02706834|2223464|FG001|Overall Study|Voluntary Withdrawal|0
1129426|NCT02706834|2223465|FG002|Overall Study|Voluntary Withdrawal|0
1129427|NCT02706834|2223466|FG003|Overall Study|Voluntary Withdrawal|0
1129428|NCT02706834|2223467|FG004|Overall Study|Voluntary Withdrawal|0
1129429|NCT02706834|2223468|FG005|Overall Study|Voluntary Withdrawal|0
1129430|NCT02706834|2223469|FG006|Overall Study|Voluntary Withdrawal|0
1129431|NCT02706834|2223470|FG007|Overall Study|Voluntary Withdrawal|0
1129432|NCT02706834|2223471|FG008|Overall Study|Voluntary Withdrawal|0
1129433|NCT02706834|2223472|FG009|Overall Study|Voluntary Withdrawal|1
1129434|NCT02706834|2223473|FG010|Overall Study|Voluntary Withdrawal|0
1129435|NCT02706834|2223463|FG000|Overall Study|Other Reason Not Specified|1
1129436|NCT02706834|2223464|FG001|Overall Study|Other Reason Not Specified|0
1129437|NCT02706834|2223465|FG002|Overall Study|Other Reason Not Specified|0
1129438|NCT02706834|2223466|FG003|Overall Study|Other Reason Not Specified|0
1129439|NCT02706834|2223467|FG004|Overall Study|Other Reason Not Specified|1
1129440|NCT02706834|2223468|FG005|Overall Study|Other Reason Not Specified|0
1129441|NCT02706834|2223469|FG006|Overall Study|Other Reason Not Specified|0
1129442|NCT02706834|2223470|FG007|Overall Study|Other Reason Not Specified|0
1129443|NCT02706834|2223471|FG008|Overall Study|Other Reason Not Specified|0
1129444|NCT02706834|2223472|FG009|Overall Study|Other Reason Not Specified|0
1129445|NCT02706834|2223473|FG010|Overall Study|Other Reason Not Specified|0
1129446|NCT02706847|2223521|FG000|Day 1 to Week 12|Adverse Event|2
1129447|NCT02706847|2223522|FG001|Day 1 to Week 12|Adverse Event|2
1129448|NCT02706847|2223523|FG002|Day 1 to Week 12|Adverse Event|1
1129449|NCT02706847|2223524|FG003|Day 1 to Week 12|Adverse Event|12
1129450|NCT02706847|2223521|FG000|Day 1 to Week 12|Withdrawal by Subject|2
1129451|NCT02706847|2223522|FG001|Day 1 to Week 12|Withdrawal by Subject|1
1129452|NCT02706847|2223523|FG002|Day 1 to Week 12|Withdrawal by Subject|4
1129453|NCT02706847|2223524|FG003|Day 1 to Week 12|Withdrawal by Subject|2
1129454|NCT02706847|2223521|FG000|Day 1 to Week 12|Lost to Follow-up|2
1129455|NCT02706847|2223522|FG001|Day 1 to Week 12|Lost to Follow-up|1
1129456|NCT02706847|2223523|FG002|Day 1 to Week 12|Lost to Follow-up|0
1129457|NCT02706847|2223524|FG003|Day 1 to Week 12|Lost to Follow-up|0
1129458|NCT02706847|2223521|FG000|Day 1 to Week 12|Other|4
1129459|NCT02706847|2223522|FG001|Day 1 to Week 12|Other|4
1129460|NCT02706847|2223523|FG002|Day 1 to Week 12|Other|2
1129461|NCT02706847|2223524|FG003|Day 1 to Week 12|Other|2
1129462|NCT02706847|2223521|FG000|Day 1 to Week 12|Randomized in Error|0
1129463|NCT02706847|2223522|FG001|Day 1 to Week 12|Randomized in Error|0
1129464|NCT02706847|2223523|FG002|Day 1 to Week 12|Randomized in Error|1
1129465|NCT02706847|2223524|FG003|Day 1 to Week 12|Randomized in Error|0
1129466|NCT02706847|2223521|FG000|Week 12 to Week 24|Adverse Event|1
1129467|NCT02706847|2223522|FG001|Week 12 to Week 24|Adverse Event|2
1129468|NCT02706847|2223523|FG002|Week 12 to Week 24|Adverse Event|2
1129469|NCT02706847|2223524|FG003|Week 12 to Week 24|Adverse Event|5
1129470|NCT02706847|2223521|FG000|Week 12 to Week 24|Withdrawal by Subject|1
1129471|NCT02706847|2223522|FG001|Week 12 to Week 24|Withdrawal by Subject|0
1129472|NCT02706847|2223523|FG002|Week 12 to Week 24|Withdrawal by Subject|1
1129473|NCT02706847|2223524|FG003|Week 12 to Week 24|Withdrawal by Subject|4
1129474|NCT02706847|2223521|FG000|Week 12 to Week 24|Lost to Follow-up|0
1129475|NCT02706847|2223522|FG001|Week 12 to Week 24|Lost to Follow-up|0
1129476|NCT02706847|2223523|FG002|Week 12 to Week 24|Lost to Follow-up|0
1129477|NCT02706847|2223524|FG003|Week 12 to Week 24|Lost to Follow-up|1
1129478|NCT02706847|2223521|FG000|Week 12 to Week 24|Other|1
1129479|NCT02706847|2223522|FG001|Week 12 to Week 24|Other|0
1129480|NCT02706847|2223523|FG002|Week 12 to Week 24|Other|1
1129481|NCT02706847|2223524|FG003|Week 12 to Week 24|Other|4
1129482|NCT02706873|2223538|FG000|Overall Study|Adverse Event|13
1129483|NCT02706873|2223539|FG001|Overall Study|Adverse Event|3
1129484|NCT02706873|2223540|FG002|Overall Study|Adverse Event|13
1129485|NCT02706873|2223541|FG003|Overall Study|Adverse Event|12
1129486|NCT02706873|2223538|FG000|Overall Study|Withdrawal by Subject|15
1129487|NCT02706873|2223539|FG001|Overall Study|Withdrawal by Subject|0
1129488|NCT02706873|2223540|FG002|Overall Study|Withdrawal by Subject|8
1129489|NCT02706873|2223541|FG003|Overall Study|Withdrawal by Subject|11
1129490|NCT02706873|2223538|FG000|Overall Study|Lost to Follow-up|3
1129491|NCT02706873|2223539|FG001|Overall Study|Lost to Follow-up|0
1129492|NCT02706873|2223540|FG002|Overall Study|Lost to Follow-up|4
1129493|NCT02706873|2223541|FG003|Overall Study|Lost to Follow-up|2
900111|NCT00725725|1873169|FG001|Overall Study|Adverse Event|3
900112|NCT00725725|1873170|FG002|Overall Study|Adverse Event|2
900113|NCT00725725|1873168|FG000|Overall Study|Lost to Follow-up|2
900114|NCT00725725|1873169|FG001|Overall Study|Lost to Follow-up|0
900115|NCT00725725|1873170|FG002|Overall Study|Lost to Follow-up|2
900116|NCT00725725|1873168|FG000|Overall Study|Withdrawal by Subject|1
900117|NCT00725725|1873169|FG001|Overall Study|Withdrawal by Subject|0
900118|NCT00725725|1873170|FG002|Overall Study|Withdrawal by Subject|1
900119|NCT00725725|1873168|FG000|Overall Study|Protocol Violation|0
900120|NCT00725725|1873169|FG001|Overall Study|Protocol Violation|1
1129494|NCT02706873|2223538|FG000|Overall Study|Lack of Efficacy|10
1129495|NCT02706873|2223539|FG001|Overall Study|Lack of Efficacy|0
1129496|NCT02706873|2223540|FG002|Overall Study|Lack of Efficacy|0
1129497|NCT02706873|2223541|FG003|Overall Study|Lack of Efficacy|3
1129498|NCT02706873|2223538|FG000|Overall Study|Other|5
1129499|NCT02706873|2223539|FG001|Overall Study|Other|1
1129500|NCT02706873|2223540|FG002|Overall Study|Other|2
1129501|NCT02706873|2223541|FG003|Overall Study|Other|3
1129502|NCT02706873|2223538|FG000|Overall Study|Not Dosed|1
1129503|NCT02706873|2223539|FG001|Overall Study|Not Dosed|0
1129504|NCT02706873|2223540|FG002|Overall Study|Not Dosed|0
1129505|NCT02706873|2223541|FG003|Overall Study|Not Dosed|1
1129506|NCT02706873|2223538|FG000|Overall Study|Ongoing|0
1129507|NCT02706873|2223539|FG001|Overall Study|Ongoing|0
1129508|NCT02706873|2223540|FG002|Overall Study|Ongoing|0
1129509|NCT02706873|2223541|FG003|Overall Study|Ongoing|1
1129510|NCT02706886|2223562|FG000|Part A: SAD Period|Withdrawal by Subject|0
1129511|NCT02706886|2223563|FG001|Part A: SAD Period|Withdrawal by Subject|0
1129512|NCT02706886|2223564|FG002|Part A: SAD Period|Withdrawal by Subject|0
1129513|NCT02706886|2223565|FG003|Part A: SAD Period|Withdrawal by Subject|2
1129514|NCT02706886|2223566|FG004|Part A: SAD Period|Withdrawal by Subject|0
1129515|NCT02706886|2223567|FG005|Part A: SAD Period|Withdrawal by Subject|0
1129516|NCT02706886|2223568|FG006|Part A: SAD Period|Withdrawal by Subject|0
1129517|NCT02706886|2223569|FG007|Part A: SAD Period|Withdrawal by Subject|0
1129518|NCT02706886|2223570|FG008|Part A: SAD Period|Withdrawal by Subject|0
1129519|NCT02706899|2223615|FG000|Overall Study|Withdrawal by Subject|1
1129520|NCT02706899|2223616|FG001|Overall Study|Withdrawal by Subject|0
1129521|NCT02706899|2223615|FG000|Overall Study|Death|8
1129522|NCT02706899|2223616|FG001|Overall Study|Death|0
1129523|NCT02706899|2223615|FG000|Overall Study|Study Termination by Sponsor|4
1129524|NCT02706899|2223616|FG001|Overall Study|Study Termination by Sponsor|6
1129525|NCT02706938|2223669|FG000|First Period, 6 Weeks|Adverse Event|8
1129526|NCT02706938|2223670|FG001|First Period, 6 Weeks|Adverse Event|0
1129527|NCT02706938|2223669|FG000|First Period, 6 Weeks|Lost to Follow-up|2
1129528|NCT02706938|2223670|FG001|First Period, 6 Weeks|Lost to Follow-up|2
1129529|NCT02706938|2223669|FG000|First Period, 6 Weeks|Withdrawal by Subject|1
1129530|NCT02706938|2223670|FG001|First Period, 6 Weeks|Withdrawal by Subject|0
1129531|NCT02706938|2223669|FG000|Second Period, 6 Weeks|Adverse Event|0
1129532|NCT02706938|2223670|FG001|Second Period, 6 Weeks|Adverse Event|7
1129533|NCT02706938|2223669|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0
1129534|NCT02706938|2223670|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3
1129535|NCT02706951|2223680|FG000|Overall Study|Adverse Event|1
1129536|NCT02706951|2223681|FG001|Overall Study|Adverse Event|5
1129537|NCT02706951|2223682|FG002|Overall Study|Adverse Event|3
1129538|NCT02706951|2223680|FG000|Overall Study|Withdrawal by Subject|11
1129539|NCT02706951|2223681|FG001|Overall Study|Withdrawal by Subject|6
1129540|NCT02706951|2223682|FG002|Overall Study|Withdrawal by Subject|6
1129541|NCT02706951|2223680|FG000|Overall Study|Lost to Follow-up|0
1129542|NCT02706951|2223681|FG001|Overall Study|Lost to Follow-up|4
1129543|NCT02706951|2223682|FG002|Overall Study|Lost to Follow-up|1
1129544|NCT02706951|2223680|FG000|Overall Study|Other|2
1129545|NCT02706951|2223681|FG001|Overall Study|Other|1
1129546|NCT02706951|2223682|FG002|Overall Study|Other|0
1129547|NCT02707601|2223728|FG000|Overall Study|Death|0
1129548|NCT02707601|2223729|FG001|Overall Study|Death|1
1129549|NCT02707601|2223728|FG000|Overall Study|Lack of Efficacy|0
1129550|NCT02707601|2223729|FG001|Overall Study|Lack of Efficacy|1
1129551|NCT02707601|2223728|FG000|Overall Study|Investigator's Discretion|1
1129552|NCT02707601|2223729|FG001|Overall Study|Investigator's Discretion|0
1129553|NCT02707601|2223728|FG000|Overall Study|Withdrew Consent|0
1129554|NCT02707601|2223729|FG001|Overall Study|Withdrew Consent|1
1129555|NCT02707601|2223728|FG000|Overall Study|Lost to Follow-up|1
1129556|NCT02707601|2223729|FG001|Overall Study|Lost to Follow-up|1
1129557|NCT02707601|2223728|FG000|Overall Study|Participants Randomized but Not Treated|2
1129558|NCT02707601|2223729|FG001|Overall Study|Participants Randomized but Not Treated|0
1129559|NCT02707640|2223741|FG000|Overall Study|Adverse Event|4
1129560|NCT02707640|2223742|FG001|Overall Study|Adverse Event|2
1129561|NCT02707640|2223741|FG000|Overall Study|Death|1
1129562|NCT02707640|2223742|FG001|Overall Study|Death|2
1129563|NCT02707640|2223741|FG000|Overall Study|Physician Decision|2
1129564|NCT02707640|2223742|FG001|Overall Study|Physician Decision|0
1129565|NCT02707640|2223741|FG000|Overall Study|Withdrawal by Subject|0
1129566|NCT02707640|2223742|FG001|Overall Study|Withdrawal by Subject|1
1129567|NCT02707640|2223741|FG000|Overall Study|Participant's Personal Decision|1
1129568|NCT02707640|2223742|FG001|Overall Study|Participant's Personal Decision|2
1129569|NCT02707640|2223741|FG000|Overall Study|Sponsor Discretion|1
1129570|NCT02707640|2223742|FG001|Overall Study|Sponsor Discretion|0
1129571|NCT02707757|2223750|FG000|Overall Study|Protocol Violation|3
1129572|NCT02707757|2223751|FG001|Overall Study|Protocol Violation|2
1129573|NCT02707757|2223750|FG000|Overall Study|Withdrawal by Subject|2
1129574|NCT02707757|2223751|FG001|Overall Study|Withdrawal by Subject|0
1129575|NCT02707757|2223750|FG000|Overall Study|Death|0
1129576|NCT02707757|2223751|FG001|Overall Study|Death|1
1129577|NCT02707757|2223750|FG000|Overall Study|Adverse Event|6
1129578|NCT02707757|2223751|FG001|Overall Study|Adverse Event|4
1129579|NCT02707757|2223750|FG000|Overall Study|Renal transplant/elective operation|1
1129580|NCT02707757|2223751|FG001|Overall Study|Renal transplant/elective operation|5
1129581|NCT02707861|2223770|FG000|Overall Study|Went onto commercial drug|30
1129582|NCT02707861|2223771|FG001|Overall Study|Went onto commercial drug|23
1129583|NCT02707861|2223770|FG000|Overall Study|Adverse Event|2
1129584|NCT02707861|2223771|FG001|Overall Study|Adverse Event|3
1129585|NCT02707861|2223770|FG000|Overall Study|Death|5
1129586|NCT02707861|2223771|FG001|Overall Study|Death|2
1129587|NCT02707861|2223770|FG000|Overall Study|Lack of Efficacy|0
1129588|NCT02707861|2223771|FG001|Overall Study|Lack of Efficacy|2
1129589|NCT02707861|2223770|FG000|Overall Study|Physician Decision|1
1129590|NCT02707861|2223771|FG001|Overall Study|Physician Decision|4
1129591|NCT02707861|2223770|FG000|Overall Study|Withdrawal by Subject|2
1129592|NCT02707861|2223771|FG001|Overall Study|Withdrawal by Subject|1
1129593|NCT02707861|2223770|FG000|Overall Study|Lost to Follow-up|1
1129594|NCT02707861|2223771|FG001|Overall Study|Lost to Follow-up|3
1129595|NCT02707952|2223781|FG000|Overall Study|Adverse Event|1
1129596|NCT02707952|2223782|FG001|Overall Study|Adverse Event|0
1129597|NCT02707952|2223783|FG002|Overall Study|Adverse Event|0
1129598|NCT02707952|2223784|FG003|Overall Study|Adverse Event|0
1129599|NCT02707952|2223781|FG000|Overall Study|Lost to Follow-up|1
1129600|NCT02707952|2223782|FG001|Overall Study|Lost to Follow-up|0
1129601|NCT02707952|2223783|FG002|Overall Study|Lost to Follow-up|0
1129602|NCT02707952|2223784|FG003|Overall Study|Lost to Follow-up|0
1129603|NCT02707952|2223781|FG000|Overall Study|Withdrawal by Subject|0
1129604|NCT02707952|2223782|FG001|Overall Study|Withdrawal by Subject|1
1129605|NCT02707952|2223783|FG002|Overall Study|Withdrawal by Subject|2
1129606|NCT02707952|2223784|FG003|Overall Study|Withdrawal by Subject|0
1129607|NCT02707965|2223805|FG000|Overall Study|Withdrawal by Subject|0
1129608|NCT02707965|2223806|FG001|Overall Study|Withdrawal by Subject|0
1129609|NCT02707965|2223807|FG002|Overall Study|Withdrawal by Subject|1
1129610|NCT02707965|2223808|FG003|Overall Study|Withdrawal by Subject|0
1129611|NCT02707965|2223809|FG004|Overall Study|Withdrawal by Subject|0
1129612|NCT02707965|2223810|FG005|Overall Study|Withdrawal by Subject|0
1129613|NCT02707965|2223811|FG006|Overall Study|Withdrawal by Subject|0
1129614|NCT02707965|2223812|FG007|Overall Study|Withdrawal by Subject|2
1129615|NCT02707965|2223813|FG008|Overall Study|Withdrawal by Subject|0
1129616|NCT02707965|2223814|FG009|Overall Study|Withdrawal by Subject|0
1129617|NCT02707965|2223815|FG010|Overall Study|Withdrawal by Subject|0
1129618|NCT02707965|2223816|FG011|Overall Study|Withdrawal by Subject|0
1129619|NCT02707965|2223817|FG012|Overall Study|Withdrawal by Subject|0
1129620|NCT02707965|2223818|FG013|Overall Study|Withdrawal by Subject|0
1129621|NCT02707965|2223819|FG014|Overall Study|Withdrawal by Subject|0
1129622|NCT02707965|2223820|FG015|Overall Study|Withdrawal by Subject|0
1129623|NCT02707965|2223805|FG000|Overall Study|PI decisions|0
1129624|NCT02707965|2223806|FG001|Overall Study|PI decisions|0
1129625|NCT02707965|2223807|FG002|Overall Study|PI decisions|0
1129626|NCT02707965|2223808|FG003|Overall Study|PI decisions|0
1129627|NCT02707965|2223809|FG004|Overall Study|PI decisions|0
1129628|NCT02707965|2223810|FG005|Overall Study|PI decisions|0
1129629|NCT02707965|2223811|FG006|Overall Study|PI decisions|0
1129630|NCT02707965|2223812|FG007|Overall Study|PI decisions|0
1129631|NCT02707965|2223813|FG008|Overall Study|PI decisions|0
1129632|NCT02707965|2223814|FG009|Overall Study|PI decisions|0
1129633|NCT02707965|2223815|FG010|Overall Study|PI decisions|0
1129634|NCT02707965|2223816|FG011|Overall Study|PI decisions|0
1129635|NCT02707965|2223817|FG012|Overall Study|PI decisions|0
1129636|NCT02707965|2223818|FG013|Overall Study|PI decisions|0
1129637|NCT02707965|2223819|FG014|Overall Study|PI decisions|2
1129638|NCT02707965|2223820|FG015|Overall Study|PI decisions|0
1129639|NCT02707965|2223805|FG000|Overall Study|Protocol deviation|1
1129640|NCT02707965|2223806|FG001|Overall Study|Protocol deviation|1
1129641|NCT02707965|2223807|FG002|Overall Study|Protocol deviation|0
1129642|NCT02707965|2223808|FG003|Overall Study|Protocol deviation|0
1129643|NCT02707965|2223809|FG004|Overall Study|Protocol deviation|0
1129644|NCT02707965|2223810|FG005|Overall Study|Protocol deviation|0
1129645|NCT02707965|2223811|FG006|Overall Study|Protocol deviation|0
1129646|NCT02707965|2223812|FG007|Overall Study|Protocol deviation|1
1129647|NCT02707965|2223813|FG008|Overall Study|Protocol deviation|0
1129648|NCT02707965|2223814|FG009|Overall Study|Protocol deviation|0
1129649|NCT02707965|2223815|FG010|Overall Study|Protocol deviation|0
1129650|NCT02707965|2223816|FG011|Overall Study|Protocol deviation|0
1129651|NCT02707965|2223817|FG012|Overall Study|Protocol deviation|0
1129652|NCT02707965|2223818|FG013|Overall Study|Protocol deviation|0
1129653|NCT02707965|2223819|FG014|Overall Study|Protocol deviation|0
1129654|NCT02707965|2223820|FG015|Overall Study|Protocol deviation|0
1129655|NCT02707991|2223855|FG000|Overall Study|Protocol Violation|1
1129656|NCT02707991|2223856|FG001|Overall Study|Protocol Violation|0
1129657|NCT02707991|2223855|FG000|Overall Study|Became ineligible|0
1129658|NCT02707991|2223856|FG001|Overall Study|Became ineligible|1
1129659|NCT02708095|2223865|FG000|Overall Study|Adverse Event|4
1129660|NCT02708095|2223866|FG001|Overall Study|Adverse Event|10
1129661|NCT02708095|2223867|FG002|Overall Study|Adverse Event|11
1129662|NCT02708095|2223865|FG000|Overall Study|Lack of Efficacy|9
1129663|NCT02708095|2223866|FG001|Overall Study|Lack of Efficacy|3
1129664|NCT02708095|2223867|FG002|Overall Study|Lack of Efficacy|0
1129665|NCT02708095|2223865|FG000|Overall Study|Lost to Follow-up|2
1129666|NCT02708095|2223866|FG001|Overall Study|Lost to Follow-up|0
1129667|NCT02708095|2223867|FG002|Overall Study|Lost to Follow-up|0
1129668|NCT02708095|2223865|FG000|Overall Study|Physician Decision|2
1129669|NCT02708095|2223866|FG001|Overall Study|Physician Decision|3
1129670|NCT02708095|2223867|FG002|Overall Study|Physician Decision|2
1129671|NCT02708095|2223865|FG000|Overall Study|Protocol Violation|0
1129672|NCT02708095|2223866|FG001|Overall Study|Protocol Violation|0
1129673|NCT02708095|2223867|FG002|Overall Study|Protocol Violation|1
1129674|NCT02708095|2223865|FG000|Overall Study|Withdrawal by Subject|5
1129675|NCT02708095|2223866|FG001|Overall Study|Withdrawal by Subject|3
1129676|NCT02708095|2223867|FG002|Overall Study|Withdrawal by Subject|4
1129677|NCT02708121|2223879|FG000|Overall Study|Withdrawn by Study Team|1
1129678|NCT02708121|2223880|FG001|Overall Study|Withdrawn by Study Team|1
1129679|NCT02708121|2223879|FG000|Overall Study|Withdrawal by Subject|0
1129680|NCT02708121|2223880|FG001|Overall Study|Withdrawal by Subject|4
1129681|NCT02708277|2223923|FG000|Overall Study|Lost to Follow-up|7
1129682|NCT02708277|2223924|FG001|Overall Study|Lost to Follow-up|4
1129683|NCT02708355|2223942|FG000|Overall Study|Adverse Event|1
1129684|NCT02708355|2223943|FG001|Overall Study|Adverse Event|0
1129685|NCT02708355|2223944|FG002|Overall Study|Adverse Event|0
1129686|NCT02708485|2223961|FG000|Overall Study|Withdrawal by Subject|3
1129687|NCT02708485|2223962|FG001|Overall Study|Withdrawal by Subject|2
1129688|NCT02708498|2223976|FG000|Overall Study|Death|20
1129689|NCT02708498|2223977|FG001|Overall Study|Death|19
1129690|NCT02708498|2223978|FG002|Overall Study|Death|0
1129691|NCT02708498|2223979|FG003|Overall Study|Death|0
1129692|NCT02708498|2223980|FG004|Overall Study|Death|1
1129693|NCT02708498|2223981|FG005|Overall Study|Death|0
1129694|NCT02708498|2223982|FG006|Overall Study|Death|0
1129695|NCT02708498|2223983|FG007|Overall Study|Death|0
1129696|NCT02708498|2223976|FG000|Overall Study|Unknown reason, missing data|0
1129697|NCT02708498|2223977|FG001|Overall Study|Unknown reason, missing data|0
1129698|NCT02708498|2223978|FG002|Overall Study|Unknown reason, missing data|62
1129699|NCT02708498|2223979|FG003|Overall Study|Unknown reason, missing data|51
1129700|NCT02708498|2223980|FG004|Overall Study|Unknown reason, missing data|195
1129701|NCT02708498|2223981|FG005|Overall Study|Unknown reason, missing data|132
1129702|NCT02708498|2223982|FG006|Overall Study|Unknown reason, missing data|0
1129703|NCT02708498|2223983|FG007|Overall Study|Unknown reason, missing data|0
1129704|NCT02708524|2224003|FG000|Overall Study|Adverse Event|0
1129705|NCT02708524|2224004|FG001|Overall Study|Adverse Event|1
1129706|NCT02708524|2224005|FG002|Overall Study|Adverse Event|0
1129707|NCT02708524|2224006|FG003|Overall Study|Adverse Event|0
900121|NCT00725725|1873170|FG002|Overall Study|Protocol Violation|0
900122|NCT00725764|1873188|FG000|Overall Study|Withdrawal by Subject|2
900123|NCT00725764|1873188|FG000|Overall Study|Physician Decision|1
900124|NCT00725764|1873188|FG000|Overall Study|Progressive Disease|7
900125|NCT00725764|1873188|FG000|Overall Study|Lost to Follow-up|1
900126|NCT00725764|1873188|FG000|Overall Study|Death|1
900127|NCT00725764|1873188|FG000|Overall Study|Participant non compliant with protocol|1
900128|NCT00725764|1873188|FG000|Overall Study|Decline in performance status|1
900129|NCT00725842|1873193|FG000|Overall Study|Lost to Follow-up|19
900130|NCT00725842|1873193|FG000|Overall Study|Death|1
900131|NCT00725842|1873193|FG000|Overall Study|Positive HCV-RNA at Visit 2|13
900132|NCT00725842|1873193|FG000|Overall Study|Consent date prior to study start date|5
900133|NCT00725842|1873193|FG000|Overall Study|Inclusion criterion not met|1
900134|NCT00725842|1873193|FG000|Overall Study|No Visit 1 data|1
900135|NCT00725920|1873199|FG000|Overall Study|Lack of Efficacy|3
900136|NCT00725920|1873200|FG001|Overall Study|Lack of Efficacy|6
900137|NCT00726063|1873257|FG000|Overall Study|Adverse Event|9
900138|NCT00726063|1873258|FG001|Overall Study|Adverse Event|7
900139|NCT00726232|1873270|FG000|Initial Phase (Dose-finding)|Death|0
900140|NCT00726232|1873271|FG001|Initial Phase (Dose-finding)|Death|0
900141|NCT00726232|1873272|FG002|Initial Phase (Dose-finding)|Death|0
900142|NCT00726232|1873273|FG003|Initial Phase (Dose-finding)|Death|0
1129708|NCT02708524|2224003|FG000|Overall Study|Lens Discomfort|1
1129709|NCT02708524|2224004|FG001|Overall Study|Lens Discomfort|0
1129710|NCT02708524|2224005|FG002|Overall Study|Lens Discomfort|1
1129711|NCT02708524|2224006|FG003|Overall Study|Lens Discomfort|0
1129712|NCT02708524|2224003|FG000|Overall Study|Lost to Follow-up|1
1129713|NCT02708524|2224004|FG001|Overall Study|Lost to Follow-up|1
1129714|NCT02708524|2224005|FG002|Overall Study|Lost to Follow-up|1
1129715|NCT02708524|2224006|FG003|Overall Study|Lost to Follow-up|0
1129716|NCT02708524|2224003|FG000|Overall Study|Protocol Violation|0
1129717|NCT02708524|2224004|FG001|Overall Study|Protocol Violation|1
1129718|NCT02708524|2224005|FG002|Overall Study|Protocol Violation|0
1129719|NCT02708524|2224006|FG003|Overall Study|Protocol Violation|0
1129720|NCT02708524|2224003|FG000|Overall Study|Withdrawal by Subject|1
1129721|NCT02708524|2224004|FG001|Overall Study|Withdrawal by Subject|1
1129722|NCT02708524|2224005|FG002|Overall Study|Withdrawal by Subject|0
1129723|NCT02708524|2224006|FG003|Overall Study|Withdrawal by Subject|0
1129724|NCT02708524|2224003|FG000|Overall Study|Dispensed incorrect study lens|0
1129725|NCT02708524|2224004|FG001|Overall Study|Dispensed incorrect study lens|1
1129726|NCT02708524|2224005|FG002|Overall Study|Dispensed incorrect study lens|1
1129727|NCT02708524|2224006|FG003|Overall Study|Dispensed incorrect study lens|0
1129728|NCT02708524|2224003|FG000|Overall Study|Did not wear lens at final visit|0
1129729|NCT02708524|2224004|FG001|Overall Study|Did not wear lens at final visit|1
1129730|NCT02708524|2224005|FG002|Overall Study|Did not wear lens at final visit|0
1129731|NCT02708524|2224006|FG003|Overall Study|Did not wear lens at final visit|0
1129732|NCT02708524|2224003|FG000|Overall Study|Subject lost study lens|1
1129733|NCT02708524|2224004|FG001|Overall Study|Subject lost study lens|0
1129734|NCT02708524|2224005|FG002|Overall Study|Subject lost study lens|0
1129735|NCT02708524|2224006|FG003|Overall Study|Subject lost study lens|0
1129736|NCT02708966|2224048|FG000|Overall Study|Lost to Follow-up|2
1129737|NCT02708966|2224049|FG001|Overall Study|Lost to Follow-up|2
1129738|NCT02709005|2224057|FG000|Overall Study|Lost to Follow-up|1
1129739|NCT02709005|2224058|FG001|Overall Study|Lost to Follow-up|1
1129740|NCT02709005|2224057|FG000|Overall Study|Withdrawal by Subject|3
1129741|NCT02709005|2224058|FG001|Overall Study|Withdrawal by Subject|0
1129742|NCT02709096|2224077|FG000|Overall Study|non-compliance|1
1129743|NCT02709096|2224078|FG001|Overall Study|non-compliance|1
1129744|NCT02709109|2224088|FG000|Treatment Period 1 (28 Days)|Adverse Event|3
1129745|NCT02709109|2224089|FG001|Treatment Period 1 (28 Days)|Adverse Event|3
1129746|NCT02709109|2224090|FG002|Treatment Period 1 (28 Days)|Adverse Event|1
1129747|NCT02709109|2224091|FG003|Treatment Period 1 (28 Days)|Adverse Event|0
1129748|NCT02709109|2224088|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0
1129749|NCT02709109|2224089|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2
1129750|NCT02709109|2224090|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0
1129751|NCT02709109|2224091|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0
1129752|NCT02709109|2224088|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1
1129753|NCT02709109|2224089|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
1129754|NCT02709109|2224090|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
1129755|NCT02709109|2224091|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
1129756|NCT02709109|2224088|FG000|Washout Period (28 Days)|Other|2
1129757|NCT02709109|2224089|FG001|Washout Period (28 Days)|Other|2
1129758|NCT02709109|2224090|FG002|Washout Period (28 Days)|Other|3
1129759|NCT02709109|2224091|FG003|Washout Period (28 Days)|Other|0
1129760|NCT02709109|2224088|FG000|Treatment Period 2 (28 Days)|Adverse Event|2
1129761|NCT02709109|2224089|FG001|Treatment Period 2 (28 Days)|Adverse Event|3
1129762|NCT02709109|2224090|FG002|Treatment Period 2 (28 Days)|Adverse Event|0
1129763|NCT02709109|2224091|FG003|Treatment Period 2 (28 Days)|Adverse Event|0
1129764|NCT02709109|2224088|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0
1129765|NCT02709109|2224089|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1
1129766|NCT02709109|2224090|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1
1129767|NCT02709109|2224091|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0
1129768|NCT02709109|2224088|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0
1129769|NCT02709109|2224089|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0
1129770|NCT02709109|2224090|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1
1129771|NCT02709109|2224091|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0
1129772|NCT02709109|2224088|FG000|Treatment Period 2 (28 Days)|Other|0
1129773|NCT02709109|2224089|FG001|Treatment Period 2 (28 Days)|Other|0
1129774|NCT02709109|2224090|FG002|Treatment Period 2 (28 Days)|Other|1
1129775|NCT02709109|2224091|FG003|Treatment Period 2 (28 Days)|Other|0
1129776|NCT02709330|2224102|FG000|Overall Study|Death|5
1129777|NCT02709330|2224103|FG001|Overall Study|Death|0
1129778|NCT02709330|2224102|FG000|Overall Study|Lost to Follow-up|2
1129779|NCT02709330|2224103|FG001|Overall Study|Lost to Follow-up|0
1129780|NCT02709330|2224102|FG000|Overall Study|Physician Decision|2
1129781|NCT02709330|2224103|FG001|Overall Study|Physician Decision|0
1129782|NCT02709330|2224102|FG000|Overall Study|Withdrawal by Subject|4
1129783|NCT02709330|2224103|FG001|Overall Study|Withdrawal by Subject|0
1129784|NCT02709369|2224109|FG000|Overall Study|Lost to Follow-up|15
1129785|NCT02709369|2224109|FG000|Overall Study|Withdrawal by Subject|10
1129786|NCT02709369|2224109|FG000|Overall Study|Did not received intervention|2
1129787|NCT02709486|2224116|FG000|Overall Study|Adverse Event|2
1129788|NCT02709486|2224117|FG001|Overall Study|Adverse Event|5
1129789|NCT02709486|2224118|FG002|Overall Study|Adverse Event|3
1129790|NCT02709486|2224116|FG000|Overall Study|Death|0
1129791|NCT02709486|2224117|FG001|Overall Study|Death|0
1129792|NCT02709486|2224118|FG002|Overall Study|Death|2
1129793|NCT02709486|2224116|FG000|Overall Study|Insufficient clinical response|7
1129794|NCT02709486|2224117|FG001|Overall Study|Insufficient clinical response|3
1129795|NCT02709486|2224118|FG002|Overall Study|Insufficient clinical response|3
1129796|NCT02709486|2224116|FG000|Overall Study|Lost to Follow-up|3
1129797|NCT02709486|2224117|FG001|Overall Study|Lost to Follow-up|2
1129798|NCT02709486|2224118|FG002|Overall Study|Lost to Follow-up|2
1129799|NCT02709486|2224116|FG000|Overall Study|Other|0
1129800|NCT02709486|2224117|FG001|Overall Study|Other|2
1129801|NCT02709486|2224118|FG002|Overall Study|Other|3
1129802|NCT02709486|2224116|FG000|Overall Study|Withdrawal by Subject|32
1129803|NCT02709486|2224117|FG001|Overall Study|Withdrawal by Subject|22
1129804|NCT02709486|2224118|FG002|Overall Study|Withdrawal by Subject|32
1129805|NCT02709538|2224129|FG000|Overall Study|Adverse Event|13
1129806|NCT02709538|2224130|FG001|Overall Study|Adverse Event|2
1129807|NCT02709538|2224131|FG002|Overall Study|Adverse Event|3
1129808|NCT02709538|2224129|FG000|Overall Study|Lack of Efficacy|1
1129809|NCT02709538|2224130|FG001|Overall Study|Lack of Efficacy|0
1129810|NCT02709538|2224131|FG002|Overall Study|Lack of Efficacy|0
1129811|NCT02709538|2224129|FG000|Overall Study|Lost to Follow-up|24
1129812|NCT02709538|2224130|FG001|Overall Study|Lost to Follow-up|8
1129813|NCT02709538|2224131|FG002|Overall Study|Lost to Follow-up|4
1129814|NCT02709538|2224129|FG000|Overall Study|Physician Decision|1
1129815|NCT02709538|2224130|FG001|Overall Study|Physician Decision|0
1129816|NCT02709538|2224131|FG002|Overall Study|Physician Decision|0
1129817|NCT02709538|2224129|FG000|Overall Study|Withdrawal by Subject|40
1129818|NCT02709538|2224130|FG001|Overall Study|Withdrawal by Subject|7
1129819|NCT02709538|2224131|FG002|Overall Study|Withdrawal by Subject|4
1129820|NCT02709538|2224129|FG000|Overall Study|Non-compliance with study procedures|5
1129821|NCT02709538|2224130|FG001|Overall Study|Non-compliance with study procedures|0
1129822|NCT02709538|2224131|FG002|Overall Study|Non-compliance with study procedures|0
1129823|NCT02709538|2224129|FG000|Overall Study|Non-compliance with study drug|2
1129824|NCT02709538|2224130|FG001|Overall Study|Non-compliance with study drug|0
1129825|NCT02709538|2224131|FG002|Overall Study|Non-compliance with study drug|0
1129826|NCT02709538|2224129|FG000|Overall Study|Protocol deviation|10
1129827|NCT02709538|2224130|FG001|Overall Study|Protocol deviation|4
1129828|NCT02709538|2224131|FG002|Overall Study|Protocol deviation|4
1129829|NCT02709538|2224129|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1
1129830|NCT02709538|2224130|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0
1129831|NCT02709538|2224131|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0
1129832|NCT02709538|2224129|FG000|Overall Study|Other|16
1129833|NCT02709538|2224130|FG001|Overall Study|Other|7
1129834|NCT02709538|2224131|FG002|Overall Study|Other|5
1129835|NCT02709577|2224141|FG000|Overall Study|non-accommodating anatomy|0
1129836|NCT02709577|2224142|FG001|Overall Study|non-accommodating anatomy|1
1129837|NCT02709577|2224143|FG002|Overall Study|non-accommodating anatomy|0
1129838|NCT02709577|2224144|FG003|Overall Study|non-accommodating anatomy|0
1129839|NCT02709577|2224141|FG000|Overall Study|procedural complication|0
1129840|NCT02709577|2224142|FG001|Overall Study|procedural complication|1
1129841|NCT02709577|2224143|FG002|Overall Study|procedural complication|0
1129842|NCT02709577|2224144|FG003|Overall Study|procedural complication|0
1129843|NCT02709577|2224141|FG000|Overall Study|Withdrawal by Subject|2
1129844|NCT02709577|2224142|FG001|Overall Study|Withdrawal by Subject|3
1129845|NCT02709577|2224143|FG002|Overall Study|Withdrawal by Subject|2
1129846|NCT02709577|2224144|FG003|Overall Study|Withdrawal by Subject|0
1129847|NCT02709746|2224174|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4
1129848|NCT02709746|2224175|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0
1129849|NCT02709746|2224176|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0
1129850|NCT02709746|2224177|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0
1129851|NCT02709746|2224178|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0
1129852|NCT02709746|2224174|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14
1129853|NCT02709746|2224175|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0
1129854|NCT02709746|2224176|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0
1129855|NCT02709746|2224177|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0
1129856|NCT02709746|2224178|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0
1129857|NCT02709746|2224174|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12
1129858|NCT02709746|2224175|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
1129859|NCT02709746|2224176|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
1129860|NCT02709746|2224177|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
1129861|NCT02709746|2224178|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
1129862|NCT02709746|2224174|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7
1129863|NCT02709746|2224175|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
1129864|NCT02709746|2224176|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
1129865|NCT02709746|2224177|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
1129866|NCT02709746|2224178|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
1129867|NCT02709746|2224174|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2
1129868|NCT02709746|2224175|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0
1129869|NCT02709746|2224176|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0
1129870|NCT02709746|2224177|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0
1129871|NCT02709746|2224178|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0
1129872|NCT02709746|2224174|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12
1129873|NCT02709746|2224175|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
1129874|NCT02709746|2224176|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
1129875|NCT02709746|2224177|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
1129876|NCT02709746|2224178|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
1129877|NCT02709746|2224174|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7
1129878|NCT02709746|2224175|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
1129879|NCT02709746|2224176|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
1129880|NCT02709746|2224177|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
1129881|NCT02709746|2224178|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
1129882|NCT02709746|2224174|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7
1129883|NCT02709746|2224175|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
1129884|NCT02709746|2224176|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
1129885|NCT02709746|2224177|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
1129886|NCT02709746|2224178|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
1129887|NCT02709746|2224174|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103
1129888|NCT02709746|2224175|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
1129889|NCT02709746|2224176|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
1129890|NCT02709746|2224177|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
1129891|NCT02709746|2224178|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
1129892|NCT02709746|2224174|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0
1129893|NCT02709746|2224175|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1
1129894|NCT02709746|2224176|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0
1129895|NCT02709746|2224177|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0
1129896|NCT02709746|2224178|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2
1129897|NCT02709746|2224174|FG000|Phase B (Double-blind Treatment Period)|Other|0
1129898|NCT02709746|2224175|FG001|Phase B (Double-blind Treatment Period)|Other|6
1129899|NCT02709746|2224176|FG002|Phase B (Double-blind Treatment Period)|Other|5
1129900|NCT02709746|2224177|FG003|Phase B (Double-blind Treatment Period)|Other|6
1129901|NCT02709746|2224178|FG004|Phase B (Double-blind Treatment Period)|Other|7
1129902|NCT02709746|2224174|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
1129903|NCT02709746|2224175|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
1129904|NCT02709746|2224176|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4
1129905|NCT02709746|2224177|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
1129906|NCT02709746|2224178|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
1129907|NCT02709746|2224174|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
1129908|NCT02709746|2224175|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3
1129909|NCT02709746|2224176|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
1129910|NCT02709746|2224177|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1
1129911|NCT02709746|2224178|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2
1129912|NCT02709746|2224174|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0
1129913|NCT02709746|2224175|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4
1129914|NCT02709746|2224176|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8
1129915|NCT02709746|2224177|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5
1129916|NCT02709746|2224178|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2
1129917|NCT02709746|2224174|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0
1129918|NCT02709746|2224175|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
1129919|NCT02709746|2224176|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
1129920|NCT02709746|2224177|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
1129921|NCT02709746|2224178|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1
1129922|NCT02709746|2224174|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0
1129923|NCT02709746|2224175|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0
1129924|NCT02709746|2224176|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1
1129925|NCT02709746|2224177|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0
1129926|NCT02709746|2224178|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0
1129927|NCT02709746|2224174|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
1129928|NCT02709746|2224175|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4
1129929|NCT02709746|2224176|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
1129930|NCT02709746|2224177|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
1129931|NCT02709746|2224178|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
1129932|NCT02709785|2224193|FG000|Overall Study|Withdrawal by Subject|1
1129933|NCT02709785|2224194|FG001|Overall Study|Withdrawal by Subject|2
1129934|NCT02709785|2224195|FG002|Overall Study|Withdrawal by Subject|1
1129935|NCT02709889|2224211|FG000|Overall Study|Withdrawal by Subject|11
1129936|NCT02709889|2224212|FG001|Overall Study|Withdrawal by Subject|10
1129937|NCT02709889|2224213|FG002|Overall Study|Withdrawal by Subject|2
1129938|NCT02709889|2224214|FG003|Overall Study|Withdrawal by Subject|12
1129939|NCT02709889|2224211|FG000|Overall Study|Death|25
1129940|NCT02709889|2224212|FG001|Overall Study|Death|38
1129941|NCT02709889|2224213|FG002|Overall Study|Death|4
1129942|NCT02709889|2224214|FG003|Overall Study|Death|44
1129943|NCT02709889|2224211|FG000|Overall Study|Physician Decision|1
1129944|NCT02709889|2224212|FG001|Overall Study|Physician Decision|2
1129945|NCT02709889|2224213|FG002|Overall Study|Physician Decision|3
1129946|NCT02709889|2224214|FG003|Overall Study|Physician Decision|5
1129947|NCT02709889|2224211|FG000|Overall Study|Lost to Follow-up|2
1129948|NCT02709889|2224212|FG001|Overall Study|Lost to Follow-up|0
1129949|NCT02709889|2224213|FG002|Overall Study|Lost to Follow-up|0
1129950|NCT02709889|2224214|FG003|Overall Study|Lost to Follow-up|4
1129951|NCT02709889|2224211|FG000|Overall Study|Study Terminated by Sponsor|4
1129952|NCT02709889|2224212|FG001|Overall Study|Study Terminated by Sponsor|6
1129953|NCT02709889|2224213|FG002|Overall Study|Study Terminated by Sponsor|2
1129954|NCT02709889|2224214|FG003|Overall Study|Study Terminated by Sponsor|17
1129955|NCT02709889|2224211|FG000|Overall Study|Other, Not Specified|0
1129956|NCT02709889|2224212|FG001|Overall Study|Other, Not Specified|1
1129957|NCT02709889|2224213|FG002|Overall Study|Other, Not Specified|1
1129958|NCT02709889|2224214|FG003|Overall Study|Other, Not Specified|6
1129959|NCT02710045|2224262|FG000|Overall Study|Death|1
1129960|NCT02710045|2224263|FG001|Overall Study|Death|2
1129961|NCT02710045|2224264|FG002|Overall Study|Death|0
1129962|NCT02710045|2224262|FG000|Overall Study|Withdrawal by Subject|6
1129963|NCT02710045|2224263|FG001|Overall Study|Withdrawal by Subject|6
1129964|NCT02710045|2224264|FG002|Overall Study|Withdrawal by Subject|2
1129965|NCT02710045|2224262|FG000|Overall Study|Protocol Violation|1
1129966|NCT02710045|2224263|FG001|Overall Study|Protocol Violation|2
1129967|NCT02710045|2224264|FG002|Overall Study|Protocol Violation|3
1129968|NCT02710045|2224262|FG000|Overall Study|Lost to Follow-up|3
1129969|NCT02710045|2224263|FG001|Overall Study|Lost to Follow-up|6
1129970|NCT02710045|2224264|FG002|Overall Study|Lost to Follow-up|7
1129971|NCT02710045|2224262|FG000|Overall Study|Physician Decision|0
1129972|NCT02710045|2224263|FG001|Overall Study|Physician Decision|0
1129973|NCT02710045|2224264|FG002|Overall Study|Physician Decision|1
1129974|NCT02710045|2224262|FG000|Overall Study|Poor Attendance|0
1129975|NCT02710045|2224263|FG001|Overall Study|Poor Attendance|1
1129976|NCT02710045|2224264|FG002|Overall Study|Poor Attendance|0
1129977|NCT02710071|2224274|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3
1129978|NCT02710071|2224275|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4
1129979|NCT02710071|2224274|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1
1129980|NCT02710071|2224275|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
1129981|NCT02710136|2224284|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
1129982|NCT02710136|2224285|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
1129983|NCT02710214|2224294|FG000|Overall Study|Lost to Follow-up|1
1129984|NCT02710214|2224295|FG001|Overall Study|Lost to Follow-up|0
1129985|NCT02710214|2224294|FG000|Overall Study|Lack of Efficacy|0
1129986|NCT02710214|2224295|FG001|Overall Study|Lack of Efficacy|1
1129987|NCT02710214|2224294|FG000|Overall Study|Death|0
1129988|NCT02710214|2224295|FG001|Overall Study|Death|1
1129989|NCT02710292|2224305|FG000|Period 1, First 10 Days of Wear|Adverse Event|0
1129990|NCT02710292|2224306|FG001|Period 1, First 10 Days of Wear|Adverse Event|1
1129991|NCT02710292|2224305|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
1129992|NCT02710292|2224306|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
1129993|NCT02710422|2224315|FG000|Overall Study|Termination of study|9
1129994|NCT02710422|2224316|FG001|Overall Study|Termination of study|9
1129995|NCT02710669|2224390|FG000|Overall Study|Physician Decision|2
1129996|NCT02710669|2224391|FG001|Overall Study|Physician Decision|1
1129997|NCT02710669|2224392|FG002|Overall Study|Physician Decision|0
1129998|NCT02710669|2224390|FG000|Overall Study|Institutional delays (including COVID)|2
1129999|NCT02710669|2224391|FG001|Overall Study|Institutional delays (including COVID)|2
1130000|NCT02710669|2224392|FG002|Overall Study|Institutional delays (including COVID)|0
1130001|NCT02710669|2224390|FG000|Overall Study|arrived in afib/aflutter|10
1130002|NCT02710669|2224391|FG001|Overall Study|arrived in afib/aflutter|8
1130003|NCT02710669|2224392|FG002|Overall Study|arrived in afib/aflutter|2
1130004|NCT02711306|2224420|FG000|Overall Study|Withdrawal by Subject|2
1130005|NCT02711306|2224421|FG001|Overall Study|Withdrawal by Subject|2
1130006|NCT02711345|2224437|FG000|Overall Study|Adverse Event|0
1130007|NCT02711345|2224438|FG001|Overall Study|Adverse Event|0
1130008|NCT02711345|2224439|FG002|Overall Study|Adverse Event|0
1130009|NCT02711345|2224440|FG003|Overall Study|Adverse Event|1
1130010|NCT02711345|2224441|FG004|Overall Study|Adverse Event|1
1130011|NCT02711345|2224442|FG005|Overall Study|Adverse Event|2
1130012|NCT02711345|2224443|FG006|Overall Study|Adverse Event|1
1130013|NCT02711345|2224444|FG007|Overall Study|Adverse Event|0
1130014|NCT02711345|2224445|FG008|Overall Study|Adverse Event|0
1130015|NCT02711345|2224446|FG009|Overall Study|Adverse Event|2
1130016|NCT02711345|2224437|FG000|Overall Study|Physician Decision|0
1130017|NCT02711345|2224438|FG001|Overall Study|Physician Decision|0
1130018|NCT02711345|2224439|FG002|Overall Study|Physician Decision|1
1130019|NCT02711345|2224440|FG003|Overall Study|Physician Decision|0
1130020|NCT02711345|2224441|FG004|Overall Study|Physician Decision|0
1130021|NCT02711345|2224442|FG005|Overall Study|Physician Decision|0
1130022|NCT02711345|2224443|FG006|Overall Study|Physician Decision|0
1130023|NCT02711345|2224444|FG007|Overall Study|Physician Decision|0
1130024|NCT02711345|2224445|FG008|Overall Study|Physician Decision|1
1130025|NCT02711345|2224446|FG009|Overall Study|Physician Decision|0
1130026|NCT02711345|2224437|FG000|Overall Study|Progressive disease|1
1130027|NCT02711345|2224438|FG001|Overall Study|Progressive disease|3
1130028|NCT02711345|2224439|FG002|Overall Study|Progressive disease|5
1130029|NCT02711345|2224440|FG003|Overall Study|Progressive disease|3
1130030|NCT02711345|2224441|FG004|Overall Study|Progressive disease|7
1130031|NCT02711345|2224442|FG005|Overall Study|Progressive disease|2
1130032|NCT02711345|2224443|FG006|Overall Study|Progressive disease|8
1130033|NCT02711345|2224444|FG007|Overall Study|Progressive disease|4
1130034|NCT02711345|2224445|FG008|Overall Study|Progressive disease|5
1130035|NCT02711345|2224446|FG009|Overall Study|Progressive disease|6
1130036|NCT02711345|2224437|FG000|Overall Study|Subject/guardian decision|0
1130037|NCT02711345|2224438|FG001|Overall Study|Subject/guardian decision|0
1130038|NCT02711345|2224439|FG002|Overall Study|Subject/guardian decision|0
1130039|NCT02711345|2224440|FG003|Overall Study|Subject/guardian decision|0
1130040|NCT02711345|2224441|FG004|Overall Study|Subject/guardian decision|0
1130041|NCT02711345|2224442|FG005|Overall Study|Subject/guardian decision|2
1130042|NCT02711345|2224443|FG006|Overall Study|Subject/guardian decision|3
1130043|NCT02711345|2224444|FG007|Overall Study|Subject/guardian decision|1
1130044|NCT02711345|2224445|FG008|Overall Study|Subject/guardian decision|0
1130045|NCT02711345|2224446|FG009|Overall Study|Subject/guardian decision|4
1130046|NCT02711345|2224437|FG000|Overall Study|Death|1
1130047|NCT02711345|2224438|FG001|Overall Study|Death|0
1130048|NCT02711345|2224439|FG002|Overall Study|Death|0
1130049|NCT02711345|2224440|FG003|Overall Study|Death|0
1130050|NCT02711345|2224441|FG004|Overall Study|Death|0
1130051|NCT02711345|2224442|FG005|Overall Study|Death|0
1130052|NCT02711345|2224443|FG006|Overall Study|Death|0
1130053|NCT02711345|2224444|FG007|Overall Study|Death|1
1130054|NCT02711345|2224445|FG008|Overall Study|Death|0
1130055|NCT02711345|2224446|FG009|Overall Study|Death|0
1130056|NCT02711553|2224477|FG000|Overall Study|Withdrawal by Subject|2
1130057|NCT02711553|2224478|FG001|Overall Study|Withdrawal by Subject|1
1130058|NCT02711553|2224479|FG002|Overall Study|Withdrawal by Subject|1
1130059|NCT02711553|2224480|FG003|Overall Study|Withdrawal by Subject|0
1130060|NCT02711553|2224477|FG000|Overall Study|Lost to Follow-up|3
1130061|NCT02711553|2224478|FG001|Overall Study|Lost to Follow-up|3
1130062|NCT02711553|2224479|FG002|Overall Study|Lost to Follow-up|6
1130063|NCT02711553|2224480|FG003|Overall Study|Lost to Follow-up|3
1130064|NCT02711553|2224477|FG000|Overall Study|On Study Treatment at Study Conclusion|1
1130065|NCT02711553|2224478|FG001|Overall Study|On Study Treatment at Study Conclusion|1
1130066|NCT02711553|2224479|FG002|Overall Study|On Study Treatment at Study Conclusion|3
1130067|NCT02711553|2224480|FG003|Overall Study|On Study Treatment at Study Conclusion|1
1130068|NCT02711800|2224492|FG000|Overall Study|Lost to Follow-up|1
1130069|NCT02711800|2224492|FG000|Overall Study|Withdrawal by Subject|1
1130070|NCT02711956|2224520|FG000|Overall Study|Adverse Event|0
1130071|NCT02711956|2224521|FG001|Overall Study|Adverse Event|0
1130072|NCT02711956|2224522|FG002|Overall Study|Adverse Event|0
1130073|NCT02711956|2224523|FG003|Overall Study|Adverse Event|1
1130074|NCT02711956|2224524|FG004|Overall Study|Adverse Event|2
1130075|NCT02711956|2224525|FG005|Overall Study|Adverse Event|0
1130076|NCT02711956|2224526|FG006|Overall Study|Adverse Event|0
1130077|NCT02711956|2224527|FG007|Overall Study|Adverse Event|1
1130078|NCT02711956|2224528|FG008|Overall Study|Adverse Event|1
1130079|NCT02711956|2224529|FG009|Overall Study|Adverse Event|1
1130080|NCT02711956|2224530|FG010|Overall Study|Adverse Event|1
1130081|NCT02711956|2224531|FG011|Overall Study|Adverse Event|0
1130082|NCT02711956|2224532|FG012|Overall Study|Adverse Event|0
1130083|NCT02711956|2224533|FG013|Overall Study|Adverse Event|0
1130084|NCT02711956|2224534|FG014|Overall Study|Adverse Event|2
1130085|NCT02711956|2224520|FG000|Overall Study|Physician Decision|0
1130086|NCT02711956|2224521|FG001|Overall Study|Physician Decision|0
1130087|NCT02711956|2224522|FG002|Overall Study|Physician Decision|0
1130088|NCT02711956|2224523|FG003|Overall Study|Physician Decision|2
1130089|NCT02711956|2224524|FG004|Overall Study|Physician Decision|0
1130090|NCT02711956|2224525|FG005|Overall Study|Physician Decision|0
1130091|NCT02711956|2224526|FG006|Overall Study|Physician Decision|0
1130092|NCT02711956|2224527|FG007|Overall Study|Physician Decision|0
1130093|NCT02711956|2224528|FG008|Overall Study|Physician Decision|0
1130094|NCT02711956|2224529|FG009|Overall Study|Physician Decision|0
1130095|NCT02711956|2224530|FG010|Overall Study|Physician Decision|0
1130096|NCT02711956|2224531|FG011|Overall Study|Physician Decision|0
1130097|NCT02711956|2224532|FG012|Overall Study|Physician Decision|0
1130098|NCT02711956|2224533|FG013|Overall Study|Physician Decision|0
1130099|NCT02711956|2224534|FG014|Overall Study|Physician Decision|0
1130100|NCT02711956|2224520|FG000|Overall Study|Withdrawal by Subject|0
1130101|NCT02711956|2224521|FG001|Overall Study|Withdrawal by Subject|0
1130102|NCT02711956|2224522|FG002|Overall Study|Withdrawal by Subject|0
1130103|NCT02711956|2224523|FG003|Overall Study|Withdrawal by Subject|0
1130104|NCT02711956|2224524|FG004|Overall Study|Withdrawal by Subject|0
1130105|NCT02711956|2224525|FG005|Overall Study|Withdrawal by Subject|0
1130106|NCT02711956|2224526|FG006|Overall Study|Withdrawal by Subject|1
1130107|NCT02711956|2224527|FG007|Overall Study|Withdrawal by Subject|0
1130108|NCT02711956|2224528|FG008|Overall Study|Withdrawal by Subject|0
1130109|NCT02711956|2224529|FG009|Overall Study|Withdrawal by Subject|0
1130110|NCT02711956|2224530|FG010|Overall Study|Withdrawal by Subject|0
1130111|NCT02711956|2224531|FG011|Overall Study|Withdrawal by Subject|1
1130112|NCT02711956|2224532|FG012|Overall Study|Withdrawal by Subject|6
1130113|NCT02711956|2224533|FG013|Overall Study|Withdrawal by Subject|0
1130114|NCT02711956|2224534|FG014|Overall Study|Withdrawal by Subject|1
1130115|NCT02711956|2224520|FG000|Overall Study|Clinical progression|1
1130116|NCT02711956|2224521|FG001|Overall Study|Clinical progression|0
1130117|NCT02711956|2224522|FG002|Overall Study|Clinical progression|0
1130118|NCT02711956|2224523|FG003|Overall Study|Clinical progression|0
1130119|NCT02711956|2224524|FG004|Overall Study|Clinical progression|0
1130120|NCT02711956|2224525|FG005|Overall Study|Clinical progression|0
1130121|NCT02711956|2224526|FG006|Overall Study|Clinical progression|1
1130122|NCT02711956|2224527|FG007|Overall Study|Clinical progression|0
1130123|NCT02711956|2224528|FG008|Overall Study|Clinical progression|1
1130124|NCT02711956|2224529|FG009|Overall Study|Clinical progression|0
1130125|NCT02711956|2224530|FG010|Overall Study|Clinical progression|0
1130126|NCT02711956|2224531|FG011|Overall Study|Clinical progression|2
1130127|NCT02711956|2224532|FG012|Overall Study|Clinical progression|4
1130128|NCT02711956|2224533|FG013|Overall Study|Clinical progression|1
1130129|NCT02711956|2224534|FG014|Overall Study|Clinical progression|1
1130130|NCT02711956|2224520|FG000|Overall Study|Radiographic progression|1
1130131|NCT02711956|2224521|FG001|Overall Study|Radiographic progression|1
1130132|NCT02711956|2224522|FG002|Overall Study|Radiographic progression|2
1130133|NCT02711956|2224523|FG003|Overall Study|Radiographic progression|0
1130134|NCT02711956|2224524|FG004|Overall Study|Radiographic progression|1
1130135|NCT02711956|2224525|FG005|Overall Study|Radiographic progression|0
1130136|NCT02711956|2224526|FG006|Overall Study|Radiographic progression|0
1130137|NCT02711956|2224527|FG007|Overall Study|Radiographic progression|0
1130138|NCT02711956|2224528|FG008|Overall Study|Radiographic progression|2
1130139|NCT02711956|2224529|FG009|Overall Study|Radiographic progression|1
1130140|NCT02711956|2224530|FG010|Overall Study|Radiographic progression|0
1130141|NCT02711956|2224531|FG011|Overall Study|Radiographic progression|5
1130142|NCT02711956|2224532|FG012|Overall Study|Radiographic progression|3
1130143|NCT02711956|2224533|FG013|Overall Study|Radiographic progression|0
1130144|NCT02711956|2224534|FG014|Overall Study|Radiographic progression|1
1130145|NCT02711956|2224520|FG000|Overall Study|PSA progression with clinical progression|0
1130146|NCT02711956|2224521|FG001|Overall Study|PSA progression with clinical progression|0
1130147|NCT02711956|2224522|FG002|Overall Study|PSA progression with clinical progression|0
1130148|NCT02711956|2224523|FG003|Overall Study|PSA progression with clinical progression|0
1130149|NCT02711956|2224524|FG004|Overall Study|PSA progression with clinical progression|1
1130150|NCT02711956|2224525|FG005|Overall Study|PSA progression with clinical progression|0
1130151|NCT02711956|2224526|FG006|Overall Study|PSA progression with clinical progression|0
1130152|NCT02711956|2224527|FG007|Overall Study|PSA progression with clinical progression|0
1130153|NCT02711956|2224528|FG008|Overall Study|PSA progression with clinical progression|0
1130154|NCT02711956|2224529|FG009|Overall Study|PSA progression with clinical progression|0
1130155|NCT02711956|2224530|FG010|Overall Study|PSA progression with clinical progression|0
1130156|NCT02711956|2224531|FG011|Overall Study|PSA progression with clinical progression|0
1130157|NCT02711956|2224532|FG012|Overall Study|PSA progression with clinical progression|1
1130158|NCT02711956|2224533|FG013|Overall Study|PSA progression with clinical progression|1
1130159|NCT02711956|2224534|FG014|Overall Study|PSA progression with clinical progression|0
1130160|NCT02711956|2224520|FG000|Overall Study|PSA progression with radiographic progression|0
1130161|NCT02711956|2224521|FG001|Overall Study|PSA progression with radiographic progression|1
1130162|NCT02711956|2224522|FG002|Overall Study|PSA progression with radiographic progression|0
1130163|NCT02711956|2224523|FG003|Overall Study|PSA progression with radiographic progression|0
1130164|NCT02711956|2224524|FG004|Overall Study|PSA progression with radiographic progression|0
1130165|NCT02711956|2224525|FG005|Overall Study|PSA progression with radiographic progression|2
1130166|NCT02711956|2224526|FG006|Overall Study|PSA progression with radiographic progression|2
1130167|NCT02711956|2224527|FG007|Overall Study|PSA progression with radiographic progression|1
1130168|NCT02711956|2224528|FG008|Overall Study|PSA progression with radiographic progression|0
1130169|NCT02711956|2224529|FG009|Overall Study|PSA progression with radiographic progression|1
1130170|NCT02711956|2224530|FG010|Overall Study|PSA progression with radiographic progression|0
1130171|NCT02711956|2224531|FG011|Overall Study|PSA progression with radiographic progression|1
1130172|NCT02711956|2224532|FG012|Overall Study|PSA progression with radiographic progression|2
1130173|NCT02711956|2224533|FG013|Overall Study|PSA progression with radiographic progression|3
1130174|NCT02711956|2224534|FG014|Overall Study|PSA progression with radiographic progression|3
1130175|NCT02711995|2224575|FG000|Washout (90 Days)|Conflicting medication|1
1130176|NCT02712008|2224584|FG000|Baseline (Day 1) up to Week 12|Death|3
1130177|NCT02712008|2224585|FG001|Baseline (Day 1) up to Week 12|Death|0
1130178|NCT02712008|2224586|FG002|Baseline (Day 1) up to Week 12|Death|0
1130179|NCT02712008|2224587|FG003|Baseline (Day 1) up to Week 12|Death|0
1130180|NCT02712008|2224588|FG004|Baseline (Day 1) up to Week 12|Death|0
1130181|NCT02712008|2224589|FG005|Baseline (Day 1) up to Week 12|Death|0
1130182|NCT02712008|2224590|FG006|Baseline (Day 1) up to Week 12|Death|0
1130183|NCT02712008|2224591|FG007|Baseline (Day 1) up to Week 12|Death|0
1162086|NCT03382912|2284107|FG001|Overall Study|Sponsor Decision|6
1130184|NCT02712008|2224584|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130185|NCT02712008|2224585|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
1130186|NCT02712008|2224586|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
1130187|NCT02712008|2224587|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130188|NCT02712008|2224588|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130189|NCT02712008|2224589|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130190|NCT02712008|2224590|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130191|NCT02712008|2224591|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130192|NCT02712008|2224584|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
1130193|NCT02712008|2224585|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130194|NCT02712008|2224586|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
1130195|NCT02712008|2224587|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130196|NCT02712008|2224588|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130197|NCT02712008|2224589|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130198|NCT02712008|2224590|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130199|NCT02712008|2224591|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130200|NCT02712008|2224584|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0
1130201|NCT02712008|2224585|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0
1130202|NCT02712008|2224586|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1
1130203|NCT02712008|2224587|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0
1130204|NCT02712008|2224588|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0
1130205|NCT02712008|2224589|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0
1130206|NCT02712008|2224590|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0
1130207|NCT02712008|2224591|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0
1130208|NCT02712008|2224584|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0
1130209|NCT02712008|2224585|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1
1130210|NCT02712008|2224586|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0
1130211|NCT02712008|2224587|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0
1130212|NCT02712008|2224588|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0
1130213|NCT02712008|2224589|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0
1130214|NCT02712008|2224590|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0
1130215|NCT02712008|2224591|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0
1130216|NCT02712008|2224584|FG000|From Week 12 up to Week 36|Adverse Event|0
1130217|NCT02712008|2224585|FG001|From Week 12 up to Week 36|Adverse Event|0
1130218|NCT02712008|2224586|FG002|From Week 12 up to Week 36|Adverse Event|0
1130219|NCT02712008|2224587|FG003|From Week 12 up to Week 36|Adverse Event|0
1130220|NCT02712008|2224588|FG004|From Week 12 up to Week 36|Adverse Event|1
1130221|NCT02712008|2224589|FG005|From Week 12 up to Week 36|Adverse Event|0
1130222|NCT02712008|2224590|FG006|From Week 12 up to Week 36|Adverse Event|0
1130223|NCT02712008|2224591|FG007|From Week 12 up to Week 36|Adverse Event|2
1130224|NCT02712008|2224584|FG000|From Week 12 up to Week 36|Death|1
1130225|NCT02712008|2224585|FG001|From Week 12 up to Week 36|Death|0
1130226|NCT02712008|2224586|FG002|From Week 12 up to Week 36|Death|0
1130227|NCT02712008|2224587|FG003|From Week 12 up to Week 36|Death|0
1130228|NCT02712008|2224588|FG004|From Week 12 up to Week 36|Death|0
1130229|NCT02712008|2224589|FG005|From Week 12 up to Week 36|Death|0
1130230|NCT02712008|2224590|FG006|From Week 12 up to Week 36|Death|1
1130231|NCT02712008|2224591|FG007|From Week 12 up to Week 36|Death|0
1130232|NCT02712008|2224584|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
1130233|NCT02712008|2224585|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
1130234|NCT02712008|2224586|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
1130235|NCT02712008|2224587|FG003|From Week 12 up to Week 36|Lost to Follow-up|1
1130236|NCT02712008|2224588|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
1130237|NCT02712008|2224589|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
1130238|NCT02712008|2224590|FG006|From Week 12 up to Week 36|Lost to Follow-up|1
1130239|NCT02712008|2224591|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
1130240|NCT02712008|2224584|FG000|From Week 12 up to Week 36|Physician Decision|0
1130241|NCT02712008|2224585|FG001|From Week 12 up to Week 36|Physician Decision|0
1130242|NCT02712008|2224586|FG002|From Week 12 up to Week 36|Physician Decision|0
1130243|NCT02712008|2224587|FG003|From Week 12 up to Week 36|Physician Decision|1
1130244|NCT02712008|2224588|FG004|From Week 12 up to Week 36|Physician Decision|1
1130245|NCT02712008|2224589|FG005|From Week 12 up to Week 36|Physician Decision|0
1130246|NCT02712008|2224590|FG006|From Week 12 up to Week 36|Physician Decision|0
1130247|NCT02712008|2224591|FG007|From Week 12 up to Week 36|Physician Decision|0
1130248|NCT02712008|2224584|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0
1130249|NCT02712008|2224585|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0
1130250|NCT02712008|2224586|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0
1130251|NCT02712008|2224587|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0
1130252|NCT02712008|2224588|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0
1130253|NCT02712008|2224589|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0
1130254|NCT02712008|2224590|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3
1130255|NCT02712008|2224591|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2
1130256|NCT02712320|2224621|FG000|Overall Study|Lost to Follow-up|1
1130257|NCT02712320|2224621|FG000|Overall Study|Withdrawal by Subject|1
1130258|NCT02712320|2224621|FG000|Overall Study|Transferred to another facility|1
1130259|NCT02712320|2224621|FG000|Overall Study|Treating with the prohibited medications|2
1130260|NCT02712333|2224627|FG000|First Period|Withdrawal by Subject|3
1130261|NCT02712333|2224628|FG001|First Period|Withdrawal by Subject|2
1130262|NCT02712398|2224656|FG000|Overall Study|Withdrawal by Subject|6
1130263|NCT02712398|2224656|FG000|Overall Study|Lost to Follow-up|6
1130264|NCT02712398|2224656|FG000|Overall Study|Sponsor Decision|1
1130265|NCT02712398|2224656|FG000|Overall Study|Physician Decision|1
1130266|NCT02712398|2224656|FG000|Overall Study|Death|2
1130267|NCT02712398|2224656|FG000|Overall Study|Re-operation|21
1130268|NCT02712424|2224662|FG000|Overall Study|Lost to Follow-up|34
1130269|NCT02712424|2224663|FG001|Overall Study|Lost to Follow-up|32
1130270|NCT02712554|2224671|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0
1130271|NCT02712554|2224672|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13
1130272|NCT02712554|2224671|FG000|Part B: Qualification Phase|Sponsor Decision|0
1130273|NCT02712554|2224672|FG001|Part B: Qualification Phase|Sponsor Decision|4
1130274|NCT02712554|2224671|FG000|Part B: Qualification Phase|Withdrawal by Subject|0
1130275|NCT02712554|2224672|FG001|Part B: Qualification Phase|Withdrawal by Subject|3
1130276|NCT02712554|2224671|FG000|Part B: Qualification Phase|Adverse Event|0
1130277|NCT02712554|2224672|FG001|Part B: Qualification Phase|Adverse Event|1
1130278|NCT02712554|2224671|FG000|Part B: Treatment Phase|Adverse Event|0
1130279|NCT02712554|2224672|FG001|Part B: Treatment Phase|Adverse Event|1
1130280|NCT02712554|2224671|FG000|Part B: Treatment Phase|Withdrawal by Subject|0
1130281|NCT02712554|2224672|FG001|Part B: Treatment Phase|Withdrawal by Subject|1
1130282|NCT02712554|2224671|FG000|Part B: Treatment Phase|Other|0
1130283|NCT02712554|2224672|FG001|Part B: Treatment Phase|Other|1
1130284|NCT02712788|2224697|FG000|Overall Study|Physician Decision|1
1130285|NCT02712788|2224698|FG001|Overall Study|Physician Decision|0
1130286|NCT02712788|2224697|FG000|Overall Study|Protocol Violation|1
1130287|NCT02712788|2224698|FG001|Overall Study|Protocol Violation|0
1130288|NCT02712983|2224713|FG000|Treatment Phase|Adverse Event|3
1130289|NCT02712983|2224714|FG001|Treatment Phase|Adverse Event|1
1130290|NCT02712983|2224715|FG002|Treatment Phase|Adverse Event|1
1130291|NCT02712983|2224716|FG003|Treatment Phase|Adverse Event|4
1130292|NCT02712983|2224717|FG004|Treatment Phase|Adverse Event|3
1130293|NCT02712983|2224718|FG005|Treatment Phase|Adverse Event|0
1130294|NCT02712983|2224719|FG006|Treatment Phase|Adverse Event|6
1130295|NCT02712983|2224720|FG007|Treatment Phase|Adverse Event|6
1130296|NCT02712983|2224721|FG008|Treatment Phase|Adverse Event|1
1130297|NCT02712983|2224713|FG000|Treatment Phase|Protocol Deviation|0
1130298|NCT02712983|2224714|FG001|Treatment Phase|Protocol Deviation|0
1130299|NCT02712983|2224715|FG002|Treatment Phase|Protocol Deviation|0
1130300|NCT02712983|2224716|FG003|Treatment Phase|Protocol Deviation|2
1130301|NCT02712983|2224717|FG004|Treatment Phase|Protocol Deviation|0
1130302|NCT02712983|2224718|FG005|Treatment Phase|Protocol Deviation|0
1130303|NCT02712983|2224719|FG006|Treatment Phase|Protocol Deviation|1
1130304|NCT02712983|2224720|FG007|Treatment Phase|Protocol Deviation|0
1130305|NCT02712983|2224721|FG008|Treatment Phase|Protocol Deviation|0
1130306|NCT02712983|2224713|FG000|Treatment Phase|Technical Problems|0
1130307|NCT02712983|2224714|FG001|Treatment Phase|Technical Problems|0
1130308|NCT02712983|2224715|FG002|Treatment Phase|Technical Problems|0
1130309|NCT02712983|2224716|FG003|Treatment Phase|Technical Problems|0
1130310|NCT02712983|2224717|FG004|Treatment Phase|Technical Problems|0
1130311|NCT02712983|2224718|FG005|Treatment Phase|Technical Problems|0
1130312|NCT02712983|2224719|FG006|Treatment Phase|Technical Problems|1
1130313|NCT02712983|2224720|FG007|Treatment Phase|Technical Problems|0
1130314|NCT02712983|2224721|FG008|Treatment Phase|Technical Problems|0
1130315|NCT02712983|2224713|FG000|Treatment Phase|Physician Decision|0
1130316|NCT02712983|2224714|FG001|Treatment Phase|Physician Decision|0
1130317|NCT02712983|2224715|FG002|Treatment Phase|Physician Decision|0
1130318|NCT02712983|2224716|FG003|Treatment Phase|Physician Decision|0
1130319|NCT02712983|2224717|FG004|Treatment Phase|Physician Decision|0
1130320|NCT02712983|2224718|FG005|Treatment Phase|Physician Decision|0
1130321|NCT02712983|2224719|FG006|Treatment Phase|Physician Decision|0
1130322|NCT02712983|2224720|FG007|Treatment Phase|Physician Decision|1
1130323|NCT02712983|2224721|FG008|Treatment Phase|Physician Decision|1
1130324|NCT02712983|2224713|FG000|Treatment Phase|Subject Decision|2
1130325|NCT02712983|2224714|FG001|Treatment Phase|Subject Decision|0
1130326|NCT02712983|2224715|FG002|Treatment Phase|Subject Decision|0
1130327|NCT02712983|2224716|FG003|Treatment Phase|Subject Decision|2
1130328|NCT02712983|2224717|FG004|Treatment Phase|Subject Decision|1
1130329|NCT02712983|2224718|FG005|Treatment Phase|Subject Decision|0
1130330|NCT02712983|2224719|FG006|Treatment Phase|Subject Decision|1
1130331|NCT02712983|2224720|FG007|Treatment Phase|Subject Decision|2
1130332|NCT02712983|2224721|FG008|Treatment Phase|Subject Decision|0
1130333|NCT02712983|2224713|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
1130334|NCT02712983|2224714|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
1130335|NCT02712983|2224715|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
1130336|NCT02712983|2224716|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
1130337|NCT02712983|2224717|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
1130338|NCT02712983|2224718|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
1130339|NCT02712983|2224719|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
1130340|NCT02712983|2224720|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
1130341|NCT02712983|2224721|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
1130342|NCT02712983|2224713|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
1130343|NCT02712983|2224714|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
1130344|NCT02712983|2224715|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
1130345|NCT02712983|2224716|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1
1130346|NCT02712983|2224717|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
1130347|NCT02712983|2224718|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
1130348|NCT02712983|2224719|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
1130349|NCT02712983|2224720|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
1130350|NCT02712983|2224721|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
1130351|NCT02712983|2224713|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
1130352|NCT02712983|2224714|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
1130353|NCT02712983|2224715|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
1130354|NCT02712983|2224716|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
1130355|NCT02712983|2224717|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
1130356|NCT02712983|2224718|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
1130357|NCT02712983|2224719|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
1130358|NCT02712983|2224720|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
1130359|NCT02712983|2224721|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
1130360|NCT02712996|2224743|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0
1130361|NCT02712996|2224744|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1
1130362|NCT02713204|2224768|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1
1130363|NCT02713204|2224769|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0
1130364|NCT02713204|2224770|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1
1130365|NCT02713204|2224771|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0
1130366|NCT02713204|2224772|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0
1130367|NCT02713204|2224773|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0
1130368|NCT02713204|2224774|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0
1130369|NCT02713204|2224775|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0
1130370|NCT02713204|2224768|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130371|NCT02713204|2224769|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130372|NCT02713204|2224770|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
1130373|NCT02713204|2224771|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130374|NCT02713204|2224772|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130375|NCT02713204|2224773|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130376|NCT02713204|2224774|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130377|NCT02713204|2224775|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1130378|NCT02713204|2224768|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130379|NCT02713204|2224769|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
1130380|NCT02713204|2224770|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130381|NCT02713204|2224771|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130382|NCT02713204|2224772|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130383|NCT02713204|2224773|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130384|NCT02713204|2224774|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130385|NCT02713204|2224775|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1130386|NCT02713204|2224768|FG000|From Week 12 up to Week 36|Adverse Event|1
1130387|NCT02713204|2224769|FG001|From Week 12 up to Week 36|Adverse Event|0
1130388|NCT02713204|2224770|FG002|From Week 12 up to Week 36|Adverse Event|0
1130389|NCT02713204|2224771|FG003|From Week 12 up to Week 36|Adverse Event|1
1130390|NCT02713204|2224772|FG004|From Week 12 up to Week 36|Adverse Event|1
1130391|NCT02713204|2224773|FG005|From Week 12 up to Week 36|Adverse Event|0
1130392|NCT02713204|2224774|FG006|From Week 12 up to Week 36|Adverse Event|2
1130393|NCT02713204|2224775|FG007|From Week 12 up to Week 36|Adverse Event|1
1130394|NCT02713204|2224768|FG000|From Week 12 up to Week 36|Death|0
1130395|NCT02713204|2224769|FG001|From Week 12 up to Week 36|Death|0
1130396|NCT02713204|2224770|FG002|From Week 12 up to Week 36|Death|0
1130397|NCT02713204|2224771|FG003|From Week 12 up to Week 36|Death|1
1130398|NCT02713204|2224772|FG004|From Week 12 up to Week 36|Death|0
1130399|NCT02713204|2224773|FG005|From Week 12 up to Week 36|Death|1
1130400|NCT02713204|2224774|FG006|From Week 12 up to Week 36|Death|0
1130401|NCT02713204|2224775|FG007|From Week 12 up to Week 36|Death|3
1130402|NCT02713204|2224768|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
1130403|NCT02713204|2224769|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
1130404|NCT02713204|2224770|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
1130405|NCT02713204|2224771|FG003|From Week 12 up to Week 36|Lost to Follow-up|2
1130406|NCT02713204|2224772|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
1130407|NCT02713204|2224773|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
1130408|NCT02713204|2224774|FG006|From Week 12 up to Week 36|Lost to Follow-up|0
1130409|NCT02713204|2224775|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
1130410|NCT02713204|2224768|FG000|From Week 12 up to Week 36|Participant Re-located|0
1130411|NCT02713204|2224769|FG001|From Week 12 up to Week 36|Participant Re-located|0
1130412|NCT02713204|2224770|FG002|From Week 12 up to Week 36|Participant Re-located|0
1130413|NCT02713204|2224771|FG003|From Week 12 up to Week 36|Participant Re-located|0
1130414|NCT02713204|2224772|FG004|From Week 12 up to Week 36|Participant Re-located|1
1130415|NCT02713204|2224773|FG005|From Week 12 up to Week 36|Participant Re-located|0
1130416|NCT02713204|2224774|FG006|From Week 12 up to Week 36|Participant Re-located|0
1130417|NCT02713204|2224775|FG007|From Week 12 up to Week 36|Participant Re-located|0
1130418|NCT02713243|2224806|FG000|Overall Study|Abnormal laboratory value(s)#|1
1130419|NCT02713243|2224807|FG001|Overall Study|Abnormal laboratory value(s)#|0
1130420|NCT02713243|2224806|FG000|Overall Study|Administrative problems|0
1130421|NCT02713243|2224807|FG001|Overall Study|Administrative problems|1
1130422|NCT02713243|2224806|FG000|Overall Study|Protocol deviation|0
1130423|NCT02713243|2224807|FG001|Overall Study|Protocol deviation|1
1130424|NCT02713490|2224823|FG000|Overall Study|Withdrawal by Subject|2
1130425|NCT02713490|2224824|FG001|Overall Study|Withdrawal by Subject|1
1130426|NCT02713490|2224823|FG000|Overall Study|Did not receive study drug|1
1130427|NCT02713490|2224824|FG001|Overall Study|Did not receive study drug|0
1130428|NCT02713490|2224823|FG000|Overall Study|Met exclusion criteria|0
1130429|NCT02713490|2224824|FG001|Overall Study|Met exclusion criteria|1
1130430|NCT02713529|2224837|FG000|Overall Study|Withdrawal by Subject|3
1130431|NCT02713529|2224838|FG001|Overall Study|Withdrawal by Subject|1
1130432|NCT02713529|2224839|FG002|Overall Study|Withdrawal by Subject|4
1130433|NCT02713529|2224840|FG003|Overall Study|Withdrawal by Subject|2
1130434|NCT02713529|2224841|FG004|Overall Study|Withdrawal by Subject|0
1130435|NCT02713529|2224842|FG005|Overall Study|Withdrawal by Subject|1
1130436|NCT02713529|2224843|FG006|Overall Study|Withdrawal by Subject|1
1130437|NCT02713529|2224837|FG000|Overall Study|Lost to Follow-up|1
1130438|NCT02713529|2224838|FG001|Overall Study|Lost to Follow-up|0
1130439|NCT02713529|2224839|FG002|Overall Study|Lost to Follow-up|1
1130440|NCT02713529|2224840|FG003|Overall Study|Lost to Follow-up|0
1130441|NCT02713529|2224841|FG004|Overall Study|Lost to Follow-up|0
1130442|NCT02713529|2224842|FG005|Overall Study|Lost to Follow-up|0
1130443|NCT02713529|2224843|FG006|Overall Study|Lost to Follow-up|0
1130444|NCT02713529|2224837|FG000|Overall Study|Death|3
1130445|NCT02713529|2224838|FG001|Overall Study|Death|3
1130446|NCT02713529|2224839|FG002|Overall Study|Death|26
1130447|NCT02713529|2224840|FG003|Overall Study|Death|27
1130448|NCT02713529|2224841|FG004|Overall Study|Death|3
1130449|NCT02713529|2224842|FG005|Overall Study|Death|13
1130450|NCT02713529|2224843|FG006|Overall Study|Death|3
1130451|NCT02713542|2224865|FG000|Overall Study|Use of prohibited medication|14
1130452|NCT02713542|2224866|FG001|Overall Study|Use of prohibited medication|5
1130453|NCT02713542|2224865|FG000|Overall Study|Withdrawal by Subject|4
1130454|NCT02713542|2224866|FG001|Overall Study|Withdrawal by Subject|1
1130455|NCT02713594|2224874|FG000|Overall Study|Withdrawal by Subject|32
1130456|NCT02713594|2224875|FG001|Overall Study|Withdrawal by Subject|22
1130457|NCT02713594|2224874|FG000|Overall Study|Lost to Follow-up|358
1130458|NCT02713594|2224875|FG001|Overall Study|Lost to Follow-up|374
1130459|NCT02713789|2224924|FG000|Overall Study|Lost to Follow-up|0
1130460|NCT02713789|2224925|FG001|Overall Study|Lost to Follow-up|1
1130461|NCT02713789|2224926|FG002|Overall Study|Lost to Follow-up|1
1130462|NCT02713828|2224936|FG000|Overall Study|Death|2
1130463|NCT02713828|2224937|FG001|Overall Study|Death|0
1130464|NCT02713828|2224936|FG000|Overall Study|Withdrawal by Subject|1
1130465|NCT02713828|2224937|FG001|Overall Study|Withdrawal by Subject|0
1130466|NCT02713828|2224936|FG000|Overall Study|study terminated but patient allowed to|2
1130467|NCT02713828|2224937|FG001|Overall Study|study terminated but patient allowed to|0
1130468|NCT02713867|2224944|FG000|Randomization|Other Reason|2
1130469|NCT02713867|2224945|FG001|Randomization|Other Reason|1
1130470|NCT02713867|2224944|FG000|Randomization|Participant Withdrew consent|0
1130471|NCT02713867|2224945|FG001|Randomization|Participant Withdrew consent|2
1130472|NCT02713867|2224944|FG000|Treatment Period|Not Reported|1
1130473|NCT02713867|2224945|FG001|Treatment Period|Not Reported|0
1130474|NCT02713867|2224944|FG000|Treatment Period|Other Reasons|12
1130475|NCT02713867|2224945|FG001|Treatment Period|Other Reasons|18
1130476|NCT02713867|2224944|FG000|Treatment Period|Administrative reason by sponsor|9
1130477|NCT02713867|2224945|FG001|Treatment Period|Administrative reason by sponsor|4
1130478|NCT02713867|2224944|FG000|Treatment Period|No longer meets study criteria|2
1130479|NCT02713867|2224945|FG001|Treatment Period|No longer meets study criteria|1
1130480|NCT02713867|2224944|FG000|Treatment Period|Poor/Non Compliance|1
1130481|NCT02713867|2224945|FG001|Treatment Period|Poor/Non Compliance|0
1130482|NCT02713867|2224944|FG000|Treatment Period|Maximum Clinical Benefit|3
1130483|NCT02713867|2224945|FG001|Treatment Period|Maximum Clinical Benefit|4
1130484|NCT02713867|2224944|FG000|Treatment Period|Withdrew consent|1
1130485|NCT02713867|2224945|FG001|Treatment Period|Withdrew consent|6
1130486|NCT02713867|2224944|FG000|Treatment Period|Requested to Discontinue|8
1130487|NCT02713867|2224945|FG001|Treatment Period|Requested to Discontinue|7
1130488|NCT02713867|2224944|FG000|Treatment Period|AE unrelated to Study Drug|8
1130489|NCT02713867|2224945|FG001|Treatment Period|AE unrelated to Study Drug|9
1130490|NCT02713867|2224944|FG000|Treatment Period|Death|7
1130491|NCT02713867|2224945|FG001|Treatment Period|Death|3
1130492|NCT02713867|2224944|FG000|Treatment Period|Study Drug Toxicity|16
1130493|NCT02713867|2224945|FG001|Treatment Period|Study Drug Toxicity|20
1130494|NCT02713867|2224944|FG000|Treatment Period|Disease Progression|79
1130495|NCT02713867|2224945|FG001|Treatment Period|Disease Progression|78
1130496|NCT02714062|2224954|FG000|Overall Study|Adverse Event|0
1130497|NCT02714062|2224955|FG001|Overall Study|Adverse Event|0
1130498|NCT02714062|2224956|FG002|Overall Study|Adverse Event|2
1130499|NCT02714062|2224954|FG000|Overall Study|Withdrawal by Subject|1
1130500|NCT02714062|2224955|FG001|Overall Study|Withdrawal by Subject|0
1130501|NCT02714062|2224956|FG002|Overall Study|Withdrawal by Subject|1
1130502|NCT02714062|2224954|FG000|Overall Study|Protocol Violation|0
1130503|NCT02714062|2224955|FG001|Overall Study|Protocol Violation|1
1130504|NCT02714062|2224956|FG002|Overall Study|Protocol Violation|0
1130505|NCT02714153|2224966|FG000|Overall Study|Death|1
1130542|NCT02714426|2225004|FG000|Overall Study|Withdrawal by Subject|2
1130543|NCT02714426|2225005|FG001|Overall Study|Withdrawal by Subject|2
1130544|NCT02714569|2225031|FG000|Part A Second Intervention|Withdrawal by Subject|0
1130545|NCT02714569|2225032|FG001|Part A Second Intervention|Withdrawal by Subject|1
1130546|NCT02714569|2225033|FG002|Part A Second Intervention|Withdrawal by Subject|0
1130547|NCT02714569|2225034|FG003|Part A Second Intervention|Withdrawal by Subject|0
1130548|NCT02714569|2225035|FG004|Part A Second Intervention|Withdrawal by Subject|0
1130549|NCT02714569|2225036|FG005|Part A Second Intervention|Withdrawal by Subject|0
1130550|NCT02714569|2225037|FG006|Part A Second Intervention|Withdrawal by Subject|0
1130551|NCT02714569|2225038|FG007|Part A Second Intervention|Withdrawal by Subject|0
1130552|NCT02714569|2225039|FG008|Part A Second Intervention|Withdrawal by Subject|0
1130553|NCT02714569|2225040|FG009|Part A Second Intervention|Withdrawal by Subject|0
1130554|NCT02714569|2225041|FG010|Part A Second Intervention|Withdrawal by Subject|0
1130555|NCT02714569|2225031|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
1130556|NCT02714569|2225032|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
1130557|NCT02714569|2225033|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
1130558|NCT02714569|2225034|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1
1130559|NCT02714569|2225035|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
1130560|NCT02714569|2225036|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
1130561|NCT02714569|2225037|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
1130562|NCT02714569|2225038|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
1130563|NCT02714569|2225039|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
1130564|NCT02714569|2225040|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
1130565|NCT02714569|2225041|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
1130566|NCT02714569|2225031|FG000|Part A Third Intervention|Adverse Event|0
1130567|NCT02714569|2225032|FG001|Part A Third Intervention|Adverse Event|0
1130568|NCT02714569|2225033|FG002|Part A Third Intervention|Adverse Event|1
1130569|NCT02714569|2225034|FG003|Part A Third Intervention|Adverse Event|0
1130570|NCT02714569|2225035|FG004|Part A Third Intervention|Adverse Event|0
1130571|NCT02714569|2225036|FG005|Part A Third Intervention|Adverse Event|0
1130572|NCT02714569|2225037|FG006|Part A Third Intervention|Adverse Event|0
1130573|NCT02714569|2225038|FG007|Part A Third Intervention|Adverse Event|0
1130574|NCT02714569|2225039|FG008|Part A Third Intervention|Adverse Event|0
1130575|NCT02714569|2225040|FG009|Part A Third Intervention|Adverse Event|0
1130576|NCT02714569|2225041|FG010|Part A Third Intervention|Adverse Event|0
1130577|NCT02714569|2225031|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
1130578|NCT02714569|2225032|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
1130579|NCT02714569|2225033|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
1130580|NCT02714569|2225034|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
1130581|NCT02714569|2225035|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
1130582|NCT02714569|2225036|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
1130583|NCT02714569|2225037|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
1130584|NCT02714569|2225038|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
1130585|NCT02714569|2225039|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
1130586|NCT02714569|2225040|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
1130587|NCT02714569|2225041|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
1130588|NCT02714569|2225031|FG000|Part B (Overall)|Lost to Follow-up|0
1130589|NCT02714569|2225032|FG001|Part B (Overall)|Lost to Follow-up|0
1130590|NCT02714569|2225033|FG002|Part B (Overall)|Lost to Follow-up|0
1130591|NCT02714569|2225034|FG003|Part B (Overall)|Lost to Follow-up|0
1130592|NCT02714569|2225035|FG004|Part B (Overall)|Lost to Follow-up|0
1130593|NCT02714569|2225036|FG005|Part B (Overall)|Lost to Follow-up|0
1130594|NCT02714569|2225037|FG006|Part B (Overall)|Lost to Follow-up|1
1130595|NCT02714569|2225038|FG007|Part B (Overall)|Lost to Follow-up|0
1130596|NCT02714569|2225039|FG008|Part B (Overall)|Lost to Follow-up|0
1130597|NCT02714569|2225040|FG009|Part B (Overall)|Lost to Follow-up|0
1130598|NCT02714569|2225041|FG010|Part B (Overall)|Lost to Follow-up|0
1130599|NCT02714569|2225031|FG000|Part B (Overall)|Withdrawal by Subject|0
1130600|NCT02714569|2225032|FG001|Part B (Overall)|Withdrawal by Subject|0
1130601|NCT02714569|2225033|FG002|Part B (Overall)|Withdrawal by Subject|0
1130602|NCT02714569|2225034|FG003|Part B (Overall)|Withdrawal by Subject|0
1130603|NCT02714569|2225035|FG004|Part B (Overall)|Withdrawal by Subject|0
1130604|NCT02714569|2225036|FG005|Part B (Overall)|Withdrawal by Subject|0
1130605|NCT02714569|2225037|FG006|Part B (Overall)|Withdrawal by Subject|0
1130606|NCT02714569|2225038|FG007|Part B (Overall)|Withdrawal by Subject|1
1130607|NCT02714569|2225039|FG008|Part B (Overall)|Withdrawal by Subject|0
1130608|NCT02714569|2225040|FG009|Part B (Overall)|Withdrawal by Subject|1
1130609|NCT02714569|2225041|FG010|Part B (Overall)|Withdrawal by Subject|0
1130610|NCT02714569|2225031|FG000|Part B (Overall)|Adverse Event|0
1130611|NCT02714569|2225032|FG001|Part B (Overall)|Adverse Event|0
1130612|NCT02714569|2225033|FG002|Part B (Overall)|Adverse Event|0
1130613|NCT02714569|2225034|FG003|Part B (Overall)|Adverse Event|0
1130614|NCT02714569|2225035|FG004|Part B (Overall)|Adverse Event|0
900143|NCT00726232|1873274|FG004|Initial Phase (Dose-finding)|Death|1
900144|NCT00726232|1873275|FG005|Initial Phase (Dose-finding)|Death|0
900145|NCT00726232|1873276|FG006|Initial Phase (Dose-finding)|Death|0
900146|NCT00726232|1873277|FG007|Initial Phase (Dose-finding)|Death|0
900147|NCT00726232|1873270|FG000|Initial Phase (Dose-finding)|Adverse Event|2
900148|NCT00726232|1873271|FG001|Initial Phase (Dose-finding)|Adverse Event|2
900149|NCT00726232|1873272|FG002|Initial Phase (Dose-finding)|Adverse Event|2
900150|NCT00726232|1873273|FG003|Initial Phase (Dose-finding)|Adverse Event|1
900151|NCT00726232|1873274|FG004|Initial Phase (Dose-finding)|Adverse Event|7
900152|NCT00726232|1873275|FG005|Initial Phase (Dose-finding)|Adverse Event|3
900153|NCT00726232|1873276|FG006|Initial Phase (Dose-finding)|Adverse Event|0
900154|NCT00726232|1873277|FG007|Initial Phase (Dose-finding)|Adverse Event|0
900155|NCT00726232|1873270|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2
900156|NCT00726232|1873271|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0
900157|NCT00726232|1873272|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0
900158|NCT00726232|1873273|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1
900159|NCT00726232|1873274|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0
900160|NCT00726232|1873275|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2
900161|NCT00726232|1873276|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0
900162|NCT00726232|1873277|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0
900163|NCT00726232|1873270|FG000|Initial Phase (Dose-finding)|Disease progression|3
900164|NCT00726232|1873271|FG001|Initial Phase (Dose-finding)|Disease progression|1
1130615|NCT02714569|2225036|FG005|Part B (Overall)|Adverse Event|0
1130616|NCT02714569|2225037|FG006|Part B (Overall)|Adverse Event|0
1130617|NCT02714569|2225038|FG007|Part B (Overall)|Adverse Event|0
1130618|NCT02714569|2225039|FG008|Part B (Overall)|Adverse Event|0
1130619|NCT02714569|2225040|FG009|Part B (Overall)|Adverse Event|1
1130620|NCT02714569|2225041|FG010|Part B (Overall)|Adverse Event|0
1130621|NCT02714595|2225103|FG000|Overall Study|Lost to Follow-up|1
1130622|NCT02714595|2225104|FG001|Overall Study|Lost to Follow-up|0
1130623|NCT02714595|2225103|FG000|Overall Study|Withdrawal by Subject|1
1130624|NCT02714595|2225104|FG001|Overall Study|Withdrawal by Subject|2
1130625|NCT02714595|2225103|FG000|Overall Study|Lack of Efficacy|0
1130626|NCT02714595|2225104|FG001|Overall Study|Lack of Efficacy|1
1130627|NCT02714595|2225103|FG000|Overall Study|Death|30
1130628|NCT02714595|2225104|FG001|Overall Study|Death|9
1130629|NCT02714595|2225103|FG000|Overall Study|Other-Miscellaneous|0
1130630|NCT02714595|2225104|FG001|Overall Study|Other-Miscellaneous|1
1130631|NCT02714868|2225130|FG000|Overall Study|Withdrawal by Subject|3
1130632|NCT02714868|2225131|FG001|Overall Study|Withdrawal by Subject|0
1130633|NCT02714868|2225130|FG000|Overall Study|PI withdrawal safety risk self/others|1
1130634|NCT02714868|2225131|FG001|Overall Study|PI withdrawal safety risk self/others|0
1130635|NCT02714868|2225130|FG000|Overall Study|PI withdraw did not meet inclusion|1
1130636|NCT02714868|2225131|FG001|Overall Study|PI withdraw did not meet inclusion|0
1130637|NCT02715258|2225165|FG000|Overall Study|Withdrawal by Subject|6
1130638|NCT02715258|2225166|FG001|Overall Study|Withdrawal by Subject|1
1130639|NCT02715258|2225165|FG000|Overall Study|Lost to Follow-up|7
1130640|NCT02715258|2225166|FG001|Overall Study|Lost to Follow-up|1
1130641|NCT02715258|2225165|FG000|Overall Study|Terminated by Sponsor|0
1130642|NCT02715258|2225166|FG001|Overall Study|Terminated by Sponsor|1
1130643|NCT02715258|2225165|FG000|Overall Study|Death|0
1130644|NCT02715258|2225166|FG001|Overall Study|Death|1
1130645|NCT02715258|2225165|FG000|Overall Study|Subject non-compliant|1
1130646|NCT02715258|2225166|FG001|Overall Study|Subject non-compliant|1
1130647|NCT02715258|2225165|FG000|Overall Study|GCP violation|2
1130648|NCT02715258|2225166|FG001|Overall Study|GCP violation|1
1130649|NCT02715726|2225182|FG000|Overall Study|Adverse Event|2
1130650|NCT02715726|2225183|FG001|Overall Study|Adverse Event|6
1130651|NCT02715726|2225182|FG000|Overall Study|Protocol Violation|1
1130652|NCT02715726|2225183|FG001|Overall Study|Protocol Violation|0
1130653|NCT02715726|2225182|FG000|Overall Study|Death|2
1130654|NCT02715726|2225183|FG001|Overall Study|Death|1
1130655|NCT02715726|2225182|FG000|Overall Study|Participant moved|1
1130656|NCT02715726|2225183|FG001|Overall Study|Participant moved|3
1130657|NCT02715726|2225182|FG000|Overall Study|Other than specified above|11
1130658|NCT02715726|2225183|FG001|Overall Study|Other than specified above|15
1130659|NCT02715726|2225182|FG000|Overall Study|Randomized but not treated|1
1130660|NCT02715726|2225183|FG001|Overall Study|Randomized but not treated|2
1130661|NCT02715804|2225191|FG000|Overall Study|Death|222
1130662|NCT02715804|2225192|FG001|Overall Study|Death|106
1130663|NCT02715804|2225191|FG000|Overall Study|Withdrawal by Subject|5
1130664|NCT02715804|2225192|FG001|Overall Study|Withdrawal by Subject|4
1130665|NCT02715804|2225191|FG000|Overall Study|Other than specified|2
1130666|NCT02715804|2225192|FG001|Overall Study|Other than specified|3
1130667|NCT02716194|2225201|FG000|Period 1 - ADVATE|Withdrawal by Subject|1
1130668|NCT02716194|2225202|FG001|Period 1 - ADVATE|Withdrawal by Subject|1
1130669|NCT02716194|2225203|FG002|Period 1 - ADVATE|Withdrawal by Subject|0
1130670|NCT02716298|2225224|FG000|First Intervention (1 Month)|Lens discomfort|1
1130671|NCT02716298|2225225|FG001|First Intervention (1 Month)|Lens discomfort|1
1130672|NCT02716584|2225251|FG000|Overall Study|Lost to Follow-up|8
1130673|NCT02716584|2225252|FG001|Overall Study|Lost to Follow-up|5
1130674|NCT02716779|2225283|FG000|Monotherapy|Adverse Event|0
1130675|NCT02716779|2225284|FG001|Monotherapy|Adverse Event|1
1130676|NCT02716779|2225285|FG002|Monotherapy|Adverse Event|1
1130677|NCT02716779|2225283|FG000|Combination Therapy|Adverse Event|0
1130678|NCT02716779|2225284|FG001|Combination Therapy|Adverse Event|2
1130679|NCT02716779|2225285|FG002|Combination Therapy|Adverse Event|1
1130680|NCT02716805|2225299|FG000|Overall Study|Progressive disease|2
1130681|NCT02716805|2225300|FG001|Overall Study|Progressive disease|0
1130682|NCT02716805|2225301|FG002|Overall Study|Progressive disease|0
1130683|NCT02716805|2225302|FG003|Overall Study|Progressive disease|0
1130684|NCT02716896|2225339|FG000|Overall Study|Physician Decision|0
1130685|NCT02716896|2225340|FG001|Overall Study|Physician Decision|1
1130686|NCT02716987|2225352|FG000|Overall Study|Ligand synthesis failure|0
1130687|NCT02716987|2225353|FG001|Overall Study|Ligand synthesis failure|0
1130688|NCT02716987|2225354|FG002|Overall Study|Ligand synthesis failure|1
1130689|NCT02716987|2225355|FG003|Overall Study|Ligand synthesis failure|0
1130690|NCT02716987|2225356|FG004|Overall Study|Ligand synthesis failure|0
1130691|NCT02716987|2225357|FG005|Overall Study|Ligand synthesis failure|0
1130692|NCT02716987|2225352|FG000|Overall Study|Withdrawal by Subject|0
1130693|NCT02716987|2225353|FG001|Overall Study|Withdrawal by Subject|0
1130694|NCT02716987|2225354|FG002|Overall Study|Withdrawal by Subject|0
1130695|NCT02716987|2225355|FG003|Overall Study|Withdrawal by Subject|0
1130696|NCT02716987|2225356|FG004|Overall Study|Withdrawal by Subject|1
1130697|NCT02716987|2225357|FG005|Overall Study|Withdrawal by Subject|1
1130698|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Adverse Event|19
1130699|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Adverse Event|7
1130700|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
1130701|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
1130702|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Adverse Event|0
1130703|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2
1130704|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1
1130705|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1130706|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1130707|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1130708|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
1130709|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
1130710|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
1130711|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
1130712|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
1130713|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3
1130714|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1
1130715|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
1130716|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
1130717|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0
1130718|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
1130719|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
1130720|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
1130721|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
1130722|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
1130723|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9
1130724|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4
1130725|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0
1130726|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0
1130727|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0
1130728|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
1130729|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
1130730|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
1130731|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
1130732|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
1130733|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3
1130734|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3
1130735|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0
1130736|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0
1130737|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0
1130738|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
1130739|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
1130740|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
1130741|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
1130742|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
1130743|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Technical error|1
1130744|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Technical error|0
1130745|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Technical error|0
1130746|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Technical error|0
1130747|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Technical error|0
1130748|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Patient decision|5
1130749|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Patient decision|2
1130750|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Patient decision|0
1130751|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Patient decision|0
1130752|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Patient decision|0
1130753|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
1130754|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
1130755|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
1130756|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
1130757|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
1130758|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1
1130759|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0
1130760|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0
1130761|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0
1130762|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0
1130763|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
1130764|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
1130765|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
1130766|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
1130767|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
1130768|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Investigator decision|2
1130769|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Investigator decision|1
1130770|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Investigator decision|0
1130771|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Investigator decision|0
1130772|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Investigator decision|0
1130773|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
1130774|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
1130775|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
1130776|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
1130777|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
1130778|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
1130779|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
1130780|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
1130781|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
1130782|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
1130783|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
1130784|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
1130785|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
1130786|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
1130787|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
1130788|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1
1130789|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0
1130790|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0
1130791|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0
1130792|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0
1130793|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0
1130794|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1
1130795|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0
1130796|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0
1130797|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0
1130798|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1
1130799|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0
1130800|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0
1130801|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0
1130802|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0
1130803|NCT02717195|2225386|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
1130804|NCT02717195|2225387|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
1130805|NCT02717195|2225388|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
1130806|NCT02717195|2225389|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
1130807|NCT02717195|2225390|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
1130808|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0
1130809|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0
1130810|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10
1130811|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11
1130812|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8
1130813|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
1130814|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
1130815|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
1130816|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
1130817|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
1130818|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
1130819|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
1130820|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
1130821|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
1130822|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
900165|NCT00726232|1873272|FG002|Initial Phase (Dose-finding)|Disease progression|0
900166|NCT00726232|1873273|FG003|Initial Phase (Dose-finding)|Disease progression|0
900167|NCT00726232|1873274|FG004|Initial Phase (Dose-finding)|Disease progression|0
900168|NCT00726232|1873275|FG005|Initial Phase (Dose-finding)|Disease progression|0
900169|NCT00726232|1873276|FG006|Initial Phase (Dose-finding)|Disease progression|0
1130823|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0
1130824|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0
1130825|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1
1130826|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0
1130827|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1
1130828|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
1130829|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
1130830|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
1130831|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
1130832|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
1130833|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
1130834|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
1130835|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
1130836|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
1130837|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
1130838|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
1130839|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
1130840|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
1130841|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
1130842|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
1130843|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Patient decision|0
1130844|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Patient decision|0
1130845|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Patient decision|0
1130846|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Patient decision|2
1130847|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Patient decision|2
1130848|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0
1130849|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0
1130850|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0
1130851|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1
1130852|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1
1130853|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0
1130854|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0
1130855|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0
1130856|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0
1130857|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1
1130858|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Change of residence|0
1130859|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Change of residence|0
1130860|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Change of residence|0
1130861|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Change of residence|1
1130862|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Change of residence|1
1130863|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
1130864|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
1130865|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
1130866|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
1130867|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
1130868|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0
1130869|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0
1130870|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1
1130871|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0
1130872|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0
1130873|NCT02717195|2225386|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0
1130874|NCT02717195|2225387|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0
1130875|NCT02717195|2225388|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0
1130876|NCT02717195|2225389|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1
1130877|NCT02717195|2225390|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1
1130878|NCT02717494|2225415|FG000|First Intervention (Step 1)|Lost to Follow-up|4
1130879|NCT02717494|2225416|FG001|First Intervention (Step 1)|Lost to Follow-up|7
1130880|NCT02717494|2225417|FG002|First Intervention (Step 1)|Lost to Follow-up|3
1130881|NCT02717494|2225415|FG000|First Intervention (Step 1)|Withdrawal by Subject|2
1130882|NCT02717494|2225416|FG001|First Intervention (Step 1)|Withdrawal by Subject|0
1130883|NCT02717494|2225417|FG002|First Intervention (Step 1)|Withdrawal by Subject|1
1130884|NCT02717494|2225415|FG000|First Intervention (Step 1)|Death|0
1130885|NCT02717494|2225416|FG001|First Intervention (Step 1)|Death|0
1130886|NCT02717494|2225417|FG002|First Intervention (Step 1)|Death|1
1130887|NCT02717494|2225415|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
1130888|NCT02717494|2225416|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
1130889|NCT02717494|2225417|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
1130890|NCT02717546|2225443|FG000|Overall Study|Lost to Follow-up|12
1130891|NCT02717754|2225453|FG000|Overall Study|Incorrect Infusion Duration|0
1130892|NCT02717754|2225454|FG001|Overall Study|Incorrect Infusion Duration|0
1130893|NCT02717754|2225455|FG002|Overall Study|Incorrect Infusion Duration|0
1130894|NCT02717754|2225456|FG003|Overall Study|Incorrect Infusion Duration|10
1130895|NCT02717754|2225457|FG004|Overall Study|Incorrect Infusion Duration|20
1130896|NCT02717754|2225458|FG005|Overall Study|Incorrect Infusion Duration|20
1130897|NCT02718131|2225483|FG000|Overall Study|Withdrawal by Subject|1
1130898|NCT02718131|2225484|FG001|Overall Study|Withdrawal by Subject|0
1130899|NCT02718131|2225483|FG000|Overall Study|Adverse Event|1
1130900|NCT02718131|2225484|FG001|Overall Study|Adverse Event|0
1130901|NCT02718131|2225483|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1
1130902|NCT02718131|2225484|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0
1130903|NCT02718326|2225503|FG000|Overall Study|Adverse Event|4
1130904|NCT02718326|2225504|FG001|Overall Study|Adverse Event|9
1130905|NCT02718326|2225505|FG002|Overall Study|Adverse Event|0
1130906|NCT02718326|2225503|FG000|Overall Study|Death|8
1130907|NCT02718326|2225504|FG001|Overall Study|Death|1
1130908|NCT02718326|2225505|FG002|Overall Study|Death|2
1130909|NCT02718326|2225503|FG000|Overall Study|Withdrawal by Subject|4
1130910|NCT02718326|2225504|FG001|Overall Study|Withdrawal by Subject|9
1130911|NCT02718326|2225505|FG002|Overall Study|Withdrawal by Subject|6
1130912|NCT02718326|2225503|FG000|Overall Study|Lost to Follow-up|18
1130913|NCT02718326|2225504|FG001|Overall Study|Lost to Follow-up|5
1130914|NCT02718326|2225505|FG002|Overall Study|Lost to Follow-up|14
1130915|NCT02718326|2225503|FG000|Overall Study|Protocol Deviation|1
1130916|NCT02718326|2225504|FG001|Overall Study|Protocol Deviation|0
1130917|NCT02718326|2225505|FG002|Overall Study|Protocol Deviation|0
1130918|NCT02718326|2225503|FG000|Overall Study|Pregnancy|1
1130919|NCT02718326|2225504|FG001|Overall Study|Pregnancy|0
1130920|NCT02718326|2225505|FG002|Overall Study|Pregnancy|0
1130921|NCT02718417|2225518|FG000|Chemotherapy Phase (CP)|Adverse Event|9
1130922|NCT02718417|2225519|FG001|Chemotherapy Phase (CP)|Adverse Event|14
1130923|NCT02718417|2225520|FG002|Chemotherapy Phase (CP)|Adverse Event|13
1130924|NCT02718417|2225518|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5
1130925|NCT02718417|2225519|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4
1130926|NCT02718417|2225520|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1
1130927|NCT02718417|2225518|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3
1130928|NCT02718417|2225519|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2
1130929|NCT02718417|2225520|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1
1130930|NCT02718417|2225518|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4
1130931|NCT02718417|2225519|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2
1130932|NCT02718417|2225520|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1
1130933|NCT02718417|2225518|FG000|Chemotherapy Phase (CP)|Physician's decision|5
1130934|NCT02718417|2225519|FG001|Chemotherapy Phase (CP)|Physician's decision|0
1130935|NCT02718417|2225520|FG002|Chemotherapy Phase (CP)|Physician's decision|4
1130936|NCT02718417|2225518|FG000|Chemotherapy Phase (CP)|Progressive disease|11
1130937|NCT02718417|2225519|FG001|Chemotherapy Phase (CP)|Progressive disease|7
1130938|NCT02718417|2225520|FG002|Chemotherapy Phase (CP)|Progressive disease|10
1130939|NCT02718417|2225518|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13
1130940|NCT02718417|2225519|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8
1130941|NCT02718417|2225520|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15
1130942|NCT02718417|2225518|FG000|Chemotherapy Phase (CP)|Other|2
1130943|NCT02718417|2225519|FG001|Chemotherapy Phase (CP)|Other|0
1130944|NCT02718417|2225520|FG002|Chemotherapy Phase (CP)|Other|1
1130945|NCT02718417|2225518|FG000|Maintenance Phase (MP)|Adverse Event|21
1130946|NCT02718417|2225519|FG001|Maintenance Phase (MP)|Adverse Event|26
1130947|NCT02718417|2225520|FG002|Maintenance Phase (MP)|Adverse Event|0
1130948|NCT02718417|2225518|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1
1130949|NCT02718417|2225519|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1
1130950|NCT02718417|2225520|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0
1130951|NCT02718417|2225518|FG000|Maintenance Phase (MP)|Global deterioration of health status|5
1130952|NCT02718417|2225519|FG001|Maintenance Phase (MP)|Global deterioration of health status|3
1130953|NCT02718417|2225520|FG002|Maintenance Phase (MP)|Global deterioration of health status|0
1130954|NCT02718417|2225518|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0
1130955|NCT02718417|2225519|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1
1130956|NCT02718417|2225520|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0
1130957|NCT02718417|2225518|FG000|Maintenance Phase (MP)|Physician's decision|6
1130958|NCT02718417|2225519|FG001|Maintenance Phase (MP)|Physician's decision|7
1130959|NCT02718417|2225520|FG002|Maintenance Phase (MP)|Physician's decision|0
1130960|NCT02718417|2225518|FG000|Maintenance Phase (MP)|Progressive disease|100
1130961|NCT02718417|2225519|FG001|Maintenance Phase (MP)|Progressive disease|88
1130962|NCT02718417|2225520|FG002|Maintenance Phase (MP)|Progressive disease|0
1130963|NCT02718417|2225518|FG000|Maintenance Phase (MP)|Other|2
1130964|NCT02718417|2225519|FG001|Maintenance Phase (MP)|Other|1
1130965|NCT02718417|2225520|FG002|Maintenance Phase (MP)|Other|0
1130966|NCT02718417|2225518|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17
1130967|NCT02718417|2225519|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20
1130968|NCT02718417|2225520|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0
1130969|NCT02718417|2225518|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114
1130970|NCT02718417|2225519|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140
1130971|NCT02718417|2225520|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0
1130972|NCT02718417|2225518|FG000|Observation Phase (OP)|Adverse Event|0
1130973|NCT02718417|2225519|FG001|Observation Phase (OP)|Adverse Event|0
1130974|NCT02718417|2225520|FG002|Observation Phase (OP)|Adverse Event|1
1130975|NCT02718417|2225518|FG000|Observation Phase (OP)|Death leading to discontinuation|0
1130976|NCT02718417|2225519|FG001|Observation Phase (OP)|Death leading to discontinuation|0
1130977|NCT02718417|2225520|FG002|Observation Phase (OP)|Death leading to discontinuation|2
1130978|NCT02718417|2225518|FG000|Observation Phase (OP)|Lost to Follow-up|0
1130979|NCT02718417|2225519|FG001|Observation Phase (OP)|Lost to Follow-up|0
1130980|NCT02718417|2225520|FG002|Observation Phase (OP)|Lost to Follow-up|1
1130981|NCT02718417|2225518|FG000|Observation Phase (OP)|Physician Decision|0
1130982|NCT02718417|2225519|FG001|Observation Phase (OP)|Physician Decision|0
1130983|NCT02718417|2225520|FG002|Observation Phase (OP)|Physician Decision|9
1130984|NCT02718417|2225518|FG000|Observation Phase (OP)|Progressive disease|0
1130985|NCT02718417|2225519|FG001|Observation Phase (OP)|Progressive disease|0
1130986|NCT02718417|2225520|FG002|Observation Phase (OP)|Progressive disease|92
1130987|NCT02718417|2225518|FG000|Observation Phase (OP)|Study terminated by sponsor|0
1130988|NCT02718417|2225519|FG001|Observation Phase (OP)|Study terminated by sponsor|0
1130989|NCT02718417|2225520|FG002|Observation Phase (OP)|Study terminated by sponsor|135
1130990|NCT02718417|2225518|FG000|Observation Phase (OP)|Withdrawal by Subject|0
1130991|NCT02718417|2225519|FG001|Observation Phase (OP)|Withdrawal by Subject|0
1130992|NCT02718417|2225520|FG002|Observation Phase (OP)|Withdrawal by Subject|34
1130993|NCT02718417|2225518|FG000|Observation Phase (OP)|Global deterioration of health status|0
1130994|NCT02718417|2225519|FG001|Observation Phase (OP)|Global deterioration of health status|0
1130995|NCT02718417|2225520|FG002|Observation Phase (OP)|Global deterioration of health status|1
1130996|NCT02718417|2225518|FG000|Observation Phase (OP)|Other|0
1130997|NCT02718417|2225519|FG001|Observation Phase (OP)|Other|0
1130998|NCT02718417|2225520|FG002|Observation Phase (OP)|Other|7
1130999|NCT02718417|2225518|FG000|Follow-up Phase|Adverse Event|3
1131000|NCT02718417|2225519|FG001|Follow-up Phase|Adverse Event|1
1131001|NCT02718417|2225520|FG002|Follow-up Phase|Adverse Event|1
1131002|NCT02718417|2225518|FG000|Follow-up Phase|Other|4
1131003|NCT02718417|2225519|FG001|Follow-up Phase|Other|6
1131004|NCT02718417|2225520|FG002|Follow-up Phase|Other|4
1131005|NCT02718417|2225518|FG000|Follow-up Phase|Withdrawal by Subject|19
1131006|NCT02718417|2225519|FG001|Follow-up Phase|Withdrawal by Subject|17
1131007|NCT02718417|2225520|FG002|Follow-up Phase|Withdrawal by Subject|5
1131008|NCT02718417|2225518|FG000|Follow-up Phase|Study terminated by sponsor|100
1131009|NCT02718417|2225519|FG001|Follow-up Phase|Study terminated by sponsor|138
1131010|NCT02718417|2225520|FG002|Follow-up Phase|Study terminated by sponsor|6
1131011|NCT02718417|2225518|FG000|Follow-up Phase|Lost to Follow-up|2
1131012|NCT02718417|2225519|FG001|Follow-up Phase|Lost to Follow-up|3
1131013|NCT02718417|2225520|FG002|Follow-up Phase|Lost to Follow-up|0
1131014|NCT02718417|2225518|FG000|Follow-up Phase|Death leading to discontinuation|7
1131015|NCT02718417|2225519|FG001|Follow-up Phase|Death leading to discontinuation|7
1131016|NCT02718417|2225520|FG002|Follow-up Phase|Death leading to discontinuation|3
1131017|NCT02718417|2225518|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20
1131018|NCT02718417|2225519|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17
1131019|NCT02718417|2225520|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11
1131020|NCT02718417|2225518|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
1131021|NCT02718417|2225519|FG001|Long-term Follow-up Phase|Lost to Follow-up|4
1131022|NCT02718417|2225520|FG002|Long-term Follow-up Phase|Lost to Follow-up|3
1131023|NCT02718417|2225518|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105
1131024|NCT02718417|2225519|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80
1131025|NCT02718417|2225520|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112
1131026|NCT02718417|2225518|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6
1131027|NCT02718417|2225519|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9
1131028|NCT02718417|2225520|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9
1131029|NCT02718417|2225518|FG000|Long-term Follow-up Phase|Other|0
1131030|NCT02718417|2225519|FG001|Long-term Follow-up Phase|Other|2
1131031|NCT02718417|2225520|FG002|Long-term Follow-up Phase|Other|0
1131032|NCT02719028|2225578|FG000|Overall Study|Adverse Event|2
1131033|NCT02719028|2225579|FG001|Overall Study|Adverse Event|1
1131034|NCT02719028|2225580|FG002|Overall Study|Adverse Event|4
1131035|NCT02719028|2225581|FG003|Overall Study|Adverse Event|8
1131036|NCT02719028|2225578|FG000|Overall Study|Physician Decision|0
1131037|NCT02719028|2225579|FG001|Overall Study|Physician Decision|1
1131038|NCT02719028|2225580|FG002|Overall Study|Physician Decision|1
1131039|NCT02719028|2225581|FG003|Overall Study|Physician Decision|1
1131040|NCT02719028|2225578|FG000|Overall Study|Use of prohibited medication|0
1131041|NCT02719028|2225579|FG001|Overall Study|Use of prohibited medication|0
1131042|NCT02719028|2225580|FG002|Overall Study|Use of prohibited medication|1
1131043|NCT02719028|2225581|FG003|Overall Study|Use of prohibited medication|0
1131044|NCT02719028|2225578|FG000|Overall Study|Protocol Violation|0
1131045|NCT02719028|2225579|FG001|Overall Study|Protocol Violation|0
1131046|NCT02719028|2225580|FG002|Overall Study|Protocol Violation|0
1131047|NCT02719028|2225581|FG003|Overall Study|Protocol Violation|1
1131048|NCT02719171|2225609|FG000|Overall Study|Adverse Event|1
1131049|NCT02719171|2225610|FG001|Overall Study|Adverse Event|2
1131050|NCT02719171|2225611|FG002|Overall Study|Adverse Event|0
1131051|NCT02719171|2225612|FG003|Overall Study|Adverse Event|0
1131052|NCT02719171|2225613|FG004|Overall Study|Adverse Event|2
1131053|NCT02719171|2225609|FG000|Overall Study|Lost to Follow-up|0
1131054|NCT02719171|2225610|FG001|Overall Study|Lost to Follow-up|0
1131055|NCT02719171|2225611|FG002|Overall Study|Lost to Follow-up|1
1131056|NCT02719171|2225612|FG003|Overall Study|Lost to Follow-up|0
1131057|NCT02719171|2225613|FG004|Overall Study|Lost to Follow-up|0
1131058|NCT02719171|2225609|FG000|Overall Study|Subject Withdrawal|0
1131059|NCT02719171|2225610|FG001|Overall Study|Subject Withdrawal|2
1131060|NCT02719171|2225611|FG002|Overall Study|Subject Withdrawal|2
1131061|NCT02719171|2225612|FG003|Overall Study|Subject Withdrawal|1
1131062|NCT02719171|2225613|FG004|Overall Study|Subject Withdrawal|0
1131063|NCT02719171|2225609|FG000|Overall Study|Other|0
1131064|NCT02719171|2225610|FG001|Overall Study|Other|0
1131065|NCT02719171|2225611|FG002|Overall Study|Other|0
1131066|NCT02719171|2225612|FG003|Overall Study|Other|1
1131067|NCT02719171|2225613|FG004|Overall Study|Other|0
1131068|NCT02719353|2225628|FG000|First Intervention|Physician Decision|0
1131069|NCT02719353|2225629|FG001|First Intervention|Physician Decision|1
1131073|NCT02719743|2225661|FG000|Overall Study|Consent withdrawal|0
1131074|NCT02719743|2225662|FG001|Overall Study|Consent withdrawal|2
1131075|NCT02719743|2225663|FG002|Overall Study|Consent withdrawal|0
1131076|NCT02719743|2225664|FG003|Overall Study|Consent withdrawal|1
1131077|NCT02719743|2225665|FG004|Overall Study|Consent withdrawal|0
1131078|NCT02719743|2225661|FG000|Overall Study|Migrated/moved from study area|0
1131079|NCT02719743|2225662|FG001|Overall Study|Migrated/moved from study area|0
1131080|NCT02719743|2225663|FG002|Overall Study|Migrated/moved from study area|0
1131081|NCT02719743|2225664|FG003|Overall Study|Migrated/moved from study area|0
1131082|NCT02719743|2225665|FG004|Overall Study|Migrated/moved from study area|2
1131083|NCT02719743|2225661|FG000|Overall Study|Lost to Follow-up|1
1131084|NCT02719743|2225662|FG001|Overall Study|Lost to Follow-up|1
1131085|NCT02719743|2225663|FG002|Overall Study|Lost to Follow-up|0
1131086|NCT02719743|2225664|FG003|Overall Study|Lost to Follow-up|0
1131087|NCT02719743|2225665|FG004|Overall Study|Lost to Follow-up|0
1131088|NCT02720042|2225686|FG000|Overall Study|Death|3
1131089|NCT02720042|2225686|FG000|Overall Study|Lost to Follow-up|4
1131090|NCT02720042|2225686|FG000|Overall Study|Withdrawal by Subject|1
1131091|NCT02720042|2225686|FG000|Overall Study|Physician Decision|3
1131092|NCT02720042|2225686|FG000|Overall Study|Phasix Mesh explanted|1
1131093|NCT02720042|2225686|FG000|Overall Study|unable due to non-study-related illness|3
1131094|NCT02720081|2225692|FG000|Overall Study|Adverse Event|0
1131095|NCT02720081|2225693|FG001|Overall Study|Adverse Event|3
1131096|NCT02720081|2225692|FG000|Overall Study|Protocol Violation|4
1131097|NCT02720081|2225693|FG001|Overall Study|Protocol Violation|1
1131098|NCT02720198|2225705|FG000|Overall Study|Withdrawal by Subject|0
1131099|NCT02720198|2225706|FG001|Overall Study|Withdrawal by Subject|1
1131100|NCT02720484|2225716|FG000|Treatment on Study|Adverse Event|1
1131101|NCT02720484|2225716|FG000|Treatment on Study|Withdrawal by Subject|1
1131102|NCT02720484|2225716|FG000|Treatment on Study|Progressive Disease|4
1131103|NCT02720484|2225716|FG000|Follow Up for 2 Years|Withdrawal by Subject|1
1131104|NCT02720484|2225716|FG000|Follow Up for 2 Years|Death|3
1131105|NCT02720484|2225716|FG000|Follow Up for 2 Years|Lost to Follow-up|2
1131106|NCT02720523|2225724|FG000|Period 1: Placebo-controlled Period|Adverse Event|0
1131107|NCT02720523|2225725|FG001|Period 1: Placebo-controlled Period|Adverse Event|0
1131108|NCT02720523|2225726|FG002|Period 1: Placebo-controlled Period|Adverse Event|1
1131109|NCT02720523|2225727|FG003|Period 1: Placebo-controlled Period|Adverse Event|5
1131110|NCT02720523|2225728|FG004|Period 1: Placebo-controlled Period|Adverse Event|0
1131111|NCT02720523|2225729|FG005|Period 1: Placebo-controlled Period|Adverse Event|0
1131112|NCT02720523|2225730|FG006|Period 1: Placebo-controlled Period|Adverse Event|0
1131113|NCT02720523|2225724|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
1131114|NCT02720523|2225725|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1131115|NCT02720523|2225726|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1131116|NCT02720523|2225727|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1131117|NCT02720523|2225728|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1131118|NCT02720523|2225729|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1131119|NCT02720523|2225730|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1131120|NCT02720523|2225724|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1
1131121|NCT02720523|2225725|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1131122|NCT02720523|2225726|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1131123|NCT02720523|2225727|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1131124|NCT02720523|2225728|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1131125|NCT02720523|2225729|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1131126|NCT02720523|2225730|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1131127|NCT02720523|2225724|FG000|Period 1: Placebo-controlled Period|Other|0
1131128|NCT02720523|2225725|FG001|Period 1: Placebo-controlled Period|Other|0
1131129|NCT02720523|2225726|FG002|Period 1: Placebo-controlled Period|Other|1
1131130|NCT02720523|2225727|FG003|Period 1: Placebo-controlled Period|Other|1
1131131|NCT02720523|2225728|FG004|Period 1: Placebo-controlled Period|Other|0
1131132|NCT02720523|2225729|FG005|Period 1: Placebo-controlled Period|Other|0
1131133|NCT02720523|2225730|FG006|Period 1: Placebo-controlled Period|Other|0
1131134|NCT02720523|2225724|FG000|Period 2: Long-term Extension Period|Ongoing|0
1131135|NCT02720523|2225725|FG001|Period 2: Long-term Extension Period|Ongoing|0
1131136|NCT02720523|2225726|FG002|Period 2: Long-term Extension Period|Ongoing|0
1131137|NCT02720523|2225727|FG003|Period 2: Long-term Extension Period|Ongoing|0
1131138|NCT02720523|2225728|FG004|Period 2: Long-term Extension Period|Ongoing|57
1131139|NCT02720523|2225729|FG005|Period 2: Long-term Extension Period|Ongoing|54
1131140|NCT02720523|2225730|FG006|Period 2: Long-term Extension Period|Ongoing|45
1131141|NCT02720523|2225724|FG000|Period 2: Long-term Extension Period|Adverse Event|0
1131142|NCT02720523|2225725|FG001|Period 2: Long-term Extension Period|Adverse Event|0
1131143|NCT02720523|2225726|FG002|Period 2: Long-term Extension Period|Adverse Event|0
1131144|NCT02720523|2225727|FG003|Period 2: Long-term Extension Period|Adverse Event|0
1131145|NCT02720523|2225728|FG004|Period 2: Long-term Extension Period|Adverse Event|4
1131146|NCT02720523|2225729|FG005|Period 2: Long-term Extension Period|Adverse Event|7
1131147|NCT02720523|2225730|FG006|Period 2: Long-term Extension Period|Adverse Event|11
1131148|NCT02720523|2225724|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0
1131149|NCT02720523|2225725|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0
1131150|NCT02720523|2225726|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0
1131151|NCT02720523|2225727|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0
1131152|NCT02720523|2225728|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2
1131153|NCT02720523|2225729|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1
1131154|NCT02720523|2225730|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1
1131155|NCT02720523|2225724|FG000|Period 2: Long-term Extension Period|Other|0
1131156|NCT02720523|2225725|FG001|Period 2: Long-term Extension Period|Other|0
1131157|NCT02720523|2225726|FG002|Period 2: Long-term Extension Period|Other|0
1131158|NCT02720523|2225727|FG003|Period 2: Long-term Extension Period|Other|0
1131159|NCT02720523|2225728|FG004|Period 2: Long-term Extension Period|Other|2
1131160|NCT02720523|2225729|FG005|Period 2: Long-term Extension Period|Other|0
1131161|NCT02720523|2225730|FG006|Period 2: Long-term Extension Period|Other|3
1131162|NCT02720536|2225743|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11
1131163|NCT02720536|2225743|FG000|Overall Study|PR - pregnancy|2
1131164|NCT02720536|2225743|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2
1131165|NCT02720536|2225743|FG000|Overall Study|PR - death|1
1131166|NCT02720536|2225743|FG000|Overall Study|PR - adverse event|1
1131167|NCT02720536|2225743|FG000|Overall Study|PR - abnormal lab value(s)|1
1131168|NCT02720536|2225743|FG000|Overall Study|PR- unwilling to comply with procedures|1
1131169|NCT02720757|2225757|FG000|Overall Study|Other reason|5
1131170|NCT02720757|2225757|FG000|Overall Study|Loss of contact|4
1131171|NCT02720757|2225757|FG000|Overall Study|Informed consent withdrawal|1
1131172|NCT02720757|2225757|FG000|Overall Study|Patients wish to withdraw|2
1131173|NCT02720757|2225757|FG000|Overall Study|Missing|3
1131174|NCT02720757|2225757|FG000|Overall Study|General exclusion|3
1131175|NCT02721147|2225783|FG000|Overall Study|Lost to Follow-up|2
1131176|NCT02721147|2225784|FG001|Overall Study|Lost to Follow-up|0
1131177|NCT02721147|2225785|FG002|Overall Study|Lost to Follow-up|0
1131178|NCT02721251|2225796|FG000|Overall Study|Withdrawal by Subject|8
1131179|NCT02721251|2225797|FG001|Overall Study|Withdrawal by Subject|7
1131180|NCT02721251|2225798|FG002|Overall Study|Withdrawal by Subject|9
1131181|NCT02721251|2225796|FG000|Overall Study|poor adherence|2
1131182|NCT02721251|2225797|FG001|Overall Study|poor adherence|2
1131183|NCT02721251|2225798|FG002|Overall Study|poor adherence|2
1131184|NCT02721355|2225809|FG000|Overall Study|Lost to Follow-up|6
1131185|NCT02721355|2225810|FG001|Overall Study|Lost to Follow-up|1
1131186|NCT02721875|2225822|FG000|Overall Study|Progressive disease/relapse|1
1131187|NCT02721875|2225823|FG001|Overall Study|Progressive disease/relapse|0
1131188|NCT02721966|2225832|FG000|Overall Study|Protocol Violation|1
1131189|NCT02721966|2225833|FG001|Overall Study|Protocol Violation|0
1131190|NCT02721966|2225834|FG002|Overall Study|Protocol Violation|0
1131191|NCT02721966|2225835|FG003|Overall Study|Protocol Violation|0
1131192|NCT02721966|2225836|FG004|Overall Study|Protocol Violation|0
1131193|NCT02721966|2225832|FG000|Overall Study|Withdrawal by Subject|9
1131194|NCT02721966|2225833|FG001|Overall Study|Withdrawal by Subject|2
1131195|NCT02721966|2225834|FG002|Overall Study|Withdrawal by Subject|3
1131196|NCT02721966|2225835|FG003|Overall Study|Withdrawal by Subject|7
1131197|NCT02721966|2225836|FG004|Overall Study|Withdrawal by Subject|0
1131198|NCT02721966|2225832|FG000|Overall Study|Adverse Event|4
1131199|NCT02721966|2225833|FG001|Overall Study|Adverse Event|4
1131200|NCT02721966|2225834|FG002|Overall Study|Adverse Event|3
1131201|NCT02721966|2225835|FG003|Overall Study|Adverse Event|0
1131202|NCT02721966|2225836|FG004|Overall Study|Adverse Event|0
1131203|NCT02721966|2225832|FG000|Overall Study|Death|1
1131204|NCT02721966|2225833|FG001|Overall Study|Death|0
1131205|NCT02721966|2225834|FG002|Overall Study|Death|0
1131206|NCT02721966|2225835|FG003|Overall Study|Death|0
1131207|NCT02721966|2225836|FG004|Overall Study|Death|0
1131208|NCT02721966|2225832|FG000|Overall Study|Lack of Efficacy|7
1131209|NCT02721966|2225833|FG001|Overall Study|Lack of Efficacy|4
1131210|NCT02721966|2225834|FG002|Overall Study|Lack of Efficacy|0
1131211|NCT02721966|2225835|FG003|Overall Study|Lack of Efficacy|0
1131212|NCT02721966|2225836|FG004|Overall Study|Lack of Efficacy|0
1131213|NCT02721966|2225832|FG000|Overall Study|Lost to Follow-up|0
1131214|NCT02721966|2225833|FG001|Overall Study|Lost to Follow-up|0
1131215|NCT02721966|2225834|FG002|Overall Study|Lost to Follow-up|3
1131216|NCT02721966|2225835|FG003|Overall Study|Lost to Follow-up|0
1131217|NCT02721966|2225836|FG004|Overall Study|Lost to Follow-up|0
1131218|NCT02721966|2225832|FG000|Overall Study|Physician Decision|1
1131219|NCT02721966|2225833|FG001|Overall Study|Physician Decision|1
1131220|NCT02721966|2225834|FG002|Overall Study|Physician Decision|0
1131221|NCT02721966|2225835|FG003|Overall Study|Physician Decision|0
1131222|NCT02721966|2225836|FG004|Overall Study|Physician Decision|0
1131223|NCT02721966|2225832|FG000|Overall Study|Pregnancy|1
1131224|NCT02721966|2225833|FG001|Overall Study|Pregnancy|0
1131225|NCT02721966|2225834|FG002|Overall Study|Pregnancy|0
1131226|NCT02721966|2225835|FG003|Overall Study|Pregnancy|0
1131227|NCT02721966|2225836|FG004|Overall Study|Pregnancy|0
1131228|NCT02721966|2225832|FG000|Overall Study|Did not continue to period 2|5
1131229|NCT02721966|2225833|FG001|Overall Study|Did not continue to period 2|12
1131230|NCT02721966|2225834|FG002|Overall Study|Did not continue to period 2|0
1131231|NCT02721966|2225835|FG003|Overall Study|Did not continue to period 2|0
1131232|NCT02721966|2225836|FG004|Overall Study|Did not continue to period 2|5
1131233|NCT02722044|2225848|FG000|Overall Study|Adverse Event|2
1131234|NCT02722044|2225848|FG000|Overall Study|Physician Decision|1
1131235|NCT02722044|2225848|FG000|Overall Study|Withdrawal by Subject|1
1131236|NCT02722044|2225848|FG000|Overall Study|Did Not Meet Criteria at Week 14|1
1131237|NCT02722148|2225853|FG000|Overall Study|Lost to Follow-up|2
1131238|NCT02722148|2225853|FG000|Overall Study|Non compliant with treatment regimen|3
1131239|NCT02722278|2225869|FG000|Overall Study|Withdrawal by Subject|5
1131240|NCT02722278|2225870|FG001|Overall Study|Withdrawal by Subject|3
1131241|NCT02722278|2225869|FG000|Overall Study|Adverse Event|4
1131242|NCT02722278|2225870|FG001|Overall Study|Adverse Event|1
1131243|NCT02722278|2225869|FG000|Overall Study|Lost to Follow-up|2
1131244|NCT02722278|2225870|FG001|Overall Study|Lost to Follow-up|0
1131245|NCT02722278|2225869|FG000|Overall Study|Protocol Violation|1
1131246|NCT02722278|2225870|FG001|Overall Study|Protocol Violation|0
1131247|NCT02722278|2225869|FG000|Overall Study|High PSA pre-study/ not eligible|0
1131248|NCT02722278|2225870|FG001|Overall Study|High PSA pre-study/ not eligible|1
1131249|NCT02722278|2225869|FG000|Overall Study|Subject declined after tx assignment|0
1131250|NCT02722278|2225870|FG001|Overall Study|Subject declined after tx assignment|1
1131251|NCT02722278|2225869|FG000|Overall Study|Site closure not study related|0
1131252|NCT02722278|2225870|FG001|Overall Study|Site closure not study related|1
1131253|NCT02722304|2225883|FG000|Overall Study|Study Terminated by Sponsor|1
1131254|NCT02722304|2225884|FG001|Overall Study|Study Terminated by Sponsor|0
1131255|NCT02722304|2225885|FG002|Overall Study|Study Terminated by Sponsor|2
1131256|NCT02722304|2225886|FG003|Overall Study|Study Terminated by Sponsor|1
1131257|NCT02722304|2225887|FG004|Overall Study|Study Terminated by Sponsor|1
1131258|NCT02722304|2225883|FG000|Overall Study|Other|0
1131259|NCT02722304|2225884|FG001|Overall Study|Other|0
1131260|NCT02722304|2225885|FG002|Overall Study|Other|0
1131261|NCT02722304|2225886|FG003|Overall Study|Other|1
1131262|NCT02722304|2225887|FG004|Overall Study|Other|1
1131263|NCT02722499|2225914|FG000|Overall Study|Lost to Follow-up|2
1131264|NCT02722499|2225915|FG001|Overall Study|Lost to Follow-up|0
1131265|NCT02722499|2225916|FG002|Overall Study|Lost to Follow-up|1
1131266|NCT02722928|2225943|FG000|Overall Study|Standard CT was not as required per prot|5
1131267|NCT02722928|2225944|FG001|Overall Study|Standard CT was not as required per prot|13
1131268|NCT02722928|2225943|FG000|Overall Study|Required Intraoperative MRI|5
1131269|NCT02722928|2225944|FG001|Overall Study|Required Intraoperative MRI|7
1131270|NCT02722967|2225966|FG000|Overall Study|Adverse Event|1
1131271|NCT02722967|2225967|FG001|Overall Study|Adverse Event|0
1131272|NCT02722967|2225968|FG002|Overall Study|Adverse Event|0
1131273|NCT02722967|2225966|FG000|Overall Study|Lost to Follow-up|0
1131274|NCT02722967|2225967|FG001|Overall Study|Lost to Follow-up|1
1131275|NCT02722967|2225968|FG002|Overall Study|Lost to Follow-up|0
1131276|NCT02722967|2225966|FG000|Overall Study|Non-compliance with patch wearing|2
1131277|NCT02722967|2225967|FG001|Overall Study|Non-compliance with patch wearing|1
1131278|NCT02722967|2225968|FG002|Overall Study|Non-compliance with patch wearing|1
1131279|NCT02722967|2225966|FG000|Overall Study|Withdrawal by Subject|1
1131280|NCT02722967|2225967|FG001|Overall Study|Withdrawal by Subject|0
1131281|NCT02722967|2225968|FG002|Overall Study|Withdrawal by Subject|1
1131282|NCT02722967|2225966|FG000|Overall Study|Physician Decision|1
1131283|NCT02722967|2225967|FG001|Overall Study|Physician Decision|0
1131284|NCT02722967|2225968|FG002|Overall Study|Physician Decision|0
1131285|NCT02722967|2225966|FG000|Overall Study|Non-adherence of the patch to the skin|0
1131286|NCT02722967|2225967|FG001|Overall Study|Non-adherence of the patch to the skin|0
1131287|NCT02722967|2225968|FG002|Overall Study|Non-adherence of the patch to the skin|2
1131288|NCT02723006|2225979|FG000|Overall Study|Withdrawal by Subject|0
1131289|NCT02723006|2225980|FG001|Overall Study|Withdrawal by Subject|1
1131290|NCT02723006|2225981|FG002|Overall Study|Withdrawal by Subject|1
1131291|NCT02723006|2225979|FG000|Overall Study|Study Terminated by Sponsor|1
1131292|NCT02723006|2225980|FG001|Overall Study|Study Terminated by Sponsor|6
1131293|NCT02723006|2225981|FG002|Overall Study|Study Terminated by Sponsor|6
1131294|NCT02723084|2225991|FG000|Overall Study|Withdrawal by Subject|1
1131295|NCT02723084|2225992|FG001|Overall Study|Withdrawal by Subject|1
1131296|NCT02723084|2225991|FG000|Overall Study|Lost to Follow-up|3
1131297|NCT02723084|2225992|FG001|Overall Study|Lost to Follow-up|0
1131298|NCT02723175|2226000|FG000|Overall Study|Lost to 1 Month Follow Up|3
1131299|NCT02723175|2226001|FG001|Overall Study|Lost to 1 Month Follow Up|2
1131300|NCT02723175|2226000|FG000|Overall Study|Lost to 3 Month Follow Up|1
1131301|NCT02723175|2226001|FG001|Overall Study|Lost to 3 Month Follow Up|1
1131302|NCT02723188|2226010|FG000|Overall Study|Withdrawal by Subject|1
1131303|NCT02723188|2226011|FG001|Overall Study|Withdrawal by Subject|0
1131304|NCT02723188|2226012|FG002|Overall Study|Withdrawal by Subject|0
1131305|NCT02723201|2226023|FG000|Second Intervention Period|Protocol Violation|1
1131306|NCT02723201|2226024|FG001|Second Intervention Period|Protocol Violation|0
1131307|NCT02723201|2226025|FG002|Second Intervention Period|Protocol Violation|0
1131308|NCT02723201|2226023|FG000|Second Intervention Period|Adverse Event|1
1131309|NCT02723201|2226024|FG001|Second Intervention Period|Adverse Event|0
1131310|NCT02723201|2226025|FG002|Second Intervention Period|Adverse Event|0
1131311|NCT02723344|2226041|FG000|Overall Study|Lost to Follow-up|0
1131312|NCT02723344|2226042|FG001|Overall Study|Lost to Follow-up|4
1131313|NCT02723591|2226050|FG000|Overall Study|Adverse Event|48
1131314|NCT02723591|2226051|FG001|Overall Study|Adverse Event|40
1131315|NCT02723591|2226050|FG000|Overall Study|Death|2
1131316|NCT02723591|2226051|FG001|Overall Study|Death|2
1131317|NCT02723591|2226050|FG000|Overall Study|Lack of Efficacy|4
1131318|NCT02723591|2226051|FG001|Overall Study|Lack of Efficacy|3
1131319|NCT02723591|2226050|FG000|Overall Study|Lost to Follow-up|1
1131320|NCT02723591|2226051|FG001|Overall Study|Lost to Follow-up|7
1131321|NCT02723591|2226050|FG000|Overall Study|Protocol Violation|20
1131322|NCT02723591|2226051|FG001|Overall Study|Protocol Violation|23
1131323|NCT02723591|2226050|FG000|Overall Study|Withdrawal by Subject|4
1131324|NCT02723591|2226051|FG001|Overall Study|Withdrawal by Subject|8
1131325|NCT02723591|2226050|FG000|Overall Study|Randomized but Never Received StudyDrug|12
1131326|NCT02723591|2226051|FG001|Overall Study|Randomized but Never Received StudyDrug|12
1131327|NCT02723591|2226050|FG000|Overall Study|Miscellaneous|5
1131328|NCT02723591|2226051|FG001|Overall Study|Miscellaneous|6
1131329|NCT02723630|2226063|FG000|Intervention Period 1|Adverse Event|1
1131330|NCT02723630|2226064|FG001|Intervention Period 1|Adverse Event|0
1131331|NCT02723630|2226065|FG002|Intervention Period 1|Adverse Event|0
1131332|NCT02723630|2226066|FG003|Intervention Period 1|Adverse Event|0
1131333|NCT02723630|2226067|FG004|Intervention Period 1|Adverse Event|0
1131334|NCT02723630|2226068|FG005|Intervention Period 1|Adverse Event|0
1131335|NCT02723630|2226063|FG000|Intervention Period 3|consumption of restricted item|0
1131336|NCT02723630|2226064|FG001|Intervention Period 3|consumption of restricted item|1
1131337|NCT02723630|2226065|FG002|Intervention Period 3|consumption of restricted item|0
1131338|NCT02723630|2226066|FG003|Intervention Period 3|consumption of restricted item|0
1131339|NCT02723630|2226067|FG004|Intervention Period 3|consumption of restricted item|0
1131340|NCT02723630|2226068|FG005|Intervention Period 3|consumption of restricted item|0
1131341|NCT02724020|2226108|FG000|Overall Study|Death|16
1131342|NCT02724020|2226109|FG001|Overall Study|Death|18
1131343|NCT02724020|2226110|FG002|Overall Study|Death|19
1131344|NCT02724020|2226108|FG000|Overall Study|Lost to Follow-up|0
1131345|NCT02724020|2226109|FG001|Overall Study|Lost to Follow-up|3
1131346|NCT02724020|2226110|FG002|Overall Study|Lost to Follow-up|0
1131347|NCT02724020|2226108|FG000|Overall Study|Site Terminated by Sponsor|15
1131348|NCT02724020|2226109|FG001|Overall Study|Site Terminated by Sponsor|8
1131349|NCT02724020|2226110|FG002|Overall Study|Site Terminated by Sponsor|8
1131350|NCT02724020|2226108|FG000|Overall Study|Withdrawal by Subject|1
1131351|NCT02724020|2226109|FG001|Overall Study|Withdrawal by Subject|3
1131352|NCT02724020|2226110|FG002|Overall Study|Withdrawal by Subject|5
1131353|NCT02724111|2226133|FG000|Overall Study|Protocol Violation|2
1131354|NCT02724111|2226134|FG001|Overall Study|Protocol Violation|5
1131355|NCT02724462|2226151|FG000|3 Month Follow-up Survey|Lost to Follow-up|171
1131356|NCT02724462|2226152|FG001|3 Month Follow-up Survey|Lost to Follow-up|151
1131357|NCT02724462|2226151|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40
1131358|NCT02724462|2226152|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48
1131359|NCT02724462|2226151|FG000|6 Month Follow-up Survey|Lost to Follow-up|156
1131360|NCT02724462|2226152|FG001|6 Month Follow-up Survey|Lost to Follow-up|123
1131361|NCT02724462|2226151|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40
1131362|NCT02724462|2226152|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48
1131363|NCT02724462|2226151|FG000|12 Month Follow-up Survey|Lost to Follow-up|174
1131364|NCT02724462|2226152|FG001|12 Month Follow-up Survey|Lost to Follow-up|134
1131365|NCT02724462|2226151|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40
1131366|NCT02724462|2226152|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48
1131367|NCT02724592|2226160|FG000|Overall Study|Lost to Follow-up|4
1131368|NCT02724592|2226161|FG001|Overall Study|Lost to Follow-up|1
1131369|NCT02724644|2226169|FG000|Overall Study|Adverse Event|7
1131370|NCT02724644|2226170|FG001|Overall Study|Adverse Event|1
1131371|NCT02724644|2226169|FG000|Overall Study|Lost to Follow-up|6
1131372|NCT02724644|2226170|FG001|Overall Study|Lost to Follow-up|2
1131373|NCT02724644|2226169|FG000|Overall Study|Withdrawal by Subject|7
1131374|NCT02724644|2226170|FG001|Overall Study|Withdrawal by Subject|1
1131375|NCT02724644|2226169|FG000|Overall Study|Administrative|1
1131376|NCT02724644|2226170|FG001|Overall Study|Administrative|0
1131377|NCT02724839|2226192|FG000|Overall Study|Withdrawal by Subject|1
1131378|NCT02724839|2226193|FG001|Overall Study|Withdrawal by Subject|1
1131379|NCT02724839|2226194|FG002|Overall Study|Withdrawal by Subject|0
1131380|NCT02724839|2226192|FG000|Overall Study|Lost to Follow-up|0
1131381|NCT02724839|2226193|FG001|Overall Study|Lost to Follow-up|3
1131382|NCT02724839|2226194|FG002|Overall Study|Lost to Follow-up|2
1131383|NCT02724839|2226192|FG000|Overall Study|Physician Decision|0
1131384|NCT02724839|2226193|FG001|Overall Study|Physician Decision|0
1131385|NCT02724839|2226194|FG002|Overall Study|Physician Decision|3
1131386|NCT02724878|2226209|FG000|Overall Study|Still on Active Therapy|15
1131387|NCT02724878|2226209|FG000|Overall Study|Disease Progression|31
1131388|NCT02724878|2226209|FG000|Overall Study|Toxicity|5
1131389|NCT02724878|2226209|FG000|Overall Study|Death|1
1131390|NCT02724878|2226209|FG000|Overall Study|Withdrawal by Subject|4
1131391|NCT02724878|2226209|FG000|Overall Study|Lost to Follow-up|2
1131392|NCT02724878|2226209|FG000|Overall Study|Protocol Violation|1
1131393|NCT02724878|2226209|FG000|Overall Study|Ineligible for Study Drug|5
1131394|NCT02724878|2226209|FG000|Overall Study|Other|1
1131395|NCT02724956|2226215|FG000|Overall Study|Physician Decision|1
1131396|NCT02724956|2226216|FG001|Overall Study|Physician Decision|0
1131397|NCT02724956|2226215|FG000|Overall Study|Lack of Efficacy|0
1131398|NCT02724956|2226216|FG001|Overall Study|Lack of Efficacy|1
1131399|NCT02724956|2226215|FG000|Overall Study|Withdrawal by Subject|0
1131400|NCT02724956|2226216|FG001|Overall Study|Withdrawal by Subject|1
1131401|NCT02725008|2226224|FG000|Overall Study|Lost to Follow-up|7
1131402|NCT02725008|2226225|FG001|Overall Study|Lost to Follow-up|9
1131403|NCT02725008|2226224|FG000|Overall Study|Withdrawal by Subject|2
1131404|NCT02725008|2226225|FG001|Overall Study|Withdrawal by Subject|2
1131405|NCT02725008|2226224|FG000|Overall Study|Admitted to hospital|0
1131406|NCT02725008|2226225|FG001|Overall Study|Admitted to hospital|1
1131407|NCT02725268|2226235|FG000|Overall Study|Death|58
1131408|NCT02725268|2226236|FG001|Overall Study|Death|59
1131409|NCT02725268|2226237|FG002|Overall Study|Death|30
1131410|NCT02725268|2226238|FG003|Overall Study|Death|16
1131411|NCT02725268|2226235|FG000|Overall Study|Lost to Follow-up|4
1131412|NCT02725268|2226236|FG001|Overall Study|Lost to Follow-up|3
1131413|NCT02725268|2226237|FG002|Overall Study|Lost to Follow-up|0
1131414|NCT02725268|2226238|FG003|Overall Study|Lost to Follow-up|1
1131415|NCT02725268|2226235|FG000|Overall Study|Site Terminated by Sponsor|0
1131416|NCT02725268|2226236|FG001|Overall Study|Site Terminated by Sponsor|1
1131417|NCT02725268|2226237|FG002|Overall Study|Site Terminated by Sponsor|0
1131418|NCT02725268|2226238|FG003|Overall Study|Site Terminated by Sponsor|0
1131419|NCT02725268|2226235|FG000|Overall Study|Withdrawal by Subject|8
1131420|NCT02725268|2226236|FG001|Overall Study|Withdrawal by Subject|6
1131421|NCT02725268|2226237|FG002|Overall Study|Withdrawal by Subject|8
1131422|NCT02725268|2226238|FG003|Overall Study|Withdrawal by Subject|1
1131423|NCT02725268|2226235|FG000|Overall Study|Reason not Specified|2
1131424|NCT02725268|2226236|FG001|Overall Study|Reason not Specified|1
1131425|NCT02725268|2226237|FG002|Overall Study|Reason not Specified|0
1131426|NCT02725268|2226238|FG003|Overall Study|Reason not Specified|0
1131427|NCT02725476|2226263|FG000|Overall Study|Physician Decision|2
1131428|NCT02725476|2226264|FG001|Overall Study|Physician Decision|0
1131429|NCT02725476|2226263|FG000|Overall Study|Adverse Event|1
1131430|NCT02725476|2226264|FG001|Overall Study|Adverse Event|1
1131431|NCT02725515|2226272|FG000|Overall Study|Refused infusion (no study treatment)|1
1131432|NCT02725515|2226273|FG001|Overall Study|Refused infusion (no study treatment)|0
1131433|NCT02725515|2226272|FG000|Overall Study|Loss of Improvement per Protocol|14
1131434|NCT02725515|2226273|FG001|Overall Study|Loss of Improvement per Protocol|25
1131435|NCT02725515|2226272|FG000|Overall Study|Withdrawal by Subject|2
1131436|NCT02725515|2226273|FG001|Overall Study|Withdrawal by Subject|1
1131437|NCT02725515|2226272|FG000|Overall Study|Non-Compliance With Study Drug|0
1131438|NCT02725515|2226273|FG001|Overall Study|Non-Compliance With Study Drug|3
1131439|NCT02725515|2226272|FG000|Overall Study|Lost to Follow-up|1
1131440|NCT02725515|2226273|FG001|Overall Study|Lost to Follow-up|1
1131441|NCT02725515|2226272|FG000|Overall Study|Adverse Event|7
1131442|NCT02725515|2226273|FG001|Overall Study|Adverse Event|2
1131443|NCT02725515|2226272|FG000|Overall Study|No Documented Disease Improvement|0
1131444|NCT02725515|2226273|FG001|Overall Study|No Documented Disease Improvement|1
1131445|NCT02725515|2226272|FG000|Overall Study|Completed Study Under Original Protocol|0
1131446|NCT02725515|2226273|FG001|Overall Study|Completed Study Under Original Protocol|1
1131447|NCT02725515|2226272|FG000|Overall Study|Lack of Response|0
1131448|NCT02725515|2226273|FG001|Overall Study|Lack of Response|1
1131449|NCT02725593|2226281|FG000|Blinded Treatment Period|Withdrawal by Subject|4
1131450|NCT02725593|2226282|FG001|Blinded Treatment Period|Withdrawal by Subject|3
1131451|NCT02725593|2226281|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0
1131452|NCT02725593|2226282|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2
1131453|NCT02725593|2226281|FG000|Blinded Treatment Period|Lost to Follow-up|1
1131454|NCT02725593|2226282|FG001|Blinded Treatment Period|Lost to Follow-up|1
1131455|NCT02725593|2226281|FG000|Long Term Extension|Withdrawal by Subject|1
1131456|NCT02725593|2226282|FG001|Long Term Extension|Withdrawal by Subject|1
1131457|NCT02725710|2226294|FG000|Overall Study|Lost to Follow-up|1
1131458|NCT02725710|2226295|FG001|Overall Study|Lost to Follow-up|0
1131459|NCT02725788|2226303|FG000|Overall Study|Lost to Follow-up|1
1131460|NCT02725788|2226304|FG001|Overall Study|Lost to Follow-up|1
1131461|NCT02725788|2226303|FG000|Overall Study|Protocol Violation|0
1131462|NCT02725788|2226304|FG001|Overall Study|Protocol Violation|1
1131463|NCT02725866|2226319|FG000|Overall Study|Failure to return|6
1131464|NCT02725866|2226319|FG000|Overall Study|Withdrew consent|3
1131465|NCT02725866|2226319|FG000|Overall Study|Insufficient virological response|1
1131466|NCT02725866|2226319|FG000|Overall Study|Other, not specified|4
1131467|NCT02726022|2226323|FG000|Overall Study|Adverse Event|14
1131468|NCT02726022|2226323|FG000|Overall Study|Treatment Failure|8
1131469|NCT02726022|2226323|FG000|Overall Study|Poor Compliance|13
1131470|NCT02726022|2226323|FG000|Overall Study|Treatment Failure and Poor Compliance|1
1131471|NCT02726074|2226327|FG000|Overall Study|Withdrawal by Subject|4
1131472|NCT02726074|2226327|FG000|Overall Study|Adverse Event|14
1131473|NCT02726074|2226327|FG000|Overall Study|Protocol Violation|3
1131474|NCT02726074|2226327|FG000|Overall Study|Lost to Follow-up|2
1131475|NCT02726074|2226327|FG000|Overall Study|Others|3
1131476|NCT02726113|2226333|FG000|Total Enrollment|Physician Decision|0
1131477|NCT02726113|2226334|FG001|Total Enrollment|Physician Decision|1
1131478|NCT02726113|2226333|FG000|Total Enrollment|Protocol Violation|1
1131479|NCT02726113|2226334|FG001|Total Enrollment|Protocol Violation|0
1131480|NCT02726113|2226333|FG000|Total Enrollment|Withdrawal by Subject|2
1131481|NCT02726113|2226334|FG001|Total Enrollment|Withdrawal by Subject|1
1131482|NCT02726113|2226333|FG000|Total Enrollment|Insurance non-coverage for surgery|1
1131483|NCT02726113|2226334|FG001|Total Enrollment|Insurance non-coverage for surgery|1
1131484|NCT02726113|2226333|FG000|Genomic Analysis|Protocol Violation|1
1131485|NCT02726113|2226334|FG001|Genomic Analysis|Protocol Violation|0
1131486|NCT02726113|2226333|FG000|Genomic Analysis|Withdrawal by Subject|2
1131487|NCT02726113|2226334|FG001|Genomic Analysis|Withdrawal by Subject|1
1131488|NCT02726113|2226333|FG000|Genomic Analysis|Insurance non-coverage for surgery|1
1131489|NCT02726113|2226334|FG001|Genomic Analysis|Insurance non-coverage for surgery|1
1131490|NCT02726945|2226387|FG000|Overall Study|Withdrawal by Subject|0
1131491|NCT02726945|2226388|FG001|Overall Study|Withdrawal by Subject|0
1131492|NCT02726945|2226389|FG002|Overall Study|Withdrawal by Subject|1
1131493|NCT02726945|2226387|FG000|Overall Study|Elected to have total knee replacement|0
1131494|NCT02726945|2226388|FG001|Overall Study|Elected to have total knee replacement|1
1131495|NCT02726945|2226389|FG002|Overall Study|Elected to have total knee replacement|0
1131496|NCT02727192|2226408|FG000|Overall Study|Lost to Follow-up|1
1131497|NCT02727192|2226409|FG001|Overall Study|Lost to Follow-up|0
1131498|NCT02727192|2226410|FG002|Overall Study|Lost to Follow-up|0
1131499|NCT02727322|2226419|FG000|Overall Study|Withdrawal by Subject|1
1131500|NCT02727322|2226420|FG001|Overall Study|Withdrawal by Subject|1
1131501|NCT02727322|2226419|FG000|Overall Study|Protocol Violation|1
1131502|NCT02727322|2226420|FG001|Overall Study|Protocol Violation|0
1131503|NCT02727660|2226433|FG000|Overall Study|Lack of Efficacy|40
1131504|NCT02727660|2226434|FG001|Overall Study|Lack of Efficacy|40
1131505|NCT02727660|2226435|FG002|Overall Study|Lack of Efficacy|70
1131506|NCT02727660|2226433|FG000|Overall Study|Adverse Event|28
1131507|NCT02727660|2226434|FG001|Overall Study|Adverse Event|21
1131508|NCT02727660|2226435|FG002|Overall Study|Adverse Event|32
1131509|NCT02727660|2226433|FG000|Overall Study|Withdrawal by Subject|26
1131510|NCT02727660|2226434|FG001|Overall Study|Withdrawal by Subject|25
1131511|NCT02727660|2226435|FG002|Overall Study|Withdrawal by Subject|30
1131512|NCT02727660|2226433|FG000|Overall Study|Physician Decision|3
1131513|NCT02727660|2226434|FG001|Overall Study|Physician Decision|8
1131514|NCT02727660|2226435|FG002|Overall Study|Physician Decision|14
1131515|NCT02727660|2226433|FG000|Overall Study|Lost to Follow-up|5
1131516|NCT02727660|2226434|FG001|Overall Study|Lost to Follow-up|9
1131517|NCT02727660|2226435|FG002|Overall Study|Lost to Follow-up|8
1131518|NCT02727660|2226433|FG000|Overall Study|Protocol Violation|7
1131519|NCT02727660|2226434|FG001|Overall Study|Protocol Violation|5
1131520|NCT02727660|2226435|FG002|Overall Study|Protocol Violation|5
1131521|NCT02727660|2226433|FG000|Overall Study|Protocol Specified Disc. Criteria|5
1131522|NCT02727660|2226434|FG001|Overall Study|Protocol Specified Disc. Criteria|5
1131523|NCT02727660|2226435|FG002|Overall Study|Protocol Specified Disc. Criteria|2
1131524|NCT02727660|2226433|FG000|Overall Study|Administrative Reasons|2
1131525|NCT02727660|2226434|FG001|Overall Study|Administrative Reasons|3
1131526|NCT02727660|2226435|FG002|Overall Study|Administrative Reasons|4
1131527|NCT02727699|2226445|FG000|Overall Study|Adverse Event|2
1131528|NCT02727699|2226446|FG001|Overall Study|Adverse Event|0
1131529|NCT02727699|2226445|FG000|Overall Study|Withdrawal by Subject|5
900170|NCT00726232|1873277|FG007|Initial Phase (Dose-finding)|Disease progression|0
900171|NCT00726232|1873270|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
900172|NCT00726232|1873271|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
900173|NCT00726232|1873272|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
1090783|NCT02248818|2158521|FG003|Screening|Lost to Follow-up|0
1090784|NCT02248818|2158522|FG004|Screening|Lost to Follow-up|0
1090785|NCT02248818|2158523|FG005|Screening|Lost to Follow-up|0
1090786|NCT02248818|2158524|FG006|Screening|Lost to Follow-up|0
1090787|NCT02248818|2158525|FG007|Screening|Lost to Follow-up|0
1090788|NCT02248818|2158526|FG008|Screening|Lost to Follow-up|7
1090789|NCT02248818|2158518|FG000|Randomised Study|Administrative - randomization error|0
1090790|NCT02248818|2158519|FG001|Randomised Study|Administrative - randomization error|0
1090791|NCT02248818|2158520|FG002|Randomised Study|Administrative - randomization error|0
1090792|NCT02248818|2158521|FG003|Randomised Study|Administrative - randomization error|0
1090793|NCT02248818|2158522|FG004|Randomised Study|Administrative - randomization error|0
1131530|NCT02727699|2226446|FG001|Overall Study|Withdrawal by Subject|3
1131531|NCT02727699|2226445|FG000|Overall Study|Protocol Violation|0
1131532|NCT02727699|2226446|FG001|Overall Study|Protocol Violation|1
1131533|NCT02727699|2226445|FG000|Overall Study|Physician Decision|0
1131534|NCT02727699|2226446|FG001|Overall Study|Physician Decision|1
1131535|NCT02727699|2226445|FG000|Overall Study|Lost to Follow-up|1
1131536|NCT02727699|2226446|FG001|Overall Study|Lost to Follow-up|0
1131537|NCT02727699|2226445|FG000|Overall Study|Sponsor Decision|1
1131538|NCT02727699|2226446|FG001|Overall Study|Sponsor Decision|0
1131539|NCT02727777|2226459|FG000|Overall Study|Screen Failure|2
1131540|NCT02727777|2226460|FG001|Overall Study|Screen Failure|0
1131541|NCT02727777|2226461|FG002|Overall Study|Screen Failure|0
1131542|NCT02727777|2226459|FG000|Overall Study|Progressive disease|2
1131543|NCT02727777|2226460|FG001|Overall Study|Progressive disease|0
1131544|NCT02727777|2226461|FG002|Overall Study|Progressive disease|0
1131545|NCT02728089|2226505|FG000|Overall Study|Physician Decision|2
1131546|NCT02728089|2226505|FG000|Overall Study|Withdrawal by Subject|1
1131547|NCT02728102|2226512|FG000|Overall Study|Death|1
1131548|NCT02728102|2226513|FG001|Overall Study|Death|0
1131549|NCT02728102|2226514|FG002|Overall Study|Death|0
1131550|NCT02728102|2226512|FG000|Overall Study|Withdrawal by Subject|0
1131551|NCT02728102|2226513|FG001|Overall Study|Withdrawal by Subject|2
1131552|NCT02728102|2226514|FG002|Overall Study|Withdrawal by Subject|2
1131553|NCT02728206|2226521|FG000|Overall Study|Death|1
1131554|NCT02728830|2226539|FG000|Overall Study|Exclusionary Surgery|9
1131555|NCT02728830|2226539|FG000|Overall Study|Exclusionary Pathology|6
1131556|NCT02728830|2226539|FG000|Overall Study|Physician Decision|3
1131557|NCT02728830|2226539|FG000|Overall Study|Withdrawal by Subject|2
1131558|NCT02728830|2226539|FG000|Overall Study|Lost to Follow-up|1
1131559|NCT02728830|2226539|FG000|Overall Study|Exclusionary Lab Values|1
1131560|NCT02728830|2226539|FG000|Overall Study|Contraindicated Illness|1
1131561|NCT02728830|2226539|FG000|Overall Study|Language Barrier|1
1131562|NCT02728895|2226545|FG000|Overall Study|Other|1
1131563|NCT02728895|2226546|FG001|Overall Study|Other|2
1131564|NCT02728895|2226545|FG000|Overall Study|Withdrawal by Subject|0
1131565|NCT02728895|2226546|FG001|Overall Study|Withdrawal by Subject|3
1131566|NCT02729025|2226554|FG000|Overall Study|Sponsor Decision|0
1131567|NCT02729025|2226555|FG001|Overall Study|Sponsor Decision|1
1131568|NCT02729051|2226587|FG000|Overall Study|Adverse Event|21
1131569|NCT02729051|2226588|FG001|Overall Study|Adverse Event|11
1131570|NCT02729051|2226587|FG000|Overall Study|Lack of Efficacy|1
1131571|NCT02729051|2226588|FG001|Overall Study|Lack of Efficacy|1
1131572|NCT02729051|2226587|FG000|Overall Study|Lost to Follow-up|1
1131573|NCT02729051|2226588|FG001|Overall Study|Lost to Follow-up|2
1131574|NCT02729051|2226587|FG000|Overall Study|Physician Decision|1
1131575|NCT02729051|2226588|FG001|Overall Study|Physician Decision|1
1131576|NCT02729051|2226587|FG000|Overall Study|Withdrawal by Subject|6
1131577|NCT02729051|2226588|FG001|Overall Study|Withdrawal by Subject|17
1131578|NCT02729194|2226594|FG000|Overall Study|Withdrawal by Subject|3
1131579|NCT02729545|2226600|FG000|Overall Study|Pregnancy|1
1131580|NCT02729545|2226601|FG001|Overall Study|Pregnancy|1
1131581|NCT02729545|2226600|FG000|Overall Study|Lost to Follow-up|0
1131582|NCT02729545|2226601|FG001|Overall Study|Lost to Follow-up|1
1131583|NCT02729545|2226600|FG000|Overall Study|Withdrawal by Subject|2
1131584|NCT02729545|2226601|FG001|Overall Study|Withdrawal by Subject|3
1131585|NCT02729740|2226607|FG000|Overall Study|Early Termination|130
1131586|NCT02729740|2226607|FG000|Overall Study|Other|1
1131587|NCT02729753|2226613|FG000|Overall Study|Device Malfunction. No units in stock.|0
1131588|NCT02729753|2226614|FG001|Overall Study|Device Malfunction. No units in stock.|1
1131589|NCT02729831|2226627|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
1131590|NCT02729831|2226628|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
1131591|NCT02729831|2226629|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
1131592|NCT02729831|2226630|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
1131593|NCT02729831|2226627|FG000|1 Week Post-visit|Lost to Follow-up|43
1131594|NCT02729831|2226628|FG001|1 Week Post-visit|Lost to Follow-up|40
1131595|NCT02729831|2226629|FG002|1 Week Post-visit|Lost to Follow-up|38
1131596|NCT02729831|2226630|FG003|1 Week Post-visit|Lost to Follow-up|36
1131597|NCT02729831|2226627|FG000|6 Month Follow-up|Lost to Follow-up|54
1131598|NCT02729831|2226628|FG001|6 Month Follow-up|Lost to Follow-up|51
1131599|NCT02729831|2226629|FG002|6 Month Follow-up|Lost to Follow-up|48
1131600|NCT02729831|2226630|FG003|6 Month Follow-up|Lost to Follow-up|42
1131601|NCT02729831|2226627|FG000|6 Month Follow-up|Death|1
1131602|NCT02729831|2226628|FG001|6 Month Follow-up|Death|3
1131603|NCT02729831|2226629|FG002|6 Month Follow-up|Death|0
1131604|NCT02729831|2226630|FG003|6 Month Follow-up|Death|1
1131605|NCT02729896|2226643|FG000|Overall Study|Death|0
1131606|NCT02729896|2226644|FG001|Overall Study|Death|2
1131607|NCT02729896|2226645|FG002|Overall Study|Death|13
1131608|NCT02729896|2226643|FG000|Overall Study|Lost to Follow-up|0
1131609|NCT02729896|2226644|FG001|Overall Study|Lost to Follow-up|2
1131610|NCT02729896|2226645|FG002|Overall Study|Lost to Follow-up|3
1131611|NCT02729896|2226643|FG000|Overall Study|Other|0
1131612|NCT02729896|2226644|FG001|Overall Study|Other|2
1131613|NCT02729896|2226645|FG002|Overall Study|Other|0
1131614|NCT02729896|2226643|FG000|Overall Study|Physician Decision|1
1131615|NCT02729896|2226644|FG001|Overall Study|Physician Decision|2
1131616|NCT02729896|2226645|FG002|Overall Study|Physician Decision|3
1131617|NCT02729896|2226643|FG000|Overall Study|Progressive Disease|0
1131618|NCT02729896|2226644|FG001|Overall Study|Progressive Disease|1
1131619|NCT02729896|2226645|FG002|Overall Study|Progressive Disease|0
1131620|NCT02729896|2226643|FG000|Overall Study|Withdrawal by Subject|1
1131621|NCT02729896|2226644|FG001|Overall Study|Withdrawal by Subject|0
1131622|NCT02729896|2226645|FG002|Overall Study|Withdrawal by Subject|3
1131623|NCT02729909|2226656|FG000|Overall Study|Lost to Follow-up|0
1131624|NCT02729909|2226657|FG001|Overall Study|Lost to Follow-up|1
1131625|NCT02729909|2226656|FG000|Overall Study|Lack of Efficacy|0
1131626|NCT02729909|2226657|FG001|Overall Study|Lack of Efficacy|2
1131627|NCT02729909|2226656|FG000|Overall Study|Significant Protocol Deviation|0
1131628|NCT02729909|2226657|FG001|Overall Study|Significant Protocol Deviation|2
1131629|NCT02729909|2226656|FG000|Overall Study|Voluntary Withdrawal|1
1131630|NCT02729909|2226657|FG001|Overall Study|Voluntary Withdrawal|0
1131631|NCT02730169|2226671|FG000|Overall Study|Protocol Violation|1
1131632|NCT02730169|2226672|FG001|Overall Study|Protocol Violation|0
1131633|NCT02730169|2226673|FG002|Overall Study|Protocol Violation|0
1131634|NCT02730169|2226674|FG003|Overall Study|Protocol Violation|1
1131635|NCT02730169|2226671|FG000|Overall Study|Adverse Event|2
1131636|NCT02730169|2226672|FG001|Overall Study|Adverse Event|3
1131637|NCT02730169|2226673|FG002|Overall Study|Adverse Event|3
1131638|NCT02730169|2226674|FG003|Overall Study|Adverse Event|0
1131639|NCT02730169|2226671|FG000|Overall Study|Adverse Event of Special Interest|0
1131640|NCT02730169|2226672|FG001|Overall Study|Adverse Event of Special Interest|1
1131641|NCT02730169|2226673|FG002|Overall Study|Adverse Event of Special Interest|2
1131642|NCT02730169|2226674|FG003|Overall Study|Adverse Event of Special Interest|0
1131643|NCT02730169|2226671|FG000|Overall Study|Withdrawal by Subject|6
1131644|NCT02730169|2226672|FG001|Overall Study|Withdrawal by Subject|11
1131645|NCT02730169|2226673|FG002|Overall Study|Withdrawal by Subject|6
1131646|NCT02730169|2226674|FG003|Overall Study|Withdrawal by Subject|8
1131647|NCT02730169|2226671|FG000|Overall Study|Lost to Follow-up|5
1131648|NCT02730169|2226672|FG001|Overall Study|Lost to Follow-up|6
1131649|NCT02730169|2226673|FG002|Overall Study|Lost to Follow-up|5
1131650|NCT02730169|2226674|FG003|Overall Study|Lost to Follow-up|6
1131651|NCT02730169|2226671|FG000|Overall Study|Other|0
1131652|NCT02730169|2226672|FG001|Overall Study|Other|0
1131653|NCT02730169|2226673|FG002|Overall Study|Other|1
1131654|NCT02730169|2226674|FG003|Overall Study|Other|1
1131655|NCT02730195|2226684|FG000|Overall Study|Withdrawal by Subject|1
1131656|NCT02730208|2226690|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
1131657|NCT02730208|2226691|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
1131658|NCT02730351|2226714|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1
1131659|NCT02730351|2226715|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0
1131660|NCT02730351|2226714|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0
1131661|NCT02730351|2226715|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1
1131662|NCT02730351|2226714|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
1131663|NCT02730351|2226715|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
1131664|NCT02730351|2226714|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1
1131665|NCT02730351|2226715|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0
1131666|NCT02730351|2226714|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
1131667|NCT02730351|2226715|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
1131668|NCT02730377|2226723|FG000|Overall Study|Other|5
1131669|NCT02730377|2226724|FG001|Overall Study|Other|4
1131670|NCT02730377|2226723|FG000|Overall Study|Death|1
1131671|NCT02730377|2226724|FG001|Overall Study|Death|8
1131672|NCT02730377|2226723|FG000|Overall Study|Inadequate glycaemic control|368
1131673|NCT02730377|2226724|FG001|Overall Study|Inadequate glycaemic control|473
1131674|NCT02730377|2226723|FG000|Overall Study|Adverse Event|79
1131675|NCT02730377|2226724|FG001|Overall Study|Adverse Event|41
1131676|NCT02730377|2226723|FG000|Overall Study|Protocol Violation|23
1131677|NCT02730377|2226724|FG001|Overall Study|Protocol Violation|30
1131678|NCT02730377|2226723|FG000|Overall Study|Lack of Efficacy|4
1131679|NCT02730377|2226724|FG001|Overall Study|Lack of Efficacy|13
1131680|NCT02730377|2226723|FG000|Overall Study|Pregnancy|0
1131681|NCT02730377|2226724|FG001|Overall Study|Pregnancy|1
1131682|NCT02730377|2226723|FG000|Overall Study|Withdrawal by Subject|45
1131683|NCT02730377|2226724|FG001|Overall Study|Withdrawal by Subject|42
1131684|NCT02730377|2226723|FG000|Overall Study|Lost to Follow-up|25
1131685|NCT02730377|2226724|FG001|Overall Study|Lost to Follow-up|21
1131686|NCT02730455|2226738|FG000|Overall Study|Death|5
1131687|NCT02730455|2226739|FG001|Overall Study|Death|6
1131688|NCT02730455|2226740|FG002|Overall Study|Death|4
1131689|NCT02730455|2226738|FG000|Overall Study|Consent withdrawn|2
1131690|NCT02730455|2226739|FG001|Overall Study|Consent withdrawn|4
1131691|NCT02730455|2226740|FG002|Overall Study|Consent withdrawn|1
1131692|NCT02730455|2226738|FG000|Overall Study|Lost to Follow-up|3
1131693|NCT02730455|2226739|FG001|Overall Study|Lost to Follow-up|1
1131694|NCT02730455|2226740|FG002|Overall Study|Lost to Follow-up|4
1131695|NCT02730455|2226738|FG000|Overall Study|Other|1
1131696|NCT02730455|2226739|FG001|Overall Study|Other|1
1131697|NCT02730455|2226740|FG002|Overall Study|Other|2
1131698|NCT02730455|2226738|FG000|Overall Study|Other|2
1131699|NCT02730455|2226739|FG001|Overall Study|Other|2
1131700|NCT02730455|2226740|FG002|Overall Study|Other|0
1131701|NCT02730598|2226750|FG000|Overall Study|Withdrawal by Subject|3
1131702|NCT02730598|2226751|FG001|Overall Study|Withdrawal by Subject|3
1131703|NCT02730598|2226750|FG000|Overall Study|Protocol Violation|0
1131704|NCT02730598|2226751|FG001|Overall Study|Protocol Violation|1
1131705|NCT02730598|2226750|FG000|Overall Study|Unrelated Injury affecting outcomes.|1
1131706|NCT02730598|2226751|FG001|Overall Study|Unrelated Injury affecting outcomes.|0
1131707|NCT02730728|2226764|FG000|Overall Study|Withdrawal by Subject|0
1131708|NCT02730728|2226765|FG001|Overall Study|Withdrawal by Subject|1
1131709|NCT02730728|2226766|FG002|Overall Study|Withdrawal by Subject|0
1131710|NCT02730728|2226764|FG000|Overall Study|Lack of Efficacy|0
1131711|NCT02730728|2226765|FG001|Overall Study|Lack of Efficacy|1
1131712|NCT02730728|2226766|FG002|Overall Study|Lack of Efficacy|1
1131713|NCT02730819|2226774|FG000|Overall Study|Lost to Follow-up|9
1131714|NCT02730871|2226780|FG000|Overall Study|Adverse Event|6
1131715|NCT02730871|2226781|FG001|Overall Study|Adverse Event|0
1131716|NCT02731131|2226811|FG000|Overall Study|Psychiatric Disorder|0
1131717|NCT02731131|2226812|FG001|Overall Study|Psychiatric Disorder|1
1131718|NCT02731131|2226811|FG000|Overall Study|Refused Therapy|0
1131719|NCT02731131|2226812|FG001|Overall Study|Refused Therapy|1
1131720|NCT02731157|2226818|FG000|First Rejuvenated RCE|Withdrawal by Subject|1
1131721|NCT02731638|2226884|FG000|Overall Study|Lost to Follow-up|6
1131722|NCT02731638|2226885|FG001|Overall Study|Lost to Follow-up|9
1131723|NCT02731690|2226891|FG000|Overall Study|Adverse Event|1
1131724|NCT02731690|2226891|FG000|Overall Study|Withdrawal by Subject|3
1131725|NCT02731690|2226891|FG000|Overall Study|Discontinuation of Study by Sponsor|26
1131726|NCT02731729|2226897|FG000|Overall Study|Death|2
1131727|NCT02731729|2226898|FG001|Overall Study|Death|2
1131728|NCT02731729|2226897|FG000|Overall Study|Study terminated by Sponsor|6
1131729|NCT02731729|2226898|FG001|Overall Study|Study terminated by Sponsor|6
1131730|NCT02731729|2226897|FG000|Overall Study|Withdrawal by Subject|1
1131731|NCT02731729|2226898|FG001|Overall Study|Withdrawal by Subject|0
1131732|NCT02731742|2226908|FG000|Overall Study|Death|1
1131733|NCT02731742|2226909|FG001|Overall Study|Death|2
1131734|NCT02731742|2226910|FG002|Overall Study|Death|5
1131735|NCT02731742|2226911|FG003|Overall Study|Death|0
1131736|NCT02731742|2226908|FG000|Overall Study|Physician Decision|0
1131737|NCT02731742|2226909|FG001|Overall Study|Physician Decision|0
1131738|NCT02731742|2226910|FG002|Overall Study|Physician Decision|0
1131739|NCT02731742|2226911|FG003|Overall Study|Physician Decision|1
1131740|NCT02731742|2226908|FG000|Overall Study|Study Terminated by Sponsor|2
1131741|NCT02731742|2226909|FG001|Overall Study|Study Terminated by Sponsor|1
1131742|NCT02731742|2226910|FG002|Overall Study|Study Terminated by Sponsor|1
1131743|NCT02731742|2226911|FG003|Overall Study|Study Terminated by Sponsor|1
1131744|NCT02731755|2226921|FG000|First Intervention|Withdrawal by Subject|0
1131745|NCT02731755|2226922|FG001|First Intervention|Withdrawal by Subject|2
1131746|NCT02732015|2226948|FG000|Overall Study|Lost to Follow-up|0
1131747|NCT02732015|2226949|FG001|Overall Study|Lost to Follow-up|1
1131748|NCT02732119|2226960|FG000|Phase I|Adverse Event|1
1131749|NCT02732119|2226961|FG001|Phase I|Adverse Event|3
1131750|NCT02732119|2226962|FG002|Phase I|Adverse Event|1
1131751|NCT02732119|2226963|FG003|Phase I|Adverse Event|0
1131752|NCT02732119|2226964|FG004|Phase I|Adverse Event|0
1131753|NCT02732119|2226960|FG000|Phase I|Progressive disease|7
1131754|NCT02732119|2226961|FG001|Phase I|Progressive disease|3
1131755|NCT02732119|2226962|FG002|Phase I|Progressive disease|2
1131756|NCT02732119|2226963|FG003|Phase I|Progressive disease|0
1131757|NCT02732119|2226964|FG004|Phase I|Progressive disease|0
1131758|NCT02732119|2226960|FG000|Phase I|Protocol deviation|0
1131759|NCT02732119|2226961|FG001|Phase I|Protocol deviation|1
1131760|NCT02732119|2226962|FG002|Phase I|Protocol deviation|0
1131761|NCT02732119|2226963|FG003|Phase I|Protocol deviation|0
1131762|NCT02732119|2226964|FG004|Phase I|Protocol deviation|0
1131763|NCT02732119|2226960|FG000|Phase I|Physician Decision|0
1131764|NCT02732119|2226961|FG001|Phase I|Physician Decision|3
1131765|NCT02732119|2226962|FG002|Phase I|Physician Decision|4
1131766|NCT02732119|2226963|FG003|Phase I|Physician Decision|0
1131767|NCT02732119|2226964|FG004|Phase I|Physician Decision|0
1131768|NCT02732119|2226960|FG000|Phase II|Adverse Event|0
1131769|NCT02732119|2226961|FG001|Phase II|Adverse Event|0
1131770|NCT02732119|2226962|FG002|Phase II|Adverse Event|0
1131771|NCT02732119|2226963|FG003|Phase II|Adverse Event|3
1131772|NCT02732119|2226964|FG004|Phase II|Adverse Event|3
1131773|NCT02732119|2226960|FG000|Phase II|Death|0
1131774|NCT02732119|2226961|FG001|Phase II|Death|0
1131775|NCT02732119|2226962|FG002|Phase II|Death|0
1131776|NCT02732119|2226963|FG003|Phase II|Death|1
1131777|NCT02732119|2226964|FG004|Phase II|Death|0
1131778|NCT02732119|2226960|FG000|Phase II|Progressive dissease|0
1131779|NCT02732119|2226961|FG001|Phase II|Progressive dissease|0
1131780|NCT02732119|2226962|FG002|Phase II|Progressive dissease|0
1131781|NCT02732119|2226963|FG003|Phase II|Progressive dissease|30
1131782|NCT02732119|2226964|FG004|Phase II|Progressive dissease|23
1131783|NCT02732119|2226960|FG000|Phase II|Study terminated by sponsor|0
1131784|NCT02732119|2226961|FG001|Phase II|Study terminated by sponsor|0
1131785|NCT02732119|2226962|FG002|Phase II|Study terminated by sponsor|0
1131786|NCT02732119|2226963|FG003|Phase II|Study terminated by sponsor|2
1131787|NCT02732119|2226964|FG004|Phase II|Study terminated by sponsor|2
1131788|NCT02732119|2226960|FG000|Phase II|Other|0
1131789|NCT02732119|2226961|FG001|Phase II|Other|0
1131790|NCT02732119|2226962|FG002|Phase II|Other|0
1131791|NCT02732119|2226963|FG003|Phase II|Other|2
1131792|NCT02732119|2226964|FG004|Phase II|Other|0
1131793|NCT02732119|2226960|FG000|Phase II|Physician Decision|0
1131794|NCT02732119|2226961|FG001|Phase II|Physician Decision|0
1131795|NCT02732119|2226962|FG002|Phase II|Physician Decision|0
1131796|NCT02732119|2226963|FG003|Phase II|Physician Decision|8
1131797|NCT02732119|2226964|FG004|Phase II|Physician Decision|5
1131798|NCT02732210|2227015|FG000|Overall Study|Site Closed|0
1131799|NCT02732210|2227016|FG001|Overall Study|Site Closed|11
1131800|NCT02732210|2227015|FG000|Overall Study|Study Ended|13
1131801|NCT02732210|2227016|FG001|Overall Study|Study Ended|13
1131802|NCT02732210|2227015|FG000|Overall Study|Withdrawal by Subject|28
1131803|NCT02732210|2227016|FG001|Overall Study|Withdrawal by Subject|87
1131804|NCT02732210|2227015|FG000|Overall Study|Lost to Follow-up|5
1131805|NCT02732210|2227016|FG001|Overall Study|Lost to Follow-up|57
1131806|NCT02732210|2227015|FG000|Overall Study|Death|4
1131807|NCT02732210|2227016|FG001|Overall Study|Death|15
1131808|NCT02732210|2227015|FG000|Overall Study|Other|35
1131809|NCT02732210|2227016|FG001|Overall Study|Other|103
1131810|NCT02732210|2227015|FG000|Overall Study|Missing|0
1131811|NCT02732210|2227016|FG001|Overall Study|Missing|8
1131812|NCT02732561|2227036|FG000|Overall Study|Lost to Follow-up|1
1131813|NCT02732561|2227037|FG001|Overall Study|Lost to Follow-up|1
1131814|NCT02732561|2227036|FG000|Overall Study|Withdrawal by Subject|1
1131815|NCT02732561|2227037|FG001|Overall Study|Withdrawal by Subject|0
1131816|NCT02732639|2227057|FG000|Overall Study|Lost to Follow-up|1
1131817|NCT02732847|2227063|FG000|Overall Study|some filled early|42
1131818|NCT02732847|2227064|FG001|Overall Study|some filled early|42
1131819|NCT02732912|2227081|FG000|Overall Study|Discharged before night|2
1131820|NCT02732912|2227082|FG001|Overall Study|Discharged before night|6
1131821|NCT02732912|2227081|FG000|Overall Study|Incomplete completion of questionnaire|2
1131822|NCT02732912|2227082|FG001|Overall Study|Incomplete completion of questionnaire|3
1131823|NCT02732912|2227081|FG000|Overall Study|No outcome; discharged or refused|6
1131824|NCT02732912|2227082|FG001|Overall Study|No outcome; discharged or refused|9
1131825|NCT02732938|2227090|FG000|Overall Study|Death|0
1131826|NCT02732938|2227091|FG001|Overall Study|Death|11
1131827|NCT02732938|2227092|FG002|Overall Study|Death|0
1131828|NCT02732938|2227090|FG000|Overall Study|Randomized but did not receive treatment|0
1131829|NCT02732938|2227091|FG001|Overall Study|Randomized but did not receive treatment|1
1131830|NCT02732938|2227092|FG002|Overall Study|Randomized but did not receive treatment|0
1131831|NCT02732938|2227090|FG000|Overall Study|Refused further follow-up|1
1131832|NCT02732938|2227091|FG001|Overall Study|Refused further follow-up|0
1131833|NCT02732938|2227092|FG002|Overall Study|Refused further follow-up|0
1131834|NCT02732938|2227090|FG000|Overall Study|Study terminated by sponsor|3
1131835|NCT02732938|2227091|FG001|Overall Study|Study terminated by sponsor|6
1131836|NCT02732938|2227092|FG002|Overall Study|Study terminated by sponsor|0
1131837|NCT02732951|2227102|FG000|Overall Study|Other than listed|1
1131838|NCT02732951|2227103|FG001|Overall Study|Other than listed|0
1131839|NCT02732951|2227102|FG000|Overall Study|Lost to Follow-up|0
1131840|NCT02732951|2227103|FG001|Overall Study|Lost to Follow-up|1
1131841|NCT02732951|2227102|FG000|Overall Study|Adverse Event|4
1131842|NCT02732951|2227103|FG001|Overall Study|Adverse Event|4
1131843|NCT02732951|2227102|FG000|Overall Study|Protocol Violation|0
1131844|NCT02732951|2227103|FG001|Overall Study|Protocol Violation|1
1132035|NCT02733367|2227196|FG000|Overall Study|Withdrawal by Subject|6
1132036|NCT02733627|2227209|FG000|Overall Study|Adverse Event|0
1132037|NCT02733627|2227210|FG001|Overall Study|Adverse Event|1
1132038|NCT02733627|2227211|FG002|Overall Study|Adverse Event|1
1132039|NCT02733627|2227212|FG003|Overall Study|Adverse Event|0
1132040|NCT02733627|2227209|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
1132041|NCT02733627|2227210|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
1132042|NCT02733627|2227211|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1
1132043|NCT02733627|2227212|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
1132044|NCT02733991|2227245|FG000|Overall Study|Adverse Event|1
1132045|NCT02733991|2227246|FG001|Overall Study|Adverse Event|0
1132046|NCT02733991|2227245|FG000|Overall Study|Withdrawal by Subject|0
1132047|NCT02733991|2227246|FG001|Overall Study|Withdrawal by Subject|5
1132048|NCT02734212|2227272|FG000|Overall Study|Lost to Follow-up|5
1132049|NCT02734212|2227273|FG001|Overall Study|Lost to Follow-up|10
1132050|NCT02734433|2227300|FG000|Overall Study|Disease progression|1
1132051|NCT02734433|2227301|FG001|Overall Study|Disease progression|5
1132052|NCT02734433|2227300|FG000|Overall Study|Clinical progression|0
1132053|NCT02734433|2227301|FG001|Overall Study|Clinical progression|1
1132054|NCT02734433|2227300|FG000|Overall Study|Withdrawal by Subject|1
1132055|NCT02734433|2227301|FG001|Overall Study|Withdrawal by Subject|2
1132056|NCT02734693|2227336|FG000|Overall Study|Adverse Event|1
1132057|NCT02734693|2227337|FG001|Overall Study|Adverse Event|3
1132058|NCT02734693|2227338|FG002|Overall Study|Adverse Event|3
1132059|NCT02734693|2227336|FG000|Overall Study|Lack of Efficacy|1
1132060|NCT02734693|2227337|FG001|Overall Study|Lack of Efficacy|0
1132061|NCT02734693|2227338|FG002|Overall Study|Lack of Efficacy|0
1132062|NCT02734693|2227336|FG000|Overall Study|Lost to Follow-up|2
1132063|NCT02734693|2227337|FG001|Overall Study|Lost to Follow-up|0
1132064|NCT02734693|2227338|FG002|Overall Study|Lost to Follow-up|0
1132065|NCT02734693|2227336|FG000|Overall Study|Protocol Violation|1
1132066|NCT02734693|2227337|FG001|Overall Study|Protocol Violation|0
1132067|NCT02734693|2227338|FG002|Overall Study|Protocol Violation|0
1132068|NCT02734693|2227336|FG000|Overall Study|Withdrawal by Subject|1
1132069|NCT02734693|2227337|FG001|Overall Study|Withdrawal by Subject|0
1132070|NCT02734693|2227338|FG002|Overall Study|Withdrawal by Subject|0
1132071|NCT02734810|2227348|FG000|Overall Study|Adverse Event|1
1132072|NCT02734810|2227349|FG001|Overall Study|Adverse Event|0
1132073|NCT02734810|2227348|FG000|Overall Study|Lack of Efficacy|1
1132074|NCT02734810|2227349|FG001|Overall Study|Lack of Efficacy|0
1132075|NCT02734862|2227371|FG000|Part A|Death|3
1132076|NCT02734862|2227372|FG001|Part A|Death|4
1132077|NCT02734862|2227373|FG002|Part A|Death|6
1132078|NCT02734862|2227371|FG000|Part A|Lost to Follow-up|2
1132079|NCT02734862|2227372|FG001|Part A|Lost to Follow-up|1
1132080|NCT02734862|2227373|FG002|Part A|Lost to Follow-up|1
1132081|NCT02734862|2227371|FG000|Part A|Withdrawal by Subject|1
1132082|NCT02734862|2227372|FG001|Part A|Withdrawal by Subject|1
1132083|NCT02734862|2227373|FG002|Part A|Withdrawal by Subject|2
1132084|NCT02734862|2227371|FG000|Part A|Physician Decision|2
1132085|NCT02734862|2227372|FG001|Part A|Physician Decision|0
1132086|NCT02734862|2227373|FG002|Part A|Physician Decision|1
1132087|NCT02734862|2227371|FG000|Part A|Adverse Event|2
1132088|NCT02734862|2227372|FG001|Part A|Adverse Event|0
1132089|NCT02734862|2227373|FG002|Part A|Adverse Event|1
1132090|NCT02734862|2227371|FG000|Part A|Noncompliance|1
1132091|NCT02734862|2227372|FG001|Part A|Noncompliance|1
1132092|NCT02734862|2227373|FG002|Part A|Noncompliance|0
1132093|NCT02734862|2227371|FG000|Part A|Other|1
1132094|NCT02734862|2227372|FG001|Part A|Other|1
1132095|NCT02734862|2227373|FG002|Part A|Other|3
1132096|NCT02734862|2227371|FG000|Part B|Death|8
1132097|NCT02734862|2227372|FG001|Part B|Death|3
1132098|NCT02734862|2227373|FG002|Part B|Death|5
1132099|NCT02734862|2227371|FG000|Part B|Lost to Follow-up|2
1132100|NCT02734862|2227372|FG001|Part B|Lost to Follow-up|2
1132101|NCT02734862|2227373|FG002|Part B|Lost to Follow-up|0
1132102|NCT02734862|2227371|FG000|Part B|Withdrawal by Subject|3
1132103|NCT02734862|2227372|FG001|Part B|Withdrawal by Subject|1
1132104|NCT02734862|2227373|FG002|Part B|Withdrawal by Subject|0
1132105|NCT02734862|2227371|FG000|Part B|Other|0
1132106|NCT02734862|2227372|FG001|Part B|Other|1
1132107|NCT02734862|2227373|FG002|Part B|Other|0
1132108|NCT02735044|2227400|FG000|Overall Study|Adverse Event|3
1132109|NCT02735044|2227401|FG001|Overall Study|Adverse Event|3
1132110|NCT02735044|2227400|FG000|Overall Study|Lack of Efficacy|1
1132111|NCT02735044|2227401|FG001|Overall Study|Lack of Efficacy|0
1132112|NCT02735044|2227400|FG000|Overall Study|Poor compliance to protocol|7
1132113|NCT02735044|2227401|FG001|Overall Study|Poor compliance to protocol|7
1132114|NCT02735044|2227400|FG000|Overall Study|Randomized and not treated|0
1132115|NCT02735044|2227401|FG001|Overall Study|Randomized and not treated|2
1132116|NCT02735044|2227400|FG000|Overall Study|Other, not specified above|5
1132117|NCT02735044|2227401|FG001|Overall Study|Other, not specified above|11
1132118|NCT02735096|2227407|FG000|Overall Study|No symptoms in clinic/personal leave|1
1132119|NCT02735200|2227432|FG000|Overall Study|Lost to Follow-up|0
1132120|NCT02735200|2227433|FG001|Overall Study|Lost to Follow-up|5
1132121|NCT02735200|2227432|FG000|Overall Study|Withdrawal by Subject|8
1132122|NCT02735200|2227433|FG001|Overall Study|Withdrawal by Subject|0
1132123|NCT02735421|2227456|FG000|Overall Study|Adverse Event|2
1132124|NCT02735421|2227456|FG000|Overall Study|Withdrawal by Subject|6
1132125|NCT02735421|2227456|FG000|Overall Study|Lost to Follow-up|3
1132126|NCT02735421|2227456|FG000|Overall Study|Inadequate compliance to treatment|1
1132127|NCT02735421|2227456|FG000|Overall Study|Pregnancy|1
1132128|NCT02735577|2227476|FG000|Disulfiram Treatment|Lost to Follow-up|1
1132129|NCT02735577|2227476|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2
1132130|NCT02735915|2227493|FG000|Overall Study|Not vaccinated but subject ID assigned|8
1132131|NCT02735915|2227493|FG000|Overall Study|Withdrawal following SAE|2
1132132|NCT02735915|2227493|FG000|Overall Study|Withdrawal by Subject|1
1132133|NCT02735980|2227502|FG000|Overall Study|Adverse Event|0
1132134|NCT02735980|2227503|FG001|Overall Study|Adverse Event|4
1132135|NCT02735980|2227504|FG002|Overall Study|Adverse Event|1
1132136|NCT02735980|2227502|FG000|Overall Study|Death|5
1132137|NCT02735980|2227503|FG001|Overall Study|Death|4
1132138|NCT02735980|2227504|FG002|Overall Study|Death|0
1132139|NCT02735980|2227502|FG000|Overall Study|Physician Decision|3
1132140|NCT02735980|2227503|FG001|Overall Study|Physician Decision|1
1132141|NCT02735980|2227504|FG002|Overall Study|Physician Decision|0
1132142|NCT02735980|2227502|FG000|Overall Study|Screen failure|1
1132143|NCT02735980|2227503|FG001|Overall Study|Screen failure|0
1132144|NCT02735980|2227504|FG002|Overall Study|Screen failure|0
1132145|NCT02735980|2227502|FG000|Overall Study|Withdrawal by Subject|1
1132146|NCT02735980|2227503|FG001|Overall Study|Withdrawal by Subject|2
1132147|NCT02735980|2227504|FG002|Overall Study|Withdrawal by Subject|0
1132148|NCT02736188|2227526|FG000|Overall Study|Discontinuation of Study by Sponsor|134
1132149|NCT02736188|2227526|FG000|Overall Study|Adverse Event|1
1132150|NCT02736188|2227526|FG000|Overall Study|Withdrawal by Subject|1
1132151|NCT02736188|2227526|FG000|Overall Study|Other|6
1132152|NCT02736409|2227536|FG000|Overall Study|Withdrawal by Subject|4
1132153|NCT02736409|2227537|FG001|Overall Study|Withdrawal by Subject|2
1132154|NCT02736409|2227538|FG002|Overall Study|Withdrawal by Subject|17
1132155|NCT02736409|2227539|FG003|Overall Study|Withdrawal by Subject|3
1132156|NCT02736409|2227536|FG000|Overall Study|Non-Compliance with Study Drug|0
1132157|NCT02736409|2227537|FG001|Overall Study|Non-Compliance with Study Drug|0
1132158|NCT02736409|2227538|FG002|Overall Study|Non-Compliance with Study Drug|0
1132159|NCT02736409|2227539|FG003|Overall Study|Non-Compliance with Study Drug|1
1132160|NCT02736409|2227536|FG000|Overall Study|Adverse Event|0
1132161|NCT02736409|2227537|FG001|Overall Study|Adverse Event|1
1132162|NCT02736409|2227538|FG002|Overall Study|Adverse Event|5
1132163|NCT02736409|2227539|FG003|Overall Study|Adverse Event|4
1132164|NCT02736409|2227536|FG000|Overall Study|Other|0
1132165|NCT02736409|2227537|FG001|Overall Study|Other|0
1132166|NCT02736409|2227538|FG002|Overall Study|Other|1
1132167|NCT02736409|2227539|FG003|Overall Study|Other|1
1132168|NCT02736409|2227536|FG000|Overall Study|Pregnancy|0
1132169|NCT02736409|2227537|FG001|Overall Study|Pregnancy|0
1132170|NCT02736409|2227538|FG002|Overall Study|Pregnancy|1
1132171|NCT02736409|2227539|FG003|Overall Study|Pregnancy|0
1132172|NCT02736409|2227536|FG000|Overall Study|Lost to Follow-up|0
1132173|NCT02736409|2227537|FG001|Overall Study|Lost to Follow-up|0
1132174|NCT02736409|2227538|FG002|Overall Study|Lost to Follow-up|2
1132175|NCT02736409|2227539|FG003|Overall Study|Lost to Follow-up|1
1132176|NCT02736409|2227536|FG000|Overall Study|Physician Decision|0
1132177|NCT02736409|2227537|FG001|Overall Study|Physician Decision|0
1132178|NCT02736409|2227538|FG002|Overall Study|Physician Decision|0
1132179|NCT02736409|2227539|FG003|Overall Study|Physician Decision|2
1132180|NCT02736474|2227552|FG000|Overall Study|Lost to Follow-up|0
1132181|NCT02736474|2227553|FG001|Overall Study|Lost to Follow-up|1
1132182|NCT02736578|2227561|FG000|Overall Study|Adverse Event|1
1132183|NCT02736578|2227562|FG001|Overall Study|Adverse Event|0
1132184|NCT02736721|2227572|FG000|Overall Study|Adverse Event|8
1132185|NCT02736721|2227572|FG000|Overall Study|Lost to Follow-up|3
1132186|NCT02736721|2227572|FG000|Overall Study|Other|5
1132187|NCT02736825|2227578|FG000|Overall Study|Lost to Follow-up|10
1132188|NCT02736825|2227579|FG001|Overall Study|Lost to Follow-up|11
1132189|NCT02736825|2227578|FG000|Overall Study|Early Termination|0
1132190|NCT02736825|2227579|FG001|Overall Study|Early Termination|1
1132191|NCT02736890|2227588|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1
1132192|NCT02736890|2227589|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2
1132193|NCT02736890|2227588|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1
1132194|NCT02736890|2227589|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0
1132195|NCT02737358|2227643|FG000|Overall Study|Withdrawal by Subject|7
1132196|NCT02737358|2227644|FG001|Overall Study|Withdrawal by Subject|12
1132197|NCT02737358|2227643|FG000|Overall Study|Lost to Follow-up|2
1132198|NCT02737358|2227644|FG001|Overall Study|Lost to Follow-up|3
1132199|NCT02737501|2227662|FG000|Randomized Phase|Died|41
1132200|NCT02737501|2227663|FG001|Randomized Phase|Died|29
1132201|NCT02737501|2227664|FG002|Randomized Phase|Died|0
1132202|NCT02737501|2227662|FG000|Randomized Phase|Withdrawal by Subject|16
1132203|NCT02737501|2227663|FG001|Randomized Phase|Withdrawal by Subject|6
1132204|NCT02737501|2227664|FG002|Randomized Phase|Withdrawal by Subject|0
1132205|NCT02737501|2227662|FG000|Randomized Phase|Lost to Follow-up|0
1132206|NCT02737501|2227663|FG001|Randomized Phase|Lost to Follow-up|1
1132207|NCT02737501|2227664|FG002|Randomized Phase|Lost to Follow-up|0
1132208|NCT02737501|2227662|FG000|Randomized Phase|Site Terminated by Sponsor|58
1132209|NCT02737501|2227663|FG001|Randomized Phase|Site Terminated by Sponsor|16
1132210|NCT02737501|2227664|FG002|Randomized Phase|Site Terminated by Sponsor|0
1132211|NCT02737501|2227662|FG000|Randomized Phase|Reason not Specified|1
1132212|NCT02737501|2227663|FG001|Randomized Phase|Reason not Specified|1
1132213|NCT02737501|2227664|FG002|Randomized Phase|Reason not Specified|0
1132214|NCT02737501|2227662|FG000|Randomized Phase|Never Treated|1
1132215|NCT02737501|2227663|FG001|Randomized Phase|Never Treated|1
1132216|NCT02737501|2227664|FG002|Randomized Phase|Never Treated|0
1132217|NCT02737501|2227662|FG000|Crossover Phase|Died|0
1132218|NCT02737501|2227663|FG001|Crossover Phase|Died|0
1132219|NCT02737501|2227664|FG002|Crossover Phase|Died|22
1132220|NCT02737501|2227662|FG000|Crossover Phase|Withdrew Consent|0
1132221|NCT02737501|2227663|FG001|Crossover Phase|Withdrew Consent|0
1132222|NCT02737501|2227664|FG002|Crossover Phase|Withdrew Consent|9
1132223|NCT02737501|2227662|FG000|Crossover Phase|Physician Decision|0
1132224|NCT02737501|2227663|FG001|Crossover Phase|Physician Decision|0
1132225|NCT02737501|2227664|FG002|Crossover Phase|Physician Decision|1
1132226|NCT02737501|2227662|FG000|Crossover Phase|Site Terminated by Sponsor|0
1132227|NCT02737501|2227663|FG001|Crossover Phase|Site Terminated by Sponsor|0
1132228|NCT02737501|2227664|FG002|Crossover Phase|Site Terminated by Sponsor|23
1132229|NCT02737592|2227682|FG000|Overall Study|Withdrawal by Subject|1
1132230|NCT02737618|2227686|FG000|Overall Study|Withdrawal by Subject|9
1132231|NCT02737722|2227698|FG000|Overall Study|Physician Decision|0
1132232|NCT02737722|2227699|FG001|Overall Study|Physician Decision|0
1132233|NCT02737722|2227700|FG002|Overall Study|Physician Decision|1
1132234|NCT02737722|2227701|FG003|Overall Study|Physician Decision|0
1132235|NCT02737826|2227711|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0
1132236|NCT02737826|2227712|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12
1132237|NCT02737826|2227713|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14
1132238|NCT02737852|2227722|FG000|Overall Study|Withdrawal by Subject|2
1132239|NCT02737930|2227746|FG000|Overall Study|Withdrawal by Subject|0
1132240|NCT02737930|2227747|FG001|Overall Study|Withdrawal by Subject|1
1132241|NCT02738008|2227756|FG000|Overall Study|Study Terminated by Sponsor|1
1132242|NCT02738008|2227757|FG001|Overall Study|Study Terminated by Sponsor|5
1132243|NCT02738008|2227758|FG002|Overall Study|Study Terminated by Sponsor|3
1132244|NCT02738008|2227756|FG000|Overall Study|Adverse Event|0
1132245|NCT02738008|2227757|FG001|Overall Study|Adverse Event|1
1132246|NCT02738008|2227758|FG002|Overall Study|Adverse Event|2
1132247|NCT02738138|2227780|FG000|Overall Study|Adverse Event|0
1132248|NCT02738138|2227781|FG001|Overall Study|Adverse Event|1
1132249|NCT02738138|2227780|FG000|Overall Study|Lost to Follow-up|2
1132250|NCT02738138|2227781|FG001|Overall Study|Lost to Follow-up|0
1132251|NCT02738138|2227780|FG000|Overall Study|Other - not further specified|1
1132252|NCT02738138|2227781|FG001|Overall Study|Other - not further specified|0
1132253|NCT02738151|2227788|FG000|Overall Study|Randomized but not treated|4
1132254|NCT02738151|2227789|FG001|Overall Study|Randomized but not treated|1
1132255|NCT02738151|2227788|FG000|Overall Study|Adverse Event|4
1132256|NCT02738151|2227789|FG001|Overall Study|Adverse Event|5
1132257|NCT02738151|2227788|FG000|Overall Study|Hypoglycemia|0
1132258|NCT02738151|2227789|FG001|Overall Study|Hypoglycemia|1
1132259|NCT02738151|2227788|FG000|Overall Study|Poor Compliance to Protocol|4
1132260|NCT02738151|2227789|FG001|Overall Study|Poor Compliance to Protocol|3
1132261|NCT02738151|2227788|FG000|Overall Study|Other than specified above|11
1132262|NCT02738151|2227789|FG001|Overall Study|Other than specified above|21
1132263|NCT02738203|2227797|FG000|Overall Study|Failed IUD Insertion|2
1132264|NCT02738203|2227798|FG001|Overall Study|Failed IUD Insertion|2
1132265|NCT02738203|2227797|FG000|Overall Study|Protocol Violation|0
1132266|NCT02738203|2227798|FG001|Overall Study|Protocol Violation|1
1132267|NCT02738333|2227820|FG000|Overall Study|Death|1
1132268|NCT02738333|2227821|FG001|Overall Study|Death|0
1132269|NCT02738333|2227822|FG002|Overall Study|Death|0
1132270|NCT02738333|2227820|FG000|Overall Study|Lost to Follow-up|1
1132271|NCT02738333|2227821|FG001|Overall Study|Lost to Follow-up|0
1132272|NCT02738333|2227822|FG002|Overall Study|Lost to Follow-up|0
1132273|NCT02738450|2227834|FG000|Overall Study|Withdrawal by Subject|0
1132274|NCT02738450|2227835|FG001|Overall Study|Withdrawal by Subject|2
1132275|NCT02738450|2227836|FG002|Overall Study|Withdrawal by Subject|0
1132276|NCT02738580|2227847|FG000|Overall Study|Adverse Event|1
1132277|NCT02738580|2227848|FG001|Overall Study|Adverse Event|0
1132278|NCT02738580|2227847|FG000|Overall Study|Lack of Efficacy|3
1132279|NCT02738580|2227848|FG001|Overall Study|Lack of Efficacy|2
1132280|NCT02738580|2227847|FG000|Overall Study|Withdrawal by Subject|0
1132281|NCT02738580|2227848|FG001|Overall Study|Withdrawal by Subject|1
1132282|NCT02738580|2227847|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
1132283|NCT02738580|2227848|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
1132284|NCT02738775|2227860|FG000|Overall Study|Withdrawal by Subject|0
1132285|NCT02738775|2227861|FG001|Overall Study|Withdrawal by Subject|1
1132286|NCT02738775|2227862|FG002|Overall Study|Withdrawal by Subject|0
1132287|NCT02738775|2227863|FG003|Overall Study|Withdrawal by Subject|0
1132288|NCT02738775|2227864|FG004|Overall Study|Withdrawal by Subject|0
1132289|NCT02738775|2227865|FG005|Overall Study|Withdrawal by Subject|0
1132290|NCT02738775|2227860|FG000|Overall Study|Adverse Event|0
1132291|NCT02738775|2227861|FG001|Overall Study|Adverse Event|0
1132292|NCT02738775|2227862|FG002|Overall Study|Adverse Event|0
1132293|NCT02738775|2227863|FG003|Overall Study|Adverse Event|1
1132294|NCT02738775|2227864|FG004|Overall Study|Adverse Event|0
1132295|NCT02738775|2227865|FG005|Overall Study|Adverse Event|0
1132296|NCT02738775|2227860|FG000|Overall Study|Pregnancy|0
1132297|NCT02738775|2227861|FG001|Overall Study|Pregnancy|1
1132298|NCT02738775|2227862|FG002|Overall Study|Pregnancy|0
1132299|NCT02738775|2227863|FG003|Overall Study|Pregnancy|0
1132300|NCT02738775|2227864|FG004|Overall Study|Pregnancy|0
1132301|NCT02738775|2227865|FG005|Overall Study|Pregnancy|0
1132302|NCT02738775|2227860|FG000|Overall Study|Missing|0
1132303|NCT02738775|2227861|FG001|Overall Study|Missing|0
1132304|NCT02738775|2227862|FG002|Overall Study|Missing|0
1132305|NCT02738775|2227863|FG003|Overall Study|Missing|0
1132306|NCT02738775|2227864|FG004|Overall Study|Missing|0
1132307|NCT02738775|2227865|FG005|Overall Study|Missing|1
1132308|NCT02738801|2227885|FG000|Overall Study|Adverse Event|1
1132309|NCT02738801|2227886|FG001|Overall Study|Adverse Event|1
1132310|NCT02738801|2227885|FG000|Overall Study|Withdrawal by Subject|0
1132311|NCT02738801|2227886|FG001|Overall Study|Withdrawal by Subject|1
1132312|NCT02738840|2227893|FG000|Overall Study|MRI Scan not Performed|5
1132313|NCT02738840|2227893|FG000|Overall Study|Lost to Follow-up|1
1132314|NCT02738840|2227893|FG000|Overall Study|Subject Participation Terminated by Investigator|1
1132315|NCT02738840|2227893|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1
1132316|NCT02738879|2227903|FG000|Overall Study|Adverse Event|1
1132317|NCT02738879|2227904|FG001|Overall Study|Adverse Event|1
1132318|NCT02738879|2227903|FG000|Overall Study|Death|0
1132319|NCT02738879|2227904|FG001|Overall Study|Death|2
1132320|NCT02738879|2227903|FG000|Overall Study|Lost to Follow-up|1
1132321|NCT02738879|2227904|FG001|Overall Study|Lost to Follow-up|5
1132322|NCT02738879|2227903|FG000|Overall Study|Protocol Violation|1
1132323|NCT02738879|2227904|FG001|Overall Study|Protocol Violation|3
1132324|NCT02738879|2227903|FG000|Overall Study|Physician Decision|3
1132325|NCT02738879|2227904|FG001|Overall Study|Physician Decision|4
1132326|NCT02738879|2227903|FG000|Overall Study|Pregnancy|0
1132327|NCT02738879|2227904|FG001|Overall Study|Pregnancy|1
1132328|NCT02738879|2227903|FG000|Overall Study|Screen Failure|1
1132329|NCT02738879|2227904|FG001|Overall Study|Screen Failure|2
1132330|NCT02738879|2227903|FG000|Overall Study|Site Discontinued Study Participation|1
1132331|NCT02738879|2227904|FG001|Overall Study|Site Discontinued Study Participation|0
1132332|NCT02738879|2227903|FG000|Overall Study|Withdrawal by Subject|5
1132333|NCT02738879|2227904|FG001|Overall Study|Withdrawal by Subject|7
1132334|NCT02739269|2227920|FG000|Overall Study|Protocol Violation|5
1132335|NCT02739269|2227921|FG001|Overall Study|Protocol Violation|0
1132336|NCT02739269|2227920|FG000|Overall Study|Cycle cancellation|2
1132337|NCT02739269|2227921|FG001|Overall Study|Cycle cancellation|2
1132338|NCT02739269|2227920|FG000|Overall Study|Withdrawal by Subject|0
1132339|NCT02739269|2227921|FG001|Overall Study|Withdrawal by Subject|2
1132340|NCT02739321|2227929|FG000|Overall Study|Lack of Efficacy|1
1132341|NCT02739321|2227930|FG001|Overall Study|Lack of Efficacy|1
1132342|NCT02739321|2227929|FG000|Overall Study|Lost to Follow-up|1
1132343|NCT02739321|2227930|FG001|Overall Study|Lost to Follow-up|1
1132344|NCT02739321|2227929|FG000|Overall Study|Withdrawal by Subject|1
1132345|NCT02739321|2227930|FG001|Overall Study|Withdrawal by Subject|2
1132346|NCT02739360|2227945|FG000|Overall Study|Adverse Event|1
1132347|NCT02739360|2227945|FG000|Overall Study|Study terminated by Sponsor|2
1132348|NCT02739594|2227951|FG000|Overall Study|Undesired Event|3
1132349|NCT02739594|2227952|FG001|Overall Study|Undesired Event|4
1132350|NCT02739594|2227951|FG000|Overall Study|Violation of Eligibility Criteria|1
1132351|NCT02739594|2227952|FG001|Overall Study|Violation of Eligibility Criteria|2
1132352|NCT02739594|2227951|FG000|Overall Study|Protocol Violation|5
1132353|NCT02739594|2227952|FG001|Overall Study|Protocol Violation|6
1132354|NCT02739594|2227951|FG000|Overall Study|Death|4
1132355|NCT02739594|2227952|FG001|Overall Study|Death|2
1132356|NCT02739594|2227951|FG000|Overall Study|Renal Insufficiency|4
1132357|NCT02739594|2227952|FG001|Overall Study|Renal Insufficiency|6
1132358|NCT02739594|2227951|FG000|Overall Study|Administrative Reasons|1
1132359|NCT02739594|2227952|FG001|Overall Study|Administrative Reasons|3
1132360|NCT02739594|2227951|FG000|Overall Study|Withdrawal by Subject|1
1132361|NCT02739594|2227952|FG001|Overall Study|Withdrawal by Subject|1
1132362|NCT02739594|2227951|FG000|Overall Study|Lost to Follow-up|0
1132363|NCT02739594|2227952|FG001|Overall Study|Lost to Follow-up|1
1132364|NCT02739594|2227951|FG000|Overall Study|Elevated Serum Creatinine|0
1132365|NCT02739594|2227952|FG001|Overall Study|Elevated Serum Creatinine|1
1132366|NCT02739594|2227951|FG000|Overall Study|Other|6
1132367|NCT02739594|2227952|FG001|Overall Study|Other|2
1132368|NCT02739828|2227977|FG000|Overall Study|Adverse Event|1
1132369|NCT02739828|2227977|FG000|Overall Study|Lost to Follow-up|4
1132370|NCT02739984|2227983|FG000|Overall Study|Sponsor Decision|1
1132371|NCT02739984|2227984|FG001|Overall Study|Sponsor Decision|0
1132372|NCT02739984|2227983|FG000|Overall Study|Withdrawal by Subject|1
1132373|NCT02739984|2227984|FG001|Overall Study|Withdrawal by Subject|1
1132374|NCT02739984|2227983|FG000|Overall Study|Death|0
1132375|NCT02739984|2227984|FG001|Overall Study|Death|1
1132376|NCT02739984|2227983|FG000|Overall Study|Lost to Follow-up|3
1132377|NCT02739984|2227984|FG001|Overall Study|Lost to Follow-up|0
1132378|NCT02739997|2227990|FG000|Overall Study|Death|1
1132379|NCT02739997|2227990|FG000|Overall Study|Withdrawal by Subject|1
1132380|NCT02740049|2227994|FG000|Overall Study|Isolated cells did not grow sufficiently|1
1132381|NCT02740478|2228035|FG000|Overall Study|Withdrawal by Subject|1
1132382|NCT02741076|2228114|FG000|Overall Study|Adverse Event|0
1132383|NCT02741076|2228115|FG001|Overall Study|Adverse Event|1
1132384|NCT02741076|2228116|FG002|Overall Study|Adverse Event|1
1132385|NCT02741076|2228117|FG003|Overall Study|Adverse Event|0
1132386|NCT02741076|2228114|FG000|Overall Study|Lack of Efficacy|1
1132387|NCT02741076|2228115|FG001|Overall Study|Lack of Efficacy|0
1132388|NCT02741076|2228116|FG002|Overall Study|Lack of Efficacy|0
1132389|NCT02741076|2228117|FG003|Overall Study|Lack of Efficacy|0
1132390|NCT02741076|2228114|FG000|Overall Study|Withdrawal by Subject|0
1132391|NCT02741076|2228115|FG001|Overall Study|Withdrawal by Subject|1
1132392|NCT02741076|2228116|FG002|Overall Study|Withdrawal by Subject|0
1132393|NCT02741076|2228117|FG003|Overall Study|Withdrawal by Subject|0
1132394|NCT02741076|2228114|FG000|Overall Study|Sponsor Request|2
1132395|NCT02741076|2228115|FG001|Overall Study|Sponsor Request|3
1132396|NCT02741076|2228116|FG002|Overall Study|Sponsor Request|0
1132397|NCT02741076|2228117|FG003|Overall Study|Sponsor Request|1
1132398|NCT02741076|2228114|FG000|Overall Study|No additional information available|0
1132399|NCT02741076|2228115|FG001|Overall Study|No additional information available|0
1132400|NCT02741076|2228116|FG002|Overall Study|No additional information available|1
1132401|NCT02741076|2228117|FG003|Overall Study|No additional information available|1
1132402|NCT02741245|2228133|FG000|Overall Study|Adverse Event|0
1132403|NCT02741245|2228134|FG001|Overall Study|Adverse Event|0
1132404|NCT02741245|2228135|FG002|Overall Study|Adverse Event|0
1132405|NCT02741245|2228136|FG003|Overall Study|Adverse Event|2
1132406|NCT02741245|2228137|FG004|Overall Study|Adverse Event|2
1132407|NCT02741245|2228133|FG000|Overall Study|Protocol Violation|0
1132408|NCT02741245|2228134|FG001|Overall Study|Protocol Violation|1
1132409|NCT02741245|2228135|FG002|Overall Study|Protocol Violation|0
1132410|NCT02741245|2228136|FG003|Overall Study|Protocol Violation|1
1132411|NCT02741245|2228137|FG004|Overall Study|Protocol Violation|0
1132412|NCT02741245|2228133|FG000|Overall Study|Withdrawal by Subject|0
1132413|NCT02741245|2228134|FG001|Overall Study|Withdrawal by Subject|0
1132414|NCT02741245|2228135|FG002|Overall Study|Withdrawal by Subject|0
1132415|NCT02741245|2228136|FG003|Overall Study|Withdrawal by Subject|1
1132416|NCT02741245|2228137|FG004|Overall Study|Withdrawal by Subject|0
1132417|NCT02741271|2228151|FG000|Overall Study|Lost to Follow-up|2
1132418|NCT02741271|2228152|FG001|Overall Study|Lost to Follow-up|0
1132419|NCT02741271|2228151|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1132420|NCT02741271|2228152|FG001|Overall Study|Withdrawal by Parent/Guardian|2
1132421|NCT02741310|2228177|FG000|Overall Study|Sponsor Decision|2
1132422|NCT02741310|2228178|FG001|Overall Study|Sponsor Decision|2
1132423|NCT02741518|2228194|FG000|Overall Study|Withdrawal by Subject|1
1132424|NCT02741518|2228195|FG001|Overall Study|Withdrawal by Subject|1
1132425|NCT02741596|2228203|FG000|Overall Study|Adverse Event|1
1132426|NCT02741596|2228204|FG001|Overall Study|Adverse Event|5
1132427|NCT02741596|2228203|FG000|Overall Study|Lost to Follow-up|1
1132428|NCT02741596|2228204|FG001|Overall Study|Lost to Follow-up|1
1132429|NCT02741596|2228203|FG000|Overall Study|Physician Decision|2
1132430|NCT02741596|2228204|FG001|Overall Study|Physician Decision|1
1132431|NCT02741596|2228203|FG000|Overall Study|Pregnancy|3
1132432|NCT02741596|2228204|FG001|Overall Study|Pregnancy|1
1132433|NCT02741596|2228203|FG000|Overall Study|Other (Unspecified)|0
1132434|NCT02741596|2228204|FG001|Overall Study|Other (Unspecified)|3
1132435|NCT02741596|2228203|FG000|Overall Study|Subject withdrawn-Other|17
1132436|NCT02741596|2228204|FG001|Overall Study|Subject withdrawn-Other|4
1132437|NCT02741596|2228203|FG000|Overall Study|Subject withdrawn-to commercial product|54
1132438|NCT02741596|2228204|FG001|Overall Study|Subject withdrawn-to commercial product|63
1132439|NCT02741635|2228210|FG000|Overall Study|Withdrawal by Subject|1
1132440|NCT02741713|2228226|FG000|Overall Study|Surgery type changed intra-operatively|2
1132441|NCT02741713|2228227|FG001|Overall Study|Surgery type changed intra-operatively|1
1132442|NCT02742103|2228240|FG000|Overall Study|Protocol Violation|1
1132443|NCT02742103|2228241|FG001|Overall Study|Protocol Violation|0
1132444|NCT02742103|2228240|FG000|Overall Study|Death|2
1132445|NCT02742103|2228241|FG001|Overall Study|Death|2
1132446|NCT02742103|2228240|FG000|Overall Study|Adverse Event|1
1132447|NCT02742103|2228241|FG001|Overall Study|Adverse Event|0
1132448|NCT02742103|2228240|FG000|Overall Study|Moved to another town|0
1132449|NCT02742103|2228241|FG001|Overall Study|Moved to another town|1
1132450|NCT02742103|2228240|FG000|Overall Study|Withdrawal by Subject|5
1132451|NCT02742103|2228241|FG001|Overall Study|Withdrawal by Subject|2
1132452|NCT02742441|2228261|FG000|Overall Study|Lost to Follow-up|4
1132453|NCT02742441|2228262|FG001|Overall Study|Lost to Follow-up|4
1132454|NCT02742441|2228261|FG000|Overall Study|Withdrawal by Subject|2
1132455|NCT02742441|2228262|FG001|Overall Study|Withdrawal by Subject|2
1132456|NCT02742441|2228261|FG000|Overall Study|Adverse Event|0
1132457|NCT02742441|2228262|FG001|Overall Study|Adverse Event|2
1132458|NCT02742519|2228270|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
1132459|NCT02742519|2228271|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
1132460|NCT02742519|2228272|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
1132461|NCT02742519|2228270|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
1132462|NCT02742519|2228271|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
1132463|NCT02742519|2228272|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
1132464|NCT02742519|2228270|FG000|Part 2 Open Label Period (32 Weeks)|Other|0
1132465|NCT02742519|2228271|FG001|Part 2 Open Label Period (32 Weeks)|Other|0
1132466|NCT02742519|2228272|FG002|Part 2 Open Label Period (32 Weeks)|Other|1
1132467|NCT02742649|2228292|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5
1132468|NCT02742649|2228293|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1132469|NCT02742649|2228294|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1132470|NCT02742649|2228295|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1132471|NCT02742649|2228296|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1132472|NCT02742649|2228292|FG000|Double-Blind Treatment Period|Adverse Event|0
1132473|NCT02742649|2228293|FG001|Double-Blind Treatment Period|Adverse Event|1
1132474|NCT02742649|2228294|FG002|Double-Blind Treatment Period|Adverse Event|0
1132475|NCT02742649|2228295|FG003|Double-Blind Treatment Period|Adverse Event|0
1132476|NCT02742649|2228296|FG004|Double-Blind Treatment Period|Adverse Event|0
1132477|NCT02742649|2228292|FG000|Open-Label Period|Lost to Follow-up|0
1132478|NCT02742649|2228293|FG001|Open-Label Period|Lost to Follow-up|0
1132479|NCT02742649|2228294|FG002|Open-Label Period|Lost to Follow-up|0
1132480|NCT02742649|2228295|FG003|Open-Label Period|Lost to Follow-up|0
1132481|NCT02742649|2228296|FG004|Open-Label Period|Lost to Follow-up|1
1132482|NCT02742818|2228406|FG000|Overall Study|Adverse Event|0
1132483|NCT02742818|2228407|FG001|Overall Study|Adverse Event|1
1132484|NCT02742818|2228406|FG000|Overall Study|Protocol Violation|0
1132485|NCT02742818|2228407|FG001|Overall Study|Protocol Violation|1
1132486|NCT02743117|2228430|FG000|Overall Study|Lost to Follow-up|0
1132487|NCT02743117|2228431|FG001|Overall Study|Lost to Follow-up|1
1132488|NCT02743117|2228430|FG000|Overall Study|Other|1
1132489|NCT02743117|2228431|FG001|Overall Study|Other|0
1132490|NCT02743221|2228439|FG000|Overall Study|Progressive disease|29
1132491|NCT02743221|2228440|FG001|Overall Study|Progressive disease|38
1132492|NCT02743221|2228439|FG000|Overall Study|Adverse Event|17
1132493|NCT02743221|2228440|FG001|Overall Study|Adverse Event|14
1132494|NCT02743221|2228439|FG000|Overall Study|non medical reason|8
1132495|NCT02743221|2228440|FG001|Overall Study|non medical reason|2
1132496|NCT02743221|2228439|FG000|Overall Study|Physician Decision|2
1132497|NCT02743221|2228440|FG001|Overall Study|Physician Decision|5
1132498|NCT02743221|2228439|FG000|Overall Study|Patient not eligible, not treated|0
1132499|NCT02743221|2228440|FG001|Overall Study|Patient not eligible, not treated|1
1132500|NCT02743494|2228480|FG000|Pre-treatment Period|Participant request to discontinue treatment|0
1132501|NCT02743494|2228481|FG001|Pre-treatment Period|Participant request to discontinue treatment|1
1132502|NCT02743494|2228480|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0
1132503|NCT02743494|2228481|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1
1132504|NCT02743494|2228480|FG000|Treatment Period|Completed treatment|229
1132505|NCT02743494|2228481|FG001|Treatment Period|Completed treatment|99
1132506|NCT02743494|2228480|FG000|Treatment Period|Disease recurrence|149
1132507|NCT02743494|2228481|FG001|Treatment Period|Disease recurrence|113
1132508|NCT02743494|2228480|FG000|Treatment Period|Study drug toxicity|57
1132509|NCT02743494|2228481|FG001|Treatment Period|Study drug toxicity|8
1132510|NCT02743494|2228480|FG000|Treatment Period|Death|1
1132511|NCT02743494|2228481|FG001|Treatment Period|Death|0
1132512|NCT02743494|2228480|FG000|Treatment Period|Adverse event unrelated to study drug|15
1132513|NCT02743494|2228481|FG001|Treatment Period|Adverse event unrelated to study drug|9
1132514|NCT02743494|2228480|FG000|Treatment Period|Participant request to discontinue treatment|30
1132515|NCT02743494|2228481|FG001|Treatment Period|Participant request to discontinue treatment|5
1132516|NCT02743494|2228480|FG000|Treatment Period|Participant withdrew consent|12
1132517|NCT02743494|2228481|FG001|Treatment Period|Participant withdrew consent|4
1132518|NCT02743494|2228480|FG000|Treatment Period|Lost to Follow-up|0
1132519|NCT02743494|2228481|FG001|Treatment Period|Lost to Follow-up|1
1132520|NCT02743494|2228480|FG000|Treatment Period|Poor/Non-compliance|1
1132521|NCT02743494|2228481|FG001|Treatment Period|Poor/Non-compliance|0
1132522|NCT02743494|2228480|FG000|Treatment Period|Other reasons|7
1132523|NCT02743494|2228481|FG001|Treatment Period|Other reasons|2
1132524|NCT02743520|2228487|FG000|Overall Study|Withdrawal by Subject|1
1132525|NCT02743780|2228505|FG000|Part 3 (7 Days)|Adverse Event|0
1132526|NCT02743780|2228506|FG001|Part 3 (7 Days)|Adverse Event|0
1132527|NCT02743780|2228507|FG002|Part 3 (7 Days)|Adverse Event|1
1132528|NCT02743780|2228508|FG003|Part 3 (7 Days)|Adverse Event|0
1132529|NCT02743780|2228509|FG004|Part 3 (7 Days)|Adverse Event|0
1132530|NCT02743793|2228531|FG000|Overall Study|Death|1
1132531|NCT02743793|2228532|FG001|Overall Study|Death|1
1132532|NCT02743793|2228531|FG000|Overall Study|Withdrawal by Subject|0
1132533|NCT02743793|2228532|FG001|Overall Study|Withdrawal by Subject|1
1132534|NCT02743793|2228531|FG000|Overall Study|Screen Failure|4
1132535|NCT02743793|2228532|FG001|Overall Study|Screen Failure|0
1132536|NCT02743793|2228531|FG000|Overall Study|No Primary Care Physician|0
1132537|NCT02743793|2228532|FG001|Overall Study|No Primary Care Physician|1
1132538|NCT02743793|2228531|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0
1132539|NCT02743793|2228532|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1
1132540|NCT02743793|2228531|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0
1132541|NCT02743793|2228532|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32
1132542|NCT02743949|2228549|FG000|Overall Study|Adverse Event|0
1132543|NCT02743949|2228550|FG001|Overall Study|Adverse Event|0
1132544|NCT02743949|2228551|FG002|Overall Study|Adverse Event|2
1132545|NCT02743949|2228549|FG000|Overall Study|Significant Protocol Deviation|2
1132546|NCT02743949|2228550|FG001|Overall Study|Significant Protocol Deviation|0
1132547|NCT02743949|2228551|FG002|Overall Study|Significant Protocol Deviation|1
1132548|NCT02743949|2228549|FG000|Overall Study|Voluntary Withdrawal|2
1132549|NCT02743949|2228550|FG001|Overall Study|Voluntary Withdrawal|1
1132550|NCT02743949|2228551|FG002|Overall Study|Voluntary Withdrawal|0
1132551|NCT02743962|2228561|FG000|Overall Study|Atrophic vaginitis diagnosed|1
1132552|NCT02743962|2228562|FG001|Overall Study|Atrophic vaginitis diagnosed|0
1132553|NCT02744066|2228573|FG000|Overall Study|Withdrawal by parent|0
1132554|NCT02744066|2228574|FG001|Overall Study|Withdrawal by parent|1
1132555|NCT02744066|2228573|FG000|Overall Study|Discharged from NICU prior to completion|0
1132556|NCT02744066|2228574|FG001|Overall Study|Discharged from NICU prior to completion|4
1132557|NCT02744391|2228582|FG000|Overall Study|Lost to Follow-up|9
1132558|NCT02744391|2228582|FG000|Overall Study|Physician Decision|2
1132559|NCT02744391|2228582|FG000|Overall Study|Withdrawal by Subject|3
1132560|NCT02744755|2228594|FG000|Study Period 1|Protocol Violation|2
1132561|NCT02744755|2228595|FG001|Study Period 1|Protocol Violation|1
1132562|NCT02744755|2228594|FG000|Study Period 1|not defined|0
1132563|NCT02744755|2228595|FG001|Study Period 1|not defined|1
1132564|NCT02744755|2228594|FG000|Study Period 1|Pregnancy|1
1132565|NCT02744755|2228595|FG001|Study Period 1|Pregnancy|0
1132566|NCT02744755|2228594|FG000|Study Period 1|Adverse Event|1
1132567|NCT02744755|2228595|FG001|Study Period 1|Adverse Event|1
1132568|NCT02744755|2228594|FG000|Study Period 1|Lost to Follow-up|1
1132569|NCT02744755|2228595|FG001|Study Period 1|Lost to Follow-up|1
1132570|NCT02744755|2228594|FG000|Study Period 1|Lack of Efficacy|1
1132571|NCT02744755|2228595|FG001|Study Period 1|Lack of Efficacy|0
1132572|NCT02744755|2228594|FG000|Study Period 1|Withdrawal by Subject|8
1132573|NCT02744755|2228595|FG001|Study Period 1|Withdrawal by Subject|4
1132574|NCT02744755|2228594|FG000|Study Period 2|Adverse Event|5
1132575|NCT02744755|2228595|FG001|Study Period 2|Adverse Event|0
1132576|NCT02744755|2228594|FG000|Study Period 2|Protocol Violation|1
1132577|NCT02744755|2228595|FG001|Study Period 2|Protocol Violation|0
1132578|NCT02744755|2228594|FG000|Study Period 2|not defined|3
1132579|NCT02744755|2228595|FG001|Study Period 2|not defined|2
1132580|NCT02744755|2228594|FG000|Study Period 2|Lost to Follow-up|0
1132581|NCT02744755|2228595|FG001|Study Period 2|Lost to Follow-up|2
1132582|NCT02744755|2228594|FG000|Study Period 2|Withdrawal by Subject|2
1132583|NCT02744755|2228595|FG001|Study Period 2|Withdrawal by Subject|2
1132584|NCT02744755|2228594|FG000|Study Period 2|Lack of Efficacy|3
1132585|NCT02744755|2228595|FG001|Study Period 2|Lack of Efficacy|2
1132586|NCT02744898|2228613|FG000|Overall Study|Progressive Disease|2
1132587|NCT02744898|2228613|FG000|Overall Study|Physician Decision|1
1132588|NCT02744898|2228613|FG000|Overall Study|Toxicity|1
1132589|NCT02745080|2228619|FG000|Overall Study|Adverse Event|13
1132590|NCT02745080|2228620|FG001|Overall Study|Adverse Event|21
1132591|NCT02745080|2228619|FG000|Overall Study|Lack of Efficacy|11
1132592|NCT02745080|2228620|FG001|Overall Study|Lack of Efficacy|23
1132593|NCT02745080|2228619|FG000|Overall Study|Lost to Follow-up|3
1132594|NCT02745080|2228620|FG001|Overall Study|Lost to Follow-up|3
1132595|NCT02745080|2228619|FG000|Overall Study|Physician Decision|3
1132596|NCT02745080|2228620|FG001|Overall Study|Physician Decision|0
1132597|NCT02745080|2228619|FG000|Overall Study|Protocol Violation|3
1132598|NCT02745080|2228620|FG001|Overall Study|Protocol Violation|1
1132599|NCT02745080|2228619|FG000|Overall Study|Withdrawal by Subject|22
1132600|NCT02745080|2228620|FG001|Overall Study|Withdrawal by Subject|41
1132601|NCT02745119|2228631|FG000|Overall Study|Adverse Event|1
1132602|NCT02745119|2228632|FG001|Overall Study|Adverse Event|0
1132603|NCT02745119|2228633|FG002|Overall Study|Adverse Event|1
1132604|NCT02745119|2228634|FG003|Overall Study|Adverse Event|3
1132605|NCT02745119|2228631|FG000|Overall Study|Death|3
1132606|NCT02745119|2228632|FG001|Overall Study|Death|3
1132607|NCT02745119|2228633|FG002|Overall Study|Death|0
1132608|NCT02745119|2228634|FG003|Overall Study|Death|4
1132609|NCT02745119|2228631|FG000|Overall Study|Lost to Follow-up|0
1132610|NCT02745119|2228632|FG001|Overall Study|Lost to Follow-up|0
1132611|NCT02745119|2228633|FG002|Overall Study|Lost to Follow-up|0
1132612|NCT02745119|2228634|FG003|Overall Study|Lost to Follow-up|1
1132613|NCT02745119|2228631|FG000|Overall Study|Protocol Deviation|0
1132614|NCT02745119|2228632|FG001|Overall Study|Protocol Deviation|0
1132615|NCT02745119|2228633|FG002|Overall Study|Protocol Deviation|0
1132616|NCT02745119|2228634|FG003|Overall Study|Protocol Deviation|1
1132617|NCT02745119|2228631|FG000|Overall Study|Withdrawal by Subject|7
1132618|NCT02745119|2228632|FG001|Overall Study|Withdrawal by Subject|15
1132619|NCT02745119|2228633|FG002|Overall Study|Withdrawal by Subject|8
1132620|NCT02745119|2228634|FG003|Overall Study|Withdrawal by Subject|14
1132621|NCT02745119|2228631|FG000|Overall Study|Study Terminated by Sponsor|134
1132622|NCT02745119|2228632|FG001|Overall Study|Study Terminated by Sponsor|252
1132623|NCT02745119|2228633|FG002|Overall Study|Study Terminated by Sponsor|135
1132624|NCT02745119|2228634|FG003|Overall Study|Study Terminated by Sponsor|251
1132625|NCT02745119|2228631|FG000|Overall Study|Physician Decision|0
1132626|NCT02745119|2228632|FG001|Overall Study|Physician Decision|2
1132627|NCT02745119|2228633|FG002|Overall Study|Physician Decision|2
1132628|NCT02745119|2228634|FG003|Overall Study|Physician Decision|2
1132629|NCT02745119|2228631|FG000|Overall Study|Reason Not Specified|0
1132630|NCT02745119|2228632|FG001|Overall Study|Reason Not Specified|2
1132631|NCT02745119|2228633|FG002|Overall Study|Reason Not Specified|0
1132632|NCT02745119|2228634|FG003|Overall Study|Reason Not Specified|1
1132633|NCT02745145|2228649|FG000|Overall Study|Adverse Event|1
1132634|NCT02745145|2228650|FG001|Overall Study|Adverse Event|0
1132635|NCT02745145|2228651|FG002|Overall Study|Adverse Event|0
1132636|NCT02745145|2228649|FG000|Overall Study|Death|0
1132637|NCT02745145|2228650|FG001|Overall Study|Death|1
1132638|NCT02745145|2228651|FG002|Overall Study|Death|0
1132639|NCT02745145|2228649|FG000|Overall Study|Progressive disease|0
1132640|NCT02745145|2228650|FG001|Overall Study|Progressive disease|0
1132641|NCT02745145|2228651|FG002|Overall Study|Progressive disease|1
1132642|NCT02745145|2228649|FG000|Overall Study|Withdrew consent|1
1132643|NCT02745145|2228650|FG001|Overall Study|Withdrew consent|1
1132644|NCT02745145|2228651|FG002|Overall Study|Withdrew consent|1
1132645|NCT02745145|2228649|FG000|Overall Study|Study Termination|8
1132646|NCT02745145|2228650|FG001|Overall Study|Study Termination|3
1132647|NCT02745145|2228651|FG002|Overall Study|Study Termination|7
1132648|NCT02745392|2228672|FG000|Overall Study|Lost to Follow-up|0
1132649|NCT02745392|2228673|FG001|Overall Study|Lost to Follow-up|1
1132650|NCT02745392|2228674|FG002|Overall Study|Lost to Follow-up|0
1132651|NCT02745392|2228675|FG003|Overall Study|Lost to Follow-up|0
1132652|NCT02745535|2228685|FG000|Overall Study|Death|1
1132653|NCT02745535|2228685|FG000|Overall Study|Adverse Event|3
1132654|NCT02745535|2228685|FG000|Overall Study|Lost to Follow-up|2
1132655|NCT02746575|2228721|FG000|Overall Study|Surgery cancelled or time chaned|13
1132656|NCT02746575|2228721|FG000|Overall Study|Received epidural|10
1132657|NCT02746575|2228721|FG000|Overall Study|Withdrawal by Subject|3
1132658|NCT02746575|2228721|FG000|Overall Study|Bradycardia/hypotension|9
1132659|NCT02746575|2228721|FG000|Overall Study|Study paused|8
1132660|NCT02746575|2228721|FG000|Overall Study|put on beta-blocker|3
1132661|NCT02746575|2228721|FG000|Overall Study|type of surgery|1
1132662|NCT02746575|2228721|FG000|Overall Study|typ of surgery|1
1132663|NCT02746575|2228721|FG000|Overall Study|PI unavailable|1
1132664|NCT02746575|2228721|FG000|Overall Study|Unknown history of CVA|1
1132665|NCT02746627|2228728|FG000|Overall Study|Withdrawal by Subject|1
1132666|NCT02746627|2228729|FG001|Overall Study|Withdrawal by Subject|1
1132667|NCT02746627|2228730|FG002|Overall Study|Withdrawal by Subject|1
1132668|NCT02746679|2228740|FG000|Overall Study|Lost to Follow-up|4
1132669|NCT02746679|2228741|FG001|Overall Study|Lost to Follow-up|6
1132670|NCT02746705|2228749|FG000|Overall Study|Physician Decision|1
1132671|NCT02746705|2228750|FG001|Overall Study|Physician Decision|1
1132672|NCT02746705|2228749|FG000|Overall Study|Lost to Follow-up|1
1132673|NCT02746705|2228750|FG001|Overall Study|Lost to Follow-up|0
1132674|NCT02746705|2228749|FG000|Overall Study|outlier scores deemed not valid|0
900174|NCT00726232|1873273|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
900175|NCT00726232|1873274|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
1132675|NCT02746705|2228750|FG001|Overall Study|outlier scores deemed not valid|1
1132676|NCT02746874|2228764|FG000|Overall Study|Withdrawal by Subject|0
1132677|NCT02746874|2228765|FG001|Overall Study|Withdrawal by Subject|1
1132678|NCT02746874|2228764|FG000|Overall Study|Surgery Date Changed|0
1132679|NCT02746874|2228765|FG001|Overall Study|Surgery Date Changed|2
1132680|NCT02747004|2228785|FG000|Overall Study|Withdrawal by Subject|8
1132681|NCT02747004|2228786|FG001|Overall Study|Withdrawal by Subject|5
1132682|NCT02747004|2228787|FG002|Overall Study|Withdrawal by Subject|4
1132683|NCT02747004|2228785|FG000|Overall Study|Lost to Follow-up|1
1132684|NCT02747004|2228786|FG001|Overall Study|Lost to Follow-up|2
1132685|NCT02747004|2228787|FG002|Overall Study|Lost to Follow-up|2
1132686|NCT02747004|2228785|FG000|Overall Study|on study treatment/follow-up|48
1132687|NCT02747004|2228786|FG001|Overall Study|on study treatment/follow-up|42
1132688|NCT02747004|2228787|FG002|Overall Study|on study treatment/follow-up|41
1132689|NCT02747043|2228797|FG000|Overall Study|Other|1
1132690|NCT02747043|2228798|FG001|Overall Study|Other|1
1132691|NCT02747043|2228797|FG000|Overall Study|Adverse Event|3
1132692|NCT02747043|2228798|FG001|Overall Study|Adverse Event|1
1132693|NCT02747043|2228797|FG000|Overall Study|Withdrawal by Subject|1
1132694|NCT02747043|2228798|FG001|Overall Study|Withdrawal by Subject|1
1132695|NCT02747043|2228797|FG000|Overall Study|Physician Decision|1
1132696|NCT02747043|2228798|FG001|Overall Study|Physician Decision|1
1132697|NCT02747043|2228797|FG000|Overall Study|Protocol Violation|0
1132698|NCT02747043|2228798|FG001|Overall Study|Protocol Violation|1
1132699|NCT02747043|2228797|FG000|Overall Study|Disease progression|4
1132700|NCT02747043|2228798|FG001|Overall Study|Disease progression|0
1132701|NCT02747108|2228806|FG000|Overall Study|Death|2
1132702|NCT02747108|2228807|FG001|Overall Study|Death|2
1132703|NCT02747108|2228806|FG000|Overall Study|Withdrawal by Subject|1
1132704|NCT02747108|2228807|FG001|Overall Study|Withdrawal by Subject|0
1132705|NCT02747108|2228806|FG000|Overall Study|Protocol Violation|2
1132706|NCT02747108|2228807|FG001|Overall Study|Protocol Violation|0
1132707|NCT02747238|2228829|FG000|Overall Study|Lack of Efficacy|0
1132708|NCT02747238|2228830|FG001|Overall Study|Lack of Efficacy|1
1132709|NCT02747238|2228829|FG000|Overall Study|Data lost|3
1132710|NCT02747238|2228830|FG001|Overall Study|Data lost|5
1132711|NCT02747420|2228838|FG000|Overall Study|Lost to Follow-up|4
1132712|NCT02747420|2228839|FG001|Overall Study|Lost to Follow-up|2
1132713|NCT02747420|2228838|FG000|Overall Study|Withdrawal by Subject|3
1132714|NCT02747420|2228839|FG001|Overall Study|Withdrawal by Subject|2
1132715|NCT02747875|2228881|FG000|Overall Study|Physician Decision|1
1132716|NCT02747875|2228882|FG001|Overall Study|Physician Decision|0
1132717|NCT02747875|2228881|FG000|Overall Study|Adverse Event|0
1132718|NCT02747875|2228882|FG001|Overall Study|Adverse Event|1
1132719|NCT02747927|2228890|FG000|Overall Study|Adverse Event|5
1132720|NCT02747927|2228891|FG001|Overall Study|Adverse Event|14
1132721|NCT02747927|2228890|FG000|Overall Study|Lost to Follow-up|22
1132722|NCT02747927|2228891|FG001|Overall Study|Lost to Follow-up|43
1132723|NCT02747927|2228890|FG000|Overall Study|Pregnancy|34
1132724|NCT02747927|2228891|FG001|Overall Study|Pregnancy|66
1132725|NCT02747927|2228890|FG000|Overall Study|Protocol Violation|2
1132726|NCT02747927|2228891|FG001|Overall Study|Protocol Violation|4
1132727|NCT02747927|2228890|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147
1132728|NCT02747927|2228891|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304
1132729|NCT02747927|2228890|FG000|Overall Study|Reason not Specified|11
1132730|NCT02747927|2228891|FG001|Overall Study|Reason not Specified|27
1132731|NCT02748057|2228899|FG000|Overall Study|Adverse Event|1
1132732|NCT02748057|2228900|FG001|Overall Study|Adverse Event|0
1132733|NCT02748057|2228899|FG000|Overall Study|Physician Decision|0
1132734|NCT02748057|2228900|FG001|Overall Study|Physician Decision|1
1132735|NCT02748057|2228899|FG000|Overall Study|Protocol Violation|2
1132736|NCT02748057|2228900|FG001|Overall Study|Protocol Violation|1
1132737|NCT02748057|2228899|FG000|Overall Study|Participant Moved|1
1132738|NCT02748057|2228900|FG001|Overall Study|Participant Moved|0
1132739|NCT02748057|2228899|FG000|Overall Study|Withdrawal by Subject|1
1132740|NCT02748057|2228900|FG001|Overall Study|Withdrawal by Subject|0
1132741|NCT02748213|2228926|FG000|Overall Study|Withdrawal Prior to Treatment|1
900176|NCT00726232|1873275|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
1132742|NCT02748213|2228927|FG001|Overall Study|Withdrawal Prior to Treatment|2
1132743|NCT02748213|2228926|FG000|Overall Study|Abnormal Laboratory Test|1
1132744|NCT02748213|2228927|FG001|Overall Study|Abnormal Laboratory Test|0
1132745|NCT02748213|2228926|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
1132746|NCT02748213|2228927|FG001|Overall Study|Adverse Event or Intercurrent Illness|11
1132747|NCT02748213|2228926|FG000|Overall Study|Death|5
1132748|NCT02748213|2228927|FG001|Overall Study|Death|3
1132749|NCT02748213|2228926|FG000|Overall Study|Insufficient Therapeutic Response|56
1132750|NCT02748213|2228927|FG001|Overall Study|Insufficient Therapeutic Response|57
1132751|NCT02748213|2228926|FG000|Overall Study|Violation of Selection Criteria|2
1132752|NCT02748213|2228927|FG001|Overall Study|Violation of Selection Criteria|0
1132753|NCT02748213|2228926|FG000|Overall Study|Protocol Violation|6
1132754|NCT02748213|2228927|FG001|Overall Study|Protocol Violation|4
1132755|NCT02748213|2228926|FG000|Overall Study|Refused Treatment*|6
1132756|NCT02748213|2228927|FG001|Overall Study|Refused Treatment*|6
1132757|NCT02748213|2228926|FG000|Overall Study|Failure to Return|1
1132758|NCT02748213|2228927|FG001|Overall Study|Failure to Return|0
1132759|NCT02748213|2228926|FG000|Overall Study|Other|30
1132760|NCT02748213|2228927|FG001|Overall Study|Other|29
1132761|NCT02748317|2228933|FG000|Overall Study|Withdrawal by Subject|14
1132762|NCT02748317|2228933|FG000|Overall Study|Lost to Follow-up|8
1132763|NCT02748317|2228933|FG000|Overall Study|Death|1
1132764|NCT02748356|2228937|FG000|Overall Study|Withdrawal by Subject|1
1132765|NCT02748512|2228943|FG000|Overall Study|Lost to Follow-up|1
1132766|NCT02748512|2228944|FG001|Overall Study|Lost to Follow-up|1
1132771|NCT02748694|2228973|FG000|Overall Study|Voluntary Withdrawal|0
1132772|NCT02748694|2228974|FG001|Overall Study|Voluntary Withdrawal|0
1132773|NCT02748694|2228975|FG002|Overall Study|Voluntary Withdrawal|0
1132774|NCT02748694|2228976|FG003|Overall Study|Voluntary Withdrawal|0
1132775|NCT02748694|2228977|FG004|Overall Study|Voluntary Withdrawal|0
1132776|NCT02748694|2228978|FG005|Overall Study|Voluntary Withdrawal|0
1132777|NCT02748694|2228979|FG006|Overall Study|Voluntary Withdrawal|0
1132778|NCT02748694|2228980|FG007|Overall Study|Voluntary Withdrawal|0
1132779|NCT02748694|2228981|FG008|Overall Study|Voluntary Withdrawal|0
1132780|NCT02748694|2228982|FG009|Overall Study|Voluntary Withdrawal|0
1132781|NCT02748694|2228983|FG010|Overall Study|Voluntary Withdrawal|0
1132782|NCT02748694|2228984|FG011|Overall Study|Voluntary Withdrawal|0
1132783|NCT02748694|2228985|FG012|Overall Study|Voluntary Withdrawal|0
1132784|NCT02748694|2228986|FG013|Overall Study|Voluntary Withdrawal|0
1132785|NCT02748694|2228987|FG014|Overall Study|Voluntary Withdrawal|2
1132786|NCT02748863|2229063|FG000|Treatment Period 1|Adverse Event|0
1132787|NCT02748863|2229064|FG001|Treatment Period 1|Adverse Event|1
1132788|NCT02748863|2229065|FG002|Treatment Period 1|Adverse Event|0
1132789|NCT02748863|2229066|FG003|Treatment Period 1|Adverse Event|0
1132790|NCT02748863|2229067|FG004|Treatment Period 1|Adverse Event|0
1132791|NCT02748863|2229063|FG000|Treatment Period 1|Lack of Efficacy|0
1132792|NCT02748863|2229064|FG001|Treatment Period 1|Lack of Efficacy|0
1132793|NCT02748863|2229065|FG002|Treatment Period 1|Lack of Efficacy|1
1132794|NCT02748863|2229066|FG003|Treatment Period 1|Lack of Efficacy|0
1132795|NCT02748863|2229067|FG004|Treatment Period 1|Lack of Efficacy|0
1132796|NCT02748863|2229063|FG000|Treatment Period 1|Withdrawal by Subject|0
1132797|NCT02748863|2229064|FG001|Treatment Period 1|Withdrawal by Subject|1
1132798|NCT02748863|2229065|FG002|Treatment Period 1|Withdrawal by Subject|1
1132799|NCT02748863|2229066|FG003|Treatment Period 1|Withdrawal by Subject|0
1132800|NCT02748863|2229067|FG004|Treatment Period 1|Withdrawal by Subject|0
1132801|NCT02748863|2229063|FG000|Treatment Period 2|Lost to Follow-up|2
1132802|NCT02748863|2229064|FG001|Treatment Period 2|Lost to Follow-up|0
1132803|NCT02748863|2229065|FG002|Treatment Period 2|Lost to Follow-up|0
1132804|NCT02748863|2229066|FG003|Treatment Period 2|Lost to Follow-up|0
1132805|NCT02748863|2229067|FG004|Treatment Period 2|Lost to Follow-up|0
1132806|NCT02748863|2229063|FG000|Treatment Period 2|Adverse Event|3
1132807|NCT02748863|2229064|FG001|Treatment Period 2|Adverse Event|2
1132808|NCT02748863|2229065|FG002|Treatment Period 2|Adverse Event|0
1132809|NCT02748863|2229066|FG003|Treatment Period 2|Adverse Event|2
1132810|NCT02748863|2229067|FG004|Treatment Period 2|Adverse Event|0
1132811|NCT02748863|2229063|FG000|Treatment Period 2|Lack of Efficacy|0
1132812|NCT02748863|2229064|FG001|Treatment Period 2|Lack of Efficacy|1
1132813|NCT02748863|2229065|FG002|Treatment Period 2|Lack of Efficacy|0
1132814|NCT02748863|2229066|FG003|Treatment Period 2|Lack of Efficacy|0
1132815|NCT02748863|2229067|FG004|Treatment Period 2|Lack of Efficacy|0
1132816|NCT02748863|2229063|FG000|Treatment Period 2|Pregnancy|0
1132817|NCT02748863|2229064|FG001|Treatment Period 2|Pregnancy|0
1132818|NCT02748863|2229065|FG002|Treatment Period 2|Pregnancy|0
1132819|NCT02748863|2229066|FG003|Treatment Period 2|Pregnancy|0
1132820|NCT02748863|2229067|FG004|Treatment Period 2|Pregnancy|1
1132821|NCT02749370|2229098|FG000|Overall Study|Withdrawal by Subject|11
1132822|NCT02749370|2229098|FG000|Overall Study|Lost to Follow-up|3
1132823|NCT02749721|2229102|FG000|Screening|Withdrawal by Subject|1
1132824|NCT02749721|2229102|FG000|Screening|Lost to Follow-up|2
1132825|NCT02749721|2229102|FG000|Screening|Protocol Violation|3
1132826|NCT02749721|2229102|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2
1132827|NCT02749721|2229102|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1
1132828|NCT02749799|2229108|FG000|Overall Study|Adverse Event|2
1132829|NCT02749799|2229108|FG000|Overall Study|Lost to Follow-up|4
1132830|NCT02749799|2229108|FG000|Overall Study|Protocol Violation|1
1132831|NCT02749799|2229108|FG000|Overall Study|Withdrawal by Subject|1
1132832|NCT02750306|2229129|FG000|Overall Study|Withdrawal by Subject|5
1132833|NCT02750306|2229130|FG001|Overall Study|Withdrawal by Subject|2
1132834|NCT02750306|2229129|FG000|Overall Study|Protocol Violation|1
1132835|NCT02750306|2229130|FG001|Overall Study|Protocol Violation|0
1132836|NCT02750332|2229136|FG000|Treatment Period 1|Withdrawal by Subject|0
1132837|NCT02750332|2229137|FG001|Treatment Period 1|Withdrawal by Subject|1
1132838|NCT02750345|2229143|FG000|Intervention 1|Adverse Event|0
1132839|NCT02750345|2229144|FG001|Intervention 1|Adverse Event|0
1132840|NCT02750345|2229145|FG002|Intervention 1|Adverse Event|0
1132841|NCT02750345|2229146|FG003|Intervention 1|Adverse Event|0
1132842|NCT02750345|2229147|FG004|Intervention 1|Adverse Event|1
1132843|NCT02750345|2229148|FG005|Intervention 1|Adverse Event|0
1132844|NCT02750410|2229160|FG000|Double-Blind Treatment Period|Adverse Event|2
1132845|NCT02750410|2229161|FG001|Double-Blind Treatment Period|Adverse Event|2
1132846|NCT02750410|2229160|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
1132847|NCT02750410|2229161|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
1132848|NCT02750410|2229160|FG000|Open-Label Extension Period|Adverse Event|5
1132849|NCT02750410|2229161|FG001|Open-Label Extension Period|Adverse Event|3
1132850|NCT02750410|2229160|FG000|Open-Label Extension Period|Protocol Violation|0
1132851|NCT02750410|2229161|FG001|Open-Label Extension Period|Protocol Violation|1
1132852|NCT02750410|2229160|FG000|Open-Label Extension Period|Withdrawal by Subject|1
1132853|NCT02750410|2229161|FG001|Open-Label Extension Period|Withdrawal by Subject|2
1132854|NCT02750501|2229171|FG000|Overall Study|Adverse Event|4
1132855|NCT02750501|2229171|FG000|Overall Study|Physician Decision|1
1132856|NCT02750501|2229171|FG000|Overall Study|Protocol Violation|1
1132857|NCT02750501|2229171|FG000|Overall Study|G-tube came out|1
1132858|NCT02750501|2229171|FG000|Overall Study|Non-compliant use of PERT|1
1132859|NCT02750514|2229184|FG000|Track 1|Disease progression|20
1132860|NCT02750514|2229185|FG001|Track 1|Disease progression|1
1132861|NCT02750514|2229186|FG002|Track 1|Disease progression|0
1132862|NCT02750514|2229187|FG003|Track 1|Disease progression|1
1132863|NCT02750514|2229188|FG004|Track 1|Disease progression|0
1132864|NCT02750514|2229184|FG000|Track 1|Adverse event unrelated to study drug|1
1132865|NCT02750514|2229185|FG001|Track 1|Adverse event unrelated to study drug|0
1132866|NCT02750514|2229186|FG002|Track 1|Adverse event unrelated to study drug|0
1132867|NCT02750514|2229187|FG003|Track 1|Adverse event unrelated to study drug|0
1132868|NCT02750514|2229188|FG004|Track 1|Adverse event unrelated to study drug|0
1132869|NCT02750514|2229184|FG000|Track 1|Study drug toxicity|4
1132870|NCT02750514|2229185|FG001|Track 1|Study drug toxicity|1
1132871|NCT02750514|2229186|FG002|Track 1|Study drug toxicity|0
1132872|NCT02750514|2229187|FG003|Track 1|Study drug toxicity|1
1132873|NCT02750514|2229188|FG004|Track 1|Study drug toxicity|0
1132874|NCT02750514|2229184|FG000|Track 1|Participant request to discontinue|1
1132875|NCT02750514|2229185|FG001|Track 1|Participant request to discontinue|0
1132876|NCT02750514|2229186|FG002|Track 1|Participant request to discontinue|0
1132877|NCT02750514|2229187|FG003|Track 1|Participant request to discontinue|0
1132878|NCT02750514|2229188|FG004|Track 1|Participant request to discontinue|0
1132879|NCT02750514|2229184|FG000|Track 1|Other reasons|1
1132880|NCT02750514|2229185|FG001|Track 1|Other reasons|0
1132881|NCT02750514|2229186|FG002|Track 1|Other reasons|0
1132882|NCT02750514|2229187|FG003|Track 1|Other reasons|0
1132883|NCT02750514|2229188|FG004|Track 1|Other reasons|0
1132884|NCT02750514|2229184|FG000|Track 2|Disease progression|4
1132885|NCT02750514|2229185|FG001|Track 2|Disease progression|5
1132886|NCT02750514|2229186|FG002|Track 2|Disease progression|2
1132887|NCT02750514|2229187|FG003|Track 2|Disease progression|5
1132888|NCT02750514|2229188|FG004|Track 2|Disease progression|0
1132889|NCT02750514|2229184|FG000|Track 2|Adverse event unrelated to study drug|1
1132890|NCT02750514|2229185|FG001|Track 2|Adverse event unrelated to study drug|0
1132891|NCT02750514|2229186|FG002|Track 2|Adverse event unrelated to study drug|0
1132892|NCT02750514|2229187|FG003|Track 2|Adverse event unrelated to study drug|0
1132893|NCT02750514|2229188|FG004|Track 2|Adverse event unrelated to study drug|0
1132894|NCT02750514|2229184|FG000|Track 2|Study drug toxicity|1
1132895|NCT02750514|2229185|FG001|Track 2|Study drug toxicity|2
1132896|NCT02750514|2229186|FG002|Track 2|Study drug toxicity|0
1132897|NCT02750514|2229187|FG003|Track 2|Study drug toxicity|2
1132898|NCT02750514|2229188|FG004|Track 2|Study drug toxicity|0
1132899|NCT02750514|2229184|FG000|Track 2|Participant withdrew consent|0
1132900|NCT02750514|2229185|FG001|Track 2|Participant withdrew consent|1
1132901|NCT02750514|2229186|FG002|Track 2|Participant withdrew consent|0
1132902|NCT02750514|2229187|FG003|Track 2|Participant withdrew consent|0
1132903|NCT02750514|2229188|FG004|Track 2|Participant withdrew consent|0
1132904|NCT02750514|2229184|FG000|Track 3|Disease progression|0
1132905|NCT02750514|2229185|FG001|Track 3|Disease progression|24
1132906|NCT02750514|2229186|FG002|Track 3|Disease progression|13
1132907|NCT02750514|2229187|FG003|Track 3|Disease progression|14
1132908|NCT02750514|2229188|FG004|Track 3|Disease progression|0
1132909|NCT02750514|2229184|FG000|Track 3|Adverse event unrelated to study drug|0
1132910|NCT02750514|2229185|FG001|Track 3|Adverse event unrelated to study drug|1
1132911|NCT02750514|2229186|FG002|Track 3|Adverse event unrelated to study drug|1
1132912|NCT02750514|2229187|FG003|Track 3|Adverse event unrelated to study drug|1
1132913|NCT02750514|2229188|FG004|Track 3|Adverse event unrelated to study drug|0
1132914|NCT02750514|2229184|FG000|Track 3|Study drug toxicity|0
1132915|NCT02750514|2229185|FG001|Track 3|Study drug toxicity|3
1132916|NCT02750514|2229186|FG002|Track 3|Study drug toxicity|0
1132917|NCT02750514|2229187|FG003|Track 3|Study drug toxicity|1
1132918|NCT02750514|2229188|FG004|Track 3|Study drug toxicity|0
1132919|NCT02750514|2229184|FG000|Track 3|Participant request to discontinue|0
1132920|NCT02750514|2229185|FG001|Track 3|Participant request to discontinue|2
1132921|NCT02750514|2229186|FG002|Track 3|Participant request to discontinue|0
1132922|NCT02750514|2229187|FG003|Track 3|Participant request to discontinue|0
1132923|NCT02750514|2229188|FG004|Track 3|Participant request to discontinue|0
1132924|NCT02750514|2229184|FG000|Track 3|Participant withdrew consent|0
1132925|NCT02750514|2229185|FG001|Track 3|Participant withdrew consent|3
1132926|NCT02750514|2229186|FG002|Track 3|Participant withdrew consent|1
1132927|NCT02750514|2229187|FG003|Track 3|Participant withdrew consent|0
1132928|NCT02750514|2229188|FG004|Track 3|Participant withdrew consent|0
1132929|NCT02750514|2229184|FG000|Track 3|Other reasons|0
1132930|NCT02750514|2229185|FG001|Track 3|Other reasons|3
1132931|NCT02750514|2229186|FG002|Track 3|Other reasons|0
1132932|NCT02750514|2229187|FG003|Track 3|Other reasons|0
1132933|NCT02750514|2229188|FG004|Track 3|Other reasons|0
1132934|NCT02750514|2229184|FG000|Track 4|Study drug toxicity|0
1132935|NCT02750514|2229185|FG001|Track 4|Study drug toxicity|6
1132936|NCT02750514|2229186|FG002|Track 4|Study drug toxicity|0
1132937|NCT02750514|2229187|FG003|Track 4|Study drug toxicity|5
1132938|NCT02750514|2229188|FG004|Track 4|Study drug toxicity|0
1132939|NCT02750514|2229184|FG000|Track 4|Participant request to discontinue|0
1132940|NCT02750514|2229185|FG001|Track 4|Participant request to discontinue|1
1132941|NCT02750514|2229186|FG002|Track 4|Participant request to discontinue|0
1132942|NCT02750514|2229187|FG003|Track 4|Participant request to discontinue|1
1132943|NCT02750514|2229188|FG004|Track 4|Participant request to discontinue|0
1132944|NCT02750514|2229184|FG000|Track 4|Participant withdrew consent|0
1132945|NCT02750514|2229185|FG001|Track 4|Participant withdrew consent|1
1132946|NCT02750514|2229186|FG002|Track 4|Participant withdrew consent|0
1132947|NCT02750514|2229187|FG003|Track 4|Participant withdrew consent|0
1132948|NCT02750514|2229188|FG004|Track 4|Participant withdrew consent|0
1132949|NCT02750514|2229184|FG000|Track 4|Other reasons|0
1132950|NCT02750514|2229185|FG001|Track 4|Other reasons|5
1132951|NCT02750514|2229186|FG002|Track 4|Other reasons|0
1132952|NCT02750514|2229187|FG003|Track 4|Other reasons|3
1132953|NCT02750514|2229188|FG004|Track 4|Other reasons|0
1132954|NCT02750514|2229184|FG000|Track 4|Disease progression|0
1132955|NCT02750514|2229185|FG001|Track 4|Disease progression|33
1132956|NCT02750514|2229186|FG002|Track 4|Disease progression|0
1132957|NCT02750514|2229187|FG003|Track 4|Disease progression|32
1132958|NCT02750514|2229188|FG004|Track 4|Disease progression|0
1132959|NCT02750514|2229184|FG000|Track 4|Adverse event unrelated to study drug|0
1132960|NCT02750514|2229185|FG001|Track 4|Adverse event unrelated to study drug|5
1132961|NCT02750514|2229186|FG002|Track 4|Adverse event unrelated to study drug|0
1132962|NCT02750514|2229187|FG003|Track 4|Adverse event unrelated to study drug|0
1132963|NCT02750514|2229188|FG004|Track 4|Adverse event unrelated to study drug|0
1132964|NCT02750514|2229184|FG000|Track 4|Death|0
1132965|NCT02750514|2229185|FG001|Track 4|Death|0
1132966|NCT02750514|2229186|FG002|Track 4|Death|0
1132967|NCT02750514|2229187|FG003|Track 4|Death|1
1132968|NCT02750514|2229188|FG004|Track 4|Death|0
1132969|NCT02750514|2229184|FG000|Track 5|Disease progression|0
1132970|NCT02750514|2229185|FG001|Track 5|Disease progression|0
1132971|NCT02750514|2229186|FG002|Track 5|Disease progression|0
1132972|NCT02750514|2229187|FG003|Track 5|Disease progression|0
1132973|NCT02750514|2229188|FG004|Track 5|Disease progression|34
1132974|NCT02750514|2229184|FG000|Track 5|Adverse event unrelated to study drug|0
1132975|NCT02750514|2229185|FG001|Track 5|Adverse event unrelated to study drug|0
1132976|NCT02750514|2229186|FG002|Track 5|Adverse event unrelated to study drug|0
1132977|NCT02750514|2229187|FG003|Track 5|Adverse event unrelated to study drug|0
1132978|NCT02750514|2229188|FG004|Track 5|Adverse event unrelated to study drug|2
1132979|NCT02750514|2229184|FG000|Track 5|Study drug toxicity|0
1132980|NCT02750514|2229185|FG001|Track 5|Study drug toxicity|0
1132981|NCT02750514|2229186|FG002|Track 5|Study drug toxicity|0
1132982|NCT02750514|2229187|FG003|Track 5|Study drug toxicity|0
1132983|NCT02750514|2229188|FG004|Track 5|Study drug toxicity|2
1132984|NCT02750514|2229184|FG000|Track 5|Participant request to discontinue|0
1132985|NCT02750514|2229185|FG001|Track 5|Participant request to discontinue|0
1132986|NCT02750514|2229186|FG002|Track 5|Participant request to discontinue|0
1132987|NCT02750514|2229187|FG003|Track 5|Participant request to discontinue|0
1132988|NCT02750514|2229188|FG004|Track 5|Participant request to discontinue|3
1132989|NCT02750514|2229184|FG000|Track 5|Other reasons|0
1132990|NCT02750514|2229185|FG001|Track 5|Other reasons|0
1132991|NCT02750514|2229186|FG002|Track 5|Other reasons|0
1132992|NCT02750514|2229187|FG003|Track 5|Other reasons|0
1132993|NCT02750514|2229188|FG004|Track 5|Other reasons|2
1132994|NCT02750592|2229208|FG000|Overall Study|Adverse Event|3
1132995|NCT02750592|2229208|FG000|Overall Study|Lack of Efficacy|2
900177|NCT00726232|1873276|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
900178|NCT00726232|1873277|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
900179|NCT00726232|1873270|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
900180|NCT00726232|1873271|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
900181|NCT00726232|1873272|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
900182|NCT00726232|1873273|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
900183|NCT00726232|1873274|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
1132996|NCT02750618|2229212|FG000|Overall Study|Withdrawal by Subject|1
1132997|NCT02750709|2229216|FG000|Treatment Period 1|Adverse Event|0
1132998|NCT02750709|2229217|FG001|Treatment Period 1|Adverse Event|0
1132999|NCT02750709|2229218|FG002|Treatment Period 1|Adverse Event|0
1133000|NCT02750709|2229219|FG003|Treatment Period 1|Adverse Event|0
1133001|NCT02750709|2229220|FG004|Treatment Period 1|Adverse Event|0
1133002|NCT02750709|2229221|FG005|Treatment Period 1|Adverse Event|1
1133003|NCT02750761|2229235|FG000|Overall Study|Lost to Follow-up|0
1133004|NCT02750761|2229236|FG001|Overall Study|Lost to Follow-up|0
1133005|NCT02750761|2229237|FG002|Overall Study|Lost to Follow-up|1
1133006|NCT02750761|2229238|FG003|Overall Study|Lost to Follow-up|0
1133007|NCT02750761|2229239|FG004|Overall Study|Lost to Follow-up|0
1133008|NCT02750761|2229240|FG005|Overall Study|Lost to Follow-up|0
1133009|NCT02750800|2229264|FG000|Overall Study|Adverse Event|18
1133010|NCT02750800|2229264|FG000|Overall Study|Lost to Follow-up|12
1133011|NCT02750800|2229264|FG000|Overall Study|Investigator decision|53
1133012|NCT02750800|2229264|FG000|Overall Study|Patient request|12
1133013|NCT02750800|2229264|FG000|Overall Study|Other, not specified|3
1133014|NCT02750813|2229282|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
1133015|NCT02750813|2229283|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
1133016|NCT02750813|2229282|FG000|Period 1, First 14 Days of Wear|Reason not given|0
1133017|NCT02750813|2229283|FG001|Period 1, First 14 Days of Wear|Reason not given|1
1133018|NCT02750930|2229290|FG000|Overall Study|Study closed/terminated|8
1133019|NCT02750943|2229296|FG000|Overall Study|Lost to Follow-up|1
1133020|NCT02750943|2229297|FG001|Overall Study|Lost to Follow-up|2
1133021|NCT02750943|2229296|FG000|Overall Study|Withdrawal by Subject|5
1133022|NCT02750943|2229297|FG001|Overall Study|Withdrawal by Subject|7
1133023|NCT02751320|2229303|FG000|Overall Study|Adverse Event|2
1133024|NCT02751320|2229303|FG000|Overall Study|Withdrawal by Subject|1
1133025|NCT02751359|2229328|FG000|Overall Study|Lost to Follow-up|1
1133026|NCT02751424|2229356|FG000|Part 2|Adverse Event|0
1133027|NCT02751424|2229357|FG001|Part 2|Adverse Event|0
1133028|NCT02751424|2229358|FG002|Part 2|Adverse Event|0
1133029|NCT02751424|2229359|FG003|Part 2|Adverse Event|0
1133030|NCT02751424|2229360|FG004|Part 2|Adverse Event|0
1133031|NCT02751424|2229361|FG005|Part 2|Adverse Event|0
1133032|NCT02751424|2229362|FG006|Part 2|Adverse Event|0
1133033|NCT02751424|2229363|FG007|Part 2|Adverse Event|5
1133034|NCT02751424|2229364|FG008|Part 2|Adverse Event|0
1133035|NCT02751450|2229389|FG000|Overall Study|Adverse Event|1
1133036|NCT02751450|2229390|FG001|Overall Study|Adverse Event|0
1133037|NCT02751580|2229398|FG000|Overall Study|Lost to Follow-up|4
1133038|NCT02751580|2229398|FG000|Overall Study|Death|2
1133039|NCT02751827|2229405|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
1133040|NCT02751827|2229406|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
1133041|NCT02751827|2229407|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1
1133042|NCT02751931|2229429|FG000|Overall Study|Adverse Event|3
1133043|NCT02751931|2229430|FG001|Overall Study|Adverse Event|0
1133044|NCT02751931|2229429|FG000|Overall Study|Other: Miscelleneous|10
1133045|NCT02751931|2229430|FG001|Overall Study|Other: Miscelleneous|8
1133046|NCT02751983|2229444|FG000|Treatment|Stopped ACT, but Remained in study|2
1133047|NCT02751983|2229445|FG001|Treatment|Stopped ACT, but Remained in study|0
1133048|NCT02751983|2229444|FG000|Treatment|Discharged prior to beginning ACT|2
1133049|NCT02751983|2229445|FG001|Treatment|Discharged prior to beginning ACT|0
1133050|NCT02751983|2229444|FG000|Post-Treatment Assessment|Lost to Follow-up|5
1133051|NCT02751983|2229445|FG001|Post-Treatment Assessment|Lost to Follow-up|0
1133052|NCT02751983|2229444|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14
1133053|NCT02751983|2229445|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12
1133054|NCT02751983|2229444|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12
1133055|NCT02751983|2229445|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16
1133056|NCT02752048|2229454|FG000|Overall Study|Withdrawal by Subject|0
1133057|NCT02752048|2229455|FG001|Overall Study|Withdrawal by Subject|0
1133058|NCT02752048|2229456|FG002|Overall Study|Withdrawal by Subject|3
1133059|NCT02752074|2229466|FG000|Overall Study|Lost to Follow-up|1
1133060|NCT02752074|2229467|FG001|Overall Study|Lost to Follow-up|4
1133061|NCT02752074|2229466|FG000|Overall Study|Death|146
1133062|NCT02752074|2229467|FG001|Overall Study|Death|129
1133063|NCT02752074|2229466|FG000|Overall Study|Withdrawal by Subject|9
1133064|NCT02752074|2229467|FG001|Overall Study|Withdrawal by Subject|10
1133065|NCT02752087|2229473|FG000|Washout|Physician Decision|1
1133066|NCT02752087|2229474|FG001|Washout|Physician Decision|0
1133067|NCT02752633|2229498|FG000|Overall Study|Withdrawal by Subject|1
1133068|NCT02752776|2229505|FG000|Overall Study|Adverse Event|15
1133069|NCT02752776|2229506|FG001|Overall Study|Adverse Event|23
1133070|NCT02752776|2229507|FG002|Overall Study|Adverse Event|11
1133071|NCT02752776|2229505|FG000|Overall Study|Lack of Efficacy|2
1133072|NCT02752776|2229506|FG001|Overall Study|Lack of Efficacy|6
1133073|NCT02752776|2229507|FG002|Overall Study|Lack of Efficacy|14
1133074|NCT02752776|2229505|FG000|Overall Study|Lost to Follow-up|11
1133075|NCT02752776|2229506|FG001|Overall Study|Lost to Follow-up|12
1133076|NCT02752776|2229507|FG002|Overall Study|Lost to Follow-up|4
1133077|NCT02752776|2229505|FG000|Overall Study|Non-compliance with study treatment|0
1133078|NCT02752776|2229506|FG001|Overall Study|Non-compliance with study treatment|0
1133079|NCT02752776|2229507|FG002|Overall Study|Non-compliance with study treatment|1
1133080|NCT02752776|2229505|FG000|Overall Study|Physician Decision|2
1133081|NCT02752776|2229506|FG001|Overall Study|Physician Decision|6
1133082|NCT02752776|2229507|FG002|Overall Study|Physician Decision|2
1133083|NCT02752776|2229505|FG000|Overall Study|Pregnancy|1
1133084|NCT02752776|2229506|FG001|Overall Study|Pregnancy|6
1133085|NCT02752776|2229507|FG002|Overall Study|Pregnancy|3
1133086|NCT02752776|2229505|FG000|Overall Study|Protocol Violation|10
1133087|NCT02752776|2229506|FG001|Overall Study|Protocol Violation|13
1133088|NCT02752776|2229507|FG002|Overall Study|Protocol Violation|6
1133089|NCT02752776|2229505|FG000|Overall Study|Subject/guardian decision|8
1133090|NCT02752776|2229506|FG001|Overall Study|Subject/guardian decision|6
1133091|NCT02752776|2229507|FG002|Overall Study|Subject/guardian decision|4
1133092|NCT02752776|2229505|FG000|Overall Study|Death|0
1133093|NCT02752776|2229506|FG001|Overall Study|Death|0
1133094|NCT02752776|2229507|FG002|Overall Study|Death|1
1133095|NCT02752776|2229505|FG000|Overall Study|Withdrawal by Subject|3
1133096|NCT02752776|2229506|FG001|Overall Study|Withdrawal by Subject|4
1133097|NCT02752776|2229507|FG002|Overall Study|Withdrawal by Subject|2
1133098|NCT02752802|2229519|FG000|Overall Study|Contrast Volume Not Collected|1
1133099|NCT02752802|2229520|FG001|Overall Study|Contrast Volume Not Collected|0
1133100|NCT02752906|2229540|FG000|Overall Study|Protocol Violation|2
1133101|NCT02752906|2229541|FG001|Overall Study|Protocol Violation|1
1133102|NCT02752906|2229540|FG000|Overall Study|Withdrawal by Subject|2
1133103|NCT02752906|2229541|FG001|Overall Study|Withdrawal by Subject|2
1133104|NCT02752906|2229540|FG000|Overall Study|Lost to Follow-up|3
1133105|NCT02752906|2229541|FG001|Overall Study|Lost to Follow-up|2
1133106|NCT02752958|2229547|FG000|Overall Study|Adverse Event|3
1133107|NCT02752958|2229547|FG000|Overall Study|Lost to Follow-up|1
1133108|NCT02752958|2229547|FG000|Overall Study|Protocol Violation|1
1133109|NCT02752958|2229547|FG000|Overall Study|Withdrawal by Subject|2
1133110|NCT02752958|2229547|FG000|Overall Study|Other (Reason not specified)|2
1133111|NCT02753075|2229556|FG000|Overall Study|Adverse Event|2
1133112|NCT02753075|2229557|FG001|Overall Study|Adverse Event|1
1133113|NCT02753075|2229558|FG002|Overall Study|Adverse Event|0
1133114|NCT02753075|2229556|FG000|Overall Study|Lost to Follow-up|2
1133115|NCT02753075|2229557|FG001|Overall Study|Lost to Follow-up|0
1133116|NCT02753075|2229558|FG002|Overall Study|Lost to Follow-up|0
1133117|NCT02753075|2229556|FG000|Overall Study|Withdrawal of Consent|1
1133118|NCT02753075|2229557|FG001|Overall Study|Withdrawal of Consent|1
1133119|NCT02753075|2229558|FG002|Overall Study|Withdrawal of Consent|3
1133120|NCT02753075|2229556|FG000|Overall Study|Physician Decision|3
1133121|NCT02753075|2229557|FG001|Overall Study|Physician Decision|1
1133122|NCT02753075|2229558|FG002|Overall Study|Physician Decision|0
1133123|NCT02753400|2229569|FG000|Overall Study|Adverse Event|3
1133124|NCT02753400|2229570|FG001|Overall Study|Adverse Event|0
1133125|NCT02753400|2229569|FG000|Overall Study|Withdrawal by Subject|2
1133126|NCT02753400|2229570|FG001|Overall Study|Withdrawal by Subject|1
1133127|NCT02753595|2229587|FG000|Overall Study|Sponsor termination|2
1133128|NCT02753595|2229588|FG001|Overall Study|Sponsor termination|2
1133129|NCT02753816|2229611|FG000|Overall Study|Protocol Violation|0
1133130|NCT02753816|2229612|FG001|Overall Study|Protocol Violation|1
1133131|NCT02753816|2229613|FG002|Overall Study|Protocol Violation|0
1133132|NCT02753946|2229672|FG000|Overall Study|Adverse Event|7
1133133|NCT02753946|2229673|FG001|Overall Study|Adverse Event|6
1133134|NCT02753946|2229672|FG000|Overall Study|Withdrawal by Subject|6
1133135|NCT02753946|2229673|FG001|Overall Study|Withdrawal by Subject|1
1133136|NCT02753946|2229672|FG000|Overall Study|Lack of Efficacy|1
1133137|NCT02753946|2229673|FG001|Overall Study|Lack of Efficacy|0
1133138|NCT02753946|2229672|FG000|Overall Study|Physician Decision|0
1133139|NCT02753946|2229673|FG001|Overall Study|Physician Decision|2
1133140|NCT02754440|2229701|FG000|Overall Study|Protocol Violation|3
1133141|NCT02754440|2229702|FG001|Overall Study|Protocol Violation|2
1133142|NCT02754440|2229703|FG002|Overall Study|Protocol Violation|2
1133143|NCT02754440|2229704|FG003|Overall Study|Protocol Violation|6
1133144|NCT02754440|2229701|FG000|Overall Study|Adverse Event|3
1133145|NCT02754440|2229702|FG001|Overall Study|Adverse Event|1
1133146|NCT02754440|2229703|FG002|Overall Study|Adverse Event|0
1133147|NCT02754440|2229704|FG003|Overall Study|Adverse Event|9
1133148|NCT02754440|2229701|FG000|Overall Study|Withdrawal by Subject|0
1133149|NCT02754440|2229702|FG001|Overall Study|Withdrawal by Subject|0
1133150|NCT02754440|2229703|FG002|Overall Study|Withdrawal by Subject|0
1133151|NCT02754440|2229704|FG003|Overall Study|Withdrawal by Subject|1
1133152|NCT02754440|2229701|FG000|Overall Study|Equipment failure|0
1133153|NCT02754440|2229702|FG001|Overall Study|Equipment failure|5
1133154|NCT02754440|2229703|FG002|Overall Study|Equipment failure|5
1133155|NCT02754440|2229704|FG003|Overall Study|Equipment failure|7
1133156|NCT02754440|2229701|FG000|Overall Study|Subject issues not resulting in AE|0
1133157|NCT02754440|2229702|FG001|Overall Study|Subject issues not resulting in AE|0
1133158|NCT02754440|2229703|FG002|Overall Study|Subject issues not resulting in AE|0
1133159|NCT02754440|2229704|FG003|Overall Study|Subject issues not resulting in AE|12
1133160|NCT02754492|2229717|FG000|Overall Study|Protocol Violation|2
1133161|NCT02754492|2229718|FG001|Overall Study|Protocol Violation|2
1133162|NCT02754492|2229719|FG002|Overall Study|Protocol Violation|0
1133163|NCT02754492|2229720|FG003|Overall Study|Protocol Violation|1
1133164|NCT02754492|2229717|FG000|Overall Study|Withdrawal by Subject|2
1133165|NCT02754492|2229718|FG001|Overall Study|Withdrawal by Subject|0
1133166|NCT02754492|2229719|FG002|Overall Study|Withdrawal by Subject|0
1133167|NCT02754492|2229720|FG003|Overall Study|Withdrawal by Subject|0
1133168|NCT02754492|2229717|FG000|Overall Study|Equipment malfuntion|0
1133169|NCT02754492|2229718|FG001|Overall Study|Equipment malfuntion|0
1133170|NCT02754492|2229719|FG002|Overall Study|Equipment malfuntion|2
1133171|NCT02754492|2229720|FG003|Overall Study|Equipment malfuntion|5
1133172|NCT02754492|2229717|FG000|Overall Study|Adverse Event|0
1133173|NCT02754492|2229718|FG001|Overall Study|Adverse Event|0
1133174|NCT02754492|2229719|FG002|Overall Study|Adverse Event|0
1133175|NCT02754492|2229720|FG003|Overall Study|Adverse Event|13
1133176|NCT02754492|2229717|FG000|Overall Study|Venous access issues not resulting in AE|0
1133177|NCT02754492|2229718|FG001|Overall Study|Venous access issues not resulting in AE|0
1133178|NCT02754492|2229719|FG002|Overall Study|Venous access issues not resulting in AE|0
1133179|NCT02754492|2229720|FG003|Overall Study|Venous access issues not resulting in AE|4
1133180|NCT02755090|2229761|FG000|Overall Study|equipment malfunction|1
1133181|NCT02755090|2229762|FG001|Overall Study|equipment malfunction|0
1133182|NCT02755116|2229770|FG000|Overall Study|surgery converted to open, pt admitted|3
1133183|NCT02755116|2229771|FG001|Overall Study|surgery converted to open, pt admitted|1
1133184|NCT02755649|2229791|FG000|Overall Study|Transitioned into OLE study|99
1133185|NCT02755649|2229792|FG001|Overall Study|Transitioned into OLE study|98
1133186|NCT02755649|2229793|FG002|Overall Study|Transitioned into OLE study|100
1133187|NCT02755649|2229791|FG000|Overall Study|Did Not Complete Follow-up Visits|1
1133188|NCT02755649|2229792|FG001|Overall Study|Did Not Complete Follow-up Visits|0
1133189|NCT02755649|2229793|FG002|Overall Study|Did Not Complete Follow-up Visits|0
1133190|NCT02755649|2229791|FG000|Overall Study|Physician Decision|0
1133191|NCT02755649|2229792|FG001|Overall Study|Physician Decision|0
1133192|NCT02755649|2229793|FG002|Overall Study|Physician Decision|2
1133193|NCT02755649|2229791|FG000|Overall Study|Withdrawal by Subject|0
1133194|NCT02755649|2229792|FG001|Overall Study|Withdrawal by Subject|1
1133195|NCT02755649|2229793|FG002|Overall Study|Withdrawal by Subject|0
1133196|NCT02755649|2229791|FG000|Overall Study|Undecided|1
1133197|NCT02755649|2229792|FG001|Overall Study|Undecided|0
900184|NCT00726232|1873275|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
900185|NCT00726232|1873276|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
900186|NCT00726232|1873277|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
900187|NCT00726232|1873270|FG000|Initial Phase (Dose-finding)|Unspecified reason|1
1133198|NCT02755649|2229793|FG002|Overall Study|Undecided|0
1133199|NCT02755805|2229803|FG000|Overall Study|Lost to Follow-up|1
1133200|NCT02755805|2229804|FG001|Overall Study|Lost to Follow-up|2
1133201|NCT02755805|2229803|FG000|Overall Study|Refused assessments|1
1133202|NCT02755805|2229804|FG001|Overall Study|Refused assessments|0
1133203|NCT02755805|2229803|FG000|Overall Study|Withdrawal by Subject|0
1133204|NCT02755805|2229804|FG001|Overall Study|Withdrawal by Subject|2
1133205|NCT02755818|2229814|FG000|Overall Study|Withdrawal by Subject|0
1133206|NCT02755818|2229815|FG001|Overall Study|Withdrawal by Subject|0
1133207|NCT02755818|2229816|FG002|Overall Study|Withdrawal by Subject|0
1133208|NCT02755818|2229817|FG003|Overall Study|Withdrawal by Subject|2
1133209|NCT02755818|2229814|FG000|Overall Study|withdrawal by PI|0
1133210|NCT02755818|2229815|FG001|Overall Study|withdrawal by PI|0
1133211|NCT02755818|2229816|FG002|Overall Study|withdrawal by PI|1
1133212|NCT02755818|2229817|FG003|Overall Study|withdrawal by PI|1
1133213|NCT02755831|2229831|FG000|Overall Study|Lost to Follow-up|3
1133214|NCT02755831|2229832|FG001|Overall Study|Lost to Follow-up|3
1133215|NCT02756013|2229842|FG000|Overall Study|Adverse Event|1
1133216|NCT02756013|2229842|FG000|Overall Study|Hypersensitivity|1
1133217|NCT02756078|2229846|FG000|Period 1|Unsatisfactory Lens Fitting|0
1133218|NCT02756078|2229847|FG001|Period 1|Unsatisfactory Lens Fitting|1
1133219|NCT02756078|2229846|FG000|Period 1|Lost to Follow-up|0
1133220|NCT02756078|2229847|FG001|Period 1|Lost to Follow-up|2
1133221|NCT02756078|2229846|FG000|Period 1|Protocol Violation|0
1133222|NCT02756078|2229847|FG001|Period 1|Protocol Violation|1
1133223|NCT02756078|2229846|FG000|Period 1|Adverse Event|1
1133224|NCT02756078|2229847|FG001|Period 1|Adverse Event|10
1133225|NCT02756078|2229846|FG000|Period 1|Withdrawal by Subject|6
1133226|NCT02756078|2229847|FG001|Period 1|Withdrawal by Subject|6
1133227|NCT02756078|2229846|FG000|Period 1|Lens Discomfort|2
1133228|NCT02756078|2229847|FG001|Period 1|Lens Discomfort|2
1133229|NCT02756078|2229846|FG000|Period 2|Adverse Event|3
1133230|NCT02756078|2229847|FG001|Period 2|Adverse Event|5
1133231|NCT02756078|2229846|FG000|Period 2|Unsatisfactory Lens Fitting|0
1133232|NCT02756078|2229847|FG001|Period 2|Unsatisfactory Lens Fitting|1
1133233|NCT02756078|2229846|FG000|Period 2|Withdrawal by Subject|3
1133234|NCT02756078|2229847|FG001|Period 2|Withdrawal by Subject|1
1133235|NCT02756182|2229853|FG000|Overall Study|StudyTechnical Difficulties|4
1133252|NCT02756338|2229876|FG000|Overall Study|Withdrawn by Investigator|1
1133253|NCT02756338|2229876|FG000|Overall Study|Device Replaced with Pacemaker|4
1133254|NCT02756364|2229892|FG000|Overall Study|Site Terminated by Sponsor|24
1133255|NCT02756364|2229893|FG001|Overall Study|Site Terminated by Sponsor|30
1133256|NCT02756364|2229894|FG002|Overall Study|Site Terminated by Sponsor|21
1133257|NCT02756364|2229892|FG000|Overall Study|Death|20
1133258|NCT02756364|2229893|FG001|Overall Study|Death|15
1133259|NCT02756364|2229894|FG002|Overall Study|Death|18
1133260|NCT02756364|2229892|FG000|Overall Study|Withdrawal by Patient|2
1133261|NCT02756364|2229893|FG001|Overall Study|Withdrawal by Patient|1
1133262|NCT02756364|2229894|FG002|Overall Study|Withdrawal by Patient|8
1133263|NCT02756364|2229892|FG000|Overall Study|Lost to Follow-up|0
1133264|NCT02756364|2229893|FG001|Overall Study|Lost to Follow-up|1
1133265|NCT02756364|2229894|FG002|Overall Study|Lost to Follow-up|1
1133266|NCT02756611|2229911|FG000|Overall Study|Death|39
1133267|NCT02756611|2229911|FG000|Overall Study|Withdrawal by Subject|1
1133268|NCT02756611|2229911|FG000|Overall Study|Lost to Follow-up|2
1133269|NCT02756611|2229911|FG000|Overall Study|Other|7
1133270|NCT02756611|2229911|FG000|Overall Study|Missing|2
1133271|NCT02756611|2229911|FG000|Overall Study|Active on Study|205
1133272|NCT02756637|2229926|FG000|Overall Study|Not eligible for initial SWOG study|10
1133273|NCT02756637|2229927|FG001|Overall Study|Not eligible for initial SWOG study|10
1133274|NCT02756637|2229926|FG000|Overall Study|No available NLR value|44
1133275|NCT02756637|2229927|FG001|Overall Study|No available NLR value|44
1133276|NCT02756637|2229926|FG000|Overall Study|Did not complete curative therapy|33
1133277|NCT02756637|2229927|FG001|Overall Study|Did not complete curative therapy|0
1133278|NCT02756650|2229933|FG000|Overall Study|Physician Decision|1
1133279|NCT02756650|2229933|FG000|Overall Study|Adverse Event|1
1133280|NCT02756819|2229980|FG000|Overall Study|Lost for observation|23
1133281|NCT02756819|2229980|FG000|Overall Study|Patient's unwillingness|16
1133282|NCT02756819|2229980|FG000|Overall Study|Insufficient efficacy|2
1133283|NCT02756819|2229980|FG000|Overall Study|Adverse Event|2
1133284|NCT02756819|2229980|FG000|Overall Study|Reason not Specified|9
1133285|NCT02756832|2229984|FG000|Overall Study|Lost for Observation after Baseline|6
1133286|NCT02756832|2229984|FG000|Overall Study|Lost for Observation|13
1133287|NCT02756832|2229984|FG000|Overall Study|Patient's Unwillingness|12
1133288|NCT02756832|2229984|FG000|Overall Study|Insufficient Efficacy|2
1133289|NCT02756832|2229984|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1
1133290|NCT02756832|2229984|FG000|Overall Study|Reason not Specified|9
1133291|NCT02756832|2229984|FG000|Overall Study|Protocol Deviation|10
1133292|NCT02757352|2230098|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
1133293|NCT02757352|2230099|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
1133294|NCT02757352|2230100|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
1133295|NCT02757352|2230101|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
1133296|NCT02757352|2230102|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
1133297|NCT02757352|2230103|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
1133298|NCT02757352|2230104|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
1133299|NCT02757352|2230105|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
1133300|NCT02757352|2230106|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
1133301|NCT02757352|2230107|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
1133302|NCT02757352|2230098|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
1133303|NCT02757352|2230099|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
1133304|NCT02757352|2230100|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
1133305|NCT02757352|2230101|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
1133306|NCT02757352|2230102|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
1133307|NCT02757352|2230103|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
1133308|NCT02757352|2230104|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
1133309|NCT02757352|2230105|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
1133310|NCT02757352|2230106|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
1133311|NCT02757352|2230107|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
1133312|NCT02757352|2230098|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
1133313|NCT02757352|2230099|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
1133314|NCT02757352|2230100|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
1133315|NCT02757352|2230101|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
1133316|NCT02757352|2230102|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
1133317|NCT02757352|2230103|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
1133318|NCT02757352|2230104|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
1133319|NCT02757352|2230105|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
1133320|NCT02757352|2230106|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
1133321|NCT02757352|2230107|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
1133322|NCT02757352|2230098|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
1133323|NCT02757352|2230099|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
1133324|NCT02757352|2230100|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
1133325|NCT02757352|2230101|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
1133326|NCT02757352|2230102|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
1133327|NCT02757352|2230103|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
1133328|NCT02757352|2230104|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
1133329|NCT02757352|2230105|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
1133330|NCT02757352|2230106|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
1133331|NCT02757352|2230107|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
1133332|NCT02757352|2230098|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
1133333|NCT02757352|2230099|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
1133334|NCT02757352|2230100|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
1133335|NCT02757352|2230101|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
1133336|NCT02757352|2230102|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
1133337|NCT02757352|2230103|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
1133338|NCT02757352|2230104|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
1133339|NCT02757352|2230105|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
1133340|NCT02757352|2230106|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
1133341|NCT02757352|2230107|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
1133342|NCT02757352|2230098|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
1133343|NCT02757352|2230099|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
1133344|NCT02757352|2230100|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
1133345|NCT02757352|2230101|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133346|NCT02757352|2230102|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133347|NCT02757352|2230103|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133348|NCT02757352|2230104|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133349|NCT02757352|2230105|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133350|NCT02757352|2230106|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133351|NCT02757352|2230107|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133352|NCT02757352|2230098|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
1133353|NCT02757352|2230099|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
1133354|NCT02757352|2230100|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
1133355|NCT02757352|2230101|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
1133356|NCT02757352|2230102|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
1133357|NCT02757352|2230103|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
1133358|NCT02757352|2230104|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
1133359|NCT02757352|2230105|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
1133360|NCT02757352|2230106|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
1133361|NCT02757352|2230107|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
1133362|NCT02757352|2230098|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
1133363|NCT02757352|2230099|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
1133364|NCT02757352|2230100|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
1133365|NCT02757352|2230101|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
1133366|NCT02757352|2230102|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
1133367|NCT02757352|2230103|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
1133368|NCT02757352|2230104|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
1133369|NCT02757352|2230105|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
1133370|NCT02757352|2230106|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
1133371|NCT02757352|2230107|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
1133372|NCT02757352|2230098|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
1133373|NCT02757352|2230099|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
1133374|NCT02757352|2230100|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
1133375|NCT02757352|2230101|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
1133376|NCT02757352|2230102|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
1133377|NCT02757352|2230103|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
1133378|NCT02757352|2230104|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
1133379|NCT02757352|2230105|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
1133380|NCT02757352|2230106|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
1133381|NCT02757352|2230107|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
1133382|NCT02757352|2230098|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
1133383|NCT02757352|2230099|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
1133384|NCT02757352|2230100|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
1133385|NCT02757352|2230101|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
1133386|NCT02757352|2230102|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
1133387|NCT02757352|2230103|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
1133388|NCT02757352|2230104|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
1133389|NCT02757352|2230105|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
1133390|NCT02757352|2230106|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
1133391|NCT02757352|2230107|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
1133392|NCT02757352|2230098|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
1133393|NCT02757352|2230099|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
1133394|NCT02757352|2230100|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
1133395|NCT02757352|2230101|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
1133396|NCT02757352|2230102|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
1133397|NCT02757352|2230103|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
1133398|NCT02757352|2230104|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
1133399|NCT02757352|2230105|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
1133400|NCT02757352|2230106|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
1133401|NCT02757352|2230107|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
1133402|NCT02757352|2230098|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133403|NCT02757352|2230099|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133404|NCT02757352|2230100|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133405|NCT02757352|2230101|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
1133406|NCT02757352|2230102|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
1133407|NCT02757352|2230103|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
1133408|NCT02757352|2230104|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133409|NCT02757352|2230105|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133410|NCT02757352|2230106|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133411|NCT02757352|2230107|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
1133412|NCT02757352|2230098|FG000|Follow-Up Period|Adverse Event|0
1133413|NCT02757352|2230099|FG001|Follow-Up Period|Adverse Event|0
1133414|NCT02757352|2230100|FG002|Follow-Up Period|Adverse Event|0
1133415|NCT02757352|2230101|FG003|Follow-Up Period|Adverse Event|0
1133416|NCT02757352|2230102|FG004|Follow-Up Period|Adverse Event|0
1133417|NCT02757352|2230103|FG005|Follow-Up Period|Adverse Event|0
1133418|NCT02757352|2230104|FG006|Follow-Up Period|Adverse Event|1
1133419|NCT02757352|2230105|FG007|Follow-Up Period|Adverse Event|0
1133420|NCT02757352|2230106|FG008|Follow-Up Period|Adverse Event|2
1133421|NCT02757352|2230107|FG009|Follow-Up Period|Adverse Event|0
1133422|NCT02757352|2230098|FG000|Follow-Up Period|Lost to Follow-up|0
1133423|NCT02757352|2230099|FG001|Follow-Up Period|Lost to Follow-up|0
1133424|NCT02757352|2230100|FG002|Follow-Up Period|Lost to Follow-up|0
1133425|NCT02757352|2230101|FG003|Follow-Up Period|Lost to Follow-up|0
1133426|NCT02757352|2230102|FG004|Follow-Up Period|Lost to Follow-up|0
1133427|NCT02757352|2230103|FG005|Follow-Up Period|Lost to Follow-up|0
1133428|NCT02757352|2230104|FG006|Follow-Up Period|Lost to Follow-up|0
1133429|NCT02757352|2230105|FG007|Follow-Up Period|Lost to Follow-up|0
1133430|NCT02757352|2230106|FG008|Follow-Up Period|Lost to Follow-up|1
1133431|NCT02757352|2230107|FG009|Follow-Up Period|Lost to Follow-up|0
1133432|NCT02757352|2230098|FG000|Follow-Up Period|Lack of Efficacy|0
1133433|NCT02757352|2230099|FG001|Follow-Up Period|Lack of Efficacy|0
1133434|NCT02757352|2230100|FG002|Follow-Up Period|Lack of Efficacy|0
1133435|NCT02757352|2230101|FG003|Follow-Up Period|Lack of Efficacy|0
1133436|NCT02757352|2230102|FG004|Follow-Up Period|Lack of Efficacy|0
1133437|NCT02757352|2230103|FG005|Follow-Up Period|Lack of Efficacy|0
1133438|NCT02757352|2230104|FG006|Follow-Up Period|Lack of Efficacy|0
1133439|NCT02757352|2230105|FG007|Follow-Up Period|Lack of Efficacy|0
1133440|NCT02757352|2230106|FG008|Follow-Up Period|Lack of Efficacy|1
1133441|NCT02757352|2230107|FG009|Follow-Up Period|Lack of Efficacy|1
1133442|NCT02757352|2230098|FG000|Follow-Up Period|Withdrawal by Subject|0
1133443|NCT02757352|2230099|FG001|Follow-Up Period|Withdrawal by Subject|0
1133444|NCT02757352|2230100|FG002|Follow-Up Period|Withdrawal by Subject|0
1133445|NCT02757352|2230101|FG003|Follow-Up Period|Withdrawal by Subject|0
1133446|NCT02757352|2230102|FG004|Follow-Up Period|Withdrawal by Subject|0
1133447|NCT02757352|2230103|FG005|Follow-Up Period|Withdrawal by Subject|0
1133448|NCT02757352|2230104|FG006|Follow-Up Period|Withdrawal by Subject|0
1133449|NCT02757352|2230105|FG007|Follow-Up Period|Withdrawal by Subject|1
1133450|NCT02757352|2230106|FG008|Follow-Up Period|Withdrawal by Subject|6
1133451|NCT02757352|2230107|FG009|Follow-Up Period|Withdrawal by Subject|2
1133452|NCT02757430|2230138|FG000|Overall Study|Physician Decision|6
1133453|NCT02757430|2230138|FG000|Overall Study|Inclusion/Exclusion criteria not met|3
1133454|NCT02757430|2230138|FG000|Overall Study|No informed consent|1
1133455|NCT02757430|2230138|FG000|Overall Study|No procedure performed|2
1133456|NCT02757625|2230155|FG000|Overall Study|Investigator's discretion|0
1133457|NCT02757625|2230156|FG001|Overall Study|Investigator's discretion|0
1133458|NCT02757625|2230157|FG002|Overall Study|Investigator's discretion|1
1133459|NCT02757625|2230158|FG003|Overall Study|Investigator's discretion|0
1133460|NCT02757625|2230155|FG000|Overall Study|Adverse Event|0
1133461|NCT02757625|2230156|FG001|Overall Study|Adverse Event|0
1133462|NCT02757625|2230157|FG002|Overall Study|Adverse Event|1
1133463|NCT02757625|2230158|FG003|Overall Study|Adverse Event|0
1133464|NCT02757768|2230172|FG000|Overall Study|Randomized Never Received Study Drug|3
1133465|NCT02757768|2230173|FG001|Overall Study|Randomized Never Received Study Drug|4
1133466|NCT02757768|2230172|FG000|Overall Study|Adverse Event|5
1133467|NCT02757768|2230173|FG001|Overall Study|Adverse Event|3
1133468|NCT02757768|2230172|FG000|Overall Study|Lack of Efficacy|2
1133469|NCT02757768|2230173|FG001|Overall Study|Lack of Efficacy|1
1133470|NCT02757768|2230172|FG000|Overall Study|Lost to Follow-up|1
1133471|NCT02757768|2230173|FG001|Overall Study|Lost to Follow-up|0
1133472|NCT02757768|2230172|FG000|Overall Study|Protocol Deviation|2
1133473|NCT02757768|2230173|FG001|Overall Study|Protocol Deviation|9
1133474|NCT02757768|2230172|FG000|Overall Study|Withdrawal by Subject|16
1133475|NCT02757768|2230173|FG001|Overall Study|Withdrawal by Subject|9
1133476|NCT02757768|2230172|FG000|Overall Study|Miscellaneous|4
1133477|NCT02757768|2230173|FG001|Overall Study|Miscellaneous|2
1133478|NCT02757963|2230191|FG000|Overall Study|Adverse Event|3
1133479|NCT02757963|2230191|FG000|Overall Study|Reached Stopping Criteria|1054
1133480|NCT02757963|2230191|FG000|Overall Study|Lost to Follow-up|5
1133481|NCT02757963|2230191|FG000|Overall Study|Physician Decision|1
1133482|NCT02757963|2230191|FG000|Overall Study|Withdrawal by Subject|34
1133483|NCT02758171|2230219|FG000|Wash-out|Withdrawal by Subject|1
1133484|NCT02758171|2230220|FG001|Wash-out|Withdrawal by Subject|0
1133485|NCT02758171|2230219|FG000|Wash-out|Other reason|1
1133486|NCT02758171|2230220|FG001|Wash-out|Other reason|0
1133487|NCT02758301|2230232|FG000|Overall Study|Death|12
1133488|NCT02758301|2230233|FG001|Overall Study|Death|0
1133489|NCT02758301|2230232|FG000|Overall Study|Physician Decision|10
1133490|NCT02758301|2230233|FG001|Overall Study|Physician Decision|1
1133491|NCT02758301|2230232|FG000|Overall Study|Withdrawal by Subject|5
1133492|NCT02758301|2230233|FG001|Overall Study|Withdrawal by Subject|6
1133493|NCT02758301|2230232|FG000|Overall Study|Lost to Follow-up|7
1133494|NCT02758301|2230233|FG001|Overall Study|Lost to Follow-up|0
1133495|NCT02758301|2230232|FG000|Overall Study|Protocol Violation|0
1133496|NCT02758301|2230233|FG001|Overall Study|Protocol Violation|1
1133497|NCT02758613|2230243|FG000|Treatment|Physician and Sponsor Decision|1
1133498|NCT02758613|2230244|FG001|Treatment|Physician and Sponsor Decision|0
1133499|NCT02758613|2230245|FG002|Treatment|Physician and Sponsor Decision|0
1133500|NCT02758613|2230246|FG003|Treatment|Physician and Sponsor Decision|0
1133501|NCT02758613|2230243|FG000|Treatment|Withdrawal by Subject|1
1133502|NCT02758613|2230244|FG001|Treatment|Withdrawal by Subject|0
1133503|NCT02758613|2230245|FG002|Treatment|Withdrawal by Subject|1
1133504|NCT02758613|2230246|FG003|Treatment|Withdrawal by Subject|0
1133505|NCT02759016|2230274|FG000|Overall Study|Not treated with BI 836826|1
1133506|NCT02759016|2230275|FG001|Overall Study|Not treated with BI 836826|0
1133507|NCT02759016|2230274|FG000|Overall Study|Progressive disease|1
1133508|NCT02759016|2230275|FG001|Overall Study|Progressive disease|0
1133509|NCT02759016|2230274|FG000|Overall Study|SD, PR-MRDpos or PR-L|0
1133510|NCT02759016|2230275|FG001|Overall Study|SD, PR-MRDpos or PR-L|2
1133511|NCT02759016|2230274|FG000|Overall Study|Other not defined above|2
1133512|NCT02759016|2230275|FG001|Overall Study|Other not defined above|1
1133513|NCT02759055|2230284|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927
1133514|NCT02759055|2230285|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508
1133515|NCT02759120|2230293|FG000|Overall Study|Death|34
1133516|NCT02759120|2230294|FG001|Overall Study|Death|36
1133517|NCT02759120|2230293|FG000|Overall Study|Lost to Follow-up|4
1133518|NCT02759120|2230294|FG001|Overall Study|Lost to Follow-up|7
1133519|NCT02759120|2230293|FG000|Overall Study|Physician Decision|3
1133520|NCT02759120|2230294|FG001|Overall Study|Physician Decision|0
1133521|NCT02759120|2230293|FG000|Overall Study|Withdrawal by Subject|28
1133522|NCT02759120|2230294|FG001|Overall Study|Withdrawal by Subject|15
1133523|NCT02759120|2230293|FG000|Overall Study|Moved out of area|3
1133524|NCT02759120|2230294|FG001|Overall Study|Moved out of area|4
1133525|NCT02759120|2230293|FG000|Overall Study|Lung transplant|3
1133526|NCT02759120|2230294|FG001|Overall Study|Lung transplant|5
1133527|NCT02759120|2230293|FG000|Overall Study|Other reason not completed|10
1133528|NCT02759120|2230294|FG001|Overall Study|Other reason not completed|12
1133529|NCT02759185|2230332|FG000|Overall Study|Adverse Event|0
1133530|NCT02759185|2230333|FG001|Overall Study|Adverse Event|1
1133531|NCT02759185|2230334|FG002|Overall Study|Adverse Event|2
1133532|NCT02759185|2230335|FG003|Overall Study|Adverse Event|0
1133533|NCT02759185|2230332|FG000|Overall Study|Withdrawal by Subject|1
1133534|NCT02759185|2230333|FG001|Overall Study|Withdrawal by Subject|0
1133535|NCT02759185|2230334|FG002|Overall Study|Withdrawal by Subject|0
1133536|NCT02759185|2230335|FG003|Overall Study|Withdrawal by Subject|0
1133537|NCT02759315|2230355|FG000|Overall Study|Adverse Event|0
1133538|NCT02759315|2230356|FG001|Overall Study|Adverse Event|0
1133539|NCT02759315|2230357|FG002|Overall Study|Adverse Event|0
1133540|NCT02759315|2230358|FG003|Overall Study|Adverse Event|1
1133541|NCT02759315|2230359|FG004|Overall Study|Adverse Event|0
1133542|NCT02759315|2230355|FG000|Overall Study|Death|0
1133543|NCT02759315|2230356|FG001|Overall Study|Death|0
1133544|NCT02759315|2230357|FG002|Overall Study|Death|1
1133545|NCT02759315|2230358|FG003|Overall Study|Death|0
1133546|NCT02759315|2230359|FG004|Overall Study|Death|0
1133547|NCT02759315|2230355|FG000|Overall Study|Lost to Follow-up|2
1133548|NCT02759315|2230356|FG001|Overall Study|Lost to Follow-up|0
1133549|NCT02759315|2230357|FG002|Overall Study|Lost to Follow-up|4
1133550|NCT02759315|2230358|FG003|Overall Study|Lost to Follow-up|0
1133551|NCT02759315|2230359|FG004|Overall Study|Lost to Follow-up|0
1133552|NCT02759315|2230355|FG000|Overall Study|Protocol Violation|0
1133553|NCT02759315|2230356|FG001|Overall Study|Protocol Violation|1
1133554|NCT02759315|2230357|FG002|Overall Study|Protocol Violation|0
1133555|NCT02759315|2230358|FG003|Overall Study|Protocol Violation|0
1133556|NCT02759315|2230359|FG004|Overall Study|Protocol Violation|0
1133557|NCT02759315|2230355|FG000|Overall Study|Study terminated prior to completion|2
1133558|NCT02759315|2230356|FG001|Overall Study|Study terminated prior to completion|0
1133559|NCT02759315|2230357|FG002|Overall Study|Study terminated prior to completion|5
1133560|NCT02759315|2230358|FG003|Overall Study|Study terminated prior to completion|0
1133561|NCT02759315|2230359|FG004|Overall Study|Study terminated prior to completion|1
1133562|NCT02759471|2230392|FG000|Overall Study|discomfort|2
1133563|NCT02759562|2230400|FG000|Open-Label Treatment Period|Withdrew Consent|1
1133564|NCT02759562|2230401|FG001|Open-Label Treatment Period|Withdrew Consent|0
1133565|NCT02759562|2230400|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1
1133566|NCT02759562|2230401|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2
1133567|NCT02759692|2230412|FG000|Period 1|Test article no longer available|1
1133568|NCT02759692|2230413|FG001|Period 1|Test article no longer available|1
1133569|NCT02759692|2230412|FG000|Period 1|No longer meets eligibility criteria.|1
1133570|NCT02759692|2230413|FG001|Period 1|No longer meets eligibility criteria.|0
1133571|NCT02759692|2230412|FG000|Period 1|Miss-Randomized|1
1133572|NCT02759692|2230413|FG001|Period 1|Miss-Randomized|1
1133573|NCT02759692|2230412|FG000|Period 2|Lost to Follow-up|1
1133574|NCT02759692|2230413|FG001|Period 2|Lost to Follow-up|0
1133575|NCT02759692|2230412|FG000|Period 2|Test article no longer available|0
1133576|NCT02759692|2230413|FG001|Period 2|Test article no longer available|1
1133577|NCT02759939|2230423|FG000|Overall Study|Missing data on first outcome assessed|11
1133578|NCT02759939|2230424|FG001|Overall Study|Missing data on first outcome assessed|2
1133579|NCT02759939|2230425|FG002|Overall Study|Missing data on first outcome assessed|5
1133580|NCT02759939|2230426|FG003|Overall Study|Missing data on first outcome assessed|2
1133581|NCT02759939|2230423|FG000|Overall Study|Ineligible for T2 and T3|310
1133582|NCT02759939|2230424|FG001|Overall Study|Ineligible for T2 and T3|179
1133583|NCT02759939|2230425|FG002|Overall Study|Ineligible for T2 and T3|366
1133584|NCT02759939|2230426|FG003|Overall Study|Ineligible for T2 and T3|391
1133585|NCT02759939|2230423|FG000|Overall Study|Lost to Follow-up|735
1133586|NCT02759939|2230424|FG001|Overall Study|Lost to Follow-up|791
1133587|NCT02759939|2230425|FG002|Overall Study|Lost to Follow-up|783
1133588|NCT02759939|2230426|FG003|Overall Study|Lost to Follow-up|650
1133589|NCT02760069|2230449|FG000|Overall Study|Withdrawal by Subject|0
1133590|NCT02760069|2230450|FG001|Overall Study|Withdrawal by Subject|1
1133591|NCT02760069|2230451|FG002|Overall Study|Withdrawal by Subject|1
1133592|NCT02760368|2230497|FG000|Overall Study|Withdrawal by Subject|12
1133593|NCT02760368|2230498|FG001|Overall Study|Withdrawal by Subject|8
1133594|NCT02760368|2230499|FG002|Overall Study|Withdrawal by Subject|9
1133595|NCT02760368|2230497|FG000|Overall Study|Screen Failure|0
1133596|NCT02760368|2230498|FG001|Overall Study|Screen Failure|0
1133597|NCT02760368|2230499|FG002|Overall Study|Screen Failure|1
1133598|NCT02760368|2230497|FG000|Overall Study|Death|1
1133599|NCT02760368|2230498|FG001|Overall Study|Death|0
1133600|NCT02760368|2230499|FG002|Overall Study|Death|0
1133601|NCT02760368|2230497|FG000|Overall Study|Withdrawal by Sponsor|0
1133602|NCT02760368|2230498|FG001|Overall Study|Withdrawal by Sponsor|0
1133603|NCT02760368|2230499|FG002|Overall Study|Withdrawal by Sponsor|1
1133604|NCT02760407|2230511|FG000|Overall Study|Death|2
1133605|NCT02760407|2230512|FG001|Overall Study|Death|3
1133606|NCT02760407|2230513|FG002|Overall Study|Death|1
1133607|NCT02760407|2230514|FG003|Overall Study|Death|1
1133608|NCT02760407|2230511|FG000|Overall Study|Lost to Follow-up|1
1133609|NCT02760407|2230512|FG001|Overall Study|Lost to Follow-up|7
1133610|NCT02760407|2230513|FG002|Overall Study|Lost to Follow-up|4
1133611|NCT02760407|2230514|FG003|Overall Study|Lost to Follow-up|6
1133612|NCT02760407|2230511|FG000|Overall Study|Withdrawal by Subject|25
1133613|NCT02760407|2230512|FG001|Overall Study|Withdrawal by Subject|31
1133614|NCT02760407|2230513|FG002|Overall Study|Withdrawal by Subject|37
1133615|NCT02760407|2230514|FG003|Overall Study|Withdrawal by Subject|25
1133616|NCT02760407|2230511|FG000|Overall Study|Violation of Eligibility criteria|0
1133617|NCT02760407|2230512|FG001|Overall Study|Violation of Eligibility criteria|0
1133618|NCT02760407|2230513|FG002|Overall Study|Violation of Eligibility criteria|1
1133619|NCT02760407|2230514|FG003|Overall Study|Violation of Eligibility criteria|1
1133620|NCT02760407|2230511|FG000|Overall Study|Personal reasons|0
1133621|NCT02760407|2230512|FG001|Overall Study|Personal reasons|0
1133622|NCT02760407|2230513|FG002|Overall Study|Personal reasons|0
1133623|NCT02760407|2230514|FG003|Overall Study|Personal reasons|1
1133624|NCT02760407|2230511|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1
1133625|NCT02760407|2230512|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
1133626|NCT02760407|2230513|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
1133627|NCT02760407|2230514|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
1133628|NCT02760407|2230511|FG000|Overall Study|Use of prohibited Medication|0
1133629|NCT02760407|2230512|FG001|Overall Study|Use of prohibited Medication|0
1133630|NCT02760407|2230513|FG002|Overall Study|Use of prohibited Medication|1
1133631|NCT02760407|2230514|FG003|Overall Study|Use of prohibited Medication|0
1133632|NCT02760407|2230511|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
1133633|NCT02760407|2230512|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
1133634|NCT02760407|2230513|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1
1133635|NCT02760407|2230514|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
1133636|NCT02760407|2230511|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1
1133637|NCT02760407|2230512|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
1133638|NCT02760407|2230513|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
1133639|NCT02760407|2230514|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
1133640|NCT02760407|2230511|FG000|Overall Study|Investigator's Decision (Adverse Event)|0
1133641|NCT02760407|2230512|FG001|Overall Study|Investigator's Decision (Adverse Event)|1
1133642|NCT02760407|2230513|FG002|Overall Study|Investigator's Decision (Adverse Event)|0
1133643|NCT02760407|2230514|FG003|Overall Study|Investigator's Decision (Adverse Event)|0
1133644|NCT02760407|2230511|FG000|Overall Study|Inadequately Enrolled|0
1133645|NCT02760407|2230512|FG001|Overall Study|Inadequately Enrolled|0
1133646|NCT02760407|2230513|FG002|Overall Study|Inadequately Enrolled|0
1133647|NCT02760407|2230514|FG003|Overall Study|Inadequately Enrolled|1
1133648|NCT02760407|2230511|FG000|Overall Study|Withdrawal By PI's Decision|0
1133649|NCT02760407|2230512|FG001|Overall Study|Withdrawal By PI's Decision|1
1133650|NCT02760407|2230513|FG002|Overall Study|Withdrawal By PI's Decision|0
1133651|NCT02760407|2230514|FG003|Overall Study|Withdrawal By PI's Decision|0
1133652|NCT02760407|2230511|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
1133653|NCT02760407|2230512|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
1133654|NCT02760407|2230513|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
1133655|NCT02760407|2230514|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
1162087|NCT03382912|2284106|FG000|Overall Study|Withdrawal by Subject|0
1133656|NCT02760407|2230511|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
1133657|NCT02760407|2230512|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
1133658|NCT02760407|2230513|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1
1133659|NCT02760407|2230514|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
1133660|NCT02760407|2230511|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1
1133661|NCT02760407|2230512|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
1133662|NCT02760407|2230513|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
1133663|NCT02760407|2230514|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
1133664|NCT02760407|2230511|FG000|Overall Study|Study Treatment Was Terminated At The Site|0
1133665|NCT02760407|2230512|FG001|Overall Study|Study Treatment Was Terminated At The Site|0
1133666|NCT02760407|2230513|FG002|Overall Study|Study Treatment Was Terminated At The Site|1
1133667|NCT02760407|2230514|FG003|Overall Study|Study Treatment Was Terminated At The Site|0
1133668|NCT02760407|2230511|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1
1133669|NCT02760407|2230512|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
1133670|NCT02760407|2230513|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
1133671|NCT02760407|2230514|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
1133672|NCT02760407|2230511|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1
1133673|NCT02760407|2230512|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
1133674|NCT02760407|2230513|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
1133675|NCT02760407|2230514|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
1133676|NCT02760407|2230511|FG000|Overall Study|Lack Of Efficacy Per PI|0
1133677|NCT02760407|2230512|FG001|Overall Study|Lack Of Efficacy Per PI|0
1133678|NCT02760407|2230513|FG002|Overall Study|Lack Of Efficacy Per PI|0
1133679|NCT02760407|2230514|FG003|Overall Study|Lack Of Efficacy Per PI|1
1133680|NCT02760407|2230511|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1
1133681|NCT02760407|2230512|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
1133682|NCT02760407|2230513|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
1133683|NCT02760407|2230514|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
1133684|NCT02760407|2230511|FG000|Overall Study|Investigator recorded as Adverse Event|1
1133685|NCT02760407|2230512|FG001|Overall Study|Investigator recorded as Adverse Event|0
1133686|NCT02760407|2230513|FG002|Overall Study|Investigator recorded as Adverse Event|2
1133687|NCT02760407|2230514|FG003|Overall Study|Investigator recorded as Adverse Event|0
1133688|NCT02760433|2230530|FG000|Overall Study|Lost to Follow-up|1
1133689|NCT02760433|2230531|FG001|Overall Study|Lost to Follow-up|0
1133690|NCT02760433|2230532|FG002|Overall Study|Lost to Follow-up|1
1133691|NCT02760433|2230533|FG003|Overall Study|Lost to Follow-up|0
1133692|NCT02760433|2230534|FG004|Overall Study|Lost to Follow-up|0
1133693|NCT02760433|2230530|FG000|Overall Study|Withdrawal by Subject|23
1133694|NCT02760433|2230531|FG001|Overall Study|Withdrawal by Subject|9
1133695|NCT02760433|2230532|FG002|Overall Study|Withdrawal by Subject|0
1133696|NCT02760433|2230533|FG003|Overall Study|Withdrawal by Subject|2
1133697|NCT02760433|2230534|FG004|Overall Study|Withdrawal by Subject|9
1133698|NCT02760433|2230530|FG000|Overall Study|Lack of Response At Week 14|0
1133699|NCT02760433|2230531|FG001|Overall Study|Lack of Response At Week 14|0
1133700|NCT02760433|2230532|FG002|Overall Study|Lack of Response At Week 14|0
1133701|NCT02760433|2230533|FG003|Overall Study|Lack of Response At Week 14|0
1133702|NCT02760433|2230534|FG004|Overall Study|Lack of Response At Week 14|1
1133703|NCT02760433|2230530|FG000|Overall Study|Subject refused to continue the study|1
1133704|NCT02760433|2230531|FG001|Overall Study|Subject refused to continue the study|0
1133705|NCT02760433|2230532|FG002|Overall Study|Subject refused to continue the study|0
1133706|NCT02760433|2230533|FG003|Overall Study|Subject refused to continue the study|0
1133707|NCT02760433|2230534|FG004|Overall Study|Subject refused to continue the study|0
1133708|NCT02760433|2230530|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2
1133709|NCT02760433|2230531|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0
1133710|NCT02760433|2230532|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0
1133711|NCT02760433|2230533|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0
1133712|NCT02760433|2230534|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0
1133713|NCT02760433|2230530|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
1133714|NCT02760433|2230531|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1
1133715|NCT02760433|2230532|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
1133716|NCT02760433|2230533|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
1133717|NCT02760433|2230534|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
1133718|NCT02760654|2230553|FG000|Overall Study|Lost to Follow-up|3
1133719|NCT02760654|2230554|FG001|Overall Study|Lost to Follow-up|3
1133720|NCT02760654|2230553|FG000|Overall Study|Withdrawal by Subject|4
1133721|NCT02760654|2230554|FG001|Overall Study|Withdrawal by Subject|3
1133722|NCT02760810|2230560|FG000|Overall Study|Protocol Violation|1
1133723|NCT02760927|2230573|FG000|Overall Study|Tube Slippage from Device|1
1133724|NCT02761330|2230592|FG000|Treatment Week 1|Withdrawal by Subject|0
1133725|NCT02761330|2230593|FG001|Treatment Week 1|Withdrawal by Subject|0
1133726|NCT02761330|2230594|FG002|Treatment Week 1|Withdrawal by Subject|0
1133727|NCT02761330|2230595|FG003|Treatment Week 1|Withdrawal by Subject|1
1133728|NCT02761330|2230596|FG004|Treatment Week 1|Withdrawal by Subject|0
1133729|NCT02761330|2230597|FG005|Treatment Week 1|Withdrawal by Subject|1
1133730|NCT02761629|2230613|FG000|Overall Study|Adverse Event/Intercurrent Illness|7
1133731|NCT02761629|2230614|FG001|Overall Study|Adverse Event/Intercurrent Illness|5
1133732|NCT02761629|2230613|FG000|Overall Study|Insufficient Therapeutic Response|2
1133733|NCT02761629|2230614|FG001|Overall Study|Insufficient Therapeutic Response|7
1133734|NCT02761629|2230613|FG000|Overall Study|Failure to Return|2
1133735|NCT02761629|2230614|FG001|Overall Study|Failure to Return|4
1133736|NCT02761629|2230613|FG000|Overall Study|Did not Cooperate/Refused Treatment|2
1133737|NCT02761629|2230614|FG001|Overall Study|Did not Cooperate/Refused Treatment|4
1133738|NCT02761629|2230613|FG000|Overall Study|Protocol Violation|2
1133739|NCT02761629|2230614|FG001|Overall Study|Protocol Violation|2
1133740|NCT02761629|2230613|FG000|Overall Study|Withdrawal by Subject|0
1133741|NCT02761629|2230614|FG001|Overall Study|Withdrawal by Subject|3
1133742|NCT02761629|2230613|FG000|Overall Study|Other|0
1133743|NCT02761629|2230614|FG001|Overall Study|Other|2
1133744|NCT02761629|2230613|FG000|Overall Study|Lost to Follow-up|4
1133745|NCT02761629|2230614|FG001|Overall Study|Lost to Follow-up|1
1133746|NCT02761629|2230613|FG000|Overall Study|Randomized But Not Treated|8
1133747|NCT02761629|2230614|FG001|Overall Study|Randomized But Not Treated|4
1133748|NCT02761642|2230620|FG000|Overall Study|Did not Receive Study Treatment|3
1133749|NCT02761642|2230620|FG000|Overall Study|Adverse Event|13
1133750|NCT02761642|2230620|FG000|Overall Study|Withdrawal by Subject|2
1133751|NCT02761642|2230620|FG000|Overall Study|Non-compliant|7
1133752|NCT02761642|2230620|FG000|Overall Study|Death|3
1133753|NCT02761642|2230620|FG000|Overall Study|Lack of Efficacy|20
1133754|NCT02761642|2230620|FG000|Overall Study|Physician Decision|1
1133755|NCT02761642|2230620|FG000|Overall Study|Reason Unspecified|21
1133756|NCT02761733|2230628|FG000|Overall Study|Death|3
1133757|NCT02761733|2230629|FG001|Overall Study|Death|5
1133758|NCT02761733|2230630|FG002|Overall Study|Death|1
1133759|NCT02761733|2230631|FG003|Overall Study|Death|1
1133760|NCT02761733|2230628|FG000|Overall Study|Lost to Follow-up|6
1133761|NCT02761733|2230629|FG001|Overall Study|Lost to Follow-up|7
1133762|NCT02761733|2230630|FG002|Overall Study|Lost to Follow-up|0
1133763|NCT02761733|2230631|FG003|Overall Study|Lost to Follow-up|3
1133764|NCT02761733|2230628|FG000|Overall Study|Physician Decision|4
1133765|NCT02761733|2230629|FG001|Overall Study|Physician Decision|0
1133766|NCT02761733|2230630|FG002|Overall Study|Physician Decision|0
1133767|NCT02761733|2230631|FG003|Overall Study|Physician Decision|0
1133768|NCT02761733|2230628|FG000|Overall Study|Withdrawal by Subject|2
1133769|NCT02761733|2230629|FG001|Overall Study|Withdrawal by Subject|0
1133770|NCT02761733|2230630|FG002|Overall Study|Withdrawal by Subject|0
1133771|NCT02761733|2230631|FG003|Overall Study|Withdrawal by Subject|0
1133772|NCT02761733|2230628|FG000|Overall Study|Discharged from Study Site|10
1133773|NCT02761733|2230629|FG001|Overall Study|Discharged from Study Site|9
1133774|NCT02761733|2230630|FG002|Overall Study|Discharged from Study Site|25
1133775|NCT02761733|2230631|FG003|Overall Study|Discharged from Study Site|11
1133776|NCT02761733|2230628|FG000|Overall Study|Cognitive Impairment|5
1133777|NCT02761733|2230629|FG001|Overall Study|Cognitive Impairment|0
1133778|NCT02761733|2230630|FG002|Overall Study|Cognitive Impairment|1
1133779|NCT02761733|2230631|FG003|Overall Study|Cognitive Impairment|0
1133780|NCT02761915|2230647|FG000|Overall Study|Death|3
1133781|NCT02761915|2230648|FG001|Overall Study|Death|1
1133782|NCT02761915|2230649|FG002|Overall Study|Death|1
1133783|NCT02761915|2230650|FG003|Overall Study|Death|1
1133784|NCT02761915|2230651|FG004|Overall Study|Death|0
1133785|NCT02761915|2230652|FG005|Overall Study|Death|1
1133786|NCT02761915|2230647|FG000|Overall Study|Withdrawal by Subject|1
1133787|NCT02761915|2230648|FG001|Overall Study|Withdrawal by Subject|0
1133788|NCT02761915|2230649|FG002|Overall Study|Withdrawal by Subject|0
1133789|NCT02761915|2230650|FG003|Overall Study|Withdrawal by Subject|0
1133790|NCT02761915|2230651|FG004|Overall Study|Withdrawal by Subject|1
1133791|NCT02761915|2230652|FG005|Overall Study|Withdrawal by Subject|2
1133792|NCT02761915|2230647|FG000|Overall Study|Disease Progression|0
1133793|NCT02761915|2230648|FG001|Overall Study|Disease Progression|0
1133794|NCT02761915|2230649|FG002|Overall Study|Disease Progression|0
1133795|NCT02761915|2230650|FG003|Overall Study|Disease Progression|2
1133796|NCT02761915|2230651|FG004|Overall Study|Disease Progression|2
1133797|NCT02761915|2230652|FG005|Overall Study|Disease Progression|2
1133798|NCT02761980|2230686|FG000|Overall Study|Adverse Event|4
1133799|NCT02761980|2230687|FG001|Overall Study|Adverse Event|6
1133800|NCT02761980|2230688|FG002|Overall Study|Adverse Event|5
1133801|NCT02761980|2230689|FG003|Overall Study|Adverse Event|6
1133802|NCT02761980|2230686|FG000|Overall Study|Withdrawal by Subject|0
1133803|NCT02761980|2230687|FG001|Overall Study|Withdrawal by Subject|1
1133804|NCT02761980|2230688|FG002|Overall Study|Withdrawal by Subject|0
1133805|NCT02761980|2230689|FG003|Overall Study|Withdrawal by Subject|0
1133806|NCT02761980|2230686|FG000|Overall Study|Other|0
1133807|NCT02761980|2230687|FG001|Overall Study|Other|0
1133808|NCT02761980|2230688|FG002|Overall Study|Other|1
1133809|NCT02761980|2230689|FG003|Overall Study|Other|0
1133810|NCT02761993|2230702|FG000|Overall Study|Adverse Event|0
1133811|NCT02761993|2230703|FG001|Overall Study|Adverse Event|2
1133812|NCT02761993|2230704|FG002|Overall Study|Adverse Event|0
1133813|NCT02761993|2230702|FG000|Overall Study|Lost to Follow-up|1
1133814|NCT02761993|2230703|FG001|Overall Study|Lost to Follow-up|3
1133815|NCT02761993|2230704|FG002|Overall Study|Lost to Follow-up|2
1133816|NCT02761993|2230702|FG000|Overall Study|Withdrawal by Subject|1
1133817|NCT02761993|2230703|FG001|Overall Study|Withdrawal by Subject|1
1133818|NCT02761993|2230704|FG002|Overall Study|Withdrawal by Subject|2
1133819|NCT02762084|2230725|FG000|Overall Study|Withdrawal by Subject|1
1133820|NCT02762084|2230726|FG001|Overall Study|Withdrawal by Subject|0
1133821|NCT02762084|2230727|FG002|Overall Study|Withdrawal by Subject|0
1133822|NCT02762084|2230725|FG000|Overall Study|Adverse Event|0
1133823|NCT02762084|2230726|FG001|Overall Study|Adverse Event|0
1133824|NCT02762084|2230727|FG002|Overall Study|Adverse Event|1
1133825|NCT02762370|2230748|FG000|Overall Study|Protocol Violation|1
1133826|NCT02762370|2230749|FG001|Overall Study|Protocol Violation|0
1133827|NCT02762500|2230759|FG000|Overall Study|Lack of Efficacy|1
1133828|NCT02762500|2230760|FG001|Overall Study|Lack of Efficacy|0
1133829|NCT02762500|2230759|FG000|Overall Study|Withdrawal by Subject|1
1133830|NCT02762500|2230760|FG001|Overall Study|Withdrawal by Subject|1
1133831|NCT02762500|2230759|FG000|Overall Study|Adverse Event|0
1133832|NCT02762500|2230760|FG001|Overall Study|Adverse Event|2
1133833|NCT02762565|2230770|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11
1133834|NCT02762578|2230776|FG000|Overall Study|Adverse Event|1
1133835|NCT02762578|2230777|FG001|Overall Study|Adverse Event|6
1133836|NCT02762578|2230776|FG000|Overall Study|Protocol Violation|4
1133837|NCT02762578|2230777|FG001|Overall Study|Protocol Violation|2
1133838|NCT02762578|2230776|FG000|Overall Study|Withdrawal by Subject|4
1133839|NCT02762578|2230777|FG001|Overall Study|Withdrawal by Subject|2
1133840|NCT02762578|2230776|FG000|Overall Study|Unclassified|6
1133841|NCT02762578|2230777|FG001|Overall Study|Unclassified|0
1133842|NCT02762994|2230816|FG000|Overall Study|Withdrawal by Subject|0
1133843|NCT02762994|2230817|FG001|Overall Study|Withdrawal by Subject|1
1133844|NCT02762994|2230818|FG002|Overall Study|Withdrawal by Subject|2
1133845|NCT02762994|2230819|FG003|Overall Study|Withdrawal by Subject|0
1133846|NCT02762994|2230816|FG000|Overall Study|Protocol Violation|1
1133847|NCT02762994|2230817|FG001|Overall Study|Protocol Violation|0
1133848|NCT02762994|2230818|FG002|Overall Study|Protocol Violation|0
1133849|NCT02762994|2230819|FG003|Overall Study|Protocol Violation|2
1133850|NCT02763046|2230836|FG000|Overall Study|Adverse Event|5
1133851|NCT02763046|2230837|FG001|Overall Study|Adverse Event|4
1133852|NCT02763046|2230838|FG002|Overall Study|Adverse Event|0
1133853|NCT02763046|2230836|FG000|Overall Study|Lack of Efficacy|1
1133854|NCT02763046|2230837|FG001|Overall Study|Lack of Efficacy|1
1133855|NCT02763046|2230838|FG002|Overall Study|Lack of Efficacy|3
1133856|NCT02763046|2230836|FG000|Overall Study|Physician Decision|1
1133857|NCT02763046|2230837|FG001|Overall Study|Physician Decision|0
1133858|NCT02763046|2230838|FG002|Overall Study|Physician Decision|1
1133859|NCT02763046|2230836|FG000|Overall Study|Subject/guardian decision|2
1133860|NCT02763046|2230837|FG001|Overall Study|Subject/guardian decision|0
1133861|NCT02763046|2230838|FG002|Overall Study|Subject/guardian decision|4
1133862|NCT02763189|2230858|FG000|Overall Study|Device failure|0
1133863|NCT02763189|2230859|FG001|Overall Study|Device failure|2
1133864|NCT02763215|2230865|FG000|Overall Study|Participants withdrew from study|3
1133865|NCT02763215|2230865|FG000|Overall Study|Missed visit|1
1133866|NCT02763215|2230865|FG000|Overall Study|Visit outside visit-window|1
1133867|NCT02763215|2230865|FG000|Overall Study|Death|1
1133868|NCT02763215|2230865|FG000|Overall Study|Lost to Follow-up|1
1133869|NCT02763254|2230869|FG000|Overall Study|Adverse Event|1
1133870|NCT02763566|2230877|FG000|Overall Study|Lost to Follow-up|1
1133871|NCT02763566|2230878|FG001|Overall Study|Lost to Follow-up|4
1133872|NCT02763566|2230879|FG002|Overall Study|Lost to Follow-up|0
1133873|NCT02763566|2230880|FG003|Overall Study|Lost to Follow-up|1
1133874|NCT02763566|2230877|FG000|Overall Study|On study treatment at study conclusion|114
1133875|NCT02763566|2230878|FG001|Overall Study|On study treatment at study conclusion|34
1133876|NCT02763566|2230879|FG002|Overall Study|On study treatment at study conclusion|54
1133877|NCT02763566|2230880|FG003|Overall Study|On study treatment at study conclusion|13
1133878|NCT02763566|2230877|FG000|Overall Study|Withdrawal by Subject|3
1133879|NCT02763566|2230878|FG001|Overall Study|Withdrawal by Subject|1
1133880|NCT02763566|2230879|FG002|Overall Study|Withdrawal by Subject|0
1133881|NCT02763566|2230880|FG003|Overall Study|Withdrawal by Subject|0
1133882|NCT02763579|2230896|FG000|Overall Study|Death|101
1133883|NCT02763579|2230897|FG001|Overall Study|Death|132
1133884|NCT02763579|2230896|FG000|Overall Study|Lost to Follow-up|3
1133885|NCT02763579|2230897|FG001|Overall Study|Lost to Follow-up|1
1133886|NCT02763579|2230896|FG000|Overall Study|Withdrawal by Subject|18
1133887|NCT02763579|2230897|FG001|Overall Study|Withdrawal by Subject|9
1133888|NCT02763579|2230896|FG000|Overall Study|Physician Decision|2
1133889|NCT02763579|2230897|FG001|Overall Study|Physician Decision|0
1133890|NCT02763579|2230896|FG000|Overall Study|On-going in study|77
1133891|NCT02763579|2230897|FG001|Overall Study|On-going in study|60
1133892|NCT02763644|2230905|FG000|Overall Study|Patient/guardian decision|1
1133893|NCT02763644|2230906|FG001|Overall Study|Patient/guardian decision|0
1133894|NCT02763644|2230905|FG000|Overall Study|Death|1
1133895|NCT02763644|2230906|FG001|Overall Study|Death|1
1133896|NCT02763644|2230905|FG000|Overall Study|Adverse Event|1
1133897|NCT02763644|2230906|FG001|Overall Study|Adverse Event|1
1133898|NCT02764151|2230961|FG000|Overall Study|Subject refused further follow-up|0
1133899|NCT02764151|2230962|FG001|Overall Study|Subject refused further follow-up|0
1133900|NCT02764151|2230963|FG002|Overall Study|Subject refused further follow-up|0
1133901|NCT02764151|2230964|FG003|Overall Study|Subject refused further follow-up|1
1133902|NCT02764151|2230961|FG000|Overall Study|Other|0
1133903|NCT02764151|2230962|FG001|Overall Study|Other|0
1133904|NCT02764151|2230963|FG002|Overall Study|Other|0
1133905|NCT02764151|2230964|FG003|Overall Study|Other|2
1133906|NCT02764190|2230980|FG000|Overall Study|Lost to Follow-up|17
1133907|NCT02764190|2230981|FG001|Overall Study|Lost to Follow-up|13
1133908|NCT02764229|2230987|FG000|Overall Study|Withdrawal by Subject|15
1133909|NCT02764229|2230987|FG000|Overall Study|Adverse Event|9
1133910|NCT02764229|2230987|FG000|Overall Study|Physician Decision|5
1133911|NCT02764229|2230987|FG000|Overall Study|Lost to Follow-up|3
1133912|NCT02764229|2230987|FG000|Overall Study|Lack of Efficacy|1
1133913|NCT02764229|2230987|FG000|Overall Study|Study Stopped by Sponsor|69
1133914|NCT02764320|2230993|FG000|Overall Study|Withdrawal by Subject|35
1133915|NCT02764320|2230994|FG001|Overall Study|Withdrawal by Subject|38
1133916|NCT02764320|2230993|FG000|Overall Study|Protocol Violation|11
1133917|NCT02764320|2230994|FG001|Overall Study|Protocol Violation|6
1133918|NCT02764320|2230993|FG000|Overall Study|Adverse Event|2
1133919|NCT02764320|2230994|FG001|Overall Study|Adverse Event|0
1133920|NCT02764320|2230993|FG000|Overall Study|Health Issues unable to continue|2
1133921|NCT02764320|2230994|FG001|Overall Study|Health Issues unable to continue|0
1133922|NCT02764320|2230993|FG000|Overall Study|Did not meet inclusion criteria|1
1133923|NCT02764320|2230994|FG001|Overall Study|Did not meet inclusion criteria|0
1133924|NCT02764320|2230993|FG000|Overall Study|Subject moved|0
1133925|NCT02764320|2230994|FG001|Overall Study|Subject moved|2
1133926|NCT02764320|2230993|FG000|Overall Study|Overused medication unavailable|0
1133927|NCT02764320|2230994|FG001|Overall Study|Overused medication unavailable|1
1133928|NCT02764320|2230993|FG000|Overall Study|Seeking care outside site|0
1133929|NCT02764320|2230994|FG001|Overall Study|Seeking care outside site|1
1133930|NCT02764320|2230993|FG000|Overall Study|Technology barriers|0
1133931|NCT02764320|2230994|FG001|Overall Study|Technology barriers|1
1133932|NCT02764333|2231000|FG000|Overall Study|Ineligible|1
1133933|NCT02764697|2231013|FG000|Overall Study|Lack of Efficacy|3
1133934|NCT02764762|2231017|FG000|Overall Study|Adverse Event|5
1133935|NCT02764762|2231017|FG000|Overall Study|Voluntary Withdrawal|3
1133936|NCT02764762|2231017|FG000|Overall Study|Significant Deviation|1
1133937|NCT02764775|2231021|FG000|Overall Study|Death|1
1133938|NCT02764775|2231021|FG000|Overall Study|Lost to Follow-up|2
1133939|NCT02764775|2231021|FG000|Overall Study|Withdrawal by Subject|3
1133940|NCT02765035|2231036|FG000|First Intervention (90 Days)|Adverse Event|1
1133941|NCT02765035|2231037|FG001|First Intervention (90 Days)|Adverse Event|1
1133942|NCT02765035|2231036|FG000|Second Intervention (30 Days)|Protocol Violation|2
1133943|NCT02765035|2231037|FG001|Second Intervention (30 Days)|Protocol Violation|2
1133944|NCT02765100|2231046|FG000|Overall Study|subject found ineligible after baseline|1
1133945|NCT02765100|2231047|FG001|Overall Study|subject found ineligible after baseline|1
1133946|NCT02765100|2231046|FG000|Overall Study|Lost to Follow-up|0
1133947|NCT02765100|2231047|FG001|Overall Study|Lost to Follow-up|1
1133948|NCT02765165|2231060|FG000|Treatment Period|Progressive disease|3
1133949|NCT02765165|2231061|FG001|Treatment Period|Progressive disease|2
1133950|NCT02765165|2231062|FG002|Treatment Period|Progressive disease|3
1133951|NCT02765165|2231063|FG003|Treatment Period|Progressive disease|3
1133952|NCT02765165|2231064|FG004|Treatment Period|Progressive disease|4
1133953|NCT02765165|2231065|FG005|Treatment Period|Progressive disease|2
1133954|NCT02765165|2231066|FG006|Treatment Period|Progressive disease|2
1133955|NCT02765165|2231060|FG000|Treatment Period|Physician Decision|0
1133956|NCT02765165|2231061|FG001|Treatment Period|Physician Decision|1
1133957|NCT02765165|2231062|FG002|Treatment Period|Physician Decision|0
1133958|NCT02765165|2231063|FG003|Treatment Period|Physician Decision|0
1133959|NCT02765165|2231064|FG004|Treatment Period|Physician Decision|0
1133960|NCT02765165|2231065|FG005|Treatment Period|Physician Decision|0
1133961|NCT02765165|2231066|FG006|Treatment Period|Physician Decision|0
1133962|NCT02765165|2231060|FG000|Treatment Period|Adverse Event|0
1133963|NCT02765165|2231061|FG001|Treatment Period|Adverse Event|1
1133964|NCT02765165|2231062|FG002|Treatment Period|Adverse Event|0
1133965|NCT02765165|2231063|FG003|Treatment Period|Adverse Event|0
1133966|NCT02765165|2231064|FG004|Treatment Period|Adverse Event|0
1133967|NCT02765165|2231065|FG005|Treatment Period|Adverse Event|0
1133968|NCT02765165|2231066|FG006|Treatment Period|Adverse Event|0
1133969|NCT02765165|2231060|FG000|Treatment Period|Withdrawal by Subject|0
1133970|NCT02765165|2231061|FG001|Treatment Period|Withdrawal by Subject|0
1133971|NCT02765165|2231062|FG002|Treatment Period|Withdrawal by Subject|0
1133972|NCT02765165|2231063|FG003|Treatment Period|Withdrawal by Subject|0
1133973|NCT02765165|2231064|FG004|Treatment Period|Withdrawal by Subject|2
1133974|NCT02765165|2231065|FG005|Treatment Period|Withdrawal by Subject|0
1133975|NCT02765165|2231066|FG006|Treatment Period|Withdrawal by Subject|0
1133976|NCT02765165|2231060|FG000|Treatment Period|Study terminated|0
1133977|NCT02765165|2231061|FG001|Treatment Period|Study terminated|0
1133978|NCT02765165|2231062|FG002|Treatment Period|Study terminated|0
1133979|NCT02765165|2231063|FG003|Treatment Period|Study terminated|0
1133980|NCT02765165|2231064|FG004|Treatment Period|Study terminated|0
900188|NCT00726232|1873271|FG001|Initial Phase (Dose-finding)|Unspecified reason|0
900189|NCT00726232|1873272|FG002|Initial Phase (Dose-finding)|Unspecified reason|0
900190|NCT00726232|1873273|FG003|Initial Phase (Dose-finding)|Unspecified reason|0
900191|NCT00726232|1873274|FG004|Initial Phase (Dose-finding)|Unspecified reason|0
900192|NCT00726232|1873275|FG005|Initial Phase (Dose-finding)|Unspecified reason|0
900193|NCT00726232|1873276|FG006|Initial Phase (Dose-finding)|Unspecified reason|0
1133981|NCT02765165|2231065|FG005|Treatment Period|Study terminated|1
1133982|NCT02765165|2231066|FG006|Treatment Period|Study terminated|2
1133983|NCT02765165|2231060|FG000|Post-treatment Follow-up|Death|1
1133984|NCT02765165|2231061|FG001|Post-treatment Follow-up|Death|2
1133985|NCT02765165|2231062|FG002|Post-treatment Follow-up|Death|1
1133986|NCT02765165|2231063|FG003|Post-treatment Follow-up|Death|1
1133987|NCT02765165|2231064|FG004|Post-treatment Follow-up|Death|1
1133988|NCT02765165|2231065|FG005|Post-treatment Follow-up|Death|1
1133989|NCT02765165|2231066|FG006|Post-treatment Follow-up|Death|0
1133990|NCT02765165|2231060|FG000|Post-treatment Follow-up|Lost to Follow-up|0
1133991|NCT02765165|2231061|FG001|Post-treatment Follow-up|Lost to Follow-up|0
1133992|NCT02765165|2231062|FG002|Post-treatment Follow-up|Lost to Follow-up|0
1133993|NCT02765165|2231063|FG003|Post-treatment Follow-up|Lost to Follow-up|1
1133994|NCT02765165|2231064|FG004|Post-treatment Follow-up|Lost to Follow-up|0
1133995|NCT02765165|2231065|FG005|Post-treatment Follow-up|Lost to Follow-up|0
1133996|NCT02765165|2231066|FG006|Post-treatment Follow-up|Lost to Follow-up|0
1133997|NCT02765165|2231060|FG000|Post-treatment Follow-up|Site terminated by sponsor|0
1133998|NCT02765165|2231061|FG001|Post-treatment Follow-up|Site terminated by sponsor|0
1133999|NCT02765165|2231062|FG002|Post-treatment Follow-up|Site terminated by sponsor|1
1134000|NCT02765165|2231063|FG003|Post-treatment Follow-up|Site terminated by sponsor|0
1134001|NCT02765165|2231064|FG004|Post-treatment Follow-up|Site terminated by sponsor|0
1134002|NCT02765165|2231065|FG005|Post-treatment Follow-up|Site terminated by sponsor|0
1134003|NCT02765165|2231066|FG006|Post-treatment Follow-up|Site terminated by sponsor|0
1134004|NCT02765165|2231060|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0
1134005|NCT02765165|2231061|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0
1134006|NCT02765165|2231062|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1
1134007|NCT02765165|2231063|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1
1134008|NCT02765165|2231064|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0
1134009|NCT02765165|2231065|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0
1134010|NCT02765165|2231066|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0
1134011|NCT02765165|2231060|FG000|Post-treatment Follow-up|Withdrawal by Subject|0
1134012|NCT02765165|2231061|FG001|Post-treatment Follow-up|Withdrawal by Subject|1
900194|NCT00726232|1873277|FG007|Initial Phase (Dose-finding)|Unspecified reason|0
900195|NCT00726232|1873270|FG000|Expansion Phase|Death|0
900196|NCT00726232|1873271|FG001|Expansion Phase|Death|0
900197|NCT00726232|1873272|FG002|Expansion Phase|Death|0
900198|NCT00726232|1873273|FG003|Expansion Phase|Death|0
900199|NCT00726232|1873274|FG004|Expansion Phase|Death|0
900200|NCT00726232|1873275|FG005|Expansion Phase|Death|0
900201|NCT00726232|1873276|FG006|Expansion Phase|Death|0
900202|NCT00726232|1873277|FG007|Expansion Phase|Death|1
900203|NCT00726232|1873270|FG000|Expansion Phase|Adverse Event|0
900204|NCT00726232|1873271|FG001|Expansion Phase|Adverse Event|0
900205|NCT00726232|1873272|FG002|Expansion Phase|Adverse Event|0
900206|NCT00726232|1873273|FG003|Expansion Phase|Adverse Event|0
900207|NCT00726232|1873274|FG004|Expansion Phase|Adverse Event|0
900208|NCT00726232|1873275|FG005|Expansion Phase|Adverse Event|0
900209|NCT00726232|1873276|FG006|Expansion Phase|Adverse Event|6
900210|NCT00726232|1873277|FG007|Expansion Phase|Adverse Event|11
900211|NCT00726232|1873270|FG000|Expansion Phase|Withdrawal by Subject|0
900212|NCT00726232|1873271|FG001|Expansion Phase|Withdrawal by Subject|0
900213|NCT00726232|1873272|FG002|Expansion Phase|Withdrawal by Subject|0
900214|NCT00726232|1873273|FG003|Expansion Phase|Withdrawal by Subject|0
900215|NCT00726232|1873274|FG004|Expansion Phase|Withdrawal by Subject|0
900216|NCT00726232|1873275|FG005|Expansion Phase|Withdrawal by Subject|0
900217|NCT00726232|1873276|FG006|Expansion Phase|Withdrawal by Subject|2
900218|NCT00726232|1873277|FG007|Expansion Phase|Withdrawal by Subject|3
900219|NCT00726232|1873270|FG000|Expansion Phase|Disease progression|0
900220|NCT00726232|1873271|FG001|Expansion Phase|Disease progression|0
900221|NCT00726232|1873272|FG002|Expansion Phase|Disease progression|0
900222|NCT00726232|1873273|FG003|Expansion Phase|Disease progression|0
900223|NCT00726232|1873274|FG004|Expansion Phase|Disease progression|0
900224|NCT00726232|1873275|FG005|Expansion Phase|Disease progression|0
900225|NCT00726232|1873276|FG006|Expansion Phase|Disease progression|4
900226|NCT00726232|1873277|FG007|Expansion Phase|Disease progression|0
1134013|NCT02765165|2231062|FG002|Post-treatment Follow-up|Withdrawal by Subject|0
1134014|NCT02765165|2231063|FG003|Post-treatment Follow-up|Withdrawal by Subject|0
1134015|NCT02765165|2231064|FG004|Post-treatment Follow-up|Withdrawal by Subject|0
1134016|NCT02765165|2231065|FG005|Post-treatment Follow-up|Withdrawal by Subject|0
1134017|NCT02765165|2231066|FG006|Post-treatment Follow-up|Withdrawal by Subject|0
1134018|NCT02765165|2231060|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0
1134019|NCT02765165|2231061|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0
1134020|NCT02765165|2231062|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0
1134021|NCT02765165|2231063|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0
1134022|NCT02765165|2231064|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2
1134023|NCT02765165|2231065|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2
1134024|NCT02765165|2231066|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1
1134025|NCT02765490|2231106|FG000|Overall Study|Lost to Follow-up|1
1134026|NCT02765490|2231107|FG001|Overall Study|Lost to Follow-up|1
1134027|NCT02765490|2231106|FG000|Overall Study|Other|0
1134028|NCT02765490|2231107|FG001|Overall Study|Other|1
1134029|NCT02765490|2231106|FG000|Overall Study|Death|0
1134030|NCT02765490|2231107|FG001|Overall Study|Death|1
1134031|NCT02766023|2231115|FG000|Overall Study|Lost to Follow-up|23
1134032|NCT02766023|2231116|FG001|Overall Study|Lost to Follow-up|11
1134033|NCT02766023|2231115|FG000|Overall Study|Pregnancy|1
1134034|NCT02766023|2231116|FG001|Overall Study|Pregnancy|0
1134035|NCT02766023|2231115|FG000|Overall Study|Adverse Event|1
1134036|NCT02766023|2231116|FG001|Overall Study|Adverse Event|0
1134037|NCT02766023|2231115|FG000|Overall Study|Withdrawal by Subject|4
1134038|NCT02766023|2231116|FG001|Overall Study|Withdrawal by Subject|5
1134039|NCT02766023|2231115|FG000|Overall Study|Physician Decision|1
1134040|NCT02766023|2231116|FG001|Overall Study|Physician Decision|0
1134041|NCT02766023|2231115|FG000|Overall Study|Not Eligible at Enrollment|0
1134042|NCT02766023|2231116|FG001|Overall Study|Not Eligible at Enrollment|1
1134043|NCT02766088|2231122|FG000|Overall Study|Sponsor study termination|498
1134044|NCT02766088|2231122|FG000|Overall Study|Migrated/moved from the study area|1
1134045|NCT02766088|2231122|FG000|Overall Study|Lost to Follow-up|5
1134046|NCT02766088|2231122|FG000|Overall Study|Other|1
1134047|NCT02766088|2231122|FG000|Overall Study|Death|1
1134048|NCT02766283|2231135|FG000|Overall Study|Lost to Follow-up|27
1134049|NCT02766400|2231154|FG000|Overall Study|Death|1
1134050|NCT02766400|2231155|FG001|Overall Study|Death|2
1134051|NCT02766400|2231154|FG000|Overall Study|Withdrawal by Subject|1
1134052|NCT02766400|2231155|FG001|Overall Study|Withdrawal by Subject|0
1134053|NCT02766608|2231179|FG000|Overall Study|Adverse Event|27
1134054|NCT02766608|2231180|FG001|Overall Study|Adverse Event|22
1134055|NCT02766608|2231181|FG002|Overall Study|Adverse Event|17
1134056|NCT02766608|2231182|FG003|Overall Study|Adverse Event|13
1134057|NCT02766608|2231183|FG004|Overall Study|Adverse Event|12
1134058|NCT02766608|2231179|FG000|Overall Study|Withdrawal by Subject|21
1134059|NCT02766608|2231180|FG001|Overall Study|Withdrawal by Subject|20
1134060|NCT02766608|2231181|FG002|Overall Study|Withdrawal by Subject|24
1134061|NCT02766608|2231182|FG003|Overall Study|Withdrawal by Subject|13
1134062|NCT02766608|2231183|FG004|Overall Study|Withdrawal by Subject|10
1134063|NCT02766608|2231179|FG000|Overall Study|Lack of Efficacy|16
1134064|NCT02766608|2231180|FG001|Overall Study|Lack of Efficacy|15
1134065|NCT02766608|2231181|FG002|Overall Study|Lack of Efficacy|32
1134066|NCT02766608|2231182|FG003|Overall Study|Lack of Efficacy|8
1134067|NCT02766608|2231183|FG004|Overall Study|Lack of Efficacy|2
1134068|NCT02766608|2231179|FG000|Overall Study|Lost to Follow-up|6
1134069|NCT02766608|2231180|FG001|Overall Study|Lost to Follow-up|3
1134070|NCT02766608|2231181|FG002|Overall Study|Lost to Follow-up|5
1134071|NCT02766608|2231182|FG003|Overall Study|Lost to Follow-up|2
1134072|NCT02766608|2231183|FG004|Overall Study|Lost to Follow-up|2
1134073|NCT02766608|2231179|FG000|Overall Study|Physician Decision|3
1134074|NCT02766608|2231180|FG001|Overall Study|Physician Decision|2
1134075|NCT02766608|2231181|FG002|Overall Study|Physician Decision|3
1134076|NCT02766608|2231182|FG003|Overall Study|Physician Decision|1
1134077|NCT02766608|2231183|FG004|Overall Study|Physician Decision|2
1134078|NCT02766608|2231179|FG000|Overall Study|Protocol disc criteria|3
1134079|NCT02766608|2231180|FG001|Overall Study|Protocol disc criteria|3
1134080|NCT02766608|2231181|FG002|Overall Study|Protocol disc criteria|4
1134081|NCT02766608|2231182|FG003|Overall Study|Protocol disc criteria|0
1134082|NCT02766608|2231183|FG004|Overall Study|Protocol disc criteria|0
1134083|NCT02766608|2231179|FG000|Overall Study|Protocol Violation|0
1134084|NCT02766608|2231180|FG001|Overall Study|Protocol Violation|4
1134085|NCT02766608|2231181|FG002|Overall Study|Protocol Violation|4
1134086|NCT02766608|2231182|FG003|Overall Study|Protocol Violation|0
1134087|NCT02766608|2231183|FG004|Overall Study|Protocol Violation|1
1134088|NCT02766608|2231179|FG000|Overall Study|Administrative Reasons|3
1134089|NCT02766608|2231180|FG001|Overall Study|Administrative Reasons|1
1134090|NCT02766608|2231181|FG002|Overall Study|Administrative Reasons|1
1134091|NCT02766608|2231182|FG003|Overall Study|Administrative Reasons|0
1134092|NCT02766608|2231183|FG004|Overall Study|Administrative Reasons|0
1134093|NCT02766777|2231211|FG000|Overall Study|Adverse Event|12
1134094|NCT02766777|2231211|FG000|Overall Study|Lost to Follow-up|16
1134095|NCT02766777|2231211|FG000|Overall Study|Non-Compliance With Study Drug|1
1134096|NCT02766777|2231211|FG000|Overall Study|Protocol Violation|1
1134097|NCT02766777|2231211|FG000|Overall Study|Withdrawal by Subject|4
1134098|NCT02767323|2231260|FG000|Overall Study|Withdrawal by Subject|17
1134099|NCT02767323|2231261|FG001|Overall Study|Withdrawal by Subject|5
1134100|NCT02767323|2231262|FG002|Overall Study|Withdrawal by Subject|13
1134101|NCT02767323|2231263|FG003|Overall Study|Withdrawal by Subject|0
1134102|NCT02767323|2231260|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
1134103|NCT02767323|2231261|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20
1134104|NCT02767323|2231262|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
1134105|NCT02767323|2231263|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0
1134106|NCT02767765|2231318|FG000|Overall Study|Adverse Event|4
1134107|NCT02767765|2231318|FG000|Overall Study|Death|1
1134108|NCT02767765|2231318|FG000|Overall Study|Insufficient response|1
1134109|NCT02767765|2231318|FG000|Overall Study|Lost to Follow-up|2
1134110|NCT02767765|2231318|FG000|Overall Study|Investigator decision|1
1134111|NCT02767765|2231318|FG000|Overall Study|Non-Compliance|1
1134112|NCT02767765|2231318|FG000|Overall Study|Withdrawal by Subject|1
1134113|NCT02768103|2231351|FG000|Overall Study|1 participant did not fit in the fMRI|1
1134114|NCT02768194|2231364|FG000|Period 1|Adverse Event|0
1134115|NCT02768194|2231365|FG001|Period 1|Adverse Event|0
1134116|NCT02768194|2231366|FG002|Period 1|Adverse Event|0
1134117|NCT02768194|2231367|FG003|Period 1|Adverse Event|1
1134118|NCT02768194|2231368|FG004|Period 1|Adverse Event|0
1134119|NCT02768194|2231369|FG005|Period 1|Adverse Event|0
1134120|NCT02768194|2231364|FG000|Period 2|Other (Reason not specified)|1
1134121|NCT02768194|2231365|FG001|Period 2|Other (Reason not specified)|0
1134122|NCT02768194|2231366|FG002|Period 2|Other (Reason not specified)|0
1134123|NCT02768194|2231367|FG003|Period 2|Other (Reason not specified)|0
1134124|NCT02768194|2231368|FG004|Period 2|Other (Reason not specified)|0
1134125|NCT02768194|2231369|FG005|Period 2|Other (Reason not specified)|0
1134126|NCT02768194|2231364|FG000|Period 3|Other (Reason not specified)|0
1134127|NCT02768194|2231365|FG001|Period 3|Other (Reason not specified)|1
1134128|NCT02768194|2231366|FG002|Period 3|Other (Reason not specified)|0
1134129|NCT02768194|2231367|FG003|Period 3|Other (Reason not specified)|0
1134130|NCT02768194|2231368|FG004|Period 3|Other (Reason not specified)|0
1134131|NCT02768194|2231369|FG005|Period 3|Other (Reason not specified)|0
1134132|NCT02768298|2231379|FG000|Overall Study|Adverse Event|1
1134133|NCT02768298|2231380|FG001|Overall Study|Adverse Event|4
1134134|NCT02768298|2231379|FG000|Overall Study|Death|2
1134135|NCT02768298|2231380|FG001|Overall Study|Death|1
1134136|NCT02768298|2231379|FG000|Overall Study|Non-compliance with study treatment|0
1134137|NCT02768298|2231380|FG001|Overall Study|Non-compliance with study treatment|1
1134138|NCT02768298|2231379|FG000|Overall Study|Subject/guardian decision|1
1134139|NCT02768298|2231380|FG001|Overall Study|Subject/guardian decision|0
1134140|NCT02768298|2231379|FG000|Overall Study|Withdrawal of informed consent|0
1134141|NCT02768298|2231380|FG001|Overall Study|Withdrawal of informed consent|1
1134142|NCT02768792|2231404|FG000|Overall Study|Adverse Event|1
1134143|NCT02768870|2231408|FG000|Overall Study|Not Implanted with Device|2
1134144|NCT02768870|2231408|FG000|Overall Study|Death|1
1134145|NCT02768870|2231408|FG000|Overall Study|Reoperation|4
1134146|NCT02768870|2231408|FG000|Overall Study|On Study|19
1134147|NCT02769065|2231442|FG000|Overall Study|Voluntary Withdrawal|1
1134148|NCT02769065|2231443|FG001|Overall Study|Voluntary Withdrawal|0
1134149|NCT02769065|2231444|FG002|Overall Study|Voluntary Withdrawal|0
1134150|NCT02769065|2231445|FG003|Overall Study|Voluntary Withdrawal|0
1134151|NCT02769065|2231446|FG004|Overall Study|Voluntary Withdrawal|0
1134152|NCT02769065|2231447|FG005|Overall Study|Voluntary Withdrawal|0
1134153|NCT02769065|2231448|FG006|Overall Study|Voluntary Withdrawal|0
1134154|NCT02769065|2231449|FG007|Overall Study|Voluntary Withdrawal|0
1134155|NCT02769065|2231450|FG008|Overall Study|Voluntary Withdrawal|0
1134156|NCT02769065|2231451|FG009|Overall Study|Voluntary Withdrawal|0
1134157|NCT02769065|2231452|FG010|Overall Study|Voluntary Withdrawal|0
1134158|NCT02769065|2231453|FG011|Overall Study|Voluntary Withdrawal|0
1134159|NCT02769065|2231454|FG012|Overall Study|Voluntary Withdrawal|0
1134160|NCT02769065|2231455|FG013|Overall Study|Voluntary Withdrawal|0
1134161|NCT02769065|2231456|FG014|Overall Study|Voluntary Withdrawal|0
1134162|NCT02769065|2231457|FG015|Overall Study|Voluntary Withdrawal|0
1134163|NCT02769065|2231458|FG016|Overall Study|Voluntary Withdrawal|0
1134164|NCT02769065|2231459|FG017|Overall Study|Voluntary Withdrawal|0
1134165|NCT02769065|2231460|FG018|Overall Study|Voluntary Withdrawal|0
1134166|NCT02769065|2231461|FG019|Overall Study|Voluntary Withdrawal|0
1134167|NCT02769065|2231462|FG020|Overall Study|Voluntary Withdrawal|0
1134168|NCT02769065|2231463|FG021|Overall Study|Voluntary Withdrawal|0
1134169|NCT02769065|2231464|FG022|Overall Study|Voluntary Withdrawal|0
1134170|NCT02769065|2231465|FG023|Overall Study|Voluntary Withdrawal|0
1134171|NCT02769065|2231466|FG024|Overall Study|Voluntary Withdrawal|0
1134172|NCT02769065|2231467|FG025|Overall Study|Voluntary Withdrawal|0
1134173|NCT02769065|2231468|FG026|Overall Study|Voluntary Withdrawal|0
1134174|NCT02769065|2231469|FG027|Overall Study|Voluntary Withdrawal|0
1134175|NCT02769065|2231470|FG028|Overall Study|Voluntary Withdrawal|0
1134176|NCT02769065|2231471|FG029|Overall Study|Voluntary Withdrawal|0
1134177|NCT02769065|2231442|FG000|Overall Study|Reason Not Specified|0
1134178|NCT02769065|2231443|FG001|Overall Study|Reason Not Specified|0
1134179|NCT02769065|2231444|FG002|Overall Study|Reason Not Specified|0
1134180|NCT02769065|2231445|FG003|Overall Study|Reason Not Specified|0
1134181|NCT02769065|2231446|FG004|Overall Study|Reason Not Specified|0
1134182|NCT02769065|2231447|FG005|Overall Study|Reason Not Specified|0
1134183|NCT02769065|2231448|FG006|Overall Study|Reason Not Specified|1
1134184|NCT02769065|2231449|FG007|Overall Study|Reason Not Specified|0
1134185|NCT02769065|2231450|FG008|Overall Study|Reason Not Specified|0
1134186|NCT02769065|2231451|FG009|Overall Study|Reason Not Specified|0
1134187|NCT02769065|2231452|FG010|Overall Study|Reason Not Specified|0
1134188|NCT02769065|2231453|FG011|Overall Study|Reason Not Specified|0
1134189|NCT02769065|2231454|FG012|Overall Study|Reason Not Specified|0
1134190|NCT02769065|2231455|FG013|Overall Study|Reason Not Specified|0
1134191|NCT02769065|2231456|FG014|Overall Study|Reason Not Specified|0
1134192|NCT02769065|2231457|FG015|Overall Study|Reason Not Specified|0
1134193|NCT02769065|2231458|FG016|Overall Study|Reason Not Specified|0
1134194|NCT02769065|2231459|FG017|Overall Study|Reason Not Specified|0
1134195|NCT02769065|2231460|FG018|Overall Study|Reason Not Specified|0
1134196|NCT02769065|2231461|FG019|Overall Study|Reason Not Specified|0
1134197|NCT02769065|2231462|FG020|Overall Study|Reason Not Specified|0
1134198|NCT02769065|2231463|FG021|Overall Study|Reason Not Specified|0
1134199|NCT02769065|2231464|FG022|Overall Study|Reason Not Specified|0
1134200|NCT02769065|2231465|FG023|Overall Study|Reason Not Specified|0
1134201|NCT02769065|2231466|FG024|Overall Study|Reason Not Specified|0
1134202|NCT02769065|2231467|FG025|Overall Study|Reason Not Specified|0
1134203|NCT02769065|2231468|FG026|Overall Study|Reason Not Specified|0
1134204|NCT02769065|2231469|FG027|Overall Study|Reason Not Specified|0
1134205|NCT02769065|2231470|FG028|Overall Study|Reason Not Specified|0
1134206|NCT02769065|2231471|FG029|Overall Study|Reason Not Specified|0
1134207|NCT02769065|2231442|FG000|Overall Study|Pre-treatment Event/Adverse Event|0
1134208|NCT02769065|2231443|FG001|Overall Study|Pre-treatment Event/Adverse Event|0
1134209|NCT02769065|2231444|FG002|Overall Study|Pre-treatment Event/Adverse Event|0
1134210|NCT02769065|2231445|FG003|Overall Study|Pre-treatment Event/Adverse Event|0
1134211|NCT02769065|2231446|FG004|Overall Study|Pre-treatment Event/Adverse Event|0
1134212|NCT02769065|2231447|FG005|Overall Study|Pre-treatment Event/Adverse Event|0
1134213|NCT02769065|2231448|FG006|Overall Study|Pre-treatment Event/Adverse Event|0
1134214|NCT02769065|2231449|FG007|Overall Study|Pre-treatment Event/Adverse Event|0
1134215|NCT02769065|2231450|FG008|Overall Study|Pre-treatment Event/Adverse Event|0
1134216|NCT02769065|2231451|FG009|Overall Study|Pre-treatment Event/Adverse Event|0
1134217|NCT02769065|2231452|FG010|Overall Study|Pre-treatment Event/Adverse Event|1
1134218|NCT02769065|2231453|FG011|Overall Study|Pre-treatment Event/Adverse Event|0
1134219|NCT02769065|2231454|FG012|Overall Study|Pre-treatment Event/Adverse Event|0
1134220|NCT02769065|2231455|FG013|Overall Study|Pre-treatment Event/Adverse Event|0
1134221|NCT02769065|2231456|FG014|Overall Study|Pre-treatment Event/Adverse Event|0
1134222|NCT02769065|2231457|FG015|Overall Study|Pre-treatment Event/Adverse Event|0
1134223|NCT02769065|2231458|FG016|Overall Study|Pre-treatment Event/Adverse Event|0
1134224|NCT02769065|2231459|FG017|Overall Study|Pre-treatment Event/Adverse Event|0
1134225|NCT02769065|2231460|FG018|Overall Study|Pre-treatment Event/Adverse Event|0
1134226|NCT02769065|2231461|FG019|Overall Study|Pre-treatment Event/Adverse Event|0
1134227|NCT02769065|2231462|FG020|Overall Study|Pre-treatment Event/Adverse Event|0
1134228|NCT02769065|2231463|FG021|Overall Study|Pre-treatment Event/Adverse Event|0
1134229|NCT02769065|2231464|FG022|Overall Study|Pre-treatment Event/Adverse Event|0
1134230|NCT02769065|2231465|FG023|Overall Study|Pre-treatment Event/Adverse Event|0
1134231|NCT02769065|2231466|FG024|Overall Study|Pre-treatment Event/Adverse Event|0
1134232|NCT02769065|2231467|FG025|Overall Study|Pre-treatment Event/Adverse Event|0
1134233|NCT02769065|2231468|FG026|Overall Study|Pre-treatment Event/Adverse Event|0
1134234|NCT02769065|2231469|FG027|Overall Study|Pre-treatment Event/Adverse Event|0
1134235|NCT02769065|2231470|FG028|Overall Study|Pre-treatment Event/Adverse Event|0
1134236|NCT02769065|2231471|FG029|Overall Study|Pre-treatment Event/Adverse Event|0
1134237|NCT02769247|2231568|FG000|Overall Study|Withdrawal by Subject|1
1134238|NCT02769247|2231569|FG001|Overall Study|Withdrawal by Subject|0
1134239|NCT02769247|2231570|FG002|Overall Study|Withdrawal by Subject|0
1134240|NCT02769247|2231571|FG003|Overall Study|Withdrawal by Subject|1
1134241|NCT02769247|2231568|FG000|Overall Study|Protocol Violation|0
1134242|NCT02769247|2231569|FG001|Overall Study|Protocol Violation|0
1134243|NCT02769247|2231570|FG002|Overall Study|Protocol Violation|1
1134244|NCT02769247|2231571|FG003|Overall Study|Protocol Violation|0
1134245|NCT02769247|2231568|FG000|Overall Study|Physician Decision|1
1134246|NCT02769247|2231569|FG001|Overall Study|Physician Decision|0
1134247|NCT02769247|2231570|FG002|Overall Study|Physician Decision|0
1134248|NCT02769247|2231571|FG003|Overall Study|Physician Decision|0
1134249|NCT02769312|2231587|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
1134250|NCT02769312|2231588|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
1134251|NCT02769312|2231587|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1
1134252|NCT02769312|2231588|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0
1134253|NCT02769312|2231587|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
1134254|NCT02769312|2231588|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
1134255|NCT02769312|2231587|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
1134256|NCT02769312|2231588|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
1134257|NCT02769312|2231587|FG000|Follow-up|Lost to Follow-up|1
1134258|NCT02769312|2231588|FG001|Follow-up|Lost to Follow-up|1
1134259|NCT02769481|2231611|FG000|Overall Study|Protocol Violation|1
1134260|NCT02769481|2231612|FG001|Overall Study|Protocol Violation|0
1134261|NCT02769481|2231611|FG000|Overall Study|Adverse Event|3
1134262|NCT02769481|2231612|FG001|Overall Study|Adverse Event|6
1134263|NCT02769481|2231611|FG000|Overall Study|Entry Criteria Not Met|1
1134264|NCT02769481|2231612|FG001|Overall Study|Entry Criteria Not Met|2
1134265|NCT02769481|2231611|FG000|Overall Study|Withdrawal by Subject|14
1134266|NCT02769481|2231612|FG001|Overall Study|Withdrawal by Subject|16
1134267|NCT02769481|2231611|FG000|Overall Study|Lost to Follow-up|9
1134268|NCT02769481|2231612|FG001|Overall Study|Lost to Follow-up|9
1134269|NCT02769481|2231611|FG000|Overall Study|Physician Decision|0
1134270|NCT02769481|2231612|FG001|Overall Study|Physician Decision|1
1134271|NCT02769481|2231611|FG000|Overall Study|Terminated by Sponsor|1
1134272|NCT02769481|2231612|FG001|Overall Study|Terminated by Sponsor|0
1134273|NCT02769481|2231611|FG000|Overall Study|Death|0
1134274|NCT02769481|2231612|FG001|Overall Study|Death|1
1134275|NCT02769481|2231611|FG000|Overall Study|Undefined|4
1134276|NCT02769481|2231612|FG001|Overall Study|Undefined|1
1134277|NCT02769624|2231618|FG000|Overall Study|Lost to Follow-up|0
1134278|NCT02769624|2231619|FG001|Overall Study|Lost to Follow-up|1
1134279|NCT02769858|2231629|FG000|Overall Study|Withdrawal by Subject|2
1134280|NCT02770170|2231642|FG000|Overall Study|Withdrawal by Subject|0
1134281|NCT02770170|2231643|FG001|Overall Study|Withdrawal by Subject|0
1134282|NCT02770170|2231644|FG002|Overall Study|Withdrawal by Subject|0
1134283|NCT02770170|2231645|FG003|Overall Study|Withdrawal by Subject|2
1134284|NCT02770170|2231642|FG000|Overall Study|due to pregnancy|1
1134285|NCT02770170|2231643|FG001|Overall Study|due to pregnancy|0
1134286|NCT02770170|2231644|FG002|Overall Study|due to pregnancy|0
1134287|NCT02770170|2231645|FG003|Overall Study|due to pregnancy|0
1134288|NCT02770170|2231642|FG000|Overall Study|Lack of Efficacy|2
1134289|NCT02770170|2231643|FG001|Overall Study|Lack of Efficacy|0
1134290|NCT02770170|2231644|FG002|Overall Study|Lack of Efficacy|0
1134291|NCT02770170|2231645|FG003|Overall Study|Lack of Efficacy|1
1134292|NCT02770170|2231642|FG000|Overall Study|Adverse Event|4
1134293|NCT02770170|2231643|FG001|Overall Study|Adverse Event|3
1134294|NCT02770170|2231644|FG002|Overall Study|Adverse Event|5
1134295|NCT02770170|2231645|FG003|Overall Study|Adverse Event|3
1134296|NCT02770170|2231642|FG000|Overall Study|due to disease worsening|0
1134297|NCT02770170|2231643|FG001|Overall Study|due to disease worsening|0
1134298|NCT02770170|2231644|FG002|Overall Study|due to disease worsening|0
1134299|NCT02770170|2231645|FG003|Overall Study|due to disease worsening|1
1134300|NCT02770248|2231657|FG000|Overall Study|Adverse Event|0
1134301|NCT02770248|2231658|FG001|Overall Study|Adverse Event|1
1134302|NCT02770248|2231657|FG000|Overall Study|Randomized in error, prior to treatment|0
1134303|NCT02770248|2231658|FG001|Overall Study|Randomized in error, prior to treatment|1
1134304|NCT02770547|2231711|FG000|Overall Study|Patient non-compliant|1
1134305|NCT02770547|2231712|FG001|Overall Study|Patient non-compliant|0
1134306|NCT02770547|2231711|FG000|Overall Study|Adverse Event|0
1134307|NCT02770547|2231712|FG001|Overall Study|Adverse Event|1
1134308|NCT02770612|2231718|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1
1134309|NCT02770820|2231726|FG000|Overall Study|Death|1
1134310|NCT02770820|2231726|FG000|Overall Study|Physician Decision|2
1134311|NCT02771145|2231750|FG000|Overall Study|Adverse Event|3
1134312|NCT02771145|2231750|FG000|Overall Study|Lost to Follow-up|1
1134313|NCT02771210|2231772|FG000|Period 1|Adverse Event|5
1134314|NCT02771210|2231773|FG001|Period 1|Adverse Event|3
1134315|NCT02771210|2231772|FG000|Period 1|Lack of Efficacy|3
1134316|NCT02771210|2231773|FG001|Period 1|Lack of Efficacy|6
1134317|NCT02771210|2231772|FG000|Period 1|Lost to Follow-up|2
1134318|NCT02771210|2231773|FG001|Period 1|Lost to Follow-up|0
1134319|NCT02771210|2231772|FG000|Period 1|Physician Decision|0
1134320|NCT02771210|2231773|FG001|Period 1|Physician Decision|1
1134321|NCT02771210|2231772|FG000|Period 1|Withdrawal by Subject|0
1134322|NCT02771210|2231773|FG001|Period 1|Withdrawal by Subject|3
1134323|NCT02771210|2231772|FG000|Period 1|Withdrawal of informed consent|1
1134324|NCT02771210|2231773|FG001|Period 1|Withdrawal of informed consent|5
1134325|NCT02771210|2231772|FG000|Period 2|Adverse Event|1
1134326|NCT02771210|2231773|FG001|Period 2|Adverse Event|0
1134327|NCT02771210|2231772|FG000|Period 2|Lack of Efficacy|0
1134328|NCT02771210|2231773|FG001|Period 2|Lack of Efficacy|1
1134329|NCT02771210|2231772|FG000|Period 2|Withdrawal by Subject|1
1134330|NCT02771210|2231773|FG001|Period 2|Withdrawal by Subject|0
1134331|NCT02771210|2231772|FG000|Period 2|Withdrawal of informed consent|0
1134332|NCT02771210|2231773|FG001|Period 2|Withdrawal of informed consent|2
1134333|NCT02771275|2231779|FG000|Overall Study|Reoperation|2
1134334|NCT02771275|2231779|FG000|Overall Study|On Study|11
1134335|NCT02771366|2231798|FG000|Period 1|Withdrawal by Subject|0
1134336|NCT02771366|2231799|FG001|Period 1|Withdrawal by Subject|2
1134337|NCT02771366|2231798|FG000|Period 2 (Crossover)|Withdrawal by Subject|2
1134338|NCT02771366|2231799|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
1134339|NCT02771522|2231806|FG000|Overall Study|Lost to Follow-up|3
1134340|NCT02771522|2231806|FG000|Overall Study|Withdrawal by Subject|2
1134341|NCT02771522|2231806|FG000|Overall Study|No white spot lesions|3
1134342|NCT02772757|2231874|FG000|Overall Study|Withdrawal by Subject|1
1134343|NCT02772757|2231875|FG001|Overall Study|Withdrawal by Subject|0
1134344|NCT02772757|2231876|FG002|Overall Study|Withdrawal by Subject|1
1134345|NCT02772757|2231874|FG000|Overall Study|Protocol Violation|0
1134346|NCT02772757|2231875|FG001|Overall Study|Protocol Violation|0
1134347|NCT02772757|2231876|FG002|Overall Study|Protocol Violation|1
1134348|NCT02772757|2231874|FG000|Overall Study|Physician Decision|0
1134349|NCT02772757|2231875|FG001|Overall Study|Physician Decision|3
1134350|NCT02772757|2231876|FG002|Overall Study|Physician Decision|3
1134351|NCT02772809|2231894|FG000|Overall Study|not completed some tasks|6
1134352|NCT02772978|2231903|FG000|Overall Study|Withdrawal by Subject|1
1134353|NCT02772978|2231904|FG001|Overall Study|Withdrawal by Subject|1
1134354|NCT02773368|2231911|FG000|Overall Study|Lost to Follow-up|4
1134355|NCT02773368|2231912|FG001|Overall Study|Lost to Follow-up|1
1134356|NCT02773368|2231911|FG000|Overall Study|Withdrawal by Subject|5
1134357|NCT02773368|2231912|FG001|Overall Study|Withdrawal by Subject|1
1134358|NCT02773368|2231911|FG000|Overall Study|Unclassified|1
1134359|NCT02773368|2231912|FG001|Overall Study|Unclassified|1
1134360|NCT02773368|2231911|FG000|Overall Study|Missing|0
1134361|NCT02773368|2231912|FG001|Overall Study|Missing|1
1134362|NCT02773446|2231924|FG000|First Admission|Withdrawal by Subject|0
1134363|NCT02773446|2231925|FG001|First Admission|Withdrawal by Subject|0
1134364|NCT02773446|2231926|FG002|First Admission|Withdrawal by Subject|0
1134365|NCT02773446|2231927|FG003|First Admission|Withdrawal by Subject|1
1134366|NCT02773446|2231928|FG004|First Admission|Withdrawal by Subject|0
1134367|NCT02773446|2231929|FG005|First Admission|Withdrawal by Subject|0
1134368|NCT02773446|2231924|FG000|First Admission|Lost to Follow-up|1
1134369|NCT02773446|2231925|FG001|First Admission|Lost to Follow-up|0
1134370|NCT02773446|2231926|FG002|First Admission|Lost to Follow-up|0
1134371|NCT02773446|2231927|FG003|First Admission|Lost to Follow-up|0
1134372|NCT02773446|2231928|FG004|First Admission|Lost to Follow-up|0
1134373|NCT02773446|2231929|FG005|First Admission|Lost to Follow-up|0
1134374|NCT02773537|2231949|FG000|Overall Study|Lost to Follow-up|0
1134375|NCT02773537|2231950|FG001|Overall Study|Lost to Follow-up|1
1134376|NCT02773537|2231951|FG002|Overall Study|Lost to Follow-up|4
1134377|NCT02774278|2232021|FG000|Overall Study|Lack of Efficacy|199
1134378|NCT02774278|2232021|FG000|Overall Study|Death|29
1134379|NCT02774278|2232021|FG000|Overall Study|Adverse event/intercurrent illness|16
1134380|NCT02774278|2232021|FG000|Overall Study|Refused treatment/did not cooperate|9
1134381|NCT02774278|2232021|FG000|Overall Study|Administrative reasons|6
1134382|NCT02774278|2232021|FG000|Overall Study|Withdrawal by Subject|3
1134383|NCT02774278|2232021|FG000|Overall Study|Protocol Violation|2
1134384|NCT02774681|2232049|FG000|Treatment on Study|Progressive Disease|7
1134385|NCT02774681|2232049|FG000|Follow-Up for 3 Years|Death|11
1134386|NCT02774681|2232049|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1
1134387|NCT02775344|2232092|FG000|Overall Study|No ovarian cyst identified|3
1134388|NCT02775344|2232093|FG001|Overall Study|No ovarian cyst identified|2
1134405|NCT02775864|2232121|FG000|Overall Study|Data ended end of 2010|1764
1134406|NCT02775864|2232122|FG001|Overall Study|Data ended end of 2010|2880
1134407|NCT02775864|2232123|FG002|Overall Study|Data ended end of 2010|1140
1134408|NCT02775864|2232124|FG003|Overall Study|Data ended end of 2010|1194
1134409|NCT02775864|2232121|FG000|Overall Study|Medicaid eligibility discontinued|1478
1134410|NCT02775864|2232122|FG001|Overall Study|Medicaid eligibility discontinued|2019
1134411|NCT02775864|2232123|FG002|Overall Study|Medicaid eligibility discontinued|720
1134412|NCT02775864|2232124|FG003|Overall Study|Medicaid eligibility discontinued|890
1134413|NCT02775903|2232139|FG000|Overall Study|Ongoing|14
1134414|NCT02775903|2232140|FG001|Overall Study|Ongoing|15
1134415|NCT02775903|2232141|FG002|Overall Study|Ongoing|15
1134416|NCT02775903|2232142|FG003|Overall Study|Ongoing|19
1134417|NCT02775903|2232139|FG000|Overall Study|Death|19
1134418|NCT02775903|2232140|FG001|Overall Study|Death|18
1134419|NCT02775903|2232141|FG002|Overall Study|Death|38
1134420|NCT02775903|2232142|FG003|Overall Study|Death|35
1134421|NCT02775903|2232139|FG000|Overall Study|Withdrawal by Subject|5
1134422|NCT02775903|2232140|FG001|Overall Study|Withdrawal by Subject|5
1134423|NCT02775903|2232141|FG002|Overall Study|Withdrawal by Subject|5
1134424|NCT02775903|2232142|FG003|Overall Study|Withdrawal by Subject|4
1134425|NCT02775903|2232139|FG000|Overall Study|Adverse Event|0
1134426|NCT02775903|2232140|FG001|Overall Study|Adverse Event|0
1134427|NCT02775903|2232141|FG002|Overall Study|Adverse Event|1
1134428|NCT02775903|2232142|FG003|Overall Study|Adverse Event|1
1134429|NCT02775903|2232139|FG000|Overall Study|Lost to Follow-up|0
1134430|NCT02775903|2232140|FG001|Overall Study|Lost to Follow-up|0
1134431|NCT02775903|2232141|FG002|Overall Study|Lost to Follow-up|1
1134432|NCT02775903|2232142|FG003|Overall Study|Lost to Follow-up|1
1134433|NCT02775903|2232139|FG000|Overall Study|Other-Miscellaneous|4
1134434|NCT02775903|2232140|FG001|Overall Study|Other-Miscellaneous|3
1134435|NCT02775903|2232141|FG002|Overall Study|Other-Miscellaneous|4
1134436|NCT02775903|2232142|FG003|Overall Study|Other-Miscellaneous|5
1134437|NCT02775916|2232158|FG000|Overall Study|Adverse Event|1
1134438|NCT02775916|2232159|FG001|Overall Study|Adverse Event|0
1134439|NCT02775916|2232158|FG000|Overall Study|Subject/Guardian Decision|2
1134440|NCT02775916|2232159|FG001|Overall Study|Subject/Guardian Decision|0
1134441|NCT02776033|2232168|FG000|Overall Study|Withdrawal by Subject|0
1134442|NCT02776033|2232169|FG001|Overall Study|Withdrawal by Subject|0
1134443|NCT02776033|2232170|FG002|Overall Study|Withdrawal by Subject|2
1134444|NCT02776033|2232168|FG000|Overall Study|Physician Decision|2
1134445|NCT02776033|2232169|FG001|Overall Study|Physician Decision|0
1134446|NCT02776033|2232170|FG002|Overall Study|Physician Decision|0
1134447|NCT02776033|2232168|FG000|Overall Study|Lost to Follow-up|1
1134448|NCT02776033|2232169|FG001|Overall Study|Lost to Follow-up|0
1134449|NCT02776033|2232170|FG002|Overall Study|Lost to Follow-up|0
1134450|NCT02776033|2232168|FG000|Overall Study|Adverse Event|1
1134451|NCT02776033|2232169|FG001|Overall Study|Adverse Event|2
1134452|NCT02776033|2232170|FG002|Overall Study|Adverse Event|0
1134453|NCT02776553|2232186|FG000|Overall Study|Lost to Follow-up|1
1134454|NCT02776553|2232187|FG001|Overall Study|Lost to Follow-up|0
1134455|NCT02776553|2232186|FG000|Overall Study|got liver transplant|1
1134456|NCT02776553|2232187|FG001|Overall Study|got liver transplant|2
1134457|NCT02776553|2232186|FG000|Overall Study|had other surgery|1
1134458|NCT02776553|2232187|FG001|Overall Study|had other surgery|0
1134459|NCT02776553|2232186|FG000|Overall Study|Protocol Violation|0
1134460|NCT02776553|2232187|FG001|Overall Study|Protocol Violation|1
1134461|NCT02776670|2232204|FG000|Overall Study|Adverse Event|0
1134462|NCT02776670|2232205|FG001|Overall Study|Adverse Event|2
1134463|NCT02776670|2232204|FG000|Overall Study|Protocol Violation|0
1134464|NCT02776670|2232205|FG001|Overall Study|Protocol Violation|2
1134465|NCT02776670|2232204|FG000|Overall Study|Withdrawal by Subject|0
1134466|NCT02776670|2232205|FG001|Overall Study|Withdrawal by Subject|1
1134467|NCT02776670|2232204|FG000|Overall Study|Other - Reason not given|0
1134468|NCT02776670|2232205|FG001|Overall Study|Other - Reason not given|1
1134469|NCT02776683|2232211|FG000|Pre-switch Period|Protocol Violation|1
1134470|NCT02776683|2232212|FG001|Pre-switch Period|Protocol Violation|0
1134471|NCT02776683|2232211|FG000|Pre-switch Period|Adverse Event|21
1134472|NCT02776683|2232212|FG001|Pre-switch Period|Adverse Event|0
1134473|NCT02776683|2232211|FG000|Pre-switch Period|Withdrawal by Subject|9
1134474|NCT02776683|2232212|FG001|Pre-switch Period|Withdrawal by Subject|0
1134475|NCT02776683|2232211|FG000|Pre-switch Period|Physician Decision|7
1134476|NCT02776683|2232212|FG001|Pre-switch Period|Physician Decision|0
1134477|NCT02776683|2232211|FG000|Pre-switch Period|Progressive disease|39
1134478|NCT02776683|2232212|FG001|Pre-switch Period|Progressive disease|0
1134479|NCT02776683|2232211|FG000|Pre-switch Period|Other than listed|3
1134480|NCT02776683|2232212|FG001|Pre-switch Period|Other than listed|0
1134481|NCT02776683|2232211|FG000|Post-switch Period|Adverse Event|0
1134482|NCT02776683|2232212|FG001|Post-switch Period|Adverse Event|3
1134483|NCT02776683|2232211|FG000|Post-switch Period|Withdrawal by Subject|0
1134484|NCT02776683|2232212|FG001|Post-switch Period|Withdrawal by Subject|2
1134485|NCT02776683|2232211|FG000|Post-switch Period|Physician Decision|0
1134486|NCT02776683|2232212|FG001|Post-switch Period|Physician Decision|3
1134487|NCT02776683|2232211|FG000|Post-switch Period|Progressive disease|0
1134488|NCT02776683|2232212|FG001|Post-switch Period|Progressive disease|20
1134489|NCT02776683|2232211|FG000|Post-switch Period|Other than listed|0
1134490|NCT02776683|2232212|FG001|Post-switch Period|Other than listed|15
1134491|NCT02777086|2232247|FG000|Overall Study|Lost to Follow-up|96
1134492|NCT02777086|2232248|FG001|Overall Study|Lost to Follow-up|99
1134493|NCT02777125|2232256|FG000|Overall Study|Consent form violation|14
1134494|NCT02777125|2232257|FG001|Overall Study|Consent form violation|12
1134495|NCT02777125|2232256|FG000|Overall Study|Assent form violation|21
1134496|NCT02777125|2232257|FG001|Overall Study|Assent form violation|23
1134497|NCT02777125|2232256|FG000|Overall Study|Protocol Violation|8
1134498|NCT02777125|2232257|FG001|Overall Study|Protocol Violation|12
1134499|NCT02777242|2232264|FG000|Overall Study|Other|2
1134500|NCT02777242|2232264|FG000|Overall Study|Lost to Follow-up|1
1134501|NCT02777242|2232264|FG000|Overall Study|Multiple|1
1134502|NCT02777242|2232264|FG000|Overall Study|Sponsor's request|1
1134503|NCT02777242|2232264|FG000|Overall Study|Withdrawal by Subject|1
1134504|NCT02777333|2232292|FG000|Overall Study|Withdrawal by Subject|0
1134505|NCT02777333|2232293|FG001|Overall Study|Withdrawal by Subject|1
1134506|NCT02777333|2232292|FG000|Overall Study|Lost to Follow-up|0
1134507|NCT02777333|2232293|FG001|Overall Study|Lost to Follow-up|1
1134508|NCT02777554|2232301|FG000|Overall Study|Adverse Event|4
1134509|NCT02777554|2232302|FG001|Overall Study|Adverse Event|4
1134510|NCT02777554|2232303|FG002|Overall Study|Adverse Event|0
1134511|NCT02777554|2232304|FG003|Overall Study|Adverse Event|1
1134512|NCT02777554|2232305|FG004|Overall Study|Adverse Event|0
1134513|NCT02777554|2232306|FG005|Overall Study|Adverse Event|0
1134514|NCT02777554|2232301|FG000|Overall Study|Withdrawal by Subject|3
1134515|NCT02777554|2232302|FG001|Overall Study|Withdrawal by Subject|1
1134516|NCT02777554|2232303|FG002|Overall Study|Withdrawal by Subject|1
1134517|NCT02777554|2232304|FG003|Overall Study|Withdrawal by Subject|0
1134518|NCT02777554|2232305|FG004|Overall Study|Withdrawal by Subject|0
1134519|NCT02777554|2232306|FG005|Overall Study|Withdrawal by Subject|0
1134520|NCT02777554|2232301|FG000|Overall Study|Discharged early due to hurricane|22
1134521|NCT02777554|2232302|FG001|Overall Study|Discharged early due to hurricane|20
1134522|NCT02777554|2232303|FG002|Overall Study|Discharged early due to hurricane|0
1134523|NCT02777554|2232304|FG003|Overall Study|Discharged early due to hurricane|0
1134524|NCT02777554|2232305|FG004|Overall Study|Discharged early due to hurricane|0
1134525|NCT02777554|2232306|FG005|Overall Study|Discharged early due to hurricane|0
1134526|NCT02777554|2232301|FG000|Overall Study|Other - Miscellaneous|1
1134527|NCT02777554|2232302|FG001|Overall Study|Other - Miscellaneous|0
1134528|NCT02777554|2232303|FG002|Overall Study|Other - Miscellaneous|0
1134529|NCT02777554|2232304|FG003|Overall Study|Other - Miscellaneous|0
1134530|NCT02777554|2232305|FG004|Overall Study|Other - Miscellaneous|0
1134531|NCT02777554|2232306|FG005|Overall Study|Other - Miscellaneous|0
1134532|NCT02777827|2232343|FG000|Washout Between Periods 3 and 4|Protocol Violation|0
1134533|NCT02777827|2232344|FG001|Washout Between Periods 3 and 4|Protocol Violation|0
1134534|NCT02777827|2232345|FG002|Washout Between Periods 3 and 4|Protocol Violation|1
1134535|NCT02777827|2232346|FG003|Washout Between Periods 3 and 4|Protocol Violation|0
1134536|NCT02777827|2232347|FG004|Washout Between Periods 3 and 4|Protocol Violation|0
1134537|NCT02777827|2232348|FG005|Washout Between Periods 3 and 4|Protocol Violation|0
1134538|NCT02777918|2232364|FG000|Overall Study|Medical reasons|1
1134539|NCT02777918|2232365|FG001|Overall Study|Medical reasons|2
1134540|NCT02777918|2232364|FG000|Overall Study|Too busy / stressed|1
1134541|NCT02777918|2232365|FG001|Overall Study|Too busy / stressed|1
1134542|NCT02777918|2232364|FG000|Overall Study|Withdrawal by Subject|1
1134543|NCT02777918|2232365|FG001|Overall Study|Withdrawal by Subject|1
1134544|NCT02777970|2232392|FG000|Overall Study|Lost to Follow-up|0
1134545|NCT02777970|2232393|FG001|Overall Study|Lost to Follow-up|1
1134546|NCT02777970|2232394|FG002|Overall Study|Lost to Follow-up|0
1134547|NCT02777970|2232392|FG000|Overall Study|Protocol Violation|1
1134548|NCT02777970|2232393|FG001|Overall Study|Protocol Violation|0
1134549|NCT02777970|2232394|FG002|Overall Study|Protocol Violation|0
1134550|NCT02778074|2232406|FG000|Overall Study|Lost to Follow-up|7
1134551|NCT02778074|2232407|FG001|Overall Study|Lost to Follow-up|10
1134552|NCT02778100|2232415|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1
1134553|NCT02778100|2232416|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0
1134574|NCT02778555|2232465|FG000|Overall Study|Withdrawal by Subject|55
1134575|NCT02778555|2232466|FG001|Overall Study|Withdrawal by Subject|32
1134576|NCT02778555|2232467|FG002|Overall Study|Withdrawal by Subject|107
1134577|NCT02778867|2232477|FG000|Phase 1|Withdrawal by Subject|2
1134578|NCT02778867|2232478|FG001|Phase 1|Withdrawal by Subject|3
1134579|NCT02778867|2232479|FG002|Phase 1|Withdrawal by Subject|0
1134580|NCT02778867|2232480|FG003|Phase 1|Withdrawal by Subject|0
1134581|NCT02778867|2232477|FG000|Phase 2|Withdrawal by Subject|0
1134582|NCT02778867|2232478|FG001|Phase 2|Withdrawal by Subject|0
1134583|NCT02778867|2232479|FG002|Phase 2|Withdrawal by Subject|1
1134584|NCT02778867|2232480|FG003|Phase 2|Withdrawal by Subject|0
1134585|NCT02778867|2232477|FG000|Phase 2|Physician Decision|0
1134586|NCT02778867|2232478|FG001|Phase 2|Physician Decision|0
1134587|NCT02778867|2232479|FG002|Phase 2|Physician Decision|0
1134588|NCT02778867|2232480|FG003|Phase 2|Physician Decision|1
1134589|NCT02778867|2232477|FG000|Phase 2|Adverse Event|0
1134590|NCT02778867|2232478|FG001|Phase 2|Adverse Event|0
1134591|NCT02778867|2232479|FG002|Phase 2|Adverse Event|0
1134592|NCT02778867|2232480|FG003|Phase 2|Adverse Event|1
1134593|NCT02779075|2232510|FG000|Overall Study|Withdrawal by Subject|1
1134594|NCT02779075|2232511|FG001|Overall Study|Withdrawal by Subject|3
1134595|NCT02779075|2232510|FG000|Overall Study|IV lost during 2nd study|1
1134596|NCT02779075|2232511|FG001|Overall Study|IV lost during 2nd study|0
1134600|NCT02780115|2232572|FG000|Overall Study|Withdrawal by Subject|0
1134601|NCT02780115|2232573|FG001|Overall Study|Withdrawal by Subject|1
1134602|NCT02780115|2232574|FG002|Overall Study|Withdrawal by Subject|1
1134603|NCT02780115|2232575|FG003|Overall Study|Withdrawal by Subject|0
1134604|NCT02780115|2232576|FG004|Overall Study|Withdrawal by Subject|0
1134605|NCT02780115|2232572|FG000|Overall Study|Adverse Event|0
1134606|NCT02780115|2232573|FG001|Overall Study|Adverse Event|0
1134607|NCT02780115|2232574|FG002|Overall Study|Adverse Event|0
1134608|NCT02780115|2232575|FG003|Overall Study|Adverse Event|1
1134609|NCT02780115|2232576|FG004|Overall Study|Adverse Event|1
1134610|NCT02780167|2232593|FG000|Overall Study|Adverse Event|9
1134611|NCT02780167|2232594|FG001|Overall Study|Adverse Event|8
1134612|NCT02780167|2232595|FG002|Overall Study|Adverse Event|8
1134613|NCT02780167|2232596|FG003|Overall Study|Adverse Event|12
1134614|NCT02780167|2232597|FG004|Overall Study|Adverse Event|8
1134615|NCT02780167|2232593|FG000|Overall Study|Lack of Efficacy|6
1134616|NCT02780167|2232594|FG001|Overall Study|Lack of Efficacy|5
1134617|NCT02780167|2232595|FG002|Overall Study|Lack of Efficacy|6
1134618|NCT02780167|2232596|FG003|Overall Study|Lack of Efficacy|1
1134619|NCT02780167|2232597|FG004|Overall Study|Lack of Efficacy|0
1134620|NCT02780167|2232593|FG000|Overall Study|Lost to Follow-up|2
1134621|NCT02780167|2232594|FG001|Overall Study|Lost to Follow-up|0
1134622|NCT02780167|2232595|FG002|Overall Study|Lost to Follow-up|1
1134623|NCT02780167|2232596|FG003|Overall Study|Lost to Follow-up|0
1134624|NCT02780167|2232597|FG004|Overall Study|Lost to Follow-up|0
1134625|NCT02780167|2232593|FG000|Overall Study|Does not meet entrance criteria|0
1134626|NCT02780167|2232594|FG001|Overall Study|Does not meet entrance criteria|0
1134627|NCT02780167|2232595|FG002|Overall Study|Does not meet entrance criteria|1
1134628|NCT02780167|2232596|FG003|Overall Study|Does not meet entrance criteria|0
1134629|NCT02780167|2232597|FG004|Overall Study|Does not meet entrance criteria|0
1134630|NCT02780167|2232593|FG000|Overall Study|No longer meets eligibility criteria|0
1134631|NCT02780167|2232594|FG001|Overall Study|No longer meets eligibility criteria|0
1134632|NCT02780167|2232595|FG002|Overall Study|No longer meets eligibility criteria|0
1134633|NCT02780167|2232596|FG003|Overall Study|No longer meets eligibility criteria|1
1134634|NCT02780167|2232597|FG004|Overall Study|No longer meets eligibility criteria|1
1134635|NCT02780167|2232593|FG000|Overall Study|Protocol Violation|5
1134636|NCT02780167|2232594|FG001|Overall Study|Protocol Violation|5
1134637|NCT02780167|2232595|FG002|Overall Study|Protocol Violation|1
1134638|NCT02780167|2232596|FG003|Overall Study|Protocol Violation|1
1134639|NCT02780167|2232597|FG004|Overall Study|Protocol Violation|2
1134640|NCT02780167|2232593|FG000|Overall Study|Withdrawal by Subject|6
1134641|NCT02780167|2232594|FG001|Overall Study|Withdrawal by Subject|4
1134642|NCT02780167|2232595|FG002|Overall Study|Withdrawal by Subject|4
1134643|NCT02780167|2232596|FG003|Overall Study|Withdrawal by Subject|3
1134644|NCT02780167|2232597|FG004|Overall Study|Withdrawal by Subject|4
1134645|NCT02780167|2232593|FG000|Overall Study|Other|0
1134646|NCT02780167|2232594|FG001|Overall Study|Other|0
1134647|NCT02780167|2232595|FG002|Overall Study|Other|3
1134648|NCT02780167|2232596|FG003|Overall Study|Other|1
1134649|NCT02780167|2232597|FG004|Overall Study|Other|2
1134650|NCT02780388|2232618|FG000|Overall Study|Lost to Follow-up|0
1134651|NCT02780388|2232619|FG001|Overall Study|Lost to Follow-up|1
1134652|NCT02780388|2232620|FG002|Overall Study|Lost to Follow-up|0
1134653|NCT02780388|2232621|FG003|Overall Study|Lost to Follow-up|0
1134654|NCT02780388|2232622|FG004|Overall Study|Lost to Follow-up|0
1134655|NCT02780388|2232618|FG000|Overall Study|Withdrawal by Subject|1
1134656|NCT02780388|2232619|FG001|Overall Study|Withdrawal by Subject|1
1134657|NCT02780388|2232620|FG002|Overall Study|Withdrawal by Subject|0
1134658|NCT02780388|2232621|FG003|Overall Study|Withdrawal by Subject|0
1134659|NCT02780388|2232622|FG004|Overall Study|Withdrawal by Subject|0
1134660|NCT02780687|2232656|FG000|Overall Study|Adverse Event|1
1134661|NCT02780687|2232657|FG001|Overall Study|Adverse Event|1
1134662|NCT02780687|2232656|FG000|Overall Study|Withdrawal by Subject|2
1134663|NCT02780687|2232657|FG001|Overall Study|Withdrawal by Subject|1
1134664|NCT02780687|2232656|FG000|Overall Study|Switched to commercial program (in CTP)|2
1134665|NCT02780687|2232657|FG001|Overall Study|Switched to commercial program (in CTP)|0
1134666|NCT02780687|2232656|FG000|Overall Study|progressive disease|29
1134667|NCT02780687|2232657|FG001|Overall Study|progressive disease|6
1134668|NCT02780700|2232662|FG000|Overall Study|Progressive disease|1
1134669|NCT02780856|2232698|FG000|Overall Study|Lost to Follow-up|1
1134670|NCT02781311|2232722|FG000|Overall Study|Adverse Event|2
1134671|NCT02781311|2232723|FG001|Overall Study|Adverse Event|6
1134672|NCT02781311|2232724|FG002|Overall Study|Adverse Event|1
1134673|NCT02781311|2232722|FG000|Overall Study|Withdrawal of Consent|11
1134674|NCT02781311|2232723|FG001|Overall Study|Withdrawal of Consent|12
1134675|NCT02781311|2232724|FG002|Overall Study|Withdrawal of Consent|2
1134676|NCT02781311|2232722|FG000|Overall Study|Lost to Follow-up|11
1134677|NCT02781311|2232723|FG001|Overall Study|Lost to Follow-up|8
1134678|NCT02781311|2232724|FG002|Overall Study|Lost to Follow-up|1
1134679|NCT02781311|2232722|FG000|Overall Study|Non-Compliance with Study Drug|2
1134680|NCT02781311|2232723|FG001|Overall Study|Non-Compliance with Study Drug|0
1134681|NCT02781311|2232724|FG002|Overall Study|Non-Compliance with Study Drug|0
1134682|NCT02781324|2232733|FG000|Overall Study|Withdrawal by Subject|1
1134683|NCT02781324|2232734|FG001|Overall Study|Withdrawal by Subject|0
1134684|NCT02781324|2232733|FG000|Overall Study|Physician Decision|1
1134685|NCT02781324|2232734|FG001|Overall Study|Physician Decision|2
1134686|NCT02781558|2232770|FG000|Overall Study|Lost to Follow-up|2
1134687|NCT02781558|2232771|FG001|Overall Study|Lost to Follow-up|2
1134688|NCT02781558|2232770|FG000|Overall Study|Adverse Event|1
1134689|NCT02781558|2232771|FG001|Overall Study|Adverse Event|0
1134690|NCT02781818|2232815|FG000|Overall Study|Lost to Follow-up|4
1134691|NCT02781818|2232816|FG001|Overall Study|Lost to Follow-up|2
1134692|NCT02781818|2232817|FG002|Overall Study|Lost to Follow-up|1
1134693|NCT02781844|2232829|FG000|Treatment Period 1|Adverse Event|0
1134694|NCT02781844|2232830|FG001|Treatment Period 1|Adverse Event|0
1134695|NCT02781844|2232831|FG002|Treatment Period 1|Adverse Event|0
1134696|NCT02781844|2232832|FG003|Treatment Period 1|Adverse Event|0
1134697|NCT02781844|2232833|FG004|Treatment Period 1|Adverse Event|0
1134698|NCT02781844|2232834|FG005|Treatment Period 1|Adverse Event|1
1134699|NCT02781844|2232835|FG006|Treatment Period 1|Adverse Event|0
1134700|NCT02781844|2232836|FG007|Treatment Period 1|Adverse Event|0
1134701|NCT02782169|2232859|FG000|Overall Study|Lost to Follow-up|1
1134702|NCT02782169|2232860|FG001|Overall Study|Lost to Follow-up|2
1134703|NCT02782325|2232868|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
1134704|NCT02782325|2232869|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
1134705|NCT02782325|2232870|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
1134706|NCT02782325|2232868|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
1134707|NCT02782325|2232869|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
1134708|NCT02782325|2232870|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
1134709|NCT02782377|2232886|FG000|Overall Study|Physician Decision|5
1134710|NCT02782676|2232891|FG000|Overall Study|Lost to Follow-up|0
1134711|NCT02782676|2232892|FG001|Overall Study|Lost to Follow-up|1
1134712|NCT02782741|2232900|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0
1134713|NCT02782741|2232901|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4
1134714|NCT02782741|2232900|FG000|Blinded Treatment Period: up to Week 49|Other|0
1134715|NCT02782741|2232901|FG001|Blinded Treatment Period: up to Week 49|Other|1
1134716|NCT02782741|2232900|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2
1134717|NCT02782741|2232901|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1
1134718|NCT02782741|2232900|FG000|Open-label Long-term: Week 50 to 145|Other|1
1134719|NCT02782741|2232901|FG001|Open-label Long-term: Week 50 to 145|Other|0
1134720|NCT02782741|2232900|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48
1134721|NCT02782741|2232901|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43
1134722|NCT02782780|2232913|FG000|Overall Study|dropped out after randomization.|7
1134723|NCT02782780|2232914|FG001|Overall Study|dropped out after randomization.|5
1134724|NCT02782780|2232913|FG000|Overall Study|Protocol Violation|0
1134725|NCT02782780|2232914|FG001|Overall Study|Protocol Violation|2
1134726|NCT02782923|2232920|FG000|Overall Study|Lost to Follow-up|15
1134727|NCT02783066|2232933|FG000|Overall Study|Withdrawal by Subject|13
1134728|NCT02783170|2232940|FG000|Overall Study|Randomized but not Vaccinated|1
1134729|NCT02783170|2232941|FG001|Overall Study|Randomized but not Vaccinated|0
1134730|NCT02783573|2232964|FG000|Placebo-Controlled Treatment Period|Adverse Event|13
1134731|NCT02783573|2232965|FG001|Placebo-Controlled Treatment Period|Adverse Event|17
1134732|NCT02783573|2232966|FG002|Placebo-Controlled Treatment Period|Adverse Event|13
1134733|NCT02783573|2232964|FG000|Placebo-Controlled Treatment Period|Death|4
1134734|NCT02783573|2232965|FG001|Placebo-Controlled Treatment Period|Death|2
1134735|NCT02783573|2232966|FG002|Placebo-Controlled Treatment Period|Death|3
1134736|NCT02783573|2232964|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0
1134737|NCT02783573|2232965|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0
1134738|NCT02783573|2232966|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2
1134739|NCT02783573|2232964|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3
1134740|NCT02783573|2232965|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3
1134741|NCT02783573|2232966|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1
1134742|NCT02783573|2232964|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0
1134743|NCT02783573|2232965|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1
1134744|NCT02783573|2232966|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0
1134745|NCT02783573|2232964|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
1134746|NCT02783573|2232965|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
1134747|NCT02783573|2232966|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
1134748|NCT02783573|2232964|FG000|Placebo-Controlled Treatment Period|Physician Decision|3
1134749|NCT02783573|2232965|FG001|Placebo-Controlled Treatment Period|Physician Decision|1
1134750|NCT02783573|2232966|FG002|Placebo-Controlled Treatment Period|Physician Decision|3
1134751|NCT02783573|2232964|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1
1134752|NCT02783573|2232965|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2
1134753|NCT02783573|2232966|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0
1162088|NCT03382912|2284107|FG001|Overall Study|Withdrawal by Subject|5
1134754|NCT02783573|2232964|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
1134755|NCT02783573|2232965|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
1134756|NCT02783573|2232966|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
1134757|NCT02783573|2232964|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
1134758|NCT02783573|2232965|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
1134759|NCT02783573|2232966|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
1134760|NCT02783573|2232964|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494
1134761|NCT02783573|2232965|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512
1134762|NCT02783573|2232966|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492
1134763|NCT02783573|2232964|FG000|Delayed-Start Period|Sponsor Decision|0
1134764|NCT02783573|2232965|FG001|Delayed-Start Period|Sponsor Decision|17
1134765|NCT02783573|2232966|FG002|Delayed-Start Period|Sponsor Decision|12
1134766|NCT02783599|2232977|FG000|Overall Study|Progressive disease|23
1134767|NCT02783599|2232977|FG000|Overall Study|Surgical Resection|10
1134768|NCT02783599|2232977|FG000|Overall Study|Adverse Event|4
1134769|NCT02783599|2232977|FG000|Overall Study|Physician Decision|2
1134770|NCT02783599|2232977|FG000|Overall Study|Death|1
1134771|NCT02783729|2232992|FG000|Overall Study|Lack of Efficacy|1
1134772|NCT02783729|2232993|FG001|Overall Study|Lack of Efficacy|0
1134773|NCT02783729|2232994|FG002|Overall Study|Lack of Efficacy|0
1134774|NCT02783729|2232995|FG003|Overall Study|Lack of Efficacy|0
1134775|NCT02783729|2232992|FG000|Overall Study|Adverse Event|2
1134776|NCT02783729|2232993|FG001|Overall Study|Adverse Event|6
1134777|NCT02783729|2232994|FG002|Overall Study|Adverse Event|2
1134778|NCT02783729|2232995|FG003|Overall Study|Adverse Event|3
1134779|NCT02783729|2232992|FG000|Overall Study|Other|1
1134780|NCT02783729|2232993|FG001|Overall Study|Other|6
1134781|NCT02783729|2232994|FG002|Overall Study|Other|2
1134782|NCT02783729|2232995|FG003|Overall Study|Other|3
1134783|NCT02783729|2232992|FG000|Overall Study|Withdrawal by Subject|2
1134784|NCT02783729|2232993|FG001|Overall Study|Withdrawal by Subject|3
1134785|NCT02783729|2232994|FG002|Overall Study|Withdrawal by Subject|1
1134786|NCT02783729|2232995|FG003|Overall Study|Withdrawal by Subject|2
1134787|NCT02783729|2232992|FG000|Overall Study|Participant's choice|2
1134788|NCT02783729|2232993|FG001|Overall Study|Participant's choice|1
1134789|NCT02783729|2232994|FG002|Overall Study|Participant's choice|2
1134790|NCT02783729|2232995|FG003|Overall Study|Participant's choice|1
1134791|NCT02783729|2232992|FG000|Overall Study|Lost to Follow-up|2
1134792|NCT02783729|2232993|FG001|Overall Study|Lost to Follow-up|1
1134793|NCT02783729|2232994|FG002|Overall Study|Lost to Follow-up|1
1134794|NCT02783729|2232995|FG003|Overall Study|Lost to Follow-up|0
1134795|NCT02783768|2233010|FG000|Overall Study|Lost to Follow-up|1
1134796|NCT02783768|2233011|FG001|Overall Study|Lost to Follow-up|0
1134797|NCT02783911|2233047|FG000|Overall Study|Lost to Follow-up|3
1134798|NCT02783911|2233048|FG001|Overall Study|Lost to Follow-up|32
1134799|NCT02784106|2233065|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
1134800|NCT02784106|2233066|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
1134801|NCT02784106|2233067|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
1134802|NCT02784106|2233068|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
1134803|NCT02784106|2233065|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
1134804|NCT02784106|2233066|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
1134805|NCT02784106|2233067|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1134806|NCT02784106|2233068|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1134807|NCT02784106|2233065|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2
1134808|NCT02784106|2233066|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0
1134809|NCT02784106|2233067|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0
1134810|NCT02784106|2233068|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0
1134811|NCT02784106|2233065|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
1134812|NCT02784106|2233066|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1134813|NCT02784106|2233067|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1134814|NCT02784106|2233068|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1134815|NCT02784106|2233065|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0
1134816|NCT02784106|2233066|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0
1134817|NCT02784106|2233067|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2
1134818|NCT02784106|2233068|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1
1134819|NCT02784106|2233065|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
1134820|NCT02784106|2233066|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
1134821|NCT02784106|2233067|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
1134822|NCT02784106|2233068|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
1134823|NCT02784431|2233094|FG000|Overall Study|Unsuccessful Implant Attempt|1
1134824|NCT02784431|2233094|FG000|Overall Study|Early Study Termination|19
1134833|NCT02784834|2233139|FG000|Overall Study|Lack of Efficacy|1
1134834|NCT02785458|2233232|FG000|1 Month|Withdrawal by Subject|2
1134835|NCT02785458|2233233|FG001|1 Month|Withdrawal by Subject|1
1134836|NCT02785458|2233232|FG000|1 Month|Lost to Follow-up|38
1134837|NCT02785458|2233233|FG001|1 Month|Lost to Follow-up|31
1134838|NCT02785458|2233232|FG000|1 Month|Deemed Ineligible|1
1134839|NCT02785458|2233233|FG001|1 Month|Deemed Ineligible|0
1134840|NCT02785458|2233232|FG000|1 Month|Completed Evaluation by Baseline|42
1134841|NCT02785458|2233233|FG001|1 Month|Completed Evaluation by Baseline|39
1134842|NCT02785458|2233232|FG000|1 Month|Partial Interview|0
1134843|NCT02785458|2233233|FG001|1 Month|Partial Interview|4
1134844|NCT02785458|2233232|FG000|3 Months|Withdrawal by Subject|3
1134845|NCT02785458|2233233|FG001|3 Months|Withdrawal by Subject|1
1134846|NCT02785458|2233232|FG000|3 Months|Lost to Follow-up|25
1134847|NCT02785458|2233233|FG001|3 Months|Lost to Follow-up|21
1134848|NCT02785458|2233232|FG000|3 Months|Completed Evaluation at 1 Month|100
1134849|NCT02785458|2233233|FG001|3 Months|Completed Evaluation at 1 Month|89
1134850|NCT02785588|2233239|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
1134851|NCT02785588|2233239|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
1134852|NCT02785770|2233243|FG000|Intervention Period 2 (1 Day)|Adverse Event|0
1134853|NCT02785770|2233244|FG001|Intervention Period 2 (1 Day)|Adverse Event|1
1134854|NCT02785770|2233245|FG002|Intervention Period 2 (1 Day)|Adverse Event|0
1134855|NCT02785770|2233246|FG003|Intervention Period 2 (1 Day)|Adverse Event|0
1134856|NCT02785770|2233243|FG000|Intervention Period 2 (1 Day)|Family related obligations|0
1134857|NCT02785770|2233244|FG001|Intervention Period 2 (1 Day)|Family related obligations|0
1134858|NCT02785770|2233245|FG002|Intervention Period 2 (1 Day)|Family related obligations|1
1134859|NCT02785770|2233246|FG003|Intervention Period 2 (1 Day)|Family related obligations|0
1134860|NCT02785770|2233243|FG000|Intervention Period 3 (1 Day)|Adverse Event|0
1134861|NCT02785770|2233244|FG001|Intervention Period 3 (1 Day)|Adverse Event|0
1134862|NCT02785770|2233245|FG002|Intervention Period 3 (1 Day)|Adverse Event|0
1134863|NCT02785770|2233246|FG003|Intervention Period 3 (1 Day)|Adverse Event|1
1134864|NCT02785900|2233261|FG000|Overall Study|Study Termination by Sponsor|64
1134865|NCT02785900|2233262|FG001|Overall Study|Study Termination by Sponsor|81
1134866|NCT02785900|2233261|FG000|Overall Study|Death|46
1134867|NCT02785900|2233262|FG001|Overall Study|Death|32
1134868|NCT02785900|2233261|FG000|Overall Study|Withdrawal by Subject|4
1134869|NCT02785900|2233262|FG001|Overall Study|Withdrawal by Subject|8
1134870|NCT02785900|2233261|FG000|Overall Study|Physician Decision|3
1134871|NCT02785900|2233262|FG001|Overall Study|Physician Decision|2
1134872|NCT02785913|2233268|FG000|Overall Study|Adverse Event|5
1134873|NCT02785913|2233268|FG000|Overall Study|Death|2
1134874|NCT02785913|2233268|FG000|Overall Study|Progression|18
1134875|NCT02785913|2233268|FG000|Overall Study|Not protocol specified|1
1134876|NCT02785939|2233275|FG000|Overall Study|Progression|25
1134877|NCT02785939|2233276|FG001|Overall Study|Progression|8
1134878|NCT02785939|2233275|FG000|Overall Study|Adverse Event|3
1134879|NCT02785939|2233276|FG001|Overall Study|Adverse Event|1
1134880|NCT02785939|2233275|FG000|Overall Study|Death|1
1134881|NCT02785939|2233276|FG001|Overall Study|Death|0
1134882|NCT02785939|2233275|FG000|Overall Study|Refusal|1
1134883|NCT02785939|2233276|FG001|Overall Study|Refusal|0
1134884|NCT02785939|2233275|FG000|Overall Study|Deteriorating health|1
1134885|NCT02785939|2233276|FG001|Overall Study|Deteriorating health|0
1134886|NCT02785939|2233275|FG000|Overall Study|Not protocol specified|0
1134887|NCT02785939|2233276|FG001|Overall Study|Not protocol specified|1
1134888|NCT02786004|2233284|FG000|Overall Study|Withdrawal by Subject|0
1134889|NCT02786004|2233285|FG001|Overall Study|Withdrawal by Subject|1
1135022|NCT02786836|2233460|FG000|Overall Study|Death|1
1135023|NCT02786836|2233460|FG000|Overall Study|Lack of Efficacy|2
1135024|NCT02786836|2233460|FG000|Overall Study|Protocol Violation|3
1135025|NCT02786836|2233460|FG000|Overall Study|Withdrawal by Subject|3
1135026|NCT02786836|2233460|FG000|Overall Study|Liver Transplantation|2
1135027|NCT02786836|2233460|FG000|Overall Study|Device or Pharmacy Issues|3
1135028|NCT02786901|2233468|FG000|Overall Study|Adverse Event|1
1135029|NCT02786901|2233469|FG001|Overall Study|Adverse Event|1
1135030|NCT02786901|2233470|FG002|Overall Study|Adverse Event|2
1135031|NCT02786901|2233468|FG000|Overall Study|Physician Decision|1
1135032|NCT02786901|2233469|FG001|Overall Study|Physician Decision|0
1135033|NCT02786901|2233470|FG002|Overall Study|Physician Decision|0
1135034|NCT02786901|2233468|FG000|Overall Study|Rescue Therapy Use|71
1135035|NCT02786901|2233469|FG001|Overall Study|Rescue Therapy Use|49
1135036|NCT02786901|2233470|FG002|Overall Study|Rescue Therapy Use|33
1135037|NCT02786901|2233468|FG000|Overall Study|Subject Request/Lost to Follow up|1
1135038|NCT02786901|2233469|FG001|Overall Study|Subject Request/Lost to Follow up|5
1135039|NCT02786901|2233470|FG002|Overall Study|Subject Request/Lost to Follow up|5
1135040|NCT02786901|2233468|FG000|Overall Study|Disallowed medication|1
1135041|NCT02786901|2233469|FG001|Overall Study|Disallowed medication|1
1135042|NCT02786901|2233470|FG002|Overall Study|Disallowed medication|0
1135043|NCT02786901|2233468|FG000|Overall Study|Randomized in error|2
1135044|NCT02786901|2233469|FG001|Overall Study|Randomized in error|0
1135045|NCT02786901|2233470|FG002|Overall Study|Randomized in error|1
1135046|NCT02786927|2233478|FG000|Overall Study|Adverse Event|1
1135047|NCT02786927|2233478|FG000|Overall Study|Protocol Violation|4
1135048|NCT02786953|2233485|FG000|Overall Study|Withdrawal by Subject|3
1135049|NCT02786953|2233486|FG001|Overall Study|Withdrawal by Subject|0
1135050|NCT02786953|2233485|FG000|Overall Study|Physician Decision|0
1135051|NCT02786953|2233486|FG001|Overall Study|Physician Decision|1
1135054|NCT02787083|2233516|FG000|Overall Study|Adverse Event|1
1135055|NCT02787083|2233517|FG001|Overall Study|Adverse Event|0
1135056|NCT02787083|2233516|FG000|Overall Study|Withdrawal by Subject|2
1135057|NCT02787083|2233517|FG001|Overall Study|Withdrawal by Subject|2
1135058|NCT02787304|2233531|FG000|Overall Study|Adverse Event|9
1135059|NCT02787304|2233532|FG001|Overall Study|Adverse Event|3
1135060|NCT02787304|2233533|FG002|Overall Study|Adverse Event|8
1135061|NCT02787304|2233534|FG003|Overall Study|Adverse Event|1
1135062|NCT02787304|2233531|FG000|Overall Study|Withdrawal by Subject|1
1135063|NCT02787304|2233532|FG001|Overall Study|Withdrawal by Subject|4
1135064|NCT02787304|2233533|FG002|Overall Study|Withdrawal by Subject|0
1135065|NCT02787304|2233534|FG003|Overall Study|Withdrawal by Subject|0
1135066|NCT02787304|2233531|FG000|Overall Study|Lost to Follow-up|1
1135067|NCT02787304|2233532|FG001|Overall Study|Lost to Follow-up|0
1135068|NCT02787304|2233533|FG002|Overall Study|Lost to Follow-up|0
1135069|NCT02787304|2233534|FG003|Overall Study|Lost to Follow-up|1
1135070|NCT02787304|2233531|FG000|Overall Study|Noncompliance with study drug|0
1135071|NCT02787304|2233532|FG001|Overall Study|Noncompliance with study drug|0
1135072|NCT02787304|2233533|FG002|Overall Study|Noncompliance with study drug|1
1135073|NCT02787304|2233534|FG003|Overall Study|Noncompliance with study drug|0
1135074|NCT02787304|2233531|FG000|Overall Study|Physician Decision|0
1135075|NCT02787304|2233532|FG001|Overall Study|Physician Decision|0
1135076|NCT02787304|2233533|FG002|Overall Study|Physician Decision|1
1135077|NCT02787304|2233534|FG003|Overall Study|Physician Decision|0
1135078|NCT02787304|2233531|FG000|Overall Study|Study terminated by sponsor|25
1135079|NCT02787304|2233532|FG001|Overall Study|Study terminated by sponsor|31
1135080|NCT02787304|2233533|FG002|Overall Study|Study terminated by sponsor|31
1135081|NCT02787304|2233534|FG003|Overall Study|Study terminated by sponsor|32
1135082|NCT02787551|2233546|FG000|Core Period: 26 Weeks|Adverse Event|10
1135083|NCT02787551|2233547|FG001|Core Period: 26 Weeks|Adverse Event|0
1135084|NCT02787551|2233546|FG000|Core Period: 26 Weeks|Lack of Efficacy|1
1135085|NCT02787551|2233547|FG001|Core Period: 26 Weeks|Lack of Efficacy|0
1135086|NCT02787551|2233546|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2
1135087|NCT02787551|2233547|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0
1135088|NCT02787551|2233546|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9
1135089|NCT02787551|2233547|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9
1135090|NCT02787551|2233546|FG000|Core Period: 26 Weeks|Randomized but not treated|2
1135091|NCT02787551|2233547|FG001|Core Period: 26 Weeks|Randomized but not treated|1
1135092|NCT02787551|2233546|FG000|Core Period: 26 Weeks|Other than specified|3
1135093|NCT02787551|2233547|FG001|Core Period: 26 Weeks|Other than specified|1
1135094|NCT02787551|2233546|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
1135095|NCT02787551|2233547|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
1135096|NCT02787551|2233546|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
1135097|NCT02787551|2233547|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
1135098|NCT02787551|2233546|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
1135099|NCT02787551|2233547|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
1135102|NCT02787863|2233608|FG000|Overall Study|Death|1
1135103|NCT02787863|2233609|FG001|Overall Study|Death|0
1135104|NCT02787863|2233610|FG002|Overall Study|Death|1
1135105|NCT02787863|2233611|FG003|Overall Study|Death|0
1135106|NCT02787863|2233612|FG004|Overall Study|Death|0
1135107|NCT02787863|2233613|FG005|Overall Study|Death|0
1135108|NCT02787863|2233614|FG006|Overall Study|Death|0
1135109|NCT02787863|2233615|FG007|Overall Study|Death|0
1135110|NCT02787863|2233608|FG000|Overall Study|Withdrawal by Subject|0
1135111|NCT02787863|2233609|FG001|Overall Study|Withdrawal by Subject|1
1135112|NCT02787863|2233610|FG002|Overall Study|Withdrawal by Subject|1
1135113|NCT02787863|2233611|FG003|Overall Study|Withdrawal by Subject|0
1135114|NCT02787863|2233612|FG004|Overall Study|Withdrawal by Subject|0
1135115|NCT02787863|2233613|FG005|Overall Study|Withdrawal by Subject|0
1135116|NCT02787863|2233614|FG006|Overall Study|Withdrawal by Subject|0
1135117|NCT02787863|2233615|FG007|Overall Study|Withdrawal by Subject|0
1135118|NCT02788175|2233674|FG000|Overall Study|Protocol Violation|3
1135119|NCT02788175|2233674|FG000|Overall Study|Withdrawal by Subject|4
1135120|NCT02788175|2233674|FG000|Overall Study|Ineligible prior to study agent|6
1135121|NCT02788201|2233713|FG000|Overall Study|Death|1
1135122|NCT02788201|2233714|FG001|Overall Study|Death|1
1135123|NCT02788201|2233715|FG002|Overall Study|Death|1
1135124|NCT02788201|2233716|FG003|Overall Study|Death|1
1135125|NCT02788201|2233717|FG004|Overall Study|Death|0
1135126|NCT02788201|2233718|FG005|Overall Study|Death|1
1135127|NCT02788201|2233713|FG000|Overall Study|Ineligible|0
1135128|NCT02788201|2233714|FG001|Overall Study|Ineligible|0
1135129|NCT02788201|2233715|FG002|Overall Study|Ineligible|0
1135130|NCT02788201|2233716|FG003|Overall Study|Ineligible|0
1135131|NCT02788201|2233717|FG004|Overall Study|Ineligible|0
1135132|NCT02788201|2233718|FG005|Overall Study|Ineligible|1
1135133|NCT02788201|2233713|FG000|Overall Study|Withdrawal by Subject|0
1135134|NCT02788201|2233714|FG001|Overall Study|Withdrawal by Subject|0
1135135|NCT02788201|2233715|FG002|Overall Study|Withdrawal by Subject|0
1135136|NCT02788201|2233716|FG003|Overall Study|Withdrawal by Subject|0
1135137|NCT02788201|2233717|FG004|Overall Study|Withdrawal by Subject|0
1135138|NCT02788201|2233718|FG005|Overall Study|Withdrawal by Subject|1
1135139|NCT02788279|2233737|FG000|Overall Study|Death|62
1135140|NCT02788279|2233738|FG001|Overall Study|Death|136
1135141|NCT02788279|2233739|FG002|Overall Study|Death|72
1135142|NCT02788279|2233737|FG000|Overall Study|Withdrawal by Subject|10
1135143|NCT02788279|2233738|FG001|Overall Study|Withdrawal by Subject|15
1135144|NCT02788279|2233739|FG002|Overall Study|Withdrawal by Subject|5
1135145|NCT02788279|2233737|FG000|Overall Study|Lost to Follow-up|0
1135146|NCT02788279|2233738|FG001|Overall Study|Lost to Follow-up|3
1135147|NCT02788279|2233739|FG002|Overall Study|Lost to Follow-up|2
1135148|NCT02788279|2233737|FG000|Overall Study|Sponsor decision|18
1135149|NCT02788279|2233738|FG001|Overall Study|Sponsor decision|29
1135150|NCT02788279|2233739|FG002|Overall Study|Sponsor decision|11
1135151|NCT02788357|2233752|FG000|Overall Study|Lost to Follow-up|3
1135152|NCT02788357|2233753|FG001|Overall Study|Lost to Follow-up|0
1135153|NCT02788474|2233761|FG000|Double Blind Treatment Period|Not treated|1
1135154|NCT02788474|2233762|FG001|Double Blind Treatment Period|Not treated|0
1135155|NCT02788474|2233761|FG000|Double Blind Treatment Period|Patient's refusal|3
1135156|NCT02788474|2233762|FG001|Double Blind Treatment Period|Patient's refusal|0
1135157|NCT02788474|2233761|FG000|Double Blind Treatment Period|Adverse Event|6
1135158|NCT02788474|2233762|FG001|Double Blind Treatment Period|Adverse Event|4
1135159|NCT02788474|2233761|FG000|Open Label Treatment Period|Adverse Event|29
1135160|NCT02788474|2233762|FG001|Open Label Treatment Period|Adverse Event|9
1135161|NCT02788474|2233761|FG000|Open Label Treatment Period|Other than reason specified|1
1135162|NCT02788474|2233762|FG001|Open Label Treatment Period|Other than reason specified|0
1135163|NCT02788474|2233761|FG000|Open Label Treatment Period|Patient's refusal|1
1135164|NCT02788474|2233762|FG001|Open Label Treatment Period|Patient's refusal|3
1135165|NCT02788474|2233761|FG000|Open Label Treatment Period|Non-compliance|1
1135166|NCT02788474|2233762|FG001|Open Label Treatment Period|Non-compliance|0
1135167|NCT02788513|2233774|FG000|Overall Study|Withdrawal by Subject|3
1135168|NCT02788513|2233775|FG001|Overall Study|Withdrawal by Subject|0
1135169|NCT02788513|2233776|FG002|Overall Study|Withdrawal by Subject|2
1135170|NCT02788513|2233777|FG003|Overall Study|Withdrawal by Subject|3
1135171|NCT02788513|2233778|FG004|Overall Study|Withdrawal by Subject|1
1135172|NCT02788513|2233774|FG000|Overall Study|Lost to Follow-up|1
1135173|NCT02788513|2233775|FG001|Overall Study|Lost to Follow-up|0
1135174|NCT02788513|2233776|FG002|Overall Study|Lost to Follow-up|0
1135175|NCT02788513|2233777|FG003|Overall Study|Lost to Follow-up|0
1135176|NCT02788513|2233778|FG004|Overall Study|Lost to Follow-up|1
1135177|NCT02788513|2233774|FG000|Overall Study|Adverse Event|5
1135178|NCT02788513|2233775|FG001|Overall Study|Adverse Event|8
1135179|NCT02788513|2233776|FG002|Overall Study|Adverse Event|4
1135180|NCT02788513|2233777|FG003|Overall Study|Adverse Event|2
1135181|NCT02788513|2233778|FG004|Overall Study|Adverse Event|2
1135182|NCT02788513|2233774|FG000|Overall Study|Protocol Violation|0
1135183|NCT02788513|2233775|FG001|Overall Study|Protocol Violation|0
1135184|NCT02788513|2233776|FG002|Overall Study|Protocol Violation|1
1135185|NCT02788513|2233777|FG003|Overall Study|Protocol Violation|1
1135186|NCT02788513|2233778|FG004|Overall Study|Protocol Violation|0
1135187|NCT02788513|2233774|FG000|Overall Study|Subject decided to stop taking treatment|0
1135188|NCT02788513|2233775|FG001|Overall Study|Subject decided to stop taking treatment|0
1135189|NCT02788513|2233776|FG002|Overall Study|Subject decided to stop taking treatment|1
1135190|NCT02788513|2233777|FG003|Overall Study|Subject decided to stop taking treatment|0
1135191|NCT02788513|2233778|FG004|Overall Study|Subject decided to stop taking treatment|0
1135192|NCT02788513|2233774|FG000|Overall Study|Decision by the study team|0
1135193|NCT02788513|2233775|FG001|Overall Study|Decision by the study team|0
1135194|NCT02788513|2233776|FG002|Overall Study|Decision by the study team|0
1135195|NCT02788513|2233777|FG003|Overall Study|Decision by the study team|0
1135196|NCT02788513|2233778|FG004|Overall Study|Decision by the study team|1
1135197|NCT02788656|2233792|FG000|Overall Study|Withdrawal by Subject|1
1135198|NCT02788656|2233793|FG001|Overall Study|Withdrawal by Subject|0
1135199|NCT02788747|2233802|FG000|Overall Study|Adverse Event|1
1135200|NCT02788747|2233803|FG001|Overall Study|Adverse Event|0
1135201|NCT02788747|2233804|FG002|Overall Study|Adverse Event|0
1135202|NCT02789111|2233845|FG000|Overall Study|Withdrawal by Subject|1
1135203|NCT02789111|2233846|FG001|Overall Study|Withdrawal by Subject|4
1135204|NCT02789137|2233854|FG000|Overall Study|Dropped out/Died|58
1135205|NCT02789176|2233863|FG000|Overall Study|Death|0
1135206|NCT02789176|2233864|FG001|Overall Study|Death|0
1135207|NCT02789176|2233865|FG002|Overall Study|Death|3
1135208|NCT02789176|2233866|FG003|Overall Study|Death|0
1135209|NCT02789176|2233863|FG000|Overall Study|Withdrawal by Subject|0
1135210|NCT02789176|2233864|FG001|Overall Study|Withdrawal by Subject|0
1135211|NCT02789176|2233865|FG002|Overall Study|Withdrawal by Subject|1
1135212|NCT02789176|2233866|FG003|Overall Study|Withdrawal by Subject|0
1135213|NCT02789176|2233863|FG000|Overall Study|Lost to Follow-up|8
1135214|NCT02789176|2233864|FG001|Overall Study|Lost to Follow-up|2
1135215|NCT02789176|2233865|FG002|Overall Study|Lost to Follow-up|6
1135216|NCT02789176|2233866|FG003|Overall Study|Lost to Follow-up|1
1135217|NCT02790073|2233885|FG000|Overall Study|Death|1
1135218|NCT02790073|2233885|FG000|Overall Study|Withdrawal from HD|1
1135219|NCT02790073|2233885|FG000|Overall Study|Withdrawal by Subject|1
1135220|NCT02790138|2233891|FG000|Overall Study|Adverse Event|5
1135221|NCT02790138|2233892|FG001|Overall Study|Adverse Event|2
1135222|NCT02790138|2233891|FG000|Overall Study|Significant Protocol Deviation|0
1135223|NCT02790138|2233892|FG001|Overall Study|Significant Protocol Deviation|1
1135224|NCT02790138|2233891|FG000|Overall Study|Lost to Follow-up|1
1135225|NCT02790138|2233892|FG001|Overall Study|Lost to Follow-up|0
1135226|NCT02790138|2233891|FG000|Overall Study|Voluntary Withdrawal|8
1135227|NCT02790138|2233892|FG001|Overall Study|Voluntary Withdrawal|9
1135228|NCT02790138|2233891|FG000|Overall Study|Lack of Efficacy|6
1135229|NCT02790138|2233892|FG001|Overall Study|Lack of Efficacy|7
1135230|NCT02790138|2233891|FG000|Overall Study|Reason not Specified|1
1135231|NCT02790138|2233892|FG001|Overall Study|Reason not Specified|0
1135232|NCT02790437|2233904|FG000|Overall Study|Patient graft failure - nephrectomy|1
1135233|NCT02790437|2233905|FG001|Overall Study|Patient graft failure - nephrectomy|0
1135234|NCT02790437|2233904|FG000|Overall Study|Adverse Event|1
1135235|NCT02790437|2233905|FG001|Overall Study|Adverse Event|0
1135236|NCT02790437|2233904|FG000|Overall Study|Withdrawal by Subject|1
1135237|NCT02790437|2233905|FG001|Overall Study|Withdrawal by Subject|0
1135238|NCT02790606|2233927|FG000|Overall Study|Death|27
1135239|NCT02790606|2233927|FG000|Overall Study|Lost to Follow-up|4
1135240|NCT02790606|2233927|FG000|Overall Study|Physician Decision|3
1135241|NCT02790606|2233927|FG000|Overall Study|Withdrawal by Subject|1
1135242|NCT02791191|2233954|FG000|Overall Study|Adverse Event|2
1135243|NCT02791191|2233955|FG001|Overall Study|Adverse Event|4
1135244|NCT02791191|2233956|FG002|Overall Study|Adverse Event|5
1135245|NCT02791191|2233954|FG000|Overall Study|Lack of Efficacy|0
1135246|NCT02791191|2233955|FG001|Overall Study|Lack of Efficacy|1
1135247|NCT02791191|2233956|FG002|Overall Study|Lack of Efficacy|0
1135248|NCT02791191|2233954|FG000|Overall Study|Study Drug Non-Compliance|0
1135249|NCT02791191|2233955|FG001|Overall Study|Study Drug Non-Compliance|2
1135250|NCT02791191|2233956|FG002|Overall Study|Study Drug Non-Compliance|0
1135251|NCT02791191|2233954|FG000|Overall Study|Site Closed by Sponsor|1
1135252|NCT02791191|2233955|FG001|Overall Study|Site Closed by Sponsor|1
1135253|NCT02791191|2233956|FG002|Overall Study|Site Closed by Sponsor|3
1135254|NCT02791191|2233954|FG000|Overall Study|Progressive Disease|1
1135255|NCT02791191|2233955|FG001|Overall Study|Progressive Disease|0
1135256|NCT02791191|2233956|FG002|Overall Study|Progressive Disease|0
1135257|NCT02791191|2233954|FG000|Overall Study|Study Terminated by Sponsor|29
1135258|NCT02791191|2233955|FG001|Overall Study|Study Terminated by Sponsor|101
1135259|NCT02791191|2233956|FG002|Overall Study|Study Terminated by Sponsor|109
1135260|NCT02791191|2233954|FG000|Overall Study|Withdrawal by Subject|3
1135261|NCT02791191|2233955|FG001|Overall Study|Withdrawal by Subject|1
1135262|NCT02791191|2233956|FG002|Overall Study|Withdrawal by Subject|3
1135263|NCT02791191|2233954|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2
1135264|NCT02791191|2233955|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1
1135265|NCT02791191|2233956|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0
1135266|NCT02791269|2233966|FG000|Overall Study|Lost to Follow-up|0
1135267|NCT02791269|2233967|FG001|Overall Study|Lost to Follow-up|1
1135268|NCT02791438|2233999|FG000|Treatment Period|Adverse Event|1
1135269|NCT02791438|2234000|FG001|Treatment Period|Adverse Event|0
1135270|NCT02791438|2233999|FG000|Treatment Period|Withdrawal by Subject|0
1135271|NCT02791438|2234000|FG001|Treatment Period|Withdrawal by Subject|1
1135272|NCT02791438|2233999|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
1135273|NCT02791438|2234000|FG001|Treatment Period|Withdrawal by Parent/Guardian|0
1135274|NCT02791490|2234008|FG000|Overall Study|Lost to Follow-up|1
1135275|NCT02791490|2234009|FG001|Overall Study|Lost to Follow-up|2
1135276|NCT02791490|2234008|FG000|Overall Study|Withdrawal by Subject|2
1135277|NCT02791490|2234009|FG001|Overall Study|Withdrawal by Subject|6
1135278|NCT02791516|2234017|FG000|Overall Study|Withdrawal by Subject|1
1135279|NCT02791516|2234018|FG001|Overall Study|Withdrawal by Subject|1
1135280|NCT02791659|2234026|FG000|Overall Study|Protocol Violation|0
1135281|NCT02791659|2234027|FG001|Overall Study|Protocol Violation|1
1135282|NCT02791763|2234036|FG000|Overall Study|Protocol Violation|0
1135283|NCT02791763|2234037|FG001|Overall Study|Protocol Violation|0
1135284|NCT02791763|2234038|FG002|Overall Study|Protocol Violation|1
1135285|NCT02791763|2234036|FG000|Overall Study|Withdrawal by Subject|5
1135286|NCT02791763|2234037|FG001|Overall Study|Withdrawal by Subject|1
1135287|NCT02791763|2234038|FG002|Overall Study|Withdrawal by Subject|0
1135288|NCT02791763|2234036|FG000|Overall Study|Physician Decision|0
1135289|NCT02791763|2234037|FG001|Overall Study|Physician Decision|1
1135290|NCT02791763|2234038|FG002|Overall Study|Physician Decision|0
1135291|NCT02791763|2234036|FG000|Overall Study|Needs maintenance/changes in dialysis|16
1135292|NCT02791763|2234037|FG001|Overall Study|Needs maintenance/changes in dialysis|19
1135293|NCT02791763|2234038|FG002|Overall Study|Needs maintenance/changes in dialysis|5
1135294|NCT02791763|2234036|FG000|Overall Study|Cancer event|1
1135295|NCT02791763|2234037|FG001|Overall Study|Cancer event|3
1135296|NCT02791763|2234038|FG002|Overall Study|Cancer event|0
1135297|NCT02791763|2234036|FG000|Overall Study|Participant had renal transplant|3
1135298|NCT02791763|2234037|FG001|Overall Study|Participant had renal transplant|0
1135299|NCT02791763|2234038|FG002|Overall Study|Participant had renal transplant|0
1135300|NCT02791763|2234036|FG000|Overall Study|Met hemoglobin stopping criteria|1
1135301|NCT02791763|2234037|FG001|Overall Study|Met hemoglobin stopping criteria|0
1135302|NCT02791763|2234038|FG002|Overall Study|Met hemoglobin stopping criteria|0
1135303|NCT02791763|2234036|FG000|Overall Study|Adverse Event|12
1135304|NCT02791763|2234037|FG001|Overall Study|Adverse Event|13
1135305|NCT02791763|2234038|FG002|Overall Study|Adverse Event|7
1135306|NCT02791893|2234057|FG000|Blinded Phase|Lost to Follow-up|2
1135307|NCT02791893|2234058|FG001|Blinded Phase|Lost to Follow-up|2
1135308|NCT02791893|2234057|FG000|Blinded Phase|Withdrawal by Subject|1
1135309|NCT02791893|2234058|FG001|Blinded Phase|Withdrawal by Subject|2
1135310|NCT02791893|2234057|FG000|Open Label Phase|Lost to Follow-up|3
1135311|NCT02791893|2234058|FG001|Open Label Phase|Lost to Follow-up|0
1135312|NCT02791893|2234057|FG000|Open Label Phase|Withdrawal by Subject|0
1135313|NCT02791893|2234058|FG001|Open Label Phase|Withdrawal by Subject|2
1135314|NCT02792062|2234101|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
1135315|NCT02792062|2234102|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1135316|NCT02792062|2234103|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1135317|NCT02792062|2234104|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1135318|NCT02792062|2234105|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1135319|NCT02792062|2234106|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1135320|NCT02792192|2234118|FG000|Overall Study|Death|1
1135321|NCT02792192|2234119|FG001|Overall Study|Death|0
1135322|NCT02792192|2234120|FG002|Overall Study|Death|0
1135323|NCT02792192|2234121|FG003|Overall Study|Death|0
1135324|NCT02792192|2234118|FG000|Overall Study|Informed Consent Withdrawn|4
1135325|NCT02792192|2234119|FG001|Overall Study|Informed Consent Withdrawn|0
900227|NCT00726232|1873270|FG000|Expansion Phase|Termination of the trial by sponsor|0
900228|NCT00726232|1873271|FG001|Expansion Phase|Termination of the trial by sponsor|0
900229|NCT00726232|1873272|FG002|Expansion Phase|Termination of the trial by sponsor|0
900230|NCT00726232|1873273|FG003|Expansion Phase|Termination of the trial by sponsor|0
1135326|NCT02792192|2234120|FG002|Overall Study|Informed Consent Withdrawn|0
1135327|NCT02792192|2234121|FG003|Overall Study|Informed Consent Withdrawn|0
1135328|NCT02792192|2234118|FG000|Overall Study|Physician Decision|1
1135329|NCT02792192|2234119|FG001|Overall Study|Physician Decision|0
1135330|NCT02792192|2234120|FG002|Overall Study|Physician Decision|0
1135331|NCT02792192|2234121|FG003|Overall Study|Physician Decision|0
1135332|NCT02792192|2234118|FG000|Overall Study|Progressive Disease|0
1135333|NCT02792192|2234119|FG001|Overall Study|Progressive Disease|1
1135334|NCT02792192|2234120|FG002|Overall Study|Progressive Disease|0
1135335|NCT02792192|2234121|FG003|Overall Study|Progressive Disease|0
1135336|NCT02792192|2234118|FG000|Overall Study|Study Terminated By Sponsor|6
1135337|NCT02792192|2234119|FG001|Overall Study|Study Terminated By Sponsor|10
1135338|NCT02792192|2234120|FG002|Overall Study|Study Terminated By Sponsor|0
1135339|NCT02792192|2234121|FG003|Overall Study|Study Terminated By Sponsor|0
1135340|NCT02792218|2234134|FG000|Overall Study|Patient/guardian decision|15
1135341|NCT02792218|2234135|FG001|Overall Study|Patient/guardian decision|42
1135342|NCT02792218|2234134|FG000|Overall Study|Adverse Event|15
1135343|NCT02792218|2234135|FG001|Overall Study|Adverse Event|14
1135344|NCT02792218|2234134|FG000|Overall Study|Lost to Follow-up|10
1135345|NCT02792218|2234135|FG001|Overall Study|Lost to Follow-up|5
1135346|NCT02792218|2234134|FG000|Overall Study|Lack of Efficacy|1
1135347|NCT02792218|2234135|FG001|Overall Study|Lack of Efficacy|12
1135348|NCT02792218|2234134|FG000|Overall Study|Physician Decision|4
1135349|NCT02792218|2234135|FG001|Overall Study|Physician Decision|4
1135350|NCT02792218|2234134|FG000|Overall Study|Protocol deviation|3
1135351|NCT02792218|2234135|FG001|Overall Study|Protocol deviation|2
1135352|NCT02792218|2234134|FG000|Overall Study|New therapy for study indication|0
1135353|NCT02792218|2234135|FG001|Overall Study|New therapy for study indication|1
1135354|NCT02792218|2234134|FG000|Overall Study|Non-compliance with study treatment|0
1135355|NCT02792218|2234135|FG001|Overall Study|Non-compliance with study treatment|1
1135356|NCT02792218|2234134|FG000|Overall Study|Pregnancy|1
1135357|NCT02792218|2234135|FG001|Overall Study|Pregnancy|0
1135358|NCT02792231|2234143|FG000|Overall Study|Patient/guardian decision|32
1135359|NCT02792231|2234144|FG001|Overall Study|Patient/guardian decision|42
1135360|NCT02792231|2234143|FG000|Overall Study|Adverse Event|15
1135361|NCT02792231|2234144|FG001|Overall Study|Adverse Event|11
1135362|NCT02792231|2234143|FG000|Overall Study|Physician Decision|14
1135363|NCT02792231|2234144|FG001|Overall Study|Physician Decision|12
1135364|NCT02792231|2234143|FG000|Overall Study|Lack of Efficacy|7
1135365|NCT02792231|2234144|FG001|Overall Study|Lack of Efficacy|9
1135366|NCT02792231|2234143|FG000|Overall Study|Lost to Follow-up|9
1135367|NCT02792231|2234144|FG001|Overall Study|Lost to Follow-up|5
1135368|NCT02792231|2234143|FG000|Overall Study|Pregnancy|1
1135369|NCT02792231|2234144|FG001|Overall Study|Pregnancy|3
1135370|NCT02792231|2234143|FG000|Overall Study|Non-compliance with study treatment|2
1135371|NCT02792231|2234144|FG001|Overall Study|Non-compliance with study treatment|1
1135372|NCT02792231|2234143|FG000|Overall Study|Protocol deviation|2
1135373|NCT02792231|2234144|FG001|Overall Study|Protocol deviation|0
1135374|NCT02792231|2234143|FG000|Overall Study|Technical problems|0
1135375|NCT02792231|2234144|FG001|Overall Study|Technical problems|1
1135376|NCT02792504|2234150|FG000|Overall Study|Lost to Follow-up|24
1135377|NCT02792504|2234150|FG000|Overall Study|Violated inclusion/exclusion criteria|6
1135378|NCT02792517|2234154|FG000|Overall Study|Withdrawal by Subject|10
1135379|NCT02792517|2234154|FG000|Overall Study|Decision by Sponsor|7
1135380|NCT02792517|2234154|FG000|Overall Study|Lost to Follow-up|3
1135381|NCT02792699|2234161|FG000|Overall Study|Adverse Event|1
1135382|NCT02792699|2234162|FG001|Overall Study|Adverse Event|2
1135383|NCT02792699|2234163|FG002|Overall Study|Adverse Event|4
1135384|NCT02792699|2234161|FG000|Overall Study|Withdrawal by Subject|4
1135385|NCT02792699|2234162|FG001|Overall Study|Withdrawal by Subject|4
1135386|NCT02792699|2234163|FG002|Overall Study|Withdrawal by Subject|3
1135387|NCT02792699|2234161|FG000|Overall Study|Lost to Follow-up|0
1135388|NCT02792699|2234162|FG001|Overall Study|Lost to Follow-up|1
1135389|NCT02792699|2234163|FG002|Overall Study|Lost to Follow-up|2
1135390|NCT02792699|2234161|FG000|Overall Study|Physician Decision|2
1135391|NCT02792699|2234162|FG001|Overall Study|Physician Decision|0
1135392|NCT02792699|2234163|FG002|Overall Study|Physician Decision|0
1135393|NCT02792699|2234161|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1
1135394|NCT02792699|2234162|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3
1135395|NCT02792699|2234163|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1
1135396|NCT02792699|2234161|FG000|Overall Study|Other|1
1135397|NCT02792699|2234162|FG001|Overall Study|Other|0
1135398|NCT02792699|2234163|FG002|Overall Study|Other|0
1135399|NCT02792777|2234180|FG000|Overall Study|Withdrawal by Subject|2
1135400|NCT02792777|2234181|FG001|Overall Study|Withdrawal by Subject|0
1135401|NCT02792777|2234180|FG000|Overall Study|Recording malfunction|2
1135402|NCT02792777|2234181|FG001|Overall Study|Recording malfunction|0
1135403|NCT02792777|2234180|FG000|Overall Study|Later determined to be ineligible|2
1135404|NCT02792777|2234181|FG001|Overall Study|Later determined to be ineligible|0
1135405|NCT02792777|2234180|FG000|Overall Study|Participant interviewed twice|1
1135406|NCT02792777|2234181|FG001|Overall Study|Participant interviewed twice|0
1135407|NCT02792829|2234196|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0
1135408|NCT02792829|2234197|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1
1162089|NCT03383146|2284115|FG000|Overall Study|Screen Failure|1
1135409|NCT02792829|2234198|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0
1135410|NCT02792829|2234199|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0
1135411|NCT02792829|2234200|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0
1135412|NCT02792829|2234201|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0
1135413|NCT02792829|2234202|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0
1135414|NCT02792829|2234203|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0
1135415|NCT02792829|2234196|FG000|Treatment Period 2|Adverse Event|0
1135416|NCT02792829|2234197|FG001|Treatment Period 2|Adverse Event|0
1135417|NCT02792829|2234198|FG002|Treatment Period 2|Adverse Event|0
1135418|NCT02792829|2234199|FG003|Treatment Period 2|Adverse Event|0
1135419|NCT02792829|2234200|FG004|Treatment Period 2|Adverse Event|1
1135420|NCT02792829|2234201|FG005|Treatment Period 2|Adverse Event|0
1135421|NCT02792829|2234202|FG006|Treatment Period 2|Adverse Event|1
1135422|NCT02792829|2234203|FG007|Treatment Period 2|Adverse Event|1
1135423|NCT02792829|2234196|FG000|Treatment Period 2|Use of proscribed medications|0
1135424|NCT02792829|2234197|FG001|Treatment Period 2|Use of proscribed medications|0
1135425|NCT02792829|2234198|FG002|Treatment Period 2|Use of proscribed medications|0
1135426|NCT02792829|2234199|FG003|Treatment Period 2|Use of proscribed medications|0
1135427|NCT02792829|2234200|FG004|Treatment Period 2|Use of proscribed medications|0
1135428|NCT02792829|2234201|FG005|Treatment Period 2|Use of proscribed medications|0
1135429|NCT02792829|2234202|FG006|Treatment Period 2|Use of proscribed medications|0
1135430|NCT02792829|2234203|FG007|Treatment Period 2|Use of proscribed medications|1
1135431|NCT02793128|2234233|FG000|Overall Study|Death|4
1135432|NCT02793128|2234233|FG000|Overall Study|Withdrawal by Subject|2
1135433|NCT02793128|2234233|FG000|Overall Study|Physician Decision|1
1135434|NCT02793128|2234233|FG000|Overall Study|Comorbid conditions and noncompliance|1
1135435|NCT02793128|2234233|FG000|Overall Study|Patient elected nephroureterectomy|1
1135436|NCT02793232|2234267|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1135437|NCT02793232|2234268|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1135438|NCT02793232|2234269|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1135439|NCT02793232|2234270|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1135440|NCT02793232|2234271|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
1135441|NCT02793232|2234272|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1135442|NCT02793232|2234273|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
1135443|NCT02793232|2234274|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1135444|NCT02793232|2234275|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1135445|NCT02793622|2234311|FG000|Overall Study|Lost to Follow-up|31
1135446|NCT02793622|2234312|FG001|Overall Study|Lost to Follow-up|19
1135447|NCT02793622|2234311|FG000|Overall Study|Withdrawal by Subject|21
1135448|NCT02793622|2234312|FG001|Overall Study|Withdrawal by Subject|17
1135449|NCT02793622|2234311|FG000|Overall Study|Adverse Event|0
1135450|NCT02793622|2234312|FG001|Overall Study|Adverse Event|1
1135451|NCT02793622|2234311|FG000|Overall Study|Protocol Violation|1
1135452|NCT02793622|2234312|FG001|Overall Study|Protocol Violation|5
1135453|NCT02793947|2234389|FG000|Overall Study|Death|1
1135454|NCT02793947|2234390|FG001|Overall Study|Death|0
1135455|NCT02793947|2234389|FG000|Overall Study|Physician Decision|1
1135456|NCT02793947|2234390|FG001|Overall Study|Physician Decision|5
1135457|NCT02794103|2234396|FG000|Overall Study|Loss to follow up due to high sedation|3
1135458|NCT02794246|2234408|FG000|Overall Study|Withdrawal by Subject|2
1135459|NCT02794246|2234408|FG000|Overall Study|Physician Decision|4
1135460|NCT02794480|2234423|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1135461|NCT02794480|2234424|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1135462|NCT02794480|2234425|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
1135463|NCT02794480|2234426|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1135464|NCT02794480|2234423|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1135465|NCT02794480|2234424|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1135466|NCT02794480|2234425|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
1135467|NCT02794480|2234426|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1135468|NCT02794480|2234423|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1135469|NCT02794480|2234424|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1135470|NCT02794480|2234425|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1135471|NCT02794480|2234426|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
1135472|NCT02794480|2234423|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1135473|NCT02794480|2234424|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
1135474|NCT02794480|2234425|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1135475|NCT02794480|2234426|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1135476|NCT02794480|2234423|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1135477|NCT02794480|2234424|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1135478|NCT02794480|2234425|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1135479|NCT02794480|2234426|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1135480|NCT02794870|2234474|FG000|Overall Study|Withdrawal by Subject|2
1135481|NCT02794870|2234475|FG001|Overall Study|Withdrawal by Subject|0
1135482|NCT02794974|2234483|FG000|Overall Study|Physician Decision|0
1135483|NCT02794974|2234484|FG001|Overall Study|Physician Decision|1
1135484|NCT02795767|2234506|FG000|Overall Study|Received Commercial Emicizumab|1
1135485|NCT02795767|2234507|FG001|Overall Study|Received Commercial Emicizumab|0
1135486|NCT02795767|2234508|FG002|Overall Study|Received Commercial Emicizumab|0
1135487|NCT02795832|2234553|FG000|Overall Study|Adverse Event|0
1135488|NCT02795832|2234554|FG001|Overall Study|Adverse Event|0
1135489|NCT02795832|2234555|FG002|Overall Study|Adverse Event|0
1135490|NCT02795832|2234556|FG003|Overall Study|Adverse Event|0
1135491|NCT02795832|2234557|FG004|Overall Study|Adverse Event|0
1135492|NCT02795832|2234558|FG005|Overall Study|Adverse Event|3
1135493|NCT02796560|2234623|FG000|Overall Study|Adverse Event|2
1135494|NCT02796560|2234624|FG001|Overall Study|Adverse Event|0
1135495|NCT02796560|2234623|FG000|Overall Study|Withdrawal by Subject|2
1135496|NCT02796560|2234624|FG001|Overall Study|Withdrawal by Subject|2
1135497|NCT02796651|2234634|FG000|Overall Study|Adverse Event|6
1135498|NCT02796651|2234634|FG000|Overall Study|Lost to Follow-up|1
1135499|NCT02796651|2234634|FG000|Overall Study|Withdrawal by Subject|4
1135500|NCT02796651|2234634|FG000|Overall Study|Protocol Violation|4
1135501|NCT02796651|2234634|FG000|Overall Study|Lack of Efficacy|1
1135502|NCT02796651|2234634|FG000|Overall Study|Other|10
1135503|NCT02796664|2234651|FG000|Overall Study|Withdrawal by Subject|0
1135504|NCT02796664|2234652|FG001|Overall Study|Withdrawal by Subject|3
1135505|NCT02796664|2234651|FG000|Overall Study|Noncompliance|1
1135506|NCT02796664|2234652|FG001|Overall Study|Noncompliance|1
1135507|NCT02796664|2234651|FG000|Overall Study|Death|0
1135508|NCT02796664|2234652|FG001|Overall Study|Death|1
1135509|NCT02796677|2234664|FG000|Overall Study|Adverse Event|11
1135510|NCT02796677|2234665|FG001|Overall Study|Adverse Event|22
1135511|NCT02796677|2234666|FG002|Overall Study|Adverse Event|14
1135512|NCT02796677|2234667|FG003|Overall Study|Adverse Event|14
1135513|NCT02796677|2234664|FG000|Overall Study|Protocol Violation|7
1135514|NCT02796677|2234665|FG001|Overall Study|Protocol Violation|5
1135515|NCT02796677|2234666|FG002|Overall Study|Protocol Violation|4
1135516|NCT02796677|2234667|FG003|Overall Study|Protocol Violation|8
1135517|NCT02796677|2234664|FG000|Overall Study|Lost to Follow-up|1
1135518|NCT02796677|2234665|FG001|Overall Study|Lost to Follow-up|5
1135519|NCT02796677|2234666|FG002|Overall Study|Lost to Follow-up|2
1135520|NCT02796677|2234667|FG003|Overall Study|Lost to Follow-up|2
1135521|NCT02796677|2234664|FG000|Overall Study|Lack of Efficacy|7
1135522|NCT02796677|2234665|FG001|Overall Study|Lack of Efficacy|9
1135523|NCT02796677|2234666|FG002|Overall Study|Lack of Efficacy|14
1135524|NCT02796677|2234667|FG003|Overall Study|Lack of Efficacy|20
1135525|NCT02796677|2234664|FG000|Overall Study|Withdrawal by Subject|4
1135526|NCT02796677|2234665|FG001|Overall Study|Withdrawal by Subject|14
1135527|NCT02796677|2234666|FG002|Overall Study|Withdrawal by Subject|6
1135528|NCT02796677|2234667|FG003|Overall Study|Withdrawal by Subject|7
1135529|NCT02796677|2234664|FG000|Overall Study|Progressive disease|6
1135530|NCT02796677|2234665|FG001|Overall Study|Progressive disease|15
1135531|NCT02796677|2234666|FG002|Overall Study|Progressive disease|13
1135532|NCT02796677|2234667|FG003|Overall Study|Progressive disease|18
1135533|NCT02796677|2234664|FG000|Overall Study|Reason not mentioned|2
1135534|NCT02796677|2234665|FG001|Overall Study|Reason not mentioned|3
1135535|NCT02796677|2234666|FG002|Overall Study|Reason not mentioned|0
1135536|NCT02796677|2234667|FG003|Overall Study|Reason not mentioned|5
1135537|NCT02796755|2234681|FG000|Overall Study|Adverse Event|2
1135538|NCT02796755|2234682|FG001|Overall Study|Adverse Event|0
1135539|NCT02796963|2234696|FG000|Overall Study|Lost to Follow-up|89
1135540|NCT02796963|2234697|FG001|Overall Study|Lost to Follow-up|76
1135541|NCT02796963|2234698|FG002|Overall Study|Lost to Follow-up|69
1135542|NCT02796963|2234699|FG003|Overall Study|Lost to Follow-up|72
1135543|NCT02797080|2234722|FG000|Overall Study|Lost to Follow-up|1
1135544|NCT02797080|2234722|FG000|Overall Study|Withdrawal by Subject|1
1135545|NCT02797132|2234726|FG000|Part A (15 Days)|Adverse Event|1
1135546|NCT02797132|2234726|FG000|Part B (24 Weeks)|Adverse Event|3
1135547|NCT02797171|2234745|FG000|Overall Study|Lost to Follow-up|2
1135548|NCT02797171|2234746|FG001|Overall Study|Lost to Follow-up|0
1135549|NCT02797171|2234747|FG002|Overall Study|Lost to Follow-up|2
1135550|NCT02797171|2234748|FG003|Overall Study|Lost to Follow-up|1
1135551|NCT02797171|2234749|FG004|Overall Study|Lost to Follow-up|2
1135552|NCT02797171|2234750|FG005|Overall Study|Lost to Follow-up|0
1135553|NCT02797171|2234745|FG000|Overall Study|Withdrawal by Subject|1
1135554|NCT02797171|2234746|FG001|Overall Study|Withdrawal by Subject|1
1135555|NCT02797171|2234747|FG002|Overall Study|Withdrawal by Subject|0
1135556|NCT02797171|2234748|FG003|Overall Study|Withdrawal by Subject|0
1135557|NCT02797171|2234749|FG004|Overall Study|Withdrawal by Subject|0
1135558|NCT02797171|2234750|FG005|Overall Study|Withdrawal by Subject|0
1135559|NCT02797171|2234745|FG000|Overall Study|Protocol Violation|1
1135560|NCT02797171|2234746|FG001|Overall Study|Protocol Violation|0
1135561|NCT02797171|2234747|FG002|Overall Study|Protocol Violation|0
1135562|NCT02797171|2234748|FG003|Overall Study|Protocol Violation|0
1135563|NCT02797171|2234749|FG004|Overall Study|Protocol Violation|0
1135564|NCT02797171|2234750|FG005|Overall Study|Protocol Violation|0
1135565|NCT02797171|2234745|FG000|Overall Study|Participant unable to adhere|0
1135566|NCT02797171|2234746|FG001|Overall Study|Participant unable to adhere|1
1135567|NCT02797171|2234747|FG002|Overall Study|Participant unable to adhere|0
1135568|NCT02797171|2234748|FG003|Overall Study|Participant unable to adhere|0
1135569|NCT02797171|2234749|FG004|Overall Study|Participant unable to adhere|0
1135570|NCT02797171|2234750|FG005|Overall Study|Participant unable to adhere|0
1135571|NCT02797171|2234745|FG000|Overall Study|Not Randomized|0
1135572|NCT02797171|2234746|FG001|Overall Study|Not Randomized|0
1135573|NCT02797171|2234747|FG002|Overall Study|Not Randomized|0
1135574|NCT02797171|2234748|FG003|Overall Study|Not Randomized|0
1135575|NCT02797171|2234749|FG004|Overall Study|Not Randomized|0
1135576|NCT02797171|2234750|FG005|Overall Study|Not Randomized|1
1135577|NCT02797522|2234775|FG000|Overall Study|Study Terminated by Sponsor|0
1135578|NCT02797522|2234776|FG001|Overall Study|Study Terminated by Sponsor|0
1135579|NCT02797522|2234777|FG002|Overall Study|Study Terminated by Sponsor|0
1135580|NCT02797522|2234778|FG003|Overall Study|Study Terminated by Sponsor|0
1135581|NCT02797522|2234779|FG004|Overall Study|Study Terminated by Sponsor|0
1135582|NCT02797522|2234780|FG005|Overall Study|Study Terminated by Sponsor|0
1135583|NCT02797522|2234781|FG006|Overall Study|Study Terminated by Sponsor|0
1135584|NCT02797522|2234782|FG007|Overall Study|Study Terminated by Sponsor|4
1135585|NCT02797522|2234783|FG008|Overall Study|Study Terminated by Sponsor|2
1135586|NCT02797522|2234784|FG009|Overall Study|Study Terminated by Sponsor|4
1135587|NCT02797522|2234785|FG010|Overall Study|Study Terminated by Sponsor|1
1135588|NCT02797678|2234822|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25
1135589|NCT02797678|2234823|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0
1135590|NCT02797678|2234824|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0
1135591|NCT02797678|2234825|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0
1135592|NCT02797678|2234822|FG000|First Intervention (5 Nights)|study/device use non-compliance|0
1135593|NCT02797678|2234823|FG001|First Intervention (5 Nights)|study/device use non-compliance|1
1135594|NCT02797678|2234824|FG002|First Intervention (5 Nights)|study/device use non-compliance|0
1135595|NCT02797678|2234825|FG003|First Intervention (5 Nights)|study/device use non-compliance|0
1135596|NCT02797678|2234822|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0
1135597|NCT02797678|2234823|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0
1135598|NCT02797678|2234824|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1
1135599|NCT02797678|2234825|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0
1135600|NCT02797808|2234840|FG000|Overall Study|Withdrawal by Subject|1
1135601|NCT02797808|2234841|FG001|Overall Study|Withdrawal by Subject|1
1135602|NCT02797808|2234840|FG000|Overall Study|Physician Decision|6
1135603|NCT02797808|2234841|FG001|Overall Study|Physician Decision|2
1135604|NCT02798315|2234884|FG000|Overall Study|Failure to return|1
1135605|NCT02798835|2234923|FG000|Overall Study|Protocol Violation|0
1135606|NCT02798835|2234924|FG001|Overall Study|Protocol Violation|0
1135607|NCT02798835|2234925|FG002|Overall Study|Protocol Violation|3
1135608|NCT02798861|2234933|FG000|Overall Study|Lost to Follow-up|22
1135609|NCT02798861|2234933|FG000|Overall Study|Withdrawal by Subject|1
1135610|NCT02799069|2234979|FG000|Overall Study|Adverse Event|0
1135611|NCT02799069|2234980|FG001|Overall Study|Adverse Event|2
1135612|NCT02799069|2234981|FG002|Overall Study|Adverse Event|2
1135613|NCT02799069|2234979|FG000|Overall Study|Lack of Efficacy|2
1135614|NCT02799069|2234980|FG001|Overall Study|Lack of Efficacy|0
1135615|NCT02799069|2234981|FG002|Overall Study|Lack of Efficacy|0
1135616|NCT02799069|2234979|FG000|Overall Study|Lost to Follow-up|1
1135617|NCT02799069|2234980|FG001|Overall Study|Lost to Follow-up|1
1135618|NCT02799069|2234981|FG002|Overall Study|Lost to Follow-up|0
1135619|NCT02799069|2234979|FG000|Overall Study|Withdrawal by Subject|4
1135620|NCT02799069|2234980|FG001|Overall Study|Withdrawal by Subject|4
1135621|NCT02799069|2234981|FG002|Overall Study|Withdrawal by Subject|3
1135622|NCT02799069|2234979|FG000|Overall Study|Protocol Violation|1
1135623|NCT02799069|2234980|FG001|Overall Study|Protocol Violation|0
1135624|NCT02799069|2234981|FG002|Overall Study|Protocol Violation|2
1135625|NCT02799082|2234991|FG000|Overall Study|Refused second PDT or withdraw consent|4
1135626|NCT02799082|2234992|FG001|Overall Study|Refused second PDT or withdraw consent|3
1135627|NCT02799082|2234991|FG000|Overall Study|Protocol Violation|0
1135628|NCT02799082|2234992|FG001|Overall Study|Protocol Violation|1
1135629|NCT02799381|2235017|FG000|Overall Study|Withdrew consent|3
1135630|NCT02799381|2235018|FG001|Overall Study|Withdrew consent|2
1135631|NCT02799381|2235017|FG000|Overall Study|Adverse Event|0
1135632|NCT02799381|2235018|FG001|Overall Study|Adverse Event|1
1135633|NCT02799381|2235017|FG000|Overall Study|Participant did not take any study drug|1
1135634|NCT02799381|2235018|FG001|Overall Study|Participant did not take any study drug|0
1135635|NCT02799472|2235026|FG000|Overall Study|Withdrawal by Subject|2
1135636|NCT02799472|2235027|FG001|Overall Study|Withdrawal by Subject|4
1135637|NCT02799472|2235026|FG000|Overall Study|Lack of Efficacy|2
1135638|NCT02799472|2235027|FG001|Overall Study|Lack of Efficacy|0
1135639|NCT02799472|2235026|FG000|Overall Study|Lost to Follow-up|0
1135640|NCT02799472|2235027|FG001|Overall Study|Lost to Follow-up|1
1135641|NCT02799745|2235044|FG000|Overall Study|Participant moved out of state|1
1135642|NCT02799745|2235045|FG001|Overall Study|Participant moved out of state|0
1135643|NCT02799745|2235044|FG000|Overall Study|Discontinued due to planned surgery|1
1135644|NCT02799745|2235045|FG001|Overall Study|Discontinued due to planned surgery|0
1135645|NCT02799745|2235044|FG000|Overall Study|Withdrawal by Subject|16
1135646|NCT02799745|2235045|FG001|Overall Study|Withdrawal by Subject|25
1135647|NCT02799745|2235044|FG000|Overall Study|Protocol Deviation|4
1135648|NCT02799745|2235045|FG001|Overall Study|Protocol Deviation|5
1135649|NCT02799745|2235044|FG000|Overall Study|Progressive Disease|28
1135650|NCT02799745|2235045|FG001|Overall Study|Progressive Disease|38
1135651|NCT02799745|2235044|FG000|Overall Study|Lost to Follow-up|3
1135652|NCT02799745|2235045|FG001|Overall Study|Lost to Follow-up|2
1135653|NCT02799745|2235044|FG000|Overall Study|Death|3
1135654|NCT02799745|2235045|FG001|Overall Study|Death|0
1135655|NCT02799745|2235044|FG000|Overall Study|Adverse Event|0
1135656|NCT02799745|2235045|FG001|Overall Study|Adverse Event|1
1135657|NCT02799784|2235051|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
1135658|NCT02799784|2235052|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
1135659|NCT02799784|2235051|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
1135660|NCT02799784|2235052|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
1135661|NCT02799784|2235051|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
1135662|NCT02799784|2235052|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
1135663|NCT02799784|2235051|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
1135664|NCT02799784|2235052|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
1135665|NCT02799784|2235051|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
1135666|NCT02799784|2235052|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
1135667|NCT02799784|2235051|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
1135668|NCT02799784|2235052|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
1135669|NCT02800642|2235084|FG000|Overall Study|Death|3
1135670|NCT02800642|2235084|FG000|Overall Study|Other|10
1135671|NCT02800642|2235084|FG000|Overall Study|Physician Decision|2
1135672|NCT02800642|2235084|FG000|Overall Study|Adverse Event|6
1135673|NCT02800642|2235084|FG000|Overall Study|Withdrawal by Subject|3
1135674|NCT02800642|2235084|FG000|Overall Study|Lost to Follow-up|1
1135675|NCT02800928|2235088|FG000|Overall Study|Withdrawal by Subject|1
1135676|NCT02800928|2235089|FG001|Overall Study|Withdrawal by Subject|1
1135677|NCT02800928|2235088|FG000|Overall Study|Protocol Violation|1
1135678|NCT02800928|2235089|FG001|Overall Study|Protocol Violation|1
1135679|NCT02801396|2235114|FG000|Period 1|Withdrawal by Subject|0
1135680|NCT02801396|2235115|FG001|Period 1|Withdrawal by Subject|0
1135681|NCT02801396|2235116|FG002|Period 1|Withdrawal by Subject|0
1135682|NCT02801396|2235117|FG003|Period 1|Withdrawal by Subject|0
1135683|NCT02801396|2235118|FG004|Period 1|Withdrawal by Subject|1
1135684|NCT02801396|2235119|FG005|Period 1|Withdrawal by Subject|0
1135685|NCT02801578|2235127|FG000|Overall Study|Adverse Event|2
1135686|NCT02801617|2235133|FG000|Overall Study|Protocol Violation|2
1135687|NCT02801617|2235134|FG001|Overall Study|Protocol Violation|6
1135688|NCT02801669|2235146|FG000|Overall Study|Death|66
1135689|NCT02801669|2235147|FG001|Overall Study|Death|69
1135690|NCT02801669|2235146|FG000|Overall Study|Withdrawal by Subject|81
1135691|NCT02801669|2235147|FG001|Overall Study|Withdrawal by Subject|77
1135692|NCT02801669|2235146|FG000|Overall Study|Other|4
1135693|NCT02801669|2235147|FG001|Overall Study|Other|6
1135694|NCT02801877|2235157|FG000|Overall Study|Lost to Follow-up|1
1135695|NCT02801877|2235158|FG001|Overall Study|Lost to Follow-up|1
1135696|NCT02801877|2235159|FG002|Overall Study|Lost to Follow-up|2
1135697|NCT02801877|2235160|FG003|Overall Study|Lost to Follow-up|0
1135698|NCT02801877|2235157|FG000|Overall Study|Never Started Treatment|2
1135699|NCT02801877|2235158|FG001|Overall Study|Never Started Treatment|0
1135700|NCT02801877|2235159|FG002|Overall Study|Never Started Treatment|4
1135701|NCT02801877|2235160|FG003|Overall Study|Never Started Treatment|0
1135702|NCT02802319|2235207|FG000|Overall Study|Physician Decision|2
1135703|NCT02802319|2235208|FG001|Overall Study|Physician Decision|1
1135704|NCT02802319|2235207|FG000|Overall Study|Lost to Follow-up|0
1135705|NCT02802319|2235208|FG001|Overall Study|Lost to Follow-up|4
1135706|NCT02802345|2235216|FG000|Overall Study|Not Treated|0
1135707|NCT02802345|2235217|FG001|Overall Study|Not Treated|1
1135708|NCT02802345|2235216|FG000|Overall Study|Adverse Event|28
1135709|NCT02802345|2235217|FG001|Overall Study|Adverse Event|20
1135710|NCT02802345|2235216|FG000|Overall Study|Withdrawal by Subject|3
1135711|NCT02802345|2235217|FG001|Overall Study|Withdrawal by Subject|3
1135712|NCT02802345|2235216|FG000|Overall Study|Protocol Violation|0
1135713|NCT02802345|2235217|FG001|Overall Study|Protocol Violation|1
1135714|NCT02802345|2235216|FG000|Overall Study|Other than listed|1
1135715|NCT02802345|2235217|FG001|Overall Study|Other than listed|5
1135716|NCT02802735|2235269|FG000|Overall Study|Withdrawal by Subject|0
1135717|NCT02802735|2235270|FG001|Overall Study|Withdrawal by Subject|1
1135718|NCT02802735|2235271|FG002|Overall Study|Withdrawal by Subject|0
1135719|NCT02802735|2235272|FG003|Overall Study|Withdrawal by Subject|0
1135720|NCT02802735|2235273|FG004|Overall Study|Withdrawal by Subject|0
1135721|NCT02802865|2235290|FG000|Overall Study|Pregnancy|1
1135722|NCT02802865|2235291|FG001|Overall Study|Pregnancy|1
1135723|NCT02802865|2235290|FG000|Overall Study|Ineliegible due to tuberculosis|0
1135724|NCT02802865|2235291|FG001|Overall Study|Ineliegible due to tuberculosis|1
1135725|NCT02802878|2235299|FG000|Overall Study|Withdrawal by Subject|3
1135726|NCT02802878|2235300|FG001|Overall Study|Withdrawal by Subject|3
1135727|NCT02802878|2235299|FG000|Overall Study|Protocol Violation|1
1135728|NCT02802878|2235300|FG001|Overall Study|Protocol Violation|0
1135729|NCT02803138|2235306|FG000|Overall Study|Failure to return|38
1135730|NCT02803138|2235306|FG000|Overall Study|Insufficient virological response|2
1135731|NCT02803138|2235306|FG000|Overall Study|Withdrawn consent|1
1135732|NCT02803138|2235306|FG000|Overall Study|Death|1
1135733|NCT02803138|2235306|FG000|Overall Study|Other, not specified|28
1135734|NCT02804178|2235345|FG000|Overall Study|Adverse Event|1
1135735|NCT02804399|2235349|FG000|Period 2|Adverse Event|0
1135736|NCT02804399|2235350|FG001|Period 2|Adverse Event|1
1135737|NCT02804750|2235370|FG000|Period 1|Adverse Event|0
1135738|NCT02804750|2235371|FG001|Period 1|Adverse Event|2
1135739|NCT02804750|2235370|FG000|Period 1|Withdrawal by Subject|0
1135740|NCT02804750|2235371|FG001|Period 1|Withdrawal by Subject|1
1135741|NCT02804750|2235370|FG000|Period 2|Adverse Event|1
1135742|NCT02804750|2235371|FG001|Period 2|Adverse Event|0
1135743|NCT02804750|2235370|FG000|Period 3|Adverse Event|0
1135744|NCT02804750|2235371|FG001|Period 3|Adverse Event|2
1135745|NCT02804750|2235370|FG000|Period 4|Adverse Event|0
1135746|NCT02804750|2235371|FG001|Period 4|Adverse Event|5
1135747|NCT02804763|2235383|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1
1135748|NCT02804763|2235384|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
1135749|NCT02804763|2235385|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
1135750|NCT02804763|2235386|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
1135751|NCT02804763|2235383|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
1135752|NCT02804763|2235384|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
1135753|NCT02804763|2235385|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1
1135754|NCT02804763|2235386|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2
1135755|NCT02804763|2235383|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
1135756|NCT02804763|2235384|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1
1135757|NCT02804763|2235385|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
1135758|NCT02804763|2235386|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
1135759|NCT02804763|2235383|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2
1135760|NCT02804763|2235384|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0
1135761|NCT02804763|2235385|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
1135762|NCT02804763|2235386|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
1135763|NCT02804763|2235383|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4
1135764|NCT02804763|2235384|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0
1135765|NCT02804763|2235385|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
1135766|NCT02804763|2235386|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
1135767|NCT02804763|2235383|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
1135768|NCT02804763|2235384|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1
1135769|NCT02804763|2235385|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
1135770|NCT02804763|2235386|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
1135771|NCT02805309|2235407|FG000|Overall Study|Lost to Follow-up|2
1135772|NCT02805309|2235408|FG001|Overall Study|Lost to Follow-up|2
1135773|NCT02805309|2235409|FG002|Overall Study|Lost to Follow-up|2
1135774|NCT02805309|2235407|FG000|Overall Study|Post-Randomization Exclusion|0
1135775|NCT02805309|2235408|FG001|Overall Study|Post-Randomization Exclusion|2
1135776|NCT02805309|2235409|FG002|Overall Study|Post-Randomization Exclusion|1
1135777|NCT02805660|2235433|FG000|Overall Study|Death|5
1135778|NCT02805660|2235434|FG001|Overall Study|Death|2
1135779|NCT02805660|2235435|FG002|Overall Study|Death|9
1135780|NCT02805660|2235436|FG003|Overall Study|Death|5
1135781|NCT02805660|2235437|FG004|Overall Study|Death|0
1135782|NCT02805660|2235438|FG005|Overall Study|Death|14
1135783|NCT02805660|2235439|FG006|Overall Study|Death|12
1135784|NCT02805660|2235433|FG000|Overall Study|Lost to Follow-up|0
1135785|NCT02805660|2235434|FG001|Overall Study|Lost to Follow-up|1
1135786|NCT02805660|2235435|FG002|Overall Study|Lost to Follow-up|1
1135787|NCT02805660|2235436|FG003|Overall Study|Lost to Follow-up|2
1135788|NCT02805660|2235437|FG004|Overall Study|Lost to Follow-up|0
1135789|NCT02805660|2235438|FG005|Overall Study|Lost to Follow-up|0
1135790|NCT02805660|2235439|FG006|Overall Study|Lost to Follow-up|0
1135791|NCT02805660|2235433|FG000|Overall Study|Withdrawal by Subject|0
1135792|NCT02805660|2235434|FG001|Overall Study|Withdrawal by Subject|0
1135793|NCT02805660|2235435|FG002|Overall Study|Withdrawal by Subject|0
1135794|NCT02805660|2235436|FG003|Overall Study|Withdrawal by Subject|3
1135795|NCT02805660|2235437|FG004|Overall Study|Withdrawal by Subject|1
1135796|NCT02805660|2235438|FG005|Overall Study|Withdrawal by Subject|0
1135797|NCT02805660|2235439|FG006|Overall Study|Withdrawal by Subject|2
1135798|NCT02805660|2235433|FG000|Overall Study|Study terminated by Sponsor|0
1135799|NCT02805660|2235434|FG001|Overall Study|Study terminated by Sponsor|0
1135800|NCT02805660|2235435|FG002|Overall Study|Study terminated by Sponsor|1
1135801|NCT02805660|2235436|FG003|Overall Study|Study terminated by Sponsor|4
1135802|NCT02805660|2235437|FG004|Overall Study|Study terminated by Sponsor|2
1135803|NCT02805660|2235438|FG005|Overall Study|Study terminated by Sponsor|3
1135804|NCT02805660|2235439|FG006|Overall Study|Study terminated by Sponsor|1
1135805|NCT02805660|2235433|FG000|Overall Study|Miscellaneous|0
1135806|NCT02805660|2235434|FG001|Overall Study|Miscellaneous|1
1135807|NCT02805660|2235435|FG002|Overall Study|Miscellaneous|0
1135808|NCT02805660|2235436|FG003|Overall Study|Miscellaneous|4
1135809|NCT02805660|2235437|FG004|Overall Study|Miscellaneous|0
1135810|NCT02805660|2235438|FG005|Overall Study|Miscellaneous|6
1135811|NCT02805660|2235439|FG006|Overall Study|Miscellaneous|4
1135812|NCT02805790|2235470|FG000|Second Intervention (4 Weeks)|Physician Decision|0
1135813|NCT02805790|2235471|FG001|Second Intervention (4 Weeks)|Physician Decision|1
1135814|NCT02805907|2235479|FG000|Overall Study|Lost to Follow-up|3
1135815|NCT02805907|2235480|FG001|Overall Study|Lost to Follow-up|3
1135816|NCT02805972|2235488|FG000|Washout Period|Lost to Follow-up|3
1135817|NCT02805972|2235489|FG001|Washout Period|Lost to Follow-up|0
1135818|NCT02806024|2235507|FG000|Overall Study|Night Delivery|1
1135819|NCT02806024|2235508|FG001|Overall Study|Night Delivery|1
1135820|NCT02806024|2235507|FG000|Overall Study|DVT during antepartum admission|0
1135821|NCT02806024|2235508|FG001|Overall Study|DVT during antepartum admission|1
1135822|NCT02806232|2235523|FG000|Overall Study|Lost to Follow-up|1
1135823|NCT02806232|2235524|FG001|Overall Study|Lost to Follow-up|2
1135824|NCT02806232|2235525|FG002|Overall Study|Lost to Follow-up|1
1135825|NCT02806232|2235526|FG003|Overall Study|Lost to Follow-up|0
1135826|NCT02806232|2235527|FG004|Overall Study|Lost to Follow-up|0
1135827|NCT02806232|2235528|FG005|Overall Study|Lost to Follow-up|1
1135828|NCT02806232|2235529|FG006|Overall Study|Lost to Follow-up|0
1135829|NCT02806232|2235530|FG007|Overall Study|Lost to Follow-up|0
1135830|NCT02806232|2235531|FG008|Overall Study|Lost to Follow-up|0
1135831|NCT02806232|2235523|FG000|Overall Study|Withdrawal by Subject|0
1135832|NCT02806232|2235524|FG001|Overall Study|Withdrawal by Subject|2
1135833|NCT02806232|2235525|FG002|Overall Study|Withdrawal by Subject|0
1135834|NCT02806232|2235526|FG003|Overall Study|Withdrawal by Subject|0
1135835|NCT02806232|2235527|FG004|Overall Study|Withdrawal by Subject|2
1135836|NCT02806232|2235528|FG005|Overall Study|Withdrawal by Subject|1
1135837|NCT02806232|2235529|FG006|Overall Study|Withdrawal by Subject|0
1135838|NCT02806232|2235530|FG007|Overall Study|Withdrawal by Subject|0
1135839|NCT02806232|2235531|FG008|Overall Study|Withdrawal by Subject|0
1135840|NCT02806414|2235551|FG000|Overall Study|Lost to Follow-up|2
1135841|NCT02806505|2235557|FG000|Overall Study|Adverse event/intercurrent illness|1
1135842|NCT02806505|2235558|FG001|Overall Study|Adverse event/intercurrent illness|3
1135843|NCT02806505|2235557|FG000|Overall Study|Death|4
1135844|NCT02806505|2235558|FG001|Overall Study|Death|0
1135845|NCT02806505|2235557|FG000|Overall Study|Did not cooperate/refused treatment|3
1135846|NCT02806505|2235558|FG001|Overall Study|Did not cooperate/refused treatment|3
1135847|NCT02806505|2235557|FG000|Overall Study|Failure to return|0
1135848|NCT02806505|2235558|FG001|Overall Study|Failure to return|1
1135849|NCT02806505|2235557|FG000|Overall Study|Insufficient therapeutic response|2
1135850|NCT02806505|2235558|FG001|Overall Study|Insufficient therapeutic response|4
1135851|NCT02806713|2235570|FG000|Overall Study|Urethral injury during procedure|1
1135852|NCT02806713|2235571|FG001|Overall Study|Urethral injury during procedure|0
1135853|NCT02806713|2235570|FG000|Overall Study|cancelled surgery|1
1135854|NCT02806713|2235571|FG001|Overall Study|cancelled surgery|2
1135855|NCT02806726|2235577|FG000|Overall Study|Lost to Follow-up|1
1135856|NCT02806947|2235613|FG000|Overall Study|Withdrawal by Subject|5
1135857|NCT02806947|2235614|FG001|Overall Study|Withdrawal by Subject|1
1135858|NCT02806973|2235620|FG000|Period 1|Withdrawal by Subject|0
1135859|NCT02806973|2235621|FG001|Period 1|Withdrawal by Subject|2
1135860|NCT02806973|2235622|FG002|Period 1|Withdrawal by Subject|1
1135861|NCT02806973|2235623|FG003|Period 1|Withdrawal by Subject|1
1135862|NCT02806973|2235620|FG000|Period 1|Adverse Event|0
1135863|NCT02806973|2235621|FG001|Period 1|Adverse Event|0
1135864|NCT02806973|2235622|FG002|Period 1|Adverse Event|0
1135865|NCT02806973|2235623|FG003|Period 1|Adverse Event|1
1135866|NCT02806973|2235620|FG000|Period 3|Withdrawal by Subject|0
1135867|NCT02806973|2235621|FG001|Period 3|Withdrawal by Subject|0
1135868|NCT02806973|2235622|FG002|Period 3|Withdrawal by Subject|0
1135869|NCT02806973|2235623|FG003|Period 3|Withdrawal by Subject|3
1135870|NCT02806973|2235620|FG000|Period 3|Adverse Event|0
1135871|NCT02806973|2235621|FG001|Period 3|Adverse Event|0
1135872|NCT02806973|2235622|FG002|Period 3|Adverse Event|1
1135873|NCT02806973|2235623|FG003|Period 3|Adverse Event|0
1135874|NCT02806986|2235633|FG000|Treatment Stage 1|Adverse Event|1
1135875|NCT02806986|2235633|FG000|Treatment Stage 2|Adverse Event|3
1135876|NCT02806986|2235633|FG000|Treatment Stage 2|Withdrawal by Subject|2
1135877|NCT02807259|2235643|FG000|Baseline (3 Months)|migration, refusal, not available|77
1135878|NCT02807259|2235644|FG001|Baseline (3 Months)|migration, refusal, not available|112
1135879|NCT02807259|2235643|FG000|Midline (3 Months)|migration, refusal, not available|30
1135880|NCT02807259|2235644|FG001|Midline (3 Months)|migration, refusal, not available|34
1135881|NCT02807259|2235643|FG000|Endline (3 Months)|migration, refusal, not available|35
1135882|NCT02807259|2235644|FG001|Endline (3 Months)|migration, refusal, not available|87
1135883|NCT02807376|2235654|FG000|Overall Study|Intra-operative exclusion criteria|3
1135884|NCT02807376|2235655|FG001|Overall Study|Intra-operative exclusion criteria|0
1135885|NCT02807376|2235654|FG000|Overall Study|Lost to Follow-up|0
1135886|NCT02807376|2235655|FG001|Overall Study|Lost to Follow-up|1
1135887|NCT02807402|2235661|FG000|Overall Study|Failure to Return|1
1135888|NCT02807402|2235661|FG000|Overall Study|Death|3
1135889|NCT02807402|2235661|FG000|Overall Study|Other|2
1135890|NCT02807623|2235676|FG000|Overall Study|Lost to Follow-up|23
1135891|NCT02807623|2235677|FG001|Overall Study|Lost to Follow-up|18
1135892|NCT02807623|2235678|FG002|Overall Study|Lost to Follow-up|22
1135893|NCT02807623|2235676|FG000|Overall Study|Drug intolerance|0
1135894|NCT02807623|2235677|FG001|Overall Study|Drug intolerance|1
1135895|NCT02807623|2235678|FG002|Overall Study|Drug intolerance|0
1135896|NCT02807623|2235676|FG000|Overall Study|incomplete blood draw|0
1135897|NCT02807623|2235677|FG001|Overall Study|incomplete blood draw|2
1135898|NCT02807623|2235678|FG002|Overall Study|incomplete blood draw|1
1135899|NCT02807844|2235705|FG000|Overall Study|Physician Decision|0
1135900|NCT02807844|2235706|FG001|Overall Study|Physician Decision|0
1135901|NCT02807844|2235707|FG002|Overall Study|Physician Decision|0
1135902|NCT02807844|2235708|FG003|Overall Study|Physician Decision|0
1135903|NCT02807844|2235709|FG004|Overall Study|Physician Decision|0
1135904|NCT02807844|2235710|FG005|Overall Study|Physician Decision|0
1135905|NCT02807844|2235711|FG006|Overall Study|Physician Decision|3
1135906|NCT02807844|2235712|FG007|Overall Study|Physician Decision|0
1135907|NCT02807844|2235713|FG008|Overall Study|Physician Decision|1
1135908|NCT02807844|2235714|FG009|Overall Study|Physician Decision|2
1135909|NCT02807844|2235705|FG000|Overall Study|Death|0
1135910|NCT02807844|2235706|FG001|Overall Study|Death|0
1135911|NCT02807844|2235707|FG002|Overall Study|Death|2
1135912|NCT02807844|2235708|FG003|Overall Study|Death|4
1135913|NCT02807844|2235709|FG004|Overall Study|Death|1
1135914|NCT02807844|2235710|FG005|Overall Study|Death|2
1135915|NCT02807844|2235711|FG006|Overall Study|Death|1
1135916|NCT02807844|2235712|FG007|Overall Study|Death|2
1135917|NCT02807844|2235713|FG008|Overall Study|Death|0
1135918|NCT02807844|2235714|FG009|Overall Study|Death|1
1135919|NCT02807844|2235705|FG000|Overall Study|Withdrawal by Subject|0
1135920|NCT02807844|2235706|FG001|Overall Study|Withdrawal by Subject|0
1135921|NCT02807844|2235707|FG002|Overall Study|Withdrawal by Subject|2
1135922|NCT02807844|2235708|FG003|Overall Study|Withdrawal by Subject|1
1135923|NCT02807844|2235709|FG004|Overall Study|Withdrawal by Subject|1
1135924|NCT02807844|2235710|FG005|Overall Study|Withdrawal by Subject|0
1135925|NCT02807844|2235711|FG006|Overall Study|Withdrawal by Subject|1
1135926|NCT02807844|2235712|FG007|Overall Study|Withdrawal by Subject|0
1135927|NCT02807844|2235713|FG008|Overall Study|Withdrawal by Subject|0
1135928|NCT02807844|2235714|FG009|Overall Study|Withdrawal by Subject|0
1135929|NCT02807844|2235705|FG000|Overall Study|Progressive disease|5
1135930|NCT02807844|2235706|FG001|Overall Study|Progressive disease|12
1135931|NCT02807844|2235707|FG002|Overall Study|Progressive disease|8
1135932|NCT02807844|2235708|FG003|Overall Study|Progressive disease|8
1135933|NCT02807844|2235709|FG004|Overall Study|Progressive disease|3
1135934|NCT02807844|2235710|FG005|Overall Study|Progressive disease|8
1135935|NCT02807844|2235711|FG006|Overall Study|Progressive disease|14
1135936|NCT02807844|2235712|FG007|Overall Study|Progressive disease|17
1135937|NCT02807844|2235713|FG008|Overall Study|Progressive disease|19
1135938|NCT02807844|2235714|FG009|Overall Study|Progressive disease|15
1135939|NCT02807844|2235705|FG000|Overall Study|Adverse Event|1
1135940|NCT02807844|2235706|FG001|Overall Study|Adverse Event|0
1135941|NCT02807844|2235707|FG002|Overall Study|Adverse Event|0
1135942|NCT02807844|2235708|FG003|Overall Study|Adverse Event|0
1135943|NCT02807844|2235709|FG004|Overall Study|Adverse Event|1
1135944|NCT02807844|2235710|FG005|Overall Study|Adverse Event|1
1135945|NCT02807844|2235711|FG006|Overall Study|Adverse Event|1
1135946|NCT02807844|2235712|FG007|Overall Study|Adverse Event|1
1135947|NCT02807844|2235713|FG008|Overall Study|Adverse Event|1
1135948|NCT02807844|2235714|FG009|Overall Study|Adverse Event|2
1135949|NCT02807857|2235740|FG000|Enrolled Set|Patients not suitable for follow-up.|551
1135950|NCT02807857|2235740|FG000|Follow-Up Set|Study Terminated By Sponsor|131
1135951|NCT02807857|2235740|FG000|Follow-Up Set|Withdrawal by Subject|8
1135952|NCT02807857|2235740|FG000|Follow-Up Set|Lost to Follow-up|7
1135953|NCT02807857|2235740|FG000|Follow-Up Set|Physician Decision|6
1135954|NCT02807857|2235740|FG000|Follow-Up Set|Adverse Event|3
1135955|NCT02807857|2235740|FG000|Follow-Up Set|Death|27
1135956|NCT02807857|2235740|FG000|Follow-Up Set|Relocation|2
1135957|NCT02807948|2235750|FG000|Overall Study|Physician Decision|1
1135958|NCT02807948|2235751|FG001|Overall Study|Physician Decision|0
1135959|NCT02808312|2235802|FG000|Overall Study|Enrolled but Never Treated|0
1135960|NCT02808312|2235803|FG001|Overall Study|Enrolled but Never Treated|0
1135961|NCT02808312|2235804|FG002|Overall Study|Enrolled but Never Treated|1
1135962|NCT02808312|2235805|FG003|Overall Study|Enrolled but Never Treated|0
1135963|NCT02808312|2235806|FG004|Overall Study|Enrolled but Never Treated|0
1135964|NCT02808338|2235823|FG000|Screening|Screen Failure|10
1135965|NCT02808338|2235823|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1
1135966|NCT02808338|2235823|FG000|Overnight In-lab Polysomonography|Reason not given|1
1135967|NCT02808429|2235837|FG000|Overall Study|Lost to Follow-up|1
1135968|NCT02808429|2235838|FG001|Overall Study|Lost to Follow-up|0
1135969|NCT02808429|2235839|FG002|Overall Study|Lost to Follow-up|0
1135970|NCT02808429|2235837|FG000|Overall Study|Protocol Violation|0
1135971|NCT02808429|2235838|FG001|Overall Study|Protocol Violation|1
1135972|NCT02808429|2235839|FG002|Overall Study|Protocol Violation|0
1135973|NCT02808429|2235837|FG000|Overall Study|Premature study termination by sponsor|2
1135974|NCT02808429|2235838|FG001|Overall Study|Premature study termination by sponsor|0
1135975|NCT02808429|2235839|FG002|Overall Study|Premature study termination by sponsor|1
1135976|NCT02808429|2235837|FG000|Overall Study|Relocation|0
1135977|NCT02808429|2235838|FG001|Overall Study|Relocation|0
1135978|NCT02808429|2235839|FG002|Overall Study|Relocation|1
1135979|NCT02808819|2235849|FG000|Overall Study|eg. no treatment efficacy on asthma|5
1135980|NCT02808819|2235850|FG001|Overall Study|eg. no treatment efficacy on asthma|4
1135981|NCT02808819|2235849|FG000|Overall Study|Withdrawal by Subject|10
1135982|NCT02808819|2235850|FG001|Overall Study|Withdrawal by Subject|13
1135983|NCT02808819|2235849|FG000|Overall Study|Site terminated by sponsor|2
1135984|NCT02808819|2235850|FG001|Overall Study|Site terminated by sponsor|0
1135985|NCT02808819|2235849|FG000|Overall Study|Pregnancy|1
1135986|NCT02808819|2235850|FG001|Overall Study|Pregnancy|0
1135987|NCT02808819|2235849|FG000|Overall Study|Lost to Follow-up|1
1135988|NCT02808819|2235850|FG001|Overall Study|Lost to Follow-up|6
1135989|NCT02808819|2235849|FG000|Overall Study|Protocol Violation|0
1135990|NCT02808819|2235850|FG001|Overall Study|Protocol Violation|1
1135991|NCT02808819|2235849|FG000|Overall Study|Development of study-specific withdrawal criteria|8
1135992|NCT02808819|2235850|FG001|Overall Study|Development of study-specific withdrawal criteria|3
1135993|NCT02808819|2235849|FG000|Overall Study|Death|1
1135994|NCT02808819|2235850|FG001|Overall Study|Death|0
1135995|NCT02808819|2235849|FG000|Overall Study|Adverse Event|3
1135996|NCT02808819|2235850|FG001|Overall Study|Adverse Event|4
1135997|NCT02808975|2235859|FG000|Overall Study|Adverse Event|3
1135998|NCT02808975|2235860|FG001|Overall Study|Adverse Event|4
1135999|NCT02808975|2235859|FG000|Overall Study|Withdrew consent|9
1136000|NCT02808975|2235860|FG001|Overall Study|Withdrew consent|8
1136001|NCT02808975|2235859|FG000|Overall Study|Lost to Follow-up|4
1136002|NCT02808975|2235860|FG001|Overall Study|Lost to Follow-up|6
1136003|NCT02808975|2235859|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1
1136004|NCT02808975|2235860|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0
1136005|NCT02808975|2235859|FG000|Overall Study|Other, not specified|5
1136006|NCT02808975|2235860|FG001|Overall Study|Other, not specified|1
1136007|NCT02809053|2235868|FG000|Overall Study|Death|0
1136008|NCT02809053|2235869|FG001|Overall Study|Death|1
1136009|NCT02809053|2235868|FG000|Overall Study|Lost to Follow-up|3
1136010|NCT02809053|2235869|FG001|Overall Study|Lost to Follow-up|1
1136011|NCT02809053|2235868|FG000|Overall Study|Withdrawal by Subject|2
1136012|NCT02809053|2235869|FG001|Overall Study|Withdrawal by Subject|3
1136013|NCT02809053|2235868|FG000|Overall Study|Disease Progression|2
1136014|NCT02809053|2235869|FG001|Overall Study|Disease Progression|1
1136015|NCT02809833|2235909|FG000|Overall Study|Death|3
1136016|NCT02809833|2235909|FG000|Overall Study|Intolerance|54
1136017|NCT02809833|2235909|FG000|Overall Study|Lack of Efficacy|89
1136018|NCT02809833|2235909|FG000|Overall Study|Remission/Treatment No Longer Needed|3
1136019|NCT02809833|2235909|FG000|Overall Study|Noncompliance|1
1136020|NCT02809833|2235909|FG000|Overall Study|Withdrawal by Subject|34
1136021|NCT02809833|2235909|FG000|Overall Study|Lost to Follow-up|35
1136022|NCT02809833|2235909|FG000|Overall Study|Adverse Event (AE)|24
1136023|NCT02809833|2235909|FG000|Overall Study|Other|5
1136024|NCT02809833|2235909|FG000|Overall Study|Missing Information|52
1136025|NCT02809976|2235935|FG000|Overall Study|Lost to Follow-up|1
1136026|NCT02809976|2235935|FG000|Overall Study|Withdrawal by Subject|1
1136027|NCT02810340|2235951|FG000|Overall Study|Withdrawal by Subject|1
1136028|NCT02810340|2235952|FG001|Overall Study|Withdrawal by Subject|0
1136029|NCT02810340|2235953|FG002|Overall Study|Withdrawal by Subject|0
1136030|NCT02810340|2235951|FG000|Overall Study|Incarceration|0
1136031|NCT02810340|2235952|FG001|Overall Study|Incarceration|1
1136032|NCT02810340|2235953|FG002|Overall Study|Incarceration|0
1136033|NCT02810340|2235951|FG000|Overall Study|Lost to Follow-up|0
1136034|NCT02810340|2235952|FG001|Overall Study|Lost to Follow-up|0
1136035|NCT02810340|2235953|FG002|Overall Study|Lost to Follow-up|1
1136036|NCT02810392|2235963|FG000|Overall Study|Subject too ill to continue|1
1136037|NCT02810392|2235964|FG001|Overall Study|Subject too ill to continue|0
1136038|NCT02810392|2235963|FG000|Overall Study|COVID 19 research restrictions|0
1136039|NCT02810392|2235964|FG001|Overall Study|COVID 19 research restrictions|1
1136068|NCT02810457|2236048|FG000|Overall Study|Randomised but no treatment received|2
1136069|NCT02810457|2236049|FG001|Overall Study|Randomised but no treatment received|1
1136070|NCT02810457|2236048|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191
1136071|NCT02810457|2236049|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199
1136072|NCT02810457|2236048|FG000|Overall Study|Adverse Event|37
1136073|NCT02810457|2236049|FG001|Overall Study|Adverse Event|43
1136074|NCT02810457|2236048|FG000|Overall Study|Patient decision|31
1136075|NCT02810457|2236049|FG001|Overall Study|Patient decision|35
1136076|NCT02810457|2236048|FG000|Overall Study|Patient lost to follow-up|2
1136077|NCT02810457|2236049|FG001|Overall Study|Patient lost to follow-up|2
1136078|NCT02810457|2236048|FG000|Overall Study|Death|39
1136079|NCT02810457|2236049|FG001|Overall Study|Death|28
1136080|NCT02810457|2236048|FG000|Overall Study|Ongoing at data cutoff and discontinued|3
1136081|NCT02810457|2236049|FG001|Overall Study|Ongoing at data cutoff and discontinued|2
1136082|NCT02810457|2236048|FG000|Overall Study|Clinical progression|15
1136083|NCT02810457|2236049|FG001|Overall Study|Clinical progression|16
1136084|NCT02810457|2236048|FG000|Overall Study|Investigator decision|3
1136085|NCT02810457|2236049|FG001|Overall Study|Investigator decision|2
1136086|NCT02810457|2236048|FG000|Overall Study|Patient ineligibility|3
1136087|NCT02810457|2236049|FG001|Overall Study|Patient ineligibility|0
1136088|NCT02810457|2236048|FG000|Overall Study|Miscalculated PD|1
1136089|NCT02810457|2236049|FG001|Overall Study|Miscalculated PD|0
1136090|NCT02810457|2236048|FG000|Overall Study|Physician Decision|0
1136091|NCT02810457|2236049|FG001|Overall Study|Physician Decision|1
1136092|NCT02810951|2236076|FG000|Overall Study|Adverse Event|1
1136093|NCT02810964|2236084|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1
1136094|NCT02810964|2236085|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2
1136095|NCT02810964|2236084|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1
1136096|NCT02810964|2236085|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0
1136097|NCT02810964|2236084|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0
1136098|NCT02810964|2236085|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1
1136099|NCT02810964|2236084|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1
1136100|NCT02810964|2236085|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0
1136101|NCT02811159|2236091|FG000|Treatment Course 1|Lost to Follow-up|1
1136102|NCT02811640|2236118|FG000|Overall Study|Technology malfunction|2
1136103|NCT02811861|2236125|FG000|Overall Study|Radiological Disease Progression|123
1136104|NCT02811861|2236126|FG001|Overall Study|Radiological Disease Progression|97
1136105|NCT02811861|2236127|FG002|Overall Study|Radiological Disease Progression|174
1136106|NCT02811861|2236125|FG000|Overall Study|Clinical Disease Progression|20
1136107|NCT02811861|2236126|FG001|Overall Study|Clinical Disease Progression|19
1136108|NCT02811861|2236127|FG002|Overall Study|Clinical Disease Progression|22
1136109|NCT02811861|2236125|FG000|Overall Study|Adverse Event|63
1136110|NCT02811861|2236126|FG001|Overall Study|Adverse Event|60
1136111|NCT02811861|2236127|FG002|Overall Study|Adverse Event|41
1136112|NCT02811861|2236125|FG000|Overall Study|Lost to Follow-up|0
1136113|NCT02811861|2236126|FG001|Overall Study|Lost to Follow-up|0
1136114|NCT02811861|2236127|FG002|Overall Study|Lost to Follow-up|1
900231|NCT00726232|1873274|FG004|Expansion Phase|Termination of the trial by sponsor|0
900232|NCT00726232|1873275|FG005|Expansion Phase|Termination of the trial by sponsor|0
900233|NCT00726232|1873276|FG006|Expansion Phase|Termination of the trial by sponsor|10
900234|NCT00726232|1873277|FG007|Expansion Phase|Termination of the trial by sponsor|16
900235|NCT00726232|1873270|FG000|Expansion Phase|Per Investigator: lack of response|0
900236|NCT00726232|1873271|FG001|Expansion Phase|Per Investigator: lack of response|0
900237|NCT00726232|1873272|FG002|Expansion Phase|Per Investigator: lack of response|0
900238|NCT00726232|1873273|FG003|Expansion Phase|Per Investigator: lack of response|0
900239|NCT00726232|1873274|FG004|Expansion Phase|Per Investigator: lack of response|0
900240|NCT00726232|1873275|FG005|Expansion Phase|Per Investigator: lack of response|0
900241|NCT00726232|1873276|FG006|Expansion Phase|Per Investigator: lack of response|1
900242|NCT00726232|1873277|FG007|Expansion Phase|Per Investigator: lack of response|7
900243|NCT00726232|1873270|FG000|Expansion Phase|Unspecified reason|0
900244|NCT00726232|1873271|FG001|Expansion Phase|Unspecified reason|0
900245|NCT00726232|1873272|FG002|Expansion Phase|Unspecified reason|0
900246|NCT00726232|1873273|FG003|Expansion Phase|Unspecified reason|0
900247|NCT00726232|1873274|FG004|Expansion Phase|Unspecified reason|0
900248|NCT00726232|1873275|FG005|Expansion Phase|Unspecified reason|0
900249|NCT00726232|1873276|FG006|Expansion Phase|Unspecified reason|1
900250|NCT00726232|1873277|FG007|Expansion Phase|Unspecified reason|0
900251|NCT00726323|1873298|FG000|Overall Study|Withdrawal by Subject|3
900252|NCT00726323|1873299|FG001|Overall Study|Withdrawal by Subject|1
900253|NCT00726323|1873298|FG000|Overall Study|Physician Decision|1
900254|NCT00726323|1873299|FG001|Overall Study|Physician Decision|0
900255|NCT00726323|1873298|FG000|Overall Study|Progressive disease|23
900256|NCT00726323|1873299|FG001|Overall Study|Progressive disease|16
900257|NCT00726323|1873298|FG000|Overall Study|Clinical progression|0
900258|NCT00726323|1873299|FG001|Overall Study|Clinical progression|3
900259|NCT00726323|1873298|FG000|Overall Study|Adverse Event|9
1136115|NCT02811861|2236125|FG000|Overall Study|Subject Choice|29
1136116|NCT02811861|2236126|FG001|Overall Study|Subject Choice|17
1136117|NCT02811861|2236127|FG002|Overall Study|Subject Choice|23
1136118|NCT02811861|2236125|FG000|Overall Study|Withdrawal by Subject|4
1136119|NCT02811861|2236126|FG001|Overall Study|Withdrawal by Subject|4
1136120|NCT02811861|2236127|FG002|Overall Study|Withdrawal by Subject|9
1136121|NCT02811861|2236125|FG000|Overall Study|Other|4
1136122|NCT02811861|2236126|FG001|Overall Study|Other|13
1136123|NCT02811861|2236127|FG002|Overall Study|Other|3
1136124|NCT02811861|2236125|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112
1136125|NCT02811861|2236126|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142
1136126|NCT02811861|2236127|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67
1136127|NCT02811861|2236125|FG000|Overall Study|Randomized but not treated|2
1136128|NCT02811861|2236126|FG001|Overall Study|Randomized but not treated|3
1136129|NCT02811861|2236127|FG002|Overall Study|Randomized but not treated|17
1136130|NCT02812186|2236171|FG000|Period 1|Post randomization screen failure|5
1136131|NCT02812186|2236172|FG001|Period 1|Post randomization screen failure|9
1136132|NCT02812186|2236171|FG000|Period 1|nonevaluable data sets|6
1136133|NCT02812186|2236172|FG001|Period 1|nonevaluable data sets|6
1136134|NCT02813421|2236219|FG000|Overall Study|Withdrawal by Subject|1
1136135|NCT02813421|2236220|FG001|Overall Study|Withdrawal by Subject|2
1136136|NCT02813421|2236219|FG000|Overall Study|Lost to Follow-up|1
1136137|NCT02813421|2236220|FG001|Overall Study|Lost to Follow-up|1
1136138|NCT02813577|2236239|FG000|Overall Study|Study terminated|4
1136139|NCT02813681|2236246|FG000|Overall Study|Physician Decision|5
1136140|NCT02813681|2236247|FG001|Overall Study|Physician Decision|5
1136141|NCT02813681|2236248|FG002|Overall Study|Physician Decision|0
1136142|NCT02813681|2236246|FG000|Overall Study|Lost to Follow-up|0
1136143|NCT02813681|2236247|FG001|Overall Study|Lost to Follow-up|1
1136144|NCT02813681|2236248|FG002|Overall Study|Lost to Follow-up|0
1136145|NCT02813694|2236260|FG000|Overall Study|Physician Decision|0
1136146|NCT02813694|2236261|FG001|Overall Study|Physician Decision|1
1136147|NCT02813694|2236260|FG000|Overall Study|Withdrawal by Subject|10
1136148|NCT02813694|2236261|FG001|Overall Study|Withdrawal by Subject|9
1136149|NCT02813694|2236260|FG000|Overall Study|Lost to Follow-up|1
1136150|NCT02813694|2236261|FG001|Overall Study|Lost to Follow-up|1
1136151|NCT02813694|2236260|FG000|Overall Study|Death|3
1136152|NCT02813694|2236261|FG001|Overall Study|Death|3
1136153|NCT02813694|2236260|FG000|Overall Study|Randomized- did not receive study drug|2
1136154|NCT02813694|2236261|FG001|Overall Study|Randomized- did not receive study drug|0
1136155|NCT02813694|2236260|FG000|Overall Study|Patient hospitalized|1
1136156|NCT02813694|2236261|FG001|Overall Study|Patient hospitalized|0
1136157|NCT02814175|2236269|FG000|Part 1|Adverse Event|2
1136158|NCT02814175|2236270|FG001|Part 1|Adverse Event|3
1136159|NCT02814175|2236271|FG002|Part 1|Adverse Event|0
1136160|NCT02814175|2236272|FG003|Part 1|Adverse Event|0
1136161|NCT02814175|2236273|FG004|Part 1|Adverse Event|0
1136162|NCT02814175|2236274|FG005|Part 1|Adverse Event|0
1136163|NCT02814175|2236269|FG000|Part 1|Withdrawal Consent|8
1136164|NCT02814175|2236270|FG001|Part 1|Withdrawal Consent|1
1136165|NCT02814175|2236271|FG002|Part 1|Withdrawal Consent|0
1136166|NCT02814175|2236272|FG003|Part 1|Withdrawal Consent|0
1136167|NCT02814175|2236273|FG004|Part 1|Withdrawal Consent|0
1136168|NCT02814175|2236274|FG005|Part 1|Withdrawal Consent|0
1136169|NCT02814175|2236269|FG000|Part 1|Lost to Follow-up|1
1136170|NCT02814175|2236270|FG001|Part 1|Lost to Follow-up|0
1136171|NCT02814175|2236271|FG002|Part 1|Lost to Follow-up|0
1136172|NCT02814175|2236272|FG003|Part 1|Lost to Follow-up|0
1136173|NCT02814175|2236273|FG004|Part 1|Lost to Follow-up|0
1136174|NCT02814175|2236274|FG005|Part 1|Lost to Follow-up|0
1136175|NCT02814175|2236269|FG000|Part 1|Lack of Efficacy|1
1136176|NCT02814175|2236270|FG001|Part 1|Lack of Efficacy|2
1136177|NCT02814175|2236271|FG002|Part 1|Lack of Efficacy|0
1136178|NCT02814175|2236272|FG003|Part 1|Lack of Efficacy|0
1136179|NCT02814175|2236273|FG004|Part 1|Lack of Efficacy|0
1136180|NCT02814175|2236274|FG005|Part 1|Lack of Efficacy|0
1136181|NCT02814175|2236269|FG000|Part 2|Adverse Event|0
1136182|NCT02814175|2236270|FG001|Part 2|Adverse Event|0
1136183|NCT02814175|2236271|FG002|Part 2|Adverse Event|0
1136184|NCT02814175|2236272|FG003|Part 2|Adverse Event|1
1136185|NCT02814175|2236273|FG004|Part 2|Adverse Event|1
1136186|NCT02814175|2236274|FG005|Part 2|Adverse Event|2
1136187|NCT02814175|2236269|FG000|Part 2|Withdrawal Consent|0
1136188|NCT02814175|2236270|FG001|Part 2|Withdrawal Consent|0
1136189|NCT02814175|2236271|FG002|Part 2|Withdrawal Consent|0
1136190|NCT02814175|2236272|FG003|Part 2|Withdrawal Consent|2
1136191|NCT02814175|2236273|FG004|Part 2|Withdrawal Consent|1
1136192|NCT02814175|2236274|FG005|Part 2|Withdrawal Consent|1
1136193|NCT02814175|2236269|FG000|Part 2|Lost to Follow-up|0
1136194|NCT02814175|2236270|FG001|Part 2|Lost to Follow-up|0
1136195|NCT02814175|2236271|FG002|Part 2|Lost to Follow-up|0
1136196|NCT02814175|2236272|FG003|Part 2|Lost to Follow-up|1
1136197|NCT02814175|2236273|FG004|Part 2|Lost to Follow-up|0
1136198|NCT02814175|2236274|FG005|Part 2|Lost to Follow-up|0
1136199|NCT02814175|2236269|FG000|Part 2|Lack of Efficacy|0
1136200|NCT02814175|2236270|FG001|Part 2|Lack of Efficacy|0
900260|NCT00726323|1873299|FG001|Overall Study|Adverse Event|9
900261|NCT00726323|1873298|FG000|Overall Study|Death|1
900262|NCT00726323|1873299|FG001|Overall Study|Death|0
900263|NCT00726323|1873298|FG000|Overall Study|Participant wished to discontinue|0
1136201|NCT02814175|2236271|FG002|Part 2|Lack of Efficacy|0
1136202|NCT02814175|2236272|FG003|Part 2|Lack of Efficacy|0
1136203|NCT02814175|2236273|FG004|Part 2|Lack of Efficacy|0
1136204|NCT02814175|2236274|FG005|Part 2|Lack of Efficacy|3
1136205|NCT02814565|2236324|FG000|Overall Study|Lack of Efficacy|0
1136206|NCT02814565|2236325|FG001|Overall Study|Lack of Efficacy|1
1136207|NCT02814565|2236324|FG000|Overall Study|Subject decision, caused by AE Influenza|1
1136208|NCT02814565|2236325|FG001|Overall Study|Subject decision, caused by AE Influenza|1
1136209|NCT02814643|2236333|FG000|Overall Study|Lost to Follow-up|0
1136210|NCT02814643|2236334|FG001|Overall Study|Lost to Follow-up|1
1136211|NCT02814643|2236333|FG000|Overall Study|Withdrawal by Subject|1
1136212|NCT02814643|2236334|FG001|Overall Study|Withdrawal by Subject|2
1136213|NCT02814838|2236359|FG000|Overall Study|3 agreed dates for the final visit missed|1
1136214|NCT02814838|2236360|FG001|Overall Study|3 agreed dates for the final visit missed|0
1136215|NCT02814838|2236359|FG000|Overall Study|Consent withdrawal|1
1136216|NCT02814838|2236360|FG001|Overall Study|Consent withdrawal|1
1136263|NCT02815293|2236410|FG000|Overall Study|Study termination by sponsor|10
1136264|NCT02815293|2236411|FG001|Overall Study|Study termination by sponsor|7
1136265|NCT02815293|2236412|FG002|Overall Study|Study termination by sponsor|0
1136266|NCT02815293|2236410|FG000|Overall Study|Participants not randomized|0
1136267|NCT02815293|2236411|FG001|Overall Study|Participants not randomized|0
1136268|NCT02815293|2236412|FG002|Overall Study|Participants not randomized|18
1136269|NCT02815293|2236410|FG000|Overall Study|Adverse Event|0
1136270|NCT02815293|2236411|FG001|Overall Study|Adverse Event|1
1136271|NCT02815293|2236412|FG002|Overall Study|Adverse Event|0
1136272|NCT02815670|2236427|FG000|Overall Study|Prematurely discontinued of the trial|1
1136273|NCT02815735|2236453|FG000|First Intervention (4 Weeks)|Discomfort|1
1136274|NCT02815735|2236454|FG001|First Intervention (4 Weeks)|Discomfort|0
1136275|NCT02815735|2236453|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1
1136276|NCT02815735|2236454|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
1136277|NCT02815735|2236453|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0
1136278|NCT02815735|2236454|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1
1136279|NCT02815735|2236453|FG000|Second Intervention (4 Weeks)|Protocol Violation|1
1136280|NCT02815735|2236454|FG001|Second Intervention (4 Weeks)|Protocol Violation|0
1136281|NCT02816138|2236488|FG000|Overall Study|Adverse Event|1
1136282|NCT02816398|2236513|FG000|Overall Study|Death|5
1136283|NCT02816398|2236513|FG000|Overall Study|Lack of Efficacy|8
1136284|NCT02816398|2236513|FG000|Overall Study|Lost to Follow-up|1
1136285|NCT02817087|2236544|FG000|Overall Study|Withdrawal by Subject|2
1136286|NCT02817087|2236545|FG001|Overall Study|Withdrawal by Subject|0
1136287|NCT02817516|2236555|FG000|Overall Study|Other|0
1136288|NCT02817516|2236556|FG001|Overall Study|Other|0
1136289|NCT02817516|2236557|FG002|Overall Study|Other|1
1136290|NCT02817516|2236558|FG003|Overall Study|Other|0
1136291|NCT02817555|2236573|FG000|Overall Study|Death|1
1136292|NCT02817555|2236574|FG001|Overall Study|Death|3
1136293|NCT02817555|2236573|FG000|Overall Study|moved away|1
1136294|NCT02817555|2236574|FG001|Overall Study|moved away|0
1136295|NCT02817555|2236573|FG000|Overall Study|transplant|1
1136296|NCT02817555|2236574|FG001|Overall Study|transplant|1
1136297|NCT02817555|2236573|FG000|Overall Study|changed to Peritoneal Dialysis|0
1136298|NCT02817555|2236574|FG001|Overall Study|changed to Peritoneal Dialysis|1
1136299|NCT02817594|2236580|FG000|Overall Study|Withdrawal by Subject|1
1136300|NCT02817594|2236580|FG000|Overall Study|Other|1
1136301|NCT02817594|2236580|FG000|Overall Study|Did Not Receive Treatment|1
1136302|NCT02817776|2236597|FG000|Overall Study|Excluded|33
1136303|NCT02817776|2236597|FG000|Overall Study|Lost to Follow-up|20
1136304|NCT02817776|2236597|FG000|Overall Study|Withdrawal by Subject|33
1136305|NCT02817776|2236597|FG000|Overall Study|Death|2
1136306|NCT02817828|2236601|FG000|Overall Study|Lost to Follow-up|41
1136307|NCT02817828|2236601|FG000|Overall Study|Adverse event not related to bleeding|104
1136308|NCT02817828|2236601|FG000|Overall Study|Adverse event related to bleeding|53
1136309|NCT02817828|2236601|FG000|Overall Study|Protocol Violation|11
1136310|NCT02817828|2236601|FG000|Overall Study|Pregnancy|7
1136311|NCT02817828|2236601|FG000|Overall Study|Pregnancy wish|15
1136312|NCT02817828|2236601|FG000|Overall Study|Withdrawal by Subject|78
1136313|NCT02817828|2236601|FG000|Overall Study|Other|26
1136314|NCT02817841|2236610|FG000|Overall Study|Lost to Follow-up|287
1136315|NCT02817841|2236610|FG000|Overall Study|Withdrawal by Subject|183
1136316|NCT02817841|2236610|FG000|Overall Study|Adverse event not related to bleeding|131
1136317|NCT02817841|2236610|FG000|Overall Study|Adverse event related to bleeding|51
1136318|NCT02817841|2236610|FG000|Overall Study|Pregnancy|32
1136319|NCT02817841|2236610|FG000|Overall Study|Pregnancy wish|17
1136320|NCT02817841|2236610|FG000|Overall Study|Other reasons|53
1136321|NCT02817841|2236610|FG000|Overall Study|Protocol Violation|94
1136322|NCT02817906|2236620|FG000|Overall Study|Adverse Event|3
1136323|NCT02817906|2236621|FG001|Overall Study|Adverse Event|0
1136324|NCT02817906|2236620|FG000|Overall Study|Lack of Efficacy|1
1136325|NCT02817906|2236621|FG001|Overall Study|Lack of Efficacy|0
1136326|NCT02817906|2236620|FG000|Overall Study|Protocol Violation|1
1136327|NCT02817906|2236621|FG001|Overall Study|Protocol Violation|1
1136328|NCT02817906|2236620|FG000|Overall Study|Study Terminated by Sponsor|2
1136329|NCT02817906|2236621|FG001|Overall Study|Study Terminated by Sponsor|2
1136330|NCT02817906|2236620|FG000|Overall Study|Withdrawal by Subject|7
1136331|NCT02817906|2236621|FG001|Overall Study|Withdrawal by Subject|0
1136332|NCT02817906|2236620|FG000|Overall Study|Other|2
1136333|NCT02817906|2236621|FG001|Overall Study|Other|2
1136334|NCT02818036|2236629|FG000|Overall Study|head did not fit in fMRI scanner headres|1
1136335|NCT02818036|2236630|FG001|Overall Study|head did not fit in fMRI scanner headres|0
1136336|NCT02818036|2236629|FG000|Overall Study|Withdrawal by Subject|1
1136337|NCT02818036|2236630|FG001|Overall Study|Withdrawal by Subject|0
1136338|NCT02818777|2236668|FG000|Overall Study|Adverse Event|3
1136339|NCT02818920|2236678|FG000|Overall Study|Unresectable|4
1136340|NCT02818920|2236678|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1
1136341|NCT02818920|2236678|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
1136342|NCT02818920|2236678|FG000|Overall Study|Adverse Event|3
1136343|NCT02818920|2236678|FG000|Overall Study|Developed Other Disease|1
1136344|NCT02818920|2236678|FG000|Overall Study|Refused Further Treatment|1
1136345|NCT02818998|2236685|FG000|Overall Study|Adverse Event|3
1136346|NCT02818998|2236686|FG001|Overall Study|Adverse Event|2
1136347|NCT02818998|2236687|FG002|Overall Study|Adverse Event|1
1136348|NCT02818998|2236685|FG000|Overall Study|Lost to Follow-up|4
1136349|NCT02818998|2236686|FG001|Overall Study|Lost to Follow-up|1
1136350|NCT02818998|2236687|FG002|Overall Study|Lost to Follow-up|2
1136351|NCT02818998|2236685|FG000|Overall Study|Withdrawal by sponsor|0
1136352|NCT02818998|2236686|FG001|Overall Study|Withdrawal by sponsor|1
1136353|NCT02818998|2236687|FG002|Overall Study|Withdrawal by sponsor|1
1136354|NCT02818998|2236685|FG000|Overall Study|Death|3
1136355|NCT02818998|2236686|FG001|Overall Study|Death|6
1136356|NCT02818998|2236687|FG002|Overall Study|Death|8
1136357|NCT02818998|2236685|FG000|Overall Study|Withdrawal by Subject|7
1136358|NCT02818998|2236686|FG001|Overall Study|Withdrawal by Subject|6
1136359|NCT02818998|2236687|FG002|Overall Study|Withdrawal by Subject|6
1136360|NCT02818998|2236685|FG000|Overall Study|Physician Decision|1
1136361|NCT02818998|2236686|FG001|Overall Study|Physician Decision|0
1136362|NCT02818998|2236687|FG002|Overall Study|Physician Decision|0
1136363|NCT02819297|2236716|FG000|Overall Study|Withdrawal by Subject|25
1136364|NCT02819297|2236717|FG001|Overall Study|Withdrawal by Subject|13
1136365|NCT02819297|2236716|FG000|Overall Study|Lost to Follow-up|12
1136366|NCT02819297|2236717|FG001|Overall Study|Lost to Follow-up|14
1136367|NCT02819297|2236716|FG000|Overall Study|Adverse Event|12
1136368|NCT02819297|2236717|FG001|Overall Study|Adverse Event|10
1136369|NCT02819297|2236716|FG000|Overall Study|Physician Decision|5
1136370|NCT02819297|2236717|FG001|Overall Study|Physician Decision|5
1136371|NCT02819297|2236716|FG000|Overall Study|Lack of Efficacy|5
1136372|NCT02819297|2236717|FG001|Overall Study|Lack of Efficacy|8
1136373|NCT02819297|2236716|FG000|Overall Study|Protocol Violation|1
1136374|NCT02819297|2236717|FG001|Overall Study|Protocol Violation|2
1136375|NCT02819310|2236723|FG000|Overall Study|Withdrawal by Subject|37
1136376|NCT02819310|2236723|FG000|Overall Study|Lost to Follow-up|16
1136377|NCT02819310|2236723|FG000|Overall Study|Adverse Event|13
1136378|NCT02819310|2236723|FG000|Overall Study|Lack of Efficacy|5
1136379|NCT02819310|2236723|FG000|Overall Study|Physician Decision|8
1136380|NCT02819310|2236723|FG000|Overall Study|Protocol Violation|30
1136381|NCT02819479|2236740|FG000|Overall Study|Adverse Event|2
1136382|NCT02819726|2236752|FG000|Part A (All Participants)|Lost to Follow-up|0
1136383|NCT02819726|2236753|FG001|Part A (All Participants)|Lost to Follow-up|1
1136384|NCT02819726|2236754|FG002|Part A (All Participants)|Lost to Follow-up|0
1136385|NCT02819726|2236755|FG003|Part A (All Participants)|Lost to Follow-up|0
1136386|NCT02819726|2236752|FG000|Part A (All Participants)|Withdrawal by Subject|3
1136387|NCT02819726|2236753|FG001|Part A (All Participants)|Withdrawal by Subject|5
1136388|NCT02819726|2236754|FG002|Part A (All Participants)|Withdrawal by Subject|6
1136389|NCT02819726|2236755|FG003|Part A (All Participants)|Withdrawal by Subject|0
1136390|NCT02819726|2236752|FG000|Part A (All Participants)|Protocol non-compliance|3
1136391|NCT02819726|2236753|FG001|Part A (All Participants)|Protocol non-compliance|4
1136392|NCT02819726|2236754|FG002|Part A (All Participants)|Protocol non-compliance|5
1136393|NCT02819726|2236755|FG003|Part A (All Participants)|Protocol non-compliance|0
1136394|NCT02819726|2236752|FG000|Part B (All Participants)|Lost to Follow-up|1
1136395|NCT02819726|2236753|FG001|Part B (All Participants)|Lost to Follow-up|1
1136396|NCT02819726|2236754|FG002|Part B (All Participants)|Lost to Follow-up|2
1136397|NCT02819726|2236755|FG003|Part B (All Participants)|Lost to Follow-up|2
1136398|NCT02819726|2236752|FG000|Part B (All Participants)|Withdrawal by Subject|2
1136399|NCT02819726|2236753|FG001|Part B (All Participants)|Withdrawal by Subject|1
1136400|NCT02819726|2236754|FG002|Part B (All Participants)|Withdrawal by Subject|1
1136401|NCT02819726|2236755|FG003|Part B (All Participants)|Withdrawal by Subject|0
1136402|NCT02819726|2236752|FG000|Part B (All Participants)|Protocol non-compliance|0
1136403|NCT02819726|2236753|FG001|Part B (All Participants)|Protocol non-compliance|0
1136404|NCT02819726|2236754|FG002|Part B (All Participants)|Protocol non-compliance|1
1136405|NCT02819726|2236755|FG003|Part B (All Participants)|Protocol non-compliance|0
1136406|NCT02820038|2236786|FG000|Overall Study|Lost to Follow-up|7
1136407|NCT02820038|2236787|FG001|Overall Study|Lost to Follow-up|11
1136408|NCT02820038|2236788|FG002|Overall Study|Lost to Follow-up|2
1136409|NCT02820038|2236789|FG003|Overall Study|Lost to Follow-up|9
1136410|NCT02820038|2236786|FG000|Overall Study|Withdrawal by Subject|3
1136411|NCT02820038|2236787|FG001|Overall Study|Withdrawal by Subject|14
1136412|NCT02820038|2236788|FG002|Overall Study|Withdrawal by Subject|3
1136413|NCT02820038|2236789|FG003|Overall Study|Withdrawal by Subject|13
1136414|NCT02820298|2236811|FG000|Overall Study|Withdrawal by Subject|0
900264|NCT00726323|1873299|FG001|Overall Study|Participant wished to discontinue|1
900265|NCT00726323|1873298|FG000|Overall Study|Metastatic lesions inferred cyst|0
900266|NCT00726323|1873299|FG001|Overall Study|Metastatic lesions inferred cyst|1
900267|NCT00726388|1873309|FG000|Overall Study|Withdrawal by Subject|5
900268|NCT00726388|1873309|FG000|Overall Study|Adverse Event|3
900269|NCT00726388|1873309|FG000|Overall Study|Lost to Follow-up|10
900270|NCT00726388|1873309|FG000|Overall Study|Participants Non-compliant With Study Procedures|5
900271|NCT00726388|1873309|FG000|Overall Study|Other|5
1136415|NCT02820298|2236812|FG001|Overall Study|Withdrawal by Subject|1
1136416|NCT02820298|2236811|FG000|Overall Study|Physician Decision|1
1136417|NCT02820298|2236812|FG001|Overall Study|Physician Decision|0
1136418|NCT02820298|2236811|FG000|Overall Study|Protocol Violation|0
1136419|NCT02820298|2236812|FG001|Overall Study|Protocol Violation|1
1136420|NCT02820597|2236845|FG000|Overall Study|Lost to Follow-up|12
1162090|NCT03383146|2284116|FG001|Overall Study|Screen Failure|0
1162091|NCT03383146|2284115|FG000|Overall Study|Adverse Event|6
1162092|NCT03383146|2284116|FG001|Overall Study|Adverse Event|18
1162093|NCT03383146|2284115|FG000|Overall Study|Lack of Efficacy|0
1162094|NCT03383146|2284116|FG001|Overall Study|Lack of Efficacy|3
1162095|NCT03383146|2284115|FG000|Overall Study|Withdrawal by Subject|20
1162096|NCT03383146|2284116|FG001|Overall Study|Withdrawal by Subject|36
1162097|NCT03383146|2284115|FG000|Overall Study|Lost to Follow-up|5
1162098|NCT03383146|2284116|FG001|Overall Study|Lost to Follow-up|15
900272|NCT00726388|1873309|FG000|Overall Study|Enrolled, Not Treated|79
900273|NCT00726453|1873322|FG000|Primary Enrollment Group|Death|18
900274|NCT00726453|1873323|FG001|Primary Enrollment Group|Death|0
900275|NCT00726453|1873322|FG000|Primary Enrollment Group|Withdrawal by Subject|13
900276|NCT00726453|1873323|FG001|Primary Enrollment Group|Withdrawal by Subject|0
900277|NCT00726453|1873322|FG000|38 mm Length Group|Death|0
900278|NCT00726453|1873323|FG001|38 mm Length Group|Death|3
900279|NCT00726557|1873328|FG000|Overall Study|Screening failure|4
900280|NCT00726557|1873328|FG000|Overall Study|No end of treatment documentation|37
900281|NCT00726557|1873328|FG000|Overall Study|No follow-up documentation available|55
900282|NCT00726557|1873328|FG000|Overall Study|Treatment less than 3 months|17
900283|NCT00726557|1873328|FG000|Overall Study|Inclusion criteria not met|15
900284|NCT00726609|1873333|FG000|Overall Study|Adverse Event|10
900285|NCT00726609|1873333|FG000|Overall Study|Withdrawal by Subject|2
900286|NCT00726609|1873333|FG000|Overall Study|Lack of Efficacy|25
900287|NCT00726609|1873333|FG000|Overall Study|Other|16
900288|NCT00726609|1873333|FG000|Overall Study|Missing|42
900289|NCT00726609|1873333|FG000|Overall Study|Other|3
900290|NCT00726622|1873339|FG000|Overall Study|Withdrawal by Subject|16
900291|NCT00726622|1873340|FG001|Overall Study|Withdrawal by Subject|2
900292|NCT00726622|1873339|FG000|Overall Study|Physician Decision|0
900293|NCT00726622|1873340|FG001|Overall Study|Physician Decision|1
900294|NCT00726622|1873339|FG000|Overall Study|Metastasis|2
900295|NCT00726622|1873340|FG001|Overall Study|Metastasis|0
900296|NCT00726661|1873348|FG000|Overall Study|Lost to Follow-up|36
900297|NCT00726661|1873349|FG001|Overall Study|Lost to Follow-up|11
900298|NCT00726661|1873348|FG000|Overall Study|Withdrawal by Subject|17
900299|NCT00726661|1873349|FG001|Overall Study|Withdrawal by Subject|13
900300|NCT00726661|1873348|FG000|Overall Study|Trial terminated by sponsor|214
900301|NCT00726661|1873349|FG001|Overall Study|Trial terminated by sponsor|187
900302|NCT00726661|1873348|FG000|Overall Study|Death|475
900303|NCT00726661|1873349|FG001|Overall Study|Death|159
900304|NCT00726661|1873348|FG000|Overall Study|Physician Decision|25
900305|NCT00726661|1873349|FG001|Overall Study|Physician Decision|13
1136421|NCT02820844|2236851|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
1136422|NCT02820844|2236852|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
1136423|NCT02820844|2236853|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
1136424|NCT02820844|2236854|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
1136425|NCT02820844|2236855|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
1136426|NCT02820844|2236856|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
1136427|NCT02820844|2236851|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
1136428|NCT02820844|2236852|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
1136429|NCT02820844|2236853|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
1136430|NCT02820844|2236854|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
1136431|NCT02820844|2236855|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
1136432|NCT02820844|2236856|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
1136433|NCT02820844|2236851|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
1136434|NCT02820844|2236852|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
1136435|NCT02820844|2236853|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
1136436|NCT02820844|2236854|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
1136437|NCT02820844|2236855|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
1136438|NCT02820844|2236856|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
1136439|NCT02820844|2236851|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2
1136440|NCT02820844|2236852|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1
1136441|NCT02820844|2236853|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0
1136442|NCT02820844|2236854|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0
1136443|NCT02820844|2236855|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0
1136444|NCT02820844|2236856|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0
1136445|NCT02820844|2236851|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
1136446|NCT02820844|2236852|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
1136447|NCT02820844|2236853|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
1136448|NCT02820844|2236854|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
1136449|NCT02820844|2236855|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
1136450|NCT02820844|2236856|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
1136451|NCT02820844|2236851|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
1136452|NCT02820844|2236852|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
1136453|NCT02820844|2236853|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
1136454|NCT02820844|2236854|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
1136455|NCT02820844|2236855|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
1136456|NCT02820844|2236856|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
1136457|NCT02820844|2236851|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
1136458|NCT02820844|2236852|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
1136459|NCT02820844|2236853|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
1136460|NCT02820844|2236854|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
1136461|NCT02820844|2236855|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
1136462|NCT02820844|2236856|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
1136463|NCT02820844|2236851|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1136464|NCT02820844|2236852|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1136465|NCT02820844|2236853|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
1136466|NCT02820844|2236854|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
1136467|NCT02820844|2236855|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1136468|NCT02820844|2236856|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1136469|NCT02820844|2236851|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
900306|NCT00726661|1873348|FG000|Overall Study|Other|47
1136470|NCT02820844|2236852|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
1136471|NCT02820844|2236853|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
1136472|NCT02820844|2236854|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
1136473|NCT02820844|2236855|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
1136474|NCT02820844|2236856|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
1136475|NCT02820844|2236851|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1136476|NCT02820844|2236852|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1136477|NCT02820844|2236853|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1136478|NCT02820844|2236854|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1136479|NCT02820844|2236855|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1136480|NCT02820844|2236856|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
1136484|NCT02821416|2236919|FG000|Overall Study|Adverse Event|0
1136485|NCT02821416|2236920|FG001|Overall Study|Adverse Event|1
1136486|NCT02821416|2236919|FG000|Overall Study|Withdrawal by Subject|2
1136487|NCT02821416|2236920|FG001|Overall Study|Withdrawal by Subject|0
1136488|NCT02821416|2236919|FG000|Overall Study|Lost to Follow-up|1
1136489|NCT02821416|2236920|FG001|Overall Study|Lost to Follow-up|0
1136490|NCT02821715|2236931|FG000|Overall Study|Protocol Violation|1
1136491|NCT02821715|2236932|FG001|Overall Study|Protocol Violation|0
1136492|NCT02821715|2236933|FG002|Overall Study|Protocol Violation|0
1136493|NCT02821715|2236934|FG003|Overall Study|Protocol Violation|0
1136494|NCT02821715|2236935|FG004|Overall Study|Protocol Violation|0
1136495|NCT02821715|2236936|FG005|Overall Study|Protocol Violation|0
1136496|NCT02821819|2236944|FG000|Overall Study|Protocol Violation|1
1136497|NCT02821910|2236954|FG000|Overall Study|Withdrawal by Subject|0
1136498|NCT02821910|2236955|FG001|Overall Study|Withdrawal by Subject|0
1136499|NCT02821910|2236956|FG002|Overall Study|Withdrawal by Subject|1
1136500|NCT02821910|2236957|FG003|Overall Study|Withdrawal by Subject|0
1136501|NCT02821910|2236958|FG004|Overall Study|Withdrawal by Subject|0
1136502|NCT02821910|2236959|FG005|Overall Study|Withdrawal by Subject|1
1136503|NCT02821910|2236954|FG000|Overall Study|Other than specified|1
1136504|NCT02821910|2236955|FG001|Overall Study|Other than specified|0
1136505|NCT02821910|2236956|FG002|Overall Study|Other than specified|1
1136506|NCT02821910|2236957|FG003|Overall Study|Other than specified|0
1136507|NCT02821910|2236958|FG004|Overall Study|Other than specified|0
1136508|NCT02821910|2236959|FG005|Overall Study|Other than specified|0
1136509|NCT02821962|2236975|FG000|Overall Study|Lost to Follow-up|2
1136510|NCT02821962|2236976|FG001|Overall Study|Lost to Follow-up|0
1136511|NCT02822222|2236984|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1
1136512|NCT02822222|2236985|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0
1136513|NCT02822235|2236993|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
1136514|NCT02822235|2236994|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
1136515|NCT02822235|2236993|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2
1136516|NCT02822235|2236994|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0
1136517|NCT02822235|2236993|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
1136518|NCT02822235|2236994|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
1136519|NCT02822235|2236993|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
1136520|NCT02822235|2236994|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
1136521|NCT02822235|2236993|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1
1136522|NCT02822235|2236994|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0
1136523|NCT02822235|2236993|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
1136524|NCT02822235|2236994|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
1136525|NCT02822794|2237045|FG000|Overall Study|Withdrew Consent|1
1136526|NCT02822794|2237046|FG001|Overall Study|Withdrew Consent|0
1136527|NCT02823470|2237092|FG000|Overall Study|Adverse Event|1
1136528|NCT02823470|2237093|FG001|Overall Study|Adverse Event|0
1136529|NCT02823470|2237092|FG000|Overall Study|Study terminated by sponsor|8
1136530|NCT02823470|2237093|FG001|Overall Study|Study terminated by sponsor|15
900307|NCT00726661|1873349|FG001|Overall Study|Other|35
900308|NCT00726752|1873376|FG000|Overall Study|Lack of Efficacy|6
900309|NCT00726882|1873380|FG000|Overall Study|Withdrawal by Subject|5
900310|NCT00726882|1873380|FG000|Overall Study|Lost to Follow-up|7
900311|NCT00726882|1873380|FG000|Overall Study|Other|10
900312|NCT00726895|1873386|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
900313|NCT00726895|1873387|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
900314|NCT00726986|1873394|FG000|Induction Phase|Adverse Event|4
900315|NCT00726986|1873394|FG000|Induction Phase|Withdrawal by Subject|2
900316|NCT00726986|1873394|FG000|Induction Phase|Death|2
900317|NCT00726986|1873394|FG000|Induction Phase|Lack of Efficacy|5
900318|NCT00726986|1873394|FG000|Induction Phase|Secondary Disease|2
900319|NCT00726986|1873394|FG000|Maintenance Phase|Adverse Event|1
900320|NCT00726986|1873394|FG000|Maintenance Phase|Lack of Efficacy|2
900321|NCT00726999|1873400|FG000|Overall Study|Physician Decision|0
900322|NCT00726999|1873401|FG001|Overall Study|Physician Decision|1
900323|NCT00726999|1873400|FG000|Overall Study|Withdrawal by Subject|2
1136531|NCT02823964|2237108|FG000|Overall Study|Adverse Event|2
1136532|NCT02823964|2237108|FG000|Overall Study|Physician Decision|1
1136533|NCT02823964|2237108|FG000|Overall Study|Lack of Efficacy|1
1136534|NCT02823964|2237108|FG000|Overall Study|Withdrawal by Subject|1
1136535|NCT02824198|2237114|FG000|Overall Study|Non-compliance with the protocol|5
1136536|NCT02824198|2237115|FG001|Overall Study|Non-compliance with the protocol|1
1136537|NCT02824198|2237114|FG000|Overall Study|Lost to Follow-up|5
1136538|NCT02824198|2237115|FG001|Overall Study|Lost to Follow-up|2
1136539|NCT02824198|2237114|FG000|Overall Study|Withdrawal by Subject|5
1136540|NCT02824198|2237115|FG001|Overall Study|Withdrawal by Subject|0
1136541|NCT02824224|2237125|FG000|Overall Study|Discontinued, IUS expulsion|0
1136542|NCT02824224|2237126|FG001|Overall Study|Discontinued, IUS expulsion|1
1136543|NCT02824224|2237125|FG000|Overall Study|Did not show up for allocation visit|2
1136544|NCT02824224|2237126|FG001|Overall Study|Did not show up for allocation visit|0
1136545|NCT02824432|2237134|FG000|Overall Study|Major Protocol Deviation|1
1136546|NCT02824432|2237135|FG001|Overall Study|Major Protocol Deviation|0
1136547|NCT02824562|2237143|FG000|Overall Study|Lost to Follow-up|3
1136548|NCT02824562|2237144|FG001|Overall Study|Lost to Follow-up|4
1136549|NCT02824562|2237143|FG000|Overall Study|Death|0
1136550|NCT02824562|2237144|FG001|Overall Study|Death|1
1136551|NCT02825251|2237167|FG000|Overall Study|Adverse Event|0
1136552|NCT02825251|2237168|FG001|Overall Study|Adverse Event|1
1136553|NCT02825251|2237167|FG000|Overall Study|Lost to Follow-up|0
1136554|NCT02825251|2237168|FG001|Overall Study|Lost to Follow-up|1
1136555|NCT02825251|2237167|FG000|Overall Study|Withdrawal by Subject|1
1136556|NCT02825251|2237168|FG001|Overall Study|Withdrawal by Subject|4
1136557|NCT02825251|2237167|FG000|Overall Study|Unclassified|2
1136558|NCT02825251|2237168|FG001|Overall Study|Unclassified|0
1136559|NCT02825420|2237176|FG000|Overall Study|Death|30
1136560|NCT02825420|2237177|FG001|Overall Study|Death|12
1136561|NCT02825420|2237176|FG000|Overall Study|Progressive disease|6
1136562|NCT02825420|2237177|FG001|Overall Study|Progressive disease|1
1136563|NCT02825420|2237176|FG000|Overall Study|Lost to Follow-up|2
1136564|NCT02825420|2237177|FG001|Overall Study|Lost to Follow-up|2
1136565|NCT02825420|2237176|FG000|Overall Study|Withdrawal by Subject|1
1136566|NCT02825420|2237177|FG001|Overall Study|Withdrawal by Subject|1
1136567|NCT02825420|2237176|FG000|Overall Study|Protocol amendment not signed|1
900324|NCT00726999|1873401|FG001|Overall Study|Withdrawal by Subject|0
900325|NCT00726999|1873400|FG000|Overall Study|Protocol Violation|1
900326|NCT00726999|1873401|FG001|Overall Study|Protocol Violation|0
900327|NCT00727025|1873409|FG000|Overall Study|Physician Decision|23
900328|NCT00727194|1873435|FG000|Screening Period|Low QMG scores|0
900329|NCT00727194|1873436|FG001|Screening Period|Low QMG scores|0
900330|NCT00727194|1873437|FG002|Screening Period|Low QMG scores|6
900331|NCT00727194|1873435|FG000|Screening Period|Lacked AChR antibodies|0
900332|NCT00727194|1873436|FG001|Screening Period|Lacked AChR antibodies|0
900333|NCT00727194|1873437|FG002|Screening Period|Lacked AChR antibodies|5
900334|NCT00727194|1873435|FG000|Screening Period|Not stable on concomitant MG therapy|0
900335|NCT00727194|1873436|FG001|Screening Period|Not stable on concomitant MG therapy|0
1136568|NCT02825420|2237177|FG001|Overall Study|Protocol amendment not signed|1
1136569|NCT02825420|2237176|FG000|Overall Study|Physician Decision|1
1136570|NCT02825420|2237177|FG001|Overall Study|Physician Decision|0
1136571|NCT02825420|2237176|FG000|Overall Study|Did not receive PLD|2
1136572|NCT02825420|2237177|FG001|Overall Study|Did not receive PLD|0
1136573|NCT02825550|2237188|FG000|Overall Study|Physician Decision|1
1136574|NCT02825992|2237219|FG000|Overall Study|Withdrawal by Subject|4
1136575|NCT02825992|2237219|FG000|Overall Study|Lost to Follow-up|2
1136576|NCT02825992|2237219|FG000|Overall Study|Procedure terminated|2
1136577|NCT02826421|2237233|FG000|Overall Study|Adverse Event|1
1136578|NCT02826421|2237234|FG001|Overall Study|Adverse Event|0
1136579|NCT02826421|2237235|FG002|Overall Study|Adverse Event|0
1136580|NCT02826421|2237236|FG003|Overall Study|Adverse Event|1
1136581|NCT02826421|2237233|FG000|Overall Study|Withdrawal by Subject|1
1136582|NCT02826421|2237234|FG001|Overall Study|Withdrawal by Subject|3
1136583|NCT02826421|2237235|FG002|Overall Study|Withdrawal by Subject|1
1136584|NCT02826421|2237236|FG003|Overall Study|Withdrawal by Subject|1
1136585|NCT02826421|2237233|FG000|Overall Study|Reason not given|1
1136586|NCT02826421|2237234|FG001|Overall Study|Reason not given|0
900336|NCT00727194|1873437|FG002|Screening Period|Not stable on concomitant MG therapy|2
900337|NCT00727194|1873435|FG000|Screening Period|Severe infections|0
900338|NCT00727194|1873436|FG001|Screening Period|Severe infections|0
900339|NCT00727194|1873437|FG002|Screening Period|Severe infections|2
900340|NCT00727194|1873435|FG000|Screening Period|History of thymoma|0
900341|NCT00727194|1873436|FG001|Screening Period|History of thymoma|0
900342|NCT00727194|1873437|FG002|Screening Period|History of thymoma|1
900343|NCT00727194|1873435|FG000|Treatment Period 2|Lack of Efficacy|0
900344|NCT00727194|1873436|FG001|Treatment Period 2|Lack of Efficacy|1
900345|NCT00727194|1873437|FG002|Treatment Period 2|Lack of Efficacy|0
900346|NCT00727246|1873464|FG000|Overall Study|could not complete MRI|0
900347|NCT00727246|1873465|FG001|Overall Study|could not complete MRI|1
900348|NCT00727246|1873466|FG002|Overall Study|could not complete MRI|0
900349|NCT00727246|1873467|FG003|Overall Study|could not complete MRI|1
900350|NCT00727246|1873464|FG000|Overall Study|incidental finding|0
900351|NCT00727246|1873465|FG001|Overall Study|incidental finding|0
1136587|NCT02826421|2237235|FG002|Overall Study|Reason not given|1
1136588|NCT02826421|2237236|FG003|Overall Study|Reason not given|0
1136589|NCT02826603|2237249|FG000|Overall Study|Adverse Event|17
1136590|NCT02826603|2237250|FG001|Overall Study|Adverse Event|9
1136591|NCT02826603|2237249|FG000|Overall Study|Lack of Efficacy|4
1136592|NCT02826603|2237250|FG001|Overall Study|Lack of Efficacy|9
1136593|NCT02826603|2237249|FG000|Overall Study|Lost to Follow-up|13
1136594|NCT02826603|2237250|FG001|Overall Study|Lost to Follow-up|12
1136595|NCT02826603|2237249|FG000|Overall Study|Noncompliance with treatment|0
1136596|NCT02826603|2237250|FG001|Overall Study|Noncompliance with treatment|2
1136597|NCT02826603|2237249|FG000|Overall Study|Physician Decision|1
1136598|NCT02826603|2237250|FG001|Overall Study|Physician Decision|7
1136599|NCT02826603|2237249|FG000|Overall Study|Pregnancy|1
1136600|NCT02826603|2237250|FG001|Overall Study|Pregnancy|2
1136601|NCT02826603|2237249|FG000|Overall Study|Protocol Violation|3
1136602|NCT02826603|2237250|FG001|Overall Study|Protocol Violation|3
1136603|NCT02826603|2237249|FG000|Overall Study|Withdrawal by Subject|20
1136604|NCT02826603|2237250|FG001|Overall Study|Withdrawal by Subject|19
1136605|NCT02826603|2237249|FG000|Overall Study|Death|2
1136606|NCT02826603|2237250|FG001|Overall Study|Death|0
1136607|NCT02826603|2237249|FG000|Overall Study|New therapy for study indication|0
1136608|NCT02826603|2237250|FG001|Overall Study|New therapy for study indication|1
1136609|NCT02826798|2237273|FG000|Overall Study|Withdrawal by Subject|0
1136610|NCT02826798|2237274|FG001|Overall Study|Withdrawal by Subject|1
1136611|NCT02826798|2237275|FG002|Overall Study|Withdrawal by Subject|0
1136612|NCT02826798|2237276|FG003|Overall Study|Withdrawal by Subject|1
1136613|NCT02826798|2237277|FG004|Overall Study|Withdrawal by Subject|0
1136614|NCT02827500|2237291|FG000|Overall Study|Death|7
1136615|NCT02827500|2237292|FG001|Overall Study|Death|3
1136616|NCT02827500|2237291|FG000|Overall Study|Lost to Follow-up|1
1136617|NCT02827500|2237292|FG001|Overall Study|Lost to Follow-up|1
1136618|NCT02827500|2237291|FG000|Overall Study|Withdrawal by Subject|3
1136619|NCT02827500|2237292|FG001|Overall Study|Withdrawal by Subject|1
1136620|NCT02827500|2237291|FG000|Overall Study|Missing primary endpoint data|3
1136621|NCT02827500|2237292|FG001|Overall Study|Missing primary endpoint data|1
1136622|NCT02827500|2237291|FG000|Overall Study|Other|5
1136623|NCT02827500|2237292|FG001|Overall Study|Other|1
1136624|NCT02827708|2237300|FG000|Overall Study|Lost to Follow-up|3
1136625|NCT02827708|2237301|FG001|Overall Study|Lost to Follow-up|1
1136626|NCT02827708|2237300|FG000|Overall Study|Withdrawal by Subject|1
1136627|NCT02827708|2237301|FG001|Overall Study|Withdrawal by Subject|2
1136628|NCT02827708|2237300|FG000|Overall Study|Death|1
1136629|NCT02827708|2237301|FG001|Overall Study|Death|2
1136630|NCT02828020|2237310|FG000|Treatment Period|Adverse Event|3
1136631|NCT02828020|2237311|FG001|Treatment Period|Adverse Event|1
1136632|NCT02828020|2237312|FG002|Treatment Period|Adverse Event|1
1136633|NCT02828020|2237310|FG000|Treatment Period|Withdrawal of Consent|10
1136634|NCT02828020|2237311|FG001|Treatment Period|Withdrawal of Consent|14
1136635|NCT02828020|2237312|FG002|Treatment Period|Withdrawal of Consent|9
1136636|NCT02828020|2237310|FG000|Treatment Period|Lost to Follow-up|21
1136637|NCT02828020|2237311|FG001|Treatment Period|Lost to Follow-up|24
1136638|NCT02828020|2237312|FG002|Treatment Period|Lost to Follow-up|18
1136639|NCT02828020|2237310|FG000|Treatment Period|Lack of Qualifying Event|44
1136640|NCT02828020|2237311|FG001|Treatment Period|Lack of Qualifying Event|53
1136641|NCT02828020|2237312|FG002|Treatment Period|Lack of Qualifying Event|43
1136642|NCT02828020|2237310|FG000|Treatment Period|Pregnancy|0
1136643|NCT02828020|2237311|FG001|Treatment Period|Pregnancy|2
1136644|NCT02828020|2237312|FG002|Treatment Period|Pregnancy|0
1136645|NCT02828020|2237310|FG000|Treatment Period|Protocol Violation|2
1136646|NCT02828020|2237311|FG001|Treatment Period|Protocol Violation|4
1136647|NCT02828020|2237312|FG002|Treatment Period|Protocol Violation|7
1136648|NCT02828020|2237310|FG000|Treatment Period|Other Miscellaneous Reasons|0
1136649|NCT02828020|2237311|FG001|Treatment Period|Other Miscellaneous Reasons|1
1136650|NCT02828020|2237312|FG002|Treatment Period|Other Miscellaneous Reasons|0
1136651|NCT02828020|2237310|FG000|Safety Follow-up Period|Withdrawal of Consent|10
1136652|NCT02828020|2237311|FG001|Safety Follow-up Period|Withdrawal of Consent|8
1136653|NCT02828020|2237312|FG002|Safety Follow-up Period|Withdrawal of Consent|7
1136654|NCT02828020|2237310|FG000|Safety Follow-up Period|Lost to Follow-up|9
1136655|NCT02828020|2237311|FG001|Safety Follow-up Period|Lost to Follow-up|8
1136656|NCT02828020|2237312|FG002|Safety Follow-up Period|Lost to Follow-up|11
1136657|NCT02828020|2237310|FG000|Safety Follow-up Period|Protocol Violation|0
1136658|NCT02828020|2237311|FG001|Safety Follow-up Period|Protocol Violation|2
1136659|NCT02828020|2237312|FG002|Safety Follow-up Period|Protocol Violation|1
1136660|NCT02828020|2237310|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1
1136661|NCT02828020|2237311|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0
1136662|NCT02828020|2237312|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
1136663|NCT02828111|2237325|FG000|Overall Study|Withdrawal by Subject|0
1136664|NCT02828111|2237326|FG001|Overall Study|Withdrawal by Subject|0
1136665|NCT02828111|2237327|FG002|Overall Study|Withdrawal by Subject|2
1136666|NCT02828111|2237328|FG003|Overall Study|Withdrawal by Subject|0
1136667|NCT02828111|2237329|FG004|Overall Study|Withdrawal by Subject|0
1136668|NCT02828111|2237325|FG000|Overall Study|Lost to Follow-up|0
1136669|NCT02828111|2237326|FG001|Overall Study|Lost to Follow-up|0
1136670|NCT02828111|2237327|FG002|Overall Study|Lost to Follow-up|0
1136671|NCT02828111|2237328|FG003|Overall Study|Lost to Follow-up|1
1136672|NCT02828111|2237329|FG004|Overall Study|Lost to Follow-up|1
1136673|NCT02828241|2237365|FG000|Overall Study|Adverse Event|7
1136674|NCT02828241|2237366|FG001|Overall Study|Adverse Event|2
1136675|NCT02828241|2237365|FG000|Overall Study|Protocol Violation|1
1136676|NCT02828241|2237366|FG001|Overall Study|Protocol Violation|0
1136677|NCT02828358|2237394|FG000|Overall Study|Physician Decision|7
1136678|NCT02828358|2237395|FG001|Overall Study|Physician Decision|1
1136679|NCT02828358|2237394|FG000|Overall Study|Treatment Failure|6
1136680|NCT02828358|2237395|FG001|Overall Study|Treatment Failure|0
1136681|NCT02828358|2237394|FG000|Overall Study|Patients without KMT2A rearrangement|0
1136682|NCT02828358|2237395|FG001|Overall Study|Patients without KMT2A rearrangement|21
1136683|NCT02828358|2237394|FG000|Overall Study|Refusal of further protocol therapy|2
1136684|NCT02828358|2237395|FG001|Overall Study|Refusal of further protocol therapy|0
1136685|NCT02828358|2237394|FG000|Overall Study|Relapse|25
1136686|NCT02828358|2237395|FG001|Overall Study|Relapse|0
1136687|NCT02828358|2237394|FG000|Overall Study|Still on therapy|5
1136688|NCT02828358|2237395|FG001|Overall Study|Still on therapy|0
1136689|NCT02828436|2237400|FG000|Period 1|Did Not Meet Inclusion Criteria|0
1136690|NCT02828436|2237401|FG001|Period 1|Did Not Meet Inclusion Criteria|3
1136691|NCT02828436|2237400|FG000|Period 1|Lost to Follow-up|0
1136692|NCT02828436|2237401|FG001|Period 1|Lost to Follow-up|1
1136693|NCT02828436|2237400|FG000|Period 2|Withdrawal by Subject|4
1136694|NCT02828436|2237401|FG001|Period 2|Withdrawal by Subject|0
1136695|NCT02828436|2237400|FG000|Period 2|Did Not Meet Inclusion Criteria|3
1136696|NCT02828436|2237401|FG001|Period 2|Did Not Meet Inclusion Criteria|0
1136697|NCT02828436|2237400|FG000|Period 2|Lost to Follow-up|1
1136698|NCT02828436|2237401|FG001|Period 2|Lost to Follow-up|0
1136699|NCT02828644|2237409|FG000|Overall Study|Lost to Follow-up|23
1136700|NCT02828644|2237410|FG001|Overall Study|Lost to Follow-up|22
1136703|NCT02829138|2237441|FG000|Overall Study|Withdrawal by Subject|1
1136704|NCT02829138|2237442|FG001|Overall Study|Withdrawal by Subject|0
1136705|NCT02829775|2237478|FG000|Overall Study|Death|1
1136706|NCT02829775|2237478|FG000|Overall Study|Withdrawal by Subject|3
1136707|NCT02829775|2237478|FG000|Overall Study|Disease remission|1
1136708|NCT02829918|2237483|FG000|Overall Study|Death|2
1136709|NCT02829918|2237483|FG000|Overall Study|Withdrawal by Subject|4
1136710|NCT02829918|2237483|FG000|Overall Study|Adverse Event|1
1136711|NCT02829918|2237483|FG000|Overall Study|Progression|1
1136712|NCT02829944|2237489|FG000|Overall Study|Physician Decision|0
1136713|NCT02829944|2237490|FG001|Overall Study|Physician Decision|1
1136714|NCT02829944|2237489|FG000|Overall Study|Screen Failure|2
1136715|NCT02829944|2237490|FG001|Overall Study|Screen Failure|2
1136716|NCT02829944|2237489|FG000|Overall Study|Inadequate Neuraxial Block|1
1136717|NCT02829944|2237490|FG001|Overall Study|Inadequate Neuraxial Block|1
1136718|NCT02829944|2237489|FG000|Overall Study|Withdrawal by Subject|2
1136719|NCT02829944|2237490|FG001|Overall Study|Withdrawal by Subject|1
1136720|NCT02829944|2237489|FG000|Overall Study|Catheter Displacement|1
1136721|NCT02829944|2237490|FG001|Overall Study|Catheter Displacement|0
1136722|NCT02829944|2237489|FG000|Overall Study|Catheter broke|0
1136723|NCT02829944|2237490|FG001|Overall Study|Catheter broke|1
1136724|NCT02829944|2237489|FG000|Overall Study|Staff unavailable|0
1136725|NCT02829944|2237490|FG001|Overall Study|Staff unavailable|1
1136726|NCT02829996|2237510|FG000|Overall Study|Withdrawal by Subject|1
1136727|NCT02829996|2237511|FG001|Overall Study|Withdrawal by Subject|0
1136728|NCT02829996|2237512|FG002|Overall Study|Withdrawal by Subject|0
1136729|NCT02829996|2237513|FG003|Overall Study|Withdrawal by Subject|0
1136730|NCT02829996|2237514|FG004|Overall Study|Withdrawal by Subject|0
1136731|NCT02830087|2237542|FG000|Overall Study|No study staff to follow-up patients|4
1136732|NCT02830087|2237543|FG001|Overall Study|No study staff to follow-up patients|4
1136733|NCT02830087|2237544|FG002|Overall Study|No study staff to follow-up patients|4
1136734|NCT02830087|2237545|FG003|Overall Study|No study staff to follow-up patients|3
1136735|NCT02830087|2237546|FG004|Overall Study|No study staff to follow-up patients|3
1136736|NCT02830087|2237547|FG005|Overall Study|No study staff to follow-up patients|3
1136737|NCT02830776|2237565|FG000|Overall Study|Lost to Follow-up|1
1136738|NCT02830880|2237570|FG000|Overall Study|Adverse reaction to chemotherapy|1
1136739|NCT02830880|2237570|FG000|Overall Study|Death|1
1136740|NCT02830880|2237570|FG000|Overall Study|Physician Decision|1
1136741|NCT02830893|2237576|FG000|Overall Study|Relocation to out of the country|1
1136742|NCT02830893|2237577|FG001|Overall Study|Relocation to out of the country|0
1136743|NCT02830893|2237576|FG000|Overall Study|Lost to Follow-up|0
1136744|NCT02830893|2237577|FG001|Overall Study|Lost to Follow-up|2
1136745|NCT02830893|2237576|FG000|Overall Study|Discharged to SNF, no transportation.|0
1136746|NCT02830893|2237577|FG001|Overall Study|Discharged to SNF, no transportation.|1
1136747|NCT02831257|2237583|FG000|Overall Study|Lack of Efficacy|3
1136748|NCT02831257|2237583|FG000|Overall Study|Adverse Event|2
1136749|NCT02831257|2237583|FG000|Overall Study|Physician Decision|1
1136750|NCT02831257|2237583|FG000|Overall Study|Withdrawal by Subject|6
1136751|NCT02831387|2237589|FG000|Overall Study|Withdrawal by Subject|1
1136752|NCT02831387|2237590|FG001|Overall Study|Withdrawal by Subject|1
1136753|NCT02831387|2237589|FG000|Overall Study|Discontinued due to stock recovery|0
1136754|NCT02831387|2237590|FG001|Overall Study|Discontinued due to stock recovery|1
1136787|NCT02831855|2237633|FG000|Open Label Phase (24 Weeks)|Adverse Event|39
1136788|NCT02831855|2237634|FG001|Open Label Phase (24 Weeks)|Adverse Event|0
1136789|NCT02831855|2237635|FG002|Open Label Phase (24 Weeks)|Adverse Event|0
1136790|NCT02831855|2237633|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8
1136791|NCT02831855|2237634|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0
1136792|NCT02831855|2237635|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0
1136793|NCT02831855|2237633|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
1136794|NCT02831855|2237634|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
1136795|NCT02831855|2237635|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
1136796|NCT02831855|2237633|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
1136797|NCT02831855|2237634|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
1136798|NCT02831855|2237635|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
1136799|NCT02831855|2237633|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5
1136800|NCT02831855|2237634|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0
1136801|NCT02831855|2237635|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0
1136802|NCT02831855|2237633|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
1136803|NCT02831855|2237634|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
1136804|NCT02831855|2237635|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
1136805|NCT02831855|2237633|FG000|Open Label Phase (24 Weeks)|Other|4
1136806|NCT02831855|2237634|FG001|Open Label Phase (24 Weeks)|Other|0
1136807|NCT02831855|2237635|FG002|Open Label Phase (24 Weeks)|Other|0
1136808|NCT02831855|2237633|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0
1136809|NCT02831855|2237634|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6
1136810|NCT02831855|2237635|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6
1136811|NCT02831855|2237633|FG000|Double Blind Phase (24 Weeks)|Death|0
1136812|NCT02831855|2237634|FG001|Double Blind Phase (24 Weeks)|Death|0
1136813|NCT02831855|2237635|FG002|Double Blind Phase (24 Weeks)|Death|2
1136814|NCT02831855|2237633|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
1136815|NCT02831855|2237634|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
1136816|NCT02831855|2237635|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
1136817|NCT02831855|2237633|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0
1136818|NCT02831855|2237634|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1
1136819|NCT02831855|2237635|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0
1136820|NCT02831855|2237633|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
1136821|NCT02831855|2237634|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
1136822|NCT02831855|2237635|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
1136823|NCT02831855|2237633|FG000|Double Blind Phase (24 Weeks)|Other|0
1136824|NCT02831855|2237634|FG001|Double Blind Phase (24 Weeks)|Other|2
1136825|NCT02831855|2237635|FG002|Double Blind Phase (24 Weeks)|Other|5
1136826|NCT02831855|2237633|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
1136827|NCT02831855|2237634|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
1136828|NCT02831855|2237635|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
1136829|NCT02831855|2237633|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0
1136830|NCT02831855|2237634|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5
1136831|NCT02831855|2237635|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2
1136832|NCT02831855|2237633|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
1136833|NCT02831855|2237634|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
1136834|NCT02831855|2237635|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
1136835|NCT02832037|2237661|FG000|Overall Study|Administrative reasons|0
1136836|NCT02832037|2237662|FG001|Overall Study|Administrative reasons|0
1136837|NCT02832037|2237663|FG002|Overall Study|Administrative reasons|1
1136838|NCT02832037|2237664|FG003|Overall Study|Administrative reasons|0
1136839|NCT02832037|2237665|FG004|Overall Study|Administrative reasons|0
1136840|NCT02832037|2237661|FG000|Overall Study|Protocol Violation|3
1136841|NCT02832037|2237662|FG001|Overall Study|Protocol Violation|0
1136842|NCT02832037|2237663|FG002|Overall Study|Protocol Violation|4
1136843|NCT02832037|2237664|FG003|Overall Study|Protocol Violation|1
1136844|NCT02832037|2237665|FG004|Overall Study|Protocol Violation|2
1136845|NCT02832037|2237661|FG000|Overall Study|Lost to Follow-up|2
1136846|NCT02832037|2237662|FG001|Overall Study|Lost to Follow-up|0
1136847|NCT02832037|2237663|FG002|Overall Study|Lost to Follow-up|3
1136848|NCT02832037|2237664|FG003|Overall Study|Lost to Follow-up|0
1136849|NCT02832037|2237665|FG004|Overall Study|Lost to Follow-up|5
1136850|NCT02832037|2237661|FG000|Overall Study|Withdrawal by Subject|9
1136851|NCT02832037|2237662|FG001|Overall Study|Withdrawal by Subject|8
1136852|NCT02832037|2237663|FG002|Overall Study|Withdrawal by Subject|0
1136853|NCT02832037|2237664|FG003|Overall Study|Withdrawal by Subject|4
1136854|NCT02832037|2237665|FG004|Overall Study|Withdrawal by Subject|8
1136855|NCT02832037|2237661|FG000|Overall Study|Adverse Event|5
1136856|NCT02832037|2237662|FG001|Overall Study|Adverse Event|4
1136857|NCT02832037|2237663|FG002|Overall Study|Adverse Event|0
1136858|NCT02832037|2237664|FG003|Overall Study|Adverse Event|2
1136859|NCT02832037|2237665|FG004|Overall Study|Adverse Event|4
1136860|NCT02832167|2237690|FG000|Treatment Period 1|Disease progression|92
1136861|NCT02832167|2237690|FG000|Treatment Period 1|Adverse event unrelated to study drug|11
1136862|NCT02832167|2237690|FG000|Treatment Period 1|Death|1
1136863|NCT02832167|2237690|FG000|Treatment Period 1|Study Drug Toxicity|6
1136864|NCT02832167|2237690|FG000|Treatment Period 1|Participant request to discontinue|9
1136865|NCT02832167|2237690|FG000|Treatment Period 1|No longer meet study criteria|1
1136866|NCT02832167|2237690|FG000|Treatment Period 1|Participant withdrew consent|3
1136867|NCT02832167|2237690|FG000|Treatment Period 1|Other reasons|6
1136868|NCT02832167|2237690|FG000|Transition From Period 1 to Period 2|Other reasons|1
1136869|NCT02832167|2237690|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1
1136870|NCT02832167|2237690|FG000|Transition From Period 1 to Period 2|Death|2
1136871|NCT02832167|2237690|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3
1136872|NCT02832167|2237690|FG000|Treatment Period 2|Disease progression|68
1136873|NCT02832167|2237690|FG000|Treatment Period 2|Adverse event unrelated to study drug|1
1136874|NCT02832167|2237690|FG000|Treatment Period 2|Maximum clinical benefit|1
1136875|NCT02832167|2237690|FG000|Treatment Period 2|Study Drug Toxicity|5
1136876|NCT02832167|2237690|FG000|Treatment Period 2|Participant request to discontinue|2
1136877|NCT02832167|2237690|FG000|Treatment Period 2|Participant withdrew consent|3
1136878|NCT02832167|2237690|FG000|Treatment Period 2|Other reasons|3
1136879|NCT02832375|2237700|FG000|Overall Study|Lost to Follow-up|1
1136880|NCT02832375|2237701|FG001|Overall Study|Lost to Follow-up|0
1136881|NCT02832375|2237700|FG000|Overall Study|Withdrawal of Consent|1
1136882|NCT02832375|2237701|FG001|Overall Study|Withdrawal of Consent|0
1136883|NCT02832622|2237708|FG000|Overall Study|MPP not programmed|1259
1136884|NCT02832622|2237708|FG000|Overall Study|Withdrawal by Subject|123
1136885|NCT02832622|2237708|FG000|Overall Study|Death|119
1136886|NCT02832622|2237708|FG000|Overall Study|Unsuccessful CRT implant|93
1136887|NCT02832622|2237708|FG000|Overall Study|Lost to Follow-up|45
900352|NCT00727246|1873466|FG002|Overall Study|incidental finding|0
900353|NCT00727246|1873467|FG003|Overall Study|incidental finding|1
900354|NCT00727246|1873464|FG000|Overall Study|withdrawn|0
900355|NCT00727246|1873465|FG001|Overall Study|withdrawn|0
900356|NCT00727246|1873466|FG002|Overall Study|withdrawn|1
900357|NCT00727246|1873467|FG003|Overall Study|withdrawn|0
900358|NCT00727259|1873477|FG000|Overall Study|Not all questionnaires completed|1055
900359|NCT00727272|1873482|FG000|Washout Period A|Adverse Event|0
900360|NCT00727272|1873483|FG001|Washout Period A|Adverse Event|0
1136888|NCT02832622|2237708|FG000|Overall Study|Patient non-compliance|42
1136889|NCT02832622|2237708|FG000|Overall Study|Withdrawal by other reasons|25
1136890|NCT02832622|2237708|FG000|Overall Study|System explant|24
1136891|NCT02832622|2237708|FG000|Overall Study|Physician Decision|6
1136892|NCT02833077|2237719|FG000|Overall Study|Adverse Event|1
1136893|NCT02833077|2237720|FG001|Overall Study|Adverse Event|2
1136894|NCT02833077|2237719|FG000|Overall Study|Lost to Follow-up|10
1136895|NCT02833077|2237720|FG001|Overall Study|Lost to Follow-up|1
1136896|NCT02833077|2237719|FG000|Overall Study|Personal Reasons|6
1136897|NCT02833077|2237720|FG001|Overall Study|Personal Reasons|4
1136898|NCT02833077|2237719|FG000|Overall Study|Protocol Deviation|0
1136899|NCT02833077|2237720|FG001|Overall Study|Protocol Deviation|1
1136900|NCT02833350|2237738|FG000|Overall Study|Adverse Event|0
1136901|NCT02833350|2237739|FG001|Overall Study|Adverse Event|3
1136902|NCT02833350|2237740|FG002|Overall Study|Adverse Event|4
1136903|NCT02833350|2237741|FG003|Overall Study|Adverse Event|4
1136904|NCT02833350|2237742|FG004|Overall Study|Adverse Event|1
1136905|NCT02833350|2237743|FG005|Overall Study|Adverse Event|0
1136906|NCT02833350|2237744|FG006|Overall Study|Adverse Event|1
1136907|NCT02833350|2237738|FG000|Overall Study|Death|0
1136908|NCT02833350|2237739|FG001|Overall Study|Death|0
1136909|NCT02833350|2237740|FG002|Overall Study|Death|1
1136910|NCT02833350|2237741|FG003|Overall Study|Death|0
1136911|NCT02833350|2237742|FG004|Overall Study|Death|0
1136912|NCT02833350|2237743|FG005|Overall Study|Death|0
1136913|NCT02833350|2237744|FG006|Overall Study|Death|0
1136914|NCT02833350|2237738|FG000|Overall Study|Lack of Efficacy|0
1136915|NCT02833350|2237739|FG001|Overall Study|Lack of Efficacy|2
1136916|NCT02833350|2237740|FG002|Overall Study|Lack of Efficacy|1
1136917|NCT02833350|2237741|FG003|Overall Study|Lack of Efficacy|4
1136918|NCT02833350|2237742|FG004|Overall Study|Lack of Efficacy|0
1136919|NCT02833350|2237743|FG005|Overall Study|Lack of Efficacy|1
1136920|NCT02833350|2237744|FG006|Overall Study|Lack of Efficacy|1
1136921|NCT02833350|2237738|FG000|Overall Study|Lost to Follow-up|0
1136922|NCT02833350|2237739|FG001|Overall Study|Lost to Follow-up|1
1136923|NCT02833350|2237740|FG002|Overall Study|Lost to Follow-up|0
1136924|NCT02833350|2237741|FG003|Overall Study|Lost to Follow-up|0
1136925|NCT02833350|2237742|FG004|Overall Study|Lost to Follow-up|0
1136926|NCT02833350|2237743|FG005|Overall Study|Lost to Follow-up|0
1136927|NCT02833350|2237744|FG006|Overall Study|Lost to Follow-up|1
1136928|NCT02833350|2237738|FG000|Overall Study|Withdrawal by Subject|3
1136929|NCT02833350|2237739|FG001|Overall Study|Withdrawal by Subject|3
1136930|NCT02833350|2237740|FG002|Overall Study|Withdrawal by Subject|2
1136931|NCT02833350|2237741|FG003|Overall Study|Withdrawal by Subject|0
1136932|NCT02833350|2237742|FG004|Overall Study|Withdrawal by Subject|2
1136933|NCT02833350|2237743|FG005|Overall Study|Withdrawal by Subject|0
1136934|NCT02833350|2237744|FG006|Overall Study|Withdrawal by Subject|2
1136935|NCT02833844|2237774|FG000|Double-Blind Period|Withdrawal by Subject|2
1136936|NCT02833844|2237775|FG001|Double-Blind Period|Withdrawal by Subject|3
1136937|NCT02833844|2237774|FG000|Double-Blind Period|Protocol Violation|0
1136938|NCT02833844|2237775|FG001|Double-Blind Period|Protocol Violation|4
1136939|NCT02833844|2237774|FG000|Open-Label Period|Death|0
1136940|NCT02833844|2237775|FG001|Open-Label Period|Death|2
1136941|NCT02833844|2237774|FG000|Open-Label Period|Lost to Follow-up|1
1136942|NCT02833844|2237775|FG001|Open-Label Period|Lost to Follow-up|0
1136943|NCT02833844|2237774|FG000|Open-Label Period|Withdrawal by Subject|1
1136944|NCT02833844|2237775|FG001|Open-Label Period|Withdrawal by Subject|0
1136945|NCT02833948|2237793|FG000|Overall Study|Death|2
1136946|NCT02833948|2237794|FG001|Overall Study|Death|3
1136947|NCT02833948|2237793|FG000|Overall Study|were not scanned|8
1136948|NCT02833948|2237794|FG001|Overall Study|were not scanned|13
1136949|NCT02833948|2237793|FG000|Overall Study|scans could not be evaluated|5
1136950|NCT02833948|2237794|FG001|Overall Study|scans could not be evaluated|2
1136951|NCT02833974|2237806|FG000|Overall Study|Lost to Follow-up|1
1136952|NCT02833974|2237807|FG001|Overall Study|Lost to Follow-up|0
1136953|NCT02833974|2237806|FG000|Overall Study|Adverse Event|0
1136954|NCT02833974|2237807|FG001|Overall Study|Adverse Event|3
1136955|NCT02834247|2237817|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1
1136956|NCT02834247|2237818|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2
1136957|NCT02834247|2237819|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0
1136958|NCT02834247|2237820|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0
1136959|NCT02834247|2237817|FG000|Dose Escalation Phase|Death|5
1136960|NCT02834247|2237818|FG001|Dose Escalation Phase|Death|6
1136961|NCT02834247|2237819|FG002|Dose Escalation Phase|Death|5
1136962|NCT02834247|2237820|FG003|Dose Escalation Phase|Death|0
1136963|NCT02834247|2237817|FG000|Dose Escalation Phase|Lost to Follow-up|0
1136964|NCT02834247|2237818|FG001|Dose Escalation Phase|Lost to Follow-up|1
1136965|NCT02834247|2237819|FG002|Dose Escalation Phase|Lost to Follow-up|0
1136966|NCT02834247|2237820|FG003|Dose Escalation Phase|Lost to Follow-up|0
1136967|NCT02834247|2237817|FG000|Dose Escalation Phase|Withdrawal by Subject|2
1136968|NCT02834247|2237818|FG001|Dose Escalation Phase|Withdrawal by Subject|2
1136969|NCT02834247|2237819|FG002|Dose Escalation Phase|Withdrawal by Subject|0
1136970|NCT02834247|2237820|FG003|Dose Escalation Phase|Withdrawal by Subject|0
1136971|NCT02834247|2237817|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0
1136972|NCT02834247|2237818|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0
1136973|NCT02834247|2237819|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0
1136974|NCT02834247|2237820|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7
1136975|NCT02834247|2237817|FG000|Dose Expansion Phase|Death|0
1136976|NCT02834247|2237818|FG001|Dose Expansion Phase|Death|0
1136977|NCT02834247|2237819|FG002|Dose Expansion Phase|Death|0
1136978|NCT02834247|2237820|FG003|Dose Expansion Phase|Death|8
1136979|NCT02834247|2237817|FG000|Dose Expansion Phase|Lost to Follow-up|0
1136980|NCT02834247|2237818|FG001|Dose Expansion Phase|Lost to Follow-up|0
1136981|NCT02834247|2237819|FG002|Dose Expansion Phase|Lost to Follow-up|0
1136982|NCT02834247|2237820|FG003|Dose Expansion Phase|Lost to Follow-up|1
1136983|NCT02834247|2237817|FG000|Dose Expansion Phase|Withdrawal by Subject|0
1136984|NCT02834247|2237818|FG001|Dose Expansion Phase|Withdrawal by Subject|0
1136985|NCT02834247|2237819|FG002|Dose Expansion Phase|Withdrawal by Subject|0
1136986|NCT02834247|2237820|FG003|Dose Expansion Phase|Withdrawal by Subject|1
1136987|NCT02834390|2237834|FG000|Induction Phase|Progressive disease|0
1136988|NCT02834390|2237835|FG001|Induction Phase|Progressive disease|1
1136989|NCT02834390|2237834|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2
1136990|NCT02834390|2237835|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0
1136991|NCT02834390|2237834|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0
1136992|NCT02834390|2237835|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1
1136993|NCT02834390|2237834|FG000|Consolidation Phase|Physician Decision|1
1136994|NCT02834390|2237835|FG001|Consolidation Phase|Physician Decision|1
1136995|NCT02834819|2237875|FG000|Overall Study|Did not complete 7 day follow up call.|5
1136996|NCT02834819|2237876|FG001|Overall Study|Did not complete 7 day follow up call.|0
1136997|NCT02835092|2237885|FG000|Overall Study|Withdrawal by Subject|3
1136998|NCT02835092|2237886|FG001|Overall Study|Withdrawal by Subject|6
1136999|NCT02835092|2237887|FG002|Overall Study|Withdrawal by Subject|3
1137000|NCT02835092|2237885|FG000|Overall Study|Lost to Follow-up|0
1137001|NCT02835092|2237886|FG001|Overall Study|Lost to Follow-up|2
1137002|NCT02835092|2237887|FG002|Overall Study|Lost to Follow-up|0
1137003|NCT02835339|2237906|FG000|Overall Study|Did not receive allocated intervention|13
1137004|NCT02835339|2237907|FG001|Overall Study|Did not receive allocated intervention|16
1137005|NCT02835495|2237915|FG000|Overall Study|Cancer diagnosis prior intervention|1
1137006|NCT02835495|2237916|FG001|Overall Study|Cancer diagnosis prior intervention|0
1137007|NCT02835495|2237915|FG000|Overall Study|Declined in-person follow-up visit|4
1137008|NCT02835495|2237916|FG001|Overall Study|Declined in-person follow-up visit|2
1137018|NCT02835820|2237953|FG000|Overall Study|Baseline Screen Failure|0
1137019|NCT02835820|2237954|FG001|Overall Study|Baseline Screen Failure|3
1137030|NCT02836249|2237975|FG000|Overall Study|Randomized but Never Treated|0
1137031|NCT02836249|2237976|FG001|Overall Study|Randomized but Never Treated|1
1137032|NCT02836249|2237975|FG000|Overall Study|Pregnancy|2
1137033|NCT02836249|2237976|FG001|Overall Study|Pregnancy|0
1137034|NCT02836249|2237975|FG000|Overall Study|Withdrew Consent|0
1137035|NCT02836249|2237976|FG001|Overall Study|Withdrew Consent|1
1137036|NCT02836249|2237975|FG000|Overall Study|Lost to Follow-up|0
1137037|NCT02836249|2237976|FG001|Overall Study|Lost to Follow-up|1
1137038|NCT02836249|2237975|FG000|Overall Study|Still on Study|121
1137039|NCT02836249|2237976|FG001|Overall Study|Still on Study|55
1137040|NCT02836496|2237984|FG000|Overall Study|Adverse Event|2
1137041|NCT02836496|2237985|FG001|Overall Study|Adverse Event|1
1137042|NCT02836496|2237984|FG000|Overall Study|Withdrawal by Subject|0
1137043|NCT02836496|2237985|FG001|Overall Study|Withdrawal by Subject|1
1137044|NCT02836613|2237993|FG000|Overall Study|Accidental drowning|1
1137045|NCT02836613|2237994|FG001|Overall Study|Accidental drowning|0
1137046|NCT02836613|2237993|FG000|Overall Study|Lost to Follow-up|0
1137047|NCT02836613|2237994|FG001|Overall Study|Lost to Follow-up|1
1137048|NCT02836613|2237993|FG000|Overall Study|Withdrawal by Subject|0
1137049|NCT02836613|2237994|FG001|Overall Study|Withdrawal by Subject|2
1137050|NCT02836652|2238002|FG000|Overall Study|Death|3
1137051|NCT02836652|2238003|FG001|Overall Study|Death|3
1137052|NCT02836652|2238002|FG000|Overall Study|Transplant/Explant|3
1137053|NCT02836652|2238003|FG001|Overall Study|Transplant/Explant|4
1137054|NCT02836652|2238002|FG000|Overall Study|Withdrawn|9
1137055|NCT02836652|2238003|FG001|Overall Study|Withdrawn|9
1137056|NCT02836652|2238002|FG000|Overall Study|Not on treatment regimen post-op day 15|3
1137057|NCT02836652|2238003|FG001|Overall Study|Not on treatment regimen post-op day 15|3
1137058|NCT02836769|2238009|FG000|Overall Study|Lost to Follow-up|10
1137059|NCT02836769|2238009|FG000|Overall Study|Medical withdrawal|2
1137060|NCT02836769|2238009|FG000|Overall Study|Withdrawal by Subject|3
1137061|NCT02836873|2238015|FG000|Overall Study|Protocol Violation|0
1137062|NCT02836873|2238016|FG001|Overall Study|Protocol Violation|1
1137063|NCT02836873|2238015|FG000|Overall Study|Adverse Event|1
1137064|NCT02836873|2238016|FG001|Overall Study|Adverse Event|4
1137065|NCT02836873|2238015|FG000|Overall Study|Withdrawal by Subject|2
1137066|NCT02836873|2238016|FG001|Overall Study|Withdrawal by Subject|2
1137067|NCT02836873|2238015|FG000|Overall Study|Lost to Follow-up|1
1137068|NCT02836873|2238016|FG001|Overall Study|Lost to Follow-up|3
1137069|NCT02836873|2238015|FG000|Overall Study|Physician Decision|0
1137070|NCT02836873|2238016|FG001|Overall Study|Physician Decision|1
1137071|NCT02836873|2238015|FG000|Overall Study|Other|1
1137072|NCT02836873|2238016|FG001|Overall Study|Other|0
1137091|NCT02837731|2238062|FG000|Allocation|Admitted to General Floor|3
1137092|NCT02837731|2238063|FG001|Allocation|Admitted to General Floor|4
1137093|NCT02837731|2238062|FG000|Allocation|Immediate surgery/withdrew|2
1137094|NCT02837731|2238063|FG001|Allocation|Immediate surgery/withdrew|0
1137095|NCT02837731|2238062|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1
1137096|NCT02837731|2238063|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0
1137097|NCT02837731|2238062|FG000|Allocation|Withdrawal by Subject|2
1137098|NCT02837731|2238063|FG001|Allocation|Withdrawal by Subject|0
1137099|NCT02837731|2238062|FG000|Allocation|Device not available|1
1137100|NCT02837731|2238063|FG001|Allocation|Device not available|0
1137101|NCT02837731|2238062|FG000|Allocation|Protocol not implemented|7
1137102|NCT02837731|2238063|FG001|Allocation|Protocol not implemented|0
1137103|NCT02837731|2238062|FG000|Allocation|Moribund/Do not resuscitate|2
1137104|NCT02837731|2238063|FG001|Allocation|Moribund/Do not resuscitate|0
1137105|NCT02837731|2238062|FG000|Allocation|Did not meet sepsis criteria|1
1137106|NCT02837731|2238063|FG001|Allocation|Did not meet sepsis criteria|2
1137107|NCT02837731|2238062|FG000|Allocation|Known aortic abnormalities|0
1137108|NCT02837731|2238063|FG001|Allocation|Known aortic abnormalities|1
1137109|NCT02837952|2238084|FG000|Overall Study|Adverse Event|0
1137110|NCT02837952|2238085|FG001|Overall Study|Adverse Event|1
1137111|NCT02837952|2238084|FG000|Overall Study|Withdrawal by Subject|4
1137112|NCT02837952|2238085|FG001|Overall Study|Withdrawal by Subject|5
1137113|NCT02837952|2238084|FG000|Overall Study|Medication Error|1
1137114|NCT02837952|2238085|FG001|Overall Study|Medication Error|0
1137115|NCT02838017|2238093|FG000|Overall Study|Lost to Follow-up|14
1137116|NCT02838017|2238094|FG001|Overall Study|Lost to Follow-up|11
1137117|NCT02838134|2238102|FG000|Overall Study|Lost to Follow-up|1
1137118|NCT02838134|2238103|FG001|Overall Study|Lost to Follow-up|2
1137119|NCT02838134|2238102|FG000|Overall Study|logistic problems|1
1137120|NCT02838134|2238103|FG001|Overall Study|logistic problems|1
1137121|NCT02838420|2238115|FG000|Overall Study|Ongoing in Study|113
1137122|NCT02838420|2238116|FG001|Overall Study|Ongoing in Study|45
1137123|NCT02838420|2238115|FG000|Overall Study|Lost to Follow-up|1
1137124|NCT02838420|2238116|FG001|Overall Study|Lost to Follow-up|0
1137125|NCT02838420|2238115|FG000|Overall Study|Withdrawal by Subject|3
1137126|NCT02838420|2238116|FG001|Overall Study|Withdrawal by Subject|4
1137127|NCT02838420|2238115|FG000|Overall Study|Death|8
1137128|NCT02838420|2238116|FG001|Overall Study|Death|13
1137129|NCT02838628|2238124|FG000|Recurrence Follow-up Period|AK Recurrence|18
1137130|NCT02838628|2238125|FG001|Recurrence Follow-up Period|AK Recurrence|13
1137131|NCT02838628|2238124|FG000|Recurrence Follow-up Period|Adverse Event|1
1137132|NCT02838628|2238125|FG001|Recurrence Follow-up Period|Adverse Event|0
1137133|NCT02838628|2238124|FG000|Recurrence Follow-up Period|Non-compliance|0
1137134|NCT02838628|2238125|FG001|Recurrence Follow-up Period|Non-compliance|1
1137135|NCT02838628|2238124|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
1137136|NCT02838628|2238125|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2
1137137|NCT02838628|2238124|FG000|Recurrence Follow-up Period|Other un-specified|1
1137138|NCT02838628|2238125|FG001|Recurrence Follow-up Period|Other un-specified|1
1137139|NCT02838901|2238134|FG000|Overall Study|Withdrawal by Subject|1
1137140|NCT02838901|2238135|FG001|Overall Study|Withdrawal by Subject|1
1137141|NCT02838901|2238134|FG000|Overall Study|Lost to Follow-up|1
1137142|NCT02838901|2238135|FG001|Overall Study|Lost to Follow-up|1
1137143|NCT02839200|2238149|FG000|Overall Study|Withdrawal by Subject|2
1137144|NCT02839200|2238150|FG001|Overall Study|Withdrawal by Subject|0
1137145|NCT02839200|2238151|FG002|Overall Study|Withdrawal by Subject|1
1137146|NCT02839200|2238152|FG003|Overall Study|Withdrawal by Subject|0
1137147|NCT02839200|2238153|FG004|Overall Study|Withdrawal by Subject|0
1137148|NCT02839200|2238154|FG005|Overall Study|Withdrawal by Subject|1
1137149|NCT02839200|2238149|FG000|Overall Study|Lost to Follow-up|2
1137150|NCT02839200|2238150|FG001|Overall Study|Lost to Follow-up|0
1137151|NCT02839200|2238151|FG002|Overall Study|Lost to Follow-up|0
1137152|NCT02839200|2238152|FG003|Overall Study|Lost to Follow-up|0
1137153|NCT02839200|2238153|FG004|Overall Study|Lost to Follow-up|1
1137154|NCT02839200|2238154|FG005|Overall Study|Lost to Follow-up|0
1137155|NCT02839200|2238149|FG000|Overall Study|Adverse Event|0
1137156|NCT02839200|2238150|FG001|Overall Study|Adverse Event|0
1137157|NCT02839200|2238151|FG002|Overall Study|Adverse Event|0
1137158|NCT02839200|2238152|FG003|Overall Study|Adverse Event|0
1137159|NCT02839200|2238153|FG004|Overall Study|Adverse Event|1
1137160|NCT02839200|2238154|FG005|Overall Study|Adverse Event|0
1137161|NCT02839200|2238149|FG000|Overall Study|Randomized in error|0
1137162|NCT02839200|2238150|FG001|Overall Study|Randomized in error|1
1137163|NCT02839200|2238151|FG002|Overall Study|Randomized in error|0
1137164|NCT02839200|2238152|FG003|Overall Study|Randomized in error|0
1137165|NCT02839200|2238153|FG004|Overall Study|Randomized in error|0
1137166|NCT02839200|2238154|FG005|Overall Study|Randomized in error|0
1137167|NCT02839330|2238172|FG000|Overall Study|Adverse Event|0
1137168|NCT02839330|2238173|FG001|Overall Study|Adverse Event|1
1137169|NCT02839330|2238174|FG002|Overall Study|Adverse Event|2
1137170|NCT02839330|2238175|FG003|Overall Study|Adverse Event|2
1137171|NCT02839330|2238172|FG000|Overall Study|Death|4
1137172|NCT02839330|2238173|FG001|Overall Study|Death|6
1137173|NCT02839330|2238174|FG002|Overall Study|Death|1
1137174|NCT02839330|2238175|FG003|Overall Study|Death|1
1137175|NCT02839330|2238172|FG000|Overall Study|Withdrawal by Subject|27
1137176|NCT02839330|2238173|FG001|Overall Study|Withdrawal by Subject|19
1137177|NCT02839330|2238174|FG002|Overall Study|Withdrawal by Subject|11
1137178|NCT02839330|2238175|FG003|Overall Study|Withdrawal by Subject|13
1137179|NCT02839330|2238172|FG000|Overall Study|Lost to Follow-up|22
1137180|NCT02839330|2238173|FG001|Overall Study|Lost to Follow-up|27
1137181|NCT02839330|2238174|FG002|Overall Study|Lost to Follow-up|29
1137182|NCT02839330|2238175|FG003|Overall Study|Lost to Follow-up|25
1137183|NCT02839330|2238172|FG000|Overall Study|Administrative Reason|0
1137184|NCT02839330|2238173|FG001|Overall Study|Administrative Reason|0
1137185|NCT02839330|2238174|FG002|Overall Study|Administrative Reason|0
1137186|NCT02839330|2238175|FG003|Overall Study|Administrative Reason|1
1137187|NCT02839330|2238172|FG000|Overall Study|Protocol Violation|1
1137188|NCT02839330|2238173|FG001|Overall Study|Protocol Violation|2
1137189|NCT02839330|2238174|FG002|Overall Study|Protocol Violation|2
1137190|NCT02839330|2238175|FG003|Overall Study|Protocol Violation|3
1137191|NCT02839330|2238172|FG000|Overall Study|Other reason, not specified|4
1137192|NCT02839330|2238173|FG001|Overall Study|Other reason, not specified|3
1137193|NCT02839330|2238174|FG002|Overall Study|Other reason, not specified|3
1137194|NCT02839330|2238175|FG003|Overall Study|Other reason, not specified|6
1137195|NCT02839681|2238186|FG000|Overall Study|Death|2
1137196|NCT02839746|2238190|FG000|Overall Study|Not met selection criteria|12
1137197|NCT02839798|2238217|FG000|Overall Study|Withdrawal by Subject|2
1137198|NCT02839876|2238223|FG000|Overall Study|Protocol Violation|10
1137199|NCT02839876|2238224|FG001|Overall Study|Protocol Violation|11
1137200|NCT02840253|2238264|FG000|Overall Study|Unsuccessful block|4
1137201|NCT02840461|2238271|FG000|Overall Study|Adverse Event|1
1137202|NCT02840461|2238272|FG001|Overall Study|Adverse Event|5
1137203|NCT02840461|2238273|FG002|Overall Study|Adverse Event|3
1137204|NCT02840461|2238271|FG000|Overall Study|Lost to Follow-up|10
1137205|NCT02840461|2238272|FG001|Overall Study|Lost to Follow-up|7
1137206|NCT02840461|2238273|FG002|Overall Study|Lost to Follow-up|6
1137207|NCT02840461|2238271|FG000|Overall Study|Non-Comliance with Dosing Requirements|0
1137208|NCT02840461|2238272|FG001|Overall Study|Non-Comliance with Dosing Requirements|1
1137209|NCT02840461|2238273|FG002|Overall Study|Non-Comliance with Dosing Requirements|0
1137210|NCT02840461|2238271|FG000|Overall Study|Protocol Violation|2
1137211|NCT02840461|2238272|FG001|Overall Study|Protocol Violation|3
1137212|NCT02840461|2238273|FG002|Overall Study|Protocol Violation|1
1137213|NCT02840461|2238271|FG000|Overall Study|Withdrawal by Subject|10
1137214|NCT02840461|2238272|FG001|Overall Study|Withdrawal by Subject|6
1137215|NCT02840461|2238273|FG002|Overall Study|Withdrawal by Subject|2
1137216|NCT02840461|2238271|FG000|Overall Study|Worsening of Symptom & Kit Error|0
1137217|NCT02840461|2238272|FG001|Overall Study|Worsening of Symptom & Kit Error|0
1137218|NCT02840461|2238273|FG002|Overall Study|Worsening of Symptom & Kit Error|2
1137219|NCT02840474|2238284|FG000|Overall Study|Lost to Follow-up|1
1137220|NCT02840474|2238285|FG001|Overall Study|Lost to Follow-up|0
1137221|NCT02840721|2238291|FG000|Treatment Period|Adverse Event|1
1137222|NCT02840721|2238291|FG000|Follow-Up|Lack of Efficacy|1
1137223|NCT02840721|2238291|FG000|Follow-Up|Withdrawal by Subject|4
1137224|NCT02840721|2238291|FG000|Follow-Up|Withdrawal of Consent|2
1137225|NCT02841709|2238368|FG000|5th Intervention|Adverse Event|2
1137226|NCT02841709|2238369|FG001|5th Intervention|Adverse Event|0
1137227|NCT02841709|2238370|FG002|5th Intervention|Adverse Event|0
1137228|NCT02841709|2238371|FG003|5th Intervention|Adverse Event|0
1137229|NCT02841709|2238372|FG004|5th Intervention|Adverse Event|2
1137230|NCT02841787|2238388|FG000|Overall Study|Lost to Follow-up|1
1137231|NCT02841787|2238389|FG001|Overall Study|Lost to Follow-up|0
1137232|NCT02841787|2238390|FG002|Overall Study|Lost to Follow-up|0
1137233|NCT02841787|2238388|FG000|Overall Study|Symptoms dropped below threshold|1
1137234|NCT02841787|2238389|FG001|Overall Study|Symptoms dropped below threshold|0
1137235|NCT02841787|2238390|FG002|Overall Study|Symptoms dropped below threshold|0
1137236|NCT02841787|2238388|FG000|Overall Study|Withdrawal by Subject|1
1137237|NCT02841787|2238389|FG001|Overall Study|Withdrawal by Subject|4
1137238|NCT02841787|2238390|FG002|Overall Study|Withdrawal by Subject|0
1137239|NCT02842073|2238407|FG000|Overall Study|Withdrawal by Subject|1
1137240|NCT02842086|2238413|FG000|Overall Study|Randomized but Never Treated|6
1137241|NCT02842086|2238414|FG001|Overall Study|Randomized but Never Treated|6
1137242|NCT02842086|2238413|FG000|Overall Study|Still in Double-Blind Phase|7
1137243|NCT02842086|2238414|FG001|Overall Study|Still in Double-Blind Phase|3
1137244|NCT02842086|2238413|FG000|Overall Study|Adverse Event|18
1137245|NCT02842086|2238414|FG001|Overall Study|Adverse Event|20
1137246|NCT02842086|2238413|FG000|Overall Study|Death|3
1137247|NCT02842086|2238414|FG001|Overall Study|Death|3
1137248|NCT02842086|2238413|FG000|Overall Study|Investigator's Discretion|9
1137249|NCT02842086|2238414|FG001|Overall Study|Investigator's Discretion|13
1137250|NCT02842086|2238413|FG000|Overall Study|Non-Compliance with Study Drug|9
1137251|NCT02842086|2238414|FG001|Overall Study|Non-Compliance with Study Drug|8
1137252|NCT02842086|2238413|FG000|Overall Study|Protocol Violation|8
1137253|NCT02842086|2238414|FG001|Overall Study|Protocol Violation|4
1137254|NCT02842086|2238413|FG000|Overall Study|Withdrew Consent|205
1137255|NCT02842086|2238414|FG001|Overall Study|Withdrew Consent|194
1137256|NCT02842086|2238413|FG000|Overall Study|Lost to Follow-up|274
1137257|NCT02842086|2238414|FG001|Overall Study|Lost to Follow-up|236
1137258|NCT02842086|2238413|FG000|Overall Study|HIV-1 Infection|5
1137259|NCT02842086|2238414|FG001|Overall Study|HIV-1 Infection|6
1137260|NCT02842151|2238420|FG000|Overall Study|Adverse Event|1
1137261|NCT02842151|2238420|FG000|Overall Study|Subject moved too far away|1
1137262|NCT02842736|2238435|FG000|Overall Study|Lost to Follow-up|13
1137263|NCT02842736|2238435|FG000|Overall Study|Intervention for menstrual bleeding|17
1137264|NCT02842736|2238435|FG000|Overall Study|Withdrawal by Subject|4
1137265|NCT02842736|2238435|FG000|Overall Study|Pregnancy|3
1137266|NCT02842736|2238435|FG000|Overall Study|Hysterectomy for fibroids|2
1137267|NCT02842736|2238435|FG000|Overall Study|Hysterectomy for uterine prolapse|1
1137268|NCT02842736|2238435|FG000|Overall Study|IUD: Mirena|1
1137269|NCT02842853|2238443|FG000|Overall Study|Non-compliance with the protocol|3
1137270|NCT02842853|2238444|FG001|Overall Study|Non-compliance with the protocol|7
1137271|NCT02842853|2238445|FG002|Overall Study|Non-compliance with the protocol|2
1137272|NCT02842853|2238446|FG003|Overall Study|Non-compliance with the protocol|5
1137273|NCT02842853|2238443|FG000|Overall Study|Subject met exclusion criteria|0
1137274|NCT02842853|2238444|FG001|Overall Study|Subject met exclusion criteria|1
1137275|NCT02842853|2238445|FG002|Overall Study|Subject met exclusion criteria|0
1137276|NCT02842853|2238446|FG003|Overall Study|Subject met exclusion criteria|0
1137277|NCT02842853|2238443|FG000|Overall Study|Withdrawal by Subject|11
1137278|NCT02842853|2238444|FG001|Overall Study|Withdrawal by Subject|13
1137279|NCT02842853|2238445|FG002|Overall Study|Withdrawal by Subject|9
1137280|NCT02842853|2238446|FG003|Overall Study|Withdrawal by Subject|8
1137281|NCT02842853|2238443|FG000|Overall Study|Lost to Follow-up|9
1137282|NCT02842853|2238444|FG001|Overall Study|Lost to Follow-up|13
1137283|NCT02842853|2238445|FG002|Overall Study|Lost to Follow-up|10
1137284|NCT02842853|2238446|FG003|Overall Study|Lost to Follow-up|11
1137285|NCT02842866|2238460|FG000|Overall Study|Serious Adverse Event|0
1137286|NCT02842866|2238461|FG001|Overall Study|Serious Adverse Event|1
1137287|NCT02842866|2238460|FG000|Overall Study|Protocol Violation|4
1137288|NCT02842866|2238461|FG001|Overall Study|Protocol Violation|2
1137289|NCT02842866|2238460|FG000|Overall Study|Lost to Follow-up|2
1137290|NCT02842866|2238461|FG001|Overall Study|Lost to Follow-up|0
1137291|NCT02842866|2238460|FG000|Overall Study|Withdrawal by Subject|1
900361|NCT00727272|1873484|FG002|Washout Period A|Adverse Event|1
900362|NCT00727272|1873482|FG000|Washout Period B|Withdrawal by Subject|0
900363|NCT00727272|1873483|FG001|Washout Period B|Withdrawal by Subject|0
900364|NCT00727272|1873484|FG002|Washout Period B|Withdrawal by Subject|1
900365|NCT00727311|1873498|FG000|Overall Study|Did not receive drug|316
900366|NCT00727311|1873498|FG000|Overall Study|Missing end of therapy data|205
900367|NCT00727311|1873498|FG000|Overall Study|Adverse Event|58
900368|NCT00727311|1873498|FG000|Overall Study|Lack of Efficacy|242
900369|NCT00727311|1873498|FG000|Overall Study|Lost to Follow-up|73
900370|NCT00727311|1873498|FG000|Overall Study|Withdrawal by Subject|77
900371|NCT00727311|1873498|FG000|Overall Study|Other|97
900372|NCT00727311|1873498|FG000|Overall Study|Multiple reasons|39
900373|NCT00727402|1873524|FG000|Overall Study|Physician Decision|116
900374|NCT00727415|1873528|FG000|Phase I|Dose Limiting Toxicity|2
900375|NCT00727441|1873535|FG000|Overall Study|Disease Progression|11
1137292|NCT02842866|2238461|FG001|Overall Study|Withdrawal by Subject|0
1137293|NCT02843178|2238471|FG000|Overall Study|Lost to Follow-up|8
1137294|NCT02843178|2238472|FG001|Overall Study|Lost to Follow-up|8
1137295|NCT02843178|2238473|FG002|Overall Study|Lost to Follow-up|6
1137296|NCT02843178|2238474|FG003|Overall Study|Lost to Follow-up|3
1137297|NCT02843178|2238471|FG000|Overall Study|Withdrawal by Subject|0
1137298|NCT02843178|2238472|FG001|Overall Study|Withdrawal by Subject|0
1137299|NCT02843178|2238473|FG002|Overall Study|Withdrawal by Subject|1
1137300|NCT02843178|2238474|FG003|Overall Study|Withdrawal by Subject|1
1137301|NCT02844439|2238506|FG000|Overall Study|Withdrawal by Subject|1
1137302|NCT02844439|2238506|FG000|Overall Study|Lost to Follow-up|2
1137303|NCT02844439|2238506|FG000|Overall Study|Termination by Sponsor|4
1137304|NCT02844439|2238506|FG000|Overall Study|Death|28
1137305|NCT02844439|2238506|FG000|Overall Study|Other|5
1137306|NCT02844543|2238517|FG000|Overall Study|Withdrawal by Subject|4
1137307|NCT02844543|2238517|FG000|Overall Study|Did not meet eligibility criteria|1
1137308|NCT02844920|2238534|FG000|Overall Study|Lost to Follow-up|2
1137309|NCT02845336|2238553|FG000|Overall Study|Lost to Follow-up|3
1137310|NCT02845336|2238554|FG001|Overall Study|Lost to Follow-up|1
1137311|NCT02845336|2238553|FG000|Overall Study|Inability to get medication|2
1137312|NCT02845336|2238554|FG001|Overall Study|Inability to get medication|0
1137313|NCT02845375|2238563|FG000|Overall Study|upper airway obstruction|1
1137314|NCT02845375|2238564|FG001|Overall Study|upper airway obstruction|2
1137315|NCT02845375|2238565|FG002|Overall Study|upper airway obstruction|1
1137316|NCT02846324|2238613|FG000|Overall Study|Other|1
1137317|NCT02846324|2238614|FG001|Overall Study|Other|0
1137318|NCT02846324|2238615|FG002|Overall Study|Other|0
1137319|NCT02846324|2238616|FG003|Overall Study|Other|0
1137320|NCT02846324|2238613|FG000|Overall Study|Withdrawal by Subject|1
1137321|NCT02846324|2238614|FG001|Overall Study|Withdrawal by Subject|0
1137322|NCT02846324|2238615|FG002|Overall Study|Withdrawal by Subject|4
1137323|NCT02846324|2238616|FG003|Overall Study|Withdrawal by Subject|0
1137324|NCT02846415|2238637|FG000|Overall Study|Lost to Follow-up|2
1137325|NCT02846415|2238638|FG001|Overall Study|Lost to Follow-up|0
1137326|NCT02846415|2238637|FG000|Overall Study|Withdrawal by Subject|1
1137327|NCT02846415|2238638|FG001|Overall Study|Withdrawal by Subject|1
1137328|NCT02846558|2238648|FG000|Overall Study|Adverse Event|1
1137329|NCT02846558|2238649|FG001|Overall Study|Adverse Event|0
1137330|NCT02846558|2238650|FG002|Overall Study|Adverse Event|0
1137331|NCT02846558|2238651|FG003|Overall Study|Adverse Event|0
1137332|NCT02846558|2238648|FG000|Overall Study|Withdrawal by Subject|5
1137333|NCT02846558|2238649|FG001|Overall Study|Withdrawal by Subject|4
1137334|NCT02846558|2238650|FG002|Overall Study|Withdrawal by Subject|2
1137335|NCT02846558|2238651|FG003|Overall Study|Withdrawal by Subject|2
1137336|NCT02846558|2238648|FG000|Overall Study|Lost to Follow-up|2
1137337|NCT02846558|2238649|FG001|Overall Study|Lost to Follow-up|0
1137338|NCT02846558|2238650|FG002|Overall Study|Lost to Follow-up|0
1137339|NCT02846558|2238651|FG003|Overall Study|Lost to Follow-up|0
1137340|NCT02846779|2238684|FG000|Overall Study|Lost Enrollment|83
1137341|NCT02846779|2238685|FG001|Overall Study|Lost Enrollment|82
1137342|NCT02846779|2238686|FG002|Overall Study|Lost Enrollment|86
1137343|NCT02846779|2238684|FG000|Overall Study|Less than 31 days of follow-up|56
1137344|NCT02846779|2238685|FG001|Overall Study|Less than 31 days of follow-up|45
1137345|NCT02846779|2238686|FG002|Overall Study|Less than 31 days of follow-up|52
1137346|NCT02847182|2238722|FG000|Overall Study|Withdrawal by Subject|0
1137347|NCT02847182|2238723|FG001|Overall Study|Withdrawal by Subject|1
1137348|NCT02847260|2238735|FG000|Overall Study|Adverse Event|3
1137349|NCT02847260|2238735|FG000|Overall Study|Withdrawal by Subject|2
1137350|NCT02847260|2238735|FG000|Overall Study|Clinical Deterioration|1
1137351|NCT02847260|2238735|FG000|Overall Study|Physician Decision|1
1137352|NCT02847494|2238741|FG000|Overall Study|Lost to Follow-up|8
1137353|NCT02847494|2238742|FG001|Overall Study|Lost to Follow-up|5
1137354|NCT02847637|2238752|FG000|Overall Study|Withdrew from treatment due to AE|0
1137355|NCT02847637|2238753|FG001|Overall Study|Withdrew from treatment due to AE|0
1137356|NCT02847637|2238754|FG002|Overall Study|Withdrew from treatment due to AE|1
1137357|NCT02847637|2238755|FG003|Overall Study|Withdrew from treatment due to AE|0
1137358|NCT02847637|2238752|FG000|Overall Study|Ongoing treatment with emicizumab|16
1137359|NCT02847637|2238753|FG001|Overall Study|Ongoing treatment with emicizumab|35
1137360|NCT02847637|2238754|FG002|Overall Study|Ongoing treatment with emicizumab|34
1137361|NCT02847637|2238755|FG003|Overall Study|Ongoing treatment with emicizumab|63
1137362|NCT02847637|2238752|FG000|Overall Study|First emicizumab dose delayed|1
1137363|NCT02847637|2238753|FG001|Overall Study|First emicizumab dose delayed|0
1137364|NCT02847637|2238754|FG002|Overall Study|First emicizumab dose delayed|0
1137365|NCT02847637|2238755|FG003|Overall Study|First emicizumab dose delayed|0
1137366|NCT02847650|2238777|FG000|Overall Study|Adverse Event|2
1137367|NCT02847650|2238778|FG001|Overall Study|Adverse Event|4
1137368|NCT02847650|2238777|FG000|Overall Study|Lost to Follow-up|1
1137369|NCT02847650|2238778|FG001|Overall Study|Lost to Follow-up|0
1137370|NCT02847650|2238777|FG000|Overall Study|Protocol Violation|0
1137371|NCT02847650|2238778|FG001|Overall Study|Protocol Violation|1
1137372|NCT02847650|2238777|FG000|Overall Study|Withdrawal by Subject|1
1137373|NCT02847650|2238778|FG001|Overall Study|Withdrawal by Subject|1
1137374|NCT02847858|2238786|FG000|Overall Study|Lost to Follow-up|401
1137375|NCT02847858|2238787|FG001|Overall Study|Lost to Follow-up|269
1137376|NCT02848313|2238817|FG000|Overall Study|Adverse Event|1
1137377|NCT02848313|2238818|FG001|Overall Study|Adverse Event|2
1137378|NCT02848313|2238817|FG000|Overall Study|Lack of Efficacy|0
1137379|NCT02848313|2238818|FG001|Overall Study|Lack of Efficacy|1
1137380|NCT02848313|2238817|FG000|Overall Study|Withdrawal by Subject|1
1137381|NCT02848313|2238818|FG001|Overall Study|Withdrawal by Subject|1
1137382|NCT02848313|2238817|FG000|Overall Study|Lost to follow up|1
1137383|NCT02848313|2238818|FG001|Overall Study|Lost to follow up|0
1137384|NCT02848326|2238830|FG000|Treatment Period|Adverse Event|5
1137385|NCT02848326|2238831|FG001|Treatment Period|Adverse Event|4
1137386|NCT02848326|2238832|FG002|Treatment Period|Adverse Event|11
1137387|NCT02848326|2238833|FG003|Treatment Period|Adverse Event|6
1137388|NCT02848326|2238834|FG004|Treatment Period|Adverse Event|5
1137389|NCT02848326|2238835|FG005|Treatment Period|Adverse Event|7
1137390|NCT02848326|2238830|FG000|Treatment Period|Withdrawal of Consent|20
1137391|NCT02848326|2238831|FG001|Treatment Period|Withdrawal of Consent|6
1137392|NCT02848326|2238832|FG002|Treatment Period|Withdrawal of Consent|9
1137393|NCT02848326|2238833|FG003|Treatment Period|Withdrawal of Consent|6
1137394|NCT02848326|2238834|FG004|Treatment Period|Withdrawal of Consent|9
1137395|NCT02848326|2238835|FG005|Treatment Period|Withdrawal of Consent|6
1137396|NCT02848326|2238830|FG000|Treatment Period|Lost to Follow-up|5
1137397|NCT02848326|2238831|FG001|Treatment Period|Lost to Follow-up|1
1137398|NCT02848326|2238832|FG002|Treatment Period|Lost to Follow-up|11
1137399|NCT02848326|2238833|FG003|Treatment Period|Lost to Follow-up|7
1137400|NCT02848326|2238834|FG004|Treatment Period|Lost to Follow-up|2
1137401|NCT02848326|2238835|FG005|Treatment Period|Lost to Follow-up|3
1137402|NCT02848326|2238830|FG000|Treatment Period|Pregnancy|0
1137403|NCT02848326|2238831|FG001|Treatment Period|Pregnancy|0
1137404|NCT02848326|2238832|FG002|Treatment Period|Pregnancy|1
1137405|NCT02848326|2238833|FG003|Treatment Period|Pregnancy|1
1137406|NCT02848326|2238834|FG004|Treatment Period|Pregnancy|0
1137407|NCT02848326|2238835|FG005|Treatment Period|Pregnancy|1
1137408|NCT02848326|2238830|FG000|Treatment Period|Protocol Violation|4
1137409|NCT02848326|2238831|FG001|Treatment Period|Protocol Violation|3
1137410|NCT02848326|2238832|FG002|Treatment Period|Protocol Violation|4
1137411|NCT02848326|2238833|FG003|Treatment Period|Protocol Violation|2
1137412|NCT02848326|2238834|FG004|Treatment Period|Protocol Violation|3
1137413|NCT02848326|2238835|FG005|Treatment Period|Protocol Violation|3
1137414|NCT02848326|2238830|FG000|Treatment Period|Non-compliance with Study Drug|4
1137415|NCT02848326|2238831|FG001|Treatment Period|Non-compliance with Study Drug|0
1137416|NCT02848326|2238832|FG002|Treatment Period|Non-compliance with Study Drug|0
1137417|NCT02848326|2238833|FG003|Treatment Period|Non-compliance with Study Drug|1
1137418|NCT02848326|2238834|FG004|Treatment Period|Non-compliance with Study Drug|0
1137419|NCT02848326|2238835|FG005|Treatment Period|Non-compliance with Study Drug|0
1137420|NCT02848326|2238830|FG000|Safety Follow-up Period|Withdrawal of Consent|0
1137421|NCT02848326|2238831|FG001|Safety Follow-up Period|Withdrawal of Consent|1
1137422|NCT02848326|2238832|FG002|Safety Follow-up Period|Withdrawal of Consent|1
1137423|NCT02848326|2238833|FG003|Safety Follow-up Period|Withdrawal of Consent|0
1137424|NCT02848326|2238834|FG004|Safety Follow-up Period|Withdrawal of Consent|0
1137425|NCT02848326|2238835|FG005|Safety Follow-up Period|Withdrawal of Consent|2
1137426|NCT02848326|2238830|FG000|Safety Follow-up Period|Lost to Follow-up|4
1137427|NCT02848326|2238831|FG001|Safety Follow-up Period|Lost to Follow-up|0
1137428|NCT02848326|2238832|FG002|Safety Follow-up Period|Lost to Follow-up|2
1137429|NCT02848326|2238833|FG003|Safety Follow-up Period|Lost to Follow-up|0
1137430|NCT02848326|2238834|FG004|Safety Follow-up Period|Lost to Follow-up|1
1137431|NCT02848326|2238835|FG005|Safety Follow-up Period|Lost to Follow-up|3
1137432|NCT02848599|2238851|FG000|Overall Study|Protocol Violation|7
1137433|NCT02848599|2238852|FG001|Overall Study|Protocol Violation|9
1137434|NCT02848651|2238860|FG000|Overall Study|Death|85
1137435|NCT02848651|2238860|FG000|Overall Study|Lost to Follow-up|1
1137436|NCT02848651|2238860|FG000|Overall Study|Non-Compliance|1
1137437|NCT02848651|2238860|FG000|Overall Study|Symptomatic Deterioration|1
1137438|NCT02848651|2238860|FG000|Overall Study|Physician Decision|4
1137439|NCT02848651|2238860|FG000|Overall Study|Withdrawal by Subject|14
1137440|NCT02848664|2238880|FG000|Overall Study|Withdrawal by Subject|2
1137441|NCT02848664|2238880|FG000|Overall Study|Adverse Event|1
1137442|NCT02848664|2238880|FG000|Overall Study|no assistance for device training|1
1137443|NCT02848729|2238890|FG000|Overall Study|Withdrawal by Subject|1
1137444|NCT02848729|2238891|FG001|Overall Study|Withdrawal by Subject|0
1137445|NCT02848729|2238890|FG000|Overall Study|Emesis|15
1137446|NCT02848729|2238891|FG001|Overall Study|Emesis|11
1137447|NCT02848833|2238904|FG000|Overall Study|subject who are duplicated|1
1137448|NCT02848833|2238904|FG000|Overall Study|have not taken the study drug|11
1137449|NCT02848833|2238904|FG000|Overall Study|follow-up failure|6
1137450|NCT02848833|2238904|FG000|Overall Study|Protocol Violation|119
1137451|NCT02849080|2238910|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
1137452|NCT02849080|2238911|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
1137453|NCT02849080|2238912|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
1137454|NCT02849080|2238913|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
1137455|NCT02849080|2238910|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
1137456|NCT02849080|2238911|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
1137457|NCT02849080|2238912|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
1137458|NCT02849080|2238913|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
1137459|NCT02849080|2238910|FG000|Main Phase: 0 - 52 Weeks|Death|0
1137460|NCT02849080|2238911|FG001|Main Phase: 0 - 52 Weeks|Death|2
1137461|NCT02849080|2238912|FG002|Main Phase: 0 - 52 Weeks|Death|0
1137462|NCT02849080|2238913|FG003|Main Phase: 0 - 52 Weeks|Death|0
1137463|NCT02849080|2238910|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
1137464|NCT02849080|2238911|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
1137465|NCT02849080|2238912|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
1137466|NCT02849080|2238913|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
1137467|NCT02849080|2238910|FG000|Extension Phase: 53 - 104 Weeks|Other|0
1137468|NCT02849080|2238911|FG001|Extension Phase: 53 - 104 Weeks|Other|0
1137469|NCT02849080|2238912|FG002|Extension Phase: 53 - 104 Weeks|Other|1
1137470|NCT02849080|2238913|FG003|Extension Phase: 53 - 104 Weeks|Other|0
1137471|NCT02849080|2238910|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
1137472|NCT02849080|2238911|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
1137473|NCT02849080|2238912|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
1137474|NCT02849080|2238913|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
1137475|NCT02849509|2238960|FG000|Overall Study|Worsening of disease under study|1
1137476|NCT02849509|2238961|FG001|Overall Study|Worsening of disease under study|1
1137477|NCT02849509|2238962|FG002|Overall Study|Worsening of disease under study|1
1137478|NCT02849509|2238960|FG000|Overall Study|Worsening of other pre-existing disease|0
1137479|NCT02849509|2238961|FG001|Overall Study|Worsening of other pre-existing disease|1
1137480|NCT02849509|2238962|FG002|Overall Study|Worsening of other pre-existing disease|2
1137481|NCT02849509|2238960|FG000|Overall Study|Other adverse event|36
1137482|NCT02849509|2238961|FG001|Overall Study|Other adverse event|41
1137483|NCT02849509|2238962|FG002|Overall Study|Other adverse event|8
1137484|NCT02849509|2238960|FG000|Overall Study|Withdrawal by Subject|6
1137485|NCT02849509|2238961|FG001|Overall Study|Withdrawal by Subject|17
1137486|NCT02849509|2238962|FG002|Overall Study|Withdrawal by Subject|12
1137487|NCT02849509|2238960|FG000|Overall Study|Lost to Follow-up|27
1137488|NCT02849509|2238961|FG001|Overall Study|Lost to Follow-up|67
1137489|NCT02849509|2238962|FG002|Overall Study|Lost to Follow-up|36
1137490|NCT02849509|2238960|FG000|Overall Study|Other, reason not specified|14
1137491|NCT02849509|2238961|FG001|Overall Study|Other, reason not specified|29
1137492|NCT02849509|2238962|FG002|Overall Study|Other, reason not specified|25
1137493|NCT02849509|2238960|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6
1137494|NCT02849509|2238961|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10
1137495|NCT02849509|2238962|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1
1137512|NCT02849678|2238993|FG000|Overall Study|Protocol Violation|3
1137513|NCT02849678|2238994|FG001|Overall Study|Protocol Violation|6
1137514|NCT02849704|2239002|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
1137515|NCT02849704|2239003|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
1137516|NCT02849704|2239002|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
1137517|NCT02849704|2239003|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
1137518|NCT02849704|2239002|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
1137519|NCT02849704|2239003|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
1137522|NCT02850276|2239039|FG000|Overall Study|screen failure|43
1137523|NCT02850276|2239039|FG000|Overall Study|Withdrawal by Subject|14
1137524|NCT02850276|2239039|FG000|Overall Study|Physician Decision|2
1137525|NCT02850276|2239039|FG000|Overall Study|Lost to Follow-up|2
1137526|NCT02850965|2239055|FG000|Overall Study|Other than listed|3
1137527|NCT02850965|2239056|FG001|Overall Study|Other than listed|4
1137528|NCT02850965|2239055|FG000|Overall Study|Protocol Violation|0
1137529|NCT02850965|2239056|FG001|Overall Study|Protocol Violation|2
1137530|NCT02850965|2239055|FG000|Overall Study|Lost to Follow-up|5
1137531|NCT02850965|2239056|FG001|Overall Study|Lost to Follow-up|3
1137532|NCT02850965|2239055|FG000|Overall Study|Lack of Efficacy|4
1137533|NCT02850965|2239056|FG001|Overall Study|Lack of Efficacy|8
1137534|NCT02850965|2239055|FG000|Overall Study|Adverse Event|3
1137535|NCT02850965|2239056|FG001|Overall Study|Adverse Event|2
1137536|NCT02850965|2239055|FG000|Overall Study|Withdrawal by Subject|3
1137537|NCT02850965|2239056|FG001|Overall Study|Withdrawal by Subject|4
1137538|NCT02850965|2239055|FG000|Overall Study|Physician Decision|0
1137539|NCT02850965|2239056|FG001|Overall Study|Physician Decision|1
1137540|NCT02850965|2239055|FG000|Overall Study|Randomized but not treated|0
1137541|NCT02850965|2239056|FG001|Overall Study|Randomized but not treated|1
1137542|NCT02850978|2239062|FG000|Overall Study|Uncollectable CRF|27
1137543|NCT02850978|2239062|FG000|Overall Study|No visit since the first visit|35
1137544|NCT02850978|2239062|FG000|Overall Study|Adverse Event|81
1137545|NCT02850978|2239062|FG000|Overall Study|Lack of Efficacy|40
1137546|NCT02850978|2239062|FG000|Overall Study|Improvement in condition|34
1137547|NCT02850978|2239062|FG000|Overall Study|Lost to Follow-up|121
1137548|NCT02850978|2239062|FG000|Overall Study|Reason not listed|88
1137549|NCT02851069|2239066|FG000|Overall Study|Failure to Return|3
1137550|NCT02851069|2239066|FG000|Overall Study|Other|3
1137551|NCT02851615|2239082|FG000|Overall Study|Cognitive Issue|1
1137552|NCT02851615|2239083|FG001|Overall Study|Cognitive Issue|0
1137553|NCT02851615|2239082|FG000|Overall Study|Lost to Follow-up|0
1137554|NCT02851615|2239083|FG001|Overall Study|Lost to Follow-up|4
1137555|NCT02852005|2239101|FG000|Overall Study|Lost to Follow-up|0
1137556|NCT02852005|2239102|FG001|Overall Study|Lost to Follow-up|0
1137557|NCT02852005|2239103|FG002|Overall Study|Lost to Follow-up|0
1137558|NCT02852005|2239104|FG003|Overall Study|Lost to Follow-up|0
1137559|NCT02852005|2239105|FG004|Overall Study|Lost to Follow-up|1
1137560|NCT02852005|2239101|FG000|Overall Study|Withdrawal by Subject|1
1137561|NCT02852005|2239102|FG001|Overall Study|Withdrawal by Subject|0
1137562|NCT02852005|2239103|FG002|Overall Study|Withdrawal by Subject|0
1137563|NCT02852005|2239104|FG003|Overall Study|Withdrawal by Subject|0
1137564|NCT02852005|2239105|FG004|Overall Study|Withdrawal by Subject|0
1137565|NCT02852265|2239121|FG000|3-month Follow-up|Lost to Follow-up|1
1137566|NCT02852265|2239122|FG001|3-month Follow-up|Lost to Follow-up|1
1137567|NCT02852434|2239138|FG000|Overall Study|Withdrawal by Subject|0
1137568|NCT02852434|2239139|FG001|Overall Study|Withdrawal by Subject|1
1137569|NCT02852434|2239138|FG000|Overall Study|Unsuccessful Dilator Procedure|2
1137570|NCT02852434|2239139|FG001|Overall Study|Unsuccessful Dilator Procedure|0
1137571|NCT02852967|2239150|FG000|Overall Study|Adverse Event|3
1137572|NCT02852967|2239151|FG001|Overall Study|Adverse Event|1
1137573|NCT02852967|2239152|FG002|Overall Study|Adverse Event|0
1137574|NCT02852967|2239153|FG003|Overall Study|Adverse Event|1
1137575|NCT02852967|2239154|FG004|Overall Study|Adverse Event|0
1137576|NCT02852967|2239150|FG000|Overall Study|Death|1
1137577|NCT02852967|2239151|FG001|Overall Study|Death|0
1137578|NCT02852967|2239152|FG002|Overall Study|Death|0
1137579|NCT02852967|2239153|FG003|Overall Study|Death|0
1137580|NCT02852967|2239154|FG004|Overall Study|Death|0
1137581|NCT02852967|2239150|FG000|Overall Study|Lost to Follow-up|1
1137582|NCT02852967|2239151|FG001|Overall Study|Lost to Follow-up|2
1137583|NCT02852967|2239152|FG002|Overall Study|Lost to Follow-up|3
1137584|NCT02852967|2239153|FG003|Overall Study|Lost to Follow-up|4
1137585|NCT02852967|2239154|FG004|Overall Study|Lost to Follow-up|4
1137586|NCT02852967|2239150|FG000|Overall Study|Withdrawal by Subject|6
1137587|NCT02852967|2239151|FG001|Overall Study|Withdrawal by Subject|12
1137588|NCT02852967|2239152|FG002|Overall Study|Withdrawal by Subject|7
1137589|NCT02852967|2239153|FG003|Overall Study|Withdrawal by Subject|10
1137590|NCT02852967|2239154|FG004|Overall Study|Withdrawal by Subject|10
1137591|NCT02852967|2239150|FG000|Overall Study|SAE|0
1137592|NCT02852967|2239151|FG001|Overall Study|SAE|0
1137593|NCT02852967|2239152|FG002|Overall Study|SAE|0
1137594|NCT02852967|2239153|FG003|Overall Study|SAE|3
1137595|NCT02852967|2239154|FG004|Overall Study|SAE|0
1137596|NCT02852967|2239150|FG000|Overall Study|Elevated Liver Enzymes|2
1137597|NCT02852967|2239151|FG001|Overall Study|Elevated Liver Enzymes|0
1137598|NCT02852967|2239152|FG002|Overall Study|Elevated Liver Enzymes|0
1137599|NCT02852967|2239153|FG003|Overall Study|Elevated Liver Enzymes|2
1137600|NCT02852967|2239154|FG004|Overall Study|Elevated Liver Enzymes|2
1137601|NCT02852967|2239150|FG000|Overall Study|Physician Decision|0
1137602|NCT02852967|2239151|FG001|Overall Study|Physician Decision|0
1137603|NCT02852967|2239152|FG002|Overall Study|Physician Decision|0
1137604|NCT02852967|2239153|FG003|Overall Study|Physician Decision|1
1137605|NCT02852967|2239154|FG004|Overall Study|Physician Decision|0
1137606|NCT02852967|2239150|FG000|Overall Study|Lack of Efficacy|0
1137607|NCT02852967|2239151|FG001|Overall Study|Lack of Efficacy|1
1137608|NCT02852967|2239152|FG002|Overall Study|Lack of Efficacy|0
1137609|NCT02852967|2239153|FG003|Overall Study|Lack of Efficacy|0
1137610|NCT02852967|2239154|FG004|Overall Study|Lack of Efficacy|0
1137611|NCT02852967|2239150|FG000|Overall Study|Non-compliance|0
1137612|NCT02852967|2239151|FG001|Overall Study|Non-compliance|0
1137613|NCT02852967|2239152|FG002|Overall Study|Non-compliance|1
1137614|NCT02852967|2239153|FG003|Overall Study|Non-compliance|1
1137615|NCT02852967|2239154|FG004|Overall Study|Non-compliance|0
1137616|NCT02852967|2239150|FG000|Overall Study|Dispensing Drug Violation|0
1137617|NCT02852967|2239151|FG001|Overall Study|Dispensing Drug Violation|0
1137618|NCT02852967|2239152|FG002|Overall Study|Dispensing Drug Violation|1
1137619|NCT02852967|2239153|FG003|Overall Study|Dispensing Drug Violation|0
1137620|NCT02852967|2239154|FG004|Overall Study|Dispensing Drug Violation|0
1137621|NCT02852967|2239150|FG000|Overall Study|Inclusion/Exclusion Violation|1
1137622|NCT02852967|2239151|FG001|Overall Study|Inclusion/Exclusion Violation|0
1137623|NCT02852967|2239152|FG002|Overall Study|Inclusion/Exclusion Violation|0
1137624|NCT02852967|2239153|FG003|Overall Study|Inclusion/Exclusion Violation|0
1137625|NCT02852967|2239154|FG004|Overall Study|Inclusion/Exclusion Violation|0
1137626|NCT02853032|2239176|FG000|Overall Study|Adverse Event|4
1137627|NCT02853032|2239177|FG001|Overall Study|Adverse Event|0
1137628|NCT02853032|2239176|FG000|Overall Study|Withdrawal by Subject|3
1137629|NCT02853032|2239177|FG001|Overall Study|Withdrawal by Subject|1
1137630|NCT02853032|2239176|FG000|Overall Study|Requested to withdraw from all treatment|2
1137631|NCT02853032|2239177|FG001|Overall Study|Requested to withdraw from all treatment|2
1137632|NCT02853123|2239185|FG000|Treatment Period 1|Adverse Event|0
1137633|NCT02853123|2239186|FG001|Treatment Period 1|Adverse Event|3
1137634|NCT02853123|2239185|FG000|Washout Period|Worsening of COPD|0
1137635|NCT02853123|2239186|FG001|Washout Period|Worsening of COPD|3
1137636|NCT02853123|2239185|FG000|Washout Period|Adverse Event|1
1137637|NCT02853123|2239186|FG001|Washout Period|Adverse Event|0
1137638|NCT02853305|2239196|FG000|Overall Study|Death|244
1137639|NCT02853305|2239197|FG001|Overall Study|Death|207
1137640|NCT02853305|2239198|FG002|Overall Study|Death|263
1137641|NCT02853305|2239196|FG000|Overall Study|Withdrawal by Subject|2
1137642|NCT02853305|2239197|FG001|Overall Study|Withdrawal by Subject|4
1137643|NCT02853305|2239198|FG002|Overall Study|Withdrawal by Subject|2
1137644|NCT02853305|2239196|FG000|Overall Study|Ongoing in Trial|105
1137645|NCT02853305|2239197|FG001|Overall Study|Ongoing in Trial|96
1137646|NCT02853305|2239198|FG002|Overall Study|Ongoing in Trial|87
1137647|NCT02853318|2239206|FG000|Overall Study|Withdrawal by Subject|1
1137648|NCT02853331|2239212|FG000|Overall Study|Death|59
1137649|NCT02853331|2239213|FG001|Overall Study|Death|95
1137650|NCT02853331|2239212|FG000|Overall Study|Withdrawal by Subject|5
1137651|NCT02853331|2239213|FG001|Overall Study|Withdrawal by Subject|9
1137652|NCT02853331|2239212|FG000|Overall Study|Ongoing in study|368
1137653|NCT02853331|2239213|FG001|Overall Study|Ongoing in study|325
1137654|NCT02853435|2239222|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1137655|NCT02853435|2239223|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1137656|NCT02853435|2239224|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1137657|NCT02853435|2239225|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1137658|NCT02853435|2239226|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
1137659|NCT02853435|2239227|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1137660|NCT02853760|2239257|FG000|Washout (1 Week)|acute illness (not connected with the study)|0
1137661|NCT02853760|2239258|FG001|Washout (1 Week)|acute illness (not connected with the study)|0
1137662|NCT02853760|2239259|FG002|Washout (1 Week)|acute illness (not connected with the study)|1
1137663|NCT02853760|2239260|FG003|Washout (1 Week)|acute illness (not connected with the study)|2
1137664|NCT02853760|2239261|FG004|Washout (1 Week)|acute illness (not connected with the study)|0
1137665|NCT02853760|2239262|FG005|Washout (1 Week)|acute illness (not connected with the study)|2
1137666|NCT02853929|2239272|FG000|Overall Study|Lost to Follow-up|3
1137667|NCT02853929|2239273|FG001|Overall Study|Lost to Follow-up|0
1137668|NCT02853929|2239272|FG000|Overall Study|Withdrawal by Subject|1
1137669|NCT02853929|2239273|FG001|Overall Study|Withdrawal by Subject|0
1137670|NCT02853929|2239272|FG000|Overall Study|Subjects enrolled but not vaccinated|7
1137671|NCT02853929|2239273|FG001|Overall Study|Subjects enrolled but not vaccinated|4
1137672|NCT02854527|2239298|FG000|Overall Study|Adverse Event|0
1137673|NCT02854527|2239299|FG001|Overall Study|Adverse Event|0
1137674|NCT02854527|2239300|FG002|Overall Study|Adverse Event|0
1137675|NCT02854527|2239301|FG003|Overall Study|Adverse Event|0
1137676|NCT02854527|2239302|FG004|Overall Study|Adverse Event|1
1137677|NCT02854527|2239303|FG005|Overall Study|Adverse Event|0
1137678|NCT02854527|2239304|FG006|Overall Study|Adverse Event|0
1137679|NCT02854527|2239305|FG007|Overall Study|Adverse Event|0
1137680|NCT02854527|2239306|FG008|Overall Study|Adverse Event|0
1137681|NCT02854527|2239307|FG009|Overall Study|Adverse Event|0
1137682|NCT02854527|2239298|FG000|Overall Study|Lost to Follow-up|0
1137683|NCT02854527|2239299|FG001|Overall Study|Lost to Follow-up|0
1137684|NCT02854527|2239300|FG002|Overall Study|Lost to Follow-up|0
1137685|NCT02854527|2239301|FG003|Overall Study|Lost to Follow-up|1
1137686|NCT02854527|2239302|FG004|Overall Study|Lost to Follow-up|0
1137687|NCT02854527|2239303|FG005|Overall Study|Lost to Follow-up|0
1137688|NCT02854527|2239304|FG006|Overall Study|Lost to Follow-up|0
1137689|NCT02854527|2239305|FG007|Overall Study|Lost to Follow-up|0
1137690|NCT02854527|2239306|FG008|Overall Study|Lost to Follow-up|0
1137691|NCT02854527|2239307|FG009|Overall Study|Lost to Follow-up|0
1137692|NCT02854605|2239328|FG000|Overall Study|Adverse Event|1
1137693|NCT02854605|2239329|FG001|Overall Study|Adverse Event|5
1137694|NCT02854605|2239330|FG002|Overall Study|Adverse Event|2
1137695|NCT02854605|2239328|FG000|Overall Study|Lost to Follow-up|0
1137696|NCT02854605|2239329|FG001|Overall Study|Lost to Follow-up|2
1137697|NCT02854605|2239330|FG002|Overall Study|Lost to Follow-up|0
1137698|NCT02854605|2239328|FG000|Overall Study|Withdrew Consent|1
1137699|NCT02854605|2239329|FG001|Overall Study|Withdrew Consent|0
1137700|NCT02854605|2239330|FG002|Overall Study|Withdrew Consent|1
1137701|NCT02854605|2239328|FG000|Overall Study|Investigator's Discretion|1
1137702|NCT02854605|2239329|FG001|Overall Study|Investigator's Discretion|0
1137703|NCT02854605|2239330|FG002|Overall Study|Investigator's Discretion|0
1137704|NCT02854605|2239328|FG000|Overall Study|Protocol Violation|0
1137705|NCT02854605|2239329|FG001|Overall Study|Protocol Violation|0
1137706|NCT02854605|2239330|FG002|Overall Study|Protocol Violation|1
1137707|NCT02854631|2239340|FG000|Overall Study|Adverse Event|1
1137708|NCT02854631|2239341|FG001|Overall Study|Adverse Event|2
1137709|NCT02854631|2239340|FG000|Overall Study|Withdrew Consent|3
1137710|NCT02854631|2239341|FG001|Overall Study|Withdrew Consent|2
1137711|NCT02854631|2239340|FG000|Overall Study|Investigator's Discretion|2
1137712|NCT02854631|2239341|FG001|Overall Study|Investigator's Discretion|0
1137713|NCT02854631|2239340|FG000|Overall Study|Death|12
1137714|NCT02854631|2239341|FG001|Overall Study|Death|8
1137715|NCT02854631|2239340|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
1137716|NCT02854631|2239341|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
1137717|NCT02854631|2239340|FG000|Overall Study|Protocol Violation|0
1137718|NCT02854631|2239341|FG001|Overall Study|Protocol Violation|1
1137719|NCT02854631|2239340|FG000|Overall Study|Subjects Randomized but Never Treated|2
1137720|NCT02854631|2239341|FG001|Overall Study|Subjects Randomized but Never Treated|0
1137721|NCT02854631|2239340|FG000|Overall Study|Lost to Follow-up|4
1137722|NCT02854631|2239341|FG001|Overall Study|Lost to Follow-up|2
1137723|NCT02854800|2239350|FG000|Overall Study|Protocol Violation|16
1137724|NCT02854800|2239351|FG001|Overall Study|Protocol Violation|11
1137725|NCT02854800|2239352|FG002|Overall Study|Protocol Violation|3
1137726|NCT02854800|2239350|FG000|Overall Study|Withdrawal by Subject|4
1137727|NCT02854800|2239351|FG001|Overall Study|Withdrawal by Subject|2
1137728|NCT02854800|2239352|FG002|Overall Study|Withdrawal by Subject|3
1137729|NCT02855164|2239389|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0
1137730|NCT02855164|2239390|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0
1137731|NCT02855164|2239391|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1
1137732|NCT02855164|2239392|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2
1137733|NCT02855164|2239393|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1
1137734|NCT02855164|2239394|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0
1137735|NCT02855164|2239395|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0
1137736|NCT02855164|2239396|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0
1137737|NCT02855164|2239389|FG000|Parts A + B (Randomized Set)|Physician Decision|0
1137738|NCT02855164|2239390|FG001|Parts A + B (Randomized Set)|Physician Decision|0
1137739|NCT02855164|2239391|FG002|Parts A + B (Randomized Set)|Physician Decision|0
1137740|NCT02855164|2239392|FG003|Parts A + B (Randomized Set)|Physician Decision|2
1137741|NCT02855164|2239393|FG004|Parts A + B (Randomized Set)|Physician Decision|0
1137742|NCT02855164|2239394|FG005|Parts A + B (Randomized Set)|Physician Decision|0
1137743|NCT02855164|2239395|FG006|Parts A + B (Randomized Set)|Physician Decision|0
1137744|NCT02855164|2239396|FG007|Parts A + B (Randomized Set)|Physician Decision|0
1137745|NCT02855164|2239389|FG000|Parts A + B (Randomized Set)|Adverse Event|0
1137746|NCT02855164|2239390|FG001|Parts A + B (Randomized Set)|Adverse Event|0
1137747|NCT02855164|2239391|FG002|Parts A + B (Randomized Set)|Adverse Event|0
1137748|NCT02855164|2239392|FG003|Parts A + B (Randomized Set)|Adverse Event|4
1137749|NCT02855164|2239393|FG004|Parts A + B (Randomized Set)|Adverse Event|0
1137750|NCT02855164|2239394|FG005|Parts A + B (Randomized Set)|Adverse Event|0
1137751|NCT02855164|2239395|FG006|Parts A + B (Randomized Set)|Adverse Event|0
1137752|NCT02855164|2239396|FG007|Parts A + B (Randomized Set)|Adverse Event|0
1137753|NCT02855164|2239389|FG000|Part C (Randomized Set)|Adverse Event|0
1137754|NCT02855164|2239390|FG001|Part C (Randomized Set)|Adverse Event|0
1137755|NCT02855164|2239391|FG002|Part C (Randomized Set)|Adverse Event|0
1137756|NCT02855164|2239392|FG003|Part C (Randomized Set)|Adverse Event|0
1137757|NCT02855164|2239393|FG004|Part C (Randomized Set)|Adverse Event|0
1137758|NCT02855164|2239394|FG005|Part C (Randomized Set)|Adverse Event|5
1137759|NCT02855164|2239395|FG006|Part C (Randomized Set)|Adverse Event|9
1137760|NCT02855164|2239396|FG007|Part C (Randomized Set)|Adverse Event|2
1137761|NCT02855164|2239389|FG000|Part C (Randomized Set)|Lost to Follow-up|0
1137762|NCT02855164|2239390|FG001|Part C (Randomized Set)|Lost to Follow-up|0
1137763|NCT02855164|2239391|FG002|Part C (Randomized Set)|Lost to Follow-up|0
1137764|NCT02855164|2239392|FG003|Part C (Randomized Set)|Lost to Follow-up|0
1137765|NCT02855164|2239393|FG004|Part C (Randomized Set)|Lost to Follow-up|0
1137766|NCT02855164|2239394|FG005|Part C (Randomized Set)|Lost to Follow-up|1
1137767|NCT02855164|2239395|FG006|Part C (Randomized Set)|Lost to Follow-up|1
1137768|NCT02855164|2239396|FG007|Part C (Randomized Set)|Lost to Follow-up|1
1137769|NCT02855164|2239389|FG000|Part C (Randomized Set)|Physician Decision|0
1137770|NCT02855164|2239390|FG001|Part C (Randomized Set)|Physician Decision|0
1137771|NCT02855164|2239391|FG002|Part C (Randomized Set)|Physician Decision|0
1137772|NCT02855164|2239392|FG003|Part C (Randomized Set)|Physician Decision|0
1137773|NCT02855164|2239393|FG004|Part C (Randomized Set)|Physician Decision|0
1137774|NCT02855164|2239394|FG005|Part C (Randomized Set)|Physician Decision|1
1137775|NCT02855164|2239395|FG006|Part C (Randomized Set)|Physician Decision|0
1137776|NCT02855164|2239396|FG007|Part C (Randomized Set)|Physician Decision|1
1137777|NCT02855164|2239389|FG000|Part C (Randomized Set)|Withdrawal by Subject|0
1137778|NCT02855164|2239390|FG001|Part C (Randomized Set)|Withdrawal by Subject|0
1137779|NCT02855164|2239391|FG002|Part C (Randomized Set)|Withdrawal by Subject|0
1137780|NCT02855164|2239392|FG003|Part C (Randomized Set)|Withdrawal by Subject|0
1137781|NCT02855164|2239393|FG004|Part C (Randomized Set)|Withdrawal by Subject|0
1137782|NCT02855164|2239394|FG005|Part C (Randomized Set)|Withdrawal by Subject|5
1137783|NCT02855164|2239395|FG006|Part C (Randomized Set)|Withdrawal by Subject|4
1137784|NCT02855164|2239396|FG007|Part C (Randomized Set)|Withdrawal by Subject|3
1137785|NCT02855359|2239444|FG000|Overall Study|Death|2
1137786|NCT02855359|2239445|FG001|Overall Study|Death|2
1137787|NCT02855359|2239446|FG002|Overall Study|Death|0
1137788|NCT02855359|2239447|FG003|Overall Study|Death|0
1137789|NCT02855359|2239444|FG000|Overall Study|Study Termination by Sponsor|9
1137790|NCT02855359|2239445|FG001|Overall Study|Study Termination by Sponsor|11
1137791|NCT02855359|2239446|FG002|Overall Study|Study Termination by Sponsor|0
1137792|NCT02855359|2239447|FG003|Overall Study|Study Termination by Sponsor|0
900376|NCT00727441|1873536|FG001|Overall Study|Disease Progression|14
900377|NCT00727441|1873537|FG002|Overall Study|Disease Progression|17
900378|NCT00727441|1873535|FG000|Overall Study|Eligibility|7
900379|NCT00727441|1873536|FG001|Overall Study|Eligibility|5
900380|NCT00727441|1873537|FG002|Overall Study|Eligibility|7
900381|NCT00727441|1873535|FG000|Overall Study|Death|0
900382|NCT00727441|1873536|FG001|Overall Study|Death|1
900383|NCT00727441|1873537|FG002|Overall Study|Death|1
900384|NCT00727441|1873535|FG000|Overall Study|Physician Decision|0
900385|NCT00727441|1873536|FG001|Overall Study|Physician Decision|1
900386|NCT00727441|1873537|FG002|Overall Study|Physician Decision|0
900387|NCT00727441|1873535|FG000|Overall Study|Withdrawal by Subject|0
900388|NCT00727441|1873536|FG001|Overall Study|Withdrawal by Subject|1
900389|NCT00727441|1873537|FG002|Overall Study|Withdrawal by Subject|0
900390|NCT00727506|1873554|FG000|Overall Study|Adverse Event|0
900391|NCT00727506|1873555|FG001|Overall Study|Adverse Event|0
900392|NCT00727506|1873556|FG002|Overall Study|Adverse Event|4
900393|NCT00727506|1873557|FG003|Overall Study|Adverse Event|4
900394|NCT00727506|1873558|FG004|Overall Study|Adverse Event|1
900395|NCT00727506|1873559|FG005|Overall Study|Adverse Event|8
900396|NCT00727506|1873554|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
900397|NCT00727506|1873555|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
900398|NCT00727506|1873556|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
900399|NCT00727506|1873557|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
900400|NCT00727506|1873558|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
900401|NCT00727506|1873559|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0
900402|NCT00727506|1873554|FG000|Overall Study|Progressive disease|4
900403|NCT00727506|1873555|FG001|Overall Study|Progressive disease|7
900404|NCT00727506|1873556|FG002|Overall Study|Progressive disease|9
900405|NCT00727506|1873557|FG003|Overall Study|Progressive disease|28
900406|NCT00727506|1873558|FG004|Overall Study|Progressive disease|38
900407|NCT00727506|1873559|FG005|Overall Study|Progressive disease|28
900408|NCT00727506|1873554|FG000|Overall Study|Refused to continue medication|0
900409|NCT00727506|1873555|FG001|Overall Study|Refused to continue medication|1
900410|NCT00727506|1873556|FG002|Overall Study|Refused to continue medication|2
900411|NCT00727506|1873557|FG003|Overall Study|Refused to continue medication|3
900412|NCT00727506|1873558|FG004|Overall Study|Refused to continue medication|1
900413|NCT00727506|1873559|FG005|Overall Study|Refused to continue medication|2
900414|NCT00727506|1873554|FG000|Overall Study|Other reason not described above|0
900415|NCT00727506|1873555|FG001|Overall Study|Other reason not described above|0
900416|NCT00727506|1873556|FG002|Overall Study|Other reason not described above|1
900417|NCT00727506|1873557|FG003|Overall Study|Other reason not described above|4
900418|NCT00727506|1873558|FG004|Overall Study|Other reason not described above|1
900419|NCT00727506|1873559|FG005|Overall Study|Other reason not described above|1
900420|NCT00727532|1873579|FG000|Overall Study|Adverse Event|1
900421|NCT00727532|1873579|FG000|Overall Study|Withdrawal by Subject|1
900422|NCT00727558|1873585|FG000|Overall Study|Lens issue|0
900423|NCT00727558|1873586|FG001|Overall Study|Lens issue|1
900424|NCT00727558|1873585|FG000|Overall Study|Adverse Event|0
900425|NCT00727558|1873586|FG001|Overall Study|Adverse Event|1
900426|NCT00727558|1873585|FG000|Overall Study|Subject unable to return for follow-up|1
900427|NCT00727558|1873586|FG001|Overall Study|Subject unable to return for follow-up|1
900428|NCT00727558|1873585|FG000|Overall Study|Lost to Follow-up|1
900429|NCT00727558|1873586|FG001|Overall Study|Lost to Follow-up|0
900430|NCT00727571|1873596|FG000|Overall Study|Ineligibility determined|1
900431|NCT00727571|1873597|FG001|Overall Study|Ineligibility determined|1
900432|NCT00727571|1873598|FG002|Overall Study|Ineligibility determined|1
900433|NCT00727571|1873599|FG003|Overall Study|Ineligibility determined|0
900434|NCT00727571|1873596|FG000|Overall Study|Death|0
900435|NCT00727571|1873597|FG001|Overall Study|Death|19
900436|NCT00727571|1873598|FG002|Overall Study|Death|5
900437|NCT00727571|1873599|FG003|Overall Study|Death|1
900438|NCT00727571|1873596|FG000|Overall Study|Physician Decision|0
900439|NCT00727571|1873597|FG001|Overall Study|Physician Decision|5
900440|NCT00727571|1873598|FG002|Overall Study|Physician Decision|0
900441|NCT00727571|1873599|FG003|Overall Study|Physician Decision|0
900442|NCT00727571|1873596|FG000|Overall Study|Withdrawal by Subject|0
900443|NCT00727571|1873597|FG001|Overall Study|Withdrawal by Subject|10
900444|NCT00727571|1873598|FG002|Overall Study|Withdrawal by Subject|11
900445|NCT00727571|1873599|FG003|Overall Study|Withdrawal by Subject|0
1137793|NCT02855450|2239465|FG000|Overall Study|Adverse Event|1
1137794|NCT02855450|2239466|FG001|Overall Study|Adverse Event|0
1137795|NCT02855450|2239465|FG000|Overall Study|Lost to Follow-up|4
1137796|NCT02855450|2239466|FG001|Overall Study|Lost to Follow-up|0
1137797|NCT02855541|2239472|FG000|Overall Study|Change in health status|2
1137798|NCT02855541|2239472|FG000|Overall Study|Withdrawal by Subject|2
1137799|NCT02856282|2239489|FG000|Overall Study|Withdrawal by Subject|1
1137800|NCT02856555|2239509|FG000|Overall Study|Adverse Event|1
1137801|NCT02856555|2239510|FG001|Overall Study|Adverse Event|0
1137802|NCT02856555|2239511|FG002|Overall Study|Adverse Event|0
1137803|NCT02856555|2239509|FG000|Overall Study|Lost to Follow-up|1
1137804|NCT02856555|2239510|FG001|Overall Study|Lost to Follow-up|3
1137805|NCT02856555|2239511|FG002|Overall Study|Lost to Follow-up|0
1137806|NCT02856555|2239509|FG000|Overall Study|Withdrawal by Subject|3
1137807|NCT02856555|2239510|FG001|Overall Study|Withdrawal by Subject|0
1137808|NCT02856555|2239511|FG002|Overall Study|Withdrawal by Subject|0
1137809|NCT02856555|2239509|FG000|Overall Study|Randomized but Never Treated|0
1137810|NCT02856555|2239510|FG001|Overall Study|Randomized but Never Treated|1
1137811|NCT02856555|2239511|FG002|Overall Study|Randomized but Never Treated|0
1137812|NCT02856802|2239521|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
1137813|NCT02856802|2239522|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2
1137814|NCT02856802|2239521|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1
1137815|NCT02856802|2239522|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0
1137816|NCT02856802|2239521|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
1137817|NCT02856802|2239522|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
1137818|NCT02856802|2239521|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1
1137819|NCT02856802|2239522|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0
1137820|NCT02856802|2239521|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0
1137821|NCT02856802|2239522|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2
1137822|NCT02856802|2239521|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1
1137823|NCT02856802|2239522|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0
1137824|NCT02856880|2239549|FG000|Overall Study|Withdrawal of consent|1
1137825|NCT02857283|2239570|FG000|First Exposure|Withdrawal by Subject|1
1137826|NCT02857283|2239571|FG001|First Exposure|Withdrawal by Subject|0
1137845|NCT02857816|2239587|FG000|Overall Study|Screen Failure|33
1137846|NCT02857816|2239587|FG000|Overall Study|Withdrawal by Subject|4
1137847|NCT02857816|2239587|FG000|Overall Study|Lost to Follow-up|1
1137848|NCT02858076|2239603|FG000|Overall Study|Death|6
1137849|NCT02858076|2239604|FG001|Overall Study|Death|3
1137850|NCT02858076|2239603|FG000|Overall Study|Withdrawal by Subject|1
1137851|NCT02858076|2239604|FG001|Overall Study|Withdrawal by Subject|5
1137852|NCT02858076|2239603|FG000|Overall Study|Lost to Follow-up|2
1137853|NCT02858076|2239604|FG001|Overall Study|Lost to Follow-up|7
1137854|NCT02858076|2239603|FG000|Overall Study|Completed Out of Window|1
1137855|NCT02858076|2239604|FG001|Overall Study|Completed Out of Window|3
1137856|NCT02858180|2239619|FG000|Overall Study|Lost to Follow-up|0
1137857|NCT02858180|2239620|FG001|Overall Study|Lost to Follow-up|2
1137858|NCT02858401|2239655|FG000|Overall Study|Withdrew Consent|0
1137859|NCT02858401|2239656|FG001|Overall Study|Withdrew Consent|0
1137860|NCT02858401|2239657|FG002|Overall Study|Withdrew Consent|0
1137861|NCT02858401|2239658|FG003|Overall Study|Withdrew Consent|0
1137862|NCT02858401|2239659|FG004|Overall Study|Withdrew Consent|0
1137863|NCT02858401|2239660|FG005|Overall Study|Withdrew Consent|1
1137864|NCT02858401|2239661|FG006|Overall Study|Withdrew Consent|0
1137865|NCT02858401|2239655|FG000|Overall Study|Lost to Follow-up|0
1137866|NCT02858401|2239656|FG001|Overall Study|Lost to Follow-up|1
1137867|NCT02858401|2239657|FG002|Overall Study|Lost to Follow-up|0
1137868|NCT02858401|2239658|FG003|Overall Study|Lost to Follow-up|0
1137869|NCT02858401|2239659|FG004|Overall Study|Lost to Follow-up|0
1137870|NCT02858401|2239660|FG005|Overall Study|Lost to Follow-up|0
1137871|NCT02858401|2239661|FG006|Overall Study|Lost to Follow-up|0
1137872|NCT02858440|2239686|FG000|Overall Study|Lost to Follow-up|3
1137873|NCT02858440|2239686|FG000|Overall Study|Protocol Violation|2
1137874|NCT02858440|2239686|FG000|Overall Study|Consent withdrawal|3
1137875|NCT02858440|2239686|FG000|Overall Study|Migrated/moved from study area|4
1137876|NCT02858492|2239694|FG000|Overall Study|Withdrawal by Subject|0
1137877|NCT02858492|2239695|FG001|Overall Study|Withdrawal by Subject|1
1137878|NCT02858492|2239696|FG002|Overall Study|Withdrawal by Subject|0
1137879|NCT02858492|2239697|FG003|Overall Study|Withdrawal by Subject|1
1137880|NCT02858492|2239694|FG000|Overall Study|Adverse Event|0
1137881|NCT02858492|2239695|FG001|Overall Study|Adverse Event|0
1137882|NCT02858492|2239696|FG002|Overall Study|Adverse Event|0
1137883|NCT02858492|2239697|FG003|Overall Study|Adverse Event|3
1137884|NCT02858492|2239694|FG000|Overall Study|Lack of Efficacy|0
1137885|NCT02858492|2239695|FG001|Overall Study|Lack of Efficacy|0
1137886|NCT02858492|2239696|FG002|Overall Study|Lack of Efficacy|0
1137887|NCT02858492|2239697|FG003|Overall Study|Lack of Efficacy|1
1137888|NCT02858492|2239694|FG000|Overall Study|Protocol defined stopping criteria|0
1137889|NCT02858492|2239695|FG001|Overall Study|Protocol defined stopping criteria|0
1137890|NCT02858492|2239696|FG002|Overall Study|Protocol defined stopping criteria|0
1137891|NCT02858492|2239697|FG003|Overall Study|Protocol defined stopping criteria|1
1137892|NCT02858726|2239726|FG000|Overall Study|Adverse Event|4
1137893|NCT02858726|2239727|FG001|Overall Study|Adverse Event|4
1137894|NCT02858726|2239728|FG002|Overall Study|Adverse Event|9
1137895|NCT02858726|2239729|FG003|Overall Study|Adverse Event|1
1137896|NCT02858726|2239726|FG000|Overall Study|Physician Decision|0
1137897|NCT02858726|2239727|FG001|Overall Study|Physician Decision|0
1137898|NCT02858726|2239728|FG002|Overall Study|Physician Decision|1
1137899|NCT02858726|2239729|FG003|Overall Study|Physician Decision|0
1137900|NCT02858726|2239726|FG000|Overall Study|Protocol Violation|0
1137901|NCT02858726|2239727|FG001|Overall Study|Protocol Violation|0
1137902|NCT02858726|2239728|FG002|Overall Study|Protocol Violation|0
1137903|NCT02858726|2239729|FG003|Overall Study|Protocol Violation|1
1137904|NCT02858726|2239726|FG000|Overall Study|Study Terminated by Sponsor|0
1137905|NCT02858726|2239727|FG001|Overall Study|Study Terminated by Sponsor|0
1137906|NCT02858726|2239728|FG002|Overall Study|Study Terminated by Sponsor|0
1137907|NCT02858726|2239729|FG003|Overall Study|Study Terminated by Sponsor|1
1137908|NCT02858726|2239726|FG000|Overall Study|Withdrawal by Subject|1
1137909|NCT02858726|2239727|FG001|Overall Study|Withdrawal by Subject|2
1137910|NCT02858726|2239728|FG002|Overall Study|Withdrawal by Subject|1
900446|NCT00727571|1873596|FG000|Overall Study|Subject Non Compliance|0
900447|NCT00727571|1873597|FG001|Overall Study|Subject Non Compliance|6
900448|NCT00727571|1873598|FG002|Overall Study|Subject Non Compliance|0
900449|NCT00727571|1873599|FG003|Overall Study|Subject Non Compliance|4
900450|NCT00727571|1873596|FG000|Overall Study|Dismissed from nursing home|0
900451|NCT00727571|1873597|FG001|Overall Study|Dismissed from nursing home|9
900452|NCT00727571|1873598|FG002|Overall Study|Dismissed from nursing home|5
900453|NCT00727571|1873599|FG003|Overall Study|Dismissed from nursing home|0
900454|NCT00727571|1873596|FG000|Overall Study|Hospitalization|0
900455|NCT00727571|1873597|FG001|Overall Study|Hospitalization|1
900456|NCT00727571|1873598|FG002|Overall Study|Hospitalization|0
900457|NCT00727571|1873599|FG003|Overall Study|Hospitalization|1
900458|NCT00727571|1873596|FG000|Overall Study|AE not leading to hospitalization|0
900459|NCT00727571|1873597|FG001|Overall Study|AE not leading to hospitalization|0
900460|NCT00727571|1873598|FG002|Overall Study|AE not leading to hospitalization|2
900461|NCT00727571|1873599|FG003|Overall Study|AE not leading to hospitalization|0
900462|NCT00727571|1873596|FG000|Overall Study|Other|0
900463|NCT00727571|1873597|FG001|Overall Study|Other|4
900464|NCT00727571|1873598|FG002|Overall Study|Other|6
900465|NCT00727571|1873599|FG003|Overall Study|Other|0
900466|NCT00727649|1873629|FG000|First Intervention (4-weeks)|Lost to Follow-up|1
900467|NCT00727649|1873630|FG001|First Intervention (4-weeks)|Lost to Follow-up|2
900468|NCT00727649|1873629|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2
900469|NCT00727649|1873630|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1
900470|NCT00727649|1873629|FG000|Wash-out (2-weeks)|Lost to Follow-up|3
900471|NCT00727649|1873630|FG001|Wash-out (2-weeks)|Lost to Follow-up|1
900472|NCT00727649|1873629|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1
900473|NCT00727649|1873630|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2
900474|NCT00727649|1873629|FG000|Second Intervention (4-weeks)|Death|1
900475|NCT00727649|1873630|FG001|Second Intervention (4-weeks)|Death|0
900476|NCT00727649|1873629|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0
900477|NCT00727649|1873630|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1
900478|NCT00727649|1873629|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0
900479|NCT00727649|1873630|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2
900480|NCT00727714|1873638|FG000|Overall Study|Lost to Follow-up|2
900481|NCT00727844|1873653|FG000|Initial Randomization|Physician Decision|2
900482|NCT00727844|1873654|FG001|Initial Randomization|Physician Decision|0
900483|NCT00727844|1873655|FG002|Initial Randomization|Physician Decision|0
900484|NCT00727844|1873656|FG003|Initial Randomization|Physician Decision|0
900485|NCT00727909|1873675|FG000|Overall Study|Withdrawal by Subject|5
900486|NCT00727909|1873676|FG001|Overall Study|Withdrawal by Subject|11
900487|NCT00727909|1873677|FG002|Overall Study|Withdrawal by Subject|8
900488|NCT00727909|1873678|FG003|Overall Study|Withdrawal by Subject|5
900489|NCT00727909|1873675|FG000|Overall Study|Death|0
900490|NCT00727909|1873676|FG001|Overall Study|Death|0
900491|NCT00727909|1873677|FG002|Overall Study|Death|1
900492|NCT00727909|1873678|FG003|Overall Study|Death|0
900493|NCT00727961|1873682|FG000|Overall Study|Lost to Follow-up|1
900494|NCT00727961|1873682|FG000|Overall Study|Adverse Event|4
900495|NCT00727961|1873682|FG000|Overall Study|Patient's refusal|2
900496|NCT00727961|1873682|FG000|Overall Study|Progression|30
1137911|NCT02858726|2239729|FG003|Overall Study|Withdrawal by Subject|0
1137912|NCT02858726|2239726|FG000|Overall Study|Noncompliance|0
1137913|NCT02858726|2239727|FG001|Overall Study|Noncompliance|1
1137914|NCT02858726|2239728|FG002|Overall Study|Noncompliance|0
1137915|NCT02858726|2239729|FG003|Overall Study|Noncompliance|0
1137916|NCT02859142|2239745|FG000|Overall Study|Adverse Event|1
1137917|NCT02859142|2239746|FG001|Overall Study|Adverse Event|2
1137918|NCT02859142|2239745|FG000|Overall Study|Lost to Follow-up|1
1137919|NCT02859142|2239746|FG001|Overall Study|Lost to Follow-up|4
1137920|NCT02859142|2239745|FG000|Overall Study|Withdrawal by Subject|2
1137921|NCT02859142|2239746|FG001|Overall Study|Withdrawal by Subject|0
1137922|NCT02859142|2239745|FG000|Overall Study|Scheduling difficulties|0
1137923|NCT02859142|2239746|FG001|Overall Study|Scheduling difficulties|3
1137924|NCT02859246|2239752|FG000|Overall Study|Screen fails|3
1137925|NCT02859246|2239752|FG000|Overall Study|Adverse Event|1
1137926|NCT02859246|2239752|FG000|Overall Study|Withdrawal by Subject|1
1137927|NCT02859324|2239760|FG000|Overall Study|Death|4
1137928|NCT02859324|2239761|FG001|Overall Study|Death|6
1137929|NCT02859324|2239762|FG002|Overall Study|Death|5
1137930|NCT02859324|2239760|FG000|Overall Study|Other reasons|3
1137931|NCT02859324|2239761|FG001|Overall Study|Other reasons|3
1137932|NCT02859324|2239762|FG002|Overall Study|Other reasons|0
1137933|NCT02859454|2239791|FG000|Overall Study|PI discretion/off study prior to trtmt|1
1137934|NCT02860130|2239811|FG000|Overall Study|Adverse Event|2
1137935|NCT02860130|2239812|FG001|Overall Study|Adverse Event|3
1137936|NCT02860130|2239811|FG000|Overall Study|Protocol Violation|1
1137937|NCT02860130|2239812|FG001|Overall Study|Protocol Violation|1
1137938|NCT02860130|2239811|FG000|Overall Study|Withdrawal by Subject|0
1137939|NCT02860130|2239812|FG001|Overall Study|Withdrawal by Subject|2
1137940|NCT02860130|2239811|FG000|Overall Study|Physician Decision|2
1137941|NCT02860130|2239812|FG001|Overall Study|Physician Decision|2
1137942|NCT02860130|2239811|FG000|Overall Study|Other|2
1137943|NCT02860130|2239812|FG001|Overall Study|Other|1
1137944|NCT02860546|2239845|FG000|Overall Study|Clinical Progression|6
1137945|NCT02860546|2239845|FG000|Overall Study|Radiological Progression|12
1137955|NCT02861534|2239897|FG000|Overall Study|Death|541
1137956|NCT02861534|2239898|FG001|Overall Study|Death|552
1137957|NCT02861534|2239897|FG000|Overall Study|Lost to Follow-up|14
1137958|NCT02861534|2239898|FG001|Overall Study|Lost to Follow-up|14
1137959|NCT02861534|2239897|FG000|Overall Study|Site Terminated by Sponsor|4
1137960|NCT02861534|2239898|FG001|Overall Study|Site Terminated by Sponsor|3
1137961|NCT02861534|2239897|FG000|Overall Study|Withdrawal by Subject|15
1137962|NCT02861534|2239898|FG001|Overall Study|Withdrawal by Subject|18
1137963|NCT02861586|2239912|FG000|Overall Study|Withdrawal by Subject|1
900497|NCT00728130|1873686|FG000|Overall Study|Withdrawal by Subject|1
900498|NCT00728130|1873686|FG000|Overall Study|Paperwork not completed in time|1
900499|NCT00728130|1873686|FG000|Overall Study|Physician Decision|1
900500|NCT00728182|1873692|FG000|Overall Study|Adverse Event|1
900501|NCT00728182|1873693|FG001|Overall Study|Adverse Event|0
900502|NCT00728182|1873692|FG000|Overall Study|Lost to Follow-up|2
900503|NCT00728182|1873693|FG001|Overall Study|Lost to Follow-up|0
900504|NCT00728182|1873692|FG000|Overall Study|Death|0
900505|NCT00728182|1873693|FG001|Overall Study|Death|2
900506|NCT00728182|1873692|FG000|Overall Study|Protocol Noncompliance|0
900507|NCT00728182|1873693|FG001|Overall Study|Protocol Noncompliance|1
900508|NCT00728416|1873707|FG000|Overall Study|Adverse Event|1
900509|NCT00728416|1873708|FG001|Overall Study|Adverse Event|1
900510|NCT00728416|1873707|FG000|Overall Study|Treatment Failure|0
900511|NCT00728416|1873708|FG001|Overall Study|Treatment Failure|1
900512|NCT00728416|1873707|FG000|Overall Study|Withdrawal by Subject|1
900513|NCT00728416|1873708|FG001|Overall Study|Withdrawal by Subject|0
900514|NCT00728468|1873714|FG000|Overall Study|Enrolled but not treated|1
900515|NCT00728468|1873714|FG000|Overall Study|Death|1
900516|NCT00728468|1873714|FG000|Overall Study|Protocol Violation|4
900517|NCT00728468|1873714|FG000|Overall Study|Objective progression or relapse|9
900518|NCT00728468|1873714|FG000|Overall Study|Study terminated by sponsor|1
900519|NCT00728481|1873720|FG000|Overall Study|Withdrawal by Subject|0
900520|NCT00728481|1873721|FG001|Overall Study|Withdrawal by Subject|1
900521|NCT00728481|1873720|FG000|Overall Study|Adverse Event|0
900522|NCT00728481|1873721|FG001|Overall Study|Adverse Event|1
900523|NCT00728481|1873720|FG000|Overall Study|Study medication non-compliance|0
900524|NCT00728481|1873721|FG001|Overall Study|Study medication non-compliance|2
900525|NCT00728481|1873720|FG000|Overall Study|Incorrectly assigned to opposite arm|1
900526|NCT00728481|1873721|FG001|Overall Study|Incorrectly assigned to opposite arm|0
1137964|NCT02861586|2239913|FG001|Overall Study|Withdrawal by Subject|2
1137965|NCT02861586|2239914|FG002|Overall Study|Withdrawal by Subject|0
1137966|NCT02861586|2239915|FG003|Overall Study|Withdrawal by Subject|0
1137967|NCT02861586|2239916|FG004|Overall Study|Withdrawal by Subject|0
1137968|NCT02861586|2239917|FG005|Overall Study|Withdrawal by Subject|1
1137969|NCT02861586|2239918|FG006|Overall Study|Withdrawal by Subject|1
1137970|NCT02861586|2239919|FG007|Overall Study|Withdrawal by Subject|0
1137971|NCT02861586|2239912|FG000|Overall Study|Lost to Follow-up|3
1137972|NCT02861586|2239913|FG001|Overall Study|Lost to Follow-up|1
1137973|NCT02861586|2239914|FG002|Overall Study|Lost to Follow-up|1
1137974|NCT02861586|2239915|FG003|Overall Study|Lost to Follow-up|0
1137975|NCT02861586|2239916|FG004|Overall Study|Lost to Follow-up|0
1137976|NCT02861586|2239917|FG005|Overall Study|Lost to Follow-up|3
1137977|NCT02861586|2239918|FG006|Overall Study|Lost to Follow-up|0
1137978|NCT02861586|2239919|FG007|Overall Study|Lost to Follow-up|0
1137979|NCT02861586|2239912|FG000|Overall Study|Adverse Event|0
1137980|NCT02861586|2239913|FG001|Overall Study|Adverse Event|0
1137981|NCT02861586|2239914|FG002|Overall Study|Adverse Event|0
1137982|NCT02861586|2239915|FG003|Overall Study|Adverse Event|0
1137983|NCT02861586|2239916|FG004|Overall Study|Adverse Event|0
1137984|NCT02861586|2239917|FG005|Overall Study|Adverse Event|1
1137985|NCT02861586|2239918|FG006|Overall Study|Adverse Event|0
1137986|NCT02861586|2239919|FG007|Overall Study|Adverse Event|0
1137987|NCT02861664|2239944|FG000|Overall Study|Withdrawal of Consent|0
1137988|NCT02861664|2239945|FG001|Overall Study|Withdrawal of Consent|1
1137989|NCT02861807|2239953|FG000|Overall Study|Lost to Follow-up|7
1137990|NCT02861807|2239954|FG001|Overall Study|Lost to Follow-up|6
1137991|NCT02861807|2239953|FG000|Overall Study|Withdrawal by Subject|5
1137992|NCT02861807|2239954|FG001|Overall Study|Withdrawal by Subject|8
1137993|NCT02862106|2239995|FG000|Overall Study|Adverse Event|4
1137994|NCT02862106|2239996|FG001|Overall Study|Adverse Event|0
1137995|NCT02862106|2239995|FG000|Overall Study|Protocol Violation|16
1137996|NCT02862106|2239996|FG001|Overall Study|Protocol Violation|1
1137997|NCT02862106|2239995|FG000|Overall Study|Lost to Follow-up|15
1137998|NCT02862106|2239996|FG001|Overall Study|Lost to Follow-up|5
1137999|NCT02862106|2239995|FG000|Overall Study|Withdrawal by Subject|2
1138000|NCT02862106|2239996|FG001|Overall Study|Withdrawal by Subject|0
1138001|NCT02862106|2239995|FG000|Overall Study|Subjects moved to other city|1
1138002|NCT02862106|2239996|FG001|Overall Study|Subjects moved to other city|0
1138003|NCT02862535|2240012|FG000|Overall Study|Death|7
1138004|NCT02862535|2240013|FG001|Overall Study|Death|3
1138005|NCT02862535|2240014|FG002|Overall Study|Death|2
1138006|NCT02862535|2240015|FG003|Overall Study|Death|5
1138007|NCT02862535|2240012|FG000|Overall Study|Study Terminated by Sponsor|1
1138008|NCT02862535|2240013|FG001|Overall Study|Study Terminated by Sponsor|3
1138009|NCT02862535|2240014|FG002|Overall Study|Study Terminated by Sponsor|8
1138010|NCT02862535|2240015|FG003|Overall Study|Study Terminated by Sponsor|5
1138011|NCT02862535|2240012|FG000|Overall Study|Enrolled, not Treated|1
1138012|NCT02862535|2240013|FG001|Overall Study|Enrolled, not Treated|0
1138013|NCT02862535|2240014|FG002|Overall Study|Enrolled, not Treated|0
1138014|NCT02862535|2240015|FG003|Overall Study|Enrolled, not Treated|1
1138015|NCT02862548|2240027|FG000|Open-Label Phase|Death|0
1138016|NCT02862548|2240028|FG001|Open-Label Phase|Death|1
1138017|NCT02862548|2240027|FG000|Open-Label Extension Phase|Still on Study|26
1138018|NCT02862548|2240028|FG001|Open-Label Extension Phase|Still on Study|24
1138019|NCT02862574|2240037|FG000|Double-Blind Treatment Period|Adverse Event|0
1138020|NCT02862574|2240038|FG001|Double-Blind Treatment Period|Adverse Event|1
1138021|NCT02862574|2240039|FG002|Double-Blind Treatment Period|Adverse Event|0
1138022|NCT02862574|2240037|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3
1138023|NCT02862574|2240038|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1
1138024|NCT02862574|2240039|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4
1138025|NCT02862574|2240037|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2
1138026|NCT02862574|2240038|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3
1138027|NCT02862574|2240039|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1
1138028|NCT02862600|2240048|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
1138029|NCT02862600|2240048|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3
1138030|NCT02862600|2240048|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
1138031|NCT02862600|2240048|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
1138032|NCT02862730|2240054|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1138033|NCT02862730|2240055|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1138034|NCT02862730|2240056|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
1138035|NCT02862730|2240057|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1138036|NCT02862730|2240058|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1138037|NCT02862730|2240059|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1138038|NCT02862730|2240060|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1138039|NCT02862730|2240054|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1
1138040|NCT02862730|2240055|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0
1138041|NCT02862730|2240056|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0
1138042|NCT02862730|2240057|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0
1138043|NCT02862730|2240058|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0
1138044|NCT02862730|2240059|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0
1138045|NCT02862730|2240060|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0
1138046|NCT02862730|2240054|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1138047|NCT02862730|2240055|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1138048|NCT02862730|2240056|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
1138049|NCT02862730|2240057|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1138050|NCT02862730|2240058|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
1138051|NCT02862730|2240059|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1138052|NCT02862730|2240060|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1138053|NCT02862730|2240054|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1138054|NCT02862730|2240055|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1138055|NCT02862730|2240056|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1138056|NCT02862730|2240057|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
1138057|NCT02862730|2240058|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1138058|NCT02862730|2240059|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1138059|NCT02862730|2240060|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1138060|NCT02863354|2240120|FG000|Year 1|Lost to Follow-up|1
1138061|NCT02863354|2240121|FG001|Year 1|Lost to Follow-up|1
1138062|NCT02863354|2240120|FG000|Year 1|Withdrawal by Subject|3
1138063|NCT02863354|2240121|FG001|Year 1|Withdrawal by Subject|0
1138064|NCT02863354|2240120|FG000|Year 1|Death|0
1138065|NCT02863354|2240121|FG001|Year 1|Death|1
1138066|NCT02863354|2240120|FG000|Year 2|Lost to Follow-up|2
1138067|NCT02863354|2240121|FG001|Year 2|Lost to Follow-up|2
1138068|NCT02863419|2240130|FG000|Overall Study|Lost to Follow-up|0
1138069|NCT02863419|2240131|FG001|Overall Study|Lost to Follow-up|1
1138070|NCT02863419|2240132|FG002|Overall Study|Lost to Follow-up|4
1138071|NCT02863419|2240130|FG000|Overall Study|Withdrawal by Subject|5
1138072|NCT02863419|2240131|FG001|Overall Study|Withdrawal by Subject|5
1138073|NCT02863419|2240132|FG002|Overall Study|Withdrawal by Subject|3
1138074|NCT02863419|2240130|FG000|Overall Study|Died|3
1138075|NCT02863419|2240131|FG001|Overall Study|Died|4
1138076|NCT02863419|2240132|FG002|Overall Study|Died|1
1138077|NCT02863575|2240143|FG000|Overall Study|Participants Unable To Swallow Capsule|1
1138078|NCT02863575|2240144|FG001|Overall Study|Participants Unable To Swallow Capsule|0
1138079|NCT02863575|2240145|FG002|Overall Study|Participants Unable To Swallow Capsule|0
1138080|NCT02863575|2240143|FG000|Overall Study|Withdrawal by Subject|0
1138081|NCT02863575|2240144|FG001|Overall Study|Withdrawal by Subject|1
1138082|NCT02863575|2240145|FG002|Overall Study|Withdrawal by Subject|1
1138083|NCT02863575|2240143|FG000|Overall Study|Adverse Event|0
1138084|NCT02863575|2240144|FG001|Overall Study|Adverse Event|1
1138085|NCT02863575|2240145|FG002|Overall Study|Adverse Event|0
900527|NCT00728494|1873729|FG000|Overall Study|Adverse Event|7
900528|NCT00728494|1873730|FG001|Overall Study|Adverse Event|0
900529|NCT00728494|1873729|FG000|Overall Study|Withdrawal by Subject|0
900530|NCT00728494|1873730|FG001|Overall Study|Withdrawal by Subject|2
900531|NCT00728494|1873729|FG000|Overall Study|Lack of Efficacy|2
900532|NCT00728494|1873730|FG001|Overall Study|Lack of Efficacy|4
900533|NCT00728494|1873729|FG000|Overall Study|No data available|0
900534|NCT00728494|1873730|FG001|Overall Study|No data available|1
900535|NCT00728689|1873747|FG000|Washout Period (Days 4 - 10)|Death in family|1
900536|NCT00728689|1873748|FG001|Washout Period (Days 4 - 10)|Death in family|0
900537|NCT00728754|1873768|FG000|Permanent Prosthesis Placement|Adverse Event|1
900538|NCT00728754|1873769|FG001|Permanent Prosthesis Placement|Adverse Event|1
900539|NCT00728754|1873768|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3
900540|NCT00728754|1873769|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3
900541|NCT00728754|1873768|FG000|One Year Post Placement Follow-up|Adverse Event|1
900542|NCT00728754|1873769|FG001|One Year Post Placement Follow-up|Adverse Event|0
900543|NCT00728884|1873784|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13
900544|NCT00728884|1873784|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4
900545|NCT00728936|1873808|FG000|Overall Study|Withdrawal by Subject|0
900546|NCT00728936|1873809|FG001|Overall Study|Withdrawal by Subject|0
900547|NCT00728936|1873810|FG002|Overall Study|Withdrawal by Subject|0
900548|NCT00728936|1873811|FG003|Overall Study|Withdrawal by Subject|0
900549|NCT00728936|1873812|FG004|Overall Study|Withdrawal by Subject|0
900550|NCT00728936|1873813|FG005|Overall Study|Withdrawal by Subject|1
900551|NCT00728936|1873814|FG006|Overall Study|Withdrawal by Subject|0
900552|NCT00728949|1873832|FG000|Overall Study|Adverse Event|8
900553|NCT00728949|1873833|FG001|Overall Study|Adverse Event|0
900554|NCT00728949|1873832|FG000|Overall Study|Withdrawal by Subject|2
900555|NCT00728949|1873833|FG001|Overall Study|Withdrawal by Subject|2
900556|NCT00728949|1873832|FG000|Overall Study|Abnormal Lab Results|0
900557|NCT00728949|1873833|FG001|Overall Study|Abnormal Lab Results|2
900558|NCT00728949|1873832|FG000|Overall Study|On treatment at cutoff date|1
900559|NCT00728949|1873833|FG001|Overall Study|On treatment at cutoff date|0
900560|NCT00728962|1873839|FG000|Implant Placement Surgery|Adverse Event|8
1138086|NCT02864082|2240168|FG000|Overall Study|Adverse Event|1
1138087|NCT02864082|2240169|FG001|Overall Study|Adverse Event|1
1138088|NCT02864082|2240168|FG000|Overall Study|Lost to Follow-up|0
1138089|NCT02864082|2240169|FG001|Overall Study|Lost to Follow-up|1
1138090|NCT02864082|2240168|FG000|Overall Study|Withdrawal by Subject|2
1138091|NCT02864082|2240169|FG001|Overall Study|Withdrawal by Subject|2
1138092|NCT02864316|2240191|FG000|Overall Study|Progressive Disease|2
1138093|NCT02864316|2240192|FG001|Overall Study|Progressive Disease|1
1138094|NCT02864316|2240191|FG000|Overall Study|Adverse Event|0
1138095|NCT02864316|2240192|FG001|Overall Study|Adverse Event|1
1138096|NCT02864342|2240200|FG000|Overall Study|Eligibility Criteria Deviation|2
1138097|NCT02864342|2240201|FG001|Overall Study|Eligibility Criteria Deviation|3
1138098|NCT02864342|2240200|FG000|Overall Study|Withdrawal by Subject|4
1138099|NCT02864342|2240201|FG001|Overall Study|Withdrawal by Subject|2
1138100|NCT02864342|2240200|FG000|Overall Study|Device Technology Issue|6
1138101|NCT02864342|2240201|FG001|Overall Study|Device Technology Issue|7
1138102|NCT02864342|2240200|FG000|Overall Study|Death|0
1138103|NCT02864342|2240201|FG001|Overall Study|Death|1
1138104|NCT02864342|2240200|FG000|Overall Study|Did Not Start Treatment with Symbicort|0
1138105|NCT02864342|2240201|FG001|Overall Study|Did Not Start Treatment with Symbicort|1
1138106|NCT02864342|2240200|FG000|Overall Study|Lost to Follow-up|1
1138107|NCT02864342|2240201|FG001|Overall Study|Lost to Follow-up|5
1138108|NCT02864342|2240200|FG000|Overall Study|Lost Device|1
1138109|NCT02864342|2240201|FG001|Overall Study|Lost Device|0
1138110|NCT02864342|2240200|FG000|Overall Study|Adverse Event|1
1138111|NCT02864342|2240201|FG001|Overall Study|Adverse Event|0
1138112|NCT02864381|2240245|FG000|Overall Study|Death|58
1138113|NCT02864381|2240246|FG001|Overall Study|Death|61
1138114|NCT02864381|2240245|FG000|Overall Study|Withdrew Consent|5
1138115|NCT02864381|2240246|FG001|Overall Study|Withdrew Consent|6
1138116|NCT02864381|2240245|FG000|Overall Study|Reason Unknown|7
1138117|NCT02864381|2240246|FG001|Overall Study|Reason Unknown|3
1138118|NCT02864381|2240245|FG000|Overall Study|Lost to Follow-up|1
1138119|NCT02864381|2240246|FG001|Overall Study|Lost to Follow-up|1
1138120|NCT02864381|2240245|FG000|Overall Study|Investigator's Discretion|1
1138121|NCT02864381|2240246|FG001|Overall Study|Investigator's Discretion|0
1138122|NCT02864381|2240245|FG000|Overall Study|Protocol Violation|0
1138123|NCT02864381|2240246|FG001|Overall Study|Protocol Violation|1
1138124|NCT02864394|2240254|FG000|Overall Study|Death|135
1138125|NCT02864394|2240255|FG001|Overall Study|Death|150
1138126|NCT02864394|2240254|FG000|Overall Study|Withdrawal by Subject|1
1138127|NCT02864394|2240255|FG001|Overall Study|Withdrawal by Subject|9
1138128|NCT02864394|2240254|FG000|Overall Study|Ongoing In Study|77
1138129|NCT02864394|2240255|FG001|Overall Study|Ongoing In Study|53
1138130|NCT02865187|2240282|FG000|Overall Study|Lost to Follow-up|12
1138131|NCT02865187|2240283|FG001|Overall Study|Lost to Follow-up|7
1138132|NCT02865187|2240282|FG000|Overall Study|Adverse Event|1
1138133|NCT02865187|2240283|FG001|Overall Study|Adverse Event|0
1138134|NCT02865499|2240351|FG000|Baseline|Adverse Event|1
1138135|NCT02865499|2240351|FG000|Baseline|Withdrawal by Subject|1
1138136|NCT02865538|2240360|FG000|Overall Study|Withdrawal by Subject|0
1138137|NCT02865538|2240361|FG001|Overall Study|Withdrawal by Subject|0
1138138|NCT02865538|2240362|FG002|Overall Study|Withdrawal by Subject|1
1138139|NCT02865538|2240363|FG003|Overall Study|Withdrawal by Subject|0
1138140|NCT02865538|2240364|FG004|Overall Study|Withdrawal by Subject|0
1138141|NCT02865538|2240360|FG000|Overall Study|Lost to Follow-up|1
1138142|NCT02865538|2240361|FG001|Overall Study|Lost to Follow-up|0
1138143|NCT02865538|2240362|FG002|Overall Study|Lost to Follow-up|0
1138144|NCT02865538|2240363|FG003|Overall Study|Lost to Follow-up|0
1138145|NCT02865538|2240364|FG004|Overall Study|Lost to Follow-up|0
1138146|NCT02866175|2240400|FG000|Overall Study|Adverse Event|56
1138147|NCT02866175|2240401|FG001|Overall Study|Adverse Event|54
1138148|NCT02866175|2240400|FG000|Overall Study|Withdrawal by Subject|31
1138149|NCT02866175|2240401|FG001|Overall Study|Withdrawal by Subject|52
1138150|NCT02866175|2240400|FG000|Overall Study|Death|30
1138151|NCT02866175|2240401|FG001|Overall Study|Death|23
1138152|NCT02866175|2240400|FG000|Overall Study|Other|7
1138153|NCT02866175|2240401|FG001|Overall Study|Other|14
1138154|NCT02866175|2240400|FG000|Overall Study|Progressive disease|1
1138155|NCT02866175|2240401|FG001|Overall Study|Progressive disease|1
1138156|NCT02866175|2240400|FG000|Overall Study|Lost to Follow-up|2
1138157|NCT02866175|2240401|FG001|Overall Study|Lost to Follow-up|0
1138158|NCT02866175|2240400|FG000|Overall Study|Lack of Efficacy|0
1138159|NCT02866175|2240401|FG001|Overall Study|Lack of Efficacy|1
1138160|NCT02866175|2240400|FG000|Overall Study|Physician Decision|3
1138161|NCT02866175|2240401|FG001|Overall Study|Physician Decision|15
1138162|NCT02866175|2240400|FG000|Overall Study|Did not receive treatment|5
1138163|NCT02866175|2240401|FG001|Overall Study|Did not receive treatment|15
1138164|NCT02866695|2240417|FG000|Overall Study|Adverse Event|1
1138165|NCT02866695|2240417|FG000|Overall Study|Lost to Follow-up|1
1138166|NCT02866942|2240421|FG000|Overall Study|Invalid consent|1
1138167|NCT02867709|2240475|FG000|Treatment Period|Adverse Event|1
1138168|NCT02867709|2240476|FG001|Treatment Period|Adverse Event|1
1138169|NCT02867709|2240477|FG002|Treatment Period|Adverse Event|2
1138170|NCT02867709|2240475|FG000|Treatment Period|Withdrawal of Consent|7
1138171|NCT02867709|2240476|FG001|Treatment Period|Withdrawal of Consent|9
1138172|NCT02867709|2240477|FG002|Treatment Period|Withdrawal of Consent|8
1138173|NCT02867709|2240475|FG000|Treatment Period|Lost to Follow-up|17
1138174|NCT02867709|2240476|FG001|Treatment Period|Lost to Follow-up|20
1138175|NCT02867709|2240477|FG002|Treatment Period|Lost to Follow-up|20
1138176|NCT02867709|2240475|FG000|Treatment Period|Lack of Qualifying Event|42
1138177|NCT02867709|2240476|FG001|Treatment Period|Lack of Qualifying Event|55
1138178|NCT02867709|2240477|FG002|Treatment Period|Lack of Qualifying Event|42
1138179|NCT02867709|2240475|FG000|Treatment Period|Protocol Violation|3
1138180|NCT02867709|2240476|FG001|Treatment Period|Protocol Violation|2
1138181|NCT02867709|2240477|FG002|Treatment Period|Protocol Violation|3
1138182|NCT02867709|2240475|FG000|Safety Follow-up Period|Withdrawal of Consent|1
1138183|NCT02867709|2240476|FG001|Safety Follow-up Period|Withdrawal of Consent|8
1138184|NCT02867709|2240477|FG002|Safety Follow-up Period|Withdrawal of Consent|6
1138185|NCT02867709|2240475|FG000|Safety Follow-up Period|Lost to Follow-up|10
1138186|NCT02867709|2240476|FG001|Safety Follow-up Period|Lost to Follow-up|5
1138187|NCT02867709|2240477|FG002|Safety Follow-up Period|Lost to Follow-up|7
1138188|NCT02867709|2240475|FG000|Safety Follow-up Period|Pregnancy|0
1138189|NCT02867709|2240476|FG001|Safety Follow-up Period|Pregnancy|1
1138190|NCT02867709|2240477|FG002|Safety Follow-up Period|Pregnancy|0
1138191|NCT02867709|2240475|FG000|Safety Follow-up Period|Protocol Violation|0
1138192|NCT02867709|2240476|FG001|Safety Follow-up Period|Protocol Violation|1
1138193|NCT02867709|2240477|FG002|Safety Follow-up Period|Protocol Violation|1
1138194|NCT02867995|2240487|FG000|Overall Study|Withdrawal by Subject|0
1138195|NCT02867995|2240488|FG001|Overall Study|Withdrawal by Subject|1
1138196|NCT02867995|2240487|FG000|Overall Study|Lost to Follow-up|0
1138197|NCT02867995|2240488|FG001|Overall Study|Lost to Follow-up|2
1138198|NCT02868216|2240500|FG000|Overall Study|Death|0
1138199|NCT02868216|2240501|FG001|Overall Study|Death|1
1138200|NCT02868216|2240500|FG000|Overall Study|coronary artery bypass|1
1138201|NCT02868216|2240501|FG001|Overall Study|coronary artery bypass|0
1138202|NCT02868216|2240500|FG000|Overall Study|Withdrawal by Subject|7
1138203|NCT02868216|2240501|FG001|Overall Study|Withdrawal by Subject|5
1138204|NCT02868229|2240511|FG000|Overall Study|Adverse Event|1
1138205|NCT02868229|2240512|FG001|Overall Study|Adverse Event|0
1138206|NCT02868229|2240513|FG002|Overall Study|Adverse Event|0
1138207|NCT02868229|2240514|FG003|Overall Study|Adverse Event|1
1138208|NCT02868229|2240511|FG000|Overall Study|Death|0
1138209|NCT02868229|2240512|FG001|Overall Study|Death|0
1138210|NCT02868229|2240513|FG002|Overall Study|Death|1
1138211|NCT02868229|2240514|FG003|Overall Study|Death|1
1138212|NCT02868229|2240511|FG000|Overall Study|Missed dose|0
1138213|NCT02868229|2240512|FG001|Overall Study|Missed dose|0
1138214|NCT02868229|2240513|FG002|Overall Study|Missed dose|0
1138215|NCT02868229|2240514|FG003|Overall Study|Missed dose|3
1138216|NCT02868281|2240537|FG000|Overall Study|Adverse Event|2
1138217|NCT02868281|2240538|FG001|Overall Study|Adverse Event|2
1138218|NCT02868281|2240537|FG000|Overall Study|Protocol Violation|13
1138219|NCT02868281|2240538|FG001|Overall Study|Protocol Violation|10
1138220|NCT02868281|2240537|FG000|Overall Study|Lost to Follow-up|3
1138221|NCT02868281|2240538|FG001|Overall Study|Lost to Follow-up|6
1138222|NCT02868281|2240537|FG000|Overall Study|Withdrawal by Subject|11
1138223|NCT02868281|2240538|FG001|Overall Study|Withdrawal by Subject|15
1138224|NCT02868281|2240537|FG000|Overall Study|Physician Decision|2
1138225|NCT02868281|2240538|FG001|Overall Study|Physician Decision|0
1138226|NCT02868281|2240537|FG000|Overall Study|Had protocol-defined asthma exacerbation|8
900561|NCT00728962|1873839|FG000|Implant Placement Surgery|Lost to Follow-up|1
900562|NCT00728962|1873839|FG000|Implant Placement Surgery|Protocol Violation|1
900563|NCT00728962|1873839|FG000|Permanent Prosthesis Placement|Adverse Event|3
900564|NCT00728962|1873839|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3
900565|NCT00728988|1873845|FG000|Overall Study|Not Treated|2
900566|NCT00728988|1873846|FG001|Overall Study|Not Treated|2
900567|NCT00728988|1873845|FG000|Overall Study|Death|1
900568|NCT00728988|1873846|FG001|Overall Study|Death|1
900569|NCT00728988|1873845|FG000|Overall Study|Adverse Event|3
900570|NCT00728988|1873846|FG001|Overall Study|Adverse Event|2
900571|NCT00728988|1873845|FG000|Overall Study|Other|85
900572|NCT00728988|1873846|FG001|Overall Study|Other|77
900573|NCT00728988|1873845|FG000|Overall Study|Withdrawal by Subject|2
900574|NCT00728988|1873846|FG001|Overall Study|Withdrawal by Subject|6
900575|NCT00729157|1873870|FG000|Overall Study|Withdrawal by Subject|1
900576|NCT00729183|1873876|FG000|Overall Study|Adverse Event|11
900577|NCT00729183|1873877|FG001|Overall Study|Adverse Event|5
900578|NCT00729183|1873876|FG000|Overall Study|Lack of Efficacy|0
900579|NCT00729183|1873877|FG001|Overall Study|Lack of Efficacy|1
900580|NCT00729183|1873876|FG000|Overall Study|Lost to Follow-up|3
900581|NCT00729183|1873877|FG001|Overall Study|Lost to Follow-up|1
900582|NCT00729183|1873876|FG000|Overall Study|Physician Decision|1
900583|NCT00729183|1873877|FG001|Overall Study|Physician Decision|1
900584|NCT00729183|1873876|FG000|Overall Study|Protocol Violation|1
900585|NCT00729183|1873877|FG001|Overall Study|Protocol Violation|0
900586|NCT00729183|1873876|FG000|Overall Study|Withdrawal by Subject|9
900587|NCT00729183|1873877|FG001|Overall Study|Withdrawal by Subject|7
900588|NCT00729248|1873883|FG000|Overall Study|Physician Decision|2
900589|NCT00729326|1873890|FG000|Overall Study|Lost to Follow-up|2
900590|NCT00729326|1873891|FG001|Overall Study|Lost to Follow-up|0
900591|NCT00729326|1873890|FG000|Overall Study|Physician Decision|0
900592|NCT00729326|1873891|FG001|Overall Study|Physician Decision|1
1138227|NCT02868281|2240538|FG001|Overall Study|Had protocol-defined asthma exacerbation|8
1138228|NCT02868281|2240537|FG000|Overall Study|Inclusion/exclusion criteria violation|3
1138229|NCT02868281|2240538|FG001|Overall Study|Inclusion/exclusion criteria violation|2
1138230|NCT02868281|2240537|FG000|Overall Study|Long journey/moving away|1
1138231|NCT02868281|2240538|FG001|Overall Study|Long journey/moving away|1
1138232|NCT02868554|2240547|FG000|Overall Study|Lost to Follow-up|3
1138233|NCT02868554|2240548|FG001|Overall Study|Lost to Follow-up|0
1138234|NCT02868554|2240549|FG002|Overall Study|Lost to Follow-up|1
1138235|NCT02869438|2240589|FG000|Overall Study|Lost to Follow-up|1
1138236|NCT02869438|2240590|FG001|Overall Study|Lost to Follow-up|0
1138237|NCT02869438|2240589|FG000|Overall Study|Adverse Event|1
1138238|NCT02869438|2240590|FG001|Overall Study|Adverse Event|0
1138239|NCT02869438|2240589|FG000|Overall Study|Withdrawal by Subject|1
1138240|NCT02869438|2240590|FG001|Overall Study|Withdrawal by Subject|2
1138241|NCT02869893|2240600|FG000|Overall Study|participant aversion to IV|5
1138242|NCT02869893|2240600|FG000|Overall Study|participant fear of MRI scanner|2
1138243|NCT02870933|2240665|FG000|Overall Study|Death|2
1138244|NCT02870933|2240666|FG001|Overall Study|Death|1
1138245|NCT02870933|2240665|FG000|Overall Study|Withdrawal by Subject|0
1138246|NCT02870933|2240666|FG001|Overall Study|Withdrawal by Subject|1
1138247|NCT02870972|2240678|FG000|Overall Study|Adverse Event|1
1138248|NCT02870972|2240679|FG001|Overall Study|Adverse Event|0
1138249|NCT02870972|2240680|FG002|Overall Study|Adverse Event|0
1138250|NCT02870972|2240681|FG003|Overall Study|Adverse Event|0
1138251|NCT02870972|2240682|FG004|Overall Study|Adverse Event|0
1138252|NCT02871375|2240718|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
1138253|NCT02871375|2240719|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
1138254|NCT02871492|2240759|FG000|Overall Study|Lost to Follow-up|6
1138255|NCT02871492|2240760|FG001|Overall Study|Lost to Follow-up|3
1138256|NCT02871492|2240761|FG002|Overall Study|Lost to Follow-up|5
1138257|NCT02871492|2240759|FG000|Overall Study|Withdrawal by Subject|0
1138258|NCT02871492|2240760|FG001|Overall Study|Withdrawal by Subject|0
1138259|NCT02871492|2240761|FG002|Overall Study|Withdrawal by Subject|1
1138260|NCT02871635|2240780|FG000|Overall Study|Primary lack of efficacy|4
1138261|NCT02871635|2240781|FG001|Overall Study|Primary lack of efficacy|4
1138262|NCT02871635|2240780|FG000|Overall Study|Protocol Violation|3
1138263|NCT02871635|2240781|FG001|Overall Study|Protocol Violation|1
1138264|NCT02871635|2240780|FG000|Overall Study|Lost to Follow-up|1
1138265|NCT02871635|2240781|FG001|Overall Study|Lost to Follow-up|2
1138266|NCT02871635|2240780|FG000|Overall Study|Pregnancy|0
1138267|NCT02871635|2240781|FG001|Overall Study|Pregnancy|2
1138268|NCT02871635|2240780|FG000|Overall Study|Physician Decision|1
1138269|NCT02871635|2240781|FG001|Overall Study|Physician Decision|1
1138270|NCT02871635|2240780|FG000|Overall Study|Withdrawal by Subject|3
1138271|NCT02871635|2240781|FG001|Overall Study|Withdrawal by Subject|4
1138272|NCT02871635|2240780|FG000|Overall Study|Adverse Event|4
1138273|NCT02871635|2240781|FG001|Overall Study|Adverse Event|4
1138274|NCT02871635|2240780|FG000|Overall Study|Secondary lack of efficacy|2
1138275|NCT02871635|2240781|FG001|Overall Study|Secondary lack of efficacy|1
1138276|NCT02871739|2240793|FG000|Overall Study|Lost to Follow-up|3
1138277|NCT02871739|2240794|FG001|Overall Study|Lost to Follow-up|2
1138278|NCT02871739|2240795|FG002|Overall Study|Lost to Follow-up|0
1138279|NCT02871739|2240796|FG003|Overall Study|Lost to Follow-up|2
900593|NCT00729326|1873890|FG000|Overall Study|Protocol Violation|3
900594|NCT00729326|1873891|FG001|Overall Study|Protocol Violation|2
900595|NCT00729326|1873890|FG000|Overall Study|Subject Decision|4
900596|NCT00729326|1873891|FG001|Overall Study|Subject Decision|4
900597|NCT00729326|1873890|FG000|Overall Study|Sponsor Decision|1
900598|NCT00729326|1873891|FG001|Overall Study|Sponsor Decision|2
900599|NCT00729378|1873899|FG000|Baseline|Did not complete study measurements|72
900600|NCT00729378|1873900|FG001|Baseline|Did not complete study measurements|33
900601|NCT00729378|1873899|FG000|Baseline|Withdrawal by Subject|66
900602|NCT00729378|1873900|FG001|Baseline|Withdrawal by Subject|59
900603|NCT00729378|1873899|FG000|12-months|Lost to Follow-up|100
900604|NCT00729378|1873900|FG001|12-months|Lost to Follow-up|65
900605|NCT00729378|1873899|FG000|24-months|Lost to Follow-up|72
900606|NCT00729378|1873900|FG001|24-months|Lost to Follow-up|51
900607|NCT00729378|1873899|FG000|36-months|Lost to Follow-up|15
900608|NCT00729378|1873900|FG001|36-months|Lost to Follow-up|6
900609|NCT00729469|1873921|FG000|Overall Study|Adverse Event|14
900610|NCT00729469|1873922|FG001|Overall Study|Adverse Event|25
900611|NCT00729469|1873921|FG000|Overall Study|Lost to Follow-up|9
900612|NCT00729469|1873922|FG001|Overall Study|Lost to Follow-up|9
900613|NCT00729469|1873921|FG000|Overall Study|Protocol Violation|2
900614|NCT00729469|1873922|FG001|Overall Study|Protocol Violation|1
900615|NCT00729469|1873921|FG000|Overall Study|Withdrawal by Subject|19
900616|NCT00729469|1873922|FG001|Overall Study|Withdrawal by Subject|8
900617|NCT00729469|1873921|FG000|Overall Study|Other-Not mentioned|9
900618|NCT00729469|1873922|FG001|Overall Study|Other-Not mentioned|4
900619|NCT00729586|1873947|FG000|Overall Study|Ineligible|0
900620|NCT00729586|1873948|FG001|Overall Study|Ineligible|1
900621|NCT00729586|1873947|FG000|Overall Study|never treated|1
900622|NCT00729586|1873948|FG001|Overall Study|never treated|0
900623|NCT00729612|1873955|FG000|Overall Study|Non evaluable for response|10
1138280|NCT02872012|2240811|FG000|Overall Study|Withdrawal by Subject|1
1138281|NCT02872012|2240812|FG001|Overall Study|Withdrawal by Subject|0
1138282|NCT02872012|2240813|FG002|Overall Study|Withdrawal by Subject|0
1138283|NCT02872012|2240814|FG003|Overall Study|Withdrawal by Subject|0
1138284|NCT02872012|2240815|FG004|Overall Study|Withdrawal by Subject|0
1138285|NCT02872142|2240840|FG000|Overall Study|Adverse Event|2
1138286|NCT02872142|2240840|FG000|Overall Study|Death|1
1138287|NCT02872142|2240840|FG000|Overall Study|Participant Decision|3
1138288|NCT02872285|2240846|FG000|Overall Study|Withdrawal by Subject|2
1138289|NCT02872285|2240847|FG001|Overall Study|Withdrawal by Subject|0
1138290|NCT02872285|2240846|FG000|Overall Study|Lost to Follow-up|2
1138291|NCT02872285|2240847|FG001|Overall Study|Lost to Follow-up|2
1138292|NCT02872285|2240846|FG000|Overall Study|Discontinued due to back surgery|1
1138293|NCT02872285|2240847|FG001|Overall Study|Discontinued due to back surgery|0
1138294|NCT02872311|2240858|FG000|Overall Study|Death|2
1138295|NCT02872311|2240859|FG001|Overall Study|Death|0
1138296|NCT02872311|2240860|FG002|Overall Study|Death|0
1138297|NCT02872311|2240861|FG003|Overall Study|Death|0
1138298|NCT02872311|2240862|FG004|Overall Study|Death|0
1138299|NCT02872311|2240858|FG000|Overall Study|Lost to Follow-up|2
1138300|NCT02872311|2240859|FG001|Overall Study|Lost to Follow-up|0
900624|NCT00729651|1873961|FG000|Overall Study|Withdrawal by Subject|5
900625|NCT00729651|1873962|FG001|Overall Study|Withdrawal by Subject|6
900626|NCT00729651|1873961|FG000|Overall Study|Lost to Follow-up|5
900627|NCT00729651|1873962|FG001|Overall Study|Lost to Follow-up|4
900628|NCT00729651|1873961|FG000|Overall Study|Protocol Violation|0
900629|NCT00729651|1873962|FG001|Overall Study|Protocol Violation|1
900630|NCT00729651|1873961|FG000|Overall Study|Adverse Event|7
900631|NCT00729651|1873962|FG001|Overall Study|Adverse Event|3
900632|NCT00729651|1873961|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
900633|NCT00729651|1873962|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
900634|NCT00729651|1873961|FG000|Overall Study|Subject's private reason|2
900635|NCT00729651|1873962|FG001|Overall Study|Subject's private reason|0
900636|NCT00729690|1873982|FG000|Overall Study|IT Catheter Malfunction|0
900637|NCT00729690|1873983|FG001|Overall Study|IT Catheter Malfunction|2
900638|NCT00729690|1873984|FG002|Overall Study|IT Catheter Malfunction|2
900639|NCT00729833|1874000|FG000|Overall Study|Death|5
900640|NCT00729833|1874001|FG001|Overall Study|Death|1
900641|NCT00729833|1874002|FG002|Overall Study|Death|3
900642|NCT00729833|1874003|FG003|Overall Study|Death|5
900643|NCT00729833|1874000|FG000|Overall Study|Study Terminated by Sponsor|0
900644|NCT00729833|1874001|FG001|Overall Study|Study Terminated by Sponsor|0
900645|NCT00729833|1874002|FG002|Overall Study|Study Terminated by Sponsor|1
900646|NCT00729833|1874003|FG003|Overall Study|Study Terminated by Sponsor|0
900647|NCT00729833|1874000|FG000|Overall Study|Lost to Follow-up|1
900648|NCT00729833|1874001|FG001|Overall Study|Lost to Follow-up|0
900649|NCT00729833|1874002|FG002|Overall Study|Lost to Follow-up|0
900650|NCT00729833|1874003|FG003|Overall Study|Lost to Follow-up|0
900651|NCT00729833|1874000|FG000|Overall Study|Withdrawal by Subject|3
900652|NCT00729833|1874001|FG001|Overall Study|Withdrawal by Subject|1
900653|NCT00729833|1874002|FG002|Overall Study|Withdrawal by Subject|3
900654|NCT00729833|1874003|FG003|Overall Study|Withdrawal by Subject|0
900655|NCT00729833|1874000|FG000|Overall Study|Unspecified Reasons|11
900656|NCT00729833|1874001|FG001|Overall Study|Unspecified Reasons|5
900657|NCT00729833|1874002|FG002|Overall Study|Unspecified Reasons|5
900658|NCT00729833|1874003|FG003|Overall Study|Unspecified Reasons|1
900659|NCT00729859|1874026|FG000|Overall Study|Adverse Event|0
900660|NCT00729859|1874027|FG001|Overall Study|Adverse Event|1
900661|NCT00729859|1874028|FG002|Overall Study|Adverse Event|0
900662|NCT00729859|1874026|FG000|Overall Study|Withdrawal by Subject|0
900663|NCT00729859|1874027|FG001|Overall Study|Withdrawal by Subject|1
900664|NCT00729859|1874028|FG002|Overall Study|Withdrawal by Subject|0
900665|NCT00729937|1874057|FG000|Overall Study|Lost to Follow-up|49
900666|NCT00729937|1874058|FG001|Overall Study|Lost to Follow-up|58
900667|NCT00729937|1874059|FG002|Overall Study|Lost to Follow-up|18
900668|NCT00729937|1874060|FG003|Overall Study|Lost to Follow-up|33
900669|NCT00729937|1874061|FG004|Overall Study|Lost to Follow-up|18
900670|NCT00729937|1874062|FG005|Overall Study|Lost to Follow-up|23
900671|NCT00729937|1874057|FG000|Overall Study|Physician Decision|7
900672|NCT00729937|1874058|FG001|Overall Study|Physician Decision|16
900673|NCT00729937|1874059|FG002|Overall Study|Physician Decision|2
900674|NCT00729937|1874060|FG003|Overall Study|Physician Decision|0
900675|NCT00729937|1874061|FG004|Overall Study|Physician Decision|5
900676|NCT00729937|1874062|FG005|Overall Study|Physician Decision|8
900677|NCT00729937|1874057|FG000|Overall Study|Death|1
900678|NCT00729937|1874058|FG001|Overall Study|Death|0
900679|NCT00729937|1874059|FG002|Overall Study|Death|1
900680|NCT00729937|1874060|FG003|Overall Study|Death|0
900681|NCT00729937|1874061|FG004|Overall Study|Death|0
900682|NCT00729937|1874062|FG005|Overall Study|Death|1
900683|NCT00729937|1874057|FG000|Overall Study|Withdrawal by Subject|3
900684|NCT00729937|1874058|FG001|Overall Study|Withdrawal by Subject|5
900685|NCT00729937|1874059|FG002|Overall Study|Withdrawal by Subject|6
900686|NCT00729937|1874060|FG003|Overall Study|Withdrawal by Subject|0
1138301|NCT02872311|2240860|FG002|Overall Study|Lost to Follow-up|0
1138302|NCT02872311|2240861|FG003|Overall Study|Lost to Follow-up|0
1138303|NCT02872311|2240862|FG004|Overall Study|Lost to Follow-up|0
1138304|NCT02872311|2240858|FG000|Overall Study|Protocol Violation|0
1138305|NCT02872311|2240859|FG001|Overall Study|Protocol Violation|2
1138306|NCT02872311|2240860|FG002|Overall Study|Protocol Violation|1
1138307|NCT02872311|2240861|FG003|Overall Study|Protocol Violation|0
1138308|NCT02872311|2240862|FG004|Overall Study|Protocol Violation|0
1138309|NCT02872935|2240912|FG000|Overall Study|Other|0
1138310|NCT02872935|2240913|FG001|Overall Study|Other|1
1138313|NCT02873208|2240937|FG000|Overall Study|Withdrawal by Subject|36
1138314|NCT02873208|2240937|FG000|Overall Study|Lost to Follow-up|22
1138315|NCT02873208|2240937|FG000|Overall Study|Adverse Event|15
1138316|NCT02873208|2240937|FG000|Overall Study|Non-compliance with study drug|12
1138317|NCT02873208|2240937|FG000|Overall Study|Protocol Violation|8
1138318|NCT02873208|2240937|FG000|Overall Study|Pregnancy|2
1138319|NCT02873208|2240937|FG000|Overall Study|Incarceration|1
1138320|NCT02873208|2240937|FG000|Overall Study|Lack of Efficacy|1
1138321|NCT02873208|2240937|FG000|Overall Study|Physician Decision|1
1138322|NCT02873221|2240944|FG000|Treatment Period|Other Miscellaneous Reasons|0
1138323|NCT02873221|2240945|FG001|Treatment Period|Other Miscellaneous Reasons|2
1138324|NCT02873221|2240946|FG002|Treatment Period|Other Miscellaneous Reasons|1
1138325|NCT02873221|2240944|FG000|Treatment Period|Non-Compliance with Study Drug|0
1138326|NCT02873221|2240945|FG001|Treatment Period|Non-Compliance with Study Drug|3
1138327|NCT02873221|2240946|FG002|Treatment Period|Non-Compliance with Study Drug|2
1138328|NCT02873221|2240944|FG000|Treatment Period|Protocol Violation|2
1138329|NCT02873221|2240945|FG001|Treatment Period|Protocol Violation|5
1138330|NCT02873221|2240946|FG002|Treatment Period|Protocol Violation|8
1138331|NCT02873221|2240944|FG000|Treatment Period|Pregnancy|4
1138332|NCT02873221|2240945|FG001|Treatment Period|Pregnancy|6
1138333|NCT02873221|2240946|FG002|Treatment Period|Pregnancy|3
1138334|NCT02873221|2240944|FG000|Treatment Period|Lack of Qualifying Event|0
1138335|NCT02873221|2240945|FG001|Treatment Period|Lack of Qualifying Event|3
1138336|NCT02873221|2240946|FG002|Treatment Period|Lack of Qualifying Event|1
1138337|NCT02873221|2240944|FG000|Treatment Period|Withdrawal of Consent|52
1138338|NCT02873221|2240945|FG001|Treatment Period|Withdrawal of Consent|51
1138339|NCT02873221|2240946|FG002|Treatment Period|Withdrawal of Consent|41
1138340|NCT02873221|2240944|FG000|Treatment Period|Lack of Efficacy|0
1138341|NCT02873221|2240945|FG001|Treatment Period|Lack of Efficacy|17
1138342|NCT02873221|2240946|FG002|Treatment Period|Lack of Efficacy|12
1138343|NCT02873221|2240944|FG000|Treatment Period|Adverse Event|4
1138344|NCT02873221|2240945|FG001|Treatment Period|Adverse Event|9
1138345|NCT02873221|2240946|FG002|Treatment Period|Adverse Event|11
1138346|NCT02873221|2240944|FG000|Treatment Period|Lost to Follow-up|26
1138347|NCT02873221|2240945|FG001|Treatment Period|Lost to Follow-up|30
1138348|NCT02873221|2240946|FG002|Treatment Period|Lost to Follow-up|26
1138349|NCT02873221|2240944|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0
1138350|NCT02873221|2240945|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2
1138351|NCT02873221|2240946|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
1138352|NCT02873221|2240944|FG000|Safety Follow-up Period|Protocol Violation|0
1138353|NCT02873221|2240945|FG001|Safety Follow-up Period|Protocol Violation|0
1138354|NCT02873221|2240946|FG002|Safety Follow-up Period|Protocol Violation|1
1138355|NCT02873221|2240944|FG000|Safety Follow-up Period|Lost to Follow-up|3
1138356|NCT02873221|2240945|FG001|Safety Follow-up Period|Lost to Follow-up|5
1138357|NCT02873221|2240946|FG002|Safety Follow-up Period|Lost to Follow-up|5
1138358|NCT02873221|2240944|FG000|Safety Follow-up Period|Withdrawal of Consent|4
1138359|NCT02873221|2240945|FG001|Safety Follow-up Period|Withdrawal of Consent|10
1138360|NCT02873221|2240946|FG002|Safety Follow-up Period|Withdrawal of Consent|8
1138361|NCT02873338|2240978|FG000|Overall Study|Adverse Event|0
1138362|NCT02873338|2240979|FG001|Overall Study|Adverse Event|2
1138363|NCT02873338|2240980|FG002|Overall Study|Adverse Event|1
1138364|NCT02873338|2240978|FG000|Overall Study|Death|2
1138365|NCT02873338|2240979|FG001|Overall Study|Death|1
1138366|NCT02873338|2240980|FG002|Overall Study|Death|1
900687|NCT00729937|1874061|FG004|Overall Study|Withdrawal by Subject|4
900688|NCT00729937|1874062|FG005|Overall Study|Withdrawal by Subject|2
900689|NCT00729937|1874057|FG000|Overall Study|Randomized but not treated|12
900690|NCT00729937|1874058|FG001|Overall Study|Randomized but not treated|6
900691|NCT00729937|1874059|FG002|Overall Study|Randomized but not treated|1
900692|NCT00729937|1874060|FG003|Overall Study|Randomized but not treated|0
900693|NCT00729937|1874061|FG004|Overall Study|Randomized but not treated|1
900694|NCT00729937|1874062|FG005|Overall Study|Randomized but not treated|3
900695|NCT00729937|1874057|FG000|Overall Study|Did not meet eligibility criteria|2
900696|NCT00729937|1874058|FG001|Overall Study|Did not meet eligibility criteria|1
900697|NCT00729937|1874059|FG002|Overall Study|Did not meet eligibility criteria|0
900698|NCT00729937|1874060|FG003|Overall Study|Did not meet eligibility criteria|0
900699|NCT00729937|1874061|FG004|Overall Study|Did not meet eligibility criteria|0
900700|NCT00729937|1874062|FG005|Overall Study|Did not meet eligibility criteria|0
900701|NCT00729937|1874057|FG000|Overall Study|Incarcerated|0
1138367|NCT02873338|2240978|FG000|Overall Study|Withdrawal by Subject|2
1138368|NCT02873338|2240979|FG001|Overall Study|Withdrawal by Subject|1
1138369|NCT02873338|2240980|FG002|Overall Study|Withdrawal by Subject|3
1138370|NCT02873338|2240978|FG000|Overall Study|Lack of Efficacy|0
1138371|NCT02873338|2240979|FG001|Overall Study|Lack of Efficacy|2
1138372|NCT02873338|2240980|FG002|Overall Study|Lack of Efficacy|0
1138373|NCT02873338|2240978|FG000|Overall Study|Other or Missing|14
1138374|NCT02873338|2240979|FG001|Overall Study|Other or Missing|15
1138375|NCT02873338|2240980|FG002|Overall Study|Other or Missing|13
1138376|NCT02873377|2240990|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
1138377|NCT02873377|2240991|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
1138378|NCT02873377|2240990|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
1138379|NCT02873377|2240991|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
1138380|NCT02873429|2241000|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
1138381|NCT02873429|2241001|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
1138382|NCT02873429|2241000|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2
1138383|NCT02873429|2241001|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2
1138384|NCT02873429|2241000|FG000|16 Weeks|Lost to Follow-up|3
1138385|NCT02873429|2241001|FG001|16 Weeks|Lost to Follow-up|0
1138386|NCT02873689|2241026|FG000|Overall Study|Lack of Efficacy|1
1138387|NCT02873689|2241027|FG001|Overall Study|Lack of Efficacy|0
1138388|NCT02873689|2241026|FG000|Overall Study|Withdrawal by Subject|2
1138389|NCT02873689|2241027|FG001|Overall Study|Withdrawal by Subject|2
1138390|NCT02873689|2241026|FG000|Overall Study|Protocol Violation|1
1138391|NCT02873689|2241027|FG001|Overall Study|Protocol Violation|0
1138392|NCT02873689|2241026|FG000|Overall Study|Adverse Event|2
1138393|NCT02873689|2241027|FG001|Overall Study|Adverse Event|2
1138394|NCT02873689|2241026|FG000|Overall Study|Randomized but not Treated|1
1138395|NCT02873689|2241027|FG001|Overall Study|Randomized but not Treated|1
1138396|NCT02873702|2241035|FG000|Healing Period (up to Week 8)|Adverse Event|1
1138397|NCT02873702|2241036|FG001|Healing Period (up to Week 8)|Adverse Event|0
1138398|NCT02873702|2241037|FG002|Healing Period (up to Week 8)|Adverse Event|0
1138399|NCT02873702|2241038|FG003|Healing Period (up to Week 8)|Adverse Event|0
1138400|NCT02873702|2241035|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0
1138401|NCT02873702|2241036|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1
1138402|NCT02873702|2241037|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0
1138403|NCT02873702|2241038|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0
1138404|NCT02873702|2241035|FG000|Maintenance Period (up to Month 6)|Adverse Event|0
1138405|NCT02873702|2241036|FG001|Maintenance Period (up to Month 6)|Adverse Event|0
1138406|NCT02873702|2241037|FG002|Maintenance Period (up to Month 6)|Adverse Event|1
1138407|NCT02873702|2241038|FG003|Maintenance Period (up to Month 6)|Adverse Event|0
1138408|NCT02873702|2241035|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0
1138409|NCT02873702|2241036|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0
1138410|NCT02873702|2241037|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4
1138411|NCT02873702|2241038|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1
1138412|NCT02873702|2241035|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
1138413|NCT02873702|2241036|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
1138414|NCT02873702|2241037|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
1138415|NCT02873702|2241038|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
1138416|NCT02873754|2241048|FG000|Overall Study|Lost to Follow-up|5
1138417|NCT02873754|2241048|FG000|Overall Study|Couldn't complete study procedures|1
1138418|NCT02873936|2241059|FG000|Overall Study|Withdrew Consent|4
1138419|NCT02873936|2241060|FG001|Overall Study|Withdrew Consent|11
1138420|NCT02873936|2241061|FG002|Overall Study|Withdrew Consent|20
1138421|NCT02873936|2241059|FG000|Overall Study|Investigator's Discretion|3
1138422|NCT02873936|2241060|FG001|Overall Study|Investigator's Discretion|5
1138423|NCT02873936|2241061|FG002|Overall Study|Investigator's Discretion|4
1138424|NCT02873936|2241059|FG000|Overall Study|Adverse Event|3
1138425|NCT02873936|2241060|FG001|Overall Study|Adverse Event|5
1138426|NCT02873936|2241061|FG002|Overall Study|Adverse Event|3
1138427|NCT02873936|2241059|FG000|Overall Study|Protocol Violation|0
1138428|NCT02873936|2241060|FG001|Overall Study|Protocol Violation|1
1138429|NCT02873936|2241061|FG002|Overall Study|Protocol Violation|3
1138430|NCT02873936|2241059|FG000|Overall Study|Lost to Follow-up|1
1138431|NCT02873936|2241060|FG001|Overall Study|Lost to Follow-up|1
1138432|NCT02873936|2241061|FG002|Overall Study|Lost to Follow-up|1
1138433|NCT02873936|2241059|FG000|Overall Study|Non-compliance With Study Drug|1
1138434|NCT02873936|2241060|FG001|Overall Study|Non-compliance With Study Drug|0
1138435|NCT02873936|2241061|FG002|Overall Study|Non-compliance With Study Drug|1
900702|NCT00729937|1874058|FG001|Overall Study|Incarcerated|2
900703|NCT00729937|1874059|FG002|Overall Study|Incarcerated|1
900704|NCT00729937|1874060|FG003|Overall Study|Incarcerated|1
900705|NCT00729937|1874061|FG004|Overall Study|Incarcerated|0
900706|NCT00729937|1874062|FG005|Overall Study|Incarcerated|0
900707|NCT00730015|1874079|FG000|Overall Study|Adverse Event|11
900708|NCT00730015|1874080|FG001|Overall Study|Adverse Event|10
900709|NCT00730015|1874081|FG002|Overall Study|Adverse Event|8
900710|NCT00730015|1874079|FG000|Overall Study|Protocol Violation|2
900711|NCT00730015|1874080|FG001|Overall Study|Protocol Violation|6
900712|NCT00730015|1874081|FG002|Overall Study|Protocol Violation|4
900713|NCT00730015|1874079|FG000|Overall Study|Withdrawal by Subject|12
900714|NCT00730015|1874080|FG001|Overall Study|Withdrawal by Subject|12
900715|NCT00730015|1874081|FG002|Overall Study|Withdrawal by Subject|8
900716|NCT00730015|1874079|FG000|Overall Study|Lost to Follow-up|4
1138436|NCT02873936|2241059|FG000|Overall Study|Randomized but not Dosed|1
1138437|NCT02873936|2241060|FG001|Overall Study|Randomized but not Dosed|0
1138438|NCT02873936|2241061|FG002|Overall Study|Randomized but not Dosed|0
1138439|NCT02874534|2241088|FG000|Overall Study|Withdrawal by Subject|5
1138440|NCT02874534|2241089|FG001|Overall Study|Withdrawal by Subject|8
1138441|NCT02874534|2241088|FG000|Overall Study|Lost to Follow-up|2
1138442|NCT02874534|2241089|FG001|Overall Study|Lost to Follow-up|2
1138443|NCT02874534|2241088|FG000|Overall Study|Ongoing in study|1
1138444|NCT02874534|2241089|FG001|Overall Study|Ongoing in study|1
1138460|NCT02874794|2241110|FG000|Overall Study|Physician Decision|3
1138461|NCT02874794|2241111|FG001|Overall Study|Physician Decision|2
1138462|NCT02874794|2241110|FG000|Overall Study|Withdrawal by Subject|2
1138463|NCT02874794|2241111|FG001|Overall Study|Withdrawal by Subject|8
1138464|NCT02874794|2241110|FG000|Overall Study|Death|2
1138465|NCT02874794|2241111|FG001|Overall Study|Death|1
1138466|NCT02874924|2241133|FG000|Overall Study|Adverse Event|2
1138467|NCT02874924|2241134|FG001|Overall Study|Adverse Event|0
1138468|NCT02874924|2241135|FG002|Overall Study|Adverse Event|0
1138469|NCT02874924|2241133|FG000|Overall Study|Withdrawal by Subject|1
1138470|NCT02874924|2241134|FG001|Overall Study|Withdrawal by Subject|0
1138471|NCT02874924|2241135|FG002|Overall Study|Withdrawal by Subject|0
1138472|NCT02875028|2241145|FG000|Washout Period|Withdrawal by Subject|0
1138473|NCT02875028|2241146|FG001|Washout Period|Withdrawal by Subject|1
1138474|NCT02875080|2241157|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2
1138475|NCT02875080|2241158|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
1138476|NCT02875080|2241159|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
1138477|NCT02875340|2241167|FG000|Overall Study|Death|2
1138478|NCT02875340|2241167|FG000|Overall Study|Withdrawal by Subject|2
1138479|NCT02875340|2241167|FG000|Overall Study|Physician Decision|3
1138480|NCT02875340|2241167|FG000|Overall Study|Adverse Event|1
1138481|NCT02875366|2241179|FG000|Overall Study|Adverse Event|0
1138482|NCT02875366|2241180|FG001|Overall Study|Adverse Event|2
1138483|NCT02875366|2241179|FG000|Overall Study|Noncompliance|0
1138484|NCT02875366|2241180|FG001|Overall Study|Noncompliance|1
1138485|NCT02875392|2241188|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7
1138486|NCT02875392|2241189|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8
1138487|NCT02875613|2241195|FG000|Overall Study|Withdrawal by Subject|1
1138488|NCT02875834|2241203|FG000|Open-label Phase|Withdrawal by Subject|3
1138489|NCT02875834|2241204|FG001|Open-label Phase|Withdrawal by Subject|0
1138490|NCT02875834|2241205|FG002|Open-label Phase|Withdrawal by Subject|0
1138491|NCT02875834|2241206|FG003|Open-label Phase|Withdrawal by Subject|0
1138492|NCT02875834|2241203|FG000|Open-label Phase|(Not collected)|4
1138493|NCT02875834|2241204|FG001|Open-label Phase|(Not collected)|0
1138494|NCT02875834|2241205|FG002|Open-label Phase|(Not collected)|0
1138495|NCT02875834|2241206|FG003|Open-label Phase|(Not collected)|0
1138496|NCT02875834|2241203|FG000|Randomized Treatment Phase|Withdrawal by Subject|0
1138497|NCT02875834|2241204|FG001|Randomized Treatment Phase|Withdrawal by Subject|3
1138498|NCT02875834|2241205|FG002|Randomized Treatment Phase|Withdrawal by Subject|1
1138499|NCT02875834|2241206|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
1138500|NCT02875834|2241203|FG000|Randomized Treatment Phase|Protocol Violation|0
1138501|NCT02875834|2241204|FG001|Randomized Treatment Phase|Protocol Violation|2
1138502|NCT02875834|2241205|FG002|Randomized Treatment Phase|Protocol Violation|0
1138503|NCT02875834|2241206|FG003|Randomized Treatment Phase|Protocol Violation|0
1138504|NCT02875834|2241203|FG000|Randomized Treatment Phase|(Not collected)|0
1138505|NCT02875834|2241204|FG001|Randomized Treatment Phase|(Not collected)|9
1138506|NCT02875834|2241205|FG002|Randomized Treatment Phase|(Not collected)|10
1138507|NCT02875834|2241206|FG003|Randomized Treatment Phase|(Not collected)|9
1138508|NCT02875977|2241218|FG000|Overall Study|Lost to Follow-up|42
1138509|NCT02875977|2241219|FG001|Overall Study|Lost to Follow-up|29
1138510|NCT02876601|2241269|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
1138511|NCT02876601|2241270|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
1138512|NCT02876601|2241271|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
1138513|NCT02876601|2241272|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
1138514|NCT02877004|2241364|FG000|Overall Study|Pregnancy|0
1138515|NCT02877004|2241365|FG001|Overall Study|Pregnancy|0
1138516|NCT02877004|2241366|FG002|Overall Study|Pregnancy|1
1138517|NCT02877082|2241374|FG000|Overall Study|Trial was closed early|5
1138518|NCT02877680|2241399|FG000|Overall Study|Lost to Follow-up|1
1138519|NCT02877680|2241400|FG001|Overall Study|Lost to Follow-up|1
1138520|NCT02877927|2241412|FG000|Overall Study|Adverse Event|1
1138521|NCT02877927|2241413|FG001|Overall Study|Adverse Event|0
1138522|NCT02877927|2241412|FG000|Overall Study|Lost to Follow-up|37
1138523|NCT02877927|2241413|FG001|Overall Study|Lost to Follow-up|38
1138524|NCT02877927|2241412|FG000|Overall Study|Withdrawal by Subject|11
1138525|NCT02877927|2241413|FG001|Overall Study|Withdrawal by Subject|12
1138526|NCT02877927|2241412|FG000|Overall Study|Physician Decision|0
1138527|NCT02877927|2241413|FG001|Overall Study|Physician Decision|1
1138528|NCT02877927|2241412|FG000|Overall Study|Missed EOT/PTE Visit|5
1138529|NCT02877927|2241413|FG001|Overall Study|Missed EOT/PTE Visit|6
1138530|NCT02878213|2241423|FG000|Overall Study|Withdrawal by Subject|2
1138531|NCT02878213|2241423|FG000|Overall Study|Adverse Event|1
1138532|NCT02878330|2241430|FG000|Overall Study|Death|3
1138533|NCT02878330|2241431|FG001|Overall Study|Death|2
1138534|NCT02878330|2241430|FG000|Overall Study|Lost to Follow-up|11
1138535|NCT02878330|2241431|FG001|Overall Study|Lost to Follow-up|26
1138536|NCT02878330|2241430|FG000|Overall Study|Withdrawal by Subject|11
1138537|NCT02878330|2241431|FG001|Overall Study|Withdrawal by Subject|21
1138538|NCT02878330|2241430|FG000|Overall Study|Other|4
1138539|NCT02878330|2241431|FG001|Overall Study|Other|7
1138540|NCT02878590|2241456|FG000|Overall Study|Withdrawal by Subject|2
1138541|NCT02878603|2241462|FG000|Overall Study|Lost to Follow-up|4
1138542|NCT02878603|2241463|FG001|Overall Study|Lost to Follow-up|1
1138543|NCT02878603|2241462|FG000|Overall Study|Withdrawal by Subject|1
1138544|NCT02878603|2241463|FG001|Overall Study|Withdrawal by Subject|1
1138545|NCT02878603|2241462|FG000|Overall Study|Death|1
1138546|NCT02878603|2241463|FG001|Overall Study|Death|0
1138547|NCT02878603|2241462|FG000|Overall Study|Physician Decision|0
1138548|NCT02878603|2241463|FG001|Overall Study|Physician Decision|3
1138549|NCT02879383|2241488|FG000|First 24 Weeks|Physician Decision|0
1138550|NCT02879383|2241489|FG001|First 24 Weeks|Physician Decision|1
1138551|NCT02879383|2241490|FG002|First 24 Weeks|Physician Decision|0
1138552|NCT02879383|2241491|FG003|First 24 Weeks|Physician Decision|0
1138553|NCT02879578|2241506|FG000|Overall Study|Adverse Event|1
1138554|NCT02879578|2241507|FG001|Overall Study|Adverse Event|2
1138555|NCT02879578|2241508|FG002|Overall Study|Adverse Event|14
1138556|NCT02879578|2241506|FG000|Overall Study|Protocol Violation|0
1138557|NCT02879578|2241507|FG001|Overall Study|Protocol Violation|1
1138558|NCT02879578|2241508|FG002|Overall Study|Protocol Violation|1
1138559|NCT02879578|2241506|FG000|Overall Study|Withdrawal by Subject|8
1138560|NCT02879578|2241507|FG001|Overall Study|Withdrawal by Subject|6
1138561|NCT02879578|2241508|FG002|Overall Study|Withdrawal by Subject|9
1138562|NCT02879578|2241506|FG000|Overall Study|Lost to Follow-up|1
1138563|NCT02879578|2241507|FG001|Overall Study|Lost to Follow-up|0
1138564|NCT02879578|2241508|FG002|Overall Study|Lost to Follow-up|4
1138565|NCT02879578|2241506|FG000|Overall Study|Physician Decision|0
1138566|NCT02879578|2241507|FG001|Overall Study|Physician Decision|0
1138567|NCT02879578|2241508|FG002|Overall Study|Physician Decision|4
1138568|NCT02880761|2241602|FG000|Overall Study|Death|6
900717|NCT00730015|1874080|FG001|Overall Study|Lost to Follow-up|10
900718|NCT00730015|1874081|FG002|Overall Study|Lost to Follow-up|3
900719|NCT00730015|1874079|FG000|Overall Study|Lack of Efficacy|1
900720|NCT00730015|1874080|FG001|Overall Study|Lack of Efficacy|2
900721|NCT00730015|1874081|FG002|Overall Study|Lack of Efficacy|8
900722|NCT00730015|1874079|FG000|Overall Study|Other Reason|1
900723|NCT00730015|1874080|FG001|Overall Study|Other Reason|0
900724|NCT00730015|1874081|FG002|Overall Study|Other Reason|1
900725|NCT00730028|1874099|FG000|Overall Study|Adverse Event|23
900726|NCT00730028|1874100|FG001|Overall Study|Adverse Event|26
900727|NCT00730028|1874101|FG002|Overall Study|Adverse Event|16
900728|NCT00730028|1874102|FG003|Overall Study|Adverse Event|20
900729|NCT00730028|1874103|FG004|Overall Study|Adverse Event|43
900730|NCT00730028|1874099|FG000|Overall Study|Lost to Follow-up|13
900731|NCT00730028|1874100|FG001|Overall Study|Lost to Follow-up|26
900732|NCT00730028|1874101|FG002|Overall Study|Lost to Follow-up|22
900733|NCT00730028|1874102|FG003|Overall Study|Lost to Follow-up|26
900734|NCT00730028|1874103|FG004|Overall Study|Lost to Follow-up|25
900735|NCT00730028|1874099|FG000|Overall Study|Protocol Violation|6
900736|NCT00730028|1874100|FG001|Overall Study|Protocol Violation|1
900737|NCT00730028|1874101|FG002|Overall Study|Protocol Violation|1
900738|NCT00730028|1874102|FG003|Overall Study|Protocol Violation|2
900739|NCT00730028|1874103|FG004|Overall Study|Protocol Violation|0
900740|NCT00730028|1874099|FG000|Overall Study|Withdrawal by Subject|9
900741|NCT00730028|1874100|FG001|Overall Study|Withdrawal by Subject|5
900742|NCT00730028|1874101|FG002|Overall Study|Withdrawal by Subject|4
900743|NCT00730028|1874102|FG003|Overall Study|Withdrawal by Subject|5
900744|NCT00730028|1874103|FG004|Overall Study|Withdrawal by Subject|9
900745|NCT00730028|1874099|FG000|Overall Study|Physician Decision|3
900746|NCT00730028|1874100|FG001|Overall Study|Physician Decision|3
900747|NCT00730028|1874101|FG002|Overall Study|Physician Decision|2
900748|NCT00730028|1874102|FG003|Overall Study|Physician Decision|3
1138569|NCT02880761|2241603|FG001|Overall Study|Death|8
1138570|NCT02880761|2241602|FG000|Overall Study|Withdrawal by Subject|3
1138571|NCT02880761|2241603|FG001|Overall Study|Withdrawal by Subject|6
1138572|NCT02880761|2241602|FG000|Overall Study|Protocol Violation|4
1138573|NCT02880761|2241603|FG001|Overall Study|Protocol Violation|3
1138574|NCT02880761|2241602|FG000|Overall Study|Lost to Follow-up|3
1138575|NCT02880761|2241603|FG001|Overall Study|Lost to Follow-up|4
1138576|NCT02880865|2241615|FG000|Overall Study|Adverse Event|1
1138577|NCT02880865|2241616|FG001|Overall Study|Adverse Event|0
1138578|NCT02880865|2241615|FG000|Overall Study|Withdrawal by Subject|0
1138579|NCT02880865|2241616|FG001|Overall Study|Withdrawal by Subject|2
1138580|NCT02880865|2241615|FG000|Overall Study|Physician Decision|0
1138581|NCT02880865|2241616|FG001|Overall Study|Physician Decision|1
1138582|NCT02881047|2241671|FG000|Overall Study|Adverse Event|1
1138583|NCT02881047|2241671|FG000|Overall Study|Withdrawal by Subject|1
1138584|NCT02881957|2241707|FG000|Overall Study|Comfort care|0
1138585|NCT02881957|2241708|FG001|Overall Study|Comfort care|1
1138586|NCT02881957|2241707|FG000|Overall Study|Concurrent trial enrollment|0
1138587|NCT02881957|2241708|FG001|Overall Study|Concurrent trial enrollment|1
1138588|NCT02881957|2241707|FG000|Overall Study|Discharged within 48 hours|0
1138589|NCT02881957|2241708|FG001|Overall Study|Discharged within 48 hours|1
1138590|NCT02881957|2241707|FG000|Overall Study|Withdrawal by Subject|2
1138591|NCT02881957|2241708|FG001|Overall Study|Withdrawal by Subject|1
1138592|NCT02881957|2241707|FG000|Overall Study|Protocol Violation|1
1138593|NCT02881957|2241708|FG001|Overall Study|Protocol Violation|0
1138594|NCT02882152|2241725|FG000|Overall Study|Lost to Follow-up|1
1138595|NCT02882152|2241726|FG001|Overall Study|Lost to Follow-up|0
1138596|NCT02882854|2241751|FG000|Overall Study|Lost to Follow-up|1
1138597|NCT02882854|2241752|FG001|Overall Study|Lost to Follow-up|2
1138598|NCT02882854|2241751|FG000|Overall Study|Physician Decision|0
1138599|NCT02882854|2241752|FG001|Overall Study|Physician Decision|1
1138600|NCT02883244|2241760|FG000|Overall Study|Lost to Follow-up|0
1138601|NCT02883244|2241761|FG001|Overall Study|Lost to Follow-up|1
1138602|NCT02883452|2241782|FG000|Overall Study|Withdrawal by Subject|1
1138603|NCT02883452|2241783|FG001|Overall Study|Withdrawal by Subject|1
1138604|NCT02883452|2241784|FG002|Overall Study|Withdrawal by Subject|3
1138605|NCT02883452|2241785|FG003|Overall Study|Withdrawal by Subject|0
1138606|NCT02883452|2241786|FG004|Overall Study|Withdrawal by Subject|2
1138607|NCT02883452|2241787|FG005|Overall Study|Withdrawal by Subject|5
1138608|NCT02883452|2241782|FG000|Overall Study|Disease progression|1
1138609|NCT02883452|2241783|FG001|Overall Study|Disease progression|0
1138610|NCT02883452|2241784|FG002|Overall Study|Disease progression|0
900749|NCT00730028|1874103|FG004|Overall Study|Physician Decision|2
900750|NCT00730028|1874099|FG000|Overall Study|Treatment Failure|5
900751|NCT00730028|1874100|FG001|Overall Study|Treatment Failure|5
900752|NCT00730028|1874101|FG002|Overall Study|Treatment Failure|0
900753|NCT00730028|1874102|FG003|Overall Study|Treatment Failure|0
900754|NCT00730028|1874103|FG004|Overall Study|Treatment Failure|1
900755|NCT00730028|1874099|FG000|Overall Study|Randomization Error|1
900756|NCT00730028|1874100|FG001|Overall Study|Randomization Error|0
900757|NCT00730028|1874101|FG002|Overall Study|Randomization Error|0
900758|NCT00730028|1874102|FG003|Overall Study|Randomization Error|0
900759|NCT00730028|1874103|FG004|Overall Study|Randomization Error|2
900760|NCT00730041|1874117|FG000|Overall Study|Lost to Follow-up|0
900761|NCT00730041|1874118|FG001|Overall Study|Lost to Follow-up|2
900762|NCT00730132|1874124|FG000|Overall Study|Protocol Violation|154
900763|NCT00730132|1874124|FG000|Overall Study|Death|1
900764|NCT00730158|1874133|FG000|Overall Study|Withdrawal by Subject|1
900765|NCT00730158|1874134|FG001|Overall Study|Withdrawal by Subject|1
900766|NCT00730171|1874144|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
900767|NCT00730171|1874144|FG000|Overall Study|Adverse Event|193
900768|NCT00730171|1874144|FG000|Overall Study|Protocol Violation|48
900769|NCT00730171|1874144|FG000|Overall Study|Withdrawal by Subject|202
900770|NCT00730171|1874144|FG000|Overall Study|Lost to Follow-up|121
900771|NCT00730171|1874144|FG000|Overall Study|Insufficient Therapeutic Response|141
900772|NCT00730171|1874144|FG000|Overall Study|Other|61
900773|NCT00730236|1874152|FG000|Overall Study|Adverse Event|4
900774|NCT00730236|1874152|FG000|Overall Study|Withdrawal by Subject|1
900775|NCT00730236|1874152|FG000|Overall Study|Non-compliance|1
900776|NCT00730275|1874160|FG000|Overall Study|Withdrawal by Subject|0
900777|NCT00730275|1874161|FG001|Overall Study|Withdrawal by Subject|0
900778|NCT00730275|1874162|FG002|Overall Study|Withdrawal by Subject|0
900779|NCT00730275|1874163|FG003|Overall Study|Withdrawal by Subject|1
900780|NCT00730327|1874176|FG000|Overall Study|Lost to Follow-up|14
900781|NCT00730327|1874177|FG001|Overall Study|Lost to Follow-up|16
900782|NCT00730327|1874176|FG000|Overall Study|Adverse Event|8
900783|NCT00730327|1874177|FG001|Overall Study|Adverse Event|1
900784|NCT00730327|1874176|FG000|Overall Study|Withdrawal by Subject|3
900785|NCT00730327|1874177|FG001|Overall Study|Withdrawal by Subject|13
900786|NCT00730327|1874176|FG000|Overall Study|Subject withdrew (reason not specified)|2
900787|NCT00730327|1874177|FG001|Overall Study|Subject withdrew (reason not specified)|7
900788|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Adverse Event|5
900789|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Adverse Event|10
900790|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Adverse Event|4
900791|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Adverse Event|8
900792|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Adverse Event|4
900793|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4
900794|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5
900795|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6
900796|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4
900797|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4
900798|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
900799|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
900800|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
900801|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
1138611|NCT02883452|2241785|FG003|Overall Study|Disease progression|1
1138612|NCT02883452|2241786|FG004|Overall Study|Disease progression|4
1138613|NCT02883452|2241787|FG005|Overall Study|Disease progression|5
1138614|NCT02883452|2241782|FG000|Overall Study|Adverse Event|2
1138615|NCT02883452|2241783|FG001|Overall Study|Adverse Event|1
1138616|NCT02883452|2241784|FG002|Overall Study|Adverse Event|1
900802|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
900803|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7
900804|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1
900805|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2
900806|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5
900807|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8
900808|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Did not met eligibility|0
900809|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Did not met eligibility|0
900810|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Did not met eligibility|1
900811|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Did not met eligibility|0
900812|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Did not met eligibility|0
900813|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0
900814|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0
900815|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1
900816|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0
900817|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0
900818|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1
900819|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0
900820|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0
900821|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0
900822|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0
900823|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0
900824|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1
900825|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0
900826|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0
900827|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0
900828|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0
900829|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1
900830|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0
900831|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0
900832|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2
900833|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
900834|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
900835|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
900836|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
900837|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
900838|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Misrandomized|0
900839|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Misrandomized|1
900840|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Misrandomized|0
900841|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Misrandomized|0
900842|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Misrandomized|0
900843|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Study drug interrupted|0
900844|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Study drug interrupted|1
900845|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Study drug interrupted|0
900846|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Study drug interrupted|0
900847|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Study drug interrupted|0
900848|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
900849|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
900850|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
900851|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
900852|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
900853|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
900854|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
900855|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
900856|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1138617|NCT02883452|2241785|FG003|Overall Study|Adverse Event|1
1138618|NCT02883452|2241786|FG004|Overall Study|Adverse Event|1
1138619|NCT02883452|2241787|FG005|Overall Study|Adverse Event|3
1138620|NCT02883452|2241782|FG000|Overall Study|Physician Decision|0
1138621|NCT02883452|2241783|FG001|Overall Study|Physician Decision|0
1138622|NCT02883452|2241784|FG002|Overall Study|Physician Decision|0
1138623|NCT02883452|2241785|FG003|Overall Study|Physician Decision|0
1138624|NCT02883452|2241786|FG004|Overall Study|Physician Decision|4
1138625|NCT02883452|2241787|FG005|Overall Study|Physician Decision|1
1138626|NCT02883452|2241782|FG000|Overall Study|Death|1
1138627|NCT02883452|2241783|FG001|Overall Study|Death|0
1138628|NCT02883452|2241784|FG002|Overall Study|Death|1
1138629|NCT02883452|2241785|FG003|Overall Study|Death|0
1138630|NCT02883452|2241786|FG004|Overall Study|Death|0
1138631|NCT02883452|2241787|FG005|Overall Study|Death|0
1138632|NCT02883452|2241782|FG000|Overall Study|Other|0
1138633|NCT02883452|2241783|FG001|Overall Study|Other|0
1138634|NCT02883452|2241784|FG002|Overall Study|Other|0
1138635|NCT02883452|2241785|FG003|Overall Study|Other|0
1138636|NCT02883452|2241786|FG004|Overall Study|Other|0
1138637|NCT02883452|2241787|FG005|Overall Study|Other|1
1138638|NCT02884089|2241802|FG000|Period 1|Dosing error|2
1138639|NCT02884089|2241803|FG001|Period 1|Dosing error|2
1138640|NCT02884089|2241804|FG002|Period 1|Dosing error|0
1138641|NCT02884089|2241805|FG003|Period 1|Dosing error|0
1138642|NCT02884089|2241802|FG000|Washout Period 1|Lost to Follow-up|0
1138643|NCT02884089|2241803|FG001|Washout Period 1|Lost to Follow-up|1
1138644|NCT02884089|2241804|FG002|Washout Period 1|Lost to Follow-up|0
1138645|NCT02884089|2241805|FG003|Washout Period 1|Lost to Follow-up|1
1138646|NCT02884089|2241802|FG000|Washout Period 1|Withdrawal by Subject|0
1138647|NCT02884089|2241803|FG001|Washout Period 1|Withdrawal by Subject|1
1138648|NCT02884089|2241804|FG002|Washout Period 1|Withdrawal by Subject|0
1138649|NCT02884089|2241805|FG003|Washout Period 1|Withdrawal by Subject|0
1138650|NCT02884089|2241802|FG000|Period 2|Adverse Event|1
1138651|NCT02884089|2241803|FG001|Period 2|Adverse Event|0
1138652|NCT02884089|2241804|FG002|Period 2|Adverse Event|0
1138653|NCT02884089|2241805|FG003|Period 2|Adverse Event|0
1138654|NCT02884089|2241802|FG000|Period 3|Withdrawal by Subject|0
1138655|NCT02884089|2241803|FG001|Period 3|Withdrawal by Subject|0
1138656|NCT02884089|2241804|FG002|Period 3|Withdrawal by Subject|1
1138657|NCT02884089|2241805|FG003|Period 3|Withdrawal by Subject|0
1138658|NCT02884089|2241802|FG000|Washout Period 3|Withdrawal by Subject|0
1138659|NCT02884089|2241803|FG001|Washout Period 3|Withdrawal by Subject|0
1138660|NCT02884089|2241804|FG002|Washout Period 3|Withdrawal by Subject|1
1138661|NCT02884089|2241805|FG003|Washout Period 3|Withdrawal by Subject|0
1138662|NCT02884089|2241802|FG000|Washout Period 3|Lost to Follow-up|0
1138663|NCT02884089|2241803|FG001|Washout Period 3|Lost to Follow-up|0
1138664|NCT02884089|2241804|FG002|Washout Period 3|Lost to Follow-up|0
1138665|NCT02884089|2241805|FG003|Washout Period 3|Lost to Follow-up|1
1138666|NCT02884089|2241802|FG000|Period 4|Withdrawal by Subject|0
1138667|NCT02884089|2241803|FG001|Period 4|Withdrawal by Subject|1
1138668|NCT02884089|2241804|FG002|Period 4|Withdrawal by Subject|0
1138669|NCT02884089|2241805|FG003|Period 4|Withdrawal by Subject|0
1138670|NCT02884089|2241802|FG000|Period 4|Lost to Follow-up|1
1138671|NCT02884089|2241803|FG001|Period 4|Lost to Follow-up|0
1138672|NCT02884089|2241804|FG002|Period 4|Lost to Follow-up|0
900857|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
900858|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Change of location|0
900859|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Change of location|0
900860|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Change of location|0
900861|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Change of location|1
900862|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Change of location|0
900863|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Pregnancy|0
900864|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Pregnancy|1
900865|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Pregnancy|0
900866|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Pregnancy|0
900867|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Pregnancy|0
900868|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
900869|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
900870|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
900871|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
900872|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
900873|NCT00730405|1874192|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1
900874|NCT00730405|1874193|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0
900875|NCT00730405|1874194|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0
900876|NCT00730405|1874195|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0
900877|NCT00730405|1874196|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0
900878|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Adverse Event|2
900879|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Adverse Event|6
900880|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Adverse Event|2
900881|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Adverse Event|3
900882|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Adverse Event|4
1138673|NCT02884089|2241805|FG003|Period 4|Lost to Follow-up|0
1138674|NCT02884089|2241802|FG000|Follow-up Visit|Withdrawal by Subject|1
1138675|NCT02884089|2241803|FG001|Follow-up Visit|Withdrawal by Subject|0
1138676|NCT02884089|2241804|FG002|Follow-up Visit|Withdrawal by Subject|0
1138677|NCT02884089|2241805|FG003|Follow-up Visit|Withdrawal by Subject|1
1138678|NCT02885181|2241875|FG000|Overall Study|Investigator's Discretion|0
1138679|NCT02885181|2241876|FG001|Overall Study|Investigator's Discretion|1
1138680|NCT02885181|2241877|FG002|Overall Study|Investigator's Discretion|0
1138681|NCT02885181|2241878|FG003|Overall Study|Investigator's Discretion|1
1138682|NCT02885181|2241875|FG000|Overall Study|Adverse Event|0
1138683|NCT02885181|2241876|FG001|Overall Study|Adverse Event|0
1138684|NCT02885181|2241877|FG002|Overall Study|Adverse Event|0
1138685|NCT02885181|2241878|FG003|Overall Study|Adverse Event|1
1138686|NCT02885181|2241875|FG000|Overall Study|Withdrawal by Subject|0
1138687|NCT02885181|2241876|FG001|Overall Study|Withdrawal by Subject|0
1138688|NCT02885181|2241877|FG002|Overall Study|Withdrawal by Subject|0
1138689|NCT02885181|2241878|FG003|Overall Study|Withdrawal by Subject|1
1138690|NCT02886338|2241974|FG000|Overall Study|Withdrawal by Subject|1
1138691|NCT02886494|2241980|FG000|Overall Study|Adverse Event|1
1138692|NCT02886494|2241981|FG001|Overall Study|Adverse Event|0
1138693|NCT02886494|2241980|FG000|Overall Study|Withdrawal by Subject|12
1138694|NCT02886494|2241981|FG001|Overall Study|Withdrawal by Subject|3
1138695|NCT02886494|2241980|FG000|Overall Study|Protocol Violation|4
900883|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7
900884|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6
900885|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8
900886|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4
900887|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6
900888|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7
900889|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3
900890|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3
900891|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6
900892|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10
900893|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Death|0
900894|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Death|1
900895|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Death|0
900896|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Death|1
900897|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Death|0
900898|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Change of location|1
900899|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Change of location|1
900900|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Change of location|0
900901|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Change of location|1
900902|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Change of location|0
900903|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Did not met eligibility|0
900904|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Did not met eligibility|0
900905|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Did not met eligibility|1
900906|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Did not met eligibility|0
900907|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Did not met eligibility|0
900908|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0
900909|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0
900910|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1
900911|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0
900912|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0
900913|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
900914|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
900915|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
900916|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
900917|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
900918|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
900919|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
900920|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
900921|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
900922|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
900923|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1
900924|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0
900925|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0
900926|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0
900927|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0
900928|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0
900929|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0
900930|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0
900931|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1
900932|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0
900933|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
1138696|NCT02886494|2241981|FG001|Overall Study|Protocol Violation|1
1138697|NCT02886624|2241990|FG000|12-week Post Treatment Follow-up|Death|1
1138698|NCT02886624|2241990|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1
1138699|NCT02886702|2241997|FG000|Overall Study|Other|4
1138700|NCT02886702|2241998|FG001|Overall Study|Other|3
1138701|NCT02886702|2241999|FG002|Overall Study|Other|9
1138702|NCT02886702|2241997|FG000|Overall Study|Withdrawal by Subject|24
1138703|NCT02886702|2241998|FG001|Overall Study|Withdrawal by Subject|18
1138704|NCT02886702|2241999|FG002|Overall Study|Withdrawal by Subject|22
1138705|NCT02886702|2241997|FG000|Overall Study|Significant Worsening of Condition|0
1138706|NCT02886702|2241998|FG001|Overall Study|Significant Worsening of Condition|1
1138707|NCT02886702|2241999|FG002|Overall Study|Significant Worsening of Condition|0
1138708|NCT02886702|2241997|FG000|Overall Study|Protocol Violation|2
1138709|NCT02886702|2241998|FG001|Overall Study|Protocol Violation|2
1138710|NCT02886702|2241999|FG002|Overall Study|Protocol Violation|1
1138711|NCT02886702|2241997|FG000|Overall Study|Non-Compliance With Study Drug|0
1138712|NCT02886702|2241998|FG001|Overall Study|Non-Compliance With Study Drug|1
1138713|NCT02886702|2241999|FG002|Overall Study|Non-Compliance With Study Drug|4
1138714|NCT02886702|2241997|FG000|Overall Study|Lost to Follow-up|11
1138715|NCT02886702|2241998|FG001|Overall Study|Lost to Follow-up|13
1138716|NCT02886702|2241999|FG002|Overall Study|Lost to Follow-up|8
1138717|NCT02886702|2241997|FG000|Overall Study|Lack of Efficacy|3
1138718|NCT02886702|2241998|FG001|Overall Study|Lack of Efficacy|4
1138719|NCT02886702|2241999|FG002|Overall Study|Lack of Efficacy|5
1138720|NCT02886702|2241997|FG000|Overall Study|Adverse Event|4
1138721|NCT02886702|2241998|FG001|Overall Study|Adverse Event|9
1138722|NCT02886702|2241999|FG002|Overall Study|Adverse Event|3
1138723|NCT02886702|2241997|FG000|Overall Study|Administrative Reasons|0
1138724|NCT02886702|2241998|FG001|Overall Study|Administrative Reasons|0
1138725|NCT02886702|2241999|FG002|Overall Study|Administrative Reasons|1
1138726|NCT02886715|2242010|FG000|Overall Study|Non-Compliance With Study Drug|0
1138727|NCT02886715|2242011|FG001|Overall Study|Non-Compliance With Study Drug|2
1138728|NCT02886715|2242012|FG002|Overall Study|Non-Compliance With Study Drug|0
1138729|NCT02886715|2242010|FG000|Overall Study|Adverse Event|4
1138730|NCT02886715|2242011|FG001|Overall Study|Adverse Event|2
1138731|NCT02886715|2242012|FG002|Overall Study|Adverse Event|0
1138732|NCT02886715|2242010|FG000|Overall Study|Lack of Efficacy|0
1138733|NCT02886715|2242011|FG001|Overall Study|Lack of Efficacy|2
1138734|NCT02886715|2242012|FG002|Overall Study|Lack of Efficacy|1
1138735|NCT02886715|2242010|FG000|Overall Study|Lost to Follow-up|29
1138736|NCT02886715|2242011|FG001|Overall Study|Lost to Follow-up|26
1138737|NCT02886715|2242012|FG002|Overall Study|Lost to Follow-up|10
900934|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
900935|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
900936|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
900937|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
900938|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1
900939|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1
900940|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0
900941|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0
900942|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0
900943|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Use of restricted medication|0
900944|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Use of restricted medication|1
900945|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Use of restricted medication|0
900946|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Use of restricted medication|0
900947|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Use of restricted medication|0
900948|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Non-compliance|1
900949|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Non-compliance|0
900950|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Non-compliance|2
900951|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Non-compliance|0
900952|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Non-compliance|0
900953|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Missing|0
900954|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Missing|0
900955|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Missing|2
900956|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Missing|0
900957|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Missing|0
900958|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0
900959|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0
900960|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0
900961|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0
1138738|NCT02886715|2242010|FG000|Overall Study|Pregnancy|1
1138739|NCT02886715|2242011|FG001|Overall Study|Pregnancy|1
1138740|NCT02886715|2242012|FG002|Overall Study|Pregnancy|1
1138741|NCT02886715|2242010|FG000|Overall Study|Protocol Violation|3
1138742|NCT02886715|2242011|FG001|Overall Study|Protocol Violation|2
1138743|NCT02886715|2242012|FG002|Overall Study|Protocol Violation|1
1138744|NCT02886715|2242010|FG000|Overall Study|Withdrawal by Subject|20
1138745|NCT02886715|2242011|FG001|Overall Study|Withdrawal by Subject|18
1138746|NCT02886715|2242012|FG002|Overall Study|Withdrawal by Subject|5
1138747|NCT02886715|2242010|FG000|Overall Study|missing|7
1138748|NCT02886715|2242011|FG001|Overall Study|missing|2
1138749|NCT02886715|2242012|FG002|Overall Study|missing|2
1138750|NCT02886728|2242024|FG000|Overall Study|Withdrew Consent|31
1138751|NCT02886728|2242025|FG001|Overall Study|Withdrew Consent|13
1138752|NCT02886728|2242026|FG002|Overall Study|Withdrew Consent|11
1138753|NCT02886728|2242027|FG003|Overall Study|Withdrew Consent|47
1138754|NCT02886728|2242024|FG000|Overall Study|Lost to Follow-up|12
1138755|NCT02886728|2242025|FG001|Overall Study|Lost to Follow-up|6
1138756|NCT02886728|2242026|FG002|Overall Study|Lost to Follow-up|13
1138757|NCT02886728|2242027|FG003|Overall Study|Lost to Follow-up|12
1138758|NCT02886728|2242024|FG000|Overall Study|Adverse Event|13
1138759|NCT02886728|2242025|FG001|Overall Study|Adverse Event|5
1138760|NCT02886728|2242026|FG002|Overall Study|Adverse Event|5
1138761|NCT02886728|2242027|FG003|Overall Study|Adverse Event|11
1138762|NCT02886728|2242024|FG000|Overall Study|Investigator's Discretion|11
1138763|NCT02886728|2242025|FG001|Overall Study|Investigator's Discretion|7
1138764|NCT02886728|2242026|FG002|Overall Study|Investigator's Discretion|5
1138765|NCT02886728|2242027|FG003|Overall Study|Investigator's Discretion|11
1138766|NCT02886728|2242024|FG000|Overall Study|Death|3
1138767|NCT02886728|2242025|FG001|Overall Study|Death|1
1138768|NCT02886728|2242026|FG002|Overall Study|Death|0
1138769|NCT02886728|2242027|FG003|Overall Study|Death|0
1138770|NCT02886728|2242024|FG000|Overall Study|Protocol Violation|0
1138771|NCT02886728|2242025|FG001|Overall Study|Protocol Violation|0
1138772|NCT02886728|2242026|FG002|Overall Study|Protocol Violation|0
1138773|NCT02886728|2242027|FG003|Overall Study|Protocol Violation|4
900962|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1
900963|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
900964|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
900965|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
900966|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
900967|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
900968|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Mis-randomized|0
900969|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Mis-randomized|1
900970|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Mis-randomized|0
900971|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Mis-randomized|0
900972|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Mis-randomized|0
900973|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Other Protocol violation|0
900974|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Other Protocol violation|0
900975|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Other Protocol violation|1
900976|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Other Protocol violation|0
900977|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Other Protocol violation|0
900978|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
900979|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
900980|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
900981|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
900982|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
900983|NCT00730405|1874192|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1
900984|NCT00730405|1874193|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0
900985|NCT00730405|1874194|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0
900986|NCT00730405|1874195|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0
900987|NCT00730405|1874196|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0
1138774|NCT02886728|2242024|FG000|Overall Study|Non-Compliance with Study Drug|1
1138775|NCT02886728|2242025|FG001|Overall Study|Non-Compliance with Study Drug|0
1138776|NCT02886728|2242026|FG002|Overall Study|Non-Compliance with Study Drug|1
1138777|NCT02886728|2242027|FG003|Overall Study|Non-Compliance with Study Drug|0
1138778|NCT02886728|2242024|FG000|Overall Study|Pregnancy|0
1138779|NCT02886728|2242025|FG001|Overall Study|Pregnancy|0
1138780|NCT02886728|2242026|FG002|Overall Study|Pregnancy|1
1138781|NCT02886728|2242027|FG003|Overall Study|Pregnancy|0
1138782|NCT02886728|2242024|FG000|Overall Study|Randomized but Not Dosed|1
1138783|NCT02886728|2242025|FG001|Overall Study|Randomized but Not Dosed|0
1138784|NCT02886728|2242026|FG002|Overall Study|Randomized but Not Dosed|0
1138785|NCT02886728|2242027|FG003|Overall Study|Randomized but Not Dosed|2
1138786|NCT02887183|2242044|FG000|Overall Study|Adverse Event|44
1138787|NCT02887183|2242044|FG000|Overall Study|Death|30
1138788|NCT02887183|2242044|FG000|Overall Study|Pregnancy|1
1138789|NCT02887183|2242044|FG000|Overall Study|Protocol Violation|6
1138790|NCT02887183|2242044|FG000|Overall Study|Technical Problems|2
1138791|NCT02887183|2242044|FG000|Overall Study|Lost to Follow-up|13
1138792|NCT02887183|2242044|FG000|Overall Study|Physician Decision|10
1138793|NCT02887183|2242044|FG000|Overall Study|Withdrawal by Subject|35
1138794|NCT02887521|2242060|FG000|Overall Study|Withdrawal by Subject|0
901033|NCT00730691|1874263|FG000|Overall Study|Adverse Event|4
901034|NCT00730691|1874264|FG001|Overall Study|Adverse Event|8
901035|NCT00730691|1874265|FG002|Overall Study|Adverse Event|11
901036|NCT00730691|1874266|FG003|Overall Study|Adverse Event|11
901037|NCT00730691|1874267|FG004|Overall Study|Adverse Event|23
901038|NCT00730691|1874263|FG000|Overall Study|Lack of Efficacy|4
901039|NCT00730691|1874264|FG001|Overall Study|Lack of Efficacy|4
901040|NCT00730691|1874265|FG002|Overall Study|Lack of Efficacy|2
901041|NCT00730691|1874266|FG003|Overall Study|Lack of Efficacy|1
901042|NCT00730691|1874267|FG004|Overall Study|Lack of Efficacy|1
901043|NCT00730691|1874263|FG000|Overall Study|Non-compliance with Study Drug|6
901044|NCT00730691|1874264|FG001|Overall Study|Non-compliance with Study Drug|1
901045|NCT00730691|1874265|FG002|Overall Study|Non-compliance with Study Drug|6
901046|NCT00730691|1874266|FG003|Overall Study|Non-compliance with Study Drug|3
901047|NCT00730691|1874267|FG004|Overall Study|Non-compliance with Study Drug|3
901048|NCT00730691|1874263|FG000|Overall Study|Protocol Deviations|3
901049|NCT00730691|1874264|FG001|Overall Study|Protocol Deviations|5
901050|NCT00730691|1874265|FG002|Overall Study|Protocol Deviations|3
901051|NCT00730691|1874266|FG003|Overall Study|Protocol Deviations|7
901052|NCT00730691|1874267|FG004|Overall Study|Protocol Deviations|5
901053|NCT00730691|1874263|FG000|Overall Study|Withdrawal of Consent|7
901054|NCT00730691|1874264|FG001|Overall Study|Withdrawal of Consent|9
901055|NCT00730691|1874265|FG002|Overall Study|Withdrawal of Consent|3
901056|NCT00730691|1874266|FG003|Overall Study|Withdrawal of Consent|6
901057|NCT00730691|1874267|FG004|Overall Study|Withdrawal of Consent|3
901058|NCT00730691|1874263|FG000|Overall Study|Lost to Follow-up|11
901059|NCT00730691|1874264|FG001|Overall Study|Lost to Follow-up|8
901060|NCT00730691|1874265|FG002|Overall Study|Lost to Follow-up|13
901061|NCT00730691|1874266|FG003|Overall Study|Lost to Follow-up|15
901062|NCT00730691|1874267|FG004|Overall Study|Lost to Follow-up|13
901063|NCT00730691|1874263|FG000|Overall Study|Other|1
901064|NCT00730691|1874264|FG001|Overall Study|Other|1
901065|NCT00730691|1874265|FG002|Overall Study|Other|1
901066|NCT00730691|1874266|FG003|Overall Study|Other|2
901067|NCT00730691|1874267|FG004|Overall Study|Other|2
901068|NCT00730756|1874285|FG000|Overall Study|Adverse Event|2
901069|NCT00730756|1874286|FG001|Overall Study|Adverse Event|0
901070|NCT00730756|1874285|FG000|Overall Study|Lack of Efficacy|1
901071|NCT00730756|1874286|FG001|Overall Study|Lack of Efficacy|1
901072|NCT00730756|1874285|FG000|Overall Study|Protocol Deviation|1
901073|NCT00730756|1874286|FG001|Overall Study|Protocol Deviation|2
901074|NCT00730756|1874285|FG000|Overall Study|Lost to Follow-up|0
901075|NCT00730756|1874286|FG001|Overall Study|Lost to Follow-up|1
901076|NCT00730756|1874285|FG000|Overall Study|Withdrew Consent|0
901077|NCT00730756|1874286|FG001|Overall Study|Withdrew Consent|1
901078|NCT00730847|1874292|FG000|Overall Study|Adverse Event|1
901079|NCT00730847|1874292|FG000|Overall Study|Protocol Violation|2
1138795|NCT02887521|2242061|FG001|Overall Study|Withdrawal by Subject|3
1138796|NCT02887989|2242069|FG000|Overall Study|Withdrawal by Subject|8
1138797|NCT02887989|2242070|FG001|Overall Study|Withdrawal by Subject|11
1138798|NCT02887989|2242069|FG000|Overall Study|Death|1
1138799|NCT02887989|2242070|FG001|Overall Study|Death|0
1138800|NCT02888080|2242078|FG000|Overall Study|Subject / Guardian decision|1
1138801|NCT02888080|2242079|FG001|Overall Study|Subject / Guardian decision|3
1138802|NCT02888080|2242078|FG000|Overall Study|New Therapy for study indication|1
1138803|NCT02888080|2242079|FG001|Overall Study|New Therapy for study indication|0
1138804|NCT02888080|2242078|FG000|Overall Study|Lack of Efficacy|0
1138805|NCT02888080|2242079|FG001|Overall Study|Lack of Efficacy|1
1138806|NCT02888080|2242078|FG000|Overall Study|Adverse Event|0
1138807|NCT02888080|2242079|FG001|Overall Study|Adverse Event|1
1138808|NCT02888106|2242102|FG000|Overall Study|Withdrawal by Subject|1
1138809|NCT02888106|2242103|FG001|Overall Study|Withdrawal by Subject|2
1138810|NCT02888106|2242104|FG002|Overall Study|Withdrawal by Subject|0
901080|NCT00730847|1874292|FG000|Overall Study|Withdrawal by Subject|16
901081|NCT00730847|1874292|FG000|Overall Study|Lost to Follow-up|67
901082|NCT00730847|1874292|FG000|Overall Study|Unknown completion status|21
901083|NCT00730847|1874292|FG000|Overall Study|Other|24
901084|NCT00730912|1874299|FG000|Overall Study|Discontinued|0
901085|NCT00730912|1874300|FG001|Overall Study|Discontinued|0
901086|NCT00730912|1874301|FG002|Overall Study|Discontinued|1
901087|NCT00730925|1874309|FG000|Overall Study|Progressive Disease|21
901088|NCT00730925|1874309|FG000|Overall Study|Dose reducing Event|2
901089|NCT00730925|1874309|FG000|Overall Study|Other Averse Event|7
901090|NCT00730925|1874309|FG000|Overall Study|Protocol Violation|1
901091|NCT00730925|1874309|FG000|Overall Study|Withdrawal by Subject|1
901092|NCT00730925|1874309|FG000|Overall Study|Switch to combination therapy|8
901093|NCT00730925|1874309|FG000|Overall Study|Other|1
901094|NCT00731042|1874320|FG000|Second Intervention|Did not meet inclusion criteria|0
901095|NCT00731042|1874321|FG001|Second Intervention|Did not meet inclusion criteria|2
901096|NCT00731120|1874346|FG000|Overall Study|Adverse Event|7
901097|NCT00731120|1874347|FG001|Overall Study|Adverse Event|6
901098|NCT00731120|1874348|FG002|Overall Study|Adverse Event|8
901099|NCT00731120|1874346|FG000|Overall Study|Lack of Efficacy|4
901100|NCT00731120|1874347|FG001|Overall Study|Lack of Efficacy|5
901101|NCT00731120|1874348|FG002|Overall Study|Lack of Efficacy|4
901102|NCT00731120|1874346|FG000|Overall Study|Noncompliance with Study Drug|3
901103|NCT00731120|1874347|FG001|Overall Study|Noncompliance with Study Drug|3
901104|NCT00731120|1874348|FG002|Overall Study|Noncompliance with Study Drug|1
901105|NCT00731120|1874346|FG000|Overall Study|Protocol Deviations|1
901106|NCT00731120|1874347|FG001|Overall Study|Protocol Deviations|6
901107|NCT00731120|1874348|FG002|Overall Study|Protocol Deviations|1
901108|NCT00731120|1874346|FG000|Overall Study|Withdrawal of Consent|13
901109|NCT00731120|1874347|FG001|Overall Study|Withdrawal of Consent|8
901110|NCT00731120|1874348|FG002|Overall Study|Withdrawal of Consent|4
901111|NCT00731120|1874346|FG000|Overall Study|Lost to Follow-up|10
901112|NCT00731120|1874347|FG001|Overall Study|Lost to Follow-up|15
901113|NCT00731120|1874348|FG002|Overall Study|Lost to Follow-up|17
901114|NCT00731120|1874346|FG000|Overall Study|Other|4
901115|NCT00731120|1874347|FG001|Overall Study|Other|0
901116|NCT00731120|1874348|FG002|Overall Study|Other|1
901117|NCT00731133|1874356|FG000|Overall Study|Withdrawal by Subject|10
901118|NCT00731549|1874381|FG000|Overall Study|Lost to Follow-up|19
901119|NCT00731549|1874381|FG000|Overall Study|Met withdrawal criteria|24
901120|NCT00731549|1874381|FG000|Overall Study|Physician Decision|16
901121|NCT00731549|1874381|FG000|Overall Study|Withdrawal by Subject|89
901122|NCT00731549|1874381|FG000|Overall Study|Protocol deviation|1
901123|NCT00731549|1874381|FG000|Overall Study|Adverse Event|31
901124|NCT00731549|1874381|FG000|Overall Study|Lack of efficacy with AE|37
901125|NCT00731549|1874381|FG000|Overall Study|Lack of efficacy without AE|6
901126|NCT00731666|1874417|FG000|Overall Study|Adverse Event|2
901127|NCT00731666|1874417|FG000|Overall Study|Lost to Follow-up|8
901128|NCT00731666|1874417|FG000|Overall Study|Withdrawal by Subject|2
901129|NCT00731679|1874423|FG000|Overall Study|Adverse Event|7
901130|NCT00731679|1874424|FG001|Overall Study|Adverse Event|8
901131|NCT00731679|1874423|FG000|Overall Study|Withdrawal by Subject|8
901132|NCT00731679|1874424|FG001|Overall Study|Withdrawal by Subject|8
901133|NCT00731679|1874423|FG000|Overall Study|Lost to Follow-up|7
901134|NCT00731679|1874424|FG001|Overall Study|Lost to Follow-up|8
901135|NCT00731679|1874423|FG000|Overall Study|Noncompliance|0
901136|NCT00731679|1874424|FG001|Overall Study|Noncompliance|1
901137|NCT00731679|1874423|FG000|Overall Study|Pregnancy|0
901138|NCT00731679|1874424|FG001|Overall Study|Pregnancy|1
901139|NCT00731692|1874433|FG000|Core Study (36 Months)|Lack of Efficacy|11
901140|NCT00731692|1874434|FG001|Core Study (36 Months)|Lack of Efficacy|23
901141|NCT00731692|1874435|FG002|Core Study (36 Months)|Lack of Efficacy|64
901142|NCT00731692|1874433|FG000|Core Study (36 Months)|Physician Decision|1
901143|NCT00731692|1874434|FG001|Core Study (36 Months)|Physician Decision|0
901144|NCT00731692|1874435|FG002|Core Study (36 Months)|Physician Decision|2
901145|NCT00731692|1874433|FG000|Core Study (36 Months)|Death|2
901146|NCT00731692|1874434|FG001|Core Study (36 Months)|Death|1
901147|NCT00731692|1874435|FG002|Core Study (36 Months)|Death|2
901148|NCT00731692|1874433|FG000|Core Study (36 Months)|Lost to Follow-up|1
1138811|NCT02888106|2242105|FG003|Overall Study|Withdrawal by Subject|1
1138812|NCT02888106|2242106|FG004|Overall Study|Withdrawal by Subject|0
1138813|NCT02888106|2242107|FG005|Overall Study|Withdrawal by Subject|0
1138814|NCT02888106|2242102|FG000|Overall Study|Lost to Follow-up|1
1138815|NCT02888106|2242103|FG001|Overall Study|Lost to Follow-up|0
1138816|NCT02888106|2242104|FG002|Overall Study|Lost to Follow-up|0
1138817|NCT02888106|2242105|FG003|Overall Study|Lost to Follow-up|1
1138818|NCT02888106|2242106|FG004|Overall Study|Lost to Follow-up|0
1138819|NCT02888106|2242107|FG005|Overall Study|Lost to Follow-up|1
1138820|NCT02888106|2242102|FG000|Overall Study|Adverse Event|2
1138821|NCT02888106|2242103|FG001|Overall Study|Adverse Event|0
1138822|NCT02888106|2242104|FG002|Overall Study|Adverse Event|0
1138823|NCT02888106|2242105|FG003|Overall Study|Adverse Event|0
1138824|NCT02888106|2242106|FG004|Overall Study|Adverse Event|0
1138825|NCT02888106|2242107|FG005|Overall Study|Adverse Event|0
1138826|NCT02888106|2242102|FG000|Overall Study|Withdrawal of consent|0
1138827|NCT02888106|2242103|FG001|Overall Study|Withdrawal of consent|0
901149|NCT00731692|1874434|FG001|Core Study (36 Months)|Lost to Follow-up|3
901150|NCT00731692|1874435|FG002|Core Study (36 Months)|Lost to Follow-up|3
901151|NCT00731692|1874433|FG000|Core Study (36 Months)|Administrative|2
901152|NCT00731692|1874434|FG001|Core Study (36 Months)|Administrative|2
901153|NCT00731692|1874435|FG002|Core Study (36 Months)|Administrative|6
901154|NCT00731692|1874433|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4
901155|NCT00731692|1874434|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3
901156|NCT00731692|1874435|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5
901157|NCT00731692|1874433|FG000|Core Study (36 Months)|Protocol Violation|4
901158|NCT00731692|1874434|FG001|Core Study (36 Months)|Protocol Violation|5
901159|NCT00731692|1874435|FG002|Core Study (36 Months)|Protocol Violation|8
901160|NCT00731692|1874433|FG000|Core Study (36 Months)|Abnormal Lab values|6
901161|NCT00731692|1874434|FG001|Core Study (36 Months)|Abnormal Lab values|19
901162|NCT00731692|1874435|FG002|Core Study (36 Months)|Abnormal Lab values|5
901163|NCT00731692|1874433|FG000|Core Study (36 Months)|Adverse Event|25
901164|NCT00731692|1874434|FG001|Core Study (36 Months)|Adverse Event|28
901165|NCT00731692|1874435|FG002|Core Study (36 Months)|Adverse Event|29
901166|NCT00731692|1874433|FG000|Core Study (36 Months)|Withdrawal by Subject|12
901167|NCT00731692|1874434|FG001|Core Study (36 Months)|Withdrawal by Subject|32
901168|NCT00731692|1874435|FG002|Core Study (36 Months)|Withdrawal by Subject|46
901169|NCT00731692|1874433|FG000|Extension Phase|Admin Problems: Terminated # patients|69
901170|NCT00731692|1874434|FG001|Extension Phase|Admin Problems: Terminated # patients|189
901171|NCT00731692|1874435|FG002|Extension Phase|Admin Problems: Terminated # patients|277
901172|NCT00731692|1874433|FG000|Extension Phase|Abnormal test procedure|0
901173|NCT00731692|1874434|FG001|Extension Phase|Abnormal test procedure|0
901174|NCT00731692|1874435|FG002|Extension Phase|Abnormal test procedure|1
901175|NCT00731692|1874433|FG000|Extension Phase|Abnormal lab values|0
901176|NCT00731692|1874434|FG001|Extension Phase|Abnormal lab values|0
901177|NCT00731692|1874435|FG002|Extension Phase|Abnormal lab values|1
901178|NCT00731692|1874433|FG000|Extension Phase|Lost to Follow-up|0
901179|NCT00731692|1874434|FG001|Extension Phase|Lost to Follow-up|1
901180|NCT00731692|1874435|FG002|Extension Phase|Lost to Follow-up|4
901181|NCT00731692|1874433|FG000|Extension Phase|Withdrawal by Subject|4
901182|NCT00731692|1874434|FG001|Extension Phase|Withdrawal by Subject|5
901183|NCT00731692|1874435|FG002|Extension Phase|Withdrawal by Subject|3
901184|NCT00731692|1874433|FG000|Extension Phase|Adverse Event|1
901185|NCT00731692|1874434|FG001|Extension Phase|Adverse Event|1
901186|NCT00731692|1874435|FG002|Extension Phase|Adverse Event|15
901187|NCT00731783|1874453|FG000|One Month Follow-Up Visit|Lost to Follow-up|14
901188|NCT00731783|1874454|FG001|One Month Follow-Up Visit|Lost to Follow-up|22
901189|NCT00731783|1874453|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7
901190|NCT00731783|1874454|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16
901191|NCT00731783|1874453|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6
901192|NCT00731783|1874454|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3
901193|NCT00731783|1874453|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6
901194|NCT00731783|1874454|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7
901195|NCT00731822|1874462|FG000|Overall Study|Adverse Event|2
901196|NCT00731822|1874463|FG001|Overall Study|Adverse Event|1
901197|NCT00731822|1874462|FG000|Overall Study|Protocol Violation|1
901198|NCT00731822|1874463|FG001|Overall Study|Protocol Violation|0
901199|NCT00731822|1874462|FG000|Overall Study|Lost to Follow-up|1
901200|NCT00731822|1874463|FG001|Overall Study|Lost to Follow-up|0
901201|NCT00731939|1874478|FG000|Overall Study|Adverse Event|6
901202|NCT00731939|1874478|FG000|Overall Study|Lost to Follow-up|15
901203|NCT00731939|1874478|FG000|Overall Study|Not implanted with study device|9
901204|NCT00731939|1874478|FG000|Overall Study|Withdrawal by Subject|2
901205|NCT00731939|1874478|FG000|Overall Study|Did not meet enrollment criteria|2
901206|NCT00732069|1874486|FG000|Washout After First Study Drug|Adverse Event|1
901207|NCT00732069|1874487|FG001|Washout After First Study Drug|Adverse Event|0
901208|NCT00732069|1874488|FG002|Washout After First Study Drug|Adverse Event|0
901209|NCT00732069|1874489|FG003|Washout After First Study Drug|Adverse Event|0
901210|NCT00732069|1874490|FG004|Washout After First Study Drug|Adverse Event|0
901211|NCT00732069|1874491|FG005|Washout After First Study Drug|Adverse Event|0
901212|NCT00732160|1874503|FG000|Overall Study|Adverse Event|1
1138828|NCT02888106|2242104|FG002|Overall Study|Withdrawal of consent|0
1138829|NCT02888106|2242105|FG003|Overall Study|Withdrawal of consent|0
1138830|NCT02888106|2242106|FG004|Overall Study|Withdrawal of consent|1
1138831|NCT02888106|2242107|FG005|Overall Study|Withdrawal of consent|0
1138832|NCT02888106|2242102|FG000|Overall Study|Pregnancy|1
1138833|NCT02888106|2242103|FG001|Overall Study|Pregnancy|0
1138834|NCT02888106|2242104|FG002|Overall Study|Pregnancy|0
1138835|NCT02888106|2242105|FG003|Overall Study|Pregnancy|0
1138836|NCT02888106|2242106|FG004|Overall Study|Pregnancy|0
1138837|NCT02888106|2242107|FG005|Overall Study|Pregnancy|0
1138838|NCT02888171|2242129|FG000|Overall Study|Lost to Follow-up|2
1138839|NCT02888171|2242130|FG001|Overall Study|Lost to Follow-up|1
1138840|NCT02888171|2242129|FG000|Overall Study|Withdrawal by Subject|3
1138841|NCT02888171|2242130|FG001|Overall Study|Withdrawal by Subject|2
1138842|NCT02888171|2242129|FG000|Overall Study|Adverse Event|0
1138843|NCT02888171|2242130|FG001|Overall Study|Adverse Event|1
1138844|NCT02888756|2242160|FG000|Analytical Treatment Interruption|Physician Decision|10
901213|NCT00732160|1874504|FG001|Overall Study|Adverse Event|0
901214|NCT00732160|1874505|FG002|Overall Study|Adverse Event|1
901215|NCT00732160|1874506|FG003|Overall Study|Adverse Event|1
901216|NCT00732160|1874503|FG000|Overall Study|scheduling|4
901217|NCT00732160|1874504|FG001|Overall Study|scheduling|4
901218|NCT00732160|1874505|FG002|Overall Study|scheduling|2
901219|NCT00732160|1874506|FG003|Overall Study|scheduling|1
901220|NCT00732199|1874518|FG000|Overall Study|Withdrawal by Subject|25
901221|NCT00732199|1874519|FG001|Overall Study|Withdrawal by Subject|18
901222|NCT00732199|1874518|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9
901223|NCT00732199|1874519|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8
901224|NCT00732238|1874586|FG000|Overall Study|Bacteremia|4
901225|NCT00732238|1874587|FG001|Overall Study|Bacteremia|1
901226|NCT00732238|1874586|FG000|Overall Study|Asymptomatic bacteriuria|1
901227|NCT00732238|1874587|FG001|Overall Study|Asymptomatic bacteriuria|0
901228|NCT00732251|1874595|FG000|Overall Study|Lost to Follow-up|3
901229|NCT00732251|1874595|FG000|Overall Study|Withdrawal by Subject|3
901230|NCT00732251|1874595|FG000|Overall Study|Early Term due to Site Closure|1
901231|NCT00732303|1874599|FG000|Overall Study|Study Terminated|2
901232|NCT00732381|1874605|FG000|Overall Study|Adverse Event|1
901233|NCT00732381|1874606|FG001|Overall Study|Adverse Event|0
901234|NCT00732381|1874605|FG000|Overall Study|Treatment Failure|1
901235|NCT00732381|1874606|FG001|Overall Study|Treatment Failure|1
901236|NCT00732472|1874616|FG000|Overall Study|Adverse Event|0
901237|NCT00732472|1874617|FG001|Overall Study|Adverse Event|1
901238|NCT00732472|1874618|FG002|Overall Study|Adverse Event|1
901239|NCT00732472|1874619|FG003|Overall Study|Adverse Event|1
901240|NCT00732472|1874616|FG000|Overall Study|Protocol Violation|0
901241|NCT00732472|1874617|FG001|Overall Study|Protocol Violation|0
901242|NCT00732472|1874618|FG002|Overall Study|Protocol Violation|0
901243|NCT00732472|1874619|FG003|Overall Study|Protocol Violation|1
901244|NCT00732472|1874616|FG000|Overall Study|Withdrawal by Subject|0
901245|NCT00732472|1874617|FG001|Overall Study|Withdrawal by Subject|2
901246|NCT00732472|1874618|FG002|Overall Study|Withdrawal by Subject|0
901247|NCT00732472|1874619|FG003|Overall Study|Withdrawal by Subject|1
901248|NCT00732498|1874630|FG000|Overall Study|Ineligible|1
901249|NCT00732498|1874630|FG000|Overall Study|Adverse Event|2
901250|NCT00732498|1874630|FG000|Overall Study|Physician Decision|3
901251|NCT00732615|1874636|FG000|Overall Study|Withdrawal by Subject|3
901252|NCT00732615|1874637|FG001|Overall Study|Withdrawal by Subject|1
901253|NCT00732615|1874636|FG000|Overall Study|Lost to Follow-up|0
901254|NCT00732615|1874637|FG001|Overall Study|Lost to Follow-up|1
901255|NCT00732615|1874636|FG000|Overall Study|Adverse Event|0
901256|NCT00732615|1874637|FG001|Overall Study|Adverse Event|2
901257|NCT00732615|1874636|FG000|Overall Study|Physician Decision|3
901258|NCT00732615|1874637|FG001|Overall Study|Physician Decision|0
901259|NCT00732615|1874636|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1
901260|NCT00732615|1874637|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1
901261|NCT00732641|1874646|FG000|Overall Study|Relapse or Progressive Disease|65
901262|NCT00732641|1874647|FG001|Overall Study|Relapse or Progressive Disease|101
901263|NCT00732641|1874646|FG000|Overall Study|Serious Adverse Events|12
901264|NCT00732641|1874647|FG001|Overall Study|Serious Adverse Events|3
901265|NCT00732641|1874646|FG000|Overall Study|Physician Decision|6
901266|NCT00732641|1874647|FG001|Overall Study|Physician Decision|0
901267|NCT00732641|1874646|FG000|Overall Study|Withdrawal by Subject|4
901268|NCT00732641|1874647|FG001|Overall Study|Withdrawal by Subject|2
901269|NCT00732641|1874646|FG000|Overall Study|Unable to Complete|1
901270|NCT00732641|1874647|FG001|Overall Study|Unable to Complete|1
901271|NCT00732641|1874646|FG000|Overall Study|Other|18
901272|NCT00732641|1874647|FG001|Overall Study|Other|5
901273|NCT00732758|1874668|FG000|Overall Study|Lost to Follow-up|8
901274|NCT00732758|1874669|FG001|Overall Study|Lost to Follow-up|16
901275|NCT00732875|1874675|FG000|Overall Study|Adverse Event|16
901276|NCT00732875|1874675|FG000|Overall Study|Withdrawal by Subject|6
901277|NCT00732875|1874675|FG000|Overall Study|Lack of Efficacy|13
901278|NCT00732940|1874690|FG000|Overall Study|Withdrawal by Subject|1
901279|NCT00732940|1874691|FG001|Overall Study|Withdrawal by Subject|2
901280|NCT00732940|1874690|FG000|Overall Study|Adverse Event|0
901281|NCT00732940|1874691|FG001|Overall Study|Adverse Event|1
1138845|NCT02888756|2242161|FG001|Analytical Treatment Interruption|Physician Decision|6
1138846|NCT02888756|2242162|FG002|Analytical Treatment Interruption|Physician Decision|5
1138847|NCT02889562|2242193|FG000|Overall Study|Physician Decision|0
1138848|NCT02889562|2242194|FG001|Overall Study|Physician Decision|1
1138849|NCT02889562|2242193|FG000|Overall Study|Withdrawal by Subject|0
1138850|NCT02889562|2242194|FG001|Overall Study|Withdrawal by Subject|1
901282|NCT00732940|1874690|FG000|Overall Study|Lost to Follow-up|1
901283|NCT00732940|1874691|FG001|Overall Study|Lost to Follow-up|0
901284|NCT00732992|1874699|FG000|Overall Study|Adverse Event|1
901285|NCT00732992|1874700|FG001|Overall Study|Adverse Event|1
901286|NCT00732992|1874699|FG000|Overall Study|Objective Progression or Relapse|3
901287|NCT00732992|1874700|FG001|Overall Study|Objective Progression or Relapse|5
901288|NCT00732992|1874699|FG000|Overall Study|Global Deterioration of Health Status|1
901289|NCT00732992|1874700|FG001|Overall Study|Global Deterioration of Health Status|0
901290|NCT00732992|1874699|FG000|Overall Study|Withdrawal by Subject|1
901291|NCT00732992|1874700|FG001|Overall Study|Withdrawal by Subject|0
901292|NCT00733005|1874709|FG000|Overall Study|Adverse Event|0
901293|NCT00733005|1874710|FG001|Overall Study|Adverse Event|1
901294|NCT00733005|1874709|FG000|Overall Study|Treatment Failure|0
901295|NCT00733005|1874710|FG001|Overall Study|Treatment Failure|1
901296|NCT00733005|1874709|FG000|Overall Study|Withdrawal by Subject|0
901297|NCT00733005|1874710|FG001|Overall Study|Withdrawal by Subject|1
901298|NCT00733005|1874709|FG000|Overall Study|Protocol Violation|2
901299|NCT00733005|1874710|FG001|Overall Study|Protocol Violation|0
901300|NCT00733226|1874737|FG000|Overall Study|Withdrawal by Subject|1
901301|NCT00733226|1874738|FG001|Overall Study|Withdrawal by Subject|0
901302|NCT00733226|1874737|FG000|Overall Study|Lost to Follow-up|2
901303|NCT00733226|1874738|FG001|Overall Study|Lost to Follow-up|0
901304|NCT00733226|1874737|FG000|Overall Study|moved to another place|2
901305|NCT00733226|1874738|FG001|Overall Study|moved to another place|0
901306|NCT00733291|1874751|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
901307|NCT00733291|1874752|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
901308|NCT00733291|1874753|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
901309|NCT00733291|1874754|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
901310|NCT00733304|1874768|FG000|Overall Study|Adverse Event|3
901311|NCT00733304|1874769|FG001|Overall Study|Adverse Event|0
901312|NCT00733304|1874770|FG002|Overall Study|Adverse Event|0
901313|NCT00733304|1874768|FG000|Overall Study|Lack of Efficacy|0
901314|NCT00733304|1874769|FG001|Overall Study|Lack of Efficacy|0
901315|NCT00733304|1874770|FG002|Overall Study|Lack of Efficacy|2
901316|NCT00733304|1874768|FG000|Overall Study|Lost to Follow-up|0
901317|NCT00733304|1874769|FG001|Overall Study|Lost to Follow-up|1
901318|NCT00733304|1874770|FG002|Overall Study|Lost to Follow-up|0
901319|NCT00733304|1874768|FG000|Overall Study|Physician Decision|3
901320|NCT00733304|1874769|FG001|Overall Study|Physician Decision|1
901321|NCT00733304|1874770|FG002|Overall Study|Physician Decision|3
901322|NCT00733304|1874768|FG000|Overall Study|Withdrawal by Subject|1
901323|NCT00733304|1874769|FG001|Overall Study|Withdrawal by Subject|1
901324|NCT00733304|1874770|FG002|Overall Study|Withdrawal by Subject|0
901325|NCT00733369|1874805|FG000|Overall Study|Lost to Follow-up|2
901326|NCT00733369|1874806|FG001|Overall Study|Lost to Follow-up|1
901327|NCT00733369|1874805|FG000|Overall Study|Adverse Event|4
901328|NCT00733369|1874806|FG001|Overall Study|Adverse Event|4
901329|NCT00733369|1874805|FG000|Overall Study|Protocol Violation|4
901330|NCT00733369|1874806|FG001|Overall Study|Protocol Violation|4
901331|NCT00733408|1874812|FG000|Overall Study|Adverse Event|4
901332|NCT00733421|1874818|FG000|Overall Study|Withdrawal by Subject|1
901333|NCT00733421|1874819|FG001|Overall Study|Withdrawal by Subject|1
901334|NCT00733499|1874827|FG000|Pre-operative|Protocol Violation|0
901335|NCT00733499|1874828|FG001|Pre-operative|Protocol Violation|1
901336|NCT00733499|1874827|FG000|3 Months Follow-up|Death|1
901337|NCT00733499|1874828|FG001|3 Months Follow-up|Death|2
901338|NCT00733499|1874827|FG000|6 Months Follow-up|Death|0
901339|NCT00733499|1874828|FG001|6 Months Follow-up|Death|2
901340|NCT00733499|1874827|FG000|6 Months Follow-up|Adverse Event|0
901341|NCT00733499|1874828|FG001|6 Months Follow-up|Adverse Event|1
901342|NCT00733499|1874827|FG000|12 Months Follow-up|Death|2
901343|NCT00733499|1874828|FG001|12 Months Follow-up|Death|1
901344|NCT00733499|1874827|FG000|24 Months Follow-up|Death|0
901345|NCT00733499|1874828|FG001|24 Months Follow-up|Death|1
901346|NCT00733499|1874827|FG000|5 Year Followup|Adverse Event|2
901347|NCT00733499|1874828|FG001|5 Year Followup|Adverse Event|2
901348|NCT00733499|1874827|FG000|5 Year Followup|Non device related AE|0
901349|NCT00733499|1874828|FG001|5 Year Followup|Non device related AE|1
901350|NCT00733499|1874827|FG000|5 Year Followup|Revision of Study Implant|0
901351|NCT00733499|1874828|FG001|5 Year Followup|Revision of Study Implant|1
901352|NCT00733499|1874827|FG000|5 Year Followup|Lost to Follow-up|2
901353|NCT00733499|1874828|FG001|5 Year Followup|Lost to Follow-up|0
901354|NCT00733499|1874827|FG000|5 Year Followup|Death|13
901355|NCT00733499|1874828|FG001|5 Year Followup|Death|19
901356|NCT00733499|1874827|FG000|5 Year Followup|missing, unable to locate|0
901357|NCT00733499|1874828|FG001|5 Year Followup|missing, unable to locate|1
901358|NCT00733499|1874827|FG000|5 Year Followup|Withdrawal by Subject|4
1138851|NCT02889796|2242204|FG000|Overall Study|Withdrew Consent|18
1138852|NCT02889796|2242205|FG001|Overall Study|Withdrew Consent|29
1138853|NCT02889796|2242206|FG002|Overall Study|Withdrew Consent|20
1138854|NCT02889796|2242207|FG003|Overall Study|Withdrew Consent|1
1138855|NCT02889796|2242208|FG004|Overall Study|Withdrew Consent|2
901359|NCT00733499|1874828|FG001|5 Year Followup|Withdrawal by Subject|1
901360|NCT00733499|1874827|FG000|10 Year Followup|Death|9
901361|NCT00733499|1874828|FG001|10 Year Followup|Death|7
901362|NCT00733499|1874827|FG000|10 Year Followup|Adverse Event|3
901363|NCT00733499|1874828|FG001|10 Year Followup|Adverse Event|3
901364|NCT00733499|1874827|FG000|10 Year Followup|Lost to Follow-up|3
901365|NCT00733499|1874828|FG001|10 Year Followup|Lost to Follow-up|2
901366|NCT00733499|1874827|FG000|10 Year Followup|Withdrawal by Subject|5
901367|NCT00733499|1874828|FG001|10 Year Followup|Withdrawal by Subject|5
901368|NCT00733499|1874827|FG000|10 Year Followup|missing, unable to locate|0
901369|NCT00733499|1874828|FG001|10 Year Followup|missing, unable to locate|2
901370|NCT00733746|1874838|FG000|Overall Study|Ineligible|5
901371|NCT00733824|1874847|FG000|Phase I|Withdrawal by Subject|1
901372|NCT00733824|1874848|FG001|Phase I|Withdrawal by Subject|0
901373|NCT00733824|1874849|FG002|Phase I|Withdrawal by Subject|0
901374|NCT00733824|1874850|FG003|Phase I|Withdrawal by Subject|0
901375|NCT00733824|1874851|FG004|Phase I|Withdrawal by Subject|0
901376|NCT00733902|1874869|FG000|Overall Study|Death|0
901377|NCT00733902|1874870|FG001|Overall Study|Death|0
901378|NCT00733902|1874871|FG002|Overall Study|Death|0
901379|NCT00733902|1874872|FG003|Overall Study|Death|1
901380|NCT00733902|1874869|FG000|Overall Study|Adverse Event|3
901381|NCT00733902|1874870|FG001|Overall Study|Adverse Event|4
901382|NCT00733902|1874871|FG002|Overall Study|Adverse Event|7
901383|NCT00733902|1874872|FG003|Overall Study|Adverse Event|11
901384|NCT00733902|1874869|FG000|Overall Study|Lack of Efficacy|56
901385|NCT00733902|1874870|FG001|Overall Study|Lack of Efficacy|21
901386|NCT00733902|1874871|FG002|Overall Study|Lack of Efficacy|34
901387|NCT00733902|1874872|FG003|Overall Study|Lack of Efficacy|23
901388|NCT00733902|1874869|FG000|Overall Study|Protocol Violation|4
901389|NCT00733902|1874870|FG001|Overall Study|Protocol Violation|6
901390|NCT00733902|1874871|FG002|Overall Study|Protocol Violation|3
901391|NCT00733902|1874872|FG003|Overall Study|Protocol Violation|3
901392|NCT00733902|1874869|FG000|Overall Study|Withdrawal by Subject|10
901393|NCT00733902|1874870|FG001|Overall Study|Withdrawal by Subject|5
901394|NCT00733902|1874871|FG002|Overall Study|Withdrawal by Subject|4
901395|NCT00733902|1874872|FG003|Overall Study|Withdrawal by Subject|16
901396|NCT00733902|1874869|FG000|Overall Study|Entered extension study|89
901397|NCT00733902|1874870|FG001|Overall Study|Entered extension study|124
901398|NCT00733902|1874871|FG002|Overall Study|Entered extension study|111
901399|NCT00733902|1874872|FG003|Overall Study|Entered extension study|109
901400|NCT00733902|1874869|FG000|Overall Study|Randomized but not treated|2
901401|NCT00733902|1874870|FG001|Overall Study|Randomized but not treated|2
901402|NCT00733902|1874871|FG002|Overall Study|Randomized but not treated|2
901403|NCT00733902|1874872|FG003|Overall Study|Randomized but not treated|1
901404|NCT00733954|1874884|FG000|Overall Study|Lost to Follow-up|5
901405|NCT00733954|1874885|FG001|Overall Study|Lost to Follow-up|2
901406|NCT00733954|1874884|FG000|Overall Study|Protocol Violation|1
901407|NCT00733954|1874885|FG001|Overall Study|Protocol Violation|0
901408|NCT00733954|1874884|FG000|Overall Study|Withdrawal by Subject|2
901409|NCT00733954|1874885|FG001|Overall Study|Withdrawal by Subject|0
901410|NCT00733980|1874893|FG000|Overall Study|Adverse Event|5
901411|NCT00733980|1874894|FG001|Overall Study|Adverse Event|2
901412|NCT00733980|1874893|FG000|Overall Study|Lack of Efficacy|0
901413|NCT00733980|1874894|FG001|Overall Study|Lack of Efficacy|1
901414|NCT00733980|1874893|FG000|Overall Study|Protocol Violation|2
901415|NCT00733980|1874894|FG001|Overall Study|Protocol Violation|1
901416|NCT00733980|1874893|FG000|Overall Study|Protocol defined stopping criteria reach|1
901417|NCT00733980|1874894|FG001|Overall Study|Protocol defined stopping criteria reach|1
901418|NCT00733980|1874893|FG000|Overall Study|Lost to Follow-up|6
901419|NCT00733980|1874894|FG001|Overall Study|Lost to Follow-up|11
901420|NCT00733980|1874893|FG000|Overall Study|Physician Decision|2
901421|NCT00733980|1874894|FG001|Overall Study|Physician Decision|3
901422|NCT00733980|1874893|FG000|Overall Study|Withdrawal by Subject|6
901423|NCT00733980|1874894|FG001|Overall Study|Withdrawal by Subject|2
901424|NCT00734032|1874919|FG000|Overall Study|Adverse Event|0
901425|NCT00734032|1874920|FG001|Overall Study|Adverse Event|1
901426|NCT00734032|1874921|FG002|Overall Study|Adverse Event|0
901427|NCT00734032|1874922|FG003|Overall Study|Adverse Event|0
901428|NCT00734071|1874934|FG000|Overall Study|Adverse Event|4
901429|NCT00734071|1874935|FG001|Overall Study|Adverse Event|3
901430|NCT00734071|1874934|FG000|Overall Study|Lack of Efficacy|3
901431|NCT00734071|1874935|FG001|Overall Study|Lack of Efficacy|1
901432|NCT00734071|1874934|FG000|Overall Study|Noncompliance|2
901433|NCT00734071|1874935|FG001|Overall Study|Noncompliance|2
901434|NCT00734071|1874934|FG000|Overall Study|Protocol Deviations|3
901435|NCT00734071|1874935|FG001|Overall Study|Protocol Deviations|4
901436|NCT00734071|1874934|FG000|Overall Study|Voluntary Withdrawal|9
901437|NCT00734071|1874935|FG001|Overall Study|Voluntary Withdrawal|7
901438|NCT00734071|1874934|FG000|Overall Study|Lost to Follow-up|16
901439|NCT00734071|1874935|FG001|Overall Study|Lost to Follow-up|8
901440|NCT00734071|1874934|FG000|Overall Study|Other|1
1138856|NCT02889796|2242209|FG005|Overall Study|Withdrew Consent|35
1138857|NCT02889796|2242204|FG000|Overall Study|Investigator's Discretion|10
901441|NCT00734071|1874935|FG001|Overall Study|Other|2
901442|NCT00734097|1874941|FG000|Screening|Protocol Violation|12
901443|NCT00734097|1874941|FG000|Screening|Withdrawal by Subject|5
901444|NCT00734097|1874941|FG000|Screening|Lost to Follow-up|2
901445|NCT00734097|1874941|FG000|Screening|Unconfirmed pregnancy|1
901446|NCT00734097|1874941|FG000|Open Label|Lost to Follow-up|7
901447|NCT00734097|1874941|FG000|Open Label|Withdrawal by Subject|5
901448|NCT00734097|1874941|FG000|Open Label|Protocol Violation|4
901449|NCT00734149|1874945|FG000|Overall Study|Withdrawal by Subject|1
901450|NCT00734162|1874955|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0
901451|NCT00734162|1874956|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1
901452|NCT00734162|1874957|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0
901453|NCT00734162|1874958|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2
901454|NCT00734162|1874955|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
901455|NCT00734162|1874956|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
901456|NCT00734162|1874957|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
901457|NCT00734162|1874958|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
901458|NCT00734162|1874955|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
901459|NCT00734162|1874956|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
901460|NCT00734162|1874957|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
901461|NCT00734162|1874958|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
901462|NCT00734162|1874955|FG000|Open-Label Phase|Withdrew Consent|1
901463|NCT00734162|1874956|FG001|Open-Label Phase|Withdrew Consent|0
901464|NCT00734162|1874957|FG002|Open-Label Phase|Withdrew Consent|1
901465|NCT00734162|1874958|FG003|Open-Label Phase|Withdrew Consent|1
901466|NCT00734162|1874955|FG000|Open-Label Phase|Lost to Follow-up|1
901467|NCT00734162|1874956|FG001|Open-Label Phase|Lost to Follow-up|2
901468|NCT00734162|1874957|FG002|Open-Label Phase|Lost to Follow-up|0
901469|NCT00734162|1874958|FG003|Open-Label Phase|Lost to Follow-up|1
901470|NCT00734162|1874955|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0
901471|NCT00734162|1874956|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
901472|NCT00734162|1874957|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
901473|NCT00734162|1874958|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1
901474|NCT00734214|1874974|FG000|Overall Study|Withdrawal by Subject|3
901475|NCT00734214|1874975|FG001|Overall Study|Withdrawal by Subject|4
901476|NCT00734214|1874974|FG000|Overall Study|MD withdrawal|1
901477|NCT00734214|1874975|FG001|Overall Study|MD withdrawal|0
901478|NCT00734474|1875036|FG000|Overall Study|Entry Criteria Not Met|0
901479|NCT00734474|1875037|FG001|Overall Study|Entry Criteria Not Met|0
901480|NCT00734474|1875038|FG002|Overall Study|Entry Criteria Not Met|5
901481|NCT00734474|1875039|FG003|Overall Study|Entry Criteria Not Met|0
901482|NCT00734474|1875040|FG004|Overall Study|Entry Criteria Not Met|3
901483|NCT00734474|1875041|FG005|Overall Study|Entry Criteria Not Met|1
901484|NCT00734474|1875042|FG006|Overall Study|Entry Criteria Not Met|0
901485|NCT00734474|1875043|FG007|Overall Study|Entry Criteria Not Met|1
901486|NCT00734474|1875044|FG008|Overall Study|Entry Criteria Not Met|1
901487|NCT00734474|1875036|FG000|Overall Study|Lost to Follow-up|1
901488|NCT00734474|1875037|FG001|Overall Study|Lost to Follow-up|0
901489|NCT00734474|1875038|FG002|Overall Study|Lost to Follow-up|13
901490|NCT00734474|1875039|FG003|Overall Study|Lost to Follow-up|0
901491|NCT00734474|1875040|FG004|Overall Study|Lost to Follow-up|11
901492|NCT00734474|1875041|FG005|Overall Study|Lost to Follow-up|1
901493|NCT00734474|1875042|FG006|Overall Study|Lost to Follow-up|0
901494|NCT00734474|1875043|FG007|Overall Study|Lost to Follow-up|9
901495|NCT00734474|1875044|FG008|Overall Study|Lost to Follow-up|4
901496|NCT00734474|1875036|FG000|Overall Study|Withdrawal by Subject|2
901497|NCT00734474|1875037|FG001|Overall Study|Withdrawal by Subject|1
901498|NCT00734474|1875038|FG002|Overall Study|Withdrawal by Subject|18
901499|NCT00734474|1875039|FG003|Overall Study|Withdrawal by Subject|0
901500|NCT00734474|1875040|FG004|Overall Study|Withdrawal by Subject|24
901501|NCT00734474|1875041|FG005|Overall Study|Withdrawal by Subject|2
901502|NCT00734474|1875042|FG006|Overall Study|Withdrawal by Subject|0
901503|NCT00734474|1875043|FG007|Overall Study|Withdrawal by Subject|36
901504|NCT00734474|1875044|FG008|Overall Study|Withdrawal by Subject|21
901505|NCT00734474|1875036|FG000|Overall Study|Physician Decision|0
901506|NCT00734474|1875037|FG001|Overall Study|Physician Decision|0
901507|NCT00734474|1875038|FG002|Overall Study|Physician Decision|4
901508|NCT00734474|1875039|FG003|Overall Study|Physician Decision|1
901509|NCT00734474|1875040|FG004|Overall Study|Physician Decision|11
901510|NCT00734474|1875041|FG005|Overall Study|Physician Decision|0
901511|NCT00734474|1875042|FG006|Overall Study|Physician Decision|0
901512|NCT00734474|1875043|FG007|Overall Study|Physician Decision|9
901513|NCT00734474|1875044|FG008|Overall Study|Physician Decision|9
901514|NCT00734474|1875036|FG000|Overall Study|Adverse Event|4
901515|NCT00734474|1875037|FG001|Overall Study|Adverse Event|4
901516|NCT00734474|1875038|FG002|Overall Study|Adverse Event|63
901517|NCT00734474|1875039|FG003|Overall Study|Adverse Event|1
901518|NCT00734474|1875040|FG004|Overall Study|Adverse Event|64
901519|NCT00734474|1875041|FG005|Overall Study|Adverse Event|0
1138858|NCT02889796|2242205|FG001|Overall Study|Investigator's Discretion|9
1138859|NCT02889796|2242206|FG002|Overall Study|Investigator's Discretion|10
1138860|NCT02889796|2242207|FG003|Overall Study|Investigator's Discretion|3
1138861|NCT02889796|2242208|FG004|Overall Study|Investigator's Discretion|0
1138862|NCT02889796|2242209|FG005|Overall Study|Investigator's Discretion|15
1138863|NCT02889796|2242204|FG000|Overall Study|Adverse Event|17
1138864|NCT02889796|2242205|FG001|Overall Study|Adverse Event|8
1138865|NCT02889796|2242206|FG002|Overall Study|Adverse Event|8
1138866|NCT02889796|2242207|FG003|Overall Study|Adverse Event|4
1138867|NCT02889796|2242208|FG004|Overall Study|Adverse Event|1
1138868|NCT02889796|2242209|FG005|Overall Study|Adverse Event|7
1138869|NCT02889796|2242204|FG000|Overall Study|Lost to Follow-up|5
1138870|NCT02889796|2242205|FG001|Overall Study|Lost to Follow-up|7
1138871|NCT02889796|2242206|FG002|Overall Study|Lost to Follow-up|2
1138872|NCT02889796|2242207|FG003|Overall Study|Lost to Follow-up|0
1138873|NCT02889796|2242208|FG004|Overall Study|Lost to Follow-up|2
1138874|NCT02889796|2242209|FG005|Overall Study|Lost to Follow-up|6
1138875|NCT02889796|2242204|FG000|Overall Study|Protocol Violation|0
1138876|NCT02889796|2242205|FG001|Overall Study|Protocol Violation|1
1138877|NCT02889796|2242206|FG002|Overall Study|Protocol Violation|3
1138878|NCT02889796|2242207|FG003|Overall Study|Protocol Violation|0
1138879|NCT02889796|2242208|FG004|Overall Study|Protocol Violation|0
1138880|NCT02889796|2242209|FG005|Overall Study|Protocol Violation|4
1138881|NCT02889796|2242204|FG000|Overall Study|Non-compliance With Study Drug|0
1138882|NCT02889796|2242205|FG001|Overall Study|Non-compliance With Study Drug|2
1138883|NCT02889796|2242206|FG002|Overall Study|Non-compliance With Study Drug|0
1138884|NCT02889796|2242207|FG003|Overall Study|Non-compliance With Study Drug|0
1138885|NCT02889796|2242208|FG004|Overall Study|Non-compliance With Study Drug|1
1138886|NCT02889796|2242209|FG005|Overall Study|Non-compliance With Study Drug|2
1138887|NCT02889796|2242204|FG000|Overall Study|Death|1
1138888|NCT02889796|2242205|FG001|Overall Study|Death|1
1138889|NCT02889796|2242206|FG002|Overall Study|Death|0
1138890|NCT02889796|2242207|FG003|Overall Study|Death|1
1138891|NCT02889796|2242208|FG004|Overall Study|Death|0
1138892|NCT02889796|2242209|FG005|Overall Study|Death|1
1138893|NCT02889796|2242204|FG000|Overall Study|Pregnancy|0
1138894|NCT02889796|2242205|FG001|Overall Study|Pregnancy|1
1138895|NCT02889796|2242206|FG002|Overall Study|Pregnancy|1
1138896|NCT02889796|2242207|FG003|Overall Study|Pregnancy|0
1138897|NCT02889796|2242208|FG004|Overall Study|Pregnancy|0
1138898|NCT02889796|2242209|FG005|Overall Study|Pregnancy|0
1138899|NCT02889796|2242204|FG000|Overall Study|Randomized but not Dosed|2
1138900|NCT02889796|2242205|FG001|Overall Study|Randomized but not Dosed|0
1138901|NCT02889796|2242206|FG002|Overall Study|Randomized but not Dosed|0
1138902|NCT02889796|2242207|FG003|Overall Study|Randomized but not Dosed|0
1138903|NCT02889796|2242208|FG004|Overall Study|Randomized but not Dosed|0
1138904|NCT02889796|2242209|FG005|Overall Study|Randomized but not Dosed|2
1138905|NCT02889861|2242232|FG000|Overall Study|Ongoing in Survival Follow-up|2
1138906|NCT02889900|2242241|FG000|Overall Study|Adverse Event|11
1138907|NCT02889900|2242241|FG000|Overall Study|Condition under investigation worsened|32
1138908|NCT02889900|2242241|FG000|Overall Study|Other|5
1138909|NCT02889900|2242241|FG000|Overall Study|Withdrawal by Subject|7
1138910|NCT02889900|2242241|FG000|Overall Study|Not treated|2
1138919|NCT02890992|2242277|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0
1138920|NCT02890992|2242278|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1
1138921|NCT02890992|2242279|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0
1138922|NCT02890992|2242280|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0
1138923|NCT02890992|2242281|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0
1138924|NCT02890992|2242282|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0
1138925|NCT02890992|2242283|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0
1138926|NCT02890992|2242284|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0
1138927|NCT02890992|2242277|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0
1138928|NCT02890992|2242278|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0
1138929|NCT02890992|2242279|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0
1138930|NCT02890992|2242280|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0
1138931|NCT02890992|2242281|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0
1138932|NCT02890992|2242282|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0
1138933|NCT02890992|2242283|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1
1138934|NCT02890992|2242284|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1
1138935|NCT02890992|2242277|FG000|130 Weeks Open-Label Extension Period|Other than specified|0
1138936|NCT02890992|2242278|FG001|130 Weeks Open-Label Extension Period|Other than specified|2
1138937|NCT02890992|2242279|FG002|130 Weeks Open-Label Extension Period|Other than specified|0
1138938|NCT02890992|2242280|FG003|130 Weeks Open-Label Extension Period|Other than specified|0
1138939|NCT02890992|2242281|FG004|130 Weeks Open-Label Extension Period|Other than specified|0
1138940|NCT02890992|2242282|FG005|130 Weeks Open-Label Extension Period|Other than specified|0
1138941|NCT02890992|2242283|FG006|130 Weeks Open-Label Extension Period|Other than specified|0
1138942|NCT02890992|2242284|FG007|130 Weeks Open-Label Extension Period|Other than specified|0
1138943|NCT02891070|2242311|FG000|Overall Study|Adverse Event|1
1138944|NCT02891070|2242312|FG001|Overall Study|Adverse Event|0
1138945|NCT02891070|2242311|FG000|Overall Study|Physician Decision|0
1138946|NCT02891070|2242312|FG001|Overall Study|Physician Decision|1
1138947|NCT02891070|2242311|FG000|Overall Study|Lost to Follow-up|4
1138948|NCT02891070|2242312|FG001|Overall Study|Lost to Follow-up|4
1138949|NCT02891070|2242311|FG000|Overall Study|Other|1
1138950|NCT02891070|2242312|FG001|Overall Study|Other|0
1138951|NCT02891070|2242311|FG000|Overall Study|Protocol Violation|0
1138952|NCT02891070|2242312|FG001|Overall Study|Protocol Violation|1
1138953|NCT02891070|2242311|FG000|Overall Study|Withdrawal by Subject|1
1138954|NCT02891070|2242312|FG001|Overall Study|Withdrawal by Subject|2
1138955|NCT02891070|2242311|FG000|Overall Study|Death|3
1138956|NCT02891070|2242312|FG001|Overall Study|Death|0
1138957|NCT02891174|2242320|FG000|First Intervention (24 Hours)|Declined any study medication|1
1138958|NCT02891174|2242321|FG001|First Intervention (24 Hours)|Declined any study medication|5
1138959|NCT02891174|2242320|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0
1138960|NCT02891174|2242321|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2
1138961|NCT02891174|2242320|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2
1138962|NCT02891174|2242321|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6
1138963|NCT02891174|2242320|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1
1138964|NCT02891174|2242321|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0
1138965|NCT02891174|2242320|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3
1138966|NCT02891174|2242321|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5
1138967|NCT02891174|2242320|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
1138968|NCT02891174|2242321|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
1138969|NCT02891174|2242320|FG000|Second Intervention (24 Hours)|Protocol Violation|0
1138970|NCT02891174|2242321|FG001|Second Intervention (24 Hours)|Protocol Violation|1
1138971|NCT02891200|2242333|FG000|Overall Study|Lost to Follow-up|31
1138972|NCT02891200|2242334|FG001|Overall Study|Lost to Follow-up|36
1138973|NCT02891200|2242333|FG000|Overall Study|Death|10
1138974|NCT02891200|2242334|FG001|Overall Study|Death|9
1138975|NCT02891200|2242333|FG000|Overall Study|Withdrawal by Subject|1
901520|NCT00734474|1875042|FG006|Overall Study|Adverse Event|1
901521|NCT00734474|1875043|FG007|Overall Study|Adverse Event|65
901522|NCT00734474|1875044|FG008|Overall Study|Adverse Event|39
901523|NCT00734474|1875036|FG000|Overall Study|Protocol Violation|0
901524|NCT00734474|1875037|FG001|Overall Study|Protocol Violation|0
901525|NCT00734474|1875038|FG002|Overall Study|Protocol Violation|4
1138976|NCT02891200|2242334|FG001|Overall Study|Withdrawal by Subject|4
1138977|NCT02891408|2242347|FG000|Overall Study|Lost to Follow-up|0
1138978|NCT02891408|2242348|FG001|Overall Study|Lost to Follow-up|0
1138979|NCT02891408|2242349|FG002|Overall Study|Lost to Follow-up|1
1138980|NCT02891408|2242350|FG003|Overall Study|Lost to Follow-up|0
1138981|NCT02891408|2242351|FG004|Overall Study|Lost to Follow-up|0
1138982|NCT02891408|2242352|FG005|Overall Study|Lost to Follow-up|0
1138983|NCT02891408|2242353|FG006|Overall Study|Lost to Follow-up|0
1138984|NCT02891681|2242391|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
1138985|NCT02891681|2242392|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
1138986|NCT02891681|2242393|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1
1138987|NCT02891681|2242391|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2
1138988|NCT02891681|2242392|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
1138989|NCT02891681|2242393|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
1138990|NCT02891681|2242391|FG000|Overall Study|Taken off study after first imaging appointment|1
1138991|NCT02891681|2242392|FG001|Overall Study|Taken off study after first imaging appointment|0
1138992|NCT02891681|2242393|FG002|Overall Study|Taken off study after first imaging appointment|0
1138993|NCT02891850|2242403|FG000|Overall Study|Adverse Event|3
1138994|NCT02891850|2242404|FG001|Overall Study|Adverse Event|0
1138995|NCT02891850|2242403|FG000|Overall Study|Death|0
1138996|NCT02891850|2242404|FG001|Overall Study|Death|4
1138997|NCT02891850|2242403|FG000|Overall Study|Physician Decision|1
1138998|NCT02891850|2242404|FG001|Overall Study|Physician Decision|0
1138999|NCT02891850|2242403|FG000|Overall Study|Pregnancy|1
1139000|NCT02891850|2242404|FG001|Overall Study|Pregnancy|0
1139001|NCT02891850|2242403|FG000|Overall Study|Withdrawal by Subject|2
1139002|NCT02891850|2242404|FG001|Overall Study|Withdrawal by Subject|3
1139003|NCT02891915|2242416|FG000|Overall Study|Enrolled but Treatment Not Administered|6
1139004|NCT02891915|2242417|FG001|Overall Study|Enrolled but Treatment Not Administered|4
1139005|NCT02891915|2242416|FG000|Overall Study|Withdrawal by Subject|3
1139006|NCT02891915|2242417|FG001|Overall Study|Withdrawal by Subject|3
1139007|NCT02891915|2242416|FG000|Overall Study|Became Ineligible After Enrollment|2
1139008|NCT02891915|2242417|FG001|Overall Study|Became Ineligible After Enrollment|1
1139009|NCT02891915|2242416|FG000|Overall Study|Lost to Follow-up|1
1139010|NCT02891915|2242417|FG001|Overall Study|Lost to Follow-up|4
1139011|NCT02891915|2242416|FG000|Overall Study|Physician Decision|1
1139012|NCT02891915|2242417|FG001|Overall Study|Physician Decision|0
1139013|NCT02892019|2242425|FG000|Overall Study|randomized but not treated|0
1139014|NCT02892019|2242426|FG001|Overall Study|randomized but not treated|1
1139015|NCT02892019|2242425|FG000|Overall Study|Withdrawal by Subject|0
1139016|NCT02892019|2242426|FG001|Overall Study|Withdrawal by Subject|1
1139017|NCT02892019|2242425|FG000|Overall Study|Adverse Event|1
1139018|NCT02892019|2242426|FG001|Overall Study|Adverse Event|1
1139019|NCT02892344|2242443|FG000|Overall Study|Protocol deviation|3
1139020|NCT02892344|2242444|FG001|Overall Study|Protocol deviation|4
1139021|NCT02892344|2242443|FG000|Overall Study|Adverse Event|1
1139022|NCT02892344|2242444|FG001|Overall Study|Adverse Event|8
1139023|NCT02892344|2242443|FG000|Overall Study|Lost to Follow-up|0
1139024|NCT02892344|2242444|FG001|Overall Study|Lost to Follow-up|1
1139025|NCT02892344|2242443|FG000|Overall Study|Non-compliance with study treatment|0
1139026|NCT02892344|2242444|FG001|Overall Study|Non-compliance with study treatment|1
1139027|NCT02892344|2242443|FG000|Overall Study|Physician Decision|0
1139028|NCT02892344|2242444|FG001|Overall Study|Physician Decision|2
1139029|NCT02892344|2242443|FG000|Overall Study|Subject/guardian decision|0
1139030|NCT02892344|2242444|FG001|Overall Study|Subject/guardian decision|4
1139031|NCT02892344|2242443|FG000|Overall Study|Technical problems|0
1139032|NCT02892344|2242444|FG001|Overall Study|Technical problems|1
1139033|NCT02892409|2242452|FG000|Overall Study|Adverse Event|1
1139034|NCT02892409|2242453|FG001|Overall Study|Adverse Event|0
1139035|NCT02892409|2242452|FG000|Overall Study|Withdrawal by Subject|2
1139036|NCT02892409|2242453|FG001|Overall Study|Withdrawal by Subject|1
1139037|NCT02892422|2242459|FG000|Overall Study|Enrolled not treated|4
1139038|NCT02892422|2242459|FG000|Overall Study|Adverse Event|38
1139039|NCT02892422|2242459|FG000|Overall Study|Lack of Efficacy|32
1139040|NCT02892422|2242459|FG000|Overall Study|Non-compliance with study drug|11
1139041|NCT02892422|2242459|FG000|Overall Study|Protocol Violation|4
1139042|NCT02892422|2242459|FG000|Overall Study|Withdrawal by Subject|56
1139043|NCT02892422|2242459|FG000|Overall Study|Lost to Follow-up|5
1139044|NCT02892422|2242459|FG000|Overall Study|sponsor information 16159A results|21
1139045|NCT02892422|2242459|FG000|Overall Study|withdrawal of consent|13
1139046|NCT02892422|2242459|FG000|Overall Study|exclusion criteria met|3
1139047|NCT02892422|2242459|FG000|Overall Study|moving elsewhere|4
1139048|NCT02892422|2242459|FG000|Overall Study|non-compliance|10
1139049|NCT02892422|2242459|FG000|Overall Study|patient legally incapable|1
1139050|NCT02892422|2242459|FG000|Overall Study|patient decision|7
1139051|NCT02892422|2242459|FG000|Overall Study|Investigator decision|1
1139052|NCT02892448|2242466|FG000|Overall Study|Screening failure|2
1139053|NCT02892448|2242467|FG001|Overall Study|Screening failure|2
1139054|NCT02892448|2242468|FG002|Overall Study|Screening failure|1
1139055|NCT02892513|2242478|FG000|Overall Study|Withdrawal by Subject|0
1139056|NCT02892513|2242479|FG001|Overall Study|Withdrawal by Subject|1
1139057|NCT02892734|2242485|FG000|Treatment on Study|Progressive Disease|2
1139058|NCT02892734|2242485|FG000|Follow up for 2 Years|Death|2
1139059|NCT02892734|2242485|FG000|Follow up for 2 Years|Study closed early|1
1139060|NCT02892760|2242489|FG000|Overall Study|Withdrawal by Subject|3
1139061|NCT02894502|2242512|FG000|Baseline|Withdrawal by Subject|24
1139062|NCT02894502|2242513|FG001|Baseline|Withdrawal by Subject|31
1139063|NCT02894502|2242514|FG002|Baseline|Withdrawal by Subject|36
1139064|NCT02894502|2242512|FG000|Baseline|Death|3
1139065|NCT02894502|2242513|FG001|Baseline|Death|1
1139066|NCT02894502|2242514|FG002|Baseline|Death|9
1139067|NCT02894502|2242512|FG000|First Follow up|Withdrawal by Subject|32
1139068|NCT02894502|2242513|FG001|First Follow up|Withdrawal by Subject|29
1139069|NCT02894502|2242514|FG002|First Follow up|Withdrawal by Subject|37
1139070|NCT02894502|2242512|FG000|First Follow up|Death|2
1139071|NCT02894502|2242513|FG001|First Follow up|Death|2
1139072|NCT02894502|2242514|FG002|First Follow up|Death|3
1139073|NCT02894502|2242512|FG000|Second Follow up|Withdrawal by Subject|13
1139074|NCT02894502|2242513|FG001|Second Follow up|Withdrawal by Subject|15
1139075|NCT02894502|2242514|FG002|Second Follow up|Withdrawal by Subject|13
1139076|NCT02894502|2242512|FG000|Second Follow up|Death|2
1139077|NCT02894502|2242513|FG001|Second Follow up|Death|3
1139078|NCT02894502|2242514|FG002|Second Follow up|Death|1
1139079|NCT02894502|2242512|FG000|Third Follow up|Withdrawal by Subject|5
1139080|NCT02894502|2242513|FG001|Third Follow up|Withdrawal by Subject|6
1139081|NCT02894502|2242514|FG002|Third Follow up|Withdrawal by Subject|3
1139082|NCT02894502|2242512|FG000|Third Follow up|Death|1
1139083|NCT02894502|2242513|FG001|Third Follow up|Death|1
1139084|NCT02894502|2242514|FG002|Third Follow up|Death|0
1139085|NCT02894840|2242529|FG000|Overall Study|Lost to Follow-up|1
1139086|NCT02894840|2242530|FG001|Overall Study|Lost to Follow-up|0
1139087|NCT02894840|2242531|FG002|Overall Study|Lost to Follow-up|3
1139088|NCT02894840|2242532|FG003|Overall Study|Lost to Follow-up|0
1139089|NCT02895295|2242574|FG000|Overall Study|Survey Non-response|71
1139090|NCT02895295|2242575|FG001|Overall Study|Survey Non-response|94
1139091|NCT02895295|2242576|FG002|Overall Study|Survey Non-response|92
1139092|NCT02895347|2242586|FG000|Overall Study|Withdrawal by Subject|3
1139093|NCT02895347|2242587|FG001|Overall Study|Withdrawal by Subject|1
1139094|NCT02895360|2242600|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4
1139095|NCT02895360|2242601|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
1139096|NCT02895360|2242602|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
1139097|NCT02895360|2242603|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
1139098|NCT02895360|2242604|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
1139099|NCT02895360|2242605|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
1139100|NCT02895360|2242600|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
1139101|NCT02895360|2242601|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3
1139102|NCT02895360|2242602|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
1139103|NCT02895360|2242603|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
1139104|NCT02895360|2242604|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
1139105|NCT02895360|2242605|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
1139106|NCT02895360|2242600|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
1139107|NCT02895360|2242601|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
1139108|NCT02895360|2242602|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2
1139109|NCT02895360|2242603|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
1139110|NCT02895360|2242604|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
1139111|NCT02895360|2242605|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
1139112|NCT02895360|2242600|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
1139113|NCT02895360|2242601|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
1139114|NCT02895360|2242602|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7
1139115|NCT02895360|2242603|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
1139116|NCT02895360|2242604|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
1139117|NCT02895360|2242605|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
1139118|NCT02895360|2242600|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
1139119|NCT02895360|2242601|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
1139120|NCT02895360|2242602|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
1139121|NCT02895360|2242603|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4
1139122|NCT02895360|2242604|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
1139123|NCT02895360|2242605|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
1139124|NCT02895360|2242600|FG000|Phase 2a|Adverse Event|0
1139125|NCT02895360|2242601|FG001|Phase 2a|Adverse Event|0
1139126|NCT02895360|2242602|FG002|Phase 2a|Adverse Event|0
1139127|NCT02895360|2242603|FG003|Phase 2a|Adverse Event|0
1139128|NCT02895360|2242604|FG004|Phase 2a|Adverse Event|0
1139129|NCT02895360|2242605|FG005|Phase 2a|Adverse Event|1
1139130|NCT02895360|2242600|FG000|Phase 2a|Progressive disease|0
1139131|NCT02895360|2242601|FG001|Phase 2a|Progressive disease|0
1139132|NCT02895360|2242602|FG002|Phase 2a|Progressive disease|0
1139133|NCT02895360|2242603|FG003|Phase 2a|Progressive disease|0
1139134|NCT02895360|2242604|FG004|Phase 2a|Progressive disease|11
1139135|NCT02895360|2242605|FG005|Phase 2a|Progressive disease|11
1139136|NCT02895945|2242639|FG000|Overall Study|Physician Decision|2
1139137|NCT02895945|2242640|FG001|Overall Study|Physician Decision|1
1139138|NCT02896127|2242655|FG000|COMPLETED WEEK 52|Adverse Event|9
1139139|NCT02896127|2242656|FG001|COMPLETED WEEK 52|Adverse Event|2
1139140|NCT02896127|2242655|FG000|COMPLETED WEEK 52|Lack of Efficacy|2
1139141|NCT02896127|2242656|FG001|COMPLETED WEEK 52|Lack of Efficacy|3
1139142|NCT02896127|2242655|FG000|COMPLETED WEEK 52|Lost to Follow-up|0
1139143|NCT02896127|2242656|FG001|COMPLETED WEEK 52|Lost to Follow-up|1
1139144|NCT02896127|2242655|FG000|COMPLETED WEEK 52|Physician Decision|1
1139145|NCT02896127|2242656|FG001|COMPLETED WEEK 52|Physician Decision|1
1139146|NCT02896127|2242655|FG000|COMPLETED WEEK 52|Pregnancy|2
1139147|NCT02896127|2242656|FG001|COMPLETED WEEK 52|Pregnancy|0
1139148|NCT02896127|2242655|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12
1139149|NCT02896127|2242656|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4
1139150|NCT02896127|2242655|FG000|COMPLETED WEEK 52|Technical problems|1
1139151|NCT02896127|2242656|FG001|COMPLETED WEEK 52|Technical problems|0
1139152|NCT02896127|2242655|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2
1139153|NCT02896127|2242656|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3
1139154|NCT02896127|2242655|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0
1139155|NCT02896127|2242656|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1
1139156|NCT02896127|2242655|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1
1139157|NCT02896127|2242656|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0
1139158|NCT02896127|2242655|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1
1139159|NCT02896127|2242656|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0
1139160|NCT02896127|2242655|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0
1139161|NCT02896127|2242656|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1
1139162|NCT02896296|2242662|FG000|Overall Study|Adverse Event|1
1139163|NCT02896296|2242662|FG000|Overall Study|Lost to Follow-up|19
1139164|NCT02896296|2242662|FG000|Overall Study|Pregnancy|1
1139165|NCT02896296|2242662|FG000|Overall Study|Physician Decision|2
1139166|NCT02896296|2242662|FG000|Overall Study|Withdrawal by Subject|10
1139167|NCT02896296|2242662|FG000|Overall Study|Site closing|7
1139168|NCT02896296|2242662|FG000|Overall Study|Incarceration|1
1139169|NCT02896296|2242662|FG000|Overall Study|Relocation|1
1139170|NCT02896361|2242666|FG000|Third Intervention (2 Weeks)|Protocol Violation|1
1139171|NCT02896361|2242667|FG001|Third Intervention (2 Weeks)|Protocol Violation|0
1139172|NCT02896361|2242668|FG002|Third Intervention (2 Weeks)|Protocol Violation|0
1139173|NCT02896361|2242666|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
1139174|NCT02896361|2242667|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
1139175|NCT02896361|2242668|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
1139176|NCT02896400|2242696|FG000|1 Month Follow-up|Lost to Follow-up|7
1139177|NCT02896400|2242697|FG001|1 Month Follow-up|Lost to Follow-up|7
1139178|NCT02896400|2242698|FG002|1 Month Follow-up|Lost to Follow-up|5
1139179|NCT02896400|2242699|FG003|1 Month Follow-up|Lost to Follow-up|8
1139180|NCT02896400|2242700|FG004|1 Month Follow-up|Lost to Follow-up|9
1139181|NCT02896400|2242701|FG005|1 Month Follow-up|Lost to Follow-up|6
1139182|NCT02896400|2242702|FG006|1 Month Follow-up|Lost to Follow-up|5
1139183|NCT02896400|2242703|FG007|1 Month Follow-up|Lost to Follow-up|6
1139184|NCT02896400|2242704|FG008|1 Month Follow-up|Lost to Follow-up|4
1139185|NCT02896400|2242705|FG009|1 Month Follow-up|Lost to Follow-up|7
1139186|NCT02896400|2242706|FG010|1 Month Follow-up|Lost to Follow-up|5
1139187|NCT02896400|2242707|FG011|1 Month Follow-up|Lost to Follow-up|5
1139188|NCT02896400|2242708|FG012|1 Month Follow-up|Lost to Follow-up|3
1139189|NCT02896400|2242709|FG013|1 Month Follow-up|Lost to Follow-up|4
1139190|NCT02896400|2242710|FG014|1 Month Follow-up|Lost to Follow-up|1
1139191|NCT02896400|2242711|FG015|1 Month Follow-up|Lost to Follow-up|2
1139192|NCT02896400|2242696|FG000|1 Month Follow-up|Death|0
1139193|NCT02896400|2242697|FG001|1 Month Follow-up|Death|0
1139194|NCT02896400|2242698|FG002|1 Month Follow-up|Death|0
1139195|NCT02896400|2242699|FG003|1 Month Follow-up|Death|0
1139196|NCT02896400|2242700|FG004|1 Month Follow-up|Death|0
1139197|NCT02896400|2242701|FG005|1 Month Follow-up|Death|0
1139198|NCT02896400|2242702|FG006|1 Month Follow-up|Death|0
1139199|NCT02896400|2242703|FG007|1 Month Follow-up|Death|0
1139200|NCT02896400|2242704|FG008|1 Month Follow-up|Death|0
1139201|NCT02896400|2242705|FG009|1 Month Follow-up|Death|0
1139202|NCT02896400|2242706|FG010|1 Month Follow-up|Death|0
1139203|NCT02896400|2242707|FG011|1 Month Follow-up|Death|0
1139204|NCT02896400|2242708|FG012|1 Month Follow-up|Death|0
1139205|NCT02896400|2242709|FG013|1 Month Follow-up|Death|0
1139206|NCT02896400|2242710|FG014|1 Month Follow-up|Death|0
1139207|NCT02896400|2242711|FG015|1 Month Follow-up|Death|1
1139208|NCT02896400|2242696|FG000|3 Month Follow-up|Lost to Follow-up|6
1139209|NCT02896400|2242697|FG001|3 Month Follow-up|Lost to Follow-up|3
1139210|NCT02896400|2242698|FG002|3 Month Follow-up|Lost to Follow-up|6
1139211|NCT02896400|2242699|FG003|3 Month Follow-up|Lost to Follow-up|11
1139212|NCT02896400|2242700|FG004|3 Month Follow-up|Lost to Follow-up|12
1139213|NCT02896400|2242701|FG005|3 Month Follow-up|Lost to Follow-up|6
1139214|NCT02896400|2242702|FG006|3 Month Follow-up|Lost to Follow-up|4
1139215|NCT02896400|2242703|FG007|3 Month Follow-up|Lost to Follow-up|3
1139216|NCT02896400|2242704|FG008|3 Month Follow-up|Lost to Follow-up|6
1139217|NCT02896400|2242705|FG009|3 Month Follow-up|Lost to Follow-up|5
1139218|NCT02896400|2242706|FG010|3 Month Follow-up|Lost to Follow-up|6
1139219|NCT02896400|2242707|FG011|3 Month Follow-up|Lost to Follow-up|6
1139220|NCT02896400|2242708|FG012|3 Month Follow-up|Lost to Follow-up|3
1139221|NCT02896400|2242709|FG013|3 Month Follow-up|Lost to Follow-up|5
1139222|NCT02896400|2242710|FG014|3 Month Follow-up|Lost to Follow-up|3
1139223|NCT02896400|2242711|FG015|3 Month Follow-up|Lost to Follow-up|2
1139224|NCT02896400|2242696|FG000|3 Month Follow-up|Death|0
1139225|NCT02896400|2242697|FG001|3 Month Follow-up|Death|0
1139226|NCT02896400|2242698|FG002|3 Month Follow-up|Death|0
1139227|NCT02896400|2242699|FG003|3 Month Follow-up|Death|0
1139228|NCT02896400|2242700|FG004|3 Month Follow-up|Death|0
1139229|NCT02896400|2242701|FG005|3 Month Follow-up|Death|0
1139230|NCT02896400|2242702|FG006|3 Month Follow-up|Death|0
1139231|NCT02896400|2242703|FG007|3 Month Follow-up|Death|0
1139232|NCT02896400|2242704|FG008|3 Month Follow-up|Death|0
1139233|NCT02896400|2242705|FG009|3 Month Follow-up|Death|0
1139234|NCT02896400|2242706|FG010|3 Month Follow-up|Death|0
1139235|NCT02896400|2242707|FG011|3 Month Follow-up|Death|0
1139236|NCT02896400|2242708|FG012|3 Month Follow-up|Death|0
1139237|NCT02896400|2242709|FG013|3 Month Follow-up|Death|1
1139238|NCT02896400|2242710|FG014|3 Month Follow-up|Death|1
1139239|NCT02896400|2242711|FG015|3 Month Follow-up|Death|0
1139240|NCT02896400|2242696|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1
1139241|NCT02896400|2242697|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0
1139242|NCT02896400|2242698|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1
1139243|NCT02896400|2242699|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1
1139244|NCT02896400|2242700|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0
1139245|NCT02896400|2242701|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1
1139246|NCT02896400|2242702|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3
1139247|NCT02896400|2242703|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2
1139248|NCT02896400|2242704|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1
1139249|NCT02896400|2242705|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1
1139250|NCT02896400|2242706|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0
1139251|NCT02896400|2242707|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0
1139252|NCT02896400|2242708|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1
1139253|NCT02896400|2242709|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0
1139254|NCT02896400|2242710|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3
1139255|NCT02896400|2242711|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1
1139256|NCT02896400|2242696|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
1139257|NCT02896400|2242697|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
1139258|NCT02896400|2242698|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46
1139259|NCT02896400|2242699|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40
1139260|NCT02896400|2242700|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
1139261|NCT02896400|2242701|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
1139262|NCT02896400|2242702|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
1139263|NCT02896400|2242703|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47
1139264|NCT02896400|2242704|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44
1139265|NCT02896400|2242705|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
1139266|NCT02896400|2242706|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55
1139267|NCT02896400|2242707|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41
1139268|NCT02896400|2242708|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
1139269|NCT02896400|2242709|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
1139270|NCT02896400|2242710|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
1139271|NCT02896400|2242711|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56
1139272|NCT02896569|2242739|FG000|Overall Study|Lost to Follow-up|2
1139273|NCT02896569|2242740|FG001|Overall Study|Lost to Follow-up|1
1139274|NCT02896569|2242739|FG000|Overall Study|Physician Decision|1
1139275|NCT02896569|2242740|FG001|Overall Study|Physician Decision|3
1139276|NCT02896569|2242739|FG000|Overall Study|Adverse Event|0
1139277|NCT02896569|2242740|FG001|Overall Study|Adverse Event|1
1139278|NCT02896569|2242739|FG000|Overall Study|Withdrawal by Subject|1
1139279|NCT02896569|2242740|FG001|Overall Study|Withdrawal by Subject|0
1139290|NCT02897349|2242799|FG000|Overall Study|Lost to Follow-up|2
1139291|NCT02897349|2242800|FG001|Overall Study|Lost to Follow-up|2
1139292|NCT02897349|2242799|FG000|Overall Study|Adverse Event|3
1139293|NCT02897349|2242800|FG001|Overall Study|Adverse Event|3
1139294|NCT02897349|2242799|FG000|Overall Study|Other than listed above|0
1139295|NCT02897349|2242800|FG001|Overall Study|Other than listed above|1
1139296|NCT02898077|2242808|FG000|Overall Study|Adverse Event|21
1139297|NCT02898077|2242809|FG001|Overall Study|Adverse Event|7
1139298|NCT02898077|2242808|FG000|Overall Study|Withdrawal by Subject|51
1139299|NCT02898077|2242809|FG001|Overall Study|Withdrawal by Subject|14
1139300|NCT02898077|2242808|FG000|Overall Study|Physician Decision|12
1139301|NCT02898077|2242809|FG001|Overall Study|Physician Decision|4
1139302|NCT02898077|2242808|FG000|Overall Study|Non-compliance With Study Drug|3
1139303|NCT02898077|2242809|FG001|Overall Study|Non-compliance With Study Drug|2
1139304|NCT02898077|2242808|FG000|Overall Study|Protocol Deviation|3
1139305|NCT02898077|2242809|FG001|Overall Study|Protocol Deviation|0
1139306|NCT02898077|2242808|FG000|Overall Study|On Study Treatment|5
1139307|NCT02898077|2242809|FG001|Overall Study|On Study Treatment|3
1139308|NCT02898116|2242828|FG000|Overall Study|Adverse Event|1
1139309|NCT02898116|2242828|FG000|Overall Study|Progressive disease|1
1139310|NCT02898259|2242837|FG000|Overall Study|Adverse Event|0
1139311|NCT02898259|2242838|FG001|Overall Study|Adverse Event|0
1139312|NCT02898259|2242839|FG002|Overall Study|Adverse Event|1
1139313|NCT02898259|2242840|FG003|Overall Study|Adverse Event|0
1139314|NCT02898259|2242841|FG004|Overall Study|Adverse Event|0
1139315|NCT02898259|2242837|FG000|Overall Study|Lack of Efficacy|1
1139316|NCT02898259|2242838|FG001|Overall Study|Lack of Efficacy|1
1139317|NCT02898259|2242839|FG002|Overall Study|Lack of Efficacy|3
1139318|NCT02898259|2242840|FG003|Overall Study|Lack of Efficacy|0
1139319|NCT02898259|2242841|FG004|Overall Study|Lack of Efficacy|0
1139320|NCT02898259|2242837|FG000|Overall Study|Lost to Follow-up|0
1139321|NCT02898259|2242838|FG001|Overall Study|Lost to Follow-up|0
1139322|NCT02898259|2242839|FG002|Overall Study|Lost to Follow-up|1
1139323|NCT02898259|2242840|FG003|Overall Study|Lost to Follow-up|0
1139324|NCT02898259|2242841|FG004|Overall Study|Lost to Follow-up|0
1139325|NCT02898259|2242837|FG000|Overall Study|Transformation before study began|0
1139326|NCT02898259|2242838|FG001|Overall Study|Transformation before study began|0
1139327|NCT02898259|2242839|FG002|Overall Study|Transformation before study began|0
1139328|NCT02898259|2242840|FG003|Overall Study|Transformation before study began|1
1139329|NCT02898259|2242841|FG004|Overall Study|Transformation before study began|0
1139330|NCT02898454|2242852|FG000|Overall Study|Adverse Event|4
1139331|NCT02898454|2242853|FG001|Overall Study|Adverse Event|1
1139332|NCT02898454|2242854|FG002|Overall Study|Adverse Event|2
1139333|NCT02898454|2242852|FG000|Overall Study|Protocol Violation|1
1139334|NCT02898454|2242853|FG001|Overall Study|Protocol Violation|0
1139335|NCT02898454|2242854|FG002|Overall Study|Protocol Violation|1
1139336|NCT02898454|2242852|FG000|Overall Study|Lack of Efficacy|4
1139337|NCT02898454|2242853|FG001|Overall Study|Lack of Efficacy|1
1139338|NCT02898454|2242854|FG002|Overall Study|Lack of Efficacy|0
1139339|NCT02898454|2242852|FG000|Overall Study|Withdrawal by Subject|6
1139340|NCT02898454|2242853|FG001|Overall Study|Withdrawal by Subject|3
1139341|NCT02898454|2242854|FG002|Overall Study|Withdrawal by Subject|3
1139342|NCT02898454|2242852|FG000|Overall Study|Lost to Follow-up|1
1139343|NCT02898454|2242853|FG001|Overall Study|Lost to Follow-up|0
1139344|NCT02898454|2242854|FG002|Overall Study|Lost to Follow-up|0
1139345|NCT02898454|2242852|FG000|Overall Study|Did Not Met Eligibility Criteria|1
1139346|NCT02898454|2242853|FG001|Overall Study|Did Not Met Eligibility Criteria|0
1139347|NCT02898454|2242854|FG002|Overall Study|Did Not Met Eligibility Criteria|0
1139348|NCT02898597|2242869|FG000|Overall Study|Protocol Violation|4
1139349|NCT02898597|2242870|FG001|Overall Study|Protocol Violation|2
1139350|NCT02898597|2242869|FG000|Overall Study|Lost to Follow-up|0
1139351|NCT02898597|2242870|FG001|Overall Study|Lost to Follow-up|9
1139352|NCT02898597|2242869|FG000|Overall Study|Death|0
1139353|NCT02898597|2242870|FG001|Overall Study|Death|1
1139354|NCT02898662|2242878|FG000|Overall Study|Adverse Event|1
1139355|NCT02898662|2242879|FG001|Overall Study|Adverse Event|0
1139356|NCT02898662|2242878|FG000|Overall Study|Loss of asthma control|23
1139357|NCT02898662|2242879|FG001|Overall Study|Loss of asthma control|24
1139358|NCT02898662|2242878|FG000|Overall Study|Withdrawal by Subject|4
1139359|NCT02898662|2242879|FG001|Overall Study|Withdrawal by Subject|1
1139360|NCT02898662|2242878|FG000|Overall Study|Technical issue|0
1139361|NCT02898662|2242879|FG001|Overall Study|Technical issue|1
1139362|NCT02898662|2242878|FG000|Overall Study|Randomized in error|0
1139363|NCT02898662|2242879|FG001|Overall Study|Randomized in error|1
1139364|NCT02898662|2242878|FG000|Overall Study|Subject decision|1
1139365|NCT02898662|2242879|FG001|Overall Study|Subject decision|0
1139366|NCT02898662|2242878|FG000|Overall Study|Other|0
1139367|NCT02898662|2242879|FG001|Overall Study|Other|1
1139368|NCT02899156|2242905|FG000|Overall Study|Death|1
1139369|NCT02899156|2242906|FG001|Overall Study|Death|0
1139370|NCT02899156|2242905|FG000|Overall Study|Physician Decision|0
1139371|NCT02899156|2242906|FG001|Overall Study|Physician Decision|1
1139372|NCT02899195|2242912|FG000|Concurrent Durvalumab|Adverse Event|4
1139373|NCT02899195|2242912|FG000|Concurrent Durvalumab|Physician Decision|1
1139374|NCT02899195|2242912|FG000|Concurrent Durvalumab|Withdrawal by Subject|1
1139375|NCT02899195|2242912|FG000|Concurrent Durvalumab|Progressive Disease|5
1139376|NCT02899195|2242912|FG000|Maintenance Durvalumab|Adverse Event|1
1139377|NCT02899195|2242912|FG000|Maintenance Durvalumab|Physician Decision|1
1139378|NCT02899195|2242912|FG000|Maintenance Durvalumab|Withdrawal by Subject|1
1139379|NCT02899195|2242912|FG000|Maintenance Durvalumab|Progressive Disease|31
1139380|NCT02899299|2242918|FG000|Pre-treatment|Participant request to discontinue study treatment|0
1139381|NCT02899299|2242919|FG001|Pre-treatment|Participant request to discontinue study treatment|3
1139382|NCT02899299|2242918|FG000|Pre-treatment|Participant withdrew consent|1
1139383|NCT02899299|2242919|FG001|Pre-treatment|Participant withdrew consent|11
1139384|NCT02899299|2242918|FG000|Pre-treatment|Participant no longer meets study criteria|2
1139385|NCT02899299|2242919|FG001|Pre-treatment|Participant no longer meets study criteria|3
1139386|NCT02899299|2242918|FG000|Pre-treatment|Not reported|0
1139387|NCT02899299|2242919|FG001|Pre-treatment|Not reported|1
1139388|NCT02899299|2242918|FG000|Treatment|Disease Progression|182
1139389|NCT02899299|2242919|FG001|Treatment|Disease Progression|44
1139390|NCT02899299|2242918|FG000|Treatment|Study Drug Toxicity|59
1139391|NCT02899299|2242919|FG001|Treatment|Study Drug Toxicity|24
1139392|NCT02899299|2242918|FG000|Treatment|Adverse Event unrelated to Study Drug|12
1139393|NCT02899299|2242919|FG001|Treatment|Adverse Event unrelated to Study Drug|9
1139394|NCT02899299|2242918|FG000|Treatment|Participant request to discontinue Study treatment|4
1139395|NCT02899299|2242919|FG001|Treatment|Participant request to discontinue Study treatment|10
1139396|NCT02899299|2242918|FG000|Treatment|Participant withdrew consent|6
1139397|NCT02899299|2242919|FG001|Treatment|Participant withdrew consent|3
1139398|NCT02899299|2242918|FG000|Treatment|Lost to Follow-up|0
1139399|NCT02899299|2242919|FG001|Treatment|Lost to Follow-up|1
1139400|NCT02899299|2242918|FG000|Treatment|Maximum Clinical Benefit|10
1139401|NCT02899299|2242919|FG001|Treatment|Maximum Clinical Benefit|2
1139402|NCT02899299|2242918|FG000|Treatment|Poor/Non-compliance|1
1139403|NCT02899299|2242919|FG001|Treatment|Poor/Non-compliance|0
1139404|NCT02899299|2242918|FG000|Treatment|Participant no longer meets Study criteria|4
1139405|NCT02899299|2242919|FG001|Treatment|Participant no longer meets Study criteria|0
1139406|NCT02899299|2242918|FG000|Treatment|Administrative reason by Sponsor|2
1139407|NCT02899299|2242919|FG001|Treatment|Administrative reason by Sponsor|0
1139408|NCT02899299|2242918|FG000|Treatment|Other reasons|11
1139409|NCT02899299|2242919|FG001|Treatment|Other reasons|2
1139410|NCT02899299|2242918|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4
1139411|NCT02899299|2242919|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189
1139412|NCT02899338|2242927|FG000|Overall Study|Adverse Event|1
1139413|NCT02899338|2242928|FG001|Overall Study|Adverse Event|2
1139414|NCT02899338|2242927|FG000|Overall Study|Withdrawal by Subject|2
1139415|NCT02899338|2242928|FG001|Overall Study|Withdrawal by Subject|0
1139416|NCT02899377|2242936|FG000|Overall Study|Adverse Event|1
1139417|NCT02899377|2242937|FG001|Overall Study|Adverse Event|0
1139418|NCT02899962|2242973|FG000|Open-label Phase|Adverse Event|2
1139419|NCT02899962|2242974|FG001|Open-label Phase|Adverse Event|0
1139420|NCT02899962|2242975|FG002|Open-label Phase|Adverse Event|0
1139421|NCT02899962|2242973|FG000|Open-label Phase|Lost to Follow-up|9
1139422|NCT02899962|2242974|FG001|Open-label Phase|Lost to Follow-up|0
1139423|NCT02899962|2242975|FG002|Open-label Phase|Lost to Follow-up|0
1139424|NCT02899962|2242973|FG000|Open-label Phase|Other reasons|9
1139425|NCT02899962|2242974|FG001|Open-label Phase|Other reasons|0
1139426|NCT02899962|2242975|FG002|Open-label Phase|Other reasons|0
1139427|NCT02899962|2242973|FG000|Open-label Phase|Withdrawal by Subject|7
1139428|NCT02899962|2242974|FG001|Open-label Phase|Withdrawal by Subject|0
1139429|NCT02899962|2242975|FG002|Open-label Phase|Withdrawal by Subject|0
1139430|NCT02899962|2242973|FG000|Maintenance Phase|Adverse Event|0
1139431|NCT02899962|2242974|FG001|Maintenance Phase|Adverse Event|2
1139432|NCT02899962|2242975|FG002|Maintenance Phase|Adverse Event|1
1139433|NCT02899962|2242973|FG000|Maintenance Phase|Death|0
1139434|NCT02899962|2242974|FG001|Maintenance Phase|Death|0
1139435|NCT02899962|2242975|FG002|Maintenance Phase|Death|1
1139436|NCT02899962|2242973|FG000|Maintenance Phase|Lack of Efficacy|0
1139437|NCT02899962|2242974|FG001|Maintenance Phase|Lack of Efficacy|20
1139438|NCT02899962|2242975|FG002|Maintenance Phase|Lack of Efficacy|16
1139439|NCT02899962|2242973|FG000|Maintenance Phase|Lost to Follow-up|0
1139440|NCT02899962|2242974|FG001|Maintenance Phase|Lost to Follow-up|12
1139441|NCT02899962|2242975|FG002|Maintenance Phase|Lost to Follow-up|14
1139442|NCT02899962|2242973|FG000|Maintenance Phase|Other reasons|0
1139443|NCT02899962|2242974|FG001|Maintenance Phase|Other reasons|9
1139444|NCT02899962|2242975|FG002|Maintenance Phase|Other reasons|13
1139445|NCT02899962|2242973|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0
1139446|NCT02899962|2242974|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3
1139447|NCT02899962|2242975|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2
1139448|NCT02899962|2242973|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0
1139449|NCT02899962|2242974|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65
1139450|NCT02899962|2242975|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70
1139451|NCT02899962|2242973|FG000|Maintenance Phase|Withdrawal by Subject|0
1139452|NCT02899962|2242974|FG001|Maintenance Phase|Withdrawal by Subject|30
1139453|NCT02899962|2242975|FG002|Maintenance Phase|Withdrawal by Subject|36
1139454|NCT02899988|2242986|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
1139455|NCT02899988|2242987|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1
1139456|NCT02899988|2242988|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
1139457|NCT02899988|2242989|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
1139458|NCT02899988|2242990|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
1139459|NCT02899988|2242991|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
1139460|NCT02899988|2242992|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
1139461|NCT02899988|2242993|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
1139462|NCT02899988|2242994|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
1139463|NCT02899988|2242995|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
1139464|NCT02899988|2242996|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
1139465|NCT02899988|2242986|FG000|Induction Period (16 Weeks)|Adverse Event|0
1139466|NCT02899988|2242987|FG001|Induction Period (16 Weeks)|Adverse Event|0
1139467|NCT02899988|2242988|FG002|Induction Period (16 Weeks)|Adverse Event|0
1139468|NCT02899988|2242989|FG003|Induction Period (16 Weeks)|Adverse Event|2
1139469|NCT02899988|2242990|FG004|Induction Period (16 Weeks)|Adverse Event|0
1139470|NCT02899988|2242991|FG005|Induction Period (16 Weeks)|Adverse Event|0
1139471|NCT02899988|2242992|FG006|Induction Period (16 Weeks)|Adverse Event|0
1139472|NCT02899988|2242993|FG007|Induction Period (16 Weeks)|Adverse Event|0
1139473|NCT02899988|2242994|FG008|Induction Period (16 Weeks)|Adverse Event|0
1139474|NCT02899988|2242995|FG009|Induction Period (16 Weeks)|Adverse Event|0
1139475|NCT02899988|2242996|FG010|Induction Period (16 Weeks)|Adverse Event|0
1139476|NCT02899988|2242986|FG000|Induction Period (16 Weeks)|Physician Decision|0
1139477|NCT02899988|2242987|FG001|Induction Period (16 Weeks)|Physician Decision|1
1139478|NCT02899988|2242988|FG002|Induction Period (16 Weeks)|Physician Decision|0
1139479|NCT02899988|2242989|FG003|Induction Period (16 Weeks)|Physician Decision|0
1139480|NCT02899988|2242990|FG004|Induction Period (16 Weeks)|Physician Decision|0
1139481|NCT02899988|2242991|FG005|Induction Period (16 Weeks)|Physician Decision|0
1139482|NCT02899988|2242992|FG006|Induction Period (16 Weeks)|Physician Decision|0
1139483|NCT02899988|2242993|FG007|Induction Period (16 Weeks)|Physician Decision|0
1139484|NCT02899988|2242994|FG008|Induction Period (16 Weeks)|Physician Decision|0
1139485|NCT02899988|2242995|FG009|Induction Period (16 Weeks)|Physician Decision|0
1139486|NCT02899988|2242996|FG010|Induction Period (16 Weeks)|Physician Decision|0
1139487|NCT02899988|2242986|FG000|Maintenance Period (88 Weeks)|Adverse Event|0
1139488|NCT02899988|2242987|FG001|Maintenance Period (88 Weeks)|Adverse Event|0
1139489|NCT02899988|2242988|FG002|Maintenance Period (88 Weeks)|Adverse Event|0
1139490|NCT02899988|2242989|FG003|Maintenance Period (88 Weeks)|Adverse Event|0
1139491|NCT02899988|2242990|FG004|Maintenance Period (88 Weeks)|Adverse Event|1
1139492|NCT02899988|2242991|FG005|Maintenance Period (88 Weeks)|Adverse Event|2
1139493|NCT02899988|2242992|FG006|Maintenance Period (88 Weeks)|Adverse Event|1
1139494|NCT02899988|2242993|FG007|Maintenance Period (88 Weeks)|Adverse Event|2
1139495|NCT02899988|2242994|FG008|Maintenance Period (88 Weeks)|Adverse Event|2
1139496|NCT02899988|2242995|FG009|Maintenance Period (88 Weeks)|Adverse Event|2
1139497|NCT02899988|2242996|FG010|Maintenance Period (88 Weeks)|Adverse Event|1
1139498|NCT02899988|2242986|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0
1139499|NCT02899988|2242987|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0
1139500|NCT02899988|2242988|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0
1139501|NCT02899988|2242989|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0
1139502|NCT02899988|2242990|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0
1139503|NCT02899988|2242991|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1
1139504|NCT02899988|2242992|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0
1139505|NCT02899988|2242993|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1
1139506|NCT02899988|2242994|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0
1139507|NCT02899988|2242995|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0
1139508|NCT02899988|2242996|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0
1139509|NCT02899988|2242986|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
1139510|NCT02899988|2242987|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
1139511|NCT02899988|2242988|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
1139512|NCT02899988|2242989|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
1139513|NCT02899988|2242990|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
1139514|NCT02899988|2242991|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
1139515|NCT02899988|2242992|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3
1139516|NCT02899988|2242993|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
1139517|NCT02899988|2242994|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
1139518|NCT02899988|2242995|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
1139519|NCT02899988|2242996|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
1139520|NCT02900092|2243028|FG000|Overall Study|Adverse Event|1
1139521|NCT02900170|2243032|FG000|Overall Study|Lost to Follow-up|8
1139522|NCT02900378|2243038|FG000|Randomization (Visit 2)|Adverse Event|14
1139523|NCT02900378|2243039|FG001|Randomization (Visit 2)|Adverse Event|11
1139524|NCT02900378|2243038|FG000|Randomization (Visit 2)|Death|1
1139525|NCT02900378|2243039|FG001|Randomization (Visit 2)|Death|4
1139526|NCT02900378|2243038|FG000|Randomization (Visit 2)|Lost to Follow-up|1
1139527|NCT02900378|2243039|FG001|Randomization (Visit 2)|Lost to Follow-up|0
1139528|NCT02900378|2243038|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1
1139529|NCT02900378|2243039|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1
1139530|NCT02900378|2243038|FG000|Randomization (Visit 2)|Protocol Deviation|1
1139531|NCT02900378|2243039|FG001|Randomization (Visit 2)|Protocol Deviation|7
1139532|NCT02900378|2243038|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
1139533|NCT02900378|2243039|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
1139534|NCT02900378|2243038|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0
1139535|NCT02900378|2243039|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2
1139536|NCT02901054|2243045|FG000|Overall Study|Physician Decision|1
1139537|NCT02901054|2243045|FG000|Overall Study|Withdrawal by Subject|3
1139538|NCT02901431|2243079|FG000|PK Part|Adverse Event|0
1139539|NCT02901431|2243080|FG001|PK Part|Adverse Event|1
1139540|NCT02901431|2243081|FG002|PK Part|Adverse Event|0
901526|NCT00734474|1875039|FG003|Overall Study|Protocol Violation|0
901527|NCT00734474|1875040|FG004|Overall Study|Protocol Violation|3
901528|NCT00734474|1875041|FG005|Overall Study|Protocol Violation|0
901529|NCT00734474|1875042|FG006|Overall Study|Protocol Violation|0
901530|NCT00734474|1875043|FG007|Overall Study|Protocol Violation|3
901531|NCT00734474|1875044|FG008|Overall Study|Protocol Violation|1
901532|NCT00734474|1875036|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8
1139541|NCT02901431|2243082|FG003|PK Part|Adverse Event|0
1139542|NCT02901431|2243083|FG004|PK Part|Adverse Event|0
1139543|NCT02901431|2243084|FG005|PK Part|Adverse Event|0
1139544|NCT02901431|2243085|FG006|PK Part|Adverse Event|0
1139545|NCT02901431|2243086|FG007|PK Part|Adverse Event|0
1139546|NCT02901431|2243087|FG008|PK Part|Adverse Event|0
1139547|NCT02901431|2243088|FG009|PK Part|Adverse Event|0
1139548|NCT02901431|2243089|FG010|PK Part|Adverse Event|0
1139549|NCT02901431|2243090|FG011|PK Part|Adverse Event|0
1139550|NCT02901431|2243091|FG012|PK Part|Adverse Event|0
1139551|NCT02901431|2243079|FG000|PK Part|Lost to Follow-up|0
1139552|NCT02901431|2243080|FG001|PK Part|Lost to Follow-up|0
1139553|NCT02901431|2243081|FG002|PK Part|Lost to Follow-up|1
1139554|NCT02901431|2243082|FG003|PK Part|Lost to Follow-up|0
1139555|NCT02901431|2243083|FG004|PK Part|Lost to Follow-up|0
1139556|NCT02901431|2243084|FG005|PK Part|Lost to Follow-up|0
1139557|NCT02901431|2243085|FG006|PK Part|Lost to Follow-up|0
1139558|NCT02901431|2243086|FG007|PK Part|Lost to Follow-up|0
1139559|NCT02901431|2243087|FG008|PK Part|Lost to Follow-up|0
1139560|NCT02901431|2243088|FG009|PK Part|Lost to Follow-up|0
1139561|NCT02901431|2243089|FG010|PK Part|Lost to Follow-up|0
1139562|NCT02901431|2243090|FG011|PK Part|Lost to Follow-up|0
1139563|NCT02901431|2243091|FG012|PK Part|Lost to Follow-up|0
1139564|NCT02901431|2243079|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2
1139565|NCT02901431|2243080|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0
1139566|NCT02901431|2243081|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0
1139567|NCT02901431|2243082|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0
1139568|NCT02901431|2243083|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0
1139569|NCT02901431|2243084|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0
1139570|NCT02901431|2243085|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0
1139571|NCT02901431|2243086|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0
1139572|NCT02901431|2243087|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0
1139573|NCT02901431|2243088|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0
1139574|NCT02901431|2243089|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0
1139575|NCT02901431|2243090|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0
1139576|NCT02901431|2243091|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0
1139577|NCT02901431|2243079|FG000|PK Part|Pending dose confirmation|0
1139578|NCT02901431|2243080|FG001|PK Part|Pending dose confirmation|1
1139579|NCT02901431|2243081|FG002|PK Part|Pending dose confirmation|0
1139580|NCT02901431|2243082|FG003|PK Part|Pending dose confirmation|0
1139581|NCT02901431|2243083|FG004|PK Part|Pending dose confirmation|0
1139582|NCT02901431|2243084|FG005|PK Part|Pending dose confirmation|0
1139583|NCT02901431|2243085|FG006|PK Part|Pending dose confirmation|0
1139584|NCT02901431|2243086|FG007|PK Part|Pending dose confirmation|0
1139585|NCT02901431|2243087|FG008|PK Part|Pending dose confirmation|0
1139586|NCT02901431|2243088|FG009|PK Part|Pending dose confirmation|0
1139587|NCT02901431|2243089|FG010|PK Part|Pending dose confirmation|0
1139588|NCT02901431|2243090|FG011|PK Part|Pending dose confirmation|0
1139589|NCT02901431|2243091|FG012|PK Part|Pending dose confirmation|0
1139590|NCT02901431|2243079|FG000|PK Part|8 weeks of treatment ran out|2
1139591|NCT02901431|2243080|FG001|PK Part|8 weeks of treatment ran out|0
1139592|NCT02901431|2243081|FG002|PK Part|8 weeks of treatment ran out|0
1139593|NCT02901431|2243082|FG003|PK Part|8 weeks of treatment ran out|0
1139594|NCT02901431|2243083|FG004|PK Part|8 weeks of treatment ran out|0
1139595|NCT02901431|2243084|FG005|PK Part|8 weeks of treatment ran out|0
1139596|NCT02901431|2243085|FG006|PK Part|8 weeks of treatment ran out|0
1139597|NCT02901431|2243086|FG007|PK Part|8 weeks of treatment ran out|0
1139598|NCT02901431|2243087|FG008|PK Part|8 weeks of treatment ran out|0
1139599|NCT02901431|2243088|FG009|PK Part|8 weeks of treatment ran out|0
1139600|NCT02901431|2243089|FG010|PK Part|8 weeks of treatment ran out|0
1139601|NCT02901431|2243090|FG011|PK Part|8 weeks of treatment ran out|0
1139602|NCT02901431|2243091|FG012|PK Part|8 weeks of treatment ran out|0
1139603|NCT02901431|2243079|FG000|PK Part|Stopped treatment after 8 weeks|1
1139604|NCT02901431|2243080|FG001|PK Part|Stopped treatment after 8 weeks|0
1139605|NCT02901431|2243081|FG002|PK Part|Stopped treatment after 8 weeks|1
1139606|NCT02901431|2243082|FG003|PK Part|Stopped treatment after 8 weeks|0
1139607|NCT02901431|2243083|FG004|PK Part|Stopped treatment after 8 weeks|0
1139608|NCT02901431|2243084|FG005|PK Part|Stopped treatment after 8 weeks|0
1139609|NCT02901431|2243085|FG006|PK Part|Stopped treatment after 8 weeks|0
1139610|NCT02901431|2243086|FG007|PK Part|Stopped treatment after 8 weeks|0
1139611|NCT02901431|2243087|FG008|PK Part|Stopped treatment after 8 weeks|0
1139612|NCT02901431|2243088|FG009|PK Part|Stopped treatment after 8 weeks|0
1139613|NCT02901431|2243089|FG010|PK Part|Stopped treatment after 8 weeks|0
1139614|NCT02901431|2243090|FG011|PK Part|Stopped treatment after 8 weeks|0
901533|NCT00734474|1875037|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25
1139615|NCT02901431|2243091|FG012|PK Part|Stopped treatment after 8 weeks|0
1139616|NCT02901431|2243079|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1
1139617|NCT02901431|2243080|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
1139618|NCT02901431|2243081|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4
1139619|NCT02901431|2243082|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
1139620|NCT02901431|2243083|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
1139621|NCT02901431|2243084|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
1139622|NCT02901431|2243085|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
1139623|NCT02901431|2243086|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
1139624|NCT02901431|2243087|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
1139625|NCT02901431|2243088|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
1139626|NCT02901431|2243089|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
1139627|NCT02901431|2243090|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
1139628|NCT02901431|2243091|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
1139629|NCT02901431|2243079|FG000|PK Part|Discontinued per Sponsor|0
1139630|NCT02901431|2243080|FG001|PK Part|Discontinued per Sponsor|3
1139631|NCT02901431|2243081|FG002|PK Part|Discontinued per Sponsor|0
1139632|NCT02901431|2243082|FG003|PK Part|Discontinued per Sponsor|0
1139633|NCT02901431|2243083|FG004|PK Part|Discontinued per Sponsor|0
1139634|NCT02901431|2243084|FG005|PK Part|Discontinued per Sponsor|0
1139635|NCT02901431|2243085|FG006|PK Part|Discontinued per Sponsor|0
1139636|NCT02901431|2243086|FG007|PK Part|Discontinued per Sponsor|0
1139637|NCT02901431|2243087|FG008|PK Part|Discontinued per Sponsor|0
1139638|NCT02901431|2243088|FG009|PK Part|Discontinued per Sponsor|0
1139639|NCT02901431|2243089|FG010|PK Part|Discontinued per Sponsor|0
1139640|NCT02901431|2243090|FG011|PK Part|Discontinued per Sponsor|0
1139641|NCT02901431|2243091|FG012|PK Part|Discontinued per Sponsor|0
1139642|NCT02901431|2243079|FG000|PK Part|Withdrawal by Subject|1
1139643|NCT02901431|2243080|FG001|PK Part|Withdrawal by Subject|1
1139644|NCT02901431|2243081|FG002|PK Part|Withdrawal by Subject|3
1139645|NCT02901431|2243082|FG003|PK Part|Withdrawal by Subject|0
1139646|NCT02901431|2243083|FG004|PK Part|Withdrawal by Subject|0
1139647|NCT02901431|2243084|FG005|PK Part|Withdrawal by Subject|0
1139648|NCT02901431|2243085|FG006|PK Part|Withdrawal by Subject|0
1139649|NCT02901431|2243086|FG007|PK Part|Withdrawal by Subject|0
1139650|NCT02901431|2243087|FG008|PK Part|Withdrawal by Subject|0
1139651|NCT02901431|2243088|FG009|PK Part|Withdrawal by Subject|0
1139652|NCT02901431|2243089|FG010|PK Part|Withdrawal by Subject|0
1139653|NCT02901431|2243090|FG011|PK Part|Withdrawal by Subject|0
1139654|NCT02901431|2243091|FG012|PK Part|Withdrawal by Subject|0
1139655|NCT02901431|2243079|FG000|Main Treatment Part|Adverse Event|0
1139656|NCT02901431|2243080|FG001|Main Treatment Part|Adverse Event|0
1139657|NCT02901431|2243081|FG002|Main Treatment Part|Adverse Event|0
1139658|NCT02901431|2243082|FG003|Main Treatment Part|Adverse Event|3
1139659|NCT02901431|2243083|FG004|Main Treatment Part|Adverse Event|3
1139660|NCT02901431|2243084|FG005|Main Treatment Part|Adverse Event|4
1139661|NCT02901431|2243085|FG006|Main Treatment Part|Adverse Event|1
1139662|NCT02901431|2243086|FG007|Main Treatment Part|Adverse Event|0
1139663|NCT02901431|2243087|FG008|Main Treatment Part|Adverse Event|0
1139664|NCT02901431|2243088|FG009|Main Treatment Part|Adverse Event|0
1139665|NCT02901431|2243089|FG010|Main Treatment Part|Adverse Event|0
1139666|NCT02901431|2243090|FG011|Main Treatment Part|Adverse Event|0
1139667|NCT02901431|2243091|FG012|Main Treatment Part|Adverse Event|0
1139668|NCT02901431|2243079|FG000|Main Treatment Part|Lack of Efficacy|0
1139669|NCT02901431|2243080|FG001|Main Treatment Part|Lack of Efficacy|0
1139670|NCT02901431|2243081|FG002|Main Treatment Part|Lack of Efficacy|0
1139671|NCT02901431|2243082|FG003|Main Treatment Part|Lack of Efficacy|1
1139672|NCT02901431|2243083|FG004|Main Treatment Part|Lack of Efficacy|0
1139673|NCT02901431|2243084|FG005|Main Treatment Part|Lack of Efficacy|0
1139674|NCT02901431|2243085|FG006|Main Treatment Part|Lack of Efficacy|0
1139675|NCT02901431|2243086|FG007|Main Treatment Part|Lack of Efficacy|0
1139676|NCT02901431|2243087|FG008|Main Treatment Part|Lack of Efficacy|0
1139677|NCT02901431|2243088|FG009|Main Treatment Part|Lack of Efficacy|0
1139678|NCT02901431|2243089|FG010|Main Treatment Part|Lack of Efficacy|0
1139679|NCT02901431|2243090|FG011|Main Treatment Part|Lack of Efficacy|0
1139680|NCT02901431|2243091|FG012|Main Treatment Part|Lack of Efficacy|0
1139681|NCT02901431|2243079|FG000|Main Treatment Part|Lost to Follow-up|0
1139682|NCT02901431|2243080|FG001|Main Treatment Part|Lost to Follow-up|0
1139683|NCT02901431|2243081|FG002|Main Treatment Part|Lost to Follow-up|0
1139684|NCT02901431|2243082|FG003|Main Treatment Part|Lost to Follow-up|3
1139685|NCT02901431|2243083|FG004|Main Treatment Part|Lost to Follow-up|1
1139686|NCT02901431|2243084|FG005|Main Treatment Part|Lost to Follow-up|2
1139687|NCT02901431|2243085|FG006|Main Treatment Part|Lost to Follow-up|3
1139688|NCT02901431|2243086|FG007|Main Treatment Part|Lost to Follow-up|0
1139689|NCT02901431|2243087|FG008|Main Treatment Part|Lost to Follow-up|0
1139690|NCT02901431|2243088|FG009|Main Treatment Part|Lost to Follow-up|0
1139691|NCT02901431|2243089|FG010|Main Treatment Part|Lost to Follow-up|0
1139692|NCT02901431|2243090|FG011|Main Treatment Part|Lost to Follow-up|0
1139693|NCT02901431|2243091|FG012|Main Treatment Part|Lost to Follow-up|0
1139694|NCT02901431|2243079|FG000|Main Treatment Part|Withdrawal by Caregiver|0
1139695|NCT02901431|2243080|FG001|Main Treatment Part|Withdrawal by Caregiver|0
1139696|NCT02901431|2243081|FG002|Main Treatment Part|Withdrawal by Caregiver|0
1139697|NCT02901431|2243082|FG003|Main Treatment Part|Withdrawal by Caregiver|0
1139698|NCT02901431|2243083|FG004|Main Treatment Part|Withdrawal by Caregiver|0
1139699|NCT02901431|2243084|FG005|Main Treatment Part|Withdrawal by Caregiver|1
1139700|NCT02901431|2243085|FG006|Main Treatment Part|Withdrawal by Caregiver|0
1139701|NCT02901431|2243086|FG007|Main Treatment Part|Withdrawal by Caregiver|0
1139702|NCT02901431|2243087|FG008|Main Treatment Part|Withdrawal by Caregiver|0
1139703|NCT02901431|2243088|FG009|Main Treatment Part|Withdrawal by Caregiver|0
1139704|NCT02901431|2243089|FG010|Main Treatment Part|Withdrawal by Caregiver|0
1139705|NCT02901431|2243090|FG011|Main Treatment Part|Withdrawal by Caregiver|0
1139706|NCT02901431|2243091|FG012|Main Treatment Part|Withdrawal by Caregiver|0
1139707|NCT02901431|2243079|FG000|Main Treatment Part|Physician Decision|0
1139708|NCT02901431|2243080|FG001|Main Treatment Part|Physician Decision|0
1139709|NCT02901431|2243081|FG002|Main Treatment Part|Physician Decision|0
1139710|NCT02901431|2243082|FG003|Main Treatment Part|Physician Decision|1
1139711|NCT02901431|2243083|FG004|Main Treatment Part|Physician Decision|0
1139712|NCT02901431|2243084|FG005|Main Treatment Part|Physician Decision|0
1139713|NCT02901431|2243085|FG006|Main Treatment Part|Physician Decision|1
1139714|NCT02901431|2243086|FG007|Main Treatment Part|Physician Decision|0
1139715|NCT02901431|2243087|FG008|Main Treatment Part|Physician Decision|0
1139716|NCT02901431|2243088|FG009|Main Treatment Part|Physician Decision|0
1139717|NCT02901431|2243089|FG010|Main Treatment Part|Physician Decision|0
1139718|NCT02901431|2243090|FG011|Main Treatment Part|Physician Decision|0
1139719|NCT02901431|2243091|FG012|Main Treatment Part|Physician Decision|0
1139720|NCT02901431|2243079|FG000|Main Treatment Part|Withdrawal by Subject|0
1139721|NCT02901431|2243080|FG001|Main Treatment Part|Withdrawal by Subject|0
1139722|NCT02901431|2243081|FG002|Main Treatment Part|Withdrawal by Subject|0
1139723|NCT02901431|2243082|FG003|Main Treatment Part|Withdrawal by Subject|18
1139724|NCT02901431|2243083|FG004|Main Treatment Part|Withdrawal by Subject|3
1139725|NCT02901431|2243084|FG005|Main Treatment Part|Withdrawal by Subject|5
1139726|NCT02901431|2243085|FG006|Main Treatment Part|Withdrawal by Subject|6
1139727|NCT02901431|2243086|FG007|Main Treatment Part|Withdrawal by Subject|0
1139728|NCT02901431|2243087|FG008|Main Treatment Part|Withdrawal by Subject|0
1139729|NCT02901431|2243088|FG009|Main Treatment Part|Withdrawal by Subject|0
1139730|NCT02901431|2243089|FG010|Main Treatment Part|Withdrawal by Subject|0
1139731|NCT02901431|2243090|FG011|Main Treatment Part|Withdrawal by Subject|0
1139732|NCT02901431|2243091|FG012|Main Treatment Part|Withdrawal by Subject|0
1139733|NCT02901431|2243079|FG000|Open Label Part|Adverse Event|0
1139734|NCT02901431|2243080|FG001|Open Label Part|Adverse Event|0
1139735|NCT02901431|2243081|FG002|Open Label Part|Adverse Event|0
1139736|NCT02901431|2243082|FG003|Open Label Part|Adverse Event|0
1139737|NCT02901431|2243083|FG004|Open Label Part|Adverse Event|0
1139738|NCT02901431|2243084|FG005|Open Label Part|Adverse Event|0
1139739|NCT02901431|2243085|FG006|Open Label Part|Adverse Event|0
1139740|NCT02901431|2243086|FG007|Open Label Part|Adverse Event|0
1139741|NCT02901431|2243087|FG008|Open Label Part|Adverse Event|4
1139742|NCT02901431|2243088|FG009|Open Label Part|Adverse Event|4
1139743|NCT02901431|2243089|FG010|Open Label Part|Adverse Event|0
1139744|NCT02901431|2243090|FG011|Open Label Part|Adverse Event|4
1139745|NCT02901431|2243091|FG012|Open Label Part|Adverse Event|1
1139746|NCT02901431|2243079|FG000|Open Label Part|Lost to Follow-up|0
1139747|NCT02901431|2243080|FG001|Open Label Part|Lost to Follow-up|0
1139748|NCT02901431|2243081|FG002|Open Label Part|Lost to Follow-up|0
1139749|NCT02901431|2243082|FG003|Open Label Part|Lost to Follow-up|0
1139750|NCT02901431|2243083|FG004|Open Label Part|Lost to Follow-up|0
1139751|NCT02901431|2243084|FG005|Open Label Part|Lost to Follow-up|0
1139752|NCT02901431|2243085|FG006|Open Label Part|Lost to Follow-up|0
1139753|NCT02901431|2243086|FG007|Open Label Part|Lost to Follow-up|0
1139754|NCT02901431|2243087|FG008|Open Label Part|Lost to Follow-up|2
1139755|NCT02901431|2243088|FG009|Open Label Part|Lost to Follow-up|2
1139756|NCT02901431|2243089|FG010|Open Label Part|Lost to Follow-up|1
1139757|NCT02901431|2243090|FG011|Open Label Part|Lost to Follow-up|1
1139758|NCT02901431|2243091|FG012|Open Label Part|Lost to Follow-up|1
1139759|NCT02901431|2243079|FG000|Open Label Part|Physician Decision|0
1139760|NCT02901431|2243080|FG001|Open Label Part|Physician Decision|0
1139761|NCT02901431|2243081|FG002|Open Label Part|Physician Decision|0
1139762|NCT02901431|2243082|FG003|Open Label Part|Physician Decision|0
1139763|NCT02901431|2243083|FG004|Open Label Part|Physician Decision|0
1139764|NCT02901431|2243084|FG005|Open Label Part|Physician Decision|0
1139765|NCT02901431|2243085|FG006|Open Label Part|Physician Decision|0
1139766|NCT02901431|2243086|FG007|Open Label Part|Physician Decision|0
1139767|NCT02901431|2243087|FG008|Open Label Part|Physician Decision|1
1139768|NCT02901431|2243088|FG009|Open Label Part|Physician Decision|1
1139769|NCT02901431|2243089|FG010|Open Label Part|Physician Decision|0
1139770|NCT02901431|2243090|FG011|Open Label Part|Physician Decision|0
1139771|NCT02901431|2243091|FG012|Open Label Part|Physician Decision|0
1139772|NCT02901431|2243079|FG000|Open Label Part|Study Terminated By Sponsor|0
1139773|NCT02901431|2243080|FG001|Open Label Part|Study Terminated By Sponsor|0
1139774|NCT02901431|2243081|FG002|Open Label Part|Study Terminated By Sponsor|0
1139775|NCT02901431|2243082|FG003|Open Label Part|Study Terminated By Sponsor|0
1139776|NCT02901431|2243083|FG004|Open Label Part|Study Terminated By Sponsor|0
1139777|NCT02901431|2243084|FG005|Open Label Part|Study Terminated By Sponsor|0
1139778|NCT02901431|2243085|FG006|Open Label Part|Study Terminated By Sponsor|0
1139779|NCT02901431|2243086|FG007|Open Label Part|Study Terminated By Sponsor|0
1139780|NCT02901431|2243087|FG008|Open Label Part|Study Terminated By Sponsor|35
1139781|NCT02901431|2243088|FG009|Open Label Part|Study Terminated By Sponsor|12
1139782|NCT02901431|2243089|FG010|Open Label Part|Study Terminated By Sponsor|21
1139783|NCT02901431|2243090|FG011|Open Label Part|Study Terminated By Sponsor|31
1139784|NCT02901431|2243091|FG012|Open Label Part|Study Terminated By Sponsor|0
1139785|NCT02901431|2243079|FG000|Open Label Part|Withdrawal by Subject|0
1139786|NCT02901431|2243080|FG001|Open Label Part|Withdrawal by Subject|0
1139787|NCT02901431|2243081|FG002|Open Label Part|Withdrawal by Subject|0
1139788|NCT02901431|2243082|FG003|Open Label Part|Withdrawal by Subject|0
1139789|NCT02901431|2243083|FG004|Open Label Part|Withdrawal by Subject|0
1139790|NCT02901431|2243084|FG005|Open Label Part|Withdrawal by Subject|0
1139791|NCT02901431|2243085|FG006|Open Label Part|Withdrawal by Subject|0
1139792|NCT02901431|2243086|FG007|Open Label Part|Withdrawal by Subject|0
1139793|NCT02901431|2243087|FG008|Open Label Part|Withdrawal by Subject|6
1139794|NCT02901431|2243088|FG009|Open Label Part|Withdrawal by Subject|5
1139795|NCT02901431|2243089|FG010|Open Label Part|Withdrawal by Subject|7
1139796|NCT02901431|2243090|FG011|Open Label Part|Withdrawal by Subject|3
1139797|NCT02901431|2243091|FG012|Open Label Part|Withdrawal by Subject|1
1139798|NCT02901548|2243116|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4
1139799|NCT02902809|2243179|FG000|Overall Study|Discontinuation of asthma program|28
1139800|NCT02902965|2243191|FG000|Overall Study|Withdrawal by Subject|10
1139801|NCT02903030|2243198|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
1139802|NCT02903030|2243199|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
1139803|NCT02903238|2243217|FG000|Overall Study|Lost to Follow-up|4
1139804|NCT02903368|2243224|FG000|Overall Study|Not sprcified|4
1139805|NCT02903368|2243225|FG001|Overall Study|Not sprcified|0
1139806|NCT02903420|2243253|FG000|Overall Study|Death|3
1139807|NCT02903511|2243268|FG000|Overall Study|Withdrawal by Subject|1
1139808|NCT02903511|2243269|FG001|Overall Study|Withdrawal by Subject|0
1139809|NCT02903511|2243268|FG000|Overall Study|Lost to Follow-up|3
1139810|NCT02903511|2243269|FG001|Overall Study|Lost to Follow-up|2
1139811|NCT02903823|2243275|FG000|Overall Study|Physician Decision|5
1139812|NCT02903823|2243275|FG000|Overall Study|Could not advance catheter|1
1139813|NCT02903823|2243275|FG000|Overall Study|Catheter dislodgement|1
901534|NCT00734474|1875038|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0
901535|NCT00734474|1875039|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8
901536|NCT00734474|1875040|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0
901537|NCT00734474|1875041|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21
901538|NCT00734474|1875042|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23
901539|NCT00734474|1875043|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0
901540|NCT00734474|1875044|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0
901541|NCT00734474|1875036|FG000|Overall Study|Sponsor Decision|0
901542|NCT00734474|1875037|FG001|Overall Study|Sponsor Decision|0
901543|NCT00734474|1875038|FG002|Overall Study|Sponsor Decision|0
901544|NCT00734474|1875039|FG003|Overall Study|Sponsor Decision|0
901545|NCT00734474|1875040|FG004|Overall Study|Sponsor Decision|2
901546|NCT00734474|1875041|FG005|Overall Study|Sponsor Decision|0
901547|NCT00734474|1875042|FG006|Overall Study|Sponsor Decision|0
901548|NCT00734474|1875043|FG007|Overall Study|Sponsor Decision|0
901549|NCT00734474|1875044|FG008|Overall Study|Sponsor Decision|0
901550|NCT00734474|1875036|FG000|Overall Study|Death|0
901551|NCT00734474|1875037|FG001|Overall Study|Death|0
901552|NCT00734474|1875038|FG002|Overall Study|Death|1
901553|NCT00734474|1875039|FG003|Overall Study|Death|0
901554|NCT00734474|1875040|FG004|Overall Study|Death|0
1139886|NCT02903966|2243330|FG000|Part A (Day 1 to 43)|Adverse Event|1
1139887|NCT02903966|2243331|FG001|Part A (Day 1 to 43)|Adverse Event|0
1139888|NCT02903966|2243330|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0
1139889|NCT02903966|2243331|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1
1139890|NCT02903966|2243330|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0
1139891|NCT02903966|2243331|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1
1139892|NCT02904096|2243354|FG000|Overall Study|Adverse Event|1
1139893|NCT02904096|2243355|FG001|Overall Study|Adverse Event|0
1139894|NCT02904096|2243354|FG000|Overall Study|Withdrawal by Subject|4
1139895|NCT02904096|2243355|FG001|Overall Study|Withdrawal by Subject|3
1139896|NCT02904096|2243354|FG000|Overall Study|Lost to Follow-up|10
1139897|NCT02904096|2243355|FG001|Overall Study|Lost to Follow-up|17
1139898|NCT02904096|2243354|FG000|Overall Study|Non-compliant|3
1139899|NCT02904096|2243355|FG001|Overall Study|Non-compliant|1
1139900|NCT02904096|2243354|FG000|Overall Study|Sponsor instructed|1
1139901|NCT02904096|2243355|FG001|Overall Study|Sponsor instructed|0
1139902|NCT02904200|2243361|FG000|Overall Study|Withdrawal by Subject|1
1139903|NCT02904200|2243362|FG001|Overall Study|Withdrawal by Subject|0
1139904|NCT02904265|2243399|FG000|Overall Study|Physician Decision|1
1139905|NCT02904265|2243400|FG001|Overall Study|Physician Decision|2
1139906|NCT02904512|2243408|FG000|Overall Study|Withdrawal by Subject|1
1139907|NCT02904512|2243409|FG001|Overall Study|Withdrawal by Subject|0
1139908|NCT02904512|2243408|FG000|Overall Study|Transferred to ICU|1
1139909|NCT02904512|2243409|FG001|Overall Study|Transferred to ICU|0
1139910|NCT02904512|2243408|FG000|Overall Study|Minor Bleeding at site of device insertion|1
1139911|NCT02904512|2243409|FG001|Overall Study|Minor Bleeding at site of device insertion|0
1139912|NCT02904902|2243415|FG000|Overall Study|Withdrawal by Subject|1
1139913|NCT02904954|2243430|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1
1139914|NCT02904954|2243431|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1
1139915|NCT02904954|2243430|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1
1139916|NCT02904954|2243431|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0
1139917|NCT02904954|2243430|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2
1139918|NCT02904954|2243431|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3
1139919|NCT02904954|2243430|FG000|Adjuvant Durvalumab|Recurrence|2
901555|NCT00734474|1875041|FG005|Overall Study|Death|0
901556|NCT00734474|1875042|FG006|Overall Study|Death|0
901557|NCT00734474|1875043|FG007|Overall Study|Death|2
901558|NCT00734474|1875044|FG008|Overall Study|Death|1
1139920|NCT02904954|2243431|FG001|Adjuvant Durvalumab|Recurrence|0
1139921|NCT02904954|2243430|FG000|Adjuvant Durvalumab|Adverse Event|2
1139922|NCT02904954|2243431|FG001|Adjuvant Durvalumab|Adverse Event|6
1139923|NCT02904954|2243430|FG000|Adjuvant Durvalumab|Participant wishes|12
1139924|NCT02904954|2243431|FG001|Adjuvant Durvalumab|Participant wishes|5
1139925|NCT02904954|2243430|FG000|Adjuvant Durvalumab|Physician Decision|2
1139926|NCT02904954|2243431|FG001|Adjuvant Durvalumab|Physician Decision|1
1139927|NCT02904954|2243430|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1
1139928|NCT02904954|2243431|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0
1139929|NCT02904954|2243430|FG000|Adjuvant Durvalumab|Death|0
1139930|NCT02904954|2243431|FG001|Adjuvant Durvalumab|Death|1
1139931|NCT02904954|2243430|FG000|Adjuvant Durvalumab|Prostate cancer|1
1139932|NCT02904954|2243431|FG001|Adjuvant Durvalumab|Prostate cancer|0
1139933|NCT02904954|2243430|FG000|Adjuvant Durvalumab|Currently on treatment|1
1139934|NCT02904954|2243431|FG001|Adjuvant Durvalumab|Currently on treatment|3
1139935|NCT02905006|2243445|FG000|Overall Study|Adverse Event|1
1139936|NCT02905006|2243446|FG001|Overall Study|Adverse Event|1
1139937|NCT02905006|2243447|FG002|Overall Study|Adverse Event|1
1139938|NCT02905006|2243448|FG003|Overall Study|Adverse Event|1
1139939|NCT02905006|2243449|FG004|Overall Study|Adverse Event|0
1139940|NCT02905006|2243450|FG005|Overall Study|Adverse Event|1
1139941|NCT02905006|2243445|FG000|Overall Study|Lack of Efficacy|1
1139942|NCT02905006|2243446|FG001|Overall Study|Lack of Efficacy|0
1139943|NCT02905006|2243447|FG002|Overall Study|Lack of Efficacy|0
1139944|NCT02905006|2243448|FG003|Overall Study|Lack of Efficacy|0
1139945|NCT02905006|2243449|FG004|Overall Study|Lack of Efficacy|0
1139946|NCT02905006|2243450|FG005|Overall Study|Lack of Efficacy|0
1139947|NCT02905006|2243445|FG000|Overall Study|Protocol Violation|2
1139948|NCT02905006|2243446|FG001|Overall Study|Protocol Violation|0
1139949|NCT02905006|2243447|FG002|Overall Study|Protocol Violation|0
1139950|NCT02905006|2243448|FG003|Overall Study|Protocol Violation|0
1139951|NCT02905006|2243449|FG004|Overall Study|Protocol Violation|0
1139952|NCT02905006|2243450|FG005|Overall Study|Protocol Violation|0
1139953|NCT02905006|2243445|FG000|Overall Study|Lost to Follow-up|0
1139954|NCT02905006|2243446|FG001|Overall Study|Lost to Follow-up|0
1139955|NCT02905006|2243447|FG002|Overall Study|Lost to Follow-up|0
1139956|NCT02905006|2243448|FG003|Overall Study|Lost to Follow-up|1
1139957|NCT02905006|2243449|FG004|Overall Study|Lost to Follow-up|1
1139958|NCT02905006|2243450|FG005|Overall Study|Lost to Follow-up|0
1139959|NCT02905006|2243445|FG000|Overall Study|Withdrawal by Subject|0
1139960|NCT02905006|2243446|FG001|Overall Study|Withdrawal by Subject|0
1139961|NCT02905006|2243447|FG002|Overall Study|Withdrawal by Subject|1
1139962|NCT02905006|2243448|FG003|Overall Study|Withdrawal by Subject|1
1139963|NCT02905006|2243449|FG004|Overall Study|Withdrawal by Subject|0
1139964|NCT02905006|2243450|FG005|Overall Study|Withdrawal by Subject|1
1139965|NCT02905006|2243445|FG000|Overall Study|Screening exclusion criteria met|1
1139966|NCT02905006|2243446|FG001|Overall Study|Screening exclusion criteria met|0
1139967|NCT02905006|2243447|FG002|Overall Study|Screening exclusion criteria met|0
1139968|NCT02905006|2243448|FG003|Overall Study|Screening exclusion criteria met|0
1139969|NCT02905006|2243449|FG004|Overall Study|Screening exclusion criteria met|0
1139970|NCT02905006|2243450|FG005|Overall Study|Screening exclusion criteria met|0
1139971|NCT02905006|2243445|FG000|Overall Study|Lab withdrawal criterion met|0
1139972|NCT02905006|2243446|FG001|Overall Study|Lab withdrawal criterion met|1
1139973|NCT02905006|2243447|FG002|Overall Study|Lab withdrawal criterion met|2
1139974|NCT02905006|2243448|FG003|Overall Study|Lab withdrawal criterion met|2
1139975|NCT02905006|2243449|FG004|Overall Study|Lab withdrawal criterion met|2
1139976|NCT02905006|2243450|FG005|Overall Study|Lab withdrawal criterion met|1
1139977|NCT02905006|2243445|FG000|Overall Study|Positive for Tuberculosis|0
1139978|NCT02905006|2243446|FG001|Overall Study|Positive for Tuberculosis|1
1139979|NCT02905006|2243447|FG002|Overall Study|Positive for Tuberculosis|0
1139980|NCT02905006|2243448|FG003|Overall Study|Positive for Tuberculosis|0
1139981|NCT02905006|2243449|FG004|Overall Study|Positive for Tuberculosis|0
1139982|NCT02905006|2243450|FG005|Overall Study|Positive for Tuberculosis|0
1139983|NCT02905006|2243445|FG000|Overall Study|Subject positive for Hep B|0
1139984|NCT02905006|2243446|FG001|Overall Study|Subject positive for Hep B|0
1139985|NCT02905006|2243447|FG002|Overall Study|Subject positive for Hep B|1
1139986|NCT02905006|2243448|FG003|Overall Study|Subject positive for Hep B|0
1139987|NCT02905006|2243449|FG004|Overall Study|Subject positive for Hep B|0
1139988|NCT02905006|2243450|FG005|Overall Study|Subject positive for Hep B|0
1139989|NCT02905006|2243445|FG000|Overall Study|Patient moved abroad|0
1139990|NCT02905006|2243446|FG001|Overall Study|Patient moved abroad|0
1139991|NCT02905006|2243447|FG002|Overall Study|Patient moved abroad|0
1139992|NCT02905006|2243448|FG003|Overall Study|Patient moved abroad|1
1139993|NCT02905006|2243449|FG004|Overall Study|Patient moved abroad|0
1139994|NCT02905006|2243450|FG005|Overall Study|Patient moved abroad|0
1139995|NCT02905006|2243445|FG000|Overall Study|Patient randomized by mistake|0
1139996|NCT02905006|2243446|FG001|Overall Study|Patient randomized by mistake|0
1139997|NCT02905006|2243447|FG002|Overall Study|Patient randomized by mistake|0
1139998|NCT02905006|2243448|FG003|Overall Study|Patient randomized by mistake|0
1139999|NCT02905006|2243449|FG004|Overall Study|Patient randomized by mistake|0
1140000|NCT02905006|2243450|FG005|Overall Study|Patient randomized by mistake|1
1140001|NCT02905149|2243490|FG000|Overall Study|Lost to Follow-up|2
1140002|NCT02905149|2243491|FG001|Overall Study|Lost to Follow-up|0
1140003|NCT02905266|2243499|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1
1140004|NCT02905266|2243500|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0
1140005|NCT02905266|2243499|FG000|Treatment Phase Part 1|Disease Progression|6
1140006|NCT02905266|2243500|FG001|Treatment Phase Part 1|Disease Progression|7
1140007|NCT02905266|2243499|FG000|Treatment Phase Part 1|Study Drug Toxicity|22
1140008|NCT02905266|2243500|FG001|Treatment Phase Part 1|Study Drug Toxicity|16
1140009|NCT02905266|2243499|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1
1140010|NCT02905266|2243500|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0
1140011|NCT02905266|2243499|FG000|Transition From Part 1 to Part 2|Disease progression|2
1140012|NCT02905266|2243500|FG001|Transition From Part 1 to Part 2|Disease progression|1
1140013|NCT02905266|2243499|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0
1140014|NCT02905266|2243500|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4
1140015|NCT02905266|2243499|FG000|Transition From Part 1 to Part 2|Death|0
1140016|NCT02905266|2243500|FG001|Transition From Part 1 to Part 2|Death|1
1140017|NCT02905266|2243499|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0
1140018|NCT02905266|2243500|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1
1140019|NCT02905266|2243499|FG000|Transition From Part 1 to Part 2|Adverse Event|1
1140020|NCT02905266|2243500|FG001|Transition From Part 1 to Part 2|Adverse Event|1
1140021|NCT02905266|2243499|FG000|Maintenance Phase Part 2|Disease Progression|9
1140022|NCT02905266|2243500|FG001|Maintenance Phase Part 2|Disease Progression|2
1140023|NCT02905266|2243499|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3
1140024|NCT02905266|2243500|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4
1140025|NCT02905266|2243499|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0
1140026|NCT02905266|2243500|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2
1140027|NCT02905331|2243508|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
1140028|NCT02905331|2243509|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
1140029|NCT02905331|2243510|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
1140030|NCT02905331|2243508|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
1140031|NCT02905331|2243509|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
1140032|NCT02905331|2243510|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
1140033|NCT02905331|2243508|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
1140034|NCT02905331|2243509|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
1140035|NCT02905331|2243510|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
1140036|NCT02905331|2243508|FG000|Active Treatment and Follow up (wk16-40)|Other|0
1140037|NCT02905331|2243509|FG001|Active Treatment and Follow up (wk16-40)|Other|6
1140038|NCT02905331|2243510|FG002|Active Treatment and Follow up (wk16-40)|Other|0
1140039|NCT02905331|2243508|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
1140040|NCT02905331|2243509|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
1140041|NCT02905331|2243510|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
1140042|NCT02905435|2243518|FG000|Overall Study|Death|2
1140043|NCT02905435|2243518|FG000|Overall Study|Physician Decision|1
1140044|NCT02905435|2243518|FG000|Overall Study|Lost to Follow-up|4
1140045|NCT02905825|2243523|FG000|Overall Study|Protocol Violation|11
1140046|NCT02905825|2243523|FG000|Overall Study|Device Malfunction|1
1140047|NCT02906358|2243533|FG000|Overall Study|Withdrawal by Subject|10
1140048|NCT02906358|2243534|FG001|Overall Study|Withdrawal by Subject|7
1140049|NCT02906358|2243533|FG000|Overall Study|Lost to Follow-up|12
1140050|NCT02906358|2243534|FG001|Overall Study|Lost to Follow-up|15
1140051|NCT02906579|2243551|FG000|Overall Study|Adverse Event|1
1140052|NCT02906579|2243551|FG000|Overall Study|Physician Decision|1
1140053|NCT02906644|2243573|FG000|First 2 Weeks|Withdrawal by Subject|0
1140054|NCT02906644|2243574|FG001|First 2 Weeks|Withdrawal by Subject|2
1140055|NCT02906644|2243573|FG000|First 2 Weeks|Physician Decision|1
1140056|NCT02906644|2243574|FG001|First 2 Weeks|Physician Decision|1
1140057|NCT02906644|2243573|FG000|Weeks 3 to 14|Withdrawal by Subject|13
1140058|NCT02906644|2243574|FG001|Weeks 3 to 14|Withdrawal by Subject|7
1140059|NCT02906644|2243573|FG000|Weeks 3 to 14|Lost to Follow-up|3
1140060|NCT02906644|2243574|FG001|Weeks 3 to 14|Lost to Follow-up|4
1140061|NCT02906670|2243591|FG000|Cohort 1, QW|Radiological Progression|1
1140062|NCT02906670|2243592|FG001|Cohort 1, QW|Radiological Progression|0
1140063|NCT02906670|2243593|FG002|Cohort 1, QW|Radiological Progression|0
1140064|NCT02906670|2243594|FG003|Cohort 1, QW|Radiological Progression|0
1140065|NCT02906670|2243595|FG004|Cohort 1, QW|Radiological Progression|0
1140066|NCT02906670|2243596|FG005|Cohort 1, QW|Radiological Progression|0
1140067|NCT02906670|2243597|FG006|Cohort 1, QW|Radiological Progression|0
1140068|NCT02906670|2243598|FG007|Cohort 1, QW|Radiological Progression|0
1140069|NCT02906670|2243599|FG008|Cohort 1, QW|Radiological Progression|0
1140070|NCT02906670|2243600|FG009|Cohort 1, QW|Radiological Progression|0
1140071|NCT02906670|2243591|FG000|Cohort 2, QW|Radiological Progression|0
1140072|NCT02906670|2243592|FG001|Cohort 2, QW|Radiological Progression|1
1140073|NCT02906670|2243593|FG002|Cohort 2, QW|Radiological Progression|0
1140074|NCT02906670|2243594|FG003|Cohort 2, QW|Radiological Progression|0
1140075|NCT02906670|2243595|FG004|Cohort 2, QW|Radiological Progression|0
1140076|NCT02906670|2243596|FG005|Cohort 2, QW|Radiological Progression|0
1140077|NCT02906670|2243597|FG006|Cohort 2, QW|Radiological Progression|0
1140078|NCT02906670|2243598|FG007|Cohort 2, QW|Radiological Progression|0
1140079|NCT02906670|2243599|FG008|Cohort 2, QW|Radiological Progression|0
1140080|NCT02906670|2243600|FG009|Cohort 2, QW|Radiological Progression|0
1140081|NCT02906670|2243591|FG000|Cohort 3, QW|Radiological Progression|0
1140082|NCT02906670|2243592|FG001|Cohort 3, QW|Radiological Progression|0
1140083|NCT02906670|2243593|FG002|Cohort 3, QW|Radiological Progression|2
1140084|NCT02906670|2243594|FG003|Cohort 3, QW|Radiological Progression|0
1140085|NCT02906670|2243595|FG004|Cohort 3, QW|Radiological Progression|0
1140086|NCT02906670|2243596|FG005|Cohort 3, QW|Radiological Progression|0
1140087|NCT02906670|2243597|FG006|Cohort 3, QW|Radiological Progression|0
1140088|NCT02906670|2243598|FG007|Cohort 3, QW|Radiological Progression|0
1140089|NCT02906670|2243599|FG008|Cohort 3, QW|Radiological Progression|0
1140090|NCT02906670|2243600|FG009|Cohort 3, QW|Radiological Progression|0
1140091|NCT02906670|2243591|FG000|Cohort 3, QW|Lack of Clinical Benefit|0
1140092|NCT02906670|2243592|FG001|Cohort 3, QW|Lack of Clinical Benefit|0
1140093|NCT02906670|2243593|FG002|Cohort 3, QW|Lack of Clinical Benefit|2
1140094|NCT02906670|2243594|FG003|Cohort 3, QW|Lack of Clinical Benefit|0
1140095|NCT02906670|2243595|FG004|Cohort 3, QW|Lack of Clinical Benefit|0
1140096|NCT02906670|2243596|FG005|Cohort 3, QW|Lack of Clinical Benefit|0
1140097|NCT02906670|2243597|FG006|Cohort 3, QW|Lack of Clinical Benefit|0
1140098|NCT02906670|2243598|FG007|Cohort 3, QW|Lack of Clinical Benefit|0
1140099|NCT02906670|2243599|FG008|Cohort 3, QW|Lack of Clinical Benefit|0
1140100|NCT02906670|2243600|FG009|Cohort 3, QW|Lack of Clinical Benefit|0
1140101|NCT02906670|2243591|FG000|Cohort 4, Q2W|Radiological Progression|0
1140102|NCT02906670|2243592|FG001|Cohort 4, Q2W|Radiological Progression|0
1140103|NCT02906670|2243593|FG002|Cohort 4, Q2W|Radiological Progression|0
1140104|NCT02906670|2243594|FG003|Cohort 4, Q2W|Radiological Progression|0
1140105|NCT02906670|2243595|FG004|Cohort 4, Q2W|Radiological Progression|0
1140106|NCT02906670|2243596|FG005|Cohort 4, Q2W|Radiological Progression|1
1140107|NCT02906670|2243597|FG006|Cohort 4, Q2W|Radiological Progression|0
1140108|NCT02906670|2243598|FG007|Cohort 4, Q2W|Radiological Progression|0
1140109|NCT02906670|2243599|FG008|Cohort 4, Q2W|Radiological Progression|0
1140110|NCT02906670|2243600|FG009|Cohort 4, Q2W|Radiological Progression|0
1140111|NCT02906670|2243591|FG000|Cohort 4, Q2W|Clinical Progression|0
1140112|NCT02906670|2243592|FG001|Cohort 4, Q2W|Clinical Progression|0
1140113|NCT02906670|2243593|FG002|Cohort 4, Q2W|Clinical Progression|0
1140114|NCT02906670|2243594|FG003|Cohort 4, Q2W|Clinical Progression|0
1140115|NCT02906670|2243595|FG004|Cohort 4, Q2W|Clinical Progression|0
1140116|NCT02906670|2243596|FG005|Cohort 4, Q2W|Clinical Progression|2
1140117|NCT02906670|2243597|FG006|Cohort 4, Q2W|Clinical Progression|0
1140118|NCT02906670|2243598|FG007|Cohort 4, Q2W|Clinical Progression|0
1140119|NCT02906670|2243599|FG008|Cohort 4, Q2W|Clinical Progression|0
1140120|NCT02906670|2243600|FG009|Cohort 4, Q2W|Clinical Progression|0
1140121|NCT02906670|2243591|FG000|Cohort 5, Q2W|Radiological Progression|0
1140122|NCT02906670|2243592|FG001|Cohort 5, Q2W|Radiological Progression|0
1140123|NCT02906670|2243593|FG002|Cohort 5, Q2W|Radiological Progression|0
1140124|NCT02906670|2243594|FG003|Cohort 5, Q2W|Radiological Progression|0
1140125|NCT02906670|2243595|FG004|Cohort 5, Q2W|Radiological Progression|0
1140126|NCT02906670|2243596|FG005|Cohort 5, Q2W|Radiological Progression|0
1140127|NCT02906670|2243597|FG006|Cohort 5, Q2W|Radiological Progression|4
1140128|NCT02906670|2243598|FG007|Cohort 5, Q2W|Radiological Progression|0
1140129|NCT02906670|2243599|FG008|Cohort 5, Q2W|Radiological Progression|0
1140130|NCT02906670|2243600|FG009|Cohort 5, Q2W|Radiological Progression|0
1140131|NCT02906670|2243591|FG000|Cohort 5, Q2W|Clinical Progression|0
1140132|NCT02906670|2243592|FG001|Cohort 5, Q2W|Clinical Progression|0
1140133|NCT02906670|2243593|FG002|Cohort 5, Q2W|Clinical Progression|0
1140134|NCT02906670|2243594|FG003|Cohort 5, Q2W|Clinical Progression|0
1140135|NCT02906670|2243595|FG004|Cohort 5, Q2W|Clinical Progression|0
1140136|NCT02906670|2243596|FG005|Cohort 5, Q2W|Clinical Progression|0
1140137|NCT02906670|2243597|FG006|Cohort 5, Q2W|Clinical Progression|1
1140138|NCT02906670|2243598|FG007|Cohort 5, Q2W|Clinical Progression|0
1140139|NCT02906670|2243599|FG008|Cohort 5, Q2W|Clinical Progression|0
1140140|NCT02906670|2243600|FG009|Cohort 5, Q2W|Clinical Progression|0
1140141|NCT02906670|2243591|FG000|Cohort 5, Q2W|Adverse Event|0
1140142|NCT02906670|2243592|FG001|Cohort 5, Q2W|Adverse Event|0
1140143|NCT02906670|2243593|FG002|Cohort 5, Q2W|Adverse Event|0
1140144|NCT02906670|2243594|FG003|Cohort 5, Q2W|Adverse Event|0
1140145|NCT02906670|2243595|FG004|Cohort 5, Q2W|Adverse Event|0
1140146|NCT02906670|2243596|FG005|Cohort 5, Q2W|Adverse Event|0
1140147|NCT02906670|2243597|FG006|Cohort 5, Q2W|Adverse Event|1
1140148|NCT02906670|2243598|FG007|Cohort 5, Q2W|Adverse Event|0
1140149|NCT02906670|2243599|FG008|Cohort 5, Q2W|Adverse Event|0
1140150|NCT02906670|2243600|FG009|Cohort 5, Q2W|Adverse Event|0
1140151|NCT02906670|2243591|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0
1140152|NCT02906670|2243592|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0
1140153|NCT02906670|2243593|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0
1140154|NCT02906670|2243594|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0
1140155|NCT02906670|2243595|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0
1140156|NCT02906670|2243596|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0
1140157|NCT02906670|2243597|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1
1140158|NCT02906670|2243598|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0
1140159|NCT02906670|2243599|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0
1140160|NCT02906670|2243600|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0
1140161|NCT02906670|2243591|FG000|Cohort 5P, Q2W|Radiological Progression|0
1140162|NCT02906670|2243592|FG001|Cohort 5P, Q2W|Radiological Progression|0
1140163|NCT02906670|2243593|FG002|Cohort 5P, Q2W|Radiological Progression|0
1140164|NCT02906670|2243594|FG003|Cohort 5P, Q2W|Radiological Progression|0
1140165|NCT02906670|2243595|FG004|Cohort 5P, Q2W|Radiological Progression|0
1140166|NCT02906670|2243596|FG005|Cohort 5P, Q2W|Radiological Progression|0
1140167|NCT02906670|2243597|FG006|Cohort 5P, Q2W|Radiological Progression|0
1140168|NCT02906670|2243598|FG007|Cohort 5P, Q2W|Radiological Progression|2
1140169|NCT02906670|2243599|FG008|Cohort 5P, Q2W|Radiological Progression|0
1140170|NCT02906670|2243600|FG009|Cohort 5P, Q2W|Radiological Progression|0
1140171|NCT02906670|2243591|FG000|Cohort 5P, Q2W|Adverse Event|0
1140172|NCT02906670|2243592|FG001|Cohort 5P, Q2W|Adverse Event|0
1140173|NCT02906670|2243593|FG002|Cohort 5P, Q2W|Adverse Event|0
1140174|NCT02906670|2243594|FG003|Cohort 5P, Q2W|Adverse Event|0
1140175|NCT02906670|2243595|FG004|Cohort 5P, Q2W|Adverse Event|0
1140176|NCT02906670|2243596|FG005|Cohort 5P, Q2W|Adverse Event|0
1140177|NCT02906670|2243597|FG006|Cohort 5P, Q2W|Adverse Event|0
1140178|NCT02906670|2243598|FG007|Cohort 5P, Q2W|Adverse Event|1
1140179|NCT02906670|2243599|FG008|Cohort 5P, Q2W|Adverse Event|0
1140180|NCT02906670|2243600|FG009|Cohort 5P, Q2W|Adverse Event|0
1140181|NCT02906670|2243591|FG000|Cohort 6P, Q2W|Radiological Progression|0
1140182|NCT02906670|2243592|FG001|Cohort 6P, Q2W|Radiological Progression|0
1140183|NCT02906670|2243593|FG002|Cohort 6P, Q2W|Radiological Progression|0
1140184|NCT02906670|2243594|FG003|Cohort 6P, Q2W|Radiological Progression|0
1140185|NCT02906670|2243595|FG004|Cohort 6P, Q2W|Radiological Progression|0
1140186|NCT02906670|2243596|FG005|Cohort 6P, Q2W|Radiological Progression|0
1140187|NCT02906670|2243597|FG006|Cohort 6P, Q2W|Radiological Progression|0
1140188|NCT02906670|2243598|FG007|Cohort 6P, Q2W|Radiological Progression|0
1140189|NCT02906670|2243599|FG008|Cohort 6P, Q2W|Radiological Progression|1
1140190|NCT02906670|2243600|FG009|Cohort 6P, Q2W|Radiological Progression|0
1140191|NCT02906670|2243591|FG000|Cohort 6P, Q2W|Clinical Progression|0
1140192|NCT02906670|2243592|FG001|Cohort 6P, Q2W|Clinical Progression|0
1140193|NCT02906670|2243593|FG002|Cohort 6P, Q2W|Clinical Progression|0
1140194|NCT02906670|2243594|FG003|Cohort 6P, Q2W|Clinical Progression|0
1140195|NCT02906670|2243595|FG004|Cohort 6P, Q2W|Clinical Progression|0
1140196|NCT02906670|2243596|FG005|Cohort 6P, Q2W|Clinical Progression|0
1140197|NCT02906670|2243597|FG006|Cohort 6P, Q2W|Clinical Progression|0
1140198|NCT02906670|2243598|FG007|Cohort 6P, Q2W|Clinical Progression|0
1140199|NCT02906670|2243599|FG008|Cohort 6P, Q2W|Clinical Progression|3
1140200|NCT02906670|2243600|FG009|Cohort 6P, Q2W|Clinical Progression|0
1140201|NCT02906670|2243591|FG000|Cohort 4P, QW|Radiological Progression|0
1140202|NCT02906670|2243592|FG001|Cohort 4P, QW|Radiological Progression|0
1140203|NCT02906670|2243593|FG002|Cohort 4P, QW|Radiological Progression|0
1140204|NCT02906670|2243594|FG003|Cohort 4P, QW|Radiological Progression|3
1140205|NCT02906670|2243595|FG004|Cohort 4P, QW|Radiological Progression|0
1140206|NCT02906670|2243596|FG005|Cohort 4P, QW|Radiological Progression|0
1140207|NCT02906670|2243597|FG006|Cohort 4P, QW|Radiological Progression|0
1140208|NCT02906670|2243598|FG007|Cohort 4P, QW|Radiological Progression|0
1140209|NCT02906670|2243599|FG008|Cohort 4P, QW|Radiological Progression|0
1140210|NCT02906670|2243600|FG009|Cohort 4P, QW|Radiological Progression|0
1140211|NCT02906670|2243591|FG000|Cohort 7P, Q2W|Adverse Event|0
1140212|NCT02906670|2243592|FG001|Cohort 7P, Q2W|Adverse Event|0
1140213|NCT02906670|2243593|FG002|Cohort 7P, Q2W|Adverse Event|0
1140214|NCT02906670|2243594|FG003|Cohort 7P, Q2W|Adverse Event|0
1140215|NCT02906670|2243595|FG004|Cohort 7P, Q2W|Adverse Event|0
1140216|NCT02906670|2243596|FG005|Cohort 7P, Q2W|Adverse Event|0
1140217|NCT02906670|2243597|FG006|Cohort 7P, Q2W|Adverse Event|0
1140218|NCT02906670|2243598|FG007|Cohort 7P, Q2W|Adverse Event|0
1140219|NCT02906670|2243599|FG008|Cohort 7P, Q2W|Adverse Event|0
1140220|NCT02906670|2243600|FG009|Cohort 7P, Q2W|Adverse Event|1
1140221|NCT02906670|2243591|FG000|Cohort 7P, Q2W|Physician Decision|0
1140222|NCT02906670|2243592|FG001|Cohort 7P, Q2W|Physician Decision|0
1140223|NCT02906670|2243593|FG002|Cohort 7P, Q2W|Physician Decision|0
1140224|NCT02906670|2243594|FG003|Cohort 7P, Q2W|Physician Decision|0
1140225|NCT02906670|2243595|FG004|Cohort 7P, Q2W|Physician Decision|0
1140226|NCT02906670|2243596|FG005|Cohort 7P, Q2W|Physician Decision|0
1140227|NCT02906670|2243597|FG006|Cohort 7P, Q2W|Physician Decision|0
1140228|NCT02906670|2243598|FG007|Cohort 7P, Q2W|Physician Decision|0
1140229|NCT02906670|2243599|FG008|Cohort 7P, Q2W|Physician Decision|0
1140230|NCT02906670|2243600|FG009|Cohort 7P, Q2W|Physician Decision|1
1140231|NCT02906670|2243591|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
1140232|NCT02906670|2243592|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
1140233|NCT02906670|2243593|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
1140234|NCT02906670|2243594|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
1140235|NCT02906670|2243595|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
1140236|NCT02906670|2243596|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
1140237|NCT02906670|2243597|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
1140238|NCT02906670|2243598|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
1140239|NCT02906670|2243599|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
1140240|NCT02906670|2243600|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1
1140241|NCT02906670|2243591|FG000|Cohort 5P, QW|Radiological Progression|0
1140242|NCT02906670|2243592|FG001|Cohort 5P, QW|Radiological Progression|0
1140243|NCT02906670|2243593|FG002|Cohort 5P, QW|Radiological Progression|0
1140244|NCT02906670|2243594|FG003|Cohort 5P, QW|Radiological Progression|0
1140245|NCT02906670|2243595|FG004|Cohort 5P, QW|Radiological Progression|3
1140246|NCT02906670|2243596|FG005|Cohort 5P, QW|Radiological Progression|0
1140247|NCT02906670|2243597|FG006|Cohort 5P, QW|Radiological Progression|0
1140248|NCT02906670|2243598|FG007|Cohort 5P, QW|Radiological Progression|0
1140249|NCT02906670|2243599|FG008|Cohort 5P, QW|Radiological Progression|0
1140250|NCT02906670|2243600|FG009|Cohort 5P, QW|Radiological Progression|0
1140251|NCT02906709|2243656|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1
1140252|NCT02906709|2243657|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2
1140253|NCT02906709|2243656|FG000|Phase A (Week 0 to Week 16)|Death|0
1140254|NCT02906709|2243657|FG001|Phase A (Week 0 to Week 16)|Death|1
1140255|NCT02906709|2243656|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
1140256|NCT02906709|2243657|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
1140257|NCT02906709|2243656|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
1140258|NCT02906709|2243657|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
1140259|NCT02906917|2243684|FG000|Initiation Period (Week 0-26)|Unclassified|1
1140260|NCT02906917|2243685|FG001|Initiation Period (Week 0-26)|Unclassified|3
1140261|NCT02906917|2243684|FG000|Initiation Period (Week 0-26)|Adverse Event|1
1140262|NCT02906917|2243685|FG001|Initiation Period (Week 0-26)|Adverse Event|0
1140263|NCT02906917|2243684|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1
1140264|NCT02906917|2243685|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4
1140265|NCT02906917|2243684|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3
1140266|NCT02906917|2243685|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4
1140267|NCT02906917|2243684|FG000|Intensification Period (Week 26-38)|Unclassified|3
1140268|NCT02906917|2243685|FG001|Intensification Period (Week 26-38)|Unclassified|2
1140269|NCT02906917|2243684|FG000|Intensification Period (Week 26-38)|Adverse Event|0
1140270|NCT02906917|2243685|FG001|Intensification Period (Week 26-38)|Adverse Event|2
1140271|NCT02906917|2243684|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3
1140272|NCT02906917|2243685|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1
1140273|NCT02906917|2243684|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3
1140274|NCT02906917|2243685|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2
1140275|NCT02907177|2243723|FG000|Overall Study|Death|0
1140276|NCT02907177|2243724|FG001|Overall Study|Death|1
1140277|NCT02907177|2243723|FG000|Overall Study|Physician Decision|3
1140278|NCT02907177|2243724|FG001|Overall Study|Physician Decision|3
1140279|NCT02907177|2243723|FG000|Overall Study|Withdrawal by Subject|15
1140280|NCT02907177|2243724|FG001|Overall Study|Withdrawal by Subject|7
1140281|NCT02907177|2243723|FG000|Overall Study|Sponsor's Decision|50
1140282|NCT02907177|2243724|FG001|Overall Study|Sponsor's Decision|57
1140283|NCT02907216|2243732|FG000|Overall Study|No benefit to be obtained by continuing|0
1140284|NCT02907216|2243733|FG001|Overall Study|No benefit to be obtained by continuing|1
1140285|NCT02907216|2243732|FG000|Overall Study|Withdrawal by Subject|1
1140286|NCT02907216|2243733|FG001|Overall Study|Withdrawal by Subject|0
1140287|NCT02907463|2243747|FG000|Overall Study|Lost to Follow-up|17
1140288|NCT02907463|2243747|FG000|Overall Study|Death|10
1140289|NCT02907463|2243747|FG000|Overall Study|Withdrawal by Subject|4
1140290|NCT02907463|2243747|FG000|Overall Study|MIS Approach was not used|2
1140291|NCT02907463|2243747|FG000|Overall Study|Not Implanted with Study Device|2
1140292|NCT02907463|2243747|FG000|Overall Study|Device Explanted|1
1140293|NCT02907463|2243747|FG000|Overall Study|Missing Exit Form|1
1140294|NCT02907619|2243771|FG000|Overall Study|Study terminated by sponsor|18
1140295|NCT02907619|2243772|FG001|Overall Study|Study terminated by sponsor|18
1140296|NCT02907619|2243773|FG002|Overall Study|Study terminated by sponsor|19
1140297|NCT02907619|2243771|FG000|Overall Study|Death|0
1140298|NCT02907619|2243772|FG001|Overall Study|Death|0
1140299|NCT02907619|2243773|FG002|Overall Study|Death|1
1140300|NCT02907619|2243771|FG000|Overall Study|Withdrawal by Subject|1
1140301|NCT02907619|2243772|FG001|Overall Study|Withdrawal by Subject|1
1140302|NCT02907619|2243773|FG002|Overall Study|Withdrawal by Subject|0
1140303|NCT02907619|2243771|FG000|Overall Study|Other|0
1140304|NCT02907619|2243772|FG001|Overall Study|Other|1
1140305|NCT02907619|2243773|FG002|Overall Study|Other|0
1140306|NCT02907892|2243794|FG000|Overall Study|Lost to Follow-up|27
1140307|NCT02907892|2243795|FG001|Overall Study|Lost to Follow-up|40
1140308|NCT02908100|2243811|FG000|Overall Study|Adverse Event|7
1140309|NCT02908100|2243812|FG001|Overall Study|Adverse Event|6
1140310|NCT02908100|2243813|FG002|Overall Study|Adverse Event|9
1140311|NCT02908100|2243811|FG000|Overall Study|Death|2
1140312|NCT02908100|2243812|FG001|Overall Study|Death|0
1140313|NCT02908100|2243813|FG002|Overall Study|Death|0
1140314|NCT02908100|2243811|FG000|Overall Study|Lack of Efficacy|2
1140315|NCT02908100|2243812|FG001|Overall Study|Lack of Efficacy|3
1140316|NCT02908100|2243813|FG002|Overall Study|Lack of Efficacy|3
1140317|NCT02908100|2243811|FG000|Overall Study|Lost to Follow-up|0
1140318|NCT02908100|2243812|FG001|Overall Study|Lost to Follow-up|1
1140319|NCT02908100|2243813|FG002|Overall Study|Lost to Follow-up|2
1140320|NCT02908100|2243811|FG000|Overall Study|Non-Compliance With Study Drug|1
1140321|NCT02908100|2243812|FG001|Overall Study|Non-Compliance With Study Drug|1
1140322|NCT02908100|2243813|FG002|Overall Study|Non-Compliance With Study Drug|2
1140323|NCT02908100|2243811|FG000|Overall Study|Non-Compliance With Contraceptive Method|1
1140324|NCT02908100|2243812|FG001|Overall Study|Non-Compliance With Contraceptive Method|0
1140325|NCT02908100|2243813|FG002|Overall Study|Non-Compliance With Contraceptive Method|0
1140326|NCT02908100|2243811|FG000|Overall Study|Physician Decision|0
1140327|NCT02908100|2243812|FG001|Overall Study|Physician Decision|1
1140328|NCT02908100|2243813|FG002|Overall Study|Physician Decision|0
1140329|NCT02908100|2243811|FG000|Overall Study|Pregnancy|1
1140330|NCT02908100|2243812|FG001|Overall Study|Pregnancy|2
1140331|NCT02908100|2243813|FG002|Overall Study|Pregnancy|0
1140332|NCT02908100|2243811|FG000|Overall Study|Withdrawal by Subject|8
1140333|NCT02908100|2243812|FG001|Overall Study|Withdrawal by Subject|7
1140334|NCT02908100|2243813|FG002|Overall Study|Withdrawal by Subject|5
1140335|NCT02908100|2243811|FG000|Overall Study|Randomised in Error|1
1140336|NCT02908100|2243812|FG001|Overall Study|Randomised in Error|0
1140337|NCT02908100|2243813|FG002|Overall Study|Randomised in Error|0
1140338|NCT02908347|2243855|FG000|Overall Study|Adverse Event|0
1140339|NCT02908347|2243856|FG001|Overall Study|Adverse Event|1
1140340|NCT02908347|2243855|FG000|Overall Study|Lost to Follow-up|1
1140341|NCT02908347|2243856|FG001|Overall Study|Lost to Follow-up|0
1140342|NCT02908464|2243878|FG000|Overall Study|Withdrawal by Subject|2
1140343|NCT02908464|2243879|FG001|Overall Study|Withdrawal by Subject|1
1140344|NCT02908464|2243878|FG000|Overall Study|Found ineligible after randomization|0
1140345|NCT02908464|2243879|FG001|Overall Study|Found ineligible after randomization|2
1140346|NCT02908529|2243895|FG000|Overall Study|Lost to Follow-up|0
1140347|NCT02908529|2243896|FG001|Overall Study|Lost to Follow-up|2
1140398|NCT02908841|2243976|FG000|Overall Study|Physician Decision|4
1140399|NCT02908841|2243977|FG001|Overall Study|Physician Decision|0
1140400|NCT02908880|2243983|FG000|Overall Study|Lost to Follow-up|4
1140401|NCT02908880|2243983|FG000|Overall Study|Explantation of the device|1
1140402|NCT02908880|2243983|FG000|Overall Study|Withdrawal by Subject|17
1140403|NCT02908880|2243983|FG000|Overall Study|Death|5
1140404|NCT02909101|2243989|FG000|Overall Study|Lost to Follow-up|1
1140405|NCT02909101|2243990|FG001|Overall Study|Lost to Follow-up|1
1140406|NCT02909153|2244014|FG000|Overall Study|Withdrawal by Subject|0
1140407|NCT02909153|2244015|FG001|Overall Study|Withdrawal by Subject|1
1140408|NCT02909153|2244016|FG002|Overall Study|Withdrawal by Subject|0
1140409|NCT02909153|2244017|FG003|Overall Study|Withdrawal by Subject|0
1140410|NCT02909153|2244018|FG004|Overall Study|Withdrawal by Subject|0
1140411|NCT02909504|2244039|FG000|Overall Study|Adverse Event|2
1140412|NCT02909504|2244039|FG000|Overall Study|Lack of Efficacy|3
1140413|NCT02909504|2244039|FG000|Overall Study|Withdrawal by Subject|4
1140414|NCT02909504|2244039|FG000|Overall Study|Pregnancy|1
1140415|NCT02909504|2244039|FG000|Overall Study|Subject moved|1
1140416|NCT02909504|2244039|FG000|Overall Study|Lost to Follow-up|1
1140417|NCT02909907|2244058|FG000|Overall Study|Withdrawal by Subject|0
1140418|NCT02909907|2244059|FG001|Overall Study|Withdrawal by Subject|1
1140419|NCT02910011|2244074|FG000|Overall Study|Physician Decision|2
1140420|NCT02910037|2244080|FG000|Overall Study|Withdrawal by Subject|4
1140421|NCT02910037|2244080|FG000|Overall Study|Lost to Follow-up|6
1140422|NCT02910063|2244100|FG000|Phase 2|Withdrawal by Subject|3
1140423|NCT02910063|2244101|FG001|Phase 2|Withdrawal by Subject|0
1140424|NCT02910063|2244102|FG002|Phase 2|Withdrawal by Subject|0
1140425|NCT02910063|2244100|FG000|Phase 2|Lost to Follow-up|1
1140426|NCT02910063|2244101|FG001|Phase 2|Lost to Follow-up|0
1140427|NCT02910063|2244102|FG002|Phase 2|Lost to Follow-up|0
1140428|NCT02910063|2244100|FG000|Phase 2|Death|24
1140429|NCT02910063|2244101|FG001|Phase 2|Death|0
1140430|NCT02910063|2244102|FG002|Phase 2|Death|0
1140431|NCT02910089|2244113|FG000|Overall Study|Lost insurance eligibility|22
1140432|NCT02910089|2244114|FG001|Overall Study|Lost insurance eligibility|16
1140433|NCT02910167|2244134|FG000|Overall Study|Adverse Event|1
1140434|NCT02910167|2244134|FG000|Overall Study|Lost to Follow-up|18
1140435|NCT02910713|2244156|FG000|Overall Study|Protocol Violation|2
1140436|NCT02910713|2244156|FG000|Overall Study|Subject Choice|4
1140437|NCT02910713|2244156|FG000|Overall Study|Received One Application|10
1140438|NCT02910713|2244156|FG000|Overall Study|Received Neither Application|18
1140439|NCT02910713|2244156|FG000|Overall Study|Enrollment cap|7
1140440|NCT02910713|2244156|FG000|Overall Study|Investigator Discretion|1
1140441|NCT02910739|2244163|FG000|Overall Study|Adverse Event|1
1140442|NCT02910739|2244164|FG001|Overall Study|Adverse Event|0
1140443|NCT02910739|2244165|FG002|Overall Study|Adverse Event|0
1140444|NCT02910739|2244166|FG003|Overall Study|Adverse Event|0
1140445|NCT02911025|2244172|FG000|Overall Study|Lost to Follow-up|3
1140446|NCT02911116|2244178|FG000|Overall Study|Insufficient Therapeutic Response|1
1140447|NCT02911116|2244179|FG001|Overall Study|Insufficient Therapeutic Response|0
1140448|NCT02911116|2244178|FG000|Overall Study|Lost to Follow-up|0
1140449|NCT02911116|2244179|FG001|Overall Study|Lost to Follow-up|1
1140450|NCT02911285|2244187|FG000|Overall Study|Lost to Follow-up|8
1140451|NCT02911285|2244188|FG001|Overall Study|Lost to Follow-up|5
1140452|NCT02911285|2244187|FG000|Overall Study|Participant got a job and no longer had time to participate.|1
1140453|NCT02911285|2244188|FG001|Overall Study|Participant got a job and no longer had time to participate.|0
1140454|NCT02911519|2244210|FG000|Overall Study|Lost to Follow-up|2
1140455|NCT02911519|2244211|FG001|Overall Study|Lost to Follow-up|2
1140456|NCT02911519|2244210|FG000|Overall Study|Death|0
1140457|NCT02911519|2244211|FG001|Overall Study|Death|2
1140458|NCT02911688|2244219|FG000|Washout|Lost to Follow-up|1
1140459|NCT02911688|2244220|FG001|Washout|Lost to Follow-up|1
1140460|NCT02911688|2244219|FG000|Washout|Withdrawal by Subject|0
1140461|NCT02911688|2244220|FG001|Washout|Withdrawal by Subject|1
1140462|NCT02911948|2244319|FG000|Overall Study|Protocol Violation|0
1140463|NCT02911948|2244320|FG001|Overall Study|Protocol Violation|1
1140464|NCT02911948|2244319|FG000|Overall Study|Withdrawal by Subject|0
1140465|NCT02911948|2244320|FG001|Overall Study|Withdrawal by Subject|2
1140466|NCT02911948|2244319|FG000|Overall Study|Lack of Efficacy|0
1140467|NCT02911948|2244320|FG001|Overall Study|Lack of Efficacy|1
1140468|NCT02911948|2244319|FG000|Overall Study|Unclassified|0
1140469|NCT02911948|2244320|FG001|Overall Study|Unclassified|3
1140470|NCT02912455|2244347|FG000|Overall Study|Withdrawal by Subject|0
1140471|NCT02912455|2244348|FG001|Overall Study|Withdrawal by Subject|1
1140472|NCT02912455|2244347|FG000|Overall Study|Lack of Efficacy|0
1140473|NCT02912455|2244348|FG001|Overall Study|Lack of Efficacy|1
1140474|NCT02912455|2244347|FG000|Overall Study|Lost to Follow-up|2
1140475|NCT02912455|2244348|FG001|Overall Study|Lost to Follow-up|1
1140476|NCT02912468|2244356|FG000|Overall Study|Adverse Event|3
1140477|NCT02912468|2244357|FG001|Overall Study|Adverse Event|2
1140478|NCT02912468|2244356|FG000|Overall Study|Withdrawal by Subject|6
1140479|NCT02912468|2244357|FG001|Overall Study|Withdrawal by Subject|2
1140480|NCT02912468|2244356|FG000|Overall Study|Randomized and not treated|0
1140481|NCT02912468|2244357|FG001|Overall Study|Randomized and not treated|1
1140482|NCT02912650|2244368|FG000|Overall Study|Withdrawal by Subject|1
1140483|NCT02912650|2244369|FG001|Overall Study|Withdrawal by Subject|0
1140484|NCT02912650|2244370|FG002|Overall Study|Withdrawal by Subject|1
1140485|NCT02912650|2244371|FG003|Overall Study|Withdrawal by Subject|5
1140486|NCT02912650|2244368|FG000|Overall Study|Adverse Event|0
1140487|NCT02912650|2244369|FG001|Overall Study|Adverse Event|0
1140488|NCT02912650|2244370|FG002|Overall Study|Adverse Event|1
1140489|NCT02912650|2244371|FG003|Overall Study|Adverse Event|0
1140490|NCT02913105|2244384|FG000|Overall Study|Adverse Event|11
1140491|NCT02913105|2244385|FG001|Overall Study|Adverse Event|0
1140492|NCT02913105|2244386|FG002|Overall Study|Adverse Event|4
1140493|NCT02913105|2244384|FG000|Overall Study|Non-Compliance With Study Drug|0
1140494|NCT02913105|2244385|FG001|Overall Study|Non-Compliance With Study Drug|0
1140495|NCT02913105|2244386|FG002|Overall Study|Non-Compliance With Study Drug|1
1140496|NCT02913105|2244384|FG000|Overall Study|Reason Not Specified|3
1140497|NCT02913105|2244385|FG001|Overall Study|Reason Not Specified|1
1140498|NCT02913105|2244386|FG002|Overall Study|Reason Not Specified|1
1140499|NCT02913105|2244384|FG000|Overall Study|Physician Decision|1
1140500|NCT02913105|2244385|FG001|Overall Study|Physician Decision|1
1140501|NCT02913105|2244386|FG002|Overall Study|Physician Decision|0
1140502|NCT02913105|2244384|FG000|Overall Study|Withdrawal by Subject|0
1140503|NCT02913105|2244385|FG001|Overall Study|Withdrawal by Subject|3
1140504|NCT02913105|2244386|FG002|Overall Study|Withdrawal by Subject|1
1140505|NCT02913326|2244406|FG000|Overall Study|Reason not listed|0
1140506|NCT02913326|2244407|FG001|Overall Study|Reason not listed|1
1140507|NCT02913326|2244406|FG000|Overall Study|Lost to Follow-up|0
1140508|NCT02913326|2244407|FG001|Overall Study|Lost to Follow-up|1
1140509|NCT02913326|2244406|FG000|Overall Study|Adverse Event|1
1140510|NCT02913326|2244407|FG001|Overall Study|Adverse Event|0
1140517|NCT02914184|2244461|FG000|Overall Study|Lost to Follow-up|7
1140518|NCT02914184|2244462|FG001|Overall Study|Lost to Follow-up|10
1140519|NCT02914184|2244463|FG002|Overall Study|Lost to Follow-up|8
1140520|NCT02914184|2244464|FG003|Overall Study|Lost to Follow-up|7
1140521|NCT02914184|2244461|FG000|Overall Study|Withdrawal by Subject|4
1140522|NCT02914184|2244462|FG001|Overall Study|Withdrawal by Subject|2
1140523|NCT02914184|2244463|FG002|Overall Study|Withdrawal by Subject|7
1140524|NCT02914184|2244464|FG003|Overall Study|Withdrawal by Subject|3
1140525|NCT02914184|2244461|FG000|Overall Study|Other|1
1140526|NCT02914184|2244462|FG001|Overall Study|Other|0
1140527|NCT02914184|2244463|FG002|Overall Study|Other|0
1140528|NCT02914184|2244464|FG003|Overall Study|Other|0
1140529|NCT02914184|2244461|FG000|Overall Study|Migrated/moved from the study area|2
1140530|NCT02914184|2244462|FG001|Overall Study|Migrated/moved from the study area|1
1140531|NCT02914184|2244463|FG002|Overall Study|Migrated/moved from the study area|2
1140532|NCT02914184|2244464|FG003|Overall Study|Migrated/moved from the study area|1
1140533|NCT02914236|2244485|FG000|Overall Study|Lost to Follow-up|1
1140534|NCT02914275|2244491|FG000|Overall Study|Lost to Follow-up|84
1140535|NCT02914275|2244492|FG001|Overall Study|Lost to Follow-up|29
1140536|NCT02914275|2244491|FG000|Overall Study|Withdrawal by Subject|26
1140537|NCT02914275|2244492|FG001|Overall Study|Withdrawal by Subject|10
1140538|NCT02914275|2244491|FG000|Overall Study|Protocol Violation|1
1140539|NCT02914275|2244492|FG001|Overall Study|Protocol Violation|1
1140540|NCT02914275|2244491|FG000|Overall Study|Physician Decision|3
1140541|NCT02914275|2244492|FG001|Overall Study|Physician Decision|1
1140542|NCT02914275|2244491|FG000|Overall Study|Other|4
1140543|NCT02914275|2244492|FG001|Overall Study|Other|1
1140544|NCT02914275|2244491|FG000|Overall Study|Excluded due to invalid informed consent|3
1140545|NCT02914275|2244492|FG001|Overall Study|Excluded due to invalid informed consent|0
1140546|NCT02914457|2244502|FG000|Overall Study|Withdrawal by Subject|1
1140547|NCT02914457|2244502|FG000|Overall Study|Physician Decision|1
1140548|NCT02914457|2244502|FG000|Overall Study|No veins available for lead placement|1
1140549|NCT02914457|2244502|FG000|Overall Study|Electrical instability of patient|1
1140550|NCT02914457|2244502|FG000|Overall Study|ECG acquisition error due to sweating|1
1140551|NCT02914457|2244502|FG000|Overall Study|Protocol Violation|1
1140552|NCT02914522|2244523|FG000|Induction Study: Up to Week 11|Adverse Event|5
1140553|NCT02914522|2244524|FG001|Induction Study: Up to Week 11|Adverse Event|6
1140554|NCT02914522|2244525|FG002|Induction Study: Up to Week 11|Adverse Event|4
1140555|NCT02914522|2244526|FG003|Induction Study: Up to Week 11|Adverse Event|18
901559|NCT00734474|1875036|FG000|Overall Study|Lack of Efficacy|0
901560|NCT00734474|1875037|FG001|Overall Study|Lack of Efficacy|0
901561|NCT00734474|1875038|FG002|Overall Study|Lack of Efficacy|4
901562|NCT00734474|1875039|FG003|Overall Study|Lack of Efficacy|0
901563|NCT00734474|1875040|FG004|Overall Study|Lack of Efficacy|0
901564|NCT00734474|1875041|FG005|Overall Study|Lack of Efficacy|0
901565|NCT00734474|1875042|FG006|Overall Study|Lack of Efficacy|0
901566|NCT00734474|1875043|FG007|Overall Study|Lack of Efficacy|4
901567|NCT00734474|1875044|FG008|Overall Study|Lack of Efficacy|6
901568|NCT00734539|1875076|FG000|Main Study|Death|33
901569|NCT00734539|1875077|FG001|Main Study|Death|32
901570|NCT00734539|1875076|FG000|Main Study|Physician Decision|2
901571|NCT00734539|1875077|FG001|Main Study|Physician Decision|0
901572|NCT00734539|1875076|FG000|Main Study|Withdrawal by Subject|1
901573|NCT00734539|1875077|FG001|Main Study|Withdrawal by Subject|3
901574|NCT00734539|1875076|FG000|Main Study|Enrolled in error; ineligible|1
901575|NCT00734539|1875077|FG001|Main Study|Enrolled in error; ineligible|0
901576|NCT00734578|1875089|FG000|Overall Study|Adverse Event|4
901577|NCT00734578|1875090|FG001|Overall Study|Adverse Event|6
901578|NCT00734578|1875091|FG002|Overall Study|Adverse Event|1
1140556|NCT02914522|2244527|FG004|Induction Study: Up to Week 11|Adverse Event|14
1140557|NCT02914522|2244528|FG005|Induction Study: Up to Week 11|Adverse Event|10
1140558|NCT02914522|2244529|FG006|Induction Study: Up to Week 11|Adverse Event|0
1140559|NCT02914522|2244530|FG007|Induction Study: Up to Week 11|Adverse Event|0
1140560|NCT02914522|2244531|FG008|Induction Study: Up to Week 11|Adverse Event|0
1140561|NCT02914522|2244532|FG009|Induction Study: Up to Week 11|Adverse Event|0
1140562|NCT02914522|2244533|FG010|Induction Study: Up to Week 11|Adverse Event|0
1140563|NCT02914522|2244523|FG000|Induction Study: Up to Week 11|Withdrew Consent|4
1140564|NCT02914522|2244524|FG001|Induction Study: Up to Week 11|Withdrew Consent|11
1140565|NCT02914522|2244525|FG002|Induction Study: Up to Week 11|Withdrew Consent|4
1140566|NCT02914522|2244526|FG003|Induction Study: Up to Week 11|Withdrew Consent|6
1140567|NCT02914522|2244527|FG004|Induction Study: Up to Week 11|Withdrew Consent|3
1140568|NCT02914522|2244528|FG005|Induction Study: Up to Week 11|Withdrew Consent|3
1140569|NCT02914522|2244529|FG006|Induction Study: Up to Week 11|Withdrew Consent|0
1140570|NCT02914522|2244530|FG007|Induction Study: Up to Week 11|Withdrew Consent|0
1140571|NCT02914522|2244531|FG008|Induction Study: Up to Week 11|Withdrew Consent|0
1140572|NCT02914522|2244532|FG009|Induction Study: Up to Week 11|Withdrew Consent|0
1140573|NCT02914522|2244533|FG010|Induction Study: Up to Week 11|Withdrew Consent|0
1140574|NCT02914522|2244523|FG000|Induction Study: Up to Week 11|Protocol Violation|0
1140575|NCT02914522|2244524|FG001|Induction Study: Up to Week 11|Protocol Violation|2
1140576|NCT02914522|2244525|FG002|Induction Study: Up to Week 11|Protocol Violation|1
1140577|NCT02914522|2244526|FG003|Induction Study: Up to Week 11|Protocol Violation|3
1140578|NCT02914522|2244527|FG004|Induction Study: Up to Week 11|Protocol Violation|4
1140579|NCT02914522|2244528|FG005|Induction Study: Up to Week 11|Protocol Violation|2
1140580|NCT02914522|2244529|FG006|Induction Study: Up to Week 11|Protocol Violation|0
1140581|NCT02914522|2244530|FG007|Induction Study: Up to Week 11|Protocol Violation|0
1140582|NCT02914522|2244531|FG008|Induction Study: Up to Week 11|Protocol Violation|0
1140583|NCT02914522|2244532|FG009|Induction Study: Up to Week 11|Protocol Violation|0
1140584|NCT02914522|2244533|FG010|Induction Study: Up to Week 11|Protocol Violation|0
1140585|NCT02914522|2244523|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0
1140586|NCT02914522|2244524|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2
1140587|NCT02914522|2244525|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1
1140588|NCT02914522|2244526|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1
1140589|NCT02914522|2244527|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0
1140590|NCT02914522|2244528|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0
1140591|NCT02914522|2244529|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0
1140592|NCT02914522|2244530|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0
1140593|NCT02914522|2244531|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0
1140594|NCT02914522|2244532|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0
1140595|NCT02914522|2244533|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0
1140596|NCT02914522|2244523|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0
1140597|NCT02914522|2244524|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0
1140598|NCT02914522|2244525|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0
1140599|NCT02914522|2244526|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0
1140600|NCT02914522|2244527|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1
1140601|NCT02914522|2244528|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0
1140602|NCT02914522|2244529|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0
1140603|NCT02914522|2244530|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0
1140604|NCT02914522|2244531|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0
1140605|NCT02914522|2244532|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0
1140606|NCT02914522|2244533|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0
1140607|NCT02914522|2244523|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1
1140608|NCT02914522|2244524|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
1140609|NCT02914522|2244525|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
1140610|NCT02914522|2244526|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
1140611|NCT02914522|2244527|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
1140612|NCT02914522|2244528|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
1140613|NCT02914522|2244529|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
1140614|NCT02914522|2244530|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
1140615|NCT02914522|2244531|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
1140616|NCT02914522|2244532|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
1140617|NCT02914522|2244533|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
1140618|NCT02914522|2244523|FG000|Induction Study: Up to Week 11|Pregnancy|0
1140619|NCT02914522|2244524|FG001|Induction Study: Up to Week 11|Pregnancy|0
1140620|NCT02914522|2244525|FG002|Induction Study: Up to Week 11|Pregnancy|0
1140621|NCT02914522|2244526|FG003|Induction Study: Up to Week 11|Pregnancy|0
1140622|NCT02914522|2244527|FG004|Induction Study: Up to Week 11|Pregnancy|1
1140623|NCT02914522|2244528|FG005|Induction Study: Up to Week 11|Pregnancy|0
1140624|NCT02914522|2244529|FG006|Induction Study: Up to Week 11|Pregnancy|0
1140625|NCT02914522|2244530|FG007|Induction Study: Up to Week 11|Pregnancy|0
1140626|NCT02914522|2244531|FG008|Induction Study: Up to Week 11|Pregnancy|0
1140627|NCT02914522|2244532|FG009|Induction Study: Up to Week 11|Pregnancy|0
1140628|NCT02914522|2244533|FG010|Induction Study: Up to Week 11|Pregnancy|0
1140629|NCT02914522|2244523|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0
1140630|NCT02914522|2244524|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1
1140631|NCT02914522|2244525|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0
1140632|NCT02914522|2244526|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0
1140633|NCT02914522|2244527|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1
1140634|NCT02914522|2244528|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1
1140635|NCT02914522|2244529|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0
1140636|NCT02914522|2244530|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0
1140637|NCT02914522|2244531|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0
1140638|NCT02914522|2244532|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0
1140639|NCT02914522|2244533|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0
1140640|NCT02914522|2244523|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
1140641|NCT02914522|2244524|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
1140642|NCT02914522|2244525|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
1140643|NCT02914522|2244526|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
1140644|NCT02914522|2244527|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
1140645|NCT02914522|2244528|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
1140646|NCT02914522|2244529|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34
1140647|NCT02914522|2244530|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49
1140648|NCT02914522|2244531|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53
1140649|NCT02914522|2244532|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39
1140650|NCT02914522|2244533|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21
1140651|NCT02914522|2244523|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0
1140652|NCT02914522|2244524|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0
1140653|NCT02914522|2244525|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0
1140654|NCT02914522|2244526|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0
1140655|NCT02914522|2244527|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0
1140656|NCT02914522|2244528|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0
1140657|NCT02914522|2244529|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7
1140658|NCT02914522|2244530|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2
1140659|NCT02914522|2244531|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10
1140660|NCT02914522|2244532|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4
1140661|NCT02914522|2244533|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3
1140662|NCT02914522|2244523|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
1140663|NCT02914522|2244524|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
1140664|NCT02914522|2244525|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
1140665|NCT02914522|2244526|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
1140666|NCT02914522|2244527|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
1140667|NCT02914522|2244528|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
1140668|NCT02914522|2244529|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
1140669|NCT02914522|2244530|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
1140670|NCT02914522|2244531|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3
1140671|NCT02914522|2244532|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
1140672|NCT02914522|2244533|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1
1140673|NCT02914522|2244523|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
1140674|NCT02914522|2244524|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
1140675|NCT02914522|2244525|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
1140676|NCT02914522|2244526|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
1140677|NCT02914522|2244527|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
1140678|NCT02914522|2244528|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
1140679|NCT02914522|2244529|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
1140680|NCT02914522|2244530|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1
1140681|NCT02914522|2244531|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6
1140682|NCT02914522|2244532|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3
1140683|NCT02914522|2244533|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
1140684|NCT02914522|2244523|FG000|Maintenance Study: Week 11 to Week 58|Death|0
1140685|NCT02914522|2244524|FG001|Maintenance Study: Week 11 to Week 58|Death|0
1140686|NCT02914522|2244525|FG002|Maintenance Study: Week 11 to Week 58|Death|0
1140687|NCT02914522|2244526|FG003|Maintenance Study: Week 11 to Week 58|Death|0
1140688|NCT02914522|2244527|FG004|Maintenance Study: Week 11 to Week 58|Death|0
1140689|NCT02914522|2244528|FG005|Maintenance Study: Week 11 to Week 58|Death|0
1140690|NCT02914522|2244529|FG006|Maintenance Study: Week 11 to Week 58|Death|2
1162099|NCT03383146|2284115|FG000|Overall Study|Death|0
1140691|NCT02914522|2244530|FG007|Maintenance Study: Week 11 to Week 58|Death|0
1140692|NCT02914522|2244531|FG008|Maintenance Study: Week 11 to Week 58|Death|0
1140693|NCT02914522|2244532|FG009|Maintenance Study: Week 11 to Week 58|Death|0
1140694|NCT02914522|2244533|FG010|Maintenance Study: Week 11 to Week 58|Death|0
1140695|NCT02914522|2244523|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
1140696|NCT02914522|2244524|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
1140697|NCT02914522|2244525|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
1140698|NCT02914522|2244526|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
1140699|NCT02914522|2244527|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
1140700|NCT02914522|2244528|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
1140701|NCT02914522|2244529|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
1140702|NCT02914522|2244530|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1
1140703|NCT02914522|2244531|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2
1140704|NCT02914522|2244532|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
1140705|NCT02914522|2244533|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
1140706|NCT02914522|2244523|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0
1140707|NCT02914522|2244524|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0
1140708|NCT02914522|2244525|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0
1140709|NCT02914522|2244526|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0
1140710|NCT02914522|2244527|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0
1140711|NCT02914522|2244528|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0
1140712|NCT02914522|2244529|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0
1140713|NCT02914522|2244530|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0
1140714|NCT02914522|2244531|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1
1140715|NCT02914522|2244532|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2
1140716|NCT02914522|2244533|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0
1140717|NCT02914522|2244523|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
1140718|NCT02914522|2244524|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
1140719|NCT02914522|2244525|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
1140720|NCT02914522|2244526|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
1140721|NCT02914522|2244527|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
1140722|NCT02914522|2244528|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
1140723|NCT02914522|2244529|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
1140724|NCT02914522|2244530|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
1140725|NCT02914522|2244531|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
1140726|NCT02914522|2244532|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1
1140727|NCT02914522|2244533|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
1140728|NCT02914548|2244563|FG000|Overall Study|Adverse Event|15
1140729|NCT02914548|2244564|FG001|Overall Study|Adverse Event|7
1140730|NCT02914548|2244565|FG002|Overall Study|Adverse Event|15
1140731|NCT02914548|2244563|FG000|Overall Study|Physician Decision|2
1140732|NCT02914548|2244564|FG001|Overall Study|Physician Decision|2
1140733|NCT02914548|2244565|FG002|Overall Study|Physician Decision|0
1140734|NCT02914548|2244563|FG000|Overall Study|Protocol Violation|1
1140735|NCT02914548|2244564|FG001|Overall Study|Protocol Violation|0
1140736|NCT02914548|2244565|FG002|Overall Study|Protocol Violation|0
1140737|NCT02914548|2244563|FG000|Overall Study|Withdrawal by Subject|3
1140738|NCT02914548|2244564|FG001|Overall Study|Withdrawal by Subject|4
1140739|NCT02914548|2244565|FG002|Overall Study|Withdrawal by Subject|4
1140740|NCT02914548|2244563|FG000|Overall Study|>40% of body surface area|0
1140741|NCT02914548|2244564|FG001|Overall Study|>40% of body surface area|1
1140742|NCT02914548|2244565|FG002|Overall Study|>40% of body surface area|1
1140743|NCT02914834|2244586|FG000|Overall Study|Study halted due to COVID|1
1140744|NCT02914834|2244587|FG001|Overall Study|Study halted due to COVID|1
1140745|NCT02914834|2244586|FG000|Overall Study|1 subject withdrew|0
1140746|NCT02914834|2244587|FG001|Overall Study|1 subject withdrew|1
1140747|NCT02915016|2244601|FG000|Overall Study|Lost to Follow-up|4
1140748|NCT02915016|2244602|FG001|Overall Study|Lost to Follow-up|2
1140749|NCT02915016|2244603|FG002|Overall Study|Lost to Follow-up|5
1140750|NCT02915016|2244604|FG003|Overall Study|Lost to Follow-up|3
1140751|NCT02915016|2244605|FG004|Overall Study|Lost to Follow-up|5
1140752|NCT02915016|2244606|FG005|Overall Study|Lost to Follow-up|2
1140753|NCT02915016|2244607|FG006|Overall Study|Lost to Follow-up|8
1140754|NCT02915016|2244608|FG007|Overall Study|Lost to Follow-up|2
1140755|NCT02915016|2244601|FG000|Overall Study|Physician Decision|0
1140756|NCT02915016|2244602|FG001|Overall Study|Physician Decision|0
1140757|NCT02915016|2244603|FG002|Overall Study|Physician Decision|1
1140758|NCT02915016|2244604|FG003|Overall Study|Physician Decision|0
1140759|NCT02915016|2244605|FG004|Overall Study|Physician Decision|0
1140760|NCT02915016|2244606|FG005|Overall Study|Physician Decision|1
1140761|NCT02915016|2244607|FG006|Overall Study|Physician Decision|2
1140762|NCT02915016|2244608|FG007|Overall Study|Physician Decision|0
1140763|NCT02915016|2244601|FG000|Overall Study|Withdrawal by Subject|2
1140764|NCT02915016|2244602|FG001|Overall Study|Withdrawal by Subject|0
1140765|NCT02915016|2244603|FG002|Overall Study|Withdrawal by Subject|1
1140766|NCT02915016|2244604|FG003|Overall Study|Withdrawal by Subject|0
1140767|NCT02915016|2244605|FG004|Overall Study|Withdrawal by Subject|1
1140768|NCT02915016|2244606|FG005|Overall Study|Withdrawal by Subject|3
1140769|NCT02915016|2244607|FG006|Overall Study|Withdrawal by Subject|1
1140770|NCT02915016|2244608|FG007|Overall Study|Withdrawal by Subject|1
1140771|NCT02915016|2244601|FG000|Overall Study|Elected not to continue|0
1140772|NCT02915016|2244602|FG001|Overall Study|Elected not to continue|0
1140773|NCT02915016|2244603|FG002|Overall Study|Elected not to continue|0
1140774|NCT02915016|2244604|FG003|Overall Study|Elected not to continue|1
1140775|NCT02915016|2244605|FG004|Overall Study|Elected not to continue|0
1140776|NCT02915016|2244606|FG005|Overall Study|Elected not to continue|0
1140777|NCT02915016|2244607|FG006|Overall Study|Elected not to continue|1
1140778|NCT02915016|2244608|FG007|Overall Study|Elected not to continue|0
1140779|NCT02915016|2244601|FG000|Overall Study|HIV infection|1
1140780|NCT02915016|2244602|FG001|Overall Study|HIV infection|1
1140781|NCT02915016|2244603|FG002|Overall Study|HIV infection|1
1140782|NCT02915016|2244604|FG003|Overall Study|HIV infection|0
1140783|NCT02915016|2244605|FG004|Overall Study|HIV infection|1
1140784|NCT02915016|2244606|FG005|Overall Study|HIV infection|0
1140785|NCT02915016|2244607|FG006|Overall Study|HIV infection|0
1140786|NCT02915016|2244608|FG007|Overall Study|HIV infection|0
1140787|NCT02915016|2244601|FG000|Overall Study|Participant unable to adhere|0
1140788|NCT02915016|2244602|FG001|Overall Study|Participant unable to adhere|0
1140789|NCT02915016|2244603|FG002|Overall Study|Participant unable to adhere|0
1140790|NCT02915016|2244604|FG003|Overall Study|Participant unable to adhere|0
1140791|NCT02915016|2244605|FG004|Overall Study|Participant unable to adhere|0
1140792|NCT02915016|2244606|FG005|Overall Study|Participant unable to adhere|0
1140793|NCT02915016|2244607|FG006|Overall Study|Participant unable to adhere|0
1140794|NCT02915016|2244608|FG007|Overall Study|Participant unable to adhere|1
1140795|NCT02915159|2244637|FG000|Overall Study|Participant no longer meets criteria|2
1140796|NCT02915159|2244638|FG001|Overall Study|Participant no longer meets criteria|0
1140797|NCT02915159|2244637|FG000|Overall Study|poor/non-compliance|1
1140798|NCT02915159|2244638|FG001|Overall Study|poor/non-compliance|0
1140799|NCT02915159|2244637|FG000|Overall Study|Participant withdrew consent|5
1140800|NCT02915159|2244638|FG001|Overall Study|Participant withdrew consent|1
1140801|NCT02915159|2244637|FG000|Overall Study|Request to discontinue treatment|1
1140802|NCT02915159|2244638|FG001|Overall Study|Request to discontinue treatment|2
1140803|NCT02915159|2244637|FG000|Overall Study|Adverse Event|2
1140804|NCT02915159|2244638|FG001|Overall Study|Adverse Event|2
1140805|NCT02915159|2244637|FG000|Overall Study|Lack of Efficacy|0
1140806|NCT02915159|2244638|FG001|Overall Study|Lack of Efficacy|3
1140807|NCT02915302|2244650|FG000|Overall Study|Adverse Event|3
1140808|NCT02915302|2244651|FG001|Overall Study|Adverse Event|0
1140809|NCT02915302|2244650|FG000|Overall Study|Protocol Violation|20
1140810|NCT02915302|2244651|FG001|Overall Study|Protocol Violation|27
1140811|NCT02915302|2244650|FG000|Overall Study|Lost to Follow-up|19
1140812|NCT02915302|2244651|FG001|Overall Study|Lost to Follow-up|22
1140813|NCT02915302|2244650|FG000|Overall Study|Withdrawal by Subject|22
1140814|NCT02915302|2244651|FG001|Overall Study|Withdrawal by Subject|29
1140815|NCT02915302|2244650|FG000|Overall Study|Other|1
1140816|NCT02915302|2244651|FG001|Overall Study|Other|0
1140819|NCT02915835|2244686|FG000|Overall Study|Physician Decision|1
1140820|NCT02915835|2244687|FG001|Overall Study|Physician Decision|0
1140821|NCT02915835|2244686|FG000|Overall Study|Withdrawal by Subject|0
1140822|NCT02915835|2244687|FG001|Overall Study|Withdrawal by Subject|1
1140823|NCT02915874|2244695|FG000|Overall Study|Lost to Follow-up|5
1140824|NCT02915874|2244696|FG001|Overall Study|Lost to Follow-up|4
1140825|NCT02915874|2244695|FG000|Overall Study|Withdrawal by Subject|1
1140826|NCT02915874|2244696|FG001|Overall Study|Withdrawal by Subject|1
1140827|NCT02915874|2244695|FG000|Overall Study|Started New Anxiety Medication|0
1140828|NCT02915874|2244696|FG001|Overall Study|Started New Anxiety Medication|1
1140829|NCT02915978|2244705|FG000|Overall Study|Adverse Event|2
1140830|NCT02915978|2244706|FG001|Overall Study|Adverse Event|1
1140831|NCT02915978|2244707|FG002|Overall Study|Adverse Event|0
1140832|NCT02916056|2244715|FG000|Overall Study|Adverse Event|6
1140833|NCT02916056|2244715|FG000|Overall Study|Lost to Follow-up|1
1140834|NCT02916056|2244715|FG000|Overall Study|Other|12
1140835|NCT02916056|2244715|FG000|Overall Study|Protocol Violation|1
1140836|NCT02916056|2244715|FG000|Overall Study|Withdrawal by Subject|8
1140837|NCT02916056|2244715|FG000|Overall Study|Study Terminated by Sponsor|269
1140838|NCT02916433|2244730|FG000|Overall Study|Withdrawal by Subject|1
901579|NCT00734578|1875089|FG000|Overall Study|Protocol Violation|8
901580|NCT00734578|1875090|FG001|Overall Study|Protocol Violation|6
901581|NCT00734578|1875091|FG002|Overall Study|Protocol Violation|3
901582|NCT00734578|1875089|FG000|Overall Study|Withdrawal by Subject|7
901583|NCT00734578|1875090|FG001|Overall Study|Withdrawal by Subject|8
901584|NCT00734578|1875091|FG002|Overall Study|Withdrawal by Subject|11
901585|NCT00734578|1875089|FG000|Overall Study|Lost to Follow-up|9
901586|NCT00734578|1875090|FG001|Overall Study|Lost to Follow-up|3
901587|NCT00734578|1875091|FG002|Overall Study|Lost to Follow-up|5
901588|NCT00734578|1875089|FG000|Overall Study|Lack of Efficacy|3
901589|NCT00734578|1875090|FG001|Overall Study|Lack of Efficacy|2
1140839|NCT02916433|2244731|FG001|Overall Study|Withdrawal by Subject|0
1140840|NCT02916433|2244730|FG000|Overall Study|Physician Decision|1
1140841|NCT02916433|2244731|FG001|Overall Study|Physician Decision|0
1140842|NCT02916693|2244753|FG000|Overall Study|Lost to Follow-up|7
1140843|NCT02916927|2244767|FG000|Overall Study|Discharged prior to study drug receipt|0
1140844|NCT02916927|2244768|FG001|Overall Study|Discharged prior to study drug receipt|2
1140845|NCT02916927|2244767|FG000|Overall Study|At radiology for 45 & 60 min time points|0
1140846|NCT02916927|2244768|FG001|Overall Study|At radiology for 45 & 60 min time points|1
1140847|NCT02916927|2244767|FG000|Overall Study|Withdrawal before first time point|1
1140848|NCT02916927|2244768|FG001|Overall Study|Withdrawal before first time point|0
1140849|NCT02917031|2244777|FG000|Overall Study|Reason not specified|7
1140850|NCT02917031|2244778|FG001|Overall Study|Reason not specified|5
1140851|NCT02917031|2244779|FG002|Overall Study|Reason not specified|6
1140852|NCT02917031|2244777|FG000|Overall Study|Development of study-specific withdrawal criteria|1
1140853|NCT02917031|2244778|FG001|Overall Study|Development of study-specific withdrawal criteria|1
1140854|NCT02917031|2244779|FG002|Overall Study|Development of study-specific withdrawal criteria|0
1140855|NCT02917031|2244777|FG000|Overall Study|Withdrawal by Subject|3
1140856|NCT02917031|2244778|FG001|Overall Study|Withdrawal by Subject|3
1140857|NCT02917031|2244779|FG002|Overall Study|Withdrawal by Subject|0
1140858|NCT02917031|2244777|FG000|Overall Study|Physician Decision|1
1140859|NCT02917031|2244778|FG001|Overall Study|Physician Decision|0
1140860|NCT02917031|2244779|FG002|Overall Study|Physician Decision|0
1140861|NCT02917031|2244777|FG000|Overall Study|Adverse Event|4
1140862|NCT02917031|2244778|FG001|Overall Study|Adverse Event|1
1140863|NCT02917031|2244779|FG002|Overall Study|Adverse Event|5
1140864|NCT02917031|2244777|FG000|Overall Study|Death|2
1140865|NCT02917031|2244778|FG001|Overall Study|Death|3
1140866|NCT02917031|2244779|FG002|Overall Study|Death|4
1140867|NCT02917265|2244799|FG000|Overall Study|Physician Decision|1
1140868|NCT02917265|2244800|FG001|Overall Study|Physician Decision|0
1140869|NCT02917265|2244799|FG000|Overall Study|Withdrawal by Subject|1
1140870|NCT02917265|2244800|FG001|Overall Study|Withdrawal by Subject|0
1140871|NCT02917941|2244845|FG000|Treatment Period|Adverse Event|11
1140872|NCT02917941|2244845|FG000|Treatment Period|Progressive Disease|11
1140873|NCT02917941|2244845|FG000|Treatment Period|Reason not Specified|2
1140874|NCT02917941|2244845|FG000|Survival Follow-up Period|Lost to Follow-up|1
1140875|NCT02917941|2244845|FG000|Survival Follow-up Period|Withdrawal by Subject|4
1140876|NCT02918071|2244849|FG000|Overall Study|Withdrawal by Subject|2
1140877|NCT02918071|2244849|FG000|Overall Study|Lost to Follow-up|1
1140878|NCT02918266|2244868|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0
1140879|NCT02918266|2244869|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1140880|NCT02918266|2244870|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1140881|NCT02918266|2244871|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1140882|NCT02918266|2244872|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1140883|NCT02918266|2244873|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1140884|NCT02918266|2244874|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2
1140885|NCT02918266|2244875|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1140886|NCT02918266|2244876|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2
1140887|NCT02918266|2244877|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1140888|NCT02918266|2244878|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1140889|NCT02918318|2244911|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1
1140890|NCT02918318|2244912|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4
1140891|NCT02918318|2244913|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2
1140892|NCT02918318|2244914|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3
1140893|NCT02918318|2244915|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0
1140894|NCT02918318|2244911|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
1140895|NCT02918318|2244912|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
1140896|NCT02918318|2244913|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
1140897|NCT02918318|2244914|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2
1140898|NCT02918318|2244915|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
1140899|NCT02918318|2244911|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
1140900|NCT02918318|2244912|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
1140901|NCT02918318|2244913|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
1140902|NCT02918318|2244914|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1
1140903|NCT02918318|2244915|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
1140904|NCT02918318|2244911|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
1140905|NCT02918318|2244912|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
1140906|NCT02918318|2244913|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
1140907|NCT02918318|2244914|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
1140908|NCT02918318|2244915|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
1140909|NCT02918318|2244911|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
1140910|NCT02918318|2244912|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
1140911|NCT02918318|2244913|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
1140912|NCT02918318|2244914|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1
1140913|NCT02918318|2244915|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
1140914|NCT02918318|2244911|FG000|Double-blind Induction Phase: 4 Weeks|Other|0
1140915|NCT02918318|2244912|FG001|Double-blind Induction Phase: 4 Weeks|Other|2
1140916|NCT02918318|2244913|FG002|Double-blind Induction Phase: 4 Weeks|Other|0
1140917|NCT02918318|2244914|FG003|Double-blind Induction Phase: 4 Weeks|Other|1
1140918|NCT02918318|2244915|FG004|Double-blind Induction Phase: 4 Weeks|Other|0
1140919|NCT02918318|2244911|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
1140920|NCT02918318|2244912|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
1140921|NCT02918318|2244913|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
1140922|NCT02918318|2244914|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2
1140923|NCT02918318|2244915|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
1140924|NCT02918318|2244911|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
1140925|NCT02918318|2244912|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
1140926|NCT02918318|2244913|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
1140927|NCT02918318|2244914|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
1140928|NCT02918318|2244915|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
1140929|NCT02918318|2244911|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
1140930|NCT02918318|2244912|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
1140931|NCT02918318|2244913|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
1140932|NCT02918318|2244914|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
1140933|NCT02918318|2244915|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
1140934|NCT02918318|2244911|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0
1140935|NCT02918318|2244912|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3
1140936|NCT02918318|2244913|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1
1140937|NCT02918318|2244914|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1
1140938|NCT02918318|2244915|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0
1140939|NCT02918318|2244911|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
1140940|NCT02918318|2244912|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
1140941|NCT02918318|2244913|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
1140942|NCT02918318|2244914|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
1140943|NCT02918318|2244915|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1
1140944|NCT02918318|2244911|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
1140945|NCT02918318|2244912|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
1140946|NCT02918318|2244913|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
1140947|NCT02918318|2244914|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
1140948|NCT02918318|2244915|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1
1140949|NCT02918552|2244973|FG000|Overall Study|Failed Pharmacokinetics|1
1140950|NCT02918552|2244974|FG001|Overall Study|Failed Pharmacokinetics|0
1140951|NCT02918552|2244973|FG000|Overall Study|Withdrawal by Subject|0
1140952|NCT02918552|2244974|FG001|Overall Study|Withdrawal by Subject|1
1140953|NCT02918552|2244973|FG000|Overall Study|Lost to Follow-up|0
1140954|NCT02918552|2244974|FG001|Overall Study|Lost to Follow-up|1
1140955|NCT02918877|2245073|FG000|Overall Study|Withdrawal by Subject|2
1140956|NCT02918877|2245074|FG001|Overall Study|Withdrawal by Subject|2
1140957|NCT02918877|2245073|FG000|Overall Study|Surgery cancelled|1
1140958|NCT02918877|2245074|FG001|Overall Study|Surgery cancelled|0
1140959|NCT02918877|2245073|FG000|Overall Study|Physician Decision|1
1140960|NCT02918877|2245074|FG001|Overall Study|Physician Decision|0
1140961|NCT02918877|2245073|FG000|Overall Study|Received intraoperative steroids|1
1140962|NCT02918877|2245074|FG001|Overall Study|Received intraoperative steroids|0
1140963|NCT02918877|2245073|FG000|Overall Study|Unable to obtain lab samples|1
1140964|NCT02918877|2245074|FG001|Overall Study|Unable to obtain lab samples|0
1140965|NCT02918877|2245073|FG000|Overall Study|Unsafe to perform BAL|0
1140966|NCT02918877|2245074|FG001|Overall Study|Unsafe to perform BAL|1
1140967|NCT02919267|2245103|FG000|Overall Study|Protocol Violation|0
1140968|NCT02919267|2245104|FG001|Overall Study|Protocol Violation|3
1140969|NCT02919267|2245105|FG002|Overall Study|Protocol Violation|3
1140970|NCT02919267|2245106|FG003|Overall Study|Protocol Violation|4
1140971|NCT02919475|2245130|FG000|Overall Study|Adverse Event|3
1140972|NCT02919475|2245131|FG001|Overall Study|Adverse Event|3
1140973|NCT02919475|2245132|FG002|Overall Study|Adverse Event|3
1140974|NCT02919475|2245133|FG003|Overall Study|Adverse Event|9
1140975|NCT02919475|2245134|FG004|Overall Study|Adverse Event|2
1140976|NCT02919475|2245130|FG000|Overall Study|Death|0
1140977|NCT02919475|2245131|FG001|Overall Study|Death|1
1140978|NCT02919475|2245132|FG002|Overall Study|Death|0
1140979|NCT02919475|2245133|FG003|Overall Study|Death|0
1140980|NCT02919475|2245134|FG004|Overall Study|Death|0
1140981|NCT02919475|2245130|FG000|Overall Study|Lost to Follow-up|0
1140982|NCT02919475|2245131|FG001|Overall Study|Lost to Follow-up|0
1140983|NCT02919475|2245132|FG002|Overall Study|Lost to Follow-up|0
1140984|NCT02919475|2245133|FG003|Overall Study|Lost to Follow-up|1
1140985|NCT02919475|2245134|FG004|Overall Study|Lost to Follow-up|0
1140986|NCT02919475|2245130|FG000|Overall Study|Withdrawal by Subject|2
1140987|NCT02919475|2245131|FG001|Overall Study|Withdrawal by Subject|3
1140988|NCT02919475|2245132|FG002|Overall Study|Withdrawal by Subject|1
1140989|NCT02919475|2245133|FG003|Overall Study|Withdrawal by Subject|2
1140990|NCT02919475|2245134|FG004|Overall Study|Withdrawal by Subject|2
901590|NCT00734578|1875091|FG002|Overall Study|Lack of Efficacy|5
901591|NCT00734578|1875089|FG000|Overall Study|Randomized in error|1
901592|NCT00734578|1875090|FG001|Overall Study|Randomized in error|0
1140991|NCT02919475|2245130|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
1140992|NCT02919475|2245131|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1
1140993|NCT02919475|2245132|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1
1140994|NCT02919475|2245133|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1
1140995|NCT02919475|2245134|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1140996|NCT02919683|2245155|FG000|Post-Surgery Follow-Up|Death|2
1140997|NCT02919683|2245156|FG001|Post-Surgery Follow-Up|Death|2
1140998|NCT02919683|2245155|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1
1140999|NCT02919683|2245156|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0
1141000|NCT02919696|2245165|FG000|Overall Study|Adverse Event|1
1141001|NCT02919696|2245166|FG001|Overall Study|Adverse Event|2
1141002|NCT02919696|2245165|FG000|Overall Study|Withdrawal by Subject|2
1141003|NCT02919696|2245166|FG001|Overall Study|Withdrawal by Subject|1
1141004|NCT02919696|2245165|FG000|Overall Study|Sponsor Decision|1
1141005|NCT02919696|2245166|FG001|Overall Study|Sponsor Decision|1
1141006|NCT02919696|2245165|FG000|Overall Study|Never Treated|0
1141007|NCT02919696|2245166|FG001|Overall Study|Never Treated|1
1141008|NCT02919761|2245178|FG000|Part 1: Open Label|Withdrawal by Subject|12
1141009|NCT02919761|2245179|FG001|Part 1: Open Label|Withdrawal by Subject|0
1141010|NCT02919761|2245180|FG002|Part 1: Open Label|Withdrawal by Subject|0
1141011|NCT02919761|2245178|FG000|Part 1: Open Label|Adverse Event|1
1141012|NCT02919761|2245179|FG001|Part 1: Open Label|Adverse Event|0
1141013|NCT02919761|2245180|FG002|Part 1: Open Label|Adverse Event|0
1141014|NCT02919761|2245178|FG000|Part 1: Open Label|Lost to Follow-up|1
1141015|NCT02919761|2245179|FG001|Part 1: Open Label|Lost to Follow-up|0
1141016|NCT02919761|2245180|FG002|Part 1: Open Label|Lost to Follow-up|0
1141017|NCT02919761|2245178|FG000|Part 1: Open Label|Met withdrawal criteria|5
1141018|NCT02919761|2245179|FG001|Part 1: Open Label|Met withdrawal criteria|0
1141019|NCT02919761|2245180|FG002|Part 1: Open Label|Met withdrawal criteria|0
1141020|NCT02919761|2245178|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
1141021|NCT02919761|2245179|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
1141022|NCT02919761|2245180|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
1141023|NCT02919761|2245178|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1
1141024|NCT02919761|2245179|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0
1141025|NCT02919761|2245180|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0
1141026|NCT02919761|2245178|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1
1141027|NCT02919761|2245179|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0
1141028|NCT02919761|2245180|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0
1141029|NCT02919761|2245178|FG000|Part 1: Open Label|Termination by Sponsor|1
1141030|NCT02919761|2245179|FG001|Part 1: Open Label|Termination by Sponsor|0
1141031|NCT02919761|2245180|FG002|Part 1: Open Label|Termination by Sponsor|0
1141032|NCT02919761|2245178|FG000|Part 2: Double-blind|Withdrawal by Subject|0
1141033|NCT02919761|2245179|FG001|Part 2: Double-blind|Withdrawal by Subject|0
1141034|NCT02919761|2245180|FG002|Part 2: Double-blind|Withdrawal by Subject|2
1141035|NCT02919761|2245178|FG000|Part 2: Double-blind|Adverse Event|0
1141036|NCT02919761|2245179|FG001|Part 2: Double-blind|Adverse Event|1
1141037|NCT02919761|2245180|FG002|Part 2: Double-blind|Adverse Event|0
1141038|NCT02919761|2245178|FG000|Part 2: Double-blind|Lost to Follow-up|0
1141039|NCT02919761|2245179|FG001|Part 2: Double-blind|Lost to Follow-up|0
1141040|NCT02919761|2245180|FG002|Part 2: Double-blind|Lost to Follow-up|3
1141041|NCT02919761|2245178|FG000|Part 2: Double-blind|Met withdrawal criteria|0
1141042|NCT02919761|2245179|FG001|Part 2: Double-blind|Met withdrawal criteria|1
1141043|NCT02919761|2245180|FG002|Part 2: Double-blind|Met withdrawal criteria|2
1141044|NCT02919761|2245178|FG000|Part 2: Double-blind|Worsening of disease activity|0
1141045|NCT02919761|2245179|FG001|Part 2: Double-blind|Worsening of disease activity|4
1141046|NCT02919761|2245180|FG002|Part 2: Double-blind|Worsening of disease activity|10
1141047|NCT02919761|2245178|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0
1141048|NCT02919761|2245179|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0
1141049|NCT02919761|2245180|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1
1141050|NCT02919761|2245178|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0
1141051|NCT02919761|2245179|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0
1141052|NCT02919761|2245180|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1
1141053|NCT02919761|2245178|FG000|Part 2: Double-blind|Discontinued exclusion 16|0
1141054|NCT02919761|2245179|FG001|Part 2: Double-blind|Discontinued exclusion 16|0
1141055|NCT02919761|2245180|FG002|Part 2: Double-blind|Discontinued exclusion 16|2
1141056|NCT02919995|2245217|FG000|Overall Study|Adverse Event|0
1141057|NCT02919995|2245218|FG001|Overall Study|Adverse Event|0
1141058|NCT02919995|2245219|FG002|Overall Study|Adverse Event|0
1141059|NCT02919995|2245220|FG003|Overall Study|Adverse Event|0
1141060|NCT02919995|2245221|FG004|Overall Study|Adverse Event|0
1141061|NCT02919995|2245222|FG005|Overall Study|Adverse Event|1
1141062|NCT02920528|2245237|FG000|Overall Study|Incomplete Data|1
1141063|NCT02920528|2245238|FG001|Overall Study|Incomplete Data|1
1141064|NCT02920528|2245239|FG002|Overall Study|Incomplete Data|1
1141065|NCT02920528|2245237|FG000|Overall Study|Adverse Event|0
901593|NCT00734578|1875091|FG002|Overall Study|Randomized in error|0
1141066|NCT02920528|2245238|FG001|Overall Study|Adverse Event|0
1141067|NCT02920528|2245239|FG002|Overall Study|Adverse Event|3
1141068|NCT02920528|2245237|FG000|Overall Study|Did not meet inclusion criteria|2
1141069|NCT02920528|2245238|FG001|Overall Study|Did not meet inclusion criteria|0
1141070|NCT02920528|2245239|FG002|Overall Study|Did not meet inclusion criteria|1
1141071|NCT02920957|2245277|FG000|First Intervention : 1 Month|Withdrawal by Subject|2
1141072|NCT02920957|2245278|FG001|First Intervention : 1 Month|Withdrawal by Subject|0
1141073|NCT02920957|2245277|FG000|First Intervention : 1 Month|Lost to Follow-up|1
1141074|NCT02920957|2245278|FG001|First Intervention : 1 Month|Lost to Follow-up|0
1141075|NCT02920957|2245277|FG000|First Intervention : 1 Month|Adverse Event|1
1141076|NCT02920957|2245278|FG001|First Intervention : 1 Month|Adverse Event|0
1141077|NCT02920957|2245277|FG000|Second Intervention: 1 Month|Lost to Follow-up|0
1141078|NCT02920957|2245278|FG001|Second Intervention: 1 Month|Lost to Follow-up|1
1141079|NCT02920970|2245295|FG000|First Intervention|Protocol Violation|0
1141080|NCT02920970|2245296|FG001|First Intervention|Protocol Violation|1
1141081|NCT02920970|2245295|FG000|First Intervention|Adverse Event|0
1141082|NCT02920970|2245296|FG001|First Intervention|Adverse Event|1
1141083|NCT02920970|2245295|FG000|Second Intervention|Poor Lens Fit|1
1141084|NCT02920970|2245296|FG001|Second Intervention|Poor Lens Fit|0
1141085|NCT02920983|2245304|FG000|Dispense 1|Unacceptable Lens Fit|0
1141086|NCT02920983|2245305|FG001|Dispense 1|Unacceptable Lens Fit|0
1141087|NCT02920983|2245306|FG002|Dispense 1|Unacceptable Lens Fit|0
1141088|NCT02920983|2245307|FG003|Dispense 1|Unacceptable Lens Fit|0
1141089|NCT02920983|2245308|FG004|Dispense 1|Unacceptable Lens Fit|1
1141090|NCT02920983|2245309|FG005|Dispense 1|Unacceptable Lens Fit|0
1141091|NCT02920983|2245304|FG000|Dispense 2|Unscceptable lens fit|1
1141092|NCT02920983|2245305|FG001|Dispense 2|Unscceptable lens fit|0
1141093|NCT02920983|2245306|FG002|Dispense 2|Unscceptable lens fit|0
1141094|NCT02920983|2245307|FG003|Dispense 2|Unscceptable lens fit|0
1141095|NCT02920983|2245308|FG004|Dispense 2|Unscceptable lens fit|1
1141096|NCT02920983|2245309|FG005|Dispense 2|Unscceptable lens fit|0
1141097|NCT02920983|2245304|FG000|Dispense 3|Unacceptable Lens Fit|1
1141098|NCT02920983|2245305|FG001|Dispense 3|Unacceptable Lens Fit|1
1141099|NCT02920983|2245306|FG002|Dispense 3|Unacceptable Lens Fit|0
1141100|NCT02920983|2245307|FG003|Dispense 3|Unacceptable Lens Fit|0
1141101|NCT02920983|2245308|FG004|Dispense 3|Unacceptable Lens Fit|1
1141102|NCT02920983|2245309|FG005|Dispense 3|Unacceptable Lens Fit|0
1141103|NCT02921087|2245323|FG000|Overall Study|Withdrawal by Subject|0
1141104|NCT02921087|2245324|FG001|Overall Study|Withdrawal by Subject|1
1141105|NCT02921425|2245368|FG000|Overall Study|Protocol Violation|9
1141106|NCT02921750|2245382|FG000|Overall Study|Adverse Event|1
1141107|NCT02921750|2245383|FG001|Overall Study|Adverse Event|2
1141108|NCT02921750|2245382|FG000|Overall Study|Withdrawal by Subject|1
1141109|NCT02921750|2245383|FG001|Overall Study|Withdrawal by Subject|1
1141110|NCT02921750|2245382|FG000|Overall Study|Lost to Follow-up|3
1141111|NCT02921750|2245383|FG001|Overall Study|Lost to Follow-up|3
1141112|NCT02921750|2245382|FG000|Overall Study|Wound healed|3
1141113|NCT02921750|2245383|FG001|Overall Study|Wound healed|3
1141114|NCT02921750|2245382|FG000|Overall Study|Serious Adverse Event|1
1141115|NCT02921750|2245383|FG001|Overall Study|Serious Adverse Event|2
1141116|NCT02922153|2245403|FG000|Overall Study|Death|8
1141117|NCT02922153|2245404|FG001|Overall Study|Death|1
1141118|NCT02922153|2245403|FG000|Overall Study|Lost to Follow-up|1
1141119|NCT02922153|2245404|FG001|Overall Study|Lost to Follow-up|0
1141120|NCT02922153|2245403|FG000|Overall Study|Physician Decision|1
1141121|NCT02922153|2245404|FG001|Overall Study|Physician Decision|1
1141122|NCT02922634|2245427|FG000|Overall Study|Withdrawal by Subject|5
1141123|NCT02922634|2245427|FG000|Overall Study|Did not have their surgery|5
1141124|NCT02923115|2245484|FG000|Overall Study|Lost to Follow-up|0
1141125|NCT02923115|2245485|FG001|Overall Study|Lost to Follow-up|0
1141126|NCT02923115|2245486|FG002|Overall Study|Lost to Follow-up|0
1141127|NCT02923115|2245487|FG003|Overall Study|Lost to Follow-up|1
1141128|NCT02923115|2245488|FG004|Overall Study|Lost to Follow-up|0
1141129|NCT02923115|2245489|FG005|Overall Study|Lost to Follow-up|0
1141130|NCT02923115|2245484|FG000|Overall Study|Withdrawal by Subject|0
1141131|NCT02923115|2245485|FG001|Overall Study|Withdrawal by Subject|1
1141132|NCT02923115|2245486|FG002|Overall Study|Withdrawal by Subject|0
1141133|NCT02923115|2245487|FG003|Overall Study|Withdrawal by Subject|0
1141134|NCT02923115|2245488|FG004|Overall Study|Withdrawal by Subject|0
1141135|NCT02923115|2245489|FG005|Overall Study|Withdrawal by Subject|0
1141136|NCT02923115|2245484|FG000|Overall Study|Randomized, but not dosed|0
1141137|NCT02923115|2245485|FG001|Overall Study|Randomized, but not dosed|0
1141138|NCT02923115|2245486|FG002|Overall Study|Randomized, but not dosed|3
1141139|NCT02923115|2245487|FG003|Overall Study|Randomized, but not dosed|1
1141140|NCT02923115|2245488|FG004|Overall Study|Randomized, but not dosed|5
1141141|NCT02923115|2245489|FG005|Overall Study|Randomized, but not dosed|0
1141142|NCT02923180|2245508|FG000|Overall Study|Off Study Due to Detectable PSA|13
1141143|NCT02923180|2245508|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13
1141144|NCT02923245|2245514|FG000|Overall Study|ultrasound order was cancelled|2
1141145|NCT02923245|2245515|FG001|Overall Study|ultrasound order was cancelled|1
1141146|NCT02923349|2245538|FG000|Overall Study|Other|1
1141147|NCT02923349|2245539|FG001|Overall Study|Other|2
1141148|NCT02923349|2245540|FG002|Overall Study|Other|4
1141149|NCT02923349|2245541|FG003|Overall Study|Other|1
1141150|NCT02923349|2245542|FG004|Overall Study|Other|3
1141151|NCT02923349|2245543|FG005|Overall Study|Other|0
1141152|NCT02923349|2245544|FG006|Overall Study|Other|1
1141153|NCT02923349|2245538|FG000|Overall Study|Withdrawal by Subject|2
1141154|NCT02923349|2245539|FG001|Overall Study|Withdrawal by Subject|2
1141155|NCT02923349|2245540|FG002|Overall Study|Withdrawal by Subject|8
1141156|NCT02923349|2245541|FG003|Overall Study|Withdrawal by Subject|10
1141157|NCT02923349|2245542|FG004|Overall Study|Withdrawal by Subject|12
1141158|NCT02923349|2245543|FG005|Overall Study|Withdrawal by Subject|3
1141159|NCT02923349|2245544|FG006|Overall Study|Withdrawal by Subject|0
1141160|NCT02923349|2245538|FG000|Overall Study|Physician Decision|0
1141161|NCT02923349|2245539|FG001|Overall Study|Physician Decision|0
1141162|NCT02923349|2245540|FG002|Overall Study|Physician Decision|0
1141163|NCT02923349|2245541|FG003|Overall Study|Physician Decision|1
1141164|NCT02923349|2245542|FG004|Overall Study|Physician Decision|1
1141165|NCT02923349|2245543|FG005|Overall Study|Physician Decision|0
1141166|NCT02923349|2245544|FG006|Overall Study|Physician Decision|2
1141167|NCT02923349|2245538|FG000|Overall Study|Lost to Follow-up|0
1141168|NCT02923349|2245539|FG001|Overall Study|Lost to Follow-up|0
1141169|NCT02923349|2245540|FG002|Overall Study|Lost to Follow-up|3
1141170|NCT02923349|2245541|FG003|Overall Study|Lost to Follow-up|0
1141171|NCT02923349|2245542|FG004|Overall Study|Lost to Follow-up|1
1141172|NCT02923349|2245543|FG005|Overall Study|Lost to Follow-up|1
1141173|NCT02923349|2245544|FG006|Overall Study|Lost to Follow-up|0
1141174|NCT02923349|2245538|FG000|Overall Study|Death|1
1141175|NCT02923349|2245539|FG001|Overall Study|Death|0
1141176|NCT02923349|2245540|FG002|Overall Study|Death|2
1141177|NCT02923349|2245541|FG003|Overall Study|Death|4
1141178|NCT02923349|2245542|FG004|Overall Study|Death|2
1141179|NCT02923349|2245543|FG005|Overall Study|Death|3
1141180|NCT02923349|2245544|FG006|Overall Study|Death|0
1141181|NCT02923427|2245562|FG000|Overall Study|convert to laparatomy|2
1141182|NCT02923427|2245563|FG001|Overall Study|convert to laparatomy|2
1141183|NCT02923427|2245562|FG000|Overall Study|destaturation|1
1141184|NCT02923427|2245563|FG001|Overall Study|destaturation|0
1141185|NCT02923427|2245562|FG000|Overall Study|can not replace LMA|1
1141186|NCT02923427|2245563|FG001|Overall Study|can not replace LMA|0
1141187|NCT02923921|2245580|FG000|Overall Study|Sponsor Decision|39
1141188|NCT02923921|2245581|FG001|Overall Study|Sponsor Decision|38
1141189|NCT02923921|2245580|FG000|Overall Study|Lost to Follow-up|1
1141190|NCT02923921|2245581|FG001|Overall Study|Lost to Follow-up|0
1141191|NCT02923921|2245580|FG000|Overall Study|Withdrawal by Subject|6
1141192|NCT02923921|2245581|FG001|Overall Study|Withdrawal by Subject|13
1141193|NCT02923921|2245580|FG000|Overall Study|Unknown, Not Collected|7
1141194|NCT02923921|2245581|FG001|Overall Study|Unknown, Not Collected|6
1141195|NCT02924051|2245589|FG000|Overall Study|Withdrawal by Subject|1
1141196|NCT02924051|2245590|FG001|Overall Study|Withdrawal by Subject|9
1141197|NCT02924129|2245600|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2
1141198|NCT02924129|2245601|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1
1141199|NCT02924129|2245600|FG000|Overall Study|Withdrawal by Subject|2
1141200|NCT02924129|2245601|FG001|Overall Study|Withdrawal by Subject|2
1141201|NCT02924129|2245600|FG000|Overall Study|Physician Decision|1
1141202|NCT02924129|2245601|FG001|Overall Study|Physician Decision|0
1141203|NCT02924129|2245600|FG000|Overall Study|Missed Visit|0
1141204|NCT02924129|2245601|FG001|Overall Study|Missed Visit|1
1141205|NCT02924428|2245618|FG000|Overall Study|Adverse Event|1
1141206|NCT02924428|2245619|FG001|Overall Study|Adverse Event|0
1141207|NCT02924428|2245618|FG000|Overall Study|Physician Decision|1
1141208|NCT02924428|2245619|FG001|Overall Study|Physician Decision|0
1141209|NCT02924428|2245618|FG000|Overall Study|Lost to Follow-up|2
1141210|NCT02924428|2245619|FG001|Overall Study|Lost to Follow-up|4
1141211|NCT02924428|2245618|FG000|Overall Study|Pregnancy|0
1141212|NCT02924428|2245619|FG001|Overall Study|Pregnancy|1
1141213|NCT02924688|2245631|FG000|Overall Study|Adverse Event|9
1141214|NCT02924688|2245632|FG001|Overall Study|Adverse Event|3
1141215|NCT02924688|2245633|FG002|Overall Study|Adverse Event|2
1141216|NCT02924688|2245634|FG003|Overall Study|Adverse Event|2
1141217|NCT02924688|2245635|FG004|Overall Study|Adverse Event|3
1141218|NCT02924688|2245636|FG005|Overall Study|Adverse Event|2
1141219|NCT02924688|2245631|FG000|Overall Study|Lack of Efficacy|2
1141220|NCT02924688|2245632|FG001|Overall Study|Lack of Efficacy|3
1141221|NCT02924688|2245633|FG002|Overall Study|Lack of Efficacy|4
1141222|NCT02924688|2245634|FG003|Overall Study|Lack of Efficacy|2
1141223|NCT02924688|2245635|FG004|Overall Study|Lack of Efficacy|1
1141224|NCT02924688|2245636|FG005|Overall Study|Lack of Efficacy|1
1141225|NCT02924688|2245631|FG000|Overall Study|Protocol Violation|3
1141226|NCT02924688|2245632|FG001|Overall Study|Protocol Violation|7
1141227|NCT02924688|2245633|FG002|Overall Study|Protocol Violation|5
1141228|NCT02924688|2245634|FG003|Overall Study|Protocol Violation|6
1141229|NCT02924688|2245635|FG004|Overall Study|Protocol Violation|2
1141230|NCT02924688|2245636|FG005|Overall Study|Protocol Violation|2
1141231|NCT02924688|2245631|FG000|Overall Study|Protocol defined withdrawal criteria met|1
1141232|NCT02924688|2245632|FG001|Overall Study|Protocol defined withdrawal criteria met|0
1141233|NCT02924688|2245633|FG002|Overall Study|Protocol defined withdrawal criteria met|1
1141234|NCT02924688|2245634|FG003|Overall Study|Protocol defined withdrawal criteria met|1
1141235|NCT02924688|2245635|FG004|Overall Study|Protocol defined withdrawal criteria met|1
1141236|NCT02924688|2245636|FG005|Overall Study|Protocol defined withdrawal criteria met|0
1141237|NCT02924688|2245631|FG000|Overall Study|Lost to Follow-up|2
1141238|NCT02924688|2245632|FG001|Overall Study|Lost to Follow-up|4
1141239|NCT02924688|2245633|FG002|Overall Study|Lost to Follow-up|2
1141240|NCT02924688|2245634|FG003|Overall Study|Lost to Follow-up|4
1141241|NCT02924688|2245635|FG004|Overall Study|Lost to Follow-up|2
1141242|NCT02924688|2245636|FG005|Overall Study|Lost to Follow-up|4
1141243|NCT02924688|2245631|FG000|Overall Study|Physician Decision|2
1141244|NCT02924688|2245632|FG001|Overall Study|Physician Decision|1
1141245|NCT02924688|2245633|FG002|Overall Study|Physician Decision|0
1141246|NCT02924688|2245634|FG003|Overall Study|Physician Decision|1
1141247|NCT02924688|2245635|FG004|Overall Study|Physician Decision|1
1141248|NCT02924688|2245636|FG005|Overall Study|Physician Decision|1
1141249|NCT02924688|2245631|FG000|Overall Study|Withdrawal by Subject|14
1141250|NCT02924688|2245632|FG001|Overall Study|Withdrawal by Subject|13
1141251|NCT02924688|2245633|FG002|Overall Study|Withdrawal by Subject|9
1141252|NCT02924688|2245634|FG003|Overall Study|Withdrawal by Subject|12
1141253|NCT02924688|2245635|FG004|Overall Study|Withdrawal by Subject|13
1141254|NCT02924688|2245636|FG005|Overall Study|Withdrawal by Subject|14
1141255|NCT02924883|2245655|FG000|Overall Study|Death|39
1141256|NCT02924883|2245656|FG001|Overall Study|Death|20
1141257|NCT02924883|2245655|FG000|Overall Study|Lost to Follow-up|1
1141258|NCT02924883|2245656|FG001|Overall Study|Lost to Follow-up|0
1141259|NCT02924883|2245655|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0
1141260|NCT02924883|2245656|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1
1141261|NCT02924883|2245655|FG000|Overall Study|Protocol Violation|1
1141262|NCT02924883|2245656|FG001|Overall Study|Protocol Violation|0
1141263|NCT02924883|2245655|FG000|Overall Study|Withdrawal by Subject|22
1141264|NCT02924883|2245656|FG001|Overall Study|Withdrawal by Subject|16
1141265|NCT02924883|2245655|FG000|Overall Study|Progressive Disease|1
1141266|NCT02924883|2245656|FG001|Overall Study|Progressive Disease|0
1141267|NCT02924883|2245655|FG000|Overall Study|Study Terminated by Sponsor|69
1141268|NCT02924883|2245656|FG001|Overall Study|Study Terminated by Sponsor|32
1141269|NCT02925117|2245677|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1
1141270|NCT02925117|2245678|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3
1141271|NCT02925117|2245679|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1
1141272|NCT02925117|2245680|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2
1141273|NCT02925117|2245681|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0
1141274|NCT02925117|2245682|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0
1141275|NCT02925117|2245683|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0
1141276|NCT02925117|2245684|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0
1141277|NCT02925117|2245685|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0
1141278|NCT02925117|2245686|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0
1141279|NCT02925117|2245687|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0
1141280|NCT02925117|2245688|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0
1141281|NCT02925117|2245677|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10
1141282|NCT02925117|2245678|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
1141283|NCT02925117|2245679|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
1141284|NCT02925117|2245680|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
1141285|NCT02925117|2245681|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
1141286|NCT02925117|2245682|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
1141287|NCT02925117|2245683|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
1141288|NCT02925117|2245684|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
1141289|NCT02925117|2245685|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
1141290|NCT02925117|2245686|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
1141291|NCT02925117|2245687|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
1141292|NCT02925117|2245688|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
1141293|NCT02925117|2245677|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2
1141294|NCT02925117|2245678|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1
1141295|NCT02925117|2245679|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
1141296|NCT02925117|2245680|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
1141297|NCT02925117|2245681|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
1141298|NCT02925117|2245682|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
1141299|NCT02925117|2245683|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
1141300|NCT02925117|2245684|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
1141301|NCT02925117|2245685|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
1141302|NCT02925117|2245686|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
1141303|NCT02925117|2245687|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
1141304|NCT02925117|2245688|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
1141305|NCT02925117|2245677|FG000|Period 1 (Weeks 0 - 16)|Other|5
1141306|NCT02925117|2245678|FG001|Period 1 (Weeks 0 - 16)|Other|4
1141307|NCT02925117|2245679|FG002|Period 1 (Weeks 0 - 16)|Other|1
1141308|NCT02925117|2245680|FG003|Period 1 (Weeks 0 - 16)|Other|1
1141309|NCT02925117|2245681|FG004|Period 1 (Weeks 0 - 16)|Other|0
1141310|NCT02925117|2245682|FG005|Period 1 (Weeks 0 - 16)|Other|0
1141311|NCT02925117|2245683|FG006|Period 1 (Weeks 0 - 16)|Other|0
1141312|NCT02925117|2245684|FG007|Period 1 (Weeks 0 - 16)|Other|0
1141313|NCT02925117|2245685|FG008|Period 1 (Weeks 0 - 16)|Other|0
1141314|NCT02925117|2245686|FG009|Period 1 (Weeks 0 - 16)|Other|0
1141315|NCT02925117|2245687|FG010|Period 1 (Weeks 0 - 16)|Other|0
1141316|NCT02925117|2245688|FG011|Period 1 (Weeks 0 - 16)|Other|0
1141317|NCT02925117|2245677|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0
1141318|NCT02925117|2245678|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0
1141319|NCT02925117|2245679|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0
1141320|NCT02925117|2245680|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0
1141321|NCT02925117|2245681|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0
1141322|NCT02925117|2245682|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1
1141323|NCT02925117|2245683|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0
1141324|NCT02925117|2245684|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0
1141325|NCT02925117|2245685|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0
1141326|NCT02925117|2245686|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0
1141327|NCT02925117|2245687|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3
1141328|NCT02925117|2245688|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2
1141329|NCT02925117|2245677|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
1141330|NCT02925117|2245678|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
1141331|NCT02925117|2245679|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
1141332|NCT02925117|2245680|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
1141333|NCT02925117|2245681|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
1141334|NCT02925117|2245682|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1
1141335|NCT02925117|2245683|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4
1141336|NCT02925117|2245684|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3
1141337|NCT02925117|2245685|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
1141338|NCT02925117|2245686|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
1141339|NCT02925117|2245687|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
1141340|NCT02925117|2245688|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
1141341|NCT02925117|2245677|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
1141342|NCT02925117|2245678|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
1141343|NCT02925117|2245679|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
1141344|NCT02925117|2245680|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
1141345|NCT02925117|2245681|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
1141346|NCT02925117|2245682|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2
1141347|NCT02925117|2245683|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
1141348|NCT02925117|2245684|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
1141349|NCT02925117|2245685|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
1141350|NCT02925117|2245686|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
1141351|NCT02925117|2245687|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
1141352|NCT02925117|2245688|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
1141353|NCT02925117|2245677|FG000|Period 2 (Weeks 16 - 88)|Other|0
1141354|NCT02925117|2245678|FG001|Period 2 (Weeks 16 - 88)|Other|0
1141355|NCT02925117|2245679|FG002|Period 2 (Weeks 16 - 88)|Other|0
1141356|NCT02925117|2245680|FG003|Period 2 (Weeks 16 - 88)|Other|0
1141357|NCT02925117|2245681|FG004|Period 2 (Weeks 16 - 88)|Other|1
1141358|NCT02925117|2245682|FG005|Period 2 (Weeks 16 - 88)|Other|1
1141359|NCT02925117|2245683|FG006|Period 2 (Weeks 16 - 88)|Other|1
1141360|NCT02925117|2245684|FG007|Period 2 (Weeks 16 - 88)|Other|1
1141361|NCT02925117|2245685|FG008|Period 2 (Weeks 16 - 88)|Other|3
1141362|NCT02925117|2245686|FG009|Period 2 (Weeks 16 - 88)|Other|4
1141363|NCT02925117|2245687|FG010|Period 2 (Weeks 16 - 88)|Other|3
1141364|NCT02925117|2245688|FG011|Period 2 (Weeks 16 - 88)|Other|0
1141365|NCT02925312|2245716|FG000|Overall Study|Lost to Follow-up|25
1141366|NCT02925312|2245717|FG001|Overall Study|Lost to Follow-up|0
1141367|NCT02925312|2245716|FG000|Overall Study|Adverse Event|2
1141368|NCT02925312|2245717|FG001|Overall Study|Adverse Event|0
1141369|NCT02925403|2245725|FG000|Overall Study|Lost to Follow-up|0
1141370|NCT02925403|2245726|FG001|Overall Study|Lost to Follow-up|1
1141371|NCT02925455|2245734|FG000|Overall Study|Withdrawal by Subject|2
1141372|NCT02925455|2245735|FG001|Overall Study|Withdrawal by Subject|0
1141373|NCT02925494|2245745|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
1141374|NCT02925494|2245746|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
1141375|NCT02925494|2245747|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
1141376|NCT02925494|2245748|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23
1141377|NCT02925494|2245745|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
1141378|NCT02925494|2245746|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
1141379|NCT02925494|2245747|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9
1141380|NCT02925494|2245748|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10
1141381|NCT02925494|2245745|FG000|Post-Treatment Follow-Up Period|Other|1
1141382|NCT02925494|2245746|FG001|Post-Treatment Follow-Up Period|Other|4
1141383|NCT02925494|2245747|FG002|Post-Treatment Follow-Up Period|Other|3
1141384|NCT02925494|2245748|FG003|Post-Treatment Follow-Up Period|Other|6
1141385|NCT02925494|2245745|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1
1141386|NCT02925494|2245746|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
1141387|NCT02925494|2245747|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
1141388|NCT02925494|2245748|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6
1141389|NCT02925494|2245745|FG000|Post-Treatment Follow-Up Period|Pregnancy|1
1141390|NCT02925494|2245746|FG001|Post-Treatment Follow-Up Period|Pregnancy|0
1141391|NCT02925494|2245747|FG002|Post-Treatment Follow-Up Period|Pregnancy|1
1141392|NCT02925494|2245748|FG003|Post-Treatment Follow-Up Period|Pregnancy|2
1141393|NCT02925494|2245745|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
1141394|NCT02925494|2245746|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
1141395|NCT02925494|2245747|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
1141396|NCT02925494|2245748|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2
1141397|NCT02925494|2245745|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
1141398|NCT02925494|2245746|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
1141399|NCT02925494|2245747|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
1141400|NCT02925494|2245748|FG003|Post-Treatment Follow-Up Period|Adverse Event|1
1141401|NCT02925741|2245770|FG000|Overall Study|Withdrawal by Subject|11
1141402|NCT02925741|2245771|FG001|Overall Study|Withdrawal by Subject|0
1141403|NCT02925923|2245791|FG000|Overall Study|blood samples hemolyzed|0
1141404|NCT02925923|2245792|FG001|Overall Study|blood samples hemolyzed|2
1141405|NCT02926209|2245807|FG000|Study Cohort|Poor Bowel Preparation|1
1141406|NCT02926209|2245808|FG001|Study Cohort|Poor Bowel Preparation|0
1141407|NCT02926573|2245817|FG000|Overall Study|Nausea|1
1141408|NCT02926573|2245818|FG001|Overall Study|Nausea|0
1141409|NCT02926573|2245817|FG000|Overall Study|Remain intubated|2
1141410|NCT02926573|2245818|FG001|Overall Study|Remain intubated|2
1141411|NCT02926573|2245817|FG000|Overall Study|Change in surgery plan|3
1141412|NCT02926573|2245818|FG001|Overall Study|Change in surgery plan|1
1141413|NCT02926573|2245817|FG000|Overall Study|Change to outpatient status|5
1141414|NCT02926573|2245818|FG001|Overall Study|Change to outpatient status|1
1141415|NCT02926573|2245817|FG000|Overall Study|Withdrawal by Subject|0
1141416|NCT02926573|2245818|FG001|Overall Study|Withdrawal by Subject|2
1141417|NCT02926573|2245817|FG000|Overall Study|Return to operating room|0
1141418|NCT02926573|2245818|FG001|Overall Study|Return to operating room|2
1141419|NCT02926573|2245817|FG000|Overall Study|Delirium|0
1141420|NCT02926573|2245818|FG001|Overall Study|Delirium|1
1141421|NCT02926937|2245841|FG000|Overall Study|Adverse Event|0
1141422|NCT02926937|2245842|FG001|Overall Study|Adverse Event|1
1141423|NCT02926937|2245843|FG002|Overall Study|Adverse Event|1
1141424|NCT02926937|2245841|FG000|Overall Study|Poor Compliance to Protocol|1
1141425|NCT02926937|2245842|FG001|Overall Study|Poor Compliance to Protocol|0
1141426|NCT02926937|2245843|FG002|Overall Study|Poor Compliance to Protocol|0
1141427|NCT02926937|2245841|FG000|Overall Study|Lost to Follow-up|4
1141428|NCT02926937|2245842|FG001|Overall Study|Lost to Follow-up|5
1141429|NCT02926937|2245843|FG002|Overall Study|Lost to Follow-up|0
1141430|NCT02926937|2245841|FG000|Overall Study|At the Participant's own Request|11
1141431|NCT02926937|2245842|FG001|Overall Study|At the Participant's own Request|5
1141432|NCT02926937|2245843|FG002|Overall Study|At the Participant's own Request|8
1141433|NCT02926937|2245841|FG000|Overall Study|Reason not Specified|3
1141434|NCT02926937|2245842|FG001|Overall Study|Reason not Specified|4
1141435|NCT02926937|2245843|FG002|Overall Study|Reason not Specified|2
1141436|NCT02926950|2245854|FG000|Overall Study|Adverse Event|4
1141437|NCT02926950|2245855|FG001|Overall Study|Adverse Event|6
1141438|NCT02926950|2245854|FG000|Overall Study|At the participant's own request|21
1141439|NCT02926950|2245855|FG001|Overall Study|At the participant's own request|25
1141440|NCT02926950|2245854|FG000|Overall Study|Reason not Specified|17
1141441|NCT02926950|2245855|FG001|Overall Study|Reason not Specified|9
1141442|NCT02926950|2245854|FG000|Overall Study|Lost to Follow-up|7
1141443|NCT02926950|2245855|FG001|Overall Study|Lost to Follow-up|8
1141444|NCT02927080|2245872|FG000|Overall Study|Withdrawal by Subject|0
1141445|NCT02927080|2245873|FG001|Overall Study|Withdrawal by Subject|0
1141446|NCT02927080|2245874|FG002|Overall Study|Withdrawal by Subject|0
1141447|NCT02927080|2245875|FG003|Overall Study|Withdrawal by Subject|0
1141448|NCT02927080|2245876|FG004|Overall Study|Withdrawal by Subject|1
1141449|NCT02927080|2245877|FG005|Overall Study|Withdrawal by Subject|0
1141450|NCT02927080|2245878|FG006|Overall Study|Withdrawal by Subject|1
1141451|NCT02927080|2245879|FG007|Overall Study|Withdrawal by Subject|1
1141452|NCT02927080|2245880|FG008|Overall Study|Withdrawal by Subject|0
1141453|NCT02927080|2245881|FG009|Overall Study|Withdrawal by Subject|2
1141454|NCT02927080|2245872|FG000|Overall Study|Willingness to comply with protocol|0
1141455|NCT02927080|2245873|FG001|Overall Study|Willingness to comply with protocol|0
1141456|NCT02927080|2245874|FG002|Overall Study|Willingness to comply with protocol|0
1141457|NCT02927080|2245875|FG003|Overall Study|Willingness to comply with protocol|0
1141458|NCT02927080|2245876|FG004|Overall Study|Willingness to comply with protocol|0
1141459|NCT02927080|2245877|FG005|Overall Study|Willingness to comply with protocol|0
1141460|NCT02927080|2245878|FG006|Overall Study|Willingness to comply with protocol|0
1141461|NCT02927080|2245879|FG007|Overall Study|Willingness to comply with protocol|0
1141462|NCT02927080|2245880|FG008|Overall Study|Willingness to comply with protocol|0
1141463|NCT02927080|2245881|FG009|Overall Study|Willingness to comply with protocol|1
1141464|NCT02927080|2245872|FG000|Overall Study|Study terminated by Sponsor|0
1141465|NCT02927080|2245873|FG001|Overall Study|Study terminated by Sponsor|0
1141466|NCT02927080|2245874|FG002|Overall Study|Study terminated by Sponsor|0
1141467|NCT02927080|2245875|FG003|Overall Study|Study terminated by Sponsor|0
1141468|NCT02927080|2245876|FG004|Overall Study|Study terminated by Sponsor|0
1141469|NCT02927080|2245877|FG005|Overall Study|Study terminated by Sponsor|0
1141470|NCT02927080|2245878|FG006|Overall Study|Study terminated by Sponsor|6
1141471|NCT02927080|2245879|FG007|Overall Study|Study terminated by Sponsor|7
1141472|NCT02927080|2245880|FG008|Overall Study|Study terminated by Sponsor|2
1141473|NCT02927080|2245881|FG009|Overall Study|Study terminated by Sponsor|3
1141474|NCT02927080|2245872|FG000|Overall Study|Adverse Event|0
1141475|NCT02927080|2245873|FG001|Overall Study|Adverse Event|1
1141476|NCT02927080|2245874|FG002|Overall Study|Adverse Event|0
1141477|NCT02927080|2245875|FG003|Overall Study|Adverse Event|0
1141478|NCT02927080|2245876|FG004|Overall Study|Adverse Event|0
1141479|NCT02927080|2245877|FG005|Overall Study|Adverse Event|0
1141480|NCT02927080|2245878|FG006|Overall Study|Adverse Event|0
1141481|NCT02927080|2245879|FG007|Overall Study|Adverse Event|1
1141482|NCT02927080|2245880|FG008|Overall Study|Adverse Event|0
1141483|NCT02927080|2245881|FG009|Overall Study|Adverse Event|1
1141484|NCT02927080|2245872|FG000|Overall Study|Other|0
1141485|NCT02927080|2245873|FG001|Overall Study|Other|0
1141486|NCT02927080|2245874|FG002|Overall Study|Other|0
1141487|NCT02927080|2245875|FG003|Overall Study|Other|0
1141488|NCT02927080|2245876|FG004|Overall Study|Other|0
1141489|NCT02927080|2245877|FG005|Overall Study|Other|0
1141490|NCT02927080|2245878|FG006|Overall Study|Other|1
1141491|NCT02927080|2245879|FG007|Overall Study|Other|0
1141492|NCT02927080|2245880|FG008|Overall Study|Other|1
1141493|NCT02927080|2245881|FG009|Overall Study|Other|0
1141494|NCT02927171|2245928|FG000|Overall Study|Lost to Follow-up|0
1141495|NCT02927171|2245929|FG001|Overall Study|Lost to Follow-up|1
1141496|NCT02927301|2245941|FG000|Overall Study|Adverse Event|7
1141497|NCT02927301|2245941|FG000|Overall Study|Withdrawal by Subject|1
1141498|NCT02927301|2245941|FG000|Overall Study|Physician Decision|2
1141499|NCT02927366|2245956|FG000|Overall Study|Adverse Event|1
1141500|NCT02927366|2245957|FG001|Overall Study|Adverse Event|0
1141501|NCT02927366|2245956|FG000|Overall Study|Patient schedule|1
1141502|NCT02927366|2245957|FG001|Overall Study|Patient schedule|0
1141503|NCT02927431|2245966|FG000|Overall Study|Withdrawal by Subject|0
1141504|NCT02927431|2245967|FG001|Overall Study|Withdrawal by Subject|0
1141505|NCT02927431|2245968|FG002|Overall Study|Withdrawal by Subject|1
1141506|NCT02927795|2246000|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19
1141507|NCT02927795|2246000|FG000|Overall Study|Not Treated|4
1141508|NCT02927834|2246007|FG000|Overall Study|Lost to Follow-up|1
1141509|NCT02927834|2246008|FG001|Overall Study|Lost to Follow-up|2
1141510|NCT02927834|2246009|FG002|Overall Study|Lost to Follow-up|2
1141511|NCT02927873|2246023|FG000|Overall Study|Lost to Follow-up|0
1141512|NCT02927873|2246024|FG001|Overall Study|Lost to Follow-up|1
1141513|NCT02927873|2246025|FG002|Overall Study|Lost to Follow-up|0
1141514|NCT02927873|2246026|FG003|Overall Study|Lost to Follow-up|0
1141515|NCT02927873|2246027|FG004|Overall Study|Lost to Follow-up|0
1141516|NCT02927873|2246028|FG005|Overall Study|Lost to Follow-up|0
1141517|NCT02927873|2246023|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
1141518|NCT02927873|2246024|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
1141519|NCT02927873|2246025|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
1141520|NCT02927873|2246026|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
1141521|NCT02927873|2246027|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
1141522|NCT02927873|2246028|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
1141523|NCT02927873|2246023|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1141524|NCT02927873|2246024|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1141525|NCT02927873|2246025|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1141526|NCT02927873|2246026|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1141527|NCT02927873|2246027|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1141528|NCT02927873|2246028|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
1141529|NCT02927873|2246023|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
1141530|NCT02927873|2246024|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1
1141531|NCT02927873|2246025|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
1141532|NCT02927873|2246026|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
1141533|NCT02927873|2246027|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
1141534|NCT02927873|2246028|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
1141535|NCT02927873|2246023|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1
1141536|NCT02927873|2246024|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
1141537|NCT02927873|2246025|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
1141538|NCT02927873|2246026|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
1141539|NCT02927873|2246027|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
1141540|NCT02927873|2246028|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
1141541|NCT02927873|2246023|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1
1141542|NCT02927873|2246024|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
1141543|NCT02927873|2246025|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
1141544|NCT02927873|2246026|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
1141545|NCT02927873|2246027|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
1141546|NCT02927873|2246028|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
1141547|NCT02927925|2246042|FG000|Overall Study|Death|16
1141548|NCT02927925|2246042|FG000|Overall Study|Physician Decision|1
1141549|NCT02927925|2246042|FG000|Overall Study|Withdrawal by Subject|11
1141550|NCT02927925|2246042|FG000|Overall Study|Other|3
1141551|NCT02927925|2246042|FG000|Overall Study|Disease progression at clinical cutoff|1
1141552|NCT02927938|2246050|FG000|Overall Study|Death|0
1141553|NCT02927938|2246051|FG001|Overall Study|Death|1
1141554|NCT02927938|2246052|FG002|Overall Study|Death|0
1141555|NCT02927938|2246053|FG003|Overall Study|Death|4
1141556|NCT02927938|2246050|FG000|Overall Study|Early Study Termination|1
1141557|NCT02927938|2246051|FG001|Overall Study|Early Study Termination|5
1141558|NCT02927938|2246052|FG002|Overall Study|Early Study Termination|4
1141559|NCT02927938|2246053|FG003|Overall Study|Early Study Termination|3
1141560|NCT02928029|2246063|FG000|Overall Study|Withdrawal by Subject|0
1141561|NCT02928029|2246064|FG001|Overall Study|Withdrawal by Subject|1
1141562|NCT02928029|2246063|FG000|Overall Study|Radiological progression|1
1141563|NCT02928029|2246064|FG001|Overall Study|Radiological progression|0
1141564|NCT02928029|2246063|FG000|Overall Study|Clinical progression|1
1141565|NCT02928029|2246064|FG001|Overall Study|Clinical progression|2
1141566|NCT02928029|2246063|FG000|Overall Study|AE not related to clinical progression|1
1141567|NCT02928029|2246064|FG001|Overall Study|AE not related to clinical progression|1
901594|NCT00734578|1875089|FG000|Overall Study|Exclusion criteria|1
901595|NCT00734578|1875090|FG001|Overall Study|Exclusion criteria|0
901596|NCT00734578|1875091|FG002|Overall Study|Exclusion criteria|0
1141612|NCT02928770|2246125|FG000|Overall Study|Withdrawal by Subject|2
1141613|NCT02928848|2246131|FG000|Arm 2|Withdrawal by Subject|1
1141614|NCT02928848|2246132|FG001|Arm 2|Withdrawal by Subject|0
1141615|NCT02928952|2246142|FG000|Overall Study|Lost to Follow-up|5
1141616|NCT02928952|2246143|FG001|Overall Study|Lost to Follow-up|5
1141617|NCT02928952|2246142|FG000|Overall Study|Withdrawal by Subject|5
1141618|NCT02928952|2246143|FG001|Overall Study|Withdrawal by Subject|1
1141619|NCT02928952|2246142|FG000|Overall Study|Physician Decision|0
1141620|NCT02928952|2246143|FG001|Overall Study|Physician Decision|1
1141621|NCT02929329|2246151|FG000|Overall Study|Withdrawal by Subject|24
1141622|NCT02929329|2246152|FG001|Overall Study|Withdrawal by Subject|21
1141623|NCT02929329|2246151|FG000|Overall Study|Lost to Follow-up|26
1141624|NCT02929329|2246152|FG001|Overall Study|Lost to Follow-up|20
1141625|NCT02929329|2246151|FG000|Overall Study|Death|1054
1141626|NCT02929329|2246152|FG001|Overall Study|Death|1051
1141627|NCT02929407|2246162|FG000|Overall Study|Adverse Event|1
1141628|NCT02929498|2246169|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
1141629|NCT02929498|2246170|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
1141630|NCT02929498|2246171|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
1141631|NCT02929498|2246169|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
1141632|NCT02929498|2246170|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
1141633|NCT02929498|2246171|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
1141634|NCT02930005|2246213|FG000|Overall Study|Lost to Follow-up|1
1141635|NCT02930005|2246214|FG001|Overall Study|Lost to Follow-up|5
1141636|NCT02930018|2246222|FG000|Overall Study|Lost to Follow-up|1
1141637|NCT02930018|2246223|FG001|Overall Study|Lost to Follow-up|1
1141638|NCT02930018|2246222|FG000|Overall Study|Withdrawal by Subject|5
1141639|NCT02930018|2246223|FG001|Overall Study|Withdrawal by Subject|2
1141640|NCT02930226|2246246|FG000|Overall Study|Technical Problems: Leak in plasma bag|0
1141641|NCT02930226|2246247|FG001|Overall Study|Technical Problems: Leak in plasma bag|0
1141642|NCT02930226|2246248|FG002|Overall Study|Technical Problems: Leak in plasma bag|0
1141643|NCT02930226|2246249|FG003|Overall Study|Technical Problems: Leak in plasma bag|0
1141644|NCT02930226|2246250|FG004|Overall Study|Technical Problems: Leak in plasma bag|1
1141645|NCT02930226|2246251|FG005|Overall Study|Technical Problems: Leak in plasma bag|0
1141646|NCT02930343|2246269|FG000|Overall Study|Lost to Follow-up|9
1141647|NCT02930343|2246270|FG001|Overall Study|Lost to Follow-up|7
1141648|NCT02930837|2246314|FG000|Overall Study|Adverse Event|6
1141649|NCT02930837|2246314|FG000|Overall Study|Lost to Follow-up|5
1141650|NCT02930837|2246314|FG000|Overall Study|Withdrawal by Subject|1
1141651|NCT02930941|2246320|FG000|Overall Study|Lost to Follow-up|1
1141652|NCT02930941|2246321|FG001|Overall Study|Lost to Follow-up|2
1141653|NCT02931396|2246355|FG000|Overall Study|Lost to Follow-up|3
1141654|NCT02931396|2246356|FG001|Overall Study|Lost to Follow-up|0
1141655|NCT02931396|2246355|FG000|Overall Study|Withdrawal by Subject|2
1141656|NCT02931396|2246356|FG001|Overall Study|Withdrawal by Subject|0
1141657|NCT02931539|2246364|FG000|Period 1: Treatment Phase|Investigator discretion|1
1141658|NCT02931539|2246365|FG001|Period 1: Treatment Phase|Investigator discretion|1
1141659|NCT02931539|2246366|FG002|Period 1: Treatment Phase|Investigator discretion|0
1141660|NCT02931539|2246364|FG000|Period 1: Treatment Phase|Adverse Event|5
1141661|NCT02931539|2246365|FG001|Period 1: Treatment Phase|Adverse Event|1
1141662|NCT02931539|2246366|FG002|Period 1: Treatment Phase|Adverse Event|0
1141663|NCT02931539|2246364|FG000|Period 1: Treatment Phase|Lost to Follow-up|1
1141664|NCT02931539|2246365|FG001|Period 1: Treatment Phase|Lost to Follow-up|2
1141665|NCT02931539|2246366|FG002|Period 1: Treatment Phase|Lost to Follow-up|0
1141666|NCT02931539|2246364|FG000|Period 1: Treatment Phase|Death|8
1141667|NCT02931539|2246365|FG001|Period 1: Treatment Phase|Death|24
1141668|NCT02931539|2246366|FG002|Period 1: Treatment Phase|Death|0
1141669|NCT02931539|2246364|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16
1141670|NCT02931539|2246365|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8
1141671|NCT02931539|2246366|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0
1141672|NCT02931539|2246364|FG000|Period 1: Treatment Phase|Protocol Violation|6
1141673|NCT02931539|2246365|FG001|Period 1: Treatment Phase|Protocol Violation|0
1141674|NCT02931539|2246366|FG002|Period 1: Treatment Phase|Protocol Violation|0
1141675|NCT02931539|2246364|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22
1141676|NCT02931539|2246365|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
1141677|NCT02931539|2246366|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
1141678|NCT02931539|2246364|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
1141679|NCT02931539|2246365|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
1141680|NCT02931539|2246366|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2
1141681|NCT02931838|2246395|FG000|Overall Study|Reason not provided by investigator|1
1141682|NCT02931838|2246396|FG001|Overall Study|Reason not provided by investigator|0
1141683|NCT02931838|2246397|FG002|Overall Study|Reason not provided by investigator|1
1141684|NCT02931838|2246398|FG003|Overall Study|Reason not provided by investigator|0
1141685|NCT02931838|2246399|FG004|Overall Study|Reason not provided by investigator|0
1141686|NCT02931838|2246400|FG005|Overall Study|Reason not provided by investigator|0
1141687|NCT02931838|2246395|FG000|Overall Study|Poor/non-compliance|0
1141688|NCT02931838|2246396|FG001|Overall Study|Poor/non-compliance|0
1141689|NCT02931838|2246397|FG002|Overall Study|Poor/non-compliance|1
1141690|NCT02931838|2246398|FG003|Overall Study|Poor/non-compliance|0
1141691|NCT02931838|2246399|FG004|Overall Study|Poor/non-compliance|0
1141692|NCT02931838|2246400|FG005|Overall Study|Poor/non-compliance|0
1141693|NCT02931838|2246395|FG000|Overall Study|Lack of Efficacy|5
1141694|NCT02931838|2246396|FG001|Overall Study|Lack of Efficacy|4
1141695|NCT02931838|2246397|FG002|Overall Study|Lack of Efficacy|0
1141696|NCT02931838|2246398|FG003|Overall Study|Lack of Efficacy|0
1141697|NCT02931838|2246399|FG004|Overall Study|Lack of Efficacy|0
1141698|NCT02931838|2246400|FG005|Overall Study|Lack of Efficacy|1
1141699|NCT02931838|2246395|FG000|Overall Study|Lost to Follow-up|1
1141700|NCT02931838|2246396|FG001|Overall Study|Lost to Follow-up|0
1141701|NCT02931838|2246397|FG002|Overall Study|Lost to Follow-up|1
1141702|NCT02931838|2246398|FG003|Overall Study|Lost to Follow-up|1
1141703|NCT02931838|2246399|FG004|Overall Study|Lost to Follow-up|2
1141704|NCT02931838|2246400|FG005|Overall Study|Lost to Follow-up|0
1141705|NCT02931838|2246395|FG000|Overall Study|Subject request to discontinue treatment|4
1141706|NCT02931838|2246396|FG001|Overall Study|Subject request to discontinue treatment|3
1141707|NCT02931838|2246397|FG002|Overall Study|Subject request to discontinue treatment|3
1141708|NCT02931838|2246398|FG003|Overall Study|Subject request to discontinue treatment|0
1141709|NCT02931838|2246399|FG004|Overall Study|Subject request to discontinue treatment|1
1141710|NCT02931838|2246400|FG005|Overall Study|Subject request to discontinue treatment|0
1141711|NCT02931838|2246395|FG000|Overall Study|Withdrawal by Subject|1
1141712|NCT02931838|2246396|FG001|Overall Study|Withdrawal by Subject|2
1141713|NCT02931838|2246397|FG002|Overall Study|Withdrawal by Subject|0
1141714|NCT02931838|2246398|FG003|Overall Study|Withdrawal by Subject|1
1141715|NCT02931838|2246399|FG004|Overall Study|Withdrawal by Subject|0
1141716|NCT02931838|2246400|FG005|Overall Study|Withdrawal by Subject|0
1141717|NCT02931838|2246395|FG000|Overall Study|Adverse Event|2
1141718|NCT02931838|2246396|FG001|Overall Study|Adverse Event|1
1141719|NCT02931838|2246397|FG002|Overall Study|Adverse Event|2
1141720|NCT02931838|2246398|FG003|Overall Study|Adverse Event|1
1141721|NCT02931838|2246399|FG004|Overall Study|Adverse Event|3
1141722|NCT02931838|2246400|FG005|Overall Study|Adverse Event|1
1141723|NCT02932228|2246421|FG000|Overall Study|Death|8
1141724|NCT02932228|2246422|FG001|Overall Study|Death|23
1141725|NCT02932228|2246421|FG000|Overall Study|not eligible upon chart review|2
1141726|NCT02932228|2246422|FG001|Overall Study|not eligible upon chart review|5
1141727|NCT02932267|2246430|FG000|Overall Study|Withdrawal by Subject|3
1141728|NCT02932267|2246430|FG000|Overall Study|Lost to Follow-up|4
1141729|NCT02932267|2246430|FG000|Overall Study|Pregnancy|1
1141730|NCT02932306|2246436|FG000|Overall Study|Withdrawal by Subject|16
1141731|NCT02932306|2246437|FG001|Overall Study|Withdrawal by Subject|25
1141732|NCT02932306|2246436|FG000|Overall Study|Adverse Event|3
1141733|NCT02932306|2246437|FG001|Overall Study|Adverse Event|0
1141734|NCT02932306|2246436|FG000|Overall Study|Pregnancy|2
1141735|NCT02932306|2246437|FG001|Overall Study|Pregnancy|0
1141736|NCT02932306|2246436|FG000|Overall Study|Protocol Violation|1
1141737|NCT02932306|2246437|FG001|Overall Study|Protocol Violation|1
1141738|NCT02932306|2246436|FG000|Overall Study|Noncompliance with Study Drug|1
1141739|NCT02932306|2246437|FG001|Overall Study|Noncompliance with Study Drug|1
1141740|NCT02932306|2246436|FG000|Overall Study|Lost to Follow-up|36
1141741|NCT02932306|2246437|FG001|Overall Study|Lost to Follow-up|40
1141742|NCT02932306|2246436|FG000|Overall Study|Withdrawal by Parent or Guardian|6
1141743|NCT02932306|2246437|FG001|Overall Study|Withdrawal by Parent or Guardian|8
1141744|NCT02932306|2246436|FG000|Overall Study|Lack of Efficacy|0
1141745|NCT02932306|2246437|FG001|Overall Study|Lack of Efficacy|2
1141746|NCT02932306|2246436|FG000|Overall Study|Worsening condition|2
1141747|NCT02932306|2246437|FG001|Overall Study|Worsening condition|0
1141748|NCT02932306|2246436|FG000|Overall Study|Withdrew due to burning,itching,stinging|1
1141749|NCT02932306|2246437|FG001|Overall Study|Withdrew due to burning,itching,stinging|0
1141750|NCT02932332|2246447|FG000|Overall Study|Withdrawal by Subject|1
1141751|NCT02932332|2246448|FG001|Overall Study|Withdrawal by Subject|1
1141752|NCT02932332|2246449|FG002|Overall Study|Withdrawal by Subject|0
1141753|NCT02932332|2246450|FG003|Overall Study|Withdrawal by Subject|1
1141754|NCT02932332|2246447|FG000|Overall Study|Chest pain|0
1141755|NCT02932332|2246448|FG001|Overall Study|Chest pain|0
1141756|NCT02932332|2246449|FG002|Overall Study|Chest pain|0
1141757|NCT02932332|2246450|FG003|Overall Study|Chest pain|1
1141758|NCT02932332|2246447|FG000|Overall Study|Not Dyspneic cough|1
1141759|NCT02932332|2246448|FG001|Overall Study|Not Dyspneic cough|2
1141760|NCT02932332|2246449|FG002|Overall Study|Not Dyspneic cough|1
1141761|NCT02932332|2246450|FG003|Overall Study|Not Dyspneic cough|0
1141762|NCT02932462|2246462|FG000|Overall Study|Adverse Event|1
1141763|NCT02932462|2246463|FG001|Overall Study|Adverse Event|2
1141764|NCT02932462|2246462|FG000|Overall Study|Lost to Follow-up|4
1141765|NCT02932462|2246463|FG001|Overall Study|Lost to Follow-up|1
1141766|NCT02932462|2246462|FG000|Overall Study|Protocol Violation|0
1141767|NCT02932462|2246463|FG001|Overall Study|Protocol Violation|5
1141768|NCT02932462|2246462|FG000|Overall Study|Withdrawal by Subject|1
1141769|NCT02932462|2246463|FG001|Overall Study|Withdrawal by Subject|4
1141770|NCT02932462|2246462|FG000|Overall Study|Non-Compliance With Study Drug|0
1141771|NCT02932462|2246463|FG001|Overall Study|Non-Compliance With Study Drug|1
1141772|NCT02932462|2246462|FG000|Overall Study|Progressive Disease|1
1141773|NCT02932462|2246463|FG001|Overall Study|Progressive Disease|0
1141774|NCT02932878|2246483|FG000|Overall Study|Due to Lab Results|2
1141775|NCT02932878|2246484|FG001|Overall Study|Due to Lab Results|1
1141776|NCT02932891|2246490|FG000|Overall Study|Lost to Follow-up|2
1141777|NCT02932891|2246490|FG000|Overall Study|HPA Suppress|2
1141778|NCT02932904|2246498|FG000|Overall Study|Reason not Specified|1
1141779|NCT02932904|2246499|FG001|Overall Study|Reason not Specified|0
1141780|NCT02932904|2246500|FG002|Overall Study|Reason not Specified|2
1141781|NCT02932904|2246501|FG003|Overall Study|Reason not Specified|2
1141782|NCT02932904|2246498|FG000|Overall Study|Noncompliance with Study Drug|2
1141783|NCT02932904|2246499|FG001|Overall Study|Noncompliance with Study Drug|3
1141784|NCT02932904|2246500|FG002|Overall Study|Noncompliance with Study Drug|3
1141785|NCT02932904|2246501|FG003|Overall Study|Noncompliance with Study Drug|4
1141786|NCT02932904|2246498|FG000|Overall Study|Pregnancy|0
1141787|NCT02932904|2246499|FG001|Overall Study|Pregnancy|1
1141788|NCT02932904|2246500|FG002|Overall Study|Pregnancy|1
1141789|NCT02932904|2246501|FG003|Overall Study|Pregnancy|0
1141790|NCT02932904|2246498|FG000|Overall Study|Study Termination|0
1141791|NCT02932904|2246499|FG001|Overall Study|Study Termination|1
1141792|NCT02932904|2246500|FG002|Overall Study|Study Termination|0
1141793|NCT02932904|2246501|FG003|Overall Study|Study Termination|0
1141794|NCT02932904|2246498|FG000|Overall Study|Voluntary Withdrawal|2
1141795|NCT02932904|2246499|FG001|Overall Study|Voluntary Withdrawal|1
1141796|NCT02932904|2246500|FG002|Overall Study|Voluntary Withdrawal|4
1141797|NCT02932904|2246501|FG003|Overall Study|Voluntary Withdrawal|2
1141798|NCT02932904|2246498|FG000|Overall Study|Lost to Follow-up|5
1141799|NCT02932904|2246499|FG001|Overall Study|Lost to Follow-up|3
1141800|NCT02932904|2246500|FG002|Overall Study|Lost to Follow-up|6
1141801|NCT02932904|2246501|FG003|Overall Study|Lost to Follow-up|0
1141802|NCT02932904|2246498|FG000|Overall Study|Significant Protocol Deviation|2
1141803|NCT02932904|2246499|FG001|Overall Study|Significant Protocol Deviation|3
1141804|NCT02932904|2246500|FG002|Overall Study|Significant Protocol Deviation|6
1141805|NCT02932904|2246501|FG003|Overall Study|Significant Protocol Deviation|1
1141806|NCT02932904|2246498|FG000|Overall Study|Pretreatment Event/Adverse Event|3
1141807|NCT02932904|2246499|FG001|Overall Study|Pretreatment Event/Adverse Event|5
1141808|NCT02932904|2246500|FG002|Overall Study|Pretreatment Event/Adverse Event|1
1141809|NCT02932904|2246501|FG003|Overall Study|Pretreatment Event/Adverse Event|3
1141810|NCT02932904|2246498|FG000|Overall Study|Randomized But Not Treated|1
1141811|NCT02932904|2246499|FG001|Overall Study|Randomized But Not Treated|1
1141812|NCT02932904|2246500|FG002|Overall Study|Randomized But Not Treated|0
1141813|NCT02932904|2246501|FG003|Overall Study|Randomized But Not Treated|2
1141814|NCT02932943|2246516|FG000|Overall Study|Lost to Follow-up|0
1141815|NCT02932943|2246517|FG001|Overall Study|Lost to Follow-up|2
1141816|NCT02932943|2246516|FG000|Overall Study|Adverse Event|2
1141817|NCT02932943|2246517|FG001|Overall Study|Adverse Event|2
1141818|NCT02932943|2246516|FG000|Overall Study|Withdrawal by Subject|3
1141819|NCT02932943|2246517|FG001|Overall Study|Withdrawal by Subject|3
1141820|NCT02933060|2246529|FG000|Overall Study|Withdrawal by Subject|0
1141821|NCT02933060|2246530|FG001|Overall Study|Withdrawal by Subject|1
1141822|NCT02933489|2246577|FG000|Overall Study|Ineligible|3
1141823|NCT02933489|2246578|FG001|Overall Study|Ineligible|3
1141824|NCT02933489|2246577|FG000|Overall Study|Withdrawal by Subject|27
1141825|NCT02933489|2246578|FG001|Overall Study|Withdrawal by Subject|18
1141826|NCT02933489|2246577|FG000|Overall Study|Unable to complete exams (other)|14
1141827|NCT02933489|2246578|FG001|Overall Study|Unable to complete exams (other)|7
1141828|NCT02933528|2246593|FG000|Overall Study|Lost to Follow-up|2
1141829|NCT02934178|2246623|FG000|Received Vaccination 2|Death|0
1141830|NCT02934178|2246624|FG001|Received Vaccination 2|Death|1
1141831|NCT02934178|2246623|FG000|Received Vaccination 3|Withdrawal by Subject|1
1141832|NCT02934178|2246624|FG001|Received Vaccination 3|Withdrawal by Subject|0
1141833|NCT02935192|2246706|FG000|Overall Study|Withdrawal by Subject|8
1141834|NCT02935192|2246707|FG001|Overall Study|Withdrawal by Subject|4
1141835|NCT02935452|2246715|FG000|Overall Study|work and life commintment|3
1141836|NCT02935452|2246716|FG001|Overall Study|work and life commintment|1
1141837|NCT02935673|2246733|FG000|Overall Study|Adverse Event|0
1141838|NCT02935673|2246734|FG001|Overall Study|Adverse Event|1
1141839|NCT02935673|2246735|FG002|Overall Study|Adverse Event|0
1141840|NCT02935673|2246733|FG000|Overall Study|Withdrawal by Subject|1
1141841|NCT02935673|2246734|FG001|Overall Study|Withdrawal by Subject|2
1141842|NCT02935673|2246735|FG002|Overall Study|Withdrawal by Subject|0
1141843|NCT02935842|2246775|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2
1141844|NCT02935842|2246776|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0
1141845|NCT02935842|2246777|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0
1141846|NCT02935842|2246778|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0
1141847|NCT02935842|2246775|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1
1141848|NCT02935842|2246776|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
1141849|NCT02935842|2246777|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
1141850|NCT02935842|2246778|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0
1141851|NCT02935842|2246775|FG000|Testing and Therapy Period 3|Accident prior to treatment|2
1141852|NCT02935842|2246776|FG001|Testing and Therapy Period 3|Accident prior to treatment|2
1141853|NCT02935842|2246777|FG002|Testing and Therapy Period 3|Accident prior to treatment|0
1141854|NCT02935842|2246778|FG003|Testing and Therapy Period 3|Accident prior to treatment|0
1141855|NCT02935842|2246775|FG000|Testing and Therapy Period 3|Lost to Follow-up|0
1141856|NCT02935842|2246776|FG001|Testing and Therapy Period 3|Lost to Follow-up|0
1141857|NCT02935842|2246777|FG002|Testing and Therapy Period 3|Lost to Follow-up|0
1141858|NCT02935842|2246778|FG003|Testing and Therapy Period 3|Lost to Follow-up|1
1141859|NCT02935842|2246775|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0
1141860|NCT02935842|2246776|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0
1141861|NCT02935842|2246777|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3
1141862|NCT02935842|2246778|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0
1141863|NCT02935894|2246795|FG000|Overall Study|Subject dismissed|1
1141864|NCT02936037|2246801|FG000|Double-Blind Treatment Period|Protocol Violation|1
1141865|NCT02936037|2246802|FG001|Double-Blind Treatment Period|Protocol Violation|4
1141866|NCT02936037|2246801|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2
1141867|NCT02936037|2246802|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8
1141868|NCT02936037|2246801|FG000|Double-Blind Treatment Period|Lack of Efficacy|4
1141869|NCT02936037|2246802|FG001|Double-Blind Treatment Period|Lack of Efficacy|12
1141870|NCT02936037|2246801|FG000|Double-Blind Treatment Period|Death|0
1141871|NCT02936037|2246802|FG001|Double-Blind Treatment Period|Death|1
1141872|NCT02936037|2246801|FG000|Double-Blind Treatment Period|Adverse Event|11
1141873|NCT02936037|2246802|FG001|Double-Blind Treatment Period|Adverse Event|11
1141874|NCT02936037|2246801|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31
1141875|NCT02936037|2246802|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28
1141876|NCT02936037|2246801|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
1141877|NCT02936037|2246802|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
1141878|NCT02936037|2246801|FG000|Open Label Extension|Adverse Event|0
1141879|NCT02936037|2246802|FG001|Open Label Extension|Adverse Event|3
1141880|NCT02936037|2246801|FG000|Open Label Extension|Other|0
1141881|NCT02936037|2246802|FG001|Open Label Extension|Other|3
1141882|NCT02936037|2246801|FG000|Open Label Extension|Withdrawal by Subject|0
1141883|NCT02936037|2246802|FG001|Open Label Extension|Withdrawal by Subject|4
1141884|NCT02936635|2246823|FG000|Overall Study|Adverse Event|43
1141885|NCT02936635|2246824|FG001|Overall Study|Adverse Event|25
1141886|NCT02936635|2246823|FG000|Overall Study|Progressive Disease|10
1141887|NCT02936635|2246824|FG001|Overall Study|Progressive Disease|18
1141888|NCT02936635|2246823|FG000|Overall Study|Sponsor Discretion|10
1141889|NCT02936635|2246824|FG001|Overall Study|Sponsor Discretion|16
1141890|NCT02936635|2246823|FG000|Overall Study|Death|9
1141891|NCT02936635|2246824|FG001|Overall Study|Death|15
1141892|NCT02936635|2246823|FG000|Overall Study|Withdrawal by Subject|8
1141893|NCT02936635|2246824|FG001|Overall Study|Withdrawal by Subject|15
1141894|NCT02936635|2246823|FG000|Overall Study|Physician Decision|2
1141895|NCT02936635|2246824|FG001|Overall Study|Physician Decision|9
1141896|NCT02936635|2246823|FG000|Overall Study|Lost to Follow-up|1
1141897|NCT02936635|2246824|FG001|Overall Study|Lost to Follow-up|2
1141898|NCT02936635|2246823|FG000|Overall Study|Protocol Violation|1
1141899|NCT02936635|2246824|FG001|Overall Study|Protocol Violation|0
1141900|NCT02936635|2246823|FG000|Overall Study|Lack of effect/Entry into other study|31
1141901|NCT02936635|2246824|FG001|Overall Study|Lack of effect/Entry into other study|65
1141902|NCT02936869|2246836|FG000|Overall Study|Lost to Follow-up|1
1141903|NCT02936869|2246837|FG001|Overall Study|Lost to Follow-up|3
1141904|NCT02936869|2246836|FG000|Overall Study|Death|0
1141905|NCT02936869|2246837|FG001|Overall Study|Death|1
1141906|NCT02936869|2246836|FG000|Overall Study|Legal Case|0
1141907|NCT02936869|2246837|FG001|Overall Study|Legal Case|1
1141908|NCT02936869|2246836|FG000|Overall Study|Protocol Violation|1
1141909|NCT02936869|2246837|FG001|Overall Study|Protocol Violation|0
1141910|NCT02937350|2246913|FG000|Overall Study|Withdrawal by Subject|0
1141911|NCT02937350|2246914|FG001|Overall Study|Withdrawal by Subject|1
1141912|NCT02937350|2246915|FG002|Overall Study|Withdrawal by Subject|0
1141913|NCT02937454|2246923|FG000|Overall Study|Adverse Event|0
1141914|NCT02937454|2246924|FG001|Overall Study|Adverse Event|1
1141915|NCT02937454|2246923|FG000|Overall Study|Death|98
1141916|NCT02937454|2246924|FG001|Overall Study|Death|95
1141917|NCT02937454|2246923|FG000|Overall Study|Lost to Follow-up|1
1141918|NCT02937454|2246924|FG001|Overall Study|Lost to Follow-up|1
1141919|NCT02937454|2246923|FG000|Overall Study|Physician Decision|0
1141920|NCT02937454|2246924|FG001|Overall Study|Physician Decision|1
1141921|NCT02937454|2246923|FG000|Overall Study|Protocol Violation|6
1141922|NCT02937454|2246924|FG001|Overall Study|Protocol Violation|10
1141923|NCT02937454|2246923|FG000|Overall Study|Withdrawal by Subject|27
1141924|NCT02937454|2246924|FG001|Overall Study|Withdrawal by Subject|15
1141925|NCT02937454|2246923|FG000|Overall Study|Other|8
1141926|NCT02937454|2246924|FG001|Overall Study|Other|5
1141927|NCT02937545|2246942|FG000|Overall Study|Withdrawal by Subject|1
1141928|NCT02937545|2246943|FG001|Overall Study|Withdrawal by Subject|2
1141929|NCT02937545|2246944|FG002|Overall Study|Withdrawal by Subject|6
1141930|NCT02937545|2246945|FG003|Overall Study|Withdrawal by Subject|7
1141931|NCT02937545|2246942|FG000|Overall Study|Lost to Follow-up|1
1141932|NCT02937545|2246943|FG001|Overall Study|Lost to Follow-up|0
1141933|NCT02937545|2246944|FG002|Overall Study|Lost to Follow-up|0
1141934|NCT02937545|2246945|FG003|Overall Study|Lost to Follow-up|0
1141935|NCT02937584|2246966|FG000|Period 1|Adverse Event|1
1141936|NCT02937584|2246967|FG001|Period 1|Adverse Event|2
1141937|NCT02937584|2246966|FG000|Washout|Adverse Event|0
1141938|NCT02937584|2246967|FG001|Washout|Adverse Event|1
1141939|NCT02937636|2246984|FG000|Overall Study|Other (Not specified)|3
1141940|NCT02937636|2246985|FG001|Overall Study|Other (Not specified)|2
1141941|NCT02937701|2246994|FG000|Day 1 to Week 22|Adverse Event|11
1141942|NCT02937701|2246995|FG001|Day 1 to Week 22|Adverse Event|14
1141943|NCT02937701|2246996|FG002|Day 1 to Week 22|Adverse Event|0
1141944|NCT02937701|2246997|FG003|Day 1 to Week 22|Adverse Event|0
1141945|NCT02937701|2246998|FG004|Day 1 to Week 22|Adverse Event|0
1141946|NCT02937701|2246994|FG000|Day 1 to Week 22|Protocol Specified Criteria|7
1141947|NCT02937701|2246995|FG001|Day 1 to Week 22|Protocol Specified Criteria|7
1141948|NCT02937701|2246996|FG002|Day 1 to Week 22|Protocol Specified Criteria|0
1141949|NCT02937701|2246997|FG003|Day 1 to Week 22|Protocol Specified Criteria|0
1141950|NCT02937701|2246998|FG004|Day 1 to Week 22|Protocol Specified Criteria|0
1141951|NCT02937701|2246994|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
1141952|NCT02937701|2246995|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
1141953|NCT02937701|2246996|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
1141954|NCT02937701|2246997|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
1141955|NCT02937701|2246998|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
1141956|NCT02937701|2246994|FG000|Day 1 to Week 22|Withdrawal by Subject|6
1141957|NCT02937701|2246995|FG001|Day 1 to Week 22|Withdrawal by Subject|6
1141958|NCT02937701|2246996|FG002|Day 1 to Week 22|Withdrawal by Subject|0
1141959|NCT02937701|2246997|FG003|Day 1 to Week 22|Withdrawal by Subject|0
1141960|NCT02937701|2246998|FG004|Day 1 to Week 22|Withdrawal by Subject|0
1141961|NCT02937701|2246994|FG000|Day 1 to Week 22|Death|1
1141962|NCT02937701|2246995|FG001|Day 1 to Week 22|Death|1
1141963|NCT02937701|2246996|FG002|Day 1 to Week 22|Death|0
1141964|NCT02937701|2246997|FG003|Day 1 to Week 22|Death|0
1141965|NCT02937701|2246998|FG004|Day 1 to Week 22|Death|0
1141966|NCT02937701|2246994|FG000|Day 1 to Week 22|Protocol Violation|1
1141967|NCT02937701|2246995|FG001|Day 1 to Week 22|Protocol Violation|1
1141968|NCT02937701|2246996|FG002|Day 1 to Week 22|Protocol Violation|0
1141969|NCT02937701|2246997|FG003|Day 1 to Week 22|Protocol Violation|0
1141970|NCT02937701|2246998|FG004|Day 1 to Week 22|Protocol Violation|0
1141971|NCT02937701|2246994|FG000|Day 1 to Week 22|Lost to Follow-up|1
1141972|NCT02937701|2246995|FG001|Day 1 to Week 22|Lost to Follow-up|1
1141973|NCT02937701|2246996|FG002|Day 1 to Week 22|Lost to Follow-up|0
1141974|NCT02937701|2246997|FG003|Day 1 to Week 22|Lost to Follow-up|0
1141975|NCT02937701|2246998|FG004|Day 1 to Week 22|Lost to Follow-up|0
1141976|NCT02937701|2246994|FG000|Day 1 to Week 22|Physician Decision|2
1141977|NCT02937701|2246995|FG001|Day 1 to Week 22|Physician Decision|0
1141978|NCT02937701|2246996|FG002|Day 1 to Week 22|Physician Decision|0
1141979|NCT02937701|2246997|FG003|Day 1 to Week 22|Physician Decision|0
1141980|NCT02937701|2246998|FG004|Day 1 to Week 22|Physician Decision|0
1141981|NCT02937701|2246994|FG000|Day 1 to Week 22|Other|1
1141982|NCT02937701|2246995|FG001|Day 1 to Week 22|Other|0
1141983|NCT02937701|2246996|FG002|Day 1 to Week 22|Other|0
1141984|NCT02937701|2246997|FG003|Day 1 to Week 22|Other|0
1141985|NCT02937701|2246998|FG004|Day 1 to Week 22|Other|0
1141986|NCT02937701|2246994|FG000|Week 22 to Week 50|Adverse Event|0
1141987|NCT02937701|2246995|FG001|Week 22 to Week 50|Adverse Event|0
1141988|NCT02937701|2246996|FG002|Week 22 to Week 50|Adverse Event|10
1141989|NCT02937701|2246997|FG003|Week 22 to Week 50|Adverse Event|3
1141990|NCT02937701|2246998|FG004|Week 22 to Week 50|Adverse Event|3
1141991|NCT02937701|2246994|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
1141992|NCT02937701|2246995|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
1141993|NCT02937701|2246996|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
1141994|NCT02937701|2246997|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
1141995|NCT02937701|2246998|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
1141996|NCT02937701|2246994|FG000|Week 22 to Week 50|Withdrawal by Subject|0
1141997|NCT02937701|2246995|FG001|Week 22 to Week 50|Withdrawal by Subject|0
1141998|NCT02937701|2246996|FG002|Week 22 to Week 50|Withdrawal by Subject|8
1141999|NCT02937701|2246997|FG003|Week 22 to Week 50|Withdrawal by Subject|2
1142000|NCT02937701|2246998|FG004|Week 22 to Week 50|Withdrawal by Subject|1
1142001|NCT02937701|2246994|FG000|Week 22 to Week 50|Lost to Follow-up|0
1142002|NCT02937701|2246995|FG001|Week 22 to Week 50|Lost to Follow-up|0
1142003|NCT02937701|2246996|FG002|Week 22 to Week 50|Lost to Follow-up|2
1142004|NCT02937701|2246997|FG003|Week 22 to Week 50|Lost to Follow-up|0
1142005|NCT02937701|2246998|FG004|Week 22 to Week 50|Lost to Follow-up|1
1142006|NCT02937701|2246994|FG000|Week 22 to Week 50|Physician Decision|0
1142007|NCT02937701|2246995|FG001|Week 22 to Week 50|Physician Decision|0
1142008|NCT02937701|2246996|FG002|Week 22 to Week 50|Physician Decision|2
1142009|NCT02937701|2246997|FG003|Week 22 to Week 50|Physician Decision|0
1142010|NCT02937701|2246998|FG004|Week 22 to Week 50|Physician Decision|1
1142011|NCT02937701|2246994|FG000|Week 22 to Week 50|Other|0
1142012|NCT02937701|2246995|FG001|Week 22 to Week 50|Other|0
1142013|NCT02937701|2246996|FG002|Week 22 to Week 50|Other|0
1142014|NCT02937701|2246997|FG003|Week 22 to Week 50|Other|0
1142015|NCT02937701|2246998|FG004|Week 22 to Week 50|Other|1
1142016|NCT02937740|2247012|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
1142017|NCT02937740|2247013|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
1142018|NCT02937740|2247012|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0
1142019|NCT02937740|2247013|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10
1142020|NCT02937740|2247012|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
1142021|NCT02937740|2247013|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
1142022|NCT02937740|2247012|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
1142023|NCT02937740|2247013|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
1142024|NCT02937740|2247012|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
1142025|NCT02937740|2247013|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
1142026|NCT02937740|2247012|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
1142027|NCT02937740|2247013|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
1142028|NCT02937870|2247034|FG000|Overall Study|Adverse Event|1
1142029|NCT02937870|2247034|FG000|Overall Study|Protocol Deviation|2
1142030|NCT02938520|2247108|FG000|Overall Study|On-going at the time of analysis|258
1142031|NCT02938520|2247109|FG001|Overall Study|On-going at the time of analysis|261
1142032|NCT02938520|2247108|FG000|Overall Study|Physician Decision|2
1142033|NCT02938520|2247109|FG001|Overall Study|Physician Decision|5
1142034|NCT02938520|2247108|FG000|Overall Study|Lost to Follow-up|2
1142035|NCT02938520|2247109|FG001|Overall Study|Lost to Follow-up|2
1142036|NCT02938520|2247108|FG000|Overall Study|Withdrawal by Subject|7
1142037|NCT02938520|2247109|FG001|Overall Study|Withdrawal by Subject|7
1142038|NCT02938520|2247108|FG000|Overall Study|Protocol Violation|0
1142039|NCT02938520|2247109|FG001|Overall Study|Protocol Violation|1
1142040|NCT02938520|2247108|FG000|Overall Study|Lack of Efficacy|5
1142041|NCT02938520|2247109|FG001|Overall Study|Lack of Efficacy|3
1142042|NCT02938520|2247108|FG000|Overall Study|Adverse Event|9
1142043|NCT02938520|2247109|FG001|Overall Study|Adverse Event|4
1142044|NCT02938585|2247122|FG000|Overall Study|Withdrawal by parent or guardian|0
1142045|NCT02938585|2247123|FG001|Overall Study|Withdrawal by parent or guardian|1
1142046|NCT02938585|2247124|FG002|Overall Study|Withdrawal by parent or guardian|0
1142047|NCT02938585|2247125|FG003|Overall Study|Withdrawal by parent or guardian|0
1142048|NCT02938585|2247122|FG000|Overall Study|Withdrawal by Subject|0
1142049|NCT02938585|2247123|FG001|Overall Study|Withdrawal by Subject|0
1142050|NCT02938585|2247124|FG002|Overall Study|Withdrawal by Subject|0
1142051|NCT02938585|2247125|FG003|Overall Study|Withdrawal by Subject|5
1142052|NCT02939014|2247160|FG000|Overall Study|Lost to Follow-up|1
1142053|NCT02939014|2247161|FG001|Overall Study|Lost to Follow-up|0
1142054|NCT02939014|2247160|FG000|Overall Study|Death|4
1142055|NCT02939014|2247161|FG001|Overall Study|Death|3
1142056|NCT02939079|2247170|FG000|Overall Study|Adverse Event|2
1142057|NCT02939079|2247171|FG001|Overall Study|Adverse Event|1
1142058|NCT02939079|2247170|FG000|Overall Study|Lost to Follow-up|0
1142059|NCT02939079|2247171|FG001|Overall Study|Lost to Follow-up|2
1142060|NCT02939079|2247170|FG000|Overall Study|Protocol Violation|1
1142061|NCT02939079|2247171|FG001|Overall Study|Protocol Violation|0
1142062|NCT02939079|2247170|FG000|Overall Study|Withdrawal by Subject|0
1142063|NCT02939079|2247171|FG001|Overall Study|Withdrawal by Subject|1
1142064|NCT02939079|2247170|FG000|Overall Study|relapse during the study|1
1142065|NCT02939079|2247171|FG001|Overall Study|relapse during the study|1
1142066|NCT02939131|2247184|FG000|Overall Study|Unable to get to clinic|6
1142067|NCT02939131|2247185|FG001|Overall Study|Unable to get to clinic|4
1142068|NCT02939131|2247184|FG000|Overall Study|Lost to Follow-up|2
1142069|NCT02939131|2247185|FG001|Overall Study|Lost to Follow-up|4
1142070|NCT02939131|2247184|FG000|Overall Study|severe debilitation|1
1142071|NCT02939131|2247185|FG001|Overall Study|severe debilitation|0
1142072|NCT02939131|2247184|FG000|Overall Study|Other|0
1142073|NCT02939131|2247185|FG001|Overall Study|Other|1
1142074|NCT02939131|2247184|FG000|Overall Study|not willing to adhere to protocol|2
1142075|NCT02939131|2247185|FG001|Overall Study|not willing to adhere to protocol|0
1142076|NCT02939560|2247235|FG000|Overall Study|Withdrawal by Subject|2
1142077|NCT02939560|2247235|FG000|Overall Study|Protocol Violation|1
1142078|NCT02939599|2247241|FG000|Overall Study|Adverse Event|1
1142079|NCT02939599|2247242|FG001|Overall Study|Adverse Event|0
1142080|NCT02939599|2247241|FG000|Overall Study|Study Terminated By Sponsor|2
1142081|NCT02939599|2247242|FG001|Overall Study|Study Terminated By Sponsor|2
1142082|NCT02939716|2247253|FG000|Overall Study|scanner failure|0
1142083|NCT02939716|2247254|FG001|Overall Study|scanner failure|0
1142084|NCT02939716|2247255|FG002|Overall Study|scanner failure|0
1142085|NCT02939716|2247256|FG003|Overall Study|scanner failure|1
1142086|NCT02939716|2247257|FG004|Overall Study|scanner failure|1
1142087|NCT02939716|2247258|FG005|Overall Study|scanner failure|1
1142088|NCT02939781|2247275|FG000|Overall Study|Protocol Violation|8
1142089|NCT02939781|2247275|FG000|Overall Study|Withdrawal by Subject|1
1142090|NCT02939937|2247282|FG000|Overall Study|Adverse Event|5
1142091|NCT02939937|2247283|FG001|Overall Study|Adverse Event|0
1142092|NCT02939937|2247282|FG000|Overall Study|Lost to Follow-up|1
1142093|NCT02939937|2247283|FG001|Overall Study|Lost to Follow-up|3
1142094|NCT02939950|2247291|FG000|Overall Study|Lost to Follow-up|13
1142095|NCT02939950|2247292|FG001|Overall Study|Lost to Follow-up|16
1142096|NCT02939950|2247291|FG000|Overall Study|Positive slit lamp findings|0
1142097|NCT02939950|2247292|FG001|Overall Study|Positive slit lamp findings|1
1142098|NCT02939950|2247291|FG000|Overall Study|Chalazion upper lid|0
1142099|NCT02939950|2247292|FG001|Overall Study|Chalazion upper lid|1
1142100|NCT02939950|2247291|FG000|Overall Study|Lack of motivation|0
1142101|NCT02939950|2247292|FG001|Overall Study|Lack of motivation|2
1142102|NCT02939950|2247291|FG000|Overall Study|Unacceptable distance lens visual acuity|1
1142103|NCT02939950|2247292|FG001|Overall Study|Unacceptable distance lens visual acuity|1
1142104|NCT02939950|2247291|FG000|Overall Study|Military orders|1
1142105|NCT02939950|2247292|FG001|Overall Study|Military orders|0
1142106|NCT02939950|2247291|FG000|Overall Study|Participant Relocated|5
1142107|NCT02939950|2247292|FG001|Overall Study|Participant Relocated|3
1142108|NCT02939950|2247291|FG000|Overall Study|Study related symptoms|8
1142109|NCT02939950|2247292|FG001|Overall Study|Study related symptoms|8
1142110|NCT02939950|2247291|FG000|Overall Study|Unacceptable lens movement|2
1142111|NCT02939950|2247292|FG001|Overall Study|Unacceptable lens movement|0
1142112|NCT02939950|2247291|FG000|Overall Study|Protocol Violation|6
1142113|NCT02939950|2247292|FG001|Overall Study|Protocol Violation|3
1142114|NCT02939950|2247291|FG000|Overall Study|Physician Decision|2
1142115|NCT02939950|2247292|FG001|Overall Study|Physician Decision|0
1142116|NCT02939950|2247291|FG000|Overall Study|Pregnancy|6
1142117|NCT02939950|2247292|FG001|Overall Study|Pregnancy|7
1142118|NCT02939950|2247291|FG000|Overall Study|Withdrawal by Subject|12
1142119|NCT02939950|2247292|FG001|Overall Study|Withdrawal by Subject|28
1142120|NCT02939950|2247291|FG000|Overall Study|Adverse Event|7
1142121|NCT02939950|2247292|FG001|Overall Study|Adverse Event|3
1142122|NCT02939950|2247291|FG000|Overall Study|Randomized, not dispensed|1
1142123|NCT02939950|2247292|FG001|Overall Study|Randomized, not dispensed|0
1142124|NCT02939950|2247291|FG000|Overall Study|Ineligible at Baseline|2
1142125|NCT02939950|2247292|FG001|Overall Study|Ineligible at Baseline|8
1142126|NCT02940392|2247313|FG000|Overall Study|Lost to Follow-up|3
1142127|NCT02940392|2247313|FG000|Overall Study|Retreatment|3
1142128|NCT02940392|2247313|FG000|Overall Study|Death|2
1142129|NCT02940522|2247319|FG000|Overall Study|Lost to Follow-up|1
1142130|NCT02940522|2247320|FG001|Overall Study|Lost to Follow-up|2
1142131|NCT02940522|2247319|FG000|Overall Study|Withdrawal by Subject|1
1142132|NCT02940522|2247320|FG001|Overall Study|Withdrawal by Subject|0
1142133|NCT02940574|2247328|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
1142134|NCT02940574|2247329|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
1142135|NCT02940574|2247328|FG000|1-year Follow-up|Lost to Follow-up|3
1142136|NCT02940574|2247329|FG001|1-year Follow-up|Lost to Follow-up|4
1142137|NCT02940626|2247341|FG000|Overall Study|Death|40
1142138|NCT02940626|2247342|FG001|Overall Study|Death|32
1142139|NCT02940626|2247341|FG000|Overall Study|Lost to Follow-up|5
1142140|NCT02940626|2247342|FG001|Overall Study|Lost to Follow-up|2
1142141|NCT02940626|2247341|FG000|Overall Study|Withdrawal by Subject|1
1142142|NCT02940626|2247342|FG001|Overall Study|Withdrawal by Subject|0
1142143|NCT02940626|2247341|FG000|Overall Study|Transfer to Hospice Care|1
1142144|NCT02940626|2247342|FG001|Overall Study|Transfer to Hospice Care|0
1142145|NCT02940626|2247341|FG000|Overall Study|Prohibited Concomitant Medication|0
1142146|NCT02940626|2247342|FG001|Overall Study|Prohibited Concomitant Medication|1
1142147|NCT02940691|2247350|FG000|Overall Study|Lost to Follow-up|5
1142148|NCT02940691|2247350|FG000|Overall Study|Incarceration|1
1142149|NCT02940730|2247357|FG000|Intervention 2|Physician Decision|7
1142150|NCT02940730|2247358|FG001|Intervention 2|Physician Decision|0
1142151|NCT02940860|2247366|FG000|Overall Study|Non-serious AE|1
1142152|NCT02940860|2247367|FG001|Overall Study|Non-serious AE|2
1142153|NCT02940860|2247366|FG000|Overall Study|Serious AE|7
1142154|NCT02940860|2247367|FG001|Overall Study|Serious AE|3
1142155|NCT02940860|2247366|FG000|Overall Study|Withdrawal by Subject|19
1142156|NCT02940860|2247367|FG001|Overall Study|Withdrawal by Subject|9
1142157|NCT02940860|2247366|FG000|Overall Study|Lost to Follow-up|13
1142158|NCT02940860|2247367|FG001|Overall Study|Lost to Follow-up|7
1142159|NCT02940860|2247366|FG000|Overall Study|Physician Decision|5
1142160|NCT02940860|2247367|FG001|Overall Study|Physician Decision|3
1142161|NCT02940860|2247366|FG000|Overall Study|Sponsor Decision|0
1142162|NCT02940860|2247367|FG001|Overall Study|Sponsor Decision|1
1142163|NCT02940860|2247366|FG000|Overall Study|Protocol Violation|0
1142164|NCT02940860|2247367|FG001|Overall Study|Protocol Violation|2
1142165|NCT02940860|2247366|FG000|Overall Study|Death|3
1142166|NCT02940860|2247367|FG001|Overall Study|Death|2
1142167|NCT02940860|2247366|FG000|Overall Study|Moved, poor venous access, transport|6
1142168|NCT02940860|2247367|FG001|Overall Study|Moved, poor venous access, transport|4
1142169|NCT02940860|2247366|FG000|Overall Study|Not treated|2
1142170|NCT02940860|2247367|FG001|Overall Study|Not treated|2
1142171|NCT02940886|2247377|FG000|Overall Study|Adverse Event|7
1142172|NCT02940886|2247378|FG001|Overall Study|Adverse Event|3
1142173|NCT02940886|2247377|FG000|Overall Study|Protocol Violation|0
1142174|NCT02940886|2247378|FG001|Overall Study|Protocol Violation|2
1142175|NCT02940886|2247377|FG000|Overall Study|Withdrawal by Subject|28
1142176|NCT02940886|2247378|FG001|Overall Study|Withdrawal by Subject|20
1142177|NCT02940886|2247377|FG000|Overall Study|Death|1
1142178|NCT02940886|2247378|FG001|Overall Study|Death|0
1142179|NCT02940886|2247377|FG000|Overall Study|Lack of Efficacy|1
1142180|NCT02940886|2247378|FG001|Overall Study|Lack of Efficacy|0
1142181|NCT02940886|2247377|FG000|Overall Study|Lost to Follow-up|49
1142182|NCT02940886|2247378|FG001|Overall Study|Lost to Follow-up|21
1142183|NCT02940886|2247377|FG000|Overall Study|Physician Decision|9
1142184|NCT02940886|2247378|FG001|Overall Study|Physician Decision|4
1142185|NCT02940886|2247377|FG000|Overall Study|Sponsor decision|0
1142186|NCT02940886|2247378|FG001|Overall Study|Sponsor decision|1
1142187|NCT02940886|2247377|FG000|Overall Study|No treatment|7
1142188|NCT02940886|2247378|FG001|Overall Study|No treatment|2
1142189|NCT02940886|2247377|FG000|Overall Study|Enrolment error|0
1142190|NCT02940886|2247378|FG001|Overall Study|Enrolment error|1
1142191|NCT02941523|2247392|FG000|Monotherapy|Withdrawal by Subject|0
1142192|NCT02941523|2247393|FG001|Monotherapy|Withdrawal by Subject|1
1142193|NCT02941523|2247392|FG000|Carboplatin Combination Therapy|Adverse Event|0
1142194|NCT02941523|2247393|FG001|Carboplatin Combination Therapy|Adverse Event|1
1142195|NCT02941523|2247392|FG000|Carboplatin Combination Therapy|Death|1
1142196|NCT02941523|2247393|FG001|Carboplatin Combination Therapy|Death|2
1142197|NCT02941523|2247392|FG000|Carboplatin Combination Therapy|Disease progression|2
1142198|NCT02941523|2247393|FG001|Carboplatin Combination Therapy|Disease progression|0
1142199|NCT02941523|2247392|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2
1142200|NCT02941523|2247393|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1
1142201|NCT02941627|2247418|FG000|Overall Study|Death|1
1142202|NCT02941627|2247418|FG000|Overall Study|Surgical failure|1
1142203|NCT02941627|2247418|FG000|Overall Study|cholesteatoma prevented implantation|1
1142221|NCT02942264|2247493|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0
1142222|NCT02942264|2247494|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1
1142223|NCT02942264|2247495|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0
1142224|NCT02942264|2247496|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0
1142225|NCT02942264|2247497|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0
1142226|NCT02942264|2247498|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0
1142227|NCT02942264|2247499|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1
1142228|NCT02942264|2247500|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0
1142229|NCT02942264|2247501|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0
1142230|NCT02942264|2247493|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
1142231|NCT02942264|2247494|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
1142232|NCT02942264|2247495|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
1142233|NCT02942264|2247496|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
1142234|NCT02942264|2247497|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
1142235|NCT02942264|2247498|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
1142236|NCT02942264|2247499|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
1142237|NCT02942264|2247500|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
1142238|NCT02942264|2247501|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1
1142239|NCT02942407|2247528|FG000|Overall Study|Lost to Follow-up|3
1142240|NCT02942407|2247529|FG001|Overall Study|Lost to Follow-up|2
1142241|NCT02942407|2247528|FG000|Overall Study|Withdrawal by Subject|7
1142242|NCT02942407|2247529|FG001|Overall Study|Withdrawal by Subject|9
1142243|NCT02942407|2247528|FG000|Overall Study|Death|16
1142244|NCT02942407|2247529|FG001|Overall Study|Death|13
1142245|NCT02942485|2247545|FG000|Overall Study|Lost to Follow-up|1
1142246|NCT02942485|2247546|FG001|Overall Study|Lost to Follow-up|0
1142247|NCT02942576|2247554|FG000|Overall Study|Adverse Event|28
1142248|NCT02942576|2247555|FG001|Overall Study|Adverse Event|6
1142249|NCT02942576|2247554|FG000|Overall Study|Withdrawal by Subject|7
1142250|NCT02942576|2247555|FG001|Overall Study|Withdrawal by Subject|5
1142251|NCT02942576|2247554|FG000|Overall Study|Physician Decision|1
1142252|NCT02942576|2247555|FG001|Overall Study|Physician Decision|4
1142253|NCT02942576|2247554|FG000|Overall Study|Other|10
1142254|NCT02942576|2247555|FG001|Overall Study|Other|8
1142255|NCT02942771|2247573|FG000|Overall Study|Adverse Event|1
1142256|NCT02942771|2247574|FG001|Overall Study|Adverse Event|0
1142257|NCT02942771|2247575|FG002|Overall Study|Adverse Event|0
1142258|NCT02942771|2247576|FG003|Overall Study|Adverse Event|0
1142259|NCT02942771|2247577|FG004|Overall Study|Adverse Event|2
1142260|NCT02942771|2247573|FG000|Overall Study|Lost to Follow-up|1
1142261|NCT02942771|2247574|FG001|Overall Study|Lost to Follow-up|0
1142262|NCT02942771|2247575|FG002|Overall Study|Lost to Follow-up|0
1142263|NCT02942771|2247576|FG003|Overall Study|Lost to Follow-up|0
1142264|NCT02942771|2247577|FG004|Overall Study|Lost to Follow-up|0
1142265|NCT02942771|2247573|FG000|Overall Study|Withdrawal by Subject|1
1142266|NCT02942771|2247574|FG001|Overall Study|Withdrawal by Subject|0
1142267|NCT02942771|2247575|FG002|Overall Study|Withdrawal by Subject|0
1142268|NCT02942771|2247576|FG003|Overall Study|Withdrawal by Subject|0
1142269|NCT02942771|2247577|FG004|Overall Study|Withdrawal by Subject|2
1142270|NCT02943070|2247602|FG000|Overall Study|Physician Decision|1
1142271|NCT02943070|2247602|FG000|Overall Study|Adverse Event|2
1142272|NCT02943070|2247602|FG000|Overall Study|Death|2
1142273|NCT02943070|2247602|FG000|Overall Study|Withdrawal by Subject|3
1142274|NCT02943070|2247602|FG000|Overall Study|Lost to Follow-up|4
1142275|NCT02943070|2247602|FG000|Overall Study|Retreatment or TURP|13
1142276|NCT02943070|2247602|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18
1142277|NCT02943096|2247615|FG000|Overall Study|Lack of Efficacy|0
1142278|NCT02943096|2247616|FG001|Overall Study|Lack of Efficacy|1
1142279|NCT02943447|2247640|FG000|Blinded Study Phase|Withdrew Consent|1
1142280|NCT02943447|2247641|FG001|Blinded Study Phase|Withdrew Consent|2
1142281|NCT02943447|2247642|FG002|Blinded Study Phase|Withdrew Consent|1
1142282|NCT02943447|2247640|FG000|Blinded Study Phase|Adverse Event|3
1142283|NCT02943447|2247641|FG001|Blinded Study Phase|Adverse Event|0
1142284|NCT02943447|2247642|FG002|Blinded Study Phase|Adverse Event|0
1142285|NCT02943447|2247640|FG000|Blinded Study Phase|Investigator's discretion|1
1142286|NCT02943447|2247641|FG001|Blinded Study Phase|Investigator's discretion|0
1142287|NCT02943447|2247642|FG002|Blinded Study Phase|Investigator's discretion|0
1142288|NCT02943447|2247640|FG000|Open-Label Extension Phase|Study terminated by sponsor|10
1142289|NCT02943447|2247641|FG001|Open-Label Extension Phase|Study terminated by sponsor|12
1142290|NCT02943447|2247642|FG002|Open-Label Extension Phase|Study terminated by sponsor|6
1142291|NCT02943447|2247640|FG000|Open-Label Extension Phase|Adverse Event|4
1142292|NCT02943447|2247641|FG001|Open-Label Extension Phase|Adverse Event|7
1142293|NCT02943447|2247642|FG002|Open-Label Extension Phase|Adverse Event|3
1142294|NCT02943447|2247640|FG000|Open-Label Extension Phase|Lack of Efficacy|3
1142295|NCT02943447|2247641|FG001|Open-Label Extension Phase|Lack of Efficacy|4
1142296|NCT02943447|2247642|FG002|Open-Label Extension Phase|Lack of Efficacy|0
1142297|NCT02943447|2247640|FG000|Open-Label Extension Phase|Withdrew consent|1
1142298|NCT02943447|2247641|FG001|Open-Label Extension Phase|Withdrew consent|1
1142299|NCT02943447|2247642|FG002|Open-Label Extension Phase|Withdrew consent|1
1142300|NCT02943447|2247640|FG000|Open-Label Extension Phase|Lost to Follow-up|0
1142301|NCT02943447|2247641|FG001|Open-Label Extension Phase|Lost to Follow-up|1
1142302|NCT02943447|2247642|FG002|Open-Label Extension Phase|Lost to Follow-up|0
1142303|NCT02943460|2247662|FG000|Blinded Study Phase|Adverse Event|3
1142304|NCT02943460|2247663|FG001|Blinded Study Phase|Adverse Event|0
1142305|NCT02943460|2247664|FG002|Blinded Study Phase|Adverse Event|0
1142306|NCT02943460|2247662|FG000|Blinded Study Phase|Withdrew Consent|0
1142307|NCT02943460|2247663|FG001|Blinded Study Phase|Withdrew Consent|1
1142308|NCT02943460|2247664|FG002|Blinded Study Phase|Withdrew Consent|0
1142309|NCT02943460|2247662|FG000|Open Label Extension (OLE) Phase|Adverse Event|2
1142310|NCT02943460|2247663|FG001|Open Label Extension (OLE) Phase|Adverse Event|5
1142311|NCT02943460|2247664|FG002|Open Label Extension (OLE) Phase|Adverse Event|2
1142312|NCT02943460|2247662|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2
1142313|NCT02943460|2247663|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1
1142314|NCT02943460|2247664|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0
1142315|NCT02943460|2247662|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1
1142316|NCT02943460|2247663|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1
1142317|NCT02943460|2247664|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0
1142318|NCT02943473|2247673|FG000|Overall Study|enrolled but not dosed|1
1142319|NCT02943473|2247673|FG000|Overall Study|screen failure|1
1142320|NCT02943473|2247673|FG000|Overall Study|Physician Decision|4
1142321|NCT02943564|2247689|FG000|Overall Study|Miscellaneous Reasons|0
1142322|NCT02943564|2247690|FG001|Overall Study|Miscellaneous Reasons|0
1142323|NCT02943564|2247691|FG002|Overall Study|Miscellaneous Reasons|3
1142324|NCT02943564|2247689|FG000|Overall Study|Site terminated by sponsor|0
1142325|NCT02943564|2247690|FG001|Overall Study|Site terminated by sponsor|1
1142326|NCT02943564|2247691|FG002|Overall Study|Site terminated by sponsor|0
901597|NCT00734591|1875101|FG000|Screening for Prospective Period|Site did not participate|1604
901598|NCT00734591|1875102|FG001|Screening for Prospective Period|Site did not participate|1488
901599|NCT00734591|1875101|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913
901600|NCT00734591|1875102|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803
1142327|NCT02943564|2247689|FG000|Overall Study|Non-compliance with study drug|0
1142328|NCT02943564|2247690|FG001|Overall Study|Non-compliance with study drug|1
1142329|NCT02943564|2247691|FG002|Overall Study|Non-compliance with study drug|0
1142330|NCT02943564|2247689|FG000|Overall Study|Pregnancy|0
1142331|NCT02943564|2247690|FG001|Overall Study|Pregnancy|1
1142332|NCT02943564|2247691|FG002|Overall Study|Pregnancy|1
1142333|NCT02943564|2247689|FG000|Overall Study|Protocol Violation|2
1142334|NCT02943564|2247690|FG001|Overall Study|Protocol Violation|2
1142335|NCT02943564|2247691|FG002|Overall Study|Protocol Violation|2
1142336|NCT02943564|2247689|FG000|Overall Study|Lost to Follow-up|1
1142337|NCT02943564|2247690|FG001|Overall Study|Lost to Follow-up|0
1142338|NCT02943564|2247691|FG002|Overall Study|Lost to Follow-up|0
1142339|NCT02943564|2247689|FG000|Overall Study|Withdrawal by Subject|6
1142340|NCT02943564|2247690|FG001|Overall Study|Withdrawal by Subject|5
1142341|NCT02943564|2247691|FG002|Overall Study|Withdrawal by Subject|2
1142342|NCT02943564|2247689|FG000|Overall Study|Adverse Event|1
1142343|NCT02943564|2247690|FG001|Overall Study|Adverse Event|2
1142344|NCT02943564|2247691|FG002|Overall Study|Adverse Event|1
1142345|NCT02943564|2247689|FG000|Overall Study|Lack of Efficacy|0
1142346|NCT02943564|2247690|FG001|Overall Study|Lack of Efficacy|1
1142347|NCT02943564|2247691|FG002|Overall Study|Lack of Efficacy|0
1142348|NCT02943577|2247701|FG000|Overall Study|Protocol Violation|0
1142349|NCT02943577|2247702|FG001|Overall Study|Protocol Violation|1
1142350|NCT02943577|2247701|FG000|Overall Study|Adverse Event|3
1142351|NCT02943577|2247702|FG001|Overall Study|Adverse Event|2
1142352|NCT02943577|2247701|FG000|Overall Study|Lost to Follow-up|0
1142353|NCT02943577|2247702|FG001|Overall Study|Lost to Follow-up|1
1142354|NCT02943577|2247701|FG000|Overall Study|Withdrawal by Subject|1
1142355|NCT02943577|2247702|FG001|Overall Study|Withdrawal by Subject|1
1142356|NCT02943577|2247701|FG000|Overall Study|Pregnancy|1
1142357|NCT02943577|2247702|FG001|Overall Study|Pregnancy|0
1142358|NCT02943668|2247708|FG000|Overall Study|Disease Progression|1
1142359|NCT02944383|2247723|FG000|Overall Study|Lost to Follow-up|0
1142360|NCT02944383|2247724|FG001|Overall Study|Lost to Follow-up|0
1142361|NCT02944383|2247725|FG002|Overall Study|Lost to Follow-up|1
1142362|NCT02944383|2247723|FG000|Overall Study|Withdrawal by Subject|1
1142363|NCT02944383|2247724|FG001|Overall Study|Withdrawal by Subject|0
1142364|NCT02944383|2247725|FG002|Overall Study|Withdrawal by Subject|0
1142365|NCT02944448|2247737|FG000|Overall Study|Adverse Event|37
1142366|NCT02944448|2247738|FG001|Overall Study|Adverse Event|6
1142367|NCT02944448|2247737|FG000|Overall Study|Lack of Efficacy|8
1142368|NCT02944448|2247738|FG001|Overall Study|Lack of Efficacy|5
1142369|NCT02944448|2247737|FG000|Overall Study|Lost to Follow-up|3
1142370|NCT02944448|2247738|FG001|Overall Study|Lost to Follow-up|1
1142371|NCT02944448|2247737|FG000|Overall Study|Protocol Violation|25
1142372|NCT02944448|2247738|FG001|Overall Study|Protocol Violation|7
1142373|NCT02944448|2247737|FG000|Overall Study|Withdrawal by Subject|14
1142374|NCT02944448|2247738|FG001|Overall Study|Withdrawal by Subject|4
1142375|NCT02944448|2247737|FG000|Overall Study|Sponsor did not supply drug in time|0
1142376|NCT02944448|2247738|FG001|Overall Study|Sponsor did not supply drug in time|1
1142377|NCT02944448|2247737|FG000|Overall Study|Noncompliant with dosing|1
1142378|NCT02944448|2247738|FG001|Overall Study|Noncompliant with dosing|0
1142379|NCT02944448|2247737|FG000|Overall Study|Abnormal laboratory values|1
1142380|NCT02944448|2247738|FG001|Overall Study|Abnormal laboratory values|0
1142381|NCT02944513|2247751|FG000|Overall Study|Withdrawal by Subject|4
1142382|NCT02944513|2247752|FG001|Overall Study|Withdrawal by Subject|1
1142383|NCT02944656|2247765|FG000|Overall Study|No longer eligible|3
1142384|NCT02944656|2247766|FG001|Overall Study|No longer eligible|0
1142385|NCT02944656|2247765|FG000|Overall Study|Lost to Follow-up|7
1142386|NCT02944656|2247766|FG001|Overall Study|Lost to Follow-up|10
1142387|NCT02944968|2247772|FG000|Overall Study|Subject excluded before study procedure|1
1142388|NCT02944968|2247772|FG000|Overall Study|Subject didn't meet eligibility criteria|2
1142389|NCT02945046|2247779|FG000|Overall Study|Adverse Event|1
1142390|NCT02945046|2247780|FG001|Overall Study|Adverse Event|0
1142391|NCT02945046|2247781|FG002|Overall Study|Adverse Event|2
1142392|NCT02945046|2247779|FG000|Overall Study|Withdrawal by Subject|3
1142393|NCT02945046|2247780|FG001|Overall Study|Withdrawal by Subject|3
1142394|NCT02945046|2247781|FG002|Overall Study|Withdrawal by Subject|3
1142395|NCT02945046|2247779|FG000|Overall Study|Protocol Violation|2
1142396|NCT02945046|2247780|FG001|Overall Study|Protocol Violation|3
1142397|NCT02945046|2247781|FG002|Overall Study|Protocol Violation|2
1142398|NCT02945046|2247779|FG000|Overall Study|Lost to Follow-up|1
1142399|NCT02945046|2247780|FG001|Overall Study|Lost to Follow-up|1
1142400|NCT02945046|2247781|FG002|Overall Study|Lost to Follow-up|0
1142401|NCT02945046|2247779|FG000|Overall Study|Lack of Efficacy|1
1142402|NCT02945046|2247780|FG001|Overall Study|Lack of Efficacy|2
1142403|NCT02945046|2247781|FG002|Overall Study|Lack of Efficacy|1
1142404|NCT02945046|2247779|FG000|Overall Study|Other than specified|5
1142405|NCT02945046|2247780|FG001|Overall Study|Other than specified|4
1142406|NCT02945046|2247781|FG002|Overall Study|Other than specified|7
1142407|NCT02945254|2247795|FG000|Overall Study|Lost to Follow-up|1
1142408|NCT02945254|2247796|FG001|Overall Study|Lost to Follow-up|0
1142409|NCT02945254|2247795|FG000|Overall Study|Withdrawal by Subject|1
1142410|NCT02945254|2247796|FG001|Overall Study|Withdrawal by Subject|0
1142411|NCT02945410|2247808|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
1142412|NCT02945410|2247809|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3
1142413|NCT02945410|2247810|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0
1142414|NCT02945410|2247811|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0
1142415|NCT02945410|2247812|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0
1142416|NCT02945410|2247813|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0
1142417|NCT02945410|2247808|FG000|Intervention 1 (5 Days)|Adverse Event|1
1142418|NCT02945410|2247809|FG001|Intervention 1 (5 Days)|Adverse Event|0
1142419|NCT02945410|2247810|FG002|Intervention 1 (5 Days)|Adverse Event|0
1142420|NCT02945410|2247811|FG003|Intervention 1 (5 Days)|Adverse Event|0
1142421|NCT02945410|2247812|FG004|Intervention 1 (5 Days)|Adverse Event|0
1142422|NCT02945410|2247813|FG005|Intervention 1 (5 Days)|Adverse Event|1
1142423|NCT02945410|2247808|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0
1142424|NCT02945410|2247809|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0
1142425|NCT02945410|2247810|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2
1142426|NCT02945410|2247811|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0
1142427|NCT02945410|2247812|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1
1142428|NCT02945410|2247813|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0
1142429|NCT02945657|2247834|FG000|Overall Study|Adverse Event|1
1142430|NCT02945657|2247834|FG000|Overall Study|Withdrawal by Parent/Guardian|3
1142431|NCT02946385|2247899|FG000|Overall Study|Lost to Follow-up|0
1142432|NCT02946385|2247900|FG001|Overall Study|Lost to Follow-up|0
1142433|NCT02946385|2247901|FG002|Overall Study|Lost to Follow-up|3
1142434|NCT02946385|2247902|FG003|Overall Study|Lost to Follow-up|0
1142435|NCT02946385|2247903|FG004|Overall Study|Lost to Follow-up|2
1142436|NCT02946385|2247904|FG005|Overall Study|Lost to Follow-up|1
1142437|NCT02946463|2247926|FG000|Primary Evaluation Period|Physician Decision|0
1142438|NCT02946463|2247927|FG001|Primary Evaluation Period|Physician Decision|1
1142439|NCT02946463|2247926|FG000|Primary Evaluation Period|Withdrawal by Subject|0
1142440|NCT02946463|2247927|FG001|Primary Evaluation Period|Withdrawal by Subject|1
1142441|NCT02946515|2247939|FG000|Overall Study|Lost to Follow-up|2
1142442|NCT02946515|2247940|FG001|Overall Study|Lost to Follow-up|1
1142443|NCT02946580|2247948|FG000|Overall Study|Withdrawal by Subject|1
1142444|NCT02946580|2247949|FG001|Overall Study|Withdrawal by Subject|2
1142445|NCT02946580|2247948|FG000|Overall Study|Adverse Event|0
1142446|NCT02946580|2247949|FG001|Overall Study|Adverse Event|2
1142447|NCT02946580|2247948|FG000|Overall Study|Did not undergo posterior spinal fusion|0
1142448|NCT02946580|2247949|FG001|Overall Study|Did not undergo posterior spinal fusion|1
1142449|NCT02946918|2247964|FG000|Overall Study|Patient unblinded himself|1
1142450|NCT02946918|2247965|FG001|Overall Study|Patient unblinded himself|0
1142451|NCT02946918|2247964|FG000|Overall Study|Physician Decision|0
1142452|NCT02946918|2247965|FG001|Overall Study|Physician Decision|2
1142453|NCT02946918|2247964|FG000|Overall Study|Ran out of study medication|0
1142454|NCT02946918|2247965|FG001|Overall Study|Ran out of study medication|1
1142455|NCT02948582|2248007|FG000|Washout Period 1|Adverse Event|0
1142456|NCT02948582|2248008|FG001|Washout Period 1|Adverse Event|2
1142457|NCT02948582|2248009|FG002|Washout Period 1|Adverse Event|0
1142458|NCT02948582|2248010|FG003|Washout Period 1|Adverse Event|0
1142459|NCT02948582|2248011|FG004|Washout Period 1|Adverse Event|0
1142460|NCT02948582|2248012|FG005|Washout Period 1|Adverse Event|0
1142461|NCT02948582|2248007|FG000|Washout Period 1|Protocol Violation|0
1142462|NCT02948582|2248008|FG001|Washout Period 1|Protocol Violation|0
1142463|NCT02948582|2248009|FG002|Washout Period 1|Protocol Violation|0
1142464|NCT02948582|2248010|FG003|Washout Period 1|Protocol Violation|0
1142465|NCT02948582|2248011|FG004|Washout Period 1|Protocol Violation|0
1142466|NCT02948582|2248012|FG005|Washout Period 1|Protocol Violation|1
1142467|NCT02948582|2248007|FG000|Washout Period 2|Adverse Event|0
1142468|NCT02948582|2248008|FG001|Washout Period 2|Adverse Event|1
1142469|NCT02948582|2248009|FG002|Washout Period 2|Adverse Event|0
1142470|NCT02948582|2248010|FG003|Washout Period 2|Adverse Event|0
1142471|NCT02948582|2248011|FG004|Washout Period 2|Adverse Event|0
1142472|NCT02948582|2248012|FG005|Washout Period 2|Adverse Event|0
1142473|NCT02948582|2248007|FG000|Washout Period 2|personal reasons|0
1142474|NCT02948582|2248008|FG001|Washout Period 2|personal reasons|0
1142475|NCT02948582|2248009|FG002|Washout Period 2|personal reasons|0
1142476|NCT02948582|2248010|FG003|Washout Period 2|personal reasons|1
1142477|NCT02948582|2248011|FG004|Washout Period 2|personal reasons|0
1142478|NCT02948582|2248012|FG005|Washout Period 2|personal reasons|0
1142479|NCT02948582|2248007|FG000|Washout Period 4|Adverse Event|1
1142480|NCT02948582|2248008|FG001|Washout Period 4|Adverse Event|0
1142481|NCT02948582|2248009|FG002|Washout Period 4|Adverse Event|1
1142482|NCT02948582|2248010|FG003|Washout Period 4|Adverse Event|0
1142483|NCT02948582|2248011|FG004|Washout Period 4|Adverse Event|0
1142484|NCT02948582|2248012|FG005|Washout Period 4|Adverse Event|0
1142485|NCT02948634|2248028|FG000|Overall Study|Lack of efficacy and study suspended|10
1142486|NCT02948634|2248029|FG001|Overall Study|Lack of efficacy and study suspended|2
1142487|NCT02948777|2248035|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1
1142488|NCT02948829|2248040|FG000|Overall Study|Withdrawal by Subject|4
1142489|NCT02948829|2248040|FG000|Overall Study|Ongoing (at data cut-off date: 29 May 2018)|195
1142490|NCT02948829|2248040|FG000|Overall Study|Non-Compliance with Study Procedures|1
1142491|NCT02948959|2248061|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0
1142492|NCT02948959|2248062|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2
1142493|NCT02948959|2248061|FG000|52 Weeks Treatment Period|Adverse Event|2
1142494|NCT02948959|2248062|FG001|52 Weeks Treatment Period|Adverse Event|5
1142495|NCT02948959|2248061|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2
1142496|NCT02948959|2248062|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2
1142497|NCT02948959|2248061|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1
1142498|NCT02948959|2248062|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6
1142499|NCT02948959|2248061|FG000|52 Weeks Treatment Period|Randomized by error|0
1142500|NCT02948959|2248062|FG001|52 Weeks Treatment Period|Randomized by error|5
1142501|NCT02948959|2248061|FG000|52 Weeks Treatment Period|Randomized and not treated|0
1142502|NCT02948959|2248062|FG001|52 Weeks Treatment Period|Randomized and not treated|3
1142503|NCT02948959|2248061|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0
1142504|NCT02948959|2248062|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1
1142505|NCT02948959|2248061|FG000|52 Weeks Treatment Period|Change of residence location|0
1142506|NCT02948959|2248062|FG001|52 Weeks Treatment Period|Change of residence location|1
1142507|NCT02948959|2248061|FG000|12 Weeks Follow-up Period|Adverse Event|0
1142508|NCT02948959|2248062|FG001|12 Weeks Follow-up Period|Adverse Event|2
1142509|NCT02948959|2248061|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1
1142510|NCT02948959|2248062|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2
1142511|NCT02948959|2248061|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3
1142512|NCT02948959|2248062|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3
1142513|NCT02948959|2248061|FG000|12 Weeks Follow-up Period|Randomized by error|0
1142514|NCT02948959|2248062|FG001|12 Weeks Follow-up Period|Randomized by error|3
1142515|NCT02948959|2248061|FG000|12 Weeks Follow-up Period|Change of residence location|0
1142516|NCT02948959|2248062|FG001|12 Weeks Follow-up Period|Change of residence location|2
1142517|NCT02948959|2248061|FG000|12 Weeks Follow-up Period|Study site closure|1
1142518|NCT02948959|2248062|FG001|12 Weeks Follow-up Period|Study site closure|0
1142519|NCT02949011|2248079|FG000|Overall Study|Adverse Event|6
1142520|NCT02949011|2248080|FG001|Overall Study|Adverse Event|7
1142521|NCT02949011|2248081|FG002|Overall Study|Adverse Event|3
1142522|NCT02949011|2248079|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
1142523|NCT02949011|2248080|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0
1142524|NCT02949011|2248081|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3
1142525|NCT02949011|2248079|FG000|Overall Study|Protocol Deviation|5
1142526|NCT02949011|2248080|FG001|Overall Study|Protocol Deviation|3
1142527|NCT02949011|2248081|FG002|Overall Study|Protocol Deviation|3
1142528|NCT02949011|2248079|FG000|Overall Study|Lack of Efficacy|0
1142529|NCT02949011|2248080|FG001|Overall Study|Lack of Efficacy|2
1142530|NCT02949011|2248081|FG002|Overall Study|Lack of Efficacy|0
1142531|NCT02949011|2248079|FG000|Overall Study|Withdrawal by Subject|13
1142532|NCT02949011|2248080|FG001|Overall Study|Withdrawal by Subject|13
1142533|NCT02949011|2248081|FG002|Overall Study|Withdrawal by Subject|21
1142534|NCT02949011|2248079|FG000|Overall Study|Lost to Follow-up|7
1142535|NCT02949011|2248080|FG001|Overall Study|Lost to Follow-up|5
1142536|NCT02949011|2248081|FG002|Overall Study|Lost to Follow-up|5
1142537|NCT02949011|2248079|FG000|Overall Study|Death|0
1142538|NCT02949011|2248080|FG001|Overall Study|Death|0
1142539|NCT02949011|2248081|FG002|Overall Study|Death|1
1142540|NCT02949011|2248079|FG000|Overall Study|Miscellaneous|2
1142541|NCT02949011|2248080|FG001|Overall Study|Miscellaneous|4
1142542|NCT02949011|2248081|FG002|Overall Study|Miscellaneous|6
1142543|NCT02949024|2248091|FG000|Overall Study|Withdrawal by Subject|0
1142544|NCT02949024|2248092|FG001|Overall Study|Withdrawal by Subject|1
1142545|NCT02949128|2248100|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
1142546|NCT02949128|2248100|FG000|Initial Evaluation Period|Adverse Event|3
1142547|NCT02949128|2248100|FG000|Initial Evaluation Period|Death|2
1142548|NCT02949128|2248100|FG000|Initial Evaluation Period|Physician Decision|1
1142549|NCT02949128|2248100|FG000|Initial Evaluation Period|Protocol Violation|1
1142550|NCT02949128|2248100|FG000|Extension Period|Physician Decision|1
1142551|NCT02949128|2248100|FG000|Extension Period|Withdrawal by Subject|1
1142552|NCT02949219|2248111|FG000|Overall Study|Withdrawal by Subject|1
1142553|NCT02949271|2248117|FG000|Overall Study|Lack of Efficacy|5
1142554|NCT02949271|2248118|FG001|Overall Study|Lack of Efficacy|4
1142555|NCT02949271|2248117|FG000|Overall Study|Lost to Follow-up|3
1142556|NCT02949271|2248118|FG001|Overall Study|Lost to Follow-up|6
1142557|NCT02949271|2248117|FG000|Overall Study|Physician Decision|5
1142558|NCT02949271|2248118|FG001|Overall Study|Physician Decision|5
1142559|NCT02949271|2248117|FG000|Overall Study|Protocol Violation|6
1142560|NCT02949271|2248118|FG001|Overall Study|Protocol Violation|3
1142561|NCT02949271|2248117|FG000|Overall Study|Withdrawal by Subject|1
1142562|NCT02949271|2248118|FG001|Overall Study|Withdrawal by Subject|0
1142563|NCT02949271|2248117|FG000|Overall Study|Delivered prior to intervention|7
1142564|NCT02949271|2248118|FG001|Overall Study|Delivered prior to intervention|9
1142565|NCT02949271|2248117|FG000|Overall Study|Outside the window for cervical dilation|2
1142566|NCT02949271|2248118|FG001|Overall Study|Outside the window for cervical dilation|3
1142567|NCT02949973|2248178|FG000|Overall Study|Physician Decision|1
1142568|NCT02950545|2248201|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0
1142569|NCT02950545|2248202|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0
1142570|NCT02950545|2248203|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0
1142571|NCT02950545|2248204|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0
1142572|NCT02950545|2248205|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0
1142573|NCT02950545|2248206|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1
1142574|NCT02950545|2248201|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1
1142575|NCT02950545|2248202|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0
1142576|NCT02950545|2248203|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0
1142577|NCT02950545|2248204|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1
901601|NCT00734591|1875101|FG000|Prospective Period|Withdrawal by Subject|11
901602|NCT00734591|1875102|FG001|Prospective Period|Withdrawal by Subject|9
901603|NCT00734591|1875101|FG000|Prospective Period|Lost to Follow-up|37
901604|NCT00734591|1875102|FG001|Prospective Period|Lost to Follow-up|33
901605|NCT00734591|1875101|FG000|Prospective Period|Study Terminated|1
901606|NCT00734591|1875102|FG001|Prospective Period|Study Terminated|0
1142578|NCT02950545|2248205|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0
1142579|NCT02950545|2248206|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1
1142580|NCT02950545|2248201|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0
1142581|NCT02950545|2248202|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0
1142582|NCT02950545|2248203|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0
1142583|NCT02950545|2248204|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0
1142584|NCT02950545|2248205|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1
1142585|NCT02950545|2248206|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0
1142586|NCT02950545|2248201|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1
1142587|NCT02950545|2248202|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0
1142588|NCT02950545|2248203|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0
1142589|NCT02950545|2248204|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0
1142590|NCT02950545|2248205|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0
1142591|NCT02950545|2248206|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0
1142592|NCT02950545|2248201|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0
1142593|NCT02950545|2248202|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0
1142594|NCT02950545|2248203|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0
1142595|NCT02950545|2248204|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0
1142596|NCT02950545|2248205|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0
1142597|NCT02950545|2248206|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1
1142598|NCT02950558|2248214|FG000|Overall Study|Lost to Follow-up|2
1142599|NCT02950558|2248215|FG001|Overall Study|Lost to Follow-up|0
1142600|NCT02950831|2248231|FG000|Overall Study|Lost to Follow-up|1
1142601|NCT02950831|2248231|FG000|Overall Study|Withdrawal by Subject|3
1142602|NCT02950831|2248231|FG000|Overall Study|stimulation trail failure|5
1142619|NCT02951156|2248276|FG000|Overall Study|Death|3
1142620|NCT02951156|2248277|FG001|Overall Study|Death|8
1142621|NCT02951156|2248278|FG002|Overall Study|Death|5
1142622|NCT02951156|2248276|FG000|Overall Study|Progressive disease|1
1142623|NCT02951156|2248277|FG001|Overall Study|Progressive disease|0
1142624|NCT02951156|2248278|FG002|Overall Study|Progressive disease|1
1142625|NCT02951156|2248276|FG000|Overall Study|Withdrawal by Subject|0
1142626|NCT02951156|2248277|FG001|Overall Study|Withdrawal by Subject|0
1142627|NCT02951156|2248278|FG002|Overall Study|Withdrawal by Subject|1
1142628|NCT02951156|2248276|FG000|Overall Study|Study terminated by sponsor|0
1142629|NCT02951156|2248277|FG001|Overall Study|Study terminated by sponsor|0
1142630|NCT02951156|2248278|FG002|Overall Study|Study terminated by sponsor|1
1142631|NCT02951156|2248276|FG000|Overall Study|Other|5
1142632|NCT02951156|2248277|FG001|Overall Study|Other|1
1142633|NCT02951156|2248278|FG002|Overall Study|Other|2
1142634|NCT02951429|2248403|FG000|Overall Study|Adverse Event|3
1142635|NCT02951429|2248404|FG001|Overall Study|Adverse Event|7
1142636|NCT02951429|2248403|FG000|Overall Study|Death|28
1142637|NCT02951429|2248404|FG001|Overall Study|Death|36
1142638|NCT02951429|2248403|FG000|Overall Study|Lack of Efficacy|0
1142639|NCT02951429|2248404|FG001|Overall Study|Lack of Efficacy|1
1142640|NCT02951429|2248403|FG000|Overall Study|Lost to Follow-up|0
1142641|NCT02951429|2248404|FG001|Overall Study|Lost to Follow-up|1
1142642|NCT02951429|2248403|FG000|Overall Study|Lung Transplantation|9
1142643|NCT02951429|2248404|FG001|Overall Study|Lung Transplantation|6
1142644|NCT02951429|2248403|FG000|Overall Study|Other|1
1142645|NCT02951429|2248404|FG001|Overall Study|Other|3
1142646|NCT02951429|2248403|FG000|Overall Study|Progressive Disease|1
1142647|NCT02951429|2248404|FG001|Overall Study|Progressive Disease|1
1142648|NCT02951429|2248403|FG000|Overall Study|Withdrawal by Subject|7
1142649|NCT02951429|2248404|FG001|Overall Study|Withdrawal by Subject|11
1142650|NCT02951429|2248403|FG000|Overall Study|Participant ongoing in the study|23
1142651|NCT02951429|2248404|FG001|Overall Study|Participant ongoing in the study|17
1142652|NCT02951533|2248421|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0
1142653|NCT02951533|2248422|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16
1142654|NCT02951533|2248423|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0
901607|NCT00734591|1875101|FG000|Prospective Period|Other|2
901608|NCT00734591|1875102|FG001|Prospective Period|Other|2
901609|NCT00734604|1875114|FG000|Overall Study|Adverse Event|0
901610|NCT00734604|1875115|FG001|Overall Study|Adverse Event|2
901611|NCT00734604|1875116|FG002|Overall Study|Adverse Event|0
901612|NCT00734604|1875117|FG003|Overall Study|Adverse Event|2
901613|NCT00734604|1875118|FG004|Overall Study|Adverse Event|1
901614|NCT00734604|1875119|FG005|Overall Study|Adverse Event|1
901615|NCT00734604|1875114|FG000|Overall Study|Serious Adverse Event|1
901616|NCT00734604|1875115|FG001|Overall Study|Serious Adverse Event|0
901617|NCT00734604|1875116|FG002|Overall Study|Serious Adverse Event|1
901618|NCT00734604|1875117|FG003|Overall Study|Serious Adverse Event|2
901619|NCT00734604|1875118|FG004|Overall Study|Serious Adverse Event|0
901620|NCT00734604|1875119|FG005|Overall Study|Serious Adverse Event|1
901621|NCT00734604|1875114|FG000|Overall Study|Lost to Follow-up|1
901622|NCT00734604|1875115|FG001|Overall Study|Lost to Follow-up|2
901623|NCT00734604|1875116|FG002|Overall Study|Lost to Follow-up|2
901624|NCT00734604|1875117|FG003|Overall Study|Lost to Follow-up|4
901625|NCT00734604|1875118|FG004|Overall Study|Lost to Follow-up|2
901626|NCT00734604|1875119|FG005|Overall Study|Lost to Follow-up|3
1142655|NCT02951533|2248421|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
1142656|NCT02951533|2248422|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
1142657|NCT02951533|2248423|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
1142658|NCT02951533|2248421|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
1142659|NCT02951533|2248422|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
1142660|NCT02951533|2248423|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
1142661|NCT02951533|2248421|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
1142662|NCT02951533|2248422|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
1142663|NCT02951533|2248423|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
1142664|NCT02951533|2248421|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0
1142665|NCT02951533|2248422|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1
1142666|NCT02951533|2248423|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0
1142667|NCT02951533|2248421|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
1142668|NCT02951533|2248422|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
1142669|NCT02951533|2248423|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
1142670|NCT02951533|2248421|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0
1142671|NCT02951533|2248422|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2
1142672|NCT02951533|2248423|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0
1142673|NCT02951533|2248421|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
1142674|NCT02951533|2248422|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
1142675|NCT02951533|2248423|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
1142676|NCT02951533|2248421|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
1142677|NCT02951533|2248422|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
1142678|NCT02951533|2248423|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
1142679|NCT02951533|2248421|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
1142680|NCT02951533|2248422|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
1142681|NCT02951533|2248423|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
1142682|NCT02951533|2248421|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
1142683|NCT02951533|2248422|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
1142684|NCT02951533|2248423|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
1142689|NCT02951780|2248462|FG000|Period 1|Adverse Event|0
1142690|NCT02951780|2248463|FG001|Period 1|Adverse Event|0
1142691|NCT02951780|2248464|FG002|Period 1|Adverse Event|0
1142692|NCT02951780|2248465|FG003|Period 1|Adverse Event|1
1142693|NCT02951780|2248466|FG004|Period 1|Adverse Event|0
1142694|NCT02951780|2248467|FG005|Period 1|Adverse Event|0
1142695|NCT02951780|2248468|FG006|Period 1|Adverse Event|0
1142696|NCT02951780|2248469|FG007|Period 1|Adverse Event|0
1142697|NCT02951780|2248470|FG008|Period 1|Adverse Event|0
1142698|NCT02951780|2248462|FG000|Period 1|Scheduling Conflicts|0
1142699|NCT02951780|2248463|FG001|Period 1|Scheduling Conflicts|0
1142700|NCT02951780|2248464|FG002|Period 1|Scheduling Conflicts|0
1142701|NCT02951780|2248465|FG003|Period 1|Scheduling Conflicts|0
1142702|NCT02951780|2248466|FG004|Period 1|Scheduling Conflicts|0
1142703|NCT02951780|2248467|FG005|Period 1|Scheduling Conflicts|0
1142704|NCT02951780|2248468|FG006|Period 1|Scheduling Conflicts|0
1142705|NCT02951780|2248469|FG007|Period 1|Scheduling Conflicts|1
1142706|NCT02951780|2248470|FG008|Period 1|Scheduling Conflicts|0
1142707|NCT02951780|2248462|FG000|Period 2|Scheduling Conflicts|0
1142708|NCT02951780|2248463|FG001|Period 2|Scheduling Conflicts|0
1142709|NCT02951780|2248464|FG002|Period 2|Scheduling Conflicts|0
1142710|NCT02951780|2248465|FG003|Period 2|Scheduling Conflicts|0
1142711|NCT02951780|2248466|FG004|Period 2|Scheduling Conflicts|0
1142712|NCT02951780|2248467|FG005|Period 2|Scheduling Conflicts|0
1142713|NCT02951780|2248468|FG006|Period 2|Scheduling Conflicts|0
1142714|NCT02951780|2248469|FG007|Period 2|Scheduling Conflicts|1
1142715|NCT02951780|2248470|FG008|Period 2|Scheduling Conflicts|0
1142716|NCT02951819|2248492|FG000|Overall Study|Death|9
1142717|NCT02951819|2248493|FG001|Overall Study|Death|7
1142718|NCT02951819|2248492|FG000|Overall Study|Withdrawal by Subject|3
1142719|NCT02951819|2248493|FG001|Overall Study|Withdrawal by Subject|0
1142720|NCT02951819|2248492|FG000|Overall Study|Adverse Event|1
1142721|NCT02951819|2248493|FG001|Overall Study|Adverse Event|0
1142722|NCT02951819|2248492|FG000|Overall Study|Lack of Efficacy|4
1142723|NCT02951819|2248493|FG001|Overall Study|Lack of Efficacy|0
1142724|NCT02951819|2248492|FG000|Overall Study|Lost to Follow-up|1
1142725|NCT02951819|2248493|FG001|Overall Study|Lost to Follow-up|0
1142726|NCT02951819|2248492|FG000|Overall Study|Progressive Disease|1
1142727|NCT02951819|2248493|FG001|Overall Study|Progressive Disease|0
1142728|NCT02951819|2248492|FG000|Overall Study|Other|9
1142729|NCT02951819|2248493|FG001|Overall Study|Other|0
1142730|NCT02951988|2248515|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8
1142731|NCT02951988|2248516|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0
1142732|NCT02951988|2248517|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0
1142733|NCT02951988|2248518|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0
1142734|NCT02951988|2248515|FG000|Open-Label Treatment Period|Study terminated by sponsor|9
1142735|NCT02951988|2248516|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
1142736|NCT02951988|2248517|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
1142737|NCT02951988|2248518|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
1142738|NCT02951988|2248515|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2
1142739|NCT02951988|2248516|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0
1142740|NCT02951988|2248517|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0
1142741|NCT02951988|2248518|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0
1142742|NCT02951988|2248515|FG000|Open-Label Treatment Period|Non-compliance with study drug|5
1142743|NCT02951988|2248516|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
1142744|NCT02951988|2248517|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
1142745|NCT02951988|2248518|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
1142746|NCT02951988|2248515|FG000|Open-Label Treatment Period|Protocol Violation|22
1142747|NCT02951988|2248516|FG001|Open-Label Treatment Period|Protocol Violation|0
1142748|NCT02951988|2248517|FG002|Open-Label Treatment Period|Protocol Violation|0
1142749|NCT02951988|2248518|FG003|Open-Label Treatment Period|Protocol Violation|0
1142750|NCT02951988|2248515|FG000|Open-Label Treatment Period|Pregnancy|2
1142751|NCT02951988|2248516|FG001|Open-Label Treatment Period|Pregnancy|0
1142752|NCT02951988|2248517|FG002|Open-Label Treatment Period|Pregnancy|0
1142753|NCT02951988|2248518|FG003|Open-Label Treatment Period|Pregnancy|0
1142754|NCT02951988|2248515|FG000|Open-Label Treatment Period|Lost to Follow-up|28
1142755|NCT02951988|2248516|FG001|Open-Label Treatment Period|Lost to Follow-up|0
1142756|NCT02951988|2248517|FG002|Open-Label Treatment Period|Lost to Follow-up|0
1142757|NCT02951988|2248518|FG003|Open-Label Treatment Period|Lost to Follow-up|0
1142758|NCT02951988|2248515|FG000|Open-Label Treatment Period|Withdrawal by Subject|78
1142759|NCT02951988|2248516|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
1142760|NCT02951988|2248517|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
1142761|NCT02951988|2248518|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
1142762|NCT02951988|2248515|FG000|Open-Label Treatment Period|Lack of Efficacy|49
1142763|NCT02951988|2248516|FG001|Open-Label Treatment Period|Lack of Efficacy|0
1142764|NCT02951988|2248517|FG002|Open-Label Treatment Period|Lack of Efficacy|0
1142765|NCT02951988|2248518|FG003|Open-Label Treatment Period|Lack of Efficacy|0
1142766|NCT02951988|2248515|FG000|Open-Label Treatment Period|Adverse Event|45
1142767|NCT02951988|2248516|FG001|Open-Label Treatment Period|Adverse Event|0
1142768|NCT02951988|2248517|FG002|Open-Label Treatment Period|Adverse Event|0
1142769|NCT02951988|2248518|FG003|Open-Label Treatment Period|Adverse Event|0
1142770|NCT02951988|2248515|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0
1142771|NCT02951988|2248516|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0
1142772|NCT02951988|2248517|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1
1142773|NCT02951988|2248518|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1
1142774|NCT02951988|2248515|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0
1142775|NCT02951988|2248516|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58
1142776|NCT02951988|2248517|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54
1142777|NCT02951988|2248518|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69
1142778|NCT02951988|2248515|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0
1142779|NCT02951988|2248516|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1
1142780|NCT02951988|2248517|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3
1142781|NCT02951988|2248518|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0
1142782|NCT02951988|2248515|FG000|Double-Blind Treatment Period|Protocol Violation|0
1142783|NCT02951988|2248516|FG001|Double-Blind Treatment Period|Protocol Violation|4
1142784|NCT02951988|2248517|FG002|Double-Blind Treatment Period|Protocol Violation|4
1142785|NCT02951988|2248518|FG003|Double-Blind Treatment Period|Protocol Violation|8
1142786|NCT02951988|2248515|FG000|Double-Blind Treatment Period|Pregnancy|0
1142787|NCT02951988|2248516|FG001|Double-Blind Treatment Period|Pregnancy|1
1142788|NCT02951988|2248517|FG002|Double-Blind Treatment Period|Pregnancy|1
1142789|NCT02951988|2248518|FG003|Double-Blind Treatment Period|Pregnancy|0
1142790|NCT02951988|2248515|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
1142791|NCT02951988|2248516|FG001|Double-Blind Treatment Period|Lost to Follow-up|4
1142792|NCT02951988|2248517|FG002|Double-Blind Treatment Period|Lost to Follow-up|12
1142793|NCT02951988|2248518|FG003|Double-Blind Treatment Period|Lost to Follow-up|3
1142794|NCT02951988|2248515|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
1142795|NCT02951988|2248516|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23
1142796|NCT02951988|2248517|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22
1142797|NCT02951988|2248518|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28
1142798|NCT02951988|2248515|FG000|Double-Blind Treatment Period|Adverse Event|0
1142799|NCT02951988|2248516|FG001|Double-Blind Treatment Period|Adverse Event|8
1142800|NCT02951988|2248517|FG002|Double-Blind Treatment Period|Adverse Event|3
1142801|NCT02951988|2248518|FG003|Double-Blind Treatment Period|Adverse Event|6
1142802|NCT02951988|2248515|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0
1142803|NCT02951988|2248516|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2
1142804|NCT02951988|2248517|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1
1142805|NCT02951988|2248518|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0
1142806|NCT02952001|2248530|FG000|Overall Study|Adverse Event|3
1142807|NCT02952001|2248531|FG001|Overall Study|Adverse Event|0
1142808|NCT02952001|2248530|FG000|Overall Study|Prohibited therapy|10
1142809|NCT02952001|2248531|FG001|Overall Study|Prohibited therapy|3
1142810|NCT02952001|2248530|FG000|Overall Study|Due to Posterior Capsular Opacity|1
1142811|NCT02952001|2248531|FG001|Overall Study|Due to Posterior Capsular Opacity|0
1142812|NCT02952261|2248540|FG000|Overall Study|Withdrawal by Subject|4
1142813|NCT02952261|2248541|FG001|Overall Study|Withdrawal by Subject|5
1142814|NCT02952261|2248540|FG000|Overall Study|Protocol Violation|1
1142815|NCT02952261|2248541|FG001|Overall Study|Protocol Violation|0
1142816|NCT02952313|2248547|FG000|Primary Endpoint|Lost to Follow-up|4
1142817|NCT02952313|2248547|FG000|Primary Endpoint|Withdrawal by Subject|1
1142818|NCT02952313|2248547|FG000|Primary Endpoint|Lack of Efficacy|1
1142819|NCT02952313|2248547|FG000|Primary Endpoint|Missed visit|1
1142820|NCT02952313|2248547|FG000|Long-term Follow-up|Lost to Follow-up|12
1142821|NCT02952313|2248547|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7
1142822|NCT02952313|2248547|FG000|Long-term Follow-up|Lack of Efficacy|6
1142823|NCT02952313|2248547|FG000|Long-term Follow-up|Withdrawal by Subject|5
1142824|NCT02952313|2248547|FG000|Long-term Follow-up|Physician Decision|1
1142825|NCT02952313|2248547|FG000|Long-term Follow-up|Death|1
1142826|NCT02952586|2248554|FG000|Lead-In Phase (7 Days)|Death|0
1142827|NCT02952586|2248555|FG001|Lead-In Phase (7 Days)|Death|1
1142828|NCT02952586|2248554|FG000|Lead-In Phase (7 Days)|Adverse Event|3
1142829|NCT02952586|2248555|FG001|Lead-In Phase (7 Days)|Adverse Event|0
1142830|NCT02952586|2248554|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0
1142831|NCT02952586|2248555|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1
1142832|NCT02952586|2248554|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2
1142833|NCT02952586|2248555|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2
1142834|NCT02952586|2248554|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5
1142835|NCT02952586|2248555|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8
1142836|NCT02952586|2248554|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
1142837|NCT02952586|2248555|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
1142838|NCT02952586|2248554|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2
1142839|NCT02952586|2248555|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1
1142840|NCT02952586|2248554|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1
1142841|NCT02952586|2248555|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0
1142842|NCT02952586|2248554|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10
1142843|NCT02952586|2248555|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4
1142844|NCT02952586|2248554|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
1142845|NCT02952586|2248555|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
1142846|NCT02952586|2248554|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2
1142847|NCT02952586|2248555|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1
1142848|NCT02952586|2248554|FG000|CRT for Cisplatin (63 Days)|Death|3
1142849|NCT02952586|2248555|FG001|CRT for Cisplatin (63 Days)|Death|8
1142850|NCT02952586|2248554|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82
1142851|NCT02952586|2248555|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81
1142852|NCT02952586|2248554|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12
1142853|NCT02952586|2248555|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10
1142854|NCT02952586|2248554|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1
1142855|NCT02952586|2248555|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0
1142856|NCT02952586|2248554|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11
1142857|NCT02952586|2248555|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3
1142858|NCT02952586|2248554|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
1142859|NCT02952586|2248555|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
1142860|NCT02952586|2248554|FG000|CRT for Cisplatin (63 Days)|Other|1
1142861|NCT02952586|2248555|FG001|CRT for Cisplatin (63 Days)|Other|1
1142862|NCT02952586|2248554|FG000|CRT for IMRT (63 Days)|Death|5
1142863|NCT02952586|2248555|FG001|CRT for IMRT (63 Days)|Death|8
1142864|NCT02952586|2248554|FG000|CRT for IMRT (63 Days)|Adverse Event|5
1142865|NCT02952586|2248555|FG001|CRT for IMRT (63 Days)|Adverse Event|5
1142866|NCT02952586|2248554|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1
1142867|NCT02952586|2248555|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0
1142868|NCT02952586|2248554|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10
1142869|NCT02952586|2248555|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6
1142870|NCT02952586|2248554|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1
1142871|NCT02952586|2248555|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1
1142872|NCT02952586|2248554|FG000|CRT for IMRT (63 Days)|Other|1
1142873|NCT02952586|2248555|FG001|CRT for IMRT (63 Days)|Other|0
1142874|NCT02952586|2248554|FG000|Maintenance Phase (12 Months)|Death|17
1142875|NCT02952586|2248555|FG001|Maintenance Phase (12 Months)|Death|11
1142876|NCT02952586|2248554|FG000|Maintenance Phase (12 Months)|Progressive disease|60
1142877|NCT02952586|2248555|FG001|Maintenance Phase (12 Months)|Progressive disease|54
1142878|NCT02952586|2248554|FG000|Maintenance Phase (12 Months)|Adverse Event|24
1142879|NCT02952586|2248555|FG001|Maintenance Phase (12 Months)|Adverse Event|21
1142880|NCT02952586|2248554|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
1142881|NCT02952586|2248555|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
1142882|NCT02952586|2248554|FG000|Maintenance Phase (12 Months)|Physician Decision|1
1142883|NCT02952586|2248555|FG001|Maintenance Phase (12 Months)|Physician Decision|1
1142884|NCT02952586|2248554|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14
1142885|NCT02952586|2248555|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5
1142886|NCT02952586|2248554|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31
1142887|NCT02952586|2248555|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25
1142888|NCT02952586|2248554|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1
1142889|NCT02952586|2248555|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2
1142890|NCT02952586|2248554|FG000|Maintenance Phase (12 Months)|Other|2
1142891|NCT02952586|2248555|FG001|Maintenance Phase (12 Months)|Other|1
1142892|NCT02952586|2248554|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1
1142893|NCT02952586|2248555|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6
1142894|NCT02952586|2248554|FG000|Follow-Up Phase (90 Days)|Death|12
1142895|NCT02952586|2248555|FG001|Follow-Up Phase (90 Days)|Death|10
1142896|NCT02952586|2248554|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6
1142897|NCT02952586|2248555|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2
1142898|NCT02952586|2248554|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1
1142899|NCT02952586|2248555|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1
1142900|NCT02952586|2248554|FG000|Follow-Up Phase (90 Days)|Other|7
1142901|NCT02952586|2248555|FG001|Follow-Up Phase (90 Days)|Other|5
1142902|NCT02952586|2248554|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32
1142903|NCT02952586|2248555|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50
1142904|NCT02952586|2248554|FG000|LT Follow-up (up to 45 Months)|Death|51
1142905|NCT02952586|2248555|FG001|LT Follow-up (up to 45 Months)|Death|31
1142906|NCT02952586|2248554|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7
1142907|NCT02952586|2248555|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1
1142908|NCT02952586|2248554|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2
1142909|NCT02952586|2248555|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4
1142910|NCT02952586|2248554|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187
1142911|NCT02952586|2248555|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201
1142912|NCT02952820|2248565|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
1142913|NCT02952820|2248566|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
1142914|NCT02952820|2248567|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
1142915|NCT02952820|2248565|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
1142916|NCT02952820|2248566|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
1142917|NCT02952820|2248567|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
1142918|NCT02952820|2248565|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15
1142919|NCT02952820|2248566|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12
1142920|NCT02952820|2248567|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17
1142921|NCT02952820|2248565|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
1142922|NCT02952820|2248566|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
1142923|NCT02952820|2248567|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
1142924|NCT02952820|2248565|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0
1142925|NCT02952820|2248566|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14
1142926|NCT02952820|2248567|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13
1142927|NCT02952820|2248565|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
1142928|NCT02952820|2248566|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
1142929|NCT02952820|2248567|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
1142930|NCT02952820|2248565|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4
1142931|NCT02952820|2248566|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4
1142932|NCT02952820|2248567|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4
1142933|NCT02952820|2248565|FG000|Active Treatment Period (6 Months)|Adverse Event|0
1142934|NCT02952820|2248566|FG001|Active Treatment Period (6 Months)|Adverse Event|6
1142935|NCT02952820|2248567|FG002|Active Treatment Period (6 Months)|Adverse Event|5
1142936|NCT02952820|2248565|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0
1142937|NCT02952820|2248566|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4
1142938|NCT02952820|2248567|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6
1142939|NCT02952820|2248565|FG000|Active Treatment Period (6 Months)|Subject choice|0
1142940|NCT02952820|2248566|FG001|Active Treatment Period (6 Months)|Subject choice|10
1142941|NCT02952820|2248567|FG002|Active Treatment Period (6 Months)|Subject choice|7
1142942|NCT02952820|2248565|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
1142943|NCT02952820|2248566|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
1142944|NCT02952820|2248567|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
1142945|NCT02952820|2248565|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0
1142946|NCT02952820|2248566|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6
1142947|NCT02952820|2248567|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8
1142948|NCT02952820|2248565|FG000|Active Treatment Period (6 Months)|Other than specified|0
1142949|NCT02952820|2248566|FG001|Active Treatment Period (6 Months)|Other than specified|6
1142950|NCT02952820|2248567|FG002|Active Treatment Period (6 Months)|Other than specified|2
1142951|NCT02952820|2248565|FG000|Active Treatment Period (6 Months)|Not treated|0
1142952|NCT02952820|2248566|FG001|Active Treatment Period (6 Months)|Not treated|0
1142953|NCT02952820|2248567|FG002|Active Treatment Period (6 Months)|Not treated|1
1142954|NCT02952898|2248646|FG000|Overall Study|Withdrawal by Subject|10
1142955|NCT02952898|2248647|FG001|Overall Study|Withdrawal by Subject|8
1142956|NCT02952898|2248648|FG002|Overall Study|Withdrawal by Subject|8
1142957|NCT02952898|2248646|FG000|Overall Study|Adverse Event|8
1142958|NCT02952898|2248647|FG001|Overall Study|Adverse Event|8
1142959|NCT02952898|2248648|FG002|Overall Study|Adverse Event|3
1142960|NCT02952898|2248646|FG000|Overall Study|Lost to Follow-up|3
1142961|NCT02952898|2248647|FG001|Overall Study|Lost to Follow-up|2
1142962|NCT02952898|2248648|FG002|Overall Study|Lost to Follow-up|2
1142963|NCT02952898|2248646|FG000|Overall Study|Non-compliance with study drug|1
1142964|NCT02952898|2248647|FG001|Overall Study|Non-compliance with study drug|1
1142965|NCT02952898|2248648|FG002|Overall Study|Non-compliance with study drug|2
1142966|NCT02953262|2248660|FG000|Overall Study|Used portal during 6 months prior to randomization|3
1142967|NCT02953262|2248661|FG001|Overall Study|Used portal during 6 months prior to randomization|6
1142968|NCT02953262|2248662|FG002|Overall Study|Used portal during 6 months prior to randomization|3
1142969|NCT02953262|2248663|FG003|Overall Study|Used portal during 6 months prior to randomization|3
1142970|NCT02953639|2248705|FG000|Overall Study|Adverse Event|2
1142971|NCT02953639|2248706|FG001|Overall Study|Adverse Event|0
1142972|NCT02953639|2248707|FG002|Overall Study|Adverse Event|1
1142973|NCT02953639|2248705|FG000|Overall Study|Lost to Follow-up|8
1142974|NCT02953639|2248706|FG001|Overall Study|Lost to Follow-up|4
1142975|NCT02953639|2248707|FG002|Overall Study|Lost to Follow-up|3
1142976|NCT02953639|2248705|FG000|Overall Study|Non-Compliance With Study Drug|0
1142977|NCT02953639|2248706|FG001|Overall Study|Non-Compliance With Study Drug|2
1142978|NCT02953639|2248707|FG002|Overall Study|Non-Compliance With Study Drug|1
1142979|NCT02953639|2248705|FG000|Overall Study|Multiple Reasons|1
1142980|NCT02953639|2248706|FG001|Overall Study|Multiple Reasons|0
1142981|NCT02953639|2248707|FG002|Overall Study|Multiple Reasons|1
1142982|NCT02953639|2248705|FG000|Overall Study|Physician Decision|1
1142983|NCT02953639|2248706|FG001|Overall Study|Physician Decision|0
1142984|NCT02953639|2248707|FG002|Overall Study|Physician Decision|0
1142985|NCT02953639|2248705|FG000|Overall Study|Withdrawal by Subject|7
1142986|NCT02953639|2248706|FG001|Overall Study|Withdrawal by Subject|8
1142987|NCT02953639|2248707|FG002|Overall Study|Withdrawal by Subject|10
1142988|NCT02953639|2248705|FG000|Overall Study|Completed or Discontinued information is missing|1
1142989|NCT02953639|2248706|FG001|Overall Study|Completed or Discontinued information is missing|0
1142990|NCT02953639|2248707|FG002|Overall Study|Completed or Discontinued information is missing|0
1142991|NCT02953678|2248717|FG000|Overall Study|Adverse Event|20
1142992|NCT02953678|2248717|FG000|Overall Study|Death|7
1142993|NCT02953678|2248717|FG000|Overall Study|Physician Decision|23
1142994|NCT02953678|2248717|FG000|Overall Study|Progressive Disease of GVHD|7
1142995|NCT02953678|2248717|FG000|Overall Study|Relapse of Underlying Malignancy|3
1142996|NCT02953678|2248717|FG000|Overall Study|Withdrawal by participant|3
1142997|NCT02953678|2248717|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5
1142998|NCT02953678|2248717|FG000|Overall Study|Participants were transferred to commercial product.|3
1142999|NCT02953782|2248730|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5
1143000|NCT02953782|2248731|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2
1143001|NCT02953782|2248732|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
1143002|NCT02953782|2248733|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
1143003|NCT02953782|2248734|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4
1143004|NCT02953782|2248735|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
1143005|NCT02953782|2248736|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
1143006|NCT02953782|2248737|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
1143007|NCT02953782|2248730|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
1143008|NCT02953782|2248731|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
1143009|NCT02953782|2248732|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2
1143010|NCT02953782|2248733|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
1143011|NCT02953782|2248734|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
1143012|NCT02953782|2248735|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
1143013|NCT02953782|2248736|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
1143014|NCT02953782|2248737|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
1143015|NCT02953782|2248730|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
1143016|NCT02953782|2248731|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
1143017|NCT02953782|2248732|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
1143018|NCT02953782|2248733|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
1143019|NCT02953782|2248734|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
1143020|NCT02953782|2248735|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
1143021|NCT02953782|2248736|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
1143022|NCT02953782|2248737|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
1143023|NCT02953782|2248730|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
1143024|NCT02953782|2248731|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
1143025|NCT02953782|2248732|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
1143026|NCT02953782|2248733|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
1143027|NCT02953782|2248734|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
1143028|NCT02953782|2248735|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
1143029|NCT02953782|2248736|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
1143030|NCT02953782|2248737|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
1143031|NCT02953782|2248730|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
1143032|NCT02953782|2248731|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
1143033|NCT02953782|2248732|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
1143034|NCT02953782|2248733|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
1143035|NCT02953782|2248734|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
1143036|NCT02953782|2248735|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14
1143037|NCT02953782|2248736|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11
1143038|NCT02953782|2248737|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8
1143039|NCT02953782|2248730|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
1143040|NCT02953782|2248731|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
1143041|NCT02953782|2248732|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
1143042|NCT02953782|2248733|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
1143043|NCT02953782|2248734|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
1143044|NCT02953782|2248735|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1
1143045|NCT02953782|2248736|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2
1143046|NCT02953782|2248737|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3
1143047|NCT02953782|2248730|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
1143048|NCT02953782|2248731|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
1143049|NCT02953782|2248732|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
1143050|NCT02953782|2248733|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
1143051|NCT02953782|2248734|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
1143052|NCT02953782|2248735|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
1143053|NCT02953782|2248736|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
1143054|NCT02953782|2248737|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4
1143055|NCT02953782|2248730|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
1143056|NCT02953782|2248731|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
1143057|NCT02953782|2248732|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
1143058|NCT02953782|2248733|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
1143059|NCT02953782|2248734|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
1143060|NCT02953782|2248735|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
1143061|NCT02953782|2248736|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1
1143062|NCT02953782|2248737|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
1143063|NCT02953821|2248760|FG000|Overall Study|Adverse Event|0
1143064|NCT02953821|2248761|FG001|Overall Study|Adverse Event|4
1143065|NCT02953821|2248760|FG000|Overall Study|Death|1
1143066|NCT02953821|2248761|FG001|Overall Study|Death|0
1143067|NCT02953821|2248760|FG000|Overall Study|Progressive Disease|5
1143068|NCT02953821|2248761|FG001|Overall Study|Progressive Disease|1
1143069|NCT02953821|2248760|FG000|Overall Study|Lost to Follow-up|2
1143070|NCT02953821|2248761|FG001|Overall Study|Lost to Follow-up|0
1143071|NCT02953821|2248760|FG000|Overall Study|Physician Decision|1
1143072|NCT02953821|2248761|FG001|Overall Study|Physician Decision|1
1143073|NCT02953821|2248760|FG000|Overall Study|Withdrawal by Subject|3
1143074|NCT02953821|2248761|FG001|Overall Study|Withdrawal by Subject|3
1143075|NCT02953821|2248760|FG000|Overall Study|Change of address|0
1143076|NCT02953821|2248761|FG001|Overall Study|Change of address|1
1143077|NCT02953821|2248760|FG000|Overall Study|Lack of Efficacy|1
1143078|NCT02953821|2248761|FG001|Overall Study|Lack of Efficacy|0
1143079|NCT02953821|2248760|FG000|Overall Study|Out of state for indeterminate time|0
1143080|NCT02953821|2248761|FG001|Overall Study|Out of state for indeterminate time|1
1143081|NCT02953821|2248760|FG000|Overall Study|No improvement|0
1143082|NCT02953821|2248761|FG001|Overall Study|No improvement|1
1143083|NCT02953821|2248760|FG000|Overall Study|Refused follow-up visit|2
1143084|NCT02953821|2248761|FG001|Overall Study|Refused follow-up visit|1
1143085|NCT02953938|2248783|FG000|Overall Study|Adverse Event|0
1143086|NCT02953938|2248784|FG001|Overall Study|Adverse Event|1
1143087|NCT02953938|2248783|FG000|Overall Study|Withdrawal by Subject|1
1143088|NCT02953938|2248784|FG001|Overall Study|Withdrawal by Subject|1
1143089|NCT02954172|2248793|FG000|Overall Study|Protocol Violation|3
1143090|NCT02954172|2248794|FG001|Overall Study|Protocol Violation|0
1143091|NCT02954172|2248793|FG000|Overall Study|allergic reaction|2
1143092|NCT02954172|2248794|FG001|Overall Study|allergic reaction|1
1143093|NCT02954172|2248793|FG000|Overall Study|non-measurable lesions at baseline|1
1143094|NCT02954172|2248794|FG001|Overall Study|non-measurable lesions at baseline|2
1143095|NCT02954354|2248813|FG000|Overall Study|Adverse Event|2
1143096|NCT02954354|2248814|FG001|Overall Study|Adverse Event|2
1143097|NCT02954354|2248815|FG002|Overall Study|Adverse Event|4
1143098|NCT02954354|2248813|FG000|Overall Study|Failure to Meet Eligibility Criteria|1
1143099|NCT02954354|2248814|FG001|Overall Study|Failure to Meet Eligibility Criteria|0
1143100|NCT02954354|2248815|FG002|Overall Study|Failure to Meet Eligibility Criteria|0
1143101|NCT02954354|2248813|FG000|Overall Study|Lack of Efficacy|0
1143102|NCT02954354|2248814|FG001|Overall Study|Lack of Efficacy|2
1143103|NCT02954354|2248815|FG002|Overall Study|Lack of Efficacy|0
1143104|NCT02954354|2248813|FG000|Overall Study|Withdrawal by Subject|17
1143105|NCT02954354|2248814|FG001|Overall Study|Withdrawal by Subject|9
1143106|NCT02954354|2248815|FG002|Overall Study|Withdrawal by Subject|11
1143107|NCT02954354|2248813|FG000|Overall Study|Lost to Follow-up|12
1143108|NCT02954354|2248814|FG001|Overall Study|Lost to Follow-up|5
1143109|NCT02954354|2248815|FG002|Overall Study|Lost to Follow-up|0
1143110|NCT02954354|2248813|FG000|Overall Study|Miscellaneous|2
1143111|NCT02954354|2248814|FG001|Overall Study|Miscellaneous|2
1143112|NCT02954354|2248815|FG002|Overall Study|Miscellaneous|1
1143113|NCT02954575|2248846|FG000|Overall Study|Withdrawal by Subject|2
1143114|NCT02954575|2248846|FG000|Overall Study|Adverse Event|1
1143115|NCT02954601|2248858|FG000|First Intervention (Five Days)|Withdrawal by Subject|0
1143116|NCT02954601|2248859|FG001|First Intervention (Five Days)|Withdrawal by Subject|0
1143117|NCT02954601|2248860|FG002|First Intervention (Five Days)|Withdrawal by Subject|1
1143118|NCT02954601|2248861|FG003|First Intervention (Five Days)|Withdrawal by Subject|0
1143119|NCT02954653|2248873|FG000|Overall Study|Death|3
1143120|NCT02954653|2248874|FG001|Overall Study|Death|1
1143121|NCT02954653|2248875|FG002|Overall Study|Death|0
1143122|NCT02954653|2248876|FG003|Overall Study|Death|0
1143123|NCT02954653|2248877|FG004|Overall Study|Death|0
1143124|NCT02954653|2248878|FG005|Overall Study|Death|0
1143125|NCT02954653|2248879|FG006|Overall Study|Death|0
1143126|NCT02954653|2248880|FG007|Overall Study|Death|0
1143127|NCT02954653|2248881|FG008|Overall Study|Death|0
1143128|NCT02954653|2248873|FG000|Overall Study|Randomized but did not receive treatment|1
1143129|NCT02954653|2248874|FG001|Overall Study|Randomized but did not receive treatment|0
1143130|NCT02954653|2248875|FG002|Overall Study|Randomized but did not receive treatment|0
1143131|NCT02954653|2248876|FG003|Overall Study|Randomized but did not receive treatment|0
1143132|NCT02954653|2248877|FG004|Overall Study|Randomized but did not receive treatment|0
1143133|NCT02954653|2248878|FG005|Overall Study|Randomized but did not receive treatment|0
1143134|NCT02954653|2248879|FG006|Overall Study|Randomized but did not receive treatment|0
1143135|NCT02954653|2248880|FG007|Overall Study|Randomized but did not receive treatment|0
1143136|NCT02954653|2248881|FG008|Overall Study|Randomized but did not receive treatment|0
1143137|NCT02954653|2248873|FG000|Overall Study|Started another anti-cancer therapy|0
1143138|NCT02954653|2248874|FG001|Overall Study|Started another anti-cancer therapy|1
1143139|NCT02954653|2248875|FG002|Overall Study|Started another anti-cancer therapy|0
1143140|NCT02954653|2248876|FG003|Overall Study|Started another anti-cancer therapy|0
1143141|NCT02954653|2248877|FG004|Overall Study|Started another anti-cancer therapy|0
1143142|NCT02954653|2248878|FG005|Overall Study|Started another anti-cancer therapy|0
1143143|NCT02954653|2248879|FG006|Overall Study|Started another anti-cancer therapy|0
1143144|NCT02954653|2248880|FG007|Overall Study|Started another anti-cancer therapy|0
1143145|NCT02954653|2248881|FG008|Overall Study|Started another anti-cancer therapy|0
1143146|NCT02954653|2248873|FG000|Overall Study|Treatment failure and consent withdrawal|0
1143147|NCT02954653|2248874|FG001|Overall Study|Treatment failure and consent withdrawal|1
1143148|NCT02954653|2248875|FG002|Overall Study|Treatment failure and consent withdrawal|0
1143149|NCT02954653|2248876|FG003|Overall Study|Treatment failure and consent withdrawal|0
1143150|NCT02954653|2248877|FG004|Overall Study|Treatment failure and consent withdrawal|0
1143151|NCT02954653|2248878|FG005|Overall Study|Treatment failure and consent withdrawal|0
1143152|NCT02954653|2248879|FG006|Overall Study|Treatment failure and consent withdrawal|0
1143153|NCT02954653|2248880|FG007|Overall Study|Treatment failure and consent withdrawal|0
1143154|NCT02954653|2248881|FG008|Overall Study|Treatment failure and consent withdrawal|0
1143155|NCT02954848|2248895|FG000|Overall Study|Randomized but Not Treated|0
1143156|NCT02954848|2248896|FG001|Overall Study|Randomized but Not Treated|1
1143157|NCT02954848|2248895|FG000|Overall Study|Adverse Event|2
1143158|NCT02954848|2248896|FG001|Overall Study|Adverse Event|3
1143159|NCT02954848|2248895|FG000|Overall Study|Withdrawal by Participant|0
1143160|NCT02954848|2248896|FG001|Overall Study|Withdrawal by Participant|1
1143161|NCT02954887|2248902|FG000|Overall Study|Withdrawal by Subject|3
1143162|NCT02954887|2248902|FG000|Overall Study|Lack of Efficacy|3
1143163|NCT02954887|2248902|FG000|Overall Study|Other|1
1143164|NCT02955069|2248908|FG000|Overall Study|Adverse Event|7
1143165|NCT02955069|2248909|FG001|Overall Study|Adverse Event|2
1143166|NCT02955069|2248908|FG000|Overall Study|Death|7
1143167|NCT02955069|2248909|FG001|Overall Study|Death|3
1143168|NCT02955069|2248908|FG000|Overall Study|Physician Decision|10
901627|NCT00734604|1875114|FG000|Overall Study|Physician Decision|0
901628|NCT00734604|1875115|FG001|Overall Study|Physician Decision|1
901629|NCT00734604|1875116|FG002|Overall Study|Physician Decision|1
901630|NCT00734604|1875117|FG003|Overall Study|Physician Decision|0
901631|NCT00734604|1875118|FG004|Overall Study|Physician Decision|0
901632|NCT00734604|1875119|FG005|Overall Study|Physician Decision|0
901633|NCT00734604|1875114|FG000|Overall Study|Protocol Violation|0
901634|NCT00734604|1875115|FG001|Overall Study|Protocol Violation|2
901635|NCT00734604|1875116|FG002|Overall Study|Protocol Violation|0
901636|NCT00734604|1875117|FG003|Overall Study|Protocol Violation|0
1143169|NCT02955069|2248909|FG001|Overall Study|Physician Decision|2
1143170|NCT02955069|2248908|FG000|Overall Study|Progressive disease|64
1143171|NCT02955069|2248909|FG001|Overall Study|Progressive disease|13
1143172|NCT02955069|2248908|FG000|Overall Study|Study terminated by sponsor|4
1143173|NCT02955069|2248909|FG001|Overall Study|Study terminated by sponsor|0
1143174|NCT02955069|2248908|FG000|Overall Study|Subject/Guardian decision|3
1143175|NCT02955069|2248909|FG001|Overall Study|Subject/Guardian decision|1
1143176|NCT02955186|2248923|FG000|Overall Study|Withdrawal by Subject|6
1143177|NCT02955186|2248924|FG001|Overall Study|Withdrawal by Subject|2
1143178|NCT02955186|2248923|FG000|Overall Study|Protocol Violation|1
1143179|NCT02955186|2248924|FG001|Overall Study|Protocol Violation|0
1143180|NCT02955212|2248932|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4
1143181|NCT02955212|2248933|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7
1143182|NCT02955212|2248932|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8
1143183|NCT02955212|2248933|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3
1143184|NCT02955212|2248932|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1
1143185|NCT02955212|2248933|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0
1143186|NCT02955212|2248932|FG000|Period 1: Double-blind Treatment Period|Other|3
1143187|NCT02955212|2248933|FG001|Period 1: Double-blind Treatment Period|Other|2
1143188|NCT02955212|2248932|FG000|Period 2: Open-label Extension|Adverse Event|11
1143189|NCT02955212|2248933|FG001|Period 2: Open-label Extension|Adverse Event|7
1143190|NCT02955212|2248932|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1
1143191|NCT02955212|2248933|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4
1143192|NCT02955212|2248932|FG000|Period 2: Open-label Extension|Lack of Efficacy|3
1143193|NCT02955212|2248933|FG001|Period 2: Open-label Extension|Lack of Efficacy|2
1143194|NCT02955212|2248932|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0
1143195|NCT02955212|2248933|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1
1143196|NCT02955212|2248932|FG000|Period 2: Open-label Extension|Other|2
1143197|NCT02955212|2248933|FG001|Period 2: Open-label Extension|Other|4
1143198|NCT02955797|2248952|FG000|Overall Study|Protocol Violation|1
1143199|NCT02955797|2248953|FG001|Overall Study|Protocol Violation|0
1143200|NCT02955797|2248954|FG002|Overall Study|Protocol Violation|0
1143201|NCT02955797|2248955|FG003|Overall Study|Protocol Violation|1
1143202|NCT02955797|2248952|FG000|Overall Study|Withdrawal by Subject|2
1143203|NCT02955797|2248953|FG001|Overall Study|Withdrawal by Subject|2
1143204|NCT02955797|2248954|FG002|Overall Study|Withdrawal by Subject|0
1143205|NCT02955797|2248955|FG003|Overall Study|Withdrawal by Subject|1
1143206|NCT02955797|2248952|FG000|Overall Study|Lost to Follow-up|0
1143207|NCT02955797|2248953|FG001|Overall Study|Lost to Follow-up|1
1143208|NCT02955797|2248954|FG002|Overall Study|Lost to Follow-up|0
1143209|NCT02955797|2248955|FG003|Overall Study|Lost to Follow-up|0
1143210|NCT02956057|2249001|FG000|Overall Study|Discontinued intervention|14
1143211|NCT02956057|2249002|FG001|Overall Study|Discontinued intervention|10
1143212|NCT02956057|2249003|FG002|Overall Study|Discontinued intervention|7
1143213|NCT02956057|2249004|FG003|Overall Study|Discontinued intervention|14
1143214|NCT02956057|2249005|FG004|Overall Study|Discontinued intervention|4
1143215|NCT02956057|2249006|FG005|Overall Study|Discontinued intervention|17
1143216|NCT02956057|2249001|FG000|Overall Study|Lost to Follow-up|0
1143217|NCT02956057|2249002|FG001|Overall Study|Lost to Follow-up|2
1143218|NCT02956057|2249003|FG002|Overall Study|Lost to Follow-up|1
1143219|NCT02956057|2249004|FG003|Overall Study|Lost to Follow-up|1
1143220|NCT02956057|2249005|FG004|Overall Study|Lost to Follow-up|1
1143221|NCT02956057|2249006|FG005|Overall Study|Lost to Follow-up|0
1143222|NCT02956278|2249043|FG000|Overall Study|Withdrawal by Subject|6
1143223|NCT02956278|2249044|FG001|Overall Study|Withdrawal by Subject|2
1143224|NCT02956278|2249045|FG002|Overall Study|Withdrawal by Subject|0
1143225|NCT02956460|2249068|FG000|Lens 1|Lost to Follow-up|1
1143226|NCT02956460|2249069|FG001|Lens 1|Lost to Follow-up|0
1143227|NCT02956486|2249077|FG000|Core Phase|Adverse Event|51
1143228|NCT02956486|2249078|FG001|Core Phase|Adverse Event|88
1143229|NCT02956486|2249079|FG002|Core Phase|Adverse Event|0
1143230|NCT02956486|2249077|FG000|Core Phase|Lost to Follow-up|8
1143231|NCT02956486|2249078|FG001|Core Phase|Lost to Follow-up|6
1143232|NCT02956486|2249079|FG002|Core Phase|Lost to Follow-up|0
1143233|NCT02956486|2249077|FG000|Core Phase|Inadequate therapeutic effect|4
1143234|NCT02956486|2249078|FG001|Core Phase|Inadequate therapeutic effect|5
1143235|NCT02956486|2249079|FG002|Core Phase|Inadequate therapeutic effect|0
1143236|NCT02956486|2249077|FG000|Core Phase|Withdrawal by Subject|101
1143237|NCT02956486|2249078|FG001|Core Phase|Withdrawal by Subject|104
1143238|NCT02956486|2249079|FG002|Core Phase|Withdrawal by Subject|0
1143239|NCT02956486|2249077|FG000|Core Phase|Study terminated by sponsor|888
1143240|NCT02956486|2249078|FG001|Core Phase|Study terminated by sponsor|848
1143241|NCT02956486|2249079|FG002|Core Phase|Study terminated by sponsor|0
1143242|NCT02956486|2249077|FG000|Core Phase|Other|27
1143243|NCT02956486|2249078|FG001|Core Phase|Other|18
1143244|NCT02956486|2249079|FG002|Core Phase|Other|0
1143245|NCT02956486|2249077|FG000|Core Phase|Not treated|0
1143246|NCT02956486|2249078|FG001|Core Phase|Not treated|3
1143247|NCT02956486|2249079|FG002|Core Phase|Not treated|0
1143248|NCT02956486|2249077|FG000|Extension Phase|Adverse Event|0
1143249|NCT02956486|2249078|FG001|Extension Phase|Adverse Event|0
1143250|NCT02956486|2249079|FG002|Extension Phase|Adverse Event|2
1143251|NCT02956486|2249077|FG000|Extension Phase|Study terminated by sponsor|0
1143252|NCT02956486|2249078|FG001|Extension Phase|Study terminated by sponsor|0
1143253|NCT02956486|2249079|FG002|Extension Phase|Study terminated by sponsor|16
1143254|NCT02956486|2249077|FG000|Extension Phase|Not Treated|0
1143255|NCT02956486|2249078|FG001|Extension Phase|Not Treated|0
1143256|NCT02956486|2249079|FG002|Extension Phase|Not Treated|1
1143257|NCT02956629|2249103|FG000|Overall Study|Adverse Event|0
1143258|NCT02956629|2249104|FG001|Overall Study|Adverse Event|0
1143259|NCT02956629|2249105|FG002|Overall Study|Adverse Event|1
1143260|NCT02956629|2249106|FG003|Overall Study|Adverse Event|0
1143261|NCT02956629|2249107|FG004|Overall Study|Adverse Event|0
1143262|NCT02956629|2249108|FG005|Overall Study|Adverse Event|0
1143263|NCT02956629|2249103|FG000|Overall Study|Lost to Follow-up|2
1143264|NCT02956629|2249104|FG001|Overall Study|Lost to Follow-up|5
1143265|NCT02956629|2249105|FG002|Overall Study|Lost to Follow-up|3
1143266|NCT02956629|2249106|FG003|Overall Study|Lost to Follow-up|1
1143267|NCT02956629|2249107|FG004|Overall Study|Lost to Follow-up|0
1143268|NCT02956629|2249108|FG005|Overall Study|Lost to Follow-up|1
1143269|NCT02956629|2249103|FG000|Overall Study|Withdrawal by Subject|3
1143270|NCT02956629|2249104|FG001|Overall Study|Withdrawal by Subject|1
1143271|NCT02956629|2249105|FG002|Overall Study|Withdrawal by Subject|0
1143272|NCT02956629|2249106|FG003|Overall Study|Withdrawal by Subject|0
1143273|NCT02956629|2249107|FG004|Overall Study|Withdrawal by Subject|0
1143274|NCT02956629|2249108|FG005|Overall Study|Withdrawal by Subject|0
1143275|NCT02956837|2249144|FG000|Overall Study|Serious Adverse Events|0
1143276|NCT02956837|2249145|FG001|Overall Study|Serious Adverse Events|1
1143277|NCT02956837|2249146|FG002|Overall Study|Serious Adverse Events|0
1143278|NCT02956837|2249147|FG003|Overall Study|Serious Adverse Events|0
1143279|NCT02956837|2249144|FG000|Overall Study|Withdrawal by Subject|0
1143280|NCT02956837|2249145|FG001|Overall Study|Withdrawal by Subject|1
1143281|NCT02956837|2249146|FG002|Overall Study|Withdrawal by Subject|0
1143282|NCT02956837|2249147|FG003|Overall Study|Withdrawal by Subject|3
1143283|NCT02956837|2249144|FG000|Overall Study|Lost to Follow-up|0
1143284|NCT02956837|2249145|FG001|Overall Study|Lost to Follow-up|1
1143285|NCT02956837|2249146|FG002|Overall Study|Lost to Follow-up|2
1143286|NCT02956837|2249147|FG003|Overall Study|Lost to Follow-up|0
1143287|NCT02956967|2249160|FG000|Overall Study|Adverse Event|3
1143288|NCT02956967|2249160|FG000|Overall Study|Reason non-related to neutropenia|10
1143289|NCT02956967|2249160|FG000|Overall Study|Lost to Follow-up|5
1143290|NCT02956967|2249160|FG000|Overall Study|Missing|1
1143291|NCT02956967|2249160|FG000|Overall Study|Termination of Nivestim administration|29
1143292|NCT02957136|2249170|FG000|Overall Study|Withdrawal by Subject|2
1143293|NCT02957136|2249171|FG001|Overall Study|Withdrawal by Subject|1
1143294|NCT02957331|2249188|FG000|Overall Study|Protocol Violation|1
1143295|NCT02957331|2249189|FG001|Overall Study|Protocol Violation|0
1143296|NCT02957682|2249213|FG000|Overall Study|Adverse Event|64
1143297|NCT02957682|2249214|FG001|Overall Study|Adverse Event|67
1143298|NCT02957682|2249213|FG000|Overall Study|Poor Compliance to Protocol|30
1143299|NCT02957682|2249214|FG001|Overall Study|Poor Compliance to Protocol|26
1143300|NCT02957682|2249213|FG000|Overall Study|Physician Decision|4
1143301|NCT02957682|2249214|FG001|Overall Study|Physician Decision|4
1143302|NCT02957682|2249213|FG000|Overall Study|Study Terminated by Sponsor|4
1143303|NCT02957682|2249214|FG001|Overall Study|Study Terminated by Sponsor|3
1143304|NCT02957682|2249213|FG000|Overall Study|Subject Moved|10
1143305|NCT02957682|2249214|FG001|Overall Study|Subject Moved|16
1143306|NCT02957682|2249213|FG000|Overall Study|Withdrawal by Subject|64
1143307|NCT02957682|2249214|FG001|Overall Study|Withdrawal by Subject|33
1143308|NCT02957682|2249213|FG000|Overall Study|Related to IMP Administration|3
1143309|NCT02957682|2249214|FG001|Overall Study|Related to IMP Administration|6
1143310|NCT02957682|2249213|FG000|Overall Study|Non-disclosed|16
1143311|NCT02957682|2249214|FG001|Overall Study|Non-disclosed|12
1143312|NCT02957682|2249213|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3
1143313|NCT02957682|2249214|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2
1143314|NCT02957747|2249222|FG000|Overall Study|Withdrawal by Subject|0
1143315|NCT02957747|2249223|FG001|Overall Study|Withdrawal by Subject|3
1143316|NCT02957747|2249222|FG000|Overall Study|Lost to Follow-up|10
1143317|NCT02957747|2249223|FG001|Overall Study|Lost to Follow-up|5
1143318|NCT02957942|2249232|FG000|Overall Study|Withdrawal by Subject|0
1143319|NCT02957942|2249233|FG001|Overall Study|Withdrawal by Subject|1
1143320|NCT02957942|2249232|FG000|Overall Study|Practicing experiment protocol|0
1143321|NCT02957942|2249233|FG001|Overall Study|Practicing experiment protocol|6
1143322|NCT02958267|2249241|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
1143323|NCT02958267|2249242|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
1143324|NCT02958267|2249241|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1
1143325|NCT02958267|2249242|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0
1143326|NCT02958267|2249241|FG000|Follow-up Visits|Additional treatment pursued|2
1143327|NCT02958267|2249242|FG001|Follow-up Visits|Additional treatment pursued|1
1143328|NCT02958527|2249257|FG000|Overall Study|Not collected CRFs|12
1143329|NCT02958553|2249270|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
1143330|NCT02958553|2249270|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
1143331|NCT02959138|2249370|FG000|Overall Study|Enrolled but Never Treated|0
1143332|NCT02959138|2249371|FG001|Overall Study|Enrolled but Never Treated|1
1143333|NCT02959138|2249372|FG002|Overall Study|Enrolled but Never Treated|0
1143334|NCT02959177|2249387|FG000|Double-Blind Treatment Phase|Adverse Event|5
1143335|NCT02959177|2249388|FG001|Double-Blind Treatment Phase|Adverse Event|2
1143336|NCT02959177|2249389|FG002|Double-Blind Treatment Phase|Adverse Event|0
1143337|NCT02959177|2249387|FG000|Double-Blind Treatment Phase|Physician Decision|1
1143338|NCT02959177|2249388|FG001|Double-Blind Treatment Phase|Physician Decision|0
1143339|NCT02959177|2249389|FG002|Double-Blind Treatment Phase|Physician Decision|0
1143340|NCT02959177|2249387|FG000|Double-Blind Treatment Phase|Protocol Violation|0
1143341|NCT02959177|2249388|FG001|Double-Blind Treatment Phase|Protocol Violation|1
1143342|NCT02959177|2249389|FG002|Double-Blind Treatment Phase|Protocol Violation|0
1143343|NCT02959177|2249387|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5
1143344|NCT02959177|2249388|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0
1143345|NCT02959177|2249389|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5
1143346|NCT02959177|2249387|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1
1143347|NCT02959177|2249388|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0
1143348|NCT02959177|2249389|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0
1143349|NCT02959177|2249387|FG000|Follow-up Post Treatment Phase|Adverse Event|0
1143350|NCT02959177|2249388|FG001|Follow-up Post Treatment Phase|Adverse Event|1
1143351|NCT02959177|2249389|FG002|Follow-up Post Treatment Phase|Adverse Event|0
1143352|NCT02959177|2249387|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0
1143353|NCT02959177|2249388|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0
1143354|NCT02959177|2249389|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2
1143355|NCT02959190|2249407|FG000|Open Label|Adverse Event|5
1143356|NCT02959190|2249408|FG001|Open Label|Adverse Event|7
1143357|NCT02959190|2249409|FG002|Open Label|Adverse Event|3
1143358|NCT02959190|2249410|FG003|Open Label|Adverse Event|4
1143359|NCT02959190|2249407|FG000|Open Label|Pregnancy|0
1143360|NCT02959190|2249408|FG001|Open Label|Pregnancy|1
1143361|NCT02959190|2249409|FG002|Open Label|Pregnancy|0
1143362|NCT02959190|2249410|FG003|Open Label|Pregnancy|0
1143363|NCT02959190|2249407|FG000|Open Label|Withdrawal by Subject|2
1143364|NCT02959190|2249408|FG001|Open Label|Withdrawal by Subject|8
1143365|NCT02959190|2249409|FG002|Open Label|Withdrawal by Subject|0
1143366|NCT02959190|2249410|FG003|Open Label|Withdrawal by Subject|0
1143367|NCT02959190|2249407|FG000|Open Label|Physician Decision|0
1143368|NCT02959190|2249408|FG001|Open Label|Physician Decision|0
1143369|NCT02959190|2249409|FG002|Open Label|Physician Decision|1
1143370|NCT02959190|2249410|FG003|Open Label|Physician Decision|0
1143371|NCT02959190|2249407|FG000|Open Label|Protocol Violation|0
1143372|NCT02959190|2249408|FG001|Open Label|Protocol Violation|0
1143373|NCT02959190|2249409|FG002|Open Label|Protocol Violation|0
1143374|NCT02959190|2249410|FG003|Open Label|Protocol Violation|2
1143375|NCT02959190|2249407|FG000|Post Treatment Follow Up|Adverse Event|1
1143376|NCT02959190|2249408|FG001|Post Treatment Follow Up|Adverse Event|1
1143377|NCT02959190|2249409|FG002|Post Treatment Follow Up|Adverse Event|0
1143378|NCT02959190|2249410|FG003|Post Treatment Follow Up|Adverse Event|0
1143379|NCT02959190|2249407|FG000|Post Treatment Follow Up|Withdrawal by Subject|2
1143380|NCT02959190|2249408|FG001|Post Treatment Follow Up|Withdrawal by Subject|0
1143381|NCT02959190|2249409|FG002|Post Treatment Follow Up|Withdrawal by Subject|1
1143382|NCT02959190|2249410|FG003|Post Treatment Follow Up|Withdrawal by Subject|0
1143383|NCT02959437|2249442|FG000|Overall Study|Death|33
1143384|NCT02959437|2249443|FG001|Overall Study|Death|3
1143385|NCT02959437|2249444|FG002|Overall Study|Death|0
1143386|NCT02959437|2249445|FG003|Overall Study|Death|0
1143387|NCT02959437|2249442|FG000|Overall Study|Lost to Follow-up|3
1143388|NCT02959437|2249443|FG001|Overall Study|Lost to Follow-up|1
1143389|NCT02959437|2249444|FG002|Overall Study|Lost to Follow-up|0
1143390|NCT02959437|2249445|FG003|Overall Study|Lost to Follow-up|0
1143391|NCT02959437|2249442|FG000|Overall Study|Withdrawal by Subject|11
1143392|NCT02959437|2249443|FG001|Overall Study|Withdrawal by Subject|3
1143393|NCT02959437|2249444|FG002|Overall Study|Withdrawal by Subject|0
1143394|NCT02959437|2249445|FG003|Overall Study|Withdrawal by Subject|0
1143395|NCT02959437|2249442|FG000|Overall Study|Progressive Disease|9
1143396|NCT02959437|2249443|FG001|Overall Study|Progressive Disease|1
1143397|NCT02959437|2249444|FG002|Overall Study|Progressive Disease|0
1143398|NCT02959437|2249445|FG003|Overall Study|Progressive Disease|0
1143399|NCT02959437|2249442|FG000|Overall Study|Study Terminated by Sponsor|4
1143400|NCT02959437|2249443|FG001|Overall Study|Study Terminated by Sponsor|0
1143401|NCT02959437|2249444|FG002|Overall Study|Study Terminated by Sponsor|0
1143402|NCT02959437|2249445|FG003|Overall Study|Study Terminated by Sponsor|0
1143403|NCT02959437|2249442|FG000|Overall Study|Other Unspecified|2
1143404|NCT02959437|2249443|FG001|Overall Study|Other Unspecified|0
1143405|NCT02959437|2249444|FG002|Overall Study|Other Unspecified|0
1143406|NCT02959437|2249445|FG003|Overall Study|Other Unspecified|0
1143407|NCT02959671|2249456|FG000|Overall Study|Adverse Event|2
1143408|NCT02959671|2249456|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3
1143409|NCT02959814|2249460|FG000|Overall Study|Excluded based on diagnostic angiography|16
1143410|NCT02959814|2249460|FG000|Overall Study|Excluded based on anatomical criteria|2
1143411|NCT02959814|2249460|FG000|Overall Study|Protocol Violation|7
1143412|NCT02959814|2249460|FG000|Overall Study|FFR not measured|2
1143413|NCT02959814|2249460|FG000|Overall Study|In-procedure QFR not computed|6
1143414|NCT02959814|2249460|FG000|Overall Study|Excluded by FFR core-lab|24
1143415|NCT02959866|2249496|FG000|Overall Study|Withdrawal by Subject|1
1143416|NCT02959892|2249503|FG000|Overall Study|PET tracer synthesis failure|1
1143417|NCT02959892|2249504|FG001|Overall Study|PET tracer synthesis failure|0
1143418|NCT02959892|2249503|FG000|Overall Study|Study termination|0
1143419|NCT02959892|2249504|FG001|Overall Study|Study termination|1
1143420|NCT02959970|2249521|FG000|Overall Study|Adverse Event|1
1143421|NCT02959970|2249522|FG001|Overall Study|Adverse Event|0
1143422|NCT02959970|2249521|FG000|Overall Study|Withdrawal by Subject|0
1143423|NCT02959970|2249522|FG001|Overall Study|Withdrawal by Subject|2
1143424|NCT02959970|2249521|FG000|Overall Study|Lost to Follow-up|1
1143425|NCT02959970|2249522|FG001|Overall Study|Lost to Follow-up|5
1143426|NCT02959983|2249532|FG000|Overall Study|Protocol Violation|0
1143427|NCT02959983|2249533|FG001|Overall Study|Protocol Violation|1
1143428|NCT02959983|2249532|FG000|Overall Study|Lack of Efficacy|0
1143429|NCT02959983|2249533|FG001|Overall Study|Lack of Efficacy|1
1143430|NCT02959983|2249532|FG000|Overall Study|Lost to Follow-up|12
1143431|NCT02959983|2249533|FG001|Overall Study|Lost to Follow-up|9
1143432|NCT02959983|2249532|FG000|Overall Study|Other|1
1143433|NCT02959983|2249533|FG001|Overall Study|Other|1
1143434|NCT02959983|2249532|FG000|Overall Study|Physician Decision|1
1143435|NCT02959983|2249533|FG001|Overall Study|Physician Decision|0
1143436|NCT02959983|2249532|FG000|Overall Study|Adverse Event|5
1143437|NCT02959983|2249533|FG001|Overall Study|Adverse Event|1
1143438|NCT02959983|2249532|FG000|Overall Study|Withdrawal by Subject|7
1143439|NCT02959983|2249533|FG001|Overall Study|Withdrawal by Subject|12
1143440|NCT02960217|2249550|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1
1143441|NCT02960217|2249551|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0
1143442|NCT02960217|2249550|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0
1143443|NCT02960217|2249551|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1
1143444|NCT02960217|2249550|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
1143445|NCT02960217|2249551|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
1143446|NCT02960217|2249550|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
1143447|NCT02960217|2249551|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
1143448|NCT02960217|2249550|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
1143449|NCT02960217|2249551|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
1143450|NCT02960217|2249550|FG000|Open-Label Extension Phase|Adverse Event|1
1143451|NCT02960217|2249551|FG001|Open-Label Extension Phase|Adverse Event|0
1143452|NCT02960217|2249550|FG000|Open-Label Extension Phase|Sponsor Decision|18
1143453|NCT02960217|2249551|FG001|Open-Label Extension Phase|Sponsor Decision|11
1143454|NCT02960217|2249550|FG000|Open-Label Extension Phase|Lack of Efficacy|1
1143455|NCT02960217|2249551|FG001|Open-Label Extension Phase|Lack of Efficacy|1
1143456|NCT02960217|2249550|FG000|Open-Label Extension Phase|Other, Not Specified|0
1143457|NCT02960217|2249551|FG001|Open-Label Extension Phase|Other, Not Specified|1
1143458|NCT02960438|2249570|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
1143459|NCT02960438|2249571|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1
1143460|NCT02960438|2249572|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
1143461|NCT02960438|2249573|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5
1143462|NCT02960438|2249570|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2
1143463|NCT02960438|2249571|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1
1143464|NCT02960438|2249572|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0
1143465|NCT02960438|2249573|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3
1143466|NCT02960438|2249570|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2
1143467|NCT02960438|2249571|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
1143468|NCT02960438|2249572|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
1143469|NCT02960438|2249573|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
1143470|NCT02960438|2249570|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
1143471|NCT02960438|2249571|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
1143472|NCT02960438|2249572|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
1143473|NCT02960438|2249573|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
1143474|NCT02960438|2249570|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0
1143475|NCT02960438|2249571|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0
1143476|NCT02960438|2249572|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1
1143477|NCT02960438|2249573|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0
1143478|NCT02960438|2249570|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2
1143479|NCT02960438|2249571|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
901637|NCT00734604|1875118|FG004|Overall Study|Protocol Violation|1
901638|NCT00734604|1875119|FG005|Overall Study|Protocol Violation|0
901639|NCT00734604|1875114|FG000|Overall Study|Sponsor Decision|1
901640|NCT00734604|1875115|FG001|Overall Study|Sponsor Decision|2
901641|NCT00734604|1875116|FG002|Overall Study|Sponsor Decision|1
901642|NCT00734604|1875117|FG003|Overall Study|Sponsor Decision|0
901643|NCT00734604|1875118|FG004|Overall Study|Sponsor Decision|2
901644|NCT00734604|1875119|FG005|Overall Study|Sponsor Decision|0
901645|NCT00734604|1875114|FG000|Overall Study|Withdrawal by Subject|0
901646|NCT00734604|1875115|FG001|Overall Study|Withdrawal by Subject|2
901647|NCT00734604|1875116|FG002|Overall Study|Withdrawal by Subject|0
901648|NCT00734604|1875117|FG003|Overall Study|Withdrawal by Subject|1
901649|NCT00734604|1875118|FG004|Overall Study|Withdrawal by Subject|2
901650|NCT00734604|1875119|FG005|Overall Study|Withdrawal by Subject|1
901651|NCT00734604|1875114|FG000|Overall Study|Lack of Efficacy|0
901652|NCT00734604|1875115|FG001|Overall Study|Lack of Efficacy|1
901653|NCT00734604|1875116|FG002|Overall Study|Lack of Efficacy|1
901654|NCT00734604|1875117|FG003|Overall Study|Lack of Efficacy|0
901655|NCT00734604|1875118|FG004|Overall Study|Lack of Efficacy|0
901656|NCT00734604|1875119|FG005|Overall Study|Lack of Efficacy|0
901657|NCT00734617|1875132|FG000|Overall Study|Adverse Event|4
901658|NCT00734617|1875133|FG001|Overall Study|Adverse Event|7
901659|NCT00734617|1875132|FG000|Overall Study|Withdrawal by Subject|103
901660|NCT00734617|1875133|FG001|Overall Study|Withdrawal by Subject|95
901661|NCT00734630|1875141|FG000|Overall Study|Lack of Efficacy|4
901662|NCT00734630|1875142|FG001|Overall Study|Lack of Efficacy|4
901663|NCT00734630|1875141|FG000|Overall Study|Withdrawal by Subject|7
901664|NCT00734630|1875142|FG001|Overall Study|Withdrawal by Subject|9
901665|NCT00734630|1875141|FG000|Overall Study|Lost to Follow-up|13
901666|NCT00734630|1875142|FG001|Overall Study|Lost to Follow-up|7
901667|NCT00734630|1875141|FG000|Overall Study|Protocol Violation|0
901668|NCT00734630|1875142|FG001|Overall Study|Protocol Violation|3
901669|NCT00734630|1875141|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
901670|NCT00734630|1875142|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
901671|NCT00734630|1875141|FG000|Overall Study|Adverse Event|3
901672|NCT00734630|1875142|FG001|Overall Study|Adverse Event|6
901673|NCT00734630|1875141|FG000|Overall Study|Randomized in Error|0
901674|NCT00734630|1875142|FG001|Overall Study|Randomized in Error|1
901675|NCT00734630|1875141|FG000|Overall Study|Tested Positive for Illegal Drug Use|1
901676|NCT00734630|1875142|FG001|Overall Study|Tested Positive for Illegal Drug Use|1
901677|NCT00734630|1875141|FG000|Overall Study|Poor Compliance|1
901678|NCT00734630|1875142|FG001|Overall Study|Poor Compliance|1
901679|NCT00734656|1875148|FG000|Lab Session 1|Withdrawal by Subject|2
901680|NCT00734656|1875149|FG001|Lab Session 1|Withdrawal by Subject|0
901681|NCT00734656|1875150|FG002|Lab Session 1|Withdrawal by Subject|0
901682|NCT00734656|1875151|FG003|Lab Session 1|Withdrawal by Subject|0
901683|NCT00734656|1875148|FG000|Washout 1|Withdrawal by Subject|1
901684|NCT00734656|1875149|FG001|Washout 1|Withdrawal by Subject|5
901685|NCT00734656|1875150|FG002|Washout 1|Withdrawal by Subject|2
901686|NCT00734656|1875151|FG003|Washout 1|Withdrawal by Subject|3
901687|NCT00734656|1875148|FG000|Lab Session 2|Withdrawal by Subject|1
901688|NCT00734656|1875149|FG001|Lab Session 2|Withdrawal by Subject|0
901689|NCT00734656|1875150|FG002|Lab Session 2|Withdrawal by Subject|0
901690|NCT00734656|1875151|FG003|Lab Session 2|Withdrawal by Subject|1
901691|NCT00734656|1875148|FG000|Washout 2|Withdrawal by Subject|1
901692|NCT00734656|1875149|FG001|Washout 2|Withdrawal by Subject|1
901693|NCT00734656|1875150|FG002|Washout 2|Withdrawal by Subject|1
901694|NCT00734656|1875151|FG003|Washout 2|Withdrawal by Subject|0
901695|NCT00734656|1875148|FG000|Washout 3|Withdrawal by Subject|1
901696|NCT00734656|1875149|FG001|Washout 3|Withdrawal by Subject|0
901697|NCT00734656|1875150|FG002|Washout 3|Withdrawal by Subject|0
901698|NCT00734656|1875151|FG003|Washout 3|Withdrawal by Subject|1
901699|NCT00734656|1875148|FG000|Lab Session 4|Withdrawal by Subject|0
901700|NCT00734656|1875149|FG001|Lab Session 4|Withdrawal by Subject|0
901701|NCT00734656|1875150|FG002|Lab Session 4|Withdrawal by Subject|0
901702|NCT00734656|1875151|FG003|Lab Session 4|Withdrawal by Subject|1
901703|NCT00734747|1875166|FG000|SRS Procedure|No staples placed|3
901704|NCT00734747|1875166|FG000|6 Month Follow-up|Did not meet inclusion criteria|3
901705|NCT00734851|1875179|FG000|Overall Study|Withdrawal by Subject|2
901706|NCT00734851|1875179|FG000|Overall Study|Lost to Follow-up|1
901707|NCT00734851|1875179|FG000|Overall Study|Physician Decision|18
901708|NCT00734929|1875194|FG000|Overall Study|Lost to Follow-up|1
901709|NCT00734929|1875195|FG001|Overall Study|Lost to Follow-up|2
901710|NCT00734929|1875194|FG000|Overall Study|No intervention/ screen fail|5
901711|NCT00734929|1875195|FG001|Overall Study|No intervention/ screen fail|3
901712|NCT00734994|1875212|FG000|Overall Study|Withdrawal by Subject|1
901713|NCT00735007|1875217|FG000|Overall Study|Adverse Event|4
901714|NCT00735007|1875217|FG000|Overall Study|Protocol Violation|1
901715|NCT00735072|1875223|FG000|Overall Study|interrupted study med during ARV change|1
901716|NCT00735072|1875224|FG001|Overall Study|interrupted study med during ARV change|0
901717|NCT00735072|1875223|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0
901718|NCT00735072|1875224|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1
901719|NCT00735371|1875241|FG000|Overall Study|Adverse Event|3
901720|NCT00735371|1875242|FG001|Overall Study|Adverse Event|3
901721|NCT00735371|1875243|FG002|Overall Study|Adverse Event|4
901722|NCT00735371|1875244|FG003|Overall Study|Adverse Event|1
901723|NCT00735371|1875241|FG000|Overall Study|Protocol Violation|2
901724|NCT00735371|1875242|FG001|Overall Study|Protocol Violation|2
901725|NCT00735371|1875243|FG002|Overall Study|Protocol Violation|0
901726|NCT00735371|1875244|FG003|Overall Study|Protocol Violation|3
901727|NCT00735371|1875241|FG000|Overall Study|Withdrawal by Subject|0
901728|NCT00735371|1875242|FG001|Overall Study|Withdrawal by Subject|2
901729|NCT00735371|1875243|FG002|Overall Study|Withdrawal by Subject|2
901730|NCT00735371|1875244|FG003|Overall Study|Withdrawal by Subject|0
901731|NCT00735371|1875241|FG000|Overall Study|Lost to Follow-up|1
901732|NCT00735371|1875242|FG001|Overall Study|Lost to Follow-up|1
901733|NCT00735371|1875243|FG002|Overall Study|Lost to Follow-up|3
901734|NCT00735371|1875244|FG003|Overall Study|Lost to Follow-up|1
901735|NCT00735371|1875241|FG000|Overall Study|Lack of Efficacy|4
901736|NCT00735371|1875242|FG001|Overall Study|Lack of Efficacy|2
901737|NCT00735371|1875243|FG002|Overall Study|Lack of Efficacy|0
901738|NCT00735371|1875244|FG003|Overall Study|Lack of Efficacy|4
901739|NCT00735371|1875241|FG000|Overall Study|Sponsor Decision|3
901740|NCT00735371|1875242|FG001|Overall Study|Sponsor Decision|1
901741|NCT00735371|1875243|FG002|Overall Study|Sponsor Decision|0
901742|NCT00735371|1875244|FG003|Overall Study|Sponsor Decision|1
901743|NCT00735371|1875241|FG000|Overall Study|Protocol Violation|0
901744|NCT00735371|1875242|FG001|Overall Study|Protocol Violation|1
901745|NCT00735371|1875243|FG002|Overall Study|Protocol Violation|2
901746|NCT00735371|1875244|FG003|Overall Study|Protocol Violation|0
901747|NCT00735371|1875241|FG000|Overall Study|Prior Vyvanse Exposure|1
901748|NCT00735371|1875242|FG001|Overall Study|Prior Vyvanse Exposure|1
901749|NCT00735371|1875243|FG002|Overall Study|Prior Vyvanse Exposure|0
901750|NCT00735371|1875244|FG003|Overall Study|Prior Vyvanse Exposure|0
901751|NCT00735371|1875241|FG000|Overall Study|Exclusion criteria|1
901752|NCT00735371|1875242|FG001|Overall Study|Exclusion criteria|0
901753|NCT00735371|1875243|FG002|Overall Study|Exclusion criteria|0
901754|NCT00735371|1875244|FG003|Overall Study|Exclusion criteria|0
901755|NCT00735397|1875254|FG000|Overall Study|Adverse Event|194
901756|NCT00735397|1875254|FG000|Overall Study|Lost to Follow-up|33
901757|NCT00735397|1875254|FG000|Overall Study|Participant choice|252
901758|NCT00735397|1875254|FG000|Overall Study|Inadequate therapeutic effect|202
901759|NCT00735397|1875254|FG000|Overall Study|Administrative/Other|502
901760|NCT00735475|1875290|FG000|Overall Study|Adverse Event|0
901761|NCT00735475|1875291|FG001|Overall Study|Adverse Event|1
901762|NCT00735475|1875290|FG000|Overall Study|Death|1
901763|NCT00735475|1875291|FG001|Overall Study|Death|1
901764|NCT00735475|1875290|FG000|Overall Study|Lost to Follow-up|3
901765|NCT00735475|1875291|FG001|Overall Study|Lost to Follow-up|3
901766|NCT00735475|1875290|FG000|Overall Study|Physician Decision|0
901767|NCT00735475|1875291|FG001|Overall Study|Physician Decision|1
901768|NCT00735475|1875290|FG000|Overall Study|Withdrawal by Subject|4
901769|NCT00735475|1875291|FG001|Overall Study|Withdrawal by Subject|5
901770|NCT00735644|1875306|FG000|Overall Study|Did not receive study vaccine|0
901771|NCT00735644|1875307|FG001|Overall Study|Did not receive study vaccine|1
901772|NCT00735644|1875308|FG002|Overall Study|Did not receive study vaccine|0
901773|NCT00735644|1875309|FG003|Overall Study|Did not receive study vaccine|0
901774|NCT00735644|1875310|FG004|Overall Study|Did not receive study vaccine|0
901775|NCT00735644|1875306|FG000|Overall Study|Withdrawal by Subject|0
901776|NCT00735644|1875307|FG001|Overall Study|Withdrawal by Subject|1
901777|NCT00735644|1875308|FG002|Overall Study|Withdrawal by Subject|1
901778|NCT00735644|1875309|FG003|Overall Study|Withdrawal by Subject|1
901779|NCT00735644|1875310|FG004|Overall Study|Withdrawal by Subject|0
901780|NCT00735696|1875338|FG000|Overall Study|Withdrawal by Subject|1
901781|NCT00735696|1875338|FG000|Overall Study|Enrolled but never Treated|1
901782|NCT00735709|1875346|FG000|Overall Study|Adverse Event|2
901783|NCT00735709|1875347|FG001|Overall Study|Adverse Event|3
901784|NCT00735709|1875348|FG002|Overall Study|Adverse Event|1
901785|NCT00735709|1875349|FG003|Overall Study|Adverse Event|5
901786|NCT00735709|1875346|FG000|Overall Study|Lack of Efficacy|8
901787|NCT00735709|1875347|FG001|Overall Study|Lack of Efficacy|4
901788|NCT00735709|1875348|FG002|Overall Study|Lack of Efficacy|2
901789|NCT00735709|1875349|FG003|Overall Study|Lack of Efficacy|3
901790|NCT00735709|1875346|FG000|Overall Study|Noncompliance|0
901791|NCT00735709|1875347|FG001|Overall Study|Noncompliance|0
901792|NCT00735709|1875348|FG002|Overall Study|Noncompliance|1
901793|NCT00735709|1875349|FG003|Overall Study|Noncompliance|0
901794|NCT00735709|1875346|FG000|Overall Study|Protocol deviations|1
901795|NCT00735709|1875347|FG001|Overall Study|Protocol deviations|2
901796|NCT00735709|1875348|FG002|Overall Study|Protocol deviations|1
901797|NCT00735709|1875349|FG003|Overall Study|Protocol deviations|1
901798|NCT00735709|1875346|FG000|Overall Study|Voluntary Withdrawal|1
901799|NCT00735709|1875347|FG001|Overall Study|Voluntary Withdrawal|3
901800|NCT00735709|1875348|FG002|Overall Study|Voluntary Withdrawal|5
901801|NCT00735709|1875349|FG003|Overall Study|Voluntary Withdrawal|7
901802|NCT00735709|1875346|FG000|Overall Study|Lost to Follow-up|0
901803|NCT00735709|1875347|FG001|Overall Study|Lost to Follow-up|1
901804|NCT00735709|1875348|FG002|Overall Study|Lost to Follow-up|1
901805|NCT00735709|1875349|FG003|Overall Study|Lost to Follow-up|1
901806|NCT00735709|1875346|FG000|Overall Study|Excluded medication|1
901807|NCT00735709|1875347|FG001|Overall Study|Excluded medication|0
901808|NCT00735709|1875348|FG002|Overall Study|Excluded medication|0
901809|NCT00735709|1875349|FG003|Overall Study|Excluded medication|1
901810|NCT00735878|1875386|FG000|Phase I- Dose Determination|Withdrawal by Subject|0
901811|NCT00735878|1875387|FG001|Phase I- Dose Determination|Withdrawal by Subject|0
901812|NCT00735878|1875388|FG002|Phase I- Dose Determination|Withdrawal by Subject|1
901813|NCT00735904|1875399|FG000|Overall Study|Adverse Event|3
901814|NCT00735904|1875399|FG000|Overall Study|Death|20
901815|NCT00735904|1875399|FG000|Overall Study|Protocol Violation|1
901816|NCT00735904|1875399|FG000|Overall Study|Withdrawal by Subject|1
901817|NCT00735904|1875399|FG000|Overall Study|Study Terminated by Sponsor|5
901818|NCT00735904|1875399|FG000|Overall Study|Other|8
901819|NCT00735943|1875407|FG000|Overall Study|Lost to Follow-up|1
901820|NCT00735943|1875407|FG000|Overall Study|Adverse Event|1
901821|NCT00736034|1875415|FG000|Overall Study|Adverse Event|2
901822|NCT00736099|1875431|FG000|Overall Study|Adverse Event|61
901823|NCT00736099|1875432|FG001|Overall Study|Adverse Event|18
901824|NCT00736099|1875431|FG000|Overall Study|Protocol Violation|10
901825|NCT00736099|1875432|FG001|Overall Study|Protocol Violation|4
901826|NCT00736099|1875431|FG000|Overall Study|Lost to Follow-up|12
1143480|NCT02960438|2249572|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0
1143481|NCT02960438|2249573|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
1143482|NCT02960438|2249570|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
1143483|NCT02960438|2249571|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2
1143484|NCT02960438|2249572|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4
1143485|NCT02960438|2249573|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
1143486|NCT02960438|2249570|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
1143487|NCT02960438|2249571|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
1143488|NCT02960438|2249572|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1
1143489|NCT02960438|2249573|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
1143490|NCT02960438|2249570|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
1143491|NCT02960438|2249571|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
1143492|NCT02960438|2249572|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0
1143493|NCT02960438|2249573|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
1143494|NCT02960438|2249570|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
1143495|NCT02960438|2249571|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5
1143496|NCT02960438|2249572|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
1143497|NCT02960438|2249573|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6
1143498|NCT02960438|2249570|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
1143499|NCT02960438|2249571|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
1143500|NCT02960438|2249572|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
1143501|NCT02960438|2249573|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
1143502|NCT02960438|2249570|FG000|Extension Phase (Open-label): 80 Weeks|Other|0
1143503|NCT02960438|2249571|FG001|Extension Phase (Open-label): 80 Weeks|Other|0
1143504|NCT02960438|2249572|FG002|Extension Phase (Open-label): 80 Weeks|Other|1
1143505|NCT02960438|2249573|FG003|Extension Phase (Open-label): 80 Weeks|Other|1
1143506|NCT02960490|2249593|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3
1143507|NCT02960490|2249594|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2
1143508|NCT02960490|2249595|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
1143509|NCT02960490|2249596|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
1143510|NCT02960490|2249597|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
1143511|NCT02960490|2249598|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
1143512|NCT02960490|2249599|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
1143513|NCT02960490|2249600|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
1143514|NCT02960490|2249601|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
1143515|NCT02960490|2249602|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
1143516|NCT02960490|2249593|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
1143517|NCT02960490|2249594|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1
1143518|NCT02960490|2249595|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
1143519|NCT02960490|2249596|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
1143520|NCT02960490|2249597|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
1143521|NCT02960490|2249598|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
1143522|NCT02960490|2249599|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
1143523|NCT02960490|2249600|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
1143524|NCT02960490|2249601|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
1143525|NCT02960490|2249602|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
1143526|NCT02960490|2249593|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1
1143527|NCT02960490|2249594|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2
1143528|NCT02960490|2249595|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
1143529|NCT02960490|2249596|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
1162100|NCT03383146|2284116|FG001|Overall Study|Death|2
1143530|NCT02960490|2249597|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
1143531|NCT02960490|2249598|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
1143532|NCT02960490|2249599|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
1143533|NCT02960490|2249600|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
1143534|NCT02960490|2249601|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
1143535|NCT02960490|2249602|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
1143536|NCT02960490|2249593|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
1143537|NCT02960490|2249594|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
1143538|NCT02960490|2249595|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
1143539|NCT02960490|2249596|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
1143540|NCT02960490|2249597|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
1143541|NCT02960490|2249598|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
1143542|NCT02960490|2249599|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
1143543|NCT02960490|2249600|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
1143544|NCT02960490|2249601|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
1143545|NCT02960490|2249602|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
1143546|NCT02960490|2249593|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
1143547|NCT02960490|2249594|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
1143548|NCT02960490|2249595|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
1143549|NCT02960490|2249596|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
1143550|NCT02960490|2249597|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
1143551|NCT02960490|2249598|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2
1143552|NCT02960490|2249599|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
1143553|NCT02960490|2249600|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
1143554|NCT02960490|2249601|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
1143555|NCT02960490|2249602|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
1143556|NCT02960490|2249593|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0
1143557|NCT02960490|2249594|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0
1143558|NCT02960490|2249595|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1
1143559|NCT02960490|2249596|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0
1143560|NCT02960490|2249597|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1
1143561|NCT02960490|2249598|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0
1143562|NCT02960490|2249599|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0
1143563|NCT02960490|2249600|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0
1143564|NCT02960490|2249601|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0
1143565|NCT02960490|2249602|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0
1143566|NCT02960490|2249593|FG000|Re-randomized Participants: 12 Weeks|Other|0
1143567|NCT02960490|2249594|FG001|Re-randomized Participants: 12 Weeks|Other|0
1143568|NCT02960490|2249595|FG002|Re-randomized Participants: 12 Weeks|Other|0
1143569|NCT02960490|2249596|FG003|Re-randomized Participants: 12 Weeks|Other|1
1143570|NCT02960490|2249597|FG004|Re-randomized Participants: 12 Weeks|Other|0
1143571|NCT02960490|2249598|FG005|Re-randomized Participants: 12 Weeks|Other|0
1143572|NCT02960490|2249599|FG006|Re-randomized Participants: 12 Weeks|Other|0
1143573|NCT02960490|2249600|FG007|Re-randomized Participants: 12 Weeks|Other|0
1143574|NCT02960490|2249601|FG008|Re-randomized Participants: 12 Weeks|Other|0
1143575|NCT02960490|2249602|FG009|Re-randomized Participants: 12 Weeks|Other|0
1143576|NCT02960490|2249593|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
1143577|NCT02960490|2249594|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
1143578|NCT02960490|2249595|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
1143579|NCT02960490|2249596|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
1143580|NCT02960490|2249597|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
1143581|NCT02960490|2249598|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
1143582|NCT02960490|2249599|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3
1143583|NCT02960490|2249600|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
1143584|NCT02960490|2249601|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
1143585|NCT02960490|2249602|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
1143586|NCT02960490|2249593|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
1143587|NCT02960490|2249594|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
1143588|NCT02960490|2249595|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
1143589|NCT02960490|2249596|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
1143590|NCT02960490|2249597|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
1143591|NCT02960490|2249598|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
1143592|NCT02960490|2249599|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
1143593|NCT02960490|2249600|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1
1143594|NCT02960490|2249601|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
1143595|NCT02960490|2249602|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
1143596|NCT02960490|2249593|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
1143597|NCT02960490|2249594|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
1143598|NCT02960490|2249595|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
1143599|NCT02960490|2249596|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
1143600|NCT02960490|2249597|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
1143601|NCT02960490|2249598|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
1143602|NCT02960490|2249599|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4
1143603|NCT02960490|2249600|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
1143604|NCT02960490|2249601|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
1143605|NCT02960490|2249602|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7
1143606|NCT02960490|2249593|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
1143607|NCT02960490|2249594|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
1143608|NCT02960490|2249595|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
1143609|NCT02960490|2249596|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
1143610|NCT02960490|2249597|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
1143611|NCT02960490|2249598|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
1143612|NCT02960490|2249599|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2
1143613|NCT02960490|2249600|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
1143614|NCT02960490|2249601|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
1143615|NCT02960490|2249602|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
1143616|NCT02960490|2249593|FG000|Extension Phase(Open-label): 80 Weeks|Other|0
1143617|NCT02960490|2249594|FG001|Extension Phase(Open-label): 80 Weeks|Other|0
1143618|NCT02960490|2249595|FG002|Extension Phase(Open-label): 80 Weeks|Other|0
1143619|NCT02960490|2249596|FG003|Extension Phase(Open-label): 80 Weeks|Other|0
1143620|NCT02960490|2249597|FG004|Extension Phase(Open-label): 80 Weeks|Other|0
1143621|NCT02960490|2249598|FG005|Extension Phase(Open-label): 80 Weeks|Other|0
1143622|NCT02960490|2249599|FG006|Extension Phase(Open-label): 80 Weeks|Other|0
1143623|NCT02960490|2249600|FG007|Extension Phase(Open-label): 80 Weeks|Other|1
901827|NCT00736099|1875432|FG001|Overall Study|Lost to Follow-up|5
901828|NCT00736099|1875431|FG000|Overall Study|Withdrawal by Subject|42
901829|NCT00736099|1875432|FG001|Overall Study|Withdrawal by Subject|13
901830|NCT00736099|1875431|FG000|Overall Study|Lack of Efficacy|15
901831|NCT00736099|1875432|FG001|Overall Study|Lack of Efficacy|8
901832|NCT00736099|1875431|FG000|Overall Study|Other reason|43
901833|NCT00736099|1875432|FG001|Overall Study|Other reason|10
901834|NCT00736190|1875447|FG000|Overall Study|Pregnancy|1
901835|NCT00736190|1875447|FG000|Overall Study|Withdrawal by Subject|1
901836|NCT00736190|1875447|FG000|Overall Study|Adverse Event|1
901837|NCT00736255|1875471|FG000|Overall Study|Adverse Event|1
901838|NCT00736255|1875472|FG001|Overall Study|Adverse Event|0
901839|NCT00736255|1875471|FG000|Overall Study|Physician Decision|1
901840|NCT00736255|1875472|FG001|Overall Study|Physician Decision|0
901841|NCT00736255|1875471|FG000|Overall Study|Non-compliance|1
901842|NCT00736255|1875472|FG001|Overall Study|Non-compliance|1
901843|NCT00736333|1875478|FG000|Overall Study|Did Not Receive Drug or Not Documented|7
901844|NCT00736333|1875478|FG000|Overall Study|Data Missing|2
901845|NCT00736333|1875478|FG000|Overall Study|Tumor Progression|75
901846|NCT00736333|1875478|FG000|Overall Study|Toxicity|6
901847|NCT00736333|1875478|FG000|Overall Study|Withdrawal by Subject|10
901848|NCT00736333|1875478|FG000|Overall Study|Death|7
901849|NCT00736333|1875478|FG000|Overall Study|Other|4
901850|NCT00736450|1875482|FG000|Overall Study|Not ABC gene eligible|19
901851|NCT00736450|1875482|FG000|Overall Study|Withdrawal by Subject|5
901852|NCT00736450|1875482|FG000|Overall Study|Physician Decision|1
901853|NCT00736476|1875488|FG000|Overall Study|Adverse Event|1
901854|NCT00736476|1875489|FG001|Overall Study|Adverse Event|0
901855|NCT00736489|1875501|FG000|Period 1|Lost to Follow-up|1
901856|NCT00736489|1875502|FG001|Period 1|Lost to Follow-up|0
901857|NCT00736489|1875503|FG002|Period 1|Lost to Follow-up|0
901858|NCT00736489|1875504|FG003|Period 1|Lost to Follow-up|0
901859|NCT00736489|1875505|FG004|Period 1|Lost to Follow-up|0
1143624|NCT02960490|2249601|FG008|Extension Phase(Open-label): 80 Weeks|Other|0
1143625|NCT02960490|2249602|FG009|Extension Phase(Open-label): 80 Weeks|Other|0
1143626|NCT02960854|2249626|FG000|Overall Study|Not Disclosed|2
1143627|NCT02960854|2249627|FG001|Overall Study|Not Disclosed|2
1143628|NCT02960854|2249626|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
1143629|NCT02960854|2249627|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
1143630|NCT02960854|2249626|FG000|Overall Study|Subject Withdrew Consent|0
1143631|NCT02960854|2249627|FG001|Overall Study|Subject Withdrew Consent|1
1143632|NCT02960854|2249626|FG000|Overall Study|Death|4
1143633|NCT02960854|2249627|FG001|Overall Study|Death|6
1143634|NCT02960893|2249635|FG000|Randomization Phase (8-week)|Adverse Event|5
1143635|NCT02960893|2249636|FG001|Randomization Phase (8-week)|Adverse Event|0
1143636|NCT02960893|2249635|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2
1143637|NCT02960893|2249636|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1
1143638|NCT02960893|2249635|FG000|Randomization Phase (8-week)|Reason Not Specified|0
1143639|NCT02960893|2249636|FG001|Randomization Phase (8-week)|Reason Not Specified|1
1143640|NCT02960893|2249635|FG000|Extension Phase (48-week)|Adverse Event|2
1143641|NCT02960893|2249636|FG001|Extension Phase (48-week)|Adverse Event|3
1143642|NCT02960893|2249635|FG000|Extension Phase (48-week)|Withdrawal by Subject|8
1143643|NCT02960893|2249636|FG001|Extension Phase (48-week)|Withdrawal by Subject|8
1143644|NCT02960893|2249635|FG000|Extension Phase (48-week)|Other Reason|2
1143645|NCT02960893|2249636|FG001|Extension Phase (48-week)|Other Reason|1
1143646|NCT02960893|2249635|FG000|Extension Phase (48-week)|Lost to Follow-up|1
1143647|NCT02960893|2249636|FG001|Extension Phase (48-week)|Lost to Follow-up|1
901860|NCT00736489|1875506|FG005|Period 1|Lost to Follow-up|0
901861|NCT00736489|1875501|FG000|Period 1|Withdrawal by Subject|0
901862|NCT00736489|1875502|FG001|Period 1|Withdrawal by Subject|0
901863|NCT00736489|1875503|FG002|Period 1|Withdrawal by Subject|0
901864|NCT00736489|1875504|FG003|Period 1|Withdrawal by Subject|0
901865|NCT00736489|1875505|FG004|Period 1|Withdrawal by Subject|0
901866|NCT00736489|1875506|FG005|Period 1|Withdrawal by Subject|1
901867|NCT00736502|1875520|FG000|Overall Study|Adverse Event|22
901868|NCT00736502|1875520|FG000|Overall Study|Lack of Efficacy|16
901869|NCT00736502|1875520|FG000|Overall Study|Lost to Follow-up|27
901870|NCT00736645|1875548|FG000|Overall Study|Adverse Event|0
901871|NCT00736645|1875549|FG001|Overall Study|Adverse Event|2
901872|NCT00736645|1875550|FG002|Overall Study|Adverse Event|0
901873|NCT00736645|1875551|FG003|Overall Study|Adverse Event|0
901874|NCT00736723|1875563|FG000|Overall Study|Withdrawal by Subject|4
901875|NCT00736723|1875564|FG001|Overall Study|Withdrawal by Subject|3
901876|NCT00736840|1875570|FG000|Overall Study|Lost to Follow-up|13
901877|NCT00736853|1875574|FG000|Open-Label Period|Physician Decision|2
901878|NCT00736853|1875575|FG001|Open-Label Period|Physician Decision|0
901879|NCT00736853|1875576|FG002|Open-Label Period|Physician Decision|0
901880|NCT00736853|1875574|FG000|Open-Label Period|Adverse Event|31
901881|NCT00736853|1875575|FG001|Open-Label Period|Adverse Event|0
901882|NCT00736853|1875576|FG002|Open-Label Period|Adverse Event|0
901883|NCT00736853|1875574|FG000|Open-Label Period|Withdrawal by Subject|16
901884|NCT00736853|1875575|FG001|Open-Label Period|Withdrawal by Subject|0
901885|NCT00736853|1875576|FG002|Open-Label Period|Withdrawal by Subject|0
901886|NCT00736853|1875574|FG000|Open-Label Period|Started but not treated|42
901887|NCT00736853|1875575|FG001|Open-Label Period|Started but not treated|0
901888|NCT00736853|1875576|FG002|Open-Label Period|Started but not treated|0
901889|NCT00736853|1875574|FG000|Open-Label Period|Failed to meet the transfer criteria|40
901890|NCT00736853|1875575|FG001|Open-Label Period|Failed to meet the transfer criteria|0
901891|NCT00736853|1875576|FG002|Open-Label Period|Failed to meet the transfer criteria|0
901892|NCT00736853|1875574|FG000|Open-Label Period|Unable to attend hospital appointments|1
901893|NCT00736853|1875575|FG001|Open-Label Period|Unable to attend hospital appointments|0
901894|NCT00736853|1875576|FG002|Open-Label Period|Unable to attend hospital appointments|0
901895|NCT00736853|1875574|FG000|Double-Blind Period|Lack of Efficacy|0
901896|NCT00736853|1875575|FG001|Double-Blind Period|Lack of Efficacy|19
901897|NCT00736853|1875576|FG002|Double-Blind Period|Lack of Efficacy|42
901898|NCT00736853|1875574|FG000|Double-Blind Period|Adverse Event|0
901899|NCT00736853|1875575|FG001|Double-Blind Period|Adverse Event|3
901900|NCT00736853|1875576|FG002|Double-Blind Period|Adverse Event|2
901901|NCT00736853|1875574|FG000|Double-Blind Period|Withdrawal by Subject|0
901902|NCT00736853|1875575|FG001|Double-Blind Period|Withdrawal by Subject|1
901903|NCT00736853|1875576|FG002|Double-Blind Period|Withdrawal by Subject|4
901904|NCT00736853|1875574|FG000|Double-Blind Period|Ineligible to participate the study|0
901905|NCT00736853|1875575|FG001|Double-Blind Period|Ineligible to participate the study|1
901906|NCT00736853|1875576|FG002|Double-Blind Period|Ineligible to participate the study|0
901907|NCT00736879|1875589|FG000|Double Blind Treatment Period|Lack of Efficacy|1
901908|NCT00736879|1875590|FG001|Double Blind Treatment Period|Lack of Efficacy|0
901909|NCT00736879|1875591|FG002|Double Blind Treatment Period|Lack of Efficacy|0
901910|NCT00736879|1875592|FG003|Double Blind Treatment Period|Lack of Efficacy|0
901911|NCT00736879|1875589|FG000|Double Blind Treatment Period|Adverse Event|0
901912|NCT00736879|1875590|FG001|Double Blind Treatment Period|Adverse Event|1
901913|NCT00736879|1875591|FG002|Double Blind Treatment Period|Adverse Event|1
901914|NCT00736879|1875592|FG003|Double Blind Treatment Period|Adverse Event|0
901915|NCT00736879|1875589|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
901916|NCT00736879|1875590|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
901917|NCT00736879|1875591|FG002|Double Blind Treatment Period|Withdrawal by Subject|3
901918|NCT00736879|1875592|FG003|Double Blind Treatment Period|Withdrawal by Subject|3
901919|NCT00736879|1875589|FG000|Double Blind Treatment Period|Lost to Follow-up|0
901920|NCT00736879|1875590|FG001|Double Blind Treatment Period|Lost to Follow-up|0
901921|NCT00736879|1875591|FG002|Double Blind Treatment Period|Lost to Follow-up|2
901922|NCT00736879|1875592|FG003|Double Blind Treatment Period|Lost to Follow-up|1
901923|NCT00736879|1875589|FG000|Double Blind Treatment Period|Poor non-compliance|0
901924|NCT00736879|1875590|FG001|Double Blind Treatment Period|Poor non-compliance|0
901925|NCT00736879|1875591|FG002|Double Blind Treatment Period|Poor non-compliance|1
901926|NCT00736879|1875592|FG003|Double Blind Treatment Period|Poor non-compliance|1
901927|NCT00736879|1875589|FG000|Double Blind Treatment Period|No longer met criteria|0
901928|NCT00736879|1875590|FG001|Double Blind Treatment Period|No longer met criteria|1
901929|NCT00736879|1875591|FG002|Double Blind Treatment Period|No longer met criteria|0
1143648|NCT02960893|2249635|FG000|Extension Phase (48-week)|Sponsors Decision|1
1143649|NCT02960893|2249636|FG001|Extension Phase (48-week)|Sponsors Decision|0
1143650|NCT02961218|2249669|FG000|Overall Study|Lost to Follow-up|0
1143651|NCT02961218|2249670|FG001|Overall Study|Lost to Follow-up|2
1143652|NCT02961218|2249669|FG000|Overall Study|Physician Decision|0
1143653|NCT02961218|2249670|FG001|Overall Study|Physician Decision|2
1143654|NCT02961218|2249669|FG000|Overall Study|Subject/Guardian Decision|3
1143655|NCT02961218|2249670|FG001|Overall Study|Subject/Guardian Decision|1
1143656|NCT02961244|2249680|FG000|Overall Study|Protocol Violation|0
1143657|NCT02961244|2249681|FG001|Overall Study|Protocol Violation|1
1143658|NCT02961244|2249680|FG000|Overall Study|Withdrawal by Subject|1
1143659|NCT02961244|2249681|FG001|Overall Study|Withdrawal by Subject|2
1143660|NCT02961244|2249680|FG000|Overall Study|Surgery plan change after study approval|0
1143661|NCT02961244|2249681|FG001|Overall Study|Surgery plan change after study approval|2
1143662|NCT02961244|2249680|FG000|Overall Study|Lost to Follow-up|0
1143663|NCT02961244|2249681|FG001|Overall Study|Lost to Follow-up|2
1143664|NCT02961244|2249680|FG000|Overall Study|İnadequate data|0
1143665|NCT02961244|2249681|FG001|Overall Study|İnadequate data|2
1143666|NCT02961374|2249687|FG000|Overall Study|Adverse Event|4
1143667|NCT02961751|2249691|FG000|Overall Study|Lost to Follow-up|11
1143668|NCT02961751|2249691|FG000|Overall Study|Physician Decision|2
1143669|NCT02961751|2249691|FG000|Overall Study|Not Eligible at Enrollment|1
1143670|NCT02961751|2249691|FG000|Overall Study|Protocol Violation|1
1143671|NCT02961764|2249697|FG000|Overall Study|Protocol Violation|0
1143672|NCT02961764|2249698|FG001|Overall Study|Protocol Violation|1
1143673|NCT02961764|2249697|FG000|Overall Study|Death|2
1143674|NCT02961764|2249698|FG001|Overall Study|Death|0
1143675|NCT02961764|2249697|FG000|Overall Study|Lost to Follow-up|35
1143676|NCT02961764|2249698|FG001|Overall Study|Lost to Follow-up|24
1143677|NCT02961764|2249697|FG000|Overall Study|Withdrawal by Subject|2
1143678|NCT02961764|2249698|FG001|Overall Study|Withdrawal by Subject|0
1143679|NCT02961790|2249708|FG000|Overall Study|Canceled|4
1143680|NCT02961790|2249709|FG001|Overall Study|Canceled|5
1143681|NCT02961790|2249710|FG002|Overall Study|Canceled|1
1143682|NCT02961790|2249711|FG003|Overall Study|Canceled|4
1143683|NCT02961790|2249708|FG000|Overall Study|without baseline data|4
1143684|NCT02961790|2249709|FG001|Overall Study|without baseline data|0
1143685|NCT02961790|2249710|FG002|Overall Study|without baseline data|1
1143686|NCT02961790|2249711|FG003|Overall Study|without baseline data|0
1143687|NCT02961790|2249708|FG000|Overall Study|without post baseline data|7
1143688|NCT02961790|2249709|FG001|Overall Study|without post baseline data|6
1143689|NCT02961790|2249710|FG002|Overall Study|without post baseline data|4
1143690|NCT02961790|2249711|FG003|Overall Study|without post baseline data|1
1143691|NCT02961920|2249728|FG000|Overall Study|did not achive stydy protocol schedule|1
1143692|NCT02961920|2249729|FG001|Overall Study|did not achive stydy protocol schedule|1
1143693|NCT02962284|2249750|FG000|Overall Study|Death|2
1143694|NCT02962284|2249751|FG001|Overall Study|Death|0
1143695|NCT02962284|2249750|FG000|Overall Study|Progressive disease|2
1143696|NCT02962284|2249751|FG001|Overall Study|Progressive disease|3
1143697|NCT02962284|2249750|FG000|Overall Study|Withdrawal by Subject|1
1143698|NCT02962284|2249751|FG001|Overall Study|Withdrawal by Subject|0
1143699|NCT02962648|2249779|FG000|Overall Study|Withdrawal by Subject|3
1143700|NCT02962648|2249779|FG000|Overall Study|Lost to Follow-up|3
1143701|NCT02962648|2249779|FG000|Overall Study|Physician Decision|1
1143702|NCT02962648|2249779|FG000|Overall Study|Subject had problems with transportation|2
1143703|NCT02962674|2249783|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49
1143704|NCT02962739|2249800|FG000|Overall Study|Withdrawal by Subject|0
1143705|NCT02962739|2249801|FG001|Overall Study|Withdrawal by Subject|1
1143706|NCT02962739|2249802|FG002|Overall Study|Withdrawal by Subject|0
1143707|NCT02962739|2249803|FG003|Overall Study|Withdrawal by Subject|0
1143708|NCT02962739|2249804|FG004|Overall Study|Withdrawal by Subject|0
1143709|NCT02962739|2249805|FG005|Overall Study|Withdrawal by Subject|0
1143710|NCT02962739|2249800|FG000|Overall Study|Protocol Violation|0
1143711|NCT02962739|2249801|FG001|Overall Study|Protocol Violation|0
1143712|NCT02962739|2249802|FG002|Overall Study|Protocol Violation|1
1143713|NCT02962739|2249803|FG003|Overall Study|Protocol Violation|0
1143714|NCT02962739|2249804|FG004|Overall Study|Protocol Violation|1
1143715|NCT02962739|2249805|FG005|Overall Study|Protocol Violation|0
1143716|NCT02962765|2249811|FG000|Overall Study|Protocol Violation|9
1143717|NCT02962765|2249811|FG000|Overall Study|Withdrawal by Subject|3
1143718|NCT02962765|2249811|FG000|Overall Study|Lost to Follow-up|1
1143719|NCT02962765|2249811|FG000|Overall Study|Death|1
1143720|NCT02962765|2249811|FG000|Overall Study|Limited access to study medication|3
1143721|NCT02962882|2249822|FG000|Overall Study|Adverse Event|2
1143722|NCT02962882|2249822|FG000|Overall Study|Withdrawal by Subject|2
1143723|NCT02962882|2249822|FG000|Overall Study|Transfer from ICU|32
1143724|NCT02962908|2249831|FG000|Overall Study|Lost to Follow-up|0
1143725|NCT02962908|2249832|FG001|Overall Study|Lost to Follow-up|3
1143726|NCT02962908|2249833|FG002|Overall Study|Lost to Follow-up|0
1143727|NCT02962908|2249834|FG003|Overall Study|Lost to Follow-up|1
1143728|NCT02962908|2249831|FG000|Overall Study|Withdrawal by Subject|0
1143729|NCT02962908|2249832|FG001|Overall Study|Withdrawal by Subject|3
1143730|NCT02962908|2249833|FG002|Overall Study|Withdrawal by Subject|0
1143731|NCT02962908|2249834|FG003|Overall Study|Withdrawal by Subject|2
1143732|NCT02962908|2249831|FG000|Overall Study|Protocol Violation|0
1143733|NCT02962908|2249832|FG001|Overall Study|Protocol Violation|1
1143734|NCT02962908|2249833|FG002|Overall Study|Protocol Violation|0
1143735|NCT02962908|2249834|FG003|Overall Study|Protocol Violation|0
1143736|NCT02962908|2249831|FG000|Overall Study|Physician Decision|0
1143737|NCT02962908|2249832|FG001|Overall Study|Physician Decision|1
1143738|NCT02962908|2249833|FG002|Overall Study|Physician Decision|0
1143739|NCT02962908|2249834|FG003|Overall Study|Physician Decision|0
1143740|NCT02962960|2249862|FG000|Overall Study|Withdrawal by Subject|1
1143741|NCT02962960|2249863|FG001|Overall Study|Withdrawal by Subject|1
1143742|NCT02962960|2249864|FG002|Overall Study|Withdrawal by Subject|0
1143743|NCT02962960|2249862|FG000|Overall Study|Adverse Event|1
1143744|NCT02962960|2249863|FG001|Overall Study|Adverse Event|1
1143745|NCT02962960|2249864|FG002|Overall Study|Adverse Event|0
1143746|NCT02962960|2249862|FG000|Overall Study|Protocol Violation|1
1143747|NCT02962960|2249863|FG001|Overall Study|Protocol Violation|0
1143748|NCT02962960|2249864|FG002|Overall Study|Protocol Violation|0
1143749|NCT02963311|2249874|FG000|Overall Study|Withdrawal by Subject|1
1143750|NCT02963311|2249874|FG000|Overall Study|Screen Failure|4
1143751|NCT02963441|2249909|FG000|Overall Study|Protocol violation or withdrawn|8
1143752|NCT02963441|2249909|FG000|Overall Study|Ungradeable by FPRC or IDx|40
1143753|NCT02963441|2249909|FG000|Overall Study|IDx-DR insufficient quality|33
1143754|NCT02963506|2249919|FG000|Double-Blind Period|Adverse Event|0
1143755|NCT02963506|2249920|FG001|Double-Blind Period|Adverse Event|0
1143756|NCT02963506|2249921|FG002|Double-Blind Period|Adverse Event|1
1143757|NCT02963506|2249922|FG003|Double-Blind Period|Adverse Event|0
1143758|NCT02963506|2249923|FG004|Double-Blind Period|Adverse Event|0
1143759|NCT02963506|2249924|FG005|Double-Blind Period|Adverse Event|0
1143760|NCT02963506|2249925|FG006|Double-Blind Period|Adverse Event|0
1143761|NCT02963506|2249926|FG007|Double-Blind Period|Adverse Event|0
1143762|NCT02963506|2249927|FG008|Double-Blind Period|Adverse Event|0
1143763|NCT02963506|2249928|FG009|Double-Blind Period|Adverse Event|0
1143764|NCT02963506|2249929|FG010|Double-Blind Period|Adverse Event|0
1143765|NCT02963506|2249930|FG011|Double-Blind Period|Adverse Event|0
1143766|NCT02963506|2249931|FG012|Double-Blind Period|Adverse Event|0
1143767|NCT02963506|2249919|FG000|Double-Blind Period|Death|0
1143768|NCT02963506|2249920|FG001|Double-Blind Period|Death|0
1143769|NCT02963506|2249921|FG002|Double-Blind Period|Death|0
1143770|NCT02963506|2249922|FG003|Double-Blind Period|Death|1
1143771|NCT02963506|2249923|FG004|Double-Blind Period|Death|0
1143772|NCT02963506|2249924|FG005|Double-Blind Period|Death|0
1143773|NCT02963506|2249925|FG006|Double-Blind Period|Death|0
1143774|NCT02963506|2249926|FG007|Double-Blind Period|Death|0
1143775|NCT02963506|2249927|FG008|Double-Blind Period|Death|0
1143776|NCT02963506|2249928|FG009|Double-Blind Period|Death|0
1143777|NCT02963506|2249929|FG010|Double-Blind Period|Death|0
1143778|NCT02963506|2249930|FG011|Double-Blind Period|Death|0
1143779|NCT02963506|2249931|FG012|Double-Blind Period|Death|0
1143780|NCT02963506|2249919|FG000|Double-Blind Period|Lost to Follow-up|0
1143781|NCT02963506|2249920|FG001|Double-Blind Period|Lost to Follow-up|1
1143782|NCT02963506|2249921|FG002|Double-Blind Period|Lost to Follow-up|0
1143783|NCT02963506|2249922|FG003|Double-Blind Period|Lost to Follow-up|0
1143784|NCT02963506|2249923|FG004|Double-Blind Period|Lost to Follow-up|0
1143785|NCT02963506|2249924|FG005|Double-Blind Period|Lost to Follow-up|0
1143786|NCT02963506|2249925|FG006|Double-Blind Period|Lost to Follow-up|0
1143787|NCT02963506|2249926|FG007|Double-Blind Period|Lost to Follow-up|0
1143788|NCT02963506|2249927|FG008|Double-Blind Period|Lost to Follow-up|0
1143789|NCT02963506|2249928|FG009|Double-Blind Period|Lost to Follow-up|0
1143790|NCT02963506|2249929|FG010|Double-Blind Period|Lost to Follow-up|0
1143791|NCT02963506|2249930|FG011|Double-Blind Period|Lost to Follow-up|0
1143792|NCT02963506|2249931|FG012|Double-Blind Period|Lost to Follow-up|0
1143793|NCT02963506|2249919|FG000|Double-Blind Period|Withdrawal by Subject|0
1143794|NCT02963506|2249920|FG001|Double-Blind Period|Withdrawal by Subject|0
1143795|NCT02963506|2249921|FG002|Double-Blind Period|Withdrawal by Subject|1
1143796|NCT02963506|2249922|FG003|Double-Blind Period|Withdrawal by Subject|1
1143797|NCT02963506|2249923|FG004|Double-Blind Period|Withdrawal by Subject|0
1143798|NCT02963506|2249924|FG005|Double-Blind Period|Withdrawal by Subject|0
1143799|NCT02963506|2249925|FG006|Double-Blind Period|Withdrawal by Subject|0
1143800|NCT02963506|2249926|FG007|Double-Blind Period|Withdrawal by Subject|0
1143801|NCT02963506|2249927|FG008|Double-Blind Period|Withdrawal by Subject|0
1143802|NCT02963506|2249928|FG009|Double-Blind Period|Withdrawal by Subject|0
1143803|NCT02963506|2249929|FG010|Double-Blind Period|Withdrawal by Subject|0
1143804|NCT02963506|2249930|FG011|Double-Blind Period|Withdrawal by Subject|0
1143805|NCT02963506|2249931|FG012|Double-Blind Period|Withdrawal by Subject|0
1143806|NCT02963506|2249919|FG000|Double-Blind Period|No compliance|0
1143807|NCT02963506|2249920|FG001|Double-Blind Period|No compliance|1
1143808|NCT02963506|2249921|FG002|Double-Blind Period|No compliance|0
1143809|NCT02963506|2249922|FG003|Double-Blind Period|No compliance|0
1143810|NCT02963506|2249923|FG004|Double-Blind Period|No compliance|0
1143811|NCT02963506|2249924|FG005|Double-Blind Period|No compliance|0
1143812|NCT02963506|2249925|FG006|Double-Blind Period|No compliance|0
1143813|NCT02963506|2249926|FG007|Double-Blind Period|No compliance|0
1143814|NCT02963506|2249927|FG008|Double-Blind Period|No compliance|0
1143815|NCT02963506|2249928|FG009|Double-Blind Period|No compliance|0
1143816|NCT02963506|2249929|FG010|Double-Blind Period|No compliance|0
1143817|NCT02963506|2249930|FG011|Double-Blind Period|No compliance|0
1143818|NCT02963506|2249931|FG012|Double-Blind Period|No compliance|0
1143819|NCT02963506|2249919|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143820|NCT02963506|2249920|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1
1143821|NCT02963506|2249921|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143822|NCT02963506|2249922|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143823|NCT02963506|2249923|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143824|NCT02963506|2249924|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143825|NCT02963506|2249925|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143826|NCT02963506|2249926|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143827|NCT02963506|2249927|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143828|NCT02963506|2249928|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143829|NCT02963506|2249929|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143830|NCT02963506|2249930|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143831|NCT02963506|2249931|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0
1143832|NCT02963506|2249919|FG000|Dose-Blind Period|Adverse Event|0
1143833|NCT02963506|2249920|FG001|Dose-Blind Period|Adverse Event|0
1143834|NCT02963506|2249921|FG002|Dose-Blind Period|Adverse Event|0
1143835|NCT02963506|2249922|FG003|Dose-Blind Period|Adverse Event|0
1143836|NCT02963506|2249923|FG004|Dose-Blind Period|Adverse Event|0
1143837|NCT02963506|2249924|FG005|Dose-Blind Period|Adverse Event|1
1143838|NCT02963506|2249925|FG006|Dose-Blind Period|Adverse Event|3
1143839|NCT02963506|2249926|FG007|Dose-Blind Period|Adverse Event|2
1143840|NCT02963506|2249927|FG008|Dose-Blind Period|Adverse Event|2
1143841|NCT02963506|2249928|FG009|Dose-Blind Period|Adverse Event|2
1143842|NCT02963506|2249929|FG010|Dose-Blind Period|Adverse Event|1
1143843|NCT02963506|2249930|FG011|Dose-Blind Period|Adverse Event|1
1143844|NCT02963506|2249931|FG012|Dose-Blind Period|Adverse Event|6
1143845|NCT02963506|2249919|FG000|Dose-Blind Period|Lack of Efficacy|0
1143846|NCT02963506|2249920|FG001|Dose-Blind Period|Lack of Efficacy|0
1143847|NCT02963506|2249921|FG002|Dose-Blind Period|Lack of Efficacy|0
1143848|NCT02963506|2249922|FG003|Dose-Blind Period|Lack of Efficacy|0
1143849|NCT02963506|2249923|FG004|Dose-Blind Period|Lack of Efficacy|0
1143850|NCT02963506|2249924|FG005|Dose-Blind Period|Lack of Efficacy|0
1143851|NCT02963506|2249925|FG006|Dose-Blind Period|Lack of Efficacy|0
1143852|NCT02963506|2249926|FG007|Dose-Blind Period|Lack of Efficacy|1
1143853|NCT02963506|2249927|FG008|Dose-Blind Period|Lack of Efficacy|0
1143854|NCT02963506|2249928|FG009|Dose-Blind Period|Lack of Efficacy|1
1143855|NCT02963506|2249929|FG010|Dose-Blind Period|Lack of Efficacy|0
1143856|NCT02963506|2249930|FG011|Dose-Blind Period|Lack of Efficacy|0
1143857|NCT02963506|2249931|FG012|Dose-Blind Period|Lack of Efficacy|0
1143858|NCT02963506|2249919|FG000|Dose-Blind Period|Lost to Follow-up|0
1143859|NCT02963506|2249920|FG001|Dose-Blind Period|Lost to Follow-up|0
1143860|NCT02963506|2249921|FG002|Dose-Blind Period|Lost to Follow-up|0
1143861|NCT02963506|2249922|FG003|Dose-Blind Period|Lost to Follow-up|0
1143862|NCT02963506|2249923|FG004|Dose-Blind Period|Lost to Follow-up|0
1143863|NCT02963506|2249924|FG005|Dose-Blind Period|Lost to Follow-up|1
1143864|NCT02963506|2249925|FG006|Dose-Blind Period|Lost to Follow-up|0
1143865|NCT02963506|2249926|FG007|Dose-Blind Period|Lost to Follow-up|0
1143866|NCT02963506|2249927|FG008|Dose-Blind Period|Lost to Follow-up|1
1143867|NCT02963506|2249928|FG009|Dose-Blind Period|Lost to Follow-up|0
1143868|NCT02963506|2249929|FG010|Dose-Blind Period|Lost to Follow-up|0
1143869|NCT02963506|2249930|FG011|Dose-Blind Period|Lost to Follow-up|1
1143870|NCT02963506|2249931|FG012|Dose-Blind Period|Lost to Follow-up|0
1143871|NCT02963506|2249919|FG000|Dose-Blind Period|Withdrawal by Subject|0
1143872|NCT02963506|2249920|FG001|Dose-Blind Period|Withdrawal by Subject|0
1143873|NCT02963506|2249921|FG002|Dose-Blind Period|Withdrawal by Subject|0
1143874|NCT02963506|2249922|FG003|Dose-Blind Period|Withdrawal by Subject|0
1143875|NCT02963506|2249923|FG004|Dose-Blind Period|Withdrawal by Subject|0
1143876|NCT02963506|2249924|FG005|Dose-Blind Period|Withdrawal by Subject|1
1143877|NCT02963506|2249925|FG006|Dose-Blind Period|Withdrawal by Subject|2
1143878|NCT02963506|2249926|FG007|Dose-Blind Period|Withdrawal by Subject|2
1143879|NCT02963506|2249927|FG008|Dose-Blind Period|Withdrawal by Subject|0
1143880|NCT02963506|2249928|FG009|Dose-Blind Period|Withdrawal by Subject|1
1143881|NCT02963506|2249929|FG010|Dose-Blind Period|Withdrawal by Subject|0
1143882|NCT02963506|2249930|FG011|Dose-Blind Period|Withdrawal by Subject|0
1143883|NCT02963506|2249931|FG012|Dose-Blind Period|Withdrawal by Subject|0
1143884|NCT02963506|2249919|FG000|Dose-Blind Period|Sponsor decision|0
1143885|NCT02963506|2249920|FG001|Dose-Blind Period|Sponsor decision|0
1143886|NCT02963506|2249921|FG002|Dose-Blind Period|Sponsor decision|0
1143887|NCT02963506|2249922|FG003|Dose-Blind Period|Sponsor decision|0
1143888|NCT02963506|2249923|FG004|Dose-Blind Period|Sponsor decision|0
1143889|NCT02963506|2249924|FG005|Dose-Blind Period|Sponsor decision|1
1143890|NCT02963506|2249925|FG006|Dose-Blind Period|Sponsor decision|0
1143891|NCT02963506|2249926|FG007|Dose-Blind Period|Sponsor decision|0
1143892|NCT02963506|2249927|FG008|Dose-Blind Period|Sponsor decision|0
1143893|NCT02963506|2249928|FG009|Dose-Blind Period|Sponsor decision|0
1143894|NCT02963506|2249929|FG010|Dose-Blind Period|Sponsor decision|0
1143895|NCT02963506|2249930|FG011|Dose-Blind Period|Sponsor decision|0
1143896|NCT02963506|2249931|FG012|Dose-Blind Period|Sponsor decision|0
1143897|NCT02963506|2249919|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0
1143898|NCT02963506|2249920|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0
1143899|NCT02963506|2249921|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0
1143900|NCT02963506|2249922|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0
1143901|NCT02963506|2249923|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0
1143902|NCT02963506|2249924|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0
1143903|NCT02963506|2249925|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0
1143904|NCT02963506|2249926|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0
1143905|NCT02963506|2249927|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0
1143906|NCT02963506|2249928|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0
1143907|NCT02963506|2249929|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0
1143908|NCT02963506|2249930|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0
1143909|NCT02963506|2249931|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1
1143910|NCT02963701|2249959|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
1143911|NCT02963701|2249960|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
1143912|NCT02963922|2249968|FG000|Overall Study|Adverse Event|15
1143913|NCT02963922|2249969|FG001|Overall Study|Adverse Event|6
1143914|NCT02963922|2249968|FG000|Overall Study|Protocol deviation|6
1143915|NCT02963922|2249969|FG001|Overall Study|Protocol deviation|6
1143916|NCT02963922|2249968|FG000|Overall Study|Lack of Efficacy|1
1143917|NCT02963922|2249969|FG001|Overall Study|Lack of Efficacy|1
1143918|NCT02963922|2249968|FG000|Overall Study|Lost to Follow-up|2
1143919|NCT02963922|2249969|FG001|Overall Study|Lost to Follow-up|3
1143920|NCT02963922|2249968|FG000|Overall Study|Other|8
1143921|NCT02963922|2249969|FG001|Overall Study|Other|14
1143922|NCT02963935|2249977|FG000|Overall Study|Adverse Event|12
1143923|NCT02963935|2249978|FG001|Overall Study|Adverse Event|6
1143924|NCT02963935|2249977|FG000|Overall Study|Protocol Violation|2
1143925|NCT02963935|2249978|FG001|Overall Study|Protocol Violation|1
1143926|NCT02963935|2249977|FG000|Overall Study|Lack of Efficacy|0
1143927|NCT02963935|2249978|FG001|Overall Study|Lack of Efficacy|2
1143928|NCT02963935|2249977|FG000|Overall Study|Lost to Follow-up|1
1143929|NCT02963935|2249978|FG001|Overall Study|Lost to Follow-up|6
1143930|NCT02963935|2249977|FG000|Overall Study|Unclassified|13
1143931|NCT02963935|2249978|FG001|Overall Study|Unclassified|22
1143932|NCT02964234|2250003|FG000|Overall Study|Lost to Follow-up|22
1143933|NCT02964234|2250004|FG001|Overall Study|Lost to Follow-up|13
1143934|NCT02964247|2250012|FG000|Overall Study|Lost to Follow-up|2
1143935|NCT02964247|2250013|FG001|Overall Study|Lost to Follow-up|0
1143936|NCT02964247|2250012|FG000|Overall Study|Withdrawal by Subject|1
1143937|NCT02964247|2250013|FG001|Overall Study|Withdrawal by Subject|2
1143938|NCT02964312|2250019|FG000|Overall Study|Lost to Follow-up|28
1143939|NCT02964312|2250019|FG000|Overall Study|Withdrawal by Subject|11
1143940|NCT02964312|2250019|FG000|Overall Study|Lack of Efficacy|10
1143941|NCT02964312|2250019|FG000|Overall Study|Did not consent to long-term FU|14
1143942|NCT02964312|2250019|FG000|Overall Study|Death|1
1143943|NCT02964325|2250028|FG000|Overall Study|Lost to Follow-up|3
1143944|NCT02964325|2250029|FG001|Overall Study|Lost to Follow-up|3
1143945|NCT02964325|2250028|FG000|Overall Study|Physician Decision|5
1143946|NCT02964325|2250029|FG001|Overall Study|Physician Decision|4
1143947|NCT02964325|2250028|FG000|Overall Study|Death|1
1143948|NCT02964325|2250029|FG001|Overall Study|Death|3
1143949|NCT02964325|2250028|FG000|Overall Study|Withdrawal by Subject|2
1143950|NCT02964325|2250029|FG001|Overall Study|Withdrawal by Subject|1
1143951|NCT02964325|2250028|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10
1143952|NCT02964325|2250029|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12
1143953|NCT02964338|2250038|FG000|Overall Study|Sponsor terminated study for futility|12
1143954|NCT02964338|2250039|FG001|Overall Study|Sponsor terminated study for futility|15
1143955|NCT02964338|2250040|FG002|Overall Study|Sponsor terminated study for futility|14
1143956|NCT02964338|2250038|FG000|Overall Study|Lack of Efficacy|0
1143957|NCT02964338|2250039|FG001|Overall Study|Lack of Efficacy|3
1143958|NCT02964338|2250040|FG002|Overall Study|Lack of Efficacy|0
1143959|NCT02964338|2250038|FG000|Overall Study|Lost to Follow-up|1
1143960|NCT02964338|2250039|FG001|Overall Study|Lost to Follow-up|0
1143961|NCT02964338|2250040|FG002|Overall Study|Lost to Follow-up|3
1143962|NCT02964338|2250038|FG000|Overall Study|Protocol Violation|0
1143963|NCT02964338|2250039|FG001|Overall Study|Protocol Violation|1
1143964|NCT02964338|2250040|FG002|Overall Study|Protocol Violation|0
1143965|NCT02964338|2250038|FG000|Overall Study|Withdrawal by Subject|1
1143966|NCT02964338|2250039|FG001|Overall Study|Withdrawal by Subject|3
1143967|NCT02964338|2250040|FG002|Overall Study|Withdrawal by Subject|1
1143968|NCT02964338|2250038|FG000|Overall Study|Adverse Event|2
1143969|NCT02964338|2250039|FG001|Overall Study|Adverse Event|1
1143970|NCT02964338|2250040|FG002|Overall Study|Adverse Event|1
1143971|NCT02964338|2250038|FG000|Overall Study|Non-compliant with e-diary|0
1143972|NCT02964338|2250039|FG001|Overall Study|Non-compliant with e-diary|1
1143973|NCT02964338|2250040|FG002|Overall Study|Non-compliant with e-diary|0
1143974|NCT02964338|2250038|FG000|Overall Study|Did not meet criteria|1
1143975|NCT02964338|2250039|FG001|Overall Study|Did not meet criteria|0
1143976|NCT02964338|2250040|FG002|Overall Study|Did not meet criteria|0
1143977|NCT02965378|2250097|FG000|Overall Study|Progression|16
1143978|NCT02965378|2250098|FG001|Overall Study|Progression|4
1143979|NCT02965378|2250097|FG000|Overall Study|Adverse Event|5
1143980|NCT02965378|2250098|FG001|Overall Study|Adverse Event|2
901930|NCT00736879|1875592|FG003|Double Blind Treatment Period|No longer met criteria|0
901931|NCT00736879|1875589|FG000|Double Blind Treatment Period|non-specified|0
901932|NCT00736879|1875590|FG001|Double Blind Treatment Period|non-specified|1
901933|NCT00736879|1875591|FG002|Double Blind Treatment Period|non-specified|0
901934|NCT00736879|1875592|FG003|Double Blind Treatment Period|non-specified|0
901935|NCT00736879|1875589|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
901936|NCT00736879|1875590|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
901937|NCT00736879|1875591|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
901938|NCT00736879|1875592|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
901939|NCT00736879|1875589|FG000|Follow up Period - No Drug Treatment|non-specified|1
901940|NCT00736879|1875590|FG001|Follow up Period - No Drug Treatment|non-specified|2
901941|NCT00736879|1875591|FG002|Follow up Period - No Drug Treatment|non-specified|0
901942|NCT00736879|1875592|FG003|Follow up Period - No Drug Treatment|non-specified|0
901943|NCT00736944|1875605|FG000|Induction|Death|1
901944|NCT00736944|1875605|FG000|Definitive Treatment|Physician Decision|1
901945|NCT00736957|1875612|FG000|Overall Study|Adverse Event|43
901946|NCT00736957|1875612|FG000|Overall Study|Withdrawal by Subject|49
901947|NCT00736957|1875612|FG000|Overall Study|violation of eligibility criteria|2
901948|NCT00736957|1875612|FG000|Overall Study|did not attend hospital appointments|1
901949|NCT00736957|1875612|FG000|Overall Study|not eligible for Treatment Period I|22
901950|NCT00736957|1875612|FG000|Overall Study|Physician Decision|5
901951|NCT00736996|1875619|FG000|Overall Study|Lost to Follow-up|1
901952|NCT00736996|1875620|FG001|Overall Study|Lost to Follow-up|9
901953|NCT00736996|1875621|FG002|Overall Study|Lost to Follow-up|2
901954|NCT00737048|1875632|FG000|Overall Study|Physician Decision|0
901955|NCT00737048|1875633|FG001|Overall Study|Physician Decision|0
901956|NCT00737048|1875634|FG002|Overall Study|Physician Decision|1
901957|NCT00737048|1875632|FG000|Overall Study|Adverse Event|0
901958|NCT00737048|1875633|FG001|Overall Study|Adverse Event|1
901959|NCT00737048|1875634|FG002|Overall Study|Adverse Event|0
901960|NCT00737048|1875632|FG000|Overall Study|Worsening of the symptoms|3
901961|NCT00737048|1875633|FG001|Overall Study|Worsening of the symptoms|5
901962|NCT00737048|1875634|FG002|Overall Study|Worsening of the symptoms|3
901963|NCT00737061|1875642|FG000|Waiting Period|Lost to Follow-up|6
901964|NCT00737061|1875642|FG000|Waiting Period|Withdrawal by Subject|1
901965|NCT00737061|1875642|FG000|Waiting Period|Bilateral placement failure|34
901966|NCT00737061|1875642|FG000|Waiting Period|Deemed patent following HSG|26
901967|NCT00737061|1875642|FG000|Waiting Period|Alternative contraception failure|3
901968|NCT00737061|1875642|FG000|Waiting Period|Elected surgical tubal ligation|5
901969|NCT00737061|1875642|FG000|1 Year Wearing Period|Lost to Follow-up|11
901970|NCT00737061|1875642|FG000|1 Year Wearing Period|Withdrawal by Subject|2
901971|NCT00737061|1875642|FG000|1 Year Wearing Period|Discontinued reilance|3
901972|NCT00737061|1875642|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1
901973|NCT00737100|1875649|FG000|Overall Study|Adverse Event|6
901974|NCT00737100|1875650|FG001|Overall Study|Adverse Event|5
901975|NCT00737100|1875651|FG002|Overall Study|Adverse Event|3
901976|NCT00737100|1875649|FG000|Overall Study|Lost to Follow-up|0
901977|NCT00737100|1875650|FG001|Overall Study|Lost to Follow-up|1
901978|NCT00737100|1875651|FG002|Overall Study|Lost to Follow-up|0
901979|NCT00737100|1875649|FG000|Overall Study|Withdrawal by Subject|0
901980|NCT00737100|1875650|FG001|Overall Study|Withdrawal by Subject|0
901981|NCT00737100|1875651|FG002|Overall Study|Withdrawal by Subject|3
901982|NCT00737100|1875649|FG000|Overall Study|Reason discontinued not explained above|1
901983|NCT00737100|1875650|FG001|Overall Study|Reason discontinued not explained above|1
901984|NCT00737100|1875651|FG002|Overall Study|Reason discontinued not explained above|1
901985|NCT00737438|1875689|FG000|Overall Study|Withdrawal by Subject|2
901986|NCT00737438|1875689|FG000|Overall Study|Patient ineligible|1
901987|NCT00737464|1875693|FG000|Overall Study|Adverse Event|1
901988|NCT00737464|1875693|FG000|Overall Study|Death|6
901989|NCT00737464|1875693|FG000|Overall Study|Other - Failure to Return|1
901990|NCT00737464|1875693|FG000|Overall Study|Refused Treatment / Withdrew Consent|6
901991|NCT00737464|1875693|FG000|Overall Study|Other reasons|4
901992|NCT00737477|1875697|FG000|Overall Study|Adverse Event|9
901993|NCT00737477|1875697|FG000|Overall Study|Death|9
901994|NCT00737477|1875697|FG000|Overall Study|Treatment Refusal|1
901995|NCT00737477|1875697|FG000|Overall Study|Withdrawal by Subject|1
901996|NCT00737477|1875697|FG000|Overall Study|Renal Transplantation|10
901997|NCT00737477|1875697|FG000|Overall Study|Other|4
901998|NCT00737529|1875701|FG000|Overall Study|Disease Progression|95
901999|NCT00737529|1875701|FG000|Overall Study|Adverse Event|24
902000|NCT00737529|1875701|FG000|Overall Study|Withdrawal by Subject|5
902001|NCT00737529|1875701|FG000|Overall Study|Death|4
902002|NCT00737529|1875701|FG000|Overall Study|Protocol Violation|1
902003|NCT00737529|1875701|FG000|Overall Study|Other|4
902004|NCT00737568|1875707|FG000|Treatment Period Through Week 240|Investigator's Discretion|6
902005|NCT00737568|1875708|FG001|Treatment Period Through Week 240|Investigator's Discretion|5
902006|NCT00737568|1875707|FG000|Treatment Period Through Week 240|Withdrew Consent|5
902007|NCT00737568|1875708|FG001|Treatment Period Through Week 240|Withdrew Consent|6
902008|NCT00737568|1875707|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
902009|NCT00737568|1875708|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
902010|NCT00737568|1875707|FG000|Treatment Period Through Week 240|Lost to Follow-up|3
902011|NCT00737568|1875708|FG001|Treatment Period Through Week 240|Lost to Follow-up|3
1143981|NCT02965378|2250097|FG000|Overall Study|Death|2
1143982|NCT02965378|2250098|FG001|Overall Study|Death|0
1143983|NCT02965378|2250097|FG000|Overall Study|Refusal|2
1143984|NCT02965378|2250098|FG001|Overall Study|Refusal|1
1143985|NCT02965378|2250097|FG000|Overall Study|Not protocol specified|0
1143986|NCT02965378|2250098|FG001|Overall Study|Not protocol specified|2
1143987|NCT02965456|2250106|FG000|Overall Study|Lost to Follow-up|40
1143988|NCT02965456|2250107|FG001|Overall Study|Lost to Follow-up|18
1143989|NCT02965456|2250106|FG000|Overall Study|Subject Request|22
1143990|NCT02965456|2250107|FG001|Overall Study|Subject Request|13
1143991|NCT02965456|2250106|FG000|Overall Study|Withdrawal by Parent or Guardian|3
1143992|NCT02965456|2250107|FG001|Overall Study|Withdrawal by Parent or Guardian|6
1143993|NCT02965456|2250106|FG000|Overall Study|Adverse Event|3
1143994|NCT02965456|2250107|FG001|Overall Study|Adverse Event|0
1143995|NCT02965456|2250106|FG000|Overall Study|Noncompliance with Study Drug|1
1143996|NCT02965456|2250107|FG001|Overall Study|Noncompliance with Study Drug|1
1143997|NCT02965456|2250106|FG000|Overall Study|Worsening Condition|0
1143998|NCT02965456|2250107|FG001|Overall Study|Worsening Condition|2
1143999|NCT02965456|2250106|FG000|Overall Study|Lack of Efficacy|1
1144000|NCT02965456|2250107|FG001|Overall Study|Lack of Efficacy|0
1144001|NCT02965456|2250106|FG000|Overall Study|Physician Decision|0
1144002|NCT02965456|2250107|FG001|Overall Study|Physician Decision|1
1144003|NCT02965456|2250106|FG000|Overall Study|Pregnancy|1
1144004|NCT02965456|2250107|FG001|Overall Study|Pregnancy|0
1144005|NCT02965456|2250106|FG000|Overall Study|Protocol Violation|0
1144006|NCT02965456|2250107|FG001|Overall Study|Protocol Violation|1
1144007|NCT02965456|2250106|FG000|Overall Study|Participant ran out of study drug|0
1144008|NCT02965456|2250107|FG001|Overall Study|Participant ran out of study drug|1
1144009|NCT02965573|2250123|FG000|Overall Study|Lack of Efficacy|1
1144010|NCT02965573|2250124|FG001|Overall Study|Lack of Efficacy|0
1144011|NCT02965599|2250132|FG000|Overall Study|Protocol-defined stop criteria reached|1
1144012|NCT02965599|2250133|FG001|Overall Study|Protocol-defined stop criteria reached|0
1144013|NCT02965820|2250166|FG000|Period 2, Second 30 Days|Adverse Event|1
1144014|NCT02965820|2250167|FG001|Period 2, Second 30 Days|Adverse Event|1
1144015|NCT02965833|2250173|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
1144016|NCT02965833|2250174|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
1144017|NCT02965833|2250173|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1144018|NCT02965833|2250174|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1144019|NCT02965833|2250173|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1
1144020|NCT02965833|2250174|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0
1144021|NCT02965833|2250173|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
1144022|NCT02965833|2250174|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
1144023|NCT02965833|2250173|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2
1144024|NCT02965833|2250174|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0
1144025|NCT02966002|2250199|FG000|Overall Study|Withdrawal by Subject|2
1144026|NCT02966002|2250199|FG000|Overall Study|Adverse Event|1
1144027|NCT02966002|2250199|FG000|Overall Study|Lost to Follow-up|1
1144028|NCT02966015|2250205|FG000|Inclusion Visit|did not answer questionnaire|8
1144029|NCT02966015|2250206|FG001|Inclusion Visit|did not answer questionnaire|3
1144030|NCT02966028|2250215|FG000|Overall Study|Adverse Event|7
1144031|NCT02966028|2250216|FG001|Overall Study|Adverse Event|13
1144032|NCT02966028|2250217|FG002|Overall Study|Adverse Event|10
1144033|NCT02966028|2250215|FG000|Overall Study|Physician Decision|1
1144034|NCT02966028|2250216|FG001|Overall Study|Physician Decision|0
1144035|NCT02966028|2250217|FG002|Overall Study|Physician Decision|2
1144036|NCT02966028|2250215|FG000|Overall Study|Withdrawal by Subject|7
1144037|NCT02966028|2250216|FG001|Overall Study|Withdrawal by Subject|5
1144038|NCT02966028|2250217|FG002|Overall Study|Withdrawal by Subject|5
1144039|NCT02966028|2250215|FG000|Overall Study|Kidney transplant Changed dialysis units|9
1144040|NCT02966028|2250216|FG001|Overall Study|Kidney transplant Changed dialysis units|16
1144041|NCT02966028|2250217|FG002|Overall Study|Kidney transplant Changed dialysis units|14
1144042|NCT02966314|2250238|FG000|Overall Study|Lost to Follow-up|1
1144043|NCT02966314|2250239|FG001|Overall Study|Lost to Follow-up|0
1144044|NCT02966340|2250245|FG000|Overall Study|Adverse Event|0
1144045|NCT02966340|2250246|FG001|Overall Study|Adverse Event|1
1144046|NCT02966340|2250245|FG000|Overall Study|Lost to Follow-up|0
1144047|NCT02966340|2250246|FG001|Overall Study|Lost to Follow-up|1
1144048|NCT02966340|2250245|FG000|Overall Study|Withdrawal by Subject|1
1144049|NCT02966340|2250246|FG001|Overall Study|Withdrawal by Subject|0
1144050|NCT02966340|2250245|FG000|Overall Study|data acquisition error|1
1144051|NCT02966340|2250246|FG001|Overall Study|data acquisition error|0
1144052|NCT02966340|2250245|FG000|Overall Study|startle non-responder|1
1144053|NCT02966340|2250246|FG001|Overall Study|startle non-responder|1
1144054|NCT02966353|2250252|FG000|Overall Study|Withdrawal by Subject|7
1144055|NCT02966353|2250252|FG000|Overall Study|Adverse Event|4
1144056|NCT02966353|2250252|FG000|Overall Study|Death|4
1144057|NCT02966353|2250252|FG000|Overall Study|Physician Decision|3
1144058|NCT02966353|2250252|FG000|Overall Study|Progressive disease|2
1144059|NCT02966353|2250252|FG000|Overall Study|Protocol deviation|2
1144060|NCT02966509|2250258|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2
1144061|NCT02966509|2250259|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3
1144062|NCT02966509|2250258|FG000|Baseline Satisfaction Survey|Death|0
1144063|NCT02966509|2250259|FG001|Baseline Satisfaction Survey|Death|1
1144064|NCT02966509|2250258|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1
1144065|NCT02966509|2250259|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1
1144066|NCT02966509|2250258|FG000|Baseline Satisfaction Survey|Refused to Answer|1
1144067|NCT02966509|2250259|FG001|Baseline Satisfaction Survey|Refused to Answer|2
1144068|NCT02966509|2250258|FG000|6 Month Satisfaction Decision Survey|Death|22
1144069|NCT02966509|2250259|FG001|6 Month Satisfaction Decision Survey|Death|25
1144070|NCT02966509|2250258|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
1144071|NCT02966509|2250259|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
1144072|NCT02966509|2250258|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
1144073|NCT02966509|2250259|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
1144074|NCT02966509|2250258|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0
1144075|NCT02966509|2250259|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2
1144076|NCT02966509|2250258|FG000|6 Month Satisfaction Survey|Death|36
1144077|NCT02966509|2250259|FG001|6 Month Satisfaction Survey|Death|33
1144078|NCT02966509|2250258|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2
1144079|NCT02966509|2250259|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3
1144080|NCT02966509|2250258|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1
1144081|NCT02966509|2250259|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1
1144082|NCT02966509|2250258|FG000|6 Month Satisfaction Survey|Refused to Answer|8
1144083|NCT02966509|2250259|FG001|6 Month Satisfaction Survey|Refused to Answer|11
1144084|NCT02966509|2250258|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
1144085|NCT02966509|2250259|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
1144086|NCT02966509|2250258|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45
1144087|NCT02966509|2250259|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48
1144088|NCT02966795|2250267|FG000|Overall Study|Patient Left the Country|0
1144089|NCT02966795|2250268|FG001|Overall Study|Patient Left the Country|1
1144090|NCT02966834|2250279|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0
1144091|NCT02966834|2250280|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0
1144092|NCT02966834|2250281|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0
1144093|NCT02966834|2250282|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0
1144094|NCT02966834|2250283|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1
1144095|NCT02966834|2250284|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0
1144096|NCT02966834|2250279|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1
1144097|NCT02966834|2250280|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
1144098|NCT02966834|2250281|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
1144099|NCT02966834|2250282|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
1144100|NCT02966834|2250283|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
1144101|NCT02966834|2250284|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
1144102|NCT02966834|2250279|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
1144103|NCT02966834|2250280|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
1144104|NCT02966834|2250281|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4
1144105|NCT02966834|2250282|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8
1144106|NCT02966834|2250283|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
1144107|NCT02966834|2250284|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5
1144108|NCT02966834|2250279|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0
1144109|NCT02966834|2250280|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0
1144110|NCT02966834|2250281|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1
1144111|NCT02966834|2250282|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2
1144112|NCT02966834|2250283|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0
1144113|NCT02966834|2250284|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1
1144114|NCT02966834|2250279|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
1144115|NCT02966834|2250280|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
1144116|NCT02966834|2250281|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
1144117|NCT02966834|2250282|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2
1144118|NCT02966834|2250283|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
1144119|NCT02966834|2250284|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
1144120|NCT02966834|2250279|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0
1144121|NCT02966834|2250280|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0
1144122|NCT02966834|2250281|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0
1144123|NCT02966834|2250282|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1
1144124|NCT02966834|2250283|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0
1144125|NCT02966834|2250284|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0
1144126|NCT02967055|2250342|FG000|Overall Study|Excluded|40
1144127|NCT02967055|2250342|FG000|Overall Study|Screen fail|3
1144128|NCT02967055|2250342|FG000|Overall Study|Lost to Follow-up|2
1144129|NCT02967055|2250342|FG000|Overall Study|Stopped due to side effects|3
1144130|NCT02967055|2250342|FG000|Overall Study|Stopped due to drug cost|1
1144131|NCT02967562|2250411|FG000|Overall Study|Consent not obtained|1
1144132|NCT02967562|2250412|FG001|Overall Study|Consent not obtained|0
1144133|NCT02967562|2250411|FG000|Overall Study|High leak precluding analysis|1
1144134|NCT02967562|2250412|FG001|Overall Study|High leak precluding analysis|1
1144135|NCT02967679|2250418|FG000|Overall Study|Adverse Event|1
1144136|NCT02968004|2250435|FG000|Overall Study|Adverse Event|1
1144137|NCT02968004|2250436|FG001|Overall Study|Adverse Event|0
1144138|NCT02968004|2250435|FG000|Overall Study|Withdrawal by Subject|0
1144139|NCT02968004|2250436|FG001|Overall Study|Withdrawal by Subject|1
1144140|NCT02968173|2250446|FG000|Overall Study|Withdrawal by Subject|1
1144141|NCT02968433|2250501|FG000|Overall Study|Withdrawal by Subject|1
1144148|NCT02968576|2250520|FG000|Overall Study|Pregnancy|0
1144149|NCT02968576|2250521|FG001|Overall Study|Pregnancy|1
1144150|NCT02968979|2250551|FG000|Overall Study|Protocol Violation|7
1144151|NCT02968979|2250551|FG000|Overall Study|Withdrawal by Subject|1
1144152|NCT02969018|2250618|FG000|Overall Study|Adverse Event|2
1144153|NCT02969018|2250619|FG001|Overall Study|Adverse Event|4
1144154|NCT02969018|2250620|FG002|Overall Study|Adverse Event|1
1144155|NCT02969018|2250621|FG003|Overall Study|Adverse Event|2
1144156|NCT02969018|2250622|FG004|Overall Study|Adverse Event|0
1144157|NCT02969018|2250623|FG005|Overall Study|Adverse Event|1
1144158|NCT02969018|2250624|FG006|Overall Study|Adverse Event|2
1144159|NCT02969018|2250625|FG007|Overall Study|Adverse Event|0
1144160|NCT02969018|2250618|FG000|Overall Study|Lack of Efficacy|0
1144161|NCT02969018|2250619|FG001|Overall Study|Lack of Efficacy|1
1144162|NCT02969018|2250620|FG002|Overall Study|Lack of Efficacy|0
1144163|NCT02969018|2250621|FG003|Overall Study|Lack of Efficacy|0
1144164|NCT02969018|2250622|FG004|Overall Study|Lack of Efficacy|1
1144165|NCT02969018|2250623|FG005|Overall Study|Lack of Efficacy|1
1144166|NCT02969018|2250624|FG006|Overall Study|Lack of Efficacy|1
1144167|NCT02969018|2250625|FG007|Overall Study|Lack of Efficacy|1
1144168|NCT02969018|2250618|FG000|Overall Study|Lost to Follow-up|1
1144169|NCT02969018|2250619|FG001|Overall Study|Lost to Follow-up|2
1144170|NCT02969018|2250620|FG002|Overall Study|Lost to Follow-up|2
1144171|NCT02969018|2250621|FG003|Overall Study|Lost to Follow-up|0
1144172|NCT02969018|2250622|FG004|Overall Study|Lost to Follow-up|1
1144173|NCT02969018|2250623|FG005|Overall Study|Lost to Follow-up|1
1144174|NCT02969018|2250624|FG006|Overall Study|Lost to Follow-up|0
1144175|NCT02969018|2250625|FG007|Overall Study|Lost to Follow-up|1
1144176|NCT02969018|2250618|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
1144177|NCT02969018|2250619|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
1144178|NCT02969018|2250620|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
1144179|NCT02969018|2250621|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
1144180|NCT02969018|2250622|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
1144181|NCT02969018|2250623|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
1144182|NCT02969018|2250624|FG006|Overall Study|No Longer Meets Eligibility Criteria|1
1144183|NCT02969018|2250625|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
1144184|NCT02969018|2250618|FG000|Overall Study|Non-Compliance With Study Drug|1
1144185|NCT02969018|2250619|FG001|Overall Study|Non-Compliance With Study Drug|0
1144186|NCT02969018|2250620|FG002|Overall Study|Non-Compliance With Study Drug|0
1144187|NCT02969018|2250621|FG003|Overall Study|Non-Compliance With Study Drug|0
1144188|NCT02969018|2250622|FG004|Overall Study|Non-Compliance With Study Drug|0
1144189|NCT02969018|2250623|FG005|Overall Study|Non-Compliance With Study Drug|0
1144190|NCT02969018|2250624|FG006|Overall Study|Non-Compliance With Study Drug|0
1144191|NCT02969018|2250625|FG007|Overall Study|Non-Compliance With Study Drug|0
1144192|NCT02969018|2250618|FG000|Overall Study|Other|0
1144193|NCT02969018|2250619|FG001|Overall Study|Other|0
1144194|NCT02969018|2250620|FG002|Overall Study|Other|0
1144195|NCT02969018|2250621|FG003|Overall Study|Other|1
1144196|NCT02969018|2250622|FG004|Overall Study|Other|0
1144197|NCT02969018|2250623|FG005|Overall Study|Other|0
1144198|NCT02969018|2250624|FG006|Overall Study|Other|0
1144199|NCT02969018|2250625|FG007|Overall Study|Other|2
1144200|NCT02969018|2250618|FG000|Overall Study|Pregnancy|0
1144201|NCT02969018|2250619|FG001|Overall Study|Pregnancy|0
1144202|NCT02969018|2250620|FG002|Overall Study|Pregnancy|0
1144203|NCT02969018|2250621|FG003|Overall Study|Pregnancy|0
1144204|NCT02969018|2250622|FG004|Overall Study|Pregnancy|0
1144205|NCT02969018|2250623|FG005|Overall Study|Pregnancy|1
1144206|NCT02969018|2250624|FG006|Overall Study|Pregnancy|0
1144207|NCT02969018|2250625|FG007|Overall Study|Pregnancy|0
1144208|NCT02969018|2250618|FG000|Overall Study|Protocol Violation|0
1144209|NCT02969018|2250619|FG001|Overall Study|Protocol Violation|0
1144210|NCT02969018|2250620|FG002|Overall Study|Protocol Violation|1
1144211|NCT02969018|2250621|FG003|Overall Study|Protocol Violation|1
1144212|NCT02969018|2250622|FG004|Overall Study|Protocol Violation|0
1144213|NCT02969018|2250623|FG005|Overall Study|Protocol Violation|0
1144214|NCT02969018|2250624|FG006|Overall Study|Protocol Violation|0
1144215|NCT02969018|2250625|FG007|Overall Study|Protocol Violation|0
1144216|NCT02969018|2250618|FG000|Overall Study|Withdrawal by Subject|0
1144217|NCT02969018|2250619|FG001|Overall Study|Withdrawal by Subject|1
1144218|NCT02969018|2250620|FG002|Overall Study|Withdrawal by Subject|2
1144219|NCT02969018|2250621|FG003|Overall Study|Withdrawal by Subject|1
1144220|NCT02969018|2250622|FG004|Overall Study|Withdrawal by Subject|0
1144221|NCT02969018|2250623|FG005|Overall Study|Withdrawal by Subject|4
1144222|NCT02969018|2250624|FG006|Overall Study|Withdrawal by Subject|4
1144223|NCT02969018|2250625|FG007|Overall Study|Withdrawal by Subject|3
1144224|NCT02969044|2250657|FG000|Overall Study|Withdrawal by Subject|2
1144225|NCT02969044|2250658|FG001|Overall Study|Withdrawal by Subject|6
1144226|NCT02969044|2250657|FG000|Overall Study|Adverse Event|3
1144227|NCT02969044|2250658|FG001|Overall Study|Adverse Event|0
1144228|NCT02969187|2250666|FG000|Overall Study|Physician Decision|12
1144229|NCT02969187|2250667|FG001|Overall Study|Physician Decision|13
1144230|NCT02969356|2250680|FG000|Overall Study|Adverse Event|7
1144231|NCT02969356|2250680|FG000|Overall Study|Consent withdrawn|2
1144232|NCT02969356|2250680|FG000|Overall Study|Lost to Follow-up|3
1144233|NCT02969356|2250680|FG000|Overall Study|Did not need to be reinjected|6
1144234|NCT02969356|2250680|FG000|Overall Study|Personal reasons|5
1144235|NCT02969382|2250686|FG000|Overall Study|Adverse Event|8
1144236|NCT02969382|2250687|FG001|Overall Study|Adverse Event|10
1144237|NCT02969382|2250686|FG000|Overall Study|Lack of Efficacy|4
1144238|NCT02969382|2250687|FG001|Overall Study|Lack of Efficacy|5
1144239|NCT02969382|2250686|FG000|Overall Study|Death|0
1144240|NCT02969382|2250687|FG001|Overall Study|Death|1
1144241|NCT02969382|2250686|FG000|Overall Study|PROTOCOL DEVIATION|0
1144242|NCT02969382|2250687|FG001|Overall Study|PROTOCOL DEVIATION|1
1144243|NCT02969382|2250686|FG000|Overall Study|Withdrawal by Subject|14
1144244|NCT02969382|2250687|FG001|Overall Study|Withdrawal by Subject|9
1144245|NCT02969408|2250693|FG000|Overall Study|Adverse Event|2
1144246|NCT02969408|2250693|FG000|Overall Study|Withdrawal by Subject|8
1144247|NCT02969408|2250693|FG000|Overall Study|Lost to Follow-up|4
1144248|NCT02969408|2250693|FG000|Overall Study|Protocol Violation|1
1144249|NCT02969408|2250693|FG000|Overall Study|Other than specified|1
1144250|NCT02969525|2250715|FG000|Double-Blind Period|Adverse Event|0
1144251|NCT02969525|2250716|FG001|Double-Blind Period|Adverse Event|0
1144252|NCT02969525|2250717|FG002|Double-Blind Period|Adverse Event|1
1144253|NCT02969525|2250718|FG003|Double-Blind Period|Adverse Event|1
1144254|NCT02969525|2250719|FG004|Double-Blind Period|Adverse Event|0
1144255|NCT02969525|2250720|FG005|Double-Blind Period|Adverse Event|0
1144256|NCT02969525|2250721|FG006|Double-Blind Period|Adverse Event|0
1144257|NCT02969525|2250722|FG007|Double-Blind Period|Adverse Event|0
1144258|NCT02969525|2250723|FG008|Double-Blind Period|Adverse Event|0
1144259|NCT02969525|2250724|FG009|Double-Blind Period|Adverse Event|0
1144260|NCT02969525|2250725|FG010|Double-Blind Period|Adverse Event|0
1144261|NCT02969525|2250726|FG011|Double-Blind Period|Adverse Event|0
1144262|NCT02969525|2250715|FG000|Double-Blind Period|LOW EGFR|0
1144263|NCT02969525|2250716|FG001|Double-Blind Period|LOW EGFR|0
1144264|NCT02969525|2250717|FG002|Double-Blind Period|LOW EGFR|0
1144265|NCT02969525|2250718|FG003|Double-Blind Period|LOW EGFR|1
1144266|NCT02969525|2250719|FG004|Double-Blind Period|LOW EGFR|0
1144267|NCT02969525|2250720|FG005|Double-Blind Period|LOW EGFR|0
1144268|NCT02969525|2250721|FG006|Double-Blind Period|LOW EGFR|0
1144269|NCT02969525|2250722|FG007|Double-Blind Period|LOW EGFR|0
1144270|NCT02969525|2250723|FG008|Double-Blind Period|LOW EGFR|0
1144271|NCT02969525|2250724|FG009|Double-Blind Period|LOW EGFR|0
1144272|NCT02969525|2250725|FG010|Double-Blind Period|LOW EGFR|0
1144273|NCT02969525|2250726|FG011|Double-Blind Period|LOW EGFR|0
1144274|NCT02969525|2250715|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2
1144275|NCT02969525|2250716|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0
1144276|NCT02969525|2250717|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0
1144277|NCT02969525|2250718|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2
1144278|NCT02969525|2250719|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0
1144279|NCT02969525|2250720|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0
1144280|NCT02969525|2250721|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0
1144281|NCT02969525|2250722|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0
1144282|NCT02969525|2250723|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0
1144283|NCT02969525|2250724|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0
1144284|NCT02969525|2250725|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0
1144285|NCT02969525|2250726|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0
1144286|NCT02969525|2250715|FG000|Dose-Blind Period|Adverse Event|0
1144287|NCT02969525|2250716|FG001|Dose-Blind Period|Adverse Event|0
1144288|NCT02969525|2250717|FG002|Dose-Blind Period|Adverse Event|0
1144289|NCT02969525|2250718|FG003|Dose-Blind Period|Adverse Event|0
1144290|NCT02969525|2250719|FG004|Dose-Blind Period|Adverse Event|0
1144291|NCT02969525|2250720|FG005|Dose-Blind Period|Adverse Event|0
1144292|NCT02969525|2250721|FG006|Dose-Blind Period|Adverse Event|0
1144293|NCT02969525|2250722|FG007|Dose-Blind Period|Adverse Event|0
1144294|NCT02969525|2250723|FG008|Dose-Blind Period|Adverse Event|0
1144295|NCT02969525|2250724|FG009|Dose-Blind Period|Adverse Event|1
1144296|NCT02969525|2250725|FG010|Dose-Blind Period|Adverse Event|1
1144297|NCT02969525|2250726|FG011|Dose-Blind Period|Adverse Event|1
1144298|NCT02969525|2250715|FG000|Dose-Blind Period|Withdrawal by Subject|0
1144299|NCT02969525|2250716|FG001|Dose-Blind Period|Withdrawal by Subject|0
1144300|NCT02969525|2250717|FG002|Dose-Blind Period|Withdrawal by Subject|0
1144301|NCT02969525|2250718|FG003|Dose-Blind Period|Withdrawal by Subject|0
1144302|NCT02969525|2250719|FG004|Dose-Blind Period|Withdrawal by Subject|0
1144303|NCT02969525|2250720|FG005|Dose-Blind Period|Withdrawal by Subject|0
1144304|NCT02969525|2250721|FG006|Dose-Blind Period|Withdrawal by Subject|2
1144305|NCT02969525|2250722|FG007|Dose-Blind Period|Withdrawal by Subject|0
1144306|NCT02969525|2250723|FG008|Dose-Blind Period|Withdrawal by Subject|1
1144307|NCT02969525|2250724|FG009|Dose-Blind Period|Withdrawal by Subject|2
1144308|NCT02969525|2250725|FG010|Dose-Blind Period|Withdrawal by Subject|0
1144309|NCT02969525|2250726|FG011|Dose-Blind Period|Withdrawal by Subject|0
1144310|NCT02969525|2250715|FG000|Dose-Blind Period|Non-cooperating patient|0
1144311|NCT02969525|2250716|FG001|Dose-Blind Period|Non-cooperating patient|0
1144312|NCT02969525|2250717|FG002|Dose-Blind Period|Non-cooperating patient|0
1144313|NCT02969525|2250718|FG003|Dose-Blind Period|Non-cooperating patient|0
1144314|NCT02969525|2250719|FG004|Dose-Blind Period|Non-cooperating patient|0
1144315|NCT02969525|2250720|FG005|Dose-Blind Period|Non-cooperating patient|0
1144316|NCT02969525|2250721|FG006|Dose-Blind Period|Non-cooperating patient|0
1144317|NCT02969525|2250722|FG007|Dose-Blind Period|Non-cooperating patient|0
1144318|NCT02969525|2250723|FG008|Dose-Blind Period|Non-cooperating patient|0
1144319|NCT02969525|2250724|FG009|Dose-Blind Period|Non-cooperating patient|0
1144320|NCT02969525|2250725|FG010|Dose-Blind Period|Non-cooperating patient|0
1144321|NCT02969525|2250726|FG011|Dose-Blind Period|Non-cooperating patient|1
1144322|NCT02969525|2250715|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
1144323|NCT02969525|2250716|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
1144324|NCT02969525|2250717|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
1144325|NCT02969525|2250718|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
1144326|NCT02969525|2250719|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
1144327|NCT02969525|2250720|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
1144328|NCT02969525|2250721|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
1144329|NCT02969525|2250722|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
1144330|NCT02969525|2250723|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
1144331|NCT02969525|2250724|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
1144332|NCT02969525|2250725|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1
1144333|NCT02969525|2250726|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
1144334|NCT02969590|2250748|FG000|Screening Period|Hormones not suppressed post Lupron|1
1144335|NCT02969590|2250749|FG001|Screening Period|Hormones not suppressed post Lupron|0
1144336|NCT02969590|2250750|FG002|Screening Period|Hormones not suppressed post Lupron|0
1144337|NCT02969655|2250762|FG000|Overall Study|Withdrawal by Subject|3
1144338|NCT02969655|2250763|FG001|Overall Study|Withdrawal by Subject|2
1144339|NCT02969655|2250762|FG000|Overall Study|Physician Decision|4
1144340|NCT02969655|2250763|FG001|Overall Study|Physician Decision|3
1144341|NCT02969655|2250762|FG000|Overall Study|Protocol-specified withdrawal criteria|4
1144342|NCT02969655|2250763|FG001|Overall Study|Protocol-specified withdrawal criteria|2
1144343|NCT02969655|2250762|FG000|Overall Study|Adverse Event|10
1144344|NCT02969655|2250763|FG001|Overall Study|Adverse Event|8
1144345|NCT02969707|2250772|FG000|Overall Study|Adverse Event|1
1144346|NCT02969707|2250773|FG001|Overall Study|Adverse Event|2
1144347|NCT02969707|2250772|FG000|Overall Study|Lost to Follow-up|3
1144348|NCT02969707|2250773|FG001|Overall Study|Lost to Follow-up|0
1144349|NCT02969707|2250772|FG000|Overall Study|Physician Decision|0
1144350|NCT02969707|2250773|FG001|Overall Study|Physician Decision|1
1144351|NCT02969707|2250772|FG000|Overall Study|Protocol Violation|1
1144352|NCT02969707|2250773|FG001|Overall Study|Protocol Violation|1
1144353|NCT02969707|2250772|FG000|Overall Study|Withdrawal by Subject|3
1144354|NCT02969707|2250773|FG001|Overall Study|Withdrawal by Subject|4
1144355|NCT02969863|2250784|FG000|Overall Study|Physician Decision|1
1144356|NCT02969863|2250785|FG001|Overall Study|Physician Decision|0
1144357|NCT02969863|2250786|FG002|Overall Study|Physician Decision|0
1144358|NCT02969863|2250787|FG003|Overall Study|Physician Decision|0
1144359|NCT02969863|2250788|FG004|Overall Study|Physician Decision|0
1144360|NCT02969863|2250789|FG005|Overall Study|Physician Decision|0
1144361|NCT02970292|2250837|FG000|Overall Study|Physician Decision|1
1144362|NCT02970292|2250838|FG001|Overall Study|Physician Decision|1
1144363|NCT02970292|2250837|FG000|Overall Study|Withdrawal by Subject|11
1144364|NCT02970292|2250838|FG001|Overall Study|Withdrawal by Subject|5
1144365|NCT02970292|2250837|FG000|Overall Study|Noncompliance with study drug|2
1144366|NCT02970292|2250838|FG001|Overall Study|Noncompliance with study drug|2
1144367|NCT02970292|2250837|FG000|Overall Study|Adverse Event|5
1144368|NCT02970292|2250838|FG001|Overall Study|Adverse Event|0
1144369|NCT02970292|2250837|FG000|Overall Study|Lack of Efficacy|1
1144370|NCT02970292|2250838|FG001|Overall Study|Lack of Efficacy|0
1144371|NCT02970292|2250837|FG000|Overall Study|Lost to Follow-up|1
1144372|NCT02970292|2250838|FG001|Overall Study|Lost to Follow-up|0
1144373|NCT02970292|2250837|FG000|Overall Study|Protocol Violation|2
1144374|NCT02970292|2250838|FG001|Overall Study|Protocol Violation|0
1144375|NCT02970292|2250837|FG000|Overall Study|Other|1
1144376|NCT02970292|2250838|FG001|Overall Study|Other|0
1144377|NCT02970305|2250846|FG000|Overall Study|Adverse Event|10
1144378|NCT02970305|2250847|FG001|Overall Study|Adverse Event|6
1144379|NCT02970305|2250846|FG000|Overall Study|Lack of Efficacy|1
1144380|NCT02970305|2250847|FG001|Overall Study|Lack of Efficacy|1
1144381|NCT02970305|2250846|FG000|Overall Study|Noncompliance with study drug|2
1144382|NCT02970305|2250847|FG001|Overall Study|Noncompliance with study drug|4
1144383|NCT02970305|2250846|FG000|Overall Study|Protocol Violation|2
1144384|NCT02970305|2250847|FG001|Overall Study|Protocol Violation|2
1144385|NCT02970305|2250846|FG000|Overall Study|Withdrawal by Subject|12
1144386|NCT02970305|2250847|FG001|Overall Study|Withdrawal by Subject|11
1144387|NCT02970305|2250846|FG000|Overall Study|Not further specified|1
1144388|NCT02970305|2250847|FG001|Overall Study|Not further specified|2
1144389|NCT02970305|2250846|FG000|Overall Study|Lost to Follow-up|1
1144390|NCT02970305|2250847|FG001|Overall Study|Lost to Follow-up|2
1144391|NCT02970669|2250891|FG000|Double-blind Period|Adverse Event|4
1144392|NCT02970669|2250892|FG001|Double-blind Period|Adverse Event|0
1144393|NCT02970669|2250891|FG000|Double-blind Period|Death|1
1144394|NCT02970669|2250892|FG001|Double-blind Period|Death|0
1144395|NCT02970669|2250891|FG000|Double-blind Period|Study terminated by sponsor|1
1144396|NCT02970669|2250892|FG001|Double-blind Period|Study terminated by sponsor|2
1144397|NCT02970669|2250891|FG000|Double-blind Period|Physician Decision|0
1144398|NCT02970669|2250892|FG001|Double-blind Period|Physician Decision|2
1144399|NCT02970669|2250891|FG000|Double-blind Period|Withdrawal by Subject|2
1144400|NCT02970669|2250892|FG001|Double-blind Period|Withdrawal by Subject|2
1144401|NCT02970669|2250891|FG000|Open-label Period|Withdrawal by Subject|2
1144402|NCT02970669|2250892|FG001|Open-label Period|Withdrawal by Subject|2
1144403|NCT02970669|2250891|FG000|Open-label Period|Adverse Event|1
1144404|NCT02970669|2250892|FG001|Open-label Period|Adverse Event|0
1144405|NCT02970669|2250891|FG000|Open-label Period|Physician Decision|1
1144406|NCT02970669|2250892|FG001|Open-label Period|Physician Decision|0
1144407|NCT02970942|2250913|FG000|Overall Study|Death|0
1144408|NCT02970942|2250914|FG001|Overall Study|Death|1
1144409|NCT02970942|2250915|FG002|Overall Study|Death|0
1144410|NCT02970942|2250916|FG003|Overall Study|Death|0
1144411|NCT02970942|2250913|FG000|Overall Study|Lost to Follow-up|1
1144412|NCT02970942|2250914|FG001|Overall Study|Lost to Follow-up|0
1144413|NCT02970942|2250915|FG002|Overall Study|Lost to Follow-up|2
1144414|NCT02970942|2250916|FG003|Overall Study|Lost to Follow-up|1
1144415|NCT02970942|2250913|FG000|Overall Study|Withdrawal by Subject|3
1144416|NCT02970942|2250914|FG001|Overall Study|Withdrawal by Subject|5
1144417|NCT02970942|2250915|FG002|Overall Study|Withdrawal by Subject|3
1144418|NCT02970942|2250916|FG003|Overall Study|Withdrawal by Subject|2
1144419|NCT02971007|2250933|FG000|Overall Study|Adverse Event|1
1144420|NCT02971007|2250934|FG001|Overall Study|Adverse Event|0
1144421|NCT02971007|2250935|FG002|Overall Study|Adverse Event|0
1144422|NCT02971007|2250933|FG000|Overall Study|Lost to Follow-up|0
1144423|NCT02971007|2250934|FG001|Overall Study|Lost to Follow-up|1
1144424|NCT02971007|2250935|FG002|Overall Study|Lost to Follow-up|1
1144425|NCT02971007|2250933|FG000|Overall Study|Withdrawal by Subject|0
1144426|NCT02971007|2250934|FG001|Overall Study|Withdrawal by Subject|1
1144427|NCT02971007|2250935|FG002|Overall Study|Withdrawal by Subject|0
1144428|NCT02971007|2250933|FG000|Overall Study|Patient had yeast at Day 5 visit|1
1144429|NCT02971007|2250934|FG001|Overall Study|Patient had yeast at Day 5 visit|0
1144430|NCT02971007|2250935|FG002|Overall Study|Patient had yeast at Day 5 visit|0
1144431|NCT02971007|2250933|FG000|Overall Study|Patient discontinued study drug|0
1144432|NCT02971007|2250934|FG001|Overall Study|Patient discontinued study drug|1
1144433|NCT02971007|2250935|FG002|Overall Study|Patient discontinued study drug|0
1144434|NCT02971163|2250945|FG000|Overall Study|Lost to Follow-up|4
1144435|NCT02971163|2250946|FG001|Overall Study|Lost to Follow-up|2
1144436|NCT02971202|2250955|FG000|Overall Study|Pregnancy|1
1144437|NCT02971202|2250956|FG001|Overall Study|Pregnancy|0
1144438|NCT02971202|2250957|FG002|Overall Study|Pregnancy|0
1144439|NCT02971202|2250955|FG000|Overall Study|screen fail after consent|1
1144440|NCT02971202|2250956|FG001|Overall Study|screen fail after consent|0
1144441|NCT02971202|2250957|FG002|Overall Study|screen fail after consent|1
1144442|NCT02971228|2250965|FG000|Overall Study|Withdrawal by Subject|1
1144443|NCT02971228|2250966|FG001|Overall Study|Withdrawal by Subject|1
1144444|NCT02971228|2250967|FG002|Overall Study|Withdrawal by Subject|0
1144445|NCT02971228|2250968|FG003|Overall Study|Withdrawal by Subject|0
1144446|NCT02971228|2250969|FG004|Overall Study|Withdrawal by Subject|0
1144447|NCT02971228|2250965|FG000|Overall Study|Logistical challenges|0
1144448|NCT02971228|2250966|FG001|Overall Study|Logistical challenges|1
1144449|NCT02971228|2250967|FG002|Overall Study|Logistical challenges|0
1144450|NCT02971228|2250968|FG003|Overall Study|Logistical challenges|0
1144451|NCT02971228|2250969|FG004|Overall Study|Logistical challenges|0
1144452|NCT02971605|2250995|FG000|Overall Study|Withdrawal by Subject|1
1144453|NCT02971670|2251013|FG000|Overall Study|Withdrawal by Subject|4
1144454|NCT02971670|2251014|FG001|Overall Study|Withdrawal by Subject|1
1144455|NCT02971670|2251015|FG002|Overall Study|Withdrawal by Subject|1
1144456|NCT02971670|2251016|FG003|Overall Study|Withdrawal by Subject|2
1144457|NCT02971683|2251028|FG000|Overall Study|Other reasons|0
1144458|NCT02971683|2251029|FG001|Overall Study|Other reasons|1
1144459|NCT02971683|2251028|FG000|Overall Study|Poor/Non-Compliance|0
1144460|NCT02971683|2251029|FG001|Overall Study|Poor/Non-Compliance|1
1144461|NCT02971683|2251028|FG000|Overall Study|Lost to Follow-up|1
1144462|NCT02971683|2251029|FG001|Overall Study|Lost to Follow-up|0
1144463|NCT02971683|2251028|FG000|Overall Study|Participant withdrew consent|1
1144464|NCT02971683|2251029|FG001|Overall Study|Participant withdrew consent|1
1144465|NCT02971683|2251028|FG000|Overall Study|Participant request to discontinue study treatment|1
1144466|NCT02971683|2251029|FG001|Overall Study|Participant request to discontinue study treatment|1
1144467|NCT02971683|2251028|FG000|Overall Study|Adverse Event|1
1144468|NCT02971683|2251029|FG001|Overall Study|Adverse Event|2
1144469|NCT02971683|2251028|FG000|Overall Study|Lack of Efficacy|2
1144470|NCT02971683|2251029|FG001|Overall Study|Lack of Efficacy|2
1144471|NCT02971800|2251044|FG000|Overall Study|Protocol Violation|1
1144472|NCT02971800|2251044|FG000|Overall Study|Withdrawal by Subject|1
1144473|NCT02971800|2251044|FG000|Overall Study|Exclusion criteria prior intervention|1
1144474|NCT02971800|2251044|FG000|Overall Study|Number evaluable participant already reached|4
1144475|NCT02972242|2251050|FG000|Overall Study|Withdrawal by Subject|1
1144476|NCT02972242|2251051|FG001|Overall Study|Withdrawal by Subject|0
1144477|NCT02972359|2251057|FG000|Overall Study|Incl. criteria not met/Exclusion met|2
1144478|NCT02972359|2251057|FG000|Overall Study|Lack of Efficacy|1
1144479|NCT02972359|2251057|FG000|Overall Study|Adverse Event|4
1144480|NCT02972359|2251057|FG000|Overall Study|Death|1
1144481|NCT02972359|2251057|FG000|Overall Study|Withdrawal by Subject|30
1144482|NCT02972359|2251057|FG000|Overall Study|Protocol Violation|1
1144483|NCT02972359|2251057|FG000|Overall Study|Lost to Follow-up|26
1144484|NCT02972359|2251057|FG000|Overall Study|Other reasons|5
1144485|NCT02972359|2251057|FG000|Overall Study|Missing|1
1144486|NCT02972502|2251063|FG000|Overall Study|Lost to Follow-up|3
1144487|NCT02972502|2251064|FG001|Overall Study|Lost to Follow-up|1
1144488|NCT02972502|2251063|FG000|Overall Study|Withdrawal by Subject|1
1144489|NCT02972502|2251064|FG001|Overall Study|Withdrawal by Subject|1
1144490|NCT02972515|2251070|FG000|Overall Study|Lost to Follow-up|78
1144491|NCT02972632|2251083|FG000|Overall Study|Pretreatment Event/Adverse Event|3
1144492|NCT02972632|2251083|FG000|Overall Study|Lost to Follow-up|4
1144493|NCT02972632|2251083|FG000|Overall Study|Voluntary Withdrawal|10
1144494|NCT02972658|2251091|FG000|Overall Study|Adverse Event|0
1144495|NCT02972658|2251092|FG001|Overall Study|Adverse Event|3
1144496|NCT02972658|2251093|FG002|Overall Study|Adverse Event|0
1144497|NCT02972658|2251094|FG003|Overall Study|Adverse Event|2
1144498|NCT02972658|2251091|FG000|Overall Study|Other-determined by Investigator|1
1144499|NCT02972658|2251092|FG001|Overall Study|Other-determined by Investigator|1
1144500|NCT02972658|2251093|FG002|Overall Study|Other-determined by Investigator|0
1144501|NCT02972658|2251094|FG003|Overall Study|Other-determined by Investigator|0
1144502|NCT02972658|2251091|FG000|Overall Study|Death|0
1144503|NCT02972658|2251092|FG001|Overall Study|Death|0
1144504|NCT02972658|2251093|FG002|Overall Study|Death|0
1144505|NCT02972658|2251094|FG003|Overall Study|Death|1
1144506|NCT02972658|2251091|FG000|Overall Study|Lost to Follow-up|0
1144507|NCT02972658|2251092|FG001|Overall Study|Lost to Follow-up|1
1144508|NCT02972658|2251093|FG002|Overall Study|Lost to Follow-up|1
1144509|NCT02972658|2251094|FG003|Overall Study|Lost to Follow-up|2
1144510|NCT02972658|2251091|FG000|Overall Study|Progressive Disease|0
1144511|NCT02972658|2251092|FG001|Overall Study|Progressive Disease|1
1144512|NCT02972658|2251093|FG002|Overall Study|Progressive Disease|0
1144513|NCT02972658|2251094|FG003|Overall Study|Progressive Disease|1
1144514|NCT02972658|2251091|FG000|Overall Study|Withdrawal by Subject|4
1144515|NCT02972658|2251092|FG001|Overall Study|Withdrawal by Subject|4
1144516|NCT02972658|2251093|FG002|Overall Study|Withdrawal by Subject|1
1144517|NCT02972658|2251094|FG003|Overall Study|Withdrawal by Subject|6
1144518|NCT02972658|2251091|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1
1144519|NCT02972658|2251092|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1
1144520|NCT02972658|2251093|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1
1144521|NCT02972658|2251094|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0
1144522|NCT02972658|2251091|FG000|Overall Study|Sponsor Decision|70
1144523|NCT02972658|2251092|FG001|Overall Study|Sponsor Decision|127
1144524|NCT02972658|2251093|FG002|Overall Study|Sponsor Decision|72
1144525|NCT02972658|2251094|FG003|Overall Study|Sponsor Decision|119
1144526|NCT02973048|2251106|FG000|Overall Study|Epidural catheter insertion failure|1
1144527|NCT02973048|2251107|FG001|Overall Study|Epidural catheter insertion failure|0
1144528|NCT02973048|2251106|FG000|Overall Study|Withdrawal by Subject|0
1144529|NCT02973048|2251107|FG001|Overall Study|Withdrawal by Subject|3
1144530|NCT02973087|2251115|FG000|Overall Study|Withdrawal by Subject|2
1144531|NCT02973087|2251116|FG001|Overall Study|Withdrawal by Subject|1
1144532|NCT02973087|2251115|FG000|Overall Study|Adverse Event|1
1144533|NCT02973087|2251116|FG001|Overall Study|Adverse Event|0
1144534|NCT02973087|2251115|FG000|Overall Study|other|1
1144535|NCT02973087|2251116|FG001|Overall Study|other|1
1144536|NCT02973100|2251127|FG000|Overall Study|Adverse Event|1
1144537|NCT02973100|2251128|FG001|Overall Study|Adverse Event|2
1144538|NCT02973100|2251129|FG002|Overall Study|Adverse Event|1
1144539|NCT02973100|2251130|FG003|Overall Study|Adverse Event|2
1144540|NCT02973100|2251127|FG000|Overall Study|Lost to Follow-up|3
1144541|NCT02973100|2251128|FG001|Overall Study|Lost to Follow-up|1
1144542|NCT02973100|2251129|FG002|Overall Study|Lost to Follow-up|1
1144543|NCT02973100|2251130|FG003|Overall Study|Lost to Follow-up|0
1144544|NCT02973100|2251127|FG000|Overall Study|Withdrawal by Subject|3
1144545|NCT02973100|2251128|FG001|Overall Study|Withdrawal by Subject|5
1144546|NCT02973100|2251129|FG002|Overall Study|Withdrawal by Subject|1
1144547|NCT02973100|2251130|FG003|Overall Study|Withdrawal by Subject|4
1144548|NCT02973100|2251127|FG000|Overall Study|Notification of change in address|0
1144549|NCT02973100|2251128|FG001|Overall Study|Notification of change in address|0
1144550|NCT02973100|2251129|FG002|Overall Study|Notification of change in address|0
1144551|NCT02973100|2251130|FG003|Overall Study|Notification of change in address|1
1144552|NCT02973100|2251127|FG000|Overall Study|Failed to attend Safety followup period|0
1144553|NCT02973100|2251128|FG001|Overall Study|Failed to attend Safety followup period|0
1144554|NCT02973100|2251129|FG002|Overall Study|Failed to attend Safety followup period|1
1144555|NCT02973100|2251130|FG003|Overall Study|Failed to attend Safety followup period|0
1144556|NCT02973321|2251148|FG000|Overall Study|Other than specified|0
1144557|NCT02973321|2251149|FG001|Overall Study|Other than specified|5
1144558|NCT02973321|2251150|FG002|Overall Study|Other than specified|3
1144559|NCT02973321|2251151|FG003|Overall Study|Other than specified|3
1144560|NCT02973321|2251152|FG004|Overall Study|Other than specified|1
1144561|NCT02973321|2251148|FG000|Overall Study|Lack of Efficacy|0
1144562|NCT02973321|2251149|FG001|Overall Study|Lack of Efficacy|0
1144563|NCT02973321|2251150|FG002|Overall Study|Lack of Efficacy|0
1144564|NCT02973321|2251151|FG003|Overall Study|Lack of Efficacy|0
1144565|NCT02973321|2251152|FG004|Overall Study|Lack of Efficacy|1
1144566|NCT02973321|2251148|FG000|Overall Study|Adverse Event|1
1144567|NCT02973321|2251149|FG001|Overall Study|Adverse Event|10
1144568|NCT02973321|2251150|FG002|Overall Study|Adverse Event|11
1144569|NCT02973321|2251151|FG003|Overall Study|Adverse Event|13
1144570|NCT02973321|2251152|FG004|Overall Study|Adverse Event|3
1144571|NCT02973477|2251185|FG000|First Intervention|Lost to Follow-up|0
1144572|NCT02973477|2251186|FG001|First Intervention|Lost to Follow-up|2
1144573|NCT02973477|2251185|FG000|Washout|Withdrawal by Subject|1
1144574|NCT02973477|2251186|FG001|Washout|Withdrawal by Subject|0
1144575|NCT02973477|2251185|FG000|Second Intervention|Lost to Follow-up|1
1144576|NCT02973477|2251186|FG001|Second Intervention|Lost to Follow-up|0
1144577|NCT02973802|2251216|FG000|Overall Study|Lost to Follow-up|1
1144578|NCT02973802|2251216|FG000|Overall Study|Withdrawal by Subject|1
1144579|NCT02974010|2251225|FG000|Overall Study|Lost to Follow-up|3
1144580|NCT02974010|2251226|FG001|Overall Study|Lost to Follow-up|1
1144581|NCT02974010|2251227|FG002|Overall Study|Lost to Follow-up|0
1144582|NCT02974010|2251228|FG003|Overall Study|Lost to Follow-up|0
1144583|NCT02974010|2251225|FG000|Overall Study|Withdrawal by Subject|2
1144584|NCT02974010|2251226|FG001|Overall Study|Withdrawal by Subject|1
1144585|NCT02974010|2251227|FG002|Overall Study|Withdrawal by Subject|0
1144586|NCT02974010|2251228|FG003|Overall Study|Withdrawal by Subject|0
1144587|NCT02974010|2251225|FG000|Overall Study|Adverse Event|0
1144588|NCT02974010|2251226|FG001|Overall Study|Adverse Event|1
1144589|NCT02974010|2251227|FG002|Overall Study|Adverse Event|0
1144590|NCT02974010|2251228|FG003|Overall Study|Adverse Event|0
1144591|NCT02974010|2251225|FG000|Overall Study|Completed day 42 but did not return for day 70|1
1144592|NCT02974010|2251226|FG001|Overall Study|Completed day 42 but did not return for day 70|0
1144593|NCT02974010|2251227|FG002|Overall Study|Completed day 42 but did not return for day 70|1
1144594|NCT02974010|2251228|FG003|Overall Study|Completed day 42 but did not return for day 70|0
1144595|NCT02974010|2251225|FG000|Overall Study|Lack of Efficacy|0
1144596|NCT02974010|2251226|FG001|Overall Study|Lack of Efficacy|0
1144597|NCT02974010|2251227|FG002|Overall Study|Lack of Efficacy|1
1144598|NCT02974010|2251228|FG003|Overall Study|Lack of Efficacy|0
1144599|NCT02974088|2251240|FG000|Overall Study|Lost to Follow-up|0
1144600|NCT02974088|2251241|FG001|Overall Study|Lost to Follow-up|2
1144601|NCT02974088|2251240|FG000|Overall Study|Adverse Event|0
1144602|NCT02974088|2251241|FG001|Overall Study|Adverse Event|1
1144603|NCT02974114|2251250|FG000|Overall Study|Other (Not specified)|0
1144604|NCT02974114|2251251|FG001|Overall Study|Other (Not specified)|1
1144605|NCT02974114|2251252|FG002|Overall Study|Other (Not specified)|2
1144606|NCT02974140|2251262|FG000|Overall Study|Adverse Event|2
1144607|NCT02974140|2251262|FG000|Overall Study|Lost to Follow-up|1
1144608|NCT02974140|2251262|FG000|Overall Study|Study Terminated by Sponsor|36
1144609|NCT02974153|2251272|FG000|Overall Study|Adverse Event|6
1144610|NCT02974153|2251273|FG001|Overall Study|Adverse Event|0
1144611|NCT02974153|2251274|FG002|Overall Study|Adverse Event|1
1144612|NCT02974153|2251272|FG000|Overall Study|Lack of Efficacy|6
1144613|NCT02974153|2251273|FG001|Overall Study|Lack of Efficacy|5
1144614|NCT02974153|2251274|FG002|Overall Study|Lack of Efficacy|10
1144615|NCT02974153|2251272|FG000|Overall Study|Lost to Follow-up|9
1144616|NCT02974153|2251273|FG001|Overall Study|Lost to Follow-up|10
1144617|NCT02974153|2251274|FG002|Overall Study|Lost to Follow-up|17
1144618|NCT02974153|2251272|FG000|Overall Study|Physician Decision|0
1144619|NCT02974153|2251273|FG001|Overall Study|Physician Decision|2
1144620|NCT02974153|2251274|FG002|Overall Study|Physician Decision|1
1144621|NCT02974153|2251272|FG000|Overall Study|Withdrawal by Subject|9
1144622|NCT02974153|2251273|FG001|Overall Study|Withdrawal by Subject|16
1144623|NCT02974153|2251274|FG002|Overall Study|Withdrawal by Subject|11
1144624|NCT02974153|2251272|FG000|Overall Study|Study Burden|8
1144625|NCT02974153|2251273|FG001|Overall Study|Study Burden|7
1144626|NCT02974153|2251274|FG002|Overall Study|Study Burden|3
1144627|NCT02974153|2251272|FG000|Overall Study|Other|14
1144628|NCT02974153|2251273|FG001|Overall Study|Other|8
1144629|NCT02974153|2251274|FG002|Overall Study|Other|7
1144630|NCT02974543|2251293|FG000|Overall Study|Withdrawal by Subject|1
1144631|NCT02974543|2251294|FG001|Overall Study|Withdrawal by Subject|0
1144632|NCT02974634|2251310|FG000|Overall Study|Advanced disease|12
1144633|NCT02974634|2251311|FG001|Overall Study|Advanced disease|3
1144634|NCT02974634|2251310|FG000|Overall Study|Noncompliance|3
1144635|NCT02974634|2251311|FG001|Overall Study|Noncompliance|7
1144636|NCT02974634|2251310|FG000|Overall Study|intervention technology related issues|5
1144637|NCT02974634|2251311|FG001|Overall Study|intervention technology related issues|0
1144638|NCT02974634|2251310|FG000|Overall Study|Death|8
1144639|NCT02974634|2251311|FG001|Overall Study|Death|11
1144640|NCT02974842|2251318|FG000|Overall Study|Withdrawal by Subject|4
1144641|NCT02974842|2251318|FG000|Overall Study|Screen failures|4
1144642|NCT02974868|2251346|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1
1144643|NCT02974868|2251347|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1
1144644|NCT02974868|2251348|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2
1144645|NCT02974868|2251349|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4
1144646|NCT02974868|2251346|FG000|Initial 24-Week Treatment Period (TP)|others|3
1144647|NCT02974868|2251347|FG001|Initial 24-Week Treatment Period (TP)|others|8
1144648|NCT02974868|2251348|FG002|Initial 24-Week Treatment Period (TP)|others|1
1144649|NCT02974868|2251349|FG003|Initial 24-Week Treatment Period (TP)|others|8
1144650|NCT02974868|2251346|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
1144651|NCT02974868|2251347|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
1144652|NCT02974868|2251348|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
1144653|NCT02974868|2251349|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
1144654|NCT02974868|2251346|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
1144655|NCT02974868|2251347|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
1144656|NCT02974868|2251348|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
1144657|NCT02974868|2251349|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
1144658|NCT02975206|2251393|FG000|Overall Study|Withdrawal by Subject|14
1144659|NCT02975206|2251394|FG001|Overall Study|Withdrawal by Subject|11
1144660|NCT02975206|2251395|FG002|Overall Study|Withdrawal by Subject|11
1144661|NCT02975206|2251393|FG000|Overall Study|Other (e.g., lost to follow up)|13
1144662|NCT02975206|2251394|FG001|Overall Study|Other (e.g., lost to follow up)|6
1144663|NCT02975206|2251395|FG002|Overall Study|Other (e.g., lost to follow up)|6
1144664|NCT02975336|2251416|FG000|DBPC (52 Weeks)|Adverse Event|16
1144665|NCT02975336|2251417|FG001|DBPC (52 Weeks)|Adverse Event|17
1144666|NCT02975336|2251418|FG002|DBPC (52 Weeks)|Adverse Event|13
1144667|NCT02975336|2251419|FG003|DBPC (52 Weeks)|Adverse Event|18
1144668|NCT02975336|2251420|FG004|DBPC (52 Weeks)|Adverse Event|0
1144669|NCT02975336|2251421|FG005|DBPC (52 Weeks)|Adverse Event|0
1144670|NCT02975336|2251422|FG006|DBPC (52 Weeks)|Adverse Event|0
1144671|NCT02975336|2251423|FG007|DBPC (52 Weeks)|Adverse Event|0
1144672|NCT02975336|2251416|FG000|DBPC (52 Weeks)|Lost to Follow-up|2
1144673|NCT02975336|2251417|FG001|DBPC (52 Weeks)|Lost to Follow-up|1
1144674|NCT02975336|2251418|FG002|DBPC (52 Weeks)|Lost to Follow-up|2
1144675|NCT02975336|2251419|FG003|DBPC (52 Weeks)|Lost to Follow-up|4
1144676|NCT02975336|2251420|FG004|DBPC (52 Weeks)|Lost to Follow-up|0
1144677|NCT02975336|2251421|FG005|DBPC (52 Weeks)|Lost to Follow-up|0
1144678|NCT02975336|2251422|FG006|DBPC (52 Weeks)|Lost to Follow-up|0
1144679|NCT02975336|2251423|FG007|DBPC (52 Weeks)|Lost to Follow-up|0
1144680|NCT02975336|2251416|FG000|DBPC (52 Weeks)|Protocol Violation|4
1144681|NCT02975336|2251417|FG001|DBPC (52 Weeks)|Protocol Violation|1
1144682|NCT02975336|2251418|FG002|DBPC (52 Weeks)|Protocol Violation|3
1144683|NCT02975336|2251419|FG003|DBPC (52 Weeks)|Protocol Violation|1
1144684|NCT02975336|2251420|FG004|DBPC (52 Weeks)|Protocol Violation|0
1144685|NCT02975336|2251421|FG005|DBPC (52 Weeks)|Protocol Violation|0
1144686|NCT02975336|2251422|FG006|DBPC (52 Weeks)|Protocol Violation|0
1144687|NCT02975336|2251423|FG007|DBPC (52 Weeks)|Protocol Violation|0
1144688|NCT02975336|2251416|FG000|DBPC (52 Weeks)|Lack of Efficacy|4
1144689|NCT02975336|2251417|FG001|DBPC (52 Weeks)|Lack of Efficacy|4
1144690|NCT02975336|2251418|FG002|DBPC (52 Weeks)|Lack of Efficacy|2
1144691|NCT02975336|2251419|FG003|DBPC (52 Weeks)|Lack of Efficacy|3
1144692|NCT02975336|2251420|FG004|DBPC (52 Weeks)|Lack of Efficacy|0
1144693|NCT02975336|2251421|FG005|DBPC (52 Weeks)|Lack of Efficacy|0
1144694|NCT02975336|2251422|FG006|DBPC (52 Weeks)|Lack of Efficacy|0
1144695|NCT02975336|2251423|FG007|DBPC (52 Weeks)|Lack of Efficacy|0
1144696|NCT02975336|2251416|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1
1144697|NCT02975336|2251417|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0
1144698|NCT02975336|2251418|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1
1144699|NCT02975336|2251419|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3
1144700|NCT02975336|2251420|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0
1144701|NCT02975336|2251421|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0
1144702|NCT02975336|2251422|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0
1144703|NCT02975336|2251423|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0
1144704|NCT02975336|2251416|FG000|DBPC (52 Weeks)|Premature termination of the study|5
1144705|NCT02975336|2251417|FG001|DBPC (52 Weeks)|Premature termination of the study|6
1144706|NCT02975336|2251418|FG002|DBPC (52 Weeks)|Premature termination of the study|6
1144707|NCT02975336|2251419|FG003|DBPC (52 Weeks)|Premature termination of the study|4
1144708|NCT02975336|2251420|FG004|DBPC (52 Weeks)|Premature termination of the study|0
1144709|NCT02975336|2251421|FG005|DBPC (52 Weeks)|Premature termination of the study|0
1162101|NCT03383146|2284115|FG000|Overall Study|Physician Decision|0
1144710|NCT02975336|2251422|FG006|DBPC (52 Weeks)|Premature termination of the study|0
1144711|NCT02975336|2251423|FG007|DBPC (52 Weeks)|Premature termination of the study|0
1144712|NCT02975336|2251416|FG000|LTE (104 Weeks)|Adverse Event|0
1144713|NCT02975336|2251417|FG001|LTE (104 Weeks)|Adverse Event|0
1144714|NCT02975336|2251418|FG002|LTE (104 Weeks)|Adverse Event|0
1144715|NCT02975336|2251419|FG003|LTE (104 Weeks)|Adverse Event|0
1144716|NCT02975336|2251420|FG004|LTE (104 Weeks)|Adverse Event|7
1144717|NCT02975336|2251421|FG005|LTE (104 Weeks)|Adverse Event|4
1144718|NCT02975336|2251422|FG006|LTE (104 Weeks)|Adverse Event|2
1144719|NCT02975336|2251423|FG007|LTE (104 Weeks)|Adverse Event|0
1144720|NCT02975336|2251416|FG000|LTE (104 Weeks)|Lost to Follow-up|0
1144721|NCT02975336|2251417|FG001|LTE (104 Weeks)|Lost to Follow-up|0
1144722|NCT02975336|2251418|FG002|LTE (104 Weeks)|Lost to Follow-up|0
1144723|NCT02975336|2251419|FG003|LTE (104 Weeks)|Lost to Follow-up|0
1144724|NCT02975336|2251420|FG004|LTE (104 Weeks)|Lost to Follow-up|0
1144725|NCT02975336|2251421|FG005|LTE (104 Weeks)|Lost to Follow-up|1
1144726|NCT02975336|2251422|FG006|LTE (104 Weeks)|Lost to Follow-up|0
1144727|NCT02975336|2251423|FG007|LTE (104 Weeks)|Lost to Follow-up|0
1144728|NCT02975336|2251416|FG000|LTE (104 Weeks)|Lack of Efficacy|0
1144729|NCT02975336|2251417|FG001|LTE (104 Weeks)|Lack of Efficacy|0
1144730|NCT02975336|2251418|FG002|LTE (104 Weeks)|Lack of Efficacy|0
1144731|NCT02975336|2251419|FG003|LTE (104 Weeks)|Lack of Efficacy|0
1144732|NCT02975336|2251420|FG004|LTE (104 Weeks)|Lack of Efficacy|0
1144733|NCT02975336|2251421|FG005|LTE (104 Weeks)|Lack of Efficacy|1
1144734|NCT02975336|2251422|FG006|LTE (104 Weeks)|Lack of Efficacy|2
1144735|NCT02975336|2251423|FG007|LTE (104 Weeks)|Lack of Efficacy|0
1144736|NCT02975336|2251416|FG000|LTE (104 Weeks)|Other|0
1144737|NCT02975336|2251417|FG001|LTE (104 Weeks)|Other|0
1144738|NCT02975336|2251418|FG002|LTE (104 Weeks)|Other|0
1144739|NCT02975336|2251419|FG003|LTE (104 Weeks)|Other|0
1144740|NCT02975336|2251420|FG004|LTE (104 Weeks)|Other|55
1144741|NCT02975336|2251421|FG005|LTE (104 Weeks)|Other|63
1144742|NCT02975336|2251422|FG006|LTE (104 Weeks)|Other|76
1144743|NCT02975336|2251423|FG007|LTE (104 Weeks)|Other|72
1144744|NCT02975349|2251442|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
1144745|NCT02975349|2251443|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
1144746|NCT02975349|2251444|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
1144747|NCT02975349|2251445|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
1144748|NCT02975349|2251446|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
1144749|NCT02975349|2251447|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
1144750|NCT02975349|2251442|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1
1144751|NCT02975349|2251443|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
1144752|NCT02975349|2251444|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
1144753|NCT02975349|2251445|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
1144754|NCT02975349|2251446|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
1144755|NCT02975349|2251447|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
1144756|NCT02975349|2251442|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4
1144757|NCT02975349|2251443|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0
1144758|NCT02975349|2251444|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1
1144759|NCT02975349|2251445|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2
1144760|NCT02975349|2251446|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6
1144761|NCT02975349|2251447|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2
1144762|NCT02975349|2251442|FG000|Active Treatment Period (24 Weeks)|Un-specified|0
1144763|NCT02975349|2251443|FG001|Active Treatment Period (24 Weeks)|Un-specified|0
1144764|NCT02975349|2251444|FG002|Active Treatment Period (24 Weeks)|Un-specified|1
1144765|NCT02975349|2251445|FG003|Active Treatment Period (24 Weeks)|Un-specified|0
1144766|NCT02975349|2251446|FG004|Active Treatment Period (24 Weeks)|Un-specified|0
1144767|NCT02975349|2251447|FG005|Active Treatment Period (24 Weeks)|Un-specified|0
1144768|NCT02975349|2251442|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0
1144769|NCT02975349|2251443|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1
1144770|NCT02975349|2251444|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1
1144771|NCT02975349|2251445|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2
1144772|NCT02975349|2251446|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1
1144773|NCT02975349|2251447|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0
1144774|NCT02975349|2251442|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
1144775|NCT02975349|2251443|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5
1144776|NCT02975349|2251444|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2
1144777|NCT02975349|2251445|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
1144778|NCT02975349|2251446|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
1144779|NCT02975349|2251447|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
1144780|NCT02975349|2251442|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
1144781|NCT02975349|2251443|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
1144782|NCT02975349|2251444|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1
1144783|NCT02975349|2251445|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
1144784|NCT02975349|2251446|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
1144785|NCT02975349|2251447|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
1144786|NCT02975349|2251442|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0
1144787|NCT02975349|2251443|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1
1144788|NCT02975349|2251444|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0
1144789|NCT02975349|2251445|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0
1144790|NCT02975349|2251446|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0
1144791|NCT02975349|2251447|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0
1144792|NCT02975349|2251442|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0
1144793|NCT02975349|2251443|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0
1144794|NCT02975349|2251444|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0
1144795|NCT02975349|2251445|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1
1144796|NCT02975349|2251446|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0
1144797|NCT02975349|2251447|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0
1144798|NCT02975700|2251479|FG000|Overall Study|Adverse Event|1
1144799|NCT02975700|2251479|FG000|Overall Study|Progressive disease|3
1144800|NCT02975700|2251479|FG000|Overall Study|Failed screening criteria|2
1144801|NCT02975973|2251496|FG000|Overall Study|Adverse Event|1
1144802|NCT02975973|2251497|FG001|Overall Study|Adverse Event|1
1144803|NCT02975973|2251498|FG002|Overall Study|Adverse Event|1
1144804|NCT02975973|2251499|FG003|Overall Study|Adverse Event|0
1144805|NCT02976103|2251511|FG000|Overall Study|Withdrawal by Subject|1
1144806|NCT02976103|2251512|FG001|Overall Study|Withdrawal by Subject|0
1144807|NCT02976103|2251511|FG000|Overall Study|Lost to Follow-up|12
1144808|NCT02976103|2251512|FG001|Overall Study|Lost to Follow-up|8
1144809|NCT02976519|2251531|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1144810|NCT02976519|2251532|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
1144811|NCT02976519|2251533|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1144812|NCT02976519|2251534|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1144813|NCT02976519|2251535|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1144814|NCT02976519|2251536|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1144815|NCT02976519|2251537|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1144816|NCT02976519|2251531|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1144817|NCT02976519|2251532|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1144818|NCT02976519|2251533|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1144819|NCT02976519|2251534|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
1144820|NCT02976519|2251535|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1144821|NCT02976519|2251536|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1144822|NCT02976519|2251537|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1144823|NCT02976519|2251531|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0
1144824|NCT02976519|2251532|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0
1144825|NCT02976519|2251533|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0
1144826|NCT02976519|2251534|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0
1144827|NCT02976519|2251535|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0
1144828|NCT02976519|2251536|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0
1144829|NCT02976519|2251537|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1
1144830|NCT02976519|2251531|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1144831|NCT02976519|2251532|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1144832|NCT02976519|2251533|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1144833|NCT02976519|2251534|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1144834|NCT02976519|2251535|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1144835|NCT02976519|2251536|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1144836|NCT02976519|2251537|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
1144837|NCT02976519|2251531|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1144838|NCT02976519|2251532|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1144839|NCT02976519|2251533|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1144840|NCT02976519|2251534|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1144841|NCT02976519|2251535|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1144842|NCT02976519|2251536|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1144843|NCT02976519|2251537|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1
1144844|NCT02977507|2251557|FG000|Overall Study|Protocol Deviation|1
1144845|NCT02977507|2251558|FG001|Overall Study|Protocol Deviation|0
1144846|NCT02977507|2251557|FG000|Overall Study|Lost to Follow-up|1
1144847|NCT02977507|2251558|FG001|Overall Study|Lost to Follow-up|0
1144848|NCT02977572|2251567|FG000|Overall Study|Exclusion criterion|2
1144849|NCT02977572|2251568|FG001|Overall Study|Exclusion criterion|2
1144850|NCT02978417|2251602|FG000|Overall Study|Lost to Follow-up|2
1144851|NCT02978417|2251603|FG001|Overall Study|Lost to Follow-up|2
902012|NCT00737568|1875707|FG000|Treatment Period Through Week 240|Protocol Violation|2
902013|NCT00737568|1875708|FG001|Treatment Period Through Week 240|Protocol Violation|3
902014|NCT00737568|1875707|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
902015|NCT00737568|1875708|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
902016|NCT00737568|1875707|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
902017|NCT00737568|1875708|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
902018|NCT00737568|1875707|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0
902019|NCT00737568|1875708|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1
902020|NCT00737568|1875707|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
902021|NCT00737568|1875708|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
902022|NCT00737633|1875716|FG000|Overall Study|Study terminated by sponsor|44
902023|NCT00737633|1875717|FG001|Overall Study|Study terminated by sponsor|55
902024|NCT00737633|1875716|FG000|Overall Study|Lost to Follow-up|0
902025|NCT00737633|1875717|FG001|Overall Study|Lost to Follow-up|1
902026|NCT00737633|1875716|FG000|Overall Study|protocol non-compliance|0
902027|NCT00737633|1875717|FG001|Overall Study|protocol non-compliance|1
902028|NCT00737672|1875725|FG000|Overall Study|Graft Abandonment|48
902029|NCT00737672|1875726|FG001|Overall Study|Graft Abandonment|56
902030|NCT00737672|1875725|FG000|Overall Study|Death|23
902031|NCT00737672|1875726|FG001|Overall Study|Death|22
1144882|NCT02979197|2251663|FG000|Overall Study|Adverse Event|4
1144883|NCT02979197|2251664|FG001|Overall Study|Adverse Event|2
1144884|NCT02979197|2251665|FG002|Overall Study|Adverse Event|0
1144885|NCT02979197|2251663|FG000|Overall Study|Protocol Violation|0
1144886|NCT02979197|2251664|FG001|Overall Study|Protocol Violation|1
1144887|NCT02979197|2251665|FG002|Overall Study|Protocol Violation|0
1144888|NCT02979197|2251663|FG000|Overall Study|Subject unable to commit to study dates|0
1144889|NCT02979197|2251664|FG001|Overall Study|Subject unable to commit to study dates|1
1144890|NCT02979197|2251665|FG002|Overall Study|Subject unable to commit to study dates|0
1144891|NCT02979249|2251673|FG000|Overall Study|Lost to Follow-up|2
1144892|NCT02979249|2251673|FG000|Overall Study|Withdrawal by Subject|4
1144893|NCT02979431|2251699|FG000|Overall Study|Parent/guardian withdrew consent|2
1144894|NCT02979431|2251700|FG001|Overall Study|Parent/guardian withdrew consent|1
1144895|NCT02979431|2251701|FG002|Overall Study|Parent/guardian withdrew consent|1
1144896|NCT02979431|2251702|FG003|Overall Study|Parent/guardian withdrew consent|1
1144897|NCT02979431|2251699|FG000|Overall Study|Randomized but received no study drug|1
1144898|NCT02979431|2251700|FG001|Overall Study|Randomized but received no study drug|1
1144899|NCT02979431|2251701|FG002|Overall Study|Randomized but received no study drug|0
1144900|NCT02979431|2251702|FG003|Overall Study|Randomized but received no study drug|0
1144901|NCT02979431|2251699|FG000|Overall Study|Adverse Event|0
1144902|NCT02979431|2251700|FG001|Overall Study|Adverse Event|0
1144903|NCT02979431|2251701|FG002|Overall Study|Adverse Event|1
1144904|NCT02979431|2251702|FG003|Overall Study|Adverse Event|0
1144905|NCT02979431|2251699|FG000|Overall Study|Subject left country after Day14|1
1144906|NCT02979431|2251700|FG001|Overall Study|Subject left country after Day14|0
1144907|NCT02979431|2251701|FG002|Overall Study|Subject left country after Day14|0
1144908|NCT02979431|2251702|FG003|Overall Study|Subject left country after Day14|0
1144909|NCT02979535|2251736|FG000|Overall Study|Non compliance with the protocol|78
1144910|NCT02979535|2251737|FG001|Overall Study|Non compliance with the protocol|82
1144911|NCT02979535|2251736|FG000|Overall Study|Consent withdrawn by participant|11
1144912|NCT02979535|2251737|FG001|Overall Study|Consent withdrawn by participant|18
1144913|NCT02979535|2251736|FG000|Overall Study|Lost to Follow-up|6
1144914|NCT02979535|2251737|FG001|Overall Study|Lost to Follow-up|1
1144915|NCT02979613|2251745|FG000|Double-Blind Phase|Withdrew Consent|2
1144916|NCT02979613|2251746|FG001|Double-Blind Phase|Withdrew Consent|4
1144917|NCT02979613|2251745|FG000|Double-Blind Phase|Pregnancy|2
1144918|NCT02979613|2251746|FG001|Double-Blind Phase|Pregnancy|2
1144919|NCT02979613|2251745|FG000|Double-Blind Phase|Adverse Event|2
1144920|NCT02979613|2251746|FG001|Double-Blind Phase|Adverse Event|0
1144921|NCT02979613|2251745|FG000|Double-Blind Phase|Lost to Follow-up|1
1144922|NCT02979613|2251746|FG001|Double-Blind Phase|Lost to Follow-up|1
1144923|NCT02979613|2251745|FG000|Double-Blind Phase|Protocol Violation|1
1144924|NCT02979613|2251746|FG001|Double-Blind Phase|Protocol Violation|1
1162102|NCT03383146|2284116|FG001|Overall Study|Physician Decision|1
1144925|NCT02979613|2251745|FG000|Double-Blind Phase|Randomized but Never Treated|2
1144926|NCT02979613|2251746|FG001|Double-Blind Phase|Randomized but Never Treated|0
1144927|NCT02979613|2251745|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2
1144928|NCT02979613|2251746|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4
1144929|NCT02979613|2251745|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1
1144930|NCT02979613|2251746|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
1144931|NCT02979613|2251745|FG000|Open-Label Extension (OLE) Phase|Death|0
1144932|NCT02979613|2251746|FG001|Open-Label Extension (OLE) Phase|Death|1
1144933|NCT02979613|2251745|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0
1144934|NCT02979613|2251746|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1
1144935|NCT02979639|2251763|FG000|Overall Study|Withdrawal based on medical judgement|1
1144936|NCT02979639|2251763|FG000|Overall Study|Lost to Follow-up|8
1144937|NCT02979639|2251763|FG000|Overall Study|Withdrawal by Subject|3
1144938|NCT02979639|2251763|FG000|Overall Study|Adverse Event|2
1144939|NCT02980042|2251787|FG000|Overall Study|Lost to Follow-up|5
1144940|NCT02980042|2251788|FG001|Overall Study|Lost to Follow-up|0
1144941|NCT02980042|2251787|FG000|Overall Study|Insurance issues/treatment plan changes|2
1144942|NCT02980042|2251788|FG001|Overall Study|Insurance issues/treatment plan changes|0
1144943|NCT02980107|2251808|FG000|Overall Study|Withdrawal by Subject|51
1144944|NCT02980107|2251809|FG001|Overall Study|Withdrawal by Subject|62
1144945|NCT02980133|2251819|FG000|Overall Study|Other than specified|1
1144946|NCT02980133|2251820|FG001|Overall Study|Other than specified|1
1144947|NCT02980133|2251821|FG002|Overall Study|Other than specified|2
1144948|NCT02980133|2251822|FG003|Overall Study|Other than specified|2
1144949|NCT02980133|2251819|FG000|Overall Study|Lost to Follow-up|0
1144950|NCT02980133|2251820|FG001|Overall Study|Lost to Follow-up|0
1144951|NCT02980133|2251821|FG002|Overall Study|Lost to Follow-up|1
1144952|NCT02980133|2251822|FG003|Overall Study|Lost to Follow-up|3
1144953|NCT02980133|2251819|FG000|Overall Study|Protocol Violation|0
1144954|NCT02980133|2251820|FG001|Overall Study|Protocol Violation|1
1144955|NCT02980133|2251821|FG002|Overall Study|Protocol Violation|0
1144956|NCT02980133|2251822|FG003|Overall Study|Protocol Violation|0
1144957|NCT02980133|2251819|FG000|Overall Study|Withdrawal by parent/guardian|6
1144958|NCT02980133|2251820|FG001|Overall Study|Withdrawal by parent/guardian|3
1144959|NCT02980133|2251821|FG002|Overall Study|Withdrawal by parent/guardian|3
1144960|NCT02980133|2251822|FG003|Overall Study|Withdrawal by parent/guardian|1
1144961|NCT02980133|2251819|FG000|Overall Study|Withdrawal by Subject|0
1144962|NCT02980133|2251820|FG001|Overall Study|Withdrawal by Subject|0
1144963|NCT02980133|2251821|FG002|Overall Study|Withdrawal by Subject|1
1144964|NCT02980133|2251822|FG003|Overall Study|Withdrawal by Subject|0
1144965|NCT02980224|2251841|FG000|Overall Study|Adverse Event|4
1144966|NCT02980224|2251842|FG001|Overall Study|Adverse Event|1
1144967|NCT02980224|2251841|FG000|Overall Study|Withdrawal by Subject|0
1144968|NCT02980224|2251842|FG001|Overall Study|Withdrawal by Subject|2
1144969|NCT02980523|2251853|FG000|Overall Study|Lost to Follow-up|1
1144970|NCT02980523|2251854|FG001|Overall Study|Lost to Follow-up|4
1144971|NCT02980523|2251855|FG002|Overall Study|Lost to Follow-up|1
1144972|NCT02980523|2251856|FG003|Overall Study|Lost to Follow-up|2
1144973|NCT02980523|2251857|FG004|Overall Study|Lost to Follow-up|1
1144974|NCT02980523|2251853|FG000|Overall Study|Excluded from analysis|1
1144975|NCT02980523|2251854|FG001|Overall Study|Excluded from analysis|3
1144976|NCT02980523|2251855|FG002|Overall Study|Excluded from analysis|1
1144977|NCT02980523|2251856|FG003|Overall Study|Excluded from analysis|1
1144978|NCT02980523|2251857|FG004|Overall Study|Excluded from analysis|1
1144979|NCT02980523|2251853|FG000|Overall Study|Lack of Efficacy|1
1144980|NCT02980523|2251854|FG001|Overall Study|Lack of Efficacy|4
1144981|NCT02980523|2251855|FG002|Overall Study|Lack of Efficacy|4
1144982|NCT02980523|2251856|FG003|Overall Study|Lack of Efficacy|5
1144983|NCT02980523|2251857|FG004|Overall Study|Lack of Efficacy|8
1144984|NCT02980523|2251853|FG000|Overall Study|Did not receive intervention|0
1144985|NCT02980523|2251854|FG001|Overall Study|Did not receive intervention|0
1144986|NCT02980523|2251855|FG002|Overall Study|Did not receive intervention|0
1144987|NCT02980523|2251856|FG003|Overall Study|Did not receive intervention|1
1144988|NCT02980523|2251857|FG004|Overall Study|Did not receive intervention|0
1144989|NCT02980601|2251874|FG000|Overall Study|Lost to Follow-up|2
1144990|NCT02980601|2251875|FG001|Overall Study|Lost to Follow-up|2
1144991|NCT02980601|2251874|FG000|Overall Study|Death|0
1144992|NCT02980601|2251875|FG001|Overall Study|Death|1
1144993|NCT02980601|2251874|FG000|Overall Study|Graft loss|1
1144994|NCT02980601|2251875|FG001|Overall Study|Graft loss|0
1144995|NCT02980601|2251874|FG000|Overall Study|Failed to sign consent|2
1144996|NCT02980601|2251875|FG001|Overall Study|Failed to sign consent|0
1144997|NCT02980692|2251895|FG000|Overall Study|Adverse Event|0
1144998|NCT02980692|2251896|FG001|Overall Study|Adverse Event|2
1144999|NCT02980692|2251897|FG002|Overall Study|Adverse Event|0
1145000|NCT02980692|2251898|FG003|Overall Study|Adverse Event|0
1145001|NCT02980692|2251899|FG004|Overall Study|Adverse Event|1
1145002|NCT02980692|2251895|FG000|Overall Study|Withdrawal by Subject|4
1145003|NCT02980692|2251896|FG001|Overall Study|Withdrawal by Subject|3
1145004|NCT02980692|2251897|FG002|Overall Study|Withdrawal by Subject|6
1145005|NCT02980692|2251898|FG003|Overall Study|Withdrawal by Subject|6
1145006|NCT02980692|2251899|FG004|Overall Study|Withdrawal by Subject|7
1145007|NCT02980692|2251895|FG000|Overall Study|Lost to Follow-up|3
1145008|NCT02980692|2251896|FG001|Overall Study|Lost to Follow-up|0
1145009|NCT02980692|2251897|FG002|Overall Study|Lost to Follow-up|4
1145010|NCT02980692|2251898|FG003|Overall Study|Lost to Follow-up|1
1145011|NCT02980692|2251899|FG004|Overall Study|Lost to Follow-up|1
1145012|NCT02980692|2251895|FG000|Overall Study|Death|1
1145013|NCT02980692|2251896|FG001|Overall Study|Death|0
1145014|NCT02980692|2251897|FG002|Overall Study|Death|0
1145015|NCT02980692|2251898|FG003|Overall Study|Death|0
1145016|NCT02980692|2251899|FG004|Overall Study|Death|0
1145017|NCT02980692|2251895|FG000|Overall Study|Physician Decision|0
1145018|NCT02980692|2251896|FG001|Overall Study|Physician Decision|0
1145019|NCT02980692|2251897|FG002|Overall Study|Physician Decision|1
1145020|NCT02980692|2251898|FG003|Overall Study|Physician Decision|1
1145021|NCT02980692|2251899|FG004|Overall Study|Physician Decision|0
1145022|NCT02980692|2251895|FG000|Overall Study|NON COMPLIANCE|1
1145023|NCT02980692|2251896|FG001|Overall Study|NON COMPLIANCE|0
1145024|NCT02980692|2251897|FG002|Overall Study|NON COMPLIANCE|0
1145025|NCT02980692|2251898|FG003|Overall Study|NON COMPLIANCE|0
1145026|NCT02980692|2251899|FG004|Overall Study|NON COMPLIANCE|0
1145027|NCT02980692|2251895|FG000|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
1145028|NCT02980692|2251896|FG001|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|1
1145029|NCT02980692|2251897|FG002|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
1145030|NCT02980692|2251898|FG003|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
1145031|NCT02980692|2251899|FG004|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
1145032|NCT02980692|2251895|FG000|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
1145033|NCT02980692|2251896|FG001|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
1145034|NCT02980692|2251897|FG002|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|1
1145035|NCT02980692|2251898|FG003|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
1145036|NCT02980692|2251899|FG004|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
1145037|NCT02980692|2251895|FG000|Overall Study|Lack of Efficacy|0
1145038|NCT02980692|2251896|FG001|Overall Study|Lack of Efficacy|0
1145039|NCT02980692|2251897|FG002|Overall Study|Lack of Efficacy|0
1145040|NCT02980692|2251898|FG003|Overall Study|Lack of Efficacy|1
1145041|NCT02980692|2251899|FG004|Overall Study|Lack of Efficacy|0
1145042|NCT02980692|2251895|FG000|Overall Study|RELOCATION|0
1145043|NCT02980692|2251896|FG001|Overall Study|RELOCATION|0
1145044|NCT02980692|2251897|FG002|Overall Study|RELOCATION|0
1145045|NCT02980692|2251898|FG003|Overall Study|RELOCATION|0
1145046|NCT02980692|2251899|FG004|Overall Study|RELOCATION|1
1145047|NCT02980692|2251895|FG000|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
1145048|NCT02980692|2251896|FG001|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
1145049|NCT02980692|2251897|FG002|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
1145050|NCT02980692|2251898|FG003|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
1145051|NCT02980692|2251899|FG004|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|1
1145052|NCT02980705|2251914|FG000|Overall Study|Adverse Event|0
1145053|NCT02980705|2251915|FG001|Overall Study|Adverse Event|1
1145054|NCT02980705|2251914|FG000|Overall Study|Withdrawal by Subject|6
1145055|NCT02980705|2251915|FG001|Overall Study|Withdrawal by Subject|9
1145056|NCT02980705|2251914|FG000|Overall Study|withdrew participation|0
1145057|NCT02980705|2251915|FG001|Overall Study|withdrew participation|1
1145058|NCT02980705|2251914|FG000|Overall Study|Lost to Follow-up|2
1145059|NCT02980705|2251915|FG001|Overall Study|Lost to Follow-up|0
1145060|NCT02980783|2251922|FG000|Overall Study|Lost to Follow-up|1
1145061|NCT02980874|2251928|FG000|Overall Study|Adverse Event|2
1145062|NCT02980874|2251929|FG001|Overall Study|Adverse Event|7
1145063|NCT02980874|2251928|FG000|Overall Study|Withdrawal by Subject|7
1145064|NCT02980874|2251929|FG001|Overall Study|Withdrawal by Subject|2
1145065|NCT02980874|2251928|FG000|Overall Study|Lost to Follow-up|5
1145066|NCT02980874|2251929|FG001|Overall Study|Lost to Follow-up|5
1145067|NCT02980874|2251928|FG000|Overall Study|Includes premature discontinuation due to study termination.|88
1145068|NCT02980874|2251929|FG001|Overall Study|Includes premature discontinuation due to study termination.|88
1145069|NCT02980874|2251928|FG000|Overall Study|Unknown study completion status|1
1145070|NCT02980874|2251929|FG001|Overall Study|Unknown study completion status|0
1145071|NCT02981342|2251948|FG000|Overall Study|Adverse Event|0
1145072|NCT02981342|2251949|FG001|Overall Study|Adverse Event|0
1145073|NCT02981342|2251950|FG002|Overall Study|Adverse Event|0
1145074|NCT02981342|2251951|FG003|Overall Study|Adverse Event|1
1145075|NCT02981342|2251948|FG000|Overall Study|Death|0
1145076|NCT02981342|2251949|FG001|Overall Study|Death|9
1145077|NCT02981342|2251950|FG002|Overall Study|Death|9
1145078|NCT02981342|2251951|FG003|Overall Study|Death|4
1145079|NCT02981342|2251948|FG000|Overall Study|Withdrawal by Subject|0
1145080|NCT02981342|2251949|FG001|Overall Study|Withdrawal by Subject|0
1145081|NCT02981342|2251950|FG002|Overall Study|Withdrawal by Subject|3
1145082|NCT02981342|2251951|FG003|Overall Study|Withdrawal by Subject|1
1145083|NCT02981342|2251948|FG000|Overall Study|Study closed by sponsor|0
1145084|NCT02981342|2251949|FG001|Overall Study|Study closed by sponsor|0
1145085|NCT02981342|2251950|FG002|Overall Study|Study closed by sponsor|1
1145086|NCT02981342|2251951|FG003|Overall Study|Study closed by sponsor|1
1145087|NCT02981342|2251948|FG000|Overall Study|Randomized, Never Treated|0
1145088|NCT02981342|2251949|FG001|Overall Study|Randomized, Never Treated|1
1145089|NCT02981342|2251950|FG002|Overall Study|Randomized, Never Treated|0
1145090|NCT02981342|2251951|FG003|Overall Study|Randomized, Never Treated|7
1145091|NCT02981342|2251948|FG000|Overall Study|Lost to Follow-up|0
1145092|NCT02981342|2251949|FG001|Overall Study|Lost to Follow-up|1
1145093|NCT02981342|2251950|FG002|Overall Study|Lost to Follow-up|0
1145094|NCT02981342|2251951|FG003|Overall Study|Lost to Follow-up|0
1145095|NCT02981524|2251999|FG000|Overall Study|Progressive Disease|14
1145096|NCT02981524|2251999|FG000|Overall Study|Death (unrelated)|1
1145097|NCT02981524|2251999|FG000|Overall Study|Treatment Related Toxicity|1
1145098|NCT02981524|2251999|FG000|Overall Study|Withdrawal by Subject|1
1145099|NCT02981953|2252025|FG000|Overall Study|Death|9
1145100|NCT02981953|2252025|FG000|Overall Study|Withdrawal by Subject|1
1145101|NCT02981953|2252025|FG000|Overall Study|Withdrawal to non-compliance|1
1145102|NCT02982018|2252031|FG000|Overall Study|Incorrect Lens Dispensed|1
1145103|NCT02982018|2252032|FG001|Overall Study|Incorrect Lens Dispensed|0
1145104|NCT02982018|2252031|FG000|Overall Study|Protocol Violation|1
1145105|NCT02982018|2252032|FG001|Overall Study|Protocol Violation|1
1145106|NCT02982018|2252031|FG000|Overall Study|Adverse Event|1
1145107|NCT02982018|2252032|FG001|Overall Study|Adverse Event|1
1145108|NCT02982018|2252031|FG000|Overall Study|Lens Discomfort|2
1145109|NCT02982018|2252032|FG001|Overall Study|Lens Discomfort|0
1145110|NCT02982018|2252031|FG000|Overall Study|Withdrawal by Subject|0
1145111|NCT02982018|2252032|FG001|Overall Study|Withdrawal by Subject|1
1145112|NCT02982187|2252040|FG000|Overall Study|Withdrawal by Subject|0
1145113|NCT02982187|2252041|FG001|Overall Study|Withdrawal by Subject|0
1145114|NCT02982187|2252042|FG002|Overall Study|Withdrawal by Subject|0
1145115|NCT02982187|2252043|FG003|Overall Study|Withdrawal by Subject|0
1145116|NCT02982187|2252044|FG004|Overall Study|Withdrawal by Subject|0
1145117|NCT02982187|2252045|FG005|Overall Study|Withdrawal by Subject|0
1145118|NCT02982187|2252046|FG006|Overall Study|Withdrawal by Subject|1
1145119|NCT02982187|2252047|FG007|Overall Study|Withdrawal by Subject|0
1145120|NCT02982213|2252059|FG000|Overall Study|Did not complete follow up questionnaire|5
1145121|NCT02982213|2252060|FG001|Overall Study|Did not complete follow up questionnaire|1
1145122|NCT02982239|2252068|FG000|Overall Study|Lost to Follow-up|3
1145123|NCT02982239|2252069|FG001|Overall Study|Lost to Follow-up|2
1145124|NCT02982590|2252078|FG000|Overall Study|Lost to Follow-up|0
1145125|NCT02982590|2252079|FG001|Overall Study|Lost to Follow-up|1
1145126|NCT02982590|2252078|FG000|Overall Study|Death|4
1145127|NCT02982590|2252079|FG001|Overall Study|Death|0
1145128|NCT02982772|2252087|FG000|Intervention|Lost to Follow-up|19
1145129|NCT02982772|2252088|FG001|Intervention|Lost to Follow-up|13
1145130|NCT02982772|2252087|FG000|1M Follow-Up|Lost to Follow-up|21
1145131|NCT02982772|2252088|FG001|1M Follow-Up|Lost to Follow-up|18
902032|NCT00737672|1875725|FG000|Overall Study|Withdrawal by Subject|1
902033|NCT00737672|1875726|FG001|Overall Study|Withdrawal by Subject|2
902034|NCT00737672|1875725|FG000|Overall Study|Lost to Follow-up|1
902035|NCT00737672|1875726|FG001|Overall Study|Lost to Follow-up|0
902036|NCT00737672|1875725|FG000|Overall Study|Miscellaneous|7
902037|NCT00737672|1875726|FG001|Overall Study|Miscellaneous|1
902038|NCT00737672|1875725|FG000|Overall Study|Physician Decision|0
902039|NCT00737672|1875726|FG001|Overall Study|Physician Decision|2
902040|NCT00737698|1875735|FG000|Overall Study|Withdrawal by Subject|6
902041|NCT00737698|1875736|FG001|Overall Study|Withdrawal by Subject|5
902042|NCT00737698|1875737|FG002|Overall Study|Withdrawal by Subject|3
902043|NCT00737698|1875735|FG000|Overall Study|Death|0
902044|NCT00737698|1875736|FG001|Overall Study|Death|0
902045|NCT00737698|1875737|FG002|Overall Study|Death|1
902046|NCT00737711|1875745|FG000|Overall Study|Adverse Event|2
902047|NCT00737711|1875745|FG000|Overall Study|Death|8
902048|NCT00737711|1875745|FG000|Overall Study|Failure to return|4
902049|NCT00737711|1875745|FG000|Overall Study|Protocol Violation|1
902050|NCT00737711|1875745|FG000|Overall Study|Withdrawal by Subject|5
902051|NCT00737711|1875745|FG000|Overall Study|Blood transfusion|6
902052|NCT00737711|1875745|FG000|Overall Study|Other|5
902053|NCT00738062|1875795|FG000|Open Label Treatment|Lack of Efficacy|5
902054|NCT00738062|1875796|FG001|Open Label Treatment|Lack of Efficacy|0
902055|NCT00738062|1875797|FG002|Open Label Treatment|Lack of Efficacy|0
902056|NCT00738062|1875795|FG000|Open Label Treatment|Adverse Event|11
902057|NCT00738062|1875796|FG001|Open Label Treatment|Adverse Event|0
902058|NCT00738062|1875797|FG002|Open Label Treatment|Adverse Event|0
902059|NCT00738062|1875795|FG000|Open Label Treatment|Protocol Violation|2
902060|NCT00738062|1875796|FG001|Open Label Treatment|Protocol Violation|0
902061|NCT00738062|1875797|FG002|Open Label Treatment|Protocol Violation|0
902062|NCT00738062|1875795|FG000|Open Label Treatment|Withdrawal by Subject|9
902063|NCT00738062|1875796|FG001|Open Label Treatment|Withdrawal by Subject|0
902064|NCT00738062|1875797|FG002|Open Label Treatment|Withdrawal by Subject|0
902065|NCT00738062|1875795|FG000|Open Label Treatment|Investigator Decision|1
902066|NCT00738062|1875796|FG001|Open Label Treatment|Investigator Decision|0
1145132|NCT02982772|2252087|FG000|3M Follow-Up|Lost to Follow-up|17
1145133|NCT02982772|2252088|FG001|3M Follow-Up|Lost to Follow-up|11
1145134|NCT02982772|2252087|FG000|6M Follow-Up|Lost to Follow-up|11
1145135|NCT02982772|2252088|FG001|6M Follow-Up|Lost to Follow-up|9
1145136|NCT02982772|2252087|FG000|12M Follow-Up|Lost to Follow-up|11
1145137|NCT02982772|2252088|FG001|12M Follow-Up|Lost to Follow-up|5
1145138|NCT02982863|2252101|FG000|Overall Study|Not eligible patients|809
1145139|NCT02982863|2252102|FG001|Overall Study|Not eligible patients|4261
1145140|NCT02982863|2252103|FG002|Overall Study|Not eligible patients|1852
1145141|NCT02982863|2252104|FG003|Overall Study|Not eligible patients|1400
1145142|NCT02982863|2252105|FG004|Overall Study|Not eligible patients|492
1145143|NCT02983227|2252153|FG000|Overall Study|Adverse Event|21
1145144|NCT02983227|2252154|FG001|Overall Study|Adverse Event|3
1145145|NCT02983227|2252153|FG000|Overall Study|Death|3
1145146|NCT02983227|2252154|FG001|Overall Study|Death|0
1145147|NCT02983227|2252153|FG000|Overall Study|Lack of Efficacy|8
1145148|NCT02983227|2252154|FG001|Overall Study|Lack of Efficacy|1
1145149|NCT02983227|2252153|FG000|Overall Study|Lost to Follow-up|3
1145150|NCT02983227|2252154|FG001|Overall Study|Lost to Follow-up|0
1145151|NCT02983227|2252153|FG000|Overall Study|Multiple Reasons|2
1145152|NCT02983227|2252154|FG001|Overall Study|Multiple Reasons|1
1145153|NCT02983227|2252153|FG000|Overall Study|Physician Decision|3
1145154|NCT02983227|2252154|FG001|Overall Study|Physician Decision|1
1145155|NCT02983227|2252153|FG000|Overall Study|Withdrawal by Subject|19
1145156|NCT02983227|2252154|FG001|Overall Study|Withdrawal by Subject|8
1145157|NCT02983305|2252162|FG000|Overall Study|incomplete data|2
1145158|NCT02983305|2252163|FG001|Overall Study|incomplete data|0
1145159|NCT02983604|2252203|FG000|Overall Study|Enrolled but not Treated|0
1145160|NCT02983604|2252204|FG001|Overall Study|Enrolled but not Treated|0
1145161|NCT02983604|2252205|FG002|Overall Study|Enrolled but not Treated|1
1145162|NCT02983604|2252206|FG003|Overall Study|Enrolled but not Treated|0
1145169|NCT02984267|2252240|FG000|Overall Study|Protocol Violation|1
1145170|NCT02984267|2252241|FG001|Overall Study|Protocol Violation|0
1145171|NCT02984267|2252240|FG000|Overall Study|Withdrawal by Subject|0
1145172|NCT02984267|2252241|FG001|Overall Study|Withdrawal by Subject|1
1145173|NCT02984683|2252279|FG000|Overall Study|Adverse Event|3
1145174|NCT02984683|2252280|FG001|Overall Study|Adverse Event|3
1145175|NCT02984683|2252279|FG000|Overall Study|Withdrawal by Subject|1
1145176|NCT02984683|2252280|FG001|Overall Study|Withdrawal by Subject|0
1145177|NCT02984683|2252279|FG000|Overall Study|Disease progression|7
1145178|NCT02984683|2252280|FG001|Overall Study|Disease progression|9
1145179|NCT02984943|2252309|FG000|Overall Study|Withdrawal by Subject|3
1145180|NCT02984943|2252309|FG000|Overall Study|Physician Decision|1
1145181|NCT02984982|2252315|FG000|Overall Study|Adverse Event|2
1145182|NCT02984982|2252316|FG001|Overall Study|Adverse Event|5
1145183|NCT02984982|2252315|FG000|Overall Study|Poor Compliance to Protocol|4
1145184|NCT02984982|2252316|FG001|Overall Study|Poor Compliance to Protocol|4
1145185|NCT02984982|2252315|FG000|Overall Study|Withdrawal by Subject|2
1145186|NCT02984982|2252316|FG001|Overall Study|Withdrawal by Subject|0
1145187|NCT02984982|2252315|FG000|Overall Study|Randomized but not treated|0
1145188|NCT02984982|2252316|FG001|Overall Study|Randomized but not treated|1
1145189|NCT02984995|2252325|FG000|Overall Study|Required stem cell transplant|13
1145190|NCT02984995|2252326|FG001|Overall Study|Required stem cell transplant|2
1145191|NCT02984995|2252325|FG000|Overall Study|Progressive disease|11
1145192|NCT02984995|2252326|FG001|Overall Study|Progressive disease|1
1145193|NCT02984995|2252325|FG000|Overall Study|Adverse Event|1
1145194|NCT02984995|2252326|FG001|Overall Study|Adverse Event|0
1145195|NCT02985021|2252338|FG000|Overall Study|Inability to comply with study procedures|1
1145196|NCT02985398|2252342|FG000|Overall Study|Adverse Event|1
1145197|NCT02985398|2252342|FG000|Overall Study|Lost to Follow-up|4
1145198|NCT02985398|2252342|FG000|Overall Study|Withdrawal by Subject|8
1145199|NCT02985398|2252342|FG000|Overall Study|Study Burden|9
1145200|NCT02985450|2252346|FG000|Overall Study|Lost to Follow-up|7
1145204|NCT02985879|2252378|FG000|Overall Study|Adverse Event|7
1145205|NCT02985879|2252379|FG001|Overall Study|Adverse Event|9
1145206|NCT02985879|2252380|FG002|Overall Study|Adverse Event|7
1145207|NCT02985879|2252378|FG000|Overall Study|Withdrew consent|6
1145208|NCT02985879|2252379|FG001|Overall Study|Withdrew consent|8
1145209|NCT02985879|2252380|FG002|Overall Study|Withdrew consent|10
1145210|NCT02985879|2252378|FG000|Overall Study|Lost to Follow-up|1
1145211|NCT02985879|2252379|FG001|Overall Study|Lost to Follow-up|0
1145212|NCT02985879|2252380|FG002|Overall Study|Lost to Follow-up|2
1145213|NCT02985879|2252378|FG000|Overall Study|Other, not specified|62
1145214|NCT02985879|2252379|FG001|Overall Study|Other, not specified|58
1145215|NCT02985879|2252380|FG002|Overall Study|Other, not specified|58
1145216|NCT02985996|2252399|FG000|Overall Study|Withdrawal by Subject|0
1145217|NCT02985996|2252400|FG001|Overall Study|Withdrawal by Subject|0
1145218|NCT02985996|2252401|FG002|Overall Study|Withdrawal by Subject|1
1145219|NCT02985996|2252402|FG003|Overall Study|Withdrawal by Subject|0
1145220|NCT02985996|2252403|FG004|Overall Study|Withdrawal by Subject|0
1145221|NCT02985996|2252399|FG000|Overall Study|Protocol Violation|0
1145222|NCT02985996|2252400|FG001|Overall Study|Protocol Violation|1
1145223|NCT02985996|2252401|FG002|Overall Study|Protocol Violation|0
1145224|NCT02985996|2252402|FG003|Overall Study|Protocol Violation|0
1145225|NCT02985996|2252403|FG004|Overall Study|Protocol Violation|0
1145226|NCT02986074|2252419|FG000|First Trial Period|Adverse Event|1
1145227|NCT02986074|2252420|FG001|First Trial Period|Adverse Event|0
1145228|NCT02986074|2252421|FG002|First Trial Period|Adverse Event|0
1145229|NCT02986074|2252422|FG003|First Trial Period|Adverse Event|0
1145230|NCT02986074|2252419|FG000|Follow up Period|system explant|0
1145231|NCT02986074|2252420|FG001|Follow up Period|system explant|0
1145232|NCT02986074|2252421|FG002|Follow up Period|system explant|1
1145233|NCT02986074|2252422|FG003|Follow up Period|system explant|2
1145234|NCT02986074|2252419|FG000|Follow up Period|Physician Decision|0
1145235|NCT02986074|2252420|FG001|Follow up Period|Physician Decision|0
1145236|NCT02986074|2252421|FG002|Follow up Period|Physician Decision|0
1145237|NCT02986074|2252422|FG003|Follow up Period|Physician Decision|1
1145238|NCT02986139|2252429|FG000|Overall Study|Sponsor Decision|1
1145239|NCT02986139|2252430|FG001|Overall Study|Sponsor Decision|2
1145240|NCT02986139|2252429|FG000|Overall Study|Withdrawal by Subject|0
1145241|NCT02986139|2252430|FG001|Overall Study|Withdrawal by Subject|1
1145242|NCT02986139|2252429|FG000|Overall Study|Lost to Follow-up|0
1145243|NCT02986139|2252430|FG001|Overall Study|Lost to Follow-up|1
1145244|NCT02986373|2252444|FG000|Overall Study|Adverse Event|4
1145245|NCT02986373|2252444|FG000|Overall Study|Lost to Follow-up|1
1145246|NCT02986373|2252444|FG000|Overall Study|Withdrawal by Subject|10
1145247|NCT02986373|2252444|FG000|Overall Study|Other|24
1145248|NCT02986854|2252477|FG000|Overall Study|Withdrawal by Subject|0
1145249|NCT02986854|2252478|FG001|Overall Study|Withdrawal by Subject|1
1145250|NCT02986854|2252479|FG002|Overall Study|Withdrawal by Subject|1
1145251|NCT02986854|2252477|FG000|Overall Study|Lost to Follow-up|3
1145252|NCT02986854|2252478|FG001|Overall Study|Lost to Follow-up|11
1145253|NCT02986854|2252479|FG002|Overall Study|Lost to Follow-up|2
1145254|NCT02987205|2252498|FG000|Overall Study|Adverse Event|1
1145255|NCT02987205|2252498|FG000|Overall Study|Withdrawal by Subject|3
1145256|NCT02987543|2252521|FG000|Overall Study|Ongoing study at data cut off|49
1145257|NCT02987543|2252522|FG001|Overall Study|Ongoing study at data cut off|21
1145258|NCT02987543|2252523|FG002|Overall Study|Ongoing study at data cut off|19
1145259|NCT02987543|2252524|FG003|Overall Study|Ongoing study at data cut off|12
1145260|NCT02987543|2252521|FG000|Overall Study|Death|88
1145261|NCT02987543|2252522|FG001|Overall Study|Death|54
1145262|NCT02987543|2252523|FG002|Overall Study|Death|67
1145263|NCT02987543|2252524|FG003|Overall Study|Death|28
1145264|NCT02987543|2252521|FG000|Overall Study|Lost to Follow-up|3
1145265|NCT02987543|2252522|FG001|Overall Study|Lost to Follow-up|0
1145266|NCT02987543|2252523|FG002|Overall Study|Lost to Follow-up|1
1145267|NCT02987543|2252524|FG003|Overall Study|Lost to Follow-up|0
1145268|NCT02987543|2252521|FG000|Overall Study|Screen failure|0
1145269|NCT02987543|2252522|FG001|Overall Study|Screen failure|0
1145270|NCT02987543|2252523|FG002|Overall Study|Screen failure|0
1145271|NCT02987543|2252524|FG003|Overall Study|Screen failure|1
1145272|NCT02987543|2252521|FG000|Overall Study|Withdrawal by Subject|21
1145273|NCT02987543|2252522|FG001|Overall Study|Withdrawal by Subject|7
1145274|NCT02987543|2252523|FG002|Overall Study|Withdrawal by Subject|7
1145275|NCT02987543|2252524|FG003|Overall Study|Withdrawal by Subject|6
1145276|NCT02987543|2252521|FG000|Overall Study|Study terminated by sponsor|1
1145277|NCT02987543|2252522|FG001|Overall Study|Study terminated by sponsor|0
1145278|NCT02987543|2252523|FG002|Overall Study|Study terminated by sponsor|0
1145279|NCT02987543|2252524|FG003|Overall Study|Study terminated by sponsor|0
1145280|NCT02987543|2252521|FG000|Overall Study|Investigator decision|0
1145281|NCT02987543|2252522|FG001|Overall Study|Investigator decision|1
1145282|NCT02987543|2252523|FG002|Overall Study|Investigator decision|0
1145283|NCT02987543|2252524|FG003|Overall Study|Investigator decision|0
1145284|NCT02987543|2252521|FG000|Overall Study|Disease progression|0
1145285|NCT02987543|2252522|FG001|Overall Study|Disease progression|0
1145286|NCT02987543|2252523|FG002|Overall Study|Disease progression|0
1145287|NCT02987543|2252524|FG003|Overall Study|Disease progression|1
1145288|NCT02987660|2252541|FG000|Overall Study|Study terminated by sponsor|10
1145289|NCT02987660|2252542|FG001|Overall Study|Study terminated by sponsor|10
1145290|NCT02987959|2252583|FG000|Overall Study|Grantor stopped supply of drugs|6
1145291|NCT02987972|2252590|FG000|Overall Study|Adverse Event|1
1145292|NCT02987972|2252591|FG001|Overall Study|Adverse Event|1
1145293|NCT02987972|2252592|FG002|Overall Study|Adverse Event|0
1145294|NCT02987972|2252590|FG000|Overall Study|Death|1
1145295|NCT02987972|2252591|FG001|Overall Study|Death|0
1145296|NCT02987972|2252592|FG002|Overall Study|Death|0
1145297|NCT02987972|2252590|FG000|Overall Study|Lack of Efficacy|9
1145298|NCT02987972|2252591|FG001|Overall Study|Lack of Efficacy|12
1145299|NCT02987972|2252592|FG002|Overall Study|Lack of Efficacy|12
1145300|NCT02987972|2252590|FG000|Overall Study|Lost to Follow-up|7
1145301|NCT02987972|2252591|FG001|Overall Study|Lost to Follow-up|8
1145302|NCT02987972|2252592|FG002|Overall Study|Lost to Follow-up|4
1145303|NCT02987972|2252590|FG000|Overall Study|Physician Decision|1
1145304|NCT02987972|2252591|FG001|Overall Study|Physician Decision|6
1145305|NCT02987972|2252592|FG002|Overall Study|Physician Decision|0
1145306|NCT02987972|2252590|FG000|Overall Study|Protocol Violation|2
1145307|NCT02987972|2252591|FG001|Overall Study|Protocol Violation|1
1145308|NCT02987972|2252592|FG002|Overall Study|Protocol Violation|5
1145309|NCT02987972|2252590|FG000|Overall Study|Withdrawal by Subject|22
1145310|NCT02987972|2252591|FG001|Overall Study|Withdrawal by Subject|17
1145311|NCT02987972|2252592|FG002|Overall Study|Withdrawal by Subject|21
1145312|NCT02988115|2252611|FG000|Overall Study|Adverse Event|6
1145313|NCT02988115|2252612|FG001|Overall Study|Adverse Event|1
1145314|NCT02988115|2252611|FG000|Overall Study|Sponsor Decision|5
1145315|NCT02988115|2252612|FG001|Overall Study|Sponsor Decision|2
1145316|NCT02988115|2252611|FG000|Overall Study|Withdrawal by Subject|1
1145317|NCT02988115|2252612|FG001|Overall Study|Withdrawal by Subject|1
1145318|NCT02988115|2252611|FG000|Overall Study|Withdrawn by Mistake|1
1145319|NCT02988115|2252612|FG001|Overall Study|Withdrawn by Mistake|0
1145320|NCT02988115|2252611|FG000|Overall Study|Lost to Follow-up|1
1145321|NCT02988115|2252612|FG001|Overall Study|Lost to Follow-up|0
1145322|NCT02988219|2252629|FG000|Overall Study|Lack of Efficacy|1
1145323|NCT02988219|2252630|FG001|Overall Study|Lack of Efficacy|1
1145324|NCT02988219|2252629|FG000|Overall Study|Withdrawal by Subject|0
1145325|NCT02988219|2252630|FG001|Overall Study|Withdrawal by Subject|2
1145326|NCT02988622|2252645|FG000|Overall Study|Lost to Follow-up|17
1145327|NCT02989168|2252675|FG000|Overall Study|Withdrawal by Subject|2
1145328|NCT02989168|2252676|FG001|Overall Study|Withdrawal by Subject|0
1145329|NCT02989168|2252675|FG000|Overall Study|Physician Decision|0
1145330|NCT02989168|2252676|FG001|Overall Study|Physician Decision|1
1145331|NCT02989168|2252675|FG000|Overall Study|Adverse Event|1
1145332|NCT02989168|2252676|FG001|Overall Study|Adverse Event|2
1145333|NCT02989168|2252675|FG000|Overall Study|Sponsor stopped study.|1
1145334|NCT02989168|2252676|FG001|Overall Study|Sponsor stopped study.|0
1145335|NCT02989389|2252698|FG000|Period 1|Lost to Follow-up|0
1145336|NCT02989389|2252699|FG001|Period 1|Lost to Follow-up|1
1145337|NCT02989389|2252700|FG002|Period 1|Lost to Follow-up|0
1145338|NCT02989389|2252701|FG003|Period 1|Lost to Follow-up|0
1145339|NCT02989389|2252702|FG004|Period 1|Lost to Follow-up|0
1145340|NCT02989389|2252703|FG005|Period 1|Lost to Follow-up|0
1145341|NCT02989389|2252704|FG006|Period 1|Lost to Follow-up|0
1145342|NCT02989389|2252705|FG007|Period 1|Lost to Follow-up|0
1145343|NCT02989389|2252706|FG008|Period 1|Lost to Follow-up|0
1145344|NCT02989389|2252707|FG009|Period 1|Lost to Follow-up|0
1145345|NCT02989389|2252698|FG000|Period 1|Physician Decision|0
1145346|NCT02989389|2252699|FG001|Period 1|Physician Decision|0
1145347|NCT02989389|2252700|FG002|Period 1|Physician Decision|0
1145348|NCT02989389|2252701|FG003|Period 1|Physician Decision|0
1145349|NCT02989389|2252702|FG004|Period 1|Physician Decision|0
1145350|NCT02989389|2252703|FG005|Period 1|Physician Decision|0
1145351|NCT02989389|2252704|FG006|Period 1|Physician Decision|0
1145352|NCT02989389|2252705|FG007|Period 1|Physician Decision|0
1145353|NCT02989389|2252706|FG008|Period 1|Physician Decision|1
1145354|NCT02989389|2252707|FG009|Period 1|Physician Decision|0
1145355|NCT02989610|2252764|FG000|Overall Study|Withdrawal/Other reasons|39
1145356|NCT02989649|2252768|FG000|Overall Study|Patient/Investigator's Decision to Stop|403
1145357|NCT02989649|2252768|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1
1145358|NCT02989649|2252768|FG000|Overall Study|Lost For Observation During Study|3
1145359|NCT02989649|2252768|FG000|Overall Study|Reason Not Specified|13
1145360|NCT02989805|2252794|FG000|Overall Study|invalid consent|6
1145361|NCT02989805|2252795|FG001|Overall Study|invalid consent|4
1145362|NCT02990000|2252803|FG000|Overall Study|Failed to provide data beyond baseline|36
1145363|NCT02990000|2252804|FG001|Overall Study|Failed to provide data beyond baseline|34
1145364|NCT02990338|2252812|FG000|Overall Study|Adverse Event|19
1145365|NCT02990338|2252813|FG001|Overall Study|Adverse Event|11
1145366|NCT02990338|2252812|FG000|Overall Study|Progressive disease|88
1145367|NCT02990338|2252813|FG001|Overall Study|Progressive disease|66
1145368|NCT02990338|2252812|FG000|Overall Study|Poor compliance to protocol|0
1145369|NCT02990338|2252813|FG001|Overall Study|Poor compliance to protocol|1
1145370|NCT02990338|2252812|FG000|Overall Study|Withdrawal by Subject|6
1145371|NCT02990338|2252813|FG001|Overall Study|Withdrawal by Subject|5
1145372|NCT02990338|2252812|FG000|Overall Study|Other|1
1145373|NCT02990338|2252813|FG001|Overall Study|Other|4
1145374|NCT02990338|2252812|FG000|Overall Study|Randomized but not treated|4
1145375|NCT02990338|2252813|FG001|Overall Study|Randomized but not treated|2
1145376|NCT02990910|2252822|FG000|Overall Study|Lack of Efficacy|6
1145377|NCT02990910|2252823|FG001|Overall Study|Lack of Efficacy|10
1145378|NCT02991040|2252829|FG000|Overall Study|Withdrawal by Subject|2
1145379|NCT02991040|2252829|FG000|Overall Study|Lost to Follow-up|2
1145380|NCT02991118|2252837|FG000|Overall Study|Death|3
1145381|NCT02991118|2252838|FG001|Overall Study|Death|8
1145382|NCT02991118|2252837|FG000|Overall Study|Protocol Violation|0
1145383|NCT02991118|2252838|FG001|Overall Study|Protocol Violation|3
1145384|NCT02991118|2252837|FG000|Overall Study|Physician Decision|0
1145385|NCT02991118|2252838|FG001|Overall Study|Physician Decision|1
1145386|NCT02991118|2252837|FG000|Overall Study|Moved out of the country|0
1145387|NCT02991118|2252838|FG001|Overall Study|Moved out of the country|1
1145388|NCT02991118|2252837|FG000|Overall Study|Adverse Event|2
1145389|NCT02991118|2252838|FG001|Overall Study|Adverse Event|2
1145390|NCT02991118|2252837|FG000|Overall Study|Withdrawal by Subject|1
1145391|NCT02991118|2252838|FG001|Overall Study|Withdrawal by Subject|7
1145392|NCT02991118|2252837|FG000|Overall Study|Could not attend study visits|0
1145393|NCT02991118|2252838|FG001|Overall Study|Could not attend study visits|1
1145394|NCT02991118|2252837|FG000|Overall Study|Lost to Follow-up|1
1145395|NCT02991118|2252838|FG001|Overall Study|Lost to Follow-up|9
1145396|NCT02991859|2252892|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145397|NCT02991859|2252893|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
1145398|NCT02991859|2252894|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145399|NCT02991859|2252895|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145400|NCT02991859|2252896|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
1145401|NCT02991859|2252897|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145402|NCT02991859|2252898|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145403|NCT02991859|2252899|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145404|NCT02991859|2252900|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145405|NCT02991859|2252901|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145406|NCT02991859|2252902|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145407|NCT02991859|2252903|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145408|NCT02991859|2252904|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145409|NCT02991859|2252905|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145410|NCT02991859|2252906|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145411|NCT02991859|2252907|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145412|NCT02991859|2252908|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
1145413|NCT02991859|2252892|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145414|NCT02991859|2252893|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145415|NCT02991859|2252894|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145416|NCT02991859|2252895|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145417|NCT02991859|2252896|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145418|NCT02991859|2252897|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145419|NCT02991859|2252898|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145420|NCT02991859|2252899|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145421|NCT02991859|2252900|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145422|NCT02991859|2252901|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145423|NCT02991859|2252902|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145424|NCT02991859|2252903|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145425|NCT02991859|2252904|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
1145426|NCT02991859|2252905|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
1145427|NCT02991859|2252906|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145428|NCT02991859|2252907|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145429|NCT02991859|2252908|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
1145430|NCT02991859|2252892|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145431|NCT02991859|2252893|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145432|NCT02991859|2252894|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145433|NCT02991859|2252895|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145434|NCT02991859|2252896|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145435|NCT02991859|2252897|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1
1145436|NCT02991859|2252898|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145437|NCT02991859|2252899|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145438|NCT02991859|2252900|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145439|NCT02991859|2252901|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145440|NCT02991859|2252902|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145441|NCT02991859|2252903|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145442|NCT02991859|2252904|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145443|NCT02991859|2252905|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145444|NCT02991859|2252906|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145445|NCT02991859|2252907|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145446|NCT02991859|2252908|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0
1145447|NCT02991859|2252892|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0
1145448|NCT02991859|2252893|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0
1145449|NCT02991859|2252894|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0
1145450|NCT02991859|2252895|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0
1145451|NCT02991859|2252896|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0
1145452|NCT02991859|2252897|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0
1145453|NCT02991859|2252898|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0
1145454|NCT02991859|2252899|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0
1145455|NCT02991859|2252900|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0
1145456|NCT02991859|2252901|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1
1145457|NCT02991859|2252902|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0
1145458|NCT02991859|2252903|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0
1145459|NCT02991859|2252904|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0
1145460|NCT02991859|2252905|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0
1145461|NCT02991859|2252906|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0
1145462|NCT02991859|2252907|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0
1145463|NCT02991859|2252908|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0
1145464|NCT02991859|2252892|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145465|NCT02991859|2252893|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145466|NCT02991859|2252894|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145467|NCT02991859|2252895|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145468|NCT02991859|2252896|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145469|NCT02991859|2252897|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145470|NCT02991859|2252898|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145471|NCT02991859|2252899|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145472|NCT02991859|2252900|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
1145473|NCT02991859|2252901|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145474|NCT02991859|2252902|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145475|NCT02991859|2252903|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145476|NCT02991859|2252904|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145477|NCT02991859|2252905|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145478|NCT02991859|2252906|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145479|NCT02991859|2252907|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145480|NCT02991859|2252908|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
1145481|NCT02992132|2253024|FG000|Overall Study|Adverse Event|4
1145482|NCT02992132|2253025|FG001|Overall Study|Adverse Event|1
1145483|NCT02992132|2253026|FG002|Overall Study|Adverse Event|3
1145484|NCT02992132|2253024|FG000|Overall Study|Lack of Efficacy|2
1145485|NCT02992132|2253025|FG001|Overall Study|Lack of Efficacy|0
1145486|NCT02992132|2253026|FG002|Overall Study|Lack of Efficacy|0
1145487|NCT02992132|2253024|FG000|Overall Study|Non-compliance with study drug|2
1145488|NCT02992132|2253025|FG001|Overall Study|Non-compliance with study drug|0
1145489|NCT02992132|2253026|FG002|Overall Study|Non-compliance with study drug|0
1145490|NCT02992132|2253024|FG000|Overall Study|Progressive disease|1
1145491|NCT02992132|2253025|FG001|Overall Study|Progressive disease|0
1145492|NCT02992132|2253026|FG002|Overall Study|Progressive disease|0
1145493|NCT02992132|2253024|FG000|Overall Study|Protocol Violation|2
1145494|NCT02992132|2253025|FG001|Overall Study|Protocol Violation|2
1145495|NCT02992132|2253026|FG002|Overall Study|Protocol Violation|0
1145496|NCT02992132|2253024|FG000|Overall Study|Caregiver withdrew consent|2
1145497|NCT02992132|2253025|FG001|Overall Study|Caregiver withdrew consent|3
1145498|NCT02992132|2253026|FG002|Overall Study|Caregiver withdrew consent|2
1145499|NCT02992132|2253024|FG000|Overall Study|Withdrawal by Subject|0
1145500|NCT02992132|2253025|FG001|Overall Study|Withdrawal by Subject|2
1145501|NCT02992132|2253026|FG002|Overall Study|Withdrawal by Subject|1
1145502|NCT02992132|2253024|FG000|Overall Study|Physician Decision|0
1145503|NCT02992132|2253025|FG001|Overall Study|Physician Decision|0
1145504|NCT02992132|2253026|FG002|Overall Study|Physician Decision|1
1145505|NCT02992288|2253060|FG000|Overall Study|Adverse Event|8
1145506|NCT02992288|2253061|FG001|Overall Study|Adverse Event|2
1145507|NCT02992288|2253062|FG002|Overall Study|Adverse Event|2
1145508|NCT02992288|2253063|FG003|Overall Study|Adverse Event|2
1145509|NCT02992288|2253064|FG004|Overall Study|Adverse Event|2
1145510|NCT02992288|2253065|FG005|Overall Study|Adverse Event|7
1145511|NCT02992288|2253060|FG000|Overall Study|Non-compliance with study drug|0
1145512|NCT02992288|2253061|FG001|Overall Study|Non-compliance with study drug|1
1145513|NCT02992288|2253062|FG002|Overall Study|Non-compliance with study drug|1
1145514|NCT02992288|2253063|FG003|Overall Study|Non-compliance with study drug|0
1145515|NCT02992288|2253064|FG004|Overall Study|Non-compliance with study drug|1
1145516|NCT02992288|2253065|FG005|Overall Study|Non-compliance with study drug|0
1145517|NCT02992288|2253060|FG000|Overall Study|Physician Decision|3
1145518|NCT02992288|2253061|FG001|Overall Study|Physician Decision|0
1145519|NCT02992288|2253062|FG002|Overall Study|Physician Decision|1
1145520|NCT02992288|2253063|FG003|Overall Study|Physician Decision|0
1145521|NCT02992288|2253064|FG004|Overall Study|Physician Decision|0
1145522|NCT02992288|2253065|FG005|Overall Study|Physician Decision|1
1145523|NCT02992288|2253060|FG000|Overall Study|Death|2
1145524|NCT02992288|2253061|FG001|Overall Study|Death|0
1145525|NCT02992288|2253062|FG002|Overall Study|Death|2
1145526|NCT02992288|2253063|FG003|Overall Study|Death|1
1145527|NCT02992288|2253064|FG004|Overall Study|Death|2
1145528|NCT02992288|2253065|FG005|Overall Study|Death|0
1145529|NCT02992288|2253060|FG000|Overall Study|Lost to Follow-up|0
1145530|NCT02992288|2253061|FG001|Overall Study|Lost to Follow-up|0
1145531|NCT02992288|2253062|FG002|Overall Study|Lost to Follow-up|0
1145532|NCT02992288|2253063|FG003|Overall Study|Lost to Follow-up|1
1145533|NCT02992288|2253064|FG004|Overall Study|Lost to Follow-up|0
1145534|NCT02992288|2253065|FG005|Overall Study|Lost to Follow-up|0
1145535|NCT02992288|2253060|FG000|Overall Study|Protocol Violation|0
1145536|NCT02992288|2253061|FG001|Overall Study|Protocol Violation|0
1145537|NCT02992288|2253062|FG002|Overall Study|Protocol Violation|0
1145538|NCT02992288|2253063|FG003|Overall Study|Protocol Violation|0
1145539|NCT02992288|2253064|FG004|Overall Study|Protocol Violation|0
1145540|NCT02992288|2253065|FG005|Overall Study|Protocol Violation|1
1145541|NCT02992288|2253060|FG000|Overall Study|Withdrawal by Subject|4
1145542|NCT02992288|2253061|FG001|Overall Study|Withdrawal by Subject|2
1145543|NCT02992288|2253062|FG002|Overall Study|Withdrawal by Subject|1
1145544|NCT02992288|2253063|FG003|Overall Study|Withdrawal by Subject|5
1145545|NCT02992288|2253064|FG004|Overall Study|Withdrawal by Subject|3
1145546|NCT02992288|2253065|FG005|Overall Study|Withdrawal by Subject|4
1145547|NCT02992418|2253081|FG000|Overall Study|Withdrawal by Subject|11
1145548|NCT02992418|2253082|FG001|Overall Study|Withdrawal by Subject|12
1145549|NCT02992418|2253081|FG000|Overall Study|Non-compliance with the protocol|308
1145550|NCT02992418|2253082|FG001|Overall Study|Non-compliance with the protocol|308
1145551|NCT02992418|2253081|FG000|Overall Study|Lost to Follow-up|27
1145552|NCT02992418|2253082|FG001|Overall Study|Lost to Follow-up|22
1145553|NCT02992691|2253088|FG000|Overall Study|Adverse Event|2
1145554|NCT02992691|2253088|FG000|Overall Study|Withdrawal by Subject|1
1145555|NCT02992899|2253105|FG000|Overall Study|Withdrawal by Subject|1
1145556|NCT02992899|2253106|FG001|Overall Study|Withdrawal by Subject|0
1145557|NCT02992899|2253105|FG000|Overall Study|Lost to Follow-up|1
1145558|NCT02992899|2253106|FG001|Overall Study|Lost to Follow-up|3
1145559|NCT02993250|2253120|FG000|Overall Study|Lost to Follow-up|0
1145560|NCT02993250|2253121|FG001|Overall Study|Lost to Follow-up|1
1145561|NCT02993471|2253145|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
1145562|NCT02993471|2253145|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
1145563|NCT02993731|2253169|FG000|Overall Study|Study Termination|101
1145564|NCT02993731|2253170|FG001|Overall Study|Study Termination|105
1145565|NCT02993757|2253188|FG000|Overall Study|Non compliance with the protocol|155
1145566|NCT02993757|2253189|FG001|Overall Study|Non compliance with the protocol|170
1145567|NCT02993757|2253188|FG000|Overall Study|Lost to Follow-up|1
1145568|NCT02993757|2253189|FG001|Overall Study|Lost to Follow-up|0
1145569|NCT02993757|2253188|FG000|Overall Study|Voluntary withdraw not due adverse event|8
1145570|NCT02993757|2253189|FG001|Overall Study|Voluntary withdraw not due adverse event|8
1145571|NCT02993783|2253197|FG000|Overall Study|Reason not Specified|6
1145572|NCT02993783|2253198|FG001|Overall Study|Reason not Specified|9
1145573|NCT02994056|2253216|FG000|Overall Study|Death|8
1145574|NCT02994056|2253216|FG000|Overall Study|Withdrew Consent|1
1145575|NCT02994108|2253231|FG000|Intervention Messages|Withdrawal by Subject|2
1145576|NCT02994108|2253232|FG001|Intervention Messages|Withdrawal by Subject|0
1145577|NCT02994108|2253231|FG000|Phase 1 Assessment|Lost to Follow-up|5
1145578|NCT02994108|2253232|FG001|Phase 1 Assessment|Lost to Follow-up|3
1145579|NCT02994108|2253231|FG000|Phase 2 Assessment|Lost to Follow-up|8
1145580|NCT02994108|2253232|FG001|Phase 2 Assessment|Lost to Follow-up|7
1145581|NCT02994108|2253231|FG000|Phase 2 Assessment|Withdrawal by Subject|1
1145582|NCT02994108|2253232|FG001|Phase 2 Assessment|Withdrawal by Subject|0
1145583|NCT02994394|2253250|FG000|Period 1 (Days 1 to 3)|Adverse Event|0
1145584|NCT02994394|2253251|FG001|Period 1 (Days 1 to 3)|Adverse Event|0
1145585|NCT02994394|2253252|FG002|Period 1 (Days 1 to 3)|Adverse Event|1
1145586|NCT02994394|2253253|FG003|Period 1 (Days 1 to 3)|Adverse Event|0
1145587|NCT02994394|2253254|FG004|Period 1 (Days 1 to 3)|Adverse Event|0
1145588|NCT02994394|2253255|FG005|Period 1 (Days 1 to 3)|Adverse Event|0
1145589|NCT02994394|2253250|FG000|Period 2 (Days 4 to 6)|Adverse Event|0
1145590|NCT02994394|2253251|FG001|Period 2 (Days 4 to 6)|Adverse Event|1
1145591|NCT02994394|2253252|FG002|Period 2 (Days 4 to 6)|Adverse Event|0
1145592|NCT02994394|2253253|FG003|Period 2 (Days 4 to 6)|Adverse Event|0
1145593|NCT02994394|2253254|FG004|Period 2 (Days 4 to 6)|Adverse Event|1
1145594|NCT02994394|2253255|FG005|Period 2 (Days 4 to 6)|Adverse Event|0
1145595|NCT02994654|2253269|FG000|Overall Study|Lost to Follow-up|1
1145596|NCT02994940|2253281|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6
1145597|NCT02994940|2253282|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0
1145598|NCT02994940|2253281|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1
1145599|NCT02994940|2253282|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0
1145600|NCT02994940|2253281|FG000|Overall Study|Did not receive study medications: red dye allergy|0
1145601|NCT02994940|2253282|FG001|Overall Study|Did not receive study medications: red dye allergy|1
1145602|NCT02995980|2253306|FG000|Overall Study|Lost to Follow-up|14
1145603|NCT02996097|2253311|FG000|Overall Study|Lost to Follow-up|11
1145604|NCT02996097|2253312|FG001|Overall Study|Lost to Follow-up|11
1145605|NCT02996448|2253317|FG000|Overall Study|Study terminated due to adverse effects|3
1145606|NCT02996474|2253322|FG000|Overall Study|Physician Decision|5
1145607|NCT02996500|2253332|FG000|Overall Study|Adverse Event|1
1145608|NCT02996500|2253333|FG001|Overall Study|Adverse Event|1
1145609|NCT02996500|2253334|FG002|Overall Study|Adverse Event|4
1145610|NCT02996500|2253335|FG003|Overall Study|Adverse Event|3
1145611|NCT02996500|2253336|FG004|Overall Study|Adverse Event|1
1145612|NCT02996500|2253337|FG005|Overall Study|Adverse Event|2
1145613|NCT02996500|2253332|FG000|Overall Study|Lack of Efficacy|0
1145614|NCT02996500|2253333|FG001|Overall Study|Lack of Efficacy|0
1145615|NCT02996500|2253334|FG002|Overall Study|Lack of Efficacy|0
1145616|NCT02996500|2253335|FG003|Overall Study|Lack of Efficacy|0
1145617|NCT02996500|2253336|FG004|Overall Study|Lack of Efficacy|2
1145618|NCT02996500|2253337|FG005|Overall Study|Lack of Efficacy|0
1145619|NCT02996500|2253332|FG000|Overall Study|Lost to Follow-up|1
902067|NCT00738062|1875797|FG002|Open Label Treatment|Investigator Decision|0
902068|NCT00738062|1875795|FG000|Open-Label Extension|Adverse Event|5
902069|NCT00738062|1875796|FG001|Open-Label Extension|Adverse Event|0
902070|NCT00738062|1875797|FG002|Open-Label Extension|Adverse Event|0
902071|NCT00738062|1875795|FG000|Open-Label Extension|Physician Decision|1
902072|NCT00738062|1875796|FG001|Open-Label Extension|Physician Decision|0
902073|NCT00738062|1875797|FG002|Open-Label Extension|Physician Decision|0
902074|NCT00738062|1875795|FG000|Open-Label Extension|Lack of Efficacy|2
902075|NCT00738062|1875796|FG001|Open-Label Extension|Lack of Efficacy|0
902076|NCT00738062|1875797|FG002|Open-Label Extension|Lack of Efficacy|0
902077|NCT00738062|1875795|FG000|Open-Label Extension|Withdrawal by Subject|6
902078|NCT00738062|1875796|FG001|Open-Label Extension|Withdrawal by Subject|0
902079|NCT00738062|1875797|FG002|Open-Label Extension|Withdrawal by Subject|0
902080|NCT00738062|1875795|FG000|Open-Label Extension|Protocol Violation|1
902081|NCT00738062|1875796|FG001|Open-Label Extension|Protocol Violation|0
902082|NCT00738062|1875797|FG002|Open-Label Extension|Protocol Violation|0
902083|NCT00738062|1875795|FG000|Open-Label Extension|Study Terminated|2
902084|NCT00738062|1875796|FG001|Open-Label Extension|Study Terminated|0
902085|NCT00738062|1875797|FG002|Open-Label Extension|Study Terminated|0
902086|NCT00738101|1875806|FG000|Overall Study|Physician Decision|5
1145620|NCT02996500|2253333|FG001|Overall Study|Lost to Follow-up|0
1145621|NCT02996500|2253334|FG002|Overall Study|Lost to Follow-up|0
1145622|NCT02996500|2253335|FG003|Overall Study|Lost to Follow-up|0
1145623|NCT02996500|2253336|FG004|Overall Study|Lost to Follow-up|0
1145624|NCT02996500|2253337|FG005|Overall Study|Lost to Follow-up|1
1145625|NCT02996500|2253332|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
1145626|NCT02996500|2253333|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
1145627|NCT02996500|2253334|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
1145628|NCT02996500|2253335|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
1145629|NCT02996500|2253336|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
1145630|NCT02996500|2253337|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
1145631|NCT02996500|2253332|FG000|Overall Study|Non-Compliance With Study Drug|0
1145632|NCT02996500|2253333|FG001|Overall Study|Non-Compliance With Study Drug|0
1145633|NCT02996500|2253334|FG002|Overall Study|Non-Compliance With Study Drug|0
1145634|NCT02996500|2253335|FG003|Overall Study|Non-Compliance With Study Drug|0
1145635|NCT02996500|2253336|FG004|Overall Study|Non-Compliance With Study Drug|0
1145636|NCT02996500|2253337|FG005|Overall Study|Non-Compliance With Study Drug|1
1145637|NCT02996500|2253332|FG000|Overall Study|Progressive Disease|1
1145638|NCT02996500|2253333|FG001|Overall Study|Progressive Disease|0
1145639|NCT02996500|2253334|FG002|Overall Study|Progressive Disease|0
1145640|NCT02996500|2253335|FG003|Overall Study|Progressive Disease|0
1145641|NCT02996500|2253336|FG004|Overall Study|Progressive Disease|0
1145642|NCT02996500|2253337|FG005|Overall Study|Progressive Disease|0
1145643|NCT02996500|2253332|FG000|Overall Study|Other|2
1145644|NCT02996500|2253333|FG001|Overall Study|Other|0
1145645|NCT02996500|2253334|FG002|Overall Study|Other|2
1145646|NCT02996500|2253335|FG003|Overall Study|Other|0
1145647|NCT02996500|2253336|FG004|Overall Study|Other|0
1145648|NCT02996500|2253337|FG005|Overall Study|Other|0
1145649|NCT02996500|2253332|FG000|Overall Study|Protocol Violation|0
1145650|NCT02996500|2253333|FG001|Overall Study|Protocol Violation|0
1145651|NCT02996500|2253334|FG002|Overall Study|Protocol Violation|0
1145652|NCT02996500|2253335|FG003|Overall Study|Protocol Violation|1
1145653|NCT02996500|2253336|FG004|Overall Study|Protocol Violation|0
1145654|NCT02996500|2253337|FG005|Overall Study|Protocol Violation|0
1145655|NCT02996500|2253332|FG000|Overall Study|Withdrawal by Subject|3
1145656|NCT02996500|2253333|FG001|Overall Study|Withdrawal by Subject|0
1145657|NCT02996500|2253334|FG002|Overall Study|Withdrawal by Subject|3
1145658|NCT02996500|2253335|FG003|Overall Study|Withdrawal by Subject|0
1145659|NCT02996500|2253336|FG004|Overall Study|Withdrawal by Subject|2
1145660|NCT02996500|2253337|FG005|Overall Study|Withdrawal by Subject|0
1145661|NCT02996682|2253366|FG000|Overall Study|Death|0
1145662|NCT02996682|2253367|FG001|Overall Study|Death|3
1145663|NCT02996968|2253384|FG000|Overall Study|Withdrawal by Subject|1
1145664|NCT02996968|2253385|FG001|Overall Study|Withdrawal by Subject|0
1145665|NCT02997163|2253407|FG000|Overall Study|Adverse Event|1
1145666|NCT02997163|2253408|FG001|Overall Study|Adverse Event|0
1145667|NCT02997163|2253409|FG002|Overall Study|Adverse Event|0
1145668|NCT02997163|2253410|FG003|Overall Study|Adverse Event|1
1145669|NCT02997176|2253424|FG000|Overall Study|Adverse Event|0
1145670|NCT02997176|2253425|FG001|Overall Study|Adverse Event|0
1145671|NCT02997176|2253426|FG002|Overall Study|Adverse Event|0
1145672|NCT02997176|2253427|FG003|Overall Study|Adverse Event|8
1145673|NCT02997176|2253424|FG000|Overall Study|Progressive Disease|1
1145674|NCT02997176|2253425|FG001|Overall Study|Progressive Disease|0
1145675|NCT02997176|2253426|FG002|Overall Study|Progressive Disease|1
1145676|NCT02997176|2253427|FG003|Overall Study|Progressive Disease|1
1145677|NCT02997176|2253424|FG000|Overall Study|Death|0
1145678|NCT02997176|2253425|FG001|Overall Study|Death|0
1145679|NCT02997176|2253426|FG002|Overall Study|Death|1
1145680|NCT02997176|2253427|FG003|Overall Study|Death|1
1145681|NCT02997176|2253424|FG000|Overall Study|Withdrawal by Subject|0
902087|NCT00738101|1875806|FG000|Overall Study|Death|1
902088|NCT00738101|1875806|FG000|Overall Study|Repeat enrollment|1
1145682|NCT02997176|2253425|FG001|Overall Study|Withdrawal by Subject|2
1145683|NCT02997176|2253426|FG002|Overall Study|Withdrawal by Subject|0
1145684|NCT02997176|2253427|FG003|Overall Study|Withdrawal by Subject|1
1145685|NCT02998021|2253470|FG000|Overall Study|Withdrawal by Subject|3
1145686|NCT02998021|2253471|FG001|Overall Study|Withdrawal by Subject|1
1145687|NCT02998021|2253470|FG000|Overall Study|unsafe home|0
1145688|NCT02998021|2253471|FG001|Overall Study|unsafe home|1
1145689|NCT02998151|2253477|FG000|Overall Study|Withdrawal by Subject|3
1145690|NCT02998151|2253477|FG000|Overall Study|Participant declined to re-enroll for baclofen|8
1145691|NCT02998151|2253477|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13
1145692|NCT02998476|2253491|FG000|Overall Study|Ongoing in study|21
1145693|NCT02998476|2253492|FG001|Overall Study|Ongoing in study|1
1145694|NCT02998476|2253491|FG000|Overall Study|Disease Progression|1
1145695|NCT02998476|2253492|FG001|Overall Study|Disease Progression|0
1145696|NCT02998476|2253491|FG000|Overall Study|Withdrawal by Subject|1
1145697|NCT02998476|2253492|FG001|Overall Study|Withdrawal by Subject|2
1145698|NCT02998476|2253491|FG000|Overall Study|Death|32
1145699|NCT02998476|2253492|FG001|Overall Study|Death|2
1145700|NCT02998541|2253500|FG000|Overall Study|Adverse Event|4
1145701|NCT02998541|2253501|FG001|Overall Study|Adverse Event|5
1145702|NCT02998541|2253502|FG002|Overall Study|Adverse Event|1
1145703|NCT02998541|2253500|FG000|Overall Study|Protocol Violation|1
1145704|NCT02998541|2253501|FG001|Overall Study|Protocol Violation|0
1145705|NCT02998541|2253502|FG002|Overall Study|Protocol Violation|0
1145706|NCT02998541|2253500|FG000|Overall Study|Withdrawal by Subject|3
1145707|NCT02998541|2253501|FG001|Overall Study|Withdrawal by Subject|1
1145708|NCT02998541|2253502|FG002|Overall Study|Withdrawal by Subject|0
1145709|NCT02998541|2253500|FG000|Overall Study|Lost to Follow-up|0
1145710|NCT02998541|2253501|FG001|Overall Study|Lost to Follow-up|3
1145711|NCT02998541|2253502|FG002|Overall Study|Lost to Follow-up|1
1145712|NCT02998541|2253500|FG000|Overall Study|Physician Decision|0
1145713|NCT02998541|2253501|FG001|Overall Study|Physician Decision|0
1145714|NCT02998541|2253502|FG002|Overall Study|Physician Decision|3
1145715|NCT02998541|2253500|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1145716|NCT02998541|2253501|FG001|Overall Study|Withdrawal by Parent/Guardian|0
1145717|NCT02998541|2253502|FG002|Overall Study|Withdrawal by Parent/Guardian|1
1145718|NCT02998554|2253512|FG000|Overall Study|Adverse Event|8
1145719|NCT02998554|2253513|FG001|Overall Study|Adverse Event|3
1145720|NCT02998554|2253512|FG000|Overall Study|Protocol deviation|1
1145721|NCT02998554|2253513|FG001|Overall Study|Protocol deviation|0
1145722|NCT02998554|2253512|FG000|Overall Study|Withdrawal by Subject|2
1145723|NCT02998554|2253513|FG001|Overall Study|Withdrawal by Subject|6
1145724|NCT02998554|2253512|FG000|Overall Study|Lost to Follow-up|0
1145725|NCT02998554|2253513|FG001|Overall Study|Lost to Follow-up|1
1145726|NCT02998554|2253512|FG000|Overall Study|Lack of Efficacy|0
1145727|NCT02998554|2253513|FG001|Overall Study|Lack of Efficacy|1
1145728|NCT02998671|2253526|FG000|Period 1|Study Terminated By Sponsor|2
1145729|NCT02998671|2253527|FG001|Period 1|Study Terminated By Sponsor|1
1145730|NCT02998671|2253528|FG002|Period 1|Study Terminated By Sponsor|0
1145731|NCT02998671|2253529|FG003|Period 1|Study Terminated By Sponsor|0
1145732|NCT02998671|2253530|FG004|Period 1|Study Terminated By Sponsor|1
1145733|NCT02998671|2253526|FG000|Period 1|Withdrawal by Subject|1
1145734|NCT02998671|2253527|FG001|Period 1|Withdrawal by Subject|2
1145735|NCT02998671|2253528|FG002|Period 1|Withdrawal by Subject|0
1145736|NCT02998671|2253529|FG003|Period 1|Withdrawal by Subject|0
1145737|NCT02998671|2253530|FG004|Period 1|Withdrawal by Subject|2
1145738|NCT02998671|2253526|FG000|Period 1|Pregnancy|1
1145739|NCT02998671|2253527|FG001|Period 1|Pregnancy|0
1145740|NCT02998671|2253528|FG002|Period 1|Pregnancy|0
1145741|NCT02998671|2253529|FG003|Period 1|Pregnancy|0
1145742|NCT02998671|2253530|FG004|Period 1|Pregnancy|0
1145743|NCT02998671|2253526|FG000|Period 1|Adverse Event|0
1145744|NCT02998671|2253527|FG001|Period 1|Adverse Event|0
1145745|NCT02998671|2253528|FG002|Period 1|Adverse Event|0
1145746|NCT02998671|2253529|FG003|Period 1|Adverse Event|0
1145747|NCT02998671|2253530|FG004|Period 1|Adverse Event|1
1145748|NCT02998671|2253526|FG000|Period 2|Adverse Event|0
1145749|NCT02998671|2253527|FG001|Period 2|Adverse Event|1
1145750|NCT02998671|2253528|FG002|Period 2|Adverse Event|0
1145751|NCT02998671|2253529|FG003|Period 2|Adverse Event|0
1145752|NCT02998671|2253530|FG004|Period 2|Adverse Event|0
1145753|NCT02998671|2253526|FG000|Period 2|Study Terminated By Sponsor|3
1145754|NCT02998671|2253527|FG001|Period 2|Study Terminated By Sponsor|5
1145755|NCT02998671|2253528|FG002|Period 2|Study Terminated By Sponsor|1
1145756|NCT02998671|2253529|FG003|Period 2|Study Terminated By Sponsor|3
1145757|NCT02998671|2253530|FG004|Period 2|Study Terminated By Sponsor|0
1145758|NCT02998671|2253526|FG000|Period 2|Withdrawal by Subject|0
1145759|NCT02998671|2253527|FG001|Period 2|Withdrawal by Subject|1
1145760|NCT02998671|2253528|FG002|Period 2|Withdrawal by Subject|0
1145761|NCT02998671|2253529|FG003|Period 2|Withdrawal by Subject|0
1145762|NCT02998671|2253530|FG004|Period 2|Withdrawal by Subject|0
1145763|NCT02998671|2253526|FG000|Period 2|Lost to Follow-up|0
1145764|NCT02998671|2253527|FG001|Period 2|Lost to Follow-up|0
1145765|NCT02998671|2253528|FG002|Period 2|Lost to Follow-up|0
1145766|NCT02998671|2253529|FG003|Period 2|Lost to Follow-up|1
1145767|NCT02998671|2253530|FG004|Period 2|Lost to Follow-up|0
1145768|NCT02998996|2253565|FG000|Overall Study|Lost to Follow-up|0
1145769|NCT02998996|2253566|FG001|Overall Study|Lost to Follow-up|0
1145770|NCT02998996|2253567|FG002|Overall Study|Lost to Follow-up|1
1145771|NCT02998996|2253568|FG003|Overall Study|Lost to Follow-up|0
1145772|NCT02998996|2253569|FG004|Overall Study|Lost to Follow-up|0
1145773|NCT02998996|2253570|FG005|Overall Study|Lost to Follow-up|0
1145774|NCT02998996|2253565|FG000|Overall Study|Pregnancy|0
1145775|NCT02998996|2253566|FG001|Overall Study|Pregnancy|1
1145776|NCT02998996|2253567|FG002|Overall Study|Pregnancy|0
1145777|NCT02998996|2253568|FG003|Overall Study|Pregnancy|0
1145778|NCT02998996|2253569|FG004|Overall Study|Pregnancy|0
1145779|NCT02998996|2253570|FG005|Overall Study|Pregnancy|0
1145780|NCT02998996|2253565|FG000|Overall Study|Family reasons|0
1145781|NCT02998996|2253566|FG001|Overall Study|Family reasons|0
1145782|NCT02998996|2253567|FG002|Overall Study|Family reasons|0
1145783|NCT02998996|2253568|FG003|Overall Study|Family reasons|0
1145784|NCT02998996|2253569|FG004|Overall Study|Family reasons|1
1145785|NCT02998996|2253570|FG005|Overall Study|Family reasons|0
1145786|NCT02999100|2253590|FG000|Part 1 (up to 15 Days)|Adverse Event|0
1145787|NCT02999100|2253591|FG001|Part 1 (up to 15 Days)|Adverse Event|1
1145788|NCT02999100|2253592|FG002|Part 1 (up to 15 Days)|Adverse Event|0
1145789|NCT02999100|2253593|FG003|Part 1 (up to 15 Days)|Adverse Event|0
1145790|NCT02999100|2253594|FG004|Part 1 (up to 15 Days)|Adverse Event|0
1145791|NCT02999100|2253595|FG005|Part 1 (up to 15 Days)|Adverse Event|0
1145792|NCT02999100|2253590|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
1145793|NCT02999100|2253591|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
1145794|NCT02999100|2253592|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
1145795|NCT02999100|2253593|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
1145796|NCT02999100|2253594|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
1145797|NCT02999100|2253595|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
1145798|NCT02999100|2253590|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
1145799|NCT02999100|2253591|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
1145800|NCT02999100|2253592|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
1145801|NCT02999100|2253593|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
1145802|NCT02999100|2253594|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
1145803|NCT02999100|2253595|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
1145804|NCT02999178|2253619|FG000|Overall Study|Adverse Event|85
1145805|NCT02999178|2253620|FG001|Overall Study|Adverse Event|62
1145806|NCT02999178|2253619|FG000|Overall Study|Protocol Violation|1
1145807|NCT02999178|2253620|FG001|Overall Study|Protocol Violation|2
1145808|NCT02999178|2253619|FG000|Overall Study|Lost to Follow-up|0
1145809|NCT02999178|2253620|FG001|Overall Study|Lost to Follow-up|2
1145810|NCT02999178|2253619|FG000|Overall Study|Withdrawal by Subject|21
1145811|NCT02999178|2253620|FG001|Overall Study|Withdrawal by Subject|21
1145812|NCT02999178|2253619|FG000|Overall Study|Other reason not defined above|7
1145813|NCT02999178|2253620|FG001|Overall Study|Other reason not defined above|13
1145814|NCT02999191|2253629|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0
1145815|NCT02999191|2253630|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1
1145816|NCT02999191|2253631|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0
1145817|NCT02999633|2253639|FG000|Overall Study|Adverse Event|2
1145818|NCT02999633|2253639|FG000|Overall Study|Progressive disease|12
1145819|NCT02999672|2253645|FG000|Overall Study|Death|0
1145820|NCT02999672|2253646|FG001|Overall Study|Death|1
1145821|NCT02999672|2253645|FG000|Overall Study|Study Terminated by Sponsor|0
1145822|NCT02999672|2253646|FG001|Overall Study|Study Terminated by Sponsor|1
1145823|NCT02999672|2253645|FG000|Overall Study|Progressive Disease|9
1145824|NCT02999672|2253646|FG001|Overall Study|Progressive Disease|5
1145825|NCT02999672|2253645|FG000|Overall Study|Adverse Event|4
1145826|NCT02999672|2253646|FG001|Overall Study|Adverse Event|0
1145827|NCT03000075|2253668|FG000|Part A|Adverse Event|4
1145828|NCT03000075|2253669|FG001|Part A|Adverse Event|0
1145829|NCT03000075|2253670|FG002|Part A|Adverse Event|0
1145830|NCT03000075|2253671|FG003|Part A|Adverse Event|0
1145831|NCT03000075|2253672|FG004|Part A|Adverse Event|0
1145832|NCT03000075|2253673|FG005|Part A|Adverse Event|0
1145833|NCT03000075|2253674|FG006|Part A|Adverse Event|0
1145834|NCT03000075|2253668|FG000|Part B|Not dosed due to AE|0
1145835|NCT03000075|2253669|FG001|Part B|Not dosed due to AE|0
1145836|NCT03000075|2253670|FG002|Part B|Not dosed due to AE|0
1145837|NCT03000075|2253671|FG003|Part B|Not dosed due to AE|0
1145838|NCT03000075|2253672|FG004|Part B|Not dosed due to AE|0
1145839|NCT03000075|2253673|FG005|Part B|Not dosed due to AE|2
1145840|NCT03000075|2253674|FG006|Part B|Not dosed due to AE|1
1145841|NCT03000075|2253668|FG000|Part B|Adverse Event|0
1145842|NCT03000075|2253669|FG001|Part B|Adverse Event|0
1145843|NCT03000075|2253670|FG002|Part B|Adverse Event|0
1145844|NCT03000075|2253671|FG003|Part B|Adverse Event|0
1145845|NCT03000075|2253672|FG004|Part B|Adverse Event|1
1145846|NCT03000075|2253673|FG005|Part B|Adverse Event|0
1145847|NCT03000075|2253674|FG006|Part B|Adverse Event|0
1145848|NCT03000348|2253723|FG000|Overall Study|Adverse Event|1
1145849|NCT03000348|2253724|FG001|Overall Study|Adverse Event|1
1145850|NCT03000348|2253725|FG002|Overall Study|Adverse Event|1
1145851|NCT03000348|2253726|FG003|Overall Study|Adverse Event|1
1145852|NCT03000348|2253727|FG004|Overall Study|Adverse Event|1
1145853|NCT03000348|2253728|FG005|Overall Study|Adverse Event|1
1145854|NCT03000348|2253723|FG000|Overall Study|Lost to Follow-up|0
1145855|NCT03000348|2253724|FG001|Overall Study|Lost to Follow-up|0
1145856|NCT03000348|2253725|FG002|Overall Study|Lost to Follow-up|1
1145857|NCT03000348|2253726|FG003|Overall Study|Lost to Follow-up|0
1145858|NCT03000348|2253727|FG004|Overall Study|Lost to Follow-up|0
1145859|NCT03000348|2253728|FG005|Overall Study|Lost to Follow-up|0
1145860|NCT03000348|2253723|FG000|Overall Study|Withdrawal by Subject|0
1145861|NCT03000348|2253724|FG001|Overall Study|Withdrawal by Subject|1
1145862|NCT03000348|2253725|FG002|Overall Study|Withdrawal by Subject|0
1145863|NCT03000348|2253726|FG003|Overall Study|Withdrawal by Subject|0
1145864|NCT03000348|2253727|FG004|Overall Study|Withdrawal by Subject|0
1145865|NCT03000348|2253728|FG005|Overall Study|Withdrawal by Subject|0
1145866|NCT03000348|2253723|FG000|Overall Study|Consent|0
1145867|NCT03000348|2253724|FG001|Overall Study|Consent|0
1145868|NCT03000348|2253725|FG002|Overall Study|Consent|0
1145869|NCT03000348|2253726|FG003|Overall Study|Consent|0
1145870|NCT03000348|2253727|FG004|Overall Study|Consent|1
1145871|NCT03000348|2253728|FG005|Overall Study|Consent|0
1145872|NCT03000348|2253723|FG000|Overall Study|Failure to expectorate sputum|1
1145873|NCT03000348|2253724|FG001|Overall Study|Failure to expectorate sputum|0
1145874|NCT03000348|2253725|FG002|Overall Study|Failure to expectorate sputum|1
1145875|NCT03000348|2253726|FG003|Overall Study|Failure to expectorate sputum|0
1145876|NCT03000348|2253727|FG004|Overall Study|Failure to expectorate sputum|1
1145877|NCT03000348|2253728|FG005|Overall Study|Failure to expectorate sputum|0
1145878|NCT03000348|2253723|FG000|Overall Study|No gram negative|1
1145879|NCT03000348|2253724|FG001|Overall Study|No gram negative|2
1145880|NCT03000348|2253725|FG002|Overall Study|No gram negative|1
1145881|NCT03000348|2253726|FG003|Overall Study|No gram negative|1
1145882|NCT03000348|2253727|FG004|Overall Study|No gram negative|1
1145883|NCT03000348|2253728|FG005|Overall Study|No gram negative|1
1145884|NCT03000348|2253723|FG000|Overall Study|Patient had no transport|0
1145885|NCT03000348|2253724|FG001|Overall Study|Patient had no transport|0
1145886|NCT03000348|2253725|FG002|Overall Study|Patient had no transport|0
1145887|NCT03000348|2253726|FG003|Overall Study|Patient had no transport|1
1145888|NCT03000348|2253727|FG004|Overall Study|Patient had no transport|0
1145889|NCT03000348|2253728|FG005|Overall Study|Patient had no transport|0
1145890|NCT03000348|2253723|FG000|Overall Study|Dosing|0
1145891|NCT03000348|2253724|FG001|Overall Study|Dosing|0
1145892|NCT03000348|2253725|FG002|Overall Study|Dosing|0
1145893|NCT03000348|2253726|FG003|Overall Study|Dosing|0
1145894|NCT03000348|2253727|FG004|Overall Study|Dosing|1
1145895|NCT03000348|2253728|FG005|Overall Study|Dosing|0
1145896|NCT03000452|2253745|FG000|Treatment Period|Death|1
1145897|NCT03000452|2253745|FG000|Treatment Period|Progressive Disease (PD)|14
1145898|NCT03000452|2253745|FG000|Treatment Period|Physician Decision|1
1145899|NCT03000452|2253745|FG000|Treatment Period|Miscellaneous|2
1145900|NCT03000452|2253745|FG000|Follow-Up Period|Study Terminated by Sponsor|1
1145901|NCT03000452|2253745|FG000|Follow-Up Period|Death|3
1145902|NCT03000452|2253745|FG000|Follow-Up Period|Withdrawal by Subject|3
1145914|NCT03000673|2253795|FG000|Overall Study|Withdrawal by Subject|1
1145915|NCT03000673|2253796|FG001|Overall Study|Withdrawal by Subject|0
1145916|NCT03000673|2253797|FG002|Overall Study|Withdrawal by Subject|0
1145917|NCT03000673|2253798|FG003|Overall Study|Withdrawal by Subject|0
1145918|NCT03000686|2253811|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0
1145919|NCT03000686|2253812|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1
1145920|NCT03000686|2253813|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0
1145921|NCT03000686|2253814|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0
1145922|NCT03001011|2253828|FG000|Overall Study|Adverse Event|9
1145923|NCT03001011|2253829|FG001|Overall Study|Adverse Event|3
1145924|NCT03001011|2253828|FG000|Overall Study|Chronic kidney disease lead to dialysis|15
1145925|NCT03001011|2253829|FG001|Overall Study|Chronic kidney disease lead to dialysis|10
1145926|NCT03001011|2253828|FG000|Overall Study|Other than specified above|3
1145927|NCT03001011|2253829|FG001|Overall Study|Other than specified above|8
1145928|NCT03001076|2253838|FG000|Overall Study|Withdrawal by patient|2
1145929|NCT03001076|2253839|FG001|Overall Study|Withdrawal by patient|0
1145930|NCT03001076|2253838|FG000|Overall Study|Other|1
1145931|NCT03001076|2253839|FG001|Overall Study|Other|0
1145932|NCT03001076|2253838|FG000|Overall Study|Adverse Event|3
1145933|NCT03001076|2253839|FG001|Overall Study|Adverse Event|3
1145934|NCT03001076|2253838|FG000|Overall Study|Sponsor decision|1
1145935|NCT03001076|2253839|FG001|Overall Study|Sponsor decision|0
1145936|NCT03001076|2253838|FG000|Overall Study|Lost to Follow-up|0
1145937|NCT03001076|2253839|FG001|Overall Study|Lost to Follow-up|2
1145938|NCT03001219|2253847|FG000|Proof of Concept|Study Termination by Sponsor|0
1145939|NCT03001219|2253848|FG001|Proof of Concept|Study Termination by Sponsor|1
1145940|NCT03001219|2253847|FG000|Proof of Concept|Withdrawal by Subject|0
1145941|NCT03001219|2253848|FG001|Proof of Concept|Withdrawal by Subject|4
1145942|NCT03001219|2253847|FG000|Proof of Concept|Protocol Deviation|0
1145943|NCT03001219|2253848|FG001|Proof of Concept|Protocol Deviation|1
1145944|NCT03001219|2253847|FG000|Proof of Concept|Adverse Event|1
1145945|NCT03001219|2253848|FG001|Proof of Concept|Adverse Event|1
1145946|NCT03001219|2253847|FG000|Proof of Concept|Physician Decision|1
1145947|NCT03001219|2253848|FG001|Proof of Concept|Physician Decision|0
1145948|NCT03001219|2253847|FG000|Extension Period Analysis|Study Termination by Sponsor|0
1145949|NCT03001219|2253848|FG001|Extension Period Analysis|Study Termination by Sponsor|36
1145950|NCT03001219|2253847|FG000|Extension Period Analysis|Participant Non-Compliance|0
1145951|NCT03001219|2253848|FG001|Extension Period Analysis|Participant Non-Compliance|1
1145952|NCT03001219|2253847|FG000|Extension Period Analysis|Physician Decision|0
1145953|NCT03001219|2253848|FG001|Extension Period Analysis|Physician Decision|1
1145954|NCT03001219|2253847|FG000|Extension Period Analysis|Adverse Event|1
1145955|NCT03001219|2253848|FG001|Extension Period Analysis|Adverse Event|1
1145956|NCT03001219|2253847|FG000|Extension Period Analysis|Protocol Deviation|0
1145957|NCT03001219|2253848|FG001|Extension Period Analysis|Protocol Deviation|1
1145958|NCT03001219|2253847|FG000|Extension Period Analysis|Withdrawal by Subject|4
1145959|NCT03001219|2253848|FG001|Extension Period Analysis|Withdrawal by Subject|5
1145960|NCT03001557|2253886|FG000|Core Phase|Randomized but not treated|0
1145961|NCT03001557|2253887|FG001|Core Phase|Randomized but not treated|0
1145962|NCT03001557|2253888|FG002|Core Phase|Randomized but not treated|1
1145963|NCT03001557|2253889|FG003|Core Phase|Randomized but not treated|0
1145964|NCT03001557|2253890|FG004|Core Phase|Randomized but not treated|0
1145965|NCT03001557|2253891|FG005|Core Phase|Randomized but not treated|0
1145966|NCT03001557|2253892|FG006|Core Phase|Randomized but not treated|0
1145967|NCT03001557|2253893|FG007|Core Phase|Randomized but not treated|0
1145968|NCT03001557|2253886|FG000|Extension Phase|Adverse Event|0
1145969|NCT03001557|2253887|FG001|Extension Phase|Adverse Event|0
1145970|NCT03001557|2253888|FG002|Extension Phase|Adverse Event|0
1145971|NCT03001557|2253889|FG003|Extension Phase|Adverse Event|0
1145972|NCT03001557|2253890|FG004|Extension Phase|Adverse Event|0
1145973|NCT03001557|2253891|FG005|Extension Phase|Adverse Event|2
1145974|NCT03001557|2253892|FG006|Extension Phase|Adverse Event|0
1145975|NCT03001557|2253893|FG007|Extension Phase|Adverse Event|0
1145976|NCT03001557|2253886|FG000|Extension Phase|Withdrawal by Subject|0
1145977|NCT03001557|2253887|FG001|Extension Phase|Withdrawal by Subject|0
1145978|NCT03001557|2253888|FG002|Extension Phase|Withdrawal by Subject|0
1145979|NCT03001557|2253889|FG003|Extension Phase|Withdrawal by Subject|0
1145980|NCT03001557|2253890|FG004|Extension Phase|Withdrawal by Subject|0
1145981|NCT03001557|2253891|FG005|Extension Phase|Withdrawal by Subject|1
1145982|NCT03001557|2253892|FG006|Extension Phase|Withdrawal by Subject|5
1145983|NCT03001557|2253893|FG007|Extension Phase|Withdrawal by Subject|2
1145984|NCT03001557|2253886|FG000|Extension Phase|Lost to Follow-up|0
1145985|NCT03001557|2253887|FG001|Extension Phase|Lost to Follow-up|0
1145986|NCT03001557|2253888|FG002|Extension Phase|Lost to Follow-up|0
1145987|NCT03001557|2253889|FG003|Extension Phase|Lost to Follow-up|0
1145988|NCT03001557|2253890|FG004|Extension Phase|Lost to Follow-up|0
1145989|NCT03001557|2253891|FG005|Extension Phase|Lost to Follow-up|0
1145990|NCT03001557|2253892|FG006|Extension Phase|Lost to Follow-up|2
1145991|NCT03001557|2253893|FG007|Extension Phase|Lost to Follow-up|1
1145992|NCT03001557|2253886|FG000|Extension Phase|Administrative Reason|0
1145993|NCT03001557|2253887|FG001|Extension Phase|Administrative Reason|0
1145994|NCT03001557|2253888|FG002|Extension Phase|Administrative Reason|0
1145995|NCT03001557|2253889|FG003|Extension Phase|Administrative Reason|0
1145996|NCT03001557|2253890|FG004|Extension Phase|Administrative Reason|0
1145997|NCT03001557|2253891|FG005|Extension Phase|Administrative Reason|1
1145998|NCT03001557|2253892|FG006|Extension Phase|Administrative Reason|3
1145999|NCT03001557|2253893|FG007|Extension Phase|Administrative Reason|3
1146000|NCT03001557|2253886|FG000|Extension Phase|Loss of caregiver|0
1146001|NCT03001557|2253887|FG001|Extension Phase|Loss of caregiver|0
1146002|NCT03001557|2253888|FG002|Extension Phase|Loss of caregiver|0
1146003|NCT03001557|2253889|FG003|Extension Phase|Loss of caregiver|0
1146004|NCT03001557|2253890|FG004|Extension Phase|Loss of caregiver|0
1146005|NCT03001557|2253891|FG005|Extension Phase|Loss of caregiver|0
1146006|NCT03001557|2253892|FG006|Extension Phase|Loss of caregiver|1
1146007|NCT03001557|2253893|FG007|Extension Phase|Loss of caregiver|0
1146008|NCT03001557|2253886|FG000|Extension Phase|Others|0
1146009|NCT03001557|2253887|FG001|Extension Phase|Others|0
1146010|NCT03001557|2253888|FG002|Extension Phase|Others|0
1146011|NCT03001557|2253889|FG003|Extension Phase|Others|0
1146012|NCT03001557|2253890|FG004|Extension Phase|Others|0
1146013|NCT03001557|2253891|FG005|Extension Phase|Others|1
1146014|NCT03001557|2253892|FG006|Extension Phase|Others|3
1146015|NCT03001557|2253893|FG007|Extension Phase|Others|0
1146016|NCT03002038|2253953|FG000|Overall Study|Adverse Event|3
1146017|NCT03002038|2253954|FG001|Overall Study|Adverse Event|1
1146018|NCT03002038|2253953|FG000|Overall Study|Withdrawal by Subject|8
1146019|NCT03002038|2253954|FG001|Overall Study|Withdrawal by Subject|4
1146020|NCT03002038|2253953|FG000|Overall Study|Immigration to another region|0
1146021|NCT03002038|2253954|FG001|Overall Study|Immigration to another region|2
902089|NCT00738283|1875810|FG000|Overall Study|Death|1
902090|NCT00738283|1875810|FG000|Overall Study|Transfer to another facility|2
902091|NCT00738283|1875810|FG000|Overall Study|Discharge home prior to end of study|1
902092|NCT00738374|1875822|FG000|Induction Treatment Phase|Adverse Event|14
902093|NCT00738374|1875823|FG001|Induction Treatment Phase|Adverse Event|0
902094|NCT00738374|1875824|FG002|Induction Treatment Phase|Adverse Event|0
902095|NCT00738374|1875825|FG003|Induction Treatment Phase|Adverse Event|0
902096|NCT00738374|1875822|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4
902097|NCT00738374|1875823|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0
902098|NCT00738374|1875824|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0
902099|NCT00738374|1875825|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0
902100|NCT00738374|1875822|FG000|Induction Treatment Phase|Physician Decision|2
902101|NCT00738374|1875823|FG001|Induction Treatment Phase|Physician Decision|0
902102|NCT00738374|1875824|FG002|Induction Treatment Phase|Physician Decision|0
902103|NCT00738374|1875825|FG003|Induction Treatment Phase|Physician Decision|0
902104|NCT00738374|1875822|FG000|Induction Treatment Phase|Protocol Violation|2
902105|NCT00738374|1875823|FG001|Induction Treatment Phase|Protocol Violation|0
902106|NCT00738374|1875824|FG002|Induction Treatment Phase|Protocol Violation|0
902107|NCT00738374|1875825|FG003|Induction Treatment Phase|Protocol Violation|0
902108|NCT00738374|1875822|FG000|Induction Treatment Phase|Non-compliance|1
902109|NCT00738374|1875823|FG001|Induction Treatment Phase|Non-compliance|0
902110|NCT00738374|1875824|FG002|Induction Treatment Phase|Non-compliance|0
902111|NCT00738374|1875825|FG003|Induction Treatment Phase|Non-compliance|0
902112|NCT00738374|1875822|FG000|Induction Treatment Phase|Withdrawal by Subject|1
902113|NCT00738374|1875823|FG001|Induction Treatment Phase|Withdrawal by Subject|0
902114|NCT00738374|1875824|FG002|Induction Treatment Phase|Withdrawal by Subject|0
902115|NCT00738374|1875825|FG003|Induction Treatment Phase|Withdrawal by Subject|0
902116|NCT00738374|1875822|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0
902117|NCT00738374|1875823|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1
902118|NCT00738374|1875824|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2
902119|NCT00738374|1875825|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0
902120|NCT00738374|1875822|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
902121|NCT00738374|1875823|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
902122|NCT00738374|1875824|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
902123|NCT00738374|1875825|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
902124|NCT00738374|1875822|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
902125|NCT00738374|1875823|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
902126|NCT00738374|1875824|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
902127|NCT00738374|1875825|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
902128|NCT00738374|1875822|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0
902129|NCT00738374|1875823|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1
902130|NCT00738374|1875824|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0
902131|NCT00738374|1875825|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0
902132|NCT00738374|1875822|FG000|Maintenance Treatment/Observation Phase|Other|0
902133|NCT00738374|1875823|FG001|Maintenance Treatment/Observation Phase|Other|1
902134|NCT00738374|1875824|FG002|Maintenance Treatment/Observation Phase|Other|0
902135|NCT00738374|1875825|FG003|Maintenance Treatment/Observation Phase|Other|0
902136|NCT00738400|1875836|FG000|Overall Study|Adverse Event|3
902137|NCT00738400|1875837|FG001|Overall Study|Adverse Event|1
902138|NCT00738400|1875836|FG000|Overall Study|Withdrawal by Subject|0
902139|NCT00738400|1875837|FG001|Overall Study|Withdrawal by Subject|1
902140|NCT00738400|1875836|FG000|Overall Study|Lack of Efficacy|0
902141|NCT00738400|1875837|FG001|Overall Study|Lack of Efficacy|1
902142|NCT00738400|1875836|FG000|Overall Study|Lost to Follow-up|0
902143|NCT00738400|1875837|FG001|Overall Study|Lost to Follow-up|3
902144|NCT00738400|1875836|FG000|Overall Study|Protocol Violation|1
902145|NCT00738400|1875837|FG001|Overall Study|Protocol Violation|0
902146|NCT00738400|1875836|FG000|Overall Study|Non-compliant with study medication|0
902147|NCT00738400|1875837|FG001|Overall Study|Non-compliant with study medication|1
902148|NCT00738530|1875854|FG000|Overall Study|Death|220
902149|NCT00738530|1875855|FG001|Overall Study|Death|224
902150|NCT00738530|1875854|FG000|Overall Study|Lost to Follow-up|8
902151|NCT00738530|1875855|FG001|Overall Study|Lost to Follow-up|6
902152|NCT00738530|1875854|FG000|Overall Study|Withdrawal by Subject|6
902153|NCT00738530|1875855|FG001|Overall Study|Withdrawal by Subject|8
902154|NCT00738673|1875867|FG000|Overall Study|Adverse Event|1
902155|NCT00738673|1875868|FG001|Overall Study|Adverse Event|0
902156|NCT00738673|1875867|FG000|Overall Study|Lack of Efficacy|19
902157|NCT00738673|1875868|FG001|Overall Study|Lack of Efficacy|8
902158|NCT00738673|1875867|FG000|Overall Study|Protocol Violation|1
902159|NCT00738673|1875868|FG001|Overall Study|Protocol Violation|2
902160|NCT00738673|1875867|FG000|Overall Study|Withdrawal by Subject|3
902161|NCT00738673|1875868|FG001|Overall Study|Withdrawal by Subject|1
902162|NCT00738699|1875876|FG000|Overall Study|Withdrawal by Subject|5
902163|NCT00738699|1875877|FG001|Overall Study|Withdrawal by Subject|0
902164|NCT00738699|1875876|FG000|Overall Study|Lost to Follow-up|1
902165|NCT00738699|1875877|FG001|Overall Study|Lost to Follow-up|0
902166|NCT00738699|1875876|FG000|Overall Study|Death|144
902167|NCT00738699|1875877|FG001|Overall Study|Death|68
902168|NCT00738699|1875876|FG000|Overall Study|Discontinuation of study by Sponsor|123
902169|NCT00738699|1875877|FG001|Overall Study|Discontinuation of study by Sponsor|72
902170|NCT00738699|1875876|FG000|Overall Study|Other|2
902171|NCT00738699|1875877|FG001|Overall Study|Other|0
914249|NCT00813761|1891999|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
914250|NCT00813761|1892000|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
914251|NCT00813761|1892001|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
1146022|NCT03002077|2253960|FG000|Overall Study|Non-compliance with Study Drug|4
1146023|NCT03002077|2253960|FG000|Overall Study|Non-compliance w/Background ADT|1
1146024|NCT03002077|2253960|FG000|Overall Study|Study Terminated by Sponsor|257
1146025|NCT03002077|2253960|FG000|Overall Study|Site Terminated by Sponsor|5
1146026|NCT03002077|2253960|FG000|Overall Study|Miscellaneous Reasons|10
1146027|NCT03002077|2253960|FG000|Overall Study|Adverse Event|23
1146028|NCT03002077|2253960|FG000|Overall Study|Lack of Efficacy|20
1146029|NCT03002077|2253960|FG000|Overall Study|Withdrawal by Subject|72
1146030|NCT03002077|2253960|FG000|Overall Study|Lost to Follow-up|21
1146031|NCT03002077|2253960|FG000|Overall Study|Pregnancy|4
1146032|NCT03002077|2253960|FG000|Overall Study|Protocol Violation|21
1146033|NCT03002194|2253964|FG000|Overall Study|Lost to Follow-up|6
1146034|NCT03002194|2253964|FG000|Overall Study|Adverse Event|1
1146035|NCT03002194|2253964|FG000|Overall Study|Lack of Efficacy|1
1146036|NCT03002194|2253964|FG000|Overall Study|Withdrawal by Subject|2
1146037|NCT03002311|2253970|FG000|Overall Study|Lost to Follow-up|13
1146038|NCT03002311|2253971|FG001|Overall Study|Lost to Follow-up|26
1146039|NCT03002311|2253970|FG000|Overall Study|Referral provider called to schedule app|3
1146040|NCT03002311|2253971|FG001|Overall Study|Referral provider called to schedule app|3
1146041|NCT03002311|2253970|FG000|Overall Study|Physician Decision|3
1146042|NCT03002311|2253971|FG001|Overall Study|Physician Decision|1
1146043|NCT03002610|2253989|FG000|Overall Study|Withdrawal by Subject|6
1146044|NCT03002610|2253990|FG001|Overall Study|Withdrawal by Subject|25
1146045|NCT03002610|2253991|FG002|Overall Study|Withdrawal by Subject|13
1146046|NCT03002623|2254001|FG000|Overall Study|Lost to Follow-up|1
1146047|NCT03002623|2254002|FG001|Overall Study|Lost to Follow-up|0
1146048|NCT03002623|2254001|FG000|Overall Study|Physician Decision|1
1146049|NCT03002623|2254002|FG001|Overall Study|Physician Decision|1
1146050|NCT03002818|2254022|FG000|Overall Study|Decision of the investigator|1
1146051|NCT03003000|2254042|FG000|Overall Study|Adverse Event|1
1146052|NCT03003000|2254043|FG001|Overall Study|Adverse Event|2
1146053|NCT03003000|2254044|FG002|Overall Study|Adverse Event|3
1146054|NCT03003000|2254042|FG000|Overall Study|Lack of Efficacy|1
1146055|NCT03003000|2254043|FG001|Overall Study|Lack of Efficacy|0
1146056|NCT03003000|2254044|FG002|Overall Study|Lack of Efficacy|0
1146057|NCT03003000|2254042|FG000|Overall Study|Non-compliant with protocol|0
1146058|NCT03003000|2254043|FG001|Overall Study|Non-compliant with protocol|1
1146059|NCT03003000|2254044|FG002|Overall Study|Non-compliant with protocol|1
1146060|NCT03003000|2254042|FG000|Overall Study|Refused to continue medication|2
1146061|NCT03003000|2254043|FG001|Overall Study|Refused to continue medication|0
1146062|NCT03003000|2254044|FG002|Overall Study|Refused to continue medication|0
1146063|NCT03003000|2254042|FG000|Overall Study|Other than listed|1
1146064|NCT03003000|2254043|FG001|Overall Study|Other than listed|1
1146065|NCT03003000|2254044|FG002|Overall Study|Other than listed|1
1146066|NCT03003390|2254063|FG000|Overall Study|Physician Decision|2
1146067|NCT03003390|2254064|FG001|Overall Study|Physician Decision|0
1146068|NCT03003390|2254063|FG000|Overall Study|Parent refused intervention|2
1146069|NCT03003390|2254064|FG001|Overall Study|Parent refused intervention|0
1146070|NCT03003494|2254075|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28
914252|NCT00813761|1892002|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
914253|NCT00813761|1891999|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0
914254|NCT00813761|1892000|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0
1146099|NCT03003676|2254098|FG000|Overall Study|Lack of Efficacy|5
1146100|NCT03003676|2254099|FG001|Overall Study|Lack of Efficacy|7
1146101|NCT03003676|2254098|FG000|Overall Study|Withdrawal by Subject|0
1146102|NCT03003676|2254099|FG001|Overall Study|Withdrawal by Subject|1
1146103|NCT03003676|2254098|FG000|Overall Study|Hepatitis B infection|1
1146104|NCT03003676|2254099|FG001|Overall Study|Hepatitis B infection|0
1146105|NCT03004469|2254128|FG000|Overall Study|Adverse Event|6
1146106|NCT03004469|2254129|FG001|Overall Study|Adverse Event|4
1146107|NCT03004469|2254130|FG002|Overall Study|Adverse Event|6
1146108|NCT03004469|2254128|FG000|Overall Study|Lack of Efficacy|1
1146109|NCT03004469|2254129|FG001|Overall Study|Lack of Efficacy|0
1146110|NCT03004469|2254130|FG002|Overall Study|Lack of Efficacy|1
1146111|NCT03004469|2254128|FG000|Overall Study|Lost to Follow-up|23
1146112|NCT03004469|2254129|FG001|Overall Study|Lost to Follow-up|14
1146113|NCT03004469|2254130|FG002|Overall Study|Lost to Follow-up|6
1146114|NCT03004469|2254128|FG000|Overall Study|Non-Compliance with Study Drug|2
1146115|NCT03004469|2254129|FG001|Overall Study|Non-Compliance with Study Drug|0
1146116|NCT03004469|2254130|FG002|Overall Study|Non-Compliance with Study Drug|0
1146117|NCT03004469|2254128|FG000|Overall Study|Protocol Violation|0
1146118|NCT03004469|2254129|FG001|Overall Study|Protocol Violation|0
1146119|NCT03004469|2254130|FG002|Overall Study|Protocol Violation|1
1146120|NCT03004469|2254128|FG000|Overall Study|Withdrawal by Subject|29
1146121|NCT03004469|2254129|FG001|Overall Study|Withdrawal by Subject|27
1146122|NCT03004469|2254130|FG002|Overall Study|Withdrawal by Subject|10
1146123|NCT03004469|2254128|FG000|Overall Study|Other unspecified reason|0
1146124|NCT03004469|2254129|FG001|Overall Study|Other unspecified reason|4
1146125|NCT03004469|2254130|FG002|Overall Study|Other unspecified reason|1
1146126|NCT03004924|2254198|FG000|Overall Study|Adverse Event|6
1146127|NCT03004924|2254199|FG001|Overall Study|Adverse Event|5
1146128|NCT03004924|2254200|FG002|Overall Study|Adverse Event|10
1146129|NCT03004924|2254198|FG000|Overall Study|Protocol Violation|4
1146130|NCT03004924|2254199|FG001|Overall Study|Protocol Violation|0
1146131|NCT03004924|2254200|FG002|Overall Study|Protocol Violation|1
1146132|NCT03004924|2254198|FG000|Overall Study|Withdrawal by Subject|5
1146133|NCT03004924|2254199|FG001|Overall Study|Withdrawal by Subject|3
1146134|NCT03004924|2254200|FG002|Overall Study|Withdrawal by Subject|5
1146135|NCT03004924|2254198|FG000|Overall Study|Lost to Follow-up|6
1146136|NCT03004924|2254199|FG001|Overall Study|Lost to Follow-up|1
1146137|NCT03004924|2254200|FG002|Overall Study|Lost to Follow-up|4
1146138|NCT03004924|2254198|FG000|Overall Study|Lack of Efficacy|2
1146139|NCT03004924|2254199|FG001|Overall Study|Lack of Efficacy|4
1146140|NCT03004924|2254200|FG002|Overall Study|Lack of Efficacy|2
1146141|NCT03004924|2254198|FG000|Overall Study|Physician Decision|1
1146142|NCT03004924|2254199|FG001|Overall Study|Physician Decision|0
1146143|NCT03004924|2254200|FG002|Overall Study|Physician Decision|1
1146144|NCT03004924|2254198|FG000|Overall Study|Withdrawal by parent/guardian|1
1146145|NCT03004924|2254199|FG001|Overall Study|Withdrawal by parent/guardian|0
1146146|NCT03004924|2254200|FG002|Overall Study|Withdrawal by parent/guardian|2
1146147|NCT03004924|2254198|FG000|Overall Study|Screen Failure|1
1146148|NCT03004924|2254199|FG001|Overall Study|Screen Failure|0
1146149|NCT03004924|2254200|FG002|Overall Study|Screen Failure|0
1146150|NCT03004924|2254198|FG000|Overall Study|Pregnancy|0
1146151|NCT03004924|2254199|FG001|Overall Study|Pregnancy|1
1146152|NCT03004924|2254200|FG002|Overall Study|Pregnancy|0
1146153|NCT03004924|2254198|FG000|Overall Study|Terminated by Sponsor|0
1146154|NCT03004924|2254199|FG001|Overall Study|Terminated by Sponsor|0
1146155|NCT03004924|2254200|FG002|Overall Study|Terminated by Sponsor|1
1146156|NCT03004924|2254198|FG000|Overall Study|Missed Study Visit|0
1146157|NCT03004924|2254199|FG001|Overall Study|Missed Study Visit|0
1146158|NCT03004924|2254200|FG002|Overall Study|Missed Study Visit|2
1146159|NCT03004924|2254198|FG000|Overall Study|HSV1 Positive|1
1146160|NCT03004924|2254199|FG001|Overall Study|HSV1 Positive|0
1146161|NCT03004924|2254200|FG002|Overall Study|HSV1 Positive|0
1146162|NCT03005067|2254222|FG000|Overall Study|Withdrawal by Subject|3
1146163|NCT03005067|2254223|FG001|Overall Study|Withdrawal by Subject|2
1146164|NCT03005067|2254222|FG000|Overall Study|Adverse Event|4
1146165|NCT03005067|2254223|FG001|Overall Study|Adverse Event|3
1146166|NCT03005067|2254222|FG000|Overall Study|Other (reason not specified)|3
1146167|NCT03005067|2254223|FG001|Overall Study|Other (reason not specified)|1
1146168|NCT03005067|2254222|FG000|Overall Study|Protocol Violation|0
1146169|NCT03005067|2254223|FG001|Overall Study|Protocol Violation|1
1146170|NCT03005106|2254229|FG000|Overall Study|Lost to Follow-up|16
1146171|NCT03005106|2254229|FG000|Overall Study|Adverse Event|1
1146172|NCT03005106|2254229|FG000|Overall Study|Physician Decision|1
1146173|NCT03005106|2254229|FG000|Overall Study|Death|2
1146174|NCT03005288|2254235|FG000|Overall Study|Withdrawal by Subject|7
1146175|NCT03005288|2254236|FG001|Overall Study|Withdrawal by Subject|5
1146176|NCT03005288|2254235|FG000|Overall Study|Lost to Follow-up|0
1146177|NCT03005288|2254236|FG001|Overall Study|Lost to Follow-up|1
1146178|NCT03005288|2254235|FG000|Overall Study|Adverse Event|5
1146179|NCT03005288|2254236|FG001|Overall Study|Adverse Event|0
1146180|NCT03005288|2254235|FG000|Overall Study|Protocol deviation|0
1146181|NCT03005288|2254236|FG001|Overall Study|Protocol deviation|1
1146182|NCT03005288|2254235|FG000|Overall Study|Physician Decision|0
1146183|NCT03005288|2254236|FG001|Overall Study|Physician Decision|1
1146184|NCT03006341|2254246|FG000|Overall Study|Not linked in the EMR|25069
1146185|NCT03006341|2254247|FG001|Overall Study|Not linked in the EMR|67505
1146186|NCT03006341|2254248|FG002|Overall Study|Not linked in the EMR|30993
1146187|NCT03006341|2254249|FG003|Overall Study|Not linked in the EMR|10685
1146188|NCT03006393|2254259|FG000|Overall Study|Withdrawal by Subject|1
1146189|NCT03006393|2254260|FG001|Overall Study|Withdrawal by Subject|1
1146190|NCT03006393|2254259|FG000|Overall Study|Pregnancy|0
1146191|NCT03006393|2254260|FG001|Overall Study|Pregnancy|1
1146192|NCT03006393|2254259|FG000|Overall Study|Lost to Follow-up|0
1146193|NCT03006393|2254260|FG001|Overall Study|Lost to Follow-up|1
1146194|NCT03006458|2254266|FG000|First Intervention|Unsatisfied Vision|0
1146195|NCT03006458|2254267|FG001|First Intervention|Unsatisfied Vision|3
1146196|NCT03006562|2254284|FG000|Overall Study|Lost to Follow-up|0
1146197|NCT03006562|2254285|FG001|Overall Study|Lost to Follow-up|1
1146198|NCT03006848|2254291|FG000|Overall Study|Adverse Event|1
1146199|NCT03006848|2254291|FG000|Overall Study|Physician Decision|1
1146200|NCT03006848|2254291|FG000|Overall Study|Lack of Efficacy|16
1146201|NCT03006887|2254302|FG000|Overall Study|Adverse Event|1
1146202|NCT03006926|2254308|FG000|Overall Study|Death|0
1146203|NCT03006926|2254309|FG001|Overall Study|Death|33
1146204|NCT03006926|2254308|FG000|Overall Study|Ongoing Survival Follow-up|0
1146205|NCT03006926|2254309|FG001|Overall Study|Ongoing Survival Follow-up|26
1146206|NCT03006926|2254308|FG000|Overall Study|Ongoing-on Treatment|0
1146207|NCT03006926|2254309|FG001|Overall Study|Ongoing-on Treatment|36
1146208|NCT03006926|2254308|FG000|Overall Study|Lost to Follow-up|0
1146209|NCT03006926|2254309|FG001|Overall Study|Lost to Follow-up|1
1146210|NCT03006926|2254308|FG000|Overall Study|Withdrawal by Subject|0
1146211|NCT03006926|2254309|FG001|Overall Study|Withdrawal by Subject|2
1146212|NCT03007472|2254335|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2
1146213|NCT03007472|2254335|FG000|Overall Study|Death|2
1146214|NCT03007472|2254335|FG000|Overall Study|Loss to Follow Up|1
1146215|NCT03007953|2254341|FG000|Overall Study|Withdrawal by Subject|5
1146216|NCT03007953|2254342|FG001|Overall Study|Withdrawal by Subject|2
1146217|NCT03007953|2254341|FG000|Overall Study|Death|5
1146218|NCT03007953|2254342|FG001|Overall Study|Death|7
1146219|NCT03007953|2254341|FG000|Overall Study|Lost to Follow-up|3
1146220|NCT03007953|2254342|FG001|Overall Study|Lost to Follow-up|2
1146221|NCT03007953|2254341|FG000|Overall Study|Enrolled in Hospice|3
1146222|NCT03007953|2254342|FG001|Overall Study|Enrolled in Hospice|2
1146223|NCT03007966|2254350|FG000|Overall Study|Did not meeting inclusion/exclusion|1
1146224|NCT03007966|2254351|FG001|Overall Study|Did not meeting inclusion/exclusion|0
1146225|NCT03007979|2254358|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1
1146226|NCT03008070|2254365|FG000|Overall Study|Adverse Event|3
1146227|NCT03008070|2254366|FG001|Overall Study|Adverse Event|3
1146228|NCT03008070|2254367|FG002|Overall Study|Adverse Event|3
1146229|NCT03008070|2254365|FG000|Overall Study|Lost to Follow-up|1
1146230|NCT03008070|2254366|FG001|Overall Study|Lost to Follow-up|1
1146231|NCT03008070|2254367|FG002|Overall Study|Lost to Follow-up|0
1146232|NCT03008070|2254365|FG000|Overall Study|Non compliance|0
1146233|NCT03008070|2254366|FG001|Overall Study|Non compliance|1
1146234|NCT03008070|2254367|FG002|Overall Study|Non compliance|1
1146235|NCT03008070|2254365|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0
1146236|NCT03008070|2254366|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1
1146237|NCT03008070|2254367|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0
1146238|NCT03008070|2254365|FG000|Overall Study|Withdrawal by Subject|2
1146239|NCT03008070|2254366|FG001|Overall Study|Withdrawal by Subject|0
1146240|NCT03008070|2254367|FG002|Overall Study|Withdrawal by Subject|1
1146241|NCT03008070|2254365|FG000|Overall Study|Use of prohibited drug|0
1146242|NCT03008070|2254366|FG001|Overall Study|Use of prohibited drug|0
1146243|NCT03008070|2254367|FG002|Overall Study|Use of prohibited drug|2
1146244|NCT03008460|2254396|FG000|Overall Study|Protocol deviation|0
1146245|NCT03008460|2254397|FG001|Overall Study|Protocol deviation|2
1146246|NCT03008460|2254396|FG000|Overall Study|Study drug not dispensed|0
1146247|NCT03008460|2254397|FG001|Overall Study|Study drug not dispensed|1
1146248|NCT03008460|2254396|FG000|Overall Study|Adverse Event|0
1146249|NCT03008460|2254397|FG001|Overall Study|Adverse Event|1
1146250|NCT03008460|2254396|FG000|Overall Study|Withdrawal by Subject|5
1146251|NCT03008460|2254397|FG001|Overall Study|Withdrawal by Subject|6
1146252|NCT03008460|2254396|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1
1146253|NCT03008460|2254397|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0
1146254|NCT03008460|2254396|FG000|Overall Study|End of study visit outside permitted time window|0
1146255|NCT03008460|2254397|FG001|Overall Study|End of study visit outside permitted time window|1
1146256|NCT03008460|2254396|FG000|Overall Study|Lost to Follow-up|1
1146257|NCT03008460|2254397|FG001|Overall Study|Lost to Follow-up|3
1146258|NCT03008915|2254443|FG000|Treatment 1|Withdrawal by Subject|0
1146259|NCT03008915|2254444|FG001|Treatment 1|Withdrawal by Subject|1
1146260|NCT03010254|2254479|FG000|Overall Study|Adverse Event|0
1146261|NCT03010254|2254480|FG001|Overall Study|Adverse Event|1
1146262|NCT03010254|2254479|FG000|Overall Study|Lost to Follow-up|4
1146263|NCT03010254|2254480|FG001|Overall Study|Lost to Follow-up|0
1146264|NCT03010254|2254479|FG000|Overall Study|Withdrawal by Subject|1
1146265|NCT03010254|2254480|FG001|Overall Study|Withdrawal by Subject|1
1146266|NCT03010254|2254479|FG000|Overall Study|Other|2
1146267|NCT03010254|2254480|FG001|Overall Study|Other|3
1146268|NCT03010462|2254495|FG000|Overall Study|Withdrawal by Subject|3
1146269|NCT03010462|2254496|FG001|Overall Study|Withdrawal by Subject|1
1146270|NCT03010501|2254511|FG000|Study Week 1|Withdrawal by Subject|2
1146271|NCT03010501|2254512|FG001|Study Week 1|Withdrawal by Subject|1
1146272|NCT03010501|2254513|FG002|Study Week 1|Withdrawal by Subject|0
1146273|NCT03010501|2254514|FG003|Study Week 1|Withdrawal by Subject|2
1146274|NCT03010501|2254515|FG004|Study Week 1|Withdrawal by Subject|0
1146275|NCT03010501|2254516|FG005|Study Week 1|Withdrawal by Subject|0
1146276|NCT03010501|2254511|FG000|Study Week 3|Withdrawal by Subject|0
1146277|NCT03010501|2254512|FG001|Study Week 3|Withdrawal by Subject|0
1146278|NCT03010501|2254513|FG002|Study Week 3|Withdrawal by Subject|0
1146279|NCT03010501|2254514|FG003|Study Week 3|Withdrawal by Subject|1
1146280|NCT03010501|2254515|FG004|Study Week 3|Withdrawal by Subject|0
1146281|NCT03010501|2254516|FG005|Study Week 3|Withdrawal by Subject|0
1146282|NCT03010527|2254527|FG000|Overall Study|Death|0
1146283|NCT03010527|2254528|FG001|Overall Study|Death|0
1146284|NCT03010527|2254529|FG002|Overall Study|Death|1
1146285|NCT03010527|2254527|FG000|Overall Study|Adverse Event|0
1146286|NCT03010527|2254528|FG001|Overall Study|Adverse Event|4
1146287|NCT03010527|2254529|FG002|Overall Study|Adverse Event|2
1146288|NCT03010527|2254527|FG000|Overall Study|Protocol Violation|0
1146289|NCT03010527|2254528|FG001|Overall Study|Protocol Violation|1
1146290|NCT03010527|2254529|FG002|Overall Study|Protocol Violation|0
1146291|NCT03010527|2254527|FG000|Overall Study|Lost to Follow-up|0
1146292|NCT03010527|2254528|FG001|Overall Study|Lost to Follow-up|2
1146293|NCT03010527|2254529|FG002|Overall Study|Lost to Follow-up|1
1146294|NCT03010527|2254527|FG000|Overall Study|Withdrawal by Subject|0
1146295|NCT03010527|2254528|FG001|Overall Study|Withdrawal by Subject|3
1146296|NCT03010527|2254529|FG002|Overall Study|Withdrawal by Subject|4
1146297|NCT03010527|2254527|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0
1146298|NCT03010527|2254528|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4
1146299|NCT03010527|2254529|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6
1146300|NCT03010527|2254527|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0
1146301|NCT03010527|2254528|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4
1146302|NCT03010527|2254529|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2
1146303|NCT03010527|2254527|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
1146304|NCT03010527|2254528|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1
1146305|NCT03010527|2254529|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
1146306|NCT03011034|2254587|FG000|Overall Study|Adverse Event|1
1146307|NCT03011034|2254588|FG001|Overall Study|Adverse Event|0
1146308|NCT03011099|2254596|FG000|Overall Study|Withdrawal by Subject|0
1146309|NCT03011099|2254597|FG001|Overall Study|Withdrawal by Subject|2
1146310|NCT03011333|2254612|FG000|Overall Study|Lost to Follow-up|0
1146311|NCT03011333|2254613|FG001|Overall Study|Lost to Follow-up|1
1146312|NCT03011333|2254614|FG002|Overall Study|Lost to Follow-up|0
1146313|NCT03011333|2254615|FG003|Overall Study|Lost to Follow-up|1
1146314|NCT03011333|2254616|FG004|Overall Study|Lost to Follow-up|4
1146315|NCT03011333|2254617|FG005|Overall Study|Lost to Follow-up|4
1146316|NCT03011333|2254618|FG006|Overall Study|Lost to Follow-up|5
1146317|NCT03011840|2254636|FG000|Overall Study|Not received PIL in post PIL phase|0
1146318|NCT03011840|2254637|FG001|Overall Study|Not received PIL in post PIL phase|21
1146319|NCT03011892|2254649|FG000|Double Blind (DB) Period|Adverse Event|0
1146320|NCT03011892|2254650|FG001|Double Blind (DB) Period|Adverse Event|1
1146321|NCT03011892|2254651|FG002|Double Blind (DB) Period|Adverse Event|1
1146322|NCT03011892|2254652|FG003|Double Blind (DB) Period|Adverse Event|0
1146323|NCT03011892|2254653|FG004|Double Blind (DB) Period|Adverse Event|0
1146324|NCT03011892|2254654|FG005|Double Blind (DB) Period|Adverse Event|0
1146325|NCT03011892|2254655|FG006|Double Blind (DB) Period|Adverse Event|0
1146326|NCT03011892|2254656|FG007|Double Blind (DB) Period|Adverse Event|0
1146327|NCT03011892|2254657|FG008|Double Blind (DB) Period|Adverse Event|0
1146328|NCT03011892|2254658|FG009|Double Blind (DB) Period|Adverse Event|0
1146329|NCT03011892|2254659|FG010|Double Blind (DB) Period|Adverse Event|0
1146330|NCT03011892|2254660|FG011|Double Blind (DB) Period|Adverse Event|0
1146331|NCT03011892|2254649|FG000|Double Blind (DB) Period|Lack of Efficacy|1
1146332|NCT03011892|2254650|FG001|Double Blind (DB) Period|Lack of Efficacy|0
1146333|NCT03011892|2254651|FG002|Double Blind (DB) Period|Lack of Efficacy|0
1146334|NCT03011892|2254652|FG003|Double Blind (DB) Period|Lack of Efficacy|0
1146335|NCT03011892|2254653|FG004|Double Blind (DB) Period|Lack of Efficacy|0
1146336|NCT03011892|2254654|FG005|Double Blind (DB) Period|Lack of Efficacy|0
1146337|NCT03011892|2254655|FG006|Double Blind (DB) Period|Lack of Efficacy|0
1146338|NCT03011892|2254656|FG007|Double Blind (DB) Period|Lack of Efficacy|0
1146339|NCT03011892|2254657|FG008|Double Blind (DB) Period|Lack of Efficacy|0
1146340|NCT03011892|2254658|FG009|Double Blind (DB) Period|Lack of Efficacy|0
1146341|NCT03011892|2254659|FG010|Double Blind (DB) Period|Lack of Efficacy|0
1146342|NCT03011892|2254660|FG011|Double Blind (DB) Period|Lack of Efficacy|0
1146343|NCT03011892|2254649|FG000|Double Blind (DB) Period|Lost to Follow-up|0
1146344|NCT03011892|2254650|FG001|Double Blind (DB) Period|Lost to Follow-up|3
1146345|NCT03011892|2254651|FG002|Double Blind (DB) Period|Lost to Follow-up|2
1146346|NCT03011892|2254652|FG003|Double Blind (DB) Period|Lost to Follow-up|5
1146347|NCT03011892|2254653|FG004|Double Blind (DB) Period|Lost to Follow-up|0
1146348|NCT03011892|2254654|FG005|Double Blind (DB) Period|Lost to Follow-up|2
1146349|NCT03011892|2254655|FG006|Double Blind (DB) Period|Lost to Follow-up|0
1146350|NCT03011892|2254656|FG007|Double Blind (DB) Period|Lost to Follow-up|0
1146351|NCT03011892|2254657|FG008|Double Blind (DB) Period|Lost to Follow-up|0
1146352|NCT03011892|2254658|FG009|Double Blind (DB) Period|Lost to Follow-up|0
1146353|NCT03011892|2254659|FG010|Double Blind (DB) Period|Lost to Follow-up|0
1146354|NCT03011892|2254660|FG011|Double Blind (DB) Period|Lost to Follow-up|0
1146355|NCT03011892|2254649|FG000|Double Blind (DB) Period|Other|1
1146356|NCT03011892|2254650|FG001|Double Blind (DB) Period|Other|1
1146357|NCT03011892|2254651|FG002|Double Blind (DB) Period|Other|1
1146358|NCT03011892|2254652|FG003|Double Blind (DB) Period|Other|0
1146359|NCT03011892|2254653|FG004|Double Blind (DB) Period|Other|1
1146360|NCT03011892|2254654|FG005|Double Blind (DB) Period|Other|0
1146361|NCT03011892|2254655|FG006|Double Blind (DB) Period|Other|0
1146362|NCT03011892|2254656|FG007|Double Blind (DB) Period|Other|0
1146363|NCT03011892|2254657|FG008|Double Blind (DB) Period|Other|0
1146364|NCT03011892|2254658|FG009|Double Blind (DB) Period|Other|0
1146365|NCT03011892|2254659|FG010|Double Blind (DB) Period|Other|0
1146366|NCT03011892|2254660|FG011|Double Blind (DB) Period|Other|0
1146367|NCT03011892|2254649|FG000|Double Blind (DB) Period|Physician Decision|1
1146368|NCT03011892|2254650|FG001|Double Blind (DB) Period|Physician Decision|0
1146369|NCT03011892|2254651|FG002|Double Blind (DB) Period|Physician Decision|1
1146370|NCT03011892|2254652|FG003|Double Blind (DB) Period|Physician Decision|0
1146371|NCT03011892|2254653|FG004|Double Blind (DB) Period|Physician Decision|0
1146372|NCT03011892|2254654|FG005|Double Blind (DB) Period|Physician Decision|0
1146373|NCT03011892|2254655|FG006|Double Blind (DB) Period|Physician Decision|0
1146374|NCT03011892|2254656|FG007|Double Blind (DB) Period|Physician Decision|0
1146375|NCT03011892|2254657|FG008|Double Blind (DB) Period|Physician Decision|0
1146376|NCT03011892|2254658|FG009|Double Blind (DB) Period|Physician Decision|0
1146377|NCT03011892|2254659|FG010|Double Blind (DB) Period|Physician Decision|0
1146378|NCT03011892|2254660|FG011|Double Blind (DB) Period|Physician Decision|0
1146379|NCT03011892|2254649|FG000|Double Blind (DB) Period|Pregnancy|0
1146380|NCT03011892|2254650|FG001|Double Blind (DB) Period|Pregnancy|0
1146381|NCT03011892|2254651|FG002|Double Blind (DB) Period|Pregnancy|0
1146382|NCT03011892|2254652|FG003|Double Blind (DB) Period|Pregnancy|0
1146383|NCT03011892|2254653|FG004|Double Blind (DB) Period|Pregnancy|1
1146384|NCT03011892|2254654|FG005|Double Blind (DB) Period|Pregnancy|0
1146385|NCT03011892|2254655|FG006|Double Blind (DB) Period|Pregnancy|0
1146386|NCT03011892|2254656|FG007|Double Blind (DB) Period|Pregnancy|0
1146387|NCT03011892|2254657|FG008|Double Blind (DB) Period|Pregnancy|0
1146388|NCT03011892|2254658|FG009|Double Blind (DB) Period|Pregnancy|0
1146389|NCT03011892|2254659|FG010|Double Blind (DB) Period|Pregnancy|0
1146390|NCT03011892|2254660|FG011|Double Blind (DB) Period|Pregnancy|0
1146391|NCT03011892|2254649|FG000|Double Blind (DB) Period|Protocol Violation|1
1146392|NCT03011892|2254650|FG001|Double Blind (DB) Period|Protocol Violation|0
1146393|NCT03011892|2254651|FG002|Double Blind (DB) Period|Protocol Violation|0
1146394|NCT03011892|2254652|FG003|Double Blind (DB) Period|Protocol Violation|0
1146395|NCT03011892|2254653|FG004|Double Blind (DB) Period|Protocol Violation|0
1146396|NCT03011892|2254654|FG005|Double Blind (DB) Period|Protocol Violation|0
1146397|NCT03011892|2254655|FG006|Double Blind (DB) Period|Protocol Violation|0
1146398|NCT03011892|2254656|FG007|Double Blind (DB) Period|Protocol Violation|0
1146399|NCT03011892|2254657|FG008|Double Blind (DB) Period|Protocol Violation|0
1146400|NCT03011892|2254658|FG009|Double Blind (DB) Period|Protocol Violation|0
1146401|NCT03011892|2254659|FG010|Double Blind (DB) Period|Protocol Violation|0
1146402|NCT03011892|2254660|FG011|Double Blind (DB) Period|Protocol Violation|0
1146403|NCT03011892|2254649|FG000|Double Blind (DB) Period|Withdrawal by Subject|7
1146404|NCT03011892|2254650|FG001|Double Blind (DB) Period|Withdrawal by Subject|5
1146405|NCT03011892|2254651|FG002|Double Blind (DB) Period|Withdrawal by Subject|1
1146406|NCT03011892|2254652|FG003|Double Blind (DB) Period|Withdrawal by Subject|2
1146407|NCT03011892|2254653|FG004|Double Blind (DB) Period|Withdrawal by Subject|4
1146408|NCT03011892|2254654|FG005|Double Blind (DB) Period|Withdrawal by Subject|3
1146409|NCT03011892|2254655|FG006|Double Blind (DB) Period|Withdrawal by Subject|0
1146410|NCT03011892|2254656|FG007|Double Blind (DB) Period|Withdrawal by Subject|0
1146411|NCT03011892|2254657|FG008|Double Blind (DB) Period|Withdrawal by Subject|0
1146412|NCT03011892|2254658|FG009|Double Blind (DB) Period|Withdrawal by Subject|0
1146413|NCT03011892|2254659|FG010|Double Blind (DB) Period|Withdrawal by Subject|0
1146414|NCT03011892|2254660|FG011|Double Blind (DB) Period|Withdrawal by Subject|0
1146415|NCT03011892|2254649|FG000|Double Blind (DB) Period|Randomized but not treated|0
1146416|NCT03011892|2254650|FG001|Double Blind (DB) Period|Randomized but not treated|0
1146417|NCT03011892|2254651|FG002|Double Blind (DB) Period|Randomized but not treated|0
1146418|NCT03011892|2254652|FG003|Double Blind (DB) Period|Randomized but not treated|0
1146419|NCT03011892|2254653|FG004|Double Blind (DB) Period|Randomized but not treated|1
1146420|NCT03011892|2254654|FG005|Double Blind (DB) Period|Randomized but not treated|0
1146421|NCT03011892|2254655|FG006|Double Blind (DB) Period|Randomized but not treated|0
1146422|NCT03011892|2254656|FG007|Double Blind (DB) Period|Randomized but not treated|0
1146423|NCT03011892|2254657|FG008|Double Blind (DB) Period|Randomized but not treated|0
1146424|NCT03011892|2254658|FG009|Double Blind (DB) Period|Randomized but not treated|0
1146425|NCT03011892|2254659|FG010|Double Blind (DB) Period|Randomized but not treated|0
1146426|NCT03011892|2254660|FG011|Double Blind (DB) Period|Randomized but not treated|0
1146427|NCT03011892|2254649|FG000|Open Label (OL) Period|Lost to Follow-up|0
1146428|NCT03011892|2254650|FG001|Open Label (OL) Period|Lost to Follow-up|0
1146429|NCT03011892|2254651|FG002|Open Label (OL) Period|Lost to Follow-up|0
1146430|NCT03011892|2254652|FG003|Open Label (OL) Period|Lost to Follow-up|0
1146431|NCT03011892|2254653|FG004|Open Label (OL) Period|Lost to Follow-up|0
1146432|NCT03011892|2254654|FG005|Open Label (OL) Period|Lost to Follow-up|0
1146433|NCT03011892|2254655|FG006|Open Label (OL) Period|Lost to Follow-up|4
1146434|NCT03011892|2254656|FG007|Open Label (OL) Period|Lost to Follow-up|2
1146435|NCT03011892|2254657|FG008|Open Label (OL) Period|Lost to Follow-up|1
1146436|NCT03011892|2254658|FG009|Open Label (OL) Period|Lost to Follow-up|0
1146437|NCT03011892|2254659|FG010|Open Label (OL) Period|Lost to Follow-up|1
1146438|NCT03011892|2254660|FG011|Open Label (OL) Period|Lost to Follow-up|1
1146439|NCT03011892|2254649|FG000|Open Label (OL) Period|Withdrawal by Subject|0
1146440|NCT03011892|2254650|FG001|Open Label (OL) Period|Withdrawal by Subject|0
1146441|NCT03011892|2254651|FG002|Open Label (OL) Period|Withdrawal by Subject|0
1146442|NCT03011892|2254652|FG003|Open Label (OL) Period|Withdrawal by Subject|0
1146443|NCT03011892|2254653|FG004|Open Label (OL) Period|Withdrawal by Subject|0
1146444|NCT03011892|2254654|FG005|Open Label (OL) Period|Withdrawal by Subject|0
1146445|NCT03011892|2254655|FG006|Open Label (OL) Period|Withdrawal by Subject|3
1146446|NCT03011892|2254656|FG007|Open Label (OL) Period|Withdrawal by Subject|0
1146447|NCT03011892|2254657|FG008|Open Label (OL) Period|Withdrawal by Subject|1
1146448|NCT03011892|2254658|FG009|Open Label (OL) Period|Withdrawal by Subject|0
1146449|NCT03011892|2254659|FG010|Open Label (OL) Period|Withdrawal by Subject|1
1146450|NCT03011892|2254660|FG011|Open Label (OL) Period|Withdrawal by Subject|2
1146451|NCT03011892|2254649|FG000|Open Label (OL) Period|Reason not specified|0
1146452|NCT03011892|2254650|FG001|Open Label (OL) Period|Reason not specified|0
1146453|NCT03011892|2254651|FG002|Open Label (OL) Period|Reason not specified|0
1146454|NCT03011892|2254652|FG003|Open Label (OL) Period|Reason not specified|0
1146455|NCT03011892|2254653|FG004|Open Label (OL) Period|Reason not specified|0
1146456|NCT03011892|2254654|FG005|Open Label (OL) Period|Reason not specified|0
1146457|NCT03011892|2254655|FG006|Open Label (OL) Period|Reason not specified|0
1146458|NCT03011892|2254656|FG007|Open Label (OL) Period|Reason not specified|1
1146459|NCT03011892|2254657|FG008|Open Label (OL) Period|Reason not specified|0
1146460|NCT03011892|2254658|FG009|Open Label (OL) Period|Reason not specified|0
1146461|NCT03011892|2254659|FG010|Open Label (OL) Period|Reason not specified|0
1146462|NCT03011892|2254660|FG011|Open Label (OL) Period|Reason not specified|0
1146463|NCT03012061|2254690|FG000|Overall Study|Withdrawal by Subject|1
1146464|NCT03012061|2254691|FG001|Overall Study|Withdrawal by Subject|5
1146465|NCT03012061|2254692|FG002|Overall Study|Withdrawal by Subject|4
1146466|NCT03012061|2254690|FG000|Overall Study|Investigator Site Closed|1
1146467|NCT03012061|2254691|FG001|Overall Study|Investigator Site Closed|2
1146468|NCT03012061|2254692|FG002|Overall Study|Investigator Site Closed|0
1146469|NCT03012061|2254690|FG000|Overall Study|Lost to Follow-up|2
1146470|NCT03012061|2254691|FG001|Overall Study|Lost to Follow-up|1
1146471|NCT03012061|2254692|FG002|Overall Study|Lost to Follow-up|0
1146472|NCT03012061|2254690|FG000|Overall Study|Study closed/ Terminated|0
1146473|NCT03012061|2254691|FG001|Overall Study|Study closed/ Terminated|0
1146474|NCT03012061|2254692|FG002|Overall Study|Study closed/ Terminated|1
1146475|NCT03012061|2254690|FG000|Overall Study|Met Protocol Withdrawal Criterion|0
1146476|NCT03012061|2254691|FG001|Overall Study|Met Protocol Withdrawal Criterion|0
1146477|NCT03012061|2254692|FG002|Overall Study|Met Protocol Withdrawal Criterion|1
1146478|NCT03012061|2254690|FG000|Overall Study|Protocol Violation|0
1146479|NCT03012061|2254691|FG001|Overall Study|Protocol Violation|0
1146480|NCT03012061|2254692|FG002|Overall Study|Protocol Violation|2
1146481|NCT03012061|2254690|FG000|Overall Study|Lack of Efficacy|0
1146482|NCT03012061|2254691|FG001|Overall Study|Lack of Efficacy|1
1146483|NCT03012061|2254692|FG002|Overall Study|Lack of Efficacy|0
1146484|NCT03012061|2254690|FG000|Overall Study|Adverse Event|2
1146485|NCT03012061|2254691|FG001|Overall Study|Adverse Event|0
1146486|NCT03012061|2254692|FG002|Overall Study|Adverse Event|0
1146487|NCT03012334|2254724|FG000|Period 1|Withdrawal by Subject|0
1146488|NCT03012334|2254725|FG001|Period 1|Withdrawal by Subject|0
1146489|NCT03012334|2254726|FG002|Period 1|Withdrawal by Subject|0
1146490|NCT03012334|2254727|FG003|Period 1|Withdrawal by Subject|0
1146491|NCT03012334|2254728|FG004|Period 1|Withdrawal by Subject|0
1146492|NCT03012334|2254729|FG005|Period 1|Withdrawal by Subject|0
1146493|NCT03012334|2254730|FG006|Period 1|Withdrawal by Subject|0
1146494|NCT03012334|2254731|FG007|Period 1|Withdrawal by Subject|0
1146495|NCT03012334|2254732|FG008|Period 1|Withdrawal by Subject|0
1146496|NCT03012334|2254733|FG009|Period 1|Withdrawal by Subject|1
1146497|NCT03012334|2254724|FG000|Period 2|Withdrawal by Subject|0
1146498|NCT03012334|2254725|FG001|Period 2|Withdrawal by Subject|1
1146499|NCT03012334|2254726|FG002|Period 2|Withdrawal by Subject|0
1146500|NCT03012334|2254727|FG003|Period 2|Withdrawal by Subject|0
1146501|NCT03012334|2254728|FG004|Period 2|Withdrawal by Subject|0
1146502|NCT03012334|2254729|FG005|Period 2|Withdrawal by Subject|0
1146503|NCT03012334|2254730|FG006|Period 2|Withdrawal by Subject|0
1146504|NCT03012334|2254731|FG007|Period 2|Withdrawal by Subject|0
1146505|NCT03012334|2254732|FG008|Period 2|Withdrawal by Subject|0
1146506|NCT03012334|2254733|FG009|Period 2|Withdrawal by Subject|0
1146507|NCT03012334|2254724|FG000|Period 2|Protocol Violation|0
1146508|NCT03012334|2254725|FG001|Period 2|Protocol Violation|0
1146509|NCT03012334|2254726|FG002|Period 2|Protocol Violation|1
1146510|NCT03012334|2254727|FG003|Period 2|Protocol Violation|0
1146511|NCT03012334|2254728|FG004|Period 2|Protocol Violation|0
1146512|NCT03012334|2254729|FG005|Period 2|Protocol Violation|0
1146513|NCT03012334|2254730|FG006|Period 2|Protocol Violation|0
1146514|NCT03012334|2254731|FG007|Period 2|Protocol Violation|1
1146515|NCT03012334|2254732|FG008|Period 2|Protocol Violation|0
1146516|NCT03012334|2254733|FG009|Period 2|Protocol Violation|0
1146517|NCT03012334|2254724|FG000|Period 4|Non-Compliance|0
1146518|NCT03012334|2254725|FG001|Period 4|Non-Compliance|0
1146519|NCT03012334|2254726|FG002|Period 4|Non-Compliance|0
1146520|NCT03012334|2254727|FG003|Period 4|Non-Compliance|0
1146521|NCT03012334|2254728|FG004|Period 4|Non-Compliance|0
1146522|NCT03012334|2254729|FG005|Period 4|Non-Compliance|0
1146523|NCT03012334|2254730|FG006|Period 4|Non-Compliance|1
1146524|NCT03012334|2254731|FG007|Period 4|Non-Compliance|0
1146525|NCT03012334|2254732|FG008|Period 4|Non-Compliance|0
1146526|NCT03012334|2254733|FG009|Period 4|Non-Compliance|0
1146527|NCT03012334|2254724|FG000|Period 4|Adverse Event|0
1146528|NCT03012334|2254725|FG001|Period 4|Adverse Event|0
1146529|NCT03012334|2254726|FG002|Period 4|Adverse Event|0
1146530|NCT03012334|2254727|FG003|Period 4|Adverse Event|0
1146531|NCT03012334|2254728|FG004|Period 4|Adverse Event|0
1146532|NCT03012334|2254729|FG005|Period 4|Adverse Event|0
1146533|NCT03012334|2254730|FG006|Period 4|Adverse Event|0
1146534|NCT03012334|2254731|FG007|Period 4|Adverse Event|0
1146535|NCT03012334|2254732|FG008|Period 4|Adverse Event|1
1146536|NCT03012334|2254733|FG009|Period 4|Adverse Event|0
1146537|NCT03012828|2254768|FG000|Overall Study|Lost to Follow-up|1
1146538|NCT03012828|2254769|FG001|Overall Study|Lost to Follow-up|0
1146539|NCT03012828|2254770|FG002|Overall Study|Lost to Follow-up|1
1146540|NCT03012828|2254771|FG003|Overall Study|Lost to Follow-up|0
1146541|NCT03012828|2254772|FG004|Overall Study|Lost to Follow-up|1
1146542|NCT03012828|2254773|FG005|Overall Study|Lost to Follow-up|0
1146543|NCT03012828|2254768|FG000|Overall Study|Withdrawal by Subject|0
1146544|NCT03012828|2254769|FG001|Overall Study|Withdrawal by Subject|0
1146545|NCT03012828|2254770|FG002|Overall Study|Withdrawal by Subject|1
1146546|NCT03012828|2254771|FG003|Overall Study|Withdrawal by Subject|0
1146547|NCT03012828|2254772|FG004|Overall Study|Withdrawal by Subject|0
1146548|NCT03012828|2254773|FG005|Overall Study|Withdrawal by Subject|1
1146549|NCT03012828|2254768|FG000|Overall Study|Non-compliance with protocol|0
1146550|NCT03012828|2254769|FG001|Overall Study|Non-compliance with protocol|0
1146551|NCT03012828|2254770|FG002|Overall Study|Non-compliance with protocol|0
1146552|NCT03012828|2254771|FG003|Overall Study|Non-compliance with protocol|0
1146553|NCT03012828|2254772|FG004|Overall Study|Non-compliance with protocol|1
1146554|NCT03012828|2254773|FG005|Overall Study|Non-compliance with protocol|0
1146555|NCT03012828|2254768|FG000|Overall Study|Delay to last visit would delay DBL|0
1146556|NCT03012828|2254769|FG001|Overall Study|Delay to last visit would delay DBL|0
1146557|NCT03012828|2254770|FG002|Overall Study|Delay to last visit would delay DBL|0
1146558|NCT03012828|2254771|FG003|Overall Study|Delay to last visit would delay DBL|0
1146559|NCT03012828|2254772|FG004|Overall Study|Delay to last visit would delay DBL|0
1146560|NCT03012828|2254773|FG005|Overall Study|Delay to last visit would delay DBL|1
1146561|NCT03012841|2254789|FG000|Overall Study|Protocol Violation|0
1146562|NCT03012841|2254790|FG001|Overall Study|Protocol Violation|10
1146563|NCT03012841|2254789|FG000|Overall Study|Lost to Follow-up|6
1146564|NCT03012841|2254790|FG001|Overall Study|Lost to Follow-up|1
1146565|NCT03012841|2254789|FG000|Overall Study|Withdrawal by Subject|6
1146566|NCT03012841|2254790|FG001|Overall Study|Withdrawal by Subject|0
1146567|NCT03012841|2254789|FG000|Overall Study|Unable to complete 12 month visit|6
1146568|NCT03012841|2254790|FG001|Overall Study|Unable to complete 12 month visit|0
1146569|NCT03012841|2254789|FG000|Overall Study|Subject relocation|1
1146570|NCT03012841|2254790|FG001|Overall Study|Subject relocation|0
1146571|NCT03012841|2254789|FG000|Overall Study|Seasonal winter travel|1
902172|NCT00738881|1875885|FG000|Overall Study|Withdrawal by Subject|0
902173|NCT00738881|1875886|FG001|Overall Study|Withdrawal by Subject|2
902174|NCT00738894|1875894|FG000|Overall Study|Lost to Follow-up|23
902175|NCT00738894|1875895|FG001|Overall Study|Lost to Follow-up|13
902176|NCT00738894|1875894|FG000|Overall Study|Withdrawal by Subject|10
902177|NCT00738894|1875895|FG001|Overall Study|Withdrawal by Subject|15
902178|NCT00738894|1875894|FG000|Overall Study|Physician Decision|4
902179|NCT00738894|1875895|FG001|Overall Study|Physician Decision|5
902180|NCT00738894|1875894|FG000|Overall Study|Death|2
902181|NCT00738894|1875895|FG001|Overall Study|Death|0
902182|NCT00739102|1875901|FG000|Overall Study|Death|5
902183|NCT00739102|1875901|FG000|Overall Study|Withdrawal by Subject|10
902184|NCT00739297|1875905|FG000|First Washout Period of 4-7 Days|Adverse Event|0
902185|NCT00739297|1875906|FG001|First Washout Period of 4-7 Days|Adverse Event|0
902186|NCT00739297|1875907|FG002|First Washout Period of 4-7 Days|Adverse Event|0
902187|NCT00739297|1875908|FG003|First Washout Period of 4-7 Days|Adverse Event|2
1146572|NCT03012841|2254790|FG001|Overall Study|Seasonal winter travel|0
1146573|NCT03012841|2254789|FG000|Overall Study|Physician Decision|0
1146574|NCT03012841|2254790|FG001|Overall Study|Physician Decision|2
1146575|NCT03012841|2254789|FG000|Overall Study|No ablation performed|0
1146576|NCT03012841|2254790|FG001|Overall Study|No ablation performed|2
1146577|NCT03012841|2254789|FG000|Overall Study|Study reached n=165 treated subject cap|0
1146578|NCT03012841|2254790|FG001|Overall Study|Study reached n=165 treated subject cap|5
1146579|NCT03012841|2254789|FG000|Overall Study|Insurance change|0
1146580|NCT03012841|2254790|FG001|Overall Study|Insurance change|1
1146581|NCT03013985|2254797|FG000|Overall Study|Protocol Violation|2
1146582|NCT03013985|2254798|FG001|Overall Study|Protocol Violation|2
1146583|NCT03013985|2254797|FG000|Overall Study|Withdrawal by Subject|14
1146584|NCT03013985|2254798|FG001|Overall Study|Withdrawal by Subject|17
1146585|NCT03014011|2254804|FG000|First Intervention|Withdrawal by Subject|1
1146586|NCT03014011|2254805|FG001|First Intervention|Withdrawal by Subject|0
1146587|NCT03014011|2254804|FG000|Washout|Withdrawal by Subject|1
1146588|NCT03014011|2254805|FG001|Washout|Withdrawal by Subject|0
1146589|NCT03014180|2254811|FG000|Overall Study|Protocol Violation|2
1146590|NCT03014206|2254819|FG000|Overall Study|Registration Violation|12
1146591|NCT03014453|2254823|FG000|Overall Study|Lost to Follow-up|12
1146592|NCT03014453|2254823|FG000|Overall Study|Discontinued GER|3
1146593|NCT03014453|2254823|FG000|Overall Study|Excluded|19
1146594|NCT03014453|2254823|FG000|Overall Study|Refused to take part in|37
1146595|NCT03014479|2254829|FG000|Overall Study|Adverse Event|0
1146596|NCT03014479|2254830|FG001|Overall Study|Adverse Event|1
1146597|NCT03014479|2254829|FG000|Overall Study|Voluntary Withdrawal|0
1146598|NCT03014479|2254830|FG001|Overall Study|Voluntary Withdrawal|2
1146599|NCT03014479|2254829|FG000|Overall Study|Unacceptable Inability of Site Visit|0
1146600|NCT03014479|2254830|FG001|Overall Study|Unacceptable Inability of Site Visit|1
1146601|NCT03014674|2254848|FG000|Overall Study|Withdrawal by Subject|1
1146602|NCT03014674|2254849|FG001|Overall Study|Withdrawal by Subject|0
1146603|NCT03014674|2254850|FG002|Overall Study|Withdrawal by Subject|0
1146604|NCT03015116|2254870|FG000|Overall Study|Lost to Follow-up|3
1146605|NCT03015116|2254871|FG001|Overall Study|Lost to Follow-up|0
1146606|NCT03015116|2254872|FG002|Overall Study|Lost to Follow-up|2
1146607|NCT03015116|2254870|FG000|Overall Study|Withdrawal by Subject|3
1146608|NCT03015116|2254871|FG001|Overall Study|Withdrawal by Subject|1
1146609|NCT03015116|2254872|FG002|Overall Study|Withdrawal by Subject|0
1146610|NCT03015116|2254870|FG000|Overall Study|Subject has New Medical Status|1
1146611|NCT03015116|2254871|FG001|Overall Study|Subject has New Medical Status|0
1146612|NCT03015116|2254872|FG002|Overall Study|Subject has New Medical Status|0
1146613|NCT03015116|2254870|FG000|Overall Study|Physician Decision|0
1146614|NCT03015116|2254871|FG001|Overall Study|Physician Decision|1
1146615|NCT03015116|2254872|FG002|Overall Study|Physician Decision|0
1146616|NCT03015181|2254895|FG000|Overall Study|Enrolled, but product never administered|1
1146617|NCT03015181|2254896|FG001|Overall Study|Enrolled, but product never administered|0
1146618|NCT03015181|2254897|FG002|Overall Study|Enrolled, but product never administered|0
1146619|NCT03015181|2254898|FG003|Overall Study|Enrolled, but product never administered|0
1146620|NCT03015181|2254899|FG004|Overall Study|Enrolled, but product never administered|0
1146621|NCT03015181|2254900|FG005|Overall Study|Enrolled, but product never administered|0
1146622|NCT03015181|2254901|FG006|Overall Study|Enrolled, but product never administered|0
1146623|NCT03015181|2254895|FG000|Overall Study|Withdrawal by Subject|0
1146624|NCT03015181|2254896|FG001|Overall Study|Withdrawal by Subject|0
1146625|NCT03015181|2254897|FG002|Overall Study|Withdrawal by Subject|0
1146626|NCT03015181|2254898|FG003|Overall Study|Withdrawal by Subject|0
1146627|NCT03015181|2254899|FG004|Overall Study|Withdrawal by Subject|0
1146628|NCT03015181|2254900|FG005|Overall Study|Withdrawal by Subject|1
1146629|NCT03015181|2254901|FG006|Overall Study|Withdrawal by Subject|0
1146630|NCT03015181|2254895|FG000|Overall Study|Physician Decision|0
1146631|NCT03015181|2254896|FG001|Overall Study|Physician Decision|0
1146632|NCT03015181|2254897|FG002|Overall Study|Physician Decision|0
1146633|NCT03015181|2254898|FG003|Overall Study|Physician Decision|0
1146634|NCT03015181|2254899|FG004|Overall Study|Physician Decision|0
1146635|NCT03015181|2254900|FG005|Overall Study|Physician Decision|0
1146636|NCT03015181|2254901|FG006|Overall Study|Physician Decision|1
1146637|NCT03015194|2254937|FG000|Overall Study|Death|10
1146638|NCT03015194|2254937|FG000|Overall Study|Withdrawal by Subject|2
1146639|NCT03015220|2254946|FG000|Overall Study|Withdrawal by Subject|3
1146640|NCT03015220|2254947|FG001|Overall Study|Withdrawal by Subject|2
1146641|NCT03015220|2254948|FG002|Overall Study|Withdrawal by Subject|2
1146642|NCT03015220|2254949|FG003|Overall Study|Withdrawal by Subject|2
1146643|NCT03015220|2254946|FG000|Overall Study|Lost to Follow-up|0
1146644|NCT03015220|2254947|FG001|Overall Study|Lost to Follow-up|0
1146645|NCT03015220|2254948|FG002|Overall Study|Lost to Follow-up|1
1146646|NCT03015220|2254949|FG003|Overall Study|Lost to Follow-up|0
1146647|NCT03015363|2254959|FG000|Overall Study|Physician Decision|14
1146648|NCT03015363|2254959|FG000|Overall Study|Withdrawal by Subject|3
1146649|NCT03015532|2254971|FG000|Overall Study|Adverse Event|0
1146650|NCT03015532|2254972|FG001|Overall Study|Adverse Event|0
1146651|NCT03015532|2254973|FG002|Overall Study|Adverse Event|0
1146652|NCT03015532|2254974|FG003|Overall Study|Adverse Event|0
1146653|NCT03015532|2254975|FG004|Overall Study|Adverse Event|0
1146654|NCT03015532|2254976|FG005|Overall Study|Adverse Event|2
1146655|NCT03015532|2254977|FG006|Overall Study|Adverse Event|1
1146656|NCT03015532|2254978|FG007|Overall Study|Adverse Event|0
1146657|NCT03015532|2254971|FG000|Overall Study|Withdrawal by Subject|0
1146658|NCT03015532|2254972|FG001|Overall Study|Withdrawal by Subject|0
1146659|NCT03015532|2254973|FG002|Overall Study|Withdrawal by Subject|0
1146660|NCT03015532|2254974|FG003|Overall Study|Withdrawal by Subject|0
1146661|NCT03015532|2254975|FG004|Overall Study|Withdrawal by Subject|0
1146662|NCT03015532|2254976|FG005|Overall Study|Withdrawal by Subject|0
1146663|NCT03015532|2254977|FG006|Overall Study|Withdrawal by Subject|1
1146664|NCT03015532|2254978|FG007|Overall Study|Withdrawal by Subject|0
1146665|NCT03016078|2255011|FG000|Overall Study|Protocol Violation|1
1146666|NCT03016078|2255011|FG000|Overall Study|Protocol Violation|1
1146677|NCT03016325|2255032|FG000|Treatment Period|Participant withdrew consent|0
1146678|NCT03016325|2255033|FG001|Treatment Period|Participant withdrew consent|1
1146679|NCT03016325|2255034|FG002|Treatment Period|Participant withdrew consent|0
1146680|NCT03016325|2255035|FG003|Treatment Period|Participant withdrew consent|0
1146681|NCT03016325|2255036|FG004|Treatment Period|Participant withdrew consent|0
1146682|NCT03016325|2255037|FG005|Treatment Period|Participant withdrew consent|0
1146683|NCT03016325|2255038|FG006|Treatment Period|Participant withdrew consent|0
1146684|NCT03016325|2255039|FG007|Treatment Period|Participant withdrew consent|0
1146685|NCT03016325|2255032|FG000|Treatment Period|Death|0
1146686|NCT03016325|2255033|FG001|Treatment Period|Death|0
1146687|NCT03016325|2255034|FG002|Treatment Period|Death|0
1146688|NCT03016325|2255035|FG003|Treatment Period|Death|0
1146689|NCT03016325|2255036|FG004|Treatment Period|Death|2
1146690|NCT03016325|2255037|FG005|Treatment Period|Death|0
1146691|NCT03016325|2255038|FG006|Treatment Period|Death|0
1146692|NCT03016325|2255039|FG007|Treatment Period|Death|0
1146693|NCT03016325|2255032|FG000|Treatment Period|Participant refuses assessments|0
1146694|NCT03016325|2255033|FG001|Treatment Period|Participant refuses assessments|0
1146695|NCT03016325|2255034|FG002|Treatment Period|Participant refuses assessments|1
1146696|NCT03016325|2255035|FG003|Treatment Period|Participant refuses assessments|0
1146697|NCT03016325|2255036|FG004|Treatment Period|Participant refuses assessments|0
1146698|NCT03016325|2255037|FG005|Treatment Period|Participant refuses assessments|0
1146699|NCT03016325|2255038|FG006|Treatment Period|Participant refuses assessments|0
1146700|NCT03016325|2255039|FG007|Treatment Period|Participant refuses assessments|0
1146701|NCT03016325|2255032|FG000|32-Day Follow-Up Period|Death|2
1146702|NCT03016325|2255033|FG001|32-Day Follow-Up Period|Death|0
1146703|NCT03016325|2255034|FG002|32-Day Follow-Up Period|Death|5
1146704|NCT03016325|2255035|FG003|32-Day Follow-Up Period|Death|6
1146705|NCT03016325|2255036|FG004|32-Day Follow-Up Period|Death|3
1146706|NCT03016325|2255037|FG005|32-Day Follow-Up Period|Death|0
1146707|NCT03016325|2255038|FG006|32-Day Follow-Up Period|Death|0
1146708|NCT03016325|2255039|FG007|32-Day Follow-Up Period|Death|0
1146709|NCT03016325|2255032|FG000|32-Day Follow-Up Period|Lost to Follow-up|1
1146710|NCT03016325|2255033|FG001|32-Day Follow-Up Period|Lost to Follow-up|0
1146711|NCT03016325|2255034|FG002|32-Day Follow-Up Period|Lost to Follow-up|1
1146712|NCT03016325|2255035|FG003|32-Day Follow-Up Period|Lost to Follow-up|1
1146713|NCT03016325|2255036|FG004|32-Day Follow-Up Period|Lost to Follow-up|0
1146714|NCT03016325|2255037|FG005|32-Day Follow-Up Period|Lost to Follow-up|0
1146715|NCT03016325|2255038|FG006|32-Day Follow-Up Period|Lost to Follow-up|0
1146716|NCT03016325|2255039|FG007|32-Day Follow-Up Period|Lost to Follow-up|0
1146717|NCT03016325|2255032|FG000|32-Day Follow-Up Period|Poor/non-compliance|1
1146718|NCT03016325|2255033|FG001|32-Day Follow-Up Period|Poor/non-compliance|0
1146719|NCT03016325|2255034|FG002|32-Day Follow-Up Period|Poor/non-compliance|0
1146720|NCT03016325|2255035|FG003|32-Day Follow-Up Period|Poor/non-compliance|1
1146721|NCT03016325|2255036|FG004|32-Day Follow-Up Period|Poor/non-compliance|1
1146722|NCT03016325|2255037|FG005|32-Day Follow-Up Period|Poor/non-compliance|0
1146723|NCT03016325|2255038|FG006|32-Day Follow-Up Period|Poor/non-compliance|0
1146724|NCT03016325|2255039|FG007|32-Day Follow-Up Period|Poor/non-compliance|0
1146725|NCT03016325|2255032|FG000|32-Day Follow-Up Period|Participant refused to visit|0
1146726|NCT03016325|2255033|FG001|32-Day Follow-Up Period|Participant refused to visit|1
1146727|NCT03016325|2255034|FG002|32-Day Follow-Up Period|Participant refused to visit|2
1146728|NCT03016325|2255035|FG003|32-Day Follow-Up Period|Participant refused to visit|0
1146729|NCT03016325|2255036|FG004|32-Day Follow-Up Period|Participant refused to visit|2
1146730|NCT03016325|2255037|FG005|32-Day Follow-Up Period|Participant refused to visit|0
1146731|NCT03016325|2255038|FG006|32-Day Follow-Up Period|Participant refused to visit|0
1146732|NCT03016325|2255039|FG007|32-Day Follow-Up Period|Participant refused to visit|0
1146733|NCT03016325|2255032|FG000|32-Day Follow-Up Period|Participant withdrew consent|0
1146734|NCT03016325|2255033|FG001|32-Day Follow-Up Period|Participant withdrew consent|0
1146735|NCT03016325|2255034|FG002|32-Day Follow-Up Period|Participant withdrew consent|0
1146736|NCT03016325|2255035|FG003|32-Day Follow-Up Period|Participant withdrew consent|0
1146737|NCT03016325|2255036|FG004|32-Day Follow-Up Period|Participant withdrew consent|2
1146738|NCT03016325|2255037|FG005|32-Day Follow-Up Period|Participant withdrew consent|0
1146739|NCT03016325|2255038|FG006|32-Day Follow-Up Period|Participant withdrew consent|1
1146740|NCT03016325|2255039|FG007|32-Day Follow-Up Period|Participant withdrew consent|0
1146741|NCT03016325|2255032|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
1146742|NCT03016325|2255033|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
1146743|NCT03016325|2255034|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1
1146744|NCT03016325|2255035|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
1146745|NCT03016325|2255036|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
1146746|NCT03016325|2255037|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
1146747|NCT03016325|2255038|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
1146748|NCT03016325|2255039|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
1146749|NCT03016325|2255032|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
1146750|NCT03016325|2255033|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1
1146751|NCT03016325|2255034|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
1146752|NCT03016325|2255035|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
1146753|NCT03016325|2255036|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
1146754|NCT03016325|2255037|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
1146755|NCT03016325|2255038|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
1146756|NCT03016325|2255039|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
1146757|NCT03016325|2255032|FG000|182-Day Follow-Up Period|Death|3
1146758|NCT03016325|2255033|FG001|182-Day Follow-Up Period|Death|3
1146759|NCT03016325|2255034|FG002|182-Day Follow-Up Period|Death|11
1146760|NCT03016325|2255035|FG003|182-Day Follow-Up Period|Death|12
1146761|NCT03016325|2255036|FG004|182-Day Follow-Up Period|Death|9
1146762|NCT03016325|2255037|FG005|182-Day Follow-Up Period|Death|0
1146763|NCT03016325|2255038|FG006|182-Day Follow-Up Period|Death|0
1146764|NCT03016325|2255039|FG007|182-Day Follow-Up Period|Death|1
1146765|NCT03016325|2255032|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1
1146766|NCT03016325|2255033|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0
1146767|NCT03016325|2255034|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0
1146768|NCT03016325|2255035|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0
1146769|NCT03016325|2255036|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0
1146770|NCT03016325|2255037|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0
1146771|NCT03016325|2255038|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0
1146772|NCT03016325|2255039|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0
1146773|NCT03016325|2255032|FG000|182-Day Follow-Up Period|Participant withdrew consent|0
1146774|NCT03016325|2255033|FG001|182-Day Follow-Up Period|Participant withdrew consent|0
1146775|NCT03016325|2255034|FG002|182-Day Follow-Up Period|Participant withdrew consent|0
1146776|NCT03016325|2255035|FG003|182-Day Follow-Up Period|Participant withdrew consent|0
1146777|NCT03016325|2255036|FG004|182-Day Follow-Up Period|Participant withdrew consent|1
1146778|NCT03016325|2255037|FG005|182-Day Follow-Up Period|Participant withdrew consent|0
1146779|NCT03016325|2255038|FG006|182-Day Follow-Up Period|Participant withdrew consent|1
1146780|NCT03016325|2255039|FG007|182-Day Follow-Up Period|Participant withdrew consent|0
1146781|NCT03016325|2255032|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0
1146782|NCT03016325|2255033|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0
1146783|NCT03016325|2255034|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0
1146784|NCT03016325|2255035|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0
1146785|NCT03016325|2255036|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1
1146786|NCT03016325|2255037|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0
1146787|NCT03016325|2255038|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0
1146788|NCT03016325|2255039|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0
1146789|NCT03016325|2255032|FG000|182-Day Follow-Up Period|Alive, per civil unit|0
1146790|NCT03016325|2255033|FG001|182-Day Follow-Up Period|Alive, per civil unit|0
1146791|NCT03016325|2255034|FG002|182-Day Follow-Up Period|Alive, per civil unit|0
1146792|NCT03016325|2255035|FG003|182-Day Follow-Up Period|Alive, per civil unit|0
1146793|NCT03016325|2255036|FG004|182-Day Follow-Up Period|Alive, per civil unit|1
1146794|NCT03016325|2255037|FG005|182-Day Follow-Up Period|Alive, per civil unit|0
1146795|NCT03016325|2255038|FG006|182-Day Follow-Up Period|Alive, per civil unit|0
1146796|NCT03016325|2255039|FG007|182-Day Follow-Up Period|Alive, per civil unit|0
1146797|NCT03016325|2255032|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0
1146798|NCT03016325|2255033|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0
1146799|NCT03016325|2255034|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0
1146800|NCT03016325|2255035|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1
1146801|NCT03016325|2255036|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0
1146802|NCT03016325|2255037|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0
1146803|NCT03016325|2255038|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0
1146804|NCT03016325|2255039|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0
1146805|NCT03016325|2255032|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
1146806|NCT03016325|2255033|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1
1146807|NCT03016325|2255034|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
1146808|NCT03016325|2255035|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
1146809|NCT03016325|2255036|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
1146810|NCT03016325|2255037|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
1146811|NCT03016325|2255038|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
1146812|NCT03016325|2255039|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
1146813|NCT03016325|2255032|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
1146814|NCT03016325|2255033|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
1146815|NCT03016325|2255034|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
1146816|NCT03016325|2255035|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
1146817|NCT03016325|2255036|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
1146818|NCT03016325|2255037|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5
1146819|NCT03016325|2255038|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3
1146820|NCT03016325|2255039|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4
1146821|NCT03016403|2255064|FG000|Baseline|Death|5
1146822|NCT03016403|2255065|FG001|Baseline|Death|8
1146823|NCT03016403|2255066|FG002|Baseline|Death|1
1146824|NCT03016403|2255067|FG003|Baseline|Death|0
1146825|NCT03016403|2255064|FG000|Baseline|Withdrawal by Subject|2
1146826|NCT03016403|2255065|FG001|Baseline|Withdrawal by Subject|8
1146827|NCT03016403|2255066|FG002|Baseline|Withdrawal by Subject|4
1146828|NCT03016403|2255067|FG003|Baseline|Withdrawal by Subject|10
1146829|NCT03016403|2255064|FG000|Baseline|Lost to Follow-up|9
1146830|NCT03016403|2255065|FG001|Baseline|Lost to Follow-up|11
1146831|NCT03016403|2255066|FG002|Baseline|Lost to Follow-up|6
1146832|NCT03016403|2255067|FG003|Baseline|Lost to Follow-up|24
1146833|NCT03016403|2255064|FG000|6-week Follow-up|Death|1
1146834|NCT03016403|2255065|FG001|6-week Follow-up|Death|4
1146835|NCT03016403|2255066|FG002|6-week Follow-up|Death|0
1146836|NCT03016403|2255067|FG003|6-week Follow-up|Death|0
1146837|NCT03016403|2255064|FG000|6-week Follow-up|Lost to Follow-up|2
1146838|NCT03016403|2255065|FG001|6-week Follow-up|Lost to Follow-up|7
1146839|NCT03016403|2255066|FG002|6-week Follow-up|Lost to Follow-up|4
1146840|NCT03016403|2255067|FG003|6-week Follow-up|Lost to Follow-up|8
1146841|NCT03016403|2255064|FG000|6-week Follow-up|Withdrawal by Subject|0
1146842|NCT03016403|2255065|FG001|6-week Follow-up|Withdrawal by Subject|2
1146843|NCT03016403|2255066|FG002|6-week Follow-up|Withdrawal by Subject|0
1146844|NCT03016403|2255067|FG003|6-week Follow-up|Withdrawal by Subject|1
1146845|NCT03016403|2255064|FG000|3-month Follow-up and 6-month Follow-up|Death|6
1146846|NCT03016403|2255065|FG001|3-month Follow-up and 6-month Follow-up|Death|4
1146847|NCT03016403|2255066|FG002|3-month Follow-up and 6-month Follow-up|Death|0
1146848|NCT03016403|2255067|FG003|3-month Follow-up and 6-month Follow-up|Death|0
1146849|NCT03016403|2255064|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
1146850|NCT03016403|2255065|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7
1146851|NCT03016403|2255066|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8
1146852|NCT03016403|2255067|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
1146853|NCT03016403|2255064|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
1146854|NCT03016403|2255065|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
1146855|NCT03016403|2255066|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
1146856|NCT03016403|2255067|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1
1146857|NCT03016598|2255081|FG000|Overall Study|Lost to Follow-up|0
1146858|NCT03016598|2255082|FG001|Overall Study|Lost to Follow-up|2
1146859|NCT03017079|2255090|FG000|Overall Study|Physician Decision|1
1146860|NCT03017079|2255091|FG001|Overall Study|Physician Decision|1
1146861|NCT03017079|2255090|FG000|Overall Study|Death|3
1146862|NCT03017079|2255091|FG001|Overall Study|Death|2
1146863|NCT03017079|2255090|FG000|Overall Study|Lack of Efficacy|2
1146864|NCT03017079|2255091|FG001|Overall Study|Lack of Efficacy|2
1146865|NCT03017079|2255090|FG000|Overall Study|Protocol Violation|0
1146866|NCT03017079|2255091|FG001|Overall Study|Protocol Violation|1
1146867|NCT03017235|2255106|FG000|Overall Study|Withdrawal by Subject|4
1146868|NCT03017235|2255107|FG001|Overall Study|Withdrawal by Subject|3
1146869|NCT03017235|2255106|FG000|Overall Study|Lost to Follow-up|2
1146870|NCT03017235|2255107|FG001|Overall Study|Lost to Follow-up|7
1146871|NCT03017235|2255106|FG000|Overall Study|Adverse Event|0
1146872|NCT03017235|2255107|FG001|Overall Study|Adverse Event|1
1146873|NCT03017235|2255106|FG000|Overall Study|Protocol Violation|2
1146874|NCT03017235|2255107|FG001|Overall Study|Protocol Violation|1
1146875|NCT03017235|2255106|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4
1146876|NCT03017235|2255107|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2
1146877|NCT03017612|2255126|FG000|Overall Study|Adverse Event|2
1146878|NCT03017846|2255130|FG000|Overall Study|Lost to Follow-up|3
1146879|NCT03017846|2255130|FG000|Overall Study|Adverse Event|2
1146880|NCT03018249|2255186|FG000|Overall Study|Withdrawal by Subject|2
1146881|NCT03018249|2255187|FG001|Overall Study|Withdrawal by Subject|2
1146882|NCT03018340|2255195|FG000|Overall Study|Adverse Event|1
1146883|NCT03018340|2255196|FG001|Overall Study|Adverse Event|2
1146884|NCT03018340|2255195|FG000|Overall Study|Withdrawal by Subject|0
1146885|NCT03018340|2255196|FG001|Overall Study|Withdrawal by Subject|8
1146886|NCT03018340|2255195|FG000|Overall Study|Lack of Efficacy|0
1146887|NCT03018340|2255196|FG001|Overall Study|Lack of Efficacy|1
1146888|NCT03018340|2255195|FG000|Overall Study|Non-compliance with study drug/procedure|3
1146889|NCT03018340|2255196|FG001|Overall Study|Non-compliance with study drug/procedure|4
1146890|NCT03018340|2255195|FG000|Overall Study|Lost to Follow-up|1
1146891|NCT03018340|2255196|FG001|Overall Study|Lost to Follow-up|7
1146892|NCT03018340|2255195|FG000|Overall Study|Protocol Violation|3
1146893|NCT03018340|2255196|FG001|Overall Study|Protocol Violation|7
1146894|NCT03018340|2255195|FG000|Overall Study|Not further specified|0
1146895|NCT03018340|2255196|FG001|Overall Study|Not further specified|1
1146896|NCT03018691|2255209|FG000|Overall Study|Adverse Event|1
1146897|NCT03018691|2255210|FG001|Overall Study|Adverse Event|1
1146898|NCT03018691|2255211|FG002|Overall Study|Adverse Event|4
1146899|NCT03018691|2255209|FG000|Overall Study|Lack of Efficacy|0
1146900|NCT03018691|2255210|FG001|Overall Study|Lack of Efficacy|0
1146901|NCT03018691|2255211|FG002|Overall Study|Lack of Efficacy|1
1146902|NCT03018691|2255209|FG000|Overall Study|Withdrawal by Subject|0
1146903|NCT03018691|2255210|FG001|Overall Study|Withdrawal by Subject|0
1146904|NCT03018691|2255211|FG002|Overall Study|Withdrawal by Subject|1
1146905|NCT03018691|2255209|FG000|Overall Study|Withdrawal by parent/guardian|1
1146906|NCT03018691|2255210|FG001|Overall Study|Withdrawal by parent/guardian|0
1146907|NCT03018691|2255211|FG002|Overall Study|Withdrawal by parent/guardian|1
1146908|NCT03018938|2255248|FG000|Overall Study|Death|0
1146909|NCT03018938|2255249|FG001|Overall Study|Death|1
1146910|NCT03018938|2255248|FG000|Overall Study|Lost to Follow-up|21
1146911|NCT03018938|2255249|FG001|Overall Study|Lost to Follow-up|32
1146912|NCT03018938|2255248|FG000|Overall Study|Withdrawal by Subject|38
1146913|NCT03018938|2255249|FG001|Overall Study|Withdrawal by Subject|45
1146914|NCT03018938|2255248|FG000|Overall Study|Physician Decision|3
1146915|NCT03018938|2255249|FG001|Overall Study|Physician Decision|2
1146916|NCT03018938|2255248|FG000|Overall Study|Sponsor Decision|0
1146917|NCT03018938|2255249|FG001|Overall Study|Sponsor Decision|1
1146918|NCT03018938|2255248|FG000|Overall Study|Screen failure-After randomization|4
1146919|NCT03018938|2255249|FG001|Overall Study|Screen failure-After randomization|2
1146920|NCT03018938|2255248|FG000|Overall Study|Not recorded|0
1146921|NCT03018938|2255249|FG001|Overall Study|Not recorded|2
1146922|NCT03019289|2255290|FG000|Overall Study|Adverse Event|1
1146923|NCT03019289|2255291|FG001|Overall Study|Adverse Event|0
1146924|NCT03019289|2255292|FG002|Overall Study|Adverse Event|0
1146925|NCT03019289|2255293|FG003|Overall Study|Adverse Event|0
1146926|NCT03019289|2255294|FG004|Overall Study|Adverse Event|0
1146927|NCT03019289|2255295|FG005|Overall Study|Adverse Event|0
1146928|NCT03019289|2255296|FG006|Overall Study|Adverse Event|0
1146929|NCT03019289|2255297|FG007|Overall Study|Adverse Event|0
1146930|NCT03019289|2255298|FG008|Overall Study|Adverse Event|1
1146931|NCT03019289|2255290|FG000|Overall Study|Other|1
1146932|NCT03019289|2255291|FG001|Overall Study|Other|0
1146933|NCT03019289|2255292|FG002|Overall Study|Other|0
1146934|NCT03019289|2255293|FG003|Overall Study|Other|0
1146935|NCT03019289|2255294|FG004|Overall Study|Other|0
1146936|NCT03019289|2255295|FG005|Overall Study|Other|0
1146937|NCT03019289|2255296|FG006|Overall Study|Other|0
1146938|NCT03019289|2255297|FG007|Overall Study|Other|0
1146939|NCT03019289|2255298|FG008|Overall Study|Other|0
1146940|NCT03019406|2255323|FG000|ETP: Ongoing From Week 26|Ongoing|6
1146941|NCT03019406|2255324|FG001|ETP: Ongoing From Week 26|Ongoing|5
1146942|NCT03019406|2255325|FG002|ETP: Ongoing From Week 26|Ongoing|5
1146943|NCT03019406|2255326|FG003|ETP: Ongoing From Week 26|Ongoing|3
1146944|NCT03019458|2255341|FG000|Overall Study|Death|0
1146945|NCT03019458|2255342|FG001|Overall Study|Death|1
1146946|NCT03019549|2255350|FG000|Washout|DId not meet genotype criteria|11
1146947|NCT03019549|2255350|FG000|Period 2|Adverse Event|2
1146948|NCT03019549|2255350|FG000|Period 2|Physician Decision|2
1146949|NCT03019549|2255350|FG000|Period 2|Withdrawal by Subject|1
1146950|NCT03019627|2255365|FG000|Overall Study|Adverse Event|8
1146951|NCT03019627|2255366|FG001|Overall Study|Adverse Event|0
1146952|NCT03019627|2255365|FG000|Overall Study|Unrelated to adverse event|1
1146953|NCT03019627|2255366|FG001|Overall Study|Unrelated to adverse event|3
1146954|NCT03019627|2255365|FG000|Overall Study|Lost to Follow-up|2
1146955|NCT03019627|2255366|FG001|Overall Study|Lost to Follow-up|1
1146956|NCT03019627|2255365|FG000|Overall Study|not compliance|2
1146957|NCT03019627|2255366|FG001|Overall Study|not compliance|2
1146958|NCT03019627|2255365|FG000|Overall Study|Other|2
1146959|NCT03019627|2255366|FG001|Overall Study|Other|2
1146960|NCT03019965|2255408|FG000|Overall Study|Withdrawal by Subject|1
1146961|NCT03019965|2255409|FG001|Overall Study|Withdrawal by Subject|0
1146962|NCT03019965|2255408|FG000|Overall Study|Protocol Violation|1
1146963|NCT03019965|2255409|FG001|Overall Study|Protocol Violation|3
1146964|NCT03019965|2255408|FG000|Overall Study|viral or fungal infection|3
1146965|NCT03019965|2255409|FG001|Overall Study|viral or fungal infection|4
1146966|NCT03019965|2255408|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4
1146967|NCT03019965|2255409|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5
1146968|NCT03019965|2255408|FG000|Overall Study|Physician Decision|1
1146969|NCT03019965|2255409|FG001|Overall Study|Physician Decision|1
1146970|NCT03020069|2255421|FG000|Overall Study|Lost to Follow-up|0
1146971|NCT03020069|2255422|FG001|Overall Study|Lost to Follow-up|1
1146972|NCT03020407|2255448|FG000|Overall Study|Withdrawal by Subject|2
1146973|NCT03020407|2255449|FG001|Overall Study|Withdrawal by Subject|1
1146974|NCT03020407|2255448|FG000|Overall Study|Lost to Follow-up|2
1146975|NCT03020407|2255449|FG001|Overall Study|Lost to Follow-up|3
1146976|NCT03020407|2255448|FG000|Overall Study|Protocol Violation|0
1146977|NCT03020407|2255449|FG001|Overall Study|Protocol Violation|1
1146978|NCT03020576|2255505|FG000|Overall Study|Withdrawal by Subject|1
1146979|NCT03020576|2255506|FG001|Overall Study|Withdrawal by Subject|2
1146980|NCT03020615|2255515|FG000|Overall Study|Physician Decision|3
1146981|NCT03020615|2255516|FG001|Overall Study|Physician Decision|1
1146982|NCT03020615|2255517|FG002|Overall Study|Physician Decision|2
1146983|NCT03020615|2255515|FG000|Overall Study|Parent/guardian/patient choice|3
1146984|NCT03020615|2255516|FG001|Overall Study|Parent/guardian/patient choice|0
1146985|NCT03020615|2255517|FG002|Overall Study|Parent/guardian/patient choice|4
1146986|NCT03020615|2255515|FG000|Overall Study|Screen failure|0
1146987|NCT03020615|2255516|FG001|Overall Study|Screen failure|0
1146988|NCT03020615|2255517|FG002|Overall Study|Screen failure|1
1146989|NCT03020615|2255515|FG000|Overall Study|Death|1
1146990|NCT03020615|2255516|FG001|Overall Study|Death|0
1146991|NCT03020615|2255517|FG002|Overall Study|Death|0
1146992|NCT03020615|2255515|FG000|Overall Study|Lost to Follow-up|0
1146993|NCT03020615|2255516|FG001|Overall Study|Lost to Follow-up|1
1146994|NCT03020615|2255517|FG002|Overall Study|Lost to Follow-up|0
1146995|NCT03020641|2255530|FG000|Overall Study|Lost to Follow-up|0
1146996|NCT03020641|2255531|FG001|Overall Study|Lost to Follow-up|1
1146997|NCT03020641|2255530|FG000|Overall Study|Converted to open surgery|2
1146998|NCT03020641|2255531|FG001|Overall Study|Converted to open surgery|1
1146999|NCT03020641|2255530|FG000|Overall Study|for surgery not performed|0
1147000|NCT03020641|2255531|FG001|Overall Study|for surgery not performed|1
1147001|NCT03020745|2255557|FG000|Part 2 (Up to 169 Days)|Adverse Event|0
1147002|NCT03020745|2255558|FG001|Part 2 (Up to 169 Days)|Adverse Event|0
1147003|NCT03020745|2255559|FG002|Part 2 (Up to 169 Days)|Adverse Event|0
1147004|NCT03020745|2255560|FG003|Part 2 (Up to 169 Days)|Adverse Event|0
1147005|NCT03020745|2255561|FG004|Part 2 (Up to 169 Days)|Adverse Event|0
1147006|NCT03020745|2255562|FG005|Part 2 (Up to 169 Days)|Adverse Event|0
1147007|NCT03020745|2255563|FG006|Part 2 (Up to 169 Days)|Adverse Event|0
1147008|NCT03020745|2255564|FG007|Part 2 (Up to 169 Days)|Adverse Event|0
1147009|NCT03020745|2255565|FG008|Part 2 (Up to 169 Days)|Adverse Event|1
1147010|NCT03020745|2255566|FG009|Part 2 (Up to 169 Days)|Adverse Event|0
1147011|NCT03020745|2255557|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
1147012|NCT03020745|2255558|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
1147013|NCT03020745|2255559|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
1147014|NCT03020745|2255560|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
1147015|NCT03020745|2255561|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
1147016|NCT03020745|2255562|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
1147017|NCT03020745|2255563|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
1147018|NCT03020745|2255564|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1
1147019|NCT03020745|2255565|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
1147020|NCT03020745|2255566|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
1147021|NCT03020745|2255557|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
1147022|NCT03020745|2255558|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
1147023|NCT03020745|2255559|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
1147024|NCT03020745|2255560|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
1147025|NCT03020745|2255561|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
1147026|NCT03020745|2255562|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
1147027|NCT03020745|2255563|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
1147028|NCT03020745|2255564|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
1147029|NCT03020745|2255565|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
1147030|NCT03020745|2255566|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
1147031|NCT03020745|2255557|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
1147032|NCT03020745|2255558|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
1147033|NCT03020745|2255559|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
1147034|NCT03020745|2255560|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
1147035|NCT03020745|2255561|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
1147036|NCT03020745|2255562|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
1147037|NCT03020745|2255563|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
1147038|NCT03020745|2255564|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
1147039|NCT03020745|2255565|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2
1147040|NCT03020745|2255566|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
1147041|NCT03020888|2255590|FG000|Overall Study|Physician Decision|4
1147042|NCT03020888|2255590|FG000|Overall Study|Withdrawal by Subject|6
1147043|NCT03020888|2255590|FG000|Overall Study|Insurance coverage|2
1147044|NCT03020888|2255590|FG000|Overall Study|Lost to Follow-up|1
1147045|NCT03020966|2255596|FG000|Overall Study|Withdrawal by Subject|2
1147046|NCT03020966|2255597|FG001|Overall Study|Withdrawal by Subject|0
1147047|NCT03020992|2255603|FG000|Overall Study|Adverse Event|5
1147048|NCT03020992|2255603|FG000|Overall Study|Withdrawal by Subject|1
1147049|NCT03021005|2255610|FG000|Overall Study|Lost to Follow-up|39
1147050|NCT03021005|2255611|FG001|Overall Study|Lost to Follow-up|26
1147051|NCT03021018|2255620|FG000|Overall Study|Adverse Event|1
1147052|NCT03021018|2255621|FG001|Overall Study|Adverse Event|0
1147053|NCT03021018|2255622|FG002|Overall Study|Adverse Event|0
1147054|NCT03021018|2255620|FG000|Overall Study|Fall with subsequent nasal fracture|1
1147055|NCT03021018|2255621|FG001|Overall Study|Fall with subsequent nasal fracture|0
1147056|NCT03021018|2255622|FG002|Overall Study|Fall with subsequent nasal fracture|0
1147057|NCT03021187|2255634|FG000|Overall Study|Death|0
1147058|NCT03021187|2255635|FG001|Overall Study|Death|0
1147059|NCT03021187|2255636|FG002|Overall Study|Death|3
1147060|NCT03021187|2255637|FG003|Overall Study|Death|0
1147061|NCT03021187|2255634|FG000|Overall Study|Withdrawal by Subject|0
1147062|NCT03021187|2255635|FG001|Overall Study|Withdrawal by Subject|6
1147063|NCT03021187|2255636|FG002|Overall Study|Withdrawal by Subject|2
1147064|NCT03021187|2255637|FG003|Overall Study|Withdrawal by Subject|5
1147065|NCT03021187|2255634|FG000|Overall Study|Lost to Follow-up|10
1147066|NCT03021187|2255635|FG001|Overall Study|Lost to Follow-up|3
1147067|NCT03021187|2255636|FG002|Overall Study|Lost to Follow-up|1
1147068|NCT03021187|2255637|FG003|Overall Study|Lost to Follow-up|4
1147069|NCT03021265|2255647|FG000|Overall Study|Adverse Event|29
1147070|NCT03021265|2255647|FG000|Overall Study|Lack of Efficacy|3
1147071|NCT03021265|2255647|FG000|Overall Study|Improved|17
1147072|NCT03021265|2255647|FG000|Overall Study|Lost to Follow-up|67
1147073|NCT03021265|2255647|FG000|Overall Study|No reason given|2
1147074|NCT03021265|2255647|FG000|Overall Study|No visit since the first visit|4
1147075|NCT03021304|2255651|FG000|Overall Study|Lack of Efficacy|1
1147076|NCT03021499|2255666|FG000|Overall Study|Adverse Event|1
1147077|NCT03021499|2255667|FG001|Overall Study|Adverse Event|0
1147078|NCT03021499|2255666|FG000|Overall Study|Death|1
1147079|NCT03021499|2255667|FG001|Overall Study|Death|5
1147080|NCT03021499|2255666|FG000|Overall Study|Lack of Efficacy|0
1147081|NCT03021499|2255667|FG001|Overall Study|Lack of Efficacy|1
1147082|NCT03021499|2255666|FG000|Overall Study|Lost to Follow-up|1
1147083|NCT03021499|2255667|FG001|Overall Study|Lost to Follow-up|3
1147084|NCT03021499|2255666|FG000|Overall Study|Physician Decision|2
1147085|NCT03021499|2255667|FG001|Overall Study|Physician Decision|3
1147086|NCT03021499|2255666|FG000|Overall Study|Pregnancy|1
1147087|NCT03021499|2255667|FG001|Overall Study|Pregnancy|0
1147088|NCT03021499|2255666|FG000|Overall Study|Withdrawal by Subject|7
1147089|NCT03021499|2255667|FG001|Overall Study|Withdrawal by Subject|14
1147090|NCT03021499|2255666|FG000|Overall Study|Prohibited medication required|1
1147091|NCT03021499|2255667|FG001|Overall Study|Prohibited medication required|0
1147092|NCT03021499|2255666|FG000|Overall Study|Protocol non-compliance|1
1147093|NCT03021499|2255667|FG001|Overall Study|Protocol non-compliance|1
1147094|NCT03021499|2255666|FG000|Overall Study|None of the above|0
1147095|NCT03021499|2255667|FG001|Overall Study|None of the above|4
1147096|NCT03021499|2255666|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1
1147097|NCT03021499|2255667|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0
1147098|NCT03021564|2255686|FG000|Overall Study|Death|84
1147099|NCT03021564|2255687|FG001|Overall Study|Death|466
1147100|NCT03021564|2255686|FG000|Overall Study|Lost to Follow-up|0
1147101|NCT03021564|2255687|FG001|Overall Study|Lost to Follow-up|2
1147102|NCT03021642|2255697|FG000|Washout Period (21 Days)|Adverse Event|1
1147103|NCT03021642|2255698|FG001|Washout Period (21 Days)|Adverse Event|1
1147104|NCT03021668|2255706|FG000|Overall Study|Physician Decision|0
1147105|NCT03021668|2255707|FG001|Overall Study|Physician Decision|1
1147106|NCT03022045|2255728|FG000|Overall Study|Adverse Event|0
1147107|NCT03022045|2255729|FG001|Overall Study|Adverse Event|1
1147108|NCT03022045|2255728|FG000|Overall Study|Withdrawal by Subject|1
1147109|NCT03022045|2255729|FG001|Overall Study|Withdrawal by Subject|1
1147110|NCT03022084|2255741|FG000|Overall Study|Lost to Follow-up|2
1147111|NCT03022084|2255742|FG001|Overall Study|Lost to Follow-up|3
1147112|NCT03022370|2255752|FG000|Overall Study|Death|6
1147113|NCT03022370|2255753|FG001|Overall Study|Death|12
1147114|NCT03022370|2255752|FG000|Overall Study|Lost to Follow-up|174
1147115|NCT03022370|2255753|FG001|Overall Study|Lost to Follow-up|109
1147116|NCT03022422|2255794|FG000|Overall Study|3 subjects consented but not vaccinated|0
1147117|NCT03022422|2255795|FG001|Overall Study|3 subjects consented but not vaccinated|0
1147118|NCT03022422|2255796|FG002|Overall Study|3 subjects consented but not vaccinated|3
1147119|NCT03022422|2255797|FG003|Overall Study|3 subjects consented but not vaccinated|0
1147120|NCT03022422|2255798|FG004|Overall Study|3 subjects consented but not vaccinated|0
1147121|NCT03022422|2255799|FG005|Overall Study|3 subjects consented but not vaccinated|0
1147122|NCT03022630|2255854|FG000|Overall Study|Death|9
1147123|NCT03022630|2255855|FG001|Overall Study|Death|7
1147124|NCT03022630|2255854|FG000|Overall Study|Withdrawal by Subject|0
1147125|NCT03022630|2255855|FG001|Overall Study|Withdrawal by Subject|5
1147126|NCT03022799|2255879|FG000|Overall Study|Adverse Event|0
1147127|NCT03022799|2255880|FG001|Overall Study|Adverse Event|0
1147128|NCT03022799|2255881|FG002|Overall Study|Adverse Event|0
1147129|NCT03022799|2255882|FG003|Overall Study|Adverse Event|0
1147130|NCT03022799|2255883|FG004|Overall Study|Adverse Event|0
1147131|NCT03022799|2255884|FG005|Overall Study|Adverse Event|0
1147132|NCT03022799|2255885|FG006|Overall Study|Adverse Event|0
1147133|NCT03022799|2255886|FG007|Overall Study|Adverse Event|0
1147134|NCT03022799|2255887|FG008|Overall Study|Adverse Event|0
1147135|NCT03022799|2255888|FG009|Overall Study|Adverse Event|1
1147136|NCT03022799|2255889|FG010|Overall Study|Adverse Event|1
1147137|NCT03022799|2255890|FG011|Overall Study|Adverse Event|0
1147138|NCT03022799|2255891|FG012|Overall Study|Adverse Event|0
1147139|NCT03022981|2255949|FG000|Overall Study|Adverse Event|0
1147140|NCT03022981|2255950|FG001|Overall Study|Adverse Event|1
1147141|NCT03022981|2255951|FG002|Overall Study|Adverse Event|0
1147142|NCT03022981|2255949|FG000|Overall Study|Investigator's Discretion|0
1147143|NCT03022981|2255950|FG001|Overall Study|Investigator's Discretion|1
1147144|NCT03022981|2255951|FG002|Overall Study|Investigator's Discretion|2
1147145|NCT03022981|2255949|FG000|Overall Study|Lost to Follow-up|6
1147146|NCT03022981|2255950|FG001|Overall Study|Lost to Follow-up|2
1147147|NCT03022981|2255951|FG002|Overall Study|Lost to Follow-up|1
1147148|NCT03022981|2255949|FG000|Overall Study|Non-Compliance With Study Drug|0
1147149|NCT03022981|2255950|FG001|Overall Study|Non-Compliance With Study Drug|0
1147150|NCT03022981|2255951|FG002|Overall Study|Non-Compliance With Study Drug|2
1147151|NCT03022981|2255949|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0
1147152|NCT03022981|2255950|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0
1147153|NCT03022981|2255951|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1
1147154|NCT03023137|2255971|FG000|Overall Study|Multiple pregnancy|2
1147155|NCT03023137|2255972|FG001|Overall Study|Multiple pregnancy|4
1147156|NCT03023137|2255971|FG000|Overall Study|Lost to Follow-up|1
1147157|NCT03023137|2255972|FG001|Overall Study|Lost to Follow-up|1
1147158|NCT03023137|2255971|FG000|Overall Study|Protocol Violation|0
1147159|NCT03023137|2255972|FG001|Overall Study|Protocol Violation|4
1147160|NCT03023137|2255971|FG000|Overall Study|Lost the baby in a car accident|1
1147161|NCT03023137|2255972|FG001|Overall Study|Lost the baby in a car accident|0
1147162|NCT03023397|2255986|FG000|Run-In|Failed screening allergen challenge|1
1147163|NCT03023397|2255987|FG001|Run-In|Failed screening allergen challenge|0
1147164|NCT03023397|2255988|FG002|Run-In|Failed screening allergen challenge|0
1147165|NCT03023397|2255986|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1
1147166|NCT03023397|2255987|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
1147167|NCT03023397|2255988|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
1147168|NCT03023423|2256000|FG000|Overall Study|Death|5
1147169|NCT03023423|2256001|FG001|Overall Study|Death|12
1147170|NCT03023423|2256002|FG002|Overall Study|Death|20
1147171|NCT03023423|2256000|FG000|Overall Study|Other|0
1147172|NCT03023423|2256001|FG001|Overall Study|Other|2
1147173|NCT03023423|2256002|FG002|Overall Study|Other|2
1147174|NCT03023423|2256000|FG000|Overall Study|Ongoing|2
1147175|NCT03023423|2256001|FG001|Overall Study|Ongoing|32
1147176|NCT03023423|2256002|FG002|Overall Study|Ongoing|24
1147177|NCT03023722|2256053|FG000|Overall Study|No follow-up assessment|4
1147178|NCT03023813|2256060|FG000|Overall Study|Lost to Follow-up|1
1147179|NCT03023813|2256061|FG001|Overall Study|Lost to Follow-up|2
1147180|NCT03023813|2256062|FG002|Overall Study|Lost to Follow-up|0
1147181|NCT03023826|2256070|FG000|Period 1|Withdrawal by Subject|0
1147182|NCT03023826|2256071|FG001|Period 1|Withdrawal by Subject|0
1147183|NCT03023826|2256072|FG002|Period 1|Withdrawal by Subject|0
1147184|NCT03023826|2256073|FG003|Period 1|Withdrawal by Subject|0
1147185|NCT03023826|2256074|FG004|Period 1|Withdrawal by Subject|1
1147186|NCT03023826|2256075|FG005|Period 1|Withdrawal by Subject|0
1147187|NCT03023878|2256083|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11
1147188|NCT03023878|2256083|FG000|Pre-Study Run-In Period|Death|1
1147189|NCT03023878|2256083|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5
1147190|NCT03023878|2256083|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2
1147191|NCT03023878|2256083|FG000|Treatment Period|Disease Progression|1
1147192|NCT03023878|2256083|FG000|Treatment Period|Withdrawal by Subject|1
1147193|NCT03023878|2256083|FG000|Treatment Period|Adverse Event|1
1147194|NCT03023878|2256083|FG000|Long Term Follow-Up Period|Death|2
1147195|NCT03024606|2256102|FG000|Overall Study|Withdrawal by Subject|9
1147196|NCT03024606|2256103|FG001|Overall Study|Withdrawal by Subject|10
1147197|NCT03024970|2256109|FG000|First Intervention|Adverse Event|1
1147198|NCT03024970|2256110|FG001|First Intervention|Adverse Event|0
1147199|NCT03024970|2256109|FG000|Second Intervention|Lost to Follow-up|1
1147200|NCT03024970|2256110|FG001|Second Intervention|Lost to Follow-up|0
1147201|NCT03025217|2256116|FG000|Overall Study|Pregnancy|1
1147202|NCT03025217|2256116|FG000|Overall Study|Lost to Follow-up|1
1147203|NCT03025217|2256116|FG000|Overall Study|Not eligible, poor English|2
1147210|NCT03026075|2256142|FG000|Overall Study|Physician Decision|1
1147211|NCT03026088|2256146|FG000|Overall Study|Study termination|20
1147212|NCT03026166|2256152|FG000|Overall Study|Death|22
1147213|NCT03026166|2256153|FG001|Overall Study|Death|7
1147214|NCT03026166|2256152|FG000|Overall Study|Physician Decision|2
1147215|NCT03026166|2256153|FG001|Overall Study|Physician Decision|0
1147216|NCT03026166|2256152|FG000|Overall Study|Withdrawal by Subject|1
1147217|NCT03026166|2256153|FG001|Overall Study|Withdrawal by Subject|2
1147218|NCT03026166|2256152|FG000|Overall Study|Lost to Follow-up|1
1147219|NCT03026166|2256153|FG001|Overall Study|Lost to Follow-up|0
1147220|NCT03026166|2256152|FG000|Overall Study|Study Terminated by Sponsor|3
1147221|NCT03026166|2256153|FG001|Overall Study|Study Terminated by Sponsor|3
1147222|NCT03026166|2256152|FG000|Overall Study|Other|1
1147223|NCT03026166|2256153|FG001|Overall Study|Other|0
1147224|NCT03026257|2256165|FG000|Overall Study|Adverse Event|3
1147225|NCT03026257|2256166|FG001|Overall Study|Adverse Event|0
1147226|NCT03026257|2256167|FG002|Overall Study|Adverse Event|0
1147227|NCT03026257|2256168|FG003|Overall Study|Adverse Event|0
1147228|NCT03026257|2256169|FG004|Overall Study|Adverse Event|0
1147229|NCT03026257|2256170|FG005|Overall Study|Adverse Event|0
1147230|NCT03026257|2256165|FG000|Overall Study|Lost to Follow-up|1
1147231|NCT03026257|2256166|FG001|Overall Study|Lost to Follow-up|0
1147232|NCT03026257|2256167|FG002|Overall Study|Lost to Follow-up|0
1147233|NCT03026257|2256168|FG003|Overall Study|Lost to Follow-up|0
1147234|NCT03026257|2256169|FG004|Overall Study|Lost to Follow-up|0
1147235|NCT03026257|2256170|FG005|Overall Study|Lost to Follow-up|0
1147236|NCT03026257|2256165|FG000|Overall Study|Protocol Violation|1
1147237|NCT03026257|2256166|FG001|Overall Study|Protocol Violation|0
1147238|NCT03026257|2256167|FG002|Overall Study|Protocol Violation|0
1147239|NCT03026257|2256168|FG003|Overall Study|Protocol Violation|1
1147240|NCT03026257|2256169|FG004|Overall Study|Protocol Violation|1
1147241|NCT03026257|2256170|FG005|Overall Study|Protocol Violation|0
1147242|NCT03026257|2256165|FG000|Overall Study|Withdrawal by Subject|1
1147243|NCT03026257|2256166|FG001|Overall Study|Withdrawal by Subject|1
1147244|NCT03026257|2256167|FG002|Overall Study|Withdrawal by Subject|0
1147245|NCT03026257|2256168|FG003|Overall Study|Withdrawal by Subject|0
1147246|NCT03026257|2256169|FG004|Overall Study|Withdrawal by Subject|0
1147247|NCT03026257|2256170|FG005|Overall Study|Withdrawal by Subject|0
1147248|NCT03026283|2256184|FG000|CCTA Diagnosis|CCTA not performed as planned|9
1147249|NCT03026283|2256185|FG001|CCTA Diagnosis|CCTA not performed as planned|0
1147250|NCT03026283|2256186|FG002|CCTA Diagnosis|CCTA not performed as planned|0
1147251|NCT03026283|2256187|FG003|CCTA Diagnosis|CCTA not performed as planned|0
1147252|NCT03026283|2256188|FG004|CCTA Diagnosis|CCTA not performed as planned|0
1147253|NCT03026283|2256189|FG005|CCTA Diagnosis|CCTA not performed as planned|0
1147254|NCT03026283|2256190|FG006|CCTA Diagnosis|CCTA not performed as planned|0
1147255|NCT03026283|2256191|FG007|CCTA Diagnosis|CCTA not performed as planned|0
1147256|NCT03026283|2256184|FG000|CCTA Diagnosis|Withdrawal by Subject|5
1147257|NCT03026283|2256185|FG001|CCTA Diagnosis|Withdrawal by Subject|0
1147258|NCT03026283|2256186|FG002|CCTA Diagnosis|Withdrawal by Subject|0
1147259|NCT03026283|2256187|FG003|CCTA Diagnosis|Withdrawal by Subject|0
1147260|NCT03026283|2256188|FG004|CCTA Diagnosis|Withdrawal by Subject|0
1147261|NCT03026283|2256189|FG005|CCTA Diagnosis|Withdrawal by Subject|0
1147262|NCT03026283|2256190|FG006|CCTA Diagnosis|Withdrawal by Subject|0
1147263|NCT03026283|2256191|FG007|CCTA Diagnosis|Withdrawal by Subject|0
1147264|NCT03026283|2256184|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
1147265|NCT03026283|2256185|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3
1147266|NCT03026283|2256186|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
1147267|NCT03026283|2256187|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
1147268|NCT03026283|2256188|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
1147269|NCT03026283|2256189|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
1147270|NCT03026283|2256190|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
1147271|NCT03026283|2256191|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
1147272|NCT03026283|2256184|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
1147273|NCT03026283|2256185|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
1147274|NCT03026283|2256186|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15
1147275|NCT03026283|2256187|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
1147276|NCT03026283|2256188|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
1147277|NCT03026283|2256189|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
1147278|NCT03026283|2256190|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
1147279|NCT03026283|2256191|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
1147280|NCT03026283|2256184|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
1147281|NCT03026283|2256185|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
1147282|NCT03026283|2256186|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
1147283|NCT03026283|2256187|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8
1147284|NCT03026283|2256188|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11
1147285|NCT03026283|2256189|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
1147286|NCT03026283|2256190|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
1147287|NCT03026283|2256191|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
1147288|NCT03026283|2256184|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
1147289|NCT03026283|2256185|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
1147290|NCT03026283|2256186|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
1147291|NCT03026283|2256187|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9
1147292|NCT03026283|2256188|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
1147293|NCT03026283|2256189|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
1147294|NCT03026283|2256190|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
1147295|NCT03026283|2256191|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
1147296|NCT03026283|2256184|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
1147297|NCT03026283|2256185|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
1147298|NCT03026283|2256186|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
1147299|NCT03026283|2256187|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2
1147300|NCT03026283|2256188|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
1147301|NCT03026283|2256189|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7
1147302|NCT03026283|2256190|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
1147303|NCT03026283|2256191|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
1147304|NCT03026283|2256184|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
1147305|NCT03026283|2256185|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
1147306|NCT03026283|2256186|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
1147307|NCT03026283|2256187|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1
1147308|NCT03026283|2256188|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
1147309|NCT03026283|2256189|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
1147310|NCT03026283|2256190|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
1147311|NCT03026283|2256191|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
1147312|NCT03026283|2256184|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
1147313|NCT03026283|2256185|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
1147314|NCT03026283|2256186|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
1147315|NCT03026283|2256187|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
1147316|NCT03026283|2256188|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25
1147317|NCT03026283|2256189|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19
1147318|NCT03026283|2256190|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
1147319|NCT03026283|2256191|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
1147320|NCT03026530|2256206|FG000|Overall Study|Lost to Follow-up|19
1147321|NCT03026530|2256207|FG001|Overall Study|Lost to Follow-up|24
1147322|NCT03026530|2256206|FG000|Overall Study|Protocol Violation|2
1147323|NCT03026530|2256207|FG001|Overall Study|Protocol Violation|5
1147324|NCT03027466|2256244|FG000|Overall Study|Opting out of the app|1869
1147325|NCT03027466|2256245|FG001|Overall Study|Opting out of the app|1819
1147326|NCT03027466|2256246|FG002|Overall Study|Opting out of the app|1743
1147327|NCT03027466|2256247|FG003|Overall Study|Opting out of the app|1821
1147328|NCT03027557|2256260|FG000|Overall Study|Adverse Event|1
1147329|NCT03027557|2256261|FG001|Overall Study|Adverse Event|0
1147330|NCT03027557|2256262|FG002|Overall Study|Adverse Event|0
1147331|NCT03028012|2256282|FG000|Overall Study|Lost to Follow-up|2
1147332|NCT03028012|2256283|FG001|Overall Study|Lost to Follow-up|3
1147333|NCT03028012|2256284|FG002|Overall Study|Lost to Follow-up|3
1147334|NCT03028129|2256317|FG000|Overall Study|Adverse Event|13
1147335|NCT03028129|2256318|FG001|Overall Study|Adverse Event|2
1147336|NCT03028129|2256317|FG000|Overall Study|Lost to Follow-up|50
1147337|NCT03028129|2256318|FG001|Overall Study|Lost to Follow-up|38
1147338|NCT03028129|2256317|FG000|Overall Study|Physician Decision|0
1147339|NCT03028129|2256318|FG001|Overall Study|Physician Decision|1
1147340|NCT03028129|2256317|FG000|Overall Study|Protocol Violation|1
1147341|NCT03028129|2256318|FG001|Overall Study|Protocol Violation|1
1147342|NCT03028129|2256317|FG000|Overall Study|Withdrawal by Subject|62
1147343|NCT03028129|2256318|FG001|Overall Study|Withdrawal by Subject|45
1147344|NCT03028142|2256324|FG000|Overall Study|Adverse Event|1
1147345|NCT03028142|2256325|FG001|Overall Study|Adverse Event|1
1147346|NCT03028142|2256326|FG002|Overall Study|Adverse Event|0
1147347|NCT03028142|2256327|FG003|Overall Study|Adverse Event|0
1147348|NCT03028142|2256328|FG004|Overall Study|Adverse Event|0
1147349|NCT03028142|2256329|FG005|Overall Study|Adverse Event|1
1147350|NCT03028142|2256324|FG000|Overall Study|Withdrawal by Subject|0
1147351|NCT03028142|2256325|FG001|Overall Study|Withdrawal by Subject|0
1147352|NCT03028142|2256326|FG002|Overall Study|Withdrawal by Subject|0
1147353|NCT03028142|2256327|FG003|Overall Study|Withdrawal by Subject|0
1147354|NCT03028142|2256328|FG004|Overall Study|Withdrawal by Subject|1
1147355|NCT03028142|2256329|FG005|Overall Study|Withdrawal by Subject|0
1147356|NCT03028415|2256362|FG000|Overall Study|Lost to Follow-up|6
1147357|NCT03028415|2256363|FG001|Overall Study|Lost to Follow-up|3
1147358|NCT03028415|2256362|FG000|Overall Study|Withdrawal by Subject|1
1147359|NCT03028415|2256363|FG001|Overall Study|Withdrawal by Subject|0
1147360|NCT03028415|2256362|FG000|Overall Study|Discontinued due to COVID-19|1
1147361|NCT03028415|2256363|FG001|Overall Study|Discontinued due to COVID-19|0
1147362|NCT03028870|2256403|FG000|Overall Study|Adverse Event|7
1147363|NCT03028870|2256404|FG001|Overall Study|Adverse Event|4
1147364|NCT03028870|2256405|FG002|Overall Study|Adverse Event|3
1147365|NCT03028870|2256406|FG003|Overall Study|Adverse Event|3
1147366|NCT03028870|2256403|FG000|Overall Study|Withdrawal by Subject|1
1147367|NCT03028870|2256404|FG001|Overall Study|Withdrawal by Subject|1
1147368|NCT03028870|2256405|FG002|Overall Study|Withdrawal by Subject|1
1147369|NCT03028870|2256406|FG003|Overall Study|Withdrawal by Subject|2
1147370|NCT03028870|2256403|FG000|Overall Study|Lost to Follow-up|1
1147371|NCT03028870|2256404|FG001|Overall Study|Lost to Follow-up|0
1147372|NCT03028870|2256405|FG002|Overall Study|Lost to Follow-up|0
1147373|NCT03028870|2256406|FG003|Overall Study|Lost to Follow-up|0
1147374|NCT03028870|2256403|FG000|Overall Study|Lack of Efficacy|3
1147375|NCT03028870|2256404|FG001|Overall Study|Lack of Efficacy|0
1147376|NCT03028870|2256405|FG002|Overall Study|Lack of Efficacy|0
1147377|NCT03028870|2256406|FG003|Overall Study|Lack of Efficacy|0
1147378|NCT03028870|2256403|FG000|Overall Study|Administrative|5
1147379|NCT03028870|2256404|FG001|Overall Study|Administrative|5
1147380|NCT03028870|2256405|FG002|Overall Study|Administrative|12
1147381|NCT03028870|2256406|FG003|Overall Study|Administrative|4
1147382|NCT03029143|2256473|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8
1147383|NCT03029143|2256474|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
1147384|NCT03029143|2256475|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
1147385|NCT03029143|2256473|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12
1147386|NCT03029143|2256474|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
1147387|NCT03029143|2256475|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
1147388|NCT03029143|2256473|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1
1147389|NCT03029143|2256474|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0
1147390|NCT03029143|2256475|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0
1147391|NCT03029143|2256473|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6
1147392|NCT03029143|2256474|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
1147393|NCT03029143|2256475|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
1147394|NCT03029143|2256473|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142
1147395|NCT03029143|2256474|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0
1147396|NCT03029143|2256475|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0
1147397|NCT03029143|2256473|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0
1147398|NCT03029143|2256474|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3
1147399|NCT03029143|2256475|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9
1147400|NCT03029143|2256473|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0
1147401|NCT03029143|2256474|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1
1147402|NCT03029143|2256475|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3
1147403|NCT03029143|2256473|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0
1147404|NCT03029143|2256474|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1
1147405|NCT03029143|2256475|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3
1147406|NCT03029143|2256473|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0
1147407|NCT03029143|2256474|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10
1147408|NCT03029143|2256475|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1
1147409|NCT03029143|2256473|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0
1147410|NCT03029143|2256474|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6
1147411|NCT03029143|2256475|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7
1147412|NCT03029143|2256473|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0
1147413|NCT03029143|2256474|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2
1147414|NCT03029143|2256475|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1
1147415|NCT03029208|2256486|FG000|Overall Study|Withdrawal by Subject|2
1147416|NCT03029208|2256487|FG001|Overall Study|Withdrawal by Subject|3
1147417|NCT03029208|2256486|FG000|Overall Study|Lost to Follow-up|0
1147418|NCT03029208|2256487|FG001|Overall Study|Lost to Follow-up|1
1147419|NCT03029247|2256504|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3
1147420|NCT03029247|2256505|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0
1147421|NCT03029247|2256504|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
1147422|NCT03029247|2256505|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
1147423|NCT03029247|2256504|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7
1147424|NCT03029247|2256505|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4
1147425|NCT03029247|2256504|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
1147426|NCT03029247|2256505|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
1147427|NCT03029585|2256513|FG000|Overall Study|Death|1
1147428|NCT03029585|2256514|FG001|Overall Study|Death|1
1147429|NCT03029585|2256513|FG000|Overall Study|Withdrawal by Subject|1
1147430|NCT03029585|2256514|FG001|Overall Study|Withdrawal by Subject|0
1147431|NCT03029624|2256520|FG000|Overall Study|Adverse Event|1
1147432|NCT03029624|2256520|FG000|Overall Study|Withdrawal by Subject|1
1147433|NCT03029624|2256520|FG000|Overall Study|Lack of Efficacy|1
1147434|NCT03029624|2256520|FG000|Overall Study|MRI need|2
1147435|NCT03029650|2256526|FG000|Washout (1 Week)|Withdrawal by Subject|1
1147436|NCT03029650|2256527|FG001|Washout (1 Week)|Withdrawal by Subject|1
1147437|NCT03029650|2256526|FG000|Washout (1 Week)|Physician Decision|0
1147438|NCT03029650|2256527|FG001|Washout (1 Week)|Physician Decision|1
1147439|NCT03029780|2256548|FG000|Overall Study|Disease Progression|1
1147440|NCT03029780|2256549|FG001|Overall Study|Disease Progression|3
1147441|NCT03029780|2256548|FG000|Overall Study|Study Drug Toxicity|5
1147442|NCT03029780|2256549|FG001|Overall Study|Study Drug Toxicity|5
1162103|NCT03383146|2284115|FG000|Overall Study|Protocol Deviation|1
1147443|NCT03029780|2256548|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0
1147444|NCT03029780|2256549|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
1147445|NCT03029819|2256557|FG000|Overall Study|Lost to Follow-up|3
1147446|NCT03029819|2256558|FG001|Overall Study|Lost to Follow-up|5
1147447|NCT03029819|2256557|FG000|Overall Study|Removed due to disruptive behavior|0
1147448|NCT03029819|2256558|FG001|Overall Study|Removed due to disruptive behavior|1
1147449|NCT03030599|2256576|FG000|Open Label Treatment and Titration|Protocol deviation|8
1147450|NCT03030599|2256577|FG001|Open Label Treatment and Titration|Protocol deviation|0
1147451|NCT03030599|2256578|FG002|Open Label Treatment and Titration|Protocol deviation|0
1147452|NCT03030599|2256576|FG000|Open Label Treatment and Titration|Other|1
1147453|NCT03030599|2256577|FG001|Open Label Treatment and Titration|Other|0
1147454|NCT03030599|2256578|FG002|Open Label Treatment and Titration|Other|0
1147455|NCT03030599|2256576|FG000|Open Label Treatment and Titration|Physician Decision|3
1147456|NCT03030599|2256577|FG001|Open Label Treatment and Titration|Physician Decision|0
1147457|NCT03030599|2256578|FG002|Open Label Treatment and Titration|Physician Decision|0
1147458|NCT03030599|2256576|FG000|Open Label Treatment and Titration|Lack of Efficacy|1
1147459|NCT03030599|2256577|FG001|Open Label Treatment and Titration|Lack of Efficacy|0
1147460|NCT03030599|2256578|FG002|Open Label Treatment and Titration|Lack of Efficacy|0
1147461|NCT03030599|2256576|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4
1147462|NCT03030599|2256577|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
1147463|NCT03030599|2256578|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
1147464|NCT03030599|2256576|FG000|Open Label Treatment and Titration|Adverse Event|18
1147465|NCT03030599|2256577|FG001|Open Label Treatment and Titration|Adverse Event|0
1147466|NCT03030599|2256578|FG002|Open Label Treatment and Titration|Adverse Event|0
1147467|NCT03030599|2256576|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6
1147468|NCT03030599|2256577|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0
1147469|NCT03030599|2256578|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0
1147470|NCT03030599|2256576|FG000|Open Label Treatment and Titration|Sponsor decision|2
1147471|NCT03030599|2256577|FG001|Open Label Treatment and Titration|Sponsor decision|0
1147472|NCT03030599|2256578|FG002|Open Label Treatment and Titration|Sponsor decision|0
1147473|NCT03030599|2256576|FG000|Open Label Treatment and Titration|Lost to Follow-up|3
1147474|NCT03030599|2256577|FG001|Open Label Treatment and Titration|Lost to Follow-up|0
1147475|NCT03030599|2256578|FG002|Open Label Treatment and Titration|Lost to Follow-up|0
1147476|NCT03030599|2256576|FG000|Stable Dose|Protocol deviation|3
1147477|NCT03030599|2256577|FG001|Stable Dose|Protocol deviation|0
1147478|NCT03030599|2256578|FG002|Stable Dose|Protocol deviation|0
1147479|NCT03030599|2256576|FG000|Stable Dose|Adverse Event|1
1147480|NCT03030599|2256577|FG001|Stable Dose|Adverse Event|0
1147481|NCT03030599|2256578|FG002|Stable Dose|Adverse Event|0
1147482|NCT03030599|2256576|FG000|Stable Dose|Lost to Follow-up|1
1147483|NCT03030599|2256577|FG001|Stable Dose|Lost to Follow-up|0
1147484|NCT03030599|2256578|FG002|Stable Dose|Lost to Follow-up|0
1147485|NCT03030599|2256576|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0
1147486|NCT03030599|2256577|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0
1147487|NCT03030599|2256578|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2
1147488|NCT03030599|2256576|FG000|Double Blind Randomized Withdrawal|Adverse Event|0
1147489|NCT03030599|2256577|FG001|Double Blind Randomized Withdrawal|Adverse Event|0
1147490|NCT03030599|2256578|FG002|Double Blind Randomized Withdrawal|Adverse Event|3
1147491|NCT03030599|2256576|FG000|Double Blind Randomized Withdrawal|Randomized in error|0
1147492|NCT03030599|2256577|FG001|Double Blind Randomized Withdrawal|Randomized in error|0
1147493|NCT03030599|2256578|FG002|Double Blind Randomized Withdrawal|Randomized in error|2
1147494|NCT03030599|2256576|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
1147495|NCT03030599|2256577|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
1147496|NCT03030599|2256578|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1
1147497|NCT03030599|2256576|FG000|Open-label Extension|Adverse Event|3
1147498|NCT03030599|2256577|FG001|Open-label Extension|Adverse Event|0
1147499|NCT03030599|2256578|FG002|Open-label Extension|Adverse Event|0
1147500|NCT03030599|2256576|FG000|Open-label Extension|Lost to Follow-up|2
1147501|NCT03030599|2256577|FG001|Open-label Extension|Lost to Follow-up|0
1147502|NCT03030599|2256578|FG002|Open-label Extension|Lost to Follow-up|0
1147503|NCT03030599|2256576|FG000|Open-label Extension|Lack of Efficacy|1
1147504|NCT03030599|2256577|FG001|Open-label Extension|Lack of Efficacy|0
1147505|NCT03030599|2256578|FG002|Open-label Extension|Lack of Efficacy|0
1147506|NCT03030599|2256576|FG000|Open-label Extension|Other Reason|1
1147507|NCT03030599|2256577|FG001|Open-label Extension|Other Reason|0
1147508|NCT03030599|2256578|FG002|Open-label Extension|Other Reason|0
1147509|NCT03030989|2256621|FG000|Overall Study|Fever|2
1147510|NCT03030989|2256622|FG001|Overall Study|Fever|2
1147511|NCT03030989|2256621|FG000|Overall Study|Rash|2
1147512|NCT03030989|2256622|FG001|Overall Study|Rash|1
1147513|NCT03030989|2256621|FG000|Overall Study|Fatigue/Overwhelmed|1
1147514|NCT03030989|2256622|FG001|Overall Study|Fatigue/Overwhelmed|5
1147515|NCT03030989|2256621|FG000|Overall Study|Positive Blood Cultures|2
1147516|NCT03030989|2256622|FG001|Overall Study|Positive Blood Cultures|1
1147517|NCT03030989|2256621|FG000|Overall Study|Line Removed|0
1147518|NCT03030989|2256622|FG001|Overall Study|Line Removed|2
1147519|NCT03030989|2256621|FG000|Overall Study|No longer interested|5
1147520|NCT03030989|2256622|FG001|Overall Study|No longer interested|3
1147521|NCT03031431|2256628|FG000|Overall Study|Infant removed by maternal request|1
1147522|NCT03031496|2256632|FG000|Period 1|Adverse Event|2
1147523|NCT03031496|2256633|FG001|Period 1|Adverse Event|0
1147524|NCT03031496|2256632|FG000|Period 1|Withdrawal by Subject|0
1147525|NCT03031496|2256633|FG001|Period 1|Withdrawal by Subject|2
1147526|NCT03031678|2256639|FG000|Overall Study|Study closed prior to completion|1
1147527|NCT03031899|2256656|FG000|Overall Study|Protocol Violation|1
1147528|NCT03031899|2256656|FG000|Overall Study|lesion disappeared after stopping habit|1
1147529|NCT03031938|2256666|FG000|Overall Study|Death|1
1147530|NCT03031938|2256667|FG001|Overall Study|Death|0
1147531|NCT03032380|2256695|FG000|Overall Study|Adverse Event|0
1147532|NCT03032380|2256696|FG001|Overall Study|Adverse Event|1
1147533|NCT03032380|2256695|FG000|Overall Study|Lack of Efficacy|1
1147534|NCT03032380|2256696|FG001|Overall Study|Lack of Efficacy|0
1147535|NCT03032380|2256695|FG000|Overall Study|Withdrawal by Subject|2
1147536|NCT03032380|2256696|FG001|Overall Study|Withdrawal by Subject|3
1147537|NCT03032380|2256695|FG000|Overall Study|Recovery|0
1147538|NCT03032380|2256696|FG001|Overall Study|Recovery|1
1147539|NCT03032380|2256695|FG000|Overall Study|Death|39
1147540|NCT03032380|2256696|FG001|Overall Study|Death|34
1147541|NCT03032380|2256695|FG000|Overall Study|Other - Miscellaneous|0
1147542|NCT03032380|2256696|FG001|Overall Study|Other - Miscellaneous|1
1147553|NCT03032523|2256726|FG000|Overall Study|Withdrawal by Subject|2
1147554|NCT03032523|2256727|FG001|Overall Study|Withdrawal by Subject|2
1147555|NCT03032523|2256726|FG000|Overall Study|Physician Decision|1
1147556|NCT03032523|2256727|FG001|Overall Study|Physician Decision|0
1147561|NCT03033394|2256776|FG000|Completed Pharmacokinetic Analysis|Missing data|1
1147562|NCT03033394|2256776|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3
1147563|NCT03033394|2256776|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1
1147564|NCT03033394|2256776|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1
1147565|NCT03033394|2256776|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1
1147566|NCT03033784|2256816|FG000|Overall Study|Anxiety related to MRI scanner|0
1147567|NCT03033784|2256817|FG001|Overall Study|Anxiety related to MRI scanner|1
1147568|NCT03033784|2256818|FG002|Overall Study|Anxiety related to MRI scanner|0
1147569|NCT03033784|2256819|FG003|Overall Study|Anxiety related to MRI scanner|0
1147570|NCT03033784|2256820|FG004|Overall Study|Anxiety related to MRI scanner|0
1147571|NCT03033784|2256821|FG005|Overall Study|Anxiety related to MRI scanner|0
1147572|NCT03033784|2256822|FG006|Overall Study|Anxiety related to MRI scanner|0
1147573|NCT03033784|2256823|FG007|Overall Study|Anxiety related to MRI scanner|0
1147574|NCT03033784|2256824|FG008|Overall Study|Anxiety related to MRI scanner|0
1147575|NCT03033784|2256825|FG009|Overall Study|Anxiety related to MRI scanner|0
1147576|NCT03033784|2256826|FG010|Overall Study|Anxiety related to MRI scanner|0
1147577|NCT03033784|2256827|FG011|Overall Study|Anxiety related to MRI scanner|0
1147578|NCT03033784|2256828|FG012|Overall Study|Anxiety related to MRI scanner|0
1147579|NCT03033784|2256816|FG000|Overall Study|Withdrawal by Subject|0
1147580|NCT03033784|2256817|FG001|Overall Study|Withdrawal by Subject|0
1147581|NCT03033784|2256818|FG002|Overall Study|Withdrawal by Subject|0
1147582|NCT03033784|2256819|FG003|Overall Study|Withdrawal by Subject|0
1147583|NCT03033784|2256820|FG004|Overall Study|Withdrawal by Subject|0
1147584|NCT03033784|2256821|FG005|Overall Study|Withdrawal by Subject|0
1147585|NCT03033784|2256822|FG006|Overall Study|Withdrawal by Subject|0
1147586|NCT03033784|2256823|FG007|Overall Study|Withdrawal by Subject|0
1147587|NCT03033784|2256824|FG008|Overall Study|Withdrawal by Subject|0
1147588|NCT03033784|2256825|FG009|Overall Study|Withdrawal by Subject|0
1147589|NCT03033784|2256826|FG010|Overall Study|Withdrawal by Subject|0
1147590|NCT03033784|2256827|FG011|Overall Study|Withdrawal by Subject|0
1147591|NCT03033784|2256828|FG012|Overall Study|Withdrawal by Subject|2
1147592|NCT03034044|2256848|FG000|Overall Study|Enrolled, but not received Xyntha|1
1147593|NCT03034057|2256852|FG000|Overall Study|Withdrawal by Subject|10
1147594|NCT03034057|2256852|FG000|Overall Study|Protocol Violation|1
1147595|NCT03034057|2256852|FG000|Overall Study|Not defined|2
1147596|NCT03034057|2256852|FG000|Overall Study|Lost to Follow-up|19
1147597|NCT03034057|2256852|FG000|Overall Study|Adverse Event|22
1147598|NCT03034057|2256852|FG000|Overall Study|Medication error without associated AE|1
1147599|NCT03034135|2256856|FG000|Overall Study|Withdrawal by Subject|2
1147600|NCT03034460|2256862|FG000|Overall Study|Adverse Event|0
1147601|NCT03034460|2256863|FG001|Overall Study|Adverse Event|1
1147602|NCT03034460|2256862|FG000|Overall Study|Withdrawal by Subject|2
1147603|NCT03034460|2256863|FG001|Overall Study|Withdrawal by Subject|2
1147604|NCT03034460|2256862|FG000|Overall Study|Personal Reasons|1
1147605|NCT03034460|2256863|FG001|Overall Study|Personal Reasons|0
1147606|NCT03034577|2256875|FG000|Overall Study|Withdrawal by Subject|6
1147607|NCT03034577|2256876|FG001|Overall Study|Withdrawal by Subject|9
1147608|NCT03034577|2256875|FG000|Overall Study|Lost to Follow-up|25
1147609|NCT03034577|2256876|FG001|Overall Study|Lost to Follow-up|26
1147610|NCT03034772|2256886|FG000|Overall Study|Adverse Event|0
1147611|NCT03034772|2256887|FG001|Overall Study|Adverse Event|1
1147612|NCT03034772|2256886|FG000|Overall Study|Withdrawal by Subject|0
1147613|NCT03034772|2256887|FG001|Overall Study|Withdrawal by Subject|1
1147614|NCT03034915|2256896|FG000|Overall Study|Adverse Event|29
1147615|NCT03034915|2256897|FG001|Overall Study|Adverse Event|32
1147616|NCT03034915|2256898|FG002|Overall Study|Adverse Event|22
1147617|NCT03034915|2256896|FG000|Overall Study|Lost to Follow-up|5
1147618|NCT03034915|2256897|FG001|Overall Study|Lost to Follow-up|13
1147619|NCT03034915|2256898|FG002|Overall Study|Lost to Follow-up|3
1147620|NCT03034915|2256896|FG000|Overall Study|Withdrawal by Subject|29
1147621|NCT03034915|2256897|FG001|Overall Study|Withdrawal by Subject|46
1147622|NCT03034915|2256898|FG002|Overall Study|Withdrawal by Subject|41
1147623|NCT03034915|2256896|FG000|Overall Study|Protocol Deviation|2
1147624|NCT03034915|2256897|FG001|Overall Study|Protocol Deviation|14
1147625|NCT03034915|2256898|FG002|Overall Study|Protocol Deviation|7
1147626|NCT03034915|2256896|FG000|Overall Study|Lack of Efficacy|8
1147627|NCT03034915|2256897|FG001|Overall Study|Lack of Efficacy|16
1147628|NCT03034915|2256898|FG002|Overall Study|Lack of Efficacy|18
1147629|NCT03034915|2256896|FG000|Overall Study|Site closed|2
1147630|NCT03034915|2256897|FG001|Overall Study|Site closed|2
1147631|NCT03034915|2256898|FG002|Overall Study|Site closed|4
1147632|NCT03034915|2256896|FG000|Overall Study|Protocol-defined withdrawal criteria met|19
1147633|NCT03034915|2256897|FG001|Overall Study|Protocol-defined withdrawal criteria met|26
1147634|NCT03034915|2256898|FG002|Overall Study|Protocol-defined withdrawal criteria met|29
1147635|NCT03034915|2256896|FG000|Overall Study|Physician Decision|1
1147636|NCT03034915|2256897|FG001|Overall Study|Physician Decision|5
1147637|NCT03034915|2256898|FG002|Overall Study|Physician Decision|2
1147638|NCT03034954|2256920|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1
1147639|NCT03034954|2256921|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0
1147640|NCT03034967|2256933|FG000|Overall Study|Withdrawal by Subject|9
1147641|NCT03034967|2256934|FG001|Overall Study|Withdrawal by Subject|2
1147642|NCT03034967|2256935|FG002|Overall Study|Withdrawal by Subject|6
1147643|NCT03034967|2256936|FG003|Overall Study|Withdrawal by Subject|6
1147644|NCT03034967|2256937|FG004|Overall Study|Withdrawal by Subject|9
1147645|NCT03034967|2256938|FG005|Overall Study|Withdrawal by Subject|2
1147646|NCT03034967|2256933|FG000|Overall Study|Physician Decision|1
1147647|NCT03034967|2256934|FG001|Overall Study|Physician Decision|0
1147648|NCT03034967|2256935|FG002|Overall Study|Physician Decision|1
1147649|NCT03034967|2256936|FG003|Overall Study|Physician Decision|1
1147650|NCT03034967|2256937|FG004|Overall Study|Physician Decision|1
1147651|NCT03034967|2256938|FG005|Overall Study|Physician Decision|0
1147652|NCT03034967|2256933|FG000|Overall Study|Lost to Follow-up|0
1147653|NCT03034967|2256934|FG001|Overall Study|Lost to Follow-up|0
1147654|NCT03034967|2256935|FG002|Overall Study|Lost to Follow-up|0
1147655|NCT03034967|2256936|FG003|Overall Study|Lost to Follow-up|1
1147656|NCT03034967|2256937|FG004|Overall Study|Lost to Follow-up|0
1147657|NCT03034967|2256938|FG005|Overall Study|Lost to Follow-up|2
1147658|NCT03034967|2256933|FG000|Overall Study|Liver function test abnormality|0
1147659|NCT03034967|2256934|FG001|Overall Study|Liver function test abnormality|0
1147660|NCT03034967|2256935|FG002|Overall Study|Liver function test abnormality|1
1147661|NCT03034967|2256936|FG003|Overall Study|Liver function test abnormality|0
1147662|NCT03034967|2256937|FG004|Overall Study|Liver function test abnormality|0
1147663|NCT03034967|2256938|FG005|Overall Study|Liver function test abnormality|0
1147664|NCT03034967|2256933|FG000|Overall Study|Protocol Violation|1
1147665|NCT03034967|2256934|FG001|Overall Study|Protocol Violation|0
1147666|NCT03034967|2256935|FG002|Overall Study|Protocol Violation|0
1147667|NCT03034967|2256936|FG003|Overall Study|Protocol Violation|0
1147668|NCT03034967|2256937|FG004|Overall Study|Protocol Violation|0
1147669|NCT03034967|2256938|FG005|Overall Study|Protocol Violation|2
1147670|NCT03034967|2256933|FG000|Overall Study|Lack of Efficacy|0
1147671|NCT03034967|2256934|FG001|Overall Study|Lack of Efficacy|1
1147672|NCT03034967|2256935|FG002|Overall Study|Lack of Efficacy|2
1147673|NCT03034967|2256936|FG003|Overall Study|Lack of Efficacy|1
1147674|NCT03034967|2256937|FG004|Overall Study|Lack of Efficacy|1
1147675|NCT03034967|2256938|FG005|Overall Study|Lack of Efficacy|0
1147676|NCT03034967|2256933|FG000|Overall Study|Adverse Event, non-fatal|3
1147677|NCT03034967|2256934|FG001|Overall Study|Adverse Event, non-fatal|1
1147678|NCT03034967|2256935|FG002|Overall Study|Adverse Event, non-fatal|2
1147679|NCT03034967|2256936|FG003|Overall Study|Adverse Event, non-fatal|0
1147680|NCT03034967|2256937|FG004|Overall Study|Adverse Event, non-fatal|2
1147681|NCT03034967|2256938|FG005|Overall Study|Adverse Event, non-fatal|8
1147682|NCT03034967|2256933|FG000|Overall Study|Adverse Event, Serious Fatal|0
1147683|NCT03034967|2256934|FG001|Overall Study|Adverse Event, Serious Fatal|1
1147684|NCT03034967|2256935|FG002|Overall Study|Adverse Event, Serious Fatal|1
1147685|NCT03034967|2256936|FG003|Overall Study|Adverse Event, Serious Fatal|2
1147686|NCT03034967|2256937|FG004|Overall Study|Adverse Event, Serious Fatal|1
1147687|NCT03034967|2256938|FG005|Overall Study|Adverse Event, Serious Fatal|1
1147688|NCT03035032|2256957|FG000|Overall Study|Adverse Event|2
1147689|NCT03035032|2256957|FG000|Overall Study|Death|9
1147690|NCT03035032|2256957|FG000|Overall Study|Lost to Follow-up|1
1147691|NCT03035032|2256957|FG000|Overall Study|Progressive Disease|22
1147692|NCT03035032|2256957|FG000|Overall Study|Protocol Violation|2
1147693|NCT03035032|2256957|FG000|Overall Study|Withdrawal by Subject|2
1147694|NCT03035032|2256957|FG000|Overall Study|Physician Decision|5
1147695|NCT03035864|2257021|FG000|Treatment Period|Adverse Event|1
1147696|NCT03035864|2257022|FG001|Treatment Period|Adverse Event|0
1147697|NCT03035864|2257021|FG000|Treatment Period|Other|3
1147698|NCT03035864|2257022|FG001|Treatment Period|Other|1
1147699|NCT03035864|2257021|FG000|Follow-up Period|Adverse Event|1
1147700|NCT03035864|2257022|FG001|Follow-up Period|Adverse Event|0
1147701|NCT03035864|2257021|FG000|Follow-up Period|Lost to Follow-up|6
1147702|NCT03035864|2257022|FG001|Follow-up Period|Lost to Follow-up|2
1147703|NCT03035864|2257021|FG000|Follow-up Period|Physician Decision|1
1147704|NCT03035864|2257022|FG001|Follow-up Period|Physician Decision|0
1147705|NCT03035864|2257021|FG000|Follow-up Period|Other|3
1147706|NCT03035864|2257022|FG001|Follow-up Period|Other|2
1147707|NCT03035916|2257031|FG000|Overall Study|Puncture failed|0
1147708|NCT03035916|2257032|FG001|Overall Study|Puncture failed|2
1147709|NCT03035916|2257033|FG002|Overall Study|Puncture failed|0
1147710|NCT03035942|2257049|FG000|Overall Study|Adverse Event|8
1147711|NCT03035942|2257050|FG001|Overall Study|Adverse Event|4
1147712|NCT03035942|2257051|FG002|Overall Study|Adverse Event|5
1147713|NCT03036072|2257072|FG000|Overall Study|Death|0
1147714|NCT03036072|2257073|FG001|Overall Study|Death|1
1147715|NCT03036072|2257072|FG000|Overall Study|Withdrawal by Subject|0
1147716|NCT03036072|2257073|FG001|Overall Study|Withdrawal by Subject|1
1147717|NCT03036072|2257072|FG000|Overall Study|Physician Decision|0
1147718|NCT03036072|2257073|FG001|Overall Study|Physician Decision|1
1147719|NCT03036124|2257081|FG000|Overall Study|Lost to Follow-up|0
1147720|NCT03036124|2257082|FG001|Overall Study|Lost to Follow-up|2
1147721|NCT03036124|2257081|FG000|Overall Study|Withdrawal by Subject|5
1147722|NCT03036124|2257082|FG001|Overall Study|Withdrawal by Subject|4
1147723|NCT03036150|2257090|FG000|Overall Study|Withdrawal by Subject|8
1147724|NCT03036150|2257091|FG001|Overall Study|Withdrawal by Subject|3
1147725|NCT03036150|2257090|FG000|Overall Study|Lost to Follow-up|2
1147726|NCT03036150|2257091|FG001|Overall Study|Lost to Follow-up|2
1147727|NCT03036813|2257187|FG000|Overall Study|Adverse Event|6
1147728|NCT03036813|2257188|FG001|Overall Study|Adverse Event|11
1147729|NCT03036813|2257189|FG002|Overall Study|Adverse Event|6
1147730|NCT03036813|2257187|FG000|Overall Study|Withdrawal by Subject|12
1147731|NCT03036813|2257188|FG001|Overall Study|Withdrawal by Subject|6
1147732|NCT03036813|2257189|FG002|Overall Study|Withdrawal by Subject|10
1147733|NCT03036813|2257187|FG000|Overall Study|Lost to Follow-up|1
1147734|NCT03036813|2257188|FG001|Overall Study|Lost to Follow-up|1
1147735|NCT03036813|2257189|FG002|Overall Study|Lost to Follow-up|0
1147736|NCT03036813|2257187|FG000|Overall Study|Physician Decision|2
1147737|NCT03036813|2257188|FG001|Overall Study|Physician Decision|1
1147738|NCT03036813|2257189|FG002|Overall Study|Physician Decision|1
1147739|NCT03036813|2257187|FG000|Overall Study|Non-Compliance|1
1147740|NCT03036813|2257188|FG001|Overall Study|Non-Compliance|5
1147741|NCT03036813|2257189|FG002|Overall Study|Non-Compliance|3
1147742|NCT03036813|2257187|FG000|Overall Study|Pregnancy|0
1147743|NCT03036813|2257188|FG001|Overall Study|Pregnancy|0
1147744|NCT03036813|2257189|FG002|Overall Study|Pregnancy|1
1147745|NCT03036813|2257187|FG000|Overall Study|Other|0
1147746|NCT03036813|2257188|FG001|Overall Study|Other|3
1147747|NCT03036813|2257189|FG002|Overall Study|Other|5
1147748|NCT03036839|2257203|FG000|Overall Study|Adverse Event|0
1147749|NCT03036839|2257204|FG001|Overall Study|Adverse Event|0
1147750|NCT03036839|2257205|FG002|Overall Study|Adverse Event|1
1147751|NCT03036839|2257203|FG000|Overall Study|Death|3
1147752|NCT03036839|2257204|FG001|Overall Study|Death|0
1147753|NCT03036839|2257205|FG002|Overall Study|Death|3
1147754|NCT03036839|2257203|FG000|Overall Study|Withdrew Consent|0
1147755|NCT03036839|2257204|FG001|Overall Study|Withdrew Consent|0
1147756|NCT03036839|2257205|FG002|Overall Study|Withdrew Consent|1
1147757|NCT03036852|2257219|FG000|Overall Study|Death|2
1147758|NCT03036852|2257219|FG000|Overall Study|Lack of Efficacy|2
1147759|NCT03036852|2257219|FG000|Overall Study|Adverse Event|1
1147760|NCT03036852|2257219|FG000|Overall Study|Lost to Follow-up|1
1147761|NCT03037307|2257267|FG000|Period 1|Did Not Meet Study Criteria|0
1147762|NCT03037307|2257268|FG001|Period 1|Did Not Meet Study Criteria|0
1147763|NCT03037307|2257269|FG002|Period 1|Did Not Meet Study Criteria|0
1147764|NCT03037307|2257270|FG003|Period 1|Did Not Meet Study Criteria|1
1147765|NCT03037307|2257271|FG004|Period 1|Did Not Meet Study Criteria|0
1147766|NCT03037307|2257272|FG005|Period 1|Did Not Meet Study Criteria|0
1147767|NCT03037489|2257283|FG000|Overall Study|Adverse Event|4
1147768|NCT03037489|2257284|FG001|Overall Study|Adverse Event|0
1147769|NCT03037489|2257283|FG000|Overall Study|Withdrawal by Subject|3
1147770|NCT03037489|2257284|FG001|Overall Study|Withdrawal by Subject|0
1147771|NCT03037580|2257301|FG000|Overall Study|Withdrawal by Subject|3
1147772|NCT03037580|2257302|FG001|Overall Study|Withdrawal by Subject|0
1147773|NCT03037580|2257301|FG000|Overall Study|Adverse Event|1
1147774|NCT03037580|2257302|FG001|Overall Study|Adverse Event|0
1147775|NCT03037580|2257301|FG000|Overall Study|Study Terminated by Sponsor|12
1147776|NCT03037580|2257302|FG001|Overall Study|Study Terminated by Sponsor|15
1147777|NCT03037580|2257301|FG000|Overall Study|Death|0
1147778|NCT03037580|2257302|FG001|Overall Study|Death|1
1147779|NCT03037619|2257310|FG000|Overall Study|Lost to Follow-up|0
1147780|NCT03037619|2257311|FG001|Overall Study|Lost to Follow-up|1
1147782|NCT03038113|2257357|FG000|Overall Study|Withdrawal by Subject|0
1147783|NCT03038113|2257358|FG001|Overall Study|Withdrawal by Subject|0
1147784|NCT03038113|2257359|FG002|Overall Study|Withdrawal by Subject|1
1147785|NCT03038113|2257360|FG003|Overall Study|Withdrawal by Subject|0
1147786|NCT03038113|2257361|FG004|Overall Study|Withdrawal by Subject|0
1147787|NCT03038113|2257362|FG005|Overall Study|Withdrawal by Subject|0
1147788|NCT03038113|2257363|FG006|Overall Study|Withdrawal by Subject|0
1147789|NCT03038113|2257364|FG007|Overall Study|Withdrawal by Subject|0
1147790|NCT03038113|2257365|FG008|Overall Study|Withdrawal by Subject|0
1147791|NCT03038113|2257366|FG009|Overall Study|Withdrawal by Subject|0
1147792|NCT03038113|2257367|FG010|Overall Study|Withdrawal by Subject|0
1147793|NCT03038113|2257368|FG011|Overall Study|Withdrawal by Subject|0
1147794|NCT03038113|2257369|FG012|Overall Study|Withdrawal by Subject|0
1147795|NCT03038113|2257370|FG013|Overall Study|Withdrawal by Subject|1
1147796|NCT03038113|2257357|FG000|Overall Study|Lost to Follow-up|0
1147797|NCT03038113|2257358|FG001|Overall Study|Lost to Follow-up|0
1147798|NCT03038113|2257359|FG002|Overall Study|Lost to Follow-up|0
1147799|NCT03038113|2257360|FG003|Overall Study|Lost to Follow-up|0
1147800|NCT03038113|2257361|FG004|Overall Study|Lost to Follow-up|0
1147801|NCT03038113|2257362|FG005|Overall Study|Lost to Follow-up|0
1147802|NCT03038113|2257363|FG006|Overall Study|Lost to Follow-up|1
1147803|NCT03038113|2257364|FG007|Overall Study|Lost to Follow-up|0
1147804|NCT03038113|2257365|FG008|Overall Study|Lost to Follow-up|0
1147805|NCT03038113|2257366|FG009|Overall Study|Lost to Follow-up|0
1147806|NCT03038113|2257367|FG010|Overall Study|Lost to Follow-up|0
1147807|NCT03038113|2257368|FG011|Overall Study|Lost to Follow-up|0
1147808|NCT03038113|2257369|FG012|Overall Study|Lost to Follow-up|0
1147809|NCT03038113|2257370|FG013|Overall Study|Lost to Follow-up|0
1147810|NCT03038126|2257419|FG000|Overall Study|Death|1
1147811|NCT03038126|2257420|FG001|Overall Study|Death|1
1147812|NCT03038126|2257419|FG000|Overall Study|Withdrawal by Subject|5
1147813|NCT03038126|2257420|FG001|Overall Study|Withdrawal by Subject|0
1147814|NCT03038126|2257419|FG000|Overall Study|Lost to Follow-up|0
1147815|NCT03038126|2257420|FG001|Overall Study|Lost to Follow-up|1
1147816|NCT03038126|2257419|FG000|Overall Study|Long Term Hospitalization|2
1147817|NCT03038126|2257420|FG001|Overall Study|Long Term Hospitalization|0
1147818|NCT03038126|2257419|FG000|Overall Study|Too Ill to Participate|1
1147819|NCT03038126|2257420|FG001|Overall Study|Too Ill to Participate|2
1147823|NCT03038620|2257455|FG000|Overall Study|Lost to Follow-up|18
1147824|NCT03038620|2257456|FG001|Overall Study|Lost to Follow-up|23
1147825|NCT03038620|2257455|FG000|Overall Study|Withdrawal by Subject|0
1147826|NCT03038620|2257456|FG001|Overall Study|Withdrawal by Subject|15
1147827|NCT03038620|2257455|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1
1147828|NCT03038620|2257456|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0
1147829|NCT03038880|2257484|FG000|Overall Study|Death|1
1147830|NCT03038880|2257485|FG001|Overall Study|Death|2
1147831|NCT03038880|2257486|FG002|Overall Study|Death|0
1147832|NCT03038880|2257484|FG000|Overall Study|Physician Decision|2
1147833|NCT03038880|2257485|FG001|Overall Study|Physician Decision|1
1147834|NCT03038880|2257486|FG002|Overall Study|Physician Decision|0
1147835|NCT03039023|2257499|FG000|Overall Study|Withdrawal by Subject|1
1147836|NCT03039023|2257500|FG001|Overall Study|Withdrawal by Subject|0
1147837|NCT03039023|2257501|FG002|Overall Study|Withdrawal by Subject|1
1147838|NCT03039023|2257502|FG003|Overall Study|Withdrawal by Subject|1
1147839|NCT03039023|2257503|FG004|Overall Study|Withdrawal by Subject|0
1147840|NCT03039023|2257499|FG000|Overall Study|Physician Decision|0
1147841|NCT03039023|2257500|FG001|Overall Study|Physician Decision|0
1147842|NCT03039023|2257501|FG002|Overall Study|Physician Decision|0
1147843|NCT03039023|2257502|FG003|Overall Study|Physician Decision|1
1147844|NCT03039023|2257503|FG004|Overall Study|Physician Decision|0
1147845|NCT03039192|2257535|FG000|Overall Study|Lost to Follow-up|4
1147846|NCT03039192|2257536|FG001|Overall Study|Lost to Follow-up|4
1147847|NCT03039192|2257535|FG000|Overall Study|Adverse event, serious fatal|0
1147848|NCT03039192|2257536|FG001|Overall Study|Adverse event, serious fatal|1
1147849|NCT03039192|2257535|FG000|Overall Study|Adverse event, non-fatal|0
1147850|NCT03039192|2257536|FG001|Overall Study|Adverse event, non-fatal|2
1147851|NCT03039192|2257535|FG000|Overall Study|Withdrawal by Subject|6
1147852|NCT03039192|2257536|FG001|Overall Study|Withdrawal by Subject|9
1147853|NCT03039192|2257535|FG000|Overall Study|Discontinued from treatment phase|19
1147854|NCT03039192|2257536|FG001|Overall Study|Discontinued from treatment phase|12
1147855|NCT03039192|2257535|FG000|Overall Study|Other|3
1147856|NCT03039192|2257536|FG001|Overall Study|Other|2
1147857|NCT03039283|2257542|FG000|Overall Study|Protocol Violation|2
1147858|NCT03039569|2257557|FG000|Overall Study|Lost to Follow-up|5
1147859|NCT03039569|2257558|FG001|Overall Study|Lost to Follow-up|4
1147860|NCT03039621|2257567|FG000|Overall Study|Violation of inclusion criteria|3
1147861|NCT03039621|2257568|FG001|Overall Study|Violation of inclusion criteria|2
1147862|NCT03039621|2257567|FG000|Overall Study|Non-compliance with protocol requirement|4
1147863|NCT03039621|2257568|FG001|Overall Study|Non-compliance with protocol requirement|5
1147864|NCT03039621|2257567|FG000|Overall Study|Necessity to use drugs forbidden by pro|4
1147865|NCT03039621|2257568|FG001|Overall Study|Necessity to use drugs forbidden by pro|7
1147866|NCT03039621|2257567|FG000|Overall Study|Violation of non-inclusion criteria|1
1147867|NCT03039621|2257568|FG001|Overall Study|Violation of non-inclusion criteria|2
1147868|NCT03039686|2257577|FG000|Double-blind Period|Administrative Reason by Sponsor|24
1147869|NCT03039686|2257578|FG001|Double-blind Period|Administrative Reason by Sponsor|25
1147870|NCT03039686|2257579|FG002|Double-blind Period|Administrative Reason by Sponsor|21
1147871|NCT03039686|2257577|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1
1147872|NCT03039686|2257578|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2
1147873|NCT03039686|2257579|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0
1147874|NCT03039686|2257577|FG000|Double-blind Period|Withdrawal by Subject|2
1147875|NCT03039686|2257578|FG001|Double-blind Period|Withdrawal by Subject|2
1147876|NCT03039686|2257579|FG002|Double-blind Period|Withdrawal by Subject|1
1147877|NCT03039686|2257577|FG000|Double-blind Period|Death|0
1147878|NCT03039686|2257578|FG001|Double-blind Period|Death|0
1147879|NCT03039686|2257579|FG002|Double-blind Period|Death|1
1147880|NCT03039686|2257577|FG000|Open Label Period|Administrative Reason by Sponsor|0
1147881|NCT03039686|2257578|FG001|Open Label Period|Administrative Reason by Sponsor|34
1147882|NCT03039686|2257579|FG002|Open Label Period|Administrative Reason by Sponsor|41
1147883|NCT03039686|2257577|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0
1147884|NCT03039686|2257578|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1
1147885|NCT03039686|2257579|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0
1147886|NCT03039686|2257577|FG000|Open Label Period|Withdrawal by Subject|0
1147887|NCT03039686|2257578|FG001|Open Label Period|Withdrawal by Subject|3
1147888|NCT03039686|2257579|FG002|Open Label Period|Withdrawal by Subject|1
1147889|NCT03039699|2257599|FG000|Overall Study|Incorrect inclusion|5
1147890|NCT03039699|2257600|FG001|Overall Study|Incorrect inclusion|4
1147891|NCT03039699|2257599|FG000|Overall Study|Lack of data to assess study endpoint|5
1147892|NCT03039699|2257600|FG001|Overall Study|Lack of data to assess study endpoint|3
1147893|NCT03039699|2257599|FG000|Overall Study|Bacterial infection|12
1147894|NCT03039699|2257600|FG001|Overall Study|Bacterial infection|28
1147895|NCT03039738|2257608|FG000|Overall Study|Incomplete data sets|54
1147896|NCT03039738|2257609|FG001|Overall Study|Incomplete data sets|0
1147897|NCT03040024|2257631|FG000|Overall Study|Adverse Event|0
1147898|NCT03040024|2257632|FG001|Overall Study|Adverse Event|1
1147899|NCT03040024|2257633|FG002|Overall Study|Adverse Event|0
1147900|NCT03040024|2257631|FG000|Overall Study|Death|0
1147901|NCT03040024|2257632|FG001|Overall Study|Death|1
1147902|NCT03040024|2257633|FG002|Overall Study|Death|0
1147903|NCT03040024|2257631|FG000|Overall Study|Physician Decision|0
1147904|NCT03040024|2257632|FG001|Overall Study|Physician Decision|0
1147905|NCT03040024|2257633|FG002|Overall Study|Physician Decision|1
1147906|NCT03040336|2257652|FG000|Overall Study|Death|1
1147907|NCT03040336|2257653|FG001|Overall Study|Death|0
1147908|NCT03040336|2257652|FG000|Overall Study|Withdrawal by Subject|2
1147909|NCT03040336|2257653|FG001|Overall Study|Withdrawal by Subject|3
1147910|NCT03040674|2257710|FG000|Overall Study|Lost to Follow-up|225
1147911|NCT03040674|2257710|FG000|Overall Study|Death|23
1147912|NCT03040687|2257718|FG000|Overall Study|Withdrawal by Subject|1
1147913|NCT03040687|2257719|FG001|Overall Study|Withdrawal by Subject|0
1147914|NCT03040687|2257720|FG002|Overall Study|Withdrawal by Subject|0
1147915|NCT03040713|2257728|FG000|Overall Study|Positive amyloid scan|3
1147916|NCT03040986|2257738|FG000|Overall Study|Hospice|1
1147917|NCT03040986|2257739|FG001|Overall Study|Hospice|0
1147918|NCT03040986|2257738|FG000|Overall Study|Adverse Event|2
1147919|NCT03040986|2257739|FG001|Overall Study|Adverse Event|1
1147920|NCT03040986|2257738|FG000|Overall Study|Disease progression on study|3
1147921|NCT03040986|2257739|FG001|Overall Study|Disease progression on study|1
1147922|NCT03041025|2257750|FG000|Overall Study|Adverse Event|0
1147923|NCT03041025|2257751|FG001|Overall Study|Adverse Event|0
1147924|NCT03041025|2257752|FG002|Overall Study|Adverse Event|1
1147925|NCT03041025|2257750|FG000|Overall Study|Lost to Follow-up|1
1147926|NCT03041025|2257751|FG001|Overall Study|Lost to Follow-up|0
1147927|NCT03041025|2257752|FG002|Overall Study|Lost to Follow-up|0
1147928|NCT03041025|2257750|FG000|Overall Study|Withdrawal by Subject|0
1147929|NCT03041025|2257751|FG001|Overall Study|Withdrawal by Subject|0
1147930|NCT03041025|2257752|FG002|Overall Study|Withdrawal by Subject|1
1147931|NCT03041038|2257765|FG000|Overall Study|Withdrawal by Subject|4
1147932|NCT03041038|2257766|FG001|Overall Study|Withdrawal by Subject|0
1147933|NCT03041038|2257765|FG000|Overall Study|Lost to Follow-up|1
1147934|NCT03041038|2257766|FG001|Overall Study|Lost to Follow-up|1
1147935|NCT03041038|2257765|FG000|Overall Study|Protocol Violation|1
1147936|NCT03041038|2257766|FG001|Overall Study|Protocol Violation|1
1147937|NCT03041090|2257776|FG000|Overall Study|technical error|0
1147938|NCT03041090|2257777|FG001|Overall Study|technical error|3
1147939|NCT03041116|2257785|FG000|Double-blind|Death|0
1147940|NCT03041116|2257786|FG001|Double-blind|Death|2
1147941|NCT03041116|2257785|FG000|Double-blind|Withdrawal by Subject|0
1147942|NCT03041116|2257786|FG001|Double-blind|Withdrawal by Subject|4
1147943|NCT03041116|2257785|FG000|Open-label|Death|1
1147944|NCT03041116|2257786|FG001|Open-label|Death|0
1147945|NCT03041116|2257785|FG000|Open-label|Termination of the study by Sponsor|39
1147946|NCT03041116|2257786|FG001|Open-label|Termination of the study by Sponsor|37
1147947|NCT03041116|2257785|FG000|Open-label|Withdrawal by Subject|1
1147948|NCT03041116|2257786|FG001|Open-label|Withdrawal by Subject|0
1147949|NCT03041181|2257798|FG000|Overall Study|Disease Progression|1
1147950|NCT03041181|2257799|FG001|Overall Study|Disease Progression|2
1147951|NCT03041792|2257831|FG000|Overall Study|Adverse Event|4
1147952|NCT03041792|2257832|FG001|Overall Study|Adverse Event|0
1147953|NCT03041792|2257831|FG000|Overall Study|Death in the family|0
1147954|NCT03041792|2257832|FG001|Overall Study|Death in the family|2
1147955|NCT03041792|2257831|FG000|Overall Study|Randomized but not treated|0
1147956|NCT03041792|2257832|FG001|Overall Study|Randomized but not treated|1
1147957|NCT03042312|2257883|FG000|Overall Study|Administrative Reason|1
1147958|NCT03042312|2257884|FG001|Overall Study|Administrative Reason|1
1147959|NCT03042312|2257883|FG000|Overall Study|Adverse Event|0
1147960|NCT03042312|2257884|FG001|Overall Study|Adverse Event|1
1147961|NCT03042312|2257883|FG000|Overall Study|Lost to Follow-up|1
1147962|NCT03042312|2257884|FG001|Overall Study|Lost to Follow-up|3
1147963|NCT03042312|2257883|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4
1147964|NCT03042312|2257884|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2
1147965|NCT03042312|2257883|FG000|Overall Study|Withdrawal by Subject|4
1147966|NCT03042312|2257884|FG001|Overall Study|Withdrawal by Subject|5
1147967|NCT03042559|2257892|FG000|Overall Study|drop out|1
1147968|NCT03042559|2257893|FG001|Overall Study|drop out|1
1147969|NCT03042767|2257910|FG000|Overall Study|Lost to Follow-up|1
1147970|NCT03042767|2257911|FG001|Overall Study|Lost to Follow-up|2
1147971|NCT03042910|2257917|FG000|Overall Study|Adverse Event|1
1147972|NCT03042910|2257917|FG000|Overall Study|Disease Progression|2
1147973|NCT03042910|2257917|FG000|Overall Study|Withdrawal by Subject|3
1147974|NCT03042910|2257917|FG000|Overall Study|Enrolled but not treated|1
1147975|NCT03043365|2257950|FG000|Weeks 0 to Week 8|Adverse Event|1
1147976|NCT03043365|2257951|FG001|Weeks 0 to Week 8|Adverse Event|3
1147977|NCT03043365|2257950|FG000|Weeks 0 to Week 8|Lost to Follow-up|2
1147978|NCT03043365|2257951|FG001|Weeks 0 to Week 8|Lost to Follow-up|0
1147979|NCT03043365|2257950|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1
1147980|NCT03043365|2257951|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0
1147981|NCT03043560|2257970|FG000|Overall Study|Discontinued Intervention|1
1147982|NCT03043560|2257971|FG001|Overall Study|Discontinued Intervention|2
1147983|NCT03043560|2257970|FG000|Overall Study|Lost to Follow-up|0
1147984|NCT03043560|2257971|FG001|Overall Study|Lost to Follow-up|1
1147985|NCT03043651|2257981|FG000|Overall Study|Death|1
1147986|NCT03043651|2257981|FG000|Overall Study|Progressive Disease|2
1147987|NCT03043651|2257981|FG000|Overall Study|Adverse Event|2
1147988|NCT03043651|2257981|FG000|Overall Study|Withdrawal by Subject|4
1147989|NCT03043651|2257981|FG000|Overall Study|Study Terminated by Sponsor|39
1147990|NCT03043872|2257988|FG000|Overall Study|Withdrawal by Subject|6
1147991|NCT03043872|2257989|FG001|Overall Study|Withdrawal by Subject|4
1147992|NCT03043872|2257990|FG002|Overall Study|Withdrawal by Subject|12
1147993|NCT03043872|2257988|FG000|Overall Study|Lost to Follow-up|2
1147994|NCT03043872|2257989|FG001|Overall Study|Lost to Follow-up|1
1147995|NCT03043872|2257990|FG002|Overall Study|Lost to Follow-up|1
1147996|NCT03043872|2257988|FG000|Overall Study|Death|204
1147997|NCT03043872|2257989|FG001|Overall Study|Death|207
1147998|NCT03043872|2257990|FG002|Overall Study|Death|225
1147999|NCT03044106|2258031|FG000|Washout (1 Week)|Withdrawal by Subject|0
1148000|NCT03044106|2258032|FG001|Washout (1 Week)|Withdrawal by Subject|2
1148001|NCT03044197|2258047|FG000|Overall Study|Withdrawal by Subject|3
1148002|NCT03044197|2258048|FG001|Overall Study|Withdrawal by Subject|1
1148003|NCT03044249|2258056|FG000|Overall Study|Adverse Event|4
1148004|NCT03044249|2258057|FG001|Overall Study|Adverse Event|9
1148005|NCT03044249|2258056|FG000|Overall Study|Lost to Follow-up|1
1148006|NCT03044249|2258057|FG001|Overall Study|Lost to Follow-up|0
1148007|NCT03044249|2258056|FG000|Overall Study|Non-compliance with Study Drug|1
1148008|NCT03044249|2258057|FG001|Overall Study|Non-compliance with Study Drug|0
1148009|NCT03044249|2258056|FG000|Overall Study|Study Terminated by Sponsor|2
1148010|NCT03044249|2258057|FG001|Overall Study|Study Terminated by Sponsor|0
1148011|NCT03044249|2258056|FG000|Overall Study|Withdrawal by Subject|2
1148012|NCT03044249|2258057|FG001|Overall Study|Withdrawal by Subject|5
1148013|NCT03044353|2258071|FG000|Overall Study|Adverse Event|0
1148014|NCT03044353|2258072|FG001|Overall Study|Adverse Event|1
1148015|NCT03044353|2258073|FG002|Overall Study|Adverse Event|0
1148016|NCT03044431|2258084|FG000|Overall Study|Lost to Follow-up|59
1148017|NCT03044574|2258090|FG000|Overall Study|Lost to Follow-up|37
1148018|NCT03044574|2258091|FG001|Overall Study|Lost to Follow-up|45
1148019|NCT03044730|2258106|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1
1148020|NCT03044730|2258106|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1
1148021|NCT03044730|2258106|FG000|3 Cycles of Pembro + Capecitab|Death|1
1148022|NCT03044730|2258106|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1
1148023|NCT03044730|2258106|FG000|Cycles 4 and Beyond|Progressive Disease|9
1148024|NCT03044730|2258106|FG000|Cycles 4 and Beyond|Adverse Event|1
1148025|NCT03044730|2258106|FG000|On Follow-up for 2 Years|Still in follow-up|7
1148026|NCT03044730|2258106|FG000|On Follow-up for 2 Years|Lost to Follow-up|1
1148027|NCT03044730|2258106|FG000|On Follow-up for 2 Years|Death|17
1148028|NCT03044886|2258114|FG000|Overall Study|Lost to Follow-up|15
1148029|NCT03044886|2258115|FG001|Overall Study|Lost to Follow-up|10
1148030|NCT03044886|2258116|FG002|Overall Study|Lost to Follow-up|12
1148031|NCT03045081|2258126|FG000|Overall Study|Withdrawal by Subject|6
1148032|NCT03045081|2258127|FG001|Overall Study|Withdrawal by Subject|11
1148033|NCT03045302|2258133|FG000|Overall Study|Pre-treatment adverse event|1
1148034|NCT03045328|2258137|FG000|Overall Study|Withdrawal by Subject|2
1148035|NCT03046056|2258222|FG000|Overall Study|Non-responder at Week 10|6
1148036|NCT03046056|2258223|FG001|Overall Study|Non-responder at Week 10|6
1148037|NCT03046056|2258224|FG002|Overall Study|Non-responder at Week 10|4
1148038|NCT03046056|2258222|FG000|Overall Study|Protocol-specified Disease Worsening|3
1148039|NCT03046056|2258223|FG001|Overall Study|Protocol-specified Disease Worsening|3
1148040|NCT03046056|2258224|FG002|Overall Study|Protocol-specified Disease Worsening|1
1148041|NCT03046056|2258222|FG000|Overall Study|Adverse Event|1
1148042|NCT03046056|2258223|FG001|Overall Study|Adverse Event|5
1148043|NCT03046056|2258224|FG002|Overall Study|Adverse Event|0
1148044|NCT03046056|2258222|FG000|Overall Study|Non-compliance With Study Drug|0
1148045|NCT03046056|2258223|FG001|Overall Study|Non-compliance With Study Drug|0
1148046|NCT03046056|2258224|FG002|Overall Study|Non-compliance With Study Drug|2
1148047|NCT03046056|2258222|FG000|Overall Study|Protocol Violation|1
1148048|NCT03046056|2258223|FG001|Overall Study|Protocol Violation|1
1148049|NCT03046056|2258224|FG002|Overall Study|Protocol Violation|0
1148050|NCT03046056|2258222|FG000|Overall Study|Investigator's Discretion|0
1148051|NCT03046056|2258223|FG001|Overall Study|Investigator's Discretion|1
1148052|NCT03046056|2258224|FG002|Overall Study|Investigator's Discretion|0
1148053|NCT03046056|2258222|FG000|Overall Study|Withdrew Consent|1
1148054|NCT03046056|2258223|FG001|Overall Study|Withdrew Consent|0
1148055|NCT03046056|2258224|FG002|Overall Study|Withdrew Consent|0
1148056|NCT03046446|2258250|FG000|Overall Study|Lack of Efficacy|7
1148057|NCT03046446|2258250|FG000|Overall Study|Adverse Event|6
1148058|NCT03046446|2258250|FG000|Overall Study|Lost to Follow-up|3
1148059|NCT03046446|2258250|FG000|Overall Study|Withdrawal by Subject|14
1148060|NCT03046446|2258250|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3
1148061|NCT03046446|2258250|FG000|Overall Study|Disease Progression (see caveats)|25
1148062|NCT03046446|2258250|FG000|Overall Study|Non OA related knee surgery|1
1148063|NCT03047551|2258313|FG000|Overall Study|Did not receive TAS|1
1148064|NCT03047551|2258314|FG001|Overall Study|Did not receive TAS|0
1148065|NCT03047551|2258313|FG000|Overall Study|Physician Decision|1
1148066|NCT03047551|2258314|FG001|Overall Study|Physician Decision|0
1148067|NCT03047551|2258313|FG000|Overall Study|Withdrawal by Subject|0
1148068|NCT03047551|2258314|FG001|Overall Study|Withdrawal by Subject|1
1148069|NCT03047551|2258313|FG000|Overall Study|Probe malfunction|0
1148070|NCT03047551|2258314|FG001|Overall Study|Probe malfunction|1
1148071|NCT03047551|2258313|FG000|Overall Study|Ineligible|0
1148072|NCT03047551|2258314|FG001|Overall Study|Ineligible|1
1148073|NCT03047720|2258322|FG000|First Intervention (6weeks)|Participant data entry insufficient|7
1148074|NCT03047720|2258323|FG001|First Intervention (6weeks)|Participant data entry insufficient|0
1148075|NCT03047980|2258329|FG000|Overall Study|Adverse Event|1
1148076|NCT03048058|2258339|FG000|Overall Study|Lost to Follow-up|4
1148077|NCT03048058|2258340|FG001|Overall Study|Lost to Follow-up|0
1148078|NCT03048058|2258339|FG000|Overall Study|Withdrawal by Subject|0
1148079|NCT03048058|2258340|FG001|Overall Study|Withdrawal by Subject|4
1148098|NCT03048500|2258382|FG000|2 Cycles of Treatment|Withdrawal by Subject|1
1148099|NCT03048500|2258382|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4
1148100|NCT03048500|2258382|FG000|Reached 1st Response/Continued Treatment|Death|1
1148101|NCT03048500|2258382|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1
1162104|NCT03383146|2284116|FG001|Overall Study|Protocol Deviation|8
1148102|NCT03048500|2258382|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1
1148103|NCT03048500|2258382|FG000|Follow up for 3 Years|Currently in Follow-up|4
1148104|NCT03048500|2258382|FG000|Follow up for 3 Years|Death|12
1148105|NCT03048747|2258386|FG000|Overall Study|Adverse Event|2
1148106|NCT03048747|2258386|FG000|Overall Study|Participant Met Withdrawal Criteria|2
1148107|NCT03048747|2258386|FG000|Overall Study|Physician Decision|1
1148108|NCT03049280|2258400|FG000|Overall Study|Physician Decision|1
1148109|NCT03049488|2258412|FG000|Overall Study|Lost to Follow-up|1
1148110|NCT03049488|2258413|FG001|Overall Study|Lost to Follow-up|1
1148111|NCT03049488|2258414|FG002|Overall Study|Lost to Follow-up|0
1148112|NCT03049488|2258415|FG003|Overall Study|Lost to Follow-up|0
1148113|NCT03049488|2258416|FG004|Overall Study|Lost to Follow-up|0
1148114|NCT03049488|2258417|FG005|Overall Study|Lost to Follow-up|0
1148115|NCT03049488|2258412|FG000|Overall Study|Moved from Area|1
1148116|NCT03049488|2258413|FG001|Overall Study|Moved from Area|0
1148117|NCT03049488|2258414|FG002|Overall Study|Moved from Area|0
1148118|NCT03049488|2258415|FG003|Overall Study|Moved from Area|1
1148119|NCT03049488|2258416|FG004|Overall Study|Moved from Area|1
1148120|NCT03049488|2258417|FG005|Overall Study|Moved from Area|0
1148121|NCT03049488|2258412|FG000|Overall Study|Physician Decision|0
1148122|NCT03049488|2258413|FG001|Overall Study|Physician Decision|1
1148123|NCT03049488|2258414|FG002|Overall Study|Physician Decision|0
1148124|NCT03049488|2258415|FG003|Overall Study|Physician Decision|0
1148125|NCT03049488|2258416|FG004|Overall Study|Physician Decision|0
1148126|NCT03049488|2258417|FG005|Overall Study|Physician Decision|0
1148127|NCT03049488|2258412|FG000|Overall Study|Withdrawal by Subject|0
1148128|NCT03049488|2258413|FG001|Overall Study|Withdrawal by Subject|0
1148129|NCT03049488|2258414|FG002|Overall Study|Withdrawal by Subject|0
1148130|NCT03049488|2258415|FG003|Overall Study|Withdrawal by Subject|1
1148131|NCT03049488|2258416|FG004|Overall Study|Withdrawal by Subject|1
1148132|NCT03049488|2258417|FG005|Overall Study|Withdrawal by Subject|0
1148133|NCT03049748|2258443|FG000|Overall Study|Lost to Follow-up|1
1148134|NCT03049748|2258444|FG001|Overall Study|Lost to Follow-up|0
1148135|NCT03049748|2258443|FG000|Overall Study|Death|3
1148136|NCT03049748|2258444|FG001|Overall Study|Death|0
1148137|NCT03049748|2258443|FG000|Overall Study|Withdrawal by Subject|0
1148138|NCT03049748|2258444|FG001|Overall Study|Withdrawal by Subject|3
1148139|NCT03049748|2258443|FG000|Overall Study|Protocol Violation|0
1148140|NCT03049748|2258444|FG001|Overall Study|Protocol Violation|2
1148141|NCT03049748|2258443|FG000|Overall Study|Moved out of state (relocation)|0
1148142|NCT03049748|2258444|FG001|Overall Study|Moved out of state (relocation)|1
1148143|NCT03049852|2258453|FG000|Overall Study|Lost to Follow-up|0
1148144|NCT03049852|2258454|FG001|Overall Study|Lost to Follow-up|1
1148145|NCT03049852|2258455|FG002|Overall Study|Lost to Follow-up|0
1148146|NCT03050307|2258540|FG000|Overall Study|Adverse Event|4
1148147|NCT03050307|2258541|FG001|Overall Study|Adverse Event|2
1148148|NCT03050307|2258540|FG000|Overall Study|Significant Protocol Deviation|0
1148149|NCT03050307|2258541|FG001|Overall Study|Significant Protocol Deviation|1
1148150|NCT03050307|2258540|FG000|Overall Study|Lost to Follow-up|0
1148151|NCT03050307|2258541|FG001|Overall Study|Lost to Follow-up|1
1148152|NCT03050307|2258540|FG000|Overall Study|Voluntary Withdrawal|3
1148153|NCT03050307|2258541|FG001|Overall Study|Voluntary Withdrawal|4
1148154|NCT03050307|2258540|FG000|Overall Study|Reason not Specified|1
1148155|NCT03050307|2258541|FG001|Overall Study|Reason not Specified|1
1148156|NCT03050359|2258560|FG000|Overall Study|Randomized But Not Treated|2
1148157|NCT03050359|2258561|FG001|Overall Study|Randomized But Not Treated|0
1148158|NCT03050359|2258560|FG000|Overall Study|Pretreatment Event/Adverse Event|5
1148159|NCT03050359|2258561|FG001|Overall Study|Pretreatment Event/Adverse Event|10
1148160|NCT03050359|2258560|FG000|Overall Study|Significant Protocol Deviation|2
1148161|NCT03050359|2258561|FG001|Overall Study|Significant Protocol Deviation|3
1148162|NCT03050359|2258560|FG000|Overall Study|Lost to Follow-up|2
1148163|NCT03050359|2258561|FG001|Overall Study|Lost to Follow-up|1
1148164|NCT03050359|2258560|FG000|Overall Study|Voluntary Withdrawal|4
1148165|NCT03050359|2258561|FG001|Overall Study|Voluntary Withdrawal|6
1148166|NCT03050359|2258560|FG000|Overall Study|Pregnancy|1
1148167|NCT03050359|2258561|FG001|Overall Study|Pregnancy|0
1148168|NCT03050359|2258560|FG000|Overall Study|Reason Not Specified|1
1148169|NCT03050359|2258561|FG001|Overall Study|Reason Not Specified|0
1148170|NCT03050372|2258569|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1
1148171|NCT03050372|2258570|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0
1148172|NCT03050372|2258569|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
1148173|NCT03050372|2258570|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
1148174|NCT03050450|2258580|FG000|Overall Study|Physician Decision|1
1148175|NCT03050450|2258581|FG001|Overall Study|Physician Decision|0
1148176|NCT03050450|2258582|FG002|Overall Study|Physician Decision|0
1148177|NCT03050450|2258583|FG003|Overall Study|Physician Decision|0
1148178|NCT03050450|2258584|FG004|Overall Study|Physician Decision|0
1148179|NCT03050801|2258665|FG000|Experiment 1|Lost to Follow-up|0
1148180|NCT03050801|2258666|FG001|Experiment 1|Lost to Follow-up|1
1148181|NCT03050801|2258667|FG002|Experiment 1|Lost to Follow-up|0
1148182|NCT03050801|2258668|FG003|Experiment 1|Lost to Follow-up|0
1148183|NCT03050801|2258669|FG004|Experiment 1|Lost to Follow-up|0
1148184|NCT03050801|2258670|FG005|Experiment 1|Lost to Follow-up|0
1148185|NCT03050801|2258665|FG000|Experiment 1|Physician Decision|0
1148186|NCT03050801|2258666|FG001|Experiment 1|Physician Decision|3
1148187|NCT03050801|2258667|FG002|Experiment 1|Physician Decision|0
1148188|NCT03050801|2258668|FG003|Experiment 1|Physician Decision|0
1148189|NCT03050801|2258669|FG004|Experiment 1|Physician Decision|0
1148190|NCT03050801|2258670|FG005|Experiment 1|Physician Decision|0
1148191|NCT03050801|2258665|FG000|Experiment 1|Change of experimental design|0
1148192|NCT03050801|2258666|FG001|Experiment 1|Change of experimental design|3
1148193|NCT03050801|2258667|FG002|Experiment 1|Change of experimental design|0
1148194|NCT03050801|2258668|FG003|Experiment 1|Change of experimental design|0
1148195|NCT03050801|2258669|FG004|Experiment 1|Change of experimental design|0
1148196|NCT03050801|2258670|FG005|Experiment 1|Change of experimental design|0
1148197|NCT03050801|2258665|FG000|Experiment 1|Unable to obtain critical rTMS measure|0
1148198|NCT03050801|2258666|FG001|Experiment 1|Unable to obtain critical rTMS measure|0
1148199|NCT03050801|2258667|FG002|Experiment 1|Unable to obtain critical rTMS measure|2
1148200|NCT03050801|2258668|FG003|Experiment 1|Unable to obtain critical rTMS measure|0
1148201|NCT03050801|2258669|FG004|Experiment 1|Unable to obtain critical rTMS measure|0
1148202|NCT03050801|2258670|FG005|Experiment 1|Unable to obtain critical rTMS measure|0
1148203|NCT03050801|2258665|FG000|Experiment 2|Lost to Follow-up|0
1148204|NCT03050801|2258666|FG001|Experiment 2|Lost to Follow-up|0
1148205|NCT03050801|2258667|FG002|Experiment 2|Lost to Follow-up|0
1148206|NCT03050801|2258668|FG003|Experiment 2|Lost to Follow-up|1
1148207|NCT03050801|2258669|FG004|Experiment 2|Lost to Follow-up|1
1148208|NCT03050801|2258670|FG005|Experiment 2|Lost to Follow-up|0
1148209|NCT03050801|2258665|FG000|Experiment 2|Physician Decision|0
1148210|NCT03050801|2258666|FG001|Experiment 2|Physician Decision|0
1148211|NCT03050801|2258667|FG002|Experiment 2|Physician Decision|0
1148212|NCT03050801|2258668|FG003|Experiment 2|Physician Decision|0
1148213|NCT03050801|2258669|FG004|Experiment 2|Physician Decision|1
1148214|NCT03050801|2258670|FG005|Experiment 2|Physician Decision|0
1148215|NCT03050801|2258665|FG000|Experiment 2|Pregnancy|0
1148216|NCT03050801|2258666|FG001|Experiment 2|Pregnancy|0
1148217|NCT03050801|2258667|FG002|Experiment 2|Pregnancy|0
1148218|NCT03050801|2258668|FG003|Experiment 2|Pregnancy|0
1148219|NCT03050801|2258669|FG004|Experiment 2|Pregnancy|1
1148220|NCT03050801|2258670|FG005|Experiment 2|Pregnancy|0
1148221|NCT03050801|2258665|FG000|Experiment 2|Withdrawal by Subject|0
1148222|NCT03050801|2258666|FG001|Experiment 2|Withdrawal by Subject|0
1148223|NCT03050801|2258667|FG002|Experiment 2|Withdrawal by Subject|0
1148224|NCT03050801|2258668|FG003|Experiment 2|Withdrawal by Subject|1
1148225|NCT03050801|2258669|FG004|Experiment 2|Withdrawal by Subject|0
1148226|NCT03050801|2258670|FG005|Experiment 2|Withdrawal by Subject|0
1148227|NCT03050801|2258665|FG000|Experiment 2|Poor data quality|0
1148228|NCT03050801|2258666|FG001|Experiment 2|Poor data quality|0
1148229|NCT03050801|2258667|FG002|Experiment 2|Poor data quality|0
1148230|NCT03050801|2258668|FG003|Experiment 2|Poor data quality|4
1148231|NCT03050801|2258669|FG004|Experiment 2|Poor data quality|1
1148232|NCT03050801|2258670|FG005|Experiment 2|Poor data quality|0
1148233|NCT03050801|2258665|FG000|Experiment 2|Discomfort during stimulation|0
1148234|NCT03050801|2258666|FG001|Experiment 2|Discomfort during stimulation|0
1148235|NCT03050801|2258667|FG002|Experiment 2|Discomfort during stimulation|0
1148236|NCT03050801|2258668|FG003|Experiment 2|Discomfort during stimulation|0
1148237|NCT03050801|2258669|FG004|Experiment 2|Discomfort during stimulation|0
1148238|NCT03050801|2258670|FG005|Experiment 2|Discomfort during stimulation|2
1148239|NCT03051100|2258698|FG000|Overall Study|Withdrawal by Subject|1
1148240|NCT03051100|2258699|FG001|Overall Study|Withdrawal by Subject|0
1148241|NCT03051165|2258705|FG000|Overall Study|Withdrawal by Subject|1
1148242|NCT03051165|2258705|FG000|Overall Study|Early termination of study|12
1148299|NCT03051607|2258746|FG000|Overall Study|Adverse Event|66
1148300|NCT03051620|2258750|FG000|Overall Study|Lost to Follow-up|6
1148301|NCT03051620|2258750|FG000|Overall Study|n=124 enrolled in extension (all completed)|12
1148302|NCT03052322|2258790|FG000|Overall Study|Other un-specified|1
1148303|NCT03052322|2258791|FG001|Overall Study|Other un-specified|2
1148304|NCT03052322|2258790|FG000|Overall Study|Withdrawal by Subject|10
1148305|NCT03052322|2258791|FG001|Overall Study|Withdrawal by Subject|9
1148306|NCT03052322|2258790|FG000|Overall Study|Death|0
1148307|NCT03052322|2258791|FG001|Overall Study|Death|2
1148308|NCT03052322|2258790|FG000|Overall Study|Lack of Efficacy|1
1148309|NCT03052322|2258791|FG001|Overall Study|Lack of Efficacy|2
1148310|NCT03052322|2258790|FG000|Overall Study|Protocol Violation|1
1148311|NCT03052322|2258791|FG001|Overall Study|Protocol Violation|0
1148312|NCT03052322|2258790|FG000|Overall Study|Lost to Follow-up|2
1148313|NCT03052322|2258791|FG001|Overall Study|Lost to Follow-up|4
1148314|NCT03052322|2258790|FG000|Overall Study|Adverse Event|6
1148315|NCT03052322|2258791|FG001|Overall Study|Adverse Event|13
1148316|NCT03052426|2258800|FG000|Overall Study|Withdrawal by Subject|0
1148317|NCT03052426|2258801|FG001|Overall Study|Withdrawal by Subject|1
1148318|NCT03052426|2258802|FG002|Overall Study|Withdrawal by Subject|0
1148319|NCT03052426|2258800|FG000|Overall Study|Lost to Follow-up|2
1148320|NCT03052426|2258801|FG001|Overall Study|Lost to Follow-up|0
1148321|NCT03052426|2258802|FG002|Overall Study|Lost to Follow-up|1
1148322|NCT03052517|2258818|FG000|Overall Study|Study Terminated By Sponsor|928
1148323|NCT03052517|2258819|FG001|Overall Study|Study Terminated By Sponsor|938
1148324|NCT03052517|2258820|FG002|Overall Study|Study Terminated By Sponsor|296
1148325|NCT03052517|2258818|FG000|Overall Study|Subject/Guardian Decision|50
1148326|NCT03052517|2258819|FG001|Overall Study|Subject/Guardian Decision|45
1148327|NCT03052517|2258820|FG002|Overall Study|Subject/Guardian Decision|22
1148328|NCT03052517|2258818|FG000|Overall Study|Lack of Efficacy|23
1148329|NCT03052517|2258819|FG001|Overall Study|Lack of Efficacy|14
1148330|NCT03052517|2258820|FG002|Overall Study|Lack of Efficacy|7
1148331|NCT03052517|2258818|FG000|Overall Study|Adverse Event|6
1148332|NCT03052517|2258819|FG001|Overall Study|Adverse Event|5
1148333|NCT03052517|2258820|FG002|Overall Study|Adverse Event|0
1148334|NCT03052517|2258818|FG000|Overall Study|Physician Decision|4
1148335|NCT03052517|2258819|FG001|Overall Study|Physician Decision|5
1148336|NCT03052517|2258820|FG002|Overall Study|Physician Decision|1
1148337|NCT03052517|2258818|FG000|Overall Study|Death|3
1148338|NCT03052517|2258819|FG001|Overall Study|Death|0
1148339|NCT03052517|2258820|FG002|Overall Study|Death|1
1148340|NCT03052517|2258818|FG000|Overall Study|Lost to Follow-up|2
1148341|NCT03052517|2258819|FG001|Overall Study|Lost to Follow-up|4
1148342|NCT03052517|2258820|FG002|Overall Study|Lost to Follow-up|0
1148343|NCT03052517|2258818|FG000|Overall Study|Pregnancy|1
1148344|NCT03052517|2258819|FG001|Overall Study|Pregnancy|0
1148345|NCT03052517|2258820|FG002|Overall Study|Pregnancy|1
1148346|NCT03052517|2258818|FG000|Overall Study|Non-Compliance With Study Treatment|0
1148347|NCT03052517|2258819|FG001|Overall Study|Non-Compliance With Study Treatment|2
1148348|NCT03052517|2258820|FG002|Overall Study|Non-Compliance With Study Treatment|0
1148349|NCT03052517|2258818|FG000|Overall Study|Technical Problems|0
1148350|NCT03052517|2258819|FG001|Overall Study|Technical Problems|1
1148351|NCT03052517|2258820|FG002|Overall Study|Technical Problems|0
1148352|NCT03052725|2258843|FG000|Overall Study|Adverse Event|2
1148353|NCT03052725|2258844|FG001|Overall Study|Adverse Event|0
1148354|NCT03052725|2258843|FG000|Overall Study|Withdrawal by Subject|3
1148355|NCT03052725|2258844|FG001|Overall Study|Withdrawal by Subject|4
1148356|NCT03052725|2258843|FG000|Overall Study|Pregnancy|0
1148357|NCT03052725|2258844|FG001|Overall Study|Pregnancy|1
1148358|NCT03052725|2258843|FG000|Overall Study|Site closure|0
1148359|NCT03052725|2258844|FG001|Overall Study|Site closure|1
1148360|NCT03052725|2258843|FG000|Overall Study|Study terminated by sponsor|143
1148361|NCT03052725|2258844|FG001|Overall Study|Study terminated by sponsor|144
1148362|NCT03052751|2258851|FG000|Dosing Period 1|Adverse Event|0
1148363|NCT03052751|2258852|FG001|Dosing Period 1|Adverse Event|1
1148364|NCT03052751|2258853|FG002|Dosing Period 1|Adverse Event|0
1148365|NCT03052751|2258854|FG003|Dosing Period 1|Adverse Event|0
1148366|NCT03052751|2258855|FG004|Dosing Period 1|Adverse Event|0
1148367|NCT03052751|2258856|FG005|Dosing Period 1|Adverse Event|0
1148368|NCT03052751|2258851|FG000|Dosing Period 2|Adverse Event|0
1148369|NCT03052751|2258852|FG001|Dosing Period 2|Adverse Event|0
1148370|NCT03052751|2258853|FG002|Dosing Period 2|Adverse Event|3
1148371|NCT03052751|2258854|FG003|Dosing Period 2|Adverse Event|0
1148372|NCT03052751|2258855|FG004|Dosing Period 2|Adverse Event|0
1148373|NCT03052751|2258856|FG005|Dosing Period 2|Adverse Event|0
1148374|NCT03052751|2258851|FG000|Observation Period|Adverse Event|0
1148375|NCT03052751|2258852|FG001|Observation Period|Adverse Event|0
1148376|NCT03052751|2258853|FG002|Observation Period|Adverse Event|0
1148377|NCT03052751|2258854|FG003|Observation Period|Adverse Event|0
1148378|NCT03052751|2258855|FG004|Observation Period|Adverse Event|1
1148379|NCT03052751|2258856|FG005|Observation Period|Adverse Event|0
1148380|NCT03052764|2258868|FG000|Double-Blind Treatment Period|Adverse Event|2
1148381|NCT03052764|2258869|FG001|Double-Blind Treatment Period|Adverse Event|0
1148382|NCT03052764|2258868|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
1148383|NCT03052764|2258869|FG001|Double-Blind Treatment Period|Lack of Efficacy|0
1148384|NCT03052764|2258868|FG000|Double-Blind Treatment Period|Protocol Violation|2
1148385|NCT03052764|2258869|FG001|Double-Blind Treatment Period|Protocol Violation|1
1148386|NCT03052764|2258868|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3
1148387|NCT03052764|2258869|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
1148388|NCT03052764|2258868|FG000|Double-Blind Treatment Period|Reason not Specified|2
1148389|NCT03052764|2258869|FG001|Double-Blind Treatment Period|Reason not Specified|1
1148390|NCT03052816|2258879|FG000|Overall Study|Withdrawal by Subject|1
1148391|NCT03052816|2258880|FG001|Overall Study|Withdrawal by Subject|0
1148392|NCT03052816|2258879|FG000|Overall Study|Desired opioids|2
1148393|NCT03052816|2258880|FG001|Overall Study|Desired opioids|0
1148395|NCT03052959|2258894|FG000|Overall Study|Lost to Follow-up|4
1148396|NCT03052959|2258895|FG001|Overall Study|Lost to Follow-up|5
1148397|NCT03053050|2258915|FG000|Randomized Phase|Study Terminated by Sponsor|259
1148398|NCT03053050|2258916|FG001|Randomized Phase|Study Terminated by Sponsor|260
1148399|NCT03053050|2258917|FG002|Randomized Phase|Study Terminated by Sponsor|128
1148400|NCT03053050|2258918|FG003|Randomized Phase|Study Terminated by Sponsor|0
1148401|NCT03053050|2258915|FG000|Randomized Phase|Withdrew Consent|16
1148402|NCT03053050|2258916|FG001|Randomized Phase|Withdrew Consent|8
1148403|NCT03053050|2258917|FG002|Randomized Phase|Withdrew Consent|9
1148404|NCT03053050|2258918|FG003|Randomized Phase|Withdrew Consent|0
1148405|NCT03053050|2258915|FG000|Randomized Phase|Investigator's Discretion|6
1148406|NCT03053050|2258916|FG001|Randomized Phase|Investigator's Discretion|6
1148407|NCT03053050|2258917|FG002|Randomized Phase|Investigator's Discretion|3
1148408|NCT03053050|2258918|FG003|Randomized Phase|Investigator's Discretion|0
1148409|NCT03053050|2258915|FG000|Randomized Phase|Lost to Follow-up|5
1148410|NCT03053050|2258916|FG001|Randomized Phase|Lost to Follow-up|1
1148411|NCT03053050|2258917|FG002|Randomized Phase|Lost to Follow-up|1
1148412|NCT03053050|2258918|FG003|Randomized Phase|Lost to Follow-up|0
1148413|NCT03053050|2258915|FG000|Randomized Phase|Adverse Event|0
1148414|NCT03053050|2258916|FG001|Randomized Phase|Adverse Event|1
1148415|NCT03053050|2258917|FG002|Randomized Phase|Adverse Event|0
1148416|NCT03053050|2258918|FG003|Randomized Phase|Adverse Event|0
1148417|NCT03053050|2258915|FG000|Randomized Phase|Randomized but Never Treated|2
1148418|NCT03053050|2258916|FG001|Randomized Phase|Randomized but Never Treated|2
1148419|NCT03053050|2258917|FG002|Randomized Phase|Randomized but Never Treated|2
1148420|NCT03053050|2258918|FG003|Randomized Phase|Randomized but Never Treated|0
1148421|NCT03053050|2258915|FG000|Randomized Phase|Entered the Open-Label Phase|36
1148422|NCT03053050|2258916|FG001|Randomized Phase|Entered the Open-Label Phase|45
1148423|NCT03053050|2258917|FG002|Randomized Phase|Entered the Open-Label Phase|18
1148424|NCT03053050|2258918|FG003|Randomized Phase|Entered the Open-Label Phase|0
1148425|NCT03053050|2258915|FG000|Open-label Phase|Study Terminated by Sponsor|0
1148426|NCT03053050|2258916|FG001|Open-label Phase|Study Terminated by Sponsor|0
1148427|NCT03053050|2258917|FG002|Open-label Phase|Study Terminated by Sponsor|0
1148428|NCT03053050|2258918|FG003|Open-label Phase|Study Terminated by Sponsor|89
1148429|NCT03053050|2258915|FG000|Open-label Phase|Withdrew Consent|0
1148430|NCT03053050|2258916|FG001|Open-label Phase|Withdrew Consent|0
1148431|NCT03053050|2258917|FG002|Open-label Phase|Withdrew Consent|0
1148432|NCT03053050|2258918|FG003|Open-label Phase|Withdrew Consent|6
1148433|NCT03053050|2258915|FG000|Open-label Phase|Investigator's Discretion|0
1148434|NCT03053050|2258916|FG001|Open-label Phase|Investigator's Discretion|0
1148435|NCT03053050|2258917|FG002|Open-label Phase|Investigator's Discretion|0
1148436|NCT03053050|2258918|FG003|Open-label Phase|Investigator's Discretion|4
1148437|NCT03053063|2258930|FG000|Randomized Phase|Study Terminated by Sponsor|326
1148438|NCT03053063|2258931|FG001|Randomized Phase|Study Terminated by Sponsor|317
1148439|NCT03053063|2258932|FG002|Randomized Phase|Study Terminated by Sponsor|161
1148440|NCT03053063|2258933|FG003|Randomized Phase|Study Terminated by Sponsor|0
1148441|NCT03053063|2258930|FG000|Randomized Phase|Withdrew consent|8
1148442|NCT03053063|2258931|FG001|Randomized Phase|Withdrew consent|11
1148443|NCT03053063|2258932|FG002|Randomized Phase|Withdrew consent|5
1148444|NCT03053063|2258933|FG003|Randomized Phase|Withdrew consent|0
1148445|NCT03053063|2258930|FG000|Randomized Phase|Investigator's Discretion|8
1148446|NCT03053063|2258931|FG001|Randomized Phase|Investigator's Discretion|6
1148447|NCT03053063|2258932|FG002|Randomized Phase|Investigator's Discretion|2
1148448|NCT03053063|2258933|FG003|Randomized Phase|Investigator's Discretion|0
1148449|NCT03053063|2258930|FG000|Randomized Phase|Lost to Follow-up|3
1148450|NCT03053063|2258931|FG001|Randomized Phase|Lost to Follow-up|5
1148451|NCT03053063|2258932|FG002|Randomized Phase|Lost to Follow-up|1
1148452|NCT03053063|2258933|FG003|Randomized Phase|Lost to Follow-up|0
1148453|NCT03053063|2258930|FG000|Randomized Phase|Adverse Event|0
1148454|NCT03053063|2258931|FG001|Randomized Phase|Adverse Event|1
1148455|NCT03053063|2258932|FG002|Randomized Phase|Adverse Event|0
1148456|NCT03053063|2258933|FG003|Randomized Phase|Adverse Event|0
1148457|NCT03053063|2258930|FG000|Randomized Phase|Randomized but Never Treated|1
1148458|NCT03053063|2258931|FG001|Randomized Phase|Randomized but Never Treated|3
1148459|NCT03053063|2258932|FG002|Randomized Phase|Randomized but Never Treated|2
1148460|NCT03053063|2258933|FG003|Randomized Phase|Randomized but Never Treated|0
1148461|NCT03053063|2258930|FG000|Randomized Phase|Entered the Open-Label Phase|9
1148462|NCT03053063|2258931|FG001|Randomized Phase|Entered the Open-Label Phase|11
1148463|NCT03053063|2258932|FG002|Randomized Phase|Entered the Open-Label Phase|3
1148464|NCT03053063|2258933|FG003|Randomized Phase|Entered the Open-Label Phase|0
1148465|NCT03053063|2258930|FG000|Open-Label Phase|Study Terminated by Sponsor|0
1148466|NCT03053063|2258931|FG001|Open-Label Phase|Study Terminated by Sponsor|0
1148467|NCT03053063|2258932|FG002|Open-Label Phase|Study Terminated by Sponsor|0
1148468|NCT03053063|2258933|FG003|Open-Label Phase|Study Terminated by Sponsor|19
1148469|NCT03053063|2258930|FG000|Open-Label Phase|Death|0
1148470|NCT03053063|2258931|FG001|Open-Label Phase|Death|0
1148471|NCT03053063|2258932|FG002|Open-Label Phase|Death|0
1148472|NCT03053063|2258933|FG003|Open-Label Phase|Death|2
1148473|NCT03053063|2258930|FG000|Open-Label Phase|Investigator's discretion|0
1148474|NCT03053063|2258931|FG001|Open-Label Phase|Investigator's discretion|0
1148475|NCT03053063|2258932|FG002|Open-Label Phase|Investigator's discretion|0
1148476|NCT03053063|2258933|FG003|Open-Label Phase|Investigator's discretion|2
1148477|NCT03053102|2258942|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1
1148478|NCT03053102|2258942|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1
1148479|NCT03053180|2258947|FG000|Overall Study|Failure to Return|1
1148480|NCT03053271|2258951|FG000|Overall Study|Did not meet randomization criteria|3
1148481|NCT03053271|2258951|FG000|Overall Study|Withdrawal by Subject|1
1148482|NCT03053427|2258967|FG000|Overall Study|Adverse Event|4
1148483|NCT03053427|2258968|FG001|Overall Study|Adverse Event|4
1148484|NCT03053427|2258967|FG000|Overall Study|Lack of Efficacy|1
1148485|NCT03053427|2258968|FG001|Overall Study|Lack of Efficacy|3
1148486|NCT03053427|2258967|FG000|Overall Study|Lost to Follow-up|2
1148487|NCT03053427|2258968|FG001|Overall Study|Lost to Follow-up|2
1148488|NCT03053427|2258967|FG000|Overall Study|Worsening of the target disease|0
1148489|NCT03053427|2258968|FG001|Overall Study|Worsening of the target disease|1
1148490|NCT03053427|2258967|FG000|Overall Study|Protocol Deviation|3
1148491|NCT03053427|2258968|FG001|Overall Study|Protocol Deviation|3
1148492|NCT03053427|2258967|FG000|Overall Study|Withdrawal by Subject|3
1148493|NCT03053427|2258968|FG001|Overall Study|Withdrawal by Subject|2
1148494|NCT03053427|2258967|FG000|Overall Study|Miscellaneous|0
1148495|NCT03053427|2258968|FG001|Overall Study|Miscellaneous|1
1148496|NCT03053492|2258976|FG000|Overall Study|Adverse Event|1
1148497|NCT03053492|2258977|FG001|Overall Study|Adverse Event|1
1148498|NCT03053492|2258976|FG000|Overall Study|Withdrawal by Subject|7
1148499|NCT03053492|2258977|FG001|Overall Study|Withdrawal by Subject|5
1148500|NCT03054064|2258994|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1
1148501|NCT03054064|2258994|FG000|Overall Study|Investigator Decision|2
1148502|NCT03054064|2258994|FG000|Overall Study|Bladder Issue|1
1148503|NCT03054064|2258994|FG000|Overall Study|High Blood Pressure|1
1148504|NCT03054064|2258994|FG000|Overall Study|Change in Status|1
1148505|NCT03054337|2259026|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1
1148506|NCT03054337|2259027|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2
1148507|NCT03054337|2259028|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1
1148508|NCT03054337|2259029|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0
1148509|NCT03054337|2259030|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0
1148510|NCT03054337|2259031|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1
1148511|NCT03054350|2259064|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
1148512|NCT03054350|2259065|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
1148513|NCT03054350|2259066|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1
1148514|NCT03054350|2259067|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
1148515|NCT03054350|2259068|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
1148516|NCT03054350|2259069|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3
1148517|NCT03054350|2259064|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
1148518|NCT03054350|2259065|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
1148519|NCT03054350|2259066|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1
1148520|NCT03054350|2259067|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
1148521|NCT03054350|2259068|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
1148522|NCT03054350|2259069|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
1148523|NCT03054350|2259064|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
1148524|NCT03054350|2259065|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
1148525|NCT03054350|2259066|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
1148526|NCT03054350|2259067|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
1148527|NCT03054350|2259068|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
1148528|NCT03054350|2259069|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
1148529|NCT03054350|2259064|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0
1148530|NCT03054350|2259065|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0
1148531|NCT03054350|2259066|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1
1148532|NCT03054350|2259067|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0
1148533|NCT03054350|2259068|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0
1148534|NCT03054350|2259069|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0
1148535|NCT03054428|2259103|FG000|Overall Study|Physician Decision|0
1148536|NCT03054428|2259104|FG001|Overall Study|Physician Decision|1
1148537|NCT03054428|2259105|FG002|Overall Study|Physician Decision|1
1148538|NCT03054428|2259103|FG000|Overall Study|Lack of Efficacy|3
1148539|NCT03054428|2259104|FG001|Overall Study|Lack of Efficacy|1
1148540|NCT03054428|2259105|FG002|Overall Study|Lack of Efficacy|0
1148541|NCT03054428|2259103|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0
1148542|NCT03054428|2259104|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0
1148543|NCT03054428|2259105|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1
1148544|NCT03054428|2259103|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1
1148545|NCT03054428|2259104|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0
1148546|NCT03054428|2259105|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0
1148547|NCT03054428|2259103|FG000|Overall Study|Transitioned to OLE study|76
1148548|NCT03054428|2259104|FG001|Overall Study|Transitioned to OLE study|76
1148549|NCT03054428|2259105|FG002|Overall Study|Transitioned to OLE study|73
1148550|NCT03054428|2259103|FG000|Overall Study|Withdrawal by Subject|3
1148551|NCT03054428|2259104|FG001|Overall Study|Withdrawal by Subject|2
1148552|NCT03054428|2259105|FG002|Overall Study|Withdrawal by Subject|3
1148553|NCT03054428|2259103|FG000|Overall Study|Lost to Follow-up|0
1148554|NCT03054428|2259104|FG001|Overall Study|Lost to Follow-up|0
1148555|NCT03054428|2259105|FG002|Overall Study|Lost to Follow-up|1
1148556|NCT03054870|2259200|FG000|Day of Ventilation Imaging|Protocol Violation|4
1148557|NCT03054870|2259200|FG000|Day of Ventilation Imaging|Lost to Follow-up|1
1148558|NCT03055195|2259252|FG000|Overall Study|Lack of Efficacy|1
1148559|NCT03055195|2259253|FG001|Overall Study|Lack of Efficacy|0
1148560|NCT03055195|2259252|FG000|Overall Study|Withdrawal by Subject|6
1148561|NCT03055195|2259253|FG001|Overall Study|Withdrawal by Subject|7
1148562|NCT03055195|2259252|FG000|Overall Study|Study Terminated by Sponsor|2
1148563|NCT03055195|2259253|FG001|Overall Study|Study Terminated by Sponsor|6
1148564|NCT03055195|2259252|FG000|Overall Study|Protocol Violation|2
1148565|NCT03055195|2259253|FG001|Overall Study|Protocol Violation|1
1148566|NCT03055195|2259252|FG000|Overall Study|Physician Decision|1
1148567|NCT03055195|2259253|FG001|Overall Study|Physician Decision|0
1148568|NCT03055221|2259259|FG000|Overall Study|Adverse Event|2
1148569|NCT03055221|2259259|FG000|Overall Study|Withdrawal by Subject|4
1148570|NCT03055221|2259259|FG000|Overall Study|Death|6
1148571|NCT03055221|2259259|FG000|Overall Study|Physician Decision|1
1148572|NCT03055221|2259259|FG000|Overall Study|Study terminated by Sponsor|3
1148573|NCT03055260|2259265|FG000|Overall Study|Withdrawal by Subject|1
1148574|NCT03055260|2259266|FG001|Overall Study|Withdrawal by Subject|0
1148575|NCT03055338|2259275|FG000|Overall Study|Lost to Follow-up|9
1148576|NCT03055338|2259276|FG001|Overall Study|Lost to Follow-up|2
1148577|NCT03055338|2259277|FG002|Overall Study|Lost to Follow-up|3
1148578|NCT03055338|2259275|FG000|Overall Study|No Post-treatment Protocol Contact|0
1148579|NCT03055338|2259276|FG001|Overall Study|No Post-treatment Protocol Contact|1
1148580|NCT03055338|2259277|FG002|Overall Study|No Post-treatment Protocol Contact|0
1148581|NCT03055338|2259275|FG000|Overall Study|Physician Decision|0
1148582|NCT03055338|2259276|FG001|Overall Study|Physician Decision|0
1148583|NCT03055338|2259277|FG002|Overall Study|Physician Decision|2
1148584|NCT03055338|2259275|FG000|Overall Study|Withdrawal by Subject|9
1148585|NCT03055338|2259276|FG001|Overall Study|Withdrawal by Subject|8
1148586|NCT03055338|2259277|FG002|Overall Study|Withdrawal by Subject|7
1148587|NCT03055494|2259287|FG000|Overall Study|Lost to Follow-up|6
1148588|NCT03055494|2259288|FG001|Overall Study|Lost to Follow-up|0
1148589|NCT03055494|2259287|FG000|Overall Study|Physician Decision|2
1148590|NCT03055494|2259288|FG001|Overall Study|Physician Decision|0
1148591|NCT03055494|2259287|FG000|Overall Study|Withdrawal by Subject|1
1148592|NCT03055494|2259288|FG001|Overall Study|Withdrawal by Subject|0
1148593|NCT03055494|2259287|FG000|Overall Study|Adverse Event|0
1148594|NCT03055494|2259288|FG001|Overall Study|Adverse Event|1
1148595|NCT03055494|2259287|FG000|Overall Study|Non-compliance with study treatment|1
1148596|NCT03055494|2259288|FG001|Overall Study|Non-compliance with study treatment|0
1148597|NCT03055624|2259295|FG000|Overall Study|Study closed|9
1148598|NCT03055806|2259307|FG000|Overall Study|Adverse Event|0
1148599|NCT03055806|2259308|FG001|Overall Study|Adverse Event|0
1148600|NCT03055806|2259309|FG002|Overall Study|Adverse Event|1
1148601|NCT03055806|2259310|FG003|Overall Study|Adverse Event|1
1148602|NCT03055806|2259307|FG000|Overall Study|Lost to Follow-up|0
1148603|NCT03055806|2259308|FG001|Overall Study|Lost to Follow-up|3
1148604|NCT03055806|2259309|FG002|Overall Study|Lost to Follow-up|6
1148605|NCT03055806|2259310|FG003|Overall Study|Lost to Follow-up|7
1148606|NCT03055806|2259307|FG000|Overall Study|Physician Decision|1
1148607|NCT03055806|2259308|FG001|Overall Study|Physician Decision|0
1148608|NCT03055806|2259309|FG002|Overall Study|Physician Decision|0
1148609|NCT03055806|2259310|FG003|Overall Study|Physician Decision|1
1148610|NCT03055806|2259307|FG000|Overall Study|Protocol Violation|1
1148611|NCT03055806|2259308|FG001|Overall Study|Protocol Violation|0
1148612|NCT03055806|2259309|FG002|Overall Study|Protocol Violation|0
1148613|NCT03055806|2259310|FG003|Overall Study|Protocol Violation|0
1148614|NCT03055806|2259307|FG000|Overall Study|Withdrawal of consent to continue drug|1
1148615|NCT03055806|2259308|FG001|Overall Study|Withdrawal of consent to continue drug|1
1148616|NCT03055806|2259309|FG002|Overall Study|Withdrawal of consent to continue drug|2
1148617|NCT03055806|2259310|FG003|Overall Study|Withdrawal of consent to continue drug|0
1148618|NCT03055806|2259307|FG000|Overall Study|Withdrawal of consent to continue study|2
1148619|NCT03055806|2259308|FG001|Overall Study|Withdrawal of consent to continue study|3
1148620|NCT03055806|2259309|FG002|Overall Study|Withdrawal of consent to continue study|4
1148621|NCT03055806|2259310|FG003|Overall Study|Withdrawal of consent to continue study|6
1148622|NCT03055806|2259307|FG000|Overall Study|Partner not willing to try intercourse|1
1148623|NCT03055806|2259308|FG001|Overall Study|Partner not willing to try intercourse|0
1148624|NCT03055806|2259309|FG002|Overall Study|Partner not willing to try intercourse|0
1148625|NCT03055806|2259310|FG003|Overall Study|Partner not willing to try intercourse|0
1148626|NCT03055832|2259322|FG000|Week 2|Withdrawal by Subject|1
1148627|NCT03055832|2259323|FG001|Week 2|Withdrawal by Subject|0
1148628|NCT03055858|2259343|FG000|Overall Study|Death|5
1148629|NCT03055858|2259343|FG000|Overall Study|Adverse Event|1
1148630|NCT03055936|2259355|FG000|Overall Study|Adverse Event|0
1148631|NCT03055936|2259356|FG001|Overall Study|Adverse Event|1
1148632|NCT03055936|2259357|FG002|Overall Study|Adverse Event|1
1148633|NCT03055936|2259358|FG003|Overall Study|Adverse Event|1
1148634|NCT03055936|2259355|FG000|Overall Study|Personal reason|2
1148635|NCT03055936|2259356|FG001|Overall Study|Personal reason|0
1148636|NCT03055936|2259357|FG002|Overall Study|Personal reason|1
1148637|NCT03055936|2259358|FG003|Overall Study|Personal reason|0
1148638|NCT03055988|2259392|FG000|Period 1|Adverse Event|0
1148639|NCT03055988|2259393|FG001|Period 1|Adverse Event|1
1148640|NCT03055988|2259392|FG000|Period 1|Lost to Follow-up|1
1148641|NCT03055988|2259393|FG001|Period 1|Lost to Follow-up|0
1148642|NCT03055988|2259392|FG000|Period 1|Withdrawal by Subject|0
1148643|NCT03055988|2259393|FG001|Period 1|Withdrawal by Subject|4
1148644|NCT03055988|2259392|FG000|Period 2|Adverse Event|0
1148645|NCT03055988|2259393|FG001|Period 2|Adverse Event|1
1148646|NCT03055988|2259392|FG000|Period 2|Other than listed|1
1148647|NCT03055988|2259393|FG001|Period 2|Other than listed|1
1148648|NCT03056040|2259401|FG000|Primary Evaluation Period|Withdrawal by Subject|1
1148649|NCT03056040|2259402|FG001|Primary Evaluation Period|Withdrawal by Subject|1
1148650|NCT03056040|2259401|FG000|Primary Evaluation Period|Lack of Efficacy|0
1148651|NCT03056040|2259402|FG001|Primary Evaluation Period|Lack of Efficacy|1
1148652|NCT03056040|2259401|FG000|Primary Evaluation Period|Pregnancy|0
1148653|NCT03056040|2259402|FG001|Primary Evaluation Period|Pregnancy|1
1148654|NCT03056300|2259412|FG000|Overall Study|Surgical reason per study protocol|3
1148655|NCT03056352|2259416|FG000|Overall Study|Lost to Follow-up|1
1148656|NCT03056573|2259438|FG000|Overall Study|Death|2
1148657|NCT03056573|2259439|FG001|Overall Study|Death|4
1148658|NCT03056573|2259438|FG000|Overall Study|Withdrawal by Subject|2
1148659|NCT03056573|2259439|FG001|Overall Study|Withdrawal by Subject|0
1148660|NCT03056573|2259438|FG000|Overall Study|Lost to Follow-up|1
1148661|NCT03056573|2259439|FG001|Overall Study|Lost to Follow-up|1
1148662|NCT03056690|2259447|FG000|Overall Study|Adverse Event|3
1148663|NCT03056690|2259448|FG001|Overall Study|Adverse Event|2
1148664|NCT03056690|2259447|FG000|Overall Study|Lack of Efficacy|1
1148665|NCT03056690|2259448|FG001|Overall Study|Lack of Efficacy|2
1148666|NCT03056690|2259447|FG000|Overall Study|Lost to Follow-up|3
1148667|NCT03056690|2259448|FG001|Overall Study|Lost to Follow-up|2
1148668|NCT03056690|2259447|FG000|Overall Study|Protocol Violation|2
1148669|NCT03056690|2259448|FG001|Overall Study|Protocol Violation|2
1148670|NCT03056690|2259447|FG000|Overall Study|Withdrawal by Subject|3
1148671|NCT03056690|2259448|FG001|Overall Study|Withdrawal by Subject|6
1148672|NCT03056690|2259447|FG000|Overall Study|Non-compliance with Study Drug|1
1148673|NCT03056690|2259448|FG001|Overall Study|Non-compliance with Study Drug|0
1148674|NCT03056690|2259447|FG000|Overall Study|Miscellaneous|1
1148675|NCT03056690|2259448|FG001|Overall Study|Miscellaneous|2
1148676|NCT03057496|2259471|FG000|Overall Study|Withdrawal by Subject|8
1148677|NCT03057496|2259471|FG000|Overall Study|Lost to Follow-up|5
1148678|NCT03057496|2259471|FG000|Overall Study|Did not use device during home trial|3
1148679|NCT03057496|2259471|FG000|Overall Study|Device failure|2
1148680|NCT03057977|2259492|FG000|Discontinuation From Treatment|Withdrawal by Subject|124
1148681|NCT03057977|2259493|FG001|Discontinuation From Treatment|Withdrawal by Subject|92
1148682|NCT03057977|2259492|FG000|Discontinuation From Treatment|Lost to Follow-up|11
1148683|NCT03057977|2259493|FG001|Discontinuation From Treatment|Lost to Follow-up|17
1148684|NCT03057977|2259492|FG000|Discontinuation From Treatment|Protocol Violation|6
1148685|NCT03057977|2259493|FG001|Discontinuation From Treatment|Protocol Violation|5
1148686|NCT03057977|2259492|FG000|Discontinuation From Treatment|Not treated|4
1148687|NCT03057977|2259493|FG001|Discontinuation From Treatment|Not treated|0
1148688|NCT03057977|2259492|FG000|Discontinuation From Treatment|Adverse Event|343
1148689|NCT03057977|2259493|FG001|Discontinuation From Treatment|Adverse Event|337
1148690|NCT03057977|2259492|FG000|Discontinuation From Treatment|Reason Unknown|0
1148691|NCT03057977|2259493|FG001|Discontinuation From Treatment|Reason Unknown|1
1148692|NCT03057977|2259492|FG000|Discontinuation From Treatment|Personal Reasons|1
1148693|NCT03057977|2259493|FG001|Discontinuation From Treatment|Personal Reasons|1
1148694|NCT03057977|2259492|FG000|Discontinuation From Treatment|Unblinded medication|1
1148695|NCT03057977|2259493|FG001|Discontinuation From Treatment|Unblinded medication|0
1148696|NCT03057977|2259492|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
1148697|NCT03057977|2259493|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
1148698|NCT03057977|2259492|FG000|Discontinuation From Treatment|Principle Investigator Decision|2
1148699|NCT03057977|2259493|FG001|Discontinuation From Treatment|Principle Investigator Decision|0
1148700|NCT03057977|2259492|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2
1148701|NCT03057977|2259493|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4
902188|NCT00739297|1875909|FG004|First Washout Period of 4-7 Days|Adverse Event|0
902189|NCT00739297|1875910|FG005|First Washout Period of 4-7 Days|Adverse Event|0
902190|NCT00739297|1875911|FG006|First Washout Period of 4-7 Days|Adverse Event|2
902191|NCT00739297|1875905|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
902192|NCT00739297|1875906|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
902193|NCT00739297|1875907|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
902194|NCT00739297|1875908|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
902195|NCT00739297|1875909|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
902196|NCT00739297|1875910|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
902197|NCT00739297|1875911|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
902198|NCT00739310|1875927|FG000|Overall Study|Poor adherance to prescribed therapy|4
902199|NCT00739310|1875927|FG000|Overall Study|Withdrawal by Subject|1
902200|NCT00739310|1875927|FG000|Overall Study|Lost to Follow-up|2
902201|NCT00739596|1875952|FG000|Overall Study|Adverse Event|12
902202|NCT00739596|1875953|FG001|Overall Study|Adverse Event|6
902203|NCT00739596|1875952|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
902204|NCT00739596|1875953|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
902205|NCT00739596|1875952|FG000|Overall Study|Patient Withdrew Consent|8
902206|NCT00739596|1875953|FG001|Overall Study|Patient Withdrew Consent|8
902207|NCT00739596|1875952|FG000|Overall Study|Lost to Follow-up|0
902208|NCT00739596|1875953|FG001|Overall Study|Lost to Follow-up|2
902209|NCT00739596|1875952|FG000|Overall Study|Protocol Deviation|1
902210|NCT00739596|1875953|FG001|Overall Study|Protocol Deviation|1
902211|NCT00739648|1875961|FG000|Overall Study|Adverse Event|3
902212|NCT00739648|1875962|FG001|Overall Study|Adverse Event|15
902213|NCT00739648|1875961|FG000|Overall Study|Withdrawal by Subject|13
902214|NCT00739648|1875962|FG001|Overall Study|Withdrawal by Subject|25
902215|NCT00739648|1875961|FG000|Overall Study|Lost to Follow-up|4
902216|NCT00739648|1875962|FG001|Overall Study|Lost to Follow-up|7
902217|NCT00739648|1875961|FG000|Overall Study|Death|2
902218|NCT00739648|1875962|FG001|Overall Study|Death|0
902219|NCT00739648|1875961|FG000|Overall Study|Do not know|4
902220|NCT00739648|1875962|FG001|Overall Study|Do not know|6
1148702|NCT03057977|2259492|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4
1148703|NCT03057977|2259493|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3
1148704|NCT03057977|2259492|FG000|Discontinuation From Treatment|Unable to continue treatment|4
1148705|NCT03057977|2259493|FG001|Discontinuation From Treatment|Unable to continue treatment|1
1148706|NCT03057977|2259492|FG000|Discontinuation From Treatment|Not attending study visit|3
1148707|NCT03057977|2259493|FG001|Discontinuation From Treatment|Not attending study visit|10
1148708|NCT03057977|2259492|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1
1148709|NCT03057977|2259493|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4
1148710|NCT03057977|2259492|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8
1148711|NCT03057977|2259493|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6
1148712|NCT03057977|2259492|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
1148713|NCT03057977|2259493|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
1148714|NCT03057977|2259492|FG000|Discontinuation From Trial|Limited follow-up agreed|2
1148715|NCT03057977|2259493|FG001|Discontinuation From Trial|Limited follow-up agreed|2
1148716|NCT03057977|2259492|FG000|Discontinuation From Trial|Withdrawal by Subject|9
1148717|NCT03057977|2259493|FG001|Discontinuation From Trial|Withdrawal by Subject|11
1148718|NCT03058679|2259501|FG000|Baseline to Week 6|Lost to Follow-up|3
1148719|NCT03058679|2259502|FG001|Baseline to Week 6|Lost to Follow-up|2
1148720|NCT03058679|2259501|FG000|Baseline to Week 6|Change in Crohn's disease medication|4
1148721|NCT03058679|2259502|FG001|Baseline to Week 6|Change in Crohn's disease medication|2
1148722|NCT03058679|2259501|FG000|Baseline to Week 6|Adverse Event|6
1148723|NCT03058679|2259502|FG001|Baseline to Week 6|Adverse Event|6
1148724|NCT03058679|2259501|FG000|Baseline to Week 6|Withdrawal by Subject|4
1148725|NCT03058679|2259502|FG001|Baseline to Week 6|Withdrawal by Subject|3
1148726|NCT03058679|2259501|FG000|Baseline to Week 6|Difficulty following the diet|0
1148727|NCT03058679|2259502|FG001|Baseline to Week 6|Difficulty following the diet|2
1148728|NCT03058679|2259501|FG000|Baseline to Week 6|Physician Decision|1
1148729|NCT03058679|2259502|FG001|Baseline to Week 6|Physician Decision|0
1148730|NCT03058679|2259501|FG000|Week 6 to Week 12|Change in medication|5
1148731|NCT03058679|2259502|FG001|Week 6 to Week 12|Change in medication|7
1148732|NCT03058679|2259501|FG000|Week 6 to Week 12|Adverse Event|4
1148733|NCT03058679|2259502|FG001|Week 6 to Week 12|Adverse Event|3
1148734|NCT03058679|2259501|FG000|Week 6 to Week 12|Withdrawal by Subject|9
1148735|NCT03058679|2259502|FG001|Week 6 to Week 12|Withdrawal by Subject|4
1148736|NCT03058679|2259501|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2
1148737|NCT03058679|2259502|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3
1148738|NCT03058692|2259510|FG000|Overall Study|Lost to Follow-up|2
1148739|NCT03058692|2259511|FG001|Overall Study|Lost to Follow-up|1
1148740|NCT03058692|2259510|FG000|Overall Study|Withdrawal by Subject|1
1148741|NCT03058692|2259511|FG001|Overall Study|Withdrawal by Subject|1
1148742|NCT03058991|2259521|FG000|Overall Study|Lost to Follow-up|17
1148743|NCT03058991|2259522|FG001|Overall Study|Lost to Follow-up|12
1148744|NCT03058991|2259523|FG002|Overall Study|Lost to Follow-up|12
1148745|NCT03058991|2259521|FG000|Overall Study|Withdrawal by Subject|1
1148746|NCT03058991|2259522|FG001|Overall Study|Withdrawal by Subject|0
1148747|NCT03058991|2259523|FG002|Overall Study|Withdrawal by Subject|0
1148748|NCT03060447|2259546|FG000|Overall Study|Withdrawal by Subject|2
1148749|NCT03060447|2259547|FG001|Overall Study|Withdrawal by Subject|0
1148750|NCT03060512|2259565|FG000|Overall Study|Adverse Event|4
1148751|NCT03060512|2259566|FG001|Overall Study|Adverse Event|6
1148752|NCT03060512|2259565|FG000|Overall Study|Lost to Follow-up|1
1148753|NCT03060512|2259566|FG001|Overall Study|Lost to Follow-up|1
1148754|NCT03060512|2259565|FG000|Overall Study|Withdrawal by Subject|1
1148755|NCT03060512|2259566|FG001|Overall Study|Withdrawal by Subject|0
1148756|NCT03060512|2259565|FG000|Overall Study|Non-compliance with study medication|1
1148757|NCT03060512|2259566|FG001|Overall Study|Non-compliance with study medication|2
1148758|NCT03060551|2259577|FG000|Overall Study|Withdrawal by Subject|1
1148759|NCT03060551|2259577|FG000|Overall Study|Adverse Event|1
1148760|NCT03061097|2259592|FG000|Overall Study|Withdrawal by Subject|0
1148761|NCT03061097|2259593|FG001|Overall Study|Withdrawal by Subject|3
1148762|NCT03061175|2259601|FG000|Baseline|Participant was deemed ineligible|1
1148763|NCT03061175|2259602|FG001|Baseline|Participant was deemed ineligible|0
1148764|NCT03061175|2259601|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6
1148765|NCT03061175|2259602|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2
1148766|NCT03061175|2259601|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0
1148767|NCT03061175|2259602|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1
1148768|NCT03061175|2259601|FG000|Followup 2 at 6 Months|Lost to Follow-up|4
1148769|NCT03061175|2259602|FG001|Followup 2 at 6 Months|Lost to Follow-up|7
1148770|NCT03061188|2259612|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0
1148771|NCT03061188|2259613|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0
1148772|NCT03061188|2259614|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1
1148773|NCT03061188|2259615|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1
902221|NCT00739661|1875974|FG000|Overall Study|Adverse Event|2
902222|NCT00739661|1875975|FG001|Overall Study|Adverse Event|0
902223|NCT00739661|1875974|FG000|Overall Study|Physician decision to withdraw patient|1
902224|NCT00739661|1875975|FG001|Overall Study|Physician decision to withdraw patient|0
1148774|NCT03061188|2259612|FG000|On Follow-up for 3 Years|Death|0
1148775|NCT03061188|2259613|FG001|On Follow-up for 3 Years|Death|3
1148776|NCT03061188|2259614|FG002|On Follow-up for 3 Years|Death|5
1148777|NCT03061188|2259615|FG003|On Follow-up for 3 Years|Death|2
1148778|NCT03061188|2259612|FG000|On Follow-up for 3 Years|Still in follow-up|0
1148779|NCT03061188|2259613|FG001|On Follow-up for 3 Years|Still in follow-up|0
1148780|NCT03061188|2259614|FG002|On Follow-up for 3 Years|Still in follow-up|0
1148781|NCT03061188|2259615|FG003|On Follow-up for 3 Years|Still in follow-up|3
1148782|NCT03061214|2259633|FG000|Overall Study|Withdrawal by Subject|21
1148783|NCT03061214|2259634|FG001|Overall Study|Withdrawal by Subject|26
1148784|NCT03061214|2259635|FG002|Overall Study|Withdrawal by Subject|9
1148785|NCT03061214|2259633|FG000|Overall Study|Lost to Follow-up|3
1148786|NCT03061214|2259634|FG001|Overall Study|Lost to Follow-up|1
1148787|NCT03061214|2259635|FG002|Overall Study|Lost to Follow-up|1
1148788|NCT03061214|2259633|FG000|Overall Study|Death|1
1148789|NCT03061214|2259634|FG001|Overall Study|Death|1
1148790|NCT03061214|2259635|FG002|Overall Study|Death|0
1148791|NCT03061331|2259645|FG000|Washout Period (8 Weeks)|Adverse Event|2
1148792|NCT03061331|2259646|FG001|Washout Period (8 Weeks)|Adverse Event|1
1148793|NCT03062891|2259707|FG000|Overall Study|Withdrawal by Subject|2
1148794|NCT03062891|2259708|FG001|Overall Study|Withdrawal by Subject|0
1148795|NCT03062891|2259707|FG000|Overall Study|Lost to Follow-up|50
1148796|NCT03062891|2259708|FG001|Overall Study|Lost to Follow-up|38
1148797|NCT03063086|2259735|FG000|Overall Study|technical problems|1
1148798|NCT03063086|2259736|FG001|Overall Study|technical problems|0
1148799|NCT03063086|2259737|FG002|Overall Study|technical problems|0
1148800|NCT03063086|2259738|FG003|Overall Study|technical problems|0
1148801|NCT03063086|2259739|FG004|Overall Study|technical problems|0
1148802|NCT03063086|2259740|FG005|Overall Study|technical problems|0
1148803|NCT03063086|2259735|FG000|Overall Study|Adverse Event|1
1148804|NCT03063086|2259736|FG001|Overall Study|Adverse Event|1
1148805|NCT03063086|2259737|FG002|Overall Study|Adverse Event|1
1148806|NCT03063086|2259738|FG003|Overall Study|Adverse Event|1
1148807|NCT03063086|2259739|FG004|Overall Study|Adverse Event|0
1148808|NCT03063086|2259740|FG005|Overall Study|Adverse Event|0
1148809|NCT03063086|2259735|FG000|Overall Study|subject/guardian decision|1
1148810|NCT03063086|2259736|FG001|Overall Study|subject/guardian decision|0
1148811|NCT03063086|2259737|FG002|Overall Study|subject/guardian decision|0
1148812|NCT03063086|2259738|FG003|Overall Study|subject/guardian decision|0
1148813|NCT03063086|2259739|FG004|Overall Study|subject/guardian decision|0
1148814|NCT03063086|2259740|FG005|Overall Study|subject/guardian decision|0
1148815|NCT03063086|2259735|FG000|Overall Study|Non-compliance with study treatment|0
1148816|NCT03063086|2259736|FG001|Overall Study|Non-compliance with study treatment|0
1148817|NCT03063086|2259737|FG002|Overall Study|Non-compliance with study treatment|0
1148818|NCT03063086|2259738|FG003|Overall Study|Non-compliance with study treatment|1
1148819|NCT03063086|2259739|FG004|Overall Study|Non-compliance with study treatment|0
1148820|NCT03063086|2259740|FG005|Overall Study|Non-compliance with study treatment|1
1148821|NCT03063086|2259735|FG000|Overall Study|Physician Decision|0
1148822|NCT03063086|2259736|FG001|Overall Study|Physician Decision|0
1148823|NCT03063086|2259737|FG002|Overall Study|Physician Decision|0
1148824|NCT03063086|2259738|FG003|Overall Study|Physician Decision|1
1148825|NCT03063086|2259739|FG004|Overall Study|Physician Decision|0
1148826|NCT03063086|2259740|FG005|Overall Study|Physician Decision|0
1148847|NCT03064438|2259839|FG000|Overall Study|Lost to Follow-up|1
1148848|NCT03064438|2259840|FG001|Overall Study|Lost to Follow-up|0
1148849|NCT03064438|2259839|FG000|Overall Study|Withdrawal by Subject|0
1148850|NCT03064438|2259840|FG001|Overall Study|Withdrawal by Subject|1
1148851|NCT03064451|2259846|FG000|Overall Study|Lost to Follow-up|1
1148852|NCT03064451|2259846|FG000|Overall Study|Mapping Failure|4
1148853|NCT03064451|2259846|FG000|Overall Study|Exited prior to procedure|8
1148854|NCT03064451|2259846|FG000|Overall Study|Withdrew consent: 3-month FU visit|1
1148857|NCT03064841|2259854|FG000|Overall Study|Inclusion/exclusion criteria violation|4
1148858|NCT03064841|2259854|FG000|Overall Study|No glycated haemoglobinA1c measurement|11
1148859|NCT03064841|2259854|FG000|Overall Study|Screen failure|2
1148860|NCT03065023|2259862|FG000|Overall Study|Progressive Disease|0
1148861|NCT03065023|2259863|FG001|Overall Study|Progressive Disease|1
1148862|NCT03065023|2259864|FG002|Overall Study|Progressive Disease|0
1148863|NCT03065023|2259865|FG003|Overall Study|Progressive Disease|0
1148864|NCT03065023|2259866|FG004|Overall Study|Progressive Disease|0
1148865|NCT03065023|2259862|FG000|Overall Study|Death|2
1148866|NCT03065023|2259863|FG001|Overall Study|Death|0
1148867|NCT03065023|2259864|FG002|Overall Study|Death|1
1148868|NCT03065023|2259865|FG003|Overall Study|Death|1
1148869|NCT03065023|2259866|FG004|Overall Study|Death|0
1148870|NCT03065023|2259862|FG000|Overall Study|Lost to Follow-up|0
1148871|NCT03065023|2259863|FG001|Overall Study|Lost to Follow-up|1
1148872|NCT03065023|2259864|FG002|Overall Study|Lost to Follow-up|0
1148873|NCT03065023|2259865|FG003|Overall Study|Lost to Follow-up|0
1148874|NCT03065023|2259866|FG004|Overall Study|Lost to Follow-up|0
1148875|NCT03065023|2259862|FG000|Overall Study|Participant Decision|0
1148876|NCT03065023|2259863|FG001|Overall Study|Participant Decision|0
1148877|NCT03065023|2259864|FG002|Overall Study|Participant Decision|0
1148878|NCT03065023|2259865|FG003|Overall Study|Participant Decision|1
1148879|NCT03065023|2259866|FG004|Overall Study|Participant Decision|0
1148880|NCT03065023|2259862|FG000|Overall Study|Withdrawal by Subject|0
1148881|NCT03065023|2259863|FG001|Overall Study|Withdrawal by Subject|0
1148882|NCT03065023|2259864|FG002|Overall Study|Withdrawal by Subject|0
1148883|NCT03065023|2259865|FG003|Overall Study|Withdrawal by Subject|1
1148884|NCT03065023|2259866|FG004|Overall Study|Withdrawal by Subject|0
1148885|NCT03065400|2259903|FG000|Overall Study|Adverse Event|1
1148886|NCT03065400|2259903|FG000|Overall Study|Physician Decision|3
1148887|NCT03065400|2259903|FG000|Overall Study|Withdrawal by Subject|1
1148888|NCT03065400|2259903|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5
1148889|NCT03065530|2259911|FG000|Overall Study|Lack of Efficacy|1
1148890|NCT03065530|2259912|FG001|Overall Study|Lack of Efficacy|1
1148891|NCT03065530|2259913|FG002|Overall Study|Lack of Efficacy|0
1148892|NCT03065530|2259914|FG003|Overall Study|Lack of Efficacy|1
1148893|NCT03065530|2259911|FG000|Overall Study|Protocol Violation|1
1148894|NCT03065530|2259912|FG001|Overall Study|Protocol Violation|0
1148895|NCT03065530|2259913|FG002|Overall Study|Protocol Violation|1
1148896|NCT03065530|2259914|FG003|Overall Study|Protocol Violation|1
1148897|NCT03066193|2259945|FG000|Overall Study|Withdrawal by Subject|1
1148898|NCT03066609|2259952|FG000|INDUCTION|Pregnancy|0
1148899|NCT03066609|2259953|FG001|INDUCTION|Pregnancy|0
1148900|NCT03066609|2259954|FG002|INDUCTION|Pregnancy|1
1148901|NCT03066609|2259955|FG003|INDUCTION|Pregnancy|0
1148902|NCT03066609|2259952|FG000|INDUCTION|Lack of Efficacy|0
1148903|NCT03066609|2259953|FG001|INDUCTION|Lack of Efficacy|0
1148904|NCT03066609|2259954|FG002|INDUCTION|Lack of Efficacy|1
1148905|NCT03066609|2259955|FG003|INDUCTION|Lack of Efficacy|0
1148906|NCT03066609|2259952|FG000|INDUCTION|Adverse Event|2
1148907|NCT03066609|2259953|FG001|INDUCTION|Adverse Event|2
1148908|NCT03066609|2259954|FG002|INDUCTION|Adverse Event|0
1148909|NCT03066609|2259955|FG003|INDUCTION|Adverse Event|0
1148910|NCT03066609|2259952|FG000|MAINTENANCE|Adverse Event|0
1148911|NCT03066609|2259953|FG001|MAINTENANCE|Adverse Event|0
1148912|NCT03066609|2259954|FG002|MAINTENANCE|Adverse Event|0
1148913|NCT03066609|2259955|FG003|MAINTENANCE|Adverse Event|1
1148914|NCT03066609|2259952|FG000|MAINTENANCE|Withdrawal by Subject|4
1148915|NCT03066609|2259953|FG001|MAINTENANCE|Withdrawal by Subject|2
1148916|NCT03066609|2259954|FG002|MAINTENANCE|Withdrawal by Subject|1
1148917|NCT03066609|2259955|FG003|MAINTENANCE|Withdrawal by Subject|1
1148918|NCT03066609|2259952|FG000|MAINTENANCE|Lost to Follow-up|0
1148919|NCT03066609|2259953|FG001|MAINTENANCE|Lost to Follow-up|1
1148920|NCT03066609|2259954|FG002|MAINTENANCE|Lost to Follow-up|1
1148921|NCT03066609|2259955|FG003|MAINTENANCE|Lost to Follow-up|0
1148922|NCT03066609|2259952|FG000|MAINTENANCE|Pregnancy|1
1148923|NCT03066609|2259953|FG001|MAINTENANCE|Pregnancy|0
1148924|NCT03066609|2259954|FG002|MAINTENANCE|Pregnancy|0
1148925|NCT03066609|2259955|FG003|MAINTENANCE|Pregnancy|0
1148926|NCT03066609|2259952|FG000|MAINTENANCE|Lack of Efficacy|2
1148927|NCT03066609|2259953|FG001|MAINTENANCE|Lack of Efficacy|1
1148928|NCT03066609|2259954|FG002|MAINTENANCE|Lack of Efficacy|0
1148929|NCT03066609|2259955|FG003|MAINTENANCE|Lack of Efficacy|1
1148930|NCT03066609|2259952|FG000|OVERALL STUDY|Adverse Event|2
1148931|NCT03066609|2259953|FG001|OVERALL STUDY|Adverse Event|2
1148932|NCT03066609|2259954|FG002|OVERALL STUDY|Adverse Event|0
1148933|NCT03066609|2259955|FG003|OVERALL STUDY|Adverse Event|1
1148934|NCT03066609|2259952|FG000|OVERALL STUDY|Withdrawal by Subject|4
1148935|NCT03066609|2259953|FG001|OVERALL STUDY|Withdrawal by Subject|2
1148936|NCT03066609|2259954|FG002|OVERALL STUDY|Withdrawal by Subject|1
1148937|NCT03066609|2259955|FG003|OVERALL STUDY|Withdrawal by Subject|2
1148938|NCT03066609|2259952|FG000|OVERALL STUDY|Lost to Follow-up|1
1148939|NCT03066609|2259953|FG001|OVERALL STUDY|Lost to Follow-up|1
1148940|NCT03066609|2259954|FG002|OVERALL STUDY|Lost to Follow-up|1
1148941|NCT03066609|2259955|FG003|OVERALL STUDY|Lost to Follow-up|1
1148942|NCT03066609|2259952|FG000|OVERALL STUDY|Pregnancy|1
1148943|NCT03066609|2259953|FG001|OVERALL STUDY|Pregnancy|0
1148944|NCT03066609|2259954|FG002|OVERALL STUDY|Pregnancy|1
1148945|NCT03066609|2259955|FG003|OVERALL STUDY|Pregnancy|0
1148946|NCT03066609|2259952|FG000|OVERALL STUDY|Lack of Efficacy|2
1148947|NCT03066609|2259953|FG001|OVERALL STUDY|Lack of Efficacy|1
1148948|NCT03066609|2259954|FG002|OVERALL STUDY|Lack of Efficacy|1
1148949|NCT03066609|2259955|FG003|OVERALL STUDY|Lack of Efficacy|1
1148950|NCT03066609|2259952|FG000|OVERALL STUDY|discontinued follow up|0
1148951|NCT03066609|2259953|FG001|OVERALL STUDY|discontinued follow up|2
1148952|NCT03066609|2259954|FG002|OVERALL STUDY|discontinued follow up|0
1148953|NCT03066609|2259955|FG003|OVERALL STUDY|discontinued follow up|0
1148958|NCT03066778|2259977|FG000|Overall Study|Death|167
1148959|NCT03066778|2259978|FG001|Overall Study|Death|183
1148960|NCT03066778|2259977|FG000|Overall Study|Withdrawal by Subject|4
1148961|NCT03066778|2259978|FG001|Overall Study|Withdrawal by Subject|5
1148962|NCT03066778|2259977|FG000|Overall Study|Ongoing in Study|57
1148963|NCT03066778|2259978|FG001|Overall Study|Ongoing in Study|37
1148964|NCT03066804|2259986|FG000|Overall Study|Physician Decision|0
1148965|NCT03066804|2259987|FG001|Overall Study|Physician Decision|4
1148966|NCT03066804|2259986|FG000|Overall Study|Death|23
1148967|NCT03066804|2259987|FG001|Overall Study|Death|17
1148968|NCT03066804|2259986|FG000|Overall Study|Withdrawal by Subject|19
1148969|NCT03066804|2259987|FG001|Overall Study|Withdrawal by Subject|25
1148970|NCT03066804|2259986|FG000|Overall Study|Lost to Follow-up|2
1148971|NCT03066804|2259987|FG001|Overall Study|Lost to Follow-up|0
1148972|NCT03066804|2259986|FG000|Overall Study|Adverse Event|2
1148973|NCT03066804|2259987|FG001|Overall Study|Adverse Event|3
1148974|NCT03066804|2259986|FG000|Overall Study|Technical problems|5
1148975|NCT03066804|2259987|FG001|Overall Study|Technical problems|1
1148976|NCT03066830|2259996|FG000|Overall Study|At the Participant's own Request|16
1148977|NCT03066830|2259997|FG001|Overall Study|At the Participant's own Request|17
1148978|NCT03066830|2259996|FG000|Overall Study|Other|3
1148979|NCT03066830|2259997|FG001|Overall Study|Other|0
1148980|NCT03066830|2259996|FG000|Overall Study|Poor Compliance to Protocol|1
1148981|NCT03066830|2259997|FG001|Overall Study|Poor Compliance to Protocol|0
1148982|NCT03066830|2259996|FG000|Overall Study|Adverse Event|2
1148983|NCT03066830|2259997|FG001|Overall Study|Adverse Event|2
1148984|NCT03066830|2259996|FG000|Overall Study|Lost to Follow-up|11
1148985|NCT03066830|2259997|FG001|Overall Study|Lost to Follow-up|3
1148986|NCT03066999|2260011|FG000|Overall Study|abnormal urethraBladder neck contracture|0
1148987|NCT03066999|2260012|FG001|Overall Study|abnormal urethraBladder neck contracture|2
1148988|NCT03067129|2260023|FG000|Overall Study|Ongoing|45
1148989|NCT03067129|2260024|FG001|Overall Study|Ongoing|28
1148990|NCT03067129|2260025|FG002|Overall Study|Ongoing|27
1148991|NCT03067129|2260026|FG003|Overall Study|Ongoing|23
1148992|NCT03067129|2260023|FG000|Overall Study|Partially dosed; refused to swallow entire dose|0
1148993|NCT03067129|2260024|FG001|Overall Study|Partially dosed; refused to swallow entire dose|0
1148994|NCT03067129|2260025|FG002|Overall Study|Partially dosed; refused to swallow entire dose|0
1148995|NCT03067129|2260026|FG003|Overall Study|Partially dosed; refused to swallow entire dose|1
1148996|NCT03067311|2260046|FG000|Overall Study|Lost to Follow-up|1
1148997|NCT03067311|2260047|FG001|Overall Study|Lost to Follow-up|1
1148998|NCT03067311|2260046|FG000|Overall Study|Moved away|1
1148999|NCT03067311|2260047|FG001|Overall Study|Moved away|1
1149000|NCT03067441|2260055|FG000|Overall Study|Withdrawal by Subject|16
1149001|NCT03067441|2260056|FG001|Overall Study|Withdrawal by Subject|34
1149002|NCT03067441|2260055|FG000|Overall Study|Lost to Follow-up|7
1149003|NCT03067441|2260056|FG001|Overall Study|Lost to Follow-up|5
1149004|NCT03067441|2260055|FG000|Overall Study|Adverse Event|7
1149005|NCT03067441|2260056|FG001|Overall Study|Adverse Event|14
1149006|NCT03067441|2260055|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1
1149007|NCT03067441|2260056|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0
1149008|NCT03067441|2260055|FG000|Overall Study|Physician Decision|1
1149009|NCT03067441|2260056|FG001|Overall Study|Physician Decision|3
1149010|NCT03067441|2260055|FG000|Overall Study|Other|1
1149011|NCT03067441|2260056|FG001|Overall Study|Other|1
1149012|NCT03067987|2260075|FG000|Overall Study|Lost to Follow-up|7
1149013|NCT03067987|2260076|FG001|Overall Study|Lost to Follow-up|10
1149014|NCT03067987|2260075|FG000|Overall Study|Protocol Violation|1
1149015|NCT03067987|2260076|FG001|Overall Study|Protocol Violation|2
1149016|NCT03067987|2260075|FG000|Overall Study|Withdrawal by Subject|2
1149017|NCT03067987|2260076|FG001|Overall Study|Withdrawal by Subject|1
1149018|NCT03068455|2260098|FG000|Pre-treatment Period|Disease progression|0
1149019|NCT03068455|2260099|FG001|Pre-treatment Period|Disease progression|1
1149020|NCT03068455|2260098|FG000|Pre-treatment Period|Participant withdrew consent|1
902225|NCT00739661|1875974|FG000|Overall Study|Patient decision to withdraw|9
902226|NCT00739661|1875975|FG001|Overall Study|Patient decision to withdraw|4
902227|NCT00739661|1875974|FG000|Overall Study|Disease progression, radiographic|33
902228|NCT00739661|1875975|FG001|Overall Study|Disease progression, radiographic|37
902229|NCT00739661|1875974|FG000|Overall Study|Reason for discontinuation not available|1
902230|NCT00739661|1875975|FG001|Overall Study|Reason for discontinuation not available|1
902231|NCT00739674|1875983|FG000|Overall Study|Screening failures|19
902232|NCT00739674|1875984|FG001|Overall Study|Screening failures|17
902233|NCT00739674|1875983|FG000|Overall Study|Site 212 removal|19
1149021|NCT03068455|2260099|FG001|Pre-treatment Period|Participant withdrew consent|1
1149022|NCT03068455|2260098|FG000|Pre-treatment Period|Poor/non-compliance|0
1149023|NCT03068455|2260099|FG001|Pre-treatment Period|Poor/non-compliance|1
1149024|NCT03068455|2260098|FG000|Pre-treatment Period|Participant no longer meets study criteria|1
1149025|NCT03068455|2260099|FG001|Pre-treatment Period|Participant no longer meets study criteria|3
1149026|NCT03068455|2260098|FG000|Pre-treatment Period|Not reported|2
1149027|NCT03068455|2260099|FG001|Pre-treatment Period|Not reported|1
1149028|NCT03068455|2260098|FG000|Treatment Period|Disease progression|166
1149029|NCT03068455|2260099|FG001|Treatment Period|Disease progression|208
1149030|NCT03068455|2260098|FG000|Treatment Period|Study drug toxicity|317
1149031|NCT03068455|2260099|FG001|Treatment Period|Study drug toxicity|104
1149032|NCT03068455|2260098|FG000|Treatment Period|Adverse Event unrelated to study drug|15
1149033|NCT03068455|2260099|FG001|Treatment Period|Adverse Event unrelated to study drug|7
1149034|NCT03068455|2260098|FG000|Treatment Period|Participant request to stop therapy|33
1149035|NCT03068455|2260099|FG001|Treatment Period|Participant request to stop therapy|20
1149036|NCT03068455|2260098|FG000|Treatment Period|Participant withdrew consent|5
1149037|NCT03068455|2260099|FG001|Treatment Period|Participant withdrew consent|10
1149038|NCT03068455|2260098|FG000|Treatment Period|Poor/non-compliance|3
1149039|NCT03068455|2260099|FG001|Treatment Period|Poor/non-compliance|0
1149040|NCT03068455|2260098|FG000|Treatment Period|Participant no longer meets study criteria|1
1149041|NCT03068455|2260099|FG001|Treatment Period|Participant no longer meets study criteria|3
1149042|NCT03068455|2260098|FG000|Treatment Period|Other reasons|12
1149043|NCT03068455|2260099|FG001|Treatment Period|Other reasons|4
1149044|NCT03068468|2260107|FG000|Placebo-Controlled Period|Randomized but not Treated|1
1149045|NCT03068468|2260108|FG001|Placebo-Controlled Period|Randomized but not Treated|3
1149046|NCT03068468|2260109|FG002|Placebo-Controlled Period|Randomized but not Treated|0
1149047|NCT03068468|2260110|FG003|Placebo-Controlled Period|Randomized but not Treated|0
1149048|NCT03068468|2260107|FG000|Placebo-Controlled Period|Lack of Efficacy|0
1149049|NCT03068468|2260108|FG001|Placebo-Controlled Period|Lack of Efficacy|1
1149050|NCT03068468|2260109|FG002|Placebo-Controlled Period|Lack of Efficacy|0
1149051|NCT03068468|2260110|FG003|Placebo-Controlled Period|Lack of Efficacy|0
1149052|NCT03068468|2260107|FG000|Placebo-Controlled Period|Adverse Event|16
1149053|NCT03068468|2260108|FG001|Placebo-Controlled Period|Adverse Event|21
1149054|NCT03068468|2260109|FG002|Placebo-Controlled Period|Adverse Event|0
1149055|NCT03068468|2260110|FG003|Placebo-Controlled Period|Adverse Event|0
1149056|NCT03068468|2260107|FG000|Placebo-Controlled Period|Withdrawal by Subject|3
1149057|NCT03068468|2260108|FG001|Placebo-Controlled Period|Withdrawal by Subject|11
902234|NCT00739674|1875984|FG001|Overall Study|Site 212 removal|13
902235|NCT00739674|1875983|FG000|Overall Study|No follow-up data|33
902236|NCT00739674|1875984|FG001|Overall Study|No follow-up data|18
1149058|NCT03068468|2260109|FG002|Placebo-Controlled Period|Withdrawal by Subject|0
1149059|NCT03068468|2260110|FG003|Placebo-Controlled Period|Withdrawal by Subject|0
1149060|NCT03068468|2260107|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
1149061|NCT03068468|2260108|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2
1149062|NCT03068468|2260109|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
1149063|NCT03068468|2260110|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
1149064|NCT03068468|2260107|FG000|Placebo-Controlled Period|Reason Not Specified|1
1149065|NCT03068468|2260108|FG001|Placebo-Controlled Period|Reason Not Specified|6
1149066|NCT03068468|2260109|FG002|Placebo-Controlled Period|Reason Not Specified|0
1149067|NCT03068468|2260110|FG003|Placebo-Controlled Period|Reason Not Specified|0
1149068|NCT03068468|2260107|FG000|Placebo-Controlled Period|Death|0
1149069|NCT03068468|2260108|FG001|Placebo-Controlled Period|Death|1
1149070|NCT03068468|2260109|FG002|Placebo-Controlled Period|Death|0
1149071|NCT03068468|2260110|FG003|Placebo-Controlled Period|Death|0
1149072|NCT03068468|2260107|FG000|Open-Label Extension Period|Lack of Efficacy|0
1149073|NCT03068468|2260108|FG001|Open-Label Extension Period|Lack of Efficacy|0
1149074|NCT03068468|2260109|FG002|Open-Label Extension Period|Lack of Efficacy|1
1149075|NCT03068468|2260110|FG003|Open-Label Extension Period|Lack of Efficacy|2
1149076|NCT03068468|2260107|FG000|Open-Label Extension Period|Adverse Event|0
1149077|NCT03068468|2260108|FG001|Open-Label Extension Period|Adverse Event|0
1149078|NCT03068468|2260109|FG002|Open-Label Extension Period|Adverse Event|13
1149079|NCT03068468|2260110|FG003|Open-Label Extension Period|Adverse Event|17
1149080|NCT03068468|2260107|FG000|Open-Label Extension Period|Withdrawal by Subject|0
1149081|NCT03068468|2260108|FG001|Open-Label Extension Period|Withdrawal by Subject|0
1149082|NCT03068468|2260109|FG002|Open-Label Extension Period|Withdrawal by Subject|7
1149083|NCT03068468|2260110|FG003|Open-Label Extension Period|Withdrawal by Subject|20
1149084|NCT03068468|2260107|FG000|Open-Label Extension Period|Death|0
1149085|NCT03068468|2260108|FG001|Open-Label Extension Period|Death|0
1149086|NCT03068468|2260109|FG002|Open-Label Extension Period|Death|0
1149087|NCT03068468|2260110|FG003|Open-Label Extension Period|Death|1
1149088|NCT03068468|2260107|FG000|Open-Label Extension Period|Lost to Follow-up|0
1149089|NCT03068468|2260108|FG001|Open-Label Extension Period|Lost to Follow-up|0
1149090|NCT03068468|2260109|FG002|Open-Label Extension Period|Lost to Follow-up|1
1149091|NCT03068468|2260110|FG003|Open-Label Extension Period|Lost to Follow-up|0
1149092|NCT03068468|2260107|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
1149093|NCT03068468|2260108|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
1149094|NCT03068468|2260109|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2
1149095|NCT03068468|2260110|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
1149096|NCT03068468|2260107|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0
1149097|NCT03068468|2260108|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0
1149098|NCT03068468|2260109|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115
1149099|NCT03068468|2260110|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228
1149100|NCT03068468|2260107|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
1149101|NCT03068468|2260108|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
1149102|NCT03068468|2260109|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
1149103|NCT03068468|2260110|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4
1149104|NCT03068468|2260107|FG000|Open-Label Extension Period|Reason not Specified|0
1149105|NCT03068468|2260108|FG001|Open-Label Extension Period|Reason not Specified|0
1149106|NCT03068468|2260109|FG002|Open-Label Extension Period|Reason not Specified|1
1149107|NCT03068468|2260110|FG003|Open-Label Extension Period|Reason not Specified|4
1149108|NCT03068715|2260129|FG000|Overall Study|No longer met inclusion criteria|1
1149109|NCT03068715|2260130|FG001|Overall Study|No longer met inclusion criteria|0
1149110|NCT03068754|2260140|FG000|Randomized Treatment Period (RTP)|Adverse Event|1
1149111|NCT03068754|2260141|FG001|Randomized Treatment Period (RTP)|Adverse Event|3
1149112|NCT03068754|2260142|FG002|Randomized Treatment Period (RTP)|Adverse Event|0
1149113|NCT03068754|2260143|FG003|Randomized Treatment Period (RTP)|Adverse Event|0
1149114|NCT03068754|2260140|FG000|Randomized Treatment Period (RTP)|Death|2
1149115|NCT03068754|2260141|FG001|Randomized Treatment Period (RTP)|Death|2
1149116|NCT03068754|2260142|FG002|Randomized Treatment Period (RTP)|Death|0
1149117|NCT03068754|2260143|FG003|Randomized Treatment Period (RTP)|Death|0
1149118|NCT03068754|2260140|FG000|Randomized Treatment Period (RTP)|Disease progression|1
1149119|NCT03068754|2260141|FG001|Randomized Treatment Period (RTP)|Disease progression|2
1149120|NCT03068754|2260142|FG002|Randomized Treatment Period (RTP)|Disease progression|0
1149121|NCT03068754|2260143|FG003|Randomized Treatment Period (RTP)|Disease progression|0
1149122|NCT03068754|2260140|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1
1149123|NCT03068754|2260141|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0
1149124|NCT03068754|2260142|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0
1149125|NCT03068754|2260143|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0
1149126|NCT03068754|2260140|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6
1149127|NCT03068754|2260141|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2
1149128|NCT03068754|2260142|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
1149129|NCT03068754|2260143|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
1149130|NCT03068754|2260140|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1
1149131|NCT03068754|2260141|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0
1149132|NCT03068754|2260142|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0
1149133|NCT03068754|2260143|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0
1149134|NCT03068754|2260140|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
1149135|NCT03068754|2260141|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1
1149136|NCT03068754|2260142|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
1149137|NCT03068754|2260143|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
1149138|NCT03068754|2260140|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55
1149139|NCT03068754|2260141|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29
1149140|NCT03068754|2260142|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
1149141|NCT03068754|2260143|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
1149142|NCT03068754|2260140|FG000|Open Label Extension Period (OLE)|Adverse Event|0
1149143|NCT03068754|2260141|FG001|Open Label Extension Period (OLE)|Adverse Event|0
1149144|NCT03068754|2260142|FG002|Open Label Extension Period (OLE)|Adverse Event|0
1149145|NCT03068754|2260143|FG003|Open Label Extension Period (OLE)|Adverse Event|1
1149146|NCT03068754|2260140|FG000|Open Label Extension Period (OLE)|Death|0
1149147|NCT03068754|2260141|FG001|Open Label Extension Period (OLE)|Death|0
1149148|NCT03068754|2260142|FG002|Open Label Extension Period (OLE)|Death|0
1149149|NCT03068754|2260143|FG003|Open Label Extension Period (OLE)|Death|1
1149150|NCT03068754|2260140|FG000|Open Label Extension Period (OLE)|Disease progression|0
1149151|NCT03068754|2260141|FG001|Open Label Extension Period (OLE)|Disease progression|0
1149152|NCT03068754|2260142|FG002|Open Label Extension Period (OLE)|Disease progression|3
1149153|NCT03068754|2260143|FG003|Open Label Extension Period (OLE)|Disease progression|1
1149154|NCT03068754|2260140|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0
1149155|NCT03068754|2260141|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0
1149156|NCT03068754|2260142|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5
1149157|NCT03068754|2260143|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0
1149158|NCT03068754|2260140|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
1149159|NCT03068754|2260141|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
1149160|NCT03068754|2260142|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1
1149161|NCT03068754|2260143|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
1149162|NCT03068754|2260140|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
1149163|NCT03068754|2260141|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
1149164|NCT03068754|2260142|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12
1149165|NCT03068754|2260143|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3
1149166|NCT03068767|2260155|FG000|Overall Study|Lost to Follow-up|7
1149167|NCT03068767|2260156|FG001|Overall Study|Lost to Follow-up|3
1149168|NCT03068767|2260155|FG000|Overall Study|Protocol Violation|3
1149169|NCT03068767|2260156|FG001|Overall Study|Protocol Violation|0
1149170|NCT03069313|2260196|FG000|Overall Study|Adverse Event|5
1149171|NCT03069352|2260202|FG000|Overall Study|Ongoing|12
1149172|NCT03069352|2260203|FG001|Overall Study|Ongoing|40
1149173|NCT03069365|2260209|FG000|Overall Study|Adverse Event|1
1149174|NCT03069482|2260215|FG000|Overall Study|Lost to Follow-up|0
1149175|NCT03069482|2260216|FG001|Overall Study|Lost to Follow-up|1
1149176|NCT03069482|2260215|FG000|Overall Study|Physician Decision|1
1149177|NCT03069482|2260216|FG001|Overall Study|Physician Decision|0
1149178|NCT03069716|2260236|FG000|Run-in Period (2 Weeks)|Adverse Event|1
1149179|NCT03069716|2260237|FG001|Run-in Period (2 Weeks)|Adverse Event|0
1149180|NCT03069716|2260238|FG002|Run-in Period (2 Weeks)|Adverse Event|0
1149181|NCT03069716|2260236|FG000|Run-in Period (2 Weeks)|Protocol Violation|1
1149182|NCT03069716|2260237|FG001|Run-in Period (2 Weeks)|Protocol Violation|0
1149183|NCT03069716|2260238|FG002|Run-in Period (2 Weeks)|Protocol Violation|0
1149184|NCT03069716|2260236|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5
1149185|NCT03069716|2260237|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0
1149186|NCT03069716|2260238|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0
1149187|NCT03069716|2260236|FG000|Randomized Treatment|Withdrawal by Subject|0
1149188|NCT03069716|2260237|FG001|Randomized Treatment|Withdrawal by Subject|2
1149189|NCT03069716|2260238|FG002|Randomized Treatment|Withdrawal by Subject|0
1149190|NCT03069989|2260247|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
1149191|NCT03069989|2260248|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
1149192|NCT03070171|2260257|FG000|Treatment Period 2 + Washout|Other Adverse Event|0
1149193|NCT03070171|2260258|FG001|Treatment Period 2 + Washout|Other Adverse Event|1
1149194|NCT03070171|2260257|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0
1149195|NCT03070171|2260258|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1
1149196|NCT03070392|2260273|FG000|Overall Study|Not Treated|7
1149197|NCT03070392|2260274|FG001|Overall Study|Not Treated|0
1149198|NCT03070392|2260275|FG002|Overall Study|Not Treated|3
1149199|NCT03070392|2260276|FG003|Overall Study|Not Treated|12
1149200|NCT03070392|2260273|FG000|Overall Study|Death|3
1149201|NCT03070392|2260274|FG001|Overall Study|Death|0
1149202|NCT03070392|2260275|FG002|Overall Study|Death|0
1149203|NCT03070392|2260276|FG003|Overall Study|Death|1
1149204|NCT03070392|2260273|FG000|Overall Study|Withdrawal by Subject|7
1149205|NCT03070392|2260274|FG001|Overall Study|Withdrawal by Subject|0
1149206|NCT03070392|2260275|FG002|Overall Study|Withdrawal by Subject|0
1149207|NCT03070392|2260276|FG003|Overall Study|Withdrawal by Subject|3
1149208|NCT03070392|2260273|FG000|Overall Study|Physician Decision|1
1149209|NCT03070392|2260274|FG001|Overall Study|Physician Decision|0
1149210|NCT03070392|2260275|FG002|Overall Study|Physician Decision|0
1149211|NCT03070392|2260276|FG003|Overall Study|Physician Decision|2
1149212|NCT03070392|2260273|FG000|Overall Study|Progressive Disease|154
1149213|NCT03070392|2260274|FG001|Overall Study|Progressive Disease|6
1149214|NCT03070392|2260275|FG002|Overall Study|Progressive Disease|2
1149215|NCT03070392|2260276|FG003|Overall Study|Progressive Disease|70
1149216|NCT03070392|2260273|FG000|Overall Study|Adverse Event|6
1149217|NCT03070392|2260274|FG001|Overall Study|Adverse Event|1
1149218|NCT03070392|2260275|FG002|Overall Study|Adverse Event|1
1149219|NCT03070392|2260276|FG003|Overall Study|Adverse Event|3
1149220|NCT03070392|2260273|FG000|Overall Study|Alternate anticancer treatment|1
1149221|NCT03070392|2260274|FG001|Overall Study|Alternate anticancer treatment|0
902237|NCT00739674|1875983|FG000|Overall Study|Dietician consultation >30 days|1
902238|NCT00739674|1875984|FG001|Overall Study|Dietician consultation >30 days|9
902239|NCT00739674|1875983|FG000|Overall Study|Adverse Event|22
902240|NCT00739674|1875984|FG001|Overall Study|Adverse Event|13
902241|NCT00739674|1875983|FG000|Overall Study|Death|1
902242|NCT00739674|1875984|FG001|Overall Study|Death|0
902243|NCT00739674|1875983|FG000|Overall Study|Lack of Efficacy|1
902244|NCT00739674|1875984|FG001|Overall Study|Lack of Efficacy|0
902245|NCT00739674|1875983|FG000|Overall Study|Lost to Follow-up|52
902246|NCT00739674|1875984|FG001|Overall Study|Lost to Follow-up|30
902247|NCT00739674|1875983|FG000|Overall Study|Protocol Violation|5
902248|NCT00739674|1875984|FG001|Overall Study|Protocol Violation|5
902249|NCT00739674|1875983|FG000|Overall Study|Withdrawal by Subject|9
902250|NCT00739674|1875984|FG001|Overall Study|Withdrawal by Subject|9
902251|NCT00739674|1875983|FG000|Overall Study|Reason missing|2
902252|NCT00739674|1875984|FG001|Overall Study|Reason missing|0
902253|NCT00739674|1875983|FG000|Overall Study|Clinic closed|6
902254|NCT00739674|1875984|FG001|Overall Study|Clinic closed|4
902255|NCT00739674|1875983|FG000|Overall Study|Patient moved|3
902256|NCT00739674|1875984|FG001|Overall Study|Patient moved|2
902257|NCT00739674|1875983|FG000|Overall Study|Non compliant|4
902258|NCT00739674|1875984|FG001|Overall Study|Non compliant|0
1149222|NCT03070392|2260275|FG002|Overall Study|Alternate anticancer treatment|0
1149223|NCT03070392|2260276|FG003|Overall Study|Alternate anticancer treatment|1
1149224|NCT03070392|2260273|FG000|Overall Study|Ongoing|73
1149225|NCT03070392|2260274|FG001|Overall Study|Ongoing|0
1149226|NCT03070392|2260275|FG002|Overall Study|Ongoing|0
1149227|NCT03070392|2260276|FG003|Overall Study|Ongoing|11
1149228|NCT03070431|2260282|FG000|Overall Study|Withdrawal by Subject|2
1149229|NCT03070431|2260282|FG000|Overall Study|Lost to Follow-up|2
1149230|NCT03070483|2260318|FG000|Overall Study|Lost to Follow-up|2
1149231|NCT03070782|2260346|FG000|Overall Study|Adverse Event|3
1149232|NCT03070782|2260347|FG001|Overall Study|Adverse Event|0
1149233|NCT03070782|2260348|FG002|Overall Study|Adverse Event|3
1149234|NCT03070782|2260349|FG003|Overall Study|Adverse Event|1
1149235|NCT03070782|2260350|FG004|Overall Study|Adverse Event|6
1149236|NCT03070782|2260351|FG005|Overall Study|Adverse Event|2
1149237|NCT03070782|2260346|FG000|Overall Study|Withdrawal by Subject|2
1149238|NCT03070782|2260347|FG001|Overall Study|Withdrawal by Subject|1
1149239|NCT03070782|2260348|FG002|Overall Study|Withdrawal by Subject|1
1149240|NCT03070782|2260349|FG003|Overall Study|Withdrawal by Subject|0
1149241|NCT03070782|2260350|FG004|Overall Study|Withdrawal by Subject|4
1149242|NCT03070782|2260351|FG005|Overall Study|Withdrawal by Subject|3
1149243|NCT03070782|2260346|FG000|Overall Study|Reason Not Specified|2
1149244|NCT03070782|2260347|FG001|Overall Study|Reason Not Specified|0
1149245|NCT03070782|2260348|FG002|Overall Study|Reason Not Specified|0
1149246|NCT03070782|2260349|FG003|Overall Study|Reason Not Specified|1
1149247|NCT03070782|2260350|FG004|Overall Study|Reason Not Specified|2
1149248|NCT03070782|2260351|FG005|Overall Study|Reason Not Specified|1
1149249|NCT03070782|2260346|FG000|Overall Study|Ineligibility|0
1149250|NCT03070782|2260347|FG001|Overall Study|Ineligibility|0
1149251|NCT03070782|2260348|FG002|Overall Study|Ineligibility|0
1149252|NCT03070782|2260349|FG003|Overall Study|Ineligibility|1
1149253|NCT03070782|2260350|FG004|Overall Study|Ineligibility|0
1149254|NCT03070782|2260351|FG005|Overall Study|Ineligibility|1
902259|NCT00739674|1875983|FG000|Overall Study|Unable to attend visit|3
902260|NCT00739674|1875984|FG001|Overall Study|Unable to attend visit|1
902261|NCT00739674|1875983|FG000|Overall Study|Home monitoring off meds|1
902262|NCT00739674|1875984|FG001|Overall Study|Home monitoring off meds|0
902263|NCT00739674|1875983|FG000|Overall Study|Erectile dysfunction|0
902264|NCT00739674|1875984|FG001|Overall Study|Erectile dysfunction|1
902265|NCT00739908|1876030|FG000|Overall Study|Adverse Event|5
902266|NCT00739908|1876031|FG001|Overall Study|Adverse Event|6
902267|NCT00739908|1876030|FG000|Overall Study|Withdrawal by Subject|4
902268|NCT00739908|1876031|FG001|Overall Study|Withdrawal by Subject|2
902269|NCT00739908|1876030|FG000|Overall Study|Lost to Follow-up|14
902270|NCT00739908|1876031|FG001|Overall Study|Lost to Follow-up|9
902271|NCT00739908|1876030|FG000|Overall Study|Non-Compliance With Study Procedures|2
902272|NCT00739908|1876031|FG001|Overall Study|Non-Compliance With Study Procedures|3
902273|NCT00739908|1876030|FG000|Overall Study|Non-Compliance With Study Medication|0
902274|NCT00739908|1876031|FG001|Overall Study|Non-Compliance With Study Medication|3
902275|NCT00739908|1876030|FG000|Overall Study|Lack of Efficacy|0
902276|NCT00739908|1876031|FG001|Overall Study|Lack of Efficacy|1
902277|NCT00739908|1876030|FG000|Overall Study|Relocation|0
902278|NCT00739908|1876031|FG001|Overall Study|Relocation|1
902279|NCT00739934|1876039|FG000|Voriconazole IV|Adverse Event|6
902280|NCT00739934|1876039|FG000|Voriconazole Oral|Other|3
902281|NCT00739973|1876061|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
902282|NCT00739973|1876062|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
902283|NCT00739973|1876063|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
902284|NCT00739973|1876064|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
902285|NCT00739973|1876065|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
902286|NCT00739973|1876066|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
902287|NCT00739973|1876067|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
902288|NCT00739973|1876068|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
902289|NCT00739973|1876069|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
902290|NCT00739973|1876061|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
902291|NCT00739973|1876062|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
902292|NCT00739973|1876063|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
902293|NCT00739973|1876064|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
902294|NCT00739973|1876065|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
902295|NCT00739973|1876066|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
902296|NCT00739973|1876067|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
902297|NCT00739973|1876068|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
902298|NCT00739973|1876069|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
902299|NCT00739973|1876061|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
902300|NCT00739973|1876062|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
902301|NCT00739973|1876063|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
902302|NCT00739973|1876064|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
902303|NCT00739973|1876065|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
902304|NCT00739973|1876066|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
902305|NCT00739973|1876067|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
902306|NCT00739973|1876068|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1149255|NCT03070782|2260346|FG000|Overall Study|Pregnancy|0
1149256|NCT03070782|2260347|FG001|Overall Study|Pregnancy|0
1149257|NCT03070782|2260348|FG002|Overall Study|Pregnancy|0
1149258|NCT03070782|2260349|FG003|Overall Study|Pregnancy|1
1149259|NCT03070782|2260350|FG004|Overall Study|Pregnancy|0
1149260|NCT03070782|2260351|FG005|Overall Study|Pregnancy|0
1149261|NCT03070782|2260346|FG000|Overall Study|Investigator Judgement|0
1149262|NCT03070782|2260347|FG001|Overall Study|Investigator Judgement|0
1149263|NCT03070782|2260348|FG002|Overall Study|Investigator Judgement|0
1149264|NCT03070782|2260349|FG003|Overall Study|Investigator Judgement|1
1149265|NCT03070782|2260350|FG004|Overall Study|Investigator Judgement|0
1149266|NCT03070782|2260351|FG005|Overall Study|Investigator Judgement|0
1149267|NCT03070964|2260365|FG000|Overall Study|Progressive disease|8
1149268|NCT03070964|2260365|FG000|Overall Study|Treatment-unrelated adverse event|2
1149269|NCT03070964|2260365|FG000|Overall Study|Never treated|1
1149270|NCT03070964|2260365|FG000|Overall Study|Physician Decision|1
1149271|NCT03070964|2260365|FG000|Overall Study|Withdrawal by Subject|1
1149272|NCT03070964|2260365|FG000|Overall Study|Adverse Event|1
1149273|NCT03071094|2260371|FG000|Overall Study|Death|1
1149274|NCT03071094|2260372|FG001|Overall Study|Death|1
1149275|NCT03071094|2260371|FG000|Overall Study|Adverse Event|1
1149276|NCT03071094|2260372|FG001|Overall Study|Adverse Event|0
1149277|NCT03071263|2260380|FG000|Overall Study|Adverse Event|1
1149278|NCT03071263|2260381|FG001|Overall Study|Adverse Event|3
1149279|NCT03071263|2260380|FG000|Overall Study|Withdrawal by Subject|1
1149280|NCT03071263|2260381|FG001|Overall Study|Withdrawal by Subject|3
1149281|NCT03071263|2260380|FG000|Overall Study|Physician Decision|1
1149282|NCT03071263|2260381|FG001|Overall Study|Physician Decision|0
1149283|NCT03071263|2260380|FG000|Overall Study|Participant moved to another city|0
1149284|NCT03071263|2260381|FG001|Overall Study|Participant moved to another city|1
1149285|NCT03071276|2260387|FG000|Overall Study|Adverse Event|1
1149286|NCT03071276|2260387|FG000|Overall Study|Lack of Efficacy|14
1149296|NCT03072160|2260418|FG000|Overall Study|Adverse Event|3
1149297|NCT03072160|2260419|FG001|Overall Study|Adverse Event|1
1149298|NCT03072160|2260418|FG000|Overall Study|Refused further treatment|6
1149299|NCT03072160|2260419|FG001|Overall Study|Refused further treatment|1
1149300|NCT03072160|2260418|FG000|Overall Study|Physician Decision|1
1149301|NCT03072160|2260419|FG001|Overall Study|Physician Decision|0
1149302|NCT03072160|2260418|FG000|Overall Study|Disease progression on study|1
1149303|NCT03072160|2260419|FG001|Overall Study|Disease progression on study|1
1149304|NCT03072160|2260418|FG000|Overall Study|No contact|0
1149305|NCT03072160|2260419|FG001|Overall Study|No contact|1
1149306|NCT03072719|2260476|FG000|Overall Study|Adverse Event|1
1149307|NCT03072719|2260477|FG001|Overall Study|Adverse Event|1
1149308|NCT03072875|2260492|FG000|Overall Study|Lost to Follow-up|1
1149309|NCT03073005|2260505|FG000|Overall Study|Death|6
1149310|NCT03073005|2260506|FG001|Overall Study|Death|0
902307|NCT00739973|1876069|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
902308|NCT00739973|1876061|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
902309|NCT00739973|1876062|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
902310|NCT00739973|1876063|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
902311|NCT00739973|1876064|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
902312|NCT00739973|1876065|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
902313|NCT00739973|1876066|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
902314|NCT00739973|1876067|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
902315|NCT00739973|1876068|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
902316|NCT00739973|1876069|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
902317|NCT00739973|1876061|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
902318|NCT00739973|1876062|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
902319|NCT00739973|1876063|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
902320|NCT00739973|1876064|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
902321|NCT00739973|1876065|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
902322|NCT00739973|1876066|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
902323|NCT00739973|1876067|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
902324|NCT00739973|1876068|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
902325|NCT00739973|1876069|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
902326|NCT00739973|1876061|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
914255|NCT00813761|1892001|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3
1149311|NCT03073005|2260507|FG002|Overall Study|Death|7
1149312|NCT03073005|2260508|FG003|Overall Study|Death|0
1149313|NCT03073005|2260505|FG000|Overall Study|caregiver withdrew bc of pt death|0
1149314|NCT03073005|2260506|FG001|Overall Study|caregiver withdrew bc of pt death|6
1149315|NCT03073005|2260507|FG002|Overall Study|caregiver withdrew bc of pt death|0
1149316|NCT03073005|2260508|FG003|Overall Study|caregiver withdrew bc of pt death|7
1149317|NCT03073005|2260505|FG000|Overall Study|Lost to Follow-up|2
1149318|NCT03073005|2260506|FG001|Overall Study|Lost to Follow-up|2
1149319|NCT03073005|2260507|FG002|Overall Study|Lost to Follow-up|1
1149320|NCT03073005|2260508|FG003|Overall Study|Lost to Follow-up|2
1149321|NCT03073005|2260505|FG000|Overall Study|Withdrawal by Subject|0
1149322|NCT03073005|2260506|FG001|Overall Study|Withdrawal by Subject|4
1149323|NCT03073005|2260507|FG002|Overall Study|Withdrawal by Subject|4
1149324|NCT03073005|2260508|FG003|Overall Study|Withdrawal by Subject|4
1149325|NCT03073109|2260523|FG000|Overall Study|Adverse Event|0
1149326|NCT03073109|2260524|FG001|Overall Study|Adverse Event|1
1149327|NCT03073109|2260523|FG000|Overall Study|Other|2
1149328|NCT03073109|2260524|FG001|Overall Study|Other|0
1149329|NCT03073109|2260523|FG000|Overall Study|Lost to Follow-up|8
1149330|NCT03073109|2260524|FG001|Overall Study|Lost to Follow-up|1
1149331|NCT03073200|2260559|FG000|Double Blind Treatment Period|Protocol Violation|1
1149332|NCT03073200|2260560|FG001|Double Blind Treatment Period|Protocol Violation|0
1149333|NCT03073200|2260561|FG002|Double Blind Treatment Period|Protocol Violation|0
1149334|NCT03073200|2260562|FG003|Double Blind Treatment Period|Protocol Violation|0
1149335|NCT03073200|2260563|FG004|Double Blind Treatment Period|Protocol Violation|0
1149336|NCT03073200|2260564|FG005|Double Blind Treatment Period|Protocol Violation|0
1149337|NCT03073200|2260565|FG006|Double Blind Treatment Period|Protocol Violation|0
1149338|NCT03073200|2260566|FG007|Double Blind Treatment Period|Protocol Violation|0
1149339|NCT03073200|2260567|FG008|Double Blind Treatment Period|Protocol Violation|0
1149340|NCT03073200|2260568|FG009|Double Blind Treatment Period|Protocol Violation|0
1149341|NCT03073200|2260569|FG010|Double Blind Treatment Period|Protocol Violation|0
1149342|NCT03073200|2260570|FG011|Double Blind Treatment Period|Protocol Violation|0
1149343|NCT03073200|2260571|FG012|Double Blind Treatment Period|Protocol Violation|0
1149344|NCT03073200|2260572|FG013|Double Blind Treatment Period|Protocol Violation|0
1149345|NCT03073200|2260573|FG014|Double Blind Treatment Period|Protocol Violation|0
1149346|NCT03073200|2260559|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149347|NCT03073200|2260560|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1
1149348|NCT03073200|2260561|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149349|NCT03073200|2260562|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149350|NCT03073200|2260563|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149351|NCT03073200|2260564|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149352|NCT03073200|2260565|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149353|NCT03073200|2260566|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149354|NCT03073200|2260567|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149355|NCT03073200|2260568|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149356|NCT03073200|2260569|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149357|NCT03073200|2260570|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149358|NCT03073200|2260571|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149359|NCT03073200|2260572|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149360|NCT03073200|2260573|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
1149361|NCT03073200|2260559|FG000|Double Blind Treatment Period|Withdrawal by Subject|1
1149362|NCT03073200|2260560|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
1149363|NCT03073200|2260561|FG002|Double Blind Treatment Period|Withdrawal by Subject|0
1149364|NCT03073200|2260562|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
1149365|NCT03073200|2260563|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
1149366|NCT03073200|2260564|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
1149367|NCT03073200|2260565|FG006|Double Blind Treatment Period|Withdrawal by Subject|0
1149368|NCT03073200|2260566|FG007|Double Blind Treatment Period|Withdrawal by Subject|0
1149369|NCT03073200|2260567|FG008|Double Blind Treatment Period|Withdrawal by Subject|0
1149370|NCT03073200|2260568|FG009|Double Blind Treatment Period|Withdrawal by Subject|0
1149371|NCT03073200|2260569|FG010|Double Blind Treatment Period|Withdrawal by Subject|0
1149372|NCT03073200|2260570|FG011|Double Blind Treatment Period|Withdrawal by Subject|0
1149373|NCT03073200|2260571|FG012|Double Blind Treatment Period|Withdrawal by Subject|0
1149374|NCT03073200|2260572|FG013|Double Blind Treatment Period|Withdrawal by Subject|0
1149375|NCT03073200|2260573|FG014|Double Blind Treatment Period|Withdrawal by Subject|0
1149376|NCT03073200|2260559|FG000|Open-Label Maintenance Period|Lost to Follow-up|0
1149377|NCT03073200|2260560|FG001|Open-Label Maintenance Period|Lost to Follow-up|0
1149378|NCT03073200|2260561|FG002|Open-Label Maintenance Period|Lost to Follow-up|0
1149379|NCT03073200|2260562|FG003|Open-Label Maintenance Period|Lost to Follow-up|1
1149380|NCT03073200|2260563|FG004|Open-Label Maintenance Period|Lost to Follow-up|2
1149381|NCT03073200|2260564|FG005|Open-Label Maintenance Period|Lost to Follow-up|0
1149382|NCT03073200|2260565|FG006|Open-Label Maintenance Period|Lost to Follow-up|0
1149383|NCT03073200|2260566|FG007|Open-Label Maintenance Period|Lost to Follow-up|0
1149384|NCT03073200|2260567|FG008|Open-Label Maintenance Period|Lost to Follow-up|0
1149385|NCT03073200|2260568|FG009|Open-Label Maintenance Period|Lost to Follow-up|0
1149386|NCT03073200|2260569|FG010|Open-Label Maintenance Period|Lost to Follow-up|0
1149387|NCT03073200|2260570|FG011|Open-Label Maintenance Period|Lost to Follow-up|0
1149388|NCT03073200|2260571|FG012|Open-Label Maintenance Period|Lost to Follow-up|0
1149389|NCT03073200|2260572|FG013|Open-Label Maintenance Period|Lost to Follow-up|0
1149390|NCT03073200|2260573|FG014|Open-Label Maintenance Period|Lost to Follow-up|0
1149391|NCT03073200|2260559|FG000|Open-Label Maintenance Period|Participant moved to another city|0
1149392|NCT03073200|2260560|FG001|Open-Label Maintenance Period|Participant moved to another city|0
1149393|NCT03073200|2260561|FG002|Open-Label Maintenance Period|Participant moved to another city|0
1149394|NCT03073200|2260562|FG003|Open-Label Maintenance Period|Participant moved to another city|1
1149395|NCT03073200|2260563|FG004|Open-Label Maintenance Period|Participant moved to another city|0
1149396|NCT03073200|2260564|FG005|Open-Label Maintenance Period|Participant moved to another city|0
1149397|NCT03073200|2260565|FG006|Open-Label Maintenance Period|Participant moved to another city|0
1149398|NCT03073200|2260566|FG007|Open-Label Maintenance Period|Participant moved to another city|0
1149399|NCT03073200|2260567|FG008|Open-Label Maintenance Period|Participant moved to another city|0
1149400|NCT03073200|2260568|FG009|Open-Label Maintenance Period|Participant moved to another city|0
1149401|NCT03073200|2260569|FG010|Open-Label Maintenance Period|Participant moved to another city|0
1149402|NCT03073200|2260570|FG011|Open-Label Maintenance Period|Participant moved to another city|0
1149403|NCT03073200|2260571|FG012|Open-Label Maintenance Period|Participant moved to another city|0
1149404|NCT03073200|2260572|FG013|Open-Label Maintenance Period|Participant moved to another city|0
1149405|NCT03073200|2260573|FG014|Open-Label Maintenance Period|Participant moved to another city|0
1149406|NCT03073200|2260559|FG000|Open-Label Maintenance Period|Lack of Efficacy|0
1149407|NCT03073200|2260560|FG001|Open-Label Maintenance Period|Lack of Efficacy|0
1149408|NCT03073200|2260561|FG002|Open-Label Maintenance Period|Lack of Efficacy|0
1149409|NCT03073200|2260562|FG003|Open-Label Maintenance Period|Lack of Efficacy|0
1149410|NCT03073200|2260563|FG004|Open-Label Maintenance Period|Lack of Efficacy|1
1149411|NCT03073200|2260564|FG005|Open-Label Maintenance Period|Lack of Efficacy|0
1149412|NCT03073200|2260565|FG006|Open-Label Maintenance Period|Lack of Efficacy|0
1149413|NCT03073200|2260566|FG007|Open-Label Maintenance Period|Lack of Efficacy|0
1149414|NCT03073200|2260567|FG008|Open-Label Maintenance Period|Lack of Efficacy|0
1149415|NCT03073200|2260568|FG009|Open-Label Maintenance Period|Lack of Efficacy|0
1149416|NCT03073200|2260569|FG010|Open-Label Maintenance Period|Lack of Efficacy|0
1149417|NCT03073200|2260570|FG011|Open-Label Maintenance Period|Lack of Efficacy|0
1149418|NCT03073200|2260571|FG012|Open-Label Maintenance Period|Lack of Efficacy|0
1149419|NCT03073200|2260572|FG013|Open-Label Maintenance Period|Lack of Efficacy|0
1149420|NCT03073200|2260573|FG014|Open-Label Maintenance Period|Lack of Efficacy|0
1149421|NCT03073200|2260559|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0
1149422|NCT03073200|2260560|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0
1149423|NCT03073200|2260561|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0
1149424|NCT03073200|2260562|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2
1149425|NCT03073200|2260563|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1
1149426|NCT03073200|2260564|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0
1149427|NCT03073200|2260565|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0
1149428|NCT03073200|2260566|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0
1149429|NCT03073200|2260567|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0
1149430|NCT03073200|2260568|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0
1149431|NCT03073200|2260569|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0
1149432|NCT03073200|2260570|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0
1149433|NCT03073200|2260571|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0
1149434|NCT03073200|2260572|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0
1149435|NCT03073200|2260573|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0
1149436|NCT03073200|2260559|FG000|Extension Period|Lost to Follow-up|0
1149437|NCT03073200|2260560|FG001|Extension Period|Lost to Follow-up|0
1149438|NCT03073200|2260561|FG002|Extension Period|Lost to Follow-up|0
1149439|NCT03073200|2260562|FG003|Extension Period|Lost to Follow-up|0
1149440|NCT03073200|2260563|FG004|Extension Period|Lost to Follow-up|0
1149441|NCT03073200|2260564|FG005|Extension Period|Lost to Follow-up|0
1149442|NCT03073200|2260565|FG006|Extension Period|Lost to Follow-up|1
1149443|NCT03073200|2260566|FG007|Extension Period|Lost to Follow-up|1
1149444|NCT03073200|2260567|FG008|Extension Period|Lost to Follow-up|0
1149445|NCT03073200|2260568|FG009|Extension Period|Lost to Follow-up|0
1149446|NCT03073200|2260569|FG010|Extension Period|Lost to Follow-up|0
1149447|NCT03073200|2260570|FG011|Extension Period|Lost to Follow-up|0
1149448|NCT03073200|2260571|FG012|Extension Period|Lost to Follow-up|0
1149449|NCT03073200|2260572|FG013|Extension Period|Lost to Follow-up|0
1149450|NCT03073200|2260573|FG014|Extension Period|Lost to Follow-up|0
902327|NCT00739973|1876062|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
902328|NCT00739973|1876063|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
902329|NCT00739973|1876064|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
902330|NCT00739973|1876065|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
902331|NCT00739973|1876066|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
902332|NCT00739973|1876067|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1149451|NCT03073200|2260559|FG000|Extension Period|Sponsor Decision|0
1149452|NCT03073200|2260560|FG001|Extension Period|Sponsor Decision|0
1149453|NCT03073200|2260561|FG002|Extension Period|Sponsor Decision|0
1149454|NCT03073200|2260562|FG003|Extension Period|Sponsor Decision|0
1149455|NCT03073200|2260563|FG004|Extension Period|Sponsor Decision|0
1149456|NCT03073200|2260564|FG005|Extension Period|Sponsor Decision|0
1149457|NCT03073200|2260565|FG006|Extension Period|Sponsor Decision|0
1149458|NCT03073200|2260566|FG007|Extension Period|Sponsor Decision|0
1149459|NCT03073200|2260567|FG008|Extension Period|Sponsor Decision|1
1149460|NCT03073200|2260568|FG009|Extension Period|Sponsor Decision|0
1149461|NCT03073200|2260569|FG010|Extension Period|Sponsor Decision|0
1149462|NCT03073200|2260570|FG011|Extension Period|Sponsor Decision|0
1149463|NCT03073200|2260571|FG012|Extension Period|Sponsor Decision|0
1149464|NCT03073200|2260572|FG013|Extension Period|Sponsor Decision|0
1149465|NCT03073200|2260573|FG014|Extension Period|Sponsor Decision|0
1149466|NCT03073200|2260559|FG000|Extension Period|Withdrawal by Parent/Guardian|0
1149467|NCT03073200|2260560|FG001|Extension Period|Withdrawal by Parent/Guardian|0
1149468|NCT03073200|2260561|FG002|Extension Period|Withdrawal by Parent/Guardian|0
1149469|NCT03073200|2260562|FG003|Extension Period|Withdrawal by Parent/Guardian|0
1149470|NCT03073200|2260563|FG004|Extension Period|Withdrawal by Parent/Guardian|0
1149471|NCT03073200|2260564|FG005|Extension Period|Withdrawal by Parent/Guardian|0
1149472|NCT03073200|2260565|FG006|Extension Period|Withdrawal by Parent/Guardian|1
1149473|NCT03073200|2260566|FG007|Extension Period|Withdrawal by Parent/Guardian|3
1149474|NCT03073200|2260567|FG008|Extension Period|Withdrawal by Parent/Guardian|1
1149475|NCT03073200|2260568|FG009|Extension Period|Withdrawal by Parent/Guardian|0
1149476|NCT03073200|2260569|FG010|Extension Period|Withdrawal by Parent/Guardian|0
1149477|NCT03073200|2260570|FG011|Extension Period|Withdrawal by Parent/Guardian|0
1149478|NCT03073200|2260571|FG012|Extension Period|Withdrawal by Parent/Guardian|0
1149479|NCT03073200|2260572|FG013|Extension Period|Withdrawal by Parent/Guardian|0
1149480|NCT03073200|2260573|FG014|Extension Period|Withdrawal by Parent/Guardian|0
1149481|NCT03073200|2260559|FG000|Extension Period|Withdrawal by Subject|0
1149482|NCT03073200|2260560|FG001|Extension Period|Withdrawal by Subject|0
1149483|NCT03073200|2260561|FG002|Extension Period|Withdrawal by Subject|0
1149484|NCT03073200|2260562|FG003|Extension Period|Withdrawal by Subject|0
1149485|NCT03073200|2260563|FG004|Extension Period|Withdrawal by Subject|0
1149486|NCT03073200|2260564|FG005|Extension Period|Withdrawal by Subject|0
1149487|NCT03073200|2260565|FG006|Extension Period|Withdrawal by Subject|1
1149488|NCT03073200|2260566|FG007|Extension Period|Withdrawal by Subject|2
1149489|NCT03073200|2260567|FG008|Extension Period|Withdrawal by Subject|0
1149490|NCT03073200|2260568|FG009|Extension Period|Withdrawal by Subject|0
1149491|NCT03073200|2260569|FG010|Extension Period|Withdrawal by Subject|0
1149492|NCT03073200|2260570|FG011|Extension Period|Withdrawal by Subject|0
1149493|NCT03073200|2260571|FG012|Extension Period|Withdrawal by Subject|0
1149494|NCT03073200|2260572|FG013|Extension Period|Withdrawal by Subject|0
902333|NCT00739973|1876068|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
902334|NCT00739973|1876069|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
902335|NCT00739973|1876061|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
902336|NCT00739973|1876062|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
902337|NCT00739973|1876063|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
902338|NCT00739973|1876064|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
902339|NCT00739973|1876065|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
902340|NCT00739973|1876066|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
902341|NCT00739973|1876067|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
902342|NCT00739973|1876068|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
902343|NCT00739973|1876069|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
902344|NCT00739973|1876061|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
902345|NCT00739973|1876062|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
902346|NCT00739973|1876063|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
902347|NCT00739973|1876064|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
902348|NCT00739973|1876065|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
902349|NCT00739973|1876066|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
902350|NCT00739973|1876067|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
902351|NCT00739973|1876068|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
902352|NCT00739973|1876069|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
902353|NCT00739973|1876061|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
902354|NCT00739973|1876062|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
902355|NCT00739973|1876063|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
902356|NCT00739973|1876064|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
902357|NCT00739973|1876065|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
902358|NCT00739973|1876066|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
902359|NCT00739973|1876067|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
902360|NCT00739973|1876068|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
902361|NCT00739973|1876069|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
902362|NCT00739973|1876061|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
914256|NCT00813761|1892002|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0
1149495|NCT03073200|2260573|FG014|Extension Period|Withdrawal by Subject|0
1149496|NCT03073200|2260559|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
1149497|NCT03073200|2260560|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
1149498|NCT03073200|2260561|FG002|Randomized Withdrawal Period|Lost to Follow-up|0
1149499|NCT03073200|2260562|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
1149500|NCT03073200|2260563|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
1149501|NCT03073200|2260564|FG005|Randomized Withdrawal Period|Lost to Follow-up|0
1149502|NCT03073200|2260565|FG006|Randomized Withdrawal Period|Lost to Follow-up|0
1149503|NCT03073200|2260566|FG007|Randomized Withdrawal Period|Lost to Follow-up|0
1149504|NCT03073200|2260567|FG008|Randomized Withdrawal Period|Lost to Follow-up|0
1149505|NCT03073200|2260568|FG009|Randomized Withdrawal Period|Lost to Follow-up|0
1149506|NCT03073200|2260569|FG010|Randomized Withdrawal Period|Lost to Follow-up|0
1149507|NCT03073200|2260570|FG011|Randomized Withdrawal Period|Lost to Follow-up|1
1149508|NCT03073200|2260571|FG012|Randomized Withdrawal Period|Lost to Follow-up|0
1149509|NCT03073200|2260572|FG013|Randomized Withdrawal Period|Lost to Follow-up|0
1149510|NCT03073200|2260573|FG014|Randomized Withdrawal Period|Lost to Follow-up|0
1149511|NCT03073200|2260559|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149512|NCT03073200|2260560|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149513|NCT03073200|2260561|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149514|NCT03073200|2260562|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149515|NCT03073200|2260563|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149516|NCT03073200|2260564|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149517|NCT03073200|2260565|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149518|NCT03073200|2260566|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149519|NCT03073200|2260567|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149520|NCT03073200|2260568|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149521|NCT03073200|2260569|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149522|NCT03073200|2260570|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1
1149523|NCT03073200|2260571|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149524|NCT03073200|2260572|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149525|NCT03073200|2260573|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
1149526|NCT03073200|2260559|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
1149527|NCT03073200|2260560|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
1149528|NCT03073200|2260561|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
1149529|NCT03073200|2260562|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
1149530|NCT03073200|2260563|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0
1149531|NCT03073200|2260564|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0
1149532|NCT03073200|2260565|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0
1149533|NCT03073200|2260566|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0
1149534|NCT03073200|2260567|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0
1149535|NCT03073200|2260568|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0
1149536|NCT03073200|2260569|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1
1149537|NCT03073200|2260570|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1
1149538|NCT03073200|2260571|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0
1149539|NCT03073200|2260572|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0
1149540|NCT03073200|2260573|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0
1149541|NCT03073200|2260559|FG000|Randomized Withdrawal Period|Adverse Event|0
1149542|NCT03073200|2260560|FG001|Randomized Withdrawal Period|Adverse Event|0
1149543|NCT03073200|2260561|FG002|Randomized Withdrawal Period|Adverse Event|0
1149544|NCT03073200|2260562|FG003|Randomized Withdrawal Period|Adverse Event|0
1149545|NCT03073200|2260563|FG004|Randomized Withdrawal Period|Adverse Event|0
1149546|NCT03073200|2260564|FG005|Randomized Withdrawal Period|Adverse Event|0
1149547|NCT03073200|2260565|FG006|Randomized Withdrawal Period|Adverse Event|0
1149548|NCT03073200|2260566|FG007|Randomized Withdrawal Period|Adverse Event|0
1149549|NCT03073200|2260567|FG008|Randomized Withdrawal Period|Adverse Event|0
1149550|NCT03073200|2260568|FG009|Randomized Withdrawal Period|Adverse Event|0
1149551|NCT03073200|2260569|FG010|Randomized Withdrawal Period|Adverse Event|1
1149552|NCT03073200|2260570|FG011|Randomized Withdrawal Period|Adverse Event|0
1149553|NCT03073200|2260571|FG012|Randomized Withdrawal Period|Adverse Event|0
1149554|NCT03073200|2260572|FG013|Randomized Withdrawal Period|Adverse Event|0
1149555|NCT03073200|2260573|FG014|Randomized Withdrawal Period|Adverse Event|0
1149556|NCT03073200|2260559|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
1149557|NCT03073200|2260560|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
1149558|NCT03073200|2260561|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
1149559|NCT03073200|2260562|FG003|Post-Treatment Follow-Up Period|Adverse Event|0
1149560|NCT03073200|2260563|FG004|Post-Treatment Follow-Up Period|Adverse Event|0
1149561|NCT03073200|2260564|FG005|Post-Treatment Follow-Up Period|Adverse Event|0
1149562|NCT03073200|2260565|FG006|Post-Treatment Follow-Up Period|Adverse Event|0
1149563|NCT03073200|2260566|FG007|Post-Treatment Follow-Up Period|Adverse Event|0
1149564|NCT03073200|2260567|FG008|Post-Treatment Follow-Up Period|Adverse Event|0
1149565|NCT03073200|2260568|FG009|Post-Treatment Follow-Up Period|Adverse Event|0
1149566|NCT03073200|2260569|FG010|Post-Treatment Follow-Up Period|Adverse Event|0
1149567|NCT03073200|2260570|FG011|Post-Treatment Follow-Up Period|Adverse Event|0
1149568|NCT03073200|2260571|FG012|Post-Treatment Follow-Up Period|Adverse Event|0
1149569|NCT03073200|2260572|FG013|Post-Treatment Follow-Up Period|Adverse Event|2
1149570|NCT03073200|2260573|FG014|Post-Treatment Follow-Up Period|Adverse Event|0
1149571|NCT03073200|2260559|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149572|NCT03073200|2260560|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149573|NCT03073200|2260561|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149574|NCT03073200|2260562|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149575|NCT03073200|2260563|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149576|NCT03073200|2260564|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149577|NCT03073200|2260565|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149578|NCT03073200|2260566|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149579|NCT03073200|2260567|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
902363|NCT00739973|1876062|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
902364|NCT00739973|1876063|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
902365|NCT00739973|1876064|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
902366|NCT00739973|1876065|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
902367|NCT00739973|1876066|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
902368|NCT00739973|1876067|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
902369|NCT00739973|1876068|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
902370|NCT00739973|1876069|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
902371|NCT00739973|1876061|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
902372|NCT00739973|1876062|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
902373|NCT00739973|1876063|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
902374|NCT00739973|1876064|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
902375|NCT00739973|1876065|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
902376|NCT00739973|1876066|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
902377|NCT00739973|1876067|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
902378|NCT00739973|1876068|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
902379|NCT00739973|1876069|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
902380|NCT00739973|1876061|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
902381|NCT00739973|1876062|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
902382|NCT00739973|1876063|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
902383|NCT00739973|1876064|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
902384|NCT00739973|1876065|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
902385|NCT00739973|1876066|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
902386|NCT00739973|1876067|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
902387|NCT00739973|1876068|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
902388|NCT00739973|1876069|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
902389|NCT00739973|1876061|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
902390|NCT00739973|1876062|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
902391|NCT00739973|1876063|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
902392|NCT00739973|1876064|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
902393|NCT00739973|1876065|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
902394|NCT00739973|1876066|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
902395|NCT00739973|1876067|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
902396|NCT00739973|1876068|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
902397|NCT00739973|1876069|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
902398|NCT00739973|1876061|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
902399|NCT00739973|1876062|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
902400|NCT00739973|1876063|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
902401|NCT00739973|1876064|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
902402|NCT00739973|1876065|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
902403|NCT00739973|1876066|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
902404|NCT00739973|1876067|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
902405|NCT00739973|1876068|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
902406|NCT00739973|1876069|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
902407|NCT00739973|1876061|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
902408|NCT00739973|1876062|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
902409|NCT00739973|1876063|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
902410|NCT00739973|1876064|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
902411|NCT00739973|1876065|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
902412|NCT00739973|1876066|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1149580|NCT03073200|2260568|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149581|NCT03073200|2260569|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149582|NCT03073200|2260570|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149583|NCT03073200|2260571|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149584|NCT03073200|2260572|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
1149585|NCT03073200|2260573|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1149586|NCT03073200|2260559|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149587|NCT03073200|2260560|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149588|NCT03073200|2260561|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149589|NCT03073200|2260562|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149590|NCT03073200|2260563|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149591|NCT03073200|2260564|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149592|NCT03073200|2260565|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149593|NCT03073200|2260566|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149594|NCT03073200|2260567|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149595|NCT03073200|2260568|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149596|NCT03073200|2260569|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149597|NCT03073200|2260570|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149598|NCT03073200|2260571|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149599|NCT03073200|2260572|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1
1149600|NCT03073200|2260573|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0
1149601|NCT03073200|2260559|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
1149602|NCT03073200|2260560|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
1149603|NCT03073200|2260561|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
1149604|NCT03073200|2260562|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
1149605|NCT03073200|2260563|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
1149606|NCT03073200|2260564|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
1149607|NCT03073200|2260565|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
1149608|NCT03073200|2260566|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
1149609|NCT03073200|2260567|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
1149610|NCT03073200|2260568|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
1149611|NCT03073200|2260569|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
1149612|NCT03073200|2260570|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
1149613|NCT03073200|2260571|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
1149614|NCT03073200|2260572|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
1149615|NCT03073200|2260573|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0
1149616|NCT03073200|2260559|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149617|NCT03073200|2260560|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
902413|NCT00739973|1876067|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
902414|NCT00739973|1876068|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
902415|NCT00739973|1876069|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
902416|NCT00739973|1876061|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
902417|NCT00739973|1876062|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
902418|NCT00739973|1876063|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
902419|NCT00739973|1876064|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
902420|NCT00739973|1876065|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
902421|NCT00739973|1876066|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
902422|NCT00739973|1876067|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
902423|NCT00739973|1876068|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
902424|NCT00739973|1876069|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
902425|NCT00739973|1876061|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
902426|NCT00739973|1876062|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
902427|NCT00739973|1876063|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
902428|NCT00739973|1876064|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
902429|NCT00739973|1876065|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
902430|NCT00739973|1876066|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
902431|NCT00739973|1876067|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
902432|NCT00739973|1876068|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
902433|NCT00739973|1876069|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
902434|NCT00740051|1876113|FG000|Overall Study|Lack of Efficacy|2
902435|NCT00740051|1876114|FG001|Overall Study|Lack of Efficacy|5
902436|NCT00740051|1876113|FG000|Overall Study|Adverse Event|1
902437|NCT00740051|1876114|FG001|Overall Study|Adverse Event|4
902438|NCT00740051|1876113|FG000|Overall Study|Protocol Violation|2
902439|NCT00740051|1876114|FG001|Overall Study|Protocol Violation|6
902440|NCT00740051|1876113|FG000|Overall Study|Lost to Follow-up|3
902441|NCT00740051|1876114|FG001|Overall Study|Lost to Follow-up|8
902442|NCT00740051|1876113|FG000|Overall Study|Withdrawal by Subject|6
1149618|NCT03073200|2260561|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149619|NCT03073200|2260562|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149620|NCT03073200|2260563|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149621|NCT03073200|2260564|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149622|NCT03073200|2260565|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149623|NCT03073200|2260566|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149624|NCT03073200|2260567|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149625|NCT03073200|2260568|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149626|NCT03073200|2260569|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149627|NCT03073200|2260570|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149628|NCT03073200|2260571|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149629|NCT03073200|2260572|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
1149630|NCT03073200|2260573|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1
1149631|NCT03073200|2260559|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149632|NCT03073200|2260560|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149633|NCT03073200|2260561|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149634|NCT03073200|2260562|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149635|NCT03073200|2260563|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149636|NCT03073200|2260564|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149637|NCT03073200|2260565|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149638|NCT03073200|2260566|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149639|NCT03073200|2260567|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149640|NCT03073200|2260568|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149641|NCT03073200|2260569|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149642|NCT03073200|2260570|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149643|NCT03073200|2260571|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149644|NCT03073200|2260572|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11
1149645|NCT03073200|2260573|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
1149646|NCT03073200|2260559|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149647|NCT03073200|2260560|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149648|NCT03073200|2260561|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149649|NCT03073200|2260562|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149650|NCT03073200|2260563|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149651|NCT03073200|2260564|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149652|NCT03073200|2260565|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149653|NCT03073200|2260566|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149654|NCT03073200|2260567|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149655|NCT03073200|2260568|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149656|NCT03073200|2260569|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149657|NCT03073200|2260570|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149658|NCT03073200|2260571|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149659|NCT03073200|2260572|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9
1149660|NCT03073200|2260573|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1149661|NCT03073200|2260559|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149662|NCT03073200|2260560|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149663|NCT03073200|2260561|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149664|NCT03073200|2260562|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149665|NCT03073200|2260563|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149666|NCT03073200|2260564|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149667|NCT03073200|2260565|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149668|NCT03073200|2260566|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149669|NCT03073200|2260567|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149670|NCT03073200|2260568|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149671|NCT03073200|2260569|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149672|NCT03073200|2260570|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149673|NCT03073200|2260571|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149674|NCT03073200|2260572|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2
1149675|NCT03073200|2260573|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
1149676|NCT03073213|2260598|FG000|Multiple Dose Period|Protocol Violation|0
1149677|NCT03073213|2260599|FG001|Multiple Dose Period|Protocol Violation|0
1149678|NCT03073213|2260600|FG002|Multiple Dose Period|Protocol Violation|1
1149679|NCT03073798|2260628|FG000|Overall Study|Adverse Event|1
1149680|NCT03073798|2260628|FG000|Overall Study|Withdrawal by Subject|1
1149681|NCT03074162|2260653|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0
1149682|NCT03074162|2260654|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0
1149683|NCT03074162|2260655|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1
1149684|NCT03074162|2260656|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0
1149685|NCT03074162|2260657|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0
1149686|NCT03074162|2260658|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0
1149687|NCT03074162|2260653|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0
1149688|NCT03074162|2260654|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0
1149689|NCT03074162|2260655|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1
1149690|NCT03074162|2260656|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0
1149691|NCT03074162|2260657|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0
1149692|NCT03074162|2260658|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1
1149693|NCT03074162|2260653|FG000|Period 3|Withdrawal by Subject|1
1149694|NCT03074162|2260654|FG001|Period 3|Withdrawal by Subject|0
1149695|NCT03074162|2260655|FG002|Period 3|Withdrawal by Subject|0
1149696|NCT03074162|2260656|FG003|Period 3|Withdrawal by Subject|0
1149697|NCT03074162|2260657|FG004|Period 3|Withdrawal by Subject|1
1149698|NCT03074162|2260658|FG005|Period 3|Withdrawal by Subject|0
1149699|NCT03074331|2260666|FG000|Overall Study|Enrolled but Not Treated|1
1149700|NCT03074331|2260666|FG000|Overall Study|Lost to Follow-up|5
1149701|NCT03074331|2260666|FG000|Overall Study|Withdrew Consent|1
1149702|NCT03074500|2260682|FG000|Overall Study|Lost to Follow-up|1
1149703|NCT03074500|2260683|FG001|Overall Study|Lost to Follow-up|0
1149704|NCT03074500|2260684|FG002|Overall Study|Lost to Follow-up|0
1149705|NCT03074500|2260682|FG000|Overall Study|Lack of Efficacy|0
1149706|NCT03074500|2260683|FG001|Overall Study|Lack of Efficacy|1
1149707|NCT03074500|2260684|FG002|Overall Study|Lack of Efficacy|0
1149708|NCT03074500|2260682|FG000|Overall Study|Adverse Event|0
1149709|NCT03074500|2260683|FG001|Overall Study|Adverse Event|0
1149710|NCT03074500|2260684|FG002|Overall Study|Adverse Event|1
1149711|NCT03075163|2260723|FG000|Overall Study|not eligible for treatment limb|138
1149712|NCT03075163|2260724|FG001|Overall Study|not eligible for treatment limb|138
1149713|NCT03075267|2260733|FG000|Overall Study|Protocol Violation|1
1149714|NCT03075267|2260734|FG001|Overall Study|Protocol Violation|0
1149715|NCT03075267|2260735|FG002|Overall Study|Protocol Violation|0
1149716|NCT03075410|2260752|FG000|Part A-Period 2 (14 Days)|Personal reasons|1
1149717|NCT03075410|2260753|FG001|Part A-Period 2 (14 Days)|Personal reasons|0
1149718|NCT03075410|2260754|FG002|Part A-Period 2 (14 Days)|Personal reasons|1
1149719|NCT03075410|2260755|FG003|Part A-Period 2 (14 Days)|Personal reasons|0
902443|NCT00740051|1876114|FG001|Overall Study|Withdrawal by Subject|8
902444|NCT00740051|1876113|FG000|Overall Study|Other reason (not specified)|4
902445|NCT00740051|1876114|FG001|Overall Study|Other reason (not specified)|1
902446|NCT00740220|1876143|FG000|Overall Study|screen failures (non-COPD patients)|9
902447|NCT00740480|1876156|FG000|Overall Study|Adverse Event|1
902448|NCT00740480|1876156|FG000|Overall Study|Physician Decision|1
902449|NCT00740584|1876159|FG000|Overall Study|Withdrawal by Subject|1
902450|NCT00740636|1876166|FG000|Overall Study|Adverse Event|0
902451|NCT00740636|1876167|FG001|Overall Study|Adverse Event|2
902452|NCT00740636|1876166|FG000|Overall Study|Patient Ineligible|0
902453|NCT00740636|1876167|FG001|Overall Study|Patient Ineligible|1
902454|NCT00740636|1876166|FG000|Overall Study|Patient Not Treated|0
902455|NCT00740636|1876167|FG001|Overall Study|Patient Not Treated|1
902456|NCT00740636|1876166|FG000|Overall Study|Progressive Disease|1
902457|NCT00740636|1876167|FG001|Overall Study|Progressive Disease|0
902458|NCT00740636|1876166|FG000|Overall Study|Death|1
902459|NCT00740636|1876167|FG001|Overall Study|Death|0
902460|NCT00740714|1876176|FG000|Overall Study|Withdrawal by Subject|17
902461|NCT00740714|1876177|FG001|Overall Study|Withdrawal by Subject|19
902462|NCT00740714|1876178|FG002|Overall Study|Withdrawal by Subject|29
902463|NCT00740779|1876192|FG000|Overall Study|Adverse Event|4
902464|NCT00740779|1876193|FG001|Overall Study|Adverse Event|6
902465|NCT00740779|1876194|FG002|Overall Study|Adverse Event|3
902466|NCT00740779|1876192|FG000|Overall Study|Protocol Violation|1
902467|NCT00740779|1876193|FG001|Overall Study|Protocol Violation|1
902468|NCT00740779|1876194|FG002|Overall Study|Protocol Violation|1
902469|NCT00740779|1876192|FG000|Overall Study|Lack of Efficacy|0
902470|NCT00740779|1876193|FG001|Overall Study|Lack of Efficacy|0
902471|NCT00740779|1876194|FG002|Overall Study|Lack of Efficacy|2
902472|NCT00740779|1876192|FG000|Overall Study|Withdrawal by Subject|2
902473|NCT00740779|1876193|FG001|Overall Study|Withdrawal by Subject|4
902474|NCT00740779|1876194|FG002|Overall Study|Withdrawal by Subject|2
902475|NCT00740779|1876192|FG000|Overall Study|Lost to Follow-up|2
902476|NCT00740779|1876193|FG001|Overall Study|Lost to Follow-up|3
902477|NCT00740779|1876194|FG002|Overall Study|Lost to Follow-up|5
902478|NCT00740792|1876206|FG000|Overall Study|Adverse Event|3
902479|NCT00740792|1876207|FG001|Overall Study|Adverse Event|1
902480|NCT00740792|1876208|FG002|Overall Study|Adverse Event|1
902481|NCT00740792|1876209|FG003|Overall Study|Adverse Event|3
902482|NCT00740792|1876206|FG000|Overall Study|Lack of Efficacy|1
902483|NCT00740792|1876207|FG001|Overall Study|Lack of Efficacy|1
902484|NCT00740792|1876208|FG002|Overall Study|Lack of Efficacy|0
902485|NCT00740792|1876209|FG003|Overall Study|Lack of Efficacy|3
902486|NCT00740792|1876206|FG000|Overall Study|Lost to Follow-up|2
902487|NCT00740792|1876207|FG001|Overall Study|Lost to Follow-up|1
1149720|NCT03075410|2260756|FG004|Part A-Period 2 (14 Days)|Personal reasons|0
1149721|NCT03075410|2260757|FG005|Part A-Period 2 (14 Days)|Personal reasons|0
1149722|NCT03075410|2260758|FG006|Part A-Period 2 (14 Days)|Personal reasons|0
1149723|NCT03075410|2260759|FG007|Part A-Period 2 (14 Days)|Personal reasons|0
1149724|NCT03075410|2260760|FG008|Part A-Period 2 (14 Days)|Personal reasons|0
1149725|NCT03075410|2260752|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
1149726|NCT03075410|2260753|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1149727|NCT03075410|2260754|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1149728|NCT03075410|2260755|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1149729|NCT03075410|2260756|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1149730|NCT03075410|2260757|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1149731|NCT03075410|2260758|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1149732|NCT03075410|2260759|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1149733|NCT03075410|2260760|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1149734|NCT03075501|2260790|FG000|Overall Study|Scheduling difficulties|15
1149735|NCT03075501|2260791|FG001|Overall Study|Scheduling difficulties|9
1149736|NCT03075527|2260798|FG000|Overall Study|Ongoing treatment|2
1149737|NCT03075644|2260808|FG000|Overall Study|Withdrawal by Subject|1
1149738|NCT03075644|2260809|FG001|Overall Study|Withdrawal by Subject|1
1149739|NCT03075761|2260818|FG000|Overall Study|Lost to Follow-up|1
1149740|NCT03075761|2260819|FG001|Overall Study|Lost to Follow-up|6
1149741|NCT03075839|2260830|FG000|Overall Study|Lost to Follow-up|4
1149742|NCT03075878|2260834|FG000|Overall Study|Physician Decision|1
1149743|NCT03075891|2260840|FG000|Overall Study|Withdrawal by Subject|3
1149744|NCT03075891|2260841|FG001|Overall Study|Withdrawal by Subject|6
1149745|NCT03075891|2260840|FG000|Overall Study|Lost to Follow-up|1
1149746|NCT03075891|2260841|FG001|Overall Study|Lost to Follow-up|0
1149747|NCT03075891|2260840|FG000|Overall Study|Pregnancy|3
902488|NCT00740792|1876208|FG002|Overall Study|Lost to Follow-up|0
902489|NCT00740792|1876209|FG003|Overall Study|Lost to Follow-up|0
902490|NCT00740792|1876206|FG000|Overall Study|Protocol Violation|0
902491|NCT00740792|1876207|FG001|Overall Study|Protocol Violation|1
902492|NCT00740792|1876208|FG002|Overall Study|Protocol Violation|0
902493|NCT00740792|1876209|FG003|Overall Study|Protocol Violation|2
902494|NCT00740792|1876206|FG000|Overall Study|Withdrawal by Subject|1
902495|NCT00740792|1876207|FG001|Overall Study|Withdrawal by Subject|1
902496|NCT00740792|1876208|FG002|Overall Study|Withdrawal by Subject|0
902497|NCT00740792|1876209|FG003|Overall Study|Withdrawal by Subject|0
902498|NCT00740792|1876206|FG000|Overall Study|administrative|3
902499|NCT00740792|1876207|FG001|Overall Study|administrative|3
902500|NCT00740792|1876208|FG002|Overall Study|administrative|8
902501|NCT00740792|1876209|FG003|Overall Study|administrative|2
902502|NCT00740857|1876235|FG000|Overall Study|Withdrawal by Subject|1
902503|NCT00740857|1876236|FG001|Overall Study|Withdrawal by Subject|0
902504|NCT00740857|1876237|FG002|Overall Study|Withdrawal by Subject|0
902505|NCT00740870|1876245|FG000|Overall Study|Not Catheterized|4
902506|NCT00740870|1876245|FG000|Overall Study|Further testing contraindicated implant|17
902507|NCT00741013|1876255|FG000|Overall Study|Adverse Event|1
902508|NCT00741013|1876256|FG001|Overall Study|Adverse Event|0
902509|NCT00741013|1876257|FG002|Overall Study|Adverse Event|0
902510|NCT00741013|1876255|FG000|Overall Study|Withdrawal by Subject|0
902511|NCT00741013|1876256|FG001|Overall Study|Withdrawal by Subject|0
1149748|NCT03075891|2260841|FG001|Overall Study|Pregnancy|1
1149749|NCT03075891|2260840|FG000|Overall Study|visits not performed (no time)|1
1149750|NCT03075891|2260841|FG001|Overall Study|visits not performed (no time)|0
1149751|NCT03075891|2260840|FG000|Overall Study|Drug abuse relapse issue|0
1149752|NCT03075891|2260841|FG001|Overall Study|Drug abuse relapse issue|1
1149753|NCT03075891|2260840|FG000|Overall Study|Participant requiring study withdrawal|0
902512|NCT00741013|1876257|FG002|Overall Study|Withdrawal by Subject|1
902513|NCT00741013|1876255|FG000|Overall Study|Discovered failed screen after enrolled|0
902514|NCT00741013|1876256|FG001|Overall Study|Discovered failed screen after enrolled|2
902515|NCT00741013|1876257|FG002|Overall Study|Discovered failed screen after enrolled|0
902516|NCT00741039|1876273|FG000|Overall Study|Patient non-compliance|2
902517|NCT00741039|1876274|FG001|Overall Study|Patient non-compliance|0
902518|NCT00741091|1876280|FG000|Overall Study|Death|13
902519|NCT00741091|1876280|FG000|Overall Study|Lost to Follow-up|16
902520|NCT00741091|1876280|FG000|Overall Study|Withdrawal by Subject|6
902521|NCT00741091|1876280|FG000|Overall Study|Missed Visit|22
902522|NCT00741260|1876310|FG000|Overall Study|Disease Progression|3
902523|NCT00741260|1876311|FG001|Overall Study|Disease Progression|5
902524|NCT00741260|1876312|FG002|Overall Study|Disease Progression|3
902525|NCT00741260|1876313|FG003|Overall Study|Disease Progression|3
902526|NCT00741260|1876314|FG004|Overall Study|Disease Progression|5
902527|NCT00741260|1876315|FG005|Overall Study|Disease Progression|37
902528|NCT00741260|1876316|FG006|Overall Study|Disease Progression|4
902529|NCT00741260|1876310|FG000|Overall Study|Death|0
902530|NCT00741260|1876311|FG001|Overall Study|Death|1
902531|NCT00741260|1876312|FG002|Overall Study|Death|0
902532|NCT00741260|1876313|FG003|Overall Study|Death|1
902533|NCT00741260|1876314|FG004|Overall Study|Death|2
902534|NCT00741260|1876315|FG005|Overall Study|Death|2
1149754|NCT03075891|2260841|FG001|Overall Study|Participant requiring study withdrawal|1
1149755|NCT03075891|2260840|FG000|Overall Study|Adverse event, non-fatal|1
1149756|NCT03075891|2260841|FG001|Overall Study|Adverse event, non-fatal|4
1149757|NCT03075904|2260849|FG000|Overall Study|Physician Decision|3
1149758|NCT03075904|2260849|FG000|Overall Study|Need for Medication not Permitted|1
1149759|NCT03076190|2260855|FG000|Overall Study|Lost to Follow-up|9
1149760|NCT03076190|2260856|FG001|Overall Study|Lost to Follow-up|34
1149761|NCT03076190|2260855|FG000|Overall Study|Excluded from Analysis (zero duration ev|9
1149762|NCT03076190|2260856|FG001|Overall Study|Excluded from Analysis (zero duration ev|7
1149763|NCT03076515|2260882|FG000|Overall Study|DMC decision based on interim analysis|25
1149764|NCT03076515|2260883|FG001|Overall Study|DMC decision based on interim analysis|29
1149765|NCT03076970|2260889|FG000|Washout Period 2|Adverse Event|0
1149766|NCT03076970|2260890|FG001|Washout Period 2|Adverse Event|0
1149767|NCT03076970|2260891|FG002|Washout Period 2|Adverse Event|0
1149768|NCT03076970|2260892|FG003|Washout Period 2|Adverse Event|0
1149769|NCT03076970|2260893|FG004|Washout Period 2|Adverse Event|1
1149770|NCT03076970|2260894|FG005|Washout Period 2|Adverse Event|0
1149771|NCT03076970|2260889|FG000|Period 3|Withdrawal by Subject|0
1149772|NCT03076970|2260890|FG001|Period 3|Withdrawal by Subject|0
1149773|NCT03076970|2260891|FG002|Period 3|Withdrawal by Subject|0
1149774|NCT03076970|2260892|FG003|Period 3|Withdrawal by Subject|0
1149775|NCT03076970|2260893|FG004|Period 3|Withdrawal by Subject|0
1149776|NCT03076970|2260894|FG005|Period 3|Withdrawal by Subject|1
1149777|NCT03076970|2260889|FG000|Period 3|Failure to meet I/E criteria|0
1149778|NCT03076970|2260890|FG001|Period 3|Failure to meet I/E criteria|0
1149779|NCT03076970|2260891|FG002|Period 3|Failure to meet I/E criteria|0
1149780|NCT03076970|2260892|FG003|Period 3|Failure to meet I/E criteria|0
1149781|NCT03076970|2260893|FG004|Period 3|Failure to meet I/E criteria|1
1149782|NCT03076970|2260894|FG005|Period 3|Failure to meet I/E criteria|0
1149783|NCT03076996|2260914|FG000|Overall Study|Withdrawal by Subject|2
1149784|NCT03076996|2260914|FG000|Overall Study|Lost to Follow-up|3
1149785|NCT03076996|2260914|FG000|Overall Study|Literacy precluded participation|1
1149786|NCT03077438|2260945|FG000|Overall Study|Protocol Violation|3
1149787|NCT03077438|2260946|FG001|Overall Study|Protocol Violation|5
1149788|NCT03077438|2260945|FG000|Overall Study|Withdrawal by Subject|3
1149789|NCT03077438|2260946|FG001|Overall Study|Withdrawal by Subject|6
1149790|NCT03077438|2260945|FG000|Overall Study|Lost to Follow-up|6
1149791|NCT03077438|2260946|FG001|Overall Study|Lost to Follow-up|3
1149792|NCT03077607|2260958|FG000|Period 1 (15 Days)|Adverse Event|1
1149793|NCT03077607|2260959|FG001|Period 1 (15 Days)|Adverse Event|0
1149794|NCT03077607|2260958|FG000|Period 1 (15 Days)|Death|1
1149795|NCT03077607|2260959|FG001|Period 1 (15 Days)|Death|0
1149796|NCT03077607|2260958|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
1149797|NCT03077607|2260959|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
1149798|NCT03077607|2260958|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
1149799|NCT03077607|2260959|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
1149800|NCT03077646|2260979|FG000|Overall Study|Lost to Follow-up|29
1149801|NCT03077646|2260980|FG001|Overall Study|Lost to Follow-up|30
1149802|NCT03077646|2260981|FG002|Overall Study|Lost to Follow-up|31
1149803|NCT03077659|2260992|FG000|Overall Study|Withdrawal by Subject|0
1149804|NCT03077659|2260993|FG001|Overall Study|Withdrawal by Subject|0
1149805|NCT03077659|2260994|FG002|Overall Study|Withdrawal by Subject|1
1149806|NCT03077711|2261007|FG000|Overall Study|Lost to Follow-up|2
1149807|NCT03077711|2261008|FG001|Overall Study|Lost to Follow-up|2
1149808|NCT03077711|2261007|FG000|Overall Study|noncompliant taking medication|2
1149809|NCT03077711|2261008|FG001|Overall Study|noncompliant taking medication|0
1149810|NCT03077724|2261018|FG000|Overall Study|Lost to Follow-up|5
1149811|NCT03077724|2261019|FG001|Overall Study|Lost to Follow-up|1
1149812|NCT03077724|2261018|FG000|Overall Study|Withdrawal by Subject|3
1149813|NCT03077724|2261019|FG001|Overall Study|Withdrawal by Subject|1
1149814|NCT03077919|2261037|FG000|Overall Study|Lost to Follow-up|4
1149815|NCT03077919|2261038|FG001|Overall Study|Lost to Follow-up|1
1149832|NCT03078556|2261104|FG000|Treatment Period 1 (4 Days)|Adverse Event|0
1149833|NCT03078556|2261105|FG001|Treatment Period 1 (4 Days)|Adverse Event|1
1149834|NCT03078556|2261106|FG002|Treatment Period 1 (4 Days)|Adverse Event|0
1149835|NCT03078556|2261107|FG003|Treatment Period 1 (4 Days)|Adverse Event|0
1149836|NCT03078556|2261104|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2
1149837|NCT03078556|2261105|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0
1149838|NCT03078556|2261106|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1
1149839|NCT03078556|2261107|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0
1149840|NCT03078556|2261104|FG000|Washout Period 1 (7 Days)|Adverse Event|0
1149841|NCT03078556|2261105|FG001|Washout Period 1 (7 Days)|Adverse Event|1
1149842|NCT03078556|2261106|FG002|Washout Period 1 (7 Days)|Adverse Event|0
1149843|NCT03078556|2261107|FG003|Washout Period 1 (7 Days)|Adverse Event|1
1149844|NCT03078556|2261104|FG000|Washout Period 1 (7 Days)|Physician Decision|0
1149845|NCT03078556|2261105|FG001|Washout Period 1 (7 Days)|Physician Decision|1
1149846|NCT03078556|2261106|FG002|Washout Period 1 (7 Days)|Physician Decision|0
1149847|NCT03078556|2261107|FG003|Washout Period 1 (7 Days)|Physician Decision|0
1149848|NCT03078582|2261134|FG000|Overall Study|Adverse Event|0
1149849|NCT03078582|2261135|FG001|Overall Study|Adverse Event|8
1149850|NCT03078751|2261165|FG000|Overall Study|Adverse Event|4
1149851|NCT03078751|2261166|FG001|Overall Study|Adverse Event|0
1149852|NCT03078751|2261165|FG000|Overall Study|Physician Decision|1
1149853|NCT03078751|2261166|FG001|Overall Study|Physician Decision|0
1149854|NCT03078751|2261165|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0
1149855|NCT03078751|2261166|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23
1149856|NCT03078751|2261165|FG000|Overall Study|Subject/guardian decision|8
1149857|NCT03078751|2261166|FG001|Overall Study|Subject/guardian decision|1
1149858|NCT03078751|2261165|FG000|Overall Study|Untreated|0
1149859|NCT03078751|2261166|FG001|Overall Study|Untreated|4
1149860|NCT03078816|2261172|FG000|Overall Study|Withdrawal by Subject|1
1149861|NCT03078907|2261178|FG000|Overall Study|Adverse Event|2
1149862|NCT03078907|2261179|FG001|Overall Study|Adverse Event|0
1149863|NCT03078907|2261178|FG000|Overall Study|Other|1
1149864|NCT03078907|2261179|FG001|Overall Study|Other|0
1149865|NCT03078907|2261178|FG000|Overall Study|Protocol Violation|0
1149866|NCT03078907|2261179|FG001|Overall Study|Protocol Violation|1
1149867|NCT03080454|2261224|FG000|Baseline|Adverse Event|2
1149868|NCT03080454|2261224|FG000|Anodal Doublestim (5 Days)|Adverse Event|1
1149869|NCT03080454|2261224|FG000|Anodal FU (7 Days)|Lost to Follow-up|4
1149870|NCT03080493|2261233|FG000|Overall Study|Did not provide NRS pain results|1
1149871|NCT03080493|2261234|FG001|Overall Study|Did not provide NRS pain results|0
1149872|NCT03080493|2261233|FG000|Overall Study|Adverse Event|0
1149873|NCT03080493|2261234|FG001|Overall Study|Adverse Event|1
1149874|NCT03080493|2261233|FG000|Overall Study|Randomization error (parity group)|0
1149875|NCT03080493|2261234|FG001|Overall Study|Randomization error (parity group)|1
1149876|NCT03080961|2261240|FG000|Overall Study|Withdrawal by Subject|3
1149877|NCT03081884|2261258|FG000|Overall Study|deferred prostate cancer treatment|1
1149878|NCT03081884|2261258|FG000|Overall Study|metastasis managed with systemic therapy|3
1149879|NCT03082261|2261272|FG000|Overall Study|Death|4
1149880|NCT03082261|2261272|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1
1149881|NCT03082261|2261272|FG000|Overall Study|Insurance denial|1
1149882|NCT03082261|2261272|FG000|Overall Study|Peripheral lead added|1
1149883|NCT03082261|2261272|FG000|Overall Study|Withdrawal by Subject|40
1149884|NCT03082261|2261272|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2
1149885|NCT03082261|2261272|FG000|Overall Study|Subject implanted with device other than study device|1
1149886|NCT03082261|2261272|FG000|Overall Study|Lost to Follow-up|14
1149887|NCT03082261|2261272|FG000|Overall Study|Subject moved to a different state|1
1149888|NCT03082261|2261272|FG000|Overall Study|Subject non-compliance|2
1149889|NCT03082261|2261272|FG000|Overall Study|Subject participation terminated by investigator|9
1149890|NCT03082261|2261272|FG000|Overall Study|Subject participation terminated by sponsor|4
1149891|NCT03082261|2261272|FG000|Overall Study|System explant|19
1149892|NCT03082261|2261272|FG000|Overall Study|Unable to place lead(s)|2
1149893|NCT03082261|2261272|FG000|Overall Study|Unsuccessful trial evaluation period|19
1149894|NCT03082599|2261309|FG000|Overall Study|Lost to Follow-up|1
1149895|NCT03082599|2261310|FG001|Overall Study|Lost to Follow-up|0
1149896|NCT03083132|2261327|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0
1149897|NCT03083132|2261328|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2
1149898|NCT03083132|2261327|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1
1149899|NCT03083132|2261328|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0
1149900|NCT03083132|2261327|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0
1149901|NCT03083132|2261328|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1
1149902|NCT03083470|2261348|FG000|Overall Study|Lost to Follow-up|0
1149903|NCT03083470|2261349|FG001|Overall Study|Lost to Follow-up|0
1149904|NCT03083470|2261350|FG002|Overall Study|Lost to Follow-up|0
1149905|NCT03083470|2261351|FG003|Overall Study|Lost to Follow-up|0
1149906|NCT03083470|2261352|FG004|Overall Study|Lost to Follow-up|1
1149907|NCT03083470|2261348|FG000|Overall Study|Withdrawal by Subject|0
1149908|NCT03083470|2261349|FG001|Overall Study|Withdrawal by Subject|0
1149909|NCT03083470|2261350|FG002|Overall Study|Withdrawal by Subject|0
1149910|NCT03083470|2261351|FG003|Overall Study|Withdrawal by Subject|0
1149911|NCT03083470|2261352|FG004|Overall Study|Withdrawal by Subject|1
1149912|NCT03083483|2261367|FG000|Overall Study|Adverse Event|1
1149913|NCT03083483|2261368|FG001|Overall Study|Adverse Event|1
1149914|NCT03083483|2261369|FG002|Overall Study|Adverse Event|1
1149915|NCT03083483|2261367|FG000|Overall Study|Lost to Follow-up|2
1149916|NCT03083483|2261368|FG001|Overall Study|Lost to Follow-up|1
1149917|NCT03083483|2261369|FG002|Overall Study|Lost to Follow-up|1
1149918|NCT03083483|2261367|FG000|Overall Study|technological issues|1
1149919|NCT03083483|2261368|FG001|Overall Study|technological issues|0
1149920|NCT03083483|2261369|FG002|Overall Study|technological issues|1
1149921|NCT03083639|2261379|FG000|Washout Period (at Least 6 Days)|Pregnancy|0
1149922|NCT03083639|2261380|FG001|Washout Period (at Least 6 Days)|Pregnancy|1
1149923|NCT03083639|2261379|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1
1149924|NCT03083639|2261380|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0
1149925|NCT03083847|2261405|FG000|Main|Physician Decision|0
1149926|NCT03083847|2261406|FG001|Main|Physician Decision|0
1149927|NCT03083847|2261407|FG002|Main|Physician Decision|0
1149928|NCT03083847|2261408|FG003|Main|Physician Decision|0
1149929|NCT03083847|2261409|FG004|Main|Physician Decision|0
1149930|NCT03083847|2261410|FG005|Main|Physician Decision|1
1149931|NCT03083847|2261411|FG006|Main|Physician Decision|0
1149932|NCT03083847|2261412|FG007|Main|Physician Decision|0
1149933|NCT03083847|2261413|FG008|Main|Physician Decision|0
1149934|NCT03083847|2261414|FG009|Main|Physician Decision|0
1149935|NCT03083847|2261405|FG000|Main|Pregnancy|0
1149936|NCT03083847|2261406|FG001|Main|Pregnancy|0
1149937|NCT03083847|2261407|FG002|Main|Pregnancy|0
1149938|NCT03083847|2261408|FG003|Main|Pregnancy|0
1149939|NCT03083847|2261409|FG004|Main|Pregnancy|0
1149940|NCT03083847|2261410|FG005|Main|Pregnancy|0
1149941|NCT03083847|2261411|FG006|Main|Pregnancy|0
1149942|NCT03083847|2261412|FG007|Main|Pregnancy|1
1149943|NCT03083847|2261413|FG008|Main|Pregnancy|0
1149944|NCT03083847|2261414|FG009|Main|Pregnancy|0
1149945|NCT03083847|2261405|FG000|Main|Adverse Event|0
1149946|NCT03083847|2261406|FG001|Main|Adverse Event|0
1149947|NCT03083847|2261407|FG002|Main|Adverse Event|0
1149948|NCT03083847|2261408|FG003|Main|Adverse Event|0
1149949|NCT03083847|2261409|FG004|Main|Adverse Event|0
1149950|NCT03083847|2261410|FG005|Main|Adverse Event|0
1149951|NCT03083847|2261411|FG006|Main|Adverse Event|0
1149952|NCT03083847|2261412|FG007|Main|Adverse Event|2
1149953|NCT03083847|2261413|FG008|Main|Adverse Event|0
1149954|NCT03083847|2261414|FG009|Main|Adverse Event|0
1149955|NCT03083847|2261405|FG000|Main|Withdrawal by Subject|0
1149956|NCT03083847|2261406|FG001|Main|Withdrawal by Subject|0
1149957|NCT03083847|2261407|FG002|Main|Withdrawal by Subject|0
1149958|NCT03083847|2261408|FG003|Main|Withdrawal by Subject|0
1149959|NCT03083847|2261409|FG004|Main|Withdrawal by Subject|0
1149960|NCT03083847|2261410|FG005|Main|Withdrawal by Subject|0
1149961|NCT03083847|2261411|FG006|Main|Withdrawal by Subject|1
1149962|NCT03083847|2261412|FG007|Main|Withdrawal by Subject|1
1149963|NCT03083847|2261413|FG008|Main|Withdrawal by Subject|0
1149964|NCT03083847|2261414|FG009|Main|Withdrawal by Subject|0
1149965|NCT03083990|2261444|FG000|Overall Study|Adverse Event|1
1149966|NCT03083990|2261445|FG001|Overall Study|Adverse Event|0
1149967|NCT03084302|2261451|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9
1149968|NCT03084302|2261451|FG000|Overall Study|No valid objective monitor data|6
1149969|NCT03084315|2261458|FG000|Overall Study|Lost to Follow-up|8
1149970|NCT03084315|2261459|FG001|Overall Study|Lost to Follow-up|7
1149971|NCT03084315|2261458|FG000|Overall Study|Withdrawal by Subject|2
1149972|NCT03084315|2261459|FG001|Overall Study|Withdrawal by Subject|2
1149973|NCT03084471|2261465|FG000|Overall Study|Development of study specific discontinuation criteria|2
1149974|NCT03084471|2261465|FG000|Overall Study|Condition under investigation worsened|84
1149975|NCT03084471|2261465|FG000|Overall Study|Lack of therapeutic response|2
1149976|NCT03084471|2261465|FG000|Overall Study|Protocol Violation|1
1149977|NCT03084471|2261465|FG000|Overall Study|Adverse Event|73
1149978|NCT03084471|2261465|FG000|Overall Study|Withdrawal by Subject|12
1149979|NCT03084471|2261465|FG000|Overall Study|Disease relapse|181
1149980|NCT03084471|2261465|FG000|Overall Study|Subjective disease progression|359
1149981|NCT03084471|2261465|FG000|Overall Study|Other (as recorded)|33
1149982|NCT03084471|2261465|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120
1149983|NCT03084796|2261478|FG000|Overall Study|Adverse Event|4
1149984|NCT03084796|2261479|FG001|Overall Study|Adverse Event|5
1149985|NCT03084796|2261480|FG002|Overall Study|Adverse Event|6
1149986|NCT03084796|2261481|FG003|Overall Study|Adverse Event|2
1149987|NCT03084796|2261482|FG004|Overall Study|Adverse Event|3
1149988|NCT03084796|2261483|FG005|Overall Study|Adverse Event|5
1149989|NCT03084796|2261478|FG000|Overall Study|Withdrawal by Subject|3
1149990|NCT03084796|2261479|FG001|Overall Study|Withdrawal by Subject|5
1149991|NCT03084796|2261480|FG002|Overall Study|Withdrawal by Subject|2
1149992|NCT03084796|2261481|FG003|Overall Study|Withdrawal by Subject|1
1149993|NCT03084796|2261482|FG004|Overall Study|Withdrawal by Subject|3
1149994|NCT03084796|2261483|FG005|Overall Study|Withdrawal by Subject|0
1149995|NCT03084796|2261478|FG000|Overall Study|Protocol Violation|0
1149996|NCT03084796|2261479|FG001|Overall Study|Protocol Violation|0
902535|NCT00741260|1876316|FG006|Overall Study|Death|1
902536|NCT00741260|1876310|FG000|Overall Study|Withdrawal by Subject|0
902537|NCT00741260|1876311|FG001|Overall Study|Withdrawal by Subject|0
902538|NCT00741260|1876312|FG002|Overall Study|Withdrawal by Subject|0
1149997|NCT03084796|2261480|FG002|Overall Study|Protocol Violation|1
1149998|NCT03084796|2261481|FG003|Overall Study|Protocol Violation|0
1149999|NCT03084796|2261482|FG004|Overall Study|Protocol Violation|1
1150000|NCT03084796|2261483|FG005|Overall Study|Protocol Violation|1
1150001|NCT03084796|2261478|FG000|Overall Study|Lack of Efficacy|0
1150002|NCT03084796|2261479|FG001|Overall Study|Lack of Efficacy|0
1150003|NCT03084796|2261480|FG002|Overall Study|Lack of Efficacy|1
1150004|NCT03084796|2261481|FG003|Overall Study|Lack of Efficacy|0
1150005|NCT03084796|2261482|FG004|Overall Study|Lack of Efficacy|1
1150006|NCT03084796|2261483|FG005|Overall Study|Lack of Efficacy|0
1150007|NCT03084796|2261478|FG000|Overall Study|Lost to Follow-up|0
1150008|NCT03084796|2261479|FG001|Overall Study|Lost to Follow-up|0
1150009|NCT03084796|2261480|FG002|Overall Study|Lost to Follow-up|1
1150010|NCT03084796|2261481|FG003|Overall Study|Lost to Follow-up|1
1150011|NCT03084796|2261482|FG004|Overall Study|Lost to Follow-up|3
1150012|NCT03084796|2261483|FG005|Overall Study|Lost to Follow-up|1
1150013|NCT03084796|2261478|FG000|Overall Study|Randomization error|0
902539|NCT00741260|1876313|FG003|Overall Study|Withdrawal by Subject|0
902540|NCT00741260|1876314|FG004|Overall Study|Withdrawal by Subject|1
902541|NCT00741260|1876315|FG005|Overall Study|Withdrawal by Subject|3
1150014|NCT03084796|2261479|FG001|Overall Study|Randomization error|0
1150015|NCT03084796|2261480|FG002|Overall Study|Randomization error|1
1150016|NCT03084796|2261481|FG003|Overall Study|Randomization error|0
1150017|NCT03084796|2261482|FG004|Overall Study|Randomization error|0
1150018|NCT03084796|2261483|FG005|Overall Study|Randomization error|0
1150019|NCT03085017|2261499|FG000|Overall Study|Death|0
1150020|NCT03085017|2261500|FG001|Overall Study|Death|3
902542|NCT00741260|1876316|FG006|Overall Study|Withdrawal by Subject|1
902543|NCT00741260|1876310|FG000|Overall Study|Physician Decision|1
902544|NCT00741260|1876311|FG001|Overall Study|Physician Decision|1
902545|NCT00741260|1876312|FG002|Overall Study|Physician Decision|0
902546|NCT00741260|1876313|FG003|Overall Study|Physician Decision|0
902547|NCT00741260|1876314|FG004|Overall Study|Physician Decision|0
902548|NCT00741260|1876315|FG005|Overall Study|Physician Decision|0
902549|NCT00741260|1876316|FG006|Overall Study|Physician Decision|0
902550|NCT00741260|1876310|FG000|Overall Study|Other|2
902551|NCT00741260|1876311|FG001|Overall Study|Other|1
902552|NCT00741260|1876312|FG002|Overall Study|Other|1
902553|NCT00741260|1876313|FG003|Overall Study|Other|2
902554|NCT00741260|1876314|FG004|Overall Study|Other|1
902555|NCT00741260|1876315|FG005|Overall Study|Other|3
902556|NCT00741260|1876316|FG006|Overall Study|Other|1
902557|NCT00741286|1876352|FG000|Overall Study|Lost to Follow-up|15
902558|NCT00741286|1876353|FG001|Overall Study|Lost to Follow-up|10
902559|NCT00741286|1876352|FG000|Overall Study|Adverse Event|1
902560|NCT00741286|1876353|FG001|Overall Study|Adverse Event|6
902561|NCT00741286|1876352|FG000|Overall Study|Protocol Violation|3
902562|NCT00741286|1876353|FG001|Overall Study|Protocol Violation|2
902563|NCT00741286|1876352|FG000|Overall Study|Primary Outcome|1
902564|NCT00741286|1876353|FG001|Overall Study|Primary Outcome|1
902565|NCT00741338|1876361|FG000|Overall Study|Adverse Event|0
902566|NCT00741338|1876362|FG001|Overall Study|Adverse Event|1
902567|NCT00741598|1876404|FG000|Overall Study|Lost to Follow-up|3
902568|NCT00741598|1876405|FG001|Overall Study|Lost to Follow-up|4
902569|NCT00741598|1876404|FG000|Overall Study|Lack of Efficacy|1
902570|NCT00741598|1876405|FG001|Overall Study|Lack of Efficacy|2
902571|NCT00741598|1876404|FG000|Overall Study|Physician Decision|1
902572|NCT00741598|1876405|FG001|Overall Study|Physician Decision|1
902573|NCT00741598|1876404|FG000|Overall Study|Pregnancy|1
902574|NCT00741598|1876405|FG001|Overall Study|Pregnancy|0
902575|NCT00741598|1876404|FG000|Overall Study|Withdrawal by Subject|3
902576|NCT00741598|1876405|FG001|Overall Study|Withdrawal by Subject|2
902577|NCT00741611|1876415|FG000|Overall Study|Death|0
902578|NCT00741611|1876416|FG001|Overall Study|Death|0
902579|NCT00741611|1876417|FG002|Overall Study|Death|1
902580|NCT00741611|1876415|FG000|Overall Study|Withdrawal by Subject|0
902581|NCT00741611|1876416|FG001|Overall Study|Withdrawal by Subject|2
902582|NCT00741611|1876417|FG002|Overall Study|Withdrawal by Subject|2
902583|NCT00741819|1876426|FG000|Overall Study|Adverse Event|3
902584|NCT00741819|1876426|FG000|Overall Study|Withdrawal by Subject|3
902585|NCT00741819|1876426|FG000|Overall Study|Death|1
902586|NCT00741819|1876426|FG000|Overall Study|Disease progression|1
902587|NCT00741936|1876443|FG000|Overall Study|Lost to Follow-up|1
902588|NCT00741936|1876444|FG001|Overall Study|Lost to Follow-up|1
902589|NCT00741936|1876443|FG000|Overall Study|Adverse Event|3
902590|NCT00741936|1876444|FG001|Overall Study|Adverse Event|4
902591|NCT00741936|1876443|FG000|Overall Study|Pregnancy|0
902592|NCT00741936|1876444|FG001|Overall Study|Pregnancy|1
902593|NCT00741936|1876443|FG000|Overall Study|Protocol Violation|2
1150037|NCT03085238|2261518|FG000|Overall Study|Adverse Event|2
1150038|NCT03085238|2261518|FG000|Overall Study|Death|2
1150039|NCT03085758|2261534|FG000|Overall Study|Death|26
1150040|NCT03085758|2261535|FG001|Overall Study|Death|24
1150041|NCT03085758|2261536|FG002|Overall Study|Death|53
1150042|NCT03085758|2261534|FG000|Overall Study|Lost to Follow-up|1
1150043|NCT03085758|2261535|FG001|Overall Study|Lost to Follow-up|1
1150044|NCT03085758|2261536|FG002|Overall Study|Lost to Follow-up|1
1150045|NCT03085758|2261534|FG000|Overall Study|Withdrawal by Subject|2
1150046|NCT03085758|2261535|FG001|Overall Study|Withdrawal by Subject|2
1150047|NCT03085758|2261536|FG002|Overall Study|Withdrawal by Subject|1
1150048|NCT03085758|2261534|FG000|Overall Study|Refusal to recall it up to day 90|0
1150049|NCT03085758|2261535|FG001|Overall Study|Refusal to recall it up to day 90|0
1150050|NCT03085758|2261536|FG002|Overall Study|Refusal to recall it up to day 90|1
1150051|NCT03085758|2261534|FG000|Overall Study|Pt seen by doctor in digestive surgery|0
1150052|NCT03085758|2261535|FG001|Overall Study|Pt seen by doctor in digestive surgery|1
1150053|NCT03085758|2261536|FG002|Overall Study|Pt seen by doctor in digestive surgery|0
1150054|NCT03085797|2261550|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1
1150055|NCT03085797|2261551|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0
1150056|NCT03085797|2261550|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16
1150057|NCT03085797|2261551|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17
1150058|NCT03085797|2261550|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0
1150059|NCT03085797|2261551|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1
1150060|NCT03085914|2261579|FG000|Overall Study|Death|6
1150061|NCT03085914|2261580|FG001|Overall Study|Death|6
1150062|NCT03085914|2261581|FG002|Overall Study|Death|4
1150063|NCT03085914|2261582|FG003|Overall Study|Death|1
1150064|NCT03085914|2261583|FG004|Overall Study|Death|5
1150065|NCT03085914|2261584|FG005|Overall Study|Death|2
1150066|NCT03085914|2261585|FG006|Overall Study|Death|2
1150067|NCT03085914|2261579|FG000|Overall Study|Withdrawal by Subject|1
1150068|NCT03085914|2261580|FG001|Overall Study|Withdrawal by Subject|1
1150069|NCT03085914|2261581|FG002|Overall Study|Withdrawal by Subject|2
1150070|NCT03085914|2261582|FG003|Overall Study|Withdrawal by Subject|2
1150071|NCT03085914|2261583|FG004|Overall Study|Withdrawal by Subject|2
1150072|NCT03085914|2261584|FG005|Overall Study|Withdrawal by Subject|0
1150073|NCT03085914|2261585|FG006|Overall Study|Withdrawal by Subject|1
1150074|NCT03085914|2261579|FG000|Overall Study|Lost to Follow-up|0
1150075|NCT03085914|2261580|FG001|Overall Study|Lost to Follow-up|0
1150076|NCT03085914|2261581|FG002|Overall Study|Lost to Follow-up|1
1150077|NCT03085914|2261582|FG003|Overall Study|Lost to Follow-up|0
1150078|NCT03085914|2261583|FG004|Overall Study|Lost to Follow-up|0
1150079|NCT03085914|2261584|FG005|Overall Study|Lost to Follow-up|1
1150080|NCT03085914|2261585|FG006|Overall Study|Lost to Follow-up|1
902594|NCT00741936|1876444|FG001|Overall Study|Protocol Violation|0
902595|NCT00741936|1876443|FG000|Overall Study|Lack of Efficacy|0
902596|NCT00741936|1876444|FG001|Overall Study|Lack of Efficacy|2
902597|NCT00741936|1876443|FG000|Overall Study|Low compliance|3
902598|NCT00741936|1876444|FG001|Overall Study|Low compliance|0
902603|NCT00742001|1876462|FG000|Overall Study|Withdrawn; health exclusion (flu)|0
902604|NCT00742001|1876463|FG001|Overall Study|Withdrawn; health exclusion (flu)|0
902605|NCT00742001|1876464|FG002|Overall Study|Withdrawn; health exclusion (flu)|1
902606|NCT00742027|1876475|FG000|Overall Study|Disease Progression|76
902607|NCT00742027|1876475|FG000|Overall Study|New Cancer Therapy|19
902608|NCT00742027|1876475|FG000|Overall Study|Withdrawal by Subject|18
902609|NCT00742027|1876475|FG000|Overall Study|Death|7
902610|NCT00742027|1876475|FG000|Overall Study|Lost to Follow-up|4
902611|NCT00742027|1876475|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2
902612|NCT00742027|1876475|FG000|Overall Study|Missing|2
902613|NCT00742027|1876475|FG000|Overall Study|Administrative Problems|1
902614|NCT00742079|1876485|FG000|Overall Study|Lost to Follow-up|0
902615|NCT00742079|1876486|FG001|Overall Study|Lost to Follow-up|1
902616|NCT00742183|1876503|FG000|Overall Study|Adverse Event|2
902617|NCT00742183|1876504|FG001|Overall Study|Adverse Event|2
902618|NCT00742183|1876503|FG000|Overall Study|Death|1
902619|NCT00742183|1876504|FG001|Overall Study|Death|0
902620|NCT00742183|1876503|FG000|Overall Study|Physician Decision|0
902621|NCT00742183|1876504|FG001|Overall Study|Physician Decision|2
902622|NCT00742183|1876503|FG000|Overall Study|Lost to Follow-up|4
902623|NCT00742183|1876504|FG001|Overall Study|Lost to Follow-up|4
902624|NCT00742183|1876503|FG000|Overall Study|Required skin-graft|1
902625|NCT00742183|1876504|FG001|Overall Study|Required skin-graft|1
902626|NCT00742183|1876503|FG000|Overall Study|Withdrawal by Subject|1
1150081|NCT03085914|2261579|FG000|Overall Study|Reason was not specified,|2
1150082|NCT03085914|2261580|FG001|Overall Study|Reason was not specified,|2
1150083|NCT03085914|2261581|FG002|Overall Study|Reason was not specified,|2
1150084|NCT03085914|2261582|FG003|Overall Study|Reason was not specified,|3
1150085|NCT03085914|2261583|FG004|Overall Study|Reason was not specified,|3
1150086|NCT03085914|2261584|FG005|Overall Study|Reason was not specified,|3
1150087|NCT03085914|2261585|FG006|Overall Study|Reason was not specified,|6
1150088|NCT03085914|2261579|FG000|Overall Study|Progressive Disease|0
1150089|NCT03085914|2261580|FG001|Overall Study|Progressive Disease|0
1150090|NCT03085914|2261581|FG002|Overall Study|Progressive Disease|2
1150091|NCT03085914|2261582|FG003|Overall Study|Progressive Disease|2
1150092|NCT03085914|2261583|FG004|Overall Study|Progressive Disease|1
1150093|NCT03085914|2261584|FG005|Overall Study|Progressive Disease|1
1150094|NCT03085914|2261585|FG006|Overall Study|Progressive Disease|1
1150095|NCT03085914|2261579|FG000|Overall Study|Study Terminated by the Sponsor|0
1150096|NCT03085914|2261580|FG001|Overall Study|Study Terminated by the Sponsor|0
1150097|NCT03085914|2261581|FG002|Overall Study|Study Terminated by the Sponsor|0
1150098|NCT03085914|2261582|FG003|Overall Study|Study Terminated by the Sponsor|1
1150099|NCT03085914|2261583|FG004|Overall Study|Study Terminated by the Sponsor|2
1150100|NCT03085914|2261584|FG005|Overall Study|Study Terminated by the Sponsor|1
1150101|NCT03085914|2261585|FG006|Overall Study|Study Terminated by the Sponsor|0
1150102|NCT03085927|2261606|FG000|Overall Study|Withdrawal by Subject|1
1150103|NCT03085927|2261607|FG001|Overall Study|Withdrawal by Subject|4
1150104|NCT03085927|2261606|FG000|Overall Study|Lost to Follow-up|3
1150105|NCT03085927|2261607|FG001|Overall Study|Lost to Follow-up|1
1150106|NCT03085927|2261606|FG000|Overall Study|Death|1
1150107|NCT03085927|2261607|FG001|Overall Study|Death|0
1150108|NCT03085927|2261606|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1
1150109|NCT03085927|2261607|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0
1150110|NCT03085927|2261606|FG000|Overall Study|Dyad Became Ineligible|0
1150111|NCT03085927|2261607|FG001|Overall Study|Dyad Became Ineligible|1
1150112|NCT03086018|2261615|FG000|Final Testing for End of Trial|Adverse Event|1
1150113|NCT03086018|2261615|FG000|Final Testing for End of Trial|Withdrawal by Subject|1
1150114|NCT03086057|2261625|FG000|Stage 1: PrEP Uptake|Incarcerated|3
1150115|NCT03086057|2261626|FG001|Stage 1: PrEP Uptake|Incarcerated|1
1150116|NCT03086057|2261627|FG002|Stage 1: PrEP Uptake|Incarcerated|0
1150117|NCT03086057|2261628|FG003|Stage 1: PrEP Uptake|Incarcerated|0
1150118|NCT03086057|2261625|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1
1150119|NCT03086057|2261626|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4
1150120|NCT03086057|2261627|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0
1150121|NCT03086057|2261628|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0
1150122|NCT03086057|2261625|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6
1150123|NCT03086057|2261626|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5
1150124|NCT03086057|2261627|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0
1150125|NCT03086057|2261628|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0
1150126|NCT03086057|2261625|FG000|Stage 1: PrEP Uptake|Death|1
1150127|NCT03086057|2261626|FG001|Stage 1: PrEP Uptake|Death|0
1150128|NCT03086057|2261627|FG002|Stage 1: PrEP Uptake|Death|0
1150129|NCT03086057|2261628|FG003|Stage 1: PrEP Uptake|Death|0
1150130|NCT03086057|2261625|FG000|Stage 2: PrEP Adherence|Incarcerated|0
1150131|NCT03086057|2261626|FG001|Stage 2: PrEP Adherence|Incarcerated|0
1150132|NCT03086057|2261627|FG002|Stage 2: PrEP Adherence|Incarcerated|2
1150133|NCT03086057|2261628|FG003|Stage 2: PrEP Adherence|Incarcerated|0
1150134|NCT03086057|2261625|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0
1150135|NCT03086057|2261626|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0
1150136|NCT03086057|2261627|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1
1150137|NCT03086057|2261628|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0
1150138|NCT03086057|2261625|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0
1150139|NCT03086057|2261626|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0
1150140|NCT03086057|2261627|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3
1150141|NCT03086057|2261628|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2
1150142|NCT03086135|2261638|FG000|Overall Study|Adverse Event|1
1150143|NCT03086135|2261638|FG000|Overall Study|Lost to Follow-up|2
1150144|NCT03086330|2261660|FG000|Overall Study|Withdrawal by Subject|3
1150145|NCT03086330|2261661|FG001|Overall Study|Withdrawal by Subject|2
1150146|NCT03086330|2261660|FG000|Overall Study|Lost to Follow-up|1
1150147|NCT03086330|2261661|FG001|Overall Study|Lost to Follow-up|2
1150148|NCT03086343|2261669|FG000|Overall Study|Adverse Event|7
1150149|NCT03086343|2261670|FG001|Overall Study|Adverse Event|7
1150150|NCT03086343|2261669|FG000|Overall Study|Withdrawal by Subject|10
1150151|NCT03086343|2261670|FG001|Overall Study|Withdrawal by Subject|6
1150152|NCT03086343|2261669|FG000|Overall Study|Lost to Follow-up|3
1150153|NCT03086343|2261670|FG001|Overall Study|Lost to Follow-up|1
1150154|NCT03086343|2261669|FG000|Overall Study|Lack of Efficacy|4
1150155|NCT03086343|2261670|FG001|Overall Study|Lack of Efficacy|6
1150156|NCT03086343|2261669|FG000|Overall Study|Other, not specified|8
1150157|NCT03086343|2261670|FG001|Overall Study|Other, not specified|4
1150158|NCT03086343|2261669|FG000|Overall Study|Missing|0
1150159|NCT03086343|2261670|FG001|Overall Study|Missing|1
1150160|NCT03086447|2261691|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
1150161|NCT03086447|2261692|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
1150162|NCT03086447|2261691|FG000|Overall Study|Lost Lens|2
1150163|NCT03086447|2261692|FG001|Overall Study|Lost Lens|5
1150164|NCT03086447|2261691|FG000|Overall Study|Product quality complaint|0
1150165|NCT03086447|2261692|FG001|Overall Study|Product quality complaint|1
1150166|NCT03086447|2261691|FG000|Overall Study|Lens Damage|1
1150167|NCT03086447|2261692|FG001|Overall Study|Lens Damage|6
1150168|NCT03086447|2261691|FG000|Overall Study|Unsatisfactory Lens Fitting|0
1150169|NCT03086447|2261692|FG001|Overall Study|Unsatisfactory Lens Fitting|1
1150170|NCT03086447|2261691|FG000|Overall Study|Test Article No Longer Available|1
1150171|NCT03086447|2261692|FG001|Overall Study|Test Article No Longer Available|0
1150172|NCT03086447|2261691|FG000|Overall Study|Protocol Violation|2
1150173|NCT03086447|2261692|FG001|Overall Study|Protocol Violation|4
1150174|NCT03086447|2261691|FG000|Overall Study|Lost to Follow-up|0
1150175|NCT03086447|2261692|FG001|Overall Study|Lost to Follow-up|1
1150176|NCT03086447|2261691|FG000|Overall Study|Adverse Event|3
1150177|NCT03086447|2261692|FG001|Overall Study|Adverse Event|0
1150178|NCT03086447|2261691|FG000|Overall Study|Lens Discomfort|2
1150179|NCT03086447|2261692|FG001|Overall Study|Lens Discomfort|1
1150180|NCT03086460|2261698|FG000|Study Participants|Lost to Follow-up|2
1150181|NCT03086460|2261698|FG000|Study Participants|Protocol Violation|1
1150182|NCT03086460|2261698|FG000|Study Participants|Withdrawal by Subject|6
1150183|NCT03086460|2261698|FG000|Treatment A|Lost to Follow-up|1
1150184|NCT03086460|2261698|FG000|Treatment A|Protocol Violation|1
1150185|NCT03086460|2261698|FG000|Treatment A|Withdrawal by Subject|2
1150186|NCT03086460|2261698|FG000|Treatment C|Withdrawal by Subject|2
1150187|NCT03086460|2261698|FG000|Treatment E|Lost to Follow-up|1
1150188|NCT03086460|2261698|FG000|Treatment E|Withdrawal by Subject|3
1150189|NCT03086551|2261715|FG000|First Intervention|Failure to meet inclusion criterion|1
1150190|NCT03086551|2261716|FG001|First Intervention|Failure to meet inclusion criterion|0
1150191|NCT03086551|2261715|FG000|First Intervention|Lost to Follow-up|0
1150192|NCT03086551|2261716|FG001|First Intervention|Lost to Follow-up|1
1150193|NCT03086551|2261715|FG000|Washout|Lost to Follow-up|1
1150194|NCT03086551|2261716|FG001|Washout|Lost to Follow-up|2
1150195|NCT03086551|2261715|FG000|Washout|Withdrawal by Subject|2
1150196|NCT03086551|2261716|FG001|Washout|Withdrawal by Subject|1
1150197|NCT03087513|2261742|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2
1150198|NCT03087643|2261766|FG000|Overall Study|Withdrawal by Subject|2
1150199|NCT03087643|2261767|FG001|Overall Study|Withdrawal by Subject|4
1150200|NCT03087643|2261766|FG000|Overall Study|Death|2
1150201|NCT03087643|2261767|FG001|Overall Study|Death|2
1150202|NCT03087786|2261775|FG000|Overall Study|Withdrawal by Subject|2
1150203|NCT03087786|2261776|FG001|Overall Study|Withdrawal by Subject|0
1150204|NCT03087851|2261785|FG000|Overall Study|Withdraw on medical grounds|0
1150205|NCT03087851|2261786|FG001|Overall Study|Withdraw on medical grounds|1
1150206|NCT03087851|2261787|FG002|Overall Study|Withdraw on medical grounds|2
1150207|NCT03088917|2261843|FG000|Overall Study|In care/cured elsewhere|15
1150208|NCT03088917|2261843|FG000|Overall Study|Refuse re-evaluation|13
1150209|NCT03088917|2261843|FG000|Overall Study|Contact not established|13
1150210|NCT03088917|2261843|FG000|Overall Study|Severe comorbidity/short life expectancy|5
1150211|NCT03088917|2261843|FG000|Overall Study|Moved outside study region|50
1150212|NCT03089047|2261851|FG000|Overall Study|Lost to Follow-up|1
1150213|NCT03089047|2261852|FG001|Overall Study|Lost to Follow-up|0
1150214|NCT03089216|2261862|FG000|Overall Study|Adverse Event|0
1150215|NCT03089216|2261863|FG001|Overall Study|Adverse Event|0
1150216|NCT03089216|2261864|FG002|Overall Study|Adverse Event|0
1150217|NCT03089216|2261865|FG003|Overall Study|Adverse Event|1
1150218|NCT03089580|2261879|FG000|Overall Study|Lost to Follow-up|2
1150219|NCT03089697|2261887|FG000|Overall Study|Adverse Event|1
1150220|NCT03089697|2261888|FG001|Overall Study|Adverse Event|2
1150221|NCT03089697|2261887|FG000|Overall Study|Withdrawal by Subject|1
1150222|NCT03089697|2261888|FG001|Overall Study|Withdrawal by Subject|0
1150223|NCT03089853|2261896|FG000|Overall Study|Lost to Follow-up|2
1150224|NCT03089853|2261897|FG001|Overall Study|Lost to Follow-up|1
1150225|NCT03089944|2261917|FG000|Overall Study|Lost to Follow-up|8
1150226|NCT03089944|2261917|FG000|Overall Study|Withdrew Consent|2
1150227|NCT03089944|2261917|FG000|Overall Study|Adverse Event|1
1150228|NCT03089944|2261917|FG000|Overall Study|Other|1
1150229|NCT03090100|2261923|FG000|Overall Study|Adverse Event|9
1150230|NCT03090100|2261924|FG001|Overall Study|Adverse Event|11
1150231|NCT03090100|2261923|FG000|Overall Study|Pregnancy|1
1150232|NCT03090100|2261924|FG001|Overall Study|Pregnancy|1
1150233|NCT03090100|2261923|FG000|Overall Study|Lack of Efficacy|2
1150234|NCT03090100|2261924|FG001|Overall Study|Lack of Efficacy|7
1150235|NCT03090100|2261923|FG000|Overall Study|Lost to Follow-up|2
1150236|NCT03090100|2261924|FG001|Overall Study|Lost to Follow-up|2
1150237|NCT03090100|2261923|FG000|Overall Study|Withdrawal by Subject|7
1150238|NCT03090100|2261924|FG001|Overall Study|Withdrawal by Subject|19
1150239|NCT03090100|2261923|FG000|Overall Study|Protocol Violation|2
1150240|NCT03090100|2261924|FG001|Overall Study|Protocol Violation|6
1150241|NCT03090100|2261923|FG000|Overall Study|Non-compliance|2
1150242|NCT03090100|2261924|FG001|Overall Study|Non-compliance|0
1150243|NCT03090100|2261923|FG000|Overall Study|Other|2
1150244|NCT03090100|2261924|FG001|Overall Study|Other|2
1150245|NCT03091192|2261959|FG000|Overall Study|Study terminated by sponsor|21
1150246|NCT03091192|2261960|FG001|Overall Study|Study terminated by sponsor|14
1150247|NCT03091192|2261959|FG000|Overall Study|Death|9
1150248|NCT03091192|2261960|FG001|Overall Study|Death|13
1150249|NCT03091192|2261959|FG000|Overall Study|Withdrawal by Subject|2
1150250|NCT03091192|2261960|FG001|Overall Study|Withdrawal by Subject|0
1150251|NCT03091192|2261959|FG000|Overall Study|Lost to Follow-up|1
1150252|NCT03091192|2261960|FG001|Overall Study|Lost to Follow-up|0
1150253|NCT03091348|2261968|FG000|Overall Study|Lost to Follow-up|2
1150254|NCT03091348|2261969|FG001|Overall Study|Lost to Follow-up|1
1150255|NCT03091400|2261982|FG000|Washout - 2 Weeks|Withdrawal by Subject|1
1150256|NCT03091400|2261983|FG001|Washout - 2 Weeks|Withdrawal by Subject|0
1150257|NCT03091439|2261991|FG000|Overall Study|Study Terminated by the Sponsor|1
1150258|NCT03091439|2261992|FG001|Overall Study|Study Terminated by the Sponsor|0
1150259|NCT03091738|2262017|FG000|Overall Study|Adverse Event|1
1150260|NCT03091738|2262017|FG000|Overall Study|Lost to Follow-up|1
1150261|NCT03091777|2262028|FG000|Overall Study|Pregnancy|2
1150262|NCT03091777|2262029|FG001|Overall Study|Pregnancy|1
1150263|NCT03091777|2262030|FG002|Overall Study|Pregnancy|0
1150264|NCT03091777|2262028|FG000|Overall Study|Adverse Event|2
1150265|NCT03091777|2262029|FG001|Overall Study|Adverse Event|1
1150266|NCT03091777|2262030|FG002|Overall Study|Adverse Event|4
1150267|NCT03091777|2262028|FG000|Overall Study|Withdrawal by Subject|4
1150268|NCT03091777|2262029|FG001|Overall Study|Withdrawal by Subject|2
1150269|NCT03091777|2262030|FG002|Overall Study|Withdrawal by Subject|6
1150270|NCT03091777|2262028|FG000|Overall Study|Protocol Violation|2
1150271|NCT03091777|2262029|FG001|Overall Study|Protocol Violation|1
1150272|NCT03091777|2262030|FG002|Overall Study|Protocol Violation|1
1150273|NCT03091777|2262028|FG000|Overall Study|Lost to Follow-up|12
1150274|NCT03091777|2262029|FG001|Overall Study|Lost to Follow-up|14
1150275|NCT03091777|2262030|FG002|Overall Study|Lost to Follow-up|7
1150276|NCT03091777|2262028|FG000|Overall Study|Lack of Efficacy|0
902627|NCT00742183|1876504|FG001|Overall Study|Withdrawal by Subject|0
902628|NCT00742183|1876503|FG000|Overall Study|Lack of Efficacy|0
902629|NCT00742183|1876504|FG001|Overall Study|Lack of Efficacy|3
902630|NCT00742209|1876515|FG000|Overall Study|Adverse Event|11
902631|NCT00742209|1876516|FG001|Overall Study|Adverse Event|4
902632|NCT00742209|1876517|FG002|Overall Study|Adverse Event|17
902633|NCT00742209|1876518|FG003|Overall Study|Adverse Event|16
902634|NCT00742209|1876519|FG004|Overall Study|Adverse Event|13
902635|NCT00742209|1876515|FG000|Overall Study|Participant Withdrew Consent|8
902636|NCT00742209|1876516|FG001|Overall Study|Participant Withdrew Consent|4
902637|NCT00742209|1876517|FG002|Overall Study|Participant Withdrew Consent|14
902638|NCT00742209|1876518|FG003|Overall Study|Participant Withdrew Consent|7
902639|NCT00742209|1876519|FG004|Overall Study|Participant Withdrew Consent|4
902640|NCT00742209|1876515|FG000|Overall Study|Protocol Violation|6
902641|NCT00742209|1876516|FG001|Overall Study|Protocol Violation|5
902642|NCT00742209|1876517|FG002|Overall Study|Protocol Violation|4
902643|NCT00742209|1876518|FG003|Overall Study|Protocol Violation|5
902644|NCT00742209|1876519|FG004|Overall Study|Protocol Violation|3
902645|NCT00742209|1876515|FG000|Overall Study|Lost to Follow-up|3
902646|NCT00742209|1876516|FG001|Overall Study|Lost to Follow-up|4
902647|NCT00742209|1876517|FG002|Overall Study|Lost to Follow-up|5
902648|NCT00742209|1876518|FG003|Overall Study|Lost to Follow-up|5
902649|NCT00742209|1876519|FG004|Overall Study|Lost to Follow-up|3
902650|NCT00742209|1876515|FG000|Overall Study|Lack of Efficacy|6
902651|NCT00742209|1876516|FG001|Overall Study|Lack of Efficacy|1
902652|NCT00742209|1876517|FG002|Overall Study|Lack of Efficacy|1
902653|NCT00742209|1876518|FG003|Overall Study|Lack of Efficacy|3
902654|NCT00742209|1876519|FG004|Overall Study|Lack of Efficacy|1
902655|NCT00742209|1876515|FG000|Overall Study|Investigator Discretion|0
902656|NCT00742209|1876516|FG001|Overall Study|Investigator Discretion|0
902657|NCT00742209|1876517|FG002|Overall Study|Investigator Discretion|5
902658|NCT00742209|1876518|FG003|Overall Study|Investigator Discretion|1
902659|NCT00742209|1876519|FG004|Overall Study|Investigator Discretion|1
902660|NCT00742235|1876534|FG000|Overall Study|Lost to Follow-up|0
902661|NCT00742235|1876535|FG001|Overall Study|Lost to Follow-up|31
902662|NCT00742274|1876543|FG000|Overall Study|Death|1
902663|NCT00742274|1876544|FG001|Overall Study|Death|0
902664|NCT00742274|1876543|FG000|Overall Study|Withdrawal by Subject|1
902665|NCT00742274|1876544|FG001|Overall Study|Withdrawal by Subject|2
902666|NCT00742274|1876543|FG000|Overall Study|Removed for medical reasons|1
902667|NCT00742274|1876544|FG001|Overall Study|Removed for medical reasons|1
902668|NCT00742326|1876561|FG000|Overall Study|Physician Decision|0
902669|NCT00742326|1876562|FG001|Overall Study|Physician Decision|1
902670|NCT00742391|1876570|FG000|Overall Study|Adverse Event|2
902671|NCT00742391|1876571|FG001|Overall Study|Adverse Event|1
902672|NCT00742391|1876570|FG000|Overall Study|Lost to Follow-up|1
902673|NCT00742391|1876571|FG001|Overall Study|Lost to Follow-up|0
902674|NCT00742391|1876570|FG000|Overall Study|Protocol Violation|1
902675|NCT00742391|1876571|FG001|Overall Study|Protocol Violation|0
902676|NCT00742417|1876579|FG000|Randomized|Withdrawal by legal representative|0
902677|NCT00742417|1876580|FG001|Randomized|Withdrawal by legal representative|1
902678|NCT00742417|1876579|FG000|Randomized|Withdrawal by Subject|1
902679|NCT00742417|1876580|FG001|Randomized|Withdrawal by Subject|0
902680|NCT00742417|1876579|FG000|Randomized|Physician Decision|1
902681|NCT00742417|1876580|FG001|Randomized|Physician Decision|0
902682|NCT00742417|1876579|FG000|Intensive Period|Withdrawal by Subject|1
902683|NCT00742417|1876580|FG001|Intensive Period|Withdrawal by Subject|1
1150277|NCT03091777|2262029|FG001|Overall Study|Lack of Efficacy|0
1150278|NCT03091777|2262030|FG002|Overall Study|Lack of Efficacy|5
1150279|NCT03091777|2262028|FG000|Overall Study|Noncompliance with study drug|2
1150280|NCT03091777|2262029|FG001|Overall Study|Noncompliance with study drug|3
902684|NCT00742417|1876579|FG000|Intensive Period|Adverse Event|2
902685|NCT00742417|1876580|FG001|Intensive Period|Adverse Event|0
902686|NCT00742508|1876599|FG000|8-Week Primary Evaluation Period|Adverse Event|2
902687|NCT00742508|1876600|FG001|8-Week Primary Evaluation Period|Adverse Event|4
902688|NCT00742508|1876599|FG000|8-Week Primary Evaluation Period|Protocol Violation|1
902689|NCT00742508|1876600|FG001|8-Week Primary Evaluation Period|Protocol Violation|0
902690|NCT00742508|1876599|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
902691|NCT00742508|1876600|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
902692|NCT00742508|1876599|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0
902693|NCT00742508|1876600|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2
902694|NCT00742508|1876599|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
902695|NCT00742508|1876600|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
902696|NCT00742560|1876611|FG000|Overall Study|Adverse Event|0
902697|NCT00742560|1876612|FG001|Overall Study|Adverse Event|0
902698|NCT00742560|1876613|FG002|Overall Study|Adverse Event|1
902699|NCT00742560|1876614|FG003|Overall Study|Adverse Event|1
902700|NCT00742560|1876615|FG004|Overall Study|Adverse Event|1
902701|NCT00742560|1876611|FG000|Overall Study|Death|0
902702|NCT00742560|1876612|FG001|Overall Study|Death|2
902703|NCT00742560|1876613|FG002|Overall Study|Death|0
902704|NCT00742560|1876614|FG003|Overall Study|Death|2
902705|NCT00742560|1876615|FG004|Overall Study|Death|3
902706|NCT00742560|1876611|FG000|Overall Study|Subject's Decision|1
902707|NCT00742560|1876612|FG001|Overall Study|Subject's Decision|0
902708|NCT00742560|1876613|FG002|Overall Study|Subject's Decision|2
902709|NCT00742560|1876614|FG003|Overall Study|Subject's Decision|3
902710|NCT00742560|1876615|FG004|Overall Study|Subject's Decision|3
902711|NCT00742560|1876611|FG000|Overall Study|Investigator's Decision|0
902712|NCT00742560|1876612|FG001|Overall Study|Investigator's Decision|0
902713|NCT00742560|1876613|FG002|Overall Study|Investigator's Decision|4
902714|NCT00742560|1876614|FG003|Overall Study|Investigator's Decision|1
902715|NCT00742560|1876615|FG004|Overall Study|Investigator's Decision|0
902716|NCT00742560|1876611|FG000|Overall Study|Disease Progression|1
902717|NCT00742560|1876612|FG001|Overall Study|Disease Progression|0
902718|NCT00742560|1876613|FG002|Overall Study|Disease Progression|5
902719|NCT00742560|1876614|FG003|Overall Study|Disease Progression|17
902720|NCT00742560|1876615|FG004|Overall Study|Disease Progression|16
902721|NCT00742560|1876611|FG000|Overall Study|New Multiple Myeloma Therapy|1
902722|NCT00742560|1876612|FG001|Overall Study|New Multiple Myeloma Therapy|0
902723|NCT00742560|1876613|FG002|Overall Study|New Multiple Myeloma Therapy|2
902724|NCT00742560|1876614|FG003|Overall Study|New Multiple Myeloma Therapy|3
902725|NCT00742560|1876615|FG004|Overall Study|New Multiple Myeloma Therapy|4
902726|NCT00742560|1876611|FG000|Overall Study|Other|0
902727|NCT00742560|1876612|FG001|Overall Study|Other|1
902728|NCT00742560|1876613|FG002|Overall Study|Other|8
902729|NCT00742560|1876614|FG003|Overall Study|Other|9
902730|NCT00742560|1876615|FG004|Overall Study|Other|9
902731|NCT00742560|1876611|FG000|Overall Study|MIssing|0
902732|NCT00742560|1876612|FG001|Overall Study|MIssing|0
902733|NCT00742560|1876613|FG002|Overall Study|MIssing|0
902734|NCT00742560|1876614|FG003|Overall Study|MIssing|0
902735|NCT00742560|1876615|FG004|Overall Study|MIssing|1
902736|NCT00742625|1876655|FG000|Remission Induction|Progression|6
902737|NCT00742625|1876655|FG000|Remission Induction|Failed induction|8
902738|NCT00742625|1876655|FG000|Remission Induction|Adverse Event|3
902739|NCT00742625|1876655|FG000|Remission Induction|Death|10
902740|NCT00742625|1876655|FG000|Remission Induction|Refusal|5
902741|NCT00742625|1876655|FG000|Remission Induction|Non protocol treatment|17
902742|NCT00742625|1876655|FG000|Remission Induction|Other, not specified|5
902743|NCT00742625|1876655|FG000|Consolidation|Progression|5
902744|NCT00742625|1876655|FG000|Consolidation|Adverse Event|1
902745|NCT00742625|1876655|FG000|Consolidation|Death|1
902746|NCT00742625|1876655|FG000|Consolidation|Refused|1
902747|NCT00742625|1876655|FG000|Consolidation|Non protocol therapy|13
902748|NCT00742781|1876662|FG000|Overall Study|Withdrawal by Subject|3
902749|NCT00742859|1876671|FG000|Overall Study|Adverse Event|5
902750|NCT00742859|1876672|FG001|Overall Study|Adverse Event|6
902751|NCT00742859|1876673|FG002|Overall Study|Adverse Event|3
902752|NCT00742859|1876674|FG003|Overall Study|Adverse Event|1
902753|NCT00742859|1876671|FG000|Overall Study|Death|1
902754|NCT00742859|1876672|FG001|Overall Study|Death|0
902755|NCT00742859|1876673|FG002|Overall Study|Death|0
902756|NCT00742859|1876674|FG003|Overall Study|Death|1
902757|NCT00742859|1876671|FG000|Overall Study|Physician Decision|1
902758|NCT00742859|1876672|FG001|Overall Study|Physician Decision|2
902759|NCT00742859|1876673|FG002|Overall Study|Physician Decision|0
902760|NCT00742859|1876674|FG003|Overall Study|Physician Decision|0
902761|NCT00742859|1876671|FG000|Overall Study|Withdrawal by Subject|4
902762|NCT00742859|1876672|FG001|Overall Study|Withdrawal by Subject|2
902763|NCT00742859|1876673|FG002|Overall Study|Withdrawal by Subject|4
1150281|NCT03091777|2262030|FG002|Overall Study|Noncompliance with study drug|1
1150282|NCT03091777|2262028|FG000|Overall Study|Physician Decision|1
1150283|NCT03091777|2262029|FG001|Overall Study|Physician Decision|0
1150284|NCT03091777|2262030|FG002|Overall Study|Physician Decision|1
1150285|NCT03091777|2262028|FG000|Overall Study|Abnormal Laboratory Value|7
1150286|NCT03091777|2262029|FG001|Overall Study|Abnormal Laboratory Value|11
1150287|NCT03091777|2262030|FG002|Overall Study|Abnormal Laboratory Value|12
1150290|NCT03092375|2262086|FG000|Overall Study|Lack of Efficacy|0
1150291|NCT03092375|2262087|FG001|Overall Study|Lack of Efficacy|1
1150292|NCT03092375|2262088|FG002|Overall Study|Lack of Efficacy|1
1150293|NCT03092375|2262089|FG003|Overall Study|Lack of Efficacy|0
1150294|NCT03092479|2262108|FG000|Overall Study|Lost to Follow-up|3
1150295|NCT03092479|2262109|FG001|Overall Study|Lost to Follow-up|2
1150296|NCT03092479|2262108|FG000|Overall Study|Withdrawal by Subject|4
1150297|NCT03092479|2262109|FG001|Overall Study|Withdrawal by Subject|0
1150298|NCT03092726|2262117|FG000|Overall Study|Adverse Event|3
1150299|NCT03092726|2262118|FG001|Overall Study|Adverse Event|10
1150300|NCT03092726|2262117|FG000|Overall Study|Lack of Efficacy|0
1150301|NCT03092726|2262118|FG001|Overall Study|Lack of Efficacy|1
1150302|NCT03092726|2262117|FG000|Overall Study|Lost to Follow-up|1
1150303|NCT03092726|2262118|FG001|Overall Study|Lost to Follow-up|0
1150304|NCT03092726|2262117|FG000|Overall Study|Withdrawal by Subject|5
1150305|NCT03092726|2262118|FG001|Overall Study|Withdrawal by Subject|3
1150306|NCT03092752|2262124|FG000|Overall Study|Aged <40 years|14209
1150307|NCT03092752|2262124|FG000|Overall Study|At least one claim with T2DM|61299
1150308|NCT03092752|2262124|FG000|Overall Study|Having no claim of study drugs|29282
1150309|NCT03092752|2262124|FG000|Overall Study|Average hospital visit interval >92 days|10779
1150310|NCT03092752|2262124|FG000|Overall Study|<6 month history|245900
1150311|NCT03092791|2262153|FG000|Overall Study|Lost to Follow-up|0
1150312|NCT03092791|2262154|FG001|Overall Study|Lost to Follow-up|0
1150313|NCT03092791|2262155|FG002|Overall Study|Lost to Follow-up|0
1150314|NCT03092791|2262156|FG003|Overall Study|Lost to Follow-up|0
1150315|NCT03092791|2262157|FG004|Overall Study|Lost to Follow-up|0
1150316|NCT03092791|2262158|FG005|Overall Study|Lost to Follow-up|0
1150317|NCT03092791|2262159|FG006|Overall Study|Lost to Follow-up|1
1150318|NCT03092791|2262160|FG007|Overall Study|Lost to Follow-up|0
1150319|NCT03092791|2262153|FG000|Overall Study|Withdrawal of Consent|0
1150320|NCT03092791|2262154|FG001|Overall Study|Withdrawal of Consent|0
1150321|NCT03092791|2262155|FG002|Overall Study|Withdrawal of Consent|0
1150322|NCT03092791|2262156|FG003|Overall Study|Withdrawal of Consent|0
1150323|NCT03092791|2262157|FG004|Overall Study|Withdrawal of Consent|4
1150324|NCT03092791|2262158|FG005|Overall Study|Withdrawal of Consent|12
1150325|NCT03092791|2262159|FG006|Overall Study|Withdrawal of Consent|6
1150326|NCT03092791|2262160|FG007|Overall Study|Withdrawal of Consent|4
1150327|NCT03092791|2262153|FG000|Overall Study|Study Termination|0
1150328|NCT03092791|2262154|FG001|Overall Study|Study Termination|0
1150329|NCT03092791|2262155|FG002|Overall Study|Study Termination|0
1150330|NCT03092791|2262156|FG003|Overall Study|Study Termination|0
1150331|NCT03092791|2262157|FG004|Overall Study|Study Termination|55
1150332|NCT03092791|2262158|FG005|Overall Study|Study Termination|46
1150333|NCT03092791|2262159|FG006|Overall Study|Study Termination|53
1150334|NCT03092791|2262160|FG007|Overall Study|Study Termination|55
1150335|NCT03092791|2262153|FG000|Overall Study|Death|0
1150336|NCT03092791|2262154|FG001|Overall Study|Death|0
1150337|NCT03092791|2262155|FG002|Overall Study|Death|0
1150338|NCT03092791|2262156|FG003|Overall Study|Death|0
1150339|NCT03092791|2262157|FG004|Overall Study|Death|0
1150340|NCT03092791|2262158|FG005|Overall Study|Death|1
1150341|NCT03092791|2262159|FG006|Overall Study|Death|0
1150342|NCT03092791|2262160|FG007|Overall Study|Death|1
1150343|NCT03092791|2262153|FG000|Overall Study|Reason Not Specified|0
1150344|NCT03092791|2262154|FG001|Overall Study|Reason Not Specified|0
1150345|NCT03092791|2262155|FG002|Overall Study|Reason Not Specified|0
1150346|NCT03092791|2262156|FG003|Overall Study|Reason Not Specified|0
1150347|NCT03092791|2262157|FG004|Overall Study|Reason Not Specified|1
1150348|NCT03092791|2262158|FG005|Overall Study|Reason Not Specified|1
1150349|NCT03092791|2262159|FG006|Overall Study|Reason Not Specified|0
1150350|NCT03092791|2262160|FG007|Overall Study|Reason Not Specified|0
1150351|NCT03093181|2262220|FG000|Overall Study|Withdrawal by Subject|2
1150352|NCT03093181|2262221|FG001|Overall Study|Withdrawal by Subject|1
1150353|NCT03093181|2262222|FG002|Overall Study|Withdrawal by Subject|2
1150354|NCT03093181|2262220|FG000|Overall Study|Other (Not specified)|1
1150355|NCT03093181|2262221|FG001|Overall Study|Other (Not specified)|0
1150356|NCT03093181|2262222|FG002|Overall Study|Other (Not specified)|0
1150357|NCT03093181|2262220|FG000|Overall Study|Adverse Event|0
1150358|NCT03093181|2262221|FG001|Overall Study|Adverse Event|1
1150359|NCT03093181|2262222|FG002|Overall Study|Adverse Event|0
1150360|NCT03093181|2262220|FG000|Overall Study|Other (Protocol violation)|0
1150361|NCT03093181|2262221|FG001|Overall Study|Other (Protocol violation)|0
1150362|NCT03093181|2262222|FG002|Overall Study|Other (Protocol violation)|1
1150363|NCT03093324|2262254|FG000|Overall Study|Adverse Event|4
1150364|NCT03093324|2262255|FG001|Overall Study|Adverse Event|15
1150365|NCT03093324|2262254|FG000|Overall Study|Lost to Follow-up|1
1150366|NCT03093324|2262255|FG001|Overall Study|Lost to Follow-up|0
1150367|NCT03093324|2262254|FG000|Overall Study|Protocol Deviation|2
1150368|NCT03093324|2262255|FG001|Overall Study|Protocol Deviation|2
1150369|NCT03093324|2262254|FG000|Overall Study|Withdrawal by Subject|2
1150370|NCT03093324|2262255|FG001|Overall Study|Withdrawal by Subject|2
1150371|NCT03093350|2262261|FG000|Overall Study|Death|1
1150372|NCT03093350|2262261|FG000|Overall Study|Signed consent, never began treartment|1
1150373|NCT03093415|2262268|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17
1150374|NCT03093415|2262269|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36
1150375|NCT03093415|2262270|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0
1150376|NCT03093415|2262268|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40
1150377|NCT03093415|2262269|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
1150378|NCT03093415|2262270|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
1150379|NCT03093415|2262268|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28
1150380|NCT03093415|2262269|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6
1150381|NCT03093415|2262270|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0
1150382|NCT03093415|2262268|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
1150383|NCT03093415|2262269|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12
1150384|NCT03093415|2262270|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
1150385|NCT03093415|2262268|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18
1150386|NCT03093415|2262269|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12
1150387|NCT03093415|2262270|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0
1150388|NCT03093415|2262268|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
1150389|NCT03093415|2262269|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
1150390|NCT03093415|2262270|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0
1150391|NCT03093415|2262268|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15
1150392|NCT03093415|2262269|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32
1150393|NCT03093415|2262270|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0
1150394|NCT03093415|2262268|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5
1150395|NCT03093415|2262269|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3
1150396|NCT03093415|2262270|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0
1150397|NCT03093415|2262268|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4
902764|NCT00742859|1876674|FG003|Overall Study|Withdrawal by Subject|1
902765|NCT00742859|1876671|FG000|Overall Study|Endpoint|0
902766|NCT00742859|1876672|FG001|Overall Study|Endpoint|1
902767|NCT00742859|1876673|FG002|Overall Study|Endpoint|1
902768|NCT00742859|1876674|FG003|Overall Study|Endpoint|2
902769|NCT00742859|1876671|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0
902770|NCT00742859|1876672|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1
902771|NCT00742859|1876673|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1
902772|NCT00742859|1876674|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0
902773|NCT00742859|1876671|FG000|Overall Study|Sponsor req visit schedule noncompliance|0
902774|NCT00742859|1876672|FG001|Overall Study|Sponsor req visit schedule noncompliance|0
902775|NCT00742859|1876673|FG002|Overall Study|Sponsor req visit schedule noncompliance|0
902776|NCT00742859|1876674|FG003|Overall Study|Sponsor req visit schedule noncompliance|1
902777|NCT00742859|1876671|FG000|Overall Study|Sponsor request patient out of town|0
902778|NCT00742859|1876672|FG001|Overall Study|Sponsor request patient out of town|0
902779|NCT00742859|1876673|FG002|Overall Study|Sponsor request patient out of town|1
902780|NCT00742859|1876674|FG003|Overall Study|Sponsor request patient out of town|1
902781|NCT00742859|1876671|FG000|Overall Study|Site error|0
902782|NCT00742859|1876672|FG001|Overall Study|Site error|0
902783|NCT00742859|1876673|FG002|Overall Study|Site error|1
902784|NCT00742859|1876674|FG003|Overall Study|Site error|1
902785|NCT00742885|1876695|FG000|Overall Study|Lost to Follow-up|1
902786|NCT00742885|1876696|FG001|Overall Study|Lost to Follow-up|0
902787|NCT00742924|1876709|FG000|Overall Study|Adverse Event|0
902788|NCT00742924|1876710|FG001|Overall Study|Adverse Event|0
902789|NCT00742924|1876711|FG002|Overall Study|Adverse Event|1
902790|NCT00742924|1876712|FG003|Overall Study|Adverse Event|1
902791|NCT00742924|1876709|FG000|Overall Study|Lack of Efficacy|5
902792|NCT00742924|1876710|FG001|Overall Study|Lack of Efficacy|1
902793|NCT00742924|1876711|FG002|Overall Study|Lack of Efficacy|2
902794|NCT00742924|1876712|FG003|Overall Study|Lack of Efficacy|4
902795|NCT00742924|1876709|FG000|Overall Study|Physician Decision|0
902796|NCT00742924|1876710|FG001|Overall Study|Physician Decision|0
902797|NCT00742924|1876711|FG002|Overall Study|Physician Decision|0
902798|NCT00742924|1876712|FG003|Overall Study|Physician Decision|1
902799|NCT00742924|1876709|FG000|Overall Study|Withdrawal by Subject|0
902800|NCT00742924|1876710|FG001|Overall Study|Withdrawal by Subject|1
902801|NCT00742924|1876711|FG002|Overall Study|Withdrawal by Subject|1
902802|NCT00742924|1876712|FG003|Overall Study|Withdrawal by Subject|0
902803|NCT00743106|1876737|FG000|Overall Study|Met intraoperative exclusion criterion|8
902804|NCT00743106|1876738|FG001|Overall Study|Met intraoperative exclusion criterion|5
902805|NCT00743119|1876744|FG000|Overall Study|unreliable|3
1150398|NCT03093415|2262269|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2
1150399|NCT03093415|2262270|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0
902806|NCT00743119|1876744|FG000|Overall Study|Withdrawal by Subject|1
902807|NCT00743145|1876756|FG000|Overall Study|Withdrawal by Subject|1
902808|NCT00743145|1876756|FG000|Overall Study|Adverse Event|2
902809|NCT00743145|1876756|FG000|Overall Study|Pregnancy|1
902810|NCT00743249|1876772|FG000|Overall Study|Adverse Event|0
902811|NCT00743249|1876773|FG001|Overall Study|Adverse Event|4
902812|NCT00743249|1876772|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0
902813|NCT00743249|1876773|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1
902814|NCT00743249|1876772|FG000|Overall Study|Unsuccessful insertion of stent|2
902815|NCT00743249|1876773|FG001|Overall Study|Unsuccessful insertion of stent|1
902816|NCT00743275|1876785|FG000|Overall Study|Protocol Violation|0
902817|NCT00743275|1876786|FG001|Overall Study|Protocol Violation|1
902818|NCT00743288|1876792|FG000|Overall Study|Adverse Event|1
902819|NCT00743288|1876793|FG001|Overall Study|Adverse Event|1
902820|NCT00743288|1876794|FG002|Overall Study|Adverse Event|2
902821|NCT00743288|1876795|FG003|Overall Study|Adverse Event|2
902822|NCT00743288|1876796|FG004|Overall Study|Adverse Event|1
902823|NCT00743288|1876797|FG005|Overall Study|Adverse Event|1
902824|NCT00743288|1876798|FG006|Overall Study|Adverse Event|2
902825|NCT00743288|1876792|FG000|Overall Study|Withdrawal by Subject|0
902826|NCT00743288|1876793|FG001|Overall Study|Withdrawal by Subject|0
902827|NCT00743288|1876794|FG002|Overall Study|Withdrawal by Subject|1
902828|NCT00743288|1876795|FG003|Overall Study|Withdrawal by Subject|0
902829|NCT00743288|1876796|FG004|Overall Study|Withdrawal by Subject|0
902830|NCT00743288|1876797|FG005|Overall Study|Withdrawal by Subject|1
902831|NCT00743288|1876798|FG006|Overall Study|Withdrawal by Subject|1
902832|NCT00743288|1876792|FG000|Overall Study|Progressive disease (PD)|2
902833|NCT00743288|1876793|FG001|Overall Study|Progressive disease (PD)|0
902834|NCT00743288|1876794|FG002|Overall Study|Progressive disease (PD)|1
902835|NCT00743288|1876795|FG003|Overall Study|Progressive disease (PD)|4
902836|NCT00743288|1876796|FG004|Overall Study|Progressive disease (PD)|5
902837|NCT00743288|1876797|FG005|Overall Study|Progressive disease (PD)|3
902838|NCT00743288|1876798|FG006|Overall Study|Progressive disease (PD)|6
902839|NCT00743288|1876792|FG000|Overall Study|Worsening of condition (Not PD)|0
902840|NCT00743288|1876793|FG001|Overall Study|Worsening of condition (Not PD)|2
902841|NCT00743288|1876794|FG002|Overall Study|Worsening of condition (Not PD)|1
902842|NCT00743288|1876795|FG003|Overall Study|Worsening of condition (Not PD)|1
902843|NCT00743288|1876796|FG004|Overall Study|Worsening of condition (Not PD)|0
902844|NCT00743288|1876797|FG005|Overall Study|Worsening of condition (Not PD)|0
902845|NCT00743288|1876798|FG006|Overall Study|Worsening of condition (Not PD)|0
902846|NCT00743340|1876809|FG000|Overall Study|Study medication non-compliance|1
902847|NCT00743340|1876809|FG000|Overall Study|Lost to Follow-up|1
902848|NCT00743340|1876809|FG000|Overall Study|Withdrawal from the Study|5
902849|NCT00743340|1876809|FG000|Overall Study|Protocol Violation|1
902850|NCT00743340|1876809|FG000|Overall Study|Virologic failure|8
902851|NCT00743340|1876809|FG000|Overall Study|Pregnancy|1
902852|NCT00743340|1876809|FG000|Overall Study|Rolled over to other Gilead Study|23
902853|NCT00743340|1876809|FG000|Overall Study|Participant Relocated|1
902854|NCT00743366|1876813|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3
902855|NCT00743366|1876814|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3
902856|NCT00743431|1876820|FG000|Overall Study|Toxicity|6
902857|NCT00743431|1876820|FG000|Overall Study|Tumor progression|56
902858|NCT00743431|1876820|FG000|Overall Study|Withdrawal by Subject|13
902859|NCT00743431|1876820|FG000|Overall Study|Death|9
902860|NCT00743431|1876820|FG000|Overall Study|Reason for discontinuation not specified|29
902861|NCT00743431|1876820|FG000|Overall Study|No documentation available|13
902862|NCT00743444|1876824|FG000|First Intervention|Catheter placement problems|0
902863|NCT00743444|1876825|FG001|First Intervention|Catheter placement problems|1
902864|NCT00743444|1876824|FG000|Washout Period|Adverse Event|0
902865|NCT00743444|1876825|FG001|Washout Period|Adverse Event|1
902866|NCT00743483|1876831|FG000|Baseline Period|Physician Decision|1
902867|NCT00743483|1876831|FG000|Treatment Period|Adverse Event|1
902868|NCT00743509|1876835|FG000|Overall Study|Withdrawal by Subject|2
902869|NCT00743652|1876848|FG000|Overall Study|Parent/Legal Guardian Request|3
902870|NCT00743652|1876849|FG001|Overall Study|Parent/Legal Guardian Request|2
902871|NCT00743652|1876850|FG002|Overall Study|Parent/Legal Guardian Request|2
902872|NCT00743652|1876851|FG003|Overall Study|Parent/Legal Guardian Request|2
902873|NCT00743652|1876852|FG004|Overall Study|Parent/Legal Guardian Request|0
902874|NCT00743652|1876848|FG000|Overall Study|Adverse Event|3
902875|NCT00743652|1876849|FG001|Overall Study|Adverse Event|0
902876|NCT00743652|1876850|FG002|Overall Study|Adverse Event|0
902877|NCT00743652|1876851|FG003|Overall Study|Adverse Event|0
902878|NCT00743652|1876852|FG004|Overall Study|Adverse Event|0
902879|NCT00743652|1876848|FG000|Overall Study|Death|2
902880|NCT00743652|1876849|FG001|Overall Study|Death|0
902881|NCT00743652|1876850|FG002|Overall Study|Death|0
902882|NCT00743652|1876851|FG003|Overall Study|Death|0
902883|NCT00743652|1876852|FG004|Overall Study|Death|0
902884|NCT00743652|1876848|FG000|Overall Study|Investigator Request|0
902885|NCT00743652|1876849|FG001|Overall Study|Investigator Request|0
1150400|NCT03093415|2262268|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9
1150401|NCT03093415|2262269|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3
1150402|NCT03093415|2262270|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0
1150403|NCT03093415|2262268|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1
1150404|NCT03093415|2262269|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8
1150405|NCT03093415|2262270|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3
1150406|NCT03093454|2262280|FG000|Overall Study|Withdrawal by Subject|1
1150407|NCT03093454|2262281|FG001|Overall Study|Withdrawal by Subject|1
1150408|NCT03093454|2262280|FG000|Overall Study|Scheduling conflict|3
1150409|NCT03093454|2262281|FG001|Overall Study|Scheduling conflict|1
1150410|NCT03093454|2262280|FG000|Overall Study|Physician Decision|2
1150411|NCT03093454|2262281|FG001|Overall Study|Physician Decision|1
1150412|NCT03093870|2262303|FG000|Overall Study|Withdrawal by Subject|2
1150413|NCT03093870|2262304|FG001|Overall Study|Withdrawal by Subject|6
1150414|NCT03093870|2262305|FG002|Overall Study|Withdrawal by Subject|5
1150415|NCT03093870|2262303|FG000|Overall Study|Death|1
1150416|NCT03093870|2262304|FG001|Overall Study|Death|35
1150417|NCT03093870|2262305|FG002|Overall Study|Death|35
1150418|NCT03093870|2262303|FG000|Overall Study|Radiographic disease progression|10
1150419|NCT03093870|2262304|FG001|Overall Study|Radiographic disease progression|0
1150420|NCT03093870|2262305|FG002|Overall Study|Radiographic disease progression|0
1150421|NCT03093870|2262303|FG000|Overall Study|Clinical disease progression|1
1150422|NCT03093870|2262304|FG001|Overall Study|Clinical disease progression|0
1150423|NCT03093870|2262305|FG002|Overall Study|Clinical disease progression|0
1150424|NCT03093870|2262303|FG000|Overall Study|Physician Decision|2
902886|NCT00743652|1876850|FG002|Overall Study|Investigator Request|0
902887|NCT00743652|1876851|FG003|Overall Study|Investigator Request|2
902888|NCT00743652|1876852|FG004|Overall Study|Investigator Request|0
902889|NCT00743652|1876848|FG000|Overall Study|Other|1
902890|NCT00743652|1876849|FG001|Overall Study|Other|1
902891|NCT00743652|1876850|FG002|Overall Study|Other|0
902892|NCT00743652|1876851|FG003|Overall Study|Other|0
902893|NCT00743652|1876852|FG004|Overall Study|Other|0
902894|NCT00743652|1876848|FG000|Overall Study|Lost to Follow-up|1
902895|NCT00743652|1876849|FG001|Overall Study|Lost to Follow-up|0
902896|NCT00743652|1876850|FG002|Overall Study|Lost to Follow-up|0
902897|NCT00743652|1876851|FG003|Overall Study|Lost to Follow-up|0
902898|NCT00743652|1876852|FG004|Overall Study|Lost to Follow-up|0
902899|NCT00744042|1876894|FG000|Overall Study|Withdrawal by Subject|1
902900|NCT00744055|1876906|FG000|Overall Study|Withdrawal by Subject|6
902901|NCT00744055|1876907|FG001|Overall Study|Withdrawal by Subject|9
902902|NCT00744055|1876906|FG000|Overall Study|Lack of Efficacy|0
902903|NCT00744055|1876907|FG001|Overall Study|Lack of Efficacy|1
902904|NCT00744055|1876906|FG000|Overall Study|Physician Decision|0
902905|NCT00744055|1876907|FG001|Overall Study|Physician Decision|2
902906|NCT00744055|1876906|FG000|Overall Study|Protocol Violation|1
902907|NCT00744055|1876907|FG001|Overall Study|Protocol Violation|1
902908|NCT00744055|1876906|FG000|Overall Study|Lost to Follow-up|0
902909|NCT00744055|1876907|FG001|Overall Study|Lost to Follow-up|1
902910|NCT00744237|1876932|FG000|Overall Study|Lack of Efficacy|1
902911|NCT00744237|1876933|FG001|Overall Study|Lack of Efficacy|1
902912|NCT00744237|1876934|FG002|Overall Study|Lack of Efficacy|0
902913|NCT00744237|1876932|FG000|Overall Study|Withdrawal by Subject|9
902914|NCT00744237|1876933|FG001|Overall Study|Withdrawal by Subject|5
902915|NCT00744237|1876934|FG002|Overall Study|Withdrawal by Subject|3
902916|NCT00744237|1876932|FG000|Overall Study|Lost to Follow-up|1
902917|NCT00744237|1876933|FG001|Overall Study|Lost to Follow-up|1
902918|NCT00744237|1876934|FG002|Overall Study|Lost to Follow-up|1
902919|NCT00744237|1876932|FG000|Overall Study|Protocol Violation|3
902920|NCT00744237|1876933|FG001|Overall Study|Protocol Violation|4
902921|NCT00744237|1876934|FG002|Overall Study|Protocol Violation|3
902922|NCT00744237|1876932|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
902923|NCT00744237|1876933|FG001|Overall Study|Inclusion/Exclusion criteria not met|0
902924|NCT00744237|1876934|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
902925|NCT00744237|1876932|FG000|Overall Study|Dosing Error|1
902926|NCT00744237|1876933|FG001|Overall Study|Dosing Error|0
902927|NCT00744237|1876934|FG002|Overall Study|Dosing Error|1
902928|NCT00744237|1876932|FG000|Overall Study|Study Drug Error|1
902929|NCT00744237|1876933|FG001|Overall Study|Study Drug Error|0
902930|NCT00744237|1876934|FG002|Overall Study|Study Drug Error|0
902931|NCT00744237|1876932|FG000|Overall Study|Prohibited Concomitant Medication|0
902932|NCT00744237|1876933|FG001|Overall Study|Prohibited Concomitant Medication|0
902933|NCT00744237|1876934|FG002|Overall Study|Prohibited Concomitant Medication|1
902934|NCT00744237|1876932|FG000|Overall Study|Poor Compliance|0
902935|NCT00744237|1876933|FG001|Overall Study|Poor Compliance|2
902936|NCT00744237|1876934|FG002|Overall Study|Poor Compliance|0
902937|NCT00744237|1876932|FG000|Overall Study|Administrative. Site Closed|1
902938|NCT00744237|1876933|FG001|Overall Study|Administrative. Site Closed|1
902939|NCT00744237|1876934|FG002|Overall Study|Administrative. Site Closed|1
902940|NCT00744237|1876932|FG000|Overall Study|Adverse Event|9
902941|NCT00744237|1876933|FG001|Overall Study|Adverse Event|13
902942|NCT00744237|1876934|FG002|Overall Study|Adverse Event|5
902943|NCT00744263|1876944|FG000|Overall Study|Death|3006
1150425|NCT03093870|2262304|FG001|Overall Study|Physician Decision|0
1150426|NCT03093870|2262305|FG002|Overall Study|Physician Decision|0
1150427|NCT03093870|2262303|FG000|Overall Study|Adverse Event|7
1150428|NCT03093870|2262304|FG001|Overall Study|Adverse Event|0
1150429|NCT03093870|2262305|FG002|Overall Study|Adverse Event|0
1150430|NCT03093870|2262303|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1
1150431|NCT03093870|2262304|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
1150432|NCT03093870|2262305|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
1150433|NCT03093870|2262303|FG000|Overall Study|Lost to Follow-up|0
1150434|NCT03093870|2262304|FG001|Overall Study|Lost to Follow-up|0
1150435|NCT03093870|2262305|FG002|Overall Study|Lost to Follow-up|1
1150436|NCT03094195|2262316|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
1150437|NCT03094195|2262317|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
1150438|NCT03094195|2262318|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
1150439|NCT03094195|2262319|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
1150440|NCT03094195|2262320|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
1150441|NCT03094195|2262321|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
1150442|NCT03094195|2262322|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
902944|NCT00744263|1876945|FG001|Overall Study|Death|3005
902945|NCT00744263|1876944|FG000|Overall Study|Lost to Follow-up|2038
902946|NCT00744263|1876945|FG001|Overall Study|Lost to Follow-up|2135
902947|NCT00744263|1876944|FG000|Overall Study|Withdrawal by Subject|166
902948|NCT00744263|1876945|FG001|Overall Study|Withdrawal by Subject|150
902949|NCT00744263|1876944|FG000|Overall Study|Physician Decision|20
902950|NCT00744263|1876945|FG001|Overall Study|Physician Decision|23
902951|NCT00744263|1876944|FG000|Overall Study|Protocol Violation|3
902952|NCT00744263|1876945|FG001|Overall Study|Protocol Violation|5
902953|NCT00744263|1876944|FG000|Overall Study|Adverse Event|1
902954|NCT00744263|1876945|FG001|Overall Study|Adverse Event|0
902955|NCT00744263|1876944|FG000|Overall Study|Other|2
902956|NCT00744263|1876945|FG001|Overall Study|Other|2
902957|NCT00744328|1876956|FG000|Overall Study|Lost to Follow-up|2
902958|NCT00744328|1876957|FG001|Overall Study|Lost to Follow-up|5
902959|NCT00744328|1876958|FG002|Overall Study|Lost to Follow-up|3
902960|NCT00744328|1876956|FG000|Overall Study|Withdrawal by Subject|5
902961|NCT00744328|1876957|FG001|Overall Study|Withdrawal by Subject|3
902962|NCT00744328|1876958|FG002|Overall Study|Withdrawal by Subject|4
902963|NCT00744328|1876956|FG000|Overall Study|Found ineligible after randomization|0
902964|NCT00744328|1876957|FG001|Overall Study|Found ineligible after randomization|0
902965|NCT00744328|1876958|FG002|Overall Study|Found ineligible after randomization|1
902966|NCT00744471|1876980|FG000|Overall Study|Randomized but not treated|1
902967|NCT00744471|1876981|FG001|Overall Study|Randomized but not treated|1
902968|NCT00744471|1876982|FG002|Overall Study|Randomized but not treated|4
902969|NCT00744471|1876983|FG003|Overall Study|Randomized but not treated|0
902970|NCT00744471|1876980|FG000|Overall Study|Death|0
902971|NCT00744471|1876981|FG001|Overall Study|Death|0
902972|NCT00744471|1876982|FG002|Overall Study|Death|0
902973|NCT00744471|1876983|FG003|Overall Study|Death|1
902974|NCT00744471|1876980|FG000|Overall Study|Adverse Event|6
902975|NCT00744471|1876981|FG001|Overall Study|Adverse Event|7
902976|NCT00744471|1876982|FG002|Overall Study|Adverse Event|5
902977|NCT00744471|1876983|FG003|Overall Study|Adverse Event|9
902978|NCT00744471|1876980|FG000|Overall Study|Withdrawal by Subject|9
902979|NCT00744471|1876981|FG001|Overall Study|Withdrawal by Subject|9
902980|NCT00744471|1876982|FG002|Overall Study|Withdrawal by Subject|15
902981|NCT00744471|1876983|FG003|Overall Study|Withdrawal by Subject|12
902982|NCT00744471|1876980|FG000|Overall Study|Protocol Violation|1
902983|NCT00744471|1876981|FG001|Overall Study|Protocol Violation|4
902984|NCT00744471|1876982|FG002|Overall Study|Protocol Violation|1
902985|NCT00744471|1876983|FG003|Overall Study|Protocol Violation|2
902986|NCT00744471|1876980|FG000|Overall Study|Entered extension study|41
902987|NCT00744471|1876981|FG001|Overall Study|Entered extension study|84
902988|NCT00744471|1876982|FG002|Overall Study|Entered extension study|100
902989|NCT00744471|1876983|FG003|Overall Study|Entered extension study|91
902990|NCT00744471|1876980|FG000|Overall Study|Other|2
902991|NCT00744471|1876981|FG001|Overall Study|Other|3
902992|NCT00744471|1876982|FG002|Overall Study|Other|6
902993|NCT00744471|1876983|FG003|Overall Study|Other|2
902994|NCT00744471|1876980|FG000|Overall Study|Lack of Efficacy|83
902995|NCT00744471|1876981|FG001|Overall Study|Lack of Efficacy|37
902996|NCT00744471|1876982|FG002|Overall Study|Lack of Efficacy|19
902997|NCT00744471|1876983|FG003|Overall Study|Lack of Efficacy|31
902998|NCT00744471|1876980|FG000|Overall Study|Lost to Follow-up|0
902999|NCT00744471|1876981|FG001|Overall Study|Lost to Follow-up|0
903000|NCT00744471|1876982|FG002|Overall Study|Lost to Follow-up|2
903001|NCT00744471|1876983|FG003|Overall Study|Lost to Follow-up|0
903002|NCT00744497|1876995|FG000|Overall Study|Withdrawal by Subject|21
903003|NCT00744497|1876996|FG001|Overall Study|Withdrawal by Subject|18
903004|NCT00744497|1876995|FG000|Overall Study|Death|11
903005|NCT00744497|1876996|FG001|Overall Study|Death|9
903006|NCT00744497|1876995|FG000|Overall Study|Lost to Follow-up|4
903007|NCT00744497|1876996|FG001|Overall Study|Lost to Follow-up|2
1150443|NCT03094195|2262323|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
1150444|NCT03094195|2262316|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
1150445|NCT03094195|2262317|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2
1150446|NCT03094195|2262318|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1
1150447|NCT03094195|2262319|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
1150448|NCT03094195|2262320|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
903008|NCT00744497|1876995|FG000|Overall Study|Poor compliance/noncompliance|9
903009|NCT00744497|1876996|FG001|Overall Study|Poor compliance/noncompliance|5
903010|NCT00744497|1876995|FG000|Overall Study|No longer meets study criteria|7
903011|NCT00744497|1876996|FG001|Overall Study|No longer meets study criteria|3
903012|NCT00744497|1876995|FG000|Overall Study|Administrative Reason By Sponsor|25
903013|NCT00744497|1876996|FG001|Overall Study|Administrative Reason By Sponsor|8
903014|NCT00744497|1876995|FG000|Overall Study|Disease progression|312
903015|NCT00744497|1876996|FG001|Overall Study|Disease progression|219
903016|NCT00744497|1876995|FG000|Overall Study|Study drug toxicity|68
903017|NCT00744497|1876996|FG001|Overall Study|Study drug toxicity|141
903018|NCT00744497|1876995|FG000|Overall Study|Adverse event unrelated to study drug|78
903019|NCT00744497|1876996|FG001|Overall Study|Adverse event unrelated to study drug|122
903020|NCT00744497|1876995|FG000|Overall Study|Patient requested to stop study drug|65
903021|NCT00744497|1876996|FG001|Overall Study|Patient requested to stop study drug|80
903022|NCT00744497|1876995|FG000|Overall Study|Maximum clinical benefit|141
903023|NCT00744497|1876996|FG001|Overall Study|Maximum clinical benefit|142
903024|NCT00744497|1876995|FG000|Overall Study|Not defined|19
903025|NCT00744497|1876996|FG001|Overall Study|Not defined|13
903026|NCT00744523|1877004|FG000|30 Days After the Procedure|Insufficient follow-up|0
903027|NCT00744523|1877005|FG001|30 Days After the Procedure|Insufficient follow-up|5
903028|NCT00744627|1877015|FG000|Overall Study|Adverse Event|6
903029|NCT00744627|1877016|FG001|Overall Study|Adverse Event|9
903030|NCT00744627|1877015|FG000|Overall Study|Lack of Efficacy|7
903031|NCT00744627|1877016|FG001|Overall Study|Lack of Efficacy|3
903032|NCT00744627|1877015|FG000|Overall Study|Noncompliance|0
903033|NCT00744627|1877016|FG001|Overall Study|Noncompliance|1
903034|NCT00744627|1877015|FG000|Overall Study|Protocol Deviations|0
903035|NCT00744627|1877016|FG001|Overall Study|Protocol Deviations|2
903036|NCT00744627|1877015|FG000|Overall Study|Voluntary Withdrawal|9
903037|NCT00744627|1877016|FG001|Overall Study|Voluntary Withdrawal|6
903038|NCT00744627|1877015|FG000|Overall Study|Lost to Follow-up|2
903039|NCT00744627|1877016|FG001|Overall Study|Lost to Follow-up|1
903040|NCT00744627|1877015|FG000|Overall Study|Other|1
903041|NCT00744627|1877016|FG001|Overall Study|Other|0
903042|NCT00744653|1877022|FG000|Overall Study|antineoplastic treatment|11
903043|NCT00744653|1877022|FG000|Overall Study|Death|1
903044|NCT00744653|1877022|FG000|Overall Study|Lost to Follow-up|1
903045|NCT00744653|1877022|FG000|Overall Study|Physician Decision|3
903046|NCT00744757|1877031|FG000|Overall Study|Objective disease progression|7
903047|NCT00744757|1877031|FG000|Overall Study|Physician Decision|5
903048|NCT00744757|1877031|FG000|Overall Study|Withdrawal by Subject|1
903049|NCT00744757|1877031|FG000|Overall Study|Death|6
903050|NCT00744757|1877031|FG000|Overall Study|Adverse Event|2
903051|NCT00744796|1877035|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12
903052|NCT00744861|1877052|FG000|Feasibility Stage 1|Withdrawal by Subject|1
903053|NCT00744861|1877053|FG001|Feasibility Stage 1|Withdrawal by Subject|1
903054|NCT00744861|1877054|FG002|Feasibility Stage 1|Withdrawal by Subject|0
903055|NCT00744861|1877055|FG003|Feasibility Stage 1|Withdrawal by Subject|0
903056|NCT00744861|1877052|FG000|Feasibility Stage 1|Pregnancy|0
903057|NCT00744861|1877053|FG001|Feasibility Stage 1|Pregnancy|1
903058|NCT00744861|1877054|FG002|Feasibility Stage 1|Pregnancy|0
903059|NCT00744861|1877055|FG003|Feasibility Stage 1|Pregnancy|0
903060|NCT00744861|1877052|FG000|Pivotal Stage 2|Adverse Event|0
903061|NCT00744861|1877053|FG001|Pivotal Stage 2|Adverse Event|0
903062|NCT00744861|1877054|FG002|Pivotal Stage 2|Adverse Event|6
903063|NCT00744861|1877055|FG003|Pivotal Stage 2|Adverse Event|11
903064|NCT00744861|1877052|FG000|Pivotal Stage 2|Death|0
903065|NCT00744861|1877053|FG001|Pivotal Stage 2|Death|0
903066|NCT00744861|1877054|FG002|Pivotal Stage 2|Death|0
903067|NCT00744861|1877055|FG003|Pivotal Stage 2|Death|1
903068|NCT00744861|1877052|FG000|Pivotal Stage 2|Lost to Follow-up|0
903069|NCT00744861|1877053|FG001|Pivotal Stage 2|Lost to Follow-up|0
903070|NCT00744861|1877054|FG002|Pivotal Stage 2|Lost to Follow-up|13
903071|NCT00744861|1877055|FG003|Pivotal Stage 2|Lost to Follow-up|14
903072|NCT00744861|1877052|FG000|Pivotal Stage 2|Physician Decision|0
903073|NCT00744861|1877053|FG001|Pivotal Stage 2|Physician Decision|0
903074|NCT00744861|1877054|FG002|Pivotal Stage 2|Physician Decision|3
903075|NCT00744861|1877055|FG003|Pivotal Stage 2|Physician Decision|1
903076|NCT00744861|1877052|FG000|Pivotal Stage 2|Protocol Violation|0
903077|NCT00744861|1877053|FG001|Pivotal Stage 2|Protocol Violation|0
903078|NCT00744861|1877054|FG002|Pivotal Stage 2|Protocol Violation|0
903079|NCT00744861|1877055|FG003|Pivotal Stage 2|Protocol Violation|1
903080|NCT00744861|1877052|FG000|Pivotal Stage 2|Withdrawal by Subject|0
903081|NCT00744861|1877053|FG001|Pivotal Stage 2|Withdrawal by Subject|0
1150449|NCT03094195|2262321|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0
1150450|NCT03094195|2262322|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0
1150451|NCT03094195|2262323|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0
1150452|NCT03094195|2262316|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0
1150453|NCT03094195|2262317|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0
1150454|NCT03094195|2262318|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1
1150455|NCT03094195|2262319|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
1150456|NCT03094195|2262320|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
1150457|NCT03094195|2262321|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0
1150458|NCT03094195|2262322|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0
1150459|NCT03094195|2262323|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0
1150460|NCT03094195|2262316|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
1150461|NCT03094195|2262317|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
1150462|NCT03094195|2262318|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
1150463|NCT03094195|2262319|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
1150464|NCT03094195|2262320|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
1150465|NCT03094195|2262321|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
1150466|NCT03094195|2262322|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
1150467|NCT03094195|2262323|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
1150468|NCT03094611|2262347|FG000|Overall Study|Lack of Efficacy|1
1150469|NCT03094611|2262347|FG000|Overall Study|Stem Cell Transplant|1
1150470|NCT03095027|2262370|FG000|Period 2, Second Week of Wear|Adverse Event|1
1150471|NCT03095027|2262371|FG001|Period 2, Second Week of Wear|Adverse Event|0
1150472|NCT03095118|2262386|FG000|Overall Study|Adverse Event|1
1150473|NCT03095118|2262386|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1
1150474|NCT03095508|2262401|FG000|Overall Study|Adverse Event|0
1150475|NCT03095508|2262402|FG001|Overall Study|Adverse Event|1
1150476|NCT03095521|2262410|FG000|Overall Study|Withdrawal by Subject|0
1150477|NCT03095521|2262411|FG001|Overall Study|Withdrawal by Subject|1
1150478|NCT03095521|2262410|FG000|Overall Study|Lost to Follow-up|0
1150479|NCT03095521|2262411|FG001|Overall Study|Lost to Follow-up|1
1150480|NCT03095599|2262419|FG000|Overall Study|Withdrawal by Subject|1
1150481|NCT03095599|2262420|FG001|Overall Study|Withdrawal by Subject|0
1150482|NCT03095599|2262419|FG000|Overall Study|Lost to Follow-up|1
1150483|NCT03095599|2262420|FG001|Overall Study|Lost to Follow-up|0
1150484|NCT03095599|2262419|FG000|Overall Study|Withdrawal prior to vaccination|1
1150485|NCT03095599|2262420|FG001|Overall Study|Withdrawal prior to vaccination|0
1150486|NCT03095651|2262465|FG000|Overall Study|Lost to Follow-up|1
1150487|NCT03095651|2262466|FG001|Overall Study|Lost to Follow-up|1
1150488|NCT03095651|2262467|FG002|Overall Study|Lost to Follow-up|0
1150489|NCT03095651|2262468|FG003|Overall Study|Lost to Follow-up|1
1150490|NCT03095651|2262469|FG004|Overall Study|Lost to Follow-up|0
1150491|NCT03095651|2262470|FG005|Overall Study|Lost to Follow-up|0
1150492|NCT03095651|2262471|FG006|Overall Study|Lost to Follow-up|0
1150493|NCT03095651|2262472|FG007|Overall Study|Lost to Follow-up|0
1150494|NCT03095651|2262465|FG000|Overall Study|Withdrawal by Subject|0
1150495|NCT03095651|2262466|FG001|Overall Study|Withdrawal by Subject|0
1150496|NCT03095651|2262467|FG002|Overall Study|Withdrawal by Subject|0
1150497|NCT03095651|2262468|FG003|Overall Study|Withdrawal by Subject|0
1150498|NCT03095651|2262469|FG004|Overall Study|Withdrawal by Subject|0
1150499|NCT03095651|2262470|FG005|Overall Study|Withdrawal by Subject|1
1150500|NCT03095651|2262471|FG006|Overall Study|Withdrawal by Subject|0
1150501|NCT03095651|2262472|FG007|Overall Study|Withdrawal by Subject|0
1150502|NCT03096314|2262500|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9
1150503|NCT03096314|2262501|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12
1150504|NCT03096483|2262528|FG000|Overall Study|Withdrawal by site|1
1150505|NCT03096847|2262556|FG000|Overall Study|Other|2
1150506|NCT03096847|2262557|FG001|Overall Study|Other|1
1150507|NCT03096847|2262558|FG002|Overall Study|Other|2
1150508|NCT03096847|2262556|FG000|Overall Study|Lost to Follow-up|1
1150509|NCT03096847|2262557|FG001|Overall Study|Lost to Follow-up|0
1150510|NCT03096847|2262558|FG002|Overall Study|Lost to Follow-up|1
1150511|NCT03096847|2262556|FG000|Overall Study|Death|6
1150512|NCT03096847|2262557|FG001|Overall Study|Death|0
903082|NCT00744861|1877054|FG002|Pivotal Stage 2|Withdrawal by Subject|20
903083|NCT00744861|1877055|FG003|Pivotal Stage 2|Withdrawal by Subject|14
903084|NCT00744861|1877052|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0
903085|NCT00744861|1877053|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0
903086|NCT00744861|1877054|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60
903087|NCT00744861|1877055|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63
903088|NCT00744874|1877063|FG000|Overall Study|Lost to Follow-up|1
903089|NCT00744874|1877063|FG000|Overall Study|Withdrawal by Subject|1
903090|NCT00744874|1877063|FG000|Overall Study|Study Device not available at procedure|1
903091|NCT00744874|1877063|FG000|Overall Study|Unable to accomodate schedule|1
903092|NCT00744939|1877078|FG000|Overall Study|Withdrawal by Subject|9
903093|NCT00744939|1877078|FG000|Overall Study|Protocol Violation|13
903094|NCT00744939|1877078|FG000|Overall Study|Death|24
903095|NCT00744939|1877078|FG000|Overall Study|distance|4
903096|NCT00744939|1877078|FG000|Overall Study|Lost to Follow-up|12
903097|NCT00744939|1877078|FG000|Overall Study|Medical history exclusionary|1
1150513|NCT03096847|2262558|FG002|Overall Study|Death|2
1150514|NCT03096847|2262556|FG000|Overall Study|Protocol Violation|3
1150515|NCT03096847|2262557|FG001|Overall Study|Protocol Violation|0
1150516|NCT03096847|2262558|FG002|Overall Study|Protocol Violation|6
1150517|NCT03096847|2262556|FG000|Overall Study|Physician Decision|12
1150518|NCT03096847|2262557|FG001|Overall Study|Physician Decision|2
1150519|NCT03096847|2262558|FG002|Overall Study|Physician Decision|8
1150520|NCT03096847|2262556|FG000|Overall Study|Withdrawal by Subject|24
1150521|NCT03096847|2262557|FG001|Overall Study|Withdrawal by Subject|1
1150522|NCT03096847|2262558|FG002|Overall Study|Withdrawal by Subject|12
1150523|NCT03096847|2262556|FG000|Overall Study|Adverse Event|72
1150524|NCT03096847|2262557|FG001|Overall Study|Adverse Event|6
1150525|NCT03096847|2262558|FG002|Overall Study|Adverse Event|28
1150526|NCT03096847|2262556|FG000|Overall Study|Progressive disease|97
1150527|NCT03096847|2262557|FG001|Overall Study|Progressive disease|10
1150528|NCT03096847|2262558|FG002|Overall Study|Progressive disease|78
1150529|NCT03096847|2262556|FG000|Overall Study|Non-compliance with study medication|1
1150530|NCT03096847|2262557|FG001|Overall Study|Non-compliance with study medication|0
1150531|NCT03096847|2262558|FG002|Overall Study|Non-compliance with study medication|0
1150532|NCT03096847|2262556|FG000|Overall Study|New therapy for study indication|1
1150533|NCT03096847|2262557|FG001|Overall Study|New therapy for study indication|0
1150534|NCT03096847|2262558|FG002|Overall Study|New therapy for study indication|1
1150535|NCT03097029|2262585|FG000|Overall Study|Withdrawal by Subject|1
1150536|NCT03097133|2262591|FG000|Overall Study|Lost to Follow-up|3
1150537|NCT03097133|2262592|FG001|Overall Study|Lost to Follow-up|2
1150538|NCT03097133|2262591|FG000|Overall Study|Withdrawal by Subject|2
1150539|NCT03097133|2262592|FG001|Overall Study|Withdrawal by Subject|5
1150540|NCT03097133|2262591|FG000|Overall Study|Discontinued DB, not entered FU Phase|21
1150541|NCT03097133|2262592|FG001|Overall Study|Discontinued DB, not entered FU Phase|25
1150542|NCT03097133|2262591|FG000|Overall Study|Other|3
1150543|NCT03097133|2262592|FG001|Overall Study|Other|2
1150544|NCT03097133|2262591|FG000|Overall Study|Adverse Event|1
1150545|NCT03097133|2262592|FG001|Overall Study|Adverse Event|0
1150546|NCT03097289|2262598|FG000|Overall Study|Adverse Event|1
1150547|NCT03097289|2262598|FG000|Overall Study|Equipment failure|2
1150548|NCT03097289|2262598|FG000|Overall Study|Collected platelet product unusable|3
1150549|NCT03097315|2262603|FG000|Overall Study|Withdrawal by Subject|1
1150550|NCT03097588|2262637|FG000|Overall Study|Adverse Event|1
1150551|NCT03097614|2262641|FG000|Overall Study|Adverse Event|3
1150552|NCT03097861|2262666|FG000|Overall Study|Adverse Event|3
1150553|NCT03097861|2262667|FG001|Overall Study|Adverse Event|8
1150554|NCT03097861|2262668|FG002|Overall Study|Adverse Event|4
1150555|NCT03097861|2262666|FG000|Overall Study|Investigator Decision|0
1150556|NCT03097861|2262667|FG001|Overall Study|Investigator Decision|1
1150557|NCT03097861|2262668|FG002|Overall Study|Investigator Decision|0
1150558|NCT03097861|2262666|FG000|Overall Study|Lost to Follow-up|0
1150559|NCT03097861|2262667|FG001|Overall Study|Lost to Follow-up|7
1150560|NCT03097861|2262668|FG002|Overall Study|Lost to Follow-up|1
1150561|NCT03097861|2262666|FG000|Overall Study|Withdrawal by Subject|1
1150562|NCT03097861|2262667|FG001|Overall Study|Withdrawal by Subject|5
1150563|NCT03097861|2262668|FG002|Overall Study|Withdrawal by Subject|3
1150564|NCT03097861|2262666|FG000|Overall Study|Reason not provided|3
1150565|NCT03097861|2262667|FG001|Overall Study|Reason not provided|1
1150566|NCT03097861|2262668|FG002|Overall Study|Reason not provided|1
1150567|NCT03098030|2262682|FG000|Overall Study|Death|10
1150568|NCT03098030|2262683|FG001|Overall Study|Death|156
1150569|NCT03098030|2262684|FG002|Overall Study|Death|156
1150570|NCT03098030|2262685|FG003|Overall Study|Death|82
1150571|NCT03098030|2262682|FG000|Overall Study|Withdrawal by Subject|0
903098|NCT00744939|1877078|FG000|Overall Study|Did not receive Magnevist|7
903099|NCT00744939|1877078|FG000|Overall Study|Failed inclusion/exclusion criteria|19
903100|NCT00744939|1877078|FG000|Overall Study|coma|1
903101|NCT00744939|1877078|FG000|Overall Study|incorrect race|1
903102|NCT00744978|1877101|FG000|Period 1|Lost to Follow-up|1
903103|NCT00744978|1877102|FG001|Period 1|Lost to Follow-up|0
903104|NCT00744978|1877101|FG000|Period 1|Withdrawal by Subject|0
903105|NCT00744978|1877102|FG001|Period 1|Withdrawal by Subject|2
903106|NCT00744978|1877101|FG000|Period 1|Other|0
903107|NCT00744978|1877102|FG001|Period 1|Other|2
903108|NCT00744978|1877101|FG000|Period 1|Adverse Event|4
903109|NCT00744978|1877102|FG001|Period 1|Adverse Event|0
903110|NCT00744978|1877101|FG000|Period 1|Randomized but not Treated|1
903111|NCT00744978|1877102|FG001|Period 1|Randomized but not Treated|1
903112|NCT00744978|1877101|FG000|Period 2|Adverse Event|0
903113|NCT00744978|1877102|FG001|Period 2|Adverse Event|1
903114|NCT00744991|1877108|FG000|Overall Study|Progressive Disease|11
903115|NCT00744991|1877108|FG000|Overall Study|Withdrawal by Subject|8
903116|NCT00744991|1877108|FG000|Overall Study|Physician Decision|3
903117|NCT00744991|1877108|FG000|Overall Study|Adverse Event|2
903118|NCT00744991|1877108|FG000|Overall Study|Protocol Entry Criteria Unmet|1
903119|NCT00745095|1877121|FG000|Overall Study|Declined to participate|1
903120|NCT00745095|1877122|FG001|Overall Study|Declined to participate|0
903121|NCT00745095|1877123|FG002|Overall Study|Declined to participate|0
903122|NCT00745095|1877124|FG003|Overall Study|Declined to participate|0
903123|NCT00745095|1877125|FG004|Overall Study|Declined to participate|92
1150572|NCT03098030|2262683|FG001|Overall Study|Withdrawal by Subject|7
1150573|NCT03098030|2262684|FG002|Overall Study|Withdrawal by Subject|8
1150574|NCT03098030|2262685|FG003|Overall Study|Withdrawal by Subject|2
1150575|NCT03098030|2262682|FG000|Overall Study|Lost to Follow-up|0
1150576|NCT03098030|2262683|FG001|Overall Study|Lost to Follow-up|0
1150577|NCT03098030|2262684|FG002|Overall Study|Lost to Follow-up|2
1150578|NCT03098030|2262685|FG003|Overall Study|Lost to Follow-up|1
1150579|NCT03098433|2262718|FG000|Overall Study|Withdrawal by Subject|10
1150580|NCT03098550|2262726|FG000|Overall Study|Disease Progression|30
1150581|NCT03098550|2262727|FG001|Overall Study|Disease Progression|19
1150582|NCT03098550|2262728|FG002|Overall Study|Disease Progression|41
1150583|NCT03098550|2262726|FG000|Overall Study|Study Drug Toxicity|2
1150584|NCT03098550|2262727|FG001|Overall Study|Study Drug Toxicity|1
1150585|NCT03098550|2262728|FG002|Overall Study|Study Drug Toxicity|0
1150586|NCT03098550|2262726|FG000|Overall Study|Death|1
1150587|NCT03098550|2262727|FG001|Overall Study|Death|0
1150588|NCT03098550|2262728|FG002|Overall Study|Death|0
1150589|NCT03098550|2262726|FG000|Overall Study|Adverse Event unrelated to Study Drug|6
1150590|NCT03098550|2262727|FG001|Overall Study|Adverse Event unrelated to Study Drug|0
1150591|NCT03098550|2262728|FG002|Overall Study|Adverse Event unrelated to Study Drug|1
1150592|NCT03098550|2262726|FG000|Overall Study|Administrative reason by sponsor|0
1150593|NCT03098550|2262727|FG001|Overall Study|Administrative reason by sponsor|0
1150594|NCT03098550|2262728|FG002|Overall Study|Administrative reason by sponsor|1
1150595|NCT03098550|2262726|FG000|Overall Study|Other reasons|2
1150596|NCT03098550|2262727|FG001|Overall Study|Other reasons|0
1150597|NCT03098550|2262728|FG002|Overall Study|Other reasons|0
1150598|NCT03098979|2262773|FG000|Overall Study|Adverse Event|1
1150599|NCT03098979|2262774|FG001|Overall Study|Adverse Event|0
1150600|NCT03098979|2262775|FG002|Overall Study|Adverse Event|1
1150601|NCT03098979|2262776|FG003|Overall Study|Adverse Event|4
1150602|NCT03098979|2262777|FG004|Overall Study|Adverse Event|6
1150603|NCT03098979|2262778|FG005|Overall Study|Adverse Event|1
1150604|NCT03098979|2262773|FG000|Overall Study|Withdrawal by Subject|2
1150605|NCT03098979|2262774|FG001|Overall Study|Withdrawal by Subject|1
1150606|NCT03098979|2262775|FG002|Overall Study|Withdrawal by Subject|1
1150607|NCT03098979|2262776|FG003|Overall Study|Withdrawal by Subject|1
1150608|NCT03098979|2262777|FG004|Overall Study|Withdrawal by Subject|2
1150609|NCT03098979|2262778|FG005|Overall Study|Withdrawal by Subject|1
1150610|NCT03098979|2262773|FG000|Overall Study|Death|1
1150611|NCT03098979|2262774|FG001|Overall Study|Death|0
1150612|NCT03098979|2262775|FG002|Overall Study|Death|2
903124|NCT00745095|1877126|FG005|Overall Study|Declined to participate|95
903125|NCT00745095|1877121|FG000|Overall Study|Ineligible due to GFR criteria|0
903126|NCT00745095|1877122|FG001|Overall Study|Ineligible due to GFR criteria|2
903127|NCT00745095|1877123|FG002|Overall Study|Ineligible due to GFR criteria|3
903128|NCT00745095|1877124|FG003|Overall Study|Ineligible due to GFR criteria|3
903129|NCT00745095|1877125|FG004|Overall Study|Ineligible due to GFR criteria|30
903130|NCT00745095|1877126|FG005|Overall Study|Ineligible due to GFR criteria|28
903131|NCT00745121|1877145|FG000|Overall Study|Death|3
903132|NCT00745121|1877146|FG001|Overall Study|Death|0
903133|NCT00745121|1877145|FG000|Overall Study|Adverse Event|1
903134|NCT00745121|1877146|FG001|Overall Study|Adverse Event|0
903135|NCT00745121|1877145|FG000|Overall Study|Lost to Follow-up|1
903136|NCT00745121|1877146|FG001|Overall Study|Lost to Follow-up|0
903137|NCT00745121|1877145|FG000|Overall Study|Withdrawal by Subject|4
903138|NCT00745121|1877146|FG001|Overall Study|Withdrawal by Subject|2
903139|NCT00745251|1877154|FG000|Overall Study|Adverse Event|1
903140|NCT00745251|1877155|FG001|Overall Study|Adverse Event|2
903141|NCT00745251|1877154|FG000|Overall Study|Withdrawal by Subject|1
903142|NCT00745251|1877155|FG001|Overall Study|Withdrawal by Subject|1
903143|NCT00745368|1877170|FG000|Overall Study|Unable to provide sample|3
903144|NCT00745420|1877174|FG000|Overall Study|Ineligible|1
903145|NCT00745498|1877181|FG000|Overall Study|Lost to Follow-up|1
903146|NCT00745498|1877182|FG001|Overall Study|Lost to Follow-up|1
903147|NCT00745498|1877183|FG002|Overall Study|Lost to Follow-up|3
903148|NCT00745498|1877181|FG000|Overall Study|Injection of intravitreal silicone oil o|3
903149|NCT00745498|1877182|FG001|Overall Study|Injection of intravitreal silicone oil o|4
903150|NCT00745498|1877183|FG002|Overall Study|Injection of intravitreal silicone oil o|4
903151|NCT00745498|1877181|FG000|Overall Study|Non-PDR related VH|0
903152|NCT00745498|1877182|FG001|Overall Study|Non-PDR related VH|1
903153|NCT00745498|1877183|FG002|Overall Study|Non-PDR related VH|1
903154|NCT00745498|1877181|FG000|Overall Study|Edophthalmitis after preoperative IVB|1
903155|NCT00745498|1877182|FG001|Overall Study|Edophthalmitis after preoperative IVB|0
903156|NCT00745498|1877183|FG002|Overall Study|Edophthalmitis after preoperative IVB|0
903157|NCT00745615|1877195|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
903158|NCT00745615|1877196|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
903159|NCT00745615|1877197|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
903160|NCT00745615|1877198|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
903161|NCT00745615|1877199|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
903162|NCT00745615|1877200|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
903163|NCT00745615|1877195|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0
903164|NCT00745615|1877196|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1
1150613|NCT03098979|2262776|FG003|Overall Study|Death|0
1150614|NCT03098979|2262777|FG004|Overall Study|Death|1
1150615|NCT03098979|2262778|FG005|Overall Study|Death|0
1150616|NCT03098979|2262773|FG000|Overall Study|Physician Decision|2
1150617|NCT03098979|2262774|FG001|Overall Study|Physician Decision|1
1150618|NCT03098979|2262775|FG002|Overall Study|Physician Decision|0
1150619|NCT03098979|2262776|FG003|Overall Study|Physician Decision|0
1150620|NCT03098979|2262777|FG004|Overall Study|Physician Decision|0
1150621|NCT03098979|2262778|FG005|Overall Study|Physician Decision|0
1150622|NCT03098979|2262773|FG000|Overall Study|Non-compliance|0
1150623|NCT03098979|2262774|FG001|Overall Study|Non-compliance|0
1150624|NCT03098979|2262775|FG002|Overall Study|Non-compliance|0
1150625|NCT03098979|2262776|FG003|Overall Study|Non-compliance|0
1150626|NCT03098979|2262777|FG004|Overall Study|Non-compliance|0
1150627|NCT03098979|2262778|FG005|Overall Study|Non-compliance|1
1150628|NCT03098979|2262773|FG000|Overall Study|Protocol Violation|0
1150629|NCT03098979|2262774|FG001|Overall Study|Protocol Violation|0
1150630|NCT03098979|2262775|FG002|Overall Study|Protocol Violation|0
1150631|NCT03098979|2262776|FG003|Overall Study|Protocol Violation|0
1150632|NCT03098979|2262777|FG004|Overall Study|Protocol Violation|0
1150633|NCT03098979|2262778|FG005|Overall Study|Protocol Violation|1
1150634|NCT03099096|2262792|FG000|Overall Study|Adverse Event|1
1150635|NCT03099096|2262792|FG000|Overall Study|Physician Decision|1
1150636|NCT03099161|2262799|FG000|Overall Study|Adverse Event|0
1150637|NCT03099161|2262800|FG001|Overall Study|Adverse Event|0
1150638|NCT03099161|2262801|FG002|Overall Study|Adverse Event|2
1150639|NCT03099161|2262799|FG000|Overall Study|Physician Decision|2
1150640|NCT03099161|2262800|FG001|Overall Study|Physician Decision|0
1150641|NCT03099161|2262801|FG002|Overall Study|Physician Decision|0
1150642|NCT03099161|2262799|FG000|Overall Study|Progressive Disease|1
1150643|NCT03099161|2262800|FG001|Overall Study|Progressive Disease|4
1150644|NCT03099161|2262801|FG002|Overall Study|Progressive Disease|1
1150645|NCT03099187|2262811|FG000|Double-blind Treatment|Adverse Event|19
1150646|NCT03099187|2262812|FG001|Double-blind Treatment|Adverse Event|1
1150647|NCT03099187|2262813|FG002|Double-blind Treatment|Adverse Event|0
1150648|NCT03099187|2262814|FG003|Double-blind Treatment|Adverse Event|0
1150649|NCT03099187|2262811|FG000|Double-blind Treatment|Death|1
1150650|NCT03099187|2262812|FG001|Double-blind Treatment|Death|3
1150651|NCT03099187|2262813|FG002|Double-blind Treatment|Death|0
1150652|NCT03099187|2262814|FG003|Double-blind Treatment|Death|0
1150653|NCT03099187|2262811|FG000|Double-blind Treatment|Lack of Efficacy|1
1150654|NCT03099187|2262812|FG001|Double-blind Treatment|Lack of Efficacy|0
1150655|NCT03099187|2262813|FG002|Double-blind Treatment|Lack of Efficacy|0
1150656|NCT03099187|2262814|FG003|Double-blind Treatment|Lack of Efficacy|0
1150657|NCT03099187|2262811|FG000|Double-blind Treatment|Physician Decision|2
1150658|NCT03099187|2262812|FG001|Double-blind Treatment|Physician Decision|1
1150659|NCT03099187|2262813|FG002|Double-blind Treatment|Physician Decision|0
1150660|NCT03099187|2262814|FG003|Double-blind Treatment|Physician Decision|0
1150661|NCT03099187|2262811|FG000|Double-blind Treatment|Withdrawal by Subject|9
1150662|NCT03099187|2262812|FG001|Double-blind Treatment|Withdrawal by Subject|4
1150663|NCT03099187|2262813|FG002|Double-blind Treatment|Withdrawal by Subject|0
1150664|NCT03099187|2262814|FG003|Double-blind Treatment|Withdrawal by Subject|0
1150665|NCT03099187|2262811|FG000|Double-blind Treatment|Lung transplantation|0
1150666|NCT03099187|2262812|FG001|Double-blind Treatment|Lung transplantation|1
1150667|NCT03099187|2262813|FG002|Double-blind Treatment|Lung transplantation|0
1150668|NCT03099187|2262814|FG003|Double-blind Treatment|Lung transplantation|0
1150669|NCT03099187|2262811|FG000|Double-blind Treatment|Non-compliance with study drug|0
1150670|NCT03099187|2262812|FG001|Double-blind Treatment|Non-compliance with study drug|2
1150671|NCT03099187|2262813|FG002|Double-blind Treatment|Non-compliance with study drug|0
1150672|NCT03099187|2262814|FG003|Double-blind Treatment|Non-compliance with study drug|0
1150673|NCT03099187|2262811|FG000|Double-blind Treatment|Disease progression|0
1150674|NCT03099187|2262812|FG001|Double-blind Treatment|Disease progression|1
903165|NCT00745615|1877197|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0
903166|NCT00745615|1877198|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0
903167|NCT00745615|1877199|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0
903168|NCT00745615|1877200|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0
903169|NCT00745615|1877195|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2
903170|NCT00745615|1877196|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3
903171|NCT00745615|1877197|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1
903172|NCT00745615|1877198|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1
903173|NCT00745615|1877199|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0
903174|NCT00745615|1877200|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0
903175|NCT00745615|1877195|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0
903176|NCT00745615|1877196|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1
903177|NCT00745615|1877197|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0
903178|NCT00745615|1877198|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0
903179|NCT00745615|1877199|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0
903180|NCT00745615|1877200|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0
903181|NCT00745615|1877195|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0
903182|NCT00745615|1877196|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1
903183|NCT00745615|1877197|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0
1150675|NCT03099187|2262813|FG002|Double-blind Treatment|Disease progression|0
1150676|NCT03099187|2262814|FG003|Double-blind Treatment|Disease progression|0
1150677|NCT03099187|2262811|FG000|Double-blind Treatment|Randomization error|0
1150678|NCT03099187|2262812|FG001|Double-blind Treatment|Randomization error|2
1150679|NCT03099187|2262813|FG002|Double-blind Treatment|Randomization error|0
1150680|NCT03099187|2262814|FG003|Double-blind Treatment|Randomization error|0
1150681|NCT03099187|2262811|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1
1150682|NCT03099187|2262812|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1
903184|NCT00745615|1877198|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0
903185|NCT00745615|1877199|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0
903186|NCT00745615|1877200|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0
903187|NCT00745615|1877195|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
903188|NCT00745615|1877196|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
903189|NCT00745615|1877197|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
903190|NCT00745615|1877198|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
903191|NCT00745615|1877199|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
903192|NCT00745615|1877200|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
903193|NCT00745615|1877195|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
903194|NCT00745615|1877196|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
903195|NCT00745615|1877197|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
903196|NCT00745615|1877198|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
903197|NCT00745615|1877199|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
903198|NCT00745615|1877200|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
903199|NCT00745615|1877195|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
903200|NCT00745615|1877196|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
903201|NCT00745615|1877197|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
903202|NCT00745615|1877198|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
903203|NCT00745615|1877199|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
903204|NCT00745615|1877200|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
903205|NCT00745615|1877195|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
903206|NCT00745615|1877196|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
903207|NCT00745615|1877197|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
903208|NCT00745615|1877198|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
903209|NCT00745615|1877199|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
903210|NCT00745615|1877200|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
903211|NCT00745615|1877195|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
903212|NCT00745615|1877196|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
903213|NCT00745615|1877197|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
903214|NCT00745615|1877198|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
903215|NCT00745615|1877199|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
903216|NCT00745615|1877200|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
903217|NCT00745615|1877195|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
903218|NCT00745615|1877196|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
903219|NCT00745615|1877197|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
903220|NCT00745615|1877198|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
903221|NCT00745615|1877199|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
903222|NCT00745615|1877200|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
903223|NCT00745615|1877195|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
903224|NCT00745615|1877196|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
903225|NCT00745615|1877197|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
903226|NCT00745615|1877198|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
903227|NCT00745615|1877199|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
903228|NCT00745615|1877200|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
903229|NCT00745615|1877195|FG000|Open-Label (up to Approx 10.5 Years)|Death|0
903230|NCT00745615|1877196|FG001|Open-Label (up to Approx 10.5 Years)|Death|0
903231|NCT00745615|1877197|FG002|Open-Label (up to Approx 10.5 Years)|Death|0
903232|NCT00745615|1877198|FG003|Open-Label (up to Approx 10.5 Years)|Death|0
903233|NCT00745615|1877199|FG004|Open-Label (up to Approx 10.5 Years)|Death|0
903234|NCT00745615|1877200|FG005|Open-Label (up to Approx 10.5 Years)|Death|1
903235|NCT00745615|1877195|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
903236|NCT00745615|1877196|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
903237|NCT00745615|1877197|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
903238|NCT00745615|1877198|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
903239|NCT00745615|1877199|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
903240|NCT00745615|1877200|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
903241|NCT00745823|1877214|FG000|Overall Study|Adverse Event|5
903242|NCT00745823|1877215|FG001|Overall Study|Adverse Event|3
903243|NCT00745823|1877214|FG000|Overall Study|Lack of Efficacy|20
903244|NCT00745823|1877215|FG001|Overall Study|Lack of Efficacy|6
903245|NCT00745823|1877214|FG000|Overall Study|Lost to Follow-up|10
903246|NCT00745823|1877215|FG001|Overall Study|Lost to Follow-up|11
903247|NCT00745823|1877214|FG000|Overall Study|Physician Decision|10
1150683|NCT03099187|2262813|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0
1150684|NCT03099187|2262814|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0
1150685|NCT03099187|2262811|FG000|12-month Safety Follow-up|Adverse Event|0
1150686|NCT03099187|2262812|FG001|12-month Safety Follow-up|Adverse Event|0
1150687|NCT03099187|2262813|FG002|12-month Safety Follow-up|Adverse Event|5
1150688|NCT03099187|2262814|FG003|12-month Safety Follow-up|Adverse Event|12
1150689|NCT03099187|2262811|FG000|12-month Safety Follow-up|Death|0
1150690|NCT03099187|2262812|FG001|12-month Safety Follow-up|Death|0
1150691|NCT03099187|2262813|FG002|12-month Safety Follow-up|Death|7
1150692|NCT03099187|2262814|FG003|12-month Safety Follow-up|Death|9
1150693|NCT03099187|2262811|FG000|12-month Safety Follow-up|Lung transplantation|0
1150694|NCT03099187|2262812|FG001|12-month Safety Follow-up|Lung transplantation|0
1150695|NCT03099187|2262813|FG002|12-month Safety Follow-up|Lung transplantation|2
1150696|NCT03099187|2262814|FG003|12-month Safety Follow-up|Lung transplantation|1
1150697|NCT03099187|2262811|FG000|12-month Safety Follow-up|Lost to Follow-up|0
1150698|NCT03099187|2262812|FG001|12-month Safety Follow-up|Lost to Follow-up|0
1150699|NCT03099187|2262813|FG002|12-month Safety Follow-up|Lost to Follow-up|1
1150700|NCT03099187|2262814|FG003|12-month Safety Follow-up|Lost to Follow-up|0
1150701|NCT03099187|2262811|FG000|12-month Safety Follow-up|Symptomatic deterioration|0
1150702|NCT03099187|2262812|FG001|12-month Safety Follow-up|Symptomatic deterioration|0
1150703|NCT03099187|2262813|FG002|12-month Safety Follow-up|Symptomatic deterioration|1
1150704|NCT03099187|2262814|FG003|12-month Safety Follow-up|Symptomatic deterioration|1
1150705|NCT03099187|2262811|FG000|12-month Safety Follow-up|Withdrawal by Subject|0
1150706|NCT03099187|2262812|FG001|12-month Safety Follow-up|Withdrawal by Subject|0
1150707|NCT03099187|2262813|FG002|12-month Safety Follow-up|Withdrawal by Subject|3
1150708|NCT03099187|2262814|FG003|12-month Safety Follow-up|Withdrawal by Subject|2
1150709|NCT03099187|2262811|FG000|12-month Safety Follow-up|Due to hospitalization|0
1150710|NCT03099187|2262812|FG001|12-month Safety Follow-up|Due to hospitalization|0
1150711|NCT03099187|2262813|FG002|12-month Safety Follow-up|Due to hospitalization|0
1150712|NCT03099187|2262814|FG003|12-month Safety Follow-up|Due to hospitalization|1
1150713|NCT03099538|2262834|FG000|Overall Study|Lack of Efficacy|3
1150714|NCT03099694|2262847|FG000|Overall Study|Withdrawal by Subject|11
1150715|NCT03099694|2262848|FG001|Overall Study|Withdrawal by Subject|13
1150716|NCT03099694|2262847|FG000|Overall Study|Lost to Follow-up|9
1150717|NCT03099694|2262848|FG001|Overall Study|Lost to Follow-up|5
1150718|NCT03100058|2262864|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1150719|NCT03100058|2262865|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1150720|NCT03100058|2262866|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
1150721|NCT03100058|2262867|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
1150722|NCT03100058|2262868|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
1150723|NCT03100058|2262869|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1150724|NCT03100058|2262870|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
1150725|NCT03100058|2262871|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
1150726|NCT03100058|2262872|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
1150727|NCT03100058|2262873|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1150728|NCT03100058|2262874|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1150729|NCT03100058|2262875|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1150730|NCT03100058|2262876|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1150731|NCT03100058|2262864|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
1150732|NCT03100058|2262865|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
1150733|NCT03100058|2262866|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
1150734|NCT03100058|2262867|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
1150735|NCT03100058|2262868|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
1150736|NCT03100058|2262869|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
1150737|NCT03100058|2262870|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
1150738|NCT03100058|2262871|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
1150739|NCT03100058|2262872|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
1150740|NCT03100058|2262873|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
1150741|NCT03100058|2262874|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
1150742|NCT03100058|2262875|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
1150743|NCT03100058|2262876|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
1150744|NCT03100058|2262864|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1150745|NCT03100058|2262865|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
1150746|NCT03100058|2262866|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
1150747|NCT03100058|2262867|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1150748|NCT03100058|2262868|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1150749|NCT03100058|2262869|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
1150750|NCT03100058|2262870|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
1150751|NCT03100058|2262871|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1150752|NCT03100058|2262872|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1150753|NCT03100058|2262873|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1150754|NCT03100058|2262874|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1150755|NCT03100058|2262875|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1150756|NCT03100058|2262876|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1150757|NCT03100058|2262864|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1150758|NCT03100058|2262865|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
1150759|NCT03100058|2262866|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
1150760|NCT03100058|2262867|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1150761|NCT03100058|2262868|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1150762|NCT03100058|2262869|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1150763|NCT03100058|2262870|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
1150764|NCT03100058|2262871|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1150765|NCT03100058|2262872|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
1150766|NCT03100058|2262873|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1150767|NCT03100058|2262874|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1150768|NCT03100058|2262875|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1150769|NCT03100058|2262876|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1150770|NCT03100058|2262864|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1150771|NCT03100058|2262865|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1150772|NCT03100058|2262866|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1150773|NCT03100058|2262867|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
903248|NCT00745823|1877215|FG001|Overall Study|Physician Decision|5
903249|NCT00745823|1877214|FG000|Overall Study|Pregnancy|0
903250|NCT00745823|1877215|FG001|Overall Study|Pregnancy|4
903251|NCT00745823|1877214|FG000|Overall Study|Withdrawal by Subject|14
903252|NCT00745823|1877215|FG001|Overall Study|Withdrawal by Subject|8
903253|NCT00745823|1877214|FG000|Overall Study|Study Terminated by Sponsor|326
903254|NCT00745823|1877215|FG001|Overall Study|Study Terminated by Sponsor|349
903255|NCT00745849|1877223|FG000|First Intervention|Withdrawal by Subject|0
903256|NCT00745849|1877224|FG001|First Intervention|Withdrawal by Subject|1
903257|NCT00745849|1877223|FG000|First Intervention|Lost to Follow-up|1
903258|NCT00745849|1877224|FG001|First Intervention|Lost to Follow-up|1
903259|NCT00745849|1877223|FG000|Second Intervention|Lost to Follow-up|2
903260|NCT00745849|1877224|FG001|Second Intervention|Lost to Follow-up|1
903261|NCT00745875|1877232|FG000|Overall Study|Continuing study treatment|4
903262|NCT00745875|1877233|FG001|Overall Study|Continuing study treatment|4
903263|NCT00745901|1877241|FG000|Overall Study|Adverse Event|3
903264|NCT00745901|1877242|FG001|Overall Study|Adverse Event|4
903265|NCT00745901|1877241|FG000|Overall Study|Protocol Violation|0
903266|NCT00745901|1877242|FG001|Overall Study|Protocol Violation|1
903267|NCT00745901|1877241|FG000|Overall Study|Withdrawal by Subject|1
903268|NCT00745901|1877242|FG001|Overall Study|Withdrawal by Subject|0
903269|NCT00745901|1877241|FG000|Overall Study|Lost to Follow-up|7
903270|NCT00745901|1877242|FG001|Overall Study|Lost to Follow-up|4
903271|NCT00745901|1877241|FG000|Overall Study|Pregnancy|2
903272|NCT00745901|1877242|FG001|Overall Study|Pregnancy|4
903273|NCT00745901|1877241|FG000|Overall Study|Lack of compliance|2
903274|NCT00745901|1877242|FG001|Overall Study|Lack of compliance|2
903275|NCT00745901|1877241|FG000|Overall Study|Patient's next menses did not start with|1
903276|NCT00745901|1877242|FG001|Overall Study|Patient's next menses did not start with|0
903277|NCT00745901|1877241|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0
903278|NCT00745901|1877242|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2
903279|NCT00745901|1877241|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1
903280|NCT00745901|1877242|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1
903281|NCT00745901|1877241|FG000|Overall Study|Patient didn't take any study medication|7
903282|NCT00745901|1877242|FG001|Overall Study|Patient didn't take any study medication|3
903283|NCT00746096|1877259|FG000|Overall Study|Adverse Event|1
903284|NCT00746096|1877260|FG001|Overall Study|Adverse Event|0
903285|NCT00746096|1877259|FG000|Overall Study|Withdrawal by Subject|5
903286|NCT00746096|1877260|FG001|Overall Study|Withdrawal by Subject|1
903287|NCT00746096|1877259|FG000|Overall Study|Lost to Follow-up|2
903288|NCT00746096|1877260|FG001|Overall Study|Lost to Follow-up|1
903289|NCT00746096|1877259|FG000|Overall Study|Protocol Violation|1
903290|NCT00746096|1877260|FG001|Overall Study|Protocol Violation|0
903291|NCT00746096|1877259|FG000|Overall Study|No study drug treatment|1
903292|NCT00746096|1877260|FG001|Overall Study|No study drug treatment|1
903293|NCT00746252|1877286|FG000|Overall Study|weight gain >7.5 %|1
903294|NCT00746252|1877287|FG001|Overall Study|weight gain >7.5 %|2
903295|NCT00746330|1877297|FG000|Period 1|Abnormal test procedure result|0
903296|NCT00746330|1877298|FG001|Period 1|Abnormal test procedure result|0
903297|NCT00746330|1877299|FG002|Period 1|Abnormal test procedure result|1
903298|NCT00746330|1877300|FG003|Period 1|Abnormal test procedure result|0
903299|NCT00746356|1877311|FG000|Overall Study|Withdrawal by Subject|2
903300|NCT00746356|1877312|FG001|Overall Study|Withdrawal by Subject|3
903301|NCT00746356|1877311|FG000|Overall Study|Death|7
903302|NCT00746356|1877312|FG001|Overall Study|Death|3
903303|NCT00746356|1877311|FG000|Overall Study|Lost to Follow-up|1
903304|NCT00746356|1877312|FG001|Overall Study|Lost to Follow-up|0
903305|NCT00746356|1877311|FG000|Overall Study|Removal of Device|0
903306|NCT00746356|1877312|FG001|Overall Study|Removal of Device|1
903307|NCT00746356|1877311|FG000|Overall Study|Patient relocated|1
903308|NCT00746356|1877312|FG001|Overall Study|Patient relocated|0
1150774|NCT03100058|2262868|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1150775|NCT03100058|2262869|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1150776|NCT03100058|2262870|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
903309|NCT00746551|1877357|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2
903310|NCT00746551|1877358|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4
903311|NCT00746551|1877357|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
903312|NCT00746551|1877358|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
903313|NCT00746551|1877357|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
903314|NCT00746551|1877358|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
903315|NCT00746564|1877364|FG000|Overall Study|Required Pacemaker/ICD Implant|2
903316|NCT00746590|1877370|FG000|Overall Study|Death|1
903317|NCT00746733|1877397|FG000|Second Intervention|Adverse Event|1
903318|NCT00746733|1877398|FG001|Second Intervention|Adverse Event|0
903319|NCT00746733|1877397|FG000|Third Intervention|Withdrawal by Subject|1
903320|NCT00746733|1877398|FG001|Third Intervention|Withdrawal by Subject|1
903321|NCT00746785|1877414|FG000|Overall Study|Lost to Follow-up|29
903322|NCT00746785|1877415|FG001|Overall Study|Lost to Follow-up|25
903323|NCT00746785|1877416|FG002|Overall Study|Lost to Follow-up|27
903324|NCT00746798|1877428|FG000|Overall Study|Protocol Violation|0
903325|NCT00746798|1877429|FG001|Overall Study|Protocol Violation|1
903326|NCT00746798|1877430|FG002|Overall Study|Protocol Violation|0
903327|NCT00746798|1877431|FG003|Overall Study|Protocol Violation|0
903328|NCT00746798|1877428|FG000|Overall Study|Withdrawal by Subject|0
903329|NCT00746798|1877429|FG001|Overall Study|Withdrawal by Subject|1
903330|NCT00746798|1877430|FG002|Overall Study|Withdrawal by Subject|1
903331|NCT00746798|1877431|FG003|Overall Study|Withdrawal by Subject|0
903332|NCT00746798|1877428|FG000|Overall Study|Death|0
903333|NCT00746798|1877429|FG001|Overall Study|Death|0
903334|NCT00746798|1877430|FG002|Overall Study|Death|2
903335|NCT00746798|1877431|FG003|Overall Study|Death|0
903336|NCT00746798|1877428|FG000|Overall Study|Participant unable to return for visit|1
903337|NCT00746798|1877429|FG001|Overall Study|Participant unable to return for visit|0
903338|NCT00746798|1877430|FG002|Overall Study|Participant unable to return for visit|0
903339|NCT00746798|1877431|FG003|Overall Study|Participant unable to return for visit|0
903340|NCT00746941|1877465|FG000|Overall Study|Death|2
903341|NCT00746941|1877466|FG001|Overall Study|Death|0
903342|NCT00746941|1877467|FG002|Overall Study|Death|0
903343|NCT00746941|1877468|FG003|Overall Study|Death|6
903344|NCT00746941|1877465|FG000|Overall Study|Physician Decision|0
903345|NCT00746941|1877466|FG001|Overall Study|Physician Decision|0
903346|NCT00746941|1877467|FG002|Overall Study|Physician Decision|2
903347|NCT00746941|1877468|FG003|Overall Study|Physician Decision|0
903348|NCT00746941|1877465|FG000|Overall Study|Withdrawal by Subject|3
903349|NCT00746941|1877466|FG001|Overall Study|Withdrawal by Subject|0
903350|NCT00746941|1877467|FG002|Overall Study|Withdrawal by Subject|0
903351|NCT00746941|1877468|FG003|Overall Study|Withdrawal by Subject|2
903352|NCT00746941|1877465|FG000|Overall Study|Other, reason not provided|2
903353|NCT00746941|1877466|FG001|Overall Study|Other, reason not provided|4
903354|NCT00746941|1877467|FG002|Overall Study|Other, reason not provided|0
903355|NCT00746941|1877468|FG003|Overall Study|Other, reason not provided|4
903356|NCT00746941|1877465|FG000|Overall Study|Adverse Event|0
903357|NCT00746941|1877466|FG001|Overall Study|Adverse Event|0
903358|NCT00746941|1877467|FG002|Overall Study|Adverse Event|0
903359|NCT00746941|1877468|FG003|Overall Study|Adverse Event|1
903360|NCT00747006|1877488|FG000|Overall Study|Adverse Event|1
903361|NCT00747006|1877489|FG001|Overall Study|Adverse Event|0
903362|NCT00747006|1877490|FG002|Overall Study|Adverse Event|0
903363|NCT00747006|1877488|FG000|Overall Study|Lost to Follow-up|0
903364|NCT00747006|1877489|FG001|Overall Study|Lost to Follow-up|1
903365|NCT00747006|1877490|FG002|Overall Study|Lost to Follow-up|0
903366|NCT00747006|1877488|FG000|Overall Study|Physician Decision|2
903367|NCT00747006|1877489|FG001|Overall Study|Physician Decision|0
903368|NCT00747006|1877490|FG002|Overall Study|Physician Decision|1
903369|NCT00747149|1877503|FG000|Overall Study|Adverse Event|0
903370|NCT00747149|1877504|FG001|Overall Study|Adverse Event|15
903371|NCT00747149|1877503|FG000|Overall Study|Lost to Follow-up|0
903372|NCT00747149|1877504|FG001|Overall Study|Lost to Follow-up|10
903373|NCT00747149|1877503|FG000|Overall Study|Withdrawal by Subject|0
903374|NCT00747149|1877504|FG001|Overall Study|Withdrawal by Subject|6
903375|NCT00747149|1877503|FG000|Overall Study|Did not receive treatment|0
903376|NCT00747149|1877504|FG001|Overall Study|Did not receive treatment|1
903377|NCT00747149|1877503|FG000|Overall Study|Incorrect enrollment|0
903378|NCT00747149|1877504|FG001|Overall Study|Incorrect enrollment|6
903379|NCT00747149|1877503|FG000|Overall Study|Severe non-compliance to protocol|0
903380|NCT00747149|1877504|FG001|Overall Study|Severe non-compliance to protocol|1
903381|NCT00747149|1877503|FG000|Overall Study|Not reported|1
903382|NCT00747149|1877504|FG001|Overall Study|Not reported|4
903383|NCT00747227|1877527|FG000|Overall Study|Death|3
903384|NCT00747227|1877528|FG001|Overall Study|Death|1
903385|NCT00747227|1877527|FG000|Overall Study|Withdrawal by Subject|1
903386|NCT00747227|1877528|FG001|Overall Study|Withdrawal by Subject|0
903387|NCT00747227|1877527|FG000|Overall Study|Lost to Follow-up|1
903388|NCT00747227|1877528|FG001|Overall Study|Lost to Follow-up|2
1150777|NCT03100058|2262871|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
1150778|NCT03100058|2262872|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
903389|NCT00747227|1877527|FG000|Overall Study|Illness|1
903390|NCT00747227|1877528|FG001|Overall Study|Illness|1
903391|NCT00747344|1877536|FG000|Controlled Period|Adverse Event|3
903392|NCT00747344|1877537|FG001|Controlled Period|Adverse Event|0
903393|NCT00747344|1877538|FG002|Controlled Period|Adverse Event|0
903394|NCT00747344|1877539|FG003|Controlled Period|Adverse Event|0
903395|NCT00747344|1877536|FG000|Controlled Period|Lack of Efficacy|2
903396|NCT00747344|1877537|FG001|Controlled Period|Lack of Efficacy|1
903397|NCT00747344|1877538|FG002|Controlled Period|Lack of Efficacy|0
903398|NCT00747344|1877539|FG003|Controlled Period|Lack of Efficacy|0
903399|NCT00747344|1877536|FG000|Controlled Period|Other|0
903400|NCT00747344|1877537|FG001|Controlled Period|Other|3
903401|NCT00747344|1877538|FG002|Controlled Period|Other|0
903402|NCT00747344|1877539|FG003|Controlled Period|Other|0
903403|NCT00747344|1877536|FG000|After Controlled Period|Adverse Event|0
903404|NCT00747344|1877537|FG001|After Controlled Period|Adverse Event|0
903405|NCT00747344|1877538|FG002|After Controlled Period|Adverse Event|0
903406|NCT00747344|1877539|FG003|After Controlled Period|Adverse Event|1
903407|NCT00747435|1877547|FG000|Overall Study|Lost to Follow-up|2
903408|NCT00747435|1877547|FG000|Overall Study|Withdrawal by Subject|3
903409|NCT00747435|1877547|FG000|Overall Study|Still undergoing follow up|1
903410|NCT00747474|1877551|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
903411|NCT00747474|1877552|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
903412|NCT00747474|1877553|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
903413|NCT00747474|1877554|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
903414|NCT00747474|1877555|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
903415|NCT00747474|1877556|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
903416|NCT00747474|1877557|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
903417|NCT00747474|1877558|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
903418|NCT00747474|1877559|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
903419|NCT00747474|1877560|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
903420|NCT00747474|1877561|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
903421|NCT00747474|1877562|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
903422|NCT00747565|1877573|FG000|Overall Study|Withdrawal by Subject|10
903423|NCT00747565|1877574|FG001|Overall Study|Withdrawal by Subject|6
903424|NCT00747565|1877573|FG000|Overall Study|Lost to Follow-up|4
903425|NCT00747565|1877574|FG001|Overall Study|Lost to Follow-up|1
903426|NCT00747617|1877582|FG000|Overall Study|Lost to Follow-up|3
903427|NCT00747617|1877583|FG001|Overall Study|Lost to Follow-up|1
903428|NCT00747643|1877591|FG000|Overall Study|Withdrawal by Subject|36
903429|NCT00747643|1877592|FG001|Overall Study|Withdrawal by Subject|27
903430|NCT00747812|1877613|FG000|Overall Study|Research Site Staff Relocation|5
903431|NCT00747812|1877614|FG001|Overall Study|Research Site Staff Relocation|3
903432|NCT00748033|1877622|FG000|Overall Study|Adverse Event|0
903433|NCT00748033|1877623|FG001|Overall Study|Adverse Event|1
903434|NCT00748098|1877646|FG000|First Treatment Intervention Period|Adverse Event|1
903435|NCT00748098|1877647|FG001|First Treatment Intervention Period|Adverse Event|1
903436|NCT00748098|1877646|FG000|First Treatment Intervention Period|Protocol Violation|1
903437|NCT00748098|1877647|FG001|First Treatment Intervention Period|Protocol Violation|0
903438|NCT00748098|1877646|FG000|First Treatment Intervention Period|Lost to Follow-up|1
903439|NCT00748098|1877647|FG001|First Treatment Intervention Period|Lost to Follow-up|0
903440|NCT00748098|1877646|FG000|First Treatment Intervention Period|Withdrawal by Subject|2
903441|NCT00748098|1877647|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
903442|NCT00748098|1877646|FG000|First Taper Period|Protocol Violation|1
903443|NCT00748098|1877647|FG001|First Taper Period|Protocol Violation|0
903444|NCT00748098|1877646|FG000|First Taper Period|Withdrawal by Subject|2
903445|NCT00748098|1877647|FG001|First Taper Period|Withdrawal by Subject|0
903446|NCT00748098|1877646|FG000|First Taper Period|Protocol Stopping Criteria Met|0
903447|NCT00748098|1877647|FG001|First Taper Period|Protocol Stopping Criteria Met|1
903448|NCT00748098|1877646|FG000|1-Week Washout Period|Adverse Event|0
903449|NCT00748098|1877647|FG001|1-Week Washout Period|Adverse Event|1
903450|NCT00748098|1877646|FG000|1-Week Washout Period|Withdrawal by Subject|2
903451|NCT00748098|1877647|FG001|1-Week Washout Period|Withdrawal by Subject|0
903452|NCT00748098|1877646|FG000|Second Treatment Intervention Period|Adverse Event|4
903453|NCT00748098|1877647|FG001|Second Treatment Intervention Period|Adverse Event|1
903454|NCT00748098|1877646|FG000|Second Treatment Intervention Period|Lost to Follow-up|1
903455|NCT00748098|1877647|FG001|Second Treatment Intervention Period|Lost to Follow-up|1
903456|NCT00748098|1877646|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1
903457|NCT00748098|1877647|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1
903458|NCT00748189|1877656|FG000|Overall Study|Death|99
903459|NCT00748189|1877657|FG001|Overall Study|Death|84
903460|NCT00748189|1877656|FG000|Overall Study|Withdrawal by Subject|23
903461|NCT00748189|1877657|FG001|Overall Study|Withdrawal by Subject|29
903462|NCT00748189|1877656|FG000|Overall Study|Physician Decision|16
903463|NCT00748189|1877657|FG001|Overall Study|Physician Decision|5
903464|NCT00748189|1877656|FG000|Overall Study|Lost to Follow-up|8
1150779|NCT03100058|2262873|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1150780|NCT03100058|2262874|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1150781|NCT03100058|2262875|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1150782|NCT03100058|2262876|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1150783|NCT03100058|2262864|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1150784|NCT03100058|2262865|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1150785|NCT03100058|2262866|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1150786|NCT03100058|2262867|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
1150787|NCT03100058|2262868|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1150788|NCT03100058|2262869|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1150789|NCT03100058|2262870|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
1150790|NCT03100058|2262871|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1150791|NCT03100058|2262872|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1150792|NCT03100058|2262873|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1150793|NCT03100058|2262874|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1150794|NCT03100058|2262875|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1150795|NCT03100058|2262876|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1150796|NCT03100058|2262864|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0
1150797|NCT03100058|2262865|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1
1150798|NCT03100058|2262866|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0
1150799|NCT03100058|2262867|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0
1150800|NCT03100058|2262868|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0
1150801|NCT03100058|2262869|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0
1150802|NCT03100058|2262870|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0
1150803|NCT03100058|2262871|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0
1150804|NCT03100058|2262872|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0
1150805|NCT03100058|2262873|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0
1150806|NCT03100058|2262874|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0
1150807|NCT03100058|2262875|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0
1150808|NCT03100058|2262876|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0
1150809|NCT03100058|2262864|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
1150810|NCT03100058|2262865|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150811|NCT03100058|2262866|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150812|NCT03100058|2262867|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150813|NCT03100058|2262868|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150814|NCT03100058|2262869|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150815|NCT03100058|2262870|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150816|NCT03100058|2262871|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150817|NCT03100058|2262872|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150818|NCT03100058|2262873|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150819|NCT03100058|2262874|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150820|NCT03100058|2262875|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150821|NCT03100058|2262876|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1150822|NCT03100058|2262864|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150823|NCT03100058|2262865|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150824|NCT03100058|2262866|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150825|NCT03100058|2262867|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150826|NCT03100058|2262868|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150827|NCT03100058|2262869|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150828|NCT03100058|2262870|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
1150829|NCT03100058|2262871|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150830|NCT03100058|2262872|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150831|NCT03100058|2262873|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150832|NCT03100058|2262874|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150833|NCT03100058|2262875|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150834|NCT03100058|2262876|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1150835|NCT03100058|2262864|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1150836|NCT03100058|2262865|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1150837|NCT03100058|2262866|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1150838|NCT03100058|2262867|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1150839|NCT03100058|2262868|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1150840|NCT03100058|2262869|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1150841|NCT03100058|2262870|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1150842|NCT03100058|2262871|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1150843|NCT03100058|2262872|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1150844|NCT03100058|2262873|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1150845|NCT03100058|2262874|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
1150846|NCT03100058|2262875|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
1150847|NCT03100058|2262876|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
1150848|NCT03100058|2262864|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1150849|NCT03100058|2262865|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1150850|NCT03100058|2262866|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1150851|NCT03100058|2262867|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1150852|NCT03100058|2262868|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1150853|NCT03100058|2262869|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1150854|NCT03100058|2262870|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1150855|NCT03100058|2262871|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1150856|NCT03100058|2262872|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1150857|NCT03100058|2262873|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1150858|NCT03100058|2262874|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
1150859|NCT03100058|2262875|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
1150860|NCT03100058|2262876|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1150861|NCT03100058|2262864|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1150862|NCT03100058|2262865|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1150863|NCT03100058|2262866|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1150864|NCT03100058|2262867|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1150865|NCT03100058|2262868|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1150866|NCT03100058|2262869|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1150867|NCT03100058|2262870|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1150868|NCT03100058|2262871|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1150869|NCT03100058|2262872|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1150870|NCT03100058|2262873|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
1150871|NCT03100058|2262874|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
1150872|NCT03100058|2262875|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1150873|NCT03100058|2262876|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
1150874|NCT03100058|2262864|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150875|NCT03100058|2262865|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150876|NCT03100058|2262866|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150877|NCT03100058|2262867|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150878|NCT03100058|2262868|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150879|NCT03100058|2262869|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150880|NCT03100058|2262870|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150881|NCT03100058|2262871|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150882|NCT03100058|2262872|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150883|NCT03100058|2262873|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150884|NCT03100058|2262874|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1
1150885|NCT03100058|2262875|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150886|NCT03100058|2262876|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1150887|NCT03100058|2262864|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150888|NCT03100058|2262865|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150889|NCT03100058|2262866|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150890|NCT03100058|2262867|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150891|NCT03100058|2262868|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150892|NCT03100058|2262869|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150893|NCT03100058|2262870|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150894|NCT03100058|2262871|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150895|NCT03100058|2262872|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150896|NCT03100058|2262873|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150897|NCT03100058|2262874|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150898|NCT03100058|2262875|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1150899|NCT03100058|2262876|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
1150900|NCT03100058|2262864|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150901|NCT03100058|2262865|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150902|NCT03100058|2262866|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150903|NCT03100058|2262867|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150904|NCT03100058|2262868|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150905|NCT03100058|2262869|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150906|NCT03100058|2262870|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150907|NCT03100058|2262871|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150908|NCT03100058|2262872|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150909|NCT03100058|2262873|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
1150910|NCT03100058|2262874|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150911|NCT03100058|2262875|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150912|NCT03100058|2262876|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1150922|NCT03100344|2262936|FG000|Overall Study|Adverse Event|0
1150923|NCT03100344|2262937|FG001|Overall Study|Adverse Event|3
1150924|NCT03100344|2262938|FG002|Overall Study|Adverse Event|2
1150925|NCT03100344|2262939|FG003|Overall Study|Adverse Event|3
1150926|NCT03100344|2262936|FG000|Overall Study|Lack of Efficacy|2
1150927|NCT03100344|2262937|FG001|Overall Study|Lack of Efficacy|0
1150928|NCT03100344|2262938|FG002|Overall Study|Lack of Efficacy|0
1150929|NCT03100344|2262939|FG003|Overall Study|Lack of Efficacy|0
1150930|NCT03100344|2262936|FG000|Overall Study|Protocol Violation|1
1150931|NCT03100344|2262937|FG001|Overall Study|Protocol Violation|0
1150932|NCT03100344|2262938|FG002|Overall Study|Protocol Violation|0
1150933|NCT03100344|2262939|FG003|Overall Study|Protocol Violation|0
1150934|NCT03100344|2262936|FG000|Overall Study|Withdrawal by Subject|10
1150935|NCT03100344|2262937|FG001|Overall Study|Withdrawal by Subject|7
1150936|NCT03100344|2262938|FG002|Overall Study|Withdrawal by Subject|4
1150937|NCT03100344|2262939|FG003|Overall Study|Withdrawal by Subject|8
1150938|NCT03100344|2262936|FG000|Overall Study|Lost to Follow-up|1
1150939|NCT03100344|2262937|FG001|Overall Study|Lost to Follow-up|1
1150940|NCT03100344|2262938|FG002|Overall Study|Lost to Follow-up|1
1150941|NCT03100344|2262939|FG003|Overall Study|Lost to Follow-up|1
1150942|NCT03100825|2262954|FG000|Overall Study|Participant/Guardian Decision|7
1150943|NCT03100825|2262954|FG000|Overall Study|Physician Decision|1
1150944|NCT03100838|2262958|FG000|Overall Study|Adverse Event|1
1150945|NCT03100838|2262959|FG001|Overall Study|Adverse Event|0
1150946|NCT03100838|2262960|FG002|Overall Study|Adverse Event|0
1150947|NCT03100838|2262961|FG003|Overall Study|Adverse Event|0
1150948|NCT03100838|2262958|FG000|Overall Study|Physician Decision|1
1150949|NCT03100838|2262959|FG001|Overall Study|Physician Decision|1
1150950|NCT03100838|2262960|FG002|Overall Study|Physician Decision|1
1150951|NCT03100838|2262961|FG003|Overall Study|Physician Decision|1
1150952|NCT03100838|2262958|FG000|Overall Study|Pregnancy|0
1150953|NCT03100838|2262959|FG001|Overall Study|Pregnancy|1
1150954|NCT03100838|2262960|FG002|Overall Study|Pregnancy|0
1150955|NCT03100838|2262961|FG003|Overall Study|Pregnancy|0
1150956|NCT03100838|2262958|FG000|Overall Study|Lost to Follow-up|0
1150957|NCT03100838|2262959|FG001|Overall Study|Lost to Follow-up|0
1150958|NCT03100838|2262960|FG002|Overall Study|Lost to Follow-up|1
1150959|NCT03100838|2262961|FG003|Overall Study|Lost to Follow-up|0
1150960|NCT03100942|2262979|FG000|Randomized Treatment Period|Withdrew Consent|4
1150961|NCT03100942|2262980|FG001|Randomized Treatment Period|Withdrew Consent|5
1150962|NCT03100942|2262981|FG002|Randomized Treatment Period|Withdrew Consent|3
1150963|NCT03100942|2262982|FG003|Randomized Treatment Period|Withdrew Consent|3
1150964|NCT03100942|2262983|FG004|Randomized Treatment Period|Withdrew Consent|0
1150965|NCT03100942|2262984|FG005|Randomized Treatment Period|Withdrew Consent|0
1150966|NCT03100942|2262985|FG006|Randomized Treatment Period|Withdrew Consent|0
1150967|NCT03100942|2262979|FG000|Randomized Treatment Period|Adverse Event|5
1150968|NCT03100942|2262980|FG001|Randomized Treatment Period|Adverse Event|2
1150969|NCT03100942|2262981|FG002|Randomized Treatment Period|Adverse Event|1
1150970|NCT03100942|2262982|FG003|Randomized Treatment Period|Adverse Event|0
1150971|NCT03100942|2262983|FG004|Randomized Treatment Period|Adverse Event|0
1150972|NCT03100942|2262984|FG005|Randomized Treatment Period|Adverse Event|0
1150973|NCT03100942|2262985|FG006|Randomized Treatment Period|Adverse Event|0
1150974|NCT03100942|2262979|FG000|Randomized Treatment Period|Investigator's Discretion|2
1150975|NCT03100942|2262980|FG001|Randomized Treatment Period|Investigator's Discretion|1
1150976|NCT03100942|2262981|FG002|Randomized Treatment Period|Investigator's Discretion|0
1150977|NCT03100942|2262982|FG003|Randomized Treatment Period|Investigator's Discretion|0
1150978|NCT03100942|2262983|FG004|Randomized Treatment Period|Investigator's Discretion|0
1150979|NCT03100942|2262984|FG005|Randomized Treatment Period|Investigator's Discretion|0
1150980|NCT03100942|2262985|FG006|Randomized Treatment Period|Investigator's Discretion|0
1150981|NCT03100942|2262979|FG000|Randomized Treatment Period|Protocol Violation|0
1150982|NCT03100942|2262980|FG001|Randomized Treatment Period|Protocol Violation|1
1150983|NCT03100942|2262981|FG002|Randomized Treatment Period|Protocol Violation|1
1150984|NCT03100942|2262982|FG003|Randomized Treatment Period|Protocol Violation|1
1150985|NCT03100942|2262983|FG004|Randomized Treatment Period|Protocol Violation|0
1150986|NCT03100942|2262984|FG005|Randomized Treatment Period|Protocol Violation|0
1150987|NCT03100942|2262985|FG006|Randomized Treatment Period|Protocol Violation|0
1150988|NCT03100942|2262979|FG000|Randomized Treatment Period|Lost to Follow-up|0
1150989|NCT03100942|2262980|FG001|Randomized Treatment Period|Lost to Follow-up|0
1150990|NCT03100942|2262981|FG002|Randomized Treatment Period|Lost to Follow-up|1
1150991|NCT03100942|2262982|FG003|Randomized Treatment Period|Lost to Follow-up|0
1150992|NCT03100942|2262983|FG004|Randomized Treatment Period|Lost to Follow-up|0
1150993|NCT03100942|2262984|FG005|Randomized Treatment Period|Lost to Follow-up|0
1150994|NCT03100942|2262985|FG006|Randomized Treatment Period|Lost to Follow-up|0
1150995|NCT03100942|2262979|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
1150996|NCT03100942|2262980|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
1150997|NCT03100942|2262981|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
1150998|NCT03100942|2262982|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
1150999|NCT03100942|2262983|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
1151000|NCT03100942|2262984|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
1151001|NCT03100942|2262985|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
1151002|NCT03100942|2262979|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0
1151003|NCT03100942|2262980|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0
1151004|NCT03100942|2262981|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0
1151005|NCT03100942|2262982|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0
1151006|NCT03100942|2262983|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0
1151007|NCT03100942|2262984|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0
1151008|NCT03100942|2262985|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1
1151009|NCT03101020|2263009|FG000|Overall Study|Lack of time to participate|1
1151010|NCT03101020|2263010|FG001|Overall Study|Lack of time to participate|0
1151011|NCT03101020|2263009|FG000|Overall Study|Ran over by a car|0
1151012|NCT03101020|2263010|FG001|Overall Study|Ran over by a car|1
1151013|NCT03101020|2263009|FG000|Overall Study|Withdrawal by Subject|0
1151014|NCT03101020|2263010|FG001|Overall Study|Withdrawal by Subject|2
1151015|NCT03101150|2263040|FG000|Overall Study|Lost to Follow-up|2
1151016|NCT03101150|2263041|FG001|Overall Study|Lost to Follow-up|4
1151017|NCT03101150|2263040|FG000|Overall Study|Miscarriage|3
1151018|NCT03101150|2263041|FG001|Overall Study|Miscarriage|6
1151019|NCT03101241|2263049|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4
1151020|NCT03101241|2263050|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2
1151021|NCT03101241|2263049|FG000|Overall Study|Participant withdrew consent|3
1151022|NCT03101241|2263050|FG001|Overall Study|Participant withdrew consent|1
1151023|NCT03101241|2263049|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2
1151024|NCT03101241|2263050|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0
1151025|NCT03101241|2263049|FG000|Overall Study|Lost to Follow-up|2
1151026|NCT03101241|2263050|FG001|Overall Study|Lost to Follow-up|0
1151027|NCT03101241|2263049|FG000|Overall Study|Lack of Efficacy|0
1151028|NCT03101241|2263050|FG001|Overall Study|Lack of Efficacy|1
1151029|NCT03101241|2263049|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0
1151030|NCT03101241|2263050|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1
1151031|NCT03101267|2263059|FG000|Primary Study Period|Withdrawal by Subject|1
1151032|NCT03101267|2263060|FG001|Primary Study Period|Withdrawal by Subject|2
1151033|NCT03101267|2263061|FG002|Primary Study Period|Withdrawal by Subject|3
1151034|NCT03101267|2263059|FG000|Primary Study Period|Miscellaneous|2
1151035|NCT03101267|2263060|FG001|Primary Study Period|Miscellaneous|0
1151036|NCT03101267|2263061|FG002|Primary Study Period|Miscellaneous|0
1151037|NCT03101293|2263071|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1
1151038|NCT03101293|2263072|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0
1151039|NCT03101358|2263082|FG000|Overall Study|Non-compliance with study schedule|1
1151040|NCT03101358|2263083|FG001|Overall Study|Non-compliance with study schedule|0
1151041|NCT03101358|2263084|FG002|Overall Study|Non-compliance with study schedule|0
1151042|NCT03101358|2263085|FG003|Overall Study|Non-compliance with study schedule|1
1151043|NCT03101358|2263082|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0
1151044|NCT03101358|2263083|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0
1151045|NCT03101358|2263084|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1
1151046|NCT03101358|2263085|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0
1151047|NCT03101358|2263082|FG000|Overall Study|Physician Decision|1
1151048|NCT03101358|2263083|FG001|Overall Study|Physician Decision|0
1151049|NCT03101358|2263084|FG002|Overall Study|Physician Decision|0
1151050|NCT03101358|2263085|FG003|Overall Study|Physician Decision|3
1151051|NCT03101358|2263082|FG000|Overall Study|Adverse Event|0
1151052|NCT03101358|2263083|FG001|Overall Study|Adverse Event|0
1151053|NCT03101358|2263084|FG002|Overall Study|Adverse Event|1
1151054|NCT03101358|2263085|FG003|Overall Study|Adverse Event|0
1151055|NCT03101358|2263082|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
1151056|NCT03101358|2263083|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
1151057|NCT03101358|2263084|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
1151058|NCT03101358|2263085|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1
1151059|NCT03101358|2263082|FG000|Overall Study|Lost to Follow-up|1
1151060|NCT03101358|2263083|FG001|Overall Study|Lost to Follow-up|0
1151061|NCT03101358|2263084|FG002|Overall Study|Lost to Follow-up|0
1151062|NCT03101358|2263085|FG003|Overall Study|Lost to Follow-up|1
1151063|NCT03101371|2263098|FG000|Overall Study|Physician Decision|0
1151064|NCT03101371|2263099|FG001|Overall Study|Physician Decision|1
1151065|NCT03101371|2263098|FG000|Overall Study|Lost to Follow-up|1
1151066|NCT03101371|2263099|FG001|Overall Study|Lost to Follow-up|4
1151067|NCT03101371|2263098|FG000|Overall Study|Did not meet eligibility criteria|2
1151068|NCT03101371|2263099|FG001|Overall Study|Did not meet eligibility criteria|1
1151069|NCT03101462|2263107|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1
1151070|NCT03101462|2263108|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1
1151071|NCT03101514|2263114|FG000|Overall Study|Withdrawal by Subject|4
1151072|NCT03101514|2263114|FG000|Overall Study|Protocol Violation|2
1151073|NCT03101514|2263114|FG000|Overall Study|patient's information was incomplete|1
1151074|NCT03101592|2263130|FG000|Overall Study|participant files could not be located|111
1151075|NCT03101592|2263131|FG001|Overall Study|participant files could not be located|170
1151076|NCT03101592|2263132|FG002|Overall Study|participant files could not be located|118
1151077|NCT03102034|2263148|FG000|Overall Study|Withdrawal by Subject|1
1151078|NCT03102034|2263149|FG001|Overall Study|Withdrawal by Subject|0
1151079|NCT03102710|2263186|FG000|Overall Study|Dental metal affected MRI scan quality|1
1151080|NCT03102710|2263187|FG001|Overall Study|Dental metal affected MRI scan quality|0
1151081|NCT03102710|2263188|FG002|Overall Study|Dental metal affected MRI scan quality|0
1151082|NCT03102710|2263186|FG000|Overall Study|Technical issues during final MRI scan|0
1151083|NCT03102710|2263187|FG001|Overall Study|Technical issues during final MRI scan|1
1151084|NCT03102710|2263188|FG002|Overall Study|Technical issues during final MRI scan|0
1151085|NCT03102710|2263186|FG000|Overall Study|Nausea during MRI scan|0
1151086|NCT03102710|2263187|FG001|Overall Study|Nausea during MRI scan|1
1151087|NCT03102710|2263188|FG002|Overall Study|Nausea during MRI scan|0
1151088|NCT03102710|2263186|FG000|Overall Study|Subject unable to attend final session|0
1151089|NCT03102710|2263187|FG001|Overall Study|Subject unable to attend final session|1
1151090|NCT03102710|2263188|FG002|Overall Study|Subject unable to attend final session|0
1151091|NCT03102762|2263207|FG000|Overall Study|Lost to Follow-up|1
1151092|NCT03102762|2263208|FG001|Overall Study|Lost to Follow-up|0
1151093|NCT03102918|2263230|FG000|Overall Study|Protocol Violation|1
1151094|NCT03102918|2263231|FG001|Overall Study|Protocol Violation|0
1151095|NCT03103100|2263244|FG000|Overall Study|Adverse Event|1
1151096|NCT03103100|2263245|FG001|Overall Study|Adverse Event|0
1151097|NCT03103100|2263246|FG002|Overall Study|Adverse Event|0
1151098|NCT03103100|2263244|FG000|Overall Study|Physician Decision|1
1151099|NCT03103100|2263245|FG001|Overall Study|Physician Decision|0
1151100|NCT03103100|2263246|FG002|Overall Study|Physician Decision|2
1151101|NCT03103503|2263287|FG000|Overall Study|Death|64
1151102|NCT03103503|2263287|FG000|Overall Study|Physician Decision|57
1151103|NCT03103503|2263287|FG000|Overall Study|Withdrawal by Subject|10
1151104|NCT03103503|2263287|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10
1151105|NCT03103503|2263287|FG000|Overall Study|Lost to Follow-up|3
1151106|NCT03103503|2263287|FG000|Overall Study|Study Closure|757
1151107|NCT03103542|2263291|FG000|Overall Study|Physician Decision|2
1151108|NCT03103542|2263291|FG000|Overall Study|Adverse Event|2
1151109|NCT03103542|2263291|FG000|Overall Study|Other|2
1151110|NCT03103542|2263291|FG000|Overall Study|Withdrawal by Subject|1
1151111|NCT03103763|2263299|FG000|Overall Study|Death|15
1151112|NCT03103763|2263300|FG001|Overall Study|Death|5
1151113|NCT03103763|2263301|FG002|Overall Study|Death|5
1151114|NCT03103763|2263299|FG000|Overall Study|Withdrawal by Subject|0
1151115|NCT03103763|2263300|FG001|Overall Study|Withdrawal by Subject|3
1151116|NCT03103763|2263301|FG002|Overall Study|Withdrawal by Subject|2
1151117|NCT03103906|2263311|FG000|Overall Study|Adverse Event|2
1151118|NCT03103906|2263312|FG001|Overall Study|Adverse Event|3
1151119|NCT03103906|2263311|FG000|Overall Study|Other|2
1151120|NCT03103906|2263312|FG001|Overall Study|Other|0
1151121|NCT03103919|2263320|FG000|Overall Study|Adverse Event|2
1151122|NCT03103919|2263321|FG001|Overall Study|Adverse Event|2
1151123|NCT03104816|2263381|FG000|Overall Study|Lack of Efficacy|0
1151124|NCT03104816|2263382|FG001|Overall Study|Lack of Efficacy|2
1151125|NCT03104816|2263383|FG002|Overall Study|Lack of Efficacy|0
1151126|NCT03104816|2263381|FG000|Overall Study|Protocol Violation|2
1151127|NCT03104816|2263382|FG001|Overall Study|Protocol Violation|0
1151128|NCT03104816|2263383|FG002|Overall Study|Protocol Violation|2
1151129|NCT03105297|2263400|FG000|Baseline Phase (Day 1)|Other|21
1151130|NCT03105297|2263400|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
1151131|NCT03105297|2263400|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
1151132|NCT03105362|2263411|FG000|Overall Study|Withdrawal by Subject|1
1151133|NCT03105362|2263411|FG000|Overall Study|Lost to Follow-up|1
1151134|NCT03106077|2263435|FG000|Overall Study|Screen Failure|94
1151135|NCT03106077|2263436|FG001|Overall Study|Screen Failure|0
1151136|NCT03106753|2263457|FG000|Overall Study|Withdrawal by Subject|0
1151137|NCT03106753|2263458|FG001|Overall Study|Withdrawal by Subject|1
1151138|NCT03107026|2263482|FG000|Overall Study|Adverse Event|2
1151139|NCT03107026|2263483|FG001|Overall Study|Adverse Event|14
1151140|NCT03107026|2263484|FG002|Overall Study|Adverse Event|23
1151141|NCT03107026|2263482|FG000|Overall Study|Lost to Follow-up|12
1151142|NCT03107026|2263483|FG001|Overall Study|Lost to Follow-up|12
1151143|NCT03107026|2263484|FG002|Overall Study|Lost to Follow-up|13
1151144|NCT03107026|2263482|FG000|Overall Study|Protocol Violation|1
1151145|NCT03107026|2263483|FG001|Overall Study|Protocol Violation|2
1151146|NCT03107026|2263484|FG002|Overall Study|Protocol Violation|0
1151147|NCT03107026|2263482|FG000|Overall Study|Pregnancy|1
1151148|NCT03107026|2263483|FG001|Overall Study|Pregnancy|0
1151149|NCT03107026|2263484|FG002|Overall Study|Pregnancy|0
1151150|NCT03107026|2263482|FG000|Overall Study|Withdrawal by Subject|13
1151151|NCT03107026|2263483|FG001|Overall Study|Withdrawal by Subject|5
1151152|NCT03107026|2263484|FG002|Overall Study|Withdrawal by Subject|17
1151153|NCT03107026|2263482|FG000|Overall Study|non compliance with study visits|1
1151154|NCT03107026|2263483|FG001|Overall Study|non compliance with study visits|2
1151155|NCT03107026|2263484|FG002|Overall Study|non compliance with study visits|0
1151156|NCT03107026|2263482|FG000|Overall Study|non-compliance with study drug|2
1151157|NCT03107026|2263483|FG001|Overall Study|non-compliance with study drug|2
1151158|NCT03107026|2263484|FG002|Overall Study|non-compliance with study drug|3
1151159|NCT03107026|2263482|FG000|Overall Study|Physician Decision|0
1151160|NCT03107026|2263483|FG001|Overall Study|Physician Decision|1
1151161|NCT03107026|2263484|FG002|Overall Study|Physician Decision|0
1151162|NCT03107052|2263495|FG000|Overall Study|Adverse Event|6
1151163|NCT03107052|2263496|FG001|Overall Study|Adverse Event|1
1151164|NCT03107052|2263497|FG002|Overall Study|Adverse Event|2
1151165|NCT03107052|2263495|FG000|Overall Study|Withdrawal by Subject|9
1151166|NCT03107052|2263496|FG001|Overall Study|Withdrawal by Subject|5
1151167|NCT03107052|2263497|FG002|Overall Study|Withdrawal by Subject|8
1151168|NCT03107052|2263495|FG000|Overall Study|Protocol Violation|6
1151169|NCT03107052|2263496|FG001|Overall Study|Protocol Violation|0
1151170|NCT03107052|2263497|FG002|Overall Study|Protocol Violation|3
1151171|NCT03107052|2263495|FG000|Overall Study|Lost to Follow-up|4
1151172|NCT03107052|2263496|FG001|Overall Study|Lost to Follow-up|0
1151173|NCT03107052|2263497|FG002|Overall Study|Lost to Follow-up|1
1151174|NCT03107052|2263495|FG000|Overall Study|Lack of Efficacy|23
1151175|NCT03107052|2263496|FG001|Overall Study|Lack of Efficacy|7
1151176|NCT03107052|2263497|FG002|Overall Study|Lack of Efficacy|4
1151177|NCT03107052|2263495|FG000|Overall Study|Other than specified|4
1151178|NCT03107052|2263496|FG001|Overall Study|Other than specified|2
1151179|NCT03107052|2263497|FG002|Overall Study|Other than specified|0
1151180|NCT03107052|2263495|FG000|Overall Study|Study terminated due to futility|67
1151181|NCT03107052|2263496|FG001|Overall Study|Study terminated due to futility|31
1151182|NCT03107052|2263497|FG002|Overall Study|Study terminated due to futility|23
1151183|NCT03107091|2263505|FG000|Overall Study|Physician Decision|1
1151184|NCT03107377|2263512|FG000|Overall Study|Adverse Event|3
1151185|NCT03107377|2263513|FG001|Overall Study|Adverse Event|3
1151186|NCT03107377|2263512|FG000|Overall Study|Protocol Violation|9
1151187|NCT03107377|2263513|FG001|Overall Study|Protocol Violation|12
1151188|NCT03107377|2263512|FG000|Overall Study|Physician Decision|3
1151189|NCT03107377|2263513|FG001|Overall Study|Physician Decision|6
1151190|NCT03107377|2263512|FG000|Overall Study|Pregnancy|7
1151191|NCT03107377|2263513|FG001|Overall Study|Pregnancy|7
1151192|NCT03107377|2263512|FG000|Overall Study|Withdrawal by Subject|16
1151193|NCT03107377|2263513|FG001|Overall Study|Withdrawal by Subject|22
1151194|NCT03107377|2263512|FG000|Overall Study|Lost to Follow-up|37
1151195|NCT03107377|2263513|FG001|Overall Study|Lost to Follow-up|34
1151196|NCT03107377|2263512|FG000|Overall Study|Other reason not specified|16
1151197|NCT03107377|2263513|FG001|Overall Study|Other reason not specified|15
1151198|NCT03107611|2263522|FG000|Overall Study|Adverse Event|1
1151199|NCT03107611|2263523|FG001|Overall Study|Adverse Event|0
1151200|NCT03107611|2263524|FG002|Overall Study|Adverse Event|2
1151201|NCT03107611|2263522|FG000|Overall Study|Lost to Follow-up|3
1151202|NCT03107611|2263523|FG001|Overall Study|Lost to Follow-up|3
1151203|NCT03107611|2263524|FG002|Overall Study|Lost to Follow-up|3
1151204|NCT03107611|2263522|FG000|Overall Study|Protocol Violation|0
1151205|NCT03107611|2263523|FG001|Overall Study|Protocol Violation|0
1151206|NCT03107611|2263524|FG002|Overall Study|Protocol Violation|1
1151207|NCT03107611|2263522|FG000|Overall Study|Withdrawal by Subject|1
1151208|NCT03107611|2263523|FG001|Overall Study|Withdrawal by Subject|0
1151209|NCT03107611|2263524|FG002|Overall Study|Withdrawal by Subject|1
1151210|NCT03107611|2263522|FG000|Overall Study|Worsening signs/symptoms|2
1151211|NCT03107611|2263523|FG001|Overall Study|Worsening signs/symptoms|1
1151212|NCT03107611|2263524|FG002|Overall Study|Worsening signs/symptoms|2
1151213|NCT03107715|2263534|FG000|Overall Study|did not deliver at the home hospital|4
1151214|NCT03107715|2263535|FG001|Overall Study|did not deliver at the home hospital|6
1151215|NCT03107715|2263534|FG000|Overall Study|infant stillborn|0
1151216|NCT03107715|2263535|FG001|Overall Study|infant stillborn|1
1151217|NCT03107793|2263550|FG000|Induction Period (16 Weeks)|Adverse Event|5
1151218|NCT03107793|2263551|FG001|Induction Period (16 Weeks)|Adverse Event|0
1151219|NCT03107793|2263552|FG002|Induction Period (16 Weeks)|Adverse Event|0
1151220|NCT03107793|2263550|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3
1151221|NCT03107793|2263551|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0
1151222|NCT03107793|2263552|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
1151223|NCT03107793|2263550|FG000|Induction Period (16 Weeks)|Physician Decision|1
1151224|NCT03107793|2263551|FG001|Induction Period (16 Weeks)|Physician Decision|0
1151225|NCT03107793|2263552|FG002|Induction Period (16 Weeks)|Physician Decision|0
1151226|NCT03107793|2263550|FG000|Induction Period (16 Weeks)|Progressive Disease|1
1151227|NCT03107793|2263551|FG001|Induction Period (16 Weeks)|Progressive Disease|0
1151228|NCT03107793|2263552|FG002|Induction Period (16 Weeks)|Progressive Disease|0
1151229|NCT03107793|2263550|FG000|Maintenance Period (16-48 Week)|Adverse Event|0
1151230|NCT03107793|2263551|FG001|Maintenance Period (16-48 Week)|Adverse Event|6
1151231|NCT03107793|2263552|FG002|Maintenance Period (16-48 Week)|Adverse Event|10
1151232|NCT03107793|2263550|FG000|Maintenance Period (16-48 Week)|Death|0
1151233|NCT03107793|2263551|FG001|Maintenance Period (16-48 Week)|Death|2
1151234|NCT03107793|2263552|FG002|Maintenance Period (16-48 Week)|Death|0
1151235|NCT03107793|2263550|FG000|Maintenance Period (16-48 Week)|Lack of Efficacy|0
1151236|NCT03107793|2263551|FG001|Maintenance Period (16-48 Week)|Lack of Efficacy|21
1151237|NCT03107793|2263552|FG002|Maintenance Period (16-48 Week)|Lack of Efficacy|8
1151238|NCT03107793|2263550|FG000|Maintenance Period (16-48 Week)|Lost to Follow-up|0
1151239|NCT03107793|2263551|FG001|Maintenance Period (16-48 Week)|Lost to Follow-up|1
1151240|NCT03107793|2263552|FG002|Maintenance Period (16-48 Week)|Lost to Follow-up|0
1151241|NCT03107793|2263550|FG000|Maintenance Period (16-48 Week)|Withdrawal by Subject|0
1151242|NCT03107793|2263551|FG001|Maintenance Period (16-48 Week)|Withdrawal by Subject|12
1151243|NCT03107793|2263552|FG002|Maintenance Period (16-48 Week)|Withdrawal by Subject|4
1151244|NCT03107793|2263550|FG000|Maintenance Period (16-48 Week)|Physician Decision|0
1151245|NCT03107793|2263551|FG001|Maintenance Period (16-48 Week)|Physician Decision|1
1151246|NCT03107793|2263552|FG002|Maintenance Period (16-48 Week)|Physician Decision|2
1151247|NCT03107793|2263550|FG000|Maintenance Period (16-48 Week)|Pregnancy|0
1151248|NCT03107793|2263551|FG001|Maintenance Period (16-48 Week)|Pregnancy|1
1151249|NCT03107793|2263552|FG002|Maintenance Period (16-48 Week)|Pregnancy|1
1151250|NCT03107793|2263550|FG000|Maintenance Period (16-48 Week)|Disease Relapse|0
1151251|NCT03107793|2263551|FG001|Maintenance Period (16-48 Week)|Disease Relapse|2
1151252|NCT03107793|2263552|FG002|Maintenance Period (16-48 Week)|Disease Relapse|1
1151253|NCT03107793|2263550|FG000|Maintenance Period (16-48 Week)|Progressive Disease|0
1151254|NCT03107793|2263551|FG001|Maintenance Period (16-48 Week)|Progressive Disease|0
1151255|NCT03107793|2263552|FG002|Maintenance Period (16-48 Week)|Progressive Disease|1
1151256|NCT03107793|2263550|FG000|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
1151257|NCT03107793|2263551|FG001|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
1151258|NCT03107793|2263552|FG002|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|1
1151259|NCT03108027|2263559|FG000|Period 1|Subject/Guardian Decision|0
1151260|NCT03108027|2263560|FG001|Period 1|Subject/Guardian Decision|0
1151261|NCT03108027|2263561|FG002|Period 1|Subject/Guardian Decision|0
1151262|NCT03108027|2263562|FG003|Period 1|Subject/Guardian Decision|2
1151263|NCT03108027|2263563|FG004|Period 1|Subject/Guardian Decision|0
1151264|NCT03108027|2263564|FG005|Period 1|Subject/Guardian Decision|0
1151265|NCT03108027|2263559|FG000|Period 3|Adverse Event|0
1151266|NCT03108027|2263560|FG001|Period 3|Adverse Event|1
1151267|NCT03108027|2263561|FG002|Period 3|Adverse Event|0
1151268|NCT03108027|2263562|FG003|Period 3|Adverse Event|0
1151269|NCT03108027|2263563|FG004|Period 3|Adverse Event|0
1151270|NCT03108027|2263564|FG005|Period 3|Adverse Event|0
1151271|NCT03108157|2263574|FG000|Overall Study|Protocol Violation|15
1151272|NCT03108157|2263575|FG001|Overall Study|Protocol Violation|4
1151273|NCT03108521|2263610|FG000|Overall Study|Lost to Follow-up|3
1151274|NCT03108521|2263611|FG001|Overall Study|Lost to Follow-up|0
1151275|NCT03108521|2263610|FG000|Overall Study|Lack of Efficacy|2
1151276|NCT03108521|2263611|FG001|Overall Study|Lack of Efficacy|0
1151277|NCT03108521|2263610|FG000|Overall Study|Physician Decision|4
1151278|NCT03108521|2263611|FG001|Overall Study|Physician Decision|0
1151279|NCT03108521|2263610|FG000|Overall Study|Adverse Event|3
1151280|NCT03108521|2263611|FG001|Overall Study|Adverse Event|0
1151281|NCT03109184|2263658|FG000|Overall Study|Lost to Follow-up|6
1151282|NCT03109184|2263659|FG001|Overall Study|Lost to Follow-up|6
1151283|NCT03109184|2263658|FG000|Overall Study|Withdrawal by Subject|1
1151284|NCT03109184|2263659|FG001|Overall Study|Withdrawal by Subject|1
1151285|NCT03110029|2263695|FG000|Overall Study|Withdrawal by Subject|1
1151286|NCT03110029|2263696|FG001|Overall Study|Withdrawal by Subject|1
1151287|NCT03110185|2263704|FG000|Overall Study|Death|0
1151288|NCT03110185|2263705|FG001|Overall Study|Death|1
1151289|NCT03110185|2263704|FG000|Overall Study|Withdrawal by Subject|2
1151290|NCT03110185|2263705|FG001|Overall Study|Withdrawal by Subject|7
1151291|NCT03110185|2263704|FG000|Overall Study|Time Constraints|0
1151292|NCT03110185|2263705|FG001|Overall Study|Time Constraints|6
1151293|NCT03110185|2263704|FG000|Overall Study|Conflict with care|5
1151294|NCT03110185|2263705|FG001|Overall Study|Conflict with care|12
1151295|NCT03110185|2263704|FG000|Overall Study|Protocol Violation|1
1151296|NCT03110185|2263705|FG001|Overall Study|Protocol Violation|4
1151297|NCT03110185|2263704|FG000|Overall Study|MRI Incompatible|2
1151298|NCT03110185|2263705|FG001|Overall Study|MRI Incompatible|0
1151299|NCT03110185|2263704|FG000|Overall Study|Patient Refusal|0
1151300|NCT03110185|2263705|FG001|Overall Study|Patient Refusal|1
1151319|NCT03110562|2263745|FG000|Overall Study|Withdrawal by Subject|37
1151320|NCT03110562|2263746|FG001|Overall Study|Withdrawal by Subject|35
1151321|NCT03110562|2263745|FG000|Overall Study|Death|47
1151322|NCT03110562|2263746|FG001|Overall Study|Death|61
1151323|NCT03110562|2263745|FG000|Overall Study|Lost to Follow-up|7
1151324|NCT03110562|2263746|FG001|Overall Study|Lost to Follow-up|6
1151325|NCT03110562|2263745|FG000|Overall Study|Other|2
1151326|NCT03110562|2263746|FG001|Overall Study|Other|1
1151327|NCT03110562|2263745|FG000|Overall Study|Randomized but never treated|0
1151328|NCT03110562|2263746|FG001|Overall Study|Randomized but never treated|3
1151329|NCT03110562|2263745|FG000|Overall Study|Ongoing|102
1151330|NCT03110562|2263746|FG001|Overall Study|Ongoing|101
1151331|NCT03110770|2263773|FG000|Overall Study|Death|1
1151332|NCT03110770|2263774|FG001|Overall Study|Death|0
1151333|NCT03110770|2263775|FG002|Overall Study|Death|0
1151334|NCT03110770|2263776|FG003|Overall Study|Death|1
1151335|NCT03110770|2263777|FG004|Overall Study|Death|0
1151336|NCT03110770|2263773|FG000|Overall Study|Enrolled but did not receive product|0
1151337|NCT03110770|2263774|FG001|Overall Study|Enrolled but did not receive product|0
1151338|NCT03110770|2263775|FG002|Overall Study|Enrolled but did not receive product|0
1151339|NCT03110770|2263776|FG003|Overall Study|Enrolled but did not receive product|8
1151340|NCT03110770|2263777|FG004|Overall Study|Enrolled but did not receive product|7
1151341|NCT03110770|2263773|FG000|Overall Study|Lost to Follow-up|0
1151342|NCT03110770|2263774|FG001|Overall Study|Lost to Follow-up|0
1151343|NCT03110770|2263775|FG002|Overall Study|Lost to Follow-up|0
1151344|NCT03110770|2263776|FG003|Overall Study|Lost to Follow-up|53
1151345|NCT03110770|2263777|FG004|Overall Study|Lost to Follow-up|45
1151346|NCT03110770|2263773|FG000|Overall Study|Investigator Decision|0
1151347|NCT03110770|2263774|FG001|Overall Study|Investigator Decision|0
1151348|NCT03110770|2263775|FG002|Overall Study|Investigator Decision|0
1151349|NCT03110770|2263776|FG003|Overall Study|Investigator Decision|5
1151350|NCT03110770|2263777|FG004|Overall Study|Investigator Decision|3
1151351|NCT03110770|2263773|FG000|Overall Study|Withdrawal by Subject|0
1151352|NCT03110770|2263774|FG001|Overall Study|Withdrawal by Subject|0
1151353|NCT03110770|2263775|FG002|Overall Study|Withdrawal by Subject|0
1151354|NCT03110770|2263776|FG003|Overall Study|Withdrawal by Subject|24
1151355|NCT03110770|2263777|FG004|Overall Study|Withdrawal by Subject|24
1151356|NCT03110770|2263773|FG000|Overall Study|Moved from area|5
1151357|NCT03110770|2263774|FG001|Overall Study|Moved from area|0
1151358|NCT03110770|2263775|FG002|Overall Study|Moved from area|2
1151359|NCT03110770|2263776|FG003|Overall Study|Moved from area|42
1151360|NCT03110770|2263777|FG004|Overall Study|Moved from area|43
1151361|NCT03110770|2263773|FG000|Overall Study|Illness/Injury unrelated to product|0
1151362|NCT03110770|2263774|FG001|Overall Study|Illness/Injury unrelated to product|0
1151363|NCT03110770|2263775|FG002|Overall Study|Illness/Injury unrelated to product|0
1151364|NCT03110770|2263776|FG003|Overall Study|Illness/Injury unrelated to product|0
1151365|NCT03110770|2263777|FG004|Overall Study|Illness/Injury unrelated to product|1
1151366|NCT03111108|2263793|FG000|Overall Study|Death|0
1151367|NCT03111108|2263794|FG001|Overall Study|Death|1
1151368|NCT03111108|2263793|FG000|Overall Study|Withdrawal by Subject|1
1151369|NCT03111108|2263794|FG001|Overall Study|Withdrawal by Subject|0
1151373|NCT03113916|2263925|FG000|Overall Study|Withdrawal by Subject|9
1151374|NCT03113916|2263926|FG001|Overall Study|Withdrawal by Subject|7
1151375|NCT03113916|2263925|FG000|Overall Study|Pregnancy|1
1151376|NCT03113916|2263926|FG001|Overall Study|Pregnancy|3
1151377|NCT03113916|2263925|FG000|Overall Study|Lost to Follow-up|1
1151378|NCT03113916|2263926|FG001|Overall Study|Lost to Follow-up|2
1151379|NCT03114488|2263946|FG000|Time Period 2|Withdrawal by Subject|1
1151380|NCT03114488|2263947|FG001|Time Period 2|Withdrawal by Subject|3
1151381|NCT03114657|2263959|FG000|Overall Study|Adverse Event|9
1151382|NCT03114657|2263960|FG001|Overall Study|Adverse Event|6
1151383|NCT03114657|2263959|FG000|Overall Study|Death|4
1151384|NCT03114657|2263960|FG001|Overall Study|Death|0
1151385|NCT03114657|2263959|FG000|Overall Study|Multiple Reasons|1
1151386|NCT03114657|2263960|FG001|Overall Study|Multiple Reasons|2
1151387|NCT03114657|2263959|FG000|Overall Study|Physician Decision|2
1151388|NCT03114657|2263960|FG001|Overall Study|Physician Decision|2
1151389|NCT03114657|2263959|FG000|Overall Study|Study Terminated By Sponsor|355
1151390|NCT03114657|2263960|FG001|Overall Study|Study Terminated By Sponsor|374
1151391|NCT03114657|2263959|FG000|Overall Study|Symptomatic Deterioration|0
1151392|NCT03114657|2263960|FG001|Overall Study|Symptomatic Deterioration|1
1151393|NCT03114657|2263959|FG000|Overall Study|Withdrawal by Subject|28
1151394|NCT03114657|2263960|FG001|Overall Study|Withdrawal by Subject|22
1151395|NCT03114969|2263980|FG000|Overall Study|Lost to Follow-up|0
1151396|NCT03114969|2263981|FG001|Overall Study|Lost to Follow-up|0
1151397|NCT03114969|2263982|FG002|Overall Study|Lost to Follow-up|3
1151398|NCT03114969|2263983|FG003|Overall Study|Lost to Follow-up|2
1151399|NCT03114969|2263984|FG004|Overall Study|Lost to Follow-up|0
1151400|NCT03114969|2263985|FG005|Overall Study|Lost to Follow-up|0
1151401|NCT03114969|2263986|FG006|Overall Study|Lost to Follow-up|0
1151402|NCT03114969|2263987|FG007|Overall Study|Lost to Follow-up|0
1151403|NCT03114969|2263988|FG008|Overall Study|Lost to Follow-up|0
1151404|NCT03114969|2263980|FG000|Overall Study|Adverse Event|0
1151405|NCT03114969|2263981|FG001|Overall Study|Adverse Event|0
1151406|NCT03114969|2263982|FG002|Overall Study|Adverse Event|1
1151407|NCT03114969|2263983|FG003|Overall Study|Adverse Event|0
1151408|NCT03114969|2263984|FG004|Overall Study|Adverse Event|0
1151409|NCT03114969|2263985|FG005|Overall Study|Adverse Event|1
1151410|NCT03114969|2263986|FG006|Overall Study|Adverse Event|1
1151411|NCT03114969|2263987|FG007|Overall Study|Adverse Event|0
1151412|NCT03114969|2263988|FG008|Overall Study|Adverse Event|2
1151413|NCT03115112|2264030|FG000|Overall Study|Adverse Event|5
1151414|NCT03115112|2264031|FG001|Overall Study|Adverse Event|1
1151415|NCT03115112|2264030|FG000|Overall Study|Withdrawal by Subject|4
1151416|NCT03115112|2264031|FG001|Overall Study|Withdrawal by Subject|2
1151417|NCT03115112|2264030|FG000|Overall Study|Lost to Follow-up|0
1151418|NCT03115112|2264031|FG001|Overall Study|Lost to Follow-up|1
1151419|NCT03115112|2264030|FG000|Overall Study|Death|1
1151420|NCT03115112|2264031|FG001|Overall Study|Death|0
1151421|NCT03115112|2264030|FG000|Overall Study|Pregnancy|1
1151422|NCT03115112|2264031|FG001|Overall Study|Pregnancy|0
1151423|NCT03115112|2264030|FG000|Overall Study|Site closure|1
1151424|NCT03115112|2264031|FG001|Overall Study|Site closure|1
1151425|NCT03115476|2264055|FG000|LP0084-1369|Death|1
1151426|NCT03115476|2264056|FG001|LP0084-1369|Death|0
1151427|NCT03115476|2264057|FG002|LP0084-1369|Death|2
1151428|NCT03115476|2264055|FG000|LP0084-1369|Trial terminated by Sponsor|190
1151429|NCT03115476|2264056|FG001|LP0084-1369|Trial terminated by Sponsor|210
1151430|NCT03115476|2264057|FG002|LP0084-1369|Trial terminated by Sponsor|160
1151431|NCT03116152|2264089|FG000|Overall Study|Disease Progression|49
1151432|NCT03116152|2264090|FG001|Overall Study|Disease Progression|47
1151433|NCT03116152|2264089|FG000|Overall Study|Death|5
1151434|NCT03116152|2264090|FG001|Overall Study|Death|2
1151435|NCT03116152|2264089|FG000|Overall Study|Adverse Event|21
1151436|NCT03116152|2264090|FG001|Overall Study|Adverse Event|7
1151437|NCT03116152|2264089|FG000|Overall Study|Protocol Violation|2
1151438|NCT03116152|2264090|FG001|Overall Study|Protocol Violation|2
1151439|NCT03116152|2264089|FG000|Overall Study|Withdrawal by Subject|0
1151440|NCT03116152|2264090|FG001|Overall Study|Withdrawal by Subject|1
1151441|NCT03116152|2264089|FG000|Overall Study|Physician Decision|3
1151442|NCT03116152|2264090|FG001|Overall Study|Physician Decision|2
1151443|NCT03116152|2264089|FG000|Overall Study|other|11
1151444|NCT03116152|2264090|FG001|Overall Study|other|34
1151445|NCT03116698|2264109|FG000|Overall Study|Adverse Event|1
1151446|NCT03116698|2264110|FG001|Overall Study|Adverse Event|1
1151447|NCT03116698|2264111|FG002|Overall Study|Adverse Event|1
1151448|NCT03116698|2264112|FG003|Overall Study|Adverse Event|0
1151449|NCT03116698|2264109|FG000|Overall Study|Withdrawal by Subject|1
1151450|NCT03116698|2264110|FG001|Overall Study|Withdrawal by Subject|4
1151451|NCT03116698|2264111|FG002|Overall Study|Withdrawal by Subject|5
1151452|NCT03116698|2264112|FG003|Overall Study|Withdrawal by Subject|2
1151453|NCT03116698|2264109|FG000|Overall Study|Lost to Follow-up|2
1151454|NCT03116698|2264110|FG001|Overall Study|Lost to Follow-up|0
1151455|NCT03116698|2264111|FG002|Overall Study|Lost to Follow-up|0
1151456|NCT03116698|2264112|FG003|Overall Study|Lost to Follow-up|0
1151457|NCT03116698|2264109|FG000|Overall Study|Physician Decision|1
1151458|NCT03116698|2264110|FG001|Overall Study|Physician Decision|1
1151459|NCT03116698|2264111|FG002|Overall Study|Physician Decision|0
1151460|NCT03116698|2264112|FG003|Overall Study|Physician Decision|0
1151461|NCT03116698|2264109|FG000|Overall Study|Protocol Violation|1
1151462|NCT03116698|2264110|FG001|Overall Study|Protocol Violation|0
1151463|NCT03116698|2264111|FG002|Overall Study|Protocol Violation|0
1151464|NCT03116698|2264112|FG003|Overall Study|Protocol Violation|0
1151465|NCT03116698|2264109|FG000|Overall Study|Death|0
1151466|NCT03116698|2264110|FG001|Overall Study|Death|0
1151467|NCT03116698|2264111|FG002|Overall Study|Death|2
1151468|NCT03116698|2264112|FG003|Overall Study|Death|0
1151469|NCT03116828|2264124|FG000|Overall Study|Adverse Event|1
1151470|NCT03116828|2264125|FG001|Overall Study|Adverse Event|10
1151471|NCT03116828|2264124|FG000|Overall Study|Withdrawal by Subject|4
1151472|NCT03116828|2264125|FG001|Overall Study|Withdrawal by Subject|8
1151473|NCT03116828|2264124|FG000|Overall Study|OTHER|3
1151474|NCT03116828|2264125|FG001|Overall Study|OTHER|3
1151475|NCT03117361|2264155|FG000|Overall Study|Progressive disease|5
1151476|NCT03117361|2264155|FG000|Overall Study|Death|1
1151477|NCT03117361|2264155|FG000|Overall Study|Physician Decision|2
1151478|NCT03117361|2264155|FG000|Overall Study|On study treatment at the end of study|1
1151479|NCT03117361|2264155|FG000|Overall Study|Treatment-related adverse event|1
1151480|NCT03117738|2264196|FG000|Overall Study|Withdrawal by Subject|3
1151481|NCT03117738|2264197|FG001|Overall Study|Withdrawal by Subject|1
1151482|NCT03117738|2264196|FG000|Overall Study|Lost to Follow-up|1
1151483|NCT03117738|2264197|FG001|Overall Study|Lost to Follow-up|4
1151484|NCT03118297|2264205|FG000|Overall Study|Lost to Follow-up|0
1151485|NCT03118297|2264206|FG001|Overall Study|Lost to Follow-up|2
1151486|NCT03118518|2264218|FG000|Overall Study|Early Exit after treatment|2
1151487|NCT03118518|2264219|FG001|Overall Study|Early Exit after treatment|8
1151488|NCT03118518|2264218|FG000|Overall Study|Early Exit after randomization but prior to treatment|4
1151489|NCT03118518|2264219|FG001|Overall Study|Early Exit after randomization but prior to treatment|3
1151490|NCT03118739|2264236|FG000|Overall Study|Physician Decision|0
1151491|NCT03118739|2264237|FG001|Overall Study|Physician Decision|1
1151492|NCT03118739|2264236|FG000|Overall Study|Withdrawal by Subject|5
1151493|NCT03118739|2264237|FG001|Overall Study|Withdrawal by Subject|3
1151494|NCT03118739|2264236|FG000|Overall Study|Lost to Follow-up|2
1151495|NCT03118739|2264237|FG001|Overall Study|Lost to Follow-up|0
1151496|NCT03118765|2264248|FG000|Overall Study|Withdrawal by Subject|0
1151497|NCT03118765|2264249|FG001|Overall Study|Withdrawal by Subject|0
1151498|NCT03118765|2264250|FG002|Overall Study|Withdrawal by Subject|1
1151499|NCT03118765|2264251|FG003|Overall Study|Withdrawal by Subject|0
1151500|NCT03118765|2264252|FG004|Overall Study|Withdrawal by Subject|0
1151501|NCT03118765|2264248|FG000|Overall Study|Adverse Event|1
1151502|NCT03118765|2264249|FG001|Overall Study|Adverse Event|1
1151503|NCT03118765|2264250|FG002|Overall Study|Adverse Event|1
1151504|NCT03118765|2264251|FG003|Overall Study|Adverse Event|1
1151505|NCT03118765|2264252|FG004|Overall Study|Adverse Event|1
1151506|NCT03118765|2264248|FG000|Overall Study|Non compliance with Study Procedures|0
1151507|NCT03118765|2264249|FG001|Overall Study|Non compliance with Study Procedures|0
1151508|NCT03118765|2264250|FG002|Overall Study|Non compliance with Study Procedures|0
1151509|NCT03118765|2264251|FG003|Overall Study|Non compliance with Study Procedures|1
1151510|NCT03118765|2264252|FG004|Overall Study|Non compliance with Study Procedures|0
1151511|NCT03118765|2264248|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0
1151512|NCT03118765|2264249|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1
1151513|NCT03118765|2264250|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1
1151514|NCT03118765|2264251|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0
1151515|NCT03118765|2264252|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0
1151516|NCT03118765|2264248|FG000|Overall Study|COPD Exacerbation|1
1151517|NCT03118765|2264249|FG001|Overall Study|COPD Exacerbation|0
1151518|NCT03118765|2264250|FG002|Overall Study|COPD Exacerbation|0
1151519|NCT03118765|2264251|FG003|Overall Study|COPD Exacerbation|1
1151520|NCT03118765|2264252|FG004|Overall Study|COPD Exacerbation|0
1151521|NCT03118765|2264248|FG000|Overall Study|Lost to Follow-up|1
1151522|NCT03118765|2264249|FG001|Overall Study|Lost to Follow-up|0
1151523|NCT03118765|2264250|FG002|Overall Study|Lost to Follow-up|1
1151524|NCT03118765|2264251|FG003|Overall Study|Lost to Follow-up|0
1151525|NCT03118765|2264252|FG004|Overall Study|Lost to Follow-up|0
1151526|NCT03118765|2264248|FG000|Overall Study|Sponsor Decision|1
1151527|NCT03118765|2264249|FG001|Overall Study|Sponsor Decision|0
1151528|NCT03118765|2264250|FG002|Overall Study|Sponsor Decision|1
1151529|NCT03118765|2264251|FG003|Overall Study|Sponsor Decision|0
1151530|NCT03118765|2264252|FG004|Overall Study|Sponsor Decision|1
1151531|NCT03118934|2264272|FG000|Overall Study|Adverse Event|0
1151532|NCT03118934|2264273|FG001|Overall Study|Adverse Event|0
1151533|NCT03118934|2264274|FG002|Overall Study|Adverse Event|0
1151534|NCT03118934|2264275|FG003|Overall Study|Adverse Event|0
1151535|NCT03118934|2264276|FG004|Overall Study|Adverse Event|0
1151536|NCT03118934|2264277|FG005|Overall Study|Adverse Event|1
1151537|NCT03118934|2264272|FG000|Overall Study|Physician Decision|0
1151538|NCT03118934|2264273|FG001|Overall Study|Physician Decision|0
1151539|NCT03118934|2264274|FG002|Overall Study|Physician Decision|0
1151540|NCT03118934|2264275|FG003|Overall Study|Physician Decision|0
1151541|NCT03118934|2264276|FG004|Overall Study|Physician Decision|0
1151542|NCT03118934|2264277|FG005|Overall Study|Physician Decision|1
1151543|NCT03118934|2264272|FG000|Overall Study|Discontinued prior to exposure|0
1151544|NCT03118934|2264273|FG001|Overall Study|Discontinued prior to exposure|1
1151545|NCT03118934|2264274|FG002|Overall Study|Discontinued prior to exposure|1
1151546|NCT03118934|2264275|FG003|Overall Study|Discontinued prior to exposure|1
1151547|NCT03118934|2264276|FG004|Overall Study|Discontinued prior to exposure|2
1151548|NCT03118934|2264277|FG005|Overall Study|Discontinued prior to exposure|0
1151549|NCT03118947|2264287|FG000|Overall Study|Adverse Event|7
1151550|NCT03118947|2264287|FG000|Overall Study|Death|3
1151551|NCT03118947|2264287|FG000|Overall Study|Lack of Efficacy|4
1151552|NCT03118947|2264287|FG000|Overall Study|Non-compliance with study drug|1
1151553|NCT03118947|2264287|FG000|Overall Study|Protocol Violation|2
1151554|NCT03118947|2264287|FG000|Overall Study|Withdrawal by Subject|3
1151555|NCT03118947|2264287|FG000|Overall Study|Withdrawal by caregiver|3
1151556|NCT03118947|2264287|FG000|Overall Study|Change in patient's living situation|4
1151557|NCT03118947|2264287|FG000|Overall Study|Lost to Follow-up|2
1151558|NCT03119610|2264337|FG000|Overall Study|Adverse Event|1
1151559|NCT03119610|2264338|FG001|Overall Study|Adverse Event|0
1151560|NCT03119610|2264337|FG000|Overall Study|Lost to Follow-up|0
1151561|NCT03119610|2264338|FG001|Overall Study|Lost to Follow-up|1
1151562|NCT03119688|2264369|FG000|Overall Study|Adverse Event|4
1151563|NCT03119701|2264388|FG000|6-day Dosing|Death|4
1151564|NCT03119701|2264389|FG001|6-day Dosing|Death|1
1151565|NCT03119701|2264388|FG000|6-day Dosing|Adverse Event|3
1151566|NCT03119701|2264389|FG001|6-day Dosing|Adverse Event|0
1151567|NCT03119701|2264388|FG000|6-day Dosing|Physician Decision|0
1151568|NCT03119701|2264389|FG001|6-day Dosing|Physician Decision|1
1151569|NCT03119701|2264388|FG000|6-day Dosing|Withdrawal by Subject|0
1151570|NCT03119701|2264389|FG001|6-day Dosing|Withdrawal by Subject|1
1151571|NCT03119701|2264388|FG000|Mid-term (Final) Follow-up at D90|Death|3
1151572|NCT03119701|2264389|FG001|Mid-term (Final) Follow-up at D90|Death|1
1151573|NCT03120013|2264411|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
1151574|NCT03120013|2264412|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
1151575|NCT03120351|2264420|FG000|Overall Study|Physician Decision|1
1151576|NCT03120351|2264421|FG001|Overall Study|Physician Decision|1
1151577|NCT03120520|2264431|FG000|Overall Study|Lost to Follow-up|1
1151578|NCT03120520|2264432|FG001|Overall Study|Lost to Follow-up|1
1151579|NCT03120520|2264433|FG002|Overall Study|Lost to Follow-up|1
1151580|NCT03120520|2264434|FG003|Overall Study|Lost to Follow-up|1
1151581|NCT03120520|2264431|FG000|Overall Study|Withdrawal by Subject|3
1151582|NCT03120520|2264432|FG001|Overall Study|Withdrawal by Subject|2
1151583|NCT03120520|2264433|FG002|Overall Study|Withdrawal by Subject|3
1151584|NCT03120520|2264434|FG003|Overall Study|Withdrawal by Subject|2
1151585|NCT03120520|2264431|FG000|Overall Study|Other|0
1151586|NCT03120520|2264432|FG001|Overall Study|Other|1
1151587|NCT03120520|2264433|FG002|Overall Study|Other|0
1151588|NCT03120520|2264434|FG003|Overall Study|Other|0
1151589|NCT03121950|2264494|FG000|Overall Study|Withdrawal by Subject|11
1151590|NCT03121950|2264495|FG001|Overall Study|Withdrawal by Subject|2
1151591|NCT03122145|2264505|FG000|Overall Study|Concurrent respiratory disease|3
1151592|NCT03122145|2264506|FG001|Overall Study|Concurrent respiratory disease|0
1151593|NCT03122171|2264512|FG000|Overall Study|Withdrawal by Subject|1
1151594|NCT03122184|2264518|FG000|Overall Study|Lost to Follow-up|4
1151595|NCT03122184|2264519|FG001|Overall Study|Lost to Follow-up|6
1151596|NCT03122184|2264518|FG000|Overall Study|Withdrawal by Subject|3
1151597|NCT03122184|2264519|FG001|Overall Study|Withdrawal by Subject|0
1151598|NCT03122184|2264518|FG000|Overall Study|Terminated due to cognitive problem|1
1151599|NCT03122184|2264519|FG001|Overall Study|Terminated due to cognitive problem|0
1151600|NCT03122223|2264529|FG000|Overall Study|Withdrawal by Subject|2
1151601|NCT03122223|2264530|FG001|Overall Study|Withdrawal by Subject|2
1151602|NCT03122223|2264531|FG002|Overall Study|Withdrawal by Subject|1
1151603|NCT03122223|2264532|FG003|Overall Study|Withdrawal by Subject|0
1151604|NCT03122223|2264529|FG000|Overall Study|Lost to Follow-up|0
1151605|NCT03122223|2264530|FG001|Overall Study|Lost to Follow-up|2
1151606|NCT03122223|2264531|FG002|Overall Study|Lost to Follow-up|2
1151607|NCT03122223|2264532|FG003|Overall Study|Lost to Follow-up|0
1151608|NCT03122223|2264529|FG000|Overall Study|Participant unable to adhere|1
1151609|NCT03122223|2264530|FG001|Overall Study|Participant unable to adhere|1
1151610|NCT03122223|2264531|FG002|Overall Study|Participant unable to adhere|1
1151611|NCT03122223|2264532|FG003|Overall Study|Participant unable to adhere|0
1151612|NCT03122457|2264542|FG000|Overall Study|Withdrawal by Subject|6
1151613|NCT03122535|2264546|FG000|Overall Study|Lost to Follow-up|68
1151614|NCT03122535|2264547|FG001|Overall Study|Lost to Follow-up|68
1151615|NCT03122535|2264546|FG000|Overall Study|Physician Decision|3
1151616|NCT03122535|2264547|FG001|Overall Study|Physician Decision|3
1151617|NCT03122535|2264546|FG000|Overall Study|Withdrawal by Subject|2
1151618|NCT03122535|2264547|FG001|Overall Study|Withdrawal by Subject|2
1151619|NCT03122548|2264553|FG000|Overall Study|Death|2
1151620|NCT03122548|2264553|FG000|Overall Study|Progression - subject went into hospice|1
1151621|NCT03122548|2264553|FG000|Overall Study|Study Terminated by Sponsor|2
1151622|NCT03122860|2264576|FG000|Overall Study|Discontinued Before Treatment|1
1151623|NCT03122860|2264577|FG001|Overall Study|Discontinued Before Treatment|1
1151624|NCT03122860|2264578|FG002|Overall Study|Discontinued Before Treatment|2
1151625|NCT03122860|2264579|FG003|Overall Study|Discontinued Before Treatment|0
1151626|NCT03122860|2264580|FG004|Overall Study|Discontinued Before Treatment|1
1151627|NCT03122860|2264581|FG005|Overall Study|Discontinued Before Treatment|0
1151628|NCT03122860|2264576|FG000|Overall Study|Adverse Event|1
1151629|NCT03122860|2264577|FG001|Overall Study|Adverse Event|0
1151630|NCT03122860|2264578|FG002|Overall Study|Adverse Event|1
1151631|NCT03122860|2264579|FG003|Overall Study|Adverse Event|1
1151632|NCT03122860|2264580|FG004|Overall Study|Adverse Event|0
1151633|NCT03122860|2264581|FG005|Overall Study|Adverse Event|0
1151634|NCT03122860|2264576|FG000|Overall Study|Lost to Follow-up|5
1151635|NCT03122860|2264577|FG001|Overall Study|Lost to Follow-up|2
1151636|NCT03122860|2264578|FG002|Overall Study|Lost to Follow-up|3
1151637|NCT03122860|2264579|FG003|Overall Study|Lost to Follow-up|3
1151638|NCT03122860|2264580|FG004|Overall Study|Lost to Follow-up|5
1151639|NCT03122860|2264581|FG005|Overall Study|Lost to Follow-up|4
1151640|NCT03122860|2264576|FG000|Overall Study|Subject Non-Compliance|0
1151641|NCT03122860|2264577|FG001|Overall Study|Subject Non-Compliance|0
1151642|NCT03122860|2264578|FG002|Overall Study|Subject Non-Compliance|1
1151643|NCT03122860|2264579|FG003|Overall Study|Subject Non-Compliance|0
1151644|NCT03122860|2264580|FG004|Overall Study|Subject Non-Compliance|0
1151645|NCT03122860|2264581|FG005|Overall Study|Subject Non-Compliance|0
1151646|NCT03122860|2264576|FG000|Overall Study|Withdrawal by Subject|3
1151647|NCT03122860|2264577|FG001|Overall Study|Withdrawal by Subject|2
1151648|NCT03122860|2264578|FG002|Overall Study|Withdrawal by Subject|5
1151649|NCT03122860|2264579|FG003|Overall Study|Withdrawal by Subject|7
1151650|NCT03122860|2264580|FG004|Overall Study|Withdrawal by Subject|9
1151651|NCT03122860|2264581|FG005|Overall Study|Withdrawal by Subject|8
1151652|NCT03122886|2264598|FG000|Overall Study|Withdrawal by Subject|1
1151653|NCT03122886|2264599|FG001|Overall Study|Withdrawal by Subject|2
1151654|NCT03123120|2264621|FG000|Overall Study|Lost to Follow-up|0
1151655|NCT03123120|2264622|FG001|Overall Study|Lost to Follow-up|1
1151656|NCT03123120|2264621|FG000|Overall Study|Withdrawal by Subject|0
1151657|NCT03123120|2264622|FG001|Overall Study|Withdrawal by Subject|1
1151658|NCT03123354|2264637|FG000|Overall Study|Physician Decision|6
1151659|NCT03123471|2264643|FG000|Placebo-controlled Phase|Adverse Event|3
1151660|NCT03123471|2264644|FG001|Placebo-controlled Phase|Adverse Event|8
1151661|NCT03123471|2264643|FG000|Placebo-controlled Phase|Lack of Efficacy|3
1151662|NCT03123471|2264644|FG001|Placebo-controlled Phase|Lack of Efficacy|4
1151663|NCT03123471|2264643|FG000|Placebo-controlled Phase|Withdrawal by Subject|6
1151664|NCT03123471|2264644|FG001|Placebo-controlled Phase|Withdrawal by Subject|16
1151665|NCT03123471|2264643|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3
1151666|NCT03123471|2264644|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0
1151667|NCT03123471|2264643|FG000|Placebo-controlled Phase|Lost to Follow-up|1
1151668|NCT03123471|2264644|FG001|Placebo-controlled Phase|Lost to Follow-up|3
1151669|NCT03123471|2264643|FG000|Placebo-controlled Phase|Protocol Deviation|2
1151670|NCT03123471|2264644|FG001|Placebo-controlled Phase|Protocol Deviation|1
1151671|NCT03123471|2264643|FG000|Placebo-controlled Phase|Miscellaneous|0
1151672|NCT03123471|2264644|FG001|Placebo-controlled Phase|Miscellaneous|1
1151673|NCT03123471|2264643|FG000|Apremilast Extension Phase|Lost to Follow-up|2
1151674|NCT03123471|2264644|FG001|Apremilast Extension Phase|Lost to Follow-up|5
1151675|NCT03123471|2264643|FG000|Apremilast Extension Phase|Adverse Event|1
1151676|NCT03123471|2264644|FG001|Apremilast Extension Phase|Adverse Event|5
1151677|NCT03123471|2264643|FG000|Apremilast Extension Phase|Lack of Efficacy|2
1151678|NCT03123471|2264644|FG001|Apremilast Extension Phase|Lack of Efficacy|8
1151679|NCT03123471|2264643|FG000|Apremilast Extension Phase|Withdrawal by Subject|3
1151680|NCT03123471|2264644|FG001|Apremilast Extension Phase|Withdrawal by Subject|7
1151681|NCT03123588|2264658|FG000|Overall Study|Study Terminated by Sponsor|2
1151682|NCT03123588|2264659|FG001|Overall Study|Study Terminated by Sponsor|5
1151683|NCT03123588|2264658|FG000|Overall Study|Withdrawal by Subject|1
1151684|NCT03123588|2264659|FG001|Overall Study|Withdrawal by Subject|0
1151685|NCT03123588|2264658|FG000|Overall Study|Adverse Event|1
1151686|NCT03123588|2264659|FG001|Overall Study|Adverse Event|0
1151687|NCT03123588|2264658|FG000|Overall Study|Physician Decision|2
1151688|NCT03123588|2264659|FG001|Overall Study|Physician Decision|1
1151689|NCT03123861|2264683|FG000|Overall Study|Protocol Violation|1
1151690|NCT03123861|2264684|FG001|Overall Study|Protocol Violation|1
1151691|NCT03123861|2264683|FG000|Overall Study|Withdrawal by Subject|2
1151692|NCT03123861|2264684|FG001|Overall Study|Withdrawal by Subject|2
1151693|NCT03123939|2264703|FG000|Overall Study|Lack of Efficacy|6
1151694|NCT03123939|2264703|FG000|Overall Study|Death|5
1151695|NCT03123939|2264703|FG000|Overall Study|Physician Decision|2
1151696|NCT03123939|2264703|FG000|Overall Study|Subject/guardian decision|2
1151697|NCT03123939|2264703|FG000|Overall Study|Lost to Follow-up|1
1151698|NCT03123939|2264703|FG000|Overall Study|New therapy for study indication|1
1151699|NCT03123939|2264703|FG000|Overall Study|Protocol deviation|1
1151700|NCT03123939|2264703|FG000|Overall Study|Progressive disease|18
1151701|NCT03123939|2264703|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4
1151702|NCT03123939|2264703|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1
1151703|NCT03124108|2264716|FG000|Overall Study|Adverse Event|0
1151704|NCT03124108|2264717|FG001|Overall Study|Adverse Event|1
1151705|NCT03124108|2264718|FG002|Overall Study|Adverse Event|0
1151706|NCT03124199|2264739|FG000|Overall Study|Lost to Follow-up|4
1151707|NCT03124381|2264769|FG000|Overall Study|Lost to Follow-up|1
1151708|NCT03124381|2264770|FG001|Overall Study|Lost to Follow-up|1
1151709|NCT03124381|2264769|FG000|Overall Study|Withdrawal by Subject|6
1151710|NCT03124381|2264770|FG001|Overall Study|Withdrawal by Subject|3
1151711|NCT03124381|2264769|FG000|Overall Study|Protocol Violation|0
1151712|NCT03124381|2264770|FG001|Overall Study|Protocol Violation|1
1151713|NCT03124381|2264769|FG000|Overall Study|Adverse Event|1
1151714|NCT03124381|2264770|FG001|Overall Study|Adverse Event|1
1151715|NCT03124381|2264769|FG000|Overall Study|Non-Compliance with Study Treatment|1
1151716|NCT03124381|2264770|FG001|Overall Study|Non-Compliance with Study Treatment|0
1151717|NCT03124407|2264780|FG000|Overall Study|Lost to Follow-up|1
1151718|NCT03124407|2264781|FG001|Overall Study|Lost to Follow-up|0
1151719|NCT03124407|2264782|FG002|Overall Study|Lost to Follow-up|0
1151720|NCT03124407|2264783|FG003|Overall Study|Lost to Follow-up|0
1151721|NCT03124407|2264780|FG000|Overall Study|Adverse Event|0
1151722|NCT03124407|2264781|FG001|Overall Study|Adverse Event|0
1151723|NCT03124407|2264782|FG002|Overall Study|Adverse Event|1
1151724|NCT03124407|2264783|FG003|Overall Study|Adverse Event|0
1151725|NCT03124459|2264803|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0
1151726|NCT03124459|2264804|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0
1151727|NCT03124459|2264805|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0
1151728|NCT03124459|2264806|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0
1151729|NCT03124459|2264807|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2
1151730|NCT03124459|2264808|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0
1151731|NCT03124459|2264803|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
1151732|NCT03124459|2264804|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
1151733|NCT03124459|2264805|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
1151734|NCT03124459|2264806|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
1151735|NCT03124459|2264807|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1
1151736|NCT03124459|2264808|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
1151737|NCT03124459|2264803|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
1151738|NCT03124459|2264804|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
1151739|NCT03124459|2264805|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
1151740|NCT03124459|2264806|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11
1151741|NCT03124459|2264807|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12
1151742|NCT03124459|2264808|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
1151743|NCT03124459|2264803|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
1151744|NCT03124459|2264804|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
1151745|NCT03124459|2264805|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
1151746|NCT03124459|2264806|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1
1151747|NCT03124459|2264807|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4
1151748|NCT03124459|2264808|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
1151749|NCT03124459|2264803|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
1151750|NCT03124459|2264804|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
1151751|NCT03124459|2264805|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
1151752|NCT03124459|2264806|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
1151753|NCT03124459|2264807|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
1151754|NCT03124459|2264808|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22
1151755|NCT03124459|2264803|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0
1151756|NCT03124459|2264804|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0
1151757|NCT03124459|2264805|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0
1151758|NCT03124459|2264806|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0
1151759|NCT03124459|2264807|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0
1151760|NCT03124459|2264808|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1
1151761|NCT03124537|2264823|FG000|Overall Study|Lost to Follow-up|3
1151762|NCT03124537|2264824|FG001|Overall Study|Lost to Follow-up|5
1151763|NCT03124537|2264823|FG000|Overall Study|App Crash, Incomplete Data|7
1151764|NCT03124537|2264824|FG001|Overall Study|App Crash, Incomplete Data|8
1151765|NCT03124563|2264836|FG000|Overall Study|Lost to Follow-up|1
1151766|NCT03124563|2264837|FG001|Overall Study|Lost to Follow-up|1
1151767|NCT03124563|2264836|FG000|Overall Study|Withdrawal by Subject|1
1151768|NCT03124563|2264837|FG001|Overall Study|Withdrawal by Subject|1
1151769|NCT03124784|2264859|FG000|Overall Study|Adverse Event|1
1151770|NCT03124784|2264859|FG000|Overall Study|Computer/Equip Malfunction|1
1151771|NCT03125200|2264912|FG000|Overall Study|Study Termination|0
1151772|NCT03125200|2264913|FG001|Overall Study|Study Termination|0
1151773|NCT03125200|2264914|FG002|Overall Study|Study Termination|0
1151774|NCT03125200|2264915|FG003|Overall Study|Study Termination|1
1151775|NCT03125200|2264916|FG004|Overall Study|Study Termination|1
1151776|NCT03125200|2264917|FG005|Overall Study|Study Termination|2
1151777|NCT03125200|2264918|FG006|Overall Study|Study Termination|1
1151778|NCT03125200|2264912|FG000|Overall Study|Clinical Progression|0
1151779|NCT03125200|2264913|FG001|Overall Study|Clinical Progression|0
1151780|NCT03125200|2264914|FG002|Overall Study|Clinical Progression|0
1151781|NCT03125200|2264915|FG003|Overall Study|Clinical Progression|1
1151782|NCT03125200|2264916|FG004|Overall Study|Clinical Progression|0
1151783|NCT03125200|2264917|FG005|Overall Study|Clinical Progression|1
1151784|NCT03125200|2264918|FG006|Overall Study|Clinical Progression|0
1151785|NCT03125200|2264912|FG000|Overall Study|Progressive Disease|2
1151786|NCT03125200|2264913|FG001|Overall Study|Progressive Disease|1
1151787|NCT03125200|2264914|FG002|Overall Study|Progressive Disease|2
1151788|NCT03125200|2264915|FG003|Overall Study|Progressive Disease|1
1151789|NCT03125200|2264916|FG004|Overall Study|Progressive Disease|2
1151790|NCT03125200|2264917|FG005|Overall Study|Progressive Disease|0
1151791|NCT03125200|2264918|FG006|Overall Study|Progressive Disease|1
1151792|NCT03125200|2264912|FG000|Overall Study|Lack of Efficacy|0
1151793|NCT03125200|2264913|FG001|Overall Study|Lack of Efficacy|0
1151794|NCT03125200|2264914|FG002|Overall Study|Lack of Efficacy|0
1151795|NCT03125200|2264915|FG003|Overall Study|Lack of Efficacy|1
1151796|NCT03125200|2264916|FG004|Overall Study|Lack of Efficacy|0
1151797|NCT03125200|2264917|FG005|Overall Study|Lack of Efficacy|0
1151798|NCT03125200|2264918|FG006|Overall Study|Lack of Efficacy|0
1151799|NCT03125200|2264912|FG000|Overall Study|Toxicity|0
1151800|NCT03125200|2264913|FG001|Overall Study|Toxicity|0
1151801|NCT03125200|2264914|FG002|Overall Study|Toxicity|0
1151802|NCT03125200|2264915|FG003|Overall Study|Toxicity|1
1151803|NCT03125200|2264916|FG004|Overall Study|Toxicity|0
1151804|NCT03125200|2264917|FG005|Overall Study|Toxicity|0
1151805|NCT03125200|2264918|FG006|Overall Study|Toxicity|0
1151806|NCT03125200|2264912|FG000|Overall Study|Consent Withdrawn by Subject|0
1151807|NCT03125200|2264913|FG001|Overall Study|Consent Withdrawn by Subject|1
1151808|NCT03125200|2264914|FG002|Overall Study|Consent Withdrawn by Subject|0
1151809|NCT03125200|2264915|FG003|Overall Study|Consent Withdrawn by Subject|0
1151810|NCT03125200|2264916|FG004|Overall Study|Consent Withdrawn by Subject|1
1151811|NCT03125200|2264917|FG005|Overall Study|Consent Withdrawn by Subject|0
1151812|NCT03125200|2264918|FG006|Overall Study|Consent Withdrawn by Subject|1
1151813|NCT03125395|2264941|FG000|Overall Study|Adverse Event|2
1151814|NCT03125395|2264941|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
1151815|NCT03125395|2264941|FG000|Overall Study|Physician Decision|2
1151816|NCT03125395|2264941|FG000|Overall Study|Commercial drug is available|5
1151817|NCT03125629|2264945|FG000|Overall Study|Withdrawal by Subject|2
1151818|NCT03125629|2264945|FG000|Overall Study|Equipment malfunction|1
1151819|NCT03125902|2264959|FG000|Overall Study|Death|52
1151820|NCT03125902|2264960|FG001|Overall Study|Death|123
1151821|NCT03125902|2264959|FG000|Overall Study|Lost to Follow-up|1
1151822|NCT03125902|2264960|FG001|Overall Study|Lost to Follow-up|0
1151823|NCT03125902|2264959|FG000|Overall Study|Mastectomy|0
1151824|NCT03125902|2264960|FG001|Overall Study|Mastectomy|1
1151825|NCT03125902|2264959|FG000|Overall Study|Physician Decision|1
1151826|NCT03125902|2264960|FG001|Overall Study|Physician Decision|0
1151827|NCT03125902|2264959|FG000|Overall Study|Withdrawal by Subject|13
1151828|NCT03125902|2264960|FG001|Overall Study|Withdrawal by Subject|25
1151829|NCT03125902|2264959|FG000|Overall Study|Study is ongoing|153
1151830|NCT03125902|2264960|FG001|Overall Study|Study is ongoing|282
1151831|NCT03125915|2264971|FG000|1 Month Follow up|Lost to Follow-up|3
1151832|NCT03125915|2264972|FG001|1 Month Follow up|Lost to Follow-up|3
1151833|NCT03125915|2264973|FG002|1 Month Follow up|Lost to Follow-up|2
1151834|NCT03125915|2264974|FG003|1 Month Follow up|Lost to Follow-up|3
1151835|NCT03125915|2264971|FG000|3 Month Follow-up|Lost to Follow-up|6
1151836|NCT03125915|2264972|FG001|3 Month Follow-up|Lost to Follow-up|4
1151837|NCT03125915|2264973|FG002|3 Month Follow-up|Lost to Follow-up|4
1151838|NCT03125915|2264974|FG003|3 Month Follow-up|Lost to Follow-up|2
1151839|NCT03125915|2264971|FG000|6 Month Follow-up|Lost to Follow-up|7
1151840|NCT03125915|2264972|FG001|6 Month Follow-up|Lost to Follow-up|3
1151841|NCT03125915|2264973|FG002|6 Month Follow-up|Lost to Follow-up|6
1151842|NCT03125915|2264974|FG003|6 Month Follow-up|Lost to Follow-up|3
1151843|NCT03125941|2264986|FG000|Overall Study|did not receive intervention|1
1151844|NCT03125941|2264987|FG001|Overall Study|did not receive intervention|2
1151845|NCT03126227|2264995|FG000|Overall Study|Adverse Event|43
1151846|NCT03126227|2264996|FG001|Overall Study|Adverse Event|4
1151847|NCT03126227|2264995|FG000|Overall Study|Death|0
1151848|NCT03126227|2264996|FG001|Overall Study|Death|1
1151849|NCT03126227|2264995|FG000|Overall Study|Lost to Follow-up|0
1151850|NCT03126227|2264996|FG001|Overall Study|Lost to Follow-up|1
1151851|NCT03126227|2264995|FG000|Overall Study|Physician Decision|2
1151852|NCT03126227|2264996|FG001|Overall Study|Physician Decision|0
1151853|NCT03126227|2264995|FG000|Overall Study|Protocol Violation|1
1151854|NCT03126227|2264996|FG001|Overall Study|Protocol Violation|0
1151855|NCT03126227|2264995|FG000|Overall Study|Withdrawal by Subject|19
1151856|NCT03126227|2264996|FG001|Overall Study|Withdrawal by Subject|3
1151857|NCT03126227|2264995|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8
1151858|NCT03126227|2264996|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1
1151859|NCT03126227|2264995|FG000|Overall Study|Lack of dosing compliance|2
1151860|NCT03126227|2264996|FG001|Overall Study|Lack of dosing compliance|0
1151861|NCT03126227|2264995|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2
1151862|NCT03126227|2264996|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0
1151863|NCT03126227|2264995|FG000|Overall Study|Scheduling conflict|1
1151864|NCT03126227|2264996|FG001|Overall Study|Scheduling conflict|0
1151865|NCT03126344|2265005|FG000|Overall Study|Lost to Follow-up|0
1151866|NCT03126344|2265006|FG001|Overall Study|Lost to Follow-up|0
1151867|NCT03126344|2265007|FG002|Overall Study|Lost to Follow-up|5
1151868|NCT03126539|2265038|FG000|Overall Study|Lost to Follow-up|1
1151869|NCT03126539|2265039|FG001|Overall Study|Lost to Follow-up|1
1151870|NCT03126539|2265040|FG002|Overall Study|Lost to Follow-up|1
1151871|NCT03126539|2265041|FG003|Overall Study|Lost to Follow-up|0
1151872|NCT03126539|2265042|FG004|Overall Study|Lost to Follow-up|0
1151873|NCT03126786|2265075|FG000|Overall Study|Adverse Event|3
1151874|NCT03126786|2265076|FG001|Overall Study|Adverse Event|0
1151875|NCT03126786|2265075|FG000|Overall Study|Lost to Follow-up|0
1151876|NCT03126786|2265076|FG001|Overall Study|Lost to Follow-up|1
1151877|NCT03126786|2265075|FG000|Overall Study|Withdrawal by Subject|3
1151878|NCT03126786|2265076|FG001|Overall Study|Withdrawal by Subject|1
1151879|NCT03127384|2265110|FG000|Overall Study|Lost to Follow-up|4
1151880|NCT03127384|2265110|FG000|Overall Study|Subject request|2
1151881|NCT03127644|2265128|FG000|Overall Study|Study-specific withdrawal criteria|0
1151882|NCT03127644|2265129|FG001|Overall Study|Study-specific withdrawal criteria|0
1151883|NCT03127644|2265130|FG002|Overall Study|Study-specific withdrawal criteria|2
1151884|NCT03128099|2265168|FG000|Overall Study|High dose task was too long|0
1151885|NCT03128099|2265169|FG001|Overall Study|High dose task was too long|4
1151886|NCT03128099|2265170|FG002|Overall Study|High dose task was too long|0
1151887|NCT03128099|2265168|FG000|Overall Study|Participant got a full time job.|1
1151888|NCT03128099|2265169|FG001|Overall Study|Participant got a full time job.|0
1151889|NCT03128099|2265170|FG002|Overall Study|Participant got a full time job.|0
1151890|NCT03128099|2265168|FG000|Overall Study|Became homeless and lost contact|1
1151891|NCT03128099|2265169|FG001|Overall Study|Became homeless and lost contact|0
1151892|NCT03128099|2265170|FG002|Overall Study|Became homeless and lost contact|0
1151893|NCT03128099|2265168|FG000|Overall Study|Did not complete all the assessments|0
1151894|NCT03128099|2265169|FG001|Overall Study|Did not complete all the assessments|0
1151895|NCT03128099|2265170|FG002|Overall Study|Did not complete all the assessments|1
1151896|NCT03128307|2265176|FG000|Overall Study|Lost to Follow-up|29
1151897|NCT03128307|2265176|FG000|Overall Study|Withdrawal by Subject|5
1151898|NCT03128411|2265184|FG000|Treatment Phase|Adverse Event|18
1151899|NCT03128411|2265184|FG000|Treatment Phase|Physician Decision|1
1151900|NCT03128411|2265184|FG000|Treatment Phase|Ongoing|41
1151901|NCT03128411|2265184|FG000|Long Term Follow-up Phase|Death|1
1151902|NCT03128411|2265184|FG000|Long Term Follow-up Phase|Ongoing|18
1151903|NCT03128723|2265188|FG000|Overall Study|Withdrawal by Subject|2
1151904|NCT03128892|2265192|FG000|Overall Study|Withdrawal by Subject|2
1151905|NCT03128892|2265192|FG000|Overall Study|Physician Decision|1
1151906|NCT03128931|2265196|FG000|Overall Study|Physician Decision|1
1151907|NCT03128931|2265196|FG000|Overall Study|Equipment Issues|3
1151908|NCT03129100|2265205|FG000|Lead-In Period (Period 1)|Adverse Event|2
1151909|NCT03129100|2265206|FG001|Lead-In Period (Period 1)|Adverse Event|6
1151910|NCT03129100|2265207|FG002|Lead-In Period (Period 1)|Adverse Event|0
1151911|NCT03129100|2265208|FG003|Lead-In Period (Period 1)|Adverse Event|0
1151912|NCT03129100|2265209|FG004|Lead-In Period (Period 1)|Adverse Event|0
1151913|NCT03129100|2265210|FG005|Lead-In Period (Period 1)|Adverse Event|0
1151914|NCT03129100|2265211|FG006|Lead-In Period (Period 1)|Adverse Event|0
1151915|NCT03129100|2265212|FG007|Lead-In Period (Period 1)|Adverse Event|0
1151916|NCT03129100|2265213|FG008|Lead-In Period (Period 1)|Adverse Event|0
1151917|NCT03129100|2265214|FG009|Lead-In Period (Period 1)|Adverse Event|0
1151918|NCT03129100|2265215|FG010|Lead-In Period (Period 1)|Adverse Event|0
1151919|NCT03129100|2265205|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2
1151920|NCT03129100|2265206|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0
1151921|NCT03129100|2265207|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0
1151922|NCT03129100|2265208|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0
1151923|NCT03129100|2265209|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0
1151924|NCT03129100|2265210|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0
1151925|NCT03129100|2265211|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0
1151926|NCT03129100|2265212|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0
1151927|NCT03129100|2265213|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0
1151928|NCT03129100|2265214|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0
1151929|NCT03129100|2265215|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0
1151930|NCT03129100|2265205|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8
1151931|NCT03129100|2265206|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8
1151932|NCT03129100|2265207|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0
1151933|NCT03129100|2265208|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0
1151934|NCT03129100|2265209|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0
1151935|NCT03129100|2265210|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0
1151936|NCT03129100|2265211|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0
1151937|NCT03129100|2265212|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0
1151938|NCT03129100|2265213|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0
1151939|NCT03129100|2265214|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0
1151940|NCT03129100|2265215|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0
1151941|NCT03129100|2265205|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3
1151942|NCT03129100|2265206|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2
1151943|NCT03129100|2265207|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0
1151944|NCT03129100|2265208|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0
1151945|NCT03129100|2265209|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0
1151946|NCT03129100|2265210|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0
1151947|NCT03129100|2265211|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0
1151948|NCT03129100|2265212|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0
1151949|NCT03129100|2265213|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0
1151950|NCT03129100|2265214|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0
1151951|NCT03129100|2265215|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0
1151952|NCT03129100|2265205|FG000|Lead-In Period (Period 1)|Surgery Programmed|0
1151953|NCT03129100|2265206|FG001|Lead-In Period (Period 1)|Surgery Programmed|1
1151954|NCT03129100|2265207|FG002|Lead-In Period (Period 1)|Surgery Programmed|0
1151955|NCT03129100|2265208|FG003|Lead-In Period (Period 1)|Surgery Programmed|0
1151956|NCT03129100|2265209|FG004|Lead-In Period (Period 1)|Surgery Programmed|0
1151957|NCT03129100|2265210|FG005|Lead-In Period (Period 1)|Surgery Programmed|0
1151958|NCT03129100|2265211|FG006|Lead-In Period (Period 1)|Surgery Programmed|0
1151959|NCT03129100|2265212|FG007|Lead-In Period (Period 1)|Surgery Programmed|0
1151960|NCT03129100|2265213|FG008|Lead-In Period (Period 1)|Surgery Programmed|0
1151961|NCT03129100|2265214|FG009|Lead-In Period (Period 1)|Surgery Programmed|0
1151962|NCT03129100|2265215|FG010|Lead-In Period (Period 1)|Surgery Programmed|0
1151963|NCT03129100|2265205|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0
1151964|NCT03129100|2265206|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0
1151965|NCT03129100|2265207|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2
1151966|NCT03129100|2265208|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1
1151967|NCT03129100|2265209|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0
1151968|NCT03129100|2265210|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2
1151969|NCT03129100|2265211|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0
1151970|NCT03129100|2265212|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0
1151971|NCT03129100|2265213|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0
1151972|NCT03129100|2265214|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0
1151973|NCT03129100|2265215|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0
1151974|NCT03129100|2265205|FG000|Period2 Extension Period (Group A and B)|Death|0
1151975|NCT03129100|2265206|FG001|Period2 Extension Period (Group A and B)|Death|0
1151976|NCT03129100|2265207|FG002|Period2 Extension Period (Group A and B)|Death|1
1151977|NCT03129100|2265208|FG003|Period2 Extension Period (Group A and B)|Death|0
1151978|NCT03129100|2265209|FG004|Period2 Extension Period (Group A and B)|Death|0
1151979|NCT03129100|2265210|FG005|Period2 Extension Period (Group A and B)|Death|0
1151980|NCT03129100|2265211|FG006|Period2 Extension Period (Group A and B)|Death|0
1151981|NCT03129100|2265212|FG007|Period2 Extension Period (Group A and B)|Death|0
1151982|NCT03129100|2265213|FG008|Period2 Extension Period (Group A and B)|Death|0
1151983|NCT03129100|2265214|FG009|Period2 Extension Period (Group A and B)|Death|0
1151984|NCT03129100|2265215|FG010|Period2 Extension Period (Group A and B)|Death|0
1151985|NCT03129100|2265205|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
1151986|NCT03129100|2265206|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
1151987|NCT03129100|2265207|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13
1151988|NCT03129100|2265208|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5
1151989|NCT03129100|2265209|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
1151990|NCT03129100|2265210|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
1151991|NCT03129100|2265211|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2
1151992|NCT03129100|2265212|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
1151993|NCT03129100|2265213|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
1151994|NCT03129100|2265214|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
1151995|NCT03129100|2265215|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
1151996|NCT03129100|2265205|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0
1151997|NCT03129100|2265206|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0
1151998|NCT03129100|2265207|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1
1151999|NCT03129100|2265208|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0
1152000|NCT03129100|2265209|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0
1152001|NCT03129100|2265210|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0
1152002|NCT03129100|2265211|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0
1152003|NCT03129100|2265212|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0
1152004|NCT03129100|2265213|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0
1152005|NCT03129100|2265214|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0
1152006|NCT03129100|2265215|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0
1152007|NCT03129100|2265205|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
1152008|NCT03129100|2265206|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
1152009|NCT03129100|2265207|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2
1152010|NCT03129100|2265208|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
1152011|NCT03129100|2265209|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
1152012|NCT03129100|2265210|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
1152013|NCT03129100|2265211|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
1152014|NCT03129100|2265212|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
1152015|NCT03129100|2265213|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
1152016|NCT03129100|2265214|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
1152017|NCT03129100|2265215|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
1152018|NCT03129100|2265205|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
1152019|NCT03129100|2265206|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
1152020|NCT03129100|2265207|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2
1152021|NCT03129100|2265208|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
1152022|NCT03129100|2265209|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
1152023|NCT03129100|2265210|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
1152024|NCT03129100|2265211|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
1152025|NCT03129100|2265212|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
1152026|NCT03129100|2265213|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
1152027|NCT03129100|2265214|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
1152028|NCT03129100|2265215|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
1152029|NCT03129100|2265205|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0
1152030|NCT03129100|2265206|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0
1152031|NCT03129100|2265207|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0
1152032|NCT03129100|2265208|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0
1152033|NCT03129100|2265209|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5
1152034|NCT03129100|2265210|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6
1152035|NCT03129100|2265211|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19
1152036|NCT03129100|2265212|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0
1152037|NCT03129100|2265213|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0
1152038|NCT03129100|2265214|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0
1152039|NCT03129100|2265215|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0
1152040|NCT03129100|2265205|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
1152041|NCT03129100|2265206|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
1152042|NCT03129100|2265207|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
1152043|NCT03129100|2265208|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
1152044|NCT03129100|2265209|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
1152045|NCT03129100|2265210|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
1152046|NCT03129100|2265211|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
1152047|NCT03129100|2265212|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
1152048|NCT03129100|2265213|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
1152049|NCT03129100|2265214|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1
1152050|NCT03129100|2265215|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
1152051|NCT03130257|2265278|FG000|Overall Study|Withdrawal by Subject|1
1152052|NCT03130257|2265279|FG001|Overall Study|Withdrawal by Subject|0
1152053|NCT03130257|2265280|FG002|Overall Study|Withdrawal by Subject|2
1152054|NCT03130959|2265311|FG000|Treatment Period|Disease progression|18
1152055|NCT03130959|2265312|FG001|Treatment Period|Disease progression|15
1152056|NCT03130959|2265313|FG002|Treatment Period|Disease progression|12
1152057|NCT03130959|2265314|FG003|Treatment Period|Disease progression|8
1152058|NCT03130959|2265315|FG004|Treatment Period|Disease progression|12
1152059|NCT03130959|2265316|FG005|Treatment Period|Disease progression|11
1152060|NCT03130959|2265317|FG006|Treatment Period|Disease progression|6
1152061|NCT03130959|2265318|FG007|Treatment Period|Disease progression|9
1152062|NCT03130959|2265319|FG008|Treatment Period|Disease progression|15
1152063|NCT03130959|2265320|FG009|Treatment Period|Disease progression|9
1152064|NCT03130959|2265311|FG000|Treatment Period|Study drug toxicity|2
1152065|NCT03130959|2265312|FG001|Treatment Period|Study drug toxicity|3
1152066|NCT03130959|2265313|FG002|Treatment Period|Study drug toxicity|1
1152067|NCT03130959|2265314|FG003|Treatment Period|Study drug toxicity|2
1152068|NCT03130959|2265315|FG004|Treatment Period|Study drug toxicity|1
1152069|NCT03130959|2265316|FG005|Treatment Period|Study drug toxicity|2
1152070|NCT03130959|2265317|FG006|Treatment Period|Study drug toxicity|3
1152071|NCT03130959|2265318|FG007|Treatment Period|Study drug toxicity|0
1152072|NCT03130959|2265319|FG008|Treatment Period|Study drug toxicity|3
1152073|NCT03130959|2265320|FG009|Treatment Period|Study drug toxicity|4
1152074|NCT03130959|2265311|FG000|Treatment Period|Other reasons|1
1152075|NCT03130959|2265312|FG001|Treatment Period|Other reasons|0
1152076|NCT03130959|2265313|FG002|Treatment Period|Other reasons|0
1152077|NCT03130959|2265314|FG003|Treatment Period|Other reasons|0
1152078|NCT03130959|2265315|FG004|Treatment Period|Other reasons|0
1152079|NCT03130959|2265316|FG005|Treatment Period|Other reasons|0
1152080|NCT03130959|2265317|FG006|Treatment Period|Other reasons|1
1152081|NCT03130959|2265318|FG007|Treatment Period|Other reasons|0
1152082|NCT03130959|2265319|FG008|Treatment Period|Other reasons|0
1152083|NCT03130959|2265320|FG009|Treatment Period|Other reasons|0
1152084|NCT03130959|2265311|FG000|Treatment Period|Participant request to stop therapy|0
1152085|NCT03130959|2265312|FG001|Treatment Period|Participant request to stop therapy|1
1152086|NCT03130959|2265313|FG002|Treatment Period|Participant request to stop therapy|1
1152087|NCT03130959|2265314|FG003|Treatment Period|Participant request to stop therapy|1
1152088|NCT03130959|2265315|FG004|Treatment Period|Participant request to stop therapy|0
1152089|NCT03130959|2265316|FG005|Treatment Period|Participant request to stop therapy|0
1152090|NCT03130959|2265317|FG006|Treatment Period|Participant request to stop therapy|1
1152091|NCT03130959|2265318|FG007|Treatment Period|Participant request to stop therapy|1
1152092|NCT03130959|2265319|FG008|Treatment Period|Participant request to stop therapy|0
1152093|NCT03130959|2265320|FG009|Treatment Period|Participant request to stop therapy|0
1152094|NCT03130959|2265311|FG000|Treatment Period|Not reported|0
1152095|NCT03130959|2265312|FG001|Treatment Period|Not reported|2
1152096|NCT03130959|2265313|FG002|Treatment Period|Not reported|0
1152097|NCT03130959|2265314|FG003|Treatment Period|Not reported|1
1152098|NCT03130959|2265315|FG004|Treatment Period|Not reported|0
1152099|NCT03130959|2265316|FG005|Treatment Period|Not reported|2
1152100|NCT03130959|2265317|FG006|Treatment Period|Not reported|0
1152101|NCT03130959|2265318|FG007|Treatment Period|Not reported|0
1152102|NCT03130959|2265319|FG008|Treatment Period|Not reported|0
1152103|NCT03130959|2265320|FG009|Treatment Period|Not reported|2
1152104|NCT03130959|2265311|FG000|Treatment Period|Adverse Event unrelated to drug|0
1152105|NCT03130959|2265312|FG001|Treatment Period|Adverse Event unrelated to drug|0
1152106|NCT03130959|2265313|FG002|Treatment Period|Adverse Event unrelated to drug|1
1152107|NCT03130959|2265314|FG003|Treatment Period|Adverse Event unrelated to drug|1
1152108|NCT03130959|2265315|FG004|Treatment Period|Adverse Event unrelated to drug|1
1152109|NCT03130959|2265316|FG005|Treatment Period|Adverse Event unrelated to drug|0
1152110|NCT03130959|2265317|FG006|Treatment Period|Adverse Event unrelated to drug|1
1152111|NCT03130959|2265318|FG007|Treatment Period|Adverse Event unrelated to drug|0
1152112|NCT03130959|2265319|FG008|Treatment Period|Adverse Event unrelated to drug|1
1152113|NCT03130959|2265320|FG009|Treatment Period|Adverse Event unrelated to drug|1
1152114|NCT03130959|2265311|FG000|Treatment Period|Participant withdrew consent|0
1152115|NCT03130959|2265312|FG001|Treatment Period|Participant withdrew consent|0
1152116|NCT03130959|2265313|FG002|Treatment Period|Participant withdrew consent|0
1152117|NCT03130959|2265314|FG003|Treatment Period|Participant withdrew consent|2
1152118|NCT03130959|2265315|FG004|Treatment Period|Participant withdrew consent|1
1152119|NCT03130959|2265316|FG005|Treatment Period|Participant withdrew consent|0
1152120|NCT03130959|2265317|FG006|Treatment Period|Participant withdrew consent|0
1152121|NCT03130959|2265318|FG007|Treatment Period|Participant withdrew consent|0
1152122|NCT03130959|2265319|FG008|Treatment Period|Participant withdrew consent|0
1152123|NCT03130959|2265320|FG009|Treatment Period|Participant withdrew consent|2
1152124|NCT03130959|2265311|FG000|Follow-up Period|Death|16
1152125|NCT03130959|2265312|FG001|Follow-up Period|Death|17
1152126|NCT03130959|2265313|FG002|Follow-up Period|Death|12
1152127|NCT03130959|2265314|FG003|Follow-up Period|Death|10
1152128|NCT03130959|2265315|FG004|Follow-up Period|Death|11
1152129|NCT03130959|2265316|FG005|Follow-up Period|Death|8
1152130|NCT03130959|2265317|FG006|Follow-up Period|Death|9
1152131|NCT03130959|2265318|FG007|Follow-up Period|Death|7
1152132|NCT03130959|2265319|FG008|Follow-up Period|Death|17
1152133|NCT03130959|2265320|FG009|Follow-up Period|Death|10
1152134|NCT03130959|2265311|FG000|Follow-up Period|Participant withdrew consent|3
1152135|NCT03130959|2265312|FG001|Follow-up Period|Participant withdrew consent|1
1152136|NCT03130959|2265313|FG002|Follow-up Period|Participant withdrew consent|0
1152137|NCT03130959|2265314|FG003|Follow-up Period|Participant withdrew consent|3
1152138|NCT03130959|2265315|FG004|Follow-up Period|Participant withdrew consent|3
1152139|NCT03130959|2265316|FG005|Follow-up Period|Participant withdrew consent|0
1152140|NCT03130959|2265317|FG006|Follow-up Period|Participant withdrew consent|0
1152141|NCT03130959|2265318|FG007|Follow-up Period|Participant withdrew consent|1
1152142|NCT03130959|2265319|FG008|Follow-up Period|Participant withdrew consent|1
1152143|NCT03130959|2265320|FG009|Follow-up Period|Participant withdrew consent|3
1152144|NCT03130959|2265311|FG000|Follow-up Period|Lost to Follow-up|1
1152145|NCT03130959|2265312|FG001|Follow-up Period|Lost to Follow-up|1
1152146|NCT03130959|2265313|FG002|Follow-up Period|Lost to Follow-up|0
1152147|NCT03130959|2265314|FG003|Follow-up Period|Lost to Follow-up|0
1152148|NCT03130959|2265315|FG004|Follow-up Period|Lost to Follow-up|0
1152149|NCT03130959|2265316|FG005|Follow-up Period|Lost to Follow-up|2
1152150|NCT03130959|2265317|FG006|Follow-up Period|Lost to Follow-up|0
1152151|NCT03130959|2265318|FG007|Follow-up Period|Lost to Follow-up|0
1152152|NCT03130959|2265319|FG008|Follow-up Period|Lost to Follow-up|0
1152153|NCT03130959|2265320|FG009|Follow-up Period|Lost to Follow-up|1
1152154|NCT03130959|2265311|FG000|Follow-up Period|Other reasons|0
1152155|NCT03130959|2265312|FG001|Follow-up Period|Other reasons|1
1152156|NCT03130959|2265313|FG002|Follow-up Period|Other reasons|0
1152157|NCT03130959|2265314|FG003|Follow-up Period|Other reasons|1
1152158|NCT03130959|2265315|FG004|Follow-up Period|Other reasons|0
1152159|NCT03130959|2265316|FG005|Follow-up Period|Other reasons|0
1152160|NCT03130959|2265317|FG006|Follow-up Period|Other reasons|0
1152161|NCT03130959|2265318|FG007|Follow-up Period|Other reasons|0
1152162|NCT03130959|2265319|FG008|Follow-up Period|Other reasons|0
1152163|NCT03130959|2265320|FG009|Follow-up Period|Other reasons|2
1152164|NCT03131167|2265368|FG000|Overall Study|Other (Unspecified)|0
1152165|NCT03131167|2265369|FG001|Overall Study|Other (Unspecified)|0
1152166|NCT03131167|2265370|FG002|Overall Study|Other (Unspecified)|0
1152167|NCT03131167|2265371|FG003|Overall Study|Other (Unspecified)|0
1152168|NCT03131167|2265372|FG004|Overall Study|Other (Unspecified)|0
1152169|NCT03131167|2265373|FG005|Overall Study|Other (Unspecified)|1
1152170|NCT03131167|2265374|FG006|Overall Study|Other (Unspecified)|0
1152171|NCT03131167|2265375|FG007|Overall Study|Other (Unspecified)|0
1152172|NCT03131167|2265376|FG008|Overall Study|Other (Unspecified)|0
1152173|NCT03131167|2265377|FG009|Overall Study|Other (Unspecified)|0
1152174|NCT03131167|2265378|FG010|Overall Study|Other (Unspecified)|0
1152175|NCT03131167|2265379|FG011|Overall Study|Other (Unspecified)|0
1152176|NCT03131167|2265380|FG012|Overall Study|Other (Unspecified)|0
1152177|NCT03131219|2265432|FG000|Initial Evaluation Period|Adverse Event|1
1152178|NCT03131219|2265433|FG001|Initial Evaluation Period|Adverse Event|0
1152179|NCT03131219|2265432|FG000|Initial Evaluation Period|Protocol Violation|1
1152180|NCT03131219|2265433|FG001|Initial Evaluation Period|Protocol Violation|0
1152181|NCT03131219|2265432|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2
1152182|NCT03131219|2265433|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0
1152183|NCT03131453|2265442|FG000|Overall Study|Study terminated by Sponsor|424
1152184|NCT03131453|2265443|FG001|Overall Study|Study terminated by Sponsor|222
1152185|NCT03131453|2265444|FG002|Overall Study|Study terminated by Sponsor|438
1152186|NCT03131453|2265442|FG000|Overall Study|Withdrawal by Subject|18
1152187|NCT03131453|2265443|FG001|Overall Study|Withdrawal by Subject|7
1152188|NCT03131453|2265444|FG002|Overall Study|Withdrawal by Subject|13
1152189|NCT03131453|2265442|FG000|Overall Study|Adverse Event|10
1152190|NCT03131453|2265443|FG001|Overall Study|Adverse Event|3
1152191|NCT03131453|2265444|FG002|Overall Study|Adverse Event|3
1152192|NCT03131453|2265442|FG000|Overall Study|Lost to Follow-up|1
1152193|NCT03131453|2265443|FG001|Overall Study|Lost to Follow-up|0
1152194|NCT03131453|2265444|FG002|Overall Study|Lost to Follow-up|1
1152195|NCT03131453|2265442|FG000|Overall Study|Physician Decision|1
1152196|NCT03131453|2265443|FG001|Overall Study|Physician Decision|0
1152197|NCT03131453|2265444|FG002|Overall Study|Physician Decision|1
1152198|NCT03131453|2265442|FG000|Overall Study|Non-compliance with study treatment|1
1152199|NCT03131453|2265443|FG001|Overall Study|Non-compliance with study treatment|0
1152200|NCT03131453|2265444|FG002|Overall Study|Non-compliance with study treatment|0
1152201|NCT03131453|2265442|FG000|Overall Study|Technical problems|1
1152202|NCT03131453|2265443|FG001|Overall Study|Technical problems|0
1152203|NCT03131453|2265444|FG002|Overall Study|Technical problems|0
1152204|NCT03131453|2265442|FG000|Overall Study|Protocol deviation|0
1152205|NCT03131453|2265443|FG001|Overall Study|Protocol deviation|1
1152206|NCT03131453|2265444|FG002|Overall Study|Protocol deviation|0
1152207|NCT03131479|2265457|FG000|Overall Study|Adverse Event|0
1152208|NCT03131479|2265458|FG001|Overall Study|Adverse Event|0
1152209|NCT03131479|2265459|FG002|Overall Study|Adverse Event|1
1152210|NCT03131479|2265460|FG003|Overall Study|Adverse Event|1
1152211|NCT03131479|2265461|FG004|Overall Study|Adverse Event|0
1152212|NCT03131479|2265457|FG000|Overall Study|Subject/Guardian Decision|0
1152213|NCT03131479|2265458|FG001|Overall Study|Subject/Guardian Decision|0
1152214|NCT03131479|2265459|FG002|Overall Study|Subject/Guardian Decision|0
1152215|NCT03131479|2265460|FG003|Overall Study|Subject/Guardian Decision|1
1152216|NCT03131479|2265461|FG004|Overall Study|Subject/Guardian Decision|0
1152217|NCT03131570|2265475|FG000|Overall Study|Adverse Event|1
1152218|NCT03131570|2265476|FG001|Overall Study|Adverse Event|0
1152219|NCT03131596|2265484|FG000|Overall Study|Protocol Violation|3
1152220|NCT03131596|2265485|FG001|Overall Study|Protocol Violation|3
1152221|NCT03131596|2265484|FG000|Overall Study|Lost to Follow-up|3
1152222|NCT03131596|2265485|FG001|Overall Study|Lost to Follow-up|0
1152223|NCT03131648|2265493|FG000|Initial Treatment Period|Not dosed|2
1152224|NCT03131648|2265494|FG001|Initial Treatment Period|Not dosed|2
1152225|NCT03131648|2265495|FG002|Initial Treatment Period|Not dosed|0
1152226|NCT03131648|2265496|FG003|Initial Treatment Period|Not dosed|0
1152227|NCT03131648|2265497|FG004|Initial Treatment Period|Not dosed|0
1152228|NCT03131648|2265498|FG005|Initial Treatment Period|Not dosed|0
1152229|NCT03131648|2265499|FG006|Initial Treatment Period|Not dosed|0
1152230|NCT03131648|2265500|FG007|Initial Treatment Period|Not dosed|0
1152231|NCT03131648|2265493|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51
1152232|NCT03131648|2265494|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18
1152233|NCT03131648|2265495|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
1152234|NCT03131648|2265496|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
1152235|NCT03131648|2265497|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
1152236|NCT03131648|2265498|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
1152237|NCT03131648|2265499|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
1152238|NCT03131648|2265500|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0
1152239|NCT03131648|2265493|FG000|Open-label Treatment|Discontinued IMP|0
1152240|NCT03131648|2265494|FG001|Open-label Treatment|Discontinued IMP|0
1152241|NCT03131648|2265495|FG002|Open-label Treatment|Discontinued IMP|0
1152242|NCT03131648|2265496|FG003|Open-label Treatment|Discontinued IMP|0
1152243|NCT03131648|2265497|FG004|Open-label Treatment|Discontinued IMP|0
1152244|NCT03131648|2265498|FG005|Open-label Treatment|Discontinued IMP|0
1152245|NCT03131648|2265499|FG006|Open-label Treatment|Discontinued IMP|112
1152246|NCT03131648|2265500|FG007|Open-label Treatment|Discontinued IMP|0
1152247|NCT03131648|2265493|FG000|Open-label Treatment|Completed Week 50|0
1152248|NCT03131648|2265494|FG001|Open-label Treatment|Completed Week 50|0
1152249|NCT03131648|2265495|FG002|Open-label Treatment|Completed Week 50|0
1152250|NCT03131648|2265496|FG003|Open-label Treatment|Completed Week 50|0
1152251|NCT03131648|2265497|FG004|Open-label Treatment|Completed Week 50|0
1152252|NCT03131648|2265498|FG005|Open-label Treatment|Completed Week 50|0
1152253|NCT03131648|2265499|FG006|Open-label Treatment|Completed Week 50|6
1152254|NCT03131648|2265500|FG007|Open-label Treatment|Completed Week 50|0
1152255|NCT03131648|2265493|FG000|Maintenance Treatment Period|Not dosed|0
1152256|NCT03131648|2265494|FG001|Maintenance Treatment Period|Not dosed|0
1152257|NCT03131648|2265495|FG002|Maintenance Treatment Period|Not dosed|3
1152258|NCT03131648|2265496|FG003|Maintenance Treatment Period|Not dosed|2
1152259|NCT03131648|2265497|FG004|Maintenance Treatment Period|Not dosed|1
1152260|NCT03131648|2265498|FG005|Maintenance Treatment Period|Not dosed|0
1152261|NCT03131648|2265499|FG006|Maintenance Treatment Period|Not dosed|0
1152262|NCT03131648|2265500|FG007|Maintenance Treatment Period|Not dosed|0
1152263|NCT03131648|2265493|FG000|Maintenance Treatment Period|Discontinued IMP|0
1152264|NCT03131648|2265494|FG001|Maintenance Treatment Period|Discontinued IMP|0
1152265|NCT03131648|2265495|FG002|Maintenance Treatment Period|Discontinued IMP|3
1152266|NCT03131648|2265496|FG003|Maintenance Treatment Period|Discontinued IMP|5
1152267|NCT03131648|2265497|FG004|Maintenance Treatment Period|Discontinued IMP|4
1152268|NCT03131648|2265498|FG005|Maintenance Treatment Period|Discontinued IMP|4
1152269|NCT03131648|2265499|FG006|Maintenance Treatment Period|Discontinued IMP|0
1152270|NCT03131648|2265500|FG007|Maintenance Treatment Period|Discontinued IMP|0
1152271|NCT03131648|2265493|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
1152272|NCT03131648|2265494|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
1152273|NCT03131648|2265495|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21
1152274|NCT03131648|2265496|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18
1152275|NCT03131648|2265497|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9
1152276|NCT03131648|2265498|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10
1152277|NCT03131648|2265499|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
1152278|NCT03131648|2265500|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0
1152279|NCT03131648|2265493|FG000|Maintenance Treatment Period|Completed Week 50|0
1152280|NCT03131648|2265494|FG001|Maintenance Treatment Period|Completed Week 50|0
1152281|NCT03131648|2265495|FG002|Maintenance Treatment Period|Completed Week 50|0
1152282|NCT03131648|2265496|FG003|Maintenance Treatment Period|Completed Week 50|0
1152283|NCT03131648|2265497|FG004|Maintenance Treatment Period|Completed Week 50|1
1152284|NCT03131648|2265498|FG005|Maintenance Treatment Period|Completed Week 50|0
1152285|NCT03131648|2265499|FG006|Maintenance Treatment Period|Completed Week 50|0
1152286|NCT03131648|2265500|FG007|Maintenance Treatment Period|Completed Week 50|0
1152287|NCT03131648|2265493|FG000|Open-label (Short Term Extension)|Discontinued IMP|0
1152288|NCT03131648|2265494|FG001|Open-label (Short Term Extension)|Discontinued IMP|0
1152289|NCT03131648|2265495|FG002|Open-label (Short Term Extension)|Discontinued IMP|0
1152290|NCT03131648|2265496|FG003|Open-label (Short Term Extension)|Discontinued IMP|0
1152291|NCT03131648|2265497|FG004|Open-label (Short Term Extension)|Discontinued IMP|0
1152292|NCT03131648|2265498|FG005|Open-label (Short Term Extension)|Discontinued IMP|0
1152293|NCT03131648|2265499|FG006|Open-label (Short Term Extension)|Discontinued IMP|0
1152294|NCT03131648|2265500|FG007|Open-label (Short Term Extension)|Discontinued IMP|3
1152295|NCT03131687|2265523|FG000|Overall Study|Adverse Event|0
1152296|NCT03131687|2265524|FG001|Overall Study|Adverse Event|1
1152297|NCT03131687|2265525|FG002|Overall Study|Adverse Event|0
1152298|NCT03131687|2265526|FG003|Overall Study|Adverse Event|1
1152299|NCT03131687|2265527|FG004|Overall Study|Adverse Event|2
1152300|NCT03131687|2265528|FG005|Overall Study|Adverse Event|2
1152301|NCT03131687|2265523|FG000|Overall Study|Death|1
1152302|NCT03131687|2265524|FG001|Overall Study|Death|0
1152303|NCT03131687|2265525|FG002|Overall Study|Death|0
1152304|NCT03131687|2265526|FG003|Overall Study|Death|0
1152305|NCT03131687|2265527|FG004|Overall Study|Death|0
1152306|NCT03131687|2265528|FG005|Overall Study|Death|0
1152307|NCT03131687|2265523|FG000|Overall Study|Withdrawal by Subject|3
1152308|NCT03131687|2265524|FG001|Overall Study|Withdrawal by Subject|3
1152309|NCT03131687|2265525|FG002|Overall Study|Withdrawal by Subject|3
1152310|NCT03131687|2265526|FG003|Overall Study|Withdrawal by Subject|1
1152311|NCT03131687|2265527|FG004|Overall Study|Withdrawal by Subject|2
1152312|NCT03131687|2265528|FG005|Overall Study|Withdrawal by Subject|1
1152313|NCT03131687|2265523|FG000|Overall Study|Lost to Follow-up|1
1152314|NCT03131687|2265524|FG001|Overall Study|Lost to Follow-up|4
1152315|NCT03131687|2265525|FG002|Overall Study|Lost to Follow-up|0
1152316|NCT03131687|2265526|FG003|Overall Study|Lost to Follow-up|1
1152317|NCT03131687|2265527|FG004|Overall Study|Lost to Follow-up|4
1152318|NCT03131687|2265528|FG005|Overall Study|Lost to Follow-up|2
1152319|NCT03131687|2265523|FG000|Overall Study|Participant Started New Diabetic Drug|1
1152320|NCT03131687|2265524|FG001|Overall Study|Participant Started New Diabetic Drug|0
1152321|NCT03131687|2265525|FG002|Overall Study|Participant Started New Diabetic Drug|0
1152322|NCT03131687|2265526|FG003|Overall Study|Participant Started New Diabetic Drug|0
1152323|NCT03131687|2265527|FG004|Overall Study|Participant Started New Diabetic Drug|0
1152324|NCT03131687|2265528|FG005|Overall Study|Participant Started New Diabetic Drug|0
1152325|NCT03131687|2265523|FG000|Overall Study|Principle Investigator Decision|0
1152326|NCT03131687|2265524|FG001|Overall Study|Principle Investigator Decision|1
1152327|NCT03131687|2265525|FG002|Overall Study|Principle Investigator Decision|0
1152328|NCT03131687|2265526|FG003|Overall Study|Principle Investigator Decision|0
1152329|NCT03131687|2265527|FG004|Overall Study|Principle Investigator Decision|0
1152330|NCT03131687|2265528|FG005|Overall Study|Principle Investigator Decision|0
1152331|NCT03131687|2265523|FG000|Overall Study|Inadvertent Enrollment|0
1152332|NCT03131687|2265524|FG001|Overall Study|Inadvertent Enrollment|0
1152333|NCT03131687|2265525|FG002|Overall Study|Inadvertent Enrollment|0
1152334|NCT03131687|2265526|FG003|Overall Study|Inadvertent Enrollment|1
1152335|NCT03131687|2265527|FG004|Overall Study|Inadvertent Enrollment|0
1152336|NCT03131687|2265528|FG005|Overall Study|Inadvertent Enrollment|0
1152337|NCT03131713|2265557|FG000|Overall Study|Lost to Follow-up|5
1152338|NCT03131713|2265558|FG001|Overall Study|Lost to Follow-up|0
1152339|NCT03131895|2265568|FG000|Washout Period (at Least 5 Days)|Adverse Event|1
1152340|NCT03131895|2265569|FG001|Washout Period (at Least 5 Days)|Adverse Event|0
1152341|NCT03131895|2265570|FG002|Washout Period (at Least 5 Days)|Adverse Event|0
1152342|NCT03131895|2265571|FG003|Washout Period (at Least 5 Days)|Adverse Event|1
1152343|NCT03131895|2265568|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
1152344|NCT03131895|2265569|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3
1152345|NCT03131895|2265570|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2
1152346|NCT03131895|2265571|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3
1152347|NCT03131895|2265568|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1152348|NCT03131895|2265569|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
1152349|NCT03131895|2265570|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1152350|NCT03131895|2265571|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
1152351|NCT03131895|2265568|FG000|Washout Period (at Least 5 Days)|Other|0
1152352|NCT03131895|2265569|FG001|Washout Period (at Least 5 Days)|Other|0
1152353|NCT03131895|2265570|FG002|Washout Period (at Least 5 Days)|Other|2
1152354|NCT03131895|2265571|FG003|Washout Period (at Least 5 Days)|Other|0
1152355|NCT03131895|2265568|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0
1152356|NCT03131895|2265569|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1
1152357|NCT03131895|2265570|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0
1152358|NCT03131895|2265571|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0
1152359|NCT03131895|2265568|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
1152360|NCT03131895|2265569|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
1152361|NCT03131895|2265570|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
1152362|NCT03131895|2265571|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
1152363|NCT03131960|2265583|FG000|Overall Study|Adverse Event|0
1152364|NCT03131960|2265584|FG001|Overall Study|Adverse Event|1
1152365|NCT03131999|2265592|FG000|Overall Study|Withdrawal by Subject|0
1152366|NCT03131999|2265593|FG001|Overall Study|Withdrawal by Subject|1
1152367|NCT03132220|2265601|FG000|Overall Study|Lost to Follow-up|17
1152368|NCT03132220|2265602|FG001|Overall Study|Lost to Follow-up|8
1152369|NCT03132220|2265601|FG000|Overall Study|Withdrawal by Subject|1
1152370|NCT03132220|2265602|FG001|Overall Study|Withdrawal by Subject|4
1152371|NCT03132753|2265637|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27
1152372|NCT03132753|2265638|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32
1152373|NCT03132753|2265637|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6
1152374|NCT03132753|2265638|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2
1152375|NCT03133481|2265646|FG000|Overall Study|FC Catheter fell out post operative day1|0
1152376|NCT03133481|2265647|FG001|Overall Study|FC Catheter fell out post operative day1|4
1152377|NCT03133767|2265699|FG000|Overall Study|Lost to Follow-up|38
1152378|NCT03133767|2265700|FG001|Overall Study|Lost to Follow-up|24
1152379|NCT03133767|2265699|FG000|Overall Study|Protocol Violation|0
1152380|NCT03133767|2265700|FG001|Overall Study|Protocol Violation|1
1152381|NCT03134183|2265739|FG000|Overall Study|Withdrawal by Subject|1
1152382|NCT03134183|2265740|FG001|Overall Study|Withdrawal by Subject|1
1152383|NCT03134222|2265762|FG000|Treatment Period (Up to Week 12)|Adverse Event|4
1152384|NCT03134222|2265763|FG001|Treatment Period (Up to Week 12)|Adverse Event|1
1152385|NCT03134222|2265764|FG002|Treatment Period (Up to Week 12)|Adverse Event|0
1152386|NCT03134222|2265765|FG003|Treatment Period (Up to Week 12)|Adverse Event|0
1152387|NCT03134222|2265766|FG004|Treatment Period (Up to Week 12)|Adverse Event|0
1152388|NCT03134222|2265762|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1
1152389|NCT03134222|2265763|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1
1152390|NCT03134222|2265764|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1
1152391|NCT03134222|2265765|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0
1152392|NCT03134222|2265766|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0
1152393|NCT03134222|2265762|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0
1152394|NCT03134222|2265763|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1
1152395|NCT03134222|2265764|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0
1152396|NCT03134222|2265765|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0
1152397|NCT03134222|2265766|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0
1152398|NCT03134222|2265762|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0
1152399|NCT03134222|2265763|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1
1152400|NCT03134222|2265764|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1
1152401|NCT03134222|2265765|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0
1152402|NCT03134222|2265766|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0
1152403|NCT03134222|2265762|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0
1152404|NCT03134222|2265763|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2
1152405|NCT03134222|2265764|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0
1152406|NCT03134222|2265765|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0
1152407|NCT03134222|2265766|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1
1152408|NCT03134222|2265762|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2
1152409|NCT03134222|2265763|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
1152410|NCT03134222|2265764|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
1152411|NCT03134222|2265765|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
1152412|NCT03134222|2265766|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
1152413|NCT03134222|2265762|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
1152414|NCT03134222|2265763|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
1152415|NCT03134222|2265764|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
1152416|NCT03134222|2265765|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1
1152417|NCT03134222|2265766|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
1152418|NCT03134222|2265762|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
1152419|NCT03134222|2265763|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1
1152420|NCT03134222|2265764|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
1152421|NCT03134222|2265765|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
1152422|NCT03134222|2265766|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
1152423|NCT03134599|2265799|FG000|Week 1|Lost to Follow-up|0
1152424|NCT03134599|2265800|FG001|Week 1|Lost to Follow-up|0
1152425|NCT03134599|2265801|FG002|Week 1|Lost to Follow-up|0
1152426|NCT03134599|2265802|FG003|Week 1|Lost to Follow-up|0
1152427|NCT03134599|2265803|FG004|Week 1|Lost to Follow-up|1
1152428|NCT03134599|2265804|FG005|Week 1|Lost to Follow-up|0
1152429|NCT03134599|2265799|FG000|Week 2|Lost to Follow-up|1
1152430|NCT03134599|2265800|FG001|Week 2|Lost to Follow-up|0
1152431|NCT03134599|2265801|FG002|Week 2|Lost to Follow-up|0
1152432|NCT03134599|2265802|FG003|Week 2|Lost to Follow-up|1
1152433|NCT03134599|2265803|FG004|Week 2|Lost to Follow-up|1
1152434|NCT03134599|2265804|FG005|Week 2|Lost to Follow-up|0
1152435|NCT03134599|2265799|FG000|Week 3|Lost to Follow-up|0
1152436|NCT03134599|2265800|FG001|Week 3|Lost to Follow-up|0
1152437|NCT03134599|2265801|FG002|Week 3|Lost to Follow-up|0
1152438|NCT03134599|2265802|FG003|Week 3|Lost to Follow-up|1
1152439|NCT03134599|2265803|FG004|Week 3|Lost to Follow-up|0
1152440|NCT03134599|2265804|FG005|Week 3|Lost to Follow-up|1
1152441|NCT03134911|2265827|FG000|Overall Study|Screen failure|31
1152442|NCT03134911|2265827|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3
1152443|NCT03135028|2265910|FG000|Overall Study|Death|6
1152444|NCT03135028|2265910|FG000|Overall Study|Study Terminated by Sponsor|2
1152445|NCT03135028|2265910|FG000|Overall Study|Withdrew Consent|1
1152446|NCT03135210|2265916|FG000|Overall Study|Death|0
1152447|NCT03135210|2265917|FG001|Overall Study|Death|1
1152473|NCT03135431|2265973|FG000|Overall Study|Study Surgeon not available|2
1152474|NCT03135431|2265974|FG001|Overall Study|Study Surgeon not available|0
1152475|NCT03135522|2265982|FG000|Overall Study|Adverse Event|1
1152476|NCT03135522|2265983|FG001|Overall Study|Adverse Event|0
1152477|NCT03135548|2265996|FG000|Overall Study|Lost to Follow-up|3
1152478|NCT03135548|2265997|FG001|Overall Study|Lost to Follow-up|0
1152479|NCT03135548|2265998|FG002|Overall Study|Lost to Follow-up|0
1152480|NCT03135548|2265996|FG000|Overall Study|Withdrawal by Subject|2
1152481|NCT03135548|2265997|FG001|Overall Study|Withdrawal by Subject|2
1152482|NCT03135548|2265998|FG002|Overall Study|Withdrawal by Subject|1
1152483|NCT03135548|2265996|FG000|Overall Study|Other than listed|0
1152484|NCT03135548|2265997|FG001|Overall Study|Other than listed|2
1152485|NCT03135548|2265998|FG002|Overall Study|Other than listed|2
1152486|NCT03135899|2266014|FG000|Overall Study|Failed spirometry,unable to repeat visit|0
1152487|NCT03135899|2266015|FG001|Overall Study|Failed spirometry,unable to repeat visit|0
1152488|NCT03135899|2266016|FG002|Overall Study|Failed spirometry,unable to repeat visit|0
1152489|NCT03135899|2266017|FG003|Overall Study|Failed spirometry,unable to repeat visit|0
1152490|NCT03135899|2266018|FG004|Overall Study|Failed spirometry,unable to repeat visit|0
1152491|NCT03135899|2266019|FG005|Overall Study|Failed spirometry,unable to repeat visit|0
1152492|NCT03135899|2266020|FG006|Overall Study|Failed spirometry,unable to repeat visit|1
1152493|NCT03135899|2266021|FG007|Overall Study|Failed spirometry,unable to repeat visit|0
1152494|NCT03135899|2266014|FG000|Overall Study|Withdrawal by Subject|0
1152495|NCT03135899|2266015|FG001|Overall Study|Withdrawal by Subject|0
1152496|NCT03135899|2266016|FG002|Overall Study|Withdrawal by Subject|0
1152497|NCT03135899|2266017|FG003|Overall Study|Withdrawal by Subject|0
1152498|NCT03135899|2266018|FG004|Overall Study|Withdrawal by Subject|0
1152499|NCT03135899|2266019|FG005|Overall Study|Withdrawal by Subject|2
1152500|NCT03135899|2266020|FG006|Overall Study|Withdrawal by Subject|0
1152501|NCT03135899|2266021|FG007|Overall Study|Withdrawal by Subject|0
1152502|NCT03136068|2266037|FG000|Overall Study|Lost to Follow-up|1
1152503|NCT03136068|2266038|FG001|Overall Study|Lost to Follow-up|1
1152504|NCT03136068|2266037|FG000|Overall Study|Protocol Violation|1
1152505|NCT03136068|2266038|FG001|Overall Study|Protocol Violation|0
1152506|NCT03136107|2266044|FG000|Overall Study|Other (Not specified)|1
1152507|NCT03136159|2266054|FG000|Overall Study|chorioamnionitis|2
1152508|NCT03136159|2266055|FG001|Overall Study|chorioamnionitis|0
1152509|NCT03136159|2266054|FG000|Overall Study|vertical skin incision|1
1152510|NCT03136159|2266055|FG001|Overall Study|vertical skin incision|0
1152511|NCT03136159|2266054|FG000|Overall Study|additional dressing|1
1152512|NCT03136159|2266055|FG001|Overall Study|additional dressing|0
1152513|NCT03136159|2266054|FG000|Overall Study|never got dressing placed|1
1152514|NCT03136159|2266055|FG001|Overall Study|never got dressing placed|0
1152515|NCT03136198|2266063|FG000|Overall Study|Withdrawal by Subject|0
1152516|NCT03136198|2266064|FG001|Overall Study|Withdrawal by Subject|1
1152517|NCT03136367|2266078|FG000|T1 Consultation|discontinued mistakenly included|2
1152518|NCT03136367|2266079|FG001|T1 Consultation|discontinued mistakenly included|6
1152519|NCT03136367|2266080|FG002|T1 Consultation|discontinued mistakenly included|1
1152520|NCT03136367|2266078|FG000|T1 Consultation|Discontinued other|0
1152521|NCT03136367|2266079|FG001|T1 Consultation|Discontinued other|1
1152522|NCT03136367|2266080|FG002|T1 Consultation|Discontinued other|0
1152523|NCT03136367|2266078|FG000|T2 Post-consultation|Withdrawal by Subject|1
1152524|NCT03136367|2266079|FG001|T2 Post-consultation|Withdrawal by Subject|1
1152525|NCT03136367|2266080|FG002|T2 Post-consultation|Withdrawal by Subject|5
1152526|NCT03136367|2266078|FG000|T2 Post-consultation|discontinued mistakenly included|2
1152527|NCT03136367|2266079|FG001|T2 Post-consultation|discontinued mistakenly included|2
1152528|NCT03136367|2266080|FG002|T2 Post-consultation|discontinued mistakenly included|17
1152529|NCT03136367|2266078|FG000|T2 Post-consultation|Discontinued other|0
1152530|NCT03136367|2266079|FG001|T2 Post-consultation|Discontinued other|2
1152531|NCT03136367|2266080|FG002|T2 Post-consultation|Discontinued other|6
1152532|NCT03136367|2266078|FG000|T2 Post-consultation|Discontinued transferred care|0
1152533|NCT03136367|2266079|FG001|T2 Post-consultation|Discontinued transferred care|0
1152534|NCT03136367|2266080|FG002|T2 Post-consultation|Discontinued transferred care|3
1152535|NCT03136367|2266078|FG000|T2 Post-consultation|Discontinued lost contact|0
1152536|NCT03136367|2266079|FG001|T2 Post-consultation|Discontinued lost contact|1
1152537|NCT03136367|2266080|FG002|T2 Post-consultation|Discontinued lost contact|0
1152538|NCT03136367|2266078|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5
1152539|NCT03136367|2266079|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9
1152540|NCT03136367|2266080|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8
1152541|NCT03136367|2266078|FG000|T3 1 Week After Surgery|Discontinued transferred care|2
1152542|NCT03136367|2266079|FG001|T3 1 Week After Surgery|Discontinued transferred care|11
1152543|NCT03136367|2266080|FG002|T3 1 Week After Surgery|Discontinued transferred care|14
1152544|NCT03136367|2266078|FG000|T3 1 Week After Surgery|other discontinued|2
1152545|NCT03136367|2266079|FG001|T3 1 Week After Surgery|other discontinued|4
1152546|NCT03136367|2266080|FG002|T3 1 Week After Surgery|other discontinued|3
1152547|NCT03136367|2266078|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0
1152548|NCT03136367|2266079|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6
1152549|NCT03136367|2266080|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2
1152550|NCT03136367|2266078|FG000|T3 1 Week After Surgery|Discontinued lost contact|1
1152551|NCT03136367|2266079|FG001|T3 1 Week After Surgery|Discontinued lost contact|2
1152552|NCT03136367|2266080|FG002|T3 1 Week After Surgery|Discontinued lost contact|4
1152553|NCT03136367|2266078|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1
1152554|NCT03136367|2266079|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3
1152555|NCT03136367|2266080|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0
1152556|NCT03136367|2266078|FG000|T4 12 Weeks After Surgery|Death|0
1152557|NCT03136367|2266079|FG001|T4 12 Weeks After Surgery|Death|1
1152558|NCT03136367|2266080|FG002|T4 12 Weeks After Surgery|Death|3
1152559|NCT03136367|2266078|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1
1152560|NCT03136367|2266079|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0
1152561|NCT03136367|2266080|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0
1152562|NCT03136367|2266078|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0
1152563|NCT03136367|2266079|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1
1152564|NCT03136367|2266080|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5
1152565|NCT03136367|2266078|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0
1152566|NCT03136367|2266079|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0
1152567|NCT03136367|2266080|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1
1152568|NCT03136367|2266078|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1
1152569|NCT03136367|2266079|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1
1152570|NCT03136367|2266080|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1
1152571|NCT03136367|2266078|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1
1152572|NCT03136367|2266079|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0
1152573|NCT03136367|2266080|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0
1152574|NCT03136367|2266078|FG000|T5 1 Year After Surgery|Death|0
1152575|NCT03136367|2266079|FG001|T5 1 Year After Surgery|Death|0
1152576|NCT03136367|2266080|FG002|T5 1 Year After Surgery|Death|1
1152577|NCT03136367|2266078|FG000|T5 1 Year After Surgery|Discontinued lost contact|1
1152578|NCT03136367|2266079|FG001|T5 1 Year After Surgery|Discontinued lost contact|6
1152579|NCT03136367|2266080|FG002|T5 1 Year After Surgery|Discontinued lost contact|0
1152580|NCT03136367|2266078|FG000|T5 1 Year After Surgery|Lost to Follow-up|2
1152581|NCT03136367|2266079|FG001|T5 1 Year After Surgery|Lost to Follow-up|22
1152582|NCT03136367|2266080|FG002|T5 1 Year After Surgery|Lost to Follow-up|15
1152583|NCT03136367|2266078|FG000|T5 1 Year After Surgery|study ended before due|31
1152584|NCT03136367|2266079|FG001|T5 1 Year After Surgery|study ended before due|103
1152585|NCT03136367|2266080|FG002|T5 1 Year After Surgery|study ended before due|110
1152586|NCT03136367|2266078|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0
1152587|NCT03136367|2266079|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4
1152588|NCT03136367|2266080|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2
1152589|NCT03136380|2266093|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
1152590|NCT03136380|2266094|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
1152591|NCT03136380|2266095|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
1152592|NCT03136380|2266096|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
1152593|NCT03136380|2266097|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
1152594|NCT03136484|2266117|FG000|Overall Study|Withdrawal by Subject|19
1152595|NCT03136484|2266118|FG001|Overall Study|Withdrawal by Subject|14
1152596|NCT03136484|2266117|FG000|Overall Study|Lost to Follow-up|7
1152597|NCT03136484|2266118|FG001|Overall Study|Lost to Follow-up|8
1152598|NCT03136484|2266117|FG000|Overall Study|Death|1
1152599|NCT03136484|2266118|FG001|Overall Study|Death|0
1152600|NCT03136861|2266131|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
1152601|NCT03136861|2266132|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
1152602|NCT03136861|2266133|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
1152603|NCT03136861|2266134|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
1152604|NCT03136861|2266135|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
1152605|NCT03136861|2266136|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
1152606|NCT03136861|2266137|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
1152607|NCT03136861|2266131|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
1152608|NCT03136861|2266132|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
1152609|NCT03136861|2266133|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
1152610|NCT03136861|2266134|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
1152611|NCT03136861|2266135|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
1152612|NCT03136861|2266136|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
1152613|NCT03136861|2266137|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
1152614|NCT03136861|2266131|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
1152615|NCT03136861|2266132|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
1152616|NCT03136861|2266133|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
1152617|NCT03136861|2266134|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
1152618|NCT03136861|2266135|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
1152619|NCT03136861|2266136|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
1152620|NCT03136861|2266137|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
1152621|NCT03136861|2266131|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1152622|NCT03136861|2266132|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
1152623|NCT03136861|2266133|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1152624|NCT03136861|2266134|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1152625|NCT03136861|2266135|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1152626|NCT03136861|2266136|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1152627|NCT03136861|2266137|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1152628|NCT03136861|2266131|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
1152629|NCT03136861|2266132|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
1152630|NCT03136861|2266133|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
1152631|NCT03136861|2266134|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
1152632|NCT03136861|2266135|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
1152633|NCT03136861|2266136|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
1152634|NCT03136861|2266137|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
1152635|NCT03136861|2266131|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
1152636|NCT03136861|2266132|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
1152637|NCT03136861|2266133|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
1152638|NCT03136861|2266134|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
1152639|NCT03136861|2266135|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
1152640|NCT03136861|2266136|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
1152641|NCT03136861|2266137|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
1152642|NCT03136861|2266131|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1152643|NCT03136861|2266132|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1152644|NCT03136861|2266133|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
1152645|NCT03136861|2266134|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1152646|NCT03136861|2266135|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1152647|NCT03136861|2266136|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1152648|NCT03136861|2266137|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1152649|NCT03136861|2266131|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1152650|NCT03136861|2266132|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1152651|NCT03136861|2266133|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
1152652|NCT03136861|2266134|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1152653|NCT03136861|2266135|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1152654|NCT03136861|2266136|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1152655|NCT03136861|2266137|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1152656|NCT03137069|2266161|FG000|Overall Study|Withdrawal by Subject|1
1152657|NCT03137069|2266162|FG001|Overall Study|Withdrawal by Subject|2
1152658|NCT03137069|2266163|FG002|Overall Study|Withdrawal by Subject|2
1152659|NCT03137069|2266164|FG003|Overall Study|Withdrawal by Subject|2
1152660|NCT03137069|2266165|FG004|Overall Study|Withdrawal by Subject|0
1152661|NCT03137069|2266166|FG005|Overall Study|Withdrawal by Subject|0
1152662|NCT03137069|2266161|FG000|Overall Study|Adverse Event|0
1152663|NCT03137069|2266162|FG001|Overall Study|Adverse Event|3
1152664|NCT03137069|2266163|FG002|Overall Study|Adverse Event|1
1152665|NCT03137069|2266164|FG003|Overall Study|Adverse Event|1
1152666|NCT03137069|2266165|FG004|Overall Study|Adverse Event|0
1152667|NCT03137069|2266166|FG005|Overall Study|Adverse Event|1
1152668|NCT03137069|2266161|FG000|Overall Study|Protocol Violation|0
1152669|NCT03137069|2266162|FG001|Overall Study|Protocol Violation|1
1152670|NCT03137069|2266163|FG002|Overall Study|Protocol Violation|0
1152671|NCT03137069|2266164|FG003|Overall Study|Protocol Violation|1
1152672|NCT03137069|2266165|FG004|Overall Study|Protocol Violation|1
1152673|NCT03137069|2266166|FG005|Overall Study|Protocol Violation|1
1152674|NCT03137069|2266161|FG000|Overall Study|Physician Decision|0
1152675|NCT03137069|2266162|FG001|Overall Study|Physician Decision|0
1152676|NCT03137069|2266163|FG002|Overall Study|Physician Decision|0
1152677|NCT03137069|2266164|FG003|Overall Study|Physician Decision|1
1152678|NCT03137069|2266165|FG004|Overall Study|Physician Decision|0
1152679|NCT03137069|2266166|FG005|Overall Study|Physician Decision|0
1152680|NCT03137069|2266161|FG000|Overall Study|Study Terminated by Sponsor|0
1152681|NCT03137069|2266162|FG001|Overall Study|Study Terminated by Sponsor|0
1152682|NCT03137069|2266163|FG002|Overall Study|Study Terminated by Sponsor|0
1152683|NCT03137069|2266164|FG003|Overall Study|Study Terminated by Sponsor|0
1152684|NCT03137069|2266165|FG004|Overall Study|Study Terminated by Sponsor|1
1152685|NCT03137069|2266166|FG005|Overall Study|Study Terminated by Sponsor|0
1152686|NCT03137069|2266161|FG000|Overall Study|Data Entry Error|0
1152687|NCT03137069|2266162|FG001|Overall Study|Data Entry Error|0
1152688|NCT03137069|2266163|FG002|Overall Study|Data Entry Error|0
1152689|NCT03137069|2266164|FG003|Overall Study|Data Entry Error|1
1152690|NCT03137069|2266165|FG004|Overall Study|Data Entry Error|0
1152691|NCT03137069|2266166|FG005|Overall Study|Data Entry Error|0
1152692|NCT03137121|2266186|FG000|Overall Study|Withdrawal by Subject|0
1152693|NCT03137121|2266187|FG001|Overall Study|Withdrawal by Subject|1
1152694|NCT03137173|2266195|FG000|Overall Study|Withdrawal by Subject|8
1152695|NCT03137173|2266196|FG001|Overall Study|Withdrawal by Subject|13
1152696|NCT03137173|2266195|FG000|Overall Study|Death|1
1152697|NCT03137173|2266196|FG001|Overall Study|Death|3
1152698|NCT03137173|2266195|FG000|Overall Study|Physician Decision|1
1152699|NCT03137173|2266196|FG001|Overall Study|Physician Decision|0
1152700|NCT03137173|2266195|FG000|Overall Study|Lost to Follow-up|13
1152701|NCT03137173|2266196|FG001|Overall Study|Lost to Follow-up|18
1152702|NCT03137173|2266195|FG000|Overall Study|Other reasons|3
1152703|NCT03137173|2266196|FG001|Overall Study|Other reasons|2
1152704|NCT03137303|2266205|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1
1152705|NCT03137303|2266206|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4
1152706|NCT03137303|2266205|FG000|T1: 3-month Follow-up|Lost to Follow-up|5
1152707|NCT03137303|2266206|FG001|T1: 3-month Follow-up|Lost to Follow-up|6
1152708|NCT03137303|2266205|FG000|T2: 6-month Follow-up|Lost to Follow-up|5
1152709|NCT03137303|2266206|FG001|T2: 6-month Follow-up|Lost to Follow-up|5
1152710|NCT03137303|2266205|FG000|T3: 9-month Follow-up|Death|1
1152711|NCT03137303|2266206|FG001|T3: 9-month Follow-up|Death|0
1152712|NCT03137303|2266205|FG000|T3: 9-month Follow-up|Lost to Follow-up|4
1152713|NCT03137303|2266206|FG001|T3: 9-month Follow-up|Lost to Follow-up|4
1152714|NCT03137303|2266205|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0
1152715|NCT03137303|2266206|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1
1152716|NCT03137303|2266205|FG000|T4: 12-month Follow-up|Lost to Follow-up|7
1152717|NCT03137303|2266206|FG001|T4: 12-month Follow-up|Lost to Follow-up|4
1152718|NCT03137459|2266214|FG000|2-month Assessment|Withdrawal by Subject|13
1152719|NCT03137459|2266215|FG001|2-month Assessment|Withdrawal by Subject|3
1152720|NCT03137459|2266214|FG000|2-month Assessment|Unable to reach|42
1152721|NCT03137459|2266215|FG001|2-month Assessment|Unable to reach|32
1152722|NCT03137459|2266214|FG000|2-month Assessment|Refused assessment|7
1152723|NCT03137459|2266215|FG001|2-month Assessment|Refused assessment|5
1152724|NCT03137459|2266214|FG000|2-month Assessment|Acutely ill|6
1152725|NCT03137459|2266215|FG001|2-month Assessment|Acutely ill|2
1152726|NCT03137459|2266214|FG000|4-month Assessment|Death|4
1152727|NCT03137459|2266215|FG001|4-month Assessment|Death|2
1152728|NCT03137459|2266214|FG000|4-month Assessment|Withdrawal by Subject|4
1152729|NCT03137459|2266215|FG001|4-month Assessment|Withdrawal by Subject|2
1152730|NCT03137459|2266214|FG000|4-month Assessment|Unable to reach|44
1152731|NCT03137459|2266215|FG001|4-month Assessment|Unable to reach|29
1152732|NCT03137459|2266214|FG000|4-month Assessment|Refused assessment|24
1152733|NCT03137459|2266215|FG001|4-month Assessment|Refused assessment|10
1152734|NCT03137459|2266214|FG000|4-month Assessment|Acutely ill|2
1152735|NCT03137459|2266215|FG001|4-month Assessment|Acutely ill|3
1152736|NCT03137459|2266214|FG000|6-months|Lost to Follow-up|14
1152737|NCT03137459|2266215|FG001|6-months|Lost to Follow-up|11
1152738|NCT03137459|2266214|FG000|6-months|Death|0
1152739|NCT03137459|2266215|FG001|6-months|Death|2
1152740|NCT03137459|2266214|FG000|6-months|Refused assessment|6
1152741|NCT03137459|2266215|FG001|6-months|Refused assessment|3
1152742|NCT03137459|2266214|FG000|6-months|Acutely ill|1
1152743|NCT03137459|2266215|FG001|6-months|Acutely ill|1
1152744|NCT03137784|2266226|FG000|Overall Study|Adverse Event|1
1152745|NCT03137784|2266227|FG001|Overall Study|Adverse Event|1
1152746|NCT03137784|2266228|FG002|Overall Study|Adverse Event|0
1152747|NCT03137784|2266229|FG003|Overall Study|Adverse Event|0
1152748|NCT03137784|2266230|FG004|Overall Study|Adverse Event|0
1152749|NCT03137784|2266231|FG005|Overall Study|Adverse Event|0
1152750|NCT03137784|2266226|FG000|Overall Study|Subject/guardian decision|1
1152751|NCT03137784|2266227|FG001|Overall Study|Subject/guardian decision|0
1152752|NCT03137784|2266228|FG002|Overall Study|Subject/guardian decision|0
1152753|NCT03137784|2266229|FG003|Overall Study|Subject/guardian decision|0
1152754|NCT03137784|2266230|FG004|Overall Study|Subject/guardian decision|0
1152755|NCT03137784|2266231|FG005|Overall Study|Subject/guardian decision|0
1152756|NCT03137784|2266226|FG000|Overall Study|Non-compliance with study treatment|0
1152757|NCT03137784|2266227|FG001|Overall Study|Non-compliance with study treatment|0
1152758|NCT03137784|2266228|FG002|Overall Study|Non-compliance with study treatment|0
1152759|NCT03137784|2266229|FG003|Overall Study|Non-compliance with study treatment|0
1152760|NCT03137784|2266230|FG004|Overall Study|Non-compliance with study treatment|1
1152761|NCT03137784|2266231|FG005|Overall Study|Non-compliance with study treatment|0
1152762|NCT03137992|2266239|FG000|Washout Period 1|Adverse Event|1
1152763|NCT03137992|2266240|FG001|Washout Period 1|Adverse Event|1
1152764|NCT03137992|2266241|FG002|Washout Period 1|Adverse Event|0
1152765|NCT03137992|2266242|FG003|Washout Period 1|Adverse Event|0
1152766|NCT03137992|2266243|FG004|Washout Period 1|Adverse Event|0
1152767|NCT03137992|2266244|FG005|Washout Period 1|Adverse Event|1
1152768|NCT03137992|2266239|FG000|Washout Period 1|Withdrawal by Subject|0
1152769|NCT03137992|2266240|FG001|Washout Period 1|Withdrawal by Subject|1
1152770|NCT03137992|2266241|FG002|Washout Period 1|Withdrawal by Subject|1
1152771|NCT03137992|2266242|FG003|Washout Period 1|Withdrawal by Subject|0
1152772|NCT03137992|2266243|FG004|Washout Period 1|Withdrawal by Subject|0
1152773|NCT03137992|2266244|FG005|Washout Period 1|Withdrawal by Subject|0
1152774|NCT03137992|2266239|FG000|Washout Period 1|Principal Investigator Discretion|0
1152775|NCT03137992|2266240|FG001|Washout Period 1|Principal Investigator Discretion|1
1152776|NCT03137992|2266241|FG002|Washout Period 1|Principal Investigator Discretion|0
1152777|NCT03137992|2266242|FG003|Washout Period 1|Principal Investigator Discretion|0
1152778|NCT03137992|2266243|FG004|Washout Period 1|Principal Investigator Discretion|0
1152779|NCT03137992|2266244|FG005|Washout Period 1|Principal Investigator Discretion|0
1152780|NCT03137992|2266239|FG000|Washout Period 1|COPD Exacerbation|1
1152781|NCT03137992|2266240|FG001|Washout Period 1|COPD Exacerbation|1
1152782|NCT03137992|2266241|FG002|Washout Period 1|COPD Exacerbation|1
1152783|NCT03137992|2266242|FG003|Washout Period 1|COPD Exacerbation|0
1152784|NCT03137992|2266243|FG004|Washout Period 1|COPD Exacerbation|1
1152785|NCT03137992|2266244|FG005|Washout Period 1|COPD Exacerbation|1
1152786|NCT03137992|2266239|FG000|Washout Period 1|Subject Noncompliance|1
1152787|NCT03137992|2266240|FG001|Washout Period 1|Subject Noncompliance|0
1152788|NCT03137992|2266241|FG002|Washout Period 1|Subject Noncompliance|0
1152789|NCT03137992|2266242|FG003|Washout Period 1|Subject Noncompliance|0
1152790|NCT03137992|2266243|FG004|Washout Period 1|Subject Noncompliance|1
1152791|NCT03137992|2266244|FG005|Washout Period 1|Subject Noncompliance|0
1152792|NCT03137992|2266239|FG000|Period 2 (Visit 3)|COPD Exacerbation|1
1152793|NCT03137992|2266240|FG001|Period 2 (Visit 3)|COPD Exacerbation|1
1152794|NCT03137992|2266241|FG002|Period 2 (Visit 3)|COPD Exacerbation|0
1152795|NCT03137992|2266242|FG003|Period 2 (Visit 3)|COPD Exacerbation|0
1152796|NCT03137992|2266243|FG004|Period 2 (Visit 3)|COPD Exacerbation|0
1152797|NCT03137992|2266244|FG005|Period 2 (Visit 3)|COPD Exacerbation|1
1152798|NCT03137992|2266239|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2
1152799|NCT03137992|2266240|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3
1152800|NCT03137992|2266241|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3
1152801|NCT03137992|2266242|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4
1152802|NCT03137992|2266243|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3
1152803|NCT03137992|2266244|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7
1152804|NCT03137992|2266239|FG000|Period 2 (Visit 3)|Adverse Event|0
1152805|NCT03137992|2266240|FG001|Period 2 (Visit 3)|Adverse Event|1
1152806|NCT03137992|2266241|FG002|Period 2 (Visit 3)|Adverse Event|0
1152807|NCT03137992|2266242|FG003|Period 2 (Visit 3)|Adverse Event|0
1152808|NCT03137992|2266243|FG004|Period 2 (Visit 3)|Adverse Event|0
1152809|NCT03137992|2266244|FG005|Period 2 (Visit 3)|Adverse Event|0
1152810|NCT03137992|2266239|FG000|Period 2 (Visit 3)|Lost to Follow-up|0
1152811|NCT03137992|2266240|FG001|Period 2 (Visit 3)|Lost to Follow-up|0
1152812|NCT03137992|2266241|FG002|Period 2 (Visit 3)|Lost to Follow-up|0
1152813|NCT03137992|2266242|FG003|Period 2 (Visit 3)|Lost to Follow-up|1
1152814|NCT03137992|2266243|FG004|Period 2 (Visit 3)|Lost to Follow-up|0
1152815|NCT03137992|2266244|FG005|Period 2 (Visit 3)|Lost to Follow-up|0
1152816|NCT03137992|2266239|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0
1152817|NCT03137992|2266240|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2
1152818|NCT03137992|2266241|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0
1152819|NCT03137992|2266242|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0
1152820|NCT03137992|2266243|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1
1152821|NCT03137992|2266244|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0
1152822|NCT03137992|2266239|FG000|Washout Period 2|COPD Exacerbation|1
903465|NCT00748189|1877657|FG001|Overall Study|Lost to Follow-up|15
903466|NCT00748189|1877656|FG000|Overall Study|Study terminated by Sponsor|70
903467|NCT00748189|1877657|FG001|Overall Study|Study terminated by Sponsor|79
1152823|NCT03137992|2266240|FG001|Washout Period 2|COPD Exacerbation|1
1152824|NCT03137992|2266241|FG002|Washout Period 2|COPD Exacerbation|0
1152825|NCT03137992|2266242|FG003|Washout Period 2|COPD Exacerbation|0
1152826|NCT03137992|2266243|FG004|Washout Period 2|COPD Exacerbation|1
1152827|NCT03137992|2266244|FG005|Washout Period 2|COPD Exacerbation|0
1152828|NCT03137992|2266239|FG000|Washout Period 2|Subject Non-compliance|0
1152829|NCT03137992|2266240|FG001|Washout Period 2|Subject Non-compliance|1
1152830|NCT03137992|2266241|FG002|Washout Period 2|Subject Non-compliance|0
1152831|NCT03137992|2266242|FG003|Washout Period 2|Subject Non-compliance|0
1152832|NCT03137992|2266243|FG004|Washout Period 2|Subject Non-compliance|0
1152833|NCT03137992|2266244|FG005|Washout Period 2|Subject Non-compliance|0
1152834|NCT03137992|2266239|FG000|Washout Period 2|Adverse Event|0
1152835|NCT03137992|2266240|FG001|Washout Period 2|Adverse Event|0
1152836|NCT03137992|2266241|FG002|Washout Period 2|Adverse Event|0
1152837|NCT03137992|2266242|FG003|Washout Period 2|Adverse Event|1
1152838|NCT03137992|2266243|FG004|Washout Period 2|Adverse Event|1
1152839|NCT03137992|2266244|FG005|Washout Period 2|Adverse Event|0
1152840|NCT03137992|2266239|FG000|Washout Period 2|Withdrawal by Subject|1
1152841|NCT03137992|2266240|FG001|Washout Period 2|Withdrawal by Subject|0
1152842|NCT03137992|2266241|FG002|Washout Period 2|Withdrawal by Subject|0
1152843|NCT03137992|2266242|FG003|Washout Period 2|Withdrawal by Subject|0
1152844|NCT03137992|2266243|FG004|Washout Period 2|Withdrawal by Subject|1
1152845|NCT03137992|2266244|FG005|Washout Period 2|Withdrawal by Subject|0
1152846|NCT03137992|2266239|FG000|Washout Period 2|Sponsor Decision|0
1152847|NCT03137992|2266240|FG001|Washout Period 2|Sponsor Decision|0
1152848|NCT03137992|2266241|FG002|Washout Period 2|Sponsor Decision|0
1152849|NCT03137992|2266242|FG003|Washout Period 2|Sponsor Decision|0
1152850|NCT03137992|2266243|FG004|Washout Period 2|Sponsor Decision|0
1152851|NCT03137992|2266244|FG005|Washout Period 2|Sponsor Decision|1
1152852|NCT03137992|2266239|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6
1152853|NCT03137992|2266240|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0
1152854|NCT03137992|2266241|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2
1152855|NCT03137992|2266242|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0
1152856|NCT03137992|2266243|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2
1152857|NCT03137992|2266244|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3
1152858|NCT03137992|2266239|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0
1152859|NCT03137992|2266240|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2
1152860|NCT03137992|2266241|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1
1152861|NCT03137992|2266242|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0
1152862|NCT03137992|2266243|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1
1152863|NCT03137992|2266244|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0
1152864|NCT03137992|2266239|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1
1152865|NCT03137992|2266240|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0
1152866|NCT03137992|2266241|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1
1152867|NCT03137992|2266242|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0
1152868|NCT03137992|2266243|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0
1152869|NCT03137992|2266244|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0
1152870|NCT03137992|2266239|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0
1152871|NCT03137992|2266240|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0
1152872|NCT03137992|2266241|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0
1152873|NCT03137992|2266242|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1
1152874|NCT03137992|2266243|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0
1152875|NCT03137992|2266244|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0
1152876|NCT03137992|2266239|FG000|Part 2 (Open-label Extension)|Per study team|1
1152877|NCT03137992|2266240|FG001|Part 2 (Open-label Extension)|Per study team|0
1152878|NCT03137992|2266241|FG002|Part 2 (Open-label Extension)|Per study team|0
1152879|NCT03137992|2266242|FG003|Part 2 (Open-label Extension)|Per study team|0
1152880|NCT03137992|2266243|FG004|Part 2 (Open-label Extension)|Per study team|0
1152881|NCT03137992|2266244|FG005|Part 2 (Open-label Extension)|Per study team|0
1152882|NCT03137992|2266239|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0
1152883|NCT03137992|2266240|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0
1152884|NCT03137992|2266241|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0
1152885|NCT03137992|2266242|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0
1152886|NCT03137992|2266243|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0
1152887|NCT03137992|2266244|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1
1152888|NCT03138655|2266313|FG000|Overall Study|Adverse Event|2
1152889|NCT03138655|2266314|FG001|Overall Study|Adverse Event|1
1152890|NCT03138655|2266315|FG002|Overall Study|Adverse Event|2
1152891|NCT03138655|2266316|FG003|Overall Study|Adverse Event|1
1152892|NCT03138655|2266317|FG004|Overall Study|Adverse Event|1
1152893|NCT03138655|2266318|FG005|Overall Study|Adverse Event|4
1152894|NCT03138655|2266319|FG006|Overall Study|Adverse Event|2
1152895|NCT03138655|2266320|FG007|Overall Study|Adverse Event|2
1152896|NCT03138655|2266313|FG000|Overall Study|Withdrawal by Subject|0
1152897|NCT03138655|2266314|FG001|Overall Study|Withdrawal by Subject|1
1152898|NCT03138655|2266315|FG002|Overall Study|Withdrawal by Subject|0
1152899|NCT03138655|2266316|FG003|Overall Study|Withdrawal by Subject|0
1152900|NCT03138655|2266317|FG004|Overall Study|Withdrawal by Subject|0
1152901|NCT03138655|2266318|FG005|Overall Study|Withdrawal by Subject|0
1152902|NCT03138655|2266319|FG006|Overall Study|Withdrawal by Subject|1
1152903|NCT03138655|2266320|FG007|Overall Study|Withdrawal by Subject|0
1152904|NCT03138655|2266313|FG000|Overall Study|Reason not Specified|1
1152905|NCT03138655|2266314|FG001|Overall Study|Reason not Specified|0
1152906|NCT03138655|2266315|FG002|Overall Study|Reason not Specified|0
1152907|NCT03138655|2266316|FG003|Overall Study|Reason not Specified|2
1152908|NCT03138655|2266317|FG004|Overall Study|Reason not Specified|1
1152909|NCT03138655|2266318|FG005|Overall Study|Reason not Specified|1
1152910|NCT03138655|2266319|FG006|Overall Study|Reason not Specified|0
1152911|NCT03138655|2266320|FG007|Overall Study|Reason not Specified|0
1152912|NCT03138967|2266358|FG000|Overall Study|Death|0
1152913|NCT03138967|2266359|FG001|Overall Study|Death|1
1152914|NCT03138967|2266358|FG000|Overall Study|Physician Decision|1
1152915|NCT03138967|2266359|FG001|Overall Study|Physician Decision|3
1152916|NCT03139240|2266374|FG000|Overall Study|Lost to Follow-up|0
1152917|NCT03139240|2266375|FG001|Overall Study|Lost to Follow-up|1
1152918|NCT03139240|2266376|FG002|Overall Study|Lost to Follow-up|1
1152919|NCT03139240|2266377|FG003|Overall Study|Lost to Follow-up|0
1152920|NCT03139279|2266387|FG000|Overall Study|Physician Decision|2
1152921|NCT03139279|2266388|FG001|Overall Study|Physician Decision|0
1152922|NCT03139279|2266387|FG000|Overall Study|Protocol Violation|5
1152923|NCT03139279|2266388|FG001|Overall Study|Protocol Violation|4
1152924|NCT03139279|2266387|FG000|Overall Study|Withdrawal by Subject|0
1152925|NCT03139279|2266388|FG001|Overall Study|Withdrawal by Subject|2
1152926|NCT03139448|2266396|FG000|Overall Study|Lack of Efficacy|6
1152927|NCT03139448|2266397|FG001|Overall Study|Lack of Efficacy|7
1152928|NCT03139448|2266396|FG000|Overall Study|Location of procedure changed|2
1152929|NCT03139448|2266397|FG001|Overall Study|Location of procedure changed|8
1152930|NCT03139448|2266396|FG000|Overall Study|Withdrawal by Subject|3
1152931|NCT03139448|2266397|FG001|Overall Study|Withdrawal by Subject|6
1152932|NCT03139448|2266396|FG000|Overall Study|Screen fail|1
1152933|NCT03139448|2266397|FG001|Overall Study|Screen fail|3
1152934|NCT03139448|2266396|FG000|Overall Study|Physician Decision|0
1152935|NCT03139448|2266397|FG001|Overall Study|Physician Decision|2
1152936|NCT03139552|2266403|FG000|Overall Study|unable to attend tasting due to schedule|3
1152937|NCT03139604|2266429|FG000|Overall Study|Other|7
1152938|NCT03139604|2266430|FG001|Overall Study|Other|3
1152939|NCT03139604|2266429|FG000|Overall Study|Withdrawal by Subject|16
1152940|NCT03139604|2266430|FG001|Overall Study|Withdrawal by Subject|17
1152941|NCT03139604|2266429|FG000|Overall Study|Physician Decision|1
1152942|NCT03139604|2266430|FG001|Overall Study|Physician Decision|2
1152943|NCT03139604|2266429|FG000|Overall Study|Lost to Follow-up|3
1152944|NCT03139604|2266430|FG001|Overall Study|Lost to Follow-up|1
1152945|NCT03139604|2266429|FG000|Overall Study|Death|65
1152946|NCT03139604|2266430|FG001|Overall Study|Death|67
1152947|NCT03139604|2266429|FG000|Overall Study|Study Terminated by Sponsor|122
1152948|NCT03139604|2266430|FG001|Overall Study|Study Terminated by Sponsor|127
1152949|NCT03139604|2266429|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5
1152950|NCT03139604|2266430|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3
1152951|NCT03141086|2266464|FG000|Overall Study|Study Terminated By Sponsor|1
1152952|NCT03141086|2266465|FG001|Overall Study|Study Terminated By Sponsor|1
1152953|NCT03141086|2266464|FG000|Overall Study|Withdrawal by Subject|0
1152954|NCT03141086|2266465|FG001|Overall Study|Withdrawal by Subject|1
1152955|NCT03141086|2266464|FG000|Overall Study|Protocol Violation|0
1152956|NCT03141086|2266465|FG001|Overall Study|Protocol Violation|1
1152957|NCT03141086|2266464|FG000|Overall Study|Adverse Event|0
1152958|NCT03141086|2266465|FG001|Overall Study|Adverse Event|2
1152959|NCT03141151|2266473|FG000|Overall Study|Lost to Follow-up|3
1152960|NCT03141151|2266474|FG001|Overall Study|Lost to Follow-up|2
1152961|NCT03141151|2266473|FG000|Overall Study|Withdrawal by Subject|3
1152962|NCT03141151|2266474|FG001|Overall Study|Withdrawal by Subject|2
1152963|NCT03141307|2266509|FG000|In-Hospital|Withdrawal by Subject|0
1152964|NCT03141307|2266510|FG001|In-Hospital|Withdrawal by Subject|2
1152965|NCT03141307|2266509|FG000|In-Hospital|Protocol Violation|4
1152966|NCT03141307|2266510|FG001|In-Hospital|Protocol Violation|0
903468|NCT00748215|1877670|FG000|Overall Study|Withdrawal by Subject|7
903469|NCT00748215|1877671|FG001|Overall Study|Withdrawal by Subject|7
903470|NCT00748215|1877670|FG000|Overall Study|Treatment change|2
903471|NCT00748215|1877671|FG001|Overall Study|Treatment change|1
903472|NCT00748215|1877670|FG000|Overall Study|Change in patient condition|0
903473|NCT00748215|1877671|FG001|Overall Study|Change in patient condition|3
903474|NCT00748215|1877670|FG000|Overall Study|Non-compliant|0
903475|NCT00748215|1877671|FG001|Overall Study|Non-compliant|2
903476|NCT00748215|1877670|FG000|Overall Study|Adverse Event|0
903477|NCT00748215|1877671|FG001|Overall Study|Adverse Event|5
903478|NCT00748241|1877677|FG000|Overall Study|Implant failure|1
903479|NCT00748241|1877677|FG000|Overall Study|Lost to Follow-up|5
903480|NCT00748241|1877677|FG000|Overall Study|Death|2
903481|NCT00748540|1877690|FG000|Overall Study|Physician Decision|1
903482|NCT00748553|1877696|FG000|Overall Study|Adverse Event|0
903483|NCT00748553|1877697|FG001|Overall Study|Adverse Event|1
903484|NCT00748553|1877696|FG000|Overall Study|disease progression|2
1152967|NCT03141307|2266509|FG000|Follow-Up|Lost to Follow-up|97
1152968|NCT03141307|2266510|FG001|Follow-Up|Lost to Follow-up|54
1152969|NCT03141788|2266536|FG000|Overall Study|Lost to Follow-up|1
1152970|NCT03141788|2266536|FG000|Overall Study|Protocol Violation|3
1152971|NCT03141788|2266536|FG000|Overall Study|Withdrawal by Subject|4
1152972|NCT03141905|2266545|FG000|Overall Study|Death|3
1152973|NCT03141905|2266546|FG001|Overall Study|Death|2
1152974|NCT03141905|2266545|FG000|Overall Study|Withdrawal by Subject|1
1152975|NCT03141905|2266546|FG001|Overall Study|Withdrawal by Subject|0
1152976|NCT03141905|2266545|FG000|Overall Study|Lost to Follow-up|3
1152977|NCT03141905|2266546|FG001|Overall Study|Lost to Follow-up|7
1152978|NCT03141905|2266545|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17
1152979|NCT03141905|2266546|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10
1152980|NCT03142451|2266568|FG000|Overall Study|Adverse Event|5
1152981|NCT03142451|2266569|FG001|Overall Study|Adverse Event|2
1152982|NCT03142451|2266568|FG000|Overall Study|Lost to Follow-up|25
1152983|NCT03142451|2266569|FG001|Overall Study|Lost to Follow-up|8
1152984|NCT03142451|2266568|FG000|Overall Study|Participant request|24
1152985|NCT03142451|2266569|FG001|Overall Study|Participant request|12
1152986|NCT03142451|2266568|FG000|Overall Study|Protocol Violation|3
1152987|NCT03142451|2266569|FG001|Overall Study|Protocol Violation|1
1152988|NCT03142451|2266568|FG000|Overall Study|Other|1
1152989|NCT03142451|2266569|FG001|Overall Study|Other|1
1152990|NCT03142750|2266577|FG000|Overall Study|Lost to Follow-up|4
1152991|NCT03142750|2266578|FG001|Overall Study|Lost to Follow-up|1
1152992|NCT03142932|2266590|FG000|Overall Study|Lost to Follow-up|2
1152993|NCT03142932|2266591|FG001|Overall Study|Lost to Follow-up|11
1152994|NCT03143166|2266610|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
1152995|NCT03143855|2266629|FG000|Overall Study|Withdrawal by Subject|4
1152996|NCT03143855|2266630|FG001|Overall Study|Withdrawal by Subject|3
1152997|NCT03143855|2266629|FG000|Overall Study|Protocol Violation|1
1152998|NCT03143855|2266630|FG001|Overall Study|Protocol Violation|0
1152999|NCT03143855|2266629|FG000|Overall Study|Participant experienced withdrawal|0
1153000|NCT03143855|2266630|FG001|Overall Study|Participant experienced withdrawal|1
1153001|NCT03144180|2266660|FG000|Overall Study|STAT Delivery|1
1153002|NCT03144180|2266661|FG001|Overall Study|STAT Delivery|1
1153003|NCT03144180|2266660|FG000|Overall Study|Provider forgot to fill out forms|1
1153004|NCT03144180|2266661|FG001|Overall Study|Provider forgot to fill out forms|3
1153005|NCT03144180|2266660|FG000|Overall Study|Provider forgot to use the Q-cup|0
1153006|NCT03144180|2266661|FG001|Overall Study|Provider forgot to use the Q-cup|1
1153007|NCT03144180|2266660|FG000|Overall Study|Scrub tech removed tube cap|0
1153008|NCT03144180|2266661|FG001|Overall Study|Scrub tech removed tube cap|1
1153009|NCT03144687|2266687|FG000|Overall Study|Adverse Event|1
1153010|NCT03144687|2266688|FG001|Overall Study|Adverse Event|0
1153011|NCT03144687|2266687|FG000|Overall Study|Progressive disease|3
1153012|NCT03144687|2266688|FG001|Overall Study|Progressive disease|0
1153013|NCT03144687|2266687|FG000|Overall Study|Death|0
1153014|NCT03144687|2266688|FG001|Overall Study|Death|2
1153015|NCT03144687|2266687|FG000|Overall Study|Lost to Follow-up|0
1153016|NCT03144687|2266688|FG001|Overall Study|Lost to Follow-up|1
1153017|NCT03144687|2266687|FG000|Overall Study|Physician Decision|5
1153018|NCT03144687|2266688|FG001|Overall Study|Physician Decision|2
1153019|NCT03144687|2266687|FG000|Overall Study|Withdrawal by Subject|1
1153020|NCT03144687|2266688|FG001|Overall Study|Withdrawal by Subject|3
1153021|NCT03144687|2266687|FG000|Overall Study|Participants With Ongoing Treatment|3
1153022|NCT03144687|2266688|FG001|Overall Study|Participants With Ongoing Treatment|2
1153023|NCT03144804|2266698|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4
1153024|NCT03145064|2266702|FG000|Overall Study|Death|24
1153025|NCT03145064|2266702|FG000|Overall Study|Lost to Follow-up|3
1153026|NCT03145064|2266702|FG000|Overall Study|Withdrawal by Subject|6
1153027|NCT03145064|2266702|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4
1153028|NCT03145064|2266702|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4
1153029|NCT03145207|2266707|FG000|Overall Study|volunteer started taking allergy shots|1
1153030|NCT03145207|2266707|FG000|Overall Study|baseline blood pressure high|1
1153031|NCT03145766|2266734|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
1153032|NCT03145766|2266735|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
1153033|NCT03145766|2266736|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0
1153034|NCT03145766|2266737|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
1153035|NCT03145766|2266738|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2
1153036|NCT03145766|2266734|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
1153037|NCT03145766|2266735|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
1153038|NCT03145766|2266736|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
1153039|NCT03145766|2266737|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2
1153040|NCT03145766|2266738|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
1153041|NCT03145766|2266734|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
1153042|NCT03145766|2266735|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
1153043|NCT03145766|2266736|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
1153044|NCT03145766|2266737|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3
1153045|NCT03145766|2266738|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
1153046|NCT03145766|2266734|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4
1153047|NCT03145766|2266735|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
1153048|NCT03145766|2266736|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
1153049|NCT03145766|2266737|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
1153050|NCT03145766|2266738|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0
1153051|NCT03145766|2266734|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2
1153052|NCT03145766|2266735|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
1153053|NCT03145766|2266736|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
1153054|NCT03145766|2266737|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1
1153055|NCT03145766|2266738|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
1153056|NCT03145766|2266734|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
1153057|NCT03145766|2266735|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1
1153058|NCT03145766|2266736|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
1153059|NCT03145766|2266737|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2
1153060|NCT03145766|2266738|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3
1153061|NCT03145766|2266734|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
1153062|NCT03145766|2266735|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
1153063|NCT03145766|2266736|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
1153064|NCT03145766|2266737|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
1153065|NCT03145766|2266738|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
1153066|NCT03146403|2266768|FG000|Overall Study|Withdrawal by Subject|0
1153067|NCT03146403|2266769|FG001|Overall Study|Withdrawal by Subject|3
1153068|NCT03146403|2266768|FG000|Overall Study|Lost to Follow-up|2
1153069|NCT03146403|2266769|FG001|Overall Study|Lost to Follow-up|0
1153070|NCT03146663|2266790|FG000|Overall Study|Did not receive study treatment|1
1153071|NCT03146663|2266791|FG001|Overall Study|Did not receive study treatment|1
1153072|NCT03146741|2266798|FG000|Overall Study|Txp with non-HCV+ heart|4
1153073|NCT03146741|2266798|FG000|Overall Study|Listeted for MOT|2
1153074|NCT03146741|2266798|FG000|Overall Study|Physician Decision|2
1153075|NCT03146741|2266798|FG000|Overall Study|Awaiting txp|2
1153076|NCT03147248|2266824|FG000|Overall Study|Adverse Event|0
1153077|NCT03147248|2266825|FG001|Overall Study|Adverse Event|2
1153078|NCT03147248|2266826|FG002|Overall Study|Adverse Event|2
1153079|NCT03147248|2266827|FG003|Overall Study|Adverse Event|2
1153080|NCT03147248|2266828|FG004|Overall Study|Adverse Event|6
1153081|NCT03147248|2266829|FG005|Overall Study|Adverse Event|11
1153082|NCT03147248|2266824|FG000|Overall Study|Disease progression|1
1153083|NCT03147248|2266825|FG001|Overall Study|Disease progression|0
1153084|NCT03147248|2266826|FG002|Overall Study|Disease progression|0
1153085|NCT03147248|2266827|FG003|Overall Study|Disease progression|0
1153086|NCT03147248|2266828|FG004|Overall Study|Disease progression|0
1153087|NCT03147248|2266829|FG005|Overall Study|Disease progression|2
1153088|NCT03147248|2266824|FG000|Overall Study|Withdrawal by Subject|0
1153089|NCT03147248|2266825|FG001|Overall Study|Withdrawal by Subject|0
1153090|NCT03147248|2266826|FG002|Overall Study|Withdrawal by Subject|0
1153091|NCT03147248|2266827|FG003|Overall Study|Withdrawal by Subject|0
1153092|NCT03147248|2266828|FG004|Overall Study|Withdrawal by Subject|12
1153093|NCT03147248|2266829|FG005|Overall Study|Withdrawal by Subject|9
1153094|NCT03147248|2266824|FG000|Overall Study|Protocol Violation|0
1153095|NCT03147248|2266825|FG001|Overall Study|Protocol Violation|0
1153096|NCT03147248|2266826|FG002|Overall Study|Protocol Violation|0
1153097|NCT03147248|2266827|FG003|Overall Study|Protocol Violation|0
1153098|NCT03147248|2266828|FG004|Overall Study|Protocol Violation|2
1153099|NCT03147248|2266829|FG005|Overall Study|Protocol Violation|0
1153100|NCT03147248|2266824|FG000|Overall Study|Lost to Follow-up|0
1153101|NCT03147248|2266825|FG001|Overall Study|Lost to Follow-up|0
1153102|NCT03147248|2266826|FG002|Overall Study|Lost to Follow-up|0
1153103|NCT03147248|2266827|FG003|Overall Study|Lost to Follow-up|0
1153104|NCT03147248|2266828|FG004|Overall Study|Lost to Follow-up|2
1153105|NCT03147248|2266829|FG005|Overall Study|Lost to Follow-up|0
1153106|NCT03147248|2266824|FG000|Overall Study|Pregnancy|0
1153107|NCT03147248|2266825|FG001|Overall Study|Pregnancy|0
1153108|NCT03147248|2266826|FG002|Overall Study|Pregnancy|0
1153109|NCT03147248|2266827|FG003|Overall Study|Pregnancy|0
1153110|NCT03147248|2266828|FG004|Overall Study|Pregnancy|1
1153111|NCT03147248|2266829|FG005|Overall Study|Pregnancy|0
1153112|NCT03147248|2266824|FG000|Overall Study|Death|0
1153113|NCT03147248|2266825|FG001|Overall Study|Death|0
1153114|NCT03147248|2266826|FG002|Overall Study|Death|0
1153115|NCT03147248|2266827|FG003|Overall Study|Death|0
1153116|NCT03147248|2266828|FG004|Overall Study|Death|0
1153117|NCT03147248|2266829|FG005|Overall Study|Death|4
1153118|NCT03147248|2266824|FG000|Overall Study|Physician Decision|0
1153119|NCT03147248|2266825|FG001|Overall Study|Physician Decision|0
1153120|NCT03147248|2266826|FG002|Overall Study|Physician Decision|0
1153121|NCT03147248|2266827|FG003|Overall Study|Physician Decision|0
1153122|NCT03147248|2266828|FG004|Overall Study|Physician Decision|2
1153123|NCT03147248|2266829|FG005|Overall Study|Physician Decision|4
1153124|NCT03147248|2266824|FG000|Overall Study|Prolonged Dosing Interval|0
1153125|NCT03147248|2266825|FG001|Overall Study|Prolonged Dosing Interval|0
1153126|NCT03147248|2266826|FG002|Overall Study|Prolonged Dosing Interval|0
1153127|NCT03147248|2266827|FG003|Overall Study|Prolonged Dosing Interval|0
1153128|NCT03147248|2266828|FG004|Overall Study|Prolonged Dosing Interval|1
1153129|NCT03147248|2266829|FG005|Overall Study|Prolonged Dosing Interval|1
1153130|NCT03147495|2266845|FG000|Overall Study|Physician Decision|0
1153131|NCT03147495|2266846|FG001|Overall Study|Physician Decision|6
1153132|NCT03148067|2266869|FG000|Overall Study|Lost to Follow-up|3
1153133|NCT03148067|2266869|FG000|Overall Study|Death|1
1153134|NCT03148691|2266912|FG000|Overall Study|Protocol Violation|1
1153135|NCT03148691|2266913|FG001|Overall Study|Protocol Violation|2
1153136|NCT03148691|2266914|FG002|Overall Study|Protocol Violation|7
1153137|NCT03148691|2266912|FG000|Overall Study|Lost to Follow-up|0
1153138|NCT03148691|2266913|FG001|Overall Study|Lost to Follow-up|0
1153139|NCT03148691|2266914|FG002|Overall Study|Lost to Follow-up|1
1153140|NCT03148691|2266912|FG000|Overall Study|Other|1
1153141|NCT03148691|2266913|FG001|Overall Study|Other|0
1153142|NCT03148691|2266914|FG002|Overall Study|Other|0
1153143|NCT03148691|2266912|FG000|Overall Study|Withdrawal by Subject|1
1153144|NCT03148691|2266913|FG001|Overall Study|Withdrawal by Subject|0
1153145|NCT03148691|2266914|FG002|Overall Study|Withdrawal by Subject|0
1153146|NCT03148756|2266924|FG000|Overall Study|Study Terminated|0
1153147|NCT03148756|2266925|FG001|Overall Study|Study Terminated|1
1153156|NCT03149042|2266935|FG000|Overall Study|Invasive FFR not performed|21
1153157|NCT03149042|2266935|FG000|Overall Study|Poor CT Image Quality|1
1153158|NCT03149042|2266935|FG000|Overall Study|Invasive FFR Measurement cancelled|1
1153159|NCT03149055|2266940|FG000|Overall Study|Not treated|4
1153160|NCT03149328|2266959|FG000|Overall Study|Withdrawal by Subject|30
1153161|NCT03149328|2266960|FG001|Overall Study|Withdrawal by Subject|26
1153162|NCT03149328|2266959|FG000|Overall Study|Changed Dialysis Modality|18
1153163|NCT03149328|2266960|FG001|Overall Study|Changed Dialysis Modality|1
1153164|NCT03149328|2266959|FG000|Overall Study|Transplant|9
1153165|NCT03149328|2266960|FG001|Overall Study|Transplant|1
1153166|NCT03149328|2266959|FG000|Overall Study|Lost to Follow-up|25
1153167|NCT03149328|2266960|FG001|Overall Study|Lost to Follow-up|16
1153168|NCT03149328|2266959|FG000|Overall Study|Left Study Site|1
1153169|NCT03149328|2266960|FG001|Overall Study|Left Study Site|2
1153170|NCT03149328|2266959|FG000|Overall Study|Language Barrier|1
1153171|NCT03149328|2266960|FG001|Overall Study|Language Barrier|0
1153172|NCT03149848|2266966|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
1153173|NCT03149848|2266966|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2
1153174|NCT03150056|2267002|FG000|Overall Study|Withdrawal by Subject|0
1153175|NCT03150056|2267003|FG001|Overall Study|Withdrawal by Subject|0
1153176|NCT03150056|2267004|FG002|Overall Study|Withdrawal by Subject|0
1153177|NCT03150056|2267005|FG003|Overall Study|Withdrawal by Subject|0
1153178|NCT03150056|2267006|FG004|Overall Study|Withdrawal by Subject|0
1153179|NCT03150056|2267007|FG005|Overall Study|Withdrawal by Subject|2
1153180|NCT03150056|2267002|FG000|Overall Study|Study terminated by Sponsor|1
1153181|NCT03150056|2267003|FG001|Overall Study|Study terminated by Sponsor|3
1153182|NCT03150056|2267004|FG002|Overall Study|Study terminated by Sponsor|1
1153183|NCT03150056|2267005|FG003|Overall Study|Study terminated by Sponsor|1
1153184|NCT03150056|2267006|FG004|Overall Study|Study terminated by Sponsor|5
1153185|NCT03150056|2267007|FG005|Overall Study|Study terminated by Sponsor|6
1153186|NCT03150056|2267002|FG000|Overall Study|Death|9
1153187|NCT03150056|2267003|FG001|Overall Study|Death|2
1153188|NCT03150056|2267004|FG002|Overall Study|Death|2
1153189|NCT03150056|2267005|FG003|Overall Study|Death|7
1153190|NCT03150056|2267006|FG004|Overall Study|Death|8
1153191|NCT03150056|2267007|FG005|Overall Study|Death|10
1153192|NCT03150056|2267002|FG000|Overall Study|Ongoing in the study|0
1153193|NCT03150056|2267003|FG001|Overall Study|Ongoing in the study|0
1153194|NCT03150056|2267004|FG002|Overall Study|Ongoing in the study|1
1153195|NCT03150056|2267005|FG003|Overall Study|Ongoing in the study|1
1153196|NCT03150056|2267006|FG004|Overall Study|Ongoing in the study|3
1153197|NCT03150056|2267007|FG005|Overall Study|Ongoing in the study|0
1153198|NCT03150082|2267024|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
1153199|NCT03150082|2267025|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
1153200|NCT03150485|2267061|FG000|Overall Study|Unsatisfactory Lens Fitting|0
1153201|NCT03150485|2267062|FG001|Overall Study|Unsatisfactory Lens Fitting|1
1153202|NCT03150485|2267063|FG002|Overall Study|Unsatisfactory Lens Fitting|0
1153203|NCT03150485|2267064|FG003|Overall Study|Unsatisfactory Lens Fitting|0
1153204|NCT03150485|2267065|FG004|Overall Study|Unsatisfactory Lens Fitting|0
1153205|NCT03150485|2267066|FG005|Overall Study|Unsatisfactory Lens Fitting|0
1153206|NCT03150589|2267073|FG000|Overall Study|Withdrawal by Subject|16
1153207|NCT03150589|2267074|FG001|Overall Study|Withdrawal by Subject|9
1153208|NCT03150589|2267073|FG000|Overall Study|Adverse Event|7
1153209|NCT03150589|2267074|FG001|Overall Study|Adverse Event|6
1153210|NCT03150589|2267073|FG000|Overall Study|Protocol Violation|4
1153211|NCT03150589|2267074|FG001|Overall Study|Protocol Violation|3
1153212|NCT03150589|2267073|FG000|Overall Study|Lost to Follow-up|3
1153213|NCT03150589|2267074|FG001|Overall Study|Lost to Follow-up|3
1153214|NCT03150589|2267073|FG000|Overall Study|Death|2
1153215|NCT03150589|2267074|FG001|Overall Study|Death|3
1153216|NCT03150589|2267073|FG000|Overall Study|IP non-compliance and other reasons|12
1153217|NCT03150589|2267074|FG001|Overall Study|IP non-compliance and other reasons|3
1153218|NCT03150719|2267082|FG000|Overall Study|Adverse Event|0
1153219|NCT03150719|2267083|FG001|Overall Study|Adverse Event|1
1153220|NCT03150719|2267082|FG000|Overall Study|Death|0
1153221|NCT03150719|2267083|FG001|Overall Study|Death|1
1153222|NCT03150719|2267082|FG000|Overall Study|Other|1
1153223|NCT03150719|2267083|FG001|Overall Study|Other|0
1153224|NCT03151148|2267117|FG000|Overall Study|Lost to Follow-up|1
1153225|NCT03151148|2267118|FG001|Overall Study|Lost to Follow-up|0
1153226|NCT03151148|2267117|FG000|Overall Study|Withdrawal by Subject|1
1153227|NCT03151148|2267118|FG001|Overall Study|Withdrawal by Subject|0
1153228|NCT03151395|2267134|FG000|Overall Study|Adverse Event|2
1153229|NCT03151395|2267134|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
1153230|NCT03151395|2267134|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3
1153231|NCT03151395|2267134|FG000|Overall Study|Unspecified reason|4
1153232|NCT03151551|2267156|FG000|Open-Label Treatment Period|Adverse Event|0
1153233|NCT03151551|2267157|FG001|Open-Label Treatment Period|Adverse Event|2
1153234|NCT03151551|2267156|FG000|Open-Label Treatment Period|Lost to Follow-up|1
1153235|NCT03151551|2267157|FG001|Open-Label Treatment Period|Lost to Follow-up|1
1153236|NCT03151551|2267156|FG000|Open-Label Treatment Period|Withdrawal by Subject|12
1153237|NCT03151551|2267157|FG001|Open-Label Treatment Period|Withdrawal by Subject|18
1153238|NCT03151551|2267156|FG000|Open-Label Treatment Period|Lack of Efficacy|1
1153239|NCT03151551|2267157|FG001|Open-Label Treatment Period|Lack of Efficacy|1
1153240|NCT03151551|2267156|FG000|Open-Label Treatment Period|Physician Decision|3
1153241|NCT03151551|2267157|FG001|Open-Label Treatment Period|Physician Decision|0
1153242|NCT03151551|2267156|FG000|Open-Label Treatment Period|Protocol Deviation|1
1153243|NCT03151551|2267157|FG001|Open-Label Treatment Period|Protocol Deviation|2
1153244|NCT03151551|2267156|FG000|Post-Treatment Follow-Up Period|Adverse Event|1
1153245|NCT03151551|2267157|FG001|Post-Treatment Follow-Up Period|Adverse Event|3
1153246|NCT03151551|2267156|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4
1153247|NCT03151551|2267157|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
1153248|NCT03151551|2267156|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20
1153249|NCT03151551|2267157|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22
1153250|NCT03151551|2267156|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
1153251|NCT03151551|2267157|FG001|Post-Treatment Follow-Up Period|Physician Decision|1
1153252|NCT03152019|2267167|FG000|Overall Study|Adverse Event|0
1153253|NCT03152019|2267168|FG001|Overall Study|Adverse Event|1
1153254|NCT03152110|2267183|FG000|Overall Study|Withdrawal by Subject|3
1153255|NCT03154047|2267240|FG000|Overall Study|Death|1
1153256|NCT03154047|2267240|FG000|Overall Study|Study terminated by sponsor|76
1153257|NCT03154047|2267240|FG000|Overall Study|Withdrawal by Subject|3
1153258|NCT03154086|2267259|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153259|NCT03154086|2267260|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153260|NCT03154086|2267261|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153261|NCT03154086|2267262|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
1153262|NCT03154086|2267263|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153263|NCT03154086|2267264|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153264|NCT03154086|2267265|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153265|NCT03154086|2267266|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153266|NCT03154086|2267267|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153267|NCT03154086|2267268|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153268|NCT03154086|2267269|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153269|NCT03154086|2267270|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153270|NCT03154086|2267271|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153271|NCT03154086|2267272|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153272|NCT03154086|2267273|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1153273|NCT03154086|2267259|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153274|NCT03154086|2267260|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
1153275|NCT03154086|2267261|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153276|NCT03154086|2267262|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153277|NCT03154086|2267263|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153278|NCT03154086|2267264|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153279|NCT03154086|2267265|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153280|NCT03154086|2267266|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153281|NCT03154086|2267267|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153282|NCT03154086|2267268|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153283|NCT03154086|2267269|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153284|NCT03154086|2267270|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153285|NCT03154086|2267271|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153286|NCT03154086|2267272|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153287|NCT03154086|2267273|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1153288|NCT03154086|2267259|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153289|NCT03154086|2267260|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153290|NCT03154086|2267261|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
1153291|NCT03154086|2267262|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153292|NCT03154086|2267263|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153293|NCT03154086|2267264|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153294|NCT03154086|2267265|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153295|NCT03154086|2267266|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153296|NCT03154086|2267267|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153297|NCT03154086|2267268|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153298|NCT03154086|2267269|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153299|NCT03154086|2267270|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153300|NCT03154086|2267271|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153301|NCT03154086|2267272|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153302|NCT03154086|2267273|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1153303|NCT03154086|2267259|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
1153304|NCT03154086|2267260|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153305|NCT03154086|2267261|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153306|NCT03154086|2267262|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153307|NCT03154086|2267263|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153308|NCT03154086|2267264|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153309|NCT03154086|2267265|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153310|NCT03154086|2267266|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153311|NCT03154086|2267267|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153312|NCT03154086|2267268|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153313|NCT03154086|2267269|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153314|NCT03154086|2267270|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153315|NCT03154086|2267271|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153316|NCT03154086|2267272|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153317|NCT03154086|2267273|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1153318|NCT03154086|2267259|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153319|NCT03154086|2267260|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153320|NCT03154086|2267261|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153321|NCT03154086|2267262|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153322|NCT03154086|2267263|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153323|NCT03154086|2267264|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153324|NCT03154086|2267265|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153325|NCT03154086|2267266|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153326|NCT03154086|2267267|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
1153327|NCT03154086|2267268|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153328|NCT03154086|2267269|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153329|NCT03154086|2267270|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153330|NCT03154086|2267271|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153331|NCT03154086|2267272|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153332|NCT03154086|2267273|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1153333|NCT03154086|2267259|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153334|NCT03154086|2267260|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153335|NCT03154086|2267261|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153336|NCT03154086|2267262|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153337|NCT03154086|2267263|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153338|NCT03154086|2267264|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153339|NCT03154086|2267265|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153340|NCT03154086|2267266|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
1153341|NCT03154086|2267267|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153342|NCT03154086|2267268|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153343|NCT03154086|2267269|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153344|NCT03154086|2267270|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153345|NCT03154086|2267271|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153346|NCT03154086|2267272|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153347|NCT03154086|2267273|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1153348|NCT03154086|2267259|FG000|Part B (Up to 25 Days)|Adverse Event|0
1153349|NCT03154086|2267260|FG001|Part B (Up to 25 Days)|Adverse Event|0
1153350|NCT03154086|2267261|FG002|Part B (Up to 25 Days)|Adverse Event|0
1153351|NCT03154086|2267262|FG003|Part B (Up to 25 Days)|Adverse Event|0
1153352|NCT03154086|2267263|FG004|Part B (Up to 25 Days)|Adverse Event|0
1153353|NCT03154086|2267264|FG005|Part B (Up to 25 Days)|Adverse Event|0
1153354|NCT03154086|2267265|FG006|Part B (Up to 25 Days)|Adverse Event|0
1153355|NCT03154086|2267266|FG007|Part B (Up to 25 Days)|Adverse Event|0
1153356|NCT03154086|2267267|FG008|Part B (Up to 25 Days)|Adverse Event|0
1153357|NCT03154086|2267268|FG009|Part B (Up to 25 Days)|Adverse Event|0
1153358|NCT03154086|2267269|FG010|Part B (Up to 25 Days)|Adverse Event|1
1153359|NCT03154086|2267270|FG011|Part B (Up to 25 Days)|Adverse Event|0
1153360|NCT03154086|2267271|FG012|Part B (Up to 25 Days)|Adverse Event|0
1153361|NCT03154086|2267272|FG013|Part B (Up to 25 Days)|Adverse Event|0
1153362|NCT03154086|2267273|FG014|Part B (Up to 25 Days)|Adverse Event|0
1153363|NCT03154476|2267341|FG000|Overall Study|Lost to Follow-up|4
1153364|NCT03154476|2267342|FG001|Overall Study|Lost to Follow-up|4
1153365|NCT03155178|2267370|FG000|Overall Study|Did not meet treatment day baseline|7
1153366|NCT03155178|2267371|FG001|Overall Study|Did not meet treatment day baseline|7
1153367|NCT03155178|2267372|FG002|Overall Study|Did not meet treatment day baseline|7
1153368|NCT03155178|2267373|FG003|Overall Study|Did not meet treatment day baseline|7
1153369|NCT03155269|2267389|FG000|Overall Study|Withdrawal by Subject|4
1153370|NCT03155269|2267390|FG001|Overall Study|Withdrawal by Subject|5
1153371|NCT03155269|2267389|FG000|Overall Study|Lost to Follow-up|1
1153372|NCT03155269|2267390|FG001|Overall Study|Lost to Follow-up|2
1153373|NCT03155724|2267396|FG000|Overall Study|Death|3
1153374|NCT03155724|2267396|FG000|Overall Study|Physician Decision|1
1153375|NCT03155724|2267396|FG000|Overall Study|Study closure|7
1153376|NCT03155945|2267402|FG000|Overall Study|Lost to Follow-up|0
1153377|NCT03155945|2267403|FG001|Overall Study|Lost to Follow-up|1
1153378|NCT03155945|2267402|FG000|Overall Study|Withdrawal by Subject|0
1153379|NCT03155945|2267403|FG001|Overall Study|Withdrawal by Subject|1
1153380|NCT03155945|2267402|FG000|Overall Study|Other Reason|0
1153381|NCT03155945|2267403|FG001|Overall Study|Other Reason|1
1153390|NCT03156270|2267418|FG000|Overall Study|Failed pre-treatment screening|1
1153391|NCT03156270|2267418|FG000|Overall Study|Lost to Follow-up|1
1153392|NCT03156543|2267426|FG000|Overall Study|Withdrawal by Subject|1
1153393|NCT03156543|2267427|FG001|Overall Study|Withdrawal by Subject|0
1153394|NCT03156621|2267435|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0
1153395|NCT03156621|2267436|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2
1153396|NCT03156621|2267435|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0
1153397|NCT03156621|2267436|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1
1153398|NCT03157089|2267447|FG000|Overall Study|Treated only with pembrolizumab|1
1153399|NCT03157089|2267448|FG001|Overall Study|Treated only with pembrolizumab|0
1153400|NCT03157089|2267447|FG000|Overall Study|Adverse Event|5
1153401|NCT03157089|2267448|FG001|Overall Study|Adverse Event|4
1153402|NCT03157089|2267447|FG000|Overall Study|Progressive disease|6
1153403|NCT03157089|2267448|FG001|Overall Study|Progressive disease|8
1153404|NCT03157531|2267459|FG000|Overall Study|Death|2
1153405|NCT03157531|2267459|FG000|Overall Study|Lost to Follow-up|4
1153406|NCT03157583|2267463|FG000|Overall Study|Other (did not meet study criteria)|1
1153407|NCT03158012|2267483|FG000|Overall Study|Withdrawal by Subject|0
1153408|NCT03158012|2267484|FG001|Overall Study|Withdrawal by Subject|1
1153409|NCT03158220|2267505|FG000|Overall Study|Screen Failure|0
1153410|NCT03158220|2267506|FG001|Overall Study|Screen Failure|1
1153411|NCT03158220|2267505|FG000|Overall Study|Withdrawal by Subject|8
1153412|NCT03158220|2267506|FG001|Overall Study|Withdrawal by Subject|9
1153413|NCT03158220|2267505|FG000|Overall Study|Status unknown|0
1153414|NCT03158220|2267506|FG001|Overall Study|Status unknown|1
1153415|NCT03158220|2267505|FG000|Overall Study|Lost to Follow-up|8
1153416|NCT03158220|2267506|FG001|Overall Study|Lost to Follow-up|5
1153417|NCT03158220|2267505|FG000|Overall Study|Physician Decision|1
1153418|NCT03158220|2267506|FG001|Overall Study|Physician Decision|0
1153419|NCT03158272|2267516|FG000|Overall Study|Disease progression|3
1153420|NCT03158272|2267517|FG001|Overall Study|Disease progression|3
1153421|NCT03158272|2267518|FG002|Overall Study|Disease progression|4
1153422|NCT03158272|2267519|FG003|Overall Study|Disease progression|6
1153423|NCT03158272|2267516|FG000|Overall Study|Death|0
1153424|NCT03158272|2267517|FG001|Overall Study|Death|0
1153425|NCT03158272|2267518|FG002|Overall Study|Death|1
1153426|NCT03158272|2267519|FG003|Overall Study|Death|0
1153427|NCT03158272|2267516|FG000|Overall Study|Other reasons|0
1153428|NCT03158272|2267517|FG001|Overall Study|Other reasons|0
1153429|NCT03158272|2267518|FG002|Overall Study|Other reasons|1
1153430|NCT03158272|2267519|FG003|Overall Study|Other reasons|0
1153431|NCT03158272|2267516|FG000|Overall Study|Adverse event unrelated to the drug|0
1153432|NCT03158272|2267517|FG001|Overall Study|Adverse event unrelated to the drug|1
1153433|NCT03158272|2267518|FG002|Overall Study|Adverse event unrelated to the drug|0
1153434|NCT03158272|2267519|FG003|Overall Study|Adverse event unrelated to the drug|0
1153465|NCT03158311|2267550|FG000|Overall Study|Subject/Guardian Decision|10
1153466|NCT03158311|2267551|FG001|Overall Study|Subject/Guardian Decision|6
1153467|NCT03158311|2267552|FG002|Overall Study|Subject/Guardian Decision|11
1153468|NCT03158311|2267550|FG000|Overall Study|Adverse Event|5
1153469|NCT03158311|2267551|FG001|Overall Study|Adverse Event|3
1153470|NCT03158311|2267552|FG002|Overall Study|Adverse Event|3
1153471|NCT03158311|2267550|FG000|Overall Study|Techinical Problems|3
1153472|NCT03158311|2267551|FG001|Overall Study|Techinical Problems|1
1153473|NCT03158311|2267552|FG002|Overall Study|Techinical Problems|5
1153474|NCT03158311|2267550|FG000|Overall Study|Physician Decision|2
1153475|NCT03158311|2267551|FG001|Overall Study|Physician Decision|3
1153476|NCT03158311|2267552|FG002|Overall Study|Physician Decision|7
1153477|NCT03158311|2267550|FG000|Overall Study|Lost to Follow-up|1
1153478|NCT03158311|2267551|FG001|Overall Study|Lost to Follow-up|1
1153479|NCT03158311|2267552|FG002|Overall Study|Lost to Follow-up|1
1153480|NCT03158311|2267550|FG000|Overall Study|Sponsor decision|1
1153481|NCT03158311|2267551|FG001|Overall Study|Sponsor decision|0
1153482|NCT03158311|2267552|FG002|Overall Study|Sponsor decision|0
1153483|NCT03158311|2267550|FG000|Overall Study|Pregnancy|0
1153484|NCT03158311|2267551|FG001|Overall Study|Pregnancy|2
1153485|NCT03158311|2267552|FG002|Overall Study|Pregnancy|0
1153486|NCT03158311|2267550|FG000|Overall Study|Randomized in error|0
1153487|NCT03158311|2267551|FG001|Overall Study|Randomized in error|0
1153488|NCT03158311|2267552|FG002|Overall Study|Randomized in error|1
1153499|NCT03159091|2267584|FG000|Overall Study|Incorrect inclusion ineligible patient|5
1153500|NCT03159091|2267585|FG001|Overall Study|Incorrect inclusion ineligible patient|3
1153501|NCT03159091|2267584|FG000|Overall Study|Patient has taken no dose of study drug|0
1153502|NCT03159091|2267585|FG001|Overall Study|Patient has taken no dose of study drug|1
1153503|NCT03159455|2267628|FG000|Overall Study|Adverse Event|0
1153504|NCT03159455|2267629|FG001|Overall Study|Adverse Event|0
1153505|NCT03159455|2267630|FG002|Overall Study|Adverse Event|0
1153506|NCT03159455|2267631|FG003|Overall Study|Adverse Event|0
1153507|NCT03159455|2267632|FG004|Overall Study|Adverse Event|0
1153508|NCT03159455|2267633|FG005|Overall Study|Adverse Event|1
1153509|NCT03159468|2267657|FG000|Overall Study|Withdrawal by Subject|0
1153510|NCT03159468|2267658|FG001|Overall Study|Withdrawal by Subject|0
1153511|NCT03159468|2267659|FG002|Overall Study|Withdrawal by Subject|3
1153512|NCT03159468|2267660|FG003|Overall Study|Withdrawal by Subject|0
1153513|NCT03159468|2267661|FG004|Overall Study|Withdrawal by Subject|0
1153514|NCT03159468|2267662|FG005|Overall Study|Withdrawal by Subject|0
1153515|NCT03159611|2267678|FG000|Overall Study|Did Not Meet Inclusion Criteria|9
1153516|NCT03159611|2267679|FG001|Overall Study|Did Not Meet Inclusion Criteria|5
1153517|NCT03159611|2267678|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
1153518|NCT03159611|2267679|FG001|Overall Study|Did Not Meet Exclusion Criteria|3
1153519|NCT03159611|2267678|FG000|Overall Study|Protocol Violation|7
1153520|NCT03159611|2267679|FG001|Overall Study|Protocol Violation|4
1153521|NCT03159611|2267678|FG000|Overall Study|Adverse Event|1
1153522|NCT03159611|2267679|FG001|Overall Study|Adverse Event|0
1153523|NCT03159611|2267678|FG000|Overall Study|Withdrawal by Subject|1
1153524|NCT03159611|2267679|FG001|Overall Study|Withdrawal by Subject|1
1153525|NCT03159611|2267678|FG000|Overall Study|Non-compliance with protocol requirement|3
1153526|NCT03159611|2267679|FG001|Overall Study|Non-compliance with protocol requirement|2
1153527|NCT03159611|2267678|FG000|Overall Study|Inability to perform procedures|1
1153528|NCT03159611|2267679|FG001|Overall Study|Inability to perform procedures|0
1153529|NCT03160560|2267729|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2
1153530|NCT03160560|2267730|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
1153531|NCT03160560|2267731|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1
1153532|NCT03160560|2267732|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0
1153533|NCT03160560|2267729|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
1153534|NCT03160560|2267730|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
1153535|NCT03160560|2267731|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0
1153536|NCT03160560|2267732|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0
1153537|NCT03160573|2267746|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1
1153538|NCT03160573|2267747|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3
1153539|NCT03160573|2267748|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2
1153540|NCT03160573|2267749|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2
1153541|NCT03160703|2267763|FG000|Overall Study|Withdrawal by Subject|0
1153542|NCT03160703|2267764|FG001|Overall Study|Withdrawal by Subject|0
1153543|NCT03160703|2267765|FG002|Overall Study|Withdrawal by Subject|0
1153544|NCT03160703|2267766|FG003|Overall Study|Withdrawal by Subject|1
1153545|NCT03160716|2267776|FG000|Overall Study|Lost to Follow-up|1
1153546|NCT03160885|2267782|FG000|Initial Treatment Period|Not dosed|2
1153547|NCT03160885|2267783|FG001|Initial Treatment Period|Not dosed|0
1153548|NCT03160885|2267784|FG002|Initial Treatment Period|Not dosed|0
1153549|NCT03160885|2267785|FG003|Initial Treatment Period|Not dosed|0
1153550|NCT03160885|2267786|FG004|Initial Treatment Period|Not dosed|0
1153551|NCT03160885|2267787|FG005|Initial Treatment Period|Not dosed|0
1153552|NCT03160885|2267788|FG006|Initial Treatment Period|Not dosed|0
1153553|NCT03160885|2267782|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33
1153554|NCT03160885|2267783|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22
1153555|NCT03160885|2267784|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
1153556|NCT03160885|2267785|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
1153557|NCT03160885|2267786|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
1153558|NCT03160885|2267787|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
1153559|NCT03160885|2267788|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
1153560|NCT03160885|2267782|FG000|Open-label Treatment|Not dosed|0
1153561|NCT03160885|2267783|FG001|Open-label Treatment|Not dosed|0
1153562|NCT03160885|2267784|FG002|Open-label Treatment|Not dosed|0
1153563|NCT03160885|2267785|FG003|Open-label Treatment|Not dosed|0
1153564|NCT03160885|2267786|FG004|Open-label Treatment|Not dosed|0
1153565|NCT03160885|2267787|FG005|Open-label Treatment|Not dosed|0
1153566|NCT03160885|2267788|FG006|Open-label Treatment|Not dosed|2
1153567|NCT03160885|2267782|FG000|Open-label Treatment|Discontinued IMP|0
1153568|NCT03160885|2267783|FG001|Open-label Treatment|Discontinued IMP|0
1153569|NCT03160885|2267784|FG002|Open-label Treatment|Discontinued IMP|0
1153570|NCT03160885|2267785|FG003|Open-label Treatment|Discontinued IMP|0
1153571|NCT03160885|2267786|FG004|Open-label Treatment|Discontinued IMP|0
1153572|NCT03160885|2267787|FG005|Open-label Treatment|Discontinued IMP|0
1153573|NCT03160885|2267788|FG006|Open-label Treatment|Discontinued IMP|131
1153574|NCT03160885|2267782|FG000|Open-label Treatment|Completed Week 50|0
1153575|NCT03160885|2267783|FG001|Open-label Treatment|Completed Week 50|0
1153576|NCT03160885|2267784|FG002|Open-label Treatment|Completed Week 50|0
1153577|NCT03160885|2267785|FG003|Open-label Treatment|Completed Week 50|0
1153578|NCT03160885|2267786|FG004|Open-label Treatment|Completed Week 50|0
1153579|NCT03160885|2267787|FG005|Open-label Treatment|Completed Week 50|0
1153580|NCT03160885|2267788|FG006|Open-label Treatment|Completed Week 50|4
1153581|NCT03160885|2267782|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0
1153582|NCT03160885|2267783|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0
1153583|NCT03160885|2267784|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0
1153584|NCT03160885|2267785|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1
1153585|NCT03160885|2267786|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0
1153586|NCT03160885|2267787|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0
1153587|NCT03160885|2267788|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0
1153588|NCT03160885|2267782|FG000|Maintenance Treatment Period|Discontinued IMP|0
1153589|NCT03160885|2267783|FG001|Maintenance Treatment Period|Discontinued IMP|0
1153590|NCT03160885|2267784|FG002|Maintenance Treatment Period|Discontinued IMP|9
1153591|NCT03160885|2267785|FG003|Maintenance Treatment Period|Discontinued IMP|13
1153592|NCT03160885|2267786|FG004|Maintenance Treatment Period|Discontinued IMP|5
1153593|NCT03160885|2267787|FG005|Maintenance Treatment Period|Discontinued IMP|7
1153594|NCT03160885|2267788|FG006|Maintenance Treatment Period|Discontinued IMP|0
1153595|NCT03160885|2267782|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
1153596|NCT03160885|2267783|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
1153597|NCT03160885|2267784|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29
1153598|NCT03160885|2267785|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26
1153599|NCT03160885|2267786|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26
1153600|NCT03160885|2267787|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8
1153601|NCT03160885|2267788|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
1153602|NCT03160885|2267782|FG000|Maintenance Treatment Period|Completed Week 50|0
1153603|NCT03160885|2267783|FG001|Maintenance Treatment Period|Completed Week 50|0
1153604|NCT03160885|2267784|FG002|Maintenance Treatment Period|Completed Week 50|1
1153605|NCT03160885|2267785|FG003|Maintenance Treatment Period|Completed Week 50|0
1153606|NCT03160885|2267786|FG004|Maintenance Treatment Period|Completed Week 50|0
1153607|NCT03160885|2267787|FG005|Maintenance Treatment Period|Completed Week 50|0
1153608|NCT03160885|2267788|FG006|Maintenance Treatment Period|Completed Week 50|0
1153609|NCT03160898|2267809|FG000|Overall Study|Adverse Event|4
1153610|NCT03160898|2267810|FG001|Overall Study|Adverse Event|8
1153611|NCT03160898|2267811|FG002|Overall Study|Adverse Event|7
1153612|NCT03160898|2267812|FG003|Overall Study|Adverse Event|10
1153613|NCT03160898|2267809|FG000|Overall Study|Death|1
1153614|NCT03160898|2267810|FG001|Overall Study|Death|0
1153615|NCT03160898|2267811|FG002|Overall Study|Death|0
1153616|NCT03160898|2267812|FG003|Overall Study|Death|1
1153617|NCT03160898|2267809|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3
1153618|NCT03160898|2267810|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0
1153619|NCT03160898|2267811|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0
1153620|NCT03160898|2267812|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1
1153621|NCT03160898|2267809|FG000|Overall Study|Lost to Follow-up|1
1153622|NCT03160898|2267810|FG001|Overall Study|Lost to Follow-up|1
1153623|NCT03160898|2267811|FG002|Overall Study|Lost to Follow-up|1
1153624|NCT03160898|2267812|FG003|Overall Study|Lost to Follow-up|2
1153625|NCT03160898|2267809|FG000|Overall Study|Physician Decision|1
1153626|NCT03160898|2267810|FG001|Overall Study|Physician Decision|0
1153627|NCT03160898|2267811|FG002|Overall Study|Physician Decision|0
1153628|NCT03160898|2267812|FG003|Overall Study|Physician Decision|1
1153629|NCT03160898|2267809|FG000|Overall Study|Progressive Disease|4
1153630|NCT03160898|2267810|FG001|Overall Study|Progressive Disease|1
1153631|NCT03160898|2267811|FG002|Overall Study|Progressive Disease|2
1153632|NCT03160898|2267812|FG003|Overall Study|Progressive Disease|1
1153633|NCT03160898|2267809|FG000|Overall Study|Protocol Violation|1
1153634|NCT03160898|2267810|FG001|Overall Study|Protocol Violation|0
1153635|NCT03160898|2267811|FG002|Overall Study|Protocol Violation|2
1153636|NCT03160898|2267812|FG003|Overall Study|Protocol Violation|0
1153637|NCT03160898|2267809|FG000|Overall Study|Sponsor Discretion|2
1153638|NCT03160898|2267810|FG001|Overall Study|Sponsor Discretion|0
1153639|NCT03160898|2267811|FG002|Overall Study|Sponsor Discretion|0
1153640|NCT03160898|2267812|FG003|Overall Study|Sponsor Discretion|0
1153641|NCT03160898|2267809|FG000|Overall Study|Withdrawal by Subject|1
1153642|NCT03160898|2267810|FG001|Overall Study|Withdrawal by Subject|3
1153643|NCT03160898|2267811|FG002|Overall Study|Withdrawal by Subject|2
1153644|NCT03160898|2267812|FG003|Overall Study|Withdrawal by Subject|1
1153645|NCT03160898|2267809|FG000|Overall Study|Other|2
1153646|NCT03160898|2267810|FG001|Overall Study|Other|0
1153647|NCT03160898|2267811|FG002|Overall Study|Other|2
1153648|NCT03160898|2267812|FG003|Overall Study|Other|2
1153649|NCT03161405|2267837|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1
1153650|NCT03161483|2267848|FG000|Overall Study|Death|1
1153651|NCT03161483|2267849|FG001|Overall Study|Death|0
1153652|NCT03161483|2267850|FG002|Overall Study|Death|0
1153653|NCT03161483|2267851|FG003|Overall Study|Death|0
1153654|NCT03161483|2267848|FG000|Overall Study|Adverse Event|5
1153655|NCT03161483|2267849|FG001|Overall Study|Adverse Event|1
1153656|NCT03161483|2267850|FG002|Overall Study|Adverse Event|11
1153657|NCT03161483|2267851|FG003|Overall Study|Adverse Event|2
1153658|NCT03161483|2267848|FG000|Overall Study|Pregnancy|1
1153659|NCT03161483|2267849|FG001|Overall Study|Pregnancy|0
1153660|NCT03161483|2267850|FG002|Overall Study|Pregnancy|0
1153661|NCT03161483|2267851|FG003|Overall Study|Pregnancy|0
1153662|NCT03161483|2267848|FG000|Overall Study|Lack of Efficacy|0
1153663|NCT03161483|2267849|FG001|Overall Study|Lack of Efficacy|0
1153664|NCT03161483|2267850|FG002|Overall Study|Lack of Efficacy|1
1153665|NCT03161483|2267851|FG003|Overall Study|Lack of Efficacy|0
1153666|NCT03161483|2267848|FG000|Overall Study|Withdrawal by Subject|2
1153667|NCT03161483|2267849|FG001|Overall Study|Withdrawal by Subject|2
1153668|NCT03161483|2267850|FG002|Overall Study|Withdrawal by Subject|6
1153669|NCT03161483|2267851|FG003|Overall Study|Withdrawal by Subject|5
1153670|NCT03161483|2267848|FG000|Overall Study|Lost to Follow-up|0
1153671|NCT03161483|2267849|FG001|Overall Study|Lost to Follow-up|0
1153672|NCT03161483|2267850|FG002|Overall Study|Lost to Follow-up|1
1153673|NCT03161483|2267851|FG003|Overall Study|Lost to Follow-up|0
1153674|NCT03161483|2267848|FG000|Overall Study|Protocol Violation|0
1153675|NCT03161483|2267849|FG001|Overall Study|Protocol Violation|0
1153676|NCT03161483|2267850|FG002|Overall Study|Protocol Violation|1
1153677|NCT03161483|2267851|FG003|Overall Study|Protocol Violation|0
1153678|NCT03161483|2267848|FG000|Overall Study|Other reasons|1
1153679|NCT03161483|2267849|FG001|Overall Study|Other reasons|0
1153680|NCT03161483|2267850|FG002|Overall Study|Other reasons|0
1153681|NCT03161483|2267851|FG003|Overall Study|Other reasons|1
1153682|NCT03162055|2267872|FG000|Overall Study|Adverse Event|6
1153683|NCT03162055|2267873|FG001|Overall Study|Adverse Event|5
1153684|NCT03162055|2267872|FG000|Overall Study|Death|3
1153685|NCT03162055|2267873|FG001|Overall Study|Death|3
1153686|NCT03162055|2267872|FG000|Overall Study|Lost to Follow-up|0
1153687|NCT03162055|2267873|FG001|Overall Study|Lost to Follow-up|1
1153688|NCT03162055|2267872|FG000|Overall Study|Study-specific withdrawal criteria|22
1153689|NCT03162055|2267873|FG001|Overall Study|Study-specific withdrawal criteria|14
1153690|NCT03162055|2267872|FG000|Overall Study|Withdrawal by Subject|17
1153691|NCT03162055|2267873|FG001|Overall Study|Withdrawal by Subject|2
1153692|NCT03162055|2267872|FG000|Overall Study|Did not receive treatment|2
1153693|NCT03162055|2267873|FG001|Overall Study|Did not receive treatment|0
1153694|NCT03162055|2267872|FG000|Overall Study|Incorrect randomization|4
1153695|NCT03162055|2267873|FG001|Overall Study|Incorrect randomization|3
1153696|NCT03162055|2267872|FG000|Overall Study|Other|8
1153697|NCT03162055|2267873|FG001|Overall Study|Other|15
1153698|NCT03162328|2267879|FG000|Screening Period|Did not meet inclusion/exclusion|21
1153699|NCT03162328|2267880|FG001|Screening Period|Did not meet inclusion/exclusion|0
1153700|NCT03162328|2267881|FG002|Screening Period|Did not meet inclusion/exclusion|0
1153701|NCT03162328|2267879|FG000|Screening Period|Withdrawal by Subject|1
1153702|NCT03162328|2267880|FG001|Screening Period|Withdrawal by Subject|0
1153703|NCT03162328|2267881|FG002|Screening Period|Withdrawal by Subject|0
1153704|NCT03162328|2267879|FG000|Study Period|Withdrawal by Subject|0
1153705|NCT03162328|2267880|FG001|Study Period|Withdrawal by Subject|0
1153706|NCT03162328|2267881|FG002|Study Period|Withdrawal by Subject|1
1153707|NCT03162614|2267921|FG000|Overall Study|Lost to Follow-up|2
1153708|NCT03162614|2267922|FG001|Overall Study|Lost to Follow-up|1
1153709|NCT03162614|2267923|FG002|Overall Study|Lost to Follow-up|1
1153710|NCT03162614|2267924|FG003|Overall Study|Lost to Follow-up|1
1153711|NCT03162614|2267925|FG004|Overall Study|Lost to Follow-up|2
1153712|NCT03162614|2267926|FG005|Overall Study|Lost to Follow-up|0
1153713|NCT03162614|2267921|FG000|Overall Study|Protocol Violation|0
1153714|NCT03162614|2267922|FG001|Overall Study|Protocol Violation|1
1153715|NCT03162614|2267923|FG002|Overall Study|Protocol Violation|0
1153716|NCT03162614|2267924|FG003|Overall Study|Protocol Violation|1
1153717|NCT03162614|2267925|FG004|Overall Study|Protocol Violation|0
1153718|NCT03162614|2267926|FG005|Overall Study|Protocol Violation|0
1153719|NCT03162614|2267921|FG000|Overall Study|Withdrawal by Subject|2
1153720|NCT03162614|2267922|FG001|Overall Study|Withdrawal by Subject|1
1153721|NCT03162614|2267923|FG002|Overall Study|Withdrawal by Subject|1
1153722|NCT03162614|2267924|FG003|Overall Study|Withdrawal by Subject|1
1153723|NCT03162614|2267925|FG004|Overall Study|Withdrawal by Subject|0
1153724|NCT03162614|2267926|FG005|Overall Study|Withdrawal by Subject|0
1153725|NCT03162614|2267921|FG000|Overall Study|Missed vaccination, exclusion criteria|2
1153726|NCT03162614|2267922|FG001|Overall Study|Missed vaccination, exclusion criteria|2
1153727|NCT03162614|2267923|FG002|Overall Study|Missed vaccination, exclusion criteria|2
1153728|NCT03162614|2267924|FG003|Overall Study|Missed vaccination, exclusion criteria|4
1153729|NCT03162614|2267925|FG004|Overall Study|Missed vaccination, exclusion criteria|3
1153730|NCT03162614|2267926|FG005|Overall Study|Missed vaccination, exclusion criteria|0
1153731|NCT03162796|2267943|FG000|Placebo Controlled Period: Week 0 - 24|Other|0
1153732|NCT03162796|2267944|FG001|Placebo Controlled Period: Week 0 - 24|Other|1
1153733|NCT03162796|2267945|FG002|Placebo Controlled Period: Week 0 - 24|Other|1
1153734|NCT03162796|2267943|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1
1153735|NCT03162796|2267944|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
1153736|NCT03162796|2267945|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
1153737|NCT03162796|2267943|FG000|Placebo Controlled Period: Week 0 - 24|Death|1
1153738|NCT03162796|2267944|FG001|Placebo Controlled Period: Week 0 - 24|Death|0
1153739|NCT03162796|2267945|FG002|Placebo Controlled Period: Week 0 - 24|Death|0
1153740|NCT03162796|2267943|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1
1153741|NCT03162796|2267944|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
1153742|NCT03162796|2267945|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
1153743|NCT03162796|2267943|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3
1153744|NCT03162796|2267944|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0
1153745|NCT03162796|2267945|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1
1153746|NCT03162796|2267943|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4
1153747|NCT03162796|2267944|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
1153748|NCT03162796|2267945|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
1153749|NCT03162796|2267943|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2
1153750|NCT03162796|2267944|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3
1153751|NCT03162796|2267945|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1
1153752|NCT03162796|2267943|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
1153753|NCT03162796|2267944|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
1153754|NCT03162796|2267945|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
1153755|NCT03162796|2267943|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
1153756|NCT03162796|2267944|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
1153757|NCT03162796|2267945|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1
1153758|NCT03162796|2267943|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
1153759|NCT03162796|2267944|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2
1153760|NCT03162796|2267945|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0
1153761|NCT03162796|2267943|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
1153762|NCT03162796|2267944|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2
1153763|NCT03162796|2267945|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
1153764|NCT03163446|2267986|FG000|Overall Study|Unable to return for Day 180 visit|2
1153765|NCT03163446|2267987|FG001|Overall Study|Unable to return for Day 180 visit|0
1153766|NCT03163446|2267986|FG000|Overall Study|Withdrawal by Subject|2
1153767|NCT03163446|2267987|FG001|Overall Study|Withdrawal by Subject|6
1153768|NCT03163446|2267986|FG000|Overall Study|Death|16
1153769|NCT03163446|2267987|FG001|Overall Study|Death|5
1153770|NCT03163446|2267986|FG000|Overall Study|Lost to Follow-up|6
1153771|NCT03163446|2267987|FG001|Overall Study|Lost to Follow-up|5
1153772|NCT03163446|2267986|FG000|Overall Study|Physician Decision|1
1153773|NCT03163446|2267987|FG001|Overall Study|Physician Decision|1
1153774|NCT03163446|2267986|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1
1153775|NCT03163446|2267987|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0
1153776|NCT03164551|2268030|FG000|Overall Study|Imaging discontinued prior completion|8
1153777|NCT03164551|2268031|FG001|Overall Study|Imaging discontinued prior completion|0
1153778|NCT03164551|2268030|FG000|Overall Study|Participant was non-compliant|1
1153779|NCT03164551|2268031|FG001|Overall Study|Participant was non-compliant|0
1153780|NCT03164551|2268030|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12
1153781|NCT03164551|2268031|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14
1153782|NCT03164551|2268030|FG000|Overall Study|Other|8
1153783|NCT03164551|2268031|FG001|Overall Study|Other|2
1153784|NCT03165045|2268046|FG000|Visit 1|No registration after visit 1|9
1153785|NCT03165045|2268046|FG000|Visit 1|No treatment documented|10
1153786|NCT03165045|2268046|FG000|Visit 1|No visit 1|10
1153787|NCT03165045|2268046|FG000|Visit 2|Available CCQ score at visit 1 only|109
1153788|NCT03165045|2268046|FG000|Visit 2|No available total CCQ score at all|29
1153789|NCT03165045|2268046|FG000|Visit 2|Available total CCQ score at vist 2 only|44
1153790|NCT03165110|2268061|FG000|Overall Study|Anroid phone software incompatibility|1
1153797|NCT03165955|2268123|FG000|Treatment|Withdrawal by Subject|3
1153798|NCT03165955|2268123|FG000|Treatment|Death|1
1153799|NCT03165955|2268123|FG000|Treatment|Adverse Event|1
1153800|NCT03165955|2268123|FG000|Treatment|Progressive disease|3
1153801|NCT03166124|2268138|FG000|Treatment Period 1|Adverse Event|0
1153802|NCT03166124|2268139|FG001|Treatment Period 1|Adverse Event|0
1153803|NCT03166124|2268140|FG002|Treatment Period 1|Adverse Event|1
1153804|NCT03166124|2268141|FG003|Treatment Period 1|Adverse Event|0
1153805|NCT03166124|2268138|FG000|Wash-out Period|Withdrawal by Subject|0
1153806|NCT03166124|2268139|FG001|Wash-out Period|Withdrawal by Subject|1
1153807|NCT03166124|2268140|FG002|Wash-out Period|Withdrawal by Subject|0
1153808|NCT03166124|2268141|FG003|Wash-out Period|Withdrawal by Subject|1
1153809|NCT03166124|2268138|FG000|Wash-out Period|Adverse Event|0
1153810|NCT03166124|2268139|FG001|Wash-out Period|Adverse Event|1
1153811|NCT03166124|2268140|FG002|Wash-out Period|Adverse Event|1
1153812|NCT03166124|2268141|FG003|Wash-out Period|Adverse Event|0
1153813|NCT03166215|2268154|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
1153814|NCT03166215|2268155|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
1153815|NCT03166215|2268156|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
1153816|NCT03166215|2268154|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
1153817|NCT03166215|2268155|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
1153818|NCT03166215|2268156|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
1153819|NCT03166735|2268172|FG000|Overall Study|Not Treated|1
1153820|NCT03166735|2268173|FG001|Overall Study|Not Treated|0
1153821|NCT03166735|2268174|FG002|Overall Study|Not Treated|0
1153822|NCT03166735|2268175|FG003|Overall Study|Not Treated|0
1153823|NCT03166735|2268176|FG004|Overall Study|Not Treated|0
1153824|NCT03166735|2268172|FG000|Overall Study|follow-up not completed as planned|0
1153825|NCT03166735|2268173|FG001|Overall Study|follow-up not completed as planned|1
1153826|NCT03166735|2268174|FG002|Overall Study|follow-up not completed as planned|1
1153827|NCT03166735|2268175|FG003|Overall Study|follow-up not completed as planned|0
1153828|NCT03166735|2268176|FG004|Overall Study|follow-up not completed as planned|1
1153829|NCT03166735|2268172|FG000|Overall Study|Withdrawal by Subject|0
1153830|NCT03166735|2268173|FG001|Overall Study|Withdrawal by Subject|0
1153831|NCT03166735|2268174|FG002|Overall Study|Withdrawal by Subject|1
1153832|NCT03166735|2268175|FG003|Overall Study|Withdrawal by Subject|1
1153833|NCT03166735|2268176|FG004|Overall Study|Withdrawal by Subject|2
1153834|NCT03166735|2268172|FG000|Overall Study|Lost to Follow-up|0
1153835|NCT03166735|2268173|FG001|Overall Study|Lost to Follow-up|2
1153836|NCT03166735|2268174|FG002|Overall Study|Lost to Follow-up|1
1153837|NCT03166735|2268175|FG003|Overall Study|Lost to Follow-up|0
1153838|NCT03166735|2268176|FG004|Overall Study|Lost to Follow-up|1
1153839|NCT03167073|2268191|FG000|Overall Study|Stillbirth|1
1153840|NCT03167073|2268192|FG001|Overall Study|Stillbirth|0
1153841|NCT03167151|2268201|FG000|Overall Study|Withdrawal by Subject|1
1153842|NCT03167151|2268202|FG001|Overall Study|Withdrawal by Subject|0
1153843|NCT03167151|2268203|FG002|Overall Study|Withdrawal by Subject|0
1153844|NCT03167151|2268201|FG000|Overall Study|No evidence of tumour at surgery|0
1153845|NCT03167151|2268202|FG001|Overall Study|No evidence of tumour at surgery|1
1153846|NCT03167151|2268203|FG002|Overall Study|No evidence of tumour at surgery|1
1153847|NCT03167359|2268211|FG000|Overall Study|Physician Decision|1
1153848|NCT03167359|2268211|FG000|Overall Study|Lost to Follow-up|1
1153849|NCT03167411|2268217|FG000|Overall Study|Adverse Event|0
1153850|NCT03167411|2268218|FG001|Overall Study|Adverse Event|1
1153851|NCT03168425|2268288|FG000|Overall Study|Lost to Follow-up|5
1153852|NCT03168425|2268289|FG001|Overall Study|Lost to Follow-up|8
1153853|NCT03168425|2268288|FG000|Overall Study|unable to confirm post op opioids|2
1153854|NCT03168425|2268289|FG001|Overall Study|unable to confirm post op opioids|3
1153855|NCT03168711|2268305|FG000|Overall Study|Adverse Event|2
1153856|NCT03168711|2268306|FG001|Overall Study|Adverse Event|0
1153857|NCT03168711|2268305|FG000|Overall Study|Withdrawal by Subject|0
1153858|NCT03168711|2268306|FG001|Overall Study|Withdrawal by Subject|1
1153859|NCT03168711|2268305|FG000|Overall Study|Death|0
1153860|NCT03168711|2268306|FG001|Overall Study|Death|1
1153861|NCT03168919|2268316|FG000|Overall Study|Withdrawal by Subject|2
1153862|NCT03169153|2268328|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1153863|NCT03169153|2268329|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1153864|NCT03169153|2268328|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
1153865|NCT03169153|2268329|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
1153866|NCT03169153|2268328|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
1153867|NCT03169153|2268329|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2
1153868|NCT03169153|2268328|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1
1153869|NCT03169153|2268329|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0
1153870|NCT03169244|2268337|FG000|Overall Study|Lost to Follow-up|1
1153871|NCT03169244|2268338|FG001|Overall Study|Lost to Follow-up|2
1153872|NCT03169244|2268337|FG000|Overall Study|Adverse Event|1
1153873|NCT03169244|2268338|FG001|Overall Study|Adverse Event|0
1153874|NCT03169244|2268337|FG000|Overall Study|Withdrawal by Subject|2
1153875|NCT03169244|2268338|FG001|Overall Study|Withdrawal by Subject|2
1153876|NCT03169244|2268337|FG000|Overall Study|Physician Decision|1
1153877|NCT03169244|2268338|FG001|Overall Study|Physician Decision|0
1153878|NCT03170154|2268353|FG000|Overall Study|Lost to Follow-up|4
1153879|NCT03170154|2268353|FG000|Overall Study|Death|2
1153880|NCT03170154|2268353|FG000|Overall Study|Withdrawal by Subject|2
1153881|NCT03170193|2268369|FG000|Overall Study|Withdrawal by Subject|0
1153882|NCT03170193|2268370|FG001|Overall Study|Withdrawal by Subject|0
1153883|NCT03170193|2268371|FG002|Overall Study|Withdrawal by Subject|0
1153884|NCT03170193|2268372|FG003|Overall Study|Withdrawal by Subject|1
1153885|NCT03170193|2268373|FG004|Overall Study|Withdrawal by Subject|0
1153886|NCT03170193|2268374|FG005|Overall Study|Withdrawal by Subject|0
1153887|NCT03170193|2268375|FG006|Overall Study|Withdrawal by Subject|0
1153888|NCT03170193|2268369|FG000|Overall Study|Lost to Follow-up|1
1153889|NCT03170193|2268370|FG001|Overall Study|Lost to Follow-up|1
1153890|NCT03170193|2268371|FG002|Overall Study|Lost to Follow-up|0
1153891|NCT03170193|2268372|FG003|Overall Study|Lost to Follow-up|0
1153892|NCT03170193|2268373|FG004|Overall Study|Lost to Follow-up|0
1153893|NCT03170193|2268374|FG005|Overall Study|Lost to Follow-up|0
1153894|NCT03170193|2268375|FG006|Overall Study|Lost to Follow-up|0
1153895|NCT03170232|2268408|FG000|Overall Study|Adverse Event|0
1153896|NCT03170232|2268409|FG001|Overall Study|Adverse Event|1
1153897|NCT03170232|2268408|FG000|Overall Study|Protocol Violation|0
1153898|NCT03170232|2268409|FG001|Overall Study|Protocol Violation|1
1153899|NCT03170232|2268408|FG000|Overall Study|Lack of Efficacy|0
1153900|NCT03170232|2268409|FG001|Overall Study|Lack of Efficacy|1
1153901|NCT03170232|2268408|FG000|Overall Study|Study closed/terminated|26
1153902|NCT03170232|2268409|FG001|Overall Study|Study closed/terminated|23
1153903|NCT03170232|2268408|FG000|Overall Study|Lost to Follow-up|1
1153904|NCT03170232|2268409|FG001|Overall Study|Lost to Follow-up|0
1153905|NCT03170232|2268408|FG000|Overall Study|Withdrawal by Subject|0
1153906|NCT03170232|2268409|FG001|Overall Study|Withdrawal by Subject|1
1153907|NCT03170271|2268417|FG000|Overall Study|Adverse Event|7
1153908|NCT03170271|2268418|FG001|Overall Study|Adverse Event|2
1153909|NCT03170271|2268417|FG000|Overall Study|Lost to Follow-up|0
1153910|NCT03170271|2268418|FG001|Overall Study|Lost to Follow-up|1
1153911|NCT03170271|2268417|FG000|Overall Study|Physician Decision|1
1153912|NCT03170271|2268418|FG001|Overall Study|Physician Decision|0
1153913|NCT03170271|2268417|FG000|Overall Study|Protocol-specified withdrawal criterion|2
1153914|NCT03170271|2268418|FG001|Overall Study|Protocol-specified withdrawal criterion|1
1153915|NCT03170271|2268417|FG000|Overall Study|Withdrawal by Subject|17
1153916|NCT03170271|2268418|FG001|Overall Study|Withdrawal by Subject|5
1153917|NCT03170271|2268417|FG000|Overall Study|Other|2
1153918|NCT03170271|2268418|FG001|Overall Study|Other|2
1153919|NCT03170271|2268417|FG000|Overall Study|Randomized in error|4
1153920|NCT03170271|2268418|FG001|Overall Study|Randomized in error|0
1153921|NCT03170544|2268457|FG000|Part 1|Lost to Follow-up|1
1153922|NCT03170544|2268458|FG001|Part 1|Lost to Follow-up|0
1153923|NCT03170544|2268459|FG002|Part 1|Lost to Follow-up|0
1153924|NCT03170544|2268460|FG003|Part 1|Lost to Follow-up|0
1153925|NCT03170544|2268461|FG004|Part 1|Lost to Follow-up|0
1153926|NCT03170544|2268462|FG005|Part 1|Lost to Follow-up|0
1153927|NCT03170544|2268463|FG006|Part 1|Lost to Follow-up|0
1153928|NCT03170544|2268464|FG007|Part 1|Lost to Follow-up|0
1153929|NCT03170544|2268465|FG008|Part 1|Lost to Follow-up|0
1153930|NCT03170544|2268466|FG009|Part 1|Lost to Follow-up|0
1153931|NCT03170544|2268467|FG010|Part 1|Lost to Follow-up|0
1153932|NCT03170544|2268468|FG011|Part 1|Lost to Follow-up|0
1153933|NCT03170544|2268457|FG000|Part 1|Not treated|0
1153934|NCT03170544|2268458|FG001|Part 1|Not treated|0
1153935|NCT03170544|2268459|FG002|Part 1|Not treated|0
1153936|NCT03170544|2268460|FG003|Part 1|Not treated|1
1153937|NCT03170544|2268461|FG004|Part 1|Not treated|0
1153938|NCT03170544|2268462|FG005|Part 1|Not treated|0
1153939|NCT03170544|2268463|FG006|Part 1|Not treated|0
1153940|NCT03170544|2268464|FG007|Part 1|Not treated|0
1153941|NCT03170544|2268465|FG008|Part 1|Not treated|0
1153942|NCT03170544|2268466|FG009|Part 1|Not treated|0
1153943|NCT03170544|2268467|FG010|Part 1|Not treated|0
1153944|NCT03170544|2268468|FG011|Part 1|Not treated|0
1153945|NCT03170609|2268558|FG000|Overall Study|Death|0
1153946|NCT03170609|2268559|FG001|Overall Study|Death|0
1153947|NCT03170609|2268560|FG002|Overall Study|Death|1
1153948|NCT03170609|2268561|FG003|Overall Study|Death|0
1153949|NCT03170609|2268562|FG004|Overall Study|Death|0
1153950|NCT03170609|2268563|FG005|Overall Study|Death|0
1153951|NCT03170609|2268564|FG006|Overall Study|Death|0
1153952|NCT03170609|2268558|FG000|Overall Study|Withdrawal by Subject|1
1153953|NCT03170609|2268559|FG001|Overall Study|Withdrawal by Subject|2
1153954|NCT03170609|2268560|FG002|Overall Study|Withdrawal by Subject|0
1153955|NCT03170609|2268561|FG003|Overall Study|Withdrawal by Subject|0
1153956|NCT03170609|2268562|FG004|Overall Study|Withdrawal by Subject|0
1153957|NCT03170609|2268563|FG005|Overall Study|Withdrawal by Subject|0
1153958|NCT03170609|2268564|FG006|Overall Study|Withdrawal by Subject|1
1153959|NCT03170609|2268558|FG000|Overall Study|Lost to Follow-up|1
1153960|NCT03170609|2268559|FG001|Overall Study|Lost to Follow-up|0
1153961|NCT03170609|2268560|FG002|Overall Study|Lost to Follow-up|5
1153962|NCT03170609|2268561|FG003|Overall Study|Lost to Follow-up|2
1153963|NCT03170609|2268562|FG004|Overall Study|Lost to Follow-up|1
1153964|NCT03170609|2268563|FG005|Overall Study|Lost to Follow-up|1
1153965|NCT03170609|2268564|FG006|Overall Study|Lost to Follow-up|0
1153966|NCT03170609|2268558|FG000|Overall Study|Other|1
1153967|NCT03170609|2268559|FG001|Overall Study|Other|0
1153968|NCT03170609|2268560|FG002|Overall Study|Other|0
1153969|NCT03170609|2268561|FG003|Overall Study|Other|0
1153970|NCT03170609|2268562|FG004|Overall Study|Other|0
1153971|NCT03170609|2268563|FG005|Overall Study|Other|1
1153972|NCT03170609|2268564|FG006|Overall Study|Other|0
1153983|NCT03171415|2268610|FG000|Overall Study|Lost to Follow-up|0
1153984|NCT03171415|2268611|FG001|Overall Study|Lost to Follow-up|0
1153985|NCT03171415|2268612|FG002|Overall Study|Lost to Follow-up|0
1153986|NCT03171415|2268613|FG003|Overall Study|Lost to Follow-up|0
1153987|NCT03171415|2268614|FG004|Overall Study|Lost to Follow-up|2
1153988|NCT03172130|2268639|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3
1153989|NCT03172130|2268640|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1
1153990|NCT03172325|2268648|FG000|Overall Study|Adverse Event|2
1153991|NCT03172325|2268649|FG001|Overall Study|Adverse Event|3
1153992|NCT03172325|2268648|FG000|Overall Study|Positive PPD|1
1153993|NCT03172325|2268649|FG001|Overall Study|Positive PPD|0
1153994|NCT03172325|2268648|FG000|Overall Study|Poor Compliance|1
1153995|NCT03172325|2268649|FG001|Overall Study|Poor Compliance|1
1153996|NCT03172364|2268657|FG000|Overall Study|Adverse Event|1
1153997|NCT03172364|2268658|FG001|Overall Study|Adverse Event|1
1153998|NCT03172364|2268657|FG000|Overall Study|Protocol Violation|1
1153999|NCT03172364|2268658|FG001|Overall Study|Protocol Violation|0
1154000|NCT03172481|2268666|FG000|Double-blind|Withdrawal by Subject|1
1154001|NCT03172481|2268667|FG001|Double-blind|Withdrawal by Subject|0
1154002|NCT03172494|2268676|FG000|Overall Study|Adverse Event|5
1154003|NCT03172494|2268677|FG001|Overall Study|Adverse Event|1
1154004|NCT03172494|2268678|FG002|Overall Study|Adverse Event|15
1154005|NCT03172494|2268676|FG000|Overall Study|Protocol Violation|3
1154006|NCT03172494|2268677|FG001|Overall Study|Protocol Violation|2
1154007|NCT03172494|2268678|FG002|Overall Study|Protocol Violation|1
1154008|NCT03172494|2268676|FG000|Overall Study|Lack of Efficacy|0
1154009|NCT03172494|2268677|FG001|Overall Study|Lack of Efficacy|0
1154010|NCT03172494|2268678|FG002|Overall Study|Lack of Efficacy|4
1154011|NCT03172494|2268676|FG000|Overall Study|Pregnancy|0
1154012|NCT03172494|2268677|FG001|Overall Study|Pregnancy|1
1154013|NCT03172494|2268678|FG002|Overall Study|Pregnancy|0
1154014|NCT03172494|2268676|FG000|Overall Study|Withdrawal by Subject|10
1154015|NCT03172494|2268677|FG001|Overall Study|Withdrawal by Subject|8
1154016|NCT03172494|2268678|FG002|Overall Study|Withdrawal by Subject|8
1154017|NCT03172494|2268676|FG000|Overall Study|Severe hypoglycaemic episode|0
1154018|NCT03172494|2268677|FG001|Overall Study|Severe hypoglycaemic episode|0
1154019|NCT03172494|2268678|FG002|Overall Study|Severe hypoglycaemic episode|1
1154020|NCT03172494|2268676|FG000|Overall Study|Non-compliance towards treatment|2
1154021|NCT03172494|2268677|FG001|Overall Study|Non-compliance towards treatment|0
1154022|NCT03172494|2268678|FG002|Overall Study|Non-compliance towards treatment|0
1154023|NCT03172702|2268687|FG000|Overall Study|Adverse Event|9
1154024|NCT03172702|2268687|FG000|Overall Study|Death|2
1154025|NCT03172702|2268687|FG000|Overall Study|Study-specific Withdrawal Criteria|10
1154026|NCT03172702|2268687|FG000|Overall Study|Withdrawal by Subject|5
1154027|NCT03172702|2268687|FG000|Overall Study|Other|2
1154028|NCT03173313|2268732|FG000|Overall Study|Lost to Follow-up|2
1154029|NCT03173313|2268733|FG001|Overall Study|Lost to Follow-up|3
1154030|NCT03173313|2268732|FG000|Overall Study|Withdrawal by Subject|0
1154031|NCT03173313|2268733|FG001|Overall Study|Withdrawal by Subject|1
1154032|NCT03173313|2268732|FG000|Overall Study|Death|5
1154033|NCT03173313|2268733|FG001|Overall Study|Death|0
1154034|NCT03173313|2268732|FG000|Overall Study|Physician Decision|1
1154035|NCT03173313|2268733|FG001|Overall Study|Physician Decision|0
1154036|NCT03173313|2268732|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0
1154037|NCT03173313|2268733|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1
1154038|NCT03173313|2268732|FG000|Overall Study|Bone Fracture|1
1154039|NCT03173313|2268733|FG001|Overall Study|Bone Fracture|0
1154040|NCT03173547|2268741|FG000|Overall Study|Adverse Event|2
1154041|NCT03173547|2268742|FG001|Overall Study|Adverse Event|0
1154042|NCT03173547|2268741|FG000|Overall Study|Withdrawal by Subject|2
1154043|NCT03173547|2268742|FG001|Overall Study|Withdrawal by Subject|2
1154044|NCT03173560|2268750|FG000|Overall Study|Ongoing on Treatment|38
1154045|NCT03173560|2268751|FG001|Overall Study|Ongoing on Treatment|50
1154046|NCT03173560|2268750|FG000|Overall Study|Ongoing Survival Follow-up|56
1154047|NCT03173560|2268751|FG001|Overall Study|Ongoing Survival Follow-up|57
1154048|NCT03173560|2268750|FG000|Overall Study|Lost to Follow-up|1
1154049|NCT03173560|2268751|FG001|Overall Study|Lost to Follow-up|4
1154050|NCT03173560|2268750|FG000|Overall Study|Withdrawal by Subject|10
1154051|NCT03173560|2268751|FG001|Overall Study|Withdrawal by Subject|5
1154052|NCT03173560|2268750|FG000|Overall Study|Other|0
1154053|NCT03173560|2268751|FG001|Overall Study|Other|1
1154054|NCT03174925|2268790|FG000|Overall Study|Elastographic images not retrievable|2
1154055|NCT03174925|2268790|FG000|Overall Study|Elastography image not interpretable|1
1154056|NCT03175120|2268796|FG000|Overall Study|Adverse Event|2
1154057|NCT03175120|2268797|FG001|Overall Study|Adverse Event|2
1154058|NCT03175120|2268796|FG000|Overall Study|Protocol Violation|5
1154059|NCT03175120|2268797|FG001|Overall Study|Protocol Violation|2
1154060|NCT03175120|2268796|FG000|Overall Study|Lost to Follow-up|1
1154061|NCT03175120|2268797|FG001|Overall Study|Lost to Follow-up|0
1154062|NCT03175120|2268796|FG000|Overall Study|Withdrawal by Subject|2
1154063|NCT03175120|2268797|FG001|Overall Study|Withdrawal by Subject|5
1154064|NCT03175120|2268796|FG000|Overall Study|Other|2
1154065|NCT03175120|2268797|FG001|Overall Study|Other|3
1154066|NCT03175172|2268803|FG000|Overall Study|Death|3
1154067|NCT03175172|2268803|FG000|Overall Study|Withdrawal by Subject|3
1154068|NCT03175172|2268803|FG000|Overall Study|Lost to Follow-up|1
1154069|NCT03175172|2268803|FG000|Overall Study|Study Terminated by Sponsor|3
1154070|NCT03175562|2268807|FG000|Overall Study|Adverse Event|1
1154071|NCT03175562|2268807|FG000|Overall Study|Lost to Follow-up|3
1154072|NCT03175562|2268807|FG000|Overall Study|Withdrawal by Subject|7
1154073|NCT03175562|2268807|FG000|Overall Study|Other (Not Specified)|5
1154074|NCT03176238|2268825|FG000|Overall Study|Unacceptable AEs|15
1154075|NCT03176238|2268826|FG001|Overall Study|Unacceptable AEs|8
1154076|NCT03176238|2268825|FG000|Overall Study|Abnormal lab value(s)|2
1154077|NCT03176238|2268826|FG001|Overall Study|Abnormal lab value(s)|0
1154078|NCT03176238|2268825|FG000|Overall Study|Inter-current illness|0
1154079|NCT03176238|2268826|FG001|Overall Study|Inter-current illness|1
1154080|NCT03176238|2268825|FG000|Overall Study|Consent withdrawal|14
1154081|NCT03176238|2268826|FG001|Overall Study|Consent withdrawal|2
1154082|NCT03176238|2268825|FG000|Overall Study|Lost to Follow-up|3
1154083|NCT03176238|2268826|FG001|Overall Study|Lost to Follow-up|0
1154084|NCT03176238|2268825|FG000|Overall Study|Administrative problems|1
1154085|NCT03176238|2268826|FG001|Overall Study|Administrative problems|0
1154086|NCT03176238|2268825|FG000|Overall Study|Death|3
1154087|NCT03176238|2268826|FG001|Overall Study|Death|0
1154088|NCT03176238|2268825|FG000|Overall Study|Disease Progression|133
1154089|NCT03176238|2268826|FG001|Overall Study|Disease Progression|22
1154090|NCT03176238|2268825|FG000|Overall Study|Tx duration completed per EAP|0
1154091|NCT03176238|2268826|FG001|Overall Study|Tx duration completed per EAP|1
1154092|NCT03176238|2268825|FG000|Overall Study|Patient is switched to commercial drug|16
1154093|NCT03176238|2268826|FG001|Overall Study|Patient is switched to commercial drug|1
1154094|NCT03176238|2268825|FG000|Overall Study|Protocol Violation|1
1154095|NCT03176238|2268826|FG001|Overall Study|Protocol Violation|0
1154096|NCT03176238|2268825|FG000|Overall Study|Changes in the patient's condition|2
1154097|NCT03176238|2268826|FG001|Overall Study|Changes in the patient's condition|1
1154098|NCT03176238|2268825|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9
1154099|NCT03176238|2268826|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0
1154100|NCT03176407|2268836|FG000|Overall Study|Protocol Violation|1
1154101|NCT03176407|2268836|FG000|Overall Study|human failure|1
1154102|NCT03176407|2268836|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1
1154103|NCT03176459|2268844|FG000|Overall Study|Lost to Follow-up|5
1154104|NCT03176459|2268845|FG001|Overall Study|Lost to Follow-up|7
1154105|NCT03176784|2268864|FG000|Overall Study|Lost to Follow-up|77
1154106|NCT03176784|2268865|FG001|Overall Study|Lost to Follow-up|79
1154107|NCT03176784|2268866|FG002|Overall Study|Lost to Follow-up|79
1154108|NCT03176784|2268867|FG003|Overall Study|Lost to Follow-up|49
1154109|NCT03176784|2268864|FG000|Overall Study|Withdrawal by Subject|28
1154110|NCT03176784|2268865|FG001|Overall Study|Withdrawal by Subject|34
1154111|NCT03176784|2268866|FG002|Overall Study|Withdrawal by Subject|34
1154112|NCT03176784|2268867|FG003|Overall Study|Withdrawal by Subject|21
1154113|NCT03178045|2268935|FG000|Overall Study|Withdrawal by Subject|5
1154114|NCT03178045|2268936|FG001|Overall Study|Withdrawal by Subject|7
1154115|NCT03178045|2268935|FG000|Overall Study|Surgery Cancelled/Relocated|34
1154116|NCT03178045|2268936|FG001|Overall Study|Surgery Cancelled/Relocated|30
1154117|NCT03178045|2268935|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47
1154118|NCT03178045|2268936|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46
1154119|NCT03178266|2268945|FG000|Overall Study|Death|0
1154120|NCT03178266|2268946|FG001|Overall Study|Death|1
1154121|NCT03178266|2268945|FG000|Overall Study|Disont. Early|0
1154122|NCT03178266|2268946|FG001|Overall Study|Disont. Early|1
1154123|NCT03178266|2268945|FG000|Overall Study|Withdrawal by Subject|0
1154124|NCT03178266|2268946|FG001|Overall Study|Withdrawal by Subject|2
1154125|NCT03178487|2268961|FG000|Overall Study|Adverse Event|1
1154126|NCT03178487|2268962|FG001|Overall Study|Adverse Event|1
1154127|NCT03178487|2268961|FG000|Overall Study|Withdrawal by Subject|2
1154128|NCT03178487|2268962|FG001|Overall Study|Withdrawal by Subject|1
1154129|NCT03178487|2268961|FG000|Overall Study|Lost to Follow-up|1
1154130|NCT03178487|2268962|FG001|Overall Study|Lost to Follow-up|0
1154131|NCT03178487|2268961|FG000|Overall Study|Other|0
1154132|NCT03178487|2268962|FG001|Overall Study|Other|2
1154133|NCT03178669|2268973|FG000|Overall Study|Adverse Event|4
1154134|NCT03178669|2268974|FG001|Overall Study|Adverse Event|1
1154135|NCT03178669|2268975|FG002|Overall Study|Adverse Event|4
1154136|NCT03178669|2268976|FG003|Overall Study|Adverse Event|2
1154137|NCT03178669|2268977|FG004|Overall Study|Adverse Event|2
1154138|NCT03178669|2268973|FG000|Overall Study|Lack of Efficacy|0
1154139|NCT03178669|2268974|FG001|Overall Study|Lack of Efficacy|0
1154140|NCT03178669|2268975|FG002|Overall Study|Lack of Efficacy|2
1154141|NCT03178669|2268976|FG003|Overall Study|Lack of Efficacy|0
1154142|NCT03178669|2268977|FG004|Overall Study|Lack of Efficacy|1
1154143|NCT03178669|2268973|FG000|Overall Study|Physician Decision|0
1154144|NCT03178669|2268974|FG001|Overall Study|Physician Decision|0
1154145|NCT03178669|2268975|FG002|Overall Study|Physician Decision|0
1154146|NCT03178669|2268976|FG003|Overall Study|Physician Decision|0
1154147|NCT03178669|2268977|FG004|Overall Study|Physician Decision|1
1154148|NCT03178669|2268973|FG000|Overall Study|Withdrawal by Subject|1
1154149|NCT03178669|2268974|FG001|Overall Study|Withdrawal by Subject|0
1154150|NCT03178669|2268975|FG002|Overall Study|Withdrawal by Subject|1
1154151|NCT03178669|2268976|FG003|Overall Study|Withdrawal by Subject|1
1154152|NCT03178669|2268977|FG004|Overall Study|Withdrawal by Subject|0
1154153|NCT03178669|2268973|FG000|Overall Study|Lost to Follow-up|0
1154154|NCT03178669|2268974|FG001|Overall Study|Lost to Follow-up|0
1154155|NCT03178669|2268975|FG002|Overall Study|Lost to Follow-up|0
1154156|NCT03178669|2268976|FG003|Overall Study|Lost to Follow-up|1
1154157|NCT03178669|2268977|FG004|Overall Study|Lost to Follow-up|0
1154158|NCT03178773|2268991|FG000|Overall Study|Death|0
1154159|NCT03178773|2268992|FG001|Overall Study|Death|1
1154160|NCT03178773|2268991|FG000|Overall Study|Lost to Follow-up|29
1154161|NCT03178773|2268992|FG001|Overall Study|Lost to Follow-up|25
1154162|NCT03178773|2268991|FG000|Overall Study|Withdrawal by Subject|10
1154163|NCT03178773|2268992|FG001|Overall Study|Withdrawal by Subject|14
1154164|NCT03178851|2269002|FG000|Overall Study|Death|48
1154165|NCT03178851|2269003|FG001|Overall Study|Death|2
1154166|NCT03178851|2269004|FG002|Overall Study|Death|25
1154167|NCT03178851|2269002|FG000|Overall Study|Withdrawal by Subject|8
1154168|NCT03178851|2269003|FG001|Overall Study|Withdrawal by Subject|0
1154169|NCT03178851|2269004|FG002|Overall Study|Withdrawal by Subject|0
1154170|NCT03178851|2269002|FG000|Overall Study|Lost to Follow-up|5
1154171|NCT03178851|2269003|FG001|Overall Study|Lost to Follow-up|2
1154172|NCT03178851|2269004|FG002|Overall Study|Lost to Follow-up|0
1154173|NCT03178851|2269002|FG000|Overall Study|Adverse Event|0
1154174|NCT03178851|2269003|FG001|Overall Study|Adverse Event|0
1154175|NCT03178851|2269004|FG002|Overall Study|Adverse Event|1
1154176|NCT03178851|2269002|FG000|Overall Study|Study Termination by Sponsor|31
1154177|NCT03178851|2269003|FG001|Overall Study|Study Termination by Sponsor|7
1154178|NCT03178851|2269004|FG002|Overall Study|Study Termination by Sponsor|26
1154179|NCT03178942|2269015|FG000|Overall Study|Withdrawal by Subject|2
1154180|NCT03178942|2269016|FG001|Overall Study|Withdrawal by Subject|0
1154181|NCT03178942|2269015|FG000|Overall Study|Lost to Follow-up|1
1154182|NCT03178942|2269016|FG001|Overall Study|Lost to Follow-up|2
1154183|NCT03179319|2269024|FG000|Overall Study|Lost to Follow-up|6
1154184|NCT03179319|2269025|FG001|Overall Study|Lost to Follow-up|0
1154188|NCT03179787|2269071|FG000|Overall Study|Lost to Follow-up|15
1154189|NCT03179787|2269071|FG000|Overall Study|Case report failures|2
1154190|NCT03179787|2269071|FG000|Overall Study|Treatment not administered|1
1154191|NCT03179891|2269075|FG000|First Intervention|Withdrawal by Subject|1
1154192|NCT03179891|2269076|FG001|First Intervention|Withdrawal by Subject|1
1154193|NCT03179891|2269075|FG000|First Intervention|Unspecified reason|1
1154194|NCT03179891|2269076|FG001|First Intervention|Unspecified reason|0
1154195|NCT03179891|2269075|FG000|First Intervention|Protocol Violation|0
1154196|NCT03179891|2269076|FG001|First Intervention|Protocol Violation|1
1154197|NCT03180138|2269088|FG000|Overall Study|Mobile-phone could not be verified|2
1154198|NCT03180138|2269089|FG001|Overall Study|Mobile-phone could not be verified|13
1154199|NCT03180138|2269090|FG002|Overall Study|Mobile-phone could not be verified|15
1154200|NCT03180138|2269088|FG000|Overall Study|No prior immunization records|17
1154201|NCT03180138|2269089|FG001|Overall Study|No prior immunization records|0
1154202|NCT03180138|2269090|FG002|Overall Study|No prior immunization records|6
1154203|NCT03180138|2269088|FG000|Overall Study|Found to be >24 mon after randomization|3
1154204|NCT03180138|2269089|FG001|Overall Study|Found to be >24 mon after randomization|0
1154205|NCT03180138|2269090|FG002|Overall Study|Found to be >24 mon after randomization|3
1154206|NCT03180528|2269132|FG000|Overall Study|Adverse Event|1
1154207|NCT03180528|2269132|FG000|Overall Study|Withdrawal by Subject|1
1154208|NCT03180528|2269132|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1
1154209|NCT03180619|2269139|FG000|Overall Study|Withdrew Consent|5
1154210|NCT03180619|2269140|FG001|Overall Study|Withdrew Consent|0
1154211|NCT03180619|2269141|FG002|Overall Study|Withdrew Consent|2
1154212|NCT03180619|2269139|FG000|Overall Study|Death|2
1154213|NCT03180619|2269140|FG001|Overall Study|Death|1
1154214|NCT03180619|2269141|FG002|Overall Study|Death|2
1154215|NCT03180619|2269139|FG000|Overall Study|Adverse Event|2
1154216|NCT03180619|2269140|FG001|Overall Study|Adverse Event|0
1154217|NCT03180619|2269141|FG002|Overall Study|Adverse Event|1
1154218|NCT03180619|2269139|FG000|Overall Study|Investigator's discretion|2
1154219|NCT03180619|2269140|FG001|Overall Study|Investigator's discretion|0
1154220|NCT03180619|2269141|FG002|Overall Study|Investigator's discretion|1
1154221|NCT03180645|2269159|FG000|Overall Study|Adverse Event|0
1154222|NCT03180645|2269160|FG001|Overall Study|Adverse Event|1
1154223|NCT03180645|2269161|FG002|Overall Study|Adverse Event|2
1154224|NCT03180801|2269176|FG000|Overall Study|Physician Decision|3
1154225|NCT03180801|2269177|FG001|Overall Study|Physician Decision|3
1154226|NCT03180801|2269178|FG002|Overall Study|Physician Decision|1
1154227|NCT03180801|2269176|FG000|Overall Study|Non-compliance|1
1154228|NCT03180801|2269177|FG001|Overall Study|Non-compliance|4
1154229|NCT03180801|2269178|FG002|Overall Study|Non-compliance|0
1154230|NCT03180801|2269176|FG000|Overall Study|Inoculation Target Reached|1
1154231|NCT03180801|2269177|FG001|Overall Study|Inoculation Target Reached|1
1154232|NCT03180801|2269178|FG002|Overall Study|Inoculation Target Reached|3
1154233|NCT03180801|2269176|FG000|Overall Study|Adverse Event|1
1154234|NCT03180801|2269177|FG001|Overall Study|Adverse Event|0
1154235|NCT03180801|2269178|FG002|Overall Study|Adverse Event|2
1154236|NCT03180801|2269176|FG000|Overall Study|Withdrawal by Subject|2
1154237|NCT03180801|2269177|FG001|Overall Study|Withdrawal by Subject|2
1154238|NCT03180801|2269178|FG002|Overall Study|Withdrawal by Subject|1
1154239|NCT03180801|2269176|FG000|Overall Study|Lost to Follow-up|0
1154240|NCT03180801|2269177|FG001|Overall Study|Lost to Follow-up|2
1154241|NCT03180801|2269178|FG002|Overall Study|Lost to Follow-up|3
1154242|NCT03181451|2269210|FG000|Overall Study|Adverse Event|0
1154243|NCT03181451|2269211|FG001|Overall Study|Adverse Event|1
1154244|NCT03181451|2269212|FG002|Overall Study|Adverse Event|0
1154245|NCT03181451|2269210|FG000|Overall Study|Withdrawal by Subject|0
1154246|NCT03181451|2269211|FG001|Overall Study|Withdrawal by Subject|1
1154247|NCT03181451|2269212|FG002|Overall Study|Withdrawal by Subject|0
1154248|NCT03181503|2269224|FG000|Overall Study|Adverse Event|2
1154249|NCT03181503|2269225|FG001|Overall Study|Adverse Event|2
1154250|NCT03181503|2269224|FG000|Overall Study|Protocol Violation|1
1154251|NCT03181503|2269225|FG001|Overall Study|Protocol Violation|0
1154252|NCT03181503|2269224|FG000|Overall Study|Withdrawal by Subject|3
1154253|NCT03181503|2269225|FG001|Overall Study|Withdrawal by Subject|0
1154254|NCT03181503|2269224|FG000|Overall Study|Lost to Follow-up|1
1154255|NCT03181503|2269225|FG001|Overall Study|Lost to Follow-up|1
1154256|NCT03181594|2269234|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4
1154257|NCT03181594|2269234|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3
1154258|NCT03181594|2269234|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1
1154259|NCT03181594|2269234|FG000|Initial Study Protocol (12-month FU)|Death|1
1154260|NCT03181594|2269234|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3
1154261|NCT03181594|2269234|FG000|Long-term Extension (15-24 Month FU)|Death|2
1154274|NCT03181932|2269266|FG000|Period 1 (Double-blind Period)|Adverse Event|5
1154275|NCT03181932|2269267|FG001|Period 1 (Double-blind Period)|Adverse Event|1
1154276|NCT03181932|2269266|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0
1154277|NCT03181932|2269267|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1
1154278|NCT03181932|2269266|FG000|Period 1 (Double-blind Period)|Protocol Violation|1
1154279|NCT03181932|2269267|FG001|Period 1 (Double-blind Period)|Protocol Violation|2
1154280|NCT03181932|2269266|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5
1154281|NCT03181932|2269267|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9
1154282|NCT03181932|2269266|FG000|Period 2 (Open-label Period)|Adverse Event|1
1154283|NCT03181932|2269267|FG001|Period 2 (Open-label Period)|Adverse Event|6
1154284|NCT03181932|2269266|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0
1154285|NCT03181932|2269267|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1
1154286|NCT03181932|2269266|FG000|Period 2 (Open-label Period)|Protocol Violation|3
1154287|NCT03181932|2269267|FG001|Period 2 (Open-label Period)|Protocol Violation|1
1154288|NCT03181932|2269266|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2
1154289|NCT03181932|2269267|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5
1154290|NCT03181932|2269266|FG000|Period 2 (Open-label Period)|Reason missing|2
1154291|NCT03181932|2269267|FG001|Period 2 (Open-label Period)|Reason missing|0
1154292|NCT03181958|2269277|FG000|Overall Study|Lost to Follow-up|17
1154293|NCT03181958|2269278|FG001|Overall Study|Lost to Follow-up|21
1154294|NCT03181958|2269279|FG002|Overall Study|Lost to Follow-up|15
1154295|NCT03182738|2269310|FG000|Overall Study|Lost to Follow-up|9
1154296|NCT03182738|2269311|FG001|Overall Study|Lost to Follow-up|3
1154297|NCT03182738|2269310|FG000|Overall Study|Pregnancy|0
1154298|NCT03182738|2269311|FG001|Overall Study|Pregnancy|1
1154299|NCT03182738|2269310|FG000|Overall Study|Withdrawal by Subject|0
1154300|NCT03182738|2269311|FG001|Overall Study|Withdrawal by Subject|1
1154301|NCT03182829|2269319|FG000|Overall Study|Protocol Violation|12
1154302|NCT03182829|2269320|FG001|Overall Study|Protocol Violation|12
1154303|NCT03182829|2269319|FG000|Overall Study|Other|4
1154304|NCT03182829|2269320|FG001|Overall Study|Other|3
1154305|NCT03182868|2269331|FG000|Overall Study|Protocol Violation|3
1154306|NCT03182868|2269332|FG001|Overall Study|Protocol Violation|0
1154307|NCT03182868|2269333|FG002|Overall Study|Protocol Violation|4
1154308|NCT03182868|2269334|FG003|Overall Study|Protocol Violation|1
1154309|NCT03182868|2269335|FG004|Overall Study|Protocol Violation|8
1154310|NCT03183063|2269369|FG000|Overall Study|Withdrawal by Subject|2
1154311|NCT03183063|2269370|FG001|Overall Study|Withdrawal by Subject|0
1154312|NCT03183063|2269371|FG002|Overall Study|Withdrawal by Subject|0
1154313|NCT03183063|2269369|FG000|Overall Study|Physician Decision|3
1154314|NCT03183063|2269370|FG001|Overall Study|Physician Decision|4
1154315|NCT03183063|2269371|FG002|Overall Study|Physician Decision|4
1154316|NCT03183518|2269385|FG000|Overall Study|Other (Not specified)|2
1154317|NCT03183518|2269385|FG000|Overall Study|Other (Withdrawal of consent)|1
1154318|NCT03183908|2269401|FG000|Overall Study|Missing Symptom Diary Data|0
1154319|NCT03183908|2269402|FG001|Overall Study|Missing Symptom Diary Data|2
1154320|NCT03184077|2269414|FG000|Overall Study|Lost to Follow-up|21
1154321|NCT03184077|2269415|FG001|Overall Study|Lost to Follow-up|21
1154322|NCT03184441|2269437|FG000|Overall Study|Withdrawal by Subject|1
1154323|NCT03184519|2269444|FG000|Overall Study|Lost to Follow-up|6
1154324|NCT03184519|2269444|FG000|Overall Study|Physician Decision|21
1154325|NCT03184558|2269448|FG000|Overall Study|Withdrawal by Subject|2
1154326|NCT03184558|2269448|FG000|Overall Study|Death|16
1154327|NCT03184558|2269448|FG000|Overall Study|Lost to Follow-up|2
1154328|NCT03184558|2269448|FG000|Overall Study|Other|9
1154329|NCT03184701|2269452|FG000|Overall Study|Death|3
1154330|NCT03184701|2269452|FG000|Overall Study|Physician Decision|3
1154331|NCT03184701|2269452|FG000|Overall Study|Withdrawal by Subject|6
1154332|NCT03184701|2269452|FG000|Overall Study|Lost to Follow-up|5
1154333|NCT03184987|2269459|FG000|Overall Study|Withdrawal by Subject|0
1154334|NCT03184987|2269460|FG001|Overall Study|Withdrawal by Subject|1
1154335|NCT03184987|2269461|FG002|Overall Study|Withdrawal by Subject|2
1154336|NCT03184987|2269459|FG000|Overall Study|Physician Decision|0
1154337|NCT03184987|2269460|FG001|Overall Study|Physician Decision|0
1154338|NCT03184987|2269461|FG002|Overall Study|Physician Decision|1
1154339|NCT03184987|2269459|FG000|Overall Study|Adverse Event|1
1154340|NCT03184987|2269460|FG001|Overall Study|Adverse Event|0
1154341|NCT03184987|2269461|FG002|Overall Study|Adverse Event|1
1154342|NCT03185481|2269501|FG000|Overall Study|Adverse Event|1
1154343|NCT03185481|2269501|FG000|Overall Study|Study Terminated by Sponsor|4
1154344|NCT03186378|2269550|FG000|Overall Study|Lost to Follow-up|1
1154345|NCT03186378|2269551|FG001|Overall Study|Lost to Follow-up|0
1154346|NCT03186781|2269584|FG000|Overall Study|Lost to Follow-up|0
1154347|NCT03186781|2269585|FG001|Overall Study|Lost to Follow-up|0
1154348|NCT03186781|2269586|FG002|Overall Study|Lost to Follow-up|1
1154349|NCT03186781|2269587|FG003|Overall Study|Lost to Follow-up|0
1154350|NCT03186781|2269588|FG004|Overall Study|Lost to Follow-up|1
1154351|NCT03186781|2269589|FG005|Overall Study|Lost to Follow-up|0
1154352|NCT03186781|2269584|FG000|Overall Study|Moved from Area|0
1154353|NCT03186781|2269585|FG001|Overall Study|Moved from Area|0
1154354|NCT03186781|2269586|FG002|Overall Study|Moved from Area|0
1154355|NCT03186781|2269587|FG003|Overall Study|Moved from Area|0
1154356|NCT03186781|2269588|FG004|Overall Study|Moved from Area|1
1154357|NCT03186781|2269589|FG005|Overall Study|Moved from Area|0
1154358|NCT03186781|2269584|FG000|Overall Study|Withdrawal by Subject|0
1154359|NCT03186781|2269585|FG001|Overall Study|Withdrawal by Subject|0
1154360|NCT03186781|2269586|FG002|Overall Study|Withdrawal by Subject|0
1154361|NCT03186781|2269587|FG003|Overall Study|Withdrawal by Subject|0
1154362|NCT03186781|2269588|FG004|Overall Study|Withdrawal by Subject|1
1154363|NCT03186781|2269589|FG005|Overall Study|Withdrawal by Subject|0
1154364|NCT03187132|2269627|FG000|Inpatient Trauma Only|Lost to Follow-up|3
1154365|NCT03187132|2269628|FG001|Inpatient Trauma Only|Lost to Follow-up|12
1154366|NCT03187132|2269627|FG000|Inpatient Trauma Only|socioeconomic burden|1
1154367|NCT03187132|2269628|FG001|Inpatient Trauma Only|socioeconomic burden|0
1154368|NCT03187132|2269627|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0
1154369|NCT03187132|2269628|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5
1154370|NCT03187132|2269627|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1
1154371|NCT03187132|2269628|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0
1154372|NCT03187132|2269627|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2
1154373|NCT03187132|2269628|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5
1154374|NCT03187132|2269627|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1
1154375|NCT03187132|2269628|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0
1154376|NCT03187132|2269627|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0
1154377|NCT03187132|2269628|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2
1154378|NCT03187132|2269627|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27
1154379|NCT03187132|2269628|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47
1154380|NCT03187132|2269627|FG000|Pain Clinic Only, Fully Remote|Disease burden|6
1154381|NCT03187132|2269628|FG001|Pain Clinic Only, Fully Remote|Disease burden|5
1154382|NCT03187132|2269627|FG000|Pain Clinic Only, Fully Remote|Language barrier|0
1154383|NCT03187132|2269628|FG001|Pain Clinic Only, Fully Remote|Language barrier|1
1154384|NCT03187132|2269627|FG000|Pain Clinic Only, Fully Remote|EMR|0
1154385|NCT03187132|2269628|FG001|Pain Clinic Only, Fully Remote|EMR|1
1154386|NCT03187197|2269637|FG000|Overall Study|Stopped Pradaxa®/VKA|11
1154387|NCT03187197|2269638|FG001|Overall Study|Stopped Pradaxa®/VKA|65
1154388|NCT03187197|2269639|FG002|Overall Study|Stopped Pradaxa®/VKA|4
1154389|NCT03187197|2269637|FG000|Overall Study|Withdrawal by Subject|8
1154390|NCT03187197|2269638|FG001|Overall Study|Withdrawal by Subject|63
1154391|NCT03187197|2269639|FG002|Overall Study|Withdrawal by Subject|4
1154392|NCT03187197|2269637|FG000|Overall Study|Lost to Follow-up|1
1154393|NCT03187197|2269638|FG001|Overall Study|Lost to Follow-up|60
1154394|NCT03187197|2269639|FG002|Overall Study|Lost to Follow-up|7
1154395|NCT03187197|2269637|FG000|Overall Study|Adverse Event|6
1154396|NCT03187197|2269638|FG001|Overall Study|Adverse Event|29
1154397|NCT03187197|2269639|FG002|Overall Study|Adverse Event|0
1154398|NCT03187197|2269637|FG000|Overall Study|Death|0
1154399|NCT03187197|2269638|FG001|Overall Study|Death|11
1154400|NCT03187197|2269639|FG002|Overall Study|Death|0
1154401|NCT03187197|2269637|FG000|Overall Study|Administrative problem|1
1154402|NCT03187197|2269638|FG001|Overall Study|Administrative problem|1
1154403|NCT03187197|2269639|FG002|Overall Study|Administrative problem|0
1154404|NCT03187197|2269637|FG000|Overall Study|Reason not listed|2
1154405|NCT03187197|2269638|FG001|Overall Study|Reason not listed|54
1154406|NCT03187197|2269639|FG002|Overall Study|Reason not listed|1
1154407|NCT03187197|2269637|FG000|Overall Study|Missing|1
1154408|NCT03187197|2269638|FG001|Overall Study|Missing|32
1154409|NCT03187197|2269639|FG002|Overall Study|Missing|3
1154410|NCT03187197|2269637|FG000|Overall Study|Status missing|2
1154411|NCT03187197|2269638|FG001|Overall Study|Status missing|33
1154412|NCT03187197|2269639|FG002|Overall Study|Status missing|3
1154413|NCT03187197|2269637|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14
1154414|NCT03187197|2269638|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45
1154415|NCT03187197|2269639|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1
1154416|NCT03187262|2269647|FG000|Induction|Lack of Efficacy|2
1154417|NCT03187262|2269647|FG000|Induction|Progressive Disease|4
1154418|NCT03187262|2269647|FG000|Consolidation|Progressive Disease|5
1154419|NCT03187301|2269651|FG000|Titration Period|Adverse Event|0
1154420|NCT03187301|2269652|FG001|Titration Period|Adverse Event|0
1154421|NCT03187301|2269653|FG002|Titration Period|Adverse Event|0
1154422|NCT03187301|2269654|FG003|Titration Period|Adverse Event|0
1154423|NCT03187301|2269655|FG004|Titration Period|Adverse Event|0
1154424|NCT03187301|2269656|FG005|Titration Period|Adverse Event|0
1154425|NCT03187301|2269657|FG006|Titration Period|Adverse Event|5
1154426|NCT03187301|2269651|FG000|Titration Period|Withdrawal by Subject|0
1154427|NCT03187301|2269652|FG001|Titration Period|Withdrawal by Subject|0
1154428|NCT03187301|2269653|FG002|Titration Period|Withdrawal by Subject|0
1154429|NCT03187301|2269654|FG003|Titration Period|Withdrawal by Subject|0
1154430|NCT03187301|2269655|FG004|Titration Period|Withdrawal by Subject|0
1154431|NCT03187301|2269656|FG005|Titration Period|Withdrawal by Subject|0
1154432|NCT03187301|2269657|FG006|Titration Period|Withdrawal by Subject|1
1154433|NCT03187301|2269651|FG000|Titration Period|Exclusion Criteria Met|0
1154434|NCT03187301|2269652|FG001|Titration Period|Exclusion Criteria Met|0
1154435|NCT03187301|2269653|FG002|Titration Period|Exclusion Criteria Met|0
1154436|NCT03187301|2269654|FG003|Titration Period|Exclusion Criteria Met|0
1154437|NCT03187301|2269655|FG004|Titration Period|Exclusion Criteria Met|0
1154438|NCT03187301|2269656|FG005|Titration Period|Exclusion Criteria Met|0
1154439|NCT03187301|2269657|FG006|Titration Period|Exclusion Criteria Met|1
1154440|NCT03187301|2269651|FG000|Pre-Intervention|Withdrawal by Subject|1
1154441|NCT03187301|2269652|FG001|Pre-Intervention|Withdrawal by Subject|0
1154442|NCT03187301|2269653|FG002|Pre-Intervention|Withdrawal by Subject|0
1154443|NCT03187301|2269654|FG003|Pre-Intervention|Withdrawal by Subject|0
1154444|NCT03187301|2269655|FG004|Pre-Intervention|Withdrawal by Subject|0
1154445|NCT03187301|2269656|FG005|Pre-Intervention|Withdrawal by Subject|0
1154446|NCT03187301|2269657|FG006|Pre-Intervention|Withdrawal by Subject|0
1154447|NCT03187756|2269695|FG000|Overall Study|Termination of study|4
1154448|NCT03188055|2269701|FG000|Overall Study|Unavailable for training|0
1154449|NCT03188055|2269702|FG001|Overall Study|Unavailable for training|0
1154450|NCT03188055|2269703|FG002|Overall Study|Unavailable for training|19
1154451|NCT03188055|2269704|FG003|Overall Study|Unavailable for training|0
1154452|NCT03188055|2269705|FG004|Overall Study|Unavailable for training|0
1154453|NCT03188055|2269706|FG005|Overall Study|Unavailable for training|
1154454|NCT03188055|2269701|FG000|Overall Study|Lost to Follow-up|0
1154455|NCT03188055|2269702|FG001|Overall Study|Lost to Follow-up|18
1154456|NCT03188055|2269703|FG002|Overall Study|Lost to Follow-up|0
1154457|NCT03188055|2269704|FG003|Overall Study|Lost to Follow-up|11
1154458|NCT03188055|2269705|FG004|Overall Study|Lost to Follow-up|0
1154459|NCT03188055|2269706|FG005|Overall Study|Lost to Follow-up|
1154460|NCT03188055|2269701|FG000|Overall Study|Withdrawal by Subject|0
1154461|NCT03188055|2269702|FG001|Overall Study|Withdrawal by Subject|1
1154462|NCT03188055|2269703|FG002|Overall Study|Withdrawal by Subject|0
1154463|NCT03188055|2269704|FG003|Overall Study|Withdrawal by Subject|1
1154464|NCT03188055|2269705|FG004|Overall Study|Withdrawal by Subject|0
1154465|NCT03188055|2269706|FG005|Overall Study|Withdrawal by Subject|
1154466|NCT03188120|2269717|FG000|Overall Study|Adverse Event|4
1154467|NCT03188120|2269717|FG000|Overall Study|Insufficient Effectiveness|8
1154468|NCT03188120|2269717|FG000|Overall Study|Improved|12
1154469|NCT03188120|2269717|FG000|Overall Study|Lost to Follow-up|7
1154470|NCT03188120|2269717|FG000|Overall Study|Other than specified|3
1154471|NCT03188120|2269717|FG000|Overall Study|No visit after the first visit|13
1154472|NCT03188185|2269723|FG000|Stage 1|Adverse Event|4
1154473|NCT03188185|2269724|FG001|Stage 1|Adverse Event|12
1154474|NCT03188185|2269725|FG002|Stage 1|Adverse Event|0
1154475|NCT03188185|2269726|FG003|Stage 1|Adverse Event|0
1154476|NCT03188185|2269723|FG000|Stage 1|Lack of Efficacy|0
1154477|NCT03188185|2269724|FG001|Stage 1|Lack of Efficacy|2
1154478|NCT03188185|2269725|FG002|Stage 1|Lack of Efficacy|0
1154479|NCT03188185|2269726|FG003|Stage 1|Lack of Efficacy|0
1154480|NCT03188185|2269723|FG000|Stage 1|Lost to Follow-up|6
1154481|NCT03188185|2269724|FG001|Stage 1|Lost to Follow-up|1
1154482|NCT03188185|2269725|FG002|Stage 1|Lost to Follow-up|0
1154483|NCT03188185|2269726|FG003|Stage 1|Lost to Follow-up|0
1154484|NCT03188185|2269723|FG000|Stage 1|Withdrawal by Subject|9
1154485|NCT03188185|2269724|FG001|Stage 1|Withdrawal by Subject|0
1154486|NCT03188185|2269725|FG002|Stage 1|Withdrawal by Subject|0
1154487|NCT03188185|2269726|FG003|Stage 1|Withdrawal by Subject|0
1154488|NCT03188185|2269723|FG000|Stage 1|Identified as a professional patient|0
1154489|NCT03188185|2269724|FG001|Stage 1|Identified as a professional patient|1
1154490|NCT03188185|2269725|FG002|Stage 1|Identified as a professional patient|0
1154491|NCT03188185|2269726|FG003|Stage 1|Identified as a professional patient|0
1154492|NCT03188185|2269723|FG000|Stage 2|Adverse Event|0
1154493|NCT03188185|2269724|FG001|Stage 2|Adverse Event|0
1154494|NCT03188185|2269725|FG002|Stage 2|Adverse Event|2
1154495|NCT03188185|2269726|FG003|Stage 2|Adverse Event|4
1154496|NCT03188185|2269723|FG000|Stage 2|Lack of Efficacy|0
1154497|NCT03188185|2269724|FG001|Stage 2|Lack of Efficacy|0
1154498|NCT03188185|2269725|FG002|Stage 2|Lack of Efficacy|3
1154499|NCT03188185|2269726|FG003|Stage 2|Lack of Efficacy|0
1154500|NCT03188185|2269723|FG000|Stage 2|Lost to Follow-up|0
1154501|NCT03188185|2269724|FG001|Stage 2|Lost to Follow-up|0
1154502|NCT03188185|2269725|FG002|Stage 2|Lost to Follow-up|1
1154503|NCT03188185|2269726|FG003|Stage 2|Lost to Follow-up|0
1154504|NCT03188185|2269723|FG000|Stage 2|Physician Decision|0
1154505|NCT03188185|2269724|FG001|Stage 2|Physician Decision|0
1154506|NCT03188185|2269725|FG002|Stage 2|Physician Decision|0
1154507|NCT03188185|2269726|FG003|Stage 2|Physician Decision|1
1154508|NCT03188185|2269723|FG000|Stage 2|Withdrawal by Subject|0
1154509|NCT03188185|2269724|FG001|Stage 2|Withdrawal by Subject|0
1154510|NCT03188185|2269725|FG002|Stage 2|Withdrawal by Subject|3
1154511|NCT03188185|2269726|FG003|Stage 2|Withdrawal by Subject|1
1154512|NCT03188263|2269738|FG000|Overall Study|Withdrawal by Subject|3
1154513|NCT03188263|2269739|FG001|Overall Study|Withdrawal by Subject|0
1154514|NCT03188263|2269738|FG000|Overall Study|Physician Decision|1
1154515|NCT03188263|2269739|FG001|Overall Study|Physician Decision|0
1154516|NCT03188536|2269756|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5
1154517|NCT03188536|2269756|FG000|Overall Study|Not participated/met inclusion criteria|1
1154518|NCT03188718|2269760|FG000|Overall Study|Participant noncompliance|4
1154519|NCT03188718|2269760|FG000|Overall Study|Withdrawal by Subject|1
1154520|NCT03188718|2269760|FG000|Overall Study|Device failure|3
1154521|NCT03188991|2269768|FG000|Overall Study|Withdrawal by Subject|0
1154522|NCT03188991|2269769|FG001|Overall Study|Withdrawal by Subject|0
1154523|NCT03188991|2269770|FG002|Overall Study|Withdrawal by Subject|0
1154524|NCT03188991|2269771|FG003|Overall Study|Withdrawal by Subject|1
1154525|NCT03189446|2269785|FG000|Overall Study|Adverse Event|2
1154526|NCT03189446|2269785|FG000|Overall Study|Withdrawal by Subject|2
1154527|NCT03189446|2269785|FG000|Overall Study|Physician Decision|1
1154528|NCT03189524|2269792|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7
1154529|NCT03189524|2269793|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5
1154530|NCT03189524|2269794|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11
1154531|NCT03189524|2269792|FG000|Overall Study|Death|2
1154532|NCT03189524|2269793|FG001|Overall Study|Death|2
1154533|NCT03189524|2269794|FG002|Overall Study|Death|1
1154534|NCT03189524|2269792|FG000|Overall Study|Lost to Follow-up|1
1154535|NCT03189524|2269793|FG001|Overall Study|Lost to Follow-up|0
1154536|NCT03189524|2269794|FG002|Overall Study|Lost to Follow-up|8
1154537|NCT03189524|2269792|FG000|Overall Study|Withdrawal by Subject|1
1154538|NCT03189524|2269793|FG001|Overall Study|Withdrawal by Subject|1
1154539|NCT03189524|2269794|FG002|Overall Study|Withdrawal by Subject|3
1154540|NCT03189524|2269792|FG000|Overall Study|Progressive Disease|0
1154541|NCT03189524|2269793|FG001|Overall Study|Progressive Disease|2
1154542|NCT03189524|2269794|FG002|Overall Study|Progressive Disease|0
1154549|NCT03189745|2269826|FG000|Overall Study|Conflict in work schedule of participant|1
1154550|NCT03189745|2269827|FG001|Overall Study|Conflict in work schedule of participant|1
1154551|NCT03190369|2269872|FG000|Overall Study|Poor compliance to protocol|0
1154552|NCT03190369|2269873|FG001|Overall Study|Poor compliance to protocol|1
1154553|NCT03190369|2269872|FG000|Overall Study|Withdraw before treatment|1
1154554|NCT03190369|2269873|FG001|Overall Study|Withdraw before treatment|5
1154555|NCT03190369|2269872|FG000|Overall Study|Randomized but not treated|0
1154556|NCT03190369|2269873|FG001|Overall Study|Randomized but not treated|2
1154557|NCT03191396|2269899|FG000|Overall Study|Lost to Follow-up|0
1154558|NCT03191396|2269900|FG001|Overall Study|Lost to Follow-up|3
1154559|NCT03191396|2269899|FG000|Overall Study|Withdrawal by Subject|3
1154560|NCT03191396|2269900|FG001|Overall Study|Withdrawal by Subject|2
1154561|NCT03191552|2269909|FG000|Overall Study|Lost to Follow-up|1
1154562|NCT03191552|2269910|FG001|Overall Study|Lost to Follow-up|0
1154563|NCT03191552|2269911|FG002|Overall Study|Lost to Follow-up|0
1154564|NCT03191552|2269909|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0
1154565|NCT03191552|2269910|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1
1154566|NCT03191552|2269911|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0
1154567|NCT03191630|2269925|FG000|Overall Study|Lost to Follow-up|7
1154568|NCT03191630|2269926|FG001|Overall Study|Lost to Follow-up|7
1154569|NCT03191799|2269934|FG000|Overall Study|Withdrawal by Subject|4
1154570|NCT03191799|2269934|FG000|Overall Study|Physician Decision|2
1154571|NCT03191799|2269934|FG000|Overall Study|Lost to Follow-up|1
1154572|NCT03191799|2269934|FG000|Overall Study|Death|2
1154573|NCT03192137|2269940|FG000|Overall Study|Adverse Event|10
1154574|NCT03192137|2269941|FG001|Overall Study|Adverse Event|11
1154575|NCT03192137|2269940|FG000|Overall Study|Physician Decision|1
1154576|NCT03192137|2269941|FG001|Overall Study|Physician Decision|0
1154577|NCT03192137|2269940|FG000|Overall Study|Lack of Efficacy|20
1154578|NCT03192137|2269941|FG001|Overall Study|Lack of Efficacy|37
1154579|NCT03192137|2269940|FG000|Overall Study|Withdrawal by Subject|3
1154580|NCT03192137|2269941|FG001|Overall Study|Withdrawal by Subject|3
1154581|NCT03192137|2269940|FG000|Overall Study|Protocol Violation|4
1154582|NCT03192137|2269941|FG001|Overall Study|Protocol Violation|3
1154583|NCT03192137|2269940|FG000|Overall Study|Surgery Cancelled|4
1154584|NCT03192137|2269941|FG001|Overall Study|Surgery Cancelled|1
1154585|NCT03192137|2269940|FG000|Overall Study|Other - Various Administrative Reasons|8
1154586|NCT03192137|2269941|FG001|Overall Study|Other - Various Administrative Reasons|3
1154587|NCT03192150|2269949|FG000|Overall Study|Adverse Event|14
1154588|NCT03192150|2269950|FG001|Overall Study|Adverse Event|12
1154589|NCT03192150|2269949|FG000|Overall Study|Lack of Efficacy|23
1154590|NCT03192150|2269950|FG001|Overall Study|Lack of Efficacy|30
1154591|NCT03192150|2269949|FG000|Overall Study|Lost to Follow-up|1
1154592|NCT03192150|2269950|FG001|Overall Study|Lost to Follow-up|1
1154593|NCT03192150|2269949|FG000|Overall Study|Withdrawal by Subject|4
1154594|NCT03192150|2269950|FG001|Overall Study|Withdrawal by Subject|2
1154595|NCT03192150|2269949|FG000|Overall Study|Protocol Violation|5
1154596|NCT03192150|2269950|FG001|Overall Study|Protocol Violation|2
1154597|NCT03192150|2269949|FG000|Overall Study|Surgery Canceled|6
1154598|NCT03192150|2269950|FG001|Overall Study|Surgery Canceled|2
1154599|NCT03192150|2269949|FG000|Overall Study|Other-Various Administrative Reasons|2
1154600|NCT03192150|2269950|FG001|Overall Study|Other-Various Administrative Reasons|5
1154601|NCT03192176|2269964|FG000|Overall Study|Adverse Event|1
1154602|NCT03192176|2269965|FG001|Overall Study|Adverse Event|0
1154603|NCT03192176|2269966|FG002|Overall Study|Adverse Event|4
1154604|NCT03192176|2269967|FG003|Overall Study|Adverse Event|5
1154605|NCT03192176|2269968|FG004|Overall Study|Adverse Event|3
1154606|NCT03192176|2269969|FG005|Overall Study|Adverse Event|2
1154607|NCT03192176|2269970|FG006|Overall Study|Adverse Event|3
1154608|NCT03192176|2269971|FG007|Overall Study|Adverse Event|3
1154609|NCT03192176|2269964|FG000|Overall Study|Lost to Follow-up|0
1154610|NCT03192176|2269965|FG001|Overall Study|Lost to Follow-up|0
1154611|NCT03192176|2269966|FG002|Overall Study|Lost to Follow-up|1
1154612|NCT03192176|2269967|FG003|Overall Study|Lost to Follow-up|2
1154613|NCT03192176|2269968|FG004|Overall Study|Lost to Follow-up|3
1154614|NCT03192176|2269969|FG005|Overall Study|Lost to Follow-up|1
1154615|NCT03192176|2269970|FG006|Overall Study|Lost to Follow-up|1
1154616|NCT03192176|2269971|FG007|Overall Study|Lost to Follow-up|1
1154617|NCT03192176|2269964|FG000|Overall Study|Physician Decision|1
1154618|NCT03192176|2269965|FG001|Overall Study|Physician Decision|0
1154619|NCT03192176|2269966|FG002|Overall Study|Physician Decision|0
1154620|NCT03192176|2269967|FG003|Overall Study|Physician Decision|0
1154621|NCT03192176|2269968|FG004|Overall Study|Physician Decision|0
1154622|NCT03192176|2269969|FG005|Overall Study|Physician Decision|2
1154623|NCT03192176|2269970|FG006|Overall Study|Physician Decision|1
1154624|NCT03192176|2269971|FG007|Overall Study|Physician Decision|0
1154625|NCT03192176|2269964|FG000|Overall Study|Protocol Deviation|1
1154626|NCT03192176|2269965|FG001|Overall Study|Protocol Deviation|1
1154627|NCT03192176|2269966|FG002|Overall Study|Protocol Deviation|0
1154628|NCT03192176|2269967|FG003|Overall Study|Protocol Deviation|0
1154629|NCT03192176|2269968|FG004|Overall Study|Protocol Deviation|2
1154630|NCT03192176|2269969|FG005|Overall Study|Protocol Deviation|0
1154631|NCT03192176|2269970|FG006|Overall Study|Protocol Deviation|0
1154632|NCT03192176|2269971|FG007|Overall Study|Protocol Deviation|0
1154633|NCT03192176|2269964|FG000|Overall Study|Withdrawal by Subject|3
1154634|NCT03192176|2269965|FG001|Overall Study|Withdrawal by Subject|4
1154635|NCT03192176|2269966|FG002|Overall Study|Withdrawal by Subject|0
1154636|NCT03192176|2269967|FG003|Overall Study|Withdrawal by Subject|4
1154637|NCT03192176|2269968|FG004|Overall Study|Withdrawal by Subject|3
1154638|NCT03192176|2269969|FG005|Overall Study|Withdrawal by Subject|4
1154639|NCT03192176|2269970|FG006|Overall Study|Withdrawal by Subject|4
1154640|NCT03192176|2269971|FG007|Overall Study|Withdrawal by Subject|2
1154641|NCT03192176|2269964|FG000|Overall Study|Miscellaneous|1
1154642|NCT03192176|2269965|FG001|Overall Study|Miscellaneous|0
1154643|NCT03192176|2269966|FG002|Overall Study|Miscellaneous|1
1154644|NCT03192176|2269967|FG003|Overall Study|Miscellaneous|1
1154645|NCT03192176|2269968|FG004|Overall Study|Miscellaneous|1
1154646|NCT03192176|2269969|FG005|Overall Study|Miscellaneous|2
1154647|NCT03192176|2269970|FG006|Overall Study|Miscellaneous|0
1154648|NCT03192176|2269971|FG007|Overall Study|Miscellaneous|1
1154649|NCT03192306|2269992|FG000|Overall Study|Did not treat cold sore during study|149
1154650|NCT03192306|2269993|FG001|Overall Study|Did not treat cold sore during study|143
1154651|NCT03192306|2269992|FG000|Overall Study|Withdrawal by Subject|1
1154652|NCT03192306|2269993|FG001|Overall Study|Withdrawal by Subject|1
1154653|NCT03192306|2269992|FG000|Overall Study|Lost to Follow-up|1
1154654|NCT03192306|2269993|FG001|Overall Study|Lost to Follow-up|0
1154655|NCT03192306|2269992|FG000|Overall Study|Protocol Violation|1
1154656|NCT03192306|2269993|FG001|Overall Study|Protocol Violation|1
1154657|NCT03192475|2270001|FG000|Overall Study|Death|0
1154658|NCT03192475|2270002|FG001|Overall Study|Death|1
1154659|NCT03192475|2270001|FG000|Overall Study|Lost to Follow-up|13
1154660|NCT03192475|2270002|FG001|Overall Study|Lost to Follow-up|8
1154661|NCT03192488|2270009|FG000|First Washout (>6d)|Withdrawal by Subject|0
1154662|NCT03192488|2270010|FG001|First Washout (>6d)|Withdrawal by Subject|0
1154663|NCT03192488|2270011|FG002|First Washout (>6d)|Withdrawal by Subject|1
1154664|NCT03192488|2270012|FG003|First Washout (>6d)|Withdrawal by Subject|0
1154665|NCT03192488|2270013|FG004|First Washout (>6d)|Withdrawal by Subject|0
1154666|NCT03192488|2270014|FG005|First Washout (>6d)|Withdrawal by Subject|1
1154667|NCT03192488|2270009|FG000|Third Intervention (d1)|Adverse Event|0
1154668|NCT03192488|2270010|FG001|Third Intervention (d1)|Adverse Event|0
1154669|NCT03192488|2270011|FG002|Third Intervention (d1)|Adverse Event|0
1154670|NCT03192488|2270012|FG003|Third Intervention (d1)|Adverse Event|0
1154671|NCT03192488|2270013|FG004|Third Intervention (d1)|Adverse Event|1
1154672|NCT03192488|2270014|FG005|Third Intervention (d1)|Adverse Event|0
1154673|NCT03192904|2270043|FG000|Overall Study|Physician Decision|3
1154674|NCT03192904|2270044|FG001|Overall Study|Physician Decision|1
1154675|NCT03192904|2270043|FG000|Overall Study|Lost to Follow-up|0
1154676|NCT03192904|2270044|FG001|Overall Study|Lost to Follow-up|1
1154677|NCT03193021|2270052|FG000|Overall Study|Lost to Follow-up|1
1154678|NCT03193021|2270053|FG001|Overall Study|Lost to Follow-up|1
1154679|NCT03193047|2270061|FG000|Overall Study|Physician Decision|1
1154680|NCT03193047|2270062|FG001|Overall Study|Physician Decision|0
1154681|NCT03193047|2270061|FG000|Overall Study|Participant Left State|1
1154682|NCT03193047|2270062|FG001|Overall Study|Participant Left State|0
1154683|NCT03193736|2270108|FG000|Overall Study|Death|2
1154684|NCT03193736|2270108|FG000|Overall Study|Withdrawal by Subject|1
1154685|NCT03193736|2270108|FG000|Overall Study|Lost to Follow-up|1
1154686|NCT03193736|2270108|FG000|Overall Study|implant not received|1
1154687|NCT03194217|2270116|FG000|Overall Study|Adverse Event|0
1154688|NCT03194217|2270117|FG001|Overall Study|Adverse Event|2
1154689|NCT03194217|2270118|FG002|Overall Study|Adverse Event|3
1154690|NCT03194217|2270119|FG003|Overall Study|Adverse Event|3
1154691|NCT03194217|2270116|FG000|Overall Study|Failure to meet randomisation criteria|0
1154692|NCT03194217|2270117|FG001|Overall Study|Failure to meet randomisation criteria|0
1154693|NCT03194217|2270118|FG002|Overall Study|Failure to meet randomisation criteria|0
1154694|NCT03194217|2270119|FG003|Overall Study|Failure to meet randomisation criteria|1
1154695|NCT03194217|2270116|FG000|Overall Study|Other|0
1154696|NCT03194217|2270117|FG001|Overall Study|Other|1
1154697|NCT03194217|2270118|FG002|Overall Study|Other|1
1154698|NCT03194217|2270119|FG003|Overall Study|Other|0
1154699|NCT03194464|2270147|FG000|Overall Study|data not usable|2
1154700|NCT03194490|2270155|FG000|Overall Study|Lost to Follow-up|1
1154701|NCT03194490|2270156|FG001|Overall Study|Lost to Follow-up|3
1154702|NCT03194490|2270155|FG000|Overall Study|participant developed specific neck pain|1
1154703|NCT03194490|2270156|FG001|Overall Study|participant developed specific neck pain|0
1154752|NCT03196193|2270258|FG000|Overall Study|Adverse Event|1
1154753|NCT03196193|2270259|FG001|Overall Study|Adverse Event|0
1154754|NCT03196193|2270258|FG000|Overall Study|Computed Tomography (CT) data missing|2
1154755|NCT03196193|2270259|FG001|Overall Study|Computed Tomography (CT) data missing|0
1154756|NCT03196284|2270271|FG000|Main Part|Withdrawal by Subject|0
1154757|NCT03196284|2270272|FG001|Main Part|Withdrawal by Subject|1
1154758|NCT03196284|2270273|FG002|Main Part|Withdrawal by Subject|0
1154759|NCT03196284|2270271|FG000|Extension Part|Lack of Efficacy|0
1154760|NCT03196284|2270272|FG001|Extension Part|Lack of Efficacy|0
1154761|NCT03196284|2270273|FG002|Extension Part|Lack of Efficacy|1
1154762|NCT03196284|2270271|FG000|Extension Part|Withdrawal by Subject|0
1154763|NCT03196284|2270272|FG001|Extension Part|Withdrawal by Subject|0
1154764|NCT03196284|2270273|FG002|Extension Part|Withdrawal by Subject|1
1154765|NCT03196284|2270271|FG000|Extension Part|Physician Decision|0
1154766|NCT03196284|2270272|FG001|Extension Part|Physician Decision|0
1154767|NCT03196284|2270273|FG002|Extension Part|Physician Decision|1
1154768|NCT03196297|2270293|FG000|Main Period|Withdrawal by Subject|4
1154769|NCT03196297|2270293|FG000|Extension Period|Withdrawal by Subject|1
1154770|NCT03196297|2270293|FG000|Extension Period|Lack of Efficacy|2
1154771|NCT03196349|2270312|FG000|Overall Study|Did not receive study drug|0
1154772|NCT03196349|2270313|FG001|Overall Study|Did not receive study drug|1
1154773|NCT03196349|2270314|FG002|Overall Study|Did not receive study drug|2
1154774|NCT03196349|2270312|FG000|Overall Study|No data entered|2
1154775|NCT03196349|2270313|FG001|Overall Study|No data entered|4
1154776|NCT03196349|2270314|FG002|Overall Study|No data entered|0
1154777|NCT03196349|2270312|FG000|Overall Study|Study Terminated early|15
1154778|NCT03196349|2270313|FG001|Overall Study|Study Terminated early|9
1154779|NCT03196349|2270314|FG002|Overall Study|Study Terminated early|11
1154780|NCT03196505|2270324|FG000|Overall Study|Physician Decision|26
1154781|NCT03196505|2270325|FG001|Overall Study|Physician Decision|26
1154782|NCT03196635|2270331|FG000|Overall Study|Withdrawal by Subject|1
1154783|NCT03196791|2270351|FG000|Overall Study|Protocol Violation|7
1154784|NCT03196791|2270352|FG001|Overall Study|Protocol Violation|3
1154785|NCT03196791|2270351|FG000|Overall Study|Withdrawal by Subject|3
1154786|NCT03196791|2270352|FG001|Overall Study|Withdrawal by Subject|2
1154787|NCT03196973|2270361|FG000|Overall Study|Adverse Event|1
1154788|NCT03196973|2270362|FG001|Overall Study|Adverse Event|1
1154789|NCT03196973|2270363|FG002|Overall Study|Adverse Event|2
1154790|NCT03196973|2270361|FG000|Overall Study|Lack of Efficacy|2
1154791|NCT03196973|2270362|FG001|Overall Study|Lack of Efficacy|6
1154792|NCT03196973|2270363|FG002|Overall Study|Lack of Efficacy|1
1154793|NCT03196973|2270361|FG000|Overall Study|Lost to Follow-up|4
1154794|NCT03196973|2270362|FG001|Overall Study|Lost to Follow-up|3
1154795|NCT03196973|2270363|FG002|Overall Study|Lost to Follow-up|2
1154796|NCT03196973|2270361|FG000|Overall Study|Consent withdrawn|2
1154797|NCT03196973|2270362|FG001|Overall Study|Consent withdrawn|1
1154798|NCT03196973|2270363|FG002|Overall Study|Consent withdrawn|0
1154799|NCT03196973|2270361|FG000|Overall Study|Administration of a wrong kit of study medication|0
1154800|NCT03196973|2270362|FG001|Overall Study|Administration of a wrong kit of study medication|1
1154801|NCT03196973|2270363|FG002|Overall Study|Administration of a wrong kit of study medication|0
1154802|NCT03197129|2270386|FG000|Overall Study|did not answer the VPT: shyness|4
1154803|NCT03197129|2270387|FG001|Overall Study|did not answer the VPT: shyness|5
1154804|NCT03197324|2270395|FG000|Overall Study|Adverse Event|0
1154805|NCT03197324|2270396|FG001|Overall Study|Adverse Event|1
1154806|NCT03197376|2270406|FG000|Primary and Booster Phase|Adverse Event|0
1154807|NCT03197376|2270407|FG001|Primary and Booster Phase|Adverse Event|0
1154808|NCT03197376|2270408|FG002|Primary and Booster Phase|Adverse Event|0
1154809|NCT03197376|2270409|FG003|Primary and Booster Phase|Adverse Event|1
1154810|NCT03197376|2270406|FG000|Primary and Booster Phase|Death|1
1154811|NCT03197376|2270407|FG001|Primary and Booster Phase|Death|0
1154812|NCT03197376|2270408|FG002|Primary and Booster Phase|Death|0
1154813|NCT03197376|2270409|FG003|Primary and Booster Phase|Death|2
1154814|NCT03197376|2270406|FG000|Primary and Booster Phase|Lost to Follow-up|0
1154815|NCT03197376|2270407|FG001|Primary and Booster Phase|Lost to Follow-up|0
1154816|NCT03197376|2270408|FG002|Primary and Booster Phase|Lost to Follow-up|1
1154817|NCT03197376|2270409|FG003|Primary and Booster Phase|Lost to Follow-up|0
1154818|NCT03197376|2270406|FG000|Primary and Booster Phase|Physician Decision|1
1154819|NCT03197376|2270407|FG001|Primary and Booster Phase|Physician Decision|0
1154820|NCT03197376|2270408|FG002|Primary and Booster Phase|Physician Decision|1
1154821|NCT03197376|2270409|FG003|Primary and Booster Phase|Physician Decision|3
1154822|NCT03197376|2270406|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11
1154823|NCT03197376|2270407|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10
1154824|NCT03197376|2270408|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14
1154825|NCT03197376|2270409|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11
1154826|NCT03197376|2270406|FG000|Primary and Booster Phase|Ineligibility criteria|1
1154827|NCT03197376|2270407|FG001|Primary and Booster Phase|Ineligibility criteria|1
1154828|NCT03197376|2270408|FG002|Primary and Booster Phase|Ineligibility criteria|4
1154829|NCT03197376|2270409|FG003|Primary and Booster Phase|Ineligibility criteria|2
1154830|NCT03197376|2270406|FG000|Primary and Booster Phase|Not vaccine related|1
1154831|NCT03197376|2270407|FG001|Primary and Booster Phase|Not vaccine related|2
1154832|NCT03197376|2270408|FG002|Primary and Booster Phase|Not vaccine related|0
1154833|NCT03197376|2270409|FG003|Primary and Booster Phase|Not vaccine related|6
1154834|NCT03197376|2270406|FG000|Immune Persistence Phase|Lost to Follow-up|0
1154835|NCT03197376|2270407|FG001|Immune Persistence Phase|Lost to Follow-up|0
1154836|NCT03197376|2270408|FG002|Immune Persistence Phase|Lost to Follow-up|2
1154837|NCT03197376|2270409|FG003|Immune Persistence Phase|Lost to Follow-up|1
1154838|NCT03197376|2270406|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4
1154839|NCT03197376|2270407|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4
1154840|NCT03197376|2270408|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2
1154841|NCT03197376|2270409|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3
1154842|NCT03197376|2270406|FG000|Immune Persistence Phase|Not vaccine related|1
1154843|NCT03197376|2270407|FG001|Immune Persistence Phase|Not vaccine related|0
1154844|NCT03197376|2270408|FG002|Immune Persistence Phase|Not vaccine related|1
1154845|NCT03197376|2270409|FG003|Immune Persistence Phase|Not vaccine related|1
1154846|NCT03197558|2270467|FG000|Overall Study|Tubes not placed|1
1154847|NCT03197883|2270473|FG000|Overall Study|Adverse Event|1
1154848|NCT03197883|2270474|FG001|Overall Study|Adverse Event|1
1154849|NCT03197883|2270473|FG000|Overall Study|Lost to Follow-up|1
1154850|NCT03197883|2270474|FG001|Overall Study|Lost to Follow-up|0
1154851|NCT03197883|2270473|FG000|Overall Study|Protocol Violation|1
1154852|NCT03197883|2270474|FG001|Overall Study|Protocol Violation|0
1154853|NCT03197883|2270473|FG000|Overall Study|Other (Not Specified)|0
1154854|NCT03197883|2270474|FG001|Overall Study|Other (Not Specified)|5
1154867|NCT03198507|2270522|FG000|Overall Study|Withdrawal by Subject|1
1154868|NCT03198507|2270523|FG001|Overall Study|Withdrawal by Subject|0
1154869|NCT03198520|2270529|FG000|Overall Study|Physician Decision|2
1154870|NCT03198520|2270529|FG000|Overall Study|Protocol Violation|2
1154871|NCT03198520|2270529|FG000|Overall Study|Withdrawal by Subject|1
1154872|NCT03198520|2270529|FG000|Overall Study|Study Ended|1
1154873|NCT03198715|2270546|FG000|Overall Study|Death|0
1154874|NCT03198715|2270547|FG001|Overall Study|Death|0
1154875|NCT03198715|2270548|FG002|Overall Study|Death|1
1154876|NCT03198715|2270549|FG003|Overall Study|Death|0
1154877|NCT03198715|2270550|FG004|Overall Study|Death|2
1154878|NCT03198715|2270546|FG000|Overall Study|Other|0
1154879|NCT03198715|2270547|FG001|Overall Study|Other|1
1154880|NCT03198715|2270548|FG002|Overall Study|Other|1
1154881|NCT03198715|2270549|FG003|Overall Study|Other|0
1154882|NCT03198715|2270550|FG004|Overall Study|Other|0
1154883|NCT03198754|2270564|FG000|Overall Study|Withdrawal by Subject|5
1154884|NCT03198754|2270565|FG001|Overall Study|Withdrawal by Subject|4
1154885|NCT03198754|2270564|FG000|Overall Study|Lost to Follow-up|4
1154886|NCT03198754|2270565|FG001|Overall Study|Lost to Follow-up|3
1154887|NCT03198754|2270564|FG000|Overall Study|Ineligible|2
1154888|NCT03198754|2270565|FG001|Overall Study|Ineligible|1
1154889|NCT03198767|2270578|FG000|Overall Study|Protocol Violation|0
1154890|NCT03198767|2270579|FG001|Overall Study|Protocol Violation|0
1154891|NCT03198767|2270580|FG002|Overall Study|Protocol Violation|0
1154892|NCT03198767|2270581|FG003|Overall Study|Protocol Violation|6
1154893|NCT03198767|2270582|FG004|Overall Study|Protocol Violation|0
1154894|NCT03198767|2270583|FG005|Overall Study|Protocol Violation|0
1154895|NCT03198767|2270584|FG006|Overall Study|Protocol Violation|0
1154896|NCT03199911|2270651|FG000|Overall Study|Lost to Follow-up|5
1154897|NCT03199911|2270652|FG001|Overall Study|Lost to Follow-up|5
1154898|NCT03199911|2270651|FG000|Overall Study|Did not proceed with surgery|2
1154899|NCT03199911|2270652|FG001|Overall Study|Did not proceed with surgery|1
1154900|NCT03199963|2270660|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5
1154901|NCT03199963|2270661|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5
1154902|NCT03199963|2270660|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9
1154903|NCT03199963|2270661|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2
1154904|NCT03199963|2270660|FG000|Blinded Phase - Overall Study|Adverse Event|10
1154905|NCT03199963|2270661|FG001|Blinded Phase - Overall Study|Adverse Event|5
1154906|NCT03199963|2270660|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109
1154907|NCT03199963|2270661|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54
1154908|NCT03199963|2270660|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7
1154909|NCT03199963|2270661|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5
1154910|NCT03199963|2270660|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0
1154911|NCT03199963|2270661|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1
1154912|NCT03200366|2270672|FG000|Patient Navigation Intervention Given|Death|0
1154913|NCT03200366|2270673|FG001|Patient Navigation Intervention Given|Death|2
1154914|NCT03200366|2270674|FG002|Patient Navigation Intervention Given|Death|0
1154915|NCT03200366|2270672|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0
1154916|NCT03200366|2270673|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25
1154917|NCT03200366|2270674|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0
1154918|NCT03200366|2270672|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
1154919|NCT03200366|2270673|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1
1154920|NCT03200366|2270674|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
1154921|NCT03200366|2270672|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
1154922|NCT03200366|2270673|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2
1154923|NCT03200366|2270674|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
1154924|NCT03200366|2270672|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0
1154925|NCT03200366|2270673|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1
1154926|NCT03200366|2270674|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0
1154927|NCT03200366|2270672|FG000|6 Month Post-Baseline Interview|Death|1
1154928|NCT03200366|2270673|FG001|6 Month Post-Baseline Interview|Death|1
1154929|NCT03200366|2270674|FG002|6 Month Post-Baseline Interview|Death|1
1154930|NCT03200366|2270672|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27
1154931|NCT03200366|2270673|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21
1154932|NCT03200366|2270674|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17
1154933|NCT03200366|2270672|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1
1154934|NCT03200366|2270673|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1
1154935|NCT03200366|2270674|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0
1154936|NCT03200366|2270672|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1
1154937|NCT03200366|2270673|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
1154938|NCT03200366|2270674|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
1154939|NCT03200366|2270672|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
1154940|NCT03200366|2270673|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
1154941|NCT03200366|2270674|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1
1154942|NCT03200366|2270672|FG000|9 Month Post-Baseline Interview|Death|1
1154943|NCT03200366|2270673|FG001|9 Month Post-Baseline Interview|Death|1
1154944|NCT03200366|2270674|FG002|9 Month Post-Baseline Interview|Death|1
1154945|NCT03200366|2270672|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23
1154946|NCT03200366|2270673|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18
1154947|NCT03200366|2270674|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9
1154948|NCT03200366|2270672|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0
1154949|NCT03200366|2270673|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0
1154950|NCT03200366|2270674|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1
1154951|NCT03200366|2270672|FG000|9 Month Post-Baseline Interview|Refused interview|0
1154952|NCT03200366|2270673|FG001|9 Month Post-Baseline Interview|Refused interview|2
1154953|NCT03200366|2270674|FG002|9 Month Post-Baseline Interview|Refused interview|0
1154954|NCT03200860|2270703|FG000|Overall Study|Withdrawal by Subject|1
1154955|NCT03200860|2270704|FG001|Overall Study|Withdrawal by Subject|0
1154956|NCT03200912|2270713|FG000|Overall Study|Adverse Event|3
1154957|NCT03200912|2270714|FG001|Overall Study|Adverse Event|0
1154958|NCT03200912|2270715|FG002|Overall Study|Adverse Event|0
1154959|NCT03200912|2270713|FG000|Overall Study|Withdrawal by Subject|1
1154960|NCT03200912|2270714|FG001|Overall Study|Withdrawal by Subject|2
1154961|NCT03200912|2270715|FG002|Overall Study|Withdrawal by Subject|4
1154962|NCT03200912|2270713|FG000|Overall Study|Non-compliance with study drug|0
1154963|NCT03200912|2270714|FG001|Overall Study|Non-compliance with study drug|1
1154964|NCT03200912|2270715|FG002|Overall Study|Non-compliance with study drug|0
1154965|NCT03201003|2270734|FG000|Overall Study|Adverse Event|14
1154966|NCT03201003|2270735|FG001|Overall Study|Adverse Event|1
1154967|NCT03201003|2270734|FG000|Overall Study|Other reasons|5
1154968|NCT03201003|2270735|FG001|Overall Study|Other reasons|1
1154969|NCT03201003|2270734|FG000|Overall Study|Withdrawal by Subject|4
1154970|NCT03201003|2270735|FG001|Overall Study|Withdrawal by Subject|1
1154971|NCT03201003|2270734|FG000|Overall Study|Lost to Follow-up|2
1154972|NCT03201003|2270735|FG001|Overall Study|Lost to Follow-up|0
1154973|NCT03201003|2270734|FG000|Overall Study|Protocol Violation|1
1154974|NCT03201003|2270735|FG001|Overall Study|Protocol Violation|0
1154975|NCT03201211|2270744|FG000|Overall Study|Adverse Event|1
1154976|NCT03201211|2270745|FG001|Overall Study|Adverse Event|0
1154977|NCT03201211|2270746|FG002|Overall Study|Adverse Event|0
1154978|NCT03201211|2270744|FG000|Overall Study|Protocol Violation|1
1154979|NCT03201211|2270745|FG001|Overall Study|Protocol Violation|0
1154980|NCT03201211|2270746|FG002|Overall Study|Protocol Violation|0
1154981|NCT03201211|2270744|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
1154982|NCT03201211|2270745|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
1154983|NCT03201211|2270746|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
1154984|NCT03201211|2270744|FG000|Overall Study|OTHER unknown reasons|0
1154985|NCT03201211|2270745|FG001|Overall Study|OTHER unknown reasons|1
1154986|NCT03201211|2270746|FG002|Overall Study|OTHER unknown reasons|0
1154987|NCT03201419|2270763|FG000|Overall Study|Adverse Event|3
1154988|NCT03201419|2270764|FG001|Overall Study|Adverse Event|1
1154989|NCT03201419|2270765|FG002|Overall Study|Adverse Event|0
1154990|NCT03201419|2270766|FG003|Overall Study|Adverse Event|0
1154991|NCT03201419|2270767|FG004|Overall Study|Adverse Event|1
1154992|NCT03201419|2270768|FG005|Overall Study|Adverse Event|1
1154993|NCT03201419|2270769|FG006|Overall Study|Adverse Event|5
1154994|NCT03201419|2270770|FG007|Overall Study|Adverse Event|0
1154995|NCT03201419|2270771|FG008|Overall Study|Adverse Event|0
1154996|NCT03201419|2270763|FG000|Overall Study|Lost to Follow-up|1
1154997|NCT03201419|2270764|FG001|Overall Study|Lost to Follow-up|0
1154998|NCT03201419|2270765|FG002|Overall Study|Lost to Follow-up|0
1154999|NCT03201419|2270766|FG003|Overall Study|Lost to Follow-up|0
1155000|NCT03201419|2270767|FG004|Overall Study|Lost to Follow-up|0
1155001|NCT03201419|2270768|FG005|Overall Study|Lost to Follow-up|0
1155002|NCT03201419|2270769|FG006|Overall Study|Lost to Follow-up|0
1155003|NCT03201419|2270770|FG007|Overall Study|Lost to Follow-up|0
1155004|NCT03201419|2270771|FG008|Overall Study|Lost to Follow-up|0
1155005|NCT03201419|2270763|FG000|Overall Study|Protocol Deviation|0
1155006|NCT03201419|2270764|FG001|Overall Study|Protocol Deviation|0
1155007|NCT03201419|2270765|FG002|Overall Study|Protocol Deviation|0
1155008|NCT03201419|2270766|FG003|Overall Study|Protocol Deviation|0
1155009|NCT03201419|2270767|FG004|Overall Study|Protocol Deviation|0
1155010|NCT03201419|2270768|FG005|Overall Study|Protocol Deviation|0
1155011|NCT03201419|2270769|FG006|Overall Study|Protocol Deviation|1
1155012|NCT03201419|2270770|FG007|Overall Study|Protocol Deviation|0
1155013|NCT03201419|2270771|FG008|Overall Study|Protocol Deviation|0
1155014|NCT03201419|2270763|FG000|Overall Study|Withdrawal by Subject|4
1155015|NCT03201419|2270764|FG001|Overall Study|Withdrawal by Subject|2
1155016|NCT03201419|2270765|FG002|Overall Study|Withdrawal by Subject|1
1155017|NCT03201419|2270766|FG003|Overall Study|Withdrawal by Subject|0
1155018|NCT03201419|2270767|FG004|Overall Study|Withdrawal by Subject|0
1155019|NCT03201419|2270768|FG005|Overall Study|Withdrawal by Subject|0
1155020|NCT03201419|2270769|FG006|Overall Study|Withdrawal by Subject|0
1155021|NCT03201419|2270770|FG007|Overall Study|Withdrawal by Subject|1
1155022|NCT03201419|2270771|FG008|Overall Study|Withdrawal by Subject|2
1155023|NCT03201419|2270763|FG000|Overall Study|Other|0
1155024|NCT03201419|2270764|FG001|Overall Study|Other|0
1155025|NCT03201419|2270765|FG002|Overall Study|Other|1
1155026|NCT03201419|2270766|FG003|Overall Study|Other|0
1155027|NCT03201419|2270767|FG004|Overall Study|Other|0
1155028|NCT03201419|2270768|FG005|Overall Study|Other|0
1155029|NCT03201419|2270769|FG006|Overall Study|Other|0
1155030|NCT03201419|2270770|FG007|Overall Study|Other|0
1155031|NCT03201419|2270771|FG008|Overall Study|Other|0
1155032|NCT03201562|2270808|FG000|Overall Study|Physician Decision|0
1155033|NCT03201562|2270809|FG001|Overall Study|Physician Decision|0
1155034|NCT03201562|2270810|FG002|Overall Study|Physician Decision|1
1155035|NCT03201562|2270808|FG000|Overall Study|Adverse Event|0
1155036|NCT03201562|2270809|FG001|Overall Study|Adverse Event|0
1155037|NCT03201562|2270810|FG002|Overall Study|Adverse Event|1
1155038|NCT03201562|2270808|FG000|Overall Study|Lost to Follow-up|0
1155039|NCT03201562|2270809|FG001|Overall Study|Lost to Follow-up|1
1155040|NCT03201562|2270810|FG002|Overall Study|Lost to Follow-up|2
1155041|NCT03201809|2270820|FG000|Overall Study|Lost to Follow-up|2
1155042|NCT03201809|2270821|FG001|Overall Study|Lost to Follow-up|0
1155043|NCT03201900|2270827|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
1155044|NCT03201900|2270827|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
1155045|NCT03201900|2270827|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
1155046|NCT03201900|2270827|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
1155047|NCT03201900|2270827|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
1155048|NCT03201900|2270827|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11
1155049|NCT03201900|2270827|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2
1155050|NCT03201900|2270827|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1
1155051|NCT03201900|2270827|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1
1155052|NCT03201900|2270827|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1
1155053|NCT03201900|2270827|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1
1155054|NCT03201900|2270827|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3
1155055|NCT03201900|2270827|FG000|Extension Phase (From Week 63 to 156)|Other|1
1155068|NCT03202511|2270862|FG000|Overall Study|Withdrawal by Subject|1
1155069|NCT03202511|2270863|FG001|Overall Study|Withdrawal by Subject|0
1155070|NCT03203291|2270878|FG000|Overall Study|Withdrawal by Subject|1
1155071|NCT03203447|2270884|FG000|Overall Study|Withdrawal by Subject|2
1155072|NCT03203447|2270885|FG001|Overall Study|Withdrawal by Subject|1
1155073|NCT03203447|2270884|FG000|Overall Study|Lost to Follow-up|1
1155074|NCT03203447|2270885|FG001|Overall Study|Lost to Follow-up|10
1155075|NCT03203447|2270884|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159
1155076|NCT03203447|2270885|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152
1155077|NCT03204279|2270914|FG000|Overall Study|Withdrawal by Subject|0
1155078|NCT03204279|2270915|FG001|Overall Study|Withdrawal by Subject|1
1155079|NCT03204981|2270953|FG000|Overall Study|Physician Decision|2
1155080|NCT03204981|2270953|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4
1155081|NCT03205046|2270961|FG000|Overall Study|Death|10
1155082|NCT03205046|2270962|FG001|Overall Study|Death|6
1155083|NCT03205046|2270961|FG000|Overall Study|Withdrawal by Subject|1
1155084|NCT03205046|2270962|FG001|Overall Study|Withdrawal by Subject|2
1155085|NCT03205046|2270961|FG000|Overall Study|Lost to Follow-up|0
1155086|NCT03205046|2270962|FG001|Overall Study|Lost to Follow-up|1
1155087|NCT03205046|2270961|FG000|Overall Study|Study terminated by sponsor|2
1155088|NCT03205046|2270962|FG001|Overall Study|Study terminated by sponsor|1
1155089|NCT03205150|2270971|FG000|Overall Study|Protocol deviation|1
1155090|NCT03205150|2270972|FG001|Overall Study|Protocol deviation|3
1155091|NCT03205150|2270973|FG002|Overall Study|Protocol deviation|0
1155092|NCT03205150|2270971|FG000|Overall Study|Patient/guardian decision|0
1155093|NCT03205150|2270972|FG001|Overall Study|Patient/guardian decision|3
1155094|NCT03205150|2270973|FG002|Overall Study|Patient/guardian decision|0
1155095|NCT03205150|2270971|FG000|Overall Study|Adverse Event|1
1155096|NCT03205150|2270972|FG001|Overall Study|Adverse Event|1
1155097|NCT03205150|2270973|FG002|Overall Study|Adverse Event|1
1155098|NCT03205150|2270971|FG000|Overall Study|Lost to Follow-up|0
1155099|NCT03205150|2270972|FG001|Overall Study|Lost to Follow-up|0
1155100|NCT03205150|2270973|FG002|Overall Study|Lost to Follow-up|1
1155101|NCT03205163|2270984|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
1155102|NCT03205163|2270985|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
1155103|NCT03205371|2271021|FG000|Overall Study|Withdrawal by Subject|4
1155104|NCT03205371|2271022|FG001|Overall Study|Withdrawal by Subject|1
1155105|NCT03205371|2271023|FG002|Overall Study|Withdrawal by Subject|0
1155106|NCT03205371|2271024|FG003|Overall Study|Withdrawal by Subject|0
1155107|NCT03205371|2271025|FG004|Overall Study|Withdrawal by Subject|0
1155108|NCT03205371|2271026|FG005|Overall Study|Withdrawal by Subject|0
1155109|NCT03205371|2271027|FG006|Overall Study|Withdrawal by Subject|4
1155110|NCT03205371|2271028|FG007|Overall Study|Withdrawal by Subject|0
1155111|NCT03205371|2271029|FG008|Overall Study|Withdrawal by Subject|2
1155112|NCT03205371|2271030|FG009|Overall Study|Withdrawal by Subject|0
1155113|NCT03205371|2271031|FG010|Overall Study|Withdrawal by Subject|0
1155114|NCT03205371|2271032|FG011|Overall Study|Withdrawal by Subject|1
1155115|NCT03205371|2271021|FG000|Overall Study|Lost to Follow-up|0
1155116|NCT03205371|2271022|FG001|Overall Study|Lost to Follow-up|0
1155117|NCT03205371|2271023|FG002|Overall Study|Lost to Follow-up|0
1155118|NCT03205371|2271024|FG003|Overall Study|Lost to Follow-up|0
1155119|NCT03205371|2271025|FG004|Overall Study|Lost to Follow-up|0
1155120|NCT03205371|2271026|FG005|Overall Study|Lost to Follow-up|0
1155121|NCT03205371|2271027|FG006|Overall Study|Lost to Follow-up|5
1155122|NCT03205371|2271028|FG007|Overall Study|Lost to Follow-up|2
1155123|NCT03205371|2271029|FG008|Overall Study|Lost to Follow-up|3
1155124|NCT03205371|2271030|FG009|Overall Study|Lost to Follow-up|0
1155125|NCT03205371|2271031|FG010|Overall Study|Lost to Follow-up|0
1155126|NCT03205371|2271032|FG011|Overall Study|Lost to Follow-up|0
1155127|NCT03205371|2271021|FG000|Overall Study|Protocol Violation|0
1155128|NCT03205371|2271022|FG001|Overall Study|Protocol Violation|0
1155129|NCT03205371|2271023|FG002|Overall Study|Protocol Violation|0
1155130|NCT03205371|2271024|FG003|Overall Study|Protocol Violation|0
1155131|NCT03205371|2271025|FG004|Overall Study|Protocol Violation|0
1155132|NCT03205371|2271026|FG005|Overall Study|Protocol Violation|0
1155133|NCT03205371|2271027|FG006|Overall Study|Protocol Violation|1
1155134|NCT03205371|2271028|FG007|Overall Study|Protocol Violation|0
1155135|NCT03205371|2271029|FG008|Overall Study|Protocol Violation|0
1155136|NCT03205371|2271030|FG009|Overall Study|Protocol Violation|0
1155137|NCT03205371|2271031|FG010|Overall Study|Protocol Violation|0
1155138|NCT03205371|2271032|FG011|Overall Study|Protocol Violation|0
1155139|NCT03205371|2271021|FG000|Overall Study|Adverse Event|0
1155140|NCT03205371|2271022|FG001|Overall Study|Adverse Event|0
1155141|NCT03205371|2271023|FG002|Overall Study|Adverse Event|0
1155142|NCT03205371|2271024|FG003|Overall Study|Adverse Event|0
1155143|NCT03205371|2271025|FG004|Overall Study|Adverse Event|0
1155144|NCT03205371|2271026|FG005|Overall Study|Adverse Event|0
1155145|NCT03205371|2271027|FG006|Overall Study|Adverse Event|0
1155146|NCT03205371|2271028|FG007|Overall Study|Adverse Event|1
1155147|NCT03205371|2271029|FG008|Overall Study|Adverse Event|0
1155148|NCT03205371|2271030|FG009|Overall Study|Adverse Event|0
1155149|NCT03205371|2271031|FG010|Overall Study|Adverse Event|0
1155150|NCT03205371|2271032|FG011|Overall Study|Adverse Event|0
1155151|NCT03205488|2271081|FG000|Overall Study|Adverse Event|1
1155152|NCT03205488|2271082|FG001|Overall Study|Adverse Event|2
1155153|NCT03205488|2271083|FG002|Overall Study|Adverse Event|4
1155154|NCT03205488|2271081|FG000|Overall Study|Protocol Violation|0
1155155|NCT03205488|2271082|FG001|Overall Study|Protocol Violation|0
1155156|NCT03205488|2271083|FG002|Overall Study|Protocol Violation|1
1155157|NCT03205566|2271097|FG000|Phase 1|Protocol Violation|1
1155158|NCT03205566|2271098|FG001|Phase 1|Protocol Violation|1
1155159|NCT03206073|2271112|FG000|Overall Study|Participant Noncompliance|0
1155160|NCT03206073|2271113|FG001|Overall Study|Participant Noncompliance|1
1155161|NCT03206073|2271114|FG002|Overall Study|Participant Noncompliance|0
1155162|NCT03206073|2271115|FG003|Overall Study|Participant Noncompliance|0
1155163|NCT03206073|2271112|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1
1155164|NCT03206073|2271113|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0
1155165|NCT03206073|2271114|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0
1155166|NCT03206073|2271115|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0
1155167|NCT03206073|2271112|FG000|Overall Study|Death|0
1155168|NCT03206073|2271113|FG001|Overall Study|Death|0
1155169|NCT03206073|2271114|FG002|Overall Study|Death|1
1155170|NCT03206073|2271115|FG003|Overall Study|Death|0
1155171|NCT03206073|2271112|FG000|Overall Study|Taken off active treatment|0
1155172|NCT03206073|2271113|FG001|Overall Study|Taken off active treatment|0
1155173|NCT03206073|2271114|FG002|Overall Study|Taken off active treatment|3
1155174|NCT03206073|2271115|FG003|Overall Study|Taken off active treatment|0
1155175|NCT03206749|2271128|FG000|Overall Study|Withdrawal of consent|5
1155176|NCT03206749|2271129|FG001|Overall Study|Withdrawal of consent|3
1155177|NCT03206749|2271130|FG002|Overall Study|Withdrawal of consent|6
1155178|NCT03206749|2271128|FG000|Overall Study|Lost to Follow-up|0
1155179|NCT03206749|2271129|FG001|Overall Study|Lost to Follow-up|0
1155180|NCT03206749|2271130|FG002|Overall Study|Lost to Follow-up|1
1155181|NCT03206788|2271141|FG000|Overall Study|Withdrawal by Subject|0
1155182|NCT03206788|2271142|FG001|Overall Study|Withdrawal by Subject|1
1155183|NCT03206788|2271141|FG000|Overall Study|Adverse Event|0
1155184|NCT03206788|2271142|FG001|Overall Study|Adverse Event|1
1155185|NCT03206788|2271141|FG000|Overall Study|Physician Decision|0
1155186|NCT03206788|2271142|FG001|Overall Study|Physician Decision|1
1155187|NCT03206918|2271148|FG000|Overall Study|Death|11
1155188|NCT03206918|2271148|FG000|Overall Study|Withdrawal by Subject|5
1155189|NCT03206918|2271148|FG000|Overall Study|Study terminated by sponsor|12
1155190|NCT03206918|2271148|FG000|Overall Study|Lost to Follow-up|3
1155191|NCT03206918|2271148|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60
1155192|NCT03206970|2271153|FG000|Overall Study|Death|21
1155193|NCT03206970|2271153|FG000|Overall Study|Withdrawal by Subject|13
1155194|NCT03206970|2271153|FG000|Overall Study|Lost to Follow-up|3
1155195|NCT03206970|2271153|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49
1155196|NCT03207243|2271181|FG000|Overall Study|Adverse Event|2
1155197|NCT03207243|2271182|FG001|Overall Study|Adverse Event|2
1155198|NCT03207243|2271181|FG000|Overall Study|Loss of Asthma Control|47
1155199|NCT03207243|2271182|FG001|Overall Study|Loss of Asthma Control|31
1155200|NCT03207243|2271181|FG000|Overall Study|Withdrawal by Subject|2
1155201|NCT03207243|2271182|FG001|Overall Study|Withdrawal by Subject|4
1155202|NCT03207243|2271181|FG000|Overall Study|Physician Decision|1
1155203|NCT03207243|2271182|FG001|Overall Study|Physician Decision|1
1155204|NCT03207243|2271181|FG000|Overall Study|Lost to Follow-up|0
1155205|NCT03207243|2271182|FG001|Overall Study|Lost to Follow-up|1
1155206|NCT03207243|2271181|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7
1155207|NCT03207243|2271182|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2
1155208|NCT03207243|2271181|FG000|Overall Study|Protocol Violation|0
1155209|NCT03207243|2271182|FG001|Overall Study|Protocol Violation|3
1155210|NCT03207750|2271222|FG000|Overall Study|Adverse Event|3
1155211|NCT03207750|2271223|FG001|Overall Study|Adverse Event|2
1155212|NCT03207750|2271222|FG000|Overall Study|Lost to Follow-up|21
1155213|NCT03207750|2271223|FG001|Overall Study|Lost to Follow-up|29
1155214|NCT03207750|2271222|FG000|Overall Study|Protocol Violation|0
1155215|NCT03207750|2271223|FG001|Overall Study|Protocol Violation|1
1155216|NCT03207750|2271222|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
1155217|NCT03207750|2271223|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
1155218|NCT03207750|2271222|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
1155219|NCT03207750|2271223|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
1155220|NCT03207750|2271222|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
1155221|NCT03207750|2271223|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
1155222|NCT03207750|2271222|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
1155223|NCT03207750|2271223|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
1155224|NCT03207750|2271222|FG000|Overall Study|OTHER, NOT SPECIFIED|5
1155225|NCT03207750|2271223|FG001|Overall Study|OTHER, NOT SPECIFIED|4
1155226|NCT03207763|2271231|FG000|Overall Study|Lost to Follow-up|1
1155227|NCT03207763|2271232|FG001|Overall Study|Lost to Follow-up|0
1155228|NCT03208088|2271256|FG000|Period 2|Withdrawal by Subject|0
1155229|NCT03208088|2271257|FG001|Period 2|Withdrawal by Subject|0
1155230|NCT03208088|2271258|FG002|Period 2|Withdrawal by Subject|0
1155231|NCT03208088|2271259|FG003|Period 2|Withdrawal by Subject|0
1155232|NCT03208088|2271260|FG004|Period 2|Withdrawal by Subject|0
1155233|NCT03208088|2271261|FG005|Period 2|Withdrawal by Subject|0
1155234|NCT03208088|2271262|FG006|Period 2|Withdrawal by Subject|0
1155235|NCT03208088|2271263|FG007|Period 2|Withdrawal by Subject|0
1155236|NCT03208088|2271264|FG008|Period 2|Withdrawal by Subject|1
1155237|NCT03208088|2271265|FG009|Period 2|Withdrawal by Subject|0
1155238|NCT03208088|2271256|FG000|Period 3|Unsatisfactory Test Article|0
1155239|NCT03208088|2271257|FG001|Period 3|Unsatisfactory Test Article|0
1155240|NCT03208088|2271258|FG002|Period 3|Unsatisfactory Test Article|0
1155241|NCT03208088|2271259|FG003|Period 3|Unsatisfactory Test Article|1
1155242|NCT03208088|2271260|FG004|Period 3|Unsatisfactory Test Article|0
1155243|NCT03208088|2271261|FG005|Period 3|Unsatisfactory Test Article|0
1155244|NCT03208088|2271262|FG006|Period 3|Unsatisfactory Test Article|0
1155245|NCT03208088|2271263|FG007|Period 3|Unsatisfactory Test Article|0
1155246|NCT03208088|2271264|FG008|Period 3|Unsatisfactory Test Article|0
1155247|NCT03208088|2271265|FG009|Period 3|Unsatisfactory Test Article|0
1155248|NCT03208088|2271256|FG000|Period 4|Unsatisfactory Test Article|0
1155249|NCT03208088|2271257|FG001|Period 4|Unsatisfactory Test Article|0
1155250|NCT03208088|2271258|FG002|Period 4|Unsatisfactory Test Article|0
1155251|NCT03208088|2271259|FG003|Period 4|Unsatisfactory Test Article|1
1155252|NCT03208088|2271260|FG004|Period 4|Unsatisfactory Test Article|0
1155253|NCT03208088|2271261|FG005|Period 4|Unsatisfactory Test Article|0
1155254|NCT03208088|2271262|FG006|Period 4|Unsatisfactory Test Article|0
1155255|NCT03208088|2271263|FG007|Period 4|Unsatisfactory Test Article|0
1155256|NCT03208088|2271264|FG008|Period 4|Unsatisfactory Test Article|0
1155257|NCT03208088|2271265|FG009|Period 4|Unsatisfactory Test Article|0
1155258|NCT03208933|2271305|FG000|Overall Study|Death|3
1155259|NCT03208933|2271305|FG000|Overall Study|Withdrawal by Subject|3
1155260|NCT03208933|2271305|FG000|Overall Study|Adverse Event|1
1155261|NCT03208933|2271305|FG000|Overall Study|Lost to Follow-up|2
1155262|NCT03208933|2271305|FG000|Overall Study|Physician Decision|3
1155263|NCT03208933|2271305|FG000|Overall Study|Protocol Violation|1
1155264|NCT03209362|2271316|FG000|Overall Study|Adverse Event|0
1155265|NCT03209362|2271317|FG001|Overall Study|Adverse Event|1
1155266|NCT03209362|2271316|FG000|Overall Study|Lost to Follow-up|0
1155267|NCT03209362|2271317|FG001|Overall Study|Lost to Follow-up|1
1155268|NCT03209362|2271316|FG000|Overall Study|Withdrawal by Subject|2
1155269|NCT03209362|2271317|FG001|Overall Study|Withdrawal by Subject|0
1155270|NCT03209362|2271316|FG000|Overall Study|Other|0
1155271|NCT03209362|2271317|FG001|Overall Study|Other|1
1155272|NCT03209492|2271323|FG000|Overall Study|Case Report Forms Uncollected|5
1155273|NCT03209518|2271334|FG000|Overall Study|Case Report Forms Uncollected|1
1155274|NCT03209518|2271334|FG000|Overall Study|Protocol Deviation|1
1155275|NCT03209570|2271340|FG000|Overall Study|Death|1
1155276|NCT03209570|2271341|FG001|Overall Study|Death|0
1155277|NCT03209570|2271340|FG000|Overall Study|Incomplete Data|8
1155278|NCT03209570|2271341|FG001|Overall Study|Incomplete Data|10
1155279|NCT03209570|2271340|FG000|Overall Study|Protocol Violation|1
1155280|NCT03209570|2271341|FG001|Overall Study|Protocol Violation|0
1155281|NCT03209570|2271340|FG000|Overall Study|Withdrawal by Subject|0
1155282|NCT03209570|2271341|FG001|Overall Study|Withdrawal by Subject|3
1155283|NCT03209973|2271358|FG000|Overall Study|Withdrawal by Subject|7
1155284|NCT03209973|2271358|FG000|Overall Study|Lost to Follow-up|2
1155285|NCT03209973|2271358|FG000|Overall Study|Death|8
1155286|NCT03209973|2271358|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32
1155287|NCT03209973|2271358|FG000|Overall Study|Sponsor Decision|18
1155288|NCT03209973|2271358|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1
1155289|NCT03209973|2271358|FG000|Overall Study|Participant Refused to Return to Treatment|2
1155290|NCT03210220|2271375|FG000|Overall Study|Physician Decision|1
1155291|NCT03210220|2271376|FG001|Overall Study|Physician Decision|0
1155292|NCT03210259|2271384|FG000|12-Week Run-in Period|Adverse Event|1
1155293|NCT03210259|2271385|FG001|12-Week Run-in Period|Adverse Event|0
1155294|NCT03210259|2271386|FG002|12-Week Run-in Period|Adverse Event|0
1155295|NCT03210259|2271384|FG000|12-Week Run-in Period|Death|1
1155296|NCT03210259|2271385|FG001|12-Week Run-in Period|Death|0
1155297|NCT03210259|2271386|FG002|12-Week Run-in Period|Death|0
1155298|NCT03210259|2271384|FG000|12-Week Run-in Period|Withdrawal by Subject|9
1155299|NCT03210259|2271385|FG001|12-Week Run-in Period|Withdrawal by Subject|0
1155300|NCT03210259|2271386|FG002|12-Week Run-in Period|Withdrawal by Subject|0
1155301|NCT03210259|2271384|FG000|12-Week Run-in Period|Lost to Follow-up|4
1155302|NCT03210259|2271385|FG001|12-Week Run-in Period|Lost to Follow-up|0
1155303|NCT03210259|2271386|FG002|12-Week Run-in Period|Lost to Follow-up|0
1155304|NCT03210259|2271384|FG000|12-Week Run-in Period|Lack of Efficacy|6
1155305|NCT03210259|2271385|FG001|12-Week Run-in Period|Lack of Efficacy|0
1155306|NCT03210259|2271386|FG002|12-Week Run-in Period|Lack of Efficacy|0
1155307|NCT03210259|2271384|FG000|48-Week Randomized Responder Period|Missed study visit|0
1155308|NCT03210259|2271385|FG001|48-Week Randomized Responder Period|Missed study visit|1
1155309|NCT03210259|2271386|FG002|48-Week Randomized Responder Period|Missed study visit|2
1155310|NCT03210259|2271384|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0
1155311|NCT03210259|2271385|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3
1155312|NCT03210259|2271386|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8
1155313|NCT03210259|2271384|FG000|48-Week Randomized Responder Period|Pregnancy|0
1155314|NCT03210259|2271385|FG001|48-Week Randomized Responder Period|Pregnancy|1
1155315|NCT03210259|2271386|FG002|48-Week Randomized Responder Period|Pregnancy|0
1155316|NCT03210259|2271384|FG000|48-Week Randomized Responder Period|Physician Decision|0
1155317|NCT03210259|2271385|FG001|48-Week Randomized Responder Period|Physician Decision|0
1155318|NCT03210259|2271386|FG002|48-Week Randomized Responder Period|Physician Decision|1
1155319|NCT03210259|2271384|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0
1155320|NCT03210259|2271385|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5
1155321|NCT03210259|2271386|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17
1155322|NCT03210259|2271384|FG000|48-Week Randomized Responder Period|Adverse Event|0
1155323|NCT03210259|2271385|FG001|48-Week Randomized Responder Period|Adverse Event|1
1155324|NCT03210259|2271386|FG002|48-Week Randomized Responder Period|Adverse Event|1
1155325|NCT03210519|2271413|FG000|Overall Study|Adverse Event|2
1155326|NCT03210519|2271414|FG001|Overall Study|Adverse Event|0
1155327|NCT03210961|2271439|FG000|Overall Study|Adverse Event|0
1155328|NCT03210961|2271440|FG001|Overall Study|Adverse Event|0
1155329|NCT03210961|2271441|FG002|Overall Study|Adverse Event|0
1155330|NCT03210961|2271442|FG003|Overall Study|Adverse Event|0
1155331|NCT03210961|2271443|FG004|Overall Study|Adverse Event|0
1155332|NCT03210961|2271444|FG005|Overall Study|Adverse Event|0
1155333|NCT03210961|2271445|FG006|Overall Study|Adverse Event|0
1155334|NCT03210961|2271446|FG007|Overall Study|Adverse Event|0
1155335|NCT03210961|2271447|FG008|Overall Study|Adverse Event|0
1155336|NCT03210961|2271448|FG009|Overall Study|Adverse Event|0
1155337|NCT03210961|2271449|FG010|Overall Study|Adverse Event|0
1155338|NCT03210961|2271450|FG011|Overall Study|Adverse Event|0
1155339|NCT03210961|2271451|FG012|Overall Study|Adverse Event|0
1155340|NCT03210961|2271452|FG013|Overall Study|Adverse Event|1
1155341|NCT03210961|2271453|FG014|Overall Study|Adverse Event|0
1155342|NCT03210961|2271439|FG000|Overall Study|Lost to Follow-up|0
1155343|NCT03210961|2271440|FG001|Overall Study|Lost to Follow-up|0
1155344|NCT03210961|2271441|FG002|Overall Study|Lost to Follow-up|0
1155345|NCT03210961|2271442|FG003|Overall Study|Lost to Follow-up|0
1155346|NCT03210961|2271443|FG004|Overall Study|Lost to Follow-up|0
1155347|NCT03210961|2271444|FG005|Overall Study|Lost to Follow-up|0
1155348|NCT03210961|2271445|FG006|Overall Study|Lost to Follow-up|0
1155349|NCT03210961|2271446|FG007|Overall Study|Lost to Follow-up|0
1155350|NCT03210961|2271447|FG008|Overall Study|Lost to Follow-up|0
1155351|NCT03210961|2271448|FG009|Overall Study|Lost to Follow-up|0
1155352|NCT03210961|2271449|FG010|Overall Study|Lost to Follow-up|0
1155353|NCT03210961|2271450|FG011|Overall Study|Lost to Follow-up|0
1155354|NCT03210961|2271451|FG012|Overall Study|Lost to Follow-up|0
1155355|NCT03210961|2271452|FG013|Overall Study|Lost to Follow-up|0
1155356|NCT03210961|2271453|FG014|Overall Study|Lost to Follow-up|1
1155357|NCT03210961|2271439|FG000|Overall Study|Withdrawal by Subject|0
1155358|NCT03210961|2271440|FG001|Overall Study|Withdrawal by Subject|0
1155359|NCT03210961|2271441|FG002|Overall Study|Withdrawal by Subject|0
1155360|NCT03210961|2271442|FG003|Overall Study|Withdrawal by Subject|0
1155361|NCT03210961|2271443|FG004|Overall Study|Withdrawal by Subject|0
1155362|NCT03210961|2271444|FG005|Overall Study|Withdrawal by Subject|0
1155363|NCT03210961|2271445|FG006|Overall Study|Withdrawal by Subject|0
1155364|NCT03210961|2271446|FG007|Overall Study|Withdrawal by Subject|0
1155365|NCT03210961|2271447|FG008|Overall Study|Withdrawal by Subject|0
1155366|NCT03210961|2271448|FG009|Overall Study|Withdrawal by Subject|0
1155367|NCT03210961|2271449|FG010|Overall Study|Withdrawal by Subject|0
1155368|NCT03210961|2271450|FG011|Overall Study|Withdrawal by Subject|0
1155369|NCT03210961|2271451|FG012|Overall Study|Withdrawal by Subject|0
1155370|NCT03210961|2271452|FG013|Overall Study|Withdrawal by Subject|0
1155371|NCT03210961|2271453|FG014|Overall Study|Withdrawal by Subject|1
1155372|NCT03210961|2271439|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
1155373|NCT03210961|2271440|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
1155374|NCT03210961|2271441|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
1155375|NCT03210961|2271442|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
1155376|NCT03210961|2271443|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
1155377|NCT03210961|2271444|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
1155378|NCT03210961|2271445|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
1155379|NCT03210961|2271446|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
1155380|NCT03210961|2271447|FG008|Overall Study|No Longer Meets Eligibility Criteria|0
1155381|NCT03210961|2271448|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
1155382|NCT03210961|2271449|FG010|Overall Study|No Longer Meets Eligibility Criteria|0
1155383|NCT03210961|2271450|FG011|Overall Study|No Longer Meets Eligibility Criteria|0
1155384|NCT03210961|2271451|FG012|Overall Study|No Longer Meets Eligibility Criteria|0
1155385|NCT03210961|2271452|FG013|Overall Study|No Longer Meets Eligibility Criteria|1
1155386|NCT03210961|2271453|FG014|Overall Study|No Longer Meets Eligibility Criteria|0
1155387|NCT03210961|2271439|FG000|Overall Study|Other|0
1155388|NCT03210961|2271440|FG001|Overall Study|Other|0
1155389|NCT03210961|2271441|FG002|Overall Study|Other|0
1155390|NCT03210961|2271442|FG003|Overall Study|Other|1
1155391|NCT03210961|2271443|FG004|Overall Study|Other|0
1155392|NCT03210961|2271444|FG005|Overall Study|Other|0
1155393|NCT03210961|2271445|FG006|Overall Study|Other|1
1155394|NCT03210961|2271446|FG007|Overall Study|Other|0
1155395|NCT03210961|2271447|FG008|Overall Study|Other|0
1155396|NCT03210961|2271448|FG009|Overall Study|Other|0
1155397|NCT03210961|2271449|FG010|Overall Study|Other|1
1155398|NCT03210961|2271450|FG011|Overall Study|Other|0
1155399|NCT03210961|2271451|FG012|Overall Study|Other|2
1155400|NCT03210961|2271452|FG013|Overall Study|Other|2
1155401|NCT03210961|2271453|FG014|Overall Study|Other|0
1155402|NCT03211156|2271513|FG000|Overall Study|Withdrawal by Subject|0
1155403|NCT03211156|2271514|FG001|Overall Study|Withdrawal by Subject|2
1155404|NCT03211156|2271513|FG000|Overall Study|Lost to Follow-up|1
1155405|NCT03211156|2271514|FG001|Overall Study|Lost to Follow-up|1
1155406|NCT03211156|2271513|FG000|Overall Study|Adverse Event|1
1155407|NCT03211156|2271514|FG001|Overall Study|Adverse Event|0
1155408|NCT03211858|2271535|FG000|Overall Study|Adverse Event|8
1155409|NCT03211858|2271536|FG001|Overall Study|Adverse Event|6
1155410|NCT03211858|2271535|FG000|Overall Study|Lack of Efficacy|0
1155411|NCT03211858|2271536|FG001|Overall Study|Lack of Efficacy|4
1155412|NCT03211858|2271535|FG000|Overall Study|Poor compliance to protocol|6
1155413|NCT03211858|2271536|FG001|Overall Study|Poor compliance to protocol|2
1155414|NCT03211858|2271535|FG000|Overall Study|Non-serious Hypoglycemia|1
1155415|NCT03211858|2271536|FG001|Overall Study|Non-serious Hypoglycemia|0
1155416|NCT03211858|2271535|FG000|Overall Study|Other than specified above|22
1155417|NCT03211858|2271536|FG001|Overall Study|Other than specified above|21
1155418|NCT03212261|2271546|FG000|Overall Study|Became ineligible d/t tech|2
1155419|NCT03212261|2271546|FG000|Overall Study|Tech Trouble- No first study visit|1
1155420|NCT03212261|2271546|FG000|Overall Study|Lost to Follow-up|7
1155421|NCT03212261|2271546|FG000|Overall Study|Family Emergency|1
1155422|NCT03212261|2271546|FG000|Overall Study|Too busy/ No time|5
1155423|NCT03212326|2271551|FG000|Overall Study|Physician Decision|4
1155424|NCT03212365|2271557|FG000|Overall Study|Discharged prior to Xa level|12
1155425|NCT03212365|2271558|FG001|Overall Study|Discharged prior to Xa level|8
1155426|NCT03212365|2271557|FG000|Overall Study|Bled requiring enoxaparin cessation|4
1155427|NCT03212365|2271558|FG001|Overall Study|Bled requiring enoxaparin cessation|2
1155428|NCT03212365|2271557|FG000|Overall Study|Refused study medication|3
1155429|NCT03212365|2271558|FG001|Overall Study|Refused study medication|0
1155430|NCT03212365|2271557|FG000|Overall Study|Initiated heparin infusion on floor|1
1155431|NCT03212365|2271558|FG001|Overall Study|Initiated heparin infusion on floor|1
1155432|NCT03212365|2271557|FG000|Overall Study|Unexpected return to OR|1
1155433|NCT03212365|2271558|FG001|Overall Study|Unexpected return to OR|1
1155434|NCT03212365|2271557|FG000|Overall Study|Medication distribution error|1
1155435|NCT03212365|2271558|FG001|Overall Study|Medication distribution error|0
1155436|NCT03212365|2271557|FG000|Overall Study|Required epidural placement|1
1155437|NCT03212365|2271558|FG001|Overall Study|Required epidural placement|0
1155438|NCT03212365|2271557|FG000|Overall Study|Withdrawal by Subject|0
1155439|NCT03212365|2271558|FG001|Overall Study|Withdrawal by Subject|1
1155440|NCT03212365|2271557|FG000|Overall Study|developed acute renal failure|0
1155441|NCT03212365|2271558|FG001|Overall Study|developed acute renal failure|1
1155442|NCT03212521|2271564|FG000|Overall Study|Adverse Event|1
1155443|NCT03212521|2271564|FG000|Overall Study|Lost to Follow-up|4
1155444|NCT03212521|2271564|FG000|Overall Study|Withdrawal by Subject|1
1155445|NCT03212521|2271564|FG000|Overall Study|Other|1
1155446|NCT03212690|2271586|FG000|Overall Study|Protocol Violation|1
1155447|NCT03213366|2271596|FG000|Overall Study|Lost to Follow-up|9
1155448|NCT03213366|2271597|FG001|Overall Study|Lost to Follow-up|4
1155449|NCT03213457|2271623|FG000|Overall Study|Not Treated|1
1155450|NCT03213457|2271624|FG001|Overall Study|Not Treated|1
1155451|NCT03213457|2271625|FG002|Overall Study|Not Treated|0
1155452|NCT03213457|2271623|FG000|Overall Study|Adverse Event|16
1155453|NCT03213457|2271624|FG001|Overall Study|Adverse Event|9
1155454|NCT03213457|2271625|FG002|Overall Study|Adverse Event|41
1155455|NCT03213457|2271623|FG000|Overall Study|Non-Compliance With Study Drug|1
1155456|NCT03213457|2271624|FG001|Overall Study|Non-Compliance With Study Drug|2
1155457|NCT03213457|2271625|FG002|Overall Study|Non-Compliance With Study Drug|7
1155458|NCT03213457|2271623|FG000|Overall Study|Non-Compliance Other, Not Specified|0
1155459|NCT03213457|2271624|FG001|Overall Study|Non-Compliance Other, Not Specified|1
1155460|NCT03213457|2271625|FG002|Overall Study|Non-Compliance Other, Not Specified|5
1155461|NCT03213457|2271623|FG000|Overall Study|Withdrawal by Subject|18
1155462|NCT03213457|2271624|FG001|Overall Study|Withdrawal by Subject|7
1155463|NCT03213457|2271625|FG002|Overall Study|Withdrawal by Subject|35
1155464|NCT03213457|2271623|FG000|Overall Study|Lost to Follow-up|12
1155465|NCT03213457|2271624|FG001|Overall Study|Lost to Follow-up|12
1155466|NCT03213457|2271625|FG002|Overall Study|Lost to Follow-up|33
1155467|NCT03213457|2271623|FG000|Overall Study|Pregnancy|11
1155468|NCT03213457|2271624|FG001|Overall Study|Pregnancy|0
1155469|NCT03213457|2271625|FG002|Overall Study|Pregnancy|7
1155470|NCT03213457|2271623|FG000|Overall Study|Protocol Violation|1
1155471|NCT03213457|2271624|FG001|Overall Study|Protocol Violation|1
1155472|NCT03213457|2271625|FG002|Overall Study|Protocol Violation|6
1155473|NCT03213457|2271623|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4
1155474|NCT03213457|2271624|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0
1155475|NCT03213457|2271625|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2
1155476|NCT03213457|2271623|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
1155477|NCT03213457|2271624|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
1155478|NCT03213457|2271625|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3
1155479|NCT03213457|2271623|FG000|Overall Study|Lack of Efficacy|12
1155480|NCT03213457|2271624|FG001|Overall Study|Lack of Efficacy|2
1155481|NCT03213457|2271625|FG002|Overall Study|Lack of Efficacy|9
1155482|NCT03213457|2271623|FG000|Overall Study|Other, Not Specified|11
1155483|NCT03213457|2271624|FG001|Overall Study|Other, Not Specified|3
1155484|NCT03213457|2271625|FG002|Overall Study|Other, Not Specified|26
1155485|NCT03213509|2271635|FG000|Overall Study|Did not consent for verbal autopsy|4
1155486|NCT03213509|2271636|FG001|Overall Study|Did not consent for verbal autopsy|5
1155487|NCT03213626|2271643|FG000|Overall Study|Adverse Event|1
1155488|NCT03213626|2271643|FG000|Overall Study|Progressive Disease|6
1155489|NCT03213938|2271649|FG000|Overall Study|Lost to Follow-up|4
1155490|NCT03213938|2271650|FG001|Overall Study|Lost to Follow-up|3
1155491|NCT03213938|2271649|FG000|Overall Study|Lack of Efficacy|1
1155492|NCT03213938|2271650|FG001|Overall Study|Lack of Efficacy|0
1155493|NCT03213938|2271649|FG000|Overall Study|Decline to participate|5
1155494|NCT03213938|2271650|FG001|Overall Study|Decline to participate|4
1155495|NCT03213938|2271649|FG000|Overall Study|Without reason|4
1155496|NCT03213938|2271650|FG001|Overall Study|Without reason|5
1155497|NCT03214081|2271656|FG000|Overall Study|Case Report Forms Uncollected|9
1155498|NCT03214081|2271656|FG000|Overall Study|Protocol Deviation|54
1155499|NCT03214094|2271660|FG000|Overall Study|Case Report Forms Uncollected|14
1155500|NCT03214094|2271660|FG000|Overall Study|Protocol Deviation|46
1155501|NCT03214198|2271664|FG000|Overall Study|Case Report Forms Uncollected|18
1155502|NCT03214198|2271664|FG000|Overall Study|Protocol Deviation|18
1155503|NCT03214224|2271668|FG000|Overall Study|Protocol Violation|1
1155504|NCT03214224|2271668|FG000|Overall Study|Withdrawal by Subject|2
1155505|NCT03214224|2271668|FG000|Overall Study|Practice controls or therapists|6
1155506|NCT03214367|2271678|FG000|Lead-in Period|Withdrawal by Subject|50
1155507|NCT03214367|2271679|FG001|Lead-in Period|Withdrawal by Subject|0
1155508|NCT03214367|2271680|FG002|Lead-in Period|Withdrawal by Subject|0
1155509|NCT03214367|2271681|FG003|Lead-in Period|Withdrawal by Subject|0
1155510|NCT03214367|2271682|FG004|Lead-in Period|Withdrawal by Subject|2
1155511|NCT03214367|2271683|FG005|Lead-in Period|Withdrawal by Subject|0
1155512|NCT03214367|2271684|FG006|Lead-in Period|Withdrawal by Subject|0
1155513|NCT03214367|2271685|FG007|Lead-in Period|Withdrawal by Subject|0
1155514|NCT03214367|2271678|FG000|Lead-in Period|Adverse Event|3
1155515|NCT03214367|2271679|FG001|Lead-in Period|Adverse Event|0
1155516|NCT03214367|2271680|FG002|Lead-in Period|Adverse Event|0
1155517|NCT03214367|2271681|FG003|Lead-in Period|Adverse Event|0
1155518|NCT03214367|2271682|FG004|Lead-in Period|Adverse Event|0
1155519|NCT03214367|2271683|FG005|Lead-in Period|Adverse Event|0
1155520|NCT03214367|2271684|FG006|Lead-in Period|Adverse Event|0
1155521|NCT03214367|2271685|FG007|Lead-in Period|Adverse Event|0
1155522|NCT03214367|2271678|FG000|Lead-in Period|Lost to Follow-up|12
1155523|NCT03214367|2271679|FG001|Lead-in Period|Lost to Follow-up|0
1155524|NCT03214367|2271680|FG002|Lead-in Period|Lost to Follow-up|0
1155525|NCT03214367|2271681|FG003|Lead-in Period|Lost to Follow-up|0
1155526|NCT03214367|2271682|FG004|Lead-in Period|Lost to Follow-up|0
1155527|NCT03214367|2271683|FG005|Lead-in Period|Lost to Follow-up|0
1155528|NCT03214367|2271684|FG006|Lead-in Period|Lost to Follow-up|0
1155529|NCT03214367|2271685|FG007|Lead-in Period|Lost to Follow-up|0
1155530|NCT03214367|2271678|FG000|Lead-in Period|Sponsor Decision|11
1155531|NCT03214367|2271679|FG001|Lead-in Period|Sponsor Decision|0
1155532|NCT03214367|2271680|FG002|Lead-in Period|Sponsor Decision|0
1155533|NCT03214367|2271681|FG003|Lead-in Period|Sponsor Decision|0
1155534|NCT03214367|2271682|FG004|Lead-in Period|Sponsor Decision|0
1155535|NCT03214367|2271683|FG005|Lead-in Period|Sponsor Decision|0
1155536|NCT03214367|2271684|FG006|Lead-in Period|Sponsor Decision|0
1155537|NCT03214367|2271685|FG007|Lead-in Period|Sponsor Decision|0
1155538|NCT03214367|2271678|FG000|Lead-in Period|Physician Decision|12
1155539|NCT03214367|2271679|FG001|Lead-in Period|Physician Decision|0
1155540|NCT03214367|2271680|FG002|Lead-in Period|Physician Decision|0
1155541|NCT03214367|2271681|FG003|Lead-in Period|Physician Decision|0
1155542|NCT03214367|2271682|FG004|Lead-in Period|Physician Decision|0
1155543|NCT03214367|2271683|FG005|Lead-in Period|Physician Decision|0
1155544|NCT03214367|2271684|FG006|Lead-in Period|Physician Decision|0
1155545|NCT03214367|2271685|FG007|Lead-in Period|Physician Decision|0
1155546|NCT03214367|2271678|FG000|Lead-in Period|Protocol Violation|5
1155547|NCT03214367|2271679|FG001|Lead-in Period|Protocol Violation|0
1155548|NCT03214367|2271680|FG002|Lead-in Period|Protocol Violation|0
1155549|NCT03214367|2271681|FG003|Lead-in Period|Protocol Violation|0
1155550|NCT03214367|2271682|FG004|Lead-in Period|Protocol Violation|0
1155551|NCT03214367|2271683|FG005|Lead-in Period|Protocol Violation|0
1155552|NCT03214367|2271684|FG006|Lead-in Period|Protocol Violation|0
1155553|NCT03214367|2271685|FG007|Lead-in Period|Protocol Violation|0
1155554|NCT03214367|2271678|FG000|Lead-in Period|Treatment Interruption|1
1155555|NCT03214367|2271679|FG001|Lead-in Period|Treatment Interruption|0
1155556|NCT03214367|2271680|FG002|Lead-in Period|Treatment Interruption|0
1155557|NCT03214367|2271681|FG003|Lead-in Period|Treatment Interruption|0
1155558|NCT03214367|2271682|FG004|Lead-in Period|Treatment Interruption|0
1155559|NCT03214367|2271683|FG005|Lead-in Period|Treatment Interruption|0
1155560|NCT03214367|2271684|FG006|Lead-in Period|Treatment Interruption|0
1155561|NCT03214367|2271685|FG007|Lead-in Period|Treatment Interruption|0
1155562|NCT03214367|2271678|FG000|Treatment Period|Adverse Event|0
1155563|NCT03214367|2271679|FG001|Treatment Period|Adverse Event|1
1155564|NCT03214367|2271680|FG002|Treatment Period|Adverse Event|4
1155565|NCT03214367|2271681|FG003|Treatment Period|Adverse Event|2
1155566|NCT03214367|2271682|FG004|Treatment Period|Adverse Event|0
1155567|NCT03214367|2271683|FG005|Treatment Period|Adverse Event|0
1155568|NCT03214367|2271684|FG006|Treatment Period|Adverse Event|0
1155569|NCT03214367|2271685|FG007|Treatment Period|Adverse Event|0
1155570|NCT03214367|2271678|FG000|Treatment Period|Death|0
1155571|NCT03214367|2271679|FG001|Treatment Period|Death|1
1155572|NCT03214367|2271680|FG002|Treatment Period|Death|1
1155573|NCT03214367|2271681|FG003|Treatment Period|Death|1
1155574|NCT03214367|2271682|FG004|Treatment Period|Death|0
1155575|NCT03214367|2271683|FG005|Treatment Period|Death|0
1155576|NCT03214367|2271684|FG006|Treatment Period|Death|0
1155577|NCT03214367|2271685|FG007|Treatment Period|Death|0
1155578|NCT03214367|2271678|FG000|Treatment Period|Lost to Follow-up|0
1155579|NCT03214367|2271679|FG001|Treatment Period|Lost to Follow-up|5
1155580|NCT03214367|2271680|FG002|Treatment Period|Lost to Follow-up|3
1155581|NCT03214367|2271681|FG003|Treatment Period|Lost to Follow-up|2
1155582|NCT03214367|2271682|FG004|Treatment Period|Lost to Follow-up|0
1155583|NCT03214367|2271683|FG005|Treatment Period|Lost to Follow-up|2
1155584|NCT03214367|2271684|FG006|Treatment Period|Lost to Follow-up|1
1155585|NCT03214367|2271685|FG007|Treatment Period|Lost to Follow-up|0
1155586|NCT03214367|2271678|FG000|Treatment Period|Sponsor Decision|0
1155587|NCT03214367|2271679|FG001|Treatment Period|Sponsor Decision|3
1155588|NCT03214367|2271680|FG002|Treatment Period|Sponsor Decision|0
1155589|NCT03214367|2271681|FG003|Treatment Period|Sponsor Decision|0
1155590|NCT03214367|2271682|FG004|Treatment Period|Sponsor Decision|0
1155591|NCT03214367|2271683|FG005|Treatment Period|Sponsor Decision|0
1155592|NCT03214367|2271684|FG006|Treatment Period|Sponsor Decision|0
1155593|NCT03214367|2271685|FG007|Treatment Period|Sponsor Decision|0
1155594|NCT03214367|2271678|FG000|Treatment Period|Physician Decision|0
1155595|NCT03214367|2271679|FG001|Treatment Period|Physician Decision|1
1155596|NCT03214367|2271680|FG002|Treatment Period|Physician Decision|2
1155597|NCT03214367|2271681|FG003|Treatment Period|Physician Decision|0
1155598|NCT03214367|2271682|FG004|Treatment Period|Physician Decision|0
1155599|NCT03214367|2271683|FG005|Treatment Period|Physician Decision|0
1155600|NCT03214367|2271684|FG006|Treatment Period|Physician Decision|0
1155601|NCT03214367|2271685|FG007|Treatment Period|Physician Decision|0
1155602|NCT03214367|2271678|FG000|Treatment Period|Protocol Violation|0
1155603|NCT03214367|2271679|FG001|Treatment Period|Protocol Violation|3
1155604|NCT03214367|2271680|FG002|Treatment Period|Protocol Violation|0
1155605|NCT03214367|2271681|FG003|Treatment Period|Protocol Violation|0
1155606|NCT03214367|2271682|FG004|Treatment Period|Protocol Violation|0
1155607|NCT03214367|2271683|FG005|Treatment Period|Protocol Violation|0
1155608|NCT03214367|2271684|FG006|Treatment Period|Protocol Violation|0
1155609|NCT03214367|2271685|FG007|Treatment Period|Protocol Violation|0
1155610|NCT03214367|2271678|FG000|Treatment Period|Withdrawal by Subject|0
1155611|NCT03214367|2271679|FG001|Treatment Period|Withdrawal by Subject|20
1155612|NCT03214367|2271680|FG002|Treatment Period|Withdrawal by Subject|23
1155613|NCT03214367|2271681|FG003|Treatment Period|Withdrawal by Subject|14
1155614|NCT03214367|2271682|FG004|Treatment Period|Withdrawal by Subject|0
1155615|NCT03214367|2271683|FG005|Treatment Period|Withdrawal by Subject|1
1155616|NCT03214367|2271684|FG006|Treatment Period|Withdrawal by Subject|1
1155617|NCT03214367|2271685|FG007|Treatment Period|Withdrawal by Subject|1
1155618|NCT03214380|2271703|FG000|Lead-in|Adverse Event|3
1155619|NCT03214380|2271704|FG001|Lead-in|Adverse Event|0
1155620|NCT03214380|2271705|FG002|Lead-in|Adverse Event|0
1155621|NCT03214380|2271706|FG003|Lead-in|Adverse Event|1
1155622|NCT03214380|2271707|FG004|Lead-in|Adverse Event|0
1155623|NCT03214380|2271708|FG005|Lead-in|Adverse Event|0
1155624|NCT03214380|2271703|FG000|Lead-in|Lost to Follow-up|4
1155625|NCT03214380|2271704|FG001|Lead-in|Lost to Follow-up|0
1155626|NCT03214380|2271705|FG002|Lead-in|Lost to Follow-up|0
1155627|NCT03214380|2271706|FG003|Lead-in|Lost to Follow-up|1
1155628|NCT03214380|2271707|FG004|Lead-in|Lost to Follow-up|0
1155629|NCT03214380|2271708|FG005|Lead-in|Lost to Follow-up|0
1155630|NCT03214380|2271703|FG000|Lead-in|Eligibility Criteria|3
1155631|NCT03214380|2271704|FG001|Lead-in|Eligibility Criteria|0
1155632|NCT03214380|2271705|FG002|Lead-in|Eligibility Criteria|0
1155633|NCT03214380|2271706|FG003|Lead-in|Eligibility Criteria|0
1155634|NCT03214380|2271707|FG004|Lead-in|Eligibility Criteria|0
1155635|NCT03214380|2271708|FG005|Lead-in|Eligibility Criteria|0
1155636|NCT03214380|2271703|FG000|Lead-in|Physician Decision|6
1155637|NCT03214380|2271704|FG001|Lead-in|Physician Decision|0
1155638|NCT03214380|2271705|FG002|Lead-in|Physician Decision|0
1155639|NCT03214380|2271706|FG003|Lead-in|Physician Decision|0
1155640|NCT03214380|2271707|FG004|Lead-in|Physician Decision|0
1155641|NCT03214380|2271708|FG005|Lead-in|Physician Decision|0
1155642|NCT03214380|2271703|FG000|Lead-in|Protocol Deviation|7
1155643|NCT03214380|2271704|FG001|Lead-in|Protocol Deviation|0
1155644|NCT03214380|2271705|FG002|Lead-in|Protocol Deviation|0
1155645|NCT03214380|2271706|FG003|Lead-in|Protocol Deviation|3
1155646|NCT03214380|2271707|FG004|Lead-in|Protocol Deviation|0
1155647|NCT03214380|2271708|FG005|Lead-in|Protocol Deviation|0
1155648|NCT03214380|2271703|FG000|Lead-in|Withdrawal by Subject|41
903485|NCT00748553|1877697|FG001|Overall Study|disease progression|0
903486|NCT00748553|1877696|FG000|Overall Study|noncompliance|1
903487|NCT00748553|1877697|FG001|Overall Study|noncompliance|0
903488|NCT00748566|1877702|FG000|Overall Study|Adverse Event|49
903489|NCT00748566|1877702|FG000|Overall Study|Death|1
903490|NCT00748566|1877702|FG000|Overall Study|Lack of Efficacy|12
903491|NCT00748566|1877702|FG000|Overall Study|Lost to Follow-up|1
903492|NCT00748566|1877702|FG000|Overall Study|Protocol Violation|13
903493|NCT00748566|1877702|FG000|Overall Study|Withdrawal by Subject|22
903494|NCT00748566|1877702|FG000|Overall Study|Study terminated by sponsor|5
903495|NCT00748566|1877702|FG000|Overall Study|Other|9
903496|NCT00748709|1877716|FG000|Overall Study|Progressive disease|15
903497|NCT00748709|1877716|FG000|Overall Study|Drug reducing Toxity|2
903498|NCT00748709|1877716|FG000|Overall Study|Other Adverse Event|1
903499|NCT00748709|1877716|FG000|Overall Study|Withdrawal by Subject|1
903500|NCT00748709|1877716|FG000|Overall Study|Other Reasons|1
903501|NCT00748969|1877746|FG000|Overall Study|Withdrawal by Subject|1
903502|NCT00748969|1877747|FG001|Overall Study|Withdrawal by Subject|0
903503|NCT00748969|1877746|FG000|Overall Study|Withdrawal by Subject|0
903504|NCT00748969|1877747|FG001|Overall Study|Withdrawal by Subject|1
903505|NCT00749190|1877783|FG000|Overall Study|Adverse Event|0
903506|NCT00749190|1877784|FG001|Overall Study|Adverse Event|2
903507|NCT00749190|1877785|FG002|Overall Study|Adverse Event|0
903508|NCT00749190|1877786|FG003|Overall Study|Adverse Event|4
903509|NCT00749190|1877787|FG004|Overall Study|Adverse Event|0
903510|NCT00749190|1877788|FG005|Overall Study|Adverse Event|3
903511|NCT00749190|1877789|FG006|Overall Study|Adverse Event|0
903512|NCT00749190|1877783|FG000|Overall Study|Lack of Efficacy|3
903513|NCT00749190|1877784|FG001|Overall Study|Lack of Efficacy|1
903514|NCT00749190|1877785|FG002|Overall Study|Lack of Efficacy|1
903515|NCT00749190|1877786|FG003|Overall Study|Lack of Efficacy|0
903516|NCT00749190|1877787|FG004|Overall Study|Lack of Efficacy|0
903517|NCT00749190|1877788|FG005|Overall Study|Lack of Efficacy|1
903518|NCT00749190|1877789|FG006|Overall Study|Lack of Efficacy|0
903519|NCT00749190|1877783|FG000|Overall Study|Withdrawal by Subject|2
903520|NCT00749190|1877784|FG001|Overall Study|Withdrawal by Subject|1
1155649|NCT03214380|2271704|FG001|Lead-in|Withdrawal by Subject|0
1155650|NCT03214380|2271705|FG002|Lead-in|Withdrawal by Subject|0
1155651|NCT03214380|2271706|FG003|Lead-in|Withdrawal by Subject|14
1155652|NCT03214380|2271707|FG004|Lead-in|Withdrawal by Subject|0
1155653|NCT03214380|2271708|FG005|Lead-in|Withdrawal by Subject|0
1155654|NCT03214380|2271703|FG000|Lead-in|Family Emergency|1
1155655|NCT03214380|2271704|FG001|Lead-in|Family Emergency|0
1155656|NCT03214380|2271705|FG002|Lead-in|Family Emergency|0
1155657|NCT03214380|2271706|FG003|Lead-in|Family Emergency|0
1155658|NCT03214380|2271707|FG004|Lead-in|Family Emergency|0
1155659|NCT03214380|2271708|FG005|Lead-in|Family Emergency|0
1155660|NCT03214380|2271703|FG000|Lead-in|Natural Disaster|9
1155661|NCT03214380|2271704|FG001|Lead-in|Natural Disaster|0
1155662|NCT03214380|2271705|FG002|Lead-in|Natural Disaster|0
1155663|NCT03214380|2271706|FG003|Lead-in|Natural Disaster|0
1155664|NCT03214380|2271707|FG004|Lead-in|Natural Disaster|0
1155665|NCT03214380|2271708|FG005|Lead-in|Natural Disaster|0
1155666|NCT03214380|2271703|FG000|Lead-in|Non Compliance|1
1155667|NCT03214380|2271704|FG001|Lead-in|Non Compliance|0
1155668|NCT03214380|2271705|FG002|Lead-in|Non Compliance|0
1155669|NCT03214380|2271706|FG003|Lead-in|Non Compliance|0
1155670|NCT03214380|2271707|FG004|Lead-in|Non Compliance|0
1155671|NCT03214380|2271708|FG005|Lead-in|Non Compliance|0
1155672|NCT03214380|2271703|FG000|Lead-in|Participant Schedule|2
1155673|NCT03214380|2271704|FG001|Lead-in|Participant Schedule|0
1155674|NCT03214380|2271705|FG002|Lead-in|Participant Schedule|0
1155675|NCT03214380|2271706|FG003|Lead-in|Participant Schedule|0
1155676|NCT03214380|2271707|FG004|Lead-in|Participant Schedule|0
1155677|NCT03214380|2271708|FG005|Lead-in|Participant Schedule|0
1155678|NCT03214380|2271703|FG000|Treatment Period|Adverse Event|0
1155679|NCT03214380|2271704|FG001|Treatment Period|Adverse Event|1
1155680|NCT03214380|2271705|FG002|Treatment Period|Adverse Event|1
1155681|NCT03214380|2271706|FG003|Treatment Period|Adverse Event|0
1155682|NCT03214380|2271707|FG004|Treatment Period|Adverse Event|1
1155683|NCT03214380|2271708|FG005|Treatment Period|Adverse Event|0
1155684|NCT03214380|2271703|FG000|Treatment Period|Non-Compliance with Study Drug|0
1155685|NCT03214380|2271704|FG001|Treatment Period|Non-Compliance with Study Drug|0
1155686|NCT03214380|2271705|FG002|Treatment Period|Non-Compliance with Study Drug|0
1155687|NCT03214380|2271706|FG003|Treatment Period|Non-Compliance with Study Drug|0
1155688|NCT03214380|2271707|FG004|Treatment Period|Non-Compliance with Study Drug|1
1155689|NCT03214380|2271708|FG005|Treatment Period|Non-Compliance with Study Drug|0
1155690|NCT03214380|2271703|FG000|Treatment Period|Withdrawal by Subject|0
1155691|NCT03214380|2271704|FG001|Treatment Period|Withdrawal by Subject|10
1155692|NCT03214380|2271705|FG002|Treatment Period|Withdrawal by Subject|8
1155693|NCT03214380|2271706|FG003|Treatment Period|Withdrawal by Subject|0
1155694|NCT03214380|2271707|FG004|Treatment Period|Withdrawal by Subject|7
903521|NCT00749190|1877785|FG002|Overall Study|Withdrawal by Subject|0
903522|NCT00749190|1877786|FG003|Overall Study|Withdrawal by Subject|0
1155695|NCT03214380|2271708|FG005|Treatment Period|Withdrawal by Subject|11
1155696|NCT03214380|2271703|FG000|Treatment Period|Death|0
1155697|NCT03214380|2271704|FG001|Treatment Period|Death|1
1155698|NCT03214380|2271705|FG002|Treatment Period|Death|2
1155699|NCT03214380|2271706|FG003|Treatment Period|Death|0
1155700|NCT03214380|2271707|FG004|Treatment Period|Death|0
1155701|NCT03214380|2271708|FG005|Treatment Period|Death|0
1155702|NCT03214380|2271703|FG000|Treatment Period|Lost to Follow-up|0
1155703|NCT03214380|2271704|FG001|Treatment Period|Lost to Follow-up|6
1155704|NCT03214380|2271705|FG002|Treatment Period|Lost to Follow-up|3
1155705|NCT03214380|2271706|FG003|Treatment Period|Lost to Follow-up|0
1155706|NCT03214380|2271707|FG004|Treatment Period|Lost to Follow-up|0
1155707|NCT03214380|2271708|FG005|Treatment Period|Lost to Follow-up|0
1155708|NCT03214380|2271703|FG000|Treatment Period|Participant schedule|0
1155709|NCT03214380|2271704|FG001|Treatment Period|Participant schedule|0
1155710|NCT03214380|2271705|FG002|Treatment Period|Participant schedule|1
1155711|NCT03214380|2271706|FG003|Treatment Period|Participant schedule|0
1155712|NCT03214380|2271707|FG004|Treatment Period|Participant schedule|0
1155713|NCT03214380|2271708|FG005|Treatment Period|Participant schedule|0
1155714|NCT03214380|2271703|FG000|Treatment Period|Treatment Interruption|0
1155715|NCT03214380|2271704|FG001|Treatment Period|Treatment Interruption|0
1155716|NCT03214380|2271705|FG002|Treatment Period|Treatment Interruption|1
1155717|NCT03214380|2271706|FG003|Treatment Period|Treatment Interruption|0
1155718|NCT03214380|2271707|FG004|Treatment Period|Treatment Interruption|0
1155719|NCT03214380|2271708|FG005|Treatment Period|Treatment Interruption|0
1155720|NCT03214406|2271722|FG000|Overall Study|did not meet enrollment criteria|9
1155721|NCT03214406|2271723|FG001|Overall Study|did not meet enrollment criteria|13
1155722|NCT03214406|2271722|FG000|Overall Study|Withdrawal by Subject|1
1155723|NCT03214406|2271723|FG001|Overall Study|Withdrawal by Subject|0
1155724|NCT03214406|2271722|FG000|Overall Study|Lost to Follow-up|0
1155725|NCT03214406|2271723|FG001|Overall Study|Lost to Follow-up|2
1155726|NCT03214588|2271732|FG000|Overall Study|Adverse Event|1
1155727|NCT03214588|2271733|FG001|Overall Study|Adverse Event|0
1155728|NCT03214588|2271734|FG002|Overall Study|Adverse Event|2
1155729|NCT03214588|2271732|FG000|Overall Study|Reason Not Specified|0
1155730|NCT03214588|2271733|FG001|Overall Study|Reason Not Specified|1
1155731|NCT03214588|2271734|FG002|Overall Study|Reason Not Specified|0
1155732|NCT03214640|2271746|FG000|Overall Study|Protocol Violation|1
1155733|NCT03214640|2271747|FG001|Overall Study|Protocol Violation|2
1155734|NCT03214640|2271748|FG002|Overall Study|Protocol Violation|1
1155735|NCT03214640|2271749|FG003|Overall Study|Protocol Violation|4
1155736|NCT03214952|2271759|FG000|Overall Study|Protocol Deviation|45
1155737|NCT03214952|2271759|FG000|Overall Study|Case Report Forms Uncollected|13
1155738|NCT03215667|2271763|FG000|Overall Study|Physician Decision|4
1155739|NCT03215706|2271769|FG000|Randomization|Adverse Event unrelated to study drug|1
1155740|NCT03215706|2271770|FG001|Randomization|Adverse Event unrelated to study drug|0
1155741|NCT03215706|2271769|FG000|Randomization|participant withdrew consent|1
1155742|NCT03215706|2271770|FG001|Randomization|participant withdrew consent|3
1155743|NCT03215706|2271769|FG000|Randomization|no longer meets study criteria|1
1155744|NCT03215706|2271770|FG001|Randomization|no longer meets study criteria|4
1155745|NCT03215706|2271769|FG000|Randomization|other reasons|0
1155746|NCT03215706|2271770|FG001|Randomization|other reasons|2
1155747|NCT03215706|2271769|FG000|Treatment Period|Disease Progression|150
1155748|NCT03215706|2271770|FG001|Treatment Period|Disease Progression|142
1155749|NCT03215706|2271769|FG000|Treatment Period|Study Drug Toxicity|53
1155750|NCT03215706|2271770|FG001|Treatment Period|Study Drug Toxicity|21
1155751|NCT03215706|2271769|FG000|Treatment Period|Death|2
1155752|NCT03215706|2271770|FG001|Treatment Period|Death|1
1155753|NCT03215706|2271769|FG000|Treatment Period|Adverse event unrelated to study drug|24
1155754|NCT03215706|2271770|FG001|Treatment Period|Adverse event unrelated to study drug|23
1155755|NCT03215706|2271769|FG000|Treatment Period|Request to D/C treatment|1
1155756|NCT03215706|2271770|FG001|Treatment Period|Request to D/C treatment|6
1155757|NCT03215706|2271769|FG000|Treatment Period|Participant withdrew consent|3
1155758|NCT03215706|2271770|FG001|Treatment Period|Participant withdrew consent|4
1155759|NCT03215706|2271769|FG000|Treatment Period|Lost to Follow-up|0
1155760|NCT03215706|2271770|FG001|Treatment Period|Lost to Follow-up|1
1155761|NCT03215706|2271769|FG000|Treatment Period|Other Reasons|4
1155762|NCT03215706|2271770|FG001|Treatment Period|Other Reasons|5
1155763|NCT03215706|2271769|FG000|Treatment Period|Ongoing in the treatment period|105
1155764|NCT03215706|2271770|FG001|Treatment Period|Ongoing in the treatment period|43
1155765|NCT03215758|2271778|FG000|Overall Study|Technical Problems|1
1155766|NCT03215758|2271779|FG001|Overall Study|Technical Problems|0
1155767|NCT03215758|2271778|FG000|Overall Study|Protocol deviation|0
1155768|NCT03215758|2271779|FG001|Overall Study|Protocol deviation|1
1155769|NCT03215758|2271778|FG000|Overall Study|Physician Decision|0
1155770|NCT03215758|2271779|FG001|Overall Study|Physician Decision|1
1155771|NCT03215758|2271778|FG000|Overall Study|Death|0
1155772|NCT03215758|2271779|FG001|Overall Study|Death|1
1155773|NCT03215758|2271778|FG000|Overall Study|Adverse Event|1
1155774|NCT03215758|2271779|FG001|Overall Study|Adverse Event|2
1155775|NCT03215758|2271778|FG000|Overall Study|Subject/Guardian Decision|3
1155776|NCT03215758|2271779|FG001|Overall Study|Subject/Guardian Decision|3
1155777|NCT03215771|2271785|FG000|Overall Study|Withdrawal by Subject|2
1155778|NCT03215771|2271785|FG000|Overall Study|Physician Decision|1
1155779|NCT03216226|2271809|FG000|Overall Study|Adverse Event|3
1155780|NCT03216226|2271810|FG001|Overall Study|Adverse Event|0
1155781|NCT03216226|2271809|FG000|Overall Study|Protocol Violation|1
1155782|NCT03216226|2271810|FG001|Overall Study|Protocol Violation|3
1155783|NCT03216226|2271809|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1
1155784|NCT03216226|2271810|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0
1155785|NCT03216226|2271809|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0
1155786|NCT03216226|2271810|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1
1155787|NCT03216226|2271809|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0
1155788|NCT03216226|2271810|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1
1155789|NCT03216265|2271819|FG000|Overall Study|Adverse Event|2
1155790|NCT03216265|2271820|FG001|Overall Study|Adverse Event|0
1155791|NCT03216265|2271821|FG002|Overall Study|Adverse Event|2
1155792|NCT03216265|2271819|FG000|Overall Study|Lost to Follow-up|0
1155793|NCT03216265|2271820|FG001|Overall Study|Lost to Follow-up|1
1155794|NCT03216265|2271821|FG002|Overall Study|Lost to Follow-up|0
1155795|NCT03216265|2271819|FG000|Overall Study|Withdrawal by Subject|0
1155796|NCT03216265|2271820|FG001|Overall Study|Withdrawal by Subject|0
1155797|NCT03216265|2271821|FG002|Overall Study|Withdrawal by Subject|1
1162105|NCT03383146|2284115|FG000|Overall Study|Study Terminated by the Sponsor|48
1162106|NCT03383146|2284116|FG001|Overall Study|Study Terminated by the Sponsor|95
1162107|NCT03383146|2284115|FG000|Overall Study|Reason not Specified|4
1162108|NCT03383146|2284116|FG001|Overall Study|Reason not Specified|6
1162109|NCT03383614|2284178|FG000|Overall Study|Withdrawal by Subject|0
1162110|NCT03383614|2284179|FG001|Overall Study|Withdrawal by Subject|1
1162111|NCT03383614|2284180|FG002|Overall Study|Withdrawal by Subject|0
1162112|NCT03383614|2284181|FG003|Overall Study|Withdrawal by Subject|0
1162113|NCT03383692|2284202|FG000|Overall Study|Progressive disease as per RECIST|3
1162114|NCT03383692|2284203|FG001|Overall Study|Progressive disease as per RECIST|3
1162115|NCT03383692|2284202|FG000|Overall Study|Clinical progression|0
1162116|NCT03383692|2284203|FG001|Overall Study|Clinical progression|1
1162117|NCT03383692|2284202|FG000|Overall Study|Adverse Event|3
1162118|NCT03383692|2284203|FG001|Overall Study|Adverse Event|0
1162119|NCT03383783|2284215|FG000|Overall Study|Withdrawal by Subject|2
1162120|NCT03383887|2284231|FG000|Overall Study|Lost to Follow-up|0
1162121|NCT03383887|2284232|FG001|Overall Study|Lost to Follow-up|1
1162122|NCT03384316|2284252|FG000|Overall Study|Screen failure|0
1162123|NCT03384316|2284253|FG001|Overall Study|Screen failure|1
1162124|NCT03384693|2284270|FG000|Overall Study|Adverse Event|3
1162125|NCT03384745|2284280|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
1162126|NCT03384745|2284281|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
1162127|NCT03384745|2284282|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1
1162128|NCT03384745|2284283|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2
1162129|NCT03384745|2284284|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
1162130|NCT03384745|2284285|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
1162131|NCT03384745|2284280|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
1162132|NCT03384745|2284281|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
1162133|NCT03384745|2284282|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
1162134|NCT03384745|2284283|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
1162135|NCT03384745|2284284|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3
1162136|NCT03384745|2284285|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1
1162137|NCT03384745|2284280|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
1162138|NCT03384745|2284281|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
1162139|NCT03384745|2284282|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
1162140|NCT03384745|2284283|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
1162141|NCT03384745|2284284|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
1162142|NCT03384745|2284285|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
1162143|NCT03384745|2284280|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
1162144|NCT03384745|2284281|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
1162145|NCT03384745|2284282|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1
1162146|NCT03384745|2284283|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
1162147|NCT03384745|2284284|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
1162148|NCT03384745|2284285|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
1162149|NCT03384745|2284280|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0
1162150|NCT03384745|2284281|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0
1162151|NCT03384745|2284282|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0
1162152|NCT03384745|2284283|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1
1162153|NCT03384745|2284284|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1
1162154|NCT03384745|2284285|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0
1162155|NCT03384745|2284280|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
1162156|NCT03384745|2284281|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
1162157|NCT03384745|2284282|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
1155798|NCT03216746|2271864|FG000|Overall Study|Lost to Follow-up|6
1155799|NCT03216746|2271865|FG001|Overall Study|Lost to Follow-up|8
1155800|NCT03216746|2271866|FG002|Overall Study|Lost to Follow-up|5
1155801|NCT03216746|2271867|FG003|Overall Study|Lost to Follow-up|6
1155802|NCT03216850|2271877|FG000|Overall Study|Pre-analytical error|6
1155803|NCT03216954|2271914|FG000|Overall Study|Adverse Event|0
1155804|NCT03216954|2271915|FG001|Overall Study|Adverse Event|0
1155805|NCT03216954|2271916|FG002|Overall Study|Adverse Event|1
1155806|NCT03216954|2271917|FG003|Overall Study|Adverse Event|0
1155807|NCT03216954|2271918|FG004|Overall Study|Adverse Event|1
1155808|NCT03216954|2271914|FG000|Overall Study|Withdrawal by Subject|2
1155809|NCT03216954|2271915|FG001|Overall Study|Withdrawal by Subject|0
1155810|NCT03216954|2271916|FG002|Overall Study|Withdrawal by Subject|0
1155811|NCT03216954|2271917|FG003|Overall Study|Withdrawal by Subject|0
1155812|NCT03216954|2271918|FG004|Overall Study|Withdrawal by Subject|0
1155813|NCT03216954|2271914|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
1155814|NCT03216954|2271915|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1
1155815|NCT03216954|2271916|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
1155816|NCT03216954|2271917|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
1155817|NCT03216954|2271918|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
1155818|NCT03217968|2271926|FG000|Overall Study|Withdrawal by Subject|4
1155819|NCT03217968|2271926|FG000|Overall Study|Lost to Follow-up|1
1155820|NCT03217968|2271926|FG000|Overall Study|Protocol Violation|6
1155821|NCT03218397|2271932|FG000|Overall Study|Prior positive blood culture|8
1155822|NCT03218397|2271933|FG001|Overall Study|Prior positive blood culture|13
1155823|NCT03218397|2271932|FG000|Overall Study|Comfort care|8
1155824|NCT03218397|2271933|FG001|Overall Study|Comfort care|5
1155825|NCT03218397|2271932|FG000|Overall Study|Comfort care and positive blood culture|1
1155826|NCT03218397|2271933|FG001|Overall Study|Comfort care and positive blood culture|0
1155827|NCT03218397|2271932|FG000|Overall Study|Comfort care and mixed culture|0
1155828|NCT03218397|2271933|FG001|Overall Study|Comfort care and mixed culture|1
1155829|NCT03218397|2271932|FG000|Overall Study|Mixed culture|2
1155830|NCT03218397|2271933|FG001|Overall Study|Mixed culture|2
1155831|NCT03218397|2271932|FG000|Overall Study|Inaccessible hospital records|2
1155832|NCT03218397|2271933|FG001|Overall Study|Inaccessible hospital records|5
1155833|NCT03218397|2271932|FG000|Overall Study|No gram-negative bacilli (GNB)|0
1155834|NCT03218397|2271933|FG001|Overall Study|No gram-negative bacilli (GNB)|2
1155835|NCT03218397|2271932|FG000|Overall Study|Randomized during laboratory off hours|2
1155836|NCT03218397|2271933|FG001|Overall Study|Randomized during laboratory off hours|1
1155837|NCT03218787|2271961|FG000|Overall Study|Lost to Follow-up|12
1155838|NCT03218787|2271961|FG000|Overall Study|Withdrawal by Subject|72
1155839|NCT03218787|2271961|FG000|Overall Study|Physician Decision|11
1155840|NCT03218787|2271961|FG000|Overall Study|Death|111
1155841|NCT03219216|2271967|FG000|Overall Study|Lost to Follow-up|0
1155842|NCT03219216|2271968|FG001|Overall Study|Lost to Follow-up|1
1155843|NCT03219723|2271999|FG000|Overall Study|Case Report Forms Uncollected|6
1155844|NCT03219723|2271999|FG000|Overall Study|Protocol Deviation|4
1155845|NCT03220217|2272065|FG000|Overall Study|Withdrawal by Subject|0
1155846|NCT03220217|2272066|FG001|Overall Study|Withdrawal by Subject|1
1155847|NCT03220217|2272067|FG002|Overall Study|Withdrawal by Subject|0
1155848|NCT03220217|2272065|FG000|Overall Study|Subject Missed Procedure|0
1155849|NCT03220217|2272066|FG001|Overall Study|Subject Missed Procedure|0
1155850|NCT03220217|2272067|FG002|Overall Study|Subject Missed Procedure|1
1155851|NCT03220581|2272113|FG000|Overall Study|Withdrawal by Subject|0
1155852|NCT03220581|2272114|FG001|Overall Study|Withdrawal by Subject|1
1155853|NCT03220581|2272113|FG000|Overall Study|Lost to Follow-up|3
1155854|NCT03220581|2272114|FG001|Overall Study|Lost to Follow-up|6
1155855|NCT03220737|2272129|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4
1155856|NCT03220737|2272130|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1
1155857|NCT03220737|2272131|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4
1155858|NCT03220737|2272132|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1
1155859|NCT03220737|2272133|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4
1155860|NCT03220737|2272134|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0
1155861|NCT03220737|2272135|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0
1155862|NCT03220737|2272129|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2
1155863|NCT03220737|2272130|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1
1155864|NCT03220737|2272131|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6
1155865|NCT03220737|2272132|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1
1155866|NCT03220737|2272133|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13
1155867|NCT03220737|2272134|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1
1155868|NCT03220737|2272135|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0
1155869|NCT03220737|2272129|FG000|Main Study (Day 1 - 181)|Protocol Violation|0
1155870|NCT03220737|2272130|FG001|Main Study (Day 1 - 181)|Protocol Violation|0
1155871|NCT03220737|2272131|FG002|Main Study (Day 1 - 181)|Protocol Violation|1
1155872|NCT03220737|2272132|FG003|Main Study (Day 1 - 181)|Protocol Violation|1
1155873|NCT03220737|2272133|FG004|Main Study (Day 1 - 181)|Protocol Violation|3
1155874|NCT03220737|2272134|FG005|Main Study (Day 1 - 181)|Protocol Violation|0
1155875|NCT03220737|2272135|FG006|Main Study (Day 1 - 181)|Protocol Violation|1
1155876|NCT03220737|2272129|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
1155877|NCT03220737|2272130|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
1155878|NCT03220737|2272131|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1
1155879|NCT03220737|2272132|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
1155880|NCT03220737|2272133|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
1155881|NCT03220737|2272134|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
1155882|NCT03220737|2272135|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
1155883|NCT03220737|2272129|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
1155884|NCT03220737|2272130|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
1155885|NCT03220737|2272131|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
1155886|NCT03220737|2272132|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
1155887|NCT03220737|2272133|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2
1155888|NCT03220737|2272134|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
1155889|NCT03220737|2272135|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
1155890|NCT03220737|2272129|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1
1155891|NCT03220737|2272130|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
1155892|NCT03220737|2272131|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
1155893|NCT03220737|2272132|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
1155894|NCT03220737|2272133|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
1155895|NCT03220737|2272134|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
1155896|NCT03220737|2272135|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
1155897|NCT03220737|2272129|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9
1155898|NCT03220737|2272130|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
1155899|NCT03220737|2272131|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
1155900|NCT03220737|2272132|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
1155901|NCT03220737|2272133|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
1155902|NCT03220737|2272134|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
1155903|NCT03220737|2272135|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
1155904|NCT03220737|2272129|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1
1155905|NCT03220737|2272130|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
1155906|NCT03220737|2272131|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
1155907|NCT03220737|2272132|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
1155908|NCT03220737|2272133|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
1155909|NCT03220737|2272134|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
1155910|NCT03220737|2272135|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
1155911|NCT03221387|2272186|FG000|Overall Study|Lost to Follow-up|1
1155912|NCT03221387|2272186|FG000|Overall Study|Lung transplant|1
1155913|NCT03222141|2272222|FG000|Overall Study|Death|15
1155914|NCT03222141|2272222|FG000|Overall Study|Lost to Follow-up|3
1155915|NCT03222349|2272227|FG000|Overall Study|Treatment B not done|5
1155916|NCT03222349|2272228|FG001|Overall Study|Treatment B not done|0
1155917|NCT03222349|2272227|FG000|Overall Study|Lost to Follow-up|1
1155918|NCT03222349|2272228|FG001|Overall Study|Lost to Follow-up|2
1155919|NCT03222349|2272227|FG000|Overall Study|Withdrawal by Subject|1
1155920|NCT03222349|2272228|FG001|Overall Study|Withdrawal by Subject|0
1155921|NCT03222349|2272227|FG000|Overall Study|Treatment A not done|0
1155922|NCT03222349|2272228|FG001|Overall Study|Treatment A not done|5
1155923|NCT03222349|2272227|FG000|Overall Study|Study terminated by sponsor|1
1155924|NCT03222349|2272228|FG001|Overall Study|Study terminated by sponsor|0
1155925|NCT03222583|2272267|FG000|Overall Study|Withdrawal by Subject|3
1155926|NCT03222583|2272268|FG001|Overall Study|Withdrawal by Subject|3
1155927|NCT03222583|2272267|FG000|Overall Study|Lost to Follow-up|1
1155928|NCT03222583|2272268|FG001|Overall Study|Lost to Follow-up|0
1155929|NCT03222583|2272267|FG000|Overall Study|Other|1
1155930|NCT03222583|2272268|FG001|Overall Study|Other|3
1155931|NCT03223909|2272316|FG000|Overall Study|Protocol Violation|48
1155932|NCT03223909|2272317|FG001|Overall Study|Protocol Violation|45
1155933|NCT03223909|2272318|FG002|Overall Study|Protocol Violation|16
1155934|NCT03224130|2272328|FG000|Overall Study|consent issue|0
1155935|NCT03224130|2272329|FG001|Overall Study|consent issue|1
1155936|NCT03224182|2272337|FG000|Overall Study|Study Drug Not Instilled|6
1155937|NCT03224182|2272338|FG001|Overall Study|Study Drug Not Instilled|1
1155938|NCT03224182|2272337|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22
1155939|NCT03224182|2272338|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11
1155940|NCT03224182|2272337|FG000|Overall Study|Withdrew of Consent|4
1155941|NCT03224182|2272338|FG001|Overall Study|Withdrew of Consent|2
1155942|NCT03224182|2272337|FG000|Overall Study|Investigator Decision|3
1155943|NCT03224182|2272338|FG001|Overall Study|Investigator Decision|1
1155944|NCT03224182|2272337|FG000|Overall Study|Sponsor Decision|26
1155945|NCT03224182|2272338|FG001|Overall Study|Sponsor Decision|12
1155946|NCT03224182|2272337|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4
1155947|NCT03224182|2272338|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0
1155948|NCT03224182|2272337|FG000|Overall Study|Lost to Follow-up|1
1155949|NCT03224182|2272338|FG001|Overall Study|Lost to Follow-up|0
1155950|NCT03224182|2272337|FG000|Overall Study|Participant Had Recurrence|11
1155951|NCT03224182|2272338|FG001|Overall Study|Participant Had Recurrence|5
1155952|NCT03224182|2272337|FG000|Overall Study|Death|0
1155953|NCT03224182|2272338|FG001|Overall Study|Death|1
1155954|NCT03224182|2272337|FG000|Overall Study|Reason not Specified|3
1155955|NCT03224182|2272338|FG001|Overall Study|Reason not Specified|3
1155956|NCT03224182|2272337|FG000|Overall Study|Other|1
1155957|NCT03224182|2272338|FG001|Overall Study|Other|0
1155958|NCT03224234|2272348|FG000|Main Study|Lost to Follow-up|5
1155959|NCT03224234|2272349|FG001|Main Study|Lost to Follow-up|5
1155960|NCT03224325|2272383|FG000|Overall Study|Adverse Event|1
1155961|NCT03224325|2272384|FG001|Overall Study|Adverse Event|0
1155962|NCT03224325|2272385|FG002|Overall Study|Adverse Event|0
1155963|NCT03224325|2272386|FG003|Overall Study|Adverse Event|0
1155964|NCT03224325|2272387|FG004|Overall Study|Adverse Event|0
1155965|NCT03224325|2272388|FG005|Overall Study|Adverse Event|0
1155966|NCT03224325|2272389|FG006|Overall Study|Adverse Event|1
1155967|NCT03224325|2272383|FG000|Overall Study|Withdrawal by Subject|0
1155968|NCT03224325|2272384|FG001|Overall Study|Withdrawal by Subject|0
1155969|NCT03224325|2272385|FG002|Overall Study|Withdrawal by Subject|0
1155970|NCT03224325|2272386|FG003|Overall Study|Withdrawal by Subject|1
1155971|NCT03224325|2272387|FG004|Overall Study|Withdrawal by Subject|0
1155972|NCT03224325|2272388|FG005|Overall Study|Withdrawal by Subject|0
1155973|NCT03224325|2272389|FG006|Overall Study|Withdrawal by Subject|0
1155974|NCT03224598|2272508|FG000|Overall Study|Lost to Follow-up|0
1155975|NCT03224598|2272509|FG001|Overall Study|Lost to Follow-up|2
1155976|NCT03224598|2272510|FG002|Overall Study|Lost to Follow-up|0
1155977|NCT03224598|2272508|FG000|Overall Study|Other|0
1155978|NCT03224598|2272509|FG001|Overall Study|Other|1
1155979|NCT03224598|2272510|FG002|Overall Study|Other|0
1155980|NCT03226249|2272558|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1
1155981|NCT03226249|2272558|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29
1155982|NCT03226249|2272558|FG000|Survival Follow-up|Patients still in follow-up.|30
1155983|NCT03226275|2272566|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
1155984|NCT03226275|2272567|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
1155985|NCT03226275|2272568|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
1155986|NCT03226275|2272569|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
1155987|NCT03226275|2272566|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0
1155988|NCT03226275|2272567|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0
1155989|NCT03226275|2272568|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0
1155990|NCT03226275|2272569|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1
1155991|NCT03226353|2272579|FG000|Overall Study|Withdrawal by Subject|1
1155992|NCT03226353|2272579|FG000|Overall Study|Screen Failure|5
1155993|NCT03226392|2272605|FG000|Overall Study|Protocol Deviation|1
1155994|NCT03226392|2272606|FG001|Overall Study|Protocol Deviation|0
1155995|NCT03226392|2272605|FG000|Overall Study|Physician Decision|1
1155996|NCT03226392|2272606|FG001|Overall Study|Physician Decision|0
1155997|NCT03226392|2272605|FG000|Overall Study|Lost to Follow-up|1
1155998|NCT03226392|2272606|FG001|Overall Study|Lost to Follow-up|0
1155999|NCT03226392|2272605|FG000|Overall Study|Adverse Event|1
1156000|NCT03226392|2272606|FG001|Overall Study|Adverse Event|0
1156001|NCT03226392|2272605|FG000|Overall Study|Technical Problems|0
1156002|NCT03226392|2272606|FG001|Overall Study|Technical Problems|2
1156003|NCT03226392|2272605|FG000|Overall Study|Subject/Guardian Decision|7
1156004|NCT03226392|2272606|FG001|Overall Study|Subject/Guardian Decision|6
1156005|NCT03226769|2272629|FG000|Overall Study|Withdrawal by Subject|0
1156006|NCT03226769|2272630|FG001|Overall Study|Withdrawal by Subject|1
1156022|NCT03227445|2272658|FG000|Period 1 (28 Days)|Adverse Event|1
1156023|NCT03227445|2272659|FG001|Period 1 (28 Days)|Adverse Event|2
1156024|NCT03227445|2272660|FG002|Period 1 (28 Days)|Adverse Event|0
1156025|NCT03227445|2272661|FG003|Period 1 (28 Days)|Adverse Event|1
1156026|NCT03227445|2272658|FG000|Period 1 (28 Days)|Protocol Violation|1
1156027|NCT03227445|2272659|FG001|Period 1 (28 Days)|Protocol Violation|0
1156028|NCT03227445|2272660|FG002|Period 1 (28 Days)|Protocol Violation|0
1156029|NCT03227445|2272661|FG003|Period 1 (28 Days)|Protocol Violation|0
1156030|NCT03227445|2272658|FG000|Period 1 (28 Days)|Withdrawal by Subject|0
1156031|NCT03227445|2272659|FG001|Period 1 (28 Days)|Withdrawal by Subject|0
1156032|NCT03227445|2272660|FG002|Period 1 (28 Days)|Withdrawal by Subject|1
1156033|NCT03227445|2272661|FG003|Period 1 (28 Days)|Withdrawal by Subject|1
1156034|NCT03227445|2272658|FG000|Period 2 (28 Days)|Adverse Event|1
1156035|NCT03227445|2272659|FG001|Period 2 (28 Days)|Adverse Event|0
1156036|NCT03227445|2272660|FG002|Period 2 (28 Days)|Adverse Event|2
1156037|NCT03227445|2272661|FG003|Period 2 (28 Days)|Adverse Event|1
1156038|NCT03227445|2272658|FG000|Period 2 (28 Days)|Protocol Violation|0
1156039|NCT03227445|2272659|FG001|Period 2 (28 Days)|Protocol Violation|0
1156040|NCT03227445|2272660|FG002|Period 2 (28 Days)|Protocol Violation|0
1156041|NCT03227445|2272661|FG003|Period 2 (28 Days)|Protocol Violation|1
1156042|NCT03227445|2272658|FG000|Period 2 (28 Days)|Withdrawal by Subject|0
1156043|NCT03227445|2272659|FG001|Period 2 (28 Days)|Withdrawal by Subject|1
1156044|NCT03227445|2272660|FG002|Period 2 (28 Days)|Withdrawal by Subject|0
1156045|NCT03227445|2272661|FG003|Period 2 (28 Days)|Withdrawal by Subject|1
1156046|NCT03227692|2272672|FG000|Overall Study|Protocol Violation|1
1156047|NCT03227692|2272673|FG001|Overall Study|Protocol Violation|1
1156048|NCT03227692|2272672|FG000|Overall Study|Lost to Follow-up|4
1156049|NCT03227692|2272673|FG001|Overall Study|Lost to Follow-up|2
1156050|NCT03227692|2272672|FG000|Overall Study|Adverse Event|0
1156051|NCT03227692|2272673|FG001|Overall Study|Adverse Event|2
1156055|NCT03227861|2272683|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4
1156056|NCT03227861|2272683|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1
1156057|NCT03227861|2272683|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1
1156058|NCT03227861|2272683|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1
1156059|NCT03227861|2272683|FG000|Main Study Period (Week 0 to Week 48)|Other|5
1156060|NCT03227861|2272683|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55
1156061|NCT03227861|2272683|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16
1156062|NCT03227861|2272683|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6
1156063|NCT03227861|2272683|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1
1156064|NCT03227861|2272683|FG000|Extension Period (Week 48 to Week 96)|Other|2
1156065|NCT03228212|2272698|FG000|Period 1|Adverse Event|1
1156066|NCT03228212|2272699|FG001|Period 1|Adverse Event|0
1156067|NCT03228212|2272698|FG000|Period 1|no longer meets eligibility criteria|0
1156068|NCT03228212|2272699|FG001|Period 1|no longer meets eligibility criteria|1
1156069|NCT03228212|2272698|FG000|Period 2|Lost to Follow-up|1
1156070|NCT03228212|2272699|FG001|Period 2|Lost to Follow-up|0
1156071|NCT03228420|2272707|FG000|Overall Study|Lost to Follow-up|5
1156072|NCT03228420|2272708|FG001|Overall Study|Lost to Follow-up|3
1156073|NCT03228420|2272707|FG000|Overall Study|Withdrawal by Subject|10
1156074|NCT03228420|2272708|FG001|Overall Study|Withdrawal by Subject|0
1156075|NCT03228420|2272707|FG000|Overall Study|Adverse Event|5
1156076|NCT03228420|2272708|FG001|Overall Study|Adverse Event|2
1156077|NCT03228433|2272720|FG000|Overall Study|Lost to Follow-up|1
1156078|NCT03228433|2272721|FG001|Overall Study|Lost to Follow-up|0
1156079|NCT03228433|2272722|FG002|Overall Study|Lost to Follow-up|0
1156080|NCT03228433|2272723|FG003|Overall Study|Lost to Follow-up|0
1156081|NCT03228433|2272724|FG004|Overall Study|Lost to Follow-up|0
1156082|NCT03228433|2272725|FG005|Overall Study|Lost to Follow-up|0
1156083|NCT03228433|2272720|FG000|Overall Study|Positive alcohol test|0
1156084|NCT03228433|2272721|FG001|Overall Study|Positive alcohol test|0
1156085|NCT03228433|2272722|FG002|Overall Study|Positive alcohol test|0
1156086|NCT03228433|2272723|FG003|Overall Study|Positive alcohol test|1
1156087|NCT03228433|2272724|FG004|Overall Study|Positive alcohol test|0
1156088|NCT03228433|2272725|FG005|Overall Study|Positive alcohol test|0
1156097|NCT03228836|2272757|FG000|Overall Study|Adverse Event|3
1156098|NCT03228836|2272757|FG000|Overall Study|Withdrawal by Subject|1
1156099|NCT03228836|2272757|FG000|Overall Study|Death|1
1156100|NCT03228836|2272757|FG000|Overall Study|Physician Decision|1
1156101|NCT03228836|2272757|FG000|Overall Study|Disease Progression|7
1156102|NCT03228836|2272757|FG000|Overall Study|Other|4
1156103|NCT03229109|2272772|FG000|Overall Study|Withdrawal by Subject|0
1156104|NCT03229109|2272773|FG001|Overall Study|Withdrawal by Subject|0
1156105|NCT03229109|2272774|FG002|Overall Study|Withdrawal by Subject|0
1156106|NCT03229109|2272775|FG003|Overall Study|Withdrawal by Subject|1
1156107|NCT03229486|2272800|FG000|Overall Study|Protocol Violation|0
1156108|NCT03229486|2272801|FG001|Overall Study|Protocol Violation|1
1156109|NCT03229759|2272807|FG000|Overall Study|Screen Failure|30
1156110|NCT03230864|2272820|FG000|Prospective Confirmation (PC) Period|Adverse Event|3
1156111|NCT03230864|2272821|FG001|Prospective Confirmation (PC) Period|Adverse Event|0
1156112|NCT03230864|2272822|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
1156113|NCT03230864|2272823|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
1156114|NCT03230864|2272820|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1156115|NCT03230864|2272821|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2
1156116|NCT03230864|2272822|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1156117|NCT03230864|2272823|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1156118|NCT03230864|2272820|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1
1156119|NCT03230864|2272821|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2
1156120|NCT03230864|2272822|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
1156121|NCT03230864|2272823|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
1156122|NCT03230864|2272820|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
1156123|NCT03230864|2272821|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
1156124|NCT03230864|2272822|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
1156125|NCT03230864|2272823|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
1156126|NCT03230864|2272820|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
1156127|NCT03230864|2272821|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
1156128|NCT03230864|2272822|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
1156129|NCT03230864|2272823|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
1156130|NCT03230864|2272820|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9
1156131|NCT03230864|2272821|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9
1156132|NCT03230864|2272822|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0
1156133|NCT03230864|2272823|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0
1156134|NCT03230864|2272820|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1
1156135|NCT03230864|2272821|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0
1156136|NCT03230864|2272822|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0
1156137|NCT03230864|2272823|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0
1156138|NCT03230864|2272820|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0
1156139|NCT03230864|2272821|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0
1156140|NCT03230864|2272822|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5
1156141|NCT03230864|2272823|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1
1156142|NCT03230864|2272820|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
1156143|NCT03230864|2272821|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
1156144|NCT03230864|2272822|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
1156145|NCT03230864|2272823|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
1156146|NCT03230864|2272820|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0
1156147|NCT03230864|2272821|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0
1156148|NCT03230864|2272822|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2
1156149|NCT03230864|2272823|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0
1156150|NCT03231228|2272835|FG000|Overall Study|Lost to Follow-up|2
1156151|NCT03231228|2272836|FG001|Overall Study|Lost to Follow-up|0
1156152|NCT03231228|2272835|FG000|Overall Study|Physician Decision|1
1156153|NCT03231228|2272836|FG001|Overall Study|Physician Decision|0
1156154|NCT03231371|2272846|FG000|Overall Study|Withdrawal by Subject|1
1156155|NCT03231371|2272846|FG000|Overall Study|chose or were ineligible to have MRI|12
1156156|NCT03231709|2272852|FG000|Treatment Period 1|Reason not Specified|0
1156157|NCT03231709|2272853|FG001|Treatment Period 1|Reason not Specified|1
1156158|NCT03231709|2272852|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0
1156159|NCT03231709|2272853|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1
1156160|NCT03231800|2272865|FG000|Overall Study|Lost to Follow-up|0
1156161|NCT03231800|2272866|FG001|Overall Study|Lost to Follow-up|2
1156162|NCT03231800|2272865|FG000|Overall Study|Protocol Violation|1
1156163|NCT03231800|2272866|FG001|Overall Study|Protocol Violation|1
1156164|NCT03231800|2272865|FG000|Overall Study|reason not provided|2
1156165|NCT03231800|2272866|FG001|Overall Study|reason not provided|0
1156166|NCT03231943|2272888|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1156167|NCT03231943|2272889|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1
1156168|NCT03231943|2272890|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1
1156169|NCT03231943|2272891|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1156170|NCT03231943|2272892|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1156171|NCT03231943|2272893|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1156172|NCT03231943|2272894|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1156173|NCT03231943|2272895|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1156174|NCT03231943|2272896|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1156175|NCT03231943|2272897|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1156176|NCT03231943|2272898|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1156177|NCT03231943|2272899|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1156178|NCT03231943|2272900|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1156179|NCT03231943|2272888|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156180|NCT03231943|2272889|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
1156181|NCT03231943|2272890|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156182|NCT03231943|2272891|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156183|NCT03231943|2272892|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156184|NCT03231943|2272893|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156185|NCT03231943|2272894|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156186|NCT03231943|2272895|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156187|NCT03231943|2272896|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156188|NCT03231943|2272897|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156189|NCT03231943|2272898|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156190|NCT03231943|2272899|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156191|NCT03231943|2272900|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1156192|NCT03231943|2272888|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1
1156193|NCT03231943|2272889|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156194|NCT03231943|2272890|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156195|NCT03231943|2272891|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156196|NCT03231943|2272892|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156197|NCT03231943|2272893|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156198|NCT03231943|2272894|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156199|NCT03231943|2272895|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156200|NCT03231943|2272896|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156201|NCT03231943|2272897|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156202|NCT03231943|2272898|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156203|NCT03231943|2272899|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156204|NCT03231943|2272900|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1156205|NCT03231943|2272888|FG000|Part 2|Adverse Event|0
1156206|NCT03231943|2272889|FG001|Part 2|Adverse Event|0
1156207|NCT03231943|2272890|FG002|Part 2|Adverse Event|0
1156208|NCT03231943|2272891|FG003|Part 2|Adverse Event|0
1156209|NCT03231943|2272892|FG004|Part 2|Adverse Event|0
1156210|NCT03231943|2272893|FG005|Part 2|Adverse Event|0
1156211|NCT03231943|2272894|FG006|Part 2|Adverse Event|0
1156212|NCT03231943|2272895|FG007|Part 2|Adverse Event|0
1156213|NCT03231943|2272896|FG008|Part 2|Adverse Event|0
1156214|NCT03231943|2272897|FG009|Part 2|Adverse Event|0
1156215|NCT03231943|2272898|FG010|Part 2|Adverse Event|1
1156216|NCT03231943|2272899|FG011|Part 2|Adverse Event|0
1156217|NCT03231943|2272900|FG012|Part 2|Adverse Event|0
1156218|NCT03231943|2272888|FG000|Part 2|Withdrawal by Subject|0
1156219|NCT03231943|2272889|FG001|Part 2|Withdrawal by Subject|0
1156220|NCT03231943|2272890|FG002|Part 2|Withdrawal by Subject|0
1156221|NCT03231943|2272891|FG003|Part 2|Withdrawal by Subject|0
1156222|NCT03231943|2272892|FG004|Part 2|Withdrawal by Subject|0
1156223|NCT03231943|2272893|FG005|Part 2|Withdrawal by Subject|0
1156224|NCT03231943|2272894|FG006|Part 2|Withdrawal by Subject|0
1156225|NCT03231943|2272895|FG007|Part 2|Withdrawal by Subject|0
1156226|NCT03231943|2272896|FG008|Part 2|Withdrawal by Subject|0
1156227|NCT03231943|2272897|FG009|Part 2|Withdrawal by Subject|0
1156228|NCT03231943|2272898|FG010|Part 2|Withdrawal by Subject|0
1156229|NCT03231943|2272899|FG011|Part 2|Withdrawal by Subject|1
1156230|NCT03231943|2272900|FG012|Part 2|Withdrawal by Subject|0
1156231|NCT03232281|2272949|FG000|Overall Study|Adverse Event|1
1156232|NCT03232281|2272950|FG001|Overall Study|Adverse Event|1
1156233|NCT03232281|2272949|FG000|Overall Study|Withdrawal by Subject|5
1156234|NCT03232281|2272950|FG001|Overall Study|Withdrawal by Subject|4
1156235|NCT03232281|2272949|FG000|Overall Study|Protocol Deviation|1
1156236|NCT03232281|2272950|FG001|Overall Study|Protocol Deviation|1
1156237|NCT03232333|2272956|FG000|Overall Study|Infection or Osteomyelitis|9
1156238|NCT03232333|2272956|FG000|Overall Study|Lost to Follow-up|4
1156239|NCT03232333|2272956|FG000|Overall Study|Withdrawal by Subject|2
1156240|NCT03232567|2272964|FG000|Overall Study|Withdrawal by Subject|0
1156241|NCT03232567|2272965|FG001|Overall Study|Withdrawal by Subject|1
1156242|NCT03232567|2272966|FG002|Overall Study|Withdrawal by Subject|0
1156243|NCT03232567|2272967|FG003|Overall Study|Withdrawal by Subject|0
1156244|NCT03232983|2273011|FG000|Period 1|Physician Decision|0
1156245|NCT03232983|2273012|FG001|Period 1|Physician Decision|0
1156246|NCT03232983|2273013|FG002|Period 1|Physician Decision|1
1156247|NCT03232983|2273014|FG003|Period 1|Physician Decision|0
1156248|NCT03232983|2273011|FG000|Washout Period 2|Physician Decision|0
1156249|NCT03232983|2273012|FG001|Washout Period 2|Physician Decision|0
1156250|NCT03232983|2273013|FG002|Washout Period 2|Physician Decision|1
1156251|NCT03232983|2273014|FG003|Washout Period 2|Physician Decision|0
1156252|NCT03232983|2273011|FG000|Washout Period 2|Withdrawal by Subject|0
1156253|NCT03232983|2273012|FG001|Washout Period 2|Withdrawal by Subject|0
1156254|NCT03232983|2273013|FG002|Washout Period 2|Withdrawal by Subject|0
1156255|NCT03232983|2273014|FG003|Washout Period 2|Withdrawal by Subject|1
1156256|NCT03232983|2273011|FG000|Period 4|Withdrawal by Subject|1
1156257|NCT03232983|2273012|FG001|Period 4|Withdrawal by Subject|0
1156258|NCT03232983|2273013|FG002|Period 4|Withdrawal by Subject|0
1156259|NCT03232983|2273014|FG003|Period 4|Withdrawal by Subject|0
1156260|NCT03233009|2273026|FG000|Overall Study|Lost to Follow-up|1
1156261|NCT03233230|2273064|FG000|Overall Study|Adverse Event|6
1156262|NCT03233230|2273065|FG001|Overall Study|Adverse Event|3
1156263|NCT03233230|2273066|FG002|Overall Study|Adverse Event|6
1156264|NCT03233230|2273067|FG003|Overall Study|Adverse Event|3
1156265|NCT03233230|2273064|FG000|Overall Study|Protocol Violation|1
1156266|NCT03233230|2273065|FG001|Overall Study|Protocol Violation|2
1156267|NCT03233230|2273066|FG002|Overall Study|Protocol Violation|1
1156268|NCT03233230|2273067|FG003|Overall Study|Protocol Violation|1
1156269|NCT03233230|2273064|FG000|Overall Study|Lack of Efficacy|1
1156270|NCT03233230|2273065|FG001|Overall Study|Lack of Efficacy|0
1156271|NCT03233230|2273066|FG002|Overall Study|Lack of Efficacy|0
1156272|NCT03233230|2273067|FG003|Overall Study|Lack of Efficacy|0
1156273|NCT03233230|2273064|FG000|Overall Study|Other|5
1156274|NCT03233230|2273065|FG001|Overall Study|Other|5
1156275|NCT03233230|2273066|FG002|Overall Study|Other|5
1156276|NCT03233230|2273067|FG003|Overall Study|Other|3
1156277|NCT03233230|2273064|FG000|Overall Study|Withdrawal by Subject|2
1156278|NCT03233230|2273065|FG001|Overall Study|Withdrawal by Subject|2
1156279|NCT03233230|2273066|FG002|Overall Study|Withdrawal by Subject|0
1156280|NCT03233230|2273067|FG003|Overall Study|Withdrawal by Subject|1
1156281|NCT03233230|2273064|FG000|Overall Study|Lost to Follow-up|0
1156282|NCT03233230|2273065|FG001|Overall Study|Lost to Follow-up|3
1156283|NCT03233230|2273066|FG002|Overall Study|Lost to Follow-up|0
1156284|NCT03233230|2273067|FG003|Overall Study|Lost to Follow-up|0
1156285|NCT03233308|2273077|FG000|Overall Study|Adverse Event|1
1156286|NCT03233308|2273077|FG000|Overall Study|Protocol Violation|1
1156287|NCT03233438|2273090|FG000|Overall Study|Lost to Follow-up|4
1156288|NCT03233438|2273091|FG001|Overall Study|Lost to Follow-up|9
1156289|NCT03233438|2273090|FG000|Overall Study|Withdrawal by Subject|2
1156290|NCT03233438|2273091|FG001|Overall Study|Withdrawal by Subject|1
1156291|NCT03233438|2273090|FG000|Overall Study|No recording of dalbavancin|0
1156292|NCT03233438|2273091|FG001|Overall Study|No recording of dalbavancin|1
1156293|NCT03233529|2273097|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
1156294|NCT03233529|2273097|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
1156295|NCT03234036|2273130|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
1156296|NCT03234036|2273131|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
1156297|NCT03234036|2273132|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
1156298|NCT03234036|2273133|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
1156299|NCT03234465|2273160|FG000|Overall Study|Adverse Event|4
1156300|NCT03234465|2273161|FG001|Overall Study|Adverse Event|2
1156301|NCT03234465|2273160|FG000|Overall Study|Death|0
1156302|NCT03234465|2273161|FG001|Overall Study|Death|1
1156303|NCT03234465|2273160|FG000|Overall Study|Lost to Follow-up|1
1156304|NCT03234465|2273161|FG001|Overall Study|Lost to Follow-up|1
1156305|NCT03234465|2273160|FG000|Overall Study|Withdrawal by Subject|12
1156306|NCT03234465|2273161|FG001|Overall Study|Withdrawal by Subject|27
1156307|NCT03234465|2273160|FG000|Overall Study|Symptomatic deterioration|0
1156308|NCT03234465|2273161|FG001|Overall Study|Symptomatic deterioration|1
1156309|NCT03234465|2273160|FG000|Overall Study|Non-compliance|2
1156310|NCT03234465|2273161|FG001|Overall Study|Non-compliance|0
1156311|NCT03234465|2273160|FG000|Overall Study|Other|14
1156312|NCT03234465|2273161|FG001|Overall Study|Other|8
1156313|NCT03234608|2273169|FG000|Overall Study|Lost to Follow-up|23
1156314|NCT03234608|2273170|FG001|Overall Study|Lost to Follow-up|21
1156315|NCT03235050|2273181|FG000|Overall Study|Adverse Event|0
1156316|NCT03235050|2273182|FG001|Overall Study|Adverse Event|0
1156317|NCT03235050|2273183|FG002|Overall Study|Adverse Event|1
1156318|NCT03235050|2273184|FG003|Overall Study|Adverse Event|4
1156319|NCT03235050|2273185|FG004|Overall Study|Adverse Event|1
1156320|NCT03235050|2273181|FG000|Overall Study|Death|0
1156321|NCT03235050|2273182|FG001|Overall Study|Death|0
1156322|NCT03235050|2273183|FG002|Overall Study|Death|0
1156323|NCT03235050|2273184|FG003|Overall Study|Death|2
1156324|NCT03235050|2273185|FG004|Overall Study|Death|1
1156325|NCT03235050|2273181|FG000|Overall Study|Lost to Follow-up|1
1156326|NCT03235050|2273182|FG001|Overall Study|Lost to Follow-up|2
1156327|NCT03235050|2273183|FG002|Overall Study|Lost to Follow-up|1
1156328|NCT03235050|2273184|FG003|Overall Study|Lost to Follow-up|2
1156329|NCT03235050|2273185|FG004|Overall Study|Lost to Follow-up|0
1156330|NCT03235050|2273181|FG000|Overall Study|Withdrawal by Subject|3
1156331|NCT03235050|2273182|FG001|Overall Study|Withdrawal by Subject|2
1156332|NCT03235050|2273183|FG002|Overall Study|Withdrawal by Subject|2
1156333|NCT03235050|2273184|FG003|Overall Study|Withdrawal by Subject|5
1156334|NCT03235050|2273185|FG004|Overall Study|Withdrawal by Subject|7
1156335|NCT03235050|2273181|FG000|Overall Study|Other reasons|0
1156336|NCT03235050|2273182|FG001|Overall Study|Other reasons|1
1156337|NCT03235050|2273183|FG002|Overall Study|Other reasons|0
1156338|NCT03235050|2273184|FG003|Overall Study|Other reasons|1
1156339|NCT03235050|2273185|FG004|Overall Study|Other reasons|2
1156340|NCT03235089|2273197|FG000|Overall Study|Lost to Follow-up|1
1156341|NCT03235089|2273198|FG001|Overall Study|Lost to Follow-up|1
1156342|NCT03235089|2273197|FG000|Overall Study|Physician Decision|2
1156343|NCT03235089|2273198|FG001|Overall Study|Physician Decision|2
1156344|NCT03235115|2273205|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1156345|NCT03235115|2273206|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1156346|NCT03235115|2273207|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1156347|NCT03235115|2273208|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1156348|NCT03235115|2273209|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1156349|NCT03235115|2273210|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
1156350|NCT03235154|2273218|FG000|Overall Study|Withdrawal by Subject|1
1156351|NCT03235154|2273218|FG000|Overall Study|Adverse Event|1
1156352|NCT03235154|2273218|FG000|Overall Study|Lost to Follow-up|2
1156353|NCT03235284|2273231|FG000|Overall Study|Adverse Event|1
1156354|NCT03235284|2273232|FG001|Overall Study|Adverse Event|2
1156355|NCT03235284|2273233|FG002|Overall Study|Adverse Event|1
1156356|NCT03235349|2273241|FG000|Overall Study|Adverse Event|1
1156357|NCT03235349|2273241|FG000|Overall Study|Other|1
1156358|NCT03235479|2273251|FG000|Overall Study|Lost to Follow-up|8
1156359|NCT03235479|2273252|FG001|Overall Study|Lost to Follow-up|11
1156360|NCT03235479|2273251|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23
1156361|NCT03235479|2273252|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17
1156362|NCT03235479|2273251|FG000|Overall Study|Pregnancy|1
1156363|NCT03235479|2273252|FG001|Overall Study|Pregnancy|0
1156364|NCT03235479|2273251|FG000|Overall Study|Protocol Deviation|1
1156365|NCT03235479|2273252|FG001|Overall Study|Protocol Deviation|3
1156366|NCT03235479|2273251|FG000|Overall Study|Technical Problems|3
1156367|NCT03235479|2273252|FG001|Overall Study|Technical Problems|2
1156368|NCT03235479|2273251|FG000|Overall Study|Withdrawal by Subject|2
1156369|NCT03235479|2273252|FG001|Overall Study|Withdrawal by Subject|2
1156370|NCT03235479|2273251|FG000|Overall Study|Other Reasons|3
1156371|NCT03235479|2273252|FG001|Overall Study|Other Reasons|5
1156372|NCT03235726|2273266|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1156373|NCT03235726|2273267|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1156374|NCT03235726|2273268|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1156375|NCT03235726|2273269|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1156376|NCT03235726|2273270|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
1156377|NCT03235726|2273271|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1156378|NCT03235726|2273272|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1156379|NCT03235726|2273273|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1156380|NCT03235726|2273274|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1156381|NCT03235726|2273275|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1156382|NCT03235726|2273266|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1156383|NCT03235726|2273267|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1156384|NCT03235726|2273268|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1156385|NCT03235726|2273269|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1156386|NCT03235726|2273270|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
1156387|NCT03235726|2273271|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1156388|NCT03235726|2273272|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1156389|NCT03235726|2273273|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1156390|NCT03235726|2273274|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1156391|NCT03235726|2273275|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1156392|NCT03236246|2273330|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8
1156393|NCT03236246|2273331|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7
1156394|NCT03236246|2273330|FG000|24-Week Dose Titration Period|Lost to Follow-up|0
1156395|NCT03236246|2273331|FG001|24-Week Dose Titration Period|Lost to Follow-up|2
1156396|NCT03236246|2273330|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3
1156397|NCT03236246|2273331|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2
1156398|NCT03236246|2273330|FG000|24-Week Dose Titration Period|Investigator Judgement|1
1156399|NCT03236246|2273331|FG001|24-Week Dose Titration Period|Investigator Judgement|1
1156400|NCT03236246|2273330|FG000|24-Week Dose Titration Period|Prohibited Therapy|1
1156401|NCT03236246|2273331|FG001|24-Week Dose Titration Period|Prohibited Therapy|1
1156402|NCT03236246|2273330|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0
1156403|NCT03236246|2273331|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1
1156404|NCT03236246|2273330|FG000|24-Week Dose Titration Period|Death|3
1156405|NCT03236246|2273331|FG001|24-Week Dose Titration Period|Death|1
1156406|NCT03236246|2273330|FG000|24-Week Dose Titration Period|Protocol Violation|0
1156407|NCT03236246|2273331|FG001|24-Week Dose Titration Period|Protocol Violation|2
1156408|NCT03236246|2273330|FG000|24-Week Dose Titration Period|Adverse Event|7
1156409|NCT03236246|2273331|FG001|24-Week Dose Titration Period|Adverse Event|8
1156410|NCT03236246|2273330|FG000|24-Week Dose Titration Period|Captured as Other|1
1156411|NCT03236246|2273331|FG001|24-Week Dose Titration Period|Captured as Other|2
1156412|NCT03236246|2273330|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1
1156413|NCT03236246|2273331|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3
1156414|NCT03236246|2273330|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1
1156415|NCT03236246|2273331|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1
1156416|NCT03236246|2273330|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1
1156417|NCT03236246|2273331|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0
1156418|NCT03236246|2273330|FG000|24-Week Dose Maintenance Period|Death|0
1156419|NCT03236246|2273331|FG001|24-Week Dose Maintenance Period|Death|1
1156420|NCT03236246|2273330|FG000|24-Week Dose Maintenance Period|Adverse Event|0
1156421|NCT03236246|2273331|FG001|24-Week Dose Maintenance Period|Adverse Event|1
1156422|NCT03236311|2273339|FG000|Overall Study|Study terminated by sponsor|0
1156423|NCT03236311|2273340|FG001|Overall Study|Study terminated by sponsor|2
1156424|NCT03236311|2273339|FG000|Overall Study|Adverse Event|0
1156425|NCT03236311|2273340|FG001|Overall Study|Adverse Event|1
1156426|NCT03236506|2273349|FG000|Overall Study|Death|1
1156427|NCT03236506|2273350|FG001|Overall Study|Death|1
1156428|NCT03236506|2273351|FG002|Overall Study|Death|1
1156429|NCT03236506|2273349|FG000|Overall Study|Withdrawal by Subject|3
1156430|NCT03236506|2273350|FG001|Overall Study|Withdrawal by Subject|3
1156431|NCT03236506|2273351|FG002|Overall Study|Withdrawal by Subject|4
1156432|NCT03236506|2273349|FG000|Overall Study|Did not initiate treatment|2
1156433|NCT03236506|2273350|FG001|Overall Study|Did not initiate treatment|1
1156434|NCT03236506|2273351|FG002|Overall Study|Did not initiate treatment|2
1156435|NCT03236779|2273361|FG000|Overall Study|Lost to Follow-up|13
1156436|NCT03236779|2273362|FG001|Overall Study|Lost to Follow-up|21
1156437|NCT03237013|2273373|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
1156438|NCT03237013|2273374|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
1156439|NCT03237013|2273375|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
1156440|NCT03237065|2273385|FG000|Overall Study|Adverse Event|0
1156441|NCT03237065|2273386|FG001|Overall Study|Adverse Event|2
1156442|NCT03237065|2273385|FG000|Overall Study|Protocol Violation|0
1156443|NCT03237065|2273386|FG001|Overall Study|Protocol Violation|1
1156444|NCT03237065|2273385|FG000|Overall Study|Withdrawal by Subject|3
1156445|NCT03237065|2273386|FG001|Overall Study|Withdrawal by Subject|0
1156446|NCT03237065|2273385|FG000|Overall Study|Lost to Follow-up|1
1156447|NCT03237065|2273386|FG001|Overall Study|Lost to Follow-up|0
1156448|NCT03237065|2273385|FG000|Overall Study|Unable to obtain venous access|0
1156449|NCT03237065|2273386|FG001|Overall Study|Unable to obtain venous access|1
1156450|NCT03237481|2273424|FG000|Overall Study|Lost to Follow-up|1
1156451|NCT03237481|2273425|FG001|Overall Study|Lost to Follow-up|0
1156452|NCT03237481|2273426|FG002|Overall Study|Lost to Follow-up|0
1156453|NCT03237481|2273424|FG000|Overall Study|Protocol Violation|1
1156454|NCT03237481|2273425|FG001|Overall Study|Protocol Violation|0
1156455|NCT03237481|2273426|FG002|Overall Study|Protocol Violation|0
1156456|NCT03237481|2273424|FG000|Overall Study|Withdrawal by Subject|3
1156457|NCT03237481|2273425|FG001|Overall Study|Withdrawal by Subject|2
1156458|NCT03237481|2273426|FG002|Overall Study|Withdrawal by Subject|1
1156459|NCT03237845|2273436|FG000|Overall Study|Adverse Event|0
1156460|NCT03237845|2273437|FG001|Overall Study|Adverse Event|1
1156461|NCT03237845|2273436|FG000|Overall Study|Lost to Follow-up|13
1156462|NCT03237845|2273437|FG001|Overall Study|Lost to Follow-up|10
1156463|NCT03237845|2273436|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26
1156464|NCT03237845|2273437|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31
1156465|NCT03237845|2273436|FG000|Overall Study|Non-Compliance With Study Treatment|0
1156466|NCT03237845|2273437|FG001|Overall Study|Non-Compliance With Study Treatment|1
1156467|NCT03237845|2273436|FG000|Overall Study|Physician Decision|1
1156468|NCT03237845|2273437|FG001|Overall Study|Physician Decision|2
1156469|NCT03237845|2273436|FG000|Overall Study|Pregnancy|1
1156470|NCT03237845|2273437|FG001|Overall Study|Pregnancy|0
1156471|NCT03237845|2273436|FG000|Overall Study|Protocol Deviation|0
1156472|NCT03237845|2273437|FG001|Overall Study|Protocol Deviation|1
1156473|NCT03237845|2273436|FG000|Overall Study|Technical Problems|8
1156474|NCT03237845|2273437|FG001|Overall Study|Technical Problems|1
1156475|NCT03237845|2273436|FG000|Overall Study|Withdrawal by Subject|3
1156476|NCT03237845|2273437|FG001|Overall Study|Withdrawal by Subject|3
1156477|NCT03237845|2273436|FG000|Overall Study|Other Reasons|4
1156478|NCT03237845|2273437|FG001|Overall Study|Other Reasons|0
1156479|NCT03238001|2273447|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
1156480|NCT03238001|2273447|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
1156481|NCT03238001|2273447|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
1156482|NCT03238001|2273447|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
1156483|NCT03238001|2273447|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
1156484|NCT03238001|2273447|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
1156485|NCT03238001|2273447|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
1156486|NCT03238001|2273447|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
1156487|NCT03238352|2273462|FG000|Overall Study|Lost to Follow-up|0
1156488|NCT03238352|2273463|FG001|Overall Study|Lost to Follow-up|2
1156489|NCT03238352|2273464|FG002|Overall Study|Lost to Follow-up|1
1156490|NCT03238352|2273462|FG000|Overall Study|Withdrawal by Subject|0
1156491|NCT03238352|2273463|FG001|Overall Study|Withdrawal by Subject|1
1156492|NCT03238352|2273464|FG002|Overall Study|Withdrawal by Subject|0
1156493|NCT03238417|2273474|FG000|Overall|non-response|955
1156494|NCT03238417|2273475|FG001|Overall|non-response|1920
1156495|NCT03238417|2273474|FG000|Overall|partial completion|48
1156496|NCT03238417|2273475|FG001|Overall|partial completion|68
1156497|NCT03238417|2273474|FG000|Baseline|Partial completion|17
1156498|NCT03238417|2273475|FG001|Baseline|Partial completion|48
1156499|NCT03238417|2273474|FG000|Baseline|non-response|372
1156500|NCT03238417|2273475|FG001|Baseline|non-response|669
1156501|NCT03238417|2273474|FG000|12-month|non-response|296
1156502|NCT03238417|2273475|FG001|12-month|non-response|669
1156503|NCT03238417|2273474|FG000|12-month|partial completion|23
1156504|NCT03238417|2273475|FG001|12-month|partial completion|37
1156505|NCT03238417|2273474|FG000|24-month|non-response|287
1156506|NCT03238417|2273475|FG001|24-month|non-response|594
1156507|NCT03238417|2273474|FG000|24-month|partial completion|8
1156508|NCT03238417|2273475|FG001|24-month|partial completion|31
1156509|NCT03238651|2273486|FG000|Overall Study|Other|0
1156510|NCT03238651|2273487|FG001|Overall Study|Other|0
1156511|NCT03238651|2273488|FG002|Overall Study|Other|0
1156512|NCT03238651|2273489|FG003|Overall Study|Other|0
1156513|NCT03238651|2273490|FG004|Overall Study|Other|1
1156514|NCT03238651|2273486|FG000|Overall Study|Progressive Disease|2
1156515|NCT03238651|2273487|FG001|Overall Study|Progressive Disease|2
1156516|NCT03238651|2273488|FG002|Overall Study|Progressive Disease|2
1156517|NCT03238651|2273489|FG003|Overall Study|Progressive Disease|2
1156518|NCT03238651|2273490|FG004|Overall Study|Progressive Disease|0
1156519|NCT03238651|2273486|FG000|Overall Study|Withdrawal by Subject|0
1156520|NCT03238651|2273487|FG001|Overall Study|Withdrawal by Subject|1
1156521|NCT03238651|2273488|FG002|Overall Study|Withdrawal by Subject|0
1156522|NCT03238651|2273489|FG003|Overall Study|Withdrawal by Subject|1
1156523|NCT03238651|2273490|FG004|Overall Study|Withdrawal by Subject|0
1156524|NCT03238651|2273486|FG000|Overall Study|Adverse Event|1
1156525|NCT03238651|2273487|FG001|Overall Study|Adverse Event|3
1156526|NCT03238651|2273488|FG002|Overall Study|Adverse Event|2
1156527|NCT03238651|2273489|FG003|Overall Study|Adverse Event|0
1156528|NCT03238651|2273490|FG004|Overall Study|Adverse Event|0
1156529|NCT03238781|2273506|FG000|Overall Study|Adverse Event|1
1156530|NCT03238781|2273507|FG001|Overall Study|Adverse Event|1
1156531|NCT03238781|2273508|FG002|Overall Study|Adverse Event|2
1156532|NCT03238781|2273506|FG000|Overall Study|Lost to Follow-up|2
1156533|NCT03238781|2273507|FG001|Overall Study|Lost to Follow-up|1
1156534|NCT03238781|2273508|FG002|Overall Study|Lost to Follow-up|2
1156535|NCT03238781|2273506|FG000|Overall Study|Withdrawal by Subject|23
1156536|NCT03238781|2273507|FG001|Overall Study|Withdrawal by Subject|14
1156537|NCT03238781|2273508|FG002|Overall Study|Withdrawal by Subject|16
1156538|NCT03238781|2273506|FG000|Overall Study|Decision by sponsor|0
1156539|NCT03238781|2273507|FG001|Overall Study|Decision by sponsor|1
1156540|NCT03238781|2273508|FG002|Overall Study|Decision by sponsor|0
1156541|NCT03238911|2273518|FG000|Overall Study|Withdrawal by Subject|1
1156542|NCT03238911|2273519|FG001|Overall Study|Withdrawal by Subject|2
1156543|NCT03238911|2273518|FG000|Overall Study|Lost to Follow-up|2
1156544|NCT03238911|2273519|FG001|Overall Study|Lost to Follow-up|1
1156545|NCT03238924|2273528|FG000|Overall Study|Withdrawal by Subject|2
1156546|NCT03238924|2273529|FG001|Overall Study|Withdrawal by Subject|2
1156547|NCT03238963|2273537|FG000|Overall Study|Prohibited medication given due to hospital stay|1
1156548|NCT03238963|2273538|FG001|Overall Study|Prohibited medication given due to hospital stay|0
1156549|NCT03238963|2273537|FG000|Overall Study|Withdrawal by Subject|1
1156550|NCT03238963|2273538|FG001|Overall Study|Withdrawal by Subject|1
1156551|NCT03238963|2273537|FG000|Overall Study|Lost to Follow-up|1
1156552|NCT03238963|2273538|FG001|Overall Study|Lost to Follow-up|0
1156553|NCT03238963|2273537|FG000|Overall Study|Protocol Violation|1
1156554|NCT03238963|2273538|FG001|Overall Study|Protocol Violation|1
1156555|NCT03238963|2273537|FG000|Overall Study|Adverse Event|1
1156556|NCT03238963|2273538|FG001|Overall Study|Adverse Event|0
1156557|NCT03239470|2273549|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1
1156558|NCT03239470|2273550|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0
1156559|NCT03239483|2273556|FG000|Overall Study|Lost to Follow-up|1
1156560|NCT03239483|2273557|FG001|Overall Study|Lost to Follow-up|0
1156561|NCT03239483|2273556|FG000|Overall Study|Withdrawal by Subject|1
1156562|NCT03239483|2273557|FG001|Overall Study|Withdrawal by Subject|0
1156563|NCT03239873|2273610|FG000|Overall Study|Lost to Follow-up|15
1156564|NCT03239873|2273611|FG001|Overall Study|Lost to Follow-up|16
1156565|NCT03239873|2273610|FG000|Overall Study|Physician Decision|1
1156566|NCT03239873|2273611|FG001|Overall Study|Physician Decision|0
1156567|NCT03239873|2273610|FG000|Overall Study|Withdrawal by Parent/Guardian|12
1156568|NCT03239873|2273611|FG001|Overall Study|Withdrawal by Parent/Guardian|11
1156569|NCT03239873|2273610|FG000|Overall Study|Withdrawal by Subject|2
1156570|NCT03239873|2273611|FG001|Overall Study|Withdrawal by Subject|0
1156571|NCT03239873|2273610|FG000|Overall Study|Contraindication to study medication|1
1156572|NCT03239873|2273611|FG001|Overall Study|Contraindication to study medication|0
1156573|NCT03239873|2273610|FG000|Overall Study|Protocol Violation|1
1156574|NCT03239873|2273611|FG001|Overall Study|Protocol Violation|0
1156575|NCT03240081|2273619|FG000|Overall Study|Withdrawal by Subject|0
1156576|NCT03240081|2273620|FG001|Overall Study|Withdrawal by Subject|2
1156577|NCT03240081|2273619|FG000|Overall Study|Lost to Follow-up|0
1156578|NCT03240081|2273620|FG001|Overall Study|Lost to Follow-up|1
1156579|NCT03240133|2273629|FG000|Overall Study|Withdrawal by Subject|0
1156580|NCT03240133|2273630|FG001|Overall Study|Withdrawal by Subject|1
1156581|NCT03240133|2273631|FG002|Overall Study|Withdrawal by Subject|0
1156582|NCT03240133|2273629|FG000|Overall Study|Adverse Event|1
1156583|NCT03240133|2273630|FG001|Overall Study|Adverse Event|1
1156584|NCT03240133|2273631|FG002|Overall Study|Adverse Event|0
1156585|NCT03240133|2273629|FG000|Overall Study|Rash|1
1156586|NCT03240133|2273630|FG001|Overall Study|Rash|0
1156587|NCT03240133|2273631|FG002|Overall Study|Rash|0
1156588|NCT03240133|2273629|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1
1156589|NCT03240133|2273630|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0
1156590|NCT03240133|2273631|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0
1156591|NCT03240133|2273629|FG000|Overall Study|Intercurrent illness.|0
1156592|NCT03240133|2273630|FG001|Overall Study|Intercurrent illness.|1
1156593|NCT03240133|2273631|FG002|Overall Study|Intercurrent illness.|0
1156594|NCT03240133|2273629|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
1156595|NCT03240133|2273630|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
1156596|NCT03240133|2273631|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1
1156597|NCT03240575|2273659|FG000|Overall Study|Adverse Event|0
1156598|NCT03240575|2273660|FG001|Overall Study|Adverse Event|2
1156599|NCT03240575|2273661|FG002|Overall Study|Adverse Event|0
1156600|NCT03240575|2273662|FG003|Overall Study|Adverse Event|1
1156601|NCT03240575|2273659|FG000|Overall Study|Withdrawal by Subject|2
1156602|NCT03240575|2273660|FG001|Overall Study|Withdrawal by Subject|11
1156603|NCT03240575|2273661|FG002|Overall Study|Withdrawal by Subject|0
1156604|NCT03240575|2273662|FG003|Overall Study|Withdrawal by Subject|1
1156605|NCT03240575|2273659|FG000|Overall Study|Other|0
1156606|NCT03240575|2273660|FG001|Overall Study|Other|1
1156607|NCT03240575|2273661|FG002|Overall Study|Other|0
1156608|NCT03240575|2273662|FG003|Overall Study|Other|0
1156609|NCT03241342|2273682|FG000|Overall Study|Adverse Event|5
1156610|NCT03241342|2273683|FG001|Overall Study|Adverse Event|8
1156611|NCT03241342|2273684|FG002|Overall Study|Adverse Event|4
1156612|NCT03241342|2273682|FG000|Overall Study|Lack of Efficacy|0
1156613|NCT03241342|2273683|FG001|Overall Study|Lack of Efficacy|0
1156614|NCT03241342|2273684|FG002|Overall Study|Lack of Efficacy|1
1156615|NCT03241342|2273682|FG000|Overall Study|noncompliance with study drug|2
1156616|NCT03241342|2273683|FG001|Overall Study|noncompliance with study drug|1
1156617|NCT03241342|2273684|FG002|Overall Study|noncompliance with study drug|1
1156618|NCT03241342|2273682|FG000|Overall Study|sponsor decision|0
1156619|NCT03241342|2273683|FG001|Overall Study|sponsor decision|1
1156620|NCT03241342|2273684|FG002|Overall Study|sponsor decision|2
1156621|NCT03241342|2273682|FG000|Overall Study|not reported|15
1156622|NCT03241342|2273683|FG001|Overall Study|not reported|21
1156623|NCT03241342|2273684|FG002|Overall Study|not reported|19
1156624|NCT03241368|2273692|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25
1156625|NCT03241368|2273692|FG000|Overall Study|Lost to Follow-up|1
1156626|NCT03241368|2273692|FG000|Overall Study|Physician Decision|6
1156627|NCT03241368|2273692|FG000|Overall Study|Withdrawal by Subject|6
1156628|NCT03241368|2273692|FG000|Overall Study|Protocol Violation|1
1156629|NCT03241927|2273724|FG000|Overall Study|study terminated|1
1156630|NCT03241927|2273725|FG001|Overall Study|study terminated|0
1156631|NCT03242018|2273734|FG000|Overall Study|Adverse Event|7
1156632|NCT03242018|2273735|FG001|Overall Study|Adverse Event|7
1156633|NCT03242018|2273736|FG002|Overall Study|Adverse Event|6
1156634|NCT03242018|2273734|FG000|Overall Study|Lost to Follow-up|2
1156635|NCT03242018|2273735|FG001|Overall Study|Lost to Follow-up|2
1156636|NCT03242018|2273736|FG002|Overall Study|Lost to Follow-up|2
1156637|NCT03242018|2273734|FG000|Overall Study|At the Participant's Own Request|5
1156638|NCT03242018|2273735|FG001|Overall Study|At the Participant's Own Request|1
1156639|NCT03242018|2273736|FG002|Overall Study|At the Participant's Own Request|4
1156640|NCT03242018|2273734|FG000|Overall Study|Reason Not Specified|3
1156641|NCT03242018|2273735|FG001|Overall Study|Reason Not Specified|4
1156642|NCT03242018|2273736|FG002|Overall Study|Reason Not Specified|1
1156643|NCT03242018|2273734|FG000|Overall Study|Study Terminated by Sponsor|1
1156644|NCT03242018|2273735|FG001|Overall Study|Study Terminated by Sponsor|0
1156645|NCT03242018|2273736|FG002|Overall Study|Study Terminated by Sponsor|1
1156646|NCT03242252|2273752|FG000|Overall Study|At the Participant's own Request|18
1156647|NCT03242252|2273753|FG001|Overall Study|At the Participant's own Request|10
1156648|NCT03242252|2273754|FG002|Overall Study|At the Participant's own Request|15
1156649|NCT03242252|2273752|FG000|Overall Study|Adverse Event|8
1156650|NCT03242252|2273753|FG001|Overall Study|Adverse Event|6
1156651|NCT03242252|2273754|FG002|Overall Study|Adverse Event|9
1156652|NCT03242252|2273752|FG000|Overall Study|Poor Compliance to Protocol|0
1156653|NCT03242252|2273753|FG001|Overall Study|Poor Compliance to Protocol|2
1156654|NCT03242252|2273754|FG002|Overall Study|Poor Compliance to Protocol|3
1156655|NCT03242252|2273752|FG000|Overall Study|Study Terminated by Sponsor|1
1156656|NCT03242252|2273753|FG001|Overall Study|Study Terminated by Sponsor|0
1156657|NCT03242252|2273754|FG002|Overall Study|Study Terminated by Sponsor|0
1156658|NCT03242252|2273752|FG000|Overall Study|Reason not Specified|4
1156659|NCT03242252|2273753|FG001|Overall Study|Reason not Specified|4
1156660|NCT03242252|2273754|FG002|Overall Study|Reason not Specified|1
1156661|NCT03242252|2273752|FG000|Overall Study|Lost to Follow-up|5
1156662|NCT03242252|2273753|FG001|Overall Study|Lost to Follow-up|1
1156663|NCT03242252|2273754|FG002|Overall Study|Lost to Follow-up|4
1156664|NCT03242434|2273774|FG000|Overall Study|Death|0
1156665|NCT03242434|2273775|FG001|Overall Study|Death|2
1156666|NCT03242759|2273788|FG000|Overall Study|Adverse Event|5
1156667|NCT03242759|2273789|FG001|Overall Study|Adverse Event|1
1156668|NCT03242759|2273788|FG000|Overall Study|Withdrawal by Subject|4
1156669|NCT03242759|2273789|FG001|Overall Study|Withdrawal by Subject|3
1156670|NCT03242759|2273788|FG000|Overall Study|Lost to Follow-up|3
1156671|NCT03242759|2273789|FG001|Overall Study|Lost to Follow-up|1
1156672|NCT03242759|2273788|FG000|Overall Study|Administrative problems|1
1156673|NCT03242759|2273789|FG001|Overall Study|Administrative problems|1
1156674|NCT03242759|2273788|FG000|Overall Study|Death|22
1156675|NCT03242759|2273789|FG001|Overall Study|Death|0
1156676|NCT03242759|2273788|FG000|Overall Study|Change visit schedule|0
1156677|NCT03242759|2273789|FG001|Overall Study|Change visit schedule|1
1156678|NCT03242863|2273795|FG000|Study Week 1|Withdrawal by Subject|0
1156679|NCT03242863|2273796|FG001|Study Week 1|Withdrawal by Subject|1
1156680|NCT03242863|2273797|FG002|Study Week 1|Withdrawal by Subject|0
1156681|NCT03242863|2273798|FG003|Study Week 1|Withdrawal by Subject|0
1156682|NCT03242863|2273799|FG004|Study Week 1|Withdrawal by Subject|3
1156683|NCT03242863|2273800|FG005|Study Week 1|Withdrawal by Subject|0
1156684|NCT03242928|2273810|FG000|Overall Study|Adverse Event|2
1156685|NCT03242928|2273811|FG001|Overall Study|Adverse Event|1
1156686|NCT03242928|2273810|FG000|Overall Study|Lost to Follow-up|2
1156687|NCT03242928|2273811|FG001|Overall Study|Lost to Follow-up|0
1156688|NCT03242928|2273810|FG000|Overall Study|Physician Decision|0
1156689|NCT03242928|2273811|FG001|Overall Study|Physician Decision|1
1156690|NCT03242928|2273810|FG000|Overall Study|Withdrawal by Subject|5
1156691|NCT03242928|2273811|FG001|Overall Study|Withdrawal by Subject|3
1156692|NCT03243084|2273841|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1
1156693|NCT03243084|2273842|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0
1156694|NCT03243305|2273849|FG000|Overall Study|Lost to Follow-up|250
1156695|NCT03243305|2273849|FG000|Overall Study|Withdrawal by Subject|170
1156696|NCT03243305|2273849|FG000|Overall Study|Pregnancy|104
1156697|NCT03243305|2273849|FG000|Overall Study|Non-Compliance with Study Drug|38
1156698|NCT03243305|2273849|FG000|Overall Study|Adverse Event|23
1156699|NCT03243305|2273849|FG000|Overall Study|No sexually active|26
1156700|NCT03243305|2273849|FG000|Overall Study|Physician Decision|22
1156701|NCT03243305|2273849|FG000|Overall Study|Protocol Violation|22
1156702|NCT03243305|2273849|FG000|Overall Study|Study method no longer primary method|12
1156703|NCT03243305|2273849|FG000|Overall Study|Study Terminated by Sponsor|1
903523|NCT00749190|1877787|FG004|Overall Study|Withdrawal by Subject|0
903524|NCT00749190|1877788|FG005|Overall Study|Withdrawal by Subject|1
903525|NCT00749190|1877789|FG006|Overall Study|Withdrawal by Subject|0
903526|NCT00749190|1877783|FG000|Overall Study|Protocol Violation|0
903527|NCT00749190|1877784|FG001|Overall Study|Protocol Violation|1
903528|NCT00749190|1877785|FG002|Overall Study|Protocol Violation|0
903529|NCT00749190|1877786|FG003|Overall Study|Protocol Violation|0
903530|NCT00749190|1877787|FG004|Overall Study|Protocol Violation|0
903531|NCT00749190|1877788|FG005|Overall Study|Protocol Violation|0
903532|NCT00749190|1877789|FG006|Overall Study|Protocol Violation|1
903533|NCT00749190|1877783|FG000|Overall Study|Other reason not defined above|0
903534|NCT00749190|1877784|FG001|Overall Study|Other reason not defined above|0
903535|NCT00749190|1877785|FG002|Overall Study|Other reason not defined above|0
903536|NCT00749190|1877786|FG003|Overall Study|Other reason not defined above|1
903537|NCT00749190|1877787|FG004|Overall Study|Other reason not defined above|0
903538|NCT00749190|1877788|FG005|Overall Study|Other reason not defined above|0
1156704|NCT03243305|2273849|FG000|Overall Study|Early terminations|267
1156705|NCT03243630|2273853|FG000|Overall Study|Protocol Violation|1
1156706|NCT03243630|2273853|FG000|Overall Study|Physician Decision|1
1156707|NCT03244618|2273872|FG000|Overall Study|Lost to Follow-up|3
1156708|NCT03244618|2273873|FG001|Overall Study|Lost to Follow-up|4
1156709|NCT03244618|2273872|FG000|Overall Study|Protocol Violation|4
1156710|NCT03244618|2273873|FG001|Overall Study|Protocol Violation|3
1156711|NCT03244618|2273872|FG000|Overall Study|Withdrawal by Subject|0
1156712|NCT03244618|2273873|FG001|Overall Study|Withdrawal by Subject|2
1156713|NCT03244917|2273905|FG000|Overall Study|Lost to Follow-up|2
1156714|NCT03244917|2273906|FG001|Overall Study|Lost to Follow-up|2
1156715|NCT03245398|2273923|FG000|Overall Study|Travelled to another island|1
1156716|NCT03245398|2273924|FG001|Overall Study|Travelled to another island|0
1156717|NCT03245619|2273958|FG000|Part A (Up to Day 22)|Physician Decision|4
1156718|NCT03245619|2273959|FG001|Part A (Up to Day 22)|Physician Decision|6
1156719|NCT03245619|2273960|FG002|Part A (Up to Day 22)|Physician Decision|6
1156720|NCT03245619|2273961|FG003|Part A (Up to Day 22)|Physician Decision|0
1156721|NCT03245619|2273962|FG004|Part A (Up to Day 22)|Physician Decision|0
1156722|NCT03245619|2273963|FG005|Part A (Up to Day 22)|Physician Decision|0
1156723|NCT03245619|2273964|FG006|Part A (Up to Day 22)|Physician Decision|0
1156724|NCT03245619|2273965|FG007|Part A (Up to Day 22)|Physician Decision|0
1156725|NCT03245619|2273966|FG008|Part A (Up to Day 22)|Physician Decision|0
1156726|NCT03245619|2273967|FG009|Part A (Up to Day 22)|Physician Decision|0
1156727|NCT03245619|2273968|FG010|Part A (Up to Day 22)|Physician Decision|0
1156728|NCT03245619|2273969|FG011|Part A (Up to Day 22)|Physician Decision|0
1156729|NCT03245619|2273970|FG012|Part A (Up to Day 22)|Physician Decision|0
1156730|NCT03245619|2273971|FG013|Part A (Up to Day 22)|Physician Decision|0
1156731|NCT03245619|2273972|FG014|Part A (Up to Day 22)|Physician Decision|0
1156732|NCT03245619|2273973|FG015|Part A (Up to Day 22)|Physician Decision|0
1156733|NCT03245619|2273974|FG016|Part A (Up to Day 22)|Physician Decision|0
1156734|NCT03245723|2274035|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1
1156735|NCT03245723|2274036|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0
1156736|NCT03245723|2274035|FG000|Overall Study|Claustrophobia from wearing the mask|1
1156737|NCT03245723|2274036|FG001|Overall Study|Claustrophobia from wearing the mask|0
1156738|NCT03245723|2274035|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2
1156739|NCT03245723|2274036|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0
1156740|NCT03245723|2274035|FG000|Overall Study|Image acquisition/reconstruction failure|1
1156741|NCT03245723|2274036|FG001|Overall Study|Image acquisition/reconstruction failure|1
1156742|NCT03245736|2274042|FG000|Overall Study|Adverse Event|1
1156743|NCT03245736|2274042|FG000|Overall Study|Progressive Disease|4
1156744|NCT03246061|2274057|FG000|Overall Study|Still in follow-up|15
1156745|NCT03246061|2274058|FG001|Overall Study|Still in follow-up|21
1156746|NCT03246152|2274066|FG000|Overall Study|Lost to Follow-up|2
1156747|NCT03246152|2274066|FG000|Overall Study|Protocol Violation|1
1156748|NCT03246646|2274072|FG000|Overall Study|deemed ineligible and administratively withdrawn|1
1156749|NCT03246646|2274073|FG001|Overall Study|deemed ineligible and administratively withdrawn|0
1156750|NCT03246646|2274072|FG000|Overall Study|Withdrawal by Subject|3
1156751|NCT03246646|2274073|FG001|Overall Study|Withdrawal by Subject|0
1156752|NCT03246646|2274072|FG000|Overall Study|Lost to Follow-up|7
1156753|NCT03246646|2274073|FG001|Overall Study|Lost to Follow-up|0
1156754|NCT03246672|2274079|FG000|Overall Study|Lost to Follow-up|2
1156755|NCT03246724|2274087|FG000|Overall Study|Withdrawal by Subject|5
1156756|NCT03246724|2274088|FG001|Overall Study|Withdrawal by Subject|2
1156757|NCT03246724|2274089|FG002|Overall Study|Withdrawal by Subject|4
1156758|NCT03246724|2274090|FG003|Overall Study|Withdrawal by Subject|2
1156759|NCT03246724|2274087|FG000|Overall Study|Ineligible on day of surgery|7
1156760|NCT03246724|2274088|FG001|Overall Study|Ineligible on day of surgery|2
1156761|NCT03246724|2274089|FG002|Overall Study|Ineligible on day of surgery|0
1156762|NCT03246724|2274090|FG003|Overall Study|Ineligible on day of surgery|3
1156763|NCT03246724|2274087|FG000|Overall Study|Study completed before surgical date|2
1156764|NCT03246724|2274088|FG001|Overall Study|Study completed before surgical date|1
1156765|NCT03246724|2274089|FG002|Overall Study|Study completed before surgical date|8
1156766|NCT03246724|2274090|FG003|Overall Study|Study completed before surgical date|1
1156767|NCT03246724|2274087|FG000|Overall Study|Transferred to other arm|0
1156768|NCT03246724|2274088|FG001|Overall Study|Transferred to other arm|0
1156769|NCT03246724|2274089|FG002|Overall Study|Transferred to other arm|1
1156770|NCT03246724|2274090|FG003|Overall Study|Transferred to other arm|0
1156771|NCT03246724|2274087|FG000|Overall Study|Unable to obtain medication timely|0
1156772|NCT03246724|2274088|FG001|Overall Study|Unable to obtain medication timely|2
1156773|NCT03246724|2274089|FG002|Overall Study|Unable to obtain medication timely|2
1156774|NCT03246724|2274090|FG003|Overall Study|Unable to obtain medication timely|1
1156775|NCT03246724|2274087|FG000|Overall Study|Re-consented to participate|0
1156776|NCT03246724|2274088|FG001|Overall Study|Re-consented to participate|0
1156777|NCT03246724|2274089|FG002|Overall Study|Re-consented to participate|0
1156778|NCT03246724|2274090|FG003|Overall Study|Re-consented to participate|1
1156779|NCT03247517|2274114|FG000|Overall Study|Adverse Event|0
1156780|NCT03247517|2274115|FG001|Overall Study|Adverse Event|4
1156781|NCT03247517|2274116|FG002|Overall Study|Adverse Event|2
1156782|NCT03247517|2274114|FG000|Overall Study|Lost to Follow-up|2
1156783|NCT03247517|2274115|FG001|Overall Study|Lost to Follow-up|6
1156784|NCT03247517|2274116|FG002|Overall Study|Lost to Follow-up|4
1156785|NCT03247517|2274114|FG000|Overall Study|Consent withdrawn by caregiver|1
1156786|NCT03247517|2274115|FG001|Overall Study|Consent withdrawn by caregiver|4
1156787|NCT03247517|2274116|FG002|Overall Study|Consent withdrawn by caregiver|7
1156788|NCT03247517|2274114|FG000|Overall Study|Assent/consent withdrawn by subject|2
1156789|NCT03247517|2274115|FG001|Overall Study|Assent/consent withdrawn by subject|3
1156790|NCT03247517|2274116|FG002|Overall Study|Assent/consent withdrawn by subject|1
1156791|NCT03247517|2274114|FG000|Overall Study|Protocol Violation|0
1156792|NCT03247517|2274115|FG001|Overall Study|Protocol Violation|2
1156793|NCT03247517|2274116|FG002|Overall Study|Protocol Violation|0
1156794|NCT03247517|2274114|FG000|Overall Study|Multiple reasons|3
1156795|NCT03247517|2274115|FG001|Overall Study|Multiple reasons|1
1156796|NCT03247517|2274116|FG002|Overall Study|Multiple reasons|0
1156797|NCT03247530|2274127|FG000|Overall Study|Withdrawal by caregiver|19
1156798|NCT03247530|2274128|FG001|Overall Study|Withdrawal by caregiver|8
1156799|NCT03247530|2274129|FG002|Overall Study|Withdrawal by caregiver|10
1156800|NCT03247530|2274127|FG000|Overall Study|Lost to Follow-up|3
1156801|NCT03247530|2274128|FG001|Overall Study|Lost to Follow-up|9
1156802|NCT03247530|2274129|FG002|Overall Study|Lost to Follow-up|6
1156803|NCT03247530|2274127|FG000|Overall Study|Adverse Event|2
1156804|NCT03247530|2274128|FG001|Overall Study|Adverse Event|5
1156805|NCT03247530|2274129|FG002|Overall Study|Adverse Event|2
1156806|NCT03247530|2274127|FG000|Overall Study|Failure to follow procedure|1
1156807|NCT03247530|2274128|FG001|Overall Study|Failure to follow procedure|1
1156808|NCT03247530|2274129|FG002|Overall Study|Failure to follow procedure|1
1156809|NCT03247530|2274127|FG000|Overall Study|Withdrawal by Subject|1
1156810|NCT03247530|2274128|FG001|Overall Study|Withdrawal by Subject|1
1156811|NCT03247530|2274129|FG002|Overall Study|Withdrawal by Subject|0
1156812|NCT03247530|2274127|FG000|Overall Study|Study medication misuse|0
1156813|NCT03247530|2274128|FG001|Overall Study|Study medication misuse|1
1156814|NCT03247530|2274129|FG002|Overall Study|Study medication misuse|0
1156815|NCT03247530|2274127|FG000|Overall Study|Other, multiple categories|1
1156816|NCT03247530|2274128|FG001|Overall Study|Other, multiple categories|3
1156817|NCT03247530|2274129|FG002|Overall Study|Other, multiple categories|1
1156818|NCT03247543|2274143|FG000|Overall Study|Adverse Event|3
1156819|NCT03247543|2274144|FG001|Overall Study|Adverse Event|6
1156820|NCT03247543|2274145|FG002|Overall Study|Adverse Event|4
1156821|NCT03247543|2274143|FG000|Overall Study|Lost to Follow-up|10
1156822|NCT03247543|2274144|FG001|Overall Study|Lost to Follow-up|7
1156823|NCT03247543|2274145|FG002|Overall Study|Lost to Follow-up|8
1156824|NCT03247543|2274143|FG000|Overall Study|Consent withdrawn by caregiver|2
1156825|NCT03247543|2274144|FG001|Overall Study|Consent withdrawn by caregiver|2
1156826|NCT03247543|2274145|FG002|Overall Study|Consent withdrawn by caregiver|9
1156827|NCT03247543|2274143|FG000|Overall Study|Withdrawal by Subject|0
1156828|NCT03247543|2274144|FG001|Overall Study|Withdrawal by Subject|0
1156829|NCT03247543|2274145|FG002|Overall Study|Withdrawal by Subject|1
1156830|NCT03247543|2274143|FG000|Overall Study|Failure to Follow study procedures|1
1156831|NCT03247543|2274144|FG001|Overall Study|Failure to Follow study procedures|3
1156832|NCT03247543|2274145|FG002|Overall Study|Failure to Follow study procedures|1
1156833|NCT03247543|2274143|FG000|Overall Study|Lack of Efficacy|1
1156834|NCT03247543|2274144|FG001|Overall Study|Lack of Efficacy|0
1156835|NCT03247543|2274145|FG002|Overall Study|Lack of Efficacy|0
1156836|NCT03247543|2274143|FG000|Overall Study|Non-compliance with study visits|0
1156837|NCT03247543|2274144|FG001|Overall Study|Non-compliance with study visits|1
1156838|NCT03247543|2274145|FG002|Overall Study|Non-compliance with study visits|0
1156839|NCT03247556|2274158|FG000|Overall Study|Adverse Event|1
903539|NCT00749190|1877789|FG006|Overall Study|Other reason not defined above|0
903540|NCT00749203|1877812|FG000|no Infusion at Week 1|Lost to Follow-up|0
903541|NCT00749203|1877813|FG001|no Infusion at Week 1|Lost to Follow-up|1
903542|NCT00749203|1877812|FG000|no Infusion at Week 1|Withdrawal by Subject|0
903543|NCT00749203|1877813|FG001|no Infusion at Week 1|Withdrawal by Subject|1
903544|NCT00749203|1877812|FG000|no Infusion at Week 1|delayed-onset sedation|0
903545|NCT00749203|1877813|FG001|no Infusion at Week 1|delayed-onset sedation|1
1156840|NCT03247556|2274159|FG001|Overall Study|Adverse Event|4
1156841|NCT03247556|2274160|FG002|Overall Study|Adverse Event|5
1156842|NCT03247556|2274158|FG000|Overall Study|Lost to Follow-up|5
1156843|NCT03247556|2274159|FG001|Overall Study|Lost to Follow-up|5
1156844|NCT03247556|2274160|FG002|Overall Study|Lost to Follow-up|4
1156845|NCT03247556|2274158|FG000|Overall Study|Consent Withdrawn by Caregiver|4
1156846|NCT03247556|2274159|FG001|Overall Study|Consent Withdrawn by Caregiver|1
1156847|NCT03247556|2274160|FG002|Overall Study|Consent Withdrawn by Caregiver|5
1156848|NCT03247556|2274158|FG000|Overall Study|Assent/consent Withdrawn by Subject|0
1156849|NCT03247556|2274159|FG001|Overall Study|Assent/consent Withdrawn by Subject|2
1156850|NCT03247556|2274160|FG002|Overall Study|Assent/consent Withdrawn by Subject|2
1156851|NCT03247556|2274158|FG000|Overall Study|Protocol Violation|2
1156852|NCT03247556|2274159|FG001|Overall Study|Protocol Violation|0
1156853|NCT03247556|2274160|FG002|Overall Study|Protocol Violation|1
1156854|NCT03247556|2274158|FG000|Overall Study|Subject did not meet inclusion criteria|0
1156855|NCT03247556|2274159|FG001|Overall Study|Subject did not meet inclusion criteria|0
1156856|NCT03247556|2274160|FG002|Overall Study|Subject did not meet inclusion criteria|1
1156857|NCT03247673|2274171|FG000|Overall Study|Withdrawal by Subject|1
1156858|NCT03247673|2274172|FG001|Overall Study|Withdrawal by Subject|0
1156859|NCT03247673|2274173|FG002|Overall Study|Withdrawal by Subject|3
1156860|NCT03247673|2274171|FG000|Overall Study|Lost to Follow-up|0
1156861|NCT03247673|2274172|FG001|Overall Study|Lost to Follow-up|0
1156862|NCT03247673|2274173|FG002|Overall Study|Lost to Follow-up|1
1156863|NCT03247686|2274183|FG000|Overall Study|Withdrawal by Subject|1
1156864|NCT03247686|2274184|FG001|Overall Study|Withdrawal by Subject|2
1156865|NCT03247816|2274208|FG000|Overall Study|Adverse Event|12
1156866|NCT03247816|2274208|FG000|Overall Study|Physician Decision|3
1156867|NCT03247816|2274208|FG000|Overall Study|Lack of Efficacy|1
1156868|NCT03247816|2274208|FG000|Overall Study|Lost to Follow-up|10
1156869|NCT03247816|2274208|FG000|Overall Study|Missing Feraccru stop date|3
1156870|NCT03248037|2274225|FG000|Overall Study|Withdrawal by Subject|6
1156871|NCT03248037|2274226|FG001|Overall Study|Withdrawal by Subject|9
1156872|NCT03248037|2274225|FG000|Overall Study|Adverse Event|15
1156873|NCT03248037|2274226|FG001|Overall Study|Adverse Event|0
1156874|NCT03248492|2274246|FG000|Overall Study|Ongoing|23
1156875|NCT03248492|2274247|FG001|Overall Study|Ongoing|26
1156876|NCT03248492|2274248|FG002|Overall Study|Ongoing|3
1156877|NCT03248492|2274249|FG003|Overall Study|Ongoing|85
1156878|NCT03248492|2274250|FG004|Overall Study|Ongoing|2
903546|NCT00749203|1877812|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0
903547|NCT00749203|1877813|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1
903548|NCT00749203|1877812|FG000|Second Infusion at 2 Weeks|Protocol Violation|0
903549|NCT00749203|1877813|FG001|Second Infusion at 2 Weeks|Protocol Violation|1
903550|NCT00749203|1877812|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
903551|NCT00749203|1877813|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
903552|NCT00749398|1877834|FG000|Overall Study|Lack of Efficacy|7
903553|NCT00749398|1877834|FG000|Overall Study|Adverse Event|4
903554|NCT00749398|1877834|FG000|Overall Study|Serious adverse event|11
903555|NCT00749398|1877834|FG000|Overall Study|Withdrawal by Subject|17
903556|NCT00749398|1877834|FG000|Overall Study|Lost to Follow-up|11
903557|NCT00749398|1877834|FG000|Overall Study|Reason not specified|2
903558|NCT00749398|1877834|FG000|Overall Study|Unknown reason|1
903559|NCT00749411|1877840|FG000|Overall Study|Adverse Event|0
903560|NCT00749411|1877841|FG001|Overall Study|Adverse Event|2
903561|NCT00749411|1877840|FG000|Overall Study|Lack of Efficacy|0
903562|NCT00749411|1877841|FG001|Overall Study|Lack of Efficacy|1
903563|NCT00749411|1877840|FG000|Overall Study|Protocol Violation|1
903564|NCT00749411|1877841|FG001|Overall Study|Protocol Violation|1
903565|NCT00749411|1877840|FG000|Overall Study|Protocol-defined stopping criteria|0
903566|NCT00749411|1877841|FG001|Overall Study|Protocol-defined stopping criteria|1
903567|NCT00749463|1877850|FG000|Overall Study|Adverse Event|0
1156879|NCT03248492|2274246|FG000|Overall Study|Progressive disease per RECIST v1.1|16
1156880|NCT03248492|2274247|FG001|Overall Study|Progressive disease per RECIST v1.1|12
1156881|NCT03248492|2274248|FG002|Overall Study|Progressive disease per RECIST v1.1|9
1156882|NCT03248492|2274249|FG003|Overall Study|Progressive disease per RECIST v1.1|22
1156883|NCT03248492|2274250|FG004|Overall Study|Progressive disease per RECIST v1.1|0
1156884|NCT03248492|2274246|FG000|Overall Study|Adverse Event|6
1156885|NCT03248492|2274247|FG001|Overall Study|Adverse Event|6
1156886|NCT03248492|2274248|FG002|Overall Study|Adverse Event|8
1156887|NCT03248492|2274249|FG003|Overall Study|Adverse Event|8
1156888|NCT03248492|2274250|FG004|Overall Study|Adverse Event|1
1156889|NCT03248492|2274246|FG000|Overall Study|Withdrawal by Subject|3
1156890|NCT03248492|2274247|FG001|Overall Study|Withdrawal by Subject|3
1156891|NCT03248492|2274248|FG002|Overall Study|Withdrawal by Subject|0
1156892|NCT03248492|2274249|FG003|Overall Study|Withdrawal by Subject|3
1156893|NCT03248492|2274250|FG004|Overall Study|Withdrawal by Subject|1
1156894|NCT03248492|2274246|FG000|Overall Study|Physician Decision|1
1156895|NCT03248492|2274247|FG001|Overall Study|Physician Decision|0
1156896|NCT03248492|2274248|FG002|Overall Study|Physician Decision|1
1156897|NCT03248492|2274249|FG003|Overall Study|Physician Decision|2
1156898|NCT03248492|2274250|FG004|Overall Study|Physician Decision|0
1156899|NCT03248492|2274246|FG000|Overall Study|Death|1
1156900|NCT03248492|2274247|FG001|Overall Study|Death|0
1156901|NCT03248492|2274248|FG002|Overall Study|Death|0
1156902|NCT03248492|2274249|FG003|Overall Study|Death|6
1156903|NCT03248492|2274250|FG004|Overall Study|Death|0
1156904|NCT03248492|2274246|FG000|Overall Study|Other|0
1156905|NCT03248492|2274247|FG001|Overall Study|Other|1
1156906|NCT03248492|2274248|FG002|Overall Study|Other|0
1156907|NCT03248492|2274249|FG003|Overall Study|Other|4
1156908|NCT03248492|2274250|FG004|Overall Study|Other|0
1156909|NCT03248882|2274275|FG000|Overall Study|Adverse Event|3
1156910|NCT03248882|2274276|FG001|Overall Study|Adverse Event|3
1156911|NCT03248882|2274277|FG002|Overall Study|Adverse Event|2
1156912|NCT03248882|2274278|FG003|Overall Study|Adverse Event|6
1156913|NCT03248882|2274279|FG004|Overall Study|Adverse Event|9
1156914|NCT03248882|2274275|FG000|Overall Study|Lost to Follow-up|0
1156915|NCT03248882|2274276|FG001|Overall Study|Lost to Follow-up|0
1156916|NCT03248882|2274277|FG002|Overall Study|Lost to Follow-up|0
1156917|NCT03248882|2274278|FG003|Overall Study|Lost to Follow-up|0
1156918|NCT03248882|2274279|FG004|Overall Study|Lost to Follow-up|1
1156919|NCT03248882|2274275|FG000|Overall Study|Protocol Violation|2
1156920|NCT03248882|2274276|FG001|Overall Study|Protocol Violation|0
1156921|NCT03248882|2274277|FG002|Overall Study|Protocol Violation|2
1156922|NCT03248882|2274278|FG003|Overall Study|Protocol Violation|0
1156923|NCT03248882|2274279|FG004|Overall Study|Protocol Violation|1
1156924|NCT03248882|2274275|FG000|Overall Study|Withdrawal by Subject|2
1156925|NCT03248882|2274276|FG001|Overall Study|Withdrawal by Subject|2
1156926|NCT03248882|2274277|FG002|Overall Study|Withdrawal by Subject|3
1156927|NCT03248882|2274278|FG003|Overall Study|Withdrawal by Subject|4
1156928|NCT03248882|2274279|FG004|Overall Study|Withdrawal by Subject|2
1156929|NCT03249454|2274338|FG000|Overall Study|Withdrawal by Subject|0
1156930|NCT03249454|2274339|FG001|Overall Study|Withdrawal by Subject|0
1156931|NCT03249454|2274340|FG002|Overall Study|Withdrawal by Subject|0
1156932|NCT03249454|2274341|FG003|Overall Study|Withdrawal by Subject|0
1156933|NCT03249454|2274342|FG004|Overall Study|Withdrawal by Subject|0
1156934|NCT03249454|2274343|FG005|Overall Study|Withdrawal by Subject|0
1156935|NCT03249454|2274344|FG006|Overall Study|Withdrawal by Subject|0
1156936|NCT03249454|2274345|FG007|Overall Study|Withdrawal by Subject|0
1156937|NCT03249454|2274346|FG008|Overall Study|Withdrawal by Subject|0
1156938|NCT03249454|2274347|FG009|Overall Study|Withdrawal by Subject|1
1156939|NCT03249454|2274348|FG010|Overall Study|Withdrawal by Subject|1
1156940|NCT03249909|2274374|FG000|Overall Study|Withdrawal by Subject|3
1156941|NCT03249909|2274375|FG001|Overall Study|Withdrawal by Subject|0
1156942|NCT03249909|2274376|FG002|Overall Study|Withdrawal by Subject|0
1156943|NCT03249909|2274374|FG000|Overall Study|Adverse Event|3
1156944|NCT03249909|2274375|FG001|Overall Study|Adverse Event|0
1156945|NCT03249909|2274376|FG002|Overall Study|Adverse Event|0
1156946|NCT03249909|2274374|FG000|Overall Study|Lost to Follow-up|0
1156947|NCT03249909|2274375|FG001|Overall Study|Lost to Follow-up|1
1156948|NCT03249909|2274376|FG002|Overall Study|Lost to Follow-up|0
1156949|NCT03249935|2274387|FG000|Overall Study|Discharged from facility early|36
1156950|NCT03249935|2274387|FG000|Overall Study|Negative for chlamydia at enrollment|4
1156951|NCT03249935|2274387|FG000|Overall Study|Protocol Violation|5
1156952|NCT03250182|2274393|FG000|Overall Study|Withdrawal by Subject|1
1156953|NCT03251482|2274427|FG000|Overall Study|Withdrawal by Subject|0
1156954|NCT03251482|2274428|FG001|Overall Study|Withdrawal by Subject|1
1156955|NCT03251482|2274429|FG002|Overall Study|Withdrawal by Subject|0
1156956|NCT03251482|2274430|FG003|Overall Study|Withdrawal by Subject|0
1156957|NCT03251482|2274431|FG004|Overall Study|Withdrawal by Subject|0
1156958|NCT03251963|2274449|FG000|Overall Study|inappropriate Xa level timing|6
1156959|NCT03251963|2274450|FG001|Overall Study|inappropriate Xa level timing|3
1156960|NCT03251963|2274449|FG000|Overall Study|no peak Xa level drawn|2
1156961|NCT03251963|2274450|FG001|Overall Study|no peak Xa level drawn|0
1156962|NCT03251963|2274449|FG000|Overall Study|bled prior to Xa level|1
1156963|NCT03251963|2274450|FG001|Overall Study|bled prior to Xa level|2
1156964|NCT03252015|2274460|FG000|Overall Study|Withdrawal by Subject|0
1156965|NCT03252015|2274461|FG001|Overall Study|Withdrawal by Subject|1
1156966|NCT03252015|2274462|FG002|Overall Study|Withdrawal by Subject|1
1156967|NCT03252015|2274463|FG003|Overall Study|Withdrawal by Subject|0
1156968|NCT03252015|2274460|FG000|Overall Study|Adverse Event|1
1156969|NCT03252015|2274461|FG001|Overall Study|Adverse Event|0
1156970|NCT03252015|2274462|FG002|Overall Study|Adverse Event|0
1156971|NCT03252015|2274463|FG003|Overall Study|Adverse Event|1
1156972|NCT03252145|2274489|FG000|Overall Study|Withdrawal by Subject|1
1156973|NCT03252145|2274490|FG001|Overall Study|Withdrawal by Subject|0
1156974|NCT03252145|2274489|FG000|Overall Study|Complicating Disease|1
1156975|NCT03252145|2274490|FG001|Overall Study|Complicating Disease|2
1156976|NCT03253094|2274527|FG000|Overall Study|Adverse Event|2
1156977|NCT03253094|2274528|FG001|Overall Study|Adverse Event|0
1156978|NCT03253094|2274529|FG002|Overall Study|Adverse Event|0
1156979|NCT03253094|2274530|FG003|Overall Study|Adverse Event|0
1156980|NCT03253094|2274531|FG004|Overall Study|Adverse Event|0
1156981|NCT03253094|2274532|FG005|Overall Study|Adverse Event|0
1156982|NCT03253094|2274527|FG000|Overall Study|Lack of Efficacy|0
1156983|NCT03253094|2274528|FG001|Overall Study|Lack of Efficacy|0
1156984|NCT03253094|2274529|FG002|Overall Study|Lack of Efficacy|2
1156985|NCT03253094|2274530|FG003|Overall Study|Lack of Efficacy|1
1156986|NCT03253094|2274531|FG004|Overall Study|Lack of Efficacy|2
1156987|NCT03253094|2274532|FG005|Overall Study|Lack of Efficacy|1
1156988|NCT03253094|2274527|FG000|Overall Study|Lost to Follow-up|0
1156989|NCT03253094|2274528|FG001|Overall Study|Lost to Follow-up|0
1156990|NCT03253094|2274529|FG002|Overall Study|Lost to Follow-up|1
1156991|NCT03253094|2274530|FG003|Overall Study|Lost to Follow-up|1
1156992|NCT03253094|2274531|FG004|Overall Study|Lost to Follow-up|0
1156993|NCT03253094|2274532|FG005|Overall Study|Lost to Follow-up|1
1018317|NCT01570283|2043157|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
1018318|NCT01570283|2043158|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
1018319|NCT01570283|2043159|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
1018320|NCT01570283|2043160|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
1018321|NCT01570283|2043161|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
1018322|NCT01570283|2043162|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
1018323|NCT01570283|2043157|FG000|Cohort 2: Dose Level 2|Death|0
1018324|NCT01570283|2043158|FG001|Cohort 2: Dose Level 2|Death|0
1018325|NCT01570283|2043159|FG002|Cohort 2: Dose Level 2|Death|1
1018326|NCT01570283|2043160|FG003|Cohort 2: Dose Level 2|Death|0
1018327|NCT01570283|2043161|FG004|Cohort 2: Dose Level 2|Death|0
1018328|NCT01570283|2043162|FG005|Cohort 2: Dose Level 2|Death|0
1018329|NCT01570283|2043157|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
1018330|NCT01570283|2043158|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
1018331|NCT01570283|2043159|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
1018332|NCT01570283|2043160|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
1018333|NCT01570283|2043161|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
1018334|NCT01570283|2043162|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
1018335|NCT01570283|2043157|FG000|Cohort 3: Dose Level 3|Death|0
1018336|NCT01570283|2043158|FG001|Cohort 3: Dose Level 3|Death|0
1018337|NCT01570283|2043159|FG002|Cohort 3: Dose Level 3|Death|0
1018338|NCT01570283|2043160|FG003|Cohort 3: Dose Level 3|Death|0
1018339|NCT01570283|2043161|FG004|Cohort 3: Dose Level 3|Death|0
1018340|NCT01570283|2043162|FG005|Cohort 3: Dose Level 3|Death|1
1018341|NCT01570283|2043157|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
1018342|NCT01570283|2043158|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
1018343|NCT01570283|2043159|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
1018344|NCT01570283|2043160|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
1156994|NCT03253094|2274527|FG000|Overall Study|Physician Decision|1
1156995|NCT03253094|2274528|FG001|Overall Study|Physician Decision|0
1156996|NCT03253094|2274529|FG002|Overall Study|Physician Decision|0
1156997|NCT03253094|2274530|FG003|Overall Study|Physician Decision|1
1156998|NCT03253094|2274531|FG004|Overall Study|Physician Decision|0
1156999|NCT03253094|2274532|FG005|Overall Study|Physician Decision|2
1157000|NCT03253094|2274527|FG000|Overall Study|Withdrawal by Subject|1
1157001|NCT03253094|2274528|FG001|Overall Study|Withdrawal by Subject|2
1157002|NCT03253094|2274529|FG002|Overall Study|Withdrawal by Subject|1
1157003|NCT03253094|2274530|FG003|Overall Study|Withdrawal by Subject|0
1157004|NCT03253094|2274531|FG004|Overall Study|Withdrawal by Subject|3
1157005|NCT03253094|2274532|FG005|Overall Study|Withdrawal by Subject|0
1157006|NCT03253094|2274527|FG000|Overall Study|Other|0
1157007|NCT03253094|2274528|FG001|Overall Study|Other|1
1157008|NCT03253094|2274529|FG002|Overall Study|Other|2
1157009|NCT03253094|2274530|FG003|Overall Study|Other|1
1157010|NCT03253094|2274531|FG004|Overall Study|Other|0
1157011|NCT03253094|2274532|FG005|Overall Study|Other|0
1157015|NCT03254108|2274570|FG000|Overall Study|Adverse Event|0
1157016|NCT03254108|2274571|FG001|Overall Study|Adverse Event|2
1157017|NCT03254108|2274572|FG002|Overall Study|Adverse Event|0
1157018|NCT03254108|2274573|FG003|Overall Study|Adverse Event|1
1157019|NCT03254108|2274574|FG004|Overall Study|Adverse Event|1
1157020|NCT03254108|2274570|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
1157021|NCT03254108|2274571|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
1157022|NCT03254108|2274572|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
1157023|NCT03254108|2274573|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
1157024|NCT03254108|2274574|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2
1157025|NCT03254134|2274588|FG000|Overall Study|Not eligible patients|599
1157026|NCT03254134|2274589|FG001|Overall Study|Not eligible patients|3630
1157027|NCT03254459|2274601|FG000|Overall Study|Adverse Event|7
1157028|NCT03254459|2274602|FG001|Overall Study|Adverse Event|20
1157029|NCT03254459|2274601|FG000|Overall Study|Withdrawal by Subject Consent|3
1157030|NCT03254459|2274602|FG001|Overall Study|Withdrawal by Subject Consent|1
1157031|NCT03254459|2274601|FG000|Overall Study|Lost to Follow-up|0
1157032|NCT03254459|2274602|FG001|Overall Study|Lost to Follow-up|1
1157033|NCT03254459|2274601|FG000|Overall Study|Miscellaneous|0
1157034|NCT03254459|2274602|FG001|Overall Study|Miscellaneous|1
1157035|NCT03254602|2274608|FG000|Overall Study|Lost to Follow-up|4
1157036|NCT03255187|2274618|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
1157037|NCT03255187|2274619|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
1157038|NCT03255187|2274618|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0
1157039|NCT03255187|2274619|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1
1157040|NCT03255291|2274631|FG000|Overall Study|Determined to be ineligible|10
1157041|NCT03255291|2274632|FG001|Overall Study|Determined to be ineligible|12
1157042|NCT03255291|2274633|FG002|Overall Study|Determined to be ineligible|6
1157043|NCT03255291|2274634|FG003|Overall Study|Determined to be ineligible|6
1157044|NCT03255291|2274635|FG004|Overall Study|Determined to be ineligible|5
1157045|NCT03255291|2274636|FG005|Overall Study|Determined to be ineligible|10
1157046|NCT03255291|2274631|FG000|Overall Study|Baseline data collection issues|3
1157047|NCT03255291|2274632|FG001|Overall Study|Baseline data collection issues|0
1157048|NCT03255291|2274633|FG002|Overall Study|Baseline data collection issues|0
1157049|NCT03255291|2274634|FG003|Overall Study|Baseline data collection issues|0
1157050|NCT03255291|2274635|FG004|Overall Study|Baseline data collection issues|2
1157051|NCT03255291|2274636|FG005|Overall Study|Baseline data collection issues|0
1157052|NCT03255382|2274656|FG000|Overall Study|Adverse Event|3
1157053|NCT03255382|2274657|FG001|Overall Study|Adverse Event|0
1157054|NCT03255382|2274656|FG000|Overall Study|Lost to Follow-up|2
1157055|NCT03255382|2274657|FG001|Overall Study|Lost to Follow-up|0
1157056|NCT03255382|2274656|FG000|Overall Study|Withdrawal by Subject|2
1157057|NCT03255382|2274657|FG001|Overall Study|Withdrawal by Subject|0
1157058|NCT03255382|2274656|FG000|Overall Study|Other|6
1157059|NCT03255382|2274657|FG001|Overall Study|Other|0
1157060|NCT03255655|2274666|FG000|Overall Study|Lost to Follow-up|7
1157061|NCT03255655|2274667|FG001|Overall Study|Lost to Follow-up|4
1157062|NCT03255733|2274673|FG000|Overall Study|Lost to Follow-up|4
1157063|NCT03255824|2274679|FG000|Overall Study|Under-sedation|2
1157064|NCT03255824|2274680|FG001|Overall Study|Under-sedation|1
1157065|NCT03255941|2274694|FG000|Overall Study|Not eligible or refused injection|37
1157066|NCT03255941|2274695|FG001|Overall Study|Not eligible or refused injection|44
1157067|NCT03255941|2274696|FG002|Overall Study|Not eligible or refused injection|5
1157068|NCT03255941|2274697|FG003|Overall Study|Not eligible or refused injection|6
1157069|NCT03255941|2274694|FG000|Overall Study|Did not complete exit interview|1
1157070|NCT03255941|2274695|FG001|Overall Study|Did not complete exit interview|2
1157071|NCT03255941|2274696|FG002|Overall Study|Did not complete exit interview|0
1157072|NCT03255941|2274697|FG003|Overall Study|Did not complete exit interview|0
1157073|NCT03255980|2274723|FG000|Overall Study|Grade =>3 Skin Toxicity|1
1157074|NCT03255980|2274724|FG001|Overall Study|Grade =>3 Skin Toxicity|4
1157075|NCT03255980|2274725|FG002|Overall Study|Grade =>3 Skin Toxicity|6
1157076|NCT03255980|2274726|FG003|Overall Study|Grade =>3 Skin Toxicity|5
1157077|NCT03255980|2274723|FG000|Overall Study|Adverse Event|1
1157078|NCT03255980|2274724|FG001|Overall Study|Adverse Event|1
1157079|NCT03255980|2274725|FG002|Overall Study|Adverse Event|0
1157080|NCT03255980|2274726|FG003|Overall Study|Adverse Event|1
1157081|NCT03255980|2274723|FG000|Overall Study|Lack of compliance to study or assessmen|0
1157082|NCT03255980|2274724|FG001|Overall Study|Lack of compliance to study or assessmen|1
1157083|NCT03255980|2274725|FG002|Overall Study|Lack of compliance to study or assessmen|0
1157084|NCT03255980|2274726|FG003|Overall Study|Lack of compliance to study or assessmen|0
1157085|NCT03255980|2274723|FG000|Overall Study|Lost to Follow-up|1
1157086|NCT03255980|2274724|FG001|Overall Study|Lost to Follow-up|1
1157087|NCT03255980|2274725|FG002|Overall Study|Lost to Follow-up|0
1157088|NCT03255980|2274726|FG003|Overall Study|Lost to Follow-up|3
1157089|NCT03255980|2274723|FG000|Overall Study|Withdrawal by Subject|0
1157090|NCT03255980|2274724|FG001|Overall Study|Withdrawal by Subject|1
1157091|NCT03255980|2274725|FG002|Overall Study|Withdrawal by Subject|0
1157092|NCT03255980|2274726|FG003|Overall Study|Withdrawal by Subject|3
1157093|NCT03256526|2274778|FG000|Overall Study|Adverse Event|1
1157094|NCT03256526|2274779|FG001|Overall Study|Adverse Event|0
1157095|NCT03256526|2274780|FG002|Overall Study|Adverse Event|1
1157096|NCT03256526|2274778|FG000|Overall Study|Lost to Follow-up|1
1157097|NCT03256526|2274779|FG001|Overall Study|Lost to Follow-up|0
1157098|NCT03256526|2274780|FG002|Overall Study|Lost to Follow-up|2
1157099|NCT03256552|2274788|FG000|Overall Study|Protocol Violation|1
1157100|NCT03256552|2274788|FG000|Overall Study|Physician Decision|1
1157101|NCT03256552|2274788|FG000|Overall Study|Adverse Event|1
1157102|NCT03256552|2274788|FG000|Overall Study|Withdrawal by Subject|2
1157103|NCT03256578|2274800|FG000|Overall Study|Excluded Post Randomization|66
1157104|NCT03256578|2274801|FG001|Overall Study|Excluded Post Randomization|56
1157105|NCT03256695|2274807|FG000|Overall Study|Adverse Event|8
1157106|NCT03256695|2274807|FG000|Overall Study|Death|2
1157107|NCT03256695|2274807|FG000|Overall Study|Withdrawal by Subject|14
1157108|NCT03256695|2274807|FG000|Overall Study|Non-compliance with study drug|1
1157109|NCT03256695|2274807|FG000|Overall Study|Lost to Follow-up|3
1157110|NCT03256695|2274807|FG000|Overall Study|Lack of Efficacy|3
1157111|NCT03256695|2274807|FG000|Overall Study|Protocol Violation|5
1157112|NCT03256695|2274807|FG000|Overall Study|Other than specified|3
1157113|NCT03256851|2274817|FG000|Overall Study|Withdrawal by Subject|1
1157114|NCT03256851|2274818|FG001|Overall Study|Withdrawal by Subject|0
1157115|NCT03257358|2274844|FG000|Overall Study|Adverse Event|25
1157116|NCT03257358|2274845|FG001|Overall Study|Adverse Event|12
1157117|NCT03257358|2274844|FG000|Overall Study|Lack of Efficacy|1
1157118|NCT03257358|2274845|FG001|Overall Study|Lack of Efficacy|1
1157119|NCT03257358|2274844|FG000|Overall Study|Lost to Follow-up|12
1157120|NCT03257358|2274845|FG001|Overall Study|Lost to Follow-up|4
1157121|NCT03257358|2274844|FG000|Overall Study|Non-compliance with fingolimod treatment|4
1157122|NCT03257358|2274845|FG001|Overall Study|Non-compliance with fingolimod treatment|2
1157123|NCT03257358|2274844|FG000|Overall Study|Physician Decision|2
1157124|NCT03257358|2274845|FG001|Overall Study|Physician Decision|2
1157125|NCT03257358|2274844|FG000|Overall Study|Protocol Violation|5
1157126|NCT03257358|2274845|FG001|Overall Study|Protocol Violation|3
1157127|NCT03257358|2274844|FG000|Overall Study|Technical problems|4
1157128|NCT03257358|2274845|FG001|Overall Study|Technical problems|1
1157129|NCT03257358|2274844|FG000|Overall Study|Withdrawal by Subject|8
1157130|NCT03257358|2274845|FG001|Overall Study|Withdrawal by Subject|3
1157131|NCT03257358|2274844|FG000|Overall Study|Withdrawal of informed consent|9
1157132|NCT03257358|2274845|FG001|Overall Study|Withdrawal of informed consent|5
1157133|NCT03257358|2274844|FG000|Overall Study|New therapy for study indication|1
1157134|NCT03257358|2274845|FG001|Overall Study|New therapy for study indication|0
1157135|NCT03257358|2274844|FG000|Overall Study|No longer requires treatment|0
1157136|NCT03257358|2274845|FG001|Overall Study|No longer requires treatment|1
1157137|NCT03257371|2274851|FG000|Overall Study|Lost to Follow-up|1
1157138|NCT03257410|2274857|FG000|Overall Study|Adverse Event|2
1157139|NCT03257410|2274858|FG001|Overall Study|Adverse Event|3
1157140|NCT03257410|2274857|FG000|Overall Study|Protocol Violation|1
1157141|NCT03257410|2274858|FG001|Overall Study|Protocol Violation|2
1157142|NCT03257410|2274857|FG000|Overall Study|Lost to Follow-up|1
1157143|NCT03257410|2274858|FG001|Overall Study|Lost to Follow-up|0
1157144|NCT03257410|2274857|FG000|Overall Study|Withdrawal by Subject|1
1157145|NCT03257410|2274858|FG001|Overall Study|Withdrawal by Subject|2
1157146|NCT03257410|2274857|FG000|Overall Study|Physician Decision|1
1157147|NCT03257410|2274858|FG001|Overall Study|Physician Decision|1
1157148|NCT03257410|2274857|FG000|Overall Study|Renal transplantation|2
1157149|NCT03257410|2274858|FG001|Overall Study|Renal transplantation|0
1157150|NCT03257410|2274857|FG000|Overall Study|Switch to peritoneal dialysis|1
1157151|NCT03257410|2274858|FG001|Overall Study|Switch to peritoneal dialysis|0
1157152|NCT03257410|2274857|FG000|Overall Study|Death|3
1157153|NCT03257410|2274858|FG001|Overall Study|Death|2
1157154|NCT03257410|2274857|FG000|Overall Study|Change to another dialysis center|2
1157155|NCT03257410|2274858|FG001|Overall Study|Change to another dialysis center|2
1157156|NCT03257410|2274857|FG000|Overall Study|Missing 3 consecutive study treatments|5
1157157|NCT03257410|2274858|FG001|Overall Study|Missing 3 consecutive study treatments|6
1157158|NCT03257410|2274857|FG000|Overall Study|Miscellaneous|2
1157159|NCT03257410|2274858|FG001|Overall Study|Miscellaneous|2
1157160|NCT03257410|2274857|FG000|Overall Study|Other|0
1157161|NCT03257410|2274858|FG001|Overall Study|Other|1
1157162|NCT03257631|2274868|FG000|Overall Study|Death|8
1157163|NCT03257631|2274869|FG001|Overall Study|Death|5
1157164|NCT03257631|2274870|FG002|Overall Study|Death|13
1157165|NCT03257631|2274871|FG003|Overall Study|Death|5
1157166|NCT03257631|2274868|FG000|Overall Study|Progressive Disease|0
1157167|NCT03257631|2274869|FG001|Overall Study|Progressive Disease|0
1157168|NCT03257631|2274870|FG002|Overall Study|Progressive Disease|1
1157169|NCT03257631|2274871|FG003|Overall Study|Progressive Disease|0
1157170|NCT03257631|2274868|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1157171|NCT03257631|2274869|FG001|Overall Study|Withdrawal by Parent/Guardian|2
1157172|NCT03257631|2274870|FG002|Overall Study|Withdrawal by Parent/Guardian|4
1157173|NCT03257631|2274871|FG003|Overall Study|Withdrawal by Parent/Guardian|1
1157174|NCT03257631|2274868|FG000|Overall Study|Lost to Follow-up|0
1157175|NCT03257631|2274869|FG001|Overall Study|Lost to Follow-up|0
1157176|NCT03257631|2274870|FG002|Overall Study|Lost to Follow-up|1
1157177|NCT03257631|2274871|FG003|Overall Study|Lost to Follow-up|0
1157178|NCT03257631|2274868|FG000|Overall Study|Still on Study|3
1157179|NCT03257631|2274869|FG001|Overall Study|Still on Study|2
1157180|NCT03257631|2274870|FG002|Overall Study|Still on Study|4
1157181|NCT03257631|2274871|FG003|Overall Study|Still on Study|4
1157182|NCT03257657|2274883|FG000|Overall Study|Lost to Follow-up|0
1157183|NCT03257657|2274884|FG001|Overall Study|Lost to Follow-up|3
1157184|NCT03257657|2274883|FG000|Overall Study|Withdrawn|0
1157185|NCT03257657|2274884|FG001|Overall Study|Withdrawn|1
1157186|NCT03257657|2274883|FG000|Overall Study|Noted not eligible right after enrolled|0
1157187|NCT03257657|2274884|FG001|Overall Study|Noted not eligible right after enrolled|1
1157188|NCT03257813|2274893|FG000|Overall Study|Protocol Violation|6
1157189|NCT03257813|2274894|FG001|Overall Study|Protocol Violation|3
1157190|NCT03257865|2274905|FG000|Overall Study|Adverse Event|4
1157191|NCT03257865|2274906|FG001|Overall Study|Adverse Event|8
1157192|NCT03257865|2274905|FG000|Overall Study|Lack of Efficacy|1
1157193|NCT03257865|2274906|FG001|Overall Study|Lack of Efficacy|2
1157194|NCT03257865|2274905|FG000|Overall Study|Non-compliance with Study Drug|0
1157195|NCT03257865|2274906|FG001|Overall Study|Non-compliance with Study Drug|2
1157196|NCT03257865|2274905|FG000|Overall Study|Withdrawal by Subject|23
1157197|NCT03257865|2274906|FG001|Overall Study|Withdrawal by Subject|17
1157198|NCT03257865|2274905|FG000|Overall Study|Physician Decision|3
1157199|NCT03257865|2274906|FG001|Overall Study|Physician Decision|1
1157200|NCT03257865|2274905|FG000|Overall Study|Other|0
1157201|NCT03257865|2274906|FG001|Overall Study|Other|1
1157202|NCT03257865|2274905|FG000|Overall Study|Lost to Follow-up|4
1157203|NCT03257865|2274906|FG001|Overall Study|Lost to Follow-up|4
1157204|NCT03257995|2274912|FG000|Overall Study|Adverse Event|0
1157205|NCT03257995|2274913|FG001|Overall Study|Adverse Event|1
1157206|NCT03257995|2274914|FG002|Overall Study|Adverse Event|0
1157207|NCT03257995|2274915|FG003|Overall Study|Adverse Event|0
1157208|NCT03257995|2274916|FG004|Overall Study|Adverse Event|0
1157209|NCT03257995|2274917|FG005|Overall Study|Adverse Event|0
1157210|NCT03257995|2274912|FG000|Overall Study|Protocol deviation|0
1157211|NCT03257995|2274913|FG001|Overall Study|Protocol deviation|0
1157212|NCT03257995|2274914|FG002|Overall Study|Protocol deviation|0
1157213|NCT03257995|2274915|FG003|Overall Study|Protocol deviation|0
1157214|NCT03257995|2274916|FG004|Overall Study|Protocol deviation|0
1157215|NCT03257995|2274917|FG005|Overall Study|Protocol deviation|2
1157216|NCT03258814|2274955|FG000|Overall Study|Early Termination|4
1157217|NCT03258814|2274956|FG001|Overall Study|Early Termination|3
1157218|NCT03258814|2274957|FG002|Overall Study|Early Termination|10
1157219|NCT03259087|2274969|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0
1157220|NCT03259087|2274970|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0
1157221|NCT03259087|2274971|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0
1157222|NCT03259087|2274972|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0
1157223|NCT03259087|2274973|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1
1157224|NCT03259087|2274969|FG000|Period 2 of Part 2|Adverse Event|0
1157225|NCT03259087|2274970|FG001|Period 2 of Part 2|Adverse Event|0
1157226|NCT03259087|2274971|FG002|Period 2 of Part 2|Adverse Event|0
1157227|NCT03259087|2274972|FG003|Period 2 of Part 2|Adverse Event|0
1157228|NCT03259087|2274973|FG004|Period 2 of Part 2|Adverse Event|1
1157229|NCT03259308|2275026|FG000|Overall Study|Adverse Event|5
1157230|NCT03259308|2275027|FG001|Overall Study|Adverse Event|4
1157231|NCT03259308|2275028|FG002|Overall Study|Adverse Event|1
1157232|NCT03259308|2275026|FG000|Overall Study|Withdrawal by Subject|2
1157233|NCT03259308|2275027|FG001|Overall Study|Withdrawal by Subject|1
1157234|NCT03259308|2275028|FG002|Overall Study|Withdrawal by Subject|3
1157235|NCT03259308|2275026|FG000|Overall Study|Lost to Follow-up|0
1157236|NCT03259308|2275027|FG001|Overall Study|Lost to Follow-up|0
1157237|NCT03259308|2275028|FG002|Overall Study|Lost to Follow-up|1
1157238|NCT03259308|2275026|FG000|Overall Study|Pregnancy|0
1157239|NCT03259308|2275027|FG001|Overall Study|Pregnancy|0
1157240|NCT03259308|2275028|FG002|Overall Study|Pregnancy|1
1157241|NCT03259308|2275026|FG000|Overall Study|Protocol Deviation|0
1157242|NCT03259308|2275027|FG001|Overall Study|Protocol Deviation|3
1157243|NCT03259308|2275028|FG002|Overall Study|Protocol Deviation|0
1157244|NCT03259308|2275026|FG000|Overall Study|Lack of Efficacy|0
1157245|NCT03259308|2275027|FG001|Overall Study|Lack of Efficacy|0
1157246|NCT03259308|2275028|FG002|Overall Study|Lack of Efficacy|1
1157247|NCT03259334|2275039|FG000|Overall Study|Adverse Event|3
1157248|NCT03259334|2275040|FG001|Overall Study|Adverse Event|8
1157249|NCT03259334|2275041|FG002|Overall Study|Adverse Event|5
1157250|NCT03259334|2275039|FG000|Overall Study|Withdrawal by Subject|4
1157251|NCT03259334|2275040|FG001|Overall Study|Withdrawal by Subject|2
1157252|NCT03259334|2275041|FG002|Overall Study|Withdrawal by Subject|4
1157253|NCT03259334|2275039|FG000|Overall Study|Physician Decision|1
1157254|NCT03259334|2275040|FG001|Overall Study|Physician Decision|0
1157255|NCT03259334|2275041|FG002|Overall Study|Physician Decision|0
1157256|NCT03259334|2275039|FG000|Overall Study|Lost to Follow-up|0
1157257|NCT03259334|2275040|FG001|Overall Study|Lost to Follow-up|2
1157258|NCT03259334|2275041|FG002|Overall Study|Lost to Follow-up|1
1157259|NCT03259334|2275039|FG000|Overall Study|Protocol Deviation|0
1157260|NCT03259334|2275040|FG001|Overall Study|Protocol Deviation|3
1157261|NCT03259334|2275041|FG002|Overall Study|Protocol Deviation|2
1157262|NCT03259334|2275039|FG000|Overall Study|Lack of Efficacy|2
1157263|NCT03259334|2275040|FG001|Overall Study|Lack of Efficacy|0
1157264|NCT03259334|2275041|FG002|Overall Study|Lack of Efficacy|1
1157265|NCT03259334|2275039|FG000|Overall Study|Randomized but never treated|0
1157266|NCT03259334|2275040|FG001|Overall Study|Randomized but never treated|2
1157267|NCT03259334|2275041|FG002|Overall Study|Randomized but never treated|0
1157268|NCT03259425|2275049|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1
1157269|NCT03259490|2275055|FG000|Period 1|Withdrawal by Subject|0
1157270|NCT03259490|2275056|FG001|Period 1|Withdrawal by Subject|1
1157271|NCT03259490|2275055|FG000|Period 2|Protocol Violation|1
1157272|NCT03259490|2275056|FG001|Period 2|Protocol Violation|0
1157273|NCT03259555|2275064|FG000|Overall Study|Adverse Event|6
1157274|NCT03259555|2275065|FG001|Overall Study|Adverse Event|4
1157275|NCT03259555|2275064|FG000|Overall Study|Lack of Efficacy|6
1157276|NCT03259555|2275065|FG001|Overall Study|Lack of Efficacy|4
1157277|NCT03259555|2275064|FG000|Overall Study|Lost to Follow-up|0
1157278|NCT03259555|2275065|FG001|Overall Study|Lost to Follow-up|2
1157279|NCT03259555|2275064|FG000|Overall Study|Non-Compliance With Study Drug|1
1157280|NCT03259555|2275065|FG001|Overall Study|Non-Compliance With Study Drug|0
1157281|NCT03259555|2275064|FG000|Overall Study|Progressive Disease|0
1157282|NCT03259555|2275065|FG001|Overall Study|Progressive Disease|2
1157283|NCT03259555|2275064|FG000|Overall Study|Withdrawal by Subject|19
1157284|NCT03259555|2275065|FG001|Overall Study|Withdrawal by Subject|16
1157285|NCT03259555|2275064|FG000|Overall Study|Physician Decision|1
1157286|NCT03259555|2275065|FG001|Overall Study|Physician Decision|2
1157287|NCT03259555|2275064|FG000|Overall Study|Other|1
1157288|NCT03259555|2275065|FG001|Overall Study|Other|0
1157289|NCT03259789|2275074|FG000|Overall Study|Adverse Event|3
1157290|NCT03259789|2275075|FG001|Overall Study|Adverse Event|2
1157291|NCT03259789|2275076|FG002|Overall Study|Adverse Event|1
1157292|NCT03259789|2275074|FG000|Overall Study|Withdrawal by Subject|9
1157293|NCT03259789|2275075|FG001|Overall Study|Withdrawal by Subject|5
1157294|NCT03259789|2275076|FG002|Overall Study|Withdrawal by Subject|1
1157295|NCT03259789|2275074|FG000|Overall Study|Lost to Follow-up|5
1157296|NCT03259789|2275075|FG001|Overall Study|Lost to Follow-up|9
1157297|NCT03259789|2275076|FG002|Overall Study|Lost to Follow-up|4
1157298|NCT03259789|2275074|FG000|Overall Study|Physician Decision|0
1157299|NCT03259789|2275075|FG001|Overall Study|Physician Decision|1
1157300|NCT03259789|2275076|FG002|Overall Study|Physician Decision|0
1157301|NCT03260205|2275090|FG000|Overall Study|Adverse Event|2
1157302|NCT03260205|2275091|FG001|Overall Study|Adverse Event|0
1157303|NCT03260205|2275092|FG002|Overall Study|Adverse Event|2
1157304|NCT03260205|2275093|FG003|Overall Study|Adverse Event|2
1157305|NCT03260205|2275094|FG004|Overall Study|Adverse Event|4
1157306|NCT03260205|2275090|FG000|Overall Study|Lost to Follow-up|2
1157307|NCT03260205|2275091|FG001|Overall Study|Lost to Follow-up|2
1157308|NCT03260205|2275092|FG002|Overall Study|Lost to Follow-up|1
1157309|NCT03260205|2275093|FG003|Overall Study|Lost to Follow-up|1
1157310|NCT03260205|2275094|FG004|Overall Study|Lost to Follow-up|5
1157311|NCT03260205|2275090|FG000|Overall Study|Protocol Violation|0
1157312|NCT03260205|2275091|FG001|Overall Study|Protocol Violation|0
1157313|NCT03260205|2275092|FG002|Overall Study|Protocol Violation|2
1157314|NCT03260205|2275093|FG003|Overall Study|Protocol Violation|0
1157315|NCT03260205|2275094|FG004|Overall Study|Protocol Violation|1
1157316|NCT03260205|2275090|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4
1157317|NCT03260205|2275091|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5
1157318|NCT03260205|2275092|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1
1157319|NCT03260205|2275093|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0
1157320|NCT03260205|2275094|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2
1157321|NCT03260205|2275090|FG000|Overall Study|Other: Unspecified|0
1157322|NCT03260205|2275091|FG001|Overall Study|Other: Unspecified|0
1157323|NCT03260205|2275092|FG002|Overall Study|Other: Unspecified|3
1157324|NCT03260205|2275093|FG003|Overall Study|Other: Unspecified|1
1157325|NCT03260205|2275094|FG004|Overall Study|Other: Unspecified|1
1157326|NCT03260205|2275090|FG000|Overall Study|Participant Who Did Not Received AnyDose|1
1157327|NCT03260205|2275091|FG001|Overall Study|Participant Who Did Not Received AnyDose|1
1157328|NCT03260205|2275092|FG002|Overall Study|Participant Who Did Not Received AnyDose|2
1157329|NCT03260205|2275093|FG003|Overall Study|Participant Who Did Not Received AnyDose|3
1157330|NCT03260205|2275094|FG004|Overall Study|Participant Who Did Not Received AnyDose|1
1157331|NCT03260868|2275153|FG000|Overall Study|Poor Compliance to Protocol|0
1157332|NCT03260868|2275154|FG001|Overall Study|Poor Compliance to Protocol|2
1157333|NCT03260868|2275153|FG000|Overall Study|Study Terminated By Sponsor|2
1157334|NCT03260868|2275154|FG001|Overall Study|Study Terminated By Sponsor|1
1157335|NCT03260868|2275153|FG000|Overall Study|Other than specified above|1
1157336|NCT03260868|2275154|FG001|Overall Study|Other than specified above|0
1157337|NCT03260894|2275162|FG000|Overall Study|Death|6
1157338|NCT03260894|2275163|FG001|Overall Study|Death|8
1157339|NCT03260894|2275162|FG000|Overall Study|Withdrawal by Subject|4
1157340|NCT03260894|2275163|FG001|Overall Study|Withdrawal by Subject|11
1157341|NCT03260894|2275162|FG000|Overall Study|On-going at clinical cut off date|36
1157342|NCT03260894|2275163|FG001|Overall Study|On-going at clinical cut off date|31
1157343|NCT03261037|2275173|FG000|Overall Study|Withdrawal by Subject|2
1157344|NCT03261037|2275174|FG001|Overall Study|Withdrawal by Subject|13
1157345|NCT03261037|2275175|FG002|Overall Study|Withdrawal by Subject|0
1157346|NCT03261037|2275176|FG003|Overall Study|Withdrawal by Subject|18
1157347|NCT03261037|2275173|FG000|Overall Study|Non-compliance with study procedures|0
1157348|NCT03261037|2275174|FG001|Overall Study|Non-compliance with study procedures|2
1157349|NCT03261037|2275175|FG002|Overall Study|Non-compliance with study procedures|0
1157350|NCT03261037|2275176|FG003|Overall Study|Non-compliance with study procedures|6
1157351|NCT03261037|2275173|FG000|Overall Study|Participant moving away and can no longer be in study|0
1157352|NCT03261037|2275174|FG001|Overall Study|Participant moving away and can no longer be in study|1
1157353|NCT03261037|2275175|FG002|Overall Study|Participant moving away and can no longer be in study|0
1157354|NCT03261037|2275176|FG003|Overall Study|Participant moving away and can no longer be in study|0
1157355|NCT03261037|2275173|FG000|Overall Study|Participant came out of study due to investigator discretion|0
1157356|NCT03261037|2275174|FG001|Overall Study|Participant came out of study due to investigator discretion|2
1157357|NCT03261037|2275175|FG002|Overall Study|Participant came out of study due to investigator discretion|0
1157358|NCT03261037|2275176|FG003|Overall Study|Participant came out of study due to investigator discretion|0
1157359|NCT03261037|2275173|FG000|Overall Study|Diagnosed but protocol deviation|1
1157360|NCT03261037|2275174|FG001|Overall Study|Diagnosed but protocol deviation|0
1157361|NCT03261037|2275175|FG002|Overall Study|Diagnosed but protocol deviation|0
1157362|NCT03261037|2275176|FG003|Overall Study|Diagnosed but protocol deviation|0
1157363|NCT03261037|2275173|FG000|Overall Study|Participant did not want to continue the study|0
1157364|NCT03261037|2275174|FG001|Overall Study|Participant did not want to continue the study|1
1157365|NCT03261037|2275175|FG002|Overall Study|Participant did not want to continue the study|0
1157366|NCT03261037|2275176|FG003|Overall Study|Participant did not want to continue the study|0
1157367|NCT03261037|2275173|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0
1157368|NCT03261037|2275174|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0
1157369|NCT03261037|2275175|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0
1157370|NCT03261037|2275176|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1
1157371|NCT03261037|2275173|FG000|Overall Study|Participant presented clinical improvement|0
1157372|NCT03261037|2275174|FG001|Overall Study|Participant presented clinical improvement|2
1157373|NCT03261037|2275175|FG002|Overall Study|Participant presented clinical improvement|0
1157374|NCT03261037|2275176|FG003|Overall Study|Participant presented clinical improvement|0
1157375|NCT03261037|2275173|FG000|Overall Study|Technical difficulties|0
1157376|NCT03261037|2275174|FG001|Overall Study|Technical difficulties|0
1157377|NCT03261037|2275175|FG002|Overall Study|Technical difficulties|0
1157378|NCT03261037|2275176|FG003|Overall Study|Technical difficulties|1
1157379|NCT03261037|2275173|FG000|Overall Study|Equipment failed to work|0
1157380|NCT03261037|2275174|FG001|Overall Study|Equipment failed to work|0
1157381|NCT03261037|2275175|FG002|Overall Study|Equipment failed to work|0
1157382|NCT03261037|2275176|FG003|Overall Study|Equipment failed to work|1
1157383|NCT03261037|2275173|FG000|Overall Study|End of study for participant and no follow up|0
1157384|NCT03261037|2275174|FG001|Overall Study|End of study for participant and no follow up|0
1157385|NCT03261037|2275175|FG002|Overall Study|End of study for participant and no follow up|0
1157386|NCT03261037|2275176|FG003|Overall Study|End of study for participant and no follow up|1
1157387|NCT03261037|2275173|FG000|Overall Study|Participant was too weak to continue in study|1
1157388|NCT03261037|2275174|FG001|Overall Study|Participant was too weak to continue in study|0
1157389|NCT03261037|2275175|FG002|Overall Study|Participant was too weak to continue in study|0
1157390|NCT03261037|2275176|FG003|Overall Study|Participant was too weak to continue in study|0
1157391|NCT03261167|2275189|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
1157392|NCT03261167|2275190|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
1157393|NCT03261167|2275189|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
1157394|NCT03261167|2275190|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
1157395|NCT03261167|2275189|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
1157396|NCT03261167|2275190|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
1157397|NCT03261167|2275189|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
1157398|NCT03261167|2275190|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
1157399|NCT03261167|2275189|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
1157400|NCT03261167|2275190|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
1157401|NCT03261336|2275202|FG000|Overall Study|Adverse Event|1
1157402|NCT03261947|2275211|FG000|Overall Study|Death|10
1157403|NCT03261947|2275212|FG001|Overall Study|Death|13
1157404|NCT03261947|2275213|FG002|Overall Study|Death|17
1157405|NCT03261947|2275214|FG003|Overall Study|Death|12
1157406|NCT03261947|2275215|FG004|Overall Study|Death|8
1157407|NCT03261947|2275211|FG000|Overall Study|Lost to Follow-up|0
1157408|NCT03261947|2275212|FG001|Overall Study|Lost to Follow-up|0
1157409|NCT03261947|2275213|FG002|Overall Study|Lost to Follow-up|2
1157410|NCT03261947|2275214|FG003|Overall Study|Lost to Follow-up|1
1157411|NCT03261947|2275215|FG004|Overall Study|Lost to Follow-up|0
1157412|NCT03261947|2275211|FG000|Overall Study|Withdrawal by Subject|0
1157413|NCT03261947|2275212|FG001|Overall Study|Withdrawal by Subject|0
1157414|NCT03261947|2275213|FG002|Overall Study|Withdrawal by Subject|3
1157415|NCT03261947|2275214|FG003|Overall Study|Withdrawal by Subject|0
1157416|NCT03261947|2275215|FG004|Overall Study|Withdrawal by Subject|1
1157417|NCT03261947|2275211|FG000|Overall Study|Site Terminated by Sponsor|0
1157418|NCT03261947|2275212|FG001|Overall Study|Site Terminated by Sponsor|0
1157419|NCT03261947|2275213|FG002|Overall Study|Site Terminated by Sponsor|4
1157420|NCT03261947|2275214|FG003|Overall Study|Site Terminated by Sponsor|7
1157421|NCT03261947|2275215|FG004|Overall Study|Site Terminated by Sponsor|5
1157422|NCT03261947|2275211|FG000|Overall Study|Reason not Specified|2
1157423|NCT03261947|2275212|FG001|Overall Study|Reason not Specified|0
1157424|NCT03261947|2275213|FG002|Overall Study|Reason not Specified|4
1157425|NCT03261947|2275214|FG003|Overall Study|Reason not Specified|1
1157426|NCT03261947|2275215|FG004|Overall Study|Reason not Specified|3
1157427|NCT03262012|2275252|FG000|Overall Study|Withdrawal by Subject|15
1157428|NCT03262012|2275253|FG001|Overall Study|Withdrawal by Subject|13
1157429|NCT03262012|2275254|FG002|Overall Study|Withdrawal by Subject|8
1157430|NCT03262012|2275255|FG003|Overall Study|Withdrawal by Subject|7
1157431|NCT03262012|2275252|FG000|Overall Study|Adverse Event|10
1157432|NCT03262012|2275253|FG001|Overall Study|Adverse Event|12
1157433|NCT03262012|2275254|FG002|Overall Study|Adverse Event|4
1157434|NCT03262012|2275255|FG003|Overall Study|Adverse Event|6
1157435|NCT03262012|2275252|FG000|Overall Study|Physician Decision|2
1157436|NCT03262012|2275253|FG001|Overall Study|Physician Decision|5
1157437|NCT03262012|2275254|FG002|Overall Study|Physician Decision|1
1157438|NCT03262012|2275255|FG003|Overall Study|Physician Decision|0
1157439|NCT03262012|2275252|FG000|Overall Study|Lack of Efficacy|0
1157440|NCT03262012|2275253|FG001|Overall Study|Lack of Efficacy|5
1157441|NCT03262012|2275254|FG002|Overall Study|Lack of Efficacy|1
1157442|NCT03262012|2275255|FG003|Overall Study|Lack of Efficacy|2
1157443|NCT03262012|2275252|FG000|Overall Study|Protocol Discontinuation Criteria|0
1157444|NCT03262012|2275253|FG001|Overall Study|Protocol Discontinuation Criteria|1
1157445|NCT03262012|2275254|FG002|Overall Study|Protocol Discontinuation Criteria|0
1157446|NCT03262012|2275255|FG003|Overall Study|Protocol Discontinuation Criteria|0
1157447|NCT03262038|2275267|FG000|Overall Study|Withdrawal by Subject|0
1157448|NCT03262038|2275268|FG001|Overall Study|Withdrawal by Subject|1
1157449|NCT03262233|2275278|FG000|Overall Study|Withdrawal by Subject|12
1157450|NCT03262233|2275279|FG001|Overall Study|Withdrawal by Subject|8
1157451|NCT03262233|2275280|FG002|Overall Study|Withdrawal by Subject|21
1157452|NCT03262233|2275281|FG003|Overall Study|Withdrawal by Subject|13
1157453|NCT03262233|2275278|FG000|Overall Study|Declined due to shock|1
1157454|NCT03262233|2275279|FG001|Overall Study|Declined due to shock|2
1157455|NCT03262233|2275280|FG002|Overall Study|Declined due to shock|2
1157456|NCT03262233|2275281|FG003|Overall Study|Declined due to shock|3
1157457|NCT03262233|2275278|FG000|Overall Study|Protocol Violation|5
1157458|NCT03262233|2275279|FG001|Overall Study|Protocol Violation|10
1157459|NCT03262233|2275280|FG002|Overall Study|Protocol Violation|2
1157460|NCT03262233|2275281|FG003|Overall Study|Protocol Violation|13
1157461|NCT03262233|2275278|FG000|Overall Study|data collection artifact|0
1157462|NCT03262233|2275279|FG001|Overall Study|data collection artifact|1
1157463|NCT03262233|2275280|FG002|Overall Study|data collection artifact|0
1157464|NCT03262233|2275281|FG003|Overall Study|data collection artifact|0
1157465|NCT03262389|2275292|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1
1157466|NCT03262389|2275292|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1
1157467|NCT03262389|2275292|FG000|Overall Study|opted out of PET/MR|1
1157468|NCT03262441|2275296|FG000|Overall Study|Withdrawal by Subject|1
1157469|NCT03263442|2275302|FG000|Inpatient Phase|Death|1
1157470|NCT03263442|2275303|FG001|Inpatient Phase|Death|0
1157471|NCT03263442|2275302|FG000|Inpatient Phase|Withdrawal by Subject|1
1157472|NCT03263442|2275303|FG001|Inpatient Phase|Withdrawal by Subject|0
1157473|NCT03263442|2275302|FG000|Inpatient Phase|Inadequate Drug Exposure|0
1157474|NCT03263442|2275303|FG001|Inpatient Phase|Inadequate Drug Exposure|1
1157475|NCT03263442|2275302|FG000|1-month Follow-Up|Lost to Follow-up|1
1157476|NCT03263442|2275303|FG001|1-month Follow-Up|Lost to Follow-up|0
1157477|NCT03263442|2275302|FG000|3-month Follow-Up|Lost to Follow-up|1
1157478|NCT03263442|2275303|FG001|3-month Follow-Up|Lost to Follow-up|3
1157479|NCT03263442|2275302|FG000|6-month Follow-Up|Lost to Follow-up|2
1157480|NCT03263442|2275303|FG001|6-month Follow-Up|Lost to Follow-up|2
1157481|NCT03263702|2275313|FG000|Overall Study|Lost to Follow-up|2
1157482|NCT03263702|2275314|FG001|Overall Study|Lost to Follow-up|2
1157483|NCT03263702|2275313|FG000|Overall Study|Withdrawal by Subject|1
1157484|NCT03263702|2275314|FG001|Overall Study|Withdrawal by Subject|2
1157485|NCT03263780|2275320|FG000|Overall Study|Withdrawal by Subject|3
1157486|NCT03263780|2275320|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7
1157487|NCT03264066|2275330|FG000|Overall Study|Adverse Event|1
1157488|NCT03264066|2275331|FG001|Overall Study|Adverse Event|1
1157489|NCT03264066|2275332|FG002|Overall Study|Adverse Event|0
1157490|NCT03264066|2275333|FG003|Overall Study|Adverse Event|0
1157491|NCT03264066|2275334|FG004|Overall Study|Adverse Event|0
1157492|NCT03264066|2275335|FG005|Overall Study|Adverse Event|0
1157493|NCT03264066|2275330|FG000|Overall Study|Death|12
1157494|NCT03264066|2275331|FG001|Overall Study|Death|12
1157495|NCT03264066|2275332|FG002|Overall Study|Death|8
1157496|NCT03264066|2275333|FG003|Overall Study|Death|10
1157497|NCT03264066|2275334|FG004|Overall Study|Death|6
1157498|NCT03264066|2275335|FG005|Overall Study|Death|1
1157499|NCT03264066|2275330|FG000|Overall Study|Lost to Follow-up|1
1157500|NCT03264066|2275331|FG001|Overall Study|Lost to Follow-up|0
1157501|NCT03264066|2275332|FG002|Overall Study|Lost to Follow-up|0
1157502|NCT03264066|2275333|FG003|Overall Study|Lost to Follow-up|0
1157503|NCT03264066|2275334|FG004|Overall Study|Lost to Follow-up|0
1157504|NCT03264066|2275335|FG005|Overall Study|Lost to Follow-up|0
1157505|NCT03264066|2275330|FG000|Overall Study|Progressive Disease|0
1157506|NCT03264066|2275331|FG001|Overall Study|Progressive Disease|2
1157507|NCT03264066|2275332|FG002|Overall Study|Progressive Disease|1
1157508|NCT03264066|2275333|FG003|Overall Study|Progressive Disease|0
1157509|NCT03264066|2275334|FG004|Overall Study|Progressive Disease|0
1157510|NCT03264066|2275335|FG005|Overall Study|Progressive Disease|0
1157511|NCT03264066|2275330|FG000|Overall Study|Study Terminated by Sponsor|5
1157512|NCT03264066|2275331|FG001|Overall Study|Study Terminated by Sponsor|5
1157513|NCT03264066|2275332|FG002|Overall Study|Study Terminated by Sponsor|8
1157514|NCT03264066|2275333|FG003|Overall Study|Study Terminated by Sponsor|5
1157515|NCT03264066|2275334|FG004|Overall Study|Study Terminated by Sponsor|1
1157516|NCT03264066|2275335|FG005|Overall Study|Study Terminated by Sponsor|2
1157517|NCT03264066|2275330|FG000|Overall Study|Withdrawal by Subject|1
1157518|NCT03264066|2275331|FG001|Overall Study|Withdrawal by Subject|0
1157519|NCT03264066|2275332|FG002|Overall Study|Withdrawal by Subject|0
1157520|NCT03264066|2275333|FG003|Overall Study|Withdrawal by Subject|5
1157521|NCT03264066|2275334|FG004|Overall Study|Withdrawal by Subject|0
1157522|NCT03264066|2275335|FG005|Overall Study|Withdrawal by Subject|0
1157523|NCT03264456|2275384|FG000|Overall Study|Withdrawal by Subject|3
1157524|NCT03264456|2275384|FG000|Overall Study|Lost to Follow-up|1
1157525|NCT03265119|2275390|FG000|Overall Study|Adverse Event|2
1157526|NCT03265119|2275391|FG001|Overall Study|Adverse Event|1
1157527|NCT03265119|2275390|FG000|Overall Study|Lack of Efficacy|3
1157528|NCT03265119|2275391|FG001|Overall Study|Lack of Efficacy|0
1157529|NCT03265119|2275390|FG000|Overall Study|Protocol Violation|1
1157530|NCT03265119|2275391|FG001|Overall Study|Protocol Violation|2
1157531|NCT03265119|2275390|FG000|Overall Study|Withdrawal by Subject|2
1157532|NCT03265119|2275391|FG001|Overall Study|Withdrawal by Subject|4
1157533|NCT03265119|2275390|FG000|Overall Study|Lost to Follow-up|1
1157534|NCT03265119|2275391|FG001|Overall Study|Lost to Follow-up|0
1157535|NCT03265119|2275390|FG000|Overall Study|Lack of Compliance|1
1157536|NCT03265119|2275391|FG001|Overall Study|Lack of Compliance|0
1157537|NCT03265132|2275399|FG000|Overall Study|Adverse Event|0
1157538|NCT03265132|2275400|FG001|Overall Study|Adverse Event|1
1157539|NCT03265132|2275399|FG000|Overall Study|Lack of Efficacy|0
1157540|NCT03265132|2275400|FG001|Overall Study|Lack of Efficacy|2
1157541|NCT03265132|2275399|FG000|Overall Study|Progressive disease|0
1157542|NCT03265132|2275400|FG001|Overall Study|Progressive disease|2
1157543|NCT03265132|2275399|FG000|Overall Study|Withdrawal by Subject|0
1157544|NCT03265132|2275400|FG001|Overall Study|Withdrawal by Subject|1
1157545|NCT03265600|2275410|FG000|Overall Study|Lost to Follow-up|17
1157546|NCT03265600|2275411|FG001|Overall Study|Lost to Follow-up|5
1157547|NCT03265600|2275410|FG000|Overall Study|Withdrawal by Subject|4
1157548|NCT03265600|2275411|FG001|Overall Study|Withdrawal by Subject|2
1157549|NCT03265600|2275410|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3
1157550|NCT03265600|2275411|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5
1157551|NCT03265938|2275417|FG000|Overall Study|Withdrawal by Subject|1
1157552|NCT03265938|2275417|FG000|Overall Study|Physician Decision|1
1157553|NCT03265938|2275417|FG000|Overall Study|friable mass|6
1157554|NCT03266094|2275422|FG000|Overall Study|Lost to Follow-up|1
1157555|NCT03266094|2275422|FG000|Overall Study|Withdrawal by Subject|1
1157556|NCT03266107|2275428|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1
1157557|NCT03266107|2275428|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2
1157558|NCT03266107|2275428|FG000|3-Month Follow-up Visit|Lost to Follow-up|1
1157559|NCT03266107|2275428|FG000|12-Month Follow-up Visit|Lost to Follow-up|1
1157560|NCT03266172|2275437|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1
1157561|NCT03266172|2275438|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0
1157562|NCT03266172|2275439|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0
1157563|NCT03266172|2275437|FG000|Part A: Washout Period (7 Days)|Adverse Event|1
1157564|NCT03266172|2275438|FG001|Part A: Washout Period (7 Days)|Adverse Event|0
1157565|NCT03266172|2275439|FG002|Part A: Washout Period (7 Days)|Adverse Event|0
1157566|NCT03266172|2275437|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
1157567|NCT03266172|2275438|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
1157568|NCT03266172|2275439|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
1157569|NCT03266172|2275437|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0
1157570|NCT03266172|2275438|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2
1157571|NCT03266172|2275439|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0
1157572|NCT03266172|2275437|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
1157573|NCT03266172|2275438|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
1157574|NCT03266172|2275439|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
1157575|NCT03266172|2275437|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
1157576|NCT03266172|2275438|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
1157577|NCT03266172|2275439|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
1157578|NCT03266588|2275501|FG000|Observational Period|Screen Failure: Eligibility Criteria|439
1157579|NCT03266588|2275502|FG001|Observational Period|Screen Failure: Eligibility Criteria|228
1157580|NCT03266588|2275503|FG002|Observational Period|Screen Failure: Eligibility Criteria|140
1157581|NCT03266588|2275501|FG000|Observational Period|Withdrawal by Subject|44
1157582|NCT03266588|2275502|FG001|Observational Period|Withdrawal by Subject|22
1157583|NCT03266588|2275503|FG002|Observational Period|Withdrawal by Subject|13
1157584|NCT03266588|2275501|FG000|Observational Period|Non-compliance|18
1157585|NCT03266588|2275502|FG001|Observational Period|Non-compliance|12
1157586|NCT03266588|2275503|FG002|Observational Period|Non-compliance|10
1157587|NCT03266588|2275501|FG000|Observational Period|Lost to Follow-up|8
1157588|NCT03266588|2275502|FG001|Observational Period|Lost to Follow-up|12
1157589|NCT03266588|2275503|FG002|Observational Period|Lost to Follow-up|4
1157590|NCT03266588|2275501|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3
1157591|NCT03266588|2275502|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1
1157592|NCT03266588|2275503|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0
1157593|NCT03266588|2275501|FG000|Observational Period|Protocol Deviation|1
1157594|NCT03266588|2275502|FG001|Observational Period|Protocol Deviation|0
1157595|NCT03266588|2275503|FG002|Observational Period|Protocol Deviation|0
1157596|NCT03266588|2275501|FG000|Observational Period|Other Reasons|3
1157597|NCT03266588|2275502|FG001|Observational Period|Other Reasons|0
1157598|NCT03266588|2275503|FG002|Observational Period|Other Reasons|1
1157599|NCT03266588|2275501|FG000|Long-term Treatment Period|Adverse Event|33
1157600|NCT03266588|2275502|FG001|Long-term Treatment Period|Adverse Event|17
1157601|NCT03266588|2275503|FG002|Long-term Treatment Period|Adverse Event|8
1157602|NCT03266588|2275501|FG000|Long-term Treatment Period|Lack of Efficacy|41
1157603|NCT03266588|2275502|FG001|Long-term Treatment Period|Lack of Efficacy|31
1157604|NCT03266588|2275503|FG002|Long-term Treatment Period|Lack of Efficacy|5
1157605|NCT03266588|2275501|FG000|Long-term Treatment Period|Lost to Follow-up|39
1157606|NCT03266588|2275502|FG001|Long-term Treatment Period|Lost to Follow-up|37
1157607|NCT03266588|2275503|FG002|Long-term Treatment Period|Lost to Follow-up|8
1157608|NCT03266588|2275501|FG000|Long-term Treatment Period|Non-Compliance|126
1157609|NCT03266588|2275502|FG001|Long-term Treatment Period|Non-Compliance|57
1157610|NCT03266588|2275503|FG002|Long-term Treatment Period|Non-Compliance|7
1157611|NCT03266588|2275501|FG000|Long-term Treatment Period|Pregnancy|11
1157612|NCT03266588|2275502|FG001|Long-term Treatment Period|Pregnancy|5
1157613|NCT03266588|2275503|FG002|Long-term Treatment Period|Pregnancy|0
1157614|NCT03266588|2275501|FG000|Long-term Treatment Period|Protocol Deviation|17
1157615|NCT03266588|2275502|FG001|Long-term Treatment Period|Protocol Deviation|10
1157616|NCT03266588|2275503|FG002|Long-term Treatment Period|Protocol Deviation|4
1157617|NCT03266588|2275501|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33
1157618|NCT03266588|2275502|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
1157619|NCT03266588|2275503|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
1157620|NCT03266588|2275501|FG000|Long-term Treatment Period|Withdrawal by Subject|100
1157621|NCT03266588|2275502|FG001|Long-term Treatment Period|Withdrawal by Subject|63
1157622|NCT03266588|2275503|FG002|Long-term Treatment Period|Withdrawal by Subject|16
1157623|NCT03266588|2275501|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1
1157624|NCT03266588|2275502|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2
1157625|NCT03266588|2275503|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0
1157626|NCT03266588|2275501|FG000|Long-term Treatment Period|Other Reasons|5
1157627|NCT03266588|2275502|FG001|Long-term Treatment Period|Other Reasons|0
1157628|NCT03266588|2275503|FG002|Long-term Treatment Period|Other Reasons|0
1157629|NCT03266588|2275501|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
1157630|NCT03266588|2275502|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1
1157631|NCT03266588|2275503|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
1157632|NCT03267212|2275511|FG000|First Intervention|Lost to Follow-up|0
1157633|NCT03267212|2275512|FG001|First Intervention|Lost to Follow-up|2
1157634|NCT03267212|2275511|FG000|First Intervention|Withdrawal by Subject|1
1157635|NCT03267212|2275512|FG001|First Intervention|Withdrawal by Subject|1
1157636|NCT03267212|2275511|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
1157637|NCT03267212|2275512|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
1157638|NCT03267264|2275522|FG000|Overall Study|Withdrawal by Subject|1
1157639|NCT03267264|2275523|FG001|Overall Study|Withdrawal by Subject|0
1157640|NCT03267264|2275524|FG002|Overall Study|Withdrawal by Subject|2
1157641|NCT03267264|2275525|FG003|Overall Study|Withdrawal by Subject|4
1157642|NCT03267511|2275542|FG000|Overall Study|Lost to Follow-up|0
1157643|NCT03267511|2275543|FG001|Overall Study|Lost to Follow-up|0
1157644|NCT03267511|2275544|FG002|Overall Study|Lost to Follow-up|0
1157645|NCT03267511|2275545|FG003|Overall Study|Lost to Follow-up|1
1157646|NCT03267576|2275559|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0
1157647|NCT03267576|2275560|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1
1157648|NCT03267576|2275559|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1
1157649|NCT03267576|2275560|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1
1157650|NCT03267940|2275572|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
1157651|NCT03267940|2275573|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
1157652|NCT03267940|2275574|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
1157653|NCT03267940|2275575|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
1157654|NCT03267940|2275576|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
1157655|NCT03267940|2275577|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
1157656|NCT03267940|2275572|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
1157657|NCT03267940|2275573|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
1157658|NCT03267940|2275574|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
1157659|NCT03267940|2275575|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
1157660|NCT03267940|2275576|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
1157661|NCT03267940|2275577|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
1157662|NCT03267940|2275572|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
1157663|NCT03267940|2275573|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
1157664|NCT03267940|2275574|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
1157665|NCT03267940|2275575|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
1157666|NCT03267940|2275576|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
1157667|NCT03267940|2275577|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
1157668|NCT03267940|2275572|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7
1157669|NCT03267940|2275573|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3
1157670|NCT03267940|2275574|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0
1157671|NCT03267940|2275575|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0
1157672|NCT03267940|2275576|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0
1157673|NCT03267940|2275577|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0
1157674|NCT03267940|2275572|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
1157675|NCT03267940|2275573|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
1157676|NCT03267940|2275574|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
1157677|NCT03267940|2275575|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
1157678|NCT03267940|2275576|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
1157679|NCT03267940|2275577|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
1157680|NCT03267940|2275572|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
1157681|NCT03267940|2275573|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
1157682|NCT03267940|2275574|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
1157683|NCT03267940|2275575|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
1157684|NCT03267940|2275576|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
1157685|NCT03267940|2275577|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
1157686|NCT03267940|2275572|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
1157687|NCT03267940|2275573|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
1157688|NCT03267940|2275574|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
1157689|NCT03267940|2275575|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
1157690|NCT03267940|2275576|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
1157691|NCT03267940|2275577|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
1157692|NCT03267940|2275572|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
1157693|NCT03267940|2275573|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
1157694|NCT03267940|2275574|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
1157695|NCT03267940|2275575|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
1157696|NCT03267940|2275576|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
1157697|NCT03267940|2275577|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
1157698|NCT03267940|2275572|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0
1157699|NCT03267940|2275573|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0
1157700|NCT03267940|2275574|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10
1157701|NCT03267940|2275575|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13
1157702|NCT03267940|2275576|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0
1157703|NCT03267940|2275577|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6
1157710|NCT03268590|2275612|FG000|Overall Study|Previously unknown exclusion criteria|1
1157711|NCT03268746|2275619|FG000|Overall Study|Withdrawal by Subject|1
1157712|NCT03268941|2275634|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1157713|NCT03268941|2275635|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1157714|NCT03268941|2275636|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1157715|NCT03268941|2275637|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
1157716|NCT03268941|2275638|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1157717|NCT03268941|2275639|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1157718|NCT03268941|2275640|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1157719|NCT03268941|2275634|FG000|Part 1 (Days 1 to 9)|Adverse Event|0
1157720|NCT03268941|2275635|FG001|Part 1 (Days 1 to 9)|Adverse Event|0
1157721|NCT03268941|2275636|FG002|Part 1 (Days 1 to 9)|Adverse Event|0
1157722|NCT03268941|2275637|FG003|Part 1 (Days 1 to 9)|Adverse Event|1
1157723|NCT03268941|2275638|FG004|Part 1 (Days 1 to 9)|Adverse Event|0
1157724|NCT03268941|2275639|FG005|Part 1 (Days 1 to 9)|Adverse Event|0
1157725|NCT03268941|2275640|FG006|Part 1 (Days 1 to 9)|Adverse Event|0
1157726|NCT03268941|2275634|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1
1157727|NCT03268941|2275635|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0
1157728|NCT03268941|2275636|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0
1157729|NCT03268941|2275637|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0
1157730|NCT03268941|2275638|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0
1157731|NCT03268941|2275639|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0
1157732|NCT03268941|2275640|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0
1157733|NCT03268941|2275634|FG000|Part 2: Days 17 to 25|Reason not specified|0
1157734|NCT03268941|2275635|FG001|Part 2: Days 17 to 25|Reason not specified|0
1157735|NCT03268941|2275636|FG002|Part 2: Days 17 to 25|Reason not specified|0
1157736|NCT03268941|2275637|FG003|Part 2: Days 17 to 25|Reason not specified|0
1157737|NCT03268941|2275638|FG004|Part 2: Days 17 to 25|Reason not specified|0
1157738|NCT03268941|2275639|FG005|Part 2: Days 17 to 25|Reason not specified|0
1157739|NCT03268941|2275640|FG006|Part 2: Days 17 to 25|Reason not specified|1
1157740|NCT03268941|2275634|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0
1157741|NCT03268941|2275635|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0
1157742|NCT03268941|2275636|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0
1157743|NCT03268941|2275637|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0
1157744|NCT03268941|2275638|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0
1157745|NCT03268941|2275639|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0
1157746|NCT03268941|2275640|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1
1157747|NCT03269552|2275668|FG000|Overall Study|Adverse Event|2
1157748|NCT03270085|2275675|FG000|Overall Study|Withdrawal by Subject|1
1157749|NCT03270085|2275676|FG001|Overall Study|Withdrawal by Subject|0
1157750|NCT03270644|2275711|FG000|Day 1 Lasmiditan Reference|Physician Decision|1
1157751|NCT03270644|2275711|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1
1157752|NCT03270657|2275722|FG000|Overall Study|Withdrawal by Subject|1
1157801|NCT03271307|2275768|FG000|Overall Study|Lost to Follow-up|0
1157802|NCT03271307|2275769|FG001|Overall Study|Lost to Follow-up|0
1157803|NCT03271307|2275770|FG002|Overall Study|Lost to Follow-up|0
1157804|NCT03271307|2275771|FG003|Overall Study|Lost to Follow-up|28
1157805|NCT03271307|2275772|FG004|Overall Study|Lost to Follow-up|91
1157806|NCT03271528|2275804|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1
1157807|NCT03271528|2275805|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0
1157808|NCT03271528|2275804|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1
1157809|NCT03271528|2275805|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0
1157810|NCT03271528|2275804|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0
1157811|NCT03271528|2275805|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1
1157812|NCT03271528|2275804|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0
1157813|NCT03271528|2275805|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1
1157814|NCT03271528|2275804|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
1157815|NCT03271528|2275805|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
1157816|NCT03271528|2275804|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1
1157817|NCT03271528|2275805|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0
1157818|NCT03271528|2275804|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1
1157819|NCT03271528|2275805|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0
1157820|NCT03273153|2275822|FG000|Overall Study|Remain on Study|161
1157821|NCT03273153|2275823|FG001|Overall Study|Remain on Study|159
1157822|NCT03273153|2275822|FG000|Overall Study|Death|41
1157823|NCT03273153|2275823|FG001|Overall Study|Death|45
1157824|NCT03273153|2275822|FG000|Overall Study|Lost to Follow-up|3
1157825|NCT03273153|2275823|FG001|Overall Study|Lost to Follow-up|3
1157826|NCT03273153|2275822|FG000|Overall Study|Protocol Violation|3
1157827|NCT03273153|2275823|FG001|Overall Study|Protocol Violation|0
1157828|NCT03273153|2275822|FG000|Overall Study|Withdrawal by Subject|16
1157829|NCT03273153|2275823|FG001|Overall Study|Withdrawal by Subject|13
1157830|NCT03273153|2275822|FG000|Overall Study|Symptomatic Deterioration|0
1157831|NCT03273153|2275823|FG001|Overall Study|Symptomatic Deterioration|1
1157832|NCT03273153|2275822|FG000|Overall Study|Other|0
1157833|NCT03273153|2275823|FG001|Overall Study|Other|1
1157834|NCT03273166|2275829|FG000|Overall Study|Withdrawn prior to Completion|31
1157835|NCT03273257|2275836|FG000|Overall Study|Death|0
1157836|NCT03273257|2275837|FG001|Overall Study|Death|1
1157837|NCT03273257|2275836|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
1157838|NCT03273257|2275837|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
1157839|NCT03273257|2275836|FG000|Overall Study|Study terminated|3
1157840|NCT03273257|2275837|FG001|Overall Study|Study terminated|2
1157841|NCT03273387|2275863|FG000|Overall Study|Death|2
1157842|NCT03273387|2275864|FG001|Overall Study|Death|2
1157843|NCT03273387|2275863|FG000|Overall Study|Withdrawal by Subject|1
1157844|NCT03273387|2275864|FG001|Overall Study|Withdrawal by Subject|1
1157845|NCT03273946|2275898|FG000|Overall Study|Withdrawal by Subject|5
1157846|NCT03273946|2275898|FG000|Overall Study|Unwillingness of the guardian|1
1157847|NCT03273946|2275898|FG000|Overall Study|Participant refused to use the drug|2
1157848|NCT03273946|2275898|FG000|Overall Study|Participant relative refused to use drug|1
1157849|NCT03274076|2275904|FG000|24 Weeks Double Blind|Withdrawal by Subject|0
1157850|NCT03274076|2275905|FG001|24 Weeks Double Blind|Withdrawal by Subject|1
1157851|NCT03274076|2275906|FG002|24 Weeks Double Blind|Withdrawal by Subject|0
1157852|NCT03274076|2275907|FG003|24 Weeks Double Blind|Withdrawal by Subject|0
1157853|NCT03274076|2275904|FG000|24 Weeks Open Label|Adverse Event|0
1157854|NCT03274076|2275905|FG001|24 Weeks Open Label|Adverse Event|0
1157855|NCT03274076|2275906|FG002|24 Weeks Open Label|Adverse Event|2
1157856|NCT03274076|2275907|FG003|24 Weeks Open Label|Adverse Event|0
1157857|NCT03274076|2275904|FG000|24 Weeks Open Label|Withdrawal by Subject|0
1157858|NCT03274076|2275905|FG001|24 Weeks Open Label|Withdrawal by Subject|0
1157859|NCT03274076|2275906|FG002|24 Weeks Open Label|Withdrawal by Subject|0
1157860|NCT03274076|2275907|FG003|24 Weeks Open Label|Withdrawal by Subject|1
1157861|NCT03274440|2275926|FG000|Overall Study|Time commitment too great|1
1157862|NCT03274440|2275927|FG001|Overall Study|Time commitment too great|0
1157863|NCT03274440|2275928|FG002|Overall Study|Time commitment too great|0
1157864|NCT03274440|2275929|FG003|Overall Study|Time commitment too great|1
1157865|NCT03274440|2275930|FG004|Overall Study|Time commitment too great|0
1157866|NCT03274440|2275931|FG005|Overall Study|Time commitment too great|0
1157867|NCT03274453|2275943|FG000|Overall Study|Lost to Follow-up|2
1157868|NCT03274453|2275944|FG001|Overall Study|Lost to Follow-up|5
1157869|NCT03274453|2275945|FG002|Overall Study|Lost to Follow-up|4
1157870|NCT03274453|2275946|FG003|Overall Study|Lost to Follow-up|1
1157871|NCT03274453|2275943|FG000|Overall Study|Physician Decision|2
1157872|NCT03274453|2275944|FG001|Overall Study|Physician Decision|0
1157873|NCT03274453|2275945|FG002|Overall Study|Physician Decision|0
1157874|NCT03274453|2275946|FG003|Overall Study|Physician Decision|3
1157875|NCT03274453|2275943|FG000|Overall Study|Surgery Cancelled|0
1157876|NCT03274453|2275944|FG001|Overall Study|Surgery Cancelled|1
1157877|NCT03274453|2275945|FG002|Overall Study|Surgery Cancelled|0
1157878|NCT03274453|2275946|FG003|Overall Study|Surgery Cancelled|0
1157879|NCT03274466|2275958|FG000|Overall Study|Withdrawal by Subject|7
1157880|NCT03274466|2275959|FG001|Overall Study|Withdrawal by Subject|3
1157881|NCT03274466|2275958|FG000|Overall Study|Protocol Specified Withdrawal|5
1157882|NCT03274466|2275959|FG001|Overall Study|Protocol Specified Withdrawal|11
1157883|NCT03274466|2275958|FG000|Overall Study|Lost to Follow-up|5
1157884|NCT03274466|2275959|FG001|Overall Study|Lost to Follow-up|7
1157885|NCT03274466|2275958|FG000|Overall Study|Subject Non-compliance|0
1157886|NCT03274466|2275959|FG001|Overall Study|Subject Non-compliance|1
1157887|NCT03274466|2275958|FG000|Overall Study|Adverse Event|3
1157888|NCT03274466|2275959|FG001|Overall Study|Adverse Event|3
1157889|NCT03274466|2275958|FG000|Overall Study|Physician Decision|0
1157890|NCT03274466|2275959|FG001|Overall Study|Physician Decision|1
1157891|NCT03274466|2275958|FG000|Overall Study|Protocol Violation|3
1157892|NCT03274466|2275959|FG001|Overall Study|Protocol Violation|3
1157893|NCT03274986|2275992|FG000|Overall Study|Withdrawal by Subject|0
1157894|NCT03274986|2275993|FG001|Overall Study|Withdrawal by Subject|1
1157895|NCT03274986|2275992|FG000|Overall Study|Lost to Follow-up|0
1157896|NCT03274986|2275993|FG001|Overall Study|Lost to Follow-up|1
1157897|NCT03275246|2276013|FG000|Overall Study|Protocol Violation|5
1157898|NCT03275246|2276013|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1
1157899|NCT03275389|2276027|FG000|Overall Study|Lost to Follow-up|10
1157900|NCT03275389|2276028|FG001|Overall Study|Lost to Follow-up|10
1157901|NCT03275389|2276029|FG002|Overall Study|Lost to Follow-up|19
1157902|NCT03275389|2276030|FG003|Overall Study|Lost to Follow-up|12
1157903|NCT03275389|2276031|FG004|Overall Study|Lost to Follow-up|11
1157904|NCT03275389|2276032|FG005|Overall Study|Lost to Follow-up|12
1157905|NCT03275389|2276033|FG006|Overall Study|Lost to Follow-up|21
1157906|NCT03275389|2276034|FG007|Overall Study|Lost to Follow-up|15
1157907|NCT03275389|2276035|FG008|Overall Study|Lost to Follow-up|12
1157908|NCT03275389|2276036|FG009|Overall Study|Lost to Follow-up|14
1157909|NCT03275389|2276027|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
1157910|NCT03275389|2276028|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
1157911|NCT03275389|2276029|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
1157912|NCT03275389|2276030|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
1157913|NCT03275389|2276031|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
1157914|NCT03275389|2276032|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
1157915|NCT03275389|2276033|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
1157916|NCT03275389|2276034|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
1157917|NCT03275389|2276035|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
1157918|NCT03275389|2276036|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
1157919|NCT03275389|2276027|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
1157920|NCT03275389|2276028|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
1157921|NCT03275389|2276029|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
1157922|NCT03275389|2276030|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
1157923|NCT03275389|2276031|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
1157924|NCT03275389|2276032|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
1157925|NCT03275389|2276033|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
1157926|NCT03275389|2276034|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
1157927|NCT03275389|2276035|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
1157928|NCT03275389|2276036|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
1157929|NCT03275389|2276027|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1157930|NCT03275389|2276028|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
1157931|NCT03275389|2276029|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1157932|NCT03275389|2276030|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
1157933|NCT03275389|2276031|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1157934|NCT03275389|2276032|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1157935|NCT03275389|2276033|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
1157936|NCT03275389|2276034|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1157937|NCT03275389|2276035|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1157938|NCT03275389|2276036|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1157939|NCT03275389|2276027|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
1157940|NCT03275389|2276028|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
1157941|NCT03275389|2276029|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
1157942|NCT03275389|2276030|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
1157943|NCT03275389|2276031|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
1157944|NCT03275389|2276032|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
1157945|NCT03275389|2276033|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
1157946|NCT03275389|2276034|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
1157947|NCT03275389|2276035|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
1157948|NCT03275389|2276036|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
1157949|NCT03275389|2276027|FG000|Overall Study|Other|0
1157950|NCT03275389|2276028|FG001|Overall Study|Other|4
1157951|NCT03275389|2276029|FG002|Overall Study|Other|3
1157952|NCT03275389|2276030|FG003|Overall Study|Other|2
1157953|NCT03275389|2276031|FG004|Overall Study|Other|2
1157954|NCT03275389|2276032|FG005|Overall Study|Other|2
1157955|NCT03275389|2276033|FG006|Overall Study|Other|0
1157956|NCT03275389|2276034|FG007|Overall Study|Other|0
1157957|NCT03275389|2276035|FG008|Overall Study|Other|1
1157958|NCT03275389|2276036|FG009|Overall Study|Other|0
1157959|NCT03276026|2276090|FG000|Overall Study|Protocol Violation|1
1157960|NCT03276026|2276091|FG001|Overall Study|Protocol Violation|0
1157961|NCT03276078|2276097|FG000|Overall Study|Adverse Event|1
1157970|NCT03276975|2276130|FG000|Overall Study|Withdrawal by Subject|1
1157971|NCT03276975|2276131|FG001|Overall Study|Withdrawal by Subject|0
1157982|NCT03277352|2276159|FG000|Overall Study|Study Terminated By Sponsor|2
1157983|NCT03277352|2276159|FG000|Overall Study|Withdrawal by Subject|4
1157984|NCT03277352|2276159|FG000|Overall Study|Death|4
1157985|NCT03277794|2276179|FG000|Overall Study|Lost to Follow-up|2
1157986|NCT03277794|2276180|FG001|Overall Study|Lost to Follow-up|4
1157987|NCT03277794|2276179|FG000|Overall Study|Withdrew due to high acuity|1
1157988|NCT03277794|2276180|FG001|Overall Study|Withdrew due to high acuity|0
1157989|NCT03277846|2276189|FG000|Overall Study|Inpatient stay too brief|12
1157990|NCT03277846|2276190|FG001|Overall Study|Inpatient stay too brief|11
1157991|NCT03278028|2276198|FG000|Overall Study|Lost to Follow-up|1
1157992|NCT03278028|2276199|FG001|Overall Study|Lost to Follow-up|0
1157993|NCT03278028|2276198|FG000|Overall Study|Withdrawal by Subject|3
1157994|NCT03278028|2276199|FG001|Overall Study|Withdrawal by Subject|1
1157995|NCT03278028|2276198|FG000|Overall Study|Pregnancy|0
1157996|NCT03278028|2276199|FG001|Overall Study|Pregnancy|1
1157997|NCT03278106|2276223|FG000|Overall Study|No protocol treatment|1
1157998|NCT03278613|2276238|FG000|Overall Study|Lost to Follow-up|3
1157999|NCT03278613|2276239|FG001|Overall Study|Lost to Follow-up|1
1158000|NCT03280108|2276277|FG000|Overall Study|Lost to Follow-up|2
1158001|NCT03280108|2276278|FG001|Overall Study|Lost to Follow-up|0
1158002|NCT03280121|2276289|FG000|Overall Study|Physician Decision|1
1158003|NCT03280121|2276289|FG000|Overall Study|Lost to Follow-up|1
1158004|NCT03280121|2276289|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4
1158005|NCT03280264|2276293|FG000|Overall Study|Adverse Event|1
1158006|NCT03280264|2276293|FG000|Overall Study|Physician Decision|1
1158007|NCT03280264|2276293|FG000|Overall Study|Withdrawal by Subject|1
1158008|NCT03280381|2276300|FG000|Overall Study|Physician Decision|0
1158009|NCT03280381|2276301|FG001|Overall Study|Physician Decision|2
1158010|NCT03280537|2276310|FG000|Overall Study|Withdrawal by Subject|2
1158011|NCT03280537|2276311|FG001|Overall Study|Withdrawal by Subject|4
1018345|NCT01570283|2043161|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
1018346|NCT01570283|2043162|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
1018347|NCT01570309|2043178|FG000|Overall Study|Withdrawal by Subject|3
1018348|NCT01570309|2043179|FG001|Overall Study|Withdrawal by Subject|3
1018349|NCT01570361|2043195|FG000|Overall Study|Subject discontinued|1
1018350|NCT01570361|2043196|FG001|Overall Study|Subject discontinued|2
1018351|NCT01570361|2043195|FG000|Overall Study|Sponsor closing the study|51
1158012|NCT03280550|2276319|FG000|Overall Study|Withdrawal by Subject|2
1158013|NCT03280550|2276320|FG001|Overall Study|Withdrawal by Subject|2
1158014|NCT03280550|2276319|FG000|Overall Study|Physician Decision|0
1158015|NCT03280550|2276320|FG001|Overall Study|Physician Decision|1
1158016|NCT03280615|2276328|FG000|Overall Study|Lost to Follow-up|1
1158017|NCT03280615|2276329|FG001|Overall Study|Lost to Follow-up|2
1158018|NCT03280615|2276328|FG000|Overall Study|Adverse Event|1
1158019|NCT03280615|2276329|FG001|Overall Study|Adverse Event|1
1158020|NCT03280615|2276328|FG000|Overall Study|Withdrawal by Subject|2
1158021|NCT03280615|2276329|FG001|Overall Study|Withdrawal by Subject|2
1158022|NCT03281304|2276341|FG000|Overall Study|Adverse Event|5
1158023|NCT03281304|2276342|FG001|Overall Study|Adverse Event|2
1158024|NCT03281304|2276341|FG000|Overall Study|Lack of Efficacy|2
1158025|NCT03281304|2276342|FG001|Overall Study|Lack of Efficacy|0
1158026|NCT03281304|2276341|FG000|Overall Study|Pregnancy|1
1158027|NCT03281304|2276342|FG001|Overall Study|Pregnancy|0
1158028|NCT03281304|2276341|FG000|Overall Study|Withdrawal by Subject|5
1158029|NCT03281304|2276342|FG001|Overall Study|Withdrawal by Subject|10
1158030|NCT03281577|2276356|FG000|Overall Study|Adverse Event|0
1158031|NCT03281577|2276357|FG001|Overall Study|Adverse Event|0
1158032|NCT03281577|2276358|FG002|Overall Study|Adverse Event|0
1158033|NCT03281577|2276359|FG003|Overall Study|Adverse Event|1
1158034|NCT03281577|2276356|FG000|Overall Study|Withdrawal by Subject|1
1158035|NCT03281577|2276357|FG001|Overall Study|Withdrawal by Subject|0
1158036|NCT03281577|2276358|FG002|Overall Study|Withdrawal by Subject|0
1158037|NCT03281577|2276359|FG003|Overall Study|Withdrawal by Subject|0
1158038|NCT03281668|2276372|FG000|Overall Study|Physician Decision|1
1158039|NCT03281668|2276372|FG000|Overall Study|scheduling conflict, family circumstance|2
1158040|NCT03281668|2276372|FG000|Overall Study|Withdrawal by Subject|4
1158041|NCT03281668|2276372|FG000|Overall Study|Lost to Follow-up|1
1158042|NCT03281876|2276378|FG000|Overall Study|Adverse Event|4
1158043|NCT03281876|2276379|FG001|Overall Study|Adverse Event|15
1158044|NCT03281876|2276378|FG000|Overall Study|Lost to Follow-up|1
1158045|NCT03281876|2276379|FG001|Overall Study|Lost to Follow-up|4
1158046|NCT03281876|2276378|FG000|Overall Study|Withdrawal by Subject|11
1158047|NCT03281876|2276379|FG001|Overall Study|Withdrawal by Subject|15
1158048|NCT03281876|2276378|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
1158049|NCT03281876|2276379|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1158050|NCT03281876|2276378|FG000|Overall Study|OTHER|5
1158051|NCT03281876|2276379|FG001|Overall Study|OTHER|5
1158053|NCT03282227|2276401|FG000|Overall Study|Exposure Goals Achieved|60
1158054|NCT03282227|2276401|FG000|Overall Study|Non-compliance w/ protocol requirements|79
1158055|NCT03282227|2276401|FG000|Overall Study|Adverse Event|15
1158056|NCT03282227|2276401|FG000|Overall Study|Lost to Follow-up|21
1158057|NCT03282227|2276401|FG000|Overall Study|Withdrawal by Subject|20
1158058|NCT03282227|2276401|FG000|Overall Study|Lack of Efficacy|12
1158059|NCT03282227|2276401|FG000|Overall Study|Sponsor decision|3
1158060|NCT03282227|2276401|FG000|Overall Study|Physician Decision|2
1158061|NCT03282227|2276401|FG000|Overall Study|Pregnancy|2
1158062|NCT03282227|2276401|FG000|Overall Study|Other|1
1158063|NCT03282240|2276408|FG000|Overall Study|Adverse Event|2
1158064|NCT03282240|2276409|FG001|Overall Study|Adverse Event|2
1158065|NCT03282240|2276410|FG002|Overall Study|Adverse Event|0
1158066|NCT03282240|2276408|FG000|Overall Study|Lost to Follow-up|3
1158067|NCT03282240|2276409|FG001|Overall Study|Lost to Follow-up|0
1158068|NCT03282240|2276410|FG002|Overall Study|Lost to Follow-up|0
1158069|NCT03282240|2276408|FG000|Overall Study|Protocol Deviation|4
1158070|NCT03282240|2276409|FG001|Overall Study|Protocol Deviation|1
1158071|NCT03282240|2276410|FG002|Overall Study|Protocol Deviation|2
1158072|NCT03282240|2276408|FG000|Overall Study|Withdrawal by Subject|1
1158073|NCT03282240|2276409|FG001|Overall Study|Withdrawal by Subject|0
1158074|NCT03282240|2276410|FG002|Overall Study|Withdrawal by Subject|1
1158075|NCT03282357|2276421|FG000|Overall Study|Lost to Follow-up|3
1158076|NCT03282357|2276421|FG000|Overall Study|Withdrawal by Subject|4
1158077|NCT03282357|2276421|FG000|Overall Study|Adverse Event|1
1158078|NCT03282357|2276421|FG000|Overall Study|Other|9
1158079|NCT03283098|2276451|FG000|Overall Study|Withdrawal by Subject|0
1158080|NCT03283098|2276452|FG001|Overall Study|Withdrawal by Subject|1
1158081|NCT03283319|2276464|FG000|Overall Study|Lost to Follow-up|5
1158082|NCT03283319|2276465|FG001|Overall Study|Lost to Follow-up|4
1158083|NCT03283319|2276466|FG002|Overall Study|Lost to Follow-up|5
1158084|NCT03283319|2276467|FG003|Overall Study|Lost to Follow-up|5
1158085|NCT03283319|2276468|FG004|Overall Study|Lost to Follow-up|4
1158086|NCT03283319|2276469|FG005|Overall Study|Lost to Follow-up|3
1158087|NCT03283319|2276464|FG000|Overall Study|Withdrawal by Subject|2
1158088|NCT03283319|2276465|FG001|Overall Study|Withdrawal by Subject|2
1158089|NCT03283319|2276466|FG002|Overall Study|Withdrawal by Subject|2
1158090|NCT03283319|2276467|FG003|Overall Study|Withdrawal by Subject|1
1018352|NCT01570361|2043196|FG001|Overall Study|Sponsor closing the study|50
1018353|NCT01570361|2043195|FG000|Overall Study|Subject excluded|5
1018354|NCT01570361|2043196|FG001|Overall Study|Subject excluded|3
1018355|NCT01570361|2043195|FG000|Overall Study|Subject withdrew consent|14
1018356|NCT01570361|2043196|FG001|Overall Study|Subject withdrew consent|9
1018357|NCT01570361|2043195|FG000|Overall Study|Adverse Event|2
1158091|NCT03283319|2276468|FG004|Overall Study|Withdrawal by Subject|0
1158092|NCT03283319|2276469|FG005|Overall Study|Withdrawal by Subject|1
1158093|NCT03283319|2276464|FG000|Overall Study|BARDA regulatory agency or IRB decision|0
1158094|NCT03283319|2276465|FG001|Overall Study|BARDA regulatory agency or IRB decision|0
1158095|NCT03283319|2276466|FG002|Overall Study|BARDA regulatory agency or IRB decision|0
1158096|NCT03283319|2276467|FG003|Overall Study|BARDA regulatory agency or IRB decision|1
1158097|NCT03283319|2276468|FG004|Overall Study|BARDA regulatory agency or IRB decision|0
1158098|NCT03283319|2276469|FG005|Overall Study|BARDA regulatory agency or IRB decision|0
1158107|NCT03283553|2276503|FG000|Patient Participant Flow|Death|5
1158108|NCT03283553|2276504|FG001|Patient Participant Flow|Death|10
1158109|NCT03283553|2276503|FG000|Patient Participant Flow|Withdrawal by Subject|4
1158110|NCT03283553|2276504|FG001|Patient Participant Flow|Withdrawal by Subject|2
1158111|NCT03283553|2276503|FG000|Patient Participant Flow|Lost to Follow-up|1
1158112|NCT03283553|2276504|FG001|Patient Participant Flow|Lost to Follow-up|1
1158113|NCT03283553|2276503|FG000|Care Partner Participant Flow|Withdrawal by Subject|4
1158114|NCT03283553|2276504|FG001|Care Partner Participant Flow|Withdrawal by Subject|3
1158115|NCT03283553|2276503|FG000|Care Partner Participant Flow|Lost to Follow-up|1
1158116|NCT03283553|2276504|FG001|Care Partner Participant Flow|Lost to Follow-up|1
1158117|NCT03283553|2276503|FG000|Care Partner Participant Flow|Discontinued because patient death|5
1158118|NCT03283553|2276504|FG001|Care Partner Participant Flow|Discontinued because patient death|11
1158119|NCT03283696|2276514|FG000|Overall Study|Physician Decision|5
1158120|NCT03283696|2276515|FG001|Overall Study|Physician Decision|6
1158121|NCT03283696|2276514|FG000|Overall Study|Withdrawal by Subject|2
1158122|NCT03283696|2276515|FG001|Overall Study|Withdrawal by Subject|0
1158123|NCT03284229|2276537|FG000|Overall Study|Lost to Follow-up|3
1158124|NCT03284424|2276573|FG000|Overall Study|Death|56
1158125|NCT03284424|2276574|FG001|Overall Study|Death|13
1158126|NCT03284424|2276573|FG000|Overall Study|Lost to Follow-up|1
1158127|NCT03284424|2276574|FG001|Overall Study|Lost to Follow-up|0
1158128|NCT03284424|2276573|FG000|Overall Study|Physician Decision|1
1158129|NCT03284424|2276574|FG001|Overall Study|Physician Decision|0
1158130|NCT03284424|2276573|FG000|Overall Study|Withdrawal by Subject|3
1158131|NCT03284424|2276574|FG001|Overall Study|Withdrawal by Subject|2
1158132|NCT03284424|2276573|FG000|Overall Study|Ongoing in study|44
1158133|NCT03284424|2276574|FG001|Overall Study|Ongoing in study|39
1158134|NCT03285113|2276610|FG000|Overall Study|Unable to implant leads|2
1158135|NCT03285295|2276619|FG000|Alinity s HBsAg|Protocol Violation|11
1158136|NCT03285295|2276620|FG001|Alinity s HBsAg|Protocol Violation|0
1158137|NCT03285295|2276621|FG002|Alinity s HBsAg|Protocol Violation|0
1158138|NCT03285295|2276622|FG003|Alinity s HBsAg|Protocol Violation|0
1158139|NCT03285295|2276623|FG004|Alinity s HBsAg|Protocol Violation|0
1158140|NCT03285295|2276619|FG000|Alinity s HBsAg|No Result on Comparator Assay|17
1158141|NCT03285295|2276620|FG001|Alinity s HBsAg|No Result on Comparator Assay|0
1158142|NCT03285295|2276621|FG002|Alinity s HBsAg|No Result on Comparator Assay|0
1158143|NCT03285295|2276622|FG003|Alinity s HBsAg|No Result on Comparator Assay|0
1158144|NCT03285295|2276623|FG004|Alinity s HBsAg|No Result on Comparator Assay|0
1158145|NCT03285295|2276619|FG000|Alinity s HBsAg|No Results Generated|74
1158146|NCT03285295|2276620|FG001|Alinity s HBsAg|No Results Generated|6
1158147|NCT03285295|2276621|FG002|Alinity s HBsAg|No Results Generated|0
1158148|NCT03285295|2276622|FG003|Alinity s HBsAg|No Results Generated|0
1158149|NCT03285295|2276623|FG004|Alinity s HBsAg|No Results Generated|0
1158150|NCT03285295|2276619|FG000|Alinity s HTLV I/II|Protocol Violation|6
1158151|NCT03285295|2276620|FG001|Alinity s HTLV I/II|Protocol Violation|0
1158152|NCT03285295|2276621|FG002|Alinity s HTLV I/II|Protocol Violation|0
1158153|NCT03285295|2276622|FG003|Alinity s HTLV I/II|Protocol Violation|0
1158154|NCT03285295|2276623|FG004|Alinity s HTLV I/II|Protocol Violation|0
1158155|NCT03285295|2276619|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15
1158156|NCT03285295|2276620|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0
1158157|NCT03285295|2276621|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0
1158158|NCT03285295|2276622|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0
1158159|NCT03285295|2276623|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0
1158160|NCT03285295|2276619|FG000|Alinity s HTLV I/II|No Results Generated|70
1158161|NCT03285295|2276620|FG001|Alinity s HTLV I/II|No Results Generated|0
1158162|NCT03285295|2276621|FG002|Alinity s HTLV I/II|No Results Generated|0
1158163|NCT03285295|2276622|FG003|Alinity s HTLV I/II|No Results Generated|0
1158164|NCT03285295|2276623|FG004|Alinity s HTLV I/II|No Results Generated|0
1158165|NCT03285295|2276619|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
1158166|NCT03285295|2276620|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1158167|NCT03285295|2276621|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1158168|NCT03285295|2276622|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1158169|NCT03285295|2276623|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1158170|NCT03285295|2276619|FG000|Alinity s Anti-HCV|Protocol Violation|12
1158171|NCT03285295|2276620|FG001|Alinity s Anti-HCV|Protocol Violation|0
1158172|NCT03285295|2276621|FG002|Alinity s Anti-HCV|Protocol Violation|0
1158173|NCT03285295|2276622|FG003|Alinity s Anti-HCV|Protocol Violation|0
1158174|NCT03285295|2276623|FG004|Alinity s Anti-HCV|Protocol Violation|0
1158175|NCT03285295|2276619|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13
1158176|NCT03285295|2276620|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0
1158177|NCT03285295|2276621|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0
1158178|NCT03285295|2276622|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0
1158179|NCT03285295|2276623|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0
1158180|NCT03285295|2276619|FG000|Alinity s Anti-HCV|No Results Generated|71
1158181|NCT03285295|2276620|FG001|Alinity s Anti-HCV|No Results Generated|0
1158182|NCT03285295|2276621|FG002|Alinity s Anti-HCV|No Results Generated|0
1158183|NCT03285295|2276622|FG003|Alinity s Anti-HCV|No Results Generated|0
1158184|NCT03285295|2276623|FG004|Alinity s Anti-HCV|No Results Generated|0
1158185|NCT03285295|2276619|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
1158186|NCT03285295|2276620|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1158187|NCT03285295|2276621|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1158188|NCT03285295|2276622|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1158189|NCT03285295|2276623|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1158190|NCT03285295|2276619|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
1158191|NCT03285295|2276620|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1158192|NCT03285295|2276621|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1158193|NCT03285295|2276622|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1158194|NCT03285295|2276623|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1158195|NCT03285295|2276619|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
1158196|NCT03285295|2276620|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1158197|NCT03285295|2276621|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1158198|NCT03285295|2276622|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1158199|NCT03285295|2276623|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1158200|NCT03285295|2276619|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72
1158201|NCT03285295|2276620|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1158202|NCT03285295|2276621|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1158203|NCT03285295|2276622|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1158204|NCT03285295|2276623|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1158205|NCT03285295|2276619|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
1158206|NCT03285295|2276620|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1158207|NCT03285295|2276621|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1158208|NCT03285295|2276622|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1158209|NCT03285295|2276623|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1158210|NCT03285295|2276619|FG000|Alinity s Anti-HBc|Protocol Violation|8
1158211|NCT03285295|2276620|FG001|Alinity s Anti-HBc|Protocol Violation|0
1158212|NCT03285295|2276621|FG002|Alinity s Anti-HBc|Protocol Violation|0
1158213|NCT03285295|2276622|FG003|Alinity s Anti-HBc|Protocol Violation|0
1158214|NCT03285295|2276623|FG004|Alinity s Anti-HBc|Protocol Violation|0
1158215|NCT03285295|2276619|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13
1158216|NCT03285295|2276620|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1
1158217|NCT03285295|2276621|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0
1158218|NCT03285295|2276622|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0
1158219|NCT03285295|2276623|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0
1158220|NCT03285295|2276619|FG000|Alinity s Anti-HBc|No Results Generated|70
1158221|NCT03285295|2276620|FG001|Alinity s Anti-HBc|No Results Generated|0
1158222|NCT03285295|2276621|FG002|Alinity s Anti-HBc|No Results Generated|0
1158223|NCT03285295|2276622|FG003|Alinity s Anti-HBc|No Results Generated|0
1158224|NCT03285295|2276623|FG004|Alinity s Anti-HBc|No Results Generated|0
1158225|NCT03285295|2276619|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
1158226|NCT03285295|2276620|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1158227|NCT03285295|2276621|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1158228|NCT03285295|2276622|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1158229|NCT03285295|2276623|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1158230|NCT03285295|2276619|FG000|Alinity s Chagas|Protocol Violation|76
1158231|NCT03285295|2276620|FG001|Alinity s Chagas|Protocol Violation|0
1158232|NCT03285295|2276621|FG002|Alinity s Chagas|Protocol Violation|0
1158233|NCT03285295|2276622|FG003|Alinity s Chagas|Protocol Violation|0
1158234|NCT03285295|2276623|FG004|Alinity s Chagas|Protocol Violation|0
1158235|NCT03285295|2276619|FG000|Alinity s Chagas|No Results on Comparator Assay|38
1158236|NCT03285295|2276620|FG001|Alinity s Chagas|No Results on Comparator Assay|0
1158237|NCT03285295|2276621|FG002|Alinity s Chagas|No Results on Comparator Assay|0
1158238|NCT03285295|2276622|FG003|Alinity s Chagas|No Results on Comparator Assay|0
1158239|NCT03285295|2276623|FG004|Alinity s Chagas|No Results on Comparator Assay|0
1158240|NCT03285295|2276619|FG000|Alinity s Chagas|No Results Generated|105
1158241|NCT03285295|2276620|FG001|Alinity s Chagas|No Results Generated|0
1158242|NCT03285295|2276621|FG002|Alinity s Chagas|No Results Generated|0
1158243|NCT03285295|2276622|FG003|Alinity s Chagas|No Results Generated|0
1158244|NCT03285295|2276623|FG004|Alinity s Chagas|No Results Generated|0
1158245|NCT03285295|2276619|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13
1158246|NCT03285295|2276620|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1158247|NCT03285295|2276621|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1158248|NCT03285295|2276622|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1158249|NCT03285295|2276623|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1158250|NCT03285308|2276654|FG000|Overall Study|Adverse Event|3
1158251|NCT03285308|2276655|FG001|Overall Study|Adverse Event|7
1158252|NCT03285308|2276654|FG000|Overall Study|Withdrawal by Subject|8
1158253|NCT03285308|2276655|FG001|Overall Study|Withdrawal by Subject|9
1158254|NCT03285308|2276654|FG000|Overall Study|Lost to Follow-up|3
1158255|NCT03285308|2276655|FG001|Overall Study|Lost to Follow-up|1
1158256|NCT03285308|2276654|FG000|Overall Study|Protocol Deviation|6
1158257|NCT03285308|2276655|FG001|Overall Study|Protocol Deviation|5
1158258|NCT03285308|2276654|FG000|Overall Study|Reason not Specified|0
1158259|NCT03285308|2276655|FG001|Overall Study|Reason not Specified|1
1158260|NCT03285477|2276676|FG000|Treatment and Response Assessment Period|Death|1
1158261|NCT03285477|2276677|FG001|Treatment and Response Assessment Period|Death|0
1158262|NCT03285477|2276676|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1
1158263|NCT03285477|2276677|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0
1158264|NCT03285477|2276676|FG000|Recurrence Follow-up Period|Lost to Follow-up|0
1158265|NCT03285477|2276677|FG001|Recurrence Follow-up Period|Lost to Follow-up|1
1158266|NCT03285477|2276676|FG000|Recurrence Follow-up Period|Withdrawal of consent|1
1158267|NCT03285477|2276677|FG001|Recurrence Follow-up Period|Withdrawal of consent|3
1158268|NCT03285477|2276676|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5
1158269|NCT03285477|2276677|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51
1158270|NCT03285490|2276686|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
1158271|NCT03285490|2276687|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1
1158272|NCT03285490|2276686|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18
1158273|NCT03285490|2276687|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60
1158274|NCT03285594|2276724|FG000|Overall Study|At the Participant's Own Request|10
1158275|NCT03285594|2276725|FG001|Overall Study|At the Participant's Own Request|5
1158276|NCT03285594|2276726|FG002|Overall Study|At the Participant's Own Request|21
1158277|NCT03285594|2276724|FG000|Overall Study|Adverse Event|2
1158278|NCT03285594|2276725|FG001|Overall Study|Adverse Event|2
1158279|NCT03285594|2276726|FG002|Overall Study|Adverse Event|6
1158280|NCT03285594|2276724|FG000|Overall Study|Poor Compliance to Protocol|0
1158281|NCT03285594|2276725|FG001|Overall Study|Poor Compliance to Protocol|0
1158282|NCT03285594|2276726|FG002|Overall Study|Poor Compliance to Protocol|1
1158283|NCT03285594|2276724|FG000|Overall Study|Lost to Follow-up|0
1158284|NCT03285594|2276725|FG001|Overall Study|Lost to Follow-up|0
1158285|NCT03285594|2276726|FG002|Overall Study|Lost to Follow-up|1
1158286|NCT03285594|2276724|FG000|Overall Study|Reason Not Specified|3
1158287|NCT03285594|2276725|FG001|Overall Study|Reason Not Specified|4
1158288|NCT03285594|2276726|FG002|Overall Study|Reason Not Specified|8
1158289|NCT03285646|2276737|FG000|Overall Study|Adverse Event|1
1158290|NCT03285646|2276738|FG001|Overall Study|Adverse Event|0
1158291|NCT03285646|2276737|FG000|Overall Study|Withdrawal by Subject|10
1158292|NCT03285646|2276738|FG001|Overall Study|Withdrawal by Subject|2
1158293|NCT03285646|2276737|FG000|Overall Study|Lost to Follow-up|2
1158294|NCT03285646|2276738|FG001|Overall Study|Lost to Follow-up|1
1158295|NCT03285646|2276737|FG000|Overall Study|Investigator/Sponsor Decision|0
1158296|NCT03285646|2276738|FG001|Overall Study|Investigator/Sponsor Decision|1
1158297|NCT03285711|2276747|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2
1158298|NCT03285711|2276748|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1
1158299|NCT03285711|2276749|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0
1158300|NCT03285711|2276750|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0
1158301|NCT03285711|2276747|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1
1158302|NCT03285711|2276748|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0
1158303|NCT03285711|2276749|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0
1158304|NCT03285711|2276750|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0
1158305|NCT03285711|2276747|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
1158306|NCT03285711|2276748|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
1158307|NCT03285711|2276749|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
1158308|NCT03285711|2276750|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
1158309|NCT03285711|2276747|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
1158310|NCT03285711|2276748|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
1158311|NCT03285711|2276749|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
1158312|NCT03285711|2276750|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
1158313|NCT03285958|2276766|FG000|Overall Study|Lost to Follow-up|1
1158314|NCT03285958|2276767|FG001|Overall Study|Lost to Follow-up|1
1158315|NCT03285958|2276766|FG000|Overall Study|Withdrawal by Subject|1
1158316|NCT03285958|2276767|FG001|Overall Study|Withdrawal by Subject|0
1158317|NCT03285958|2276766|FG000|Overall Study|Not able to attend required orientation|3
1158318|NCT03285958|2276767|FG001|Overall Study|Not able to attend required orientation|0
1158319|NCT03286218|2276786|FG000|Qualification Phase Period 1|Adverse Event|1
1158320|NCT03286218|2276787|FG001|Qualification Phase Period 1|Adverse Event|0
1158321|NCT03286218|2276788|FG002|Qualification Phase Period 1|Adverse Event|0
1158322|NCT03286218|2276789|FG003|Qualification Phase Period 1|Adverse Event|0
1158323|NCT03286218|2276790|FG004|Qualification Phase Period 1|Adverse Event|0
1158324|NCT03286218|2276791|FG005|Qualification Phase Period 1|Adverse Event|0
1158325|NCT03286218|2276792|FG006|Qualification Phase Period 1|Adverse Event|0
1158326|NCT03286218|2276793|FG007|Qualification Phase Period 1|Adverse Event|0
1158327|NCT03286218|2276794|FG008|Qualification Phase Period 1|Adverse Event|0
1158328|NCT03286218|2276795|FG009|Qualification Phase Period 1|Adverse Event|0
1158329|NCT03286218|2276796|FG010|Qualification Phase Period 1|Adverse Event|0
1158330|NCT03286218|2276797|FG011|Qualification Phase Period 1|Adverse Event|0
1158331|NCT03286218|2276786|FG000|Qualification Phase Period 1|Withdrawal by Subject|0
1158332|NCT03286218|2276787|FG001|Qualification Phase Period 1|Withdrawal by Subject|1
1158333|NCT03286218|2276788|FG002|Qualification Phase Period 1|Withdrawal by Subject|0
1158334|NCT03286218|2276789|FG003|Qualification Phase Period 1|Withdrawal by Subject|0
1158335|NCT03286218|2276790|FG004|Qualification Phase Period 1|Withdrawal by Subject|0
1158336|NCT03286218|2276791|FG005|Qualification Phase Period 1|Withdrawal by Subject|0
1158337|NCT03286218|2276792|FG006|Qualification Phase Period 1|Withdrawal by Subject|0
1158338|NCT03286218|2276793|FG007|Qualification Phase Period 1|Withdrawal by Subject|0
1158339|NCT03286218|2276794|FG008|Qualification Phase Period 1|Withdrawal by Subject|0
1158340|NCT03286218|2276795|FG009|Qualification Phase Period 1|Withdrawal by Subject|0
1158341|NCT03286218|2276796|FG010|Qualification Phase Period 1|Withdrawal by Subject|0
1158342|NCT03286218|2276797|FG011|Qualification Phase Period 1|Withdrawal by Subject|0
1158343|NCT03286218|2276786|FG000|Qualification Phase Period 2|Adverse Event|0
1158344|NCT03286218|2276787|FG001|Qualification Phase Period 2|Adverse Event|1
1158345|NCT03286218|2276788|FG002|Qualification Phase Period 2|Adverse Event|0
1158346|NCT03286218|2276789|FG003|Qualification Phase Period 2|Adverse Event|0
1158347|NCT03286218|2276790|FG004|Qualification Phase Period 2|Adverse Event|0
1158348|NCT03286218|2276791|FG005|Qualification Phase Period 2|Adverse Event|0
1158349|NCT03286218|2276792|FG006|Qualification Phase Period 2|Adverse Event|0
1158350|NCT03286218|2276793|FG007|Qualification Phase Period 2|Adverse Event|0
1158351|NCT03286218|2276794|FG008|Qualification Phase Period 2|Adverse Event|0
1158352|NCT03286218|2276795|FG009|Qualification Phase Period 2|Adverse Event|0
1158353|NCT03286218|2276796|FG010|Qualification Phase Period 2|Adverse Event|0
1158354|NCT03286218|2276797|FG011|Qualification Phase Period 2|Adverse Event|0
1158355|NCT03286218|2276786|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14
1158356|NCT03286218|2276787|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15
1158357|NCT03286218|2276788|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0
1158358|NCT03286218|2276789|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0
1158359|NCT03286218|2276790|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0
1158360|NCT03286218|2276791|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0
1158361|NCT03286218|2276792|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0
1158362|NCT03286218|2276793|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0
1158363|NCT03286218|2276794|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0
1158364|NCT03286218|2276795|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0
1158365|NCT03286218|2276796|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0
1158366|NCT03286218|2276797|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0
1158367|NCT03286218|2276786|FG000|Qualification Phase Period 2|Lost to Follow-up|0
1158368|NCT03286218|2276787|FG001|Qualification Phase Period 2|Lost to Follow-up|1
1158369|NCT03286218|2276788|FG002|Qualification Phase Period 2|Lost to Follow-up|0
1158370|NCT03286218|2276789|FG003|Qualification Phase Period 2|Lost to Follow-up|0
1158371|NCT03286218|2276790|FG004|Qualification Phase Period 2|Lost to Follow-up|0
1158372|NCT03286218|2276791|FG005|Qualification Phase Period 2|Lost to Follow-up|0
1158373|NCT03286218|2276792|FG006|Qualification Phase Period 2|Lost to Follow-up|0
1158374|NCT03286218|2276793|FG007|Qualification Phase Period 2|Lost to Follow-up|0
1158375|NCT03286218|2276794|FG008|Qualification Phase Period 2|Lost to Follow-up|0
1158376|NCT03286218|2276795|FG009|Qualification Phase Period 2|Lost to Follow-up|0
1158377|NCT03286218|2276796|FG010|Qualification Phase Period 2|Lost to Follow-up|0
1158378|NCT03286218|2276797|FG011|Qualification Phase Period 2|Lost to Follow-up|0
1158379|NCT03286218|2276786|FG000|Qualification Phase Period 2|Protocol Violation|2
1158380|NCT03286218|2276787|FG001|Qualification Phase Period 2|Protocol Violation|0
1158381|NCT03286218|2276788|FG002|Qualification Phase Period 2|Protocol Violation|0
1158382|NCT03286218|2276789|FG003|Qualification Phase Period 2|Protocol Violation|0
1158383|NCT03286218|2276790|FG004|Qualification Phase Period 2|Protocol Violation|0
1158384|NCT03286218|2276791|FG005|Qualification Phase Period 2|Protocol Violation|0
1158385|NCT03286218|2276792|FG006|Qualification Phase Period 2|Protocol Violation|0
1158386|NCT03286218|2276793|FG007|Qualification Phase Period 2|Protocol Violation|0
1158387|NCT03286218|2276794|FG008|Qualification Phase Period 2|Protocol Violation|0
1158388|NCT03286218|2276795|FG009|Qualification Phase Period 2|Protocol Violation|0
1158389|NCT03286218|2276796|FG010|Qualification Phase Period 2|Protocol Violation|0
1158390|NCT03286218|2276797|FG011|Qualification Phase Period 2|Protocol Violation|0
1158391|NCT03286218|2276786|FG000|Qualification Phase Period 2|Withdrawal by Subject|1
1158392|NCT03286218|2276787|FG001|Qualification Phase Period 2|Withdrawal by Subject|2
1158393|NCT03286218|2276788|FG002|Qualification Phase Period 2|Withdrawal by Subject|0
1158394|NCT03286218|2276789|FG003|Qualification Phase Period 2|Withdrawal by Subject|0
1158395|NCT03286218|2276790|FG004|Qualification Phase Period 2|Withdrawal by Subject|0
1158396|NCT03286218|2276791|FG005|Qualification Phase Period 2|Withdrawal by Subject|0
1158397|NCT03286218|2276792|FG006|Qualification Phase Period 2|Withdrawal by Subject|0
1158398|NCT03286218|2276793|FG007|Qualification Phase Period 2|Withdrawal by Subject|0
1158399|NCT03286218|2276794|FG008|Qualification Phase Period 2|Withdrawal by Subject|0
1158400|NCT03286218|2276795|FG009|Qualification Phase Period 2|Withdrawal by Subject|0
1158401|NCT03286218|2276796|FG010|Qualification Phase Period 2|Withdrawal by Subject|0
1158402|NCT03286218|2276797|FG011|Qualification Phase Period 2|Withdrawal by Subject|0
1158403|NCT03286218|2276786|FG000|Treatment Phase Period 1|Withdrawal by Subject|0
1158404|NCT03286218|2276787|FG001|Treatment Phase Period 1|Withdrawal by Subject|0
1158405|NCT03286218|2276788|FG002|Treatment Phase Period 1|Withdrawal by Subject|1
1158406|NCT03286218|2276789|FG003|Treatment Phase Period 1|Withdrawal by Subject|1
1158407|NCT03286218|2276790|FG004|Treatment Phase Period 1|Withdrawal by Subject|0
1158408|NCT03286218|2276791|FG005|Treatment Phase Period 1|Withdrawal by Subject|1
1158409|NCT03286218|2276792|FG006|Treatment Phase Period 1|Withdrawal by Subject|0
1158410|NCT03286218|2276793|FG007|Treatment Phase Period 1|Withdrawal by Subject|0
1158411|NCT03286218|2276794|FG008|Treatment Phase Period 1|Withdrawal by Subject|0
1158412|NCT03286218|2276795|FG009|Treatment Phase Period 1|Withdrawal by Subject|0
1158413|NCT03286218|2276796|FG010|Treatment Phase Period 1|Withdrawal by Subject|0
1158414|NCT03286218|2276797|FG011|Treatment Phase Period 1|Withdrawal by Subject|1
1158415|NCT03286218|2276786|FG000|Treatment Phase Period 4|Withdrawal by Subject|0
1158416|NCT03286218|2276787|FG001|Treatment Phase Period 4|Withdrawal by Subject|0
1158417|NCT03286218|2276788|FG002|Treatment Phase Period 4|Withdrawal by Subject|0
1158418|NCT03286218|2276789|FG003|Treatment Phase Period 4|Withdrawal by Subject|0
1158419|NCT03286218|2276790|FG004|Treatment Phase Period 4|Withdrawal by Subject|0
1158420|NCT03286218|2276791|FG005|Treatment Phase Period 4|Withdrawal by Subject|0
1158421|NCT03286218|2276792|FG006|Treatment Phase Period 4|Withdrawal by Subject|0
1158422|NCT03286218|2276793|FG007|Treatment Phase Period 4|Withdrawal by Subject|0
1158423|NCT03286218|2276794|FG008|Treatment Phase Period 4|Withdrawal by Subject|0
1158424|NCT03286218|2276795|FG009|Treatment Phase Period 4|Withdrawal by Subject|0
1158425|NCT03286218|2276796|FG010|Treatment Phase Period 4|Withdrawal by Subject|0
1158426|NCT03286218|2276797|FG011|Treatment Phase Period 4|Withdrawal by Subject|1
1158427|NCT03286400|2276828|FG000|Overall Study|Death|10
1158428|NCT03286400|2276828|FG000|Overall Study|Lost to Follow-up|10
1158429|NCT03286400|2276828|FG000|Overall Study|Physician Decision|1
1158430|NCT03286400|2276828|FG000|Overall Study|Scheduling difficulty|4
1158431|NCT03286543|2276843|FG000|Consented|Screen failure before randomization|2
1158432|NCT03286543|2276844|FG001|Consented|Screen failure before randomization|0
1158433|NCT03286543|2276845|FG002|Consented|Screen failure before randomization|0
1158434|NCT03286543|2276843|FG000|Consented|Screen failure before enrollment|4
1158435|NCT03286543|2276844|FG001|Consented|Screen failure before enrollment|0
1158436|NCT03286543|2276845|FG002|Consented|Screen failure before enrollment|0
1158437|NCT03286543|2276843|FG000|Consented|TKA cancelled after enrollment|1
1158438|NCT03286543|2276844|FG001|Consented|TKA cancelled after enrollment|0
1158439|NCT03286543|2276845|FG002|Consented|TKA cancelled after enrollment|0
1158440|NCT03286543|2276843|FG000|Consented|Withdrawn from study|12
1158441|NCT03286543|2276844|FG001|Consented|Withdrawn from study|0
1158442|NCT03286543|2276845|FG002|Consented|Withdrawn from study|0
1158443|NCT03286543|2276843|FG000|Study Enrollment|TKA cancelled after enrollment|0
1158444|NCT03286543|2276844|FG001|Study Enrollment|TKA cancelled after enrollment|0
1158445|NCT03286543|2276845|FG002|Study Enrollment|TKA cancelled after enrollment|1
1158446|NCT03286543|2276843|FG000|Study Enrollment|Withdrawn from study|0
1158447|NCT03286543|2276844|FG001|Study Enrollment|Withdrawn from study|6
1158448|NCT03286543|2276845|FG002|Study Enrollment|Withdrawn from study|6
1158449|NCT03286751|2276851|FG000|Washout Period 1|Withdrawal by Subject|0
1158450|NCT03286751|2276852|FG001|Washout Period 1|Withdrawal by Subject|0
1158451|NCT03286751|2276853|FG002|Washout Period 1|Withdrawal by Subject|0
1158452|NCT03286751|2276854|FG003|Washout Period 1|Withdrawal by Subject|0
1158453|NCT03286751|2276855|FG004|Washout Period 1|Withdrawal by Subject|1
1158454|NCT03286751|2276856|FG005|Washout Period 1|Withdrawal by Subject|0
1158455|NCT03286751|2276851|FG000|Washout Period 2|Personal Reasons|0
1158456|NCT03286751|2276852|FG001|Washout Period 2|Personal Reasons|1
1158457|NCT03286751|2276853|FG002|Washout Period 2|Personal Reasons|0
1158458|NCT03286751|2276854|FG003|Washout Period 2|Personal Reasons|0
1158459|NCT03286751|2276855|FG004|Washout Period 2|Personal Reasons|0
1158460|NCT03286751|2276856|FG005|Washout Period 2|Personal Reasons|0
1158461|NCT03286751|2276851|FG000|Washout Period 5|Adverse Event|0
1158462|NCT03286751|2276852|FG001|Washout Period 5|Adverse Event|0
1158463|NCT03286751|2276853|FG002|Washout Period 5|Adverse Event|0
1158464|NCT03286751|2276854|FG003|Washout Period 5|Adverse Event|0
1158465|NCT03286751|2276855|FG004|Washout Period 5|Adverse Event|1
1158466|NCT03286751|2276856|FG005|Washout Period 5|Adverse Event|0
1158467|NCT03287089|2276891|FG000|Overall Study|Lost to Follow-up|0
1158468|NCT03287089|2276892|FG001|Overall Study|Lost to Follow-up|2
1158469|NCT03287089|2276891|FG000|Overall Study|Physician Decision|0
1158470|NCT03287089|2276892|FG001|Overall Study|Physician Decision|2
1158471|NCT03287089|2276891|FG000|Overall Study|Withdrawal by Subject|0
1158472|NCT03287089|2276892|FG001|Overall Study|Withdrawal by Subject|2
1158473|NCT03287219|2276900|FG000|Overall Study|Protocol Violation|0
1158474|NCT03287219|2276901|FG001|Overall Study|Protocol Violation|2
1158475|NCT03287622|2277012|FG000|Overall Study|Withdrawal by Subject|1
1158476|NCT03287622|2277013|FG001|Overall Study|Withdrawal by Subject|0
1158477|NCT03287622|2277012|FG000|Overall Study|Lost to Follow-up|27
1158478|NCT03287622|2277013|FG001|Overall Study|Lost to Follow-up|15
1158479|NCT03287622|2277012|FG000|Overall Study|No prescripion after surgery|28
1158480|NCT03287622|2277013|FG001|Overall Study|No prescripion after surgery|31
1158481|NCT03287622|2277012|FG000|Overall Study|prolonged Length of stay|2
1158482|NCT03287622|2277013|FG001|Overall Study|prolonged Length of stay|0
1158483|NCT03287622|2277012|FG000|Overall Study|surgery related|0
1158484|NCT03287622|2277013|FG001|Overall Study|surgery related|2
1158485|NCT03287635|2277026|FG000|Overall Study|Lost to Follow-up|5
1158486|NCT03287635|2277026|FG000|Overall Study|Withdrawal by Subject|1
1158487|NCT03287635|2277026|FG000|Overall Study|Physician Decision|1
1158488|NCT03287791|2277038|FG000|Overall Study|Insufficient Therapeutic Response|0
1158489|NCT03287791|2277039|FG001|Overall Study|Insufficient Therapeutic Response|0
1158490|NCT03287791|2277040|FG002|Overall Study|Insufficient Therapeutic Response|1
1158491|NCT03287791|2277038|FG000|Overall Study|Adverse Event|0
1158492|NCT03287791|2277039|FG001|Overall Study|Adverse Event|4
1158493|NCT03287791|2277040|FG002|Overall Study|Adverse Event|3
1158494|NCT03287791|2277038|FG000|Overall Study|Withdrawal by Subject|12
1158495|NCT03287791|2277039|FG001|Overall Study|Withdrawal by Subject|12
1158496|NCT03287791|2277040|FG002|Overall Study|Withdrawal by Subject|17
1158497|NCT03287791|2277038|FG000|Overall Study|Missed more than 6 consecutive doses|3
1158498|NCT03287791|2277039|FG001|Overall Study|Missed more than 6 consecutive doses|2
1158499|NCT03287791|2277040|FG002|Overall Study|Missed more than 6 consecutive doses|2
1158500|NCT03287791|2277038|FG000|Overall Study|Lost to Follow-up|8
1158501|NCT03287791|2277039|FG001|Overall Study|Lost to Follow-up|14
1158502|NCT03287791|2277040|FG002|Overall Study|Lost to Follow-up|11
1158503|NCT03287791|2277038|FG000|Overall Study|Protocol Violation|7
1158504|NCT03287791|2277039|FG001|Overall Study|Protocol Violation|2
1158505|NCT03287791|2277040|FG002|Overall Study|Protocol Violation|1
1158506|NCT03287791|2277038|FG000|Overall Study|Participant was enrolled at 2 sites|1
1158507|NCT03287791|2277039|FG001|Overall Study|Participant was enrolled at 2 sites|0
1158508|NCT03287791|2277040|FG002|Overall Study|Participant was enrolled at 2 sites|1
1158509|NCT03287791|2277038|FG000|Overall Study|Too much time between 2 visits|0
1158510|NCT03287791|2277039|FG001|Overall Study|Too much time between 2 visits|1
1158511|NCT03287791|2277040|FG002|Overall Study|Too much time between 2 visits|0
1158512|NCT03287791|2277038|FG000|Overall Study|Non-compliance|0
1158513|NCT03287791|2277039|FG001|Overall Study|Non-compliance|1
1158514|NCT03287791|2277040|FG002|Overall Study|Non-compliance|0
1158515|NCT03287791|2277038|FG000|Overall Study|Did not meet inclusion criteria|1
1158516|NCT03287791|2277039|FG001|Overall Study|Did not meet inclusion criteria|0
1158517|NCT03287791|2277040|FG002|Overall Study|Did not meet inclusion criteria|0
1158518|NCT03287804|2277048|FG000|Overall Study|Death|1
1158519|NCT03287804|2277048|FG000|Overall Study|Physician Decision|2
1158520|NCT03287804|2277048|FG000|Overall Study|Progressive disease|8
1158521|NCT03287869|2277064|FG000|Overall Study|Adverse Event|14
1158522|NCT03287869|2277065|FG001|Overall Study|Adverse Event|12
1158523|NCT03287869|2277064|FG000|Overall Study|Lack of Efficacy|1
1158524|NCT03287869|2277065|FG001|Overall Study|Lack of Efficacy|0
1158525|NCT03287869|2277064|FG000|Overall Study|Lost to Follow-up|13
1158526|NCT03287869|2277065|FG001|Overall Study|Lost to Follow-up|19
1158527|NCT03287869|2277064|FG000|Overall Study|Non-Compliance With Study Drug|5
1158528|NCT03287869|2277065|FG001|Overall Study|Non-Compliance With Study Drug|9
1158529|NCT03287869|2277064|FG000|Overall Study|Progressive Disease|1
1158530|NCT03287869|2277065|FG001|Overall Study|Progressive Disease|0
1158531|NCT03287869|2277064|FG000|Overall Study|Protocol Deviation|2
1158532|NCT03287869|2277065|FG001|Overall Study|Protocol Deviation|1
1158533|NCT03287869|2277064|FG000|Overall Study|Withdrawal by Subject|36
1158534|NCT03287869|2277065|FG001|Overall Study|Withdrawal by Subject|43
1158535|NCT03287869|2277064|FG000|Overall Study|Early Closure of the Site|0
1158536|NCT03287869|2277065|FG001|Overall Study|Early Closure of the Site|1
1158537|NCT03287869|2277064|FG000|Overall Study|Physician Decision|5
1158538|NCT03287869|2277065|FG001|Overall Study|Physician Decision|5
1158539|NCT03287869|2277064|FG000|Overall Study|Reason not Specified|6
1158540|NCT03287869|2277065|FG001|Overall Study|Reason not Specified|3
1158541|NCT03288714|2277077|FG000|Overall Study|Lost to Follow-up|2
1158542|NCT03288714|2277078|FG001|Overall Study|Lost to Follow-up|1
1158543|NCT03288714|2277077|FG000|Overall Study|Non-compliance with study schedule|2
1158544|NCT03288714|2277078|FG001|Overall Study|Non-compliance with study schedule|0
1018358|NCT01570361|2043196|FG001|Overall Study|Adverse Event|1
1018359|NCT01570361|2043195|FG000|Overall Study|Lost to Follow-up|4
903568|NCT00749463|1877851|FG001|Overall Study|Adverse Event|4
903569|NCT00749463|1877852|FG002|Overall Study|Adverse Event|1
903570|NCT00749463|1877850|FG000|Overall Study|Withdrawal by Subject|1
903571|NCT00749463|1877851|FG001|Overall Study|Withdrawal by Subject|0
903572|NCT00749463|1877852|FG002|Overall Study|Withdrawal by Subject|0
903573|NCT00749580|1877871|FG000|Overall Study|Lost to Follow-up|4
1018360|NCT01570361|2043196|FG001|Overall Study|Lost to Follow-up|4
1158545|NCT03288714|2277077|FG000|Overall Study|Withdrawal by Subject|3
1158546|NCT03288714|2277078|FG001|Overall Study|Withdrawal by Subject|1
1158547|NCT03288714|2277077|FG000|Overall Study|Clinical Worsening|2
1158548|NCT03288714|2277078|FG001|Overall Study|Clinical Worsening|1
1158549|NCT03288714|2277077|FG000|Overall Study|Adverse Event|1
1158550|NCT03288714|2277078|FG001|Overall Study|Adverse Event|0
1158551|NCT03288779|2277086|FG000|Overall Study|Withdrawal by Subject|3
1158552|NCT03288987|2277092|FG000|Overall Study|Protocol Violation|10
1158553|NCT03288987|2277093|FG001|Overall Study|Protocol Violation|4
1158554|NCT03289208|2277115|FG000|Overall Study|Adverse Event|1
1158555|NCT03289208|2277116|FG001|Overall Study|Adverse Event|0
1158556|NCT03289208|2277117|FG002|Overall Study|Adverse Event|0
1158557|NCT03289455|2277141|FG000|Overall Study|Death|1
1158558|NCT03289455|2277142|FG001|Overall Study|Death|0
1158559|NCT03289455|2277143|FG002|Overall Study|Death|0
1158560|NCT03289455|2277141|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0
1158561|NCT03289455|2277142|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1
1158562|NCT03289455|2277143|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0
1158563|NCT03289455|2277141|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
1158564|NCT03289455|2277142|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
1158565|NCT03289455|2277143|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1
1158566|NCT03289455|2277141|FG000|Overall Study|Progressive disease|3
1158567|NCT03289455|2277142|FG001|Overall Study|Progressive disease|4
1158568|NCT03289455|2277143|FG002|Overall Study|Progressive disease|5
1158569|NCT03289533|2277162|FG000|Overall Study|Death|12
1158570|NCT03289533|2277162|FG000|Overall Study|Terminated from study by sponsor|10
1158571|NCT03289676|2277168|FG000|Overall Study|Withdrawal by Subject|2
1158572|NCT03289676|2277169|FG001|Overall Study|Withdrawal by Subject|0
1158573|NCT03289676|2277168|FG000|Overall Study|Protocol Violation|2
1158574|NCT03289676|2277169|FG001|Overall Study|Protocol Violation|0
1158575|NCT03289676|2277168|FG000|Overall Study|Lost to Follow-up|0
1158576|NCT03289676|2277169|FG001|Overall Study|Lost to Follow-up|1
1158577|NCT03290300|2277193|FG000|Overall Study|Lost to Follow-up|3
1158578|NCT03291288|2277246|FG000|Drug-drug Interaction Phase|Adverse Event|2
1158579|NCT03291288|2277247|FG001|Drug-drug Interaction Phase|Adverse Event|0
1158580|NCT03291288|2277246|FG000|Drug-drug Interaction Phase|Disease progression|1
1158581|NCT03291288|2277247|FG001|Drug-drug Interaction Phase|Disease progression|0
1158582|NCT03291288|2277246|FG000|Drug-drug Interaction Phase|Other|3
1158583|NCT03291288|2277247|FG001|Drug-drug Interaction Phase|Other|0
1158584|NCT03291288|2277246|FG000|Pexidartinib Only|Ongoing|0
1158585|NCT03291288|2277247|FG001|Pexidartinib Only|Ongoing|2
1158586|NCT03292016|2277276|FG000|Second Washout|Adverse Event|0
1158587|NCT03292016|2277277|FG001|Second Washout|Adverse Event|1
1158588|NCT03292016|2277278|FG002|Second Washout|Adverse Event|0
1158589|NCT03292016|2277279|FG003|Second Washout|Adverse Event|0
1158590|NCT03292016|2277280|FG004|Second Washout|Adverse Event|0
1158591|NCT03292016|2277281|FG005|Second Washout|Adverse Event|0
1158592|NCT03292406|2277292|FG000|Overall Study|Progressive Disease|6
1158593|NCT03292406|2277293|FG001|Overall Study|Progressive Disease|3
1158594|NCT03292406|2277294|FG002|Overall Study|Progressive Disease|4
1158595|NCT03292406|2277292|FG000|Overall Study|Adverse Event|7
1158596|NCT03292406|2277293|FG001|Overall Study|Adverse Event|1
1158597|NCT03292406|2277294|FG002|Overall Study|Adverse Event|4
1018361|NCT01570361|2043195|FG000|Overall Study|Death|5
1018362|NCT01570361|2043196|FG001|Overall Study|Death|4
1018363|NCT01570361|2043195|FG000|Overall Study|Other|0
1018364|NCT01570361|2043196|FG001|Overall Study|Other|2
1018365|NCT01570387|2043209|FG000|Overall Study|Adverse Event|1
1018366|NCT01570387|2043210|FG001|Overall Study|Adverse Event|0
1018367|NCT01570387|2043211|FG002|Overall Study|Adverse Event|0
1018368|NCT01570387|2043212|FG003|Overall Study|Adverse Event|0
1018369|NCT01570387|2043209|FG000|Overall Study|Death|0
1018370|NCT01570387|2043210|FG001|Overall Study|Death|0
1018371|NCT01570387|2043211|FG002|Overall Study|Death|0
1018372|NCT01570387|2043212|FG003|Overall Study|Death|1
1018373|NCT01570387|2043209|FG000|Overall Study|Withdrawal by Subject|0
1018374|NCT01570387|2043210|FG001|Overall Study|Withdrawal by Subject|0
1018375|NCT01570387|2043211|FG002|Overall Study|Withdrawal by Subject|0
1018376|NCT01570387|2043212|FG003|Overall Study|Withdrawal by Subject|1
1018377|NCT01570491|2043221|FG000|Overall Study|Lost to Follow-up|3
1018378|NCT01570491|2043222|FG001|Overall Study|Lost to Follow-up|1
1018379|NCT01570491|2043221|FG000|Overall Study|treatment: not given or discontinued|2
1018380|NCT01570491|2043222|FG001|Overall Study|treatment: not given or discontinued|0
1018381|NCT01570686|2043230|FG000|Overall Study|Abnormal test procedure result(s)|1
1018382|NCT01570686|2043231|FG001|Overall Study|Abnormal test procedure result(s)|1
1018383|NCT01570686|2043230|FG000|Overall Study|Administrative problems|0
1018384|NCT01570686|2043231|FG001|Overall Study|Administrative problems|1
1018385|NCT01570686|2043230|FG000|Overall Study|Adverse Event|8
1018386|NCT01570686|2043231|FG001|Overall Study|Adverse Event|6
1018387|NCT01570686|2043230|FG000|Overall Study|Lost to Follow-up|4
1018388|NCT01570686|2043231|FG001|Overall Study|Lost to Follow-up|3
1018389|NCT01570686|2043230|FG000|Overall Study|Protocol Deviation|3
1018390|NCT01570686|2043231|FG001|Overall Study|Protocol Deviation|0
1018391|NCT01570686|2043230|FG000|Overall Study|Withdrawal by Subject|4
1158598|NCT03292406|2277292|FG000|Overall Study|Withdrawal by Subject|0
1158599|NCT03292406|2277293|FG001|Overall Study|Withdrawal by Subject|7
1158600|NCT03292406|2277294|FG002|Overall Study|Withdrawal by Subject|2
1158601|NCT03292406|2277292|FG000|Overall Study|Protocol Violation|0
1158602|NCT03292406|2277293|FG001|Overall Study|Protocol Violation|1
1158603|NCT03292406|2277294|FG002|Overall Study|Protocol Violation|1
1158604|NCT03292406|2277292|FG000|Overall Study|Other|0
1158605|NCT03292406|2277293|FG001|Overall Study|Other|1
1158606|NCT03292406|2277294|FG002|Overall Study|Other|2
1158607|NCT03292432|2277304|FG000|Overall Study|Lost to Follow-up|11
1158608|NCT03292432|2277305|FG001|Overall Study|Lost to Follow-up|8
1158609|NCT03292432|2277304|FG000|Overall Study|Death|2
1158610|NCT03292432|2277305|FG001|Overall Study|Death|1
1158611|NCT03292432|2277304|FG000|Overall Study|Withdrawal by Subject|1
1158612|NCT03292432|2277305|FG001|Overall Study|Withdrawal by Subject|2
1158613|NCT03292432|2277304|FG000|Overall Study|Site closed before any data collected|1
1158614|NCT03292432|2277305|FG001|Overall Study|Site closed before any data collected|0
1158615|NCT03292640|2277326|FG000|Overall Study|Withdrawal by Subject|17
1158616|NCT03292640|2277327|FG001|Overall Study|Withdrawal by Subject|16
1158617|NCT03292640|2277326|FG000|Overall Study|Adverse Event|20
1158618|NCT03292640|2277327|FG001|Overall Study|Adverse Event|2
1158619|NCT03292640|2277326|FG000|Overall Study|Lost to Follow-up|24
1158620|NCT03292640|2277327|FG001|Overall Study|Lost to Follow-up|24
1158621|NCT03292653|2277340|FG000|Overall Study|Adverse Event|0
1158622|NCT03292653|2277341|FG001|Overall Study|Adverse Event|0
1158623|NCT03292653|2277342|FG002|Overall Study|Adverse Event|1
1158624|NCT03292653|2277340|FG000|Overall Study|Did not Receive Treatment|1
1158625|NCT03292653|2277341|FG001|Overall Study|Did not Receive Treatment|0
1158626|NCT03292653|2277342|FG002|Overall Study|Did not Receive Treatment|0
1158627|NCT03293394|2277401|FG000|Follow-up (6 Months)|Adverse Event|4
1158628|NCT03293394|2277402|FG001|Follow-up (6 Months)|Adverse Event|2
1158629|NCT03293485|2277408|FG000|Overall Study|Death|1
1158630|NCT03293485|2277408|FG000|Overall Study|Screen Failure|2
1158631|NCT03293485|2277408|FG000|Overall Study|Withdrawal by Subject|2
1158632|NCT03293654|2277417|FG000|Overall Study|Lost to Follow-up|0
1158633|NCT03293654|2277418|FG001|Overall Study|Lost to Follow-up|1
1158634|NCT03293654|2277419|FG002|Overall Study|Lost to Follow-up|0
1158637|NCT03294317|2277441|FG000|Overall Study|Physician Decision|1
1158638|NCT03294317|2277441|FG000|Overall Study|Withdrawal by Subject|6
1158639|NCT03294317|2277441|FG000|Overall Study|Lost to Follow-up|1
1158640|NCT03294317|2277441|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1
1158641|NCT03294317|2277441|FG000|Overall Study|Failed HB lead implant|8
1158642|NCT03294317|2277441|FG000|Overall Study|Received CRT instead|1
1158643|NCT03294317|2277441|FG000|Overall Study|Exited after lead revision|2
1158644|NCT03294538|2277448|FG000|Overall Study|Adverse Event|0
1158645|NCT03294538|2277449|FG001|Overall Study|Adverse Event|1
1158646|NCT03294538|2277450|FG002|Overall Study|Adverse Event|1
1158647|NCT03294538|2277448|FG000|Overall Study|Lost to Follow-up|1
1158648|NCT03294538|2277449|FG001|Overall Study|Lost to Follow-up|0
1158649|NCT03294538|2277450|FG002|Overall Study|Lost to Follow-up|0
1158650|NCT03294538|2277448|FG000|Overall Study|Outside of Visit Window|4
1158651|NCT03294538|2277449|FG001|Overall Study|Outside of Visit Window|4
1158652|NCT03294538|2277450|FG002|Overall Study|Outside of Visit Window|1
1158653|NCT03294681|2277467|FG000|Overall Study|Withdrawal by Subject|1
1158654|NCT03294941|2277482|FG000|Overall Study|Withdrawal by Subject|0
1158655|NCT03294941|2277483|FG001|Overall Study|Withdrawal by Subject|2
1158656|NCT03295201|2277492|FG000|Overall Study|Lost to Follow-up|1
1158657|NCT03295201|2277493|FG001|Overall Study|Lost to Follow-up|1
1158658|NCT03295201|2277492|FG000|Overall Study|Hospital admission|0
1158659|NCT03295201|2277493|FG001|Overall Study|Hospital admission|1
1158660|NCT03295318|2277511|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1
1158661|NCT03295318|2277512|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0
1158662|NCT03295318|2277513|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0
1158663|NCT03295318|2277511|FG000|Overall Study|Death|1
1158664|NCT03295318|2277512|FG001|Overall Study|Death|1
1158665|NCT03295318|2277513|FG002|Overall Study|Death|1
1158666|NCT03295318|2277511|FG000|Overall Study|Protocol Violation|4
1158667|NCT03295318|2277512|FG001|Overall Study|Protocol Violation|3
1158668|NCT03295318|2277513|FG002|Overall Study|Protocol Violation|3
1158669|NCT03295318|2277511|FG000|Overall Study|Withdrawal by Subject|0
1158670|NCT03295318|2277512|FG001|Overall Study|Withdrawal by Subject|0
1158671|NCT03295318|2277513|FG002|Overall Study|Withdrawal by Subject|1
1158672|NCT03295318|2277511|FG000|Overall Study|Subject discontinued due to travel|0
1018392|NCT01570686|2043231|FG001|Overall Study|Withdrawal by Subject|4
1018393|NCT01570686|2043230|FG000|Overall Study|Unsatisfactory therapeutic effect|2
1018394|NCT01570686|2043231|FG001|Overall Study|Unsatisfactory therapeutic effect|1
1018395|NCT01570751|2043239|FG000|Period A (16 Weeks)|Protocol Violation|1
1018396|NCT01570751|2043240|FG001|Period A (16 Weeks)|Protocol Violation|1
1018397|NCT01570751|2043239|FG000|Period A (16 Weeks)|Withdrawal criteria|0
1018398|NCT01570751|2043240|FG001|Period A (16 Weeks)|Withdrawal criteria|1
1018399|NCT01570751|2043239|FG000|Period A (16 Weeks)|Unclassified|2
1158673|NCT03295318|2277512|FG001|Overall Study|Subject discontinued due to travel|1
1158674|NCT03295318|2277513|FG002|Overall Study|Subject discontinued due to travel|0
1158675|NCT03295721|2277547|FG000|Overall Study|Adverse Event|1
1158676|NCT03295721|2277548|FG001|Overall Study|Adverse Event|0
1158677|NCT03295721|2277549|FG002|Overall Study|Adverse Event|0
1158678|NCT03295721|2277547|FG000|Overall Study|Lost to Follow-up|1
1158679|NCT03295721|2277548|FG001|Overall Study|Lost to Follow-up|1
1158680|NCT03295721|2277549|FG002|Overall Study|Lost to Follow-up|1
1158681|NCT03295721|2277547|FG000|Overall Study|Withdrawal by Subject|1
1158682|NCT03295721|2277548|FG001|Overall Study|Withdrawal by Subject|0
1158683|NCT03295721|2277549|FG002|Overall Study|Withdrawal by Subject|1
1158684|NCT03295721|2277547|FG000|Overall Study|Death|0
1158685|NCT03295721|2277548|FG001|Overall Study|Death|0
1158686|NCT03295721|2277549|FG002|Overall Study|Death|1
1158687|NCT03296527|2277597|FG000|Overall Study|Adverse Event|15
1158688|NCT03296527|2277598|FG001|Overall Study|Adverse Event|33
1158689|NCT03296527|2277597|FG000|Overall Study|Protocol Deviation|4
1158690|NCT03296527|2277598|FG001|Overall Study|Protocol Deviation|0
1158691|NCT03296527|2277597|FG000|Overall Study|Subject withdrew consent|3
1158692|NCT03296527|2277598|FG001|Overall Study|Subject withdrew consent|1
1158693|NCT03296527|2277597|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9
1158694|NCT03296527|2277598|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14
1158695|NCT03296527|2277597|FG000|Overall Study|Discontinuations due to withdrawal from trial|2
1158696|NCT03296527|2277598|FG001|Overall Study|Discontinuations due to withdrawal from trial|3
1158697|NCT03296527|2277597|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0
1158698|NCT03296527|2277598|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2
1158699|NCT03296527|2277597|FG000|Overall Study|Discontinuation due to liquid in uterus|1
1158700|NCT03296527|2277598|FG001|Overall Study|Discontinuation due to liquid in uterus|0
1158701|NCT03296527|2277597|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1
1158702|NCT03296527|2277598|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0
1158703|NCT03296566|2277607|FG000|Overall Study|Lost to Follow-up|19
1158704|NCT03296566|2277608|FG001|Overall Study|Lost to Follow-up|46
1158705|NCT03296566|2277607|FG000|Overall Study|Withdrawal by Subject|0
1158706|NCT03296566|2277608|FG001|Overall Study|Withdrawal by Subject|3
1158707|NCT03297021|2277663|FG000|Overall Study|Incomplete/illegible data sheet|4
1158708|NCT03297021|2277664|FG001|Overall Study|Incomplete/illegible data sheet|2
1158709|NCT03297021|2277665|FG002|Overall Study|Incomplete/illegible data sheet|3
1158710|NCT03297021|2277663|FG000|Overall Study|Missing Post-Op Data|1
1158711|NCT03297021|2277664|FG001|Overall Study|Missing Post-Op Data|2
1158712|NCT03297021|2277665|FG002|Overall Study|Missing Post-Op Data|1
1158713|NCT03297216|2277679|FG000|Overall Study|Death|0
1158714|NCT03297216|2277680|FG001|Overall Study|Death|1
1158715|NCT03297216|2277679|FG000|Overall Study|Miscarriage|0
1158716|NCT03297216|2277680|FG001|Overall Study|Miscarriage|2
1158717|NCT03297216|2277679|FG000|Overall Study|Lost to Follow-up|3
1158718|NCT03297216|2277680|FG001|Overall Study|Lost to Follow-up|2
1158719|NCT03297294|2277695|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30
1158720|NCT03297294|2277696|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31
1158721|NCT03297294|2277697|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
1158722|NCT03297294|2277698|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
1158723|NCT03297294|2277699|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
1158724|NCT03297294|2277695|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
1158725|NCT03297294|2277696|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
1158726|NCT03297294|2277697|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
1158727|NCT03297294|2277698|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
1158728|NCT03297294|2277699|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
1158729|NCT03297294|2277695|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
1158730|NCT03297294|2277696|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1
1158731|NCT03297294|2277697|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0
1158732|NCT03297294|2277698|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
1158733|NCT03297294|2277699|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
1158734|NCT03297294|2277695|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1
1158735|NCT03297294|2277696|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1
1158736|NCT03297294|2277697|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0
1158737|NCT03297294|2277698|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
1158738|NCT03297294|2277699|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
1158739|NCT03297294|2277695|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
1158740|NCT03297294|2277696|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
1158741|NCT03297294|2277697|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
1158742|NCT03297294|2277698|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1
1158743|NCT03297294|2277699|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
1158744|NCT03297398|2277714|FG000|Overall Study|Sponsor's decision|6
1158745|NCT03297398|2277715|FG001|Overall Study|Sponsor's decision|9
1158746|NCT03297398|2277716|FG002|Overall Study|Sponsor's decision|7
1158747|NCT03297398|2277714|FG000|Overall Study|Adverse Event|1
1158748|NCT03297398|2277715|FG001|Overall Study|Adverse Event|4
1158749|NCT03297398|2277716|FG002|Overall Study|Adverse Event|4
1158750|NCT03297398|2277714|FG000|Overall Study|Withdrawal by Subject|1
1158751|NCT03297398|2277715|FG001|Overall Study|Withdrawal by Subject|2
1158752|NCT03297398|2277716|FG002|Overall Study|Withdrawal by Subject|2
1158753|NCT03297398|2277714|FG000|Overall Study|Protocol Violation|0
1158754|NCT03297398|2277715|FG001|Overall Study|Protocol Violation|2
1158755|NCT03297398|2277716|FG002|Overall Study|Protocol Violation|0
1158756|NCT03297398|2277714|FG000|Overall Study|Physician Decision|0
1158757|NCT03297398|2277715|FG001|Overall Study|Physician Decision|0
1158758|NCT03297398|2277716|FG002|Overall Study|Physician Decision|1
1158759|NCT03297398|2277714|FG000|Overall Study|Lost to Follow-up|0
1158760|NCT03297398|2277715|FG001|Overall Study|Lost to Follow-up|0
1158761|NCT03297398|2277716|FG002|Overall Study|Lost to Follow-up|1
1158762|NCT03298412|2277764|FG000|Run-in Period|Other, Not Specified|1
1158763|NCT03298412|2277764|FG000|Run-in Period|Disease Progression|1
1158764|NCT03298412|2277764|FG000|Run-in Period|Ineligibility Determined|1
1158765|NCT03298412|2277764|FG000|Run-in Period|Decision by Sponsor|6
1158770|NCT03298984|2277802|FG000|Overall Study|Physician Decision|1
1158771|NCT03298984|2277803|FG001|Overall Study|Physician Decision|0
1158772|NCT03298984|2277804|FG002|Overall Study|Physician Decision|0
1158773|NCT03298984|2277805|FG003|Overall Study|Physician Decision|6
1158774|NCT03298984|2277802|FG000|Overall Study|Lack of Efficacy|0
1158775|NCT03298984|2277803|FG001|Overall Study|Lack of Efficacy|1
1158776|NCT03298984|2277804|FG002|Overall Study|Lack of Efficacy|1
1158777|NCT03298984|2277805|FG003|Overall Study|Lack of Efficacy|4
1158778|NCT03298984|2277802|FG000|Overall Study|Relapsed disease (following remission)|0
1158779|NCT03298984|2277803|FG001|Overall Study|Relapsed disease (following remission)|0
1158780|NCT03298984|2277804|FG002|Overall Study|Relapsed disease (following remission)|1
1158781|NCT03298984|2277805|FG003|Overall Study|Relapsed disease (following remission)|1
1158782|NCT03298984|2277802|FG000|Overall Study|Adverse Event|0
1158783|NCT03298984|2277803|FG001|Overall Study|Adverse Event|0
1158784|NCT03298984|2277804|FG002|Overall Study|Adverse Event|0
1158785|NCT03298984|2277805|FG003|Overall Study|Adverse Event|1
1158786|NCT03298984|2277802|FG000|Overall Study|Death|0
1158787|NCT03298984|2277803|FG001|Overall Study|Death|0
1158788|NCT03298984|2277804|FG002|Overall Study|Death|0
1158789|NCT03298984|2277805|FG003|Overall Study|Death|2
1158790|NCT03298984|2277802|FG000|Overall Study|Insurance Company Decision|0
1158791|NCT03298984|2277803|FG001|Overall Study|Insurance Company Decision|0
1158792|NCT03298984|2277804|FG002|Overall Study|Insurance Company Decision|0
1158793|NCT03298984|2277805|FG003|Overall Study|Insurance Company Decision|1
1158794|NCT03299049|2277818|FG000|Overall Study|On-going|486
1158795|NCT03299049|2277819|FG001|Overall Study|On-going|481
1158796|NCT03299049|2277818|FG000|Overall Study|Withdrawal by Subject|6
1158797|NCT03299049|2277819|FG001|Overall Study|Withdrawal by Subject|21
1158798|NCT03299049|2277818|FG000|Overall Study|Physician Decision|5
1158799|NCT03299049|2277819|FG001|Overall Study|Physician Decision|1
1158800|NCT03299049|2277818|FG000|Overall Study|Lost to Follow-up|2
1158801|NCT03299049|2277819|FG001|Overall Study|Lost to Follow-up|0
1158802|NCT03299049|2277818|FG000|Overall Study|Pregnancy|1
1158803|NCT03299049|2277819|FG001|Overall Study|Pregnancy|3
1158804|NCT03299049|2277818|FG000|Overall Study|Protocol Violation|1
1158805|NCT03299049|2277819|FG001|Overall Study|Protocol Violation|1
1158806|NCT03299049|2277818|FG000|Overall Study|Lack of Efficacy|9
1158807|NCT03299049|2277819|FG001|Overall Study|Lack of Efficacy|3
1158808|NCT03299049|2277818|FG000|Overall Study|Adverse Event|12
1158809|NCT03299049|2277819|FG001|Overall Study|Adverse Event|13
1158810|NCT03299101|2277832|FG000|Overall Study|Lost to Follow-up|1
1158811|NCT03299101|2277832|FG000|Overall Study|Withdrawal by Subject|5
1158812|NCT03299101|2277832|FG000|Overall Study|Surgery was changed|3
1158813|NCT03299101|2277832|FG000|Overall Study|Not enough time to complete prehab|1
1158814|NCT03299244|2277838|FG000|Overall Study|Withdrawal by Subject|34
1158815|NCT03299244|2277839|FG001|Overall Study|Withdrawal by Subject|29
1158816|NCT03299244|2277838|FG000|Overall Study|Decision by Sponsor|4
1158817|NCT03299244|2277839|FG001|Overall Study|Decision by Sponsor|5
1158818|NCT03299244|2277838|FG000|Overall Study|Death|9
1158819|NCT03299244|2277839|FG001|Overall Study|Death|4
1158820|NCT03299686|2277848|FG000|Treatment Epoch|Subject/Guardian Decision|2
1158821|NCT03299686|2277849|FG001|Treatment Epoch|Subject/Guardian Decision|0
1158822|NCT03299686|2277848|FG000|Treatment Epoch|Physician Decision|1
1158823|NCT03299686|2277849|FG001|Treatment Epoch|Physician Decision|0
1158824|NCT03299686|2277848|FG000|Treatment Epoch|Adverse Event|8
1158825|NCT03299686|2277849|FG001|Treatment Epoch|Adverse Event|4
1158826|NCT03299686|2277848|FG000|Follow-up Epoch|Subject/Guardian Decision|0
1158827|NCT03299686|2277849|FG001|Follow-up Epoch|Subject/Guardian Decision|1
1158828|NCT03299881|2277857|FG000|Overall Study|Study Termination|17
1158829|NCT03299881|2277858|FG001|Overall Study|Study Termination|13
1158830|NCT03300570|2277905|FG000|Overall Study|Adverse Event|0
1158831|NCT03300570|2277906|FG001|Overall Study|Adverse Event|1
1158832|NCT03300570|2277905|FG000|Overall Study|Withdrawal by Subject|1
1158833|NCT03300570|2277906|FG001|Overall Study|Withdrawal by Subject|0
1158834|NCT03300570|2277905|FG000|Overall Study|Inadequate bowel prep|1
1158835|NCT03300570|2277906|FG001|Overall Study|Inadequate bowel prep|0
1158836|NCT03301155|2277937|FG000|Overall Study|Сompliance with exclusion criteria|8
1158837|NCT03301155|2277938|FG001|Overall Study|Сompliance with exclusion criteria|7
1158838|NCT03301623|2277985|FG000|Overall Study|Death|3
1158839|NCT03301623|2277986|FG001|Overall Study|Death|1
1158840|NCT03301623|2277985|FG000|Overall Study|Withdrawal by Subject|11
1158841|NCT03301623|2277986|FG001|Overall Study|Withdrawal by Subject|13
1158842|NCT03301623|2277985|FG000|Overall Study|Lost to Follow-up|3
1158843|NCT03301623|2277986|FG001|Overall Study|Lost to Follow-up|1
1158844|NCT03301649|2277995|FG000|Overall Study|Need alternate therapy due to live lice|17
1158845|NCT03301649|2277996|FG001|Overall Study|Need alternate therapy due to live lice|25
1158846|NCT03301649|2277997|FG002|Overall Study|Need alternate therapy due to live lice|81
1158847|NCT03301649|2277995|FG000|Overall Study|Lost to Follow-up|11
1158848|NCT03301649|2277996|FG001|Overall Study|Lost to Follow-up|11
1158849|NCT03301649|2277997|FG002|Overall Study|Lost to Follow-up|3
1158850|NCT03301649|2277995|FG000|Overall Study|Protocol Violation|0
1158851|NCT03301649|2277996|FG001|Overall Study|Protocol Violation|1
1158852|NCT03301649|2277997|FG002|Overall Study|Protocol Violation|1
1158853|NCT03301649|2277995|FG000|Overall Study|Withdrawal by Subject|10
1158854|NCT03301649|2277996|FG001|Overall Study|Withdrawal by Subject|4
1158855|NCT03301649|2277997|FG002|Overall Study|Withdrawal by Subject|0
1158856|NCT03301649|2277995|FG000|Overall Study|Other than specified|5
1158857|NCT03301649|2277996|FG001|Overall Study|Other than specified|3
1158858|NCT03301649|2277997|FG002|Overall Study|Other than specified|0
1158859|NCT03301714|2278008|FG000|Overall Study|Lost to Follow-up|10
1158860|NCT03301714|2278009|FG001|Overall Study|Lost to Follow-up|4
1158861|NCT03301714|2278010|FG002|Overall Study|Lost to Follow-up|4
1158862|NCT03301714|2278008|FG000|Overall Study|Did not receive allocated intervention|0
1158863|NCT03301714|2278009|FG001|Overall Study|Did not receive allocated intervention|2
1158864|NCT03301714|2278010|FG002|Overall Study|Did not receive allocated intervention|3
1158865|NCT03301740|2278023|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
1158866|NCT03301740|2278024|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
1158867|NCT03301740|2278023|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
1158868|NCT03301740|2278024|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
1158869|NCT03301831|2278039|FG000|Overall Study|Lost to Follow-up|5
1158870|NCT03301831|2278040|FG001|Overall Study|Lost to Follow-up|3
1158871|NCT03301831|2278039|FG000|Overall Study|Protocol Violation|4
1158872|NCT03301831|2278040|FG001|Overall Study|Protocol Violation|0
1158873|NCT03301831|2278039|FG000|Overall Study|Withdrawal by Subject|11
1158874|NCT03301831|2278040|FG001|Overall Study|Withdrawal by Subject|0
1158875|NCT03301844|2278048|FG000|Overall Study|suspected colon cancer|1
1158876|NCT03301844|2278049|FG001|Overall Study|suspected colon cancer|1
1158877|NCT03302234|2278066|FG000|Overall Study|Death|137
1158878|NCT03302234|2278067|FG001|Overall Study|Death|135
1158879|NCT03302234|2278066|FG000|Overall Study|Withdrawal by Subject|1
1158880|NCT03302234|2278067|FG001|Overall Study|Withdrawal by Subject|1
1158881|NCT03302234|2278066|FG000|Overall Study|Laryngeal carcinoma|0
1158882|NCT03302234|2278067|FG001|Overall Study|Laryngeal carcinoma|1
1158883|NCT03302559|2278078|FG000|Overall Study|Adverse Event|2
1158884|NCT03302559|2278078|FG000|Overall Study|Lost to Follow-up|1
1158885|NCT03302559|2278078|FG000|Overall Study|Withdrew Consent|3
1158886|NCT03302936|2278111|FG000|Overall Study|Protocol Violation|3
1158887|NCT03302936|2278112|FG001|Overall Study|Protocol Violation|4
1158888|NCT03302975|2278122|FG000|Overall Study|Lost to Follow-up|4
1158889|NCT03303079|2278129|FG000|Overall Study|Adverse Event|0
1158890|NCT03303079|2278130|FG001|Overall Study|Adverse Event|1
1158891|NCT03303079|2278131|FG002|Overall Study|Adverse Event|3
1158892|NCT03303079|2278129|FG000|Overall Study|Protocol Violation|5
1158893|NCT03303079|2278130|FG001|Overall Study|Protocol Violation|4
1158894|NCT03303079|2278131|FG002|Overall Study|Protocol Violation|7
1158895|NCT03303079|2278129|FG000|Overall Study|Withdrawal by Subject|2
1158896|NCT03303079|2278130|FG001|Overall Study|Withdrawal by Subject|4
1158897|NCT03303079|2278131|FG002|Overall Study|Withdrawal by Subject|2
1158898|NCT03303079|2278129|FG000|Overall Study|Other than specified|0
1158899|NCT03303079|2278130|FG001|Overall Study|Other than specified|2
1158900|NCT03303079|2278131|FG002|Overall Study|Other than specified|0
1158901|NCT03303092|2278142|FG000|Overall Study|Adverse Event|1
1158902|NCT03303092|2278143|FG001|Overall Study|Adverse Event|0
1158903|NCT03303092|2278144|FG002|Overall Study|Adverse Event|1
1158904|NCT03303092|2278142|FG000|Overall Study|Protocol Violation|1
1158905|NCT03303092|2278143|FG001|Overall Study|Protocol Violation|5
1158906|NCT03303092|2278144|FG002|Overall Study|Protocol Violation|1
1158907|NCT03303092|2278142|FG000|Overall Study|Withdrawal by Subject|1
1158908|NCT03303092|2278143|FG001|Overall Study|Withdrawal by Subject|1
1158909|NCT03303092|2278144|FG002|Overall Study|Withdrawal by Subject|3
1158910|NCT03303105|2278154|FG000|Overall Study|Adverse Event|0
1158911|NCT03303105|2278155|FG001|Overall Study|Adverse Event|2
1158912|NCT03303105|2278154|FG000|Overall Study|Lack of Efficacy|1
1158913|NCT03303105|2278155|FG001|Overall Study|Lack of Efficacy|0
1158914|NCT03303105|2278154|FG000|Overall Study|Protocol Violation|1
1158915|NCT03303105|2278155|FG001|Overall Study|Protocol Violation|0
1158916|NCT03303105|2278154|FG000|Overall Study|Withdrawal by Subject|0
1158917|NCT03303105|2278155|FG001|Overall Study|Withdrawal by Subject|2
1158918|NCT03303417|2278184|FG000|Overall Study|Withdrawal by Subject|1
1158919|NCT03303417|2278185|FG001|Overall Study|Withdrawal by Subject|1
1158920|NCT03303521|2278193|FG000|Overall Study|Withdrawal by Subject|2
1158921|NCT03303521|2278194|FG001|Overall Study|Withdrawal by Subject|0
1158922|NCT03303521|2278193|FG000|Overall Study|Death|1
1158923|NCT03303521|2278194|FG001|Overall Study|Death|0
1158924|NCT03303521|2278193|FG000|Overall Study|Kidney transplantation|0
1158925|NCT03303521|2278194|FG001|Overall Study|Kidney transplantation|1
1158926|NCT03303521|2278193|FG000|Overall Study|Investigational product discontinuation|0
1158927|NCT03303521|2278194|FG001|Overall Study|Investigational product discontinuation|1
1158928|NCT03303521|2278193|FG000|Overall Study|Transferred to non-study dialysis center|1
1158929|NCT03303521|2278194|FG001|Overall Study|Transferred to non-study dialysis center|0
1158930|NCT03303521|2278193|FG000|Overall Study|Non-comliance to study protocol|0
1158931|NCT03303521|2278194|FG001|Overall Study|Non-comliance to study protocol|1
1158932|NCT03303521|2278193|FG000|Overall Study|Adverse Event|1
1158933|NCT03303521|2278194|FG001|Overall Study|Adverse Event|0
1158934|NCT03304184|2278269|FG000|Overall Study|Withdrawal by Subject|1
1158935|NCT03304184|2278270|FG001|Overall Study|Withdrawal by Subject|2
1158936|NCT03304522|2278279|FG000|Overall Study|Adverse Event|0
1158937|NCT03304522|2278280|FG001|Overall Study|Adverse Event|4
1158938|NCT03304522|2278279|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
1158939|NCT03304522|2278280|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
1158940|NCT03304522|2278279|FG000|Overall Study|Withdrawal of consent (for other reason)|0
1158941|NCT03304522|2278280|FG001|Overall Study|Withdrawal of consent (for other reason)|2
1158942|NCT03304522|2278279|FG000|Overall Study|Other|0
1158943|NCT03304522|2278280|FG001|Overall Study|Other|1
1158944|NCT03304626|2278288|FG000|Overall Study|Adverse Event|1
1158945|NCT03304626|2278289|FG001|Overall Study|Adverse Event|0
1158946|NCT03304626|2278288|FG000|Overall Study|Lack of Efficacy|1
1158947|NCT03304626|2278289|FG001|Overall Study|Lack of Efficacy|1
1158948|NCT03304873|2278298|FG000|Overall Study|Lost to Follow-up|1
1158949|NCT03304873|2278299|FG001|Overall Study|Lost to Follow-up|8
1158950|NCT03305081|2278307|FG000|Overall Study|Lost to Follow-up|10
1158951|NCT03305081|2278308|FG001|Overall Study|Lost to Follow-up|15
1158952|NCT03305419|2278331|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1158953|NCT03305419|2278332|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
1158954|NCT03305419|2278333|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1158955|NCT03305419|2278334|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1158956|NCT03305419|2278335|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1158957|NCT03305419|2278336|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1158958|NCT03305419|2278337|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1158959|NCT03305419|2278338|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1158960|NCT03305419|2278331|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
1158961|NCT03305419|2278332|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1158962|NCT03305419|2278333|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1158963|NCT03305419|2278334|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1158964|NCT03305419|2278335|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1158965|NCT03305419|2278336|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1158966|NCT03305419|2278337|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1158967|NCT03305419|2278338|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1158968|NCT03305419|2278331|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
1158969|NCT03305419|2278332|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1158970|NCT03305419|2278333|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1158971|NCT03305419|2278334|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1158972|NCT03305419|2278335|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1158973|NCT03305419|2278336|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1158974|NCT03305419|2278337|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1158975|NCT03305419|2278338|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1158976|NCT03305419|2278331|FG000|Part B (14 Days)|Adverse Event|0
1158977|NCT03305419|2278332|FG001|Part B (14 Days)|Adverse Event|0
1158978|NCT03305419|2278333|FG002|Part B (14 Days)|Adverse Event|0
1158979|NCT03305419|2278334|FG003|Part B (14 Days)|Adverse Event|0
1158980|NCT03305419|2278335|FG004|Part B (14 Days)|Adverse Event|1
1158981|NCT03305419|2278336|FG005|Part B (14 Days)|Adverse Event|2
1158982|NCT03305419|2278337|FG006|Part B (14 Days)|Adverse Event|4
1158983|NCT03305419|2278338|FG007|Part B (14 Days)|Adverse Event|0
1018400|NCT01570751|2043240|FG001|Period A (16 Weeks)|Unclassified|3
1018401|NCT01570751|2043239|FG000|Period B (16 Weeks)|Adverse Event|1
1018402|NCT01570751|2043240|FG001|Period B (16 Weeks)|Adverse Event|0
1018403|NCT01570751|2043239|FG000|Period B (16 Weeks)|Protocol Violation|0
1018404|NCT01570751|2043240|FG001|Period B (16 Weeks)|Protocol Violation|1
1018405|NCT01570868|2043259|FG000|Overall Study|Adverse Event|8
1018406|NCT01570868|2043260|FG001|Overall Study|Adverse Event|1
1018407|NCT01570868|2043259|FG000|Overall Study|FDA Recommendation|23
1158984|NCT03305419|2278331|FG000|Part B (14 Days)|Physician Decision|0
1158985|NCT03305419|2278332|FG001|Part B (14 Days)|Physician Decision|0
1158986|NCT03305419|2278333|FG002|Part B (14 Days)|Physician Decision|0
1158987|NCT03305419|2278334|FG003|Part B (14 Days)|Physician Decision|0
1158988|NCT03305419|2278335|FG004|Part B (14 Days)|Physician Decision|2
1158989|NCT03305419|2278336|FG005|Part B (14 Days)|Physician Decision|8
1158990|NCT03305419|2278337|FG006|Part B (14 Days)|Physician Decision|1
1158991|NCT03305419|2278338|FG007|Part B (14 Days)|Physician Decision|0
1158992|NCT03305575|2278363|FG000|Overall Study|Physician Decision|1
1158993|NCT03305575|2278364|FG001|Overall Study|Physician Decision|0
1158994|NCT03305666|2278376|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2
1158995|NCT03305666|2278377|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0
1158996|NCT03305731|2278383|FG000|Overall Study|Protocol Violation|1
1158997|NCT03305770|2278389|FG000|Overall Study|Physician Decision - prior to dispense|0
1158998|NCT03305770|2278390|FG001|Overall Study|Physician Decision - prior to dispense|1
1158999|NCT03305770|2278389|FG000|Overall Study|Subject moved|1
1159000|NCT03305770|2278390|FG001|Overall Study|Subject moved|0
1159001|NCT03305809|2278402|FG000|Overall Study|Adverse Event|2
1159002|NCT03305809|2278403|FG001|Overall Study|Adverse Event|2
1159003|NCT03305809|2278404|FG002|Overall Study|Adverse Event|6
1159004|NCT03305809|2278405|FG003|Overall Study|Adverse Event|6
1159005|NCT03305809|2278402|FG000|Overall Study|Death|0
1159006|NCT03305809|2278403|FG001|Overall Study|Death|0
1159007|NCT03305809|2278404|FG002|Overall Study|Death|1
1159008|NCT03305809|2278405|FG003|Overall Study|Death|1
1159009|NCT03305809|2278402|FG000|Overall Study|Lost to Follow-up|1
1159010|NCT03305809|2278403|FG001|Overall Study|Lost to Follow-up|2
1159011|NCT03305809|2278404|FG002|Overall Study|Lost to Follow-up|0
1159012|NCT03305809|2278405|FG003|Overall Study|Lost to Follow-up|0
1159013|NCT03305809|2278402|FG000|Overall Study|Sponsor Decision|1
1159014|NCT03305809|2278403|FG001|Overall Study|Sponsor Decision|0
1159015|NCT03305809|2278404|FG002|Overall Study|Sponsor Decision|1
1159016|NCT03305809|2278405|FG003|Overall Study|Sponsor Decision|8
1159017|NCT03305809|2278402|FG000|Overall Study|Physician Decision|0
1159018|NCT03305809|2278403|FG001|Overall Study|Physician Decision|0
1159019|NCT03305809|2278404|FG002|Overall Study|Physician Decision|2
1159020|NCT03305809|2278405|FG003|Overall Study|Physician Decision|4
1159021|NCT03305809|2278402|FG000|Overall Study|Progressive Disease|0
1159022|NCT03305809|2278403|FG001|Overall Study|Progressive Disease|0
1159023|NCT03305809|2278404|FG002|Overall Study|Progressive Disease|1
1159024|NCT03305809|2278405|FG003|Overall Study|Progressive Disease|0
1159025|NCT03305809|2278402|FG000|Overall Study|Protocol Violation|1
1159026|NCT03305809|2278403|FG001|Overall Study|Protocol Violation|0
1159027|NCT03305809|2278404|FG002|Overall Study|Protocol Violation|2
1159028|NCT03305809|2278405|FG003|Overall Study|Protocol Violation|3
1159029|NCT03305809|2278402|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0
1159030|NCT03305809|2278403|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0
1159031|NCT03305809|2278404|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0
1159032|NCT03305809|2278405|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2
1159033|NCT03305809|2278402|FG000|Overall Study|Withdrawal by Subject|2
1159034|NCT03305809|2278403|FG001|Overall Study|Withdrawal by Subject|4
1159035|NCT03305809|2278404|FG002|Overall Study|Withdrawal by Subject|5
1159036|NCT03305809|2278405|FG003|Overall Study|Withdrawal by Subject|2
1159037|NCT03305809|2278402|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0
1159038|NCT03305809|2278403|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0
1159039|NCT03305809|2278404|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1
1159040|NCT03305809|2278405|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1
1159041|NCT03306043|2278434|FG000|Overall Study|Adverse Event|1
1159042|NCT03306043|2278434|FG000|Overall Study|Lost to Follow-up|1
1159043|NCT03306043|2278434|FG000|Overall Study|Withdrawal by Subject|2
1159044|NCT03306277|2278442|FG000|Overall Study|Death|1
1159045|NCT03306277|2278442|FG000|Overall Study|Adverse Event|1
1159046|NCT03306277|2278442|FG000|Overall Study|Withdrawal by Subject|1
1159047|NCT03306433|2278467|FG000|Overall Study|Lost to Follow-up|3
1159048|NCT03306433|2278467|FG000|Overall Study|Patient did not have teeth extracted|1
1159049|NCT03306433|2278467|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3
1159050|NCT03307174|2278522|FG000|Overall Study|Unplanned ICU Administrion|5
1159051|NCT03307174|2278523|FG001|Overall Study|Unplanned ICU Administrion|3
1159052|NCT03307174|2278522|FG000|Overall Study|Aborted Surgery|1
1159053|NCT03307174|2278523|FG001|Overall Study|Aborted Surgery|2
1159054|NCT03307174|2278522|FG000|Overall Study|Hypotension|6
1159055|NCT03307174|2278523|FG001|Overall Study|Hypotension|0
1159056|NCT03307174|2278522|FG000|Overall Study|Nonfunctional epidural|1
1159057|NCT03307174|2278523|FG001|Overall Study|Nonfunctional epidural|1
1159058|NCT03307174|2278522|FG000|Overall Study|Planned epidural removal|1
1159059|NCT03307174|2278523|FG001|Overall Study|Planned epidural removal|0
1159060|NCT03307174|2278522|FG000|Overall Study|Intrathecal catheter placement|0
1159061|NCT03307174|2278523|FG001|Overall Study|Intrathecal catheter placement|1
1159062|NCT03307252|2278540|FG000|Part 2, Period 1|Treatment not received|0
1159063|NCT03307252|2278541|FG001|Part 2, Period 1|Treatment not received|0
1159064|NCT03307252|2278542|FG002|Part 2, Period 1|Treatment not received|0
1159065|NCT03307252|2278543|FG003|Part 2, Period 1|Treatment not received|0
1159066|NCT03307252|2278544|FG004|Part 2, Period 1|Treatment not received|0
1159067|NCT03307252|2278545|FG005|Part 2, Period 1|Treatment not received|1
1159068|NCT03307252|2278546|FG006|Part 2, Period 1|Treatment not received|0
1159069|NCT03307252|2278547|FG007|Part 2, Period 1|Treatment not received|0
1159070|NCT03307252|2278548|FG008|Part 2, Period 1|Treatment not received|0
1159071|NCT03307252|2278549|FG009|Part 2, Period 1|Treatment not received|0
1159072|NCT03307252|2278550|FG010|Part 2, Period 1|Treatment not received|0
1159073|NCT03307252|2278540|FG000|Part 2, Period 3|Other than listed|0
1159074|NCT03307252|2278541|FG001|Part 2, Period 3|Other than listed|0
1159075|NCT03307252|2278542|FG002|Part 2, Period 3|Other than listed|0
1159076|NCT03307252|2278543|FG003|Part 2, Period 3|Other than listed|0
1159077|NCT03307252|2278544|FG004|Part 2, Period 3|Other than listed|1
1159078|NCT03307252|2278545|FG005|Part 2, Period 3|Other than listed|0
1159079|NCT03307252|2278546|FG006|Part 2, Period 3|Other than listed|0
1159080|NCT03307252|2278547|FG007|Part 2, Period 3|Other than listed|0
1159081|NCT03307252|2278548|FG008|Part 2, Period 3|Other than listed|0
1159082|NCT03307252|2278549|FG009|Part 2, Period 3|Other than listed|0
1159083|NCT03307252|2278550|FG010|Part 2, Period 3|Other than listed|0
1159084|NCT03307252|2278540|FG000|Part 2, Period 4|Other than listed|0
1159085|NCT03307252|2278541|FG001|Part 2, Period 4|Other than listed|0
1159086|NCT03307252|2278542|FG002|Part 2, Period 4|Other than listed|0
1159087|NCT03307252|2278543|FG003|Part 2, Period 4|Other than listed|0
1159088|NCT03307252|2278544|FG004|Part 2, Period 4|Other than listed|0
1159089|NCT03307252|2278545|FG005|Part 2, Period 4|Other than listed|0
1159090|NCT03307252|2278546|FG006|Part 2, Period 4|Other than listed|1
1159091|NCT03307252|2278547|FG007|Part 2, Period 4|Other than listed|0
1159092|NCT03307252|2278548|FG008|Part 2, Period 4|Other than listed|0
1159093|NCT03307252|2278549|FG009|Part 2, Period 4|Other than listed|0
1159094|NCT03307252|2278550|FG010|Part 2, Period 4|Other than listed|0
1159095|NCT03307252|2278540|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1159096|NCT03307252|2278541|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1159097|NCT03307252|2278542|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1159098|NCT03307252|2278543|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1159099|NCT03307252|2278544|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1159100|NCT03307252|2278545|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1159101|NCT03307252|2278546|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1159102|NCT03307252|2278547|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1159103|NCT03307252|2278548|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1159104|NCT03307252|2278549|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1159105|NCT03307252|2278550|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
1159106|NCT03307837|2278614|FG000|Overall Study|Withdrawal by Subject|0
1159107|NCT03307837|2278615|FG001|Overall Study|Withdrawal by Subject|0
1159108|NCT03307837|2278616|FG002|Overall Study|Withdrawal by Subject|1
1159109|NCT03307837|2278617|FG003|Overall Study|Withdrawal by Subject|0
1159110|NCT03307837|2278618|FG004|Overall Study|Withdrawal by Subject|0
1159111|NCT03307837|2278619|FG005|Overall Study|Withdrawal by Subject|1
1159112|NCT03307837|2278614|FG000|Overall Study|Lost to Follow-up|1
1159113|NCT03307837|2278615|FG001|Overall Study|Lost to Follow-up|1
1159114|NCT03307837|2278616|FG002|Overall Study|Lost to Follow-up|0
1159115|NCT03307837|2278617|FG003|Overall Study|Lost to Follow-up|0
1159116|NCT03307837|2278618|FG004|Overall Study|Lost to Follow-up|0
1159117|NCT03307837|2278619|FG005|Overall Study|Lost to Follow-up|1
1159118|NCT03308825|2278694|FG000|Overall Study|Lost to Follow-up|2
1159119|NCT03308825|2278695|FG001|Overall Study|Lost to Follow-up|2
1159120|NCT03308825|2278696|FG002|Overall Study|Lost to Follow-up|1
1159121|NCT03308825|2278697|FG003|Overall Study|Lost to Follow-up|0
1159122|NCT03308825|2278694|FG000|Overall Study|Protocol Violation|0
1159123|NCT03308825|2278695|FG001|Overall Study|Protocol Violation|2
1159124|NCT03308825|2278696|FG002|Overall Study|Protocol Violation|0
1159125|NCT03308825|2278697|FG003|Overall Study|Protocol Violation|0
1159126|NCT03308942|2278716|FG000|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
1159127|NCT03308942|2278717|FG001|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
1159128|NCT03308942|2278718|FG002|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
1159129|NCT03308942|2278719|FG003|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|0
1159130|NCT03308942|2278720|FG004|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|0
1159131|NCT03308942|2278716|FG000|Stage 1 (up to a Maximum of 29 Months)|Death|8
1159132|NCT03308942|2278717|FG001|Stage 1 (up to a Maximum of 29 Months)|Death|15
1159133|NCT03308942|2278718|FG002|Stage 1 (up to a Maximum of 29 Months)|Death|1
1159134|NCT03308942|2278719|FG003|Stage 1 (up to a Maximum of 29 Months)|Death|0
1159135|NCT03308942|2278720|FG004|Stage 1 (up to a Maximum of 29 Months)|Death|0
1159136|NCT03308942|2278716|FG000|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|7
1159137|NCT03308942|2278717|FG001|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|4
1159138|NCT03308942|2278718|FG002|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
1159139|NCT03308942|2278719|FG003|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
1159140|NCT03308942|2278720|FG004|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
1159141|NCT03308942|2278716|FG000|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
1159142|NCT03308942|2278717|FG001|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
1159143|NCT03308942|2278718|FG002|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
1159144|NCT03308942|2278719|FG003|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|3
1159145|NCT03308942|2278720|FG004|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
1159146|NCT03308942|2278716|FG000|Stage 2 (up to a Maximum of 17 Months)|Death|0
1159147|NCT03308942|2278717|FG001|Stage 2 (up to a Maximum of 17 Months)|Death|0
1159148|NCT03308942|2278718|FG002|Stage 2 (up to a Maximum of 17 Months)|Death|0
1159149|NCT03308942|2278719|FG003|Stage 2 (up to a Maximum of 17 Months)|Death|4
1159150|NCT03308942|2278720|FG004|Stage 2 (up to a Maximum of 17 Months)|Death|0
1159151|NCT03308942|2278716|FG000|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
1159152|NCT03308942|2278717|FG001|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
1159153|NCT03308942|2278718|FG002|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
1159154|NCT03308942|2278719|FG003|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|5
1159155|NCT03308942|2278720|FG004|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
1159156|NCT03308968|2278736|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3
1159157|NCT03308968|2278737|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1
1159158|NCT03308968|2278738|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4
1159159|NCT03308968|2278736|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
1159160|NCT03308968|2278737|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
1159161|NCT03308968|2278738|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
1159162|NCT03308968|2278736|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6
1159163|NCT03308968|2278737|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0
1159164|NCT03308968|2278738|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2
1159165|NCT03308968|2278736|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
1159166|NCT03308968|2278737|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
1159167|NCT03308968|2278738|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
1159168|NCT03308968|2278736|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
1159169|NCT03308968|2278737|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
1159170|NCT03308968|2278738|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
1159171|NCT03308968|2278736|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
1159172|NCT03308968|2278737|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
1159173|NCT03308968|2278738|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
1159174|NCT03308968|2278736|FG000|Double-Blind Period (12 Weeks)|Other than specified|1
1159175|NCT03308968|2278737|FG001|Double-Blind Period (12 Weeks)|Other than specified|0
1159176|NCT03308968|2278738|FG002|Double-Blind Period (12 Weeks)|Other than specified|2
1159177|NCT03308968|2278736|FG000|Open-Label Period (12 Weeks)|Other than specified|1
1159178|NCT03308968|2278737|FG001|Open-Label Period (12 Weeks)|Other than specified|2
1159179|NCT03308968|2278738|FG002|Open-Label Period (12 Weeks)|Other than specified|1
1159180|NCT03308968|2278736|FG000|Open-Label Period (12 Weeks)|Adverse Event|4
1159181|NCT03308968|2278737|FG001|Open-Label Period (12 Weeks)|Adverse Event|1
1159182|NCT03308968|2278738|FG002|Open-Label Period (12 Weeks)|Adverse Event|1
1159183|NCT03308968|2278736|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
1159184|NCT03308968|2278737|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
1159185|NCT03308968|2278738|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
1159186|NCT03308968|2278736|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0
1159187|NCT03308968|2278737|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1
1159188|NCT03308968|2278738|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1
1159189|NCT03308968|2278736|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
1159190|NCT03308968|2278737|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
1159191|NCT03308968|2278738|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
1159192|NCT03308968|2278736|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0
1159193|NCT03308968|2278737|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1
1159194|NCT03308968|2278738|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1
1159195|NCT03308968|2278736|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1
1159196|NCT03308968|2278737|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2
1159197|NCT03308968|2278738|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0
1159198|NCT03309020|2278751|FG000|Overall Study|Death|1
1159199|NCT03309020|2278752|FG001|Overall Study|Death|0
1159200|NCT03309020|2278751|FG000|Overall Study|Did not undergo surgery|2
1159201|NCT03309020|2278752|FG001|Overall Study|Did not undergo surgery|1
1159202|NCT03309202|2278773|FG000|Overall Study|Lost to Follow-up|1
1159203|NCT03309202|2278774|FG001|Overall Study|Lost to Follow-up|0
1159204|NCT03309202|2278775|FG002|Overall Study|Lost to Follow-up|0
1159205|NCT03309202|2278776|FG003|Overall Study|Lost to Follow-up|0
1159206|NCT03309605|2278807|FG000|Overall Study|Adverse Event|0
1159207|NCT03309605|2278808|FG001|Overall Study|Adverse Event|0
1159208|NCT03309605|2278809|FG002|Overall Study|Adverse Event|0
1159209|NCT03309605|2278810|FG003|Overall Study|Adverse Event|1
1159210|NCT03309605|2278811|FG004|Overall Study|Adverse Event|0
1159211|NCT03309605|2278812|FG005|Overall Study|Adverse Event|0
1159212|NCT03309605|2278813|FG006|Overall Study|Adverse Event|2
1159213|NCT03309605|2278814|FG007|Overall Study|Adverse Event|1
1159214|NCT03309605|2278807|FG000|Overall Study|Withdrawal by Subject|0
1159215|NCT03309605|2278808|FG001|Overall Study|Withdrawal by Subject|0
1159216|NCT03309605|2278809|FG002|Overall Study|Withdrawal by Subject|0
1159217|NCT03309605|2278810|FG003|Overall Study|Withdrawal by Subject|0
1159218|NCT03309605|2278811|FG004|Overall Study|Withdrawal by Subject|1
1159219|NCT03309605|2278812|FG005|Overall Study|Withdrawal by Subject|0
1159220|NCT03309605|2278813|FG006|Overall Study|Withdrawal by Subject|1
1159221|NCT03309605|2278814|FG007|Overall Study|Withdrawal by Subject|1
1159222|NCT03309696|2278834|FG000|Overall Study|Analysis of TEP data could not be completed|0
1159223|NCT03309696|2278835|FG001|Overall Study|Analysis of TEP data could not be completed|5
1159224|NCT03309696|2278836|FG002|Overall Study|Analysis of TEP data could not be completed|0
1159225|NCT03309696|2278837|FG003|Overall Study|Analysis of TEP data could not be completed|0
1159226|NCT03309943|2278866|FG000|Overall Study|Withdrawal by Subject|0
1159227|NCT03309943|2278867|FG001|Overall Study|Withdrawal by Subject|1
1159228|NCT03309943|2278866|FG000|Overall Study|Inappropriate behavior towards staff|0
1159229|NCT03309943|2278867|FG001|Overall Study|Inappropriate behavior towards staff|1
1159230|NCT03310021|2278893|FG000|Overall Study|Withdrawal by Subject|0
1159231|NCT03310021|2278894|FG001|Overall Study|Withdrawal by Subject|0
1159232|NCT03310021|2278895|FG002|Overall Study|Withdrawal by Subject|0
1159233|NCT03310021|2278896|FG003|Overall Study|Withdrawal by Subject|0
1159234|NCT03310021|2278897|FG004|Overall Study|Withdrawal by Subject|0
1159235|NCT03310021|2278898|FG005|Overall Study|Withdrawal by Subject|0
1159236|NCT03310021|2278899|FG006|Overall Study|Withdrawal by Subject|1
1159237|NCT03310021|2278900|FG007|Overall Study|Withdrawal by Subject|0
1159238|NCT03310021|2278901|FG008|Overall Study|Withdrawal by Subject|0
1159239|NCT03310021|2278902|FG009|Overall Study|Withdrawal by Subject|0
1159240|NCT03310021|2278903|FG010|Overall Study|Withdrawal by Subject|0
1159241|NCT03310021|2278904|FG011|Overall Study|Withdrawal by Subject|0
1159242|NCT03310021|2278905|FG012|Overall Study|Withdrawal by Subject|0
1159243|NCT03310021|2278906|FG013|Overall Study|Withdrawal by Subject|0
1159244|NCT03310021|2278907|FG014|Overall Study|Withdrawal by Subject|0
1159245|NCT03310021|2278908|FG015|Overall Study|Withdrawal by Subject|0
1159246|NCT03310021|2278909|FG016|Overall Study|Withdrawal by Subject|0
1159247|NCT03310021|2278910|FG017|Overall Study|Withdrawal by Subject|0
1159248|NCT03310021|2278911|FG018|Overall Study|Withdrawal by Subject|0
1159249|NCT03310021|2278912|FG019|Overall Study|Withdrawal by Subject|0
1159250|NCT03310021|2278893|FG000|Overall Study|Lost to Follow-up|0
1159251|NCT03310021|2278894|FG001|Overall Study|Lost to Follow-up|0
1159252|NCT03310021|2278895|FG002|Overall Study|Lost to Follow-up|0
1159253|NCT03310021|2278896|FG003|Overall Study|Lost to Follow-up|0
1159254|NCT03310021|2278897|FG004|Overall Study|Lost to Follow-up|0
1159255|NCT03310021|2278898|FG005|Overall Study|Lost to Follow-up|0
1159256|NCT03310021|2278899|FG006|Overall Study|Lost to Follow-up|0
1159257|NCT03310021|2278900|FG007|Overall Study|Lost to Follow-up|0
1159258|NCT03310021|2278901|FG008|Overall Study|Lost to Follow-up|0
1159259|NCT03310021|2278902|FG009|Overall Study|Lost to Follow-up|0
1159260|NCT03310021|2278903|FG010|Overall Study|Lost to Follow-up|1
1159261|NCT03310021|2278904|FG011|Overall Study|Lost to Follow-up|0
1159262|NCT03310021|2278905|FG012|Overall Study|Lost to Follow-up|0
1159263|NCT03310021|2278906|FG013|Overall Study|Lost to Follow-up|0
1159264|NCT03310021|2278907|FG014|Overall Study|Lost to Follow-up|0
1159265|NCT03310021|2278908|FG015|Overall Study|Lost to Follow-up|0
1159266|NCT03310021|2278909|FG016|Overall Study|Lost to Follow-up|0
1159267|NCT03310021|2278910|FG017|Overall Study|Lost to Follow-up|0
1159268|NCT03310021|2278911|FG018|Overall Study|Lost to Follow-up|0
1159269|NCT03310021|2278912|FG019|Overall Study|Lost to Follow-up|0
1159270|NCT03310268|2278957|FG000|Overall Study|(Not specified)|1
1159271|NCT03310268|2278958|FG001|Overall Study|(Not specified)|5
1159272|NCT03310268|2278959|FG002|Overall Study|(Not specified)|0
1159273|NCT03310411|2278967|FG000|Period 1|Adverse Event|0
1159274|NCT03310411|2278968|FG001|Period 1|Adverse Event|0
1159275|NCT03310411|2278969|FG002|Period 1|Adverse Event|0
1159276|NCT03310411|2278970|FG003|Period 1|Adverse Event|1
1159277|NCT03310580|2279005|FG000|Overall Study|Adverse Event|0
1159278|NCT03310580|2279006|FG001|Overall Study|Adverse Event|1
1159279|NCT03310580|2279007|FG002|Overall Study|Adverse Event|0
1159280|NCT03310723|2279018|FG000|Overall Study|Withdrawal by Subject|0
1159281|NCT03310723|2279019|FG001|Overall Study|Withdrawal by Subject|1
1159282|NCT03310723|2279018|FG000|Overall Study|Protocol Violation|0
1159283|NCT03310723|2279019|FG001|Overall Study|Protocol Violation|2
1159284|NCT03310775|2279027|FG000|Overall Study|Lost to Follow-up|2
1159285|NCT03310775|2279028|FG001|Overall Study|Lost to Follow-up|3
1159286|NCT03310775|2279027|FG000|Overall Study|aggravation of depression|0
1159287|NCT03310775|2279028|FG001|Overall Study|aggravation of depression|1
1159288|NCT03310970|2279034|FG000|Overall Study|Withdrawal by Subject|0
1159289|NCT03310970|2279035|FG001|Overall Study|Withdrawal by Subject|1
1159290|NCT03311230|2279046|FG000|Overall Study|Withdrawal by Subject|1
1159291|NCT03311230|2279047|FG001|Overall Study|Withdrawal by Subject|4
1159292|NCT03311230|2279048|FG002|Overall Study|Withdrawal by Subject|2
1159293|NCT03311230|2279049|FG003|Overall Study|Withdrawal by Subject|7
1159294|NCT03311230|2279046|FG000|Overall Study|Unrelated injury|0
1159295|NCT03311230|2279047|FG001|Overall Study|Unrelated injury|1
1159296|NCT03311230|2279048|FG002|Overall Study|Unrelated injury|0
1159297|NCT03311230|2279049|FG003|Overall Study|Unrelated injury|0
1159298|NCT03311373|2279059|FG000|Overall Study|Adverse Event|1
1159299|NCT03311373|2279059|FG000|Overall Study|Protocol Discontinuation Criteria|3
1159300|NCT03311373|2279059|FG000|Overall Study|Lost to Follow-up|1
1159301|NCT03311373|2279059|FG000|Overall Study|Physician Decision|1
1159302|NCT03311373|2279059|FG000|Overall Study|Withdrawal by Subject|3
1159303|NCT03311646|2279069|FG000|Overall Study|Physician Decision|1
1159304|NCT03311646|2279069|FG000|Overall Study|Withdrawal by Subject|5
1159305|NCT03311646|2279069|FG000|Overall Study|Lost to Follow-up|5
1159306|NCT03311646|2279069|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4
1159307|NCT03311659|2279074|FG000|Overall Study|Protocol Violation|1
1159308|NCT03311724|2279082|FG000|Overall Study|Physician Decision|0
1159309|NCT03311724|2279083|FG001|Overall Study|Physician Decision|0
1159310|NCT03311724|2279084|FG002|Overall Study|Physician Decision|0
1159311|NCT03311724|2279085|FG003|Overall Study|Physician Decision|1
1159312|NCT03311724|2279082|FG000|Overall Study|Protocol Violation|1
1159313|NCT03311724|2279083|FG001|Overall Study|Protocol Violation|0
1159314|NCT03311724|2279084|FG002|Overall Study|Protocol Violation|1
1159315|NCT03311724|2279085|FG003|Overall Study|Protocol Violation|0
1159316|NCT03311724|2279082|FG000|Overall Study|Withdrawal by Subject|1
1159317|NCT03311724|2279083|FG001|Overall Study|Withdrawal by Subject|1
1159318|NCT03311724|2279084|FG002|Overall Study|Withdrawal by Subject|0
1159319|NCT03311724|2279085|FG003|Overall Study|Withdrawal by Subject|0
1159320|NCT03311724|2279082|FG000|Overall Study|Lost to Follow-up|1
1159321|NCT03311724|2279083|FG001|Overall Study|Lost to Follow-up|0
1159322|NCT03311724|2279084|FG002|Overall Study|Lost to Follow-up|0
1159323|NCT03311724|2279085|FG003|Overall Study|Lost to Follow-up|0
1159324|NCT03311724|2279082|FG000|Overall Study|Sponsor Decision|0
1159325|NCT03311724|2279083|FG001|Overall Study|Sponsor Decision|0
1159326|NCT03311724|2279084|FG002|Overall Study|Sponsor Decision|1
1159327|NCT03311724|2279085|FG003|Overall Study|Sponsor Decision|0
1159328|NCT03311841|2279103|FG000|14-day Wash-out|Adverse Event|0
1159329|NCT03311841|2279104|FG001|14-day Wash-out|Adverse Event|1
1159330|NCT03311841|2279105|FG002|14-day Wash-out|Adverse Event|0
1159331|NCT03311841|2279106|FG003|14-day Wash-out|Adverse Event|0
1159332|NCT03311841|2279107|FG004|14-day Wash-out|Adverse Event|0
1159333|NCT03311841|2279103|FG000|14-day Wash-out|Non-Compliance With Study Drug|0
1159334|NCT03311841|2279104|FG001|14-day Wash-out|Non-Compliance With Study Drug|0
1159335|NCT03311841|2279105|FG002|14-day Wash-out|Non-Compliance With Study Drug|0
1159336|NCT03311841|2279106|FG003|14-day Wash-out|Non-Compliance With Study Drug|1
1159337|NCT03311841|2279107|FG004|14-day Wash-out|Non-Compliance With Study Drug|0
1159338|NCT03312114|2279146|FG000|Overall Study|All the five enrolled dropped out of the|5
1159339|NCT03312218|2279153|FG000|Overall Study|Never signed in to access the app|54
1159340|NCT03312218|2279154|FG001|Overall Study|Never signed in to access the app|58
1159341|NCT03312231|2279165|FG000|Overall Study|Lost to Follow-up|2
1159342|NCT03312231|2279166|FG001|Overall Study|Lost to Follow-up|6
1159343|NCT03312231|2279167|FG002|Overall Study|Lost to Follow-up|1
1159344|NCT03312231|2279168|FG003|Overall Study|Lost to Follow-up|3
1159345|NCT03312231|2279169|FG004|Overall Study|Lost to Follow-up|1
1159346|NCT03312231|2279165|FG000|Overall Study|Withdrawal by Subject|0
1159347|NCT03312231|2279166|FG001|Overall Study|Withdrawal by Subject|3
1159348|NCT03312231|2279167|FG002|Overall Study|Withdrawal by Subject|1
1159349|NCT03312231|2279168|FG003|Overall Study|Withdrawal by Subject|0
1159350|NCT03312231|2279169|FG004|Overall Study|Withdrawal by Subject|0
1159351|NCT03312231|2279165|FG000|Overall Study|Death|0
1159352|NCT03312231|2279166|FG001|Overall Study|Death|1
1159353|NCT03312231|2279167|FG002|Overall Study|Death|1
1159354|NCT03312231|2279168|FG003|Overall Study|Death|0
1159355|NCT03312231|2279169|FG004|Overall Study|Death|0
1159356|NCT03312231|2279165|FG000|Overall Study|Study Vaccination not Received|1
1159357|NCT03312231|2279166|FG001|Overall Study|Study Vaccination not Received|1
1159358|NCT03312231|2279167|FG002|Overall Study|Study Vaccination not Received|1
1159359|NCT03312231|2279168|FG003|Overall Study|Study Vaccination not Received|0
1159360|NCT03312231|2279169|FG004|Overall Study|Study Vaccination not Received|0
1159361|NCT03312543|2279200|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
1159362|NCT03312543|2279201|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
1159363|NCT03312543|2279200|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
1159364|NCT03312543|2279201|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
1159365|NCT03312543|2279200|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
1159366|NCT03312543|2279201|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
1159367|NCT03312543|2279200|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1
1159368|NCT03312543|2279201|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1
1159369|NCT03312543|2279200|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1
1159370|NCT03312543|2279201|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1
1159371|NCT03312543|2279200|FG000|Regression (Week 12 to Week 24)|Death|0
1159372|NCT03312543|2279201|FG001|Regression (Week 12 to Week 24)|Death|1
1159373|NCT03312933|2279211|FG000|Overall Study|Protocol Violation|15
1159374|NCT03312933|2279211|FG000|Overall Study|Lost to Follow-up|36
1159375|NCT03312933|2279211|FG000|Overall Study|Withdrawal by Subject|3
1159376|NCT03313037|2279217|FG000|Overall Study|Protocol Violation|4
1159377|NCT03313037|2279218|FG001|Overall Study|Protocol Violation|1
1159378|NCT03313037|2279217|FG000|Overall Study|Other|1
1159379|NCT03313037|2279218|FG001|Overall Study|Other|1
1159380|NCT03313037|2279217|FG000|Overall Study|Withdrawal by Subject|4
1159381|NCT03313037|2279218|FG001|Overall Study|Withdrawal by Subject|3
1159382|NCT03313037|2279217|FG000|Overall Study|No longer meets eligibility criteria|1
1159383|NCT03313037|2279218|FG001|Overall Study|No longer meets eligibility criteria|7
1159384|NCT03313037|2279217|FG000|Overall Study|Lost to Follow-up|9
1159385|NCT03313037|2279218|FG001|Overall Study|Lost to Follow-up|8
1159386|NCT03313037|2279217|FG000|Overall Study|Randomized but not treated|1
1159387|NCT03313037|2279218|FG001|Overall Study|Randomized but not treated|0
1159388|NCT03313050|2279228|FG000|Stage 2: 12 Months|Adverse Event|0
1159389|NCT03313050|2279229|FG001|Stage 2: 12 Months|Adverse Event|0
1159390|NCT03313050|2279230|FG002|Stage 2: 12 Months|Adverse Event|0
1159391|NCT03313050|2279231|FG003|Stage 2: 12 Months|Adverse Event|1
1159392|NCT03313050|2279228|FG000|Stage 2: 12 Months|Death|0
1159393|NCT03313050|2279229|FG001|Stage 2: 12 Months|Death|0
1159394|NCT03313050|2279230|FG002|Stage 2: 12 Months|Death|3
1159395|NCT03313050|2279231|FG003|Stage 2: 12 Months|Death|0
1159396|NCT03313050|2279228|FG000|Stage 2: 12 Months|Lost to Follow-up|0
1159397|NCT03313050|2279229|FG001|Stage 2: 12 Months|Lost to Follow-up|0
1159398|NCT03313050|2279230|FG002|Stage 2: 12 Months|Lost to Follow-up|1
1159399|NCT03313050|2279231|FG003|Stage 2: 12 Months|Lost to Follow-up|5
1159400|NCT03313050|2279228|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
1159401|NCT03313050|2279229|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
1159402|NCT03313050|2279230|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
1159403|NCT03313050|2279231|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3
1159404|NCT03313050|2279228|FG000|Stage 2: 12 Months|Protocol deviation|0
1159405|NCT03313050|2279229|FG001|Stage 2: 12 Months|Protocol deviation|0
1159406|NCT03313050|2279230|FG002|Stage 2: 12 Months|Protocol deviation|7
1159407|NCT03313050|2279231|FG003|Stage 2: 12 Months|Protocol deviation|7
1159408|NCT03313050|2279228|FG000|Stage 2: 12 Months|Withdrawal by Subject|0
1159409|NCT03313050|2279229|FG001|Stage 2: 12 Months|Withdrawal by Subject|0
1159410|NCT03313050|2279230|FG002|Stage 2: 12 Months|Withdrawal by Subject|0
1159411|NCT03313050|2279231|FG003|Stage 2: 12 Months|Withdrawal by Subject|3
1159412|NCT03313050|2279228|FG000|Stage 2: 12 Months|Other|0
1159413|NCT03313050|2279229|FG001|Stage 2: 12 Months|Other|0
1159414|NCT03313050|2279230|FG002|Stage 2: 12 Months|Other|0
1159415|NCT03313050|2279231|FG003|Stage 2: 12 Months|Other|1
1159416|NCT03313076|2279245|FG000|Overall Study|Withdrawal by Subject|2
1159417|NCT03313076|2279246|FG001|Overall Study|Withdrawal by Subject|0
1159418|NCT03313076|2279247|FG002|Overall Study|Withdrawal by Subject|0
1159419|NCT03313076|2279248|FG003|Overall Study|Withdrawal by Subject|0
1159420|NCT03313076|2279245|FG000|Overall Study|Lost to Follow-up|0
1159421|NCT03313076|2279246|FG001|Overall Study|Lost to Follow-up|2
1159422|NCT03313076|2279247|FG002|Overall Study|Lost to Follow-up|2
1159423|NCT03313076|2279248|FG003|Overall Study|Lost to Follow-up|2
1159424|NCT03313310|2279266|FG000|Phase 2|Lost to Follow-up|4
1159425|NCT03313310|2279267|FG001|Phase 2|Lost to Follow-up|0
1159426|NCT03313310|2279266|FG000|Phase 3|Lost to Follow-up|0
1159427|NCT03313310|2279267|FG001|Phase 3|Lost to Follow-up|1
1159428|NCT03314233|2279273|FG000|Overall Study|No longer eligible at time of delivery|1
1159429|NCT03314519|2279279|FG000|Overall Study|Protocol Violation|3
1159430|NCT03314519|2279280|FG001|Overall Study|Protocol Violation|2
1159431|NCT03314662|2279289|FG000|Overall Study|Withdrawal by Subject|1
1159432|NCT03314662|2279290|FG001|Overall Study|Withdrawal by Subject|1
1159433|NCT03314662|2279291|FG002|Overall Study|Withdrawal by Subject|1
1159434|NCT03314662|2279289|FG000|Overall Study|Lost to Follow-up|5
1159435|NCT03314662|2279290|FG001|Overall Study|Lost to Follow-up|4
1159436|NCT03314662|2279291|FG002|Overall Study|Lost to Follow-up|4
1159437|NCT03314662|2279289|FG000|Overall Study|Death|2
1159438|NCT03314662|2279290|FG001|Overall Study|Death|0
1159439|NCT03314662|2279291|FG002|Overall Study|Death|0
1159440|NCT03314857|2279316|FG000|Overall Study|Death|4
1159441|NCT03314857|2279316|FG000|Overall Study|Physician Decision|1
1159442|NCT03315208|2279335|FG000|Overall Study|Lost to Follow-up|11
1159443|NCT03315208|2279336|FG001|Overall Study|Lost to Follow-up|6
1159444|NCT03315208|2279335|FG000|Overall Study|Withdrawal by Subject|2
1159445|NCT03315208|2279336|FG001|Overall Study|Withdrawal by Subject|0
1159446|NCT03315286|2279345|FG000|Overall Study|Lost to Follow-up|0
1159447|NCT03315286|2279346|FG001|Overall Study|Lost to Follow-up|3
1159448|NCT03315286|2279345|FG000|Overall Study|Withdrawal by Subject|1
1159449|NCT03315286|2279346|FG001|Overall Study|Withdrawal by Subject|0
1159450|NCT03315286|2279345|FG000|Overall Study|Protocol Violation|0
1159451|NCT03315286|2279346|FG001|Overall Study|Protocol Violation|1
1159452|NCT03315689|2279371|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1
1159453|NCT03315689|2279372|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0
1159454|NCT03315689|2279371|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0
1159455|NCT03315689|2279372|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2
1159456|NCT03315689|2279371|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0
1159457|NCT03315689|2279372|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1
1159458|NCT03315793|2279394|FG000|Overall Study|Adverse Event|4
1159459|NCT03315793|2279395|FG001|Overall Study|Adverse Event|2
1159460|NCT03315793|2279394|FG000|Overall Study|Protocol Deviation|1
1159461|NCT03315793|2279395|FG001|Overall Study|Protocol Deviation|0
1159462|NCT03315793|2279394|FG000|Overall Study|Difficult for regular visit|0
1159463|NCT03315793|2279395|FG001|Overall Study|Difficult for regular visit|1
1159464|NCT03316131|2279412|FG000|Treatment Period 2|Protocol deviation|1
1159465|NCT03316131|2279413|FG001|Treatment Period 2|Protocol deviation|0
1159466|NCT03316170|2279421|FG000|Overall Study|Death|1
1159467|NCT03316170|2279422|FG001|Overall Study|Death|0
1159468|NCT03316170|2279421|FG000|Overall Study|Lost to Follow-up|6
1159469|NCT03316170|2279422|FG001|Overall Study|Lost to Follow-up|7
1159470|NCT03316547|2279441|FG000|Overall Study|Death|3
1159471|NCT03316547|2279442|FG001|Overall Study|Death|1
1159472|NCT03316547|2279441|FG000|Overall Study|Lost to Follow-up|6
1159473|NCT03316547|2279442|FG001|Overall Study|Lost to Follow-up|6
1159474|NCT03316547|2279441|FG000|Overall Study|Withdrawal by Subject|3
1159475|NCT03316547|2279442|FG001|Overall Study|Withdrawal by Subject|2
1159476|NCT03316547|2279441|FG000|Overall Study|Transfer to another hospital|6
1159477|NCT03316547|2279442|FG001|Overall Study|Transfer to another hospital|4
1159478|NCT03316911|2279461|FG000|Overall Study|Lost to Follow-up|33
1159479|NCT03316911|2279462|FG001|Overall Study|Lost to Follow-up|29
1159480|NCT03317379|2279511|FG000|Overall Study|Lost to Follow-up|0
1159481|NCT03317379|2279512|FG001|Overall Study|Lost to Follow-up|3
1159482|NCT03317379|2279513|FG002|Overall Study|Lost to Follow-up|2
1159483|NCT03318315|2279537|FG000|Overall Study|Lost to Follow-up|3
1159484|NCT03318315|2279538|FG001|Overall Study|Lost to Follow-up|2
1159485|NCT03318315|2279539|FG002|Overall Study|Lost to Follow-up|1
1159486|NCT03318315|2279537|FG000|Overall Study|Protocol Violation|1
1159487|NCT03318315|2279538|FG001|Overall Study|Protocol Violation|1
1159488|NCT03318315|2279539|FG002|Overall Study|Protocol Violation|1
1159489|NCT03318315|2279537|FG000|Overall Study|Withdrawal by Subject|0
1159490|NCT03318315|2279538|FG001|Overall Study|Withdrawal by Subject|0
1159491|NCT03318315|2279539|FG002|Overall Study|Withdrawal by Subject|2
1159492|NCT03318523|2279563|FG000|PC Period: Up to Year 1|Adverse Event|1
1159493|NCT03318523|2279564|FG001|PC Period: Up to Year 1|Adverse Event|0
1159494|NCT03318523|2279565|FG002|PC Period: Up to Year 1|Adverse Event|2
1159495|NCT03318523|2279566|FG003|PC Period: Up to Year 1|Adverse Event|0
1159496|NCT03318523|2279567|FG004|PC Period: Up to Year 1|Adverse Event|0
1159497|NCT03318523|2279568|FG005|PC Period: Up to Year 1|Adverse Event|0
1159498|NCT03318523|2279569|FG006|PC Period: Up to Year 1|Adverse Event|0
1159499|NCT03318523|2279570|FG007|PC Period: Up to Year 1|Adverse Event|0
1159500|NCT03318523|2279571|FG008|PC Period: Up to Year 1|Adverse Event|0
1159501|NCT03318523|2279572|FG009|PC Period: Up to Year 1|Adverse Event|0
1159502|NCT03318523|2279563|FG000|PC Period: Up to Year 1|Consent Withdrawn|3
1159503|NCT03318523|2279564|FG001|PC Period: Up to Year 1|Consent Withdrawn|2
1159504|NCT03318523|2279565|FG002|PC Period: Up to Year 1|Consent Withdrawn|0
1159505|NCT03318523|2279566|FG003|PC Period: Up to Year 1|Consent Withdrawn|4
1159506|NCT03318523|2279567|FG004|PC Period: Up to Year 1|Consent Withdrawn|0
1159507|NCT03318523|2279568|FG005|PC Period: Up to Year 1|Consent Withdrawn|0
1159508|NCT03318523|2279569|FG006|PC Period: Up to Year 1|Consent Withdrawn|0
1159509|NCT03318523|2279570|FG007|PC Period: Up to Year 1|Consent Withdrawn|0
1159510|NCT03318523|2279571|FG008|PC Period: Up to Year 1|Consent Withdrawn|0
1159511|NCT03318523|2279572|FG009|PC Period: Up to Year 1|Consent Withdrawn|0
1159512|NCT03318523|2279563|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
1159513|NCT03318523|2279564|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
1159514|NCT03318523|2279565|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
1159515|NCT03318523|2279566|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
1159516|NCT03318523|2279567|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
1159517|NCT03318523|2279568|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
1159518|NCT03318523|2279569|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
1159519|NCT03318523|2279570|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
1159520|NCT03318523|2279571|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
1159521|NCT03318523|2279572|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2
1159522|NCT03318523|2279563|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
1159523|NCT03318523|2279564|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
1159524|NCT03318523|2279565|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
1159525|NCT03318523|2279566|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
1159526|NCT03318523|2279567|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
1159527|NCT03318523|2279568|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
1159528|NCT03318523|2279569|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
1159529|NCT03318523|2279570|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
1159530|NCT03318523|2279571|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3
1159531|NCT03318523|2279572|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2
1159532|NCT03318523|2279563|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
1159533|NCT03318523|2279564|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
1159534|NCT03318523|2279565|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
1159535|NCT03318523|2279566|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
1159536|NCT03318523|2279567|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
1159537|NCT03318523|2279568|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1
1159538|NCT03318523|2279569|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
1159539|NCT03318523|2279570|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
1159540|NCT03318523|2279571|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
1159541|NCT03318523|2279572|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
1159542|NCT03318523|2279563|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
1159543|NCT03318523|2279564|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
1159544|NCT03318523|2279565|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
1159545|NCT03318523|2279566|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
1159546|NCT03318523|2279567|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
1159547|NCT03318523|2279568|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
1159548|NCT03318523|2279569|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
1159549|NCT03318523|2279570|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
1159550|NCT03318523|2279571|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
1159551|NCT03318523|2279572|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1
1159552|NCT03318523|2279563|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
1159553|NCT03318523|2279564|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
1159554|NCT03318523|2279565|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
1159555|NCT03318523|2279566|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
1159556|NCT03318523|2279567|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17
1159557|NCT03318523|2279568|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36
1159558|NCT03318523|2279569|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39
1159559|NCT03318523|2279570|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48
1159560|NCT03318523|2279571|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94
1159561|NCT03318523|2279572|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91
1159562|NCT03318523|2279563|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
1159563|NCT03318523|2279564|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
1159564|NCT03318523|2279565|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
1159565|NCT03318523|2279566|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
1159566|NCT03318523|2279567|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1
1159567|NCT03318523|2279568|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
1159568|NCT03318523|2279569|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
1159569|NCT03318523|2279570|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2
1159570|NCT03318523|2279571|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3
1159571|NCT03318523|2279572|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
1159572|NCT03318783|2279598|FG000|Overall Study|Withdrawal by Subject|0
1159573|NCT03318783|2279599|FG001|Overall Study|Withdrawal by Subject|1
1159574|NCT03318783|2279598|FG000|Overall Study|Death|0
1159575|NCT03318783|2279599|FG001|Overall Study|Death|1
1159576|NCT03318861|2279619|FG000|Overall Study|Death|1
1159577|NCT03318861|2279620|FG001|Overall Study|Death|2
1159578|NCT03318861|2279621|FG002|Overall Study|Death|2
1159579|NCT03318861|2279622|FG003|Overall Study|Death|1
1159580|NCT03318861|2279623|FG004|Overall Study|Death|1
1159581|NCT03318861|2279619|FG000|Overall Study|Still on Study|2
1159582|NCT03318861|2279620|FG001|Overall Study|Still on Study|1
1159583|NCT03318861|2279621|FG002|Overall Study|Still on Study|1
1159584|NCT03318861|2279622|FG003|Overall Study|Still on Study|2
1159585|NCT03318861|2279623|FG004|Overall Study|Still on Study|1
1159586|NCT03318861|2279619|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0
1159587|NCT03318861|2279620|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1
1159588|NCT03318861|2279621|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0
1159589|NCT03318861|2279622|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1
1159590|NCT03318861|2279623|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1
1159591|NCT03319212|2279663|FG000|Overall Study|Discontinued as moving out of local area|0
1159592|NCT03319212|2279664|FG001|Overall Study|Discontinued as moving out of local area|1
1159593|NCT03319212|2279663|FG000|Overall Study|Adverse Event|2
1159594|NCT03319212|2279664|FG001|Overall Study|Adverse Event|2
1159595|NCT03319212|2279663|FG000|Overall Study|Withdrawal by Subject|0
1159596|NCT03319212|2279664|FG001|Overall Study|Withdrawal by Subject|1
1159597|NCT03319212|2279663|FG000|Overall Study|Lost to Follow-up|0
1159598|NCT03319212|2279664|FG001|Overall Study|Lost to Follow-up|1
1159599|NCT03319212|2279663|FG000|Overall Study|Physician Decision|1
1159600|NCT03319212|2279664|FG001|Overall Study|Physician Decision|0
1159601|NCT03319719|2279678|FG000|Overall Study|Lost to Follow-up|1
1159602|NCT03319953|2279692|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1
1159603|NCT03319953|2279693|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
1159604|NCT03319953|2279694|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
1159605|NCT03319953|2279695|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
1159606|NCT03319953|2279692|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0
1159607|NCT03319953|2279693|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0
1159608|NCT03319953|2279694|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1
1159609|NCT03319953|2279695|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1
1159610|NCT03320057|2279703|FG000|Overall Study|Lost to Follow-up|4
1159611|NCT03320057|2279704|FG001|Overall Study|Lost to Follow-up|17
1159612|NCT03320057|2279703|FG000|Overall Study|Did not take mifepristone or misoprostol|2
1159613|NCT03320057|2279704|FG001|Overall Study|Did not take mifepristone or misoprostol|0
1159614|NCT03320369|2279714|FG000|Overall Study|Adverse Event|1
1159615|NCT03320369|2279714|FG000|Overall Study|Withdrawal by Subject|2
1159616|NCT03320564|2279718|FG000|Overall Study|Protocol Violation|1
1159617|NCT03320824|2279724|FG000|Overall Study|Withdrawal by Subject|8
1159618|NCT03320824|2279725|FG001|Overall Study|Withdrawal by Subject|1
1159619|NCT03320824|2279724|FG000|Overall Study|Lost to Follow-up|10
1159620|NCT03320824|2279725|FG001|Overall Study|Lost to Follow-up|1
1159621|NCT03320824|2279724|FG000|Overall Study|moved out of state|0
1159622|NCT03320824|2279725|FG001|Overall Study|moved out of state|1
1159623|NCT03320824|2279724|FG000|Overall Study|could not complete final visit|0
1159624|NCT03320824|2279725|FG001|Overall Study|could not complete final visit|1
1159625|NCT03320850|2279741|FG000|Overall Study|Lost to Follow-up|0
1159626|NCT03320850|2279742|FG001|Overall Study|Lost to Follow-up|0
1159627|NCT03320850|2279743|FG002|Overall Study|Lost to Follow-up|0
1159628|NCT03320850|2279744|FG003|Overall Study|Lost to Follow-up|0
1159629|NCT03320850|2279745|FG004|Overall Study|Lost to Follow-up|1
1159630|NCT03320850|2279746|FG005|Overall Study|Lost to Follow-up|2
1159631|NCT03320850|2279747|FG006|Overall Study|Lost to Follow-up|2
1159632|NCT03320850|2279748|FG007|Overall Study|Lost to Follow-up|0
1159633|NCT03320850|2279749|FG008|Overall Study|Lost to Follow-up|6
1159634|NCT03320850|2279750|FG009|Overall Study|Lost to Follow-up|4
1159635|NCT03320850|2279741|FG000|Overall Study|Withdrawal by Subject|0
1159636|NCT03320850|2279742|FG001|Overall Study|Withdrawal by Subject|0
1159637|NCT03320850|2279743|FG002|Overall Study|Withdrawal by Subject|0
1159638|NCT03320850|2279744|FG003|Overall Study|Withdrawal by Subject|0
1159639|NCT03320850|2279745|FG004|Overall Study|Withdrawal by Subject|1
1159640|NCT03320850|2279746|FG005|Overall Study|Withdrawal by Subject|2
1159641|NCT03320850|2279747|FG006|Overall Study|Withdrawal by Subject|4
1159642|NCT03320850|2279748|FG007|Overall Study|Withdrawal by Subject|5
1159643|NCT03320850|2279749|FG008|Overall Study|Withdrawal by Subject|2
1159644|NCT03320850|2279750|FG009|Overall Study|Withdrawal by Subject|1
1159645|NCT03320850|2279741|FG000|Overall Study|Lack of Efficacy|0
1159646|NCT03320850|2279742|FG001|Overall Study|Lack of Efficacy|0
1159647|NCT03320850|2279743|FG002|Overall Study|Lack of Efficacy|0
1159648|NCT03320850|2279744|FG003|Overall Study|Lack of Efficacy|1
1159649|NCT03320850|2279745|FG004|Overall Study|Lack of Efficacy|0
1159650|NCT03320850|2279746|FG005|Overall Study|Lack of Efficacy|1
1159651|NCT03320850|2279747|FG006|Overall Study|Lack of Efficacy|0
1159652|NCT03320850|2279748|FG007|Overall Study|Lack of Efficacy|2
1159653|NCT03320850|2279749|FG008|Overall Study|Lack of Efficacy|0
1159654|NCT03320850|2279750|FG009|Overall Study|Lack of Efficacy|3
1159655|NCT03320850|2279741|FG000|Overall Study|Failure to Meet Randomization Criteria|0
1159656|NCT03320850|2279742|FG001|Overall Study|Failure to Meet Randomization Criteria|0
1159657|NCT03320850|2279743|FG002|Overall Study|Failure to Meet Randomization Criteria|0
1159658|NCT03320850|2279744|FG003|Overall Study|Failure to Meet Randomization Criteria|0
1159659|NCT03320850|2279745|FG004|Overall Study|Failure to Meet Randomization Criteria|0
1159660|NCT03320850|2279746|FG005|Overall Study|Failure to Meet Randomization Criteria|1
1159661|NCT03320850|2279747|FG006|Overall Study|Failure to Meet Randomization Criteria|0
1159662|NCT03320850|2279748|FG007|Overall Study|Failure to Meet Randomization Criteria|0
1159663|NCT03320850|2279749|FG008|Overall Study|Failure to Meet Randomization Criteria|0
1159664|NCT03320850|2279750|FG009|Overall Study|Failure to Meet Randomization Criteria|0
1159665|NCT03320850|2279741|FG000|Overall Study|Adverse Event|0
1159666|NCT03320850|2279742|FG001|Overall Study|Adverse Event|0
1159667|NCT03320850|2279743|FG002|Overall Study|Adverse Event|0
1159668|NCT03320850|2279744|FG003|Overall Study|Adverse Event|0
1159669|NCT03320850|2279745|FG004|Overall Study|Adverse Event|0
1159670|NCT03320850|2279746|FG005|Overall Study|Adverse Event|2
1159671|NCT03320850|2279747|FG006|Overall Study|Adverse Event|1
1159672|NCT03320850|2279748|FG007|Overall Study|Adverse Event|0
1159673|NCT03320850|2279749|FG008|Overall Study|Adverse Event|2
1159674|NCT03320850|2279750|FG009|Overall Study|Adverse Event|0
1159675|NCT03320850|2279741|FG000|Overall Study|Reason Not Specified|0
1159676|NCT03320850|2279742|FG001|Overall Study|Reason Not Specified|0
1159677|NCT03320850|2279743|FG002|Overall Study|Reason Not Specified|0
1159678|NCT03320850|2279744|FG003|Overall Study|Reason Not Specified|0
1159679|NCT03320850|2279745|FG004|Overall Study|Reason Not Specified|0
1159680|NCT03320850|2279746|FG005|Overall Study|Reason Not Specified|1
1159681|NCT03320850|2279747|FG006|Overall Study|Reason Not Specified|0
1159682|NCT03320850|2279748|FG007|Overall Study|Reason Not Specified|0
1159683|NCT03320850|2279749|FG008|Overall Study|Reason Not Specified|0
1159684|NCT03320850|2279750|FG009|Overall Study|Reason Not Specified|1
1159685|NCT03320941|2279782|FG000|Overall Study|subject/guardian decision|0
1159686|NCT03320941|2279783|FG001|Overall Study|subject/guardian decision|0
1159687|NCT03320941|2279784|FG002|Overall Study|subject/guardian decision|0
1159688|NCT03320941|2279785|FG003|Overall Study|subject/guardian decision|1
1159689|NCT03320941|2279786|FG004|Overall Study|subject/guardian decision|0
1159690|NCT03321006|2279800|FG000|Overall Study|Death|1
1159691|NCT03321006|2279801|FG001|Overall Study|Death|0
1159692|NCT03321006|2279800|FG000|Overall Study|Lack of Efficacy|1
1159693|NCT03321006|2279801|FG001|Overall Study|Lack of Efficacy|0
1159694|NCT03321396|2279820|FG000|Overall Study|Physician Decision|1
1159695|NCT03321721|2279827|FG000|Overall Study|Lost to Follow-up|4
1159696|NCT03321721|2279828|FG001|Overall Study|Lost to Follow-up|8
1159697|NCT03321721|2279829|FG002|Overall Study|Lost to Follow-up|11
1159698|NCT03322293|2279841|FG000|Overall Study|Lost to Follow-up|0
1159699|NCT03322293|2279842|FG001|Overall Study|Lost to Follow-up|0
1159700|NCT03322293|2279843|FG002|Overall Study|Lost to Follow-up|1
1159701|NCT03322423|2279851|FG000|Period 1|Subject no longer eligible|0
1159702|NCT03322423|2279852|FG001|Period 1|Subject no longer eligible|1
1159703|NCT03322423|2279851|FG000|Period 1|Withdrawal by Subject|0
1159704|NCT03322423|2279852|FG001|Period 1|Withdrawal by Subject|1
1159705|NCT03322423|2279851|FG000|Period 1|Incorrect Lens Dispensed|1
1159706|NCT03322423|2279852|FG001|Period 1|Incorrect Lens Dispensed|0
1159707|NCT03322423|2279851|FG000|Period 1|Unsatisfactory Lens Fitting|1
1159708|NCT03322423|2279852|FG001|Period 1|Unsatisfactory Lens Fitting|0
1159709|NCT03322423|2279851|FG000|Period 2|Dispensed incorrect lens in left eye|0
1159710|NCT03322423|2279852|FG001|Period 2|Dispensed incorrect lens in left eye|1
1159711|NCT03322423|2279851|FG000|Period 2|Protocol Violation|1
1159712|NCT03322423|2279852|FG001|Period 2|Protocol Violation|0
1159713|NCT03322423|2279851|FG000|Period 2|Subject not eligible for Pytergiumectomy|0
1159714|NCT03322423|2279852|FG001|Period 2|Subject not eligible for Pytergiumectomy|1
1159715|NCT03322462|2279858|FG000|Overall Study|Technical difficulties|2
1159716|NCT03322462|2279858|FG000|Overall Study|Other|1
1159717|NCT03322514|2279866|FG000|Overall Study|Withdrawal by Subject|1
1159718|NCT03322514|2279867|FG001|Overall Study|Withdrawal by Subject|1
1159741|NCT03323086|2279914|FG000|Overall Study|Lost to Follow-up|3
1159742|NCT03323086|2279915|FG001|Overall Study|Lost to Follow-up|2
1159743|NCT03323164|2279923|FG000|Overall Study|Poor quality imaging/scans|2
1159744|NCT03323164|2279924|FG001|Overall Study|Poor quality imaging/scans|2
1159745|NCT03323736|2279946|FG000|Overall Study|Screen Failure|14
1159746|NCT03323736|2279947|FG001|Overall Study|Screen Failure|9
1159747|NCT03323736|2279948|FG002|Overall Study|Screen Failure|1
1159748|NCT03323736|2279946|FG000|Overall Study|Withdrawal Before Treatment|3
1159749|NCT03323736|2279947|FG001|Overall Study|Withdrawal Before Treatment|1
1159750|NCT03323736|2279948|FG002|Overall Study|Withdrawal Before Treatment|1
1159751|NCT03323736|2279946|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2
1159752|NCT03323736|2279947|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2
1159753|NCT03323736|2279948|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0
1159764|NCT03324581|2279997|FG000|Overall Study|Adverse Event|18
1159765|NCT03324581|2279998|FG001|Overall Study|Adverse Event|11
1159766|NCT03324581|2279999|FG002|Overall Study|Adverse Event|7
1159767|NCT03324581|2279997|FG000|Overall Study|Lack of Efficacy|0
1159768|NCT03324581|2279998|FG001|Overall Study|Lack of Efficacy|1
1159769|NCT03324581|2279999|FG002|Overall Study|Lack of Efficacy|0
1159770|NCT03324581|2279997|FG000|Overall Study|Lost to Follow-up|5
1159771|NCT03324581|2279998|FG001|Overall Study|Lost to Follow-up|3
1159772|NCT03324581|2279999|FG002|Overall Study|Lost to Follow-up|6
1159773|NCT03324581|2279997|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
1159774|NCT03324581|2279998|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
1159775|NCT03324581|2279999|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0
1159776|NCT03324581|2279997|FG000|Overall Study|Physician Decision|0
1159777|NCT03324581|2279998|FG001|Overall Study|Physician Decision|1
1159778|NCT03324581|2279999|FG002|Overall Study|Physician Decision|2
1159779|NCT03324581|2279997|FG000|Overall Study|Protocol Deviation|8
1159780|NCT03324581|2279998|FG001|Overall Study|Protocol Deviation|9
1159781|NCT03324581|2279999|FG002|Overall Study|Protocol Deviation|4
1159782|NCT03324581|2279997|FG000|Overall Study|Withdrawal by Subject|6
1159783|NCT03324581|2279998|FG001|Overall Study|Withdrawal by Subject|8
1159784|NCT03324581|2279999|FG002|Overall Study|Withdrawal by Subject|6
1159785|NCT03324581|2279997|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
1159786|NCT03324581|2279998|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1
1159787|NCT03324581|2279999|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
1159788|NCT03325010|2280016|FG000|Overall Study|Adverse Event|3
1159789|NCT03325010|2280017|FG001|Overall Study|Adverse Event|8
1159790|NCT03325010|2280016|FG000|Overall Study|Protocol Violation|1
1159791|NCT03325010|2280017|FG001|Overall Study|Protocol Violation|8
1159792|NCT03325010|2280016|FG000|Overall Study|Withdrawal by Subject|1
1159793|NCT03325010|2280017|FG001|Overall Study|Withdrawal by Subject|3
1159794|NCT03325010|2280016|FG000|Overall Study|Lost to Follow-up|1
1159795|NCT03325010|2280017|FG001|Overall Study|Lost to Follow-up|0
1159796|NCT03325010|2280016|FG000|Overall Study|Physician Decision|1
1159797|NCT03325010|2280017|FG001|Overall Study|Physician Decision|1
1159798|NCT03325010|2280016|FG000|Overall Study|Lack of Efficacy|2
1159799|NCT03325010|2280017|FG001|Overall Study|Lack of Efficacy|0
1159800|NCT03325556|2280023|FG000|Open-label Period|Lack of Response in OL period|70
1159801|NCT03325556|2280024|FG001|Open-label Period|Lack of Response in OL period|0
1159802|NCT03325556|2280025|FG002|Open-label Period|Lack of Response in OL period|0
1159803|NCT03325556|2280023|FG000|Open-label Period|Adverse Event|27
1159804|NCT03325556|2280024|FG001|Open-label Period|Adverse Event|0
1159805|NCT03325556|2280025|FG002|Open-label Period|Adverse Event|0
1159806|NCT03325556|2280023|FG000|Open-label Period|Death|1
1159807|NCT03325556|2280024|FG001|Open-label Period|Death|0
1159808|NCT03325556|2280025|FG002|Open-label Period|Death|0
1159809|NCT03325556|2280023|FG000|Open-label Period|Lost to Follow-up|1
1159810|NCT03325556|2280024|FG001|Open-label Period|Lost to Follow-up|0
1159811|NCT03325556|2280025|FG002|Open-label Period|Lost to Follow-up|0
1159812|NCT03325556|2280023|FG000|Open-label Period|Non-compliance with study drug|5
1159813|NCT03325556|2280024|FG001|Open-label Period|Non-compliance with study drug|0
1159814|NCT03325556|2280025|FG002|Open-label Period|Non-compliance with study drug|0
1159815|NCT03325556|2280023|FG000|Open-label Period|Use of prohibited medication|1
1018408|NCT01570868|2043260|FG001|Overall Study|FDA Recommendation|3
1018409|NCT01570868|2043259|FG000|Overall Study|Physician Decision|10
1018410|NCT01570868|2043260|FG001|Overall Study|Physician Decision|4
1018411|NCT01570868|2043259|FG000|Overall Study|Lost to Follow-up|1
1018412|NCT01570868|2043260|FG001|Overall Study|Lost to Follow-up|0
1018413|NCT01570868|2043259|FG000|Overall Study|Withdrawal by Subject|1
1018414|NCT01570868|2043260|FG001|Overall Study|Withdrawal by Subject|0
1018415|NCT01571232|2043272|FG000|Overall Study|Lost to Follow-up|0
1018416|NCT01571232|2043273|FG001|Overall Study|Lost to Follow-up|1
1018417|NCT01571232|2043272|FG000|Overall Study|Withdrawal by Subject|1
1018418|NCT01571232|2043273|FG001|Overall Study|Withdrawal by Subject|0
1018419|NCT01571284|2043280|FG000|Overall Study|Participant's decision|84
1018420|NCT01571284|2043280|FG000|Overall Study|Lost to Follow-up|3
1018421|NCT01571284|2043280|FG000|Overall Study|Enrolled but not treated|2
1018422|NCT01571284|2043280|FG000|Overall Study|Other than specified above|80
1018423|NCT01571362|2043284|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
903574|NCT00749580|1877872|FG001|Overall Study|Lost to Follow-up|8
903575|NCT00749580|1877871|FG000|Overall Study|Adverse Event|0
903576|NCT00749580|1877872|FG001|Overall Study|Adverse Event|1
903577|NCT00749684|1877900|FG000|Overall Study|Death|1
903578|NCT00749684|1877900|FG000|Overall Study|Adverse Event|27
903579|NCT00749684|1877900|FG000|Overall Study|Participant's Wish|10
903580|NCT00749684|1877900|FG000|Overall Study|Not Documented|1
903581|NCT00749684|1877900|FG000|Overall Study|Progressive Desease|31
903582|NCT00749684|1877900|FG000|Overall Study|Therapy according to protocol + AE|2
903583|NCT00749684|1877900|FG000|Overall Study|AE+discontinuation on participants wish|1
903584|NCT00749684|1877900|FG000|Overall Study|Missing|9
1018424|NCT01571362|2043285|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
1018425|NCT01571362|2043286|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
1018426|NCT01571362|2043284|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7
1018427|NCT01571362|2043285|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0
1018428|NCT01571362|2043286|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0
1018429|NCT01571362|2043284|FG000|Open-Label Conversion + Titration Period|Adverse Event|57
1018430|NCT01571362|2043285|FG001|Open-Label Conversion + Titration Period|Adverse Event|0
1018431|NCT01571362|2043286|FG002|Open-Label Conversion + Titration Period|Adverse Event|0
1159816|NCT03325556|2280024|FG001|Open-label Period|Use of prohibited medication|0
1159817|NCT03325556|2280025|FG002|Open-label Period|Use of prohibited medication|0
1159818|NCT03325556|2280023|FG000|Open-label Period|Protocol Violation|4
1159819|NCT03325556|2280024|FG001|Open-label Period|Protocol Violation|0
1159820|NCT03325556|2280025|FG002|Open-label Period|Protocol Violation|0
1159821|NCT03325556|2280023|FG000|Open-label Period|Withdrawal by Subject|17
1159822|NCT03325556|2280024|FG001|Open-label Period|Withdrawal by Subject|0
1159823|NCT03325556|2280025|FG002|Open-label Period|Withdrawal by Subject|0
1159824|NCT03325556|2280023|FG000|Open-label Period|Not otherwise specified|8
1159825|NCT03325556|2280024|FG001|Open-label Period|Not otherwise specified|0
1159826|NCT03325556|2280025|FG002|Open-label Period|Not otherwise specified|0
1159827|NCT03325556|2280023|FG000|Open-label Period|Administrative discont. at study termination|41
1159828|NCT03325556|2280024|FG001|Open-label Period|Administrative discont. at study termination|0
1159829|NCT03325556|2280025|FG002|Open-label Period|Administrative discont. at study termination|0
1159830|NCT03325556|2280023|FG000|Double-blind Period|Relapse|0
1159831|NCT03325556|2280024|FG001|Double-blind Period|Relapse|15
1159832|NCT03325556|2280025|FG002|Double-blind Period|Relapse|34
1159833|NCT03325556|2280023|FG000|Double-blind Period|Adverse Event|0
1159834|NCT03325556|2280024|FG001|Double-blind Period|Adverse Event|3
1159835|NCT03325556|2280025|FG002|Double-blind Period|Adverse Event|1
1159836|NCT03325556|2280023|FG000|Double-blind Period|Noncompliance with study drug|0
1159837|NCT03325556|2280024|FG001|Double-blind Period|Noncompliance with study drug|0
1159838|NCT03325556|2280025|FG002|Double-blind Period|Noncompliance with study drug|1
1159839|NCT03325556|2280023|FG000|Double-blind Period|Use of prohibited medication|0
1159840|NCT03325556|2280024|FG001|Double-blind Period|Use of prohibited medication|1
1159841|NCT03325556|2280025|FG002|Double-blind Period|Use of prohibited medication|0
1159842|NCT03325556|2280023|FG000|Double-blind Period|Physician Decision|0
1159843|NCT03325556|2280024|FG001|Double-blind Period|Physician Decision|0
1159844|NCT03325556|2280025|FG002|Double-blind Period|Physician Decision|1
1159845|NCT03325556|2280023|FG000|Double-blind Period|Withdrawal by Subject|0
1159846|NCT03325556|2280024|FG001|Double-blind Period|Withdrawal by Subject|6
1159847|NCT03325556|2280025|FG002|Double-blind Period|Withdrawal by Subject|4
1159848|NCT03325556|2280023|FG000|Double-blind Period|Not otherwise specified|0
1159849|NCT03325556|2280024|FG001|Double-blind Period|Not otherwise specified|1
1159850|NCT03325556|2280025|FG002|Double-blind Period|Not otherwise specified|5
1159851|NCT03325556|2280023|FG000|Double-blind Period|Administrative discont. at study termination|0
1159852|NCT03325556|2280024|FG001|Double-blind Period|Administrative discont. at study termination|35
1159853|NCT03325556|2280025|FG002|Double-blind Period|Administrative discont. at study termination|31
1159854|NCT03325673|2280034|FG000|Overall Study|Adverse Event|4
1159855|NCT03325673|2280035|FG001|Overall Study|Adverse Event|0
1159856|NCT03325881|2280054|FG000|Overall Study|Protocol Violation|0
1159857|NCT03325881|2280055|FG001|Overall Study|Protocol Violation|1
1159858|NCT03325881|2280054|FG000|Overall Study|Withdrawal by Subject|0
1159859|NCT03325881|2280055|FG001|Overall Study|Withdrawal by Subject|2
1159860|NCT03325881|2280054|FG000|Overall Study|Lack of Efficacy|2
1159861|NCT03325881|2280055|FG001|Overall Study|Lack of Efficacy|0
1159862|NCT03325881|2280054|FG000|Overall Study|Not treated|1
1159863|NCT03325881|2280055|FG001|Overall Study|Not treated|0
1159864|NCT03325894|2280065|FG000|Overall Study|Adverse Event|2
1159865|NCT03325894|2280066|FG001|Overall Study|Adverse Event|3
1159866|NCT03325894|2280065|FG000|Overall Study|Protocol Violation|1
1159867|NCT03325894|2280066|FG001|Overall Study|Protocol Violation|2
1159868|NCT03325894|2280065|FG000|Overall Study|Withdrawal by Subject|10
1159869|NCT03325894|2280066|FG001|Overall Study|Withdrawal by Subject|6
1159870|NCT03325894|2280065|FG000|Overall Study|Lost to Follow-up|4
1159871|NCT03325894|2280066|FG001|Overall Study|Lost to Follow-up|9
1159872|NCT03325894|2280065|FG000|Overall Study|Lack of Efficacy|8
1159873|NCT03325894|2280066|FG001|Overall Study|Lack of Efficacy|14
1159874|NCT03325894|2280065|FG000|Overall Study|Study Terminated by Sponsor|38
1159875|NCT03325894|2280066|FG001|Overall Study|Study Terminated by Sponsor|43
1159876|NCT03325894|2280065|FG000|Overall Study|Other (Not received Treatment)|1
1159877|NCT03325894|2280066|FG001|Overall Study|Other (Not received Treatment)|0
1159878|NCT03326323|2280075|FG000|Overall Study|Unable to receive ANH protocol|3
1159879|NCT03326518|2280082|FG000|Overall Study|Protocol Violation|1
1159880|NCT03326518|2280083|FG001|Overall Study|Protocol Violation|0
1159881|NCT03326518|2280084|FG002|Overall Study|Protocol Violation|0
1159882|NCT03326518|2280082|FG000|Overall Study|Withdrawal by Subject|1
1159883|NCT03326518|2280083|FG001|Overall Study|Withdrawal by Subject|0
1159884|NCT03326518|2280084|FG002|Overall Study|Withdrawal by Subject|0
1159885|NCT03326518|2280082|FG000|Overall Study|Lost to Follow-up|1
1159886|NCT03326518|2280083|FG001|Overall Study|Lost to Follow-up|0
1159887|NCT03326518|2280084|FG002|Overall Study|Lost to Follow-up|1
1159888|NCT03326856|2280101|FG000|Overall Study|Lost to Follow-up|1
1159889|NCT03326856|2280102|FG001|Overall Study|Lost to Follow-up|1
1159890|NCT03326856|2280103|FG002|Overall Study|Lost to Follow-up|0
1159891|NCT03326856|2280104|FG003|Overall Study|Lost to Follow-up|0
1159892|NCT03326856|2280105|FG004|Overall Study|Lost to Follow-up|0
1159893|NCT03327220|2280188|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1
1159894|NCT03327220|2280189|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2
1159895|NCT03327220|2280188|FG000|Overall Study|Investigator Decision|2
1159896|NCT03327220|2280189|FG001|Overall Study|Investigator Decision|0
1159897|NCT03327220|2280188|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0
1159898|NCT03327220|2280189|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1
903585|NCT00749775|1877913|FG000|Overall Study|Protocol Violation|24
903586|NCT00749775|1877913|FG000|Overall Study|Lost to Follow-up|36
903587|NCT00749775|1877913|FG000|Overall Study|No visit after first day of treatment|44
903588|NCT00749775|1877913|FG000|Overall Study|No drug administration|3
903589|NCT00749892|1877939|FG000|Overall Study|Withdrawal by Subject|3
903590|NCT00749944|1877956|FG000|Overall Study|Lost to Follow-up|2
1159899|NCT03327220|2280188|FG000|Overall Study|Fungal infection|1
1159900|NCT03327220|2280189|FG001|Overall Study|Fungal infection|0
1159901|NCT03327220|2280188|FG000|Overall Study|Discharged to Rehabilitation|0
1159902|NCT03327220|2280189|FG001|Overall Study|Discharged to Rehabilitation|1
1159903|NCT03327220|2280188|FG000|Overall Study|Missing|1
1159904|NCT03327220|2280189|FG001|Overall Study|Missing|0
1159905|NCT03327402|2280195|FG000|Overall Study|Withdrawal by Subject|1
1159906|NCT03327402|2280195|FG000|Overall Study|Other (Visit Out-Of-Window)|1
1159907|NCT03328182|2280209|FG000|Overall Study|Withdrawal by Subject|1
1159908|NCT03328182|2280209|FG000|Overall Study|Protocol Violation|2
1159909|NCT03328182|2280209|FG000|Overall Study|No Product Evaluated|1
1159910|NCT03328325|2280222|FG000|Overall Study|Lost to Follow-up|4
1159911|NCT03328325|2280222|FG000|Overall Study|Physician Decision|1
1159912|NCT03328325|2280222|FG000|Overall Study|Withdrawal by Subject|3
1159913|NCT03328325|2280222|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3
1159914|NCT03328832|2280232|FG000|Overall Study|Lost to Follow-up|0
1159915|NCT03328832|2280233|FG001|Overall Study|Lost to Follow-up|1
1159916|NCT03328897|2280242|FG000|Randomized-treatment Epoch|Adverse Event|4
1159917|NCT03328897|2280243|FG001|Randomized-treatment Epoch|Adverse Event|1
1159918|NCT03328897|2280244|FG002|Randomized-treatment Epoch|Adverse Event|1
1159919|NCT03328897|2280242|FG000|Randomized-treatment Epoch|Lost to Follow-up|0
1159920|NCT03328897|2280243|FG001|Randomized-treatment Epoch|Lost to Follow-up|1
1159921|NCT03328897|2280244|FG002|Randomized-treatment Epoch|Lost to Follow-up|0
1159922|NCT03328897|2280242|FG000|Randomized-treatment Epoch|Pregnancy|3
1159923|NCT03328897|2280243|FG001|Randomized-treatment Epoch|Pregnancy|0
1159924|NCT03328897|2280244|FG002|Randomized-treatment Epoch|Pregnancy|0
1159925|NCT03328897|2280242|FG000|Randomized-treatment Epoch|Patient/guardian decision|8
1159926|NCT03328897|2280243|FG001|Randomized-treatment Epoch|Patient/guardian decision|3
1159927|NCT03328897|2280244|FG002|Randomized-treatment Epoch|Patient/guardian decision|1
1159928|NCT03328897|2280242|FG000|Randomized-treatment Epoch|Lack of Efficacy|1
1159929|NCT03328897|2280243|FG001|Randomized-treatment Epoch|Lack of Efficacy|0
1159930|NCT03328897|2280244|FG002|Randomized-treatment Epoch|Lack of Efficacy|0
1159931|NCT03328897|2280242|FG000|Follow-up Epoch|Adverse Event|4
1159932|NCT03328897|2280243|FG001|Follow-up Epoch|Adverse Event|0
1159933|NCT03328897|2280244|FG002|Follow-up Epoch|Adverse Event|1
1159934|NCT03328897|2280242|FG000|Follow-up Epoch|Lack of Efficacy|1
1159935|NCT03328897|2280243|FG001|Follow-up Epoch|Lack of Efficacy|1
1159936|NCT03328897|2280244|FG002|Follow-up Epoch|Lack of Efficacy|1
1159937|NCT03328897|2280242|FG000|Follow-up Epoch|Lost to Follow-up|0
1159938|NCT03328897|2280243|FG001|Follow-up Epoch|Lost to Follow-up|1
1159939|NCT03328897|2280244|FG002|Follow-up Epoch|Lost to Follow-up|0
1159940|NCT03328897|2280242|FG000|Follow-up Epoch|Pregnancy|1
1159941|NCT03328897|2280243|FG001|Follow-up Epoch|Pregnancy|0
1159942|NCT03328897|2280244|FG002|Follow-up Epoch|Pregnancy|0
1159943|NCT03328897|2280242|FG000|Follow-up Epoch|Patient/guardian decision|2
1159944|NCT03328897|2280243|FG001|Follow-up Epoch|Patient/guardian decision|1
1159945|NCT03328897|2280244|FG002|Follow-up Epoch|Patient/guardian decision|0
1159946|NCT03329196|2280259|FG000|Overall Study|Adverse Event|10
1159947|NCT03329196|2280260|FG001|Overall Study|Adverse Event|5
1159948|NCT03329196|2280259|FG000|Overall Study|Physician Decision|2
1018432|NCT01571362|2043284|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10
1018433|NCT01571362|2043285|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0
1018434|NCT01571362|2043286|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0
1018435|NCT01571362|2043284|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
1018436|NCT01571362|2043285|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
1018437|NCT01571362|2043286|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
1018438|NCT01571362|2043284|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3
1018439|NCT01571362|2043285|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0
1018440|NCT01571362|2043286|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0
1018441|NCT01571362|2043284|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
1018442|NCT01571362|2043285|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11
1018443|NCT01571362|2043286|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5
1018444|NCT01571362|2043284|FG000|Double-Blind Treatment Period|Protocol Violation|0
1018445|NCT01571362|2043285|FG001|Double-Blind Treatment Period|Protocol Violation|8
1018446|NCT01571362|2043286|FG002|Double-Blind Treatment Period|Protocol Violation|9
1018447|NCT01571362|2043284|FG000|Double-Blind Treatment Period|Adverse Event|0
1018448|NCT01571362|2043285|FG001|Double-Blind Treatment Period|Adverse Event|9
1159949|NCT03329196|2280260|FG001|Overall Study|Physician Decision|2
1159950|NCT03329196|2280259|FG000|Overall Study|Withdrawal by Subject|11
1159951|NCT03329196|2280260|FG001|Overall Study|Withdrawal by Subject|3
1159952|NCT03329196|2280259|FG000|Overall Study|Hepatic function abnormalities|0
1159953|NCT03329196|2280260|FG001|Overall Study|Hepatic function abnormalities|1
1159954|NCT03329196|2280259|FG000|Overall Study|Conducting rescue therapy before Week 24|2
1159955|NCT03329196|2280260|FG001|Overall Study|Conducting rescue therapy before Week 24|1
1159956|NCT03329196|2280259|FG000|Overall Study|Difficult to control Hb|2
1159957|NCT03329196|2280260|FG001|Overall Study|Difficult to control Hb|3
1159958|NCT03329196|2280259|FG000|Overall Study|Dialysis or renal transplant|13
1159959|NCT03329196|2280260|FG001|Overall Study|Dialysis or renal transplant|15
1159960|NCT03329573|2280280|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
1159961|NCT03329573|2280281|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
1159962|NCT03329573|2280282|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
1159963|NCT03329573|2280283|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
1159964|NCT03329573|2280280|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
1159965|NCT03329573|2280281|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
1159966|NCT03329573|2280282|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
1159967|NCT03329573|2280283|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
1159968|NCT03329573|2280280|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
1159969|NCT03329573|2280281|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
1159970|NCT03329573|2280282|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
1159971|NCT03329573|2280283|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
1159972|NCT03329573|2280280|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
1159973|NCT03329573|2280281|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
1159974|NCT03329573|2280282|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
1159975|NCT03329573|2280283|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
1159976|NCT03329846|2280322|FG000|Overall Study|Disease progression|4
1159977|NCT03329846|2280323|FG001|Overall Study|Disease progression|6
1159978|NCT03329846|2280322|FG000|Overall Study|Study drug toxicity|1
1159979|NCT03329846|2280323|FG001|Overall Study|Study drug toxicity|0
1159980|NCT03329846|2280322|FG000|Overall Study|Participant request to discontinue treatment|0
1159981|NCT03329846|2280323|FG001|Overall Study|Participant request to discontinue treatment|1
1159982|NCT03329846|2280322|FG000|Overall Study|Participant withdrew consent|1
1159983|NCT03329846|2280323|FG001|Overall Study|Participant withdrew consent|0
1159984|NCT03329846|2280322|FG000|Overall Study|Other reasons|2
1159985|NCT03329846|2280323|FG001|Overall Study|Other reasons|2
1159986|NCT03329885|2280335|FG000|Overall Study|Sponsor discontinued the study early|0
1159987|NCT03329885|2280336|FG001|Overall Study|Sponsor discontinued the study early|0
1159988|NCT03329885|2280337|FG002|Overall Study|Sponsor discontinued the study early|0
1159989|NCT03329885|2280338|FG003|Overall Study|Sponsor discontinued the study early|0
1159990|NCT03329885|2280339|FG004|Overall Study|Sponsor discontinued the study early|0
1159991|NCT03329885|2280340|FG005|Overall Study|Sponsor discontinued the study early|0
1159992|NCT03329885|2280341|FG006|Overall Study|Sponsor discontinued the study early|1
1159993|NCT03329885|2280342|FG007|Overall Study|Sponsor discontinued the study early|1
1159994|NCT03329885|2280343|FG008|Overall Study|Sponsor discontinued the study early|0
1159995|NCT03329989|2280376|FG000|Overall Study|Withdrawal by Subject|9
1159996|NCT03329989|2280376|FG000|Overall Study|Lost to Follow-up|8
1159997|NCT03329989|2280376|FG000|Overall Study|Adverse Event|5
1159998|NCT03329989|2280376|FG000|Overall Study|Protocol Violation|1
1159999|NCT03330002|2280380|FG000|Overall Study|Lost to Follow-up|15
1160000|NCT03330002|2280380|FG000|Overall Study|Death|7
1160001|NCT03330119|2280392|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166
1160002|NCT03330119|2280393|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282
1160003|NCT03330236|2280401|FG000|Overall Study|Death|2
1160004|NCT03330236|2280402|FG001|Overall Study|Death|1
1160005|NCT03330236|2280401|FG000|Overall Study|Withdrawal by Subject|2
1160006|NCT03330236|2280402|FG001|Overall Study|Withdrawal by Subject|4
1160007|NCT03330236|2280401|FG000|Overall Study|Lost to Follow-up|0
1160008|NCT03330236|2280402|FG001|Overall Study|Lost to Follow-up|2
1160009|NCT03330236|2280401|FG000|Overall Study|Physician Decision|2
1160010|NCT03330236|2280402|FG001|Overall Study|Physician Decision|0
1160011|NCT03330236|2280401|FG000|Overall Study|Protocol Violation|4
1160012|NCT03330236|2280402|FG001|Overall Study|Protocol Violation|3
1160013|NCT03330236|2280401|FG000|Overall Study|SedLine malfunction/blinding|19
1160014|NCT03330236|2280402|FG001|Overall Study|SedLine malfunction/blinding|14
1160015|NCT03330236|2280401|FG000|Overall Study|Volatile anesthetics used|11
1160016|NCT03330236|2280402|FG001|Overall Study|Volatile anesthetics used|8
1160017|NCT03330236|2280401|FG000|Overall Study|Surgery aborted/converted to open|60
1160018|NCT03330236|2280402|FG001|Overall Study|Surgery aborted/converted to open|52
1160019|NCT03330288|2280439|FG000|Overall Study|Other reason|1
1160020|NCT03330288|2280440|FG001|Overall Study|Other reason|1
1160021|NCT03330288|2280439|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1
1160022|NCT03330288|2280440|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0
1160023|NCT03330288|2280439|FG000|Overall Study|Adverse Event|1
1160024|NCT03330288|2280440|FG001|Overall Study|Adverse Event|0
1160025|NCT03330288|2280439|FG000|Overall Study|Withdrawal by Subject|1
1160026|NCT03330288|2280440|FG001|Overall Study|Withdrawal by Subject|0
1160027|NCT03330288|2280439|FG000|Overall Study|Lost to Follow-up|26
1160028|NCT03330288|2280440|FG001|Overall Study|Lost to Follow-up|7
1160029|NCT03331042|2280471|FG000|Overall Study|Protocol Violation|1
1160030|NCT03331042|2280472|FG001|Overall Study|Protocol Violation|0
1160031|NCT03331042|2280473|FG002|Overall Study|Protocol Violation|0
1160032|NCT03331042|2280474|FG003|Overall Study|Protocol Violation|0
1160033|NCT03331042|2280471|FG000|Overall Study|Physician Decision|0
1160034|NCT03331042|2280472|FG001|Overall Study|Physician Decision|0
1160035|NCT03331042|2280473|FG002|Overall Study|Physician Decision|1
1160036|NCT03331042|2280474|FG003|Overall Study|Physician Decision|0
1160037|NCT03331042|2280471|FG000|Overall Study|Lost to Follow-up|0
1160038|NCT03331042|2280472|FG001|Overall Study|Lost to Follow-up|0
1160039|NCT03331042|2280473|FG002|Overall Study|Lost to Follow-up|0
1160040|NCT03331042|2280474|FG003|Overall Study|Lost to Follow-up|1
1160041|NCT03331315|2280501|FG000|Overall Study|Physician Decision|18
1160042|NCT03331315|2280502|FG001|Overall Study|Physician Decision|14
1160043|NCT03331666|2280512|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
1160044|NCT03331666|2280513|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
1160045|NCT03332160|2280539|FG000|Overall Study|Withdrawal by Subject|1
1160046|NCT03332160|2280540|FG001|Overall Study|Withdrawal by Subject|1
1160047|NCT03332160|2280539|FG000|Overall Study|Adverse Event|0
1160048|NCT03332160|2280540|FG001|Overall Study|Adverse Event|1
1160049|NCT03332160|2280539|FG000|Overall Study|Developed Exclusion Criteria|0
1160050|NCT03332160|2280540|FG001|Overall Study|Developed Exclusion Criteria|1
1160051|NCT03332160|2280539|FG000|Overall Study|Non-adherence to treatment|0
1160052|NCT03332160|2280540|FG001|Overall Study|Non-adherence to treatment|2
1160053|NCT03332212|2280551|FG000|Overall Study|Not treated|0
1160054|NCT03332212|2280552|FG001|Overall Study|Not treated|1
1160055|NCT03332212|2280553|FG002|Overall Study|Not treated|0
1160056|NCT03332212|2280554|FG003|Overall Study|Not treated|0
1160057|NCT03332212|2280551|FG000|Overall Study|Adverse Event|0
1160058|NCT03332212|2280552|FG001|Overall Study|Adverse Event|0
1160059|NCT03332212|2280553|FG002|Overall Study|Adverse Event|0
1160060|NCT03332212|2280554|FG003|Overall Study|Adverse Event|1
1160061|NCT03332212|2280551|FG000|Overall Study|worsening of disease under study|1
1160062|NCT03332212|2280552|FG001|Overall Study|worsening of disease under study|1
1160063|NCT03332212|2280553|FG002|Overall Study|worsening of disease under study|0
1160064|NCT03332212|2280554|FG003|Overall Study|worsening of disease under study|0
1160068|NCT03332628|2280587|FG000|Overall Study|Physician Decision|2
1160069|NCT03332771|2280596|FG000|Overall Study|Adverse Event|6
1160070|NCT03332771|2280597|FG001|Overall Study|Adverse Event|4
1160071|NCT03332771|2280598|FG002|Overall Study|Adverse Event|1
1160072|NCT03332771|2280599|FG003|Overall Study|Adverse Event|3
1160073|NCT03332771|2280596|FG000|Overall Study|Poor Compliance to Protocol|0
1160074|NCT03332771|2280597|FG001|Overall Study|Poor Compliance to Protocol|1
1160075|NCT03332771|2280598|FG002|Overall Study|Poor Compliance to Protocol|0
1160076|NCT03332771|2280599|FG003|Overall Study|Poor Compliance to Protocol|1
1160077|NCT03332771|2280596|FG000|Overall Study|Lost to Follow-up|2
1160078|NCT03332771|2280597|FG001|Overall Study|Lost to Follow-up|2
1160079|NCT03332771|2280598|FG002|Overall Study|Lost to Follow-up|1
1160080|NCT03332771|2280599|FG003|Overall Study|Lost to Follow-up|2
1160081|NCT03332771|2280596|FG000|Overall Study|At the Participant's own request|20
1160082|NCT03332771|2280597|FG001|Overall Study|At the Participant's own request|26
1160083|NCT03332771|2280598|FG002|Overall Study|At the Participant's own request|14
1160084|NCT03332771|2280599|FG003|Overall Study|At the Participant's own request|23
1160085|NCT03332771|2280596|FG000|Overall Study|Reason Not Specified|6
1160086|NCT03332771|2280597|FG001|Overall Study|Reason Not Specified|18
1160087|NCT03332771|2280598|FG002|Overall Study|Reason Not Specified|16
1160088|NCT03332771|2280599|FG003|Overall Study|Reason Not Specified|19
1160089|NCT03332784|2280629|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160090|NCT03332784|2280630|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
1160091|NCT03332784|2280631|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160092|NCT03332784|2280632|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160093|NCT03332784|2280633|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160094|NCT03332784|2280634|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160095|NCT03332784|2280635|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160096|NCT03332784|2280636|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160097|NCT03332784|2280637|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160098|NCT03332784|2280638|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160099|NCT03332784|2280639|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160100|NCT03332784|2280640|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160101|NCT03332784|2280641|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160102|NCT03332784|2280642|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160103|NCT03332784|2280643|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
1160104|NCT03332784|2280644|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160105|NCT03332784|2280645|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160106|NCT03332784|2280646|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160107|NCT03332784|2280647|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160108|NCT03332784|2280648|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
1160109|NCT03333109|2280722|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0
1160110|NCT03333109|2280723|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0
1160111|NCT03333109|2280724|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2
1160112|NCT03333109|2280722|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
1160113|NCT03333109|2280723|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
1160114|NCT03333109|2280724|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1
1160115|NCT03333109|2280722|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4
1160116|NCT03333109|2280723|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0
1160117|NCT03333109|2280724|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1
1160118|NCT03333109|2280722|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1
1160119|NCT03333109|2280723|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0
1160120|NCT03333109|2280724|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0
1160121|NCT03333109|2280722|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9
1160122|NCT03333109|2280723|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6
1160123|NCT03333109|2280724|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5
1160124|NCT03333109|2280722|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
1160125|NCT03333109|2280723|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0
1160126|NCT03333109|2280724|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
1160127|NCT03333109|2280722|FG000|Safety Follow-up Period|Lost to Follow-up|6
1160128|NCT03333109|2280723|FG001|Safety Follow-up Period|Lost to Follow-up|2
1160129|NCT03333109|2280724|FG002|Safety Follow-up Period|Lost to Follow-up|1
1160130|NCT03333109|2280722|FG000|Safety Follow-up Period|Withdrawal by Subject|7
1160131|NCT03333109|2280723|FG001|Safety Follow-up Period|Withdrawal by Subject|2
1160132|NCT03333109|2280724|FG002|Safety Follow-up Period|Withdrawal by Subject|12
1160133|NCT03333876|2280753|FG000|Screening Period|Screen Failure|4
1160134|NCT03333876|2280753|FG000|Nasal Dilator|Bed Partner Lost to follow up|6
1160135|NCT03333876|2280753|FG000|Mandibular Advancement|Adverse Event|2
1160136|NCT03333876|2280753|FG000|Mandibular Advancement|Product Damage|2
1160137|NCT03333941|2280766|FG000|Overall Study|Lost to Follow-up|10
1160138|NCT03333941|2280766|FG000|Overall Study|Death|2
1160139|NCT03333941|2280766|FG000|Overall Study|Adverse Event|1
1160140|NCT03334175|2280772|FG000|Overall Study|Lost to Follow-up|0
1160141|NCT03334175|2280773|FG001|Overall Study|Lost to Follow-up|1
1160142|NCT03334188|2280781|FG000|Overall Study|Withdrawal by Subject|0
1160143|NCT03334188|2280782|FG001|Overall Study|Withdrawal by Subject|1
1160144|NCT03334188|2280781|FG000|Overall Study|Death|1
1160145|NCT03334188|2280782|FG001|Overall Study|Death|0
1160146|NCT03334188|2280781|FG000|Overall Study|Never had qualifying clinic visit|7
1160147|NCT03334188|2280782|FG001|Overall Study|Never had qualifying clinic visit|7
1160148|NCT03334214|2280791|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
1160149|NCT03334214|2280792|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
1160150|NCT03334214|2280791|FG000|Overall Study|Withdrawal by Subject|0
1160151|NCT03334214|2280792|FG001|Overall Study|Withdrawal by Subject|1
1160152|NCT03334214|2280791|FG000|Overall Study|Other|1
1160153|NCT03334214|2280792|FG001|Overall Study|Other|0
1160154|NCT03334396|2280807|FG000|Overall Study|Adverse Event|1
1160155|NCT03334396|2280808|FG001|Overall Study|Adverse Event|0
1160156|NCT03334396|2280809|FG002|Overall Study|Adverse Event|1
1160157|NCT03334396|2280810|FG003|Overall Study|Adverse Event|0
1160158|NCT03334396|2280811|FG004|Overall Study|Adverse Event|0
1160159|NCT03334396|2280812|FG005|Overall Study|Adverse Event|0
1160160|NCT03334396|2280813|FG006|Overall Study|Adverse Event|0
1160161|NCT03334396|2280814|FG007|Overall Study|Adverse Event|0
1160162|NCT03334396|2280807|FG000|Overall Study|Lack of Efficacy|10
1160163|NCT03334396|2280808|FG001|Overall Study|Lack of Efficacy|4
1160164|NCT03334396|2280809|FG002|Overall Study|Lack of Efficacy|1
1160165|NCT03334396|2280810|FG003|Overall Study|Lack of Efficacy|3
1160166|NCT03334396|2280811|FG004|Overall Study|Lack of Efficacy|1
1160167|NCT03334396|2280812|FG005|Overall Study|Lack of Efficacy|0
1160168|NCT03334396|2280813|FG006|Overall Study|Lack of Efficacy|0
1160169|NCT03334396|2280814|FG007|Overall Study|Lack of Efficacy|1
1160170|NCT03334396|2280807|FG000|Overall Study|Lost to Follow-up|0
1160171|NCT03334396|2280808|FG001|Overall Study|Lost to Follow-up|0
1160172|NCT03334396|2280809|FG002|Overall Study|Lost to Follow-up|1
1160173|NCT03334396|2280810|FG003|Overall Study|Lost to Follow-up|0
1160174|NCT03334396|2280811|FG004|Overall Study|Lost to Follow-up|0
1160175|NCT03334396|2280812|FG005|Overall Study|Lost to Follow-up|0
1160176|NCT03334396|2280813|FG006|Overall Study|Lost to Follow-up|1
1160177|NCT03334396|2280814|FG007|Overall Study|Lost to Follow-up|0
1160178|NCT03334396|2280807|FG000|Overall Study|Physician Decision|1
1160179|NCT03334396|2280808|FG001|Overall Study|Physician Decision|0
1018449|NCT01571362|2043286|FG002|Double-Blind Treatment Period|Adverse Event|14
1018450|NCT01571362|2043284|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
1018451|NCT01571362|2043285|FG001|Double-Blind Treatment Period|Lost to Follow-up|3
1018452|NCT01571362|2043286|FG002|Double-Blind Treatment Period|Lost to Follow-up|6
1018453|NCT01571362|2043284|FG000|Double-Blind Treatment Period|Insufficient clinical response|0
1018454|NCT01571362|2043285|FG001|Double-Blind Treatment Period|Insufficient clinical response|16
1018455|NCT01571362|2043286|FG002|Double-Blind Treatment Period|Insufficient clinical response|4
1160180|NCT03334396|2280809|FG002|Overall Study|Physician Decision|0
1160181|NCT03334396|2280810|FG003|Overall Study|Physician Decision|0
1160182|NCT03334396|2280811|FG004|Overall Study|Physician Decision|0
1160183|NCT03334396|2280812|FG005|Overall Study|Physician Decision|0
1160184|NCT03334396|2280813|FG006|Overall Study|Physician Decision|0
1160185|NCT03334396|2280814|FG007|Overall Study|Physician Decision|0
1160186|NCT03334396|2280807|FG000|Overall Study|Withdrawal by Subject|10
1160187|NCT03334396|2280808|FG001|Overall Study|Withdrawal by Subject|5
1160188|NCT03334396|2280809|FG002|Overall Study|Withdrawal by Subject|7
1160189|NCT03334396|2280810|FG003|Overall Study|Withdrawal by Subject|2
1160190|NCT03334396|2280811|FG004|Overall Study|Withdrawal by Subject|2
1160191|NCT03334396|2280812|FG005|Overall Study|Withdrawal by Subject|1
1160192|NCT03334396|2280813|FG006|Overall Study|Withdrawal by Subject|2
1160193|NCT03334396|2280814|FG007|Overall Study|Withdrawal by Subject|0
1160194|NCT03334396|2280807|FG000|Overall Study|Pregnancy|0
1160195|NCT03334396|2280808|FG001|Overall Study|Pregnancy|1
1160196|NCT03334396|2280809|FG002|Overall Study|Pregnancy|0
1160197|NCT03334396|2280810|FG003|Overall Study|Pregnancy|0
1160198|NCT03334396|2280811|FG004|Overall Study|Pregnancy|0
1160199|NCT03334396|2280812|FG005|Overall Study|Pregnancy|0
1160200|NCT03334396|2280813|FG006|Overall Study|Pregnancy|0
1160201|NCT03334396|2280814|FG007|Overall Study|Pregnancy|0
1160202|NCT03334396|2280807|FG000|Overall Study|Ineligible|0
1160203|NCT03334396|2280808|FG001|Overall Study|Ineligible|1
1160204|NCT03334396|2280809|FG002|Overall Study|Ineligible|0
1160205|NCT03334396|2280810|FG003|Overall Study|Ineligible|0
1160206|NCT03334396|2280811|FG004|Overall Study|Ineligible|0
1160207|NCT03334396|2280812|FG005|Overall Study|Ineligible|0
1160208|NCT03334396|2280813|FG006|Overall Study|Ineligible|0
1160209|NCT03334396|2280814|FG007|Overall Study|Ineligible|0
1160210|NCT03334396|2280807|FG000|Overall Study|Started New Job|1
1160211|NCT03334396|2280808|FG001|Overall Study|Started New Job|0
1160212|NCT03334396|2280809|FG002|Overall Study|Started New Job|0
1160213|NCT03334396|2280810|FG003|Overall Study|Started New Job|0
1160214|NCT03334396|2280811|FG004|Overall Study|Started New Job|0
1160215|NCT03334396|2280812|FG005|Overall Study|Started New Job|0
1160216|NCT03334396|2280813|FG006|Overall Study|Started New Job|0
1160217|NCT03334396|2280814|FG007|Overall Study|Started New Job|0
1160218|NCT03334422|2280835|FG000|Overall Study|Adverse Event|1
1160219|NCT03334422|2280836|FG001|Overall Study|Adverse Event|3
1160220|NCT03334422|2280837|FG002|Overall Study|Adverse Event|2
1160221|NCT03334422|2280838|FG003|Overall Study|Adverse Event|2
1160222|NCT03334422|2280835|FG000|Overall Study|Lack of Efficacy|10
1160223|NCT03334422|2280836|FG001|Overall Study|Lack of Efficacy|2
1160224|NCT03334422|2280837|FG002|Overall Study|Lack of Efficacy|7
1160225|NCT03334422|2280838|FG003|Overall Study|Lack of Efficacy|3
1160226|NCT03334422|2280835|FG000|Overall Study|Withdrawal by Subject|8
1160227|NCT03334422|2280836|FG001|Overall Study|Withdrawal by Subject|3
1160228|NCT03334422|2280837|FG002|Overall Study|Withdrawal by Subject|1
1160229|NCT03334422|2280838|FG003|Overall Study|Withdrawal by Subject|0
1160230|NCT03334422|2280835|FG000|Overall Study|Lost to Follow-up|0
1160231|NCT03334422|2280836|FG001|Overall Study|Lost to Follow-up|0
1160232|NCT03334422|2280837|FG002|Overall Study|Lost to Follow-up|0
1160233|NCT03334422|2280838|FG003|Overall Study|Lost to Follow-up|1
1160234|NCT03334422|2280835|FG000|Overall Study|Inability to obtain laboratory samples|0
1160235|NCT03334422|2280836|FG001|Overall Study|Inability to obtain laboratory samples|1
1160236|NCT03334422|2280837|FG002|Overall Study|Inability to obtain laboratory samples|0
1160237|NCT03334422|2280838|FG003|Overall Study|Inability to obtain laboratory samples|0
1160238|NCT03334422|2280835|FG000|Overall Study|Pregnancy|0
1160239|NCT03334422|2280836|FG001|Overall Study|Pregnancy|1
1160240|NCT03334422|2280837|FG002|Overall Study|Pregnancy|0
1160241|NCT03334422|2280838|FG003|Overall Study|Pregnancy|0
1160242|NCT03334448|2280853|FG000|Washout|Personal Reason|0
1160243|NCT03334448|2280854|FG001|Washout|Personal Reason|1
1160244|NCT03334448|2280855|FG002|Washout|Personal Reason|0
1160245|NCT03334448|2280856|FG003|Washout|Personal Reason|0
1160246|NCT03334448|2280853|FG000|Washout|Protocol Violation|0
1160247|NCT03334448|2280854|FG001|Washout|Protocol Violation|0
1160248|NCT03334448|2280855|FG002|Washout|Protocol Violation|0
1160249|NCT03334448|2280856|FG003|Washout|Protocol Violation|1
1160250|NCT03334630|2280864|FG000|Overall Study|Withdrawal by Subject|7
1160251|NCT03334630|2280865|FG001|Overall Study|Withdrawal by Subject|7
1160252|NCT03334630|2280864|FG000|Overall Study|Lost to Follow-up|3
1160253|NCT03334630|2280865|FG001|Overall Study|Lost to Follow-up|1
1160254|NCT03334630|2280864|FG000|Overall Study|Adverse Event|0
1160255|NCT03334630|2280865|FG001|Overall Study|Adverse Event|1
1160256|NCT03334630|2280864|FG000|Overall Study|Physician Decision|1
1160257|NCT03334630|2280865|FG001|Overall Study|Physician Decision|1
1160258|NCT03334630|2280864|FG000|Overall Study|Enrollment closed|2
1160259|NCT03334630|2280865|FG001|Overall Study|Enrollment closed|1
1160260|NCT03334630|2280864|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0
1160261|NCT03334630|2280865|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1
1160262|NCT03334630|2280864|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1
1160263|NCT03334630|2280865|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1
1160264|NCT03334695|2280873|FG000|Overall Study|Lost to Follow-up|3
1160265|NCT03334695|2280874|FG001|Overall Study|Lost to Follow-up|3
1160266|NCT03334695|2280873|FG000|Overall Study|Physician Decision|1
1160267|NCT03334695|2280874|FG001|Overall Study|Physician Decision|2
1160268|NCT03334695|2280873|FG000|Overall Study|Protocol Violation|0
1160269|NCT03334695|2280874|FG001|Overall Study|Protocol Violation|1
1160270|NCT03334721|2280884|FG000|Overall Study|Withdrawal by Subject|1
1160271|NCT03334721|2280885|FG001|Overall Study|Withdrawal by Subject|0
1160272|NCT03334721|2280884|FG000|Overall Study|No longer met inclusion/exclusion criter|1
1160273|NCT03334721|2280885|FG001|Overall Study|No longer met inclusion/exclusion criter|0
1160274|NCT03334747|2280917|FG000|Treatment Phase|Technical problems|0
1160275|NCT03334747|2280918|FG001|Treatment Phase|Technical problems|0
1160276|NCT03334747|2280919|FG002|Treatment Phase|Technical problems|0
1160277|NCT03334747|2280920|FG003|Treatment Phase|Technical problems|0
1160278|NCT03334747|2280921|FG004|Treatment Phase|Technical problems|1
1160279|NCT03334747|2280922|FG005|Treatment Phase|Technical problems|0
1160280|NCT03334747|2280923|FG006|Treatment Phase|Technical problems|0
1160281|NCT03334747|2280924|FG007|Treatment Phase|Technical problems|0
1160282|NCT03334747|2280925|FG008|Treatment Phase|Technical problems|0
1160283|NCT03334747|2280917|FG000|Treatment Phase|Subject/guardian decision|1
1160284|NCT03334747|2280918|FG001|Treatment Phase|Subject/guardian decision|0
1160285|NCT03334747|2280919|FG002|Treatment Phase|Subject/guardian decision|0
1160286|NCT03334747|2280920|FG003|Treatment Phase|Subject/guardian decision|0
1160287|NCT03334747|2280921|FG004|Treatment Phase|Subject/guardian decision|0
1160288|NCT03334747|2280922|FG005|Treatment Phase|Subject/guardian decision|1
1160289|NCT03334747|2280923|FG006|Treatment Phase|Subject/guardian decision|0
1160290|NCT03334747|2280924|FG007|Treatment Phase|Subject/guardian decision|0
1160291|NCT03334747|2280925|FG008|Treatment Phase|Subject/guardian decision|0
1160292|NCT03334747|2280917|FG000|Follow-Up Phase|Subject/guardian decision|0
1160293|NCT03334747|2280918|FG001|Follow-Up Phase|Subject/guardian decision|0
1160294|NCT03334747|2280919|FG002|Follow-Up Phase|Subject/guardian decision|0
1160295|NCT03334747|2280920|FG003|Follow-Up Phase|Subject/guardian decision|0
1160296|NCT03334747|2280921|FG004|Follow-Up Phase|Subject/guardian decision|0
1160297|NCT03334747|2280922|FG005|Follow-Up Phase|Subject/guardian decision|0
1160298|NCT03334747|2280923|FG006|Follow-Up Phase|Subject/guardian decision|1
1160299|NCT03334747|2280924|FG007|Follow-Up Phase|Subject/guardian decision|0
1160300|NCT03334747|2280925|FG008|Follow-Up Phase|Subject/guardian decision|1
1160301|NCT03334903|2280967|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1
1160302|NCT03334903|2280968|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0
1160303|NCT03334903|2280967|FG000|Overall Study|Protocol Violation|1
1160304|NCT03334903|2280968|FG001|Overall Study|Protocol Violation|3
1160305|NCT03334903|2280967|FG000|Overall Study|Surgery postponed|1
1160306|NCT03334903|2280968|FG001|Overall Study|Surgery postponed|0
1160307|NCT03334903|2280967|FG000|Overall Study|Adverse Event|1
1160308|NCT03334903|2280968|FG001|Overall Study|Adverse Event|1
1160309|NCT03334903|2280967|FG000|Overall Study|Withdrawal by Subject|0
1160310|NCT03334903|2280968|FG001|Overall Study|Withdrawal by Subject|1
1160311|NCT03335150|2280976|FG000|Overall Study|Withdrawal by Subject|10
1160312|NCT03335150|2280977|FG001|Overall Study|Withdrawal by Subject|4
1160313|NCT03335150|2280976|FG000|Overall Study|Adverse Event|0
1160314|NCT03335150|2280977|FG001|Overall Study|Adverse Event|1
1160315|NCT03335566|2281053|FG000|Overall Study|Adverse Event|0
1160316|NCT03335566|2281054|FG001|Overall Study|Adverse Event|1
1160317|NCT03335566|2281053|FG000|Overall Study|Lost to Follow-up|1
1160318|NCT03335566|2281054|FG001|Overall Study|Lost to Follow-up|0
1160319|NCT03335566|2281053|FG000|Overall Study|Technical Problems|1
1160320|NCT03335566|2281054|FG001|Overall Study|Technical Problems|0
1160321|NCT03335566|2281053|FG000|Overall Study|Protocol Violation|1
1160322|NCT03335566|2281054|FG001|Overall Study|Protocol Violation|0
1160323|NCT03335566|2281053|FG000|Overall Study|Other than specified above|1
1160324|NCT03335566|2281054|FG001|Overall Study|Other than specified above|2
1160325|NCT03336502|2281083|FG000|Overall Study|Physician Decision|0
1160326|NCT03336502|2281084|FG001|Overall Study|Physician Decision|1
1160327|NCT03336502|2281083|FG000|Overall Study|Prohibited Drugs|1
1160328|NCT03336502|2281084|FG001|Overall Study|Prohibited Drugs|1
1160329|NCT03336502|2281083|FG000|Overall Study|Death|1
1160330|NCT03336502|2281084|FG001|Overall Study|Death|2
1160331|NCT03336502|2281083|FG000|Overall Study|Adverse Event|2
1160332|NCT03336502|2281084|FG001|Overall Study|Adverse Event|5
1160333|NCT03337139|2281105|FG000|Phase I|Withdrawal by Subject|10
1160334|NCT03337139|2281106|FG001|Phase I|Withdrawal by Subject|0
1160335|NCT03337152|2281114|FG000|Overall Study|Physician Decision|1
1160336|NCT03337152|2281115|FG001|Overall Study|Physician Decision|0
1160337|NCT03337152|2281114|FG000|Overall Study|Lost to Follow-up|1
1160338|NCT03337152|2281115|FG001|Overall Study|Lost to Follow-up|3
1160339|NCT03337152|2281114|FG000|Overall Study|Adverse Event|3
1160340|NCT03337152|2281115|FG001|Overall Study|Adverse Event|1
1160341|NCT03337152|2281114|FG000|Overall Study|Stopped drug dosing due to study halt|6
1160342|NCT03337152|2281115|FG001|Overall Study|Stopped drug dosing due to study halt|7
1160343|NCT03337308|2281127|FG000|Overall Study|Adverse Event|2
1160344|NCT03337308|2281128|FG001|Overall Study|Adverse Event|3
1160345|NCT03337308|2281129|FG002|Overall Study|Adverse Event|3
1160346|NCT03337308|2281130|FG003|Overall Study|Adverse Event|1
1160347|NCT03337308|2281127|FG000|Overall Study|Lost to Follow-up|1
1160348|NCT03337308|2281128|FG001|Overall Study|Lost to Follow-up|2
1160349|NCT03337308|2281129|FG002|Overall Study|Lost to Follow-up|0
1160350|NCT03337308|2281130|FG003|Overall Study|Lost to Follow-up|0
1160351|NCT03337308|2281127|FG000|Overall Study|Withdrawal by Subject|2
1160352|NCT03337308|2281128|FG001|Overall Study|Withdrawal by Subject|1
1160353|NCT03337308|2281129|FG002|Overall Study|Withdrawal by Subject|2
1160354|NCT03337308|2281130|FG003|Overall Study|Withdrawal by Subject|1
1160355|NCT03337308|2281127|FG000|Overall Study|Protocol Violation|0
1160356|NCT03337308|2281128|FG001|Overall Study|Protocol Violation|1
1160357|NCT03337308|2281129|FG002|Overall Study|Protocol Violation|0
1160358|NCT03337308|2281130|FG003|Overall Study|Protocol Violation|0
1160359|NCT03337477|2281142|FG000|Overall Study|not categorized into the listed ones|11
1160360|NCT03337477|2281143|FG001|Overall Study|not categorized into the listed ones|9
1160361|NCT03337477|2281142|FG000|Overall Study|Withdrawal by Subject|0
1160362|NCT03337477|2281143|FG001|Overall Study|Withdrawal by Subject|1
1160363|NCT03337477|2281142|FG000|Overall Study|Death|0
1160364|NCT03337477|2281143|FG001|Overall Study|Death|1
1160365|NCT03337477|2281142|FG000|Overall Study|Lost to Follow-up|0
1160366|NCT03337477|2281143|FG001|Overall Study|Lost to Follow-up|2
1160367|NCT03337490|2281154|FG000|Overall Study|Withdrawal by Subject|1
1160368|NCT03337490|2281155|FG001|Overall Study|Withdrawal by Subject|0
1160369|NCT03337490|2281156|FG002|Overall Study|Withdrawal by Subject|0
1160370|NCT03337490|2281154|FG000|Overall Study|Lack of Efficacy|10
1160371|NCT03337490|2281155|FG001|Overall Study|Lack of Efficacy|12
1160372|NCT03337490|2281156|FG002|Overall Study|Lack of Efficacy|35
1160373|NCT03337490|2281154|FG000|Overall Study|Physician Decision|0
1160374|NCT03337490|2281155|FG001|Overall Study|Physician Decision|1
1160375|NCT03337490|2281156|FG002|Overall Study|Physician Decision|0
1160376|NCT03337490|2281154|FG000|Overall Study|Lost to Follow-up|0
1160377|NCT03337490|2281155|FG001|Overall Study|Lost to Follow-up|1
1160378|NCT03337490|2281156|FG002|Overall Study|Lost to Follow-up|0
1160379|NCT03337542|2281164|FG000|Overall Study|Withdrew Consent|17
1160380|NCT03337542|2281164|FG000|Overall Study|Allergic Adverse Event|1
1160381|NCT03337542|2281164|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1
1160382|NCT03337542|2281164|FG000|Overall Study|Lost to Follow-up|1
1160383|NCT03337542|2281164|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1
1160384|NCT03338010|2281171|FG000|Overall Study|Withdrawal by Subject|14
1160385|NCT03338010|2281172|FG001|Overall Study|Withdrawal by Subject|8
1160386|NCT03338010|2281171|FG000|Overall Study|Lost to Follow-up|4
1160387|NCT03338010|2281172|FG001|Overall Study|Lost to Follow-up|2
1018456|NCT01571362|2043284|FG000|Double-Blind Treatment Period|Other - unspecified|0
1018457|NCT01571362|2043285|FG001|Double-Blind Treatment Period|Other - unspecified|6
1018458|NCT01571362|2043286|FG002|Double-Blind Treatment Period|Other - unspecified|1
1018459|NCT01571453|2043305|FG000|Overall Study|Adverse Event|14
1018460|NCT01571453|2043306|FG001|Overall Study|Adverse Event|32
1018461|NCT01571453|2043305|FG000|Overall Study|Lack of Efficacy|8
1018462|NCT01571453|2043306|FG001|Overall Study|Lack of Efficacy|3
1018463|NCT01571453|2043305|FG000|Overall Study|Non-compliance|2
1018464|NCT01571453|2043306|FG001|Overall Study|Non-compliance|4
1018465|NCT01571453|2043305|FG000|Overall Study|Protocol Violation|1
1018466|NCT01571453|2043306|FG001|Overall Study|Protocol Violation|5
1018467|NCT01571453|2043305|FG000|Overall Study|Withdrawal of consent|5
1018468|NCT01571453|2043306|FG001|Overall Study|Withdrawal of consent|13
1018469|NCT01571453|2043305|FG000|Overall Study|Lost to Follow-up|4
1018470|NCT01571453|2043306|FG001|Overall Study|Lost to Follow-up|2
1018471|NCT01571453|2043305|FG000|Overall Study|Administrative or other reason(s)|4
1018472|NCT01571453|2043306|FG001|Overall Study|Administrative or other reason(s)|3
1018473|NCT01571596|2043319|FG000|Overall Study|Adverse Event|2
1018474|NCT01571596|2043320|FG001|Overall Study|Adverse Event|0
1018475|NCT01571596|2043321|FG002|Overall Study|Adverse Event|0
1018476|NCT01571596|2043319|FG000|Overall Study|Study Terminated by the Sponsor|0
1018477|NCT01571596|2043320|FG001|Overall Study|Study Terminated by the Sponsor|1
1018478|NCT01571596|2043321|FG002|Overall Study|Study Terminated by the Sponsor|1
1018479|NCT01572038|2043331|FG000|Overall Study|Death|648
1018480|NCT01572038|2043331|FG000|Overall Study|Withdrawal by Subject|204
1018481|NCT01572038|2043331|FG000|Overall Study|Lost to Follow-up|81
1018482|NCT01572038|2043331|FG000|Overall Study|Physician Decision|20
1018483|NCT01572038|2043331|FG000|Overall Study|Patient Decision|14
1018484|NCT01572038|2043331|FG000|Overall Study|Progressive Disease|8
1018485|NCT01572038|2043331|FG000|Overall Study|Site Closed Before Completing Form|6
1018486|NCT01572038|2043331|FG000|Overall Study|Enrolled into Another Trial|3
1018487|NCT01572038|2043331|FG000|Overall Study|Participated in Another Trial|3
903591|NCT00749944|1877957|FG001|Overall Study|Lost to Follow-up|1
903592|NCT00749944|1877956|FG000|Overall Study|Other|1
903593|NCT00749944|1877957|FG001|Overall Study|Other|0
903594|NCT00749944|1877956|FG000|Overall Study|Withdrawal by Subject|2
903595|NCT00749944|1877957|FG001|Overall Study|Withdrawal by Subject|0
903596|NCT00749996|1877976|FG000|Overall Study|Lost to Follow-up|7
903597|NCT00749996|1877977|FG001|Overall Study|Lost to Follow-up|4
903598|NCT00749996|1877976|FG000|Overall Study|Withdrawal by Subject|5
903599|NCT00749996|1877977|FG001|Overall Study|Withdrawal by Subject|4
903600|NCT00749996|1877976|FG000|Overall Study|Protocol Violation|2
903601|NCT00749996|1877977|FG001|Overall Study|Protocol Violation|3
903602|NCT00749996|1877976|FG000|Overall Study|Physician Decision|2
903603|NCT00749996|1877977|FG001|Overall Study|Physician Decision|0
1160388|NCT03338010|2281171|FG000|Overall Study|Adverse Event|3
1160389|NCT03338010|2281172|FG001|Overall Study|Adverse Event|2
1160390|NCT03338010|2281171|FG000|Overall Study|Physician Decision|2
1160391|NCT03338010|2281172|FG001|Overall Study|Physician Decision|2
1160392|NCT03338010|2281171|FG000|Overall Study|Non-Compliance with Study Drug|0
1160393|NCT03338010|2281172|FG001|Overall Study|Non-Compliance with Study Drug|3
1160394|NCT03338010|2281171|FG000|Overall Study|Protocol Violation|0
1160395|NCT03338010|2281172|FG001|Overall Study|Protocol Violation|1
1160396|NCT03338023|2281180|FG000|Overall Study|Withdrawal by Subject|3
1160397|NCT03338023|2281181|FG001|Overall Study|Withdrawal by Subject|4
1160398|NCT03338023|2281180|FG000|Overall Study|Protocol Violation|3
1160399|NCT03338023|2281181|FG001|Overall Study|Protocol Violation|3
1160400|NCT03338023|2281180|FG000|Overall Study|Lost to Follow-up|2
1160401|NCT03338023|2281181|FG001|Overall Study|Lost to Follow-up|1
1160402|NCT03338023|2281180|FG000|Overall Study|Physician Decision|1
1160403|NCT03338023|2281181|FG001|Overall Study|Physician Decision|2
1160404|NCT03338062|2281204|FG000|Overall Study|Alternative Therapy|1
1160405|NCT03338062|2281205|FG001|Overall Study|Alternative Therapy|0
1160406|NCT03338296|2281214|FG000|Overall Study|Adverse Event|0
1160407|NCT03338296|2281215|FG001|Overall Study|Adverse Event|1
1160408|NCT03338296|2281214|FG000|Overall Study|Withdrawal by Subject|14
1160409|NCT03338296|2281215|FG001|Overall Study|Withdrawal by Subject|13
1160410|NCT03338296|2281214|FG000|Overall Study|Lost to Follow-up|10
1160411|NCT03338296|2281215|FG001|Overall Study|Lost to Follow-up|10
1160412|NCT03338296|2281214|FG000|Overall Study|Study Terminated by Sponsor|77
1160413|NCT03338296|2281215|FG001|Overall Study|Study Terminated by Sponsor|76
1160414|NCT03338296|2281214|FG000|Overall Study|Other|2
1160415|NCT03338296|2281215|FG001|Overall Study|Other|7
1160416|NCT03338296|2281214|FG000|Overall Study|Missing|0
1160417|NCT03338296|2281215|FG001|Overall Study|Missing|1
1160418|NCT03338400|2281223|FG000|Overall Study|Lost to Follow-up|1
1160419|NCT03338400|2281224|FG001|Overall Study|Lost to Follow-up|2
1160420|NCT03338569|2281257|FG000|Overall Study|Physician Decision|8
1160421|NCT03338569|2281258|FG001|Overall Study|Physician Decision|3
1160422|NCT03338569|2281257|FG000|Overall Study|Withdrawal by Subject|0
1160423|NCT03338569|2281258|FG001|Overall Study|Withdrawal by Subject|1
1160424|NCT03338569|2281257|FG000|Overall Study|Lost to Follow-up|0
1160425|NCT03338569|2281258|FG001|Overall Study|Lost to Follow-up|1
1160426|NCT03338673|2281266|FG000|Overall Study|Lost to Follow-up|1
1160427|NCT03338673|2281267|FG001|Overall Study|Lost to Follow-up|1
1160428|NCT03338816|2281291|FG000|6-Month Double-blind Period|Adverse Event|0
1160429|NCT03338816|2281292|FG001|6-Month Double-blind Period|Adverse Event|1
1160430|NCT03338816|2281291|FG000|Open-Label Extension Period|Ongoing in Study|46
1160431|NCT03338816|2281292|FG001|Open-Label Extension Period|Ongoing in Study|47
1160432|NCT03338855|2281300|FG000|Overall Study|Withdrawn as birth control pill stopped|1
1160433|NCT03338855|2281301|FG001|Overall Study|Withdrawn as birth control pill stopped|0
1160434|NCT03338894|2281307|FG000|Overall Study|not able able to attend 9 or more classes|10
1160435|NCT03338998|2281313|FG000|Treatment Period|Withdrawal by Subject|1
1160436|NCT03338998|2281314|FG001|Treatment Period|Withdrawal by Subject|1
1160437|NCT03338998|2281313|FG000|Treatment Period|Adverse Event|0
1160438|NCT03338998|2281314|FG001|Treatment Period|Adverse Event|2
1160439|NCT03338998|2281313|FG000|Treatment Period|Protocol deviation|1
1160440|NCT03338998|2281314|FG001|Treatment Period|Protocol deviation|0
1160441|NCT03338998|2281313|FG000|Treatment Period|Physician Decision|2
1160442|NCT03338998|2281314|FG001|Treatment Period|Physician Decision|0
1160443|NCT03338998|2281313|FG000|Treatment Period|Subject failed swallow test|4
1160444|NCT03338998|2281314|FG001|Treatment Period|Subject failed swallow test|0
1160445|NCT03338998|2281313|FG000|Safety Follow-Up Period|Adverse Event|0
1160446|NCT03338998|2281314|FG001|Safety Follow-Up Period|Adverse Event|1
1160447|NCT03338998|2281313|FG000|Safety Follow-Up Period|Protocol deviation|1
1160448|NCT03338998|2281314|FG001|Safety Follow-Up Period|Protocol deviation|0
1160449|NCT03338998|2281313|FG000|Safety Follow-Up Period|Lost to Follow-up|1
1160450|NCT03338998|2281314|FG001|Safety Follow-Up Period|Lost to Follow-up|0
1160451|NCT03339219|2281334|FG000|Overall Study|Death|12
1160452|NCT03339219|2281334|FG000|Overall Study|Site Terminated by Sponsor|22
1160453|NCT03339219|2281334|FG000|Overall Study|Withdrawal by Subject|1
1160454|NCT03339297|2281340|FG000|Overall Study|Relapse of Hematologic Disease|1
1160455|NCT03339297|2281341|FG001|Overall Study|Relapse of Hematologic Disease|0
1160456|NCT03339297|2281340|FG000|Overall Study|Death|10
1160457|NCT03339297|2281341|FG001|Overall Study|Death|7
1160458|NCT03339297|2281340|FG000|Overall Study|Hepatic Candidosis|1
1160459|NCT03339297|2281341|FG001|Overall Study|Hepatic Candidosis|0
1160460|NCT03339297|2281340|FG000|Overall Study|Adverse Event, Serious Fatal|0
1160461|NCT03339297|2281341|FG001|Overall Study|Adverse Event, Serious Fatal|2
1160462|NCT03339297|2281340|FG000|Overall Study|Consent Withdrawn by Participant|3
1160463|NCT03339297|2281341|FG001|Overall Study|Consent Withdrawn by Participant|3
1160464|NCT03339297|2281340|FG000|Overall Study|Disease Relapse|2
1160465|NCT03339297|2281341|FG001|Overall Study|Disease Relapse|0
1160466|NCT03339297|2281340|FG000|Overall Study|Physician Decision|1
1160467|NCT03339297|2281341|FG001|Overall Study|Physician Decision|1
1160468|NCT03339297|2281340|FG000|Overall Study|Relapse of Disease New Transplant Performed|1
1160469|NCT03339297|2281341|FG001|Overall Study|Relapse of Disease New Transplant Performed|0
1160470|NCT03339297|2281340|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1
1160471|NCT03339297|2281341|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0
1160472|NCT03339297|2281340|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1
1160473|NCT03339297|2281341|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0
1160474|NCT03339297|2281340|FG000|Overall Study|Adverse Event, Non-fatal|1
1160475|NCT03339297|2281341|FG001|Overall Study|Adverse Event, Non-fatal|0
1160476|NCT03339297|2281340|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0
1160477|NCT03339297|2281341|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1
1160478|NCT03339297|2281340|FG000|Overall Study|Patient Was Not Eligible|1
1160479|NCT03339297|2281341|FG001|Overall Study|Patient Was Not Eligible|0
1160480|NCT03339453|2281349|FG000|First Visit of Glucagon Treatment|Adverse Event|0
1160481|NCT03339453|2281350|FG001|First Visit of Glucagon Treatment|Adverse Event|1
1160482|NCT03339583|2281371|FG000|First Intervention (14 Days)|Adverse Event|1
1160483|NCT03339583|2281372|FG001|First Intervention (14 Days)|Adverse Event|0
1160484|NCT03339583|2281371|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0
1160485|NCT03339583|2281372|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1
1160486|NCT03339583|2281371|FG000|Second Intervention (14 Days)|Adverse Event|0
1160487|NCT03339583|2281372|FG001|Second Intervention (14 Days)|Adverse Event|1
1160488|NCT03339583|2281371|FG000|Follow-up (14 Days)|Physician Decision|6
1160489|NCT03339583|2281372|FG001|Follow-up (14 Days)|Physician Decision|3
1160490|NCT03339713|2281382|FG000|Overall Study|Lost to Follow-up|2
1160491|NCT03339713|2281383|FG001|Overall Study|Lost to Follow-up|1
1160492|NCT03339713|2281382|FG000|Overall Study|Protocol Violation|1
1160493|NCT03339713|2281383|FG001|Overall Study|Protocol Violation|0
1160494|NCT03339713|2281382|FG000|Overall Study|Withdrawal by Subject|1
1160495|NCT03339713|2281383|FG001|Overall Study|Withdrawal by Subject|1
1160496|NCT03339726|2281394|FG000|Overall Study|Withdrawal by Subject|1
1160497|NCT03339726|2281395|FG001|Overall Study|Withdrawal by Subject|0
1160498|NCT03339726|2281396|FG002|Overall Study|Withdrawal by Subject|0
1160499|NCT03339726|2281394|FG000|Overall Study|Lost to Follow-up|0
1160500|NCT03339726|2281395|FG001|Overall Study|Lost to Follow-up|1
1160501|NCT03339726|2281396|FG002|Overall Study|Lost to Follow-up|0
1160502|NCT03340025|2281426|FG000|Overall Study|Lost to Follow-up|2
1160503|NCT03340025|2281427|FG001|Overall Study|Lost to Follow-up|2
1160504|NCT03340961|2281511|FG000|Overall Study|Adverse Event|1
1160505|NCT03340961|2281512|FG001|Overall Study|Adverse Event|3
1160506|NCT03340961|2281513|FG002|Overall Study|Adverse Event|2
1160507|NCT03340961|2281514|FG003|Overall Study|Adverse Event|4
1160508|NCT03340961|2281511|FG000|Overall Study|Lost to Follow-up|0
1160509|NCT03340961|2281512|FG001|Overall Study|Lost to Follow-up|1
1160510|NCT03340961|2281513|FG002|Overall Study|Lost to Follow-up|0
1160511|NCT03340961|2281514|FG003|Overall Study|Lost to Follow-up|1
1160512|NCT03340961|2281511|FG000|Overall Study|Withdrawal by Subject|3
1160513|NCT03340961|2281512|FG001|Overall Study|Withdrawal by Subject|2
1160514|NCT03340961|2281513|FG002|Overall Study|Withdrawal by Subject|4
1160515|NCT03340961|2281514|FG003|Overall Study|Withdrawal by Subject|7
1160516|NCT03340961|2281511|FG000|Overall Study|Use of prohibited treatment|0
1160517|NCT03340961|2281512|FG001|Overall Study|Use of prohibited treatment|3
1160518|NCT03340961|2281513|FG002|Overall Study|Use of prohibited treatment|2
1160519|NCT03340961|2281514|FG003|Overall Study|Use of prohibited treatment|4
1160520|NCT03340961|2281511|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0
1160521|NCT03340961|2281512|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1
1160522|NCT03340961|2281513|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0
1160523|NCT03340961|2281514|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1
1160524|NCT03340961|2281511|FG000|Overall Study|Subject developed an exclusion criterion|0
1160525|NCT03340961|2281512|FG001|Overall Study|Subject developed an exclusion criterion|1
1160526|NCT03340961|2281513|FG002|Overall Study|Subject developed an exclusion criterion|0
1160527|NCT03340961|2281514|FG003|Overall Study|Subject developed an exclusion criterion|0
1160528|NCT03340961|2281511|FG000|Overall Study|Protocol Violation|1
1160529|NCT03340961|2281512|FG001|Overall Study|Protocol Violation|0
1160530|NCT03340961|2281513|FG002|Overall Study|Protocol Violation|1
1160531|NCT03340961|2281514|FG003|Overall Study|Protocol Violation|0
1160532|NCT03340961|2281511|FG000|Overall Study|Adverse Event|1
1160533|NCT03340961|2281512|FG001|Overall Study|Adverse Event|1
1160534|NCT03340961|2281513|FG002|Overall Study|Adverse Event|0
1160535|NCT03340961|2281514|FG003|Overall Study|Adverse Event|0
1160536|NCT03340961|2281511|FG000|Overall Study|Lack of Efficacy|0
1160537|NCT03340961|2281512|FG001|Overall Study|Lack of Efficacy|0
1160538|NCT03340961|2281513|FG002|Overall Study|Lack of Efficacy|0
1160539|NCT03340961|2281514|FG003|Overall Study|Lack of Efficacy|1
1160540|NCT03341273|2281526|FG000|Overall Study|Lost to Follow-up|7
1160541|NCT03341273|2281527|FG001|Overall Study|Lost to Follow-up|7
1160542|NCT03341273|2281526|FG000|Overall Study|Withdrawal by Subject|4
1160543|NCT03341273|2281527|FG001|Overall Study|Withdrawal by Subject|2
1160544|NCT03341273|2281526|FG000|Overall Study|Physician Decision|1
1160545|NCT03341273|2281527|FG001|Overall Study|Physician Decision|0
1160546|NCT03341273|2281526|FG000|Overall Study|Protocol Violation|0
1160547|NCT03341273|2281527|FG001|Overall Study|Protocol Violation|1
1160548|NCT03341273|2281526|FG000|Overall Study|Enrolled but Treatment Not Administered|6
1160549|NCT03341273|2281527|FG001|Overall Study|Enrolled but Treatment Not Administered|1
1160550|NCT03341273|2281526|FG000|Overall Study|Became ineligible after enrollment|1
1160551|NCT03341273|2281527|FG001|Overall Study|Became ineligible after enrollment|0
1160552|NCT03341273|2281526|FG000|Overall Study|Not Eligible at Enrollment|0
1160553|NCT03341273|2281527|FG001|Overall Study|Not Eligible at Enrollment|1
1160554|NCT03341273|2281526|FG000|Overall Study|Participant incarcerated|1
1160555|NCT03341273|2281527|FG001|Overall Study|Participant incarcerated|0
1160556|NCT03341299|2281533|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0
1160557|NCT03341299|2281534|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0
1160558|NCT03341299|2281535|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1
1160559|NCT03341299|2281536|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0
1160560|NCT03341312|2281548|FG000|Period 1|Withdrawal by Subject|0
1160561|NCT03341312|2281549|FG001|Period 1|Withdrawal by Subject|1
1160562|NCT03341312|2281550|FG002|Period 1|Withdrawal by Subject|0
1160563|NCT03341312|2281551|FG003|Period 1|Withdrawal by Subject|0
1160564|NCT03341507|2281563|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34
1160565|NCT03341533|2281569|FG000|Overall Study|Withdrawal by Subject|1
1160566|NCT03341533|2281570|FG001|Overall Study|Withdrawal by Subject|1
1160567|NCT03341533|2281569|FG000|Overall Study|Not eligible after randomization|2
1160568|NCT03341533|2281570|FG001|Overall Study|Not eligible after randomization|1
1160569|NCT03341637|2281582|FG000|Overall Study|Lost to Follow-up|1
1160570|NCT03341637|2281583|FG001|Overall Study|Lost to Follow-up|0
1160571|NCT03341637|2281582|FG000|Overall Study|Withdrawal by Subject|3
1160572|NCT03341637|2281583|FG001|Overall Study|Withdrawal by Subject|3
1160573|NCT03341637|2281582|FG000|Overall Study|Reason not Specified|1
1160574|NCT03341637|2281583|FG001|Overall Study|Reason not Specified|1
1160575|NCT03341923|2281613|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0
1160576|NCT03341923|2281614|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1
1160577|NCT03342001|2281631|FG000|Overall Study|Adverse Event|1
1160578|NCT03342001|2281631|FG000|Overall Study|Lost to Follow-up|1
1160579|NCT03342053|2281637|FG000|Overall Study|Adverse Event|2
1160580|NCT03342053|2281638|FG001|Overall Study|Adverse Event|0
1160581|NCT03342053|2281637|FG000|Overall Study|Withdrawal by Subject|0
1160582|NCT03342053|2281638|FG001|Overall Study|Withdrawal by Subject|1
1160583|NCT03342404|2281646|FG000|Overall Study|Withdrawal by Subject|9
1160584|NCT03342404|2281647|FG001|Overall Study|Withdrawal by Subject|10
1160585|NCT03342404|2281646|FG000|Overall Study|Lack of Efficacy|1
1160586|NCT03342404|2281647|FG001|Overall Study|Lack of Efficacy|17
1160587|NCT03342404|2281646|FG000|Overall Study|Adverse Event|3
1160588|NCT03342404|2281647|FG001|Overall Study|Adverse Event|4
1160589|NCT03342404|2281646|FG000|Overall Study|Noncompliance with study drug|1
1160590|NCT03342404|2281647|FG001|Overall Study|Noncompliance with study drug|0
1160591|NCT03342404|2281646|FG000|Overall Study|Other reasons|1
1160592|NCT03342404|2281647|FG001|Overall Study|Other reasons|0
1160593|NCT03342469|2281655|FG000|Overall Study|Withdrawal by Subject|0
1160594|NCT03342469|2281656|FG001|Overall Study|Withdrawal by Subject|1
1160595|NCT03342469|2281657|FG002|Overall Study|Withdrawal by Subject|0
1160596|NCT03342469|2281658|FG003|Overall Study|Withdrawal by Subject|0
1160597|NCT03342560|2281669|FG000|Overall Study|Lost to Follow-up|2
1160598|NCT03342690|2281677|FG000|Overall Study|Missing Information|9
1160599|NCT03342690|2281677|FG000|Overall Study|Protocol Violation|16
1160600|NCT03342898|2281684|FG000|Overall Study|Adverse Event|3
1160601|NCT03342898|2281685|FG001|Overall Study|Adverse Event|1
1160602|NCT03342898|2281686|FG002|Overall Study|Adverse Event|0
1160603|NCT03342898|2281684|FG000|Overall Study|Lost to Follow-up|44
1018488|NCT01572038|2043331|FG000|Overall Study|Termination by Sponsor|2
1018489|NCT01572038|2043331|FG000|Overall Study|Patient Deterioration|1
1018490|NCT01572038|2043331|FG000|Overall Study|Sponsor Decision|1
1018491|NCT01572389|2043379|FG000|Overall Study|Death|1
1018492|NCT01572389|2043380|FG001|Overall Study|Death|3
1018493|NCT01572389|2043379|FG000|Overall Study|Withdrawal by Subject|14
1018494|NCT01572389|2043380|FG001|Overall Study|Withdrawal by Subject|2
1018495|NCT01572389|2043379|FG000|Overall Study|Lost to Follow-up|25
903604|NCT00749996|1877976|FG000|Overall Study|Pregnancy|0
903605|NCT00749996|1877977|FG001|Overall Study|Pregnancy|2
1018496|NCT01572389|2043380|FG001|Overall Study|Lost to Follow-up|14
1018497|NCT01572389|2043379|FG000|Overall Study|Only A1C or Assessment was Collected|6
1018498|NCT01572389|2043380|FG001|Overall Study|Only A1C or Assessment was Collected|2
1018499|NCT01572675|2043397|FG000|Overall Study|End of prescribed treatment|140
1018500|NCT01572675|2043398|FG001|Overall Study|End of prescribed treatment|118
1018501|NCT01572675|2043397|FG000|Overall Study|Recovery|16
1018502|NCT01572675|2043398|FG001|Overall Study|Recovery|23
1018503|NCT01572675|2043397|FG000|Overall Study|Lack of Efficacy|31
1018504|NCT01572675|2043398|FG001|Overall Study|Lack of Efficacy|31
1018505|NCT01572675|2043397|FG000|Overall Study|Intolerance|6
1018506|NCT01572675|2043398|FG001|Overall Study|Intolerance|5
1018507|NCT01572675|2043397|FG000|Overall Study|Improved symptoms|8
1018508|NCT01572675|2043398|FG001|Overall Study|Improved symptoms|2
1018509|NCT01572675|2043397|FG000|Overall Study|Surgical intervention|3
1018510|NCT01572675|2043398|FG001|Overall Study|Surgical intervention|6
1018511|NCT01572675|2043397|FG000|Overall Study|Withdrawal by Subject|5
1018512|NCT01572675|2043398|FG001|Overall Study|Withdrawal by Subject|1
1018513|NCT01572675|2043397|FG000|Overall Study|Physician Decision|2
1160604|NCT03342898|2281685|FG001|Overall Study|Lost to Follow-up|40
1160605|NCT03342898|2281686|FG002|Overall Study|Lost to Follow-up|42
1160606|NCT03342898|2281684|FG000|Overall Study|Withdrawal of Consent|5
1160607|NCT03342898|2281685|FG001|Overall Study|Withdrawal of Consent|9
1160608|NCT03342898|2281686|FG002|Overall Study|Withdrawal of Consent|11
1160609|NCT03342898|2281684|FG000|Overall Study|Death|0
1160610|NCT03342898|2281685|FG001|Overall Study|Death|1
1160611|NCT03342898|2281686|FG002|Overall Study|Death|1
1160612|NCT03342898|2281684|FG000|Overall Study|Reason not Specified|2
1160613|NCT03342898|2281685|FG001|Overall Study|Reason not Specified|2
1160614|NCT03342898|2281686|FG002|Overall Study|Reason not Specified|0
1160615|NCT03342963|2281698|FG000|Overall Study|Adverse Event|1
1160616|NCT03342963|2281699|FG001|Overall Study|Adverse Event|2
1160617|NCT03342963|2281700|FG002|Overall Study|Adverse Event|0
1160618|NCT03342963|2281701|FG003|Overall Study|Adverse Event|0
1160619|NCT03342963|2281698|FG000|Overall Study|Withdrawal by Subject|1
1160620|NCT03342963|2281699|FG001|Overall Study|Withdrawal by Subject|0
1160621|NCT03342963|2281700|FG002|Overall Study|Withdrawal by Subject|0
1160622|NCT03342963|2281701|FG003|Overall Study|Withdrawal by Subject|0
1160623|NCT03343067|2281714|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
1160624|NCT03343067|2281715|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
1160625|NCT03343067|2281716|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
1160626|NCT03343639|2281735|FG000|Overall Study|Withdrawal by Subject|10
1160627|NCT03343639|2281736|FG001|Overall Study|Withdrawal by Subject|6
1160628|NCT03343639|2281735|FG000|Overall Study|Lost to Follow-up|4
1160629|NCT03343639|2281736|FG001|Overall Study|Lost to Follow-up|5
1160630|NCT03343639|2281735|FG000|Overall Study|Protocol Violation|0
1160631|NCT03343639|2281736|FG001|Overall Study|Protocol Violation|1
1160632|NCT03343704|2281744|FG000|Overall Study|Refused to complete follow up|0
1160633|NCT03343704|2281745|FG001|Overall Study|Refused to complete follow up|1
1160634|NCT03343704|2281744|FG000|Overall Study|Death|0
1160635|NCT03343704|2281745|FG001|Overall Study|Death|1
1160636|NCT03343704|2281744|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1
1160637|NCT03343704|2281745|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0
1160638|NCT03344172|2281755|FG000|Overall Study|Received <1 dose of treatment|1
1160639|NCT03344172|2281756|FG001|Overall Study|Received <1 dose of treatment|0
1160640|NCT03344640|2281772|FG000|Overall Study|Adverse Event|1
1160641|NCT03344640|2281773|FG001|Overall Study|Adverse Event|0
1160642|NCT03344640|2281772|FG000|Overall Study|Physician Decision|1
1160643|NCT03344640|2281773|FG001|Overall Study|Physician Decision|1
1160644|NCT03344640|2281772|FG000|Overall Study|Withdrawal by Subject|1
1160645|NCT03344640|2281773|FG001|Overall Study|Withdrawal by Subject|2
1160646|NCT03344640|2281772|FG000|Follow-up Epoch|Withdrawal by Subject|0
1160647|NCT03344640|2281773|FG001|Follow-up Epoch|Withdrawal by Subject|2
1160648|NCT03345407|2281816|FG000|Overall Study|Withdrawal by Subject|11
1160649|NCT03345407|2281817|FG001|Overall Study|Withdrawal by Subject|1
1160650|NCT03345407|2281818|FG002|Overall Study|Withdrawal by Subject|5
1160651|NCT03345407|2281819|FG003|Overall Study|Withdrawal by Subject|6
1160652|NCT03345407|2281820|FG004|Overall Study|Withdrawal by Subject|3
1160653|NCT03345407|2281821|FG005|Overall Study|Withdrawal by Subject|6
1160654|NCT03345407|2281822|FG006|Overall Study|Withdrawal by Subject|16
1160655|NCT03345407|2281816|FG000|Overall Study|Physician Decision|3
1160656|NCT03345407|2281817|FG001|Overall Study|Physician Decision|1
1160657|NCT03345407|2281818|FG002|Overall Study|Physician Decision|0
1160658|NCT03345407|2281819|FG003|Overall Study|Physician Decision|0
1160659|NCT03345407|2281820|FG004|Overall Study|Physician Decision|1
1160660|NCT03345407|2281821|FG005|Overall Study|Physician Decision|2
1160661|NCT03345407|2281822|FG006|Overall Study|Physician Decision|3
1160662|NCT03345407|2281816|FG000|Overall Study|Lost to Follow-up|2
1160663|NCT03345407|2281817|FG001|Overall Study|Lost to Follow-up|0
1160664|NCT03345407|2281818|FG002|Overall Study|Lost to Follow-up|1
1160665|NCT03345407|2281819|FG003|Overall Study|Lost to Follow-up|0
1160666|NCT03345407|2281820|FG004|Overall Study|Lost to Follow-up|1
1160667|NCT03345407|2281821|FG005|Overall Study|Lost to Follow-up|2
1160668|NCT03345407|2281822|FG006|Overall Study|Lost to Follow-up|3
1160669|NCT03345407|2281816|FG000|Overall Study|Protocol-defined stopping criteria|9
1160670|NCT03345407|2281817|FG001|Overall Study|Protocol-defined stopping criteria|0
1160671|NCT03345407|2281818|FG002|Overall Study|Protocol-defined stopping criteria|0
1160672|NCT03345407|2281819|FG003|Overall Study|Protocol-defined stopping criteria|0
1160673|NCT03345407|2281820|FG004|Overall Study|Protocol-defined stopping criteria|2
1160674|NCT03345407|2281821|FG005|Overall Study|Protocol-defined stopping criteria|1
1160675|NCT03345407|2281822|FG006|Overall Study|Protocol-defined stopping criteria|1
1160676|NCT03345407|2281816|FG000|Overall Study|Protocol Violation|2
1160677|NCT03345407|2281817|FG001|Overall Study|Protocol Violation|0
1160678|NCT03345407|2281818|FG002|Overall Study|Protocol Violation|0
1160679|NCT03345407|2281819|FG003|Overall Study|Protocol Violation|0
1160680|NCT03345407|2281820|FG004|Overall Study|Protocol Violation|1
1160681|NCT03345407|2281821|FG005|Overall Study|Protocol Violation|0
1160682|NCT03345407|2281822|FG006|Overall Study|Protocol Violation|3
1160683|NCT03345407|2281816|FG000|Overall Study|Lack of Efficacy|1
1160684|NCT03345407|2281817|FG001|Overall Study|Lack of Efficacy|1
1160685|NCT03345407|2281818|FG002|Overall Study|Lack of Efficacy|1
1160686|NCT03345407|2281819|FG003|Overall Study|Lack of Efficacy|1
1160687|NCT03345407|2281820|FG004|Overall Study|Lack of Efficacy|1
1160688|NCT03345407|2281821|FG005|Overall Study|Lack of Efficacy|0
1160689|NCT03345407|2281822|FG006|Overall Study|Lack of Efficacy|3
1160690|NCT03345407|2281816|FG000|Overall Study|Adverse Event|4
1160691|NCT03345407|2281817|FG001|Overall Study|Adverse Event|0
1160692|NCT03345407|2281818|FG002|Overall Study|Adverse Event|5
1160693|NCT03345407|2281819|FG003|Overall Study|Adverse Event|4
1160694|NCT03345407|2281820|FG004|Overall Study|Adverse Event|6
1160695|NCT03345407|2281821|FG005|Overall Study|Adverse Event|5
1160696|NCT03345407|2281822|FG006|Overall Study|Adverse Event|16
1160697|NCT03345472|2281844|FG000|Implant to 3 Months|Withdrawal by Subject|2
1160698|NCT03345472|2281844|FG000|Implant to 3 Months|Physician Decision|1
1160699|NCT03345472|2281844|FG000|Implant to 3 Months|Adverse Event|1
1160700|NCT03345472|2281844|FG000|3 Months to 12 Months|Physician Decision|3
1160701|NCT03345472|2281844|FG000|3 Months to 12 Months|Lost to Follow-up|2
1160702|NCT03345472|2281844|FG000|3 Months to 12 Months|Withdrawal by Subject|1
1160703|NCT03345472|2281844|FG000|3 Months to 12 Months|Adverse Event|1
1160704|NCT03345472|2281844|FG000|3 Months to 12 Months|Death|1
1160705|NCT03345914|2281851|FG000|Overall Study|Transition to another study at week 16|80
1160706|NCT03345914|2281852|FG001|Overall Study|Transition to another study at week 16|86
1160707|NCT03345914|2281853|FG002|Overall Study|Transition to another study at week 16|78
1160708|NCT03345914|2281851|FG000|Overall Study|Transition to OLE during follow-up|37
1160709|NCT03345914|2281852|FG001|Overall Study|Transition to OLE during follow-up|33
1160710|NCT03345914|2281853|FG002|Overall Study|Transition to OLE during follow-up|39
1160711|NCT03345914|2281851|FG000|Overall Study|Physician Decision|0
1160712|NCT03345914|2281852|FG001|Overall Study|Physician Decision|1
1160713|NCT03345914|2281853|FG002|Overall Study|Physician Decision|1
1160714|NCT03345914|2281851|FG000|Overall Study|Withdrawal by Subject|5
1160715|NCT03345914|2281852|FG001|Overall Study|Withdrawal by Subject|1
1160716|NCT03345914|2281853|FG002|Overall Study|Withdrawal by Subject|2
1160717|NCT03345914|2281851|FG000|Overall Study|Other|1
1160718|NCT03345914|2281852|FG001|Overall Study|Other|1
1160719|NCT03345914|2281853|FG002|Overall Study|Other|1
1160720|NCT03345914|2281851|FG000|Overall Study|Ongoing|0
1160721|NCT03345914|2281852|FG001|Overall Study|Ongoing|0
1160722|NCT03345914|2281853|FG002|Overall Study|Ongoing|1
1160723|NCT03345979|2281863|FG000|Overall Study|Withdrawal by Subject|20
1160724|NCT03345979|2281864|FG001|Overall Study|Withdrawal by Subject|31
1160725|NCT03345979|2281863|FG000|Overall Study|Adverse Event|10
1160726|NCT03345979|2281864|FG001|Overall Study|Adverse Event|11
1160727|NCT03345979|2281863|FG000|Overall Study|Lost to Follow-up|8
1160728|NCT03345979|2281864|FG001|Overall Study|Lost to Follow-up|9
1160729|NCT03345979|2281863|FG000|Overall Study|Lack of Efficacy|4
1160730|NCT03345979|2281864|FG001|Overall Study|Lack of Efficacy|2
1160731|NCT03345979|2281863|FG000|Overall Study|Protocol Violation|1
1160732|NCT03345979|2281864|FG001|Overall Study|Protocol Violation|3
1160733|NCT03345979|2281863|FG000|Overall Study|Physician Decision|0
1160734|NCT03345979|2281864|FG001|Overall Study|Physician Decision|2
1160735|NCT03346057|2281874|FG000|Overall Study|Death|1
1160736|NCT03346057|2281875|FG001|Overall Study|Death|2
1160737|NCT03346057|2281876|FG002|Overall Study|Death|0
1160738|NCT03346057|2281877|FG003|Overall Study|Death|0
1160739|NCT03346057|2281874|FG000|Overall Study|Lost to Follow-up|0
1160740|NCT03346057|2281875|FG001|Overall Study|Lost to Follow-up|2
1160741|NCT03346057|2281876|FG002|Overall Study|Lost to Follow-up|1
1160742|NCT03346057|2281877|FG003|Overall Study|Lost to Follow-up|0
1160743|NCT03346057|2281874|FG000|Overall Study|Ineligible For Study - Not Treated|0
1160744|NCT03346057|2281875|FG001|Overall Study|Ineligible For Study - Not Treated|1
1160745|NCT03346057|2281876|FG002|Overall Study|Ineligible For Study - Not Treated|0
1160746|NCT03346057|2281877|FG003|Overall Study|Ineligible For Study - Not Treated|0
1160747|NCT03346057|2281874|FG000|Overall Study|Renal Insufficiency - Not Treated|1
1160748|NCT03346057|2281875|FG001|Overall Study|Renal Insufficiency - Not Treated|0
1160749|NCT03346057|2281876|FG002|Overall Study|Renal Insufficiency - Not Treated|0
1160750|NCT03346057|2281877|FG003|Overall Study|Renal Insufficiency - Not Treated|0
1160751|NCT03346057|2281874|FG000|Overall Study|Physician Decision|3
1160752|NCT03346057|2281875|FG001|Overall Study|Physician Decision|2
1160753|NCT03346057|2281876|FG002|Overall Study|Physician Decision|0
1160754|NCT03346057|2281877|FG003|Overall Study|Physician Decision|2
1160755|NCT03346057|2281874|FG000|Overall Study|Randomization Mistake - Not Treated|1
1160756|NCT03346057|2281875|FG001|Overall Study|Randomization Mistake - Not Treated|1
1160757|NCT03346057|2281876|FG002|Overall Study|Randomization Mistake - Not Treated|0
1160758|NCT03346057|2281877|FG003|Overall Study|Randomization Mistake - Not Treated|0
1160759|NCT03346057|2281874|FG000|Overall Study|Withdrawal by Subject|1
1160760|NCT03346057|2281875|FG001|Overall Study|Withdrawal by Subject|0
1160761|NCT03346057|2281876|FG002|Overall Study|Withdrawal by Subject|0
1160762|NCT03346057|2281877|FG003|Overall Study|Withdrawal by Subject|0
1160763|NCT03346070|2281892|FG000|Overall Study|Death|0
1160764|NCT03346070|2281893|FG001|Overall Study|Death|0
1160765|NCT03346070|2281894|FG002|Overall Study|Death|0
1160766|NCT03346070|2281895|FG003|Overall Study|Death|0
1160767|NCT03346070|2281896|FG004|Overall Study|Death|1
1160768|NCT03346070|2281892|FG000|Overall Study|Lost to Follow-up|0
1160769|NCT03346070|2281893|FG001|Overall Study|Lost to Follow-up|1
1160770|NCT03346070|2281894|FG002|Overall Study|Lost to Follow-up|2
1160771|NCT03346070|2281895|FG003|Overall Study|Lost to Follow-up|0
1160772|NCT03346070|2281896|FG004|Overall Study|Lost to Follow-up|0
1160773|NCT03346070|2281892|FG000|Overall Study|Physician Decision|0
1160774|NCT03346070|2281893|FG001|Overall Study|Physician Decision|0
1160775|NCT03346070|2281894|FG002|Overall Study|Physician Decision|0
1160776|NCT03346070|2281895|FG003|Overall Study|Physician Decision|1
1160777|NCT03346070|2281896|FG004|Overall Study|Physician Decision|1
1160778|NCT03346070|2281892|FG000|Overall Study|Withdrawal by Subject|1
1160779|NCT03346070|2281893|FG001|Overall Study|Withdrawal by Subject|0
1160780|NCT03346070|2281894|FG002|Overall Study|Withdrawal by Subject|0
1160781|NCT03346070|2281895|FG003|Overall Study|Withdrawal by Subject|1
1160782|NCT03346070|2281896|FG004|Overall Study|Withdrawal by Subject|0
1160783|NCT03346070|2281892|FG000|Overall Study|Study medication not received as planned|2
1160784|NCT03346070|2281893|FG001|Overall Study|Study medication not received as planned|3
1160785|NCT03346070|2281894|FG002|Overall Study|Study medication not received as planned|2
1160786|NCT03346070|2281895|FG003|Overall Study|Study medication not received as planned|3
1160787|NCT03346070|2281896|FG004|Overall Study|Study medication not received as planned|2
1160788|NCT03346070|2281892|FG000|Overall Study|Screen Failure|0
1160789|NCT03346070|2281893|FG001|Overall Study|Screen Failure|0
1160790|NCT03346070|2281894|FG002|Overall Study|Screen Failure|0
1160791|NCT03346070|2281895|FG003|Overall Study|Screen Failure|1
1160792|NCT03346070|2281896|FG004|Overall Study|Screen Failure|1
1160793|NCT03346759|2281921|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2
1160794|NCT03346759|2281922|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3
1160795|NCT03346759|2281921|FG000|First Menstrual Cycle|Withdrawal by Subject|1
1160796|NCT03346759|2281922|FG001|First Menstrual Cycle|Withdrawal by Subject|0
1160797|NCT03346759|2281921|FG000|Second Menstrual Cycle|Lost to Follow-up|1
1160798|NCT03346759|2281922|FG001|Second Menstrual Cycle|Lost to Follow-up|0
1160799|NCT03347188|2281949|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
1160800|NCT03347188|2281950|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
1160801|NCT03347188|2281949|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4
1160802|NCT03347188|2281950|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8
1160803|NCT03347188|2281949|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7
1160804|NCT03347188|2281950|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4
1160805|NCT03347188|2281949|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
1160806|NCT03347188|2281950|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
1160807|NCT03347188|2281949|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1
1160808|NCT03347188|2281950|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2
1160809|NCT03347188|2281949|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26
1160810|NCT03347188|2281950|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28
1160811|NCT03347188|2281949|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1
1160812|NCT03347188|2281950|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0
1160813|NCT03347188|2281949|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0
1160814|NCT03347188|2281950|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1
1160815|NCT03347279|2281958|FG000|Overall Study|Withdrawal by Subject|8
1160816|NCT03347279|2281959|FG001|Overall Study|Withdrawal by Subject|15
1160817|NCT03347279|2281958|FG000|Overall Study|Death|0
1160818|NCT03347279|2281959|FG001|Overall Study|Death|2
1160819|NCT03347279|2281958|FG000|Overall Study|Lost to Follow-up|5
1160820|NCT03347279|2281959|FG001|Overall Study|Lost to Follow-up|2
1160821|NCT03347279|2281958|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3
1160822|NCT03347279|2281959|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4
1160823|NCT03347695|2281967|FG000|Overall Study|Death|0
1160824|NCT03347695|2281968|FG001|Overall Study|Death|4
1160825|NCT03347695|2281967|FG000|Overall Study|Lost to Follow-up|0
1160826|NCT03347695|2281968|FG001|Overall Study|Lost to Follow-up|1
1160827|NCT03349034|2282023|FG000|Overall Study|catheters dislodged during transport|2
1160828|NCT03349034|2282024|FG001|Overall Study|catheters dislodged during transport|0
1160829|NCT03349034|2282023|FG000|Overall Study|intubated for >48 hrs following surgery|1
1160830|NCT03349034|2282024|FG001|Overall Study|intubated for >48 hrs following surgery|1
1160831|NCT03349034|2282023|FG000|Overall Study|soft tissue flap used|1
1160832|NCT03349034|2282024|FG001|Overall Study|soft tissue flap used|0
1160833|NCT03349034|2282023|FG000|Overall Study|Other|0
1160834|NCT03349034|2282024|FG001|Overall Study|Other|1
1160835|NCT03349060|2282035|FG000|Overall Study|Adverse Event|9
1160836|NCT03349060|2282036|FG001|Overall Study|Adverse Event|9
1160837|NCT03349060|2282037|FG002|Overall Study|Adverse Event|7
1160838|NCT03349060|2282035|FG000|Overall Study|Lack of Efficacy|1
1160839|NCT03349060|2282036|FG001|Overall Study|Lack of Efficacy|0
1160840|NCT03349060|2282037|FG002|Overall Study|Lack of Efficacy|2
1160841|NCT03349060|2282035|FG000|Overall Study|Lost to Follow-up|2
1160842|NCT03349060|2282036|FG001|Overall Study|Lost to Follow-up|1
1160843|NCT03349060|2282037|FG002|Overall Study|Lost to Follow-up|1
1160844|NCT03349060|2282035|FG000|Overall Study|Protocol Violation|2
1160845|NCT03349060|2282036|FG001|Overall Study|Protocol Violation|2
1160846|NCT03349060|2282037|FG002|Overall Study|Protocol Violation|1
1160847|NCT03349060|2282035|FG000|Overall Study|Withdrawal by Subject|5
1160848|NCT03349060|2282036|FG001|Overall Study|Withdrawal by Subject|3
1160849|NCT03349060|2282037|FG002|Overall Study|Withdrawal by Subject|4
1160850|NCT03349060|2282035|FG000|Overall Study|Medication error,no linked adverse event|0
1160851|NCT03349060|2282036|FG001|Overall Study|Medication error,no linked adverse event|0
1160852|NCT03349060|2282037|FG002|Overall Study|Medication error,no linked adverse event|1
1160853|NCT03349060|2282035|FG000|Overall Study|Withdrawal By Parent/Guardian|0
1160854|NCT03349060|2282036|FG001|Overall Study|Withdrawal By Parent/Guardian|1
1160855|NCT03349060|2282037|FG002|Overall Study|Withdrawal By Parent/Guardian|0
1160856|NCT03349060|2282035|FG000|Overall Study|Other|2
1160857|NCT03349060|2282036|FG001|Overall Study|Other|1
1160858|NCT03349060|2282037|FG002|Overall Study|Other|0
1160859|NCT03349099|2282047|FG000|Overall Study|Physician Decision|3
1160860|NCT03349099|2282048|FG001|Overall Study|Physician Decision|4
1160861|NCT03349099|2282047|FG000|Overall Study|Stone migrated from the kidney|1
1160862|NCT03349099|2282048|FG001|Overall Study|Stone migrated from the kidney|0
1160863|NCT03349333|2282054|FG000|Overall Study|Progression of Disease|36
1160864|NCT03349333|2282054|FG000|Overall Study|Adverse Event|11
1160865|NCT03349333|2282054|FG000|Overall Study|Other|6
1160866|NCT03349333|2282054|FG000|Overall Study|Withdrawal by Subject|5
1160867|NCT03349333|2282054|FG000|Overall Study|Conditions interfere with participation|2
1160868|NCT03349333|2282054|FG000|Overall Study|Physician Decision|2
1160869|NCT03349333|2282054|FG000|Overall Study|3-week lapse between pralatrexate doses|1
1160870|NCT03349333|2282054|FG000|Overall Study|Patients in treatment less than 24 month|8
1160871|NCT03349437|2282058|FG000|Screening|Screen Fail|4
1160872|NCT03349437|2282059|FG001|Screening|Screen Fail|0
1160873|NCT03349437|2282060|FG002|Screening|Screen Fail|0
1160874|NCT03349437|2282058|FG000|Screening|Withdrawn|1
1160875|NCT03349437|2282059|FG001|Screening|Withdrawn|0
1160876|NCT03349437|2282060|FG002|Screening|Withdrawn|0
1160877|NCT03349515|2282069|FG000|Overall Study|Lack of Efficacy|2
1160878|NCT03349515|2282070|FG001|Overall Study|Lack of Efficacy|0
1160879|NCT03349515|2282069|FG000|Overall Study|Physician Decision|3
1160880|NCT03349515|2282070|FG001|Overall Study|Physician Decision|1
1160881|NCT03350256|2282138|FG000|Overall Study|Inclusion/exclusion violation|4
1160882|NCT03350256|2282138|FG000|Overall Study|Recommended for other therapies|2
1160883|NCT03350256|2282138|FG000|Overall Study|Protocol Violation|3
1160884|NCT03350256|2282138|FG000|Overall Study|Non compliance|2
1160885|NCT03350256|2282138|FG000|Overall Study|Denial by insurance|1
1160886|NCT03350256|2282138|FG000|Overall Study|Adverse Event|2
1160887|NCT03350256|2282138|FG000|Overall Study|Trial failure|12
1160888|NCT03350256|2282138|FG000|Overall Study|Did not proceed to permanent implant|3
1160889|NCT03350256|2282138|FG000|Overall Study|Withdrawal by Subject|3
1160890|NCT03350256|2282138|FG000|Overall Study|Subject moving out of state|1
1160891|NCT03350256|2282138|FG000|Overall Study|Lost to Follow-up|1
1160892|NCT03350256|2282138|FG000|Overall Study|Lack of Efficacy|2
1160896|NCT03350672|2282153|FG000|Overall Study|Withdrawal by Subject|7
1018514|NCT01572675|2043398|FG001|Overall Study|Physician Decision|2
1018515|NCT01572675|2043397|FG000|Overall Study|Death unrelated to coxibs|1
1018516|NCT01572675|2043398|FG001|Overall Study|Death unrelated to coxibs|1
1018517|NCT01572675|2043397|FG000|Overall Study|Other disease detected|1
1018518|NCT01572675|2043398|FG001|Overall Study|Other disease detected|1
1018519|NCT01572675|2043397|FG000|Overall Study|Unknown reason|1
1018520|NCT01572675|2043398|FG001|Overall Study|Unknown reason|1
1018521|NCT01572675|2043397|FG000|Overall Study|Rheumatologist new evaluation|0
1018522|NCT01572675|2043398|FG001|Overall Study|Rheumatologist new evaluation|1
1018523|NCT01572675|2043397|FG000|Overall Study|Missing data|1
1018524|NCT01572675|2043398|FG001|Overall Study|Missing data|4
1018525|NCT01572675|2043397|FG000|Overall Study|Lost to Follow-up|22
1018526|NCT01572675|2043398|FG001|Overall Study|Lost to Follow-up|27
1018527|NCT01572727|2043419|FG000|Overall Study|Adverse Event|43
1018528|NCT01572727|2043420|FG001|Overall Study|Adverse Event|15
1018529|NCT01572727|2043419|FG000|Overall Study|Lost to Follow-up|1
1018530|NCT01572727|2043420|FG001|Overall Study|Lost to Follow-up|1
1018531|NCT01572727|2043419|FG000|Overall Study|Physician Decision|23
1018532|NCT01572727|2043420|FG001|Overall Study|Physician Decision|9
1018533|NCT01572727|2043419|FG000|Overall Study|Progressive disease|59
1018534|NCT01572727|2043420|FG001|Overall Study|Progressive disease|82
1018535|NCT01572727|2043419|FG000|Overall Study|Protocol Violation|0
1018536|NCT01572727|2043420|FG001|Overall Study|Protocol Violation|1
1018537|NCT01572727|2043419|FG000|Overall Study|Study terminated by sponsor|61
1018538|NCT01572727|2043420|FG001|Overall Study|Study terminated by sponsor|83
1018539|NCT01572727|2043419|FG000|Overall Study|Parent/guardian decision|14
1018540|NCT01572727|2043420|FG001|Overall Study|Parent/guardian decision|9
1018541|NCT01572727|2043419|FG000|Overall Study|Death|2
1018542|NCT01572727|2043420|FG001|Overall Study|Death|2
1018543|NCT01572727|2043419|FG000|Overall Study|Untreated|4
1018544|NCT01572727|2043420|FG001|Overall Study|Untreated|7
1018545|NCT01572740|2043428|FG000|Overall Study|Adverse Event|1
1018546|NCT01572740|2043429|FG001|Overall Study|Adverse Event|1
1018547|NCT01572740|2043428|FG000|Overall Study|Withdrawal by Subject|1
1018548|NCT01572740|2043429|FG001|Overall Study|Withdrawal by Subject|1
1160897|NCT03350672|2282154|FG001|Overall Study|Withdrawal by Subject|0
1160898|NCT03350672|2282155|FG002|Overall Study|Withdrawal by Subject|0
1160907|NCT03351114|2282201|FG000|Overall Study|Withdrawal by Subject|1
1160908|NCT03351231|2282205|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1
1160909|NCT03351231|2282205|FG000|Combination Therapy Period|Disease progression|2
1160910|NCT03351231|2282205|FG000|Combination Therapy Period|Study drug toxicity|1
1160911|NCT03351231|2282205|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1
1160912|NCT03351231|2282205|FG000|Safety Follow-Up Period|Participant withdrew consent|1
1160913|NCT03351231|2282205|FG000|Safety Follow-Up Period|Other reason|2
1160914|NCT03351335|2282212|FG000|Overall Study|Failure to maintain inclusion/exclusion|0
1160915|NCT03351335|2282213|FG001|Overall Study|Failure to maintain inclusion/exclusion|0
1160916|NCT03351335|2282214|FG002|Overall Study|Failure to maintain inclusion/exclusion|4
1160917|NCT03351478|2282225|FG000|Overall Study|At the subject's own request|11
1160918|NCT03351478|2282226|FG001|Overall Study|At the subject's own request|12
1160919|NCT03351478|2282227|FG002|Overall Study|At the subject's own request|5
1160920|NCT03351478|2282225|FG000|Overall Study|Adverse Event|1
1160921|NCT03351478|2282226|FG001|Overall Study|Adverse Event|2
1160922|NCT03351478|2282227|FG002|Overall Study|Adverse Event|1
1160923|NCT03351478|2282225|FG000|Overall Study|Poor compliance to protocol|1
1160924|NCT03351478|2282226|FG001|Overall Study|Poor compliance to protocol|0
1160925|NCT03351478|2282227|FG002|Overall Study|Poor compliance to protocol|0
1160926|NCT03351478|2282225|FG000|Overall Study|Reason not Specified|1
1160927|NCT03351478|2282226|FG001|Overall Study|Reason not Specified|3
1160928|NCT03351478|2282227|FG002|Overall Study|Reason not Specified|0
1160929|NCT03351478|2282225|FG000|Overall Study|Lost to Follow-up|0
1160930|NCT03351478|2282226|FG001|Overall Study|Lost to Follow-up|0
1160931|NCT03351478|2282227|FG002|Overall Study|Lost to Follow-up|1
1160932|NCT03351608|2282240|FG000|Overall Study|Lost to Follow-up|0
1160933|NCT03351608|2282241|FG001|Overall Study|Lost to Follow-up|1
1160934|NCT03351608|2282242|FG002|Overall Study|Lost to Follow-up|1
1160935|NCT03351608|2282243|FG003|Overall Study|Lost to Follow-up|1
1160936|NCT03351608|2282244|FG004|Overall Study|Lost to Follow-up|1
1160937|NCT03351608|2282240|FG000|Overall Study|Physician Decision|1
1160938|NCT03351608|2282241|FG001|Overall Study|Physician Decision|0
1160939|NCT03351608|2282242|FG002|Overall Study|Physician Decision|0
1160940|NCT03351608|2282243|FG003|Overall Study|Physician Decision|2
1160941|NCT03351608|2282244|FG004|Overall Study|Physician Decision|1
1160942|NCT03351608|2282240|FG000|Overall Study|Randomized by mistake, no treatment given|0
1160943|NCT03351608|2282241|FG001|Overall Study|Randomized by mistake, no treatment given|0
1160944|NCT03351608|2282242|FG002|Overall Study|Randomized by mistake, no treatment given|0
1160945|NCT03351608|2282243|FG003|Overall Study|Randomized by mistake, no treatment given|1
1160946|NCT03351608|2282244|FG004|Overall Study|Randomized by mistake, no treatment given|0
1160947|NCT03351608|2282240|FG000|Overall Study|Withdrawal by parent/guardian|0
1160948|NCT03351608|2282241|FG001|Overall Study|Withdrawal by parent/guardian|0
1160949|NCT03351608|2282242|FG002|Overall Study|Withdrawal by parent/guardian|1
1160950|NCT03351608|2282243|FG003|Overall Study|Withdrawal by parent/guardian|1
1160951|NCT03351608|2282244|FG004|Overall Study|Withdrawal by parent/guardian|0
1160952|NCT03351608|2282240|FG000|Overall Study|Other|0
1160953|NCT03351608|2282241|FG001|Overall Study|Other|1
1160954|NCT03351608|2282242|FG002|Overall Study|Other|1
1160955|NCT03351608|2282243|FG003|Overall Study|Other|3
1160956|NCT03351608|2282244|FG004|Overall Study|Other|0
1160957|NCT03351738|2282300|FG000|Overall Study|Withdrawal by Subject|0
1160958|NCT03351738|2282301|FG001|Overall Study|Withdrawal by Subject|1
1160959|NCT03351738|2282302|FG002|Overall Study|Withdrawal by Subject|0
1160960|NCT03351738|2282303|FG003|Overall Study|Withdrawal by Subject|1
1160961|NCT03351738|2282304|FG004|Overall Study|Withdrawal by Subject|0
1160962|NCT03351738|2282305|FG005|Overall Study|Withdrawal by Subject|0
1160963|NCT03352414|2282343|FG000|Overall Study|Ineligible by operative criteria|12
1160964|NCT03352414|2282344|FG001|Overall Study|Ineligible by operative criteria|10
1160965|NCT03352453|2282354|FG000|Overall Study|Miscellaneous Reasons|1
1160966|NCT03352453|2282355|FG001|Overall Study|Miscellaneous Reasons|2
1160967|NCT03352453|2282354|FG000|Overall Study|Lack of Efficacy|1
1160968|NCT03352453|2282355|FG001|Overall Study|Lack of Efficacy|0
1160969|NCT03352453|2282354|FG000|Overall Study|Withdrawal by Subject|8
1160970|NCT03352453|2282355|FG001|Overall Study|Withdrawal by Subject|14
1160971|NCT03352453|2282354|FG000|Overall Study|Study Terminated by Sponsor|2
1160972|NCT03352453|2282355|FG001|Overall Study|Study Terminated by Sponsor|1
1160973|NCT03352453|2282354|FG000|Overall Study|Protocol Deviation|1
1160974|NCT03352453|2282355|FG001|Overall Study|Protocol Deviation|0
1160975|NCT03352453|2282354|FG000|Overall Study|Lost to Follow-up|7
1160976|NCT03352453|2282355|FG001|Overall Study|Lost to Follow-up|6
1160977|NCT03352453|2282354|FG000|Overall Study|Adverse Event|2
1160978|NCT03352453|2282355|FG001|Overall Study|Adverse Event|9
1160979|NCT03352713|2282370|FG000|Overall Study|Lost to Follow-up|8
1160980|NCT03352713|2282370|FG000|Overall Study|Withdrawn by investigator|5
1160981|NCT03352713|2282370|FG000|Overall Study|Completed 0 EMAs|8
1160982|NCT03352713|2282370|FG000|Overall Study|Device incompatible/stolen|5
1160983|NCT03353220|2282374|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4
1160984|NCT03353220|2282375|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7
1160985|NCT03353740|2282385|FG000|Overall Study|Images for these participants not viable|52
1160998|NCT03354429|2282425|FG000|Overall Study|Withdrawal by Subject|8
1160999|NCT03354429|2282426|FG001|Overall Study|Withdrawal by Subject|7
1161000|NCT03354429|2282425|FG000|Overall Study|Lost to Follow-up|1
1161001|NCT03354429|2282426|FG001|Overall Study|Lost to Follow-up|0
1161002|NCT03354637|2282444|FG000|Double-blind Period|Protocol Violation|2
1161003|NCT03354637|2282445|FG001|Double-blind Period|Protocol Violation|0
1161004|NCT03354637|2282446|FG002|Double-blind Period|Protocol Violation|0
1161005|NCT03354637|2282444|FG000|Double-blind Period|Adverse Event|1
1161006|NCT03354637|2282445|FG001|Double-blind Period|Adverse Event|2
1161007|NCT03354637|2282446|FG002|Double-blind Period|Adverse Event|0
1161008|NCT03354637|2282444|FG000|Double-blind Period|Lost to Follow-up|3
1161009|NCT03354637|2282445|FG001|Double-blind Period|Lost to Follow-up|4
1161010|NCT03354637|2282446|FG002|Double-blind Period|Lost to Follow-up|3
1161011|NCT03354637|2282444|FG000|Double-blind Period|Withdrawal by Subject|10
1161012|NCT03354637|2282445|FG001|Double-blind Period|Withdrawal by Subject|6
1161013|NCT03354637|2282446|FG002|Double-blind Period|Withdrawal by Subject|4
1161014|NCT03354637|2282444|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1
1161015|NCT03354637|2282445|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1
1161016|NCT03354637|2282446|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0
1161017|NCT03354637|2282444|FG000|Open Label Extension|Adverse Event|0
1161018|NCT03354637|2282445|FG001|Open Label Extension|Adverse Event|0
1161019|NCT03354637|2282446|FG002|Open Label Extension|Adverse Event|1
1161020|NCT03354637|2282444|FG000|Open Label Extension|Lost to Follow-up|0
1161021|NCT03354637|2282445|FG001|Open Label Extension|Lost to Follow-up|0
1161022|NCT03354637|2282446|FG002|Open Label Extension|Lost to Follow-up|2
1161023|NCT03354637|2282444|FG000|Open Label Extension|Withdrawal by Subject|0
1161024|NCT03354637|2282445|FG001|Open Label Extension|Withdrawal by Subject|0
1161025|NCT03354637|2282446|FG002|Open Label Extension|Withdrawal by Subject|5
1161026|NCT03354637|2282444|FG000|Open Label Extension|Study Terminated by Sponsor|0
1161027|NCT03354637|2282445|FG001|Open Label Extension|Study Terminated by Sponsor|0
1161028|NCT03354637|2282446|FG002|Open Label Extension|Study Terminated by Sponsor|17
1161029|NCT03354637|2282444|FG000|Open Label Extension|Subject Noncompliance|0
1161030|NCT03354637|2282445|FG001|Open Label Extension|Subject Noncompliance|0
1161031|NCT03354637|2282446|FG002|Open Label Extension|Subject Noncompliance|1
1161032|NCT03354637|2282444|FG000|Open Label Extension|Lack of Efficacy|0
1161033|NCT03354637|2282445|FG001|Open Label Extension|Lack of Efficacy|0
1161034|NCT03354637|2282446|FG002|Open Label Extension|Lack of Efficacy|1
1161035|NCT03354637|2282444|FG000|Open Label Extension|Physician Decision|0
1161036|NCT03354637|2282445|FG001|Open Label Extension|Physician Decision|0
1161037|NCT03354637|2282446|FG002|Open Label Extension|Physician Decision|1
1161038|NCT03354663|2282455|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
1161039|NCT03354663|2282455|FG000|Enrollment to Catheter Insertion|Adverse Event|1
1161040|NCT03354663|2282455|FG000|Completed 30-day Visit|Withdrawal by Subject|1
1161041|NCT03354663|2282455|FG000|Completed 30-day Visit|Missed Visit|1
1161042|NCT03355326|2282474|FG000|Overall Study|Protocol Violation|3
1161043|NCT03355326|2282475|FG001|Overall Study|Protocol Violation|3
1161044|NCT03355742|2282481|FG000|Overall Study|Lost to Follow-up|4
1161045|NCT03355742|2282481|FG000|Overall Study|Withdrawal by Subject|29
1161046|NCT03355742|2282481|FG000|Overall Study|Physician Decision|6
1161047|NCT03355742|2282481|FG000|Overall Study|Death|55
1161048|NCT03355742|2282481|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5
1161049|NCT03356145|2282491|FG000|Overall Study|Withdrawal by Subject|2
1161050|NCT03356145|2282492|FG001|Overall Study|Withdrawal by Subject|1
1161051|NCT03356145|2282491|FG000|Overall Study|Did not meet inclusion criteria|1
1161052|NCT03356145|2282492|FG001|Overall Study|Did not meet inclusion criteria|0
1161053|NCT03356977|2282498|FG000|Overall Study|Lost to Follow-up|3
1161054|NCT03356977|2282498|FG000|Overall Study|Withdrawal by parent/guardian|2
1161055|NCT03357341|2282504|FG000|Overall Study|Withdrawal by Subject|3
1161056|NCT03357341|2282505|FG001|Overall Study|Withdrawal by Subject|6
1161057|NCT03357341|2282504|FG000|Overall Study|Lost to Follow-up|4
1161058|NCT03357341|2282505|FG001|Overall Study|Lost to Follow-up|5
1161059|NCT03357341|2282504|FG000|Overall Study|Death|0
1161060|NCT03357341|2282505|FG001|Overall Study|Death|1
1161061|NCT03357471|2282527|FG000|Overall Study|Adverse Event|1
1161062|NCT03357471|2282528|FG001|Overall Study|Adverse Event|0
1161063|NCT03357471|2282527|FG000|Overall Study|Lost to Follow-up|1
1161064|NCT03357471|2282528|FG001|Overall Study|Lost to Follow-up|0
1161065|NCT03357731|2282543|FG000|Overall Study|Withdrew consent due to personal reasons|0
1161066|NCT03357731|2282544|FG001|Overall Study|Withdrew consent due to personal reasons|0
1161067|NCT03357731|2282545|FG002|Overall Study|Withdrew consent due to personal reasons|0
1161068|NCT03357731|2282546|FG003|Overall Study|Withdrew consent due to personal reasons|0
1161069|NCT03357731|2282547|FG004|Overall Study|Withdrew consent due to personal reasons|1
1161070|NCT03357731|2282548|FG005|Overall Study|Withdrew consent due to personal reasons|0
1161071|NCT03357731|2282543|FG000|Overall Study|Acute bradycardia and hypotension|0
1161072|NCT03357731|2282544|FG001|Overall Study|Acute bradycardia and hypotension|0
1161073|NCT03357731|2282545|FG002|Overall Study|Acute bradycardia and hypotension|0
1161074|NCT03357731|2282546|FG003|Overall Study|Acute bradycardia and hypotension|1
1161075|NCT03357731|2282547|FG004|Overall Study|Acute bradycardia and hypotension|0
1161076|NCT03357731|2282548|FG005|Overall Study|Acute bradycardia and hypotension|0
1161077|NCT03357731|2282543|FG000|Overall Study|Adverse Event|0
1161078|NCT03357731|2282544|FG001|Overall Study|Adverse Event|0
1161079|NCT03357731|2282545|FG002|Overall Study|Adverse Event|0
1161080|NCT03357731|2282546|FG003|Overall Study|Adverse Event|0
1161081|NCT03357731|2282547|FG004|Overall Study|Adverse Event|0
1161082|NCT03357731|2282548|FG005|Overall Study|Adverse Event|1
1161083|NCT03357731|2282543|FG000|Overall Study|Hypotension|0
1161084|NCT03357731|2282544|FG001|Overall Study|Hypotension|0
1161085|NCT03357731|2282545|FG002|Overall Study|Hypotension|1
1161086|NCT03357731|2282546|FG003|Overall Study|Hypotension|1
1161087|NCT03357731|2282547|FG004|Overall Study|Hypotension|0
1161088|NCT03357731|2282548|FG005|Overall Study|Hypotension|0
1161089|NCT03357731|2282543|FG000|Overall Study|Lost to Follow-up|0
1161090|NCT03357731|2282544|FG001|Overall Study|Lost to Follow-up|0
1161091|NCT03357731|2282545|FG002|Overall Study|Lost to Follow-up|0
1161092|NCT03357731|2282546|FG003|Overall Study|Lost to Follow-up|1
1161093|NCT03357731|2282547|FG004|Overall Study|Lost to Follow-up|0
1161094|NCT03357731|2282548|FG005|Overall Study|Lost to Follow-up|0
1161099|NCT03358147|2282570|FG000|Overall Study|Withdrawal by Subject|13
1161100|NCT03358147|2282571|FG001|Overall Study|Withdrawal by Subject|19
1161101|NCT03358147|2282572|FG002|Overall Study|Withdrawal by Subject|16
1161102|NCT03358147|2282573|FG003|Overall Study|Withdrawal by Subject|10
1161103|NCT03358147|2282574|FG004|Overall Study|Withdrawal by Subject|5
1161104|NCT03358147|2282570|FG000|Overall Study|Adverse Event|3
1161105|NCT03358147|2282571|FG001|Overall Study|Adverse Event|9
1161106|NCT03358147|2282572|FG002|Overall Study|Adverse Event|7
1161107|NCT03358147|2282573|FG003|Overall Study|Adverse Event|5
1161108|NCT03358147|2282574|FG004|Overall Study|Adverse Event|2
1161109|NCT03358147|2282570|FG000|Overall Study|Lost to Follow-up|4
1161110|NCT03358147|2282571|FG001|Overall Study|Lost to Follow-up|3
1161111|NCT03358147|2282572|FG002|Overall Study|Lost to Follow-up|7
1161112|NCT03358147|2282573|FG003|Overall Study|Lost to Follow-up|6
1161113|NCT03358147|2282574|FG004|Overall Study|Lost to Follow-up|4
1161114|NCT03358147|2282570|FG000|Overall Study|Major Protocol Deviation|11
1161115|NCT03358147|2282571|FG001|Overall Study|Major Protocol Deviation|3
1161116|NCT03358147|2282572|FG002|Overall Study|Major Protocol Deviation|2
1161117|NCT03358147|2282573|FG003|Overall Study|Major Protocol Deviation|3
1161118|NCT03358147|2282574|FG004|Overall Study|Major Protocol Deviation|1
1161119|NCT03358147|2282570|FG000|Overall Study|Protocol specified criteria|2
1161120|NCT03358147|2282571|FG001|Overall Study|Protocol specified criteria|3
1161121|NCT03358147|2282572|FG002|Overall Study|Protocol specified criteria|0
1161122|NCT03358147|2282573|FG003|Overall Study|Protocol specified criteria|3
1161123|NCT03358147|2282574|FG004|Overall Study|Protocol specified criteria|1
1161124|NCT03358147|2282570|FG000|Overall Study|Physician Decision|1
1161125|NCT03358147|2282571|FG001|Overall Study|Physician Decision|0
1161126|NCT03358147|2282572|FG002|Overall Study|Physician Decision|1
1018549|NCT01572740|2043428|FG000|Overall Study|unclassified|4
1018550|NCT01572740|2043429|FG001|Overall Study|unclassified|3
1018551|NCT01572792|2043440|FG000|Lead-in Study|Lost to Follow-up|5
1018552|NCT01572792|2043441|FG001|Lead-in Study|Lost to Follow-up|9
1018553|NCT01572792|2043442|FG002|Lead-in Study|Lost to Follow-up|4
1018554|NCT01572792|2043443|FG003|Lead-in Study|Lost to Follow-up|2
1018555|NCT01572792|2043444|FG004|Lead-in Study|Lost to Follow-up|4
1018556|NCT01572792|2043440|FG000|Lead-in Study|Withdrawal by Subject|22
1018557|NCT01572792|2043441|FG001|Lead-in Study|Withdrawal by Subject|11
1018558|NCT01572792|2043442|FG002|Lead-in Study|Withdrawal by Subject|12
1018559|NCT01572792|2043443|FG003|Lead-in Study|Withdrawal by Subject|24
1018560|NCT01572792|2043444|FG004|Lead-in Study|Withdrawal by Subject|11
1018561|NCT01572792|2043440|FG000|Lead-in Study|Protocol Violation|19
1018562|NCT01572792|2043441|FG001|Lead-in Study|Protocol Violation|10
1018563|NCT01572792|2043442|FG002|Lead-in Study|Protocol Violation|12
1018564|NCT01572792|2043443|FG003|Lead-in Study|Protocol Violation|13
1161127|NCT03358147|2282573|FG003|Overall Study|Physician Decision|6
1161128|NCT03358147|2282574|FG004|Overall Study|Physician Decision|1
1161129|NCT03358147|2282570|FG000|Overall Study|Administrative reasons|0
1161130|NCT03358147|2282571|FG001|Overall Study|Administrative reasons|1
1161131|NCT03358147|2282572|FG002|Overall Study|Administrative reasons|0
1161132|NCT03358147|2282573|FG003|Overall Study|Administrative reasons|3
1161133|NCT03358147|2282574|FG004|Overall Study|Administrative reasons|0
1161134|NCT03358147|2282570|FG000|Overall Study|Lack of Efficacy|0
1161135|NCT03358147|2282571|FG001|Overall Study|Lack of Efficacy|1
1161136|NCT03358147|2282572|FG002|Overall Study|Lack of Efficacy|1
1161137|NCT03358147|2282573|FG003|Overall Study|Lack of Efficacy|0
1161138|NCT03358147|2282574|FG004|Overall Study|Lack of Efficacy|0
1161139|NCT03358238|2282588|FG000|Overall Study|Withdrawal by Subject|0
1161140|NCT03358238|2282589|FG001|Overall Study|Withdrawal by Subject|1
1161141|NCT03358290|2282611|FG000|Overall Study|Study discontinued by Sponsor|0
1161142|NCT03358290|2282612|FG001|Overall Study|Study discontinued by Sponsor|1
1161143|NCT03358290|2282613|FG002|Overall Study|Study discontinued by Sponsor|1
1161144|NCT03358290|2282614|FG003|Overall Study|Study discontinued by Sponsor|0
1161145|NCT03358290|2282615|FG004|Overall Study|Study discontinued by Sponsor|0
1161146|NCT03358290|2282611|FG000|Overall Study|Adverse Event|0
1161147|NCT03358290|2282612|FG001|Overall Study|Adverse Event|0
1161148|NCT03358290|2282613|FG002|Overall Study|Adverse Event|1
1161149|NCT03358290|2282614|FG003|Overall Study|Adverse Event|2
1161150|NCT03358290|2282615|FG004|Overall Study|Adverse Event|0
1161151|NCT03358290|2282611|FG000|Overall Study|Withdrawal by Subject|0
1161152|NCT03358290|2282612|FG001|Overall Study|Withdrawal by Subject|0
1161153|NCT03358290|2282613|FG002|Overall Study|Withdrawal by Subject|0
1161154|NCT03358290|2282614|FG003|Overall Study|Withdrawal by Subject|0
1161155|NCT03358290|2282615|FG004|Overall Study|Withdrawal by Subject|1
1161156|NCT03358329|2282627|FG000|Overall Study|Lost to Follow-up|2
1161157|NCT03358329|2282627|FG000|Overall Study|Withdrawal by Subject|2
1161158|NCT03358407|2282652|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
1161159|NCT03358407|2282653|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
1161160|NCT03358407|2282654|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1
1161161|NCT03358407|2282655|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
1161162|NCT03358407|2282656|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
1161163|NCT03358407|2282657|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
1161164|NCT03358407|2282658|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
1161165|NCT03358407|2282659|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
1161166|NCT03358407|2282660|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
1161167|NCT03358407|2282661|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
1161168|NCT03358407|2282652|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
1161169|NCT03358407|2282653|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
1161170|NCT03358407|2282654|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
1161171|NCT03358407|2282655|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
1161172|NCT03358407|2282656|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1
1161173|NCT03358407|2282657|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
1161174|NCT03358407|2282658|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
1161175|NCT03358407|2282659|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
1161176|NCT03358407|2282660|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
1161177|NCT03358407|2282661|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
1161178|NCT03358407|2282652|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
1161179|NCT03358407|2282653|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
1161180|NCT03358407|2282654|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
1018565|NCT01572792|2043444|FG004|Lead-in Study|Protocol Violation|21
1018566|NCT01572792|2043440|FG000|Lead-in Study|Lack of Efficacy|20
1018567|NCT01572792|2043441|FG001|Lead-in Study|Lack of Efficacy|5
1018568|NCT01572792|2043442|FG002|Lead-in Study|Lack of Efficacy|4
1018569|NCT01572792|2043443|FG003|Lead-in Study|Lack of Efficacy|8
1018570|NCT01572792|2043444|FG004|Lead-in Study|Lack of Efficacy|10
1018571|NCT01572792|2043440|FG000|Lead-in Study|Adverse Event|21
1018572|NCT01572792|2043441|FG001|Lead-in Study|Adverse Event|21
1018573|NCT01572792|2043442|FG002|Lead-in Study|Adverse Event|22
1018574|NCT01572792|2043443|FG003|Lead-in Study|Adverse Event|16
1018575|NCT01572792|2043444|FG004|Lead-in Study|Adverse Event|14
1018576|NCT01572792|2043440|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14
1018577|NCT01572792|2043441|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10
1018578|NCT01572792|2043442|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8
1018579|NCT01572792|2043443|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9
1018580|NCT01572792|2043444|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9
1018581|NCT01572792|2043440|FG000|Extension Study|Lost to Follow-up|6
1018582|NCT01572792|2043441|FG001|Extension Study|Lost to Follow-up|2
1018583|NCT01572792|2043442|FG002|Extension Study|Lost to Follow-up|0
1018584|NCT01572792|2043443|FG003|Extension Study|Lost to Follow-up|3
1018585|NCT01572792|2043444|FG004|Extension Study|Lost to Follow-up|3
1018586|NCT01572792|2043440|FG000|Extension Study|Withdrawal by Subject|7
1018587|NCT01572792|2043441|FG001|Extension Study|Withdrawal by Subject|6
1018588|NCT01572792|2043442|FG002|Extension Study|Withdrawal by Subject|11
1018589|NCT01572792|2043443|FG003|Extension Study|Withdrawal by Subject|8
1161181|NCT03358407|2282655|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
1161182|NCT03358407|2282656|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
1161183|NCT03358407|2282657|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1
1161184|NCT03358407|2282658|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
1161185|NCT03358407|2282659|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2
1161186|NCT03358407|2282660|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
1161187|NCT03358407|2282661|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
1161188|NCT03358407|2282652|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
1161189|NCT03358407|2282653|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
1161190|NCT03358407|2282654|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
1161191|NCT03358407|2282655|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
1161192|NCT03358407|2282656|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
1161193|NCT03358407|2282657|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
1161194|NCT03358407|2282658|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
1161195|NCT03358407|2282659|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
1161196|NCT03358407|2282660|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
1161197|NCT03358407|2282661|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
1161198|NCT03358407|2282652|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
1161199|NCT03358407|2282653|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
1161200|NCT03358407|2282654|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
1161201|NCT03358407|2282655|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
1161202|NCT03358407|2282656|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
1161203|NCT03358407|2282657|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
1161204|NCT03358407|2282658|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
1161205|NCT03358407|2282659|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
1161206|NCT03358407|2282660|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
1161207|NCT03358407|2282661|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
1161208|NCT03358407|2282652|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
1161209|NCT03358407|2282653|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
1161210|NCT03358407|2282654|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
1018590|NCT01572792|2043444|FG004|Extension Study|Withdrawal by Subject|14
1018591|NCT01572792|2043440|FG000|Extension Study|Protocol Violation|0
1018592|NCT01572792|2043441|FG001|Extension Study|Protocol Violation|4
1018593|NCT01572792|2043442|FG002|Extension Study|Protocol Violation|3
1018594|NCT01572792|2043443|FG003|Extension Study|Protocol Violation|4
1018595|NCT01572792|2043444|FG004|Extension Study|Protocol Violation|3
1018596|NCT01572792|2043440|FG000|Extension Study|Lack of Efficacy|2
1018597|NCT01572792|2043441|FG001|Extension Study|Lack of Efficacy|3
1018598|NCT01572792|2043442|FG002|Extension Study|Lack of Efficacy|3
1018599|NCT01572792|2043443|FG003|Extension Study|Lack of Efficacy|2
1018600|NCT01572792|2043444|FG004|Extension Study|Lack of Efficacy|2
1018601|NCT01572792|2043440|FG000|Extension Study|Adverse Event|7
1018602|NCT01572792|2043441|FG001|Extension Study|Adverse Event|6
1018603|NCT01572792|2043442|FG002|Extension Study|Adverse Event|5
1018604|NCT01572792|2043443|FG003|Extension Study|Adverse Event|6
1018605|NCT01572792|2043444|FG004|Extension Study|Adverse Event|4
1018606|NCT01572792|2043440|FG000|Extension Study|Site termination/COPD exacerbation/other|3
1018607|NCT01572792|2043441|FG001|Extension Study|Site termination/COPD exacerbation/other|8
1018608|NCT01572792|2043442|FG002|Extension Study|Site termination/COPD exacerbation/other|4
1018609|NCT01572792|2043443|FG003|Extension Study|Site termination/COPD exacerbation/other|6
1018610|NCT01572792|2043444|FG004|Extension Study|Site termination/COPD exacerbation/other|6
1018611|NCT01572844|2043457|FG000|Overall Study|Physician Decision|1
1018612|NCT01572844|2043458|FG001|Overall Study|Physician Decision|1
1018613|NCT01572909|2043469|FG000|Overall Study|Adverse Event|7
1018614|NCT01572909|2043470|FG001|Overall Study|Adverse Event|2
1018615|NCT01572909|2043469|FG000|Overall Study|Death|3
1018616|NCT01572909|2043470|FG001|Overall Study|Death|1
1018617|NCT01572909|2043469|FG000|Overall Study|Lost to Follow-up|8
1018618|NCT01572909|2043470|FG001|Overall Study|Lost to Follow-up|7
1018619|NCT01572909|2043469|FG000|Overall Study|Physician Decision|1
1018620|NCT01572909|2043470|FG001|Overall Study|Physician Decision|1
1018621|NCT01572909|2043469|FG000|Overall Study|Technical Issues|1
1018622|NCT01572909|2043470|FG001|Overall Study|Technical Issues|0
1018623|NCT01572909|2043469|FG000|Overall Study|Withdrawal by Subject|12
1018624|NCT01572909|2043470|FG001|Overall Study|Withdrawal by Subject|11
1018625|NCT01572909|2043469|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0
1018626|NCT01572909|2043470|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3
1018627|NCT01572922|2043478|FG000|Overall Study|Adverse Event|1
1018628|NCT01572922|2043478|FG000|Overall Study|Protocol Violation|1
1018629|NCT01572922|2043478|FG000|Overall Study|Death|1
1018630|NCT01572948|2043489|FG000|Overall Study|Lost to Follow-up|1
1018631|NCT01572948|2043490|FG001|Overall Study|Lost to Follow-up|0
1018632|NCT01572948|2043489|FG000|Overall Study|unable to contact|0
1018633|NCT01572948|2043490|FG001|Overall Study|unable to contact|1
1161211|NCT03358407|2282655|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
1161212|NCT03358407|2282656|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
1161213|NCT03358407|2282657|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
1161214|NCT03358407|2282658|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
1161215|NCT03358407|2282659|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6
1161216|NCT03358407|2282660|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
1161217|NCT03358407|2282661|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
1161218|NCT03358472|2282692|FG000|Overall Study|Death|6
1161219|NCT03358472|2282693|FG001|Overall Study|Death|3
1161220|NCT03358472|2282694|FG002|Overall Study|Death|10
1161221|NCT03358472|2282692|FG000|Overall Study|Physician Decision|0
1161222|NCT03358472|2282693|FG001|Overall Study|Physician Decision|1
1161223|NCT03358472|2282694|FG002|Overall Study|Physician Decision|0
1161224|NCT03358472|2282692|FG000|Overall Study|Withdrawal by Subject|0
1161225|NCT03358472|2282693|FG001|Overall Study|Withdrawal by Subject|0
1161226|NCT03358472|2282694|FG002|Overall Study|Withdrawal by Subject|1
1161227|NCT03358472|2282692|FG000|Overall Study|On-going at clinical cut off date|9
1161228|NCT03358472|2282693|FG001|Overall Study|On-going at clinical cut off date|6
1161229|NCT03358472|2282694|FG002|Overall Study|On-going at clinical cut off date|5
1161230|NCT03359395|2282713|FG000|First Intervention A / B|Withdrawal by Subject|1
1161231|NCT03359395|2282714|FG001|First Intervention A / B|Withdrawal by Subject|0
1161232|NCT03359395|2282713|FG000|First Intervention A / B|Lost to Follow-up|2
1161233|NCT03359395|2282714|FG001|First Intervention A / B|Lost to Follow-up|3
1161234|NCT03359395|2282713|FG000|Second Intervention B/A|Exclusion criteria|0
1161235|NCT03359395|2282714|FG001|Second Intervention B/A|Exclusion criteria|1
1161236|NCT03359395|2282713|FG000|Second Intervention B/A|Lost to Follow-up|3
1161237|NCT03359395|2282714|FG001|Second Intervention B/A|Lost to Follow-up|2
1161238|NCT03359473|2282724|FG000|Overall Study|Adverse Event|0
1161239|NCT03359473|2282725|FG001|Overall Study|Adverse Event|2
1161240|NCT03359473|2282726|FG002|Overall Study|Adverse Event|5
1161241|NCT03359473|2282727|FG003|Overall Study|Adverse Event|3
1161242|NCT03359473|2282724|FG000|Overall Study|Lost to Follow-up|0
1161243|NCT03359473|2282725|FG001|Overall Study|Lost to Follow-up|1
1161244|NCT03359473|2282726|FG002|Overall Study|Lost to Follow-up|0
1161245|NCT03359473|2282727|FG003|Overall Study|Lost to Follow-up|0
1161246|NCT03359473|2282724|FG000|Overall Study|Physician Decision|0
1161247|NCT03359473|2282725|FG001|Overall Study|Physician Decision|1
1161248|NCT03359473|2282726|FG002|Overall Study|Physician Decision|0
1161249|NCT03359473|2282727|FG003|Overall Study|Physician Decision|1
1161250|NCT03359473|2282724|FG000|Overall Study|Withdrawal by Subject|1
1161251|NCT03359473|2282725|FG001|Overall Study|Withdrawal by Subject|2
1161252|NCT03359473|2282726|FG002|Overall Study|Withdrawal by Subject|1
1161253|NCT03359473|2282727|FG003|Overall Study|Withdrawal by Subject|0
1018634|NCT01573000|2043502|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
1018635|NCT01573000|2043503|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
1018636|NCT01573000|2043502|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
1018637|NCT01573000|2043503|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
1018638|NCT01573000|2043502|FG000|Dosimetric and Therapeutic Treatment|Death|0
1018639|NCT01573000|2043503|FG001|Dosimetric and Therapeutic Treatment|Death|1
1018640|NCT01573000|2043502|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
1018641|NCT01573000|2043503|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
1018642|NCT01573000|2043502|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
1018643|NCT01573000|2043503|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
1018644|NCT01573000|2043502|FG000|Crossover Phase|Lack of Efficacy|0
1018645|NCT01573000|2043503|FG001|Crossover Phase|Lack of Efficacy|13
1018646|NCT01573000|2043502|FG000|Crossover Phase|Lost to Follow-up|0
1018647|NCT01573000|2043503|FG001|Crossover Phase|Lost to Follow-up|2
1018648|NCT01573000|2043502|FG000|Crossover Phase|Death|0
1018649|NCT01573000|2043503|FG001|Crossover Phase|Death|3
1018650|NCT01573000|2043502|FG000|Long-Term Follow-Up|Death|3
1018651|NCT01573000|2043503|FG001|Long-Term Follow-Up|Death|0
1018652|NCT01573000|2043502|FG000|Long-Term Follow-Up|Lost to Follow-up|0
1018653|NCT01573000|2043503|FG001|Long-Term Follow-Up|Lost to Follow-up|1
1018654|NCT01573442|2043591|FG000|Overall Study|Cancels|9
1018655|NCT01573442|2043592|FG001|Overall Study|Cancels|10
1018656|NCT01573624|2043606|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1018657|NCT01573624|2043607|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1018658|NCT01573624|2043608|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
1018659|NCT01573624|2043609|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1018660|NCT01573624|2043610|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1018661|NCT01573624|2043611|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
1018662|NCT01573624|2043612|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1018663|NCT01573624|2043606|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
1018664|NCT01573624|2043607|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
1018665|NCT01573624|2043608|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
1018666|NCT01573624|2043609|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
1018667|NCT01573624|2043610|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
1018668|NCT01573624|2043611|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
1161254|NCT03359473|2282724|FG000|Overall Study|Protocol-defined stopping criteria|1
1161255|NCT03359473|2282725|FG001|Overall Study|Protocol-defined stopping criteria|0
1161256|NCT03359473|2282726|FG002|Overall Study|Protocol-defined stopping criteria|0
1161257|NCT03359473|2282727|FG003|Overall Study|Protocol-defined stopping criteria|1
1161258|NCT03359590|2282740|FG000|First Intervention|Withdrawal by Subject|1
1018669|NCT01573624|2043612|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
1018670|NCT01573624|2043606|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
1018671|NCT01573624|2043607|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1018672|NCT01573624|2043608|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1018673|NCT01573624|2043609|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1018674|NCT01573624|2043610|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1018675|NCT01573624|2043611|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1018676|NCT01573624|2043612|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1018677|NCT01573624|2043606|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1018678|NCT01573624|2043607|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1018679|NCT01573624|2043608|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1018680|NCT01573624|2043609|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1018681|NCT01573624|2043610|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1018682|NCT01573624|2043611|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
1018683|NCT01573624|2043612|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1018684|NCT01573624|2043606|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1018685|NCT01573624|2043607|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1018686|NCT01573624|2043608|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1018687|NCT01573624|2043609|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1018688|NCT01573624|2043610|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1018689|NCT01573624|2043611|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1018690|NCT01573624|2043612|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1018691|NCT01573624|2043606|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1018692|NCT01573624|2043607|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1018693|NCT01573624|2043608|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1018694|NCT01573624|2043609|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1018695|NCT01573624|2043610|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1018696|NCT01573624|2043611|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
1018697|NCT01573624|2043612|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1018698|NCT01573624|2043606|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1018699|NCT01573624|2043607|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1018700|NCT01573624|2043608|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
903606|NCT00749996|1877976|FG000|Overall Study|Adverse Event|1
903607|NCT00749996|1877977|FG001|Overall Study|Adverse Event|0
903608|NCT00749996|1877976|FG000|Overall Study|Death|1
903609|NCT00749996|1877977|FG001|Overall Study|Death|0
903610|NCT00750061|1877985|FG000|Overall Study|Adverse Event|2
903611|NCT00750061|1877986|FG001|Overall Study|Adverse Event|0
903612|NCT00750061|1877985|FG000|Overall Study|Withdrawal by Subject|0
903613|NCT00750061|1877986|FG001|Overall Study|Withdrawal by Subject|1
903614|NCT00750061|1877985|FG000|Overall Study|Physician Decision|0
903615|NCT00750061|1877986|FG001|Overall Study|Physician Decision|1
903616|NCT00750139|1877996|FG000|Overall Study|Adverse Event|1
903617|NCT00750139|1877997|FG001|Overall Study|Adverse Event|2
903618|NCT00750139|1877998|FG002|Overall Study|Adverse Event|0
903619|NCT00750139|1877999|FG003|Overall Study|Adverse Event|1
903620|NCT00750139|1877996|FG000|Overall Study|Lost to Follow-up|17
903621|NCT00750139|1877997|FG001|Overall Study|Lost to Follow-up|12
903622|NCT00750139|1877998|FG002|Overall Study|Lost to Follow-up|15
903623|NCT00750139|1877999|FG003|Overall Study|Lost to Follow-up|6
903624|NCT00750139|1877996|FG000|Overall Study|Withdrawal by Subject|3
903625|NCT00750139|1877997|FG001|Overall Study|Withdrawal by Subject|2
903626|NCT00750139|1877998|FG002|Overall Study|Withdrawal by Subject|6
903627|NCT00750139|1877999|FG003|Overall Study|Withdrawal by Subject|2
903628|NCT00750139|1877996|FG000|Overall Study|Physician Decision|1
903629|NCT00750139|1877997|FG001|Overall Study|Physician Decision|1
903630|NCT00750139|1877998|FG002|Overall Study|Physician Decision|0
903631|NCT00750139|1877999|FG003|Overall Study|Physician Decision|0
903632|NCT00750139|1877996|FG000|Overall Study|Non-compliance|1
903633|NCT00750139|1877997|FG001|Overall Study|Non-compliance|0
903634|NCT00750139|1877998|FG002|Overall Study|Non-compliance|1
903635|NCT00750139|1877999|FG003|Overall Study|Non-compliance|3
903636|NCT00750139|1877996|FG000|Overall Study|Termination by sponsor|4
903637|NCT00750139|1877997|FG001|Overall Study|Termination by sponsor|0
903638|NCT00750139|1877998|FG002|Overall Study|Termination by sponsor|0
903639|NCT00750139|1877999|FG003|Overall Study|Termination by sponsor|1
903640|NCT00750139|1877996|FG000|Overall Study|Non-specific|62
903641|NCT00750139|1877997|FG001|Overall Study|Non-specific|42
903642|NCT00750139|1877998|FG002|Overall Study|Non-specific|79
903643|NCT00750139|1877999|FG003|Overall Study|Non-specific|33
1161259|NCT03359590|2282741|FG001|First Intervention|Withdrawal by Subject|1
1161260|NCT03359590|2282740|FG000|First Intervention|Protocol Violation|0
1161261|NCT03359590|2282741|FG001|First Intervention|Protocol Violation|1
1161262|NCT03359850|2282758|FG000|PK Phase (Up to Day 8)|Physician Decision|0
1161263|NCT03359850|2282759|FG001|PK Phase (Up to Day 8)|Physician Decision|1
1161264|NCT03359850|2282758|FG000|PK Phase (Up to Day 8)|Adverse Event|1
1161265|NCT03359850|2282759|FG001|PK Phase (Up to Day 8)|Adverse Event|0
1161266|NCT03359850|2282758|FG000|Extension Phase (Up to 28 Months)|Death|2
1161267|NCT03359850|2282759|FG001|Extension Phase (Up to 28 Months)|Death|4
1161268|NCT03359850|2282758|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1
1161269|NCT03359850|2282759|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2
1161270|NCT03359850|2282758|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5
1161271|NCT03359850|2282759|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0
1161272|NCT03360071|2282773|FG000|Overall Study|Lost to Follow-up|1
1161273|NCT03360071|2282774|FG001|Overall Study|Lost to Follow-up|0
1161274|NCT03360344|2282802|FG000|Overall Study|Withdrawal by Subject|0
1161275|NCT03360344|2282803|FG001|Overall Study|Withdrawal by Subject|1
1161276|NCT03360344|2282804|FG002|Overall Study|Withdrawal by Subject|1
1161277|NCT03360747|2282821|FG000|Overall Study|Voluntary Withdrawal|1
1161278|NCT03361137|2282830|FG000|Overall Study|Reason not specified|1
1161279|NCT03361137|2282831|FG001|Overall Study|Reason not specified|0
1161280|NCT03361137|2282832|FG002|Overall Study|Reason not specified|0
1161281|NCT03361137|2282833|FG003|Overall Study|Reason not specified|0
1161282|NCT03361137|2282834|FG004|Overall Study|Reason not specified|0
1161283|NCT03361176|2282850|FG000|Overall Study|Lost to Follow-up|1
1161284|NCT03361176|2282851|FG001|Overall Study|Lost to Follow-up|2
1161285|NCT03361176|2282850|FG000|Overall Study|Adverse Event|0
1161286|NCT03361176|2282851|FG001|Overall Study|Adverse Event|2
1161287|NCT03361176|2282850|FG000|Overall Study|Withdrawal by Subject|0
1161288|NCT03361176|2282851|FG001|Overall Study|Withdrawal by Subject|1
1161289|NCT03361293|2282859|FG000|Overall Study|Lost to Follow-up|0
1161290|NCT03361293|2282860|FG001|Overall Study|Lost to Follow-up|2
1161291|NCT03361293|2282859|FG000|Overall Study|Withdrawal by Subject|1
1161292|NCT03361293|2282860|FG001|Overall Study|Withdrawal by Subject|3
1161293|NCT03361423|2282868|FG000|Overall Study|Withdrawal by Subject|4
1161294|NCT03361423|2282869|FG001|Overall Study|Withdrawal by Subject|3
1161295|NCT03361423|2282868|FG000|Overall Study|Did not treat|19
1161296|NCT03361423|2282869|FG001|Overall Study|Did not treat|18
1018701|NCT01573624|2043609|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1018702|NCT01573624|2043610|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1018703|NCT01573624|2043611|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1018704|NCT01573624|2043612|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1018705|NCT01573624|2043606|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
1018706|NCT01573624|2043607|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1018707|NCT01573624|2043608|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
1018708|NCT01573624|2043609|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
1018709|NCT01573624|2043610|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1018710|NCT01573624|2043611|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1018711|NCT01573624|2043612|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1018712|NCT01573624|2043606|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1018713|NCT01573624|2043607|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1018714|NCT01573624|2043608|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1018715|NCT01573624|2043609|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1018716|NCT01573624|2043610|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1018717|NCT01573624|2043611|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
1018718|NCT01573624|2043612|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1018719|NCT01573624|2043606|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1018720|NCT01573624|2043607|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1018721|NCT01573624|2043608|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1018722|NCT01573624|2043609|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
1018723|NCT01573624|2043610|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1018724|NCT01573624|2043611|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1018725|NCT01573624|2043612|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1018726|NCT01573624|2043606|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1018727|NCT01573624|2043607|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1018728|NCT01573624|2043608|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1018729|NCT01573624|2043609|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1018730|NCT01573624|2043610|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1018731|NCT01573624|2043611|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1018732|NCT01573624|2043612|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1018733|NCT01573624|2043606|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
1018734|NCT01573624|2043607|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
1161297|NCT03361423|2282868|FG000|Overall Study|Started >60 minutes from migraine onset|0
1161298|NCT03361423|2282869|FG001|Overall Study|Started >60 minutes from migraine onset|1
1161299|NCT03361423|2282868|FG000|Overall Study|Missing data|4
1161300|NCT03361423|2282869|FG001|Overall Study|Missing data|1
1161301|NCT03361605|2282875|FG000|Overall Study|Analyzable data not available|3
1161308|NCT03363321|2282925|FG000|Overall Study|Withdrawal by Subject|0
1161309|NCT03363321|2282926|FG001|Overall Study|Withdrawal by Subject|1
1161310|NCT03363321|2282927|FG002|Overall Study|Withdrawal by Subject|0
1161311|NCT03363321|2282928|FG003|Overall Study|Withdrawal by Subject|1
1161312|NCT03363321|2282929|FG004|Overall Study|Withdrawal by Subject|0
1161313|NCT03363776|2282945|FG000|Overall Study|Progressive disease|2
1161314|NCT03363776|2282946|FG001|Overall Study|Progressive disease|3
1161315|NCT03363776|2282947|FG002|Overall Study|Progressive disease|1
1161316|NCT03363776|2282945|FG000|Overall Study|Study drug toxicity|0
1161317|NCT03363776|2282946|FG001|Overall Study|Study drug toxicity|0
1161318|NCT03363776|2282947|FG002|Overall Study|Study drug toxicity|1
1161319|NCT03363776|2282945|FG000|Overall Study|Death|1
1161320|NCT03363776|2282946|FG001|Overall Study|Death|0
1161321|NCT03363776|2282947|FG002|Overall Study|Death|0
1161322|NCT03363906|2282987|FG000|Period 1 (Reference or Test)|Adverse Event|1
1161323|NCT03363906|2282988|FG001|Period 1 (Reference or Test)|Adverse Event|2
1161324|NCT03363906|2282987|FG000|Period 2 (Test or Reference)|Adverse Event|2
1161325|NCT03363906|2282988|FG001|Period 2 (Test or Reference)|Adverse Event|0
1161326|NCT03363906|2282987|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1
1161327|NCT03363906|2282988|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1
1161328|NCT03363906|2282987|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1
1161329|NCT03363906|2282988|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0
1161330|NCT03364023|2282994|FG000|Overall Study|Lost to Follow-up|3
1161331|NCT03364023|2282994|FG000|Overall Study|Death|14
1161332|NCT03364036|2282998|FG000|Overall Study|Adverse Event|1
1161333|NCT03364036|2282998|FG000|Overall Study|Lost to Follow-up|1
1161334|NCT03364036|2282998|FG000|Overall Study|Withdrew Consent|1
1161335|NCT03364036|2282998|FG000|Overall Study|Protocol Non-Compliance|1
1161336|NCT03364036|2282998|FG000|Overall Study|Other|2
1161337|NCT03364049|2283006|FG000|Overall Study|Death|6
1161338|NCT03364049|2283007|FG001|Overall Study|Death|4
1161339|NCT03364049|2283008|FG002|Overall Study|Death|5
1161340|NCT03364049|2283009|FG003|Overall Study|Death|14
1161341|NCT03364049|2283006|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
1161342|NCT03364049|2283007|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1
1161343|NCT03364049|2283008|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
1161344|NCT03364049|2283009|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
1161345|NCT03364049|2283006|FG000|Overall Study|Withdrawal by Subject|0
1161346|NCT03364049|2283007|FG001|Overall Study|Withdrawal by Subject|1
1161347|NCT03364049|2283008|FG002|Overall Study|Withdrawal by Subject|1
1161348|NCT03364049|2283009|FG003|Overall Study|Withdrawal by Subject|1
1161349|NCT03364192|2283019|FG000|Overall Study|Ineligible|10
1161350|NCT03364192|2283019|FG000|Overall Study|Withdrawal by Subject|5
1161351|NCT03364192|2283019|FG000|Overall Study|Lost to Follow-up|1
1161352|NCT03364309|2283027|FG000|Induction Period|Adverse Event|4
1161353|NCT03364309|2283028|FG001|Induction Period|Adverse Event|0
1161354|NCT03364309|2283029|FG002|Induction Period|Adverse Event|1
1161355|NCT03364309|2283030|FG003|Induction Period|Adverse Event|0
1161356|NCT03364309|2283031|FG004|Induction Period|Adverse Event|0
1161357|NCT03364309|2283032|FG005|Induction Period|Adverse Event|0
1161358|NCT03364309|2283033|FG006|Induction Period|Adverse Event|0
1161359|NCT03364309|2283034|FG007|Induction Period|Adverse Event|0
1161360|NCT03364309|2283035|FG008|Induction Period|Adverse Event|0
1161361|NCT03364309|2283036|FG009|Induction Period|Adverse Event|0
1161362|NCT03364309|2283037|FG010|Induction Period|Adverse Event|0
1161363|NCT03364309|2283038|FG011|Induction Period|Adverse Event|0
1161364|NCT03364309|2283039|FG012|Induction Period|Adverse Event|0
1161365|NCT03364309|2283040|FG013|Induction Period|Adverse Event|0
1161366|NCT03364309|2283041|FG014|Induction Period|Adverse Event|0
1161367|NCT03364309|2283042|FG015|Induction Period|Adverse Event|0
1018735|NCT01573624|2043608|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
1018736|NCT01573624|2043609|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
1018737|NCT01573624|2043610|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
1018738|NCT01573624|2043611|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
1018739|NCT01573624|2043612|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
1018740|NCT01573624|2043606|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1018741|NCT01573624|2043607|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
1018742|NCT01573624|2043608|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1161368|NCT03364309|2283043|FG016|Induction Period|Adverse Event|0
1161369|NCT03364309|2283044|FG017|Induction Period|Adverse Event|0
1161370|NCT03364309|2283045|FG018|Induction Period|Adverse Event|0
1161371|NCT03364309|2283027|FG000|Induction Period|Withdrawal by Subject|1
1161372|NCT03364309|2283028|FG001|Induction Period|Withdrawal by Subject|3
1161373|NCT03364309|2283029|FG002|Induction Period|Withdrawal by Subject|0
1161374|NCT03364309|2283030|FG003|Induction Period|Withdrawal by Subject|0
1161375|NCT03364309|2283031|FG004|Induction Period|Withdrawal by Subject|0
1161376|NCT03364309|2283032|FG005|Induction Period|Withdrawal by Subject|0
1161377|NCT03364309|2283033|FG006|Induction Period|Withdrawal by Subject|0
1161378|NCT03364309|2283034|FG007|Induction Period|Withdrawal by Subject|0
1161379|NCT03364309|2283035|FG008|Induction Period|Withdrawal by Subject|0
1161380|NCT03364309|2283036|FG009|Induction Period|Withdrawal by Subject|0
1161381|NCT03364309|2283037|FG010|Induction Period|Withdrawal by Subject|0
1161382|NCT03364309|2283038|FG011|Induction Period|Withdrawal by Subject|0
1161383|NCT03364309|2283039|FG012|Induction Period|Withdrawal by Subject|0
1161384|NCT03364309|2283040|FG013|Induction Period|Withdrawal by Subject|0
1161385|NCT03364309|2283041|FG014|Induction Period|Withdrawal by Subject|0
1161386|NCT03364309|2283042|FG015|Induction Period|Withdrawal by Subject|0
1161387|NCT03364309|2283043|FG016|Induction Period|Withdrawal by Subject|0
1161388|NCT03364309|2283044|FG017|Induction Period|Withdrawal by Subject|0
1161389|NCT03364309|2283045|FG018|Induction Period|Withdrawal by Subject|0
1161390|NCT03364309|2283027|FG000|Induction Period|Lost to Follow-up|1
1161391|NCT03364309|2283028|FG001|Induction Period|Lost to Follow-up|0
1161392|NCT03364309|2283029|FG002|Induction Period|Lost to Follow-up|0
1161393|NCT03364309|2283030|FG003|Induction Period|Lost to Follow-up|0
1161394|NCT03364309|2283031|FG004|Induction Period|Lost to Follow-up|0
1161395|NCT03364309|2283032|FG005|Induction Period|Lost to Follow-up|0
1161396|NCT03364309|2283033|FG006|Induction Period|Lost to Follow-up|0
1161397|NCT03364309|2283034|FG007|Induction Period|Lost to Follow-up|0
1161398|NCT03364309|2283035|FG008|Induction Period|Lost to Follow-up|0
1161399|NCT03364309|2283036|FG009|Induction Period|Lost to Follow-up|0
1161400|NCT03364309|2283037|FG010|Induction Period|Lost to Follow-up|0
1161401|NCT03364309|2283038|FG011|Induction Period|Lost to Follow-up|0
1161402|NCT03364309|2283039|FG012|Induction Period|Lost to Follow-up|0
1161403|NCT03364309|2283040|FG013|Induction Period|Lost to Follow-up|0
1161404|NCT03364309|2283041|FG014|Induction Period|Lost to Follow-up|0
1161405|NCT03364309|2283042|FG015|Induction Period|Lost to Follow-up|0
1161406|NCT03364309|2283043|FG016|Induction Period|Lost to Follow-up|0
1161407|NCT03364309|2283044|FG017|Induction Period|Lost to Follow-up|0
1161408|NCT03364309|2283045|FG018|Induction Period|Lost to Follow-up|0
1161409|NCT03364309|2283027|FG000|Induction Period|Physician Decision|0
1161410|NCT03364309|2283028|FG001|Induction Period|Physician Decision|1
1161411|NCT03364309|2283029|FG002|Induction Period|Physician Decision|0
1161412|NCT03364309|2283030|FG003|Induction Period|Physician Decision|0
1161413|NCT03364309|2283031|FG004|Induction Period|Physician Decision|0
1161414|NCT03364309|2283032|FG005|Induction Period|Physician Decision|0
1161415|NCT03364309|2283033|FG006|Induction Period|Physician Decision|0
1161416|NCT03364309|2283034|FG007|Induction Period|Physician Decision|0
1161417|NCT03364309|2283035|FG008|Induction Period|Physician Decision|0
1161418|NCT03364309|2283036|FG009|Induction Period|Physician Decision|0
1161419|NCT03364309|2283037|FG010|Induction Period|Physician Decision|0
1161420|NCT03364309|2283038|FG011|Induction Period|Physician Decision|0
1161421|NCT03364309|2283039|FG012|Induction Period|Physician Decision|0
1161422|NCT03364309|2283040|FG013|Induction Period|Physician Decision|0
1161423|NCT03364309|2283041|FG014|Induction Period|Physician Decision|0
1161424|NCT03364309|2283042|FG015|Induction Period|Physician Decision|0
1161425|NCT03364309|2283043|FG016|Induction Period|Physician Decision|0
1161426|NCT03364309|2283044|FG017|Induction Period|Physician Decision|0
1161427|NCT03364309|2283045|FG018|Induction Period|Physician Decision|0
1161428|NCT03364309|2283027|FG000|Maintenance Period|Withdrawal by Subject|0
1161429|NCT03364309|2283028|FG001|Maintenance Period|Withdrawal by Subject|0
1161430|NCT03364309|2283029|FG002|Maintenance Period|Withdrawal by Subject|0
1161431|NCT03364309|2283030|FG003|Maintenance Period|Withdrawal by Subject|1
1161432|NCT03364309|2283031|FG004|Maintenance Period|Withdrawal by Subject|3
1161433|NCT03364309|2283032|FG005|Maintenance Period|Withdrawal by Subject|1
1161434|NCT03364309|2283033|FG006|Maintenance Period|Withdrawal by Subject|3
1161435|NCT03364309|2283034|FG007|Maintenance Period|Withdrawal by Subject|0
1161436|NCT03364309|2283035|FG008|Maintenance Period|Withdrawal by Subject|1
1161437|NCT03364309|2283036|FG009|Maintenance Period|Withdrawal by Subject|1
1161438|NCT03364309|2283037|FG010|Maintenance Period|Withdrawal by Subject|2
1161439|NCT03364309|2283038|FG011|Maintenance Period|Withdrawal by Subject|0
1161440|NCT03364309|2283039|FG012|Maintenance Period|Withdrawal by Subject|0
1161441|NCT03364309|2283040|FG013|Maintenance Period|Withdrawal by Subject|0
1161442|NCT03364309|2283041|FG014|Maintenance Period|Withdrawal by Subject|0
1161443|NCT03364309|2283042|FG015|Maintenance Period|Withdrawal by Subject|0
1161444|NCT03364309|2283043|FG016|Maintenance Period|Withdrawal by Subject|0
1161445|NCT03364309|2283044|FG017|Maintenance Period|Withdrawal by Subject|0
1161446|NCT03364309|2283045|FG018|Maintenance Period|Withdrawal by Subject|0
1161447|NCT03364309|2283027|FG000|Maintenance Period|Adverse Event|0
1161448|NCT03364309|2283028|FG001|Maintenance Period|Adverse Event|0
1161449|NCT03364309|2283029|FG002|Maintenance Period|Adverse Event|0
1161450|NCT03364309|2283030|FG003|Maintenance Period|Adverse Event|0
1161451|NCT03364309|2283031|FG004|Maintenance Period|Adverse Event|2
1161452|NCT03364309|2283032|FG005|Maintenance Period|Adverse Event|0
1161453|NCT03364309|2283033|FG006|Maintenance Period|Adverse Event|3
1161454|NCT03364309|2283034|FG007|Maintenance Period|Adverse Event|0
1161455|NCT03364309|2283035|FG008|Maintenance Period|Adverse Event|1
1161456|NCT03364309|2283036|FG009|Maintenance Period|Adverse Event|0
1161457|NCT03364309|2283037|FG010|Maintenance Period|Adverse Event|2
1161458|NCT03364309|2283038|FG011|Maintenance Period|Adverse Event|0
1161459|NCT03364309|2283039|FG012|Maintenance Period|Adverse Event|0
1161460|NCT03364309|2283040|FG013|Maintenance Period|Adverse Event|0
1161461|NCT03364309|2283041|FG014|Maintenance Period|Adverse Event|0
1161462|NCT03364309|2283042|FG015|Maintenance Period|Adverse Event|0
1161463|NCT03364309|2283043|FG016|Maintenance Period|Adverse Event|0
1161464|NCT03364309|2283044|FG017|Maintenance Period|Adverse Event|0
1161465|NCT03364309|2283045|FG018|Maintenance Period|Adverse Event|0
1161466|NCT03364309|2283027|FG000|Maintenance Period|Relapsed|0
1161467|NCT03364309|2283028|FG001|Maintenance Period|Relapsed|0
1161468|NCT03364309|2283029|FG002|Maintenance Period|Relapsed|0
1161469|NCT03364309|2283030|FG003|Maintenance Period|Relapsed|43
1161470|NCT03364309|2283031|FG004|Maintenance Period|Relapsed|7
1161471|NCT03364309|2283032|FG005|Maintenance Period|Relapsed|45
1161472|NCT03364309|2283033|FG006|Maintenance Period|Relapsed|10
1161473|NCT03364309|2283034|FG007|Maintenance Period|Relapsed|2
1161474|NCT03364309|2283035|FG008|Maintenance Period|Relapsed|0
1161475|NCT03364309|2283036|FG009|Maintenance Period|Relapsed|0
1161476|NCT03364309|2283037|FG010|Maintenance Period|Relapsed|0
1018743|NCT01573624|2043609|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1018744|NCT01573624|2043610|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1018745|NCT01573624|2043611|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
1018746|NCT01573624|2043612|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1018747|NCT01573624|2043606|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
1018748|NCT01573624|2043607|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1018749|NCT01573624|2043608|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1018750|NCT01573624|2043609|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1018751|NCT01573624|2043610|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1018752|NCT01573624|2043611|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1018753|NCT01573624|2043612|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1018754|NCT01573624|2043606|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1018755|NCT01573624|2043607|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1018756|NCT01573624|2043608|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1018757|NCT01573624|2043609|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1018758|NCT01573624|2043610|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1018759|NCT01573624|2043611|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1018760|NCT01573624|2043612|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1018761|NCT01573624|2043606|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
1018762|NCT01573624|2043607|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1018763|NCT01573624|2043608|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1018764|NCT01573624|2043609|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1018765|NCT01573624|2043610|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1018766|NCT01573624|2043611|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1018767|NCT01573624|2043612|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1018768|NCT01573624|2043606|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
1018769|NCT01573624|2043607|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1018770|NCT01573624|2043608|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1018771|NCT01573624|2043609|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1018772|NCT01573624|2043610|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1018773|NCT01573624|2043611|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1018774|NCT01573624|2043612|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
1018775|NCT01573624|2043606|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
1018776|NCT01573624|2043607|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1018777|NCT01573624|2043608|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1018778|NCT01573624|2043609|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1018779|NCT01573624|2043610|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1018780|NCT01573624|2043611|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
1018781|NCT01573624|2043612|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1018782|NCT01573624|2043606|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1018783|NCT01573624|2043607|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
1018784|NCT01573624|2043608|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1018785|NCT01573624|2043609|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1018786|NCT01573624|2043610|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1018787|NCT01573624|2043611|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1161477|NCT03364309|2283038|FG011|Maintenance Period|Relapsed|0
1161478|NCT03364309|2283039|FG012|Maintenance Period|Relapsed|0
1161479|NCT03364309|2283040|FG013|Maintenance Period|Relapsed|0
1161480|NCT03364309|2283041|FG014|Maintenance Period|Relapsed|0
1161481|NCT03364309|2283042|FG015|Maintenance Period|Relapsed|0
1161482|NCT03364309|2283043|FG016|Maintenance Period|Relapsed|0
1161483|NCT03364309|2283044|FG017|Maintenance Period|Relapsed|0
1161484|NCT03364309|2283045|FG018|Maintenance Period|Relapsed|0
1161485|NCT03364309|2283027|FG000|Maintenance Period|Lack of Efficacy|0
1161486|NCT03364309|2283028|FG001|Maintenance Period|Lack of Efficacy|0
1161487|NCT03364309|2283029|FG002|Maintenance Period|Lack of Efficacy|0
1161488|NCT03364309|2283030|FG003|Maintenance Period|Lack of Efficacy|0
1161489|NCT03364309|2283031|FG004|Maintenance Period|Lack of Efficacy|0
1161490|NCT03364309|2283032|FG005|Maintenance Period|Lack of Efficacy|0
1161491|NCT03364309|2283033|FG006|Maintenance Period|Lack of Efficacy|0
1161492|NCT03364309|2283034|FG007|Maintenance Period|Lack of Efficacy|0
1161493|NCT03364309|2283035|FG008|Maintenance Period|Lack of Efficacy|1
1161494|NCT03364309|2283036|FG009|Maintenance Period|Lack of Efficacy|3
1161495|NCT03364309|2283037|FG010|Maintenance Period|Lack of Efficacy|2
1161496|NCT03364309|2283038|FG011|Maintenance Period|Lack of Efficacy|0
1161497|NCT03364309|2283039|FG012|Maintenance Period|Lack of Efficacy|0
1161498|NCT03364309|2283040|FG013|Maintenance Period|Lack of Efficacy|0
1161499|NCT03364309|2283041|FG014|Maintenance Period|Lack of Efficacy|0
1161500|NCT03364309|2283042|FG015|Maintenance Period|Lack of Efficacy|0
1161501|NCT03364309|2283043|FG016|Maintenance Period|Lack of Efficacy|0
1161502|NCT03364309|2283044|FG017|Maintenance Period|Lack of Efficacy|0
1161503|NCT03364309|2283045|FG018|Maintenance Period|Lack of Efficacy|0
1161504|NCT03364309|2283027|FG000|Maintenance Period|Death|0
1161505|NCT03364309|2283028|FG001|Maintenance Period|Death|0
1161506|NCT03364309|2283029|FG002|Maintenance Period|Death|0
1161507|NCT03364309|2283030|FG003|Maintenance Period|Death|0
1161508|NCT03364309|2283031|FG004|Maintenance Period|Death|0
1161509|NCT03364309|2283032|FG005|Maintenance Period|Death|0
1161510|NCT03364309|2283033|FG006|Maintenance Period|Death|0
1161511|NCT03364309|2283034|FG007|Maintenance Period|Death|0
1161512|NCT03364309|2283035|FG008|Maintenance Period|Death|1
1161513|NCT03364309|2283036|FG009|Maintenance Period|Death|0
1161514|NCT03364309|2283037|FG010|Maintenance Period|Death|0
1161515|NCT03364309|2283038|FG011|Maintenance Period|Death|0
1161516|NCT03364309|2283039|FG012|Maintenance Period|Death|0
1161517|NCT03364309|2283040|FG013|Maintenance Period|Death|0
1161518|NCT03364309|2283041|FG014|Maintenance Period|Death|0
1161519|NCT03364309|2283042|FG015|Maintenance Period|Death|0
1161520|NCT03364309|2283043|FG016|Maintenance Period|Death|0
1161521|NCT03364309|2283044|FG017|Maintenance Period|Death|0
1161522|NCT03364309|2283045|FG018|Maintenance Period|Death|0
1161523|NCT03364309|2283027|FG000|Maintenance Period|Lost to Follow-up|0
1161524|NCT03364309|2283028|FG001|Maintenance Period|Lost to Follow-up|0
1161525|NCT03364309|2283029|FG002|Maintenance Period|Lost to Follow-up|0
1161526|NCT03364309|2283030|FG003|Maintenance Period|Lost to Follow-up|0
1161527|NCT03364309|2283031|FG004|Maintenance Period|Lost to Follow-up|0
1161528|NCT03364309|2283032|FG005|Maintenance Period|Lost to Follow-up|0
1161529|NCT03364309|2283033|FG006|Maintenance Period|Lost to Follow-up|0
1161530|NCT03364309|2283034|FG007|Maintenance Period|Lost to Follow-up|0
1161531|NCT03364309|2283035|FG008|Maintenance Period|Lost to Follow-up|1
1161532|NCT03364309|2283036|FG009|Maintenance Period|Lost to Follow-up|0
1161533|NCT03364309|2283037|FG010|Maintenance Period|Lost to Follow-up|0
1161534|NCT03364309|2283038|FG011|Maintenance Period|Lost to Follow-up|0
1161535|NCT03364309|2283039|FG012|Maintenance Period|Lost to Follow-up|0
1161536|NCT03364309|2283040|FG013|Maintenance Period|Lost to Follow-up|0
1161537|NCT03364309|2283041|FG014|Maintenance Period|Lost to Follow-up|0
1161538|NCT03364309|2283042|FG015|Maintenance Period|Lost to Follow-up|0
1161539|NCT03364309|2283043|FG016|Maintenance Period|Lost to Follow-up|0
1161540|NCT03364309|2283044|FG017|Maintenance Period|Lost to Follow-up|0
1161541|NCT03364309|2283045|FG018|Maintenance Period|Lost to Follow-up|0
1161542|NCT03364309|2283027|FG000|Maintenance Period|Miscellaneous|0
1161543|NCT03364309|2283028|FG001|Maintenance Period|Miscellaneous|0
1161544|NCT03364309|2283029|FG002|Maintenance Period|Miscellaneous|0
1161545|NCT03364309|2283030|FG003|Maintenance Period|Miscellaneous|0
1161546|NCT03364309|2283031|FG004|Maintenance Period|Miscellaneous|0
1161547|NCT03364309|2283032|FG005|Maintenance Period|Miscellaneous|0
1161548|NCT03364309|2283033|FG006|Maintenance Period|Miscellaneous|0
1161549|NCT03364309|2283034|FG007|Maintenance Period|Miscellaneous|0
1161550|NCT03364309|2283035|FG008|Maintenance Period|Miscellaneous|1
1161551|NCT03364309|2283036|FG009|Maintenance Period|Miscellaneous|0
1161552|NCT03364309|2283037|FG010|Maintenance Period|Miscellaneous|0
1161553|NCT03364309|2283038|FG011|Maintenance Period|Miscellaneous|0
1161554|NCT03364309|2283039|FG012|Maintenance Period|Miscellaneous|0
1161555|NCT03364309|2283040|FG013|Maintenance Period|Miscellaneous|0
1161556|NCT03364309|2283041|FG014|Maintenance Period|Miscellaneous|0
1161557|NCT03364309|2283042|FG015|Maintenance Period|Miscellaneous|0
1161558|NCT03364309|2283043|FG016|Maintenance Period|Miscellaneous|0
1161559|NCT03364309|2283044|FG017|Maintenance Period|Miscellaneous|0
1161560|NCT03364309|2283045|FG018|Maintenance Period|Miscellaneous|0
1161561|NCT03364309|2283027|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161562|NCT03364309|2283028|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161563|NCT03364309|2283029|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161564|NCT03364309|2283030|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161565|NCT03364309|2283031|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161566|NCT03364309|2283032|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161567|NCT03364309|2283033|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161568|NCT03364309|2283034|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161569|NCT03364309|2283035|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161570|NCT03364309|2283036|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161571|NCT03364309|2283037|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161572|NCT03364309|2283038|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161573|NCT03364309|2283039|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161574|NCT03364309|2283040|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
1161575|NCT03364309|2283041|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
1161576|NCT03364309|2283042|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
1161577|NCT03364309|2283043|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161578|NCT03364309|2283044|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161579|NCT03364309|2283045|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
1161580|NCT03364309|2283027|FG000|Re-treatment (Maintenance) Period|Adverse Event|0
1161581|NCT03364309|2283028|FG001|Re-treatment (Maintenance) Period|Adverse Event|0
1161582|NCT03364309|2283029|FG002|Re-treatment (Maintenance) Period|Adverse Event|0
1161583|NCT03364309|2283030|FG003|Re-treatment (Maintenance) Period|Adverse Event|0
1161584|NCT03364309|2283031|FG004|Re-treatment (Maintenance) Period|Adverse Event|0
1161585|NCT03364309|2283032|FG005|Re-treatment (Maintenance) Period|Adverse Event|0
1161586|NCT03364309|2283033|FG006|Re-treatment (Maintenance) Period|Adverse Event|0
1161587|NCT03364309|2283034|FG007|Re-treatment (Maintenance) Period|Adverse Event|0
1161588|NCT03364309|2283035|FG008|Re-treatment (Maintenance) Period|Adverse Event|0
1161589|NCT03364309|2283036|FG009|Re-treatment (Maintenance) Period|Adverse Event|0
1161590|NCT03364309|2283037|FG010|Re-treatment (Maintenance) Period|Adverse Event|0
1161591|NCT03364309|2283038|FG011|Re-treatment (Maintenance) Period|Adverse Event|0
1161592|NCT03364309|2283039|FG012|Re-treatment (Maintenance) Period|Adverse Event|0
1161593|NCT03364309|2283040|FG013|Re-treatment (Maintenance) Period|Adverse Event|0
1161594|NCT03364309|2283041|FG014|Re-treatment (Maintenance) Period|Adverse Event|1
1161595|NCT03364309|2283042|FG015|Re-treatment (Maintenance) Period|Adverse Event|0
1161596|NCT03364309|2283043|FG016|Re-treatment (Maintenance) Period|Adverse Event|0
1161597|NCT03364309|2283044|FG017|Re-treatment (Maintenance) Period|Adverse Event|0
1161598|NCT03364309|2283045|FG018|Re-treatment (Maintenance) Period|Adverse Event|0
1161599|NCT03364309|2283027|FG000|Re-treatment (Maintenance) Period|Relapse|0
1161600|NCT03364309|2283028|FG001|Re-treatment (Maintenance) Period|Relapse|0
1161601|NCT03364309|2283029|FG002|Re-treatment (Maintenance) Period|Relapse|0
1161602|NCT03364309|2283030|FG003|Re-treatment (Maintenance) Period|Relapse|0
1161603|NCT03364309|2283031|FG004|Re-treatment (Maintenance) Period|Relapse|0
1161604|NCT03364309|2283032|FG005|Re-treatment (Maintenance) Period|Relapse|0
1161605|NCT03364309|2283033|FG006|Re-treatment (Maintenance) Period|Relapse|0
1161606|NCT03364309|2283034|FG007|Re-treatment (Maintenance) Period|Relapse|0
1161607|NCT03364309|2283035|FG008|Re-treatment (Maintenance) Period|Relapse|0
1161608|NCT03364309|2283036|FG009|Re-treatment (Maintenance) Period|Relapse|0
1161609|NCT03364309|2283037|FG010|Re-treatment (Maintenance) Period|Relapse|0
1161610|NCT03364309|2283038|FG011|Re-treatment (Maintenance) Period|Relapse|0
1161611|NCT03364309|2283039|FG012|Re-treatment (Maintenance) Period|Relapse|1
1161612|NCT03364309|2283040|FG013|Re-treatment (Maintenance) Period|Relapse|0
1161613|NCT03364309|2283041|FG014|Re-treatment (Maintenance) Period|Relapse|0
1161614|NCT03364309|2283042|FG015|Re-treatment (Maintenance) Period|Relapse|1
1161615|NCT03364309|2283043|FG016|Re-treatment (Maintenance) Period|Relapse|0
1161616|NCT03364309|2283044|FG017|Re-treatment (Maintenance) Period|Relapse|0
1161617|NCT03364309|2283045|FG018|Re-treatment (Maintenance) Period|Relapse|0
1161618|NCT03364309|2283027|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0
1161619|NCT03364309|2283028|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0
1161620|NCT03364309|2283029|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0
1161621|NCT03364309|2283030|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0
1161622|NCT03364309|2283031|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
1161623|NCT03364309|2283032|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0
1161624|NCT03364309|2283033|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0
1161625|NCT03364309|2283034|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0
1161626|NCT03364309|2283035|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0
1161627|NCT03364309|2283036|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0
1161628|NCT03364309|2283037|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0
1161629|NCT03364309|2283038|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0
1161630|NCT03364309|2283039|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0
1161631|NCT03364309|2283040|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0
1161632|NCT03364309|2283041|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0
1161633|NCT03364309|2283042|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0
1161634|NCT03364309|2283043|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3
1161635|NCT03364309|2283044|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19
1161636|NCT03364309|2283045|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1
1161637|NCT03364309|2283027|FG000|Post-Treatment Followup Period|Adverse Event|0
1161638|NCT03364309|2283028|FG001|Post-Treatment Followup Period|Adverse Event|0
1161639|NCT03364309|2283029|FG002|Post-Treatment Followup Period|Adverse Event|0
1161640|NCT03364309|2283030|FG003|Post-Treatment Followup Period|Adverse Event|0
1161641|NCT03364309|2283031|FG004|Post-Treatment Followup Period|Adverse Event|0
1161642|NCT03364309|2283032|FG005|Post-Treatment Followup Period|Adverse Event|0
1161643|NCT03364309|2283033|FG006|Post-Treatment Followup Period|Adverse Event|0
1161644|NCT03364309|2283034|FG007|Post-Treatment Followup Period|Adverse Event|0
1161645|NCT03364309|2283035|FG008|Post-Treatment Followup Period|Adverse Event|0
1161646|NCT03364309|2283036|FG009|Post-Treatment Followup Period|Adverse Event|0
1161647|NCT03364309|2283037|FG010|Post-Treatment Followup Period|Adverse Event|0
1161648|NCT03364309|2283038|FG011|Post-Treatment Followup Period|Adverse Event|0
1161649|NCT03364309|2283039|FG012|Post-Treatment Followup Period|Adverse Event|0
1161650|NCT03364309|2283040|FG013|Post-Treatment Followup Period|Adverse Event|0
1161651|NCT03364309|2283041|FG014|Post-Treatment Followup Period|Adverse Event|0
1161652|NCT03364309|2283042|FG015|Post-Treatment Followup Period|Adverse Event|0
1161653|NCT03364309|2283043|FG016|Post-Treatment Followup Period|Adverse Event|2
1161654|NCT03364309|2283044|FG017|Post-Treatment Followup Period|Adverse Event|6
1161655|NCT03364309|2283045|FG018|Post-Treatment Followup Period|Adverse Event|1
1161656|NCT03364309|2283027|FG000|Post-Treatment Followup Period|Lost to Follow-up|0
1161657|NCT03364309|2283028|FG001|Post-Treatment Followup Period|Lost to Follow-up|0
1161658|NCT03364309|2283029|FG002|Post-Treatment Followup Period|Lost to Follow-up|0
1161659|NCT03364309|2283030|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
1161660|NCT03364309|2283031|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
1161661|NCT03364309|2283032|FG005|Post-Treatment Followup Period|Lost to Follow-up|0
1161662|NCT03364309|2283033|FG006|Post-Treatment Followup Period|Lost to Follow-up|0
1161663|NCT03364309|2283034|FG007|Post-Treatment Followup Period|Lost to Follow-up|0
1161664|NCT03364309|2283035|FG008|Post-Treatment Followup Period|Lost to Follow-up|0
1161665|NCT03364309|2283036|FG009|Post-Treatment Followup Period|Lost to Follow-up|0
1161666|NCT03364309|2283037|FG010|Post-Treatment Followup Period|Lost to Follow-up|0
1161667|NCT03364309|2283038|FG011|Post-Treatment Followup Period|Lost to Follow-up|0
1161668|NCT03364309|2283039|FG012|Post-Treatment Followup Period|Lost to Follow-up|0
1161669|NCT03364309|2283040|FG013|Post-Treatment Followup Period|Lost to Follow-up|0
1161670|NCT03364309|2283041|FG014|Post-Treatment Followup Period|Lost to Follow-up|0
1161671|NCT03364309|2283042|FG015|Post-Treatment Followup Period|Lost to Follow-up|0
1161672|NCT03364309|2283043|FG016|Post-Treatment Followup Period|Lost to Follow-up|0
1161673|NCT03364309|2283044|FG017|Post-Treatment Followup Period|Lost to Follow-up|2
1161674|NCT03364309|2283045|FG018|Post-Treatment Followup Period|Lost to Follow-up|0
1161675|NCT03364309|2283027|FG000|Post-Treatment Followup Period|Miscellaneous|0
1161676|NCT03364309|2283028|FG001|Post-Treatment Followup Period|Miscellaneous|0
1161677|NCT03364309|2283029|FG002|Post-Treatment Followup Period|Miscellaneous|0
1161678|NCT03364309|2283030|FG003|Post-Treatment Followup Period|Miscellaneous|0
1161679|NCT03364309|2283031|FG004|Post-Treatment Followup Period|Miscellaneous|0
1161680|NCT03364309|2283032|FG005|Post-Treatment Followup Period|Miscellaneous|0
1161681|NCT03364309|2283033|FG006|Post-Treatment Followup Period|Miscellaneous|0
1161682|NCT03364309|2283034|FG007|Post-Treatment Followup Period|Miscellaneous|0
1161683|NCT03364309|2283035|FG008|Post-Treatment Followup Period|Miscellaneous|0
1161684|NCT03364309|2283036|FG009|Post-Treatment Followup Period|Miscellaneous|0
1161685|NCT03364309|2283037|FG010|Post-Treatment Followup Period|Miscellaneous|0
1161686|NCT03364309|2283038|FG011|Post-Treatment Followup Period|Miscellaneous|0
1161687|NCT03364309|2283039|FG012|Post-Treatment Followup Period|Miscellaneous|0
1018788|NCT01573624|2043612|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1018789|NCT01573624|2043606|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1018790|NCT01573624|2043607|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
1018791|NCT01573624|2043608|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1018792|NCT01573624|2043609|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1018793|NCT01573624|2043610|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1018794|NCT01573624|2043611|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1018795|NCT01573624|2043612|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1018796|NCT01573624|2043606|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1018797|NCT01573624|2043607|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1018798|NCT01573624|2043608|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1018799|NCT01573624|2043609|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1018800|NCT01573624|2043610|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1018801|NCT01573624|2043611|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1018802|NCT01573624|2043612|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1018803|NCT01573624|2043606|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1018804|NCT01573624|2043607|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1018805|NCT01573624|2043608|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1018806|NCT01573624|2043609|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1161688|NCT03364309|2283040|FG013|Post-Treatment Followup Period|Miscellaneous|0
1161689|NCT03364309|2283041|FG014|Post-Treatment Followup Period|Miscellaneous|0
1161690|NCT03364309|2283042|FG015|Post-Treatment Followup Period|Miscellaneous|0
1161691|NCT03364309|2283043|FG016|Post-Treatment Followup Period|Miscellaneous|0
1161692|NCT03364309|2283044|FG017|Post-Treatment Followup Period|Miscellaneous|4
1161693|NCT03364309|2283045|FG018|Post-Treatment Followup Period|Miscellaneous|0
1161694|NCT03364335|2283074|FG000|Overall Study|Adverse Event|3
1161695|NCT03364335|2283075|FG001|Overall Study|Adverse Event|4
1161696|NCT03364335|2283076|FG002|Overall Study|Adverse Event|1
1161697|NCT03364335|2283077|FG003|Overall Study|Adverse Event|2
1161698|NCT03364335|2283078|FG004|Overall Study|Adverse Event|0
1161699|NCT03364335|2283074|FG000|Overall Study|Lost to Follow-up|7
1161700|NCT03364335|2283075|FG001|Overall Study|Lost to Follow-up|7
1161701|NCT03364335|2283076|FG002|Overall Study|Lost to Follow-up|10
1161702|NCT03364335|2283077|FG003|Overall Study|Lost to Follow-up|11
1161703|NCT03364335|2283078|FG004|Overall Study|Lost to Follow-up|11
1018807|NCT01573624|2043610|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1018808|NCT01573624|2043611|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1018809|NCT01573624|2043612|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1018810|NCT01573624|2043606|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
1018811|NCT01573624|2043607|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1018812|NCT01573624|2043608|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1018813|NCT01573624|2043609|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1018814|NCT01573624|2043610|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
1018815|NCT01573624|2043611|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
1018816|NCT01573624|2043612|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
1018817|NCT01573624|2043606|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1018818|NCT01573624|2043607|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
1018819|NCT01573624|2043608|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1018820|NCT01573624|2043609|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
903644|NCT00750152|1878013|FG000|Overall Study|Adverse Event|2
903645|NCT00750152|1878014|FG001|Overall Study|Adverse Event|1
903646|NCT00750152|1878013|FG000|Overall Study|Lost to Follow-up|8
903647|NCT00750152|1878014|FG001|Overall Study|Lost to Follow-up|13
903648|NCT00750152|1878013|FG000|Overall Study|Withdrawal by Subject|3
903649|NCT00750152|1878014|FG001|Overall Study|Withdrawal by Subject|3
903650|NCT00750152|1878013|FG000|Overall Study|Physician Decision|1
903651|NCT00750152|1878014|FG001|Overall Study|Physician Decision|1
903652|NCT00750152|1878013|FG000|Overall Study|Non-compliance|0
903653|NCT00750152|1878014|FG001|Overall Study|Non-compliance|1
903654|NCT00750152|1878013|FG000|Overall Study|Termination by sponsor|1
903655|NCT00750152|1878014|FG001|Overall Study|Termination by sponsor|0
903656|NCT00750152|1878013|FG000|Overall Study|Other|7
903657|NCT00750152|1878014|FG001|Overall Study|Other|8
903658|NCT00750269|1878038|FG000|Overall Study|Protocol Violation|0
903659|NCT00750269|1878039|FG001|Overall Study|Protocol Violation|1
903660|NCT00750269|1878040|FG002|Overall Study|Protocol Violation|1
903661|NCT00750269|1878041|FG003|Overall Study|Protocol Violation|2
903662|NCT00750269|1878042|FG004|Overall Study|Protocol Violation|4
903663|NCT00750269|1878038|FG000|Overall Study|Withdrawal by Subject|0
903664|NCT00750269|1878039|FG001|Overall Study|Withdrawal by Subject|0
903665|NCT00750269|1878040|FG002|Overall Study|Withdrawal by Subject|2
903666|NCT00750269|1878041|FG003|Overall Study|Withdrawal by Subject|2
903667|NCT00750269|1878042|FG004|Overall Study|Withdrawal by Subject|2
903668|NCT00750269|1878038|FG000|Overall Study|Physician Decision|0
903669|NCT00750269|1878039|FG001|Overall Study|Physician Decision|0
903670|NCT00750269|1878040|FG002|Overall Study|Physician Decision|0
903671|NCT00750269|1878041|FG003|Overall Study|Physician Decision|0
903672|NCT00750269|1878042|FG004|Overall Study|Physician Decision|2
903673|NCT00750269|1878038|FG000|Overall Study|Patient too large for positioning|0
903674|NCT00750269|1878039|FG001|Overall Study|Patient too large for positioning|0
903675|NCT00750269|1878040|FG002|Overall Study|Patient too large for positioning|1
903676|NCT00750269|1878041|FG003|Overall Study|Patient too large for positioning|0
903677|NCT00750269|1878042|FG004|Overall Study|Patient too large for positioning|0
903678|NCT00750269|1878038|FG000|Overall Study|Site error|0
903679|NCT00750269|1878039|FG001|Overall Study|Site error|0
903680|NCT00750269|1878040|FG002|Overall Study|Site error|0
903681|NCT00750269|1878041|FG003|Overall Study|Site error|1
903682|NCT00750269|1878042|FG004|Overall Study|Site error|0
903683|NCT00750269|1878038|FG000|Overall Study|SBRT plan could not be drawn|0
903684|NCT00750269|1878039|FG001|Overall Study|SBRT plan could not be drawn|0
903685|NCT00750269|1878040|FG002|Overall Study|SBRT plan could not be drawn|0
903686|NCT00750269|1878041|FG003|Overall Study|SBRT plan could not be drawn|0
903687|NCT00750269|1878042|FG004|Overall Study|SBRT plan could not be drawn|1
903688|NCT00750269|1878038|FG000|Overall Study|Fiducials could not be placed|0
1161704|NCT03364608|2283090|FG000|Overall Study|Withdrawal by Subject|4
1161705|NCT03364608|2283090|FG000|Overall Study|Protocol Violation|2
1161706|NCT03364608|2283090|FG000|Overall Study|Lost to Follow-up|2
1161707|NCT03364673|2283102|FG000|Overall Study|Withdrawal by Subject|2
1161708|NCT03364673|2283102|FG000|Overall Study|Injury unrelated to study|3
1161709|NCT03364751|2283115|FG000|Overall Study|Withdrawal by Subject|1
1161710|NCT03364751|2283116|FG001|Overall Study|Withdrawal by Subject|0
1161711|NCT03364751|2283117|FG002|Overall Study|Withdrawal by Subject|0
1161712|NCT03364751|2283118|FG003|Overall Study|Withdrawal by Subject|0
1161713|NCT03364751|2283115|FG000|Overall Study|Lost to Follow-up|0
1161714|NCT03364751|2283116|FG001|Overall Study|Lost to Follow-up|1
1161715|NCT03364751|2283117|FG002|Overall Study|Lost to Follow-up|0
1161716|NCT03364751|2283118|FG003|Overall Study|Lost to Follow-up|0
1161717|NCT03365011|2283134|FG000|Overall Study|Withdrawal by Subject|1
1161718|NCT03365011|2283135|FG001|Overall Study|Withdrawal by Subject|2
1161725|NCT03365934|2283163|FG000|Overall Study|Adverse Event|1
1161726|NCT03365934|2283163|FG000|Overall Study|Withdrawal by Subject|1
1161727|NCT03366428|2283187|FG000|Overall Study|Progressive disease per RECIST v1.1|15
1161728|NCT03366428|2283187|FG000|Overall Study|Adverse Event|2
1161729|NCT03366428|2283187|FG000|Overall Study|Clinical progression|1
1161730|NCT03366428|2283187|FG000|Overall Study|Withdrawal by Subject|1
1161731|NCT03367793|2283199|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
1161732|NCT03367793|2283200|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
1161733|NCT03367793|2283201|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1
1161734|NCT03367793|2283202|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
1161735|NCT03367793|2283203|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
1161736|NCT03367793|2283204|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
1161737|NCT03368170|2283221|FG000|Overall Study|Adverse Event|2
1161738|NCT03368170|2283222|FG001|Overall Study|Adverse Event|1
1161739|NCT03368807|2283237|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3
1161740|NCT03368807|2283237|FG000|Period 1 (Blinded CGM)|Protocol Violation|1
1161741|NCT03368807|2283237|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1
1161742|NCT03368807|2283237|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1
1161743|NCT03368859|2283245|FG000|Overall Study|Withdrew Consent|5
1161744|NCT03368859|2283246|FG001|Overall Study|Withdrew Consent|4
1161745|NCT03368859|2283245|FG000|Overall Study|Death|12
1161746|NCT03368859|2283246|FG001|Overall Study|Death|6
1161747|NCT03368859|2283245|FG000|Overall Study|Study terminated by Sponsor|18
1161748|NCT03368859|2283246|FG001|Overall Study|Study terminated by Sponsor|23
1161749|NCT03368859|2283245|FG000|Overall Study|Other|1
1161750|NCT03368859|2283246|FG001|Overall Study|Other|1
1161751|NCT03369236|2283280|FG000|Double-blind Treatment Period|Accidental unblinding|0
1161752|NCT03369236|2283281|FG001|Double-blind Treatment Period|Accidental unblinding|1
1161753|NCT03369236|2283280|FG000|Open-label Extension Period|Lack of Efficacy|2
1161754|NCT03369236|2283281|FG001|Open-label Extension Period|Lack of Efficacy|1
1161755|NCT03369236|2283280|FG000|Open-label Extension Period|Adverse Event|0
1161756|NCT03369236|2283281|FG001|Open-label Extension Period|Adverse Event|1
1161757|NCT03369236|2283280|FG000|Open-label Extension Period|Sponsor decision to close study|3
1161758|NCT03369236|2283281|FG001|Open-label Extension Period|Sponsor decision to close study|4
1161759|NCT03369418|2283310|FG000|Overall Study|Withdrawal by Subject|3
1161760|NCT03369418|2283311|FG001|Overall Study|Withdrawal by Subject|3
1161761|NCT03369704|2283319|FG000|Treatment Epoch|technical problems|1
1161762|NCT03369704|2283320|FG001|Treatment Epoch|technical problems|0
1161763|NCT03369704|2283319|FG000|Treatment Epoch|Protocol Violation|1
1161764|NCT03369704|2283320|FG001|Treatment Epoch|Protocol Violation|0
1161765|NCT03369704|2283319|FG000|Treatment Epoch|Lost to Follow-up|0
1161766|NCT03369704|2283320|FG001|Treatment Epoch|Lost to Follow-up|1
1161767|NCT03369704|2283319|FG000|Treatment Epoch|Lack of Efficacy|0
1161768|NCT03369704|2283320|FG001|Treatment Epoch|Lack of Efficacy|2
1161769|NCT03369704|2283319|FG000|Treatment Epoch|Adverse Event|2
1161770|NCT03369704|2283320|FG001|Treatment Epoch|Adverse Event|0
1161771|NCT03369704|2283319|FG000|Follow-up Epoch|Lost to Follow-up|1
1161772|NCT03369704|2283320|FG001|Follow-up Epoch|Lost to Follow-up|0
1161773|NCT03369951|2283330|FG000|Overall Study|Withdrawal by Subject|3
1161774|NCT03369951|2283330|FG000|Overall Study|Death|1
1161775|NCT03369951|2283330|FG000|Overall Study|Lost to Follow-up|1
1161776|NCT03369951|2283330|FG000|Overall Study|Protocol Violation|1
1161777|NCT03370289|2283347|FG000|Overall Study|Screen Failure|1
1161778|NCT03370289|2283347|FG000|Overall Study|Sample Size Sufficient|4
1161779|NCT03370302|2283357|FG000|Dose Escalation Phase|Other|0
1161780|NCT03370302|2283358|FG001|Dose Escalation Phase|Other|1
1161781|NCT03370302|2283359|FG002|Dose Escalation Phase|Other|1
1161782|NCT03370302|2283360|FG003|Dose Escalation Phase|Other|0
1161783|NCT03370302|2283361|FG004|Dose Escalation Phase|Other|0
1161784|NCT03370302|2283362|FG005|Dose Escalation Phase|Other|0
1161785|NCT03370302|2283357|FG000|Dose Escalation Phase|Withdrawal by Subject|0
1161786|NCT03370302|2283358|FG001|Dose Escalation Phase|Withdrawal by Subject|1
1161787|NCT03370302|2283359|FG002|Dose Escalation Phase|Withdrawal by Subject|2
1161788|NCT03370302|2283360|FG003|Dose Escalation Phase|Withdrawal by Subject|0
1161789|NCT03370302|2283361|FG004|Dose Escalation Phase|Withdrawal by Subject|0
1161790|NCT03370302|2283362|FG005|Dose Escalation Phase|Withdrawal by Subject|2
1161791|NCT03370302|2283357|FG000|Dose Escalation Phase|Adverse Event|1
1018821|NCT01573624|2043610|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1018822|NCT01573624|2043611|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
1018823|NCT01573624|2043612|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1018824|NCT01573624|2043606|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
1018825|NCT01573624|2043607|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1018826|NCT01573624|2043608|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1018827|NCT01573624|2043609|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1018828|NCT01573624|2043610|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1018829|NCT01573624|2043611|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1018830|NCT01573624|2043612|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1018831|NCT01573624|2043606|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1018832|NCT01573624|2043607|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1018833|NCT01573624|2043608|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1018834|NCT01573624|2043609|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1018835|NCT01573624|2043610|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
1018836|NCT01573624|2043611|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
1018837|NCT01573624|2043612|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1018838|NCT01573624|2043606|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
1018839|NCT01573624|2043607|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1018840|NCT01573624|2043608|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1018841|NCT01573624|2043609|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1018842|NCT01573624|2043610|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1018843|NCT01573624|2043611|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1018844|NCT01573624|2043612|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1018845|NCT01573767|2043643|FG000|Overall Study|Adverse Event|0
1018846|NCT01573767|2043644|FG001|Overall Study|Adverse Event|1
1018847|NCT01573767|2043645|FG002|Overall Study|Adverse Event|0
1018848|NCT01573767|2043646|FG003|Overall Study|Adverse Event|1
1018849|NCT01573767|2043643|FG000|Overall Study|Lack of Efficacy|18
1018850|NCT01573767|2043644|FG001|Overall Study|Lack of Efficacy|15
1018851|NCT01573767|2043645|FG002|Overall Study|Lack of Efficacy|12
1018852|NCT01573767|2043646|FG003|Overall Study|Lack of Efficacy|17
1018853|NCT01573767|2043643|FG000|Overall Study|Protocol Violation|3
1018854|NCT01573767|2043644|FG001|Overall Study|Protocol Violation|1
1018855|NCT01573767|2043645|FG002|Overall Study|Protocol Violation|1
1018856|NCT01573767|2043646|FG003|Overall Study|Protocol Violation|3
1018857|NCT01573767|2043643|FG000|Overall Study|Lost to Follow-up|0
1018858|NCT01573767|2043644|FG001|Overall Study|Lost to Follow-up|1
1018859|NCT01573767|2043645|FG002|Overall Study|Lost to Follow-up|1
1018860|NCT01573767|2043646|FG003|Overall Study|Lost to Follow-up|1
1018861|NCT01573767|2043643|FG000|Overall Study|Physician Decision|1
1018862|NCT01573767|2043644|FG001|Overall Study|Physician Decision|2
1018863|NCT01573767|2043645|FG002|Overall Study|Physician Decision|0
1018864|NCT01573767|2043646|FG003|Overall Study|Physician Decision|2
1018865|NCT01573767|2043643|FG000|Overall Study|Withdrawal by Subject|0
1018866|NCT01573767|2043644|FG001|Overall Study|Withdrawal by Subject|1
1018867|NCT01573767|2043645|FG002|Overall Study|Withdrawal by Subject|0
1018868|NCT01573767|2043646|FG003|Overall Study|Withdrawal by Subject|0
1018869|NCT01573910|2043658|FG000|Overall Study|Adverse Event|4
1018870|NCT01573910|2043659|FG001|Overall Study|Adverse Event|4
1018871|NCT01573910|2043658|FG000|Overall Study|Lost to Follow-up|2
1018872|NCT01573910|2043659|FG001|Overall Study|Lost to Follow-up|1
1018873|NCT01573910|2043658|FG000|Overall Study|Withdrawal by Subject|0
1018874|NCT01573910|2043659|FG001|Overall Study|Withdrawal by Subject|1
1018875|NCT01573910|2043658|FG000|Overall Study|Protocol Violation|3
1018876|NCT01573910|2043659|FG001|Overall Study|Protocol Violation|0
1018877|NCT01573910|2043658|FG000|Overall Study|Patient decision unrelated to Advs Event|11
1018878|NCT01573910|2043659|FG001|Overall Study|Patient decision unrelated to Advs Event|11
1018879|NCT01574079|2043671|FG000|Overall Study|Physician Decision|0
1018880|NCT01574079|2043672|FG001|Overall Study|Physician Decision|2
1018881|NCT01574079|2043671|FG000|Overall Study|Lost to Follow-up|1
1018882|NCT01574079|2043672|FG001|Overall Study|Lost to Follow-up|0
1018883|NCT01574157|2043694|FG000|Overall Study|Withdrawal by Subject|4
1018884|NCT01574157|2043695|FG001|Overall Study|Withdrawal by Subject|5
1018885|NCT01574157|2043694|FG000|Overall Study|Lost to Follow-up|0
1018886|NCT01574157|2043695|FG001|Overall Study|Lost to Follow-up|3
1018887|NCT01574248|2043718|FG000|Overall Study|Withdrawal by Subject|2
1018888|NCT01574248|2043719|FG001|Overall Study|Withdrawal by Subject|0
1018889|NCT01574248|2043718|FG000|Overall Study|Missing primary endpoint data|1
1018890|NCT01574248|2043719|FG001|Overall Study|Missing primary endpoint data|0
1018891|NCT01574326|2043731|FG000|Overall Study|Randomized but not treated|0
1018892|NCT01574326|2043732|FG001|Overall Study|Randomized but not treated|1
1161792|NCT03370302|2283358|FG001|Dose Escalation Phase|Adverse Event|0
1161793|NCT03370302|2283359|FG002|Dose Escalation Phase|Adverse Event|2
1161794|NCT03370302|2283360|FG003|Dose Escalation Phase|Adverse Event|0
1161795|NCT03370302|2283361|FG004|Dose Escalation Phase|Adverse Event|0
1161796|NCT03370302|2283362|FG005|Dose Escalation Phase|Adverse Event|0
1161797|NCT03370302|2283357|FG000|Dose Escalation Phase|Progressive Disease|2
1161798|NCT03370302|2283358|FG001|Dose Escalation Phase|Progressive Disease|4
1161799|NCT03370302|2283359|FG002|Dose Escalation Phase|Progressive Disease|2
1161800|NCT03370302|2283360|FG003|Dose Escalation Phase|Progressive Disease|0
1161801|NCT03370302|2283361|FG004|Dose Escalation Phase|Progressive Disease|3
1161802|NCT03370302|2283362|FG005|Dose Escalation Phase|Progressive Disease|1
1161803|NCT03370302|2283357|FG000|Dose Expansion Phase|Progressive Disease|0
1161804|NCT03370302|2283358|FG001|Dose Expansion Phase|Progressive Disease|0
1161805|NCT03370302|2283359|FG002|Dose Expansion Phase|Progressive Disease|0
1161806|NCT03370302|2283360|FG003|Dose Expansion Phase|Progressive Disease|6
1161807|NCT03370302|2283361|FG004|Dose Expansion Phase|Progressive Disease|0
1161808|NCT03370302|2283362|FG005|Dose Expansion Phase|Progressive Disease|0
1161809|NCT03370419|2283380|FG000|Overall Study|Lost to Follow-up|16
1161810|NCT03370471|2283386|FG000|Overall Study|Withdrawal by Subject|6
1161811|NCT03370471|2283387|FG001|Overall Study|Withdrawal by Subject|1
1018893|NCT01574326|2043731|FG000|Overall Study|Withdrawal by Participant|2
1018894|NCT01574326|2043732|FG001|Overall Study|Withdrawal by Participant|4
1018895|NCT01574326|2043731|FG000|Overall Study|Physician Decision|5
1018896|NCT01574326|2043732|FG001|Overall Study|Physician Decision|3
1018897|NCT01574326|2043731|FG000|Overall Study|Adverse Event|1
1018898|NCT01574326|2043732|FG001|Overall Study|Adverse Event|3
1018899|NCT01574326|2043731|FG000|Overall Study|Other: Mainly kidney transplant|8
1018900|NCT01574326|2043732|FG001|Overall Study|Other: Mainly kidney transplant|8
1018901|NCT01574352|2043745|FG000|Overall Study|Withdrawal by Subject|6
1018902|NCT01574352|2043746|FG001|Overall Study|Withdrawal by Subject|13
1018903|NCT01574352|2043745|FG000|Overall Study|Injury in non-camp related sport|1
1018904|NCT01574352|2043746|FG001|Overall Study|Injury in non-camp related sport|0
1018905|NCT01574612|2043752|FG000|Overall Study|Adverse Event|3
1018906|NCT01574612|2043752|FG000|Overall Study|non compliant with drug|2
1018907|NCT01574612|2043752|FG000|Overall Study|Withdrawal by Subject|1
1018908|NCT01574612|2043752|FG000|Overall Study|Lost to Follow-up|2
1018909|NCT01574651|2043758|FG000|Overall Study|Lost to Follow-up|2
1018910|NCT01574651|2043759|FG001|Overall Study|Lost to Follow-up|4
1018911|NCT01574651|2043758|FG000|Overall Study|Administrative problems|0
1018912|NCT01574651|2043759|FG001|Overall Study|Administrative problems|1
1018913|NCT01574651|2043758|FG000|Overall Study|Death|3
1018914|NCT01574651|2043759|FG001|Overall Study|Death|3
1018915|NCT01574651|2043758|FG000|Overall Study|Patient's inability to use the device|0
1018916|NCT01574651|2043759|FG001|Overall Study|Patient's inability to use the device|1
1018917|NCT01574651|2043758|FG000|Overall Study|Adverse Event|36
1018918|NCT01574651|2043759|FG001|Overall Study|Adverse Event|27
1018919|NCT01574651|2043758|FG000|Overall Study|Abnormal laboratory value(s)|1
1018920|NCT01574651|2043759|FG001|Overall Study|Abnormal laboratory value(s)|0
1018921|NCT01574651|2043758|FG000|Overall Study|Abnormal test procedure result(s)|1
1018922|NCT01574651|2043759|FG001|Overall Study|Abnormal test procedure result(s)|1
1018923|NCT01574651|2043758|FG000|Overall Study|Unsatisfactory therapeutic effect|6
1018924|NCT01574651|2043759|FG001|Overall Study|Unsatisfactory therapeutic effect|0
1018925|NCT01574651|2043758|FG000|Overall Study|Protocol Violation|3
1018926|NCT01574651|2043759|FG001|Overall Study|Protocol Violation|5
1018927|NCT01574651|2043758|FG000|Overall Study|Withdrawal by Subject|9
1018928|NCT01574651|2043759|FG001|Overall Study|Withdrawal by Subject|10
1018929|NCT01574703|2043769|FG000|Overall Study|Adverse Event|0
1018930|NCT01574703|2043770|FG001|Overall Study|Adverse Event|2
1018931|NCT01574703|2043771|FG002|Overall Study|Adverse Event|1
1018932|NCT01574703|2043772|FG003|Overall Study|Adverse Event|1
1018933|NCT01574703|2043769|FG000|Overall Study|Protocol Violation|0
1018934|NCT01574703|2043770|FG001|Overall Study|Protocol Violation|0
1018935|NCT01574703|2043771|FG002|Overall Study|Protocol Violation|0
1018936|NCT01574703|2043772|FG003|Overall Study|Protocol Violation|1
1018937|NCT01574703|2043769|FG000|Overall Study|Unspecified Reason|27
1018938|NCT01574703|2043770|FG001|Overall Study|Unspecified Reason|15
1018939|NCT01574703|2043771|FG002|Overall Study|Unspecified Reason|20
1018940|NCT01574703|2043772|FG003|Overall Study|Unspecified Reason|16
1018941|NCT01574703|2043769|FG000|Overall Study|Withdrawal by Subject|53
1018942|NCT01574703|2043770|FG001|Overall Study|Withdrawal by Subject|52
1018943|NCT01574703|2043771|FG002|Overall Study|Withdrawal by Subject|36
1018944|NCT01574703|2043772|FG003|Overall Study|Withdrawal by Subject|61
1018945|NCT01574703|2043769|FG000|Overall Study|Met Withdrawal Criteria|0
1018946|NCT01574703|2043770|FG001|Overall Study|Met Withdrawal Criteria|1
1018947|NCT01574703|2043771|FG002|Overall Study|Met Withdrawal Criteria|1
1018948|NCT01574703|2043772|FG003|Overall Study|Met Withdrawal Criteria|0
1018949|NCT01574703|2043769|FG000|Overall Study|Lost to Follow-up|43
1018950|NCT01574703|2043770|FG001|Overall Study|Lost to Follow-up|41
1018951|NCT01574703|2043771|FG002|Overall Study|Lost to Follow-up|46
1018952|NCT01574703|2043772|FG003|Overall Study|Lost to Follow-up|35
1018953|NCT01574703|2043769|FG000|Overall Study|Death|2
1018954|NCT01574703|2043770|FG001|Overall Study|Death|1
1161812|NCT03370471|2283386|FG000|Overall Study|Unable to access veins for blood draw|0
1161813|NCT03370471|2283387|FG001|Overall Study|Unable to access veins for blood draw|1
1161814|NCT03370471|2283386|FG000|Overall Study|Screen fail|1
1161815|NCT03370471|2283387|FG001|Overall Study|Screen fail|0
1018955|NCT01574703|2043771|FG002|Overall Study|Death|1
1018956|NCT01574703|2043772|FG003|Overall Study|Death|0
1018957|NCT01574716|2043787|FG000|Part 1|Death|3
1018958|NCT01574716|2043788|FG001|Part 1|Death|1
1018959|NCT01574716|2043789|FG002|Part 1|Death|8
1018960|NCT01574716|2043790|FG003|Part 1|Death|0
1018961|NCT01574716|2043791|FG004|Part 1|Death|0
1018962|NCT01574716|2043787|FG000|Part 1|Discontinuation of study by sponsor|0
1018963|NCT01574716|2043788|FG001|Part 1|Discontinuation of study by sponsor|0
1018964|NCT01574716|2043789|FG002|Part 1|Discontinuation of study by sponsor|1
1018965|NCT01574716|2043790|FG003|Part 1|Discontinuation of study by sponsor|0
1018966|NCT01574716|2043791|FG004|Part 1|Discontinuation of study by sponsor|0
1018967|NCT01574716|2043787|FG000|Part 1|Withdrawal by Subject|0
1018968|NCT01574716|2043788|FG001|Part 1|Withdrawal by Subject|2
1018969|NCT01574716|2043789|FG002|Part 1|Withdrawal by Subject|0
1018970|NCT01574716|2043790|FG003|Part 1|Withdrawal by Subject|0
1018971|NCT01574716|2043791|FG004|Part 1|Withdrawal by Subject|0
1018972|NCT01574716|2043787|FG000|Part 1|Lost to Follow-up|0
1018973|NCT01574716|2043788|FG001|Part 1|Lost to Follow-up|1
1018974|NCT01574716|2043789|FG002|Part 1|Lost to Follow-up|0
1018975|NCT01574716|2043790|FG003|Part 1|Lost to Follow-up|0
1018976|NCT01574716|2043791|FG004|Part 1|Lost to Follow-up|0
1018977|NCT01574716|2043787|FG000|Part 2|Progressive disease|0
1018978|NCT01574716|2043788|FG001|Part 2|Progressive disease|0
1018979|NCT01574716|2043789|FG002|Part 2|Progressive disease|0
1018980|NCT01574716|2043790|FG003|Part 2|Progressive disease|1
1018981|NCT01574716|2043791|FG004|Part 2|Progressive disease|0
1018982|NCT01574716|2043787|FG000|Part 2|Death|0
1018983|NCT01574716|2043788|FG001|Part 2|Death|0
1018984|NCT01574716|2043789|FG002|Part 2|Death|0
1018985|NCT01574716|2043790|FG003|Part 2|Death|76
1018986|NCT01574716|2043791|FG004|Part 2|Death|35
1018987|NCT01574716|2043787|FG000|Part 2|Discontinuation of study by sponsor|0
1018988|NCT01574716|2043788|FG001|Part 2|Discontinuation of study by sponsor|0
1018989|NCT01574716|2043789|FG002|Part 2|Discontinuation of study by sponsor|0
1018990|NCT01574716|2043790|FG003|Part 2|Discontinuation of study by sponsor|51
1018991|NCT01574716|2043791|FG004|Part 2|Discontinuation of study by sponsor|31
1018992|NCT01574716|2043787|FG000|Part 2|Withdrawal by Subject|0
1018993|NCT01574716|2043788|FG001|Part 2|Withdrawal by Subject|0
1018994|NCT01574716|2043789|FG002|Part 2|Withdrawal by Subject|0
1018995|NCT01574716|2043790|FG003|Part 2|Withdrawal by Subject|5
1018996|NCT01574716|2043791|FG004|Part 2|Withdrawal by Subject|4
1018997|NCT01574716|2043787|FG000|Part 2|Brain metastases|0
1018998|NCT01574716|2043788|FG001|Part 2|Brain metastases|0
1018999|NCT01574716|2043789|FG002|Part 2|Brain metastases|0
1019000|NCT01574716|2043790|FG003|Part 2|Brain metastases|1
1019001|NCT01574716|2043791|FG004|Part 2|Brain metastases|0
1019002|NCT01574716|2043787|FG000|Part 2|Lost to Follow-up|0
1019003|NCT01574716|2043788|FG001|Part 2|Lost to Follow-up|0
1019004|NCT01574716|2043789|FG002|Part 2|Lost to Follow-up|0
1019005|NCT01574716|2043790|FG003|Part 2|Lost to Follow-up|3
1019006|NCT01574716|2043791|FG004|Part 2|Lost to Follow-up|0
1019007|NCT01575054|2043808|FG000|Overall Study|Other Reasons|5
1019008|NCT01575054|2043809|FG001|Overall Study|Other Reasons|3
1019009|NCT01575054|2043808|FG000|Overall Study|Protocol Violation|2
1019010|NCT01575054|2043809|FG001|Overall Study|Protocol Violation|1
1019011|NCT01575054|2043808|FG000|Overall Study|Personal Reasons|10
1019012|NCT01575054|2043809|FG001|Overall Study|Personal Reasons|11
1019013|NCT01575054|2043808|FG000|Overall Study|Lost to Follow-up|3
1019014|NCT01575054|2043809|FG001|Overall Study|Lost to Follow-up|3
1019015|NCT01575054|2043808|FG000|Overall Study|Adverse Event|9
1019016|NCT01575054|2043809|FG001|Overall Study|Adverse Event|8
1019017|NCT01575197|2043827|FG000|Overall Study|Migration out of study area|1
1019018|NCT01575197|2043828|FG001|Overall Study|Migration out of study area|5
1019019|NCT01575197|2043829|FG002|Overall Study|Migration out of study area|4
1019020|NCT01575197|2043827|FG000|Overall Study|SAE|0
1019021|NCT01575197|2043828|FG001|Overall Study|SAE|1
1019022|NCT01575197|2043829|FG002|Overall Study|SAE|0
1019023|NCT01575197|2043827|FG000|Overall Study|Lost to Follow-up|0
1019024|NCT01575197|2043828|FG001|Overall Study|Lost to Follow-up|1
1019025|NCT01575197|2043829|FG002|Overall Study|Lost to Follow-up|0
1019026|NCT01575197|2043827|FG000|Overall Study|Withdrawal by Subject|0
1019027|NCT01575197|2043828|FG001|Overall Study|Withdrawal by Subject|1
1019028|NCT01575197|2043829|FG002|Overall Study|Withdrawal by Subject|1
1019029|NCT01575197|2043827|FG000|Overall Study|Protocol Violation|2
1019030|NCT01575197|2043828|FG001|Overall Study|Protocol Violation|1
1019031|NCT01575197|2043829|FG002|Overall Study|Protocol Violation|1
1019032|NCT01575561|2043848|FG000|Overall Study|Adverse Event|9
1019033|NCT01575561|2043848|FG000|Overall Study|Lack of Efficacy|8
1019034|NCT01575561|2043848|FG000|Overall Study|Lost to Follow-up|6
1019035|NCT01575561|2043848|FG000|Overall Study|Protocol Violation|4
1019036|NCT01575561|2043848|FG000|Overall Study|Withdrawal by Subject|11
1019037|NCT01575561|2043848|FG000|Overall Study|administration|1
1161816|NCT03370770|2283395|FG000|Overall Study|Patient was followed in another hospital center|1
1161817|NCT03370770|2283395|FG000|Overall Study|Progressive Disease|98
1161818|NCT03370770|2283395|FG000|Overall Study|Adverse Event|2
1161819|NCT03370770|2283395|FG000|Overall Study|Death|5
1161820|NCT03371355|2283403|FG000|Overall Study|Investigator judgment|0
1161821|NCT03371355|2283404|FG001|Overall Study|Investigator judgment|0
1161822|NCT03371355|2283405|FG002|Overall Study|Investigator judgment|1
1019038|NCT01575769|2043860|FG000|Overall Study|Adverse Event|1
1019039|NCT01575769|2043860|FG000|Overall Study|Study terminated by sponsor|40
1019040|NCT01575808|2043868|FG000|Overall Study|Death|2
1019041|NCT01575808|2043869|FG001|Overall Study|Death|0
1019042|NCT01575808|2043868|FG000|Overall Study|Withdrawal by Subject|1
1019043|NCT01575808|2043869|FG001|Overall Study|Withdrawal by Subject|0
1019044|NCT01575834|2043879|FG000|Overall Study|Withdrawal by Subject|352
1019045|NCT01575834|2043880|FG001|Overall Study|Withdrawal by Subject|390
1019046|NCT01575834|2043879|FG000|Overall Study|Death|81
1019047|NCT01575834|2043880|FG001|Overall Study|Death|74
1019048|NCT01575834|2043879|FG000|Overall Study|Other|70
1019049|NCT01575834|2043880|FG001|Overall Study|Other|70
1019050|NCT01575834|2043879|FG000|Overall Study|Adverse Event|63
1019051|NCT01575834|2043880|FG001|Overall Study|Adverse Event|61
1019052|NCT01575834|2043879|FG000|Overall Study|Lost to Follow-up|55
1019053|NCT01575834|2043880|FG001|Overall Study|Lost to Follow-up|68
1019054|NCT01575834|2043879|FG000|Overall Study|Noncompliance|52
1019055|NCT01575834|2043880|FG001|Overall Study|Noncompliance|27
1019056|NCT01575834|2043879|FG000|Overall Study|Administrative decision|15
1019057|NCT01575834|2043880|FG001|Overall Study|Administrative decision|33
1019058|NCT01575834|2043879|FG000|Overall Study|Ineligibility Determined|5
1019059|NCT01575834|2043880|FG001|Overall Study|Ineligibility Determined|8
1019060|NCT01575834|2043879|FG000|Overall Study|Protocol Deviation|4
1019061|NCT01575834|2043880|FG001|Overall Study|Protocol Deviation|3
1019062|NCT01575834|2043879|FG000|Overall Study|Requirement for Alternative Therapy|2
1019063|NCT01575834|2043880|FG001|Overall Study|Requirement for Alternative Therapy|4
1019064|NCT01575860|2043890|FG000|Overall Study|Withdrawal by Subject|1
1019065|NCT01575860|2043890|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1
1019066|NCT01575873|2043899|FG000|Overall Study|Withdrawal by Subject|15
1019067|NCT01575873|2043900|FG001|Overall Study|Withdrawal by Subject|20
1019068|NCT01575873|2043901|FG002|Overall Study|Withdrawal by Subject|34
1019069|NCT01575873|2043902|FG003|Overall Study|Withdrawal by Subject|34
1019070|NCT01575873|2043899|FG000|Overall Study|Adverse Event|7
1019071|NCT01575873|2043900|FG001|Overall Study|Adverse Event|7
1019072|NCT01575873|2043901|FG002|Overall Study|Adverse Event|9
1019073|NCT01575873|2043902|FG003|Overall Study|Adverse Event|12
1019074|NCT01575873|2043899|FG000|Overall Study|Lost to Follow-up|1
1019075|NCT01575873|2043900|FG001|Overall Study|Lost to Follow-up|3
1019076|NCT01575873|2043901|FG002|Overall Study|Lost to Follow-up|13
1019077|NCT01575873|2043902|FG003|Overall Study|Lost to Follow-up|5
1019078|NCT01575873|2043899|FG000|Overall Study|Death|3
1019079|NCT01575873|2043900|FG001|Overall Study|Death|2
1019080|NCT01575873|2043901|FG002|Overall Study|Death|8
1019081|NCT01575873|2043902|FG003|Overall Study|Death|9
1019082|NCT01575873|2043899|FG000|Overall Study|Noncompliance|1
1019083|NCT01575873|2043900|FG001|Overall Study|Noncompliance|2
1019084|NCT01575873|2043901|FG002|Overall Study|Noncompliance|4
1019085|NCT01575873|2043902|FG003|Overall Study|Noncompliance|3
1019086|NCT01575873|2043899|FG000|Overall Study|Administrative decision|1
1019087|NCT01575873|2043900|FG001|Overall Study|Administrative decision|1
1019088|NCT01575873|2043901|FG002|Overall Study|Administrative decision|1
1019089|NCT01575873|2043902|FG003|Overall Study|Administrative decision|0
1019090|NCT01575873|2043899|FG000|Overall Study|Protocol deviation|0
1019091|NCT01575873|2043900|FG001|Overall Study|Protocol deviation|1
903689|NCT00750269|1878039|FG001|Overall Study|Fiducials could not be placed|0
903690|NCT00750269|1878040|FG002|Overall Study|Fiducials could not be placed|0
903691|NCT00750269|1878041|FG003|Overall Study|Fiducials could not be placed|0
903692|NCT00750269|1878042|FG004|Overall Study|Fiducials could not be placed|1
903693|NCT00750308|1878092|FG000|First Treatment|Adverse Event|0
903694|NCT00750308|1878093|FG001|First Treatment|Adverse Event|1
903695|NCT00750308|1878094|FG002|First Treatment|Adverse Event|0
903696|NCT00750308|1878095|FG003|First Treatment|Adverse Event|0
903697|NCT00750308|1878096|FG004|First Treatment|Adverse Event|0
903698|NCT00750308|1878097|FG005|First Treatment|Adverse Event|0
903699|NCT00750308|1878098|FG006|First Treatment|Adverse Event|0
903700|NCT00750308|1878099|FG007|First Treatment|Adverse Event|0
903701|NCT00750308|1878100|FG008|First Treatment|Adverse Event|0
903702|NCT00750308|1878101|FG009|First Treatment|Adverse Event|0
903703|NCT00750308|1878102|FG010|First Treatment|Adverse Event|1
903704|NCT00750308|1878103|FG011|First Treatment|Adverse Event|1
903705|NCT00750308|1878092|FG000|First Treatment|Withdrawal by Subject|0
903706|NCT00750308|1878093|FG001|First Treatment|Withdrawal by Subject|0
903707|NCT00750308|1878094|FG002|First Treatment|Withdrawal by Subject|0
903708|NCT00750308|1878095|FG003|First Treatment|Withdrawal by Subject|1
903709|NCT00750308|1878096|FG004|First Treatment|Withdrawal by Subject|0
903710|NCT00750308|1878097|FG005|First Treatment|Withdrawal by Subject|0
903711|NCT00750308|1878098|FG006|First Treatment|Withdrawal by Subject|0
1161823|NCT03371355|2283406|FG003|Overall Study|Investigator judgment|1
1161824|NCT03371355|2283403|FG000|Overall Study|Voluntary withdrawal|1
1161825|NCT03371355|2283404|FG001|Overall Study|Voluntary withdrawal|0
1161826|NCT03371355|2283405|FG002|Overall Study|Voluntary withdrawal|1
1161827|NCT03371355|2283406|FG003|Overall Study|Voluntary withdrawal|2
1161828|NCT03371355|2283403|FG000|Overall Study|Adverse Event|0
1161829|NCT03371355|2283404|FG001|Overall Study|Adverse Event|1
1161830|NCT03371355|2283405|FG002|Overall Study|Adverse Event|2
1161831|NCT03371355|2283406|FG003|Overall Study|Adverse Event|3
1161832|NCT03371355|2283403|FG000|Overall Study|Reason not Specified|0
1161833|NCT03371355|2283404|FG001|Overall Study|Reason not Specified|1
1161834|NCT03371355|2283405|FG002|Overall Study|Reason not Specified|0
1161835|NCT03371355|2283406|FG003|Overall Study|Reason not Specified|1
1161836|NCT03371381|2283420|FG000|Overall Study|Death|5
1161837|NCT03371381|2283420|FG000|Overall Study|Study terminated by sponsor|3
1161838|NCT03371381|2283420|FG000|Overall Study|Other|4
1161839|NCT03371459|2283424|FG000|Washout|Lost to Follow-up|0
1161840|NCT03371459|2283425|FG001|Washout|Lost to Follow-up|1
1161841|NCT03371732|2283433|FG000|Overall Study|Withdrawal by Subject|9
1161842|NCT03371732|2283434|FG001|Overall Study|Withdrawal by Subject|3
1161843|NCT03371732|2283433|FG000|Overall Study|Refusal to continue|3
1161844|NCT03371732|2283434|FG001|Overall Study|Refusal to continue|4
1161845|NCT03372083|2283446|FG000|Overall Study|Adverse Event|3
1161846|NCT03372083|2283446|FG000|Overall Study|Physician Decision|1
1161847|NCT03372083|2283446|FG000|Overall Study|Withdrawal by Subject|1
1019092|NCT01575873|2043901|FG002|Overall Study|Protocol deviation|0
1019093|NCT01575873|2043902|FG003|Overall Study|Protocol deviation|1
1019094|NCT01575873|2043899|FG000|Overall Study|Requirement for Alternative Therapy|0
1019095|NCT01575873|2043900|FG001|Overall Study|Requirement for Alternative Therapy|0
1019096|NCT01575873|2043901|FG002|Overall Study|Requirement for Alternative Therapy|1
1019097|NCT01575873|2043902|FG003|Overall Study|Requirement for Alternative Therapy|1
1019098|NCT01575873|2043899|FG000|Overall Study|Other|0
1019099|NCT01575873|2043900|FG001|Overall Study|Other|0
1019100|NCT01575873|2043901|FG002|Overall Study|Other|4
1019101|NCT01575873|2043902|FG003|Overall Study|Other|2
1019102|NCT01575899|2043913|FG000|Overall Study|Lost to Follow-up|3
1019103|NCT01575899|2043914|FG001|Overall Study|Lost to Follow-up|4
1019104|NCT01575899|2043915|FG002|Overall Study|Lost to Follow-up|2
1019105|NCT01575899|2043913|FG000|Overall Study|Protocol Violation|2
1019106|NCT01575899|2043914|FG001|Overall Study|Protocol Violation|1
1019107|NCT01575899|2043915|FG002|Overall Study|Protocol Violation|0
1019108|NCT01576016|2043953|FG000|Lead Safety|Death|132
1019109|NCT01576016|2043954|FG001|Lead Safety|Death|0
1019110|NCT01576016|2043953|FG000|Lead Safety|Withdrawal by Subject|81
1019111|NCT01576016|2043954|FG001|Lead Safety|Withdrawal by Subject|0
1019112|NCT01576016|2043953|FG000|Lead Safety|System Explanted without Replacement|24
1019113|NCT01576016|2043954|FG001|Lead Safety|System Explanted without Replacement|0
1019114|NCT01576016|2043953|FG000|Lead Safety|Physician Decision|14
1019115|NCT01576016|2043954|FG001|Lead Safety|Physician Decision|0
1019116|NCT01576016|2043953|FG000|Lead Safety|Lost to Follow-up|13
1019117|NCT01576016|2043954|FG001|Lead Safety|Lost to Follow-up|0
1019118|NCT01576016|2043953|FG000|Lead Safety|Unsuccessful implant|2
1019119|NCT01576016|2043954|FG001|Lead Safety|Unsuccessful implant|0
1019120|NCT01576016|2043953|FG000|Lead Safety|Sponsor request|1
1019121|NCT01576016|2043954|FG001|Lead Safety|Sponsor request|0
1019122|NCT01576016|2043953|FG000|Lead Safety|Device replaced with CRT-D|1
1019123|NCT01576016|2043954|FG001|Lead Safety|Device replaced with CRT-D|0
1019124|NCT01576016|2043953|FG000|Lead Safety|Patient on Palliative Care|1
1019125|NCT01576016|2043954|FG001|Lead Safety|Patient on Palliative Care|0
1019126|NCT01576016|2043953|FG000|Lead Safety|Patient noncompliance|1
1019127|NCT01576016|2043954|FG001|Lead Safety|Patient noncompliance|0
1019128|NCT01576016|2043953|FG000|Lead Safety|Too far from study site|1
1019129|NCT01576016|2043954|FG001|Lead Safety|Too far from study site|0
1019130|NCT01576016|2043953|FG000|Lead Safety|System deactivated|1
1019131|NCT01576016|2043954|FG001|Lead Safety|System deactivated|0
1019132|NCT01576016|2043953|FG000|Lead Safety|Patient no longer followed by study PI|1
1019133|NCT01576016|2043954|FG001|Lead Safety|Patient no longer followed by study PI|0
1019134|NCT01576016|2043953|FG000|MRI Safety|Withdrawal by Subject|0
1019135|NCT01576016|2043954|FG001|MRI Safety|Withdrawal by Subject|10
1019136|NCT01576016|2043953|FG000|MRI Safety|Non-MRI Compatible Device or Material|0
1019137|NCT01576016|2043954|FG001|MRI Safety|Non-MRI Compatible Device or Material|5
1019138|NCT01576016|2043953|FG000|MRI Safety|Has not yet completed MRI scan|0
1019139|NCT01576016|2043954|FG001|MRI Safety|Has not yet completed MRI scan|56
1019140|NCT01576016|2043953|FG000|MRI Safety|MRI scan not performed at MRI visit|0
1019141|NCT01576016|2043954|FG001|MRI Safety|MRI scan not performed at MRI visit|3
1019142|NCT01576042|2043964|FG000|Overall Study|Physician Decision|2
1019143|NCT01576042|2043965|FG001|Overall Study|Physician Decision|0
1019144|NCT01576146|2043989|FG000|Extension Period 1|Adverse Event|2
1019145|NCT01576146|2043989|FG000|Extension Period 1|Death|2
1019146|NCT01576146|2043989|FG000|Extension Period 1|Physician Decision|2
1019147|NCT01576146|2043989|FG000|Extension Period 1|Withdrawal by Subject|1
1019148|NCT01576146|2043989|FG000|Extension Period 1|Lost to Follow-up|1
1019149|NCT01576146|2043989|FG000|Extension Period 1|Parathyroidectomy|1
1019150|NCT01576146|2043989|FG000|Extension Period 1|Renal Transplant|1
1019151|NCT01576146|2043989|FG000|Extension Period 2|Sponsor Decision|13
1161848|NCT03372096|2283450|FG000|Overall Study|Study Closed|8
1161849|NCT03372369|2283459|FG000|Qualification Period|Withdrawal by Subject|16
1161850|NCT03372369|2283460|FG001|Qualification Period|Withdrawal by Subject|13
1161851|NCT03372369|2283459|FG000|Qualification Period|Inconsistent Eligibility Results|10
1161852|NCT03372369|2283460|FG001|Qualification Period|Inconsistent Eligibility Results|9
1161853|NCT03372369|2283459|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3
1161854|NCT03372369|2283460|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3
1161855|NCT03372551|2283490|FG000|First Intervention (1 Week)|Withdrawal by Subject|1
1161856|NCT03372551|2283491|FG001|First Intervention (1 Week)|Withdrawal by Subject|0
1161857|NCT03372603|2283504|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
1161858|NCT03372603|2283505|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
1161859|NCT03372603|2283504|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
1161860|NCT03372603|2283505|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
1161861|NCT03373383|2283559|FG000|Treatment Period: Wk0-16|Adverse Event|7
1161862|NCT03373383|2283560|FG001|Treatment Period: Wk0-16|Adverse Event|6
1161863|NCT03373383|2283561|FG002|Treatment Period: Wk0-16|Adverse Event|11
1161864|NCT03373383|2283562|FG003|Treatment Period: Wk0-16|Adverse Event|15
1161865|NCT03373383|2283563|FG004|Treatment Period: Wk0-16|Adverse Event|21
1161866|NCT03373383|2283559|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2
1161867|NCT03373383|2283560|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
1161868|NCT03373383|2283561|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
1161869|NCT03373383|2283562|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0
1161870|NCT03373383|2283563|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0
1161871|NCT03373383|2283559|FG000|Treatment Period: Wk0-16|Protocol Violation|0
1161872|NCT03373383|2283560|FG001|Treatment Period: Wk0-16|Protocol Violation|4
1161873|NCT03373383|2283561|FG002|Treatment Period: Wk0-16|Protocol Violation|2
1161874|NCT03373383|2283562|FG003|Treatment Period: Wk0-16|Protocol Violation|1
1161875|NCT03373383|2283563|FG004|Treatment Period: Wk0-16|Protocol Violation|0
1161876|NCT03373383|2283559|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2
1161877|NCT03373383|2283560|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0
1161878|NCT03373383|2283561|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0
1161879|NCT03373383|2283562|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0
1161880|NCT03373383|2283563|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0
1161881|NCT03373383|2283559|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2
1161882|NCT03373383|2283560|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3
1161883|NCT03373383|2283561|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2
1161884|NCT03373383|2283562|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3
1161885|NCT03373383|2283563|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3
1161886|NCT03373383|2283559|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0
1161887|NCT03373383|2283560|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1
1161888|NCT03373383|2283561|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0
1161889|NCT03373383|2283562|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0
1161890|NCT03373383|2283563|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0
1161891|NCT03373383|2283559|FG000|Treatment Period: Wk0-16|By opinion of investigator|0
1161892|NCT03373383|2283560|FG001|Treatment Period: Wk0-16|By opinion of investigator|0
1161893|NCT03373383|2283561|FG002|Treatment Period: Wk0-16|By opinion of investigator|0
1161894|NCT03373383|2283562|FG003|Treatment Period: Wk0-16|By opinion of investigator|1
1161895|NCT03373383|2283563|FG004|Treatment Period: Wk0-16|By opinion of investigator|0
1161896|NCT03373383|2283559|FG000|Treatment Period: Wk0-16|Sponsor decision|0
1161897|NCT03373383|2283560|FG001|Treatment Period: Wk0-16|Sponsor decision|0
1161898|NCT03373383|2283561|FG002|Treatment Period: Wk0-16|Sponsor decision|0
1161899|NCT03373383|2283562|FG003|Treatment Period: Wk0-16|Sponsor decision|1
1161900|NCT03373383|2283563|FG004|Treatment Period: Wk0-16|Sponsor decision|0
1161901|NCT03373383|2283559|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1
1161902|NCT03373383|2283560|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
1161903|NCT03373383|2283561|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
1161904|NCT03373383|2283562|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
1161905|NCT03373383|2283563|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
1161906|NCT03374189|2283625|FG000|Overall Study|Lost to Follow-up|1
1161907|NCT03374189|2283626|FG001|Overall Study|Lost to Follow-up|0
1161908|NCT03374358|2283634|FG000|Overall Study|Withdrawal by Subject|0
1161909|NCT03374358|2283635|FG001|Overall Study|Withdrawal by Subject|2
1161910|NCT03374488|2283643|FG000|Overall Study|Death|13
1161911|NCT03374488|2283644|FG001|Overall Study|Death|13
1161912|NCT03374488|2283643|FG000|Overall Study|Withdrawal by Subject|3
1161913|NCT03374488|2283644|FG001|Overall Study|Withdrawal by Subject|1
1161914|NCT03374488|2283643|FG000|Overall Study|Physician Decision|3
1161915|NCT03374488|2283644|FG001|Overall Study|Physician Decision|0
1161916|NCT03374995|2283666|FG000|Overall Study|Withdrawal by Subject|0
1161917|NCT03374995|2283667|FG001|Overall Study|Withdrawal by Subject|1
1161918|NCT03376321|2283707|FG000|Overall Study|Other|5
1161919|NCT03376321|2283708|FG001|Overall Study|Other|1
1161920|NCT03376321|2283707|FG000|Overall Study|Withdrawal by Subject|8
1161921|NCT03376321|2283708|FG001|Overall Study|Withdrawal by Subject|14
1161922|NCT03376321|2283707|FG000|Overall Study|Lost to Follow-up|1
1161923|NCT03376321|2283708|FG001|Overall Study|Lost to Follow-up|7
1161924|NCT03376321|2283707|FG000|Overall Study|Death|4
1161925|NCT03376321|2283708|FG001|Overall Study|Death|0
1161926|NCT03376321|2283707|FG000|Overall Study|Randomized, not treated|5
1161927|NCT03376321|2283708|FG001|Overall Study|Randomized, not treated|3
1161928|NCT03376516|2283714|FG000|Overall Study|Not treated|1
1161929|NCT03376516|2283714|FG000|Overall Study|Consent withdrawn|1
1161930|NCT03377556|2283751|FG000|Overall Study|Adverse Event|5
1161931|NCT03377556|2283751|FG000|Overall Study|Refusal unrelated to adverse events|1
1161932|NCT03377556|2283751|FG000|Overall Study|Progression/relapse|38
1161933|NCT03377556|2283751|FG000|Overall Study|Death|3
1161934|NCT03377634|2283757|FG000|Study Period|Adverse Event|1
1161935|NCT03377634|2283758|FG001|Study Period|Adverse Event|0
1161936|NCT03377634|2283757|FG000|Study Period|Withdrawal by Subject|1
1161937|NCT03377634|2283758|FG001|Study Period|Withdrawal by Subject|0
1161938|NCT03378635|2283776|FG000|Overall Study|Adverse Event|1
1161939|NCT03378635|2283777|FG001|Overall Study|Adverse Event|0
1161940|NCT03378635|2283778|FG002|Overall Study|Adverse Event|0
1161941|NCT03378635|2283776|FG000|Overall Study|Withdrawal by Subject|1
1161942|NCT03378635|2283777|FG001|Overall Study|Withdrawal by Subject|0
1161943|NCT03378635|2283778|FG002|Overall Study|Withdrawal by Subject|0
1161944|NCT03379259|2283811|FG000|Overall Study|Commenced new anti-cancer therapy|1
1161945|NCT03379259|2283812|FG001|Overall Study|Commenced new anti-cancer therapy|0
1161946|NCT03379259|2283813|FG002|Overall Study|Commenced new anti-cancer therapy|0
1161947|NCT03379259|2283814|FG003|Overall Study|Commenced new anti-cancer therapy|0
1161948|NCT03379259|2283815|FG004|Overall Study|Commenced new anti-cancer therapy|0
1161949|NCT03379259|2283816|FG005|Overall Study|Commenced new anti-cancer therapy|0
1161950|NCT03379259|2283811|FG000|Overall Study|Death|0
1161951|NCT03379259|2283812|FG001|Overall Study|Death|1
1161952|NCT03379259|2283813|FG002|Overall Study|Death|2
1161953|NCT03379259|2283814|FG003|Overall Study|Death|1
1161954|NCT03379259|2283815|FG004|Overall Study|Death|4
1161955|NCT03379259|2283816|FG005|Overall Study|Death|2
1161956|NCT03379259|2283811|FG000|Overall Study|Withdrawal by Subject|0
1161957|NCT03379259|2283812|FG001|Overall Study|Withdrawal by Subject|0
1161958|NCT03379259|2283813|FG002|Overall Study|Withdrawal by Subject|1
1161959|NCT03379259|2283814|FG003|Overall Study|Withdrawal by Subject|0
1161960|NCT03379259|2283815|FG004|Overall Study|Withdrawal by Subject|2
1161961|NCT03379259|2283816|FG005|Overall Study|Withdrawal by Subject|0
1161962|NCT03379259|2283811|FG000|Overall Study|Study terminated by sponsor|0
1161963|NCT03379259|2283812|FG001|Overall Study|Study terminated by sponsor|0
1161964|NCT03379259|2283813|FG002|Overall Study|Study terminated by sponsor|0
1161965|NCT03379259|2283814|FG003|Overall Study|Study terminated by sponsor|1
1161966|NCT03379259|2283815|FG004|Overall Study|Study terminated by sponsor|1
1161967|NCT03379259|2283816|FG005|Overall Study|Study terminated by sponsor|4
1161968|NCT03379259|2283811|FG000|Overall Study|Disease progression|0
1161969|NCT03379259|2283812|FG001|Overall Study|Disease progression|0
1161970|NCT03379259|2283813|FG002|Overall Study|Disease progression|0
1161971|NCT03379259|2283814|FG003|Overall Study|Disease progression|1
1161972|NCT03379259|2283815|FG004|Overall Study|Disease progression|0
1161973|NCT03379259|2283816|FG005|Overall Study|Disease progression|1
1161974|NCT03379259|2283811|FG000|Overall Study|Lost to Follow-up|0
1161975|NCT03379259|2283812|FG001|Overall Study|Lost to Follow-up|0
1161976|NCT03379259|2283813|FG002|Overall Study|Lost to Follow-up|0
1161977|NCT03379259|2283814|FG003|Overall Study|Lost to Follow-up|0
1161978|NCT03379259|2283815|FG004|Overall Study|Lost to Follow-up|1
1161979|NCT03379259|2283816|FG005|Overall Study|Lost to Follow-up|0
1019152|NCT01576146|2043989|FG000|Extension Period 2|Death|1
1019153|NCT01576146|2043989|FG000|Extension Period 2|Adverse Event|1
1019154|NCT01576146|2043989|FG000|Extension Period 2|Renal Transplant|1
1019155|NCT01576146|2043989|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
1019156|NCT01576159|2043997|FG000|Overall Study|Withdrawal by Subject|0
1019157|NCT01576159|2043998|FG001|Overall Study|Withdrawal by Subject|1
1019158|NCT01576159|2043999|FG002|Overall Study|Withdrawal by Subject|0
1019159|NCT01576159|2044000|FG003|Overall Study|Withdrawal by Subject|0
1019160|NCT01576159|2043997|FG000|Overall Study|Physician Decision|0
1019161|NCT01576159|2043998|FG001|Overall Study|Physician Decision|0
1019162|NCT01576159|2043999|FG002|Overall Study|Physician Decision|1
1019163|NCT01576159|2044000|FG003|Overall Study|Physician Decision|0
1019164|NCT01576159|2043997|FG000|Overall Study|Lost to Follow-up|0
1019165|NCT01576159|2043998|FG001|Overall Study|Lost to Follow-up|0
1019166|NCT01576159|2043999|FG002|Overall Study|Lost to Follow-up|0
1019167|NCT01576159|2044000|FG003|Overall Study|Lost to Follow-up|1
1019168|NCT01576159|2043997|FG000|Overall Study|Protocol Violation|1
1019169|NCT01576159|2043998|FG001|Overall Study|Protocol Violation|0
1019170|NCT01576159|2043999|FG002|Overall Study|Protocol Violation|0
1019171|NCT01576159|2044000|FG003|Overall Study|Protocol Violation|0
1161980|NCT03379259|2283811|FG000|Overall Study|Deteriorating condition|0
1161981|NCT03379259|2283812|FG001|Overall Study|Deteriorating condition|0
1161982|NCT03379259|2283813|FG002|Overall Study|Deteriorating condition|0
1161983|NCT03379259|2283814|FG003|Overall Study|Deteriorating condition|0
1161984|NCT03379259|2283815|FG004|Overall Study|Deteriorating condition|1
1161985|NCT03379259|2283816|FG005|Overall Study|Deteriorating condition|0
1161986|NCT03379376|2283833|FG000|Overall Study|Lost to Follow-up|2
1161987|NCT03379376|2283833|FG000|Overall Study|Did not wish to complete follow up|1
1161988|NCT03379376|2283833|FG000|Overall Study|Overwhelmed, didn't want to continue|1
1161989|NCT03379376|2283833|FG000|Overall Study|Death|1
1161990|NCT03379753|2283886|FG000|Overall Study|Withdrawal by Subject|2
1161991|NCT03379753|2283887|FG001|Overall Study|Withdrawal by Subject|1
1161992|NCT03379753|2283886|FG000|Overall Study|not having correct procedure|1
1019172|NCT01576172|2044019|FG000|Overall Study|Ineligible|2
1019173|NCT01576172|2044020|FG001|Overall Study|Ineligible|1
1019174|NCT01576172|2044019|FG000|Overall Study|Withdrawal by Subject|2
1019175|NCT01576172|2044020|FG001|Overall Study|Withdrawal by Subject|0
1019176|NCT01576172|2044019|FG000|Overall Study|Insurance issue|1
1019177|NCT01576172|2044020|FG001|Overall Study|Insurance issue|0
1019178|NCT01576341|2044038|FG000|Overall Study|Withdrawal by Subject|24
1019179|NCT01576341|2044038|FG000|Overall Study|Adverse Event|10
1019180|NCT01576341|2044038|FG000|Overall Study|Death|21
1019181|NCT01576341|2044038|FG000|Overall Study|Physician Decision|2
1019182|NCT01576341|2044038|FG000|Overall Study|Lost to Follow-up|2
1019183|NCT01576341|2044038|FG000|Overall Study|Kidney transplantation|10
1019184|NCT01576341|2044038|FG000|Overall Study|Protocol Violation|12
1019185|NCT01576341|2044038|FG000|Overall Study|Other|12
1019186|NCT01576367|2044045|FG000|Overall Study|Unsatisfactory therapeutic effect|2
1019187|NCT01576367|2044045|FG000|Overall Study|Moved to commercial use after 6 months|1
1019188|NCT01576406|2044055|FG000|Overall Study|Lost to Follow-up|1
1019189|NCT01576406|2044056|FG001|Overall Study|Lost to Follow-up|2
1019190|NCT01576406|2044057|FG002|Overall Study|Lost to Follow-up|0
1019191|NCT01576406|2044058|FG003|Overall Study|Lost to Follow-up|0
1019192|NCT01576406|2044059|FG004|Overall Study|Lost to Follow-up|0
1019193|NCT01576406|2044060|FG005|Overall Study|Lost to Follow-up|0
1019194|NCT01576406|2044055|FG000|Overall Study|Death|3
1019195|NCT01576406|2044056|FG001|Overall Study|Death|4
1019196|NCT01576406|2044057|FG002|Overall Study|Death|8
1019197|NCT01576406|2044058|FG003|Overall Study|Death|5
1019198|NCT01576406|2044059|FG004|Overall Study|Death|7
1019199|NCT01576406|2044060|FG005|Overall Study|Death|9
1019200|NCT01576406|2044055|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0
1019201|NCT01576406|2044056|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0
1019202|NCT01576406|2044057|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1
1019203|NCT01576406|2044058|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1
1019204|NCT01576406|2044059|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0
1019205|NCT01576406|2044060|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0
1019206|NCT01576406|2044055|FG000|Overall Study|Withdrawal the consent|2
1019207|NCT01576406|2044056|FG001|Overall Study|Withdrawal the consent|2
1019208|NCT01576406|2044057|FG002|Overall Study|Withdrawal the consent|5
1019209|NCT01576406|2044058|FG003|Overall Study|Withdrawal the consent|1
1019210|NCT01576406|2044059|FG004|Overall Study|Withdrawal the consent|1
1019211|NCT01576406|2044060|FG005|Overall Study|Withdrawal the consent|3
1019212|NCT01576406|2044055|FG000|Overall Study|Other|0
1019213|NCT01576406|2044056|FG001|Overall Study|Other|0
1019214|NCT01576406|2044057|FG002|Overall Study|Other|2
1019215|NCT01576406|2044058|FG003|Overall Study|Other|2
1019216|NCT01576406|2044059|FG004|Overall Study|Other|0
1019217|NCT01576406|2044060|FG005|Overall Study|Other|0
1019218|NCT01576484|2044085|FG000|Overall Study|Adverse Event|1
1019219|NCT01576484|2044086|FG001|Overall Study|Adverse Event|1
1019220|NCT01576484|2044085|FG000|Overall Study|Protocol Violation|0
1019221|NCT01576484|2044086|FG001|Overall Study|Protocol Violation|2
1019222|NCT01576484|2044085|FG000|Overall Study|Sponsor Decision|2
1019223|NCT01576484|2044086|FG001|Overall Study|Sponsor Decision|8
1019224|NCT01576484|2044085|FG000|Overall Study|Withdrawal by Subject|0
1019225|NCT01576484|2044086|FG001|Overall Study|Withdrawal by Subject|3
1019226|NCT01576484|2044085|FG000|Overall Study|Other|2
1019227|NCT01576484|2044086|FG001|Overall Study|Other|5
1019228|NCT01576705|2044127|FG000|Overall Study|TSH > 7 mIU/L at baseline|3
1019229|NCT01576705|2044128|FG001|Overall Study|TSH > 7 mIU/L at baseline|7
1019230|NCT01576705|2044129|FG002|Overall Study|TSH > 7 mIU/L at baseline|5
1019231|NCT01576705|2044130|FG003|Overall Study|TSH > 7 mIU/L at baseline|3
1019232|NCT01576705|2044127|FG000|Overall Study|invalid ICF|0
1019233|NCT01576705|2044128|FG001|Overall Study|invalid ICF|1
1019234|NCT01576705|2044129|FG002|Overall Study|invalid ICF|0
1019235|NCT01576705|2044130|FG003|Overall Study|invalid ICF|0
1019236|NCT01576718|2044146|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
1019237|NCT01576718|2044147|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1019238|NCT01576718|2044148|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1019239|NCT01576718|2044149|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1019240|NCT01576718|2044150|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1019241|NCT01576718|2044151|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1019242|NCT01576718|2044152|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1019243|NCT01576718|2044146|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
1019244|NCT01576718|2044147|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1019245|NCT01576718|2044148|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1019246|NCT01576718|2044149|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1161993|NCT03379753|2283887|FG001|Overall Study|not having correct procedure|2
1161994|NCT03379753|2283886|FG000|Overall Study|No primary outcome|12
1161995|NCT03379753|2283887|FG001|Overall Study|No primary outcome|22
1161996|NCT03380091|2283909|FG000|Overall Study|Withdrawal by Subject|2
1161997|NCT03380091|2283910|FG001|Overall Study|Withdrawal by Subject|1
1161998|NCT03380390|2283918|FG000|Overall Study|Adverse Event|3
1161999|NCT03380429|2283927|FG000|Overall Study|Physician Decision|0
1162000|NCT03380429|2283928|FG001|Overall Study|Physician Decision|1
1162001|NCT03380429|2283929|FG002|Overall Study|Physician Decision|0
1162002|NCT03380429|2283930|FG003|Overall Study|Physician Decision|1
1162003|NCT03380429|2283931|FG004|Overall Study|Physician Decision|1
1162004|NCT03380429|2283927|FG000|Overall Study|Withdrawal by Subject|3
1162005|NCT03380429|2283928|FG001|Overall Study|Withdrawal by Subject|3
1162006|NCT03380429|2283929|FG002|Overall Study|Withdrawal by Subject|5
1019247|NCT01576718|2044150|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1019248|NCT01576718|2044151|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1019249|NCT01576718|2044152|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1019250|NCT01576718|2044146|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
1019251|NCT01576718|2044147|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1019252|NCT01576718|2044148|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1019253|NCT01576718|2044149|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1019254|NCT01576718|2044150|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1019255|NCT01576718|2044151|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1019256|NCT01576718|2044152|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1019257|NCT01576718|2044146|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
1019258|NCT01576718|2044147|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1019259|NCT01576718|2044148|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1019260|NCT01576718|2044149|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1019261|NCT01576718|2044150|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1019262|NCT01576718|2044151|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1019263|NCT01576718|2044152|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1019264|NCT01576718|2044146|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
1019265|NCT01576718|2044147|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
1019266|NCT01576718|2044148|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
1019267|NCT01576718|2044149|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
1019268|NCT01576718|2044150|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
1019269|NCT01576718|2044151|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
1019270|NCT01576718|2044152|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
1019271|NCT01576718|2044146|FG000|Treatment Period|Adverse Event|0
1019272|NCT01576718|2044147|FG001|Treatment Period|Adverse Event|1
1019273|NCT01576718|2044148|FG002|Treatment Period|Adverse Event|1
1019274|NCT01576718|2044149|FG003|Treatment Period|Adverse Event|1
1019275|NCT01576718|2044150|FG004|Treatment Period|Adverse Event|1
1019276|NCT01576718|2044151|FG005|Treatment Period|Adverse Event|1
1019277|NCT01576718|2044152|FG006|Treatment Period|Adverse Event|0
1019278|NCT01576718|2044146|FG000|Treatment Period|Withdrawal by Subject|0
1019279|NCT01576718|2044147|FG001|Treatment Period|Withdrawal by Subject|1
1019280|NCT01576718|2044148|FG002|Treatment Period|Withdrawal by Subject|1
1019281|NCT01576718|2044149|FG003|Treatment Period|Withdrawal by Subject|0
1019282|NCT01576718|2044150|FG004|Treatment Period|Withdrawal by Subject|2
1019283|NCT01576718|2044151|FG005|Treatment Period|Withdrawal by Subject|4
1019284|NCT01576718|2044152|FG006|Treatment Period|Withdrawal by Subject|2
1019285|NCT01576718|2044146|FG000|Treatment Period|Physician Decision|0
1019286|NCT01576718|2044147|FG001|Treatment Period|Physician Decision|1
1019287|NCT01576718|2044148|FG002|Treatment Period|Physician Decision|1
1019288|NCT01576718|2044149|FG003|Treatment Period|Physician Decision|1
1019289|NCT01576718|2044150|FG004|Treatment Period|Physician Decision|1
1019290|NCT01576718|2044151|FG005|Treatment Period|Physician Decision|0
1019291|NCT01576718|2044152|FG006|Treatment Period|Physician Decision|0
1019292|NCT01576718|2044146|FG000|Treatment Period|Protocol Violation|0
1019293|NCT01576718|2044147|FG001|Treatment Period|Protocol Violation|5
1019294|NCT01576718|2044148|FG002|Treatment Period|Protocol Violation|4
1019295|NCT01576718|2044149|FG003|Treatment Period|Protocol Violation|10
1019296|NCT01576718|2044150|FG004|Treatment Period|Protocol Violation|6
1019297|NCT01576718|2044151|FG005|Treatment Period|Protocol Violation|8
1019298|NCT01576718|2044152|FG006|Treatment Period|Protocol Violation|12
1019299|NCT01576718|2044146|FG000|Treatment Period|Sponsor request|0
1019300|NCT01576718|2044147|FG001|Treatment Period|Sponsor request|1
1019301|NCT01576718|2044148|FG002|Treatment Period|Sponsor request|0
1019302|NCT01576718|2044149|FG003|Treatment Period|Sponsor request|0
1019303|NCT01576718|2044150|FG004|Treatment Period|Sponsor request|0
1019304|NCT01576718|2044151|FG005|Treatment Period|Sponsor request|1
1019305|NCT01576718|2044152|FG006|Treatment Period|Sponsor request|0
1019306|NCT01576718|2044146|FG000|Treatment Period|Met stopping criteria|0
1019307|NCT01576718|2044147|FG001|Treatment Period|Met stopping criteria|16
1019308|NCT01576718|2044148|FG002|Treatment Period|Met stopping criteria|13
1019309|NCT01576718|2044149|FG003|Treatment Period|Met stopping criteria|19
1019310|NCT01576718|2044150|FG004|Treatment Period|Met stopping criteria|16
1162007|NCT03380429|2283930|FG003|Overall Study|Withdrawal by Subject|2
1162008|NCT03380429|2283931|FG004|Overall Study|Withdrawal by Subject|1
1162009|NCT03380429|2283927|FG000|Overall Study|Lost to Follow-up|0
1162010|NCT03380429|2283928|FG001|Overall Study|Lost to Follow-up|2
1162011|NCT03380429|2283929|FG002|Overall Study|Lost to Follow-up|4
1162012|NCT03380429|2283930|FG003|Overall Study|Lost to Follow-up|3
1019311|NCT01576718|2044151|FG005|Treatment Period|Met stopping criteria|33
1019312|NCT01576718|2044152|FG006|Treatment Period|Met stopping criteria|15
1019313|NCT01576718|2044146|FG000|Treatment Period|Lost to Follow-up|0
1019314|NCT01576718|2044147|FG001|Treatment Period|Lost to Follow-up|0
1019315|NCT01576718|2044148|FG002|Treatment Period|Lost to Follow-up|0
1019316|NCT01576718|2044149|FG003|Treatment Period|Lost to Follow-up|0
1019317|NCT01576718|2044150|FG004|Treatment Period|Lost to Follow-up|1
1019318|NCT01576718|2044151|FG005|Treatment Period|Lost to Follow-up|0
1019319|NCT01576718|2044152|FG006|Treatment Period|Lost to Follow-up|0
1019320|NCT01576718|2044146|FG000|Treatment Period|Noncompliance to study medication|0
1019321|NCT01576718|2044147|FG001|Treatment Period|Noncompliance to study medication|0
1019322|NCT01576718|2044148|FG002|Treatment Period|Noncompliance to study medication|0
1019323|NCT01576718|2044149|FG003|Treatment Period|Noncompliance to study medication|0
1019324|NCT01576718|2044150|FG004|Treatment Period|Noncompliance to study medication|0
1019325|NCT01576718|2044151|FG005|Treatment Period|Noncompliance to study medication|1
1019326|NCT01576718|2044152|FG006|Treatment Period|Noncompliance to study medication|1
1019327|NCT01576783|2044168|FG000|Overall Study|Change in Medical Care|1
1019328|NCT01576783|2044169|FG001|Overall Study|Change in Medical Care|0
1019329|NCT01576783|2044168|FG000|Overall Study|Lost to Follow-up|14
1019330|NCT01576783|2044169|FG001|Overall Study|Lost to Follow-up|16
1019331|NCT01576783|2044168|FG000|Overall Study|Withdrawal by Subject|5
1019332|NCT01576783|2044169|FG001|Overall Study|Withdrawal by Subject|1
1019333|NCT01577160|2044210|FG000|Overall Study|Adverse Event|9
1019334|NCT01577160|2044210|FG000|Overall Study|Lack of Efficacy|15
1019335|NCT01577160|2044210|FG000|Overall Study|Lost to Follow-up|40
1019336|NCT01577160|2044210|FG000|Overall Study|Withdrawal by Subject|18
1019337|NCT01577160|2044210|FG000|Overall Study|Subject Uncooperative|7
1019338|NCT01577160|2044210|FG000|Overall Study|Other|9
1019339|NCT01577186|2044214|FG000|Overall Study|Adverse Event|23
1019340|NCT01577186|2044214|FG000|Overall Study|Death|1
1019341|NCT01577186|2044214|FG000|Overall Study|Lost to Follow-up|28
1019342|NCT01577186|2044214|FG000|Overall Study|Withdrawal by Subject|35
1019343|NCT01577186|2044214|FG000|Overall Study|Insufficient Response|18
1019344|NCT01577186|2044214|FG000|Overall Study|Ineligible to Continue|15
1019345|NCT01577186|2044214|FG000|Overall Study|Non-Compliant|8
1019346|NCT01577186|2044214|FG000|Overall Study|Other|2
1019347|NCT01577381|2044240|FG000|Overall Study|Discontinued|2
1019348|NCT01577381|2044241|FG001|Overall Study|Discontinued|1
1019349|NCT01577381|2044242|FG002|Overall Study|Discontinued|2
1019350|NCT01577381|2044243|FG003|Overall Study|Discontinued|2
1019351|NCT01577381|2044240|FG000|Overall Study|Ongoing at Date of Cut-Off|0
903712|NCT00750308|1878099|FG007|First Treatment|Withdrawal by Subject|1
903713|NCT00750308|1878100|FG008|First Treatment|Withdrawal by Subject|0
903714|NCT00750308|1878101|FG009|First Treatment|Withdrawal by Subject|0
903715|NCT00750308|1878102|FG010|First Treatment|Withdrawal by Subject|0
903716|NCT00750308|1878103|FG011|First Treatment|Withdrawal by Subject|0
903717|NCT00750308|1878092|FG000|Second Treatment|Adverse Event|0
903718|NCT00750308|1878093|FG001|Second Treatment|Adverse Event|0
903719|NCT00750308|1878094|FG002|Second Treatment|Adverse Event|0
903720|NCT00750308|1878095|FG003|Second Treatment|Adverse Event|0
903721|NCT00750308|1878096|FG004|Second Treatment|Adverse Event|0
903722|NCT00750308|1878097|FG005|Second Treatment|Adverse Event|1
903723|NCT00750308|1878098|FG006|Second Treatment|Adverse Event|0
903724|NCT00750308|1878099|FG007|Second Treatment|Adverse Event|0
903725|NCT00750308|1878100|FG008|Second Treatment|Adverse Event|1
903726|NCT00750308|1878101|FG009|Second Treatment|Adverse Event|0
903727|NCT00750308|1878102|FG010|Second Treatment|Adverse Event|0
903728|NCT00750308|1878103|FG011|Second Treatment|Adverse Event|0
903729|NCT00750308|1878092|FG000|Second Treatment|Withdrawal by Subject|0
903730|NCT00750308|1878093|FG001|Second Treatment|Withdrawal by Subject|0
903731|NCT00750308|1878094|FG002|Second Treatment|Withdrawal by Subject|0
903732|NCT00750308|1878095|FG003|Second Treatment|Withdrawal by Subject|0
903733|NCT00750308|1878096|FG004|Second Treatment|Withdrawal by Subject|1
903734|NCT00750308|1878097|FG005|Second Treatment|Withdrawal by Subject|0
903735|NCT00750308|1878098|FG006|Second Treatment|Withdrawal by Subject|0
903736|NCT00750308|1878099|FG007|Second Treatment|Withdrawal by Subject|0
903737|NCT00750308|1878100|FG008|Second Treatment|Withdrawal by Subject|0
903738|NCT00750308|1878101|FG009|Second Treatment|Withdrawal by Subject|0
903739|NCT00750308|1878102|FG010|Second Treatment|Withdrawal by Subject|0
903740|NCT00750308|1878103|FG011|Second Treatment|Withdrawal by Subject|0
903741|NCT00750308|1878092|FG000|Third Treatment|Withdrawal by Subject|0
903742|NCT00750308|1878093|FG001|Third Treatment|Withdrawal by Subject|1
903743|NCT00750308|1878094|FG002|Third Treatment|Withdrawal by Subject|0
903744|NCT00750308|1878095|FG003|Third Treatment|Withdrawal by Subject|0
903745|NCT00750308|1878096|FG004|Third Treatment|Withdrawal by Subject|0
903746|NCT00750308|1878097|FG005|Third Treatment|Withdrawal by Subject|0
903747|NCT00750308|1878098|FG006|Third Treatment|Withdrawal by Subject|0
1019352|NCT01577381|2044241|FG001|Overall Study|Ongoing at Date of Cut-Off|2
1019353|NCT01577381|2044242|FG002|Overall Study|Ongoing at Date of Cut-Off|1
1019354|NCT01577381|2044243|FG003|Overall Study|Ongoing at Date of Cut-Off|0
1019355|NCT01577745|2044282|FG000|Overall Study|Withdrawal by Subject|0
1019356|NCT01577745|2044283|FG001|Overall Study|Withdrawal by Subject|1
1019357|NCT01577745|2044284|FG002|Overall Study|Withdrawal by Subject|0
1019358|NCT01577745|2044285|FG003|Overall Study|Withdrawal by Subject|3
1019359|NCT01577745|2044286|FG004|Overall Study|Withdrawal by Subject|2
1019360|NCT01577745|2044287|FG005|Overall Study|Withdrawal by Subject|0
1019361|NCT01577745|2044282|FG000|Overall Study|Death|3
1019362|NCT01577745|2044283|FG001|Overall Study|Death|2
1019363|NCT01577745|2044284|FG002|Overall Study|Death|2
1019364|NCT01577745|2044285|FG003|Overall Study|Death|1
1019365|NCT01577745|2044286|FG004|Overall Study|Death|1
1019366|NCT01577745|2044287|FG005|Overall Study|Death|3
1019367|NCT01577745|2044282|FG000|Overall Study|Physician Decision|0
1019368|NCT01577745|2044283|FG001|Overall Study|Physician Decision|0
1019369|NCT01577745|2044284|FG002|Overall Study|Physician Decision|0
1019370|NCT01577745|2044285|FG003|Overall Study|Physician Decision|1
1019371|NCT01577745|2044286|FG004|Overall Study|Physician Decision|1
1019372|NCT01577745|2044287|FG005|Overall Study|Physician Decision|0
1019373|NCT01577745|2044282|FG000|Overall Study|Lost to Follow-up|0
1019374|NCT01577745|2044283|FG001|Overall Study|Lost to Follow-up|0
1019375|NCT01577745|2044284|FG002|Overall Study|Lost to Follow-up|0
1019376|NCT01577745|2044285|FG003|Overall Study|Lost to Follow-up|0
1019377|NCT01577745|2044286|FG004|Overall Study|Lost to Follow-up|0
1019378|NCT01577745|2044287|FG005|Overall Study|Lost to Follow-up|1
1019379|NCT01577745|2044282|FG000|Overall Study|Alternative Therapy|0
1019380|NCT01577745|2044283|FG001|Overall Study|Alternative Therapy|0
1019381|NCT01577745|2044284|FG002|Overall Study|Alternative Therapy|0
1019382|NCT01577745|2044285|FG003|Overall Study|Alternative Therapy|1
1019383|NCT01577745|2044286|FG004|Overall Study|Alternative Therapy|1
1019384|NCT01577745|2044287|FG005|Overall Study|Alternative Therapy|0
1019385|NCT01577758|2044306|FG000|Dose Escalation Phase|Adverse Event|0
1019386|NCT01577758|2044307|FG001|Dose Escalation Phase|Adverse Event|0
1019387|NCT01577758|2044308|FG002|Dose Escalation Phase|Adverse Event|0
1019388|NCT01577758|2044309|FG003|Dose Escalation Phase|Adverse Event|0
1019389|NCT01577758|2044310|FG004|Dose Escalation Phase|Adverse Event|0
1019390|NCT01577758|2044311|FG005|Dose Escalation Phase|Adverse Event|2
1019391|NCT01577758|2044312|FG006|Dose Escalation Phase|Adverse Event|1
1019392|NCT01577758|2044313|FG007|Dose Escalation Phase|Adverse Event|0
1019393|NCT01577758|2044306|FG000|Dose Escalation Phase|Symptomatic Deterioration|0
1019394|NCT01577758|2044307|FG001|Dose Escalation Phase|Symptomatic Deterioration|0
1019395|NCT01577758|2044308|FG002|Dose Escalation Phase|Symptomatic Deterioration|1
1019396|NCT01577758|2044309|FG003|Dose Escalation Phase|Symptomatic Deterioration|0
1019397|NCT01577758|2044310|FG004|Dose Escalation Phase|Symptomatic Deterioration|1
1019398|NCT01577758|2044311|FG005|Dose Escalation Phase|Symptomatic Deterioration|1
1019399|NCT01577758|2044312|FG006|Dose Escalation Phase|Symptomatic Deterioration|0
1019400|NCT01577758|2044313|FG007|Dose Escalation Phase|Symptomatic Deterioration|0
1019401|NCT01577758|2044306|FG000|Dose Escalation Phase|Withdrawal by Subject|0
1019402|NCT01577758|2044307|FG001|Dose Escalation Phase|Withdrawal by Subject|0
1019403|NCT01577758|2044308|FG002|Dose Escalation Phase|Withdrawal by Subject|0
1019404|NCT01577758|2044309|FG003|Dose Escalation Phase|Withdrawal by Subject|0
1019405|NCT01577758|2044310|FG004|Dose Escalation Phase|Withdrawal by Subject|0
1019406|NCT01577758|2044311|FG005|Dose Escalation Phase|Withdrawal by Subject|1
1019407|NCT01577758|2044312|FG006|Dose Escalation Phase|Withdrawal by Subject|0
1019408|NCT01577758|2044313|FG007|Dose Escalation Phase|Withdrawal by Subject|0
1019409|NCT01577758|2044306|FG000|Dose Escalation Phase|Progression Disease|2
1019410|NCT01577758|2044307|FG001|Dose Escalation Phase|Progression Disease|2
1019411|NCT01577758|2044308|FG002|Dose Escalation Phase|Progression Disease|1
1019412|NCT01577758|2044309|FG003|Dose Escalation Phase|Progression Disease|2
1019413|NCT01577758|2044310|FG004|Dose Escalation Phase|Progression Disease|5
1019414|NCT01577758|2044311|FG005|Dose Escalation Phase|Progression Disease|0
1019415|NCT01577758|2044312|FG006|Dose Escalation Phase|Progression Disease|0
1019416|NCT01577758|2044313|FG007|Dose Escalation Phase|Progression Disease|0
1019417|NCT01577758|2044306|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0
1019418|NCT01577758|2044307|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0
1019419|NCT01577758|2044308|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0
903748|NCT00750308|1878099|FG007|Third Treatment|Withdrawal by Subject|0
903749|NCT00750308|1878100|FG008|Third Treatment|Withdrawal by Subject|0
903750|NCT00750308|1878101|FG009|Third Treatment|Withdrawal by Subject|0
903751|NCT00750308|1878102|FG010|Third Treatment|Withdrawal by Subject|0
903752|NCT00750308|1878103|FG011|Third Treatment|Withdrawal by Subject|0
903753|NCT00750438|1878159|FG000|Overall Study|Protocol Violation|4
903754|NCT00750438|1878160|FG001|Overall Study|Protocol Violation|1
903755|NCT00750438|1878159|FG000|Overall Study|Physician Decision|2
903756|NCT00750438|1878160|FG001|Overall Study|Physician Decision|2
903757|NCT00750438|1878159|FG000|Overall Study|Withdrawal by Subject|1
903758|NCT00750438|1878160|FG001|Overall Study|Withdrawal by Subject|1
903759|NCT00750737|1878168|FG000|Overall Study|Withdrawal by Subject|3
903760|NCT00750737|1878169|FG001|Overall Study|Withdrawal by Subject|3
903761|NCT00750867|1878188|FG000|Overall Study|Adverse Event|2
1019420|NCT01577758|2044309|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0
1019421|NCT01577758|2044310|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0
1019422|NCT01577758|2044311|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0
1019423|NCT01577758|2044312|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0
1019424|NCT01577758|2044313|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4
1019425|NCT01577758|2044306|FG000|mCRC Expansion Phase|Withdrawal by Subject|0
1019426|NCT01577758|2044307|FG001|mCRC Expansion Phase|Withdrawal by Subject|0
1019427|NCT01577758|2044308|FG002|mCRC Expansion Phase|Withdrawal by Subject|0
1019428|NCT01577758|2044309|FG003|mCRC Expansion Phase|Withdrawal by Subject|0
1019429|NCT01577758|2044310|FG004|mCRC Expansion Phase|Withdrawal by Subject|0
1019430|NCT01577758|2044311|FG005|mCRC Expansion Phase|Withdrawal by Subject|0
1019431|NCT01577758|2044312|FG006|mCRC Expansion Phase|Withdrawal by Subject|0
1019432|NCT01577758|2044313|FG007|mCRC Expansion Phase|Withdrawal by Subject|2
1019433|NCT01577758|2044306|FG000|mCRC Expansion Phase|Progression Disease|0
1019434|NCT01577758|2044307|FG001|mCRC Expansion Phase|Progression Disease|0
1019435|NCT01577758|2044308|FG002|mCRC Expansion Phase|Progression Disease|0
1019436|NCT01577758|2044309|FG003|mCRC Expansion Phase|Progression Disease|0
1019437|NCT01577758|2044310|FG004|mCRC Expansion Phase|Progression Disease|0
1019438|NCT01577758|2044311|FG005|mCRC Expansion Phase|Progression Disease|0
1019439|NCT01577758|2044312|FG006|mCRC Expansion Phase|Progression Disease|0
1019440|NCT01577758|2044313|FG007|mCRC Expansion Phase|Progression Disease|19
1019441|NCT01578187|2044361|FG000|Usability Phase|Withdrawal by Subject|1
1019442|NCT01578239|2044369|FG000|Treatment Period|Progressive Disease|19
1019443|NCT01578239|2044370|FG001|Treatment Period|Progressive Disease|64
1019444|NCT01578239|2044369|FG000|Treatment Period|Physician Decision|17
1019445|NCT01578239|2044370|FG001|Treatment Period|Physician Decision|17
1019446|NCT01578239|2044369|FG000|Treatment Period|Adverse Event|13
1019447|NCT01578239|2044370|FG001|Treatment Period|Adverse Event|10
1019448|NCT01578239|2044369|FG000|Treatment Period|Non-compliance|2
1019449|NCT01578239|2044370|FG001|Treatment Period|Non-compliance|0
1019450|NCT01578239|2044369|FG000|Treatment Period|Withdrawal by Subject|10
1019451|NCT01578239|2044370|FG001|Treatment Period|Withdrawal by Subject|9
1019452|NCT01578239|2044369|FG000|Treatment Period|Other|6
1019453|NCT01578239|2044370|FG001|Treatment Period|Other|1
1019454|NCT01578239|2044369|FG000|Long-term Follow-Up Period|Death|69
1019455|NCT01578239|2044370|FG001|Long-term Follow-Up Period|Death|64
1019456|NCT01578239|2044369|FG000|Long-term Follow-Up Period|Consent withdrawal|4
1019457|NCT01578239|2044370|FG001|Long-term Follow-Up Period|Consent withdrawal|10
1019458|NCT01578239|2044369|FG000|Long-term Follow-Up Period|Lost to Follow-up|2
1019459|NCT01578239|2044370|FG001|Long-term Follow-Up Period|Lost to Follow-up|4
1019460|NCT01578239|2044369|FG000|Long-term Follow-Up Period|Other|2
1019461|NCT01578239|2044370|FG001|Long-term Follow-Up Period|Other|2
1019462|NCT01578330|2044402|FG000|Overall Study|Adverse Event|2
1019463|NCT01578330|2044402|FG000|Overall Study|Protocol Violation|5
1019464|NCT01578486|2044406|FG000|Overall Study|Physician Decision|3
1019465|NCT01578486|2044406|FG000|Overall Study|Withdrawal by Subject|2
1019466|NCT01578499|2044412|FG000|Overall Study|Reason not Specified|0
1019467|NCT01578499|2044413|FG001|Overall Study|Reason not Specified|1
1019468|NCT01578499|2044412|FG000|Overall Study|Lost to Follow-up|2
1019469|NCT01578499|2044413|FG001|Overall Study|Lost to Follow-up|1
1019470|NCT01578499|2044412|FG000|Overall Study|Withdrawal by Subject|10
1019471|NCT01578499|2044413|FG001|Overall Study|Withdrawal by Subject|16
1019472|NCT01578499|2044412|FG000|Overall Study|Death|20
1019473|NCT01578499|2044413|FG001|Overall Study|Death|25
1019474|NCT01578499|2044412|FG000|Overall Study|Died and End of Study Page not Completed|2
1019475|NCT01578499|2044413|FG001|Overall Study|Died and End of Study Page not Completed|0
1019476|NCT01578551|2044425|FG000|Overall Study|Adverse Event|1
1019477|NCT01578551|2044426|FG001|Overall Study|Adverse Event|0
1019478|NCT01578850|2044472|FG000|Period 1|Insufficient Clinical Response|1
1019479|NCT01578850|2044473|FG001|Period 1|Insufficient Clinical Response|0
1019480|NCT01578850|2044474|FG002|Period 1|Insufficient Clinical Response|0
1019481|NCT01578850|2044472|FG000|Period 1|Adverse Event|11
1019482|NCT01578850|2044473|FG001|Period 1|Adverse Event|0
1019483|NCT01578850|2044474|FG002|Period 1|Adverse Event|0
1019484|NCT01578850|2044472|FG000|Period 1|Death|1
1019485|NCT01578850|2044473|FG001|Period 1|Death|0
1019486|NCT01578850|2044474|FG002|Period 1|Death|0
1019487|NCT01578850|2044472|FG000|Period 1|Does Not Meet Entrance Criteria|12
1019488|NCT01578850|2044473|FG001|Period 1|Does Not Meet Entrance Criteria|0
1019489|NCT01578850|2044474|FG002|Period 1|Does Not Meet Entrance Criteria|0
1019490|NCT01578850|2044472|FG000|Period 1|Withdrawal by Subject|9
1019491|NCT01578850|2044473|FG001|Period 1|Withdrawal by Subject|0
1019492|NCT01578850|2044474|FG002|Period 1|Withdrawal by Subject|0
1019493|NCT01578850|2044472|FG000|Period 1|Study Terminated by Sponsor|3
1019494|NCT01578850|2044473|FG001|Period 1|Study Terminated by Sponsor|0
903762|NCT00750880|1878192|FG000|Overall Study|Adverse Event|76
903763|NCT00750880|1878192|FG000|Overall Study|Death|4
903764|NCT00750880|1878192|FG000|Overall Study|Lack of Efficacy|46
903765|NCT00750880|1878192|FG000|Overall Study|Lost to Follow-up|10
903766|NCT00750880|1878192|FG000|Overall Study|Protocol Violation|15
903767|NCT00750880|1878192|FG000|Overall Study|Withdrawal by Subject|33
903768|NCT00750880|1878192|FG000|Overall Study|Physician Decision|20
903769|NCT00750880|1878192|FG000|Overall Study|Administrative|11
1019495|NCT01578850|2044474|FG002|Period 1|Study Terminated by Sponsor|0
1019496|NCT01578850|2044472|FG000|Period 2|Insufficient Clinical Response|0
1019497|NCT01578850|2044473|FG001|Period 2|Insufficient Clinical Response|1
1019498|NCT01578850|2044474|FG002|Period 2|Insufficient Clinical Response|0
1019499|NCT01578850|2044472|FG000|Period 2|Adverse Event|0
1019500|NCT01578850|2044473|FG001|Period 2|Adverse Event|3
1019501|NCT01578850|2044474|FG002|Period 2|Adverse Event|6
1019502|NCT01578850|2044472|FG000|Period 2|Lost to Follow-up|0
1019503|NCT01578850|2044473|FG001|Period 2|Lost to Follow-up|1
1019504|NCT01578850|2044474|FG002|Period 2|Lost to Follow-up|2
1019505|NCT01578850|2044472|FG000|Period 2|Withdrawal by Subject|0
1019506|NCT01578850|2044473|FG001|Period 2|Withdrawal by Subject|2
1019507|NCT01578850|2044474|FG002|Period 2|Withdrawal by Subject|2
1019508|NCT01578850|2044472|FG000|Period 2|Study Terminated by Sponsor|0
1019509|NCT01578850|2044473|FG001|Period 2|Study Terminated by Sponsor|5
1019510|NCT01578850|2044474|FG002|Period 2|Study Terminated by Sponsor|4
1019511|NCT01578850|2044472|FG000|Period 2|Unspecified Reasons|0
1019512|NCT01578850|2044473|FG001|Period 2|Unspecified Reasons|1
1019513|NCT01578850|2044474|FG002|Period 2|Unspecified Reasons|0
1019514|NCT01579006|2044504|FG000|Overall Study|Lack of Efficacy|10
1019515|NCT01579006|2044504|FG000|Overall Study|Adverse Event|13
1019516|NCT01579006|2044504|FG000|Overall Study|Withdrawal by Subject|5
1019517|NCT01579006|2044504|FG000|Overall Study|Non-compliance|3
1019518|NCT01579006|2044504|FG000|Overall Study|Due to participant's health fund|1
1019519|NCT01579006|2044504|FG000|Overall Study|Scheduled surgery|1
1019520|NCT01579318|2044595|FG000|Overall Study|Disease Progression|1
1019521|NCT01579474|2044605|FG000|Overall Study|Adverse Event|1
1019522|NCT01579474|2044606|FG001|Overall Study|Adverse Event|13
1019523|NCT01579474|2044607|FG002|Overall Study|Adverse Event|2
1019524|NCT01579474|2044608|FG003|Overall Study|Adverse Event|0
1019525|NCT01579474|2044609|FG004|Overall Study|Adverse Event|0
1019526|NCT01579474|2044610|FG005|Overall Study|Adverse Event|1
1019527|NCT01579474|2044605|FG000|Overall Study|Lack of Efficacy|1
1019528|NCT01579474|2044606|FG001|Overall Study|Lack of Efficacy|0
1019529|NCT01579474|2044607|FG002|Overall Study|Lack of Efficacy|0
1019530|NCT01579474|2044608|FG003|Overall Study|Lack of Efficacy|0
1019531|NCT01579474|2044609|FG004|Overall Study|Lack of Efficacy|1
1019532|NCT01579474|2044610|FG005|Overall Study|Lack of Efficacy|0
1019533|NCT01579474|2044605|FG000|Overall Study|Withdrawal by Subject|1
1019534|NCT01579474|2044606|FG001|Overall Study|Withdrawal by Subject|0
1019535|NCT01579474|2044607|FG002|Overall Study|Withdrawal by Subject|0
1019536|NCT01579474|2044608|FG003|Overall Study|Withdrawal by Subject|0
1019537|NCT01579474|2044609|FG004|Overall Study|Withdrawal by Subject|0
1019538|NCT01579474|2044610|FG005|Overall Study|Withdrawal by Subject|0
1019539|NCT01579565|2044634|FG000|Randomized|Adverse Event|1
1019540|NCT01579565|2044635|FG001|Randomized|Adverse Event|3
1019541|NCT01579565|2044634|FG000|Randomized|Withdrawal by Subject|3
1019542|NCT01579565|2044635|FG001|Randomized|Withdrawal by Subject|0
1019543|NCT01579565|2044634|FG000|Randomized|inadequate preoperative pupil dilation|0
1019544|NCT01579565|2044635|FG001|Randomized|inadequate preoperative pupil dilation|1
1019545|NCT01579565|2044634|FG000|Randomized|prohibited preoperative eating|1
1019546|NCT01579565|2044635|FG001|Randomized|prohibited preoperative eating|0
1019547|NCT01579565|2044634|FG000|Randomized|prohibited preoperative medication|0
1019548|NCT01579565|2044635|FG001|Randomized|prohibited preoperative medication|1
1019549|NCT01579565|2044634|FG000|Treated|Physician Decision|0
1019550|NCT01579565|2044635|FG001|Treated|Physician Decision|1
1019551|NCT01579565|2044634|FG000|Treated|Lost to Follow-up|2
1019552|NCT01579565|2044635|FG001|Treated|Lost to Follow-up|1
1019553|NCT01579565|2044634|FG000|Treated|declined to return for final visit|0
1019554|NCT01579565|2044635|FG001|Treated|declined to return for final visit|1
1019555|NCT01579578|2044645|FG000|Overall Study|Death|4
1019556|NCT01579578|2044646|FG001|Overall Study|Death|1
1019557|NCT01579578|2044645|FG000|Overall Study|Lost to Follow-up|1
1019558|NCT01579578|2044646|FG001|Overall Study|Lost to Follow-up|1
1019559|NCT01579578|2044645|FG000|Overall Study|Withdrawal by Subject|2
1019560|NCT01579578|2044646|FG001|Overall Study|Withdrawal by Subject|1
1019561|NCT01579578|2044645|FG000|Overall Study|Eligibility criteria|3
1019562|NCT01579578|2044646|FG001|Overall Study|Eligibility criteria|9
1019563|NCT01579578|2044645|FG000|Overall Study|Ongoing|3
1019564|NCT01579578|2044646|FG001|Overall Study|Ongoing|0
1019565|NCT01579812|2044670|FG000|Overall Study|Ineligible after treatment start|40
1019566|NCT01579812|2044670|FG000|Overall Study|Patient choice|3
1019567|NCT01579812|2044670|FG000|Overall Study|Noncompliance|3
1019568|NCT01579812|2044670|FG000|Overall Study|Withdrawal by Subject|6
1019569|NCT01579916|2044679|FG000|Overall Study|Lost to Follow-up|6
1019570|NCT01579916|2044680|FG001|Overall Study|Lost to Follow-up|1
1019571|NCT01579916|2044679|FG000|Overall Study|Withdrawal by Subject|1
1019572|NCT01579916|2044680|FG001|Overall Study|Withdrawal by Subject|1
1019573|NCT01579916|2044679|FG000|Overall Study|Death|1
1019574|NCT01579916|2044680|FG001|Overall Study|Death|0
1019575|NCT01580020|2044688|FG000|Overall Study|Lack of Efficacy|0
1019576|NCT01580020|2044689|FG001|Overall Study|Lack of Efficacy|5
1019577|NCT01580020|2044690|FG002|Overall Study|Lack of Efficacy|0
1019578|NCT01580020|2044691|FG003|Overall Study|Lack of Efficacy|1
1019579|NCT01580020|2044688|FG000|Overall Study|Withdrawal by Subject|0
1019580|NCT01580020|2044689|FG001|Overall Study|Withdrawal by Subject|1
1019581|NCT01580020|2044690|FG002|Overall Study|Withdrawal by Subject|1
1019582|NCT01580020|2044691|FG003|Overall Study|Withdrawal by Subject|0
1019583|NCT01580020|2044688|FG000|Overall Study|Adverse Event|1
1019584|NCT01580020|2044689|FG001|Overall Study|Adverse Event|1
1019585|NCT01580020|2044690|FG002|Overall Study|Adverse Event|1
1019586|NCT01580020|2044691|FG003|Overall Study|Adverse Event|1
1019587|NCT01580020|2044688|FG000|Overall Study|Administrative Problems|0
1019588|NCT01580020|2044689|FG001|Overall Study|Administrative Problems|0
1019589|NCT01580020|2044690|FG002|Overall Study|Administrative Problems|1
1019590|NCT01580020|2044691|FG003|Overall Study|Administrative Problems|0
1019591|NCT01580020|2044688|FG000|Overall Study|Lost to Follow-up|0
1019592|NCT01580020|2044689|FG001|Overall Study|Lost to Follow-up|0
1019593|NCT01580020|2044690|FG002|Overall Study|Lost to Follow-up|1
1019594|NCT01580020|2044691|FG003|Overall Study|Lost to Follow-up|0
1019595|NCT01580293|2044732|FG000|Part A_Main Trial|Adverse Event|0
1019596|NCT01580293|2044733|FG001|Part A_Main Trial|Adverse Event|2
1019597|NCT01580293|2044734|FG002|Part A_Main Trial|Adverse Event|0
1019598|NCT01580293|2044732|FG000|Part A_Main Trial|Withdrawal by Subject|1
1019599|NCT01580293|2044733|FG001|Part A_Main Trial|Withdrawal by Subject|4
1019600|NCT01580293|2044734|FG002|Part A_Main Trial|Withdrawal by Subject|0
1019601|NCT01580293|2044732|FG000|Part A_Main Trial|Non-adherence to the protocol|1
1019602|NCT01580293|2044733|FG001|Part A_Main Trial|Non-adherence to the protocol|0
1019603|NCT01580293|2044734|FG002|Part A_Main Trial|Non-adherence to the protocol|0
1019604|NCT01580293|2044732|FG000|Part A_Extension|Adverse Event|0
1019605|NCT01580293|2044733|FG001|Part A_Extension|Adverse Event|2
1019606|NCT01580293|2044734|FG002|Part A_Extension|Adverse Event|0
1019607|NCT01580293|2044732|FG000|Part A_Extension|Withdrawal by Subject|0
1019608|NCT01580293|2044733|FG001|Part A_Extension|Withdrawal by Subject|3
1019609|NCT01580293|2044734|FG002|Part A_Extension|Withdrawal by Subject|0
1019610|NCT01580293|2044732|FG000|Part A_Extension|Lost to Follow-up|0
1019611|NCT01580293|2044733|FG001|Part A_Extension|Lost to Follow-up|1
1019612|NCT01580293|2044734|FG002|Part A_Extension|Lost to Follow-up|0
1019613|NCT01580293|2044732|FG000|Part A_Extension|Other Reason|0
1019614|NCT01580293|2044733|FG001|Part A_Extension|Other Reason|1
1019615|NCT01580293|2044734|FG002|Part A_Extension|Other Reason|0
1019616|NCT01580293|2044732|FG000|Part A_Extension|Completed Japan only|0
1019617|NCT01580293|2044733|FG001|Part A_Extension|Completed Japan only|5
1019618|NCT01580293|2044734|FG002|Part A_Extension|Completed Japan only|0
1019619|NCT01580293|2044732|FG000|Part B|Withdrawal by Subject|0
1019620|NCT01580293|2044733|FG001|Part B|Withdrawal by Subject|0
1019621|NCT01580293|2044734|FG002|Part B|Withdrawal by Subject|1
1019622|NCT01580293|2044732|FG000|Part B|Other reason|0
1019623|NCT01580293|2044733|FG001|Part B|Other reason|0
1019624|NCT01580293|2044734|FG002|Part B|Other reason|1
1019625|NCT01580488|2044795|FG000|Overall Study|Withdrawal by Subject|1
1019626|NCT01580670|2044831|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1
1019627|NCT01580670|2044831|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
1019628|NCT01580969|2044848|FG000|Overall Study|Physician Decision|3
1019629|NCT01580969|2044849|FG001|Overall Study|Physician Decision|0
1019630|NCT01580969|2044850|FG002|Overall Study|Physician Decision|0
1019631|NCT01580995|2044860|FG000|Overall Study|Lost to Follow-up|2
1019632|NCT01580995|2044861|FG001|Overall Study|Lost to Follow-up|2
1019633|NCT01581021|2044879|FG000|Overall Study|Lost to Follow-up|4
1019634|NCT01581021|2044880|FG001|Overall Study|Lost to Follow-up|6
1019635|NCT01581021|2044879|FG000|Overall Study|More than 2 hooks in thoracic|3
1019636|NCT01581021|2044880|FG001|Overall Study|More than 2 hooks in thoracic|0
1019637|NCT01581021|2044879|FG000|Overall Study|Neuromuscular|2
1019638|NCT01581021|2044880|FG001|Overall Study|Neuromuscular|1
1019639|NCT01581021|2044879|FG000|Overall Study|Not Randomized|1
1019640|NCT01581021|2044880|FG001|Overall Study|Not Randomized|2
1019641|NCT01581021|2044879|FG000|Overall Study|Lenke 6 Classification|0
1019642|NCT01581021|2044880|FG001|Overall Study|Lenke 6 Classification|1
1019643|NCT01581021|2044879|FG000|Overall Study|Lack of Efficacy|0
1019644|NCT01581021|2044880|FG001|Overall Study|Lack of Efficacy|1
1019645|NCT01581281|2044889|FG000|Overall Study|Early Study Closure|15
1019646|NCT01581281|2044890|FG001|Overall Study|Early Study Closure|6
1019647|NCT01581281|2044891|FG002|Overall Study|Early Study Closure|12
1019648|NCT01581307|2044900|FG000|Overall Study|Withdrawal by Subject|1
1019649|NCT01581593|2044947|FG000|Overall Study|Withdrawal by Subject|1
1019650|NCT01581619|2044955|FG000|Overall Study|Withdrawal by Subject|1
1019651|NCT01581619|2044955|FG000|Overall Study|Lost to Follow-up|1
1019652|NCT01581684|2044988|FG000|Overall Study|Other reason not defined|0
1019653|NCT01581684|2044989|FG001|Overall Study|Other reason not defined|0
1019654|NCT01581684|2044990|FG002|Overall Study|Other reason not defined|0
1019655|NCT01581684|2044991|FG003|Overall Study|Other reason not defined|0
1019656|NCT01581684|2044992|FG004|Overall Study|Other reason not defined|0
1019657|NCT01581684|2044993|FG005|Overall Study|Other reason not defined|0
1019658|NCT01581684|2044994|FG006|Overall Study|Other reason not defined|0
1019659|NCT01581684|2044995|FG007|Overall Study|Other reason not defined|0
1019660|NCT01581684|2044996|FG008|Overall Study|Other reason not defined|1
1019661|NCT01581684|2044997|FG009|Overall Study|Other reason not defined|0
1019662|NCT01581931|2045041|FG000|Washout|Adverse Event|0
1019663|NCT01581931|2045042|FG001|Washout|Adverse Event|1
1019664|NCT01582009|2045052|FG000|Overall Study|Withdrawal by Subject|1
1019665|NCT01582009|2045052|FG000|Overall Study|Physician Decision|1
1019666|NCT01582061|2045058|FG000|Overall Study|Lack of Efficacy|3
1019667|NCT01582061|2045059|FG001|Overall Study|Lack of Efficacy|23
1019668|NCT01582061|2045058|FG000|Overall Study|Adverse Event|12
1019669|NCT01582061|2045059|FG001|Overall Study|Adverse Event|8
1019670|NCT01582061|2045058|FG000|Overall Study|Withdrawal by Subject|10
1019671|NCT01582061|2045059|FG001|Overall Study|Withdrawal by Subject|4
1019672|NCT01582061|2045058|FG000|Overall Study|Abnormal laboratory value(s)|1
1019673|NCT01582061|2045059|FG001|Overall Study|Abnormal laboratory value(s)|0
1019674|NCT01582061|2045058|FG000|Overall Study|Death|0
1019675|NCT01582061|2045059|FG001|Overall Study|Death|1
1019676|NCT01582061|2045058|FG000|Overall Study|condition no longer requires study drug|1
1019677|NCT01582061|2045059|FG001|Overall Study|condition no longer requires study drug|0
1019678|NCT01582061|2045058|FG000|Overall Study|Lost to Follow-up|1
1019679|NCT01582061|2045059|FG001|Overall Study|Lost to Follow-up|0
1019680|NCT01582152|2045086|FG000|Overall Study|Disease Progression|4
1019681|NCT01582152|2045087|FG001|Overall Study|Disease Progression|5
1019682|NCT01582152|2045086|FG000|Overall Study|Adverse Event|2
1019683|NCT01582152|2045087|FG001|Overall Study|Adverse Event|1
1019684|NCT01582178|2045095|FG000|Overall Study|Physician Decision|6
1019685|NCT01582178|2045096|FG001|Overall Study|Physician Decision|5
1019686|NCT01582243|2045102|FG000|Overall Study|Withdrawal by Subject|1
1019687|NCT01582243|2045102|FG000|Overall Study|Adverse Event|1
1019688|NCT01582243|2045102|FG000|Overall Study|Lost to Follow-up|1
1019689|NCT01582282|2045109|FG000|Overall Study|Adverse Event|1
1019690|NCT01582282|2045110|FG001|Overall Study|Adverse Event|1
1019691|NCT01582282|2045111|FG002|Overall Study|Adverse Event|0
1019692|NCT01582282|2045109|FG000|Overall Study|Lost to Follow-up|1
1019693|NCT01582282|2045110|FG001|Overall Study|Lost to Follow-up|0
1019694|NCT01582282|2045111|FG002|Overall Study|Lost to Follow-up|0
1019695|NCT01582282|2045109|FG000|Overall Study|fasting blood glucose outside Protocol|0
1019696|NCT01582282|2045110|FG001|Overall Study|fasting blood glucose outside Protocol|1
1019697|NCT01582282|2045111|FG002|Overall Study|fasting blood glucose outside Protocol|0
1019698|NCT01582308|2045119|FG000|Period 1|Withdrawal by Subject|0
1019699|NCT01582308|2045120|FG001|Period 1|Withdrawal by Subject|0
1019700|NCT01582308|2045121|FG002|Period 1|Withdrawal by Subject|0
1019701|NCT01582308|2045122|FG003|Period 1|Withdrawal by Subject|0
1019702|NCT01582308|2045123|FG004|Period 1|Withdrawal by Subject|0
1019703|NCT01582308|2045124|FG005|Period 1|Withdrawal by Subject|0
1019704|NCT01582308|2045125|FG006|Period 1|Withdrawal by Subject|1
1019705|NCT01582308|2045126|FG007|Period 1|Withdrawal by Subject|0
1019706|NCT01582308|2045127|FG008|Period 1|Withdrawal by Subject|0
1019707|NCT01582308|2045128|FG009|Period 1|Withdrawal by Subject|0
1019708|NCT01582308|2045119|FG000|10-day Washout Following Period 1|Physician Decision|0
1019709|NCT01582308|2045120|FG001|10-day Washout Following Period 1|Physician Decision|0
1019710|NCT01582308|2045121|FG002|10-day Washout Following Period 1|Physician Decision|0
1019711|NCT01582308|2045122|FG003|10-day Washout Following Period 1|Physician Decision|0
1019712|NCT01582308|2045123|FG004|10-day Washout Following Period 1|Physician Decision|1
1019713|NCT01582308|2045124|FG005|10-day Washout Following Period 1|Physician Decision|0
1019714|NCT01582308|2045125|FG006|10-day Washout Following Period 1|Physician Decision|0
1019715|NCT01582308|2045126|FG007|10-day Washout Following Period 1|Physician Decision|0
1019716|NCT01582308|2045127|FG008|10-day Washout Following Period 1|Physician Decision|0
1019717|NCT01582308|2045128|FG009|10-day Washout Following Period 1|Physician Decision|0
1019718|NCT01582308|2045119|FG000|Period 4|Physician Decision|1
1019719|NCT01582308|2045120|FG001|Period 4|Physician Decision|0
1019720|NCT01582308|2045121|FG002|Period 4|Physician Decision|0
1019721|NCT01582308|2045122|FG003|Period 4|Physician Decision|0
1019722|NCT01582308|2045123|FG004|Period 4|Physician Decision|0
1019723|NCT01582308|2045124|FG005|Period 4|Physician Decision|1
1019724|NCT01582308|2045125|FG006|Period 4|Physician Decision|0
1019725|NCT01582308|2045126|FG007|Period 4|Physician Decision|0
1019726|NCT01582308|2045127|FG008|Period 4|Physician Decision|0
1019727|NCT01582308|2045128|FG009|Period 4|Physician Decision|1
1019728|NCT01582451|2045143|FG000|Overall Study|Adverse Event|1
1019729|NCT01582451|2045144|FG001|Overall Study|Adverse Event|3
1019730|NCT01582451|2045143|FG000|Overall Study|Death|3
1019731|NCT01582451|2045144|FG001|Overall Study|Death|3
1019732|NCT01582451|2045143|FG000|Overall Study|Lost to Follow-up|0
1019733|NCT01582451|2045144|FG001|Overall Study|Lost to Follow-up|2
1019734|NCT01582451|2045143|FG000|Overall Study|Protocol Violation|11
1019735|NCT01582451|2045144|FG001|Overall Study|Protocol Violation|3
1019736|NCT01582451|2045143|FG000|Overall Study|Withdrawal by Subject|13
1019737|NCT01582451|2045144|FG001|Overall Study|Withdrawal by Subject|9
1019738|NCT01582451|2045143|FG000|Overall Study|Physician Decision|3
1019739|NCT01582451|2045144|FG001|Overall Study|Physician Decision|0
1019740|NCT01582451|2045143|FG000|Overall Study|Sponsor Decision|1
1019741|NCT01582451|2045144|FG001|Overall Study|Sponsor Decision|0
1019742|NCT01582789|2045170|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1
1019743|NCT01582789|2045171|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0
1019744|NCT01582854|2045181|FG000|Overall Study|Death|8
1019745|NCT01582854|2045182|FG001|Overall Study|Death|5
1019746|NCT01582854|2045181|FG000|Overall Study|Adverse Event|2
1019747|NCT01582854|2045182|FG001|Overall Study|Adverse Event|3
1019748|NCT01582854|2045181|FG000|Overall Study|Withdrawal by Participant|8
1019749|NCT01582854|2045182|FG001|Overall Study|Withdrawal by Participant|11
1019750|NCT01582854|2045181|FG000|Overall Study|Lost to Follow-up|1
1019751|NCT01582854|2045182|FG001|Overall Study|Lost to Follow-up|2
1019752|NCT01582854|2045181|FG000|Overall Study|Physician Decision|0
1019753|NCT01582854|2045182|FG001|Overall Study|Physician Decision|1
1019754|NCT01582854|2045181|FG000|Overall Study|Recurrent Stroke|13
1019755|NCT01582854|2045182|FG001|Overall Study|Recurrent Stroke|8
1019756|NCT01582854|2045181|FG000|Overall Study|Disallowed Concomitant Medication|3
1019757|NCT01582854|2045182|FG001|Overall Study|Disallowed Concomitant Medication|2
1019758|NCT01582854|2045181|FG000|Overall Study|Carotid or Neurosurgery|0
1019759|NCT01582854|2045182|FG001|Overall Study|Carotid or Neurosurgery|1
1019760|NCT01582854|2045181|FG000|Overall Study|General Anaesthesia|0
1019761|NCT01582854|2045182|FG001|Overall Study|General Anaesthesia|1
1019762|NCT01582854|2045181|FG000|Overall Study|Other Miscellaneous Reason|1
1019763|NCT01582854|2045182|FG001|Overall Study|Other Miscellaneous Reason|0
1019764|NCT01582945|2045192|FG000|Overall Study|Intolerable side-effects|1
1019765|NCT01582945|2045192|FG000|Overall Study|Scheduling conflicts|1
1019766|NCT01582971|2045198|FG000|Overall Study|Death|2
1019767|NCT01582971|2045199|FG001|Overall Study|Death|1
1019768|NCT01582971|2045198|FG000|Overall Study|Lost to Follow-up|18
1019769|NCT01582971|2045199|FG001|Overall Study|Lost to Follow-up|21
1019770|NCT01582971|2045198|FG000|Overall Study|Withdrawal by Subject|4
1019771|NCT01582971|2045199|FG001|Overall Study|Withdrawal by Subject|2
1019772|NCT01582971|2045198|FG000|Overall Study|Other|15
1019773|NCT01582971|2045199|FG001|Overall Study|Other|13
1019774|NCT01583166|2045222|FG000|Overall Study|Withdrawal by Subject|4
1019775|NCT01583166|2045223|FG001|Overall Study|Withdrawal by Subject|6
1019776|NCT01583179|2045231|FG000|Overall Study|Screen failure|1
1019777|NCT01583179|2045232|FG001|Overall Study|Screen failure|2
1019778|NCT01583218|2045240|FG000|Overall Study|Withdrawal by Subject|43
1019779|NCT01583218|2045241|FG001|Overall Study|Withdrawal by Subject|29
1019780|NCT01583218|2045240|FG000|Overall Study|Death|206
1019781|NCT01583218|2045241|FG001|Overall Study|Death|211
1019782|NCT01583218|2045240|FG000|Overall Study|Lost to Follow-up|11
1019783|NCT01583218|2045241|FG001|Overall Study|Lost to Follow-up|17
1019784|NCT01583218|2045240|FG000|Overall Study|Adverse event or serious adverse event|3
1019785|NCT01583218|2045241|FG001|Overall Study|Adverse event or serious adverse event|3
1019786|NCT01583218|2045240|FG000|Overall Study|Patient /Family decision|3
1019787|NCT01583218|2045241|FG001|Overall Study|Patient /Family decision|0
1019788|NCT01583218|2045240|FG000|Overall Study|Cannot contact patient directly|1
1019789|NCT01583218|2045241|FG001|Overall Study|Cannot contact patient directly|2
1019790|NCT01583218|2045240|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
1019791|NCT01583218|2045241|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
1019792|NCT01583218|2045240|FG000|Overall Study|Patient did not wish to attend visits|0
1019793|NCT01583218|2045241|FG001|Overall Study|Patient did not wish to attend visits|1
1019794|NCT01583218|2045240|FG000|Overall Study|Patient randomized but not dosed|17
903770|NCT00750893|1878197|FG000|Overall Study|Adverse Event|5
903771|NCT00750893|1878197|FG000|Overall Study|Withdrawal by Subject|10
903772|NCT00750893|1878197|FG000|Overall Study|Lost to Follow-up|510
903773|NCT00750893|1878197|FG000|Overall Study|Other|17
903774|NCT00750919|1878201|FG000|Overall Study|Adverse Event|9
903775|NCT00750919|1878201|FG000|Overall Study|Withdrawal by Subject|1
903776|NCT00750919|1878201|FG000|Overall Study|Lack of Efficacy|8
903777|NCT00750919|1878201|FG000|Overall Study|Could not cooperate, unrelated to trial|4
903778|NCT00750919|1878201|FG000|Overall Study|Other|36
903779|NCT00751023|1878207|FG000|Overall Study|Lost to Follow-up|11
903780|NCT00751023|1878208|FG001|Overall Study|Lost to Follow-up|7
903781|NCT00751036|1878216|FG000|Overall Study|Disease Progression|28
903782|NCT00751036|1878217|FG001|Overall Study|Disease Progression|29
903783|NCT00751036|1878216|FG000|Overall Study|Adverse Event|6
903784|NCT00751036|1878217|FG001|Overall Study|Adverse Event|4
903785|NCT00751036|1878216|FG000|Overall Study|Administrative Problems|3
903786|NCT00751036|1878217|FG001|Overall Study|Administrative Problems|4
903787|NCT00751036|1878216|FG000|Overall Study|Withdrawal by Subject|5
903788|NCT00751036|1878217|FG001|Overall Study|Withdrawal by Subject|2
903789|NCT00751036|1878216|FG000|Overall Study|Death|3
903790|NCT00751036|1878217|FG001|Overall Study|Death|3
903791|NCT00751036|1878216|FG000|Overall Study|Lost to Follow-up|0
903792|NCT00751036|1878217|FG001|Overall Study|Lost to Follow-up|1
903793|NCT00751036|1878216|FG000|Overall Study|Protocol Violation|1
903794|NCT00751036|1878217|FG001|Overall Study|Protocol Violation|0
903795|NCT00751036|1878216|FG000|Overall Study|Missing end of Treatment Page|2
903796|NCT00751036|1878217|FG001|Overall Study|Missing end of Treatment Page|3
903797|NCT00751101|1878225|FG000|Overall Study|Withdrawal by Subject|1
903798|NCT00751101|1878226|FG001|Overall Study|Withdrawal by Subject|0
903799|NCT00751101|1878225|FG000|Overall Study|No HFS / Never Started Patch/|0
903800|NCT00751101|1878226|FG001|Overall Study|No HFS / Never Started Patch/|4
903801|NCT00751101|1878225|FG000|Overall Study|Never began capecitabine|1
903802|NCT00751101|1878226|FG001|Overall Study|Never began capecitabine|0
903803|NCT00751101|1878225|FG000|Overall Study|Physician Decision|0
903804|NCT00751101|1878226|FG001|Overall Study|Physician Decision|1
1019795|NCT01583218|2045241|FG001|Overall Study|Patient randomized but not dosed|16
1019796|NCT01583218|2045240|FG000|Overall Study|Patient was assessed via phone in person|1
1019797|NCT01583218|2045241|FG001|Overall Study|Patient was assessed via phone in person|0
1019798|NCT01583218|2045240|FG000|Overall Study|Patient deemed ineligible after random|2
1019799|NCT01583218|2045241|FG001|Overall Study|Patient deemed ineligible after random|0
1019800|NCT01583218|2045240|FG000|Overall Study|Patient was early terminated from study|0
1019801|NCT01583218|2045241|FG001|Overall Study|Patient was early terminated from study|1
1019802|NCT01583218|2045240|FG000|Overall Study|Patient was randomized due to mistake|1
1019803|NCT01583218|2045241|FG001|Overall Study|Patient was randomized due to mistake|0
1019804|NCT01583218|2045240|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
1019805|NCT01583218|2045241|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
1019806|NCT01583218|2045240|FG000|Overall Study|Withdraw of consent on day of random|1
1019807|NCT01583218|2045241|FG001|Overall Study|Withdraw of consent on day of random|0
1019808|NCT01583296|2045249|FG000|Overall Study|Withdrawal by Subject|11
1019809|NCT01583296|2045250|FG001|Overall Study|Withdrawal by Subject|10
1019810|NCT01583374|2045259|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
1019811|NCT01583374|2045260|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
1019812|NCT01583374|2045261|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
1019813|NCT01583374|2045262|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1019814|NCT01583374|2045263|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1019815|NCT01583374|2045264|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1019816|NCT01583374|2045265|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1019817|NCT01583374|2045266|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1019818|NCT01583374|2045267|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1019819|NCT01583374|2045259|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
1019820|NCT01583374|2045260|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
1019821|NCT01583374|2045261|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
1019822|NCT01583374|2045262|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1019823|NCT01583374|2045263|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1019824|NCT01583374|2045264|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1019825|NCT01583374|2045265|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1019826|NCT01583374|2045266|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1019827|NCT01583374|2045267|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1019828|NCT01583374|2045259|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
1019829|NCT01583374|2045260|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
1019830|NCT01583374|2045261|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1019831|NCT01583374|2045262|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1019832|NCT01583374|2045263|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1019833|NCT01583374|2045264|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1019834|NCT01583374|2045265|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1019835|NCT01583374|2045266|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1019836|NCT01583374|2045267|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1019837|NCT01583374|2045259|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
1019838|NCT01583374|2045260|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
1019839|NCT01583374|2045261|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
1019840|NCT01583374|2045262|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1019841|NCT01583374|2045263|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1019842|NCT01583374|2045264|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1019843|NCT01583374|2045265|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1019844|NCT01583374|2045266|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1019845|NCT01583374|2045267|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1019846|NCT01583374|2045259|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
1019847|NCT01583374|2045260|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
1019848|NCT01583374|2045261|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1019849|NCT01583374|2045262|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1019850|NCT01583374|2045263|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1019851|NCT01583374|2045264|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1019852|NCT01583374|2045265|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1019853|NCT01583374|2045266|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1019854|NCT01583374|2045267|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1019855|NCT01583374|2045259|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1019856|NCT01583374|2045260|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1019857|NCT01583374|2045261|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
1019858|NCT01583374|2045262|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1019859|NCT01583374|2045263|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1019860|NCT01583374|2045264|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1019861|NCT01583374|2045265|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1019862|NCT01583374|2045266|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1019863|NCT01583374|2045267|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1019864|NCT01583374|2045259|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
1019865|NCT01583374|2045260|FG001|Placebo-controlled Phase (Week 0-24)|Other|1
1019866|NCT01583374|2045261|FG002|Placebo-controlled Phase (Week 0-24)|Other|0
1019867|NCT01583374|2045262|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
1019868|NCT01583374|2045263|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
1019869|NCT01583374|2045264|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
1019870|NCT01583374|2045265|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
1019871|NCT01583374|2045266|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
1019872|NCT01583374|2045267|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
1019873|NCT01583374|2045259|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1019874|NCT01583374|2045260|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1019875|NCT01583374|2045261|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1019876|NCT01583374|2045262|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1019877|NCT01583374|2045263|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1019878|NCT01583374|2045264|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1019879|NCT01583374|2045265|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1019880|NCT01583374|2045266|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
1019881|NCT01583374|2045267|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1019882|NCT01583374|2045259|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0
1019883|NCT01583374|2045260|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1019884|NCT01583374|2045261|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2
1019885|NCT01583374|2045262|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0
1019886|NCT01583374|2045263|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1019887|NCT01583374|2045264|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1019888|NCT01583374|2045265|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0
1019889|NCT01583374|2045266|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1019890|NCT01583374|2045267|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0
1019891|NCT01583374|2045259|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
1019892|NCT01583374|2045260|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
1019893|NCT01583374|2045261|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
1019894|NCT01583374|2045262|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
1019895|NCT01583374|2045263|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
1019896|NCT01583374|2045264|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
1019897|NCT01583374|2045265|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
1019898|NCT01583374|2045266|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
1019899|NCT01583374|2045267|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
1019900|NCT01583374|2045259|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1019901|NCT01583374|2045260|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
1019902|NCT01583374|2045261|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
1019903|NCT01583374|2045262|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1019904|NCT01583374|2045263|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
1019905|NCT01583374|2045264|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1019906|NCT01583374|2045265|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1019907|NCT01583374|2045266|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1019908|NCT01583374|2045267|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1019909|NCT01583374|2045259|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1019910|NCT01583374|2045260|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1019911|NCT01583374|2045261|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
1019912|NCT01583374|2045262|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
903805|NCT00751114|1878238|FG000|Overall Study|Adverse Event|2
903806|NCT00751114|1878239|FG001|Overall Study|Adverse Event|4
903807|NCT00751114|1878238|FG000|Overall Study|Protocol Violation|8
903808|NCT00751114|1878239|FG001|Overall Study|Protocol Violation|9
903809|NCT00751114|1878238|FG000|Overall Study|Withdrawal by Subject|9
903810|NCT00751114|1878239|FG001|Overall Study|Withdrawal by Subject|4
903811|NCT00751114|1878238|FG000|Overall Study|Lost to Follow-up|4
903812|NCT00751114|1878239|FG001|Overall Study|Lost to Follow-up|7
903813|NCT00751114|1878238|FG000|Overall Study|Lack of Efficacy|0
903814|NCT00751114|1878239|FG001|Overall Study|Lack of Efficacy|7
903815|NCT00751114|1878238|FG000|Overall Study|Not Treated|13
903816|NCT00751114|1878239|FG001|Overall Study|Not Treated|1
903817|NCT00751114|1878238|FG000|Overall Study|Out of country for 2 months|1
903818|NCT00751114|1878239|FG001|Overall Study|Out of country for 2 months|0
903819|NCT00751114|1878238|FG000|Overall Study|Move to another city|1
903820|NCT00751114|1878239|FG001|Overall Study|Move to another city|0
903821|NCT00751140|1878245|FG000|Overall Study|benign angioma excluded from analysis|1
903822|NCT00751296|1878263|FG000|Overall Study|Adverse Event|2
903823|NCT00751348|1878269|FG000|Overall Study|Withdrawal by Subject|5
903824|NCT00751348|1878270|FG001|Overall Study|Withdrawal by Subject|2
1019913|NCT01583374|2045263|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
1019914|NCT01583374|2045264|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
1019915|NCT01583374|2045265|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1019916|NCT01583374|2045266|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1019917|NCT01583374|2045267|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1019918|NCT01583374|2045259|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
1019919|NCT01583374|2045260|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
1019920|NCT01583374|2045261|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
1019921|NCT01583374|2045262|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
1019922|NCT01583374|2045263|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
1019923|NCT01583374|2045264|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
1019924|NCT01583374|2045265|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
1019925|NCT01583374|2045266|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
1019926|NCT01583374|2045267|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
1019927|NCT01583374|2045259|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
1019928|NCT01583374|2045260|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
1019929|NCT01583374|2045261|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
1019930|NCT01583374|2045262|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
1019931|NCT01583374|2045263|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
903825|NCT00751348|1878269|FG000|Overall Study|Migration from study area|1
903826|NCT00751348|1878270|FG001|Overall Study|Migration from study area|0
903827|NCT00751400|1878276|FG000|Overall Study|Lost to Follow-up|10
903828|NCT00751621|1878289|FG000|Overall Study|Adverse Event|1
903829|NCT00751621|1878289|FG000|Overall Study|Withdrawal by Subject|1
903830|NCT00751621|1878289|FG000|Overall Study|Subject moved to another country|1
903831|NCT00751621|1878289|FG000|Overall Study|Poor adherence to asthma treatment|1
903832|NCT00751790|1878309|FG000|Overall Study|Lost to Follow-up|1
903833|NCT00751790|1878309|FG000|Overall Study|Death|3
903834|NCT00751790|1878309|FG000|Overall Study|Withdrawal by Subject|1
903835|NCT00751881|1878316|FG000|Core Treatment Period|Not treated|1
903836|NCT00751881|1878317|FG001|Core Treatment Period|Not treated|1
903837|NCT00751881|1878318|FG002|Core Treatment Period|Not treated|2
903838|NCT00751881|1878316|FG000|Core Treatment Period|Adverse Event|26
903839|NCT00751881|1878317|FG001|Core Treatment Period|Adverse Event|54
903840|NCT00751881|1878318|FG002|Core Treatment Period|Adverse Event|58
903841|NCT00751881|1878316|FG000|Core Treatment Period|Lack of Efficacy|37
903842|NCT00751881|1878317|FG001|Core Treatment Period|Lack of Efficacy|30
903843|NCT00751881|1878318|FG002|Core Treatment Period|Lack of Efficacy|20
903844|NCT00751881|1878316|FG000|Core Treatment Period|Poor compliance to protocol|15
903845|NCT00751881|1878317|FG001|Core Treatment Period|Poor compliance to protocol|3
903846|NCT00751881|1878318|FG002|Core Treatment Period|Poor compliance to protocol|4
903847|NCT00751881|1878316|FG000|Core Treatment Period|Lost to Follow-up|6
903848|NCT00751881|1878317|FG001|Core Treatment Period|Lost to Follow-up|4
903849|NCT00751881|1878318|FG002|Core Treatment Period|Lost to Follow-up|3
903850|NCT00751881|1878316|FG000|Core Treatment Period|Other: protocol deviation|3
903851|NCT00751881|1878317|FG001|Core Treatment Period|Other: protocol deviation|3
903852|NCT00751881|1878318|FG002|Core Treatment Period|Other: protocol deviation|7
903853|NCT00751881|1878316|FG000|Core Treatment Period|Other: wish to parent|5
903854|NCT00751881|1878317|FG001|Core Treatment Period|Other: wish to parent|7
903855|NCT00751881|1878318|FG002|Core Treatment Period|Other: wish to parent|4
903856|NCT00751881|1878316|FG000|Core Treatment Period|Other: personal/family constraints|6
903857|NCT00751881|1878317|FG001|Core Treatment Period|Other: personal/family constraints|7
903858|NCT00751881|1878318|FG002|Core Treatment Period|Other: personal/family constraints|10
903859|NCT00751881|1878316|FG000|Core Treatment Period|Other: MS treatment change|6
903860|NCT00751881|1878317|FG001|Core Treatment Period|Other: MS treatment change|4
903861|NCT00751881|1878318|FG002|Core Treatment Period|Other: MS treatment change|4
903862|NCT00751881|1878316|FG000|Core Treatment Period|Other: tolerability complaints|2
903863|NCT00751881|1878317|FG001|Core Treatment Period|Other: tolerability complaints|0
903864|NCT00751881|1878318|FG002|Core Treatment Period|Other: tolerability complaints|0
903865|NCT00751881|1878316|FG000|Core Treatment Period|Other:participant's decision/unspecified|19
903866|NCT00751881|1878317|FG001|Core Treatment Period|Other:participant's decision/unspecified|22
903867|NCT00751881|1878318|FG002|Core Treatment Period|Other:participant's decision/unspecified|16
903868|NCT00751881|1878316|FG000|Extension Study Period|Adverse Event|18
903869|NCT00751881|1878317|FG001|Extension Study Period|Adverse Event|20
903870|NCT00751881|1878318|FG002|Extension Study Period|Adverse Event|21
903871|NCT00751881|1878316|FG000|Extension Study Period|Lack of Efficacy|14
903872|NCT00751881|1878317|FG001|Extension Study Period|Lack of Efficacy|10
903873|NCT00751881|1878318|FG002|Extension Study Period|Lack of Efficacy|20
903874|NCT00751881|1878316|FG000|Extension Study Period|Lost to Follow-up|4
903875|NCT00751881|1878317|FG001|Extension Study Period|Lost to Follow-up|9
903876|NCT00751881|1878318|FG002|Extension Study Period|Lost to Follow-up|6
903877|NCT00751881|1878316|FG000|Extension Study Period|Poor Compliance to Protocol|3
903878|NCT00751881|1878317|FG001|Extension Study Period|Poor Compliance to Protocol|2
903879|NCT00751881|1878318|FG002|Extension Study Period|Poor Compliance to Protocol|1
903880|NCT00751881|1878316|FG000|Extension Study Period|Other than specified above|26
1019932|NCT01583374|2045264|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
1019933|NCT01583374|2045265|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
1019934|NCT01583374|2045266|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
1019935|NCT01583374|2045267|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
1019936|NCT01583374|2045259|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1019937|NCT01583374|2045260|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1019938|NCT01583374|2045261|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1019939|NCT01583374|2045262|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1019940|NCT01583374|2045263|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
1019941|NCT01583374|2045264|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1019942|NCT01583374|2045265|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1019943|NCT01583374|2045266|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
1019944|NCT01583374|2045267|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
1019945|NCT01583374|2045259|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
1019946|NCT01583374|2045260|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
1019947|NCT01583374|2045261|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
1019948|NCT01583374|2045262|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
1019949|NCT01583374|2045263|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
1019950|NCT01583374|2045264|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
1019951|NCT01583374|2045265|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
1019952|NCT01583374|2045266|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
1019953|NCT01583374|2045267|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
1019954|NCT01583374|2045259|FG000|Long-Term Extension Phase Weeks 52-260|Death|0
1019955|NCT01583374|2045260|FG001|Long-Term Extension Phase Weeks 52-260|Death|0
1019956|NCT01583374|2045261|FG002|Long-Term Extension Phase Weeks 52-260|Death|0
1019957|NCT01583374|2045262|FG003|Long-Term Extension Phase Weeks 52-260|Death|0
1019958|NCT01583374|2045263|FG004|Long-Term Extension Phase Weeks 52-260|Death|1
1019959|NCT01583374|2045264|FG005|Long-Term Extension Phase Weeks 52-260|Death|0
1019960|NCT01583374|2045265|FG006|Long-Term Extension Phase Weeks 52-260|Death|1
1019961|NCT01583374|2045266|FG007|Long-Term Extension Phase Weeks 52-260|Death|0
1019962|NCT01583374|2045267|FG008|Long-Term Extension Phase Weeks 52-260|Death|0
1019963|NCT01583374|2045259|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
1019964|NCT01583374|2045260|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
1019965|NCT01583374|2045261|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
1019966|NCT01583374|2045262|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
1019967|NCT01583374|2045263|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
1019968|NCT01583374|2045264|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
1019969|NCT01583374|2045265|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
1019970|NCT01583374|2045266|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
1019971|NCT01583374|2045267|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
1019972|NCT01583374|2045259|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
903881|NCT00751881|1878317|FG001|Extension Study Period|Other than specified above|30
903882|NCT00751881|1878318|FG002|Extension Study Period|Other than specified above|18
903883|NCT00751998|1878340|FG000|Overall Study|Lost to Follow-up|7
903884|NCT00751998|1878340|FG000|Overall Study|Death|11
903885|NCT00751998|1878340|FG000|Overall Study|Withdrawal by Subject|2
903886|NCT00752089|1878344|FG000|Overall Study|Adverse Event|1
903887|NCT00752089|1878344|FG000|Overall Study|Protocol Deviation|2
903888|NCT00752089|1878344|FG000|Overall Study|Could not attend visit 9|1
903889|NCT00752089|1878344|FG000|Overall Study|Not capable of wearing partial denture|1
903890|NCT00752089|1878344|FG000|Overall Study|Cannot continue the study|1
903891|NCT00752128|1878364|FG000|Overall Study|Withdrawal by Subject|4
903892|NCT00752206|1878371|FG000|Overall Study|Disease progression|8
903893|NCT00752206|1878372|FG001|Overall Study|Disease progression|11
903894|NCT00752206|1878371|FG000|Overall Study|Pregnancy|1
903895|NCT00752206|1878372|FG001|Overall Study|Pregnancy|0
903896|NCT00752219|1878380|FG000|Overall Study|Clinical failure|0
903897|NCT00752219|1878381|FG001|Overall Study|Clinical failure|1
903898|NCT00752219|1878380|FG000|Overall Study|Adverse Event|5
903899|NCT00752219|1878381|FG001|Overall Study|Adverse Event|3
903900|NCT00752219|1878380|FG000|Overall Study|Protocol deviation|1
903901|NCT00752219|1878381|FG001|Overall Study|Protocol deviation|0
903902|NCT00752219|1878380|FG000|Overall Study|Lost to Follow-up|1
903903|NCT00752219|1878381|FG001|Overall Study|Lost to Follow-up|2
903904|NCT00752219|1878380|FG000|Overall Study|Randomized but not treated|1
903905|NCT00752219|1878381|FG001|Overall Study|Randomized but not treated|0
903906|NCT00752219|1878380|FG000|Overall Study|Other|3
903907|NCT00752219|1878381|FG001|Overall Study|Other|0
903908|NCT00752232|1878394|FG000|Overall Study|Protocol Violation|0
903909|NCT00752232|1878395|FG001|Overall Study|Protocol Violation|0
903910|NCT00752232|1878396|FG002|Overall Study|Protocol Violation|0
903911|NCT00752232|1878397|FG003|Overall Study|Protocol Violation|0
1019973|NCT01583374|2045260|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
1019974|NCT01583374|2045261|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
1019975|NCT01583374|2045262|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
1019976|NCT01583374|2045263|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
1019977|NCT01583374|2045264|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
1019978|NCT01583374|2045265|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
1019979|NCT01583374|2045266|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
1019980|NCT01583374|2045267|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
1019981|NCT01583530|2045304|FG000|Overall Study|Adverse Event|0
1019982|NCT01583530|2045305|FG001|Overall Study|Adverse Event|0
1019983|NCT01583530|2045306|FG002|Overall Study|Adverse Event|0
1019984|NCT01583530|2045307|FG003|Overall Study|Adverse Event|0
1019985|NCT01583530|2045308|FG004|Overall Study|Adverse Event|0
1019986|NCT01583530|2045309|FG005|Overall Study|Adverse Event|1
1019987|NCT01583530|2045304|FG000|Overall Study|Withdrawal by Subject|0
1019988|NCT01583530|2045305|FG001|Overall Study|Withdrawal by Subject|3
1019989|NCT01583530|2045306|FG002|Overall Study|Withdrawal by Subject|0
1019990|NCT01583530|2045307|FG003|Overall Study|Withdrawal by Subject|1
1019991|NCT01583530|2045308|FG004|Overall Study|Withdrawal by Subject|1
1019992|NCT01583530|2045309|FG005|Overall Study|Withdrawal by Subject|2
1019993|NCT01583530|2045304|FG000|Overall Study|Lost to Follow-up|0
1019994|NCT01583530|2045305|FG001|Overall Study|Lost to Follow-up|0
1019995|NCT01583530|2045306|FG002|Overall Study|Lost to Follow-up|0
1019996|NCT01583530|2045307|FG003|Overall Study|Lost to Follow-up|0
1019997|NCT01583530|2045308|FG004|Overall Study|Lost to Follow-up|3
1019998|NCT01583530|2045309|FG005|Overall Study|Lost to Follow-up|0
1019999|NCT01583530|2045304|FG000|Overall Study|Lack of compliance|0
1020000|NCT01583530|2045305|FG001|Overall Study|Lack of compliance|0
1020001|NCT01583530|2045306|FG002|Overall Study|Lack of compliance|0
1020002|NCT01583530|2045307|FG003|Overall Study|Lack of compliance|0
1020003|NCT01583530|2045308|FG004|Overall Study|Lack of compliance|1
1020004|NCT01583530|2045309|FG005|Overall Study|Lack of compliance|0
1020005|NCT01584024|2045383|FG000|Overall Study|Lost to Follow-up|10
1020006|NCT01584024|2045383|FG000|Overall Study|Withdrawal by Subject|3
903912|NCT00752232|1878398|FG004|Overall Study|Protocol Violation|0
903913|NCT00752232|1878399|FG005|Overall Study|Protocol Violation|1
903914|NCT00752232|1878400|FG006|Overall Study|Protocol Violation|0
903915|NCT00752232|1878394|FG000|Overall Study|Caregiver request|2
903916|NCT00752232|1878395|FG001|Overall Study|Caregiver request|0
903917|NCT00752232|1878396|FG002|Overall Study|Caregiver request|0
903918|NCT00752232|1878397|FG003|Overall Study|Caregiver request|0
903919|NCT00752232|1878398|FG004|Overall Study|Caregiver request|1
903920|NCT00752232|1878399|FG005|Overall Study|Caregiver request|0
903921|NCT00752232|1878400|FG006|Overall Study|Caregiver request|0
903922|NCT00752232|1878394|FG000|Overall Study|Investigator request|0
903923|NCT00752232|1878395|FG001|Overall Study|Investigator request|0
1020007|NCT01584232|2045390|FG000|Overall Study|Adverse Event|3
1020008|NCT01584232|2045391|FG001|Overall Study|Adverse Event|1
1020009|NCT01584232|2045390|FG000|Overall Study|Withdrawal by Subject|2
1020010|NCT01584232|2045391|FG001|Overall Study|Withdrawal by Subject|1
1020011|NCT01584232|2045390|FG000|Overall Study|Physician Decision|2
1020012|NCT01584232|2045391|FG001|Overall Study|Physician Decision|1
1020013|NCT01584232|2045390|FG000|Overall Study|Lost to Follow-up|1
1020014|NCT01584232|2045391|FG001|Overall Study|Lost to Follow-up|0
1020015|NCT01584440|2045417|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1
1020016|NCT01584440|2045418|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
1020017|NCT01584440|2045419|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
1020018|NCT01584440|2045420|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
1020019|NCT01584440|2045421|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
1020020|NCT01584440|2045417|FG000|Stage 1 (5 Weeks)|Adverse Event|5
1020021|NCT01584440|2045418|FG001|Stage 1 (5 Weeks)|Adverse Event|3
1020022|NCT01584440|2045419|FG002|Stage 1 (5 Weeks)|Adverse Event|0
1020023|NCT01584440|2045420|FG003|Stage 1 (5 Weeks)|Adverse Event|0
1020024|NCT01584440|2045421|FG004|Stage 1 (5 Weeks)|Adverse Event|0
1020025|NCT01584440|2045417|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1
1020026|NCT01584440|2045418|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0
1020027|NCT01584440|2045419|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0
1020028|NCT01584440|2045420|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0
1020029|NCT01584440|2045421|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0
1020030|NCT01584440|2045417|FG000|Stage 1 (5 Weeks)|Protocol Violation|2
1020031|NCT01584440|2045418|FG001|Stage 1 (5 Weeks)|Protocol Violation|3
1020032|NCT01584440|2045419|FG002|Stage 1 (5 Weeks)|Protocol Violation|0
1020033|NCT01584440|2045420|FG003|Stage 1 (5 Weeks)|Protocol Violation|0
1020034|NCT01584440|2045421|FG004|Stage 1 (5 Weeks)|Protocol Violation|0
903924|NCT00752232|1878396|FG002|Overall Study|Investigator request|0
903925|NCT00752232|1878397|FG003|Overall Study|Investigator request|0
1020035|NCT01584440|2045417|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1
1020036|NCT01584440|2045418|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0
1020037|NCT01584440|2045419|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0
1020038|NCT01584440|2045420|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0
1020039|NCT01584440|2045421|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0
1020040|NCT01584440|2045417|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
1020041|NCT01584440|2045418|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2
1020042|NCT01584440|2045419|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
1020043|NCT01584440|2045420|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
1020044|NCT01584440|2045421|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
1020045|NCT01584440|2045417|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0
1020046|NCT01584440|2045418|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0
1020047|NCT01584440|2045419|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1
1020048|NCT01584440|2045420|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2
1020049|NCT01584440|2045421|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0
1020050|NCT01584440|2045417|FG000|Stage 2 (5 Weeks)|Adverse Event|0
1020051|NCT01584440|2045418|FG001|Stage 2 (5 Weeks)|Adverse Event|0
1020052|NCT01584440|2045419|FG002|Stage 2 (5 Weeks)|Adverse Event|1
1020053|NCT01584440|2045420|FG003|Stage 2 (5 Weeks)|Adverse Event|2
1020054|NCT01584440|2045421|FG004|Stage 2 (5 Weeks)|Adverse Event|1
1020055|NCT01584440|2045417|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
1020056|NCT01584440|2045418|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
1020057|NCT01584440|2045419|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1
1020058|NCT01584440|2045420|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
1020059|NCT01584440|2045421|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
1020060|NCT01584648|2045492|FG000|Overall Study|Death|136
1020061|NCT01584648|2045493|FG001|Overall Study|Death|146
1020062|NCT01584648|2045492|FG000|Overall Study|Lost to Follow-up|9
1020063|NCT01584648|2045493|FG001|Overall Study|Lost to Follow-up|9
1020064|NCT01584648|2045492|FG000|Overall Study|Investigator discretion|3
1020065|NCT01584648|2045493|FG001|Overall Study|Investigator discretion|2
1020066|NCT01584648|2045492|FG000|Overall Study|Withdrew consent|13
1020067|NCT01584648|2045493|FG001|Overall Study|Withdrew consent|4
1020068|NCT01584648|2045492|FG000|Overall Study|Study closed/terminated|50
1020069|NCT01584648|2045493|FG001|Overall Study|Study closed/terminated|23
1020070|NCT01584648|2045492|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0
1020071|NCT01584648|2045493|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28
1020072|NCT01584843|2045506|FG000|First Treatment Period|Adverse Event|0
1020073|NCT01584843|2045507|FG001|First Treatment Period|Adverse Event|0
1020074|NCT01584843|2045508|FG002|First Treatment Period|Adverse Event|1
1020075|NCT01584843|2045509|FG003|First Treatment Period|Adverse Event|0
1020076|NCT01584843|2045510|FG004|First Treatment Period|Adverse Event|0
1020077|NCT01584843|2045511|FG005|First Treatment Period|Adverse Event|0
1020078|NCT01584843|2045506|FG000|First Treatment Period|Protocol Violation|0
1020079|NCT01584843|2045507|FG001|First Treatment Period|Protocol Violation|0
1020080|NCT01584843|2045508|FG002|First Treatment Period|Protocol Violation|0
1020081|NCT01584843|2045509|FG003|First Treatment Period|Protocol Violation|0
1020082|NCT01584843|2045510|FG004|First Treatment Period|Protocol Violation|0
1020083|NCT01584843|2045511|FG005|First Treatment Period|Protocol Violation|1
1020084|NCT01584843|2045506|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1020085|NCT01584843|2045507|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1020086|NCT01584843|2045508|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1020087|NCT01584843|2045509|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1020088|NCT01584843|2045510|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1020089|NCT01584843|2045511|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1
1020090|NCT01584843|2045506|FG000|Second Treatment Period|Withdrawal by Subject|0
1020091|NCT01584843|2045507|FG001|Second Treatment Period|Withdrawal by Subject|0
1020092|NCT01584843|2045508|FG002|Second Treatment Period|Withdrawal by Subject|0
1020093|NCT01584843|2045509|FG003|Second Treatment Period|Withdrawal by Subject|0
903926|NCT00752232|1878398|FG004|Overall Study|Investigator request|1
903927|NCT00752232|1878399|FG005|Overall Study|Investigator request|0
903928|NCT00752232|1878400|FG006|Overall Study|Investigator request|0
903929|NCT00752232|1878394|FG000|Overall Study|Subject request|0
903930|NCT00752232|1878395|FG001|Overall Study|Subject request|0
903931|NCT00752232|1878396|FG002|Overall Study|Subject request|1
903932|NCT00752232|1878397|FG003|Overall Study|Subject request|0
903933|NCT00752232|1878398|FG004|Overall Study|Subject request|0
903934|NCT00752232|1878399|FG005|Overall Study|Subject request|0
903935|NCT00752232|1878400|FG006|Overall Study|Subject request|0
903936|NCT00752232|1878394|FG000|Overall Study|Group home admission|0
903937|NCT00752232|1878395|FG001|Overall Study|Group home admission|0
903938|NCT00752232|1878396|FG002|Overall Study|Group home admission|0
903939|NCT00752232|1878397|FG003|Overall Study|Group home admission|1
903940|NCT00752232|1878398|FG004|Overall Study|Group home admission|0
903941|NCT00752232|1878399|FG005|Overall Study|Group home admission|0
903942|NCT00752232|1878400|FG006|Overall Study|Group home admission|0
903943|NCT00752232|1878394|FG000|Overall Study|Caregiver could not attend the subject|0
903944|NCT00752232|1878395|FG001|Overall Study|Caregiver could not attend the subject|0
903945|NCT00752232|1878396|FG002|Overall Study|Caregiver could not attend the subject|0
903946|NCT00752232|1878397|FG003|Overall Study|Caregiver could not attend the subject|0
903947|NCT00752232|1878398|FG004|Overall Study|Caregiver could not attend the subject|1
903948|NCT00752232|1878399|FG005|Overall Study|Caregiver could not attend the subject|0
903949|NCT00752232|1878400|FG006|Overall Study|Caregiver could not attend the subject|0
903950|NCT00752557|1878420|FG000|Overall Study|Withdrawal by Subject|4
1020094|NCT01584843|2045510|FG004|Second Treatment Period|Withdrawal by Subject|0
1020095|NCT01584843|2045511|FG005|Second Treatment Period|Withdrawal by Subject|1
1020096|NCT01585025|2045530|FG000|Overall Study|Withdrawal by Subject|0
1020097|NCT01585025|2045531|FG001|Overall Study|Withdrawal by Subject|3
1020098|NCT01585025|2045532|FG002|Overall Study|Withdrawal by Subject|4
1020099|NCT01585038|2045542|FG000|Overall Study|Adverse Event|2
1020100|NCT01585038|2045543|FG001|Overall Study|Adverse Event|2
1020101|NCT01585155|2045558|FG000|Overall Study|Adverse Event|1
1020102|NCT01585155|2045558|FG000|Overall Study|Lack of Efficacy|2
1020103|NCT01585155|2045558|FG000|Overall Study|Worsening ulcerative colitis|2
1020104|NCT01585168|2045564|FG000|Overall Study|Lost to Follow-up|3
1020105|NCT01585168|2045565|FG001|Overall Study|Lost to Follow-up|1
1020106|NCT01585168|2045566|FG002|Overall Study|Lost to Follow-up|1
1020107|NCT01585168|2045567|FG003|Overall Study|Lost to Follow-up|1
1020108|NCT01585194|2045575|FG000|Overall Study|Withdrawal by Subject|1
1020109|NCT01585194|2045575|FG000|Overall Study|Physician Decision|2
1020110|NCT01585194|2045575|FG000|Overall Study|Lack of insurance|1
1020111|NCT01585246|2045588|FG000|Overall Study|Lost to Follow-up|0
1020112|NCT01585246|2045589|FG001|Overall Study|Lost to Follow-up|0
1020113|NCT01585246|2045590|FG002|Overall Study|Lost to Follow-up|2
1020114|NCT01585246|2045591|FG003|Overall Study|Lost to Follow-up|1
1020115|NCT01585246|2045592|FG004|Overall Study|Lost to Follow-up|0
1020116|NCT01585246|2045588|FG000|Overall Study|Protocol Violation|0
1020117|NCT01585246|2045589|FG001|Overall Study|Protocol Violation|0
1020118|NCT01585246|2045590|FG002|Overall Study|Protocol Violation|0
1020119|NCT01585246|2045591|FG003|Overall Study|Protocol Violation|0
1020120|NCT01585246|2045592|FG004|Overall Study|Protocol Violation|1
1020121|NCT01585246|2045588|FG000|Overall Study|Withdrawal by Subject|0
1020122|NCT01585246|2045589|FG001|Overall Study|Withdrawal by Subject|0
1020123|NCT01585246|2045590|FG002|Overall Study|Withdrawal by Subject|1
1020124|NCT01585246|2045591|FG003|Overall Study|Withdrawal by Subject|2
1020125|NCT01585246|2045592|FG004|Overall Study|Withdrawal by Subject|1
1020126|NCT01585246|2045588|FG000|Overall Study|Other|0
1020127|NCT01585246|2045589|FG001|Overall Study|Other|1
1020128|NCT01585246|2045590|FG002|Overall Study|Other|1
1020129|NCT01585246|2045591|FG003|Overall Study|Other|1
1020130|NCT01585246|2045592|FG004|Overall Study|Other|0
1020131|NCT01585272|2045607|FG000|Overall Study|Adverse Event|22
1020132|NCT01585272|2045607|FG000|Overall Study|Protocol Violation|7
1020133|NCT01585272|2045607|FG000|Overall Study|Withdrawal by Subject|10
1020134|NCT01585298|2045611|FG000|Overall Study|Study completion was not documented.|1
1020135|NCT01585298|2045611|FG000|Overall Study|Protocol deviation|1
1020136|NCT01585298|2045611|FG000|Overall Study|Administrative problems|4
1020137|NCT01585298|2045611|FG000|Overall Study|Lost to Follow-up|2
1020138|NCT01585298|2045611|FG000|Overall Study|Withdrawal by Subject|4
1020139|NCT01585298|2045611|FG000|Overall Study|Abnormal test procedure results|1
1020140|NCT01585298|2045611|FG000|Overall Study|Adverse Event|24
1020141|NCT01585428|2045623|FG000|Overall Study|Death during treatment|1
1020142|NCT01585428|2045624|FG001|Overall Study|Death during treatment|0
1020143|NCT01585558|2045643|FG000|Overall Study|Withdrawal by Subject|4
1020144|NCT01585558|2045644|FG001|Overall Study|Withdrawal by Subject|5
1020145|NCT01585558|2045645|FG002|Overall Study|Withdrawal by Subject|8
1020146|NCT01585558|2045643|FG000|Overall Study|Lost to Follow-up|2
1020147|NCT01585558|2045644|FG001|Overall Study|Lost to Follow-up|0
1020148|NCT01585558|2045645|FG002|Overall Study|Lost to Follow-up|3
1020149|NCT01585558|2045643|FG000|Overall Study|Adverse Event|3
1020150|NCT01585558|2045644|FG001|Overall Study|Adverse Event|4
1020151|NCT01585558|2045645|FG002|Overall Study|Adverse Event|1
1020152|NCT01585558|2045643|FG000|Overall Study|Protocol Violation|4
1020153|NCT01585558|2045644|FG001|Overall Study|Protocol Violation|3
1020154|NCT01585558|2045645|FG002|Overall Study|Protocol Violation|2
1020155|NCT01585558|2045643|FG000|Overall Study|Lack of Efficacy|0
1020156|NCT01585558|2045644|FG001|Overall Study|Lack of Efficacy|0
1020157|NCT01585558|2045645|FG002|Overall Study|Lack of Efficacy|1
1020158|NCT01585584|2045653|FG000|Overall Study|Lack of Efficacy|1
1020159|NCT01585584|2045653|FG000|Overall Study|Withdrawal by Subject|1
1020160|NCT01585584|2045653|FG000|Overall Study|Physician Decision|2
1020161|NCT01585766|2045667|FG000|Overall Study|Withdrawal by Subject|0
1020162|NCT01585766|2045668|FG001|Overall Study|Withdrawal by Subject|1
1020163|NCT01585766|2045669|FG002|Overall Study|Withdrawal by Subject|1
1020164|NCT01585766|2045670|FG003|Overall Study|Withdrawal by Subject|0
1020165|NCT01585766|2045671|FG004|Overall Study|Withdrawal by Subject|0
1020166|NCT01585766|2045672|FG005|Overall Study|Withdrawal by Subject|0
1020167|NCT01585766|2045667|FG000|Overall Study|Death|0
1020168|NCT01585766|2045668|FG001|Overall Study|Death|1
1020169|NCT01585766|2045669|FG002|Overall Study|Death|0
1020170|NCT01585766|2045670|FG003|Overall Study|Death|0
1020171|NCT01585766|2045671|FG004|Overall Study|Death|0
1020172|NCT01585766|2045672|FG005|Overall Study|Death|0
1020173|NCT01585766|2045667|FG000|Overall Study|Physician Decision|0
1020174|NCT01585766|2045668|FG001|Overall Study|Physician Decision|0
1020175|NCT01585766|2045669|FG002|Overall Study|Physician Decision|1
1020176|NCT01585766|2045670|FG003|Overall Study|Physician Decision|0
1020177|NCT01585766|2045671|FG004|Overall Study|Physician Decision|0
1020178|NCT01585766|2045672|FG005|Overall Study|Physician Decision|0
1020179|NCT01585831|2045705|FG000|Overall Study|Physician Decision|0
1020180|NCT01585831|2045706|FG001|Overall Study|Physician Decision|1
1020181|NCT01585831|2045705|FG000|Overall Study|Withdrawal by Subject|2
1020182|NCT01585831|2045706|FG001|Overall Study|Withdrawal by Subject|1
1020183|NCT01585961|2045712|FG000|Overall Study|Death|6
1020184|NCT01585961|2045712|FG000|Overall Study|Physician Decision|1
1020185|NCT01585961|2045712|FG000|Overall Study|Decision to use non-study catheter|1
1020186|NCT01585961|2045712|FG000|Overall Study|Withdrawal by Subject|1
1020187|NCT01585961|2045712|FG000|Overall Study|Lost to Follow-up|23
1020188|NCT01585961|2045712|FG000|Overall Study|Ablation cancelled for slow-heal wound|1
1020189|NCT01585987|2045718|FG000|Randomized|Withdrawal by Subject|0
1020190|NCT01585987|2045719|FG001|Randomized|Withdrawal by Subject|4
1020191|NCT01585987|2045718|FG000|Randomized|No longer met criteria|0
1020192|NCT01585987|2045719|FG001|Randomized|No longer met criteria|2
1020193|NCT01585987|2045718|FG000|Treated|Disease Progression|39
1020194|NCT01585987|2045719|FG001|Treated|Disease Progression|36
1020195|NCT01585987|2045718|FG000|Treated|Study Drug Toxicity|9
1020196|NCT01585987|2045719|FG001|Treated|Study Drug Toxicity|5
1020197|NCT01585987|2045718|FG000|Treated|Adverse Event|3
1020198|NCT01585987|2045719|FG001|Treated|Adverse Event|0
1020199|NCT01585987|2045718|FG000|Treated|Withdrawal by Subject|1
1020200|NCT01585987|2045719|FG001|Treated|Withdrawal by Subject|2
1020201|NCT01585987|2045718|FG000|Treated|Death|1
1020202|NCT01585987|2045719|FG001|Treated|Death|0
1020203|NCT01585987|2045718|FG000|Treated|Lost to Follow-up|0
1020204|NCT01585987|2045719|FG001|Treated|Lost to Follow-up|1
1020205|NCT01585987|2045718|FG000|Treated|Maximum Clinical Benefit|0
1020206|NCT01585987|2045719|FG001|Treated|Maximum Clinical Benefit|1
1020207|NCT01585987|2045718|FG000|Treated|Non-Specified|1
1020208|NCT01585987|2045719|FG001|Treated|Non-Specified|2
1020209|NCT01585987|2045718|FG000|Treated|Subject Request|0
1020210|NCT01585987|2045719|FG001|Treated|Subject Request|1
1020211|NCT01585987|2045718|FG000|Treated|Poor/Non-Compliance|0
1020212|NCT01585987|2045719|FG001|Treated|Poor/Non-Compliance|1
1020213|NCT01586156|2045772|FG000|Overall Study|Pregnancy|0
1020214|NCT01586156|2045773|FG001|Overall Study|Pregnancy|1
1020215|NCT01586156|2045774|FG002|Overall Study|Pregnancy|0
1020216|NCT01586195|2045782|FG000|Overall Study|Death|11
1020217|NCT01586195|2045782|FG000|Overall Study|Withdrawal of Consent|5
1020218|NCT01586195|2045782|FG000|Overall Study|Started new anti-melanoma therapy|1
1020219|NCT01586195|2045782|FG000|Overall Study|Reason not specified|9
1020220|NCT01586338|2045795|FG000|Overall Study|Adverse Event|3
1020221|NCT01586338|2045795|FG000|Overall Study|Lost to Follow-up|1
1020222|NCT01586338|2045795|FG000|Overall Study|Withdrawal by participant|3
1020223|NCT01586338|2045795|FG000|Overall Study|Other|1
1020224|NCT01586364|2045799|FG000|Overall Study|Withdrawal by Subject|40
1020225|NCT01586364|2045799|FG000|Overall Study|Adverse Event|37
1020226|NCT01586364|2045799|FG000|Overall Study|Lost to Follow-up|17
1020227|NCT01586364|2045799|FG000|Overall Study|Protocol Violation|16
1020228|NCT01586364|2045799|FG000|Overall Study|Lack of Efficacy|1
1020229|NCT01586364|2045799|FG000|Overall Study|Other-Did not feel better post-treatment|1
1020230|NCT01586364|2045799|FG000|Overall Study|Other-Subject wasn't getting much relief|1
1020231|NCT01586364|2045799|FG000|Overall Study|Other-Site closure due to PI illness|1
1020232|NCT01586364|2045799|FG000|Overall Study|Other-PI discretion, site closing|2
1020233|NCT01586364|2045799|FG000|Overall Study|Other-Not specified|1
1020234|NCT01586624|2045811|FG000|Overall Study|Adverse Event|3
1020235|NCT01586624|2045812|FG001|Overall Study|Adverse Event|0
1020236|NCT01586624|2045813|FG002|Overall Study|Adverse Event|2
1020237|NCT01586624|2045814|FG003|Overall Study|Adverse Event|1
1020238|NCT01586624|2045815|FG004|Overall Study|Adverse Event|3
1020239|NCT01586624|2045816|FG005|Overall Study|Adverse Event|3
1020240|NCT01586624|2045817|FG006|Overall Study|Adverse Event|2
1020241|NCT01586624|2045818|FG007|Overall Study|Adverse Event|3
1020242|NCT01586624|2045811|FG000|Overall Study|Physician Decision|0
1020243|NCT01586624|2045812|FG001|Overall Study|Physician Decision|1
1020244|NCT01586624|2045813|FG002|Overall Study|Physician Decision|1
1020245|NCT01586624|2045814|FG003|Overall Study|Physician Decision|0
1020246|NCT01586624|2045815|FG004|Overall Study|Physician Decision|2
1020247|NCT01586624|2045816|FG005|Overall Study|Physician Decision|0
1020248|NCT01586624|2045817|FG006|Overall Study|Physician Decision|1
1020249|NCT01586624|2045818|FG007|Overall Study|Physician Decision|1
1020250|NCT01586624|2045811|FG000|Overall Study|Withdrawal by Subject|0
1020251|NCT01586624|2045812|FG001|Overall Study|Withdrawal by Subject|0
1020252|NCT01586624|2045813|FG002|Overall Study|Withdrawal by Subject|0
1020253|NCT01586624|2045814|FG003|Overall Study|Withdrawal by Subject|1
1020254|NCT01586624|2045815|FG004|Overall Study|Withdrawal by Subject|0
1020255|NCT01586624|2045816|FG005|Overall Study|Withdrawal by Subject|0
1020256|NCT01586624|2045817|FG006|Overall Study|Withdrawal by Subject|0
1020257|NCT01586624|2045818|FG007|Overall Study|Withdrawal by Subject|0
1020258|NCT01586624|2045811|FG000|Overall Study|Evidence of disease progression|1
1020259|NCT01586624|2045812|FG001|Overall Study|Evidence of disease progression|3
1020260|NCT01586624|2045813|FG002|Overall Study|Evidence of disease progression|2
1020261|NCT01586624|2045814|FG003|Overall Study|Evidence of disease progression|5
1020262|NCT01586624|2045815|FG004|Overall Study|Evidence of disease progression|3
1020263|NCT01586624|2045816|FG005|Overall Study|Evidence of disease progression|5
1020264|NCT01586624|2045817|FG006|Overall Study|Evidence of disease progression|4
1020265|NCT01586624|2045818|FG007|Overall Study|Evidence of disease progression|6
1020266|NCT01586624|2045811|FG000|Overall Study|Screen failure (no treatment received)|0
1020267|NCT01586624|2045812|FG001|Overall Study|Screen failure (no treatment received)|0
1020268|NCT01586624|2045813|FG002|Overall Study|Screen failure (no treatment received)|0
1020269|NCT01586624|2045814|FG003|Overall Study|Screen failure (no treatment received)|0
1020270|NCT01586624|2045815|FG004|Overall Study|Screen failure (no treatment received)|0
1020271|NCT01586624|2045816|FG005|Overall Study|Screen failure (no treatment received)|0
1020272|NCT01586624|2045817|FG006|Overall Study|Screen failure (no treatment received)|1
1020273|NCT01586624|2045818|FG007|Overall Study|Screen failure (no treatment received)|0
1020274|NCT01586806|2045853|FG000|Overall Study|Protocol Violation|0
1020275|NCT01586806|2045854|FG001|Overall Study|Protocol Violation|1
1020276|NCT01586806|2045855|FG002|Overall Study|Protocol Violation|0
1020277|NCT01586806|2045853|FG000|Overall Study|Withdrawal by Subject|1
1020278|NCT01586806|2045854|FG001|Overall Study|Withdrawal by Subject|0
1020279|NCT01586806|2045855|FG002|Overall Study|Withdrawal by Subject|0
1020280|NCT01586806|2045853|FG000|Overall Study|Lost to Follow-up|2
1020281|NCT01586806|2045854|FG001|Overall Study|Lost to Follow-up|3
1020282|NCT01586806|2045855|FG002|Overall Study|Lost to Follow-up|2
1020283|NCT01586819|2045865|FG000|Overall Study|Withdrawal by Subject|1
1020284|NCT01586819|2045866|FG001|Overall Study|Withdrawal by Subject|0
1020285|NCT01586910|2045898|FG000|Overall Study|Death|4
1020286|NCT01586910|2045899|FG001|Overall Study|Death|4
1020287|NCT01586910|2045898|FG000|Overall Study|Withdrawal by Subject|6
1020288|NCT01586910|2045899|FG001|Overall Study|Withdrawal by Subject|43
1020289|NCT01586910|2045898|FG000|Overall Study|Physician withdrew Subject|5
1020290|NCT01586910|2045899|FG001|Overall Study|Physician withdrew Subject|24
1020291|NCT01587001|2045926|FG000|Overall Study|Lost to Follow-up|2
1020292|NCT01587001|2045927|FG001|Overall Study|Lost to Follow-up|0
1020293|NCT01587001|2045926|FG000|Overall Study|Insufficient samples to complete testing|4
1020294|NCT01587001|2045927|FG001|Overall Study|Insufficient samples to complete testing|1
1020295|NCT01587014|2045934|FG000|Overall Study|Death|2
1020296|NCT01587040|2045951|FG000|Overall Study|Protocol Violation|0
1020297|NCT01587040|2045952|FG001|Overall Study|Protocol Violation|0
1020298|NCT01587040|2045953|FG002|Overall Study|Protocol Violation|1
1020299|NCT01587040|2045954|FG003|Overall Study|Protocol Violation|0
1020300|NCT01587040|2045951|FG000|Overall Study|Adverse Event|0
1020301|NCT01587040|2045952|FG001|Overall Study|Adverse Event|1
1020302|NCT01587040|2045953|FG002|Overall Study|Adverse Event|10
1020303|NCT01587040|2045954|FG003|Overall Study|Adverse Event|0
1020304|NCT01587040|2045951|FG000|Overall Study|Disease progression|12
1020305|NCT01587040|2045952|FG001|Overall Study|Disease progression|1
1020306|NCT01587040|2045953|FG002|Overall Study|Disease progression|15
1020307|NCT01587040|2045954|FG003|Overall Study|Disease progression|3
1020308|NCT01587040|2045951|FG000|Overall Study|Other than specified|5
1020309|NCT01587040|2045952|FG001|Overall Study|Other than specified|1
1020310|NCT01587040|2045953|FG002|Overall Study|Other than specified|11
1020311|NCT01587040|2045954|FG003|Overall Study|Other than specified|1
1020312|NCT01587079|2045964|FG000|Overall Study|Protocol-specified criteria|9
1020313|NCT01587079|2045964|FG000|Overall Study|Protocol Violation|5
1020314|NCT01587079|2045964|FG000|Overall Study|Lost to Follow-up|2
1020315|NCT01587079|2045964|FG000|Overall Study|Physician Decision|2
1020316|NCT01587079|2045964|FG000|Overall Study|Withdrawal by Subject|7
1020317|NCT01587079|2045964|FG000|Overall Study|Adverse Event|14
1020318|NCT01587118|2046007|FG000|Overall Study|Adverse Event|3
1020319|NCT01587118|2046007|FG000|Overall Study|Lost to Follow-up|2
1020320|NCT01587118|2046007|FG000|Overall Study|Relocation|1
1020321|NCT01587118|2046007|FG000|Overall Study|nonresponse|1
1020322|NCT01587274|2046014|FG000|Overall Study|Lost to Follow-up|4
1020323|NCT01587274|2046015|FG001|Overall Study|Lost to Follow-up|5
1020324|NCT01587274|2046016|FG002|Overall Study|Lost to Follow-up|3
1020325|NCT01587651|2046027|FG000|Overall Study|Adverse Event|0
1020326|NCT01587651|2046028|FG001|Overall Study|Adverse Event|1
1020327|NCT01587651|2046029|FG002|Overall Study|Adverse Event|0
1020328|NCT01587651|2046027|FG000|Overall Study|Protocol Violation|0
1020329|NCT01587651|2046028|FG001|Overall Study|Protocol Violation|1
1020330|NCT01587651|2046029|FG002|Overall Study|Protocol Violation|1
1020331|NCT01587651|2046027|FG000|Overall Study|Withdrawal by Subject|0
1020332|NCT01587651|2046028|FG001|Overall Study|Withdrawal by Subject|1
1020333|NCT01587651|2046029|FG002|Overall Study|Withdrawal by Subject|0
1020334|NCT01587703|2046056|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
1020335|NCT01587703|2046057|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020336|NCT01587703|2046058|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020337|NCT01587703|2046059|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020338|NCT01587703|2046060|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020339|NCT01587703|2046061|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020340|NCT01587703|2046062|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1162013|NCT03380429|2283931|FG004|Overall Study|Lost to Follow-up|1
903951|NCT00752557|1878421|FG001|Overall Study|Withdrawal by Subject|3
903952|NCT00752557|1878422|FG002|Overall Study|Withdrawal by Subject|3
903953|NCT00752557|1878420|FG000|Overall Study|Unspecified resaons|0
903954|NCT00752557|1878421|FG001|Overall Study|Unspecified resaons|2
903955|NCT00752557|1878422|FG002|Overall Study|Unspecified resaons|2
903956|NCT00752557|1878420|FG000|Overall Study|Lost to Follow-up|1
1020341|NCT01587703|2046063|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020342|NCT01587703|2046064|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020343|NCT01587703|2046065|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020344|NCT01587703|2046066|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020345|NCT01587703|2046067|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020346|NCT01587703|2046068|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020347|NCT01587703|2046069|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020348|NCT01587703|2046070|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020349|NCT01587703|2046071|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020350|NCT01587703|2046072|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020351|NCT01587703|2046073|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020352|NCT01587703|2046074|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
1020353|NCT01587703|2046056|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020354|NCT01587703|2046057|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020355|NCT01587703|2046058|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020356|NCT01587703|2046059|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020357|NCT01587703|2046060|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020358|NCT01587703|2046061|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
1020359|NCT01587703|2046062|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020360|NCT01587703|2046063|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
1020361|NCT01587703|2046064|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020362|NCT01587703|2046065|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020363|NCT01587703|2046066|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020364|NCT01587703|2046067|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020365|NCT01587703|2046068|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020366|NCT01587703|2046069|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020367|NCT01587703|2046070|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020368|NCT01587703|2046071|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020369|NCT01587703|2046072|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020370|NCT01587703|2046073|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020371|NCT01587703|2046074|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
1020372|NCT01587703|2046056|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020373|NCT01587703|2046057|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020374|NCT01587703|2046058|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020375|NCT01587703|2046059|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020376|NCT01587703|2046060|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020377|NCT01587703|2046061|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020378|NCT01587703|2046062|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2
1020379|NCT01587703|2046063|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020380|NCT01587703|2046064|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020381|NCT01587703|2046065|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020382|NCT01587703|2046066|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020383|NCT01587703|2046067|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020384|NCT01587703|2046068|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020385|NCT01587703|2046069|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020386|NCT01587703|2046070|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020387|NCT01587703|2046071|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020388|NCT01587703|2046072|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020389|NCT01587703|2046073|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020390|NCT01587703|2046074|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0
1020391|NCT01587703|2046056|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2
1020392|NCT01587703|2046057|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4
903957|NCT00752557|1878421|FG001|Overall Study|Lost to Follow-up|0
903958|NCT00752557|1878422|FG002|Overall Study|Lost to Follow-up|1
903959|NCT00752609|1878434|FG000|Overall Study|Adverse Event|2
903960|NCT00752609|1878435|FG001|Overall Study|Adverse Event|2
903961|NCT00752609|1878434|FG000|Overall Study|Withdrawal by Subject|3
903962|NCT00752609|1878435|FG001|Overall Study|Withdrawal by Subject|0
903963|NCT00752609|1878434|FG000|Overall Study|Physician Decision|1
903964|NCT00752609|1878435|FG001|Overall Study|Physician Decision|0
903965|NCT00752609|1878434|FG000|Overall Study|Death|1
903966|NCT00752609|1878435|FG001|Overall Study|Death|0
903967|NCT00752609|1878434|FG000|Overall Study|Met exclusion criteria|1
903968|NCT00752609|1878435|FG001|Overall Study|Met exclusion criteria|0
903969|NCT00752609|1878434|FG000|Overall Study|Received Aranesp in error|1
903970|NCT00752609|1878435|FG001|Overall Study|Received Aranesp in error|0
903971|NCT00752622|1878444|FG000|Induction Phase|Adverse Event|3
903972|NCT00752622|1878444|FG000|Induction Phase|Other|3
903973|NCT00752622|1878444|FG000|Induction Phase|Non-responder|14
903974|NCT00752622|1878444|FG000|Induction Phase|Withdrawal by Subject|1
903975|NCT00752622|1878444|FG000|Induction Phase|Premature study termination|14
903976|NCT00752622|1878444|FG000|Observational Phase|Premature Study Termination|36
1020393|NCT01587703|2046058|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1
1020394|NCT01587703|2046059|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3
1020395|NCT01587703|2046060|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4
1020396|NCT01587703|2046061|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7
1020397|NCT01587703|2046062|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30
1020398|NCT01587703|2046063|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7
1020399|NCT01587703|2046064|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0
1020400|NCT01587703|2046065|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0
1020401|NCT01587703|2046066|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0
1020402|NCT01587703|2046067|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0
1020403|NCT01587703|2046068|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0
1020404|NCT01587703|2046069|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0
1020405|NCT01587703|2046070|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0
1020406|NCT01587703|2046071|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0
1020407|NCT01587703|2046072|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0
1020408|NCT01587703|2046073|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0
1020409|NCT01587703|2046074|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0
1020410|NCT01587703|2046056|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0
1020411|NCT01587703|2046057|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0
1020412|NCT01587703|2046058|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0
1020413|NCT01587703|2046059|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0
1020414|NCT01587703|2046060|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0
1020415|NCT01587703|2046061|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0
1020416|NCT01587703|2046062|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0
1020417|NCT01587703|2046063|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0
1020418|NCT01587703|2046064|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1
1020419|NCT01587703|2046065|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9
1020420|NCT01587703|2046066|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3
1020421|NCT01587703|2046067|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0
1020422|NCT01587703|2046068|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0
1020423|NCT01587703|2046069|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0
1020424|NCT01587703|2046070|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0
1020425|NCT01587703|2046071|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0
1020426|NCT01587703|2046072|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0
1020427|NCT01587703|2046073|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0
1020428|NCT01587703|2046074|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0
1020429|NCT01587703|2046056|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020430|NCT01587703|2046057|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020431|NCT01587703|2046058|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020432|NCT01587703|2046059|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020433|NCT01587703|2046060|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020434|NCT01587703|2046061|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020435|NCT01587703|2046062|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020436|NCT01587703|2046063|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020437|NCT01587703|2046064|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
1020438|NCT01587703|2046065|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020439|NCT01587703|2046066|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
1020440|NCT01587703|2046067|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020441|NCT01587703|2046068|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020442|NCT01587703|2046069|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020443|NCT01587703|2046070|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020444|NCT01587703|2046071|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020445|NCT01587703|2046072|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020446|NCT01587703|2046073|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020447|NCT01587703|2046074|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
1020448|NCT01587703|2046056|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020449|NCT01587703|2046057|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020450|NCT01587703|2046058|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020451|NCT01587703|2046059|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020452|NCT01587703|2046060|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020453|NCT01587703|2046061|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020454|NCT01587703|2046062|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020455|NCT01587703|2046063|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020456|NCT01587703|2046064|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020457|NCT01587703|2046065|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1
1020458|NCT01587703|2046066|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1
1020459|NCT01587703|2046067|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020460|NCT01587703|2046068|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020461|NCT01587703|2046069|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020462|NCT01587703|2046070|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1162014|NCT03380429|2283927|FG000|Overall Study|Protocol Violation|1
1020463|NCT01587703|2046071|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020464|NCT01587703|2046072|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020465|NCT01587703|2046073|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0
1020466|NCT01587703|2046074|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0
903977|NCT00752622|1878444|FG000|Observational Phase|Non-responder|2
903978|NCT00752622|1878444|FG000|Observational Phase|Withdrawal by Subject|2
903979|NCT00752622|1878444|FG000|Observational Phase|Adverse Event|1
903980|NCT00752622|1878444|FG000|Observational Phase|Other|2
903981|NCT00752622|1878444|FG000|Interventional Phase|Non-responder|2
903982|NCT00752622|1878444|FG000|Interventional Phase|Physician Decision|1
903983|NCT00752622|1878444|FG000|Interventional Phase|Premature Study Termination|5
903984|NCT00752726|1878451|FG000|Overall Study|Lost to Follow-up|2
903985|NCT00752726|1878452|FG001|Overall Study|Lost to Follow-up|1
903986|NCT00752726|1878451|FG000|Overall Study|Adverse Event|3
903987|NCT00752726|1878452|FG001|Overall Study|Adverse Event|0
903988|NCT00752726|1878451|FG000|Overall Study|Withdrawal by Subject|5
903989|NCT00752726|1878452|FG001|Overall Study|Withdrawal by Subject|10
903990|NCT00752726|1878451|FG000|Overall Study|Other Reason|1
903991|NCT00752726|1878452|FG001|Overall Study|Other Reason|2
903992|NCT00752791|1878458|FG000|Overall Study|Adverse Event|7
903993|NCT00752791|1878458|FG000|Overall Study|Withdrawal by Subject|1
903994|NCT00752791|1878458|FG000|Overall Study|Physician Decision|1
903995|NCT00752791|1878458|FG000|Overall Study|Death|1
903996|NCT00752791|1878458|FG000|Overall Study|Renal transplant|3
903997|NCT00752791|1878458|FG000|Overall Study|Switched to hemodialysis|2
903998|NCT00752791|1878458|FG000|Overall Study|Protocol deviation|1
903999|NCT00752856|1878464|FG000|Overall Study|randomized but did not do viral kinetics|0
904000|NCT00752856|1878465|FG001|Overall Study|randomized but did not do viral kinetics|1
904001|NCT00752895|1878473|FG000|Overall Study|Withdrawal by Subject|8
904002|NCT00752895|1878474|FG001|Overall Study|Withdrawal by Subject|3
904003|NCT00753012|1878497|FG000|Overall Study|Ineligible, abnormal cardiac histo|1
904004|NCT00753012|1878498|FG001|Overall Study|Ineligible, abnormal cardiac histo|0
904005|NCT00753012|1878497|FG000|Overall Study|Adverse Event|2
904006|NCT00753012|1878498|FG001|Overall Study|Adverse Event|0
904007|NCT00753012|1878497|FG000|Overall Study|Withdrawal by Subject|0
904008|NCT00753012|1878498|FG001|Overall Study|Withdrawal by Subject|1
904009|NCT00753012|1878497|FG000|Overall Study|Lost to Follow-up|4
904010|NCT00753012|1878498|FG001|Overall Study|Lost to Follow-up|0
904011|NCT00753012|1878497|FG000|Overall Study|Confounded endpoint data|1
904012|NCT00753012|1878498|FG001|Overall Study|Confounded endpoint data|0
904013|NCT00753272|1878524|FG000|Overall Study|Adverse Event|878
904014|NCT00753272|1878525|FG001|Overall Study|Adverse Event|869
904015|NCT00753272|1878524|FG000|Overall Study|Protocol Violation|28
904016|NCT00753272|1878525|FG001|Overall Study|Protocol Violation|46
904017|NCT00753272|1878524|FG000|Overall Study|Withdrawal by Subject|2481
904018|NCT00753272|1878525|FG001|Overall Study|Withdrawal by Subject|2407
904019|NCT00753272|1878524|FG000|Overall Study|Lost to Follow-up|491
904020|NCT00753272|1878525|FG001|Overall Study|Lost to Follow-up|497
904021|NCT00753272|1878524|FG000|Overall Study|Other|1104
904022|NCT00753272|1878525|FG001|Overall Study|Other|1088
904023|NCT00753415|1878562|FG000|Part A|Disease progression|1
904024|NCT00753415|1878563|FG001|Part A|Disease progression|0
904025|NCT00753415|1878564|FG002|Part A|Disease progression|1
904026|NCT00753415|1878565|FG003|Part A|Disease progression|2
904027|NCT00753415|1878566|FG004|Part A|Disease progression|0
904028|NCT00753415|1878567|FG005|Part A|Disease progression|0
904029|NCT00753415|1878568|FG006|Part A|Disease progression|0
904030|NCT00753415|1878569|FG007|Part A|Disease progression|0
904031|NCT00753415|1878570|FG008|Part A|Disease progression|0
904032|NCT00753415|1878571|FG009|Part A|Disease progression|0
904033|NCT00753415|1878562|FG000|Part A|Withdrawal by Subject|0
904034|NCT00753415|1878563|FG001|Part A|Withdrawal by Subject|0
904035|NCT00753415|1878564|FG002|Part A|Withdrawal by Subject|1
904036|NCT00753415|1878565|FG003|Part A|Withdrawal by Subject|0
904037|NCT00753415|1878566|FG004|Part A|Withdrawal by Subject|0
904038|NCT00753415|1878567|FG005|Part A|Withdrawal by Subject|0
904039|NCT00753415|1878568|FG006|Part A|Withdrawal by Subject|0
904040|NCT00753415|1878569|FG007|Part A|Withdrawal by Subject|0
904041|NCT00753415|1878570|FG008|Part A|Withdrawal by Subject|0
904042|NCT00753415|1878571|FG009|Part A|Withdrawal by Subject|0
904043|NCT00753415|1878562|FG000|Part B|Lost to Follow-up|0
904044|NCT00753415|1878563|FG001|Part B|Lost to Follow-up|0
904045|NCT00753415|1878564|FG002|Part B|Lost to Follow-up|0
904046|NCT00753415|1878565|FG003|Part B|Lost to Follow-up|0
904047|NCT00753415|1878566|FG004|Part B|Lost to Follow-up|0
904048|NCT00753415|1878567|FG005|Part B|Lost to Follow-up|0
904049|NCT00753415|1878568|FG006|Part B|Lost to Follow-up|0
904050|NCT00753415|1878569|FG007|Part B|Lost to Follow-up|1
904051|NCT00753415|1878570|FG008|Part B|Lost to Follow-up|1
904052|NCT00753415|1878571|FG009|Part B|Lost to Follow-up|0
904053|NCT00753415|1878562|FG000|Part B|Disease progression|0
904054|NCT00753415|1878563|FG001|Part B|Disease progression|0
904055|NCT00753415|1878564|FG002|Part B|Disease progression|0
904056|NCT00753415|1878565|FG003|Part B|Disease progression|0
904057|NCT00753415|1878566|FG004|Part B|Disease progression|0
904058|NCT00753415|1878567|FG005|Part B|Disease progression|0
1020467|NCT01587703|2046056|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020468|NCT01587703|2046057|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020469|NCT01587703|2046058|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020470|NCT01587703|2046059|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020471|NCT01587703|2046060|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020472|NCT01587703|2046061|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020473|NCT01587703|2046062|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020474|NCT01587703|2046063|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020475|NCT01587703|2046064|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
1020476|NCT01587703|2046065|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020477|NCT01587703|2046066|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020478|NCT01587703|2046067|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020479|NCT01587703|2046068|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020480|NCT01587703|2046069|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020481|NCT01587703|2046070|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020482|NCT01587703|2046071|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020483|NCT01587703|2046072|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020484|NCT01587703|2046073|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020485|NCT01587703|2046074|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
1020486|NCT01587703|2046056|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020487|NCT01587703|2046057|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020488|NCT01587703|2046058|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020489|NCT01587703|2046059|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020490|NCT01587703|2046060|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020491|NCT01587703|2046061|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020492|NCT01587703|2046062|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020493|NCT01587703|2046063|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020494|NCT01587703|2046064|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020495|NCT01587703|2046065|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020496|NCT01587703|2046066|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020497|NCT01587703|2046067|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020498|NCT01587703|2046068|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020499|NCT01587703|2046069|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020500|NCT01587703|2046070|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020501|NCT01587703|2046071|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020502|NCT01587703|2046072|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020503|NCT01587703|2046073|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
1020504|NCT01587703|2046074|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
1020505|NCT01587703|2046056|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020506|NCT01587703|2046057|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020507|NCT01587703|2046058|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020508|NCT01587703|2046059|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020509|NCT01587703|2046060|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020510|NCT01587703|2046061|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020511|NCT01587703|2046062|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020512|NCT01587703|2046063|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020513|NCT01587703|2046064|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020514|NCT01587703|2046065|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020515|NCT01587703|2046066|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020516|NCT01587703|2046067|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020517|NCT01587703|2046068|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020518|NCT01587703|2046069|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020519|NCT01587703|2046070|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020520|NCT01587703|2046071|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020521|NCT01587703|2046072|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0
1020522|NCT01587703|2046073|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5
1020523|NCT01587703|2046074|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4
1020524|NCT01587703|2046056|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020525|NCT01587703|2046057|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020526|NCT01587703|2046058|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020527|NCT01587703|2046059|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020528|NCT01587703|2046060|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020529|NCT01587703|2046061|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020530|NCT01587703|2046062|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020531|NCT01587703|2046063|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020532|NCT01587703|2046064|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020533|NCT01587703|2046065|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1162015|NCT03380429|2283928|FG001|Overall Study|Protocol Violation|0
1020534|NCT01587703|2046066|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
904059|NCT00753415|1878568|FG006|Part B|Disease progression|0
904060|NCT00753415|1878569|FG007|Part B|Disease progression|0
904061|NCT00753415|1878570|FG008|Part B|Disease progression|2
904062|NCT00753415|1878571|FG009|Part B|Disease progression|1
904063|NCT00753454|1878595|FG000|Overall Study|Adverse Event|4
904064|NCT00753454|1878595|FG000|Overall Study|Lack of Efficacy|1
904065|NCT00753454|1878595|FG000|Overall Study|Lost to Follow-up|3
904066|NCT00753454|1878595|FG000|Overall Study|Withdrawal by Subject|5
904067|NCT00753454|1878595|FG000|Overall Study|Investigator Decision|1
904068|NCT00753506|1878601|FG000|Overall Study|Withdrawal by Subject|4
904069|NCT00753506|1878602|FG001|Overall Study|Withdrawal by Subject|1
904070|NCT00753506|1878601|FG000|Overall Study|Lost to Follow-up|2
904071|NCT00753506|1878602|FG001|Overall Study|Lost to Follow-up|0
904072|NCT00753506|1878601|FG000|Overall Study|Other reason|1
904073|NCT00753506|1878602|FG001|Overall Study|Other reason|1
904074|NCT00753519|1878610|FG000|Overall Study|Withdrawal by Subject|0
904075|NCT00753519|1878611|FG001|Overall Study|Withdrawal by Subject|2
904076|NCT00753545|1878621|FG000|Overall Study|Death|98
904077|NCT00753545|1878622|FG001|Overall Study|Death|112
904078|NCT00753545|1878621|FG000|Overall Study|Lost to Follow-up|2
904079|NCT00753545|1878622|FG001|Overall Study|Lost to Follow-up|3
904080|NCT00753545|1878621|FG000|Overall Study|Protocol Violation|1
904081|NCT00753545|1878622|FG001|Overall Study|Protocol Violation|0
904082|NCT00753545|1878621|FG000|Overall Study|Voluntary Discontinuation of Patient|7
904083|NCT00753545|1878622|FG001|Overall Study|Voluntary Discontinuation of Patient|3
904084|NCT00753623|1878630|FG000|Phase I (14 Days)|Withdrawal by Subject|1
904085|NCT00753623|1878631|FG001|Phase I (14 Days)|Withdrawal by Subject|1
904086|NCT00753623|1878630|FG000|Phase I (14 Days)|Physician Decision|1
904087|NCT00753623|1878631|FG001|Phase I (14 Days)|Physician Decision|2
904088|NCT00753623|1878630|FG000|Phase I (14 Days)|Adverse Event|0
904089|NCT00753623|1878631|FG001|Phase I (14 Days)|Adverse Event|1
904090|NCT00753623|1878630|FG000|Washout (7 Days)|Physician Decision|1
904091|NCT00753623|1878631|FG001|Washout (7 Days)|Physician Decision|0
904092|NCT00753623|1878630|FG000|Phase II (14 Days)|Physician Decision|0
904093|NCT00753623|1878631|FG001|Phase II (14 Days)|Physician Decision|1
904094|NCT00753649|1878643|FG000|Overall Study|Migrated/moved from study area|1
904095|NCT00753649|1878644|FG001|Overall Study|Migrated/moved from study area|0
904096|NCT00753649|1878643|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3
904097|NCT00753649|1878644|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0
904098|NCT00753649|1878643|FG000|Overall Study|Lost to follow-up-complete vaccination|1
904099|NCT00753649|1878644|FG001|Overall Study|Lost to follow-up-complete vaccination|0
904100|NCT00753649|1878643|FG000|Overall Study|Protocol Violation|2
904101|NCT00753649|1878644|FG001|Overall Study|Protocol Violation|0
904102|NCT00753675|1878653|FG000|Overall Study|other reason|11
904103|NCT00753675|1878654|FG001|Overall Study|other reason|12
904104|NCT00753675|1878655|FG002|Overall Study|other reason|13
904105|NCT00753675|1878653|FG000|Overall Study|Death|1
904106|NCT00753675|1878654|FG001|Overall Study|Death|2
904107|NCT00753675|1878655|FG002|Overall Study|Death|4
904108|NCT00753675|1878653|FG000|Overall Study|Adverse Event|11
904109|NCT00753675|1878654|FG001|Overall Study|Adverse Event|9
904110|NCT00753675|1878655|FG002|Overall Study|Adverse Event|4
904111|NCT00753675|1878653|FG000|Overall Study|Objective progression of disease|35
904112|NCT00753675|1878654|FG001|Overall Study|Objective progression of disease|35
904113|NCT00753675|1878655|FG002|Overall Study|Objective progression of disease|35
904114|NCT00753675|1878653|FG000|Overall Study|Withdrawal by Subject|0
904115|NCT00753675|1878654|FG001|Overall Study|Withdrawal by Subject|1
904116|NCT00753675|1878655|FG002|Overall Study|Withdrawal by Subject|0
904117|NCT00753675|1878653|FG000|Overall Study|Lost to Follow-up|1
904118|NCT00753675|1878654|FG001|Overall Study|Lost to Follow-up|0
904119|NCT00753675|1878655|FG002|Overall Study|Lost to Follow-up|0
904120|NCT00753688|1878665|FG000|Overall Study|Death|102
904121|NCT00753688|1878666|FG001|Overall Study|Death|203
904122|NCT00753688|1878665|FG000|Overall Study|Missing|4
904123|NCT00753688|1878666|FG001|Overall Study|Missing|9
904124|NCT00753688|1878665|FG000|Overall Study|Participant Withdrew Consent|2
904125|NCT00753688|1878666|FG001|Overall Study|Participant Withdrew Consent|2
904126|NCT00753688|1878665|FG000|Overall Study|Ongoing - in Follow-up|15
904127|NCT00753688|1878666|FG001|Overall Study|Ongoing - in Follow-up|31
904128|NCT00753688|1878665|FG000|Overall Study|Adverse Event|0
904129|NCT00753688|1878666|FG001|Overall Study|Adverse Event|1
904130|NCT00753714|1878674|FG000|Overall Study|Lack of Efficacy|21
904131|NCT00753714|1878675|FG001|Overall Study|Lack of Efficacy|34
904132|NCT00753714|1878674|FG000|Overall Study|Adverse Event|26
904133|NCT00753714|1878675|FG001|Overall Study|Adverse Event|18
904134|NCT00753714|1878674|FG000|Overall Study|Protocol Violation|1
904135|NCT00753714|1878675|FG001|Overall Study|Protocol Violation|0
904136|NCT00753714|1878674|FG000|Overall Study|Lost to Follow-up|0
904137|NCT00753714|1878675|FG001|Overall Study|Lost to Follow-up|1
904138|NCT00753714|1878674|FG000|Overall Study|Withdrawal by Subject|2
904139|NCT00753714|1878675|FG001|Overall Study|Withdrawal by Subject|1
904140|NCT00753714|1878674|FG000|Overall Study|Death|3
904141|NCT00753714|1878675|FG001|Overall Study|Death|3
1020535|NCT01587703|2046067|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020536|NCT01587703|2046068|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020537|NCT01587703|2046069|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020538|NCT01587703|2046070|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020539|NCT01587703|2046071|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
1020540|NCT01587703|2046072|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020541|NCT01587703|2046073|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020542|NCT01587703|2046074|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
1020543|NCT01587703|2046056|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020544|NCT01587703|2046057|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020545|NCT01587703|2046058|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020546|NCT01587703|2046059|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020547|NCT01587703|2046060|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020548|NCT01587703|2046061|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020549|NCT01587703|2046062|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020550|NCT01587703|2046063|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020551|NCT01587703|2046064|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020552|NCT01587703|2046065|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020553|NCT01587703|2046066|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020554|NCT01587703|2046067|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
1020555|NCT01587703|2046068|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020556|NCT01587703|2046069|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020557|NCT01587703|2046070|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
1020558|NCT01587703|2046071|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020559|NCT01587703|2046072|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020560|NCT01587703|2046073|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020561|NCT01587703|2046074|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
1020562|NCT01587703|2046056|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020563|NCT01587703|2046057|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020564|NCT01587703|2046058|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020565|NCT01587703|2046059|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020566|NCT01587703|2046060|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020567|NCT01587703|2046061|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020568|NCT01587703|2046062|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020569|NCT01587703|2046063|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020570|NCT01587703|2046064|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020571|NCT01587703|2046065|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0
904142|NCT00753714|1878674|FG000|Overall Study|Other|7
904143|NCT00753714|1878675|FG001|Overall Study|Other|5
904144|NCT00753766|1878686|FG000|Overall Study|Physician Decision|1
904145|NCT00753766|1878687|FG001|Overall Study|Physician Decision|0
904146|NCT00753896|1878694|FG000|Overall Study|Adverse Event|4
904147|NCT00753896|1878694|FG000|Overall Study|Death|1
904148|NCT00753896|1878694|FG000|Overall Study|Lost to Follow-up|2
904149|NCT00753896|1878694|FG000|Overall Study|Protocol Violation|1
904150|NCT00753896|1878694|FG000|Overall Study|Withdrawal by Subject|4
904151|NCT00753896|1878694|FG000|Overall Study|Entry Criteria Not Met|4
904152|NCT00753922|1878702|FG000|Overall Study|Lost to Follow-up|155
904153|NCT00753922|1878703|FG001|Overall Study|Lost to Follow-up|24
904154|NCT00753922|1878704|FG002|Overall Study|Lost to Follow-up|28
904155|NCT00753922|1878705|FG003|Overall Study|Lost to Follow-up|5
904156|NCT00753922|1878702|FG000|Overall Study|Withdrawal by Subject|9
904157|NCT00753922|1878703|FG001|Overall Study|Withdrawal by Subject|11
904158|NCT00753922|1878704|FG002|Overall Study|Withdrawal by Subject|4
904159|NCT00753922|1878705|FG003|Overall Study|Withdrawal by Subject|2
904160|NCT00753922|1878702|FG000|Overall Study|Patient Non-compliance|55
904161|NCT00753922|1878703|FG001|Overall Study|Patient Non-compliance|22
904162|NCT00753922|1878704|FG002|Overall Study|Patient Non-compliance|14
904163|NCT00753922|1878705|FG003|Overall Study|Patient Non-compliance|11
904164|NCT00753922|1878702|FG000|Overall Study|Patients Not Completing Visit|11
904165|NCT00753922|1878703|FG001|Overall Study|Patients Not Completing Visit|0
904166|NCT00753922|1878704|FG002|Overall Study|Patients Not Completing Visit|1
904167|NCT00753922|1878705|FG003|Overall Study|Patients Not Completing Visit|0
904168|NCT00753922|1878702|FG000|Overall Study|Death|2
904169|NCT00753922|1878703|FG001|Overall Study|Death|23
904170|NCT00753922|1878704|FG002|Overall Study|Death|2
904171|NCT00753922|1878705|FG003|Overall Study|Death|1
904172|NCT00753922|1878702|FG000|Overall Study|Discontinuation Due to Explantation|14
904173|NCT00753922|1878703|FG001|Overall Study|Discontinuation Due to Explantation|14
904174|NCT00753922|1878704|FG002|Overall Study|Discontinuation Due to Explantation|14
904175|NCT00753922|1878705|FG003|Overall Study|Discontinuation Due to Explantation|4
904176|NCT00754065|1878739|FG000|Overall Study|Never received treatment|12
904177|NCT00754065|1878740|FG001|Overall Study|Never received treatment|2
904178|NCT00754065|1878739|FG000|Overall Study|Adverse Event|19
904179|NCT00754065|1878740|FG001|Overall Study|Adverse Event|25
904180|NCT00754065|1878739|FG000|Overall Study|Lost to Follow-up|7
904181|NCT00754065|1878740|FG001|Overall Study|Lost to Follow-up|11
1020572|NCT01587703|2046066|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020573|NCT01587703|2046067|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2
1020574|NCT01587703|2046068|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2
1020575|NCT01587703|2046069|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1
1020576|NCT01587703|2046070|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1
1020577|NCT01587703|2046071|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3
1020578|NCT01587703|2046072|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8
1020579|NCT01587703|2046073|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020580|NCT01587703|2046074|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0
1020581|NCT01587703|2046056|FG000|Part2(Median Exposure of 1.41 Months)|Death|0
1020582|NCT01587703|2046057|FG001|Part2(Median Exposure of 1.41 Months)|Death|0
1020583|NCT01587703|2046058|FG002|Part2(Median Exposure of 1.41 Months)|Death|0
1020584|NCT01587703|2046059|FG003|Part2(Median Exposure of 1.41 Months)|Death|0
1020585|NCT01587703|2046060|FG004|Part2(Median Exposure of 1.41 Months)|Death|0
1020586|NCT01587703|2046061|FG005|Part2(Median Exposure of 1.41 Months)|Death|0
1020587|NCT01587703|2046062|FG006|Part2(Median Exposure of 1.41 Months)|Death|0
1020588|NCT01587703|2046063|FG007|Part2(Median Exposure of 1.41 Months)|Death|0
1020589|NCT01587703|2046064|FG008|Part2(Median Exposure of 1.41 Months)|Death|0
1020590|NCT01587703|2046065|FG009|Part2(Median Exposure of 1.41 Months)|Death|0
1020591|NCT01587703|2046066|FG010|Part2(Median Exposure of 1.41 Months)|Death|0
1020592|NCT01587703|2046067|FG011|Part2(Median Exposure of 1.41 Months)|Death|8
1020593|NCT01587703|2046068|FG012|Part2(Median Exposure of 1.41 Months)|Death|12
1020594|NCT01587703|2046069|FG013|Part2(Median Exposure of 1.41 Months)|Death|21
1020595|NCT01587703|2046070|FG014|Part2(Median Exposure of 1.41 Months)|Death|16
1020596|NCT01587703|2046071|FG015|Part2(Median Exposure of 1.41 Months)|Death|17
1020597|NCT01587703|2046072|FG016|Part2(Median Exposure of 1.41 Months)|Death|5
1020598|NCT01587703|2046073|FG017|Part2(Median Exposure of 1.41 Months)|Death|0
1020599|NCT01587703|2046074|FG018|Part2(Median Exposure of 1.41 Months)|Death|0
1020600|NCT01587703|2046056|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020601|NCT01587703|2046057|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020602|NCT01587703|2046058|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020603|NCT01587703|2046059|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020604|NCT01587703|2046060|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020605|NCT01587703|2046061|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020606|NCT01587703|2046062|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020607|NCT01587703|2046063|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020608|NCT01587703|2046064|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
904182|NCT00754065|1878739|FG000|Overall Study|Protocol Violation|12
904183|NCT00754065|1878740|FG001|Overall Study|Protocol Violation|10
904184|NCT00754065|1878739|FG000|Overall Study|Withdrawal by Subject|4
904185|NCT00754065|1878740|FG001|Overall Study|Withdrawal by Subject|5
904186|NCT00754065|1878739|FG000|Overall Study|Pregnancy|6
904187|NCT00754065|1878740|FG001|Overall Study|Pregnancy|0
904188|NCT00754065|1878739|FG000|Overall Study|Reason not specified or unknown, etc.|21
904189|NCT00754065|1878740|FG001|Overall Study|Reason not specified or unknown, etc.|27
904190|NCT00754234|1878793|FG000|Overall Study|Withdrawal by Subject|3
904191|NCT00754325|1878812|FG000|Initial Treatment|Continuing Active Treatment|4
904192|NCT00754325|1878813|FG001|Initial Treatment|Continuing Active Treatment|5
904193|NCT00754325|1878812|FG000|Initial Treatment|Adverse Event|7
904194|NCT00754325|1878813|FG001|Initial Treatment|Adverse Event|6
904195|NCT00754325|1878812|FG000|Initial Treatment|Withdrawal by Subject|2
904196|NCT00754325|1878813|FG001|Initial Treatment|Withdrawal by Subject|2
904197|NCT00754325|1878812|FG000|Initial Treatment|Physician Decision|2
904198|NCT00754325|1878813|FG001|Initial Treatment|Physician Decision|0
904199|NCT00754325|1878812|FG000|Initial Treatment|Sponsor Request|0
904200|NCT00754325|1878813|FG001|Initial Treatment|Sponsor Request|1
904201|NCT00754325|1878812|FG000|Initial Treatment|Disease Progression|35
904202|NCT00754325|1878813|FG001|Initial Treatment|Disease Progression|35
904203|NCT00754338|1878824|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
904204|NCT00754338|1878825|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
904205|NCT00754338|1878826|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
904206|NCT00754338|1878827|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
904207|NCT00754338|1878824|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
904208|NCT00754338|1878825|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
904209|NCT00754338|1878826|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
904210|NCT00754338|1878827|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
904211|NCT00754390|1878850|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
904212|NCT00754390|1878850|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
904213|NCT00754390|1878850|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
904214|NCT00754390|1878850|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
904215|NCT00754442|1878859|FG000|Overall Study|Withdrawal by Subject|5
904216|NCT00754442|1878860|FG001|Overall Study|Withdrawal by Subject|3
904217|NCT00754559|1878901|FG000|Overall Study|Adverse Event|15
904218|NCT00754559|1878901|FG000|Overall Study|Protocol Violation|11
1020609|NCT01587703|2046065|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020610|NCT01587703|2046066|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020611|NCT01587703|2046067|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
1020612|NCT01587703|2046068|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020613|NCT01587703|2046069|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020614|NCT01587703|2046070|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020615|NCT01587703|2046071|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020616|NCT01587703|2046072|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020617|NCT01587703|2046073|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020618|NCT01587703|2046074|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
1020619|NCT01587885|2046133|FG000|Treatment Period 1|Failure to Return|0
1020620|NCT01587885|2046134|FG001|Treatment Period 1|Failure to Return|1
1020621|NCT01587885|2046133|FG000|Treatment Period 1|Protocol Violation|0
1020622|NCT01587885|2046134|FG001|Treatment Period 1|Protocol Violation|2
1020623|NCT01587898|2046145|FG000|Overall Study|Adverse Event|1
1020624|NCT01587898|2046146|FG001|Overall Study|Adverse Event|1
1020625|NCT01587898|2046147|FG002|Overall Study|Adverse Event|0
1020626|NCT01587898|2046148|FG003|Overall Study|Adverse Event|0
1020627|NCT01587898|2046145|FG000|Overall Study|Protocol Violation|0
1020628|NCT01587898|2046146|FG001|Overall Study|Protocol Violation|2
1020629|NCT01587898|2046147|FG002|Overall Study|Protocol Violation|1
1020630|NCT01587898|2046148|FG003|Overall Study|Protocol Violation|1
1020631|NCT01587898|2046145|FG000|Overall Study|Lost to Follow-up|0
1020632|NCT01587898|2046146|FG001|Overall Study|Lost to Follow-up|0
1020633|NCT01587898|2046147|FG002|Overall Study|Lost to Follow-up|0
1020634|NCT01587898|2046148|FG003|Overall Study|Lost to Follow-up|1
1020635|NCT01587898|2046145|FG000|Overall Study|Withdrawal by Subject|2
1020636|NCT01587898|2046146|FG001|Overall Study|Withdrawal by Subject|1
1020637|NCT01587898|2046147|FG002|Overall Study|Withdrawal by Subject|0
1020638|NCT01587898|2046148|FG003|Overall Study|Withdrawal by Subject|0
1020639|NCT01587898|2046145|FG000|Overall Study|Met haemoglobin stopping criteria|1
904219|NCT00754559|1878901|FG000|Overall Study|Lack of Efficacy|10
904220|NCT00754559|1878901|FG000|Overall Study|Lost to Follow-up|2
904221|NCT00754559|1878901|FG000|Overall Study|Administrative reason|1
904222|NCT00754559|1878901|FG000|Overall Study|Other|5
904223|NCT00754559|1878901|FG000|Overall Study|Withdrawal by Subject|3
904224|NCT00754572|1878908|FG000|Overall Study|Adverse Event|19
904225|NCT00754572|1878908|FG000|Overall Study|Other|39
904226|NCT00754572|1878908|FG000|Overall Study|Protocol Violation|3
904227|NCT00754572|1878908|FG000|Overall Study|Withdrawal by Subject|3
904228|NCT00754572|1878908|FG000|Overall Study|Lack of Efficacy|2
904229|NCT00754572|1878908|FG000|Overall Study|Death|1
904230|NCT00754572|1878908|FG000|Overall Study|Administrative Reason|3
904231|NCT00754572|1878908|FG000|Overall Study|Lost to Follow-up|1
904232|NCT00754624|1878912|FG000|Overall Study|Adverse Event|16
904233|NCT00754624|1878912|FG000|Overall Study|Death|1
904234|NCT00754624|1878912|FG000|Overall Study|Physician Decision|8
904235|NCT00754624|1878912|FG000|Overall Study|Protocol Violation|1
904236|NCT00754624|1878912|FG000|Overall Study|Withdrawal by Subject|28
904237|NCT00754624|1878912|FG000|Overall Study|Various|12
904238|NCT00754624|1878912|FG000|Overall Study|Lost to Follow-up|3
904239|NCT00754650|1878916|FG000|Overall Study|Disease Progression|2
904240|NCT00754741|1878923|FG000|Overall Study|Died or disenrolled|57
904241|NCT00754741|1878924|FG001|Overall Study|Died or disenrolled|69
904242|NCT00754741|1878925|FG002|Overall Study|Died or disenrolled|54
904243|NCT00754936|1878955|FG000|Overall Study|Lost to Follow-up|3
904244|NCT00754936|1878955|FG000|Overall Study|Physician Decision|1
904245|NCT00754936|1878955|FG000|Overall Study|Withdrawal by Subject|2
904246|NCT00754936|1878955|FG000|Overall Study|Side Effects|3
904247|NCT00754936|1878955|FG000|Overall Study|Inter-current medical events|3
904248|NCT00755079|1878970|FG000|Overall Study|Lost to Follow-up|1
904249|NCT00755079|1878971|FG001|Overall Study|Lost to Follow-up|3
904250|NCT00755079|1878970|FG000|Overall Study|Adverse Event|0
904251|NCT00755079|1878971|FG001|Overall Study|Adverse Event|1
904252|NCT00755079|1878970|FG000|Overall Study|Withdrawal by Subject|0
904253|NCT00755079|1878971|FG001|Overall Study|Withdrawal by Subject|2
904254|NCT00755105|1878980|FG000|Overall Study|Withdrawal by Subject|9
904255|NCT00755105|1878981|FG001|Overall Study|Withdrawal by Subject|11
904256|NCT00755105|1878982|FG002|Overall Study|Withdrawal by Subject|4
904257|NCT00755183|1879001|FG000|Overall Study|Adverse Event|5
904258|NCT00755183|1879002|FG001|Overall Study|Adverse Event|2
904259|NCT00755183|1879001|FG000|Overall Study|Protocol Violation|0
904260|NCT00755183|1879002|FG001|Overall Study|Protocol Violation|1
904261|NCT00755183|1879001|FG000|Overall Study|Withdrawal by Subject|0
904262|NCT00755183|1879002|FG001|Overall Study|Withdrawal by Subject|2
904263|NCT00755183|1879001|FG000|Overall Study|Administrative|2
904264|NCT00755183|1879002|FG001|Overall Study|Administrative|1
904265|NCT00755196|1879010|FG000|Overall Study|Lost to Follow-up|1
904266|NCT00755196|1879010|FG000|Overall Study|Lack of Efficiency|1
904267|NCT00755222|1879017|FG000|Overall Study|Withdrawal by Subject|4
904268|NCT00755222|1879018|FG001|Overall Study|Withdrawal by Subject|2
904269|NCT00755222|1879017|FG000|Overall Study|Adverse Event|2
904270|NCT00755222|1879018|FG001|Overall Study|Adverse Event|0
1020640|NCT01587898|2046146|FG001|Overall Study|Met haemoglobin stopping criteria|1
1020641|NCT01587898|2046147|FG002|Overall Study|Met haemoglobin stopping criteria|1
1020642|NCT01587898|2046148|FG003|Overall Study|Met haemoglobin stopping criteria|0
1020643|NCT01587924|2046165|FG000|Overall Study|Adverse Event|0
1020644|NCT01587924|2046166|FG001|Overall Study|Adverse Event|2
1020645|NCT01587924|2046167|FG002|Overall Study|Adverse Event|0
1020646|NCT01587924|2046168|FG003|Overall Study|Adverse Event|0
1020647|NCT01587924|2046165|FG000|Overall Study|Protocol Violation|2
1020648|NCT01587924|2046166|FG001|Overall Study|Protocol Violation|1
1020649|NCT01587924|2046167|FG002|Overall Study|Protocol Violation|2
1020650|NCT01587924|2046168|FG003|Overall Study|Protocol Violation|1
1020651|NCT01587924|2046165|FG000|Overall Study|Met Hemoglobin stopping criteria|2
1020652|NCT01587924|2046166|FG001|Overall Study|Met Hemoglobin stopping criteria|0
1020653|NCT01587924|2046167|FG002|Overall Study|Met Hemoglobin stopping criteria|1
1020654|NCT01587924|2046168|FG003|Overall Study|Met Hemoglobin stopping criteria|0
1020655|NCT01587924|2046165|FG000|Overall Study|Withdrawal by Subject|0
1020656|NCT01587924|2046166|FG001|Overall Study|Withdrawal by Subject|1
1020657|NCT01587924|2046167|FG002|Overall Study|Withdrawal by Subject|1
1020658|NCT01587924|2046168|FG003|Overall Study|Withdrawal by Subject|0
1020659|NCT01587989|2046193|FG000|12-Week Open-Label Run-In Period|Physician Decision|7
1020660|NCT01587989|2046194|FG001|12-Week Open-Label Run-In Period|Physician Decision|0
1020661|NCT01587989|2046195|FG002|12-Week Open-Label Run-In Period|Physician Decision|0
1020662|NCT01587989|2046193|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
1020663|NCT01587989|2046194|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
1020664|NCT01587989|2046195|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
1020665|NCT01587989|2046193|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4
1020666|NCT01587989|2046194|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0
1020667|NCT01587989|2046195|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0
1020668|NCT01587989|2046193|FG000|Randomized Study Treatment|Withdrawal by Subject|0
1020669|NCT01587989|2046194|FG001|Randomized Study Treatment|Withdrawal by Subject|1
1020670|NCT01587989|2046195|FG002|Randomized Study Treatment|Withdrawal by Subject|0
1020671|NCT01587989|2046193|FG000|Randomized Study Treatment|Screening failure|0
1020672|NCT01587989|2046194|FG001|Randomized Study Treatment|Screening failure|1
1020673|NCT01587989|2046195|FG002|Randomized Study Treatment|Screening failure|0
1020674|NCT01587989|2046193|FG000|Randomized Study Treatment|Physician Decision|0
1020675|NCT01587989|2046194|FG001|Randomized Study Treatment|Physician Decision|0
1020676|NCT01587989|2046195|FG002|Randomized Study Treatment|Physician Decision|1
1020677|NCT01588106|2046203|FG000|Overall Study|Withdrawal by Subject|5
1020678|NCT01588106|2046204|FG001|Overall Study|Withdrawal by Subject|4
1020679|NCT01588184|2046225|FG000|Overall Study|Death|1
1020680|NCT01588184|2046226|FG001|Overall Study|Death|0
1020681|NCT01588184|2046227|FG002|Overall Study|Death|0
1020682|NCT01588184|2046228|FG003|Overall Study|Death|1
1020683|NCT01588184|2046229|FG004|Overall Study|Death|1
1020684|NCT01588184|2046230|FG005|Overall Study|Death|1
1020685|NCT01588184|2046225|FG000|Overall Study|Withdrawal by Subject|2
1020686|NCT01588184|2046226|FG001|Overall Study|Withdrawal by Subject|4
1020687|NCT01588184|2046227|FG002|Overall Study|Withdrawal by Subject|0
1020688|NCT01588184|2046228|FG003|Overall Study|Withdrawal by Subject|1
1020689|NCT01588184|2046229|FG004|Overall Study|Withdrawal by Subject|0
1020690|NCT01588184|2046230|FG005|Overall Study|Withdrawal by Subject|0
1020691|NCT01588184|2046225|FG000|Overall Study|Bevacizumab treatment provision changed|0
1020692|NCT01588184|2046226|FG001|Overall Study|Bevacizumab treatment provision changed|6
1020693|NCT01588184|2046227|FG002|Overall Study|Bevacizumab treatment provision changed|2
1020694|NCT01588184|2046228|FG003|Overall Study|Bevacizumab treatment provision changed|0
904271|NCT00755222|1879017|FG000|Overall Study|Protocol Violation|2
904272|NCT00755222|1879018|FG001|Overall Study|Protocol Violation|0
904273|NCT00755326|1879044|FG000|Overall Study|Lost to Follow-up|2
904274|NCT00755326|1879045|FG001|Overall Study|Lost to Follow-up|3
904275|NCT00755417|1879055|FG000|Overall Study|Adverse Event|28
904276|NCT00755417|1879056|FG001|Overall Study|Adverse Event|20
904277|NCT00755417|1879057|FG002|Overall Study|Adverse Event|7
904278|NCT00755417|1879055|FG000|Overall Study|Lack of Efficacy|8
904279|NCT00755417|1879056|FG001|Overall Study|Lack of Efficacy|4
904280|NCT00755417|1879057|FG002|Overall Study|Lack of Efficacy|9
904281|NCT00755417|1879055|FG000|Overall Study|Protocol Violation|2
904282|NCT00755417|1879056|FG001|Overall Study|Protocol Violation|1
904283|NCT00755417|1879057|FG002|Overall Study|Protocol Violation|1
904284|NCT00755417|1879055|FG000|Overall Study|Lost to Follow-up|3
904285|NCT00755417|1879056|FG001|Overall Study|Lost to Follow-up|0
904286|NCT00755417|1879057|FG002|Overall Study|Lost to Follow-up|1
904287|NCT00755417|1879055|FG000|Overall Study|Withdrawal by Subject|12
904288|NCT00755417|1879056|FG001|Overall Study|Withdrawal by Subject|12
904289|NCT00755417|1879057|FG002|Overall Study|Withdrawal by Subject|12
904290|NCT00755417|1879055|FG000|Overall Study|Not specified or missing data|9
904291|NCT00755417|1879056|FG001|Overall Study|Not specified or missing data|18
904292|NCT00755417|1879057|FG002|Overall Study|Not specified or missing data|12
904293|NCT00755716|1879068|FG000|Overall Study|Adverse Event|1
904294|NCT00755716|1879069|FG001|Overall Study|Adverse Event|4
904295|NCT00755716|1879070|FG002|Overall Study|Adverse Event|1
904296|NCT00755716|1879068|FG000|Overall Study|Lack of Efficacy|2
904297|NCT00755716|1879069|FG001|Overall Study|Lack of Efficacy|0
904298|NCT00755716|1879070|FG002|Overall Study|Lack of Efficacy|0
1020695|NCT01588184|2046229|FG004|Overall Study|Bevacizumab treatment provision changed|1
1020696|NCT01588184|2046230|FG005|Overall Study|Bevacizumab treatment provision changed|3
1020697|NCT01588184|2046225|FG000|Overall Study|multiple reasons|0
1020698|NCT01588184|2046226|FG001|Overall Study|multiple reasons|3
1020699|NCT01588184|2046227|FG002|Overall Study|multiple reasons|0
1020700|NCT01588184|2046228|FG003|Overall Study|multiple reasons|1
1020701|NCT01588184|2046229|FG004|Overall Study|multiple reasons|0
1020702|NCT01588184|2046230|FG005|Overall Study|multiple reasons|0
1020703|NCT01588197|2046246|FG000|Overall Study|Lack of Efficacy|0
1020704|NCT01588197|2046247|FG001|Overall Study|Lack of Efficacy|1
1020705|NCT01588197|2046246|FG000|Overall Study|No MRI|1
1020706|NCT01588197|2046247|FG001|Overall Study|No MRI|0
1020707|NCT01588353|2046269|FG000|Step2|Withdrawal by Subject|0
1020708|NCT01588353|2046270|FG001|Step2|Withdrawal by Subject|1
1020709|NCT01588353|2046271|FG002|Step2|Withdrawal by Subject|0
1020710|NCT01588353|2046269|FG000|Step3|Adverse Event|0
1020711|NCT01588353|2046270|FG001|Step3|Adverse Event|0
1020712|NCT01588353|2046271|FG002|Step3|Adverse Event|2
1090794|NCT02248818|2158523|FG005|Randomised Study|Administrative - randomization error|8
1090795|NCT02248818|2158524|FG006|Randomised Study|Administrative - randomization error|0
1090796|NCT02248818|2158525|FG007|Randomised Study|Administrative - randomization error|0
1090797|NCT02248818|2158526|FG008|Randomised Study|Administrative - randomization error|0
1090798|NCT02248857|2158547|FG000|3 Month|Withdrawal by Subject|9
1090799|NCT02248857|2158548|FG001|3 Month|Withdrawal by Subject|3
1090800|NCT02248857|2158549|FG002|3 Month|Withdrawal by Subject|4
1090801|NCT02248857|2158547|FG000|3 Month|Unable to reach for 3 month|35
1090802|NCT02248857|2158548|FG001|3 Month|Unable to reach for 3 month|29
1090803|NCT02248857|2158549|FG002|3 Month|Unable to reach for 3 month|26
1090804|NCT02248857|2158547|FG000|3 Month|Partially completed, unable to finish|2
1090805|NCT02248857|2158548|FG001|3 Month|Partially completed, unable to finish|2
1090806|NCT02248857|2158549|FG002|3 Month|Partially completed, unable to finish|1
1090807|NCT02248857|2158547|FG000|6 Month|Lost to Follow-up|27
1090808|NCT02248857|2158548|FG001|6 Month|Lost to Follow-up|26
1090809|NCT02248857|2158549|FG002|6 Month|Lost to Follow-up|15
1090810|NCT02248857|2158547|FG000|6 Month|Partially completed, unable to finish|0
1090811|NCT02248857|2158548|FG001|6 Month|Partially completed, unable to finish|1
1090812|NCT02248857|2158549|FG002|6 Month|Partially completed, unable to finish|0
1090813|NCT02248857|2158547|FG000|6 Month|Withdrawal by Subject|0
1090814|NCT02248857|2158548|FG001|6 Month|Withdrawal by Subject|2
1090815|NCT02248857|2158549|FG002|6 Month|Withdrawal by Subject|2
1090816|NCT02248857|2158547|FG000|6 Month|Death|1
1090817|NCT02248857|2158548|FG001|6 Month|Death|0
1090818|NCT02248857|2158549|FG002|6 Month|Death|0
1090819|NCT02248961|2158567|FG000|Overall Study|Adverse Event|1
1090820|NCT02248961|2158568|FG001|Overall Study|Adverse Event|0
1090821|NCT02248961|2158567|FG000|Overall Study|Withdrawal by Subject|1
1090822|NCT02248961|2158568|FG001|Overall Study|Withdrawal by Subject|2
1090823|NCT02248961|2158567|FG000|Overall Study|Unmet inclusion/exclusion criteria|1
1090824|NCT02248961|2158568|FG001|Overall Study|Unmet inclusion/exclusion criteria|0
1090825|NCT02248974|2158576|FG000|1-Day Follow-Up|Lost to Follow-up|4
1090826|NCT02248974|2158577|FG001|1-Day Follow-Up|Lost to Follow-up|0
1090827|NCT02248974|2158576|FG000|1-Day Follow-Up|Withdrawal by Subject|5
1090828|NCT02248974|2158577|FG001|1-Day Follow-Up|Withdrawal by Subject|0
1090829|NCT02248974|2158576|FG000|1-Day Follow-Up|Enrolled in another study|1
1090830|NCT02248974|2158577|FG001|1-Day Follow-Up|Enrolled in another study|0
1090831|NCT02248974|2158576|FG000|1-Week Follow-Up|Became ineligible for LVAD|4
1090832|NCT02248974|2158577|FG001|1-Week Follow-Up|Became ineligible for LVAD|1
1090833|NCT02248974|2158576|FG000|1-Week Follow-Up|Enrolled in another study|1
1090834|NCT02248974|2158577|FG001|1-Week Follow-Up|Enrolled in another study|1
1090835|NCT02248974|2158576|FG000|1-Week Follow-Up|Transferred to another facility|1
1090836|NCT02248974|2158577|FG001|1-Week Follow-Up|Transferred to another facility|0
1090837|NCT02248974|2158576|FG000|1-Week Follow-Up|Cognitive Difficulty|1
1090838|NCT02248974|2158577|FG001|1-Week Follow-Up|Cognitive Difficulty|0
1090839|NCT02248974|2158576|FG000|1-Week Follow-Up|Death|1
1090840|NCT02248974|2158577|FG001|1-Week Follow-Up|Death|1
1090841|NCT02248974|2158576|FG000|1-Week Follow-Up|Excluded because of age|0
1090842|NCT02248974|2158577|FG001|1-Week Follow-Up|Excluded because of age|1
1090843|NCT02248974|2158576|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0
1090844|NCT02248974|2158577|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1
1090845|NCT02248974|2158576|FG000|1-Week Follow-Up|Timing: implanted before survey|0
1090846|NCT02248974|2158577|FG001|1-Week Follow-Up|Timing: implanted before survey|2
1090847|NCT02248974|2158576|FG000|1-Week Follow-Up|Withdrawal by Subject|0
1090848|NCT02248974|2158577|FG001|1-Week Follow-Up|Withdrawal by Subject|2
1090849|NCT02248974|2158576|FG000|1-Week Follow-Up|Lost to Follow-up|0
1090850|NCT02248974|2158577|FG001|1-Week Follow-Up|Lost to Follow-up|8
1090851|NCT02248974|2158576|FG000|1-Month Follow-Up|Lost to Follow-up|2
1090852|NCT02248974|2158577|FG001|1-Month Follow-Up|Lost to Follow-up|3
1090853|NCT02249091|2158597|FG000|Overall Study|Lack of Efficacy|8
1090854|NCT02249091|2158598|FG001|Overall Study|Lack of Efficacy|3
1090855|NCT02249091|2158597|FG000|Overall Study|Physician Decision|4
1090856|NCT02249091|2158598|FG001|Overall Study|Physician Decision|1
1090857|NCT02249091|2158597|FG000|Overall Study|Withdrawal by Subject|2
1090858|NCT02249091|2158598|FG001|Overall Study|Withdrawal by Subject|2
1020713|NCT01588366|2046283|FG000|Overall Study|Adverse Event|0
1020714|NCT01588366|2046284|FG001|Overall Study|Adverse Event|1
1020715|NCT01588366|2046285|FG002|Overall Study|Adverse Event|0
1020716|NCT01588366|2046286|FG003|Overall Study|Adverse Event|1
904299|NCT00755716|1879068|FG000|Overall Study|Lost to Follow-up|5
904300|NCT00755716|1879069|FG001|Overall Study|Lost to Follow-up|3
904301|NCT00755716|1879070|FG002|Overall Study|Lost to Follow-up|1
904302|NCT00755716|1879068|FG000|Overall Study|work schedule issues|0
904303|NCT00755716|1879069|FG001|Overall Study|work schedule issues|1
904304|NCT00755716|1879070|FG002|Overall Study|work schedule issues|1
904305|NCT00755807|1879093|FG000|Acute Phase|Adverse Event|16
904306|NCT00755807|1879094|FG001|Acute Phase|Adverse Event|5
904307|NCT00755807|1879093|FG000|Acute Phase|Protocol Violation|1
904308|NCT00755807|1879094|FG001|Acute Phase|Protocol Violation|3
904309|NCT00755807|1879093|FG000|Acute Phase|Withdrawal by Subject|1
904310|NCT00755807|1879094|FG001|Acute Phase|Withdrawal by Subject|2
904311|NCT00755807|1879093|FG000|Acute Phase|Lack of Efficacy|0
904312|NCT00755807|1879094|FG001|Acute Phase|Lack of Efficacy|1
904313|NCT00755807|1879093|FG000|Acute Phase|Physician Decision|0
904314|NCT00755807|1879094|FG001|Acute Phase|Physician Decision|1
904315|NCT00755807|1879093|FG000|Open-label Extension Phase|Adverse Event|7
904316|NCT00755807|1879094|FG001|Open-label Extension Phase|Adverse Event|7
904317|NCT00755807|1879093|FG000|Open-label Extension Phase|Protocol Violation|5
904318|NCT00755807|1879094|FG001|Open-label Extension Phase|Protocol Violation|2
904319|NCT00755807|1879093|FG000|Open-label Extension Phase|Lack of Efficacy|3
904320|NCT00755807|1879094|FG001|Open-label Extension Phase|Lack of Efficacy|3
904321|NCT00755807|1879093|FG000|Open-label Extension Phase|Withdrawal by Subject|1
904322|NCT00755807|1879094|FG001|Open-label Extension Phase|Withdrawal by Subject|3
904323|NCT00755807|1879093|FG000|Open-label Extension Phase|Lost to Follow-up|2
904324|NCT00755807|1879094|FG001|Open-label Extension Phase|Lost to Follow-up|0
904325|NCT00755807|1879093|FG000|Open-label Extension Phase|Sponsor Decision|0
904326|NCT00755807|1879094|FG001|Open-label Extension Phase|Sponsor Decision|1
904327|NCT00755846|1879110|FG000|Overall Study|Adverse Event|0
904328|NCT00755846|1879111|FG001|Overall Study|Adverse Event|0
904329|NCT00755846|1879112|FG002|Overall Study|Adverse Event|0
904330|NCT00755846|1879113|FG003|Overall Study|Adverse Event|1
904331|NCT00755846|1879114|FG004|Overall Study|Adverse Event|3
904332|NCT00755846|1879115|FG005|Overall Study|Adverse Event|2
904333|NCT00755846|1879110|FG000|Overall Study|Protocol Violation|1
904334|NCT00755846|1879111|FG001|Overall Study|Protocol Violation|1
904335|NCT00755846|1879112|FG002|Overall Study|Protocol Violation|1
904336|NCT00755846|1879113|FG003|Overall Study|Protocol Violation|1
904337|NCT00755846|1879114|FG004|Overall Study|Protocol Violation|1
904338|NCT00755846|1879115|FG005|Overall Study|Protocol Violation|1
904339|NCT00755846|1879110|FG000|Overall Study|Lost to Follow-up|0
904340|NCT00755846|1879111|FG001|Overall Study|Lost to Follow-up|2
904341|NCT00755846|1879112|FG002|Overall Study|Lost to Follow-up|1
904342|NCT00755846|1879113|FG003|Overall Study|Lost to Follow-up|0
904343|NCT00755846|1879114|FG004|Overall Study|Lost to Follow-up|4
904344|NCT00755846|1879115|FG005|Overall Study|Lost to Follow-up|2
904345|NCT00755846|1879110|FG000|Overall Study|Withdrawal by Subject|2
904346|NCT00755846|1879111|FG001|Overall Study|Withdrawal by Subject|3
904347|NCT00755846|1879112|FG002|Overall Study|Withdrawal by Subject|5
904348|NCT00755846|1879113|FG003|Overall Study|Withdrawal by Subject|2
904349|NCT00755846|1879114|FG004|Overall Study|Withdrawal by Subject|0
904350|NCT00755846|1879115|FG005|Overall Study|Withdrawal by Subject|1
904351|NCT00755846|1879110|FG000|Overall Study|Hyperglycemic Rescue|21
904352|NCT00755846|1879111|FG001|Overall Study|Hyperglycemic Rescue|7
904353|NCT00755846|1879112|FG002|Overall Study|Hyperglycemic Rescue|5
904354|NCT00755846|1879113|FG003|Overall Study|Hyperglycemic Rescue|8
904355|NCT00755846|1879114|FG004|Overall Study|Hyperglycemic Rescue|8
904356|NCT00755846|1879115|FG005|Overall Study|Hyperglycemic Rescue|7
904357|NCT00755846|1879110|FG000|Overall Study|Physician Decision|1
904358|NCT00755846|1879111|FG001|Overall Study|Physician Decision|3
904359|NCT00755846|1879112|FG002|Overall Study|Physician Decision|0
904360|NCT00755846|1879113|FG003|Overall Study|Physician Decision|1
904361|NCT00755846|1879114|FG004|Overall Study|Physician Decision|0
904362|NCT00755846|1879115|FG005|Overall Study|Physician Decision|1
904363|NCT00755846|1879110|FG000|Overall Study|Administrative Error|0
904364|NCT00755846|1879111|FG001|Overall Study|Administrative Error|1
904365|NCT00755846|1879112|FG002|Overall Study|Administrative Error|0
904366|NCT00755846|1879113|FG003|Overall Study|Administrative Error|0
904367|NCT00755846|1879114|FG004|Overall Study|Administrative Error|0
904368|NCT00755846|1879115|FG005|Overall Study|Administrative Error|0
904369|NCT00755846|1879110|FG000|Overall Study|Participant Non-compliance|0
904370|NCT00755846|1879111|FG001|Overall Study|Participant Non-compliance|0
904371|NCT00755846|1879112|FG002|Overall Study|Participant Non-compliance|0
904372|NCT00755846|1879113|FG003|Overall Study|Participant Non-compliance|0
904373|NCT00755846|1879114|FG004|Overall Study|Participant Non-compliance|1
904374|NCT00755846|1879115|FG005|Overall Study|Participant Non-compliance|0
904375|NCT00755937|1879138|FG000|Recruitment|Unknown if infliximab received|164
1020717|NCT01588366|2046287|FG004|Overall Study|Adverse Event|0
1020718|NCT01588366|2046288|FG005|Overall Study|Adverse Event|2
1020719|NCT01588405|2046304|FG000|Overall Study|Adverse Event|1
1020720|NCT01588405|2046304|FG000|Overall Study|Clinical Worsening|1
1020721|NCT01588496|2046364|FG000|Overall Study|Withdrawal by Subject|0
1020722|NCT01588496|2046365|FG001|Overall Study|Withdrawal by Subject|1
1020723|NCT01588496|2046366|FG002|Overall Study|Withdrawal by Subject|0
1020724|NCT01588509|2046376|FG000|Overall Study|Lost to Follow-up|1
1020725|NCT01588509|2046377|FG001|Overall Study|Lost to Follow-up|0
904376|NCT00755937|1879138|FG000|Observational Follow-up|Lost to Follow-up|148
904377|NCT00756002|1879144|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
904378|NCT00756002|1879145|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
904379|NCT00756002|1879144|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
904380|NCT00756002|1879145|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
904381|NCT00756002|1879144|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6
904382|NCT00756002|1879145|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6
904383|NCT00756002|1879144|FG000|Double-Blind Treatment Period|Protocol Violation|6
904384|NCT00756002|1879145|FG001|Double-Blind Treatment Period|Protocol Violation|5
904385|NCT00756002|1879144|FG000|Double-Blind Treatment Period|Other|2
904386|NCT00756002|1879145|FG001|Double-Blind Treatment Period|Other|2
904387|NCT00756275|1879183|FG000|Overall Study|Lost to Follow-up|25
904388|NCT00756275|1879184|FG001|Overall Study|Lost to Follow-up|21
904389|NCT00756275|1879183|FG000|Overall Study|Withdrawal by Subject|4
904390|NCT00756275|1879184|FG001|Overall Study|Withdrawal by Subject|7
904391|NCT00756314|1879192|FG000|Overall Study|Lost to Follow-up|2
904392|NCT00756314|1879193|FG001|Overall Study|Lost to Follow-up|59
904393|NCT00756444|1879201|FG000|Overall Study|Adverse Event|1
904394|NCT00756444|1879202|FG001|Overall Study|Adverse Event|1
904395|NCT00756444|1879201|FG000|Overall Study|Withdrawal by Subject|6
904396|NCT00756444|1879202|FG001|Overall Study|Withdrawal by Subject|8
904397|NCT00756444|1879201|FG000|Overall Study|Lost to Follow-up|0
904398|NCT00756444|1879202|FG001|Overall Study|Lost to Follow-up|1
904399|NCT00756444|1879201|FG000|Overall Study|Death|5
904400|NCT00756444|1879202|FG001|Overall Study|Death|4
904401|NCT00756444|1879201|FG000|Overall Study|Disease Progression|2
904402|NCT00756444|1879202|FG001|Overall Study|Disease Progression|7
904403|NCT00756444|1879201|FG000|Overall Study|Ineligibility Determined|1
904404|NCT00756444|1879202|FG001|Overall Study|Ineligibility Determined|0
904405|NCT00756457|1879211|FG000|Overall Study|Lost to Follow-up|1
904406|NCT00756457|1879212|FG001|Overall Study|Lost to Follow-up|2
904407|NCT00756470|1879234|FG000|Overall Study|Withdrawal by Subject|1
904408|NCT00756470|1879234|FG000|Overall Study|Adverse Event|4
904409|NCT00756574|1879261|FG000|Overall Study|Withdrawal by Subject|9
904410|NCT00756574|1879262|FG001|Overall Study|Withdrawal by Subject|7
904411|NCT00756574|1879261|FG000|Overall Study|Lost to Follow-up|4
904412|NCT00756574|1879262|FG001|Overall Study|Lost to Follow-up|4
904413|NCT00756652|1879288|FG000|Original Phase|Withdrawal by Subject|864
904414|NCT00756652|1879289|FG001|Original Phase|Withdrawal by Subject|23
904415|NCT00756652|1879288|FG000|Original Phase|Lost to Follow-up|601
904416|NCT00756652|1879289|FG001|Original Phase|Lost to Follow-up|0
904417|NCT00756652|1879288|FG000|Original Phase|Other Discontinuation|797
904418|NCT00756652|1879289|FG001|Original Phase|Other Discontinuation|5
904419|NCT00756652|1879288|FG000|Original Phase|Participant Noncompliance|18622
904420|NCT00756652|1879289|FG001|Original Phase|Participant Noncompliance|424
904421|NCT00756652|1879288|FG000|Original Phase|Unknown Discontinuation Reason|2
904422|NCT00756652|1879289|FG001|Original Phase|Unknown Discontinuation Reason|0
904423|NCT00756652|1879288|FG000|Original Phase|Participants without data|3259
904424|NCT00756652|1879289|FG001|Original Phase|Participants without data|466
904425|NCT00756652|1879288|FG000|Original Phase|Death|168
904426|NCT00756652|1879289|FG001|Original Phase|Death|1
904427|NCT00756652|1879288|FG000|Original Phase|Not due for F/U at Phase One closure|11076
904428|NCT00756652|1879289|FG001|Original Phase|Not due for F/U at Phase One closure|2
904429|NCT00756652|1879288|FG000|Re-Op Phase|Withdrawal by Subject|62
904430|NCT00756652|1879289|FG001|Re-Op Phase|Withdrawal by Subject|0
904431|NCT00756652|1879288|FG000|Re-Op Phase|Death|6
904432|NCT00756652|1879289|FG001|Re-Op Phase|Death|0
904433|NCT00756652|1879288|FG000|Re-Op Phase|Lost to Follow-up|340
904434|NCT00756652|1879289|FG001|Re-Op Phase|Lost to Follow-up|0
904435|NCT00756652|1879288|FG000|Re-Op Phase|Site Closed|2454
904436|NCT00756652|1879289|FG001|Re-Op Phase|Site Closed|0
904437|NCT00756652|1879288|FG000|Re-Op Phase|Withdrawn after explant|14
904438|NCT00756652|1879289|FG001|Re-Op Phase|Withdrawn after explant|0
904439|NCT00756717|1879298|FG000|Overall Study|Withdrawal by Subject|2
904440|NCT00756730|1879304|FG000|Overall Study|discontinued due to rash prior to week 4|0
904441|NCT00756730|1879305|FG001|Overall Study|discontinued due to rash prior to week 4|1
904442|NCT00756730|1879304|FG000|Overall Study|persistent low-level viremmia|0
904443|NCT00756730|1879305|FG001|Overall Study|persistent low-level viremmia|1
904444|NCT00756886|1879313|FG000|Overall Study|Lost to Follow-up|1
904445|NCT00756886|1879314|FG001|Overall Study|Lost to Follow-up|0
904446|NCT00756886|1879313|FG000|Overall Study|Adverse Event|0
904447|NCT00756886|1879314|FG001|Overall Study|Adverse Event|3
904448|NCT00756886|1879313|FG000|Overall Study|Lack of Efficacy|1
904449|NCT00756886|1879314|FG001|Overall Study|Lack of Efficacy|0
904450|NCT00756886|1879313|FG000|Overall Study|Ineligible|9
1020726|NCT01588548|2046389|FG000|Overall Study|Withdrawal by Subject|0
1020727|NCT01588548|2046390|FG001|Overall Study|Withdrawal by Subject|1
1020728|NCT01588548|2046391|FG002|Overall Study|Withdrawal by Subject|1
1020729|NCT01588548|2046392|FG003|Overall Study|Withdrawal by Subject|1
1020730|NCT01588548|2046393|FG004|Overall Study|Withdrawal by Subject|2
1020731|NCT01588548|2046394|FG005|Overall Study|Withdrawal by Subject|3
1020732|NCT01588548|2046389|FG000|Overall Study|Adverse Event|0
1020733|NCT01588548|2046390|FG001|Overall Study|Adverse Event|0
1020734|NCT01588548|2046391|FG002|Overall Study|Adverse Event|1
1020735|NCT01588548|2046392|FG003|Overall Study|Adverse Event|2
1020736|NCT01588548|2046393|FG004|Overall Study|Adverse Event|1
1020737|NCT01588548|2046394|FG005|Overall Study|Adverse Event|0
1020738|NCT01588548|2046389|FG000|Overall Study|Condition Under Investigation Worsened|3
1020739|NCT01588548|2046390|FG001|Overall Study|Condition Under Investigation Worsened|6
1020740|NCT01588548|2046391|FG002|Overall Study|Condition Under Investigation Worsened|4
1020741|NCT01588548|2046392|FG003|Overall Study|Condition Under Investigation Worsened|4
1020742|NCT01588548|2046393|FG004|Overall Study|Condition Under Investigation Worsened|3
1020743|NCT01588548|2046394|FG005|Overall Study|Condition Under Investigation Worsened|3
1020744|NCT01588951|2046423|FG000|Overall Study|Ineligible in retrospect|0
1020745|NCT01588951|2046424|FG001|Overall Study|Ineligible in retrospect|0
1020746|NCT01588951|2046425|FG002|Overall Study|Ineligible in retrospect|1
1020747|NCT01588990|2046433|FG000|Phase A|Withdrawal by Subject|5
1020748|NCT01588990|2046433|FG000|Phase A|Physician Decision|11
1020749|NCT01588990|2046433|FG000|Phase A|Other|14
1020750|NCT01588990|2046433|FG000|Phase A|Lost to Follow-up|1
1020751|NCT01588990|2046433|FG000|Phase A|Death|5
1020752|NCT01588990|2046433|FG000|Phase A|Adverse Event|28
1020753|NCT01588990|2046433|FG000|Phase A|Still on therapy at end of study|6
1020754|NCT01588990|2046433|FG000|Phase B|Adverse Event|2
1020755|NCT01588990|2046433|FG000|Phase B|Still on therapy at end of study|5
1020756|NCT01588990|2046433|FG000|Phase B|Withdrawal by Subject|3
1020757|NCT01588990|2046433|FG000|Phase B|Physician Decision|4
1020758|NCT01588990|2046433|FG000|Phase B|Other|2
1020759|NCT01589094|2046441|FG000|Overall Study|Did not receive treatment|2
904451|NCT00756886|1879314|FG001|Overall Study|Ineligible|4
904452|NCT00756938|1879323|FG000|12-week Base Study|Protocol-specific Criteria Met|1
904453|NCT00756938|1879324|FG001|12-week Base Study|Protocol-specific Criteria Met|0
904454|NCT00756938|1879325|FG002|12-week Base Study|Protocol-specific Criteria Met|1
904455|NCT00756938|1879326|FG003|12-week Base Study|Protocol-specific Criteria Met|0
904456|NCT00756938|1879323|FG000|12-week Base Study|Protocol Violation|0
904457|NCT00756938|1879324|FG001|12-week Base Study|Protocol Violation|0
904458|NCT00756938|1879325|FG002|12-week Base Study|Protocol Violation|1
904459|NCT00756938|1879326|FG003|12-week Base Study|Protocol Violation|0
904460|NCT00756938|1879323|FG000|12-week Base Study|Lost to Follow-up|1
904461|NCT00756938|1879324|FG001|12-week Base Study|Lost to Follow-up|0
904462|NCT00756938|1879325|FG002|12-week Base Study|Lost to Follow-up|0
904463|NCT00756938|1879326|FG003|12-week Base Study|Lost to Follow-up|0
904464|NCT00756938|1879323|FG000|Optional Extension|Lack of Efficacy|0
904465|NCT00756938|1879324|FG001|Optional Extension|Lack of Efficacy|0
904466|NCT00756938|1879325|FG002|Optional Extension|Lack of Efficacy|0
904467|NCT00756938|1879326|FG003|Optional Extension|Lack of Efficacy|1
904468|NCT00756938|1879323|FG000|Optional Extension|End of Study|0
904469|NCT00756938|1879324|FG001|Optional Extension|End of Study|0
904470|NCT00756938|1879325|FG002|Optional Extension|End of Study|0
904471|NCT00756938|1879326|FG003|Optional Extension|End of Study|11
904472|NCT00756938|1879323|FG000|Optional Extension|Protocol-specific criteria met|0
904473|NCT00756938|1879324|FG001|Optional Extension|Protocol-specific criteria met|0
904474|NCT00756938|1879325|FG002|Optional Extension|Protocol-specific criteria met|0
904475|NCT00756938|1879326|FG003|Optional Extension|Protocol-specific criteria met|9
904476|NCT00756938|1879323|FG000|Optional Extension|Physician Decision|0
904477|NCT00756938|1879324|FG001|Optional Extension|Physician Decision|0
904478|NCT00756938|1879325|FG002|Optional Extension|Physician Decision|0
904479|NCT00756938|1879326|FG003|Optional Extension|Physician Decision|3
904480|NCT00756938|1879323|FG000|Optional Extension|Lost to Follow-up|0
904481|NCT00756938|1879324|FG001|Optional Extension|Lost to Follow-up|0
904482|NCT00756938|1879325|FG002|Optional Extension|Lost to Follow-up|0
904483|NCT00756938|1879326|FG003|Optional Extension|Lost to Follow-up|1
904484|NCT00756938|1879323|FG000|Optional Extension|Protocol Violation|0
904485|NCT00756938|1879324|FG001|Optional Extension|Protocol Violation|0
904486|NCT00756938|1879325|FG002|Optional Extension|Protocol Violation|0
904487|NCT00756938|1879326|FG003|Optional Extension|Protocol Violation|1
904488|NCT00756938|1879323|FG000|Optional Extension|Withdrawal by Subject|0
904489|NCT00756938|1879324|FG001|Optional Extension|Withdrawal by Subject|0
904490|NCT00756938|1879325|FG002|Optional Extension|Withdrawal by Subject|0
904491|NCT00756938|1879326|FG003|Optional Extension|Withdrawal by Subject|10
904492|NCT00756938|1879323|FG000|Optional Extension|Adverse Event|0
904493|NCT00756938|1879324|FG001|Optional Extension|Adverse Event|0
904494|NCT00756938|1879325|FG002|Optional Extension|Adverse Event|0
904495|NCT00756938|1879326|FG003|Optional Extension|Adverse Event|1
904496|NCT00757003|1879362|FG000|Overall Study|Death|33
904497|NCT00757003|1879362|FG000|Overall Study|Lost to Follow-up|9
904498|NCT00757003|1879362|FG000|Overall Study|Withdrawal by Subject|4
904499|NCT00757003|1879362|FG000|Overall Study|Surgically explanted|2
904500|NCT00757003|1879362|FG000|Overall Study|Not implanted|1
1020760|NCT01589185|2046450|FG000|Overall Study|Death|1
1020761|NCT01589185|2046451|FG001|Overall Study|Death|2
1020762|NCT01589185|2046452|FG002|Overall Study|Death|2
1020763|NCT01589185|2046453|FG003|Overall Study|Death|0
1020764|NCT01589185|2046454|FG004|Overall Study|Death|1
1020765|NCT01589185|2046450|FG000|Overall Study|Lost to Follow-up|1
1020766|NCT01589185|2046451|FG001|Overall Study|Lost to Follow-up|0
1020767|NCT01589185|2046452|FG002|Overall Study|Lost to Follow-up|2
1020768|NCT01589185|2046453|FG003|Overall Study|Lost to Follow-up|3
1020769|NCT01589185|2046454|FG004|Overall Study|Lost to Follow-up|0
1020770|NCT01589237|2046471|FG000|Part A (52 Weeks)|Subject/guardian decision|2
1020771|NCT01589237|2046472|FG001|Part A (52 Weeks)|Subject/guardian decision|3
1020772|NCT01589237|2046473|FG002|Part A (52 Weeks)|Subject/guardian decision|2
1020773|NCT01589237|2046474|FG003|Part A (52 Weeks)|Subject/guardian decision|0
1020774|NCT01589237|2046471|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1020775|NCT01589237|2046472|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
1020776|NCT01589237|2046473|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1020777|NCT01589237|2046474|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1020778|NCT01589237|2046471|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
1020779|NCT01589237|2046472|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
1020780|NCT01589237|2046473|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
1020781|NCT01589237|2046474|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
1020782|NCT01589237|2046471|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1020783|NCT01589237|2046472|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1020784|NCT01589237|2046473|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1020785|NCT01589237|2046474|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1
1020786|NCT01589445|2046506|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1
1020787|NCT01589445|2046506|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
1020788|NCT01589445|2046506|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
1020789|NCT01589445|2046506|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
1020790|NCT01589445|2046506|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
1020791|NCT01589445|2046506|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1
1020792|NCT01589445|2046506|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2
1020793|NCT01589445|2046506|FG000|002 (Metformin)-3 Months|Protocol Violation|2
1020794|NCT01589445|2046506|FG000|002 (Metformin)-3 Months|Adverse Event|2
1020795|NCT01589445|2046506|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2
1020796|NCT01589497|2046523|FG000|Overall Study|Withdrawal by Subject|0
1020797|NCT01589497|2046524|FG001|Overall Study|Withdrawal by Subject|1
1020798|NCT01589497|2046525|FG002|Overall Study|Withdrawal by Subject|0
1020799|NCT01589497|2046526|FG003|Overall Study|Withdrawal by Subject|1
1020800|NCT01589497|2046523|FG000|Overall Study|Death|1
1020801|NCT01589497|2046524|FG001|Overall Study|Death|0
1020802|NCT01589497|2046525|FG002|Overall Study|Death|0
1020803|NCT01589497|2046526|FG003|Overall Study|Death|0
1020804|NCT01589497|2046523|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0
1020805|NCT01589497|2046524|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0
1020806|NCT01589497|2046525|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1
1020807|NCT01589497|2046526|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0
1020808|NCT01589653|2046556|FG000|Overall Study|Protocol Violation|3
1020809|NCT01589653|2046557|FG001|Overall Study|Protocol Violation|1
1020810|NCT01589653|2046556|FG000|Overall Study|Withdrawal criteria|4
904501|NCT00757172|1879367|FG000|Overall Study|Withdrawal by Subject|4
904502|NCT00757172|1879367|FG000|Overall Study|Physician Decision|3
904503|NCT00757172|1879367|FG000|Overall Study|Progression|4
904504|NCT00757237|1879373|FG000|Overall Study|Lost to Follow-up|0
904505|NCT00757237|1879374|FG001|Overall Study|Lost to Follow-up|1
904506|NCT00757237|1879373|FG000|Overall Study|Protocol Violation|0
904507|NCT00757237|1879374|FG001|Overall Study|Protocol Violation|2
904508|NCT00757237|1879373|FG000|Overall Study|Physician Decision|2
904509|NCT00757237|1879374|FG001|Overall Study|Physician Decision|3
904510|NCT00757237|1879373|FG000|Overall Study|Withdrawal by Subject|8
904511|NCT00757237|1879374|FG001|Overall Study|Withdrawal by Subject|12
904512|NCT00757237|1879373|FG000|Overall Study|Safety or Tolerability|3
904513|NCT00757237|1879374|FG001|Overall Study|Safety or Tolerability|5
904514|NCT00757237|1879373|FG000|Overall Study|Other|0
904515|NCT00757237|1879374|FG001|Overall Study|Other|2
904516|NCT00757588|1879388|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
904517|NCT00757588|1879389|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
904518|NCT00757588|1879388|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6
904519|NCT00757588|1879389|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3
904520|NCT00757588|1879388|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
904521|NCT00757588|1879389|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
904522|NCT00757588|1879388|FG000|Period 1: Short-term (24-week) Phase|Death|1
904523|NCT00757588|1879389|FG001|Period 1: Short-term (24-week) Phase|Death|0
904524|NCT00757588|1879388|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
904525|NCT00757588|1879389|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
904526|NCT00757588|1879388|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
1020811|NCT01589653|2046557|FG001|Overall Study|Withdrawal criteria|7
1020812|NCT01589653|2046556|FG000|Overall Study|Unclassified|0
1020813|NCT01589653|2046557|FG001|Overall Study|Unclassified|3
1020814|NCT01589770|2046565|FG000|Overall Study|EGFR <60ml/min|6
904527|NCT00757588|1879389|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
904528|NCT00757588|1879388|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
904529|NCT00757588|1879389|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
904530|NCT00757588|1879388|FG000|Period 1: Short-term (24-week) Phase|Other|0
904531|NCT00757588|1879389|FG001|Period 1: Short-term (24-week) Phase|Other|1
904532|NCT00757588|1879388|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
904533|NCT00757588|1879389|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
904534|NCT00757588|1879388|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4
904535|NCT00757588|1879389|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0
904536|NCT00757588|1879388|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
904537|NCT00757588|1879389|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
904538|NCT00757588|1879388|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
904539|NCT00757588|1879389|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
904540|NCT00757588|1879388|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
904541|NCT00757588|1879389|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
904542|NCT00757588|1879388|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1
904543|NCT00757588|1879389|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0
904544|NCT00757588|1879388|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
904545|NCT00757588|1879389|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
904546|NCT00757588|1879388|FG000|Period 2: Long-term (52-week) Phase|Other|1
904547|NCT00757588|1879389|FG001|Period 2: Long-term (52-week) Phase|Other|0
904548|NCT00757627|1879436|FG000|Overall Study|Adverse Event|15
904549|NCT00757627|1879436|FG000|Overall Study|Lack of Efficacy|10
904550|NCT00757627|1879436|FG000|Overall Study|Lost to Follow-up|28
904551|NCT00757627|1879436|FG000|Overall Study|Withdrawal by Subject|27
904552|NCT00757627|1879436|FG000|Overall Study|Other|1
904553|NCT00757705|1879458|FG000|Overall Study|Adverse Event|19
904554|NCT00757705|1879458|FG000|Overall Study|Lost to Follow-up|16
904555|NCT00757705|1879458|FG000|Overall Study|Withdrawal by Subject|25
904556|NCT00757705|1879458|FG000|Overall Study|Insufficient Response|26
904557|NCT00757705|1879458|FG000|Overall Study|Ineligible to continue|8
904558|NCT00757705|1879458|FG000|Overall Study|Non-compliant|9
904559|NCT00757705|1879458|FG000|Overall Study|Other|18
904560|NCT00757783|1879464|FG000|Overall Study|Adverse Event|0
904561|NCT00757783|1879465|FG001|Overall Study|Adverse Event|2
904562|NCT00757783|1879464|FG000|Overall Study|Lost to Follow-up|1
904563|NCT00757783|1879465|FG001|Overall Study|Lost to Follow-up|1
904564|NCT00757783|1879464|FG000|Overall Study|Protocol Violation|1
904565|NCT00757783|1879465|FG001|Overall Study|Protocol Violation|0
904566|NCT00757783|1879464|FG000|Overall Study|Withdrawal by Subject|2
904567|NCT00757783|1879465|FG001|Overall Study|Withdrawal by Subject|1
904568|NCT00757783|1879464|FG000|Overall Study|Other|1
904569|NCT00757783|1879465|FG001|Overall Study|Other|2
904570|NCT00757848|1879485|FG000|Overall Study|Voluntary discontinuation|1
904571|NCT00757848|1879486|FG001|Overall Study|Voluntary discontinuation|0
904572|NCT00757848|1879485|FG000|Overall Study|Adverse Event|1
904573|NCT00757848|1879486|FG001|Overall Study|Adverse Event|2
904574|NCT00757848|1879485|FG000|Overall Study|Incorrect enrolment|1
904575|NCT00757848|1879486|FG001|Overall Study|Incorrect enrolment|0
904576|NCT00758043|1879496|FG000|Overall Study|Adverse Event|1
904577|NCT00758043|1879497|FG001|Overall Study|Adverse Event|20
904578|NCT00758043|1879498|FG002|Overall Study|Adverse Event|12
904579|NCT00758043|1879499|FG003|Overall Study|Adverse Event|62
904580|NCT00758043|1879496|FG000|Overall Study|Lack of Efficacy|0
904581|NCT00758043|1879497|FG001|Overall Study|Lack of Efficacy|6
904582|NCT00758043|1879498|FG002|Overall Study|Lack of Efficacy|18
904583|NCT00758043|1879499|FG003|Overall Study|Lack of Efficacy|12
904584|NCT00758043|1879496|FG000|Overall Study|Refused Further Treatment|0
904585|NCT00758043|1879497|FG001|Overall Study|Refused Further Treatment|11
904586|NCT00758043|1879498|FG002|Overall Study|Refused Further Treatment|5
904587|NCT00758043|1879499|FG003|Overall Study|Refused Further Treatment|8
904588|NCT00758043|1879496|FG000|Overall Study|Lost to Follow-up|0
904589|NCT00758043|1879497|FG001|Overall Study|Lost to Follow-up|2
904590|NCT00758043|1879498|FG002|Overall Study|Lost to Follow-up|2
904591|NCT00758043|1879499|FG003|Overall Study|Lost to Follow-up|5
904592|NCT00758043|1879496|FG000|Overall Study|Withdrawal by Subject|0
904593|NCT00758043|1879497|FG001|Overall Study|Withdrawal by Subject|1
904594|NCT00758043|1879498|FG002|Overall Study|Withdrawal by Subject|1
904595|NCT00758043|1879499|FG003|Overall Study|Withdrawal by Subject|4
904596|NCT00758043|1879496|FG000|Overall Study|Required Prohibited Medication|0
904597|NCT00758043|1879497|FG001|Overall Study|Required Prohibited Medication|0
904598|NCT00758043|1879498|FG002|Overall Study|Required Prohibited Medication|1
904599|NCT00758043|1879499|FG003|Overall Study|Required Prohibited Medication|3
904600|NCT00758043|1879496|FG000|Overall Study|Non-Compliant With study Drug|0
904601|NCT00758043|1879497|FG001|Overall Study|Non-Compliant With study Drug|0
904602|NCT00758043|1879498|FG002|Overall Study|Non-Compliant With study Drug|0
1020815|NCT01589770|2046566|FG001|Overall Study|EGFR <60ml/min|4
1020816|NCT01589770|2046565|FG000|Overall Study|claustrophobic when entering cardiac MRI|2
1020817|NCT01589770|2046566|FG001|Overall Study|claustrophobic when entering cardiac MRI|1
1020818|NCT01589822|2046575|FG000|Overall Study|Withdrawal by Subject|1
1020819|NCT01589822|2046576|FG001|Overall Study|Withdrawal by Subject|2
1020820|NCT01589822|2046577|FG002|Overall Study|Withdrawal by Subject|0
1020821|NCT01589822|2046575|FG000|Overall Study|Death|1
1020822|NCT01589822|2046576|FG001|Overall Study|Death|0
1020823|NCT01589822|2046577|FG002|Overall Study|Death|0
1020824|NCT01589822|2046575|FG000|Overall Study|Missed 90 day visit|2
1020825|NCT01589822|2046576|FG001|Overall Study|Missed 90 day visit|1
1020826|NCT01589822|2046577|FG002|Overall Study|Missed 90 day visit|1
1020827|NCT01590017|2046592|FG000|Overall Study|Adverse Event|1
1020828|NCT01590017|2046592|FG000|Overall Study|Withdrawal by Subject|1
1020829|NCT01590017|2046592|FG000|Overall Study|Lack of Efficacy|1
1020830|NCT01590017|2046592|FG000|Overall Study|Physician Decision|1
1020831|NCT01590082|2046598|FG000|Overall Study|Withdrawal by Subject|1
1020832|NCT01590082|2046599|FG001|Overall Study|Withdrawal by Subject|0
1020833|NCT01590082|2046598|FG000|Overall Study|Ineligible|1
904603|NCT00758043|1879499|FG003|Overall Study|Non-Compliant With study Drug|1
904604|NCT00758043|1879496|FG000|Overall Study|Other Reasons|0
904605|NCT00758043|1879497|FG001|Overall Study|Other Reasons|1
904606|NCT00758043|1879498|FG002|Overall Study|Other Reasons|0
904607|NCT00758043|1879499|FG003|Overall Study|Other Reasons|5
904608|NCT00758069|1879518|FG000|Overall Study|Lack of Efficacy|0
904609|NCT00758069|1879519|FG001|Overall Study|Lack of Efficacy|0
904610|NCT00758069|1879520|FG002|Overall Study|Lack of Efficacy|1
904611|NCT00758069|1879518|FG000|Overall Study|Incorrect Study Drug|1
904612|NCT00758069|1879519|FG001|Overall Study|Incorrect Study Drug|0
904613|NCT00758069|1879520|FG002|Overall Study|Incorrect Study Drug|0
904614|NCT00758160|1879528|FG000|Overall Study|No Longer Requires Study Medication|4
904615|NCT00758160|1879528|FG000|Overall Study|Administration Problems|3
904616|NCT00758160|1879528|FG000|Overall Study|Adverse Event|15
904617|NCT00758160|1879528|FG000|Overall Study|Lack of Efficacy|10
904618|NCT00758160|1879528|FG000|Overall Study|Lost to Follow-up|14
904619|NCT00758160|1879528|FG000|Overall Study|Protocol Violation|12
904620|NCT00758160|1879528|FG000|Overall Study|Withdrawal by Subject|8
904621|NCT00758264|1879539|FG000|Active Phase|Withdrawal by Subject|0
904622|NCT00758264|1879540|FG001|Active Phase|Withdrawal by Subject|0
904623|NCT00758264|1879541|FG002|Active Phase|Withdrawal by Subject|1
904624|NCT00758264|1879539|FG000|Active Phase|Lost to Follow-up|1
904625|NCT00758264|1879540|FG001|Active Phase|Lost to Follow-up|0
904626|NCT00758264|1879541|FG002|Active Phase|Lost to Follow-up|0
904627|NCT00758264|1879539|FG000|Active Phase|Other|0
904628|NCT00758264|1879540|FG001|Active Phase|Other|0
904629|NCT00758264|1879541|FG002|Active Phase|Other|4
904630|NCT00758394|1879569|FG000|2nd Intervention Order|Lost to Follow-up|0
904631|NCT00758394|1879570|FG001|2nd Intervention Order|Lost to Follow-up|1
904632|NCT00758394|1879571|FG002|2nd Intervention Order|Lost to Follow-up|0
904633|NCT00758394|1879572|FG003|2nd Intervention Order|Lost to Follow-up|0
904634|NCT00758394|1879569|FG000|3rd Intervention|Lost to Follow-up|1
904635|NCT00758394|1879570|FG001|3rd Intervention|Lost to Follow-up|0
904636|NCT00758394|1879571|FG002|3rd Intervention|Lost to Follow-up|0
904637|NCT00758394|1879572|FG003|3rd Intervention|Lost to Follow-up|1
904638|NCT00758459|1879593|FG000|Overall Study|Adverse Event|3
904639|NCT00758459|1879594|FG001|Overall Study|Adverse Event|2
904640|NCT00758459|1879593|FG000|Overall Study|Protocol Violation|0
904641|NCT00758459|1879594|FG001|Overall Study|Protocol Violation|1
904642|NCT00758459|1879593|FG000|Overall Study|Withdrawal by Subject|0
904643|NCT00758459|1879594|FG001|Overall Study|Withdrawal by Subject|1
904644|NCT00758485|1879602|FG000|Overall Study|Lost to Follow-up|0
904645|NCT00758485|1879603|FG001|Overall Study|Lost to Follow-up|1
904646|NCT00758485|1879602|FG000|Overall Study|Not Treated|1
904647|NCT00758485|1879603|FG001|Overall Study|Not Treated|2
904648|NCT00758498|1879613|FG000|Overall Study|Adverse Event|2
904649|NCT00758498|1879614|FG001|Overall Study|Adverse Event|2
904650|NCT00758498|1879615|FG002|Overall Study|Adverse Event|3
904651|NCT00758498|1879613|FG000|Overall Study|Subject legally detained out of state|1
904652|NCT00758498|1879614|FG001|Overall Study|Subject legally detained out of state|0
904653|NCT00758498|1879615|FG002|Overall Study|Subject legally detained out of state|0
904654|NCT00758498|1879613|FG000|Overall Study|Withdrawal by Subject|0
904655|NCT00758498|1879614|FG001|Overall Study|Withdrawal by Subject|0
904656|NCT00758498|1879615|FG002|Overall Study|Withdrawal by Subject|1
904657|NCT00758498|1879613|FG000|Overall Study|Noncompliance to study procedures|0
904658|NCT00758498|1879614|FG001|Overall Study|Noncompliance to study procedures|0
904659|NCT00758498|1879615|FG002|Overall Study|Noncompliance to study procedures|1
904660|NCT00758524|1879629|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
904661|NCT00758524|1879630|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2
904662|NCT00758524|1879631|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4
904663|NCT00758524|1879632|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
904664|NCT00758524|1879633|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
904665|NCT00758524|1879634|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5
904666|NCT00758524|1879635|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
904667|NCT00758524|1879636|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
1020834|NCT01590082|2046599|FG001|Overall Study|Ineligible|0
1020835|NCT01590212|2046608|FG000|Overall Study|Withdrawal by Subject|2
1020836|NCT01590212|2046609|FG001|Overall Study|Withdrawal by Subject|2
1020837|NCT01590212|2046610|FG002|Overall Study|Withdrawal by Subject|2
1020838|NCT01590212|2046608|FG000|Overall Study|Lost to Follow-up|1
904668|NCT00758524|1879637|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
904669|NCT00758524|1879638|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
904670|NCT00758524|1879639|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
904671|NCT00758524|1879640|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
904672|NCT00758524|1879641|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
904673|NCT00758524|1879642|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
904674|NCT00758524|1879643|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
904675|NCT00758524|1879644|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
904676|NCT00758524|1879645|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
904677|NCT00758524|1879629|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
904678|NCT00758524|1879630|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904679|NCT00758524|1879631|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2
904680|NCT00758524|1879632|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
904681|NCT00758524|1879633|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1
904682|NCT00758524|1879634|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
904683|NCT00758524|1879635|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904684|NCT00758524|1879636|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904685|NCT00758524|1879637|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904686|NCT00758524|1879638|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904687|NCT00758524|1879639|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904688|NCT00758524|1879640|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904689|NCT00758524|1879641|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904690|NCT00758524|1879642|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904691|NCT00758524|1879643|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904692|NCT00758524|1879644|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904693|NCT00758524|1879645|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
904694|NCT00758524|1879629|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2
904695|NCT00758524|1879630|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1
904696|NCT00758524|1879631|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1
904697|NCT00758524|1879632|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3
904698|NCT00758524|1879633|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2
904699|NCT00758524|1879634|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1
904700|NCT00758524|1879635|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0
904701|NCT00758524|1879636|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0
904702|NCT00758524|1879637|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0
904703|NCT00758524|1879638|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0
904704|NCT00758524|1879639|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0
904705|NCT00758524|1879640|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0
904706|NCT00758524|1879641|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0
904707|NCT00758524|1879642|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0
904708|NCT00758524|1879643|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0
904709|NCT00758524|1879644|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0
904710|NCT00758524|1879645|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0
904711|NCT00758524|1879629|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904712|NCT00758524|1879630|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
904713|NCT00758524|1879631|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
904714|NCT00758524|1879632|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904715|NCT00758524|1879633|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
904716|NCT00758524|1879634|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
904717|NCT00758524|1879635|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904718|NCT00758524|1879636|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904719|NCT00758524|1879637|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904720|NCT00758524|1879638|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904721|NCT00758524|1879639|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904722|NCT00758524|1879640|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904723|NCT00758524|1879641|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904724|NCT00758524|1879642|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904725|NCT00758524|1879643|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904726|NCT00758524|1879644|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904727|NCT00758524|1879645|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
904728|NCT00758524|1879629|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0
904729|NCT00758524|1879630|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0
904730|NCT00758524|1879631|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1
904731|NCT00758524|1879632|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1
904732|NCT00758524|1879633|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0
904733|NCT00758524|1879634|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0
904734|NCT00758524|1879635|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0
904735|NCT00758524|1879636|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0
1020839|NCT01590212|2046609|FG001|Overall Study|Lost to Follow-up|2
1020840|NCT01590212|2046610|FG002|Overall Study|Lost to Follow-up|3
1020841|NCT01590433|2046629|FG000|Overall Study|Lost to Follow-up|20
1020842|NCT01590433|2046630|FG001|Overall Study|Lost to Follow-up|8
1020843|NCT01590433|2046629|FG000|Overall Study|Withdrawal by Subject|21
1020844|NCT01590433|2046630|FG001|Overall Study|Withdrawal by Subject|11
1020845|NCT01590433|2046629|FG000|Overall Study|Adverse Event|11
1020846|NCT01590433|2046630|FG001|Overall Study|Adverse Event|3
1020847|NCT01590563|2046641|FG000|Overall Study|simple uterine hyperplasia - not related|1
1020848|NCT01590758|2046648|FG000|Overall Study|Withdrawal by Subject|0
1020849|NCT01590758|2046649|FG001|Overall Study|Withdrawal by Subject|3
1020850|NCT01590758|2046648|FG000|Overall Study|Physician Decision|1
1020851|NCT01590758|2046649|FG001|Overall Study|Physician Decision|2
1020852|NCT01590758|2046648|FG000|Overall Study|Lost to Follow-up|4
1020853|NCT01590758|2046649|FG001|Overall Study|Lost to Follow-up|2
1020854|NCT01590771|2046657|FG000|Overall Study|Other Protocol Specified Criteria|5
1020855|NCT01590771|2046658|FG001|Overall Study|Other Protocol Specified Criteria|14
1020856|NCT01590771|2046657|FG000|Overall Study|Withdrawal by Subject|8
1020857|NCT01590771|2046658|FG001|Overall Study|Withdrawal by Subject|15
1020858|NCT01590771|2046657|FG000|Overall Study|Protocol Violation|1
1020859|NCT01590771|2046658|FG001|Overall Study|Protocol Violation|2
1020860|NCT01590771|2046657|FG000|Overall Study|Lost to Follow-up|1
1020861|NCT01590771|2046658|FG001|Overall Study|Lost to Follow-up|1
1020862|NCT01590771|2046657|FG000|Overall Study|Lack of Efficacy|1
1020863|NCT01590771|2046658|FG001|Overall Study|Lack of Efficacy|0
1020864|NCT01590771|2046657|FG000|Overall Study|Adverse Event|3
1020865|NCT01590771|2046658|FG001|Overall Study|Adverse Event|7
1020866|NCT01590797|2046666|FG000|Overall Study|Adverse Event|4
1020867|NCT01590797|2046667|FG001|Overall Study|Adverse Event|3
904736|NCT00758524|1879637|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0
904737|NCT00758524|1879638|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0
904738|NCT00758524|1879639|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0
904739|NCT00758524|1879640|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0
904740|NCT00758524|1879641|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0
904741|NCT00758524|1879642|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0
904742|NCT00758524|1879643|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0
904743|NCT00758524|1879644|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0
904744|NCT00758524|1879645|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0
904745|NCT00758524|1879629|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904746|NCT00758524|1879630|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904747|NCT00758524|1879631|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904748|NCT00758524|1879632|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904749|NCT00758524|1879633|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1
904750|NCT00758524|1879634|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904751|NCT00758524|1879635|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904752|NCT00758524|1879636|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904753|NCT00758524|1879637|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904754|NCT00758524|1879638|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904755|NCT00758524|1879639|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904756|NCT00758524|1879640|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904757|NCT00758524|1879641|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904758|NCT00758524|1879642|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904759|NCT00758524|1879643|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904760|NCT00758524|1879644|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904761|NCT00758524|1879645|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
904762|NCT00758524|1879629|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904763|NCT00758524|1879630|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1
904764|NCT00758524|1879631|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904765|NCT00758524|1879632|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904766|NCT00758524|1879633|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904767|NCT00758524|1879634|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904768|NCT00758524|1879635|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904769|NCT00758524|1879636|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904770|NCT00758524|1879637|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904771|NCT00758524|1879638|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904772|NCT00758524|1879639|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904773|NCT00758524|1879640|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904774|NCT00758524|1879641|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904775|NCT00758524|1879642|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904776|NCT00758524|1879643|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904777|NCT00758524|1879644|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904778|NCT00758524|1879645|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
904779|NCT00758524|1879629|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0
904780|NCT00758524|1879630|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1
904781|NCT00758524|1879631|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0
1020868|NCT01590797|2046666|FG000|Overall Study|Lack of Efficacy|0
1020869|NCT01590797|2046667|FG001|Overall Study|Lack of Efficacy|2
1020870|NCT01590797|2046666|FG000|Overall Study|Lost to Follow-up|0
1020871|NCT01590797|2046667|FG001|Overall Study|Lost to Follow-up|1
1020872|NCT01590797|2046666|FG000|Overall Study|Protocol Violation|4
1020873|NCT01590797|2046667|FG001|Overall Study|Protocol Violation|1
1020874|NCT01590797|2046666|FG000|Overall Study|Withdrawal by Subject|7
1020875|NCT01590797|2046667|FG001|Overall Study|Withdrawal by Subject|5
1020876|NCT01590797|2046666|FG000|Overall Study|Other Protocol Specified Criteria|2
1020877|NCT01590797|2046667|FG001|Overall Study|Other Protocol Specified Criteria|4
1020878|NCT01590810|2046678|FG000|Overall Study|Physician Decision|0
1020879|NCT01590810|2046679|FG001|Overall Study|Physician Decision|1
1020880|NCT01590810|2046680|FG002|Overall Study|Physician Decision|1
1020881|NCT01590810|2046681|FG003|Overall Study|Physician Decision|0
1020882|NCT01590810|2046682|FG004|Overall Study|Physician Decision|0
1020883|NCT01590888|2046729|FG000|Overall Study|Adverse Event|3
1020884|NCT01590888|2046730|FG001|Overall Study|Adverse Event|0
1020885|NCT01590888|2046731|FG002|Overall Study|Adverse Event|1
1020886|NCT01590888|2046729|FG000|Overall Study|Lost to Follow-up|1
1020887|NCT01590888|2046730|FG001|Overall Study|Lost to Follow-up|0
1020888|NCT01590888|2046731|FG002|Overall Study|Lost to Follow-up|0
1020889|NCT01591330|2046814|FG000|Period 1|Adverse Event|1
1020890|NCT01591330|2046815|FG001|Period 1|Adverse Event|0
1020891|NCT01591330|2046816|FG002|Period 1|Adverse Event|0
1020892|NCT01591330|2046817|FG003|Period 1|Adverse Event|0
1020893|NCT01591330|2046814|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1
1020894|NCT01591330|2046815|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0
1020895|NCT01591330|2046816|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0
1020896|NCT01591330|2046817|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0
1020897|NCT01591330|2046814|FG000|Period 2|Adverse Event|1
1020898|NCT01591330|2046815|FG001|Period 2|Adverse Event|0
904782|NCT00758524|1879632|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0
904783|NCT00758524|1879633|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0
904784|NCT00758524|1879634|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0
904785|NCT00758524|1879635|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0
904786|NCT00758524|1879636|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0
904787|NCT00758524|1879637|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0
904788|NCT00758524|1879638|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0
904789|NCT00758524|1879639|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0
904790|NCT00758524|1879640|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0
904791|NCT00758524|1879641|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0
904792|NCT00758524|1879642|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0
904793|NCT00758524|1879643|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0
904794|NCT00758524|1879644|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0
904795|NCT00758524|1879645|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0
904796|NCT00758524|1879629|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904797|NCT00758524|1879630|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904798|NCT00758524|1879631|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904799|NCT00758524|1879632|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904800|NCT00758524|1879633|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904801|NCT00758524|1879634|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904802|NCT00758524|1879635|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904803|NCT00758524|1879636|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904804|NCT00758524|1879637|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2
904805|NCT00758524|1879638|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904806|NCT00758524|1879639|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904807|NCT00758524|1879640|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904808|NCT00758524|1879641|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904809|NCT00758524|1879642|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904810|NCT00758524|1879643|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904811|NCT00758524|1879644|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904812|NCT00758524|1879645|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
904813|NCT00758524|1879629|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904814|NCT00758524|1879630|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904815|NCT00758524|1879631|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904816|NCT00758524|1879632|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904817|NCT00758524|1879633|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904818|NCT00758524|1879634|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904819|NCT00758524|1879635|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1
904820|NCT00758524|1879636|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
1020899|NCT01591330|2046816|FG002|Period 2|Adverse Event|0
1020900|NCT01591330|2046817|FG003|Period 2|Adverse Event|0
1020901|NCT01591382|2046829|FG000|Overall Study|Discharged Prior to Study Completion|2
1020902|NCT01591382|2046830|FG001|Overall Study|Discharged Prior to Study Completion|1
1020903|NCT01591382|2046829|FG000|Overall Study|Participant Opted for Morphine PCA|1
1020904|NCT01591382|2046830|FG001|Overall Study|Participant Opted for Morphine PCA|1
1020905|NCT01591460|2046845|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
1020906|NCT01591460|2046845|FG000|Overall Study|Futility Rule (Week 12)|7
1020907|NCT01591460|2046845|FG000|Overall Study|Futility Rule (Week 24)|3
1020908|NCT01591460|2046845|FG000|Overall Study|Rebound or Breakthrough|3
1020909|NCT01591460|2046845|FG000|Overall Study|Treatment Discontinued by Error|1
1020910|NCT01591460|2046845|FG000|Overall Study|Lost to Follow-up|1
1020911|NCT01591460|2046845|FG000|Overall Study|Noncompliance|1
1020912|NCT01591460|2046845|FG000|Overall Study|Participant Refusal|3
1020913|NCT01591460|2046845|FG000|Overall Study|Withdrawal by Subject|1
1020914|NCT01591460|2046845|FG000|Overall Study|Protocol Violation|1
1020915|NCT01591499|2046857|FG000|Baseline Visit|Withdrawal by Subject|0
1020916|NCT01591499|2046858|FG001|Baseline Visit|Withdrawal by Subject|2
1020917|NCT01591499|2046859|FG002|Baseline Visit|Withdrawal by Subject|0
1020918|NCT01591499|2046860|FG003|Baseline Visit|Withdrawal by Subject|2
1020919|NCT01591499|2046857|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
1020920|NCT01591499|2046858|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
1020921|NCT01591499|2046859|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
1020922|NCT01591499|2046860|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
1020923|NCT01591499|2046857|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4
1020924|NCT01591499|2046858|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3
1020925|NCT01591499|2046859|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1
1020926|NCT01591499|2046860|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3
1020927|NCT01591616|2046884|FG000|Overall Study|Withdrawal by Subject|1
1020928|NCT01591681|2047032|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3
1020929|NCT01591681|2047032|FG000|Overall Study|Failed to use system during run-in|1
1020930|NCT01591785|2047055|FG000|Overall Study|worsening condition|1
1020931|NCT01591785|2047056|FG001|Overall Study|worsening condition|2
1020932|NCT01591785|2047055|FG000|Overall Study|Protocol Violation|2
1020933|NCT01591785|2047056|FG001|Overall Study|Protocol Violation|0
1020934|NCT01591785|2047055|FG000|Overall Study|Lost to Follow-up|1
1020935|NCT01591785|2047056|FG001|Overall Study|Lost to Follow-up|0
1020936|NCT01591863|2047071|FG000|Overall Study|Adverse Event|3
1020937|NCT01591863|2047071|FG000|Overall Study|Withdrawal by Subject|1
1020938|NCT01591863|2047071|FG000|Overall Study|recurrence|9
1020939|NCT01591863|2047071|FG000|Overall Study|Lack of Efficacy|1
1020940|NCT01592045|2047081|FG000|Overall Study|Disease Progression|1
1020941|NCT01592045|2047082|FG001|Overall Study|Disease Progression|1
1020942|NCT01592045|2047081|FG000|Overall Study|Adverse Event|1
904821|NCT00758524|1879637|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904822|NCT00758524|1879638|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904823|NCT00758524|1879639|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904824|NCT00758524|1879640|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904825|NCT00758524|1879641|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904826|NCT00758524|1879642|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904827|NCT00758524|1879643|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904828|NCT00758524|1879644|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904829|NCT00758524|1879645|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
904830|NCT00758589|1879707|FG000|Overall Study|Adverse Event|3
904831|NCT00758589|1879708|FG001|Overall Study|Adverse Event|2
904832|NCT00758589|1879709|FG002|Overall Study|Adverse Event|5
904833|NCT00758589|1879710|FG003|Overall Study|Adverse Event|4
904834|NCT00758589|1879707|FG000|Overall Study|Withdrawal by Subject|0
904835|NCT00758589|1879708|FG001|Overall Study|Withdrawal by Subject|1
904836|NCT00758589|1879709|FG002|Overall Study|Withdrawal by Subject|1
904837|NCT00758589|1879710|FG003|Overall Study|Withdrawal by Subject|1
904838|NCT00758589|1879707|FG000|Overall Study|Palm stopped to work|0
904839|NCT00758589|1879708|FG001|Overall Study|Palm stopped to work|0
904840|NCT00758589|1879709|FG002|Overall Study|Palm stopped to work|0
904841|NCT00758589|1879710|FG003|Overall Study|Palm stopped to work|1
904842|NCT00758602|1879722|FG000|Overall Study|Adverse Event|11
904843|NCT00758602|1879723|FG001|Overall Study|Adverse Event|10
904844|NCT00758602|1879722|FG000|Overall Study|Lost to Follow-up|4
904845|NCT00758602|1879723|FG001|Overall Study|Lost to Follow-up|3
904846|NCT00758602|1879722|FG000|Overall Study|Withdrawal by Subject|1
904847|NCT00758602|1879723|FG001|Overall Study|Withdrawal by Subject|3
904848|NCT00758602|1879722|FG000|Overall Study|Protocol Violation|0
904849|NCT00758602|1879723|FG001|Overall Study|Protocol Violation|2
904850|NCT00758602|1879722|FG000|Overall Study|Death|0
904851|NCT00758602|1879723|FG001|Overall Study|Death|1
904852|NCT00758602|1879722|FG000|Overall Study|Reason not specified|3
904853|NCT00758602|1879723|FG001|Overall Study|Reason not specified|3
904854|NCT00758680|1879740|FG000|Overall Study|Adverse Event|0
904855|NCT00758680|1879741|FG001|Overall Study|Adverse Event|0
904856|NCT00758680|1879742|FG002|Overall Study|Adverse Event|0
904857|NCT00758680|1879743|FG003|Overall Study|Adverse Event|0
904858|NCT00758680|1879744|FG004|Overall Study|Adverse Event|0
904859|NCT00758680|1879745|FG005|Overall Study|Adverse Event|0
904860|NCT00758680|1879746|FG006|Overall Study|Adverse Event|0
904861|NCT00758680|1879747|FG007|Overall Study|Adverse Event|1
1020943|NCT01592045|2047082|FG001|Overall Study|Adverse Event|1
1020944|NCT01592045|2047081|FG000|Overall Study|Withdrawal by Subject|1
1020945|NCT01592045|2047082|FG001|Overall Study|Withdrawal by Subject|0
1020946|NCT01592045|2047081|FG000|Overall Study|Moved out of country|2
904862|NCT00758680|1879748|FG008|Overall Study|Adverse Event|0
904863|NCT00758680|1879749|FG009|Overall Study|Adverse Event|1
904864|NCT00758680|1879740|FG000|Overall Study|Laboratory Adverse Event|0
904865|NCT00758680|1879741|FG001|Overall Study|Laboratory Adverse Event|0
904866|NCT00758680|1879742|FG002|Overall Study|Laboratory Adverse Event|0
904867|NCT00758680|1879743|FG003|Overall Study|Laboratory Adverse Event|0
904868|NCT00758680|1879744|FG004|Overall Study|Laboratory Adverse Event|0
904869|NCT00758680|1879745|FG005|Overall Study|Laboratory Adverse Event|0
904870|NCT00758680|1879746|FG006|Overall Study|Laboratory Adverse Event|0
904871|NCT00758680|1879747|FG007|Overall Study|Laboratory Adverse Event|0
904872|NCT00758680|1879748|FG008|Overall Study|Laboratory Adverse Event|1
904873|NCT00758680|1879749|FG009|Overall Study|Laboratory Adverse Event|0
904874|NCT00758680|1879740|FG000|Overall Study|Withdrawal by Subject|0
904875|NCT00758680|1879741|FG001|Overall Study|Withdrawal by Subject|0
904876|NCT00758680|1879742|FG002|Overall Study|Withdrawal by Subject|0
904877|NCT00758680|1879743|FG003|Overall Study|Withdrawal by Subject|0
904878|NCT00758680|1879744|FG004|Overall Study|Withdrawal by Subject|0
904879|NCT00758680|1879745|FG005|Overall Study|Withdrawal by Subject|0
904880|NCT00758680|1879746|FG006|Overall Study|Withdrawal by Subject|1
904881|NCT00758680|1879747|FG007|Overall Study|Withdrawal by Subject|0
904882|NCT00758680|1879748|FG008|Overall Study|Withdrawal by Subject|1
904883|NCT00758680|1879749|FG009|Overall Study|Withdrawal by Subject|0
904884|NCT00758706|1879774|FG000|Overall Study|Adverse Event|4
904885|NCT00758706|1879775|FG001|Overall Study|Adverse Event|4
904886|NCT00758771|1879833|FG000|Overall Study|Withdrawal by Subject|1
904887|NCT00758771|1879834|FG001|Overall Study|Withdrawal by Subject|1
904888|NCT00758771|1879833|FG000|Overall Study|Did not meet eligibility criteria|2
904889|NCT00758771|1879834|FG001|Overall Study|Did not meet eligibility criteria|4
904890|NCT00759031|1879867|FG000|First Intervention (1 Day)|Physician Decision|1
904891|NCT00759031|1879868|FG001|First Intervention (1 Day)|Physician Decision|0
904892|NCT00759031|1879867|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
904893|NCT00759031|1879868|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
904894|NCT00759031|1879867|FG000|First Intervention (1 Day)|Screening failure|1
904895|NCT00759031|1879868|FG001|First Intervention (1 Day)|Screening failure|0
904896|NCT00759109|1879880|FG000|Overall Study|Adverse Event|17
904897|NCT00759109|1879881|FG001|Overall Study|Adverse Event|12
904898|NCT00759109|1879880|FG000|Overall Study|Inability to comply|1
904899|NCT00759109|1879881|FG001|Overall Study|Inability to comply|1
904900|NCT00759109|1879880|FG000|Overall Study|Withdrawal by Subject|9
904901|NCT00759109|1879881|FG001|Overall Study|Withdrawal by Subject|5
904902|NCT00759109|1879880|FG000|Overall Study|Death|4
904903|NCT00759109|1879881|FG001|Overall Study|Death|3
904904|NCT00759109|1879880|FG000|Overall Study|Lost to Follow-up|4
904905|NCT00759109|1879881|FG001|Overall Study|Lost to Follow-up|6
904906|NCT00759109|1879880|FG000|Overall Study|Started new therapy|2
904907|NCT00759109|1879881|FG001|Overall Study|Started new therapy|6
904908|NCT00759109|1879880|FG000|Overall Study|HCV RNA negative|1
904909|NCT00759109|1879881|FG001|Overall Study|HCV RNA negative|0
904910|NCT00759109|1879880|FG000|Overall Study|Participant moved to a different city|0
904911|NCT00759109|1879881|FG001|Overall Study|Participant moved to a different city|1
904912|NCT00759109|1879880|FG000|Overall Study|Participant had a liver transplant|0
904913|NCT00759109|1879881|FG001|Overall Study|Participant had a liver transplant|1
904914|NCT00759109|1879880|FG000|Overall Study|Lost during study|1
904915|NCT00759109|1879881|FG001|Overall Study|Lost during study|0
904916|NCT00759148|1879889|FG000|Overall Study|Adverse Event|1
904917|NCT00759148|1879890|FG001|Overall Study|Adverse Event|6
904918|NCT00759148|1879889|FG000|Overall Study|Withdrawal by Subject|3
904919|NCT00759148|1879890|FG001|Overall Study|Withdrawal by Subject|7
904920|NCT00759148|1879889|FG000|Overall Study|Lost to Follow-up|3
904921|NCT00759148|1879890|FG001|Overall Study|Lost to Follow-up|9
904922|NCT00759148|1879889|FG000|Overall Study|Treatment Failure|6
904923|NCT00759148|1879890|FG001|Overall Study|Treatment Failure|10
904924|NCT00759148|1879889|FG000|Overall Study|Reason not given|1
904925|NCT00759148|1879890|FG001|Overall Study|Reason not given|0
904926|NCT00759174|1879905|FG000|Overall Study|Other|0
904927|NCT00759174|1879906|FG001|Overall Study|Other|2
904928|NCT00759356|1879946|FG000|Overall Study|Adverse Event|0
904929|NCT00759356|1879947|FG001|Overall Study|Adverse Event|1
904930|NCT00759356|1879946|FG000|Overall Study|Withdrawal by Subject|0
904931|NCT00759356|1879947|FG001|Overall Study|Withdrawal by Subject|2
904932|NCT00759356|1879946|FG000|Overall Study|Subject was unable to return|1
904933|NCT00759356|1879947|FG001|Overall Study|Subject was unable to return|0
904934|NCT00759395|1879955|FG000|Overall Study|Adverse Event|1
904935|NCT00759395|1879956|FG001|Overall Study|Adverse Event|0
904936|NCT00759395|1879955|FG000|Overall Study|Withdrawal by Subject|1
904937|NCT00759395|1879956|FG001|Overall Study|Withdrawal by Subject|0
904938|NCT00759395|1879955|FG000|Overall Study|Lack of Efficacy|0
904939|NCT00759395|1879956|FG001|Overall Study|Lack of Efficacy|2
904940|NCT00759564|1879999|FG000|Washout Period (at Least 14 Days)|Adverse Event|0
1020947|NCT01592045|2047082|FG001|Overall Study|Moved out of country|0
1020948|NCT01592240|2047099|FG000|Overall Study|Adverse Event|1
1020949|NCT01592240|2047100|FG001|Overall Study|Adverse Event|0
1020950|NCT01592240|2047101|FG002|Overall Study|Adverse Event|0
1020951|NCT01592240|2047102|FG003|Overall Study|Adverse Event|1
1020952|NCT01592240|2047103|FG004|Overall Study|Adverse Event|1
1020953|NCT01592240|2047104|FG005|Overall Study|Adverse Event|0
1020954|NCT01592240|2047105|FG006|Overall Study|Adverse Event|0
1020955|NCT01592240|2047099|FG000|Overall Study|Death|0
1020956|NCT01592240|2047100|FG001|Overall Study|Death|1
1020957|NCT01592240|2047101|FG002|Overall Study|Death|0
1020958|NCT01592240|2047102|FG003|Overall Study|Death|0
1020959|NCT01592240|2047103|FG004|Overall Study|Death|0
1020960|NCT01592240|2047104|FG005|Overall Study|Death|0
1020961|NCT01592240|2047105|FG006|Overall Study|Death|0
1020962|NCT01592240|2047099|FG000|Overall Study|Lost to Follow-up|1
1020963|NCT01592240|2047100|FG001|Overall Study|Lost to Follow-up|3
1020964|NCT01592240|2047101|FG002|Overall Study|Lost to Follow-up|1
1020965|NCT01592240|2047102|FG003|Overall Study|Lost to Follow-up|0
1020966|NCT01592240|2047103|FG004|Overall Study|Lost to Follow-up|3
1020967|NCT01592240|2047104|FG005|Overall Study|Lost to Follow-up|2
1020968|NCT01592240|2047105|FG006|Overall Study|Lost to Follow-up|0
1020969|NCT01592240|2047099|FG000|Overall Study|Protocol Violation|0
1020970|NCT01592240|2047100|FG001|Overall Study|Protocol Violation|0
1020971|NCT01592240|2047101|FG002|Overall Study|Protocol Violation|0
1020972|NCT01592240|2047102|FG003|Overall Study|Protocol Violation|0
1020973|NCT01592240|2047103|FG004|Overall Study|Protocol Violation|0
1020974|NCT01592240|2047104|FG005|Overall Study|Protocol Violation|1
1020975|NCT01592240|2047105|FG006|Overall Study|Protocol Violation|0
1020976|NCT01592240|2047099|FG000|Overall Study|Withdrawal by Subject|0
1020977|NCT01592240|2047100|FG001|Overall Study|Withdrawal by Subject|4
1020978|NCT01592240|2047101|FG002|Overall Study|Withdrawal by Subject|4
1020979|NCT01592240|2047102|FG003|Overall Study|Withdrawal by Subject|1
1020980|NCT01592240|2047103|FG004|Overall Study|Withdrawal by Subject|3
1020981|NCT01592240|2047104|FG005|Overall Study|Withdrawal by Subject|0
1020982|NCT01592240|2047105|FG006|Overall Study|Withdrawal by Subject|2
1020983|NCT01592240|2047099|FG000|Overall Study|Other|0
1020984|NCT01592240|2047100|FG001|Overall Study|Other|3
1020985|NCT01592240|2047101|FG002|Overall Study|Other|1
1020986|NCT01592240|2047102|FG003|Overall Study|Other|1
1020987|NCT01592240|2047103|FG004|Overall Study|Other|0
1020988|NCT01592240|2047104|FG005|Overall Study|Other|0
1020989|NCT01592240|2047105|FG006|Overall Study|Other|1
1020990|NCT01592240|2047099|FG000|Overall Study|Did Not Meet Entrance Criteria|1
1020991|NCT01592240|2047100|FG001|Overall Study|Did Not Meet Entrance Criteria|0
1020992|NCT01592240|2047101|FG002|Overall Study|Did Not Meet Entrance Criteria|1
1020993|NCT01592240|2047102|FG003|Overall Study|Did Not Meet Entrance Criteria|0
1020994|NCT01592240|2047103|FG004|Overall Study|Did Not Meet Entrance Criteria|0
1020995|NCT01592240|2047104|FG005|Overall Study|Did Not Meet Entrance Criteria|0
1020996|NCT01592240|2047105|FG006|Overall Study|Did Not Meet Entrance Criteria|0
1020997|NCT01592292|2047128|FG000|Overall Study|Follow-up loss|3
1020998|NCT01592292|2047129|FG001|Overall Study|Follow-up loss|3
1020999|NCT01592292|2047130|FG002|Overall Study|Follow-up loss|1
1021000|NCT01592292|2047131|FG003|Overall Study|Follow-up loss|0
1021001|NCT01592292|2047128|FG000|Overall Study|Withdrew consent|2
1021002|NCT01592292|2047129|FG001|Overall Study|Withdrew consent|1
1021003|NCT01592292|2047130|FG002|Overall Study|Withdrew consent|0
1021004|NCT01592292|2047131|FG003|Overall Study|Withdrew consent|0
1021005|NCT01592292|2047128|FG000|Overall Study|Other|1
1021006|NCT01592292|2047129|FG001|Overall Study|Other|1
1021007|NCT01592292|2047130|FG002|Overall Study|Other|2
1021008|NCT01592292|2047131|FG003|Overall Study|Other|1
1021009|NCT01592344|2047139|FG000|Overall Study|Adverse Event|1
1021010|NCT01592344|2047140|FG001|Overall Study|Adverse Event|1
1021011|NCT01592344|2047139|FG000|Overall Study|Lack of Efficacy|1
1021012|NCT01592344|2047140|FG001|Overall Study|Lack of Efficacy|0
1021013|NCT01592344|2047139|FG000|Overall Study|not available at primary outcome visit|2
1021014|NCT01592344|2047140|FG001|Overall Study|not available at primary outcome visit|4
1021015|NCT01592409|2047158|FG000|Overall Study|Withdrawal by Subject|0
1021016|NCT01592409|2047159|FG001|Overall Study|Withdrawal by Subject|1
1021017|NCT01592695|2047190|FG000|Overall Study|Lost to Follow-up|8
1021018|NCT01592695|2047191|FG001|Overall Study|Lost to Follow-up|4
1021019|NCT01592708|2047199|FG000|Overall Study|Protocol Violation|3
1021020|NCT01592708|2047200|FG001|Overall Study|Protocol Violation|0
1021021|NCT01592747|2047212|FG000|Overall Study|Loss of Therapeutic Response|107
1021022|NCT01592747|2047213|FG001|Overall Study|Loss of Therapeutic Response|108
1021023|NCT01592747|2047214|FG002|Overall Study|Loss of Therapeutic Response|100
1021024|NCT01592747|2047212|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
1021025|NCT01592747|2047213|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
1021026|NCT01592747|2047214|FG002|Overall Study|Inclusion/Exclusion criteria not met|1
1021027|NCT01592747|2047212|FG000|Overall Study|Adverse Event|1
1021028|NCT01592747|2047213|FG001|Overall Study|Adverse Event|0
1021029|NCT01592747|2047214|FG002|Overall Study|Adverse Event|0
1021030|NCT01592747|2047212|FG000|Overall Study|Protocol Violation|4
1021031|NCT01592747|2047213|FG001|Overall Study|Protocol Violation|0
1021032|NCT01592747|2047214|FG002|Overall Study|Protocol Violation|4
1021033|NCT01592747|2047212|FG000|Overall Study|Lack of Efficacy|0
1021034|NCT01592747|2047213|FG001|Overall Study|Lack of Efficacy|1
1021035|NCT01592747|2047214|FG002|Overall Study|Lack of Efficacy|0
1021036|NCT01592747|2047212|FG000|Overall Study|Withdrawal by Subject|2
1021037|NCT01592747|2047213|FG001|Overall Study|Withdrawal by Subject|0
1021038|NCT01592747|2047214|FG002|Overall Study|Withdrawal by Subject|2
1021039|NCT01592747|2047212|FG000|Overall Study|Lost to Follow-up|1
1021040|NCT01592747|2047213|FG001|Overall Study|Lost to Follow-up|0
1021041|NCT01592747|2047214|FG002|Overall Study|Lost to Follow-up|1
1021042|NCT01592747|2047212|FG000|Overall Study|Other Reasons|1
1021043|NCT01592747|2047213|FG001|Overall Study|Other Reasons|1
1021044|NCT01592747|2047214|FG002|Overall Study|Other Reasons|0
1021045|NCT01592760|2047226|FG000|24-hour Follow-Up|Lost to Follow-up|4
1021046|NCT01592760|2047227|FG001|24-hour Follow-Up|Lost to Follow-up|3
1021047|NCT01592760|2047228|FG002|24-hour Follow-Up|Lost to Follow-up|2
1021048|NCT01592773|2047239|FG000|Overall Study|Study Terminated by Sponsor|582
1021049|NCT01592773|2047239|FG000|Overall Study|Withdrawal by Subject|35
1021050|NCT01592773|2047239|FG000|Overall Study|Lost to Follow-up|19
1021051|NCT01592773|2047239|FG000|Overall Study|Adverse Event|17
1021052|NCT01592773|2047239|FG000|Overall Study|Lack of Efficacy|9
1021053|NCT01592773|2047239|FG000|Overall Study|Protocol Violation|2
1021054|NCT01592773|2047239|FG000|Overall Study|Inclusion/exclusion not meet|1
1021055|NCT01592773|2047239|FG000|Overall Study|Other Reason|1
1021056|NCT01592786|2047243|FG000|Overall Study|Adverse Event|60
1021057|NCT01592786|2047243|FG000|Overall Study|Lack of Efficacy|19
1021058|NCT01592786|2047243|FG000|Overall Study|Protocol Violation|14
1021059|NCT01592786|2047243|FG000|Overall Study|Withdrawal by Subject|23
1021060|NCT01592786|2047243|FG000|Overall Study|Lost to Follow-up|19
1021061|NCT01592786|2047243|FG000|Overall Study|Other|3
1021062|NCT01592864|2047264|FG000|Overall Study|Withdrawal by Subject|0
1021063|NCT01592864|2047265|FG001|Overall Study|Withdrawal by Subject|1
1021064|NCT01593020|2047273|FG000|Overall Study|Adverse Event|1
1021065|NCT01593020|2047274|FG001|Overall Study|Adverse Event|1
1021066|NCT01593020|2047273|FG000|Overall Study|Death|0
1021067|NCT01593020|2047274|FG001|Overall Study|Death|1
1021068|NCT01593020|2047273|FG000|Overall Study|Ineligible|1
1021069|NCT01593020|2047274|FG001|Overall Study|Ineligible|0
904941|NCT00759564|1880000|FG001|Washout Period (at Least 14 Days)|Adverse Event|0
904942|NCT00759564|1880001|FG002|Washout Period (at Least 14 Days)|Adverse Event|0
1021120|NCT01593696|2047316|FG000|Dose Escalation|Progressive Disease|2
1021121|NCT01593696|2047317|FG001|Dose Escalation|Progressive Disease|0
1021122|NCT01593696|2047318|FG002|Dose Escalation|Progressive Disease|0
1021123|NCT01593696|2047319|FG003|Dose Escalation|Progressive Disease|0
1021124|NCT01593696|2047316|FG000|Dose Expansion|Fungal infection|0
1021125|NCT01593696|2047317|FG001|Dose Expansion|Fungal infection|0
1021126|NCT01593696|2047318|FG002|Dose Expansion|Fungal infection|1
1021127|NCT01593696|2047319|FG003|Dose Expansion|Fungal infection|0
1021128|NCT01593787|2047352|FG000|Overall Study|Adverse Event|1
1021129|NCT01593787|2047353|FG001|Overall Study|Adverse Event|0
1021130|NCT01593787|2047354|FG002|Overall Study|Adverse Event|0
1021131|NCT01593917|2047373|FG000|Overall Study|Death|67
1021132|NCT01593917|2047373|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60
1021133|NCT01593917|2047373|FG000|Overall Study|Withdrawal by Subject|23
1021134|NCT01593917|2047373|FG000|Overall Study|Lost to Follow-up|12
1021135|NCT01593917|2047373|FG000|Overall Study|Protocol Violation|5
1021136|NCT01593917|2047373|FG000|Overall Study|Physician Decision|3
1021137|NCT01594125|2047382|FG000|Overall Study|Withdrawal by Subject|1
1021138|NCT01594125|2047383|FG001|Overall Study|Withdrawal by Subject|0
1021139|NCT01594125|2047384|FG002|Overall Study|Withdrawal by Subject|0
1021140|NCT01594125|2047385|FG003|Overall Study|Withdrawal by Subject|1
1021141|NCT01594125|2047386|FG004|Overall Study|Withdrawal by Subject|0
1021142|NCT01594125|2047382|FG000|Overall Study|Progressive Disease|3
1021143|NCT01594125|2047383|FG001|Overall Study|Progressive Disease|12
1021144|NCT01594125|2047384|FG002|Overall Study|Progressive Disease|3
1021145|NCT01594125|2047385|FG003|Overall Study|Progressive Disease|3
1021146|NCT01594125|2047386|FG004|Overall Study|Progressive Disease|7
1021147|NCT01594281|2047401|FG000|Interventional Core Phase|Protocol Deviation|1
1021148|NCT01594281|2047402|FG001|Interventional Core Phase|Protocol Deviation|0
1021149|NCT01594281|2047403|FG002|Interventional Core Phase|Protocol Deviation|0
1021150|NCT01594281|2047401|FG000|Interventional Core Phase|Subject Withdrew Consent|0
1021151|NCT01594281|2047402|FG001|Interventional Core Phase|Subject Withdrew Consent|1
1021152|NCT01594281|2047403|FG002|Interventional Core Phase|Subject Withdrew Consent|1
1021153|NCT01594281|2047401|FG000|Interventional Core Phase|Death|1
1021154|NCT01594281|2047402|FG001|Interventional Core Phase|Death|1
1021155|NCT01594281|2047403|FG002|Interventional Core Phase|Death|2
1021156|NCT01594281|2047401|FG000|Interventional Core Phase|Lost to Follow-up|1
1021157|NCT01594281|2047402|FG001|Interventional Core Phase|Lost to Follow-up|4
1021158|NCT01594281|2047403|FG002|Interventional Core Phase|Lost to Follow-up|1
1021159|NCT01594281|2047401|FG000|Interventional Core Phase|Adverse Event|4
1021160|NCT01594281|2047402|FG001|Interventional Core Phase|Adverse Event|4
1021161|NCT01594281|2047403|FG002|Interventional Core Phase|Adverse Event|4
1021162|NCT01594281|2047401|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2
1021163|NCT01594281|2047402|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2
1021164|NCT01594281|2047403|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0
1021165|NCT01594281|2047401|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0
1021166|NCT01594281|2047402|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0
1021167|NCT01594281|2047403|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1
1021168|NCT01594281|2047401|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
1021169|NCT01594281|2047402|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
1021170|NCT01594281|2047403|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
1021171|NCT01594333|2047425|FG000|Overall Study|Death|96
1021172|NCT01594333|2047426|FG001|Overall Study|Death|83
1021173|NCT01594333|2047425|FG000|Overall Study|Lost to Follow-up|5
1021174|NCT01594333|2047426|FG001|Overall Study|Lost to Follow-up|5
1021175|NCT01594333|2047425|FG000|Overall Study|Withdrawal by Subject|60
1021176|NCT01594333|2047426|FG001|Overall Study|Withdrawal by Subject|63
1021177|NCT01594411|2047445|FG000|Overall Study|Lost to Follow-up|2
1021178|NCT01594476|2047458|FG000|Overall Study|Protocol Violation|1
1021179|NCT01594476|2047459|FG001|Overall Study|Protocol Violation|3
1021180|NCT01594749|2047523|FG000|Overall Study|Adverse Event|2
1021181|NCT01594749|2047524|FG001|Overall Study|Adverse Event|1
1021182|NCT01594749|2047523|FG000|Overall Study|Withdrawal by Subject|2
1021183|NCT01594749|2047524|FG001|Overall Study|Withdrawal by Subject|2
1021184|NCT01594749|2047523|FG000|Overall Study|Protocol Violation|2
1021185|NCT01594749|2047524|FG001|Overall Study|Protocol Violation|0
1021186|NCT01594749|2047523|FG000|Overall Study|Physician Decision|1
1021187|NCT01594749|2047524|FG001|Overall Study|Physician Decision|1
1021188|NCT01594749|2047523|FG000|Overall Study|Non-compliance with Protocol|0
1021189|NCT01594749|2047524|FG001|Overall Study|Non-compliance with Protocol|1
1021190|NCT01594749|2047523|FG000|Overall Study|Lost to Follow-up|1
1021191|NCT01594749|2047524|FG001|Overall Study|Lost to Follow-up|0
1021192|NCT01594749|2047523|FG000|Overall Study|Death|9
1021193|NCT01594749|2047524|FG001|Overall Study|Death|3
1021194|NCT01594749|2047523|FG000|Overall Study|Not Treated|4
1021195|NCT01594749|2047524|FG001|Overall Study|Not Treated|10
1021196|NCT01594749|2047523|FG000|Overall Study|Lost Source Documentation|1
1021197|NCT01594749|2047524|FG001|Overall Study|Lost Source Documentation|0
1021198|NCT01594762|2047532|FG000|Overall Study|Withdrawal by Subject|1
1021199|NCT01594762|2047533|FG001|Overall Study|Withdrawal by Subject|0
1021200|NCT01594762|2047532|FG000|Overall Study|Lost to Follow-up|10
1021201|NCT01594762|2047533|FG001|Overall Study|Lost to Follow-up|10
1021202|NCT01594827|2047541|FG000|Overall Study|Adverse Event|1
1021203|NCT01594827|2047542|FG001|Overall Study|Adverse Event|0
1021204|NCT01594827|2047541|FG000|Overall Study|Physician Decision|3
1021205|NCT01594827|2047542|FG001|Overall Study|Physician Decision|0
1021206|NCT01594853|2047552|FG000|Overall Study|Withdrawal by Subject|1
1021207|NCT01594853|2047553|FG001|Overall Study|Withdrawal by Subject|1
1021208|NCT01594853|2047552|FG000|Overall Study|Lost to Follow-up|1
1021209|NCT01594853|2047553|FG001|Overall Study|Lost to Follow-up|1
1021210|NCT01594853|2047552|FG000|Overall Study|noncompliance with exercise|0
1021211|NCT01594853|2047553|FG001|Overall Study|noncompliance with exercise|1
1021212|NCT01594931|2047562|FG000|Overall Study|Adverse Event|3
1021213|NCT01594931|2047563|FG001|Overall Study|Adverse Event|1
1021214|NCT01594931|2047564|FG002|Overall Study|Adverse Event|1
1021215|NCT01594931|2047562|FG000|Overall Study|Withdrawal by Subject|2
1021216|NCT01594931|2047563|FG001|Overall Study|Withdrawal by Subject|1
1021217|NCT01594931|2047564|FG002|Overall Study|Withdrawal by Subject|1
1021218|NCT01594931|2047562|FG000|Overall Study|Lack of Efficacy|7
1021219|NCT01594931|2047563|FG001|Overall Study|Lack of Efficacy|2
1021220|NCT01594931|2047564|FG002|Overall Study|Lack of Efficacy|2
1021221|NCT01594931|2047562|FG000|Overall Study|Lost to Follow-up|4
1021222|NCT01594931|2047563|FG001|Overall Study|Lost to Follow-up|3
1021223|NCT01594931|2047564|FG002|Overall Study|Lost to Follow-up|3
1021224|NCT01594931|2047562|FG000|Overall Study|Protocol Violation|2
1021225|NCT01594931|2047563|FG001|Overall Study|Protocol Violation|1
1021226|NCT01594931|2047564|FG002|Overall Study|Protocol Violation|0
1021227|NCT01594931|2047562|FG000|Overall Study|No defiined|11
1021228|NCT01594931|2047563|FG001|Overall Study|No defiined|4
1021229|NCT01594931|2047564|FG002|Overall Study|No defiined|7
1021230|NCT01594970|2047575|FG000|Overall Study|Non-Adverse Event Related|4
1021231|NCT01594970|2047576|FG001|Overall Study|Non-Adverse Event Related|5
1021232|NCT01594970|2047577|FG002|Overall Study|Non-Adverse Event Related|6
1021233|NCT01594970|2047575|FG000|Overall Study|Adverse Event|17
1021234|NCT01594970|2047576|FG001|Overall Study|Adverse Event|23
1021235|NCT01594970|2047577|FG002|Overall Study|Adverse Event|23
1021236|NCT01594970|2047575|FG000|Overall Study|Lost to Follow-up|54
1021237|NCT01594970|2047576|FG001|Overall Study|Lost to Follow-up|54
1021238|NCT01594970|2047577|FG002|Overall Study|Lost to Follow-up|37
1021239|NCT01595438|2047625|FG000|Overall Study|Lost to Follow-up|20
1021240|NCT01595438|2047626|FG001|Overall Study|Lost to Follow-up|20
1021241|NCT01595438|2047625|FG000|Overall Study|Withdrawal by Subject|12
1021242|NCT01595438|2047626|FG001|Overall Study|Withdrawal by Subject|12
1021243|NCT01595438|2047625|FG000|Overall Study|Other Eligibility criteria|11
1021244|NCT01595438|2047626|FG001|Overall Study|Other Eligibility criteria|9
1021245|NCT01595529|2047661|FG000|Overall Study|Adverse Event|2
1021246|NCT01595529|2047662|FG001|Overall Study|Adverse Event|0
1021247|NCT01595529|2047661|FG000|Overall Study|Subject Non-Compliant|2
1021248|NCT01595529|2047662|FG001|Overall Study|Subject Non-Compliant|0
1021249|NCT01595529|2047661|FG000|Overall Study|Lost to Follow-up|8
1021250|NCT01595529|2047662|FG001|Overall Study|Lost to Follow-up|14
1021251|NCT01595529|2047661|FG000|Overall Study|Protocol Violation|1
1021252|NCT01595529|2047662|FG001|Overall Study|Protocol Violation|2
1021253|NCT01595529|2047661|FG000|Overall Study|Physician Decision|1
1021254|NCT01595529|2047662|FG001|Overall Study|Physician Decision|0
1021255|NCT01595529|2047661|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
1021256|NCT01595529|2047662|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
1021257|NCT01595529|2047661|FG000|Overall Study|Administrative Decision|1
1021258|NCT01595529|2047662|FG001|Overall Study|Administrative Decision|0
1021259|NCT01595529|2047661|FG000|Overall Study|Entry Failure/Screening Failure|6
1021260|NCT01595529|2047662|FG001|Overall Study|Entry Failure/Screening Failure|1
1021261|NCT01595646|2047671|FG000|Overall Study|Withdrawal by Subject|1
1021262|NCT01595646|2047672|FG001|Overall Study|Withdrawal by Subject|0
1021263|NCT01595646|2047673|FG002|Overall Study|Withdrawal by Subject|0
1021264|NCT01596062|2047714|FG000|Overall Study|Adverse Event|1
1021265|NCT01596062|2047715|FG001|Overall Study|Adverse Event|0
1021266|NCT01596062|2047716|FG002|Overall Study|Adverse Event|2
1021267|NCT01596062|2047714|FG000|Overall Study|Lack of Efficacy|0
1021268|NCT01596062|2047715|FG001|Overall Study|Lack of Efficacy|0
1021269|NCT01596062|2047716|FG002|Overall Study|Lack of Efficacy|1
1021270|NCT01596127|2047728|FG000|Overall Study|Patient Ineligible|1
1021271|NCT01596335|2047754|FG000|Overall Study|exacerbation of primary disease|5
1021272|NCT01596335|2047755|FG001|Overall Study|exacerbation of primary disease|9
1021273|NCT01596504|2047764|FG000|Overall Study|Participant's Private Reason|0
1021274|NCT01596504|2047765|FG001|Overall Study|Participant's Private Reason|1
1021275|NCT01596504|2047766|FG002|Overall Study|Participant's Private Reason|0
1021276|NCT01596504|2047764|FG000|Overall Study|Adverse Event|1
1021277|NCT01596504|2047765|FG001|Overall Study|Adverse Event|2
1021278|NCT01596504|2047766|FG002|Overall Study|Adverse Event|1
1021279|NCT01596504|2047764|FG000|Overall Study|Withdrawal by Subject|1
1021280|NCT01596504|2047765|FG001|Overall Study|Withdrawal by Subject|0
1021281|NCT01596504|2047766|FG002|Overall Study|Withdrawal by Subject|0
1021282|NCT01596582|2047777|FG000|Overall Study|Deemed ineligible after study visit|3
1021283|NCT01596582|2047778|FG001|Overall Study|Deemed ineligible after study visit|6
1021284|NCT01596582|2047777|FG000|Overall Study|Missing all outcome data|1
1021285|NCT01596582|2047778|FG001|Overall Study|Missing all outcome data|1
1021286|NCT01596972|2047849|FG000|Overall Study|Physician Decision|1
1021287|NCT01596972|2047850|FG001|Overall Study|Physician Decision|9
1021288|NCT01596972|2047849|FG000|Overall Study|Lost to Follow-up|0
1021289|NCT01596972|2047850|FG001|Overall Study|Lost to Follow-up|4
1021290|NCT01596972|2047849|FG000|Overall Study|Withdrawal by Subject|0
1021291|NCT01596972|2047850|FG001|Overall Study|Withdrawal by Subject|1
904943|NCT00759564|1880002|FG003|Washout Period (at Least 14 Days)|Adverse Event|0
904944|NCT00759564|1880003|FG004|Washout Period (at Least 14 Days)|Adverse Event|1
1021292|NCT01597050|2047858|FG000|Overall Study|Withdrawal by Subject|1
1021293|NCT01597050|2047859|FG001|Overall Study|Withdrawal by Subject|0
1021294|NCT01597193|2047892|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7
1021295|NCT01597193|2047893|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8
1021296|NCT01597193|2047894|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0
1021297|NCT01597193|2047895|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0
1021298|NCT01597193|2047896|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0
1021299|NCT01597193|2047897|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0
1021300|NCT01597193|2047898|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0
1021301|NCT01597193|2047892|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
1021302|NCT01597193|2047893|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
1021303|NCT01597193|2047894|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
1021304|NCT01597193|2047895|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
1021305|NCT01597193|2047896|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
1021306|NCT01597193|2047897|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
1021307|NCT01597193|2047898|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
1021308|NCT01597193|2047892|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
1021309|NCT01597193|2047893|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
1021310|NCT01597193|2047894|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
1021311|NCT01597193|2047895|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
1021312|NCT01597193|2047896|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
1021313|NCT01597193|2047897|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
1021314|NCT01597193|2047898|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
1021315|NCT01597193|2047892|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0
1021316|NCT01597193|2047893|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0
1021317|NCT01597193|2047894|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0
1021318|NCT01597193|2047895|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0
1021319|NCT01597193|2047896|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0
1021320|NCT01597193|2047897|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1
1021321|NCT01597193|2047898|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0
1021322|NCT01597193|2047892|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
1021323|NCT01597193|2047893|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
1021324|NCT01597193|2047894|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
1021325|NCT01597193|2047895|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
1021326|NCT01597193|2047896|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
1021327|NCT01597193|2047897|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
1021328|NCT01597193|2047898|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
1021329|NCT01597245|2047923|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1
1021330|NCT01597245|2047924|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5
1021331|NCT01597245|2047925|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5
1021332|NCT01597245|2047926|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4
1021333|NCT01597245|2047927|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021334|NCT01597245|2047928|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021335|NCT01597245|2047929|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021336|NCT01597245|2047930|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021337|NCT01597245|2047931|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021338|NCT01597245|2047932|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021339|NCT01597245|2047933|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021340|NCT01597245|2047934|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021341|NCT01597245|2047935|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021342|NCT01597245|2047936|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021343|NCT01597245|2047937|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021344|NCT01597245|2047938|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021345|NCT01597245|2047939|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021346|NCT01597245|2047940|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021347|NCT01597245|2047941|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021348|NCT01597245|2047942|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021349|NCT01597245|2047943|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0
1021350|NCT01597245|2047923|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
1021351|NCT01597245|2047924|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
1021352|NCT01597245|2047925|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
1021353|NCT01597245|2047926|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
1021354|NCT01597245|2047927|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021355|NCT01597245|2047928|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021356|NCT01597245|2047929|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021357|NCT01597245|2047930|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021358|NCT01597245|2047931|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021359|NCT01597245|2047932|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021360|NCT01597245|2047933|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021361|NCT01597245|2047934|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021362|NCT01597245|2047935|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021363|NCT01597245|2047936|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021364|NCT01597245|2047937|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021365|NCT01597245|2047938|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021366|NCT01597245|2047939|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021367|NCT01597245|2047940|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021368|NCT01597245|2047941|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021369|NCT01597245|2047942|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021370|NCT01597245|2047943|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1021371|NCT01597245|2047923|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2
1021372|NCT01597245|2047924|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4
1021373|NCT01597245|2047925|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5
1021374|NCT01597245|2047926|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2
1021375|NCT01597245|2047927|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021376|NCT01597245|2047928|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021377|NCT01597245|2047929|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021378|NCT01597245|2047930|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021379|NCT01597245|2047931|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021380|NCT01597245|2047932|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021381|NCT01597245|2047933|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021382|NCT01597245|2047934|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021383|NCT01597245|2047935|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021384|NCT01597245|2047936|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021385|NCT01597245|2047937|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021386|NCT01597245|2047938|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021387|NCT01597245|2047939|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021388|NCT01597245|2047940|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021389|NCT01597245|2047941|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021390|NCT01597245|2047942|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021391|NCT01597245|2047943|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1021392|NCT01597245|2047923|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
1021393|NCT01597245|2047924|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
1021394|NCT01597245|2047925|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
1021395|NCT01597245|2047926|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021396|NCT01597245|2047927|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021397|NCT01597245|2047928|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021398|NCT01597245|2047929|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021399|NCT01597245|2047930|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021400|NCT01597245|2047931|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021401|NCT01597245|2047932|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021402|NCT01597245|2047933|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021403|NCT01597245|2047934|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021404|NCT01597245|2047935|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021405|NCT01597245|2047936|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021406|NCT01597245|2047937|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021407|NCT01597245|2047938|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021408|NCT01597245|2047939|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021409|NCT01597245|2047940|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021410|NCT01597245|2047941|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021411|NCT01597245|2047942|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021412|NCT01597245|2047943|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1021413|NCT01597245|2047923|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1
1021414|NCT01597245|2047924|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021415|NCT01597245|2047925|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021416|NCT01597245|2047926|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1
1021417|NCT01597245|2047927|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021418|NCT01597245|2047928|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021419|NCT01597245|2047929|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021420|NCT01597245|2047930|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021421|NCT01597245|2047931|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021422|NCT01597245|2047932|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021423|NCT01597245|2047933|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021424|NCT01597245|2047934|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021425|NCT01597245|2047935|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021426|NCT01597245|2047936|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021427|NCT01597245|2047937|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021428|NCT01597245|2047938|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021429|NCT01597245|2047939|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021430|NCT01597245|2047940|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021431|NCT01597245|2047941|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021432|NCT01597245|2047942|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021433|NCT01597245|2047943|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0
1021434|NCT01597245|2047923|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
1021435|NCT01597245|2047924|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
1021436|NCT01597245|2047925|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
1021437|NCT01597245|2047926|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021438|NCT01597245|2047927|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021439|NCT01597245|2047928|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021440|NCT01597245|2047929|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021441|NCT01597245|2047930|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021442|NCT01597245|2047931|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021443|NCT01597245|2047932|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021444|NCT01597245|2047933|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021445|NCT01597245|2047934|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021446|NCT01597245|2047935|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021447|NCT01597245|2047936|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021448|NCT01597245|2047937|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021449|NCT01597245|2047938|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021450|NCT01597245|2047939|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021451|NCT01597245|2047940|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021452|NCT01597245|2047941|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021453|NCT01597245|2047942|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021454|NCT01597245|2047943|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1021455|NCT01597245|2047923|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021456|NCT01597245|2047924|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021457|NCT01597245|2047925|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021458|NCT01597245|2047926|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021459|NCT01597245|2047927|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021460|NCT01597245|2047928|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1
1021461|NCT01597245|2047929|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1
1021462|NCT01597245|2047930|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021463|NCT01597245|2047931|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021464|NCT01597245|2047932|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021465|NCT01597245|2047933|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021466|NCT01597245|2047934|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021467|NCT01597245|2047935|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021468|NCT01597245|2047936|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021469|NCT01597245|2047937|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021470|NCT01597245|2047938|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021471|NCT01597245|2047939|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021472|NCT01597245|2047940|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021473|NCT01597245|2047941|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021474|NCT01597245|2047942|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021475|NCT01597245|2047943|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1021476|NCT01597245|2047923|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021477|NCT01597245|2047924|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021478|NCT01597245|2047925|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021479|NCT01597245|2047926|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021480|NCT01597245|2047927|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150
1021481|NCT01597245|2047928|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22
1021482|NCT01597245|2047929|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80
1021483|NCT01597245|2047930|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2
1021484|NCT01597245|2047931|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1090859|NCT02249091|2158597|FG000|Overall Study|Death|3
1021485|NCT01597245|2047932|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114
1021486|NCT01597245|2047933|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021487|NCT01597245|2047934|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021488|NCT01597245|2047935|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021489|NCT01597245|2047936|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021490|NCT01597245|2047937|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021491|NCT01597245|2047938|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021492|NCT01597245|2047939|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021493|NCT01597245|2047940|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021494|NCT01597245|2047941|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021495|NCT01597245|2047942|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021496|NCT01597245|2047943|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1021497|NCT01597245|2047923|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021498|NCT01597245|2047924|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021499|NCT01597245|2047925|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021500|NCT01597245|2047926|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021501|NCT01597245|2047927|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021502|NCT01597245|2047928|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
1021503|NCT01597245|2047929|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021504|NCT01597245|2047930|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021505|NCT01597245|2047931|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
1021506|NCT01597245|2047932|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021507|NCT01597245|2047933|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
1021508|NCT01597245|2047934|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
1021509|NCT01597245|2047935|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
1021510|NCT01597245|2047936|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021511|NCT01597245|2047937|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021512|NCT01597245|2047938|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021513|NCT01597245|2047939|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021514|NCT01597245|2047940|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021515|NCT01597245|2047941|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021516|NCT01597245|2047942|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021517|NCT01597245|2047943|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1021518|NCT01597245|2047923|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021519|NCT01597245|2047924|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021520|NCT01597245|2047925|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021521|NCT01597245|2047926|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021522|NCT01597245|2047927|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
1021523|NCT01597245|2047928|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
1021524|NCT01597245|2047929|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
1021525|NCT01597245|2047930|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
1021526|NCT01597245|2047931|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
1021527|NCT01597245|2047932|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
1021528|NCT01597245|2047933|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
1021529|NCT01597245|2047934|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
1021530|NCT01597245|2047935|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
1021531|NCT01597245|2047936|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021532|NCT01597245|2047937|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021533|NCT01597245|2047938|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021534|NCT01597245|2047939|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021535|NCT01597245|2047940|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021536|NCT01597245|2047941|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021537|NCT01597245|2047942|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021538|NCT01597245|2047943|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1021539|NCT01597245|2047923|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021540|NCT01597245|2047924|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021541|NCT01597245|2047925|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021542|NCT01597245|2047926|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021543|NCT01597245|2047927|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
1021544|NCT01597245|2047928|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
1021545|NCT01597245|2047929|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
1021546|NCT01597245|2047930|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021547|NCT01597245|2047931|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
1021548|NCT01597245|2047932|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
1021549|NCT01597245|2047933|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
1021550|NCT01597245|2047934|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
1021551|NCT01597245|2047935|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
1021552|NCT01597245|2047936|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021553|NCT01597245|2047937|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021554|NCT01597245|2047938|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021555|NCT01597245|2047939|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021556|NCT01597245|2047940|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021557|NCT01597245|2047941|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021558|NCT01597245|2047942|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021559|NCT01597245|2047943|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1021560|NCT01597245|2047923|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021561|NCT01597245|2047924|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021562|NCT01597245|2047925|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021563|NCT01597245|2047926|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021564|NCT01597245|2047927|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1021565|NCT01597245|2047928|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021566|NCT01597245|2047929|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021567|NCT01597245|2047930|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021568|NCT01597245|2047931|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
1021569|NCT01597245|2047932|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1021570|NCT01597245|2047933|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
1021571|NCT01597245|2047934|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021572|NCT01597245|2047935|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1021573|NCT01597245|2047936|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021574|NCT01597245|2047937|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021575|NCT01597245|2047938|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021576|NCT01597245|2047939|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021577|NCT01597245|2047940|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021578|NCT01597245|2047941|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021579|NCT01597245|2047942|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021580|NCT01597245|2047943|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1021581|NCT01597245|2047923|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021582|NCT01597245|2047924|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021583|NCT01597245|2047925|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021584|NCT01597245|2047926|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021585|NCT01597245|2047927|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
1021586|NCT01597245|2047928|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
1021587|NCT01597245|2047929|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1021588|NCT01597245|2047930|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021589|NCT01597245|2047931|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1021590|NCT01597245|2047932|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1021591|NCT01597245|2047933|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1021592|NCT01597245|2047934|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1021593|NCT01597245|2047935|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1021594|NCT01597245|2047936|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021595|NCT01597245|2047937|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021596|NCT01597245|2047938|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021597|NCT01597245|2047939|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021598|NCT01597245|2047940|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021599|NCT01597245|2047941|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021600|NCT01597245|2047942|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021601|NCT01597245|2047943|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1021602|NCT01597245|2047923|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021603|NCT01597245|2047924|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021604|NCT01597245|2047925|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021605|NCT01597245|2047926|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021606|NCT01597245|2047927|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021607|NCT01597245|2047928|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1021608|NCT01597245|2047929|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021609|NCT01597245|2047930|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021610|NCT01597245|2047931|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1021611|NCT01597245|2047932|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1021612|NCT01597245|2047933|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1021613|NCT01597245|2047934|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1021614|NCT01597245|2047935|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021615|NCT01597245|2047936|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021616|NCT01597245|2047937|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021617|NCT01597245|2047938|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021618|NCT01597245|2047939|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021619|NCT01597245|2047940|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021620|NCT01597245|2047941|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021621|NCT01597245|2047942|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021622|NCT01597245|2047943|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1021623|NCT01597245|2047923|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021624|NCT01597245|2047924|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021625|NCT01597245|2047925|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021626|NCT01597245|2047926|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021627|NCT01597245|2047927|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021628|NCT01597245|2047928|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021629|NCT01597245|2047929|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021630|NCT01597245|2047930|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021631|NCT01597245|2047931|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021632|NCT01597245|2047932|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021633|NCT01597245|2047933|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
1021634|NCT01597245|2047934|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021635|NCT01597245|2047935|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021636|NCT01597245|2047936|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021637|NCT01597245|2047937|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021638|NCT01597245|2047938|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021639|NCT01597245|2047939|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021640|NCT01597245|2047940|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021641|NCT01597245|2047941|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021642|NCT01597245|2047942|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021643|NCT01597245|2047943|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1021644|NCT01597245|2047923|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021645|NCT01597245|2047924|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021646|NCT01597245|2047925|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021647|NCT01597245|2047926|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021648|NCT01597245|2047927|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021649|NCT01597245|2047928|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021650|NCT01597245|2047929|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021651|NCT01597245|2047930|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021652|NCT01597245|2047931|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021653|NCT01597245|2047932|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021654|NCT01597245|2047933|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021655|NCT01597245|2047934|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021656|NCT01597245|2047935|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021657|NCT01597245|2047936|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1
1021658|NCT01597245|2047937|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69
1021659|NCT01597245|2047938|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70
1021660|NCT01597245|2047939|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021661|NCT01597245|2047940|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021662|NCT01597245|2047941|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021663|NCT01597245|2047942|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021664|NCT01597245|2047943|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
1021665|NCT01597245|2047923|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021666|NCT01597245|2047924|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021667|NCT01597245|2047925|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021668|NCT01597245|2047926|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021669|NCT01597245|2047927|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021670|NCT01597245|2047928|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021671|NCT01597245|2047929|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021672|NCT01597245|2047930|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021673|NCT01597245|2047931|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021674|NCT01597245|2047932|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021675|NCT01597245|2047933|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021676|NCT01597245|2047934|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021677|NCT01597245|2047935|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021678|NCT01597245|2047936|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1
1021679|NCT01597245|2047937|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62
1021680|NCT01597245|2047938|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63
1021681|NCT01597245|2047939|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021682|NCT01597245|2047940|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021683|NCT01597245|2047941|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021684|NCT01597245|2047942|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021685|NCT01597245|2047943|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
1021686|NCT01597245|2047923|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021687|NCT01597245|2047924|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021688|NCT01597245|2047925|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021689|NCT01597245|2047926|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021690|NCT01597245|2047927|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021691|NCT01597245|2047928|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021692|NCT01597245|2047929|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021693|NCT01597245|2047930|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021694|NCT01597245|2047931|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021695|NCT01597245|2047932|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021696|NCT01597245|2047933|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021697|NCT01597245|2047934|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021698|NCT01597245|2047935|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021699|NCT01597245|2047936|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021700|NCT01597245|2047937|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
1021701|NCT01597245|2047938|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
1021702|NCT01597245|2047939|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021703|NCT01597245|2047940|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021704|NCT01597245|2047941|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021705|NCT01597245|2047942|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021706|NCT01597245|2047943|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
1021707|NCT01597245|2047923|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021708|NCT01597245|2047924|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021709|NCT01597245|2047925|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021710|NCT01597245|2047926|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021711|NCT01597245|2047927|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021712|NCT01597245|2047928|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021713|NCT01597245|2047929|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021714|NCT01597245|2047930|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021715|NCT01597245|2047931|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021716|NCT01597245|2047932|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021717|NCT01597245|2047933|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021718|NCT01597245|2047934|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021719|NCT01597245|2047935|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021720|NCT01597245|2047936|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021721|NCT01597245|2047937|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
1021722|NCT01597245|2047938|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
1021723|NCT01597245|2047939|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021724|NCT01597245|2047940|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021725|NCT01597245|2047941|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021726|NCT01597245|2047942|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021727|NCT01597245|2047943|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
1021728|NCT01597245|2047923|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021729|NCT01597245|2047924|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021730|NCT01597245|2047925|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021731|NCT01597245|2047926|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021732|NCT01597245|2047927|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021733|NCT01597245|2047928|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021734|NCT01597245|2047929|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021735|NCT01597245|2047930|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021736|NCT01597245|2047931|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021737|NCT01597245|2047932|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021738|NCT01597245|2047933|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021739|NCT01597245|2047934|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021740|NCT01597245|2047935|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021741|NCT01597245|2047936|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1
1021742|NCT01597245|2047937|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11
1021743|NCT01597245|2047938|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12
1021744|NCT01597245|2047939|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021745|NCT01597245|2047940|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021746|NCT01597245|2047941|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021747|NCT01597245|2047942|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021748|NCT01597245|2047943|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
1021749|NCT01597245|2047923|FG000|Long Term Extension (Week 60 - Week 264)|Death|0
1021750|NCT01597245|2047924|FG001|Long Term Extension (Week 60 - Week 264)|Death|0
1021751|NCT01597245|2047925|FG002|Long Term Extension (Week 60 - Week 264)|Death|0
1021752|NCT01597245|2047926|FG003|Long Term Extension (Week 60 - Week 264)|Death|0
1021753|NCT01597245|2047927|FG004|Long Term Extension (Week 60 - Week 264)|Death|0
1021754|NCT01597245|2047928|FG005|Long Term Extension (Week 60 - Week 264)|Death|0
1021755|NCT01597245|2047929|FG006|Long Term Extension (Week 60 - Week 264)|Death|0
1021756|NCT01597245|2047930|FG007|Long Term Extension (Week 60 - Week 264)|Death|0
1021757|NCT01597245|2047931|FG008|Long Term Extension (Week 60 - Week 264)|Death|0
1021758|NCT01597245|2047932|FG009|Long Term Extension (Week 60 - Week 264)|Death|0
1021759|NCT01597245|2047933|FG010|Long Term Extension (Week 60 - Week 264)|Death|0
1021760|NCT01597245|2047934|FG011|Long Term Extension (Week 60 - Week 264)|Death|0
1021761|NCT01597245|2047935|FG012|Long Term Extension (Week 60 - Week 264)|Death|0
1021762|NCT01597245|2047936|FG013|Long Term Extension (Week 60 - Week 264)|Death|0
1021763|NCT01597245|2047937|FG014|Long Term Extension (Week 60 - Week 264)|Death|8
1021764|NCT01597245|2047938|FG015|Long Term Extension (Week 60 - Week 264)|Death|8
1021765|NCT01597245|2047939|FG016|Long Term Extension (Week 60 - Week 264)|Death|0
1021766|NCT01597245|2047940|FG017|Long Term Extension (Week 60 - Week 264)|Death|0
1021767|NCT01597245|2047941|FG018|Long Term Extension (Week 60 - Week 264)|Death|0
1021768|NCT01597245|2047942|FG019|Long Term Extension (Week 60 - Week 264)|Death|0
1021769|NCT01597245|2047943|FG020|Long Term Extension (Week 60 - Week 264)|Death|0
1021770|NCT01597245|2047923|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021771|NCT01597245|2047924|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021772|NCT01597245|2047925|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021773|NCT01597245|2047926|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021774|NCT01597245|2047927|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021775|NCT01597245|2047928|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021776|NCT01597245|2047929|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021777|NCT01597245|2047930|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021778|NCT01597245|2047931|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021779|NCT01597245|2047932|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021780|NCT01597245|2047933|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021781|NCT01597245|2047934|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021782|NCT01597245|2047935|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021783|NCT01597245|2047936|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021784|NCT01597245|2047937|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
1021785|NCT01597245|2047938|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
1021786|NCT01597245|2047939|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021787|NCT01597245|2047940|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021788|NCT01597245|2047941|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021789|NCT01597245|2047942|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021790|NCT01597245|2047943|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
1021791|NCT01597245|2047923|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021792|NCT01597245|2047924|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021793|NCT01597245|2047925|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021794|NCT01597245|2047926|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021795|NCT01597245|2047927|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021796|NCT01597245|2047928|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021797|NCT01597245|2047929|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021798|NCT01597245|2047930|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021799|NCT01597245|2047931|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021800|NCT01597245|2047932|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021801|NCT01597245|2047933|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021802|NCT01597245|2047934|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021803|NCT01597245|2047935|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021804|NCT01597245|2047936|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021805|NCT01597245|2047937|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
1021806|NCT01597245|2047938|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
1021807|NCT01597245|2047939|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021808|NCT01597245|2047940|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021809|NCT01597245|2047941|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021810|NCT01597245|2047942|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021811|NCT01597245|2047943|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
1021812|NCT01597245|2047923|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021813|NCT01597245|2047924|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021814|NCT01597245|2047925|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021815|NCT01597245|2047926|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021816|NCT01597245|2047927|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021817|NCT01597245|2047928|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021818|NCT01597245|2047929|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021819|NCT01597245|2047930|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021820|NCT01597245|2047931|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021821|NCT01597245|2047932|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021822|NCT01597245|2047933|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021823|NCT01597245|2047934|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021824|NCT01597245|2047935|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021825|NCT01597245|2047936|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021826|NCT01597245|2047937|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
1021827|NCT01597245|2047938|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
1021828|NCT01597245|2047939|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021829|NCT01597245|2047940|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021830|NCT01597245|2047941|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021831|NCT01597245|2047942|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021832|NCT01597245|2047943|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
1021833|NCT01597245|2047923|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021834|NCT01597245|2047924|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021835|NCT01597245|2047925|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021836|NCT01597245|2047926|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021837|NCT01597245|2047927|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021838|NCT01597245|2047928|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021839|NCT01597245|2047929|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021840|NCT01597245|2047930|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021841|NCT01597245|2047931|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021842|NCT01597245|2047932|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021843|NCT01597245|2047933|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021844|NCT01597245|2047934|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021845|NCT01597245|2047935|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021846|NCT01597245|2047936|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23
1021847|NCT01597245|2047937|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021848|NCT01597245|2047938|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021849|NCT01597245|2047939|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021850|NCT01597245|2047940|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021851|NCT01597245|2047941|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021852|NCT01597245|2047942|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021853|NCT01597245|2047943|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
1021854|NCT01597245|2047923|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021855|NCT01597245|2047924|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021856|NCT01597245|2047925|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021857|NCT01597245|2047926|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021858|NCT01597245|2047927|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021859|NCT01597245|2047928|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021860|NCT01597245|2047929|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021861|NCT01597245|2047930|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021862|NCT01597245|2047931|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021863|NCT01597245|2047932|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021864|NCT01597245|2047933|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021865|NCT01597245|2047934|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021866|NCT01597245|2047935|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021867|NCT01597245|2047936|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021868|NCT01597245|2047937|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021869|NCT01597245|2047938|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
1021870|NCT01597245|2047939|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9
1021871|NCT01597245|2047940|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5
1021872|NCT01597245|2047941|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8
1021873|NCT01597245|2047942|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63
1021874|NCT01597245|2047943|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13
1021875|NCT01597245|2047923|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021876|NCT01597245|2047924|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021877|NCT01597245|2047925|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021878|NCT01597245|2047926|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021879|NCT01597245|2047927|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021880|NCT01597245|2047928|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021881|NCT01597245|2047929|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021882|NCT01597245|2047930|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021883|NCT01597245|2047931|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021884|NCT01597245|2047932|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021885|NCT01597245|2047933|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021886|NCT01597245|2047934|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021887|NCT01597245|2047935|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021888|NCT01597245|2047936|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021889|NCT01597245|2047937|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021890|NCT01597245|2047938|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021891|NCT01597245|2047939|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
1021892|NCT01597245|2047940|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
1021893|NCT01597245|2047941|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
1021894|NCT01597245|2047942|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41
1021895|NCT01597245|2047943|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13
1021896|NCT01597245|2047923|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021897|NCT01597245|2047924|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021898|NCT01597245|2047925|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021899|NCT01597245|2047926|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021900|NCT01597245|2047927|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021901|NCT01597245|2047928|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021902|NCT01597245|2047929|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021903|NCT01597245|2047930|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021904|NCT01597245|2047931|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021905|NCT01597245|2047932|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021906|NCT01597245|2047933|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021907|NCT01597245|2047934|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021908|NCT01597245|2047935|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021909|NCT01597245|2047936|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021910|NCT01597245|2047937|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021911|NCT01597245|2047938|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021912|NCT01597245|2047939|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2
1021913|NCT01597245|2047940|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021914|NCT01597245|2047941|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
1021915|NCT01597245|2047942|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29
1021916|NCT01597245|2047943|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3
1021917|NCT01597245|2047923|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021918|NCT01597245|2047924|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021919|NCT01597245|2047925|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021920|NCT01597245|2047926|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021921|NCT01597245|2047927|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021922|NCT01597245|2047928|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021923|NCT01597245|2047929|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021924|NCT01597245|2047930|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021925|NCT01597245|2047931|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021926|NCT01597245|2047932|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021927|NCT01597245|2047933|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021928|NCT01597245|2047934|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021929|NCT01597245|2047935|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021930|NCT01597245|2047936|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021931|NCT01597245|2047937|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021932|NCT01597245|2047938|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021933|NCT01597245|2047939|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021934|NCT01597245|2047940|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
1021935|NCT01597245|2047941|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1
1021936|NCT01597245|2047942|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14
1021937|NCT01597245|2047943|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4
1021938|NCT01597245|2047923|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021939|NCT01597245|2047924|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021940|NCT01597245|2047925|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021941|NCT01597245|2047926|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021942|NCT01597245|2047927|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021943|NCT01597245|2047928|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021944|NCT01597245|2047929|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021945|NCT01597245|2047930|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021946|NCT01597245|2047931|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021947|NCT01597245|2047932|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021948|NCT01597245|2047933|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1090860|NCT02249091|2158598|FG001|Overall Study|Death|4
1021949|NCT01597245|2047934|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021950|NCT01597245|2047935|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021951|NCT01597245|2047936|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021952|NCT01597245|2047937|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021953|NCT01597245|2047938|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021954|NCT01597245|2047939|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
1021955|NCT01597245|2047940|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021956|NCT01597245|2047941|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
1021957|NCT01597245|2047942|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9
1021958|NCT01597245|2047943|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
1021959|NCT01597245|2047923|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021960|NCT01597245|2047924|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021961|NCT01597245|2047925|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021962|NCT01597245|2047926|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021963|NCT01597245|2047927|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021964|NCT01597245|2047928|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021965|NCT01597245|2047929|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021966|NCT01597245|2047930|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021967|NCT01597245|2047931|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021968|NCT01597245|2047932|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021969|NCT01597245|2047933|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021970|NCT01597245|2047934|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021971|NCT01597245|2047935|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021972|NCT01597245|2047936|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021973|NCT01597245|2047937|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021974|NCT01597245|2047938|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021975|NCT01597245|2047939|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1
1021976|NCT01597245|2047940|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021977|NCT01597245|2047941|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
1021978|NCT01597245|2047942|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6
1021979|NCT01597245|2047943|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2
1021980|NCT01597245|2047923|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021981|NCT01597245|2047924|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021982|NCT01597245|2047925|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021983|NCT01597245|2047926|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021984|NCT01597245|2047927|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021985|NCT01597245|2047928|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021986|NCT01597245|2047929|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021987|NCT01597245|2047930|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021988|NCT01597245|2047931|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021989|NCT01597245|2047932|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021990|NCT01597245|2047933|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021991|NCT01597245|2047934|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021992|NCT01597245|2047935|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021993|NCT01597245|2047936|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021994|NCT01597245|2047937|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021995|NCT01597245|2047938|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021996|NCT01597245|2047939|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2
1021997|NCT01597245|2047940|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021998|NCT01597245|2047941|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1021999|NCT01597245|2047942|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3
1022000|NCT01597245|2047943|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
1022001|NCT01597245|2047923|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022002|NCT01597245|2047924|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022003|NCT01597245|2047925|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022004|NCT01597245|2047926|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022005|NCT01597245|2047927|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022006|NCT01597245|2047928|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022007|NCT01597245|2047929|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022008|NCT01597245|2047930|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022009|NCT01597245|2047931|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022010|NCT01597245|2047932|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022011|NCT01597245|2047933|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022012|NCT01597245|2047934|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022013|NCT01597245|2047935|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022014|NCT01597245|2047936|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022015|NCT01597245|2047937|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022016|NCT01597245|2047938|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022017|NCT01597245|2047939|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
1022018|NCT01597245|2047940|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022019|NCT01597245|2047941|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022020|NCT01597245|2047942|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
1022021|NCT01597245|2047943|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
1022022|NCT01597245|2047923|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022023|NCT01597245|2047924|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022024|NCT01597245|2047925|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022025|NCT01597245|2047926|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022026|NCT01597245|2047927|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022027|NCT01597245|2047928|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022028|NCT01597245|2047929|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022029|NCT01597245|2047930|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022030|NCT01597245|2047931|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022031|NCT01597245|2047932|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022032|NCT01597245|2047933|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022033|NCT01597245|2047934|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022034|NCT01597245|2047935|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022035|NCT01597245|2047936|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022036|NCT01597245|2047937|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022037|NCT01597245|2047938|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022038|NCT01597245|2047939|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022039|NCT01597245|2047940|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022040|NCT01597245|2047941|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022041|NCT01597245|2047942|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1
1022042|NCT01597245|2047943|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
1022043|NCT01597258|2047976|FG000|Overall Study|No Drug Administration|1
1022044|NCT01597375|2047980|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1
1022045|NCT01597375|2047981|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0
1022046|NCT01597375|2047980|FG000|First Intervention (4 Weeks)|Needed surgery|1
1022047|NCT01597375|2047981|FG001|First Intervention (4 Weeks)|Needed surgery|0
1022048|NCT01597375|2047980|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
1022049|NCT01597375|2047981|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
1022050|NCT01597375|2047980|FG000|Washout (2 Weeks)|Adverse Event|1
1022051|NCT01597375|2047981|FG001|Washout (2 Weeks)|Adverse Event|0
1022052|NCT01597375|2047980|FG000|Second Intervention|Failed to react at both Aspirin|1
1022053|NCT01597375|2047981|FG001|Second Intervention|Failed to react at both Aspirin|1
1022054|NCT01597479|2048055|FG000|Overall Study|Protocol Violation|1
1022055|NCT01597479|2048056|FG001|Overall Study|Protocol Violation|0
1022056|NCT01597479|2048055|FG000|Overall Study|Lost to Follow-up|1
1022057|NCT01597479|2048056|FG001|Overall Study|Lost to Follow-up|0
1022058|NCT01597492|2048065|FG000|Overall Study|Withdrawal by Subject|1
1022059|NCT01597492|2048066|FG001|Overall Study|Withdrawal by Subject|2
1022060|NCT01597492|2048065|FG000|Overall Study|Adverse Event|3
1022061|NCT01597492|2048066|FG001|Overall Study|Adverse Event|0
1022062|NCT01597492|2048065|FG000|Overall Study|Lost to Follow-up|0
1022063|NCT01597492|2048066|FG001|Overall Study|Lost to Follow-up|2
1022064|NCT01597492|2048065|FG000|Overall Study|Other Reason|2
1022065|NCT01597492|2048066|FG001|Overall Study|Other Reason|0
1022066|NCT01597505|2048074|FG000|Overall Study|Physician Decision|5
1022067|NCT01597505|2048075|FG001|Overall Study|Physician Decision|0
1022068|NCT01597505|2048074|FG000|Overall Study|Adverse Event|19
1022069|NCT01597505|2048075|FG001|Overall Study|Adverse Event|7
1022070|NCT01597505|2048074|FG000|Overall Study|Lost to Follow-up|4
1022071|NCT01597505|2048075|FG001|Overall Study|Lost to Follow-up|2
1022072|NCT01597505|2048074|FG000|Overall Study|Withdrawal by Subject|10
1022073|NCT01597505|2048075|FG001|Overall Study|Withdrawal by Subject|18
1022074|NCT01597505|2048074|FG000|Overall Study|Other|5
1022075|NCT01597505|2048075|FG001|Overall Study|Other|6
1022076|NCT01597505|2048074|FG000|Overall Study|Missing|1
1022077|NCT01597505|2048075|FG001|Overall Study|Missing|0
1022078|NCT01597557|2048084|FG000|Overall Study|Did not undergo cardioversion procedure|4
1022079|NCT01597557|2048085|FG001|Overall Study|Did not undergo cardioversion procedure|3
1022080|NCT01597596|2048093|FG000|Overall Study|Study terminated by sponsor|1
1022081|NCT01597596|2048094|FG001|Overall Study|Study terminated by sponsor|0
1022082|NCT01597596|2048093|FG000|Overall Study|Physician Decision|0
1022083|NCT01597596|2048094|FG001|Overall Study|Physician Decision|1
1022084|NCT01597622|2048100|FG000|Overall Study|Adverse Event|7
1022085|NCT01597622|2048100|FG000|Overall Study|Lack of Efficacy|3
1022086|NCT01597622|2048100|FG000|Overall Study|Protocol Violation|1
1022087|NCT01597622|2048100|FG000|Overall Study|Lost to Follow-up|1
1022088|NCT01597622|2048100|FG000|Overall Study|Investigator Discretion|5
1022089|NCT01597622|2048100|FG000|Overall Study|Withdrawal by Subject|20
1022090|NCT01597622|2048100|FG000|Overall Study|Death|1
1022091|NCT01597635|2048107|FG000|Part A|Adverse Event|3
1022092|NCT01597635|2048108|FG001|Part A|Adverse Event|0
1022093|NCT01597635|2048109|FG002|Part A|Adverse Event|0
1022094|NCT01597635|2048107|FG000|Part B|Adverse Event|0
1022095|NCT01597635|2048108|FG001|Part B|Adverse Event|0
1022096|NCT01597635|2048109|FG002|Part B|Adverse Event|1
1022097|NCT01597635|2048107|FG000|Part B|Protocol Violation|0
1022098|NCT01597635|2048108|FG001|Part B|Protocol Violation|1
1022099|NCT01597635|2048109|FG002|Part B|Protocol Violation|0
1022100|NCT01597635|2048107|FG000|Part B|Protocol-defined stopping criteria|0
1022101|NCT01597635|2048108|FG001|Part B|Protocol-defined stopping criteria|4
1022102|NCT01597635|2048109|FG002|Part B|Protocol-defined stopping criteria|3
1022103|NCT01597635|2048107|FG000|Part B|Withdrawal by Subject|0
1022104|NCT01597635|2048108|FG001|Part B|Withdrawal by Subject|1
1022105|NCT01597635|2048109|FG002|Part B|Withdrawal by Subject|0
1022106|NCT01597791|2048149|FG000|Overall Study|Physician Decision|2
1022107|NCT01597791|2048150|FG001|Overall Study|Physician Decision|1
1022108|NCT01597791|2048149|FG000|Overall Study|Cesarean Section|6
1022109|NCT01597791|2048150|FG001|Overall Study|Cesarean Section|7
1022110|NCT01597791|2048149|FG000|Overall Study|Subject withdrawal|0
1022111|NCT01597791|2048150|FG001|Overall Study|Subject withdrawal|1
1022112|NCT01597791|2048149|FG000|Overall Study|Protocol Violation|0
1022113|NCT01597791|2048150|FG001|Overall Study|Protocol Violation|1
1022114|NCT01597908|2048185|FG000|Randomized Phase|Death|217
1022115|NCT01597908|2048186|FG001|Randomized Phase|Death|238
1022116|NCT01597908|2048187|FG002|Randomized Phase|Death|0
1022117|NCT01597908|2048185|FG000|Randomized Phase|Sponsor Decision|93
1022118|NCT01597908|2048186|FG001|Randomized Phase|Sponsor Decision|39
1022119|NCT01597908|2048187|FG002|Randomized Phase|Sponsor Decision|0
1022120|NCT01597908|2048185|FG000|Randomized Phase|Lost to Follow-up|9
1022121|NCT01597908|2048186|FG001|Randomized Phase|Lost to Follow-up|16
1022122|NCT01597908|2048187|FG002|Randomized Phase|Lost to Follow-up|0
1022123|NCT01597908|2048185|FG000|Randomized Phase|Physician Decision|6
1022124|NCT01597908|2048186|FG001|Randomized Phase|Physician Decision|3
1022125|NCT01597908|2048187|FG002|Randomized Phase|Physician Decision|0
1022126|NCT01597908|2048185|FG000|Randomized Phase|Withdrawal by Subject|26
1022127|NCT01597908|2048186|FG001|Randomized Phase|Withdrawal by Subject|22
1022128|NCT01597908|2048187|FG002|Randomized Phase|Withdrawal by Subject|0
1022129|NCT01597908|2048185|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
1022130|NCT01597908|2048186|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34
1022131|NCT01597908|2048187|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
1022132|NCT01597908|2048185|FG000|Crossover Phase|Death|0
1022133|NCT01597908|2048186|FG001|Crossover Phase|Death|0
1022134|NCT01597908|2048187|FG002|Crossover Phase|Death|11
1022135|NCT01597908|2048185|FG000|Crossover Phase|Withdrawal by Subject|0
1022136|NCT01597908|2048186|FG001|Crossover Phase|Withdrawal by Subject|0
1022137|NCT01597908|2048187|FG002|Crossover Phase|Withdrawal by Subject|3
1022138|NCT01597908|2048185|FG000|Crossover Phase|Sponsor Decision|0
1022139|NCT01597908|2048186|FG001|Crossover Phase|Sponsor Decision|0
1022140|NCT01597908|2048187|FG002|Crossover Phase|Sponsor Decision|20
1022141|NCT01597973|2048198|FG000|Overall Study|Found ineligible before study medication started|4
1022142|NCT01597973|2048199|FG001|Overall Study|Found ineligible before study medication started|2
1022143|NCT01597973|2048198|FG000|Overall Study|Eligible pathogen not confirmed|14
1022144|NCT01597973|2048199|FG001|Overall Study|Eligible pathogen not confirmed|15
1022145|NCT01597973|2048198|FG000|Overall Study|LAR not authorized to consent|0
1022146|NCT01597973|2048199|FG001|Overall Study|LAR not authorized to consent|1
1022147|NCT01597973|2048198|FG000|Overall Study|Ineligible due to early seizures|1
1022148|NCT01597973|2048199|FG001|Overall Study|Ineligible due to early seizures|0
1022149|NCT01597973|2048198|FG000|Overall Study|Ineligible due to non-target infection|1
1022150|NCT01597973|2048199|FG001|Overall Study|Ineligible due to non-target infection|1
1022151|NCT01598090|2048221|FG000|Treatment Period|Poor/non-compliance|0
1022152|NCT01598090|2048222|FG001|Treatment Period|Poor/non-compliance|2
1022153|NCT01598090|2048223|FG002|Treatment Period|Poor/non-compliance|0
1022154|NCT01598090|2048221|FG000|Treatment Period|No longer meet study criteria|0
1022155|NCT01598090|2048222|FG001|Treatment Period|No longer meet study criteria|1
1022156|NCT01598090|2048223|FG002|Treatment Period|No longer meet study criteria|0
1022157|NCT01598090|2048221|FG000|Treatment Period|Lack of Efficacy|5
1022158|NCT01598090|2048222|FG001|Treatment Period|Lack of Efficacy|14
1022159|NCT01598090|2048223|FG002|Treatment Period|Lack of Efficacy|6
1022160|NCT01598090|2048221|FG000|Treatment Period|Adverse Event|2
1022161|NCT01598090|2048222|FG001|Treatment Period|Adverse Event|33
1022162|NCT01598090|2048223|FG002|Treatment Period|Adverse Event|17
1022163|NCT01598090|2048221|FG000|Treatment Period|Other reasons|0
1022164|NCT01598090|2048222|FG001|Treatment Period|Other reasons|4
1022165|NCT01598090|2048223|FG002|Treatment Period|Other reasons|1
1022166|NCT01598090|2048221|FG000|Treatment Period|Withdrawal by Subject|3
1022167|NCT01598090|2048222|FG001|Treatment Period|Withdrawal by Subject|13
1022168|NCT01598090|2048223|FG002|Treatment Period|Withdrawal by Subject|10
1022169|NCT01598090|2048221|FG000|Treatment Period|Lost to Follow-up|1
1022170|NCT01598090|2048222|FG001|Treatment Period|Lost to Follow-up|5
1022171|NCT01598090|2048223|FG002|Treatment Period|Lost to Follow-up|1
1022172|NCT01598090|2048221|FG000|Follow-up Period|Death|0
1022173|NCT01598090|2048222|FG001|Follow-up Period|Death|1
1022174|NCT01598090|2048223|FG002|Follow-up Period|Death|0
1022175|NCT01598090|2048221|FG000|Follow-up Period|No longer required per protocol|1
1090861|NCT02249091|2158597|FG000|Overall Study|Adverse Event|1
1022176|NCT01598090|2048222|FG001|Follow-up Period|No longer required per protocol|3
1022177|NCT01598090|2048223|FG002|Follow-up Period|No longer required per protocol|2
1022178|NCT01598090|2048221|FG000|Follow-up Period|Not reported|0
1022179|NCT01598090|2048222|FG001|Follow-up Period|Not reported|10
1022180|NCT01598090|2048223|FG002|Follow-up Period|Not reported|4
1022181|NCT01598090|2048221|FG000|Follow-up Period|Withdrawal by Subject|0
1022182|NCT01598090|2048222|FG001|Follow-up Period|Withdrawal by Subject|3
1022183|NCT01598090|2048223|FG002|Follow-up Period|Withdrawal by Subject|2
1022184|NCT01598090|2048221|FG000|Follow-up Period|Other reasons|2
1022185|NCT01598090|2048222|FG001|Follow-up Period|Other reasons|8
1022186|NCT01598090|2048223|FG002|Follow-up Period|Other reasons|8
1022187|NCT01598090|2048221|FG000|Follow-up Period|Lost to Follow-up|2
1022188|NCT01598090|2048222|FG001|Follow-up Period|Lost to Follow-up|10
1022189|NCT01598090|2048223|FG002|Follow-up Period|Lost to Follow-up|12
1022190|NCT01598129|2048234|FG000|Overall Study|Disease progression|6
1022191|NCT01598129|2048234|FG000|Overall Study|Deterioration of WHO status to WHO 4|2
1022192|NCT01598129|2048234|FG000|Overall Study|Withdrawal by Subject|1
1022193|NCT01598298|2048263|FG000|Overall Study|Not eligible|5
1022194|NCT01598298|2048264|FG001|Overall Study|Not eligible|5
1022195|NCT01598298|2048263|FG000|Overall Study|Adverse Event|21
1022196|NCT01598298|2048264|FG001|Overall Study|Adverse Event|19
1022197|NCT01598298|2048263|FG000|Overall Study|Progression/relapse|0
1022198|NCT01598298|2048264|FG001|Overall Study|Progression/relapse|2
1022199|NCT01598298|2048263|FG000|Overall Study|Withdrawal by Subject|10
1022200|NCT01598298|2048264|FG001|Overall Study|Withdrawal by Subject|15
1022201|NCT01598298|2048263|FG000|Overall Study|Other reason (not protocol specified)|4
1022202|NCT01598298|2048264|FG001|Overall Study|Other reason (not protocol specified)|0
1022203|NCT01598311|2048272|FG000|Overall Study|Physician Decision|4
1022204|NCT01598311|2048273|FG001|Overall Study|Physician Decision|5
1022205|NCT01598311|2048272|FG000|Overall Study|Adverse Event|9
1022206|NCT01598311|2048273|FG001|Overall Study|Adverse Event|13
1022207|NCT01598311|2048272|FG000|Overall Study|Lost to Follow-up|7
1022208|NCT01598311|2048273|FG001|Overall Study|Lost to Follow-up|12
1022209|NCT01598311|2048272|FG000|Overall Study|Withdrawal by Subject|9
1022210|NCT01598311|2048273|FG001|Overall Study|Withdrawal by Subject|13
1022211|NCT01598311|2048272|FG000|Overall Study|No reason provided.|0
1022212|NCT01598311|2048273|FG001|Overall Study|No reason provided.|5
1022213|NCT01598311|2048272|FG000|Overall Study|Randomized but never treated|8
1022214|NCT01598311|2048273|FG001|Overall Study|Randomized but never treated|5
1022215|NCT01598311|2048272|FG000|Overall Study|Treated but no confirmed CDAD|9
1022216|NCT01598311|2048273|FG001|Overall Study|Treated but no confirmed CDAD|8
1022217|NCT01598311|2048272|FG000|Overall Study|Assigned to CB but received vancomycin|1
1022218|NCT01598311|2048273|FG001|Overall Study|Assigned to CB but received vancomycin|0
1022219|NCT01598506|2048288|FG000|Overall Study|Withdrawal by Subject|2
1022220|NCT01598532|2048293|FG000|Overall Study|Lost to Follow-up|3
1022221|NCT01598532|2048293|FG000|Overall Study|Did not meet inclusion criteria|8
1022222|NCT01598610|2048304|FG000|Overall Study|Adverse Event|1
1022223|NCT01598662|2048310|FG000|Overall Study|Lost to Follow-up|10
1022224|NCT01598662|2048311|FG001|Overall Study|Lost to Follow-up|17
1022225|NCT01598662|2048310|FG000|Overall Study|Physician Decision|1
1022226|NCT01598662|2048311|FG001|Overall Study|Physician Decision|2
1022227|NCT01598662|2048310|FG000|Overall Study|IUD expelled before month 6|0
1022228|NCT01598662|2048311|FG001|Overall Study|IUD expelled before month 6|2
1022229|NCT01598753|2048340|FG000|Overall Study|Adverse Event|1
1022230|NCT01598753|2048341|FG001|Overall Study|Adverse Event|9
1022231|NCT01598753|2048342|FG002|Overall Study|Adverse Event|1
1022232|NCT01598753|2048343|FG003|Overall Study|Adverse Event|7
1022233|NCT01598753|2048340|FG000|Overall Study|Lost to Follow-up|4
1022234|NCT01598753|2048341|FG001|Overall Study|Lost to Follow-up|3
1022235|NCT01598753|2048342|FG002|Overall Study|Lost to Follow-up|7
1022236|NCT01598753|2048343|FG003|Overall Study|Lost to Follow-up|5
1022237|NCT01598753|2048340|FG000|Overall Study|Physician Decision|0
1022238|NCT01598753|2048341|FG001|Overall Study|Physician Decision|1
1022239|NCT01598753|2048342|FG002|Overall Study|Physician Decision|0
1022240|NCT01598753|2048343|FG003|Overall Study|Physician Decision|2
1022241|NCT01598753|2048340|FG000|Overall Study|Withdrawal by Subject|7
1022242|NCT01598753|2048341|FG001|Overall Study|Withdrawal by Subject|2
1022243|NCT01598753|2048342|FG002|Overall Study|Withdrawal by Subject|0
1022244|NCT01598753|2048343|FG003|Overall Study|Withdrawal by Subject|1
1022245|NCT01598896|2048368|FG000|Overall Study|Withdrawal by Subject|0
1022246|NCT01598896|2048369|FG001|Overall Study|Withdrawal by Subject|1
1022247|NCT01598896|2048368|FG000|Overall Study|Lack of Efficacy|0
1022248|NCT01598896|2048369|FG001|Overall Study|Lack of Efficacy|1
1022249|NCT01598987|2048384|FG000|Baseline to Month 12|Administrative problems|2
1022250|NCT01598987|2048384|FG000|Baseline to Month 12|Withdrawal by Subject|4
1022251|NCT01598987|2048384|FG000|Baseline to 24 Month|Withdrawal by Subject|5
1022252|NCT01598987|2048384|FG000|Baseline to 24 Month|Administrative problems|2
1022253|NCT01598987|2048384|FG000|Baseline to 24 Month|Lost to Follow-up|1
1022254|NCT01599104|2048398|FG000|Overall Study|Withdrawal by Subject|1
1022255|NCT01599104|2048399|FG001|Overall Study|Withdrawal by Subject|1
1022256|NCT01599104|2048400|FG002|Overall Study|Withdrawal by Subject|2
1022257|NCT01599104|2048398|FG000|Overall Study|Technical Problems|1
1022258|NCT01599104|2048399|FG001|Overall Study|Technical Problems|0
1022259|NCT01599104|2048400|FG002|Overall Study|Technical Problems|0
1022260|NCT01599104|2048398|FG000|Overall Study|Physician Decision|3
1022261|NCT01599104|2048399|FG001|Overall Study|Physician Decision|2
1022262|NCT01599104|2048400|FG002|Overall Study|Physician Decision|2
1022263|NCT01599104|2048398|FG000|Overall Study|Non-compliance with study treatment|0
1022264|NCT01599104|2048399|FG001|Overall Study|Non-compliance with study treatment|1
1022265|NCT01599104|2048400|FG002|Overall Study|Non-compliance with study treatment|0
1022266|NCT01599104|2048398|FG000|Overall Study|Lack of Efficacy|4
1022267|NCT01599104|2048399|FG001|Overall Study|Lack of Efficacy|4
1022268|NCT01599104|2048400|FG002|Overall Study|Lack of Efficacy|10
1022269|NCT01599104|2048398|FG000|Overall Study|Adverse Event|7
1022270|NCT01599104|2048399|FG001|Overall Study|Adverse Event|6
1022271|NCT01599104|2048400|FG002|Overall Study|Adverse Event|12
1022272|NCT01599234|2048410|FG000|Overall Study|Adverse Event|9
1022273|NCT01599234|2048411|FG001|Overall Study|Adverse Event|5
1022274|NCT01599234|2048410|FG000|Overall Study|Withdrawal by Subject|2
1022275|NCT01599234|2048411|FG001|Overall Study|Withdrawal by Subject|1
1022276|NCT01599234|2048410|FG000|Overall Study|Lost to Follow-up|1
1022277|NCT01599234|2048411|FG001|Overall Study|Lost to Follow-up|2
1022278|NCT01599234|2048410|FG000|Overall Study|Lack of Efficacy|2
1022279|NCT01599234|2048411|FG001|Overall Study|Lack of Efficacy|4
1022280|NCT01599234|2048410|FG000|Overall Study|Unable to operate spray|1
1022281|NCT01599234|2048411|FG001|Overall Study|Unable to operate spray|0
1022282|NCT01599234|2048410|FG000|Overall Study|Sponsor request as creatinine levels <50|0
1022283|NCT01599234|2048411|FG001|Overall Study|Sponsor request as creatinine levels <50|1
1022284|NCT01599234|2048410|FG000|Overall Study|Death|1
1022285|NCT01599234|2048411|FG001|Overall Study|Death|0
1022286|NCT01599234|2048410|FG000|Overall Study|Patient would not stop driving|1
1022287|NCT01599234|2048411|FG001|Overall Study|Patient would not stop driving|0
1022288|NCT01599234|2048410|FG000|Overall Study|Contra-indication discovered|0
1022289|NCT01599234|2048411|FG001|Overall Study|Contra-indication discovered|1
1022290|NCT01599234|2048410|FG000|Overall Study|Pregnancy|0
1022291|NCT01599234|2048411|FG001|Overall Study|Pregnancy|1
1022292|NCT01599325|2048426|FG000|Primary Parent Phase|Adverse Event|5
1022293|NCT01599325|2048426|FG000|Primary Parent Phase|Disease Progression|7
1022294|NCT01599325|2048426|FG000|Primary Parent Phase|Withdrawal by Subject|20
1022295|NCT01599325|2048426|FG000|Primary Parent Phase|Death|13
1022296|NCT01599325|2048426|FG000|Primary Parent Phase|Protocol Violation|1
1022297|NCT01599325|2048426|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9
1022298|NCT01599325|2048426|FG000|Primary Parent Phase|Other|2
1022299|NCT01599325|2048426|FG000|Extension Phase|Study Closure|1
1022300|NCT01599325|2048426|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1
1022301|NCT01599325|2048426|FG000|Extension Phase|Lack of Therapeutic Effect|4
1022302|NCT01599325|2048426|FG000|Extension Phase|Disease Progression|1
1022303|NCT01599325|2048426|FG000|Extension Phase|Withdrawal by Subject|8
1022304|NCT01599585|2048433|FG000|Overall Study|Withdrawal by Subject|16
1022305|NCT01599585|2048434|FG001|Overall Study|Withdrawal by Subject|9
1022306|NCT01599585|2048433|FG000|Overall Study|Lost to Follow-up|3
1022307|NCT01599585|2048434|FG001|Overall Study|Lost to Follow-up|5
1022308|NCT01599585|2048433|FG000|Overall Study|randomized did not start treatment|3
1022309|NCT01599585|2048434|FG001|Overall Study|randomized did not start treatment|3
1022310|NCT01599637|2048443|FG000|Overall Study|administrative problems|0
1022311|NCT01599637|2048444|FG001|Overall Study|administrative problems|2
1022312|NCT01599637|2048445|FG002|Overall Study|administrative problems|0
1022313|NCT01599637|2048443|FG000|Overall Study|Adverse Event|1
1022314|NCT01599637|2048444|FG001|Overall Study|Adverse Event|0
1022315|NCT01599637|2048445|FG002|Overall Study|Adverse Event|0
1022316|NCT01599650|2048458|FG000|Overall Study|Administrative issue|1
1022317|NCT01599650|2048459|FG001|Overall Study|Administrative issue|0
1022318|NCT01599650|2048460|FG002|Overall Study|Administrative issue|1
1022319|NCT01599650|2048458|FG000|Overall Study|Physician Decision|2
1022320|NCT01599650|2048459|FG001|Overall Study|Physician Decision|0
1022321|NCT01599650|2048460|FG002|Overall Study|Physician Decision|7
1022322|NCT01599650|2048458|FG000|Overall Study|Protocol Violation|0
1022323|NCT01599650|2048459|FG001|Overall Study|Protocol Violation|3
1022324|NCT01599650|2048460|FG002|Overall Study|Protocol Violation|0
1022325|NCT01599650|2048458|FG000|Overall Study|Death|2
1022326|NCT01599650|2048459|FG001|Overall Study|Death|1
1022327|NCT01599650|2048460|FG002|Overall Study|Death|2
1022328|NCT01599650|2048458|FG000|Overall Study|Lost to Follow-up|3
1022329|NCT01599650|2048459|FG001|Overall Study|Lost to Follow-up|3
1022330|NCT01599650|2048460|FG002|Overall Study|Lost to Follow-up|3
1022331|NCT01599650|2048458|FG000|Overall Study|Withdrawal by Subject|11
1022332|NCT01599650|2048459|FG001|Overall Study|Withdrawal by Subject|11
1022333|NCT01599650|2048460|FG002|Overall Study|Withdrawal by Subject|10
1022334|NCT01599650|2048458|FG000|Overall Study|Adverse Event|3
1022335|NCT01599650|2048459|FG001|Overall Study|Adverse Event|8
1022336|NCT01599650|2048460|FG002|Overall Study|Adverse Event|4
1022337|NCT01599754|2048476|FG000|Overall Study|Anticancer therapy need not in protocol|5
1022338|NCT01599754|2048477|FG001|Overall Study|Anticancer therapy need not in protocol|2
1022339|NCT01599754|2048476|FG000|Overall Study|Participant noncompliance|4
1022340|NCT01599754|2048477|FG001|Overall Study|Participant noncompliance|4
1022341|NCT01599754|2048476|FG000|Overall Study|Lost to Follow-up|13
1022342|NCT01599754|2048477|FG001|Overall Study|Lost to Follow-up|6
1022343|NCT01599754|2048476|FG000|Overall Study|Death|31
1022344|NCT01599754|2048477|FG001|Overall Study|Death|33
1022345|NCT01599754|2048476|FG000|Overall Study|Adverse Event|3
1022346|NCT01599754|2048477|FG001|Overall Study|Adverse Event|2
1022347|NCT01599754|2048476|FG000|Overall Study|Investigator decision|1
1022348|NCT01599754|2048477|FG001|Overall Study|Investigator decision|3
1022349|NCT01599754|2048476|FG000|Overall Study|Withdrawal by Subject|24
1022350|NCT01599754|2048477|FG001|Overall Study|Withdrawal by Subject|25
1022351|NCT01599754|2048476|FG000|Overall Study|Study terminated by sponsor|282
1022352|NCT01599754|2048477|FG001|Overall Study|Study terminated by sponsor|285
1022353|NCT01599793|2048483|FG000|Overall Study|Adverse Event|2
1022354|NCT01599806|2048489|FG000|Overall Study|Lost to Follow-up|20
1022355|NCT01599806|2048490|FG001|Overall Study|Lost to Follow-up|20
1022356|NCT01599806|2048489|FG000|Overall Study|Withdrawal by Subject|12
1022357|NCT01599806|2048490|FG001|Overall Study|Withdrawal by Subject|12
1022358|NCT01599806|2048489|FG000|Overall Study|Other Eligibility criteria|11
1022359|NCT01599806|2048490|FG001|Overall Study|Other Eligibility criteria|9
1022360|NCT01600014|2048500|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
1022361|NCT01600014|2048501|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
1022362|NCT01600014|2048500|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
1022363|NCT01600014|2048501|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
1022364|NCT01600014|2048500|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6
1022365|NCT01600014|2048501|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0
1022366|NCT01600014|2048500|FG000|1. Cycle & Observation Period D1 to W52|Other|27
1022367|NCT01600014|2048501|FG001|1. Cycle & Observation Period D1 to W52|Other|0
1022368|NCT01600014|2048500|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
1022369|NCT01600014|2048501|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
1022370|NCT01600014|2048500|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
1022371|NCT01600014|2048501|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
1022372|NCT01600014|2048500|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
1022373|NCT01600014|2048501|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
1022374|NCT01600014|2048500|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
1022375|NCT01600014|2048501|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
1022376|NCT01600014|2048500|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
1022377|NCT01600014|2048501|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
1022378|NCT01600014|2048500|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
1022379|NCT01600014|2048501|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
1022380|NCT01600014|2048500|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
1022381|NCT01600014|2048501|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
1022382|NCT01600014|2048500|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
1022383|NCT01600014|2048501|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
1022384|NCT01600014|2048500|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
1022385|NCT01600014|2048501|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
1022386|NCT01600014|2048500|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
1022387|NCT01600014|2048501|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
1022388|NCT01600014|2048500|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
1022389|NCT01600014|2048501|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
1022390|NCT01600014|2048500|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
904945|NCT00759655|1880043|FG000|Overall Study|Termination of the study by sponsor|1
904946|NCT00759681|1880058|FG000|Overall Study|Death|2
904947|NCT00759681|1880059|FG001|Overall Study|Death|5
904948|NCT00759681|1880058|FG000|Overall Study|Lost to Follow-up|8
904949|NCT00759681|1880059|FG001|Overall Study|Lost to Follow-up|5
904950|NCT00759759|1880072|FG000|Overall Study|didn't return for period 2|1
904951|NCT00759759|1880073|FG001|Overall Study|didn't return for period 2|0
904952|NCT00759759|1880072|FG000|Overall Study|Didn't receive drug in period 2|1
904953|NCT00759759|1880073|FG001|Overall Study|Didn't receive drug in period 2|0
904954|NCT00759759|1880072|FG000|Overall Study|Withdrawal by Subject|2
904955|NCT00759759|1880073|FG001|Overall Study|Withdrawal by Subject|1
904956|NCT00759785|1880090|FG000|Overall Study|Participant sample not evaluable|11
904957|NCT00759785|1880091|FG001|Overall Study|Participant sample not evaluable|2
904958|NCT00759785|1880090|FG000|Overall Study|Participant sample lost|0
904959|NCT00759785|1880091|FG001|Overall Study|Participant sample lost|1
904960|NCT00759785|1880090|FG000|Overall Study|Protocol Violation|1
904961|NCT00759785|1880091|FG001|Overall Study|Protocol Violation|0
904962|NCT00759785|1880090|FG000|Overall Study|Physician Decision|0
904963|NCT00759785|1880091|FG001|Overall Study|Physician Decision|1
904964|NCT00759785|1880090|FG000|Overall Study|Withdrawal by Subject|0
904965|NCT00759785|1880091|FG001|Overall Study|Withdrawal by Subject|1
904966|NCT00759863|1880112|FG000|Overall Study|Death, moved, or lost contact|20
904967|NCT00759863|1880113|FG001|Overall Study|Death, moved, or lost contact|18
904968|NCT00759876|1880119|FG000|Overall Study|Sponsor terminated study early|36
904969|NCT00759902|1880125|FG000|Overall Study|Adverse Event|0
904970|NCT00759902|1880126|FG001|Overall Study|Adverse Event|1
1022391|NCT01600014|2048501|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
1022392|NCT01600014|2048500|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
1022393|NCT01600014|2048501|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
1022394|NCT01600053|2048519|FG000|Overall Study|Adverse Event|2
1022395|NCT01600053|2048519|FG000|Overall Study|trial will not meet the interim endpoint|9
1022396|NCT01600092|2048525|FG000|Overall Study|Adverse Event|2
1022397|NCT01600092|2048526|FG001|Overall Study|Adverse Event|0
1022398|NCT01600092|2048525|FG000|Overall Study|Lost to Follow-up|4
1022399|NCT01600092|2048526|FG001|Overall Study|Lost to Follow-up|6
1022400|NCT01600092|2048525|FG000|Overall Study|Withdrawal by parent/guardian|8
1022401|NCT01600092|2048526|FG001|Overall Study|Withdrawal by parent/guardian|6
1022402|NCT01600092|2048525|FG000|Overall Study|Physician Decision|1
1022403|NCT01600092|2048526|FG001|Overall Study|Physician Decision|1
1022404|NCT01600092|2048525|FG000|Overall Study|Randomized but not vaccinated|3
1022405|NCT01600092|2048526|FG001|Overall Study|Randomized but not vaccinated|3
1022406|NCT01600105|2048534|FG000|Total Participants|Withdrawal by Subject|1
1022407|NCT01600105|2048535|FG001|Total Participants|Withdrawal by Subject|0
1022408|NCT01600105|2048534|FG000|Total Participants|No images in PACS|10
1022409|NCT01600105|2048535|FG001|Total Participants|No images in PACS|0
1022410|NCT01600105|2048534|FG000|Total Participants|Insufficient image quality|30
1022411|NCT01600105|2048535|FG001|Total Participants|Insufficient image quality|10
1022412|NCT01600105|2048534|FG000|Sub Study I|Insufficient image quality|0
1022413|NCT01600105|2048535|FG001|Sub Study I|Insufficient image quality|10
1022414|NCT01600105|2048534|FG000|Sub Study II|Withdrawal by Subject|1
1022415|NCT01600105|2048535|FG001|Sub Study II|Withdrawal by Subject|0
1022416|NCT01600105|2048534|FG000|Sub Study II|No images in PACS|1
1022417|NCT01600105|2048535|FG001|Sub Study II|No images in PACS|0
1022418|NCT01600105|2048534|FG000|Sub Study II|Insufficient image quality|3
1022419|NCT01600105|2048535|FG001|Sub Study II|Insufficient image quality|0
1022420|NCT01600105|2048534|FG000|Sub Study III|Insufficient image quality|5
1022421|NCT01600105|2048535|FG001|Sub Study III|Insufficient image quality|0
1022422|NCT01600105|2048534|FG000|Sub Study V|Poor Image Quality|2
1022423|NCT01600105|2048535|FG001|Sub Study V|Poor Image Quality|0
1022424|NCT01600326|2048572|FG000|Overall Study|Lost to Follow-up|1
1022425|NCT01600326|2048573|FG001|Overall Study|Lost to Follow-up|1
1022426|NCT01600586|2048600|FG000|Overall Study|Physician Decision|3
1022427|NCT01600586|2048601|FG001|Overall Study|Physician Decision|3
1022428|NCT01600716|2048636|FG000|Overall Study|Other Reasons|3
1022429|NCT01600716|2048637|FG001|Overall Study|Other Reasons|1
1022430|NCT01600716|2048636|FG000|Overall Study|Personal Reasons|0
1022431|NCT01600716|2048637|FG001|Overall Study|Personal Reasons|2
1022432|NCT01600716|2048636|FG000|Overall Study|Lost to Follow-up|0
1022433|NCT01600716|2048637|FG001|Overall Study|Lost to Follow-up|2
1022434|NCT01600716|2048636|FG000|Overall Study|Pregnancy|1
1022435|NCT01600716|2048637|FG001|Overall Study|Pregnancy|0
1022436|NCT01600716|2048636|FG000|Overall Study|Lack of Efficacy|2
1022437|NCT01600716|2048637|FG001|Overall Study|Lack of Efficacy|1
1022438|NCT01600716|2048636|FG000|Overall Study|Adverse Event|1
1022439|NCT01600716|2048637|FG001|Overall Study|Adverse Event|1
1022440|NCT01600885|2048649|FG000|First Period|Adverse Event|1
1022441|NCT01600885|2048650|FG001|First Period|Adverse Event|1
1022442|NCT01600885|2048649|FG000|First Period|moved out of area|1
1022443|NCT01600885|2048650|FG001|First Period|moved out of area|0
1022444|NCT01601132|2048672|FG000|Overall Study|Patient withdrew consent|1
1022445|NCT01601132|2048672|FG000|Overall Study|Protocol deviation|1
1022446|NCT01601470|2048708|FG000|Period 2 - LCZ696|Physician Decision|1
1022447|NCT01601496|2048714|FG000|Overall Study|Physician Decision|1
1022448|NCT01601496|2048714|FG000|Overall Study|Withdrawal by Subject|1
1022449|NCT01601496|2048714|FG000|Overall Study|Lost to Follow-up|6
1022450|NCT01601496|2048714|FG000|Overall Study|Death|4
1022451|NCT01601496|2048714|FG000|Overall Study|Other: patient refusal to continue|3
1022452|NCT01601535|2048724|FG000|Phase 1|Adverse Event|1
1022453|NCT01601535|2048725|FG001|Phase 1|Adverse Event|0
1022454|NCT01601535|2048726|FG002|Phase 1|Adverse Event|2
1022455|NCT01601535|2048727|FG003|Phase 1|Adverse Event|1
1022456|NCT01601535|2048728|FG004|Phase 1|Adverse Event|0
1022457|NCT01601535|2048729|FG005|Phase 1|Adverse Event|0
1022458|NCT01601535|2048724|FG000|Phase 1|Withdrawal by Subject|2
1022459|NCT01601535|2048725|FG001|Phase 1|Withdrawal by Subject|1
1022460|NCT01601535|2048726|FG002|Phase 1|Withdrawal by Subject|1
1022461|NCT01601535|2048727|FG003|Phase 1|Withdrawal by Subject|2
1022462|NCT01601535|2048728|FG004|Phase 1|Withdrawal by Subject|0
1022463|NCT01601535|2048729|FG005|Phase 1|Withdrawal by Subject|0
1022464|NCT01601535|2048724|FG000|Phase 1|Progressive Disease|2
1022465|NCT01601535|2048725|FG001|Phase 1|Progressive Disease|3
1022466|NCT01601535|2048726|FG002|Phase 1|Progressive Disease|2
1022467|NCT01601535|2048727|FG003|Phase 1|Progressive Disease|1
1022468|NCT01601535|2048728|FG004|Phase 1|Progressive Disease|0
1022469|NCT01601535|2048729|FG005|Phase 1|Progressive Disease|0
1022470|NCT01601535|2048724|FG000|Phase 1|Started Another Treatment|1
1022471|NCT01601535|2048725|FG001|Phase 1|Started Another Treatment|2
1022472|NCT01601535|2048726|FG002|Phase 1|Started Another Treatment|0
1022473|NCT01601535|2048727|FG003|Phase 1|Started Another Treatment|0
1022474|NCT01601535|2048728|FG004|Phase 1|Started Another Treatment|0
1022475|NCT01601535|2048729|FG005|Phase 1|Started Another Treatment|0
1022476|NCT01601535|2048724|FG000|Phase 2|Adverse Event|0
1022477|NCT01601535|2048725|FG001|Phase 2|Adverse Event|0
1022478|NCT01601535|2048726|FG002|Phase 2|Adverse Event|0
1022479|NCT01601535|2048727|FG003|Phase 2|Adverse Event|0
1022480|NCT01601535|2048728|FG004|Phase 2|Adverse Event|5
1022481|NCT01601535|2048729|FG005|Phase 2|Adverse Event|1
1022482|NCT01601535|2048724|FG000|Phase 2|Withdrawal by Subject|0
1022483|NCT01601535|2048725|FG001|Phase 2|Withdrawal by Subject|0
1022484|NCT01601535|2048726|FG002|Phase 2|Withdrawal by Subject|0
1022485|NCT01601535|2048727|FG003|Phase 2|Withdrawal by Subject|0
1022486|NCT01601535|2048728|FG004|Phase 2|Withdrawal by Subject|8
1022487|NCT01601535|2048729|FG005|Phase 2|Withdrawal by Subject|2
1022488|NCT01601535|2048724|FG000|Phase 2|Progressive Disease|0
1022489|NCT01601535|2048725|FG001|Phase 2|Progressive Disease|0
1022490|NCT01601535|2048726|FG002|Phase 2|Progressive Disease|0
1022491|NCT01601535|2048727|FG003|Phase 2|Progressive Disease|0
1022492|NCT01601535|2048728|FG004|Phase 2|Progressive Disease|5
1022493|NCT01601535|2048729|FG005|Phase 2|Progressive Disease|7
1022494|NCT01601535|2048724|FG000|Phase 2|Started Another Treatment|0
1022495|NCT01601535|2048725|FG001|Phase 2|Started Another Treatment|0
1022496|NCT01601535|2048726|FG002|Phase 2|Started Another Treatment|0
1022497|NCT01601535|2048727|FG003|Phase 2|Started Another Treatment|0
1022498|NCT01601535|2048728|FG004|Phase 2|Started Another Treatment|1
1022499|NCT01601535|2048729|FG005|Phase 2|Started Another Treatment|2
1022500|NCT01601626|2048755|FG000|Overall Study|Death|1
1022501|NCT01601626|2048756|FG001|Overall Study|Death|1
1022502|NCT01601626|2048757|FG002|Overall Study|Death|1
1022503|NCT01601626|2048755|FG000|Overall Study|Lost to Follow-up|1
1022504|NCT01601626|2048756|FG001|Overall Study|Lost to Follow-up|2
1022505|NCT01601626|2048757|FG002|Overall Study|Lost to Follow-up|0
1022506|NCT01601626|2048755|FG000|Overall Study|Unable to Get to Clinic|0
1022507|NCT01601626|2048756|FG001|Overall Study|Unable to Get to Clinic|1
1022508|NCT01601626|2048757|FG002|Overall Study|Unable to Get to Clinic|0
1022509|NCT01601626|2048755|FG000|Overall Study|Withdrawal by Subject|0
1022510|NCT01601626|2048756|FG001|Overall Study|Withdrawal by Subject|1
1022511|NCT01601626|2048757|FG002|Overall Study|Withdrawal by Subject|1
1022512|NCT01601626|2048755|FG000|Overall Study|Not Willing to Adhere to Requirements|1
1022513|NCT01601626|2048756|FG001|Overall Study|Not Willing to Adhere to Requirements|0
1022514|NCT01601626|2048757|FG002|Overall Study|Not Willing to Adhere to Requirements|0
1022515|NCT01601652|2048765|FG000|Overall Study|Death|1
1022516|NCT01601704|2048775|FG000|Overall Study|Randomized but not dispensed study med|1
1022517|NCT01601704|2048776|FG001|Overall Study|Randomized but not dispensed study med|4
1022518|NCT01601821|2048788|FG000|Overall Study|Death|2
1022519|NCT01601821|2048789|FG001|Overall Study|Death|5
1022520|NCT01601821|2048788|FG000|Overall Study|Protocol Violation|2
1022521|NCT01601821|2048789|FG001|Overall Study|Protocol Violation|2
1022522|NCT01601821|2048788|FG000|Overall Study|Lost to Follow-up|6
1022523|NCT01601821|2048789|FG001|Overall Study|Lost to Follow-up|14
1022524|NCT01601821|2048788|FG000|Overall Study|Withdrawal by Subject|1
1022525|NCT01601821|2048789|FG001|Overall Study|Withdrawal by Subject|0
1022526|NCT01601821|2048788|FG000|Overall Study|Graft Loss|6
1022527|NCT01601821|2048789|FG001|Overall Study|Graft Loss|6
1022528|NCT01601821|2048788|FG000|Overall Study|Study Events|7
1022529|NCT01601821|2048789|FG001|Overall Study|Study Events|1
1022530|NCT01601821|2048788|FG000|Overall Study|Other|5
1022531|NCT01601821|2048789|FG001|Overall Study|Other|1
1022532|NCT01601847|2048797|FG000|Overall Study|Death|1
1022533|NCT01601847|2048798|FG001|Overall Study|Death|0
1022534|NCT01601847|2048797|FG000|Overall Study|Withdrawal by Subject|11
1022535|NCT01601847|2048798|FG001|Overall Study|Withdrawal by Subject|7
1022536|NCT01601847|2048797|FG000|Overall Study|Lost to Follow-up|1
1022537|NCT01601847|2048798|FG001|Overall Study|Lost to Follow-up|3
1022538|NCT01601873|2048816|FG000|Overall Study|Lost to Follow-up|2
1022539|NCT01601873|2048817|FG001|Overall Study|Lost to Follow-up|3
1022540|NCT01602120|2048842|FG000|Overall Study|Adverse Event|3
1022541|NCT01602120|2048843|FG001|Overall Study|Adverse Event|6
1022542|NCT01602120|2048844|FG002|Overall Study|Adverse Event|0
1022543|NCT01602120|2048845|FG003|Overall Study|Adverse Event|2
1022544|NCT01602120|2048842|FG000|Overall Study|Death|0
1022545|NCT01602120|2048843|FG001|Overall Study|Death|4
1022546|NCT01602120|2048844|FG002|Overall Study|Death|0
1022547|NCT01602120|2048845|FG003|Overall Study|Death|0
1022548|NCT01602120|2048842|FG000|Overall Study|Lost to Follow-up|0
1022549|NCT01602120|2048843|FG001|Overall Study|Lost to Follow-up|1
1022550|NCT01602120|2048844|FG002|Overall Study|Lost to Follow-up|0
1022551|NCT01602120|2048845|FG003|Overall Study|Lost to Follow-up|1
1022552|NCT01602120|2048842|FG000|Overall Study|Protocol Violation|1
1022553|NCT01602120|2048843|FG001|Overall Study|Protocol Violation|1
1022554|NCT01602120|2048844|FG002|Overall Study|Protocol Violation|0
1022555|NCT01602120|2048845|FG003|Overall Study|Protocol Violation|0
1022556|NCT01602120|2048842|FG000|Overall Study|Non-compliance|0
1022557|NCT01602120|2048843|FG001|Overall Study|Non-compliance|3
1022558|NCT01602120|2048844|FG002|Overall Study|Non-compliance|0
1022559|NCT01602120|2048845|FG003|Overall Study|Non-compliance|1
1022560|NCT01602120|2048842|FG000|Overall Study|Withdrawal by Subject|8
1022561|NCT01602120|2048843|FG001|Overall Study|Withdrawal by Subject|17
1022562|NCT01602120|2048844|FG002|Overall Study|Withdrawal by Subject|0
1022563|NCT01602120|2048845|FG003|Overall Study|Withdrawal by Subject|3
1022564|NCT01602120|2048842|FG000|Overall Study|Study Terminated by Sponsor|12
1022565|NCT01602120|2048843|FG001|Overall Study|Study Terminated by Sponsor|24
1022566|NCT01602120|2048844|FG002|Overall Study|Study Terminated by Sponsor|17
1022567|NCT01602120|2048845|FG003|Overall Study|Study Terminated by Sponsor|44
1022568|NCT01602120|2048842|FG000|Overall Study|Physician Decision|2
1022569|NCT01602120|2048843|FG001|Overall Study|Physician Decision|3
1022570|NCT01602120|2048844|FG002|Overall Study|Physician Decision|0
1022571|NCT01602120|2048845|FG003|Overall Study|Physician Decision|0
1022572|NCT01602120|2048842|FG000|Overall Study|Unspecified Reason|3
1022573|NCT01602120|2048843|FG001|Overall Study|Unspecified Reason|1
1022574|NCT01602120|2048844|FG002|Overall Study|Unspecified Reason|0
1022575|NCT01602120|2048845|FG003|Overall Study|Unspecified Reason|2
1022576|NCT01602224|2048879|FG000|Overall Study|Adverse Event|0
1022577|NCT01602224|2048880|FG001|Overall Study|Adverse Event|1
1022578|NCT01602224|2048881|FG002|Overall Study|Adverse Event|0
1022579|NCT01602224|2048879|FG000|Overall Study|Investigator Decison|1
1022580|NCT01602224|2048880|FG001|Overall Study|Investigator Decison|0
1022581|NCT01602224|2048881|FG002|Overall Study|Investigator Decison|0
1022582|NCT01602224|2048879|FG000|Overall Study|Lost to Follow-up|0
1022583|NCT01602224|2048880|FG001|Overall Study|Lost to Follow-up|0
1022584|NCT01602224|2048881|FG002|Overall Study|Lost to Follow-up|1
1022585|NCT01602224|2048879|FG000|Overall Study|Protocol Violation|0
1022586|NCT01602224|2048880|FG001|Overall Study|Protocol Violation|1
1022587|NCT01602224|2048881|FG002|Overall Study|Protocol Violation|0
1022588|NCT01602224|2048879|FG000|Overall Study|Sponsor Decision|2
1022589|NCT01602224|2048880|FG001|Overall Study|Sponsor Decision|3
1022590|NCT01602224|2048881|FG002|Overall Study|Sponsor Decision|2
1022591|NCT01602224|2048879|FG000|Overall Study|Withdrawal by Subject|5
1022592|NCT01602224|2048880|FG001|Overall Study|Withdrawal by Subject|3
1022593|NCT01602224|2048881|FG002|Overall Study|Withdrawal by Subject|3
1022594|NCT01602315|2048898|FG000|Overall Study|Protocol Violation|0
1022595|NCT01602315|2048899|FG001|Overall Study|Protocol Violation|0
1022596|NCT01602315|2048900|FG002|Overall Study|Protocol Violation|0
1022597|NCT01602315|2048901|FG003|Overall Study|Protocol Violation|0
1022598|NCT01602315|2048902|FG004|Overall Study|Protocol Violation|0
1022599|NCT01602315|2048903|FG005|Overall Study|Protocol Violation|1
1022600|NCT01602315|2048904|FG006|Overall Study|Protocol Violation|0
904971|NCT00759915|1880134|FG000|Overall Study|Withdrawal by Subject|1
904972|NCT00759915|1880135|FG001|Overall Study|Withdrawal by Subject|0
904973|NCT00759915|1880134|FG000|Overall Study|Adverse Event|0
904974|NCT00759915|1880135|FG001|Overall Study|Adverse Event|1
904975|NCT00759941|1880143|FG000|Overall Study|Use of medication|1
904976|NCT00759941|1880144|FG001|Overall Study|Use of medication|0
904977|NCT00759941|1880143|FG000|Overall Study|Adverse Event|1
904978|NCT00759941|1880144|FG001|Overall Study|Adverse Event|0
904979|NCT00759941|1880143|FG000|Overall Study|Exited in error by site|1
904980|NCT00759941|1880144|FG001|Overall Study|Exited in error by site|1
904981|NCT00759954|1880152|FG000|Overall Study|Personal reason|1
904982|NCT00759954|1880153|FG001|Overall Study|Personal reason|0
904983|NCT00759954|1880152|FG000|Overall Study|Adverse Event|1
904984|NCT00759954|1880153|FG001|Overall Study|Adverse Event|2
904985|NCT00760084|1880190|FG000|Overall Study|Physician Decision|5
904986|NCT00760084|1880190|FG000|Overall Study|Withdrawal by Subject|2
904987|NCT00760084|1880190|FG000|Overall Study|Progressive Disease|3
904988|NCT00760214|1880197|FG000|Overall Study|Adverse Event|8
904989|NCT00760214|1880198|FG001|Overall Study|Adverse Event|9
904990|NCT00760214|1880199|FG002|Overall Study|Adverse Event|12
1022601|NCT01602315|2048898|FG000|Overall Study|Physician Decision|2
1022602|NCT01602315|2048899|FG001|Overall Study|Physician Decision|0
1022603|NCT01602315|2048900|FG002|Overall Study|Physician Decision|0
1022604|NCT01602315|2048901|FG003|Overall Study|Physician Decision|0
1022605|NCT01602315|2048902|FG004|Overall Study|Physician Decision|2
1022606|NCT01602315|2048903|FG005|Overall Study|Physician Decision|1
1022607|NCT01602315|2048904|FG006|Overall Study|Physician Decision|1
1022608|NCT01602315|2048898|FG000|Overall Study|Disease progression|6
1022609|NCT01602315|2048899|FG001|Overall Study|Disease progression|3
1022610|NCT01602315|2048900|FG002|Overall Study|Disease progression|10
1022611|NCT01602315|2048901|FG003|Overall Study|Disease progression|1
1022612|NCT01602315|2048902|FG004|Overall Study|Disease progression|41
1022613|NCT01602315|2048903|FG005|Overall Study|Disease progression|12
1022614|NCT01602315|2048904|FG006|Overall Study|Disease progression|15
1022615|NCT01602315|2048898|FG000|Overall Study|Death|1
1022616|NCT01602315|2048899|FG001|Overall Study|Death|1
1022617|NCT01602315|2048900|FG002|Overall Study|Death|1
1022618|NCT01602315|2048901|FG003|Overall Study|Death|1
1022619|NCT01602315|2048902|FG004|Overall Study|Death|7
1022620|NCT01602315|2048903|FG005|Overall Study|Death|2
1022621|NCT01602315|2048904|FG006|Overall Study|Death|2
1022622|NCT01602315|2048898|FG000|Overall Study|Withdrawal by Subject|2
1022623|NCT01602315|2048899|FG001|Overall Study|Withdrawal by Subject|0
1022624|NCT01602315|2048900|FG002|Overall Study|Withdrawal by Subject|2
1022625|NCT01602315|2048901|FG003|Overall Study|Withdrawal by Subject|0
1022626|NCT01602315|2048902|FG004|Overall Study|Withdrawal by Subject|6
1022627|NCT01602315|2048903|FG005|Overall Study|Withdrawal by Subject|0
1022628|NCT01602315|2048904|FG006|Overall Study|Withdrawal by Subject|1
1022629|NCT01602315|2048898|FG000|Overall Study|Adverse Event|5
1022630|NCT01602315|2048899|FG001|Overall Study|Adverse Event|1
1022631|NCT01602315|2048900|FG002|Overall Study|Adverse Event|5
1022632|NCT01602315|2048901|FG003|Overall Study|Adverse Event|4
1022633|NCT01602315|2048902|FG004|Overall Study|Adverse Event|15
1022634|NCT01602315|2048903|FG005|Overall Study|Adverse Event|3
1022635|NCT01602315|2048904|FG006|Overall Study|Adverse Event|9
1022636|NCT01602315|2048898|FG000|Overall Study|Subject/guardian decision|0
1022637|NCT01602315|2048899|FG001|Overall Study|Subject/guardian decision|0
1022638|NCT01602315|2048900|FG002|Overall Study|Subject/guardian decision|0
1022639|NCT01602315|2048901|FG003|Overall Study|Subject/guardian decision|0
1022640|NCT01602315|2048902|FG004|Overall Study|Subject/guardian decision|0
1022641|NCT01602315|2048903|FG005|Overall Study|Subject/guardian decision|0
1022642|NCT01602315|2048904|FG006|Overall Study|Subject/guardian decision|1
1022643|NCT01602315|2048898|FG000|Overall Study|Cross-over patients to combo treatment|0
1022644|NCT01602315|2048899|FG001|Overall Study|Cross-over patients to combo treatment|0
1022645|NCT01602315|2048900|FG002|Overall Study|Cross-over patients to combo treatment|0
1022646|NCT01602315|2048901|FG003|Overall Study|Cross-over patients to combo treatment|0
1022647|NCT01602315|2048902|FG004|Overall Study|Cross-over patients to combo treatment|0
1022648|NCT01602315|2048903|FG005|Overall Study|Cross-over patients to combo treatment|16
1022649|NCT01602315|2048904|FG006|Overall Study|Cross-over patients to combo treatment|0
1022650|NCT01602341|2048942|FG000|Overall Study|Adverse Event|0
1022651|NCT01602341|2048943|FG001|Overall Study|Adverse Event|1
1022652|NCT01602380|2048955|FG000|Overall Study|Death|63
1022653|NCT01602380|2048956|FG001|Overall Study|Death|68
1022654|NCT01602380|2048955|FG000|Overall Study|Withdrawal by Subject|22
1022655|NCT01602380|2048956|FG001|Overall Study|Withdrawal by Subject|29
1022656|NCT01602380|2048955|FG000|Overall Study|Lost to Follow-up|6
1022657|NCT01602380|2048956|FG001|Overall Study|Lost to Follow-up|1
1022658|NCT01602380|2048955|FG000|Overall Study|Eligibility criteria not fulfilled|2
1022659|NCT01602380|2048956|FG001|Overall Study|Eligibility criteria not fulfilled|3
1022660|NCT01602419|2048962|FG000|Overall Study|Not treated with Wilate|9
1022661|NCT01602419|2048962|FG000|Overall Study|Adverse Drug Reaction|4
1022662|NCT01602419|2048962|FG000|Overall Study|Insurance issues|3
1022663|NCT01602419|2048962|FG000|Overall Study|Changed treatment centre|1
1022664|NCT01602419|2048962|FG000|Overall Study|Treatment centre closed|1
1022665|NCT01602419|2048962|FG000|Overall Study|Withdrawal by Subject|5
1022666|NCT01602419|2048962|FG000|Overall Study|Lost to Follow-up|6
1022667|NCT01602484|2049009|FG000|Overall Study|Airway issues unrelated to study|0
1022668|NCT01602484|2049010|FG001|Overall Study|Airway issues unrelated to study|1
1022669|NCT01602510|2049016|FG000|Open Label Phase|Adverse Event|46
1022670|NCT01602510|2049017|FG001|Open Label Phase|Adverse Event|0
1022671|NCT01602510|2049018|FG002|Open Label Phase|Adverse Event|0
1022672|NCT01602510|2049016|FG000|Open Label Phase|Lack of Efficacy|22
1022673|NCT01602510|2049017|FG001|Open Label Phase|Lack of Efficacy|0
1022674|NCT01602510|2049018|FG002|Open Label Phase|Lack of Efficacy|0
1022675|NCT01602510|2049016|FG000|Open Label Phase|Protocol Violation|15
1022676|NCT01602510|2049017|FG001|Open Label Phase|Protocol Violation|0
1022677|NCT01602510|2049018|FG002|Open Label Phase|Protocol Violation|0
1022678|NCT01602510|2049016|FG000|Open Label Phase|Met protocol-defined stopping criteria|122
1022679|NCT01602510|2049017|FG001|Open Label Phase|Met protocol-defined stopping criteria|0
1022680|NCT01602510|2049018|FG002|Open Label Phase|Met protocol-defined stopping criteria|0
1022681|NCT01602510|2049016|FG000|Open Label Phase|Lost to Follow-up|22
1022682|NCT01602510|2049017|FG001|Open Label Phase|Lost to Follow-up|0
1022683|NCT01602510|2049018|FG002|Open Label Phase|Lost to Follow-up|0
1022684|NCT01602510|2049016|FG000|Open Label Phase|Physician Decision|19
1022685|NCT01602510|2049017|FG001|Open Label Phase|Physician Decision|0
1022686|NCT01602510|2049018|FG002|Open Label Phase|Physician Decision|0
1022687|NCT01602510|2049016|FG000|Open Label Phase|Withdrawal by Subject|57
1022688|NCT01602510|2049017|FG001|Open Label Phase|Withdrawal by Subject|0
1022689|NCT01602510|2049018|FG002|Open Label Phase|Withdrawal by Subject|0
1022690|NCT01602510|2049016|FG000|Randomized Phase|Adverse Event|0
1022691|NCT01602510|2049017|FG001|Randomized Phase|Adverse Event|2
1022692|NCT01602510|2049018|FG002|Randomized Phase|Adverse Event|6
1022693|NCT01602510|2049016|FG000|Randomized Phase|Lack of Efficacy|0
1022694|NCT01602510|2049017|FG001|Randomized Phase|Lack of Efficacy|4
1022695|NCT01602510|2049018|FG002|Randomized Phase|Lack of Efficacy|4
1022696|NCT01602510|2049016|FG000|Randomized Phase|Protocol Violation|0
1022697|NCT01602510|2049017|FG001|Randomized Phase|Protocol Violation|3
1022698|NCT01602510|2049018|FG002|Randomized Phase|Protocol Violation|3
1022699|NCT01602510|2049016|FG000|Randomized Phase|Met protocol-defined stopping criteria|0
1022700|NCT01602510|2049017|FG001|Randomized Phase|Met protocol-defined stopping criteria|58
1022701|NCT01602510|2049018|FG002|Randomized Phase|Met protocol-defined stopping criteria|48
1022702|NCT01602510|2049016|FG000|Randomized Phase|Lost to Follow-up|0
1022703|NCT01602510|2049017|FG001|Randomized Phase|Lost to Follow-up|1
1022704|NCT01602510|2049018|FG002|Randomized Phase|Lost to Follow-up|3
1022705|NCT01602510|2049016|FG000|Randomized Phase|Physician Decision|0
1022706|NCT01602510|2049017|FG001|Randomized Phase|Physician Decision|0
1022707|NCT01602510|2049018|FG002|Randomized Phase|Physician Decision|2
1022708|NCT01602510|2049016|FG000|Randomized Phase|Withdrawal by Subject|0
1022709|NCT01602510|2049017|FG001|Randomized Phase|Withdrawal by Subject|6
1022710|NCT01602510|2049018|FG002|Randomized Phase|Withdrawal by Subject|7
1022711|NCT01602549|2049026|FG000|Overall Study|Protocol Violation|0
1022712|NCT01602549|2049027|FG001|Overall Study|Protocol Violation|1
1022713|NCT01602549|2049026|FG000|Overall Study|Withdrawal by Subject|1
1022714|NCT01602549|2049027|FG001|Overall Study|Withdrawal by Subject|0
1022715|NCT01602562|2049037|FG000|Overall Study|Adverse Event|3
1022716|NCT01602562|2049038|FG001|Overall Study|Adverse Event|1
1022717|NCT01602562|2049037|FG000|Overall Study|Physician Decision|1
1022718|NCT01602562|2049038|FG001|Overall Study|Physician Decision|1
1022719|NCT01602562|2049037|FG000|Overall Study|Withdrawal by Subject|1
1022720|NCT01602562|2049038|FG001|Overall Study|Withdrawal by Subject|1
1022743|NCT01602744|2049107|FG000|Overall Study|Death|17
1022744|NCT01602744|2049108|FG001|Overall Study|Death|15
1022745|NCT01602744|2049107|FG000|Overall Study|Lost to Follow-up|13
1022746|NCT01602744|2049108|FG001|Overall Study|Lost to Follow-up|8
1022747|NCT01602965|2049116|FG000|Overall Study|Lost to Follow-up|4
1022748|NCT01602965|2049117|FG001|Overall Study|Lost to Follow-up|2
1022749|NCT01603082|2049134|FG000|Overall Study|Adverse Event|0
904991|NCT00760214|1880197|FG000|Overall Study|Protocol Violation|3
904992|NCT00760214|1880198|FG001|Overall Study|Protocol Violation|0
904993|NCT00760214|1880199|FG002|Overall Study|Protocol Violation|3
904994|NCT00760214|1880197|FG000|Overall Study|Lost to Follow-up|0
904995|NCT00760214|1880198|FG001|Overall Study|Lost to Follow-up|0
1022750|NCT01603082|2049135|FG001|Overall Study|Adverse Event|1
1022751|NCT01603082|2049134|FG000|Overall Study|Withdrawal by Subject|1
1022752|NCT01603082|2049135|FG001|Overall Study|Withdrawal by Subject|0
1022753|NCT01603082|2049134|FG000|Overall Study|Failed inclusion criterion after dosed|1
1022754|NCT01603082|2049135|FG001|Overall Study|Failed inclusion criterion after dosed|0
1022755|NCT01603277|2049143|FG000|Overall Study|Adverse Event|1
1022756|NCT01603277|2049144|FG001|Overall Study|Adverse Event|2
1022757|NCT01603277|2049143|FG000|Overall Study|Physician Decision|0
1022758|NCT01603277|2049144|FG001|Overall Study|Physician Decision|1
1022759|NCT01603277|2049143|FG000|Overall Study|Protocol Violation|6
1022760|NCT01603277|2049144|FG001|Overall Study|Protocol Violation|10
1022761|NCT01603277|2049143|FG000|Overall Study|Withdrawal by Subject|5
1022762|NCT01603277|2049144|FG001|Overall Study|Withdrawal by Subject|4
1022763|NCT01603277|2049143|FG000|Overall Study|Non-Compliance|2
1022764|NCT01603277|2049144|FG001|Overall Study|Non-Compliance|1
1022765|NCT01603355|2049150|FG000|Overall Study|Lack of Efficacy|2
1022766|NCT01603459|2049175|FG000|Overall Study|Adverse Event|5
1022767|NCT01603459|2049175|FG000|Overall Study|Withdrawal by Subject|5
1022768|NCT01603459|2049175|FG000|Overall Study|Lost to Follow-up|3
1022769|NCT01603459|2049175|FG000|Overall Study|Predefined discontinuation criteria|3
1022770|NCT01603459|2049175|FG000|Overall Study|Non-compliance|1
1022771|NCT01603459|2049175|FG000|Overall Study|Administrative reason|1
1022772|NCT01603602|2049200|FG000|Overall Study|Adverse Event|1
1022773|NCT01603602|2049201|FG001|Overall Study|Adverse Event|0
1022774|NCT01603602|2049202|FG002|Overall Study|Adverse Event|0
1022775|NCT01603602|2049200|FG000|Overall Study|Personal Reasons|1
1022776|NCT01603602|2049201|FG001|Overall Study|Personal Reasons|0
1022777|NCT01603602|2049202|FG002|Overall Study|Personal Reasons|1
1022778|NCT01603615|2049210|FG000|Overall Study|Did not Receive Treatment|7
1022779|NCT01603615|2049210|FG000|Overall Study|Lost to Follow-up|9
1022780|NCT01603615|2049210|FG000|Overall Study|Personal Reasons|17
1022781|NCT01603615|2049210|FG000|Overall Study|Other Miscellaneous|1
1022782|NCT01603628|2049217|FG000|Overall Study|Personal Reasons|1
1022783|NCT01603628|2049218|FG001|Overall Study|Personal Reasons|1
1022784|NCT01603628|2049219|FG002|Overall Study|Personal Reasons|2
1022785|NCT01603628|2049217|FG000|Overall Study|Protocol Violation|1
1022786|NCT01603628|2049218|FG001|Overall Study|Protocol Violation|1
1022787|NCT01603628|2049219|FG002|Overall Study|Protocol Violation|0
1022788|NCT01603628|2049217|FG000|Overall Study|Lost to Follow-up|0
1022789|NCT01603628|2049218|FG001|Overall Study|Lost to Follow-up|1
1022790|NCT01603628|2049219|FG002|Overall Study|Lost to Follow-up|0
1022791|NCT01603628|2049217|FG000|Overall Study|Other Miscellaneous Reason|1
1022792|NCT01603628|2049218|FG001|Overall Study|Other Miscellaneous Reason|0
1022793|NCT01603628|2049219|FG002|Overall Study|Other Miscellaneous Reason|0
1022794|NCT01603641|2049227|FG000|Overall Study|Did not Receive Treatment|3
1022795|NCT01603641|2049227|FG000|Overall Study|Adverse Event|1
1022796|NCT01603641|2049227|FG000|Overall Study|Lack of Efficacy|1
1022797|NCT01603641|2049227|FG000|Overall Study|Lost to Follow-up|6
1022798|NCT01603641|2049227|FG000|Overall Study|Personal Reasons|18
1022799|NCT01603641|2049227|FG000|Overall Study|Other Miscellaneous Reasons|6
1022800|NCT01603875|2049234|FG000|Overall Study|Preexisting rabies antibody|3
1022801|NCT01603875|2049235|FG001|Overall Study|Preexisting rabies antibody|4
1022802|NCT01603875|2049236|FG002|Overall Study|Preexisting rabies antibody|3
1022803|NCT01603875|2049234|FG000|Overall Study|Lost to Follow-up|4
1022804|NCT01603875|2049235|FG001|Overall Study|Lost to Follow-up|3
1022805|NCT01603875|2049236|FG002|Overall Study|Lost to Follow-up|6
1022806|NCT01603875|2049234|FG000|Overall Study|Protocol Violation|0
1022807|NCT01603875|2049235|FG001|Overall Study|Protocol Violation|1
1022808|NCT01603875|2049236|FG002|Overall Study|Protocol Violation|0
1022809|NCT01604265|2049274|FG000|Overall Study|Adverse Event|1
1022810|NCT01604265|2049275|FG001|Overall Study|Adverse Event|0
1022811|NCT01604265|2049274|FG000|Overall Study|Withdrawal by Subject|1
1022812|NCT01604265|2049275|FG001|Overall Study|Withdrawal by Subject|0
1022813|NCT01604278|2049283|FG000|Overall Study|Lack of Efficacy|0
1022814|NCT01604278|2049284|FG001|Overall Study|Lack of Efficacy|1
1022815|NCT01604278|2049283|FG000|Overall Study|Lost to Follow-up|1
1022816|NCT01604278|2049284|FG001|Overall Study|Lost to Follow-up|0
1022817|NCT01604278|2049283|FG000|Overall Study|Administrative problems|2
1022818|NCT01604278|2049284|FG001|Overall Study|Administrative problems|1
1022819|NCT01604278|2049283|FG000|Overall Study|Withdrawal by Subject|3
1022820|NCT01604278|2049284|FG001|Overall Study|Withdrawal by Subject|3
1022821|NCT01604278|2049283|FG000|Overall Study|Adverse Event|3
1022822|NCT01604278|2049284|FG001|Overall Study|Adverse Event|5
1022823|NCT01604278|2049283|FG000|Overall Study|Protocol Deviation|5
1022824|NCT01604278|2049284|FG001|Overall Study|Protocol Deviation|3
1022825|NCT01604343|2049318|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
1022826|NCT01604343|2049319|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
1022827|NCT01604343|2049320|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
1022828|NCT01604343|2049321|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
1022829|NCT01604343|2049322|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
1022830|NCT01604343|2049318|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
1022831|NCT01604343|2049319|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
1022832|NCT01604343|2049320|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
1022833|NCT01604343|2049321|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
1022834|NCT01604343|2049322|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
1022835|NCT01604343|2049318|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25
1022836|NCT01604343|2049319|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0
1022837|NCT01604343|2049320|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41
1022838|NCT01604343|2049321|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0
1022839|NCT01604343|2049322|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42
1022840|NCT01604343|2049318|FG000|Prior to W52 Administration(Through W52)|Death|5
1022841|NCT01604343|2049319|FG001|Prior to W52 Administration(Through W52)|Death|0
1022842|NCT01604343|2049320|FG002|Prior to W52 Administration(Through W52)|Death|2
1022843|NCT01604343|2049321|FG003|Prior to W52 Administration(Through W52)|Death|0
1022844|NCT01604343|2049322|FG004|Prior to W52 Administration(Through W52)|Death|4
1022845|NCT01604343|2049318|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
1022846|NCT01604343|2049319|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
1022847|NCT01604343|2049320|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
1022848|NCT01604343|2049321|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
1022849|NCT01604343|2049322|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
1022850|NCT01604343|2049318|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4
1022851|NCT01604343|2049319|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0
1022852|NCT01604343|2049320|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1
1022853|NCT01604343|2049321|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0
1022854|NCT01604343|2049322|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2
1022855|NCT01604343|2049318|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1
1022856|NCT01604343|2049319|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0
1022857|NCT01604343|2049320|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1
1022858|NCT01604343|2049321|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0
1022859|NCT01604343|2049322|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0
1022860|NCT01604343|2049318|FG000|Prior to W52 Administration(Through W52)|Other|15
1022861|NCT01604343|2049319|FG001|Prior to W52 Administration(Through W52)|Other|0
1022862|NCT01604343|2049320|FG002|Prior to W52 Administration(Through W52)|Other|10
1022863|NCT01604343|2049321|FG003|Prior to W52 Administration(Through W52)|Other|0
1022864|NCT01604343|2049322|FG004|Prior to W52 Administration(Through W52)|Other|6
1022865|NCT01604343|2049318|FG000|Week 52 to Week 104|Lost to Follow-up|0
1022866|NCT01604343|2049319|FG001|Week 52 to Week 104|Lost to Follow-up|2
1022867|NCT01604343|2049320|FG002|Week 52 to Week 104|Lost to Follow-up|4
1022868|NCT01604343|2049321|FG003|Week 52 to Week 104|Lost to Follow-up|2
1022869|NCT01604343|2049322|FG004|Week 52 to Week 104|Lost to Follow-up|1
1022870|NCT01604343|2049318|FG000|Week 52 to Week 104|Withdrawal by Subject|0
1022871|NCT01604343|2049319|FG001|Week 52 to Week 104|Withdrawal by Subject|7
1022872|NCT01604343|2049320|FG002|Week 52 to Week 104|Withdrawal by Subject|12
1022873|NCT01604343|2049321|FG003|Week 52 to Week 104|Withdrawal by Subject|8
1022874|NCT01604343|2049322|FG004|Week 52 to Week 104|Withdrawal by Subject|4
1022875|NCT01604343|2049318|FG000|Week 52 to Week 104|Adverse Event|0
1022876|NCT01604343|2049319|FG001|Week 52 to Week 104|Adverse Event|12
1022877|NCT01604343|2049320|FG002|Week 52 to Week 104|Adverse Event|26
1022878|NCT01604343|2049321|FG003|Week 52 to Week 104|Adverse Event|21
1022879|NCT01604343|2049322|FG004|Week 52 to Week 104|Adverse Event|27
1022880|NCT01604343|2049318|FG000|Week 52 to Week 104|Death|0
1022881|NCT01604343|2049319|FG001|Week 52 to Week 104|Death|4
1022882|NCT01604343|2049320|FG002|Week 52 to Week 104|Death|2
1022883|NCT01604343|2049321|FG003|Week 52 to Week 104|Death|5
1022884|NCT01604343|2049322|FG004|Week 52 to Week 104|Death|0
1022885|NCT01604343|2049318|FG000|Week 52 to Week 104|Lack of Efficacy|0
1022886|NCT01604343|2049319|FG001|Week 52 to Week 104|Lack of Efficacy|6
1022887|NCT01604343|2049320|FG002|Week 52 to Week 104|Lack of Efficacy|11
1022888|NCT01604343|2049321|FG003|Week 52 to Week 104|Lack of Efficacy|2
1022889|NCT01604343|2049322|FG004|Week 52 to Week 104|Lack of Efficacy|3
1022890|NCT01604343|2049318|FG000|Week 52 to Week 104|Physician Decision|0
1022891|NCT01604343|2049319|FG001|Week 52 to Week 104|Physician Decision|1
1022892|NCT01604343|2049320|FG002|Week 52 to Week 104|Physician Decision|0
1022893|NCT01604343|2049321|FG003|Week 52 to Week 104|Physician Decision|0
1022894|NCT01604343|2049322|FG004|Week 52 to Week 104|Physician Decision|2
1022895|NCT01604343|2049318|FG000|Week 52 to Week 104|Pregnancy|0
1022896|NCT01604343|2049319|FG001|Week 52 to Week 104|Pregnancy|0
1022897|NCT01604343|2049320|FG002|Week 52 to Week 104|Pregnancy|1
1022898|NCT01604343|2049321|FG003|Week 52 to Week 104|Pregnancy|2
1022899|NCT01604343|2049322|FG004|Week 52 to Week 104|Pregnancy|1
1022900|NCT01604343|2049318|FG000|Week 52 to Week 104|Other|0
1022901|NCT01604343|2049319|FG001|Week 52 to Week 104|Other|11
1022902|NCT01604343|2049320|FG002|Week 52 to Week 104|Other|11
1022903|NCT01604343|2049321|FG003|Week 52 to Week 104|Other|6
1022904|NCT01604343|2049322|FG004|Week 52 to Week 104|Other|3
1022905|NCT01604343|2049318|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
1022906|NCT01604343|2049319|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1022907|NCT01604343|2049320|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
1022908|NCT01604343|2049321|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1022909|NCT01604343|2049322|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1022910|NCT01604343|2049318|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
1022911|NCT01604343|2049319|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
1022912|NCT01604343|2049320|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
1022913|NCT01604343|2049321|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
1022914|NCT01604343|2049322|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
1022915|NCT01604343|2049318|FG000|Safety Follow-up Period (Week 104-120)|Other|15
1022916|NCT01604343|2049319|FG001|Safety Follow-up Period (Week 104-120)|Other|2
1022917|NCT01604343|2049320|FG002|Safety Follow-up Period (Week 104-120)|Other|20
1022918|NCT01604343|2049321|FG003|Safety Follow-up Period (Week 104-120)|Other|6
1022919|NCT01604343|2049322|FG004|Safety Follow-up Period (Week 104-120)|Other|14
1022920|NCT01604408|2049334|FG000|Treatment Period 1|Protocol Violation|0
1022921|NCT01604408|2049335|FG001|Treatment Period 1|Protocol Violation|1
1022922|NCT01604408|2049334|FG000|Treatment Period 2|Withdrawal by Subject|1
1022923|NCT01604408|2049335|FG001|Treatment Period 2|Withdrawal by Subject|1
1022924|NCT01604408|2049334|FG000|Treatment Period 2|Protocol Violation|1
1022925|NCT01604408|2049335|FG001|Treatment Period 2|Protocol Violation|0
1022926|NCT01604408|2049334|FG000|Treatment Period 2|Adverse Event|0
1022927|NCT01604408|2049335|FG001|Treatment Period 2|Adverse Event|1
1022928|NCT01604408|2049334|FG000|Treatment Period 3|Protocol Violation|1
1022929|NCT01604408|2049335|FG001|Treatment Period 3|Protocol Violation|1
1022930|NCT01604408|2049334|FG000|Treatment Period 3|Adverse Event|0
1022931|NCT01604408|2049335|FG001|Treatment Period 3|Adverse Event|3
1022932|NCT01604408|2049334|FG000|Treatment Period 3|Withdrawal by Subject|3
1022933|NCT01604408|2049335|FG001|Treatment Period 3|Withdrawal by Subject|1
1022934|NCT01604408|2049334|FG000|Treatment Period 3|Sponsor Decision|1
1022935|NCT01604408|2049335|FG001|Treatment Period 3|Sponsor Decision|0
1022936|NCT01604408|2049334|FG000|Treatment Period 4|Death|1
1022937|NCT01604408|2049335|FG001|Treatment Period 4|Death|0
1022938|NCT01604408|2049334|FG000|Treatment Period 4|Withdrawal by Subject|2
1022939|NCT01604408|2049335|FG001|Treatment Period 4|Withdrawal by Subject|1
1022940|NCT01604408|2049334|FG000|Treatment Period 4|Adverse Event|0
1022941|NCT01604408|2049335|FG001|Treatment Period 4|Adverse Event|1
1022942|NCT01604408|2049334|FG000|Treatment Period 5|Adverse Event|4
1022943|NCT01604408|2049335|FG001|Treatment Period 5|Adverse Event|0
1022944|NCT01604408|2049334|FG000|Treatment Period 6|Lost to Follow-up|0
1022945|NCT01604408|2049335|FG001|Treatment Period 6|Lost to Follow-up|1
1022946|NCT01604408|2049334|FG000|Treatment Period 6|Adverse Event|2
1022947|NCT01604408|2049335|FG001|Treatment Period 6|Adverse Event|0
1022948|NCT01604408|2049334|FG000|Treatment Period 6|Sponsor decision|0
1022949|NCT01604408|2049335|FG001|Treatment Period 6|Sponsor decision|1
1022950|NCT01604408|2049334|FG000|Observation Period|Adverse Event|1
1022951|NCT01604408|2049335|FG001|Observation Period|Adverse Event|1
1022952|NCT01604408|2049334|FG000|Observation Period|Withdrawal by Subject|0
1022953|NCT01604408|2049335|FG001|Observation Period|Withdrawal by Subject|2
1022954|NCT01604785|2049348|FG000|Overall Study|Repeat Visits Not Included in Analysis|7
1022955|NCT01604785|2049349|FG001|Overall Study|Repeat Visits Not Included in Analysis|1
1022956|NCT01604824|2049359|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
1022957|NCT01604824|2049360|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
1022958|NCT01604824|2049361|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
1022959|NCT01604824|2049362|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
1022960|NCT01604824|2049363|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2
1022961|NCT01604824|2049364|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
1022962|NCT01604824|2049359|FG000|Open-label Extension (OLE) Period|Refused to come into office|0
1022963|NCT01604824|2049360|FG001|Open-label Extension (OLE) Period|Refused to come into office|0
1022964|NCT01604824|2049361|FG002|Open-label Extension (OLE) Period|Refused to come into office|0
1022965|NCT01604824|2049362|FG003|Open-label Extension (OLE) Period|Refused to come into office|0
1022966|NCT01604824|2049363|FG004|Open-label Extension (OLE) Period|Refused to come into office|1
1022967|NCT01604824|2049364|FG005|Open-label Extension (OLE) Period|Refused to come into office|0
1022968|NCT01604850|2049378|FG000|Overall Study|Enrolled but never treated|0
1022969|NCT01604850|2049379|FG001|Overall Study|Enrolled but never treated|1
1022970|NCT01604850|2049378|FG000|Overall Study|Efficacy Failure|50
1022971|NCT01604850|2049379|FG001|Overall Study|Efficacy Failure|29
1022972|NCT01604850|2049378|FG000|Overall Study|Lost to Follow-up|1
1022973|NCT01604850|2049379|FG001|Overall Study|Lost to Follow-up|0
1022974|NCT01604850|2049378|FG000|Overall Study|Subject withdrew consent|1
1022975|NCT01604850|2049379|FG001|Overall Study|Subject withdrew consent|0
1022976|NCT01604941|2049387|FG000|Overall Study|Adverse Event|1
1022977|NCT01604941|2049388|FG001|Overall Study|Adverse Event|2
1022978|NCT01604941|2049389|FG002|Overall Study|Adverse Event|0
1022979|NCT01604941|2049390|FG003|Overall Study|Adverse Event|0
1022980|NCT01604941|2049391|FG004|Overall Study|Adverse Event|1
1022981|NCT01604941|2049392|FG005|Overall Study|Adverse Event|5
1022982|NCT01604941|2049387|FG000|Overall Study|Non-compliance|1
1022983|NCT01604941|2049388|FG001|Overall Study|Non-compliance|0
1022984|NCT01604941|2049389|FG002|Overall Study|Non-compliance|0
1022985|NCT01604941|2049390|FG003|Overall Study|Non-compliance|0
1022986|NCT01604941|2049391|FG004|Overall Study|Non-compliance|0
1022987|NCT01604941|2049392|FG005|Overall Study|Non-compliance|0
1022988|NCT01604941|2049387|FG000|Overall Study|Participant Decision|0
1022989|NCT01604941|2049388|FG001|Overall Study|Participant Decision|0
1022990|NCT01604941|2049389|FG002|Overall Study|Participant Decision|0
1022991|NCT01604941|2049390|FG003|Overall Study|Participant Decision|0
1022992|NCT01604941|2049391|FG004|Overall Study|Participant Decision|0
1022993|NCT01604941|2049392|FG005|Overall Study|Participant Decision|2
1022994|NCT01604941|2049387|FG000|Overall Study|Early Study Termination|9
1022995|NCT01604941|2049388|FG001|Overall Study|Early Study Termination|2
1022996|NCT01604941|2049389|FG002|Overall Study|Early Study Termination|3
1022997|NCT01604941|2049390|FG003|Overall Study|Early Study Termination|3
1022998|NCT01604941|2049391|FG004|Overall Study|Early Study Termination|0
1022999|NCT01604941|2049392|FG005|Overall Study|Early Study Termination|0
1023000|NCT01605071|2049404|FG000|Overall Study|Withdrawal by Subject|3
1023001|NCT01605071|2049405|FG001|Overall Study|Withdrawal by Subject|2
1023002|NCT01605097|2049413|FG000|Overall Study|Protocol Violation|1
1023003|NCT01605136|2049420|FG000|Study Period|Withdrawal by Subject|2
1023004|NCT01605136|2049421|FG001|Study Period|Withdrawal by Subject|0
1023005|NCT01605136|2049420|FG000|Study Period|Physician Decision|1
1023006|NCT01605136|2049421|FG001|Study Period|Physician Decision|1
1023007|NCT01605136|2049420|FG000|Study Period|Lost to Follow-up|0
1023008|NCT01605136|2049421|FG001|Study Period|Lost to Follow-up|2
1023009|NCT01605136|2049420|FG000|Safety Follow-Up Period|Withdrawal by Subject|1
1023010|NCT01605136|2049421|FG001|Safety Follow-Up Period|Withdrawal by Subject|2
1023011|NCT01605227|2049429|FG000|Overall Study|Did not receive study treatment|2
1023012|NCT01605227|2049430|FG001|Overall Study|Did not receive study treatment|3
1023013|NCT01605227|2049429|FG000|Overall Study|Adverse Event|228
1023014|NCT01605227|2049430|FG001|Overall Study|Adverse Event|42
1023015|NCT01605227|2049429|FG000|Overall Study|Progressive Disease|132
1023016|NCT01605227|2049430|FG001|Overall Study|Progressive Disease|128
1023017|NCT01605227|2049429|FG000|Overall Study|Clinical Deterioration|227
1023018|NCT01605227|2049430|FG001|Overall Study|Clinical Deterioration|133
1023019|NCT01605227|2049429|FG000|Overall Study|Lost to Follow-up|1
1023020|NCT01605227|2049430|FG001|Overall Study|Lost to Follow-up|0
1023021|NCT01605227|2049429|FG000|Overall Study|Protocol Violation|1
1023022|NCT01605227|2049430|FG001|Overall Study|Protocol Violation|0
1023023|NCT01605227|2049429|FG000|Overall Study|Physician Decision|9
1023024|NCT01605227|2049430|FG001|Overall Study|Physician Decision|7
1023025|NCT01605227|2049429|FG000|Overall Study|Withdrawal by Subject|18
1023026|NCT01605227|2049430|FG001|Overall Study|Withdrawal by Subject|14
1023027|NCT01605227|2049429|FG000|Overall Study|Sponsor Decision|2
1023028|NCT01605227|2049430|FG001|Overall Study|Sponsor Decision|0
1023029|NCT01605227|2049429|FG000|Overall Study|Started New Therapy|1
1023030|NCT01605227|2049430|FG001|Overall Study|Started New Therapy|0
1023031|NCT01605227|2049429|FG000|Overall Study|Subject Decision|0
1023032|NCT01605227|2049430|FG001|Overall Study|Subject Decision|1
1023033|NCT01605227|2049429|FG000|Overall Study|Dose Held >6 weeks|0
1023034|NCT01605227|2049430|FG001|Overall Study|Dose Held >6 weeks|1
1023035|NCT01605396|2049447|FG000|Overall Study|Adverse Event|5
1023036|NCT01605396|2049448|FG001|Overall Study|Adverse Event|3
1023037|NCT01605396|2049447|FG000|Overall Study|Lost to Follow-up|1
1023038|NCT01605396|2049448|FG001|Overall Study|Lost to Follow-up|0
1023039|NCT01605396|2049447|FG000|Overall Study|Non-Compliance With Study Drug|1
1023040|NCT01605396|2049448|FG001|Overall Study|Non-Compliance With Study Drug|1
1023041|NCT01605396|2049447|FG000|Overall Study|Physician Decision|2
1023042|NCT01605396|2049448|FG001|Overall Study|Physician Decision|2
1023043|NCT01605396|2049447|FG000|Overall Study|Progressive Disease|23
1023044|NCT01605396|2049448|FG001|Overall Study|Progressive Disease|27
1023045|NCT01605396|2049447|FG000|Overall Study|Withdrawal by Subject|4
1023046|NCT01605396|2049448|FG001|Overall Study|Withdrawal by Subject|2
1023047|NCT01605396|2049447|FG000|Overall Study|Transfer Off Study|4
1023048|NCT01605396|2049448|FG001|Overall Study|Transfer Off Study|5
1023049|NCT01605461|2049472|FG000|Overall Study|Lost to Follow-up|3
1023050|NCT01605461|2049472|FG000|Overall Study|Withdrawal by Subject|1
1023051|NCT01605799|2049505|FG000|Overall Study|Withdrawal by Subject|2
1023052|NCT01605799|2049506|FG001|Overall Study|Withdrawal by Subject|1
1023053|NCT01605825|2049514|FG000|Overall Study|Adverse Event|4
1023054|NCT01605825|2049515|FG001|Overall Study|Adverse Event|2
1023055|NCT01605825|2049514|FG000|Overall Study|Withdrawal by Subject|0
1023056|NCT01605825|2049515|FG001|Overall Study|Withdrawal by Subject|1
1023057|NCT01605825|2049514|FG000|Overall Study|Non-Compliance -Investigational Drug|3
1023058|NCT01605825|2049515|FG001|Overall Study|Non-Compliance -Investigational Drug|0
1023059|NCT01605825|2049514|FG000|Overall Study|Non-Compliance with Protocol|3
1023060|NCT01605825|2049515|FG001|Overall Study|Non-Compliance with Protocol|0
1023061|NCT01605877|2049521|FG000|Overall Study|Withdrawal by Subject|1
1023062|NCT01605916|2049561|FG000|Overall Study|Adverse Event|1
1023063|NCT01605916|2049562|FG001|Overall Study|Adverse Event|0
1023064|NCT01605916|2049563|FG002|Overall Study|Adverse Event|0
1023065|NCT01605916|2049564|FG003|Overall Study|Adverse Event|1
1023066|NCT01605916|2049565|FG004|Overall Study|Adverse Event|0
1023067|NCT01605916|2049561|FG000|Overall Study|Lack of Efficacy|2
1023068|NCT01605916|2049562|FG001|Overall Study|Lack of Efficacy|3
1023069|NCT01605916|2049563|FG002|Overall Study|Lack of Efficacy|3
1023070|NCT01605916|2049564|FG003|Overall Study|Lack of Efficacy|5
1023071|NCT01605916|2049565|FG004|Overall Study|Lack of Efficacy|4
1023072|NCT01605916|2049561|FG000|Overall Study|Withdrawal by Subject|1
1023073|NCT01605916|2049562|FG001|Overall Study|Withdrawal by Subject|1
1023074|NCT01605916|2049563|FG002|Overall Study|Withdrawal by Subject|0
1023075|NCT01605916|2049564|FG003|Overall Study|Withdrawal by Subject|0
1023076|NCT01605916|2049565|FG004|Overall Study|Withdrawal by Subject|2
1023077|NCT01606007|2049590|FG000|Overall Study|Reason 'Other' in the protocol|0
1023078|NCT01606007|2049591|FG001|Overall Study|Reason 'Other' in the protocol|1
1023079|NCT01606007|2049592|FG002|Overall Study|Reason 'Other' in the protocol|1
1023080|NCT01606007|2049590|FG000|Overall Study|Pregnancy|0
1023081|NCT01606007|2049591|FG001|Overall Study|Pregnancy|1
1023082|NCT01606007|2049592|FG002|Overall Study|Pregnancy|1
1023083|NCT01606007|2049590|FG000|Overall Study|Withdrawal by Subject|8
1023084|NCT01606007|2049591|FG001|Overall Study|Withdrawal by Subject|6
1023085|NCT01606007|2049592|FG002|Overall Study|Withdrawal by Subject|1
1023086|NCT01606007|2049590|FG000|Overall Study|Adverse Event|0
1023087|NCT01606007|2049591|FG001|Overall Study|Adverse Event|1
1023088|NCT01606007|2049592|FG002|Overall Study|Adverse Event|1
1023089|NCT01606007|2049590|FG000|Overall Study|discontinue study treatment|0
1023090|NCT01606007|2049591|FG001|Overall Study|discontinue study treatment|2
1023091|NCT01606007|2049592|FG002|Overall Study|discontinue study treatment|1
1023092|NCT01606007|2049590|FG000|Overall Study|Lost to Follow-up|6
1023093|NCT01606007|2049591|FG001|Overall Study|Lost to Follow-up|8
1023094|NCT01606007|2049592|FG002|Overall Study|Lost to Follow-up|5
1023095|NCT01606007|2049590|FG000|Overall Study|Poor/Non-compliance|1
1023096|NCT01606007|2049591|FG001|Overall Study|Poor/Non-compliance|0
1023097|NCT01606007|2049592|FG002|Overall Study|Poor/Non-compliance|0
1023098|NCT01606137|2049609|FG000|Overall Study|Adverse Event|85
1023099|NCT01606137|2049609|FG000|Overall Study|Withdrawal by Subject|74
1023100|NCT01606137|2049609|FG000|Overall Study|Lack of Efficacy|56
1023101|NCT01606137|2049609|FG000|Overall Study|Lost to Follow-up|15
1023102|NCT01606137|2049609|FG000|Overall Study|Protocol Violation|1
1023103|NCT01606137|2049609|FG000|Overall Study|Patient non-compliance|9
1023104|NCT01606137|2049609|FG000|Overall Study|Death|1
1023105|NCT01606137|2049609|FG000|Overall Study|Decreased/no pain|4
1023106|NCT01606137|2049609|FG000|Overall Study|Issues with driving|4
1023107|NCT01606137|2049609|FG000|Overall Study|multiple sclerosis less stable|1
1023108|NCT01606137|2049609|FG000|Overall Study|Increased bilirubin|1
1023109|NCT01606137|2049609|FG000|Overall Study|Spray causes nausea|1
1023110|NCT01606137|2049609|FG000|Overall Study|Not enough improvement|4
1023111|NCT01606137|2049609|FG000|Overall Study|Wanted to try another treatment|1
1023112|NCT01606137|2049609|FG000|Overall Study|Patient leaving country|1
1023113|NCT01606137|2049609|FG000|Overall Study|Personal reasons|1
1023114|NCT01606137|2049609|FG000|Overall Study|Unable to tolerate study med. taste|1
1023115|NCT01606137|2049609|FG000|Overall Study|Patient moving|1
1023116|NCT01606137|2049609|FG000|Overall Study|Unable to collect consistent data|1
1023117|NCT01606176|2049615|FG000|Overall Study|Adverse Event|2
1023118|NCT01606176|2049616|FG001|Overall Study|Adverse Event|3
1023119|NCT01606176|2049615|FG000|Overall Study|Disease progression|1
1023120|NCT01606176|2049616|FG001|Overall Study|Disease progression|0
1023121|NCT01606176|2049615|FG000|Overall Study|Withdrawal by Subject|1
1023122|NCT01606176|2049616|FG001|Overall Study|Withdrawal by Subject|0
1023123|NCT01606189|2049622|FG000|Second Intenvention (14-20 Days)|Adverse Event|0
1023124|NCT01606189|2049623|FG001|Second Intenvention (14-20 Days)|Adverse Event|0
1023125|NCT01606189|2049624|FG002|Second Intenvention (14-20 Days)|Adverse Event|0
1023126|NCT01606189|2049625|FG003|Second Intenvention (14-20 Days)|Adverse Event|0
1023127|NCT01606189|2049626|FG004|Second Intenvention (14-20 Days)|Adverse Event|0
1023128|NCT01606189|2049627|FG005|Second Intenvention (14-20 Days)|Adverse Event|1
1023129|NCT01606189|2049622|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1023130|NCT01606189|2049623|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1023131|NCT01606189|2049624|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1023132|NCT01606189|2049625|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1023133|NCT01606189|2049626|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1023134|NCT01606189|2049627|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
1023135|NCT01606202|2049637|FG000|Overall Study|Adverse Event|5
1023136|NCT01606202|2049638|FG001|Overall Study|Adverse Event|0
1023137|NCT01606202|2049637|FG000|Overall Study|Withdrawal by Subject|2
1023138|NCT01606202|2049638|FG001|Overall Study|Withdrawal by Subject|1
1023139|NCT01606202|2049637|FG000|Overall Study|Personal problems|0
1023140|NCT01606202|2049638|FG001|Overall Study|Personal problems|1
1023141|NCT01606202|2049637|FG000|Overall Study|Problems with administration|0
1023142|NCT01606202|2049638|FG001|Overall Study|Problems with administration|1
1023143|NCT01606228|2049644|FG000|Overall Study|Lost to Follow-up|20
1023144|NCT01606228|2049644|FG000|Overall Study|Withdrawal by Subject|3
1023145|NCT01606228|2049644|FG000|Overall Study|Non-compliant|3
1023146|NCT01606228|2049644|FG000|Overall Study|Lack of Efficacy|2
1023147|NCT01606228|2049644|FG000|Overall Study|Adverse Event|1
1023148|NCT01606254|2049652|FG000|Overall Study|Withdrawal by Subject|1
1023149|NCT01606254|2049653|FG001|Overall Study|Withdrawal by Subject|3
1023150|NCT01606254|2049654|FG002|Overall Study|Withdrawal by Subject|0
1023151|NCT01606254|2049655|FG003|Overall Study|Withdrawal by Subject|2
1023152|NCT01606254|2049652|FG000|Overall Study|Adverse Event|1
1023153|NCT01606254|2049653|FG001|Overall Study|Adverse Event|1
1023154|NCT01606254|2049654|FG002|Overall Study|Adverse Event|0
1023155|NCT01606254|2049655|FG003|Overall Study|Adverse Event|1
1023156|NCT01606306|2049671|FG000|Overall Study|Lack of Efficacy|2
1023157|NCT01606306|2049672|FG001|Overall Study|Lack of Efficacy|1
1023158|NCT01606306|2049673|FG002|Overall Study|Lack of Efficacy|4
1023159|NCT01606306|2049674|FG003|Overall Study|Lack of Efficacy|4
1023160|NCT01606306|2049675|FG004|Overall Study|Lack of Efficacy|1
1023161|NCT01606306|2049676|FG005|Overall Study|Lack of Efficacy|2
1023162|NCT01606306|2049671|FG000|Overall Study|Adverse Event|1
1023163|NCT01606306|2049672|FG001|Overall Study|Adverse Event|0
1023164|NCT01606306|2049673|FG002|Overall Study|Adverse Event|1
1023165|NCT01606306|2049674|FG003|Overall Study|Adverse Event|1
1023166|NCT01606306|2049675|FG004|Overall Study|Adverse Event|2
1023167|NCT01606306|2049676|FG005|Overall Study|Adverse Event|0
1023168|NCT01606306|2049671|FG000|Overall Study|Lost to Follow-up|7
1023169|NCT01606306|2049672|FG001|Overall Study|Lost to Follow-up|4
1023170|NCT01606306|2049673|FG002|Overall Study|Lost to Follow-up|5
1023171|NCT01606306|2049674|FG003|Overall Study|Lost to Follow-up|4
1023172|NCT01606306|2049675|FG004|Overall Study|Lost to Follow-up|3
1023173|NCT01606306|2049676|FG005|Overall Study|Lost to Follow-up|5
1023174|NCT01606306|2049671|FG000|Overall Study|Withdrawal by Subject|4
1023175|NCT01606306|2049672|FG001|Overall Study|Withdrawal by Subject|3
1023176|NCT01606306|2049673|FG002|Overall Study|Withdrawal by Subject|4
1023177|NCT01606306|2049674|FG003|Overall Study|Withdrawal by Subject|4
1023178|NCT01606306|2049675|FG004|Overall Study|Withdrawal by Subject|5
1023179|NCT01606306|2049676|FG005|Overall Study|Withdrawal by Subject|4
1023180|NCT01606306|2049671|FG000|Overall Study|Physician Decision|1
1023181|NCT01606306|2049672|FG001|Overall Study|Physician Decision|2
1023182|NCT01606306|2049673|FG002|Overall Study|Physician Decision|0
1023183|NCT01606306|2049674|FG003|Overall Study|Physician Decision|0
1023184|NCT01606306|2049675|FG004|Overall Study|Physician Decision|0
1023185|NCT01606306|2049676|FG005|Overall Study|Physician Decision|0
1023186|NCT01606319|2049684|FG000|Overall Study|Lost to Follow-up|17
1023187|NCT01606319|2049685|FG001|Overall Study|Lost to Follow-up|14
1023188|NCT01606319|2049684|FG000|Overall Study|Withdrawal by Subject|9
1023189|NCT01606319|2049685|FG001|Overall Study|Withdrawal by Subject|12
1023190|NCT01606319|2049684|FG000|Overall Study|Physician Decision|1
1023191|NCT01606319|2049685|FG001|Overall Study|Physician Decision|2
1023192|NCT01606319|2049684|FG000|Overall Study|Lack of Efficacy|6
1023193|NCT01606319|2049685|FG001|Overall Study|Lack of Efficacy|8
1023194|NCT01606319|2049684|FG000|Overall Study|Adverse Event|1
1023195|NCT01606319|2049685|FG001|Overall Study|Adverse Event|4
1023196|NCT01606670|2049691|FG000|Overall Study|Adverse Event|6
1023197|NCT01606670|2049691|FG000|Overall Study|Lack of Efficacy|2
1023198|NCT01606670|2049691|FG000|Overall Study|Lost to Follow-up|3
1023199|NCT01606670|2049691|FG000|Overall Study|Withdrawal by Subject|3
1023200|NCT01606670|2049691|FG000|Overall Study|Other Reason|2
1023201|NCT01606748|2049710|FG000|Overall Study|Adverse Event|1
1023202|NCT01606748|2049711|FG001|Overall Study|Adverse Event|0
1023203|NCT01606748|2049710|FG000|Overall Study|Progressive Disease|1
1023204|NCT01606748|2049711|FG001|Overall Study|Progressive Disease|0
1023205|NCT01606748|2049710|FG000|Overall Study|Withdrawal by Subject|1
1023206|NCT01606748|2049711|FG001|Overall Study|Withdrawal by Subject|0
1023207|NCT01606761|2049732|FG000|Prior to Week 24|Lost to Follow-up|0
1023208|NCT01606761|2049733|FG001|Prior to Week 24|Lost to Follow-up|3
1023209|NCT01606761|2049734|FG002|Prior to Week 24|Lost to Follow-up|2
1023210|NCT01606761|2049735|FG003|Prior to Week 24|Lost to Follow-up|0
1023211|NCT01606761|2049736|FG004|Prior to Week 24|Lost to Follow-up|0
1023212|NCT01606761|2049732|FG000|Prior to Week 24|Withdrawal by Subject|12
1023213|NCT01606761|2049733|FG001|Prior to Week 24|Withdrawal by Subject|10
1023214|NCT01606761|2049734|FG002|Prior to Week 24|Withdrawal by Subject|9
1023215|NCT01606761|2049735|FG003|Prior to Week 24|Withdrawal by Subject|0
1023216|NCT01606761|2049736|FG004|Prior to Week 24|Withdrawal by Subject|0
1023217|NCT01606761|2049732|FG000|Prior to Week 24|Adverse Event|11
1023218|NCT01606761|2049733|FG001|Prior to Week 24|Adverse Event|18
1023219|NCT01606761|2049734|FG002|Prior to Week 24|Adverse Event|22
1023220|NCT01606761|2049735|FG003|Prior to Week 24|Adverse Event|0
1023221|NCT01606761|2049736|FG004|Prior to Week 24|Adverse Event|0
1023222|NCT01606761|2049732|FG000|Prior to Week 24|Lack of Efficacy|15
1023223|NCT01606761|2049733|FG001|Prior to Week 24|Lack of Efficacy|14
1023224|NCT01606761|2049734|FG002|Prior to Week 24|Lack of Efficacy|8
1023225|NCT01606761|2049735|FG003|Prior to Week 24|Lack of Efficacy|0
1023226|NCT01606761|2049736|FG004|Prior to Week 24|Lack of Efficacy|0
1023227|NCT01606761|2049732|FG000|Prior to Week 24|Physician Decision|0
1023228|NCT01606761|2049733|FG001|Prior to Week 24|Physician Decision|3
1023229|NCT01606761|2049734|FG002|Prior to Week 24|Physician Decision|1
1023230|NCT01606761|2049735|FG003|Prior to Week 24|Physician Decision|0
1023231|NCT01606761|2049736|FG004|Prior to Week 24|Physician Decision|0
1023232|NCT01606761|2049732|FG000|Prior to Week 24|Other|4
1023233|NCT01606761|2049733|FG001|Prior to Week 24|Other|7
1023234|NCT01606761|2049734|FG002|Prior to Week 24|Other|5
1023235|NCT01606761|2049735|FG003|Prior to Week 24|Other|0
1023236|NCT01606761|2049736|FG004|Prior to Week 24|Other|0
1023237|NCT01606761|2049732|FG000|Week 24 to Week 52|Lost to Follow-up|0
1023238|NCT01606761|2049733|FG001|Week 24 to Week 52|Lost to Follow-up|1
1023239|NCT01606761|2049734|FG002|Week 24 to Week 52|Lost to Follow-up|1
1023240|NCT01606761|2049735|FG003|Week 24 to Week 52|Lost to Follow-up|1
1023241|NCT01606761|2049736|FG004|Week 24 to Week 52|Lost to Follow-up|0
1023242|NCT01606761|2049732|FG000|Week 24 to Week 52|Withdrawal by Subject|0
1023243|NCT01606761|2049733|FG001|Week 24 to Week 52|Withdrawal by Subject|6
1023244|NCT01606761|2049734|FG002|Week 24 to Week 52|Withdrawal by Subject|3
1023245|NCT01606761|2049735|FG003|Week 24 to Week 52|Withdrawal by Subject|0
1023246|NCT01606761|2049736|FG004|Week 24 to Week 52|Withdrawal by Subject|0
1023247|NCT01606761|2049732|FG000|Week 24 to Week 52|Adverse Event|0
1023248|NCT01606761|2049733|FG001|Week 24 to Week 52|Adverse Event|11
1023249|NCT01606761|2049734|FG002|Week 24 to Week 52|Adverse Event|14
1023250|NCT01606761|2049735|FG003|Week 24 to Week 52|Adverse Event|3
1023251|NCT01606761|2049736|FG004|Week 24 to Week 52|Adverse Event|15
1023252|NCT01606761|2049732|FG000|Week 24 to Week 52|Death|0
1023253|NCT01606761|2049733|FG001|Week 24 to Week 52|Death|0
1023254|NCT01606761|2049734|FG002|Week 24 to Week 52|Death|2
1023255|NCT01606761|2049735|FG003|Week 24 to Week 52|Death|1
1023256|NCT01606761|2049736|FG004|Week 24 to Week 52|Death|0
1023257|NCT01606761|2049732|FG000|Week 24 to Week 52|Lack of Efficacy|0
1023258|NCT01606761|2049733|FG001|Week 24 to Week 52|Lack of Efficacy|13
1023259|NCT01606761|2049734|FG002|Week 24 to Week 52|Lack of Efficacy|7
1023260|NCT01606761|2049735|FG003|Week 24 to Week 52|Lack of Efficacy|10
1023261|NCT01606761|2049736|FG004|Week 24 to Week 52|Lack of Efficacy|3
1023262|NCT01606761|2049732|FG000|Week 24 to Week 52|Physician Decision|0
1023263|NCT01606761|2049733|FG001|Week 24 to Week 52|Physician Decision|1
1023264|NCT01606761|2049734|FG002|Week 24 to Week 52|Physician Decision|1
1023265|NCT01606761|2049735|FG003|Week 24 to Week 52|Physician Decision|0
1023266|NCT01606761|2049736|FG004|Week 24 to Week 52|Physician Decision|0
1023267|NCT01606761|2049732|FG000|Week 24 to Week 52|Other|0
1023268|NCT01606761|2049733|FG001|Week 24 to Week 52|Other|1
1023269|NCT01606761|2049734|FG002|Week 24 to Week 52|Other|5
1023270|NCT01606761|2049735|FG003|Week 24 to Week 52|Other|2
1023271|NCT01606761|2049736|FG004|Week 24 to Week 52|Other|2
1023272|NCT01606761|2049732|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
1023273|NCT01606761|2049733|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
1023274|NCT01606761|2049734|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
1023275|NCT01606761|2049735|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
1023276|NCT01606761|2049736|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
1023277|NCT01606761|2049732|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
1023278|NCT01606761|2049733|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
1023279|NCT01606761|2049734|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
1023280|NCT01606761|2049735|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
1023281|NCT01606761|2049736|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
1023282|NCT01606761|2049732|FG000|Safety Follow-up Period (Week 52-68)|Death|0
1023283|NCT01606761|2049733|FG001|Safety Follow-up Period (Week 52-68)|Death|0
1023284|NCT01606761|2049734|FG002|Safety Follow-up Period (Week 52-68)|Death|0
1023285|NCT01606761|2049735|FG003|Safety Follow-up Period (Week 52-68)|Death|0
1023286|NCT01606761|2049736|FG004|Safety Follow-up Period (Week 52-68)|Death|1
1023287|NCT01606761|2049732|FG000|Safety Follow-up Period (Week 52-68)|Other|0
1023288|NCT01606761|2049733|FG001|Safety Follow-up Period (Week 52-68)|Other|3
1023289|NCT01606761|2049734|FG002|Safety Follow-up Period (Week 52-68)|Other|9
1023290|NCT01606761|2049735|FG003|Safety Follow-up Period (Week 52-68)|Other|1
1023291|NCT01606761|2049736|FG004|Safety Follow-up Period (Week 52-68)|Other|3
1023292|NCT01606787|2049753|FG000|Overall Study|Withdrawal by Subject|4
1023293|NCT01606787|2049754|FG001|Overall Study|Withdrawal by Subject|5
1023294|NCT01606787|2049753|FG000|Overall Study|Surgery canceled|0
1023295|NCT01606787|2049754|FG001|Overall Study|Surgery canceled|2
1023296|NCT01606800|2049762|FG000|Overall Study|Adverse Event|3
1023297|NCT01606800|2049763|FG001|Overall Study|Adverse Event|1
1023298|NCT01606800|2049762|FG000|Overall Study|Participant withdrew consent|0
1023299|NCT01606800|2049763|FG001|Overall Study|Participant withdrew consent|1
1023300|NCT01606800|2049762|FG000|Overall Study|Missing completion status|2
1023301|NCT01606800|2049763|FG001|Overall Study|Missing completion status|0
1023302|NCT01607073|2049778|FG000|Overall Study|Adverse Event|1
1023303|NCT01607346|2049821|FG000|Overall Study|Adverse Event|3
1023304|NCT01607398|2049827|FG000|Overall Study|Adverse Event|0
1023305|NCT01607398|2049828|FG001|Overall Study|Adverse Event|2
1023306|NCT01607398|2049827|FG000|Overall Study|Severe COPD|2
1023307|NCT01607398|2049828|FG001|Overall Study|Severe COPD|0
1023308|NCT01607476|2049884|FG000|Overall Study|Withdrawal by Subject|1
1023309|NCT01607476|2049885|FG001|Overall Study|Withdrawal by Subject|0
1023310|NCT01607476|2049886|FG002|Overall Study|Withdrawal by Subject|1
1023311|NCT01607476|2049884|FG000|Overall Study|Lost to Follow-up|0
1023312|NCT01607476|2049885|FG001|Overall Study|Lost to Follow-up|0
1023313|NCT01607476|2049886|FG002|Overall Study|Lost to Follow-up|2
1023314|NCT01607554|2049894|FG000|Overall Study|Disease progression|2
1023315|NCT01607593|2049898|FG000|Overall Study|Adverse Event|15
1023316|NCT01607593|2049898|FG000|Overall Study|Lack of Efficacy|16
1023317|NCT01607593|2049898|FG000|Overall Study|Lost to Follow-up|25
1023318|NCT01607593|2049898|FG000|Overall Study|Continuation|33
1023319|NCT01607593|2049898|FG000|Overall Study|Other|4
1023320|NCT01607892|2049940|FG000|Overall Study|Need of treatment not allowed per protocol|0
1023321|NCT01607892|2049941|FG001|Overall Study|Need of treatment not allowed per protocol|0
1023322|NCT01607892|2049942|FG002|Overall Study|Need of treatment not allowed per protocol|0
1023323|NCT01607892|2049943|FG003|Overall Study|Need of treatment not allowed per protocol|1
1023324|NCT01607892|2049944|FG004|Overall Study|Need of treatment not allowed per protocol|0
1023325|NCT01607892|2049940|FG000|Overall Study|Death|4
1023326|NCT01607892|2049941|FG001|Overall Study|Death|2
1023327|NCT01607892|2049942|FG002|Overall Study|Death|8
1023328|NCT01607892|2049943|FG003|Overall Study|Death|10
1023329|NCT01607892|2049944|FG004|Overall Study|Death|3
1023330|NCT01607892|2049940|FG000|Overall Study|Investigator discretion|2
1023331|NCT01607892|2049941|FG001|Overall Study|Investigator discretion|4
1023332|NCT01607892|2049942|FG002|Overall Study|Investigator discretion|4
1023333|NCT01607892|2049943|FG003|Overall Study|Investigator discretion|8
1023334|NCT01607892|2049944|FG004|Overall Study|Investigator discretion|0
1023335|NCT01607892|2049940|FG000|Overall Study|Other treatments became available|1
1023336|NCT01607892|2049941|FG001|Overall Study|Other treatments became available|1
1023337|NCT01607892|2049942|FG002|Overall Study|Other treatments became available|0
1023338|NCT01607892|2049943|FG003|Overall Study|Other treatments became available|0
1023339|NCT01607892|2049944|FG004|Overall Study|Other treatments became available|2
1023340|NCT01607892|2049940|FG000|Overall Study|Intercurrent illness|1
1023341|NCT01607892|2049941|FG001|Overall Study|Intercurrent illness|0
1023342|NCT01607892|2049942|FG002|Overall Study|Intercurrent illness|0
1023343|NCT01607892|2049943|FG003|Overall Study|Intercurrent illness|3
1023344|NCT01607892|2049944|FG004|Overall Study|Intercurrent illness|0
1023345|NCT01607892|2049940|FG000|Overall Study|Non-Compliance with study procedures|0
1023346|NCT01607892|2049941|FG001|Overall Study|Non-Compliance with study procedures|0
1023347|NCT01607892|2049942|FG002|Overall Study|Non-Compliance with study procedures|1
1023348|NCT01607892|2049943|FG003|Overall Study|Non-Compliance with study procedures|0
1023349|NCT01607892|2049944|FG004|Overall Study|Non-Compliance with study procedures|0
1023350|NCT01607892|2049940|FG000|Overall Study|Consent withdrawn by participant|9
1023351|NCT01607892|2049941|FG001|Overall Study|Consent withdrawn by participant|4
1023352|NCT01607892|2049942|FG002|Overall Study|Consent withdrawn by participant|24
1023353|NCT01607892|2049943|FG003|Overall Study|Consent withdrawn by participant|14
1023354|NCT01607892|2049944|FG004|Overall Study|Consent withdrawn by participant|4
1023355|NCT01607892|2049940|FG000|Overall Study|Disease progression|38
1023356|NCT01607892|2049941|FG001|Overall Study|Disease progression|13
1023357|NCT01607892|2049942|FG002|Overall Study|Disease progression|37
1023358|NCT01607892|2049943|FG003|Overall Study|Disease progression|57
1023359|NCT01607892|2049944|FG004|Overall Study|Disease progression|9
1023360|NCT01607892|2049940|FG000|Overall Study|Incidence or severity of Adverse events|3
1023361|NCT01607892|2049941|FG001|Overall Study|Incidence or severity of Adverse events|3
1023362|NCT01607892|2049942|FG002|Overall Study|Incidence or severity of Adverse events|7
1023363|NCT01607892|2049943|FG003|Overall Study|Incidence or severity of Adverse events|2
1023364|NCT01607892|2049944|FG004|Overall Study|Incidence or severity of Adverse events|6
1023365|NCT01607905|2049977|FG000|Overall Study|Withdrawal by participant|7
1023366|NCT01607905|2049978|FG001|Overall Study|Withdrawal by participant|2
1023367|NCT01607905|2049979|FG002|Overall Study|Withdrawal by participant|4
1023368|NCT01607905|2049980|FG003|Overall Study|Withdrawal by participant|6
1023369|NCT01607905|2049981|FG004|Overall Study|Withdrawal by participant|0
1023370|NCT01607905|2049982|FG005|Overall Study|Withdrawal by participant|4
1023371|NCT01607905|2049983|FG006|Overall Study|Withdrawal by participant|12
1023372|NCT01607905|2049977|FG000|Overall Study|Incidence or severity of AEs|5
1023373|NCT01607905|2049978|FG001|Overall Study|Incidence or severity of AEs|1
1023374|NCT01607905|2049979|FG002|Overall Study|Incidence or severity of AEs|1
1023375|NCT01607905|2049980|FG003|Overall Study|Incidence or severity of AEs|3
1023376|NCT01607905|2049981|FG004|Overall Study|Incidence or severity of AEs|0
1023377|NCT01607905|2049982|FG005|Overall Study|Incidence or severity of AEs|2
1023378|NCT01607905|2049983|FG006|Overall Study|Incidence or severity of AEs|8
1023379|NCT01607905|2049977|FG000|Overall Study|Disease progression|44
1023380|NCT01607905|2049978|FG001|Overall Study|Disease progression|16
1023381|NCT01607905|2049979|FG002|Overall Study|Disease progression|15
1023382|NCT01607905|2049980|FG003|Overall Study|Disease progression|11
1023383|NCT01607905|2049981|FG004|Overall Study|Disease progression|6
1023384|NCT01607905|2049982|FG005|Overall Study|Disease progression|7
1023385|NCT01607905|2049983|FG006|Overall Study|Disease progression|21
1023386|NCT01607905|2049977|FG000|Overall Study|Non-compliance with study procedures|0
1023387|NCT01607905|2049978|FG001|Overall Study|Non-compliance with study procedures|0
1023388|NCT01607905|2049979|FG002|Overall Study|Non-compliance with study procedures|0
1023389|NCT01607905|2049980|FG003|Overall Study|Non-compliance with study procedures|0
1023390|NCT01607905|2049981|FG004|Overall Study|Non-compliance with study procedures|0
1023391|NCT01607905|2049982|FG005|Overall Study|Non-compliance with study procedures|0
1023392|NCT01607905|2049983|FG006|Overall Study|Non-compliance with study procedures|1
1023393|NCT01607905|2049977|FG000|Overall Study|Death|1
1023394|NCT01607905|2049978|FG001|Overall Study|Death|1
1023395|NCT01607905|2049979|FG002|Overall Study|Death|1
1023396|NCT01607905|2049980|FG003|Overall Study|Death|1
1023397|NCT01607905|2049981|FG004|Overall Study|Death|0
1023398|NCT01607905|2049982|FG005|Overall Study|Death|0
1023399|NCT01607905|2049983|FG006|Overall Study|Death|3
1023400|NCT01607905|2049977|FG000|Overall Study|Other treatments become available|1
1023401|NCT01607905|2049978|FG001|Overall Study|Other treatments become available|0
1023402|NCT01607905|2049979|FG002|Overall Study|Other treatments become available|0
1023403|NCT01607905|2049980|FG003|Overall Study|Other treatments become available|0
1023404|NCT01607905|2049981|FG004|Overall Study|Other treatments become available|0
1023405|NCT01607905|2049982|FG005|Overall Study|Other treatments become available|0
1023406|NCT01607905|2049983|FG006|Overall Study|Other treatments become available|1
1023407|NCT01607905|2049977|FG000|Overall Study|Investigator discretion|0
1023408|NCT01607905|2049978|FG001|Overall Study|Investigator discretion|0
1023409|NCT01607905|2049979|FG002|Overall Study|Investigator discretion|0
1023410|NCT01607905|2049980|FG003|Overall Study|Investigator discretion|0
1023411|NCT01607905|2049981|FG004|Overall Study|Investigator discretion|0
1023412|NCT01607905|2049982|FG005|Overall Study|Investigator discretion|1
1023413|NCT01607905|2049983|FG006|Overall Study|Investigator discretion|0
1023414|NCT01607905|2049977|FG000|Overall Study|Other|1
1023415|NCT01607905|2049978|FG001|Overall Study|Other|0
1023416|NCT01607905|2049979|FG002|Overall Study|Other|0
1023417|NCT01607905|2049980|FG003|Overall Study|Other|0
1023418|NCT01607905|2049981|FG004|Overall Study|Other|0
1023419|NCT01607905|2049982|FG005|Overall Study|Other|0
1023420|NCT01607905|2049983|FG006|Overall Study|Other|1
1023421|NCT01607905|2049977|FG000|Overall Study|Randomized but not treated|1
1023422|NCT01607905|2049978|FG001|Overall Study|Randomized but not treated|0
1023423|NCT01607905|2049979|FG002|Overall Study|Randomized but not treated|0
1023424|NCT01607905|2049980|FG003|Overall Study|Randomized but not treated|0
1023425|NCT01607905|2049981|FG004|Overall Study|Randomized but not treated|1
1023426|NCT01607905|2049982|FG005|Overall Study|Randomized but not treated|1
1023427|NCT01607905|2049983|FG006|Overall Study|Randomized but not treated|0
1023428|NCT01607957|2050043|FG000|Overall Study|Not treated|1
1023429|NCT01607957|2050044|FG001|Overall Study|Not treated|1
1023430|NCT01607957|2050043|FG000|Overall Study|Death|367
1023431|NCT01607957|2050044|FG001|Overall Study|Death|211
1023432|NCT01607957|2050043|FG000|Overall Study|Lost to Follow-up|3
1023433|NCT01607957|2050044|FG001|Overall Study|Lost to Follow-up|3
1023434|NCT01607957|2050043|FG000|Overall Study|Participant refusal|1
1023435|NCT01607957|2050044|FG001|Overall Study|Participant refusal|0
1023436|NCT01608087|2050063|FG000|Overall Study|Lost to Follow-up|0
1023437|NCT01608087|2050064|FG001|Overall Study|Lost to Follow-up|1
1023438|NCT01608087|2050065|FG002|Overall Study|Lost to Follow-up|0
1023439|NCT01608087|2050063|FG000|Overall Study|Other Reason|0
1023440|NCT01608087|2050064|FG001|Overall Study|Other Reason|1
1023441|NCT01608087|2050065|FG002|Overall Study|Other Reason|0
1023442|NCT01608308|2050111|FG000|Overall Study|pretreatment medical and billing reasons|0
1023443|NCT01608308|2050112|FG001|Overall Study|pretreatment medical and billing reasons|2
1023444|NCT01608321|2050120|FG000|Overall Study|Withdrawal by Subject|1
1023445|NCT01608321|2050121|FG001|Overall Study|Withdrawal by Subject|0
1023446|NCT01608724|2050144|FG000|Overall Study|Withdrawal by Subject|131
1023447|NCT01608724|2050144|FG000|Overall Study|Lost to Follow-up|41
1023448|NCT01608724|2050144|FG000|Overall Study|Study-specific discontinuation criteria|32
1023449|NCT01608724|2050144|FG000|Overall Study|Adverse Event|29
1023450|NCT01608724|2050144|FG000|Overall Study|Protocol Violation|6
1023451|NCT01608724|2050144|FG000|Overall Study|bood sugar too high, etc.|3
1023452|NCT01608724|2050144|FG000|Overall Study|Safety reasons|1
1023453|NCT01609010|2050175|FG000|Overall Study|Stable disease (SD)|22
1023454|NCT01609010|2050176|FG001|Overall Study|Stable disease (SD)|16
1023455|NCT01609010|2050175|FG000|Overall Study|Progressive disease (PD)|8
1023456|NCT01609010|2050176|FG001|Overall Study|Progressive disease (PD)|10
1023457|NCT01609010|2050175|FG000|Overall Study|Adverse Event|3
1023458|NCT01609010|2050176|FG001|Overall Study|Adverse Event|6
1023459|NCT01609010|2050175|FG000|Overall Study|Withdrawal by Subject|2
1023460|NCT01609010|2050176|FG001|Overall Study|Withdrawal by Subject|2
1023461|NCT01609010|2050175|FG000|Overall Study|Other|2
1023462|NCT01609010|2050176|FG001|Overall Study|Other|0
1023463|NCT01609010|2050175|FG000|Overall Study|Other malignancy|1
1023464|NCT01609010|2050176|FG001|Overall Study|Other malignancy|0
1023465|NCT01609010|2050175|FG000|Overall Study|Pathology review|2
1023466|NCT01609010|2050176|FG001|Overall Study|Pathology review|1
1023467|NCT01609010|2050175|FG000|Overall Study|Protocol Violation|1
1023468|NCT01609010|2050176|FG001|Overall Study|Protocol Violation|1
1023469|NCT01609010|2050175|FG000|Overall Study|New cancer|1
1023470|NCT01609010|2050176|FG001|Overall Study|New cancer|0
1023471|NCT01609010|2050175|FG000|Overall Study|Lost to Follow-up|1
1023472|NCT01609010|2050176|FG001|Overall Study|Lost to Follow-up|1
1023473|NCT01609023|2050182|FG000|Overall Study|Lack of Efficacy|3
1023474|NCT01609023|2050182|FG000|Overall Study|Withdrawal by Subject|4
1023475|NCT01609023|2050182|FG000|Overall Study|Lost to Follow-up|8
1023476|NCT01609023|2050182|FG000|Overall Study|Toxicity|3
1023477|NCT01609023|2050182|FG000|Overall Study|Disease progression|10
1023478|NCT01609023|2050182|FG000|Overall Study|Physician Decision|2
1023479|NCT01609023|2050182|FG000|Overall Study|Death|2
1023480|NCT01609023|2050182|FG000|Overall Study|Personal reasons|1
1023481|NCT01609062|2050188|FG000|Extension Phase|Terminated by Sponsor|14
1023482|NCT01609062|2050189|FG001|Extension Phase|Terminated by Sponsor|9
1023483|NCT01609062|2050188|FG000|Extension Phase|Discontinued drug and then was pregnant|1
1023484|NCT01609062|2050189|FG001|Extension Phase|Discontinued drug and then was pregnant|0
1023485|NCT01609062|2050188|FG000|Extension Phase|Anticipated surgery & transition to EAP|0
1023486|NCT01609062|2050189|FG001|Extension Phase|Anticipated surgery & transition to EAP|1
1023487|NCT01609218|2050196|FG000|Period 1|Adverse Event|3
1023488|NCT01609218|2050197|FG001|Period 1|Adverse Event|5
1023489|NCT01609218|2050196|FG000|Period 1|Sponsor Decision|0
1023490|NCT01609218|2050197|FG001|Period 1|Sponsor Decision|1
1023491|NCT01609218|2050196|FG000|Period 2|Adverse Event|1
1023492|NCT01609218|2050197|FG001|Period 2|Adverse Event|0
1023493|NCT01609257|2050205|FG000|Overall Study|Lost to Follow-up|2
1023494|NCT01609257|2050206|FG001|Overall Study|Lost to Follow-up|1
1023495|NCT01609257|2050205|FG000|Overall Study|Voluntary Withdrawal by Subject|0
1023496|NCT01609257|2050206|FG001|Overall Study|Voluntary Withdrawal by Subject|1
1023497|NCT01609257|2050205|FG000|Overall Study|Non-compliance/Protocol deviation|4
1023498|NCT01609257|2050206|FG001|Overall Study|Non-compliance/Protocol deviation|6
1023499|NCT01609296|2050215|FG000|Overall Study|Death|253
1023500|NCT01609296|2050215|FG000|Overall Study|Withdrawal by Subject|151
1023501|NCT01609296|2050215|FG000|Overall Study|Lost to Follow-up|21
1023502|NCT01609296|2050215|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35
1023503|NCT01609296|2050215|FG000|Overall Study|missed visit but known to be alive|28
1023504|NCT01609478|2050235|FG000|Overall Study|Adverse Event|3
1023505|NCT01609478|2050236|FG001|Overall Study|Adverse Event|1
1023506|NCT01609478|2050237|FG002|Overall Study|Adverse Event|5
1023507|NCT01609478|2050235|FG000|Overall Study|Protocol Deviation|0
1023508|NCT01609478|2050236|FG001|Overall Study|Protocol Deviation|1
1023509|NCT01609478|2050237|FG002|Overall Study|Protocol Deviation|1
1023510|NCT01609478|2050235|FG000|Overall Study|Non-Compliance with study treatment|1
1023511|NCT01609478|2050236|FG001|Overall Study|Non-Compliance with study treatment|0
1023512|NCT01609478|2050237|FG002|Overall Study|Non-Compliance with study treatment|0
1023513|NCT01609478|2050235|FG000|Overall Study|Physician Decision|1
1023514|NCT01609478|2050236|FG001|Overall Study|Physician Decision|0
1023515|NCT01609478|2050237|FG002|Overall Study|Physician Decision|1
1023516|NCT01609478|2050235|FG000|Overall Study|Withdrawal by Subject|2
1023517|NCT01609478|2050236|FG001|Overall Study|Withdrawal by Subject|0
1023518|NCT01609478|2050237|FG002|Overall Study|Withdrawal by Subject|2
1023519|NCT01609543|2050245|FG000|Overall Study|Disease Progression|28
1023520|NCT01609543|2050245|FG000|Overall Study|Adverse Event|5
1023521|NCT01609543|2050245|FG000|Overall Study|Withdrawal by Subject|1
1023522|NCT01609543|2050245|FG000|Overall Study|Protocol Violation|1
1023523|NCT01609543|2050245|FG000|Overall Study|Death|7
1023524|NCT01609556|2050266|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
1023525|NCT01609556|2050267|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
1023526|NCT01609556|2050268|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
1023527|NCT01609556|2050269|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
1023528|NCT01609556|2050270|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
1023529|NCT01609556|2050271|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
1023530|NCT01609556|2050272|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
1023531|NCT01609556|2050273|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
1023532|NCT01609556|2050274|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
1023533|NCT01609556|2050275|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
1023534|NCT01609556|2050276|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
1023535|NCT01609556|2050277|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
1023536|NCT01609556|2050278|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
1023537|NCT01609556|2050279|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
1023538|NCT01609556|2050280|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
1023539|NCT01609556|2050281|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
1023540|NCT01609556|2050266|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
1023541|NCT01609556|2050267|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
1023542|NCT01609556|2050268|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
1023543|NCT01609556|2050269|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
1023544|NCT01609556|2050270|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8
1023545|NCT01609556|2050271|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13
1023546|NCT01609556|2050272|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5
1023547|NCT01609556|2050273|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4
1023548|NCT01609556|2050274|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
1023549|NCT01609556|2050275|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
1023550|NCT01609556|2050276|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6
1023551|NCT01609556|2050277|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
1023552|NCT01609556|2050278|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
1023553|NCT01609556|2050279|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
1023554|NCT01609556|2050280|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
1023555|NCT01609556|2050281|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
1023556|NCT01609556|2050266|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
1023557|NCT01609556|2050267|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
1023558|NCT01609556|2050268|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
1023559|NCT01609556|2050269|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
1023560|NCT01609556|2050270|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
1023561|NCT01609556|2050271|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
1023562|NCT01609556|2050272|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
1023563|NCT01609556|2050273|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
1023564|NCT01609556|2050274|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
1023565|NCT01609556|2050275|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
1023566|NCT01609556|2050276|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
1023567|NCT01609556|2050277|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
1023568|NCT01609556|2050278|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
1023569|NCT01609556|2050279|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
1023570|NCT01609556|2050280|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
1023571|NCT01609556|2050281|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
1023572|NCT01609556|2050266|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023573|NCT01609556|2050267|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023574|NCT01609556|2050268|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023575|NCT01609556|2050269|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023576|NCT01609556|2050270|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023577|NCT01609556|2050271|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
1023578|NCT01609556|2050272|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023579|NCT01609556|2050273|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023580|NCT01609556|2050274|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023581|NCT01609556|2050275|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023582|NCT01609556|2050276|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023583|NCT01609556|2050277|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
1023584|NCT01609556|2050278|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023585|NCT01609556|2050279|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023586|NCT01609556|2050280|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023587|NCT01609556|2050281|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
1023588|NCT01609556|2050266|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023589|NCT01609556|2050267|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023590|NCT01609556|2050268|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023591|NCT01609556|2050269|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023592|NCT01609556|2050270|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023593|NCT01609556|2050271|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1
1023594|NCT01609556|2050272|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023595|NCT01609556|2050273|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023596|NCT01609556|2050274|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023597|NCT01609556|2050275|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023598|NCT01609556|2050276|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023599|NCT01609556|2050277|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023600|NCT01609556|2050278|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023601|NCT01609556|2050279|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023602|NCT01609556|2050280|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023603|NCT01609556|2050281|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
1023604|NCT01609556|2050266|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023605|NCT01609556|2050267|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023606|NCT01609556|2050268|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023607|NCT01609556|2050269|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023608|NCT01609556|2050270|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023609|NCT01609556|2050271|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023610|NCT01609556|2050272|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023611|NCT01609556|2050273|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023612|NCT01609556|2050274|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1
1023613|NCT01609556|2050275|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023614|NCT01609556|2050276|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023615|NCT01609556|2050277|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023616|NCT01609556|2050278|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023617|NCT01609556|2050279|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023618|NCT01609556|2050280|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023619|NCT01609556|2050281|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
1023620|NCT01609556|2050266|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2
1023621|NCT01609556|2050267|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023622|NCT01609556|2050268|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023623|NCT01609556|2050269|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023624|NCT01609556|2050270|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023625|NCT01609556|2050271|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1
1023626|NCT01609556|2050272|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023627|NCT01609556|2050273|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023628|NCT01609556|2050274|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023629|NCT01609556|2050275|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023630|NCT01609556|2050276|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1
1023631|NCT01609556|2050277|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023632|NCT01609556|2050278|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023633|NCT01609556|2050279|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023634|NCT01609556|2050280|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023635|NCT01609556|2050281|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0
1023636|NCT01609556|2050266|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023637|NCT01609556|2050267|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023638|NCT01609556|2050268|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023639|NCT01609556|2050269|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023640|NCT01609556|2050270|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023641|NCT01609556|2050271|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023642|NCT01609556|2050272|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023643|NCT01609556|2050273|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023644|NCT01609556|2050274|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023645|NCT01609556|2050275|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023646|NCT01609556|2050276|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023647|NCT01609556|2050277|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
1023648|NCT01609556|2050278|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4
1023649|NCT01609556|2050279|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
1023650|NCT01609556|2050280|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
1023651|NCT01609556|2050281|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
1023652|NCT01609556|2050266|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023653|NCT01609556|2050267|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023654|NCT01609556|2050268|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023655|NCT01609556|2050269|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023656|NCT01609556|2050270|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023657|NCT01609556|2050271|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023658|NCT01609556|2050272|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023659|NCT01609556|2050273|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023660|NCT01609556|2050274|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023661|NCT01609556|2050275|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023662|NCT01609556|2050276|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023663|NCT01609556|2050277|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
1023664|NCT01609556|2050278|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32
1023665|NCT01609556|2050279|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13
1023666|NCT01609556|2050280|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20
1023667|NCT01609556|2050281|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27
1023668|NCT01609556|2050266|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023669|NCT01609556|2050267|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023670|NCT01609556|2050268|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023671|NCT01609556|2050269|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023672|NCT01609556|2050270|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023673|NCT01609556|2050271|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023674|NCT01609556|2050272|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023675|NCT01609556|2050273|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023676|NCT01609556|2050274|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023677|NCT01609556|2050275|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023678|NCT01609556|2050276|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023679|NCT01609556|2050277|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
1023680|NCT01609556|2050278|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
1023681|NCT01609556|2050279|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
1023682|NCT01609556|2050280|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
1023683|NCT01609556|2050281|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2
1023684|NCT01609556|2050266|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
904996|NCT00760214|1880199|FG002|Overall Study|Lost to Follow-up|1
904997|NCT00760214|1880197|FG000|Overall Study|Withdrawal by Subject|12
1023685|NCT01609556|2050267|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023686|NCT01609556|2050268|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023687|NCT01609556|2050269|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023688|NCT01609556|2050270|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023689|NCT01609556|2050271|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023690|NCT01609556|2050272|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023691|NCT01609556|2050273|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023692|NCT01609556|2050274|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023693|NCT01609556|2050275|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023694|NCT01609556|2050276|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023695|NCT01609556|2050277|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023696|NCT01609556|2050278|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1
1023697|NCT01609556|2050279|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023698|NCT01609556|2050280|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023699|NCT01609556|2050281|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
1023700|NCT01609556|2050266|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023701|NCT01609556|2050267|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023702|NCT01609556|2050268|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023703|NCT01609556|2050269|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023704|NCT01609556|2050270|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023705|NCT01609556|2050271|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023706|NCT01609556|2050272|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023707|NCT01609556|2050273|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023708|NCT01609556|2050274|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023709|NCT01609556|2050275|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023710|NCT01609556|2050276|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023711|NCT01609556|2050277|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
1023712|NCT01609556|2050278|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1
1023713|NCT01609556|2050279|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4
1023714|NCT01609556|2050280|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2
1023715|NCT01609556|2050281|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5
1023716|NCT01609556|2050266|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023717|NCT01609556|2050267|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023718|NCT01609556|2050268|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023719|NCT01609556|2050269|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023720|NCT01609556|2050270|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023721|NCT01609556|2050271|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023722|NCT01609556|2050272|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023723|NCT01609556|2050273|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023724|NCT01609556|2050274|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023725|NCT01609556|2050275|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023726|NCT01609556|2050276|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023727|NCT01609556|2050277|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023728|NCT01609556|2050278|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023729|NCT01609556|2050279|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023730|NCT01609556|2050280|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
1023731|NCT01609556|2050281|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1
1023732|NCT01609556|2050266|FG000|Dose Expansion: Maximum 124 Weeks|Death|0
1023733|NCT01609556|2050267|FG001|Dose Expansion: Maximum 124 Weeks|Death|0
1023734|NCT01609556|2050268|FG002|Dose Expansion: Maximum 124 Weeks|Death|0
1023735|NCT01609556|2050269|FG003|Dose Expansion: Maximum 124 Weeks|Death|0
1023736|NCT01609556|2050270|FG004|Dose Expansion: Maximum 124 Weeks|Death|0
1023737|NCT01609556|2050271|FG005|Dose Expansion: Maximum 124 Weeks|Death|0
1023738|NCT01609556|2050272|FG006|Dose Expansion: Maximum 124 Weeks|Death|0
1023739|NCT01609556|2050273|FG007|Dose Expansion: Maximum 124 Weeks|Death|0
1023740|NCT01609556|2050274|FG008|Dose Expansion: Maximum 124 Weeks|Death|0
1023741|NCT01609556|2050275|FG009|Dose Expansion: Maximum 124 Weeks|Death|0
1023742|NCT01609556|2050276|FG010|Dose Expansion: Maximum 124 Weeks|Death|0
1023743|NCT01609556|2050277|FG011|Dose Expansion: Maximum 124 Weeks|Death|0
1023744|NCT01609556|2050278|FG012|Dose Expansion: Maximum 124 Weeks|Death|4
1023745|NCT01609556|2050279|FG013|Dose Expansion: Maximum 124 Weeks|Death|2
1023746|NCT01609556|2050280|FG014|Dose Expansion: Maximum 124 Weeks|Death|0
1023747|NCT01609556|2050281|FG015|Dose Expansion: Maximum 124 Weeks|Death|3
1023748|NCT01609556|2050266|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023749|NCT01609556|2050267|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023750|NCT01609556|2050268|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023751|NCT01609556|2050269|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023752|NCT01609556|2050270|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023753|NCT01609556|2050271|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023754|NCT01609556|2050272|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023755|NCT01609556|2050273|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023756|NCT01609556|2050274|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023757|NCT01609556|2050275|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023758|NCT01609556|2050276|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023759|NCT01609556|2050277|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023760|NCT01609556|2050278|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1
1023761|NCT01609556|2050279|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023762|NCT01609556|2050280|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023763|NCT01609556|2050281|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
1023764|NCT01609582|2050324|FG000|Overall Study|Adverse Event|20
1023765|NCT01609582|2050325|FG001|Overall Study|Adverse Event|18
1023766|NCT01609582|2050324|FG000|Overall Study|Lost to Follow-up|10
1023767|NCT01609582|2050325|FG001|Overall Study|Lost to Follow-up|10
1023768|NCT01609582|2050324|FG000|Overall Study|Withdrawal by Subject|21
1023769|NCT01609582|2050325|FG001|Overall Study|Withdrawal by Subject|15
1023770|NCT01609582|2050324|FG000|Overall Study|Study Terminated by Sponsor|1543
1023771|NCT01609582|2050325|FG001|Overall Study|Study Terminated by Sponsor|1548
1023772|NCT01609582|2050324|FG000|Overall Study|Other|9
1023773|NCT01609582|2050325|FG001|Overall Study|Other|10
1023774|NCT01609582|2050324|FG000|Overall Study|Randomized, but not treated|0
1023775|NCT01609582|2050325|FG001|Overall Study|Randomized, but not treated|3
1023779|NCT01609842|2050348|FG000|Concurrent Intervention Control|pharmacy data not available|2
1023780|NCT01609842|2050349|FG001|Concurrent Intervention Control|pharmacy data not available|0
1023781|NCT01609933|2050359|FG000|Overall Study|Adverse Event|1
1023782|NCT01609933|2050359|FG000|Overall Study|Withdrawal by Subject|3
1023783|NCT01610037|2050377|FG000|All Patients|Adverse Event|27
1023784|NCT01610037|2050378|FG001|All Patients|Adverse Event|22
1023785|NCT01610037|2050379|FG002|All Patients|Adverse Event|26
1023786|NCT01610037|2050377|FG000|All Patients|Withdrawal by Subject|12
1023787|NCT01610037|2050378|FG001|All Patients|Withdrawal by Subject|10
1023788|NCT01610037|2050379|FG002|All Patients|Withdrawal by Subject|20
1023789|NCT01610037|2050377|FG000|All Patients|Unsatisfactory therapeutic effect|9
1023790|NCT01610037|2050378|FG001|All Patients|Unsatisfactory therapeutic effect|8
1023791|NCT01610037|2050379|FG002|All Patients|Unsatisfactory therapeutic effect|27
1023792|NCT01610037|2050377|FG000|All Patients|Death|4
1023793|NCT01610037|2050378|FG001|All Patients|Death|2
1023794|NCT01610037|2050379|FG002|All Patients|Death|1
1023795|NCT01610037|2050377|FG000|All Patients|Protocol deviation|4
1023796|NCT01610037|2050378|FG001|All Patients|Protocol deviation|3
1023797|NCT01610037|2050379|FG002|All Patients|Protocol deviation|3
1023798|NCT01610037|2050377|FG000|All Patients|Abnormal laboratory value|1
1023799|NCT01610037|2050378|FG001|All Patients|Abnormal laboratory value|1
1023800|NCT01610037|2050379|FG002|All Patients|Abnormal laboratory value|0
1023801|NCT01610037|2050377|FG000|All Patients|Administrative problems|1
1023802|NCT01610037|2050378|FG001|All Patients|Administrative problems|4
1023803|NCT01610037|2050379|FG002|All Patients|Administrative problems|4
1023804|NCT01610037|2050377|FG000|All Patients|Lost to Follow-up|1
1023805|NCT01610037|2050378|FG001|All Patients|Lost to Follow-up|0
1023806|NCT01610037|2050379|FG002|All Patients|Lost to Follow-up|0
1023807|NCT01610037|2050377|FG000|All Patients|Abnormal test procedure result(s)|0
1023808|NCT01610037|2050378|FG001|All Patients|Abnormal test procedure result(s)|1
1023809|NCT01610037|2050379|FG002|All Patients|Abnormal test procedure result(s)|3
1023810|NCT01610037|2050377|FG000|Treatment and Follow up Period|Subject withdrew consent|13
1023811|NCT01610037|2050378|FG001|Treatment and Follow up Period|Subject withdrew consent|14
1023812|NCT01610037|2050379|FG002|Treatment and Follow up Period|Subject withdrew consent|16
1023813|NCT01610037|2050377|FG000|Treatment and Follow up Period|Death|10
1023814|NCT01610037|2050378|FG001|Treatment and Follow up Period|Death|5
1023815|NCT01610037|2050379|FG002|Treatment and Follow up Period|Death|4
1023816|NCT01610037|2050377|FG000|Treatment and Follow up Period|Administrative problems|1
1023817|NCT01610037|2050378|FG001|Treatment and Follow up Period|Administrative problems|3
1023818|NCT01610037|2050379|FG002|Treatment and Follow up Period|Administrative problems|2
1023819|NCT01610037|2050377|FG000|Treatment and Follow up Period|Lost to Follow-up|1
1023820|NCT01610037|2050378|FG001|Treatment and Follow up Period|Lost to Follow-up|6
1023821|NCT01610037|2050379|FG002|Treatment and Follow up Period|Lost to Follow-up|4
1023822|NCT01610063|2050389|FG000|Overall Study|Lost to Follow-up|42
1023823|NCT01610063|2050390|FG001|Overall Study|Lost to Follow-up|20
1023824|NCT01610076|2050398|FG000|Overall Study|Technical issue with video|0
1023825|NCT01610076|2050399|FG001|Overall Study|Technical issue with video|1
1023826|NCT01610076|2050398|FG000|Overall Study|Lost to Follow-up|3
1023827|NCT01610076|2050399|FG001|Overall Study|Lost to Follow-up|4
1023828|NCT01610167|2050415|FG000|Overall Study|Scheduling conflict.|0
1023829|NCT01610167|2050416|FG001|Overall Study|Scheduling conflict.|0
1023830|NCT01610167|2050417|FG002|Overall Study|Scheduling conflict.|2
1023831|NCT01610206|2050427|FG000|Overall Study|Adverse Event|10
1023832|NCT01610206|2050428|FG001|Overall Study|Adverse Event|30
1023833|NCT01610271|2050436|FG000|Overall Study|Surgery not complete|0
1023834|NCT01610271|2050437|FG001|Overall Study|Surgery not complete|1
1023835|NCT01610271|2050436|FG000|Overall Study|Prosthesis not implanted|2
1023836|NCT01610271|2050437|FG001|Overall Study|Prosthesis not implanted|3
1023837|NCT01610284|2050447|FG000|Randomization Phase|Adverse Event|1
1023838|NCT01610284|2050448|FG001|Randomization Phase|Adverse Event|0
1023839|NCT01610284|2050447|FG000|Randomization Phase|Physician Decision|1
1023840|NCT01610284|2050448|FG001|Randomization Phase|Physician Decision|1
1023841|NCT01610284|2050447|FG000|Randomization Phase|Death|0
1023842|NCT01610284|2050448|FG001|Randomization Phase|Death|1
1023843|NCT01610284|2050447|FG000|Treatment Phase|Adverse Event|80
1023844|NCT01610284|2050448|FG001|Treatment Phase|Adverse Event|12
1023845|NCT01610284|2050447|FG000|Treatment Phase|Lost to Follow-up|1
1023846|NCT01610284|2050448|FG001|Treatment Phase|Lost to Follow-up|0
1023847|NCT01610284|2050447|FG000|Treatment Phase|Non-compliance with Study Treatment|8
1023848|NCT01610284|2050448|FG001|Treatment Phase|Non-compliance with Study Treatment|1
1023849|NCT01610284|2050447|FG000|Treatment Phase|Physician Decision|27
1023850|NCT01610284|2050448|FG001|Treatment Phase|Physician Decision|24
1023851|NCT01610284|2050447|FG000|Treatment Phase|Progressive Disease|377
1023852|NCT01610284|2050448|FG001|Treatment Phase|Progressive Disease|486
1023853|NCT01610284|2050447|FG000|Treatment Phase|Protocol Deviation|2
1023854|NCT01610284|2050448|FG001|Treatment Phase|Protocol Deviation|3
1023855|NCT01610284|2050447|FG000|Treatment Phase|Study terminated by Sponsor|18
1023856|NCT01610284|2050448|FG001|Treatment Phase|Study terminated by Sponsor|15
1023857|NCT01610284|2050447|FG000|Treatment Phase|Subject/Guardian Decision|55
1023858|NCT01610284|2050448|FG001|Treatment Phase|Subject/Guardian Decision|23
1023859|NCT01610284|2050447|FG000|Treatment Phase|Death|6
1023860|NCT01610284|2050448|FG001|Treatment Phase|Death|5
1023861|NCT01610284|2050447|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
1023862|NCT01610284|2050448|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
1023863|NCT01610284|2050447|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10
1023864|NCT01610284|2050448|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3
1023865|NCT01610284|2050447|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24
1023866|NCT01610284|2050448|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8
1023867|NCT01610284|2050447|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11
1023868|NCT01610284|2050448|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
1023869|NCT01610284|2050447|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4
1023870|NCT01610284|2050448|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4
1023871|NCT01610284|2050447|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38
1023872|NCT01610284|2050448|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13
1023873|NCT01610297|2050454|FG000|Overall Study|Lost to Follow-up|1
1023874|NCT01610336|2050469|FG000|Overall Study|Progressive Disease|4
1023875|NCT01610336|2050470|FG001|Overall Study|Progressive Disease|6
1023876|NCT01610336|2050471|FG002|Overall Study|Progressive Disease|6
1023877|NCT01610336|2050472|FG003|Overall Study|Progressive Disease|5
1023878|NCT01610336|2050473|FG004|Overall Study|Progressive Disease|3
1023879|NCT01610336|2050474|FG005|Overall Study|Progressive Disease|10
1023880|NCT01610336|2050475|FG006|Overall Study|Progressive Disease|1
1023881|NCT01610336|2050476|FG007|Overall Study|Progressive Disease|6
1023882|NCT01610336|2050477|FG008|Overall Study|Progressive Disease|6
1023883|NCT01610336|2050478|FG009|Overall Study|Progressive Disease|40
1023884|NCT01610336|2050479|FG010|Overall Study|Progressive Disease|36
1023885|NCT01610336|2050469|FG000|Overall Study|Adverse Event|0
1023886|NCT01610336|2050470|FG001|Overall Study|Adverse Event|0
1023887|NCT01610336|2050471|FG002|Overall Study|Adverse Event|0
1023888|NCT01610336|2050472|FG003|Overall Study|Adverse Event|1
1023889|NCT01610336|2050473|FG004|Overall Study|Adverse Event|1
1023890|NCT01610336|2050474|FG005|Overall Study|Adverse Event|1
1023891|NCT01610336|2050475|FG006|Overall Study|Adverse Event|0
1023892|NCT01610336|2050476|FG007|Overall Study|Adverse Event|0
1023893|NCT01610336|2050477|FG008|Overall Study|Adverse Event|2
1023894|NCT01610336|2050478|FG009|Overall Study|Adverse Event|8
1023895|NCT01610336|2050479|FG010|Overall Study|Adverse Event|6
1023896|NCT01610336|2050469|FG000|Overall Study|Subject/Guardian decision|1
1023897|NCT01610336|2050470|FG001|Overall Study|Subject/Guardian decision|1
1023898|NCT01610336|2050471|FG002|Overall Study|Subject/Guardian decision|0
1023899|NCT01610336|2050472|FG003|Overall Study|Subject/Guardian decision|1
1023900|NCT01610336|2050473|FG004|Overall Study|Subject/Guardian decision|0
1023901|NCT01610336|2050474|FG005|Overall Study|Subject/Guardian decision|0
1023902|NCT01610336|2050475|FG006|Overall Study|Subject/Guardian decision|0
1023903|NCT01610336|2050476|FG007|Overall Study|Subject/Guardian decision|1
1023904|NCT01610336|2050477|FG008|Overall Study|Subject/Guardian decision|0
1023905|NCT01610336|2050478|FG009|Overall Study|Subject/Guardian decision|2
1023906|NCT01610336|2050479|FG010|Overall Study|Subject/Guardian decision|2
1023907|NCT01610336|2050469|FG000|Overall Study|Death|0
1023908|NCT01610336|2050470|FG001|Overall Study|Death|0
1023909|NCT01610336|2050471|FG002|Overall Study|Death|0
1023910|NCT01610336|2050472|FG003|Overall Study|Death|0
1023911|NCT01610336|2050473|FG004|Overall Study|Death|0
1023912|NCT01610336|2050474|FG005|Overall Study|Death|1
1023913|NCT01610336|2050475|FG006|Overall Study|Death|3
1023914|NCT01610336|2050476|FG007|Overall Study|Death|0
1023915|NCT01610336|2050477|FG008|Overall Study|Death|0
1023916|NCT01610336|2050478|FG009|Overall Study|Death|1
1023917|NCT01610336|2050479|FG010|Overall Study|Death|2
1023918|NCT01610336|2050469|FG000|Overall Study|Non-Compliance with study treatment|0
1023919|NCT01610336|2050470|FG001|Overall Study|Non-Compliance with study treatment|0
1023920|NCT01610336|2050471|FG002|Overall Study|Non-Compliance with study treatment|0
1023921|NCT01610336|2050472|FG003|Overall Study|Non-Compliance with study treatment|0
1023922|NCT01610336|2050473|FG004|Overall Study|Non-Compliance with study treatment|0
1023923|NCT01610336|2050474|FG005|Overall Study|Non-Compliance with study treatment|0
1023924|NCT01610336|2050475|FG006|Overall Study|Non-Compliance with study treatment|0
1023925|NCT01610336|2050476|FG007|Overall Study|Non-Compliance with study treatment|0
1023926|NCT01610336|2050477|FG008|Overall Study|Non-Compliance with study treatment|0
1023927|NCT01610336|2050478|FG009|Overall Study|Non-Compliance with study treatment|1
1023928|NCT01610336|2050479|FG010|Overall Study|Non-Compliance with study treatment|0
1023929|NCT01610336|2050469|FG000|Overall Study|Physician Decision|0
1023930|NCT01610336|2050470|FG001|Overall Study|Physician Decision|0
1023931|NCT01610336|2050471|FG002|Overall Study|Physician Decision|0
1023932|NCT01610336|2050472|FG003|Overall Study|Physician Decision|0
1023933|NCT01610336|2050473|FG004|Overall Study|Physician Decision|0
1023934|NCT01610336|2050474|FG005|Overall Study|Physician Decision|0
1023935|NCT01610336|2050475|FG006|Overall Study|Physician Decision|1
1023936|NCT01610336|2050476|FG007|Overall Study|Physician Decision|0
1023937|NCT01610336|2050477|FG008|Overall Study|Physician Decision|0
1023938|NCT01610336|2050478|FG009|Overall Study|Physician Decision|0
1023939|NCT01610336|2050479|FG010|Overall Study|Physician Decision|0
1023940|NCT01610336|2050469|FG000|Overall Study|Protocol Deviation|0
1023941|NCT01610336|2050470|FG001|Overall Study|Protocol Deviation|0
1023942|NCT01610336|2050471|FG002|Overall Study|Protocol Deviation|0
1023943|NCT01610336|2050472|FG003|Overall Study|Protocol Deviation|0
1023944|NCT01610336|2050473|FG004|Overall Study|Protocol Deviation|0
1023945|NCT01610336|2050474|FG005|Overall Study|Protocol Deviation|0
1023946|NCT01610336|2050475|FG006|Overall Study|Protocol Deviation|0
1023947|NCT01610336|2050476|FG007|Overall Study|Protocol Deviation|0
1023948|NCT01610336|2050477|FG008|Overall Study|Protocol Deviation|0
1023949|NCT01610336|2050478|FG009|Overall Study|Protocol Deviation|1
1023950|NCT01610336|2050479|FG010|Overall Study|Protocol Deviation|0
1023951|NCT01610336|2050469|FG000|Overall Study|Transfer to another trial|0
1023952|NCT01610336|2050470|FG001|Overall Study|Transfer to another trial|0
1023953|NCT01610336|2050471|FG002|Overall Study|Transfer to another trial|0
1023954|NCT01610336|2050472|FG003|Overall Study|Transfer to another trial|0
904998|NCT00760214|1880198|FG001|Overall Study|Withdrawal by Subject|14
904999|NCT00760214|1880199|FG002|Overall Study|Withdrawal by Subject|13
905000|NCT00760214|1880197|FG000|Overall Study|Lack of Efficacy|3
905001|NCT00760214|1880198|FG001|Overall Study|Lack of Efficacy|2
905002|NCT00760214|1880199|FG002|Overall Study|Lack of Efficacy|4
905003|NCT00760214|1880197|FG000|Overall Study|Pregnancy|0
905004|NCT00760214|1880198|FG001|Overall Study|Pregnancy|0
905005|NCT00760214|1880199|FG002|Overall Study|Pregnancy|1
905006|NCT00760214|1880197|FG000|Overall Study|Physician Decision|1
905007|NCT00760214|1880198|FG001|Overall Study|Physician Decision|1
1023955|NCT01610336|2050473|FG004|Overall Study|Transfer to another trial|0
1023956|NCT01610336|2050474|FG005|Overall Study|Transfer to another trial|0
1023957|NCT01610336|2050475|FG006|Overall Study|Transfer to another trial|0
1023958|NCT01610336|2050476|FG007|Overall Study|Transfer to another trial|0
1023959|NCT01610336|2050477|FG008|Overall Study|Transfer to another trial|0
1023960|NCT01610336|2050478|FG009|Overall Study|Transfer to another trial|0
1023961|NCT01610336|2050479|FG010|Overall Study|Transfer to another trial|1
1023962|NCT01610414|2050509|FG000|Study Start - Month 13|Serious Adverse Event|65
1023963|NCT01610414|2050510|FG001|Study Start - Month 13|Serious Adverse Event|67
1023964|NCT01610414|2050509|FG000|Study Start - Month 13|Adverse Event|14
1023965|NCT01610414|2050510|FG001|Study Start - Month 13|Adverse Event|14
1023966|NCT01610414|2050509|FG000|Study Start - Month 13|Protocol Violation|3
1023967|NCT01610414|2050510|FG001|Study Start - Month 13|Protocol Violation|1
1023968|NCT01610414|2050509|FG000|Study Start - Month 13|Withdrawal by Subject|23
1023969|NCT01610414|2050510|FG001|Study Start - Month 13|Withdrawal by Subject|30
1023970|NCT01610414|2050509|FG000|Study Start - Month 13|Migrated/moved from study area|2
1023971|NCT01610414|2050510|FG001|Study Start - Month 13|Migrated/moved from study area|4
1023972|NCT01610414|2050509|FG000|Study Start - Month 13|Lost to Follow-up|4
1023973|NCT01610414|2050510|FG001|Study Start - Month 13|Lost to Follow-up|6
1023974|NCT01610414|2050509|FG000|Study Start - Month 13|Suspected HZ episode|1
1023975|NCT01610414|2050510|FG001|Study Start - Month 13|Suspected HZ episode|3
1023976|NCT01610414|2050509|FG000|Study Start - Month 13|Other reasons for withdrawal|3
1023977|NCT01610414|2050510|FG001|Study Start - Month 13|Other reasons for withdrawal|4
1023978|NCT01610414|2050509|FG000|Month 13 - Month 25|Serious Adverse Event|35
1023979|NCT01610414|2050510|FG001|Month 13 - Month 25|Serious Adverse Event|38
1023980|NCT01610414|2050509|FG000|Month 13 - Month 25|Adverse Event|8
1023981|NCT01610414|2050510|FG001|Month 13 - Month 25|Adverse Event|4
1023982|NCT01610414|2050509|FG000|Month 13 - Month 25|Withdrawal by Subject|7
1023983|NCT01610414|2050510|FG001|Month 13 - Month 25|Withdrawal by Subject|8
1023984|NCT01610414|2050509|FG000|Month 13 - Month 25|Migrated/moved from study area|4
1023985|NCT01610414|2050510|FG001|Month 13 - Month 25|Migrated/moved from study area|2
1023986|NCT01610414|2050509|FG000|Month 13 - Month 25|Protocol Violation|0
1023987|NCT01610414|2050510|FG001|Month 13 - Month 25|Protocol Violation|2
1023988|NCT01610414|2050509|FG000|Month 13 - Month 25|Lost to Follow-up|5
1023989|NCT01610414|2050510|FG001|Month 13 - Month 25|Lost to Follow-up|9
1023990|NCT01610414|2050509|FG000|Month 13 - Month 25|Other reasons for withdrawal|6
1023991|NCT01610414|2050510|FG001|Month 13 - Month 25|Other reasons for withdrawal|7
1023992|NCT01610414|2050509|FG000|After Month 25|Study end not reached|48
1023993|NCT01610414|2050510|FG001|After Month 25|Study end not reached|53
1023994|NCT01610492|2050526|FG000|Overall Study|Adverse Event|1
1023995|NCT01610492|2050526|FG000|Overall Study|Lack of Efficacy|3
1023996|NCT01610492|2050526|FG000|Overall Study|Other: Reached stopping criteria|1
1023997|NCT01610492|2050526|FG000|Overall Study|Other:Treatment stopped due to remission|1
1023998|NCT01610557|2050534|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1023999|NCT01610557|2050535|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
1024000|NCT01610557|2050536|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1024001|NCT01610557|2050537|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1024002|NCT01610557|2050538|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1024003|NCT01610557|2050534|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0
1024004|NCT01610557|2050535|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0
1024005|NCT01610557|2050536|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0
1024006|NCT01610557|2050537|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0
1024007|NCT01610557|2050538|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3
1024008|NCT01610596|2050574|FG000|Overall Study|Lost to Follow-up|0
1024009|NCT01610596|2050575|FG001|Overall Study|Lost to Follow-up|1
1024010|NCT01610687|2050581|FG000|Overall Study|Lack of Efficacy|26
1024011|NCT01610687|2050581|FG000|Overall Study|Adverse Event|18
1024012|NCT01610687|2050581|FG000|Overall Study|Moved out of area|6
1024013|NCT01610687|2050581|FG000|Overall Study|Withdrawal by Subject|7
1024014|NCT01610687|2050581|FG000|Overall Study|Lost to Follow-up|4
1024015|NCT01610687|2050581|FG000|Overall Study|Symptom control without study medication|2
1024016|NCT01610687|2050581|FG000|Overall Study|Unable to make journey|1
1024017|NCT01610687|2050581|FG000|Overall Study|Death|1
1024018|NCT01610687|2050581|FG000|Overall Study|Cannabis affecting job|1
1024019|NCT01610687|2050581|FG000|Overall Study|Felt more alter without study medication|1
1024020|NCT01610700|2050587|FG000|Overall Study|Adverse Event|3
1024021|NCT01610700|2050588|FG001|Overall Study|Adverse Event|1
1024022|NCT01610700|2050587|FG000|Overall Study|Withdrawal by Subject|0
1024023|NCT01610700|2050588|FG001|Overall Study|Withdrawal by Subject|1
1024024|NCT01610700|2050587|FG000|Overall Study|subject took one dose of street cannabis|0
1024025|NCT01610700|2050588|FG001|Overall Study|subject took one dose of street cannabis|1
1024026|NCT01610713|2050597|FG000|Overall Study|Adverse Event|3
1024027|NCT01610713|2050598|FG001|Overall Study|Adverse Event|0
1024028|NCT01610713|2050597|FG000|Overall Study|Lack of Efficacy|1
1024029|NCT01610713|2050598|FG001|Overall Study|Lack of Efficacy|0
1024030|NCT01610713|2050597|FG000|Overall Study|low mood and poor motivation|1
1024031|NCT01610713|2050598|FG001|Overall Study|low mood and poor motivation|0
1024032|NCT01610713|2050597|FG000|Overall Study|adv. to use original dose/amitriptyline|1
1024033|NCT01610713|2050598|FG001|Overall Study|adv. to use original dose/amitriptyline|0
1024034|NCT01610713|2050597|FG000|Overall Study|Lost to Follow-up|0
1024035|NCT01610713|2050598|FG001|Overall Study|Lost to Follow-up|1
1024036|NCT01610752|2050607|FG000|Overall Study|Miscarriage/Pregnancy loss|0
1024037|NCT01610752|2050608|FG001|Overall Study|Miscarriage/Pregnancy loss|0
1024038|NCT01610752|2050609|FG002|Overall Study|Miscarriage/Pregnancy loss|4
1024039|NCT01610791|2050617|FG000|Overall Study|Lost to Follow-up|7
1024040|NCT01610791|2050617|FG000|Overall Study|Adverse Event|6
1024041|NCT01610791|2050617|FG000|Overall Study|Physician Decision|1
1024042|NCT01610791|2050617|FG000|Overall Study|Adverse event and Investigator decision|1
1024043|NCT01610791|2050617|FG000|Overall Study|Death|1
1024044|NCT01610791|2050617|FG000|Overall Study|Not determined|5
1024045|NCT01611090|2050623|FG000|Randomized Period|Lost to Follow-up|8
1024046|NCT01611090|2050624|FG001|Randomized Period|Lost to Follow-up|3
1024047|NCT01611090|2050625|FG002|Randomized Period|Lost to Follow-up|0
1024048|NCT01611090|2050623|FG000|Randomized Period|Withdrawal by Subject|22
1024049|NCT01611090|2050624|FG001|Randomized Period|Withdrawal by Subject|26
1024050|NCT01611090|2050625|FG002|Randomized Period|Withdrawal by Subject|0
1024051|NCT01611090|2050623|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
1024052|NCT01611090|2050624|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
1024053|NCT01611090|2050625|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
1024054|NCT01611090|2050623|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
1024055|NCT01611090|2050624|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
1024056|NCT01611090|2050625|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
1024057|NCT01611155|2050634|FG000|Overall Study|Adverse Event|1
1024058|NCT01611155|2050635|FG001|Overall Study|Adverse Event|1
1024059|NCT01611155|2050634|FG000|Overall Study|Refused further treatment|6
1024060|NCT01611155|2050635|FG001|Overall Study|Refused further treatment|4
1024061|NCT01611155|2050634|FG000|Overall Study|Disease progression|1
1024062|NCT01611155|2050635|FG001|Overall Study|Disease progression|0
1024063|NCT01611155|2050634|FG000|Overall Study|Withdrawal by Subject|1
1024064|NCT01611155|2050635|FG001|Overall Study|Withdrawal by Subject|0
1024065|NCT01611155|2050634|FG000|Overall Study|Alternative treatment|0
1024066|NCT01611155|2050635|FG001|Overall Study|Alternative treatment|1
1024067|NCT01611155|2050634|FG000|Overall Study|Ineligible patient|0
1024068|NCT01611155|2050635|FG001|Overall Study|Ineligible patient|1
1024069|NCT01611194|2050643|FG000|Overall Study|Lost to Follow-up|0
1024070|NCT01611194|2050644|FG001|Overall Study|Lost to Follow-up|1
1024071|NCT01611194|2050643|FG000|Overall Study|Withdrawal by Subject|0
1024072|NCT01611194|2050644|FG001|Overall Study|Withdrawal by Subject|1
1024073|NCT01611194|2050643|FG000|Overall Study|drug use|0
1024074|NCT01611194|2050644|FG001|Overall Study|drug use|1
1024075|NCT01611259|2050650|FG000|Overall Study|Physician Decision|1
1024076|NCT01611259|2050650|FG000|Overall Study|Lack of Efficacy|2
1024077|NCT01611259|2050650|FG000|Overall Study|Adverse Event|4
1024078|NCT01611259|2050650|FG000|Overall Study|Withdrawal by Subject|7
1024079|NCT01611298|2050654|FG000|Overall Study|Relapsed|2
1024080|NCT01611454|2050660|FG000|Overall Study|Lack of Efficacy|18
1024081|NCT01611454|2050661|FG001|Overall Study|Lack of Efficacy|10
1024082|NCT01611558|2050671|FG000|Induction Phase|Study drug toxicity|15
1024083|NCT01611558|2050671|FG000|Induction Phase|Disease progression|18
1024084|NCT01611558|2050671|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1
1024085|NCT01611558|2050671|FG000|Induction Phase|Adverse event unrelated to study drug|3
1024086|NCT01611558|2050671|FG000|Induction Phase|Death|1
1024087|NCT01611558|2050671|FG000|Maintenance Phase|Withdrawal by Subject|1
1024088|NCT01611558|2050671|FG000|Maintenance Phase|Elevated Uric acid|1
1024089|NCT01611792|2050699|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
1024090|NCT01611792|2050700|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
1024091|NCT01611792|2050699|FG000|Followup: at 6 Months|Lost to Follow-up|6
1024092|NCT01611792|2050700|FG001|Followup: at 6 Months|Lost to Follow-up|13
1024093|NCT01611857|2050709|FG000|Overall Study|Withdrawal by Subject|0
1024094|NCT01611857|2050710|FG001|Overall Study|Withdrawal by Subject|2
1024095|NCT01611883|2050720|FG000|Overall Study|Adverse Event|1
1024096|NCT01611883|2050721|FG001|Overall Study|Adverse Event|1
1024097|NCT01611935|2050729|FG000|Overall Study|Family Declined Participation|1
1024098|NCT01611935|2050730|FG001|Overall Study|Family Declined Participation|0
1024099|NCT01611974|2050748|FG000|Overall Study|Death|10
1024100|NCT01611974|2050749|FG001|Overall Study|Death|12
1024101|NCT01611974|2050750|FG002|Overall Study|Death|10
1024102|NCT01611974|2050748|FG000|Overall Study|Lost to Follow-up|0
1024103|NCT01611974|2050749|FG001|Overall Study|Lost to Follow-up|1
1024104|NCT01611974|2050750|FG002|Overall Study|Lost to Follow-up|0
1024105|NCT01611974|2050748|FG000|Overall Study|Physician Decision|5
1024106|NCT01611974|2050749|FG001|Overall Study|Physician Decision|1
1024107|NCT01611974|2050750|FG002|Overall Study|Physician Decision|2
1024108|NCT01611974|2050748|FG000|Overall Study|Withdrawal by Subject|0
1024109|NCT01611974|2050749|FG001|Overall Study|Withdrawal by Subject|1
1024110|NCT01611974|2050750|FG002|Overall Study|Withdrawal by Subject|4
1024111|NCT01612000|2050762|FG000|Overall Study|Lost to Follow-up|6
1024112|NCT01612000|2050763|FG001|Overall Study|Lost to Follow-up|4
1024113|NCT01612000|2050764|FG002|Overall Study|Lost to Follow-up|4
1024114|NCT01612000|2050765|FG003|Overall Study|Lost to Follow-up|8
1024115|NCT01612000|2050762|FG000|Overall Study|Physician Decision|0
1024116|NCT01612000|2050763|FG001|Overall Study|Physician Decision|0
1024117|NCT01612000|2050764|FG002|Overall Study|Physician Decision|1
1024118|NCT01612000|2050765|FG003|Overall Study|Physician Decision|0
1024119|NCT01612000|2050762|FG000|Overall Study|Withdrawal by Subject|3
1024120|NCT01612000|2050763|FG001|Overall Study|Withdrawal by Subject|1
1024121|NCT01612000|2050764|FG002|Overall Study|Withdrawal by Subject|2
1024122|NCT01612000|2050765|FG003|Overall Study|Withdrawal by Subject|2
1024123|NCT01612156|2050777|FG000|Overall Study|Protocol Violation|2
1024124|NCT01612156|2050778|FG001|Overall Study|Protocol Violation|0
1024125|NCT01612676|2050817|FG000|Overall Study|Adverse Event|2
1024126|NCT01612676|2050818|FG001|Overall Study|Adverse Event|3
1024127|NCT01612676|2050819|FG002|Overall Study|Adverse Event|1
1024128|NCT01612676|2050820|FG003|Overall Study|Adverse Event|3
1024129|NCT01612676|2050817|FG000|Overall Study|Protocol Violation|0
1024130|NCT01612676|2050818|FG001|Overall Study|Protocol Violation|1
1024131|NCT01612676|2050819|FG002|Overall Study|Protocol Violation|0
1024132|NCT01612676|2050820|FG003|Overall Study|Protocol Violation|0
1024133|NCT01612702|2050834|FG000|Overall Study|Protocol Violation|11
1024134|NCT01612702|2050835|FG001|Overall Study|Protocol Violation|11
1024135|NCT01612780|2050866|FG000|Overall Study|Treatment not completed|1
1024136|NCT01612780|2050866|FG000|Overall Study|Withdrawal by Subject|5
1024137|NCT01612858|2050881|FG000|Overall Study|Withdrawal by Subject|5
1024138|NCT01612858|2050882|FG001|Overall Study|Withdrawal by Subject|1
1024139|NCT01613027|2050906|FG000|Overall Study|Lost to Follow-up|5
1024140|NCT01613027|2050906|FG000|Overall Study|Switched Physician|1
1024141|NCT01613027|2050906|FG000|Overall Study|Lack of Efficacy|1
1024142|NCT01613027|2050906|FG000|Overall Study|Patient's Decision Due to Adverse Event|1
1024143|NCT01613131|2050930|FG000|Overall Study|Withdrawal by Subject|3
1024144|NCT01613131|2050931|FG001|Overall Study|Withdrawal by Subject|5
1024145|NCT01613222|2050937|FG000|Overall Study|Physician Decision|1
1024146|NCT01613222|2050937|FG000|Overall Study|Unable to place arterial line|1
1024147|NCT01613222|2050937|FG000|Overall Study|Reused disposable sensors|10
1024148|NCT01613248|2050956|FG000|Overall Study|Adverse Event|0
1024149|NCT01613248|2050957|FG001|Overall Study|Adverse Event|0
1024150|NCT01613248|2050958|FG002|Overall Study|Adverse Event|0
1024151|NCT01613248|2050959|FG003|Overall Study|Adverse Event|1
1024152|NCT01613248|2050960|FG004|Overall Study|Adverse Event|0
1024153|NCT01613248|2050961|FG005|Overall Study|Adverse Event|0
1024154|NCT01613248|2050956|FG000|Overall Study|Withdrawal by Subject|3
1024155|NCT01613248|2050957|FG001|Overall Study|Withdrawal by Subject|2
1024156|NCT01613248|2050958|FG002|Overall Study|Withdrawal by Subject|2
1024157|NCT01613248|2050959|FG003|Overall Study|Withdrawal by Subject|5
1024158|NCT01613248|2050960|FG004|Overall Study|Withdrawal by Subject|0
1024159|NCT01613248|2050961|FG005|Overall Study|Withdrawal by Subject|1
1024160|NCT01613248|2050956|FG000|Overall Study|Lost to Follow-up|5
1024161|NCT01613248|2050957|FG001|Overall Study|Lost to Follow-up|7
1024162|NCT01613248|2050958|FG002|Overall Study|Lost to Follow-up|4
1024163|NCT01613248|2050959|FG003|Overall Study|Lost to Follow-up|8
1024164|NCT01613248|2050960|FG004|Overall Study|Lost to Follow-up|4
1024165|NCT01613248|2050961|FG005|Overall Study|Lost to Follow-up|2
1024166|NCT01613248|2050956|FG000|Overall Study|Study Terminated by Sponsor|4
1024167|NCT01613248|2050957|FG001|Overall Study|Study Terminated by Sponsor|6
1024168|NCT01613248|2050958|FG002|Overall Study|Study Terminated by Sponsor|8
1024169|NCT01613248|2050959|FG003|Overall Study|Study Terminated by Sponsor|8
1024170|NCT01613248|2050960|FG004|Overall Study|Study Terminated by Sponsor|9
1024171|NCT01613248|2050961|FG005|Overall Study|Study Terminated by Sponsor|11
1024172|NCT01613248|2050956|FG000|Overall Study|Physician Decision|8
1024173|NCT01613248|2050957|FG001|Overall Study|Physician Decision|8
1024174|NCT01613248|2050958|FG002|Overall Study|Physician Decision|9
1024175|NCT01613248|2050959|FG003|Overall Study|Physician Decision|4
1024176|NCT01613248|2050960|FG004|Overall Study|Physician Decision|7
1024177|NCT01613248|2050961|FG005|Overall Study|Physician Decision|6
1024178|NCT01613248|2050956|FG000|Overall Study|Lack of Qualifying Event|9
1024179|NCT01613248|2050957|FG001|Overall Study|Lack of Qualifying Event|11
1024180|NCT01613248|2050958|FG002|Overall Study|Lack of Qualifying Event|10
1024181|NCT01613248|2050959|FG003|Overall Study|Lack of Qualifying Event|11
1024182|NCT01613248|2050960|FG004|Overall Study|Lack of Qualifying Event|15
1024183|NCT01613248|2050961|FG005|Overall Study|Lack of Qualifying Event|18
1024184|NCT01613248|2050956|FG000|Overall Study|Pregnancy|0
1024185|NCT01613248|2050957|FG001|Overall Study|Pregnancy|0
1024186|NCT01613248|2050958|FG002|Overall Study|Pregnancy|0
1024187|NCT01613248|2050959|FG003|Overall Study|Pregnancy|1
1024188|NCT01613248|2050960|FG004|Overall Study|Pregnancy|0
1024189|NCT01613248|2050961|FG005|Overall Study|Pregnancy|0
1024190|NCT01613326|2050994|FG000|Overall Study|Adverse Event|7
1024191|NCT01613326|2050995|FG001|Overall Study|Adverse Event|5
1024192|NCT01613326|2050994|FG000|Overall Study|Withdrawal by Subject|3
1024193|NCT01613326|2050995|FG001|Overall Study|Withdrawal by Subject|4
1024194|NCT01613326|2050994|FG000|Overall Study|Abnormal test procedure result(s)|2
1024195|NCT01613326|2050995|FG001|Overall Study|Abnormal test procedure result(s)|0
1024196|NCT01613326|2050994|FG000|Overall Study|inability to use device|1
1024197|NCT01613326|2050995|FG001|Overall Study|inability to use device|0
1024198|NCT01613326|2050994|FG000|Overall Study|Lack of Efficacy|0
1024199|NCT01613326|2050995|FG001|Overall Study|Lack of Efficacy|1
1024200|NCT01613326|2050994|FG000|Overall Study|Lost to Follow-up|0
1024201|NCT01613326|2050995|FG001|Overall Study|Lost to Follow-up|1
1024202|NCT01613326|2050994|FG000|Overall Study|Administrative|0
1024203|NCT01613326|2050995|FG001|Overall Study|Administrative|2
1024204|NCT01613326|2050994|FG000|Overall Study|Protocol Violation|0
1024205|NCT01613326|2050995|FG001|Overall Study|Protocol Violation|1
1024206|NCT01613378|2051009|FG000|Overall Study|Lack of Efficacy|13
1024207|NCT01613378|2051009|FG000|Overall Study|Adverse Event|11
1024208|NCT01613378|2051009|FG000|Overall Study|Withdrawal by Subject|8
1024209|NCT01613378|2051009|FG000|Overall Study|Death|2
1024210|NCT01613378|2051009|FG000|Overall Study|Lost to Follow-up|1
1024211|NCT01613378|2051009|FG000|Overall Study|Other Reason|4
1024212|NCT01613417|2051015|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
1024213|NCT01613417|2051016|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
1024214|NCT01613599|2051032|FG000|Overall Study|Death|9
1024215|NCT01613599|2051032|FG000|Overall Study|Lost to Follow-up|5
1024216|NCT01613599|2051032|FG000|Overall Study|Withdrawal by Subject|8
1024217|NCT01613599|2051032|FG000|Overall Study|Reason not specified|3
1024218|NCT01613716|2051036|FG000|Overall Study|screen failures|3
1024219|NCT01613716|2051036|FG000|Overall Study|Lost to Follow-up|4
1024220|NCT01614093|2051045|FG000|Overall Study|Withdrawal by Subject|1
1024221|NCT01614249|2051056|FG000|Overall Study|Lost to Follow-up|11
1024222|NCT01614249|2051057|FG001|Overall Study|Lost to Follow-up|23
1024223|NCT01614457|2051074|FG000|Overall Study|Non-Compliance|1
1024224|NCT01614457|2051075|FG001|Overall Study|Non-Compliance|0
1024225|NCT01614457|2051074|FG000|Overall Study|Pregnancy (Self or Partner)|1
1024226|NCT01614457|2051075|FG001|Overall Study|Pregnancy (Self or Partner)|0
1024227|NCT01614470|2051083|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
1024228|NCT01614470|2051084|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1024229|NCT01614470|2051085|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1024230|NCT01614470|2051083|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
1024231|NCT01614470|2051084|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
1024232|NCT01614470|2051085|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
1024233|NCT01614600|2051107|FG000|Overall Study|Unacceptable fit|1
1024234|NCT01614600|2051107|FG000|Overall Study|Discomfort|1
1024235|NCT01614600|2051107|FG000|Overall Study|Unable to remove lens at the end of day|1
1024236|NCT01614600|2051107|FG000|Overall Study|Protocol deviation|1
1024237|NCT01614769|2051125|FG000|Period 1|Discontinued due to Hypoglycemia|0
1024238|NCT01614769|2051126|FG001|Period 1|Discontinued due to Hypoglycemia|0
1024239|NCT01614769|2051127|FG002|Period 1|Discontinued due to Hypoglycemia|0
1024240|NCT01614769|2051128|FG003|Period 1|Discontinued due to Hypoglycemia|1
1024241|NCT01614769|2051129|FG004|Period 1|Discontinued due to Hypoglycemia|0
1024242|NCT01614769|2051130|FG005|Period 1|Discontinued due to Hypoglycemia|1
1024243|NCT01614769|2051125|FG000|Period 1|Protocol Violation|0
1024244|NCT01614769|2051126|FG001|Period 1|Protocol Violation|0
1024245|NCT01614769|2051127|FG002|Period 1|Protocol Violation|0
1024246|NCT01614769|2051128|FG003|Period 1|Protocol Violation|1
1024247|NCT01614769|2051129|FG004|Period 1|Protocol Violation|0
1024248|NCT01614769|2051130|FG005|Period 1|Protocol Violation|0
1024249|NCT01614769|2051125|FG000|Period 1|Withdrawal by Subject|1
1024250|NCT01614769|2051126|FG001|Period 1|Withdrawal by Subject|0
1024251|NCT01614769|2051127|FG002|Period 1|Withdrawal by Subject|0
1024252|NCT01614769|2051128|FG003|Period 1|Withdrawal by Subject|0
1024253|NCT01614769|2051129|FG004|Period 1|Withdrawal by Subject|0
1024254|NCT01614769|2051130|FG005|Period 1|Withdrawal by Subject|0
1024255|NCT01614769|2051125|FG000|Period 3|Withdrawal by Subject|0
1024256|NCT01614769|2051126|FG001|Period 3|Withdrawal by Subject|0
1024257|NCT01614769|2051127|FG002|Period 3|Withdrawal by Subject|1
1024258|NCT01614769|2051128|FG003|Period 3|Withdrawal by Subject|0
1024259|NCT01614769|2051129|FG004|Period 3|Withdrawal by Subject|0
1024260|NCT01614769|2051130|FG005|Period 3|Withdrawal by Subject|0
905008|NCT00760214|1880199|FG002|Overall Study|Physician Decision|1
905009|NCT00760214|1880197|FG000|Overall Study|Other|3
905010|NCT00760214|1880198|FG001|Overall Study|Other|4
905011|NCT00760214|1880199|FG002|Overall Study|Other|6
905012|NCT00760266|1880209|FG000|Overall Study|Adverse Event|13
905013|NCT00760266|1880210|FG001|Overall Study|Adverse Event|7
1024261|NCT01614795|2051142|FG000|Overall Study|Adverse Event|0
1024262|NCT01614795|2051143|FG001|Overall Study|Adverse Event|0
1024263|NCT01614795|2051144|FG002|Overall Study|Adverse Event|1
1024264|NCT01614795|2051145|FG003|Overall Study|Adverse Event|1
1024265|NCT01614795|2051142|FG000|Overall Study|Lack of Efficacy|10
1024266|NCT01614795|2051143|FG001|Overall Study|Lack of Efficacy|10
1024267|NCT01614795|2051144|FG002|Overall Study|Lack of Efficacy|9
1024268|NCT01614795|2051145|FG003|Overall Study|Lack of Efficacy|8
1024269|NCT01614795|2051142|FG000|Overall Study|Physician Decision|1
1024270|NCT01614795|2051143|FG001|Overall Study|Physician Decision|0
1024271|NCT01614795|2051144|FG002|Overall Study|Physician Decision|1
1024272|NCT01614795|2051145|FG003|Overall Study|Physician Decision|1
1024273|NCT01614795|2051142|FG000|Overall Study|Withdrawal by Subject|0
1024274|NCT01614795|2051143|FG001|Overall Study|Withdrawal by Subject|1
1024275|NCT01614795|2051144|FG002|Overall Study|Withdrawal by Subject|0
1024276|NCT01614795|2051145|FG003|Overall Study|Withdrawal by Subject|2
1024277|NCT01614795|2051142|FG000|Overall Study|Ineligible|0
1024278|NCT01614795|2051143|FG001|Overall Study|Ineligible|1
1024279|NCT01614795|2051144|FG002|Overall Study|Ineligible|0
1024280|NCT01614795|2051145|FG003|Overall Study|Ineligible|0
1024281|NCT01614886|2051176|FG000|Overall Study|Adverse Event|15
1024282|NCT01614886|2051177|FG001|Overall Study|Adverse Event|20
1024283|NCT01614886|2051176|FG000|Overall Study|Withdrawal by Subject|4
1024284|NCT01614886|2051177|FG001|Overall Study|Withdrawal by Subject|4
1024285|NCT01614886|2051176|FG000|Overall Study|Death|1
1024286|NCT01614886|2051177|FG001|Overall Study|Death|0
1024287|NCT01614886|2051176|FG000|Overall Study|Protocol deviation|0
1024288|NCT01614886|2051177|FG001|Overall Study|Protocol deviation|2
1024289|NCT01614925|2051202|FG000|Overall Study|Withdrawal by Subject|1
1024290|NCT01614925|2051203|FG001|Overall Study|Withdrawal by Subject|0
1024291|NCT01614925|2051202|FG000|Overall Study|Protocol Violation|3
1024292|NCT01614925|2051203|FG001|Overall Study|Protocol Violation|2
1024323|NCT01615198|2051241|FG000|Overall Study|Withdrawal by Subject|5
1024324|NCT01615198|2051242|FG001|Overall Study|Withdrawal by Subject|5
1024325|NCT01615198|2051241|FG000|Overall Study|Protocol deviation|1
1024326|NCT01615198|2051242|FG001|Overall Study|Protocol deviation|1
1024327|NCT01615198|2051241|FG000|Overall Study|Physician Decision|5
1024328|NCT01615198|2051242|FG001|Overall Study|Physician Decision|1
1024329|NCT01615198|2051241|FG000|Overall Study|Lost to Follow-up|1
1024330|NCT01615198|2051242|FG001|Overall Study|Lost to Follow-up|1
1024331|NCT01615198|2051241|FG000|Overall Study|Lack of Efficacy|1
1024332|NCT01615198|2051242|FG001|Overall Study|Lack of Efficacy|6
1024333|NCT01615198|2051241|FG000|Overall Study|Adverse Event|11
1024334|NCT01615198|2051242|FG001|Overall Study|Adverse Event|5
1024335|NCT01615263|2051250|FG000|Overall Study|Post-randomization exclusion|0
1024336|NCT01615263|2051251|FG001|Overall Study|Post-randomization exclusion|2
1024337|NCT01615328|2051259|FG000|Overall Study|Lost to Follow-up|3
1024338|NCT01615328|2051260|FG001|Overall Study|Lost to Follow-up|5
1024339|NCT01615822|2051304|FG000|Period 1|Withdrawal by Subject|0
1024340|NCT01615822|2051305|FG001|Period 1|Withdrawal by Subject|1
1024341|NCT01615822|2051306|FG002|Period 1|Withdrawal by Subject|0
1024342|NCT01615822|2051304|FG000|Period 1|Adverse Event|1
1024343|NCT01615822|2051305|FG001|Period 1|Adverse Event|1
1024344|NCT01615822|2051306|FG002|Period 1|Adverse Event|0
1024345|NCT01615822|2051304|FG000|Period 2|Lost to Follow-up|0
1024346|NCT01615822|2051305|FG001|Period 2|Lost to Follow-up|1
1024347|NCT01615822|2051306|FG002|Period 2|Lost to Follow-up|2
1024348|NCT01615939|2051319|FG000|Overall Study|Lost to Follow-up|5
1024349|NCT01615939|2051320|FG001|Overall Study|Lost to Follow-up|0
1024350|NCT01616173|2051347|FG000|Overall Study|Lost to Follow-up|0
1024351|NCT01616173|2051348|FG001|Overall Study|Lost to Follow-up|2
1024352|NCT01616173|2051349|FG002|Overall Study|Lost to Follow-up|0
1024353|NCT01616459|2051361|FG000|Overall Study|Adverse Event|1
1024354|NCT01616459|2051362|FG001|Overall Study|Adverse Event|1
1024355|NCT01616459|2051363|FG002|Overall Study|Adverse Event|2
1024356|NCT01616459|2051364|FG003|Overall Study|Adverse Event|0
1024357|NCT01616459|2051361|FG000|Overall Study|Lost to Follow-up|1
1024358|NCT01616459|2051362|FG001|Overall Study|Lost to Follow-up|11
1024359|NCT01616459|2051363|FG002|Overall Study|Lost to Follow-up|3
1024360|NCT01616459|2051364|FG003|Overall Study|Lost to Follow-up|2
1024361|NCT01616459|2051361|FG000|Overall Study|Protocol Violation|0
1024362|NCT01616459|2051362|FG001|Overall Study|Protocol Violation|0
1024363|NCT01616459|2051363|FG002|Overall Study|Protocol Violation|0
1024364|NCT01616459|2051364|FG003|Overall Study|Protocol Violation|2
1024365|NCT01616459|2051361|FG000|Overall Study|Withdrawal by Subject|2
1024366|NCT01616459|2051362|FG001|Overall Study|Withdrawal by Subject|4
1024367|NCT01616459|2051363|FG002|Overall Study|Withdrawal by Subject|4
1024368|NCT01616459|2051364|FG003|Overall Study|Withdrawal by Subject|4
1024369|NCT01616459|2051361|FG000|Overall Study|Other reason|0
1024370|NCT01616459|2051362|FG001|Overall Study|Other reason|1
1024371|NCT01616459|2051363|FG002|Overall Study|Other reason|1
1024372|NCT01616459|2051364|FG003|Overall Study|Other reason|0
1024373|NCT01616563|2051379|FG000|Overall Study|Lost to Follow-up|40
1024374|NCT01616654|2051401|FG000|Overall Study|Lack of Efficacy|1
1024375|NCT01616654|2051402|FG001|Overall Study|Lack of Efficacy|0
1024376|NCT01616654|2051403|FG002|Overall Study|Lack of Efficacy|0
1024377|NCT01616654|2051404|FG003|Overall Study|Lack of Efficacy|0
1024378|NCT01616654|2051405|FG004|Overall Study|Lack of Efficacy|1
1024379|NCT01616654|2051401|FG000|Overall Study|Adverse Event|0
1024380|NCT01616654|2051402|FG001|Overall Study|Adverse Event|1
1024381|NCT01616654|2051403|FG002|Overall Study|Adverse Event|2
1024382|NCT01616654|2051404|FG003|Overall Study|Adverse Event|1
1024383|NCT01616654|2051405|FG004|Overall Study|Adverse Event|0
1024384|NCT01616654|2051401|FG000|Overall Study|Withdrawal by Subject|2
1024385|NCT01616654|2051402|FG001|Overall Study|Withdrawal by Subject|2
1024386|NCT01616654|2051403|FG002|Overall Study|Withdrawal by Subject|3
1024387|NCT01616654|2051404|FG003|Overall Study|Withdrawal by Subject|1
1024388|NCT01616654|2051405|FG004|Overall Study|Withdrawal by Subject|5
1024389|NCT01616654|2051401|FG000|Overall Study|Protocol Violation|0
1024390|NCT01616654|2051402|FG001|Overall Study|Protocol Violation|5
1024391|NCT01616654|2051403|FG002|Overall Study|Protocol Violation|2
1024392|NCT01616654|2051404|FG003|Overall Study|Protocol Violation|4
1024393|NCT01616654|2051405|FG004|Overall Study|Protocol Violation|4
1024394|NCT01616654|2051401|FG000|Overall Study|Lost to Follow-up|1
1024395|NCT01616654|2051402|FG001|Overall Study|Lost to Follow-up|0
1024396|NCT01616654|2051403|FG002|Overall Study|Lost to Follow-up|3
1024397|NCT01616654|2051404|FG003|Overall Study|Lost to Follow-up|2
1024398|NCT01616654|2051405|FG004|Overall Study|Lost to Follow-up|1
1024399|NCT01616654|2051401|FG000|Overall Study|Pregnancy|1
1024400|NCT01616654|2051402|FG001|Overall Study|Pregnancy|0
1024401|NCT01616654|2051403|FG002|Overall Study|Pregnancy|0
1024402|NCT01616654|2051404|FG003|Overall Study|Pregnancy|0
1024403|NCT01616654|2051405|FG004|Overall Study|Pregnancy|1
1024404|NCT01616693|2051422|FG000|Evaluated for Safety|Physician Decision|1
1024405|NCT01616693|2051423|FG001|Evaluated for Safety|Physician Decision|0
1024406|NCT01616693|2051424|FG002|Evaluated for Safety|Physician Decision|1
1024407|NCT01616693|2051425|FG003|Evaluated for Safety|Physician Decision|0
1024408|NCT01616693|2051422|FG000|Received Both Vaccines|Adverse Event|2
1024409|NCT01616693|2051423|FG001|Received Both Vaccines|Adverse Event|0
1024410|NCT01616693|2051424|FG002|Received Both Vaccines|Adverse Event|0
1024411|NCT01616693|2051425|FG003|Received Both Vaccines|Adverse Event|0
1024412|NCT01616693|2051422|FG000|Received Both Vaccines|Withdrawal by Subject|7
1024413|NCT01616693|2051423|FG001|Received Both Vaccines|Withdrawal by Subject|7
1024414|NCT01616693|2051424|FG002|Received Both Vaccines|Withdrawal by Subject|8
1024415|NCT01616693|2051425|FG003|Received Both Vaccines|Withdrawal by Subject|15
1024416|NCT01616693|2051422|FG000|Received Both Vaccines|Lost to Follow-up|4
1024417|NCT01616693|2051423|FG001|Received Both Vaccines|Lost to Follow-up|3
1024418|NCT01616693|2051424|FG002|Received Both Vaccines|Lost to Follow-up|4
1024419|NCT01616693|2051425|FG003|Received Both Vaccines|Lost to Follow-up|4
1024420|NCT01616693|2051422|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4
1024421|NCT01616693|2051423|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2
1024422|NCT01616693|2051424|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6
1024423|NCT01616693|2051425|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1
1024424|NCT01616771|2051439|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4
1024425|NCT01616953|2051450|FG000|Overall Study|Lost to Follow-up|1
1024426|NCT01616953|2051451|FG001|Overall Study|Lost to Follow-up|0
1024427|NCT01616953|2051450|FG000|Overall Study|lack of bone and soft tissue|1
1024428|NCT01616953|2051451|FG001|Overall Study|lack of bone and soft tissue|0
1024429|NCT01617005|2051457|FG000|Overall Study|Pregnancy|1
1024430|NCT01617005|2051457|FG000|Overall Study|Lack of motivation for treatment|1
1024431|NCT01617070|2051461|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
1024432|NCT01617187|2051492|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1024433|NCT01617187|2051493|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1024434|NCT01617187|2051494|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1024435|NCT01617187|2051495|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
1024436|NCT01617187|2051492|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1024437|NCT01617187|2051493|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1024438|NCT01617187|2051494|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1024439|NCT01617187|2051495|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1
1024440|NCT01617187|2051492|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1
1024441|NCT01617187|2051493|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1024442|NCT01617187|2051494|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1024443|NCT01617187|2051495|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1024444|NCT01617187|2051492|FG000|Treatment Through Study Completion|Adverse Event|1
1024445|NCT01617187|2051493|FG001|Treatment Through Study Completion|Adverse Event|1
1024446|NCT01617187|2051494|FG002|Treatment Through Study Completion|Adverse Event|0
1024447|NCT01617187|2051495|FG003|Treatment Through Study Completion|Adverse Event|1
1024448|NCT01617187|2051492|FG000|Treatment Through Study Completion|Lost to Follow-up|4
1024449|NCT01617187|2051493|FG001|Treatment Through Study Completion|Lost to Follow-up|2
1024450|NCT01617187|2051494|FG002|Treatment Through Study Completion|Lost to Follow-up|2
1024451|NCT01617187|2051495|FG003|Treatment Through Study Completion|Lost to Follow-up|2
1024452|NCT01617187|2051492|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
1024453|NCT01617187|2051493|FG001|Treatment Through Study Completion|Withdrawal by Subject|8
1024454|NCT01617187|2051494|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
1024455|NCT01617187|2051495|FG003|Treatment Through Study Completion|Withdrawal by Subject|6
1024456|NCT01617187|2051492|FG000|Treatment Through Study Completion|Protocol Violation|1
1024457|NCT01617187|2051493|FG001|Treatment Through Study Completion|Protocol Violation|0
1024458|NCT01617187|2051494|FG002|Treatment Through Study Completion|Protocol Violation|0
1024459|NCT01617187|2051495|FG003|Treatment Through Study Completion|Protocol Violation|1
1024460|NCT01617434|2051517|FG000|Overall Study|Adverse Event|12
1024461|NCT01617434|2051518|FG001|Overall Study|Adverse Event|3
1024462|NCT01617434|2051517|FG000|Overall Study|Protocol Violation|8
1024463|NCT01617434|2051518|FG001|Overall Study|Protocol Violation|7
1024464|NCT01617434|2051517|FG000|Overall Study|Withdrawal Criteria|12
1024465|NCT01617434|2051518|FG001|Overall Study|Withdrawal Criteria|37
1024466|NCT01617434|2051517|FG000|Overall Study|Unclassified|3
1024467|NCT01617434|2051518|FG001|Overall Study|Unclassified|4
1024468|NCT01617447|2051526|FG000|Overall Study|Adverse Event|0
1024469|NCT01617447|2051527|FG001|Overall Study|Adverse Event|1
1024470|NCT01617447|2051526|FG000|Overall Study|Physician Decision|0
1024471|NCT01617447|2051527|FG001|Overall Study|Physician Decision|2
1024472|NCT01617460|2051533|FG000|Overall Study|Adverse Event|10
1024473|NCT01617460|2051533|FG000|Overall Study|Physician Decision|16
1024474|NCT01617460|2051533|FG000|Overall Study|Protocol Violation|5
1024475|NCT01617460|2051533|FG000|Overall Study|Withdrawal by Subject|9
1024476|NCT01617629|2051560|FG000|Overall Study|Death|2
1024477|NCT01617629|2051560|FG000|Overall Study|Investigator's Clinical Judgement|1
1024478|NCT01617629|2051560|FG000|Overall Study|Reason Not Specified|1
1024479|NCT01617629|2051560|FG000|Overall Study|Participant Withdrew Consent|2
1024480|NCT01617655|2051566|FG000|Overall Study|Adverse Event|2
1024481|NCT01617655|2051567|FG001|Overall Study|Adverse Event|3
1024482|NCT01617655|2051566|FG000|Overall Study|Poor compliance to protocol|1
1024483|NCT01617655|2051567|FG001|Overall Study|Poor compliance to protocol|4
1024484|NCT01617655|2051566|FG000|Overall Study|Participants moved|0
1024485|NCT01617655|2051567|FG001|Overall Study|Participants moved|4
1024486|NCT01617655|2051566|FG000|Overall Study|Consent withdrawn by participant|1
1024487|NCT01617655|2051567|FG001|Overall Study|Consent withdrawn by participant|1
1024488|NCT01617655|2051566|FG000|Overall Study|Last visit outside protocol visit window|1
1024489|NCT01617655|2051567|FG001|Overall Study|Last visit outside protocol visit window|10
1024490|NCT01617655|2051566|FG000|Overall Study|Site closure|3
1024491|NCT01617655|2051567|FG001|Overall Study|Site closure|5
1024492|NCT01617655|2051566|FG000|Overall Study|Other than specified above|1
1024493|NCT01617655|2051567|FG001|Overall Study|Other than specified above|2
1024494|NCT01617668|2051577|FG000|Overall Study|Adverse Event|7
1024495|NCT01617668|2051578|FG001|Overall Study|Adverse Event|0
1024496|NCT01617668|2051579|FG002|Overall Study|Adverse Event|12
1024497|NCT01617668|2051580|FG003|Overall Study|Adverse Event|5
1024498|NCT01617668|2051577|FG000|Overall Study|Physician Decision|1
1024499|NCT01617668|2051578|FG001|Overall Study|Physician Decision|2
1024500|NCT01617668|2051579|FG002|Overall Study|Physician Decision|3
1024501|NCT01617668|2051580|FG003|Overall Study|Physician Decision|0
1024502|NCT01617668|2051577|FG000|Overall Study|Progressive Disease|4
1024503|NCT01617668|2051578|FG001|Overall Study|Progressive Disease|4
1024504|NCT01617668|2051579|FG002|Overall Study|Progressive Disease|6
1024505|NCT01617668|2051580|FG003|Overall Study|Progressive Disease|9
1024506|NCT01617668|2051577|FG000|Overall Study|Subject/guardian decision|1
1024507|NCT01617668|2051578|FG001|Overall Study|Subject/guardian decision|3
1024508|NCT01617668|2051579|FG002|Overall Study|Subject/guardian decision|2
1024509|NCT01617668|2051580|FG003|Overall Study|Subject/guardian decision|1
1024510|NCT01617681|2051598|FG000|Period 1 Double Blind|Adverse Event|2
1024511|NCT01617681|2051599|FG001|Period 1 Double Blind|Adverse Event|0
1024512|NCT01617681|2051600|FG002|Period 1 Double Blind|Adverse Event|0
1024513|NCT01617681|2051601|FG003|Period 1 Double Blind|Adverse Event|2
1024514|NCT01617681|2051602|FG004|Period 1 Double Blind|Adverse Event|0
1024515|NCT01617681|2051598|FG000|Period 1 Double Blind|Withdrawal by Subject|1
1024516|NCT01617681|2051599|FG001|Period 1 Double Blind|Withdrawal by Subject|1
1024517|NCT01617681|2051600|FG002|Period 1 Double Blind|Withdrawal by Subject|1
1024518|NCT01617681|2051601|FG003|Period 1 Double Blind|Withdrawal by Subject|0
1024519|NCT01617681|2051602|FG004|Period 1 Double Blind|Withdrawal by Subject|0
1024520|NCT01617681|2051598|FG000|Period 2 Open Label|Adverse Event|0
1024521|NCT01617681|2051599|FG001|Period 2 Open Label|Adverse Event|0
1024522|NCT01617681|2051600|FG002|Period 2 Open Label|Adverse Event|0
1024523|NCT01617681|2051601|FG003|Period 2 Open Label|Adverse Event|0
1024524|NCT01617681|2051602|FG004|Period 2 Open Label|Adverse Event|3
1024525|NCT01617681|2051598|FG000|Period 2 Open Label|Withdrawal by Subject|0
1024526|NCT01617681|2051599|FG001|Period 2 Open Label|Withdrawal by Subject|0
1024527|NCT01617681|2051600|FG002|Period 2 Open Label|Withdrawal by Subject|0
1024528|NCT01617681|2051601|FG003|Period 2 Open Label|Withdrawal by Subject|0
1024529|NCT01617681|2051602|FG004|Period 2 Open Label|Withdrawal by Subject|3
1024530|NCT01617967|2051617|FG000|Overall Study|Protocol Violation|0
1024531|NCT01617967|2051618|FG001|Overall Study|Protocol Violation|0
1024532|NCT01617967|2051619|FG002|Overall Study|Protocol Violation|0
1024533|NCT01617967|2051620|FG003|Overall Study|Protocol Violation|1
1024534|NCT01617967|2051621|FG004|Overall Study|Protocol Violation|0
1024535|NCT01617967|2051622|FG005|Overall Study|Protocol Violation|0
1024536|NCT01617967|2051617|FG000|Overall Study|Withdrawal by Subject|0
1024537|NCT01617967|2051618|FG001|Overall Study|Withdrawal by Subject|0
1024538|NCT01617967|2051619|FG002|Overall Study|Withdrawal by Subject|0
1024539|NCT01617967|2051620|FG003|Overall Study|Withdrawal by Subject|0
1024540|NCT01617967|2051621|FG004|Overall Study|Withdrawal by Subject|0
1024541|NCT01617967|2051622|FG005|Overall Study|Withdrawal by Subject|1
1024542|NCT01617967|2051617|FG000|Overall Study|Dosing Suspended by Sponsor|1
1024543|NCT01617967|2051618|FG001|Overall Study|Dosing Suspended by Sponsor|0
1024544|NCT01617967|2051619|FG002|Overall Study|Dosing Suspended by Sponsor|0
1024545|NCT01617967|2051620|FG003|Overall Study|Dosing Suspended by Sponsor|0
1024546|NCT01617967|2051621|FG004|Overall Study|Dosing Suspended by Sponsor|0
1024547|NCT01617967|2051622|FG005|Overall Study|Dosing Suspended by Sponsor|0
1024548|NCT01618019|2051639|FG000|Overall Study|Withdrawal by Subject|14
1024549|NCT01618019|2051640|FG001|Overall Study|Withdrawal by Subject|14
1024550|NCT01618162|2051648|FG000|Overall Study|Protocol Violation|13
1024551|NCT01618162|2051649|FG001|Overall Study|Protocol Violation|10
1024552|NCT01618162|2051648|FG000|Overall Study|Adverse Event|9
1024553|NCT01618162|2051649|FG001|Overall Study|Adverse Event|2
1024554|NCT01618162|2051648|FG000|Overall Study|Withdrawal Criteria|2
1024555|NCT01618162|2051649|FG001|Overall Study|Withdrawal Criteria|10
1024556|NCT01618162|2051648|FG000|Overall Study|Unclassified|14
1024557|NCT01618162|2051649|FG001|Overall Study|Unclassified|13
1024558|NCT01618214|2051657|FG000|Overall Study|Adverse Event|3
1024559|NCT01618214|2051658|FG001|Overall Study|Adverse Event|1
1024560|NCT01618214|2051657|FG000|Overall Study|Lack of Efficacy|1
1024561|NCT01618214|2051658|FG001|Overall Study|Lack of Efficacy|1
1024562|NCT01618214|2051657|FG000|Overall Study|Protocol Violation|1
1024563|NCT01618214|2051658|FG001|Overall Study|Protocol Violation|4
1024564|NCT01618214|2051657|FG000|Overall Study|Withdrawal Criteria|1
1024565|NCT01618214|2051658|FG001|Overall Study|Withdrawal Criteria|2
1024566|NCT01618214|2051657|FG000|Overall Study|Unclassified|4
1024567|NCT01618214|2051658|FG001|Overall Study|Unclassified|5
1024568|NCT01618266|2051677|FG000|Overall Study|Lost to Follow-up|9
1024569|NCT01618266|2051677|FG000|Overall Study|Treatment satisfaction|10
1024570|NCT01618266|2051677|FG000|Overall Study|Other reasons|11
1024571|NCT01618266|2051677|FG000|Overall Study|Lack of Efficacy|23
1024572|NCT01618266|2051677|FG000|Overall Study|Protocol Violation|43
1024573|NCT01618305|2051683|FG000|Overall Study|Death|0
1024574|NCT01618305|2051684|FG001|Overall Study|Death|1
1024575|NCT01618305|2051683|FG000|Overall Study|Lost to Follow-up|11
1024576|NCT01618305|2051684|FG001|Overall Study|Lost to Follow-up|7
1024577|NCT01618305|2051683|FG000|Overall Study|Protocol Violation|1
1024578|NCT01618305|2051684|FG001|Overall Study|Protocol Violation|0
1024579|NCT01618305|2051683|FG000|Overall Study|Withdrawal by Subject|3
1024580|NCT01618305|2051684|FG001|Overall Study|Withdrawal by Subject|2
1024581|NCT01618669|2051709|FG000|Overall Study|Lost to Follow-up|1
1024582|NCT01618669|2051710|FG001|Overall Study|Lost to Follow-up|1
1024583|NCT01618669|2051709|FG000|Overall Study|Randomized but Never Received Study Drug|3
1024584|NCT01618669|2051710|FG001|Overall Study|Randomized but Never Received Study Drug|2
1024585|NCT01618669|2051709|FG000|Overall Study|Adverse Event|16
1024586|NCT01618669|2051710|FG001|Overall Study|Adverse Event|7
1024587|NCT01618669|2051709|FG000|Overall Study|Protocol Violation|5
1024588|NCT01618669|2051710|FG001|Overall Study|Protocol Violation|3
1024589|NCT01618669|2051709|FG000|Overall Study|Withdrawal by Subject|9
1024590|NCT01618669|2051710|FG001|Overall Study|Withdrawal by Subject|9
1024591|NCT01618669|2051709|FG000|Overall Study|Miscellaneous Reason|0
1024592|NCT01618669|2051710|FG001|Overall Study|Miscellaneous Reason|1
1024593|NCT01618695|2051732|FG000|Core Phase|Adverse Event|4
1024594|NCT01618695|2051733|FG001|Core Phase|Adverse Event|5
1024595|NCT01618695|2051734|FG002|Core Phase|Adverse Event|15
1024596|NCT01618695|2051735|FG003|Core Phase|Adverse Event|20
1024597|NCT01618695|2051732|FG000|Core Phase|Lost to Follow-up|0
1024598|NCT01618695|2051733|FG001|Core Phase|Lost to Follow-up|0
1024599|NCT01618695|2051734|FG002|Core Phase|Lost to Follow-up|1
1024600|NCT01618695|2051735|FG003|Core Phase|Lost to Follow-up|0
1024601|NCT01618695|2051732|FG000|Core Phase|Withdrawal by Subject|16
1024602|NCT01618695|2051733|FG001|Core Phase|Withdrawal by Subject|11
1024603|NCT01618695|2051734|FG002|Core Phase|Withdrawal by Subject|9
1024604|NCT01618695|2051735|FG003|Core Phase|Withdrawal by Subject|13
1024605|NCT01618695|2051732|FG000|Core Phase|Pregnancy|2
1024606|NCT01618695|2051733|FG001|Core Phase|Pregnancy|0
1024607|NCT01618695|2051734|FG002|Core Phase|Pregnancy|0
1024608|NCT01618695|2051735|FG003|Core Phase|Pregnancy|0
1024609|NCT01618695|2051732|FG000|Core Phase|Lack of Efficacy|1
1024610|NCT01618695|2051733|FG001|Core Phase|Lack of Efficacy|2
1024611|NCT01618695|2051734|FG002|Core Phase|Lack of Efficacy|1
1024612|NCT01618695|2051735|FG003|Core Phase|Lack of Efficacy|1
1024613|NCT01618695|2051732|FG000|Core Phase|Other than specified|1
1024614|NCT01618695|2051733|FG001|Core Phase|Other than specified|2
1024615|NCT01618695|2051734|FG002|Core Phase|Other than specified|2
1024616|NCT01618695|2051735|FG003|Core Phase|Other than specified|2
1024617|NCT01618695|2051732|FG000|Core Phase|Not treated|1
1024618|NCT01618695|2051733|FG001|Core Phase|Not treated|0
1024619|NCT01618695|2051734|FG002|Core Phase|Not treated|2
1024620|NCT01618695|2051735|FG003|Core Phase|Not treated|0
1024621|NCT01618695|2051732|FG000|Extension Phase|Lack of Efficacy|17
1024622|NCT01618695|2051733|FG001|Extension Phase|Lack of Efficacy|33
1024623|NCT01618695|2051734|FG002|Extension Phase|Lack of Efficacy|26
1024624|NCT01618695|2051735|FG003|Extension Phase|Lack of Efficacy|24
1024625|NCT01618695|2051732|FG000|Extension Phase|Pregnancy|2
1024626|NCT01618695|2051733|FG001|Extension Phase|Pregnancy|0
1024627|NCT01618695|2051734|FG002|Extension Phase|Pregnancy|1
1024628|NCT01618695|2051735|FG003|Extension Phase|Pregnancy|1
1024629|NCT01618695|2051732|FG000|Extension Phase|Withdrawal by Subject|43
1024630|NCT01618695|2051733|FG001|Extension Phase|Withdrawal by Subject|48
1024631|NCT01618695|2051734|FG002|Extension Phase|Withdrawal by Subject|42
1024632|NCT01618695|2051735|FG003|Extension Phase|Withdrawal by Subject|33
1024633|NCT01618695|2051732|FG000|Extension Phase|Adverse Event|18
1024634|NCT01618695|2051733|FG001|Extension Phase|Adverse Event|16
1024635|NCT01618695|2051734|FG002|Extension Phase|Adverse Event|9
1024636|NCT01618695|2051735|FG003|Extension Phase|Adverse Event|20
1024637|NCT01618695|2051732|FG000|Extension Phase|Lost to Follow-up|2
1024638|NCT01618695|2051733|FG001|Extension Phase|Lost to Follow-up|1
1024639|NCT01618695|2051734|FG002|Extension Phase|Lost to Follow-up|1
1024640|NCT01618695|2051735|FG003|Extension Phase|Lost to Follow-up|1
1024641|NCT01618695|2051732|FG000|Extension Phase|Other than specified|13
1024642|NCT01618695|2051733|FG001|Extension Phase|Other than specified|18
1024643|NCT01618695|2051734|FG002|Extension Phase|Other than specified|13
1024644|NCT01618695|2051735|FG003|Extension Phase|Other than specified|18
1024645|NCT01618708|2051748|FG000|Overall Study|Adverse Event|10
1024646|NCT01618708|2051749|FG001|Overall Study|Adverse Event|10
1024647|NCT01618708|2051748|FG000|Overall Study|Lost to Follow-up|3
1024648|NCT01618708|2051749|FG001|Overall Study|Lost to Follow-up|3
1024649|NCT01618708|2051748|FG000|Overall Study|Withdrawal by Subject|17
1024650|NCT01618708|2051749|FG001|Overall Study|Withdrawal by Subject|22
1024651|NCT01618708|2051748|FG000|Overall Study|Lack of Efficacy|8
1024652|NCT01618708|2051749|FG001|Overall Study|Lack of Efficacy|8
1024653|NCT01618708|2051748|FG000|Overall Study|Technical problems|2
1024654|NCT01618708|2051749|FG001|Overall Study|Technical problems|0
1024655|NCT01618708|2051748|FG000|Overall Study|Other than specified above|1
1024656|NCT01618708|2051749|FG001|Overall Study|Other than specified above|1
1024657|NCT01618708|2051748|FG000|Overall Study|Randomized but not treated|3
1024658|NCT01618708|2051749|FG001|Overall Study|Randomized but not treated|2
1024659|NCT01618838|2051756|FG000|Overall Study|slow accrual, trial closed prematurely.|4
1024660|NCT01618864|2051761|FG000|Overall Study|Withdrawal by Subject|2
1024661|NCT01618864|2051761|FG000|Overall Study|Lost to Follow-up|2
1024662|NCT01618916|2051776|FG000|Overall Study|Adverse Event|1
1024663|NCT01618916|2051777|FG001|Overall Study|Adverse Event|0
1024664|NCT01618916|2051778|FG002|Overall Study|Adverse Event|0
1024665|NCT01618916|2051779|FG003|Overall Study|Adverse Event|0
1024666|NCT01618916|2051780|FG004|Overall Study|Adverse Event|0
1024667|NCT01618916|2051781|FG005|Overall Study|Adverse Event|0
1024668|NCT01618916|2051776|FG000|Overall Study|Withdrawal by Subject|0
1024669|NCT01618916|2051777|FG001|Overall Study|Withdrawal by Subject|1
1024670|NCT01618916|2051778|FG002|Overall Study|Withdrawal by Subject|1
1024671|NCT01618916|2051779|FG003|Overall Study|Withdrawal by Subject|0
1024672|NCT01618916|2051780|FG004|Overall Study|Withdrawal by Subject|1
1024673|NCT01618916|2051781|FG005|Overall Study|Withdrawal by Subject|0
1024674|NCT01618916|2051776|FG000|Overall Study|Lost to Follow-up|1
1024675|NCT01618916|2051777|FG001|Overall Study|Lost to Follow-up|0
1024676|NCT01618916|2051778|FG002|Overall Study|Lost to Follow-up|0
1024677|NCT01618916|2051779|FG003|Overall Study|Lost to Follow-up|2
1024678|NCT01618916|2051780|FG004|Overall Study|Lost to Follow-up|0
1024679|NCT01618916|2051781|FG005|Overall Study|Lost to Follow-up|0
1024680|NCT01618968|2051824|FG000|Overall Study|Adverse Event|1
1024681|NCT01618968|2051825|FG001|Overall Study|Adverse Event|0
1024682|NCT01618968|2051826|FG002|Overall Study|Adverse Event|0
1024683|NCT01618968|2051827|FG003|Overall Study|Adverse Event|0
1024684|NCT01618968|2051824|FG000|Overall Study|Death|0
1024685|NCT01618968|2051825|FG001|Overall Study|Death|0
1024686|NCT01618968|2051826|FG002|Overall Study|Death|0
1024687|NCT01618968|2051827|FG003|Overall Study|Death|1
1024688|NCT01619059|2051838|FG000|Short-Term (ST) Treatment Period|Adverse Event|1
1024689|NCT01619059|2051839|FG001|Short-Term (ST) Treatment Period|Adverse Event|0
1024690|NCT01619059|2051838|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
1024691|NCT01619059|2051839|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
1090862|NCT02249091|2158598|FG001|Overall Study|Adverse Event|0
1024692|NCT01619059|2051838|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2
1024693|NCT01619059|2051839|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4
1024694|NCT01619059|2051838|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
1024695|NCT01619059|2051839|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
1024696|NCT01619059|2051838|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0
1024697|NCT01619059|2051839|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1
1024698|NCT01619059|2051838|FG000|Long-Term (LT) Treatment Period|Adverse Event|2
1024699|NCT01619059|2051839|FG001|Long-Term (LT) Treatment Period|Adverse Event|3
1024700|NCT01619059|2051838|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
1024701|NCT01619059|2051839|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
1024702|NCT01619059|2051838|FG000|Long-Term (LT) Treatment Period|Death|1
1024703|NCT01619059|2051839|FG001|Long-Term (LT) Treatment Period|Death|0
1024704|NCT01619059|2051838|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2
1024705|NCT01619059|2051839|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2
1024706|NCT01619059|2051838|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
1024707|NCT01619059|2051839|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
1024708|NCT01619085|2051845|FG000|Overall Study|Adverse Event|212
1024709|NCT01619085|2051845|FG000|Overall Study|Protocol Violation|10
1024710|NCT01619085|2051845|FG000|Overall Study|Lost to Follow-up|10
1024711|NCT01619085|2051845|FG000|Overall Study|Withdrawal by Subject|15
1024712|NCT01619085|2051845|FG000|Overall Study|Other than specified|94
1024713|NCT01619085|2051845|FG000|Overall Study|Not treated|1
1024714|NCT01619085|2051845|FG000|Overall Study|Ongoing on trial|27
1024715|NCT01619410|2051851|FG000|Overall Study|Lost to Follow-up|7
1024716|NCT01619410|2051852|FG001|Overall Study|Lost to Follow-up|4
1024717|NCT01619423|2051862|FG000|Part 1 (Dose Escalation)|High basal Mn|0
1024718|NCT01619423|2051863|FG001|Part 1 (Dose Escalation)|High basal Mn|2
1024719|NCT01619423|2051864|FG002|Part 1 (Dose Escalation)|High basal Mn|0
1024720|NCT01619423|2051865|FG003|Part 1 (Dose Escalation)|High basal Mn|0
1024721|NCT01619579|2051878|FG000|Overall Study|Withdrawal by Subject|0
1024722|NCT01619579|2051879|FG001|Overall Study|Withdrawal by Subject|3
1024723|NCT01619787|2051891|FG000|Overall Study|Lost to Follow-up|5
1024724|NCT01619852|2051917|FG000|24 Hour Assessment|Withdrawal by Subject|1
1024725|NCT01619852|2051918|FG001|24 Hour Assessment|Withdrawal by Subject|1
1024726|NCT01619852|2051917|FG000|3 Month Follow up|Lost to Follow-up|31
1024727|NCT01619852|2051918|FG001|3 Month Follow up|Lost to Follow-up|34
1024728|NCT01619865|2051925|FG000|Overall Study|Adverse Event|1
1024729|NCT01619865|2051925|FG000|Overall Study|Death|2
1024730|NCT01619865|2051925|FG000|Overall Study|subject not able to comply|1
1024731|NCT01619878|2051930|FG000|6 Week Follow-up Phase|Adverse Event|1
1024732|NCT01619878|2051930|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1
1024733|NCT01619878|2051930|FG000|Follow-up at 12 Months of Age|Death|2
1024734|NCT01620060|2051960|FG000|Overall Study|Adverse Event|9
1024735|NCT01620060|2051960|FG000|Overall Study|Protocol Violation|1
1024736|NCT01620060|2051960|FG000|Overall Study|Withdrawal by Subject|1
1024737|NCT01620060|2051960|FG000|Overall Study|Did not comply with Study Produre|1
1024738|NCT01620060|2051960|FG000|Overall Study|Family emergency|1
1024739|NCT01620060|2051960|FG000|Overall Study|Per Sponsor Decision|2
1024740|NCT01620086|2051966|FG000|Overall Study|Withdrawal by Subject|3
1024741|NCT01620086|2051967|FG001|Overall Study|Withdrawal by Subject|3
1024742|NCT01620086|2051968|FG002|Overall Study|Withdrawal by Subject|0
1024743|NCT01620086|2051966|FG000|Overall Study|failed study criteria|1
1024744|NCT01620086|2051967|FG001|Overall Study|failed study criteria|4
1024745|NCT01620086|2051968|FG002|Overall Study|failed study criteria|0
1024746|NCT01620086|2051966|FG000|Overall Study|Physician Decision|1
1024747|NCT01620086|2051967|FG001|Overall Study|Physician Decision|0
1024748|NCT01620086|2051968|FG002|Overall Study|Physician Decision|0
1024749|NCT01620138|2051979|FG000|Overall Study|Withdrawal by Subject|3
1024750|NCT01620138|2051980|FG001|Overall Study|Withdrawal by Subject|0
1024751|NCT01620138|2051979|FG000|Overall Study|Lack of Efficacy|1
1024752|NCT01620138|2051980|FG001|Overall Study|Lack of Efficacy|0
1024753|NCT01620138|2051979|FG000|Overall Study|Adverse Event|2
1024754|NCT01620138|2051980|FG001|Overall Study|Adverse Event|0
1024755|NCT01620177|2051986|FG000|Overall Study|Failure at Screening Visit|43
1024756|NCT01620177|2051986|FG000|Overall Study|Withdrawal by Subject|26
1024757|NCT01620177|2051986|FG000|Overall Study|Lost to Follow-up|7
1024758|NCT01620177|2051986|FG000|Overall Study|Physician Decision|2
1024759|NCT01620177|2051986|FG000|Overall Study|Randomized, Not Active due to Scheduling|1
1024760|NCT01620255|2052041|FG000|Overall Study|Withdrawal by Subject|4
1024761|NCT01620255|2052042|FG001|Overall Study|Withdrawal by Subject|1
1024762|NCT01620255|2052043|FG002|Overall Study|Withdrawal by Subject|1
1024763|NCT01620255|2052044|FG003|Overall Study|Withdrawal by Subject|2
1024764|NCT01620255|2052045|FG004|Overall Study|Withdrawal by Subject|4
1024765|NCT01620255|2052041|FG000|Overall Study|Participant underwent fecal transplant|0
1024766|NCT01620255|2052042|FG001|Overall Study|Participant underwent fecal transplant|0
1024767|NCT01620255|2052043|FG002|Overall Study|Participant underwent fecal transplant|1
1024768|NCT01620255|2052044|FG003|Overall Study|Participant underwent fecal transplant|0
1024769|NCT01620255|2052045|FG004|Overall Study|Participant underwent fecal transplant|0
1024770|NCT01620255|2052041|FG000|Overall Study|Non-compliance|0
1024771|NCT01620255|2052042|FG001|Overall Study|Non-compliance|1
905014|NCT00760266|1880209|FG000|Overall Study|Abnormal laboratory value(s)|1
905015|NCT00760266|1880210|FG001|Overall Study|Abnormal laboratory value(s)|0
905016|NCT00760266|1880209|FG000|Overall Study|Abnormal test procedure result(s)|1
905017|NCT00760266|1880210|FG001|Overall Study|Abnormal test procedure result(s)|0
1024772|NCT01620255|2052043|FG002|Overall Study|Non-compliance|0
1024773|NCT01620255|2052044|FG003|Overall Study|Non-compliance|0
1024774|NCT01620255|2052045|FG004|Overall Study|Non-compliance|0
1024775|NCT01620255|2052041|FG000|Overall Study|Adverse Event|0
1024776|NCT01620255|2052042|FG001|Overall Study|Adverse Event|4
1024777|NCT01620255|2052043|FG002|Overall Study|Adverse Event|0
1024778|NCT01620255|2052044|FG003|Overall Study|Adverse Event|1
1024779|NCT01620255|2052045|FG004|Overall Study|Adverse Event|1
1024780|NCT01620255|2052041|FG000|Overall Study|Withdrawn at discretion of investigator|0
1024781|NCT01620255|2052042|FG001|Overall Study|Withdrawn at discretion of investigator|0
1024782|NCT01620255|2052043|FG002|Overall Study|Withdrawn at discretion of investigator|0
1024783|NCT01620255|2052044|FG003|Overall Study|Withdrawn at discretion of investigator|0
1024784|NCT01620255|2052045|FG004|Overall Study|Withdrawn at discretion of investigator|1
1024785|NCT01620489|2052059|FG000|Overall Study|Adverse Event|17
1024786|NCT01620489|2052060|FG001|Overall Study|Adverse Event|4
1024787|NCT01620489|2052059|FG000|Overall Study|Protocol Violation|0
1024788|NCT01620489|2052060|FG001|Overall Study|Protocol Violation|3
1024789|NCT01620489|2052059|FG000|Overall Study|Withdrawal Criteria|17
1024790|NCT01620489|2052060|FG001|Overall Study|Withdrawal Criteria|25
1024791|NCT01620489|2052059|FG000|Overall Study|Unclassified|1
1024792|NCT01620489|2052060|FG001|Overall Study|Unclassified|2
1024793|NCT01620528|2052069|FG000|Treatment Period|Did Not Receive Study Drug|0
1024794|NCT01620528|2052070|FG001|Treatment Period|Did Not Receive Study Drug|0
1024795|NCT01620528|2052071|FG002|Treatment Period|Did Not Receive Study Drug|1
1024796|NCT01620528|2052069|FG000|Treatment Period|Withdrawal by Subject|35
1024797|NCT01620528|2052070|FG001|Treatment Period|Withdrawal by Subject|21
1024798|NCT01620528|2052071|FG002|Treatment Period|Withdrawal by Subject|16
1024799|NCT01620528|2052069|FG000|Treatment Period|Adverse Event|17
1024800|NCT01620528|2052070|FG001|Treatment Period|Adverse Event|13
1024801|NCT01620528|2052071|FG002|Treatment Period|Adverse Event|21
1024802|NCT01620528|2052069|FG000|Treatment Period|Lost to Follow-up|16
1024803|NCT01620528|2052070|FG001|Treatment Period|Lost to Follow-up|8
1024804|NCT01620528|2052071|FG002|Treatment Period|Lost to Follow-up|14
1024805|NCT01620528|2052069|FG000|Treatment Period|Other|9
1024806|NCT01620528|2052070|FG001|Treatment Period|Other|5
1024807|NCT01620528|2052071|FG002|Treatment Period|Other|7
1024808|NCT01620528|2052069|FG000|Treatment Period|Subject Noncompliant|11
1024809|NCT01620528|2052070|FG001|Treatment Period|Subject Noncompliant|2
1024810|NCT01620528|2052071|FG002|Treatment Period|Subject Noncompliant|2
1024811|NCT01620528|2052069|FG000|Treatment Period|Pregnancy|7
1024812|NCT01620528|2052070|FG001|Treatment Period|Pregnancy|2
1024813|NCT01620528|2052071|FG002|Treatment Period|Pregnancy|2
1024814|NCT01620528|2052069|FG000|Treatment Period|Surgery/Invasive Intervention|5
1024815|NCT01620528|2052070|FG001|Treatment Period|Surgery/Invasive Intervention|1
1024816|NCT01620528|2052071|FG002|Treatment Period|Surgery/Invasive Intervention|3
1024817|NCT01620528|2052069|FG000|Treatment Period|Exclusionary Medication Received|0
1024818|NCT01620528|2052070|FG001|Treatment Period|Exclusionary Medication Received|1
1024819|NCT01620528|2052071|FG002|Treatment Period|Exclusionary Medication Received|0
1024820|NCT01620528|2052069|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
1024821|NCT01620528|2052070|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
1024822|NCT01620528|2052071|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
1024823|NCT01620528|2052069|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
1024824|NCT01620528|2052070|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
1024825|NCT01620528|2052071|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
1024826|NCT01620528|2052069|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
1024827|NCT01620528|2052070|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
1024828|NCT01620528|2052071|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
1024829|NCT01620528|2052069|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
1024830|NCT01620528|2052070|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
1024831|NCT01620528|2052071|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
1024832|NCT01620528|2052069|FG000|Post-Treatment Follow-Up Period|Other|6
1024833|NCT01620528|2052070|FG001|Post-Treatment Follow-Up Period|Other|4
1024834|NCT01620528|2052071|FG002|Post-Treatment Follow-Up Period|Other|2
1024835|NCT01620762|2052122|FG000|Overall Study|Protocol Violation|1
1024836|NCT01620762|2052123|FG001|Overall Study|Protocol Violation|1
1024837|NCT01620762|2052124|FG002|Overall Study|Protocol Violation|1
1024838|NCT01620762|2052122|FG000|Overall Study|Adverse Event|9
1024839|NCT01620762|2052123|FG001|Overall Study|Adverse Event|5
1024840|NCT01620762|2052124|FG002|Overall Study|Adverse Event|2
1024841|NCT01620762|2052122|FG000|Overall Study|Withdrawal by Subject|23
1024842|NCT01620762|2052123|FG001|Overall Study|Withdrawal by Subject|26
1024843|NCT01620762|2052124|FG002|Overall Study|Withdrawal by Subject|27
1024844|NCT01620762|2052122|FG000|Overall Study|Lost to Follow-up|11
1024845|NCT01620762|2052123|FG001|Overall Study|Lost to Follow-up|17
1024846|NCT01620762|2052124|FG002|Overall Study|Lost to Follow-up|10
1024847|NCT01620762|2052122|FG000|Overall Study|Protocol deviation|1
1024848|NCT01620762|2052123|FG001|Overall Study|Protocol deviation|1
1024849|NCT01620762|2052124|FG002|Overall Study|Protocol deviation|6
1024850|NCT01620762|2052122|FG000|Overall Study|Subject deterioration|0
1024851|NCT01620762|2052123|FG001|Overall Study|Subject deterioration|1
1024852|NCT01620762|2052124|FG002|Overall Study|Subject deterioration|1
1024853|NCT01620762|2052122|FG000|Overall Study|Non-specified|3
1024854|NCT01620762|2052123|FG001|Overall Study|Non-specified|6
1024855|NCT01620762|2052124|FG002|Overall Study|Non-specified|5
1024856|NCT01620762|2052122|FG000|Overall Study|Use of prohibted therapies|0
1024857|NCT01620762|2052123|FG001|Overall Study|Use of prohibted therapies|1
1024858|NCT01620762|2052124|FG002|Overall Study|Use of prohibted therapies|1
1024859|NCT01620983|2052144|FG000|Overall Study|Lost to Follow-up|8
1024860|NCT01620983|2052145|FG001|Overall Study|Lost to Follow-up|4
1024861|NCT01620983|2052146|FG002|Overall Study|Lost to Follow-up|9
1024862|NCT01620983|2052144|FG000|Overall Study|Withdrawal by Subject|6
1024863|NCT01620983|2052145|FG001|Overall Study|Withdrawal by Subject|8
1024864|NCT01620983|2052146|FG002|Overall Study|Withdrawal by Subject|1
1024865|NCT01620983|2052144|FG000|Overall Study|Death|2
1024866|NCT01620983|2052145|FG001|Overall Study|Death|0
1024867|NCT01620983|2052146|FG002|Overall Study|Death|0
1024868|NCT01620983|2052144|FG000|Overall Study|Physician Decision|3
1024869|NCT01620983|2052145|FG001|Overall Study|Physician Decision|10
1024870|NCT01620983|2052146|FG002|Overall Study|Physician Decision|5
1024871|NCT01621126|2052169|FG000|Overall Study|Physician Decision|6
1024872|NCT01621178|2052176|FG000|Overall Study|Adverse Event|5
1024873|NCT01621178|2052177|FG001|Overall Study|Adverse Event|2
1024874|NCT01621178|2052178|FG002|Overall Study|Adverse Event|8
1024875|NCT01621178|2052176|FG000|Overall Study|Death|6
905018|NCT00760266|1880209|FG000|Overall Study|Lack of Efficacy|2
1024876|NCT01621178|2052177|FG001|Overall Study|Death|7
1024877|NCT01621178|2052178|FG002|Overall Study|Death|2
1024878|NCT01621178|2052176|FG000|Overall Study|Lost to Follow-up|1
1024879|NCT01621178|2052177|FG001|Overall Study|Lost to Follow-up|2
1024880|NCT01621178|2052178|FG002|Overall Study|Lost to Follow-up|1
1024881|NCT01621178|2052176|FG000|Overall Study|Withdrawal by Subject|14
1024882|NCT01621178|2052177|FG001|Overall Study|Withdrawal by Subject|17
1024883|NCT01621178|2052178|FG002|Overall Study|Withdrawal by Subject|18
1024884|NCT01621178|2052176|FG000|Overall Study|Physician Decision|5
1024885|NCT01621178|2052177|FG001|Overall Study|Physician Decision|2
1024886|NCT01621178|2052178|FG002|Overall Study|Physician Decision|7
1024887|NCT01621191|2052190|FG000|Overall Study|Adverse Event|9
1024888|NCT01621191|2052190|FG000|Overall Study|Withdrawal by Subject|8
1024889|NCT01621191|2052190|FG000|Overall Study|Lack of Efficacy|6
1024890|NCT01621191|2052190|FG000|Overall Study|Lost to Follow-up|1
1024891|NCT01621191|2052190|FG000|Overall Study|Site Removed From Study|1
1024892|NCT01621490|2052220|FG000|Overall Study|Participant completed treatment|4
1024893|NCT01621490|2052221|FG001|Overall Study|Participant completed treatment|4
1024894|NCT01621490|2052222|FG002|Overall Study|Participant completed treatment|1
1024895|NCT01621490|2052223|FG003|Overall Study|Participant completed treatment|0
1024896|NCT01621490|2052224|FG004|Overall Study|Participant completed treatment|0
1024897|NCT01621490|2052225|FG005|Overall Study|Participant completed treatment|0
1024898|NCT01621490|2052226|FG006|Overall Study|Participant completed treatment|0
1024899|NCT01621490|2052227|FG007|Overall Study|Participant completed treatment|1
1024900|NCT01621490|2052228|FG008|Overall Study|Participant completed treatment|0
1024901|NCT01621490|2052220|FG000|Overall Study|Patient could not travel|1
1024902|NCT01621490|2052221|FG001|Overall Study|Patient could not travel|0
1024903|NCT01621490|2052222|FG002|Overall Study|Patient could not travel|0
1024904|NCT01621490|2052223|FG003|Overall Study|Patient could not travel|0
1024905|NCT01621490|2052224|FG004|Overall Study|Patient could not travel|0
1024906|NCT01621490|2052225|FG005|Overall Study|Patient could not travel|0
1024907|NCT01621490|2052226|FG006|Overall Study|Patient could not travel|0
1024908|NCT01621490|2052227|FG007|Overall Study|Patient could not travel|0
1024909|NCT01621490|2052228|FG008|Overall Study|Patient could not travel|0
1024910|NCT01621490|2052220|FG000|Overall Study|Subject no longer meets study criteria|0
1024911|NCT01621490|2052221|FG001|Overall Study|Subject no longer meets study criteria|0
1024912|NCT01621490|2052222|FG002|Overall Study|Subject no longer meets study criteria|0
1024913|NCT01621490|2052223|FG003|Overall Study|Subject no longer meets study criteria|0
1024914|NCT01621490|2052224|FG004|Overall Study|Subject no longer meets study criteria|1
1024915|NCT01621490|2052225|FG005|Overall Study|Subject no longer meets study criteria|0
1024916|NCT01621490|2052226|FG006|Overall Study|Subject no longer meets study criteria|0
1024917|NCT01621490|2052227|FG007|Overall Study|Subject no longer meets study criteria|0
1024918|NCT01621490|2052228|FG008|Overall Study|Subject no longer meets study criteria|0
1024919|NCT01621490|2052220|FG000|Overall Study|Maximum clinical benefit|3
1024920|NCT01621490|2052221|FG001|Overall Study|Maximum clinical benefit|2
1024921|NCT01621490|2052222|FG002|Overall Study|Maximum clinical benefit|0
1024922|NCT01621490|2052223|FG003|Overall Study|Maximum clinical benefit|0
1024923|NCT01621490|2052224|FG004|Overall Study|Maximum clinical benefit|0
1024924|NCT01621490|2052225|FG005|Overall Study|Maximum clinical benefit|0
1024925|NCT01621490|2052226|FG006|Overall Study|Maximum clinical benefit|1
1024926|NCT01621490|2052227|FG007|Overall Study|Maximum clinical benefit|2
1024927|NCT01621490|2052228|FG008|Overall Study|Maximum clinical benefit|0
1024928|NCT01621490|2052220|FG000|Overall Study|Withdrawal by Subject|1
1024929|NCT01621490|2052221|FG001|Overall Study|Withdrawal by Subject|0
1024930|NCT01621490|2052222|FG002|Overall Study|Withdrawal by Subject|0
1024931|NCT01621490|2052223|FG003|Overall Study|Withdrawal by Subject|0
1024932|NCT01621490|2052224|FG004|Overall Study|Withdrawal by Subject|0
1024933|NCT01621490|2052225|FG005|Overall Study|Withdrawal by Subject|3
1024934|NCT01621490|2052226|FG006|Overall Study|Withdrawal by Subject|0
1024935|NCT01621490|2052227|FG007|Overall Study|Withdrawal by Subject|0
1024936|NCT01621490|2052228|FG008|Overall Study|Withdrawal by Subject|0
1024937|NCT01621490|2052220|FG000|Overall Study|Subject request to discontinue study|1
1024938|NCT01621490|2052221|FG001|Overall Study|Subject request to discontinue study|3
1024939|NCT01621490|2052222|FG002|Overall Study|Subject request to discontinue study|1
1024940|NCT01621490|2052223|FG003|Overall Study|Subject request to discontinue study|1
1024941|NCT01621490|2052224|FG004|Overall Study|Subject request to discontinue study|0
1024942|NCT01621490|2052225|FG005|Overall Study|Subject request to discontinue study|2
1024943|NCT01621490|2052226|FG006|Overall Study|Subject request to discontinue study|1
1024944|NCT01621490|2052227|FG007|Overall Study|Subject request to discontinue study|0
1024945|NCT01621490|2052228|FG008|Overall Study|Subject request to discontinue study|1
1024946|NCT01621490|2052220|FG000|Overall Study|Adverse event unrelated to study drug|2
1024947|NCT01621490|2052221|FG001|Overall Study|Adverse event unrelated to study drug|1
1024948|NCT01621490|2052222|FG002|Overall Study|Adverse event unrelated to study drug|0
1024949|NCT01621490|2052223|FG003|Overall Study|Adverse event unrelated to study drug|0
1024950|NCT01621490|2052224|FG004|Overall Study|Adverse event unrelated to study drug|0
1024951|NCT01621490|2052225|FG005|Overall Study|Adverse event unrelated to study drug|0
1024952|NCT01621490|2052226|FG006|Overall Study|Adverse event unrelated to study drug|0
1024953|NCT01621490|2052227|FG007|Overall Study|Adverse event unrelated to study drug|2
1024954|NCT01621490|2052228|FG008|Overall Study|Adverse event unrelated to study drug|1
1024955|NCT01621490|2052220|FG000|Overall Study|Disease progression|27
1024956|NCT01621490|2052221|FG001|Overall Study|Disease progression|28
1024957|NCT01621490|2052222|FG002|Overall Study|Disease progression|1
1024958|NCT01621490|2052223|FG003|Overall Study|Disease progression|5
1024959|NCT01621490|2052224|FG004|Overall Study|Disease progression|3
1024960|NCT01621490|2052225|FG005|Overall Study|Disease progression|8
1024961|NCT01621490|2052226|FG006|Overall Study|Disease progression|7
1024962|NCT01621490|2052227|FG007|Overall Study|Disease progression|0
1024963|NCT01621490|2052228|FG008|Overall Study|Disease progression|4
1024964|NCT01621490|2052220|FG000|Overall Study|Study drug toxicity|1
1024965|NCT01621490|2052221|FG001|Overall Study|Study drug toxicity|4
1024966|NCT01621490|2052222|FG002|Overall Study|Study drug toxicity|5
1024967|NCT01621490|2052223|FG003|Overall Study|Study drug toxicity|3
1024968|NCT01621490|2052224|FG004|Overall Study|Study drug toxicity|1
1024969|NCT01621490|2052225|FG005|Overall Study|Study drug toxicity|10
1024970|NCT01621490|2052226|FG006|Overall Study|Study drug toxicity|1
1024971|NCT01621490|2052227|FG007|Overall Study|Study drug toxicity|4
1024972|NCT01621490|2052228|FG008|Overall Study|Study drug toxicity|1
1024973|NCT01621490|2052220|FG000|Overall Study|Death|0
1024974|NCT01621490|2052221|FG001|Overall Study|Death|0
1024975|NCT01621490|2052222|FG002|Overall Study|Death|0
1024976|NCT01621490|2052223|FG003|Overall Study|Death|0
1024977|NCT01621490|2052224|FG004|Overall Study|Death|0
1024978|NCT01621490|2052225|FG005|Overall Study|Death|0
1024979|NCT01621490|2052226|FG006|Overall Study|Death|0
1024980|NCT01621490|2052227|FG007|Overall Study|Death|1
1024981|NCT01621490|2052228|FG008|Overall Study|Death|0
1024982|NCT01621490|2052220|FG000|Overall Study|Grade 4 Lipase elevation|1
1024983|NCT01621490|2052221|FG001|Overall Study|Grade 4 Lipase elevation|0
1024984|NCT01621490|2052222|FG002|Overall Study|Grade 4 Lipase elevation|0
1024985|NCT01621490|2052223|FG003|Overall Study|Grade 4 Lipase elevation|0
1024986|NCT01621490|2052224|FG004|Overall Study|Grade 4 Lipase elevation|0
1024987|NCT01621490|2052225|FG005|Overall Study|Grade 4 Lipase elevation|0
1024988|NCT01621490|2052226|FG006|Overall Study|Grade 4 Lipase elevation|0
1024989|NCT01621490|2052227|FG007|Overall Study|Grade 4 Lipase elevation|0
1024990|NCT01621490|2052228|FG008|Overall Study|Grade 4 Lipase elevation|0
1024991|NCT01621490|2052220|FG000|Overall Study|BMS informed of patient status|0
1024992|NCT01621490|2052221|FG001|Overall Study|BMS informed of patient status|0
1024993|NCT01621490|2052222|FG002|Overall Study|BMS informed of patient status|1
1024994|NCT01621490|2052223|FG003|Overall Study|BMS informed of patient status|0
1024995|NCT01621490|2052224|FG004|Overall Study|BMS informed of patient status|0
1024996|NCT01621490|2052225|FG005|Overall Study|BMS informed of patient status|0
1024997|NCT01621490|2052226|FG006|Overall Study|BMS informed of patient status|0
1024998|NCT01621490|2052227|FG007|Overall Study|BMS informed of patient status|0
1024999|NCT01621490|2052228|FG008|Overall Study|BMS informed of patient status|0
1025000|NCT01621490|2052220|FG000|Overall Study|Investigator decision|0
1025001|NCT01621490|2052221|FG001|Overall Study|Investigator decision|0
1025002|NCT01621490|2052222|FG002|Overall Study|Investigator decision|1
1025003|NCT01621490|2052223|FG003|Overall Study|Investigator decision|0
1025004|NCT01621490|2052224|FG004|Overall Study|Investigator decision|1
1025005|NCT01621490|2052225|FG005|Overall Study|Investigator decision|0
1025006|NCT01621490|2052226|FG006|Overall Study|Investigator decision|1
1025007|NCT01621490|2052227|FG007|Overall Study|Investigator decision|0
1025008|NCT01621490|2052228|FG008|Overall Study|Investigator decision|0
1025009|NCT01621490|2052220|FG000|Overall Study|Documented disease progression|0
1025010|NCT01621490|2052221|FG001|Overall Study|Documented disease progression|0
1025011|NCT01621490|2052222|FG002|Overall Study|Documented disease progression|1
1025012|NCT01621490|2052223|FG003|Overall Study|Documented disease progression|0
1025013|NCT01621490|2052224|FG004|Overall Study|Documented disease progression|0
1025014|NCT01621490|2052225|FG005|Overall Study|Documented disease progression|0
1025015|NCT01621490|2052226|FG006|Overall Study|Documented disease progression|0
1025016|NCT01621490|2052227|FG007|Overall Study|Documented disease progression|0
1025017|NCT01621490|2052228|FG008|Overall Study|Documented disease progression|0
1025018|NCT01621490|2052220|FG000|Overall Study|Patient reached treatment 2 yr limit|0
1025019|NCT01621490|2052221|FG001|Overall Study|Patient reached treatment 2 yr limit|1
1025020|NCT01621490|2052222|FG002|Overall Study|Patient reached treatment 2 yr limit|0
1025021|NCT01621490|2052223|FG003|Overall Study|Patient reached treatment 2 yr limit|0
1025022|NCT01621490|2052224|FG004|Overall Study|Patient reached treatment 2 yr limit|0
1025023|NCT01621490|2052225|FG005|Overall Study|Patient reached treatment 2 yr limit|0
1025024|NCT01621490|2052226|FG006|Overall Study|Patient reached treatment 2 yr limit|0
1025025|NCT01621490|2052227|FG007|Overall Study|Patient reached treatment 2 yr limit|0
1025026|NCT01621490|2052228|FG008|Overall Study|Patient reached treatment 2 yr limit|0
1025027|NCT01621490|2052220|FG000|Overall Study|Clinical deterioration|0
1025028|NCT01621490|2052221|FG001|Overall Study|Clinical deterioration|1
1025029|NCT01621490|2052222|FG002|Overall Study|Clinical deterioration|0
1025030|NCT01621490|2052223|FG003|Overall Study|Clinical deterioration|0
1025031|NCT01621490|2052224|FG004|Overall Study|Clinical deterioration|0
1025032|NCT01621490|2052225|FG005|Overall Study|Clinical deterioration|0
1025033|NCT01621490|2052226|FG006|Overall Study|Clinical deterioration|0
1025034|NCT01621490|2052227|FG007|Overall Study|Clinical deterioration|0
1025035|NCT01621490|2052228|FG008|Overall Study|Clinical deterioration|0
1025036|NCT01621490|2052220|FG000|Overall Study|Complete response|0
1025037|NCT01621490|2052221|FG001|Overall Study|Complete response|0
1025038|NCT01621490|2052222|FG002|Overall Study|Complete response|0
1025039|NCT01621490|2052223|FG003|Overall Study|Complete response|0
1025040|NCT01621490|2052224|FG004|Overall Study|Complete response|0
1025041|NCT01621490|2052225|FG005|Overall Study|Complete response|0
1025042|NCT01621490|2052226|FG006|Overall Study|Complete response|0
1025043|NCT01621490|2052227|FG007|Overall Study|Complete response|0
1025044|NCT01621490|2052228|FG008|Overall Study|Complete response|1
1025045|NCT01621490|2052220|FG000|Overall Study|Patient delayed due to toxicity|0
1025046|NCT01621490|2052221|FG001|Overall Study|Patient delayed due to toxicity|0
1025047|NCT01621490|2052222|FG002|Overall Study|Patient delayed due to toxicity|0
1025048|NCT01621490|2052223|FG003|Overall Study|Patient delayed due to toxicity|0
1025049|NCT01621490|2052224|FG004|Overall Study|Patient delayed due to toxicity|0
1025050|NCT01621490|2052225|FG005|Overall Study|Patient delayed due to toxicity|1
1025051|NCT01621490|2052226|FG006|Overall Study|Patient delayed due to toxicity|0
1025052|NCT01621490|2052227|FG007|Overall Study|Patient delayed due to toxicity|0
1025053|NCT01621490|2052228|FG008|Overall Study|Patient delayed due to toxicity|0
1025054|NCT01621542|2052347|FG000|Overall Study|Adverse Event|0
1025055|NCT01621542|2052348|FG001|Overall Study|Adverse Event|0
1025056|NCT01621542|2052349|FG002|Overall Study|Adverse Event|1
1025057|NCT01621542|2052350|FG003|Overall Study|Adverse Event|3
1025058|NCT01621542|2052351|FG004|Overall Study|Adverse Event|0
1025059|NCT01621542|2052352|FG005|Overall Study|Adverse Event|0
1025060|NCT01621542|2052347|FG000|Overall Study|Death|0
1025061|NCT01621542|2052348|FG001|Overall Study|Death|1
1025062|NCT01621542|2052349|FG002|Overall Study|Death|0
1025063|NCT01621542|2052350|FG003|Overall Study|Death|0
1025064|NCT01621542|2052351|FG004|Overall Study|Death|0
1025065|NCT01621542|2052352|FG005|Overall Study|Death|0
1025066|NCT01621542|2052347|FG000|Overall Study|Physician Decision|1
1025067|NCT01621542|2052348|FG001|Overall Study|Physician Decision|0
1025068|NCT01621542|2052349|FG002|Overall Study|Physician Decision|1
1025069|NCT01621542|2052350|FG003|Overall Study|Physician Decision|13
1025070|NCT01621542|2052351|FG004|Overall Study|Physician Decision|3
1025071|NCT01621542|2052352|FG005|Overall Study|Physician Decision|1
1025072|NCT01621542|2052347|FG000|Overall Study|Withdrawal by Subject|2
1025073|NCT01621542|2052348|FG001|Overall Study|Withdrawal by Subject|0
1025074|NCT01621542|2052349|FG002|Overall Study|Withdrawal by Subject|1
1025075|NCT01621542|2052350|FG003|Overall Study|Withdrawal by Subject|3
1025076|NCT01621542|2052351|FG004|Overall Study|Withdrawal by Subject|3
1025077|NCT01621542|2052352|FG005|Overall Study|Withdrawal by Subject|3
1025078|NCT01621542|2052347|FG000|Overall Study|progression/treatment failure|2
1025079|NCT01621542|2052348|FG001|Overall Study|progression/treatment failure|4
1025080|NCT01621542|2052349|FG002|Overall Study|progression/treatment failure|3
1025081|NCT01621542|2052350|FG003|Overall Study|progression/treatment failure|7
1025082|NCT01621542|2052351|FG004|Overall Study|progression/treatment failure|3
1025083|NCT01621542|2052352|FG005|Overall Study|progression/treatment failure|5
1025084|NCT01621542|2052347|FG000|Overall Study|Protocol Violation|0
1025085|NCT01621542|2052348|FG001|Overall Study|Protocol Violation|0
1025086|NCT01621542|2052349|FG002|Overall Study|Protocol Violation|0
1025087|NCT01621542|2052350|FG003|Overall Study|Protocol Violation|1
1025088|NCT01621542|2052351|FG004|Overall Study|Protocol Violation|0
1025089|NCT01621542|2052352|FG005|Overall Study|Protocol Violation|0
1025090|NCT01621542|2052347|FG000|Overall Study|study stopped by sponsor|0
1025091|NCT01621542|2052348|FG001|Overall Study|study stopped by sponsor|0
1025092|NCT01621542|2052349|FG002|Overall Study|study stopped by sponsor|0
1025093|NCT01621542|2052350|FG003|Overall Study|study stopped by sponsor|1
1025094|NCT01621542|2052351|FG004|Overall Study|study stopped by sponsor|0
1025095|NCT01621542|2052352|FG005|Overall Study|study stopped by sponsor|0
1025096|NCT01621802|2052411|FG000|Overall Study|Protocol Violation|0
1025097|NCT01621802|2052412|FG001|Overall Study|Protocol Violation|0
1025098|NCT01621802|2052413|FG002|Overall Study|Protocol Violation|0
1025099|NCT01621802|2052414|FG003|Overall Study|Protocol Violation|0
1025100|NCT01621802|2052415|FG004|Overall Study|Protocol Violation|0
1025101|NCT01621802|2052416|FG005|Overall Study|Protocol Violation|1
1025102|NCT01621802|2052411|FG000|Overall Study|Withdrawal by Subject|8
1025103|NCT01621802|2052412|FG001|Overall Study|Withdrawal by Subject|4
1025104|NCT01621802|2052413|FG002|Overall Study|Withdrawal by Subject|4
1025105|NCT01621802|2052414|FG003|Overall Study|Withdrawal by Subject|2
1025106|NCT01621802|2052415|FG004|Overall Study|Withdrawal by Subject|2
1025107|NCT01621802|2052416|FG005|Overall Study|Withdrawal by Subject|0
1025108|NCT01621802|2052411|FG000|Overall Study|Migrated/moved from study area|0
1025109|NCT01621802|2052412|FG001|Overall Study|Migrated/moved from study area|0
1025110|NCT01621802|2052413|FG002|Overall Study|Migrated/moved from study area|2
1025111|NCT01621802|2052414|FG003|Overall Study|Migrated/moved from study area|0
1025112|NCT01621802|2052415|FG004|Overall Study|Migrated/moved from study area|1
1025113|NCT01621802|2052416|FG005|Overall Study|Migrated/moved from study area|0
1025114|NCT01621802|2052411|FG000|Overall Study|Others|3
1025115|NCT01621802|2052412|FG001|Overall Study|Others|3
1025116|NCT01621802|2052413|FG002|Overall Study|Others|3
1025117|NCT01621802|2052414|FG003|Overall Study|Others|2
1025118|NCT01621802|2052415|FG004|Overall Study|Others|1
1025119|NCT01621802|2052416|FG005|Overall Study|Others|0
1025120|NCT01621802|2052411|FG000|Overall Study|Lost to Follow-up|36
1025121|NCT01621802|2052412|FG001|Overall Study|Lost to Follow-up|16
1025122|NCT01621802|2052413|FG002|Overall Study|Lost to Follow-up|24
1025123|NCT01621802|2052414|FG003|Overall Study|Lost to Follow-up|7
1025124|NCT01621802|2052415|FG004|Overall Study|Lost to Follow-up|31
1025125|NCT01621802|2052416|FG005|Overall Study|Lost to Follow-up|11
1025126|NCT01621880|2052435|FG000|Overall Study|Adverse Event|5
1025127|NCT01621880|2052436|FG001|Overall Study|Adverse Event|1
1025128|NCT01621880|2052435|FG000|Overall Study|Withdrawal by Subject|5
1025129|NCT01621880|2052436|FG001|Overall Study|Withdrawal by Subject|4
1025130|NCT01622231|2052454|FG000|Overall Study|Physician Decision|1
1025131|NCT01622231|2052454|FG000|Overall Study|Withdrawal by Subject|1
1025132|NCT01622348|2052480|FG000|Overall Study|Withdrawal by Subject|1
1025133|NCT01622348|2052481|FG001|Overall Study|Withdrawal by Subject|0
1025134|NCT01622348|2052482|FG002|Overall Study|Withdrawal by Subject|1
1025135|NCT01622569|2052503|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
1025136|NCT01622569|2052504|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
1025137|NCT01622569|2052505|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
1025138|NCT01622569|2052506|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
1025139|NCT01622569|2052503|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
1025140|NCT01622569|2052504|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
1025141|NCT01622569|2052505|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
1025142|NCT01622569|2052506|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
1025143|NCT01622569|2052503|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
1025144|NCT01622569|2052504|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
1025145|NCT01622569|2052505|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
1025146|NCT01622569|2052506|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
1025147|NCT01622569|2052503|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1025148|NCT01622569|2052504|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
1025149|NCT01622569|2052505|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1025150|NCT01622569|2052506|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
1025151|NCT01622569|2052503|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
1025152|NCT01622569|2052504|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
1025153|NCT01622569|2052505|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
1025154|NCT01622569|2052506|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
1025155|NCT01622569|2052503|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
1025156|NCT01622569|2052504|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
1025157|NCT01622569|2052505|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1025158|NCT01622569|2052506|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
1025159|NCT01622569|2052503|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
1025160|NCT01622569|2052504|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1025161|NCT01622569|2052505|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
1025162|NCT01622569|2052506|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
1025163|NCT01622569|2052503|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1025164|NCT01622569|2052504|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1025165|NCT01622569|2052505|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1162016|NCT03380429|2283929|FG002|Overall Study|Protocol Violation|1
1025166|NCT01622569|2052506|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
1025167|NCT01622660|2052526|FG000|Overall Study|Adverse Event|1
1025168|NCT01622673|2052536|FG000|Treatment Period 1|Withdrawal by Subject|0
1025169|NCT01622673|2052537|FG001|Treatment Period 1|Withdrawal by Subject|0
1025170|NCT01622673|2052538|FG002|Treatment Period 1|Withdrawal by Subject|0
1025171|NCT01622673|2052539|FG003|Treatment Period 1|Withdrawal by Subject|1
1025172|NCT01622673|2052540|FG004|Treatment Period 1|Withdrawal by Subject|0
1025173|NCT01622673|2052541|FG005|Treatment Period 1|Withdrawal by Subject|0
1025174|NCT01622673|2052536|FG000|Treatment Period 1|Protocol Violation|0
1025175|NCT01622673|2052537|FG001|Treatment Period 1|Protocol Violation|1
1025176|NCT01622673|2052538|FG002|Treatment Period 1|Protocol Violation|0
1025177|NCT01622673|2052539|FG003|Treatment Period 1|Protocol Violation|0
1025178|NCT01622673|2052540|FG004|Treatment Period 1|Protocol Violation|0
1025179|NCT01622673|2052541|FG005|Treatment Period 1|Protocol Violation|0
1025180|NCT01622673|2052536|FG000|Treatment Period 2|Withdrawal by Subject|0
1025181|NCT01622673|2052537|FG001|Treatment Period 2|Withdrawal by Subject|0
1025182|NCT01622673|2052538|FG002|Treatment Period 2|Withdrawal by Subject|0
1025183|NCT01622673|2052539|FG003|Treatment Period 2|Withdrawal by Subject|1
1025184|NCT01622673|2052540|FG004|Treatment Period 2|Withdrawal by Subject|0
1025185|NCT01622673|2052541|FG005|Treatment Period 2|Withdrawal by Subject|0
1025186|NCT01622673|2052536|FG000|Treatment Period 3|Protocol Violation|0
1025187|NCT01622673|2052537|FG001|Treatment Period 3|Protocol Violation|1
1025188|NCT01622673|2052538|FG002|Treatment Period 3|Protocol Violation|0
1025189|NCT01622673|2052539|FG003|Treatment Period 3|Protocol Violation|0
1025190|NCT01622673|2052540|FG004|Treatment Period 3|Protocol Violation|0
1025191|NCT01622673|2052541|FG005|Treatment Period 3|Protocol Violation|0
1025194|NCT01623050|2052584|FG000|Overall Study|Lost to Follow-up|9
1025195|NCT01623115|2052590|FG000|Overall Study|Randomized but not treated|0
1025196|NCT01623115|2052591|FG001|Overall Study|Randomized but not treated|1
1025197|NCT01623115|2052590|FG000|Overall Study|Physician Decision|1
1025198|NCT01623115|2052591|FG001|Overall Study|Physician Decision|0
1025199|NCT01623115|2052590|FG000|Overall Study|Participants moved|1
1025200|NCT01623115|2052591|FG001|Overall Study|Participants moved|5
1025201|NCT01623115|2052590|FG000|Overall Study|Adverse Event|10
1025202|NCT01623115|2052591|FG001|Overall Study|Adverse Event|13
1025203|NCT01623115|2052590|FG000|Overall Study|Poor compliance to protocol|4
1025204|NCT01623115|2052591|FG001|Overall Study|Poor compliance to protocol|10
1025205|NCT01623115|2052590|FG000|Overall Study|Consent withdrawn by participant|2
1025206|NCT01623115|2052591|FG001|Overall Study|Consent withdrawn by participant|6
1025207|NCT01623115|2052590|FG000|Overall Study|Related to study drug administration|0
1025208|NCT01623115|2052591|FG001|Overall Study|Related to study drug administration|2
1025209|NCT01623115|2052590|FG000|Overall Study|Last visit outside protocol visit window|14
1025210|NCT01623115|2052591|FG001|Overall Study|Last visit outside protocol visit window|26
1025211|NCT01623115|2052590|FG000|Overall Study|Site closure|1
1025212|NCT01623115|2052591|FG001|Overall Study|Site closure|7
1025213|NCT01623115|2052590|FG000|Overall Study|Death|0
1025214|NCT01623115|2052591|FG001|Overall Study|Death|4
1025215|NCT01623115|2052590|FG000|Overall Study|Other than specified above|0
1025216|NCT01623115|2052591|FG001|Overall Study|Other than specified above|3
1025217|NCT01623154|2052597|FG000|Overall Study|Did not drink Pranactin Citric|4
1025218|NCT01623271|2052616|FG000|Overall Study|Withdrawal by Subject|2
1025219|NCT01623310|2052620|FG000|Overall Study|Adverse Event|21
1025220|NCT01623310|2052620|FG000|Overall Study|Lost to Follow-up|18
1025221|NCT01623310|2052620|FG000|Overall Study|Lack of Efficacy|6
1025222|NCT01623310|2052620|FG000|Overall Study|Protocol Violation|6
1025223|NCT01623310|2052620|FG000|Overall Study|Withdrawal by Subject|25
1025224|NCT01623310|2052620|FG000|Overall Study|Became potentially child-bearing|1
1025225|NCT01623310|2052620|FG000|Overall Study|Diagnoses of bilateral cateracts|1
1025226|NCT01623310|2052620|FG000|Overall Study|Investigators Discretion-Noncompliant|1
1025227|NCT01623531|2052643|FG000|Overall Study|Death|1
1025228|NCT01623531|2052644|FG001|Overall Study|Death|0
1025229|NCT01623531|2052643|FG000|Overall Study|Protocol Violation|2
1025230|NCT01623531|2052644|FG001|Overall Study|Protocol Violation|1
1025231|NCT01623531|2052643|FG000|Overall Study|Missing data at primary outcome time poi|1
1025232|NCT01623531|2052644|FG001|Overall Study|Missing data at primary outcome time poi|1
1025233|NCT01623596|2052655|FG000|Overall Study|Abnormal laboratory values|2
1025234|NCT01623596|2052656|FG001|Overall Study|Abnormal laboratory values|0
1025235|NCT01623596|2052655|FG000|Overall Study|Administrative problems|9
1025236|NCT01623596|2052656|FG001|Overall Study|Administrative problems|13
1025237|NCT01623596|2052655|FG000|Overall Study|Adverse Event|20
1025238|NCT01623596|2052656|FG001|Overall Study|Adverse Event|29
1025239|NCT01623596|2052655|FG000|Overall Study|Death|0
1025240|NCT01623596|2052656|FG001|Overall Study|Death|2
1025241|NCT01623596|2052655|FG000|Overall Study|Lost to Follow-up|12
1025242|NCT01623596|2052656|FG001|Overall Study|Lost to Follow-up|16
1025243|NCT01623596|2052655|FG000|Overall Study|Withdrawal by Subject|13
1025244|NCT01623596|2052656|FG001|Overall Study|Withdrawal by Subject|31
1025245|NCT01623596|2052655|FG000|Overall Study|Patient no longer requires study drug|1
1025246|NCT01623596|2052656|FG001|Overall Study|Patient no longer requires study drug|0
1025247|NCT01623596|2052655|FG000|Overall Study|Protocol Violation|0
1025248|NCT01623596|2052656|FG001|Overall Study|Protocol Violation|6
1025249|NCT01623596|2052655|FG000|Overall Study|Lack of Efficacy|5
1025250|NCT01623596|2052656|FG001|Overall Study|Lack of Efficacy|3
1025251|NCT01623752|2052677|FG000|Phase 1 (78 Weeks)|No Data|249
1025252|NCT01623752|2052678|FG001|Phase 1 (78 Weeks)|No Data|66
1025253|NCT01623752|2052679|FG002|Phase 1 (78 Weeks)|No Data|2
1025254|NCT01623752|2052677|FG000|Phase 1 (78 Weeks)|Other|33
1025255|NCT01623752|2052678|FG001|Phase 1 (78 Weeks)|Other|20
1025256|NCT01623752|2052679|FG002|Phase 1 (78 Weeks)|Other|0
1025257|NCT01623752|2052677|FG000|Phase 1 (78 Weeks)|Adverse Event|122
1025258|NCT01623752|2052678|FG001|Phase 1 (78 Weeks)|Adverse Event|39
1025259|NCT01623752|2052679|FG002|Phase 1 (78 Weeks)|Adverse Event|0
1025260|NCT01623752|2052677|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227
1025261|NCT01623752|2052678|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82
1025262|NCT01623752|2052679|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0
1025263|NCT01623752|2052677|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14
1025264|NCT01623752|2052678|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2
1025265|NCT01623752|2052679|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0
1025266|NCT01623752|2052677|FG000|Phase 2 (78 Weeks)|Other|5
1025267|NCT01623752|2052678|FG001|Phase 2 (78 Weeks)|Other|1
1025268|NCT01623752|2052679|FG002|Phase 2 (78 Weeks)|Other|0
1025269|NCT01623752|2052677|FG000|Phase 2 (78 Weeks)|No Data|43
1025270|NCT01623752|2052678|FG001|Phase 2 (78 Weeks)|No Data|11
1025271|NCT01623752|2052679|FG002|Phase 2 (78 Weeks)|No Data|0
1025272|NCT01623752|2052677|FG000|Phase 2 (78 Weeks)|Adverse Event|4
1025273|NCT01623752|2052678|FG001|Phase 2 (78 Weeks)|Adverse Event|4
1025274|NCT01623752|2052679|FG002|Phase 2 (78 Weeks)|Adverse Event|0
1025275|NCT01623830|2052690|FG000|Overall Study|Withdrawal by Subject|6
1025276|NCT01623830|2052691|FG001|Overall Study|Withdrawal by Subject|7
1025277|NCT01623830|2052690|FG000|Overall Study|Exclusion from Study|1
1025278|NCT01623830|2052691|FG001|Overall Study|Exclusion from Study|2
1025279|NCT01624090|2052705|FG000|Overall Study|DLT, taken off therapy|0
1025280|NCT01624090|2052706|FG001|Overall Study|DLT, taken off therapy|1
1025281|NCT01624090|2052707|FG002|Overall Study|DLT, taken off therapy|0
1025282|NCT01624090|2052708|FG003|Overall Study|DLT, taken off therapy|0
1025283|NCT01624090|2052705|FG000|Overall Study|Withdrew prior to treatment|0
1025284|NCT01624090|2052706|FG001|Overall Study|Withdrew prior to treatment|1
1025285|NCT01624090|2052707|FG002|Overall Study|Withdrew prior to treatment|0
1025286|NCT01624090|2052708|FG003|Overall Study|Withdrew prior to treatment|0
1025287|NCT01624090|2052705|FG000|Overall Study|Died on study|0
1025288|NCT01624090|2052706|FG001|Overall Study|Died on study|0
1025289|NCT01624090|2052707|FG002|Overall Study|Died on study|2
1025290|NCT01624090|2052708|FG003|Overall Study|Died on study|0
1025291|NCT01624090|2052705|FG000|Overall Study|Did not complete 1 crse of therapy|0
1025292|NCT01624090|2052706|FG001|Overall Study|Did not complete 1 crse of therapy|0
1025293|NCT01624090|2052707|FG002|Overall Study|Did not complete 1 crse of therapy|2
1025294|NCT01624090|2052708|FG003|Overall Study|Did not complete 1 crse of therapy|0
1025295|NCT01624090|2052705|FG000|Overall Study|Dose escalated|0
1025296|NCT01624090|2052706|FG001|Overall Study|Dose escalated|0
1025297|NCT01624090|2052707|FG002|Overall Study|Dose escalated|3
1025298|NCT01624090|2052708|FG003|Overall Study|Dose escalated|0
1025299|NCT01624142|2052720|FG000|Overall Study|Withdrawal by Subject|14
1025300|NCT01624142|2052721|FG001|Overall Study|Withdrawal by Subject|4
1025301|NCT01624142|2052720|FG000|Overall Study|Death|3
1025302|NCT01624142|2052721|FG001|Overall Study|Death|6
1025303|NCT01624142|2052720|FG000|Overall Study|Study Closure|12
1025304|NCT01624142|2052721|FG001|Overall Study|Study Closure|6
1025305|NCT01624142|2052720|FG000|Overall Study|Lost to Follow-up|2
1025306|NCT01624142|2052721|FG001|Overall Study|Lost to Follow-up|0
1025307|NCT01624142|2052720|FG000|Overall Study|Other|1
1025308|NCT01624142|2052721|FG001|Overall Study|Other|0
1025309|NCT01624194|2052743|FG000|Overall Study|Lost to Follow-up|1
1025310|NCT01624194|2052744|FG001|Overall Study|Lost to Follow-up|0
1025311|NCT01624194|2052743|FG000|Overall Study|Withdrawal by Subject|1
1025312|NCT01624194|2052744|FG001|Overall Study|Withdrawal by Subject|0
1025313|NCT01624233|2052751|FG000|Period 2 - Induction|Adverse Event|1
1025314|NCT01624233|2052751|FG000|Period 3 - Maintenance|Adverse Event|2
1025315|NCT01624233|2052751|FG000|Period 3 - Maintenance|Lack of Efficacy|1
1025316|NCT01624233|2052751|FG000|Period 3 - Maintenance|Physician Decision|2
1025317|NCT01624233|2052751|FG000|Period 3 - Maintenance|Withdrawal by Subject|2
1025318|NCT01624233|2052751|FG000|Period 4 - Drug Free Period|Relapsed|61
1025319|NCT01624233|2052751|FG000|Period 5 - Retreatment Period|Adverse Event|5
1025320|NCT01624233|2052751|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1
1025321|NCT01624233|2052751|FG000|Period 5 - Retreatment Period|Physician Decision|1
1025322|NCT01624233|2052751|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3
1025323|NCT01624233|2052751|FG000|Period 6: Follow-up|Adverse Event|3
1025324|NCT01624233|2052751|FG000|Period 6: Follow-up|Lack of Efficacy|2
1025325|NCT01624233|2052751|FG000|Period 6: Follow-up|Physician Decision|1
1025326|NCT01624233|2052751|FG000|Period 6: Follow-up|Withdrawal by Subject|3
1025327|NCT01624259|2052761|FG000|Overall Study|Adverse Event|18
1025328|NCT01624259|2052762|FG001|Overall Study|Adverse Event|18
1025329|NCT01624259|2052761|FG000|Overall Study|Protocol Violation|1
1025330|NCT01624259|2052762|FG001|Overall Study|Protocol Violation|2
1025331|NCT01624259|2052761|FG000|Overall Study|Withdrawal by Subject|5
1025332|NCT01624259|2052762|FG001|Overall Study|Withdrawal by Subject|7
1025333|NCT01624259|2052761|FG000|Overall Study|Physician Decision|1
1025334|NCT01624259|2052762|FG001|Overall Study|Physician Decision|1
1025335|NCT01624259|2052761|FG000|Overall Study|Lost to Follow-up|2
1025336|NCT01624259|2052762|FG001|Overall Study|Lost to Follow-up|3
1025337|NCT01624259|2052761|FG000|Overall Study|Abnormal laboratory measure|3
1025338|NCT01624259|2052762|FG001|Overall Study|Abnormal laboratory measure|0
1025339|NCT01624467|2052794|FG000|Overall Study|Withdrawal by Subject|2
1025340|NCT01624467|2052794|FG000|Overall Study|Lost to Follow-up|1
1025341|NCT01624467|2052794|FG000|Overall Study|Adverse Event|7
1025342|NCT01624467|2052794|FG000|Overall Study|Progressive Disease|19
1025343|NCT01624467|2052794|FG000|Overall Study|Per Sponsor Requirement|1
1025344|NCT01624467|2052794|FG000|Overall Study|Subject Withdrew from Treatment|1
1025345|NCT01624506|2052802|FG000|Overall Study|Lost to Follow-up|29
1025346|NCT01624506|2052803|FG001|Overall Study|Lost to Follow-up|15
1025347|NCT01624506|2052802|FG000|Overall Study|Withdrawal by Subject|9
1025348|NCT01624506|2052803|FG001|Overall Study|Withdrawal by Subject|2
1025349|NCT01624506|2052802|FG000|Overall Study|Death|1
1025350|NCT01624506|2052803|FG001|Overall Study|Death|0
1025351|NCT01624506|2052802|FG000|Overall Study|LINX explants|23
1025352|NCT01624506|2052803|FG001|Overall Study|LINX explants|0
1025353|NCT01624506|2052802|FG000|Overall Study|Adverse Event|3
1025354|NCT01624506|2052803|FG001|Overall Study|Adverse Event|0
1025355|NCT01624662|2052813|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
1025356|NCT01624662|2052814|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
1025357|NCT01624662|2052815|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
1025358|NCT01624662|2052816|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
1025359|NCT01624662|2052813|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
1025360|NCT01624662|2052814|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
1025361|NCT01624662|2052815|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
1025362|NCT01624662|2052816|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
1025363|NCT01624662|2052813|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1025364|NCT01624662|2052814|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
1025365|NCT01624662|2052815|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1025366|NCT01624662|2052816|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1025367|NCT01624662|2052813|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
1025368|NCT01624662|2052814|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
1025369|NCT01624662|2052815|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
1025370|NCT01624662|2052816|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
1025371|NCT01624662|2052813|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1025372|NCT01624662|2052814|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1025373|NCT01624662|2052815|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
1025374|NCT01624662|2052816|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1025375|NCT01624662|2052813|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1025376|NCT01624662|2052814|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
1025377|NCT01624662|2052815|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1025378|NCT01624662|2052816|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1025379|NCT01624662|2052813|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1025380|NCT01624662|2052814|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1025381|NCT01624662|2052815|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
1025382|NCT01624662|2052816|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1025383|NCT01624870|2052847|FG000|Overall Study|Death|19
1025384|NCT01624870|2052847|FG000|Overall Study|Withdrawal by Subject|1
1025385|NCT01624870|2052847|FG000|Overall Study|CoreValve not implanted|6
1025386|NCT01624870|2052847|FG000|Overall Study|Lost to follow up|1
1025387|NCT01624974|2052868|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
1025388|NCT01624974|2052869|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
1025389|NCT01624974|2052868|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
1025390|NCT01624974|2052869|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
1025391|NCT01624974|2052868|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5
1025392|NCT01624974|2052869|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3
1025393|NCT01624974|2052868|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1
1025394|NCT01624974|2052869|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0
1025395|NCT01624974|2052868|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0
1025396|NCT01624974|2052869|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1
1025397|NCT01624974|2052868|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1
1025398|NCT01624974|2052869|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1
1025399|NCT01624974|2052868|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
1025400|NCT01624974|2052869|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
1025401|NCT01624974|2052868|FG000|Period IV Washout (4 Weeks)|Adverse Event|2
1025402|NCT01624974|2052869|FG001|Period IV Washout (4 Weeks)|Adverse Event|0
1025403|NCT01624974|2052868|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
1025404|NCT01624974|2052869|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
1025405|NCT01624974|2052868|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
1025406|NCT01624974|2052869|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
1025407|NCT01624974|2052868|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3
1025408|NCT01624974|2052869|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0
1025409|NCT01624974|2052868|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1
1025410|NCT01624974|2052869|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0
1025411|NCT01625000|2052881|FG000|Overall Study|Physician Decision|15
1025412|NCT01625000|2052882|FG001|Overall Study|Physician Decision|7
1025413|NCT01625000|2052883|FG002|Overall Study|Physician Decision|7
1025414|NCT01625000|2052884|FG003|Overall Study|Physician Decision|2
1025415|NCT01625000|2052885|FG004|Overall Study|Physician Decision|15
1025416|NCT01625000|2052881|FG000|Overall Study|Protocol Violation|3
1025417|NCT01625000|2052882|FG001|Overall Study|Protocol Violation|10
1025418|NCT01625000|2052883|FG002|Overall Study|Protocol Violation|4
1025419|NCT01625000|2052884|FG003|Overall Study|Protocol Violation|1
1025420|NCT01625000|2052885|FG004|Overall Study|Protocol Violation|2
1025421|NCT01625000|2052881|FG000|Overall Study|Withdrawal by Subject|19
1025422|NCT01625000|2052882|FG001|Overall Study|Withdrawal by Subject|16
1025423|NCT01625000|2052883|FG002|Overall Study|Withdrawal by Subject|11
1025424|NCT01625000|2052884|FG003|Overall Study|Withdrawal by Subject|9
1025425|NCT01625000|2052885|FG004|Overall Study|Withdrawal by Subject|17
1025426|NCT01625000|2052881|FG000|Overall Study|Adverse Event (including Death)|15
1025427|NCT01625000|2052882|FG001|Overall Study|Adverse Event (including Death)|19
1025428|NCT01625000|2052883|FG002|Overall Study|Adverse Event (including Death)|11
1025429|NCT01625000|2052884|FG003|Overall Study|Adverse Event (including Death)|7
1025430|NCT01625000|2052885|FG004|Overall Study|Adverse Event (including Death)|21
1025431|NCT01625091|2052904|FG000|Intervention|Death|1
1025432|NCT01625091|2052905|FG001|Intervention|Death|1
1025433|NCT01625091|2052904|FG000|Intervention|Withdrawal by Subject|4
1025434|NCT01625091|2052905|FG001|Intervention|Withdrawal by Subject|1
1025435|NCT01625091|2052904|FG000|Intervention|Adverse Event|0
1025436|NCT01625091|2052905|FG001|Intervention|Adverse Event|2
1025437|NCT01625091|2052904|FG000|Intervention|Lost to Follow-up|4
1025438|NCT01625091|2052905|FG001|Intervention|Lost to Follow-up|4
1025439|NCT01625091|2052904|FG000|Intervention|Study termination|2
1025440|NCT01625091|2052905|FG001|Intervention|Study termination|3
1025441|NCT01625091|2052904|FG000|Post-intervention|Death|0
1025442|NCT01625091|2052905|FG001|Post-intervention|Death|1
1025443|NCT01625091|2052904|FG000|Post-intervention|Lost to Follow-up|2
1025444|NCT01625091|2052905|FG001|Post-intervention|Lost to Follow-up|0
1025445|NCT01625091|2052904|FG000|Post-intervention|Study termination|2
1025446|NCT01625091|2052905|FG001|Post-intervention|Study termination|1
1025447|NCT01625182|2052926|FG000|Overall Study|Administrative problems|1
1025448|NCT01625182|2052927|FG001|Overall Study|Administrative problems|0
1025449|NCT01625182|2052926|FG000|Overall Study|Protocol deviation|0
1025450|NCT01625182|2052927|FG001|Overall Study|Protocol deviation|2
1025451|NCT01625182|2052926|FG000|Overall Study|Adverse Event|2
1025452|NCT01625182|2052927|FG001|Overall Study|Adverse Event|0
1025453|NCT01625182|2052926|FG000|Overall Study|Withdrawal by Subject|5
1025454|NCT01625182|2052927|FG001|Overall Study|Withdrawal by Subject|1
1025455|NCT01625182|2052926|FG000|Overall Study|Lack of Efficacy|12
1025456|NCT01625182|2052927|FG001|Overall Study|Lack of Efficacy|8
1025457|NCT01625286|2052945|FG000|Overall Study|Adverse Event|0
1025458|NCT01625286|2052946|FG001|Overall Study|Adverse Event|0
1025459|NCT01625286|2052947|FG002|Overall Study|Adverse Event|0
1025460|NCT01625286|2052948|FG003|Overall Study|Adverse Event|0
1025461|NCT01625286|2052949|FG004|Overall Study|Adverse Event|1
1025462|NCT01625286|2052950|FG005|Overall Study|Adverse Event|2
1025463|NCT01625286|2052951|FG006|Overall Study|Adverse Event|1
1025464|NCT01625286|2052945|FG000|Overall Study|Death|0
1025465|NCT01625286|2052946|FG001|Overall Study|Death|0
1025466|NCT01625286|2052947|FG002|Overall Study|Death|1
1025467|NCT01625286|2052948|FG003|Overall Study|Death|1
1025468|NCT01625286|2052949|FG004|Overall Study|Death|0
1025469|NCT01625286|2052950|FG005|Overall Study|Death|11
1025470|NCT01625286|2052951|FG006|Overall Study|Death|16
1025471|NCT01625286|2052945|FG000|Overall Study|Withdrawal by Subject|0
1025472|NCT01625286|2052946|FG001|Overall Study|Withdrawal by Subject|1
1025473|NCT01625286|2052947|FG002|Overall Study|Withdrawal by Subject|0
1025474|NCT01625286|2052948|FG003|Overall Study|Withdrawal by Subject|1
1025475|NCT01625286|2052949|FG004|Overall Study|Withdrawal by Subject|0
1025476|NCT01625286|2052950|FG005|Overall Study|Withdrawal by Subject|0
1025477|NCT01625286|2052951|FG006|Overall Study|Withdrawal by Subject|1
1025478|NCT01625286|2052945|FG000|Overall Study|Any reason not specifically recorded|0
1025479|NCT01625286|2052946|FG001|Overall Study|Any reason not specifically recorded|0
1025480|NCT01625286|2052947|FG002|Overall Study|Any reason not specifically recorded|0
1025481|NCT01625286|2052948|FG003|Overall Study|Any reason not specifically recorded|0
1025482|NCT01625286|2052949|FG004|Overall Study|Any reason not specifically recorded|0
1025483|NCT01625286|2052950|FG005|Overall Study|Any reason not specifically recorded|1
1025484|NCT01625286|2052951|FG006|Overall Study|Any reason not specifically recorded|0
1025485|NCT01625286|2052945|FG000|Overall Study|Progressive disease|6
1025486|NCT01625286|2052946|FG001|Overall Study|Progressive disease|3
1025487|NCT01625286|2052947|FG002|Overall Study|Progressive disease|4
1025488|NCT01625286|2052948|FG003|Overall Study|Progressive disease|5
1025489|NCT01625286|2052949|FG004|Overall Study|Progressive disease|5
1025490|NCT01625286|2052950|FG005|Overall Study|Progressive disease|0
1025491|NCT01625286|2052951|FG006|Overall Study|Progressive disease|0
1025492|NCT01625286|2052945|FG000|Overall Study|Lost to Follow-up|0
1025493|NCT01625286|2052946|FG001|Overall Study|Lost to Follow-up|0
1025494|NCT01625286|2052947|FG002|Overall Study|Lost to Follow-up|0
1025495|NCT01625286|2052948|FG003|Overall Study|Lost to Follow-up|0
1025496|NCT01625286|2052949|FG004|Overall Study|Lost to Follow-up|0
1025497|NCT01625286|2052950|FG005|Overall Study|Lost to Follow-up|0
1025498|NCT01625286|2052951|FG006|Overall Study|Lost to Follow-up|1
1025499|NCT01625286|2052945|FG000|Overall Study|Ongoing off-treatment at DCO|0
1025500|NCT01625286|2052946|FG001|Overall Study|Ongoing off-treatment at DCO|0
1025501|NCT01625286|2052947|FG002|Overall Study|Ongoing off-treatment at DCO|0
1025502|NCT01625286|2052948|FG003|Overall Study|Ongoing off-treatment at DCO|0
1025503|NCT01625286|2052949|FG004|Overall Study|Ongoing off-treatment at DCO|0
1025504|NCT01625286|2052950|FG005|Overall Study|Ongoing off-treatment at DCO|32
1025505|NCT01625286|2052951|FG006|Overall Study|Ongoing off-treatment at DCO|31
1025506|NCT01625286|2052945|FG000|Overall Study|Ongoing on-treatment at DCO|6
1025507|NCT01625286|2052946|FG001|Overall Study|Ongoing on-treatment at DCO|4
1025508|NCT01625286|2052947|FG002|Overall Study|Ongoing on-treatment at DCO|0
1025509|NCT01625286|2052948|FG003|Overall Study|Ongoing on-treatment at DCO|0
1025510|NCT01625286|2052949|FG004|Overall Study|Ongoing on-treatment at DCO|0
1025511|NCT01625286|2052950|FG005|Overall Study|Ongoing on-treatment at DCO|8
1025512|NCT01625286|2052951|FG006|Overall Study|Ongoing on-treatment at DCO|6
1025513|NCT01625338|2052970|FG000|Overall Study|Enrolled but not Treated|0
1025514|NCT01625338|2052971|FG001|Overall Study|Enrolled but not Treated|0
1025515|NCT01625338|2052972|FG002|Overall Study|Enrolled but not Treated|1
1025516|NCT01625338|2052970|FG000|Overall Study|Efficacy Failure|27
1025517|NCT01625338|2052971|FG001|Overall Study|Efficacy Failure|39
1025518|NCT01625338|2052972|FG002|Overall Study|Efficacy Failure|31
1025519|NCT01625338|2052970|FG000|Overall Study|Lost to Follow-up|3
1025520|NCT01625338|2052971|FG001|Overall Study|Lost to Follow-up|3
1025521|NCT01625338|2052972|FG002|Overall Study|Lost to Follow-up|2
1025522|NCT01625338|2052970|FG000|Overall Study|Investigator Decision|0
1025523|NCT01625338|2052971|FG001|Overall Study|Investigator Decision|2
1025524|NCT01625338|2052972|FG002|Overall Study|Investigator Decision|1
1025525|NCT01625338|2052970|FG000|Overall Study|Subject Withdrew Consent|1
1025526|NCT01625338|2052971|FG001|Overall Study|Subject Withdrew Consent|0
1025527|NCT01625338|2052972|FG002|Overall Study|Subject Withdrew Consent|2
1025528|NCT01625338|2052970|FG000|Overall Study|Adverse Event|1
1025529|NCT01625338|2052971|FG001|Overall Study|Adverse Event|0
1025530|NCT01625338|2052972|FG002|Overall Study|Adverse Event|1
1025531|NCT01625338|2052970|FG000|Overall Study|Study Discontinued by Sponsor|0
1025532|NCT01625338|2052971|FG001|Overall Study|Study Discontinued by Sponsor|0
1025533|NCT01625338|2052972|FG002|Overall Study|Study Discontinued by Sponsor|1
1025534|NCT01625377|2052982|FG000|Overall Study|Death|1
1025535|NCT01625377|2052983|FG001|Overall Study|Death|1
1025536|NCT01625377|2052982|FG000|Overall Study|Administrative Problem|1
1025537|NCT01625377|2052983|FG001|Overall Study|Administrative Problem|1
1025538|NCT01625377|2052982|FG000|Overall Study|Protocol Violation|0
1025539|NCT01625377|2052983|FG001|Overall Study|Protocol Violation|3
1025540|NCT01625377|2052982|FG000|Overall Study|Adverse Event|3
1025541|NCT01625377|2052983|FG001|Overall Study|Adverse Event|16
1025542|NCT01625377|2052982|FG000|Overall Study|Graft loss|1
1025543|NCT01625377|2052983|FG001|Overall Study|Graft loss|0
1025544|NCT01625377|2052982|FG000|Overall Study|Unsatisfactory therapeutic effect|0
1025545|NCT01625377|2052983|FG001|Overall Study|Unsatisfactory therapeutic effect|1
1025546|NCT01625377|2052982|FG000|Overall Study|Abnormal laboratory values|1
1025547|NCT01625377|2052983|FG001|Overall Study|Abnormal laboratory values|0
1025548|NCT01625689|2053015|FG000|Overall Study|Migration|2
1025549|NCT01625689|2053016|FG001|Overall Study|Migration|1
1025550|NCT01625845|2053024|FG000|Overall Study|Adverse Event|1
1025551|NCT01625845|2053025|FG001|Overall Study|Adverse Event|2
1025552|NCT01625845|2053024|FG000|Overall Study|Lost to Follow-up|2
1025553|NCT01625845|2053025|FG001|Overall Study|Lost to Follow-up|1
1025554|NCT01625845|2053024|FG000|Overall Study|Withdrawal by Subject|2
1025555|NCT01625845|2053025|FG001|Overall Study|Withdrawal by Subject|0
1025556|NCT01625897|2053033|FG000|Overall Study|Adverse Event|27
1025557|NCT01625897|2053034|FG001|Overall Study|Adverse Event|10
1025558|NCT01625897|2053033|FG000|Overall Study|Physician Decision|0
1025559|NCT01625897|2053034|FG001|Overall Study|Physician Decision|1
1025560|NCT01625897|2053033|FG000|Overall Study|Withdrawal by Subject|25
1025561|NCT01625897|2053034|FG001|Overall Study|Withdrawal by Subject|3
1025562|NCT01625910|2053042|FG000|Overall Study|Lost to Follow-up|3
1025563|NCT01625910|2053043|FG001|Overall Study|Lost to Follow-up|4
1025564|NCT01625988|2053058|FG000|Overall Study|Lost to Follow-up|5
1025565|NCT01625988|2053059|FG001|Overall Study|Lost to Follow-up|6
1025566|NCT01625988|2053058|FG000|Overall Study|Withdrawal by Subject|8
1025567|NCT01625988|2053059|FG001|Overall Study|Withdrawal by Subject|3
1025568|NCT01625988|2053058|FG000|Overall Study|Adverse Event|0
1025569|NCT01625988|2053059|FG001|Overall Study|Adverse Event|1
1025570|NCT01625988|2053058|FG000|Overall Study|Lack of Efficacy|0
1025571|NCT01625988|2053059|FG001|Overall Study|Lack of Efficacy|1
1025572|NCT01625988|2053058|FG000|Overall Study|Randomized Inappropriately|1
1025573|NCT01625988|2053059|FG001|Overall Study|Randomized Inappropriately|0
1025574|NCT01625988|2053058|FG000|Overall Study|Protocol Violation|0
1025575|NCT01625988|2053059|FG001|Overall Study|Protocol Violation|2
1025576|NCT01626079|2053070|FG000|Overall Study|Death|78
1025577|NCT01626079|2053071|FG001|Overall Study|Death|115
1025578|NCT01626079|2053070|FG000|Overall Study|Withdrawal by Subject|12
1025579|NCT01626079|2053071|FG001|Overall Study|Withdrawal by Subject|29
1025580|NCT01626079|2053070|FG000|Overall Study|Lost to Follow-up|3
1025581|NCT01626079|2053071|FG001|Overall Study|Lost to Follow-up|3
1025582|NCT01626079|2053070|FG000|Overall Study|Visits Expected or Not Due|74
1025583|NCT01626079|2053071|FG001|Overall Study|Visits Expected or Not Due|69
1025584|NCT01626118|2053086|FG000|Overall Study|Lack of Efficacy|1
1025585|NCT01626118|2053087|FG001|Overall Study|Lack of Efficacy|0
1025586|NCT01626118|2053088|FG002|Overall Study|Lack of Efficacy|1
1025587|NCT01626118|2053089|FG003|Overall Study|Lack of Efficacy|3
1025588|NCT01626118|2053086|FG000|Overall Study|Lost to Follow-up|1
1025589|NCT01626118|2053087|FG001|Overall Study|Lost to Follow-up|0
1025590|NCT01626118|2053088|FG002|Overall Study|Lost to Follow-up|0
1025591|NCT01626118|2053089|FG003|Overall Study|Lost to Follow-up|0
1025592|NCT01626118|2053086|FG000|Overall Study|Adverse Event|0
1025593|NCT01626118|2053087|FG001|Overall Study|Adverse Event|1
1025594|NCT01626118|2053088|FG002|Overall Study|Adverse Event|1
1025595|NCT01626118|2053089|FG003|Overall Study|Adverse Event|0
1025596|NCT01626118|2053086|FG000|Overall Study|Investigator Decision|0
1025597|NCT01626118|2053087|FG001|Overall Study|Investigator Decision|1
1025598|NCT01626118|2053088|FG002|Overall Study|Investigator Decision|0
1025599|NCT01626118|2053089|FG003|Overall Study|Investigator Decision|0
1025600|NCT01626352|2053099|FG000|Overall Study|Disease Progression|3
1025601|NCT01626352|2053099|FG000|Overall Study|Intercurrent Illness|2
1025602|NCT01626352|2053099|FG000|Overall Study|Death|2
1025603|NCT01626352|2053099|FG000|Overall Study|Withdrawal by Subject|1
1025604|NCT01626352|2053099|FG000|Overall Study|Non-Compliance|1
1025605|NCT01626352|2053099|FG000|Overall Study|Never Treated|1
1025606|NCT01626391|2053108|FG000|Overall Study|Physician Decision|1
1025607|NCT01626391|2053109|FG001|Overall Study|Physician Decision|0
1025608|NCT01626391|2053108|FG000|Overall Study|Withdrawal by Subject|1
1025609|NCT01626391|2053109|FG001|Overall Study|Withdrawal by Subject|0
1025610|NCT01626456|2053117|FG000|Overall Study|Withdrawal by Subject|21
1025611|NCT01626456|2053118|FG001|Overall Study|Withdrawal by Subject|46
1025612|NCT01626456|2053117|FG000|Overall Study|Adverse Event|2
1025613|NCT01626456|2053118|FG001|Overall Study|Adverse Event|27
1025614|NCT01626456|2053117|FG000|Overall Study|Lost to Follow-up|2
1025615|NCT01626456|2053118|FG001|Overall Study|Lost to Follow-up|27
1025616|NCT01626456|2053117|FG000|Overall Study|Lack of Efficacy|6
1025617|NCT01626456|2053118|FG001|Overall Study|Lack of Efficacy|7
1025618|NCT01626456|2053117|FG000|Overall Study|Physician Decision|1
1025619|NCT01626456|2053118|FG001|Overall Study|Physician Decision|4
1025620|NCT01626456|2053117|FG000|Overall Study|Protocol Violation|1
1025621|NCT01626456|2053118|FG001|Overall Study|Protocol Violation|1
1025622|NCT01626456|2053117|FG000|Overall Study|Site Closure|2
1025623|NCT01626456|2053118|FG001|Overall Study|Site Closure|3
1025624|NCT01626456|2053117|FG000|Overall Study|Incarceration|0
1025625|NCT01626456|2053118|FG001|Overall Study|Incarceration|2
1025626|NCT01626495|2053133|FG000|Overall Study|Adverse Event|3
1025627|NCT01626495|2053133|FG000|Overall Study|Disease progression|27
1025628|NCT01626495|2053133|FG000|Overall Study|Withdrawal by Subject|1
1025629|NCT01626495|2053133|FG000|Overall Study|Administrative problem|1
1025630|NCT01626495|2053133|FG000|Overall Study|Death|2
1025631|NCT01626495|2053133|FG000|Overall Study|Physician Decision|1
1025632|NCT01626495|2053133|FG000|Overall Study|New cancer therapy|16
1025633|NCT01626495|2053133|FG000|Overall Study|Manufacturing failure|1
1025634|NCT01626690|2053150|FG000|Overall Study|Protocol Violation|1
1025635|NCT01626690|2053151|FG001|Overall Study|Protocol Violation|0
1025636|NCT01626690|2053150|FG000|Overall Study|Adverse Event|1
905019|NCT00760266|1880210|FG001|Overall Study|Lack of Efficacy|2
905020|NCT00760266|1880209|FG000|Overall Study|Protocol deviation|2
905021|NCT00760266|1880210|FG001|Overall Study|Protocol deviation|4
905022|NCT00760266|1880209|FG000|Overall Study|Patient withdrew consent|3
905023|NCT00760266|1880210|FG001|Overall Study|Patient withdrew consent|3
905024|NCT00760266|1880209|FG000|Overall Study|Lost to Follow-up|2
905025|NCT00760266|1880210|FG001|Overall Study|Lost to Follow-up|1
905026|NCT00760266|1880209|FG000|Overall Study|Administrative Problems|0
905027|NCT00760266|1880210|FG001|Overall Study|Administrative Problems|1
905028|NCT00760383|1880218|FG000|Overall Study|moved away; withdrew; medical reasons|5
1025637|NCT01626690|2053151|FG001|Overall Study|Adverse Event|0
1025638|NCT01626859|2053172|FG000|Overall Study|Adverse Event|1
1025639|NCT01626859|2053173|FG001|Overall Study|Adverse Event|3
1025640|NCT01626859|2053174|FG002|Overall Study|Adverse Event|2
1025641|NCT01626859|2053172|FG000|Overall Study|Physician Decision|0
1025642|NCT01626859|2053173|FG001|Overall Study|Physician Decision|1
1025643|NCT01626859|2053174|FG002|Overall Study|Physician Decision|0
1025644|NCT01626859|2053172|FG000|Overall Study|Withdrawal by Subject|1
1025645|NCT01626859|2053173|FG001|Overall Study|Withdrawal by Subject|4
1025646|NCT01626859|2053174|FG002|Overall Study|Withdrawal by Subject|2
1025647|NCT01626872|2053185|FG000|Overall Study|Physician Decision|13
1025648|NCT01626872|2053186|FG001|Overall Study|Physician Decision|9
1025649|NCT01626872|2053187|FG002|Overall Study|Physician Decision|6
1025650|NCT01626872|2053185|FG000|Overall Study|Withdrawal by Subject|19
1025651|NCT01626872|2053186|FG001|Overall Study|Withdrawal by Subject|27
1025652|NCT01626872|2053187|FG002|Overall Study|Withdrawal by Subject|8
1025653|NCT01626872|2053185|FG000|Overall Study|Adverse Event (including Death)|20
1025654|NCT01626872|2053186|FG001|Overall Study|Adverse Event (including Death)|28
1025655|NCT01626872|2053187|FG002|Overall Study|Adverse Event (including Death)|8
1025656|NCT01626872|2053185|FG000|Overall Study|Protocol Violation (including Pregnancy)|0
1025657|NCT01626872|2053186|FG001|Overall Study|Protocol Violation (including Pregnancy)|2
1025658|NCT01626872|2053187|FG002|Overall Study|Protocol Violation (including Pregnancy)|2
1025659|NCT01626885|2053195|FG000|Overall Study|Adverse Event|8
1025660|NCT01626885|2053195|FG000|Overall Study|Withdrawal by Subject|4
1025661|NCT01626989|2053199|FG000|Screening Period|Screen Failure|15
1025662|NCT01626989|2053200|FG001|Screening Period|Screen Failure|0
1025663|NCT01626989|2053201|FG002|Screening Period|Screen Failure|0
1025664|NCT01626989|2053199|FG000|Screening Period|Withdrawal by Subject|2
1025665|NCT01626989|2053200|FG001|Screening Period|Withdrawal by Subject|0
1025666|NCT01626989|2053201|FG002|Screening Period|Withdrawal by Subject|0
1025667|NCT01627067|2053247|FG000|Overall Study|Screen Failure|1
1025668|NCT01627249|2053256|FG000|Overall Study|Death|3
1025669|NCT01627249|2053257|FG001|Overall Study|Death|5
1025670|NCT01627249|2053258|FG002|Overall Study|Death|3
1025671|NCT01627249|2053256|FG000|Overall Study|Withdrawal by Subject|12
1025672|NCT01627249|2053257|FG001|Overall Study|Withdrawal by Subject|6
1025673|NCT01627249|2053258|FG002|Overall Study|Withdrawal by Subject|9
1025674|NCT01627249|2053256|FG000|Overall Study|Missed Visit|1
1025675|NCT01627249|2053257|FG001|Overall Study|Missed Visit|1
1025676|NCT01627249|2053258|FG002|Overall Study|Missed Visit|0
1025677|NCT01627327|2053287|FG000|Overall Study|Adverse Event|6
1025678|NCT01627327|2053288|FG001|Overall Study|Adverse Event|12
1025679|NCT01627327|2053287|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0
1025680|NCT01627327|2053288|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2
1025681|NCT01627327|2053287|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
1025682|NCT01627327|2053288|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
1025683|NCT01627327|2053287|FG000|Overall Study|Protocol Violation|4
1025684|NCT01627327|2053288|FG001|Overall Study|Protocol Violation|10
1025685|NCT01627327|2053287|FG000|Overall Study|Lost to Follow-up|1
1025686|NCT01627327|2053288|FG001|Overall Study|Lost to Follow-up|3
1025687|NCT01627327|2053287|FG000|Overall Study|Physician Decision|1
1025688|NCT01627327|2053288|FG001|Overall Study|Physician Decision|0
1025689|NCT01627327|2053287|FG000|Overall Study|Withdrawal by Subject|3
1025690|NCT01627327|2053288|FG001|Overall Study|Withdrawal by Subject|3
1025691|NCT01627340|2053296|FG000|Overall Study|Adverse Event|1
1025692|NCT01627340|2053297|FG001|Overall Study|Adverse Event|0
1025693|NCT01627340|2053296|FG000|Overall Study|Lost to Follow-up|8
1025694|NCT01627340|2053297|FG001|Overall Study|Lost to Follow-up|4
1025695|NCT01627340|2053296|FG000|Overall Study|Pregnancy|1
1025696|NCT01627340|2053297|FG001|Overall Study|Pregnancy|0
1025697|NCT01627340|2053296|FG000|Overall Study|Withdrawal by Subject|2
1025698|NCT01627340|2053297|FG001|Overall Study|Withdrawal by Subject|0
1025699|NCT01627574|2053316|FG000|Overall Study|Withdrawal by Subject|8
1025700|NCT01627574|2053317|FG001|Overall Study|Withdrawal by Subject|5
1025701|NCT01627574|2053316|FG000|Overall Study|Lost to Follow-up|13
1025702|NCT01627574|2053317|FG001|Overall Study|Lost to Follow-up|13
1025703|NCT01627691|2053323|FG000|Overall Study|Death|11
1025704|NCT01627691|2053323|FG000|Overall Study|Lost to Follow-up|3
1025705|NCT01627691|2053323|FG000|Overall Study|Withdrawal by Subject|1
1025706|NCT01627691|2053323|FG000|Overall Study|Missed the visit|3
1025707|NCT01627782|2053331|FG000|Overall Study|Adverse Event|1
1025708|NCT01627782|2053332|FG001|Overall Study|Adverse Event|2
1025709|NCT01627782|2053333|FG002|Overall Study|Adverse Event|0
1025710|NCT01627782|2053334|FG003|Overall Study|Adverse Event|1
1025711|NCT01627782|2053331|FG000|Overall Study|Lack of Efficacy|11
1025712|NCT01627782|2053332|FG001|Overall Study|Lack of Efficacy|1
1025713|NCT01627782|2053333|FG002|Overall Study|Lack of Efficacy|15
1025714|NCT01627782|2053334|FG003|Overall Study|Lack of Efficacy|2
1025715|NCT01627782|2053331|FG000|Overall Study|Protocol Violation|1
1025716|NCT01627782|2053332|FG001|Overall Study|Protocol Violation|0
1025717|NCT01627782|2053333|FG002|Overall Study|Protocol Violation|0
1025718|NCT01627782|2053334|FG003|Overall Study|Protocol Violation|0
1025719|NCT01627782|2053331|FG000|Overall Study|Withdrawal by Subject|2
1025720|NCT01627782|2053332|FG001|Overall Study|Withdrawal by Subject|1
1025721|NCT01627782|2053333|FG002|Overall Study|Withdrawal by Subject|0
1025722|NCT01627782|2053334|FG003|Overall Study|Withdrawal by Subject|0
1025723|NCT01627782|2053331|FG000|Overall Study|Other|0
1025724|NCT01627782|2053332|FG001|Overall Study|Other|2
1025725|NCT01627782|2053333|FG002|Overall Study|Other|0
1025726|NCT01627782|2053334|FG003|Overall Study|Other|3
1025727|NCT01627782|2053331|FG000|Overall Study|Randomized But Not Treated|1
1025728|NCT01627782|2053332|FG001|Overall Study|Randomized But Not Treated|0
1025729|NCT01627782|2053333|FG002|Overall Study|Randomized But Not Treated|0
1025730|NCT01627782|2053334|FG003|Overall Study|Randomized But Not Treated|0
1025731|NCT01627860|2053348|FG000|Overall Study|Adverse Event|9
1025732|NCT01627860|2053349|FG001|Overall Study|Adverse Event|4
1025733|NCT01627860|2053348|FG000|Overall Study|Withdrawal by Subject|2
1025734|NCT01627860|2053349|FG001|Overall Study|Withdrawal by Subject|1
1025735|NCT01627860|2053348|FG000|Overall Study|Seizure frequency doubled|0
1025736|NCT01627860|2053349|FG001|Overall Study|Seizure frequency doubled|1
1025737|NCT01627860|2053348|FG000|Overall Study|Protocol Violation|1
1025738|NCT01627860|2053349|FG001|Overall Study|Protocol Violation|0
1025739|NCT01628107|2053387|FG000|Overall Study|Withdrawal by Subject|17
1025740|NCT01628107|2053387|FG000|Overall Study|Lost to Follow-up|4
1025741|NCT01628107|2053387|FG000|Overall Study|Adverse Event|33
1025742|NCT01628107|2053387|FG000|Overall Study|Physician Decision|2
1025743|NCT01628107|2053387|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1
1025744|NCT01628107|2053387|FG000|Overall Study|Non-compliant with Study Procedures|10
1025745|NCT01628107|2053387|FG000|Overall Study|Not Treated|8
1025746|NCT01628107|2053387|FG000|Overall Study|Sponsor Decision|11
1025747|NCT01628107|2053387|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7
1025748|NCT01628107|2053387|FG000|Overall Study|Relocated|8
1025749|NCT01628107|2053387|FG000|Overall Study|Kidney Transplant|9
1025750|NCT01628107|2053387|FG000|Overall Study|Use of Standard of Care|9
1025751|NCT01628120|2053391|FG000|Overall Study|Withdrawal by Subject|7
1025752|NCT01628120|2053391|FG000|Overall Study|Adverse Event|12
1025753|NCT01628120|2053391|FG000|Overall Study|Lost to Follow-up|1
1025754|NCT01628120|2053391|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2
1025755|NCT01628120|2053391|FG000|Overall Study|Non-compliant with Study Procedures|1
1025756|NCT01628120|2053391|FG000|Overall Study|Not Treated|3
1025757|NCT01628120|2053391|FG000|Overall Study|Sponsor Decision|5
1025758|NCT01628120|2053391|FG000|Overall Study|Switched Dialysis Method|2
1025759|NCT01628120|2053391|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3
1025760|NCT01628120|2053391|FG000|Overall Study|Moved or Relocated|5
1025761|NCT01628120|2053391|FG000|Overall Study|Kidney Transplant|2
1025762|NCT01628120|2053391|FG000|Overall Study|Use of Standard of Care|1
1025763|NCT01628198|2053399|FG000|Overall Study|Lost to Follow-up|7
1025764|NCT01628198|2053399|FG000|Overall Study|Withdrawal by Subject|10
1025765|NCT01628198|2053399|FG000|Overall Study|Screen failure|1
1025766|NCT01628367|2053414|FG000|Overall Study|Adverse Event|1
1025767|NCT01628367|2053415|FG001|Overall Study|Adverse Event|0
1025768|NCT01628393|2053424|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1
1025769|NCT01628393|2053425|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0
1025770|NCT01628393|2053426|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0
1025771|NCT01628393|2053427|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0
1025772|NCT01628393|2053428|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0
1025773|NCT01628393|2053424|FG000|Placebo-controlled Treatment Period|Protocol Violation|0
1025774|NCT01628393|2053425|FG001|Placebo-controlled Treatment Period|Protocol Violation|1
1025775|NCT01628393|2053426|FG002|Placebo-controlled Treatment Period|Protocol Violation|0
1025776|NCT01628393|2053427|FG003|Placebo-controlled Treatment Period|Protocol Violation|0
1025777|NCT01628393|2053428|FG004|Placebo-controlled Treatment Period|Protocol Violation|0
1025778|NCT01628393|2053424|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2
1025779|NCT01628393|2053425|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1
1025780|NCT01628393|2053426|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1
1025781|NCT01628393|2053427|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0
1025782|NCT01628393|2053428|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0
1025783|NCT01628393|2053424|FG000|Blinded Active Extension Period|Adverse Event|0
1025784|NCT01628393|2053425|FG001|Blinded Active Extension Period|Adverse Event|1
1025785|NCT01628393|2053426|FG002|Blinded Active Extension Period|Adverse Event|0
1025786|NCT01628393|2053427|FG003|Blinded Active Extension Period|Adverse Event|2
1025787|NCT01628393|2053428|FG004|Blinded Active Extension Period|Adverse Event|2
1025788|NCT01628393|2053424|FG000|Blinded Active Extension Period|Lack of Efficacy|0
1025789|NCT01628393|2053425|FG001|Blinded Active Extension Period|Lack of Efficacy|0
1025790|NCT01628393|2053426|FG002|Blinded Active Extension Period|Lack of Efficacy|2
1025791|NCT01628393|2053427|FG003|Blinded Active Extension Period|Lack of Efficacy|0
1025792|NCT01628393|2053428|FG004|Blinded Active Extension Period|Lack of Efficacy|2
1025793|NCT01628393|2053424|FG000|Blinded Active Extension Period|Physician Decision|0
1025794|NCT01628393|2053425|FG001|Blinded Active Extension Period|Physician Decision|3
1025795|NCT01628393|2053426|FG002|Blinded Active Extension Period|Physician Decision|0
1025796|NCT01628393|2053427|FG003|Blinded Active Extension Period|Physician Decision|1
1025797|NCT01628393|2053428|FG004|Blinded Active Extension Period|Physician Decision|0
1025798|NCT01628393|2053424|FG000|Blinded Active Extension Period|Protocol Violation|0
1025799|NCT01628393|2053425|FG001|Blinded Active Extension Period|Protocol Violation|0
1025800|NCT01628393|2053426|FG002|Blinded Active Extension Period|Protocol Violation|2
1025801|NCT01628393|2053427|FG003|Blinded Active Extension Period|Protocol Violation|1
1025802|NCT01628393|2053428|FG004|Blinded Active Extension Period|Protocol Violation|0
1025803|NCT01628393|2053424|FG000|Blinded Active Extension Period|Withdrawal by Subject|0
1025804|NCT01628393|2053425|FG001|Blinded Active Extension Period|Withdrawal by Subject|6
1025805|NCT01628393|2053426|FG002|Blinded Active Extension Period|Withdrawal by Subject|2
1025806|NCT01628393|2053427|FG003|Blinded Active Extension Period|Withdrawal by Subject|0
1025807|NCT01628393|2053428|FG004|Blinded Active Extension Period|Withdrawal by Subject|2
1025808|NCT01628510|2053444|FG000|Overall Study|Withdrawal by Subject|0
1025809|NCT01628510|2053445|FG001|Overall Study|Withdrawal by Subject|4
1025810|NCT01628510|2053444|FG000|Overall Study|Death|3
1025811|NCT01628510|2053445|FG001|Overall Study|Death|1
1025812|NCT01628549|2053462|FG000|Overall Study|Adverse Event|1
1025813|NCT01628549|2053463|FG001|Overall Study|Adverse Event|1
1025814|NCT01628549|2053464|FG002|Overall Study|Adverse Event|0
1025815|NCT01628549|2053465|FG003|Overall Study|Adverse Event|4
1025816|NCT01628549|2053462|FG000|Overall Study|Lost to Follow-up|3
1025817|NCT01628549|2053463|FG001|Overall Study|Lost to Follow-up|4
1025818|NCT01628549|2053464|FG002|Overall Study|Lost to Follow-up|3
1025819|NCT01628549|2053465|FG003|Overall Study|Lost to Follow-up|3
1025820|NCT01628549|2053462|FG000|Overall Study|Withdrawal by Subject|3
1025821|NCT01628549|2053463|FG001|Overall Study|Withdrawal by Subject|4
1025822|NCT01628549|2053464|FG002|Overall Study|Withdrawal by Subject|4
1025823|NCT01628549|2053465|FG003|Overall Study|Withdrawal by Subject|1
1025824|NCT01628549|2053462|FG000|Overall Study|Protocol Violation|2
1025825|NCT01628549|2053463|FG001|Overall Study|Protocol Violation|1
1025826|NCT01628549|2053464|FG002|Overall Study|Protocol Violation|1
1025827|NCT01628549|2053465|FG003|Overall Study|Protocol Violation|0
1025828|NCT01628549|2053462|FG000|Overall Study|withdrawn for noncompliance|0
1025829|NCT01628549|2053463|FG001|Overall Study|withdrawn for noncompliance|2
1025830|NCT01628549|2053464|FG002|Overall Study|withdrawn for noncompliance|1
1025831|NCT01628549|2053465|FG003|Overall Study|withdrawn for noncompliance|0
1025832|NCT01628549|2053462|FG000|Overall Study|abnormal laboratory test results|0
1025833|NCT01628549|2053463|FG001|Overall Study|abnormal laboratory test results|0
1025834|NCT01628549|2053464|FG002|Overall Study|abnormal laboratory test results|1
1025835|NCT01628549|2053465|FG003|Overall Study|abnormal laboratory test results|0
1025836|NCT01628549|2053462|FG000|Overall Study|positive pregnancy test|0
1025837|NCT01628549|2053463|FG001|Overall Study|positive pregnancy test|0
1025838|NCT01628549|2053464|FG002|Overall Study|positive pregnancy test|0
1025839|NCT01628549|2053465|FG003|Overall Study|positive pregnancy test|1
1025840|NCT01628692|2053493|FG000|Overall Study|Lack of Efficacy|4
1025841|NCT01628692|2053494|FG001|Overall Study|Lack of Efficacy|4
1025842|NCT01628692|2053495|FG002|Overall Study|Lack of Efficacy|5
1025843|NCT01628692|2053496|FG003|Overall Study|Lack of Efficacy|1
1025844|NCT01628692|2053497|FG004|Overall Study|Lack of Efficacy|4
1025845|NCT01628692|2053498|FG005|Overall Study|Lack of Efficacy|7
1025846|NCT01628692|2053493|FG000|Overall Study|Adverse Event|2
1025847|NCT01628692|2053494|FG001|Overall Study|Adverse Event|0
1025848|NCT01628692|2053495|FG002|Overall Study|Adverse Event|2
1025849|NCT01628692|2053496|FG003|Overall Study|Adverse Event|0
1025850|NCT01628692|2053497|FG004|Overall Study|Adverse Event|0
1025851|NCT01628692|2053498|FG005|Overall Study|Adverse Event|0
1025852|NCT01628692|2053493|FG000|Overall Study|Withdrawal by Subject|0
1025853|NCT01628692|2053494|FG001|Overall Study|Withdrawal by Subject|1
1025854|NCT01628692|2053495|FG002|Overall Study|Withdrawal by Subject|1
1025855|NCT01628692|2053496|FG003|Overall Study|Withdrawal by Subject|0
1025856|NCT01628692|2053497|FG004|Overall Study|Withdrawal by Subject|0
1025857|NCT01628692|2053498|FG005|Overall Study|Withdrawal by Subject|0
1025858|NCT01628692|2053493|FG000|Overall Study|Death|0
1025859|NCT01628692|2053494|FG001|Overall Study|Death|1
1025860|NCT01628692|2053495|FG002|Overall Study|Death|0
1025861|NCT01628692|2053496|FG003|Overall Study|Death|0
1025862|NCT01628692|2053497|FG004|Overall Study|Death|0
1025863|NCT01628692|2053498|FG005|Overall Study|Death|0
1025864|NCT01628692|2053493|FG000|Overall Study|Poor compliance/noncompliance|1
1025865|NCT01628692|2053494|FG001|Overall Study|Poor compliance/noncompliance|0
1025866|NCT01628692|2053495|FG002|Overall Study|Poor compliance/noncompliance|0
1025867|NCT01628692|2053496|FG003|Overall Study|Poor compliance/noncompliance|0
1025868|NCT01628692|2053497|FG004|Overall Study|Poor compliance/noncompliance|0
1025869|NCT01628692|2053498|FG005|Overall Study|Poor compliance/noncompliance|0
1025870|NCT01628692|2053493|FG000|Overall Study|Administrative reason by sponsor|0
1025871|NCT01628692|2053494|FG001|Overall Study|Administrative reason by sponsor|0
1025872|NCT01628692|2053495|FG002|Overall Study|Administrative reason by sponsor|0
1025873|NCT01628692|2053496|FG003|Overall Study|Administrative reason by sponsor|0
1025874|NCT01628692|2053497|FG004|Overall Study|Administrative reason by sponsor|0
1025875|NCT01628692|2053498|FG005|Overall Study|Administrative reason by sponsor|1
1025876|NCT01628692|2053493|FG000|Overall Study|Completed 12 Week only|0
1025877|NCT01628692|2053494|FG001|Overall Study|Completed 12 Week only|0
1025878|NCT01628692|2053495|FG002|Overall Study|Completed 12 Week only|0
1025879|NCT01628692|2053496|FG003|Overall Study|Completed 12 Week only|0
1025880|NCT01628692|2053497|FG004|Overall Study|Completed 12 Week only|0
1025881|NCT01628692|2053498|FG005|Overall Study|Completed 12 Week only|1
1025882|NCT01628848|2053526|FG000|Overall Study|Adverse Event|9
1025883|NCT01628848|2053527|FG001|Overall Study|Adverse Event|7
1025884|NCT01628848|2053526|FG000|Overall Study|Lack of Efficacy|0
1025885|NCT01628848|2053527|FG001|Overall Study|Lack of Efficacy|4
1025886|NCT01628848|2053526|FG000|Overall Study|Withdrawal by Subject|0
905029|NCT00760383|1880219|FG001|Overall Study|moved away; withdrew; medical reasons|7
1025887|NCT01628848|2053527|FG001|Overall Study|Withdrawal by Subject|2
1025888|NCT01628848|2053526|FG000|Overall Study|Physician Decision|3
1025889|NCT01628848|2053527|FG001|Overall Study|Physician Decision|1
1025890|NCT01628874|2053535|FG000|Overall Study|Physician Decision|1
1025891|NCT01628874|2053536|FG001|Overall Study|Physician Decision|1
1025892|NCT01628874|2053535|FG000|Overall Study|Age >4 months|4
1025893|NCT01628874|2053536|FG001|Overall Study|Age >4 months|2
1025894|NCT01628913|2053544|FG000|Overall Study|Adverse Event|12
1025895|NCT01628913|2053545|FG001|Overall Study|Adverse Event|5
1025896|NCT01628913|2053544|FG000|Overall Study|Disease Progression|11
1025897|NCT01628913|2053545|FG001|Overall Study|Disease Progression|14
1025898|NCT01628913|2053544|FG000|Overall Study|Protocol Violation|1
1025899|NCT01628913|2053545|FG001|Overall Study|Protocol Violation|0
1025900|NCT01628913|2053544|FG000|Overall Study|Death|1
1025901|NCT01628913|2053545|FG001|Overall Study|Death|0
1025902|NCT01628913|2053544|FG000|Overall Study|study terminated by Sponsor|4
1025903|NCT01628913|2053545|FG001|Overall Study|study terminated by Sponsor|9
1025904|NCT01628913|2053544|FG000|Overall Study|Withdrawal by Subject|1
1025905|NCT01628913|2053545|FG001|Overall Study|Withdrawal by Subject|0
1025906|NCT01628913|2053544|FG000|Overall Study|Physician Decision|1
1025907|NCT01628913|2053545|FG001|Overall Study|Physician Decision|3
1025908|NCT01628926|2053554|FG000|Overall Study|Adverse Event|13
1025909|NCT01628926|2053555|FG001|Overall Study|Adverse Event|11
1025910|NCT01628926|2053556|FG002|Overall Study|Adverse Event|9
1025911|NCT01628926|2053554|FG000|Overall Study|Lack of Efficacy|2
1025912|NCT01628926|2053555|FG001|Overall Study|Lack of Efficacy|1
1025913|NCT01628926|2053556|FG002|Overall Study|Lack of Efficacy|5
1025914|NCT01628926|2053554|FG000|Overall Study|Withdrawal by Subject|6
1025915|NCT01628926|2053555|FG001|Overall Study|Withdrawal by Subject|4
1025916|NCT01628926|2053556|FG002|Overall Study|Withdrawal by Subject|2
1025917|NCT01628926|2053554|FG000|Overall Study|Protocol Violation|0
1025918|NCT01628926|2053555|FG001|Overall Study|Protocol Violation|1
1025919|NCT01628926|2053556|FG002|Overall Study|Protocol Violation|0
1025920|NCT01628926|2053554|FG000|Overall Study|Discontinuation criteria|3
1025921|NCT01628926|2053555|FG001|Overall Study|Discontinuation criteria|4
1025922|NCT01628926|2053556|FG002|Overall Study|Discontinuation criteria|0
1025923|NCT01628926|2053554|FG000|Overall Study|Physician Decision|2
1025924|NCT01628926|2053555|FG001|Overall Study|Physician Decision|2
1025925|NCT01628926|2053556|FG002|Overall Study|Physician Decision|1
1025926|NCT01628965|2053565|FG000|Overall Study|Adverse Event|30
1025927|NCT01628965|2053565|FG000|Overall Study|Lack of Efficacy|7
1025928|NCT01628965|2053565|FG000|Overall Study|Withdrawal by Subject|3
1025929|NCT01628965|2053565|FG000|Overall Study|Lost to Follow-up|1
1025930|NCT01628965|2053565|FG000|Overall Study|Discontinuation criteria|8
1025931|NCT01629381|2053585|FG000|Overall Study|Withdrawal by Subject|2
1025932|NCT01629381|2053586|FG001|Overall Study|Withdrawal by Subject|5
1025933|NCT01629563|2053615|FG000|Overall Study|Adverse Event|16
1025934|NCT01629563|2053616|FG001|Overall Study|Adverse Event|16
1025935|NCT01629563|2053615|FG000|Overall Study|Death|2
1025936|NCT01629563|2053616|FG001|Overall Study|Death|0
1025937|NCT01629563|2053615|FG000|Overall Study|Lack of Efficacy|2
1025938|NCT01629563|2053616|FG001|Overall Study|Lack of Efficacy|3
1025939|NCT01629563|2053615|FG000|Overall Study|Lost to Follow-up|1
1025940|NCT01629563|2053616|FG001|Overall Study|Lost to Follow-up|0
1025941|NCT01629563|2053615|FG000|Overall Study|Pregnancy|1
1025942|NCT01629563|2053616|FG001|Overall Study|Pregnancy|2
1025943|NCT01629563|2053615|FG000|Overall Study|Protocol Violation|0
1025944|NCT01629563|2053616|FG001|Overall Study|Protocol Violation|1
1025945|NCT01629563|2053615|FG000|Overall Study|Withdrawal by Subject|27
1025946|NCT01629563|2053616|FG001|Overall Study|Withdrawal by Subject|20
1025947|NCT01629563|2053615|FG000|Overall Study|surgery|0
1025948|NCT01629563|2053616|FG001|Overall Study|surgery|3
1025949|NCT01629563|2053615|FG000|Overall Study|Lack of return of menses|12
1025950|NCT01629563|2053616|FG001|Overall Study|Lack of return of menses|7
1025951|NCT01629563|2053615|FG000|Overall Study|Protocol Violation|0
1025952|NCT01629563|2053616|FG001|Overall Study|Protocol Violation|1
1025953|NCT01629589|2053624|FG000|Overall Study|Protocol Violation|4
1025954|NCT01629589|2053625|FG001|Overall Study|Protocol Violation|2
1025955|NCT01629589|2053624|FG000|Overall Study|Lost to Follow-up|2
1025956|NCT01629589|2053625|FG001|Overall Study|Lost to Follow-up|1
1025957|NCT01629589|2053624|FG000|Overall Study|Withdrawal by Subject|2
1025958|NCT01629589|2053625|FG001|Overall Study|Withdrawal by Subject|3
1025959|NCT01629589|2053624|FG000|Overall Study|Did not receive study vaccine|0
1025960|NCT01629589|2053625|FG001|Overall Study|Did not receive study vaccine|1
1025961|NCT01629667|2053638|FG000|Overall Study|Lost to Follow-up|0
1025962|NCT01629667|2053639|FG001|Overall Study|Lost to Follow-up|1
1025963|NCT01629667|2053640|FG002|Overall Study|Lost to Follow-up|1
1025964|NCT01629667|2053638|FG000|Overall Study|Withdrawal by Subject|31
1025965|NCT01629667|2053639|FG001|Overall Study|Withdrawal by Subject|20
1025966|NCT01629667|2053640|FG002|Overall Study|Withdrawal by Subject|28
1025967|NCT01629667|2053638|FG000|Overall Study|Death|1
1025968|NCT01629667|2053639|FG001|Overall Study|Death|5
1025969|NCT01629667|2053640|FG002|Overall Study|Death|3
1025970|NCT01629667|2053638|FG000|Overall Study|Randomized, not treated|2
1025971|NCT01629667|2053639|FG001|Overall Study|Randomized, not treated|1
1025972|NCT01629667|2053640|FG002|Overall Study|Randomized, not treated|0
1025973|NCT01629667|2053638|FG000|Overall Study|Ongoing AE worsening right heart failure|0
1025974|NCT01629667|2053639|FG001|Overall Study|Ongoing AE worsening right heart failure|1
1025975|NCT01629667|2053640|FG002|Overall Study|Ongoing AE worsening right heart failure|0
1025976|NCT01629667|2053638|FG000|Overall Study|Requiring lung transplant|2
1025977|NCT01629667|2053639|FG001|Overall Study|Requiring lung transplant|1
1025978|NCT01629667|2053640|FG002|Overall Study|Requiring lung transplant|3
1025979|NCT01629667|2053638|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
1025980|NCT01629667|2053639|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
1025981|NCT01629667|2053640|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
1025982|NCT01629667|2053638|FG000|Overall Study|Started other medicine|1
1025983|NCT01629667|2053639|FG001|Overall Study|Started other medicine|0
1025984|NCT01629667|2053640|FG002|Overall Study|Started other medicine|1
1025985|NCT01629667|2053638|FG000|Overall Study|Site error in safety follow-up|0
1025986|NCT01629667|2053639|FG001|Overall Study|Site error in safety follow-up|0
1025987|NCT01629667|2053640|FG002|Overall Study|Site error in safety follow-up|1
1025988|NCT01629667|2053638|FG000|Overall Study|Enrolled in another clinical study|0
1025989|NCT01629667|2053639|FG001|Overall Study|Enrolled in another clinical study|1
1025990|NCT01629667|2053640|FG002|Overall Study|Enrolled in another clinical study|0
1025991|NCT01629667|2053638|FG000|Overall Study|Code break|1
1025992|NCT01629667|2053639|FG001|Overall Study|Code break|0
1025993|NCT01629667|2053640|FG002|Overall Study|Code break|0
1025994|NCT01629693|2053652|FG000|Overall Study|Lost to Follow-up|2
1025995|NCT01629693|2053653|FG001|Overall Study|Lost to Follow-up|4
1025996|NCT01629693|2053652|FG000|Overall Study|Withdrawal by Subject|2
1025997|NCT01629693|2053653|FG001|Overall Study|Withdrawal by Subject|2
1025998|NCT01629693|2053652|FG000|Overall Study|Adverse Event|1
1025999|NCT01629693|2053653|FG001|Overall Study|Adverse Event|0
1026000|NCT01629693|2053652|FG000|Overall Study|Investigator decision|0
1026001|NCT01629693|2053653|FG001|Overall Study|Investigator decision|1
1026002|NCT01629693|2053652|FG000|Overall Study|Poor comfort of study lenses|0
1026003|NCT01629693|2053653|FG001|Overall Study|Poor comfort of study lenses|2
1026004|NCT01629693|2053652|FG000|Overall Study|Subject decision unrelated to AE|0
1026005|NCT01629693|2053653|FG001|Overall Study|Subject decision unrelated to AE|1
1026006|NCT01629706|2053659|FG000|Phase 1 PureVision|Screen Failure|4
1026007|NCT01629706|2053659|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
1026008|NCT01629706|2053659|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1
1026009|NCT01629706|2053659|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
1026010|NCT01629706|2053659|FG000|Phase 2 Habitual|Screen Failure|6
1026011|NCT01629706|2053659|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
1026012|NCT01629706|2053659|FG000|Phase 2 Habitual|Relocation prior to Dispense|1
1026013|NCT01629706|2053659|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
1026014|NCT01629706|2053659|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1
1026015|NCT01629823|2053693|FG000|Trial Period|Missed visit|11
1026016|NCT01629823|2053694|FG001|Trial Period|Missed visit|9
1026017|NCT01629823|2053695|FG002|Trial Period|Missed visit|8
1026018|NCT01629823|2053693|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1026019|NCT01629823|2053694|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1026020|NCT01629823|2053695|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1026021|NCT01629823|2053693|FG000|Trial Period|Pregnancy|1
1026022|NCT01629823|2053694|FG001|Trial Period|Pregnancy|0
1026023|NCT01629823|2053695|FG002|Trial Period|Pregnancy|0
1026024|NCT01629823|2053693|FG000|Trial Period|Adverse Event|0
1026025|NCT01629823|2053694|FG001|Trial Period|Adverse Event|1
1026026|NCT01629823|2053695|FG002|Trial Period|Adverse Event|0
1026027|NCT01629823|2053693|FG000|Trial Period|Out-of-window visit|0
1026028|NCT01629823|2053694|FG001|Trial Period|Out-of-window visit|2
1026029|NCT01629823|2053695|FG002|Trial Period|Out-of-window visit|0
1026030|NCT01629823|2053693|FG000|Trial Period|Failed to hold medication|0
1026031|NCT01629823|2053694|FG001|Trial Period|Failed to hold medication|0
1026032|NCT01629823|2053695|FG002|Trial Period|Failed to hold medication|1
1026033|NCT01629823|2053693|FG000|Washout Period|Safety|2
1026034|NCT01629823|2053694|FG001|Washout Period|Safety|5
1026035|NCT01629823|2053695|FG002|Washout Period|Safety|0
1026036|NCT01629823|2053693|FG000|Washout Period|Pregnancy|1
1026037|NCT01629823|2053694|FG001|Washout Period|Pregnancy|0
1026038|NCT01629823|2053695|FG002|Washout Period|Pregnancy|0
1026039|NCT01629823|2053693|FG000|Washout Period|Protocol Violation|0
1026040|NCT01629823|2053694|FG001|Washout Period|Protocol Violation|1
1026041|NCT01629823|2053695|FG002|Washout Period|Protocol Violation|0
1026042|NCT01629953|2053714|FG000|Overall Study|Death|3
1026043|NCT01629953|2053715|FG001|Overall Study|Death|1
1026044|NCT01629953|2053714|FG000|Overall Study|Lost to Follow-up|10
1026045|NCT01629953|2053715|FG001|Overall Study|Lost to Follow-up|14
1026046|NCT01629966|2053724|FG000|Overall Study|Pregnancy|0
1026047|NCT01629966|2053725|FG001|Overall Study|Pregnancy|1
1026048|NCT01629966|2053726|FG002|Overall Study|Pregnancy|0
1026049|NCT01629966|2053724|FG000|Overall Study|Lost to Follow-up|10
1026050|NCT01629966|2053725|FG001|Overall Study|Lost to Follow-up|13
1026051|NCT01629966|2053726|FG002|Overall Study|Lost to Follow-up|9
1026052|NCT01629966|2053724|FG000|Overall Study|Withdrawal by Subject|8
1026053|NCT01629966|2053725|FG001|Overall Study|Withdrawal by Subject|9
1026054|NCT01629966|2053726|FG002|Overall Study|Withdrawal by Subject|16
1026055|NCT01629966|2053724|FG000|Overall Study|Protocol Violation|7
1026056|NCT01629966|2053725|FG001|Overall Study|Protocol Violation|9
1026057|NCT01629966|2053726|FG002|Overall Study|Protocol Violation|7
1026058|NCT01629966|2053724|FG000|Overall Study|Lack of Efficacy|5
1026059|NCT01629966|2053725|FG001|Overall Study|Lack of Efficacy|2
1026060|NCT01629966|2053726|FG002|Overall Study|Lack of Efficacy|4
1026061|NCT01629966|2053724|FG000|Overall Study|Adverse Event|11
1026062|NCT01629966|2053725|FG001|Overall Study|Adverse Event|18
1026063|NCT01629966|2053726|FG002|Overall Study|Adverse Event|30
1026064|NCT01630135|2053755|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0
1026065|NCT01630135|2053756|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2
1026066|NCT01630616|2053777|FG000|Overall Study|Adverse Event|0
1026067|NCT01630616|2053778|FG001|Overall Study|Adverse Event|0
1026068|NCT01630616|2053779|FG002|Overall Study|Adverse Event|0
1026069|NCT01630616|2053780|FG003|Overall Study|Adverse Event|1
1026070|NCT01630616|2053781|FG004|Overall Study|Adverse Event|0
1026071|NCT01630616|2053782|FG005|Overall Study|Adverse Event|0
1026072|NCT01630616|2053777|FG000|Overall Study|Withdrawal by Subject|0
1026073|NCT01630616|2053778|FG001|Overall Study|Withdrawal by Subject|0
1026074|NCT01630616|2053779|FG002|Overall Study|Withdrawal by Subject|0
1026075|NCT01630616|2053780|FG003|Overall Study|Withdrawal by Subject|2
1026076|NCT01630616|2053781|FG004|Overall Study|Withdrawal by Subject|0
1026077|NCT01630616|2053782|FG005|Overall Study|Withdrawal by Subject|0
1026078|NCT01630811|2053808|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
1026079|NCT01630811|2053809|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
1026080|NCT01630889|2053817|FG000|Overall Study|Death|2
1026081|NCT01630889|2053817|FG000|Overall Study|Withdrawal by Subject|1
1026082|NCT01630889|2053817|FG000|Overall Study|Other than Specified|2
1026083|NCT01630889|2053817|FG000|Overall Study|Lost to Follow-up|4
1026084|NCT01630889|2053817|FG000|Overall Study|Other|1
1026085|NCT01631188|2053848|FG000|Overall Study|Physician Decision|75
1026086|NCT01631214|2053854|FG000|Overall Study|Withdrawal by Subject|276
1026087|NCT01631214|2053855|FG001|Overall Study|Withdrawal by Subject|290
1026088|NCT01631214|2053854|FG000|Overall Study|Death|113
1026089|NCT01631214|2053855|FG001|Overall Study|Death|106
1026090|NCT01631214|2053854|FG000|Overall Study|Lost to Follow-up|54
1026091|NCT01631214|2053855|FG001|Overall Study|Lost to Follow-up|40
1026092|NCT01631214|2053854|FG000|Overall Study|Adverse Event|45
1026093|NCT01631214|2053855|FG001|Overall Study|Adverse Event|45
1026094|NCT01631214|2053854|FG000|Overall Study|Other|22
1026095|NCT01631214|2053855|FG001|Overall Study|Other|19
1026096|NCT01631214|2053854|FG000|Overall Study|Noncompliance|16
1026097|NCT01631214|2053855|FG001|Overall Study|Noncompliance|15
1026098|NCT01631214|2053854|FG000|Overall Study|Requirement for Alternative Therapy|8
1026099|NCT01631214|2053855|FG001|Overall Study|Requirement for Alternative Therapy|3
1026100|NCT01631214|2053854|FG000|Overall Study|Protocol Deviation|4
1026101|NCT01631214|2053855|FG001|Overall Study|Protocol Deviation|3
1026102|NCT01631214|2053854|FG000|Overall Study|Ineligibility determined|5
1026103|NCT01631214|2053855|FG001|Overall Study|Ineligibility determined|2
1026104|NCT01631214|2053854|FG000|Overall Study|Administrative Decision|1
1026105|NCT01631214|2053855|FG001|Overall Study|Administrative Decision|0
1026106|NCT01631227|2053865|FG000|Overall Study|withdrawn consent|27
1026107|NCT01631227|2053866|FG001|Overall Study|withdrawn consent|21
1026108|NCT01631227|2053865|FG000|Overall Study|Adverse Event|1
1026109|NCT01631227|2053866|FG001|Overall Study|Adverse Event|0
1026110|NCT01631227|2053865|FG000|Overall Study|administrative|2
1026111|NCT01631227|2053866|FG001|Overall Study|administrative|1
1026112|NCT01631435|2053877|FG000|Overall Study|Adverse Event|2
1026113|NCT01631435|2053877|FG000|Overall Study|Withdrawal by Subject|2
1026114|NCT01631435|2053877|FG000|Overall Study|incomplete study procedure|5
1026115|NCT01631474|2053887|FG000|Overall Study|Lost to Follow-up|8
1026116|NCT01631474|2053888|FG001|Overall Study|Lost to Follow-up|5
1026117|NCT01631474|2053889|FG002|Overall Study|Lost to Follow-up|7
1026118|NCT01631474|2053890|FG003|Overall Study|Lost to Follow-up|5
1026119|NCT01631474|2053891|FG004|Overall Study|Lost to Follow-up|5
1026120|NCT01631474|2053887|FG000|Overall Study|Withdrawal by Subject|4
1026121|NCT01631474|2053888|FG001|Overall Study|Withdrawal by Subject|4
1026122|NCT01631474|2053889|FG002|Overall Study|Withdrawal by Subject|2
1026123|NCT01631474|2053890|FG003|Overall Study|Withdrawal by Subject|6
1026124|NCT01631474|2053891|FG004|Overall Study|Withdrawal by Subject|5
1026125|NCT01631474|2053887|FG000|Overall Study|Lack of Efficacy|2
1026126|NCT01631474|2053888|FG001|Overall Study|Lack of Efficacy|2
1026127|NCT01631474|2053889|FG002|Overall Study|Lack of Efficacy|0
1026128|NCT01631474|2053890|FG003|Overall Study|Lack of Efficacy|0
1026129|NCT01631474|2053891|FG004|Overall Study|Lack of Efficacy|2
1026130|NCT01631474|2053887|FG000|Overall Study|Noncompliance with Study Drug|0
1026131|NCT01631474|2053888|FG001|Overall Study|Noncompliance with Study Drug|0
1026132|NCT01631474|2053889|FG002|Overall Study|Noncompliance with Study Drug|0
1026133|NCT01631474|2053890|FG003|Overall Study|Noncompliance with Study Drug|0
1026134|NCT01631474|2053891|FG004|Overall Study|Noncompliance with Study Drug|1
1026135|NCT01631474|2053887|FG000|Overall Study|Adverse Event|0
1026136|NCT01631474|2053888|FG001|Overall Study|Adverse Event|1
1026137|NCT01631474|2053889|FG002|Overall Study|Adverse Event|0
1026138|NCT01631474|2053890|FG003|Overall Study|Adverse Event|0
1026139|NCT01631474|2053891|FG004|Overall Study|Adverse Event|0
1026140|NCT01631747|2053959|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1
1026141|NCT01631747|2053960|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0
1026142|NCT01631747|2053959|FG000|Live Birth|Pregnancy Termination|1
1026143|NCT01631747|2053960|FG001|Live Birth|Pregnancy Termination|0
1026144|NCT01631747|2053959|FG000|Live Birth|MIscarriage|2
1026145|NCT01631747|2053960|FG001|Live Birth|MIscarriage|0
1026146|NCT01631747|2053959|FG000|Live Birth|Stillbirth|1
1026147|NCT01631747|2053960|FG001|Live Birth|Stillbirth|1
1026148|NCT01631747|2053959|FG000|One Year Infant Outcomes|Patient Refused|13
1026149|NCT01631747|2053960|FG001|One Year Infant Outcomes|Patient Refused|9
1026150|NCT01631812|2053967|FG000|Overall Study|Adverse Event|25
1026151|NCT01631812|2053967|FG000|Overall Study|Lack of Efficacy|5
1026152|NCT01631812|2053967|FG000|Overall Study|Withdrawal by Subject|4
1026153|NCT01631812|2053967|FG000|Overall Study|Physician Decision|3
1026154|NCT01631825|2053971|FG000|Overall Study|Adverse Event|42
1026155|NCT01631825|2053971|FG000|Overall Study|Lack of Efficacy|7
1026156|NCT01631825|2053971|FG000|Overall Study|Withdrawal by Subject|9
1026157|NCT01631825|2053971|FG000|Overall Study|Protocol Violation|4
1026158|NCT01631825|2053971|FG000|Overall Study|Discontinuation criteria|1
1026159|NCT01631825|2053971|FG000|Overall Study|Physician Decision|2
1026160|NCT01631864|2053977|FG000|Overall Study|Withdrawal by Subject|0
1026161|NCT01631864|2053978|FG001|Overall Study|Withdrawal by Subject|1
1026162|NCT01631864|2053977|FG000|Overall Study|Adverse Event|2
1026163|NCT01631864|2053978|FG001|Overall Study|Adverse Event|3
1026164|NCT01632150|2053993|FG000|Overall Study|Disease progression|27
1026165|NCT01632150|2053993|FG000|Overall Study|Study drug toxicity|1
1026166|NCT01632150|2053993|FG000|Overall Study|Unrelated adverse event|7
1026167|NCT01632150|2053993|FG000|Overall Study|Withdrawal by Subject|2
1026168|NCT01632150|2053993|FG000|Overall Study|Patient underwent autologous transplant|1
1026169|NCT01632150|2053993|FG000|Overall Study|Moved to compassionate program|2
1026170|NCT01632241|2054020|FG000|Double-blinded (Up to Week 52)|Site Closed|3
1026171|NCT01632241|2054021|FG001|Double-blinded (Up to Week 52)|Site Closed|5
1026172|NCT01632241|2054020|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2
1026173|NCT01632241|2054021|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6
1026174|NCT01632241|2054020|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1
1026175|NCT01632241|2054021|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8
1026176|NCT01632241|2054020|FG000|Double-blinded (Up to Week 52)|Physician Decision|9
1026177|NCT01632241|2054021|FG001|Double-blinded (Up to Week 52)|Physician Decision|12
1026178|NCT01632241|2054020|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9
1026179|NCT01632241|2054021|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15
1026180|NCT01632241|2054020|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
1026181|NCT01632241|2054021|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
1026182|NCT01632241|2054020|FG000|Double-blinded (Up to Week 52)|Adverse Event|10
1026183|NCT01632241|2054021|FG001|Double-blinded (Up to Week 52)|Adverse Event|19
1026184|NCT01632241|2054020|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
1026185|NCT01632241|2054021|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
1026186|NCT01632241|2054020|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1
1026187|NCT01632241|2054021|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4
1026188|NCT01632241|2054020|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
1026189|NCT01632241|2054021|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
1026190|NCT01632241|2054020|FG000|Open-label (Week 52 to Week 76)|Site Closed|2
1026191|NCT01632241|2054021|FG001|Open-label (Week 52 to Week 76)|Site Closed|8
1026192|NCT01632241|2054020|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0
1026193|NCT01632241|2054021|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2
1026194|NCT01632241|2054020|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
1026195|NCT01632241|2054021|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
1026196|NCT01632241|2054020|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1
1026197|NCT01632241|2054021|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0
1026198|NCT01632280|2054039|FG000|Overall Study|Withdrawal by Subject|1
1026199|NCT01632280|2054040|FG001|Overall Study|Withdrawal by Subject|0
1026200|NCT01632306|2054048|FG000|Overall Study|Protocol Violation|1
1026201|NCT01632306|2054049|FG001|Overall Study|Protocol Violation|0
1026202|NCT01632306|2054050|FG002|Overall Study|Protocol Violation|0
1026203|NCT01632345|2054061|FG000|Treatment: Part I|Adverse Event|1
1026204|NCT01632345|2054062|FG001|Treatment: Part I|Adverse Event|4
1026205|NCT01632345|2054063|FG002|Treatment: Part I|Adverse Event|2
1026206|NCT01632345|2054064|FG003|Treatment: Part I|Adverse Event|1
1026207|NCT01632345|2054065|FG004|Treatment: Part I|Adverse Event|3
1026208|NCT01632345|2054066|FG005|Treatment: Part I|Adverse Event|0
1026209|NCT01632345|2054067|FG006|Treatment: Part I|Adverse Event|0
1026210|NCT01632345|2054061|FG000|Treatment: Part I|Lack of Efficacy|0
1026211|NCT01632345|2054062|FG001|Treatment: Part I|Lack of Efficacy|1
1026212|NCT01632345|2054063|FG002|Treatment: Part I|Lack of Efficacy|0
1026213|NCT01632345|2054064|FG003|Treatment: Part I|Lack of Efficacy|1
1026214|NCT01632345|2054065|FG004|Treatment: Part I|Lack of Efficacy|1
1026215|NCT01632345|2054066|FG005|Treatment: Part I|Lack of Efficacy|0
1026216|NCT01632345|2054067|FG006|Treatment: Part I|Lack of Efficacy|0
1026217|NCT01632345|2054061|FG000|Treatment: Part I|Lost to Follow-up|3
1026218|NCT01632345|2054062|FG001|Treatment: Part I|Lost to Follow-up|2
1026219|NCT01632345|2054063|FG002|Treatment: Part I|Lost to Follow-up|1
1026220|NCT01632345|2054064|FG003|Treatment: Part I|Lost to Follow-up|3
1026221|NCT01632345|2054065|FG004|Treatment: Part I|Lost to Follow-up|4
1026222|NCT01632345|2054066|FG005|Treatment: Part I|Lost to Follow-up|0
1026223|NCT01632345|2054067|FG006|Treatment: Part I|Lost to Follow-up|0
1026224|NCT01632345|2054061|FG000|Treatment: Part I|Non-Compliance with Study Drug|3
1026225|NCT01632345|2054062|FG001|Treatment: Part I|Non-Compliance with Study Drug|2
1026226|NCT01632345|2054063|FG002|Treatment: Part I|Non-Compliance with Study Drug|2
1026227|NCT01632345|2054064|FG003|Treatment: Part I|Non-Compliance with Study Drug|1
1026228|NCT01632345|2054065|FG004|Treatment: Part I|Non-Compliance with Study Drug|0
1026229|NCT01632345|2054066|FG005|Treatment: Part I|Non-Compliance with Study Drug|0
1026230|NCT01632345|2054067|FG006|Treatment: Part I|Non-Compliance with Study Drug|0
1026231|NCT01632345|2054061|FG000|Treatment: Part I|Physician Decision|2
1026232|NCT01632345|2054062|FG001|Treatment: Part I|Physician Decision|1
1026233|NCT01632345|2054063|FG002|Treatment: Part I|Physician Decision|0
1026234|NCT01632345|2054064|FG003|Treatment: Part I|Physician Decision|0
1026235|NCT01632345|2054065|FG004|Treatment: Part I|Physician Decision|1
1026236|NCT01632345|2054066|FG005|Treatment: Part I|Physician Decision|0
1026237|NCT01632345|2054067|FG006|Treatment: Part I|Physician Decision|0
1026238|NCT01632345|2054061|FG000|Treatment: Part I|Pregnancy|0
1026239|NCT01632345|2054062|FG001|Treatment: Part I|Pregnancy|1
1026240|NCT01632345|2054063|FG002|Treatment: Part I|Pregnancy|0
1026241|NCT01632345|2054064|FG003|Treatment: Part I|Pregnancy|0
1026242|NCT01632345|2054065|FG004|Treatment: Part I|Pregnancy|0
1026243|NCT01632345|2054066|FG005|Treatment: Part I|Pregnancy|0
1026244|NCT01632345|2054067|FG006|Treatment: Part I|Pregnancy|0
1026245|NCT01632345|2054061|FG000|Treatment: Part I|Protocol Deviation|0
1026246|NCT01632345|2054062|FG001|Treatment: Part I|Protocol Deviation|0
1026247|NCT01632345|2054063|FG002|Treatment: Part I|Protocol Deviation|1
1026248|NCT01632345|2054064|FG003|Treatment: Part I|Protocol Deviation|1
1026249|NCT01632345|2054065|FG004|Treatment: Part I|Protocol Deviation|0
1026250|NCT01632345|2054066|FG005|Treatment: Part I|Protocol Deviation|0
1026251|NCT01632345|2054067|FG006|Treatment: Part I|Protocol Deviation|0
1026252|NCT01632345|2054061|FG000|Treatment: Part I|Withdrawal by Subject|3
1026253|NCT01632345|2054062|FG001|Treatment: Part I|Withdrawal by Subject|4
1026254|NCT01632345|2054063|FG002|Treatment: Part I|Withdrawal by Subject|4
1026255|NCT01632345|2054064|FG003|Treatment: Part I|Withdrawal by Subject|1
1026256|NCT01632345|2054065|FG004|Treatment: Part I|Withdrawal by Subject|4
1026257|NCT01632345|2054066|FG005|Treatment: Part I|Withdrawal by Subject|0
1026258|NCT01632345|2054067|FG006|Treatment: Part I|Withdrawal by Subject|0
1026259|NCT01632345|2054061|FG000|Treatment: Part II|Adverse Event|0
1026260|NCT01632345|2054062|FG001|Treatment: Part II|Adverse Event|0
1026261|NCT01632345|2054063|FG002|Treatment: Part II|Adverse Event|0
1026262|NCT01632345|2054064|FG003|Treatment: Part II|Adverse Event|0
1026263|NCT01632345|2054065|FG004|Treatment: Part II|Adverse Event|0
1026264|NCT01632345|2054066|FG005|Treatment: Part II|Adverse Event|3
1026265|NCT01632345|2054067|FG006|Treatment: Part II|Adverse Event|8
1026266|NCT01632345|2054061|FG000|Treatment: Part II|Lost to Follow-up|0
1026267|NCT01632345|2054062|FG001|Treatment: Part II|Lost to Follow-up|0
1026268|NCT01632345|2054063|FG002|Treatment: Part II|Lost to Follow-up|0
1026269|NCT01632345|2054064|FG003|Treatment: Part II|Lost to Follow-up|0
1026270|NCT01632345|2054065|FG004|Treatment: Part II|Lost to Follow-up|0
1026271|NCT01632345|2054066|FG005|Treatment: Part II|Lost to Follow-up|3
1026272|NCT01632345|2054067|FG006|Treatment: Part II|Lost to Follow-up|1
1026273|NCT01632345|2054061|FG000|Treatment: Part II|Non-Compliance with Study Drug|0
1026274|NCT01632345|2054062|FG001|Treatment: Part II|Non-Compliance with Study Drug|0
1026275|NCT01632345|2054063|FG002|Treatment: Part II|Non-Compliance with Study Drug|0
1026276|NCT01632345|2054064|FG003|Treatment: Part II|Non-Compliance with Study Drug|0
1026277|NCT01632345|2054065|FG004|Treatment: Part II|Non-Compliance with Study Drug|0
1026278|NCT01632345|2054066|FG005|Treatment: Part II|Non-Compliance with Study Drug|3
1026279|NCT01632345|2054067|FG006|Treatment: Part II|Non-Compliance with Study Drug|0
1026280|NCT01632345|2054061|FG000|Treatment: Part II|Withdrawal by Subject|0
1026281|NCT01632345|2054062|FG001|Treatment: Part II|Withdrawal by Subject|0
1026282|NCT01632345|2054063|FG002|Treatment: Part II|Withdrawal by Subject|0
1026283|NCT01632345|2054064|FG003|Treatment: Part II|Withdrawal by Subject|0
1026284|NCT01632345|2054065|FG004|Treatment: Part II|Withdrawal by Subject|0
1026285|NCT01632345|2054066|FG005|Treatment: Part II|Withdrawal by Subject|2
1026286|NCT01632345|2054067|FG006|Treatment: Part II|Withdrawal by Subject|2
1026287|NCT01632566|2054091|FG000|Overall Study|Withdrawal by Subject|0
1026288|NCT01632566|2054092|FG001|Overall Study|Withdrawal by Subject|1
1026289|NCT01632566|2054093|FG002|Overall Study|Withdrawal by Subject|0
1026290|NCT01632566|2054094|FG003|Overall Study|Withdrawal by Subject|0
1026291|NCT01632566|2054095|FG004|Overall Study|Withdrawal by Subject|0
1026292|NCT01632566|2054091|FG000|Overall Study|Sponsor Decision|0
1026293|NCT01632566|2054092|FG001|Overall Study|Sponsor Decision|2
1026294|NCT01632566|2054093|FG002|Overall Study|Sponsor Decision|9
1026295|NCT01632566|2054094|FG003|Overall Study|Sponsor Decision|2
1026296|NCT01632566|2054095|FG004|Overall Study|Sponsor Decision|2
1026297|NCT01632579|2054111|FG000|Washout Period|Adverse Event|1
1026298|NCT01632579|2054112|FG001|Washout Period|Adverse Event|0
1026299|NCT01632579|2054113|FG002|Washout Period|Adverse Event|0
1026300|NCT01632579|2054114|FG003|Washout Period|Adverse Event|0
1026301|NCT01632579|2054115|FG004|Washout Period|Adverse Event|0
1026302|NCT01632579|2054116|FG005|Washout Period|Adverse Event|0
1026303|NCT01632579|2054117|FG006|Washout Period|Adverse Event|0
1026304|NCT01632579|2054118|FG007|Washout Period|Adverse Event|0
1026305|NCT01632579|2054119|FG008|Washout Period|Adverse Event|0
1026306|NCT01632579|2054111|FG000|Period 2 (Second Intervention)|Adverse Event|1
1026307|NCT01632579|2054112|FG001|Period 2 (Second Intervention)|Adverse Event|0
1026308|NCT01632579|2054113|FG002|Period 2 (Second Intervention)|Adverse Event|0
1026309|NCT01632579|2054114|FG003|Period 2 (Second Intervention)|Adverse Event|0
1026310|NCT01632579|2054115|FG004|Period 2 (Second Intervention)|Adverse Event|0
1026311|NCT01632579|2054116|FG005|Period 2 (Second Intervention)|Adverse Event|0
1026312|NCT01632579|2054117|FG006|Period 2 (Second Intervention)|Adverse Event|0
1026313|NCT01632579|2054118|FG007|Period 2 (Second Intervention)|Adverse Event|0
1026314|NCT01632579|2054119|FG008|Period 2 (Second Intervention)|Adverse Event|0
1026315|NCT01632800|2054176|FG000|Overall Study|Subject did not fit in apparatus|1
1026316|NCT01632878|2054182|FG000|Screening|Physician Decision|268
1026317|NCT01632878|2054182|FG000|Treatment|Lost to Follow-up|41
1026318|NCT01632878|2054182|FG000|Treatment|Withdrawal by Subject|36
1026319|NCT01632878|2054182|FG000|Treatment|Physician Decision|34
1026320|NCT01632878|2054182|FG000|Treatment|missing information|4
1026321|NCT01632878|2054182|FG000|Treatment|no information on study completion|43
1026322|NCT01632891|2054188|FG000|Overall Study|Lost to Follow-up|0
1026323|NCT01632891|2054189|FG001|Overall Study|Lost to Follow-up|1
1026324|NCT01632891|2054188|FG000|Overall Study|Withdrawal by Subject|1
1026325|NCT01632891|2054189|FG001|Overall Study|Withdrawal by Subject|0
1026326|NCT01632904|2054201|FG000|Overall Study|Adverse Event|4
1026327|NCT01632904|2054202|FG001|Overall Study|Adverse Event|1
1026328|NCT01632904|2054201|FG000|Overall Study|Physician Decision|0
1026329|NCT01632904|2054202|FG001|Overall Study|Physician Decision|1
1026330|NCT01632904|2054201|FG000|Overall Study|Subject decision|3
1026331|NCT01632904|2054202|FG001|Overall Study|Subject decision|2
1026332|NCT01632904|2054201|FG000|Overall Study|Disease Progression|0
1026333|NCT01632904|2054202|FG001|Overall Study|Disease Progression|1
1026334|NCT01632904|2054201|FG000|Overall Study|Reason for discontinuation not available|0
1026335|NCT01632904|2054202|FG001|Overall Study|Reason for discontinuation not available|1
1026336|NCT01633060|2054216|FG000|Randomization Phase|Protocol deviation|1
1026337|NCT01633060|2054217|FG001|Randomization Phase|Protocol deviation|2
1026338|NCT01633060|2054216|FG000|Randomization Phase|Technical problem|0
1026339|NCT01633060|2054217|FG001|Randomization Phase|Technical problem|1
1026340|NCT01633060|2054216|FG000|Treatment Phase|Adverse Event|24
1026341|NCT01633060|2054217|FG001|Treatment Phase|Adverse Event|3
1026342|NCT01633060|2054216|FG000|Treatment Phase|Lost to Follow-up|1
1026343|NCT01633060|2054217|FG001|Treatment Phase|Lost to Follow-up|0
1026344|NCT01633060|2054216|FG000|Treatment Phase|Physician Decision|16
1026345|NCT01633060|2054217|FG001|Treatment Phase|Physician Decision|7
1026346|NCT01633060|2054216|FG000|Treatment Phase|Progressive Disease|210
1026347|NCT01633060|2054217|FG001|Treatment Phase|Progressive Disease|120
1026348|NCT01633060|2054216|FG000|Treatment Phase|Protocol Deviation|1
1026349|NCT01633060|2054217|FG001|Treatment Phase|Protocol Deviation|0
1026350|NCT01633060|2054216|FG000|Treatment Phase|Study Terminated by sponsor|7
1026351|NCT01633060|2054217|FG001|Treatment Phase|Study Terminated by sponsor|3
1026352|NCT01633060|2054216|FG000|Treatment Phase|Subject/guardian decision|25
1026353|NCT01633060|2054217|FG001|Treatment Phase|Subject/guardian decision|4
1026354|NCT01633060|2054216|FG000|Treatment Phase|Death|4
1026355|NCT01633060|2054217|FG001|Treatment Phase|Death|3
1026356|NCT01633060|2054216|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
1026357|NCT01633060|2054217|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
1026358|NCT01633060|2054216|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
1026359|NCT01633060|2054217|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
1026360|NCT01633060|2054216|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
1026361|NCT01633060|2054217|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
1026362|NCT01633060|2054216|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
1026363|NCT01633060|2054217|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
1026364|NCT01633060|2054216|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
1026365|NCT01633060|2054217|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
1026366|NCT01633060|2054216|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1
1026367|NCT01633060|2054217|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0
1026368|NCT01633112|2054227|FG000|Overall Study|Lack of Efficacy|1
1026369|NCT01633112|2054228|FG001|Overall Study|Lack of Efficacy|6
1026370|NCT01633112|2054229|FG002|Overall Study|Lack of Efficacy|13
1026371|NCT01633112|2054227|FG000|Overall Study|Abnormal laboratory value(s)|3
1026372|NCT01633112|2054228|FG001|Overall Study|Abnormal laboratory value(s)|1
1026373|NCT01633112|2054229|FG002|Overall Study|Abnormal laboratory value(s)|0
1026374|NCT01633112|2054227|FG000|Overall Study|Abnormal test procedure result(s)|0
1162017|NCT03380429|2283930|FG003|Overall Study|Protocol Violation|0
1026375|NCT01633112|2054228|FG001|Overall Study|Abnormal test procedure result(s)|1
1026376|NCT01633112|2054229|FG002|Overall Study|Abnormal test procedure result(s)|0
1026377|NCT01633112|2054227|FG000|Overall Study|Administrative problems|1
1026378|NCT01633112|2054228|FG001|Overall Study|Administrative problems|2
1026379|NCT01633112|2054229|FG002|Overall Study|Administrative problems|5
1026380|NCT01633112|2054227|FG000|Overall Study|Adverse Event|16
1026381|NCT01633112|2054228|FG001|Overall Study|Adverse Event|18
1026382|NCT01633112|2054229|FG002|Overall Study|Adverse Event|20
1026383|NCT01633112|2054227|FG000|Overall Study|Lost to Follow-up|7
1026384|NCT01633112|2054228|FG001|Overall Study|Lost to Follow-up|19
1026385|NCT01633112|2054229|FG002|Overall Study|Lost to Follow-up|6
1026386|NCT01633112|2054227|FG000|Overall Study|Protocol Violation|4
1026387|NCT01633112|2054228|FG001|Overall Study|Protocol Violation|0
1026388|NCT01633112|2054229|FG002|Overall Study|Protocol Violation|2
1026389|NCT01633112|2054227|FG000|Overall Study|Subject no longer requires study drug|0
1026390|NCT01633112|2054228|FG001|Overall Study|Subject no longer requires study drug|0
1026391|NCT01633112|2054229|FG002|Overall Study|Subject no longer requires study drug|1
1026392|NCT01633112|2054227|FG000|Overall Study|Withdrawal by Subject|20
1026393|NCT01633112|2054228|FG001|Overall Study|Withdrawal by Subject|12
1026394|NCT01633112|2054229|FG002|Overall Study|Withdrawal by Subject|41
1026395|NCT01633112|2054227|FG000|Overall Study|missing Study Completion CRF|1
1026396|NCT01633112|2054228|FG001|Overall Study|missing Study Completion CRF|1
1026397|NCT01633112|2054229|FG002|Overall Study|missing Study Completion CRF|4
1026398|NCT01633788|2054260|FG000|Overall Study|Adverse Event|1
1026399|NCT01633788|2054261|FG001|Overall Study|Adverse Event|3
1026400|NCT01633788|2054262|FG002|Overall Study|Adverse Event|3
1026401|NCT01633788|2054263|FG003|Overall Study|Adverse Event|3
1026402|NCT01633788|2054260|FG000|Overall Study|Lost to Follow-up|2
1026403|NCT01633788|2054261|FG001|Overall Study|Lost to Follow-up|2
1026404|NCT01633788|2054262|FG002|Overall Study|Lost to Follow-up|2
1026405|NCT01633788|2054263|FG003|Overall Study|Lost to Follow-up|0
1026406|NCT01633788|2054260|FG000|Overall Study|Personal Reasons|3
1026407|NCT01633788|2054261|FG001|Overall Study|Personal Reasons|1
1026408|NCT01633788|2054262|FG002|Overall Study|Personal Reasons|1
1026409|NCT01633788|2054263|FG003|Overall Study|Personal Reasons|3
1026410|NCT01633788|2054260|FG000|Overall Study|Protocol Violation|1
1026411|NCT01633788|2054261|FG001|Overall Study|Protocol Violation|0
1026412|NCT01633788|2054262|FG002|Overall Study|Protocol Violation|1
1026413|NCT01633788|2054263|FG003|Overall Study|Protocol Violation|0
1026414|NCT01633788|2054260|FG000|Overall Study|Other Reasons|0
1026415|NCT01633788|2054261|FG001|Overall Study|Other Reasons|2
1026416|NCT01633788|2054262|FG002|Overall Study|Other Reasons|3
1026417|NCT01633788|2054263|FG003|Overall Study|Other Reasons|7
1026418|NCT01633944|2054303|FG000|Open-label Titration Phase|Adverse Event|109
1026419|NCT01633944|2054304|FG001|Open-label Titration Phase|Adverse Event|0
1026420|NCT01633944|2054305|FG002|Open-label Titration Phase|Adverse Event|0
1026421|NCT01633944|2054303|FG000|Open-label Titration Phase|Lack of Efficacy|33
1026422|NCT01633944|2054304|FG001|Open-label Titration Phase|Lack of Efficacy|0
1026423|NCT01633944|2054305|FG002|Open-label Titration Phase|Lack of Efficacy|0
1026424|NCT01633944|2054303|FG000|Open-label Titration Phase|Withdrawal by Subject|34
1026425|NCT01633944|2054304|FG001|Open-label Titration Phase|Withdrawal by Subject|0
1026426|NCT01633944|2054305|FG002|Open-label Titration Phase|Withdrawal by Subject|0
1026427|NCT01633944|2054303|FG000|Open-label Titration Phase|Protocol Violation|24
1026428|NCT01633944|2054304|FG001|Open-label Titration Phase|Protocol Violation|0
1026429|NCT01633944|2054305|FG002|Open-label Titration Phase|Protocol Violation|0
1026430|NCT01633944|2054303|FG000|Open-label Titration Phase|Lost to Follow-up|22
1026431|NCT01633944|2054304|FG001|Open-label Titration Phase|Lost to Follow-up|0
1026432|NCT01633944|2054305|FG002|Open-label Titration Phase|Lost to Follow-up|0
1026433|NCT01633944|2054303|FG000|Open-label Titration Phase|Other|68
1026434|NCT01633944|2054304|FG001|Open-label Titration Phase|Other|0
1026435|NCT01633944|2054305|FG002|Open-label Titration Phase|Other|0
1026436|NCT01633944|2054303|FG000|Double-blind Treatment Phase|Adverse Event|0
1026437|NCT01633944|2054304|FG001|Double-blind Treatment Phase|Adverse Event|13
1026438|NCT01633944|2054305|FG002|Double-blind Treatment Phase|Adverse Event|7
1026439|NCT01633944|2054303|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
1026440|NCT01633944|2054304|FG001|Double-blind Treatment Phase|Lack of Efficacy|8
1026441|NCT01633944|2054305|FG002|Double-blind Treatment Phase|Lack of Efficacy|23
1026442|NCT01633944|2054303|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
1026443|NCT01633944|2054304|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
1026444|NCT01633944|2054305|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8
1026445|NCT01633944|2054303|FG000|Double-blind Treatment Phase|Protocol Violation|0
1026446|NCT01633944|2054304|FG001|Double-blind Treatment Phase|Protocol Violation|7
1026447|NCT01633944|2054305|FG002|Double-blind Treatment Phase|Protocol Violation|10
1026448|NCT01633944|2054303|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
1026449|NCT01633944|2054304|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
1026450|NCT01633944|2054305|FG002|Double-blind Treatment Phase|Lost to Follow-up|9
1026451|NCT01633944|2054303|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
1026452|NCT01633944|2054304|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
1026453|NCT01633944|2054305|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
1026454|NCT01633944|2054303|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0
1026455|NCT01633944|2054304|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1
1026456|NCT01633944|2054305|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0
1026457|NCT01633944|2054303|FG000|Double-blind Treatment Phase|Other|0
1026458|NCT01633944|2054304|FG001|Double-blind Treatment Phase|Other|7
1026459|NCT01633944|2054305|FG002|Double-blind Treatment Phase|Other|0
1026460|NCT01634100|2054322|FG000|Overall Study|Withdrawal by Subject|1
1026461|NCT01634100|2054323|FG001|Overall Study|Withdrawal by Subject|0
1026462|NCT01634100|2054324|FG002|Overall Study|Withdrawal by Subject|1
1026463|NCT01634100|2054325|FG003|Overall Study|Withdrawal by Subject|0
1026464|NCT01634100|2054326|FG004|Overall Study|Withdrawal by Subject|0
1026465|NCT01634100|2054327|FG005|Overall Study|Withdrawal by Subject|0
1026466|NCT01634113|2054338|FG000|Overall Study|Not treated|0
1026467|NCT01634113|2054339|FG001|Overall Study|Not treated|0
1026468|NCT01634113|2054340|FG002|Overall Study|Not treated|1
1026469|NCT01634139|2054351|FG000|Overall Study|Non compliant with protocol|1
1026470|NCT01634139|2054352|FG001|Overall Study|Non compliant with protocol|0
1026471|NCT01634139|2054353|FG002|Overall Study|Non compliant with protocol|0
1026472|NCT01634139|2054351|FG000|Overall Study|Consent withdrawn not due to AE|4
1026473|NCT01634139|2054352|FG001|Overall Study|Consent withdrawn not due to AE|3
1026474|NCT01634139|2054353|FG002|Overall Study|Consent withdrawn not due to AE|2
1026475|NCT01634139|2054351|FG000|Overall Study|Other|4
1026476|NCT01634139|2054352|FG001|Overall Study|Other|0
1026477|NCT01634139|2054353|FG002|Overall Study|Other|3
1026478|NCT01634139|2054351|FG000|Overall Study|Lost to Follow-up|0
1026479|NCT01634139|2054352|FG001|Overall Study|Lost to Follow-up|2
1026480|NCT01634139|2054353|FG002|Overall Study|Lost to Follow-up|0
1026481|NCT01634139|2054351|FG000|Overall Study|Not treated|1
1026482|NCT01634139|2054352|FG001|Overall Study|Not treated|1
1026483|NCT01634139|2054353|FG002|Overall Study|Not treated|0
1026484|NCT01634152|2054364|FG000|Overall Study|Adverse Event|2
1026485|NCT01634152|2054365|FG001|Overall Study|Adverse Event|0
1026486|NCT01634152|2054366|FG002|Overall Study|Adverse Event|2
1026487|NCT01634152|2054364|FG000|Overall Study|Consent withdrawn not due to AE|1
1026488|NCT01634152|2054365|FG001|Overall Study|Consent withdrawn not due to AE|0
1026489|NCT01634152|2054366|FG002|Overall Study|Consent withdrawn not due to AE|1
1026490|NCT01634152|2054364|FG000|Overall Study|Not treated|0
1026491|NCT01634152|2054365|FG001|Overall Study|Not treated|1
1026492|NCT01634152|2054366|FG002|Overall Study|Not treated|0
1026493|NCT01634152|2054364|FG000|Overall Study|Other reason not defined above|1
1026494|NCT01634152|2054365|FG001|Overall Study|Other reason not defined above|0
1026495|NCT01634152|2054366|FG002|Overall Study|Other reason not defined above|1
1026496|NCT01634165|2054374|FG000|Period 2|Adverse Event|0
1026497|NCT01634165|2054375|FG001|Period 2|Adverse Event|1
1026498|NCT01634165|2054376|FG002|Period 2|Adverse Event|0
1026499|NCT01634165|2054377|FG003|Period 2|Adverse Event|0
1026500|NCT01634178|2054387|FG000|Treatment Period 1|Adverse Event|0
1026501|NCT01634178|2054388|FG001|Treatment Period 1|Adverse Event|1
1026502|NCT01634178|2054387|FG000|Treatment Period 2|Adverse Event|1
1026503|NCT01634178|2054388|FG001|Treatment Period 2|Adverse Event|0
1026504|NCT01634243|2054419|FG000|Overall Study|Adverse Event|5
1026505|NCT01634243|2054420|FG001|Overall Study|Adverse Event|5
1026506|NCT01634243|2054419|FG000|Overall Study|Lack of Efficacy|1
1026507|NCT01634243|2054420|FG001|Overall Study|Lack of Efficacy|0
1026508|NCT01634360|2054447|FG000|Overall Study|Adverse Event|10
1026509|NCT01634360|2054448|FG001|Overall Study|Adverse Event|34
1026510|NCT01634360|2054447|FG000|Overall Study|subject withdrew consent|13
1026511|NCT01634360|2054448|FG001|Overall Study|subject withdrew consent|23
1026512|NCT01634360|2054447|FG000|Overall Study|Protocol Violation|1
1026513|NCT01634360|2054448|FG001|Overall Study|Protocol Violation|1
1026514|NCT01634360|2054447|FG000|Overall Study|Lack of Efficacy|4
1026515|NCT01634360|2054448|FG001|Overall Study|Lack of Efficacy|14
1026516|NCT01634360|2054447|FG000|Overall Study|Other|3
1026517|NCT01634360|2054448|FG001|Overall Study|Other|20
1026518|NCT01634360|2054447|FG000|Overall Study|Study termination by sponsor|18
1026519|NCT01634360|2054448|FG001|Overall Study|Study termination by sponsor|44
1026520|NCT01634555|2054454|FG000|Overall Study|Adverse Event|3
1026521|NCT01634555|2054454|FG000|Overall Study|Physician Decision|1
1026522|NCT01634659|2054470|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2
1026523|NCT01634659|2054471|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0
1026524|NCT01634659|2054470|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1
1026525|NCT01634659|2054471|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0
1026526|NCT01634854|2054479|FG000|Overall Study|Cesarean delivery|2
1026527|NCT01634854|2054480|FG001|Overall Study|Cesarean delivery|7
1026528|NCT01635153|2054517|FG000|Overall Study|Lost to Follow-up|40
1026529|NCT01635153|2054518|FG001|Overall Study|Lost to Follow-up|43
1026530|NCT01635218|2054527|FG000|Overall Study|Lost to Follow-up|3
1026531|NCT01635218|2054528|FG001|Overall Study|Lost to Follow-up|7
1026532|NCT01635218|2054529|FG002|Overall Study|Lost to Follow-up|6
1026533|NCT01635283|2054550|FG000|Overall Study|Tumor Progression|3
1026534|NCT01635283|2054550|FG000|Overall Study|Lost to Follow-up|1
1026535|NCT01635764|2054575|FG000|Overall Study|Adverse Event|46
1026536|NCT01635764|2054575|FG000|Overall Study|Lack of Efficacy|76
1026537|NCT01635764|2054575|FG000|Overall Study|Exceed Protocol-specified Interventions|2
1026538|NCT01635764|2054575|FG000|Overall Study|Protocol Deviation|1
1026539|NCT01635764|2054575|FG000|Overall Study|Withdrew Consent|67
1026540|NCT01635764|2054575|FG000|Overall Study|Lost to Follow-up|53
1026541|NCT01635764|2054575|FG000|Overall Study|Other|28
1026542|NCT01635855|2054586|FG000|Overall Study|Withdrawal by Subject|4
1026543|NCT01635920|2054596|FG000|Overall Study|Adverse Event|1
1026544|NCT01635920|2054597|FG001|Overall Study|Adverse Event|0
1026545|NCT01635920|2054596|FG000|Overall Study|Lost to Follow-up|0
1026546|NCT01635920|2054597|FG001|Overall Study|Lost to Follow-up|1
1026547|NCT01635920|2054596|FG000|Overall Study|Subject decision|2
1026548|NCT01635920|2054597|FG001|Overall Study|Subject decision|0
1026549|NCT01635933|2054606|FG000|Overall Study|Adverse Event|1
1026550|NCT01635933|2054607|FG001|Overall Study|Adverse Event|0
1026551|NCT01635933|2054606|FG000|Overall Study|Lost to Follow-up|0
1026552|NCT01635933|2054607|FG001|Overall Study|Lost to Follow-up|5
1026553|NCT01635933|2054606|FG000|Overall Study|Subject decision|1
1026554|NCT01635933|2054607|FG001|Overall Study|Subject decision|1
1026555|NCT01635933|2054606|FG000|Overall Study|Noncompliance|0
1026556|NCT01635933|2054607|FG001|Overall Study|Noncompliance|1
1026557|NCT01635933|2054606|FG000|Overall Study|No longer had transportation|0
1026558|NCT01635933|2054607|FG001|Overall Study|No longer had transportation|1
1026559|NCT01635998|2054615|FG000|Overall Study|Death|1
1026560|NCT01635998|2054616|FG001|Overall Study|Death|1
1026561|NCT01635998|2054615|FG000|Overall Study|Lost to Follow-up|2
1026562|NCT01635998|2054616|FG001|Overall Study|Lost to Follow-up|1
1026563|NCT01635998|2054615|FG000|Overall Study|Withdrawal by Subject|1
1026564|NCT01635998|2054616|FG001|Overall Study|Withdrawal by Subject|5
1026565|NCT01636076|2054633|FG000|Overall Study|Terminated by sponsor|1
1026566|NCT01636076|2054634|FG001|Overall Study|Terminated by sponsor|1
1026567|NCT01636076|2054633|FG000|Overall Study|Lack of Efficacy|0
1026568|NCT01636076|2054634|FG001|Overall Study|Lack of Efficacy|1
1026569|NCT01636076|2054633|FG000|Overall Study|Lost to Follow-up|1
1026570|NCT01636076|2054634|FG001|Overall Study|Lost to Follow-up|0
1026571|NCT01636076|2054633|FG000|Overall Study|Physician Decision|1
1026572|NCT01636076|2054634|FG001|Overall Study|Physician Decision|1
1026573|NCT01636076|2054633|FG000|Overall Study|Non-compliance with study treatment|1
1026574|NCT01636076|2054634|FG001|Overall Study|Non-compliance with study treatment|1
1026575|NCT01636076|2054633|FG000|Overall Study|Adverse Event|6
1026576|NCT01636076|2054634|FG001|Overall Study|Adverse Event|11
1026577|NCT01636076|2054633|FG000|Overall Study|Withdrawal by Subject|7
1026578|NCT01636076|2054634|FG001|Overall Study|Withdrawal by Subject|10
1026579|NCT01636258|2054668|FG000|Overall Study|Lost to Follow-up|1
1026580|NCT01636258|2054669|FG001|Overall Study|Lost to Follow-up|0
1026581|NCT01636362|2054695|FG000|Overall Study|Physician Decision|6
1026582|NCT01636362|2054695|FG000|Overall Study|Subject healed, not returning|1
1026583|NCT01636362|2054695|FG000|Overall Study|Withdrawal by Subject|1
1026584|NCT01636687|2054728|FG000|Induction Period|Withdrawal by Subject|1
1026585|NCT01636687|2054729|FG001|Induction Period|Withdrawal by Subject|0
1026586|NCT01636687|2054730|FG002|Induction Period|Withdrawal by Subject|0
1026587|NCT01636687|2054731|FG003|Induction Period|Withdrawal by Subject|0
1026588|NCT01636687|2054732|FG004|Induction Period|Withdrawal by Subject|0
1026589|NCT01636687|2054728|FG000|Induction Period|Adverse Event|1
1026590|NCT01636687|2054729|FG001|Induction Period|Adverse Event|0
1026591|NCT01636687|2054730|FG002|Induction Period|Adverse Event|0
1026592|NCT01636687|2054731|FG003|Induction Period|Adverse Event|0
1026593|NCT01636687|2054732|FG004|Induction Period|Adverse Event|1
1026594|NCT01636687|2054728|FG000|Induction Period|Lack of Efficacy|0
1026595|NCT01636687|2054729|FG001|Induction Period|Lack of Efficacy|0
1026596|NCT01636687|2054730|FG002|Induction Period|Lack of Efficacy|0
1026597|NCT01636687|2054731|FG003|Induction Period|Lack of Efficacy|0
1026598|NCT01636687|2054732|FG004|Induction Period|Lack of Efficacy|1
1026599|NCT01636687|2054728|FG000|Induction Period|Physician Decision|1
1026600|NCT01636687|2054729|FG001|Induction Period|Physician Decision|0
1026601|NCT01636687|2054730|FG002|Induction Period|Physician Decision|0
1026602|NCT01636687|2054731|FG003|Induction Period|Physician Decision|0
1026603|NCT01636687|2054732|FG004|Induction Period|Physician Decision|0
1026604|NCT01636687|2054728|FG000|Maintenance Period|Withdrawal by Subject|2
1026605|NCT01636687|2054729|FG001|Maintenance Period|Withdrawal by Subject|0
1026606|NCT01636687|2054730|FG002|Maintenance Period|Withdrawal by Subject|2
1026607|NCT01636687|2054731|FG003|Maintenance Period|Withdrawal by Subject|0
1026608|NCT01636687|2054732|FG004|Maintenance Period|Withdrawal by Subject|0
1026609|NCT01636687|2054728|FG000|Maintenance Period|Adverse Event|1
1026610|NCT01636687|2054729|FG001|Maintenance Period|Adverse Event|0
1026611|NCT01636687|2054730|FG002|Maintenance Period|Adverse Event|0
1026612|NCT01636687|2054731|FG003|Maintenance Period|Adverse Event|0
1026613|NCT01636687|2054732|FG004|Maintenance Period|Adverse Event|0
1026614|NCT01636687|2054728|FG000|Maintenance Period|Lack of Efficacy|4
1026615|NCT01636687|2054729|FG001|Maintenance Period|Lack of Efficacy|1
1026616|NCT01636687|2054730|FG002|Maintenance Period|Lack of Efficacy|0
1026617|NCT01636687|2054731|FG003|Maintenance Period|Lack of Efficacy|0
1026618|NCT01636687|2054732|FG004|Maintenance Period|Lack of Efficacy|0
1026619|NCT01636687|2054728|FG000|Maintenance Period|Lost to Follow-up|1
1026620|NCT01636687|2054729|FG001|Maintenance Period|Lost to Follow-up|1
1026621|NCT01636687|2054730|FG002|Maintenance Period|Lost to Follow-up|0
1026622|NCT01636687|2054731|FG003|Maintenance Period|Lost to Follow-up|0
1026623|NCT01636687|2054732|FG004|Maintenance Period|Lost to Follow-up|1
1026624|NCT01636687|2054728|FG000|Maintenance Period|Physician Decision|0
1026625|NCT01636687|2054729|FG001|Maintenance Period|Physician Decision|0
1026626|NCT01636687|2054730|FG002|Maintenance Period|Physician Decision|0
1026627|NCT01636687|2054731|FG003|Maintenance Period|Physician Decision|0
1026628|NCT01636687|2054732|FG004|Maintenance Period|Physician Decision|1
1026629|NCT01636687|2054728|FG000|Extension Period|technical problems|0
1026630|NCT01636687|2054729|FG001|Extension Period|technical problems|1
1026631|NCT01636687|2054730|FG002|Extension Period|technical problems|2
1026632|NCT01636687|2054731|FG003|Extension Period|technical problems|1
1026633|NCT01636687|2054732|FG004|Extension Period|technical problems|0
1026634|NCT01636687|2054728|FG000|Extension Period|Adverse Event|4
1026635|NCT01636687|2054729|FG001|Extension Period|Adverse Event|3
1026636|NCT01636687|2054730|FG002|Extension Period|Adverse Event|2
1026637|NCT01636687|2054731|FG003|Extension Period|Adverse Event|1
1026638|NCT01636687|2054732|FG004|Extension Period|Adverse Event|0
1026639|NCT01636687|2054728|FG000|Extension Period|Lack of Efficacy|7
1026640|NCT01636687|2054729|FG001|Extension Period|Lack of Efficacy|0
1026641|NCT01636687|2054730|FG002|Extension Period|Lack of Efficacy|2
1026642|NCT01636687|2054731|FG003|Extension Period|Lack of Efficacy|1
1026643|NCT01636687|2054732|FG004|Extension Period|Lack of Efficacy|0
1026644|NCT01636687|2054728|FG000|Extension Period|Lost to Follow-up|1
1026645|NCT01636687|2054729|FG001|Extension Period|Lost to Follow-up|0
1026646|NCT01636687|2054730|FG002|Extension Period|Lost to Follow-up|1
1026647|NCT01636687|2054731|FG003|Extension Period|Lost to Follow-up|0
1026648|NCT01636687|2054732|FG004|Extension Period|Lost to Follow-up|0
1026649|NCT01636687|2054728|FG000|Extension Period|Physician Decision|1
1026650|NCT01636687|2054729|FG001|Extension Period|Physician Decision|0
1026651|NCT01636687|2054730|FG002|Extension Period|Physician Decision|0
1026652|NCT01636687|2054731|FG003|Extension Period|Physician Decision|1
1026653|NCT01636687|2054732|FG004|Extension Period|Physician Decision|0
1026654|NCT01636687|2054728|FG000|Extension Period|study terminated by sponsor|33
1026655|NCT01636687|2054729|FG001|Extension Period|study terminated by sponsor|50
1026656|NCT01636687|2054730|FG002|Extension Period|study terminated by sponsor|17
1026657|NCT01636687|2054731|FG003|Extension Period|study terminated by sponsor|23
1026658|NCT01636687|2054732|FG004|Extension Period|study terminated by sponsor|0
1026659|NCT01636687|2054728|FG000|Extension Period|Withdrawal by Subject|1
1026660|NCT01636687|2054729|FG001|Extension Period|Withdrawal by Subject|0
1026661|NCT01636687|2054730|FG002|Extension Period|Withdrawal by Subject|1
1026662|NCT01636687|2054731|FG003|Extension Period|Withdrawal by Subject|1
1026663|NCT01636687|2054732|FG004|Extension Period|Withdrawal by Subject|0
1026664|NCT01636687|2054728|FG000|Follow-up Period|Withdrawal by Subject|1
1026665|NCT01636687|2054729|FG001|Follow-up Period|Withdrawal by Subject|0
1026666|NCT01636687|2054730|FG002|Follow-up Period|Withdrawal by Subject|0
1026667|NCT01636687|2054731|FG003|Follow-up Period|Withdrawal by Subject|0
1026668|NCT01636687|2054732|FG004|Follow-up Period|Withdrawal by Subject|1
1026669|NCT01636713|2054753|FG000|Overall Study|Adverse Event|16
1026670|NCT01636713|2054754|FG001|Overall Study|Adverse Event|16
1026671|NCT01636713|2054755|FG002|Overall Study|Adverse Event|7
1026672|NCT01636713|2054753|FG000|Overall Study|Lack of Efficacy|6
1026673|NCT01636713|2054754|FG001|Overall Study|Lack of Efficacy|6
1026674|NCT01636713|2054755|FG002|Overall Study|Lack of Efficacy|2
1026675|NCT01636713|2054753|FG000|Overall Study|Protocol Violation|3
1026676|NCT01636713|2054754|FG001|Overall Study|Protocol Violation|0
1026677|NCT01636713|2054755|FG002|Overall Study|Protocol Violation|1
1026678|NCT01636713|2054753|FG000|Overall Study|Lost to Follow-up|0
1026679|NCT01636713|2054754|FG001|Overall Study|Lost to Follow-up|0
1026680|NCT01636713|2054755|FG002|Overall Study|Lost to Follow-up|1
1026681|NCT01636713|2054753|FG000|Overall Study|Withdrawal by Subject|5
1026682|NCT01636713|2054754|FG001|Overall Study|Withdrawal by Subject|4
1026683|NCT01636713|2054755|FG002|Overall Study|Withdrawal by Subject|8
1026684|NCT01636713|2054753|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2
1026685|NCT01636713|2054754|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2
1026686|NCT01636713|2054755|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4
1026687|NCT01636778|2054767|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
1026688|NCT01636778|2054768|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
1026689|NCT01636778|2054769|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
1026690|NCT01636778|2054767|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
1026691|NCT01636778|2054768|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
1026692|NCT01636778|2054769|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
1026693|NCT01636778|2054767|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0
1026694|NCT01636778|2054768|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7
1026695|NCT01636778|2054769|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0
1026696|NCT01636778|2054767|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0
1026697|NCT01636778|2054768|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1
1026698|NCT01636778|2054769|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0
1026699|NCT01636778|2054767|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0
1026700|NCT01636778|2054768|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2
1026701|NCT01636778|2054769|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0
1026702|NCT01636778|2054767|FG000|Follow-up Period After Part 2|Other|0
1026703|NCT01636778|2054768|FG001|Follow-up Period After Part 2|Other|0
1026704|NCT01636778|2054769|FG002|Follow-up Period After Part 2|Other|1
1026705|NCT01636778|2054767|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
1026706|NCT01636778|2054768|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
1026707|NCT01636778|2054769|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
1026708|NCT01636778|2054767|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0
1026709|NCT01636778|2054768|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0
1026710|NCT01636778|2054769|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2
1026711|NCT01636934|2054783|FG000|Overall Study|Withdrawal by Subject|3
1026712|NCT01636934|2054784|FG001|Overall Study|Withdrawal by Subject|2
1026713|NCT01636934|2054783|FG000|Overall Study|Chemo cancel|1
1026714|NCT01636934|2054784|FG001|Overall Study|Chemo cancel|0
1026715|NCT01636934|2054783|FG000|Overall Study|Too ill to continue|1
1026716|NCT01636934|2054784|FG001|Overall Study|Too ill to continue|0
1026717|NCT01636934|2054783|FG000|Overall Study|Never started study medication|1
1026718|NCT01636934|2054784|FG001|Overall Study|Never started study medication|1
1026719|NCT01636947|2054792|FG000|Overall Study|Not Treated|2
1026720|NCT01636947|2054793|FG001|Overall Study|Not Treated|2
1026721|NCT01636947|2054792|FG000|Overall Study|Lost to Follow-up|4
1026722|NCT01636947|2054793|FG001|Overall Study|Lost to Follow-up|0
1026723|NCT01636947|2054792|FG000|Overall Study|Protocol Violation|1
1026724|NCT01636947|2054793|FG001|Overall Study|Protocol Violation|1
1026725|NCT01636947|2054792|FG000|Overall Study|Withdrawal by Subject|3
1026726|NCT01636947|2054793|FG001|Overall Study|Withdrawal by Subject|3
1026727|NCT01636947|2054792|FG000|Overall Study|Adverse Event|1
1026728|NCT01636947|2054793|FG001|Overall Study|Adverse Event|1
1026729|NCT01636947|2054792|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
1026730|NCT01636947|2054793|FG001|Overall Study|Did Not Meet Eligibility Criteria|4
1026731|NCT01636960|2054799|FG000|Induction Phase|Adverse Event|2
1026732|NCT01636960|2054799|FG000|Maintenance Phase|Continued drug after regulatory approval|3
1026733|NCT01636960|2054799|FG000|Maintenance Phase|Adverse Event|3
1026734|NCT01636960|2054799|FG000|Maintenance Phase|Progressive disease|1
1026735|NCT01636986|2054805|FG000|Overall Study|Withdrawal by Subject|0
1026736|NCT01636986|2054806|FG001|Overall Study|Withdrawal by Subject|1
1026737|NCT01636986|2054805|FG000|Overall Study|Corneal Staining|0
1026738|NCT01636986|2054806|FG001|Overall Study|Corneal Staining|1
1026739|NCT01637077|2054814|FG000|Overall Study|Cancel|1
1026740|NCT01637077|2054815|FG001|Overall Study|Cancel|1
1026741|NCT01637077|2054814|FG000|Overall Study|Withdrawal by Subject|1
1026742|NCT01637077|2054815|FG001|Overall Study|Withdrawal by Subject|0
1026743|NCT01637077|2054814|FG000|Overall Study|No cycle 1 questionnaire data|2
1026744|NCT01637077|2054815|FG001|Overall Study|No cycle 1 questionnaire data|0
1026745|NCT01637142|2054825|FG000|Washout Period (at Least 3 Days)|Physician Decision|1
1026746|NCT01637272|2054835|FG000|Overall Study|Adverse Event|6
1026747|NCT01637272|2054835|FG000|Overall Study|Unsatisfactory therapeutic effect|2
1026748|NCT01637272|2054835|FG000|Overall Study|Withdrawal by Subject|3
1026749|NCT01637272|2054835|FG000|Overall Study|Lost to Follow-up|2
1026750|NCT01637272|2054835|FG000|Overall Study|completed core, did not enter ext. phase|4
1026751|NCT01637272|2054835|FG000|Overall Study|Administrative problems|1
1026752|NCT01637272|2054835|FG000|Overall Study|Protocol Violation|2
1026753|NCT01637402|2054854|FG000|Standard Dose Regimen|Lack of Efficacy|2
1026754|NCT01637402|2054855|FG001|Standard Dose Regimen|Lack of Efficacy|0
1026755|NCT01637402|2054854|FG000|Standard Dose Regimen|Adverse Event|1
1026756|NCT01637402|2054855|FG001|Standard Dose Regimen|Adverse Event|0
1026757|NCT01637402|2054854|FG000|Week 12 Evaluation|Lack of Efficacy|6
1026758|NCT01637402|2054855|FG001|Week 12 Evaluation|Lack of Efficacy|0
1026759|NCT01637402|2054854|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0
1026760|NCT01637402|2054855|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4
1026761|NCT01637402|2054854|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4
1026762|NCT01637402|2054855|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
1026763|NCT01637402|2054854|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5
1026764|NCT01637402|2054855|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0
1026765|NCT01637584|2054882|FG000|Overall Study|Withdrawal by Subject|1
1026766|NCT01637584|2054883|FG001|Overall Study|Withdrawal by Subject|3
1026767|NCT01637623|2054893|FG000|Overall Study|Lost to Follow-up|0
1026768|NCT01637623|2054894|FG001|Overall Study|Lost to Follow-up|0
1026769|NCT01637623|2054895|FG002|Overall Study|Lost to Follow-up|2
1026770|NCT01637623|2054893|FG000|Overall Study|Physician Decision|1
1026771|NCT01637623|2054894|FG001|Overall Study|Physician Decision|0
1026772|NCT01637623|2054895|FG002|Overall Study|Physician Decision|1
1026773|NCT01637922|2054909|FG000|Overall Study|Adverse Event|0
1026774|NCT01637922|2054910|FG001|Overall Study|Adverse Event|1
1026775|NCT01637922|2054909|FG000|Overall Study|Protocol Violation|0
1026776|NCT01637922|2054910|FG001|Overall Study|Protocol Violation|1
1026777|NCT01637922|2054909|FG000|Overall Study|Withdrawal by Subject|0
1026778|NCT01637922|2054910|FG001|Overall Study|Withdrawal by Subject|3
1026779|NCT01637922|2054909|FG000|Overall Study|Lost to Follow-up|2
1026780|NCT01637922|2054910|FG001|Overall Study|Lost to Follow-up|0
1026781|NCT01637961|2054926|FG000|Overall Study|Ineligible: wrong primary|1
1026782|NCT01637961|2054926|FG000|Overall Study|Ineligible: inadequate pathology|1
1026783|NCT01638000|2054938|FG000|Overall Study|Randomized but Never Received Drug|7
1026784|NCT01638000|2054939|FG001|Overall Study|Randomized but Never Received Drug|10
1026785|NCT01638000|2054938|FG000|Overall Study|Adverse Event|14
1026786|NCT01638000|2054939|FG001|Overall Study|Adverse Event|16
1026787|NCT01638000|2054938|FG000|Overall Study|Lack of Efficacy|5
1026788|NCT01638000|2054939|FG001|Overall Study|Lack of Efficacy|6
1026789|NCT01638000|2054938|FG000|Overall Study|Protocol Violation|11
1026790|NCT01638000|2054939|FG001|Overall Study|Protocol Violation|13
1026791|NCT01638000|2054938|FG000|Overall Study|Withdrawal by Subject|21
1026792|NCT01638000|2054939|FG001|Overall Study|Withdrawal by Subject|24
1026793|NCT01638000|2054938|FG000|Overall Study|Miscellaneous|2
1026794|NCT01638000|2054939|FG001|Overall Study|Miscellaneous|2
1026795|NCT01638013|2054948|FG000|Overall Study|Adverse Event|36
1026796|NCT01638013|2054949|FG001|Overall Study|Adverse Event|29
1026797|NCT01638013|2054950|FG002|Overall Study|Adverse Event|48
1026798|NCT01638013|2054948|FG000|Overall Study|Lack of Efficacy|39
1026799|NCT01638013|2054949|FG001|Overall Study|Lack of Efficacy|11
1026800|NCT01638013|2054950|FG002|Overall Study|Lack of Efficacy|14
1026801|NCT01638013|2054948|FG000|Overall Study|Protocol Violation|10
1026802|NCT01638013|2054949|FG001|Overall Study|Protocol Violation|7
1026803|NCT01638013|2054950|FG002|Overall Study|Protocol Violation|11
1026804|NCT01638013|2054948|FG000|Overall Study|Met discontinuation criteria|4
1026805|NCT01638013|2054949|FG001|Overall Study|Met discontinuation criteria|0
1026806|NCT01638013|2054950|FG002|Overall Study|Met discontinuation criteria|7
1026807|NCT01638013|2054948|FG000|Overall Study|Subject Lost to Follow up|1
1026808|NCT01638013|2054949|FG001|Overall Study|Subject Lost to Follow up|0
1026809|NCT01638013|2054950|FG002|Overall Study|Subject Lost to Follow up|1
1026810|NCT01638013|2054948|FG000|Overall Study|Miscellaneous|25
1026811|NCT01638013|2054949|FG001|Overall Study|Miscellaneous|19
1026812|NCT01638013|2054950|FG002|Overall Study|Miscellaneous|23
1026813|NCT01638013|2054948|FG000|Overall Study|Withdrawal of Consent|16
1026814|NCT01638013|2054949|FG001|Overall Study|Withdrawal of Consent|12
1026815|NCT01638013|2054950|FG002|Overall Study|Withdrawal of Consent|16
1026816|NCT01638013|2054948|FG000|Overall Study|Not met inclusion or exclusion criteria|0
1026817|NCT01638013|2054949|FG001|Overall Study|Not met inclusion or exclusion criteria|0
1026818|NCT01638013|2054950|FG002|Overall Study|Not met inclusion or exclusion criteria|1
1026819|NCT01638390|2054980|FG000|Overall Study|screening failures|21
1026820|NCT01638429|2055001|FG000|Overall Study|Withdrawal by Subject|1
1026821|NCT01638546|2055021|FG000|Overall Study|Adverse Event|1
1026822|NCT01638546|2055022|FG001|Overall Study|Adverse Event|3
1026823|NCT01638559|2055030|FG000|Overall Study|Lost to Follow-up|1
1026824|NCT01638559|2055030|FG000|Overall Study|Withdrawal by Subject|1
1026825|NCT01638559|2055030|FG000|Overall Study|Subject declined to travel for biopsy|1
1026826|NCT01638819|2055047|FG000|Overall Study|Lost to Follow-up|1
1026827|NCT01638819|2055048|FG001|Overall Study|Lost to Follow-up|0
1026828|NCT01639001|2055055|FG000|Overall Study|Refused further follow-up|9
1026829|NCT01639001|2055056|FG001|Overall Study|Refused further follow-up|12
1026830|NCT01639001|2055055|FG000|Overall Study|Lost to Follow-up|3
1026831|NCT01639001|2055056|FG001|Overall Study|Lost to Follow-up|0
1026832|NCT01639001|2055055|FG000|Overall Study|Death|62
1026833|NCT01639001|2055056|FG001|Overall Study|Death|61
1026834|NCT01639001|2055055|FG000|Overall Study|Randomized but not treated|0
1026835|NCT01639001|2055056|FG001|Overall Study|Randomized but not treated|2
1026836|NCT01639001|2055055|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1
1026837|NCT01639001|2055056|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2
1026838|NCT01639040|2055066|FG000|Overall Study|Adverse Event|1
1026839|NCT01639040|2055067|FG001|Overall Study|Adverse Event|0
1026840|NCT01639144|2055078|FG000|Overall Study|Withdrawal by Subject|4
1026841|NCT01639144|2055079|FG001|Overall Study|Withdrawal by Subject|2
1026842|NCT01639144|2055078|FG000|Overall Study|Physician Decision|2
1026843|NCT01639144|2055079|FG001|Overall Study|Physician Decision|0
1026844|NCT01639144|2055078|FG000|Overall Study|Met postoperative exclusion criteria|4
1026845|NCT01639144|2055079|FG001|Overall Study|Met postoperative exclusion criteria|3
1026846|NCT01639339|2055100|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26
1026847|NCT01639339|2055101|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19
1026848|NCT01639339|2055100|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11
1026849|NCT01639339|2055101|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5
1026850|NCT01639339|2055100|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5
1026851|NCT01639339|2055101|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4
1026852|NCT01639339|2055100|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0
1026853|NCT01639339|2055101|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2
1026854|NCT01639339|2055100|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2
1026855|NCT01639339|2055101|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1
1026856|NCT01639339|2055100|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10
1026857|NCT01639339|2055101|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7
1026858|NCT01639339|2055100|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0
1026859|NCT01639339|2055101|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2
1026860|NCT01639339|2055100|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0
1026861|NCT01639339|2055101|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1
1162018|NCT03380429|2283931|FG004|Overall Study|Protocol Violation|1
1026862|NCT01639339|2055100|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0
1026863|NCT01639339|2055101|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1
1026864|NCT01639339|2055100|FG000|Open-label Period (Up to Week 28)|Adverse Event|1
1026865|NCT01639339|2055101|FG001|Open-label Period (Up to Week 28)|Adverse Event|4
1026866|NCT01639469|2055126|FG000|Overall Study|Death|4
1026867|NCT01639469|2055127|FG001|Overall Study|Death|2
1026868|NCT01639469|2055126|FG000|Overall Study|Lost to Follow-up|1
1026869|NCT01639469|2055127|FG001|Overall Study|Lost to Follow-up|1
1026870|NCT01639495|2055133|FG000|Overall Study|Lost to Follow-up|6
1026871|NCT01639495|2055133|FG000|Overall Study|Consented but didn't have study catheter|4
1026872|NCT01639495|2055133|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4
1026873|NCT01639495|2055133|FG000|Overall Study|No radiofrequency energy applied|2
1026874|NCT01639560|2055139|FG000|Overall Study|Withdrawal by Subject|9
1026875|NCT01639560|2055140|FG001|Overall Study|Withdrawal by Subject|14
1026876|NCT01639560|2055139|FG000|Overall Study|Lack of Efficacy|1
1026877|NCT01639560|2055140|FG001|Overall Study|Lack of Efficacy|2
1026878|NCT01639560|2055139|FG000|Overall Study|Lost to Follow-up|9
1026879|NCT01639560|2055140|FG001|Overall Study|Lost to Follow-up|11
1026880|NCT01639560|2055139|FG000|Overall Study|Adverse Event|0
1026881|NCT01639560|2055140|FG001|Overall Study|Adverse Event|2
1026882|NCT01639703|2055169|FG000|Overall Study|Withdrawal by Subject|5
1026883|NCT01639703|2055169|FG000|Overall Study|Other reason|7
1026884|NCT01639729|2055185|FG000|Overall Study|Withdrawal by Subject|1
1026885|NCT01639729|2055186|FG001|Overall Study|Withdrawal by Subject|0
1026886|NCT01639729|2055187|FG002|Overall Study|Withdrawal by Subject|1
1026887|NCT01639729|2055188|FG003|Overall Study|Withdrawal by Subject|1
1026888|NCT01639729|2055189|FG004|Overall Study|Withdrawal by Subject|0
1026889|NCT01639729|2055190|FG005|Overall Study|Withdrawal by Subject|0
1026890|NCT01639742|2055200|FG000|Overall Study|Study Ongoing|17
1026891|NCT01639742|2055200|FG000|Overall Study|Lost to Follow-up|1
1026892|NCT01639755|2055204|FG000|Overall Study|Study Ongoing|15
1026893|NCT01639755|2055204|FG000|Overall Study|Patient had device explantation|4
1026894|NCT01639833|2055210|FG000|Overall Study|Death|4
1026895|NCT01639833|2055211|FG001|Overall Study|Death|2
1026896|NCT01639833|2055210|FG000|Overall Study|Withdrawal by Subject|2
1026897|NCT01639833|2055211|FG001|Overall Study|Withdrawal by Subject|2
1026898|NCT01640054|2055226|FG000|Overall Study|Study-specific disc criteria|1
1026899|NCT01640054|2055226|FG000|Overall Study|Lack of Efficacy|3
1026900|NCT01640054|2055226|FG000|Overall Study|Adverse Event|2
1026901|NCT01640184|2055238|FG000|Overall Study|Death|1
1026902|NCT01640184|2055239|FG001|Overall Study|Death|0
1026903|NCT01640184|2055240|FG002|Overall Study|Death|0
1026904|NCT01640184|2055238|FG000|Overall Study|Lost to Follow-up|4
1026905|NCT01640184|2055239|FG001|Overall Study|Lost to Follow-up|1
1026906|NCT01640184|2055240|FG002|Overall Study|Lost to Follow-up|0
1026907|NCT01640184|2055238|FG000|Overall Study|Physician Decision|3
1026908|NCT01640184|2055239|FG001|Overall Study|Physician Decision|0
1026909|NCT01640184|2055240|FG002|Overall Study|Physician Decision|0
1026910|NCT01640184|2055238|FG000|Overall Study|Withdrawal by Subject|0
1026911|NCT01640184|2055239|FG001|Overall Study|Withdrawal by Subject|1
1026912|NCT01640184|2055240|FG002|Overall Study|Withdrawal by Subject|1
1026913|NCT01640184|2055238|FG000|Overall Study|Protocol Violation|0
1026914|NCT01640184|2055239|FG001|Overall Study|Protocol Violation|0
1026915|NCT01640184|2055240|FG002|Overall Study|Protocol Violation|1
1026916|NCT01640249|2055267|FG000|Period 1|Withdrawal by Subject|1
1026917|NCT01640249|2055268|FG001|Period 1|Withdrawal by Subject|0
1026918|NCT01640249|2055269|FG002|Period 1|Withdrawal by Subject|0
1026919|NCT01640249|2055270|FG003|Period 1|Withdrawal by Subject|0
1026920|NCT01640249|2055271|FG004|Period 1|Withdrawal by Subject|0
1026921|NCT01640249|2055272|FG005|Period 1|Withdrawal by Subject|1
1026922|NCT01640249|2055273|FG006|Period 1|Withdrawal by Subject|0
1026923|NCT01640288|2055294|FG000|Overall Study|Equipment Failure or Poor Image Quality|4
1026924|NCT01640288|2055295|FG001|Overall Study|Equipment Failure or Poor Image Quality|5
1026925|NCT01640288|2055294|FG000|Overall Study|Screen Failure|20
1026926|NCT01640288|2055295|FG001|Overall Study|Screen Failure|18
1026927|NCT01640288|2055294|FG000|Overall Study|Withdrawn by PI|5
1026928|NCT01640288|2055295|FG001|Overall Study|Withdrawn by PI|0
1026929|NCT01640288|2055294|FG000|Overall Study|Withdrawal by Subject|1
1026930|NCT01640288|2055295|FG001|Overall Study|Withdrawal by Subject|0
1026931|NCT01640314|2055304|FG000|Overall Study|Protocol Violation|0
1026932|NCT01640314|2055305|FG001|Overall Study|Protocol Violation|1
1026933|NCT01640353|2055329|FG000|Overall Study|Withdrew prior to treatment|10
1026934|NCT01640353|2055329|FG000|Overall Study|Withdrawn from analysis at term site|12
1026935|NCT01640353|2055329|FG000|Overall Study|Withdrawal by Subject|5
1026936|NCT01640353|2055329|FG000|Overall Study|Death|2
1026937|NCT01640353|2055329|FG000|Overall Study|Early site termination|3
1026938|NCT01640353|2055329|FG000|Overall Study|Lost to Follow-up|12
1026939|NCT01640353|2055329|FG000|Overall Study|Physician Decision|1
1026940|NCT01640366|2055333|FG000|Overall Study|Withdrawal by Subject|1
1026941|NCT01640366|2055333|FG000|Overall Study|Protocol Violation|16
1026942|NCT01640366|2055333|FG000|Overall Study|Lost to Follow-up|5
1026943|NCT01640808|2055355|FG000|Overall Study|Unable to continue dynamic CT|14
1026944|NCT01640808|2055356|FG001|Overall Study|Unable to continue dynamic CT|4
1026945|NCT01640808|2055355|FG000|Overall Study|Withdrawal by Subject|12
1026946|NCT01640808|2055356|FG001|Overall Study|Withdrawal by Subject|4
1026947|NCT01640808|2055355|FG000|Overall Study|Lost to Follow-up|4
1026948|NCT01640808|2055356|FG001|Overall Study|Lost to Follow-up|0
1026949|NCT01640808|2055355|FG000|Overall Study|Start an antiviral therapy using IFN|3
1026950|NCT01640808|2055356|FG001|Overall Study|Start an antiviral therapy using IFN|0
1026951|NCT01640808|2055355|FG000|Overall Study|Administration of anticancer drugs|2
1026952|NCT01640808|2055356|FG001|Overall Study|Administration of anticancer drugs|1
1026953|NCT01640808|2055355|FG000|Overall Study|Physician Decision|19
1026954|NCT01640808|2055356|FG001|Overall Study|Physician Decision|5
1026955|NCT01640808|2055355|FG000|Overall Study|Randomized but not treated|4
905030|NCT00760474|1880234|FG000|Period 1 (P1)|Discontinued then re-entered|1
905031|NCT00760474|1880235|FG001|Period 1 (P1)|Discontinued then re-entered|1
905032|NCT00760474|1880234|FG000|Placebo Washout Period|Other|0
905033|NCT00760474|1880235|FG001|Placebo Washout Period|Other|1
905034|NCT00760474|1880234|FG000|Period 2 (P2)|Lost to Follow-up|1
905035|NCT00760474|1880235|FG001|Period 2 (P2)|Lost to Follow-up|0
905036|NCT00760474|1880234|FG000|Period 2 (P2)|Adverse Event|0
905037|NCT00760474|1880235|FG001|Period 2 (P2)|Adverse Event|1
905038|NCT00760487|1880242|FG000|Overall Study|Unilateral implantation|3
905039|NCT00760513|1880248|FG000|Overall Study|Withdrawal by Subject|5
905040|NCT00760513|1880249|FG001|Overall Study|Withdrawal by Subject|7
905041|NCT00760552|1880275|FG000|Overall Study|Death|2
905042|NCT00760552|1880276|FG001|Overall Study|Death|0
905043|NCT00760552|1880275|FG000|Overall Study|Lost to Follow-up|11
905044|NCT00760552|1880276|FG001|Overall Study|Lost to Follow-up|10
905045|NCT00760617|1880307|FG000|Overall Study|Adverse Event|5
905046|NCT00760617|1880308|FG001|Overall Study|Adverse Event|2
905047|NCT00760617|1880309|FG002|Overall Study|Adverse Event|0
1026956|NCT01640808|2055356|FG001|Overall Study|Randomized but not treated|2
1026957|NCT01640873|2055379|FG000|Overall Study|Protocol Violation|2
1026958|NCT01640873|2055380|FG001|Overall Study|Protocol Violation|1
1026959|NCT01640925|2055388|FG000|Overall Study|Withdrawal by Subject|1
1026960|NCT01640925|2055389|FG001|Overall Study|Withdrawal by Subject|0
1026961|NCT01640925|2055388|FG000|Overall Study|Previously enrolled in this trial|13
1026962|NCT01640925|2055389|FG001|Overall Study|Previously enrolled in this trial|11
1026963|NCT01640951|2055403|FG000|Overall Study|Adverse Event|8
1026964|NCT01640951|2055404|FG001|Overall Study|Adverse Event|3
1026965|NCT01640951|2055405|FG002|Overall Study|Adverse Event|10
905048|NCT00760617|1880307|FG000|Overall Study|Lost to Follow-up|0
905049|NCT00760617|1880308|FG001|Overall Study|Lost to Follow-up|0
905050|NCT00760617|1880309|FG002|Overall Study|Lost to Follow-up|5
905051|NCT00760669|1880317|FG000|Overall Study|Not assessed for overall improvement|18
905052|NCT00760669|1880317|FG000|Overall Study|Participants missing efficacy assessment|6
905053|NCT00760669|1880317|FG000|Overall Study|Participants with overlapping cases|1
905054|NCT00760669|1880317|FG000|Overall Study|Took drug before entering in contract|5
905055|NCT00760747|1880323|FG000|Study Period II|Adverse Event|3
905056|NCT00760747|1880324|FG001|Study Period II|Adverse Event|4
905057|NCT00760747|1880323|FG000|Study Period II|Lack of Efficacy|0
905058|NCT00760747|1880324|FG001|Study Period II|Lack of Efficacy|6
905059|NCT00760747|1880323|FG000|Study Period II|Parent/Caregiver Decision|3
905060|NCT00760747|1880324|FG001|Study Period II|Parent/Caregiver Decision|0
905061|NCT00760747|1880323|FG000|Study Period II|Protocol Violation|6
905062|NCT00760747|1880324|FG001|Study Period II|Protocol Violation|3
905063|NCT00760747|1880323|FG000|Study Period II|Withdrawal by Subject|1
905064|NCT00760747|1880324|FG001|Study Period II|Withdrawal by Subject|0
905065|NCT00760747|1880323|FG000|Study Period II|No drug administered|0
905066|NCT00760747|1880324|FG001|Study Period II|No drug administered|1
905067|NCT00760747|1880323|FG000|Study Period III|Adverse Event|1
905068|NCT00760747|1880324|FG001|Study Period III|Adverse Event|0
905069|NCT00760747|1880323|FG000|Study Period III|Lack of Efficacy|1
905070|NCT00760747|1880324|FG001|Study Period III|Lack of Efficacy|0
905071|NCT00760747|1880323|FG000|Study Period III|Parent/Caregiver Decision|0
905072|NCT00760747|1880324|FG001|Study Period III|Parent/Caregiver Decision|1
905073|NCT00760747|1880323|FG000|Study Period III|Protocol Violation|1
905074|NCT00760747|1880324|FG001|Study Period III|Protocol Violation|1
905075|NCT00760747|1880323|FG000|Study Period III|Physician Decision|0
905076|NCT00760747|1880324|FG001|Study Period III|Physician Decision|1
905077|NCT00760838|1880332|FG000|Overall Study|Adverse Event|1
905078|NCT00760838|1880333|FG001|Overall Study|Adverse Event|1
905079|NCT00760838|1880332|FG000|Overall Study|Lack of Efficacy|1
905080|NCT00760838|1880333|FG001|Overall Study|Lack of Efficacy|0
905081|NCT00760838|1880332|FG000|Overall Study|Lost to Follow-up|2
905082|NCT00760838|1880333|FG001|Overall Study|Lost to Follow-up|0
905083|NCT00760838|1880332|FG000|Overall Study|Withdrawal by Subject|1
905084|NCT00760838|1880333|FG001|Overall Study|Withdrawal by Subject|1
905085|NCT00760877|1880341|FG000|Overall Study|Protocol Violation|1
905086|NCT00760877|1880342|FG001|Overall Study|Protocol Violation|0
905087|NCT00760877|1880341|FG000|Overall Study|Non-compliance with protocol treatment|2
905088|NCT00760877|1880342|FG001|Overall Study|Non-compliance with protocol treatment|1
1026966|NCT01640951|2055406|FG003|Overall Study|Adverse Event|6
1026967|NCT01640951|2055407|FG004|Overall Study|Adverse Event|1
1026968|NCT01640951|2055408|FG005|Overall Study|Adverse Event|11
1026969|NCT01640951|2055409|FG006|Overall Study|Adverse Event|1
1026970|NCT01640951|2055410|FG007|Overall Study|Adverse Event|3
1026971|NCT01640951|2055403|FG000|Overall Study|Lack of Efficacy|20
1026972|NCT01640951|2055404|FG001|Overall Study|Lack of Efficacy|1
1026973|NCT01640951|2055405|FG002|Overall Study|Lack of Efficacy|7
1026974|NCT01640951|2055406|FG003|Overall Study|Lack of Efficacy|14
1026975|NCT01640951|2055407|FG004|Overall Study|Lack of Efficacy|0
1026976|NCT01640951|2055408|FG005|Overall Study|Lack of Efficacy|6
1026977|NCT01640951|2055409|FG006|Overall Study|Lack of Efficacy|5
1026978|NCT01640951|2055410|FG007|Overall Study|Lack of Efficacy|6
1026979|NCT01640951|2055403|FG000|Overall Study|Lost to Follow-up|1
1026980|NCT01640951|2055404|FG001|Overall Study|Lost to Follow-up|0
1026981|NCT01640951|2055405|FG002|Overall Study|Lost to Follow-up|6
1026982|NCT01640951|2055406|FG003|Overall Study|Lost to Follow-up|2
1026983|NCT01640951|2055407|FG004|Overall Study|Lost to Follow-up|2
1026984|NCT01640951|2055408|FG005|Overall Study|Lost to Follow-up|3
1026985|NCT01640951|2055409|FG006|Overall Study|Lost to Follow-up|1
1026986|NCT01640951|2055410|FG007|Overall Study|Lost to Follow-up|1
1026987|NCT01640951|2055403|FG000|Overall Study|Non-compliance with study treatment|0
1026988|NCT01640951|2055404|FG001|Overall Study|Non-compliance with study treatment|0
1026989|NCT01640951|2055405|FG002|Overall Study|Non-compliance with study treatment|1
1026990|NCT01640951|2055406|FG003|Overall Study|Non-compliance with study treatment|1
1026991|NCT01640951|2055407|FG004|Overall Study|Non-compliance with study treatment|1
1026992|NCT01640951|2055408|FG005|Overall Study|Non-compliance with study treatment|4
1026993|NCT01640951|2055409|FG006|Overall Study|Non-compliance with study treatment|1
1026994|NCT01640951|2055410|FG007|Overall Study|Non-compliance with study treatment|0
1026995|NCT01640951|2055403|FG000|Overall Study|Physician Decision|2
1026996|NCT01640951|2055404|FG001|Overall Study|Physician Decision|5
1026997|NCT01640951|2055405|FG002|Overall Study|Physician Decision|2
1026998|NCT01640951|2055406|FG003|Overall Study|Physician Decision|2
1026999|NCT01640951|2055407|FG004|Overall Study|Physician Decision|2
1027000|NCT01640951|2055408|FG005|Overall Study|Physician Decision|3
1027001|NCT01640951|2055409|FG006|Overall Study|Physician Decision|3
1027002|NCT01640951|2055410|FG007|Overall Study|Physician Decision|0
1027003|NCT01640951|2055403|FG000|Overall Study|Pregnancy|3
1027004|NCT01640951|2055404|FG001|Overall Study|Pregnancy|0
1027005|NCT01640951|2055405|FG002|Overall Study|Pregnancy|0
1027006|NCT01640951|2055406|FG003|Overall Study|Pregnancy|4
1027007|NCT01640951|2055407|FG004|Overall Study|Pregnancy|0
1027008|NCT01640951|2055408|FG005|Overall Study|Pregnancy|0
1027009|NCT01640951|2055409|FG006|Overall Study|Pregnancy|2
1027010|NCT01640951|2055410|FG007|Overall Study|Pregnancy|0
1027011|NCT01640951|2055403|FG000|Overall Study|Protocol Deviation|0
1027012|NCT01640951|2055404|FG001|Overall Study|Protocol Deviation|1
1027013|NCT01640951|2055405|FG002|Overall Study|Protocol Deviation|2
1027014|NCT01640951|2055406|FG003|Overall Study|Protocol Deviation|1
1027015|NCT01640951|2055407|FG004|Overall Study|Protocol Deviation|0
1027016|NCT01640951|2055408|FG005|Overall Study|Protocol Deviation|1
1027017|NCT01640951|2055409|FG006|Overall Study|Protocol Deviation|0
1027018|NCT01640951|2055410|FG007|Overall Study|Protocol Deviation|0
1027019|NCT01640951|2055403|FG000|Overall Study|Subject/Guardian decision|12
1027020|NCT01640951|2055404|FG001|Overall Study|Subject/Guardian decision|4
1027021|NCT01640951|2055405|FG002|Overall Study|Subject/Guardian decision|13
1027022|NCT01640951|2055406|FG003|Overall Study|Subject/Guardian decision|15
1027023|NCT01640951|2055407|FG004|Overall Study|Subject/Guardian decision|7
1027024|NCT01640951|2055408|FG005|Overall Study|Subject/Guardian decision|19
1027025|NCT01640951|2055409|FG006|Overall Study|Subject/Guardian decision|5
1027026|NCT01640951|2055410|FG007|Overall Study|Subject/Guardian decision|4
1027027|NCT01640951|2055403|FG000|Overall Study|Death|0
1027028|NCT01640951|2055404|FG001|Overall Study|Death|1
1027029|NCT01640951|2055405|FG002|Overall Study|Death|1
1027030|NCT01640951|2055406|FG003|Overall Study|Death|0
1027031|NCT01640951|2055407|FG004|Overall Study|Death|0
1027032|NCT01640951|2055408|FG005|Overall Study|Death|0
1027033|NCT01640951|2055409|FG006|Overall Study|Death|0
1027034|NCT01640951|2055410|FG007|Overall Study|Death|2
1027035|NCT01640964|2055433|FG000|Overall Study|Lost to Follow-up|0
1027036|NCT01640964|2055434|FG001|Overall Study|Lost to Follow-up|0
1027037|NCT01640964|2055435|FG002|Overall Study|Lost to Follow-up|1
1027038|NCT01640964|2055433|FG000|Overall Study|Protocol Deviation|1
1027039|NCT01640964|2055434|FG001|Overall Study|Protocol Deviation|1
1027040|NCT01640964|2055435|FG002|Overall Study|Protocol Deviation|2
1027041|NCT01641081|2055453|FG000|Period 1|Sponsor request (potential unblinding)|0
1027042|NCT01641081|2055454|FG001|Period 1|Sponsor request (potential unblinding)|0
1027043|NCT01641081|2055455|FG002|Period 1|Sponsor request (potential unblinding)|0
1027044|NCT01641081|2055456|FG003|Period 1|Sponsor request (potential unblinding)|0
1027045|NCT01641081|2055457|FG004|Period 1|Sponsor request (potential unblinding)|0
1027046|NCT01641081|2055458|FG005|Period 1|Sponsor request (potential unblinding)|0
1027047|NCT01641081|2055459|FG006|Period 1|Sponsor request (potential unblinding)|1
1027048|NCT01641081|2055460|FG007|Period 1|Sponsor request (potential unblinding)|0
1027049|NCT01641081|2055461|FG008|Period 1|Sponsor request (potential unblinding)|0
1027050|NCT01641081|2055462|FG009|Period 1|Sponsor request (potential unblinding)|0
1027051|NCT01641081|2055453|FG000|Period 1|Protocol Violation|0
1027052|NCT01641081|2055454|FG001|Period 1|Protocol Violation|0
1027053|NCT01641081|2055455|FG002|Period 1|Protocol Violation|0
1027054|NCT01641081|2055456|FG003|Period 1|Protocol Violation|0
1027055|NCT01641081|2055457|FG004|Period 1|Protocol Violation|1
1027056|NCT01641081|2055458|FG005|Period 1|Protocol Violation|0
1027057|NCT01641081|2055459|FG006|Period 1|Protocol Violation|0
1027058|NCT01641081|2055460|FG007|Period 1|Protocol Violation|1
1027059|NCT01641081|2055461|FG008|Period 1|Protocol Violation|0
1027060|NCT01641081|2055462|FG009|Period 1|Protocol Violation|0
1027061|NCT01641081|2055453|FG000|Period 1|Adverse Event|1
1027062|NCT01641081|2055454|FG001|Period 1|Adverse Event|0
1027063|NCT01641081|2055455|FG002|Period 1|Adverse Event|0
1027064|NCT01641081|2055456|FG003|Period 1|Adverse Event|0
1027065|NCT01641081|2055457|FG004|Period 1|Adverse Event|0
1027066|NCT01641081|2055458|FG005|Period 1|Adverse Event|0
1027067|NCT01641081|2055459|FG006|Period 1|Adverse Event|0
1027068|NCT01641081|2055460|FG007|Period 1|Adverse Event|2
1027069|NCT01641081|2055461|FG008|Period 1|Adverse Event|0
1027070|NCT01641081|2055462|FG009|Period 1|Adverse Event|0
1027071|NCT01641081|2055453|FG000|Period 2|Adverse Event|0
1027072|NCT01641081|2055454|FG001|Period 2|Adverse Event|0
1027073|NCT01641081|2055455|FG002|Period 2|Adverse Event|0
1027074|NCT01641081|2055456|FG003|Period 2|Adverse Event|0
1027075|NCT01641081|2055457|FG004|Period 2|Adverse Event|0
1027076|NCT01641081|2055458|FG005|Period 2|Adverse Event|1
1027077|NCT01641081|2055459|FG006|Period 2|Adverse Event|0
1027078|NCT01641081|2055460|FG007|Period 2|Adverse Event|0
1027079|NCT01641081|2055461|FG008|Period 2|Adverse Event|0
1027080|NCT01641081|2055462|FG009|Period 2|Adverse Event|0
1027081|NCT01641081|2055453|FG000|Period 2|Withdrawal by Subject|0
1027082|NCT01641081|2055454|FG001|Period 2|Withdrawal by Subject|0
1027083|NCT01641081|2055455|FG002|Period 2|Withdrawal by Subject|0
1027084|NCT01641081|2055456|FG003|Period 2|Withdrawal by Subject|1
1027085|NCT01641081|2055457|FG004|Period 2|Withdrawal by Subject|0
1027086|NCT01641081|2055458|FG005|Period 2|Withdrawal by Subject|0
1027087|NCT01641081|2055459|FG006|Period 2|Withdrawal by Subject|2
1027088|NCT01641081|2055460|FG007|Period 2|Withdrawal by Subject|0
1027089|NCT01641081|2055461|FG008|Period 2|Withdrawal by Subject|0
1027090|NCT01641081|2055462|FG009|Period 2|Withdrawal by Subject|0
1027091|NCT01641081|2055453|FG000|Period 2|Protocol Violation|1
1027092|NCT01641081|2055454|FG001|Period 2|Protocol Violation|0
1027093|NCT01641081|2055455|FG002|Period 2|Protocol Violation|0
1027094|NCT01641081|2055456|FG003|Period 2|Protocol Violation|0
1027095|NCT01641081|2055457|FG004|Period 2|Protocol Violation|0
1027096|NCT01641081|2055458|FG005|Period 2|Protocol Violation|0
1027097|NCT01641081|2055459|FG006|Period 2|Protocol Violation|0
1027098|NCT01641081|2055460|FG007|Period 2|Protocol Violation|0
1027099|NCT01641081|2055461|FG008|Period 2|Protocol Violation|0
1027100|NCT01641081|2055462|FG009|Period 2|Protocol Violation|0
1027101|NCT01641081|2055453|FG000|Period 3|Adverse Event|0
1027102|NCT01641081|2055454|FG001|Period 3|Adverse Event|0
1027103|NCT01641081|2055455|FG002|Period 3|Adverse Event|1
1027104|NCT01641081|2055456|FG003|Period 3|Adverse Event|0
1027105|NCT01641081|2055457|FG004|Period 3|Adverse Event|0
1027106|NCT01641081|2055458|FG005|Period 3|Adverse Event|0
1027107|NCT01641081|2055459|FG006|Period 3|Adverse Event|0
1027108|NCT01641081|2055460|FG007|Period 3|Adverse Event|0
1027109|NCT01641081|2055461|FG008|Period 3|Adverse Event|0
1027110|NCT01641081|2055462|FG009|Period 3|Adverse Event|0
1027111|NCT01641081|2055453|FG000|Period 3|Withdrawal by Subject|0
1027112|NCT01641081|2055454|FG001|Period 3|Withdrawal by Subject|0
1027113|NCT01641081|2055455|FG002|Period 3|Withdrawal by Subject|0
1027114|NCT01641081|2055456|FG003|Period 3|Withdrawal by Subject|0
1027115|NCT01641081|2055457|FG004|Period 3|Withdrawal by Subject|0
1027116|NCT01641081|2055458|FG005|Period 3|Withdrawal by Subject|0
1027117|NCT01641081|2055459|FG006|Period 3|Withdrawal by Subject|0
1027118|NCT01641081|2055460|FG007|Period 3|Withdrawal by Subject|0
1027119|NCT01641081|2055461|FG008|Period 3|Withdrawal by Subject|1
1027120|NCT01641081|2055462|FG009|Period 3|Withdrawal by Subject|0
1027121|NCT01641081|2055453|FG000|Period 4|Adverse Event|0
1027122|NCT01641081|2055454|FG001|Period 4|Adverse Event|1
1027123|NCT01641081|2055455|FG002|Period 4|Adverse Event|0
1027124|NCT01641081|2055456|FG003|Period 4|Adverse Event|1
1027125|NCT01641081|2055457|FG004|Period 4|Adverse Event|0
1027126|NCT01641081|2055458|FG005|Period 4|Adverse Event|0
1027127|NCT01641081|2055459|FG006|Period 4|Adverse Event|0
1027128|NCT01641081|2055460|FG007|Period 4|Adverse Event|0
1027129|NCT01641081|2055461|FG008|Period 4|Adverse Event|0
1027130|NCT01641081|2055462|FG009|Period 4|Adverse Event|0
1027131|NCT01641081|2055453|FG000|Period 5|Adverse Event|0
1027132|NCT01641081|2055454|FG001|Period 5|Adverse Event|0
1027133|NCT01641081|2055455|FG002|Period 5|Adverse Event|2
1027134|NCT01641081|2055456|FG003|Period 5|Adverse Event|0
1027135|NCT01641081|2055457|FG004|Period 5|Adverse Event|0
1027136|NCT01641081|2055458|FG005|Period 5|Adverse Event|0
1027137|NCT01641081|2055459|FG006|Period 5|Adverse Event|0
1027138|NCT01641081|2055460|FG007|Period 5|Adverse Event|0
1027139|NCT01641081|2055461|FG008|Period 5|Adverse Event|0
1027140|NCT01641081|2055462|FG009|Period 5|Adverse Event|0
1027141|NCT01641133|2055484|FG000|Overall Study|Protocol Violation|0
1027142|NCT01641133|2055485|FG001|Overall Study|Protocol Violation|1
1027143|NCT01641133|2055486|FG002|Overall Study|Protocol Violation|1
1027144|NCT01641133|2055484|FG000|Overall Study|Migrated/moved from study area|5
1027145|NCT01641133|2055485|FG001|Overall Study|Migrated/moved from study area|3
1027146|NCT01641133|2055486|FG002|Overall Study|Migrated/moved from study area|1
1027147|NCT01641133|2055484|FG000|Overall Study|Adverse Event|0
1027148|NCT01641133|2055485|FG001|Overall Study|Adverse Event|0
1027149|NCT01641133|2055486|FG002|Overall Study|Adverse Event|1
1027150|NCT01641133|2055484|FG000|Overall Study|Withdrawal by Subject|5
1027151|NCT01641133|2055485|FG001|Overall Study|Withdrawal by Subject|3
1027152|NCT01641133|2055486|FG002|Overall Study|Withdrawal by Subject|3
1027153|NCT01641133|2055484|FG000|Overall Study|Lost to Follow-up|0
1027154|NCT01641133|2055485|FG001|Overall Study|Lost to Follow-up|2
1027155|NCT01641133|2055486|FG002|Overall Study|Lost to Follow-up|2
1027156|NCT01641159|2055496|FG000|Overall Study|Lost to Follow-up|2
1027157|NCT01641159|2055497|FG001|Overall Study|Lost to Follow-up|1
1027158|NCT01641159|2055496|FG000|Overall Study|Withdrawal by Subject|0
1027159|NCT01641159|2055497|FG001|Overall Study|Withdrawal by Subject|1
1027160|NCT01641198|2055506|FG000|After 12 Months of Function|Lost to Follow-up|3
1027161|NCT01641198|2055507|FG001|After 12 Months of Function|Lost to Follow-up|2
1027162|NCT01641198|2055508|FG002|After 12 Months of Function|Lost to Follow-up|2
1027163|NCT01641198|2055506|FG000|After 12 Months of Function|Protocol Violation|1
1027164|NCT01641198|2055507|FG001|After 12 Months of Function|Protocol Violation|0
1027165|NCT01641198|2055508|FG002|After 12 Months of Function|Protocol Violation|0
1027166|NCT01641198|2055506|FG000|After 12 Months of Function|Adverse Event|0
1027167|NCT01641198|2055507|FG001|After 12 Months of Function|Adverse Event|1
1027168|NCT01641198|2055508|FG002|After 12 Months of Function|Adverse Event|0
1027169|NCT01641198|2055506|FG000|After 24 Months of Function|Lost to Follow-up|4
1027170|NCT01641198|2055507|FG001|After 24 Months of Function|Lost to Follow-up|9
1027171|NCT01641198|2055508|FG002|After 24 Months of Function|Lost to Follow-up|6
1027172|NCT01641198|2055506|FG000|At 15-20 Years of Function|Lost to Follow-up|5
1027173|NCT01641198|2055507|FG001|At 15-20 Years of Function|Lost to Follow-up|1
1027174|NCT01641198|2055508|FG002|At 15-20 Years of Function|Lost to Follow-up|1
1027175|NCT01641198|2055506|FG000|At 15-20 Years of Function|Death|1
1027176|NCT01641198|2055507|FG001|At 15-20 Years of Function|Death|0
1027177|NCT01641198|2055508|FG002|At 15-20 Years of Function|Death|1
1027178|NCT01641237|2055517|FG000|Period II|Withdrawal by Subject|1
1027179|NCT01641237|2055518|FG001|Period II|Withdrawal by Subject|0
1027180|NCT01641237|2055519|FG002|Period II|Withdrawal by Subject|0
1027181|NCT01641237|2055520|FG003|Period II|Withdrawal by Subject|0
1027182|NCT01641237|2055517|FG000|Period III|Lost to Follow-up|1
1027183|NCT01641237|2055518|FG001|Period III|Lost to Follow-up|0
1027184|NCT01641237|2055519|FG002|Period III|Lost to Follow-up|0
1027185|NCT01641237|2055520|FG003|Period III|Lost to Follow-up|0
1027186|NCT01641367|2055536|FG000|Cohorts|Death|18
1027187|NCT01641367|2055537|FG001|Cohorts|Death|1
1027188|NCT01641367|2055538|FG002|Cohorts|Death|2
1027189|NCT01641367|2055539|FG003|Cohorts|Death|0
1027190|NCT01641367|2055540|FG004|Cohorts|Death|1
1027191|NCT01641367|2055541|FG005|Cohorts|Death|1
1027192|NCT01641367|2055542|FG006|Cohorts|Death|0
1027193|NCT01641367|2055543|FG007|Cohorts|Death|0
1027194|NCT01641367|2055536|FG000|Cohorts|Lost to Follow-up|16
1027195|NCT01641367|2055537|FG001|Cohorts|Lost to Follow-up|0
1027196|NCT01641367|2055538|FG002|Cohorts|Lost to Follow-up|2
1027197|NCT01641367|2055539|FG003|Cohorts|Lost to Follow-up|0
1027198|NCT01641367|2055540|FG004|Cohorts|Lost to Follow-up|2
1027199|NCT01641367|2055541|FG005|Cohorts|Lost to Follow-up|0
1027200|NCT01641367|2055542|FG006|Cohorts|Lost to Follow-up|0
1027201|NCT01641367|2055543|FG007|Cohorts|Lost to Follow-up|0
1027202|NCT01641367|2055536|FG000|Randomized Adherence Intervention|Death|0
1027203|NCT01641367|2055537|FG001|Randomized Adherence Intervention|Death|0
1027204|NCT01641367|2055538|FG002|Randomized Adherence Intervention|Death|0
1027205|NCT01641367|2055539|FG003|Randomized Adherence Intervention|Death|0
1027206|NCT01641367|2055540|FG004|Randomized Adherence Intervention|Death|0
1027207|NCT01641367|2055541|FG005|Randomized Adherence Intervention|Death|0
1027208|NCT01641367|2055542|FG006|Randomized Adherence Intervention|Death|11
1027209|NCT01641367|2055543|FG007|Randomized Adherence Intervention|Death|12
1027210|NCT01641367|2055536|FG000|Randomized Adherence Intervention|Lost to Follow-up|0
1027211|NCT01641367|2055537|FG001|Randomized Adherence Intervention|Lost to Follow-up|0
1027212|NCT01641367|2055538|FG002|Randomized Adherence Intervention|Lost to Follow-up|0
1027213|NCT01641367|2055539|FG003|Randomized Adherence Intervention|Lost to Follow-up|0
1027214|NCT01641367|2055540|FG004|Randomized Adherence Intervention|Lost to Follow-up|0
1027215|NCT01641367|2055541|FG005|Randomized Adherence Intervention|Lost to Follow-up|0
1027216|NCT01641367|2055542|FG006|Randomized Adherence Intervention|Lost to Follow-up|8
1027217|NCT01641367|2055543|FG007|Randomized Adherence Intervention|Lost to Follow-up|12
1027218|NCT01641471|2055587|FG000|Overall Study|Withdrawal by Subject|19
1027219|NCT01641471|2055588|FG001|Overall Study|Withdrawal by Subject|19
1027220|NCT01641471|2055587|FG000|Overall Study|Lost to Follow-up|2
1027221|NCT01641471|2055588|FG001|Overall Study|Lost to Follow-up|4
1027222|NCT01641471|2055587|FG000|Overall Study|Protocol Violation|2
1027223|NCT01641471|2055588|FG001|Overall Study|Protocol Violation|4
1027224|NCT01641640|2055594|FG000|Overall Study|Enrolled but not treated|1
1027225|NCT01641640|2055594|FG000|Overall Study|Efficacy failure|29
1027226|NCT01641640|2055594|FG000|Overall Study|Lost to Follow-up|3
1027227|NCT01641640|2055594|FG000|Overall Study|Withdrawal by Subject|2
1027228|NCT01641640|2055594|FG000|Overall Study|Adverse Event|1
1027229|NCT01641692|2055610|FG000|Treatment Period 1|Adverse Event|1
1027230|NCT01641692|2055611|FG001|Treatment Period 1|Adverse Event|0
1027231|NCT01641692|2055612|FG002|Treatment Period 1|Adverse Event|0
1027232|NCT01641692|2055613|FG003|Treatment Period 1|Adverse Event|0
1027233|NCT01641692|2055614|FG004|Treatment Period 1|Adverse Event|0
1027234|NCT01641692|2055615|FG005|Treatment Period 1|Adverse Event|0
1027235|NCT01641692|2055616|FG006|Treatment Period 1|Adverse Event|0
1027236|NCT01641692|2055617|FG007|Treatment Period 1|Adverse Event|0
1027237|NCT01641692|2055610|FG000|Treatment Period 1|Lack of Efficacy|0
1027238|NCT01641692|2055611|FG001|Treatment Period 1|Lack of Efficacy|0
1027239|NCT01641692|2055612|FG002|Treatment Period 1|Lack of Efficacy|0
1027240|NCT01641692|2055613|FG003|Treatment Period 1|Lack of Efficacy|0
1027241|NCT01641692|2055614|FG004|Treatment Period 1|Lack of Efficacy|0
1027242|NCT01641692|2055615|FG005|Treatment Period 1|Lack of Efficacy|0
1027243|NCT01641692|2055616|FG006|Treatment Period 1|Lack of Efficacy|0
1027244|NCT01641692|2055617|FG007|Treatment Period 1|Lack of Efficacy|1
1027245|NCT01641692|2055610|FG000|Treatment Period 1|Protocol Violation|1
1027246|NCT01641692|2055611|FG001|Treatment Period 1|Protocol Violation|0
1027247|NCT01641692|2055612|FG002|Treatment Period 1|Protocol Violation|0
1027248|NCT01641692|2055613|FG003|Treatment Period 1|Protocol Violation|0
1027249|NCT01641692|2055614|FG004|Treatment Period 1|Protocol Violation|2
1027250|NCT01641692|2055615|FG005|Treatment Period 1|Protocol Violation|0
1027251|NCT01641692|2055616|FG006|Treatment Period 1|Protocol Violation|0
1027252|NCT01641692|2055617|FG007|Treatment Period 1|Protocol Violation|0
1027253|NCT01641692|2055610|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0
1027254|NCT01641692|2055611|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0
1027255|NCT01641692|2055612|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0
1027256|NCT01641692|2055613|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0
1027257|NCT01641692|2055614|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1
1027258|NCT01641692|2055615|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0
1027259|NCT01641692|2055616|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0
1027260|NCT01641692|2055617|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1
1027261|NCT01641692|2055610|FG000|Treatment Period 1|Lost to Follow-up|0
1027262|NCT01641692|2055611|FG001|Treatment Period 1|Lost to Follow-up|0
1027263|NCT01641692|2055612|FG002|Treatment Period 1|Lost to Follow-up|1
1027264|NCT01641692|2055613|FG003|Treatment Period 1|Lost to Follow-up|0
1027265|NCT01641692|2055614|FG004|Treatment Period 1|Lost to Follow-up|0
1027266|NCT01641692|2055615|FG005|Treatment Period 1|Lost to Follow-up|0
1027267|NCT01641692|2055616|FG006|Treatment Period 1|Lost to Follow-up|0
1027268|NCT01641692|2055617|FG007|Treatment Period 1|Lost to Follow-up|0
1027269|NCT01641692|2055610|FG000|Treatment Period 1|Physician Decision|0
1027270|NCT01641692|2055611|FG001|Treatment Period 1|Physician Decision|0
1027271|NCT01641692|2055612|FG002|Treatment Period 1|Physician Decision|0
1027272|NCT01641692|2055613|FG003|Treatment Period 1|Physician Decision|0
1027273|NCT01641692|2055614|FG004|Treatment Period 1|Physician Decision|1
1027274|NCT01641692|2055615|FG005|Treatment Period 1|Physician Decision|0
1027275|NCT01641692|2055616|FG006|Treatment Period 1|Physician Decision|0
1027276|NCT01641692|2055617|FG007|Treatment Period 1|Physician Decision|0
1027277|NCT01641692|2055610|FG000|Treatment Period 1|Withdrawal by Subject|0
1027278|NCT01641692|2055611|FG001|Treatment Period 1|Withdrawal by Subject|0
1027279|NCT01641692|2055612|FG002|Treatment Period 1|Withdrawal by Subject|0
1027280|NCT01641692|2055613|FG003|Treatment Period 1|Withdrawal by Subject|0
1027281|NCT01641692|2055614|FG004|Treatment Period 1|Withdrawal by Subject|0
1027282|NCT01641692|2055615|FG005|Treatment Period 1|Withdrawal by Subject|2
1027283|NCT01641692|2055616|FG006|Treatment Period 1|Withdrawal by Subject|0
1027284|NCT01641692|2055617|FG007|Treatment Period 1|Withdrawal by Subject|1
1027285|NCT01641692|2055610|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2
1027286|NCT01641692|2055611|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0
1027287|NCT01641692|2055612|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0
1027288|NCT01641692|2055613|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0
1027289|NCT01641692|2055614|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0
1027290|NCT01641692|2055615|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0
1027291|NCT01641692|2055616|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0
1027292|NCT01641692|2055617|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0
1027293|NCT01641692|2055610|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0
1027294|NCT01641692|2055611|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0
1027295|NCT01641692|2055612|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0
1027296|NCT01641692|2055613|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0
1027297|NCT01641692|2055614|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0
1027298|NCT01641692|2055615|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0
1027299|NCT01641692|2055616|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1
1027300|NCT01641692|2055617|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0
1027301|NCT01641692|2055610|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1027302|NCT01641692|2055611|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1027303|NCT01641692|2055612|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
1027304|NCT01641692|2055613|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1027305|NCT01641692|2055614|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
1027306|NCT01641692|2055615|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1027307|NCT01641692|2055616|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1027308|NCT01641692|2055617|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1027309|NCT01641692|2055610|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1027310|NCT01641692|2055611|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1027311|NCT01641692|2055612|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1027312|NCT01641692|2055613|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1027313|NCT01641692|2055614|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1027314|NCT01641692|2055615|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1027315|NCT01641692|2055616|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1027316|NCT01641692|2055617|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1027317|NCT01641692|2055610|FG000|Treatment Period 2|Lack of Efficacy|1
1027318|NCT01641692|2055611|FG001|Treatment Period 2|Lack of Efficacy|0
1027319|NCT01641692|2055612|FG002|Treatment Period 2|Lack of Efficacy|0
1027320|NCT01641692|2055613|FG003|Treatment Period 2|Lack of Efficacy|0
1027321|NCT01641692|2055614|FG004|Treatment Period 2|Lack of Efficacy|0
1027322|NCT01641692|2055615|FG005|Treatment Period 2|Lack of Efficacy|0
1027323|NCT01641692|2055616|FG006|Treatment Period 2|Lack of Efficacy|0
1027324|NCT01641692|2055617|FG007|Treatment Period 2|Lack of Efficacy|0
1027325|NCT01641692|2055610|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
1027326|NCT01641692|2055611|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
1027327|NCT01641692|2055612|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
1027328|NCT01641692|2055613|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
1027329|NCT01641692|2055614|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
1027330|NCT01641692|2055615|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
1027331|NCT01641692|2055616|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
1027332|NCT01641692|2055617|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
1027333|NCT01641692|2055610|FG000|Treatment Period 2|Lost to Follow-up|0
1027334|NCT01641692|2055611|FG001|Treatment Period 2|Lost to Follow-up|0
1027335|NCT01641692|2055612|FG002|Treatment Period 2|Lost to Follow-up|0
1027336|NCT01641692|2055613|FG003|Treatment Period 2|Lost to Follow-up|0
1027337|NCT01641692|2055614|FG004|Treatment Period 2|Lost to Follow-up|0
1027338|NCT01641692|2055615|FG005|Treatment Period 2|Lost to Follow-up|1
1027339|NCT01641692|2055616|FG006|Treatment Period 2|Lost to Follow-up|0
1027340|NCT01641692|2055617|FG007|Treatment Period 2|Lost to Follow-up|0
1027341|NCT01641692|2055610|FG000|Treatment Period 2|Withdrawal by Subject|1
1027342|NCT01641692|2055611|FG001|Treatment Period 2|Withdrawal by Subject|0
1027343|NCT01641692|2055612|FG002|Treatment Period 2|Withdrawal by Subject|0
1027344|NCT01641692|2055613|FG003|Treatment Period 2|Withdrawal by Subject|0
1027345|NCT01641692|2055614|FG004|Treatment Period 2|Withdrawal by Subject|0
1027346|NCT01641692|2055615|FG005|Treatment Period 2|Withdrawal by Subject|1
1027347|NCT01641692|2055616|FG006|Treatment Period 2|Withdrawal by Subject|0
1027348|NCT01641692|2055617|FG007|Treatment Period 2|Withdrawal by Subject|1
1027349|NCT01641692|2055610|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1027350|NCT01641692|2055611|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1027351|NCT01641692|2055612|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1027352|NCT01641692|2055613|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1027353|NCT01641692|2055614|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
1027354|NCT01641692|2055615|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1027355|NCT01641692|2055616|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
1027356|NCT01641692|2055617|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1027357|NCT01641692|2055610|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1027358|NCT01641692|2055611|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1027359|NCT01641692|2055612|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1027360|NCT01641692|2055613|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1027361|NCT01641692|2055614|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1027362|NCT01641692|2055615|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1027363|NCT01641692|2055616|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1027364|NCT01641692|2055617|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1027365|NCT01641692|2055610|FG000|Treatment Period 3|Adverse Event|0
1027366|NCT01641692|2055611|FG001|Treatment Period 3|Adverse Event|0
1027367|NCT01641692|2055612|FG002|Treatment Period 3|Adverse Event|0
1027368|NCT01641692|2055613|FG003|Treatment Period 3|Adverse Event|0
1027369|NCT01641692|2055614|FG004|Treatment Period 3|Adverse Event|0
1027370|NCT01641692|2055615|FG005|Treatment Period 3|Adverse Event|0
1027371|NCT01641692|2055616|FG006|Treatment Period 3|Adverse Event|1
1027372|NCT01641692|2055617|FG007|Treatment Period 3|Adverse Event|0
1027373|NCT01641692|2055610|FG000|Treatment Period 3|Protocol Violation|0
1027374|NCT01641692|2055611|FG001|Treatment Period 3|Protocol Violation|0
1027375|NCT01641692|2055612|FG002|Treatment Period 3|Protocol Violation|1
1027376|NCT01641692|2055613|FG003|Treatment Period 3|Protocol Violation|0
1027377|NCT01641692|2055614|FG004|Treatment Period 3|Protocol Violation|0
1027378|NCT01641692|2055615|FG005|Treatment Period 3|Protocol Violation|0
1027379|NCT01641692|2055616|FG006|Treatment Period 3|Protocol Violation|0
1027380|NCT01641692|2055617|FG007|Treatment Period 3|Protocol Violation|0
1027381|NCT01641692|2055610|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0
1027382|NCT01641692|2055611|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
1027383|NCT01641692|2055612|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
1027384|NCT01641692|2055613|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
1027385|NCT01641692|2055614|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
1027386|NCT01641692|2055615|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
1027387|NCT01641692|2055616|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1
1027388|NCT01641692|2055617|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0
1027389|NCT01641692|2055610|FG000|Treatment Period 3|Lost to Follow-up|0
1027390|NCT01641692|2055611|FG001|Treatment Period 3|Lost to Follow-up|1
1027391|NCT01641692|2055612|FG002|Treatment Period 3|Lost to Follow-up|0
1027392|NCT01641692|2055613|FG003|Treatment Period 3|Lost to Follow-up|0
1027393|NCT01641692|2055614|FG004|Treatment Period 3|Lost to Follow-up|0
1027394|NCT01641692|2055615|FG005|Treatment Period 3|Lost to Follow-up|0
1027395|NCT01641692|2055616|FG006|Treatment Period 3|Lost to Follow-up|0
1027396|NCT01641692|2055617|FG007|Treatment Period 3|Lost to Follow-up|0
1027397|NCT01641692|2055610|FG000|Washout Period 3 or Follow-up|Protocol Violation|0
1027398|NCT01641692|2055611|FG001|Washout Period 3 or Follow-up|Protocol Violation|0
1027399|NCT01641692|2055612|FG002|Washout Period 3 or Follow-up|Protocol Violation|0
1027400|NCT01641692|2055613|FG003|Washout Period 3 or Follow-up|Protocol Violation|0
1027401|NCT01641692|2055614|FG004|Washout Period 3 or Follow-up|Protocol Violation|0
1027402|NCT01641692|2055615|FG005|Washout Period 3 or Follow-up|Protocol Violation|1
1027403|NCT01641692|2055616|FG006|Washout Period 3 or Follow-up|Protocol Violation|0
1027404|NCT01641692|2055617|FG007|Washout Period 3 or Follow-up|Protocol Violation|0
1027405|NCT01641692|2055610|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1027406|NCT01641692|2055611|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1027407|NCT01641692|2055612|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1027408|NCT01641692|2055613|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1027409|NCT01641692|2055614|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1027410|NCT01641692|2055615|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1027411|NCT01641692|2055616|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1027412|NCT01641692|2055617|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1027413|NCT01641809|2055640|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
1027414|NCT01641809|2055641|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
1027415|NCT01641809|2055642|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
1027416|NCT01641809|2055643|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
1027417|NCT01641809|2055640|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0
1027418|NCT01641809|2055641|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1
1027419|NCT01641809|2055642|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0
1027420|NCT01641809|2055643|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1
1027421|NCT01641809|2055640|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
1027422|NCT01641809|2055641|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
1027423|NCT01641809|2055642|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
1027424|NCT01641809|2055643|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
1027425|NCT01641809|2055640|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
1027426|NCT01641809|2055641|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
1027427|NCT01641809|2055642|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
1027428|NCT01641809|2055643|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
1027429|NCT01641809|2055640|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
1027430|NCT01641809|2055641|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
1027431|NCT01641809|2055642|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
1027432|NCT01641809|2055643|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
1027433|NCT01641809|2055640|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0
1027434|NCT01641809|2055641|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1
1027435|NCT01641809|2055642|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3
1027436|NCT01641809|2055643|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7
1027437|NCT01641809|2055640|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
1027438|NCT01641809|2055641|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
1027439|NCT01641809|2055642|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
1027440|NCT01641809|2055643|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
1162019|NCT03380429|2283927|FG000|Overall Study|Lack of Efficacy|0
1027441|NCT01641809|2055640|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
1027442|NCT01641809|2055641|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
1027443|NCT01641809|2055642|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
1027444|NCT01641809|2055643|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
1027445|NCT01641809|2055640|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
1027446|NCT01641809|2055641|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
1027447|NCT01641809|2055642|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
1027448|NCT01641809|2055643|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
1027449|NCT01641809|2055640|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
1027450|NCT01641809|2055641|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
1027451|NCT01641809|2055642|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
1027452|NCT01641809|2055643|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
1027453|NCT01641809|2055640|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
1027454|NCT01641809|2055641|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
1027455|NCT01641809|2055642|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
1027456|NCT01641809|2055643|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
1027457|NCT01641809|2055640|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
1027458|NCT01641809|2055641|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
1027459|NCT01641809|2055642|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
1027460|NCT01641809|2055643|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
1027461|NCT01641809|2055640|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0
1027462|NCT01641809|2055641|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1
1027463|NCT01641809|2055642|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1
1027464|NCT01641809|2055643|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0
1027465|NCT01641809|2055640|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
1027466|NCT01641809|2055641|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
1027467|NCT01641809|2055642|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
1027468|NCT01641809|2055643|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
1027469|NCT01641809|2055640|FG000|Open-label (Week 96 to Week 324)|Site closed|1
1027470|NCT01641809|2055641|FG001|Open-label (Week 96 to Week 324)|Site closed|0
1027471|NCT01641809|2055642|FG002|Open-label (Week 96 to Week 324)|Site closed|0
1027472|NCT01641809|2055643|FG003|Open-label (Week 96 to Week 324)|Site closed|0
1027473|NCT01641809|2055640|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1
1027474|NCT01641809|2055641|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1
1027475|NCT01641809|2055642|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0
1027476|NCT01641809|2055643|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0
1027477|NCT01641809|2055640|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
1027478|NCT01641809|2055641|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
1027479|NCT01641809|2055642|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
1027480|NCT01641809|2055643|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
1027481|NCT01641809|2055640|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3
1027482|NCT01641809|2055641|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2
1027483|NCT01641809|2055642|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1
1027484|NCT01641809|2055643|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0
1027485|NCT01641822|2055663|FG000|Run-in Phase|Noncompliance with study drug|1
1027486|NCT01641822|2055664|FG001|Run-in Phase|Noncompliance with study drug|0
1027487|NCT01641822|2055665|FG002|Run-in Phase|Noncompliance with study drug|0
1027488|NCT01641822|2055663|FG000|Run-in Phase|Adverse Event|3
1027489|NCT01641822|2055664|FG001|Run-in Phase|Adverse Event|0
1027490|NCT01641822|2055665|FG002|Run-in Phase|Adverse Event|0
1027491|NCT01641822|2055663|FG000|Run-in Phase|Withdrew consent|1
1027492|NCT01641822|2055664|FG001|Run-in Phase|Withdrew consent|0
1027493|NCT01641822|2055665|FG002|Run-in Phase|Withdrew consent|0
1027494|NCT01641822|2055663|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9
1027495|NCT01641822|2055664|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0
1027496|NCT01641822|2055665|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0
1027497|NCT01641822|2055663|FG000|Comparative Phase|Noncompliance with study drug|0
1027498|NCT01641822|2055664|FG001|Comparative Phase|Noncompliance with study drug|1
1027499|NCT01641822|2055665|FG002|Comparative Phase|Noncompliance with study drug|0
1027500|NCT01641822|2055663|FG000|Comparative Phase|Investigator's discretion|0
1027501|NCT01641822|2055664|FG001|Comparative Phase|Investigator's discretion|0
1027502|NCT01641822|2055665|FG002|Comparative Phase|Investigator's discretion|1
1027503|NCT01641822|2055663|FG000|Comparative Phase|Pregnancy|0
1027504|NCT01641822|2055664|FG001|Comparative Phase|Pregnancy|0
1027505|NCT01641822|2055665|FG002|Comparative Phase|Pregnancy|1
1027506|NCT01641822|2055663|FG000|Comparative Phase|Adverse event, serious fatal|0
1027507|NCT01641822|2055664|FG001|Comparative Phase|Adverse event, serious fatal|1
1027508|NCT01641822|2055665|FG002|Comparative Phase|Adverse event, serious fatal|0
1027509|NCT01641822|2055663|FG000|Comparative Phase|Withdrew consent|0
1027510|NCT01641822|2055664|FG001|Comparative Phase|Withdrew consent|3
1027511|NCT01641822|2055665|FG002|Comparative Phase|Withdrew consent|7
1027512|NCT01641822|2055663|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0
1027513|NCT01641822|2055664|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1
1027514|NCT01641822|2055665|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1
1027515|NCT01641861|2055678|FG000|Overall Study|Lost to Follow-up|21
1027516|NCT01641861|2055679|FG001|Overall Study|Lost to Follow-up|16
1027517|NCT01641861|2055678|FG000|Overall Study|Lost the tooth due to normal exfoliation|14
1027518|NCT01641861|2055679|FG001|Overall Study|Lost the tooth due to normal exfoliation|8
1027519|NCT01641861|2055678|FG000|Overall Study|Died due to drowning|0
1027520|NCT01641861|2055679|FG001|Overall Study|Died due to drowning|1
1027521|NCT01641900|2055687|FG000|Overall Study|Withdrawal by Subject|2
1027522|NCT01641900|2055688|FG001|Overall Study|Withdrawal by Subject|2
1027523|NCT01641926|2055700|FG000|Overall Study|Adverse Event|5
1027524|NCT01641926|2055701|FG001|Overall Study|Adverse Event|2
1027525|NCT01641926|2055702|FG002|Overall Study|Adverse Event|3
1027526|NCT01641926|2055703|FG003|Overall Study|Adverse Event|1
1027527|NCT01641926|2055700|FG000|Overall Study|Lost to Follow-up|2
1027528|NCT01641926|2055701|FG001|Overall Study|Lost to Follow-up|2
1027529|NCT01641926|2055702|FG002|Overall Study|Lost to Follow-up|1
1027530|NCT01641926|2055703|FG003|Overall Study|Lost to Follow-up|0
1027531|NCT01641926|2055700|FG000|Overall Study|Physician Decision|6
1027532|NCT01641926|2055701|FG001|Overall Study|Physician Decision|5
1027533|NCT01641926|2055702|FG002|Overall Study|Physician Decision|0
1027534|NCT01641926|2055703|FG003|Overall Study|Physician Decision|1
1027535|NCT01641926|2055700|FG000|Overall Study|Protocol Violation|1
1027536|NCT01641926|2055701|FG001|Overall Study|Protocol Violation|0
1027537|NCT01641926|2055702|FG002|Overall Study|Protocol Violation|0
1027538|NCT01641926|2055703|FG003|Overall Study|Protocol Violation|1
1027539|NCT01641926|2055700|FG000|Overall Study|Withdrawal by Subject|13
1027540|NCT01641926|2055701|FG001|Overall Study|Withdrawal by Subject|5
1027541|NCT01641926|2055702|FG002|Overall Study|Withdrawal by Subject|6
1027542|NCT01641926|2055703|FG003|Overall Study|Withdrawal by Subject|1
1027543|NCT01641926|2055700|FG000|Overall Study|Not Treated|1
1027544|NCT01641926|2055701|FG001|Overall Study|Not Treated|1
1027545|NCT01641926|2055702|FG002|Overall Study|Not Treated|1
1027546|NCT01641926|2055703|FG003|Overall Study|Not Treated|0
1027547|NCT01641939|2055716|FG000|Overall Study|Death|90
1027548|NCT01641939|2055717|FG001|Overall Study|Death|187
1027549|NCT01641939|2055718|FG002|Overall Study|Death|61
1027550|NCT01641939|2055716|FG000|Overall Study|Lost to Follow-up|3
1027551|NCT01641939|2055717|FG001|Overall Study|Lost to Follow-up|2
1027552|NCT01641939|2055718|FG002|Overall Study|Lost to Follow-up|1
1027553|NCT01641939|2055716|FG000|Overall Study|Withdrawal by Subject|14
1027554|NCT01641939|2055717|FG001|Overall Study|Withdrawal by Subject|11
1027555|NCT01641939|2055718|FG002|Overall Study|Withdrawal by Subject|5
1027556|NCT01641939|2055716|FG000|Overall Study|Study Terminated by Sponsor|10
1027557|NCT01641939|2055717|FG001|Overall Study|Study Terminated by Sponsor|28
1027558|NCT01641939|2055718|FG002|Overall Study|Study Terminated by Sponsor|3
1027559|NCT01641952|2055728|FG000|Overall Study|Lost to Follow-up|28
1027560|NCT01641952|2055728|FG000|Overall Study|Adverse Event|6
1027561|NCT01641991|2055744|FG000|Overall Study|Physician Decision|0
1027562|NCT01641991|2055745|FG001|Overall Study|Physician Decision|1
1027563|NCT01641991|2055746|FG002|Overall Study|Physician Decision|7
1027564|NCT01641991|2055747|FG003|Overall Study|Physician Decision|5
1027565|NCT01641991|2055744|FG000|Overall Study|Withdrawal by Subject|4
1027566|NCT01641991|2055745|FG001|Overall Study|Withdrawal by Subject|2
1027567|NCT01641991|2055746|FG002|Overall Study|Withdrawal by Subject|1
1027568|NCT01641991|2055747|FG003|Overall Study|Withdrawal by Subject|5
1027569|NCT01641991|2055744|FG000|Overall Study|Adverse Event|2
1027570|NCT01641991|2055745|FG001|Overall Study|Adverse Event|1
1027571|NCT01641991|2055746|FG002|Overall Study|Adverse Event|2
1027572|NCT01641991|2055747|FG003|Overall Study|Adverse Event|1
1027573|NCT01641991|2055744|FG000|Overall Study|Lost to Follow-up|0
1027574|NCT01641991|2055745|FG001|Overall Study|Lost to Follow-up|2
1027575|NCT01641991|2055746|FG002|Overall Study|Lost to Follow-up|3
1027576|NCT01641991|2055747|FG003|Overall Study|Lost to Follow-up|1
1027577|NCT01641991|2055744|FG000|Overall Study|Protocol Violation|1
1027578|NCT01641991|2055745|FG001|Overall Study|Protocol Violation|1
1027579|NCT01641991|2055746|FG002|Overall Study|Protocol Violation|3
1027580|NCT01641991|2055747|FG003|Overall Study|Protocol Violation|0
1027581|NCT01641991|2055744|FG000|Overall Study|Pregnancy|0
1027582|NCT01641991|2055745|FG001|Overall Study|Pregnancy|0
1027583|NCT01641991|2055746|FG002|Overall Study|Pregnancy|1
1027584|NCT01641991|2055747|FG003|Overall Study|Pregnancy|0
1027585|NCT01641991|2055744|FG000|Overall Study|no longer eligible|2
1027586|NCT01641991|2055745|FG001|Overall Study|no longer eligible|1
1027587|NCT01641991|2055746|FG002|Overall Study|no longer eligible|0
1027588|NCT01641991|2055747|FG003|Overall Study|no longer eligible|4
1027589|NCT01642004|2055762|FG000|Randomization|Adverse Event unrelated to study drug|1
1027590|NCT01642004|2055763|FG001|Randomization|Adverse Event unrelated to study drug|0
1027591|NCT01642004|2055762|FG000|Randomization|Withdrawal by Subject|1
1027592|NCT01642004|2055763|FG001|Randomization|Withdrawal by Subject|6
1027593|NCT01642004|2055762|FG000|Randomization|No longer meets study criteria|2
1027594|NCT01642004|2055763|FG001|Randomization|No longer meets study criteria|2
1027595|NCT01642004|2055762|FG000|Treatment|Disease progression|88
1027596|NCT01642004|2055763|FG001|Treatment|Disease progression|80
1027597|NCT01642004|2055762|FG000|Treatment|Study drug toxicity|5
1027598|NCT01642004|2055763|FG001|Treatment|Study drug toxicity|13
1027599|NCT01642004|2055762|FG000|Treatment|Death|1
1027600|NCT01642004|2055763|FG001|Treatment|Death|0
1027601|NCT01642004|2055762|FG000|Treatment|Adverse event unrelated to study drug|6
1027602|NCT01642004|2055763|FG001|Treatment|Adverse event unrelated to study drug|13
1027603|NCT01642004|2055762|FG000|Treatment|Withdrawal by Subject|5
1027604|NCT01642004|2055763|FG001|Treatment|Withdrawal by Subject|9
1027605|NCT01642004|2055762|FG000|Treatment|Maximum clinical benefit|2
1027606|NCT01642004|2055763|FG001|Treatment|Maximum clinical benefit|7
1027607|NCT01642004|2055762|FG000|Treatment|Poor/non-compliance|1
1027608|NCT01642004|2055763|FG001|Treatment|Poor/non-compliance|0
1027609|NCT01642004|2055762|FG000|Treatment|No longer meets study criteria|1
1027610|NCT01642004|2055763|FG001|Treatment|No longer meets study criteria|2
1027611|NCT01642004|2055762|FG000|Treatment|Other|1
1027612|NCT01642004|2055763|FG001|Treatment|Other|2
1027613|NCT01642004|2055762|FG000|Treatment|Missing from data|0
1027614|NCT01642004|2055763|FG001|Treatment|Missing from data|1
1027615|NCT01642212|2055800|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
1027616|NCT01642212|2055801|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1027617|NCT01642212|2055802|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1027618|NCT01642212|2055803|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1027619|NCT01642212|2055804|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1027620|NCT01642212|2055800|FG000|Double-blind Treatment|Other|0
1027621|NCT01642212|2055801|FG001|Double-blind Treatment|Other|2
1027622|NCT01642212|2055802|FG002|Double-blind Treatment|Other|1
1027623|NCT01642212|2055803|FG003|Double-blind Treatment|Other|0
1027624|NCT01642212|2055804|FG004|Double-blind Treatment|Other|0
1027625|NCT01642212|2055800|FG000|Double-blind Treatment|Non-compliance|0
1027626|NCT01642212|2055801|FG001|Double-blind Treatment|Non-compliance|1
1027627|NCT01642212|2055802|FG002|Double-blind Treatment|Non-compliance|0
1027628|NCT01642212|2055803|FG003|Double-blind Treatment|Non-compliance|0
1027629|NCT01642212|2055804|FG004|Double-blind Treatment|Non-compliance|0
1027630|NCT01642212|2055800|FG000|Double-blind Treatment|Adverse Event|0
1027631|NCT01642212|2055801|FG001|Double-blind Treatment|Adverse Event|0
1027632|NCT01642212|2055802|FG002|Double-blind Treatment|Adverse Event|1
1027633|NCT01642212|2055803|FG003|Double-blind Treatment|Adverse Event|0
1027634|NCT01642212|2055804|FG004|Double-blind Treatment|Adverse Event|0
1027635|NCT01642212|2055800|FG000|Open-label Extension|Adverse Event|0
1027636|NCT01642212|2055801|FG001|Open-label Extension|Adverse Event|0
1027637|NCT01642212|2055802|FG002|Open-label Extension|Adverse Event|0
1027638|NCT01642212|2055803|FG003|Open-label Extension|Adverse Event|3
1027639|NCT01642212|2055804|FG004|Open-label Extension|Adverse Event|0
1027640|NCT01642212|2055800|FG000|Open-label Extension|Sponsor Decision|0
1027641|NCT01642212|2055801|FG001|Open-label Extension|Sponsor Decision|0
1027642|NCT01642212|2055802|FG002|Open-label Extension|Sponsor Decision|0
1027643|NCT01642212|2055803|FG003|Open-label Extension|Sponsor Decision|7
1027644|NCT01642212|2055804|FG004|Open-label Extension|Sponsor Decision|4
1027645|NCT01642212|2055800|FG000|Open-label Extension|Consent Withdrawn|0
1027646|NCT01642212|2055801|FG001|Open-label Extension|Consent Withdrawn|0
1027647|NCT01642212|2055802|FG002|Open-label Extension|Consent Withdrawn|0
1027648|NCT01642212|2055803|FG003|Open-label Extension|Consent Withdrawn|0
1027649|NCT01642212|2055804|FG004|Open-label Extension|Consent Withdrawn|2
1027650|NCT01642212|2055800|FG000|Open-label Extension|Lost to Follow-up|0
1027651|NCT01642212|2055801|FG001|Open-label Extension|Lost to Follow-up|0
1027652|NCT01642212|2055802|FG002|Open-label Extension|Lost to Follow-up|0
1027653|NCT01642212|2055803|FG003|Open-label Extension|Lost to Follow-up|0
1027654|NCT01642212|2055804|FG004|Open-label Extension|Lost to Follow-up|1
1027655|NCT01642212|2055800|FG000|Open-label Extension|Other|0
1027656|NCT01642212|2055801|FG001|Open-label Extension|Other|0
1027657|NCT01642212|2055802|FG002|Open-label Extension|Other|0
1027658|NCT01642212|2055803|FG003|Open-label Extension|Other|0
1027659|NCT01642212|2055804|FG004|Open-label Extension|Other|1
1027660|NCT01642251|2055822|FG000|Overall Study|Progressive disease|0
1027661|NCT01642251|2055823|FG001|Overall Study|Progressive disease|0
1027662|NCT01642251|2055824|FG002|Overall Study|Progressive disease|3
1027663|NCT01642251|2055825|FG003|Overall Study|Progressive disease|3
1027664|NCT01642251|2055822|FG000|Overall Study|Adverse Event|0
1027665|NCT01642251|2055823|FG001|Overall Study|Adverse Event|0
1027666|NCT01642251|2055824|FG002|Overall Study|Adverse Event|5
1027667|NCT01642251|2055825|FG003|Overall Study|Adverse Event|4
1027668|NCT01642251|2055822|FG000|Overall Study|Death|0
1027669|NCT01642251|2055823|FG001|Overall Study|Death|0
1027670|NCT01642251|2055824|FG002|Overall Study|Death|1
1027671|NCT01642251|2055825|FG003|Overall Study|Death|3
1027672|NCT01642251|2055822|FG000|Overall Study|Withdrawal by Subject|0
1027673|NCT01642251|2055823|FG001|Overall Study|Withdrawal by Subject|0
1027674|NCT01642251|2055824|FG002|Overall Study|Withdrawal by Subject|1
1027675|NCT01642251|2055825|FG003|Overall Study|Withdrawal by Subject|3
1027676|NCT01642251|2055822|FG000|Overall Study|Alternative therapy|0
1027677|NCT01642251|2055823|FG001|Overall Study|Alternative therapy|0
1027678|NCT01642251|2055824|FG002|Overall Study|Alternative therapy|0
1027679|NCT01642251|2055825|FG003|Overall Study|Alternative therapy|2
1027680|NCT01642251|2055822|FG000|Overall Study|Other complicating disease|0
1027681|NCT01642251|2055823|FG001|Overall Study|Other complicating disease|0
1027682|NCT01642251|2055824|FG002|Overall Study|Other complicating disease|1
1027683|NCT01642251|2055825|FG003|Overall Study|Other complicating disease|0
1162020|NCT03380429|2283928|FG001|Overall Study|Lack of Efficacy|0
1027684|NCT01642251|2055822|FG000|Overall Study|Ineligible/never start protocol therapy|0
1027685|NCT01642251|2055823|FG001|Overall Study|Ineligible/never start protocol therapy|0
1027686|NCT01642251|2055824|FG002|Overall Study|Ineligible/never start protocol therapy|11
1027687|NCT01642251|2055825|FG003|Overall Study|Ineligible/never start protocol therapy|8
1027688|NCT01642277|2055836|FG000|Overall Study|Adverse Event|10
1027689|NCT01642277|2055837|FG001|Overall Study|Adverse Event|0
1027690|NCT01642277|2055836|FG000|Overall Study|Physician Decision|2
1027691|NCT01642277|2055837|FG001|Overall Study|Physician Decision|0
1027692|NCT01642277|2055836|FG000|Overall Study|Protocol Violation|1
1027693|NCT01642277|2055837|FG001|Overall Study|Protocol Violation|0
1027694|NCT01642277|2055836|FG000|Overall Study|Withdrawal by Subject|11
1027695|NCT01642277|2055837|FG001|Overall Study|Withdrawal by Subject|0
1027696|NCT01642407|2055844|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
1027697|NCT01642407|2055844|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
1027698|NCT01642407|2055844|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
1027699|NCT01642589|2055875|FG000|Overall Study|Withdrawal by Subject|1
1027700|NCT01642589|2055876|FG001|Overall Study|Withdrawal by Subject|1
1027701|NCT01642602|2055882|FG000|Overall Study|Adverse Event|2
1027702|NCT01642615|2055886|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
1027703|NCT01642615|2055887|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
1027704|NCT01642615|2055888|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
1027705|NCT01642615|2055886|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1
1027706|NCT01642615|2055887|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0
1027707|NCT01642615|2055888|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0
1027708|NCT01642615|2055886|FG000|Open Label Maintenance Phase|Lost to Follow-up|1
1027709|NCT01642615|2055887|FG001|Open Label Maintenance Phase|Lost to Follow-up|0
1027710|NCT01642615|2055888|FG002|Open Label Maintenance Phase|Lost to Follow-up|0
1027711|NCT01642615|2055886|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1
1027712|NCT01642615|2055887|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0
1027713|NCT01642615|2055888|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0
1027714|NCT01642615|2055886|FG000|Open Label Maintenance Phase|Did not receive treatment|1
1027715|NCT01642615|2055887|FG001|Open Label Maintenance Phase|Did not receive treatment|0
1027716|NCT01642615|2055888|FG002|Open Label Maintenance Phase|Did not receive treatment|0
1027717|NCT01642615|2055886|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0
1027718|NCT01642615|2055887|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1
1027719|NCT01642615|2055888|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3
1027720|NCT01642615|2055886|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0
1027721|NCT01642615|2055887|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5
1027722|NCT01642615|2055888|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2
1027723|NCT01642615|2055886|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
1027724|NCT01642615|2055887|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
1027725|NCT01642615|2055888|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
1027726|NCT01642615|2055886|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
1027727|NCT01642615|2055887|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
1027728|NCT01642615|2055888|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
1027729|NCT01642914|2055899|FG000|Overall Study|Adverse Event|11
1027730|NCT01642914|2055900|FG001|Overall Study|Adverse Event|7
1027731|NCT01642914|2055901|FG002|Overall Study|Adverse Event|15
1027732|NCT01642914|2055899|FG000|Overall Study|Lack of Efficacy|9
1027733|NCT01642914|2055900|FG001|Overall Study|Lack of Efficacy|4
1027734|NCT01642914|2055901|FG002|Overall Study|Lack of Efficacy|2
1027735|NCT01642914|2055899|FG000|Overall Study|Protocol Violation|15
1027736|NCT01642914|2055900|FG001|Overall Study|Protocol Violation|13
1027737|NCT01642914|2055901|FG002|Overall Study|Protocol Violation|6
1027738|NCT01642914|2055899|FG000|Overall Study|Withdrawal by Subject|5
1027739|NCT01642914|2055900|FG001|Overall Study|Withdrawal by Subject|5
1027740|NCT01642914|2055901|FG002|Overall Study|Withdrawal by Subject|10
1027741|NCT01642914|2055899|FG000|Overall Study|Lost to Follow-up|5
1027742|NCT01642914|2055900|FG001|Overall Study|Lost to Follow-up|3
1027743|NCT01642914|2055901|FG002|Overall Study|Lost to Follow-up|7
1027744|NCT01642914|2055899|FG000|Overall Study|Other Reason|1
1027745|NCT01642914|2055900|FG001|Overall Study|Other Reason|0
1027746|NCT01642914|2055901|FG002|Overall Study|Other Reason|0
1027747|NCT01643044|2055913|FG000|Overall Study|Lost to Follow-up|1
905089|NCT00760877|1880341|FG000|Overall Study|Pregnancy|1
905090|NCT00760877|1880342|FG001|Overall Study|Pregnancy|4
905091|NCT00760877|1880341|FG000|Overall Study|Death|2
905092|NCT00760877|1880342|FG001|Overall Study|Death|1
905093|NCT00760877|1880341|FG000|Overall Study|Withdrawal by Subject|7
905094|NCT00760877|1880342|FG001|Overall Study|Withdrawal by Subject|3
905095|NCT00760877|1880341|FG000|Overall Study|Adverse Event|19
905096|NCT00760877|1880342|FG001|Overall Study|Adverse Event|12
905097|NCT00760877|1880341|FG000|Overall Study|Participant diagnosed with AML|0
905098|NCT00760877|1880342|FG001|Overall Study|Participant diagnosed with AML|1
905099|NCT00760877|1880341|FG000|Overall Study|Participant not eligible to cross-over|0
905100|NCT00760877|1880342|FG001|Overall Study|Participant not eligible to cross-over|1
905101|NCT00760877|1880341|FG000|Overall Study|Physician Decision|1
1027748|NCT01643044|2055914|FG001|Overall Study|Lost to Follow-up|1
1027749|NCT01643044|2055913|FG000|Overall Study|Miscarried baby|2
1027750|NCT01643044|2055914|FG001|Overall Study|Miscarried baby|2
1027751|NCT01643044|2055913|FG000|Overall Study|Delivered outside of hospital|1
1027752|NCT01643044|2055914|FG001|Overall Study|Delivered outside of hospital|2
1027753|NCT01643408|2055938|FG000|Overall Study|Adverse Event|12
1027754|NCT01643408|2055938|FG000|Overall Study|Other|2
1027755|NCT01643473|2055944|FG000|Overall Study|Lost to Follow-up|1
1027756|NCT01643473|2055945|FG001|Overall Study|Lost to Follow-up|0
1027757|NCT01643668|2055960|FG000|Overall Study|Death|1
1027758|NCT01643772|2055980|FG000|Overall Study|Protocol Violation|0
1027759|NCT01643772|2055981|FG001|Overall Study|Protocol Violation|0
1027760|NCT01643772|2055982|FG002|Overall Study|Protocol Violation|0
1027761|NCT01643772|2055983|FG003|Overall Study|Protocol Violation|1
1027762|NCT01643772|2055980|FG000|Overall Study|Adverse Event|0
1027763|NCT01643772|2055981|FG001|Overall Study|Adverse Event|0
1027764|NCT01643772|2055982|FG002|Overall Study|Adverse Event|0
1027765|NCT01643772|2055983|FG003|Overall Study|Adverse Event|1
1027766|NCT01643798|2055995|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
1027767|NCT01643798|2055996|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
1027768|NCT01643850|2056016|FG000|Overall Study|Withdrawal by Subject|0
1027769|NCT01643850|2056017|FG001|Overall Study|Withdrawal by Subject|0
1027770|NCT01643850|2056018|FG002|Overall Study|Withdrawal by Subject|0
1027771|NCT01643850|2056019|FG003|Overall Study|Withdrawal by Subject|0
1027772|NCT01643850|2056020|FG004|Overall Study|Withdrawal by Subject|1
1027773|NCT01643850|2056021|FG005|Overall Study|Withdrawal by Subject|0
1027774|NCT01643850|2056022|FG006|Overall Study|Withdrawal by Subject|0
1027775|NCT01643850|2056023|FG007|Overall Study|Withdrawal by Subject|0
1027776|NCT01643850|2056024|FG008|Overall Study|Withdrawal by Subject|0
1027777|NCT01643850|2056016|FG000|Overall Study|Lost to Follow-up|0
1027778|NCT01643850|2056017|FG001|Overall Study|Lost to Follow-up|0
1027779|NCT01643850|2056018|FG002|Overall Study|Lost to Follow-up|0
1027780|NCT01643850|2056019|FG003|Overall Study|Lost to Follow-up|0
1027781|NCT01643850|2056020|FG004|Overall Study|Lost to Follow-up|0
1027782|NCT01643850|2056021|FG005|Overall Study|Lost to Follow-up|0
1027783|NCT01643850|2056022|FG006|Overall Study|Lost to Follow-up|1
1027784|NCT01643850|2056023|FG007|Overall Study|Lost to Follow-up|0
1027785|NCT01643850|2056024|FG008|Overall Study|Lost to Follow-up|1
1027786|NCT01643850|2056016|FG000|Overall Study|Adverse Event|0
1027787|NCT01643850|2056017|FG001|Overall Study|Adverse Event|0
1027788|NCT01643850|2056018|FG002|Overall Study|Adverse Event|0
1027789|NCT01643850|2056019|FG003|Overall Study|Adverse Event|0
1027790|NCT01643850|2056020|FG004|Overall Study|Adverse Event|1
1027791|NCT01643850|2056021|FG005|Overall Study|Adverse Event|0
1027792|NCT01643850|2056022|FG006|Overall Study|Adverse Event|0
1027793|NCT01643850|2056023|FG007|Overall Study|Adverse Event|0
1027794|NCT01643850|2056024|FG008|Overall Study|Adverse Event|0
1027795|NCT01643850|2056016|FG000|Overall Study|Administrative Problems|0
1027796|NCT01643850|2056017|FG001|Overall Study|Administrative Problems|0
1027797|NCT01643850|2056018|FG002|Overall Study|Administrative Problems|1
1027798|NCT01643850|2056019|FG003|Overall Study|Administrative Problems|0
1027799|NCT01643850|2056020|FG004|Overall Study|Administrative Problems|1
1027800|NCT01643850|2056021|FG005|Overall Study|Administrative Problems|0
1027801|NCT01643850|2056022|FG006|Overall Study|Administrative Problems|0
1027802|NCT01643850|2056023|FG007|Overall Study|Administrative Problems|0
1027803|NCT01643850|2056024|FG008|Overall Study|Administrative Problems|0
1027804|NCT01643928|2056104|FG000|Overall Study|Lost to Follow-up|1
1027805|NCT01643928|2056105|FG001|Overall Study|Lost to Follow-up|0
1027806|NCT01643928|2056106|FG002|Overall Study|Lost to Follow-up|2
1027807|NCT01643928|2056107|FG003|Overall Study|Lost to Follow-up|0
1027808|NCT01643928|2056108|FG004|Overall Study|Lost to Follow-up|0
1027809|NCT01643928|2056104|FG000|Overall Study|Withdrawal by Subject|2
1027810|NCT01643928|2056105|FG001|Overall Study|Withdrawal by Subject|0
1027811|NCT01643928|2056106|FG002|Overall Study|Withdrawal by Subject|0
1027812|NCT01643928|2056107|FG003|Overall Study|Withdrawal by Subject|1
1027813|NCT01643928|2056108|FG004|Overall Study|Withdrawal by Subject|0
1027814|NCT01643928|2056104|FG000|Overall Study|Pregnancy|0
1027815|NCT01643928|2056105|FG001|Overall Study|Pregnancy|0
1027816|NCT01643928|2056106|FG002|Overall Study|Pregnancy|0
1027817|NCT01643928|2056107|FG003|Overall Study|Pregnancy|1
1027818|NCT01643928|2056108|FG004|Overall Study|Pregnancy|0
1027819|NCT01643928|2056104|FG000|Overall Study|Other|5
1027820|NCT01643928|2056105|FG001|Overall Study|Other|1
1027821|NCT01643928|2056106|FG002|Overall Study|Other|1
1027822|NCT01643928|2056107|FG003|Overall Study|Other|0
1027823|NCT01643928|2056108|FG004|Overall Study|Other|0
1027824|NCT01643928|2056104|FG000|Overall Study|Adverse Event|2
1027825|NCT01643928|2056105|FG001|Overall Study|Adverse Event|1
1027826|NCT01643928|2056106|FG002|Overall Study|Adverse Event|0
1027827|NCT01643928|2056107|FG003|Overall Study|Adverse Event|1
1027828|NCT01643928|2056108|FG004|Overall Study|Adverse Event|2
1027829|NCT01644149|2056156|FG000|Overall Study|Withdrawal by Subject|1
1027830|NCT01644149|2056157|FG001|Overall Study|Withdrawal by Subject|0
1027831|NCT01644149|2056156|FG000|Overall Study|Lost to Follow-up|3
1027832|NCT01644149|2056157|FG001|Overall Study|Lost to Follow-up|1
1027833|NCT01644175|2056166|FG000|Overall Study|Randomized But Not Treated|0
1027834|NCT01644175|2056167|FG001|Overall Study|Randomized But Not Treated|2
1027835|NCT01644175|2056166|FG000|Overall Study|Adverse Event|8
1027836|NCT01644175|2056167|FG001|Overall Study|Adverse Event|13
1027837|NCT01644175|2056166|FG000|Overall Study|Death|1
1027838|NCT01644175|2056167|FG001|Overall Study|Death|2
1027839|NCT01644175|2056166|FG000|Overall Study|Poor compliance to protocol|9
1027840|NCT01644175|2056167|FG001|Overall Study|Poor compliance to protocol|10
1027841|NCT01644175|2056166|FG000|Overall Study|Physician Decision|1
1027842|NCT01644175|2056167|FG001|Overall Study|Physician Decision|2
1027843|NCT01644175|2056166|FG000|Overall Study|Participant Moved|1
1027844|NCT01644175|2056167|FG001|Overall Study|Participant Moved|2
1027845|NCT01644175|2056166|FG000|Overall Study|Consent withdrawn by participant|3
1027846|NCT01644175|2056167|FG001|Overall Study|Consent withdrawn by participant|4
1027847|NCT01644175|2056166|FG000|Overall Study|Related to Autoinjector Administration|2
1027848|NCT01644175|2056167|FG001|Overall Study|Related to Autoinjector Administration|1
1027849|NCT01644175|2056166|FG000|Overall Study|Last visit outside protocol visit window|4
1027850|NCT01644175|2056167|FG001|Overall Study|Last visit outside protocol visit window|11
1027851|NCT01644175|2056166|FG000|Overall Study|Selection criteria finally not met|0
1027852|NCT01644175|2056167|FG001|Overall Study|Selection criteria finally not met|1
1027853|NCT01644175|2056166|FG000|Overall Study|Site closure|2
1027854|NCT01644175|2056167|FG001|Overall Study|Site closure|2
1027855|NCT01644175|2056166|FG000|Overall Study|Lost to Follow-up|1
1027856|NCT01644175|2056167|FG001|Overall Study|Lost to Follow-up|0
1027857|NCT01644175|2056166|FG000|Overall Study|Other than specified above|0
1027858|NCT01644175|2056167|FG001|Overall Study|Other than specified above|3
1027859|NCT01644188|2056175|FG000|Overall Study|Adverse Event|44
1027860|NCT01644188|2056176|FG001|Overall Study|Adverse Event|20
1027861|NCT01644188|2056175|FG000|Overall Study|Poor compliance to protocol|26
1027862|NCT01644188|2056176|FG001|Overall Study|Poor compliance to protocol|14
1027863|NCT01644188|2056175|FG000|Overall Study|Physician Decision|1
1027864|NCT01644188|2056176|FG001|Overall Study|Physician Decision|3
1027865|NCT01644188|2056175|FG000|Overall Study|Participant moved|7
1027866|NCT01644188|2056176|FG001|Overall Study|Participant moved|2
1027867|NCT01644188|2056175|FG000|Overall Study|Related to auto-injector administration|2
1027868|NCT01644188|2056176|FG001|Overall Study|Related to auto-injector administration|2
1027869|NCT01644188|2056175|FG000|Overall Study|Consent withdrawn by participant|14
1027870|NCT01644188|2056176|FG001|Overall Study|Consent withdrawn by participant|7
1027871|NCT01644188|2056175|FG000|Overall Study|Selection criteria finally not met|2
1027872|NCT01644188|2056176|FG001|Overall Study|Selection criteria finally not met|0
1027873|NCT01644188|2056175|FG000|Overall Study|Lost to Follow-up|1
1027874|NCT01644188|2056176|FG001|Overall Study|Lost to Follow-up|0
1027875|NCT01644188|2056175|FG000|Overall Study|Death|4
1027876|NCT01644188|2056176|FG001|Overall Study|Death|3
1027877|NCT01644188|2056175|FG000|Overall Study|Last visit outside protocol visit window|14
1027878|NCT01644188|2056176|FG001|Overall Study|Last visit outside protocol visit window|16
1027879|NCT01644188|2056175|FG000|Overall Study|Site closure|1
1027880|NCT01644188|2056176|FG001|Overall Study|Site closure|1
1027881|NCT01644188|2056175|FG000|Overall Study|Other than specified above|6
1027882|NCT01644188|2056176|FG001|Overall Study|Other than specified above|7
1027883|NCT01644474|2056215|FG000|Overall Study|Poor compliance to protocol|1
1027884|NCT01644474|2056216|FG001|Overall Study|Poor compliance to protocol|0
1027885|NCT01644474|2056215|FG000|Overall Study|Consent withdrawn by participant|0
1027886|NCT01644474|2056216|FG001|Overall Study|Consent withdrawn by participant|1
1027887|NCT01644474|2056215|FG000|Overall Study|Participant moved|0
1027888|NCT01644474|2056216|FG001|Overall Study|Participant moved|1
1027889|NCT01644474|2056215|FG000|Overall Study|Adverse Event|4
1027890|NCT01644474|2056216|FG001|Overall Study|Adverse Event|5
1027891|NCT01644474|2056215|FG000|Overall Study|Site scheduling error|1
1027892|NCT01644474|2056216|FG001|Overall Study|Site scheduling error|1
1027893|NCT01644474|2056215|FG000|Overall Study|Protocol Violation|1
1027894|NCT01644474|2056216|FG001|Overall Study|Protocol Violation|0
1027895|NCT01644500|2056225|FG000|Overall Study|Adverse Event|6
1027896|NCT01644500|2056226|FG001|Overall Study|Adverse Event|1
1027897|NCT01644500|2056227|FG002|Overall Study|Adverse Event|2
1027898|NCT01644500|2056225|FG000|Overall Study|Death|0
1027899|NCT01644500|2056226|FG001|Overall Study|Death|1
1027900|NCT01644500|2056227|FG002|Overall Study|Death|0
1027901|NCT01644500|2056225|FG000|Overall Study|Lost to Follow-up|3
1027902|NCT01644500|2056226|FG001|Overall Study|Lost to Follow-up|8
1027903|NCT01644500|2056227|FG002|Overall Study|Lost to Follow-up|0
1027904|NCT01644500|2056225|FG000|Overall Study|Protocol Violation|1
1027905|NCT01644500|2056226|FG001|Overall Study|Protocol Violation|1
1027906|NCT01644500|2056227|FG002|Overall Study|Protocol Violation|0
1027907|NCT01644500|2056225|FG000|Overall Study|Withdrawal by Subject|11
1027908|NCT01644500|2056226|FG001|Overall Study|Withdrawal by Subject|12
1027909|NCT01644500|2056227|FG002|Overall Study|Withdrawal by Subject|12
1027910|NCT01644500|2056225|FG000|Overall Study|Physician Decision|1
1027911|NCT01644500|2056226|FG001|Overall Study|Physician Decision|1
1027912|NCT01644500|2056227|FG002|Overall Study|Physician Decision|1
1027913|NCT01644565|2056235|FG000|Overall Study|Undisclosed Medical History|1
1027914|NCT01644565|2056236|FG001|Overall Study|Undisclosed Medical History|0
1027915|NCT01644565|2056237|FG002|Overall Study|Undisclosed Medical History|0
1027916|NCT01644565|2056238|FG003|Overall Study|Undisclosed Medical History|0
1027917|NCT01644565|2056239|FG004|Overall Study|Undisclosed Medical History|0
1027918|NCT01644565|2056240|FG005|Overall Study|Undisclosed Medical History|0
1027919|NCT01644565|2056241|FG006|Overall Study|Undisclosed Medical History|0
1027920|NCT01644565|2056242|FG007|Overall Study|Undisclosed Medical History|0
1027921|NCT01644565|2056243|FG008|Overall Study|Undisclosed Medical History|0
1027922|NCT01644565|2056235|FG000|Overall Study|Lost to Follow-up|0
1027923|NCT01644565|2056236|FG001|Overall Study|Lost to Follow-up|0
1027924|NCT01644565|2056237|FG002|Overall Study|Lost to Follow-up|0
1027925|NCT01644565|2056238|FG003|Overall Study|Lost to Follow-up|1
1027926|NCT01644565|2056239|FG004|Overall Study|Lost to Follow-up|0
1027927|NCT01644565|2056240|FG005|Overall Study|Lost to Follow-up|0
1027928|NCT01644565|2056241|FG006|Overall Study|Lost to Follow-up|0
1027929|NCT01644565|2056242|FG007|Overall Study|Lost to Follow-up|2
1027930|NCT01644565|2056243|FG008|Overall Study|Lost to Follow-up|0
1027931|NCT01644565|2056235|FG000|Overall Study|Family emergency|0
1027932|NCT01644565|2056236|FG001|Overall Study|Family emergency|0
1027933|NCT01644565|2056237|FG002|Overall Study|Family emergency|0
1027934|NCT01644565|2056238|FG003|Overall Study|Family emergency|0
1027935|NCT01644565|2056239|FG004|Overall Study|Family emergency|1
1027936|NCT01644565|2056240|FG005|Overall Study|Family emergency|0
1027937|NCT01644565|2056241|FG006|Overall Study|Family emergency|0
1027938|NCT01644565|2056242|FG007|Overall Study|Family emergency|0
1027939|NCT01644565|2056243|FG008|Overall Study|Family emergency|0
1027940|NCT01644565|2056235|FG000|Overall Study|Relocation|0
1027941|NCT01644565|2056236|FG001|Overall Study|Relocation|0
1027942|NCT01644565|2056237|FG002|Overall Study|Relocation|0
1027943|NCT01644565|2056238|FG003|Overall Study|Relocation|0
1027944|NCT01644565|2056239|FG004|Overall Study|Relocation|0
1027945|NCT01644565|2056240|FG005|Overall Study|Relocation|0
1027946|NCT01644565|2056241|FG006|Overall Study|Relocation|0
1027947|NCT01644565|2056242|FG007|Overall Study|Relocation|0
1027948|NCT01644565|2056243|FG008|Overall Study|Relocation|1
1027949|NCT01644617|2056266|FG000|Overall Study|Withdrawal by Subject|3
1027950|NCT01644617|2056267|FG001|Overall Study|Withdrawal by Subject|4
1027951|NCT01644617|2056268|FG002|Overall Study|Withdrawal by Subject|1
1027952|NCT01644617|2056266|FG000|Overall Study|Lost to Follow-up|0
1027953|NCT01644617|2056267|FG001|Overall Study|Lost to Follow-up|1
1027954|NCT01644617|2056268|FG002|Overall Study|Lost to Follow-up|0
1027955|NCT01644617|2056266|FG000|Overall Study|Adverse Event|3
1027956|NCT01644617|2056267|FG001|Overall Study|Adverse Event|0
1027957|NCT01644617|2056268|FG002|Overall Study|Adverse Event|6
1027958|NCT01644643|2056280|FG000|Overall Study|Death|1
1027959|NCT01644643|2056281|FG001|Overall Study|Death|0
1027960|NCT01644643|2056282|FG002|Overall Study|Death|3
1027961|NCT01644643|2056283|FG003|Overall Study|Death|3
1027962|NCT01644643|2056280|FG000|Overall Study|Lost to Follow-up|0
1027963|NCT01644643|2056281|FG001|Overall Study|Lost to Follow-up|0
1027964|NCT01644643|2056282|FG002|Overall Study|Lost to Follow-up|0
1027965|NCT01644643|2056283|FG003|Overall Study|Lost to Follow-up|4
1027966|NCT01644643|2056280|FG000|Overall Study|Withdrawal by Subject|1
1027967|NCT01644643|2056281|FG001|Overall Study|Withdrawal by Subject|0
1027968|NCT01644643|2056282|FG002|Overall Study|Withdrawal by Subject|2
1027969|NCT01644643|2056283|FG003|Overall Study|Withdrawal by Subject|1
1027970|NCT01644643|2056280|FG000|Overall Study|Other Eligibility criteria|0
1027971|NCT01644643|2056281|FG001|Overall Study|Other Eligibility criteria|0
1027972|NCT01644643|2056282|FG002|Overall Study|Other Eligibility criteria|0
1027973|NCT01644643|2056283|FG003|Overall Study|Other Eligibility criteria|2
1027974|NCT01644734|2056303|FG000|Overall Study|Adverse Event|4
1027975|NCT01644734|2056303|FG000|Overall Study|Lost to Follow-up|17
1027976|NCT01644734|2056303|FG000|Overall Study|Reasons other than stated above|7
1027977|NCT01644734|2056303|FG000|Overall Study|Missing documentation|238
1027978|NCT01644890|2056309|FG000|Overall Study|Adverse Event|7
1027979|NCT01644890|2056310|FG001|Overall Study|Adverse Event|20
1027980|NCT01644890|2056309|FG000|Overall Study|Death|1
1027981|NCT01644890|2056310|FG001|Overall Study|Death|3
1027982|NCT01644890|2056309|FG000|Overall Study|Physician Decision|3
1027983|NCT01644890|2056310|FG001|Overall Study|Physician Decision|9
1027984|NCT01644890|2056309|FG000|Overall Study|Protocol Violation|6
1027985|NCT01644890|2056310|FG001|Overall Study|Protocol Violation|7
1027986|NCT01644890|2056309|FG000|Overall Study|Withdrawal by Subject|19
1027987|NCT01644890|2056310|FG001|Overall Study|Withdrawal by Subject|27
1027988|NCT01644890|2056309|FG000|Overall Study|Progression Disease|160
1027989|NCT01644890|2056310|FG001|Overall Study|Progression Disease|131
1027990|NCT01644890|2056309|FG000|Overall Study|Clinical Progression|6
1027991|NCT01644890|2056310|FG001|Overall Study|Clinical Progression|6
1027992|NCT01644890|2056309|FG000|Overall Study|> 28 days since last dose of study drug|6
1027993|NCT01644890|2056310|FG001|Overall Study|> 28 days since last dose of study drug|3
1027994|NCT01644890|2056309|FG000|Overall Study|Other|8
1027995|NCT01644890|2056310|FG001|Overall Study|Other|9
1027996|NCT01645111|2056334|FG000|Overall Study|Did not require Clevidipine|15
1027997|NCT01645176|2056338|FG000|Overall Study|Lack of Efficacy|4
1027998|NCT01645176|2056338|FG000|Overall Study|did not complete final MRI|1
1027999|NCT01645280|2056347|FG000|Overall Study|Death|0
1028000|NCT01645280|2056348|FG001|Overall Study|Death|1
1028001|NCT01645280|2056349|FG002|Overall Study|Death|0
1028002|NCT01645280|2056350|FG003|Overall Study|Death|0
1028003|NCT01645280|2056351|FG004|Overall Study|Death|0
1028004|NCT01645280|2056347|FG000|Overall Study|Withdrawal by Subject|4
1028005|NCT01645280|2056348|FG001|Overall Study|Withdrawal by Subject|0
1028006|NCT01645280|2056349|FG002|Overall Study|Withdrawal by Subject|2
1028007|NCT01645280|2056350|FG003|Overall Study|Withdrawal by Subject|4
1028008|NCT01645280|2056351|FG004|Overall Study|Withdrawal by Subject|5
1028009|NCT01645280|2056347|FG000|Overall Study|Lost to Follow-up|0
1028010|NCT01645280|2056348|FG001|Overall Study|Lost to Follow-up|0
1028011|NCT01645280|2056349|FG002|Overall Study|Lost to Follow-up|0
1028012|NCT01645280|2056350|FG003|Overall Study|Lost to Follow-up|2
1028013|NCT01645280|2056351|FG004|Overall Study|Lost to Follow-up|1
1028014|NCT01645280|2056347|FG000|Overall Study|Other|1
1028015|NCT01645280|2056348|FG001|Overall Study|Other|1
1028016|NCT01645280|2056349|FG002|Overall Study|Other|2
1028017|NCT01645280|2056350|FG003|Overall Study|Other|0
1028018|NCT01645280|2056351|FG004|Overall Study|Other|0
1028019|NCT01645280|2056347|FG000|Overall Study|Treatment not completed/Completed f/u|1
1028020|NCT01645280|2056348|FG001|Overall Study|Treatment not completed/Completed f/u|1
1028021|NCT01645280|2056349|FG002|Overall Study|Treatment not completed/Completed f/u|2
1028022|NCT01645280|2056350|FG003|Overall Study|Treatment not completed/Completed f/u|0
1028023|NCT01645280|2056351|FG004|Overall Study|Treatment not completed/Completed f/u|2
1028024|NCT01645735|2056379|FG000|Overall Study|Physician Decision|2
1028025|NCT01645735|2056380|FG001|Overall Study|Physician Decision|0
1028026|NCT01645735|2056379|FG000|Overall Study|Withdrawal by Subject|1
1028027|NCT01645735|2056380|FG001|Overall Study|Withdrawal by Subject|0
1028028|NCT01645735|2056379|FG000|Overall Study|Protocol Violation|1
1028029|NCT01645735|2056380|FG001|Overall Study|Protocol Violation|0
1028030|NCT01645735|2056379|FG000|Overall Study|Adverse Event|0
1028031|NCT01645735|2056380|FG001|Overall Study|Adverse Event|1
1028032|NCT01645930|2056387|FG000|Overall Study|Participants Ongoing on Study Treatment|22
1028033|NCT01645930|2056387|FG000|Overall Study|Progressive Disease|12
1028034|NCT01645930|2056387|FG000|Overall Study|Adverse Event|4
1028035|NCT01645930|2056387|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
1028036|NCT01645930|2056387|FG000|Overall Study|Withdrawal by Participant|2
1028037|NCT01645930|2056387|FG000|Overall Study|Reason not Defined|1
1028038|NCT01646021|2056393|FG000|Overall Study|Death|77
1028039|NCT01646021|2056394|FG001|Overall Study|Death|83
1028040|NCT01646021|2056393|FG000|Overall Study|Study Terminated by Sponsor|50
1028041|NCT01646021|2056394|FG001|Overall Study|Study Terminated by Sponsor|41
1028042|NCT01646021|2056393|FG000|Overall Study|Lost to Follow-up|2
1028043|NCT01646021|2056394|FG001|Overall Study|Lost to Follow-up|2
1028044|NCT01646021|2056393|FG000|Overall Study|Withdrawal by Subject|10
1028045|NCT01646021|2056394|FG001|Overall Study|Withdrawal by Subject|15
1028046|NCT01646073|2056402|FG000|Period A (12 Weeks)|Adverse Event|0
1028047|NCT01646073|2056403|FG001|Period A (12 Weeks)|Adverse Event|2
1028048|NCT01646073|2056402|FG000|Period A (12 Weeks)|Withdrawal by Subject|1
1028049|NCT01646073|2056403|FG001|Period A (12 Weeks)|Withdrawal by Subject|1
1028050|NCT01646073|2056402|FG000|Period A (12 Weeks)|Lack of Efficacy|1
1028051|NCT01646073|2056403|FG001|Period A (12 Weeks)|Lack of Efficacy|0
1028052|NCT01646073|2056402|FG000|Period A (12 Weeks)|Protocol Violation|0
1028053|NCT01646073|2056403|FG001|Period A (12 Weeks)|Protocol Violation|1
1028054|NCT01646073|2056402|FG000|Period A (12 Weeks)|Other|0
1028055|NCT01646073|2056403|FG001|Period A (12 Weeks)|Other|1
1028056|NCT01646073|2056402|FG000|Period B (12 Weeks)|Adverse Event|0
1028057|NCT01646073|2056403|FG001|Period B (12 Weeks)|Adverse Event|7
1028058|NCT01646073|2056402|FG000|Period B (12 Weeks)|Withdrawal by Subject|1
1028059|NCT01646073|2056403|FG001|Period B (12 Weeks)|Withdrawal by Subject|5
1028060|NCT01646073|2056402|FG000|Period B (12 Weeks)|Lost to Follow-up|0
1028061|NCT01646073|2056403|FG001|Period B (12 Weeks)|Lost to Follow-up|1
1028062|NCT01646125|2056414|FG000|Overall Study|Untreated|2
1028063|NCT01646125|2056415|FG001|Overall Study|Untreated|5
1028064|NCT01646125|2056414|FG000|Overall Study|Adverse Event|2
1028065|NCT01646125|2056415|FG001|Overall Study|Adverse Event|1
1028066|NCT01646125|2056414|FG000|Overall Study|Death|1
1028067|NCT01646125|2056415|FG001|Overall Study|Death|1
1028068|NCT01646125|2056414|FG000|Overall Study|Physician Decision|1
1028069|NCT01646125|2056415|FG001|Overall Study|Physician Decision|3
1028070|NCT01646125|2056414|FG000|Overall Study|Progressive disease|22
1028071|NCT01646125|2056415|FG001|Overall Study|Progressive disease|16
1028072|NCT01646125|2056414|FG000|Overall Study|Study terminated by sponsor|2
1028073|NCT01646125|2056415|FG001|Overall Study|Study terminated by sponsor|1
1028074|NCT01646125|2056414|FG000|Overall Study|Subject/Guardian decision|1
1028075|NCT01646125|2056415|FG001|Overall Study|Subject/Guardian decision|1
1028076|NCT01646138|2056427|FG000|Overall Study|Lost to Follow-up|0
1028077|NCT01646138|2056428|FG001|Overall Study|Lost to Follow-up|0
1028078|NCT01646138|2056429|FG002|Overall Study|Lost to Follow-up|0
1028079|NCT01646138|2056430|FG003|Overall Study|Lost to Follow-up|0
1028080|NCT01646138|2056431|FG004|Overall Study|Lost to Follow-up|2
1028081|NCT01646177|2056451|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
1028082|NCT01646177|2056452|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
1028083|NCT01646177|2056453|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
1028084|NCT01646177|2056454|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
1028085|NCT01646177|2056455|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
1028086|NCT01646177|2056456|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
1162021|NCT03380429|2283929|FG002|Overall Study|Lack of Efficacy|0
1028087|NCT01646177|2056457|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
1028088|NCT01646177|2056458|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
1028089|NCT01646177|2056459|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
1028090|NCT01646177|2056460|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
1028091|NCT01646177|2056461|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
1028092|NCT01646177|2056462|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
1028093|NCT01646177|2056451|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
1028094|NCT01646177|2056452|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
1028095|NCT01646177|2056453|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
1028096|NCT01646177|2056454|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
1028097|NCT01646177|2056455|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
1028098|NCT01646177|2056456|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
1028099|NCT01646177|2056457|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
1028100|NCT01646177|2056458|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
1028101|NCT01646177|2056459|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
1028102|NCT01646177|2056460|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
1028103|NCT01646177|2056461|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
1028104|NCT01646177|2056462|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
1028105|NCT01646177|2056451|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
1028106|NCT01646177|2056452|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
1028107|NCT01646177|2056453|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
1028108|NCT01646177|2056454|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
1028109|NCT01646177|2056455|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
1028110|NCT01646177|2056456|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
1028111|NCT01646177|2056457|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
1028112|NCT01646177|2056458|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
1028113|NCT01646177|2056459|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
1028114|NCT01646177|2056460|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
1028115|NCT01646177|2056461|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
1028116|NCT01646177|2056462|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
1028117|NCT01646177|2056451|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
1028118|NCT01646177|2056452|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
1028119|NCT01646177|2056453|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
1028120|NCT01646177|2056454|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
1028121|NCT01646177|2056455|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
1028122|NCT01646177|2056456|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
1028123|NCT01646177|2056457|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
1028124|NCT01646177|2056458|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
1028125|NCT01646177|2056459|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
1028126|NCT01646177|2056460|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
1028127|NCT01646177|2056461|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
1028128|NCT01646177|2056462|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
1028129|NCT01646177|2056451|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1028130|NCT01646177|2056452|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1028131|NCT01646177|2056453|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
1028132|NCT01646177|2056454|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
1028133|NCT01646177|2056455|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1028134|NCT01646177|2056456|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1028135|NCT01646177|2056457|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1028136|NCT01646177|2056458|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1028137|NCT01646177|2056459|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1028138|NCT01646177|2056460|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1028139|NCT01646177|2056461|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1028140|NCT01646177|2056462|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1028141|NCT01646177|2056451|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
1028142|NCT01646177|2056452|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
1028143|NCT01646177|2056453|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
1028144|NCT01646177|2056454|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1028145|NCT01646177|2056455|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1028146|NCT01646177|2056456|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1028147|NCT01646177|2056457|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1028148|NCT01646177|2056458|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1028149|NCT01646177|2056459|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1028150|NCT01646177|2056460|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1028151|NCT01646177|2056461|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1028152|NCT01646177|2056462|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1028153|NCT01646177|2056451|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0
1028154|NCT01646177|2056452|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0
1162022|NCT03380429|2283930|FG003|Overall Study|Lack of Efficacy|2
1028155|NCT01646177|2056453|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0
1028156|NCT01646177|2056454|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0
1028157|NCT01646177|2056455|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16
1028158|NCT01646177|2056456|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34
1028159|NCT01646177|2056457|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43
1028160|NCT01646177|2056458|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30
1028161|NCT01646177|2056459|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0
1028162|NCT01646177|2056460|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0
1028163|NCT01646177|2056461|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0
1028164|NCT01646177|2056462|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0
1028165|NCT01646177|2056451|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
1028166|NCT01646177|2056452|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
1028167|NCT01646177|2056453|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
1028168|NCT01646177|2056454|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
1028169|NCT01646177|2056455|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11
1028170|NCT01646177|2056456|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30
1028171|NCT01646177|2056457|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29
1028172|NCT01646177|2056458|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27
1028173|NCT01646177|2056459|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
1028174|NCT01646177|2056460|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
1028175|NCT01646177|2056461|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
1028176|NCT01646177|2056462|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
1028177|NCT01646177|2056451|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
1028178|NCT01646177|2056452|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
1028179|NCT01646177|2056453|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
1028180|NCT01646177|2056454|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
1028181|NCT01646177|2056455|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6
1028182|NCT01646177|2056456|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17
1028183|NCT01646177|2056457|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23
1028184|NCT01646177|2056458|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18
1028185|NCT01646177|2056459|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
1028186|NCT01646177|2056460|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
1028187|NCT01646177|2056461|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
1028188|NCT01646177|2056462|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
1028189|NCT01646177|2056451|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
1028190|NCT01646177|2056452|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
1028191|NCT01646177|2056453|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
1028192|NCT01646177|2056454|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
1028193|NCT01646177|2056455|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6
1028194|NCT01646177|2056456|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14
1028195|NCT01646177|2056457|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10
1028196|NCT01646177|2056458|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11
1028197|NCT01646177|2056459|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
1028198|NCT01646177|2056460|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
1028199|NCT01646177|2056461|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
1028200|NCT01646177|2056462|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
1028201|NCT01646177|2056451|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0
1028202|NCT01646177|2056452|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0
1028203|NCT01646177|2056453|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0
1028204|NCT01646177|2056454|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0
1028205|NCT01646177|2056455|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3
1028206|NCT01646177|2056456|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5
1028207|NCT01646177|2056457|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5
1028208|NCT01646177|2056458|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5
1028209|NCT01646177|2056459|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0
1028210|NCT01646177|2056460|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0
1028211|NCT01646177|2056461|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0
1028212|NCT01646177|2056462|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0
1028213|NCT01646177|2056451|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
1028214|NCT01646177|2056452|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
1028215|NCT01646177|2056453|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
1028216|NCT01646177|2056454|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
1028217|NCT01646177|2056455|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1
1028218|NCT01646177|2056456|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4
1028219|NCT01646177|2056457|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
1028220|NCT01646177|2056458|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5
1028221|NCT01646177|2056459|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
1028222|NCT01646177|2056460|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
1028223|NCT01646177|2056461|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
1028224|NCT01646177|2056462|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
1028225|NCT01646177|2056451|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
1028226|NCT01646177|2056452|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
1028227|NCT01646177|2056453|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
1028228|NCT01646177|2056454|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
1028229|NCT01646177|2056455|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3
1028230|NCT01646177|2056456|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
1028231|NCT01646177|2056457|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
1028232|NCT01646177|2056458|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
1028233|NCT01646177|2056459|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
1028234|NCT01646177|2056460|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
1028235|NCT01646177|2056461|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
1028236|NCT01646177|2056462|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
1028237|NCT01646177|2056451|FG000|Long-Term Extension Period (Week 12-264)|Death|0
1028238|NCT01646177|2056452|FG001|Long-Term Extension Period (Week 12-264)|Death|0
1028239|NCT01646177|2056453|FG002|Long-Term Extension Period (Week 12-264)|Death|0
1028240|NCT01646177|2056454|FG003|Long-Term Extension Period (Week 12-264)|Death|0
1028241|NCT01646177|2056455|FG004|Long-Term Extension Period (Week 12-264)|Death|1
1028242|NCT01646177|2056456|FG005|Long-Term Extension Period (Week 12-264)|Death|3
1028243|NCT01646177|2056457|FG006|Long-Term Extension Period (Week 12-264)|Death|1
1028244|NCT01646177|2056458|FG007|Long-Term Extension Period (Week 12-264)|Death|3
1028245|NCT01646177|2056459|FG008|Long-Term Extension Period (Week 12-264)|Death|0
1028246|NCT01646177|2056460|FG009|Long-Term Extension Period (Week 12-264)|Death|0
1028247|NCT01646177|2056461|FG010|Long-Term Extension Period (Week 12-264)|Death|0
1028248|NCT01646177|2056462|FG011|Long-Term Extension Period (Week 12-264)|Death|0
1028249|NCT01646177|2056451|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
1028250|NCT01646177|2056452|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
1028251|NCT01646177|2056453|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
1028252|NCT01646177|2056454|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
1028253|NCT01646177|2056455|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
1028254|NCT01646177|2056456|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
1028255|NCT01646177|2056457|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
1028256|NCT01646177|2056458|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4
1028257|NCT01646177|2056459|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
1028258|NCT01646177|2056460|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
1028259|NCT01646177|2056461|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
1028260|NCT01646177|2056462|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
1028261|NCT01646177|2056451|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
1028262|NCT01646177|2056452|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
1028263|NCT01646177|2056453|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
1028264|NCT01646177|2056454|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
1028265|NCT01646177|2056455|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
1028266|NCT01646177|2056456|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
1028267|NCT01646177|2056457|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
1028268|NCT01646177|2056458|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1
1028269|NCT01646177|2056459|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
1028270|NCT01646177|2056460|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
1028271|NCT01646177|2056461|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
1028272|NCT01646177|2056462|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
1028273|NCT01646177|2056451|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
1028274|NCT01646177|2056452|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
1028275|NCT01646177|2056453|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
1028276|NCT01646177|2056454|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
1028277|NCT01646177|2056455|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
1028278|NCT01646177|2056456|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3
1028279|NCT01646177|2056457|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2
1028280|NCT01646177|2056458|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1
1028281|NCT01646177|2056459|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
1028282|NCT01646177|2056460|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
1028283|NCT01646177|2056461|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
1028284|NCT01646177|2056462|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
1028285|NCT01646177|2056451|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
1028286|NCT01646177|2056452|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
1028287|NCT01646177|2056453|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
1028288|NCT01646177|2056454|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
1028289|NCT01646177|2056455|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
1028290|NCT01646177|2056456|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
1028291|NCT01646177|2056457|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
1028292|NCT01646177|2056458|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
1028293|NCT01646177|2056459|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13
1028294|NCT01646177|2056460|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28
1028295|NCT01646177|2056461|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34
1028296|NCT01646177|2056462|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30
1028297|NCT01646177|2056451|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
1028298|NCT01646177|2056452|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
1028299|NCT01646177|2056453|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
1028300|NCT01646177|2056454|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
1028301|NCT01646177|2056455|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
1028302|NCT01646177|2056456|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
1028303|NCT01646177|2056457|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
1028304|NCT01646177|2056458|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
1028305|NCT01646177|2056459|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7
1028306|NCT01646177|2056460|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21
1028307|NCT01646177|2056461|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
1028308|NCT01646177|2056462|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
1028309|NCT01646177|2056451|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
1028310|NCT01646177|2056452|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
1028311|NCT01646177|2056453|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
1028312|NCT01646177|2056454|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
1028313|NCT01646177|2056455|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
1028314|NCT01646177|2056456|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
1028315|NCT01646177|2056457|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
1028316|NCT01646177|2056458|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
1028317|NCT01646177|2056459|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4
1028318|NCT01646177|2056460|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8
1028319|NCT01646177|2056461|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
1028320|NCT01646177|2056462|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
1028321|NCT01646177|2056451|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
1028322|NCT01646177|2056452|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
1028323|NCT01646177|2056453|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
1028324|NCT01646177|2056454|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
1028325|NCT01646177|2056455|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
1028326|NCT01646177|2056456|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
1028327|NCT01646177|2056457|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
1028328|NCT01646177|2056458|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
1028329|NCT01646177|2056459|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4
1028330|NCT01646177|2056460|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
1028331|NCT01646177|2056461|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8
1028332|NCT01646177|2056462|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
1028333|NCT01646177|2056451|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
1028334|NCT01646177|2056452|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
1028335|NCT01646177|2056453|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
1028336|NCT01646177|2056454|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
1028337|NCT01646177|2056455|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
1028338|NCT01646177|2056456|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
1028339|NCT01646177|2056457|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
1028340|NCT01646177|2056458|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
1028341|NCT01646177|2056459|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1
1028342|NCT01646177|2056460|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6
1028343|NCT01646177|2056461|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4
1028344|NCT01646177|2056462|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7
1028345|NCT01646177|2056451|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
1028346|NCT01646177|2056452|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
1028347|NCT01646177|2056453|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
1028348|NCT01646177|2056454|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
1028349|NCT01646177|2056455|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
1028350|NCT01646177|2056456|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
1028351|NCT01646177|2056457|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
1028352|NCT01646177|2056458|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
1028353|NCT01646177|2056459|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1
1028354|NCT01646177|2056460|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
1028355|NCT01646177|2056461|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
1028356|NCT01646177|2056462|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3
1028357|NCT01646177|2056451|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
1028358|NCT01646177|2056452|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
1028359|NCT01646177|2056453|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
1028360|NCT01646177|2056454|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
1028361|NCT01646177|2056455|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
1028362|NCT01646177|2056456|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
1028363|NCT01646177|2056457|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
1028364|NCT01646177|2056458|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
1028365|NCT01646177|2056459|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
1028366|NCT01646177|2056460|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
1028367|NCT01646177|2056461|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
1028368|NCT01646177|2056462|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3
1028369|NCT01646177|2056451|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
1028370|NCT01646177|2056452|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
1028371|NCT01646177|2056453|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
1028372|NCT01646177|2056454|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
1028373|NCT01646177|2056455|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
1028374|NCT01646177|2056456|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
1028375|NCT01646177|2056457|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
1028376|NCT01646177|2056458|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
1028377|NCT01646177|2056459|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
1028378|NCT01646177|2056460|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
1028379|NCT01646177|2056461|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
1028380|NCT01646177|2056462|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
1028381|NCT01646177|2056451|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0
1028382|NCT01646177|2056452|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0
1028383|NCT01646177|2056453|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0
1028384|NCT01646177|2056454|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0
1028385|NCT01646177|2056455|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0
1028386|NCT01646177|2056456|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0
1028387|NCT01646177|2056457|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0
1028388|NCT01646177|2056458|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0
1028389|NCT01646177|2056459|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1
1028390|NCT01646177|2056460|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0
1028391|NCT01646177|2056461|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1
1028392|NCT01646177|2056462|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1
1028393|NCT01646177|2056451|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
1028394|NCT01646177|2056452|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
1028395|NCT01646177|2056453|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
1028396|NCT01646177|2056454|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
1028397|NCT01646177|2056455|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
1028398|NCT01646177|2056456|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
1028399|NCT01646177|2056457|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
1028400|NCT01646177|2056458|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
1028401|NCT01646177|2056459|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
1028402|NCT01646177|2056460|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
1028403|NCT01646177|2056461|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
1028404|NCT01646177|2056462|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
1028405|NCT01646203|2056485|FG000|Overall Study|Adverse Event|2
1028406|NCT01646203|2056486|FG001|Overall Study|Adverse Event|0
1028407|NCT01646203|2056487|FG002|Overall Study|Adverse Event|1
1028408|NCT01646203|2056485|FG000|Overall Study|Withdrawal by Subject|0
1028409|NCT01646203|2056486|FG001|Overall Study|Withdrawal by Subject|1
1028410|NCT01646203|2056487|FG002|Overall Study|Withdrawal by Subject|0
1028411|NCT01646203|2056485|FG000|Overall Study|Physician's Decision|0
1028412|NCT01646203|2056486|FG001|Overall Study|Physician's Decision|1
1028413|NCT01646203|2056487|FG002|Overall Study|Physician's Decision|0
1028414|NCT01646216|2056502|FG000|Overall Study|Baseline step length difference (<5cm)|10
1028415|NCT01646216|2056503|FG001|Overall Study|Baseline step length difference (<5cm)|10
1028416|NCT01646216|2056502|FG000|Overall Study|Did not complete training|0
1028417|NCT01646216|2056503|FG001|Overall Study|Did not complete training|2
1028418|NCT01646216|2056502|FG000|Overall Study|Investigator decision|1
1028419|NCT01646216|2056503|FG001|Overall Study|Investigator decision|1
1028420|NCT01646255|2056515|FG000|Overall Study|Adverse Event|7
1028421|NCT01646255|2056516|FG001|Overall Study|Adverse Event|8
1028422|NCT01646255|2056515|FG000|Overall Study|Lack of Efficacy|2
1028423|NCT01646255|2056516|FG001|Overall Study|Lack of Efficacy|0
1028424|NCT01646255|2056515|FG000|Overall Study|Withdrawal by Subject|10
1028425|NCT01646255|2056516|FG001|Overall Study|Withdrawal by Subject|6
1028426|NCT01646255|2056515|FG000|Overall Study|Compliance is not well|1
1028427|NCT01646255|2056516|FG001|Overall Study|Compliance is not well|0
1028428|NCT01646255|2056515|FG000|Overall Study|Inclusion Criteria Deviation|1
1028429|NCT01646255|2056516|FG001|Overall Study|Inclusion Criteria Deviation|0
1028430|NCT01646268|2056525|FG000|Overall Study|Adverse Event|6
1028431|NCT01646268|2056526|FG001|Overall Study|Adverse Event|7
1028432|NCT01646268|2056525|FG000|Overall Study|Lack of Efficacy|1
1028433|NCT01646268|2056526|FG001|Overall Study|Lack of Efficacy|3
1028434|NCT01646268|2056525|FG000|Overall Study|Protocol Violation|0
1028435|NCT01646268|2056526|FG001|Overall Study|Protocol Violation|1
1028436|NCT01646268|2056525|FG000|Overall Study|Withdrawal by Subject|2
1028437|NCT01646268|2056526|FG001|Overall Study|Withdrawal by Subject|5
1028438|NCT01646268|2056525|FG000|Overall Study|Other|2
1028439|NCT01646268|2056526|FG001|Overall Study|Other|0
1028440|NCT01646320|2056534|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3
1028441|NCT01646320|2056535|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0
1028442|NCT01646320|2056534|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
1028443|NCT01646320|2056535|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
1028444|NCT01646320|2056534|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2
1028445|NCT01646320|2056535|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2
1028446|NCT01646320|2056534|FG000|Short-term Period (Day 1 to Week 24)|Other|1
1028447|NCT01646320|2056535|FG001|Short-term Period (Day 1 to Week 24)|Other|0
1028448|NCT01646320|2056534|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1028449|NCT01646320|2056535|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1028450|NCT01646320|2056534|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
1028451|NCT01646320|2056535|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
1028452|NCT01646320|2056534|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
1028453|NCT01646320|2056535|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
1028454|NCT01646320|2056534|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
1028455|NCT01646320|2056535|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
1028456|NCT01646320|2056534|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4
1028457|NCT01646320|2056535|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2
1028458|NCT01646320|2056534|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
1028459|NCT01646320|2056535|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
1028460|NCT01646320|2056534|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
1028461|NCT01646320|2056535|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
1028462|NCT01646385|2056547|FG000|Overall Study|Death|202
1028463|NCT01646385|2056548|FG001|Overall Study|Death|222
1028464|NCT01646385|2056547|FG000|Overall Study|Switched to alternate biologic|636
1028465|NCT01646385|2056548|FG001|Overall Study|Switched to alternate biologic|649
1028466|NCT01646398|2056556|FG000|Overall Study|Withdrawal by Subject|1
1028467|NCT01646398|2056557|FG001|Overall Study|Withdrawal by Subject|0
1028468|NCT01646645|2056563|FG000|Overall Study|No Treated|1
1028469|NCT01646645|2056563|FG000|Overall Study|Inevaluable Donor|29
1028470|NCT01646827|2056597|FG000|Overall Study|Lost to Follow-up|0
1028471|NCT01646827|2056598|FG001|Overall Study|Lost to Follow-up|3
1028472|NCT01646827|2056597|FG000|Overall Study|Physician Decision|1
1028473|NCT01646827|2056598|FG001|Overall Study|Physician Decision|2
1028474|NCT01646827|2056597|FG000|Overall Study|Withdrawal by Subject|1
1028475|NCT01646827|2056598|FG001|Overall Study|Withdrawal by Subject|0
1028476|NCT01647282|2056617|FG000|Overall Study|Physician Decision|7
1028477|NCT01647282|2056618|FG001|Overall Study|Physician Decision|5
1028478|NCT01647516|2056640|FG000|Induction Period (IP)|Physician Decision|2
1028479|NCT01647516|2056641|FG001|Induction Period (IP)|Physician Decision|0
1028480|NCT01647516|2056642|FG002|Induction Period (IP)|Physician Decision|0
1028481|NCT01647516|2056643|FG003|Induction Period (IP)|Physician Decision|0
1028482|NCT01647516|2056644|FG004|Induction Period (IP)|Physician Decision|0
1028483|NCT01647516|2056645|FG005|Induction Period (IP)|Physician Decision|0
1028484|NCT01647516|2056640|FG000|Induction Period (IP)|Adverse Event|1
1028485|NCT01647516|2056641|FG001|Induction Period (IP)|Adverse Event|2
1028486|NCT01647516|2056642|FG002|Induction Period (IP)|Adverse Event|0
1028487|NCT01647516|2056643|FG003|Induction Period (IP)|Adverse Event|0
1028488|NCT01647516|2056644|FG004|Induction Period (IP)|Adverse Event|0
1028489|NCT01647516|2056645|FG005|Induction Period (IP)|Adverse Event|0
1028490|NCT01647516|2056640|FG000|Induction Period (IP)|Withdrawal by Subject|1
1028491|NCT01647516|2056641|FG001|Induction Period (IP)|Withdrawal by Subject|0
1028492|NCT01647516|2056642|FG002|Induction Period (IP)|Withdrawal by Subject|3
1028493|NCT01647516|2056643|FG003|Induction Period (IP)|Withdrawal by Subject|0
1028494|NCT01647516|2056644|FG004|Induction Period (IP)|Withdrawal by Subject|0
1028495|NCT01647516|2056645|FG005|Induction Period (IP)|Withdrawal by Subject|0
1028496|NCT01647516|2056640|FG000|Induction Period (IP)|Participant Choice|0
1028497|NCT01647516|2056641|FG001|Induction Period (IP)|Participant Choice|0
1028498|NCT01647516|2056642|FG002|Induction Period (IP)|Participant Choice|1
1028499|NCT01647516|2056643|FG003|Induction Period (IP)|Participant Choice|0
1028500|NCT01647516|2056644|FG004|Induction Period (IP)|Participant Choice|0
1028501|NCT01647516|2056645|FG005|Induction Period (IP)|Participant Choice|0
1028502|NCT01647516|2056640|FG000|Induction Period (IP)|Lack of Efficacy|1
1028503|NCT01647516|2056641|FG001|Induction Period (IP)|Lack of Efficacy|0
1028504|NCT01647516|2056642|FG002|Induction Period (IP)|Lack of Efficacy|0
1028505|NCT01647516|2056643|FG003|Induction Period (IP)|Lack of Efficacy|0
1028506|NCT01647516|2056644|FG004|Induction Period (IP)|Lack of Efficacy|0
1028507|NCT01647516|2056645|FG005|Induction Period (IP)|Lack of Efficacy|0
1028508|NCT01647516|2056640|FG000|Induction Period (IP)|No study drug received|1
1028509|NCT01647516|2056641|FG001|Induction Period (IP)|No study drug received|1
1028510|NCT01647516|2056642|FG002|Induction Period (IP)|No study drug received|0
1028511|NCT01647516|2056643|FG003|Induction Period (IP)|No study drug received|0
1028512|NCT01647516|2056644|FG004|Induction Period (IP)|No study drug received|0
1028513|NCT01647516|2056645|FG005|Induction Period (IP)|No study drug received|0
1028514|NCT01647516|2056640|FG000|Maintenance Period (MP)|Adverse Event|2
1028515|NCT01647516|2056641|FG001|Maintenance Period (MP)|Adverse Event|1
1028516|NCT01647516|2056642|FG002|Maintenance Period (MP)|Adverse Event|0
1028517|NCT01647516|2056643|FG003|Maintenance Period (MP)|Adverse Event|0
1028518|NCT01647516|2056644|FG004|Maintenance Period (MP)|Adverse Event|0
1028519|NCT01647516|2056645|FG005|Maintenance Period (MP)|Adverse Event|0
1028520|NCT01647516|2056640|FG000|Maintenance Period (MP)|Non-compliance|1
1028521|NCT01647516|2056641|FG001|Maintenance Period (MP)|Non-compliance|0
1028522|NCT01647516|2056642|FG002|Maintenance Period (MP)|Non-compliance|0
1028523|NCT01647516|2056643|FG003|Maintenance Period (MP)|Non-compliance|0
1028524|NCT01647516|2056644|FG004|Maintenance Period (MP)|Non-compliance|0
1028525|NCT01647516|2056645|FG005|Maintenance Period (MP)|Non-compliance|0
1028526|NCT01647516|2056640|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
1028527|NCT01647516|2056641|FG001|Maintenance Period (MP)|Withdrawal by Subject|1
1028528|NCT01647516|2056642|FG002|Maintenance Period (MP)|Withdrawal by Subject|1
1028529|NCT01647516|2056643|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
1028530|NCT01647516|2056644|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
1028531|NCT01647516|2056645|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
1028532|NCT01647516|2056640|FG000|Maintenance Period (MP)|Lack of Efficacy|1
1028533|NCT01647516|2056641|FG001|Maintenance Period (MP)|Lack of Efficacy|4
1028534|NCT01647516|2056642|FG002|Maintenance Period (MP)|Lack of Efficacy|1
1028535|NCT01647516|2056643|FG003|Maintenance Period (MP)|Lack of Efficacy|0
1028536|NCT01647516|2056644|FG004|Maintenance Period (MP)|Lack of Efficacy|0
1028537|NCT01647516|2056645|FG005|Maintenance Period (MP)|Lack of Efficacy|0
1028538|NCT01647516|2056640|FG000|Open-Label Period|Adverse Event|0
1028539|NCT01647516|2056641|FG001|Open-Label Period|Adverse Event|0
1028540|NCT01647516|2056642|FG002|Open-Label Period|Adverse Event|0
1028541|NCT01647516|2056643|FG003|Open-Label Period|Adverse Event|5
1028542|NCT01647516|2056644|FG004|Open-Label Period|Adverse Event|6
1028543|NCT01647516|2056645|FG005|Open-Label Period|Adverse Event|3
1028544|NCT01647516|2056640|FG000|Open-Label Period|Pregnancy|0
1028545|NCT01647516|2056641|FG001|Open-Label Period|Pregnancy|0
1028546|NCT01647516|2056642|FG002|Open-Label Period|Pregnancy|0
1028547|NCT01647516|2056643|FG003|Open-Label Period|Pregnancy|0
1028548|NCT01647516|2056644|FG004|Open-Label Period|Pregnancy|0
1028549|NCT01647516|2056645|FG005|Open-Label Period|Pregnancy|1
1028550|NCT01647516|2056640|FG000|Open-Label Period|Non-compliance|0
1028551|NCT01647516|2056641|FG001|Open-Label Period|Non-compliance|0
1028552|NCT01647516|2056642|FG002|Open-Label Period|Non-compliance|0
1028553|NCT01647516|2056643|FG003|Open-Label Period|Non-compliance|1
1028554|NCT01647516|2056644|FG004|Open-Label Period|Non-compliance|0
1028555|NCT01647516|2056645|FG005|Open-Label Period|Non-compliance|1
1028556|NCT01647516|2056640|FG000|Open-Label Period|Physician Decision|0
1028557|NCT01647516|2056641|FG001|Open-Label Period|Physician Decision|0
1028558|NCT01647516|2056642|FG002|Open-Label Period|Physician Decision|0
1028559|NCT01647516|2056643|FG003|Open-Label Period|Physician Decision|1
1028560|NCT01647516|2056644|FG004|Open-Label Period|Physician Decision|1
1028561|NCT01647516|2056645|FG005|Open-Label Period|Physician Decision|0
1028562|NCT01647516|2056640|FG000|Open-Label Period|Withdrawal by Subject|0
1028563|NCT01647516|2056641|FG001|Open-Label Period|Withdrawal by Subject|0
1028564|NCT01647516|2056642|FG002|Open-Label Period|Withdrawal by Subject|0
1028565|NCT01647516|2056643|FG003|Open-Label Period|Withdrawal by Subject|9
1028566|NCT01647516|2056644|FG004|Open-Label Period|Withdrawal by Subject|11
1028567|NCT01647516|2056645|FG005|Open-Label Period|Withdrawal by Subject|6
1028568|NCT01647516|2056640|FG000|Open-Label Period|Lost to Follow-up|0
1028569|NCT01647516|2056641|FG001|Open-Label Period|Lost to Follow-up|0
1028570|NCT01647516|2056642|FG002|Open-Label Period|Lost to Follow-up|0
1028571|NCT01647516|2056643|FG003|Open-Label Period|Lost to Follow-up|1
1028572|NCT01647516|2056644|FG004|Open-Label Period|Lost to Follow-up|0
1028573|NCT01647516|2056645|FG005|Open-Label Period|Lost to Follow-up|1
1028574|NCT01647516|2056640|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0
1028575|NCT01647516|2056641|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0
1028576|NCT01647516|2056642|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0
1028577|NCT01647516|2056643|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18
1028578|NCT01647516|2056644|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13
1028579|NCT01647516|2056645|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23
1028580|NCT01647516|2056640|FG000|Open-Label Period|Lack of Efficacy|0
1028581|NCT01647516|2056641|FG001|Open-Label Period|Lack of Efficacy|0
1028582|NCT01647516|2056642|FG002|Open-Label Period|Lack of Efficacy|0
1028583|NCT01647516|2056643|FG003|Open-Label Period|Lack of Efficacy|7
1028584|NCT01647516|2056644|FG004|Open-Label Period|Lack of Efficacy|9
1028585|NCT01647516|2056645|FG005|Open-Label Period|Lack of Efficacy|10
1028586|NCT01647516|2056640|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0
1028587|NCT01647516|2056641|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0
1028588|NCT01647516|2056642|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0
1028589|NCT01647516|2056643|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7
1028590|NCT01647516|2056644|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9
1028591|NCT01647516|2056645|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10
1028592|NCT01647516|2056640|FG000|Open-Label Period|No completion / discontinuation visit|0
1028593|NCT01647516|2056641|FG001|Open-Label Period|No completion / discontinuation visit|0
1028594|NCT01647516|2056642|FG002|Open-Label Period|No completion / discontinuation visit|0
1028595|NCT01647516|2056643|FG003|Open-Label Period|No completion / discontinuation visit|0
1028596|NCT01647516|2056644|FG004|Open-Label Period|No completion / discontinuation visit|2
1028597|NCT01647516|2056645|FG005|Open-Label Period|No completion / discontinuation visit|1
1028598|NCT01647542|2056663|FG000|Overall Study|Major Protocol Deviation|1
1028599|NCT01647542|2056664|FG001|Overall Study|Major Protocol Deviation|0
1028600|NCT01647542|2056665|FG002|Overall Study|Major Protocol Deviation|0
1028601|NCT01647542|2056663|FG000|Overall Study|Adverse Event|4
1028602|NCT01647542|2056664|FG001|Overall Study|Adverse Event|5
1028603|NCT01647542|2056665|FG002|Overall Study|Adverse Event|4
1028604|NCT01647542|2056663|FG000|Overall Study|Lost to Follow-up|0
1028605|NCT01647542|2056664|FG001|Overall Study|Lost to Follow-up|2
1028606|NCT01647542|2056665|FG002|Overall Study|Lost to Follow-up|2
1028607|NCT01647542|2056663|FG000|Overall Study|Withdrawal by Subject|6
1028608|NCT01647542|2056664|FG001|Overall Study|Withdrawal by Subject|4
1028609|NCT01647542|2056665|FG002|Overall Study|Withdrawal by Subject|0
1028610|NCT01647542|2056663|FG000|Overall Study|Study Termination|64
1028611|NCT01647542|2056664|FG001|Overall Study|Study Termination|61
1028612|NCT01647542|2056665|FG002|Overall Study|Study Termination|65
1028613|NCT01647542|2056663|FG000|Overall Study|Lack of Efficacy|1
1028614|NCT01647542|2056664|FG001|Overall Study|Lack of Efficacy|1
1028615|NCT01647542|2056665|FG002|Overall Study|Lack of Efficacy|0
1028616|NCT01647542|2056663|FG000|Overall Study|Death|0
1028617|NCT01647542|2056664|FG001|Overall Study|Death|0
1028618|NCT01647542|2056665|FG002|Overall Study|Death|1
1028619|NCT01647711|2056687|FG000|Overall Study|Progressive disease|6
1028620|NCT01647711|2056688|FG001|Overall Study|Progressive disease|2
1028621|NCT01647711|2056689|FG002|Overall Study|Progressive disease|6
1028622|NCT01647711|2056690|FG003|Overall Study|Progressive disease|8
1028623|NCT01647711|2056691|FG004|Overall Study|Progressive disease|2
1028624|NCT01647711|2056687|FG000|Overall Study|Other adverse event|0
1028625|NCT01647711|2056688|FG001|Overall Study|Other adverse event|0
1028626|NCT01647711|2056689|FG002|Overall Study|Other adverse event|2
1028627|NCT01647711|2056690|FG003|Overall Study|Other adverse event|0
1028628|NCT01647711|2056691|FG004|Overall Study|Other adverse event|2
1028629|NCT01647711|2056687|FG000|Overall Study|Protocol Violation|0
1028630|NCT01647711|2056688|FG001|Overall Study|Protocol Violation|0
1028631|NCT01647711|2056689|FG002|Overall Study|Protocol Violation|0
1028632|NCT01647711|2056690|FG003|Overall Study|Protocol Violation|0
1028633|NCT01647711|2056691|FG004|Overall Study|Protocol Violation|1
1028634|NCT01647711|2056687|FG000|Overall Study|Refused to continue taking medication|0
1028635|NCT01647711|2056688|FG001|Overall Study|Refused to continue taking medication|0
1028636|NCT01647711|2056689|FG002|Overall Study|Refused to continue taking medication|0
1028637|NCT01647711|2056690|FG003|Overall Study|Refused to continue taking medication|2
1028638|NCT01647711|2056691|FG004|Overall Study|Refused to continue taking medication|1
1028639|NCT01647711|2056687|FG000|Overall Study|Other reason not defined|0
1028640|NCT01647711|2056688|FG001|Overall Study|Other reason not defined|1
1028641|NCT01647711|2056689|FG002|Overall Study|Other reason not defined|1
1028642|NCT01647711|2056690|FG003|Overall Study|Other reason not defined|1
1028643|NCT01647711|2056691|FG004|Overall Study|Other reason not defined|0
1028644|NCT01647958|2056733|FG000|Initial Study|Lost to Follow-up|2
1028645|NCT01647958|2056734|FG001|Initial Study|Lost to Follow-up|3
1028646|NCT01647958|2056733|FG000|Continuation Phase|treatment received during Overall Study|39
1028647|NCT01647958|2056734|FG001|Continuation Phase|treatment received during Overall Study|0
1028648|NCT01647958|2056733|FG000|Extended Follow-up Phase|Lost to Follow-up|8
1028649|NCT01647958|2056734|FG001|Extended Follow-up Phase|Lost to Follow-up|0
1028650|NCT01648101|2056752|FG000|Titration Phase (4 Weeks)|Protocol Violation|2
1028651|NCT01648101|2056753|FG001|Titration Phase (4 Weeks)|Protocol Violation|1
1028652|NCT01648101|2056754|FG002|Titration Phase (4 Weeks)|Protocol Violation|2
1028653|NCT01648101|2056752|FG000|Titration Phase (4 Weeks)|Adverse Event|0
1028654|NCT01648101|2056753|FG001|Titration Phase (4 Weeks)|Adverse Event|2
1028655|NCT01648101|2056754|FG002|Titration Phase (4 Weeks)|Adverse Event|3
1028656|NCT01648101|2056752|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
1028657|NCT01648101|2056753|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
1028658|NCT01648101|2056754|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
1028659|NCT01648101|2056752|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1
1028660|NCT01648101|2056753|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0
1028661|NCT01648101|2056754|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1
1028662|NCT01648101|2056752|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
1028663|NCT01648101|2056753|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
1028664|NCT01648101|2056754|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
1028665|NCT01648101|2056752|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1
1028666|NCT01648101|2056753|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3
1028667|NCT01648101|2056754|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4
1028668|NCT01648101|2056752|FG000|Transition Phase (4 Weeks)|Adverse Event|4
1028669|NCT01648101|2056753|FG001|Transition Phase (4 Weeks)|Adverse Event|3
1028670|NCT01648101|2056754|FG002|Transition Phase (4 Weeks)|Adverse Event|2
1028671|NCT01648101|2056752|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0
1028672|NCT01648101|2056753|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2
1028673|NCT01648101|2056754|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0
1028674|NCT01648101|2056752|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0
1028675|NCT01648101|2056753|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0
1028676|NCT01648101|2056754|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2
1028677|NCT01648101|2056752|FG000|Transition Phase (4 Weeks)|Study Terminated|1
1028678|NCT01648101|2056753|FG001|Transition Phase (4 Weeks)|Study Terminated|0
1028679|NCT01648101|2056754|FG002|Transition Phase (4 Weeks)|Study Terminated|0
1028680|NCT01648101|2056752|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
1028681|NCT01648101|2056753|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
1028682|NCT01648101|2056754|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
1028683|NCT01648140|2056770|FG000|Overall Study|Physician Decision|1
1028684|NCT01648140|2056771|FG001|Overall Study|Physician Decision|0
1028685|NCT01648140|2056772|FG002|Overall Study|Physician Decision|0
1028686|NCT01648140|2056773|FG003|Overall Study|Physician Decision|0
1028687|NCT01648140|2056770|FG000|Overall Study|Lack of Efficacy|4
1028688|NCT01648140|2056771|FG001|Overall Study|Lack of Efficacy|7
1028689|NCT01648140|2056772|FG002|Overall Study|Lack of Efficacy|1
1028690|NCT01648140|2056773|FG003|Overall Study|Lack of Efficacy|0
1028691|NCT01648140|2056770|FG000|Overall Study|Adverse Event|3
1028692|NCT01648140|2056771|FG001|Overall Study|Adverse Event|1
1028693|NCT01648140|2056772|FG002|Overall Study|Adverse Event|2
1028694|NCT01648140|2056773|FG003|Overall Study|Adverse Event|0
1028695|NCT01648140|2056770|FG000|Overall Study|Withdrawal by Subject|2
1028696|NCT01648140|2056771|FG001|Overall Study|Withdrawal by Subject|3
1028697|NCT01648140|2056772|FG002|Overall Study|Withdrawal by Subject|3
1028698|NCT01648140|2056773|FG003|Overall Study|Withdrawal by Subject|2
1028699|NCT01648140|2056770|FG000|Overall Study|Lost to Follow-up|2
1028700|NCT01648140|2056771|FG001|Overall Study|Lost to Follow-up|1
1028701|NCT01648140|2056772|FG002|Overall Study|Lost to Follow-up|2
1028702|NCT01648140|2056773|FG003|Overall Study|Lost to Follow-up|0
1028703|NCT01648166|2056794|FG000|Overall Study|inadequate toenail samples|53
1028704|NCT01648166|2056795|FG001|Overall Study|inadequate toenail samples|100
1028705|NCT01648283|2056801|FG000|Overall Study|Withdrawal by Subject|14
1028706|NCT01648348|2056843|FG000|Overall Study|Cancel|1
1028707|NCT01648348|2056844|FG001|Overall Study|Cancel|0
1028708|NCT01648348|2056845|FG002|Overall Study|Cancel|0
1028709|NCT01648348|2056846|FG003|Overall Study|Cancel|0
1028710|NCT01648348|2056847|FG004|Overall Study|Cancel|3
1028711|NCT01648348|2056848|FG005|Overall Study|Cancel|6
1028712|NCT01648348|2056843|FG000|Overall Study|Replaced for MTD analysis|1
1028713|NCT01648348|2056844|FG001|Overall Study|Replaced for MTD analysis|0
1028714|NCT01648348|2056845|FG002|Overall Study|Replaced for MTD analysis|1
1028715|NCT01648348|2056846|FG003|Overall Study|Replaced for MTD analysis|0
1028716|NCT01648348|2056847|FG004|Overall Study|Replaced for MTD analysis|0
1028717|NCT01648348|2056848|FG005|Overall Study|Replaced for MTD analysis|0
1028718|NCT01648582|2056881|FG000|Overall Study|Adverse Event|6
1028719|NCT01648582|2056882|FG001|Overall Study|Adverse Event|11
1028720|NCT01648582|2056883|FG002|Overall Study|Adverse Event|2
1028721|NCT01648582|2056881|FG000|Overall Study|Lost to Follow-up|9
1028722|NCT01648582|2056882|FG001|Overall Study|Lost to Follow-up|6
1028723|NCT01648582|2056883|FG002|Overall Study|Lost to Follow-up|8
1028724|NCT01648582|2056881|FG000|Overall Study|Protocol Violation|1
1028725|NCT01648582|2056882|FG001|Overall Study|Protocol Violation|2
1028726|NCT01648582|2056883|FG002|Overall Study|Protocol Violation|1
1028727|NCT01648582|2056881|FG000|Overall Study|Withdrawal by Subject|15
1028728|NCT01648582|2056882|FG001|Overall Study|Withdrawal by Subject|17
1028729|NCT01648582|2056883|FG002|Overall Study|Withdrawal by Subject|17
1028730|NCT01648582|2056881|FG000|Overall Study|Physician Decision|0
1028731|NCT01648582|2056882|FG001|Overall Study|Physician Decision|1
1028732|NCT01648582|2056883|FG002|Overall Study|Physician Decision|3
1028733|NCT01648582|2056881|FG000|Overall Study|Death|1
1028734|NCT01648582|2056882|FG001|Overall Study|Death|0
1028735|NCT01648582|2056883|FG002|Overall Study|Death|0
1028736|NCT01648582|2056881|FG000|Overall Study|Sponsor Decision|0
1028737|NCT01648582|2056882|FG001|Overall Study|Sponsor Decision|1
1028738|NCT01648582|2056883|FG002|Overall Study|Sponsor Decision|1
1028739|NCT01648699|2056894|FG000|Overall Study|Death|1
1028740|NCT01648699|2056894|FG000|Overall Study|Lost to Follow-up|2
1028741|NCT01648699|2056894|FG000|Overall Study|Unspecified/unable to complete 4 visits|2
1028742|NCT01648764|2056921|FG000|Overall Study|Progressive Disease|0
1028743|NCT01648764|2056922|FG001|Overall Study|Progressive Disease|1
1028744|NCT01648764|2056923|FG002|Overall Study|Progressive Disease|0
1028745|NCT01648764|2056924|FG003|Overall Study|Progressive Disease|0
1028746|NCT01648764|2056925|FG004|Overall Study|Progressive Disease|0
1028747|NCT01648764|2056926|FG005|Overall Study|Progressive Disease|1
1028748|NCT01648764|2056927|FG006|Overall Study|Progressive Disease|1
1028749|NCT01648764|2056928|FG007|Overall Study|Progressive Disease|0
1028750|NCT01648764|2056929|FG008|Overall Study|Progressive Disease|0
1028751|NCT01648764|2056930|FG009|Overall Study|Progressive Disease|2
1028752|NCT01648764|2056931|FG010|Overall Study|Progressive Disease|0
1028753|NCT01648764|2056932|FG011|Overall Study|Progressive Disease|1
1028754|NCT01648764|2056933|FG012|Overall Study|Progressive Disease|2
1028755|NCT01648764|2056934|FG013|Overall Study|Progressive Disease|1
1028756|NCT01648764|2056921|FG000|Overall Study|Adverse Event|0
1028757|NCT01648764|2056922|FG001|Overall Study|Adverse Event|0
1028758|NCT01648764|2056923|FG002|Overall Study|Adverse Event|0
1028759|NCT01648764|2056924|FG003|Overall Study|Adverse Event|0
1028760|NCT01648764|2056925|FG004|Overall Study|Adverse Event|0
1028761|NCT01648764|2056926|FG005|Overall Study|Adverse Event|1
1028762|NCT01648764|2056927|FG006|Overall Study|Adverse Event|0
1028763|NCT01648764|2056928|FG007|Overall Study|Adverse Event|0
1028764|NCT01648764|2056929|FG008|Overall Study|Adverse Event|0
1028765|NCT01648764|2056930|FG009|Overall Study|Adverse Event|1
1028766|NCT01648764|2056931|FG010|Overall Study|Adverse Event|0
1028767|NCT01648764|2056932|FG011|Overall Study|Adverse Event|3
1028768|NCT01648764|2056933|FG012|Overall Study|Adverse Event|1
1028769|NCT01648764|2056934|FG013|Overall Study|Adverse Event|1
1028770|NCT01648764|2056921|FG000|Overall Study|Death|0
1028771|NCT01648764|2056922|FG001|Overall Study|Death|0
1028772|NCT01648764|2056923|FG002|Overall Study|Death|0
1028773|NCT01648764|2056924|FG003|Overall Study|Death|0
1028774|NCT01648764|2056925|FG004|Overall Study|Death|0
1028775|NCT01648764|2056926|FG005|Overall Study|Death|0
1028776|NCT01648764|2056927|FG006|Overall Study|Death|1
1028777|NCT01648764|2056928|FG007|Overall Study|Death|0
1028778|NCT01648764|2056929|FG008|Overall Study|Death|0
1028779|NCT01648764|2056930|FG009|Overall Study|Death|0
1028780|NCT01648764|2056931|FG010|Overall Study|Death|0
1028781|NCT01648764|2056932|FG011|Overall Study|Death|0
1028782|NCT01648764|2056933|FG012|Overall Study|Death|0
1028783|NCT01648764|2056934|FG013|Overall Study|Death|1
1028784|NCT01648764|2056921|FG000|Overall Study|Withdrawal by Subject|0
1028785|NCT01648764|2056922|FG001|Overall Study|Withdrawal by Subject|0
1028786|NCT01648764|2056923|FG002|Overall Study|Withdrawal by Subject|0
1028787|NCT01648764|2056924|FG003|Overall Study|Withdrawal by Subject|0
1028788|NCT01648764|2056925|FG004|Overall Study|Withdrawal by Subject|0
1028789|NCT01648764|2056926|FG005|Overall Study|Withdrawal by Subject|0
1028790|NCT01648764|2056927|FG006|Overall Study|Withdrawal by Subject|2
1028791|NCT01648764|2056928|FG007|Overall Study|Withdrawal by Subject|0
1028792|NCT01648764|2056929|FG008|Overall Study|Withdrawal by Subject|0
1028793|NCT01648764|2056930|FG009|Overall Study|Withdrawal by Subject|0
1028794|NCT01648764|2056931|FG010|Overall Study|Withdrawal by Subject|0
1028795|NCT01648764|2056932|FG011|Overall Study|Withdrawal by Subject|0
1028796|NCT01648764|2056933|FG012|Overall Study|Withdrawal by Subject|1
1028797|NCT01648764|2056934|FG013|Overall Study|Withdrawal by Subject|0
1028798|NCT01648764|2056921|FG000|Overall Study|Investigator Decision|0
1028799|NCT01648764|2056922|FG001|Overall Study|Investigator Decision|0
1028800|NCT01648764|2056923|FG002|Overall Study|Investigator Decision|0
1028801|NCT01648764|2056924|FG003|Overall Study|Investigator Decision|0
1028802|NCT01648764|2056925|FG004|Overall Study|Investigator Decision|0
1028803|NCT01648764|2056926|FG005|Overall Study|Investigator Decision|0
1028804|NCT01648764|2056927|FG006|Overall Study|Investigator Decision|1
1028805|NCT01648764|2056928|FG007|Overall Study|Investigator Decision|0
1028806|NCT01648764|2056929|FG008|Overall Study|Investigator Decision|0
1028807|NCT01648764|2056930|FG009|Overall Study|Investigator Decision|0
1028808|NCT01648764|2056931|FG010|Overall Study|Investigator Decision|0
1028809|NCT01648764|2056932|FG011|Overall Study|Investigator Decision|1
1028810|NCT01648764|2056933|FG012|Overall Study|Investigator Decision|0
1028811|NCT01648764|2056934|FG013|Overall Study|Investigator Decision|0
1028812|NCT01648790|2056968|FG000|Treatment 3|Withdrawal by Subject|0
1028813|NCT01648790|2056969|FG001|Treatment 3|Withdrawal by Subject|0
1028814|NCT01648790|2056970|FG002|Treatment 3|Withdrawal by Subject|0
1028815|NCT01648790|2056971|FG003|Treatment 3|Withdrawal by Subject|1
1028816|NCT01648790|2056972|FG004|Treatment 3|Withdrawal by Subject|0
1028817|NCT01649232|2056998|FG000|Overall Study|Physician Decision|2
1028818|NCT01649232|2056999|FG001|Overall Study|Physician Decision|0
1028819|NCT01649271|2057013|FG000|Overall Study|Progressive disease|4
1028820|NCT01649271|2057014|FG001|Overall Study|Progressive disease|5
1028821|NCT01649271|2057013|FG000|Overall Study|Other Adverse Event|0
1028822|NCT01649271|2057014|FG001|Overall Study|Other Adverse Event|2
1028823|NCT01649271|2057013|FG000|Overall Study|Withdrawal by Subject|1
1028824|NCT01649271|2057014|FG001|Overall Study|Withdrawal by Subject|0
1028825|NCT01649271|2057013|FG000|Overall Study|Other than stated above|1
1028826|NCT01649271|2057014|FG001|Overall Study|Other than stated above|0
1028827|NCT01649297|2057026|FG000|Overall Study|Adverse Event|5
1028828|NCT01649297|2057027|FG001|Overall Study|Adverse Event|5
1028829|NCT01649297|2057028|FG002|Overall Study|Adverse Event|4
1028830|NCT01649297|2057029|FG003|Overall Study|Adverse Event|13
1028831|NCT01649297|2057030|FG004|Overall Study|Adverse Event|1
1028832|NCT01649297|2057026|FG000|Overall Study|Lack of Efficacy|0
1028833|NCT01649297|2057027|FG001|Overall Study|Lack of Efficacy|0
1028834|NCT01649297|2057028|FG002|Overall Study|Lack of Efficacy|0
1028835|NCT01649297|2057029|FG003|Overall Study|Lack of Efficacy|0
1028836|NCT01649297|2057030|FG004|Overall Study|Lack of Efficacy|1
1028837|NCT01649297|2057026|FG000|Overall Study|Non compliant with Protocol|1
1028838|NCT01649297|2057027|FG001|Overall Study|Non compliant with Protocol|0
1028839|NCT01649297|2057028|FG002|Overall Study|Non compliant with Protocol|3
1028840|NCT01649297|2057029|FG003|Overall Study|Non compliant with Protocol|2
1028841|NCT01649297|2057030|FG004|Overall Study|Non compliant with Protocol|1
1028842|NCT01649297|2057026|FG000|Overall Study|Lost to Follow-up|1
1028843|NCT01649297|2057027|FG001|Overall Study|Lost to Follow-up|1
1028844|NCT01649297|2057028|FG002|Overall Study|Lost to Follow-up|4
1028845|NCT01649297|2057029|FG003|Overall Study|Lost to Follow-up|3
1028846|NCT01649297|2057030|FG004|Overall Study|Lost to Follow-up|0
1028847|NCT01649297|2057026|FG000|Overall Study|Patient withdrawal (not due to AE)|3
1028848|NCT01649297|2057027|FG001|Overall Study|Patient withdrawal (not due to AE)|6
1028849|NCT01649297|2057028|FG002|Overall Study|Patient withdrawal (not due to AE)|4
1028850|NCT01649297|2057029|FG003|Overall Study|Patient withdrawal (not due to AE)|1
1028851|NCT01649297|2057030|FG004|Overall Study|Patient withdrawal (not due to AE)|1
1028852|NCT01649297|2057026|FG000|Overall Study|For other reason|4
1028853|NCT01649297|2057027|FG001|Overall Study|For other reason|1
1028854|NCT01649297|2057028|FG002|Overall Study|For other reason|2
1028855|NCT01649297|2057029|FG003|Overall Study|For other reason|0
1028856|NCT01649297|2057030|FG004|Overall Study|For other reason|0
1028857|NCT01649375|2057054|FG000|Up to Week 16|Adverse Event|2
1028858|NCT01649375|2057055|FG001|Up to Week 16|Adverse Event|5
1028859|NCT01649375|2057056|FG002|Up to Week 16|Adverse Event|4
1028860|NCT01649375|2057057|FG003|Up to Week 16|Adverse Event|0
1028861|NCT01649375|2057058|FG004|Up to Week 16|Adverse Event|0
1028862|NCT01649375|2057054|FG000|Up to Week 16|Lack of Efficacy|0
1028863|NCT01649375|2057055|FG001|Up to Week 16|Lack of Efficacy|0
1028864|NCT01649375|2057056|FG002|Up to Week 16|Lack of Efficacy|1
1028865|NCT01649375|2057057|FG003|Up to Week 16|Lack of Efficacy|0
1028866|NCT01649375|2057058|FG004|Up to Week 16|Lack of Efficacy|0
1028867|NCT01649375|2057054|FG000|Up to Week 16|Physician Decision|0
1028868|NCT01649375|2057055|FG001|Up to Week 16|Physician Decision|0
1028869|NCT01649375|2057056|FG002|Up to Week 16|Physician Decision|1
1028870|NCT01649375|2057057|FG003|Up to Week 16|Physician Decision|0
1028871|NCT01649375|2057058|FG004|Up to Week 16|Physician Decision|0
1028872|NCT01649375|2057054|FG000|Up to Week 16|Withdrawal by Subject|2
1028873|NCT01649375|2057055|FG001|Up to Week 16|Withdrawal by Subject|1
1028874|NCT01649375|2057056|FG002|Up to Week 16|Withdrawal by Subject|2
1028875|NCT01649375|2057057|FG003|Up to Week 16|Withdrawal by Subject|0
1028876|NCT01649375|2057058|FG004|Up to Week 16|Withdrawal by Subject|0
1028877|NCT01649375|2057054|FG000|Up to Week 16|Death|1
1028878|NCT01649375|2057055|FG001|Up to Week 16|Death|0
1028879|NCT01649375|2057056|FG002|Up to Week 16|Death|0
1028880|NCT01649375|2057057|FG003|Up to Week 16|Death|0
1028881|NCT01649375|2057058|FG004|Up to Week 16|Death|0
1028882|NCT01649375|2057054|FG000|Week 16 up to Week 260|Lack of Efficacy|7
1028883|NCT01649375|2057055|FG001|Week 16 up to Week 260|Lack of Efficacy|4
1028884|NCT01649375|2057056|FG002|Week 16 up to Week 260|Lack of Efficacy|0
1028885|NCT01649375|2057057|FG003|Week 16 up to Week 260|Lack of Efficacy|4
1028886|NCT01649375|2057058|FG004|Week 16 up to Week 260|Lack of Efficacy|2
1028887|NCT01649375|2057054|FG000|Week 16 up to Week 260|Non-compliance|0
1028888|NCT01649375|2057055|FG001|Week 16 up to Week 260|Non-compliance|1
1028889|NCT01649375|2057056|FG002|Week 16 up to Week 260|Non-compliance|0
1028890|NCT01649375|2057057|FG003|Week 16 up to Week 260|Non-compliance|1
1028891|NCT01649375|2057058|FG004|Week 16 up to Week 260|Non-compliance|0
1028892|NCT01649375|2057054|FG000|Week 16 up to Week 260|Physician Decision|0
1028893|NCT01649375|2057055|FG001|Week 16 up to Week 260|Physician Decision|2
1028894|NCT01649375|2057056|FG002|Week 16 up to Week 260|Physician Decision|0
1028895|NCT01649375|2057057|FG003|Week 16 up to Week 260|Physician Decision|0
1028896|NCT01649375|2057058|FG004|Week 16 up to Week 260|Physician Decision|0
1028897|NCT01649375|2057054|FG000|Week 16 up to Week 260|Technical issues|0
1028898|NCT01649375|2057055|FG001|Week 16 up to Week 260|Technical issues|1
1028899|NCT01649375|2057056|FG002|Week 16 up to Week 260|Technical issues|0
1028900|NCT01649375|2057057|FG003|Week 16 up to Week 260|Technical issues|1
1028901|NCT01649375|2057058|FG004|Week 16 up to Week 260|Technical issues|0
1028902|NCT01649375|2057054|FG000|Week 16 up to Week 260|Withdrawal by Subject|7
1028903|NCT01649375|2057055|FG001|Week 16 up to Week 260|Withdrawal by Subject|2
1028904|NCT01649375|2057056|FG002|Week 16 up to Week 260|Withdrawal by Subject|0
1028905|NCT01649375|2057057|FG003|Week 16 up to Week 260|Withdrawal by Subject|3
1028906|NCT01649375|2057058|FG004|Week 16 up to Week 260|Withdrawal by Subject|1
1028907|NCT01649375|2057054|FG000|Week 16 up to Week 260|Death|1
1028908|NCT01649375|2057055|FG001|Week 16 up to Week 260|Death|1
1028909|NCT01649375|2057056|FG002|Week 16 up to Week 260|Death|0
1028910|NCT01649375|2057057|FG003|Week 16 up to Week 260|Death|0
1028911|NCT01649375|2057058|FG004|Week 16 up to Week 260|Death|0
1028912|NCT01649375|2057054|FG000|Week 16 up to Week 260|Adverse Event|5
1028913|NCT01649375|2057055|FG001|Week 16 up to Week 260|Adverse Event|2
1028914|NCT01649375|2057056|FG002|Week 16 up to Week 260|Adverse Event|0
1028915|NCT01649375|2057057|FG003|Week 16 up to Week 260|Adverse Event|3
1028916|NCT01649375|2057058|FG004|Week 16 up to Week 260|Adverse Event|2
1028917|NCT01649427|2057068|FG000|Overall Study|Adverse Event|1
1028918|NCT01649427|2057069|FG001|Overall Study|Adverse Event|1
1028919|NCT01649427|2057068|FG000|Overall Study|Withdrawal by Subject|8
1028920|NCT01649427|2057069|FG001|Overall Study|Withdrawal by Subject|7
1028921|NCT01649427|2057068|FG000|Overall Study|Lost to Follow-up|0
1028922|NCT01649427|2057069|FG001|Overall Study|Lost to Follow-up|1
1028923|NCT01649427|2057068|FG000|Overall Study|Graft loss|0
1028924|NCT01649427|2057069|FG001|Overall Study|Graft loss|1
1028925|NCT01649427|2057068|FG000|Overall Study|Surgical problems during nephrectomy|2
1028926|NCT01649427|2057069|FG001|Overall Study|Surgical problems during nephrectomy|2
1028927|NCT01649557|2057078|FG000|Overall Study|Lost to Follow-up|5
1028928|NCT01649557|2057079|FG001|Overall Study|Lost to Follow-up|0
1028929|NCT01649557|2057080|FG002|Overall Study|Lost to Follow-up|3
1028930|NCT01649557|2057078|FG000|Overall Study|Adverse Event|7
1028931|NCT01649557|2057079|FG001|Overall Study|Adverse Event|5
1028932|NCT01649557|2057080|FG002|Overall Study|Adverse Event|1
1028933|NCT01649557|2057078|FG000|Overall Study|Met withdrawal criteria|4
1028934|NCT01649557|2057079|FG001|Overall Study|Met withdrawal criteria|0
1028935|NCT01649557|2057080|FG002|Overall Study|Met withdrawal criteria|0
1028936|NCT01649557|2057078|FG000|Overall Study|Physician Decision|8
1028937|NCT01649557|2057079|FG001|Overall Study|Physician Decision|2
1028938|NCT01649557|2057080|FG002|Overall Study|Physician Decision|1
1028939|NCT01649557|2057078|FG000|Overall Study|Withdrawal by Subject|15
1028940|NCT01649557|2057079|FG001|Overall Study|Withdrawal by Subject|5
1028941|NCT01649557|2057080|FG002|Overall Study|Withdrawal by Subject|4
1028942|NCT01649557|2057078|FG000|Overall Study|Protocol deviation|0
1028943|NCT01649557|2057079|FG001|Overall Study|Protocol deviation|2
1028944|NCT01649557|2057080|FG002|Overall Study|Protocol deviation|0
1028945|NCT01649557|2057078|FG000|Overall Study|Lack of Efficacy|5
1028946|NCT01649557|2057079|FG001|Overall Study|Lack of Efficacy|0
1028947|NCT01649557|2057080|FG002|Overall Study|Lack of Efficacy|0
1028948|NCT01649765|2057108|FG000|Overall Study|Adverse Event|5
1028949|NCT01649765|2057109|FG001|Overall Study|Adverse Event|3
1028950|NCT01649765|2057108|FG000|Overall Study|Lack of Efficacy|1
1028951|NCT01649765|2057109|FG001|Overall Study|Lack of Efficacy|1
1028952|NCT01649765|2057108|FG000|Overall Study|Physician Decision|0
1028953|NCT01649765|2057109|FG001|Overall Study|Physician Decision|3
1028954|NCT01649765|2057108|FG000|Overall Study|Protocol Violation|1
1028955|NCT01649765|2057109|FG001|Overall Study|Protocol Violation|0
1028956|NCT01649765|2057108|FG000|Overall Study|Withdrawal by Subject|2
1028957|NCT01649765|2057109|FG001|Overall Study|Withdrawal by Subject|1
1028958|NCT01649791|2057116|FG000|Overall Study|Disease Progression|2
1028959|NCT01649791|2057116|FG000|Overall Study|Adverse Event|1
1028960|NCT01649804|2057120|FG000|Overall Study|Administrative/Other|8
1028961|NCT01649856|2057126|FG000|Overall Study|Withdrawal by Subject|14
1028962|NCT01649856|2057127|FG001|Overall Study|Withdrawal by Subject|14
1028963|NCT01649856|2057126|FG000|Overall Study|Protocol Violation|4
1028964|NCT01649856|2057127|FG001|Overall Study|Protocol Violation|4
1028965|NCT01649856|2057126|FG000|Overall Study|Treatment Failure|1
1028966|NCT01649856|2057127|FG001|Overall Study|Treatment Failure|1
1028967|NCT01649856|2057126|FG000|Overall Study|Death|69
1028968|NCT01649856|2057127|FG001|Overall Study|Death|34
1028969|NCT01649856|2057126|FG000|Overall Study|Stable or Progressed Disease|5
1028970|NCT01649856|2057127|FG001|Overall Study|Stable or Progressed Disease|3
1028971|NCT01649856|2057126|FG000|Overall Study|Lost to Follow-up|20
1028972|NCT01649856|2057127|FG001|Overall Study|Lost to Follow-up|16
1028973|NCT01649856|2057126|FG000|Overall Study|Lack of Compliance|6
1028974|NCT01649856|2057127|FG001|Overall Study|Lack of Compliance|1
1028975|NCT01649856|2057126|FG000|Overall Study|Other|20
1028976|NCT01649856|2057127|FG001|Overall Study|Other|5
1028977|NCT01649869|2057135|FG000|Overall Study|Family member illness|1
1028978|NCT01649869|2057136|FG001|Overall Study|Family member illness|0
1028979|NCT01649869|2057135|FG000|Overall Study|Required treatment outside protocol|1
1028980|NCT01649869|2057136|FG001|Overall Study|Required treatment outside protocol|0
1028981|NCT01649869|2057135|FG000|Overall Study|Severe hearing loss borderline eligible|0
1028982|NCT01649869|2057136|FG001|Overall Study|Severe hearing loss borderline eligible|1
1028983|NCT01650194|2057154|FG000|Overall Study|Progressive Disease (PD)|35
1028984|NCT01650194|2057154|FG000|Overall Study|Withdrawal by Subject|2
1028985|NCT01650194|2057154|FG000|Overall Study|Miscellaneous|10
1028986|NCT01650246|2057159|FG000|Overall Study|Adverse Event|23
1028987|NCT01650246|2057159|FG000|Overall Study|Protocol Violation|5
1028988|NCT01650246|2057159|FG000|Overall Study|Sponsor terminated study|53
1028989|NCT01650246|2057159|FG000|Overall Study|Lost to Follow-up|5
1028990|NCT01650246|2057159|FG000|Overall Study|Withdrawal by Subject|26
1028991|NCT01650246|2057159|FG000|Overall Study|Death|1
1028992|NCT01650246|2057159|FG000|Overall Study|Lack of Efficacy|30
1028993|NCT01650259|2057165|FG000|Overall Study|Improvement|105
1028994|NCT01650259|2057166|FG001|Overall Study|Improvement|0
1028995|NCT01650259|2057165|FG000|Overall Study|Adverse Event|127
1028996|NCT01650259|2057166|FG001|Overall Study|Adverse Event|0
1028997|NCT01650259|2057165|FG000|Overall Study|Lack of Efficacy|143
1028998|NCT01650259|2057166|FG001|Overall Study|Lack of Efficacy|0
1028999|NCT01650259|2057165|FG000|Overall Study|Lost to Follow-up|435
1029000|NCT01650259|2057166|FG001|Overall Study|Lost to Follow-up|0
1029001|NCT01650259|2057165|FG000|Overall Study|Patients had no visit after entry|70
1029002|NCT01650259|2057166|FG001|Overall Study|Patients had no visit after entry|0
1029003|NCT01650259|2057165|FG000|Overall Study|CRF not collected|98
1029004|NCT01650259|2057166|FG001|Overall Study|CRF not collected|82
1029005|NCT01650259|2057165|FG000|Overall Study|Not treated|1
1029006|NCT01650259|2057166|FG001|Overall Study|Not treated|7
1029007|NCT01650259|2057165|FG000|Overall Study|Other than listed|64
1029008|NCT01650259|2057166|FG001|Overall Study|Other than listed|146
1029009|NCT01650285|2057170|FG000|Overall Study|Adverse Event|1
1029010|NCT01650519|2057226|FG000|Overall Study|Withdrawal by Subject|1
1029011|NCT01650519|2057227|FG001|Overall Study|Withdrawal by Subject|0
1029012|NCT01650558|2057247|FG000|Overall Study|Migration out of study area|61
1029013|NCT01650558|2057248|FG001|Overall Study|Migration out of study area|71
1029014|NCT01650558|2057249|FG002|Overall Study|Migration out of study area|56
1029015|NCT01650558|2057247|FG000|Overall Study|Lost to Follow-up|10
1029016|NCT01650558|2057248|FG001|Overall Study|Lost to Follow-up|13
1029017|NCT01650558|2057249|FG002|Overall Study|Lost to Follow-up|6
1029018|NCT01650558|2057247|FG000|Overall Study|Death|10
1029019|NCT01650558|2057248|FG001|Overall Study|Death|6
1029020|NCT01650558|2057249|FG002|Overall Study|Death|8
1029021|NCT01650558|2057247|FG000|Overall Study|Withdrawal by Subject|1
1029022|NCT01650558|2057248|FG001|Overall Study|Withdrawal by Subject|1
1029023|NCT01650558|2057249|FG002|Overall Study|Withdrawal by Subject|3
1029024|NCT01650558|2057247|FG000|Overall Study|Non-compliant participant|1
1029025|NCT01650558|2057248|FG001|Overall Study|Non-compliant participant|0
1029026|NCT01650558|2057249|FG002|Overall Study|Non-compliant participant|2
1029027|NCT01650558|2057247|FG000|Overall Study|Physician Decision|0
1029028|NCT01650558|2057248|FG001|Overall Study|Physician Decision|1
1029029|NCT01650558|2057249|FG002|Overall Study|Physician Decision|0
1029030|NCT01650636|2057267|FG000|Washout up to 5 Months|Withdrawal by Subject|4
1029031|NCT01650636|2057268|FG001|Washout up to 5 Months|Withdrawal by Subject|8
1029032|NCT01650636|2057267|FG000|Washout up to 5 Months|Physician Decision|2
1029033|NCT01650636|2057268|FG001|Washout up to 5 Months|Physician Decision|2
1029034|NCT01650636|2057267|FG000|Washout up to 5 Months|Death|1
1029035|NCT01650636|2057268|FG001|Washout up to 5 Months|Death|0
1029036|NCT01650636|2057267|FG000|Washout up to 5 Months|Lost to Follow-up|2
1029037|NCT01650636|2057268|FG001|Washout up to 5 Months|Lost to Follow-up|8
1029038|NCT01650636|2057267|FG000|Washout up to 9 Months|Withdrawal by Subject|4
1029039|NCT01650636|2057268|FG001|Washout up to 9 Months|Withdrawal by Subject|2
1029040|NCT01650636|2057267|FG000|Washout up to 9 Months|Lost to Follow-up|2
1029041|NCT01650636|2057268|FG001|Washout up to 9 Months|Lost to Follow-up|1
1029042|NCT01650779|2057274|FG000|Overall Study|Withdrawal by Subject|1
1029043|NCT01650805|2057280|FG000|Overall Study|Withdrawal by Subject|1
1029044|NCT01650805|2057281|FG001|Overall Study|Withdrawal by Subject|0
1029045|NCT01650831|2057287|FG000|Overall Study|Screen failure|1
1029046|NCT01651000|2057306|FG000|Overall Study|Adverse Event|2
1029047|NCT01651000|2057307|FG001|Overall Study|Adverse Event|8
1029048|NCT01651000|2057306|FG000|Overall Study|Lost to Follow-up|3
1029049|NCT01651000|2057307|FG001|Overall Study|Lost to Follow-up|2
1029050|NCT01651000|2057306|FG000|Overall Study|Protocol Violation|0
1029051|NCT01651000|2057307|FG001|Overall Study|Protocol Violation|3
1029052|NCT01651000|2057306|FG000|Overall Study|Withdrawal by Subject|2
1029053|NCT01651000|2057307|FG001|Overall Study|Withdrawal by Subject|10
1029054|NCT01651000|2057306|FG000|Overall Study|Subject noncompliance|0
1029055|NCT01651000|2057307|FG001|Overall Study|Subject noncompliance|3
1029056|NCT01651000|2057306|FG000|Overall Study|Lack of Efficacy|1
1029057|NCT01651000|2057307|FG001|Overall Study|Lack of Efficacy|1
1029058|NCT01651000|2057306|FG000|Overall Study|Physician Decision|1
1029059|NCT01651000|2057307|FG001|Overall Study|Physician Decision|0
1029060|NCT01651000|2057306|FG000|Overall Study|Administrative reason|1
1029061|NCT01651000|2057307|FG001|Overall Study|Administrative reason|0
1029062|NCT01651000|2057306|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
1029063|NCT01651000|2057307|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
1029064|NCT01651039|2057313|FG000|Overall Study|Non-evaluables|5
1029065|NCT01651039|2057313|FG000|Overall Study|Physician Decision|2
1029066|NCT01651039|2057313|FG000|Overall Study|Withdrawal by Subject|1
1029067|NCT01651039|2057313|FG000|Overall Study|Progressive Disease|22
1029068|NCT01651052|2057317|FG000|Overall Study|Death|21
1029069|NCT01651052|2057317|FG000|Overall Study|Explant|1
1029070|NCT01651052|2057317|FG000|Overall Study|Withdrawal by Subject|1
1029071|NCT01651052|2057317|FG000|Overall Study|Lost to Follow-up|3
1029072|NCT01651117|2057333|FG000|Overall Study|Death|2
1029073|NCT01651117|2057334|FG001|Overall Study|Death|3
1029074|NCT01651117|2057335|FG002|Overall Study|Death|2
1029075|NCT01651117|2057336|FG003|Overall Study|Death|2
1029076|NCT01651208|2057372|FG000|Overall Study|Lost to Follow-up|14
1029077|NCT01651208|2057373|FG001|Overall Study|Lost to Follow-up|16
1029078|NCT01651260|2057380|FG000|Overall Study|unable to apply product|3
905102|NCT00760877|1880342|FG001|Overall Study|Physician Decision|2
905103|NCT00760877|1880341|FG000|Overall Study|Participants transferred to AMN107A2408|11
905104|NCT00760877|1880342|FG001|Overall Study|Participants transferred to AMN107A2408|1
905105|NCT00760877|1880341|FG000|Overall Study|Treatment failure|1
905106|NCT00760877|1880342|FG001|Overall Study|Treatment failure|0
905107|NCT00760929|1880353|FG000|Overall Study|Adverse Event|2
905108|NCT00760929|1880354|FG001|Overall Study|Adverse Event|0
905109|NCT00760929|1880355|FG002|Overall Study|Adverse Event|6
905110|NCT00760929|1880356|FG003|Overall Study|Adverse Event|10
905111|NCT00760929|1880353|FG000|Overall Study|Lack of Efficacy|0
1029091|NCT01651780|2057430|FG000|Overall Study|Physician decision: No 30-day visit|2
1029092|NCT01651780|2057431|FG001|Overall Study|Physician decision: No 30-day visit|1
1029093|NCT01651780|2057430|FG000|Overall Study|Reason Not Specified: No 30-day visit|2
1029094|NCT01651780|2057431|FG001|Overall Study|Reason Not Specified: No 30-day visit|2
1029095|NCT01651780|2057430|FG000|Overall Study|Withdrawal by Subject|2
1029096|NCT01651780|2057431|FG001|Overall Study|Withdrawal by Subject|0
1029097|NCT01651780|2057430|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
1029098|NCT01651780|2057431|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1029099|NCT01651780|2057430|FG000|Overall Study|Lost to Follow-up|1
1029100|NCT01651780|2057431|FG001|Overall Study|Lost to Follow-up|2
1029101|NCT01651780|2057430|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1
1029102|NCT01651780|2057431|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5
1029103|NCT01651936|2057482|FG000|Base Study|Adverse Event|3
1029104|NCT01651936|2057483|FG001|Base Study|Adverse Event|0
1029105|NCT01651936|2057484|FG002|Base Study|Adverse Event|0
1029106|NCT01651936|2057482|FG000|Base Study|Withdrawal by Subject|1
1029107|NCT01651936|2057483|FG001|Base Study|Withdrawal by Subject|1
1029108|NCT01651936|2057484|FG002|Base Study|Withdrawal by Subject|0
1029109|NCT01651936|2057482|FG000|Base Study|Early Escape|2
1029110|NCT01651936|2057483|FG001|Base Study|Early Escape|8
1029111|NCT01651936|2057484|FG002|Base Study|Early Escape|0
1029112|NCT01651936|2057482|FG000|Base Study|Study terminated by sponsor|21
1029113|NCT01651936|2057483|FG001|Base Study|Study terminated by sponsor|16
1029114|NCT01651936|2057484|FG002|Base Study|Study terminated by sponsor|0
1029115|NCT01651936|2057482|FG000|Extension Study|Lack of Efficacy|0
1029116|NCT01651936|2057483|FG001|Extension Study|Lack of Efficacy|0
1029117|NCT01651936|2057484|FG002|Extension Study|Lack of Efficacy|1
1029118|NCT01651936|2057482|FG000|Extension Study|Study terminated by sponsor|0
1029119|NCT01651936|2057483|FG001|Extension Study|Study terminated by sponsor|0
1029120|NCT01651936|2057484|FG002|Extension Study|Study terminated by sponsor|13
1029121|NCT01651949|2057494|FG000|Overall Study|Unknown status|4
1029122|NCT01651949|2057495|FG001|Overall Study|Unknown status|4
1029123|NCT01651949|2057496|FG002|Overall Study|Unknown status|0
1029124|NCT01651949|2057494|FG000|Overall Study|Lost to Follow-up|30
1029125|NCT01651949|2057495|FG001|Overall Study|Lost to Follow-up|56
1029126|NCT01651949|2057496|FG002|Overall Study|Lost to Follow-up|20
1029127|NCT01651949|2057494|FG000|Overall Study|Protocol Violation|0
1029128|NCT01651949|2057495|FG001|Overall Study|Protocol Violation|2
1029129|NCT01651949|2057496|FG002|Overall Study|Protocol Violation|1
1029130|NCT01651949|2057494|FG000|Overall Study|Physician Decision|0
1029131|NCT01651949|2057495|FG001|Overall Study|Physician Decision|2
1029132|NCT01651949|2057496|FG002|Overall Study|Physician Decision|0
1029133|NCT01651949|2057494|FG000|Overall Study|Adverse Event|0
1029134|NCT01651949|2057495|FG001|Overall Study|Adverse Event|2
1029135|NCT01651949|2057496|FG002|Overall Study|Adverse Event|1
1029136|NCT01651949|2057494|FG000|Overall Study|Screen failure|2
1029137|NCT01651949|2057495|FG001|Overall Study|Screen failure|2
1029138|NCT01651949|2057496|FG002|Overall Study|Screen failure|0
1029139|NCT01651949|2057494|FG000|Overall Study|Withdrawal by Subject|17
1029140|NCT01651949|2057495|FG001|Overall Study|Withdrawal by Subject|18
1029141|NCT01651949|2057496|FG002|Overall Study|Withdrawal by Subject|9
1029142|NCT01652287|2057525|FG000|Overall Study|Withdrawal by Subject|2
1029143|NCT01652287|2057526|FG001|Overall Study|Withdrawal by Subject|0
1029144|NCT01652469|2057534|FG000|Overall Study|Withdrawal by Subject|1
1029145|NCT01652469|2057535|FG001|Overall Study|Withdrawal by Subject|4
1029146|NCT01652469|2057534|FG000|Overall Study|Lost to Follow-up|0
1029147|NCT01652469|2057535|FG001|Overall Study|Lost to Follow-up|2
1029148|NCT01652573|2057563|FG000|Overall Study|Adverse Event|0
1029149|NCT01652573|2057564|FG001|Overall Study|Adverse Event|1
1029150|NCT01652664|2057572|FG000|Overall Study|Treatment Failure|5
1029151|NCT01652664|2057573|FG001|Overall Study|Treatment Failure|1
1029152|NCT01652664|2057572|FG000|Overall Study|Inadequate IOP control|1
1029153|NCT01652664|2057573|FG001|Overall Study|Inadequate IOP control|0
1029154|NCT01652690|2057582|FG000|Overall Study|Withdrawal by Subject|16
1029155|NCT01652690|2057583|FG001|Overall Study|Withdrawal by Subject|4
1029156|NCT01652690|2057582|FG000|Overall Study|Other|8
1029157|NCT01652690|2057583|FG001|Overall Study|Other|9
1029158|NCT01652690|2057582|FG000|Overall Study|Lost to Follow-up|6
1029159|NCT01652690|2057583|FG001|Overall Study|Lost to Follow-up|6
1029160|NCT01652690|2057582|FG000|Overall Study|Death|5
1029161|NCT01652690|2057583|FG001|Overall Study|Death|2
1029162|NCT01652703|2057595|FG000|Overall Study|Withdrawal by Subject|0
905112|NCT00760929|1880354|FG001|Overall Study|Lack of Efficacy|2
1029163|NCT01652703|2057596|FG001|Overall Study|Withdrawal by Subject|1
1029164|NCT01652703|2057597|FG002|Overall Study|Withdrawal by Subject|3
1029165|NCT01652703|2057598|FG003|Overall Study|Withdrawal by Subject|1
1029166|NCT01652703|2057599|FG004|Overall Study|Withdrawal by Subject|0
1029167|NCT01652703|2057600|FG005|Overall Study|Withdrawal by Subject|1
1029168|NCT01652703|2057595|FG000|Overall Study|Other|0
1029169|NCT01652703|2057596|FG001|Overall Study|Other|0
1029170|NCT01652703|2057597|FG002|Overall Study|Other|0
1029171|NCT01652703|2057598|FG003|Overall Study|Other|1
1029172|NCT01652703|2057599|FG004|Overall Study|Other|1
1029173|NCT01652703|2057600|FG005|Overall Study|Other|1
1029174|NCT01652716|2057616|FG000|Overall Study|Loss of glucose control|1
1029175|NCT01652716|2057617|FG001|Overall Study|Loss of glucose control|0
1029176|NCT01652716|2057616|FG000|Overall Study|Administrative|0
1029177|NCT01652716|2057617|FG001|Overall Study|Administrative|2
1029178|NCT01652716|2057616|FG000|Overall Study|Investigator decision|1
1029179|NCT01652716|2057617|FG001|Overall Study|Investigator decision|4
1029180|NCT01652716|2057616|FG000|Overall Study|Lost to Follow-up|12
1029181|NCT01652716|2057617|FG001|Overall Study|Lost to Follow-up|11
1029182|NCT01652716|2057616|FG000|Overall Study|Protocol Violation|2
1029183|NCT01652716|2057617|FG001|Overall Study|Protocol Violation|1
1029184|NCT01652716|2057616|FG000|Overall Study|Adverse Event|7
1029185|NCT01652716|2057617|FG001|Overall Study|Adverse Event|10
1029186|NCT01652716|2057616|FG000|Overall Study|Withdrawal by Subject|33
1029187|NCT01652716|2057617|FG001|Overall Study|Withdrawal by Subject|18
1029188|NCT01652729|2057626|FG000|Overall Study|Withdrawal by Subject|14
1029189|NCT01652729|2057627|FG001|Overall Study|Withdrawal by Subject|7
1029190|NCT01652729|2057628|FG002|Overall Study|Withdrawal by Subject|7
1029191|NCT01652729|2057626|FG000|Overall Study|Adverse Event|4
1029192|NCT01652729|2057627|FG001|Overall Study|Adverse Event|0
1029193|NCT01652729|2057628|FG002|Overall Study|Adverse Event|3
1029194|NCT01652729|2057626|FG000|Overall Study|Physician Decision|1
1029195|NCT01652729|2057627|FG001|Overall Study|Physician Decision|0
1029196|NCT01652729|2057628|FG002|Overall Study|Physician Decision|1
1029197|NCT01652729|2057626|FG000|Overall Study|Protocol Violation|1
1029198|NCT01652729|2057627|FG001|Overall Study|Protocol Violation|0
1029199|NCT01652729|2057628|FG002|Overall Study|Protocol Violation|0
1029200|NCT01652729|2057626|FG000|Overall Study|Lost to Follow-up|6
1029201|NCT01652729|2057627|FG001|Overall Study|Lost to Follow-up|6
1029202|NCT01652729|2057628|FG002|Overall Study|Lost to Follow-up|3
1029203|NCT01652729|2057626|FG000|Overall Study|Administrative|1
1029204|NCT01652729|2057627|FG001|Overall Study|Administrative|0
1029205|NCT01652729|2057628|FG002|Overall Study|Administrative|0
1029206|NCT01652872|2057638|FG000|Overall Study|Death|36
1029207|NCT01652872|2057639|FG001|Overall Study|Death|39
1029208|NCT01652872|2057638|FG000|Overall Study|Lost to Follow-up|28
1029209|NCT01652872|2057639|FG001|Overall Study|Lost to Follow-up|23
1029210|NCT01652872|2057638|FG000|Overall Study|Decision by sponsor|5
1029211|NCT01652872|2057639|FG001|Overall Study|Decision by sponsor|7
1029212|NCT01652872|2057638|FG000|Overall Study|Withdrawal by Subject|76
1029213|NCT01652872|2057639|FG001|Overall Study|Withdrawal by Subject|84
1029214|NCT01652885|2057645|FG000|Overall Study|Adverse Event|1
1029215|NCT01653132|2057674|FG000|First Intervention|Protocol Violation|1
1029216|NCT01653132|2057675|FG001|First Intervention|Protocol Violation|0
1029217|NCT01653158|2057685|FG000|Overall Study|Death|0
1029218|NCT01653158|2057686|FG001|Overall Study|Death|0
1029219|NCT01653158|2057687|FG002|Overall Study|Death|0
1029220|NCT01653158|2057688|FG003|Overall Study|Death|1
1029221|NCT01653158|2057689|FG004|Overall Study|Death|0
1029222|NCT01653158|2057690|FG005|Overall Study|Death|0
1029223|NCT01653158|2057691|FG006|Overall Study|Death|0
1029224|NCT01653158|2057692|FG007|Overall Study|Death|2
1029225|NCT01653158|2057685|FG000|Overall Study|Adverse Event|0
1029226|NCT01653158|2057686|FG001|Overall Study|Adverse Event|0
1029227|NCT01653158|2057687|FG002|Overall Study|Adverse Event|0
1029228|NCT01653158|2057688|FG003|Overall Study|Adverse Event|1
1029229|NCT01653158|2057689|FG004|Overall Study|Adverse Event|0
1029230|NCT01653158|2057690|FG005|Overall Study|Adverse Event|0
1029231|NCT01653158|2057691|FG006|Overall Study|Adverse Event|0
1029232|NCT01653158|2057692|FG007|Overall Study|Adverse Event|3
1029233|NCT01653158|2057685|FG000|Overall Study|Other|0
1029234|NCT01653158|2057686|FG001|Overall Study|Other|0
1029235|NCT01653158|2057687|FG002|Overall Study|Other|0
1029236|NCT01653158|2057688|FG003|Overall Study|Other|0
1029237|NCT01653158|2057689|FG004|Overall Study|Other|0
1029238|NCT01653158|2057690|FG005|Overall Study|Other|0
1029239|NCT01653158|2057691|FG006|Overall Study|Other|0
1029240|NCT01653158|2057692|FG007|Overall Study|Other|1
1029241|NCT01653158|2057685|FG000|Overall Study|Progressive disease|0
1029242|NCT01653158|2057686|FG001|Overall Study|Progressive disease|0
1029243|NCT01653158|2057687|FG002|Overall Study|Progressive disease|0
1029244|NCT01653158|2057688|FG003|Overall Study|Progressive disease|0
1029245|NCT01653158|2057689|FG004|Overall Study|Progressive disease|1
1029246|NCT01653158|2057690|FG005|Overall Study|Progressive disease|1
1029247|NCT01653158|2057691|FG006|Overall Study|Progressive disease|2
1029248|NCT01653158|2057692|FG007|Overall Study|Progressive disease|9
1029249|NCT01653158|2057685|FG000|Overall Study|Withdrawal by Subject|1
1029250|NCT01653158|2057686|FG001|Overall Study|Withdrawal by Subject|0
1029251|NCT01653158|2057687|FG002|Overall Study|Withdrawal by Subject|0
1029252|NCT01653158|2057688|FG003|Overall Study|Withdrawal by Subject|0
1029253|NCT01653158|2057689|FG004|Overall Study|Withdrawal by Subject|0
1029254|NCT01653158|2057690|FG005|Overall Study|Withdrawal by Subject|0
1029255|NCT01653158|2057691|FG006|Overall Study|Withdrawal by Subject|0
1029256|NCT01653158|2057692|FG007|Overall Study|Withdrawal by Subject|0
1029257|NCT01653262|2057719|FG000|Overall Study|Lack of Efficacy|1
1029258|NCT01653262|2057719|FG000|Overall Study|SAE, non-fatal|1
1029259|NCT01653262|2057719|FG000|Overall Study|AE, non-serious non-fatal|1
1029260|NCT01653327|2057734|FG000|Overall Study|Withdrawal by Subject|1
1029261|NCT01653704|2057775|FG000|Overall Study|Technical failure during recording|1
1029262|NCT01653704|2057776|FG001|Overall Study|Technical failure during recording|1
1029263|NCT01653704|2057775|FG000|Overall Study|Performance not reflective of training|1
1029264|NCT01653704|2057776|FG001|Overall Study|Performance not reflective of training|0
1029265|NCT01653743|2057784|FG000|Overall Study|Withdrawal by Subject|1
1029266|NCT01653743|2057785|FG001|Overall Study|Withdrawal by Subject|0
1029267|NCT01653743|2057784|FG000|Overall Study|Investigator discretion|3
1029268|NCT01653743|2057785|FG001|Overall Study|Investigator discretion|0
1029269|NCT01653782|2057794|FG000|Overall Study|Withdrawal by Subject|9
1029270|NCT01653782|2057795|FG001|Overall Study|Withdrawal by Subject|15
1029271|NCT01653782|2057796|FG002|Overall Study|Withdrawal by Subject|4
1029272|NCT01653782|2057794|FG000|Overall Study|Lost to Follow-up|7
1029273|NCT01653782|2057795|FG001|Overall Study|Lost to Follow-up|3
1029274|NCT01653782|2057796|FG002|Overall Study|Lost to Follow-up|2
1029275|NCT01653847|2057806|FG000|Overall Study|Withdrawal by Subject|1
1029276|NCT01653847|2057807|FG001|Overall Study|Withdrawal by Subject|0
1029277|NCT01653912|2057815|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1029278|NCT01653912|2057816|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
1029279|NCT01653912|2057817|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1029280|NCT01653912|2057818|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1029281|NCT01653912|2057819|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1029282|NCT01653912|2057820|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1029283|NCT01653912|2057815|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1029284|NCT01653912|2057816|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1029285|NCT01653912|2057817|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
1029286|NCT01653912|2057818|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1029287|NCT01653912|2057819|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1029288|NCT01653912|2057820|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1029289|NCT01653912|2057815|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1029290|NCT01653912|2057816|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1029291|NCT01653912|2057817|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1029292|NCT01653912|2057818|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
1029293|NCT01653912|2057819|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1029294|NCT01653912|2057820|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1029295|NCT01653912|2057815|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1029296|NCT01653912|2057816|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1029297|NCT01653912|2057817|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1029298|NCT01653912|2057818|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
1029299|NCT01653912|2057819|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1029300|NCT01653912|2057820|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1029301|NCT01653912|2057815|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0
1029302|NCT01653912|2057816|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0
1029303|NCT01653912|2057817|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0
1029304|NCT01653912|2057818|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0
1029305|NCT01653912|2057819|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0
1029306|NCT01653912|2057820|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1
1029307|NCT01653912|2057815|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1029308|NCT01653912|2057816|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1029309|NCT01653912|2057817|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1029310|NCT01653912|2057818|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1029311|NCT01653912|2057819|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1029312|NCT01653912|2057820|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6
1029313|NCT01653912|2057815|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1029314|NCT01653912|2057816|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1029315|NCT01653912|2057817|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1029316|NCT01653912|2057818|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1029317|NCT01653912|2057819|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1029318|NCT01653912|2057820|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
1029319|NCT01654224|2057845|FG000|Overall Study|Lost to Follow-up|2
1029320|NCT01654224|2057846|FG001|Overall Study|Lost to Follow-up|2
1029321|NCT01654224|2057845|FG000|Overall Study|Did not receive allocation|1
1029322|NCT01654224|2057846|FG001|Overall Study|Did not receive allocation|8
1029323|NCT01654224|2057845|FG000|Overall Study|Insufficient blood sample|3
1029324|NCT01654224|2057846|FG001|Overall Study|Insufficient blood sample|2
1029325|NCT01654250|2057854|FG000|Overall Study|Lost to Follow-up|1
1029326|NCT01654250|2057855|FG001|Overall Study|Lost to Follow-up|0
1029327|NCT01654276|2057884|FG000|Overall Study|Lack of Efficacy|1
1029328|NCT01654276|2057884|FG000|Overall Study|Lost to Follow-up|4
1029329|NCT01654276|2057884|FG000|Overall Study|Withdrawal by Subject|1
1029330|NCT01654289|2057891|FG000|Overall Study|Withdrawal by Subject|10
1029331|NCT01654289|2057892|FG001|Overall Study|Withdrawal by Subject|8
1029332|NCT01654289|2057893|FG002|Overall Study|Withdrawal by Subject|5
1029333|NCT01654289|2057891|FG000|Overall Study|Withdrew from intervention only|17
1029334|NCT01654289|2057892|FG001|Overall Study|Withdrew from intervention only|20
1029335|NCT01654289|2057893|FG002|Overall Study|Withdrew from intervention only|0
1029336|NCT01654302|2057903|FG000|Second Intervention (Day 7)|Lost to Follow-up|1
1029337|NCT01654302|2057904|FG001|Second Intervention (Day 7)|Lost to Follow-up|1
1029338|NCT01654380|2057925|FG000|Part B, Period 1|Physician Decision|0
1029339|NCT01654380|2057926|FG001|Part B, Period 1|Physician Decision|0
1029340|NCT01654380|2057927|FG002|Part B, Period 1|Physician Decision|1
1029341|NCT01654380|2057928|FG003|Part B, Period 1|Physician Decision|0
1029342|NCT01654523|2057954|FG000|Overall Study|Withdrawal by Subject|1
1029343|NCT01654536|2057960|FG000|Overall Study|Lost to Follow-up|5
1029344|NCT01654536|2057961|FG001|Overall Study|Lost to Follow-up|5
1029345|NCT01654536|2057960|FG000|Overall Study|Physician Decision|12
1029346|NCT01654536|2057961|FG001|Overall Study|Physician Decision|8
1029347|NCT01654536|2057960|FG000|Overall Study|Withdrawal by Subject|27
1029348|NCT01654536|2057961|FG001|Overall Study|Withdrawal by Subject|25
1029349|NCT01654549|2057970|FG000|Overall Study|H.pylori eradication not successful|0
1029350|NCT01654549|2057971|FG001|Overall Study|H.pylori eradication not successful|1
1029351|NCT01654601|2057983|FG000|1st Administration|Withdrawal by Subject|2
1029352|NCT01654601|2057984|FG001|1st Administration|Withdrawal by Subject|0
1029353|NCT01654601|2057983|FG000|1st Administration|Protocol Violation|0
1029354|NCT01654601|2057984|FG001|1st Administration|Protocol Violation|2
1029355|NCT01654601|2057983|FG000|2nd Administration|Adverse Event|1
1029356|NCT01654601|2057984|FG001|2nd Administration|Adverse Event|0
1029357|NCT01654601|2057983|FG000|2nd Administration|Protocol Violation|0
1029358|NCT01654601|2057984|FG001|2nd Administration|Protocol Violation|1
1029359|NCT01654666|2057993|FG000|Overall Study|Protocol Violation|7
1029360|NCT01654666|2057994|FG001|Overall Study|Protocol Violation|4
1029361|NCT01654666|2057995|FG002|Overall Study|Protocol Violation|8
1029362|NCT01654666|2057993|FG000|Overall Study|Lost to Follow-up|4
1029363|NCT01654666|2057994|FG001|Overall Study|Lost to Follow-up|5
1029364|NCT01654666|2057995|FG002|Overall Study|Lost to Follow-up|5
1029365|NCT01654666|2057993|FG000|Overall Study|Withdrawal by Subject|4
1029366|NCT01654666|2057994|FG001|Overall Study|Withdrawal by Subject|4
1029367|NCT01654666|2057995|FG002|Overall Study|Withdrawal by Subject|1
1029368|NCT01655069|2058039|FG000|Overall Study|Physician Decision|0
1029369|NCT01655069|2058040|FG001|Overall Study|Physician Decision|0
1029370|NCT01655069|2058041|FG002|Overall Study|Physician Decision|0
1029371|NCT01655069|2058042|FG003|Overall Study|Physician Decision|1
1029372|NCT01655069|2058039|FG000|Overall Study|Adverse Event|6
1029373|NCT01655069|2058040|FG001|Overall Study|Adverse Event|7
1029374|NCT01655069|2058041|FG002|Overall Study|Adverse Event|2
1029375|NCT01655069|2058042|FG003|Overall Study|Adverse Event|3
1029376|NCT01655069|2058039|FG000|Overall Study|Lack of Efficacy|0
1029377|NCT01655069|2058040|FG001|Overall Study|Lack of Efficacy|1
1029378|NCT01655069|2058041|FG002|Overall Study|Lack of Efficacy|0
1029379|NCT01655069|2058042|FG003|Overall Study|Lack of Efficacy|0
1029380|NCT01655069|2058039|FG000|Overall Study|No Treatment Needed|0
1029381|NCT01655069|2058040|FG001|Overall Study|No Treatment Needed|1
1029382|NCT01655069|2058041|FG002|Overall Study|No Treatment Needed|0
1029383|NCT01655069|2058042|FG003|Overall Study|No Treatment Needed|0
1029384|NCT01655069|2058039|FG000|Overall Study|Withdrawal by Subject|2
1029385|NCT01655069|2058040|FG001|Overall Study|Withdrawal by Subject|3
1029386|NCT01655069|2058041|FG002|Overall Study|Withdrawal by Subject|0
1029387|NCT01655069|2058042|FG003|Overall Study|Withdrawal by Subject|0
1029388|NCT01655381|2058064|FG000|Overall Study|Investigator Decision|1
1029389|NCT01655381|2058064|FG000|Overall Study|Moved to Another City|1
1029390|NCT01655381|2058064|FG000|Overall Study|Insufficient Treatment Response|1
1029391|NCT01655498|2058069|FG000|Overall Study|Unrelated health issue|2
1029392|NCT01655498|2058069|FG000|Overall Study|Protocol Violation|2
1029393|NCT01655498|2058069|FG000|Overall Study|Withdrawal by Subject|1
1029394|NCT01655693|2058088|FG000|Overall Study|Progression of Disease|92
1029395|NCT01655693|2058089|FG001|Overall Study|Progression of Disease|76
1029396|NCT01655693|2058090|FG002|Overall Study|Progression of Disease|58
1029397|NCT01655693|2058088|FG000|Overall Study|Death|8
1029398|NCT01655693|2058089|FG001|Overall Study|Death|9
1029399|NCT01655693|2058090|FG002|Overall Study|Death|12
1029400|NCT01655693|2058088|FG000|Overall Study|Serious Adverse Event|3
1029401|NCT01655693|2058089|FG001|Overall Study|Serious Adverse Event|15
1029402|NCT01655693|2058090|FG002|Overall Study|Serious Adverse Event|11
1029403|NCT01655693|2058088|FG000|Overall Study|Withdrawal by Subject|3
1029404|NCT01655693|2058089|FG001|Overall Study|Withdrawal by Subject|2
1029405|NCT01655693|2058090|FG002|Overall Study|Withdrawal by Subject|20
1029406|NCT01655693|2058088|FG000|Overall Study|Adverse Event|3
1029407|NCT01655693|2058089|FG001|Overall Study|Adverse Event|11
905113|NCT00760929|1880355|FG002|Overall Study|Lack of Efficacy|1
905114|NCT00760929|1880356|FG003|Overall Study|Lack of Efficacy|0
905115|NCT00760929|1880353|FG000|Overall Study|Withdrawal by Subject|1
905116|NCT00760929|1880354|FG001|Overall Study|Withdrawal by Subject|0
905117|NCT00760929|1880355|FG002|Overall Study|Withdrawal by Subject|9
1029408|NCT01655693|2058090|FG002|Overall Study|Adverse Event|3
1029409|NCT01655693|2058088|FG000|Overall Study|Aggravation of Liver Dysfunction|5
1029410|NCT01655693|2058089|FG001|Overall Study|Aggravation of Liver Dysfunction|4
1029411|NCT01655693|2058090|FG002|Overall Study|Aggravation of Liver Dysfunction|0
1029412|NCT01655693|2058088|FG000|Overall Study|Non-Compliance|0
1029413|NCT01655693|2058089|FG001|Overall Study|Non-Compliance|0
1029414|NCT01655693|2058090|FG002|Overall Study|Non-Compliance|7
1029415|NCT01655693|2058088|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1
1029416|NCT01655693|2058089|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3
1029417|NCT01655693|2058090|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0
1029418|NCT01655693|2058088|FG000|Overall Study|Protocol Violation|1
1029419|NCT01655693|2058089|FG001|Overall Study|Protocol Violation|0
1029420|NCT01655693|2058090|FG002|Overall Study|Protocol Violation|3
1029421|NCT01655693|2058088|FG000|Overall Study|Lost to Follow-up|1
1029422|NCT01655693|2058089|FG001|Overall Study|Lost to Follow-up|0
1029423|NCT01655693|2058090|FG002|Overall Study|Lost to Follow-up|1
1029424|NCT01655693|2058088|FG000|Overall Study|Screening Failure|1
1029425|NCT01655693|2058089|FG001|Overall Study|Screening Failure|0
1029426|NCT01655693|2058090|FG002|Overall Study|Screening Failure|0
1029427|NCT01655693|2058088|FG000|Overall Study|Other|8
1029428|NCT01655693|2058089|FG001|Overall Study|Other|6
1029429|NCT01655693|2058090|FG002|Overall Study|Other|15
1029430|NCT01655823|2058117|FG000|Overall Study|Lost to Follow-up|0
1029431|NCT01655823|2058118|FG001|Overall Study|Lost to Follow-up|1
1029432|NCT01655823|2058119|FG002|Overall Study|Lost to Follow-up|0
1029433|NCT01655823|2058120|FG003|Overall Study|Lost to Follow-up|0
1029434|NCT01655823|2058121|FG004|Overall Study|Lost to Follow-up|1
1029435|NCT01655823|2058117|FG000|Overall Study|Withdrawal by Subject|0
1029436|NCT01655823|2058118|FG001|Overall Study|Withdrawal by Subject|1
1029437|NCT01655823|2058119|FG002|Overall Study|Withdrawal by Subject|0
1029438|NCT01655823|2058120|FG003|Overall Study|Withdrawal by Subject|1
1029439|NCT01655823|2058121|FG004|Overall Study|Withdrawal by Subject|0
1029440|NCT01655901|2058133|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1
1029441|NCT01655901|2058134|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1
1029442|NCT01655901|2058135|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1
1029443|NCT01655901|2058136|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0
1029444|NCT01655901|2058137|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1
1029445|NCT01655901|2058138|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0
1029446|NCT01656161|2058151|FG000|Overall Study|Death|3
1029447|NCT01656161|2058151|FG000|Overall Study|Adverse Event|2
1029448|NCT01656161|2058151|FG000|Overall Study|Protocol Violation|1
1029449|NCT01656161|2058151|FG000|Overall Study|Withdrawal by Subject|1
1029450|NCT01656200|2058167|FG000|Overall Study|Withdrawal by Subject|1
1029451|NCT01656304|2058177|FG000|Overall Study|Ineligible, uncontrolled hypertension|1
1029452|NCT01656395|2058187|FG000|Overall Study|Adverse Event|1
1029453|NCT01656395|2058188|FG001|Overall Study|Adverse Event|14
1029454|NCT01656395|2058189|FG002|Overall Study|Adverse Event|5
1029455|NCT01656395|2058190|FG003|Overall Study|Adverse Event|4
1029456|NCT01656395|2058191|FG004|Overall Study|Adverse Event|5
1029457|NCT01656395|2058192|FG005|Overall Study|Adverse Event|7
1029458|NCT01656395|2058193|FG006|Overall Study|Adverse Event|0
1029459|NCT01656395|2058194|FG007|Overall Study|Adverse Event|0
1029460|NCT01656395|2058187|FG000|Overall Study|Lack of Efficacy|1
1029461|NCT01656395|2058188|FG001|Overall Study|Lack of Efficacy|8
1029462|NCT01656395|2058189|FG002|Overall Study|Lack of Efficacy|6
1029463|NCT01656395|2058190|FG003|Overall Study|Lack of Efficacy|1
1029464|NCT01656395|2058191|FG004|Overall Study|Lack of Efficacy|1
1029465|NCT01656395|2058192|FG005|Overall Study|Lack of Efficacy|6
1029466|NCT01656395|2058193|FG006|Overall Study|Lack of Efficacy|0
1029467|NCT01656395|2058194|FG007|Overall Study|Lack of Efficacy|0
1029468|NCT01656395|2058187|FG000|Overall Study|Lost to Follow-up|1
1029469|NCT01656395|2058188|FG001|Overall Study|Lost to Follow-up|0
1029470|NCT01656395|2058189|FG002|Overall Study|Lost to Follow-up|0
1029471|NCT01656395|2058190|FG003|Overall Study|Lost to Follow-up|0
1029472|NCT01656395|2058191|FG004|Overall Study|Lost to Follow-up|0
1029473|NCT01656395|2058192|FG005|Overall Study|Lost to Follow-up|0
1029474|NCT01656395|2058193|FG006|Overall Study|Lost to Follow-up|0
1029475|NCT01656395|2058194|FG007|Overall Study|Lost to Follow-up|0
1029476|NCT01656395|2058187|FG000|Overall Study|Non-Compliance with Study Drug|1
1029477|NCT01656395|2058188|FG001|Overall Study|Non-Compliance with Study Drug|1
1029478|NCT01656395|2058189|FG002|Overall Study|Non-Compliance with Study Drug|0
1029479|NCT01656395|2058190|FG003|Overall Study|Non-Compliance with Study Drug|0
1029480|NCT01656395|2058191|FG004|Overall Study|Non-Compliance with Study Drug|1
1029481|NCT01656395|2058192|FG005|Overall Study|Non-Compliance with Study Drug|1
1029482|NCT01656395|2058193|FG006|Overall Study|Non-Compliance with Study Drug|0
1029483|NCT01656395|2058194|FG007|Overall Study|Non-Compliance with Study Drug|0
1029484|NCT01656395|2058187|FG000|Overall Study|Other|0
1029485|NCT01656395|2058188|FG001|Overall Study|Other|0
1029486|NCT01656395|2058189|FG002|Overall Study|Other|1
1029487|NCT01656395|2058190|FG003|Overall Study|Other|0
1029488|NCT01656395|2058191|FG004|Overall Study|Other|0
1029489|NCT01656395|2058192|FG005|Overall Study|Other|1
1029490|NCT01656395|2058193|FG006|Overall Study|Other|0
1029491|NCT01656395|2058194|FG007|Overall Study|Other|0
1029492|NCT01656395|2058187|FG000|Overall Study|Physician Decision|2
1029493|NCT01656395|2058188|FG001|Overall Study|Physician Decision|3
1029494|NCT01656395|2058189|FG002|Overall Study|Physician Decision|3
1029495|NCT01656395|2058190|FG003|Overall Study|Physician Decision|2
1029496|NCT01656395|2058191|FG004|Overall Study|Physician Decision|3
1029497|NCT01656395|2058192|FG005|Overall Study|Physician Decision|3
1029498|NCT01656395|2058193|FG006|Overall Study|Physician Decision|0
1029499|NCT01656395|2058194|FG007|Overall Study|Physician Decision|0
1029500|NCT01656395|2058187|FG000|Overall Study|Pregnancy|0
1029501|NCT01656395|2058188|FG001|Overall Study|Pregnancy|0
1029502|NCT01656395|2058189|FG002|Overall Study|Pregnancy|1
1029503|NCT01656395|2058190|FG003|Overall Study|Pregnancy|0
1029504|NCT01656395|2058191|FG004|Overall Study|Pregnancy|0
1029505|NCT01656395|2058192|FG005|Overall Study|Pregnancy|0
1029506|NCT01656395|2058193|FG006|Overall Study|Pregnancy|0
1029507|NCT01656395|2058194|FG007|Overall Study|Pregnancy|0
1029508|NCT01656395|2058187|FG000|Overall Study|Progressive Disease|0
1029509|NCT01656395|2058188|FG001|Overall Study|Progressive Disease|0
1029510|NCT01656395|2058189|FG002|Overall Study|Progressive Disease|0
1029511|NCT01656395|2058190|FG003|Overall Study|Progressive Disease|0
1029512|NCT01656395|2058191|FG004|Overall Study|Progressive Disease|0
1029513|NCT01656395|2058192|FG005|Overall Study|Progressive Disease|1
1029514|NCT01656395|2058193|FG006|Overall Study|Progressive Disease|0
1029515|NCT01656395|2058194|FG007|Overall Study|Progressive Disease|0
1029516|NCT01656395|2058187|FG000|Overall Study|Protocol Violation|6
1029517|NCT01656395|2058188|FG001|Overall Study|Protocol Violation|6
1029518|NCT01656395|2058189|FG002|Overall Study|Protocol Violation|9
1029519|NCT01656395|2058190|FG003|Overall Study|Protocol Violation|2
1029520|NCT01656395|2058191|FG004|Overall Study|Protocol Violation|4
1029521|NCT01656395|2058192|FG005|Overall Study|Protocol Violation|10
1029522|NCT01656395|2058193|FG006|Overall Study|Protocol Violation|0
1029523|NCT01656395|2058194|FG007|Overall Study|Protocol Violation|0
1029524|NCT01656395|2058187|FG000|Overall Study|Screen Failure|2
1029525|NCT01656395|2058188|FG001|Overall Study|Screen Failure|1
1029526|NCT01656395|2058189|FG002|Overall Study|Screen Failure|7
1029527|NCT01656395|2058190|FG003|Overall Study|Screen Failure|1
1029528|NCT01656395|2058191|FG004|Overall Study|Screen Failure|0
1029529|NCT01656395|2058192|FG005|Overall Study|Screen Failure|8
1029530|NCT01656395|2058193|FG006|Overall Study|Screen Failure|0
1029531|NCT01656395|2058194|FG007|Overall Study|Screen Failure|0
1029532|NCT01656395|2058187|FG000|Overall Study|Withdrawal by Subject|3
1029533|NCT01656395|2058188|FG001|Overall Study|Withdrawal by Subject|1
1029534|NCT01656395|2058189|FG002|Overall Study|Withdrawal by Subject|4
1029535|NCT01656395|2058190|FG003|Overall Study|Withdrawal by Subject|2
1029536|NCT01656395|2058191|FG004|Overall Study|Withdrawal by Subject|0
1029537|NCT01656395|2058192|FG005|Overall Study|Withdrawal by Subject|3
1029538|NCT01656395|2058193|FG006|Overall Study|Withdrawal by Subject|0
1029539|NCT01656395|2058194|FG007|Overall Study|Withdrawal by Subject|0
1029540|NCT01656408|2058218|FG000|Overall Study|Adverse Event|0
1029541|NCT01656408|2058219|FG001|Overall Study|Adverse Event|0
1029542|NCT01656408|2058220|FG002|Overall Study|Adverse Event|1
1029543|NCT01656408|2058221|FG003|Overall Study|Adverse Event|0
1029544|NCT01656408|2058222|FG004|Overall Study|Adverse Event|0
1029545|NCT01656408|2058223|FG005|Overall Study|Adverse Event|1
1029546|NCT01656408|2058224|FG006|Overall Study|Adverse Event|1
1029547|NCT01656408|2058225|FG007|Overall Study|Adverse Event|0
1029548|NCT01656408|2058226|FG008|Overall Study|Adverse Event|1
1029549|NCT01656408|2058227|FG009|Overall Study|Adverse Event|0
1029550|NCT01656408|2058218|FG000|Overall Study|Physician Decision|1
1029551|NCT01656408|2058219|FG001|Overall Study|Physician Decision|0
1029552|NCT01656408|2058220|FG002|Overall Study|Physician Decision|1
1029553|NCT01656408|2058221|FG003|Overall Study|Physician Decision|0
1029554|NCT01656408|2058222|FG004|Overall Study|Physician Decision|1
1029555|NCT01656408|2058223|FG005|Overall Study|Physician Decision|1
1029556|NCT01656408|2058224|FG006|Overall Study|Physician Decision|0
1029557|NCT01656408|2058225|FG007|Overall Study|Physician Decision|1
1029558|NCT01656408|2058226|FG008|Overall Study|Physician Decision|1
1029559|NCT01656408|2058227|FG009|Overall Study|Physician Decision|3
1029560|NCT01656434|2058275|FG000|Overall Study|Adverse Event|199
1029561|NCT01656434|2058276|FG001|Overall Study|Adverse Event|63
1029562|NCT01656434|2058275|FG000|Overall Study|Enrollment terminated at trial site|2
1029563|NCT01656434|2058276|FG001|Overall Study|Enrollment terminated at trial site|0
1029564|NCT01656434|2058275|FG000|Overall Study|Lost to Follow-up|309
1029565|NCT01656434|2058276|FG001|Overall Study|Lost to Follow-up|76
1029566|NCT01656434|2058275|FG000|Overall Study|Site discontinued study participation|24
1029567|NCT01656434|2058276|FG001|Overall Study|Site discontinued study participation|9
1029568|NCT01656434|2058275|FG000|Overall Study|Screen failure|2
1029569|NCT01656434|2058276|FG001|Overall Study|Screen failure|0
1029570|NCT01656434|2058275|FG000|Overall Study|Protocol Violation|7
1029571|NCT01656434|2058276|FG001|Overall Study|Protocol Violation|0
1029572|NCT01656434|2058275|FG000|Overall Study|Pregnancy wish|18
1029573|NCT01656434|2058276|FG001|Overall Study|Pregnancy wish|6
1029574|NCT01656434|2058275|FG000|Overall Study|Pregnancy|45
1029575|NCT01656434|2058276|FG001|Overall Study|Pregnancy|10
1029576|NCT01656434|2058275|FG000|Overall Study|Physician Decision|7
1029577|NCT01656434|2058276|FG001|Overall Study|Physician Decision|2
1029578|NCT01656434|2058275|FG000|Overall Study|Non-compliance with study drug|48
1029579|NCT01656434|2058276|FG001|Overall Study|Non-compliance with study drug|9
1029580|NCT01656434|2058275|FG000|Overall Study|Study terminated by sponsor|1501
1029581|NCT01656434|2058276|FG001|Overall Study|Study terminated by sponsor|348
1029582|NCT01656434|2058275|FG000|Overall Study|Participant discontinued; drug related|13
1029583|NCT01656434|2058276|FG001|Overall Study|Participant discontinued; drug related|4
1029584|NCT01656434|2058275|FG000|Overall Study|Part. discontinued; unrelated to drug|55
1029585|NCT01656434|2058276|FG001|Overall Study|Part. discontinued; unrelated to drug|10
1029586|NCT01656434|2058275|FG000|Overall Study|Non-compliance with protocol|39
1029587|NCT01656434|2058276|FG001|Overall Study|Non-compliance with protocol|15
1029588|NCT01656434|2058275|FG000|Overall Study|Participant moved|40
1029589|NCT01656434|2058276|FG001|Overall Study|Participant moved|12
1029590|NCT01656434|2058275|FG000|Overall Study|Participant withdrew consent|28
1029591|NCT01656434|2058276|FG001|Overall Study|Participant withdrew consent|9
1029592|NCT01656434|2058275|FG000|Overall Study|Withdrawal by Subject|64
1029593|NCT01656434|2058276|FG001|Overall Study|Withdrawal by Subject|7
1029594|NCT01656733|2058314|FG000|Overall Study|No permission to collect birth outcomes|0
1029595|NCT01656733|2058315|FG001|Overall Study|No permission to collect birth outcomes|1
1029596|NCT01656733|2058314|FG000|Overall Study|Delivery at another hospital|0
1029597|NCT01656733|2058315|FG001|Overall Study|Delivery at another hospital|2
1029598|NCT01656733|2058314|FG000|Overall Study|Spontaneous abortion|0
1029599|NCT01656733|2058315|FG001|Overall Study|Spontaneous abortion|1
1029600|NCT01656759|2058323|FG000|Overall Study|Protocol Violation|2
1029601|NCT01656759|2058324|FG001|Overall Study|Protocol Violation|3
1029602|NCT01656850|2058341|FG000|First Intervention (3 Months)|Withdrawal by Subject|3
1029603|NCT01656850|2058342|FG001|First Intervention (3 Months)|Withdrawal by Subject|4
1029604|NCT01656889|2058354|FG000|Treatment Period, 12 Weeks|Adverse Event|10
1029605|NCT01656889|2058355|FG001|Treatment Period, 12 Weeks|Adverse Event|4
1029606|NCT01656889|2058354|FG000|Treatment Period, 12 Weeks|Death|0
1029607|NCT01656889|2058355|FG001|Treatment Period, 12 Weeks|Death|1
1029608|NCT01656889|2058354|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1
1029609|NCT01656889|2058355|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1
1029610|NCT01656889|2058354|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1
1029611|NCT01656889|2058355|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2
1029612|NCT01656889|2058354|FG000|Treatment Period, 12 Weeks|Protocol Violation|0
1029613|NCT01656889|2058355|FG001|Treatment Period, 12 Weeks|Protocol Violation|1
1029614|NCT01656889|2058354|FG000|Treatment Period, 12 Weeks|Moved out of the area|0
1029615|NCT01656889|2058355|FG001|Treatment Period, 12 Weeks|Moved out of the area|2
1029616|NCT01656889|2058354|FG000|Post Treatment Follow-Up, 3 Months|Death|1
1029617|NCT01656889|2058355|FG001|Post Treatment Follow-Up, 3 Months|Death|5
1029618|NCT01656889|2058354|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
1029619|NCT01656889|2058355|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
1029620|NCT01656889|2058354|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
1029621|NCT01656889|2058355|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
1029622|NCT01656889|2058354|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0
1029623|NCT01656889|2058355|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1
1029624|NCT01656967|2058363|FG000|Overall Study|faulty monitor|1
1029625|NCT01656967|2058364|FG001|Overall Study|faulty monitor|0
1029626|NCT01656967|2058363|FG000|Overall Study|unsuccessful ETT insertion|3
1029627|NCT01656967|2058364|FG001|Overall Study|unsuccessful ETT insertion|2
1029628|NCT01657019|2058374|FG000|Overall Study|Withdrawal by Subject|65
1029629|NCT01657019|2058374|FG000|Overall Study|Adverse Event|55
1029630|NCT01657019|2058374|FG000|Overall Study|Lost to Follow-up|48
1029631|NCT01657019|2058374|FG000|Overall Study|Protocol Violation|6
1029632|NCT01657019|2058374|FG000|Overall Study|Lack of Efficacy|3
1029633|NCT01657019|2058374|FG000|Overall Study|Other|58
1029634|NCT01657032|2058380|FG000|Overall Study|Lost to Follow-up|0
1029635|NCT01657032|2058381|FG001|Overall Study|Lost to Follow-up|7
1029636|NCT01657162|2058389|FG000|Overall Study|Adverse Event|26
1029637|NCT01657162|2058390|FG001|Overall Study|Adverse Event|36
1029638|NCT01657162|2058389|FG000|Overall Study|Withdrawal by Subject|13
1029639|NCT01657162|2058390|FG001|Overall Study|Withdrawal by Subject|13
1029640|NCT01657162|2058389|FG000|Overall Study|Continuing Significant Deterioration|9
1029641|NCT01657162|2058390|FG001|Overall Study|Continuing Significant Deterioration|3
1029642|NCT01657162|2058389|FG000|Overall Study|Refusal of Treatment|4
1029643|NCT01657162|2058390|FG001|Overall Study|Refusal of Treatment|6
1029644|NCT01657162|2058389|FG000|Overall Study|Lost to Follow-up|3
1029645|NCT01657162|2058390|FG001|Overall Study|Lost to Follow-up|4
1029646|NCT01657162|2058389|FG000|Overall Study|Death|2
1029647|NCT01657162|2058390|FG001|Overall Study|Death|3
1029648|NCT01657162|2058389|FG000|Overall Study|Inability to Complete Study Procedures|1
1029649|NCT01657162|2058390|FG001|Overall Study|Inability to Complete Study Procedures|7
1029650|NCT01657162|2058389|FG000|Overall Study|Protocol Violation|1
1029651|NCT01657162|2058390|FG001|Overall Study|Protocol Violation|0
1029652|NCT01657162|2058389|FG000|Overall Study|Hypersensitivity to Alendronate|0
1029653|NCT01657162|2058390|FG001|Overall Study|Hypersensitivity to Alendronate|1
1029654|NCT01657162|2058389|FG000|Overall Study|Other than Specified|0
1029655|NCT01657162|2058390|FG001|Overall Study|Other than Specified|2
1029656|NCT01657253|2058398|FG000|Overall Study|Lost to Follow-up|6
1029657|NCT01657253|2058399|FG001|Overall Study|Lost to Follow-up|5
1029658|NCT01657253|2058398|FG000|Overall Study|Withdrawal by Subject|11
1029659|NCT01657253|2058399|FG001|Overall Study|Withdrawal by Subject|12
1029660|NCT01657253|2058398|FG000|Overall Study|Adverse Event|0
1029661|NCT01657253|2058399|FG001|Overall Study|Adverse Event|1
1029662|NCT01657266|2058407|FG000|Overall Study|Lost to Follow-up|2
1029663|NCT01657266|2058408|FG001|Overall Study|Lost to Follow-up|2
1029664|NCT01657266|2058407|FG000|Overall Study|Adverse Event|2
1029665|NCT01657266|2058408|FG001|Overall Study|Adverse Event|3
1029666|NCT01657292|2058414|FG000|Overall Study|Adverse Event|6
1029667|NCT01657292|2058414|FG000|Overall Study|Withdrawal by Subject|2
1029668|NCT01657292|2058414|FG000|Overall Study|Violation of eligibility criteria|1
1029669|NCT01657292|2058414|FG000|Overall Study|Change of therapy|1
1029670|NCT01657305|2058421|FG000|Overall Study|Lack of Wound Closure at Day 28|15
1029671|NCT01657305|2058421|FG000|Overall Study|Withdrawal by Subject|4
1029672|NCT01657305|2058421|FG000|Overall Study|Adverse Event|1
1029673|NCT01657305|2058421|FG000|Overall Study|Lost to Follow-up|1
1029674|NCT01657305|2058421|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4
1029675|NCT01657370|2058483|FG000|Overall Study|Withdrawal by Subject|0
1029676|NCT01657370|2058484|FG001|Overall Study|Withdrawal by Subject|0
1029677|NCT01657370|2058485|FG002|Overall Study|Withdrawal by Subject|1
1029678|NCT01657370|2058486|FG003|Overall Study|Withdrawal by Subject|0
1029679|NCT01657370|2058487|FG004|Overall Study|Withdrawal by Subject|0
1029680|NCT01657370|2058488|FG005|Overall Study|Withdrawal by Subject|1
1029681|NCT01657370|2058483|FG000|Overall Study|Physician Decision|2
1029682|NCT01657370|2058484|FG001|Overall Study|Physician Decision|3
1029683|NCT01657370|2058485|FG002|Overall Study|Physician Decision|1
1029684|NCT01657370|2058486|FG003|Overall Study|Physician Decision|2
1029685|NCT01657370|2058487|FG004|Overall Study|Physician Decision|5
1029686|NCT01657370|2058488|FG005|Overall Study|Physician Decision|0
1029687|NCT01657370|2058483|FG000|Overall Study|Lack of Qualifying Event|1
1029688|NCT01657370|2058484|FG001|Overall Study|Lack of Qualifying Event|0
1029689|NCT01657370|2058485|FG002|Overall Study|Lack of Qualifying Event|3
1029690|NCT01657370|2058486|FG003|Overall Study|Lack of Qualifying Event|2
1029691|NCT01657370|2058487|FG004|Overall Study|Lack of Qualifying Event|1
1029692|NCT01657370|2058488|FG005|Overall Study|Lack of Qualifying Event|2
1029693|NCT01657370|2058483|FG000|Overall Study|Adverse Event|0
1029694|NCT01657370|2058484|FG001|Overall Study|Adverse Event|0
1029695|NCT01657370|2058485|FG002|Overall Study|Adverse Event|0
1029696|NCT01657370|2058486|FG003|Overall Study|Adverse Event|0
1029697|NCT01657370|2058487|FG004|Overall Study|Adverse Event|1
1029698|NCT01657370|2058488|FG005|Overall Study|Adverse Event|0
1029699|NCT01657370|2058483|FG000|Overall Study|Protocol Violation|1
1029700|NCT01657370|2058484|FG001|Overall Study|Protocol Violation|1
1029701|NCT01657370|2058485|FG002|Overall Study|Protocol Violation|1
1029702|NCT01657370|2058486|FG003|Overall Study|Protocol Violation|1
1029703|NCT01657370|2058487|FG004|Overall Study|Protocol Violation|0
1029704|NCT01657370|2058488|FG005|Overall Study|Protocol Violation|0
1029705|NCT01657370|2058483|FG000|Overall Study|Lost to Follow-up|2
1029706|NCT01657370|2058484|FG001|Overall Study|Lost to Follow-up|0
1029707|NCT01657370|2058485|FG002|Overall Study|Lost to Follow-up|1
1029708|NCT01657370|2058486|FG003|Overall Study|Lost to Follow-up|0
1029709|NCT01657370|2058487|FG004|Overall Study|Lost to Follow-up|0
1029710|NCT01657370|2058488|FG005|Overall Study|Lost to Follow-up|1
1029711|NCT01657461|2058509|FG000|Overall Study|Death|9
1029712|NCT01657461|2058510|FG001|Overall Study|Death|12
1029713|NCT01657461|2058509|FG000|Overall Study|Lost to Follow-up|0
1029714|NCT01657461|2058510|FG001|Overall Study|Lost to Follow-up|3
1029715|NCT01657461|2058509|FG000|Overall Study|Physician Decision|0
1029716|NCT01657461|2058510|FG001|Overall Study|Physician Decision|2
1029717|NCT01657461|2058509|FG000|Overall Study|Withdrawal by Subject|1
1029718|NCT01657461|2058510|FG001|Overall Study|Withdrawal by Subject|3
1029719|NCT01657760|2058522|FG000|Overall Study|Withdrawal by Subject|0
1029720|NCT01657760|2058523|FG001|Overall Study|Withdrawal by Subject|0
1029721|NCT01657760|2058524|FG002|Overall Study|Withdrawal by Subject|0
1029722|NCT01657760|2058525|FG003|Overall Study|Withdrawal by Subject|1
1029723|NCT01657760|2058522|FG000|Overall Study|Physician Decision|1
1029724|NCT01657760|2058523|FG001|Overall Study|Physician Decision|1
1029725|NCT01657760|2058524|FG002|Overall Study|Physician Decision|1
1029726|NCT01657760|2058525|FG003|Overall Study|Physician Decision|2
1029727|NCT01657799|2058540|FG000|Overall Study|Adverse Event Related to progression|6
1029728|NCT01657799|2058541|FG001|Overall Study|Adverse Event Related to progression|8
1029729|NCT01657799|2058542|FG002|Overall Study|Adverse Event Related to progression|12
1029730|NCT01657799|2058540|FG000|Overall Study|Adverse Event Not Related to Progression|5
1029731|NCT01657799|2058541|FG001|Overall Study|Adverse Event Not Related to Progression|4
1029732|NCT01657799|2058542|FG002|Overall Study|Adverse Event Not Related to Progression|4
1029733|NCT01657799|2058540|FG000|Overall Study|Withdrawal by Subject|13
1029734|NCT01657799|2058541|FG001|Overall Study|Withdrawal by Subject|10
1029735|NCT01657799|2058542|FG002|Overall Study|Withdrawal by Subject|10
1029736|NCT01657799|2058540|FG000|Overall Study|Lost to Follow-up|1
1029737|NCT01657799|2058541|FG001|Overall Study|Lost to Follow-up|0
1029738|NCT01657799|2058542|FG002|Overall Study|Lost to Follow-up|1
1029739|NCT01657799|2058540|FG000|Overall Study|Disease Progression|2
1029740|NCT01657799|2058541|FG001|Overall Study|Disease Progression|4
1029741|NCT01657799|2058542|FG002|Overall Study|Disease Progression|4
1029742|NCT01657799|2058540|FG000|Overall Study|Progressive Disease Clinical|7
1029743|NCT01657799|2058541|FG001|Overall Study|Progressive Disease Clinical|4
1029744|NCT01657799|2058542|FG002|Overall Study|Progressive Disease Clinical|7
1029745|NCT01657799|2058540|FG000|Overall Study|Radiographic & Clinical Progression|16
1029746|NCT01657799|2058541|FG001|Overall Study|Radiographic & Clinical Progression|11
1029747|NCT01657799|2058542|FG002|Overall Study|Radiographic & Clinical Progression|15
1029748|NCT01657799|2058540|FG000|Overall Study|Other|52
1029749|NCT01657799|2058541|FG001|Overall Study|Other|62
1029750|NCT01657799|2058542|FG002|Overall Study|Other|49
1029751|NCT01657877|2058550|FG000|Overall Study|Withdrawal by Subject|4
1029752|NCT01657877|2058550|FG000|Overall Study|Protocol Violation|6
1029753|NCT01657877|2058550|FG000|Overall Study|Adverse Event|2
1029754|NCT01657877|2058550|FG000|Overall Study|Other Reason|2
1029755|NCT01657903|2058567|FG000|Overall Study|Lost to Follow-up|1
1029756|NCT01657903|2058567|FG000|Overall Study|Withdrawal by Subject|1
1029757|NCT01658020|2058580|FG000|Overall Study|Adverse Event|3
1029758|NCT01658020|2058581|FG001|Overall Study|Adverse Event|3
1029759|NCT01658020|2058580|FG000|Overall Study|Lost to Follow-up|1
1029760|NCT01658020|2058581|FG001|Overall Study|Lost to Follow-up|0
1029761|NCT01658020|2058580|FG000|Overall Study|Withdrawal by Subject|4
1029762|NCT01658020|2058581|FG001|Overall Study|Withdrawal by Subject|5
1029763|NCT01658020|2058580|FG000|Overall Study|Protocol Violation|0
1029764|NCT01658020|2058581|FG001|Overall Study|Protocol Violation|1
1029765|NCT01658072|2058597|FG000|Overall Study|Protocol Violation|4
1029766|NCT01658072|2058598|FG001|Overall Study|Protocol Violation|2
1029767|NCT01658150|2058604|FG000|Overall Study|Withdrawal by Subject|1
1029768|NCT01658436|2058618|FG000|Overall Study|Adverse Event|6
1029769|NCT01658436|2058619|FG001|Overall Study|Adverse Event|5
1029770|NCT01658436|2058618|FG000|Overall Study|Physician Decision|1
1029771|NCT01658436|2058619|FG001|Overall Study|Physician Decision|0
1029772|NCT01658436|2058618|FG000|Overall Study|Progressive disease|12
1029773|NCT01658436|2058619|FG001|Overall Study|Progressive disease|4
1029774|NCT01658436|2058618|FG000|Overall Study|Study terminated by sponsor|0
1029775|NCT01658436|2058619|FG001|Overall Study|Study terminated by sponsor|1
1029776|NCT01658436|2058618|FG000|Overall Study|Subject/guardian decision|0
1029777|NCT01658436|2058619|FG001|Overall Study|Subject/guardian decision|1
1029778|NCT01658436|2058618|FG000|Overall Study|Death|1
1029779|NCT01658436|2058619|FG001|Overall Study|Death|0
1029780|NCT01658514|2058628|FG000|Overall Study|Protocol Violation|1
1029781|NCT01658514|2058629|FG001|Overall Study|Protocol Violation|0
1029782|NCT01658514|2058630|FG002|Overall Study|Protocol Violation|2
1029783|NCT01658579|2058641|FG000|Treatment Period A|Other|0
1029784|NCT01658579|2058642|FG001|Treatment Period A|Other|0
1029785|NCT01658579|2058643|FG002|Treatment Period A|Other|1
1029786|NCT01658579|2058644|FG003|Treatment Period A|Other|1
1029787|NCT01658579|2058641|FG000|Treatment Period A|Adverse Event|1
1029788|NCT01658579|2058642|FG001|Treatment Period A|Adverse Event|0
1029789|NCT01658579|2058643|FG002|Treatment Period A|Adverse Event|0
1029790|NCT01658579|2058644|FG003|Treatment Period A|Adverse Event|0
1029791|NCT01658579|2058641|FG000|Treatment Period B|Other|0
1029792|NCT01658579|2058642|FG001|Treatment Period B|Other|0
1029793|NCT01658579|2058643|FG002|Treatment Period B|Other|0
1029794|NCT01658579|2058644|FG003|Treatment Period B|Other|1
1029795|NCT01658735|2058662|FG000|Overall Study|Lack of Efficacy|1
1029796|NCT01658735|2058663|FG001|Overall Study|Lack of Efficacy|0
1029797|NCT01658735|2058664|FG002|Overall Study|Lack of Efficacy|1
1029798|NCT01658735|2058662|FG000|Overall Study|Lost to Follow-up|1
1029799|NCT01658735|2058663|FG001|Overall Study|Lost to Follow-up|1
1029800|NCT01658735|2058664|FG002|Overall Study|Lost to Follow-up|0
1029801|NCT01658735|2058662|FG000|Overall Study|Protocol Violation|0
1029802|NCT01658735|2058663|FG001|Overall Study|Protocol Violation|1
1029803|NCT01658735|2058664|FG002|Overall Study|Protocol Violation|0
1029804|NCT01658735|2058662|FG000|Overall Study|Withdrawal by Subject|3
1029805|NCT01658735|2058663|FG001|Overall Study|Withdrawal by Subject|5
1029806|NCT01658735|2058664|FG002|Overall Study|Withdrawal by Subject|3
1029807|NCT01658904|2058679|FG000|Overall Study|Principal Investigator discretion|2
1029808|NCT01658904|2058680|FG001|Overall Study|Principal Investigator discretion|0
1029809|NCT01658904|2058681|FG002|Overall Study|Principal Investigator discretion|0
1029810|NCT01658943|2058694|FG000|Overall Study|Adverse Event|6
1029811|NCT01658943|2058695|FG001|Overall Study|Adverse Event|13
1029812|NCT01658943|2058694|FG000|Overall Study|Withdrawal by Subject|9
1029813|NCT01658943|2058695|FG001|Overall Study|Withdrawal by Subject|2
1029814|NCT01658943|2058694|FG000|Overall Study|Progression/Relapse|39
1029815|NCT01658943|2058695|FG001|Overall Study|Progression/Relapse|40
1029816|NCT01658943|2058694|FG000|Overall Study|Death|4
1029817|NCT01658943|2058695|FG001|Overall Study|Death|2
1029818|NCT01658943|2058694|FG000|Overall Study|not protocol specified|4
1029819|NCT01658943|2058695|FG001|Overall Study|not protocol specified|1
1029820|NCT01658943|2058694|FG000|Overall Study|Not eligible|7
1029821|NCT01658943|2058695|FG001|Overall Study|Not eligible|9
1029822|NCT01658943|2058694|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1
1029823|NCT01658943|2058695|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0
1029824|NCT01659021|2058712|FG000|Main Study|Adverse Event|2
1029825|NCT01659021|2058713|FG001|Main Study|Adverse Event|3
1029826|NCT01659021|2058712|FG000|Main Study|Lost to Follow-up|1
905118|NCT00760929|1880356|FG003|Overall Study|Withdrawal by Subject|1
1029827|NCT01659021|2058713|FG001|Main Study|Lost to Follow-up|0
1029828|NCT01659021|2058712|FG000|Main Study|Unknown Reasons|2
1029829|NCT01659021|2058713|FG001|Main Study|Unknown Reasons|1
1029830|NCT01659021|2058712|FG000|Main Study|Physician Decision|34
1029831|NCT01659021|2058713|FG001|Main Study|Physician Decision|16
1029832|NCT01659021|2058712|FG000|Main Study|Withdrawal by Subject|19
1029833|NCT01659021|2058713|FG001|Main Study|Withdrawal by Subject|16
1029834|NCT01659021|2058712|FG000|Main Study|Study Terminated by Sponsor|16
1029835|NCT01659021|2058713|FG001|Main Study|Study Terminated by Sponsor|1
1029836|NCT01659021|2058712|FG000|Long-Term Follow Up|Lost to Follow-up|3
1029837|NCT01659021|2058713|FG001|Long-Term Follow Up|Lost to Follow-up|3
1029838|NCT01659021|2058712|FG000|Long-Term Follow Up|Withdrawal by Subject|2
1029839|NCT01659021|2058713|FG001|Long-Term Follow Up|Withdrawal by Subject|1
1029840|NCT01659125|2058723|FG000|Overall Study|Withdrawal by Subject|2
1029841|NCT01659125|2058723|FG000|Overall Study|Lost to Follow-up|7
1029842|NCT01659125|2058723|FG000|Overall Study|Technical Problem|1
1029843|NCT01659125|2058723|FG000|Overall Study|Time Constraints|2
1029844|NCT01659125|2058723|FG000|Overall Study|Failed to Start Treatment|2
1029845|NCT01659255|2058744|FG000|Overall Study|Adverse Event|0
1029846|NCT01659255|2058745|FG001|Overall Study|Adverse Event|0
1029847|NCT01659255|2058746|FG002|Overall Study|Adverse Event|0
1029848|NCT01659255|2058747|FG003|Overall Study|Adverse Event|0
1029849|NCT01659255|2058748|FG004|Overall Study|Adverse Event|0
1029850|NCT01659255|2058749|FG005|Overall Study|Adverse Event|1
1029851|NCT01659255|2058750|FG006|Overall Study|Adverse Event|1
1029852|NCT01659255|2058751|FG007|Overall Study|Adverse Event|0
1029853|NCT01659255|2058752|FG008|Overall Study|Adverse Event|0
1029854|NCT01659255|2058753|FG009|Overall Study|Adverse Event|1
1029855|NCT01659255|2058754|FG010|Overall Study|Adverse Event|0
1029856|NCT01659255|2058755|FG011|Overall Study|Adverse Event|1
1029857|NCT01659255|2058756|FG012|Overall Study|Adverse Event|0
1029858|NCT01659255|2058757|FG013|Overall Study|Adverse Event|2
1029859|NCT01659255|2058758|FG014|Overall Study|Adverse Event|0
1029860|NCT01659255|2058759|FG015|Overall Study|Adverse Event|1
1029861|NCT01659255|2058760|FG016|Overall Study|Adverse Event|0
1029862|NCT01659255|2058744|FG000|Overall Study|Death|0
1029863|NCT01659255|2058745|FG001|Overall Study|Death|1
1029864|NCT01659255|2058746|FG002|Overall Study|Death|0
1029865|NCT01659255|2058747|FG003|Overall Study|Death|0
1029866|NCT01659255|2058748|FG004|Overall Study|Death|0
1029867|NCT01659255|2058749|FG005|Overall Study|Death|0
1029868|NCT01659255|2058750|FG006|Overall Study|Death|0
1029869|NCT01659255|2058751|FG007|Overall Study|Death|1
1029870|NCT01659255|2058752|FG008|Overall Study|Death|1
1029871|NCT01659255|2058753|FG009|Overall Study|Death|0
1029872|NCT01659255|2058754|FG010|Overall Study|Death|0
1029873|NCT01659255|2058755|FG011|Overall Study|Death|0
1029874|NCT01659255|2058756|FG012|Overall Study|Death|1
1029875|NCT01659255|2058757|FG013|Overall Study|Death|1
1029876|NCT01659255|2058758|FG014|Overall Study|Death|2
1029877|NCT01659255|2058759|FG015|Overall Study|Death|1
1029878|NCT01659255|2058760|FG016|Overall Study|Death|0
1029879|NCT01659255|2058744|FG000|Overall Study|Progressive Disease|2
1029880|NCT01659255|2058745|FG001|Overall Study|Progressive Disease|0
1029881|NCT01659255|2058746|FG002|Overall Study|Progressive Disease|0
1029882|NCT01659255|2058747|FG003|Overall Study|Progressive Disease|0
1029883|NCT01659255|2058748|FG004|Overall Study|Progressive Disease|0
1029884|NCT01659255|2058749|FG005|Overall Study|Progressive Disease|0
1029885|NCT01659255|2058750|FG006|Overall Study|Progressive Disease|0
1029886|NCT01659255|2058751|FG007|Overall Study|Progressive Disease|1
1029887|NCT01659255|2058752|FG008|Overall Study|Progressive Disease|0
1029888|NCT01659255|2058753|FG009|Overall Study|Progressive Disease|2
1029889|NCT01659255|2058754|FG010|Overall Study|Progressive Disease|2
1029890|NCT01659255|2058755|FG011|Overall Study|Progressive Disease|3
1029891|NCT01659255|2058756|FG012|Overall Study|Progressive Disease|5
1029892|NCT01659255|2058757|FG013|Overall Study|Progressive Disease|13
1029893|NCT01659255|2058758|FG014|Overall Study|Progressive Disease|6
1029894|NCT01659255|2058759|FG015|Overall Study|Progressive Disease|2
1029895|NCT01659255|2058760|FG016|Overall Study|Progressive Disease|3
1029896|NCT01659255|2058744|FG000|Overall Study|Withdrew Consent|0
1029897|NCT01659255|2058745|FG001|Overall Study|Withdrew Consent|0
1029898|NCT01659255|2058746|FG002|Overall Study|Withdrew Consent|0
1029899|NCT01659255|2058747|FG003|Overall Study|Withdrew Consent|0
1029900|NCT01659255|2058748|FG004|Overall Study|Withdrew Consent|0
1029901|NCT01659255|2058749|FG005|Overall Study|Withdrew Consent|0
1029902|NCT01659255|2058750|FG006|Overall Study|Withdrew Consent|0
1029903|NCT01659255|2058751|FG007|Overall Study|Withdrew Consent|0
1029904|NCT01659255|2058752|FG008|Overall Study|Withdrew Consent|0
1029905|NCT01659255|2058753|FG009|Overall Study|Withdrew Consent|0
1029906|NCT01659255|2058754|FG010|Overall Study|Withdrew Consent|1
1029907|NCT01659255|2058755|FG011|Overall Study|Withdrew Consent|0
1029908|NCT01659255|2058756|FG012|Overall Study|Withdrew Consent|0
1029909|NCT01659255|2058757|FG013|Overall Study|Withdrew Consent|1
1029910|NCT01659255|2058758|FG014|Overall Study|Withdrew Consent|0
1029911|NCT01659255|2058759|FG015|Overall Study|Withdrew Consent|0
1029912|NCT01659255|2058760|FG016|Overall Study|Withdrew Consent|0
1029913|NCT01659255|2058744|FG000|Overall Study|Investigator Decision|0
1029914|NCT01659255|2058745|FG001|Overall Study|Investigator Decision|0
1029915|NCT01659255|2058746|FG002|Overall Study|Investigator Decision|0
1029916|NCT01659255|2058747|FG003|Overall Study|Investigator Decision|0
1029917|NCT01659255|2058748|FG004|Overall Study|Investigator Decision|0
1029918|NCT01659255|2058749|FG005|Overall Study|Investigator Decision|0
1029919|NCT01659255|2058750|FG006|Overall Study|Investigator Decision|0
1029920|NCT01659255|2058751|FG007|Overall Study|Investigator Decision|0
1029921|NCT01659255|2058752|FG008|Overall Study|Investigator Decision|0
1029922|NCT01659255|2058753|FG009|Overall Study|Investigator Decision|0
1029923|NCT01659255|2058754|FG010|Overall Study|Investigator Decision|0
1029924|NCT01659255|2058755|FG011|Overall Study|Investigator Decision|0
1029925|NCT01659255|2058756|FG012|Overall Study|Investigator Decision|1
1029926|NCT01659255|2058757|FG013|Overall Study|Investigator Decision|1
1029927|NCT01659255|2058758|FG014|Overall Study|Investigator Decision|0
1029928|NCT01659255|2058759|FG015|Overall Study|Investigator Decision|0
1029929|NCT01659255|2058760|FG016|Overall Study|Investigator Decision|0
1029930|NCT01659255|2058744|FG000|Overall Study|Sponsor's Decision|0
1029931|NCT01659255|2058745|FG001|Overall Study|Sponsor's Decision|0
1029932|NCT01659255|2058746|FG002|Overall Study|Sponsor's Decision|0
1029933|NCT01659255|2058747|FG003|Overall Study|Sponsor's Decision|0
1029934|NCT01659255|2058748|FG004|Overall Study|Sponsor's Decision|0
1029935|NCT01659255|2058749|FG005|Overall Study|Sponsor's Decision|0
1029936|NCT01659255|2058750|FG006|Overall Study|Sponsor's Decision|1
1029937|NCT01659255|2058751|FG007|Overall Study|Sponsor's Decision|0
1029938|NCT01659255|2058752|FG008|Overall Study|Sponsor's Decision|0
1029939|NCT01659255|2058753|FG009|Overall Study|Sponsor's Decision|0
1029940|NCT01659255|2058754|FG010|Overall Study|Sponsor's Decision|0
1029941|NCT01659255|2058755|FG011|Overall Study|Sponsor's Decision|0
1029942|NCT01659255|2058756|FG012|Overall Study|Sponsor's Decision|0
1029943|NCT01659255|2058757|FG013|Overall Study|Sponsor's Decision|0
1029944|NCT01659255|2058758|FG014|Overall Study|Sponsor's Decision|0
1029945|NCT01659255|2058759|FG015|Overall Study|Sponsor's Decision|0
1029946|NCT01659255|2058760|FG016|Overall Study|Sponsor's Decision|0
1029947|NCT01659255|2058744|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0
1029948|NCT01659255|2058745|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0
1029949|NCT01659255|2058746|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0
1029950|NCT01659255|2058747|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0
1029951|NCT01659255|2058748|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0
1029952|NCT01659255|2058749|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0
1029953|NCT01659255|2058750|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0
1029954|NCT01659255|2058751|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0
1029955|NCT01659255|2058752|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0
1029956|NCT01659255|2058753|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0
1029957|NCT01659255|2058754|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0
1029958|NCT01659255|2058755|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0
1029959|NCT01659255|2058756|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0
1029960|NCT01659255|2058757|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0
1029961|NCT01659255|2058758|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0
1029962|NCT01659255|2058759|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1
1029963|NCT01659255|2058760|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0
1029964|NCT01659255|2058744|FG000|Overall Study|Participant Went on to Have an Allograft|0
1029965|NCT01659255|2058745|FG001|Overall Study|Participant Went on to Have an Allograft|0
1029966|NCT01659255|2058746|FG002|Overall Study|Participant Went on to Have an Allograft|0
1029967|NCT01659255|2058747|FG003|Overall Study|Participant Went on to Have an Allograft|0
1029968|NCT01659255|2058748|FG004|Overall Study|Participant Went on to Have an Allograft|0
1029969|NCT01659255|2058749|FG005|Overall Study|Participant Went on to Have an Allograft|0
1029970|NCT01659255|2058750|FG006|Overall Study|Participant Went on to Have an Allograft|0
1029971|NCT01659255|2058751|FG007|Overall Study|Participant Went on to Have an Allograft|0
1029972|NCT01659255|2058752|FG008|Overall Study|Participant Went on to Have an Allograft|0
1029973|NCT01659255|2058753|FG009|Overall Study|Participant Went on to Have an Allograft|0
1029974|NCT01659255|2058754|FG010|Overall Study|Participant Went on to Have an Allograft|0
1029975|NCT01659255|2058755|FG011|Overall Study|Participant Went on to Have an Allograft|0
1029976|NCT01659255|2058756|FG012|Overall Study|Participant Went on to Have an Allograft|1
1029977|NCT01659255|2058757|FG013|Overall Study|Participant Went on to Have an Allograft|0
1029978|NCT01659255|2058758|FG014|Overall Study|Participant Went on to Have an Allograft|0
1029979|NCT01659255|2058759|FG015|Overall Study|Participant Went on to Have an Allograft|0
1029980|NCT01659255|2058760|FG016|Overall Study|Participant Went on to Have an Allograft|0
1029981|NCT01659320|2058807|FG000|Overall Study|Withdrawal by Subject|2
1029982|NCT01659320|2058807|FG000|Overall Study|Physician Decision|1
1029983|NCT01659567|2058811|FG000|Overall Study|Lack of Efficacy|22
1029984|NCT01659567|2058811|FG000|Overall Study|Switched to Pegferon|6
1029985|NCT01659567|2058811|FG000|Overall Study|Adverse Event|12
1029986|NCT01659567|2058811|FG000|Overall Study|Good result at early stage of treatment|5
1029987|NCT01659567|2058811|FG000|Overall Study|Withdrawal by Subject|64
1029988|NCT01659567|2058811|FG000|Overall Study|Progression of the main disease|1
1029989|NCT01659567|2058811|FG000|Overall Study|Other|13
1029990|NCT01659736|2058817|FG000|Treatment Period|Adverse Event|1
1029991|NCT01659736|2058818|FG001|Treatment Period|Adverse Event|1
1029992|NCT01659736|2058817|FG000|Treatment Period|Protocol Violation|3
1029993|NCT01659736|2058818|FG001|Treatment Period|Protocol Violation|1
1029994|NCT01659736|2058817|FG000|Treatment Period|Withdrawal by Subject|1
1029995|NCT01659736|2058818|FG001|Treatment Period|Withdrawal by Subject|0
1029996|NCT01659736|2058817|FG000|3-month Follow-up|Lost to Follow-up|0
1029997|NCT01659736|2058818|FG001|3-month Follow-up|Lost to Follow-up|1
1029998|NCT01659853|2058826|FG000|Washout , 3 to 7 Days|Adverse Event|1
1029999|NCT01659853|2058827|FG001|Washout , 3 to 7 Days|Adverse Event|0
1030000|NCT01659853|2058826|FG000|Washout , 3 to 7 Days|Protocol Violation|1
1030001|NCT01659853|2058827|FG001|Washout , 3 to 7 Days|Protocol Violation|0
1030002|NCT01659996|2058847|FG000|Overall Study|Protocol Violation|3
1030003|NCT01659996|2058848|FG001|Overall Study|Protocol Violation|3
1030004|NCT01659996|2058849|FG002|Overall Study|Protocol Violation|3
1030005|NCT01659996|2058847|FG000|Overall Study|Lost to Follow-up|1
1030006|NCT01659996|2058848|FG001|Overall Study|Lost to Follow-up|3
1030007|NCT01659996|2058849|FG002|Overall Study|Lost to Follow-up|2
1030008|NCT01659996|2058847|FG000|Overall Study|Adverse Event|0
1030009|NCT01659996|2058848|FG001|Overall Study|Adverse Event|0
1030010|NCT01659996|2058849|FG002|Overall Study|Adverse Event|1
1030011|NCT01659996|2058847|FG000|Overall Study|Withdrawal by Subject|4
1030012|NCT01659996|2058848|FG001|Overall Study|Withdrawal by Subject|1
1030013|NCT01659996|2058849|FG002|Overall Study|Withdrawal by Subject|5
1030014|NCT01660022|2058865|FG000|First Sequence (7 Days)|Withdrawal by Subject|0
1030015|NCT01660022|2058866|FG001|First Sequence (7 Days)|Withdrawal by Subject|1
1030016|NCT01660022|2058867|FG002|First Sequence (7 Days)|Withdrawal by Subject|0
1030017|NCT01660022|2058868|FG003|First Sequence (7 Days)|Withdrawal by Subject|1
1030018|NCT01660022|2058869|FG004|First Sequence (7 Days)|Withdrawal by Subject|0
1030019|NCT01660022|2058870|FG005|First Sequence (7 Days)|Withdrawal by Subject|0
1030020|NCT01660022|2058865|FG000|First Sequence (7 Days)|Adverse Event|0
1030021|NCT01660022|2058866|FG001|First Sequence (7 Days)|Adverse Event|0
1030022|NCT01660022|2058867|FG002|First Sequence (7 Days)|Adverse Event|0
1030023|NCT01660022|2058868|FG003|First Sequence (7 Days)|Adverse Event|0
1030024|NCT01660022|2058869|FG004|First Sequence (7 Days)|Adverse Event|1
1030025|NCT01660022|2058870|FG005|First Sequence (7 Days)|Adverse Event|3
1030026|NCT01660022|2058865|FG000|First Sequence (7 Days)|Protocol Violation|0
1030027|NCT01660022|2058866|FG001|First Sequence (7 Days)|Protocol Violation|0
1030028|NCT01660022|2058867|FG002|First Sequence (7 Days)|Protocol Violation|0
1030029|NCT01660022|2058868|FG003|First Sequence (7 Days)|Protocol Violation|0
1030030|NCT01660022|2058869|FG004|First Sequence (7 Days)|Protocol Violation|0
1030031|NCT01660022|2058870|FG005|First Sequence (7 Days)|Protocol Violation|1
1030032|NCT01660256|2058962|FG000|Overall Study|Adverse Event|4
1030033|NCT01660256|2058963|FG001|Overall Study|Adverse Event|0
1030034|NCT01660256|2058964|FG002|Overall Study|Adverse Event|2
1030035|NCT01660256|2058962|FG000|Overall Study|Withdrawal by Subject|1
1030036|NCT01660256|2058963|FG001|Overall Study|Withdrawal by Subject|0
1030037|NCT01660256|2058964|FG002|Overall Study|Withdrawal by Subject|2
1030038|NCT01660334|2058976|FG000|Overall Study|Lost to Follow-up|1
1030039|NCT01660412|2058980|FG000|Overall Study|Protocol Violation|0
1030040|NCT01660412|2058981|FG001|Overall Study|Protocol Violation|3
1030065|NCT01660711|2059015|FG000|Overall Study|Adverse Event|7
1030066|NCT01660711|2059015|FG000|Overall Study|Withdrawal by Subject|1
1030067|NCT01660763|2059025|FG000|Overall Study|Lack of Efficacy|45
1030068|NCT01660763|2059026|FG001|Overall Study|Lack of Efficacy|50
1030069|NCT01660763|2059025|FG000|Overall Study|Adverse Event|22
1030070|NCT01660763|2059026|FG001|Overall Study|Adverse Event|7
1030071|NCT01660763|2059025|FG000|Overall Study|Protocol Violation|1
1030072|NCT01660763|2059026|FG001|Overall Study|Protocol Violation|0
1030073|NCT01660763|2059025|FG000|Overall Study|Withdrawal by Subject|4
1030074|NCT01660763|2059026|FG001|Overall Study|Withdrawal by Subject|0
1030075|NCT01660763|2059025|FG000|Overall Study|Patient ready for early discharge|28
1030076|NCT01660763|2059026|FG001|Overall Study|Patient ready for early discharge|4
1030077|NCT01660906|2059059|FG000|Overall Study|Discontinued due to study drug toxicity|3
1030078|NCT01661062|2059063|FG000|Overall Study|Completed Treatment Off Study|3
1030079|NCT01661062|2059063|FG000|Overall Study|Withdrawal by Subject|2
1030080|NCT01661140|2059075|FG000|Open-Label Period|Adverse Event|44
1030081|NCT01661140|2059076|FG001|Open-Label Period|Adverse Event|0
1030082|NCT01661140|2059077|FG002|Open-Label Period|Adverse Event|0
1030083|NCT01661140|2059075|FG000|Open-Label Period|Protocol Violation|3
1030084|NCT01661140|2059076|FG001|Open-Label Period|Protocol Violation|0
1030085|NCT01661140|2059077|FG002|Open-Label Period|Protocol Violation|0
1030086|NCT01661140|2059075|FG000|Open-Label Period|Withdrawal by Subject|5
1030087|NCT01661140|2059076|FG001|Open-Label Period|Withdrawal by Subject|0
1030088|NCT01661140|2059077|FG002|Open-Label Period|Withdrawal by Subject|0
1030089|NCT01661140|2059075|FG000|Open-Label Period|Investigator Decision|3
1030090|NCT01661140|2059076|FG001|Open-Label Period|Investigator Decision|0
1030091|NCT01661140|2059077|FG002|Open-Label Period|Investigator Decision|0
1030092|NCT01661140|2059075|FG000|Open-Label Period|Death|1
1030093|NCT01661140|2059076|FG001|Open-Label Period|Death|0
1030094|NCT01661140|2059077|FG002|Open-Label Period|Death|0
1030095|NCT01661140|2059075|FG000|Open-Label Period|Administrative/Other|1
1030096|NCT01661140|2059076|FG001|Open-Label Period|Administrative/Other|0
1030097|NCT01661140|2059077|FG002|Open-Label Period|Administrative/Other|0
1030098|NCT01661140|2059075|FG000|Open-Label Period|Sponsor termination|16
1030099|NCT01661140|2059076|FG001|Open-Label Period|Sponsor termination|0
1030100|NCT01661140|2059077|FG002|Open-Label Period|Sponsor termination|0
1030101|NCT01661140|2059075|FG000|Open-Label Period|Did not meet EULAR criteria|1
1030102|NCT01661140|2059076|FG001|Open-Label Period|Did not meet EULAR criteria|0
1030103|NCT01661140|2059077|FG002|Open-Label Period|Did not meet EULAR criteria|0
1030104|NCT01661140|2059075|FG000|Open-Label Period|Lost to Follow-up|2
1030105|NCT01661140|2059076|FG001|Open-Label Period|Lost to Follow-up|0
1030106|NCT01661140|2059077|FG002|Open-Label Period|Lost to Follow-up|0
1030107|NCT01661140|2059075|FG000|Double-Blind Period|Refused Treatment|0
1030108|NCT01661140|2059076|FG001|Double-Blind Period|Refused Treatment|0
1030109|NCT01661140|2059077|FG002|Double-Blind Period|Refused Treatment|1
1030110|NCT01661140|2059075|FG000|Double-Blind Period|Adverse Event|0
1030111|NCT01661140|2059076|FG001|Double-Blind Period|Adverse Event|16
1030112|NCT01661140|2059077|FG002|Double-Blind Period|Adverse Event|18
1030113|NCT01661140|2059075|FG000|Double-Blind Period|Protocol Violation|0
1030114|NCT01661140|2059076|FG001|Double-Blind Period|Protocol Violation|2
1030115|NCT01661140|2059077|FG002|Double-Blind Period|Protocol Violation|3
1030116|NCT01661140|2059075|FG000|Double-Blind Period|Withdrawal by Subject|0
1030117|NCT01661140|2059076|FG001|Double-Blind Period|Withdrawal by Subject|1
1030118|NCT01661140|2059077|FG002|Double-Blind Period|Withdrawal by Subject|3
1030119|NCT01661140|2059075|FG000|Double-Blind Period|Investigator's Decision|0
1030120|NCT01661140|2059076|FG001|Double-Blind Period|Investigator's Decision|1
1030121|NCT01661140|2059077|FG002|Double-Blind Period|Investigator's Decision|2
1030122|NCT01661140|2059075|FG000|Double-Blind Period|Sponsor Termination|0
1030123|NCT01661140|2059076|FG001|Double-Blind Period|Sponsor Termination|14
1030124|NCT01661140|2059077|FG002|Double-Blind Period|Sponsor Termination|17
1030125|NCT01661140|2059075|FG000|Double-Blind Period|Administrative/Other|0
1030126|NCT01661140|2059076|FG001|Double-Blind Period|Administrative/Other|7
1030127|NCT01661140|2059077|FG002|Double-Blind Period|Administrative/Other|6
1030128|NCT01661179|2059085|FG000|Overall Study|Death|1
1030129|NCT01661179|2059085|FG000|Overall Study|Withdrawal by Subject|1
1030130|NCT01661179|2059085|FG000|Overall Study|Other Eligibility criteria|4
1030131|NCT01661205|2059089|FG000|Overall Study|Physician Decision|2
1030132|NCT01661595|2059111|FG000|Phase 1: Week 0-4|Adverse Event|1
1030133|NCT01661595|2059112|FG001|Phase 1: Week 0-4|Adverse Event|0
1030134|NCT01661595|2059113|FG002|Phase 1: Week 0-4|Adverse Event|0
1030135|NCT01661595|2059114|FG003|Phase 1: Week 0-4|Adverse Event|0
1030136|NCT01661595|2059111|FG000|Phase 2: Week 5-8.|Protocol Violation|0
1030137|NCT01661595|2059112|FG001|Phase 2: Week 5-8.|Protocol Violation|0
1030138|NCT01661595|2059113|FG002|Phase 2: Week 5-8.|Protocol Violation|1
1030139|NCT01661595|2059114|FG003|Phase 2: Week 5-8.|Protocol Violation|0
1030140|NCT01661686|2059142|FG000|Overall Study|Lost to Follow-up|2
1030141|NCT01661686|2059143|FG001|Overall Study|Lost to Follow-up|1
1030142|NCT01661686|2059142|FG000|Overall Study|did not receive allocated intervention|0
1030143|NCT01661686|2059143|FG001|Overall Study|did not receive allocated intervention|1
1030144|NCT01661790|2059191|FG000|Overall Study|Lost to Follow-up|0
1030145|NCT01661790|2059192|FG001|Overall Study|Lost to Follow-up|2
1030146|NCT01661881|2059198|FG000|Overall Study|Disease Progression|1
1030147|NCT01661933|2059202|FG000|Low-dose Gluten Challenge|Physician Decision|2
1030148|NCT01661933|2059202|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2
1030149|NCT01661972|2059219|FG000|Overall Study|Adverse Event|1
1030150|NCT01661972|2059220|FG001|Overall Study|Adverse Event|2
1030151|NCT01661972|2059219|FG000|Overall Study|Death during Treatment period|1
1030152|NCT01661972|2059220|FG001|Overall Study|Death during Treatment period|1
1030153|NCT01661972|2059219|FG000|Overall Study|Withdrawal by Subject|0
1030154|NCT01661972|2059220|FG001|Overall Study|Withdrawal by Subject|1
1030155|NCT01662024|2059228|FG000|Overall Study|Pregnancy|2
1030156|NCT01662024|2059228|FG000|Overall Study|Withdrawal by Subject|3
1030157|NCT01662063|2059237|FG000|Overall Study|Adverse Event or Intercurrent Illness|1
1030158|NCT01662063|2059238|FG001|Overall Study|Adverse Event or Intercurrent Illness|12
1030159|NCT01662063|2059239|FG002|Overall Study|Adverse Event or Intercurrent Illness|0
1030160|NCT01662063|2059237|FG000|Overall Study|Lack of Efficacy|1
1030161|NCT01662063|2059238|FG001|Overall Study|Lack of Efficacy|6
1030162|NCT01662063|2059239|FG002|Overall Study|Lack of Efficacy|0
1030163|NCT01662063|2059237|FG000|Overall Study|Lost to Follow-up|0
1030164|NCT01662063|2059238|FG001|Overall Study|Lost to Follow-up|4
1030165|NCT01662063|2059239|FG002|Overall Study|Lost to Follow-up|0
1030166|NCT01662063|2059237|FG000|Overall Study|Protocol Violation|1
1030167|NCT01662063|2059238|FG001|Overall Study|Protocol Violation|0
1030168|NCT01662063|2059239|FG002|Overall Study|Protocol Violation|0
1030169|NCT01662063|2059237|FG000|Overall Study|Withdrawal by Subject|2
1030170|NCT01662063|2059238|FG001|Overall Study|Withdrawal by Subject|4
1030171|NCT01662063|2059239|FG002|Overall Study|Withdrawal by Subject|1
1030172|NCT01662063|2059237|FG000|Overall Study|Physician Decision|0
1030173|NCT01662063|2059238|FG001|Overall Study|Physician Decision|2
1030174|NCT01662063|2059239|FG002|Overall Study|Physician Decision|0
1030175|NCT01662063|2059237|FG000|Overall Study|Other|0
1030176|NCT01662063|2059238|FG001|Overall Study|Other|1
1030177|NCT01662063|2059239|FG002|Overall Study|Other|0
1030178|NCT01662310|2059269|FG000|Run-In or Stabilization Phase|Adverse Event|11
1030179|NCT01662310|2059270|FG001|Run-In or Stabilization Phase|Adverse Event|0
1030180|NCT01662310|2059271|FG002|Run-In or Stabilization Phase|Adverse Event|0
1030181|NCT01662310|2059272|FG003|Run-In or Stabilization Phase|Adverse Event|0
1030182|NCT01662310|2059273|FG004|Run-In or Stabilization Phase|Adverse Event|0
1030183|NCT01662310|2059269|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9
1030184|NCT01662310|2059270|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0
1030185|NCT01662310|2059271|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0
1030186|NCT01662310|2059272|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0
1030187|NCT01662310|2059273|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0
1030188|NCT01662310|2059269|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4
1030189|NCT01662310|2059270|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0
1030190|NCT01662310|2059271|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0
1030191|NCT01662310|2059272|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0
1030192|NCT01662310|2059273|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0
1030193|NCT01662310|2059269|FG000|Run-In or Stabilization Phase|Protocol Violation|15
1030194|NCT01662310|2059270|FG001|Run-In or Stabilization Phase|Protocol Violation|0
1030195|NCT01662310|2059271|FG002|Run-In or Stabilization Phase|Protocol Violation|0
1030196|NCT01662310|2059272|FG003|Run-In or Stabilization Phase|Protocol Violation|0
1030197|NCT01662310|2059273|FG004|Run-In or Stabilization Phase|Protocol Violation|0
1030198|NCT01662310|2059269|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25
1030199|NCT01662310|2059270|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0
1030200|NCT01662310|2059271|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0
1030201|NCT01662310|2059272|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0
1030202|NCT01662310|2059273|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0
1030203|NCT01662310|2059269|FG000|Run-In or Stabilization Phase|Other|1
1030204|NCT01662310|2059270|FG001|Run-In or Stabilization Phase|Other|0
1030205|NCT01662310|2059271|FG002|Run-In or Stabilization Phase|Other|0
1030206|NCT01662310|2059272|FG003|Run-In or Stabilization Phase|Other|0
1030207|NCT01662310|2059273|FG004|Run-In or Stabilization Phase|Other|0
1030208|NCT01662310|2059269|FG000|Double-Blind Phase|Adverse Event|0
1030209|NCT01662310|2059270|FG001|Double-Blind Phase|Adverse Event|0
1030210|NCT01662310|2059271|FG002|Double-Blind Phase|Adverse Event|1
1030211|NCT01662310|2059272|FG003|Double-Blind Phase|Adverse Event|0
1030212|NCT01662310|2059273|FG004|Double-Blind Phase|Adverse Event|0
1030213|NCT01662310|2059269|FG000|Double-Blind Phase|Lost to Follow-up|0
1030214|NCT01662310|2059270|FG001|Double-Blind Phase|Lost to Follow-up|3
1030215|NCT01662310|2059271|FG002|Double-Blind Phase|Lost to Follow-up|0
1030216|NCT01662310|2059272|FG003|Double-Blind Phase|Lost to Follow-up|0
1030217|NCT01662310|2059273|FG004|Double-Blind Phase|Lost to Follow-up|0
1030218|NCT01662310|2059269|FG000|Double-Blind Phase|Pregnancy|0
1030219|NCT01662310|2059270|FG001|Double-Blind Phase|Pregnancy|2
1030220|NCT01662310|2059271|FG002|Double-Blind Phase|Pregnancy|0
1030221|NCT01662310|2059272|FG003|Double-Blind Phase|Pregnancy|0
1030222|NCT01662310|2059273|FG004|Double-Blind Phase|Pregnancy|0
1030223|NCT01662310|2059269|FG000|Double-Blind Phase|Withdrawal by Subject|0
1030224|NCT01662310|2059270|FG001|Double-Blind Phase|Withdrawal by Subject|9
1030225|NCT01662310|2059271|FG002|Double-Blind Phase|Withdrawal by Subject|3
1030226|NCT01662310|2059272|FG003|Double-Blind Phase|Withdrawal by Subject|0
1030227|NCT01662310|2059273|FG004|Double-Blind Phase|Withdrawal by Subject|0
1030228|NCT01662310|2059269|FG000|Double-Blind Phase|Other|0
1030229|NCT01662310|2059270|FG001|Double-Blind Phase|Other|0
1030230|NCT01662310|2059271|FG002|Double-Blind Phase|Other|1
1030231|NCT01662310|2059272|FG003|Double-Blind Phase|Other|0
1030232|NCT01662310|2059273|FG004|Double-Blind Phase|Other|0
1030233|NCT01662310|2059269|FG000|Double-Blind Phase|Randomized but not treated|0
1030234|NCT01662310|2059270|FG001|Double-Blind Phase|Randomized but not treated|1
1030235|NCT01662310|2059271|FG002|Double-Blind Phase|Randomized but not treated|0
1030236|NCT01662310|2059272|FG003|Double-Blind Phase|Randomized but not treated|0
1030237|NCT01662310|2059273|FG004|Double-Blind Phase|Randomized but not treated|0
1030238|NCT01662310|2059269|FG000|Open-Label Extension Phase|Adverse Event|0
1030239|NCT01662310|2059270|FG001|Open-Label Extension Phase|Adverse Event|0
1030240|NCT01662310|2059271|FG002|Open-Label Extension Phase|Adverse Event|0
1030241|NCT01662310|2059272|FG003|Open-Label Extension Phase|Adverse Event|3
1030242|NCT01662310|2059273|FG004|Open-Label Extension Phase|Adverse Event|0
1030243|NCT01662310|2059269|FG000|Open-Label Extension Phase|Death|0
1030244|NCT01662310|2059270|FG001|Open-Label Extension Phase|Death|0
1030245|NCT01662310|2059271|FG002|Open-Label Extension Phase|Death|0
1030246|NCT01662310|2059272|FG003|Open-Label Extension Phase|Death|1
1030247|NCT01662310|2059273|FG004|Open-Label Extension Phase|Death|0
1030248|NCT01662310|2059269|FG000|Open-Label Extension Phase|Lack of Efficacy|0
1030249|NCT01662310|2059270|FG001|Open-Label Extension Phase|Lack of Efficacy|0
1030250|NCT01662310|2059271|FG002|Open-Label Extension Phase|Lack of Efficacy|0
1030251|NCT01662310|2059272|FG003|Open-Label Extension Phase|Lack of Efficacy|2
1030252|NCT01662310|2059273|FG004|Open-Label Extension Phase|Lack of Efficacy|2
1030253|NCT01662310|2059269|FG000|Open-Label Extension Phase|Lost to Follow-up|0
1030254|NCT01662310|2059270|FG001|Open-Label Extension Phase|Lost to Follow-up|0
1030255|NCT01662310|2059271|FG002|Open-Label Extension Phase|Lost to Follow-up|0
1030256|NCT01662310|2059272|FG003|Open-Label Extension Phase|Lost to Follow-up|2
1030257|NCT01662310|2059273|FG004|Open-Label Extension Phase|Lost to Follow-up|1
1030258|NCT01662310|2059269|FG000|Open-Label Extension Phase|Pregnancy|0
1030259|NCT01662310|2059270|FG001|Open-Label Extension Phase|Pregnancy|0
1030260|NCT01662310|2059271|FG002|Open-Label Extension Phase|Pregnancy|0
1030261|NCT01662310|2059272|FG003|Open-Label Extension Phase|Pregnancy|1
1030262|NCT01662310|2059273|FG004|Open-Label Extension Phase|Pregnancy|0
1030263|NCT01662310|2059269|FG000|Open-Label Extension Phase|Withdrawal by Subject|0
1030264|NCT01662310|2059270|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
1030265|NCT01662310|2059271|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
1030266|NCT01662310|2059272|FG003|Open-Label Extension Phase|Withdrawal by Subject|2
1030267|NCT01662310|2059273|FG004|Open-Label Extension Phase|Withdrawal by Subject|7
1030268|NCT01662336|2059285|FG000|Overall Study|Adverse Event|1
1030269|NCT01662336|2059285|FG000|Overall Study|No longer on LPV/r|30
1030270|NCT01662336|2059285|FG000|Overall Study|Other|29
1030271|NCT01662336|2059285|FG000|Overall Study|Withdrawal by Subject|6
1030272|NCT01662362|2059294|FG000|Overall Study|Lost to Follow-up|38
1030273|NCT01662440|2059303|FG000|Overall Study|Adverse Event|1
1030274|NCT01662440|2059304|FG001|Overall Study|Adverse Event|0
1030275|NCT01662440|2059305|FG002|Overall Study|Adverse Event|0
1030276|NCT01662440|2059306|FG003|Overall Study|Adverse Event|1
1030277|NCT01662440|2059303|FG000|Overall Study|Death|0
1030278|NCT01662440|2059304|FG001|Overall Study|Death|1
1030279|NCT01662440|2059305|FG002|Overall Study|Death|0
1030280|NCT01662440|2059306|FG003|Overall Study|Death|0
1030281|NCT01662440|2059303|FG000|Overall Study|Lost to Follow-up|2
1030282|NCT01662440|2059304|FG001|Overall Study|Lost to Follow-up|2
1030283|NCT01662440|2059305|FG002|Overall Study|Lost to Follow-up|4
1030284|NCT01662440|2059306|FG003|Overall Study|Lost to Follow-up|1
1030285|NCT01662440|2059303|FG000|Overall Study|Subject moved to another country.|0
1030286|NCT01662440|2059304|FG001|Overall Study|Subject moved to another country.|1
1030287|NCT01662440|2059305|FG002|Overall Study|Subject moved to another country.|0
1030288|NCT01662440|2059306|FG003|Overall Study|Subject moved to another country.|0
1030289|NCT01662440|2059303|FG000|Overall Study|Protocol Violation|1
1030290|NCT01662440|2059304|FG001|Overall Study|Protocol Violation|0
1030291|NCT01662440|2059305|FG002|Overall Study|Protocol Violation|0
1030292|NCT01662440|2059306|FG003|Overall Study|Protocol Violation|0
1030293|NCT01662440|2059303|FG000|Overall Study|Withdrawal by Subject|5
1030294|NCT01662440|2059304|FG001|Overall Study|Withdrawal by Subject|2
1030295|NCT01662440|2059305|FG002|Overall Study|Withdrawal by Subject|2
1030296|NCT01662440|2059306|FG003|Overall Study|Withdrawal by Subject|2
1030297|NCT01662492|2059329|FG000|Overall Study|Other miscellaneous reasons.|1
1030298|NCT01662492|2059330|FG001|Overall Study|Other miscellaneous reasons.|0
1030299|NCT01662492|2059331|FG002|Overall Study|Other miscellaneous reasons.|1
1030300|NCT01662492|2059329|FG000|Overall Study|Withdrawal by Subject|0
1030301|NCT01662492|2059330|FG001|Overall Study|Withdrawal by Subject|0
1030302|NCT01662492|2059331|FG002|Overall Study|Withdrawal by Subject|1
1030303|NCT01662492|2059329|FG000|Overall Study|Protocol Violation|1
1030304|NCT01662492|2059330|FG001|Overall Study|Protocol Violation|0
1030305|NCT01662492|2059331|FG002|Overall Study|Protocol Violation|0
1030306|NCT01662492|2059329|FG000|Overall Study|Lost to Follow-up|0
1030307|NCT01662492|2059330|FG001|Overall Study|Lost to Follow-up|0
1030308|NCT01662492|2059331|FG002|Overall Study|Lost to Follow-up|2
1030309|NCT01662492|2059329|FG000|Overall Study|Lack of Efficacy|1
1030310|NCT01662492|2059330|FG001|Overall Study|Lack of Efficacy|1
1030311|NCT01662492|2059331|FG002|Overall Study|Lack of Efficacy|2
1030312|NCT01662505|2059342|FG000|Overall Study|Progressive disease|6
1030313|NCT01662505|2059343|FG001|Overall Study|Progressive disease|1
1030314|NCT01662505|2059344|FG002|Overall Study|Progressive disease|5
1030315|NCT01662505|2059342|FG000|Overall Study|Refused cont. medication|0
1030316|NCT01662505|2059343|FG001|Overall Study|Refused cont. medication|0
1030317|NCT01662505|2059344|FG002|Overall Study|Refused cont. medication|1
1030318|NCT01662505|2059342|FG000|Overall Study|Not specified above|1
1030319|NCT01662505|2059343|FG001|Overall Study|Not specified above|3
1030320|NCT01662505|2059344|FG002|Overall Study|Not specified above|2
1030321|NCT01662635|2059374|FG000|Overall Study|scarce samples for evaluation|30
1030322|NCT01662648|2059382|FG000|Overall Study|Death|1
1030323|NCT01662648|2059383|FG001|Overall Study|Death|3
1030324|NCT01662648|2059382|FG000|Overall Study|Adverse Event|40
1030325|NCT01662648|2059383|FG001|Overall Study|Adverse Event|37
1030326|NCT01662648|2059382|FG000|Overall Study|Lack of Efficacy|17
1030327|NCT01662648|2059383|FG001|Overall Study|Lack of Efficacy|16
1030328|NCT01662648|2059382|FG000|Overall Study|Participant ineligible to continue trial|1
1030329|NCT01662648|2059383|FG001|Overall Study|Participant ineligible to continue trial|1
1030330|NCT01662648|2059382|FG000|Overall Study|Lost to Follow-up|24
1030331|NCT01662648|2059383|FG001|Overall Study|Lost to Follow-up|36
1030332|NCT01662648|2059382|FG000|Overall Study|Withdrawal by Subject|36
1030333|NCT01662648|2059383|FG001|Overall Study|Withdrawal by Subject|53
1030334|NCT01662648|2059382|FG000|Overall Study|Participant non-compliant|16
1030335|NCT01662648|2059383|FG001|Overall Study|Participant non-compliant|20
1030336|NCT01662648|2059382|FG000|Overall Study|Other|8
1030337|NCT01662648|2059383|FG001|Overall Study|Other|11
1030338|NCT01662648|2059382|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3
1030339|NCT01662648|2059383|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0
1030340|NCT01662648|2059382|FG000|Overall Study|LOE and other reason unspecified|1
1030341|NCT01662648|2059383|FG001|Overall Study|LOE and other reason unspecified|0
1030342|NCT01662648|2059382|FG000|Overall Study|LOE and Participant non-compliant|0
1030343|NCT01662648|2059383|FG001|Overall Study|LOE and Participant non-compliant|1
1030344|NCT01662895|2059457|FG000|Overall Study|Lost to Follow-up|0
1030345|NCT01662895|2059458|FG001|Overall Study|Lost to Follow-up|1
1030346|NCT01662986|2059492|FG000|Overall Study|Adverse Event|5
1030347|NCT01662986|2059493|FG001|Overall Study|Adverse Event|4
1030348|NCT01662986|2059492|FG000|Overall Study|Protocol Violation|2
1030349|NCT01662986|2059493|FG001|Overall Study|Protocol Violation|3
1030350|NCT01662986|2059492|FG000|Overall Study|Lost to Follow-up|5
1030351|NCT01662986|2059493|FG001|Overall Study|Lost to Follow-up|4
1030352|NCT01662986|2059492|FG000|Overall Study|Withdrawal by Subject|2
1030353|NCT01662986|2059493|FG001|Overall Study|Withdrawal by Subject|2
1030354|NCT01662986|2059492|FG000|Overall Study|Not Treated|1
1030355|NCT01662986|2059493|FG001|Overall Study|Not Treated|0
1030356|NCT01662986|2059492|FG000|Overall Study|Other than stated above|3
1030357|NCT01662986|2059493|FG001|Overall Study|Other than stated above|0
1030358|NCT01662999|2059505|FG000|Period 3|Withdrawal by Subject|0
1030359|NCT01662999|2059506|FG001|Period 3|Withdrawal by Subject|1
1030360|NCT01662999|2059507|FG002|Period 3|Withdrawal by Subject|0
1030361|NCT01662999|2059508|FG003|Period 3|Withdrawal by Subject|0
1030362|NCT01662999|2059509|FG004|Period 3|Withdrawal by Subject|0
1030363|NCT01662999|2059510|FG005|Period 3|Withdrawal by Subject|0
1030364|NCT01663103|2059546|FG000|Overall Study|Withdrawal by Subject|1
1030365|NCT01663103|2059547|FG001|Overall Study|Withdrawal by Subject|2
1030366|NCT01663103|2059546|FG000|Overall Study|Adverse Event|1
1030367|NCT01663103|2059547|FG001|Overall Study|Adverse Event|0
1030368|NCT01663103|2059546|FG000|Overall Study|dog bite|1
1030369|NCT01663103|2059547|FG001|Overall Study|dog bite|0
1030370|NCT01663233|2059559|FG000|Overall Study|Withdrawal by Subject|3
1030371|NCT01663233|2059560|FG001|Overall Study|Withdrawal by Subject|2
1030372|NCT01663233|2059559|FG000|Overall Study|Protocol Deviation|1
1030373|NCT01663233|2059560|FG001|Overall Study|Protocol Deviation|4
1030374|NCT01663233|2059559|FG000|Overall Study|Lost to Follow-up|0
1030375|NCT01663233|2059560|FG001|Overall Study|Lost to Follow-up|1
1030376|NCT01663402|2059582|FG000|Overall Study|Randomized but not treated|19
1030377|NCT01663402|2059583|FG001|Overall Study|Randomized but not treated|11
1030378|NCT01663402|2059582|FG000|Overall Study|Adverse Event|347
1030379|NCT01663402|2059583|FG001|Overall Study|Adverse Event|362
1030380|NCT01663402|2059582|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0
1030381|NCT01663402|2059583|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730
1030382|NCT01663402|2059582|FG000|Overall Study|Poor compliance to protocol|529
1030383|NCT01663402|2059583|FG001|Overall Study|Poor compliance to protocol|454
1030384|NCT01663402|2059582|FG000|Overall Study|Physician Decision|77
1030385|NCT01663402|2059583|FG001|Overall Study|Physician Decision|62
1030386|NCT01663402|2059582|FG000|Overall Study|Site terminated by sponsor|1
1030387|NCT01663402|2059583|FG001|Overall Study|Site terminated by sponsor|3
1030388|NCT01663402|2059582|FG000|Overall Study|Participant moved|139
1030389|NCT01663402|2059583|FG001|Overall Study|Participant moved|104
1030390|NCT01663402|2059582|FG000|Overall Study|Withdrawal by Subject|118
1030391|NCT01663402|2059583|FG001|Overall Study|Withdrawal by Subject|91
1030392|NCT01663402|2059582|FG000|Overall Study|Related to study drug administration|96
1030393|NCT01663402|2059583|FG001|Overall Study|Related to study drug administration|105
1030394|NCT01663402|2059582|FG000|Overall Study|Lost to Follow-up|17
1030395|NCT01663402|2059583|FG001|Overall Study|Lost to Follow-up|15
1030396|NCT01663402|2059582|FG000|Overall Study|Other than specified above|172
1030397|NCT01663402|2059583|FG001|Overall Study|Other than specified above|147
1030398|NCT01663506|2059589|FG000|Overall Study|Lack of Efficacy|3
1030399|NCT01663506|2059589|FG000|Overall Study|Consent Withdrawal by Subject|1
1030400|NCT01663506|2059589|FG000|Overall Study|Lost to Follow-up|1
1030401|NCT01663506|2059589|FG000|Overall Study|Adverse Event|1
1030402|NCT01663506|2059589|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2
1030403|NCT01663532|2059595|FG000|Overall Study|Lost to Follow-up|9
1030404|NCT01663532|2059596|FG001|Overall Study|Lost to Follow-up|10
1030405|NCT01663532|2059595|FG000|Overall Study|Adverse Event|7
1030406|NCT01663532|2059596|FG001|Overall Study|Adverse Event|13
1030407|NCT01663532|2059595|FG000|Overall Study|Met Withdrawal Criteria|7
1030408|NCT01663532|2059596|FG001|Overall Study|Met Withdrawal Criteria|6
1030409|NCT01663532|2059595|FG000|Overall Study|Physician Decision|1
1030410|NCT01663532|2059596|FG001|Overall Study|Physician Decision|1
1030411|NCT01663532|2059595|FG000|Overall Study|Withdrawal by Subject|35
1030412|NCT01663532|2059596|FG001|Overall Study|Withdrawal by Subject|17
1030413|NCT01663532|2059595|FG000|Overall Study|Lack of Efficacy|15
1030414|NCT01663532|2059596|FG001|Overall Study|Lack of Efficacy|60
1030415|NCT01663623|2059604|FG000|Overall Study|Adverse Event|3
1030416|NCT01663623|2059605|FG001|Overall Study|Adverse Event|7
1030417|NCT01663623|2059604|FG000|Overall Study|Lack of Efficacy|5
1030418|NCT01663623|2059605|FG001|Overall Study|Lack of Efficacy|6
1030419|NCT01663623|2059604|FG000|Overall Study|Protocol Violation|0
1030420|NCT01663623|2059605|FG001|Overall Study|Protocol Violation|1
1030421|NCT01663623|2059604|FG000|Overall Study|Other-Study closed/terminated|1
1030422|NCT01663623|2059605|FG001|Overall Study|Other-Study closed/terminated|1
1030423|NCT01663623|2059604|FG000|Overall Study|Physician Decision|1
1030424|NCT01663623|2059605|FG001|Overall Study|Physician Decision|4
1030425|NCT01663623|2059604|FG000|Overall Study|Withdrawal by Subject|2
1030426|NCT01663623|2059605|FG001|Overall Study|Withdrawal by Subject|1
1030427|NCT01663636|2059613|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
1030428|NCT01663636|2059614|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
1030429|NCT01663714|2059620|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
1030430|NCT01663714|2059620|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11
1030431|NCT01663714|2059620|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
1030432|NCT01663714|2059620|FG000|Long-Term Follow-Up|Lost to Follow-up|1
1030433|NCT01663714|2059620|FG000|Long-Term Follow-Up|Death|4
1030434|NCT01663714|2059620|FG000|Long-Term Follow-Up|Non-compliance|1
1030435|NCT01663727|2059628|FG000|Overall Study|Death|161
1030436|NCT01663727|2059629|FG001|Overall Study|Death|155
1030437|NCT01663727|2059628|FG000|Overall Study|Lost to Follow-up|10
1030438|NCT01663727|2059629|FG001|Overall Study|Lost to Follow-up|8
1030439|NCT01663727|2059628|FG000|Overall Study|Withdrawal by Subject|18
1030440|NCT01663727|2059629|FG001|Overall Study|Withdrawal by Subject|25
1030441|NCT01663727|2059628|FG000|Overall Study|Study Terminated|51
1030442|NCT01663727|2059629|FG001|Overall Study|Study Terminated|50
1030443|NCT01663727|2059628|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1
1030444|NCT01663727|2059629|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0
1030445|NCT01663727|2059628|FG000|Overall Study|Withdrawal prior to dosing.|1
1030446|NCT01663727|2059629|FG001|Overall Study|Withdrawal prior to dosing.|0
1030447|NCT01663740|2059637|FG000|Overall Study|Lost to Follow-up|1
1030448|NCT01663740|2059638|FG001|Overall Study|Lost to Follow-up|4
1030449|NCT01663740|2059637|FG000|Overall Study|Other|9
1030450|NCT01663740|2059638|FG001|Overall Study|Other|2
1030451|NCT01663740|2059637|FG000|Overall Study|Inclusion/Exclusion not met|1
1030452|NCT01663740|2059638|FG001|Overall Study|Inclusion/Exclusion not met|0
1030453|NCT01663740|2059637|FG000|Overall Study|Death|0
1030454|NCT01663740|2059638|FG001|Overall Study|Death|1
1030455|NCT01663740|2059637|FG000|Overall Study|Withdrawal by Subject|2
1030456|NCT01663740|2059638|FG001|Overall Study|Withdrawal by Subject|1
1030457|NCT01663740|2059637|FG000|Overall Study|No end of study status|3
1030458|NCT01663740|2059638|FG001|Overall Study|No end of study status|0
1030459|NCT01663857|2059657|FG000|Overall Study|Withdrew Consent to Study Participation|0
1030460|NCT01663857|2059658|FG001|Overall Study|Withdrew Consent to Study Participation|1
1030461|NCT01663857|2059659|FG002|Overall Study|Withdrew Consent to Study Participation|7
1030462|NCT01663857|2059660|FG003|Overall Study|Withdrew Consent to Study Participation|3
1030463|NCT01663857|2059657|FG000|Overall Study|Lost to Follow-up|0
1030464|NCT01663857|2059658|FG001|Overall Study|Lost to Follow-up|0
1030465|NCT01663857|2059659|FG002|Overall Study|Lost to Follow-up|3
1030466|NCT01663857|2059660|FG003|Overall Study|Lost to Follow-up|1
1030467|NCT01663896|2059676|FG000|Overall Study|Various reasons|43
1030468|NCT01663987|2059693|FG000|Overall Study|Adverse Event|7
1030469|NCT01663987|2059694|FG001|Overall Study|Adverse Event|2
1030470|NCT01663987|2059693|FG000|Overall Study|Lost to Follow-up|1
1030471|NCT01663987|2059694|FG001|Overall Study|Lost to Follow-up|1
1030472|NCT01663987|2059693|FG000|Overall Study|Withdrawal by Subject|2
1030473|NCT01663987|2059694|FG001|Overall Study|Withdrawal by Subject|3
1030474|NCT01663987|2059693|FG000|Overall Study|Other reason not defined above|3
1030475|NCT01663987|2059694|FG001|Overall Study|Other reason not defined above|0
1030476|NCT01664039|2059702|FG000|Overall Study|Adverse Event|3
1030477|NCT01664039|2059703|FG001|Overall Study|Adverse Event|4
1030478|NCT01664039|2059702|FG000|Overall Study|Lost to Follow-up|1
1030479|NCT01664039|2059703|FG001|Overall Study|Lost to Follow-up|1
1030480|NCT01664039|2059702|FG000|Overall Study|Withdrawal by Subject|1
1030481|NCT01664039|2059703|FG001|Overall Study|Withdrawal by Subject|3
1030482|NCT01664039|2059702|FG000|Overall Study|Noncompliance|1
1030483|NCT01664039|2059703|FG001|Overall Study|Noncompliance|1
1030484|NCT01664052|2059711|FG000|Phase 1|No device placement|6
1030485|NCT01664052|2059712|FG001|Phase 1|No device placement|0
1030486|NCT01664052|2059711|FG000|Phase 1|No HSG 1 hr post placement|1
1030487|NCT01664052|2059712|FG001|Phase 1|No HSG 1 hr post placement|0
1030488|NCT01664052|2059711|FG000|Phase 2|No device placement|0
1030489|NCT01664052|2059712|FG001|Phase 2|No device placement|4
1030490|NCT01664078|2059719|FG000|Overall Study|Death|9
1030491|NCT01664078|2059719|FG000|Overall Study|Withdrawal by Subject|4
1030492|NCT01664078|2059719|FG000|Overall Study|Lost to Follow-up|2
1030493|NCT01664078|2059719|FG000|Overall Study|missed 5 year visit|1
1030494|NCT01664078|2059719|FG000|Overall Study|Other|53
1030495|NCT01664091|2059769|FG000|Overall Study|Death|1
1030496|NCT01664091|2059769|FG000|Overall Study|Disease Progression|2
1030497|NCT01664091|2059769|FG000|Overall Study|Lost to Follow-up|2
1030498|NCT01664091|2059769|FG000|Overall Study|Withdrawal by Subject|1
1030499|NCT01664104|2059774|FG000|Overall Study|Adverse Event|6
1030500|NCT01664104|2059774|FG000|Overall Study|Lack of Efficacy|2
1030501|NCT01664104|2059774|FG000|Overall Study|Withdrawal by Subject|1
1030502|NCT01664104|2059774|FG000|Overall Study|Lost to Follow-up|4
1030503|NCT01664104|2059774|FG000|Overall Study|Other|1
1030504|NCT01664104|2059774|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2
1030505|NCT01664130|2059787|FG000|Overall Study|competing secondary disease|2
1030506|NCT01664247|2059796|FG000|Overall Study|Adverse Event|5
1030507|NCT01664247|2059797|FG001|Overall Study|Adverse Event|3
1030508|NCT01664247|2059796|FG000|Overall Study|Protocol Violation|3
1030509|NCT01664247|2059797|FG001|Overall Study|Protocol Violation|5
1030510|NCT01664247|2059796|FG000|Overall Study|Withdrawal Criteria|1
1030511|NCT01664247|2059797|FG001|Overall Study|Withdrawal Criteria|4
1030512|NCT01664247|2059796|FG000|Overall Study|Unclassified|5
1030513|NCT01664247|2059797|FG001|Overall Study|Unclassified|29
1030514|NCT01664494|2059803|FG000|Overall Study|Withdrawal by Subject|27
1030515|NCT01664494|2059803|FG000|Overall Study|Death|18
1030516|NCT01664494|2059803|FG000|Overall Study|Other|49
1030517|NCT01664494|2059803|FG000|Overall Study|Lost to Follow-up|99
1030518|NCT01664533|2059807|FG000|Overall Study|Death|42
1030519|NCT01664533|2059807|FG000|Overall Study|Lost to Follow-up|3
1030520|NCT01664533|2059807|FG000|Overall Study|Study termination|9
1030521|NCT01664533|2059807|FG000|Overall Study|Protocol Violation|3
1030522|NCT01664624|2059825|FG000|Overall Study|Adverse Event|0
1030523|NCT01664624|2059826|FG001|Overall Study|Adverse Event|1
1030524|NCT01664624|2059827|FG002|Overall Study|Adverse Event|0
1030525|NCT01664624|2059828|FG003|Overall Study|Adverse Event|0
1030526|NCT01664923|2059892|FG000|Period1:Double Blind Phase-29 Months|Death|8
1030527|NCT01664923|2059893|FG001|Period1:Double Blind Phase-29 Months|Death|6
1030528|NCT01664923|2059892|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
1030529|NCT01664923|2059893|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
1030530|NCT01664923|2059892|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2
1030531|NCT01664923|2059893|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0
1030532|NCT01664923|2059892|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
1030533|NCT01664923|2059893|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
1030534|NCT01664923|2059892|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65
1030535|NCT01664923|2059893|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132
1030536|NCT01664923|2059892|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14
1030537|NCT01664923|2059893|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9
1030538|NCT01664923|2059892|FG000|Period1:Double Blind Phase-29 Months|Other|3
1030539|NCT01664923|2059893|FG001|Period1:Double Blind Phase-29 Months|Other|4
1030540|NCT01664923|2059892|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
1030541|NCT01664923|2059893|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
1030542|NCT01664923|2059892|FG000|Period 2: Open-label Phase-36 Months|Death|3
1030543|NCT01664923|2059893|FG001|Period 2: Open-label Phase-36 Months|Death|1
1030544|NCT01664923|2059892|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1
1030545|NCT01664923|2059893|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1
1030546|NCT01664923|2059892|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28
1030547|NCT01664923|2059893|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9
1030548|NCT01664923|2059892|FG000|Period 2: Open-label Phase-36 Months|Other|3
1030549|NCT01664923|2059893|FG001|Period 2: Open-label Phase-36 Months|Other|1
1030550|NCT01664923|2059892|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4
1030551|NCT01664923|2059893|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7
1030552|NCT01664923|2059892|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
1030553|NCT01664923|2059893|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
1030554|NCT01664949|2059905|FG000|Overall Study|Adverse Event|11
1030555|NCT01664949|2059906|FG001|Overall Study|Adverse Event|12
1030556|NCT01664949|2059905|FG000|Overall Study|Lack of Efficacy|1
1030557|NCT01664949|2059906|FG001|Overall Study|Lack of Efficacy|1
1030558|NCT01664949|2059905|FG000|Overall Study|Lost to Follow-up|1
1030559|NCT01664949|2059906|FG001|Overall Study|Lost to Follow-up|2
1030560|NCT01664949|2059905|FG000|Overall Study|Personal Reasons|3
1030561|NCT01664949|2059906|FG001|Overall Study|Personal Reasons|4
1030562|NCT01664949|2059905|FG000|Overall Study|Protocol Violation|5
1030563|NCT01664949|2059906|FG001|Overall Study|Protocol Violation|5
1030564|NCT01664949|2059905|FG000|Overall Study|Other Miscellaneous Reasons|3
1030565|NCT01664949|2059906|FG001|Overall Study|Other Miscellaneous Reasons|1
1030588|NCT01665430|2059989|FG000|Overall Study|Adverse Event|1
1030589|NCT01665430|2059989|FG000|Overall Study|Withdrawal by Subject|6
1030590|NCT01665430|2059989|FG000|Overall Study|Other Unspecified|2
1030591|NCT01665599|2060002|FG000|Overall Study|Adverse Event|1
1030592|NCT01665599|2060002|FG000|Overall Study|Consent Withdrawn|1
1030593|NCT01665599|2060002|FG000|Overall Study|Investigator/Sponsor decision|1
1030594|NCT01665599|2060002|FG000|Overall Study|Death|1
1030595|NCT01665599|2060002|FG000|Overall Study|Lost to Follow-up|2
1030596|NCT01665599|2060002|FG000|Overall Study|Participant Left for More Than 3 Months|1
1030597|NCT01665599|2060002|FG000|Overall Study|Could Not Continue Due to Time Constrain|1
1030598|NCT01665768|2060006|FG000|Overall Study|Adverse Event|3
1030599|NCT01665768|2060006|FG000|Overall Study|Lack of Efficacy|19
1030600|NCT01665768|2060006|FG000|Overall Study|Withdrawal by Subject|1
1030601|NCT01665807|2060013|FG000|Overall Study|Withdrawal by Subject|2
1030602|NCT01665807|2060014|FG001|Overall Study|Withdrawal by Subject|0
1030603|NCT01665807|2060015|FG002|Overall Study|Withdrawal by Subject|1
1030604|NCT01665911|2060032|FG000|Overall Study|Protocol Violation|4
1030605|NCT01665911|2060032|FG000|Overall Study|Withdrawal by Subject|1
1030606|NCT01665911|2060032|FG000|Overall Study|Adverse Event|1
1030607|NCT01666002|2060052|FG000|Overall Study|Lost to Follow-up|5
1030608|NCT01666002|2060053|FG001|Overall Study|Lost to Follow-up|0
1030609|NCT01666119|2060060|FG000|Overall Study|Adverse Event|6
1030610|NCT01666119|2060060|FG000|Overall Study|Withdrawal by Subject|16
1030611|NCT01666119|2060060|FG000|Overall Study|Lost to Follow-up|7
1030612|NCT01666119|2060060|FG000|Overall Study|non compliance with study medication, pa|18
1030613|NCT01666119|2060060|FG000|Overall Study|Subject experiencing withdrawal symptoms|5
1030614|NCT01666314|2060094|FG000|Overall Study|Adverse Event|3
1030615|NCT01666314|2060095|FG001|Overall Study|Adverse Event|13
1030616|NCT01666314|2060096|FG002|Overall Study|Adverse Event|7
1030617|NCT01666314|2060097|FG003|Overall Study|Adverse Event|7
1030618|NCT01666314|2060094|FG000|Overall Study|Progressive Disease|11
1030619|NCT01666314|2060095|FG001|Overall Study|Progressive Disease|9
1030620|NCT01666314|2060096|FG002|Overall Study|Progressive Disease|19
1030621|NCT01666314|2060097|FG003|Overall Study|Progressive Disease|20
1030622|NCT01666314|2060094|FG000|Overall Study|Symptomatic Deterioration|1
1030623|NCT01666314|2060095|FG001|Overall Study|Symptomatic Deterioration|0
1030624|NCT01666314|2060096|FG002|Overall Study|Symptomatic Deterioration|2
1030625|NCT01666314|2060097|FG003|Overall Study|Symptomatic Deterioration|0
1030626|NCT01666314|2060094|FG000|Overall Study|Unsatisfactory Therapeutic Response|7
1030627|NCT01666314|2060095|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
1030628|NCT01666314|2060096|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
1030629|NCT01666314|2060097|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
1030630|NCT01666314|2060094|FG000|Overall Study|Withdrawal by Subject|1
1030631|NCT01666314|2060095|FG001|Overall Study|Withdrawal by Subject|1
1030632|NCT01666314|2060096|FG002|Overall Study|Withdrawal by Subject|2
1030633|NCT01666314|2060097|FG003|Overall Study|Withdrawal by Subject|3
1030634|NCT01666314|2060094|FG000|Overall Study|Reason not Specified|10
1030635|NCT01666314|2060095|FG001|Overall Study|Reason not Specified|7
1030636|NCT01666314|2060096|FG002|Overall Study|Reason not Specified|5
1030637|NCT01666314|2060097|FG003|Overall Study|Reason not Specified|5
1030638|NCT01666444|2060120|FG000|Overall Study|Did not initiate treatment|2
1030639|NCT01666444|2060121|FG001|Overall Study|Did not initiate treatment|1
1030640|NCT01666652|2060132|FG000|Overall Study|Serious Adverse Event|0
1030641|NCT01666652|2060133|FG001|Overall Study|Serious Adverse Event|0
1030642|NCT01666652|2060134|FG002|Overall Study|Serious Adverse Event|0
1030643|NCT01666652|2060135|FG003|Overall Study|Serious Adverse Event|1
1030644|NCT01666652|2060136|FG004|Overall Study|Serious Adverse Event|0
1030645|NCT01666652|2060132|FG000|Overall Study|Withdrawal by Subject|0
1030646|NCT01666652|2060133|FG001|Overall Study|Withdrawal by Subject|0
1030647|NCT01666652|2060134|FG002|Overall Study|Withdrawal by Subject|0
1030648|NCT01666652|2060135|FG003|Overall Study|Withdrawal by Subject|0
1030649|NCT01666652|2060136|FG004|Overall Study|Withdrawal by Subject|1
1030650|NCT01666652|2060132|FG000|Overall Study|Moved from study area|1
1030651|NCT01666652|2060133|FG001|Overall Study|Moved from study area|0
1030652|NCT01666652|2060134|FG002|Overall Study|Moved from study area|0
1030653|NCT01666652|2060135|FG003|Overall Study|Moved from study area|2
1030654|NCT01666652|2060136|FG004|Overall Study|Moved from study area|0
1030655|NCT01666652|2060132|FG000|Overall Study|Lost to Follow-up|1
1030656|NCT01666652|2060133|FG001|Overall Study|Lost to Follow-up|1
1030657|NCT01666652|2060134|FG002|Overall Study|Lost to Follow-up|1
1030658|NCT01666652|2060135|FG003|Overall Study|Lost to Follow-up|1
1030659|NCT01666652|2060136|FG004|Overall Study|Lost to Follow-up|0
1030660|NCT01666730|2060148|FG000|Overall Study|Adverse Event|16
1030661|NCT01666730|2060148|FG000|Overall Study|Death|2
1030662|NCT01666730|2060148|FG000|Overall Study|Physician Decision|5
1030663|NCT01666730|2060148|FG000|Overall Study|Withdrawal by Subject|9
1030664|NCT01666730|2060148|FG000|Overall Study|Disease progression/relapse|18
1030665|NCT01666782|2060154|FG000|Overall Study|Received 2 doses of vaccine|0
1030666|NCT01666782|2060155|FG001|Overall Study|Received 2 doses of vaccine|1
1030667|NCT01666782|2060154|FG000|Overall Study|Enrolled both years; year 1 data used|4
1030668|NCT01666782|2060155|FG001|Overall Study|Enrolled both years; year 1 data used|0
1030669|NCT01666951|2060172|FG000|Overall Study|Not dosed|1
1030670|NCT01666951|2060173|FG001|Overall Study|Not dosed|1
1030671|NCT01667107|2060188|FG000|Overall Study|Adverse Event|4
1030672|NCT01667107|2060189|FG001|Overall Study|Adverse Event|3
1030673|NCT01667107|2060188|FG000|Overall Study|Tolerability issues|0
1030674|NCT01667107|2060189|FG001|Overall Study|Tolerability issues|2
1030675|NCT01667107|2060188|FG000|Overall Study|Protocol Violation|0
1030676|NCT01667107|2060189|FG001|Overall Study|Protocol Violation|1
1030677|NCT01667107|2060188|FG000|Overall Study|Lack of Efficacy|0
1030678|NCT01667107|2060189|FG001|Overall Study|Lack of Efficacy|1
1030679|NCT01667224|2060197|FG000|Overall Study|Withdrawal by Subject|3
1030680|NCT01667224|2060198|FG001|Overall Study|Withdrawal by Subject|1
1030681|NCT01667224|2060197|FG000|Overall Study|Protocol Violation|1
1030682|NCT01667224|2060198|FG001|Overall Study|Protocol Violation|1
1030683|NCT01667419|2060292|FG000|Overall Study|Reason Not Specified|1
1030684|NCT01667419|2060293|FG001|Overall Study|Reason Not Specified|0
1030685|NCT01667419|2060294|FG002|Overall Study|Reason Not Specified|0
1030686|NCT01667419|2060295|FG003|Overall Study|Reason Not Specified|0
1030687|NCT01667419|2060292|FG000|Overall Study|Withdrawal by Subject|16
1030688|NCT01667419|2060293|FG001|Overall Study|Withdrawal by Subject|8
1030689|NCT01667419|2060294|FG002|Overall Study|Withdrawal by Subject|9
1030690|NCT01667419|2060295|FG003|Overall Study|Withdrawal by Subject|8
1030691|NCT01667419|2060292|FG000|Overall Study|Non-compliance|0
1030692|NCT01667419|2060293|FG001|Overall Study|Non-compliance|0
1030693|NCT01667419|2060294|FG002|Overall Study|Non-compliance|0
1030694|NCT01667419|2060295|FG003|Overall Study|Non-compliance|1
1030695|NCT01667419|2060292|FG000|Overall Study|Protocol Violation|1
1030696|NCT01667419|2060293|FG001|Overall Study|Protocol Violation|0
1030697|NCT01667419|2060294|FG002|Overall Study|Protocol Violation|0
1030698|NCT01667419|2060295|FG003|Overall Study|Protocol Violation|0
1030699|NCT01667419|2060292|FG000|Overall Study|Lost to Follow-up|7
1030700|NCT01667419|2060293|FG001|Overall Study|Lost to Follow-up|6
1030701|NCT01667419|2060294|FG002|Overall Study|Lost to Follow-up|2
1030702|NCT01667419|2060295|FG003|Overall Study|Lost to Follow-up|4
1030703|NCT01667419|2060292|FG000|Overall Study|Death|18
1030704|NCT01667419|2060293|FG001|Overall Study|Death|33
1030705|NCT01667419|2060294|FG002|Overall Study|Death|25
1030706|NCT01667419|2060295|FG003|Overall Study|Death|26
1030707|NCT01667432|2060306|FG000|Overall Study|Premature Study Termination|26
1030708|NCT01667432|2060306|FG000|Overall Study|Failure to Return|10
1030709|NCT01667432|2060306|FG000|Overall Study|Moved to Another Center|3
1030710|NCT01667432|2060306|FG000|Overall Study|Lost to Follow-up|3
1030711|NCT01667432|2060306|FG000|Overall Study|Refused Treatment/Withdrew Consent|1
1030712|NCT01667432|2060306|FG000|Overall Study|Insufficient Therapeutic Response|4
1030713|NCT01667432|2060306|FG000|Overall Study|Adverse Event|1
1030714|NCT01667432|2060306|FG000|Overall Study|Protocol Deviation|2
1030715|NCT01667432|2060306|FG000|Overall Study|Principal Investigator Decision|1
1030716|NCT01667432|2060306|FG000|Overall Study|Reason Not Specified|2
1030717|NCT01667432|2060306|FG000|Overall Study|Missing Information|4
1030718|NCT01667549|2060327|FG000|Overall Study|Withdrawal by Subject|3
1030719|NCT01667549|2060328|FG001|Overall Study|Withdrawal by Subject|5
1030720|NCT01667549|2060329|FG002|Overall Study|Withdrawal by Subject|7
1030721|NCT01667549|2060330|FG003|Overall Study|Withdrawal by Subject|6
1030722|NCT01667549|2060331|FG004|Overall Study|Withdrawal by Subject|1
1030723|NCT01667562|2060348|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30
1030724|NCT01667562|2060349|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0
1030725|NCT01667562|2060348|FG000|Erlotinib Phase|Lost to Follow-up|0
1030726|NCT01667562|2060349|FG001|Erlotinib Phase|Lost to Follow-up|1
1030727|NCT01667562|2060348|FG000|Erlotinib Phase|Adverse Event|0
1030728|NCT01667562|2060349|FG001|Erlotinib Phase|Adverse Event|1
1030729|NCT01667562|2060348|FG000|Erlotinib Phase|Switch to Commercial Drug|0
1030730|NCT01667562|2060349|FG001|Erlotinib Phase|Switch to Commercial Drug|1
1030731|NCT01667679|2060356|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
1030732|NCT01667679|2060357|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
1030733|NCT01667679|2060356|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
1030734|NCT01667679|2060357|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
1030735|NCT01667679|2060356|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
1030736|NCT01667679|2060357|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
1030737|NCT01667679|2060356|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
1030738|NCT01667679|2060357|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
1030739|NCT01667679|2060356|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
1030740|NCT01667679|2060357|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
1030741|NCT01667679|2060356|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
1030742|NCT01667679|2060357|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
1030743|NCT01667679|2060356|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
1030744|NCT01667679|2060357|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
1030745|NCT01667679|2060356|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
1030746|NCT01667679|2060357|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
1030747|NCT01667679|2060356|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
1030748|NCT01667679|2060357|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
1030749|NCT01667679|2060356|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
1030750|NCT01667679|2060357|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
1030751|NCT01667679|2060356|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
1030752|NCT01667679|2060357|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
1030753|NCT01667679|2060356|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
1030754|NCT01667679|2060357|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
1030755|NCT01667679|2060356|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
1030756|NCT01667679|2060357|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
1030757|NCT01667679|2060356|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
1030758|NCT01667679|2060357|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
1030759|NCT01667679|2060356|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
1030760|NCT01667679|2060357|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
1030761|NCT01667679|2060356|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
1030762|NCT01667679|2060357|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
1030763|NCT01667679|2060356|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
1030764|NCT01667679|2060357|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
1030765|NCT01667679|2060356|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
1030766|NCT01667679|2060357|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
1030767|NCT01667679|2060356|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
1030768|NCT01667679|2060357|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
1030769|NCT01667679|2060356|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
1030770|NCT01667679|2060357|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
1030771|NCT01667679|2060356|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
1030772|NCT01667679|2060357|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
1030773|NCT01667731|2060370|FG000|Overall Study|Enrolled but not treated|0
1030774|NCT01667731|2060371|FG001|Overall Study|Enrolled but not treated|0
1030775|NCT01667731|2060372|FG002|Overall Study|Enrolled but not treated|0
1030776|NCT01667731|2060373|FG003|Overall Study|Enrolled but not treated|0
1030777|NCT01667731|2060374|FG004|Overall Study|Enrolled but not treated|1
1030778|NCT01667731|2060370|FG000|Overall Study|Efficacy Failure|1
1030779|NCT01667731|2060371|FG001|Overall Study|Efficacy Failure|12
1030780|NCT01667731|2060372|FG002|Overall Study|Efficacy Failure|0
1030781|NCT01667731|2060373|FG003|Overall Study|Efficacy Failure|1
1030782|NCT01667731|2060374|FG004|Overall Study|Efficacy Failure|24
1030783|NCT01667731|2060370|FG000|Overall Study|Lost to Follow-up|2
1030784|NCT01667731|2060371|FG001|Overall Study|Lost to Follow-up|3
1030785|NCT01667731|2060372|FG002|Overall Study|Lost to Follow-up|1
1030786|NCT01667731|2060373|FG003|Overall Study|Lost to Follow-up|1
1030787|NCT01667731|2060374|FG004|Overall Study|Lost to Follow-up|2
1030788|NCT01667731|2060370|FG000|Overall Study|Subject Withdrew Consent|2
1030789|NCT01667731|2060371|FG001|Overall Study|Subject Withdrew Consent|0
1030790|NCT01667731|2060372|FG002|Overall Study|Subject Withdrew Consent|1
1030791|NCT01667731|2060373|FG003|Overall Study|Subject Withdrew Consent|0
1030792|NCT01667731|2060374|FG004|Overall Study|Subject Withdrew Consent|1
1030793|NCT01667731|2060370|FG000|Overall Study|Death|0
1030794|NCT01667731|2060371|FG001|Overall Study|Death|1
1030795|NCT01667731|2060372|FG002|Overall Study|Death|0
1030796|NCT01667731|2060373|FG003|Overall Study|Death|0
1030797|NCT01667731|2060374|FG004|Overall Study|Death|0
1030798|NCT01667900|2060414|FG000|Part B|Death|0
1030799|NCT01667900|2060415|FG001|Part B|Death|0
1030800|NCT01667900|2060416|FG002|Part B|Death|0
1030801|NCT01667900|2060417|FG003|Part B|Death|0
1030802|NCT01667900|2060418|FG004|Part B|Death|0
1030803|NCT01667900|2060419|FG005|Part B|Death|0
1030804|NCT01667900|2060420|FG006|Part B|Death|0
1030805|NCT01667900|2060421|FG007|Part B|Death|0
1030806|NCT01667900|2060422|FG008|Part B|Death|0
1030807|NCT01667900|2060423|FG009|Part B|Death|0
1030808|NCT01667900|2060424|FG010|Part B|Death|0
1030809|NCT01667900|2060425|FG011|Part B|Death|0
1030810|NCT01667900|2060426|FG012|Part B|Death|0
1030811|NCT01667900|2060427|FG013|Part B|Death|0
1030812|NCT01667900|2060428|FG014|Part B|Death|0
1030813|NCT01667900|2060429|FG015|Part B|Death|0
1030814|NCT01667900|2060430|FG016|Part B|Death|1
1030815|NCT01667900|2060431|FG017|Part B|Death|0
1030816|NCT01667900|2060432|FG018|Part B|Death|0
1030817|NCT01667900|2060433|FG019|Part B|Death|0
1030818|NCT01667926|2060455|FG000|Overall Study|Withdrawal by Subject|1
1030819|NCT01667926|2060456|FG001|Overall Study|Withdrawal by Subject|2
1030820|NCT01667926|2060457|FG002|Overall Study|Withdrawal by Subject|2
1030821|NCT01667926|2060455|FG000|Overall Study|Physician Decision|0
1030822|NCT01667926|2060456|FG001|Overall Study|Physician Decision|0
1030823|NCT01667926|2060457|FG002|Overall Study|Physician Decision|1
1030824|NCT01667926|2060455|FG000|Overall Study|Time committment|0
1030825|NCT01667926|2060456|FG001|Overall Study|Time committment|0
1030826|NCT01667926|2060457|FG002|Overall Study|Time committment|2
1030827|NCT01667926|2060455|FG000|Overall Study|Inclusion/Exclusion Criteria|0
1030828|NCT01667926|2060456|FG001|Overall Study|Inclusion/Exclusion Criteria|0
1030829|NCT01667926|2060457|FG002|Overall Study|Inclusion/Exclusion Criteria|5
1030830|NCT01667926|2060455|FG000|Overall Study|Lost to Follow-up|1
1030831|NCT01667926|2060456|FG001|Overall Study|Lost to Follow-up|2
1030832|NCT01667926|2060457|FG002|Overall Study|Lost to Follow-up|1
1030833|NCT01667926|2060455|FG000|Overall Study|Side effects|3
1030834|NCT01667926|2060456|FG001|Overall Study|Side effects|0
1030835|NCT01667926|2060457|FG002|Overall Study|Side effects|0
1030836|NCT01668004|2060472|FG000|Overall Study|Adverse Event|7
1030837|NCT01668004|2060472|FG000|Overall Study|Withdrawal by Subject|2
1030838|NCT01668004|2060472|FG000|Overall Study|Lost to Follow-up|5
1030839|NCT01668004|2060472|FG000|Overall Study|Lack of Efficacy|9
1030840|NCT01668004|2060472|FG000|Overall Study|Non-compliance with treatment|2
1030841|NCT01668173|2060520|FG000|Overall Study|Adverse Event|3
1030842|NCT01668173|2060520|FG000|Overall Study|Trial suspension|4
1030843|NCT01668355|2060526|FG000|Overall Study|Death|3
1030844|NCT01668355|2060527|FG001|Overall Study|Death|1
1030845|NCT01668355|2060526|FG000|Overall Study|Withdrawal by Subject|6
1030846|NCT01668355|2060527|FG001|Overall Study|Withdrawal by Subject|1
1030847|NCT01668537|2060536|FG000|Overall Study|Request to Discontinue Prematurely|1
1030848|NCT01668537|2060537|FG001|Overall Study|Request to Discontinue Prematurely|1
1030849|NCT01668537|2060536|FG000|Overall Study|Subject unwilling/unable to comply|5
1030850|NCT01668537|2060537|FG001|Overall Study|Subject unwilling/unable to comply|0
1030851|NCT01668537|2060536|FG000|Overall Study|Reason Precludes Participation|1
1030852|NCT01668537|2060537|FG001|Overall Study|Reason Precludes Participation|0
1030853|NCT01668537|2060536|FG000|Overall Study|Lost to Follow-up|13
1030854|NCT01668537|2060537|FG001|Overall Study|Lost to Follow-up|6
1030855|NCT01668537|2060536|FG000|Overall Study|Other|2
1030856|NCT01668537|2060537|FG001|Overall Study|Other|3
1030857|NCT01668589|2060547|FG000|Overall Study|Lost to Follow-up|29
1030858|NCT01668589|2060548|FG001|Overall Study|Lost to Follow-up|37
1030859|NCT01668589|2060549|FG002|Overall Study|Lost to Follow-up|15
1030860|NCT01668589|2060550|FG003|Overall Study|Lost to Follow-up|5
1030861|NCT01668589|2060547|FG000|Overall Study|Full Consent/Agreement Withdrawn|54
1030862|NCT01668589|2060548|FG001|Overall Study|Full Consent/Agreement Withdrawn|8
1030863|NCT01668589|2060549|FG002|Overall Study|Full Consent/Agreement Withdrawn|11
1030864|NCT01668589|2060550|FG003|Overall Study|Full Consent/Agreement Withdrawn|4
1030865|NCT01668589|2060547|FG000|Overall Study|Death|12
1030866|NCT01668589|2060548|FG001|Overall Study|Death|3
1030867|NCT01668589|2060549|FG002|Overall Study|Death|2
1030868|NCT01668589|2060550|FG003|Overall Study|Death|11
1030869|NCT01668589|2060547|FG000|Overall Study|Other|44
1030870|NCT01668589|2060548|FG001|Overall Study|Other|10
1030871|NCT01668589|2060549|FG002|Overall Study|Other|7
1030872|NCT01668589|2060550|FG003|Overall Study|Other|15
1030873|NCT01668654|2060588|FG000|Overall Study|Study Closed/Terminated|3
1030874|NCT01668654|2060588|FG000|Overall Study|Withdrawal by Subject|1
1030875|NCT01668667|2060596|FG000|Overall Study|Adverse Event|3
1030876|NCT01668667|2060597|FG001|Overall Study|Adverse Event|6
1030877|NCT01668667|2060598|FG002|Overall Study|Adverse Event|4
1030878|NCT01668667|2060599|FG003|Overall Study|Adverse Event|4
1030879|NCT01668667|2060596|FG000|Overall Study|Lack of Efficacy|3
1030880|NCT01668667|2060597|FG001|Overall Study|Lack of Efficacy|2
1030881|NCT01668667|2060598|FG002|Overall Study|Lack of Efficacy|2
1030882|NCT01668667|2060599|FG003|Overall Study|Lack of Efficacy|3
1030883|NCT01668667|2060596|FG000|Overall Study|Protocol Violation|6
1030884|NCT01668667|2060597|FG001|Overall Study|Protocol Violation|10
1030885|NCT01668667|2060598|FG002|Overall Study|Protocol Violation|12
1030886|NCT01668667|2060599|FG003|Overall Study|Protocol Violation|5
1030887|NCT01668667|2060596|FG000|Overall Study|Lost to Follow-up|9
1030888|NCT01668667|2060597|FG001|Overall Study|Lost to Follow-up|4
1030889|NCT01668667|2060598|FG002|Overall Study|Lost to Follow-up|7
1030890|NCT01668667|2060599|FG003|Overall Study|Lost to Follow-up|6
1030891|NCT01668667|2060596|FG000|Overall Study|Physician Decision|3
1030892|NCT01668667|2060597|FG001|Overall Study|Physician Decision|0
1030893|NCT01668667|2060598|FG002|Overall Study|Physician Decision|1
1030894|NCT01668667|2060599|FG003|Overall Study|Physician Decision|0
1030895|NCT01668667|2060596|FG000|Overall Study|Withdrawal by Subject|7
1030896|NCT01668667|2060597|FG001|Overall Study|Withdrawal by Subject|4
1030897|NCT01668667|2060598|FG002|Overall Study|Withdrawal by Subject|5
1030898|NCT01668667|2060599|FG003|Overall Study|Withdrawal by Subject|5
1030899|NCT01668719|2060612|FG000|Phase I|On treatment|1
1030900|NCT01668719|2060613|FG001|Phase I|On treatment|0
1030901|NCT01668719|2060614|FG002|Phase I|On treatment|0
1030902|NCT01668719|2060612|FG000|Phase I|Adverse Event|2
1030903|NCT01668719|2060613|FG001|Phase I|Adverse Event|0
1030904|NCT01668719|2060614|FG002|Phase I|Adverse Event|0
1030905|NCT01668719|2060612|FG000|Phase I|Progression/relapse|1
1030906|NCT01668719|2060613|FG001|Phase I|Progression/relapse|0
1030907|NCT01668719|2060614|FG002|Phase I|Progression/relapse|0
1030908|NCT01668719|2060612|FG000|Phase I|not protocol specified|2
1030909|NCT01668719|2060613|FG001|Phase I|not protocol specified|0
1030910|NCT01668719|2060614|FG002|Phase I|not protocol specified|0
1030911|NCT01668719|2060612|FG000|Phase II|On treatment|0
1030912|NCT01668719|2060613|FG001|Phase II|On treatment|4
1030913|NCT01668719|2060614|FG002|Phase II|On treatment|3
1030914|NCT01668719|2060612|FG000|Phase II|Adverse Event|0
1030915|NCT01668719|2060613|FG001|Phase II|Adverse Event|18
1030916|NCT01668719|2060614|FG002|Phase II|Adverse Event|18
1030917|NCT01668719|2060612|FG000|Phase II|Refusal unrelated to adverse event|0
1030918|NCT01668719|2060613|FG001|Phase II|Refusal unrelated to adverse event|4
1030919|NCT01668719|2060614|FG002|Phase II|Refusal unrelated to adverse event|1
1030920|NCT01668719|2060612|FG000|Phase II|Progression/relapse|0
1030921|NCT01668719|2060613|FG001|Phase II|Progression/relapse|13
1030922|NCT01668719|2060614|FG002|Phase II|Progression/relapse|17
1030923|NCT01668719|2060612|FG000|Phase II|Death|0
1030924|NCT01668719|2060613|FG001|Phase II|Death|0
1030925|NCT01668719|2060614|FG002|Phase II|Death|2
1030926|NCT01668719|2060612|FG000|Phase II|not protocol specified|0
1030927|NCT01668719|2060613|FG001|Phase II|not protocol specified|13
1030928|NCT01668719|2060614|FG002|Phase II|not protocol specified|7
1030929|NCT01668784|2060626|FG000|Randomized (Pre-treatment)|Disease Progression|0
1030930|NCT01668784|2060627|FG001|Randomized (Pre-treatment)|Disease Progression|1
1030931|NCT01668784|2060626|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
1030932|NCT01668784|2060627|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
1030933|NCT01668784|2060626|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1
1030934|NCT01668784|2060627|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8
1030935|NCT01668784|2060626|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1
1030936|NCT01668784|2060627|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0
1030937|NCT01668784|2060626|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
1030938|NCT01668784|2060627|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
1030939|NCT01668784|2060626|FG000|Randomized (Pre-treatment)|Other|0
1030940|NCT01668784|2060627|FG001|Randomized (Pre-treatment)|Other|1
1030941|NCT01668784|2060626|FG000|Treated (Overall)|Disease Progression|285
1030942|NCT01668784|2060627|FG001|Treated (Overall)|Disease Progression|273
1030943|NCT01668784|2060626|FG000|Treated (Overall)|Study Drug Toxicity|35
1030944|NCT01668784|2060627|FG001|Treated (Overall)|Study Drug Toxicity|53
1030945|NCT01668784|2060626|FG000|Treated (Overall)|Death|1
1030946|NCT01668784|2060627|FG001|Treated (Overall)|Death|1
1030947|NCT01668784|2060626|FG000|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
1030948|NCT01668784|2060627|FG001|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
1030949|NCT01668784|2060626|FG000|Treated (Overall)|Request to Discontinue Study Treatment|5
1030950|NCT01668784|2060627|FG001|Treated (Overall)|Request to Discontinue Study Treatment|18
1030951|NCT01668784|2060626|FG000|Treated (Overall)|Withdrawal by Subject|2
1030952|NCT01668784|2060627|FG001|Treated (Overall)|Withdrawal by Subject|3
1030953|NCT01668784|2060626|FG000|Treated (Overall)|Maximal Clinical Benefit|2
1030954|NCT01668784|2060627|FG001|Treated (Overall)|Maximal Clinical Benefit|3
1030955|NCT01668784|2060626|FG000|Treated (Overall)|Other|0
1030956|NCT01668784|2060627|FG001|Treated (Overall)|Other|4
1030957|NCT01668797|2060635|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3
1030958|NCT01668797|2060636|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0
1030959|NCT01668797|2060637|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0
1030960|NCT01668797|2060638|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0
1030961|NCT01668797|2060635|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
1030962|NCT01668797|2060636|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1030963|NCT01668797|2060637|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1030964|NCT01668797|2060638|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1030965|NCT01668797|2060635|FG000|Phase A (Conversion Phase)|Physician Decision|2
1030966|NCT01668797|2060636|FG001|Phase A (Conversion Phase)|Physician Decision|0
1030967|NCT01668797|2060637|FG002|Phase A (Conversion Phase)|Physician Decision|0
1030968|NCT01668797|2060638|FG003|Phase A (Conversion Phase)|Physician Decision|0
1030969|NCT01668797|2060635|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16
1030970|NCT01668797|2060636|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0
1030971|NCT01668797|2060637|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0
1030972|NCT01668797|2060638|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0
1030973|NCT01668797|2060635|FG000|Phase A (Conversion Phase)|Protocol Violation|2
1030974|NCT01668797|2060636|FG001|Phase A (Conversion Phase)|Protocol Violation|0
1030975|NCT01668797|2060637|FG002|Phase A (Conversion Phase)|Protocol Violation|0
1030976|NCT01668797|2060638|FG003|Phase A (Conversion Phase)|Protocol Violation|0
1030977|NCT01668797|2060635|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7
1030978|NCT01668797|2060636|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0
1030979|NCT01668797|2060637|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0
1030980|NCT01668797|2060638|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0
1030981|NCT01668797|2060635|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
1030982|NCT01668797|2060636|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1030983|NCT01668797|2060637|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1030984|NCT01668797|2060638|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1030985|NCT01668797|2060635|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
1030986|NCT01668797|2060636|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1030987|NCT01668797|2060637|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1030988|NCT01668797|2060638|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1030989|NCT01668797|2060635|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0
1030990|NCT01668797|2060636|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16
1030991|NCT01668797|2060637|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0
1030992|NCT01668797|2060638|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0
1030993|NCT01668797|2060635|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1030994|NCT01668797|2060636|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
1030995|NCT01668797|2060637|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1030996|NCT01668797|2060638|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1030997|NCT01668797|2060635|FG000|Phase B (Stabilization Phase)|Physician Decision|0
1030998|NCT01668797|2060636|FG001|Phase B (Stabilization Phase)|Physician Decision|11
1030999|NCT01668797|2060637|FG002|Phase B (Stabilization Phase)|Physician Decision|0
1031000|NCT01668797|2060638|FG003|Phase B (Stabilization Phase)|Physician Decision|0
1031001|NCT01668797|2060635|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1031002|NCT01668797|2060636|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60
1031003|NCT01668797|2060637|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1031004|NCT01668797|2060638|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1031005|NCT01668797|2060635|FG000|Phase B (Stabilization Phase)|Protocol Violation|0
1031006|NCT01668797|2060636|FG001|Phase B (Stabilization Phase)|Protocol Violation|3
1031007|NCT01668797|2060637|FG002|Phase B (Stabilization Phase)|Protocol Violation|0
1031008|NCT01668797|2060638|FG003|Phase B (Stabilization Phase)|Protocol Violation|0
1031009|NCT01668797|2060635|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0
1031010|NCT01668797|2060636|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21
1031011|NCT01668797|2060637|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0
1031012|NCT01668797|2060638|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0
1031013|NCT01668797|2060635|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1031014|NCT01668797|2060636|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
1031015|NCT01668797|2060637|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1031016|NCT01668797|2060638|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1031017|NCT01668797|2060635|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1031018|NCT01668797|2060636|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
1031019|NCT01668797|2060637|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1031020|NCT01668797|2060638|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1031021|NCT01668797|2060635|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
1031022|NCT01668797|2060636|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
1031023|NCT01668797|2060637|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
1031024|NCT01668797|2060638|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
1031025|NCT01668797|2060635|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
1031026|NCT01668797|2060636|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
1031027|NCT01668797|2060637|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
1031028|NCT01668797|2060638|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
1031029|NCT01668797|2060635|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
1031030|NCT01668797|2060636|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
1031031|NCT01668797|2060637|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
1031032|NCT01668797|2060638|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
1031033|NCT01668797|2060635|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
1031034|NCT01668797|2060636|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
1031035|NCT01668797|2060637|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
1031036|NCT01668797|2060638|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
1031037|NCT01668797|2060635|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1031038|NCT01668797|2060636|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1031039|NCT01668797|2060637|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
1031040|NCT01668797|2060638|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1031041|NCT01668797|2060635|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
1031042|NCT01668797|2060636|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
1162023|NCT03380429|2283931|FG004|Overall Study|Lack of Efficacy|1
1031043|NCT01668797|2060637|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
1031044|NCT01668797|2060638|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
1031045|NCT01668797|2060635|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
1031046|NCT01668797|2060636|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
1031047|NCT01668797|2060637|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
1031048|NCT01668797|2060638|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
1031049|NCT01668797|2060635|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
1031050|NCT01668797|2060636|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
1031051|NCT01668797|2060637|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
1031052|NCT01668797|2060638|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
1031053|NCT01668797|2060635|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
1031054|NCT01668797|2060636|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
1031055|NCT01668797|2060637|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
1031056|NCT01668797|2060638|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
1031057|NCT01668966|2060668|FG000|Overall Study|Withdrawal by Subject|1
1031058|NCT01668966|2060668|FG000|Overall Study|Death|1
1031059|NCT01668966|2060668|FG000|Overall Study|Not treated|2
1031060|NCT01669122|2060676|FG000|Period I|Lost to Follow-up|1
1031061|NCT01669122|2060676|FG000|Washout Period II|Protocol Violation|2
1031062|NCT01669174|2060689|FG000|Overall Study|Subject withdrew consent|2
1031063|NCT01669174|2060690|FG001|Overall Study|Subject withdrew consent|2
1031064|NCT01669174|2060689|FG000|Overall Study|Lost to Follow-up|1
1031065|NCT01669174|2060690|FG001|Overall Study|Lost to Follow-up|0
1031066|NCT01669174|2060689|FG000|Overall Study|Adverse Event|2
1031067|NCT01669174|2060690|FG001|Overall Study|Adverse Event|2
1031068|NCT01669174|2060689|FG000|Overall Study|Administrative problems|1
1031069|NCT01669174|2060690|FG001|Overall Study|Administrative problems|2
1031070|NCT01669343|2060696|FG000|Part A: All Patients|Withdrawal by Subject|7
1031071|NCT01669343|2060696|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2
1031072|NCT01669343|2060696|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13
1031073|NCT01669343|2060696|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3
1031074|NCT01669343|2060696|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1
1031075|NCT01669421|2060703|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
1031076|NCT01669421|2060703|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1
1031077|NCT01669577|2060735|FG000|Overall Study|Death|22
1031078|NCT01669577|2060735|FG000|Overall Study|Lost to Follow-up|78
1031079|NCT01669577|2060735|FG000|Overall Study|Physician Decision|34
1031080|NCT01669629|2060748|FG000|Period 1|protocol deviation|1
1031081|NCT01669629|2060749|FG001|Period 1|protocol deviation|2
1031082|NCT01669798|2060805|FG000|Overall Study|Physician Decision|5
1031083|NCT01669811|2060811|FG000|Overall Study|Investigator decision|0
1031084|NCT01669811|2060812|FG001|Overall Study|Investigator decision|1
1031085|NCT01669811|2060811|FG000|Overall Study|Withdrawal by Subject|1
1031086|NCT01669811|2060812|FG001|Overall Study|Withdrawal by Subject|2
1031087|NCT01669811|2060811|FG000|Overall Study|Adverse Event|2
1031088|NCT01669811|2060812|FG001|Overall Study|Adverse Event|6
1031089|NCT01669811|2060811|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
1031090|NCT01669811|2060812|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2
1031091|NCT01669902|2060823|FG000|Overall Study|Adverse Event|11
1031092|NCT01669902|2060823|FG000|Overall Study|Lack of Efficacy|10
1031093|NCT01669902|2060823|FG000|Overall Study|Other|8
1031094|NCT01669928|2060829|FG000|First Intervention|Withdrawal by Subject|3
1031095|NCT01669928|2060830|FG001|First Intervention|Withdrawal by Subject|5
1031096|NCT01670019|2060840|FG000|Overall Study|Adverse Event|3
1031097|NCT01670019|2060841|FG001|Overall Study|Adverse Event|0
1031098|NCT01670019|2060840|FG000|Overall Study|Withdrawal by Subject|6
1031099|NCT01670019|2060841|FG001|Overall Study|Withdrawal by Subject|0
1031100|NCT01670045|2060847|FG000|Overall Study|Withdrawal by Subject|3
1031101|NCT01670045|2060847|FG000|Overall Study|Adverse Event|1
1031102|NCT01670045|2060847|FG000|Overall Study|Death|1
1031103|NCT01670045|2060847|FG000|Overall Study|Lost to Follow-up|11
1031104|NCT01670097|2060853|FG000|Overall Study|Started Phase 1 cancer treatment|1
1031105|NCT01670097|2060854|FG001|Overall Study|Started Phase 1 cancer treatment|0
1031106|NCT01670097|2060853|FG000|Overall Study|Study burden|1
1031107|NCT01670097|2060854|FG001|Overall Study|Study burden|0
1031108|NCT01670097|2060853|FG000|Overall Study|COPD exacerbation|0
1031109|NCT01670097|2060854|FG001|Overall Study|COPD exacerbation|1
1031110|NCT01670097|2060853|FG000|Overall Study|Neutropenia|0
1031111|NCT01670097|2060854|FG001|Overall Study|Neutropenia|1
1031112|NCT01670097|2060853|FG000|Overall Study|Clinical deterioration|0
1031113|NCT01670097|2060854|FG001|Overall Study|Clinical deterioration|1
1031114|NCT01670097|2060853|FG000|Overall Study|Disease progression|0
1031115|NCT01670097|2060854|FG001|Overall Study|Disease progression|1
1031116|NCT01670188|2060871|FG000|Overall Study|Death|0
1031117|NCT01670188|2060872|FG001|Overall Study|Death|1
1031118|NCT01670279|2060885|FG000|Overall Study|Adverse Event|0
1031119|NCT01670279|2060886|FG001|Overall Study|Adverse Event|1
1031120|NCT01670279|2060887|FG002|Overall Study|Adverse Event|0
1031121|NCT01670279|2060888|FG003|Overall Study|Adverse Event|0
1031122|NCT01670279|2060885|FG000|Overall Study|Physician Decision|0
1031123|NCT01670279|2060886|FG001|Overall Study|Physician Decision|1
1031124|NCT01670279|2060887|FG002|Overall Study|Physician Decision|0
1031125|NCT01670279|2060888|FG003|Overall Study|Physician Decision|0
1031126|NCT01670279|2060885|FG000|Overall Study|Participant met withdrawal criteria|0
1031127|NCT01670279|2060886|FG001|Overall Study|Participant met withdrawal criteria|0
1031128|NCT01670279|2060887|FG002|Overall Study|Participant met withdrawal criteria|0
1031129|NCT01670279|2060888|FG003|Overall Study|Participant met withdrawal criteria|1
1031130|NCT01670292|2060896|FG000|Overall Study|Lost to Follow-up|14
1031131|NCT01670500|2060919|FG000|Overall Study|Withdrawal by Subject|1
1031132|NCT01670500|2060920|FG001|Overall Study|Withdrawal by Subject|0
1031133|NCT01670526|2060928|FG000|Overall Study|Withdrawal by Subject|3
1031134|NCT01670526|2060929|FG001|Overall Study|Withdrawal by Subject|1
1031135|NCT01670526|2060928|FG000|Overall Study|Lost to Follow-up|9
1031136|NCT01670526|2060929|FG001|Overall Study|Lost to Follow-up|5
1031137|NCT01670656|2060940|FG000|Overall Study|Non-compliance with study drug|0
1031138|NCT01670656|2060941|FG001|Overall Study|Non-compliance with study drug|0
1031139|NCT01670656|2060942|FG002|Overall Study|Non-compliance with study drug|3
1031140|NCT01670656|2060943|FG003|Overall Study|Non-compliance with study drug|0
1031141|NCT01670656|2060944|FG004|Overall Study|Non-compliance with study drug|1
1031142|NCT01670656|2060940|FG000|Overall Study|Pregnancy|0
1031143|NCT01670656|2060941|FG001|Overall Study|Pregnancy|0
1031144|NCT01670656|2060942|FG002|Overall Study|Pregnancy|0
1031145|NCT01670656|2060943|FG003|Overall Study|Pregnancy|0
1031146|NCT01670656|2060944|FG004|Overall Study|Pregnancy|1
1031147|NCT01670656|2060940|FG000|Overall Study|Withdrawal by Subject|1
1031148|NCT01670656|2060941|FG001|Overall Study|Withdrawal by Subject|1
1031149|NCT01670656|2060942|FG002|Overall Study|Withdrawal by Subject|0
1031150|NCT01670656|2060943|FG003|Overall Study|Withdrawal by Subject|0
1031151|NCT01670656|2060944|FG004|Overall Study|Withdrawal by Subject|0
1031152|NCT01670656|2060940|FG000|Overall Study|Non-compliance with protocol|0
1031153|NCT01670656|2060941|FG001|Overall Study|Non-compliance with protocol|3
1031154|NCT01670656|2060942|FG002|Overall Study|Non-compliance with protocol|1
1031155|NCT01670656|2060943|FG003|Overall Study|Non-compliance with protocol|1
1031156|NCT01670656|2060944|FG004|Overall Study|Non-compliance with protocol|2
1031157|NCT01670656|2060940|FG000|Overall Study|Adverse Event|2
1031158|NCT01670656|2060941|FG001|Overall Study|Adverse Event|2
1031159|NCT01670656|2060942|FG002|Overall Study|Adverse Event|2
1031160|NCT01670656|2060943|FG003|Overall Study|Adverse Event|3
1031161|NCT01670656|2060944|FG004|Overall Study|Adverse Event|3
1031162|NCT01670656|2060940|FG000|Overall Study|Subject withdrew consent|0
1031163|NCT01670656|2060941|FG001|Overall Study|Subject withdrew consent|1
1031164|NCT01670656|2060942|FG002|Overall Study|Subject withdrew consent|2
1031165|NCT01670656|2060943|FG003|Overall Study|Subject withdrew consent|1
1031166|NCT01670656|2060944|FG004|Overall Study|Subject withdrew consent|1
1031167|NCT01670656|2060940|FG000|Overall Study|Lost to Follow-up|0
1031168|NCT01670656|2060941|FG001|Overall Study|Lost to Follow-up|0
1031169|NCT01670656|2060942|FG002|Overall Study|Lost to Follow-up|0
1031170|NCT01670656|2060943|FG003|Overall Study|Lost to Follow-up|0
1031171|NCT01670656|2060944|FG004|Overall Study|Lost to Follow-up|3
1031172|NCT01670656|2060940|FG000|Overall Study|Subject moved|0
1031173|NCT01670656|2060941|FG001|Overall Study|Subject moved|0
1031174|NCT01670656|2060942|FG002|Overall Study|Subject moved|0
1031175|NCT01670656|2060943|FG003|Overall Study|Subject moved|1
1031176|NCT01670656|2060944|FG004|Overall Study|Subject moved|0
1031177|NCT01670721|2060956|FG000|Overall Study|Participant's decision|15
1031178|NCT01670721|2060956|FG000|Overall Study|Other than specified above|38
1031179|NCT01671007|2060984|FG000|Overall Study|Other reasons than listed|166
1031180|NCT01671007|2060985|FG001|Overall Study|Other reasons than listed|373
1031181|NCT01671007|2060986|FG002|Overall Study|Other reasons than listed|197
1031182|NCT01671007|2060987|FG003|Overall Study|Other reasons than listed|228
1031183|NCT01671007|2060988|FG004|Overall Study|Other reasons than listed|14
1031184|NCT01671007|2060989|FG005|Overall Study|Other reasons than listed|71
1031185|NCT01671007|2060990|FG006|Overall Study|Other reasons than listed|17
1031186|NCT01671007|2060991|FG007|Overall Study|Other reasons than listed|66
1031187|NCT01671007|2060992|FG008|Overall Study|Other reasons than listed|0
1031188|NCT01671007|2060984|FG000|Overall Study|Withdrawal by Subject|36
1031189|NCT01671007|2060985|FG001|Overall Study|Withdrawal by Subject|59
1031190|NCT01671007|2060986|FG002|Overall Study|Withdrawal by Subject|53
1031191|NCT01671007|2060987|FG003|Overall Study|Withdrawal by Subject|58
1031192|NCT01671007|2060988|FG004|Overall Study|Withdrawal by Subject|4
1031193|NCT01671007|2060989|FG005|Overall Study|Withdrawal by Subject|15
1031194|NCT01671007|2060990|FG006|Overall Study|Withdrawal by Subject|1
1031195|NCT01671007|2060991|FG007|Overall Study|Withdrawal by Subject|19
1031196|NCT01671007|2060992|FG008|Overall Study|Withdrawal by Subject|0
1031197|NCT01671007|2060984|FG000|Overall Study|Lost to Follow-up|93
1031198|NCT01671007|2060985|FG001|Overall Study|Lost to Follow-up|142
1031199|NCT01671007|2060986|FG002|Overall Study|Lost to Follow-up|91
1031200|NCT01671007|2060987|FG003|Overall Study|Lost to Follow-up|63
1031201|NCT01671007|2060988|FG004|Overall Study|Lost to Follow-up|7
1031202|NCT01671007|2060989|FG005|Overall Study|Lost to Follow-up|20
1031203|NCT01671007|2060990|FG006|Overall Study|Lost to Follow-up|2
1031204|NCT01671007|2060991|FG007|Overall Study|Lost to Follow-up|28
1031205|NCT01671007|2060992|FG008|Overall Study|Lost to Follow-up|0
1031206|NCT01671007|2060984|FG000|Overall Study|No end of study case report form|3
1031207|NCT01671007|2060985|FG001|Overall Study|No end of study case report form|1
1031208|NCT01671007|2060986|FG002|Overall Study|No end of study case report form|0
1031209|NCT01671007|2060987|FG003|Overall Study|No end of study case report form|2
1031210|NCT01671007|2060988|FG004|Overall Study|No end of study case report form|0
1031211|NCT01671007|2060989|FG005|Overall Study|No end of study case report form|0
1031212|NCT01671007|2060990|FG006|Overall Study|No end of study case report form|0
1031213|NCT01671007|2060991|FG007|Overall Study|No end of study case report form|0
1031214|NCT01671007|2060992|FG008|Overall Study|No end of study case report form|0
1031215|NCT01671007|2060984|FG000|Overall Study|Not eligible|23
1031216|NCT01671007|2060985|FG001|Overall Study|Not eligible|76
1031217|NCT01671007|2060986|FG002|Overall Study|Not eligible|25
1031218|NCT01671007|2060987|FG003|Overall Study|Not eligible|17
1031219|NCT01671007|2060988|FG004|Overall Study|Not eligible|0
1031220|NCT01671007|2060989|FG005|Overall Study|Not eligible|6
1031221|NCT01671007|2060990|FG006|Overall Study|Not eligible|1
1031222|NCT01671007|2060991|FG007|Overall Study|Not eligible|19
1031223|NCT01671007|2060992|FG008|Overall Study|Not eligible|0
1031224|NCT01671059|2061003|FG000|Overall Study|Adverse Event|4
1031225|NCT01671059|2061003|FG000|Overall Study|Lack of Efficacy|1
1031226|NCT01671085|2061010|FG000|Overall Study|Withdrawal by Subject|1
1031227|NCT01671085|2061011|FG001|Overall Study|Withdrawal by Subject|0
1031228|NCT01671111|2061018|FG000|Overall Study|Adverse Event|2
1031229|NCT01671111|2061018|FG000|Overall Study|Lack of Efficacy|1
1031230|NCT01671111|2061018|FG000|Overall Study|Withdrawal by Subject|2
1031231|NCT01671111|2061018|FG000|Overall Study|Physician Decision|1
1031232|NCT01671111|2061018|FG000|Overall Study|Other|24
1031233|NCT01671280|2061026|FG000|Overall Study|Withdrawal by Subject|2
1031234|NCT01671319|2061039|FG000|Overall Study|Withdrawal by Subject|1
1031235|NCT01671332|2061045|FG000|Overall Study|Withdrawal by Subject|1
1031236|NCT01671332|2061046|FG001|Overall Study|Withdrawal by Subject|1
1031237|NCT01671345|2061054|FG000|Overall Study|Lost to Follow-up|10
1031238|NCT01671345|2061055|FG001|Overall Study|Lost to Follow-up|6
1031239|NCT01671345|2061054|FG000|Overall Study|visit with non-participating physician|3
1031240|NCT01671345|2061055|FG001|Overall Study|visit with non-participating physician|3
1031241|NCT01671488|2061073|FG000|Overall Study|Withdrawal by Subject|1
1031242|NCT01671748|2061088|FG000|4 Week run-in Phase|Withdrawal by Subject|1
1031243|NCT01671748|2061089|FG001|4 Week run-in Phase|Withdrawal by Subject|0
1031244|NCT01671748|2061088|FG000|4 Week run-in Phase|Adverse Event|1
1031245|NCT01671748|2061089|FG001|4 Week run-in Phase|Adverse Event|0
1031246|NCT01671748|2061088|FG000|4 Week run-in Phase|Not eligible|9
1031247|NCT01671748|2061089|FG001|4 Week run-in Phase|Not eligible|0
1031248|NCT01672294|2061113|FG000|Overall Study|Withdrawal by Subject|4
1031249|NCT01672294|2061114|FG001|Overall Study|Withdrawal by Subject|4
1031250|NCT01672294|2061115|FG002|Overall Study|Withdrawal by Subject|4
1031251|NCT01672294|2061116|FG003|Overall Study|Withdrawal by Subject|4
1031252|NCT01672294|2061113|FG000|Overall Study|Excluded by study|1
1031253|NCT01672294|2061114|FG001|Overall Study|Excluded by study|1
1031254|NCT01672294|2061115|FG002|Overall Study|Excluded by study|0
1031255|NCT01672294|2061116|FG003|Overall Study|Excluded by study|0
1031256|NCT01672294|2061113|FG000|Overall Study|Lost to Follow-up|1
1031257|NCT01672294|2061114|FG001|Overall Study|Lost to Follow-up|16
1031258|NCT01672294|2061115|FG002|Overall Study|Lost to Follow-up|7
1031259|NCT01672294|2061116|FG003|Overall Study|Lost to Follow-up|9
1031260|NCT01672710|2061137|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
1031261|NCT01672710|2061138|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
1031262|NCT01672710|2061137|FG000|3 Month Follow up|Lost to Follow-up|2
1031263|NCT01672710|2061138|FG001|3 Month Follow up|Lost to Follow-up|3
1031264|NCT01672710|2061137|FG000|3 Month Follow up|follow up due after termination date|4
1031265|NCT01672710|2061138|FG001|3 Month Follow up|follow up due after termination date|1
1031266|NCT01672723|2061144|FG000|First Intervention|Adverse Event|3
1031267|NCT01672723|2061145|FG001|First Intervention|Adverse Event|0
1031268|NCT01672736|2061151|FG000|Overall Study|Available drug expired on 31 May 16|3
1031269|NCT01672788|2061155|FG000|Washout Period 2 (7 Days)|Adverse Event|0
1031270|NCT01672788|2061156|FG001|Washout Period 2 (7 Days)|Adverse Event|0
1031271|NCT01672788|2061157|FG002|Washout Period 2 (7 Days)|Adverse Event|0
1031272|NCT01672788|2061158|FG003|Washout Period 2 (7 Days)|Adverse Event|1
1031273|NCT01672801|2061170|FG000|Overall Study|Screen Failure|0
1031274|NCT01672801|2061171|FG001|Overall Study|Screen Failure|1
1031275|NCT01672853|2061186|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0
1031276|NCT01672853|2061187|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4
1031277|NCT01672853|2061188|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0
1031278|NCT01672853|2061186|FG000|Overall Study|Pregnancy|0
1031279|NCT01672853|2061187|FG001|Overall Study|Pregnancy|1
1031280|NCT01672853|2061188|FG002|Overall Study|Pregnancy|0
1031281|NCT01672853|2061186|FG000|Overall Study|Investigator's Discretion|1
1031282|NCT01672853|2061187|FG001|Overall Study|Investigator's Discretion|0
1031283|NCT01672853|2061188|FG002|Overall Study|Investigator's Discretion|0
1031284|NCT01672853|2061186|FG000|Overall Study|Withdrew Consent|5
1031285|NCT01672853|2061187|FG001|Overall Study|Withdrew Consent|5
1031286|NCT01672853|2061188|FG002|Overall Study|Withdrew Consent|5
1031287|NCT01672853|2061186|FG000|Overall Study|Adverse Event|4
1031288|NCT01672853|2061187|FG001|Overall Study|Adverse Event|6
1031289|NCT01672853|2061188|FG002|Overall Study|Adverse Event|8
1031290|NCT01672853|2061186|FG000|Overall Study|Lost to Follow-up|0
1031291|NCT01672853|2061187|FG001|Overall Study|Lost to Follow-up|1
1031292|NCT01672853|2061188|FG002|Overall Study|Lost to Follow-up|0
1031293|NCT01672853|2061186|FG000|Overall Study|Randomized but Never Treated|0
1031294|NCT01672853|2061187|FG001|Overall Study|Randomized but Never Treated|0
1031295|NCT01672853|2061188|FG002|Overall Study|Randomized but Never Treated|1
1031296|NCT01672866|2061199|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
1031297|NCT01672866|2061200|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
1031298|NCT01672866|2061201|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
1031299|NCT01672866|2061199|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
1031300|NCT01672866|2061200|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
1031301|NCT01672866|2061201|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
1031302|NCT01672866|2061199|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
1031303|NCT01672866|2061200|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
1031304|NCT01672866|2061201|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
1031305|NCT01672866|2061199|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3
1031306|NCT01672866|2061200|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3
1031307|NCT01672866|2061201|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3
1031308|NCT01672866|2061199|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
1031309|NCT01672866|2061200|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
1031310|NCT01672866|2061201|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
1031311|NCT01672866|2061199|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
1031312|NCT01672866|2061200|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
1031313|NCT01672866|2061201|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
1031314|NCT01672866|2061199|FG000|Blinded Phase (up to 240 Weeks)|Death|0
1031315|NCT01672866|2061200|FG001|Blinded Phase (up to 240 Weeks)|Death|0
1031316|NCT01672866|2061201|FG002|Blinded Phase (up to 240 Weeks)|Death|1
1031317|NCT01672866|2061199|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
1031318|NCT01672866|2061200|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
1031319|NCT01672866|2061201|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
1031320|NCT01672866|2061199|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
1031321|NCT01672866|2061200|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
1031322|NCT01672866|2061201|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
1031323|NCT01672866|2061199|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
1031324|NCT01672866|2061200|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
1031325|NCT01672866|2061201|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
1031326|NCT01672866|2061199|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
1031327|NCT01672866|2061200|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
1031328|NCT01672866|2061201|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
1031329|NCT01672866|2061199|FG000|Open-Label Phase (up to 240 Weeks)|Death|1
1031330|NCT01672866|2061200|FG001|Open-Label Phase (up to 240 Weeks)|Death|0
1031331|NCT01672866|2061201|FG002|Open-Label Phase (up to 240 Weeks)|Death|0
1031332|NCT01672866|2061199|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
1031333|NCT01672866|2061200|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
1031334|NCT01672866|2061201|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
1031335|NCT01672879|2061214|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
1031336|NCT01672879|2061215|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
1031337|NCT01672879|2061216|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
1031338|NCT01672879|2061214|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
1031339|NCT01672879|2061215|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
1031340|NCT01672879|2061216|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
1031341|NCT01672879|2061214|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
1031342|NCT01672879|2061215|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
1031343|NCT01672879|2061216|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
1031344|NCT01672879|2061214|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
1031345|NCT01672879|2061215|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
1031346|NCT01672879|2061216|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
1031347|NCT01672879|2061214|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
1031348|NCT01672879|2061215|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
1031349|NCT01672879|2061216|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
1031350|NCT01672879|2061214|FG000|Blinded Phase (Up to 240 Weeks)|Death|0
1031351|NCT01672879|2061215|FG001|Blinded Phase (Up to 240 Weeks)|Death|2
1031352|NCT01672879|2061216|FG002|Blinded Phase (Up to 240 Weeks)|Death|0
1031353|NCT01672879|2061214|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1
1031354|NCT01672879|2061215|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0
1031355|NCT01672879|2061216|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0
1031356|NCT01672879|2061214|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
1031357|NCT01672879|2061215|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
1031358|NCT01672879|2061216|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
1031359|NCT01672879|2061214|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
1031360|NCT01672879|2061215|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
1031361|NCT01672879|2061216|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
1031362|NCT01672879|2061214|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
1031363|NCT01672879|2061215|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
1031364|NCT01672879|2061216|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
1031365|NCT01672879|2061214|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
1031366|NCT01672879|2061215|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
1031367|NCT01672879|2061216|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
1031368|NCT01672879|2061214|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
1031369|NCT01672879|2061215|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
1031370|NCT01672879|2061216|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
1031371|NCT01672879|2061214|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
1031372|NCT01672879|2061215|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
1031373|NCT01672879|2061216|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
1031374|NCT01672892|2061227|FG000|Overall Study|Protocol Violation|7
1031375|NCT01672892|2061228|FG001|Overall Study|Protocol Violation|3
1031376|NCT01672957|2061237|FG000|Overall Study|Protocol Violation|48
1031377|NCT01672957|2061237|FG000|Overall Study|Death|2
1031378|NCT01672957|2061237|FG000|Overall Study|ICF Signed After Transplantation|5
1031379|NCT01672970|2061241|FG000|Overall Study|Lack of Efficacy|12
1031380|NCT01672970|2061241|FG000|Overall Study|Adverse Event|18
1031381|NCT01672970|2061241|FG000|Overall Study|Withdrawal by Subject|2
1031382|NCT01672970|2061241|FG000|Overall Study|Lost to Follow-up|5
1031383|NCT01672970|2061241|FG000|Overall Study|Other|9
1031384|NCT01672970|2061241|FG000|Overall Study|Enrolled but not treated|1
1031385|NCT01673009|2061303|FG000|Overall Study|Physician Decision|5
1031386|NCT01673009|2061303|FG000|Overall Study|Withdrawal by Subject|8
1031387|NCT01673126|2061323|FG000|Overall Study|change of diagnosis|4
1031388|NCT01673126|2061324|FG001|Overall Study|change of diagnosis|3
1031389|NCT01673178|2061335|FG000|Overall Study|Lost to Follow-up|0
1031390|NCT01673178|2061336|FG001|Overall Study|Lost to Follow-up|1
1031391|NCT01673178|2061337|FG002|Overall Study|Lost to Follow-up|0
1031392|NCT01673178|2061338|FG003|Overall Study|Lost to Follow-up|0
1031393|NCT01673178|2061339|FG004|Overall Study|Lost to Follow-up|0
1031394|NCT01673178|2061335|FG000|Overall Study|Withdrawal by Subject|0
1031395|NCT01673178|2061336|FG001|Overall Study|Withdrawal by Subject|0
1031396|NCT01673178|2061337|FG002|Overall Study|Withdrawal by Subject|1
1031397|NCT01673178|2061338|FG003|Overall Study|Withdrawal by Subject|4
1031398|NCT01673178|2061339|FG004|Overall Study|Withdrawal by Subject|2
1031399|NCT01673178|2061335|FG000|Overall Study|Protocol Violation|1
1031400|NCT01673178|2061336|FG001|Overall Study|Protocol Violation|1
1031401|NCT01673178|2061337|FG002|Overall Study|Protocol Violation|0
1031402|NCT01673178|2061338|FG003|Overall Study|Protocol Violation|1
1031403|NCT01673178|2061339|FG004|Overall Study|Protocol Violation|0
1031404|NCT01673178|2061335|FG000|Overall Study|Adverse Event|1
1031405|NCT01673178|2061336|FG001|Overall Study|Adverse Event|0
1031406|NCT01673178|2061337|FG002|Overall Study|Adverse Event|0
1031407|NCT01673178|2061338|FG003|Overall Study|Adverse Event|2
1031408|NCT01673178|2061339|FG004|Overall Study|Adverse Event|0
1031409|NCT01673178|2061335|FG000|Overall Study|Other|1
1031410|NCT01673178|2061336|FG001|Overall Study|Other|0
1031411|NCT01673178|2061337|FG002|Overall Study|Other|2
1031412|NCT01673178|2061338|FG003|Overall Study|Other|1
1031413|NCT01673178|2061339|FG004|Overall Study|Other|0
1031414|NCT01673282|2061370|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9
1031415|NCT01673282|2061371|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5
1031416|NCT01673282|2061370|FG000|Overall Study|Lack of Efficacy|9
1031417|NCT01673282|2061371|FG001|Overall Study|Lack of Efficacy|2
1031418|NCT01673282|2061370|FG000|Overall Study|Lost to Follow-up|11
1031419|NCT01673282|2061371|FG001|Overall Study|Lost to Follow-up|10
1031420|NCT01673282|2061370|FG000|Overall Study|Withdrawal by Subject|3
1031421|NCT01673282|2061371|FG001|Overall Study|Withdrawal by Subject|3
1031422|NCT01673282|2061370|FG000|Overall Study|Other|1
1031423|NCT01673282|2061371|FG001|Overall Study|Other|6
1031424|NCT01673347|2061377|FG000|Overall Study|failure of allograft|7
1031425|NCT01673373|2061381|FG000|Overall Study|Death|2
1031426|NCT01673386|2061385|FG000|Overall Study|Study terminated by sponsor|16
1031427|NCT01673386|2061386|FG001|Overall Study|Study terminated by sponsor|22
1031428|NCT01673386|2061385|FG000|Overall Study|Adverse Event|5
1031429|NCT01673386|2061386|FG001|Overall Study|Adverse Event|2
1031430|NCT01673386|2061385|FG000|Overall Study|Progressive disease|4
1031431|NCT01673386|2061386|FG001|Overall Study|Progressive disease|1
1031432|NCT01673386|2061385|FG000|Overall Study|Withdrawal by Subject|0
1031433|NCT01673386|2061386|FG001|Overall Study|Withdrawal by Subject|2
1031434|NCT01673490|2061392|FG000|Overall Study|Lost to Follow-up|1
1031435|NCT01673490|2061392|FG000|Overall Study|Adverse Event|3
1031436|NCT01673490|2061392|FG000|Overall Study|Withdrawal by Subject|3
1031437|NCT01673594|2061407|FG000|Overall Study|Adverse Event|3
1031438|NCT01673594|2061408|FG001|Overall Study|Adverse Event|1
1031439|NCT01673594|2061407|FG000|Overall Study|Lost to Follow-up|1
1031440|NCT01673594|2061408|FG001|Overall Study|Lost to Follow-up|0
1031441|NCT01673594|2061407|FG000|Overall Study|Physician Decision|2
1031442|NCT01673594|2061408|FG001|Overall Study|Physician Decision|4
1031443|NCT01673594|2061407|FG000|Overall Study|Withdrawal by Subject|0
1031444|NCT01673594|2061408|FG001|Overall Study|Withdrawal by Subject|1
1031445|NCT01673620|2061416|FG000|Overall Study|Adverse Event|1
1031446|NCT01673620|2061417|FG001|Overall Study|Adverse Event|0
1031447|NCT01673646|2061426|FG000|Overall Study|Adverse Event|2
1031448|NCT01673646|2061427|FG001|Overall Study|Adverse Event|1
1031449|NCT01673646|2061428|FG002|Overall Study|Adverse Event|1
1031450|NCT01673646|2061426|FG000|Overall Study|Unsatisfactory therapeutic effect|0
1031451|NCT01673646|2061427|FG001|Overall Study|Unsatisfactory therapeutic effect|2
1031452|NCT01673646|2061428|FG002|Overall Study|Unsatisfactory therapeutic effect|0
1031453|NCT01673646|2061426|FG000|Overall Study|Condition no longer requires study drug|0
1031454|NCT01673646|2061427|FG001|Overall Study|Condition no longer requires study drug|1
1031455|NCT01673646|2061428|FG002|Overall Study|Condition no longer requires study drug|0
1031456|NCT01673646|2061426|FG000|Overall Study|Withdrawal by Subject|0
1031457|NCT01673646|2061427|FG001|Overall Study|Withdrawal by Subject|2
1031458|NCT01673646|2061428|FG002|Overall Study|Withdrawal by Subject|2
1031459|NCT01673646|2061426|FG000|Overall Study|Completed Core/did not enter Ext.|2
1031460|NCT01673646|2061427|FG001|Overall Study|Completed Core/did not enter Ext.|1
1031461|NCT01673646|2061428|FG002|Overall Study|Completed Core/did not enter Ext.|1
1031462|NCT01673698|2061442|FG000|Overall Study|Lost to Follow-up|51
1031463|NCT01673698|2061443|FG001|Overall Study|Lost to Follow-up|13
1031464|NCT01673854|2061463|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
1031465|NCT01673854|2061463|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
1031466|NCT01673854|2061463|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
1031467|NCT01673854|2061463|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
1031468|NCT01673854|2061463|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
1031469|NCT01673854|2061463|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
1031470|NCT01673854|2061463|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
1031471|NCT01673854|2061463|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
1031472|NCT01673854|2061463|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
1031473|NCT01673854|2061463|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
1031474|NCT01673854|2061463|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
1031475|NCT01673854|2061463|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
1031476|NCT01673867|2061469|FG000|Randomization|AE unrelated to study drug|1
1031477|NCT01673867|2061470|FG001|Randomization|AE unrelated to study drug|0
1031478|NCT01673867|2061469|FG000|Randomization|Requested treatment discontinuation|0
1031479|NCT01673867|2061470|FG001|Randomization|Requested treatment discontinuation|4
1031480|NCT01673867|2061469|FG000|Randomization|Withdrawal by Subject|0
1031481|NCT01673867|2061470|FG001|Randomization|Withdrawal by Subject|12
1031482|NCT01673867|2061469|FG000|Randomization|Lost to Follow-up|0
1031483|NCT01673867|2061470|FG001|Randomization|Lost to Follow-up|1
1031484|NCT01673867|2061469|FG000|Randomization|No longer meets criteria|4
1031485|NCT01673867|2061470|FG001|Randomization|No longer meets criteria|5
1031486|NCT01673867|2061469|FG000|Treatment|Disease Progression|194
1031487|NCT01673867|2061470|FG001|Treatment|Disease Progression|179
1031488|NCT01673867|2061469|FG000|Treatment|Study Drug Toxicity|17
1031489|NCT01673867|2061470|FG001|Treatment|Study Drug Toxicity|42
1031490|NCT01673867|2061469|FG000|Treatment|Death|1
1031491|NCT01673867|2061470|FG001|Treatment|Death|1
1031492|NCT01673867|2061469|FG000|Treatment|AE unrelated to study drug|19
1031493|NCT01673867|2061470|FG001|Treatment|AE unrelated to study drug|11
1031494|NCT01673867|2061469|FG000|Treatment|Requested treatment discontinuation|5
1031495|NCT01673867|2061470|FG001|Treatment|Requested treatment discontinuation|16
1031496|NCT01673867|2061469|FG000|Treatment|Withdrawal by Subject|4
1031497|NCT01673867|2061470|FG001|Treatment|Withdrawal by Subject|6
1031498|NCT01673867|2061469|FG000|Treatment|Maximum clinical benefit|0
1031499|NCT01673867|2061470|FG001|Treatment|Maximum clinical benefit|10
1031500|NCT01673867|2061469|FG000|Treatment|No longer meets criteria|2
1031501|NCT01673867|2061470|FG001|Treatment|No longer meets criteria|0
1031502|NCT01673867|2061469|FG000|Treatment|Required steroid therapy|1
1031503|NCT01673867|2061470|FG001|Treatment|Required steroid therapy|0
1031504|NCT01673867|2061469|FG000|Treatment|Health status not improved|1
1031505|NCT01673867|2061470|FG001|Treatment|Health status not improved|0
1031506|NCT01673867|2061469|FG000|Treatment|Required prolonged hospitalization|0
1031507|NCT01673867|2061470|FG001|Treatment|Required prolonged hospitalization|1
1031508|NCT01673867|2061469|FG000|Treatment|Symptomatic deterioration|0
1031509|NCT01673867|2061470|FG001|Treatment|Symptomatic deterioration|1
1031510|NCT01673867|2061469|FG000|Treatment|Physician Decision|0
1031511|NCT01673867|2061470|FG001|Treatment|Physician Decision|1
1031512|NCT01673984|2061490|FG000|Overall Study|Adverse Event|1
1031513|NCT01673984|2061491|FG001|Overall Study|Adverse Event|0
1031514|NCT01673984|2061490|FG000|Overall Study|Study termination|9
1031515|NCT01673984|2061491|FG001|Overall Study|Study termination|6
1031516|NCT01674010|2061497|FG000|Open Treatment Phase 1|Adverse Event|10
1031517|NCT01674010|2061498|FG001|Open Treatment Phase 1|Adverse Event|0
1031518|NCT01674010|2061499|FG002|Open Treatment Phase 1|Adverse Event|0
1031519|NCT01674010|2061497|FG000|Open Treatment Phase 1|Death|1
1031520|NCT01674010|2061498|FG001|Open Treatment Phase 1|Death|0
1031521|NCT01674010|2061499|FG002|Open Treatment Phase 1|Death|0
1031522|NCT01674010|2061497|FG000|Open Treatment Phase 1|Lost to Follow-up|19
1031523|NCT01674010|2061498|FG001|Open Treatment Phase 1|Lost to Follow-up|0
1031524|NCT01674010|2061499|FG002|Open Treatment Phase 1|Lost to Follow-up|0
1031525|NCT01674010|2061497|FG000|Open Treatment Phase 1|Physician Decision|9
1031526|NCT01674010|2061498|FG001|Open Treatment Phase 1|Physician Decision|0
1031527|NCT01674010|2061499|FG002|Open Treatment Phase 1|Physician Decision|0
1031528|NCT01674010|2061497|FG000|Open Treatment Phase 1|Protocol Violation|7
1031529|NCT01674010|2061498|FG001|Open Treatment Phase 1|Protocol Violation|0
1031530|NCT01674010|2061499|FG002|Open Treatment Phase 1|Protocol Violation|0
1031531|NCT01674010|2061497|FG000|Open Treatment Phase 1|Sponsor Decision|79
1031532|NCT01674010|2061498|FG001|Open Treatment Phase 1|Sponsor Decision|0
1031533|NCT01674010|2061499|FG002|Open Treatment Phase 1|Sponsor Decision|0
1031534|NCT01674010|2061497|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30
1031535|NCT01674010|2061498|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0
1031536|NCT01674010|2061499|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0
1031537|NCT01674010|2061497|FG000|Open Treatment Phase 1|Withdrawal by Subject|25
1031538|NCT01674010|2061498|FG001|Open Treatment Phase 1|Withdrawal by Subject|0
1031539|NCT01674010|2061499|FG002|Open Treatment Phase 1|Withdrawal by Subject|0
1031540|NCT01674010|2061497|FG000|Randomization Phase 2|Adverse Event|0
1031541|NCT01674010|2061498|FG001|Randomization Phase 2|Adverse Event|1
1031542|NCT01674010|2061499|FG002|Randomization Phase 2|Adverse Event|1
1031543|NCT01674010|2061497|FG000|Randomization Phase 2|Lost to Follow-up|0
1031544|NCT01674010|2061498|FG001|Randomization Phase 2|Lost to Follow-up|1
1031545|NCT01674010|2061499|FG002|Randomization Phase 2|Lost to Follow-up|2
1031546|NCT01674010|2061497|FG000|Randomization Phase 2|Mood episode recurrence|0
1031547|NCT01674010|2061498|FG001|Randomization Phase 2|Mood episode recurrence|8
1031548|NCT01674010|2061499|FG002|Randomization Phase 2|Mood episode recurrence|2
1031549|NCT01674010|2061497|FG000|Randomization Phase 2|Physician Decision|0
1031550|NCT01674010|2061498|FG001|Randomization Phase 2|Physician Decision|0
1031551|NCT01674010|2061499|FG002|Randomization Phase 2|Physician Decision|2
1031552|NCT01674010|2061497|FG000|Randomization Phase 2|Pregnancy|0
1031553|NCT01674010|2061498|FG001|Randomization Phase 2|Pregnancy|1
1031554|NCT01674010|2061499|FG002|Randomization Phase 2|Pregnancy|1
1031555|NCT01674010|2061497|FG000|Randomization Phase 2|Protocol Violation|0
1031556|NCT01674010|2061498|FG001|Randomization Phase 2|Protocol Violation|1
1031557|NCT01674010|2061499|FG002|Randomization Phase 2|Protocol Violation|1
1031558|NCT01674010|2061497|FG000|Randomization Phase 2|Sponsor Decision|0
1031559|NCT01674010|2061498|FG001|Randomization Phase 2|Sponsor Decision|42
1031560|NCT01674010|2061499|FG002|Randomization Phase 2|Sponsor Decision|45
1031561|NCT01674010|2061497|FG000|Randomization Phase 2|Withdrawal by Subject|0
1031562|NCT01674010|2061498|FG001|Randomization Phase 2|Withdrawal by Subject|8
1031563|NCT01674010|2061499|FG002|Randomization Phase 2|Withdrawal by Subject|7
1031564|NCT01674062|2061509|FG000|Overall Study|Insufficient Therapeutic Response|56
1031565|NCT01674062|2061510|FG001|Overall Study|Insufficient Therapeutic Response|26
1031566|NCT01674062|2061509|FG000|Overall Study|Other|8
1031567|NCT01674062|2061510|FG001|Overall Study|Other|1
1031568|NCT01674062|2061509|FG000|Overall Study|Adverse Event|1
1031569|NCT01674062|2061510|FG001|Overall Study|Adverse Event|1
1031570|NCT01674062|2061509|FG000|Overall Study|Death|0
1031571|NCT01674062|2061510|FG001|Overall Study|Death|1
1031572|NCT01674062|2061509|FG000|Overall Study|Programming Error|1
1031573|NCT01674062|2061510|FG001|Overall Study|Programming Error|0
1031574|NCT01674569|2061525|FG000|Overall Study|Adverse Event|0
1031575|NCT01674569|2061526|FG001|Overall Study|Adverse Event|2
1031576|NCT01674569|2061527|FG002|Overall Study|Adverse Event|0
1031577|NCT01674569|2061528|FG003|Overall Study|Adverse Event|1
1031578|NCT01674569|2061529|FG004|Overall Study|Adverse Event|2
1031579|NCT01674569|2061530|FG005|Overall Study|Adverse Event|2
1031580|NCT01674569|2061525|FG000|Overall Study|Protocol Violation|0
1031581|NCT01674569|2061526|FG001|Overall Study|Protocol Violation|1
1031582|NCT01674569|2061527|FG002|Overall Study|Protocol Violation|1
1031583|NCT01674569|2061528|FG003|Overall Study|Protocol Violation|0
1031584|NCT01674569|2061529|FG004|Overall Study|Protocol Violation|0
1031585|NCT01674569|2061530|FG005|Overall Study|Protocol Violation|0
1031586|NCT01674569|2061525|FG000|Overall Study|Withdrawal by Subject|0
1031587|NCT01674569|2061526|FG001|Overall Study|Withdrawal by Subject|0
1031588|NCT01674569|2061527|FG002|Overall Study|Withdrawal by Subject|1
1031589|NCT01674569|2061528|FG003|Overall Study|Withdrawal by Subject|0
1031590|NCT01674569|2061529|FG004|Overall Study|Withdrawal by Subject|0
1031591|NCT01674569|2061530|FG005|Overall Study|Withdrawal by Subject|0
1031592|NCT01674621|2061539|FG000|Overall Study|Adverse Event|3
1031593|NCT01674621|2061540|FG001|Overall Study|Adverse Event|2
1031594|NCT01674621|2061541|FG002|Overall Study|Adverse Event|5
1031595|NCT01674621|2061542|FG003|Overall Study|Adverse Event|5
1031596|NCT01674621|2061543|FG004|Overall Study|Adverse Event|1
1031597|NCT01674621|2061539|FG000|Overall Study|Inability to Complete Study Procedures|0
1031598|NCT01674621|2061540|FG001|Overall Study|Inability to Complete Study Procedures|0
1031599|NCT01674621|2061541|FG002|Overall Study|Inability to Complete Study Procedures|0
1031600|NCT01674621|2061542|FG003|Overall Study|Inability to Complete Study Procedures|0
1031601|NCT01674621|2061543|FG004|Overall Study|Inability to Complete Study Procedures|2
1031602|NCT01674621|2061539|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
1031603|NCT01674621|2061540|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
1031604|NCT01674621|2061541|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
1031605|NCT01674621|2061542|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
1031606|NCT01674621|2061543|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
1031607|NCT01674621|2061539|FG000|Overall Study|Withdrawal by Subject|2
1031608|NCT01674621|2061540|FG001|Overall Study|Withdrawal by Subject|5
1031609|NCT01674621|2061541|FG002|Overall Study|Withdrawal by Subject|2
1031610|NCT01674621|2061542|FG003|Overall Study|Withdrawal by Subject|0
1031611|NCT01674621|2061543|FG004|Overall Study|Withdrawal by Subject|1
1031612|NCT01674621|2061539|FG000|Overall Study|Other than specified|0
1031613|NCT01674621|2061540|FG001|Overall Study|Other than specified|1
1031614|NCT01674621|2061541|FG002|Overall Study|Other than specified|0
1031615|NCT01674621|2061542|FG003|Overall Study|Other than specified|0
1031616|NCT01674621|2061543|FG004|Overall Study|Other than specified|2
1031617|NCT01674634|2061556|FG000|Overall Study|Withdrawal by Subject|3
1031618|NCT01674634|2061556|FG000|Overall Study|Lost to Follow-up|3
1031619|NCT01674647|2061566|FG000|Treatment Period|Death|4
1031620|NCT01674647|2061567|FG001|Treatment Period|Death|1
1031621|NCT01674647|2061566|FG000|Treatment Period|Efficacy outcome reached|0
1031622|NCT01674647|2061567|FG001|Treatment Period|Efficacy outcome reached|1
1031623|NCT01674647|2061566|FG000|Treatment Period|Physician Decision|3
1031624|NCT01674647|2061567|FG001|Treatment Period|Physician Decision|1
1031625|NCT01674647|2061566|FG000|Treatment Period|Adverse Event|60
1031626|NCT01674647|2061567|FG001|Treatment Period|Adverse Event|22
1031627|NCT01674647|2061566|FG000|Treatment Period|Non-compliance with study drug|3
1031628|NCT01674647|2061567|FG001|Treatment Period|Non-compliance with study drug|0
1031629|NCT01674647|2061566|FG000|Treatment Period|Lost to Follow-up|1
1031630|NCT01674647|2061567|FG001|Treatment Period|Lost to Follow-up|1
1031631|NCT01674647|2061566|FG000|Treatment Period|Withdrawal by Subject|19
1031632|NCT01674647|2061567|FG001|Treatment Period|Withdrawal by Subject|16
1031633|NCT01674647|2061566|FG000|Treatment Period|Switching to other therapy|5
1031634|NCT01674647|2061567|FG001|Treatment Period|Switching to other therapy|2
1031635|NCT01674647|2061566|FG000|Treatment Period|Logistical difficulties|5
1031636|NCT01674647|2061567|FG001|Treatment Period|Logistical difficulties|8
1031637|NCT01674647|2061566|FG000|Treatment Period|Treatment failure|0
1031638|NCT01674647|2061567|FG001|Treatment Period|Treatment failure|14
1031639|NCT01674647|2061566|FG000|Treatment Period|Protocol Violation|56
1031640|NCT01674647|2061567|FG001|Treatment Period|Protocol Violation|36
1031641|NCT01674647|2061566|FG000|30-day Safety Follow-up Period|Death|3
1031642|NCT01674647|2061567|FG001|30-day Safety Follow-up Period|Death|2
1031643|NCT01674647|2061566|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0
1031644|NCT01674647|2061567|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1
1031645|NCT01674647|2061566|FG000|30-day Safety Follow-up Period|Protocol Violation|39
1031646|NCT01674647|2061567|FG001|30-day Safety Follow-up Period|Protocol Violation|22
1031647|NCT01674647|2061566|FG000|30-day Safety Follow-up Period|Logistical difficulties|1
1031648|NCT01674647|2061567|FG001|30-day Safety Follow-up Period|Logistical difficulties|3
1031649|NCT01674647|2061566|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7
1031650|NCT01674647|2061567|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8
1031651|NCT01674647|2061566|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8
1031652|NCT01674647|2061567|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5
1031653|NCT01674712|2061578|FG000|Overall Study|Adverse Event|5
1031654|NCT01674712|2061579|FG001|Overall Study|Adverse Event|6
1031655|NCT01674712|2061580|FG002|Overall Study|Adverse Event|3
1031656|NCT01674712|2061581|FG003|Overall Study|Adverse Event|4
1031657|NCT01674712|2061582|FG004|Overall Study|Adverse Event|6
1031658|NCT01674712|2061578|FG000|Overall Study|Lost to Follow-up|1
1031659|NCT01674712|2061579|FG001|Overall Study|Lost to Follow-up|0
1031660|NCT01674712|2061580|FG002|Overall Study|Lost to Follow-up|0
1031661|NCT01674712|2061581|FG003|Overall Study|Lost to Follow-up|0
1031662|NCT01674712|2061582|FG004|Overall Study|Lost to Follow-up|0
1031663|NCT01674712|2061578|FG000|Overall Study|Protocol Violation|2
1031664|NCT01674712|2061579|FG001|Overall Study|Protocol Violation|0
1031665|NCT01674712|2061580|FG002|Overall Study|Protocol Violation|0
1031666|NCT01674712|2061581|FG003|Overall Study|Protocol Violation|0
1031667|NCT01674712|2061582|FG004|Overall Study|Protocol Violation|0
1031668|NCT01674712|2061578|FG000|Overall Study|Withdrawal by Subject|2
1031669|NCT01674712|2061579|FG001|Overall Study|Withdrawal by Subject|2
1031670|NCT01674712|2061580|FG002|Overall Study|Withdrawal by Subject|5
1031671|NCT01674712|2061581|FG003|Overall Study|Withdrawal by Subject|4
1031672|NCT01674712|2061582|FG004|Overall Study|Withdrawal by Subject|3
1031673|NCT01674712|2061578|FG000|Overall Study|Administrative|0
1031674|NCT01674712|2061579|FG001|Overall Study|Administrative|1
1031675|NCT01674712|2061580|FG002|Overall Study|Administrative|0
1031676|NCT01674712|2061581|FG003|Overall Study|Administrative|0
1031677|NCT01674712|2061582|FG004|Overall Study|Administrative|1
1031678|NCT01674712|2061578|FG000|Overall Study|Lack of Efficacy|0
1031679|NCT01674712|2061579|FG001|Overall Study|Lack of Efficacy|0
1031680|NCT01674712|2061580|FG002|Overall Study|Lack of Efficacy|1
1031681|NCT01674712|2061581|FG003|Overall Study|Lack of Efficacy|0
1031682|NCT01674712|2061582|FG004|Overall Study|Lack of Efficacy|1
1031683|NCT01674725|2061596|FG000|Overall Study|Adverse Event|1
1031684|NCT01674725|2061597|FG001|Overall Study|Adverse Event|0
1031685|NCT01674725|2061596|FG000|Overall Study|Did not receive study drug|1
1031686|NCT01674725|2061597|FG001|Overall Study|Did not receive study drug|0
1031687|NCT01674725|2061596|FG000|Overall Study|Withdrawal by Subject|1
1031688|NCT01674725|2061597|FG001|Overall Study|Withdrawal by Subject|0
1031689|NCT01674725|2061596|FG000|Overall Study|Lost to Follow-up|0
1031690|NCT01674725|2061597|FG001|Overall Study|Lost to Follow-up|1
1031691|NCT01675050|2061605|FG000|Period One Treatment|Withdrawal by Subject|1
1031692|NCT01675050|2061606|FG001|Period One Treatment|Withdrawal by Subject|0
1031693|NCT01675128|2061619|FG000|Overall Study|Disease progression on study|1
1031694|NCT01675128|2061620|FG001|Overall Study|Disease progression on study|1
1031695|NCT01675128|2061621|FG002|Overall Study|Disease progression on study|1
1031696|NCT01675128|2061619|FG000|Overall Study|Refused further treatment|1
1031697|NCT01675128|2061620|FG001|Overall Study|Refused further treatment|0
1031698|NCT01675128|2061621|FG002|Overall Study|Refused further treatment|0
1031699|NCT01675128|2061619|FG000|Overall Study|Pulmonary complication; off study|0
1031700|NCT01675128|2061620|FG001|Overall Study|Pulmonary complication; off study|1
1031701|NCT01675128|2061621|FG002|Overall Study|Pulmonary complication; off study|0
1031702|NCT01675141|2061636|FG000|Overall Study|Lenalidomide outside NIH|3
1031703|NCT01675141|2061636|FG000|Overall Study|Withdrawal by Subject|3
1031704|NCT01675141|2061636|FG000|Overall Study|Physician Decision|4
1031705|NCT01675141|2061636|FG000|Overall Study|No treatment, per protocol|1
1031706|NCT01675154|2061644|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
1031707|NCT01675154|2061645|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1
1031708|NCT01675154|2061646|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
1031709|NCT01675154|2061647|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
1031710|NCT01675167|2061671|FG000|Open-label Titration Phase|Adverse Event|81
1031711|NCT01675167|2061672|FG001|Open-label Titration Phase|Adverse Event|0
1031712|NCT01675167|2061673|FG002|Open-label Titration Phase|Adverse Event|0
1031713|NCT01675167|2061671|FG000|Open-label Titration Phase|Lack of Efficacy|63
1031714|NCT01675167|2061672|FG001|Open-label Titration Phase|Lack of Efficacy|0
1031715|NCT01675167|2061673|FG002|Open-label Titration Phase|Lack of Efficacy|0
1031716|NCT01675167|2061671|FG000|Open-label Titration Phase|Withdrawal by Subject|46
1031717|NCT01675167|2061672|FG001|Open-label Titration Phase|Withdrawal by Subject|0
1031718|NCT01675167|2061673|FG002|Open-label Titration Phase|Withdrawal by Subject|0
1031719|NCT01675167|2061671|FG000|Open-label Titration Phase|Protocol Violation|43
1031720|NCT01675167|2061672|FG001|Open-label Titration Phase|Protocol Violation|0
1031721|NCT01675167|2061673|FG002|Open-label Titration Phase|Protocol Violation|0
1031722|NCT01675167|2061671|FG000|Open-label Titration Phase|Lost to Follow-up|15
1031723|NCT01675167|2061672|FG001|Open-label Titration Phase|Lost to Follow-up|0
1031724|NCT01675167|2061673|FG002|Open-label Titration Phase|Lost to Follow-up|0
1031725|NCT01675167|2061671|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
1031726|NCT01675167|2061672|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
1031727|NCT01675167|2061673|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
1031728|NCT01675167|2061671|FG000|Open-label Titration Phase|Other|55
1031729|NCT01675167|2061672|FG001|Open-label Titration Phase|Other|0
1031730|NCT01675167|2061673|FG002|Open-label Titration Phase|Other|0
1031731|NCT01675167|2061671|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
1031732|NCT01675167|2061672|FG001|Double-blind Treatment Phase|Lack of Efficacy|19
1031733|NCT01675167|2061673|FG002|Double-blind Treatment Phase|Lack of Efficacy|61
1031734|NCT01675167|2061671|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
1031735|NCT01675167|2061672|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
1031736|NCT01675167|2061673|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6
1031737|NCT01675167|2061671|FG000|Double-blind Treatment Phase|Adverse Event|0
1031738|NCT01675167|2061672|FG001|Double-blind Treatment Phase|Adverse Event|5
1031739|NCT01675167|2061673|FG002|Double-blind Treatment Phase|Adverse Event|13
1031740|NCT01675167|2061671|FG000|Double-blind Treatment Phase|Protocol Violation|0
1031741|NCT01675167|2061672|FG001|Double-blind Treatment Phase|Protocol Violation|4
1031742|NCT01675167|2061673|FG002|Double-blind Treatment Phase|Protocol Violation|11
1031743|NCT01675167|2061671|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
1031744|NCT01675167|2061672|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
1031745|NCT01675167|2061673|FG002|Double-blind Treatment Phase|Lost to Follow-up|5
1031746|NCT01675167|2061671|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
1031747|NCT01675167|2061672|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
1031748|NCT01675167|2061673|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
1031749|NCT01675167|2061671|FG000|Double-blind Treatment Phase|Other|0
1031750|NCT01675167|2061672|FG001|Double-blind Treatment Phase|Other|7
1031751|NCT01675167|2061673|FG002|Double-blind Treatment Phase|Other|5
1031752|NCT01675427|2061690|FG000|Overall Study|Withdrawal by Subject|7
1031753|NCT01675427|2061690|FG000|Overall Study|Participant Refused Sample Collection|18
1031754|NCT01675427|2061690|FG000|Overall Study|Sample not Collected by Mistake|2
1031755|NCT01675427|2061690|FG000|Overall Study|Lost to Follow-up|5
1031756|NCT01675427|2061690|FG000|Overall Study|Other|2
1031758|NCT01675492|2061737|FG000|Overall Study|study completed early - product approval|42
1031759|NCT01675531|2061742|FG000|Overall Study|Adverse Event|9
1031760|NCT01675531|2061742|FG000|Overall Study|Withdrawal by Subject|7
1031761|NCT01675531|2061742|FG000|Overall Study|Lack of Efficacy|1
1031762|NCT01675531|2061742|FG000|Overall Study|Protocol Violation|8
1031763|NCT01675544|2061747|FG000|Overall Study|Withdrawal by Subject|2
1031764|NCT01675596|2061751|FG000|Overall Study|Death|6
1031765|NCT01675596|2061751|FG000|Overall Study|Exit with other reason|1
1031766|NCT01675596|2061751|FG000|Overall Study|Missed Visit|1
1031767|NCT01675622|2061757|FG000|Overall Study|Withdrawal by Subject|2
1031768|NCT01675622|2061758|FG001|Overall Study|Withdrawal by Subject|2
1031769|NCT01675622|2061757|FG000|Overall Study|Adverse Event|12
1031770|NCT01675622|2061758|FG001|Overall Study|Adverse Event|10
1031771|NCT01675622|2061757|FG000|Overall Study|Protocol Violation|4
1031772|NCT01675622|2061758|FG001|Overall Study|Protocol Violation|1
1031773|NCT01675622|2061757|FG000|Overall Study|Lack of Efficacy|2
1031774|NCT01675622|2061758|FG001|Overall Study|Lack of Efficacy|4
1031775|NCT01675622|2061757|FG000|Overall Study|Lost to Follow-up|1
1031776|NCT01675622|2061758|FG001|Overall Study|Lost to Follow-up|3
1031777|NCT01675622|2061757|FG000|Overall Study|Other|5
1031778|NCT01675622|2061758|FG001|Overall Study|Other|4
1031779|NCT01675661|2061780|FG000|Overall Study|Lost to Follow-up|22
1031780|NCT01675661|2061781|FG001|Overall Study|Lost to Follow-up|23
1031781|NCT01675661|2061780|FG000|Overall Study|Practical problems|9
1031782|NCT01675661|2061781|FG001|Overall Study|Practical problems|5
1031783|NCT01675661|2061780|FG000|Overall Study|Moved away|5
1031784|NCT01675661|2061781|FG001|Overall Study|Moved away|6
1031785|NCT01675661|2061780|FG000|Overall Study|Withdrawal by Subject|3
1031786|NCT01675661|2061781|FG001|Overall Study|Withdrawal by Subject|7
1031787|NCT01675661|2061780|FG000|Overall Study|Physician Decision|0
1031788|NCT01675661|2061781|FG001|Overall Study|Physician Decision|2
1031789|NCT01675661|2061780|FG000|Overall Study|Death|0
1031790|NCT01675661|2061781|FG001|Overall Study|Death|1
1031791|NCT01675661|2061780|FG000|Overall Study|Other reason|1
1031792|NCT01675661|2061781|FG001|Overall Study|Other reason|2
1031793|NCT01675765|2061789|FG000|Overall Study|Progressive disease|4
1031794|NCT01675765|2061790|FG001|Overall Study|Progressive disease|4
1031795|NCT01675765|2061789|FG000|Overall Study|Adverse Event|1
1031796|NCT01675765|2061790|FG001|Overall Study|Adverse Event|2
1031797|NCT01675765|2061789|FG000|Overall Study|Withdrawal by Subject|2
1031798|NCT01675765|2061790|FG001|Overall Study|Withdrawal by Subject|0
1031799|NCT01675765|2061789|FG000|Overall Study|Death|1
1031800|NCT01675765|2061790|FG001|Overall Study|Death|0
1031801|NCT01675765|2061789|FG000|Overall Study|Clinical progression|3
1031802|NCT01675765|2061790|FG001|Overall Study|Clinical progression|2
1031803|NCT01675882|2061809|FG000|Overall Study|Adverse Event|0
1031804|NCT01675882|2061810|FG001|Overall Study|Adverse Event|2
1031805|NCT01675882|2061811|FG002|Overall Study|Adverse Event|1
1031806|NCT01675882|2061812|FG003|Overall Study|Adverse Event|0
1031807|NCT01675882|2061809|FG000|Overall Study|Participant unwilling to continue|2
1031808|NCT01675882|2061810|FG001|Overall Study|Participant unwilling to continue|4
1031809|NCT01675882|2061811|FG002|Overall Study|Participant unwilling to continue|2
1031810|NCT01675882|2061812|FG003|Overall Study|Participant unwilling to continue|1
1031811|NCT01675882|2061809|FG000|Overall Study|Lost to Follow-up|0
1031812|NCT01675882|2061810|FG001|Overall Study|Lost to Follow-up|1
1031813|NCT01675882|2061811|FG002|Overall Study|Lost to Follow-up|0
1031814|NCT01675882|2061812|FG003|Overall Study|Lost to Follow-up|0
1031815|NCT01675882|2061809|FG000|Overall Study|Non-compliance|0
1031816|NCT01675882|2061810|FG001|Overall Study|Non-compliance|0
1031817|NCT01675882|2061811|FG002|Overall Study|Non-compliance|0
1031818|NCT01675882|2061812|FG003|Overall Study|Non-compliance|1
1031819|NCT01676012|2061822|FG000|Overall Study|Adverse Event|2
1031820|NCT01676012|2061822|FG000|Overall Study|incomplete set of videos|1
1031821|NCT01676116|2061828|FG000|Overall Study|Withdrawal criteria|2
1031822|NCT01676116|2061829|FG001|Overall Study|Withdrawal criteria|14
1031823|NCT01676116|2061828|FG000|Overall Study|Adverse Event|1
1031824|NCT01676116|2061829|FG001|Overall Study|Adverse Event|2
1031825|NCT01676116|2061828|FG000|Overall Study|Unclassified|4
1031826|NCT01676116|2061829|FG001|Overall Study|Unclassified|10
1031827|NCT01676116|2061828|FG000|Overall Study|Protocol Violation|9
1031828|NCT01676116|2061829|FG001|Overall Study|Protocol Violation|3
1031829|NCT01676220|2061837|FG000|Overall Study|Randomized But Not Treated|4
1031830|NCT01676220|2061838|FG001|Overall Study|Randomized But Not Treated|1
1031831|NCT01676220|2061837|FG000|Overall Study|Adverse Event|10
1031832|NCT01676220|2061838|FG001|Overall Study|Adverse Event|8
1031833|NCT01676220|2061837|FG000|Overall Study|Lack of Efficacy|2
1031834|NCT01676220|2061838|FG001|Overall Study|Lack of Efficacy|5
1031835|NCT01676220|2061837|FG000|Overall Study|Protocol Violation|11
1031836|NCT01676220|2061838|FG001|Overall Study|Protocol Violation|12
1031837|NCT01676220|2061837|FG000|Overall Study|Received Rescue Therapy|14
1031838|NCT01676220|2061838|FG001|Overall Study|Received Rescue Therapy|22
1031839|NCT01676220|2061837|FG000|Overall Study|Personal Reason|34
1031840|NCT01676220|2061838|FG001|Overall Study|Personal Reason|45
1031841|NCT01676220|2061837|FG000|Overall Study|Lost to Follow-up|11
1031842|NCT01676220|2061838|FG001|Overall Study|Lost to Follow-up|18
1162024|NCT03380429|2283927|FG000|Overall Study|Adverse Event|1
1031843|NCT01676220|2061837|FG000|Overall Study|Selection Criterion/Protocol Violation|9
1031844|NCT01676220|2061838|FG001|Overall Study|Selection Criterion/Protocol Violation|9
1031845|NCT01676220|2061837|FG000|Overall Study|Site Closure/Site Withdrawal|1
1031846|NCT01676220|2061838|FG001|Overall Study|Site Closure/Site Withdrawal|4
1031847|NCT01676220|2061837|FG000|Overall Study|Perceived Lack of Efficacy|3
1031848|NCT01676220|2061838|FG001|Overall Study|Perceived Lack of Efficacy|1
1031849|NCT01676220|2061837|FG000|Overall Study|Non Serious Hypoglycemia|2
905119|NCT00760929|1880353|FG000|Overall Study|Lost to Follow-up|0
905120|NCT00760929|1880354|FG001|Overall Study|Lost to Follow-up|0
905121|NCT00760929|1880355|FG002|Overall Study|Lost to Follow-up|1
905122|NCT00760929|1880356|FG003|Overall Study|Lost to Follow-up|0
905123|NCT00760929|1880353|FG000|Overall Study|Progression of Disease|21
905124|NCT00760929|1880354|FG001|Overall Study|Progression of Disease|26
905125|NCT00760929|1880355|FG002|Overall Study|Progression of Disease|38
905126|NCT00760929|1880356|FG003|Overall Study|Progression of Disease|42
905127|NCT00760929|1880353|FG000|Overall Study|Other|2
905128|NCT00760929|1880354|FG001|Overall Study|Other|0
905129|NCT00760929|1880355|FG002|Overall Study|Other|2
905130|NCT00760929|1880356|FG003|Overall Study|Other|1
1031850|NCT01676220|2061838|FG001|Overall Study|Non Serious Hypoglycemia|0
1031851|NCT01676220|2061837|FG000|Overall Study|No More Need of Insulin|1
1031852|NCT01676220|2061838|FG001|Overall Study|No More Need of Insulin|0
1031853|NCT01676727|2061911|FG000|Overall Study|Death|18
1031854|NCT01676727|2061911|FG000|Overall Study|Withdrawal by Subject|6
1031855|NCT01676727|2061911|FG000|Overall Study|Screening failure|5
1031856|NCT01676727|2061911|FG000|Overall Study|Not willing to attend 1-year visit|2
1031857|NCT01676727|2061911|FG000|Overall Study|Valve explanted|1
1031858|NCT01676896|2061928|FG000|Overall Study|Withdrawal by Subject|12
1031859|NCT01676896|2061929|FG001|Overall Study|Withdrawal by Subject|7
1031860|NCT01676896|2061930|FG002|Overall Study|Withdrawal by Subject|19
1031861|NCT01676909|2061940|FG000|Overall Study|Withdrawal by Subject|3
1031862|NCT01676909|2061941|FG001|Overall Study|Withdrawal by Subject|5
1031863|NCT01676909|2061940|FG000|Overall Study|Lost to Follow-up|15
1031864|NCT01676909|2061941|FG001|Overall Study|Lost to Follow-up|9
1031865|NCT01677182|2061952|FG000|Overall Study|Adverse Event|2
1031866|NCT01677182|2061953|FG001|Overall Study|Adverse Event|1
1031867|NCT01677182|2061954|FG002|Overall Study|Adverse Event|8
1031868|NCT01677182|2061952|FG000|Overall Study|Protocol Violation|5
1031869|NCT01677182|2061953|FG001|Overall Study|Protocol Violation|1
1031870|NCT01677182|2061954|FG002|Overall Study|Protocol Violation|4
1031871|NCT01677182|2061952|FG000|Overall Study|Lost to Follow-up|4
1031872|NCT01677182|2061953|FG001|Overall Study|Lost to Follow-up|0
1031873|NCT01677182|2061954|FG002|Overall Study|Lost to Follow-up|3
1031874|NCT01677182|2061952|FG000|Overall Study|Withdrawal by Subject|7
1031875|NCT01677182|2061953|FG001|Overall Study|Withdrawal by Subject|12
1031876|NCT01677182|2061954|FG002|Overall Study|Withdrawal by Subject|10
1031877|NCT01677182|2061952|FG000|Overall Study|Study termination|12
1031878|NCT01677182|2061953|FG001|Overall Study|Study termination|9
1031879|NCT01677182|2061954|FG002|Overall Study|Study termination|11
1031880|NCT01677182|2061952|FG000|Overall Study|Lack of Efficacy|3
1031881|NCT01677182|2061953|FG001|Overall Study|Lack of Efficacy|0
1031882|NCT01677182|2061954|FG002|Overall Study|Lack of Efficacy|1
1031883|NCT01677182|2061952|FG000|Overall Study|Other reasons|1
1031884|NCT01677182|2061953|FG001|Overall Study|Other reasons|5
1031885|NCT01677182|2061954|FG002|Overall Study|Other reasons|2
1031886|NCT01677195|2061965|FG000|Overall Study|Lost to Follow-up|14
1031887|NCT01677195|2061966|FG001|Overall Study|Lost to Follow-up|22
1031888|NCT01677195|2061967|FG002|Overall Study|Lost to Follow-up|22
1031889|NCT01677195|2061965|FG000|Overall Study|Withdrawal by Subject|1
1031890|NCT01677195|2061966|FG001|Overall Study|Withdrawal by Subject|0
1031891|NCT01677195|2061967|FG002|Overall Study|Withdrawal by Subject|1
1031892|NCT01677195|2061965|FG000|Overall Study|Adverse Event|6
1031893|NCT01677195|2061966|FG001|Overall Study|Adverse Event|4
1031894|NCT01677195|2061967|FG002|Overall Study|Adverse Event|1
1031895|NCT01677195|2061965|FG000|Overall Study|Physician Decision|1
1031896|NCT01677195|2061966|FG001|Overall Study|Physician Decision|2
1031897|NCT01677195|2061967|FG002|Overall Study|Physician Decision|2
1031898|NCT01677195|2061965|FG000|Overall Study|Pregnancy|0
1031899|NCT01677195|2061966|FG001|Overall Study|Pregnancy|1
1031900|NCT01677195|2061967|FG002|Overall Study|Pregnancy|0
1031901|NCT01677195|2061965|FG000|Overall Study|Protocol Violation|7
1031902|NCT01677195|2061966|FG001|Overall Study|Protocol Violation|3
1031903|NCT01677195|2061967|FG002|Overall Study|Protocol Violation|4
1031904|NCT01677299|2061985|FG000|Overall Study|Adverse Event|0
1031905|NCT01677299|2061986|FG001|Overall Study|Adverse Event|2
1031906|NCT01677299|2061987|FG002|Overall Study|Adverse Event|1
1031907|NCT01677299|2061988|FG003|Overall Study|Adverse Event|0
1031908|NCT01677299|2061985|FG000|Overall Study|Withdrawal by Subject|0
1031909|NCT01677299|2061986|FG001|Overall Study|Withdrawal by Subject|1
1031910|NCT01677299|2061987|FG002|Overall Study|Withdrawal by Subject|0
1031911|NCT01677299|2061988|FG003|Overall Study|Withdrawal by Subject|1
1031912|NCT01677377|2062014|FG000|Overall Study|Protocol Violation|1
1031913|NCT01677377|2062015|FG001|Overall Study|Protocol Violation|0
1031914|NCT01677377|2062016|FG002|Overall Study|Protocol Violation|0
1031915|NCT01677377|2062014|FG000|Overall Study|Lost to Follow-up|0
905131|NCT00760929|1880353|FG000|Overall Study|Death|0
1031916|NCT01677377|2062015|FG001|Overall Study|Lost to Follow-up|1
1031917|NCT01677377|2062016|FG002|Overall Study|Lost to Follow-up|1
1031918|NCT01677377|2062014|FG000|Overall Study|Withdrawal by Subject|0
1031919|NCT01677377|2062015|FG001|Overall Study|Withdrawal by Subject|0
1031920|NCT01677377|2062016|FG002|Overall Study|Withdrawal by Subject|3
1031921|NCT01677377|2062014|FG000|Overall Study|Lack of Efficacy|0
1031922|NCT01677377|2062015|FG001|Overall Study|Lack of Efficacy|0
1031923|NCT01677377|2062016|FG002|Overall Study|Lack of Efficacy|1
1031924|NCT01677377|2062014|FG000|Overall Study|Pregnancy|0
1031925|NCT01677377|2062015|FG001|Overall Study|Pregnancy|0
1031926|NCT01677377|2062016|FG002|Overall Study|Pregnancy|1
1031927|NCT01677507|2062024|FG000|Initial Assignment|Adverse Event|0
1031928|NCT01677507|2062025|FG001|Initial Assignment|Adverse Event|1
1031929|NCT01677507|2062024|FG000|Initial Assignment|Protocol Violation|0
1031930|NCT01677507|2062025|FG001|Initial Assignment|Protocol Violation|1
1031931|NCT01677507|2062024|FG000|Second Assigment|Withdrawal by Subject|2
1031932|NCT01677507|2062025|FG001|Second Assigment|Withdrawal by Subject|2
1031933|NCT01677507|2062024|FG000|Second Assigment|Adverse Event|1
1031934|NCT01677507|2062025|FG001|Second Assigment|Adverse Event|3
1031935|NCT01677624|2062033|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1
1031936|NCT01677767|2062086|FG000|Overall Study|Adverse Event|1
1031937|NCT01677767|2062086|FG000|Overall Study|Death|4
1031938|NCT01677767|2062086|FG000|Overall Study|Protocol Violation|4
1031939|NCT01677767|2062086|FG000|Overall Study|Withdrawal by Subject|10
1031940|NCT01677767|2062086|FG000|Overall Study|Non-compliance by the participants|3
1031941|NCT01677858|2062097|FG000|Overall Study|Adverse Event|0
1031942|NCT01677858|2062098|FG001|Overall Study|Adverse Event|0
1031943|NCT01677858|2062099|FG002|Overall Study|Adverse Event|2
1031944|NCT01677858|2062100|FG003|Overall Study|Adverse Event|3
1031945|NCT01677858|2062101|FG004|Overall Study|Adverse Event|13
1031946|NCT01677858|2062097|FG000|Overall Study|Death|0
1031947|NCT01677858|2062098|FG001|Overall Study|Death|0
1031948|NCT01677858|2062099|FG002|Overall Study|Death|0
1031949|NCT01677858|2062100|FG003|Overall Study|Death|0
1031950|NCT01677858|2062101|FG004|Overall Study|Death|1
1031951|NCT01677858|2062097|FG000|Overall Study|Physician Decision|1
1031952|NCT01677858|2062098|FG001|Overall Study|Physician Decision|0
1031953|NCT01677858|2062099|FG002|Overall Study|Physician Decision|2
1031954|NCT01677858|2062100|FG003|Overall Study|Physician Decision|0
1031955|NCT01677858|2062101|FG004|Overall Study|Physician Decision|12
1031956|NCT01677858|2062097|FG000|Overall Study|Progressive Disease|2
1031957|NCT01677858|2062098|FG001|Overall Study|Progressive Disease|1
1031958|NCT01677858|2062099|FG002|Overall Study|Progressive Disease|9
1031959|NCT01677858|2062100|FG003|Overall Study|Progressive Disease|3
1031960|NCT01677858|2062101|FG004|Overall Study|Progressive Disease|43
1031961|NCT01677858|2062097|FG000|Overall Study|Withdrawal by Subject|0
1031962|NCT01677858|2062098|FG001|Overall Study|Withdrawal by Subject|1
1031963|NCT01677858|2062099|FG002|Overall Study|Withdrawal by Subject|1
1031964|NCT01677858|2062100|FG003|Overall Study|Withdrawal by Subject|0
1031965|NCT01677858|2062101|FG004|Overall Study|Withdrawal by Subject|15
1031966|NCT01677858|2062097|FG000|Overall Study|Lost to Follow-up|0
1031967|NCT01677858|2062098|FG001|Overall Study|Lost to Follow-up|0
1031968|NCT01677858|2062099|FG002|Overall Study|Lost to Follow-up|0
1031969|NCT01677858|2062100|FG003|Overall Study|Lost to Follow-up|0
1031970|NCT01677858|2062101|FG004|Overall Study|Lost to Follow-up|1
1031971|NCT01677910|2062121|FG000|Double-Blind Treatment Period|Adverse Event|6
1031972|NCT01677910|2062122|FG001|Double-Blind Treatment Period|Adverse Event|2
1031973|NCT01677910|2062123|FG002|Double-Blind Treatment Period|Adverse Event|3
1031974|NCT01677910|2062124|FG003|Double-Blind Treatment Period|Adverse Event|0
1031975|NCT01677910|2062121|FG000|Double-Blind Treatment Period|Physician Decision|0
1031976|NCT01677910|2062122|FG001|Double-Blind Treatment Period|Physician Decision|0
1031977|NCT01677910|2062123|FG002|Double-Blind Treatment Period|Physician Decision|1
1031978|NCT01677910|2062124|FG003|Double-Blind Treatment Period|Physician Decision|0
1031979|NCT01677910|2062121|FG000|Double-Blind Treatment Period|Withdrawal of consent|1
1031980|NCT01677910|2062122|FG001|Double-Blind Treatment Period|Withdrawal of consent|0
1031981|NCT01677910|2062123|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
1031982|NCT01677910|2062124|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
1031983|NCT01677910|2062121|FG000|Double-Blind Treatment Period|Reason Not Specified|0
1031984|NCT01677910|2062122|FG001|Double-Blind Treatment Period|Reason Not Specified|1
1031985|NCT01677910|2062123|FG002|Double-Blind Treatment Period|Reason Not Specified|0
1031986|NCT01677910|2062124|FG003|Double-Blind Treatment Period|Reason Not Specified|0
1031987|NCT01677910|2062121|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
1031988|NCT01677910|2062122|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
1031989|NCT01677910|2062123|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
1031990|NCT01677910|2062124|FG003|Open-Label Extension Period (OLE)|Physician Decision|4
1031991|NCT01677910|2062121|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
1031992|NCT01677910|2062122|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
1031993|NCT01677910|2062123|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
1031994|NCT01677910|2062124|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
1031995|NCT01677910|2062121|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1031996|NCT01677910|2062122|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1031997|NCT01677910|2062123|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1031998|NCT01677910|2062124|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
1031999|NCT01677910|2062121|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1032000|NCT01677910|2062122|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1032001|NCT01677910|2062123|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1032002|NCT01677910|2062124|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5
1032003|NCT01677910|2062121|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
1032004|NCT01677910|2062122|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
1032005|NCT01677910|2062123|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
1032006|NCT01677910|2062124|FG003|Open-Label Extension Period (OLE)|Adverse Event|15
1032007|NCT01677910|2062121|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1032008|NCT01677910|2062122|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1032009|NCT01677910|2062123|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1032010|NCT01677910|2062124|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1
1032011|NCT01677936|2062136|FG000|Overall Study|Lost to Follow-up|4
1032012|NCT01677936|2062137|FG001|Overall Study|Lost to Follow-up|1
1032013|NCT01677936|2062136|FG000|Overall Study|Protocol Violation|3
1032014|NCT01677936|2062137|FG001|Overall Study|Protocol Violation|0
1032015|NCT01677936|2062136|FG000|Overall Study|Adverse Event|1
1032016|NCT01677936|2062137|FG001|Overall Study|Adverse Event|0
1032017|NCT01677936|2062136|FG000|Overall Study|Lost to Follow-up|1
1032018|NCT01677936|2062137|FG001|Overall Study|Lost to Follow-up|0
1032019|NCT01677936|2062136|FG000|Overall Study|Protocol Violation|0
1032020|NCT01677936|2062137|FG001|Overall Study|Protocol Violation|4
1032021|NCT01677988|2062143|FG000|Overall Study|Lack of Efficacy|2
1032022|NCT01678131|2062151|FG000|Overall Study|Adverse Event|0
1032023|NCT01678131|2062152|FG001|Overall Study|Adverse Event|1
1032024|NCT01678131|2062153|FG002|Overall Study|Adverse Event|0
1032025|NCT01678131|2062151|FG000|Overall Study|Withdrawal by Subject|0
1032026|NCT01678131|2062152|FG001|Overall Study|Withdrawal by Subject|0
1032027|NCT01678131|2062153|FG002|Overall Study|Withdrawal by Subject|2
1032028|NCT01678144|2062161|FG000|Stage 1: MAR Classic|Adverse Event|1
1032029|NCT01678209|2062177|FG000|Overall Study|could not scan twice|1
1032030|NCT01678209|2062178|FG001|Overall Study|could not scan twice|1
1032031|NCT01678209|2062179|FG002|Overall Study|could not scan twice|1
1032032|NCT01678209|2062177|FG000|Overall Study|scheduling conflicts|0
1032033|NCT01678209|2062178|FG001|Overall Study|scheduling conflicts|0
1032034|NCT01678209|2062179|FG002|Overall Study|scheduling conflicts|1
1032035|NCT01678209|2062177|FG000|Overall Study|screen fail|16
1032036|NCT01678209|2062178|FG001|Overall Study|screen fail|17
1032037|NCT01678209|2062179|FG002|Overall Study|screen fail|16
1032038|NCT01678313|2062189|FG000|Completed the 3-month Therapy|Lost to Follow-up|3
1032039|NCT01678313|2062190|FG001|Completed the 3-month Therapy|Lost to Follow-up|8
1032040|NCT01678313|2062189|FG000|Completed the 3-month Therapy|Physician Decision|3
1032041|NCT01678313|2062190|FG001|Completed the 3-month Therapy|Physician Decision|4
1032042|NCT01678313|2062189|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8
1032043|NCT01678313|2062190|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9
1032044|NCT01678313|2062189|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
1032045|NCT01678313|2062190|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
1032046|NCT01678560|2062202|FG000|Overall Study|Physician Decision|4
1032047|NCT01678560|2062203|FG001|Overall Study|Physician Decision|4
1032048|NCT01678560|2062202|FG000|Overall Study|Death|0
1032049|NCT01678560|2062203|FG001|Overall Study|Death|1
1032050|NCT01678560|2062202|FG000|Overall Study|Withdrawal by Subject|0
1032051|NCT01678560|2062203|FG001|Overall Study|Withdrawal by Subject|1
1032052|NCT01678807|2062225|FG000|Overall Study|Adverse Event|4
1032053|NCT01678807|2062226|FG001|Overall Study|Adverse Event|4
1032054|NCT01678807|2062227|FG002|Overall Study|Adverse Event|0
1032055|NCT01678807|2062225|FG000|Overall Study|Withdrawn by Parent/Guardian|0
1032056|NCT01678807|2062226|FG001|Overall Study|Withdrawn by Parent/Guardian|1
1032057|NCT01678807|2062227|FG002|Overall Study|Withdrawn by Parent/Guardian|0
1032058|NCT01678820|2062238|FG000|Overall Study|Study Terminated by Sponsor|45
1032059|NCT01678820|2062239|FG001|Overall Study|Study Terminated by Sponsor|43
1032060|NCT01678820|2062240|FG002|Overall Study|Study Terminated by Sponsor|43
1032061|NCT01678820|2062238|FG000|Overall Study|Withdrawal by Subject|2
1032062|NCT01678820|2062239|FG001|Overall Study|Withdrawal by Subject|5
1032063|NCT01678820|2062240|FG002|Overall Study|Withdrawal by Subject|2
1032064|NCT01678820|2062238|FG000|Overall Study|Protocol Specified Criteria|2
1032065|NCT01678820|2062239|FG001|Overall Study|Protocol Specified Criteria|3
1032066|NCT01678820|2062240|FG002|Overall Study|Protocol Specified Criteria|1
1032067|NCT01678820|2062238|FG000|Overall Study|Adverse Event|2
1032068|NCT01678820|2062239|FG001|Overall Study|Adverse Event|2
1032069|NCT01678820|2062240|FG002|Overall Study|Adverse Event|2
1032070|NCT01678820|2062238|FG000|Overall Study|Lost to Follow-up|7
1032071|NCT01678820|2062239|FG001|Overall Study|Lost to Follow-up|2
1032072|NCT01678820|2062240|FG002|Overall Study|Lost to Follow-up|2
1032073|NCT01678820|2062238|FG000|Overall Study|Non-compliance with study drug|0
1032074|NCT01678820|2062239|FG001|Overall Study|Non-compliance with study drug|1
1032075|NCT01678820|2062240|FG002|Overall Study|Non-compliance with study drug|0
1032076|NCT01678820|2062238|FG000|Overall Study|Physician Decision|0
1032077|NCT01678820|2062239|FG001|Overall Study|Physician Decision|0
1032078|NCT01678820|2062240|FG002|Overall Study|Physician Decision|1
1032079|NCT01678820|2062238|FG000|Overall Study|Protocol Violation|4
1032080|NCT01678820|2062239|FG001|Overall Study|Protocol Violation|5
1032081|NCT01678820|2062240|FG002|Overall Study|Protocol Violation|4
1032082|NCT01678820|2062238|FG000|Overall Study|Not treated with double-blind study drug|0
1032083|NCT01678820|2062239|FG001|Overall Study|Not treated with double-blind study drug|2
1032084|NCT01678820|2062240|FG002|Overall Study|Not treated with double-blind study drug|2
1032085|NCT01678898|2062275|FG000|PB-102-F01|Adverse Event|0
1032086|NCT01678898|2062276|FG001|PB-102-F01|Adverse Event|1
1032087|NCT01678898|2062277|FG002|PB-102-F01|Adverse Event|0
1032088|NCT01678898|2062275|FG000|PB-102-F01|Physician Decision|0
1032089|NCT01678898|2062276|FG001|PB-102-F01|Physician Decision|1
1032090|NCT01678898|2062277|FG002|PB-102-F01|Physician Decision|0
1032091|NCT01678911|2062294|FG000|Second Intervention|Lost to Follow-up|2
1032092|NCT01678911|2062295|FG001|Second Intervention|Lost to Follow-up|0
1032093|NCT01678924|2062305|FG000|Overall Study|Adverse Event|1
1032094|NCT01678924|2062306|FG001|Overall Study|Adverse Event|1
1032095|NCT01678924|2062307|FG002|Overall Study|Adverse Event|0
1032096|NCT01678924|2062308|FG003|Overall Study|Adverse Event|1
1032097|NCT01678924|2062305|FG000|Overall Study|Lack of Efficacy|7
1032098|NCT01678924|2062306|FG001|Overall Study|Lack of Efficacy|2
1032099|NCT01678924|2062307|FG002|Overall Study|Lack of Efficacy|0
1032100|NCT01678924|2062308|FG003|Overall Study|Lack of Efficacy|5
1032101|NCT01678924|2062305|FG000|Overall Study|Lost to Follow-up|0
1032102|NCT01678924|2062306|FG001|Overall Study|Lost to Follow-up|4
1032103|NCT01678924|2062307|FG002|Overall Study|Lost to Follow-up|0
1032104|NCT01678924|2062308|FG003|Overall Study|Lost to Follow-up|2
1032105|NCT01678924|2062305|FG000|Overall Study|Personal Reasons|2
1032106|NCT01678924|2062306|FG001|Overall Study|Personal Reasons|2
1032107|NCT01678924|2062307|FG002|Overall Study|Personal Reasons|2
1032108|NCT01678924|2062308|FG003|Overall Study|Personal Reasons|7
1032109|NCT01678924|2062305|FG000|Overall Study|Withdrawal by Subject|0
1032110|NCT01678924|2062306|FG001|Overall Study|Withdrawal by Subject|3
1032111|NCT01678924|2062307|FG002|Overall Study|Withdrawal by Subject|0
1032112|NCT01678924|2062308|FG003|Overall Study|Withdrawal by Subject|2
1032113|NCT01678924|2062305|FG000|Overall Study|Unable to attend scheduled visits|0
1032114|NCT01678924|2062306|FG001|Overall Study|Unable to attend scheduled visits|0
1032115|NCT01678924|2062307|FG002|Overall Study|Unable to attend scheduled visits|0
1032116|NCT01678924|2062308|FG003|Overall Study|Unable to attend scheduled visits|1
1032117|NCT01679002|2062334|FG000|Overall Study|Adverse Event|1
1032118|NCT01679002|2062335|FG001|Overall Study|Adverse Event|1
1032119|NCT01679002|2062336|FG002|Overall Study|Adverse Event|0
1032120|NCT01679236|2062381|FG000|Overall Study|Lost to Follow-up|15
1032121|NCT01679236|2062382|FG001|Overall Study|Lost to Follow-up|15
1032122|NCT01679301|2062388|FG000|Screening Period|screen failure|3
1032123|NCT01679301|2062389|FG001|Screening Period|screen failure|0
1032124|NCT01679301|2062390|FG002|Screening Period|screen failure|0
1032125|NCT01679405|2062411|FG000|Overall Study|Death|2
1032126|NCT01679405|2062412|FG001|Overall Study|Death|5
1032127|NCT01679613|2062427|FG000|Overall Study|other than stated above|0
1032128|NCT01679613|2062428|FG001|Overall Study|other than stated above|1
1032129|NCT01679613|2062429|FG002|Overall Study|other than stated above|2
1032130|NCT01679613|2062430|FG003|Overall Study|other than stated above|2
1032131|NCT01680016|2062439|FG000|Overall Study|Adverse Event|0
1032132|NCT01680016|2062440|FG001|Overall Study|Adverse Event|0
1032133|NCT01680016|2062441|FG002|Overall Study|Adverse Event|1
1032134|NCT01680016|2062442|FG003|Overall Study|Adverse Event|4
1032135|NCT01680016|2062439|FG000|Overall Study|The Subject went out of The Trial|1
1032136|NCT01680016|2062440|FG001|Overall Study|The Subject went out of The Trial|0
1032137|NCT01680016|2062441|FG002|Overall Study|The Subject went out of The Trial|3
1032138|NCT01680016|2062442|FG003|Overall Study|The Subject went out of The Trial|0
1032139|NCT01680016|2062439|FG000|Overall Study|Protocol Violation|0
1032140|NCT01680016|2062440|FG001|Overall Study|Protocol Violation|1
1032141|NCT01680016|2062441|FG002|Overall Study|Protocol Violation|0
1032142|NCT01680016|2062442|FG003|Overall Study|Protocol Violation|0
1032143|NCT01680016|2062439|FG000|Overall Study|Withdrawal by Subject|5
1032144|NCT01680016|2062440|FG001|Overall Study|Withdrawal by Subject|7
1032145|NCT01680016|2062441|FG002|Overall Study|Withdrawal by Subject|1
1032146|NCT01680016|2062442|FG003|Overall Study|Withdrawal by Subject|1
1032147|NCT01680159|2062468|FG000|Screening Period|Not meet criteria for dose-up period|7
1032148|NCT01680159|2062468|FG000|Increased Dose Period|Adverse Event|6
1032149|NCT01680159|2062468|FG000|Increased Dose Period|Withdrawal by Subject|2
1032150|NCT01680341|2062534|FG000|Overall Study|Adverse Event|3
1032151|NCT01680341|2062535|FG001|Overall Study|Adverse Event|2
1032152|NCT01680341|2062534|FG000|Overall Study|Unclassified|18
1032153|NCT01680341|2062535|FG001|Overall Study|Unclassified|15
1032154|NCT01680458|2062541|FG000|Overall Study|Protocol Violation|3
1032155|NCT01680497|2062545|FG000|Overall Study|Lost to Follow-up|2
1032156|NCT01680861|2062612|FG000|Early Post-transplant Period|Protocol Violation|1
1032157|NCT01680861|2062613|FG001|Early Post-transplant Period|Protocol Violation|1
1032158|NCT01680965|2062643|FG000|Overall Study|Death|0
1032159|NCT01680965|2062644|FG001|Overall Study|Death|0
1032160|NCT01680965|2062645|FG002|Overall Study|Death|0
1032161|NCT01680965|2062646|FG003|Overall Study|Death|6
1032162|NCT01680991|2062657|FG000|Overall Study|Adverse Event|1
1032163|NCT01680991|2062658|FG001|Overall Study|Adverse Event|0
1032164|NCT01680991|2062659|FG002|Overall Study|Adverse Event|0
1032165|NCT01680991|2062657|FG000|Overall Study|Death|1
1032166|NCT01680991|2062658|FG001|Overall Study|Death|0
1032167|NCT01680991|2062659|FG002|Overall Study|Death|1
1032168|NCT01680991|2062657|FG000|Overall Study|Protocol Violation|0
1032169|NCT01680991|2062658|FG001|Overall Study|Protocol Violation|1
1032170|NCT01680991|2062659|FG002|Overall Study|Protocol Violation|0
1032171|NCT01680991|2062657|FG000|Overall Study|Withdrawal by Subject|5
1032172|NCT01680991|2062658|FG001|Overall Study|Withdrawal by Subject|1
1032173|NCT01680991|2062659|FG002|Overall Study|Withdrawal by Subject|0
1032174|NCT01680991|2062657|FG000|Overall Study|Progressive disease (PD)|0
1032175|NCT01680991|2062658|FG001|Overall Study|Progressive disease (PD)|10
1032176|NCT01680991|2062659|FG002|Overall Study|Progressive disease (PD)|0
1032177|NCT01680991|2062657|FG000|Overall Study|Physician Decision|0
1032178|NCT01680991|2062658|FG001|Overall Study|Physician Decision|7
1032179|NCT01680991|2062659|FG002|Overall Study|Physician Decision|2
1032180|NCT01680991|2062657|FG000|Overall Study|Bad physical condition|0
1032181|NCT01680991|2062658|FG001|Overall Study|Bad physical condition|0
1032182|NCT01680991|2062659|FG002|Overall Study|Bad physical condition|1
1032183|NCT01680991|2062657|FG000|Overall Study|PD confirmed in other hospital|1
1032184|NCT01680991|2062658|FG001|Overall Study|PD confirmed in other hospital|0
1032185|NCT01680991|2062659|FG002|Overall Study|PD confirmed in other hospital|0
1032186|NCT01681004|2062671|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1
1032187|NCT01681004|2062672|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2
1032188|NCT01681004|2062671|FG000|Study Completion|Lost to Follow-up|8
1032189|NCT01681004|2062672|FG001|Study Completion|Lost to Follow-up|3
1032190|NCT01681004|2062671|FG000|Study Completion|Physician Decision|1
1032191|NCT01681004|2062672|FG001|Study Completion|Physician Decision|3
1032192|NCT01681004|2062671|FG000|Study Completion|Site Termination|2
1032193|NCT01681004|2062672|FG001|Study Completion|Site Termination|1
1032194|NCT01681004|2062671|FG000|Study Completion|Death|1
1032195|NCT01681004|2062672|FG001|Study Completion|Death|1
1032196|NCT01681069|2062697|FG000|Overall Study|Withdrawal by Subject|4
1032197|NCT01681069|2062698|FG001|Overall Study|Withdrawal by Subject|5
1032198|NCT01681069|2062697|FG000|Overall Study|Protocol Violation|1
1032199|NCT01681069|2062698|FG001|Overall Study|Protocol Violation|1
1032200|NCT01681069|2062697|FG000|Overall Study|Adverse Event|0
1032201|NCT01681069|2062698|FG001|Overall Study|Adverse Event|1
1032202|NCT01681186|2062732|FG000|Washout Period From Second Intervention|Adverse Event|0
1032203|NCT01681186|2062733|FG001|Washout Period From Second Intervention|Adverse Event|0
1032204|NCT01681186|2062734|FG002|Washout Period From Second Intervention|Adverse Event|0
1032205|NCT01681186|2062735|FG003|Washout Period From Second Intervention|Adverse Event|0
1032206|NCT01681186|2062736|FG004|Washout Period From Second Intervention|Adverse Event|0
1032207|NCT01681186|2062737|FG005|Washout Period From Second Intervention|Adverse Event|0
1032208|NCT01681186|2062738|FG006|Washout Period From Second Intervention|Adverse Event|1
1032209|NCT01681186|2062739|FG007|Washout Period From Second Intervention|Adverse Event|0
1032210|NCT01681186|2062732|FG000|Washout Period From Second Intervention|Protocol Violation|0
1032211|NCT01681186|2062733|FG001|Washout Period From Second Intervention|Protocol Violation|0
1032212|NCT01681186|2062734|FG002|Washout Period From Second Intervention|Protocol Violation|0
1032213|NCT01681186|2062735|FG003|Washout Period From Second Intervention|Protocol Violation|0
1032214|NCT01681186|2062736|FG004|Washout Period From Second Intervention|Protocol Violation|0
1032215|NCT01681186|2062737|FG005|Washout Period From Second Intervention|Protocol Violation|0
1032216|NCT01681186|2062738|FG006|Washout Period From Second Intervention|Protocol Violation|0
1032217|NCT01681186|2062739|FG007|Washout Period From Second Intervention|Protocol Violation|1
1032218|NCT01681186|2062732|FG000|Washout Period From Third Intervention|Lost to Follow-up|0
1032219|NCT01681186|2062733|FG001|Washout Period From Third Intervention|Lost to Follow-up|0
1032220|NCT01681186|2062734|FG002|Washout Period From Third Intervention|Lost to Follow-up|0
1032221|NCT01681186|2062735|FG003|Washout Period From Third Intervention|Lost to Follow-up|0
1032222|NCT01681186|2062736|FG004|Washout Period From Third Intervention|Lost to Follow-up|0
1032223|NCT01681186|2062737|FG005|Washout Period From Third Intervention|Lost to Follow-up|0
1032224|NCT01681186|2062738|FG006|Washout Period From Third Intervention|Lost to Follow-up|1
1032225|NCT01681186|2062739|FG007|Washout Period From Third Intervention|Lost to Follow-up|0
1032226|NCT01681186|2062732|FG000|Fourth Intervention|Protocol Violation|0
1032227|NCT01681186|2062733|FG001|Fourth Intervention|Protocol Violation|0
1032228|NCT01681186|2062734|FG002|Fourth Intervention|Protocol Violation|0
1032229|NCT01681186|2062735|FG003|Fourth Intervention|Protocol Violation|0
1032230|NCT01681186|2062736|FG004|Fourth Intervention|Protocol Violation|0
1032231|NCT01681186|2062737|FG005|Fourth Intervention|Protocol Violation|0
1032232|NCT01681186|2062738|FG006|Fourth Intervention|Protocol Violation|0
1032233|NCT01681186|2062739|FG007|Fourth Intervention|Protocol Violation|1
1032234|NCT01681212|2062769|FG000|Overall Study|No longer met study criteria|5
1032235|NCT01681212|2062769|FG000|Overall Study|Administrative reason by sponsor|1
1032236|NCT01681277|2062778|FG000|Overall Study|Adverse Event|1
1032237|NCT01681277|2062779|FG001|Overall Study|Adverse Event|0
1032238|NCT01681277|2062780|FG002|Overall Study|Adverse Event|0
1032239|NCT01681277|2062781|FG003|Overall Study|Adverse Event|0
1032240|NCT01681277|2062782|FG004|Overall Study|Adverse Event|0
1032241|NCT01681368|2062798|FG000|Overall Study|Refused further treatment|1
1032242|NCT01681368|2062798|FG000|Overall Study|Refused further follow up|1
1032243|NCT01681433|2062804|FG000|Overall Study|Lack of Efficacy|23
1032244|NCT01681433|2062805|FG001|Overall Study|Lack of Efficacy|23
1032245|NCT01681433|2062804|FG000|Overall Study|Withdrawal by Subject|5
1032246|NCT01681433|2062805|FG001|Overall Study|Withdrawal by Subject|5
1032247|NCT01681433|2062804|FG000|Overall Study|Protocol Violation|2
1032248|NCT01681433|2062805|FG001|Overall Study|Protocol Violation|0
1032249|NCT01681433|2062804|FG000|Overall Study|Adverse Event|2
1032250|NCT01681433|2062805|FG001|Overall Study|Adverse Event|4
1032251|NCT01681433|2062804|FG000|Overall Study|Lost to Follow-up|0
1032252|NCT01681433|2062805|FG001|Overall Study|Lost to Follow-up|1
1032253|NCT01681472|2062815|FG000|Overall Study|Adverse Event|0
1032254|NCT01681472|2062816|FG001|Overall Study|Adverse Event|1
1032255|NCT01681472|2062817|FG002|Overall Study|Adverse Event|0
1032256|NCT01681472|2062818|FG003|Overall Study|Adverse Event|0
1032257|NCT01681511|2062839|FG000|Overall Study|No Treatment Received|1
1032258|NCT01681511|2062840|FG001|Overall Study|No Treatment Received|3
1032259|NCT01681511|2062839|FG000|Overall Study|Failed Inclusion/Exclusion|3
1032260|NCT01681511|2062840|FG001|Overall Study|Failed Inclusion/Exclusion|0
1032261|NCT01681511|2062839|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3
1032262|NCT01681511|2062840|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6
1032263|NCT01681511|2062839|FG000|Overall Study|No Daily Urine Sample Collected|0
1032264|NCT01681511|2062840|FG001|Overall Study|No Daily Urine Sample Collected|1
1032265|NCT01681511|2062839|FG000|Overall Study|No post-catheter sample collected|11
1032266|NCT01681511|2062840|FG001|Overall Study|No post-catheter sample collected|4
1032267|NCT01681576|2062848|FG000|Period 1|Adverse Event|1
1032268|NCT01681576|2062849|FG001|Period 1|Adverse Event|0
1032269|NCT01681576|2062848|FG000|Period 1|Protocol Deviation|1
1032270|NCT01681576|2062849|FG001|Period 1|Protocol Deviation|0
1032271|NCT01681576|2062848|FG000|Period 2|subject/guardian decision|3
1032272|NCT01681576|2062849|FG001|Period 2|subject/guardian decision|1
1032273|NCT01681576|2062848|FG000|Period 2|Non-compliance with study treatment|1
1032274|NCT01681576|2062849|FG001|Period 2|Non-compliance with study treatment|0
1032275|NCT01681628|2062859|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
1032276|NCT01681628|2062860|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
1032277|NCT01681628|2062859|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
1032278|NCT01681628|2062860|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
1032279|NCT01681628|2062859|FG000|19 Months Follow-up|Death|1
1032280|NCT01681628|2062860|FG001|19 Months Follow-up|Death|0
1032281|NCT01681628|2062859|FG000|19 Months Follow-up|Lost to Follow-up|61
1032282|NCT01681628|2062860|FG001|19 Months Follow-up|Lost to Follow-up|43
1032283|NCT01681771|2062871|FG000|Overall Study|Lost to Follow-up|4
1032284|NCT01681771|2062872|FG001|Overall Study|Lost to Follow-up|2
1032285|NCT01681836|2062882|FG000|Second Intervention|Withdrawal by Subject|0
1032286|NCT01681836|2062883|FG001|Second Intervention|Withdrawal by Subject|1
1032287|NCT01681849|2062892|FG000|Overall Study|Protocol Violation|2
1032288|NCT01681849|2062893|FG001|Overall Study|Protocol Violation|0
1032289|NCT01681849|2062894|FG002|Overall Study|Protocol Violation|0
1032290|NCT01681849|2062892|FG000|Overall Study|Withdrawal by Subject|3
1032291|NCT01681849|2062893|FG001|Overall Study|Withdrawal by Subject|5
1032292|NCT01681849|2062894|FG002|Overall Study|Withdrawal by Subject|33
1032293|NCT01681849|2062892|FG000|Overall Study|Lost to Follow-up|3
1032294|NCT01681849|2062893|FG001|Overall Study|Lost to Follow-up|2
1032295|NCT01681849|2062894|FG002|Overall Study|Lost to Follow-up|6
1032296|NCT01681992|2062904|FG000|Overall Study|Adverse Event|3
1032297|NCT01681992|2062905|FG001|Overall Study|Adverse Event|2
1032298|NCT01681992|2062906|FG002|Overall Study|Adverse Event|3
1032299|NCT01681992|2062904|FG000|Overall Study|Lost to Follow-up|36
1032300|NCT01681992|2062905|FG001|Overall Study|Lost to Follow-up|38
1032301|NCT01681992|2062906|FG002|Overall Study|Lost to Follow-up|53
1032302|NCT01681992|2062904|FG000|Overall Study|As Per Sponsor Decision|0
1032303|NCT01681992|2062905|FG001|Overall Study|As Per Sponsor Decision|0
1032304|NCT01681992|2062906|FG002|Overall Study|As Per Sponsor Decision|1
1032305|NCT01681992|2062904|FG000|Overall Study|Protocol Violation|0
1032306|NCT01681992|2062905|FG001|Overall Study|Protocol Violation|0
1032307|NCT01681992|2062906|FG002|Overall Study|Protocol Violation|1
1032308|NCT01681992|2062904|FG000|Overall Study|Withdrawal by Subject|27
1032309|NCT01681992|2062905|FG001|Overall Study|Withdrawal by Subject|30
1032310|NCT01681992|2062906|FG002|Overall Study|Withdrawal by Subject|25
1032311|NCT01682031|2062916|FG000|Overall Study|Withdrawal by Subject|0
1032312|NCT01682031|2062917|FG001|Overall Study|Withdrawal by Subject|1
1032313|NCT01682031|2062916|FG000|Overall Study|Adverse Event|0
1032314|NCT01682031|2062917|FG001|Overall Study|Adverse Event|2
1032315|NCT01682031|2062916|FG000|Overall Study|MRI results indicate increased nodul|0
1032316|NCT01682031|2062917|FG001|Overall Study|MRI results indicate increased nodul|1
1032317|NCT01682031|2062916|FG000|Overall Study|Patient could not swallow tablets|1
1032318|NCT01682031|2062917|FG001|Overall Study|Patient could not swallow tablets|0
1032319|NCT01682031|2062916|FG000|Overall Study|Patient stopped selenium on his own|0
1032320|NCT01682031|2062917|FG001|Overall Study|Patient stopped selenium on his own|1
1032321|NCT01682044|2062923|FG000|Overall Study|Death|1
1032322|NCT01682044|2062923|FG000|Overall Study|Progression|3
1032323|NCT01682083|2062929|FG000|Overall Study|Lost to Follow-up|11
1032324|NCT01682083|2062930|FG001|Overall Study|Lost to Follow-up|18
1032325|NCT01682083|2062929|FG000|Overall Study|Withdrawal by Subject|31
1032326|NCT01682083|2062930|FG001|Overall Study|Withdrawal by Subject|40
1032327|NCT01682083|2062929|FG000|Overall Study|Death|60
1032328|NCT01682083|2062930|FG001|Overall Study|Death|93
1032329|NCT01682083|2062929|FG000|Overall Study|Physician Decision|5
1032330|NCT01682083|2062930|FG001|Overall Study|Physician Decision|4
1032331|NCT01682148|2062953|FG000|Overall Study|Withdrawal by Subject|2
1032332|NCT01682148|2062954|FG001|Overall Study|Withdrawal by Subject|0
1032333|NCT01682148|2062953|FG000|Overall Study|Lost to Follow-up|1
1032334|NCT01682148|2062954|FG001|Overall Study|Lost to Follow-up|2
1032335|NCT01682148|2062953|FG000|Overall Study|Protocol Violation|1
1032336|NCT01682148|2062954|FG001|Overall Study|Protocol Violation|1
1032337|NCT01682213|2062965|FG000|Overall Study|Withdrawal by Subject|2
1032338|NCT01682460|2062970|FG000|Overall Study|Withdrawal by Subject|2
1032339|NCT01682460|2062970|FG000|Overall Study|Did not meet inclusion criteria|2
1032340|NCT01682512|2062977|FG000|Overall Study|Adverse Event|6
1032341|NCT01682512|2062978|FG001|Overall Study|Adverse Event|5
1032342|NCT01682512|2062979|FG002|Overall Study|Adverse Event|2
1032343|NCT01682512|2062977|FG000|Overall Study|Withdrawal by Subject|2
1032344|NCT01682512|2062978|FG001|Overall Study|Withdrawal by Subject|6
1032345|NCT01682512|2062979|FG002|Overall Study|Withdrawal by Subject|3
1032346|NCT01682512|2062977|FG000|Overall Study|Physician Decision|0
1032347|NCT01682512|2062978|FG001|Overall Study|Physician Decision|2
1032348|NCT01682512|2062979|FG002|Overall Study|Physician Decision|0
1032349|NCT01682512|2062977|FG000|Overall Study|Study terminated by sponsor|46
1032350|NCT01682512|2062978|FG001|Overall Study|Study terminated by sponsor|43
1032351|NCT01682512|2062979|FG002|Overall Study|Study terminated by sponsor|0
1032352|NCT01682512|2062977|FG000|Overall Study|Lost to Follow-up|3
1032353|NCT01682512|2062978|FG001|Overall Study|Lost to Follow-up|0
1032354|NCT01682512|2062979|FG002|Overall Study|Lost to Follow-up|2
1032355|NCT01682512|2062977|FG000|Overall Study|Protocol Violation|2
1032356|NCT01682512|2062978|FG001|Overall Study|Protocol Violation|3
1032357|NCT01682512|2062979|FG002|Overall Study|Protocol Violation|2
1032358|NCT01682512|2062977|FG000|Overall Study|Primary lack of efficacy|10
1032359|NCT01682512|2062978|FG001|Overall Study|Primary lack of efficacy|7
1032360|NCT01682512|2062979|FG002|Overall Study|Primary lack of efficacy|7
1032361|NCT01682512|2062977|FG000|Overall Study|Secondary lack of efficacy|1
1032362|NCT01682512|2062978|FG001|Overall Study|Secondary lack of efficacy|1
1032363|NCT01682512|2062979|FG002|Overall Study|Secondary lack of efficacy|0
1032364|NCT01682512|2062977|FG000|Overall Study|Other than stated above|2
1032365|NCT01682512|2062978|FG001|Overall Study|Other than stated above|4
1032366|NCT01682512|2062979|FG002|Overall Study|Other than stated above|2
1032367|NCT01682603|2063002|FG000|Overall Study|Lost to Follow-up|3
1032368|NCT01682681|2063023|FG000|Overall Study|Lack of Efficacy|62
1032369|NCT01682681|2063023|FG000|Overall Study|Withdrawal by Subject|1
1032370|NCT01682681|2063023|FG000|Overall Study|Moved to other hospital|10
1032371|NCT01682681|2063023|FG000|Overall Study|Lost to Follow-up|174
1032372|NCT01682681|2063023|FG000|Overall Study|Adverse Event|46
1032373|NCT01682681|2063023|FG000|Overall Study|tapering of topiramate|5
1032374|NCT01682681|2063023|FG000|Overall Study|Other|21
1032375|NCT01682681|2063023|FG000|Overall Study|Low compliance|13
1032376|NCT01682720|2063031|FG000|Overall Study|Randomized but Not Treated|0
1032377|NCT01682720|2063032|FG001|Overall Study|Randomized but Not Treated|1
1032378|NCT01682720|2063033|FG002|Overall Study|Randomized but Not Treated|1
1032379|NCT01682720|2063034|FG003|Overall Study|Randomized but Not Treated|0
1032380|NCT01682720|2063031|FG000|Overall Study|Terminated by Sponsor|83
1032381|NCT01682720|2063032|FG001|Overall Study|Terminated by Sponsor|0
1032382|NCT01682720|2063033|FG002|Overall Study|Terminated by Sponsor|0
1032383|NCT01682720|2063034|FG003|Overall Study|Terminated by Sponsor|0
1032384|NCT01682720|2063031|FG000|Overall Study|Efficacy Failure|0
1032385|NCT01682720|2063032|FG001|Overall Study|Efficacy Failure|3
1032386|NCT01682720|2063033|FG002|Overall Study|Efficacy Failure|3
1032387|NCT01682720|2063034|FG003|Overall Study|Efficacy Failure|30
1032388|NCT01682720|2063031|FG000|Overall Study|Lost to Follow-up|1
1032389|NCT01682720|2063032|FG001|Overall Study|Lost to Follow-up|1
1032390|NCT01682720|2063033|FG002|Overall Study|Lost to Follow-up|0
1032391|NCT01682720|2063034|FG003|Overall Study|Lost to Follow-up|6
1032392|NCT01682720|2063031|FG000|Overall Study|Subject Withdrew Consent|0
1032393|NCT01682720|2063032|FG001|Overall Study|Subject Withdrew Consent|0
1032394|NCT01682720|2063033|FG002|Overall Study|Subject Withdrew Consent|2
1032395|NCT01682720|2063034|FG003|Overall Study|Subject Withdrew Consent|2
1032396|NCT01682720|2063031|FG000|Overall Study|Adverse Event|1
1032397|NCT01682720|2063032|FG001|Overall Study|Adverse Event|0
1032398|NCT01682720|2063033|FG002|Overall Study|Adverse Event|1
1032399|NCT01682720|2063034|FG003|Overall Study|Adverse Event|1
1032400|NCT01682759|2063046|FG000|Overall Study|Death|2
1032401|NCT01682759|2063047|FG001|Overall Study|Death|1
1032402|NCT01682759|2063046|FG000|Overall Study|Lost to Follow-up|10
1032403|NCT01682759|2063047|FG001|Overall Study|Lost to Follow-up|13
1032404|NCT01682759|2063046|FG000|Overall Study|Physician Decision|1
1032405|NCT01682759|2063047|FG001|Overall Study|Physician Decision|1
1032406|NCT01682759|2063046|FG000|Overall Study|Withdrawal by Subject|56
1032407|NCT01682759|2063047|FG001|Overall Study|Withdrawal by Subject|55
1032408|NCT01682811|2063060|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0
1032409|NCT01682811|2063061|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0
1032410|NCT01682811|2063062|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0
1032411|NCT01682811|2063063|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0
1032412|NCT01682811|2063064|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1
1032413|NCT01682811|2063065|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0
1032414|NCT01682811|2063066|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0
1032415|NCT01682811|2063060|FG000|Part 2 Dose Level 1|Protocol Violation|0
1032416|NCT01682811|2063061|FG001|Part 2 Dose Level 1|Protocol Violation|0
1032417|NCT01682811|2063062|FG002|Part 2 Dose Level 1|Protocol Violation|0
1032418|NCT01682811|2063063|FG003|Part 2 Dose Level 1|Protocol Violation|0
1032419|NCT01682811|2063064|FG004|Part 2 Dose Level 1|Protocol Violation|4
1032420|NCT01682811|2063065|FG005|Part 2 Dose Level 1|Protocol Violation|0
1032421|NCT01682811|2063066|FG006|Part 2 Dose Level 1|Protocol Violation|0
1032422|NCT01682811|2063060|FG000|Part 2 Dose Level 1|Lost to Follow-up|0
1032423|NCT01682811|2063061|FG001|Part 2 Dose Level 1|Lost to Follow-up|0
1032424|NCT01682811|2063062|FG002|Part 2 Dose Level 1|Lost to Follow-up|0
1032425|NCT01682811|2063063|FG003|Part 2 Dose Level 1|Lost to Follow-up|0
1032426|NCT01682811|2063064|FG004|Part 2 Dose Level 1|Lost to Follow-up|6
1032427|NCT01682811|2063065|FG005|Part 2 Dose Level 1|Lost to Follow-up|0
1032428|NCT01682811|2063066|FG006|Part 2 Dose Level 1|Lost to Follow-up|0
1032429|NCT01682811|2063060|FG000|Part 2 Dose Level 2|Lost to Follow-up|0
1032430|NCT01682811|2063061|FG001|Part 2 Dose Level 2|Lost to Follow-up|0
1032431|NCT01682811|2063062|FG002|Part 2 Dose Level 2|Lost to Follow-up|0
1032432|NCT01682811|2063063|FG003|Part 2 Dose Level 2|Lost to Follow-up|0
1032433|NCT01682811|2063064|FG004|Part 2 Dose Level 2|Lost to Follow-up|0
1032434|NCT01682811|2063065|FG005|Part 2 Dose Level 2|Lost to Follow-up|3
1032435|NCT01682811|2063066|FG006|Part 2 Dose Level 2|Lost to Follow-up|0
1032436|NCT01682837|2063085|FG000|Baseline|Withdrawal by Subject|5
1032437|NCT01682863|2063098|FG000|Overall Study|Subject/guardian decision|19
1032438|NCT01682863|2063099|FG001|Overall Study|Subject/guardian decision|12
1032439|NCT01682863|2063100|FG002|Overall Study|Subject/guardian decision|10
1032440|NCT01682863|2063098|FG000|Overall Study|Lost to Follow-up|5
1032441|NCT01682863|2063099|FG001|Overall Study|Lost to Follow-up|1
1032442|NCT01682863|2063100|FG002|Overall Study|Lost to Follow-up|6
1032443|NCT01682863|2063098|FG000|Overall Study|Death|1
1032444|NCT01682863|2063099|FG001|Overall Study|Death|3
1032445|NCT01682863|2063100|FG002|Overall Study|Death|4
1032446|NCT01682863|2063098|FG000|Overall Study|Protocol deviation|1
1032447|NCT01682863|2063099|FG001|Overall Study|Protocol deviation|0
1032448|NCT01682863|2063100|FG002|Overall Study|Protocol deviation|1
1032449|NCT01682863|2063098|FG000|Overall Study|Technical problems|1
1032450|NCT01682863|2063099|FG001|Overall Study|Technical problems|0
1032451|NCT01682863|2063100|FG002|Overall Study|Technical problems|0
1032452|NCT01682863|2063098|FG000|Overall Study|Adverse Event|0
1032453|NCT01682863|2063099|FG001|Overall Study|Adverse Event|1
1032454|NCT01682863|2063100|FG002|Overall Study|Adverse Event|2
1032455|NCT01682863|2063098|FG000|Overall Study|Physician Decision|0
1032456|NCT01682863|2063099|FG001|Overall Study|Physician Decision|0
1032457|NCT01682863|2063100|FG002|Overall Study|Physician Decision|1
1032458|NCT01682876|2063112|FG000|Overall Study|Administrative reason|4
1032459|NCT01682876|2063113|FG001|Overall Study|Administrative reason|4
1032460|NCT01682876|2063114|FG002|Overall Study|Administrative reason|0
1032461|NCT01682876|2063115|FG003|Overall Study|Administrative reason|3
1032462|NCT01682876|2063112|FG000|Overall Study|Adverse Event|0
1032463|NCT01682876|2063113|FG001|Overall Study|Adverse Event|0
1032464|NCT01682876|2063114|FG002|Overall Study|Adverse Event|0
1032465|NCT01682876|2063115|FG003|Overall Study|Adverse Event|1
1032466|NCT01682876|2063112|FG000|Overall Study|Lost to Follow-up|11
1032467|NCT01682876|2063113|FG001|Overall Study|Lost to Follow-up|15
1032468|NCT01682876|2063114|FG002|Overall Study|Lost to Follow-up|9
1032469|NCT01682876|2063115|FG003|Overall Study|Lost to Follow-up|11
1032470|NCT01682876|2063112|FG000|Overall Study|Protocol Violation|1
1032471|NCT01682876|2063113|FG001|Overall Study|Protocol Violation|1
1032472|NCT01682876|2063114|FG002|Overall Study|Protocol Violation|1
1032473|NCT01682876|2063115|FG003|Overall Study|Protocol Violation|1
1032474|NCT01682876|2063112|FG000|Overall Study|Withdrawal by Subject|4
1032475|NCT01682876|2063113|FG001|Overall Study|Withdrawal by Subject|0
1032476|NCT01682876|2063114|FG002|Overall Study|Withdrawal by Subject|0
1032477|NCT01682876|2063115|FG003|Overall Study|Withdrawal by Subject|2
1032478|NCT01682876|2063112|FG000|Overall Study|Other|1
1032479|NCT01682876|2063113|FG001|Overall Study|Other|0
1032480|NCT01682876|2063114|FG002|Overall Study|Other|1
1032481|NCT01682876|2063115|FG003|Overall Study|Other|1
1032482|NCT01683019|2063140|FG000|Overall Study|Withdrawal by Subject|2
1032483|NCT01683019|2063141|FG001|Overall Study|Withdrawal by Subject|1
1032484|NCT01683019|2063142|FG002|Overall Study|Withdrawal by Subject|4
1032485|NCT01683058|2063150|FG000|Overall Study|Lost to Follow-up|9
1032486|NCT01683058|2063150|FG000|Overall Study|Adverse Event|6
1032487|NCT01683058|2063150|FG000|Overall Study|Subject Met Withdrawal Criteria|5
1032488|NCT01683058|2063150|FG000|Overall Study|Withdrawal by Subject|7
1032489|NCT01683058|2063150|FG000|Overall Study|Lack of Efficacy|2
1032490|NCT01683071|2063161|FG000|Part 1|Lack of Efficacy|1
1032491|NCT01683071|2063162|FG001|Part 1|Lack of Efficacy|0
1032492|NCT01683071|2063163|FG002|Part 1|Lack of Efficacy|0
1032493|NCT01683071|2063164|FG003|Part 1|Lack of Efficacy|3
1032494|NCT01683071|2063165|FG004|Part 1|Lack of Efficacy|0
1032495|NCT01683071|2063166|FG005|Part 1|Lack of Efficacy|0
1032496|NCT01683071|2063161|FG000|Part 1|Withdrawal by Subject|1
1032497|NCT01683071|2063162|FG001|Part 1|Withdrawal by Subject|2
1032498|NCT01683071|2063163|FG002|Part 1|Withdrawal by Subject|2
1032499|NCT01683071|2063164|FG003|Part 1|Withdrawal by Subject|1
1032500|NCT01683071|2063165|FG004|Part 1|Withdrawal by Subject|0
1032501|NCT01683071|2063166|FG005|Part 1|Withdrawal by Subject|0
1032502|NCT01683071|2063161|FG000|Part 1|Surgery Cancelled|1
1032503|NCT01683071|2063162|FG001|Part 1|Surgery Cancelled|0
1032504|NCT01683071|2063163|FG002|Part 1|Surgery Cancelled|0
1032505|NCT01683071|2063164|FG003|Part 1|Surgery Cancelled|0
1032506|NCT01683071|2063165|FG004|Part 1|Surgery Cancelled|0
1032507|NCT01683071|2063166|FG005|Part 1|Surgery Cancelled|0
1032508|NCT01683071|2063161|FG000|Part 1|Did not receive study drug|1
1032509|NCT01683071|2063162|FG001|Part 1|Did not receive study drug|0
1032510|NCT01683071|2063163|FG002|Part 1|Did not receive study drug|0
1032511|NCT01683071|2063164|FG003|Part 1|Did not receive study drug|1
1032512|NCT01683071|2063165|FG004|Part 1|Did not receive study drug|0
1032513|NCT01683071|2063166|FG005|Part 1|Did not receive study drug|0
1032514|NCT01683071|2063161|FG000|Part 1|Early termination; met exclusion criteria|0
1032515|NCT01683071|2063162|FG001|Part 1|Early termination; met exclusion criteria|2
1032516|NCT01683071|2063163|FG002|Part 1|Early termination; met exclusion criteria|1
1032517|NCT01683071|2063164|FG003|Part 1|Early termination; met exclusion criteria|0
1032518|NCT01683071|2063165|FG004|Part 1|Early termination; met exclusion criteria|0
1032519|NCT01683071|2063166|FG005|Part 1|Early termination; met exclusion criteria|0
1032520|NCT01683071|2063161|FG000|Part 2|Lack of Efficacy|0
1032521|NCT01683071|2063162|FG001|Part 2|Lack of Efficacy|0
1032522|NCT01683071|2063163|FG002|Part 2|Lack of Efficacy|0
1032523|NCT01683071|2063164|FG003|Part 2|Lack of Efficacy|0
1032524|NCT01683071|2063165|FG004|Part 2|Lack of Efficacy|3
1032525|NCT01683071|2063166|FG005|Part 2|Lack of Efficacy|4
1032526|NCT01683071|2063161|FG000|Part 2|Lost to Follow-up|0
1032527|NCT01683071|2063162|FG001|Part 2|Lost to Follow-up|0
1032528|NCT01683071|2063163|FG002|Part 2|Lost to Follow-up|0
1032529|NCT01683071|2063164|FG003|Part 2|Lost to Follow-up|0
1032530|NCT01683071|2063165|FG004|Part 2|Lost to Follow-up|2
1032531|NCT01683071|2063166|FG005|Part 2|Lost to Follow-up|0
1032532|NCT01683071|2063161|FG000|Part 2|Withdrawal by Subject|0
1032533|NCT01683071|2063162|FG001|Part 2|Withdrawal by Subject|0
1032534|NCT01683071|2063163|FG002|Part 2|Withdrawal by Subject|0
1032535|NCT01683071|2063164|FG003|Part 2|Withdrawal by Subject|0
1032536|NCT01683071|2063165|FG004|Part 2|Withdrawal by Subject|3
1032537|NCT01683071|2063166|FG005|Part 2|Withdrawal by Subject|3
1032538|NCT01683071|2063161|FG000|Part 2|Surgery cancelled|0
1032539|NCT01683071|2063162|FG001|Part 2|Surgery cancelled|0
1032540|NCT01683071|2063163|FG002|Part 2|Surgery cancelled|0
1032541|NCT01683071|2063164|FG003|Part 2|Surgery cancelled|0
1032542|NCT01683071|2063165|FG004|Part 2|Surgery cancelled|4
1032543|NCT01683071|2063166|FG005|Part 2|Surgery cancelled|2
1032544|NCT01683071|2063161|FG000|Part 2|Did not receive study drug|0
1032545|NCT01683071|2063162|FG001|Part 2|Did not receive study drug|0
1032546|NCT01683071|2063163|FG002|Part 2|Did not receive study drug|0
1032547|NCT01683071|2063164|FG003|Part 2|Did not receive study drug|0
1032548|NCT01683071|2063165|FG004|Part 2|Did not receive study drug|2
1032549|NCT01683071|2063166|FG005|Part 2|Did not receive study drug|1
1032550|NCT01683071|2063161|FG000|Part 2|Met exclusion criterion|0
1032551|NCT01683071|2063162|FG001|Part 2|Met exclusion criterion|0
1032552|NCT01683071|2063163|FG002|Part 2|Met exclusion criterion|0
1032553|NCT01683071|2063164|FG003|Part 2|Met exclusion criterion|0
1032554|NCT01683071|2063165|FG004|Part 2|Met exclusion criterion|1
1032555|NCT01683071|2063166|FG005|Part 2|Met exclusion criterion|1
1032556|NCT01683071|2063161|FG000|Part 2|Protocol deviation|0
1032557|NCT01683071|2063162|FG001|Part 2|Protocol deviation|0
1032558|NCT01683071|2063163|FG002|Part 2|Protocol deviation|0
1032559|NCT01683071|2063164|FG003|Part 2|Protocol deviation|0
1032560|NCT01683071|2063165|FG004|Part 2|Protocol deviation|1
1032561|NCT01683071|2063166|FG005|Part 2|Protocol deviation|2
1032562|NCT01683071|2063161|FG000|Part 2|Withdrawal by investigator decision|0
1032563|NCT01683071|2063162|FG001|Part 2|Withdrawal by investigator decision|0
1032564|NCT01683071|2063163|FG002|Part 2|Withdrawal by investigator decision|0
1032565|NCT01683071|2063164|FG003|Part 2|Withdrawal by investigator decision|0
1032566|NCT01683071|2063165|FG004|Part 2|Withdrawal by investigator decision|1
1032567|NCT01683071|2063166|FG005|Part 2|Withdrawal by investigator decision|2
1032568|NCT01683266|2063188|FG000|Overall Study|Adverse Event|5
1032569|NCT01683266|2063189|FG001|Overall Study|Adverse Event|4
1032570|NCT01683266|2063188|FG000|Overall Study|Lack of Efficacy|5
1032571|NCT01683266|2063189|FG001|Overall Study|Lack of Efficacy|2
1032572|NCT01683266|2063188|FG000|Overall Study|Protocol Violation|13
1032573|NCT01683266|2063189|FG001|Overall Study|Protocol Violation|6
1032574|NCT01683266|2063188|FG000|Overall Study|Personal Reason|17
1032575|NCT01683266|2063189|FG001|Overall Study|Personal Reason|25
1032576|NCT01683266|2063188|FG000|Overall Study|Selection Criterion / Protocol Violation|7
1032577|NCT01683266|2063189|FG001|Overall Study|Selection Criterion / Protocol Violation|5
1032578|NCT01683266|2063188|FG000|Overall Study|Lost to Follow-up|5
1032579|NCT01683266|2063189|FG001|Overall Study|Lost to Follow-up|0
1032580|NCT01683266|2063188|FG000|Overall Study|Site Closure / Site Withdrawal|1
1032581|NCT01683266|2063189|FG001|Overall Study|Site Closure / Site Withdrawal|3
1032582|NCT01683266|2063188|FG000|Overall Study|Nonserious Hypoglycemia|0
1032583|NCT01683266|2063189|FG001|Overall Study|Nonserious Hypoglycemia|3
1032584|NCT01683266|2063188|FG000|Overall Study|Perceived Lack of Efficacy|1
1032585|NCT01683266|2063189|FG001|Overall Study|Perceived Lack of Efficacy|1
1032586|NCT01683266|2063188|FG000|Overall Study|Possibly Hypoglycemia|1
1032587|NCT01683266|2063189|FG001|Overall Study|Possibly Hypoglycemia|0
1032588|NCT01683266|2063188|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0
1032589|NCT01683266|2063189|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1
1032590|NCT01683383|2063206|FG000|Overall Study|Infant was not transported|1
1032591|NCT01683383|2063207|FG001|Overall Study|Infant was not transported|0
1032592|NCT01683409|2063218|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1032593|NCT01683409|2063219|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1032594|NCT01683409|2063220|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
1032595|NCT01683409|2063221|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1032596|NCT01683409|2063222|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1032597|NCT01683409|2063218|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0
1032598|NCT01683409|2063219|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3
1032599|NCT01683409|2063220|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0
1032600|NCT01683409|2063221|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1
1032601|NCT01683409|2063222|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1
1032602|NCT01683409|2063218|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1032603|NCT01683409|2063219|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
1032604|NCT01683409|2063220|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1032605|NCT01683409|2063221|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1032606|NCT01683409|2063222|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1032607|NCT01683409|2063218|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1032608|NCT01683409|2063219|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1032609|NCT01683409|2063220|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1032610|NCT01683409|2063221|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
1032611|NCT01683409|2063222|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
1032612|NCT01683409|2063218|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1032613|NCT01683409|2063219|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1032614|NCT01683409|2063220|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
1032615|NCT01683409|2063221|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1032616|NCT01683409|2063222|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1032617|NCT01683409|2063218|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
1032618|NCT01683409|2063219|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1032619|NCT01683409|2063220|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1032620|NCT01683409|2063221|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
1032621|NCT01683409|2063222|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1032622|NCT01683409|2063218|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
1032623|NCT01683409|2063219|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1032624|NCT01683409|2063220|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1032625|NCT01683409|2063221|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1032626|NCT01683409|2063222|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
1032627|NCT01683409|2063218|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1
1032628|NCT01683409|2063219|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1032629|NCT01683409|2063220|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1032630|NCT01683409|2063221|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1032631|NCT01683409|2063222|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1032632|NCT01683409|2063218|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0
1032633|NCT01683409|2063219|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4
1032634|NCT01683409|2063220|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0
1032635|NCT01683409|2063221|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1
1032636|NCT01683409|2063222|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2
1032637|NCT01683409|2063218|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1032638|NCT01683409|2063219|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1032639|NCT01683409|2063220|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1032640|NCT01683409|2063221|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1032641|NCT01683409|2063222|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3
1032642|NCT01683409|2063218|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1032643|NCT01683409|2063219|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1032644|NCT01683409|2063220|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1
1032645|NCT01683409|2063221|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1032646|NCT01683409|2063222|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1032647|NCT01683565|2063263|FG000|Overall Study|Lost to Follow-up|2
1032648|NCT01683565|2063264|FG001|Overall Study|Lost to Follow-up|0
1032649|NCT01683565|2063263|FG000|Overall Study|Discontinued Intervention|1
1032650|NCT01683565|2063264|FG001|Overall Study|Discontinued Intervention|1
1032651|NCT01683604|2063272|FG000|Overall Study|Adverse Event|2
1032652|NCT01683604|2063272|FG000|Overall Study|Lack of Efficacy|1
1032653|NCT01683604|2063272|FG000|Overall Study|Other|2
1032654|NCT01683838|2063296|FG000|Overall Study|Adverse Event|12
1032655|NCT01683838|2063297|FG001|Overall Study|Adverse Event|2
1032656|NCT01683838|2063296|FG000|Overall Study|Protocol Violation|3
1032657|NCT01683838|2063297|FG001|Overall Study|Protocol Violation|1
1032658|NCT01683838|2063296|FG000|Overall Study|Withdrawal by Subject|6
1032659|NCT01683838|2063297|FG001|Overall Study|Withdrawal by Subject|5
1032660|NCT01683838|2063296|FG000|Overall Study|Lost to Follow-up|1
1032661|NCT01683838|2063297|FG001|Overall Study|Lost to Follow-up|1
1032662|NCT01683838|2063296|FG000|Overall Study|Other|4
1032663|NCT01683838|2063297|FG001|Overall Study|Other|3
1032664|NCT01683994|2063308|FG000|Overall Study|Withdrawal by Subject|1
1032665|NCT01683994|2063309|FG001|Overall Study|Withdrawal by Subject|0
1032666|NCT01683994|2063310|FG002|Overall Study|Withdrawal by Subject|0
1032667|NCT01683994|2063311|FG003|Overall Study|Withdrawal by Subject|1
1032668|NCT01683994|2063312|FG004|Overall Study|Withdrawal by Subject|0
1032669|NCT01683994|2063308|FG000|Overall Study|Intercurrent illness|0
1032670|NCT01683994|2063309|FG001|Overall Study|Intercurrent illness|0
1032671|NCT01683994|2063310|FG002|Overall Study|Intercurrent illness|0
1032672|NCT01683994|2063311|FG003|Overall Study|Intercurrent illness|2
1032673|NCT01683994|2063312|FG004|Overall Study|Intercurrent illness|1
1032674|NCT01684033|2063348|FG000|Period 1, First 30 Days|Adverse Event|1
1032675|NCT01684033|2063349|FG001|Period 1, First 30 Days|Adverse Event|1
1032676|NCT01684033|2063348|FG000|Period 1, First 30 Days|Noncompliance|1
1032677|NCT01684033|2063349|FG001|Period 1, First 30 Days|Noncompliance|0
1032678|NCT01684033|2063348|FG000|Period 1, First 30 Days|Withdrawal by Subject|1
1032679|NCT01684033|2063349|FG001|Period 1, First 30 Days|Withdrawal by Subject|0
1032680|NCT01684033|2063348|FG000|Period 1, First 30 Days|Lost to Follow-up|1
1032681|NCT01684033|2063349|FG001|Period 1, First 30 Days|Lost to Follow-up|0
1032682|NCT01684033|2063348|FG000|Period 2, Second 30 Days|Adverse Event|1
1032683|NCT01684033|2063349|FG001|Period 2, Second 30 Days|Adverse Event|0
1032684|NCT01684046|2063355|FG000|Period 1, First 30 Days|Adverse Event|0
1032685|NCT01684046|2063356|FG001|Period 1, First 30 Days|Adverse Event|2
1032686|NCT01684202|2063366|FG000|Dose-escalation Period|Adverse Event|0
1032687|NCT01684202|2063367|FG001|Dose-escalation Period|Adverse Event|1
1032688|NCT01684202|2063368|FG002|Dose-escalation Period|Adverse Event|0
1032689|NCT01684202|2063369|FG003|Dose-escalation Period|Adverse Event|0
1032690|NCT01684202|2063366|FG000|Dose-escalation Period|Withdrawal by Subject|1
1032691|NCT01684202|2063367|FG001|Dose-escalation Period|Withdrawal by Subject|0
1032692|NCT01684202|2063368|FG002|Dose-escalation Period|Withdrawal by Subject|0
1032693|NCT01684202|2063369|FG003|Dose-escalation Period|Withdrawal by Subject|0
1032694|NCT01684202|2063366|FG000|Maintenance Period|Adverse Event|1
1032695|NCT01684202|2063367|FG001|Maintenance Period|Adverse Event|1
1032696|NCT01684202|2063368|FG002|Maintenance Period|Adverse Event|1
1032697|NCT01684202|2063369|FG003|Maintenance Period|Adverse Event|1
1032698|NCT01684202|2063366|FG000|Maintenance Period|Physician Decision|0
1032699|NCT01684202|2063367|FG001|Maintenance Period|Physician Decision|1
1032700|NCT01684202|2063368|FG002|Maintenance Period|Physician Decision|0
1032701|NCT01684202|2063369|FG003|Maintenance Period|Physician Decision|0
1032702|NCT01684202|2063366|FG000|Maintenance Period|Withdrawal by Subject|0
1032703|NCT01684202|2063367|FG001|Maintenance Period|Withdrawal by Subject|1
1032704|NCT01684202|2063368|FG002|Maintenance Period|Withdrawal by Subject|0
1032705|NCT01684202|2063369|FG003|Maintenance Period|Withdrawal by Subject|0
1032706|NCT01684215|2063383|FG000|Phase 1, Part 1|Adverse Event|1
1032707|NCT01684215|2063384|FG001|Phase 1, Part 1|Adverse Event|0
1032708|NCT01684215|2063385|FG002|Phase 1, Part 1|Adverse Event|0
1032709|NCT01684215|2063386|FG003|Phase 1, Part 1|Adverse Event|0
1032710|NCT01684215|2063383|FG000|Phase 1, Part 1|Objective progression or relapse|5
1032711|NCT01684215|2063384|FG001|Phase 1, Part 1|Objective progression or relapse|6
1032712|NCT01684215|2063385|FG002|Phase 1, Part 1|Objective progression or relapse|0
1032713|NCT01684215|2063386|FG003|Phase 1, Part 1|Objective progression or relapse|0
1032714|NCT01684215|2063383|FG000|Phase 1, Part 2|Adverse Event|0
1032715|NCT01684215|2063384|FG001|Phase 1, Part 2|Adverse Event|0
1032716|NCT01684215|2063385|FG002|Phase 1, Part 2|Adverse Event|1
1032717|NCT01684215|2063386|FG003|Phase 1, Part 2|Adverse Event|0
1032718|NCT01684215|2063383|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
1032719|NCT01684215|2063384|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
1032720|NCT01684215|2063385|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
1032721|NCT01684215|2063386|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
1032722|NCT01684215|2063383|FG000|Phase 1, Part 2|Withdrawal by Subject|0
1032723|NCT01684215|2063384|FG001|Phase 1, Part 2|Withdrawal by Subject|0
1032724|NCT01684215|2063385|FG002|Phase 1, Part 2|Withdrawal by Subject|1
1032725|NCT01684215|2063386|FG003|Phase 1, Part 2|Withdrawal by Subject|0
1032726|NCT01684215|2063383|FG000|Phase 2|Death|0
1032727|NCT01684215|2063384|FG001|Phase 2|Death|0
1032728|NCT01684215|2063385|FG002|Phase 2|Death|0
1032729|NCT01684215|2063386|FG003|Phase 2|Death|8
1032730|NCT01684215|2063383|FG000|Phase 2|Study terminated by sponsor|0
1032731|NCT01684215|2063384|FG001|Phase 2|Study terminated by sponsor|0
1032732|NCT01684215|2063385|FG002|Phase 2|Study terminated by sponsor|0
1032733|NCT01684215|2063386|FG003|Phase 2|Study terminated by sponsor|30
1032734|NCT01684215|2063383|FG000|Phase 2|Enrolled but not treated|0
1032735|NCT01684215|2063384|FG001|Phase 2|Enrolled but not treated|0
1032736|NCT01684215|2063385|FG002|Phase 2|Enrolled but not treated|0
1032737|NCT01684215|2063386|FG003|Phase 2|Enrolled but not treated|1
1032738|NCT01684215|2063383|FG000|Phase 2|Lost to Follow-up|0
1032739|NCT01684215|2063384|FG001|Phase 2|Lost to Follow-up|0
1032740|NCT01684215|2063385|FG002|Phase 2|Lost to Follow-up|0
1032741|NCT01684215|2063386|FG003|Phase 2|Lost to Follow-up|4
1032742|NCT01684423|2063417|FG000|Overall Study|Withdrawal by Subject|0
1032743|NCT01684423|2063418|FG001|Overall Study|Withdrawal by Subject|0
1032744|NCT01684423|2063419|FG002|Overall Study|Withdrawal by Subject|1
1032745|NCT01684423|2063420|FG003|Overall Study|Withdrawal by Subject|0
1032746|NCT01684423|2063421|FG004|Overall Study|Withdrawal by Subject|0
1032747|NCT01684722|2063461|FG000|Overall Study|Lost to Follow-up|78
1032748|NCT01684722|2063462|FG001|Overall Study|Lost to Follow-up|56
1032749|NCT01684722|2063463|FG002|Overall Study|Lost to Follow-up|75
1032750|NCT01684722|2063464|FG003|Overall Study|Lost to Follow-up|89
1032751|NCT01684722|2063461|FG000|Overall Study|Death|19
1032752|NCT01684722|2063462|FG001|Overall Study|Death|21
1032753|NCT01684722|2063463|FG002|Overall Study|Death|19
1032754|NCT01684722|2063464|FG003|Overall Study|Death|21
1032755|NCT01684878|2063507|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1
1032756|NCT01684878|2063508|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1
1032757|NCT01684878|2063509|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0
1032758|NCT01684878|2063510|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0
1032759|NCT01684878|2063507|FG000|Part 1: Safety Run in Phase|Death|15
1032760|NCT01684878|2063508|FG001|Part 1: Safety Run in Phase|Death|20
1032761|NCT01684878|2063509|FG002|Part 1: Safety Run in Phase|Death|0
1032762|NCT01684878|2063510|FG003|Part 1: Safety Run in Phase|Death|0
1032763|NCT01684878|2063507|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0
1032764|NCT01684878|2063508|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2
1032765|NCT01684878|2063509|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0
1032766|NCT01684878|2063510|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0
1032767|NCT01684878|2063507|FG000|Part 2: Randomized Phase|Participant withdrew consent|0
1032768|NCT01684878|2063508|FG001|Part 2: Randomized Phase|Participant withdrew consent|0
1032769|NCT01684878|2063509|FG002|Part 2: Randomized Phase|Participant withdrew consent|1
1032770|NCT01684878|2063510|FG003|Part 2: Randomized Phase|Participant withdrew consent|2
1032771|NCT01684878|2063507|FG000|Part 2: Randomized Phase|Lost to Follow-up|0
1032772|NCT01684878|2063508|FG001|Part 2: Randomized Phase|Lost to Follow-up|0
1032773|NCT01684878|2063509|FG002|Part 2: Randomized Phase|Lost to Follow-up|2
1032774|NCT01684878|2063510|FG003|Part 2: Randomized Phase|Lost to Follow-up|0
1032775|NCT01684878|2063507|FG000|Part 2: Randomized Phase|Death|0
1032776|NCT01684878|2063508|FG001|Part 2: Randomized Phase|Death|0
1032777|NCT01684878|2063509|FG002|Part 2: Randomized Phase|Death|62
1032778|NCT01684878|2063510|FG003|Part 2: Randomized Phase|Death|68
1032779|NCT01684878|2063507|FG000|Part 2: Randomized Phase|Alive at data-cut|0
1032780|NCT01684878|2063508|FG001|Part 2: Randomized Phase|Alive at data-cut|0
1032781|NCT01684878|2063509|FG002|Part 2: Randomized Phase|Alive at data-cut|13
1032782|NCT01684878|2063510|FG003|Part 2: Randomized Phase|Alive at data-cut|7
1032783|NCT01684878|2063507|FG000|Part 2: Randomized Phase|Participant noncompliance|0
1032784|NCT01684878|2063508|FG001|Part 2: Randomized Phase|Participant noncompliance|0
1032785|NCT01684878|2063509|FG002|Part 2: Randomized Phase|Participant noncompliance|0
1032786|NCT01684878|2063510|FG003|Part 2: Randomized Phase|Participant noncompliance|1
1032787|NCT01684930|2063539|FG000|Overall Study|Withdrawal by Subject|3
1032788|NCT01684930|2063540|FG001|Overall Study|Withdrawal by Subject|1
1032789|NCT01684943|2063549|FG000|Overall Study|Inadequate Venous Access|3
1032790|NCT01684943|2063550|FG001|Overall Study|Inadequate Venous Access|0
1032791|NCT01684943|2063551|FG002|Overall Study|Inadequate Venous Access|0
1032792|NCT01684943|2063549|FG000|Overall Study|Principal Investigator Determination|1
1032793|NCT01684943|2063550|FG001|Overall Study|Principal Investigator Determination|0
1032794|NCT01684943|2063551|FG002|Overall Study|Principal Investigator Determination|0
1032795|NCT01684943|2063549|FG000|Overall Study|Excluded from Analysis|1
1032796|NCT01684943|2063550|FG001|Overall Study|Excluded from Analysis|1
1032797|NCT01684943|2063551|FG002|Overall Study|Excluded from Analysis|1
1032798|NCT01684943|2063549|FG000|Overall Study|Lost to Follow-up|3
1032799|NCT01684943|2063550|FG001|Overall Study|Lost to Follow-up|0
1032800|NCT01684943|2063551|FG002|Overall Study|Lost to Follow-up|0
1032801|NCT01684943|2063549|FG000|Overall Study|Planning Pregnancy|1
1032802|NCT01684943|2063550|FG001|Overall Study|Planning Pregnancy|0
1032803|NCT01684943|2063551|FG002|Overall Study|Planning Pregnancy|0
1032804|NCT01685047|2063568|FG000|Overall Study|Withdrawal by Subject|20
1032805|NCT01685047|2063568|FG000|Overall Study|Death|26
1032806|NCT01685047|2063568|FG000|Overall Study|Lost to Follow-up|8
1032807|NCT01685047|2063568|FG000|Overall Study|Physician Decision|25
1032808|NCT01685047|2063568|FG000|Overall Study|Adverse Event|5
1032809|NCT01685047|2063568|FG000|Overall Study|patient withdrawn by sponsor|1
1032810|NCT01685060|2063572|FG000|Overall Study|Rollover patients|16
1032811|NCT01685060|2063572|FG000|Overall Study|Adverse Event|12
1032812|NCT01685060|2063572|FG000|Overall Study|Progressive disease|69
1032813|NCT01685060|2063572|FG000|Overall Study|Physician Decision|14
1032814|NCT01685060|2063572|FG000|Overall Study|Subject/guardian decision|20
1032815|NCT01685060|2063572|FG000|Overall Study|Lost to Follow-up|1
1032816|NCT01685060|2063572|FG000|Overall Study|Death|8
1032817|NCT01685073|2063578|FG000|Overall Study|Lost to Follow-up|6
1032818|NCT01685073|2063579|FG001|Overall Study|Lost to Follow-up|8
1032819|NCT01685073|2063578|FG000|Overall Study|Withdrawal by Subject|24
1032820|NCT01685073|2063579|FG001|Overall Study|Withdrawal by Subject|24
1032821|NCT01685138|2063585|FG000|Overall Study|Lost to Follow-up|1
1032822|NCT01685138|2063585|FG000|Overall Study|Protocol Violation|1
1032823|NCT01685138|2063585|FG000|Overall Study|No longer requires treatment|1
1032824|NCT01685138|2063585|FG000|Overall Study|Subject/guardian decision|2
1032825|NCT01685138|2063585|FG000|Overall Study|Physician Decision|6
1032826|NCT01685138|2063585|FG000|Overall Study|Death|10
1032827|NCT01685138|2063585|FG000|Overall Study|Adverse Event|18
1032828|NCT01685138|2063585|FG000|Overall Study|Progressive disease|53
1032829|NCT01685203|2063596|FG000|Overall Study|Lost to Follow-up|3
1032830|NCT01685203|2063597|FG001|Overall Study|Lost to Follow-up|3
1032831|NCT01685203|2063598|FG002|Overall Study|Lost to Follow-up|0
1032832|NCT01685203|2063599|FG003|Overall Study|Lost to Follow-up|1
1032833|NCT01685203|2063600|FG004|Overall Study|Lost to Follow-up|0
1032834|NCT01685203|2063601|FG005|Overall Study|Lost to Follow-up|0
1032835|NCT01685203|2063602|FG006|Overall Study|Lost to Follow-up|0
1032836|NCT01685203|2063596|FG000|Overall Study|Adverse Event|0
1032837|NCT01685203|2063597|FG001|Overall Study|Adverse Event|0
1032838|NCT01685203|2063598|FG002|Overall Study|Adverse Event|0
1032839|NCT01685203|2063599|FG003|Overall Study|Adverse Event|0
1032840|NCT01685203|2063600|FG004|Overall Study|Adverse Event|0
1032841|NCT01685203|2063601|FG005|Overall Study|Adverse Event|2
1032842|NCT01685203|2063602|FG006|Overall Study|Adverse Event|0
1032843|NCT01685203|2063596|FG000|Overall Study|Adverse event and withdrew consent|1
1032844|NCT01685203|2063597|FG001|Overall Study|Adverse event and withdrew consent|0
1032845|NCT01685203|2063598|FG002|Overall Study|Adverse event and withdrew consent|0
1032846|NCT01685203|2063599|FG003|Overall Study|Adverse event and withdrew consent|0
1032847|NCT01685203|2063600|FG004|Overall Study|Adverse event and withdrew consent|0
1032848|NCT01685203|2063601|FG005|Overall Study|Adverse event and withdrew consent|0
1032849|NCT01685203|2063602|FG006|Overall Study|Adverse event and withdrew consent|0
1032850|NCT01685203|2063596|FG000|Overall Study|Patient's decision|0
1032851|NCT01685203|2063597|FG001|Overall Study|Patient's decision|0
1032852|NCT01685203|2063598|FG002|Overall Study|Patient's decision|0
1032853|NCT01685203|2063599|FG003|Overall Study|Patient's decision|0
1032854|NCT01685203|2063600|FG004|Overall Study|Patient's decision|0
1032855|NCT01685203|2063601|FG005|Overall Study|Patient's decision|1
1032856|NCT01685203|2063602|FG006|Overall Study|Patient's decision|0
1032857|NCT01685216|2063618|FG000|Overall Study|Did not receive study drug|1
1032858|NCT01685229|2063624|FG000|Overall Study|Subjects missing Study Exit form|3
1032859|NCT01685229|2063625|FG001|Overall Study|Subjects missing Study Exit form|1
1032860|NCT01685229|2063624|FG000|Overall Study|Lost to Follow-up|16
1032861|NCT01685229|2063625|FG001|Overall Study|Lost to Follow-up|10
1032862|NCT01685229|2063624|FG000|Overall Study|Withdrawal by Subject|6
1032863|NCT01685229|2063625|FG001|Overall Study|Withdrawal by Subject|5
1032864|NCT01685229|2063624|FG000|Overall Study|Death|1
1032865|NCT01685229|2063625|FG001|Overall Study|Death|0
1032866|NCT01685372|2063654|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
1032867|NCT01685372|2063655|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
1032868|NCT01685437|2063665|FG000|Overall Study|Withdrawal by Subject|22
1032869|NCT01685437|2063665|FG000|Overall Study|Lost to Follow-up|3
1032870|NCT01685437|2063665|FG000|Overall Study|Adverse Event|1
1032871|NCT01685437|2063665|FG000|Overall Study|Protocol Violation|4
1032872|NCT01685437|2063665|FG000|Overall Study|Unable to make visits due to work|1
1032873|NCT01685606|2063682|FG000|Overall Study|Withdrawal by Subject|1
1032874|NCT01685697|2063700|FG000|Overall Study|Protocol Violation|3
1032875|NCT01685697|2063701|FG001|Overall Study|Protocol Violation|3
1032876|NCT01685801|2063711|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1032877|NCT01685801|2063712|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1032878|NCT01685801|2063713|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1032879|NCT01685801|2063714|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
1032880|NCT01685801|2063711|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
1032881|NCT01685801|2063712|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
1032882|NCT01685801|2063713|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
1032883|NCT01685801|2063714|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
1032884|NCT01685840|2063733|FG000|Overall Study|Death|77
1032885|NCT01685840|2063734|FG001|Overall Study|Death|66
905132|NCT00760929|1880354|FG001|Overall Study|Death|0
905133|NCT00760929|1880355|FG002|Overall Study|Death|1
905134|NCT00760929|1880356|FG003|Overall Study|Death|0
905135|NCT00760929|1880353|FG000|Overall Study|Violation of Selection Criteria at Entry|0
905136|NCT00760929|1880354|FG001|Overall Study|Violation of Selection Criteria at Entry|0
905137|NCT00760929|1880355|FG002|Overall Study|Violation of Selection Criteria at Entry|0
905138|NCT00760929|1880356|FG003|Overall Study|Violation of Selection Criteria at Entry|1
905139|NCT00760994|1880368|FG000|Overall Study|Lost to Follow-up|4
905140|NCT00760994|1880369|FG001|Overall Study|Lost to Follow-up|4
905141|NCT00760994|1880370|FG002|Overall Study|Lost to Follow-up|3
905142|NCT00761150|1880424|FG000|Open-label Period|Adverse Event|36
905143|NCT00761150|1880425|FG001|Open-label Period|Adverse Event|0
905144|NCT00761150|1880426|FG002|Open-label Period|Adverse Event|0
1032886|NCT01685840|2063733|FG000|Overall Study|Lost to Follow-up|27
1032887|NCT01685840|2063734|FG001|Overall Study|Lost to Follow-up|25
1032888|NCT01685840|2063733|FG000|Overall Study|Physician Decision|3
1032889|NCT01685840|2063734|FG001|Overall Study|Physician Decision|7
1032890|NCT01685840|2063733|FG000|Overall Study|Withdrawal by Subject|14
1032891|NCT01685840|2063734|FG001|Overall Study|Withdrawal by Subject|17
1032892|NCT01685840|2063733|FG000|Overall Study|Futility|197
1032893|NCT01685840|2063734|FG001|Overall Study|Futility|200
1032894|NCT01685840|2063733|FG000|Overall Study|Had VAD, Dialysis or Transplant|11
1032895|NCT01685840|2063734|FG001|Overall Study|Had VAD, Dialysis or Transplant|17
1032896|NCT01685983|2063742|FG000|Overall Study|Adverse Event|7
1032897|NCT01685983|2063742|FG000|Overall Study|Death|1
1032898|NCT01685983|2063742|FG000|Overall Study|Withdrawal by Subject|19
1032899|NCT01685983|2063742|FG000|Overall Study|Protocol Violation|2
1032900|NCT01685983|2063742|FG000|Overall Study|Physician Decision|13
1032901|NCT01685983|2063742|FG000|Overall Study|Other|7
1032902|NCT01685983|2063742|FG000|Overall Study|Progressive Disease|32
1032903|NCT01685983|2063742|FG000|Overall Study|Noncompliance with Study Drug|1
1032904|NCT01686152|2063758|FG000|Overall Study|Withdrawal by Subject|11
1032905|NCT01686152|2063759|FG001|Overall Study|Withdrawal by Subject|11
1032906|NCT01686152|2063760|FG002|Overall Study|Withdrawal by Subject|3
1032907|NCT01686152|2063758|FG000|Overall Study|Drug Code Unblinded|0
1032908|NCT01686152|2063759|FG001|Overall Study|Drug Code Unblinded|1
1032909|NCT01686152|2063760|FG002|Overall Study|Drug Code Unblinded|0
1032910|NCT01686152|2063758|FG000|Overall Study|Protocol Violation|6
1032911|NCT01686152|2063759|FG001|Overall Study|Protocol Violation|1
1032912|NCT01686152|2063760|FG002|Overall Study|Protocol Violation|0
1032913|NCT01686152|2063758|FG000|Overall Study|Adverse Event|12
1032914|NCT01686152|2063759|FG001|Overall Study|Adverse Event|11
1032915|NCT01686152|2063760|FG002|Overall Study|Adverse Event|0
1032916|NCT01686152|2063758|FG000|Overall Study|Lack of Efficacy|0
1032917|NCT01686152|2063759|FG001|Overall Study|Lack of Efficacy|0
1032918|NCT01686152|2063760|FG002|Overall Study|Lack of Efficacy|1
1032919|NCT01686152|2063758|FG000|Overall Study|IP Non-compliance|5
1032920|NCT01686152|2063759|FG001|Overall Study|IP Non-compliance|5
1032921|NCT01686152|2063760|FG002|Overall Study|IP Non-compliance|0
1032922|NCT01686152|2063758|FG000|Overall Study|Lost to Follow-up|7
1032923|NCT01686152|2063759|FG001|Overall Study|Lost to Follow-up|6
1032924|NCT01686152|2063760|FG002|Overall Study|Lost to Follow-up|5
1032925|NCT01686373|2063774|FG000|Overall Study|Lost to Follow-up|3
1032926|NCT01686373|2063775|FG001|Overall Study|Lost to Follow-up|0
1032927|NCT01686373|2063774|FG000|Overall Study|Withdrawal by Subject|0
1032928|NCT01686373|2063775|FG001|Overall Study|Withdrawal by Subject|1
1032929|NCT01686373|2063774|FG000|Overall Study|Adverse Event|0
1032930|NCT01686373|2063775|FG001|Overall Study|Adverse Event|1
1032931|NCT01686438|2063784|FG000|Overall Study|Lost to Follow-up|8
1032932|NCT01686438|2063785|FG001|Overall Study|Lost to Follow-up|9
1032933|NCT01686438|2063786|FG002|Overall Study|Lost to Follow-up|10
1032934|NCT01686438|2063784|FG000|Overall Study|Adverse Event|0
1032935|NCT01686438|2063785|FG001|Overall Study|Adverse Event|0
1032936|NCT01686438|2063786|FG002|Overall Study|Adverse Event|1
1032937|NCT01686438|2063784|FG000|Overall Study|Protocol Violation|0
1032938|NCT01686438|2063785|FG001|Overall Study|Protocol Violation|0
1032939|NCT01686438|2063786|FG002|Overall Study|Protocol Violation|1
1032940|NCT01686438|2063784|FG000|Overall Study|Withdrawal by Subject|0
1032941|NCT01686438|2063785|FG001|Overall Study|Withdrawal by Subject|0
1032942|NCT01686438|2063786|FG002|Overall Study|Withdrawal by Subject|1
1032943|NCT01686568|2063826|FG000|Main Study|Withdrawal by Subject|1
1032944|NCT01686568|2063827|FG001|Main Study|Withdrawal by Subject|3
1032945|NCT01686568|2063826|FG000|Main Study|Noncompliance with protocol|0
1032946|NCT01686568|2063827|FG001|Main Study|Noncompliance with protocol|1
1032947|NCT01686568|2063826|FG000|Main Study|Liver enzymes above range of exclusion|1
1032948|NCT01686568|2063827|FG001|Main Study|Liver enzymes above range of exclusion|0
1032949|NCT01686568|2063826|FG000|Sub-Study|Not consented for sub-study|2
1032950|NCT01686568|2063827|FG001|Sub-Study|Not consented for sub-study|2
1032951|NCT01686581|2063833|FG000|Overall Study|Side-effects or Health Problems|15
1032952|NCT01686581|2063833|FG000|Overall Study|Lack of Efficacy|90
1032953|NCT01686581|2063833|FG000|Overall Study|Participant Concerned about Risks|6
1032954|NCT01686581|2063833|FG000|Overall Study|Thinks Injections Too Painful|8
1032955|NCT01686581|2063833|FG000|Overall Study|Thinks Injections Take Too Much Time|2
1032956|NCT01686581|2063833|FG000|Overall Study|Trying to get Pregnant or Nursing|2
1032957|NCT01686581|2063833|FG000|Overall Study|Thinks it is Inconvenient|17
1032958|NCT01686581|2063833|FG000|Overall Study|Other Miscellaneous Reasons|36
1032959|NCT01686581|2063833|FG000|Overall Study|Reason Missing|1
1032960|NCT01686633|2063840|FG000|Overall Study|Lack of Efficacy|33
1032961|NCT01686633|2063841|FG001|Overall Study|Lack of Efficacy|13
1032962|NCT01686633|2063842|FG002|Overall Study|Lack of Efficacy|11
1032963|NCT01686633|2063840|FG000|Overall Study|Withdrawal by Subject|8
1032964|NCT01686633|2063841|FG001|Overall Study|Withdrawal by Subject|8
1032965|NCT01686633|2063842|FG002|Overall Study|Withdrawal by Subject|5
1032966|NCT01686633|2063840|FG000|Overall Study|Physician Decision|3
1032967|NCT01686633|2063841|FG001|Overall Study|Physician Decision|4
1032968|NCT01686633|2063842|FG002|Overall Study|Physician Decision|4
1032969|NCT01686633|2063840|FG000|Overall Study|Adverse Event|4
1032970|NCT01686633|2063841|FG001|Overall Study|Adverse Event|3
1032971|NCT01686633|2063842|FG002|Overall Study|Adverse Event|3
1032972|NCT01686633|2063840|FG000|Overall Study|Protocol Violation|2
1032973|NCT01686633|2063841|FG001|Overall Study|Protocol Violation|3
1032974|NCT01686633|2063842|FG002|Overall Study|Protocol Violation|0
1032975|NCT01686633|2063840|FG000|Overall Study|Protocol-defined Stopping Criteria|1
1032976|NCT01686633|2063841|FG001|Overall Study|Protocol-defined Stopping Criteria|0
1032977|NCT01686633|2063842|FG002|Overall Study|Protocol-defined Stopping Criteria|1
1032978|NCT01686633|2063840|FG000|Overall Study|Lost to Follow-up|0
1032979|NCT01686633|2063841|FG001|Overall Study|Lost to Follow-up|1
1032980|NCT01686633|2063842|FG002|Overall Study|Lost to Follow-up|1
1032981|NCT01686828|2063882|FG000|Overall Study|Physician Decision|1
1032982|NCT01686828|2063883|FG001|Overall Study|Physician Decision|0
1032983|NCT01686828|2063884|FG002|Overall Study|Physician Decision|0
1032984|NCT01686828|2063885|FG003|Overall Study|Physician Decision|0
1032985|NCT01686828|2063882|FG000|Overall Study|New Job|0
1032986|NCT01686828|2063883|FG001|Overall Study|New Job|1
1032987|NCT01686828|2063884|FG002|Overall Study|New Job|0
1032988|NCT01686828|2063885|FG003|Overall Study|New Job|0
1032989|NCT01686828|2063882|FG000|Overall Study|Weight Loss|0
1032990|NCT01686828|2063883|FG001|Overall Study|Weight Loss|0
1032991|NCT01686828|2063884|FG002|Overall Study|Weight Loss|1
1032992|NCT01686828|2063885|FG003|Overall Study|Weight Loss|0
1032993|NCT01686932|2063901|FG000|Period 1|Adverse Event|1
1032994|NCT01686932|2063902|FG001|Period 1|Adverse Event|1
1032995|NCT01686958|2063908|FG000|Overall Study|Withdrawal by Subject|1
1032996|NCT01687101|2063926|FG000|Overall Study|Lost to Follow-up|7
1032997|NCT01687166|2063938|FG000|Overall Study|Attempt subject|2
1032998|NCT01687166|2063939|FG001|Overall Study|Attempt subject|3
1032999|NCT01687166|2063940|FG002|Overall Study|Attempt subject|2
1033000|NCT01687166|2063941|FG003|Overall Study|Attempt subject|0
1033001|NCT01687166|2063938|FG000|Overall Study|Did not meet eligibility criteria|4
1033002|NCT01687166|2063939|FG001|Overall Study|Did not meet eligibility criteria|6
1033003|NCT01687166|2063940|FG002|Overall Study|Did not meet eligibility criteria|1
1033004|NCT01687166|2063941|FG003|Overall Study|Did not meet eligibility criteria|1
1033005|NCT01687166|2063938|FG000|Overall Study|Adverse Event|2
1033006|NCT01687166|2063939|FG001|Overall Study|Adverse Event|1
1033007|NCT01687166|2063940|FG002|Overall Study|Adverse Event|0
1033008|NCT01687166|2063941|FG003|Overall Study|Adverse Event|0
1033009|NCT01687166|2063938|FG000|Overall Study|Physician Decision|3
1033010|NCT01687166|2063939|FG001|Overall Study|Physician Decision|2
1033011|NCT01687166|2063940|FG002|Overall Study|Physician Decision|1
1033012|NCT01687166|2063941|FG003|Overall Study|Physician Decision|0
1033013|NCT01687166|2063938|FG000|Overall Study|Withdrawal by Subject|11
1033014|NCT01687166|2063939|FG001|Overall Study|Withdrawal by Subject|4
1033015|NCT01687166|2063940|FG002|Overall Study|Withdrawal by Subject|3
1033016|NCT01687166|2063941|FG003|Overall Study|Withdrawal by Subject|0
1033017|NCT01687166|2063938|FG000|Overall Study|Lost to Follow-up|2
1033018|NCT01687166|2063939|FG001|Overall Study|Lost to Follow-up|5
1033019|NCT01687166|2063940|FG002|Overall Study|Lost to Follow-up|1
1033020|NCT01687166|2063941|FG003|Overall Study|Lost to Follow-up|0
1033021|NCT01687166|2063938|FG000|Overall Study|Equipment/Device Availability|0
1033022|NCT01687166|2063939|FG001|Overall Study|Equipment/Device Availability|1
1033023|NCT01687166|2063940|FG002|Overall Study|Equipment/Device Availability|0
1033024|NCT01687166|2063941|FG003|Overall Study|Equipment/Device Availability|0
1033025|NCT01687166|2063938|FG000|Overall Study|Death|1
1033026|NCT01687166|2063939|FG001|Overall Study|Death|1
1033027|NCT01687166|2063940|FG002|Overall Study|Death|0
1033028|NCT01687166|2063941|FG003|Overall Study|Death|0
1033029|NCT01687166|2063938|FG000|Overall Study|Protocol Violation|1
1033030|NCT01687166|2063939|FG001|Overall Study|Protocol Violation|1
1033031|NCT01687166|2063940|FG002|Overall Study|Protocol Violation|1
1033032|NCT01687166|2063941|FG003|Overall Study|Protocol Violation|0
1033033|NCT01687166|2063938|FG000|Overall Study|Subject moved out of state|0
1033034|NCT01687166|2063939|FG001|Overall Study|Subject moved out of state|1
1033035|NCT01687166|2063940|FG002|Overall Study|Subject moved out of state|0
1033036|NCT01687166|2063941|FG003|Overall Study|Subject moved out of state|0
1033037|NCT01687166|2063938|FG000|Overall Study|Patient unable to be compliant|1
1033038|NCT01687166|2063939|FG001|Overall Study|Patient unable to be compliant|0
1033039|NCT01687166|2063940|FG002|Overall Study|Patient unable to be compliant|0
1033040|NCT01687166|2063941|FG003|Overall Study|Patient unable to be compliant|0
1033041|NCT01687166|2063938|FG000|Overall Study|Physician choice to use different device|1
1033042|NCT01687166|2063939|FG001|Overall Study|Physician choice to use different device|2
1033043|NCT01687166|2063940|FG002|Overall Study|Physician choice to use different device|4
1033044|NCT01687166|2063941|FG003|Overall Study|Physician choice to use different device|0
1033045|NCT01687166|2063938|FG000|Overall Study|Insurance|0
1033046|NCT01687166|2063939|FG001|Overall Study|Insurance|0
1033047|NCT01687166|2063940|FG002|Overall Study|Insurance|1
1033048|NCT01687166|2063941|FG003|Overall Study|Insurance|1
1033049|NCT01687218|2063962|FG000|Overall Study|Withdrawal by Subject|2
1033050|NCT01687218|2063963|FG001|Overall Study|Withdrawal by Subject|3
1033051|NCT01687218|2063964|FG002|Overall Study|Withdrawal by Subject|0
1033052|NCT01687218|2063965|FG003|Overall Study|Withdrawal by Subject|1
1033053|NCT01687218|2063966|FG004|Overall Study|Withdrawal by Subject|1
1033054|NCT01687218|2063967|FG005|Overall Study|Withdrawal by Subject|0
1033055|NCT01687218|2063962|FG000|Overall Study|Relocated, no follow-up planned|1
1033056|NCT01687218|2063963|FG001|Overall Study|Relocated, no follow-up planned|0
1033057|NCT01687218|2063964|FG002|Overall Study|Relocated, no follow-up planned|1
1033058|NCT01687218|2063965|FG003|Overall Study|Relocated, no follow-up planned|1
1033059|NCT01687218|2063966|FG004|Overall Study|Relocated, no follow-up planned|0
1033060|NCT01687218|2063967|FG005|Overall Study|Relocated, no follow-up planned|0
1033061|NCT01687257|2063994|FG000|Overall Study|Efficacy Failure|6
1033062|NCT01687257|2063995|FG001|Overall Study|Efficacy Failure|0
1033063|NCT01687257|2063996|FG002|Overall Study|Efficacy Failure|5
1033064|NCT01687257|2063994|FG000|Overall Study|Subject Withdrew Consent|1
1033065|NCT01687257|2063995|FG001|Overall Study|Subject Withdrew Consent|1
1033066|NCT01687257|2063996|FG002|Overall Study|Subject Withdrew Consent|1
1033067|NCT01687257|2063994|FG000|Overall Study|Adverse Event|1
1033068|NCT01687257|2063995|FG001|Overall Study|Adverse Event|0
1033069|NCT01687257|2063996|FG002|Overall Study|Adverse Event|0
1033070|NCT01687257|2063994|FG000|Overall Study|Investigator's Discretion|0
1033071|NCT01687257|2063995|FG001|Overall Study|Investigator's Discretion|3
1033072|NCT01687257|2063996|FG002|Overall Study|Investigator's Discretion|0
1033073|NCT01687270|2064010|FG000|Overall Study|Lack of Efficacy|11
1033074|NCT01687270|2064010|FG000|Overall Study|Lost to Follow-up|1
1033075|NCT01687283|2064016|FG000|Overall Study|Adverse Event|11
1033076|NCT01687283|2064017|FG001|Overall Study|Adverse Event|4
1033077|NCT01687283|2064016|FG000|Overall Study|Lack of Efficacy|3
1033078|NCT01687283|2064017|FG001|Overall Study|Lack of Efficacy|1
1033079|NCT01687283|2064016|FG000|Overall Study|Protocol Violation|1
1033080|NCT01687283|2064017|FG001|Overall Study|Protocol Violation|3
1033081|NCT01687283|2064016|FG000|Overall Study|protocol defined stopping criteria|8
1033082|NCT01687283|2064017|FG001|Overall Study|protocol defined stopping criteria|10
1033083|NCT01687283|2064016|FG000|Overall Study|Lost to Follow-up|1
1033084|NCT01687283|2064017|FG001|Overall Study|Lost to Follow-up|1
1033085|NCT01687283|2064016|FG000|Overall Study|Investigator discretion|2
1033086|NCT01687283|2064017|FG001|Overall Study|Investigator discretion|0
1033087|NCT01687283|2064016|FG000|Overall Study|Withdrawal by Subject|9
1033088|NCT01687283|2064017|FG001|Overall Study|Withdrawal by Subject|8
1033089|NCT01687296|2064025|FG000|Overall Study|Lack of Efficacy|1
1033090|NCT01687296|2064026|FG001|Overall Study|Lack of Efficacy|1
1033091|NCT01687296|2064025|FG000|Overall Study|Protocol Violation|0
1033092|NCT01687296|2064026|FG001|Overall Study|Protocol Violation|1
1033093|NCT01687296|2064025|FG000|Overall Study|Withdrawal by Subject|6
1033094|NCT01687296|2064026|FG001|Overall Study|Withdrawal by Subject|3
1033095|NCT01687413|2064056|FG000|Overall Study|Withdrawal by Subject|0
1033096|NCT01687413|2064057|FG001|Overall Study|Withdrawal by Subject|2
1033097|NCT01687413|2064056|FG000|Overall Study|Not eligible|0
1033098|NCT01687413|2064057|FG001|Overall Study|Not eligible|2
1033099|NCT01687413|2064056|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1
1033100|NCT01687413|2064057|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0
1033101|NCT01687478|2064083|FG000|Overall Study|Adverse Event|3
1033102|NCT01687478|2064084|FG001|Overall Study|Adverse Event|10
1033103|NCT01687478|2064083|FG000|Overall Study|Lost to Follow-up|1
1033104|NCT01687478|2064084|FG001|Overall Study|Lost to Follow-up|3
1033105|NCT01687478|2064083|FG000|Overall Study|Protocol Violation|0
1033106|NCT01687478|2064084|FG001|Overall Study|Protocol Violation|2
1033107|NCT01687478|2064083|FG000|Overall Study|Withdrawal by Subject|21
1033108|NCT01687478|2064084|FG001|Overall Study|Withdrawal by Subject|19
1033109|NCT01687478|2064083|FG000|Overall Study|Physician Decision|1
1033110|NCT01687478|2064084|FG001|Overall Study|Physician Decision|3
1033111|NCT01687478|2064083|FG000|Overall Study|Entry Criteria Not Met|6
1033112|NCT01687478|2064084|FG001|Overall Study|Entry Criteria Not Met|2
1033113|NCT01687595|2064092|FG000|Overall Study|Withdrawal by Subject|8
1033114|NCT01687595|2064093|FG001|Overall Study|Withdrawal by Subject|0
1033115|NCT01687595|2064092|FG000|Overall Study|Lost to Follow-up|3
1033116|NCT01687595|2064093|FG001|Overall Study|Lost to Follow-up|1
1033117|NCT01687595|2064092|FG000|Overall Study|Investigator's decision|1
1033118|NCT01687595|2064093|FG001|Overall Study|Investigator's decision|0
1033119|NCT01687595|2064092|FG000|Overall Study|Sponsor's decision|1
1033120|NCT01687595|2064093|FG001|Overall Study|Sponsor's decision|0
1033121|NCT01687595|2064092|FG000|Overall Study|Noncompliance|1
1033122|NCT01687595|2064093|FG001|Overall Study|Noncompliance|2
1033123|NCT01687595|2064092|FG000|Overall Study|Other than specified|56
1033124|NCT01687595|2064093|FG001|Overall Study|Other than specified|7
1033125|NCT01687673|2064099|FG000|Overall Study|Physician Decision|1
1033126|NCT01687712|2064105|FG000|Cycle 1|Not Biochemically Pregnant|386
1033127|NCT01687712|2064106|FG001|Cycle 1|Not Biochemically Pregnant|348
1033128|NCT01687712|2064105|FG000|Cycle 1|Early Pregnancy Loss|43
1033129|NCT01687712|2064106|FG001|Cycle 1|Early Pregnancy Loss|60
1033130|NCT01687712|2064105|FG000|Cycle 1|Ectopic Pregnancy|5
1033131|NCT01687712|2064106|FG001|Cycle 1|Ectopic Pregnancy|5
1033132|NCT01687712|2064105|FG000|Cycle 1|Heterotropic Pregnancy|1
1033133|NCT01687712|2064106|FG001|Cycle 1|Heterotropic Pregnancy|0
1033134|NCT01687712|2064105|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9
1033135|NCT01687712|2064106|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14
1033136|NCT01687712|2064105|FG000|Cycle 1|Abortion|3
1033137|NCT01687712|2064106|FG001|Cycle 1|Abortion|0
1033138|NCT01687712|2064105|FG000|Cycle 1|Intrauterine Fetal Death|0
1033139|NCT01687712|2064106|FG001|Cycle 1|Intrauterine Fetal Death|1
1033140|NCT01687712|2064105|FG000|Cycle 1|Lost to Follow-up|1
1033141|NCT01687712|2064106|FG001|Cycle 1|Lost to Follow-up|1
1033142|NCT01687712|2064105|FG000|Cycle 2|Not Biochemically Pregnant|74
1033143|NCT01687712|2064106|FG001|Cycle 2|Not Biochemically Pregnant|77
1033144|NCT01687712|2064105|FG000|Cycle 2|Early Pregnancy Loss|18
1033145|NCT01687712|2064106|FG001|Cycle 2|Early Pregnancy Loss|16
1033146|NCT01687712|2064105|FG000|Cycle 2|Ectopic Pregnancy|0
1033147|NCT01687712|2064106|FG001|Cycle 2|Ectopic Pregnancy|1
1033148|NCT01687712|2064105|FG000|Cycle 2|Still Birth|1
1033149|NCT01687712|2064106|FG001|Cycle 2|Still Birth|0
1033150|NCT01687712|2064105|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0
1033151|NCT01687712|2064106|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1
1033152|NCT01687712|2064105|FG000|Cycle 3|Not Biochemically Pregnant|21
1033153|NCT01687712|2064106|FG001|Cycle 3|Not Biochemically Pregnant|22
1033154|NCT01687712|2064105|FG000|Cycle 3|Early Pregnancy Loss|1
1033155|NCT01687712|2064106|FG001|Cycle 3|Early Pregnancy Loss|2
1033156|NCT01687712|2064105|FG000|Cycle 3|Ectopic Pregnancy|1
1033157|NCT01687712|2064106|FG001|Cycle 3|Ectopic Pregnancy|0
1033158|NCT01687712|2064105|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1
1033159|NCT01687712|2064106|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0
1033160|NCT01687998|2064132|FG000|Overall Study|Withdrawal by Subject|49
1033161|NCT01687998|2064133|FG001|Overall Study|Withdrawal by Subject|51
1033162|NCT01687998|2064132|FG000|Overall Study|Known to be Alive at Study End|54
1033163|NCT01687998|2064133|FG001|Overall Study|Known to be Alive at Study End|62
1033164|NCT01687998|2064132|FG000|Overall Study|Lost to Follow-up|9
1033165|NCT01687998|2064133|FG001|Overall Study|Lost to Follow-up|7
1033166|NCT01688037|2064142|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1
1033167|NCT01688037|2064143|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
1033168|NCT01688037|2064144|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1
1033169|NCT01688037|2064142|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1
1033170|NCT01688037|2064143|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
1033171|NCT01688037|2064144|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3
1033172|NCT01688037|2064142|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
1033173|NCT01688037|2064143|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
1033174|NCT01688037|2064144|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
1033175|NCT01688037|2064142|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1033176|NCT01688037|2064143|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
1033177|NCT01688037|2064144|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1033178|NCT01688037|2064142|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0
1033179|NCT01688037|2064143|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1
1033180|NCT01688037|2064144|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0
1033181|NCT01688037|2064142|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4
1033182|NCT01688037|2064143|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1
1033183|NCT01688037|2064144|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1
1033184|NCT01688037|2064142|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0
1033185|NCT01688037|2064143|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0
1033186|NCT01688037|2064144|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2
1033187|NCT01688037|2064142|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
1033188|NCT01688037|2064143|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
1033189|NCT01688037|2064144|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
1033190|NCT01688037|2064142|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
1033191|NCT01688037|2064143|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
1033192|NCT01688037|2064144|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
1033193|NCT01688037|2064142|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
1033194|NCT01688037|2064143|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
1033195|NCT01688037|2064144|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
1033196|NCT01688050|2064156|FG000|Overall Study|Death|7
1033197|NCT01688050|2064156|FG000|Overall Study|Conversion to open repair|1
1033198|NCT01688050|2064156|FG000|Overall Study|Lost to Follow-up|13
1033199|NCT01688050|2064156|FG000|Overall Study|Withdrawal by Subject|10
1033200|NCT01688466|2064196|FG000|Overall Study|Withdrawal by Subject|2
1033201|NCT01688466|2064197|FG001|Overall Study|Withdrawal by Subject|1
1033202|NCT01688466|2064196|FG000|Overall Study|Death|0
1033203|NCT01688466|2064197|FG001|Overall Study|Death|1
1033204|NCT01688466|2064196|FG000|Overall Study|Adverse Event|0
1033205|NCT01688466|2064197|FG001|Overall Study|Adverse Event|4
1033206|NCT01688466|2064196|FG000|Overall Study|Not evaluable|0
1033207|NCT01688466|2064197|FG001|Overall Study|Not evaluable|1
1033208|NCT01688635|2064216|FG000|Washout 1|Withdrawal by Subject|1
1033209|NCT01688635|2064217|FG001|Washout 1|Withdrawal by Subject|0
1033210|NCT01688635|2064216|FG000|Washout 1|Adverse Event|0
1033211|NCT01688635|2064217|FG001|Washout 1|Adverse Event|1
1033212|NCT01688635|2064216|FG000|Washout 1|Physician Decision|0
1033213|NCT01688635|2064217|FG001|Washout 1|Physician Decision|1
1033214|NCT01688635|2064216|FG000|Washout 2|Physician Decision|1
1033215|NCT01688635|2064217|FG001|Washout 2|Physician Decision|0
1033216|NCT01688635|2064216|FG000|Washout 2|Withdrawal by Subject|1
1033217|NCT01688635|2064217|FG001|Washout 2|Withdrawal by Subject|0
1033218|NCT01688635|2064216|FG000|Washout 2|Sponsor Decision|1
1033219|NCT01688635|2064217|FG001|Washout 2|Sponsor Decision|2
1033220|NCT01688635|2064216|FG000|Washout 3|Withdrawal by Subject|1
1033221|NCT01688635|2064217|FG001|Washout 3|Withdrawal by Subject|0
1033222|NCT01688726|2064226|FG000|Overall Study|Adverse Event|1
1033223|NCT01688726|2064227|FG001|Overall Study|Adverse Event|0
1033224|NCT01688726|2064226|FG000|Overall Study|Relocated abroad|0
1033225|NCT01688726|2064227|FG001|Overall Study|Relocated abroad|1
1033226|NCT01688739|2064247|FG000|Overall Study|Administrative Decision|1
1033227|NCT01688739|2064248|FG001|Overall Study|Administrative Decision|0
1033228|NCT01688739|2064249|FG002|Overall Study|Administrative Decision|0
1033229|NCT01688739|2064250|FG003|Overall Study|Administrative Decision|0
1033230|NCT01688739|2064251|FG004|Overall Study|Administrative Decision|0
1033231|NCT01688739|2064252|FG005|Overall Study|Administrative Decision|0
1033232|NCT01688739|2064253|FG006|Overall Study|Administrative Decision|0
1033233|NCT01688739|2064254|FG007|Overall Study|Administrative Decision|0
1033234|NCT01688739|2064255|FG008|Overall Study|Administrative Decision|0
1033235|NCT01688739|2064256|FG009|Overall Study|Administrative Decision|0
1033236|NCT01688830|2064307|FG000|Overall Study|Lost to Follow-up|0
1033237|NCT01688830|2064308|FG001|Overall Study|Lost to Follow-up|0
1033238|NCT01688830|2064309|FG002|Overall Study|Lost to Follow-up|0
1033239|NCT01688830|2064310|FG003|Overall Study|Lost to Follow-up|0
1033240|NCT01688830|2064311|FG004|Overall Study|Lost to Follow-up|0
1033241|NCT01688830|2064312|FG005|Overall Study|Lost to Follow-up|0
1033242|NCT01688830|2064313|FG006|Overall Study|Lost to Follow-up|0
1033243|NCT01688830|2064314|FG007|Overall Study|Lost to Follow-up|0
1033244|NCT01688830|2064315|FG008|Overall Study|Lost to Follow-up|0
1033245|NCT01688830|2064316|FG009|Overall Study|Lost to Follow-up|0
1033246|NCT01688830|2064317|FG010|Overall Study|Lost to Follow-up|1
1033247|NCT01688830|2064318|FG011|Overall Study|Lost to Follow-up|0
1033248|NCT01688830|2064319|FG012|Overall Study|Lost to Follow-up|0
1033249|NCT01688830|2064320|FG013|Overall Study|Lost to Follow-up|0
1033250|NCT01688830|2064321|FG014|Overall Study|Lost to Follow-up|0
1033251|NCT01688830|2064322|FG015|Overall Study|Lost to Follow-up|0
1033252|NCT01688830|2064323|FG016|Overall Study|Lost to Follow-up|0
1033253|NCT01688830|2064324|FG017|Overall Study|Lost to Follow-up|0
1033254|NCT01688830|2064325|FG018|Overall Study|Lost to Follow-up|0
1033255|NCT01688830|2064326|FG019|Overall Study|Lost to Follow-up|0
1033256|NCT01688830|2064327|FG020|Overall Study|Lost to Follow-up|0
1033257|NCT01688882|2064432|FG000|Overall Study|Adverse Event|1
1033258|NCT01688882|2064433|FG001|Overall Study|Adverse Event|0
1033259|NCT01688882|2064432|FG000|Overall Study|Unsatisfactory therapeutic effect|1
1033260|NCT01688882|2064433|FG001|Overall Study|Unsatisfactory therapeutic effect|1
1033261|NCT01688882|2064432|FG000|Overall Study|Administrative problems|1
1033262|NCT01688882|2064433|FG001|Overall Study|Administrative problems|0
1033263|NCT01688921|2064449|FG000|Overall Study|Lost to Follow-up|7
1033264|NCT01688921|2064450|FG001|Overall Study|Lost to Follow-up|13
1033265|NCT01688921|2064449|FG000|Overall Study|Physician Decision|6
1033266|NCT01688921|2064450|FG001|Overall Study|Physician Decision|1
1033267|NCT01688921|2064449|FG000|Overall Study|Protocol Violation|0
1033268|NCT01688921|2064450|FG001|Overall Study|Protocol Violation|1
1033269|NCT01688921|2064449|FG000|Overall Study|informed consent|3
1033270|NCT01688921|2064450|FG001|Overall Study|informed consent|0
1033271|NCT01688973|2064459|FG000|Overall Study|Ineligible|2
1033272|NCT01688973|2064460|FG001|Overall Study|Ineligible|3
1033273|NCT01688999|2064470|FG000|Overall Study|Withdrawal by Subject|5
1033274|NCT01688999|2064471|FG001|Overall Study|Withdrawal by Subject|1
1033275|NCT01688999|2064472|FG002|Overall Study|Withdrawal by Subject|1
1033276|NCT01688999|2064470|FG000|Overall Study|Adverse Event|2
1033277|NCT01688999|2064471|FG001|Overall Study|Adverse Event|0
1033278|NCT01688999|2064472|FG002|Overall Study|Adverse Event|2
1033279|NCT01688999|2064470|FG000|Overall Study|Ineligible/Not treated|1
1033280|NCT01688999|2064471|FG001|Overall Study|Ineligible/Not treated|0
1033281|NCT01688999|2064472|FG002|Overall Study|Ineligible/Not treated|0
1033282|NCT01689207|2064495|FG000|Overall Study|Adverse Event|0
1033283|NCT01689207|2064496|FG001|Overall Study|Adverse Event|1
1033284|NCT01689207|2064497|FG002|Overall Study|Adverse Event|0
1033285|NCT01689207|2064498|FG003|Overall Study|Adverse Event|0
1033286|NCT01689207|2064499|FG004|Overall Study|Adverse Event|2
1033287|NCT01689207|2064500|FG005|Overall Study|Adverse Event|1
1033288|NCT01689207|2064501|FG006|Overall Study|Adverse Event|0
1033289|NCT01689207|2064502|FG007|Overall Study|Adverse Event|0
1033290|NCT01689207|2064503|FG008|Overall Study|Adverse Event|1
1033291|NCT01689207|2064504|FG009|Overall Study|Adverse Event|0
1033292|NCT01689207|2064505|FG010|Overall Study|Adverse Event|0
1033293|NCT01689337|2064539|FG000|Overall Study|Study Discontinuation|1
1033294|NCT01689363|2064554|FG000|Overall Study|Protocol Violation|0
1033295|NCT01689363|2064555|FG001|Overall Study|Protocol Violation|1
1033296|NCT01689363|2064556|FG002|Overall Study|Protocol Violation|0
1033297|NCT01689363|2064557|FG003|Overall Study|Protocol Violation|0
1033298|NCT01689363|2064558|FG004|Overall Study|Protocol Violation|0
1033299|NCT01689363|2064559|FG005|Overall Study|Protocol Violation|0
1033300|NCT01689363|2064560|FG006|Overall Study|Protocol Violation|0
1033301|NCT01689363|2064561|FG007|Overall Study|Protocol Violation|0
1033302|NCT01689519|2064583|FG000|Intent to Treat|Death|157
1033303|NCT01689519|2064584|FG001|Intent to Treat|Death|167
1033304|NCT01689519|2064583|FG000|Intent to Treat|Lost to Follow-up|4
1033305|NCT01689519|2064584|FG001|Intent to Treat|Lost to Follow-up|8
1033306|NCT01689519|2064583|FG000|Intent to Treat|Other|2
1033307|NCT01689519|2064584|FG001|Intent to Treat|Other|4
1033308|NCT01689519|2064583|FG000|Intent to Treat|Physician Decision|4
1033309|NCT01689519|2064584|FG001|Intent to Treat|Physician Decision|1
1033310|NCT01689519|2064583|FG000|Intent to Treat|Study terminated by Spon6sor|59
1033311|NCT01689519|2064584|FG001|Intent to Treat|Study terminated by Spon6sor|48
1033312|NCT01689519|2064583|FG000|Intent to Treat|Withdrawal by Subject|21
1033313|NCT01689519|2064584|FG001|Intent to Treat|Withdrawal by Subject|20
1033314|NCT01689519|2064583|FG000|Safety Population|Death|158
1033315|NCT01689519|2064584|FG001|Safety Population|Death|165
1033316|NCT01689519|2064583|FG000|Safety Population|Lost to Follow-up|4
1033317|NCT01689519|2064584|FG001|Safety Population|Lost to Follow-up|8
1033318|NCT01689519|2064583|FG000|Safety Population|Other|2
1033319|NCT01689519|2064584|FG001|Safety Population|Other|4
1033320|NCT01689519|2064583|FG000|Safety Population|Physician Decision|4
1033321|NCT01689519|2064584|FG001|Safety Population|Physician Decision|1
1033322|NCT01689519|2064583|FG000|Safety Population|Study Terminated By Sponsor|60
1033323|NCT01689519|2064584|FG001|Safety Population|Study Terminated By Sponsor|47
1033324|NCT01689519|2064583|FG000|Safety Population|Withdrawal by Subject|20
1033325|NCT01689519|2064584|FG001|Safety Population|Withdrawal by Subject|20
1033326|NCT01689532|2064592|FG000|Overall Study|Adverse Event|9
1033327|NCT01689532|2064593|FG001|Overall Study|Adverse Event|5
1033328|NCT01689532|2064592|FG000|Overall Study|Lack of Efficacy|2
1033329|NCT01689532|2064593|FG001|Overall Study|Lack of Efficacy|2
1033330|NCT01689532|2064592|FG000|Overall Study|Withdrawal by Subject|1
1033331|NCT01689532|2064593|FG001|Overall Study|Withdrawal by Subject|2
1033332|NCT01689532|2064592|FG000|Overall Study|Physician Decision|2
1033333|NCT01689532|2064593|FG001|Overall Study|Physician Decision|0
1033334|NCT01689649|2064599|FG000|Overall Study|Lack of Efficacy|3
1033335|NCT01689649|2064599|FG000|Overall Study|Non-compliance|11
1033336|NCT01689649|2064599|FG000|Overall Study|Protocol Violation|3
1033337|NCT01689649|2064599|FG000|Overall Study|Lost to Follow-up|5
1033338|NCT01689857|2064637|FG000|Overall Study|Lost to Follow-up|5
1033339|NCT01689857|2064638|FG001|Overall Study|Lost to Follow-up|2
1033340|NCT01690052|2064662|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
1033341|NCT01690052|2064663|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
1033342|NCT01690130|2064682|FG000|Overall Study|Subject have cancelled visit.|1
1033343|NCT01690130|2064683|FG001|Overall Study|Subject have cancelled visit.|0
1033344|NCT01690143|2064689|FG000|Overall Study|Withdrawal by Subject|1
1033345|NCT01690299|2064714|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
1033346|NCT01690299|2064715|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
1033347|NCT01690299|2064716|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
1033348|NCT01690299|2064717|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1033349|NCT01690299|2064718|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1033350|NCT01690299|2064719|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1033351|NCT01690299|2064714|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
1033352|NCT01690299|2064715|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1033353|NCT01690299|2064716|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1033354|NCT01690299|2064717|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1033355|NCT01690299|2064718|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1033356|NCT01690299|2064719|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1033357|NCT01690299|2064714|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
1033358|NCT01690299|2064715|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
1033359|NCT01690299|2064716|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1033360|NCT01690299|2064717|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1033361|NCT01690299|2064718|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1033362|NCT01690299|2064719|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1033363|NCT01690299|2064714|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2
1033364|NCT01690299|2064715|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1
1033365|NCT01690299|2064716|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1
1033366|NCT01690299|2064717|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0
1033367|NCT01690299|2064718|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0
1033368|NCT01690299|2064719|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0
1033369|NCT01690299|2064714|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1033370|NCT01690299|2064715|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1033371|NCT01690299|2064716|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1033372|NCT01690299|2064717|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
1033373|NCT01690299|2064718|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
1033374|NCT01690299|2064719|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
1033375|NCT01690299|2064714|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1033376|NCT01690299|2064715|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1033377|NCT01690299|2064716|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1033378|NCT01690299|2064717|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
1033379|NCT01690299|2064718|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
1033380|NCT01690299|2064719|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
1033381|NCT01690299|2064714|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1033382|NCT01690299|2064715|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1033383|NCT01690299|2064716|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1033384|NCT01690299|2064717|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1033385|NCT01690299|2064718|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
1033386|NCT01690299|2064719|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
1033387|NCT01690299|2064714|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1033388|NCT01690299|2064715|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1033389|NCT01690299|2064716|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1033390|NCT01690299|2064717|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
1033391|NCT01690299|2064718|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
1033392|NCT01690299|2064719|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
1033393|NCT01690299|2064714|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1033394|NCT01690299|2064715|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1033395|NCT01690299|2064716|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1033396|NCT01690299|2064717|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
1033397|NCT01690299|2064718|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
1033398|NCT01690299|2064719|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
1033399|NCT01690299|2064714|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1033400|NCT01690299|2064715|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1033401|NCT01690299|2064716|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1033402|NCT01690299|2064717|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1033403|NCT01690299|2064718|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1033404|NCT01690299|2064719|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
1033405|NCT01690520|2064742|FG000|Overall Study|Death|25
1033406|NCT01690520|2064743|FG001|Overall Study|Death|21
1033407|NCT01690520|2064742|FG000|Overall Study|Lost to Follow-up|2
1033408|NCT01690520|2064743|FG001|Overall Study|Lost to Follow-up|3
1033409|NCT01690520|2064742|FG000|Overall Study|Withdrawal by Subject|2
1033410|NCT01690520|2064743|FG001|Overall Study|Withdrawal by Subject|0
1033411|NCT01690520|2064742|FG000|Overall Study|Relapse|0
1033412|NCT01690520|2064743|FG001|Overall Study|Relapse|1
1033413|NCT01690520|2064742|FG000|Overall Study|Other|0
1033414|NCT01690520|2064743|FG001|Overall Study|Other|1
1033415|NCT01690520|2064742|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22
1033416|NCT01690520|2064743|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21
1033417|NCT01690988|2064778|FG000|Overall Study|Withdrawal by Subject|2
1033418|NCT01690988|2064779|FG001|Overall Study|Withdrawal by Subject|2
1033419|NCT01690988|2064780|FG002|Overall Study|Withdrawal by Subject|3
1033420|NCT01690988|2064778|FG000|Overall Study|Physician Decision|0
1033421|NCT01690988|2064779|FG001|Overall Study|Physician Decision|0
1033422|NCT01690988|2064780|FG002|Overall Study|Physician Decision|1
1033423|NCT01690988|2064778|FG000|Overall Study|Operation Cancelled|1
1033424|NCT01690988|2064779|FG001|Overall Study|Operation Cancelled|1
1033425|NCT01690988|2064780|FG002|Overall Study|Operation Cancelled|0
1033426|NCT01690988|2064778|FG000|Overall Study|Determined ineligible|1
1033427|NCT01690988|2064779|FG001|Overall Study|Determined ineligible|0
1033428|NCT01690988|2064780|FG002|Overall Study|Determined ineligible|0
1033429|NCT01690988|2064778|FG000|Overall Study|Death|1
1033430|NCT01690988|2064779|FG001|Overall Study|Death|1
1033431|NCT01690988|2064780|FG002|Overall Study|Death|1
1033432|NCT01690988|2064778|FG000|Overall Study|Sedated|1
1033433|NCT01690988|2064779|FG001|Overall Study|Sedated|1
1033434|NCT01690988|2064780|FG002|Overall Study|Sedated|2
1033435|NCT01691014|2064795|FG000|Overall Study|Premature Termination|1
1033436|NCT01691014|2064796|FG001|Overall Study|Premature Termination|6
1033437|NCT01691014|2064797|FG002|Overall Study|Premature Termination|0
1033438|NCT01691014|2064798|FG003|Overall Study|Premature Termination|3
1033439|NCT01691014|2064795|FG000|Overall Study|Other|0
1033440|NCT01691014|2064796|FG001|Overall Study|Other|0
1033441|NCT01691014|2064797|FG002|Overall Study|Other|2
1033442|NCT01691014|2064798|FG003|Overall Study|Other|0
1033443|NCT01691014|2064795|FG000|Overall Study|Withdrawal by Subject|0
1033444|NCT01691014|2064796|FG001|Overall Study|Withdrawal by Subject|1
1033445|NCT01691014|2064797|FG002|Overall Study|Withdrawal by Subject|1
1033446|NCT01691014|2064798|FG003|Overall Study|Withdrawal by Subject|1
1033447|NCT01691014|2064795|FG000|Overall Study|Adverse Event|0
1033448|NCT01691014|2064796|FG001|Overall Study|Adverse Event|5
1033449|NCT01691014|2064797|FG002|Overall Study|Adverse Event|1
1033450|NCT01691014|2064798|FG003|Overall Study|Adverse Event|1
1033451|NCT01691014|2064795|FG000|Overall Study|Lack of Efficacy|2
1033452|NCT01691014|2064796|FG001|Overall Study|Lack of Efficacy|3
1033453|NCT01691014|2064797|FG002|Overall Study|Lack of Efficacy|7
1033454|NCT01691014|2064798|FG003|Overall Study|Lack of Efficacy|0
1033455|NCT01691092|2064813|FG000|Overall Study|Lost to Follow-up|10
1033456|NCT01691092|2064813|FG000|Overall Study|Physician Decision|4
1033457|NCT01691092|2064813|FG000|Overall Study|Withdrawal by Subject|3
1033458|NCT01691092|2064813|FG000|Overall Study|non-compliance|3
1033459|NCT01691092|2064813|FG000|Overall Study|used for different study|2
1033460|NCT01691092|2064813|FG000|Overall Study|screen fail|19
1033461|NCT01691105|2064819|FG000|1 Month Follow-up|Lost to Follow-up|41
1033462|NCT01691105|2064820|FG001|1 Month Follow-up|Lost to Follow-up|38
1033463|NCT01691105|2064819|FG000|1 Month Follow-up|Death|2
1033464|NCT01691105|2064820|FG001|1 Month Follow-up|Death|3
1033465|NCT01691105|2064819|FG000|6 Month Follow-up|Lost to Follow-up|39
1033466|NCT01691105|2064820|FG001|6 Month Follow-up|Lost to Follow-up|58
1033467|NCT01691105|2064819|FG000|6 Month Follow-up|Death|13
1033468|NCT01691105|2064820|FG001|6 Month Follow-up|Death|13
1033469|NCT01691105|2064819|FG000|12 Month Follow-up|Lost to Follow-up|50
1033470|NCT01691105|2064820|FG001|12 Month Follow-up|Lost to Follow-up|71
1033471|NCT01691105|2064819|FG000|12 Month Follow-up|Death|22
1033472|NCT01691105|2064820|FG001|12 Month Follow-up|Death|30
1033473|NCT01691105|2064819|FG000|12 Month Biochemical Verification|Death|22
1033474|NCT01691105|2064820|FG001|12 Month Biochemical Verification|Death|30
1033475|NCT01691105|2064819|FG000|12 Month Biochemical Verification|Lost to Follow-up|50
1033476|NCT01691105|2064820|FG001|12 Month Biochemical Verification|Lost to Follow-up|71
1033477|NCT01691105|2064819|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352
1033478|NCT01691105|2064820|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401
1033479|NCT01691248|2064828|FG000|Overall Study|Protocol Violation|43
1033480|NCT01691248|2064829|FG001|Overall Study|Protocol Violation|27
1033481|NCT01691248|2064828|FG000|Overall Study|Adverse Event|24
1033482|NCT01691248|2064829|FG001|Overall Study|Adverse Event|22
1033483|NCT01691248|2064828|FG000|Overall Study|Withdrawal by Subject|20
1033484|NCT01691248|2064829|FG001|Overall Study|Withdrawal by Subject|18
1033485|NCT01691248|2064828|FG000|Overall Study|Confirmed CDAD|14
1033486|NCT01691248|2064829|FG001|Overall Study|Confirmed CDAD|31
1033487|NCT01691248|2064828|FG000|Overall Study|Lost to Follow-up|2
1033488|NCT01691248|2064829|FG001|Overall Study|Lost to Follow-up|5
1033489|NCT01691248|2064828|FG000|Overall Study|Reason not provided|4
1033490|NCT01691248|2064829|FG001|Overall Study|Reason not provided|4
1033491|NCT01691248|2064828|FG000|Overall Study|Not Treated|4
1033492|NCT01691248|2064829|FG001|Overall Study|Not Treated|7
1033493|NCT01691378|2064882|FG000|Overall Study|Withdrawal by Subject|2
1033494|NCT01691378|2064883|FG001|Overall Study|Withdrawal by Subject|0
1033495|NCT01691378|2064882|FG000|Overall Study|Lost to Follow-up|5
1033496|NCT01691378|2064883|FG001|Overall Study|Lost to Follow-up|2
1033497|NCT01691430|2064891|FG000|Overall Study|Death|17
1033498|NCT01691430|2064892|FG001|Overall Study|Death|16
1033499|NCT01691430|2064891|FG000|Overall Study|Withdrawal by Subject|5
1033500|NCT01691430|2064892|FG001|Overall Study|Withdrawal by Subject|1
1033501|NCT01691430|2064891|FG000|Overall Study|Lost to Follow-up|0
1033502|NCT01691430|2064892|FG001|Overall Study|Lost to Follow-up|3
1033503|NCT01691482|2064898|FG000|Treatment Period 2|Adverse Event|0
1033504|NCT01691482|2064899|FG001|Treatment Period 2|Adverse Event|1
1033505|NCT01691482|2064898|FG000|Treatment Period 2|Protocol Violation|1
1033506|NCT01691482|2064899|FG001|Treatment Period 2|Protocol Violation|1
1033507|NCT01691508|2064908|FG000|Overall Study|Adverse Event|3
1033508|NCT01691508|2064909|FG001|Overall Study|Adverse Event|3
1033509|NCT01691508|2064908|FG000|Overall Study|Withdrawal by Subject|1
1033510|NCT01691508|2064909|FG001|Overall Study|Withdrawal by Subject|0
1033511|NCT01691521|2064918|FG000|Overall Study|Adverse Event|4
1033512|NCT01691521|2064919|FG001|Overall Study|Adverse Event|0
1033513|NCT01691521|2064920|FG002|Overall Study|Adverse Event|1
1033514|NCT01691521|2064918|FG000|Overall Study|Lack of Efficacy|1
1033515|NCT01691521|2064919|FG001|Overall Study|Lack of Efficacy|1
1033516|NCT01691521|2064920|FG002|Overall Study|Lack of Efficacy|2
1033517|NCT01691521|2064918|FG000|Overall Study|Protocol Violation|0
1033518|NCT01691521|2064919|FG001|Overall Study|Protocol Violation|3
1033519|NCT01691521|2064920|FG002|Overall Study|Protocol Violation|0
1033520|NCT01691521|2064918|FG000|Overall Study|Lost to Follow-up|0
1033521|NCT01691521|2064919|FG001|Overall Study|Lost to Follow-up|2
1033522|NCT01691521|2064920|FG002|Overall Study|Lost to Follow-up|2
1033523|NCT01691521|2064918|FG000|Overall Study|Physician Decision|2
1033524|NCT01691521|2064919|FG001|Overall Study|Physician Decision|1
1033525|NCT01691521|2064920|FG002|Overall Study|Physician Decision|0
1033526|NCT01691521|2064918|FG000|Overall Study|Withdrawal by Subject|5
1033527|NCT01691521|2064919|FG001|Overall Study|Withdrawal by Subject|9
1033528|NCT01691521|2064920|FG002|Overall Study|Withdrawal by Subject|4
1033529|NCT01691612|2064976|FG000|Overall Study|deemed ineligible after 1st visit|6
1033530|NCT01691612|2064976|FG000|Overall Study|Adverse Event|1
1033531|NCT01691768|2064994|FG000|Overall Study|Death|0
1033532|NCT01691768|2064995|FG001|Overall Study|Death|2
1033533|NCT01691768|2064994|FG000|Overall Study|Lost to Follow-up|4
1033534|NCT01691768|2064995|FG001|Overall Study|Lost to Follow-up|3
1033535|NCT01691768|2064994|FG000|Overall Study|Withdrawal by Subject|10
1033536|NCT01691768|2064995|FG001|Overall Study|Withdrawal by Subject|9
1033537|NCT01691768|2064994|FG000|Overall Study|Relocated|0
1033538|NCT01691768|2064995|FG001|Overall Study|Relocated|1
1033539|NCT01691768|2064994|FG000|Overall Study|Investigator decision|1
1033540|NCT01691768|2064995|FG001|Overall Study|Investigator decision|1
1033541|NCT01691781|2065004|FG000|Overall Study|Withdrawal by Subject|4
1033542|NCT01691781|2065005|FG001|Overall Study|Withdrawal by Subject|3
1033543|NCT01691781|2065004|FG000|Overall Study|Physician Decision|1
1033544|NCT01691781|2065005|FG001|Overall Study|Physician Decision|1
1033545|NCT01691781|2065004|FG000|Overall Study|Protocol Violation|2
1033546|NCT01691781|2065005|FG001|Overall Study|Protocol Violation|2
1033547|NCT01691781|2065004|FG000|Overall Study|Adverse Event|0
1033548|NCT01691781|2065005|FG001|Overall Study|Adverse Event|1
1033549|NCT01691794|2065014|FG000|Overall Study|Poor/Non-Compliance|1
1033550|NCT01691794|2065015|FG001|Overall Study|Poor/Non-Compliance|4
1033551|NCT01691794|2065016|FG002|Overall Study|Poor/Non-Compliance|1
1033552|NCT01691794|2065014|FG000|Overall Study|Death|0
1033553|NCT01691794|2065015|FG001|Overall Study|Death|0
1033554|NCT01691794|2065016|FG002|Overall Study|Death|1
1033555|NCT01691794|2065014|FG000|Overall Study|Lack of Efficacy|0
1033556|NCT01691794|2065015|FG001|Overall Study|Lack of Efficacy|7
1033557|NCT01691794|2065016|FG002|Overall Study|Lack of Efficacy|1
1033558|NCT01691794|2065014|FG000|Overall Study|Participant request to discontinue|0
1033559|NCT01691794|2065015|FG001|Overall Study|Participant request to discontinue|1
1033560|NCT01691794|2065016|FG002|Overall Study|Participant request to discontinue|0
1033561|NCT01691794|2065014|FG000|Overall Study|Adverse Event|0
1033562|NCT01691794|2065015|FG001|Overall Study|Adverse Event|1
1033563|NCT01691794|2065016|FG002|Overall Study|Adverse Event|1
1033564|NCT01691794|2065014|FG000|Overall Study|Completed Only first 24 weeks of study|0
1033565|NCT01691794|2065015|FG001|Overall Study|Completed Only first 24 weeks of study|2
1033566|NCT01691794|2065016|FG002|Overall Study|Completed Only first 24 weeks of study|3
1033567|NCT01691794|2065014|FG000|Overall Study|Did not complete first 24 weeks of study|0
1033568|NCT01691794|2065015|FG001|Overall Study|Did not complete first 24 weeks of study|3
1033569|NCT01691794|2065016|FG002|Overall Study|Did not complete first 24 weeks of study|3
1033570|NCT01691820|2065026|FG000|Overall Study|Consent withdrawal (not due to an AE)|9
1033571|NCT01691820|2065027|FG001|Overall Study|Consent withdrawal (not due to an AE)|15
1033572|NCT01691820|2065026|FG000|Overall Study|Migrated/moved from study area|7
1033573|NCT01691820|2065027|FG001|Overall Study|Migrated/moved from study area|4
1033574|NCT01691820|2065026|FG000|Overall Study|Lost to Follow-up|6
1033575|NCT01691820|2065027|FG001|Overall Study|Lost to Follow-up|17
1033576|NCT01691820|2065026|FG000|Overall Study|Other (unspecified)|4
1033577|NCT01691820|2065027|FG001|Overall Study|Other (unspecified)|1
1033578|NCT01691859|2065050|FG000|Overall Study|Adverse Event|19
1033579|NCT01691859|2065050|FG000|Overall Study|Lack of Efficacy|11
1033580|NCT01691859|2065050|FG000|Overall Study|Protocol Violation|4
1033581|NCT01691859|2065050|FG000|Overall Study|Product commercially available|221
1033582|NCT01691859|2065050|FG000|Overall Study|Study closed/terminated|50
1033583|NCT01691859|2065050|FG000|Overall Study|Lost to Follow-up|5
1033584|NCT01691859|2065050|FG000|Overall Study|Physician Decision|6
1033585|NCT01691859|2065050|FG000|Overall Study|Withdrawal by Subject|31
1033586|NCT01691885|2065054|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1
1033587|NCT01691885|2065055|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1
1033588|NCT01691885|2065054|FG000|Washout Period (7-9 Days)|Adverse Event|0
1033589|NCT01691885|2065055|FG001|Washout Period (7-9 Days)|Adverse Event|1
1033590|NCT01691898|2065067|FG000|Overall Study|Death|34
1033591|NCT01691898|2065068|FG001|Overall Study|Death|32
1033592|NCT01691898|2065069|FG002|Overall Study|Death|6
1033593|NCT01691898|2065070|FG003|Overall Study|Death|3
1033594|NCT01691898|2065071|FG004|Overall Study|Death|8
1033595|NCT01691898|2065072|FG005|Overall Study|Death|31
1033596|NCT01691898|2065067|FG000|Overall Study|Adverse Event|0
1033597|NCT01691898|2065068|FG001|Overall Study|Adverse Event|1
1033598|NCT01691898|2065069|FG002|Overall Study|Adverse Event|0
1033599|NCT01691898|2065070|FG003|Overall Study|Adverse Event|1
1033600|NCT01691898|2065071|FG004|Overall Study|Adverse Event|1
1033601|NCT01691898|2065072|FG005|Overall Study|Adverse Event|0
1033602|NCT01691898|2065067|FG000|Overall Study|Progression of Disease|1
1033603|NCT01691898|2065068|FG001|Overall Study|Progression of Disease|2
1033604|NCT01691898|2065069|FG002|Overall Study|Progression of Disease|1
1033605|NCT01691898|2065070|FG003|Overall Study|Progression of Disease|0
1033606|NCT01691898|2065071|FG004|Overall Study|Progression of Disease|0
1033607|NCT01691898|2065072|FG005|Overall Study|Progression of Disease|1
1033608|NCT01691898|2065067|FG000|Overall Study|Lost to Follow-up|3
1033609|NCT01691898|2065068|FG001|Overall Study|Lost to Follow-up|1
1033610|NCT01691898|2065069|FG002|Overall Study|Lost to Follow-up|0
1033611|NCT01691898|2065070|FG003|Overall Study|Lost to Follow-up|0
1033612|NCT01691898|2065071|FG004|Overall Study|Lost to Follow-up|1
1033613|NCT01691898|2065072|FG005|Overall Study|Lost to Follow-up|0
1033614|NCT01691898|2065067|FG000|Overall Study|Withdrawal by Subject|9
1033615|NCT01691898|2065068|FG001|Overall Study|Withdrawal by Subject|8
1033616|NCT01691898|2065069|FG002|Overall Study|Withdrawal by Subject|2
1033617|NCT01691898|2065070|FG003|Overall Study|Withdrawal by Subject|1
1033618|NCT01691898|2065071|FG004|Overall Study|Withdrawal by Subject|3
1033619|NCT01691898|2065072|FG005|Overall Study|Withdrawal by Subject|3
1033620|NCT01691898|2065067|FG000|Overall Study|Non-Compliance|0
1033621|NCT01691898|2065068|FG001|Overall Study|Non-Compliance|0
1033622|NCT01691898|2065069|FG002|Overall Study|Non-Compliance|0
1033623|NCT01691898|2065070|FG003|Overall Study|Non-Compliance|0
1033624|NCT01691898|2065071|FG004|Overall Study|Non-Compliance|1
1033625|NCT01691898|2065072|FG005|Overall Study|Non-Compliance|0
1033626|NCT01692119|2065115|FG000|Overall Study|Protocol Violation|3
1033627|NCT01692119|2065116|FG001|Overall Study|Protocol Violation|1
1033628|NCT01692119|2065115|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17
1033629|NCT01692119|2065116|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0
1033630|NCT01692197|2065122|FG000|Overall Study|Failed Screening|3
1033631|NCT01692275|2065133|FG000|Overall Study|Lost to Follow-up|57
1033632|NCT01692275|2065134|FG001|Overall Study|Lost to Follow-up|48
1033633|NCT01692275|2065133|FG000|Overall Study|Withdrawal by Subject|9
1033634|NCT01692275|2065134|FG001|Overall Study|Withdrawal by Subject|11
1033635|NCT01692301|2065154|FG000|Overall Study|Adverse Event|15
1033636|NCT01692301|2065155|FG001|Overall Study|Adverse Event|12
1033637|NCT01692301|2065154|FG000|Overall Study|Death|1
1033638|NCT01692301|2065155|FG001|Overall Study|Death|2
1033639|NCT01692301|2065154|FG000|Overall Study|Lack of Efficacy|0
1033640|NCT01692301|2065155|FG001|Overall Study|Lack of Efficacy|5
1033641|NCT01692301|2065154|FG000|Overall Study|Non-compliance with study treatment|1
1033642|NCT01692301|2065155|FG001|Overall Study|Non-compliance with study treatment|2
1033643|NCT01692301|2065154|FG000|Overall Study|Protocol deviation|9
1033644|NCT01692301|2065155|FG001|Overall Study|Protocol deviation|2
1033645|NCT01692301|2065154|FG000|Overall Study|Patient/guardian decision|16
1033646|NCT01692301|2065155|FG001|Overall Study|Patient/guardian decision|15
1033647|NCT01692301|2065154|FG000|Overall Study|Technical problems|0
1033648|NCT01692301|2065155|FG001|Overall Study|Technical problems|1
1033649|NCT01692301|2065154|FG000|Overall Study|Physician Decision|2
1033650|NCT01692301|2065155|FG001|Overall Study|Physician Decision|2
1033651|NCT01692301|2065154|FG000|Overall Study|Lost to Follow-up|1
1033652|NCT01692301|2065155|FG001|Overall Study|Lost to Follow-up|1
1033653|NCT01692626|2065179|FG000|Overall Study|Death|0
1033654|NCT01692626|2065180|FG001|Overall Study|Death|1
1033655|NCT01692626|2065179|FG000|Overall Study|Adverse Event|2
1033656|NCT01692626|2065180|FG001|Overall Study|Adverse Event|3
1033657|NCT01692626|2065179|FG000|Overall Study|Protocol Violation|1
1033658|NCT01692626|2065180|FG001|Overall Study|Protocol Violation|2
1033659|NCT01692626|2065179|FG000|Overall Study|Withdrawal by Subject|1
1033660|NCT01692626|2065180|FG001|Overall Study|Withdrawal by Subject|0
1033661|NCT01692730|2065187|FG000|Overall Study|Lost to Follow-up|225
1033662|NCT01692730|2065188|FG001|Overall Study|Lost to Follow-up|227
1033663|NCT01692782|2065227|FG000|Overall Study|Adverse Event|12
1033664|NCT01692782|2065228|FG001|Overall Study|Adverse Event|32
1033665|NCT01692782|2065229|FG002|Overall Study|Adverse Event|2
1033666|NCT01692782|2065227|FG000|Overall Study|Lack of Efficacy|1
1033667|NCT01692782|2065228|FG001|Overall Study|Lack of Efficacy|2
1033668|NCT01692782|2065229|FG002|Overall Study|Lack of Efficacy|0
1033669|NCT01692782|2065227|FG000|Overall Study|Lost to Follow-up|2
1033670|NCT01692782|2065228|FG001|Overall Study|Lost to Follow-up|7
1033671|NCT01692782|2065229|FG002|Overall Study|Lost to Follow-up|1
1033672|NCT01692782|2065227|FG000|Overall Study|Pregnancy|1
1033673|NCT01692782|2065228|FG001|Overall Study|Pregnancy|0
1033674|NCT01692782|2065229|FG002|Overall Study|Pregnancy|0
1033675|NCT01692782|2065227|FG000|Overall Study|Protocol Violation|1
1033676|NCT01692782|2065228|FG001|Overall Study|Protocol Violation|0
1033677|NCT01692782|2065229|FG002|Overall Study|Protocol Violation|2
1033678|NCT01692782|2065227|FG000|Overall Study|Non-complance with study drug|0
1033679|NCT01692782|2065228|FG001|Overall Study|Non-complance with study drug|4
1033680|NCT01692782|2065229|FG002|Overall Study|Non-complance with study drug|1
1033681|NCT01692782|2065227|FG000|Overall Study|Non-compliant with study visits|0
1033682|NCT01692782|2065228|FG001|Overall Study|Non-compliant with study visits|0
1033683|NCT01692782|2065229|FG002|Overall Study|Non-compliant with study visits|1
1033684|NCT01692782|2065227|FG000|Overall Study|SAE not related to study drug|0
1033685|NCT01692782|2065228|FG001|Overall Study|SAE not related to study drug|1
1033686|NCT01692782|2065229|FG002|Overall Study|SAE not related to study drug|0
1033687|NCT01692782|2065227|FG000|Overall Study|Withdrawal by Subject|3
1033688|NCT01692782|2065228|FG001|Overall Study|Withdrawal by Subject|10
1033689|NCT01692782|2065229|FG002|Overall Study|Withdrawal by Subject|3
1033690|NCT01692938|2065239|FG000|Overall Study|Protocol Deviation|1
1033691|NCT01692938|2065240|FG001|Overall Study|Protocol Deviation|1
1033692|NCT01692938|2065239|FG000|Overall Study|Study completed prior to site completion|3
1033693|NCT01692938|2065240|FG001|Overall Study|Study completed prior to site completion|3
1033694|NCT01693029|2065270|FG000|Overall Study|Withdrawal by Subject|15
1033695|NCT01693029|2065271|FG001|Overall Study|Withdrawal by Subject|22
1033696|NCT01693029|2065270|FG000|Overall Study|Kidney transplantation|7
1033697|NCT01693029|2065271|FG001|Overall Study|Kidney transplantation|7
1033698|NCT01693029|2065270|FG000|Overall Study|Bindinging anti-EPO antibodies|6
1033699|NCT01693029|2065271|FG001|Overall Study|Bindinging anti-EPO antibodies|2
1033700|NCT01693029|2065270|FG000|Overall Study|Protocol Violation|6
1033701|NCT01693029|2065271|FG001|Overall Study|Protocol Violation|7
1033702|NCT01693029|2065270|FG000|Overall Study|Change in dialysis modality|2
1033703|NCT01693029|2065271|FG001|Overall Study|Change in dialysis modality|1
1033704|NCT01693029|2065270|FG000|Overall Study|Physician Decision|0
1033705|NCT01693029|2065271|FG001|Overall Study|Physician Decision|2
905145|NCT00761150|1880424|FG000|Open-label Period|Did not meet DB randomization criteria|11
905146|NCT00761150|1880425|FG001|Open-label Period|Did not meet DB randomization criteria|0
905147|NCT00761150|1880426|FG002|Open-label Period|Did not meet DB randomization criteria|0
905148|NCT00761150|1880424|FG000|Open-label Period|Lost to Follow-up|7
905149|NCT00761150|1880425|FG001|Open-label Period|Lost to Follow-up|0
905150|NCT00761150|1880426|FG002|Open-label Period|Lost to Follow-up|0
905151|NCT00761150|1880424|FG000|Open-label Period|Lack of Efficacy|4
905152|NCT00761150|1880425|FG001|Open-label Period|Lack of Efficacy|0
905153|NCT00761150|1880426|FG002|Open-label Period|Lack of Efficacy|0
905154|NCT00761150|1880424|FG000|Open-label Period|Withdrawal by Subject|5
905155|NCT00761150|1880425|FG001|Open-label Period|Withdrawal by Subject|0
905156|NCT00761150|1880426|FG002|Open-label Period|Withdrawal by Subject|0
905157|NCT00761150|1880424|FG000|Open-label Period|Noncompliance|2
905158|NCT00761150|1880425|FG001|Open-label Period|Noncompliance|0
905159|NCT00761150|1880426|FG002|Open-label Period|Noncompliance|0
905160|NCT00761150|1880424|FG000|Open-label Period|Other|5
905161|NCT00761150|1880425|FG001|Open-label Period|Other|0
905162|NCT00761150|1880426|FG002|Open-label Period|Other|0
905163|NCT00761150|1880424|FG000|Double-blind Period|Lack of Efficacy|0
905164|NCT00761150|1880425|FG001|Double-blind Period|Lack of Efficacy|2
905165|NCT00761150|1880426|FG002|Double-blind Period|Lack of Efficacy|19
905166|NCT00761150|1880424|FG000|Double-blind Period|Adverse Event|0
905167|NCT00761150|1880425|FG001|Double-blind Period|Adverse Event|3
905168|NCT00761150|1880426|FG002|Double-blind Period|Adverse Event|3
905169|NCT00761150|1880424|FG000|Double-blind Period|Withdrawal by Subject|0
905170|NCT00761150|1880425|FG001|Double-blind Period|Withdrawal by Subject|3
905171|NCT00761150|1880426|FG002|Double-blind Period|Withdrawal by Subject|2
1033706|NCT01693029|2065270|FG000|Overall Study|Lost to Follow-up|0
1033707|NCT01693029|2065271|FG001|Overall Study|Lost to Follow-up|1
1033708|NCT01693029|2065270|FG000|Overall Study|Adverse Event|1
1033709|NCT01693029|2065271|FG001|Overall Study|Adverse Event|6
1033710|NCT01693029|2065270|FG000|Overall Study|Death|5
1033711|NCT01693029|2065271|FG001|Overall Study|Death|8
1033712|NCT01693029|2065270|FG000|Overall Study|Non-compliance|2
1033713|NCT01693029|2065271|FG001|Overall Study|Non-compliance|1
1033714|NCT01693068|2065279|FG000|Randomization Period|On-study|2
1033715|NCT01693068|2065280|FG001|Randomization Period|On-study|5
1033716|NCT01693068|2065281|FG002|Randomization Period|On-study|0
1033717|NCT01693068|2065279|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0
1033718|NCT01693068|2065280|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0
1033719|NCT01693068|2065281|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1
1033720|NCT01693120|2065289|FG000|Enrollment|Lost to Follow-up|1
1033721|NCT01693120|2065289|FG000|Enrollment|Withdrawal by Subject|10
1033722|NCT01693120|2065289|FG000|Enrollment|Protocol Violation|46
1033723|NCT01693120|2065289|FG000|Enrollment|Physician Decision|3
1033724|NCT01693120|2065289|FG000|Enrollment|Adverse Event|1
1033725|NCT01693120|2065289|FG000|Enrollment|Study closed|8
1033726|NCT01693120|2065289|FG000|Enrollment|Other|1
1033727|NCT01693120|2065289|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
1033728|NCT01693120|2065289|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
1033729|NCT01693120|2065289|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3
1033730|NCT01693120|2065289|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1
1033731|NCT01693120|2065289|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7
1033732|NCT01693185|2065295|FG000|Overall Study|diagnostic procedure after colonoscopy|0
1033733|NCT01693185|2065296|FG001|Overall Study|diagnostic procedure after colonoscopy|6
1033734|NCT01693250|2065304|FG000|Overall Study|Lost to Follow-up|2
1033735|NCT01693250|2065305|FG001|Overall Study|Lost to Follow-up|2
1033736|NCT01693523|2065316|FG000|Overall Study|Adverse Event|2
1033737|NCT01693523|2065317|FG001|Overall Study|Adverse Event|1
1033738|NCT01693523|2065318|FG002|Overall Study|Adverse Event|0
1033739|NCT01693523|2065316|FG000|Overall Study|Death|0
1033740|NCT01693523|2065317|FG001|Overall Study|Death|1
1033741|NCT01693523|2065318|FG002|Overall Study|Death|1
1033742|NCT01693523|2065316|FG000|Overall Study|Lost to Follow-up|0
1033743|NCT01693523|2065317|FG001|Overall Study|Lost to Follow-up|0
1033744|NCT01693523|2065318|FG002|Overall Study|Lost to Follow-up|4
1033745|NCT01693523|2065316|FG000|Overall Study|Physician Decision|0
1033746|NCT01693523|2065317|FG001|Overall Study|Physician Decision|0
1033747|NCT01693523|2065318|FG002|Overall Study|Physician Decision|1
1033748|NCT01693523|2065316|FG000|Overall Study|Withdrawal by Subject|1
1033749|NCT01693523|2065317|FG001|Overall Study|Withdrawal by Subject|2
1033750|NCT01693523|2065318|FG002|Overall Study|Withdrawal by Subject|2
1033751|NCT01693523|2065316|FG000|Overall Study|Lack of compliance study medication|1
1033752|NCT01693523|2065317|FG001|Overall Study|Lack of compliance study medication|2
1033753|NCT01693523|2065318|FG002|Overall Study|Lack of compliance study medication|0
1033754|NCT01693523|2065316|FG000|Overall Study|Chemotherapy was held|1
1033755|NCT01693523|2065317|FG001|Overall Study|Chemotherapy was held|2
905172|NCT00761150|1880424|FG000|Double-blind Period|Lost to Follow-up|0
905173|NCT00761150|1880425|FG001|Double-blind Period|Lost to Follow-up|2
1033756|NCT01693523|2065318|FG002|Overall Study|Chemotherapy was held|0
1033757|NCT01693562|2065348|FG000|Escalation Phase|Withdrawal by Subject|0
1033758|NCT01693562|2065349|FG001|Escalation Phase|Withdrawal by Subject|1
1033759|NCT01693562|2065350|FG002|Escalation Phase|Withdrawal by Subject|0
1033760|NCT01693562|2065351|FG003|Escalation Phase|Withdrawal by Subject|0
1033761|NCT01693562|2065352|FG004|Escalation Phase|Withdrawal by Subject|0
1033762|NCT01693562|2065353|FG005|Escalation Phase|Withdrawal by Subject|2
1033763|NCT01693562|2065354|FG006|Escalation Phase|Withdrawal by Subject|0
1033764|NCT01693562|2065355|FG007|Escalation Phase|Withdrawal by Subject|0
1033765|NCT01693562|2065356|FG008|Escalation Phase|Withdrawal by Subject|0
1033766|NCT01693562|2065357|FG009|Escalation Phase|Withdrawal by Subject|0
1033767|NCT01693562|2065358|FG010|Escalation Phase|Withdrawal by Subject|0
1033768|NCT01693562|2065359|FG011|Escalation Phase|Withdrawal by Subject|0
1033769|NCT01693562|2065360|FG012|Escalation Phase|Withdrawal by Subject|0
1033770|NCT01693562|2065361|FG013|Escalation Phase|Withdrawal by Subject|0
1033771|NCT01693562|2065362|FG014|Escalation Phase|Withdrawal by Subject|0
1033772|NCT01693562|2065363|FG015|Escalation Phase|Withdrawal by Subject|0
1033773|NCT01693562|2065364|FG016|Escalation Phase|Withdrawal by Subject|0
1033774|NCT01693562|2065365|FG017|Escalation Phase|Withdrawal by Subject|0
1033775|NCT01693562|2065366|FG018|Escalation Phase|Withdrawal by Subject|0
1033776|NCT01693562|2065367|FG019|Escalation Phase|Withdrawal by Subject|0
1033777|NCT01693562|2065368|FG020|Escalation Phase|Withdrawal by Subject|0
1033778|NCT01693562|2065369|FG021|Escalation Phase|Withdrawal by Subject|0
1033779|NCT01693562|2065370|FG022|Escalation Phase|Withdrawal by Subject|0
1033780|NCT01693562|2065348|FG000|Escalation Phase|Death|4
1033781|NCT01693562|2065349|FG001|Escalation Phase|Death|2
1033782|NCT01693562|2065350|FG002|Escalation Phase|Death|0
1033783|NCT01693562|2065351|FG003|Escalation Phase|Death|3
1033784|NCT01693562|2065352|FG004|Escalation Phase|Death|6
1033785|NCT01693562|2065353|FG005|Escalation Phase|Death|4
1033786|NCT01693562|2065354|FG006|Escalation Phase|Death|0
1033787|NCT01693562|2065355|FG007|Escalation Phase|Death|0
1033788|NCT01693562|2065356|FG008|Escalation Phase|Death|0
1033789|NCT01693562|2065357|FG009|Escalation Phase|Death|0
1033790|NCT01693562|2065358|FG010|Escalation Phase|Death|0
1033791|NCT01693562|2065359|FG011|Escalation Phase|Death|0
1033792|NCT01693562|2065360|FG012|Escalation Phase|Death|0
1033793|NCT01693562|2065361|FG013|Escalation Phase|Death|0
1033794|NCT01693562|2065362|FG014|Escalation Phase|Death|0
1033795|NCT01693562|2065363|FG015|Escalation Phase|Death|0
1033796|NCT01693562|2065364|FG016|Escalation Phase|Death|0
1033797|NCT01693562|2065365|FG017|Escalation Phase|Death|0
1033798|NCT01693562|2065366|FG018|Escalation Phase|Death|0
1033799|NCT01693562|2065367|FG019|Escalation Phase|Death|0
1033800|NCT01693562|2065368|FG020|Escalation Phase|Death|0
1033801|NCT01693562|2065369|FG021|Escalation Phase|Death|0
1033802|NCT01693562|2065370|FG022|Escalation Phase|Death|0
1033803|NCT01693562|2065348|FG000|Escalation Phase|Lost to Follow-up|0
1033804|NCT01693562|2065349|FG001|Escalation Phase|Lost to Follow-up|1
1033805|NCT01693562|2065350|FG002|Escalation Phase|Lost to Follow-up|1
1033806|NCT01693562|2065351|FG003|Escalation Phase|Lost to Follow-up|0
1033807|NCT01693562|2065352|FG004|Escalation Phase|Lost to Follow-up|0
1033808|NCT01693562|2065353|FG005|Escalation Phase|Lost to Follow-up|0
1033809|NCT01693562|2065354|FG006|Escalation Phase|Lost to Follow-up|0
1033810|NCT01693562|2065355|FG007|Escalation Phase|Lost to Follow-up|0
1033811|NCT01693562|2065356|FG008|Escalation Phase|Lost to Follow-up|0
1033812|NCT01693562|2065357|FG009|Escalation Phase|Lost to Follow-up|0
1033813|NCT01693562|2065358|FG010|Escalation Phase|Lost to Follow-up|0
1033814|NCT01693562|2065359|FG011|Escalation Phase|Lost to Follow-up|0
1033815|NCT01693562|2065360|FG012|Escalation Phase|Lost to Follow-up|0
1033816|NCT01693562|2065361|FG013|Escalation Phase|Lost to Follow-up|0
1033817|NCT01693562|2065362|FG014|Escalation Phase|Lost to Follow-up|0
1033818|NCT01693562|2065363|FG015|Escalation Phase|Lost to Follow-up|0
1033819|NCT01693562|2065364|FG016|Escalation Phase|Lost to Follow-up|0
1033820|NCT01693562|2065365|FG017|Escalation Phase|Lost to Follow-up|0
1033821|NCT01693562|2065366|FG018|Escalation Phase|Lost to Follow-up|0
1033822|NCT01693562|2065367|FG019|Escalation Phase|Lost to Follow-up|0
1033823|NCT01693562|2065368|FG020|Escalation Phase|Lost to Follow-up|0
1033824|NCT01693562|2065369|FG021|Escalation Phase|Lost to Follow-up|0
1033825|NCT01693562|2065370|FG022|Escalation Phase|Lost to Follow-up|0
1033826|NCT01693562|2065348|FG000|Escalation Phase|Other|0
1033827|NCT01693562|2065349|FG001|Escalation Phase|Other|0
1033828|NCT01693562|2065350|FG002|Escalation Phase|Other|2
1033829|NCT01693562|2065351|FG003|Escalation Phase|Other|0
1033830|NCT01693562|2065352|FG004|Escalation Phase|Other|0
1033831|NCT01693562|2065353|FG005|Escalation Phase|Other|1
1033832|NCT01693562|2065354|FG006|Escalation Phase|Other|0
1033833|NCT01693562|2065355|FG007|Escalation Phase|Other|0
1033834|NCT01693562|2065356|FG008|Escalation Phase|Other|0
1033835|NCT01693562|2065357|FG009|Escalation Phase|Other|0
905174|NCT00761150|1880426|FG002|Double-blind Period|Lost to Follow-up|1
905175|NCT00761150|1880424|FG000|Double-blind Period|Did not meet DB randomization criteria|0
905176|NCT00761150|1880425|FG001|Double-blind Period|Did not meet DB randomization criteria|0
905177|NCT00761150|1880426|FG002|Double-blind Period|Did not meet DB randomization criteria|1
905178|NCT00761150|1880424|FG000|Double-blind Period|Noncompliance|0
905179|NCT00761150|1880425|FG001|Double-blind Period|Noncompliance|1
1033836|NCT01693562|2065358|FG010|Escalation Phase|Other|0
1033837|NCT01693562|2065359|FG011|Escalation Phase|Other|0
1033838|NCT01693562|2065360|FG012|Escalation Phase|Other|0
1033839|NCT01693562|2065361|FG013|Escalation Phase|Other|0
1033840|NCT01693562|2065362|FG014|Escalation Phase|Other|0
1033841|NCT01693562|2065363|FG015|Escalation Phase|Other|0
1033842|NCT01693562|2065364|FG016|Escalation Phase|Other|0
1033843|NCT01693562|2065365|FG017|Escalation Phase|Other|0
1033844|NCT01693562|2065366|FG018|Escalation Phase|Other|0
1033845|NCT01693562|2065367|FG019|Escalation Phase|Other|0
1033846|NCT01693562|2065368|FG020|Escalation Phase|Other|0
1033847|NCT01693562|2065369|FG021|Escalation Phase|Other|0
1033848|NCT01693562|2065370|FG022|Escalation Phase|Other|0
1033849|NCT01693562|2065348|FG000|Exploration Phase|Withdrawal by Subject|0
1033850|NCT01693562|2065349|FG001|Exploration Phase|Withdrawal by Subject|0
1033851|NCT01693562|2065350|FG002|Exploration Phase|Withdrawal by Subject|0
1033852|NCT01693562|2065351|FG003|Exploration Phase|Withdrawal by Subject|0
1033853|NCT01693562|2065352|FG004|Exploration Phase|Withdrawal by Subject|0
1033854|NCT01693562|2065353|FG005|Exploration Phase|Withdrawal by Subject|0
1033855|NCT01693562|2065354|FG006|Exploration Phase|Withdrawal by Subject|2
1033856|NCT01693562|2065355|FG007|Exploration Phase|Withdrawal by Subject|0
1033857|NCT01693562|2065356|FG008|Exploration Phase|Withdrawal by Subject|0
1033858|NCT01693562|2065357|FG009|Exploration Phase|Withdrawal by Subject|0
1033859|NCT01693562|2065358|FG010|Exploration Phase|Withdrawal by Subject|0
1033860|NCT01693562|2065359|FG011|Exploration Phase|Withdrawal by Subject|0
1033861|NCT01693562|2065360|FG012|Exploration Phase|Withdrawal by Subject|0
1033862|NCT01693562|2065361|FG013|Exploration Phase|Withdrawal by Subject|0
1033863|NCT01693562|2065362|FG014|Exploration Phase|Withdrawal by Subject|0
1033864|NCT01693562|2065363|FG015|Exploration Phase|Withdrawal by Subject|0
1033865|NCT01693562|2065364|FG016|Exploration Phase|Withdrawal by Subject|0
1033866|NCT01693562|2065365|FG017|Exploration Phase|Withdrawal by Subject|0
1033867|NCT01693562|2065366|FG018|Exploration Phase|Withdrawal by Subject|0
1033868|NCT01693562|2065367|FG019|Exploration Phase|Withdrawal by Subject|0
1033869|NCT01693562|2065368|FG020|Exploration Phase|Withdrawal by Subject|0
1033870|NCT01693562|2065369|FG021|Exploration Phase|Withdrawal by Subject|0
1033871|NCT01693562|2065370|FG022|Exploration Phase|Withdrawal by Subject|0
1033872|NCT01693562|2065348|FG000|Exploration Phase|Death|0
1033873|NCT01693562|2065349|FG001|Exploration Phase|Death|0
1033874|NCT01693562|2065350|FG002|Exploration Phase|Death|0
1033875|NCT01693562|2065351|FG003|Exploration Phase|Death|0
1033876|NCT01693562|2065352|FG004|Exploration Phase|Death|0
1033877|NCT01693562|2065353|FG005|Exploration Phase|Death|0
1033878|NCT01693562|2065354|FG006|Exploration Phase|Death|17
1033879|NCT01693562|2065355|FG007|Exploration Phase|Death|0
1033880|NCT01693562|2065356|FG008|Exploration Phase|Death|0
1033881|NCT01693562|2065357|FG009|Exploration Phase|Death|0
1033882|NCT01693562|2065358|FG010|Exploration Phase|Death|0
1033883|NCT01693562|2065359|FG011|Exploration Phase|Death|0
1033884|NCT01693562|2065360|FG012|Exploration Phase|Death|0
1033885|NCT01693562|2065361|FG013|Exploration Phase|Death|0
1033886|NCT01693562|2065362|FG014|Exploration Phase|Death|0
1033887|NCT01693562|2065363|FG015|Exploration Phase|Death|0
1033888|NCT01693562|2065364|FG016|Exploration Phase|Death|0
1033889|NCT01693562|2065365|FG017|Exploration Phase|Death|0
1033890|NCT01693562|2065366|FG018|Exploration Phase|Death|0
1033891|NCT01693562|2065367|FG019|Exploration Phase|Death|0
1033892|NCT01693562|2065368|FG020|Exploration Phase|Death|0
1033893|NCT01693562|2065369|FG021|Exploration Phase|Death|0
1033894|NCT01693562|2065370|FG022|Exploration Phase|Death|0
1033895|NCT01693562|2065348|FG000|Exploration Phase|Other|0
1033896|NCT01693562|2065349|FG001|Exploration Phase|Other|0
1033897|NCT01693562|2065350|FG002|Exploration Phase|Other|0
1033898|NCT01693562|2065351|FG003|Exploration Phase|Other|0
1033899|NCT01693562|2065352|FG004|Exploration Phase|Other|0
1033900|NCT01693562|2065353|FG005|Exploration Phase|Other|0
1033901|NCT01693562|2065354|FG006|Exploration Phase|Other|2
1033902|NCT01693562|2065355|FG007|Exploration Phase|Other|0
1033903|NCT01693562|2065356|FG008|Exploration Phase|Other|0
1033904|NCT01693562|2065357|FG009|Exploration Phase|Other|0
1033905|NCT01693562|2065358|FG010|Exploration Phase|Other|0
1033906|NCT01693562|2065359|FG011|Exploration Phase|Other|0
1033907|NCT01693562|2065360|FG012|Exploration Phase|Other|0
1033908|NCT01693562|2065361|FG013|Exploration Phase|Other|0
1033909|NCT01693562|2065362|FG014|Exploration Phase|Other|0
1033910|NCT01693562|2065363|FG015|Exploration Phase|Other|0
1033911|NCT01693562|2065364|FG016|Exploration Phase|Other|0
1033912|NCT01693562|2065365|FG017|Exploration Phase|Other|0
1033913|NCT01693562|2065366|FG018|Exploration Phase|Other|0
1033914|NCT01693562|2065367|FG019|Exploration Phase|Other|0
1033915|NCT01693562|2065368|FG020|Exploration Phase|Other|0
1033916|NCT01693562|2065369|FG021|Exploration Phase|Other|0
1033917|NCT01693562|2065370|FG022|Exploration Phase|Other|0
1033918|NCT01693562|2065348|FG000|Expansion Phase|Withdrawal by Subject|0
1033919|NCT01693562|2065349|FG001|Expansion Phase|Withdrawal by Subject|0
1033920|NCT01693562|2065350|FG002|Expansion Phase|Withdrawal by Subject|0
1033921|NCT01693562|2065351|FG003|Expansion Phase|Withdrawal by Subject|0
1033922|NCT01693562|2065352|FG004|Expansion Phase|Withdrawal by Subject|0
1033923|NCT01693562|2065353|FG005|Expansion Phase|Withdrawal by Subject|0
1033924|NCT01693562|2065354|FG006|Expansion Phase|Withdrawal by Subject|0
1033925|NCT01693562|2065355|FG007|Expansion Phase|Withdrawal by Subject|16
1033926|NCT01693562|2065356|FG008|Expansion Phase|Withdrawal by Subject|2
1033927|NCT01693562|2065357|FG009|Expansion Phase|Withdrawal by Subject|54
1033928|NCT01693562|2065358|FG010|Expansion Phase|Withdrawal by Subject|2
1033929|NCT01693562|2065359|FG011|Expansion Phase|Withdrawal by Subject|2
1033930|NCT01693562|2065360|FG012|Expansion Phase|Withdrawal by Subject|3
1033931|NCT01693562|2065361|FG013|Expansion Phase|Withdrawal by Subject|5
1033932|NCT01693562|2065362|FG014|Expansion Phase|Withdrawal by Subject|16
1033933|NCT01693562|2065363|FG015|Expansion Phase|Withdrawal by Subject|7
1033934|NCT01693562|2065364|FG016|Expansion Phase|Withdrawal by Subject|40
1033935|NCT01693562|2065365|FG017|Expansion Phase|Withdrawal by Subject|4
1033936|NCT01693562|2065366|FG018|Expansion Phase|Withdrawal by Subject|8
1033937|NCT01693562|2065367|FG019|Expansion Phase|Withdrawal by Subject|3
1033938|NCT01693562|2065368|FG020|Expansion Phase|Withdrawal by Subject|1
1033939|NCT01693562|2065369|FG021|Expansion Phase|Withdrawal by Subject|8
1033940|NCT01693562|2065370|FG022|Expansion Phase|Withdrawal by Subject|1
1033941|NCT01693562|2065348|FG000|Expansion Phase|Death|0
1033942|NCT01693562|2065349|FG001|Expansion Phase|Death|0
1033943|NCT01693562|2065350|FG002|Expansion Phase|Death|0
1033944|NCT01693562|2065351|FG003|Expansion Phase|Death|0
1033945|NCT01693562|2065352|FG004|Expansion Phase|Death|0
1033946|NCT01693562|2065353|FG005|Expansion Phase|Death|0
1033947|NCT01693562|2065354|FG006|Expansion Phase|Death|0
1033948|NCT01693562|2065355|FG007|Expansion Phase|Death|42
1033949|NCT01693562|2065356|FG008|Expansion Phase|Death|17
1033950|NCT01693562|2065357|FG009|Expansion Phase|Death|208
1033951|NCT01693562|2065358|FG010|Expansion Phase|Death|30
1033952|NCT01693562|2065359|FG011|Expansion Phase|Death|8
1033953|NCT01693562|2065360|FG012|Expansion Phase|Death|19
1033954|NCT01693562|2065361|FG013|Expansion Phase|Death|42
1033955|NCT01693562|2065362|FG014|Expansion Phase|Death|23
1033956|NCT01693562|2065363|FG015|Expansion Phase|Death|23
1033957|NCT01693562|2065364|FG016|Expansion Phase|Death|128
1033958|NCT01693562|2065365|FG017|Expansion Phase|Death|16
1033959|NCT01693562|2065366|FG018|Expansion Phase|Death|36
1033960|NCT01693562|2065367|FG019|Expansion Phase|Death|16
1033961|NCT01693562|2065368|FG020|Expansion Phase|Death|17
1033962|NCT01693562|2065369|FG021|Expansion Phase|Death|35
1033963|NCT01693562|2065370|FG022|Expansion Phase|Death|7
1033964|NCT01693562|2065348|FG000|Expansion Phase|Lost to Follow-up|0
1033965|NCT01693562|2065349|FG001|Expansion Phase|Lost to Follow-up|0
1033966|NCT01693562|2065350|FG002|Expansion Phase|Lost to Follow-up|0
1033967|NCT01693562|2065351|FG003|Expansion Phase|Lost to Follow-up|0
1033968|NCT01693562|2065352|FG004|Expansion Phase|Lost to Follow-up|0
1033969|NCT01693562|2065353|FG005|Expansion Phase|Lost to Follow-up|0
1033970|NCT01693562|2065354|FG006|Expansion Phase|Lost to Follow-up|0
1033971|NCT01693562|2065355|FG007|Expansion Phase|Lost to Follow-up|1
1033972|NCT01693562|2065356|FG008|Expansion Phase|Lost to Follow-up|2
1033973|NCT01693562|2065357|FG009|Expansion Phase|Lost to Follow-up|10
1033974|NCT01693562|2065358|FG010|Expansion Phase|Lost to Follow-up|4
1033975|NCT01693562|2065359|FG011|Expansion Phase|Lost to Follow-up|4
1033976|NCT01693562|2065360|FG012|Expansion Phase|Lost to Follow-up|1
1033977|NCT01693562|2065361|FG013|Expansion Phase|Lost to Follow-up|3
1033978|NCT01693562|2065362|FG014|Expansion Phase|Lost to Follow-up|0
1033979|NCT01693562|2065363|FG015|Expansion Phase|Lost to Follow-up|1
1033980|NCT01693562|2065364|FG016|Expansion Phase|Lost to Follow-up|1
1033981|NCT01693562|2065365|FG017|Expansion Phase|Lost to Follow-up|0
1033982|NCT01693562|2065366|FG018|Expansion Phase|Lost to Follow-up|2
1033983|NCT01693562|2065367|FG019|Expansion Phase|Lost to Follow-up|1
1033984|NCT01693562|2065368|FG020|Expansion Phase|Lost to Follow-up|2
1033985|NCT01693562|2065369|FG021|Expansion Phase|Lost to Follow-up|2
1033986|NCT01693562|2065370|FG022|Expansion Phase|Lost to Follow-up|1
1033987|NCT01693562|2065348|FG000|Expansion Phase|Other|0
1033988|NCT01693562|2065349|FG001|Expansion Phase|Other|0
1033989|NCT01693562|2065350|FG002|Expansion Phase|Other|0
1033990|NCT01693562|2065351|FG003|Expansion Phase|Other|0
1033991|NCT01693562|2065352|FG004|Expansion Phase|Other|0
1033992|NCT01693562|2065353|FG005|Expansion Phase|Other|0
1033993|NCT01693562|2065354|FG006|Expansion Phase|Other|0
1033994|NCT01693562|2065355|FG007|Expansion Phase|Other|3
1033995|NCT01693562|2065356|FG008|Expansion Phase|Other|1
1033996|NCT01693562|2065357|FG009|Expansion Phase|Other|28
1033997|NCT01693562|2065358|FG010|Expansion Phase|Other|4
1033998|NCT01693562|2065359|FG011|Expansion Phase|Other|7
1033999|NCT01693562|2065360|FG012|Expansion Phase|Other|0
1034000|NCT01693562|2065361|FG013|Expansion Phase|Other|1
1034001|NCT01693562|2065362|FG014|Expansion Phase|Other|1
1034002|NCT01693562|2065363|FG015|Expansion Phase|Other|0
1034003|NCT01693562|2065364|FG016|Expansion Phase|Other|28
1034004|NCT01693562|2065365|FG017|Expansion Phase|Other|0
1034005|NCT01693562|2065366|FG018|Expansion Phase|Other|1
1034006|NCT01693562|2065367|FG019|Expansion Phase|Other|0
1034007|NCT01693562|2065368|FG020|Expansion Phase|Other|1
1034008|NCT01693562|2065369|FG021|Expansion Phase|Other|17
1034009|NCT01693562|2065370|FG022|Expansion Phase|Other|1
1034010|NCT01693614|2065456|FG000|Overall Study|Adverse Event|7
1034011|NCT01693614|2065457|FG001|Overall Study|Adverse Event|11
1034012|NCT01693614|2065458|FG002|Overall Study|Adverse Event|5
1034013|NCT01693614|2065456|FG000|Overall Study|Disease progression|11
1034014|NCT01693614|2065457|FG001|Overall Study|Disease progression|8
1034015|NCT01693614|2065458|FG002|Overall Study|Disease progression|7
1034016|NCT01693614|2065456|FG000|Overall Study|Protocol Violation|5
1034017|NCT01693614|2065457|FG001|Overall Study|Protocol Violation|2
1034018|NCT01693614|2065458|FG002|Overall Study|Protocol Violation|1
1034019|NCT01693614|2065456|FG000|Overall Study|Death|1
1034020|NCT01693614|2065457|FG001|Overall Study|Death|0
1034021|NCT01693614|2065458|FG002|Overall Study|Death|0
1034022|NCT01693614|2065456|FG000|Overall Study|Physician Decision|1
1034023|NCT01693614|2065457|FG001|Overall Study|Physician Decision|1
1034024|NCT01693614|2065458|FG002|Overall Study|Physician Decision|4
1034025|NCT01693614|2065456|FG000|Overall Study|Withdrawal by subject/guardian|0
1034026|NCT01693614|2065457|FG001|Overall Study|Withdrawal by subject/guardian|0
1034027|NCT01693614|2065458|FG002|Overall Study|Withdrawal by subject/guardian|2
1034028|NCT01693614|2065456|FG000|Overall Study|Withdrawal by Subject|1
1034029|NCT01693614|2065457|FG001|Overall Study|Withdrawal by Subject|0
1034030|NCT01693614|2065458|FG002|Overall Study|Withdrawal by Subject|5
1034031|NCT01694121|2065494|FG000|Overall Study|Participant used false ID, was withdrawn|1
1034032|NCT01694121|2065495|FG001|Overall Study|Participant used false ID, was withdrawn|0
1034033|NCT01694420|2065519|FG000|Overall Study|Lost to Follow-up|3
1034034|NCT01694433|2065525|FG000|Overall Study|Adverse Event|7
1034035|NCT01694433|2065526|FG001|Overall Study|Adverse Event|0
1034036|NCT01694433|2065525|FG000|Overall Study|Physician Decision|1
1034037|NCT01694433|2065526|FG001|Overall Study|Physician Decision|0
1034038|NCT01694433|2065525|FG000|Overall Study|Withdrawal by Subject|3
1034039|NCT01694433|2065526|FG001|Overall Study|Withdrawal by Subject|4
1034040|NCT01694485|2065537|FG000|Overall Study|Withdrawal by Subject|20
1034041|NCT01694485|2065538|FG001|Overall Study|Withdrawal by Subject|6
1034042|NCT01694485|2065539|FG002|Overall Study|Withdrawal by Subject|7
1034043|NCT01694485|2065540|FG003|Overall Study|Withdrawal by Subject|25
1034044|NCT01694485|2065541|FG004|Overall Study|Withdrawal by Subject|18
1034045|NCT01694485|2065537|FG000|Overall Study|Sponsor Decision|3
1034046|NCT01694485|2065538|FG001|Overall Study|Sponsor Decision|0
1034047|NCT01694485|2065539|FG002|Overall Study|Sponsor Decision|0
1034048|NCT01694485|2065540|FG003|Overall Study|Sponsor Decision|2
1034049|NCT01694485|2065541|FG004|Overall Study|Sponsor Decision|0
1034050|NCT01694485|2065537|FG000|Overall Study|Lost to Follow-up|9
1034051|NCT01694485|2065538|FG001|Overall Study|Lost to Follow-up|1
1034052|NCT01694485|2065539|FG002|Overall Study|Lost to Follow-up|6
1034053|NCT01694485|2065540|FG003|Overall Study|Lost to Follow-up|10
1034054|NCT01694485|2065541|FG004|Overall Study|Lost to Follow-up|7
1034055|NCT01694485|2065537|FG000|Overall Study|Death|1
1034056|NCT01694485|2065538|FG001|Overall Study|Death|0
1034057|NCT01694485|2065539|FG002|Overall Study|Death|0
1034058|NCT01694485|2065540|FG003|Overall Study|Death|1
1034059|NCT01694485|2065541|FG004|Overall Study|Death|0
1034060|NCT01694706|2065584|FG000|Overall Study|Adverse Event|0
1034061|NCT01694706|2065585|FG001|Overall Study|Adverse Event|1
1034062|NCT01694706|2065586|FG002|Overall Study|Adverse Event|0
1034063|NCT01694706|2065584|FG000|Overall Study|other reason not defined above|1
1034064|NCT01694706|2065585|FG001|Overall Study|other reason not defined above|0
1034065|NCT01694706|2065586|FG002|Overall Study|other reason not defined above|0
1034066|NCT01694771|2065597|FG000|Overall Study|Adverse Event|18
1034067|NCT01694771|2065598|FG001|Overall Study|Adverse Event|16
1034068|NCT01694771|2065597|FG000|Overall Study|Lack of Efficacy|1
1034069|NCT01694771|2065598|FG001|Overall Study|Lack of Efficacy|0
1034070|NCT01694771|2065597|FG000|Overall Study|Non compliance protocol|7
1034071|NCT01694771|2065598|FG001|Overall Study|Non compliance protocol|6
1034072|NCT01694771|2065597|FG000|Overall Study|Lost to Follow-up|2
1034073|NCT01694771|2065598|FG001|Overall Study|Lost to Follow-up|3
1034074|NCT01694771|2065597|FG000|Overall Study|Consent withdrawn|7
1034075|NCT01694771|2065598|FG001|Overall Study|Consent withdrawn|9
1034076|NCT01694771|2065597|FG000|Overall Study|Other reasons|5
1034077|NCT01694771|2065598|FG001|Overall Study|Other reasons|6
1034078|NCT01695135|2065629|FG000|Double-blind Treatment Phase|Progressive disease|50
1034079|NCT01695135|2065630|FG001|Double-blind Treatment Phase|Progressive disease|110
1034080|NCT01695135|2065631|FG002|Double-blind Treatment Phase|Progressive disease|0
1034081|NCT01695135|2065632|FG003|Double-blind Treatment Phase|Progressive disease|0
1034082|NCT01695135|2065629|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6
1034083|NCT01695135|2065630|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14
1034084|NCT01695135|2065631|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
1034085|NCT01695135|2065632|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0
1034086|NCT01695135|2065629|FG000|Double-blind Treatment Phase|Adverse Event|7
1034087|NCT01695135|2065630|FG001|Double-blind Treatment Phase|Adverse Event|7
1034088|NCT01695135|2065631|FG002|Double-blind Treatment Phase|Adverse Event|0
1034089|NCT01695135|2065632|FG003|Double-blind Treatment Phase|Adverse Event|0
1034090|NCT01695135|2065629|FG000|Double-blind Treatment Phase|Other|1
1034091|NCT01695135|2065630|FG001|Double-blind Treatment Phase|Other|3
1034092|NCT01695135|2065631|FG002|Double-blind Treatment Phase|Other|0
1034093|NCT01695135|2065632|FG003|Double-blind Treatment Phase|Other|0
1034094|NCT01695135|2065629|FG000|Double-blind Treatment Phase|Physician Decision|6
1034095|NCT01695135|2065630|FG001|Double-blind Treatment Phase|Physician Decision|3
1034096|NCT01695135|2065631|FG002|Double-blind Treatment Phase|Physician Decision|0
1034097|NCT01695135|2065632|FG003|Double-blind Treatment Phase|Physician Decision|0
1034098|NCT01695135|2065629|FG000|Double-blind Treatment Phase|Death|1
1034099|NCT01695135|2065630|FG001|Double-blind Treatment Phase|Death|1
1034100|NCT01695135|2065631|FG002|Double-blind Treatment Phase|Death|0
1034101|NCT01695135|2065632|FG003|Double-blind Treatment Phase|Death|0
1034102|NCT01695135|2065629|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0
1034103|NCT01695135|2065630|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1
1034104|NCT01695135|2065631|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0
1034105|NCT01695135|2065632|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0
1034106|NCT01695135|2065629|FG000|Open Label Extension Treatment Phase|Progressive disease|0
1034107|NCT01695135|2065630|FG001|Open Label Extension Treatment Phase|Progressive disease|0
1034108|NCT01695135|2065631|FG002|Open Label Extension Treatment Phase|Progressive disease|13
1034109|NCT01695135|2065632|FG003|Open Label Extension Treatment Phase|Progressive disease|22
1034110|NCT01695135|2065629|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0
1034111|NCT01695135|2065630|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0
1034112|NCT01695135|2065631|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6
1034113|NCT01695135|2065632|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16
1034114|NCT01695135|2065629|FG000|Open Label Extension Treatment Phase|Adverse Event|0
1034115|NCT01695135|2065630|FG001|Open Label Extension Treatment Phase|Adverse Event|0
1034116|NCT01695135|2065631|FG002|Open Label Extension Treatment Phase|Adverse Event|11
1034117|NCT01695135|2065632|FG003|Open Label Extension Treatment Phase|Adverse Event|16
1034118|NCT01695135|2065629|FG000|Open Label Extension Treatment Phase|Other|0
1034119|NCT01695135|2065630|FG001|Open Label Extension Treatment Phase|Other|0
1034120|NCT01695135|2065631|FG002|Open Label Extension Treatment Phase|Other|4
1034121|NCT01695135|2065632|FG003|Open Label Extension Treatment Phase|Other|7
1034122|NCT01695135|2065629|FG000|Open Label Extension Treatment Phase|Physician Decision|0
1034123|NCT01695135|2065630|FG001|Open Label Extension Treatment Phase|Physician Decision|0
1034124|NCT01695135|2065631|FG002|Open Label Extension Treatment Phase|Physician Decision|4
1034125|NCT01695135|2065632|FG003|Open Label Extension Treatment Phase|Physician Decision|1
1034126|NCT01695135|2065629|FG000|Open Label Extension Treatment Phase|Death|0
1034127|NCT01695135|2065630|FG001|Open Label Extension Treatment Phase|Death|0
1034128|NCT01695135|2065631|FG002|Open Label Extension Treatment Phase|Death|2
1034129|NCT01695135|2065632|FG003|Open Label Extension Treatment Phase|Death|7
1034130|NCT01695135|2065629|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0
1034131|NCT01695135|2065630|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0
1034132|NCT01695135|2065631|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0
1034133|NCT01695135|2065632|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1
1034134|NCT01695239|2065644|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
1034135|NCT01695239|2065645|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
1034136|NCT01695239|2065646|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
1034137|NCT01695239|2065647|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
1034138|NCT01695239|2065648|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1034139|NCT01695239|2065649|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1034140|NCT01695239|2065650|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1034141|NCT01695239|2065651|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1034142|NCT01695239|2065652|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1034143|NCT01695239|2065653|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1034144|NCT01695239|2065654|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1034145|NCT01695239|2065655|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1034146|NCT01695239|2065656|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1034147|NCT01695239|2065657|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1034148|NCT01695239|2065644|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2
1034149|NCT01695239|2065645|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2
1034150|NCT01695239|2065646|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2
1034151|NCT01695239|2065647|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3
1034152|NCT01695239|2065648|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0
1034153|NCT01695239|2065649|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0
1034154|NCT01695239|2065650|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0
1034155|NCT01695239|2065651|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0
1034156|NCT01695239|2065652|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0
1034157|NCT01695239|2065653|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0
1034158|NCT01695239|2065654|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0
1034159|NCT01695239|2065655|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0
1034160|NCT01695239|2065656|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0
1034161|NCT01695239|2065657|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0
1034162|NCT01695239|2065644|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
1034163|NCT01695239|2065645|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034164|NCT01695239|2065646|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
1034165|NCT01695239|2065647|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034166|NCT01695239|2065648|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034167|NCT01695239|2065649|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034168|NCT01695239|2065650|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034169|NCT01695239|2065651|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034170|NCT01695239|2065652|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034171|NCT01695239|2065653|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034172|NCT01695239|2065654|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034173|NCT01695239|2065655|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034174|NCT01695239|2065656|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034175|NCT01695239|2065657|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1034176|NCT01695239|2065644|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
1034177|NCT01695239|2065645|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
1034178|NCT01695239|2065646|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
1034179|NCT01695239|2065647|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1034180|NCT01695239|2065648|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1034181|NCT01695239|2065649|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1034182|NCT01695239|2065650|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1034183|NCT01695239|2065651|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1034184|NCT01695239|2065652|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1034185|NCT01695239|2065653|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1034186|NCT01695239|2065654|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1034187|NCT01695239|2065655|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1034188|NCT01695239|2065656|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1034189|NCT01695239|2065657|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1034190|NCT01695239|2065644|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3
1034191|NCT01695239|2065645|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034192|NCT01695239|2065646|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1
1034193|NCT01695239|2065647|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034194|NCT01695239|2065648|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034195|NCT01695239|2065649|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034196|NCT01695239|2065650|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034197|NCT01695239|2065651|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034198|NCT01695239|2065652|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034199|NCT01695239|2065653|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034200|NCT01695239|2065654|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034201|NCT01695239|2065655|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034202|NCT01695239|2065656|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034203|NCT01695239|2065657|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1034204|NCT01695239|2065644|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
1034205|NCT01695239|2065645|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034206|NCT01695239|2065646|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
1034207|NCT01695239|2065647|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034208|NCT01695239|2065648|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034209|NCT01695239|2065649|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034210|NCT01695239|2065650|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034211|NCT01695239|2065651|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034212|NCT01695239|2065652|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034213|NCT01695239|2065653|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034214|NCT01695239|2065654|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034215|NCT01695239|2065655|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034216|NCT01695239|2065656|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034217|NCT01695239|2065657|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1034218|NCT01695239|2065644|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1
1034219|NCT01695239|2065645|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034220|NCT01695239|2065646|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0
905180|NCT00761150|1880426|FG002|Double-blind Period|Noncompliance|0
905181|NCT00761150|1880424|FG000|Double-blind Period|Other|0
905182|NCT00761150|1880425|FG001|Double-blind Period|Other|3
905183|NCT00761150|1880426|FG002|Double-blind Period|Other|3
905184|NCT00761189|1880433|FG000|Overall Study|Adverse Event|42
905185|NCT00761189|1880433|FG000|Overall Study|Lack of Efficacy|45
905186|NCT00761189|1880433|FG000|Overall Study|Lost to Follow-up|36
905187|NCT00761189|1880433|FG000|Overall Study|Withdrawal by Subject|49
905188|NCT00761189|1880433|FG000|Overall Study|Other|13
905189|NCT00761215|1880449|FG000|Overall Study|Randomized but didn't receive drug|1
905190|NCT00761215|1880450|FG001|Overall Study|Randomized but didn't receive drug|1
905191|NCT00761215|1880451|FG002|Overall Study|Randomized but didn't receive drug|2
905192|NCT00761215|1880449|FG000|Overall Study|Lost to Follow-up|6
905193|NCT00761215|1880450|FG001|Overall Study|Lost to Follow-up|3
905194|NCT00761215|1880451|FG002|Overall Study|Lost to Follow-up|6
905195|NCT00761215|1880449|FG000|Overall Study|Withdrawal by Subject|1
905196|NCT00761215|1880450|FG001|Overall Study|Withdrawal by Subject|0
905197|NCT00761215|1880451|FG002|Overall Study|Withdrawal by Subject|0
905198|NCT00761215|1880449|FG000|Overall Study|Bacteremia|1
905199|NCT00761215|1880450|FG001|Overall Study|Bacteremia|0
1034221|NCT01695239|2065647|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034222|NCT01695239|2065648|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034223|NCT01695239|2065649|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034224|NCT01695239|2065650|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034225|NCT01695239|2065651|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034226|NCT01695239|2065652|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034227|NCT01695239|2065653|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034228|NCT01695239|2065654|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034229|NCT01695239|2065655|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034230|NCT01695239|2065656|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034231|NCT01695239|2065657|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0
1034232|NCT01695239|2065644|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034233|NCT01695239|2065645|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034234|NCT01695239|2065646|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034235|NCT01695239|2065647|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034236|NCT01695239|2065648|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034237|NCT01695239|2065649|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034238|NCT01695239|2065650|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034239|NCT01695239|2065651|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
1034240|NCT01695239|2065652|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034241|NCT01695239|2065653|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034242|NCT01695239|2065654|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034243|NCT01695239|2065655|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034244|NCT01695239|2065656|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034245|NCT01695239|2065657|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1034246|NCT01695239|2065644|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034247|NCT01695239|2065645|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034248|NCT01695239|2065646|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034249|NCT01695239|2065647|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034250|NCT01695239|2065648|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034251|NCT01695239|2065649|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034252|NCT01695239|2065650|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034253|NCT01695239|2065651|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
1034254|NCT01695239|2065652|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034255|NCT01695239|2065653|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034256|NCT01695239|2065654|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034257|NCT01695239|2065655|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034258|NCT01695239|2065656|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034259|NCT01695239|2065657|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1034260|NCT01695239|2065644|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034261|NCT01695239|2065645|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034262|NCT01695239|2065646|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034263|NCT01695239|2065647|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034264|NCT01695239|2065648|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034265|NCT01695239|2065649|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034266|NCT01695239|2065650|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034267|NCT01695239|2065651|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
1034268|NCT01695239|2065652|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034269|NCT01695239|2065653|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034270|NCT01695239|2065654|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034271|NCT01695239|2065655|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034272|NCT01695239|2065656|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034273|NCT01695239|2065657|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1034274|NCT01695239|2065644|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034275|NCT01695239|2065645|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034276|NCT01695239|2065646|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034277|NCT01695239|2065647|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034278|NCT01695239|2065648|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034279|NCT01695239|2065649|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034280|NCT01695239|2065650|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034281|NCT01695239|2065651|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034282|NCT01695239|2065652|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37
1034283|NCT01695239|2065653|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31
1034284|NCT01695239|2065654|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034285|NCT01695239|2065655|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034286|NCT01695239|2065656|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034287|NCT01695239|2065657|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0
1034288|NCT01695239|2065644|FG000|Extension Long-Term Extension Periods|Adverse Event|0
1034289|NCT01695239|2065645|FG001|Extension Long-Term Extension Periods|Adverse Event|0
1034290|NCT01695239|2065646|FG002|Extension Long-Term Extension Periods|Adverse Event|0
1034291|NCT01695239|2065647|FG003|Extension Long-Term Extension Periods|Adverse Event|0
1034292|NCT01695239|2065648|FG004|Extension Long-Term Extension Periods|Adverse Event|0
1034293|NCT01695239|2065649|FG005|Extension Long-Term Extension Periods|Adverse Event|0
1034294|NCT01695239|2065650|FG006|Extension Long-Term Extension Periods|Adverse Event|0
1034295|NCT01695239|2065651|FG007|Extension Long-Term Extension Periods|Adverse Event|0
1034296|NCT01695239|2065652|FG008|Extension Long-Term Extension Periods|Adverse Event|15
1034297|NCT01695239|2065653|FG009|Extension Long-Term Extension Periods|Adverse Event|21
1034298|NCT01695239|2065654|FG010|Extension Long-Term Extension Periods|Adverse Event|0
1034299|NCT01695239|2065655|FG011|Extension Long-Term Extension Periods|Adverse Event|0
1034300|NCT01695239|2065656|FG012|Extension Long-Term Extension Periods|Adverse Event|0
1034301|NCT01695239|2065657|FG013|Extension Long-Term Extension Periods|Adverse Event|0
1034302|NCT01695239|2065644|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034303|NCT01695239|2065645|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034304|NCT01695239|2065646|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034305|NCT01695239|2065647|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034306|NCT01695239|2065648|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034307|NCT01695239|2065649|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034308|NCT01695239|2065650|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034309|NCT01695239|2065651|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034310|NCT01695239|2065652|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6
1034311|NCT01695239|2065653|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7
1034312|NCT01695239|2065654|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034313|NCT01695239|2065655|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034314|NCT01695239|2065656|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034315|NCT01695239|2065657|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1034316|NCT01695239|2065644|FG000|Extension Long-Term Extension Periods|Physician Decision|0
1034317|NCT01695239|2065645|FG001|Extension Long-Term Extension Periods|Physician Decision|0
1034318|NCT01695239|2065646|FG002|Extension Long-Term Extension Periods|Physician Decision|0
1034319|NCT01695239|2065647|FG003|Extension Long-Term Extension Periods|Physician Decision|0
1034320|NCT01695239|2065648|FG004|Extension Long-Term Extension Periods|Physician Decision|0
1034321|NCT01695239|2065649|FG005|Extension Long-Term Extension Periods|Physician Decision|0
1034322|NCT01695239|2065650|FG006|Extension Long-Term Extension Periods|Physician Decision|0
1034323|NCT01695239|2065651|FG007|Extension Long-Term Extension Periods|Physician Decision|0
1034324|NCT01695239|2065652|FG008|Extension Long-Term Extension Periods|Physician Decision|3
1034325|NCT01695239|2065653|FG009|Extension Long-Term Extension Periods|Physician Decision|0
1034326|NCT01695239|2065654|FG010|Extension Long-Term Extension Periods|Physician Decision|0
1034327|NCT01695239|2065655|FG011|Extension Long-Term Extension Periods|Physician Decision|0
1034328|NCT01695239|2065656|FG012|Extension Long-Term Extension Periods|Physician Decision|0
1034329|NCT01695239|2065657|FG013|Extension Long-Term Extension Periods|Physician Decision|0
1034330|NCT01695239|2065644|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0
1034331|NCT01695239|2065645|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0
1034332|NCT01695239|2065646|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0
1034333|NCT01695239|2065647|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0
1034334|NCT01695239|2065648|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0
905200|NCT00761215|1880451|FG002|Overall Study|Bacteremia|0
905201|NCT00761267|1880465|FG000|Overall Study|Death|1
905202|NCT00761267|1880466|FG001|Overall Study|Death|2
905203|NCT00761267|1880467|FG002|Overall Study|Death|5
905204|NCT00761267|1880465|FG000|Overall Study|Lost to Follow-up|0
905205|NCT00761267|1880466|FG001|Overall Study|Lost to Follow-up|0
905206|NCT00761267|1880467|FG002|Overall Study|Lost to Follow-up|1
905207|NCT00761267|1880465|FG000|Overall Study|Randomized but not treated|1
905208|NCT00761267|1880466|FG001|Overall Study|Randomized but not treated|1
905209|NCT00761267|1880467|FG002|Overall Study|Randomized but not treated|0
905210|NCT00761267|1880465|FG000|Overall Study|Withdrawal by Subject|0
905211|NCT00761267|1880466|FG001|Overall Study|Withdrawal by Subject|1
905212|NCT00761267|1880467|FG002|Overall Study|Withdrawal by Subject|0
905213|NCT00761280|1880488|FG000|Randomization to First Dose|Withdrawal by Subject|0
905214|NCT00761280|1880489|FG001|Randomization to First Dose|Withdrawal by Subject|2
905215|NCT00761280|1880488|FG000|Randomization to First Dose|Sponsor decision|1
905216|NCT00761280|1880489|FG001|Randomization to First Dose|Sponsor decision|0
905217|NCT00761280|1880488|FG000|Randomization to First Dose|Other|1
905218|NCT00761280|1880489|FG001|Randomization to First Dose|Other|0
905219|NCT00761280|1880488|FG000|First Dose to End of Study|End of trial|5
905220|NCT00761280|1880489|FG001|First Dose to End of Study|End of trial|5
905221|NCT00761280|1880488|FG000|First Dose to End of Study|Progressive disease|5
905222|NCT00761280|1880489|FG001|First Dose to End of Study|Progressive disease|3
1034335|NCT01695239|2065649|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0
1034336|NCT01695239|2065650|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0
1034337|NCT01695239|2065651|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0
1034338|NCT01695239|2065652|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2
1034339|NCT01695239|2065653|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1
1034340|NCT01695239|2065654|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0
1034341|NCT01695239|2065655|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0
1034342|NCT01695239|2065656|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0
1034343|NCT01695239|2065657|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0
1034344|NCT01695239|2065644|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0
1034345|NCT01695239|2065645|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0
1034346|NCT01695239|2065646|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0
1034347|NCT01695239|2065647|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0
1034348|NCT01695239|2065648|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0
1034349|NCT01695239|2065649|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0
1034350|NCT01695239|2065650|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0
1034351|NCT01695239|2065651|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0
1034352|NCT01695239|2065652|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2
1034353|NCT01695239|2065653|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1
1034354|NCT01695239|2065654|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0
1034355|NCT01695239|2065655|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0
1034356|NCT01695239|2065656|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0
1034357|NCT01695239|2065657|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0
1034358|NCT01695239|2065644|FG000|Extension Long-Term Extension Periods|Death|0
1034359|NCT01695239|2065645|FG001|Extension Long-Term Extension Periods|Death|0
1034360|NCT01695239|2065646|FG002|Extension Long-Term Extension Periods|Death|0
1034361|NCT01695239|2065647|FG003|Extension Long-Term Extension Periods|Death|0
1034362|NCT01695239|2065648|FG004|Extension Long-Term Extension Periods|Death|0
1034363|NCT01695239|2065649|FG005|Extension Long-Term Extension Periods|Death|0
1034364|NCT01695239|2065650|FG006|Extension Long-Term Extension Periods|Death|0
1034365|NCT01695239|2065651|FG007|Extension Long-Term Extension Periods|Death|0
1034366|NCT01695239|2065652|FG008|Extension Long-Term Extension Periods|Death|1
1034367|NCT01695239|2065653|FG009|Extension Long-Term Extension Periods|Death|0
1034368|NCT01695239|2065654|FG010|Extension Long-Term Extension Periods|Death|0
1034369|NCT01695239|2065655|FG011|Extension Long-Term Extension Periods|Death|0
1034370|NCT01695239|2065656|FG012|Extension Long-Term Extension Periods|Death|0
1034371|NCT01695239|2065657|FG013|Extension Long-Term Extension Periods|Death|0
1034372|NCT01695239|2065644|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1034373|NCT01695239|2065645|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1034374|NCT01695239|2065646|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1034375|NCT01695239|2065647|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1034376|NCT01695239|2065648|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1034377|NCT01695239|2065649|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
905223|NCT00761280|1880488|FG000|First Dose to End of Study|Sponsor decision|1
905224|NCT00761280|1880489|FG001|First Dose to End of Study|Sponsor decision|2
905225|NCT00761280|1880488|FG000|First Dose to End of Study|Death|1
905226|NCT00761280|1880489|FG001|First Dose to End of Study|Death|0
905227|NCT00761280|1880488|FG000|First Dose to End of Study|Lost to Follow-up|0
905228|NCT00761280|1880489|FG001|First Dose to End of Study|Lost to Follow-up|1
905229|NCT00761306|1880495|FG000|Overall Study|Adverse Event|5
905230|NCT00761306|1880495|FG000|Overall Study|Lack of Efficacy|4
905231|NCT00761306|1880495|FG000|Overall Study|Protocol Violation|2
905232|NCT00761306|1880495|FG000|Overall Study|Withdrawal of Consent|3
905233|NCT00761306|1880495|FG000|Overall Study|Lost to Follow-up|1
905234|NCT00761306|1880495|FG000|Overall Study|Administrative or Other Reasons|5
905235|NCT00761319|1880501|FG000|Overall Study|Protocol Violation|21
905236|NCT00761319|1880502|FG001|Overall Study|Protocol Violation|14
905237|NCT00761319|1880501|FG000|Overall Study|Adverse Event|11
905238|NCT00761319|1880502|FG001|Overall Study|Adverse Event|7
905239|NCT00761319|1880501|FG000|Overall Study|Withdrawal by Subject|8
905240|NCT00761319|1880502|FG001|Overall Study|Withdrawal by Subject|7
905241|NCT00761319|1880501|FG000|Overall Study|Noncompliance|4
905242|NCT00761319|1880502|FG001|Overall Study|Noncompliance|3
905243|NCT00761319|1880501|FG000|Overall Study|Lost to Follow-up|1
905244|NCT00761319|1880502|FG001|Overall Study|Lost to Follow-up|1
905245|NCT00761319|1880501|FG000|Overall Study|Nonspecified|2
905246|NCT00761319|1880502|FG001|Overall Study|Nonspecified|2
905247|NCT00761319|1880501|FG000|Overall Study|Missing|1
905248|NCT00761319|1880502|FG001|Overall Study|Missing|0
905249|NCT00761462|1880514|FG000|Treatment|Subjects never received study medication|23
905250|NCT00761462|1880515|FG001|Treatment|Subjects never received study medication|12
905251|NCT00761462|1880514|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4
905252|NCT00761462|1880515|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0
905253|NCT00761462|1880514|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
905254|NCT00761462|1880515|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
1034378|NCT01695239|2065650|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1034379|NCT01695239|2065651|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1034380|NCT01695239|2065652|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1034381|NCT01695239|2065653|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1034382|NCT01695239|2065654|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1034383|NCT01695239|2065655|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
1034384|NCT01695239|2065656|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
1034385|NCT01695239|2065657|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
1034386|NCT01695239|2065644|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034387|NCT01695239|2065645|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034388|NCT01695239|2065646|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034389|NCT01695239|2065647|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034390|NCT01695239|2065648|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034391|NCT01695239|2065649|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034392|NCT01695239|2065650|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034393|NCT01695239|2065651|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034394|NCT01695239|2065652|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034395|NCT01695239|2065653|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034396|NCT01695239|2065654|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034397|NCT01695239|2065655|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1034398|NCT01695239|2065656|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1
1034399|NCT01695239|2065657|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
1034400|NCT01695239|2065644|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
1034401|NCT01695239|2065645|FG001|Post-Treatment Follow-Up Period|Physician Decision|0
1034402|NCT01695239|2065646|FG002|Post-Treatment Follow-Up Period|Physician Decision|0
1034403|NCT01695239|2065647|FG003|Post-Treatment Follow-Up Period|Physician Decision|0
1034404|NCT01695239|2065648|FG004|Post-Treatment Follow-Up Period|Physician Decision|0
1034405|NCT01695239|2065649|FG005|Post-Treatment Follow-Up Period|Physician Decision|0
1034406|NCT01695239|2065650|FG006|Post-Treatment Follow-Up Period|Physician Decision|0
1034407|NCT01695239|2065651|FG007|Post-Treatment Follow-Up Period|Physician Decision|0
1034408|NCT01695239|2065652|FG008|Post-Treatment Follow-Up Period|Physician Decision|0
1034409|NCT01695239|2065653|FG009|Post-Treatment Follow-Up Period|Physician Decision|0
1034410|NCT01695239|2065654|FG010|Post-Treatment Follow-Up Period|Physician Decision|0
1034411|NCT01695239|2065655|FG011|Post-Treatment Follow-Up Period|Physician Decision|0
1034412|NCT01695239|2065656|FG012|Post-Treatment Follow-Up Period|Physician Decision|2
1034413|NCT01695239|2065657|FG013|Post-Treatment Follow-Up Period|Physician Decision|0
1034414|NCT01695239|2065644|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
1034415|NCT01695239|2065645|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
1034416|NCT01695239|2065646|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
1034417|NCT01695239|2065647|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
1034418|NCT01695239|2065648|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
1034419|NCT01695239|2065649|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
1034420|NCT01695239|2065650|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
1034421|NCT01695239|2065651|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
1034422|NCT01695239|2065652|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
1034423|NCT01695239|2065653|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
1034424|NCT01695239|2065654|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
1034425|NCT01695239|2065655|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
1034426|NCT01695239|2065656|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
1034427|NCT01695239|2065657|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
1034428|NCT01695746|2065724|FG000|Overall Study|Adverse Event|1
1034429|NCT01695746|2065724|FG000|Overall Study|Non-compliance by the participant|3
1034430|NCT01695746|2065724|FG000|Overall Study|Protocol Violation|5
1034431|NCT01695746|2065724|FG000|Overall Study|Participant not willing to participate|3
1034432|NCT01695772|2065729|FG000|Overall Study|Withdrawal by Subject|18
1034433|NCT01695772|2065729|FG000|Overall Study|Progressive Disease|8
1034434|NCT01695772|2065729|FG000|Overall Study|Investigator Decision|5
905255|NCT00761462|1880514|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
905256|NCT00761462|1880515|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
905257|NCT00761514|1880521|FG000|Overall Study|Adverse Event|1
905258|NCT00761514|1880521|FG000|Overall Study|Withdrawal by Subject|2
905259|NCT00761514|1880521|FG000|Overall Study|Lost to Follow-up|1
905260|NCT00761514|1880521|FG000|Overall Study|Health insurance didn't cover study drug|1
905261|NCT00761514|1880521|FG000|Overall Study|Problem complying with study visit|1
905262|NCT00761514|1880521|FG000|Overall Study|Unable to pay for medications|1
905263|NCT00761527|1880525|FG000|Overall Study|Adverse Event|3
905264|NCT00761527|1880525|FG000|Overall Study|Poor Compliance|8
905265|NCT00761527|1880525|FG000|Overall Study|Lost to Follow-up|9
905266|NCT00761527|1880525|FG000|Overall Study|Unknown reason|2
905267|NCT00761579|1880529|FG000|Overall Study|Adverse Event|10
905268|NCT00761579|1880529|FG000|Overall Study|Death|2
905269|NCT00761579|1880529|FG000|Overall Study|Lack of Efficacy|21
905270|NCT00761579|1880529|FG000|Overall Study|Lost to Follow-up|16
905271|NCT00761579|1880529|FG000|Overall Study|Pregnancy|1
1034435|NCT01695772|2065729|FG000|Overall Study|Lost to Follow-up|4
1034436|NCT01695772|2065729|FG000|Overall Study|Protocol Violation|2
1034437|NCT01695772|2065729|FG000|Overall Study|Unspecified Reason|1
1034438|NCT01695954|2065735|FG000|Overall Study|Withdrawal by Subject|4
1034439|NCT01695954|2065736|FG001|Overall Study|Withdrawal by Subject|0
1034440|NCT01695954|2065735|FG000|Overall Study|Adverse Event|0
1034441|NCT01695954|2065736|FG001|Overall Study|Adverse Event|2
1034442|NCT01695993|2065747|FG000|Overall Study|Lost to Follow-up|2
1034443|NCT01695993|2065748|FG001|Overall Study|Lost to Follow-up|1
1034444|NCT01695993|2065749|FG002|Overall Study|Lost to Follow-up|3
1034445|NCT01695993|2065747|FG000|Overall Study|Withdrawal by Subject|2
1034446|NCT01695993|2065748|FG001|Overall Study|Withdrawal by Subject|2
1034447|NCT01695993|2065749|FG002|Overall Study|Withdrawal by Subject|2
1034448|NCT01695993|2065747|FG000|Overall Study|To ill to continue|1
1034449|NCT01695993|2065748|FG001|Overall Study|To ill to continue|2
1034450|NCT01695993|2065749|FG002|Overall Study|To ill to continue|0
1034451|NCT01695993|2065747|FG000|Overall Study|Changed Medical Facility|0
1034452|NCT01695993|2065748|FG001|Overall Study|Changed Medical Facility|0
1034453|NCT01695993|2065749|FG002|Overall Study|Changed Medical Facility|1
1034454|NCT01696032|2065761|FG000|Overall Study|Withdrawal by Subject|0
1034455|NCT01696032|2065762|FG001|Overall Study|Withdrawal by Subject|0
1034456|NCT01696032|2065763|FG002|Overall Study|Withdrawal by Subject|1
1034457|NCT01696032|2065764|FG003|Overall Study|Withdrawal by Subject|2
1034458|NCT01696032|2065761|FG000|Overall Study|Death|14
1034459|NCT01696032|2065762|FG001|Overall Study|Death|4
1034460|NCT01696032|2065763|FG002|Overall Study|Death|43
1034461|NCT01696032|2065764|FG003|Overall Study|Death|18
1034462|NCT01696032|2065761|FG000|Overall Study|Lost to Follow-up|0
1034463|NCT01696032|2065762|FG001|Overall Study|Lost to Follow-up|1
1034464|NCT01696032|2065763|FG002|Overall Study|Lost to Follow-up|0
1034465|NCT01696032|2065764|FG003|Overall Study|Lost to Follow-up|0
1034466|NCT01696032|2065761|FG000|Overall Study|Database lock|0
1034467|NCT01696032|2065762|FG001|Overall Study|Database lock|1
1034468|NCT01696032|2065763|FG002|Overall Study|Database lock|7
1034469|NCT01696032|2065764|FG003|Overall Study|Database lock|2
1034470|NCT01696045|2065780|FG000|Overall Study|Study drug toxicity|1
1034471|NCT01696045|2065781|FG001|Overall Study|Study drug toxicity|5
1034472|NCT01696045|2065780|FG000|Overall Study|Disease progression|2
1034473|NCT01696045|2065781|FG001|Overall Study|Disease progression|2
1034474|NCT01696058|2065789|FG000|Overall Study|Adverse Event|21
1034475|NCT01696058|2065790|FG001|Overall Study|Adverse Event|11
1034476|NCT01696058|2065789|FG000|Overall Study|Lack of Efficacy|2
1034477|NCT01696058|2065790|FG001|Overall Study|Lack of Efficacy|3
1034478|NCT01696058|2065789|FG000|Overall Study|Protocol Violation|9
1034479|NCT01696058|2065790|FG001|Overall Study|Protocol Violation|3
1034480|NCT01696058|2065789|FG000|Overall Study|Lost to Follow-up|2
1034481|NCT01696058|2065790|FG001|Overall Study|Lost to Follow-up|5
1034482|NCT01696058|2065789|FG000|Overall Study|Withdrawal by Subject|4
1034483|NCT01696058|2065790|FG001|Overall Study|Withdrawal by Subject|6
1034484|NCT01696058|2065789|FG000|Overall Study|Other reason prematurely discontinued|5
1034485|NCT01696058|2065790|FG001|Overall Study|Other reason prematurely discontinued|3
1034486|NCT01696071|2065796|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1
1034487|NCT01696071|2065797|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0
1034488|NCT01696188|2065815|FG000|Overall Study|Protocol Violation|1
1034489|NCT01696188|2065816|FG001|Overall Study|Protocol Violation|1
1034490|NCT01696214|2065826|FG000|Overall Study|Lost to Follow-up|1
1034491|NCT01696214|2065827|FG001|Overall Study|Lost to Follow-up|0
1034492|NCT01696214|2065828|FG002|Overall Study|Lost to Follow-up|0
1034493|NCT01696214|2065829|FG003|Overall Study|Lost to Follow-up|0
1034494|NCT01696279|2065847|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
1034495|NCT01696279|2065848|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
1034496|NCT01696279|2065849|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
1034497|NCT01696279|2065850|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
1034498|NCT01696279|2065847|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
1034499|NCT01696279|2065848|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
1034500|NCT01696279|2065849|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
1034501|NCT01696279|2065850|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
1034502|NCT01696279|2065847|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
1034503|NCT01696279|2065848|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
1034504|NCT01696279|2065849|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
1034505|NCT01696279|2065850|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
1034506|NCT01696279|2065847|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
1034507|NCT01696279|2065848|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
1034508|NCT01696279|2065849|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
1034509|NCT01696279|2065850|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
1034510|NCT01696279|2065847|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
1034511|NCT01696279|2065848|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
1034512|NCT01696279|2065849|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
1034513|NCT01696279|2065850|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
1034514|NCT01696279|2065847|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
1034515|NCT01696279|2065848|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
1034516|NCT01696279|2065849|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
1034517|NCT01696279|2065850|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
1034518|NCT01696279|2065847|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
1034519|NCT01696279|2065848|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
1034520|NCT01696279|2065849|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
1034521|NCT01696279|2065850|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
1034522|NCT01696279|2065847|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
1034523|NCT01696279|2065848|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
1034524|NCT01696279|2065849|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
1034525|NCT01696279|2065850|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
1034526|NCT01696279|2065847|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
1034527|NCT01696279|2065848|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
1034528|NCT01696279|2065849|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
1034529|NCT01696279|2065850|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
1034530|NCT01696279|2065847|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
1034531|NCT01696279|2065848|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
1034532|NCT01696279|2065849|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
1034533|NCT01696279|2065850|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
1034534|NCT01696279|2065847|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
1034535|NCT01696279|2065848|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
1034536|NCT01696279|2065849|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
1034537|NCT01696279|2065850|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
1034538|NCT01696396|2065872|FG000|Overall Study|Withdrawal by Subject|19
1034539|NCT01696396|2065873|FG001|Overall Study|Withdrawal by Subject|5
1034540|NCT01696396|2065874|FG002|Overall Study|Withdrawal by Subject|19
1034541|NCT01696396|2065875|FG003|Overall Study|Withdrawal by Subject|11
1034542|NCT01696396|2065872|FG000|Overall Study|Decision by Sponsor|3
1034543|NCT01696396|2065873|FG001|Overall Study|Decision by Sponsor|1
1034544|NCT01696396|2065874|FG002|Overall Study|Decision by Sponsor|2
1034545|NCT01696396|2065875|FG003|Overall Study|Decision by Sponsor|2
1034546|NCT01696396|2065872|FG000|Overall Study|Lost to Follow-up|9
1034547|NCT01696396|2065873|FG001|Overall Study|Lost to Follow-up|1
1034548|NCT01696396|2065874|FG002|Overall Study|Lost to Follow-up|4
1034549|NCT01696396|2065875|FG003|Overall Study|Lost to Follow-up|1
1034550|NCT01696396|2065872|FG000|Overall Study|Death|0
1034551|NCT01696396|2065873|FG001|Overall Study|Death|0
1034552|NCT01696396|2065874|FG002|Overall Study|Death|1
1034553|NCT01696396|2065875|FG003|Overall Study|Death|0
1034554|NCT01696643|2065891|FG000|Overall Study|Adverse Event|15
1034555|NCT01696643|2065892|FG001|Overall Study|Adverse Event|7
1034556|NCT01696643|2065891|FG000|Overall Study|Death|1
1034557|NCT01696643|2065892|FG001|Overall Study|Death|2
1034558|NCT01696643|2065891|FG000|Overall Study|Lack of Efficacy|3
1034559|NCT01696643|2065892|FG001|Overall Study|Lack of Efficacy|0
1034560|NCT01696643|2065891|FG000|Overall Study|Lost to Follow-up|67
1034561|NCT01696643|2065892|FG001|Overall Study|Lost to Follow-up|67
1034562|NCT01696643|2065891|FG000|Overall Study|Physician Decision|3
1034563|NCT01696643|2065892|FG001|Overall Study|Physician Decision|2
1034564|NCT01696643|2065891|FG000|Overall Study|Pregnancy|0
1034565|NCT01696643|2065892|FG001|Overall Study|Pregnancy|1
1034566|NCT01696643|2065891|FG000|Overall Study|Protocol Violation|7
1034567|NCT01696643|2065892|FG001|Overall Study|Protocol Violation|7
1034568|NCT01696643|2065891|FG000|Overall Study|Study Terminated by Sponsor|286
1034569|NCT01696643|2065892|FG001|Overall Study|Study Terminated by Sponsor|294
1034570|NCT01696643|2065891|FG000|Overall Study|Withdrawal by Subject|142
1034571|NCT01696643|2065892|FG001|Overall Study|Withdrawal by Subject|149
1034572|NCT01696643|2065891|FG000|Overall Study|Participant on Restricted Bed Rest|1
1034573|NCT01696643|2065892|FG001|Overall Study|Participant on Restricted Bed Rest|0
1034574|NCT01696643|2065891|FG000|Overall Study|Site Error|2
1034575|NCT01696643|2065892|FG001|Overall Study|Site Error|1
1034576|NCT01696643|2065891|FG000|Overall Study|Participant Incarcerated|0
1034577|NCT01696643|2065892|FG001|Overall Study|Participant Incarcerated|1
1034578|NCT01696643|2065891|FG000|Overall Study|Medical Monitor Decision|0
1034579|NCT01696643|2065892|FG001|Overall Study|Medical Monitor Decision|2
1034580|NCT01696643|2065891|FG000|Overall Study|Participant Did Not Receive Study Drug|2
1034581|NCT01696643|2065892|FG001|Overall Study|Participant Did Not Receive Study Drug|2
1034582|NCT01696695|2065898|FG000|Overall Study|Disease progression|373
1034583|NCT01696695|2065898|FG000|Overall Study|Death|29
1034584|NCT01696695|2065898|FG000|Overall Study|Adverse Event|74
1034585|NCT01696695|2065898|FG000|Overall Study|Withdrawal by Subject|92
1034586|NCT01696695|2065898|FG000|Overall Study|Lost to Follow-up|48
1034587|NCT01696695|2065898|FG000|Overall Study|Other|74
1034588|NCT01696695|2065898|FG000|Overall Study|Major Protocol Violation|192
1034589|NCT01696773|2065913|FG000|Days 15-27, Washout|Adverse Event|1
1034590|NCT01696773|2065914|FG001|Days 15-27, Washout|Adverse Event|0
1034591|NCT01696877|2065922|FG000|Overall Study|Adverse Event|0
1034592|NCT01696877|2065923|FG001|Overall Study|Adverse Event|1
1034593|NCT01696929|2065931|FG000|Overall Study|Physician Decision|1
1034594|NCT01696942|2065937|FG000|Overall Study|Withdrawal by Subject|1
1034595|NCT01696942|2065938|FG001|Overall Study|Withdrawal by Subject|0
1034596|NCT01696942|2065937|FG000|Overall Study|Protocol Violation|1
1034597|NCT01696942|2065938|FG001|Overall Study|Protocol Violation|2
1034598|NCT01696942|2065937|FG000|Overall Study|screen failure|0
1034599|NCT01696942|2065938|FG001|Overall Study|screen failure|1
1034600|NCT01696955|2065946|FG000|Main Study|Protocol Violation|1
1034601|NCT01696955|2065947|FG001|Main Study|Protocol Violation|0
1034602|NCT01696955|2065946|FG000|Main Study|Withdrawal by Subject|1
1034603|NCT01696955|2065947|FG001|Main Study|Withdrawal by Subject|1
1034604|NCT01696968|2065962|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0
1034605|NCT01696968|2065963|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8
1034606|NCT01696968|2065962|FG000|Overall Study|Died Before Randomization|3
1034607|NCT01696968|2065963|FG001|Overall Study|Died Before Randomization|8
1034608|NCT01696968|2065962|FG000|Overall Study|Died Before ASU (Control)|278
1034609|NCT01696968|2065963|FG001|Overall Study|Died Before ASU (Control)|0
1034610|NCT01696968|2065962|FG000|Overall Study|Refused ASU (Control)|920
1034611|NCT01696968|2065963|FG001|Overall Study|Refused ASU (Control)|0
1034612|NCT01696968|2065962|FG000|Overall Study|Refused Screen (Lung Screening)|0
1034613|NCT01696968|2065963|FG001|Overall Study|Refused Screen (Lung Screening)|6796
1034614|NCT01696981|2065972|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0
1034615|NCT01696981|2065973|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20
1034616|NCT01696981|2065972|FG000|Overall Study|Died Before Randomization|3
1034617|NCT01696981|2065973|FG001|Overall Study|Died Before Randomization|8
1034618|NCT01696981|2065972|FG000|Overall Study|Died Before ASU (Control)|278
1034619|NCT01696981|2065973|FG001|Overall Study|Died Before ASU (Control)|0
1034620|NCT01696981|2065972|FG000|Overall Study|Refused ASU (Control)|920
1034621|NCT01696981|2065973|FG001|Overall Study|Refused ASU (Control)|0
1034622|NCT01696981|2065972|FG000|Overall Study|Refused Screen (Colorectal Screening)|0
1034623|NCT01696981|2065973|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346
1034624|NCT01696994|2065981|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
1034625|NCT01696994|2065982|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
1034626|NCT01696994|2065981|FG000|Overall Study|Died Before Randomization|1
1034627|NCT01696994|2065982|FG001|Overall Study|Died Before Randomization|2
1034628|NCT01696994|2065981|FG000|Overall Study|Died Before ASU (Control)|73
1034629|NCT01696994|2065982|FG001|Overall Study|Died Before ASU (Control)|0
1034630|NCT01696994|2065981|FG000|Overall Study|No Ovaries at Baseline|4807
1034631|NCT01696994|2065982|FG001|Overall Study|No Ovaries at Baseline|4851
1034632|NCT01696994|2065981|FG000|Overall Study|Refused ASU (Control)|311
1034633|NCT01696994|2065982|FG001|Overall Study|Refused ASU (Control)|0
1034634|NCT01696994|2065981|FG000|Overall Study|Refused Screen (Ovarian Screening)|0
1034635|NCT01696994|2065982|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582
1034636|NCT01697319|2065990|FG000|Primary Phase|Withdrawal by Subject|1
1034637|NCT01697319|2065990|FG000|Extension Phase|Terminated by Sponsor|15
1034638|NCT01697345|2065994|FG000|Overall Study|Withdrawal by Subject|1
1034639|NCT01697358|2066015|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6
1034640|NCT01697358|2066016|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0
1034641|NCT01697358|2066015|FG000|Period I: Randomization to 6 Months|Physician Decision|4
1034642|NCT01697358|2066016|FG001|Period I: Randomization to 6 Months|Physician Decision|0
1034643|NCT01697358|2066015|FG000|Period I: Randomization to 6 Months|Adverse Event|1
1034644|NCT01697358|2066016|FG001|Period I: Randomization to 6 Months|Adverse Event|1
1034645|NCT01697358|2066015|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2
1034646|NCT01697358|2066016|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0
1034647|NCT01697358|2066015|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3
1034648|NCT01697358|2066016|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12
1034649|NCT01697358|2066015|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
1034650|NCT01697358|2066016|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
1034651|NCT01697358|2066015|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
1034652|NCT01697358|2066016|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
1034653|NCT01697358|2066015|FG000|Period II: 6-24M Long-term Follow-up|Death|1
1034654|NCT01697358|2066016|FG001|Period II: 6-24M Long-term Follow-up|Death|1
1034655|NCT01697358|2066015|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0
1034656|NCT01697358|2066016|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3
1034657|NCT01697358|2066015|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
1034658|NCT01697358|2066016|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
1034659|NCT01697449|2066022|FG000|Overall Study|Disease progression|47
1034660|NCT01697449|2066022|FG000|Overall Study|Adverse Event|7
1034661|NCT01697449|2066022|FG000|Overall Study|Lost to Follow-up|5
1034662|NCT01697449|2066022|FG000|Overall Study|Withdrawal by Subject|2
1034663|NCT01697449|2066022|FG000|Overall Study|Physician Decision|1
1034664|NCT01697449|2066022|FG000|Overall Study|Death|2
1034665|NCT01697449|2066022|FG000|Overall Study|Other|1
1034666|NCT01697449|2066022|FG000|Overall Study|Missing|25
1034667|NCT01697462|2066029|FG000|Overall Study|Disease Progression|1
905272|NCT00761579|1880529|FG000|Overall Study|Withdrawal by Subject|34
905273|NCT00761579|1880529|FG000|Overall Study|Lack of compliance|2
905274|NCT00761579|1880529|FG000|Overall Study|Protocol deviation|1
1034668|NCT01697462|2066029|FG000|Overall Study|Adverse Event|6
1034669|NCT01697462|2066029|FG000|Overall Study|Lost to Follow-up|21
1034670|NCT01697462|2066029|FG000|Overall Study|Withdrawal by Subject|12
1034671|NCT01697462|2066029|FG000|Overall Study|Investigator Decision|21
1034672|NCT01697462|2066029|FG000|Overall Study|Death|1
1034673|NCT01697462|2066029|FG000|Overall Study|Other|10
1034674|NCT01697462|2066029|FG000|Overall Study|Missing|5
1034675|NCT01697501|2066033|FG000|Overall Study|Protocol Violation|2
1034676|NCT01697579|2066051|FG000|Base Study-Cycle 1|Adverse Event|1
1034677|NCT01697579|2066052|FG001|Base Study-Cycle 1|Adverse Event|0
1034678|NCT01697579|2066053|FG002|Base Study-Cycle 1|Adverse Event|0
1034679|NCT01697579|2066054|FG003|Base Study-Cycle 1|Adverse Event|0
1034680|NCT01697579|2066055|FG004|Base Study-Cycle 1|Adverse Event|0
1034681|NCT01697579|2066056|FG005|Base Study-Cycle 1|Adverse Event|0
1034682|NCT01697579|2066057|FG006|Base Study-Cycle 1|Adverse Event|0
1034683|NCT01697579|2066051|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
1034684|NCT01697579|2066052|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1034685|NCT01697579|2066053|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1034686|NCT01697579|2066054|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1034687|NCT01697579|2066055|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1034688|NCT01697579|2066056|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1034689|NCT01697579|2066057|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1034690|NCT01697579|2066051|FG000|Base Study-Cycle 1|Protocol Violation|0
1034691|NCT01697579|2066052|FG001|Base Study-Cycle 1|Protocol Violation|0
1034692|NCT01697579|2066053|FG002|Base Study-Cycle 1|Protocol Violation|0
1034693|NCT01697579|2066054|FG003|Base Study-Cycle 1|Protocol Violation|0
1034694|NCT01697579|2066055|FG004|Base Study-Cycle 1|Protocol Violation|3
1034695|NCT01697579|2066056|FG005|Base Study-Cycle 1|Protocol Violation|0
1034696|NCT01697579|2066057|FG006|Base Study-Cycle 1|Protocol Violation|0
1034697|NCT01697579|2066051|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1034698|NCT01697579|2066052|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1
1034699|NCT01697579|2066053|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1034700|NCT01697579|2066054|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1034701|NCT01697579|2066055|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1034702|NCT01697579|2066056|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1034703|NCT01697579|2066057|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1034704|NCT01697579|2066051|FG000|Base Study-Cycle 1|Technical Problems|0
1034705|NCT01697579|2066052|FG001|Base Study-Cycle 1|Technical Problems|0
1034706|NCT01697579|2066053|FG002|Base Study-Cycle 1|Technical Problems|1
1034707|NCT01697579|2066054|FG003|Base Study-Cycle 1|Technical Problems|1
1034708|NCT01697579|2066055|FG004|Base Study-Cycle 1|Technical Problems|0
1034709|NCT01697579|2066056|FG005|Base Study-Cycle 1|Technical Problems|0
1034710|NCT01697579|2066057|FG006|Base Study-Cycle 1|Technical Problems|0
1034711|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Death|0
1034712|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Death|0
1034713|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Death|0
1034714|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Death|0
1034715|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Death|0
1034716|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Death|0
1034717|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Death|2
1034718|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1034719|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1034720|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1034721|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1034722|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1034723|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
1034724|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
1034725|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Physician Decision|0
1034726|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Physician Decision|0
1034727|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Physician Decision|0
1034728|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Physician Decision|0
1034729|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Physician Decision|0
1034730|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Physician Decision|7
1034731|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Physician Decision|11
1034732|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0
1034733|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0
1034734|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0
1034735|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0
1034736|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0
1034737|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0
1034738|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4
1034739|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0
1034740|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0
1034741|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0
1034742|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0
1034743|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0
1034744|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1
1034745|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2
1034746|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1034747|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1034748|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1034749|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1034750|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1034751|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
1034752|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1034753|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1034754|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1034755|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1034756|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1034757|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1034758|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
1034759|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
1034760|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1034761|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1034762|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1034763|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1034764|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1034765|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
1034766|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
1034767|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1034768|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1034769|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1034770|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1034771|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1034772|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1034773|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
1034774|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Technical Problems|0
1034775|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Technical Problems|0
1034776|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Technical Problems|0
1034777|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Technical Problems|0
1034778|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Technical Problems|0
905275|NCT00761579|1880529|FG000|Overall Study|Drug overdose|1
905276|NCT00761579|1880529|FG000|Overall Study|Aggravation of depression|1
905277|NCT00761579|1880529|FG000|Overall Study|Aggravation of symptoms by changing drug|1
905278|NCT00761579|1880529|FG000|Overall Study|Lost survey form|1
905279|NCT00761579|1880529|FG000|Overall Study|Intake of prohibited concomitant drug|1
905280|NCT00761605|1880544|FG000|Overall Study|Adverse Event|26
905281|NCT00761605|1880544|FG000|Overall Study|Death|2
905282|NCT00761605|1880544|FG000|Overall Study|Lack of Efficacy|26
905283|NCT00761605|1880544|FG000|Overall Study|Lost to Follow-up|29
905284|NCT00761605|1880544|FG000|Overall Study|Withdrawal by Subject|37
905285|NCT00761605|1880544|FG000|Overall Study|Other|21
905286|NCT00761631|1880556|FG000|Overall Study|Parent/legal guardian request|8
905287|NCT00761631|1880557|FG001|Overall Study|Parent/legal guardian request|3
905288|NCT00761631|1880558|FG002|Overall Study|Parent/legal guardian request|8
905289|NCT00761631|1880559|FG003|Overall Study|Parent/legal guardian request|0
905290|NCT00761631|1880560|FG004|Overall Study|Parent/legal guardian request|5
905291|NCT00761631|1880561|FG005|Overall Study|Parent/legal guardian request|0
905292|NCT00761631|1880556|FG000|Overall Study|Lost to Follow-up|2
905293|NCT00761631|1880557|FG001|Overall Study|Lost to Follow-up|4
905294|NCT00761631|1880558|FG002|Overall Study|Lost to Follow-up|7
905295|NCT00761631|1880559|FG003|Overall Study|Lost to Follow-up|1
905296|NCT00761631|1880560|FG004|Overall Study|Lost to Follow-up|6
905297|NCT00761631|1880561|FG005|Overall Study|Lost to Follow-up|1
905298|NCT00761631|1880556|FG000|Overall Study|Protocol Violation|2
905299|NCT00761631|1880557|FG001|Overall Study|Protocol Violation|0
905300|NCT00761631|1880558|FG002|Overall Study|Protocol Violation|0
905301|NCT00761631|1880559|FG003|Overall Study|Protocol Violation|1
905302|NCT00761631|1880560|FG004|Overall Study|Protocol Violation|5
905303|NCT00761631|1880561|FG005|Overall Study|Protocol Violation|1
905304|NCT00761631|1880556|FG000|Overall Study|Randomized, not treated|1
905305|NCT00761631|1880557|FG001|Overall Study|Randomized, not treated|0
905306|NCT00761631|1880558|FG002|Overall Study|Randomized, not treated|0
905307|NCT00761631|1880559|FG003|Overall Study|Randomized, not treated|0
905308|NCT00761631|1880560|FG004|Overall Study|Randomized, not treated|0
905309|NCT00761631|1880561|FG005|Overall Study|Randomized, not treated|0
905310|NCT00761631|1880556|FG000|Overall Study|Failed to return|1
905311|NCT00761631|1880557|FG001|Overall Study|Failed to return|0
905312|NCT00761631|1880558|FG002|Overall Study|Failed to return|1
905313|NCT00761631|1880559|FG003|Overall Study|Failed to return|1
905314|NCT00761631|1880560|FG004|Overall Study|Failed to return|5
1034779|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Technical Problems|0
1034780|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Technical Problems|1
1034781|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Participant Moved|0
1034782|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Participant Moved|0
1034783|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Participant Moved|0
1034784|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Participant Moved|0
1034785|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Participant Moved|0
1034786|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Participant Moved|0
1034787|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Participant Moved|2
1034788|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1034789|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1034790|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1034791|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1034792|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1034793|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
1034794|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
1034795|NCT01697579|2066051|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1034796|NCT01697579|2066052|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1034797|NCT01697579|2066053|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1034798|NCT01697579|2066054|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1034799|NCT01697579|2066055|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1034800|NCT01697579|2066056|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1034801|NCT01697579|2066057|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1
1034802|NCT01697592|2066095|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
1034803|NCT01697592|2066096|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1034804|NCT01697592|2066097|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1034805|NCT01697592|2066098|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1034806|NCT01697592|2066099|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1034807|NCT01697592|2066100|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1034808|NCT01697592|2066101|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1034809|NCT01697592|2066102|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1034810|NCT01697592|2066103|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1034811|NCT01697592|2066104|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1034812|NCT01697592|2066095|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0
1034813|NCT01697592|2066096|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
1034814|NCT01697592|2066097|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
1034815|NCT01697592|2066098|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0
1034816|NCT01697592|2066099|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0
1034817|NCT01697592|2066100|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1
1034818|NCT01697592|2066101|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0
1034819|NCT01697592|2066102|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0
1034820|NCT01697592|2066103|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0
1034821|NCT01697592|2066104|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0
1034822|NCT01697592|2066095|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1
1034823|NCT01697592|2066096|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
1034824|NCT01697592|2066097|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0
1034825|NCT01697592|2066098|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0
1034826|NCT01697592|2066099|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0
1034827|NCT01697592|2066100|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0
1034828|NCT01697592|2066101|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0
1034829|NCT01697592|2066102|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0
1034830|NCT01697592|2066103|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0
1034831|NCT01697592|2066104|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0
1034832|NCT01697592|2066095|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1034833|NCT01697592|2066096|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1034834|NCT01697592|2066097|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1034835|NCT01697592|2066098|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1034836|NCT01697592|2066099|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1034837|NCT01697592|2066100|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1034838|NCT01697592|2066101|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1034839|NCT01697592|2066102|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1034840|NCT01697592|2066103|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1034841|NCT01697592|2066104|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1034842|NCT01697592|2066095|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0
1034843|NCT01697592|2066096|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2
1034844|NCT01697592|2066097|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1
1034845|NCT01697592|2066098|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2
1034846|NCT01697592|2066099|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0
1034847|NCT01697592|2066100|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0
1034848|NCT01697592|2066101|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1
1034849|NCT01697592|2066102|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0
1034850|NCT01697592|2066103|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0
1034851|NCT01697592|2066104|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1
1034852|NCT01697592|2066095|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1
1034853|NCT01697592|2066096|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0
1034854|NCT01697592|2066097|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0
1034855|NCT01697592|2066098|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1
1034856|NCT01697592|2066099|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0
1034857|NCT01697592|2066100|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0
1034858|NCT01697592|2066101|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0
1034859|NCT01697592|2066102|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0
1034860|NCT01697592|2066103|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0
1034861|NCT01697592|2066104|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0
1034862|NCT01697592|2066095|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
1034863|NCT01697592|2066096|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1034864|NCT01697592|2066097|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1034865|NCT01697592|2066098|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1034866|NCT01697592|2066099|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1034867|NCT01697592|2066100|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
1034868|NCT01697592|2066101|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1034869|NCT01697592|2066102|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
1034870|NCT01697592|2066103|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1034871|NCT01697592|2066104|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1034872|NCT01697592|2066095|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2
1034873|NCT01697592|2066096|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1
1034874|NCT01697592|2066097|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1
1034875|NCT01697592|2066098|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2
1034876|NCT01697592|2066099|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0
1034877|NCT01697592|2066100|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1
1034878|NCT01697592|2066101|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1
1034879|NCT01697592|2066102|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0
1034880|NCT01697592|2066103|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2
1034881|NCT01697592|2066104|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0
1034882|NCT01697696|2066142|FG000|Overall Study|Study terminated by sponsor|0
1034883|NCT01697696|2066143|FG001|Overall Study|Study terminated by sponsor|3
1034884|NCT01697696|2066142|FG000|Overall Study|Protocol deviation|1
1034885|NCT01697696|2066143|FG001|Overall Study|Protocol deviation|0
1034886|NCT01697696|2066142|FG000|Overall Study|Physician Decision|1
1034887|NCT01697696|2066143|FG001|Overall Study|Physician Decision|0
1034888|NCT01697696|2066142|FG000|Overall Study|Death|4
1034889|NCT01697696|2066143|FG001|Overall Study|Death|2
1034890|NCT01697696|2066142|FG000|Overall Study|Lost to Follow-up|10
1034891|NCT01697696|2066143|FG001|Overall Study|Lost to Follow-up|7
1034892|NCT01697696|2066142|FG000|Overall Study|Subject/guardian decision|31
1034893|NCT01697696|2066143|FG001|Overall Study|Subject/guardian decision|35
1034894|NCT01697748|2066160|FG000|Overall Study|ineligible skin incision|1
1034895|NCT01697748|2066161|FG001|Overall Study|ineligible skin incision|2
1034896|NCT01697748|2066160|FG000|Overall Study|ineligible uterine incision|4
1034897|NCT01697748|2066161|FG001|Overall Study|ineligible uterine incision|1
1034898|NCT01697748|2066160|FG000|Overall Study|Lost to Follow-up|53
1034899|NCT01697748|2066161|FG001|Overall Study|Lost to Follow-up|65
1034900|NCT01697956|2066169|FG000|Overall Study|Protocol Violation|1
1034901|NCT01697956|2066170|FG001|Overall Study|Protocol Violation|1
1034902|NCT01697969|2066182|FG000|Overall Study|Did not meet inc/exc criteria|3
1034903|NCT01698008|2066189|FG000|Overall Study|Withdrawal by Subject|1
1034904|NCT01698008|2066190|FG001|Overall Study|Withdrawal by Subject|2
1034905|NCT01698268|2066198|FG000|Overall Study|Physician Decision|2
1034906|NCT01698268|2066199|FG001|Overall Study|Physician Decision|1
1034907|NCT01698320|2066207|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
1034908|NCT01698320|2066208|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
1034909|NCT01698320|2066209|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
1034910|NCT01698320|2066207|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
1034911|NCT01698320|2066208|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
1034912|NCT01698320|2066209|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
1034913|NCT01698320|2066207|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
1034914|NCT01698320|2066208|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
1034915|NCT01698320|2066209|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
1034916|NCT01698320|2066207|FG000|Run-In Period (Week -1 to Day 0)|Other|1
1034917|NCT01698320|2066208|FG001|Run-In Period (Week -1 to Day 0)|Other|0
1034918|NCT01698320|2066209|FG002|Run-In Period (Week -1 to Day 0)|Other|0
1034919|NCT01698320|2066207|FG000|12-Week Double-Blind Period|Adverse Event|0
1034920|NCT01698320|2066208|FG001|12-Week Double-Blind Period|Adverse Event|1
1034921|NCT01698320|2066209|FG002|12-Week Double-Blind Period|Adverse Event|1
1034922|NCT01698320|2066207|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0
1034923|NCT01698320|2066208|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2
1034924|NCT01698320|2066209|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2
1034925|NCT01698320|2066207|FG000|12-Week Double-Blind Period|Protocol Violation|0
1034926|NCT01698320|2066208|FG001|12-Week Double-Blind Period|Protocol Violation|0
1034927|NCT01698320|2066209|FG002|12-Week Double-Blind Period|Protocol Violation|2
1034928|NCT01698320|2066207|FG000|12-Week Double-Blind Period|Pregnancy|0
905315|NCT00761631|1880561|FG005|Overall Study|Failed to return|2
905316|NCT00761631|1880556|FG000|Overall Study|Physician Decision|1
905317|NCT00761631|1880557|FG001|Overall Study|Physician Decision|0
905318|NCT00761631|1880558|FG002|Overall Study|Physician Decision|0
905319|NCT00761631|1880559|FG003|Overall Study|Physician Decision|0
905320|NCT00761631|1880560|FG004|Overall Study|Physician Decision|0
905321|NCT00761631|1880561|FG005|Overall Study|Physician Decision|0
905322|NCT00761631|1880556|FG000|Overall Study|Other|0
905323|NCT00761631|1880557|FG001|Overall Study|Other|0
905324|NCT00761631|1880558|FG002|Overall Study|Other|0
905325|NCT00761631|1880559|FG003|Overall Study|Other|0
905326|NCT00761631|1880560|FG004|Overall Study|Other|1
905327|NCT00761631|1880561|FG005|Overall Study|Other|1
905328|NCT00761657|1880593|FG000|Part 1 (up to Day 57)|Adverse Event|0
905329|NCT00761657|1880594|FG001|Part 1 (up to Day 57)|Adverse Event|0
1034929|NCT01698320|2066208|FG001|12-Week Double-Blind Period|Pregnancy|1
1034930|NCT01698320|2066209|FG002|12-Week Double-Blind Period|Pregnancy|1
1034931|NCT01698320|2066207|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
1034932|NCT01698320|2066208|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
1034933|NCT01698320|2066209|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
1034934|NCT01698320|2066207|FG000|12-Week Double-Blind Period|Lost to Follow-up|0
1034935|NCT01698320|2066208|FG001|12-Week Double-Blind Period|Lost to Follow-up|0
1034936|NCT01698320|2066209|FG002|12-Week Double-Blind Period|Lost to Follow-up|4
1034937|NCT01698320|2066207|FG000|40-Week Open-Label Period|Adverse Event|0
1034938|NCT01698320|2066208|FG001|40-Week Open-Label Period|Adverse Event|3
1034939|NCT01698320|2066209|FG002|40-Week Open-Label Period|Adverse Event|2
905330|NCT00761657|1880595|FG002|Part 1 (up to Day 57)|Adverse Event|0
905331|NCT00761657|1880596|FG003|Part 1 (up to Day 57)|Adverse Event|1
905332|NCT00761657|1880597|FG004|Part 1 (up to Day 57)|Adverse Event|0
905333|NCT00761657|1880598|FG005|Part 1 (up to Day 57)|Adverse Event|0
905334|NCT00761657|1880599|FG006|Part 1 (up to Day 57)|Adverse Event|0
905335|NCT00761657|1880600|FG007|Part 1 (up to Day 57)|Adverse Event|0
905336|NCT00761657|1880601|FG008|Part 1 (up to Day 57)|Adverse Event|0
905337|NCT00761657|1880593|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0
905338|NCT00761657|1880594|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0
905339|NCT00761657|1880595|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1
905340|NCT00761657|1880596|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1
905341|NCT00761657|1880597|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0
905342|NCT00761657|1880598|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0
905343|NCT00761657|1880599|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0
905344|NCT00761657|1880600|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0
905345|NCT00761657|1880601|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0
905346|NCT00761657|1880593|FG000|Part 1 (up to Day 57)|Sponsor Decision|0
905347|NCT00761657|1880594|FG001|Part 1 (up to Day 57)|Sponsor Decision|0
905348|NCT00761657|1880595|FG002|Part 1 (up to Day 57)|Sponsor Decision|3
905349|NCT00761657|1880596|FG003|Part 1 (up to Day 57)|Sponsor Decision|4
905350|NCT00761657|1880597|FG004|Part 1 (up to Day 57)|Sponsor Decision|0
905351|NCT00761657|1880598|FG005|Part 1 (up to Day 57)|Sponsor Decision|0
905352|NCT00761657|1880599|FG006|Part 1 (up to Day 57)|Sponsor Decision|1
905353|NCT00761657|1880600|FG007|Part 1 (up to Day 57)|Sponsor Decision|1
905354|NCT00761657|1880601|FG008|Part 1 (up to Day 57)|Sponsor Decision|1
905355|NCT00761657|1880593|FG000|Part 2 (up to Day 114)|Adverse Event|0
905356|NCT00761657|1880594|FG001|Part 2 (up to Day 114)|Adverse Event|0
905357|NCT00761657|1880595|FG002|Part 2 (up to Day 114)|Adverse Event|0
905358|NCT00761657|1880596|FG003|Part 2 (up to Day 114)|Adverse Event|0
905359|NCT00761657|1880597|FG004|Part 2 (up to Day 114)|Adverse Event|0
905360|NCT00761657|1880598|FG005|Part 2 (up to Day 114)|Adverse Event|0
905361|NCT00761657|1880599|FG006|Part 2 (up to Day 114)|Adverse Event|0
905362|NCT00761657|1880600|FG007|Part 2 (up to Day 114)|Adverse Event|0
905363|NCT00761657|1880601|FG008|Part 2 (up to Day 114)|Adverse Event|1
905364|NCT00761735|1880631|FG000|Overall Study|Lost to Follow-up|6
905365|NCT00761735|1880631|FG000|Overall Study|Withdrawal by Subject|6
905366|NCT00761735|1880631|FG000|Overall Study|Non-compliance with protocol|1
905367|NCT00761735|1880631|FG000|Overall Study|Administrative|1
905368|NCT00761748|1880639|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3
905369|NCT00761748|1880640|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0
905370|NCT00761748|1880639|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
905371|NCT00761748|1880640|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
905372|NCT00761761|1880648|FG000|Overall Study|Lost to Follow-up|3
905373|NCT00761761|1880649|FG001|Overall Study|Lost to Follow-up|1
905374|NCT00761761|1880648|FG000|Overall Study|Withdrawal by Subject|3
905375|NCT00761761|1880649|FG001|Overall Study|Withdrawal by Subject|0
905376|NCT00761774|1880657|FG000|Overall Study|Adverse Event|17
905377|NCT00761774|1880657|FG000|Overall Study|Lack of Efficacy|37
905378|NCT00761774|1880657|FG000|Overall Study|Lost to Follow-up|2
1034940|NCT01698320|2066207|FG000|40-Week Open-Label Period|Withdrawal by Subject|0
1034941|NCT01698320|2066208|FG001|40-Week Open-Label Period|Withdrawal by Subject|11
1034942|NCT01698320|2066209|FG002|40-Week Open-Label Period|Withdrawal by Subject|7
1034943|NCT01698320|2066207|FG000|40-Week Open-Label Period|Pregnancy|0
1034944|NCT01698320|2066208|FG001|40-Week Open-Label Period|Pregnancy|2
1034945|NCT01698320|2066209|FG002|40-Week Open-Label Period|Pregnancy|1
1034946|NCT01698320|2066207|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
1034947|NCT01698320|2066208|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
1034948|NCT01698320|2066209|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
1034949|NCT01698320|2066207|FG000|40-Week Open-Label Period|Lost to Follow-up|0
1034950|NCT01698320|2066208|FG001|40-Week Open-Label Period|Lost to Follow-up|2
1034951|NCT01698320|2066209|FG002|40-Week Open-Label Period|Lost to Follow-up|0
1034952|NCT01698554|2066247|FG000|Overall Study|Adverse Event|2
1034953|NCT01698554|2066248|FG001|Overall Study|Adverse Event|5
1034954|NCT01698554|2066249|FG002|Overall Study|Adverse Event|0
1034955|NCT01698554|2066250|FG003|Overall Study|Adverse Event|1
1034956|NCT01698554|2066247|FG000|Overall Study|Lost to Follow-up|1
1034957|NCT01698554|2066248|FG001|Overall Study|Lost to Follow-up|0
1034958|NCT01698554|2066249|FG002|Overall Study|Lost to Follow-up|0
1034959|NCT01698554|2066250|FG003|Overall Study|Lost to Follow-up|0
1034960|NCT01698554|2066247|FG000|Overall Study|Personal Reasons|0
1034961|NCT01698554|2066248|FG001|Overall Study|Personal Reasons|5
1034962|NCT01698554|2066249|FG002|Overall Study|Personal Reasons|1
1034963|NCT01698554|2066250|FG003|Overall Study|Personal Reasons|1
1034964|NCT01698554|2066247|FG000|Overall Study|Protocol Violation|2
1034965|NCT01698554|2066248|FG001|Overall Study|Protocol Violation|0
1034966|NCT01698554|2066249|FG002|Overall Study|Protocol Violation|1
1034967|NCT01698554|2066250|FG003|Overall Study|Protocol Violation|0
1034968|NCT01698554|2066247|FG000|Overall Study|Other Miscellaneous Reasons|1
1034969|NCT01698554|2066248|FG001|Overall Study|Other Miscellaneous Reasons|0
1034970|NCT01698554|2066249|FG002|Overall Study|Other Miscellaneous Reasons|0
1034971|NCT01698554|2066250|FG003|Overall Study|Other Miscellaneous Reasons|0
1034972|NCT01698775|2066279|FG000|Phase A|Adverse Event|2
1034973|NCT01698775|2066280|FG001|Phase A|Adverse Event|1
1034974|NCT01698775|2066279|FG000|Phase A|Death|1
1034975|NCT01698775|2066280|FG001|Phase A|Death|1
1034976|NCT01698775|2066279|FG000|Phase A|Lack of Efficacy|1
1034977|NCT01698775|2066280|FG001|Phase A|Lack of Efficacy|0
1034978|NCT01698775|2066279|FG000|Phase A|Lost to Follow-up|1
1034979|NCT01698775|2066280|FG001|Phase A|Lost to Follow-up|2
1034980|NCT01698775|2066279|FG000|Phase A|Protocol Violation|1
1034981|NCT01698775|2066280|FG001|Phase A|Protocol Violation|0
1034982|NCT01698775|2066279|FG000|Phase A|Withdrawal by Subject|3
1034983|NCT01698775|2066280|FG001|Phase A|Withdrawal by Subject|4
1034984|NCT01698775|2066279|FG000|Phase A|Kidney [transplant]|0
1034985|NCT01698775|2066280|FG001|Phase A|Kidney [transplant]|1
1034986|NCT01698775|2066279|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0
1034987|NCT01698775|2066280|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1
1034988|NCT01698775|2066279|FG000|Phase B|Adverse Event|6
1034989|NCT01698775|2066280|FG001|Phase B|Adverse Event|3
1034990|NCT01698775|2066279|FG000|Phase B|Death|0
1034991|NCT01698775|2066280|FG001|Phase B|Death|1
1034992|NCT01698775|2066279|FG000|Phase B|Lack of Efficacy|0
1034993|NCT01698775|2066280|FG001|Phase B|Lack of Efficacy|1
1034994|NCT01698775|2066279|FG000|Phase B|Lost to Follow-up|0
1034995|NCT01698775|2066280|FG001|Phase B|Lost to Follow-up|1
1034996|NCT01698775|2066279|FG000|Phase B|Physician Decision|1
1034997|NCT01698775|2066280|FG001|Phase B|Physician Decision|1
1034998|NCT01698775|2066279|FG000|Phase B|Protocol Violation|1
1034999|NCT01698775|2066280|FG001|Phase B|Protocol Violation|1
1035000|NCT01698775|2066279|FG000|Phase B|Withdrawal by Subject|6
1035001|NCT01698775|2066280|FG001|Phase B|Withdrawal by Subject|2
1035002|NCT01698801|2066290|FG000|Treatment Phase|Adverse Event|4
1035003|NCT01698801|2066290|FG000|Treatment Phase|Protocol Violation|1
1035004|NCT01698801|2066290|FG000|Treatment Phase|Other|4
1035005|NCT01698801|2066290|FG000|Treatment Phase|Withdrawal by Subject|1
1035006|NCT01698801|2066290|FG000|Treatment Phase|Disease progression|1
1035007|NCT01698801|2066290|FG000|Follow Up Phase|Withdrawal by Subject|1
1035008|NCT01698801|2066290|FG000|Follow Up Phase|Death|4
1035009|NCT01698814|2066297|FG000|Overall Study|Adverse Event|0
1035010|NCT01698814|2066298|FG001|Overall Study|Adverse Event|2
1035011|NCT01698814|2066297|FG000|Overall Study|Lost to Follow-up|0
1035012|NCT01698814|2066298|FG001|Overall Study|Lost to Follow-up|1
1035013|NCT01698814|2066297|FG000|Overall Study|Pregnancy|1
905379|NCT00761774|1880657|FG000|Overall Study|Withdrawal by Subject|9
905380|NCT00761774|1880657|FG000|Overall Study|Non-compliance|4
905381|NCT00761774|1880657|FG000|Overall Study|End of study|2
905382|NCT00761774|1880657|FG000|Overall Study|Reclassification of seizures|1
905383|NCT00761774|1880657|FG000|Overall Study|Medical decision to read SUSAR reports|1
905384|NCT00761774|1880657|FG000|Overall Study|Sponsor decision|1
905385|NCT00761774|1880657|FG000|Overall Study|Investigator clinical judgement|1
905386|NCT00761774|1880657|FG000|Overall Study|Patient moved out of study area|1
1035014|NCT01698814|2066298|FG001|Overall Study|Pregnancy|0
1035015|NCT01698814|2066297|FG000|Overall Study|Randomized in error|1
1035016|NCT01698814|2066298|FG001|Overall Study|Randomized in error|0
1035017|NCT01698879|2066307|FG000|Overall Study|Withdrawal by Subject|1
1035018|NCT01698879|2066308|FG001|Overall Study|Withdrawal by Subject|0
1035019|NCT01698879|2066309|FG002|Overall Study|Withdrawal by Subject|0
1035020|NCT01698905|2066323|FG000|Overall Study|Adverse Event|4
1035021|NCT01698905|2066323|FG000|Overall Study|Physician Decision|2
1035022|NCT01698905|2066323|FG000|Overall Study|Pregnancy|1
1035023|NCT01698905|2066323|FG000|Overall Study|Protocol Violation|1
1035024|NCT01698905|2066323|FG000|Overall Study|Subject/guardian decision|2
1035025|NCT01698905|2066323|FG000|Overall Study|Death|1
1035026|NCT01699022|2066334|FG000|Overall Study|Early discontinuation from the study|3
1035027|NCT01699087|2066339|FG000|Overall Study|Lost to Follow-up|7
1035028|NCT01699087|2066339|FG000|Overall Study|Screen failure (prior to treatment)|15
1035029|NCT01699087|2066339|FG000|Overall Study|Unable to make future visits|2
1035030|NCT01699178|2066346|FG000|Overall Study|Adverse Event|1
1035031|NCT01699178|2066347|FG001|Overall Study|Adverse Event|5
1035032|NCT01699178|2066346|FG000|Overall Study|Lost to Follow-up|1
1035033|NCT01699178|2066347|FG001|Overall Study|Lost to Follow-up|6
1035034|NCT01699178|2066346|FG000|Overall Study|Non-compliance with Study Drug|3
1035035|NCT01699178|2066347|FG001|Overall Study|Non-compliance with Study Drug|1
1035036|NCT01699178|2066346|FG000|Overall Study|Physician Decision|1
1035037|NCT01699178|2066347|FG001|Overall Study|Physician Decision|0
1035038|NCT01699178|2066346|FG000|Overall Study|Withdrawal by Subject|4
1035039|NCT01699178|2066347|FG001|Overall Study|Withdrawal by Subject|12
1035040|NCT01699178|2066346|FG000|Overall Study|Hematocrit >54%|1
1035041|NCT01699178|2066347|FG001|Overall Study|Hematocrit >54%|1
1035042|NCT01699178|2066346|FG000|Overall Study|PSA increase of >1.4 ng/mL|4
1035043|NCT01699178|2066347|FG001|Overall Study|PSA increase of >1.4 ng/mL|3
1035044|NCT01699178|2066346|FG000|Overall Study|ineligible/noncompliant/ subject reason|4
1035045|NCT01699178|2066347|FG001|Overall Study|ineligible/noncompliant/ subject reason|4
1035046|NCT01699503|2066364|FG000|Overall Study|Death|31
1035047|NCT01699503|2066365|FG001|Overall Study|Death|40
1035048|NCT01699503|2066364|FG000|Overall Study|Withdrawal by Subject|65
905387|NCT00761774|1880657|FG000|Overall Study|Coordinator leaving site|1
905388|NCT00761774|1880657|FG000|Overall Study|Subject IP non-compliance|1
905389|NCT00761774|1880657|FG000|Overall Study|IP stopped by hospital physician|1
905390|NCT00761865|1880674|FG000|Overall Study|Lost to Follow-up|8
905391|NCT00761865|1880675|FG001|Overall Study|Lost to Follow-up|7
905392|NCT00761891|1880681|FG000|Overall Study|Withdrawal by Subject|10
905393|NCT00761956|1880701|FG000|Overall Study|Lost to Follow-up|6
905394|NCT00761956|1880702|FG001|Overall Study|Lost to Follow-up|11
905395|NCT00761956|1880701|FG000|Overall Study|Withdrawal by Subject|3
905396|NCT00761956|1880702|FG001|Overall Study|Withdrawal by Subject|8
905397|NCT00761956|1880701|FG000|Overall Study|Death|0
905398|NCT00761956|1880702|FG001|Overall Study|Death|1
905399|NCT00761956|1880701|FG000|Overall Study|Adverse Event|26
905400|NCT00761956|1880702|FG001|Overall Study|Adverse Event|34
905401|NCT00761969|1880710|FG000|Overall Study|Death|112
905402|NCT00761969|1880711|FG001|Overall Study|Death|47
905403|NCT00761969|1880710|FG000|Overall Study|Lost to Follow-up|88
905404|NCT00761969|1880711|FG001|Overall Study|Lost to Follow-up|93
905405|NCT00762034|1880728|FG000|Induction Period|Protocol Violation|1
905406|NCT00762034|1880729|FG001|Induction Period|Protocol Violation|2
905407|NCT00762034|1880728|FG000|Induction Period|Entry Criterion Not Met|12
905408|NCT00762034|1880729|FG001|Induction Period|Entry Criterion Not Met|11
905409|NCT00762034|1880728|FG000|Induction Period|Adverse Event|27
905410|NCT00762034|1880729|FG001|Induction Period|Adverse Event|38
905411|NCT00762034|1880728|FG000|Induction Period|Lost to Follow-up|1
905412|NCT00762034|1880729|FG001|Induction Period|Lost to Follow-up|1
905413|NCT00762034|1880728|FG000|Induction Period|Progressive Disease|73
905414|NCT00762034|1880729|FG001|Induction Period|Progressive Disease|55
905415|NCT00762034|1880728|FG000|Induction Period|Physician Decision|21
905416|NCT00762034|1880729|FG001|Induction Period|Physician Decision|20
905417|NCT00762034|1880728|FG000|Induction Period|Withdrawal by Subject|15
905418|NCT00762034|1880729|FG001|Induction Period|Withdrawal by Subject|19
905419|NCT00762034|1880728|FG000|Induction Period|Deaths Not Due to Study Disease|19
905420|NCT00762034|1880729|FG001|Induction Period|Deaths Not Due to Study Disease|14
905421|NCT00762034|1880728|FG000|Induction Period|Deaths Due to Study Disease|9
905422|NCT00762034|1880729|FG001|Induction Period|Deaths Due to Study Disease|9
905423|NCT00762034|1880728|FG000|Maintenance Period|Protocol Violation|1
905424|NCT00762034|1880729|FG001|Maintenance Period|Protocol Violation|3
905425|NCT00762034|1880728|FG000|Maintenance Period|Entry Criterion Not Met|0
905426|NCT00762034|1880729|FG001|Maintenance Period|Entry Criterion Not Met|2
905427|NCT00762034|1880728|FG000|Maintenance Period|Adverse Event|42
905428|NCT00762034|1880729|FG001|Maintenance Period|Adverse Event|26
905429|NCT00762034|1880728|FG000|Maintenance Period|Progressive Disease|186
905430|NCT00762034|1880729|FG001|Maintenance Period|Progressive Disease|224
905431|NCT00762034|1880728|FG000|Maintenance Period|Physician Decision|25
905432|NCT00762034|1880729|FG001|Maintenance Period|Physician Decision|20
905433|NCT00762034|1880728|FG000|Maintenance Period|Withdrawal by Subject|34
905434|NCT00762034|1880729|FG001|Maintenance Period|Withdrawal by Subject|14
905435|NCT00762034|1880728|FG000|Maintenance Period|Death not due to study disease|2
905436|NCT00762034|1880729|FG001|Maintenance Period|Death not due to study disease|5
1035049|NCT01699503|2066365|FG001|Overall Study|Withdrawal by Subject|57
1035050|NCT01699503|2066364|FG000|Overall Study|Lost to Follow-up|121
1035051|NCT01699503|2066365|FG001|Overall Study|Lost to Follow-up|117
1035052|NCT01699503|2066364|FG000|Overall Study|Excluded due to quality|783
1035053|NCT01699503|2066365|FG001|Overall Study|Excluded due to quality|791
1035054|NCT01699685|2066390|FG000|Period 1|Adverse Event|1
1035055|NCT01699685|2066391|FG001|Period 1|Adverse Event|1
1035056|NCT01699685|2066390|FG000|Period 1|Medical or ethical, noncompliance|2
1035057|NCT01699685|2066391|FG001|Period 1|Medical or ethical, noncompliance|0
1035058|NCT01699685|2066390|FG000|Period 1|Other|0
1035059|NCT01699685|2066391|FG001|Period 1|Other|1
1035060|NCT01699685|2066390|FG000|Period 1|Patient request|0
1035061|NCT01699685|2066391|FG001|Period 1|Patient request|1
1035062|NCT01699685|2066390|FG000|Period 2|Lost to Follow-up|1
1035063|NCT01699685|2066391|FG001|Period 2|Lost to Follow-up|0
1035064|NCT01699750|2066409|FG000|Overall Study|Withdrew Consent|0
1035065|NCT01699750|2066410|FG001|Overall Study|Withdrew Consent|1
1035066|NCT01699750|2066409|FG000|Overall Study|Other|0
1035067|NCT01699750|2066410|FG001|Overall Study|Other|2
1035068|NCT01699789|2066426|FG000|Overall Study|Withdrawal by Subject|18
1035069|NCT01699789|2066427|FG001|Overall Study|Withdrawal by Subject|23
1035070|NCT01699789|2066426|FG000|Overall Study|Death|1
1035071|NCT01699789|2066427|FG001|Overall Study|Death|2
1035072|NCT01699789|2066426|FG000|Overall Study|Lost to Follow-up|83
1035073|NCT01699789|2066427|FG001|Overall Study|Lost to Follow-up|101
1035074|NCT01699815|2066437|FG000|Overall Study|Protocol Violation|4
1035075|NCT01699815|2066438|FG001|Overall Study|Protocol Violation|7
1035076|NCT01699815|2066437|FG000|Overall Study|record could not be located|1
1035077|NCT01699815|2066438|FG001|Overall Study|record could not be located|0
1035078|NCT01699815|2066437|FG000|Overall Study|Adverse Event|0
1035079|NCT01699815|2066438|FG001|Overall Study|Adverse Event|1
1035080|NCT01699867|2066444|FG000|Overall Study|Screening Failure|3
1035081|NCT01700049|2066452|FG000|Overall Study|Withdrawal by Subject|1
1035082|NCT01700140|2066460|FG000|Overall Study|Use of rescue drugs|3
1035083|NCT01700140|2066461|FG001|Overall Study|Use of rescue drugs|3
1035084|NCT01700140|2066462|FG002|Overall Study|Use of rescue drugs|1
1035085|NCT01700140|2066460|FG000|Overall Study|Discontinuation of radiotherapy|1
1035086|NCT01700140|2066461|FG001|Overall Study|Discontinuation of radiotherapy|0
1035087|NCT01700140|2066462|FG002|Overall Study|Discontinuation of radiotherapy|0
1035088|NCT01700140|2066460|FG000|Overall Study|Use of chemotherapy or surgical therapy|0
1035089|NCT01700140|2066461|FG001|Overall Study|Use of chemotherapy or surgical therapy|1
1035090|NCT01700140|2066462|FG002|Overall Study|Use of chemotherapy or surgical therapy|0
1035091|NCT01700140|2066460|FG000|Overall Study|Aggravation of symptoms|1
1035092|NCT01700140|2066461|FG001|Overall Study|Aggravation of symptoms|0
1035093|NCT01700140|2066462|FG002|Overall Study|Aggravation of symptoms|0
1035094|NCT01700140|2066460|FG000|Overall Study|Adverse Event|0
1035095|NCT01700140|2066461|FG001|Overall Study|Adverse Event|1
1035096|NCT01700140|2066462|FG002|Overall Study|Adverse Event|0
1035097|NCT01700140|2066460|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
1035098|NCT01700140|2066461|FG001|Overall Study|Inclusion/exclusion criteria deviation|4
1035099|NCT01700140|2066462|FG002|Overall Study|Inclusion/exclusion criteria deviation|0
1035100|NCT01700179|2066473|FG000|Overall Study|Physician Decision|2
1035101|NCT01700192|2066479|FG000|Overall Study|Adverse Event|73
1035102|NCT01700192|2066480|FG001|Overall Study|Adverse Event|18
1035103|NCT01700192|2066479|FG000|Overall Study|Lack of Efficacy|1
1035104|NCT01700192|2066480|FG001|Overall Study|Lack of Efficacy|0
1035105|NCT01700192|2066479|FG000|Overall Study|Lost to Follow-up|42
1035106|NCT01700192|2066480|FG001|Overall Study|Lost to Follow-up|29
1035107|NCT01700192|2066479|FG000|Overall Study|Noncompliance with study drug|0
1035108|NCT01700192|2066480|FG001|Overall Study|Noncompliance with study drug|5
1035109|NCT01700192|2066479|FG000|Overall Study|Physician Decision|2
1035110|NCT01700192|2066480|FG001|Overall Study|Physician Decision|3
1035111|NCT01700192|2066479|FG000|Overall Study|Pregnancy|1
1035112|NCT01700192|2066480|FG001|Overall Study|Pregnancy|4
1035113|NCT01700192|2066479|FG000|Overall Study|Progressive disease|1
1035114|NCT01700192|2066480|FG001|Overall Study|Progressive disease|0
1035115|NCT01700192|2066479|FG000|Overall Study|Protocol Violation|3
1035116|NCT01700192|2066480|FG001|Overall Study|Protocol Violation|4
1035117|NCT01700192|2066479|FG000|Overall Study|Technical problems|0
1035118|NCT01700192|2066480|FG001|Overall Study|Technical problems|1
1035119|NCT01700192|2066479|FG000|Overall Study|Withdrawal by Subject|56
1035120|NCT01700192|2066480|FG001|Overall Study|Withdrawal by Subject|64
1035121|NCT01700192|2066479|FG000|Overall Study|Never received study drug|1
1035122|NCT01700192|2066480|FG001|Overall Study|Never received study drug|0
1035123|NCT01700205|2066488|FG000|Overall Study|Withdrawal by Subject|13
1035124|NCT01700205|2066489|FG001|Overall Study|Withdrawal by Subject|13
1035125|NCT01700205|2066488|FG000|Overall Study|Protocol Violation|2
1035126|NCT01700205|2066489|FG001|Overall Study|Protocol Violation|2
1035127|NCT01700387|2066505|FG000|Overall Study|Withdrawal by Subject|1
1035128|NCT01700387|2066506|FG001|Overall Study|Withdrawal by Subject|2
1035129|NCT01700387|2066505|FG000|Overall Study|Adverse Event|1
1035130|NCT01700387|2066506|FG001|Overall Study|Adverse Event|1
1035131|NCT01700387|2066505|FG000|Overall Study|Lost to Follow-up|2
1035132|NCT01700387|2066506|FG001|Overall Study|Lost to Follow-up|1
1035133|NCT01700530|2066537|FG000|Overall Study|Withdrawal by Subject|0
1035134|NCT01700530|2066538|FG001|Overall Study|Withdrawal by Subject|3
1035135|NCT01700530|2066539|FG002|Overall Study|Withdrawal by Subject|1
1035136|NCT01700621|2066549|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7
1035137|NCT01700621|2066550|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4
1035138|NCT01700621|2066549|FG000|Analyzed for Immunogenicity|Protocol Violation|5
1035139|NCT01700621|2066550|FG001|Analyzed for Immunogenicity|Protocol Violation|1
1035140|NCT01700621|2066549|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1
1035141|NCT01700621|2066550|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2
1035142|NCT01700829|2066595|FG000|Overall Study|Withdrawal by Subject|1
1035143|NCT01700829|2066596|FG001|Overall Study|Withdrawal by Subject|1
1035144|NCT01700959|2066617|FG000|Overall Study|Adverse Event|0
1035145|NCT01700959|2066618|FG001|Overall Study|Adverse Event|1
1035146|NCT01700959|2066619|FG002|Overall Study|Adverse Event|1
1035147|NCT01700959|2066620|FG003|Overall Study|Adverse Event|2
1035148|NCT01700959|2066621|FG004|Overall Study|Adverse Event|0
1035149|NCT01700959|2066622|FG005|Overall Study|Adverse Event|2
1035150|NCT01700959|2066617|FG000|Overall Study|Withdrawal by Subject|15
1035151|NCT01700959|2066618|FG001|Overall Study|Withdrawal by Subject|9
1035152|NCT01700959|2066619|FG002|Overall Study|Withdrawal by Subject|12
1035153|NCT01700959|2066620|FG003|Overall Study|Withdrawal by Subject|11
1035154|NCT01700959|2066621|FG004|Overall Study|Withdrawal by Subject|8
1035155|NCT01700959|2066622|FG005|Overall Study|Withdrawal by Subject|12
1035156|NCT01700959|2066617|FG000|Overall Study|Ineligible|2
1035157|NCT01700959|2066618|FG001|Overall Study|Ineligible|1
1035158|NCT01700959|2066619|FG002|Overall Study|Ineligible|2
1035159|NCT01700959|2066620|FG003|Overall Study|Ineligible|0
1035160|NCT01700959|2066621|FG004|Overall Study|Ineligible|0
1035161|NCT01700959|2066622|FG005|Overall Study|Ineligible|1
1035162|NCT01700959|2066617|FG000|Overall Study|Noncompliant|9
1035163|NCT01700959|2066618|FG001|Overall Study|Noncompliant|9
1035164|NCT01700959|2066619|FG002|Overall Study|Noncompliant|17
1035165|NCT01700959|2066620|FG003|Overall Study|Noncompliant|18
1035166|NCT01700959|2066621|FG004|Overall Study|Noncompliant|15
1035167|NCT01700959|2066622|FG005|Overall Study|Noncompliant|9
1035168|NCT01700959|2066617|FG000|Overall Study|Side effects|1
1035169|NCT01700959|2066618|FG001|Overall Study|Side effects|4
1035170|NCT01700959|2066619|FG002|Overall Study|Side effects|8
1035171|NCT01700959|2066620|FG003|Overall Study|Side effects|4
1035172|NCT01700959|2066621|FG004|Overall Study|Side effects|4
1035173|NCT01700959|2066622|FG005|Overall Study|Side effects|1
1035174|NCT01700985|2066640|FG000|Overall Study|Incarcerated|0
1035175|NCT01700985|2066641|FG001|Overall Study|Incarcerated|1
1035176|NCT01701063|2066678|FG000|Overall Study|Lost to Follow-up|0
1035177|NCT01701063|2066679|FG001|Overall Study|Lost to Follow-up|1
1035178|NCT01701063|2066680|FG002|Overall Study|Lost to Follow-up|0
1035179|NCT01701063|2066678|FG000|Overall Study|Withdrawal by Subject|0
1035180|NCT01701063|2066679|FG001|Overall Study|Withdrawal by Subject|0
1035181|NCT01701063|2066680|FG002|Overall Study|Withdrawal by Subject|1
1035182|NCT01701063|2066678|FG000|Overall Study|Other|0
1035183|NCT01701063|2066679|FG001|Overall Study|Other|0
1035184|NCT01701063|2066680|FG002|Overall Study|Other|1
1035185|NCT01701193|2066719|FG000|Overall Study|Withdrawal by Subject|2
1035186|NCT01701193|2066720|FG001|Overall Study|Withdrawal by Subject|2
1035187|NCT01701193|2066721|FG002|Overall Study|Withdrawal by Subject|1
1035188|NCT01701193|2066722|FG003|Overall Study|Withdrawal by Subject|2
1035189|NCT01701193|2066719|FG000|Overall Study|Adverse Event|1
1035190|NCT01701193|2066720|FG001|Overall Study|Adverse Event|0
1035191|NCT01701193|2066721|FG002|Overall Study|Adverse Event|0
1035192|NCT01701193|2066722|FG003|Overall Study|Adverse Event|0
1035193|NCT01701245|2066737|FG000|Overall Study|Protocol Violation|1
1035194|NCT01701245|2066738|FG001|Overall Study|Protocol Violation|3
1035195|NCT01701245|2066737|FG000|Overall Study|Did not complete the open label period|11
1035196|NCT01701245|2066738|FG001|Overall Study|Did not complete the open label period|12
1035197|NCT01701258|2066748|FG000|Assessment and Scheduling|Found to be Ineligible|57
1035198|NCT01701258|2066749|FG001|Assessment and Scheduling|Found to be Ineligible|0
1035199|NCT01701258|2066750|FG002|Assessment and Scheduling|Found to be Ineligible|0
1035200|NCT01701258|2066751|FG003|Assessment and Scheduling|Found to be Ineligible|0
1035201|NCT01701258|2066752|FG004|Assessment and Scheduling|Found to be Ineligible|0
1035202|NCT01701258|2066753|FG005|Assessment and Scheduling|Found to be Ineligible|0
1035203|NCT01701258|2066754|FG006|Assessment and Scheduling|Found to be Ineligible|0
1035204|NCT01701258|2066755|FG007|Assessment and Scheduling|Found to be Ineligible|0
1035205|NCT01701258|2066756|FG008|Assessment and Scheduling|Found to be Ineligible|0
1035206|NCT01701258|2066757|FG009|Assessment and Scheduling|Found to be Ineligible|0
1035207|NCT01701258|2066758|FG010|Assessment and Scheduling|Found to be Ineligible|0
1035208|NCT01701258|2066759|FG011|Assessment and Scheduling|Found to be Ineligible|0
1035209|NCT01701258|2066760|FG012|Assessment and Scheduling|Found to be Ineligible|0
1035210|NCT01701258|2066748|FG000|Assessment and Scheduling|Lost to Follow-up|10
1035211|NCT01701258|2066749|FG001|Assessment and Scheduling|Lost to Follow-up|0
1035212|NCT01701258|2066750|FG002|Assessment and Scheduling|Lost to Follow-up|0
1035213|NCT01701258|2066751|FG003|Assessment and Scheduling|Lost to Follow-up|0
1035214|NCT01701258|2066752|FG004|Assessment and Scheduling|Lost to Follow-up|0
1035215|NCT01701258|2066753|FG005|Assessment and Scheduling|Lost to Follow-up|0
1035216|NCT01701258|2066754|FG006|Assessment and Scheduling|Lost to Follow-up|0
1035217|NCT01701258|2066755|FG007|Assessment and Scheduling|Lost to Follow-up|0
1035218|NCT01701258|2066756|FG008|Assessment and Scheduling|Lost to Follow-up|0
1035219|NCT01701258|2066757|FG009|Assessment and Scheduling|Lost to Follow-up|0
1035220|NCT01701258|2066758|FG010|Assessment and Scheduling|Lost to Follow-up|0
1035221|NCT01701258|2066759|FG011|Assessment and Scheduling|Lost to Follow-up|0
1035222|NCT01701258|2066760|FG012|Assessment and Scheduling|Lost to Follow-up|0
1035223|NCT01701258|2066748|FG000|Assessment and Scheduling|Withdrawal by Subject|14
1035224|NCT01701258|2066749|FG001|Assessment and Scheduling|Withdrawal by Subject|0
1035225|NCT01701258|2066750|FG002|Assessment and Scheduling|Withdrawal by Subject|0
1035226|NCT01701258|2066751|FG003|Assessment and Scheduling|Withdrawal by Subject|0
1035227|NCT01701258|2066752|FG004|Assessment and Scheduling|Withdrawal by Subject|0
1035228|NCT01701258|2066753|FG005|Assessment and Scheduling|Withdrawal by Subject|0
1035229|NCT01701258|2066754|FG006|Assessment and Scheduling|Withdrawal by Subject|0
1035230|NCT01701258|2066755|FG007|Assessment and Scheduling|Withdrawal by Subject|0
1035231|NCT01701258|2066756|FG008|Assessment and Scheduling|Withdrawal by Subject|0
1035232|NCT01701258|2066757|FG009|Assessment and Scheduling|Withdrawal by Subject|0
1035233|NCT01701258|2066758|FG010|Assessment and Scheduling|Withdrawal by Subject|0
1035234|NCT01701258|2066759|FG011|Assessment and Scheduling|Withdrawal by Subject|0
1035235|NCT01701258|2066760|FG012|Assessment and Scheduling|Withdrawal by Subject|0
1035236|NCT01701258|2066748|FG000|Assessment and Scheduling|Investigator Terminated|2
1035237|NCT01701258|2066749|FG001|Assessment and Scheduling|Investigator Terminated|0
1035238|NCT01701258|2066750|FG002|Assessment and Scheduling|Investigator Terminated|0
1035239|NCT01701258|2066751|FG003|Assessment and Scheduling|Investigator Terminated|0
1035240|NCT01701258|2066752|FG004|Assessment and Scheduling|Investigator Terminated|0
1035241|NCT01701258|2066753|FG005|Assessment and Scheduling|Investigator Terminated|0
1035242|NCT01701258|2066754|FG006|Assessment and Scheduling|Investigator Terminated|0
1035243|NCT01701258|2066755|FG007|Assessment and Scheduling|Investigator Terminated|0
1035244|NCT01701258|2066756|FG008|Assessment and Scheduling|Investigator Terminated|0
1035245|NCT01701258|2066757|FG009|Assessment and Scheduling|Investigator Terminated|0
1035246|NCT01701258|2066758|FG010|Assessment and Scheduling|Investigator Terminated|0
1035247|NCT01701258|2066759|FG011|Assessment and Scheduling|Investigator Terminated|0
1035248|NCT01701258|2066760|FG012|Assessment and Scheduling|Investigator Terminated|0
1035249|NCT01701362|2066795|FG000|Overall Study|Adverse events not related to study drug|1
1035250|NCT01701362|2066796|FG001|Overall Study|Adverse events not related to study drug|6
1035251|NCT01701362|2066795|FG000|Overall Study|Adverse events related to study drug|12
1035252|NCT01701362|2066796|FG001|Overall Study|Adverse events related to study drug|10
1035253|NCT01701362|2066795|FG000|Overall Study|Protocol Violation|5
1035254|NCT01701362|2066796|FG001|Overall Study|Protocol Violation|3
1035255|NCT01701362|2066795|FG000|Overall Study|No longer willing to participate|8
1035256|NCT01701362|2066796|FG001|Overall Study|No longer willing to participate|14
1035257|NCT01701362|2066795|FG000|Overall Study|Lost to Follow-up|6
1035258|NCT01701362|2066796|FG001|Overall Study|Lost to Follow-up|9
1035259|NCT01701362|2066795|FG000|Overall Study|Insufficient clinical response|6
1035260|NCT01701362|2066796|FG001|Overall Study|Insufficient clinical response|6
1035261|NCT01701362|2066795|FG000|Overall Study|Death|0
1035262|NCT01701362|2066796|FG001|Overall Study|Death|1
1035263|NCT01701362|2066795|FG000|Overall Study|Randomized but not treated|1
1035264|NCT01701362|2066796|FG001|Overall Study|Randomized but not treated|2
905437|NCT00762034|1880728|FG000|Maintenance Period|Death due to study disease|3
905438|NCT00762034|1880729|FG001|Maintenance Period|Death due to study disease|3
905439|NCT00762034|1880728|FG000|Maintenance Period|Other|1
905440|NCT00762034|1880729|FG001|Maintenance Period|Other|1
1035265|NCT01701362|2066795|FG000|Overall Study|Reasons other than those mentioned above|3
1035266|NCT01701362|2066796|FG001|Overall Study|Reasons other than those mentioned above|5
1035267|NCT01701401|2066810|FG000|Overall Study|Randomized But Not Treated|3
1035268|NCT01701401|2066811|FG001|Overall Study|Randomized But Not Treated|1
1035269|NCT01701401|2066812|FG002|Overall Study|Randomized But Not Treated|0
1035270|NCT01701401|2066813|FG003|Overall Study|Randomized But Not Treated|1
1035271|NCT01701401|2066810|FG000|Overall Study|Lost to Follow-up|5
1035272|NCT01701401|2066811|FG001|Overall Study|Lost to Follow-up|5
1035273|NCT01701401|2066812|FG002|Overall Study|Lost to Follow-up|1
1035274|NCT01701401|2066813|FG003|Overall Study|Lost to Follow-up|3
1035275|NCT01701401|2066810|FG000|Overall Study|Withdrew Consent|0
1035276|NCT01701401|2066811|FG001|Overall Study|Withdrew Consent|3
1035277|NCT01701401|2066812|FG002|Overall Study|Withdrew Consent|1
1035278|NCT01701401|2066813|FG003|Overall Study|Withdrew Consent|2
1035279|NCT01701401|2066810|FG000|Overall Study|Lack of Efficacy|1
1035280|NCT01701401|2066811|FG001|Overall Study|Lack of Efficacy|0
1035281|NCT01701401|2066812|FG002|Overall Study|Lack of Efficacy|2
1035282|NCT01701401|2066813|FG003|Overall Study|Lack of Efficacy|0
1035283|NCT01701401|2066810|FG000|Overall Study|Adverse Event|1
1035284|NCT01701401|2066811|FG001|Overall Study|Adverse Event|0
1035285|NCT01701401|2066812|FG002|Overall Study|Adverse Event|0
1035286|NCT01701401|2066813|FG003|Overall Study|Adverse Event|0
1035287|NCT01701401|2066810|FG000|Overall Study|Protocol Violation|0
1035288|NCT01701401|2066811|FG001|Overall Study|Protocol Violation|0
1035289|NCT01701401|2066812|FG002|Overall Study|Protocol Violation|1
1035290|NCT01701401|2066813|FG003|Overall Study|Protocol Violation|0
1162025|NCT03380429|2283928|FG001|Overall Study|Adverse Event|1
1035292|NCT01701973|2066874|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0
1035293|NCT01701973|2066875|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1
1035294|NCT01701973|2066876|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0
1035295|NCT01701973|2066877|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0
1035296|NCT01701973|2066878|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0
1035297|NCT01701973|2066879|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0
1035298|NCT01701973|2066880|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0
1035299|NCT01701973|2066881|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0
1035300|NCT01702025|2066934|FG000|Overall Study|Equipment failure|1
1035301|NCT01702025|2066935|FG001|Overall Study|Equipment failure|0
1035302|NCT01702025|2066936|FG002|Overall Study|Equipment failure|0
1035303|NCT01702025|2066937|FG003|Overall Study|Equipment failure|0
1035304|NCT01702025|2066934|FG000|Overall Study|Adverse Event|1
1035305|NCT01702025|2066935|FG001|Overall Study|Adverse Event|1
1035306|NCT01702025|2066936|FG002|Overall Study|Adverse Event|1
1035307|NCT01702025|2066937|FG003|Overall Study|Adverse Event|0
1035308|NCT01702246|2066965|FG000|Overall Study|Lost to Follow-up|2
1035309|NCT01702246|2066965|FG000|Overall Study|Withdrawal by Subject|2
1035310|NCT01702246|2066965|FG000|Overall Study|Physician Decision|1
1035311|NCT01702298|2066981|FG000|Overall Study|Withdrawal by Subject|1
1035312|NCT01702311|2066987|FG000|Overall Study|Withdrawal by Subject|3
1035313|NCT01702311|2066988|FG001|Overall Study|Withdrawal by Subject|2
1035314|NCT01702311|2066987|FG000|Overall Study|Discharge less than 24 hours|10
1035315|NCT01702311|2066988|FG001|Overall Study|Discharge less than 24 hours|7
1035316|NCT01702311|2066987|FG000|Overall Study|Physician Decision|3
1035317|NCT01702311|2066988|FG001|Overall Study|Physician Decision|4
1035318|NCT01702363|2066997|FG000|Overall Study|Adverse Event|14
1035319|NCT01702363|2066997|FG000|Overall Study|Lack of Efficacy|4
1035320|NCT01702363|2066997|FG000|Overall Study|Withdrawal by Subject|2
1035321|NCT01702428|2067006|FG000|Overall Study|Adverse Event|2
1035322|NCT01702428|2067007|FG001|Overall Study|Adverse Event|0
1035323|NCT01702428|2067008|FG002|Overall Study|Adverse Event|0
1035324|NCT01702428|2067009|FG003|Overall Study|Adverse Event|0
1035325|NCT01702428|2067006|FG000|Overall Study|Lost to Follow-up|33
1035326|NCT01702428|2067007|FG001|Overall Study|Lost to Follow-up|41
1035327|NCT01702428|2067008|FG002|Overall Study|Lost to Follow-up|37
1035328|NCT01702428|2067009|FG003|Overall Study|Lost to Follow-up|44
1035329|NCT01702428|2067006|FG000|Overall Study|Parents cannot assist to site|1
1035330|NCT01702428|2067007|FG001|Overall Study|Parents cannot assist to site|0
1035331|NCT01702428|2067008|FG002|Overall Study|Parents cannot assist to site|1
1035332|NCT01702428|2067009|FG003|Overall Study|Parents cannot assist to site|0
905441|NCT00762073|1880747|FG000|Overall Study|Lack of Efficacy|1
905442|NCT00762073|1880748|FG001|Overall Study|Lack of Efficacy|1
905443|NCT00762073|1880749|FG002|Overall Study|Lack of Efficacy|0
905444|NCT00762073|1880750|FG003|Overall Study|Lack of Efficacy|0
905445|NCT00762073|1880747|FG000|Overall Study|Adverse Event|1
905446|NCT00762073|1880748|FG001|Overall Study|Adverse Event|0
905447|NCT00762073|1880749|FG002|Overall Study|Adverse Event|1
905448|NCT00762073|1880750|FG003|Overall Study|Adverse Event|1
905449|NCT00762073|1880747|FG000|Overall Study|Significant Subject Noncompliance|0
905450|NCT00762073|1880748|FG001|Overall Study|Significant Subject Noncompliance|1
905451|NCT00762073|1880749|FG002|Overall Study|Significant Subject Noncompliance|0
905452|NCT00762073|1880750|FG003|Overall Study|Significant Subject Noncompliance|1
905453|NCT00762073|1880747|FG000|Overall Study|Withdrawal by Subject|1
905454|NCT00762073|1880748|FG001|Overall Study|Withdrawal by Subject|2
905455|NCT00762073|1880749|FG002|Overall Study|Withdrawal by Subject|1
905456|NCT00762073|1880750|FG003|Overall Study|Withdrawal by Subject|1
905457|NCT00762073|1880747|FG000|Overall Study|Not on treatment for >/= 77 days|1
905458|NCT00762073|1880748|FG001|Overall Study|Not on treatment for >/= 77 days|0
905459|NCT00762073|1880749|FG002|Overall Study|Not on treatment for >/= 77 days|0
905460|NCT00762073|1880750|FG003|Overall Study|Not on treatment for >/= 77 days|0
905461|NCT00762086|1880769|FG000|Overall Study|Adverse Event|2
905462|NCT00762086|1880770|FG001|Overall Study|Adverse Event|0
905463|NCT00762086|1880769|FG000|Overall Study|Lost to Follow-up|0
905464|NCT00762086|1880770|FG001|Overall Study|Lost to Follow-up|2
905465|NCT00762086|1880769|FG000|Overall Study|Non compliance|1
905466|NCT00762086|1880770|FG001|Overall Study|Non compliance|0
905467|NCT00762086|1880769|FG000|Overall Study|Withdrawal by Subject|2
905468|NCT00762086|1880770|FG001|Overall Study|Withdrawal by Subject|2
905469|NCT00762086|1880769|FG000|Overall Study|Ineligible to participate in the study|1
905470|NCT00762086|1880770|FG001|Overall Study|Ineligible to participate in the study|0
905471|NCT00762164|1880778|FG000|Overall Study|Lost to Follow-up|1
905472|NCT00762164|1880779|FG001|Overall Study|Lost to Follow-up|1
905473|NCT00762164|1880778|FG000|Overall Study|Discontinued medication|2
905474|NCT00762164|1880779|FG001|Overall Study|Discontinued medication|0
905475|NCT00762164|1880778|FG000|Overall Study|Withdrawal by Subject|0
905476|NCT00762164|1880779|FG001|Overall Study|Withdrawal by Subject|1
905477|NCT00762229|1880807|FG000|Overall Study|Lost to Follow-up|1
905478|NCT00762229|1880808|FG001|Overall Study|Lost to Follow-up|1
905479|NCT00762229|1880807|FG000|Overall Study|did not recveive intervention|0
905480|NCT00762229|1880808|FG001|Overall Study|did not recveive intervention|1
1035333|NCT01702428|2067006|FG000|Overall Study|Lost Coverage|0
1035334|NCT01702428|2067007|FG001|Overall Study|Lost Coverage|0
1035335|NCT01702428|2067008|FG002|Overall Study|Lost Coverage|0
1035336|NCT01702428|2067009|FG003|Overall Study|Lost Coverage|1
1035337|NCT01702428|2067006|FG000|Overall Study|Lost Health Plan|3
1035338|NCT01702428|2067007|FG001|Overall Study|Lost Health Plan|5
1035339|NCT01702428|2067008|FG002|Overall Study|Lost Health Plan|0
1035340|NCT01702428|2067009|FG003|Overall Study|Lost Health Plan|2
1035341|NCT01702428|2067006|FG000|Overall Study|Mother transferred care|0
1035342|NCT01702428|2067007|FG001|Overall Study|Mother transferred care|1
1035343|NCT01702428|2067008|FG002|Overall Study|Mother transferred care|0
1035344|NCT01702428|2067009|FG003|Overall Study|Mother transferred care|0
1035345|NCT01702428|2067006|FG000|Overall Study|Parents too busy|1
1035346|NCT01702428|2067007|FG001|Overall Study|Parents too busy|0
1035347|NCT01702428|2067008|FG002|Overall Study|Parents too busy|0
1035348|NCT01702428|2067009|FG003|Overall Study|Parents too busy|0
1035349|NCT01702428|2067006|FG000|Overall Study|Protocol Violation|3
1035350|NCT01702428|2067007|FG001|Overall Study|Protocol Violation|0
1035351|NCT01702428|2067008|FG002|Overall Study|Protocol Violation|1
1035352|NCT01702428|2067009|FG003|Overall Study|Protocol Violation|0
1035353|NCT01702428|2067006|FG000|Overall Study|Withdrawal by Subject|21
1035354|NCT01702428|2067007|FG001|Overall Study|Withdrawal by Subject|23
1035355|NCT01702428|2067008|FG002|Overall Study|Withdrawal by Subject|14
1035356|NCT01702428|2067009|FG003|Overall Study|Withdrawal by Subject|10
1035357|NCT01702454|2067028|FG000|Overall Study|Consent withdrawal|0
905481|NCT00762268|1880816|FG000|Overall Study|Withdrawal by Subject|3
905482|NCT00762268|1880817|FG001|Overall Study|Withdrawal by Subject|3
905483|NCT00762359|1880862|FG000|Overall Study|Adverse Event|20
905484|NCT00762359|1880863|FG001|Overall Study|Adverse Event|23
905485|NCT00762359|1880862|FG000|Overall Study|Protocol Violation|21
905486|NCT00762359|1880863|FG001|Overall Study|Protocol Violation|13
905487|NCT00762359|1880862|FG000|Overall Study|Withdrawal by Subject|13
905488|NCT00762359|1880863|FG001|Overall Study|Withdrawal by Subject|10
905489|NCT00762359|1880862|FG000|Overall Study|Lack of Efficacy|0
905490|NCT00762359|1880863|FG001|Overall Study|Lack of Efficacy|4
905491|NCT00762359|1880862|FG000|Overall Study|Institution closed|2
905492|NCT00762359|1880863|FG001|Overall Study|Institution closed|3
905493|NCT00762359|1880862|FG000|Overall Study|Physician Decision|2
905494|NCT00762359|1880863|FG001|Overall Study|Physician Decision|3
905495|NCT00762359|1880862|FG000|Overall Study|Removal|0
905496|NCT00762359|1880863|FG001|Overall Study|Removal|1
905497|NCT00762359|1880862|FG000|Overall Study|Withdrew consent|1
905498|NCT00762359|1880863|FG001|Overall Study|Withdrew consent|0
905499|NCT00762372|1880872|FG000|Overall Study|Adverse Event|1
905500|NCT00762372|1880873|FG001|Overall Study|Adverse Event|0
905501|NCT00762372|1880874|FG002|Overall Study|Adverse Event|0
905502|NCT00762385|1880888|FG000|First Intervention|Lens Issue|1
905503|NCT00762385|1880889|FG001|First Intervention|Lens Issue|1
905504|NCT00762385|1880888|FG000|First Intervention|Lost to Follow-up|0
905505|NCT00762385|1880889|FG001|First Intervention|Lost to Follow-up|2
905506|NCT00762385|1880888|FG000|First Intervention|Ineligible|1
905507|NCT00762385|1880889|FG001|First Intervention|Ineligible|0
905508|NCT00762385|1880888|FG000|First Intervention|Protocol Violation|0
905509|NCT00762385|1880889|FG001|First Intervention|Protocol Violation|1
905510|NCT00762385|1880888|FG000|Second Intervention|Protocol Violation|3
905511|NCT00762385|1880889|FG001|Second Intervention|Protocol Violation|3
905512|NCT00762411|1880900|FG000|Initial Treatment|Death|7
905513|NCT00762411|1880901|FG001|Initial Treatment|Death|6
905514|NCT00762411|1880900|FG000|Initial Treatment|Adverse Event|132
905515|NCT00762411|1880901|FG001|Initial Treatment|Adverse Event|40
905516|NCT00762411|1880900|FG000|Initial Treatment|Protocol Violation|4
905517|NCT00762411|1880901|FG001|Initial Treatment|Protocol Violation|1
905518|NCT00762411|1880900|FG000|Initial Treatment|Withdrawal by Subject|65
905519|NCT00762411|1880901|FG001|Initial Treatment|Withdrawal by Subject|52
905520|NCT00762411|1880900|FG000|Initial Treatment|Physician Decision|1
905521|NCT00762411|1880901|FG001|Initial Treatment|Physician Decision|0
905522|NCT00762411|1880900|FG000|Initial Treatment|Sponsor Decision|293
905523|NCT00762411|1880901|FG001|Initial Treatment|Sponsor Decision|401
905524|NCT00762411|1880900|FG000|Initial Treatment|Lost to Follow-up|5
905525|NCT00762411|1880901|FG001|Initial Treatment|Lost to Follow-up|0
905526|NCT00762411|1880900|FG000|Initial Treatment|Caregiver Decision|21
905527|NCT00762411|1880901|FG001|Initial Treatment|Caregiver Decision|16
905528|NCT00762411|1880900|FG000|Initial Treatment|Abnormal Lab/ECG Result|6
905529|NCT00762411|1880901|FG001|Initial Treatment|Abnormal Lab/ECG Result|4
905530|NCT00762411|1880900|FG000|Initial Treatment|Entry Criteria Exclusion|0
905531|NCT00762411|1880901|FG001|Initial Treatment|Entry Criteria Exclusion|1
905532|NCT00762411|1880900|FG000|Delayed Start|Adverse Event|0
905533|NCT00762411|1880901|FG001|Delayed Start|Adverse Event|4
905534|NCT00762411|1880900|FG000|Delayed Start|Protocol Violation|0
905535|NCT00762411|1880901|FG001|Delayed Start|Protocol Violation|1
905536|NCT00762411|1880900|FG000|Delayed Start|Sponsor Decision|16
905537|NCT00762411|1880901|FG001|Delayed Start|Sponsor Decision|20
905538|NCT00762411|1880900|FG000|Delayed Start|Caregiver Decision|1
905539|NCT00762411|1880901|FG001|Delayed Start|Caregiver Decision|1
905540|NCT00762411|1880900|FG000|Safety Follow Up (SFU)-Optional|Death|1
1035358|NCT01702454|2067029|FG001|Overall Study|Consent withdrawal|1
1035359|NCT01702454|2067028|FG000|Overall Study|Migrated/moved from study area|0
1035360|NCT01702454|2067029|FG001|Overall Study|Migrated/moved from study area|1
1035361|NCT01702454|2067028|FG000|Overall Study|Lost to Follow-up|3
1035362|NCT01702454|2067029|FG001|Overall Study|Lost to Follow-up|6
1035363|NCT01702519|2067040|FG000|Washout Period|Lost to Follow-up|1
1035364|NCT01702519|2067041|FG001|Washout Period|Lost to Follow-up|0
1035365|NCT01702519|2067040|FG000|Washout Period|Withdrawal by Subject|0
1035366|NCT01702519|2067041|FG001|Washout Period|Withdrawal by Subject|2
1035367|NCT01702532|2067053|FG000|Overall Study|Adverse Event|0
1035368|NCT01702532|2067054|FG001|Overall Study|Adverse Event|1
1035369|NCT01702558|2067066|FG000|Overall Study|Withdrawal by Subject|0
1035370|NCT01702558|2067067|FG001|Overall Study|Withdrawal by Subject|0
1035371|NCT01702558|2067068|FG002|Overall Study|Withdrawal by Subject|0
1035372|NCT01702558|2067069|FG003|Overall Study|Withdrawal by Subject|12
1035373|NCT01702558|2067070|FG004|Overall Study|Withdrawal by Subject|4
1035374|NCT01702558|2067066|FG000|Overall Study|Lost to Follow-up|0
1035375|NCT01702558|2067067|FG001|Overall Study|Lost to Follow-up|0
1035376|NCT01702558|2067068|FG002|Overall Study|Lost to Follow-up|0
1035377|NCT01702558|2067069|FG003|Overall Study|Lost to Follow-up|3
1035378|NCT01702558|2067070|FG004|Overall Study|Lost to Follow-up|0
1035379|NCT01702558|2067066|FG000|Overall Study|Death|4
1035380|NCT01702558|2067067|FG001|Overall Study|Death|3
1035381|NCT01702558|2067068|FG002|Overall Study|Death|3
1035382|NCT01702558|2067069|FG003|Overall Study|Death|16
1035383|NCT01702558|2067070|FG004|Overall Study|Death|20
1035384|NCT01702558|2067066|FG000|Overall Study|Safety Follow-Up less than 3 Months|0
1035385|NCT01702558|2067067|FG001|Overall Study|Safety Follow-Up less than 3 Months|0
1035386|NCT01702558|2067068|FG002|Overall Study|Safety Follow-Up less than 3 Months|2
1035387|NCT01702558|2067069|FG003|Overall Study|Safety Follow-Up less than 3 Months|0
1035388|NCT01702558|2067070|FG004|Overall Study|Safety Follow-Up less than 3 Months|0
1035389|NCT01702558|2067066|FG000|Overall Study|Study Terminated by Sponsor|0
1035390|NCT01702558|2067067|FG001|Overall Study|Study Terminated by Sponsor|1
1035391|NCT01702558|2067068|FG002|Overall Study|Study Terminated by Sponsor|0
905541|NCT00762411|1880901|FG001|Safety Follow Up (SFU)-Optional|Death|8
905542|NCT00762411|1880900|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0
905543|NCT00762411|1880901|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1
905544|NCT00762411|1880900|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
905545|NCT00762411|1880901|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
905546|NCT00762411|1880900|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
905547|NCT00762411|1880901|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
905548|NCT00762411|1880900|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
905549|NCT00762411|1880901|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
905550|NCT00762411|1880900|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
905551|NCT00762411|1880901|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
905552|NCT00762463|1880935|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
905553|NCT00762463|1880936|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
905554|NCT00762463|1880937|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
905555|NCT00762463|1880938|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
905556|NCT00762463|1880935|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
905557|NCT00762463|1880936|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
905558|NCT00762463|1880937|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
905559|NCT00762463|1880938|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
905560|NCT00762463|1880935|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
905561|NCT00762463|1880936|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
905562|NCT00762463|1880937|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
905563|NCT00762463|1880938|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
905564|NCT00762463|1880935|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
905565|NCT00762463|1880936|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
905566|NCT00762463|1880937|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
905567|NCT00762463|1880938|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
905568|NCT00762463|1880935|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
905569|NCT00762463|1880936|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
905570|NCT00762463|1880937|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
905571|NCT00762463|1880938|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
905572|NCT00762463|1880935|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
905573|NCT00762463|1880936|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
905574|NCT00762463|1880937|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
905575|NCT00762463|1880938|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
905576|NCT00762463|1880935|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
1035392|NCT01702558|2067069|FG003|Overall Study|Study Terminated by Sponsor|0
1035393|NCT01702558|2067070|FG004|Overall Study|Study Terminated by Sponsor|1
1035394|NCT01702558|2067066|FG000|Overall Study|Other|0
1035395|NCT01702558|2067067|FG001|Overall Study|Other|0
1035396|NCT01702558|2067068|FG002|Overall Study|Other|0
1035397|NCT01702558|2067069|FG003|Overall Study|Other|16
1035398|NCT01702558|2067070|FG004|Overall Study|Other|17
1035399|NCT01702571|2067085|FG000|Overall Study|Death|1067
1035400|NCT01702571|2067086|FG001|Overall Study|Death|76
1035401|NCT01702571|2067085|FG000|Overall Study|Lost to Follow-up|144
1035402|NCT01702571|2067086|FG001|Overall Study|Lost to Follow-up|10
1035403|NCT01702571|2067085|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4
1035404|NCT01702571|2067086|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0
1035405|NCT01702571|2067085|FG000|Overall Study|Investigator Decision|5
1035406|NCT01702571|2067086|FG001|Overall Study|Investigator Decision|0
1035407|NCT01702571|2067085|FG000|Overall Study|Not Classifiable|1
1035408|NCT01702571|2067086|FG001|Overall Study|Not Classifiable|0
1035409|NCT01702571|2067085|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93
1035410|NCT01702571|2067086|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0
1035411|NCT01702571|2067085|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0
1035412|NCT01702571|2067086|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1
1035413|NCT01702571|2067085|FG000|Overall Study|Progressive Disease|3
1035414|NCT01702571|2067086|FG001|Overall Study|Progressive Disease|0
1035415|NCT01702571|2067085|FG000|Overall Study|Protocol Violation|2
1035416|NCT01702571|2067086|FG001|Overall Study|Protocol Violation|0
1035417|NCT01702571|2067085|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9
1035418|NCT01702571|2067086|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1
1035419|NCT01702571|2067085|FG000|Overall Study|Termination By Sponsor|4
1035420|NCT01702571|2067086|FG001|Overall Study|Termination By Sponsor|0
1035421|NCT01702571|2067085|FG000|Overall Study|Withdrawal by Subject|177
1035422|NCT01702571|2067086|FG001|Overall Study|Withdrawal by Subject|29
1035423|NCT01702844|2067092|FG000|Overall Study|Adverse Event|9
1035424|NCT01702844|2067092|FG000|Overall Study|Death|1
1035425|NCT01702844|2067092|FG000|Overall Study|Withdrawal by Subject|3
1035426|NCT01702844|2067092|FG000|Overall Study|Physician Decision|6
1035427|NCT01702961|2067096|FG000|Overall Study|Additional treatment|3
1035428|NCT01702961|2067096|FG000|Overall Study|Progressive disease|5
1035429|NCT01702961|2067096|FG000|Overall Study|Relapse|20
1035430|NCT01702961|2067096|FG000|Overall Study|Death|6
1035431|NCT01702961|2067096|FG000|Overall Study|Lost to Follow-up|2
1035432|NCT01702961|2067096|FG000|Overall Study|Ongoing|11
1035433|NCT01702987|2067102|FG000|Overall Study|Withdrawal by Subject|1
1035434|NCT01702987|2067103|FG001|Overall Study|Withdrawal by Subject|0
1035435|NCT01703000|2067109|FG000|Overall Study|Death|1
1035436|NCT01703065|2067126|FG000|Overall Study|Lack of Efficacy|1
1035437|NCT01703065|2067127|FG001|Overall Study|Lack of Efficacy|0
1035438|NCT01703091|2067136|FG000|Overall Study|Adverse Event|5
1035439|NCT01703091|2067137|FG001|Overall Study|Adverse Event|3
1035440|NCT01703091|2067136|FG000|Overall Study|Physician Decision|2
1035441|NCT01703091|2067137|FG001|Overall Study|Physician Decision|1
1035442|NCT01703091|2067136|FG000|Overall Study|Withdrawal by Subject|1
1035443|NCT01703091|2067137|FG001|Overall Study|Withdrawal by Subject|0
1035444|NCT01703091|2067136|FG000|Overall Study|Sponsor Decision|1
1035445|NCT01703091|2067137|FG001|Overall Study|Sponsor Decision|0
1035446|NCT01703117|2067145|FG000|Overall Study|Adverse Event|4
1035447|NCT01703117|2067146|FG001|Overall Study|Adverse Event|3
1035448|NCT01703117|2067145|FG000|Overall Study|Withdrawal by Subject|0
1035449|NCT01703117|2067146|FG001|Overall Study|Withdrawal by Subject|1
1035450|NCT01703208|2067160|FG000|Overall Study|Death|61
1035451|NCT01703208|2067161|FG001|Overall Study|Death|48
1035452|NCT01703208|2067160|FG000|Overall Study|Lack of Efficacy|1
1035453|NCT01703208|2067161|FG001|Overall Study|Lack of Efficacy|2
1035454|NCT01703208|2067160|FG000|Overall Study|Lost to Follow-up|68
1035455|NCT01703208|2067161|FG001|Overall Study|Lost to Follow-up|62
1035456|NCT01703208|2067160|FG000|Overall Study|Non-Compliance with Study Drug|1
1035457|NCT01703208|2067161|FG001|Overall Study|Non-Compliance with Study Drug|0
1035458|NCT01703208|2067160|FG000|Overall Study|Excluded Medication|1
1035459|NCT01703208|2067161|FG001|Overall Study|Excluded Medication|2
1035460|NCT01703208|2067160|FG000|Overall Study|Site Discontinued Study Participation|23
1162026|NCT03380429|2283929|FG002|Overall Study|Adverse Event|1
905577|NCT00762463|1880936|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
905578|NCT00762463|1880937|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
905579|NCT00762463|1880938|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
905580|NCT00762463|1880935|FG000|Extension Phase (Week 6 to Week 12)|Other|0
905581|NCT00762463|1880936|FG001|Extension Phase (Week 6 to Week 12)|Other|0
1035461|NCT01703208|2067161|FG001|Overall Study|Site Discontinued Study Participation|27
1035462|NCT01703208|2067160|FG000|Overall Study|Physician Decision|11
1035463|NCT01703208|2067161|FG001|Overall Study|Physician Decision|13
1035464|NCT01703208|2067160|FG000|Overall Study|Progressive disease|2
1035465|NCT01703208|2067161|FG001|Overall Study|Progressive disease|2
1035466|NCT01703208|2067160|FG000|Overall Study|Protocol Violation|1
1035467|NCT01703208|2067161|FG001|Overall Study|Protocol Violation|1
1035468|NCT01703208|2067160|FG000|Overall Study|Study Terminated by Sponsor|1710
1035469|NCT01703208|2067161|FG001|Overall Study|Study Terminated by Sponsor|1716
1035470|NCT01703208|2067160|FG000|Overall Study|Withdrawal by Subject|205
1035471|NCT01703208|2067161|FG001|Overall Study|Withdrawal by Subject|209
1035472|NCT01703208|2067160|FG000|Overall Study|Adverse Event|14
1035473|NCT01703208|2067161|FG001|Overall Study|Adverse Event|19
1035474|NCT01703208|2067160|FG000|Overall Study|Technical Problems|0
1035475|NCT01703208|2067161|FG001|Overall Study|Technical Problems|1
1035476|NCT01703208|2067160|FG000|Overall Study|Protocol Deviation|2
1035477|NCT01703208|2067161|FG001|Overall Study|Protocol Deviation|0
1035478|NCT01703221|2067170|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2
1035479|NCT01703221|2067171|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4
1035480|NCT01703221|2067172|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0
1035481|NCT01703221|2067170|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
1035482|NCT01703221|2067171|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
1035483|NCT01703221|2067172|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
1035484|NCT01703221|2067170|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1
1035485|NCT01703221|2067171|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
1035486|NCT01703221|2067172|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
1035487|NCT01703221|2067170|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
1035488|NCT01703221|2067171|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1035489|NCT01703221|2067172|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1035490|NCT01703221|2067170|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0
1035491|NCT01703221|2067171|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
1035492|NCT01703221|2067172|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1
1035493|NCT01703221|2067170|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
1035494|NCT01703221|2067171|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
1035495|NCT01703221|2067172|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
1035496|NCT01703221|2067170|FG000|Phase B - (Week 25 to 52)|Adverse Event|2
1035497|NCT01703221|2067171|FG001|Phase B - (Week 25 to 52)|Adverse Event|3
1035498|NCT01703221|2067172|FG002|Phase B - (Week 25 to 52)|Adverse Event|2
1035499|NCT01703221|2067170|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12
1035500|NCT01703221|2067171|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10
1035501|NCT01703221|2067172|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3
1035502|NCT01703260|2067189|FG000|Overall Study|Adverse Event|1
1035503|NCT01703260|2067190|FG001|Overall Study|Adverse Event|2
1035504|NCT01703260|2067191|FG002|Overall Study|Adverse Event|2
1035505|NCT01703260|2067189|FG000|Overall Study|Lost to Follow-up|1
1035506|NCT01703260|2067190|FG001|Overall Study|Lost to Follow-up|0
1035507|NCT01703260|2067191|FG002|Overall Study|Lost to Follow-up|0
1035508|NCT01703260|2067189|FG000|Overall Study|Withdrawal by Subject|0
1035509|NCT01703260|2067190|FG001|Overall Study|Withdrawal by Subject|0
1035510|NCT01703260|2067191|FG002|Overall Study|Withdrawal by Subject|1
1035511|NCT01703260|2067189|FG000|Overall Study|Study Termination|1
1035512|NCT01703260|2067190|FG001|Overall Study|Study Termination|2
1035513|NCT01703260|2067191|FG002|Overall Study|Study Termination|0
1035514|NCT01703286|2067199|FG000|Period 1 Including Washout|Withdrawal by Subject|0
1035515|NCT01703286|2067200|FG001|Period 1 Including Washout|Withdrawal by Subject|0
1035516|NCT01703286|2067201|FG002|Period 1 Including Washout|Withdrawal by Subject|0
1035517|NCT01703286|2067202|FG003|Period 1 Including Washout|Withdrawal by Subject|1
1035518|NCT01703286|2067203|FG004|Period 1 Including Washout|Withdrawal by Subject|0
1035519|NCT01703286|2067204|FG005|Period 1 Including Washout|Withdrawal by Subject|1
1035520|NCT01703286|2067199|FG000|Period 2 Including Washout|Adverse Event|0
905582|NCT00762463|1880937|FG002|Extension Phase (Week 6 to Week 12)|Other|0
905583|NCT00762463|1880938|FG003|Extension Phase (Week 6 to Week 12)|Other|1
905584|NCT00762476|1880953|FG000|Overall Study|Adverse Event|7
905585|NCT00762476|1880954|FG001|Overall Study|Adverse Event|1
905586|NCT00762476|1880953|FG000|Overall Study|Lost to Follow-up|2
905587|NCT00762476|1880954|FG001|Overall Study|Lost to Follow-up|0
905588|NCT00762476|1880953|FG000|Overall Study|Protocol Violation|5
905589|NCT00762476|1880954|FG001|Overall Study|Protocol Violation|6
905590|NCT00762476|1880953|FG000|Overall Study|Physician Decision|2
905591|NCT00762476|1880954|FG001|Overall Study|Physician Decision|14
905592|NCT00762476|1880953|FG000|Overall Study|Withdrawal by Subject|6
905593|NCT00762476|1880954|FG001|Overall Study|Withdrawal by Subject|12
905594|NCT00762476|1880953|FG000|Overall Study|antibiotic use|0
905595|NCT00762476|1880954|FG001|Overall Study|antibiotic use|1
905596|NCT00762476|1880953|FG000|Overall Study|non-compliance with study visits|0
905597|NCT00762476|1880954|FG001|Overall Study|non-compliance with study visits|2
905598|NCT00762476|1880953|FG000|Overall Study|Seasonal allergies|1
905599|NCT00762476|1880954|FG001|Overall Study|Seasonal allergies|0
905600|NCT00762502|1880964|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4
905601|NCT00762502|1880965|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3
1035521|NCT01703286|2067200|FG001|Period 2 Including Washout|Adverse Event|0
1035522|NCT01703286|2067201|FG002|Period 2 Including Washout|Adverse Event|0
1035523|NCT01703286|2067202|FG003|Period 2 Including Washout|Adverse Event|1
1035524|NCT01703286|2067203|FG004|Period 2 Including Washout|Adverse Event|0
1035525|NCT01703286|2067204|FG005|Period 2 Including Washout|Adverse Event|0
1035526|NCT01703741|2067249|FG000|Overall Study|Withdrawal by Subject|6
1035527|NCT01703741|2067249|FG000|Overall Study|Adverse Event|2
1035528|NCT01703741|2067249|FG000|Overall Study|Physician Decision|2
1035529|NCT01703741|2067249|FG000|Overall Study|Protocol Violation|1
1035530|NCT01703741|2067249|FG000|Overall Study|Lost to Follow-up|3
1035531|NCT01703741|2067249|FG000|Overall Study|Subject did not want to continue|2
1035532|NCT01703741|2067249|FG000|Overall Study|Subject cannot comply with study visits|1
1035533|NCT01703741|2067249|FG000|Overall Study|Subject started testosterone injections|1
1035534|NCT01703819|2067255|FG000|Overall Study|Adverse Event|0
1035535|NCT01703819|2067256|FG001|Overall Study|Adverse Event|1
1035536|NCT01703819|2067255|FG000|Overall Study|Withdrawal by Subject|0
1035537|NCT01703819|2067256|FG001|Overall Study|Withdrawal by Subject|1
1035538|NCT01703832|2067264|FG000|Overall Study|Withdrawal by Subject|1
1035539|NCT01703832|2067265|FG001|Overall Study|Withdrawal by Subject|0
1035540|NCT01703845|2067273|FG000|Overall Study|Adverse Event|1
1035541|NCT01703845|2067274|FG001|Overall Study|Adverse Event|0
1035542|NCT01703845|2067273|FG000|Overall Study|Protocol Violation|1
1035543|NCT01703845|2067274|FG001|Overall Study|Protocol Violation|0
1035544|NCT01703845|2067273|FG000|Overall Study|other than stated above|1
905602|NCT00762502|1880966|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6
905603|NCT00762502|1880964|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
905604|NCT00762502|1880965|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
905605|NCT00762502|1880966|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
905606|NCT00762502|1880964|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0
905607|NCT00762502|1880965|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1
905608|NCT00762502|1880966|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0
905609|NCT00762606|1880992|FG000|Overall Study|Lost to Follow-up|18
905610|NCT00762606|1880993|FG001|Overall Study|Lost to Follow-up|13
905611|NCT00762762|1881030|FG000|Overall Study|Did not report for appointments|8
905612|NCT00762762|1881031|FG001|Overall Study|Did not report for appointments|10
905613|NCT00762788|1881043|FG000|Overall Study|Lost to Follow-up|26
905614|NCT00762788|1881044|FG001|Overall Study|Lost to Follow-up|37
905615|NCT00762788|1881045|FG002|Overall Study|Lost to Follow-up|21
905616|NCT00762788|1881046|FG003|Overall Study|Lost to Follow-up|26
905617|NCT00762788|1881047|FG004|Overall Study|Lost to Follow-up|13
905618|NCT00762788|1881048|FG005|Overall Study|Lost to Follow-up|21
905619|NCT00762892|1881073|FG000|Overall Study|Lost to Follow-up|2
905620|NCT00762892|1881074|FG001|Overall Study|Lost to Follow-up|5
905621|NCT00762892|1881073|FG000|Overall Study|Withdrawal by Subject|0
905622|NCT00762892|1881074|FG001|Overall Study|Withdrawal by Subject|1
905623|NCT00762892|1881073|FG000|Overall Study|Death|1
905624|NCT00762892|1881074|FG001|Overall Study|Death|0
905625|NCT00762892|1881073|FG000|Overall Study|Pregnancy|1
905626|NCT00762892|1881074|FG001|Overall Study|Pregnancy|0
905627|NCT00762892|1881073|FG000|Overall Study|Incarceration|1
905628|NCT00762892|1881074|FG001|Overall Study|Incarceration|0
905629|NCT00762970|1881087|FG000|Overall Study|Withdrawal by Subject|7
905630|NCT00762970|1881088|FG001|Overall Study|Withdrawal by Subject|4
905631|NCT00762970|1881089|FG002|Overall Study|Withdrawal by Subject|0
905632|NCT00762970|1881087|FG000|Overall Study|Protocol Violation|3
905633|NCT00762970|1881088|FG001|Overall Study|Protocol Violation|1
905634|NCT00762970|1881089|FG002|Overall Study|Protocol Violation|1
905635|NCT00762970|1881087|FG000|Overall Study|Lost to Follow-up|1
905636|NCT00762970|1881088|FG001|Overall Study|Lost to Follow-up|2
905637|NCT00762970|1881089|FG002|Overall Study|Lost to Follow-up|0
905638|NCT00762970|1881087|FG000|Overall Study|Difficulty of handling lens|1
905639|NCT00762970|1881088|FG001|Overall Study|Difficulty of handling lens|2
905640|NCT00762970|1881089|FG002|Overall Study|Difficulty of handling lens|0
905641|NCT00762996|1881097|FG000|Period One|Protocol Violation|0
905642|NCT00762996|1881098|FG001|Period One|Protocol Violation|0
905643|NCT00762996|1881099|FG002|Period One|Protocol Violation|1
905644|NCT00762996|1881100|FG003|Period One|Protocol Violation|0
905645|NCT00762996|1881097|FG000|Period One|ineligible|0
905646|NCT00762996|1881098|FG001|Period One|ineligible|0
905647|NCT00762996|1881099|FG002|Period One|ineligible|1
905648|NCT00762996|1881100|FG003|Period One|ineligible|1
905649|NCT00762996|1881097|FG000|Period One|Adverse Event|0
905650|NCT00762996|1881098|FG001|Period One|Adverse Event|0
905651|NCT00762996|1881099|FG002|Period One|Adverse Event|1
905652|NCT00762996|1881100|FG003|Period One|Adverse Event|0
905653|NCT00762996|1881097|FG000|Period One|Withdrawal by Subject|0
905654|NCT00762996|1881098|FG001|Period One|Withdrawal by Subject|0
905655|NCT00762996|1881099|FG002|Period One|Withdrawal by Subject|1
905656|NCT00762996|1881100|FG003|Period One|Withdrawal by Subject|0
905657|NCT00763035|1881108|FG000|First Intervention|Did not meeting inclusion/exclusion|1
905658|NCT00763035|1881109|FG001|First Intervention|Did not meeting inclusion/exclusion|0
905659|NCT00763035|1881108|FG000|First Intervention|Adverse Event|0
905660|NCT00763035|1881109|FG001|First Intervention|Adverse Event|1
905661|NCT00763035|1881108|FG000|Second Intervention|Adverse Event|1
905662|NCT00763035|1881109|FG001|Second Intervention|Adverse Event|0
905663|NCT00763035|1881108|FG000|Second Intervention|Physician Decision|2
905664|NCT00763035|1881109|FG001|Second Intervention|Physician Decision|0
1035545|NCT01703845|2067274|FG001|Overall Study|other than stated above|0
1035546|NCT01703858|2067285|FG000|Overall Study|Withdrawal by Subject|0
1035547|NCT01703858|2067286|FG001|Overall Study|Withdrawal by Subject|1
1035548|NCT01703858|2067287|FG002|Overall Study|Withdrawal by Subject|0
1035549|NCT01703988|2067304|FG000|Overall Study|Investigator Judgment|0
1035550|NCT01703988|2067305|FG001|Overall Study|Investigator Judgment|0
1035551|NCT01703988|2067306|FG002|Overall Study|Investigator Judgment|0
1035552|NCT01703988|2067307|FG003|Overall Study|Investigator Judgment|1
1035553|NCT01704079|2067320|FG000|Overall Study|Withdrawal by Subject|5
1035554|NCT01704079|2067321|FG001|Overall Study|Withdrawal by Subject|7
1035555|NCT01704079|2067320|FG000|Overall Study|Lost to Follow-up|2
1035556|NCT01704079|2067321|FG001|Overall Study|Lost to Follow-up|5
1035557|NCT01704079|2067320|FG000|Overall Study|Adverse Event|4
1035558|NCT01704079|2067321|FG001|Overall Study|Adverse Event|7
1035559|NCT01704079|2067320|FG000|Overall Study|Protocol Violation|1
1035560|NCT01704079|2067321|FG001|Overall Study|Protocol Violation|0
1035561|NCT01704079|2067320|FG000|Overall Study|Subject noncompliance|2
1035562|NCT01704079|2067321|FG001|Overall Study|Subject noncompliance|3
1035563|NCT01704079|2067320|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
1035564|NCT01704079|2067321|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
1035565|NCT01704261|2067338|FG000|Overall Study|Withdrawal by Subject|12
1035566|NCT01704261|2067339|FG001|Overall Study|Withdrawal by Subject|15
1035567|NCT01704261|2067338|FG000|Overall Study|Lost to Follow-up|1
1035568|NCT01704261|2067339|FG001|Overall Study|Lost to Follow-up|0
1035569|NCT01704287|2067348|FG000|Initial Treatment Period|Death|139
1035570|NCT01704287|2067349|FG001|Initial Treatment Period|Death|129
1035571|NCT01704287|2067350|FG002|Initial Treatment Period|Death|71
1035572|NCT01704287|2067351|FG003|Initial Treatment Period|Death|0
1035573|NCT01704287|2067352|FG004|Initial Treatment Period|Death|0
1035574|NCT01704287|2067348|FG000|Initial Treatment Period|Withdrawal by Subject|3
1035575|NCT01704287|2067349|FG001|Initial Treatment Period|Withdrawal by Subject|2
1035576|NCT01704287|2067350|FG002|Initial Treatment Period|Withdrawal by Subject|4
1035577|NCT01704287|2067351|FG003|Initial Treatment Period|Withdrawal by Subject|0
1035578|NCT01704287|2067352|FG004|Initial Treatment Period|Withdrawal by Subject|0
1035579|NCT01704287|2067348|FG000|Initial Treatment Period|Lost to Follow-up|5
1035580|NCT01704287|2067349|FG001|Initial Treatment Period|Lost to Follow-up|3
1035581|NCT01704287|2067350|FG002|Initial Treatment Period|Lost to Follow-up|0
1035582|NCT01704287|2067351|FG003|Initial Treatment Period|Lost to Follow-up|0
1035583|NCT01704287|2067352|FG004|Initial Treatment Period|Lost to Follow-up|0
1035584|NCT01704287|2067348|FG000|Initial Treatment Period|Switched to Pembrolizumab|0
1035585|NCT01704287|2067349|FG001|Initial Treatment Period|Switched to Pembrolizumab|0
1035586|NCT01704287|2067350|FG002|Initial Treatment Period|Switched to Pembrolizumab|98
1035587|NCT01704287|2067351|FG003|Initial Treatment Period|Switched to Pembrolizumab|0
1035588|NCT01704287|2067352|FG004|Initial Treatment Period|Switched to Pembrolizumab|0
1035589|NCT01704287|2067348|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1035590|NCT01704287|2067349|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1035591|NCT01704287|2067350|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1035592|NCT01704287|2067351|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
1035593|NCT01704287|2067352|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
1035594|NCT01704287|2067348|FG000|Switch to Pembrolizumab Treatment Period|Death|0
1035595|NCT01704287|2067349|FG001|Switch to Pembrolizumab Treatment Period|Death|0
1035596|NCT01704287|2067350|FG002|Switch to Pembrolizumab Treatment Period|Death|0
1035597|NCT01704287|2067351|FG003|Switch to Pembrolizumab Treatment Period|Death|35
905665|NCT00763139|1881133|FG000|Overall Study|Adverse Event|4
905666|NCT00763139|1881134|FG001|Overall Study|Adverse Event|2
905667|NCT00763139|1881133|FG000|Overall Study|Withdrawal by Subject|0
905668|NCT00763139|1881134|FG001|Overall Study|Withdrawal by Subject|1
905669|NCT00763139|1881133|FG000|Overall Study|med change not allowed by protocol|1
905670|NCT00763139|1881134|FG001|Overall Study|med change not allowed by protocol|0
905671|NCT00763256|1881159|FG000|Overall Study|Didn't return for appointments|7
905672|NCT00763256|1881160|FG001|Overall Study|Didn't return for appointments|10
905673|NCT00763269|1881168|FG000|Overall Study|Lost to Follow-up|12
905674|NCT00763269|1881169|FG001|Overall Study|Lost to Follow-up|13
905675|NCT00763282|1881177|FG000|Overall Study|Withdrawal by Subject|6
905676|NCT00763282|1881178|FG001|Overall Study|Withdrawal by Subject|5
905677|NCT00763282|1881177|FG000|Overall Study|Death|4
905678|NCT00763282|1881178|FG001|Overall Study|Death|3
905679|NCT00763282|1881177|FG000|Overall Study|Lost to Follow-up|22
905680|NCT00763282|1881178|FG001|Overall Study|Lost to Follow-up|26
905681|NCT00763321|1881189|FG000|Open-label Period|Adverse Event|24
905682|NCT00763321|1881190|FG001|Open-label Period|Adverse Event|0
905683|NCT00763321|1881191|FG002|Open-label Period|Adverse Event|0
905684|NCT00763321|1881189|FG000|Open-label Period|Lost to Follow-up|14
905685|NCT00763321|1881190|FG001|Open-label Period|Lost to Follow-up|0
905686|NCT00763321|1881191|FG002|Open-label Period|Lost to Follow-up|0
905687|NCT00763321|1881189|FG000|Open-label Period|Withdrawal by Subject|7
905688|NCT00763321|1881190|FG001|Open-label Period|Withdrawal by Subject|0
905689|NCT00763321|1881191|FG002|Open-label Period|Withdrawal by Subject|0
905690|NCT00763321|1881189|FG000|Open-label Period|Subject noncompliant|7
1035598|NCT01704287|2067352|FG004|Switch to Pembrolizumab Treatment Period|Death|37
1035599|NCT01704287|2067348|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1035600|NCT01704287|2067349|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1035601|NCT01704287|2067350|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1035602|NCT01704287|2067351|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
1035603|NCT01704287|2067352|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1035604|NCT01704456|2067394|FG000|Overall Study|Lost to Follow-up|8
1035605|NCT01704456|2067395|FG001|Overall Study|Lost to Follow-up|14
1035606|NCT01704495|2067405|FG000|Subjects Randomized|Other Reason|3
1035607|NCT01704495|2067406|FG001|Subjects Randomized|Other Reason|2
1035608|NCT01704495|2067407|FG002|Subjects Randomized|Other Reason|3
1035609|NCT01704495|2067408|FG003|Subjects Randomized|Other Reason|2
1035610|NCT01704495|2067405|FG000|Subjects Randomized|Discontinuation criteria met|4
1035611|NCT01704495|2067406|FG001|Subjects Randomized|Discontinuation criteria met|2
1035612|NCT01704495|2067407|FG002|Subjects Randomized|Discontinuation criteria met|2
1035613|NCT01704495|2067408|FG003|Subjects Randomized|Discontinuation criteria met|0
1035614|NCT01704495|2067405|FG000|Subjects Randomized|Adverse Event|8
1035615|NCT01704495|2067406|FG001|Subjects Randomized|Adverse Event|2
1035616|NCT01704495|2067407|FG002|Subjects Randomized|Adverse Event|0
1035617|NCT01704495|2067408|FG003|Subjects Randomized|Adverse Event|7
1035618|NCT01704495|2067405|FG000|Subjects Randomized|Withdrawal by Subject|5
1035619|NCT01704495|2067406|FG001|Subjects Randomized|Withdrawal by Subject|5
1035620|NCT01704495|2067407|FG002|Subjects Randomized|Withdrawal by Subject|5
1035621|NCT01704495|2067408|FG003|Subjects Randomized|Withdrawal by Subject|5
1035622|NCT01704495|2067405|FG000|Subjects Randomized|Protocol Violation|1
905691|NCT00763321|1881190|FG001|Open-label Period|Subject noncompliant|0
905692|NCT00763321|1881191|FG002|Open-label Period|Subject noncompliant|0
905693|NCT00763321|1881189|FG000|Open-label Period|Did not meet DB randomization criteria|5
905694|NCT00763321|1881190|FG001|Open-label Period|Did not meet DB randomization criteria|0
905695|NCT00763321|1881191|FG002|Open-label Period|Did not meet DB randomization criteria|0
905696|NCT00763321|1881189|FG000|Open-label Period|Lack of Efficacy|2
905697|NCT00763321|1881190|FG001|Open-label Period|Lack of Efficacy|0
905698|NCT00763321|1881191|FG002|Open-label Period|Lack of Efficacy|0
905699|NCT00763321|1881189|FG000|Open-label Period|Other|4
905700|NCT00763321|1881190|FG001|Open-label Period|Other|0
905701|NCT00763321|1881191|FG002|Open-label Period|Other|0
905702|NCT00763321|1881189|FG000|Double-blind Period|Lack of Efficacy|0
905703|NCT00763321|1881190|FG001|Double-blind Period|Lack of Efficacy|9
905704|NCT00763321|1881191|FG002|Double-blind Period|Lack of Efficacy|17
905705|NCT00763321|1881189|FG000|Double-blind Period|Adverse Event|0
905706|NCT00763321|1881190|FG001|Double-blind Period|Adverse Event|4
905707|NCT00763321|1881191|FG002|Double-blind Period|Adverse Event|4
905708|NCT00763321|1881189|FG000|Double-blind Period|Lost to Follow-up|0
905709|NCT00763321|1881190|FG001|Double-blind Period|Lost to Follow-up|4
905710|NCT00763321|1881191|FG002|Double-blind Period|Lost to Follow-up|2
905711|NCT00763321|1881189|FG000|Double-blind Period|Withdrawal by Subject|0
905712|NCT00763321|1881190|FG001|Double-blind Period|Withdrawal by Subject|2
905713|NCT00763321|1881191|FG002|Double-blind Period|Withdrawal by Subject|3
905714|NCT00763321|1881189|FG000|Double-blind Period|Other|0
905715|NCT00763321|1881190|FG001|Double-blind Period|Other|2
905716|NCT00763321|1881191|FG002|Double-blind Period|Other|3
905717|NCT00763386|1881213|FG000|Overall Study|Adverse Event|43
905718|NCT00763386|1881214|FG001|Overall Study|Adverse Event|33
905719|NCT00763386|1881213|FG000|Overall Study|Death|1
905720|NCT00763386|1881214|FG001|Overall Study|Death|2
905721|NCT00763386|1881213|FG000|Overall Study|Lost to Follow-up|3
905722|NCT00763386|1881214|FG001|Overall Study|Lost to Follow-up|3
905723|NCT00763386|1881213|FG000|Overall Study|Withdrawal by Subject|0
905724|NCT00763386|1881214|FG001|Overall Study|Withdrawal by Subject|1
905725|NCT00763386|1881213|FG000|Overall Study|CRF missing|0
905726|NCT00763386|1881214|FG001|Overall Study|CRF missing|1
905727|NCT00763386|1881213|FG000|Overall Study|Study Prosthesis Removed|1
905728|NCT00763386|1881214|FG001|Overall Study|Study Prosthesis Removed|0
905729|NCT00763451|1881233|FG000|Overall Study|Adverse Event|4
905730|NCT00763451|1881234|FG001|Overall Study|Adverse Event|6
905731|NCT00763451|1881235|FG002|Overall Study|Adverse Event|19
905732|NCT00763451|1881236|FG003|Overall Study|Adverse Event|14
905733|NCT00763451|1881233|FG000|Overall Study|Lack of Efficacy|1
905734|NCT00763451|1881234|FG001|Overall Study|Lack of Efficacy|4
905735|NCT00763451|1881235|FG002|Overall Study|Lack of Efficacy|3
905736|NCT00763451|1881236|FG003|Overall Study|Lack of Efficacy|2
905737|NCT00763451|1881233|FG000|Overall Study|Withdrawal by Subject|1
905738|NCT00763451|1881234|FG001|Overall Study|Withdrawal by Subject|6
905739|NCT00763451|1881235|FG002|Overall Study|Withdrawal by Subject|9
905740|NCT00763451|1881236|FG003|Overall Study|Withdrawal by Subject|7
905741|NCT00763451|1881233|FG000|Overall Study|Protocol Violation|0
905742|NCT00763451|1881234|FG001|Overall Study|Protocol Violation|0
905743|NCT00763451|1881235|FG002|Overall Study|Protocol Violation|1
905744|NCT00763451|1881236|FG003|Overall Study|Protocol Violation|0
905745|NCT00763451|1881233|FG000|Overall Study|Poor Compliance to Protocol|1
905746|NCT00763451|1881234|FG001|Overall Study|Poor Compliance to Protocol|1
905747|NCT00763451|1881235|FG002|Overall Study|Poor Compliance to Protocol|2
905748|NCT00763451|1881236|FG003|Overall Study|Poor Compliance to Protocol|2
1035623|NCT01704495|2067406|FG001|Subjects Randomized|Protocol Violation|1
1035624|NCT01704495|2067407|FG002|Subjects Randomized|Protocol Violation|2
1035625|NCT01704495|2067408|FG003|Subjects Randomized|Protocol Violation|0
1035626|NCT01704495|2067405|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1
1035627|NCT01704495|2067406|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3
1035628|NCT01704495|2067407|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4
1035629|NCT01704495|2067408|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3
1035630|NCT01704495|2067405|FG000|Optional Safety Extension|Adverse Event|0
1035631|NCT01704495|2067406|FG001|Optional Safety Extension|Adverse Event|4
1035632|NCT01704495|2067407|FG002|Optional Safety Extension|Adverse Event|0
1035633|NCT01704495|2067408|FG003|Optional Safety Extension|Adverse Event|1
1035634|NCT01704495|2067405|FG000|Optional Safety Extension|Other reason|27
1035635|NCT01704495|2067406|FG001|Optional Safety Extension|Other reason|29
1035636|NCT01704495|2067407|FG002|Optional Safety Extension|Other reason|30
1035637|NCT01704495|2067408|FG003|Optional Safety Extension|Other reason|28
1035638|NCT01704495|2067405|FG000|Optional Safety Extension|Withdrawal by Subject|2
1035639|NCT01704495|2067406|FG001|Optional Safety Extension|Withdrawal by Subject|0
1035640|NCT01704495|2067407|FG002|Optional Safety Extension|Withdrawal by Subject|1
1035641|NCT01704495|2067408|FG003|Optional Safety Extension|Withdrawal by Subject|2
1035642|NCT01704599|2067427|FG000|Overall Study|Adverse Event|1
1035643|NCT01704651|2067456|FG000|Overall Study|Pre-op withdrawal by subject|1
1035644|NCT01704651|2067457|FG001|Overall Study|Pre-op withdrawal by subject|1
1035645|NCT01704651|2067456|FG000|Overall Study|Pre-op change in treatment plan|1
1035646|NCT01704651|2067457|FG001|Overall Study|Pre-op change in treatment plan|4
1035647|NCT01704651|2067456|FG000|Overall Study|Nasogastric tube placement in surgery|1
1035648|NCT01704651|2067457|FG001|Overall Study|Nasogastric tube placement in surgery|1
1035649|NCT01704651|2067456|FG000|Overall Study|Post-op did not have laparotomy|2
905749|NCT00763451|1881233|FG000|Overall Study|Familial and Personal Reasons|5
905750|NCT00763451|1881234|FG001|Overall Study|Familial and Personal Reasons|3
905751|NCT00763451|1881235|FG002|Overall Study|Familial and Personal Reasons|5
905752|NCT00763451|1881236|FG003|Overall Study|Familial and Personal Reasons|4
905753|NCT00763451|1881233|FG000|Overall Study|Randomized but not Treated|1
905754|NCT00763451|1881234|FG001|Overall Study|Randomized but not Treated|1
905755|NCT00763451|1881235|FG002|Overall Study|Randomized but not Treated|0
905756|NCT00763451|1881236|FG003|Overall Study|Randomized but not Treated|0
905757|NCT00763451|1881233|FG000|Overall Study|Study Site Reason|0
905758|NCT00763451|1881234|FG001|Overall Study|Study Site Reason|1
905759|NCT00763451|1881235|FG002|Overall Study|Study Site Reason|1
905760|NCT00763451|1881236|FG003|Overall Study|Study Site Reason|1
905761|NCT00763698|1881251|FG000|Overall Study|Unsuccessful Implant|5
905762|NCT00763698|1881251|FG000|Overall Study|Death|4
905763|NCT00763698|1881251|FG000|Overall Study|Withdrawal by Subject|1
905764|NCT00763815|1881262|FG000|Overall Study|Adverse Event|14
905765|NCT00763815|1881263|FG001|Overall Study|Adverse Event|29
905766|NCT00763815|1881262|FG000|Overall Study|Lack of Efficacy|10
905767|NCT00763815|1881263|FG001|Overall Study|Lack of Efficacy|11
905768|NCT00763815|1881262|FG000|Overall Study|Poor Compliance to Protocol|6
905769|NCT00763815|1881263|FG001|Overall Study|Poor Compliance to Protocol|6
905770|NCT00763815|1881262|FG000|Overall Study|Lost to Follow-up|2
905771|NCT00763815|1881263|FG001|Overall Study|Lost to Follow-up|4
905772|NCT00763815|1881262|FG000|Overall Study|Early Termination|1
905773|NCT00763815|1881263|FG001|Overall Study|Early Termination|0
905774|NCT00763815|1881262|FG000|Overall Study|Familial and Personal Reasons|9
905775|NCT00763815|1881263|FG001|Overall Study|Familial and Personal Reasons|16
905776|NCT00763815|1881262|FG000|Overall Study|Physician Decision|1
905777|NCT00763815|1881263|FG001|Overall Study|Physician Decision|0
905778|NCT00763815|1881262|FG000|Overall Study|Withdrawal by Subject|7
905779|NCT00763815|1881263|FG001|Overall Study|Withdrawal by Subject|12
905780|NCT00763815|1881262|FG000|Overall Study|Protocol Violation|2
905781|NCT00763815|1881263|FG001|Overall Study|Protocol Violation|5
905782|NCT00763815|1881262|FG000|Overall Study|Sponsor's Decision|0
905783|NCT00763815|1881263|FG001|Overall Study|Sponsor's Decision|1
905784|NCT00763958|1881284|FG000|Overall Study|did not meet final criteria|4
905785|NCT00763958|1881285|FG001|Overall Study|did not meet final criteria|4
905786|NCT00763958|1881284|FG000|Overall Study|Lost to Follow-up|10
905787|NCT00763958|1881285|FG001|Overall Study|Lost to Follow-up|2
905788|NCT00763958|1881284|FG000|Overall Study|Believed they were receiving placebo|0
905789|NCT00763958|1881285|FG001|Overall Study|Believed they were receiving placebo|5
905790|NCT00763971|1881295|FG000|Overall Study|Adverse Event|5
905791|NCT00763971|1881296|FG001|Overall Study|Adverse Event|2
905792|NCT00763971|1881297|FG002|Overall Study|Adverse Event|4
905793|NCT00763971|1881295|FG000|Overall Study|Protocol Violation|3
905794|NCT00763971|1881296|FG001|Overall Study|Protocol Violation|3
905795|NCT00763971|1881297|FG002|Overall Study|Protocol Violation|2
905796|NCT00763971|1881295|FG000|Overall Study|Withdrawal by Subject|4
905797|NCT00763971|1881296|FG001|Overall Study|Withdrawal by Subject|5
905798|NCT00763971|1881297|FG002|Overall Study|Withdrawal by Subject|5
905799|NCT00763971|1881295|FG000|Overall Study|Lost to Follow-up|0
905800|NCT00763971|1881296|FG001|Overall Study|Lost to Follow-up|1
905801|NCT00763971|1881297|FG002|Overall Study|Lost to Follow-up|0
905802|NCT00763971|1881295|FG000|Overall Study|Lack of Efficacy|11
1035650|NCT01704651|2067457|FG001|Overall Study|Post-op did not have laparotomy|1
1035651|NCT01704755|2067465|FG000|Overall Study|Adverse Event|4
1035652|NCT01704755|2067466|FG001|Overall Study|Adverse Event|1
1035653|NCT01704755|2067465|FG000|Overall Study|Lost to Follow-up|3
1035654|NCT01704755|2067466|FG001|Overall Study|Lost to Follow-up|4
1035655|NCT01704755|2067465|FG000|Overall Study|Withdrew consent|1
1035656|NCT01704755|2067466|FG001|Overall Study|Withdrew consent|1
1035657|NCT01704755|2067465|FG000|Overall Study|Other (not specified)|3
1035658|NCT01704755|2067466|FG001|Overall Study|Other (not specified)|1
1035659|NCT01704755|2067465|FG000|Overall Study|Withdrew consent and personal issues|1
1035660|NCT01704755|2067466|FG001|Overall Study|Withdrew consent and personal issues|0
1035661|NCT01704846|2067497|FG000|Treatment Period 2|Withdrawal by Subject|0
1035662|NCT01704846|2067498|FG001|Treatment Period 2|Withdrawal by Subject|1
1035663|NCT01705080|2067516|FG000|Overall Study|Missed visit|10
1035664|NCT01705080|2067517|FG001|Overall Study|Missed visit|4
1035665|NCT01705080|2067518|FG002|Overall Study|Missed visit|1
1035666|NCT01705080|2067516|FG000|Overall Study|Death|4
1035667|NCT01705080|2067517|FG001|Overall Study|Death|4
1035668|NCT01705080|2067518|FG002|Overall Study|Death|6
1035669|NCT01705080|2067516|FG000|Overall Study|Withdrawal by Subject|61
1035670|NCT01705080|2067517|FG001|Overall Study|Withdrawal by Subject|44
1035671|NCT01705080|2067518|FG002|Overall Study|Withdrawal by Subject|9
1035672|NCT01705145|2067526|FG000|Part B|Adverse Event|1
1035673|NCT01705236|2067542|FG000|Overall Study|Lost to Follow-up|1
1035674|NCT01705236|2067542|FG000|Overall Study|Administrative problems|2
1035675|NCT01705236|2067542|FG000|Overall Study|Unsatisfactory therapeutic effect|3
1035676|NCT01705236|2067542|FG000|Overall Study|Protocol Violation|3
1035677|NCT01705236|2067542|FG000|Overall Study|Abnormal test procedure result(s)|4
1035678|NCT01705236|2067542|FG000|Overall Study|Abnormal laboratory value(s)|4
1035679|NCT01705236|2067542|FG000|Overall Study|Withdrawal by Subject|5
1035680|NCT01705236|2067542|FG000|Overall Study|Adverse Event|5
1035681|NCT01705509|2067559|FG000|Inclusion CPET|Screen Failure|5
1035682|NCT01705509|2067559|FG000|Inclusion CPET|Withdrawal by Subject|2
1035683|NCT01705509|2067559|FG000|CPET w/ Ranexa|Screen Failure|2
1035684|NCT01705574|2067565|FG000|Double-Blind Phase|Lost to Follow-up|12
1035685|NCT01705574|2067566|FG001|Double-Blind Phase|Lost to Follow-up|16
1035686|NCT01705574|2067567|FG002|Double-Blind Phase|Lost to Follow-up|0
1035687|NCT01705574|2067568|FG003|Double-Blind Phase|Lost to Follow-up|0
1035688|NCT01705574|2067565|FG000|Double-Blind Phase|Adverse Event|3
1035689|NCT01705574|2067566|FG001|Double-Blind Phase|Adverse Event|10
1035690|NCT01705574|2067567|FG002|Double-Blind Phase|Adverse Event|0
1035691|NCT01705574|2067568|FG003|Double-Blind Phase|Adverse Event|0
1035692|NCT01705574|2067565|FG000|Double-Blind Phase|Withdrew Consent|8
1035693|NCT01705574|2067566|FG001|Double-Blind Phase|Withdrew Consent|5
1035694|NCT01705574|2067567|FG002|Double-Blind Phase|Withdrew Consent|0
1035695|NCT01705574|2067568|FG003|Double-Blind Phase|Withdrew Consent|0
1035696|NCT01705574|2067565|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
1035697|NCT01705574|2067566|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5
1035698|NCT01705574|2067567|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0
1035699|NCT01705574|2067568|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0
1035700|NCT01705574|2067565|FG000|Double-Blind Phase|Pregnancy|1
1035701|NCT01705574|2067566|FG001|Double-Blind Phase|Pregnancy|1
1035702|NCT01705574|2067567|FG002|Double-Blind Phase|Pregnancy|0
1035703|NCT01705574|2067568|FG003|Double-Blind Phase|Pregnancy|0
1035704|NCT01705574|2067565|FG000|Double-Blind Phase|Protocol Violation|1
1035705|NCT01705574|2067566|FG001|Double-Blind Phase|Protocol Violation|0
1035706|NCT01705574|2067567|FG002|Double-Blind Phase|Protocol Violation|0
1035707|NCT01705574|2067568|FG003|Double-Blind Phase|Protocol Violation|0
1035708|NCT01705574|2067565|FG000|Double-Blind Phase|Randomized but Not Treated|4
1035709|NCT01705574|2067566|FG001|Double-Blind Phase|Randomized but Not Treated|4
1035710|NCT01705574|2067567|FG002|Double-Blind Phase|Randomized but Not Treated|0
1035711|NCT01705574|2067568|FG003|Double-Blind Phase|Randomized but Not Treated|0
1035712|NCT01705574|2067565|FG000|Open-Label Extension Phase|Lost to Follow-up|6
1035713|NCT01705574|2067566|FG001|Open-Label Extension Phase|Lost to Follow-up|0
1035714|NCT01705574|2067567|FG002|Open-Label Extension Phase|Lost to Follow-up|2
1035715|NCT01705574|2067568|FG003|Open-Label Extension Phase|Lost to Follow-up|2
1035716|NCT01705574|2067565|FG000|Open-Label Extension Phase|Withdrew Consent|4
1035717|NCT01705574|2067566|FG001|Open-Label Extension Phase|Withdrew Consent|0
1035718|NCT01705574|2067567|FG002|Open-Label Extension Phase|Withdrew Consent|4
1035719|NCT01705574|2067568|FG003|Open-Label Extension Phase|Withdrew Consent|1
1035720|NCT01705574|2067565|FG000|Open-Label Extension Phase|Adverse Event|3
1035721|NCT01705574|2067566|FG001|Open-Label Extension Phase|Adverse Event|0
1035722|NCT01705574|2067567|FG002|Open-Label Extension Phase|Adverse Event|0
1035723|NCT01705574|2067568|FG003|Open-Label Extension Phase|Adverse Event|1
1035724|NCT01705574|2067565|FG000|Open-Label Extension Phase|Death|2
1035725|NCT01705574|2067566|FG001|Open-Label Extension Phase|Death|0
1035726|NCT01705574|2067567|FG002|Open-Label Extension Phase|Death|1
1035727|NCT01705574|2067568|FG003|Open-Label Extension Phase|Death|0
1035728|NCT01705574|2067565|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0
1035729|NCT01705574|2067566|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0
1035730|NCT01705574|2067567|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1
1035731|NCT01705574|2067568|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0
1035732|NCT01705574|2067565|FG000|Open-Label Extension Phase|Physician Decision|0
1035733|NCT01705574|2067566|FG001|Open-Label Extension Phase|Physician Decision|0
1035734|NCT01705574|2067567|FG002|Open-Label Extension Phase|Physician Decision|2
1035735|NCT01705574|2067568|FG003|Open-Label Extension Phase|Physician Decision|0
1035736|NCT01705574|2067565|FG000|Open-Label Extension Phase|Pregnancy|0
1035737|NCT01705574|2067566|FG001|Open-Label Extension Phase|Pregnancy|0
1035738|NCT01705574|2067567|FG002|Open-Label Extension Phase|Pregnancy|1
1035739|NCT01705574|2067568|FG003|Open-Label Extension Phase|Pregnancy|1
1035740|NCT01705587|2067586|FG000|Overall Study|Withdrawal by Subject|0
1035741|NCT01705587|2067587|FG001|Overall Study|Withdrawal by Subject|1
1035742|NCT01705652|2067595|FG000|Overall Study|Adverse Event|1
1035743|NCT01705652|2067596|FG001|Overall Study|Adverse Event|0
1035744|NCT01705652|2067595|FG000|Overall Study|Withdrawal by Subject|1
1035745|NCT01705652|2067596|FG001|Overall Study|Withdrawal by Subject|2
1035746|NCT01705652|2067595|FG000|Overall Study|non-compliance|1
1035747|NCT01705652|2067596|FG001|Overall Study|non-compliance|1
1035748|NCT01705691|2067604|FG000|Overall Study|Death|1
1035749|NCT01705691|2067605|FG001|Overall Study|Death|2
1035750|NCT01705691|2067604|FG000|Overall Study|Withdrawal by Subject|1
1035751|NCT01705691|2067605|FG001|Overall Study|Withdrawal by Subject|2
1035752|NCT01705691|2067604|FG000|Overall Study|Lost to Follow-up|1
1035753|NCT01705691|2067605|FG001|Overall Study|Lost to Follow-up|1
1035754|NCT01705691|2067604|FG000|Overall Study|Other|0
1035755|NCT01705691|2067605|FG001|Overall Study|Other|1
1035756|NCT01705717|2067613|FG000|Overall Study|Adverse Event|2
1035757|NCT01705717|2067614|FG001|Overall Study|Adverse Event|2
1035758|NCT01705717|2067613|FG000|Overall Study|Lack of Efficacy|0
1035759|NCT01705717|2067614|FG001|Overall Study|Lack of Efficacy|1
1035760|NCT01705717|2067613|FG000|Overall Study|Other|0
1035761|NCT01705717|2067614|FG001|Overall Study|Other|2
1035762|NCT01705730|2067619|FG000|Overall Study|Lack of Efficacy|1
1035763|NCT01705730|2067619|FG000|Overall Study|Adverse Event|3
1035764|NCT01705730|2067619|FG000|Overall Study|Lost to Follow-up|1
1035765|NCT01705730|2067619|FG000|Overall Study|Reason not Specified|4
1035766|NCT01705977|2067634|FG000|Overall Study|Withdrawal by Subject|128
1035767|NCT01705977|2067635|FG001|Overall Study|Withdrawal by Subject|128
1035768|NCT01705977|2067634|FG000|Overall Study|Adverse Event|57
1035769|NCT01705977|2067635|FG001|Overall Study|Adverse Event|49
1035770|NCT01705977|2067634|FG000|Overall Study|Protocol Violation|2
1035771|NCT01705977|2067635|FG001|Overall Study|Protocol Violation|4
1035772|NCT01705977|2067634|FG000|Overall Study|Site closure|3
1035773|NCT01705977|2067635|FG001|Overall Study|Site closure|2
1035774|NCT01705977|2067634|FG000|Overall Study|Lost to Follow-up|33
1035775|NCT01705977|2067635|FG001|Overall Study|Lost to Follow-up|37
1035776|NCT01705977|2067634|FG000|Overall Study|Physician Decision|48
1035777|NCT01705977|2067635|FG001|Overall Study|Physician Decision|38
1035778|NCT01705977|2067634|FG000|Overall Study|Missing study conclusion form|2
1035779|NCT01705977|2067635|FG001|Overall Study|Missing study conclusion form|2
1035780|NCT01706003|2067643|FG000|Overall Study|Withdrawal by Subject|2
1035781|NCT01706003|2067644|FG001|Overall Study|Withdrawal by Subject|0
1035782|NCT01706003|2067643|FG000|Overall Study|Not scheduled|3
1035783|NCT01706003|2067644|FG001|Overall Study|Not scheduled|0
1035784|NCT01706003|2067643|FG000|Overall Study|Lost to Follow-up|6
1035785|NCT01706003|2067644|FG001|Overall Study|Lost to Follow-up|4
1035786|NCT01706146|2067659|FG000|Overall Study|Withdrawal by Subject|1
1035787|NCT01706146|2067659|FG000|Overall Study|Adverse Event|3
1035788|NCT01706146|2067659|FG000|Overall Study|Developed AF and need for antiplatelets|2
1035789|NCT01706159|2067665|FG000|Overall Study|Withdrawal Criteria|2
1035790|NCT01706159|2067666|FG001|Overall Study|Withdrawal Criteria|1
1035791|NCT01706159|2067665|FG000|Overall Study|Unclassified|6
1035792|NCT01706159|2067666|FG001|Overall Study|Unclassified|1
1035793|NCT01706198|2067674|FG000|Overall Study|Adverse Event|12
1035794|NCT01706198|2067675|FG001|Overall Study|Adverse Event|15
1035795|NCT01706198|2067674|FG000|Overall Study|Protocol Violation|7
1035796|NCT01706198|2067675|FG001|Overall Study|Protocol Violation|5
1035797|NCT01706198|2067674|FG000|Overall Study|Other: Subject reached stopping criteria|11
1035798|NCT01706198|2067675|FG001|Overall Study|Other: Subject reached stopping criteria|13
1035799|NCT01706198|2067674|FG000|Overall Study|Lost to Follow-up|97
1035800|NCT01706198|2067675|FG001|Overall Study|Lost to Follow-up|93
1035801|NCT01706198|2067674|FG000|Overall Study|Physician Decision|23
1035802|NCT01706198|2067675|FG001|Overall Study|Physician Decision|37
1035803|NCT01706198|2067674|FG000|Overall Study|Withdrawal by Subject|23
1035804|NCT01706198|2067675|FG001|Overall Study|Withdrawal by Subject|31
1035805|NCT01706250|2067681|FG000|Overall Study|Lost to Follow-up|2
1035806|NCT01706328|2067697|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
1035807|NCT01706328|2067698|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1035808|NCT01706328|2067699|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1035809|NCT01706328|2067697|FG000|2-week Run-in Period|Withdrawal by Subject|15
1035810|NCT01706328|2067698|FG001|2-week Run-in Period|Withdrawal by Subject|0
1035811|NCT01706328|2067699|FG002|2-week Run-in Period|Withdrawal by Subject|0
1035812|NCT01706328|2067697|FG000|2-week Run-in Period|Physician Decision|4
1035813|NCT01706328|2067698|FG001|2-week Run-in Period|Physician Decision|0
1035814|NCT01706328|2067699|FG002|2-week Run-in Period|Physician Decision|0
1035815|NCT01706328|2067697|FG000|2-week Run-in Period|Adverse Event|4
1035816|NCT01706328|2067698|FG001|2-week Run-in Period|Adverse Event|0
1035817|NCT01706328|2067699|FG002|2-week Run-in Period|Adverse Event|0
1035818|NCT01706328|2067697|FG000|2-week Run-in Period|Lost to Follow-up|2
1035819|NCT01706328|2067698|FG001|2-week Run-in Period|Lost to Follow-up|0
1035820|NCT01706328|2067699|FG002|2-week Run-in Period|Lost to Follow-up|0
1035821|NCT01706328|2067697|FG000|12-week Double-blind Treatment Period|Adverse Event|0
1035822|NCT01706328|2067698|FG001|12-week Double-blind Treatment Period|Adverse Event|14
1035823|NCT01706328|2067699|FG002|12-week Double-blind Treatment Period|Adverse Event|16
1035824|NCT01706328|2067697|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0
1035825|NCT01706328|2067698|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4
1035826|NCT01706328|2067699|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4
1035827|NCT01706328|2067697|FG000|12-week Double-blind Treatment Period|Protocol Violation|0
1035828|NCT01706328|2067698|FG001|12-week Double-blind Treatment Period|Protocol Violation|4
1035829|NCT01706328|2067699|FG002|12-week Double-blind Treatment Period|Protocol Violation|2
1035830|NCT01706328|2067697|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
1035831|NCT01706328|2067698|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
1035832|NCT01706328|2067699|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
1035833|NCT01706328|2067697|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0
1035834|NCT01706328|2067698|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3
1035835|NCT01706328|2067699|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1
1035836|NCT01706328|2067697|FG000|12-week Double-blind Treatment Period|Physician Decision|0
1035837|NCT01706328|2067698|FG001|12-week Double-blind Treatment Period|Physician Decision|2
1035838|NCT01706328|2067699|FG002|12-week Double-blind Treatment Period|Physician Decision|2
1035839|NCT01706328|2067697|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0
1035840|NCT01706328|2067698|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8
1035841|NCT01706328|2067699|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11
1035842|NCT01706458|2067707|FG000|Overall Study|Physician Decision|3
1035843|NCT01706458|2067708|FG001|Overall Study|Physician Decision|4
1035844|NCT01706536|2067723|FG000|Overall Study|Withdrawal by Subject|1
1035845|NCT01706536|2067724|FG001|Overall Study|Withdrawal by Subject|0
1035846|NCT01706536|2067725|FG002|Overall Study|Withdrawal by Subject|1
1035847|NCT01706536|2067726|FG003|Overall Study|Withdrawal by Subject|0
1035848|NCT01706536|2067727|FG004|Overall Study|Withdrawal by Subject|0
1035849|NCT01706536|2067723|FG000|Overall Study|Adverse Event|2
1035850|NCT01706536|2067724|FG001|Overall Study|Adverse Event|3
1035851|NCT01706536|2067725|FG002|Overall Study|Adverse Event|4
1035852|NCT01706536|2067726|FG003|Overall Study|Adverse Event|3
1035853|NCT01706536|2067727|FG004|Overall Study|Adverse Event|2
1035854|NCT01706536|2067723|FG000|Overall Study|Lack of Efficacy|1
1035855|NCT01706536|2067724|FG001|Overall Study|Lack of Efficacy|0
1035856|NCT01706536|2067725|FG002|Overall Study|Lack of Efficacy|0
1035857|NCT01706536|2067726|FG003|Overall Study|Lack of Efficacy|1
1035858|NCT01706536|2067727|FG004|Overall Study|Lack of Efficacy|0
1035859|NCT01706536|2067723|FG000|Overall Study|non compliance|0
1035860|NCT01706536|2067724|FG001|Overall Study|non compliance|1
1035861|NCT01706536|2067725|FG002|Overall Study|non compliance|0
1035862|NCT01706536|2067726|FG003|Overall Study|non compliance|0
1035863|NCT01706536|2067727|FG004|Overall Study|non compliance|0
1035864|NCT01706575|2067744|FG000|Overall Study|Participant Withdrew Consent|4
1035865|NCT01706575|2067744|FG000|Overall Study|Lost to Follow-up|2
1035866|NCT01706575|2067744|FG000|Overall Study|Started but not Treated|6
1035867|NCT01706770|2067784|FG000|Overall Study|Lost to Follow-up|1
1035868|NCT01706770|2067785|FG001|Overall Study|Lost to Follow-up|0
1035869|NCT01706770|2067784|FG000|Overall Study|Physician Decision|1
1035870|NCT01706770|2067785|FG001|Overall Study|Physician Decision|0
1035871|NCT01706926|2067799|FG000|Overall Study|Lost to Follow-up|0
1035872|NCT01706926|2067800|FG001|Overall Study|Lost to Follow-up|0
1035873|NCT01706926|2067801|FG002|Overall Study|Lost to Follow-up|1
1035874|NCT01706926|2067802|FG003|Overall Study|Lost to Follow-up|0
1035875|NCT01706926|2067799|FG000|Overall Study|Withdrawal by Subject|2
1035876|NCT01706926|2067800|FG001|Overall Study|Withdrawal by Subject|0
1035877|NCT01706926|2067801|FG002|Overall Study|Withdrawal by Subject|1
1035878|NCT01706926|2067802|FG003|Overall Study|Withdrawal by Subject|2
1035879|NCT01706926|2067799|FG000|Overall Study|Other|4
1035880|NCT01706926|2067800|FG001|Overall Study|Other|4
1035881|NCT01706926|2067801|FG002|Overall Study|Other|4
1035882|NCT01706926|2067802|FG003|Overall Study|Other|3
1035883|NCT01707004|2067839|FG000|Overall Study|Physician Decision|3
1035884|NCT01707030|2067846|FG000|Overall Study|Death|1
1035885|NCT01707030|2067847|FG001|Overall Study|Death|1
1035886|NCT01707030|2067846|FG000|Overall Study|Withdrawal by Subject|2
1035887|NCT01707030|2067847|FG001|Overall Study|Withdrawal by Subject|3
1035888|NCT01707030|2067846|FG000|Overall Study|Lost to Follow-up|8
905803|NCT00763971|1881296|FG001|Overall Study|Lack of Efficacy|22
1035889|NCT01707030|2067847|FG001|Overall Study|Lost to Follow-up|13
1035890|NCT01707147|2067880|FG000|Overall Study|Administered Trajenta prior to contract|5
1035891|NCT01707147|2067880|FG000|Overall Study|Patients who have not taken Trajenta|1
1035892|NCT01707147|2067880|FG000|Overall Study|Follow-up failure|17
1035893|NCT01707147|2067880|FG000|Overall Study|Violated inclusion/exclusion criteria|77
1035894|NCT01707290|2067900|FG000|Overall Study|Adverse event (AE)|1
1035895|NCT01707290|2067901|FG001|Overall Study|Adverse event (AE)|0
1035896|NCT01707290|2067900|FG000|Overall Study|Physician Decision|1
1035897|NCT01707290|2067901|FG001|Overall Study|Physician Decision|0
1035898|NCT01707290|2067900|FG000|Overall Study|Lost to Follow-up|3
1035899|NCT01707290|2067901|FG001|Overall Study|Lost to Follow-up|0
1035900|NCT01707290|2067900|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4
1035901|NCT01707290|2067901|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0
1035902|NCT01707290|2067900|FG000|Overall Study|Commercial drug available|60
1035903|NCT01707290|2067901|FG001|Overall Study|Commercial drug available|1
1035904|NCT01707290|2067900|FG000|Overall Study|Other unspecified|17
1035905|NCT01707290|2067901|FG001|Overall Study|Other unspecified|0
1035906|NCT01707667|2067951|FG000|Period 1|expulsion of colonic sensor catheter|1
1035907|NCT01707667|2067952|FG001|Period 1|expulsion of colonic sensor catheter|0
1035908|NCT01707693|2067960|FG000|Overall Study Allocation|Withdrawal by Subject|9
1035909|NCT01707693|2067961|FG001|Overall Study Allocation|Withdrawal by Subject|5
1035910|NCT01707693|2067960|FG000|Overall Study Allocation|Protocol Violation|4
1035911|NCT01707693|2067961|FG001|Overall Study Allocation|Protocol Violation|3
1035912|NCT01707693|2067960|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
1035913|NCT01707693|2067961|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
1035914|NCT01707693|2067960|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
1035915|NCT01707693|2067961|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
1035916|NCT01707992|2067971|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8
1035917|NCT01707992|2067972|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13
1035918|NCT01707992|2067973|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9
1035919|NCT01707992|2067974|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0
1035920|NCT01707992|2067975|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0
1035921|NCT01707992|2067976|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0
1035922|NCT01707992|2067971|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
1035923|NCT01707992|2067972|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
1035924|NCT01707992|2067973|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
1035925|NCT01707992|2067974|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
1035926|NCT01707992|2067975|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
1035927|NCT01707992|2067976|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
1035928|NCT01707992|2067971|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
1035929|NCT01707992|2067972|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
1035930|NCT01707992|2067973|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
1035931|NCT01707992|2067974|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
1035932|NCT01707992|2067975|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
1035933|NCT01707992|2067976|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
1035934|NCT01707992|2067971|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
1035935|NCT01707992|2067972|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
1035936|NCT01707992|2067973|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
1035937|NCT01707992|2067974|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
905804|NCT00763971|1881297|FG002|Overall Study|Lack of Efficacy|54
905805|NCT00763971|1881295|FG000|Overall Study|Unable to swallow capsule|2
905806|NCT00763971|1881296|FG001|Overall Study|Unable to swallow capsule|1
905807|NCT00763971|1881297|FG002|Overall Study|Unable to swallow capsule|1
905808|NCT00763971|1881295|FG000|Overall Study|Personal reason|3
905809|NCT00763971|1881296|FG001|Overall Study|Personal reason|0
905810|NCT00763971|1881297|FG002|Overall Study|Personal reason|0
905811|NCT00763971|1881295|FG000|Overall Study|Exclusion criteria met|1
905812|NCT00763971|1881296|FG001|Overall Study|Exclusion criteria met|0
905813|NCT00763971|1881297|FG002|Overall Study|Exclusion criteria met|0
905814|NCT00763971|1881295|FG000|Overall Study|Sponsor decision|1
905815|NCT00763971|1881296|FG001|Overall Study|Sponsor decision|0
905816|NCT00763971|1881297|FG002|Overall Study|Sponsor decision|0
905817|NCT00763971|1881295|FG000|Overall Study|Due to holiday season|2
905818|NCT00763971|1881296|FG001|Overall Study|Due to holiday season|0
905819|NCT00763971|1881297|FG002|Overall Study|Due to holiday season|1
905820|NCT00763971|1881295|FG000|Overall Study|Randomization error|0
905821|NCT00763971|1881296|FG001|Overall Study|Randomization error|0
905822|NCT00763971|1881297|FG002|Overall Study|Randomization error|1
905823|NCT00763971|1881295|FG000|Overall Study|Medical monitor decision|0
905824|NCT00763971|1881296|FG001|Overall Study|Medical monitor decision|0
905825|NCT00763971|1881297|FG002|Overall Study|Medical monitor decision|1
905826|NCT00763971|1881295|FG000|Overall Study|Moved to another country|0
905827|NCT00763971|1881296|FG001|Overall Study|Moved to another country|1
905828|NCT00763971|1881297|FG002|Overall Study|Moved to another country|0
905829|NCT00763971|1881295|FG000|Overall Study|Subject wanted dose reduction|0
905830|NCT00763971|1881296|FG001|Overall Study|Subject wanted dose reduction|1
905831|NCT00763971|1881297|FG002|Overall Study|Subject wanted dose reduction|0
905832|NCT00763971|1881295|FG000|Overall Study|Lack of availability|0
905833|NCT00763971|1881296|FG001|Overall Study|Lack of availability|1
905834|NCT00763971|1881297|FG002|Overall Study|Lack of availability|0
905835|NCT00763971|1881295|FG000|Overall Study|Performed final visit on phone|0
905836|NCT00763971|1881296|FG001|Overall Study|Performed final visit on phone|1
1035938|NCT01707992|2067975|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
1035939|NCT01707992|2067976|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
1035940|NCT01707992|2067971|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12
1035941|NCT01707992|2067972|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5
1035942|NCT01707992|2067973|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9
1035943|NCT01707992|2067974|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0
1035944|NCT01707992|2067975|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0
1035945|NCT01707992|2067976|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0
1035946|NCT01707992|2067971|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
1035947|NCT01707992|2067972|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
1035948|NCT01707992|2067973|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
1035949|NCT01707992|2067974|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
1035950|NCT01707992|2067975|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
1035951|NCT01707992|2067976|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
1035952|NCT01707992|2067971|FG000|Placebo-Controlled Phase (24 Months)|Death|2
1035953|NCT01707992|2067972|FG001|Placebo-Controlled Phase (24 Months)|Death|1
1035954|NCT01707992|2067973|FG002|Placebo-Controlled Phase (24 Months)|Death|1
1035955|NCT01707992|2067974|FG003|Placebo-Controlled Phase (24 Months)|Death|0
1035956|NCT01707992|2067975|FG004|Placebo-Controlled Phase (24 Months)|Death|0
1035957|NCT01707992|2067976|FG005|Placebo-Controlled Phase (24 Months)|Death|0
1035958|NCT01707992|2067971|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
1035959|NCT01707992|2067972|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
1035960|NCT01707992|2067973|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
1035961|NCT01707992|2067974|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
1035962|NCT01707992|2067975|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
1035963|NCT01707992|2067976|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
1035964|NCT01707992|2067971|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11
1035965|NCT01707992|2067972|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9
1035966|NCT01707992|2067973|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10
1035967|NCT01707992|2067974|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0
1035968|NCT01707992|2067975|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0
1035969|NCT01707992|2067976|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0
1035970|NCT01707992|2067971|FG000|Active Treatment Phase (24 Months)|Adverse Event|0
1035971|NCT01707992|2067972|FG001|Active Treatment Phase (24 Months)|Adverse Event|0
1035972|NCT01707992|2067973|FG002|Active Treatment Phase (24 Months)|Adverse Event|0
905837|NCT00763971|1881297|FG002|Overall Study|Performed final visit on phone|0
905838|NCT00763971|1881295|FG000|Overall Study|Participation in 489-326 required|1
905839|NCT00763971|1881296|FG001|Overall Study|Participation in 489-326 required|0
905840|NCT00763971|1881297|FG002|Overall Study|Participation in 489-326 required|0
905841|NCT00764322|1881311|FG000|Overall Study|Withdrawal by Subject|11
905842|NCT00764322|1881311|FG000|Overall Study|No CYP2D6 genotyping|9
905843|NCT00764361|1881330|FG000|Overall Study|Withdrawal by Subject|2
905844|NCT00764361|1881331|FG001|Overall Study|Withdrawal by Subject|3
905845|NCT00764361|1881330|FG000|Overall Study|Adverse Event|0
905846|NCT00764361|1881331|FG001|Overall Study|Adverse Event|1
905847|NCT00764465|1881343|FG000|Overall Study|Adverse Event|2
905848|NCT00764465|1881344|FG001|Overall Study|Adverse Event|0
905849|NCT00764465|1881345|FG002|Overall Study|Adverse Event|0
905850|NCT00764465|1881346|FG003|Overall Study|Adverse Event|1
905851|NCT00764465|1881347|FG004|Overall Study|Adverse Event|1
905852|NCT00764465|1881348|FG005|Overall Study|Adverse Event|1
905853|NCT00764465|1881343|FG000|Overall Study|Withdrawal by Subject|0
905854|NCT00764465|1881344|FG001|Overall Study|Withdrawal by Subject|1
905855|NCT00764465|1881345|FG002|Overall Study|Withdrawal by Subject|1
905856|NCT00764465|1881346|FG003|Overall Study|Withdrawal by Subject|0
905857|NCT00764465|1881347|FG004|Overall Study|Withdrawal by Subject|0
905858|NCT00764465|1881348|FG005|Overall Study|Withdrawal by Subject|0
905859|NCT00764478|1881368|FG000|Overall Study|Adverse Event|1
905860|NCT00764478|1881369|FG001|Overall Study|Adverse Event|1
905861|NCT00764478|1881370|FG002|Overall Study|Adverse Event|1
905862|NCT00764478|1881368|FG000|Overall Study|Withdrawal by Subject|7
905863|NCT00764478|1881369|FG001|Overall Study|Withdrawal by Subject|12
905864|NCT00764478|1881370|FG002|Overall Study|Withdrawal by Subject|1
905865|NCT00764478|1881368|FG000|Overall Study|Lost to Follow-up|7
905866|NCT00764478|1881369|FG001|Overall Study|Lost to Follow-up|8
905867|NCT00764478|1881370|FG002|Overall Study|Lost to Follow-up|5
905868|NCT00764478|1881368|FG000|Overall Study|Protocol Violation|0
905869|NCT00764478|1881369|FG001|Overall Study|Protocol Violation|1
905870|NCT00764478|1881370|FG002|Overall Study|Protocol Violation|1
905871|NCT00764491|1881380|FG000|Overall Study|Lost to Follow-up|35
905872|NCT00764491|1881381|FG001|Overall Study|Lost to Follow-up|17
905873|NCT00764504|1881390|FG000|Overall Study|Death|12
905874|NCT00764504|1881391|FG001|Overall Study|Death|6
905875|NCT00764504|1881392|FG002|Overall Study|Death|13
905876|NCT00764504|1881390|FG000|Overall Study|Revision of Device|12
905877|NCT00764504|1881391|FG001|Overall Study|Revision of Device|23
905878|NCT00764504|1881392|FG002|Overall Study|Revision of Device|14
905879|NCT00764504|1881390|FG000|Overall Study|Physician Decision|1
1035973|NCT01707992|2067974|FG003|Active Treatment Phase (24 Months)|Adverse Event|4
1035974|NCT01707992|2067975|FG004|Active Treatment Phase (24 Months)|Adverse Event|1
1035975|NCT01707992|2067976|FG005|Active Treatment Phase (24 Months)|Adverse Event|0
1035976|NCT01707992|2067971|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0
1035977|NCT01707992|2067972|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0
1035978|NCT01707992|2067973|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0
1035979|NCT01707992|2067974|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3
1035980|NCT01707992|2067975|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1
1035981|NCT01707992|2067976|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2
1035982|NCT01707992|2067971|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
1035983|NCT01707992|2067972|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
1035984|NCT01707992|2067973|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
1035985|NCT01707992|2067974|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
1035986|NCT01707992|2067975|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
1035987|NCT01707992|2067976|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
1035988|NCT01707992|2067971|FG000|Active Treatment Phase (24 Months)|Pregnancy|0
1035989|NCT01707992|2067972|FG001|Active Treatment Phase (24 Months)|Pregnancy|0
1035990|NCT01707992|2067973|FG002|Active Treatment Phase (24 Months)|Pregnancy|0
1035991|NCT01707992|2067974|FG003|Active Treatment Phase (24 Months)|Pregnancy|2
1035992|NCT01707992|2067975|FG004|Active Treatment Phase (24 Months)|Pregnancy|5
1035993|NCT01707992|2067976|FG005|Active Treatment Phase (24 Months)|Pregnancy|2
905880|NCT00764504|1881391|FG001|Overall Study|Physician Decision|0
905881|NCT00764504|1881392|FG002|Overall Study|Physician Decision|0
905882|NCT00764504|1881390|FG000|Overall Study|Withdrawal by Subject|1
905883|NCT00764504|1881391|FG001|Overall Study|Withdrawal by Subject|7
905884|NCT00764504|1881392|FG002|Overall Study|Withdrawal by Subject|4
905885|NCT00764504|1881390|FG000|Overall Study|Lost to Follow-up|40
905886|NCT00764504|1881391|FG001|Overall Study|Lost to Follow-up|34
905887|NCT00764504|1881392|FG002|Overall Study|Lost to Follow-up|72
905888|NCT00764517|1881402|FG000|Overall Study|Adverse Event|9
905889|NCT00764517|1881403|FG001|Overall Study|Adverse Event|3
905890|NCT00764517|1881402|FG000|Overall Study|Death|3
905891|NCT00764517|1881403|FG001|Overall Study|Death|11
905892|NCT00764517|1881402|FG000|Overall Study|Physician Decision|3
905893|NCT00764517|1881403|FG001|Overall Study|Physician Decision|0
905894|NCT00764660|1881411|FG000|Overall Study|Adverse Event|6
905895|NCT00764660|1881412|FG001|Overall Study|Adverse Event|3
905896|NCT00764660|1881411|FG000|Overall Study|Lost to Follow-up|3
905897|NCT00764660|1881412|FG001|Overall Study|Lost to Follow-up|4
905898|NCT00764660|1881411|FG000|Overall Study|Withdrawal by Subject|7
905899|NCT00764660|1881412|FG001|Overall Study|Withdrawal by Subject|3
905900|NCT00764660|1881411|FG000|Overall Study|Noncompliance With Protocol|5
905901|NCT00764660|1881412|FG001|Overall Study|Noncompliance With Protocol|1
905902|NCT00764660|1881411|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
905903|NCT00764660|1881412|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
905904|NCT00764673|1881418|FG000|Overall Study|Death|1
905905|NCT00764673|1881418|FG000|Overall Study|Lost to Follow-up|3
905906|NCT00764673|1881418|FG000|Overall Study|Withdrawal by Subject|6
905907|NCT00764673|1881418|FG000|Overall Study|Revision of Device|2
905908|NCT00764751|1881441|FG000|Overall Study|Adverse Event|1
905909|NCT00764751|1881442|FG001|Overall Study|Adverse Event|1
905910|NCT00764751|1881441|FG000|Overall Study|Psoriasis flare up on the scalp|1
905911|NCT00764751|1881442|FG001|Overall Study|Psoriasis flare up on the scalp|0
905912|NCT00764790|1881456|FG000|Overall Study|Protocol Violation|0
905913|NCT00764790|1881457|FG001|Overall Study|Protocol Violation|0
905914|NCT00764790|1881458|FG002|Overall Study|Protocol Violation|1
905915|NCT00764790|1881456|FG000|Overall Study|Withdrawal by Subject|10
905916|NCT00764790|1881457|FG001|Overall Study|Withdrawal by Subject|12
905917|NCT00764790|1881458|FG002|Overall Study|Withdrawal by Subject|6
905918|NCT00764790|1881456|FG000|Overall Study|Lost to Follow-up|28
905919|NCT00764790|1881457|FG001|Overall Study|Lost to Follow-up|29
905920|NCT00764790|1881458|FG002|Overall Study|Lost to Follow-up|23
905921|NCT00764868|1881466|FG000|Overall Study|Adverse Event|18
905922|NCT00764868|1881466|FG000|Overall Study|Withdrawal by Subject|31
905923|NCT00764868|1881466|FG000|Overall Study|Non-compliance|16
905924|NCT00764868|1881466|FG000|Overall Study|Lost to Follow-up|25
905925|NCT00764868|1881466|FG000|Overall Study|Lack of Efficacy|5
905926|NCT00764868|1881466|FG000|Overall Study|Subject moved|7
905927|NCT00764868|1881466|FG000|Overall Study|Pregnancy|3
905928|NCT00764868|1881466|FG000|Overall Study|Prohibited medication|1
905929|NCT00764868|1881466|FG000|Overall Study|Out of town|1
905930|NCT00764868|1881466|FG000|Overall Study|Misuse and compliance of study drug|1
905931|NCT00764868|1881466|FG000|Overall Study|Subject sent to boarding school|1
905932|NCT00764868|1881466|FG000|Overall Study|Met an exclusion criteria|1
905933|NCT00764868|1881466|FG000|Overall Study|Positive drug screen|2
905934|NCT00764868|1881466|FG000|Overall Study|Sponsor requested withdrawal|1
905935|NCT00764881|1881472|FG000|Overall Study|Adverse Event|5
905936|NCT00764881|1881473|FG001|Overall Study|Adverse Event|1
905937|NCT00764881|1881472|FG000|Overall Study|Withdrawal by Subject|1
905938|NCT00764881|1881473|FG001|Overall Study|Withdrawal by Subject|3
1035994|NCT01707992|2067971|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0
1035995|NCT01707992|2067972|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0
1035996|NCT01707992|2067973|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0
1035997|NCT01707992|2067974|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5
1035998|NCT01707992|2067975|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11
1035999|NCT01707992|2067976|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1
1036000|NCT01707992|2067971|FG000|Active Treatment Phase (24 Months)|Death|0
1036001|NCT01707992|2067972|FG001|Active Treatment Phase (24 Months)|Death|0
1036002|NCT01707992|2067973|FG002|Active Treatment Phase (24 Months)|Death|0
1036003|NCT01707992|2067974|FG003|Active Treatment Phase (24 Months)|Death|2
1036004|NCT01707992|2067975|FG004|Active Treatment Phase (24 Months)|Death|0
1036005|NCT01707992|2067976|FG005|Active Treatment Phase (24 Months)|Death|0
1036006|NCT01707992|2067971|FG000|Active Treatment Phase (24 Months)|Other than specified|0
1036007|NCT01707992|2067972|FG001|Active Treatment Phase (24 Months)|Other than specified|0
1036008|NCT01707992|2067973|FG002|Active Treatment Phase (24 Months)|Other than specified|0
1036009|NCT01707992|2067974|FG003|Active Treatment Phase (24 Months)|Other than specified|1
1036010|NCT01707992|2067975|FG004|Active Treatment Phase (24 Months)|Other than specified|5
1036011|NCT01707992|2067976|FG005|Active Treatment Phase (24 Months)|Other than specified|2
1036012|NCT01707992|2067971|FG000|Active Treatment Phase (24 Months)|Noncompliance|0
1036013|NCT01707992|2067972|FG001|Active Treatment Phase (24 Months)|Noncompliance|0
1036014|NCT01707992|2067973|FG002|Active Treatment Phase (24 Months)|Noncompliance|0
1036015|NCT01707992|2067974|FG003|Active Treatment Phase (24 Months)|Noncompliance|0
1036016|NCT01707992|2067975|FG004|Active Treatment Phase (24 Months)|Noncompliance|4
1036017|NCT01707992|2067976|FG005|Active Treatment Phase (24 Months)|Noncompliance|2
1036018|NCT01707992|2067971|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
1036019|NCT01707992|2067972|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
1162027|NCT03380429|2283930|FG003|Overall Study|Adverse Event|2
905939|NCT00764881|1881472|FG000|Overall Study|Protocol Violation|2
905940|NCT00764881|1881473|FG001|Overall Study|Protocol Violation|2
905941|NCT00764881|1881472|FG000|Overall Study|Lost to Follow-up|2
905942|NCT00764881|1881473|FG001|Overall Study|Lost to Follow-up|0
905943|NCT00764881|1881472|FG000|Overall Study|Noncompliant|1
905944|NCT00764881|1881473|FG001|Overall Study|Noncompliant|0
905945|NCT00764881|1881472|FG000|Overall Study|Accidentally discontinued study drug|1
905946|NCT00764881|1881473|FG001|Overall Study|Accidentally discontinued study drug|0
905947|NCT00764881|1881472|FG000|Overall Study|Wished to become pregnant|1
905948|NCT00764881|1881473|FG001|Overall Study|Wished to become pregnant|0
905949|NCT00764881|1881472|FG000|Overall Study|Carcinoma detected|1
905950|NCT00764881|1881473|FG001|Overall Study|Carcinoma detected|0
905951|NCT00764881|1881472|FG000|Overall Study|Possibly noncompliant (study drug)|0
905952|NCT00764881|1881473|FG001|Overall Study|Possibly noncompliant (study drug)|2
905953|NCT00764881|1881472|FG000|Overall Study|no treatment or no observation|2
905954|NCT00764881|1881473|FG001|Overall Study|no treatment or no observation|2
905955|NCT00764946|1881482|FG000|Overall Study|Lack of Efficacy|1
905956|NCT00764946|1881483|FG001|Overall Study|Lack of Efficacy|0
905957|NCT00764946|1881484|FG002|Overall Study|Lack of Efficacy|0
905958|NCT00764946|1881482|FG000|Overall Study|Lost to Follow-up|3
905959|NCT00764946|1881483|FG001|Overall Study|Lost to Follow-up|4
905960|NCT00764946|1881484|FG002|Overall Study|Lost to Follow-up|0
905961|NCT00764946|1881482|FG000|Overall Study|Physician Decision|2
905962|NCT00764946|1881483|FG001|Overall Study|Physician Decision|4
905963|NCT00764946|1881484|FG002|Overall Study|Physician Decision|0
905964|NCT00764946|1881482|FG000|Overall Study|Adverse Event|3
905965|NCT00764946|1881483|FG001|Overall Study|Adverse Event|2
905966|NCT00764946|1881484|FG002|Overall Study|Adverse Event|1
905967|NCT00764946|1881482|FG000|Overall Study|Withdrawal by Subject|3
905968|NCT00764946|1881483|FG001|Overall Study|Withdrawal by Subject|6
905969|NCT00764946|1881484|FG002|Overall Study|Withdrawal by Subject|2
905970|NCT00764946|1881482|FG000|Overall Study|Never Treated|1
905971|NCT00764946|1881483|FG001|Overall Study|Never Treated|1
905972|NCT00764946|1881484|FG002|Overall Study|Never Treated|1
905973|NCT00765037|1881498|FG000|Overall Study|Lost to Follow-up|5
905974|NCT00765037|1881498|FG000|Overall Study|Adverse Event|1
905975|NCT00765063|1881502|FG000|Overall Study|Lack of Efficacy|5
905976|NCT00765063|1881502|FG000|Overall Study|Withdrawal by Subject|1
905977|NCT00765063|1881502|FG000|Overall Study|Other|16
905978|NCT00765063|1881502|FG000|Overall Study|Protocol Violation|6
905979|NCT00765063|1881502|FG000|Overall Study|Adverse Event|4
905980|NCT00765076|1881509|FG000|Overall Study|Adverse Event|1
905981|NCT00765076|1881510|FG001|Overall Study|Adverse Event|0
905982|NCT00765076|1881511|FG002|Overall Study|Adverse Event|0
905983|NCT00765076|1881509|FG000|Overall Study|Withdrawal by Subject|0
905984|NCT00765076|1881510|FG001|Overall Study|Withdrawal by Subject|0
905985|NCT00765076|1881511|FG002|Overall Study|Withdrawal by Subject|1
905986|NCT00765102|1881519|FG000|Overall Study|Progressive disease|18
905987|NCT00765102|1881519|FG000|Overall Study|Adverse Event|6
905988|NCT00765102|1881519|FG000|Overall Study|Physician Decision|4
905989|NCT00765102|1881519|FG000|Overall Study|Withdrawal by Subject|2
905990|NCT00765102|1881519|FG000|Overall Study|Protocol Violation|1
905991|NCT00765245|1881559|FG000|Overall Study|disease progression|3
905992|NCT00765245|1881560|FG001|Overall Study|disease progression|2
1036020|NCT01707992|2067973|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
1036021|NCT01707992|2067974|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
1036022|NCT01707992|2067975|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
1036023|NCT01707992|2067976|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
1036024|NCT01707992|2067971|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
1036025|NCT01707992|2067972|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
1036026|NCT01707992|2067973|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
1036027|NCT01707992|2067974|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
1036028|NCT01707992|2067975|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
1036029|NCT01707992|2067976|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
1036030|NCT01708161|2068006|FG000|Overall Study|Adverse Event|1
1036031|NCT01708161|2068007|FG001|Overall Study|Adverse Event|3
1036032|NCT01708161|2068008|FG002|Overall Study|Adverse Event|4
1036033|NCT01708161|2068009|FG003|Overall Study|Adverse Event|2
1036034|NCT01708161|2068010|FG004|Overall Study|Adverse Event|3
1036035|NCT01708161|2068011|FG005|Overall Study|Adverse Event|0
1036036|NCT01708161|2068006|FG000|Overall Study|Death|0
1036037|NCT01708161|2068007|FG001|Overall Study|Death|0
1036038|NCT01708161|2068008|FG002|Overall Study|Death|0
1036039|NCT01708161|2068009|FG003|Overall Study|Death|1
1036040|NCT01708161|2068010|FG004|Overall Study|Death|0
1036041|NCT01708161|2068011|FG005|Overall Study|Death|1
1036042|NCT01708161|2068006|FG000|Overall Study|Withdrawal by Subject|0
1036043|NCT01708161|2068007|FG001|Overall Study|Withdrawal by Subject|1
1036044|NCT01708161|2068008|FG002|Overall Study|Withdrawal by Subject|1
1036045|NCT01708161|2068009|FG003|Overall Study|Withdrawal by Subject|0
1036046|NCT01708161|2068010|FG004|Overall Study|Withdrawal by Subject|0
1036047|NCT01708161|2068011|FG005|Overall Study|Withdrawal by Subject|0
1036048|NCT01708161|2068006|FG000|Overall Study|Administrative problems|0
1036049|NCT01708161|2068007|FG001|Overall Study|Administrative problems|1
1036050|NCT01708161|2068008|FG002|Overall Study|Administrative problems|0
1036051|NCT01708161|2068009|FG003|Overall Study|Administrative problems|0
1036052|NCT01708161|2068010|FG004|Overall Study|Administrative problems|0
905993|NCT00765245|1881559|FG000|Overall Study|Withdrawal by Subject|3
905994|NCT00765245|1881560|FG001|Overall Study|Withdrawal by Subject|0
905995|NCT00765245|1881559|FG000|Overall Study|Adverse Event|5
905996|NCT00765245|1881560|FG001|Overall Study|Adverse Event|0
905997|NCT00765245|1881559|FG000|Overall Study|Physician Decision|1
905998|NCT00765245|1881560|FG001|Overall Study|Physician Decision|0
905999|NCT00765245|1881559|FG000|Overall Study|Death|1
906000|NCT00765245|1881560|FG001|Overall Study|Death|0
906001|NCT00765336|1881568|FG000|Overall Study|Protocol Violation|4
906002|NCT00765336|1881569|FG001|Overall Study|Protocol Violation|2
906003|NCT00765336|1881568|FG000|Overall Study|Withdrawal by Subject|6
906004|NCT00765336|1881569|FG001|Overall Study|Withdrawal by Subject|4
906005|NCT00765336|1881568|FG000|Overall Study|Lost to Follow-up|7
906006|NCT00765336|1881569|FG001|Overall Study|Lost to Follow-up|9
906007|NCT00765336|1881568|FG000|Overall Study|Adverse Event|2
906008|NCT00765336|1881569|FG001|Overall Study|Adverse Event|1
906009|NCT00765362|1881575|FG000|Overall Study|Death|9
906010|NCT00765362|1881575|FG000|Overall Study|Adverse Event|2
906011|NCT00765362|1881575|FG000|Overall Study|Protocol Violation|18
906012|NCT00765362|1881575|FG000|Overall Study|Withdrawal by Subject|13
906013|NCT00765362|1881575|FG000|Overall Study|Lost to Follow-up|95
906014|NCT00765388|1881585|FG000|Period 1|Lack of Efficacy|1
906015|NCT00765388|1881586|FG001|Period 1|Lack of Efficacy|2
906016|NCT00765388|1881585|FG000|Period 1|Lost to Follow-up|0
906017|NCT00765388|1881586|FG001|Period 1|Lost to Follow-up|1
906018|NCT00765388|1881585|FG000|Period 1|Herpes Zoster|0
906019|NCT00765388|1881586|FG001|Period 1|Herpes Zoster|1
906020|NCT00765388|1881585|FG000|Period 1|Hip operation|0
906021|NCT00765388|1881586|FG001|Period 1|Hip operation|1
906022|NCT00765674|1881623|FG000|Overall Study|Adverse Event|7
906023|NCT00765674|1881624|FG001|Overall Study|Adverse Event|2
906024|NCT00765674|1881625|FG002|Overall Study|Adverse Event|8
906025|NCT00765674|1881626|FG003|Overall Study|Adverse Event|11
906026|NCT00765674|1881623|FG000|Overall Study|Abnormal Laboratory Value(s)|0
906027|NCT00765674|1881624|FG001|Overall Study|Abnormal Laboratory Value(s)|0
906028|NCT00765674|1881625|FG002|Overall Study|Abnormal Laboratory Value(s)|1
906029|NCT00765674|1881626|FG003|Overall Study|Abnormal Laboratory Value(s)|0
906030|NCT00765674|1881623|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
906031|NCT00765674|1881624|FG001|Overall Study|Abnormal Test Procedure Result(s)|3
906032|NCT00765674|1881625|FG002|Overall Study|Abnormal Test Procedure Result(s)|1
906033|NCT00765674|1881626|FG003|Overall Study|Abnormal Test Procedure Result(s)|2
906034|NCT00765674|1881623|FG000|Overall Study|Lack of Efficacy|2
906035|NCT00765674|1881624|FG001|Overall Study|Lack of Efficacy|3
906036|NCT00765674|1881625|FG002|Overall Study|Lack of Efficacy|1
906037|NCT00765674|1881626|FG003|Overall Study|Lack of Efficacy|2
906038|NCT00765674|1881623|FG000|Overall Study|Protocol Violation|2
906039|NCT00765674|1881624|FG001|Overall Study|Protocol Violation|0
906040|NCT00765674|1881625|FG002|Overall Study|Protocol Violation|1
906041|NCT00765674|1881626|FG003|Overall Study|Protocol Violation|0
1036053|NCT01708161|2068011|FG005|Overall Study|Administrative problems|0
1036054|NCT01708161|2068006|FG000|Overall Study|Disease progression|3
1036055|NCT01708161|2068007|FG001|Overall Study|Disease progression|5
1036056|NCT01708161|2068008|FG002|Overall Study|Disease progression|5
1036057|NCT01708161|2068009|FG003|Overall Study|Disease progression|13
1036058|NCT01708161|2068010|FG004|Overall Study|Disease progression|3
1036059|NCT01708161|2068011|FG005|Overall Study|Disease progression|0
1036060|NCT01708174|2068028|FG000|Treatment Period|Withdrawal by Subject|1
1036061|NCT01708174|2068029|FG001|Treatment Period|Withdrawal by Subject|0
1036062|NCT01708174|2068030|FG002|Treatment Period|Withdrawal by Subject|0
906042|NCT00765674|1881623|FG000|Overall Study|Withdrawal by Subject|5
906043|NCT00765674|1881624|FG001|Overall Study|Withdrawal by Subject|7
906044|NCT00765674|1881625|FG002|Overall Study|Withdrawal by Subject|3
906045|NCT00765674|1881626|FG003|Overall Study|Withdrawal by Subject|8
906046|NCT00765674|1881623|FG000|Overall Study|Lost to Follow-up|4
906047|NCT00765674|1881624|FG001|Overall Study|Lost to Follow-up|6
906048|NCT00765674|1881625|FG002|Overall Study|Lost to Follow-up|2
906049|NCT00765674|1881626|FG003|Overall Study|Lost to Follow-up|1
906050|NCT00765674|1881623|FG000|Overall Study|Randomized in Error - No Study Drug|0
906051|NCT00765674|1881624|FG001|Overall Study|Randomized in Error - No Study Drug|1
906052|NCT00765674|1881625|FG002|Overall Study|Randomized in Error - No Study Drug|0
906053|NCT00765674|1881626|FG003|Overall Study|Randomized in Error - No Study Drug|1
906054|NCT00765726|1881636|FG000|Overall Study|Withdrawal by Subject|1
906055|NCT00765726|1881636|FG000|Overall Study|Discontinuation of study by sponsor|8
906056|NCT00765817|1881642|FG000|Overall Study|Adverse Event|13
906057|NCT00765817|1881643|FG001|Overall Study|Adverse Event|1
906058|NCT00765817|1881642|FG000|Overall Study|Death|0
906059|NCT00765817|1881643|FG001|Overall Study|Death|1
906060|NCT00765817|1881642|FG000|Overall Study|Entry criteria not met|2
906061|NCT00765817|1881643|FG001|Overall Study|Entry criteria not met|2
906062|NCT00765817|1881642|FG000|Overall Study|Loss of glucose control|0
906063|NCT00765817|1881643|FG001|Overall Study|Loss of glucose control|2
906064|NCT00765817|1881642|FG000|Overall Study|Lost to Follow-up|1
906065|NCT00765817|1881643|FG001|Overall Study|Lost to Follow-up|3
906066|NCT00765817|1881642|FG000|Overall Study|Physician Decision|2
906067|NCT00765817|1881643|FG001|Overall Study|Physician Decision|1
906068|NCT00765817|1881642|FG000|Overall Study|Protocol Violation|1
906069|NCT00765817|1881643|FG001|Overall Study|Protocol Violation|1
906070|NCT00765817|1881642|FG000|Overall Study|Subject decision|7
906071|NCT00765817|1881643|FG001|Overall Study|Subject decision|11
906072|NCT00765843|1881652|FG000|Overall Study|Lost to Follow-up|1
906073|NCT00765843|1881653|FG001|Overall Study|Lost to Follow-up|3
906074|NCT00765843|1881654|FG002|Overall Study|Lost to Follow-up|2
906075|NCT00765843|1881652|FG000|Overall Study|did not return to receive intervention|0
906076|NCT00765843|1881653|FG001|Overall Study|did not return to receive intervention|1
906077|NCT00765843|1881654|FG002|Overall Study|did not return to receive intervention|0
906078|NCT00765843|1881652|FG000|Overall Study|Adverse Event|0
906079|NCT00765843|1881653|FG001|Overall Study|Adverse Event|0
906080|NCT00765843|1881654|FG002|Overall Study|Adverse Event|1
906081|NCT00765882|1881672|FG000|Overall Study|Adverse Event|10
906082|NCT00765882|1881673|FG001|Overall Study|Adverse Event|21
906083|NCT00765882|1881674|FG002|Overall Study|Adverse Event|20
906084|NCT00765882|1881672|FG000|Overall Study|Lack of Efficacy|4
906085|NCT00765882|1881673|FG001|Overall Study|Lack of Efficacy|0
906086|NCT00765882|1881674|FG002|Overall Study|Lack of Efficacy|1
906087|NCT00765882|1881672|FG000|Overall Study|Protocol Violation|4
906088|NCT00765882|1881673|FG001|Overall Study|Protocol Violation|3
906089|NCT00765882|1881674|FG002|Overall Study|Protocol Violation|1
906090|NCT00765882|1881672|FG000|Overall Study|Withdrawal by Subject|2
906091|NCT00765882|1881673|FG001|Overall Study|Withdrawal by Subject|6
906092|NCT00765882|1881674|FG002|Overall Study|Withdrawal by Subject|6
906093|NCT00765882|1881672|FG000|Overall Study|Lost to Follow-up|1
906094|NCT00765882|1881673|FG001|Overall Study|Lost to Follow-up|9
906095|NCT00765882|1881674|FG002|Overall Study|Lost to Follow-up|6
906096|NCT00765882|1881672|FG000|Overall Study|Other Reason|3
906097|NCT00765882|1881673|FG001|Overall Study|Other Reason|1
906098|NCT00765882|1881674|FG002|Overall Study|Other Reason|2
906099|NCT00765999|1881697|FG000|Overall Study|Adverse Event|203
906100|NCT00765999|1881697|FG000|Overall Study|Insufficient Therapeutic Response|100
906101|NCT00765999|1881697|FG000|Overall Study|Protocol Violation|95
906102|NCT00765999|1881697|FG000|Overall Study|Consent Withdrawn|202
906103|NCT00765999|1881697|FG000|Overall Study|Lost to Follow-up|131
906104|NCT00765999|1881697|FG000|Overall Study|Study Terminated by Sponsor|2
906105|NCT00765999|1881697|FG000|Overall Study|Other Miscellaneous Reasons|51
906106|NCT00766038|1881705|FG000|Overall Study|Lost to Follow-up|15
906107|NCT00766038|1881706|FG001|Overall Study|Lost to Follow-up|14
906108|NCT00766051|1881716|FG000|Overall Study|Withdrawal by Subject|2
906109|NCT00766051|1881717|FG001|Overall Study|Withdrawal by Subject|0
906110|NCT00766090|1881727|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
906111|NCT00766090|1881728|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
906112|NCT00766090|1881729|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
906113|NCT00766090|1881730|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
906114|NCT00766090|1881731|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
906115|NCT00766090|1881732|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1036063|NCT01708174|2068028|FG000|Treatment Period|Progressive disease|0
1036064|NCT01708174|2068029|FG001|Treatment Period|Progressive disease|1
1036065|NCT01708174|2068030|FG002|Treatment Period|Progressive disease|0
1036066|NCT01708174|2068028|FG000|Treatment Period|Death|0
1036067|NCT01708174|2068029|FG001|Treatment Period|Death|0
1036068|NCT01708174|2068030|FG002|Treatment Period|Death|1
1036069|NCT01708174|2068028|FG000|Treatment Period|Adverse Event|0
1036070|NCT01708174|2068029|FG001|Treatment Period|Adverse Event|1
1036071|NCT01708174|2068030|FG002|Treatment Period|Adverse Event|0
1036072|NCT01708187|2068041|FG000|Overall Study|Lost to Follow-up|0
1036073|NCT01708187|2068042|FG001|Overall Study|Lost to Follow-up|1
1036074|NCT01708291|2068079|FG000|Overall Study|fighting|2
1036075|NCT01708291|2068080|FG001|Overall Study|fighting|1
1036076|NCT01708902|2068166|FG000|Overall Study|Adverse Event|3
1036077|NCT01708902|2068167|FG001|Overall Study|Adverse Event|4
1036078|NCT01708902|2068168|FG002|Overall Study|Adverse Event|9
1036079|NCT01708902|2068169|FG003|Overall Study|Adverse Event|2
1036080|NCT01708902|2068170|FG004|Overall Study|Adverse Event|7
1036081|NCT01708902|2068171|FG005|Overall Study|Adverse Event|3
1036082|NCT01708902|2068172|FG006|Overall Study|Adverse Event|5
1036083|NCT01708902|2068166|FG000|Overall Study|Lack of Efficacy|3
1036084|NCT01708902|2068167|FG001|Overall Study|Lack of Efficacy|1
1036085|NCT01708902|2068168|FG002|Overall Study|Lack of Efficacy|0
1036086|NCT01708902|2068169|FG003|Overall Study|Lack of Efficacy|0
906116|NCT00766090|1881733|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
906117|NCT00766090|1881734|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
906118|NCT00766090|1881735|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1
906119|NCT00766090|1881736|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
906120|NCT00766090|1881737|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0
906121|NCT00766090|1881738|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
906122|NCT00766090|1881727|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2
906123|NCT00766090|1881728|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0
906124|NCT00766090|1881729|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0
906125|NCT00766090|1881730|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0
906126|NCT00766090|1881731|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0
906127|NCT00766090|1881732|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0
906128|NCT00766090|1881733|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0
906129|NCT00766090|1881734|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0
906130|NCT00766090|1881735|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0
906131|NCT00766090|1881736|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0
906132|NCT00766090|1881737|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0
906133|NCT00766090|1881738|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0
906134|NCT00766090|1881727|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
906135|NCT00766090|1881728|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
906136|NCT00766090|1881729|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
906137|NCT00766090|1881730|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
906138|NCT00766090|1881731|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
906139|NCT00766090|1881732|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
906140|NCT00766090|1881733|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
906141|NCT00766090|1881734|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
906142|NCT00766090|1881735|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
906143|NCT00766090|1881736|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
906144|NCT00766090|1881737|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
906145|NCT00766090|1881738|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
906146|NCT00766090|1881727|FG000|Washout Period 1 (14 Days)|Protocol Violation|0
906147|NCT00766090|1881728|FG001|Washout Period 1 (14 Days)|Protocol Violation|0
906148|NCT00766090|1881729|FG002|Washout Period 1 (14 Days)|Protocol Violation|1
906149|NCT00766090|1881730|FG003|Washout Period 1 (14 Days)|Protocol Violation|0
906150|NCT00766090|1881731|FG004|Washout Period 1 (14 Days)|Protocol Violation|0
906151|NCT00766090|1881732|FG005|Washout Period 1 (14 Days)|Protocol Violation|0
906152|NCT00766090|1881733|FG006|Washout Period 1 (14 Days)|Protocol Violation|0
906153|NCT00766090|1881734|FG007|Washout Period 1 (14 Days)|Protocol Violation|0
906154|NCT00766090|1881735|FG008|Washout Period 1 (14 Days)|Protocol Violation|0
906155|NCT00766090|1881736|FG009|Washout Period 1 (14 Days)|Protocol Violation|0
906156|NCT00766090|1881737|FG010|Washout Period 1 (14 Days)|Protocol Violation|0
906157|NCT00766090|1881738|FG011|Washout Period 1 (14 Days)|Protocol Violation|0
906158|NCT00766090|1881727|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
906159|NCT00766090|1881728|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0
906160|NCT00766090|1881729|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
906161|NCT00766090|1881730|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
906162|NCT00766090|1881731|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2
906163|NCT00766090|1881732|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
906164|NCT00766090|1881733|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
906165|NCT00766090|1881734|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
906166|NCT00766090|1881735|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1036087|NCT01708902|2068170|FG004|Overall Study|Lack of Efficacy|0
1036088|NCT01708902|2068171|FG005|Overall Study|Lack of Efficacy|1
1036089|NCT01708902|2068172|FG006|Overall Study|Lack of Efficacy|0
1036090|NCT01708902|2068166|FG000|Overall Study|Non compliance with protocol|0
1036091|NCT01708902|2068167|FG001|Overall Study|Non compliance with protocol|2
1036092|NCT01708902|2068168|FG002|Overall Study|Non compliance with protocol|1
1036093|NCT01708902|2068169|FG003|Overall Study|Non compliance with protocol|3
1036094|NCT01708902|2068170|FG004|Overall Study|Non compliance with protocol|0
1036095|NCT01708902|2068171|FG005|Overall Study|Non compliance with protocol|0
1036096|NCT01708902|2068172|FG006|Overall Study|Non compliance with protocol|0
1036097|NCT01708902|2068166|FG000|Overall Study|Lost to Follow-up|2
1036098|NCT01708902|2068167|FG001|Overall Study|Lost to Follow-up|1
1036099|NCT01708902|2068168|FG002|Overall Study|Lost to Follow-up|2
1036100|NCT01708902|2068169|FG003|Overall Study|Lost to Follow-up|2
1036101|NCT01708902|2068170|FG004|Overall Study|Lost to Follow-up|0
1036102|NCT01708902|2068171|FG005|Overall Study|Lost to Follow-up|0
1036103|NCT01708902|2068172|FG006|Overall Study|Lost to Follow-up|1
1036104|NCT01708902|2068166|FG000|Overall Study|Refused to continue trial medication|8
1036105|NCT01708902|2068167|FG001|Overall Study|Refused to continue trial medication|0
1036106|NCT01708902|2068168|FG002|Overall Study|Refused to continue trial medication|4
1036107|NCT01708902|2068169|FG003|Overall Study|Refused to continue trial medication|2
1036108|NCT01708902|2068170|FG004|Overall Study|Refused to continue trial medication|8
1036109|NCT01708902|2068171|FG005|Overall Study|Refused to continue trial medication|1
906167|NCT00766090|1881736|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
906168|NCT00766090|1881737|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
906169|NCT00766090|1881738|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
906170|NCT00766090|1881727|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0
906171|NCT00766090|1881728|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0
906172|NCT00766090|1881729|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1
906173|NCT00766090|1881730|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0
906174|NCT00766090|1881731|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0
906175|NCT00766090|1881732|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0
906176|NCT00766090|1881733|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0
906177|NCT00766090|1881734|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0
906178|NCT00766090|1881735|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0
906179|NCT00766090|1881736|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0
906180|NCT00766090|1881737|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0
906181|NCT00766090|1881738|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0
906182|NCT00766090|1881727|FG000|Washout Period 2 (14 Days)|Physician Decision|0
906183|NCT00766090|1881728|FG001|Washout Period 2 (14 Days)|Physician Decision|0
906184|NCT00766090|1881729|FG002|Washout Period 2 (14 Days)|Physician Decision|1
906185|NCT00766090|1881730|FG003|Washout Period 2 (14 Days)|Physician Decision|0
906186|NCT00766090|1881731|FG004|Washout Period 2 (14 Days)|Physician Decision|0
906187|NCT00766090|1881732|FG005|Washout Period 2 (14 Days)|Physician Decision|0
906188|NCT00766090|1881733|FG006|Washout Period 2 (14 Days)|Physician Decision|0
906189|NCT00766090|1881734|FG007|Washout Period 2 (14 Days)|Physician Decision|0
906190|NCT00766090|1881735|FG008|Washout Period 2 (14 Days)|Physician Decision|0
906191|NCT00766090|1881736|FG009|Washout Period 2 (14 Days)|Physician Decision|0
906192|NCT00766090|1881737|FG010|Washout Period 2 (14 Days)|Physician Decision|0
906193|NCT00766090|1881738|FG011|Washout Period 2 (14 Days)|Physician Decision|0
906194|NCT00766090|1881727|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0
906195|NCT00766090|1881728|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0
906196|NCT00766090|1881729|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0
906197|NCT00766090|1881730|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0
906198|NCT00766090|1881731|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0
906199|NCT00766090|1881732|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1
906200|NCT00766090|1881733|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0
906201|NCT00766090|1881734|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0
906202|NCT00766090|1881735|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0
906203|NCT00766090|1881736|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0
906204|NCT00766090|1881737|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0
906205|NCT00766090|1881738|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0
906206|NCT00766090|1881727|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0
906207|NCT00766090|1881728|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1
906208|NCT00766090|1881729|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0
906209|NCT00766090|1881730|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1
906210|NCT00766090|1881731|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0
906211|NCT00766090|1881732|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0
906212|NCT00766090|1881733|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0
906213|NCT00766090|1881734|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0
906214|NCT00766090|1881735|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0
906215|NCT00766090|1881736|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0
906216|NCT00766090|1881737|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0
906217|NCT00766090|1881738|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1
906218|NCT00766090|1881727|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0
906219|NCT00766090|1881728|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0
906220|NCT00766090|1881729|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0
906221|NCT00766090|1881730|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1036110|NCT01708902|2068172|FG006|Overall Study|Refused to continue trial medication|1
1036111|NCT01708902|2068166|FG000|Overall Study|Other Reason|1
1036112|NCT01708902|2068167|FG001|Overall Study|Other Reason|0
1036113|NCT01708902|2068168|FG002|Overall Study|Other Reason|1
1036114|NCT01708902|2068169|FG003|Overall Study|Other Reason|1
1036115|NCT01708902|2068170|FG004|Overall Study|Other Reason|1
1036116|NCT01708902|2068171|FG005|Overall Study|Other Reason|2
1036117|NCT01708902|2068172|FG006|Overall Study|Other Reason|0
1036118|NCT01708915|2068195|FG000|Overall Study|Adverse Event|1
1036119|NCT01708915|2068196|FG001|Overall Study|Adverse Event|0
1036120|NCT01708915|2068197|FG002|Overall Study|Adverse Event|9
1036121|NCT01708915|2068198|FG003|Overall Study|Adverse Event|13
1036122|NCT01708915|2068195|FG000|Overall Study|Lack of Efficacy|84
1036123|NCT01708915|2068196|FG001|Overall Study|Lack of Efficacy|60
1036124|NCT01708915|2068197|FG002|Overall Study|Lack of Efficacy|35
1036125|NCT01708915|2068198|FG003|Overall Study|Lack of Efficacy|15
1036126|NCT01708915|2068195|FG000|Overall Study|Protocol Violation|0
1036127|NCT01708915|2068196|FG001|Overall Study|Protocol Violation|0
1036128|NCT01708915|2068197|FG002|Overall Study|Protocol Violation|0
1036129|NCT01708915|2068198|FG003|Overall Study|Protocol Violation|1
1036130|NCT01708915|2068195|FG000|Overall Study|Withdrawal by Subject|0
1036131|NCT01708915|2068196|FG001|Overall Study|Withdrawal by Subject|1
1036132|NCT01708915|2068197|FG002|Overall Study|Withdrawal by Subject|2
1036133|NCT01708915|2068198|FG003|Overall Study|Withdrawal by Subject|2
1036134|NCT01708915|2068195|FG000|Overall Study|Other reasons than stated above|1
1036135|NCT01708915|2068196|FG001|Overall Study|Other reasons than stated above|1
1036136|NCT01708915|2068197|FG002|Overall Study|Other reasons than stated above|0
1036137|NCT01708915|2068198|FG003|Overall Study|Other reasons than stated above|2
1036138|NCT01708941|2068212|FG000|Overall Study|Adverse Event|4
1036139|NCT01708941|2068213|FG001|Overall Study|Adverse Event|6
1036140|NCT01708941|2068214|FG002|Overall Study|Adverse Event|1
1036141|NCT01708941|2068215|FG003|Overall Study|Adverse Event|0
1036142|NCT01708941|2068212|FG000|Overall Study|Death|1
1036143|NCT01708941|2068213|FG001|Overall Study|Death|1
1036144|NCT01708941|2068214|FG002|Overall Study|Death|2
1036145|NCT01708941|2068215|FG003|Overall Study|Death|14
1036146|NCT01708941|2068212|FG000|Overall Study|Withdrawal by Subject|1
1036147|NCT01708941|2068213|FG001|Overall Study|Withdrawal by Subject|0
1036148|NCT01708941|2068214|FG002|Overall Study|Withdrawal by Subject|3
1036149|NCT01708941|2068215|FG003|Overall Study|Withdrawal by Subject|4
1036150|NCT01708941|2068212|FG000|Overall Study|Disease progression|9
1036151|NCT01708941|2068213|FG001|Overall Study|Disease progression|10
1036152|NCT01708941|2068214|FG002|Overall Study|Disease progression|8
1036153|NCT01708941|2068215|FG003|Overall Study|Disease progression|0
1036154|NCT01708941|2068212|FG000|Overall Study|Alternative therapy|0
1036155|NCT01708941|2068213|FG001|Overall Study|Alternative therapy|0
1036156|NCT01708941|2068214|FG002|Overall Study|Alternative therapy|2
1036157|NCT01708941|2068215|FG003|Overall Study|Alternative therapy|0
1036158|NCT01708941|2068212|FG000|Overall Study|Ineligible and never started treatment|1
1036159|NCT01708941|2068213|FG001|Overall Study|Ineligible and never started treatment|0
1036160|NCT01708941|2068214|FG002|Overall Study|Ineligible and never started treatment|1
1036161|NCT01708941|2068215|FG003|Overall Study|Ineligible and never started treatment|0
1036162|NCT01708941|2068212|FG000|Overall Study|Never started treatment|2
1036163|NCT01708941|2068213|FG001|Overall Study|Never started treatment|1
1036164|NCT01708941|2068214|FG002|Overall Study|Never started treatment|0
1036165|NCT01708941|2068215|FG003|Overall Study|Never started treatment|0
1036166|NCT01708941|2068212|FG000|Overall Study|Ineligible|0
1036167|NCT01708941|2068213|FG001|Overall Study|Ineligible|0
1036168|NCT01708941|2068214|FG002|Overall Study|Ineligible|2
1036169|NCT01708941|2068215|FG003|Overall Study|Ineligible|0
1036170|NCT01708954|2068228|FG000|Step 1|Disease progression|26
1036171|NCT01708954|2068229|FG001|Step 1|Disease progression|17
1036172|NCT01708954|2068230|FG002|Step 1|Disease progression|14
1036173|NCT01708954|2068228|FG000|Step 1|Adverse Event|3
1036174|NCT01708954|2068229|FG001|Step 1|Adverse Event|11
1036175|NCT01708954|2068230|FG002|Step 1|Adverse Event|13
1036176|NCT01708954|2068228|FG000|Step 1|Death|3
1036177|NCT01708954|2068229|FG001|Step 1|Death|2
1036178|NCT01708954|2068230|FG002|Step 1|Death|3
1036179|NCT01708954|2068228|FG000|Step 1|Withdrawal by Subject|2
1036180|NCT01708954|2068229|FG001|Step 1|Withdrawal by Subject|5
1036181|NCT01708954|2068230|FG002|Step 1|Withdrawal by Subject|3
1036182|NCT01708954|2068228|FG000|Step 1|Other complicating disease|0
1036183|NCT01708954|2068229|FG001|Step 1|Other complicating disease|2
1036184|NCT01708954|2068230|FG002|Step 1|Other complicating disease|0
1036185|NCT01708954|2068228|FG000|Step 1|Crossed over to Step 2|2
1036186|NCT01708954|2068229|FG001|Step 1|Crossed over to Step 2|0
1036187|NCT01708954|2068230|FG002|Step 1|Crossed over to Step 2|0
1036188|NCT01708954|2068228|FG000|Step 1|Symptomatic deterioration|1
1036189|NCT01708954|2068229|FG001|Step 1|Symptomatic deterioration|0
1036190|NCT01708954|2068230|FG002|Step 1|Symptomatic deterioration|1
1036191|NCT01708954|2068228|FG000|Step 1|Off-treatment reason not submitted|1
1036192|NCT01708954|2068229|FG001|Step 1|Off-treatment reason not submitted|1
1036193|NCT01708954|2068230|FG002|Step 1|Off-treatment reason not submitted|1
1036194|NCT01708954|2068228|FG000|Step 1|Ineligible or never received treatment|4
1036195|NCT01708954|2068229|FG001|Step 1|Ineligible or never received treatment|2
1036196|NCT01708954|2068230|FG002|Step 1|Ineligible or never received treatment|8
1036197|NCT01708954|2068228|FG000|Step 2|Disease progression|9
1036198|NCT01708954|2068229|FG001|Step 2|Disease progression|4
1036199|NCT01708954|2068230|FG002|Step 2|Disease progression|0
1036200|NCT01708954|2068228|FG000|Step 2|Adverse Event|3
1036201|NCT01708954|2068229|FG001|Step 2|Adverse Event|2
1036202|NCT01708954|2068230|FG002|Step 2|Adverse Event|0
906222|NCT00766090|1881731|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1
906223|NCT00766090|1881732|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0
906224|NCT00766090|1881733|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0
906225|NCT00766090|1881734|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0
906226|NCT00766090|1881735|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0
906227|NCT00766090|1881736|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0
906228|NCT00766090|1881737|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0
906229|NCT00766090|1881738|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0
906230|NCT00766142|1881759|FG000|Overall Study|Protocol Violation|4
906231|NCT00766363|1881767|FG000|Overall Study|Withdrawal by Subject|1
906232|NCT00766363|1881768|FG001|Overall Study|Withdrawal by Subject|0
906233|NCT00766363|1881769|FG002|Overall Study|Withdrawal by Subject|0
906234|NCT00766363|1881770|FG003|Overall Study|Withdrawal by Subject|0
906235|NCT00766363|1881767|FG000|Overall Study|Adverse Event Prior to Randomization|0
906236|NCT00766363|1881768|FG001|Overall Study|Adverse Event Prior to Randomization|1
906237|NCT00766363|1881769|FG002|Overall Study|Adverse Event Prior to Randomization|0
906238|NCT00766363|1881770|FG003|Overall Study|Adverse Event Prior to Randomization|0
906239|NCT00766376|1881781|FG000|Overall Study|Withdrawal by Subject|27
906240|NCT00766415|1881787|FG000|Overall Study|Withdrawal by Subject|0
906241|NCT00766415|1881788|FG001|Overall Study|Withdrawal by Subject|1
906242|NCT00766467|1881796|FG000|Overall Study|Withdrawal by Subject|7
906243|NCT00766467|1881797|FG001|Overall Study|Withdrawal by Subject|2
906244|NCT00766467|1881796|FG000|Overall Study|Adverse Event|1
906245|NCT00766467|1881797|FG001|Overall Study|Adverse Event|1
906246|NCT00766467|1881796|FG000|Overall Study|Protocol Violation|2
906247|NCT00766467|1881797|FG001|Overall Study|Protocol Violation|4
906248|NCT00766467|1881796|FG000|Overall Study|Tumor Progression on Study|0
906249|NCT00766467|1881797|FG001|Overall Study|Tumor Progression on Study|1
906250|NCT00766467|1881796|FG000|Overall Study|Physician Decision|1
906251|NCT00766467|1881797|FG001|Overall Study|Physician Decision|0
906252|NCT00766493|1881803|FG000|30 Days Post-Procedure|Discontinued|7
906253|NCT00766493|1881803|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
906254|NCT00766493|1881803|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
906255|NCT00766506|1881809|FG000|Overall Study|Use rescue medication after 3 hours|3
906256|NCT00766506|1881810|FG001|Overall Study|Use rescue medication after 3 hours|0
906257|NCT00766506|1881809|FG000|Overall Study|Other|2
906258|NCT00766506|1881810|FG001|Overall Study|Other|2
906259|NCT00766532|1881816|FG000|Overall Study|Protocol Violation|2
906260|NCT00766597|1881820|FG000|Overall Study|Unexpected closure of study|4
906261|NCT00766597|1881820|FG000|Overall Study|Without CCR5-tropic virus|5
906262|NCT00766675|1881830|FG000|Overall Study|Adverse Event|16
906263|NCT00766675|1881830|FG000|Overall Study|Lost to Follow-up|2
906264|NCT00766675|1881830|FG000|Overall Study|Withdrawal by Subject|11
906265|NCT00766675|1881830|FG000|Overall Study|Protocol Violation|8
906266|NCT00766675|1881830|FG000|Overall Study|Participant took prohibited medication|1
906267|NCT00766675|1881830|FG000|Overall Study|Receive other anti-neoplastic treatment|1
906268|NCT00766675|1881830|FG000|Overall Study|Insufficient therapy|1
906269|NCT00766831|1881850|FG000|Overall Study|Withdrawal by Subject|4
906270|NCT00766831|1881850|FG000|Overall Study|Lost to Follow-up|3
906271|NCT00766831|1881850|FG000|Overall Study|Adverse Event|20
906272|NCT00766831|1881850|FG000|Overall Study|Protocol Violation|15
906273|NCT00766831|1881850|FG000|Overall Study|Physician Decision|5
906274|NCT00766831|1881850|FG000|Overall Study|Withdrawal of consent|26
906275|NCT00766831|1881850|FG000|Overall Study|Non cooperation by participants|14
906276|NCT00766831|1881850|FG000|Overall Study|Other|28
906277|NCT00767000|1881859|FG000|54-week Study|Adverse Event|4
906278|NCT00767000|1881860|FG001|54-week Study|Adverse Event|6
906279|NCT00767000|1881861|FG002|54-week Study|Adverse Event|6
906280|NCT00767000|1881862|FG003|54-week Study|Adverse Event|8
906281|NCT00767000|1881863|FG004|54-week Study|Adverse Event|4
906282|NCT00767000|1881859|FG000|54-week Study|Creaninine/creatinine clearance|2
906283|NCT00767000|1881860|FG001|54-week Study|Creaninine/creatinine clearance|1
906284|NCT00767000|1881861|FG002|54-week Study|Creaninine/creatinine clearance|2
906285|NCT00767000|1881862|FG003|54-week Study|Creaninine/creatinine clearance|2
906286|NCT00767000|1881863|FG004|54-week Study|Creaninine/creatinine clearance|4
906287|NCT00767000|1881859|FG000|54-week Study|Hyperglycemia|0
906288|NCT00767000|1881860|FG001|54-week Study|Hyperglycemia|0
906289|NCT00767000|1881861|FG002|54-week Study|Hyperglycemia|1
906290|NCT00767000|1881862|FG003|54-week Study|Hyperglycemia|0
906291|NCT00767000|1881863|FG004|54-week Study|Hyperglycemia|1
906292|NCT00767000|1881859|FG000|54-week Study|Hypoglycemia|0
906293|NCT00767000|1881860|FG001|54-week Study|Hypoglycemia|1
906294|NCT00767000|1881861|FG002|54-week Study|Hypoglycemia|0
906295|NCT00767000|1881862|FG003|54-week Study|Hypoglycemia|0
906296|NCT00767000|1881863|FG004|54-week Study|Hypoglycemia|0
1036203|NCT01708954|2068228|FG000|Step 2|Withdrawal by Subject|1
1036204|NCT01708954|2068229|FG001|Step 2|Withdrawal by Subject|1
1036205|NCT01708954|2068230|FG002|Step 2|Withdrawal by Subject|0
1036206|NCT01709084|2068255|FG000|Overall Study|Lost to Follow-up|4
1036207|NCT01709084|2068256|FG001|Overall Study|Lost to Follow-up|7
1036208|NCT01709084|2068255|FG000|Overall Study|Withdrawal by Subject|2
1036209|NCT01709084|2068256|FG001|Overall Study|Withdrawal by Subject|2
1036210|NCT01709084|2068255|FG000|Overall Study|Adverse Event|5
1036211|NCT01709084|2068256|FG001|Overall Study|Adverse Event|0
1036212|NCT01709084|2068255|FG000|Overall Study|Other|5
906297|NCT00767000|1881859|FG000|54-week Study|Interruption of study medication|0
906298|NCT00767000|1881860|FG001|54-week Study|Interruption of study medication|0
906299|NCT00767000|1881861|FG002|54-week Study|Interruption of study medication|1
906300|NCT00767000|1881862|FG003|54-week Study|Interruption of study medication|0
906301|NCT00767000|1881863|FG004|54-week Study|Interruption of study medication|0
906302|NCT00767000|1881859|FG000|54-week Study|Lack of Efficacy|2
906303|NCT00767000|1881860|FG001|54-week Study|Lack of Efficacy|0
906304|NCT00767000|1881861|FG002|54-week Study|Lack of Efficacy|1
906305|NCT00767000|1881862|FG003|54-week Study|Lack of Efficacy|0
906306|NCT00767000|1881863|FG004|54-week Study|Lack of Efficacy|5
906307|NCT00767000|1881859|FG000|54-week Study|Lost to Follow-up|4
906308|NCT00767000|1881860|FG001|54-week Study|Lost to Follow-up|0
906309|NCT00767000|1881861|FG002|54-week Study|Lost to Follow-up|1
906310|NCT00767000|1881862|FG003|54-week Study|Lost to Follow-up|4
906311|NCT00767000|1881863|FG004|54-week Study|Lost to Follow-up|2
906312|NCT00767000|1881859|FG000|54-week Study|Physician Decision|4
906313|NCT00767000|1881860|FG001|54-week Study|Physician Decision|0
906314|NCT00767000|1881861|FG002|54-week Study|Physician Decision|1
906315|NCT00767000|1881862|FG003|54-week Study|Physician Decision|1
906316|NCT00767000|1881863|FG004|54-week Study|Physician Decision|1
906317|NCT00767000|1881859|FG000|54-week Study|Progressive disease|0
906318|NCT00767000|1881860|FG001|54-week Study|Progressive disease|0
906319|NCT00767000|1881861|FG002|54-week Study|Progressive disease|1
906320|NCT00767000|1881862|FG003|54-week Study|Progressive disease|0
906321|NCT00767000|1881863|FG004|54-week Study|Progressive disease|0
906322|NCT00767000|1881859|FG000|54-week Study|Protocol Violation|0
906323|NCT00767000|1881860|FG001|54-week Study|Protocol Violation|0
906324|NCT00767000|1881861|FG002|54-week Study|Protocol Violation|1
906325|NCT00767000|1881862|FG003|54-week Study|Protocol Violation|2
906326|NCT00767000|1881863|FG004|54-week Study|Protocol Violation|0
906327|NCT00767000|1881859|FG000|54-week Study|Withdrawal by Subject|2
906328|NCT00767000|1881860|FG001|54-week Study|Withdrawal by Subject|3
906329|NCT00767000|1881861|FG002|54-week Study|Withdrawal by Subject|5
906330|NCT00767000|1881862|FG003|54-week Study|Withdrawal by Subject|11
906331|NCT00767000|1881863|FG004|54-week Study|Withdrawal by Subject|13
906332|NCT00767000|1881859|FG000|54-week Study|Study terminated by sponsor|90
906333|NCT00767000|1881860|FG001|54-week Study|Study terminated by sponsor|102
906334|NCT00767000|1881861|FG002|54-week Study|Study terminated by sponsor|89
906335|NCT00767000|1881862|FG003|54-week Study|Study terminated by sponsor|196
906336|NCT00767000|1881863|FG004|54-week Study|Study terminated by sponsor|194
906337|NCT00767000|1881859|FG000|54-week Study|Reason not reported|0
906338|NCT00767000|1881860|FG001|54-week Study|Reason not reported|0
906339|NCT00767000|1881861|FG002|54-week Study|Reason not reported|0
906340|NCT00767000|1881862|FG003|54-week Study|Reason not reported|1
906341|NCT00767000|1881863|FG004|54-week Study|Reason not reported|0
906342|NCT00767000|1881859|FG000|Optional 104-week Extension|Study terminated by sponsor|7
906343|NCT00767000|1881860|FG001|Optional 104-week Extension|Study terminated by sponsor|3
906344|NCT00767000|1881861|FG002|Optional 104-week Extension|Study terminated by sponsor|7
906345|NCT00767000|1881862|FG003|Optional 104-week Extension|Study terminated by sponsor|2
906346|NCT00767000|1881863|FG004|Optional 104-week Extension|Study terminated by sponsor|4
906347|NCT00767039|1881877|FG000|Overall Study|Death|5
906348|NCT00767039|1881878|FG001|Overall Study|Death|2
906349|NCT00767104|1881886|FG000|Overall Study|Lost to Follow-up|1
906350|NCT00767104|1881887|FG001|Overall Study|Lost to Follow-up|2
906351|NCT00767325|1881895|FG000|Overall Study|Lack of Efficacy|2
906352|NCT00767325|1881895|FG000|Overall Study|Adverse Event|7
906353|NCT00767325|1881895|FG000|Overall Study|Lost to Follow-up|3
906354|NCT00767325|1881895|FG000|Overall Study|No longer met study criteria|2
906355|NCT00767325|1881895|FG000|Overall Study|Missed visit due to family reasons|1
906356|NCT00767455|1881925|FG000|Overall Study|Investigator error|19
906357|NCT00767520|1881957|FG000|Overall Study|Participants still on treatment|11
906358|NCT00767520|1881958|FG001|Overall Study|Participants still on treatment|15
906359|NCT00767520|1881957|FG000|Overall Study|Randomized in error and Never treated|0
906360|NCT00767520|1881958|FG001|Overall Study|Randomized in error and Never treated|2
906361|NCT00767676|1881979|FG000|Overall Study|Investigator error|54
906362|NCT00767806|1882006|FG000|Overall Study|Adverse Event|30
906363|NCT00767806|1882007|FG001|Overall Study|Adverse Event|11
906364|NCT00767806|1882006|FG000|Overall Study|Withdrawal by Subject|8
906365|NCT00767806|1882007|FG001|Overall Study|Withdrawal by Subject|13
906366|NCT00767806|1882006|FG000|Overall Study|Protocol Violation|6
906367|NCT00767806|1882007|FG001|Overall Study|Protocol Violation|5
906368|NCT00767806|1882006|FG000|Overall Study|Lack of Efficacy|1
906369|NCT00767806|1882007|FG001|Overall Study|Lack of Efficacy|9
1036213|NCT01709084|2068256|FG001|Overall Study|Other|3
1036214|NCT01709084|2068255|FG000|Overall Study|Participant Reached a Virologic Endpoint|0
1036215|NCT01709084|2068256|FG001|Overall Study|Participant Reached a Virologic Endpoint|1
1036216|NCT01709084|2068255|FG000|Overall Study|Not Treated|0
1036217|NCT01709084|2068256|FG001|Overall Study|Not Treated|2
1036218|NCT01709110|2068264|FG000|Overall Study|Adverse Event|56
1036219|NCT01709110|2068265|FG001|Overall Study|Adverse Event|48
1036220|NCT01709110|2068264|FG000|Overall Study|Death|14
1036221|NCT01709110|2068265|FG001|Overall Study|Death|6
1036222|NCT01709110|2068264|FG000|Overall Study|Lost to Follow-up|7
1036223|NCT01709110|2068265|FG001|Overall Study|Lost to Follow-up|5
1036224|NCT01709110|2068264|FG000|Overall Study|Protocol Violation|4
1036225|NCT01709110|2068265|FG001|Overall Study|Protocol Violation|6
1036226|NCT01709110|2068264|FG000|Overall Study|Withdrawal by Subject|96
1036227|NCT01709110|2068265|FG001|Overall Study|Withdrawal by Subject|89
1036228|NCT01709110|2068264|FG000|Overall Study|Physician Decision|4
1036229|NCT01709110|2068265|FG001|Overall Study|Physician Decision|10
1036230|NCT01709110|2068264|FG000|Overall Study|Sponsor Decision|2
1036231|NCT01709110|2068265|FG001|Overall Study|Sponsor Decision|2
1036232|NCT01709110|2068264|FG000|Overall Study|Lack of Efficacy|1
1036233|NCT01709110|2068265|FG001|Overall Study|Lack of Efficacy|1
1036234|NCT01709110|2068264|FG000|Overall Study|Caregiver Decision|1
1036235|NCT01709110|2068265|FG001|Overall Study|Caregiver Decision|1
1036236|NCT01709149|2068274|FG000|Open-label Lead-in Phase|Adverse Event|109
1036237|NCT01709149|2068275|FG001|Open-label Lead-in Phase|Adverse Event|0
1036238|NCT01709149|2068276|FG002|Open-label Lead-in Phase|Adverse Event|0
1036239|NCT01709149|2068274|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2
1036240|NCT01709149|2068275|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0
1036241|NCT01709149|2068276|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0
1036242|NCT01709149|2068274|FG000|Open-label Lead-in Phase|Death|1
1036243|NCT01709149|2068275|FG001|Open-label Lead-in Phase|Death|0
1036244|NCT01709149|2068276|FG002|Open-label Lead-in Phase|Death|0
1036245|NCT01709149|2068274|FG000|Open-label Lead-in Phase|Protocol Violation|3
1036246|NCT01709149|2068275|FG001|Open-label Lead-in Phase|Protocol Violation|0
1036247|NCT01709149|2068276|FG002|Open-label Lead-in Phase|Protocol Violation|0
1036248|NCT01709149|2068274|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
1036249|NCT01709149|2068275|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12
1036250|NCT01709149|2068276|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78
1036251|NCT01709149|2068274|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1036252|NCT01709149|2068275|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
1036253|NCT01709149|2068276|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
1036254|NCT01709149|2068274|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
1036255|NCT01709149|2068275|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2
1036256|NCT01709149|2068276|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5
1036257|NCT01709149|2068274|FG000|Double-blind, Placebo-controlled Phase|Death|0
1036258|NCT01709149|2068275|FG001|Double-blind, Placebo-controlled Phase|Death|2
1036259|NCT01709149|2068276|FG002|Double-blind, Placebo-controlled Phase|Death|0
1036260|NCT01709149|2068274|FG000|Double-blind, Placebo-controlled Phase|not defined|0
1036261|NCT01709149|2068275|FG001|Double-blind, Placebo-controlled Phase|not defined|1
1036262|NCT01709149|2068276|FG002|Double-blind, Placebo-controlled Phase|not defined|2
1036263|NCT01709149|2068274|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1036264|NCT01709149|2068275|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
1036265|NCT01709149|2068276|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1036266|NCT01709162|2068285|FG000|Overall Study|Disease progression|3
1036267|NCT01709162|2068286|FG001|Overall Study|Disease progression|3
1036268|NCT01709162|2068285|FG000|Overall Study|Study drug toxicity|2
1036269|NCT01709162|2068286|FG001|Overall Study|Study drug toxicity|0
1036270|NCT01709162|2068285|FG000|Overall Study|Administrative reason by sponsor|0
1036271|NCT01709162|2068286|FG001|Overall Study|Administrative reason by sponsor|1
1036272|NCT01709162|2068285|FG000|Overall Study|Other|1
1036273|NCT01709162|2068286|FG001|Overall Study|Other|0
1036274|NCT01709162|2068285|FG000|Overall Study|Withdrawal by Subject|0
1036275|NCT01709162|2068286|FG001|Overall Study|Withdrawal by Subject|1
1036276|NCT01709227|2068294|FG000|Overall Study|Physician Decision|1
1036277|NCT01709227|2068295|FG001|Overall Study|Physician Decision|0
1036278|NCT01709227|2068294|FG000|Overall Study|Pleural Peritoneal communication|0
1036279|NCT01709227|2068295|FG001|Overall Study|Pleural Peritoneal communication|9
1036280|NCT01709305|2068302|FG000|Phase 1|Clinical Adverse Event|80
1036281|NCT01709305|2068303|FG001|Phase 1|Clinical Adverse Event|0
1036282|NCT01709305|2068304|FG002|Phase 1|Clinical Adverse Event|0
1036283|NCT01709305|2068305|FG003|Phase 1|Clinical Adverse Event|0
1036284|NCT01709305|2068306|FG004|Phase 1|Clinical Adverse Event|0
1036285|NCT01709305|2068302|FG000|Phase 1|Death|2
1036286|NCT01709305|2068303|FG001|Phase 1|Death|0
1036287|NCT01709305|2068304|FG002|Phase 1|Death|0
1036288|NCT01709305|2068305|FG003|Phase 1|Death|0
1036289|NCT01709305|2068306|FG004|Phase 1|Death|0
1036290|NCT01709305|2068302|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13
1036291|NCT01709305|2068303|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0
1036292|NCT01709305|2068304|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0
1036293|NCT01709305|2068305|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0
1036294|NCT01709305|2068306|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0
1036295|NCT01709305|2068302|FG000|Phase 1|Laboratory Adverse Event|16
1036296|NCT01709305|2068303|FG001|Phase 1|Laboratory Adverse Event|0
1036297|NCT01709305|2068304|FG002|Phase 1|Laboratory Adverse Event|0
1036298|NCT01709305|2068305|FG003|Phase 1|Laboratory Adverse Event|0
1036299|NCT01709305|2068306|FG004|Phase 1|Laboratory Adverse Event|0
1036300|NCT01709305|2068302|FG000|Phase 1|Lost to Follow-up|147
1036301|NCT01709305|2068303|FG001|Phase 1|Lost to Follow-up|0
1036302|NCT01709305|2068304|FG002|Phase 1|Lost to Follow-up|0
1036303|NCT01709305|2068305|FG003|Phase 1|Lost to Follow-up|0
1036304|NCT01709305|2068306|FG004|Phase 1|Lost to Follow-up|0
1036305|NCT01709305|2068302|FG000|Phase 1|Travel, moving, etc.|30
1036306|NCT01709305|2068303|FG001|Phase 1|Travel, moving, etc.|0
1036307|NCT01709305|2068304|FG002|Phase 1|Travel, moving, etc.|0
1036308|NCT01709305|2068305|FG003|Phase 1|Travel, moving, etc.|0
1036309|NCT01709305|2068306|FG004|Phase 1|Travel, moving, etc.|0
1036310|NCT01709305|2068302|FG000|Phase 1|Physician Decision|13
1036311|NCT01709305|2068303|FG001|Phase 1|Physician Decision|0
1036312|NCT01709305|2068304|FG002|Phase 1|Physician Decision|0
1036313|NCT01709305|2068305|FG003|Phase 1|Physician Decision|0
1036314|NCT01709305|2068306|FG004|Phase 1|Physician Decision|0
1036315|NCT01709305|2068302|FG000|Phase 1|Protocol Violation|118
1036316|NCT01709305|2068303|FG001|Phase 1|Protocol Violation|0
1036317|NCT01709305|2068304|FG002|Phase 1|Protocol Violation|0
1036318|NCT01709305|2068305|FG003|Phase 1|Protocol Violation|0
1036319|NCT01709305|2068306|FG004|Phase 1|Protocol Violation|0
1036320|NCT01709305|2068302|FG000|Phase 1|Withdrawal by Subject|218
1036321|NCT01709305|2068303|FG001|Phase 1|Withdrawal by Subject|0
1036322|NCT01709305|2068304|FG002|Phase 1|Withdrawal by Subject|0
1036323|NCT01709305|2068305|FG003|Phase 1|Withdrawal by Subject|0
1036324|NCT01709305|2068306|FG004|Phase 1|Withdrawal by Subject|0
1036325|NCT01709305|2068302|FG000|Phase 2|Clinical Adverse Event|0
1036326|NCT01709305|2068303|FG001|Phase 2|Clinical Adverse Event|10
1036327|NCT01709305|2068304|FG002|Phase 2|Clinical Adverse Event|10
1036328|NCT01709305|2068305|FG003|Phase 2|Clinical Adverse Event|6
1036329|NCT01709305|2068306|FG004|Phase 2|Clinical Adverse Event|11
1036330|NCT01709305|2068302|FG000|Phase 2|Death|0
1036331|NCT01709305|2068303|FG001|Phase 2|Death|0
1036332|NCT01709305|2068304|FG002|Phase 2|Death|1
1036333|NCT01709305|2068305|FG003|Phase 2|Death|0
1036334|NCT01709305|2068306|FG004|Phase 2|Death|0
1036335|NCT01709305|2068302|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0
1036336|NCT01709305|2068303|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0
1036337|NCT01709305|2068304|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0
1036338|NCT01709305|2068305|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0
1036339|NCT01709305|2068306|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2
1036340|NCT01709305|2068302|FG000|Phase 2|Laboratory Adverse Event|0
1036341|NCT01709305|2068303|FG001|Phase 2|Laboratory Adverse Event|1
1036342|NCT01709305|2068304|FG002|Phase 2|Laboratory Adverse Event|0
1036343|NCT01709305|2068305|FG003|Phase 2|Laboratory Adverse Event|1
1036344|NCT01709305|2068306|FG004|Phase 2|Laboratory Adverse Event|1
1036345|NCT01709305|2068302|FG000|Phase 2|Lost to Follow-up|0
1036346|NCT01709305|2068303|FG001|Phase 2|Lost to Follow-up|10
1036347|NCT01709305|2068304|FG002|Phase 2|Lost to Follow-up|6
1036348|NCT01709305|2068305|FG003|Phase 2|Lost to Follow-up|9
1036349|NCT01709305|2068306|FG004|Phase 2|Lost to Follow-up|5
1036350|NCT01709305|2068302|FG000|Phase 2|Travel, moving, etc.|0
1036351|NCT01709305|2068303|FG001|Phase 2|Travel, moving, etc.|2
1036352|NCT01709305|2068304|FG002|Phase 2|Travel, moving, etc.|3
1036353|NCT01709305|2068305|FG003|Phase 2|Travel, moving, etc.|3
1036354|NCT01709305|2068306|FG004|Phase 2|Travel, moving, etc.|5
1036355|NCT01709305|2068302|FG000|Phase 2|Physician Decision|0
1036356|NCT01709305|2068303|FG001|Phase 2|Physician Decision|2
1036357|NCT01709305|2068304|FG002|Phase 2|Physician Decision|0
1036358|NCT01709305|2068305|FG003|Phase 2|Physician Decision|1
1036359|NCT01709305|2068306|FG004|Phase 2|Physician Decision|2
1036360|NCT01709305|2068302|FG000|Phase 2|Protocol Violation|0
1036361|NCT01709305|2068303|FG001|Phase 2|Protocol Violation|19
1036362|NCT01709305|2068304|FG002|Phase 2|Protocol Violation|19
1036363|NCT01709305|2068305|FG003|Phase 2|Protocol Violation|13
1036364|NCT01709305|2068306|FG004|Phase 2|Protocol Violation|9
1036365|NCT01709305|2068302|FG000|Phase 2|Withdrawal by Subject|0
1036366|NCT01709305|2068303|FG001|Phase 2|Withdrawal by Subject|8
1036367|NCT01709305|2068304|FG002|Phase 2|Withdrawal by Subject|6
1036368|NCT01709305|2068305|FG003|Phase 2|Withdrawal by Subject|15
1036369|NCT01709305|2068306|FG004|Phase 2|Withdrawal by Subject|12
1036370|NCT01709318|2068328|FG000|Overall Study|Adverse Event|3
1036371|NCT01709318|2068329|FG001|Overall Study|Adverse Event|4
1036372|NCT01709318|2068330|FG002|Overall Study|Adverse Event|2
1036373|NCT01709318|2068331|FG003|Overall Study|Adverse Event|2
1036374|NCT01709318|2068332|FG004|Overall Study|Adverse Event|0
1036375|NCT01709318|2068333|FG005|Overall Study|Adverse Event|1
1036376|NCT01709318|2068334|FG006|Overall Study|Adverse Event|2
1036377|NCT01709318|2068328|FG000|Overall Study|Lost to Follow-up|2
1036378|NCT01709318|2068329|FG001|Overall Study|Lost to Follow-up|0
1036379|NCT01709318|2068330|FG002|Overall Study|Lost to Follow-up|0
1036380|NCT01709318|2068331|FG003|Overall Study|Lost to Follow-up|0
1036381|NCT01709318|2068332|FG004|Overall Study|Lost to Follow-up|1
1036382|NCT01709318|2068333|FG005|Overall Study|Lost to Follow-up|1
1036383|NCT01709318|2068334|FG006|Overall Study|Lost to Follow-up|1
1162028|NCT03380429|2283931|FG004|Overall Study|Adverse Event|0
1036384|NCT01709318|2068328|FG000|Overall Study|Non-compliance with Study Drug|0
1036385|NCT01709318|2068329|FG001|Overall Study|Non-compliance with Study Drug|2
1036386|NCT01709318|2068330|FG002|Overall Study|Non-compliance with Study Drug|1
1036387|NCT01709318|2068331|FG003|Overall Study|Non-compliance with Study Drug|1
1036388|NCT01709318|2068332|FG004|Overall Study|Non-compliance with Study Drug|0
1036389|NCT01709318|2068333|FG005|Overall Study|Non-compliance with Study Drug|0
1036390|NCT01709318|2068334|FG006|Overall Study|Non-compliance with Study Drug|2
1036391|NCT01709318|2068328|FG000|Overall Study|Physician Decision|0
1036392|NCT01709318|2068329|FG001|Overall Study|Physician Decision|0
1036393|NCT01709318|2068330|FG002|Overall Study|Physician Decision|0
1036394|NCT01709318|2068331|FG003|Overall Study|Physician Decision|0
1036395|NCT01709318|2068332|FG004|Overall Study|Physician Decision|0
1036396|NCT01709318|2068333|FG005|Overall Study|Physician Decision|0
1036397|NCT01709318|2068334|FG006|Overall Study|Physician Decision|1
1036398|NCT01709318|2068328|FG000|Overall Study|Pregnancy|0
1036399|NCT01709318|2068329|FG001|Overall Study|Pregnancy|0
1036400|NCT01709318|2068330|FG002|Overall Study|Pregnancy|0
1036401|NCT01709318|2068331|FG003|Overall Study|Pregnancy|0
1036402|NCT01709318|2068332|FG004|Overall Study|Pregnancy|1
1036403|NCT01709318|2068333|FG005|Overall Study|Pregnancy|0
1036404|NCT01709318|2068334|FG006|Overall Study|Pregnancy|0
1036405|NCT01709318|2068328|FG000|Overall Study|Protocol Violation|0
1036406|NCT01709318|2068329|FG001|Overall Study|Protocol Violation|0
1036407|NCT01709318|2068330|FG002|Overall Study|Protocol Violation|0
1036408|NCT01709318|2068331|FG003|Overall Study|Protocol Violation|0
1036409|NCT01709318|2068332|FG004|Overall Study|Protocol Violation|2
1036410|NCT01709318|2068333|FG005|Overall Study|Protocol Violation|0
1036411|NCT01709318|2068334|FG006|Overall Study|Protocol Violation|1
1036412|NCT01709318|2068328|FG000|Overall Study|Technical Problems|1
1036413|NCT01709318|2068329|FG001|Overall Study|Technical Problems|0
1036414|NCT01709318|2068330|FG002|Overall Study|Technical Problems|0
1036415|NCT01709318|2068331|FG003|Overall Study|Technical Problems|0
1036416|NCT01709318|2068332|FG004|Overall Study|Technical Problems|0
1036417|NCT01709318|2068333|FG005|Overall Study|Technical Problems|0
1036418|NCT01709318|2068334|FG006|Overall Study|Technical Problems|0
1036419|NCT01709318|2068328|FG000|Overall Study|Withdrawal by Subject|3
1036420|NCT01709318|2068329|FG001|Overall Study|Withdrawal by Subject|0
1036421|NCT01709318|2068330|FG002|Overall Study|Withdrawal by Subject|3
1036422|NCT01709318|2068331|FG003|Overall Study|Withdrawal by Subject|3
1036423|NCT01709318|2068332|FG004|Overall Study|Withdrawal by Subject|0
1036424|NCT01709318|2068333|FG005|Overall Study|Withdrawal by Subject|2
1036425|NCT01709318|2068334|FG006|Overall Study|Withdrawal by Subject|4
1036426|NCT01709318|2068328|FG000|Overall Study|Other Protocol Specified Criteria|0
1036427|NCT01709318|2068329|FG001|Overall Study|Other Protocol Specified Criteria|1
1036428|NCT01709318|2068330|FG002|Overall Study|Other Protocol Specified Criteria|0
1036429|NCT01709318|2068331|FG003|Overall Study|Other Protocol Specified Criteria|0
1036430|NCT01709318|2068332|FG004|Overall Study|Other Protocol Specified Criteria|0
1036431|NCT01709318|2068333|FG005|Overall Study|Other Protocol Specified Criteria|0
1036432|NCT01709318|2068334|FG006|Overall Study|Other Protocol Specified Criteria|0
1036433|NCT01709331|2068350|FG000|Overall Study|Adverse Event|1
1036434|NCT01709383|2068356|FG000|Overall Study|Lost to Follow-up|1
1036435|NCT01709383|2068357|FG001|Overall Study|Lost to Follow-up|0
1036436|NCT01709409|2068367|FG000|Overall Study|Protocol Violation|1
1036437|NCT01709409|2068368|FG001|Overall Study|Protocol Violation|0
1036438|NCT01709500|2068396|FG000|Overall Study|Randomized but not treated|0
1036439|NCT01709500|2068397|FG001|Overall Study|Randomized but not treated|1
1036440|NCT01709500|2068396|FG000|Overall Study|Adverse Event|5
1036441|NCT01709500|2068397|FG001|Overall Study|Adverse Event|1
1036442|NCT01709500|2068396|FG000|Overall Study|Poor compliance to protocol|2
1036443|NCT01709500|2068397|FG001|Overall Study|Poor compliance to protocol|1
1036444|NCT01709500|2068396|FG000|Overall Study|Other|3
1036445|NCT01709500|2068397|FG001|Overall Study|Other|1
1036446|NCT01709500|2068396|FG000|Overall Study|Related to IMP administration|1
1036447|NCT01709500|2068397|FG001|Overall Study|Related to IMP administration|0
1036448|NCT01709500|2068396|FG000|Overall Study|Treatment ongoing|156
1036449|NCT01709500|2068397|FG001|Overall Study|Treatment ongoing|78
1036450|NCT01709513|2068406|FG000|Overall Study|Randomized but not treated|0
1036451|NCT01709513|2068407|FG001|Overall Study|Randomized but not treated|1
1036452|NCT01709513|2068408|FG002|Overall Study|Randomized but not treated|0
1036453|NCT01709513|2068406|FG000|Overall Study|Adverse Event|16
1036454|NCT01709513|2068407|FG001|Overall Study|Adverse Event|31
1036455|NCT01709513|2068408|FG002|Overall Study|Adverse Event|23
1036456|NCT01709513|2068406|FG000|Overall Study|Poor compliance to protocol|2
1036457|NCT01709513|2068407|FG001|Overall Study|Poor compliance to protocol|0
1036458|NCT01709513|2068408|FG002|Overall Study|Poor compliance to protocol|0
1036459|NCT01709513|2068406|FG000|Overall Study|Other|3
1036460|NCT01709513|2068407|FG001|Overall Study|Other|11
1036461|NCT01709513|2068408|FG002|Overall Study|Other|7
1036462|NCT01709578|2068422|FG000|Overall Study|Rescued and entered in long term safety|63
1036463|NCT01709578|2068423|FG001|Overall Study|Rescued and entered in long term safety|25
1036464|NCT01709578|2068424|FG002|Overall Study|Rescued and entered in long term safety|26
1036465|NCT01709578|2068422|FG000|Overall Study|Adverse Event|9
1036466|NCT01709578|2068423|FG001|Overall Study|Adverse Event|18
1036467|NCT01709578|2068424|FG002|Overall Study|Adverse Event|17
1036468|NCT01709578|2068422|FG000|Overall Study|Lack of Efficacy|5
1036469|NCT01709578|2068423|FG001|Overall Study|Lack of Efficacy|4
1036470|NCT01709578|2068424|FG002|Overall Study|Lack of Efficacy|2
1036471|NCT01709578|2068422|FG000|Overall Study|Poor compliance to protocol|1
1036472|NCT01709578|2068423|FG001|Overall Study|Poor compliance to protocol|2
1036473|NCT01709578|2068424|FG002|Overall Study|Poor compliance to protocol|1
1036474|NCT01709578|2068422|FG000|Overall Study|Other, not related to safety or efficacy|2
1036475|NCT01709578|2068423|FG001|Overall Study|Other, not related to safety or efficacy|7
1036476|NCT01709578|2068424|FG002|Overall Study|Other, not related to safety or efficacy|5
1036477|NCT01709695|2068434|FG000|Overall Study|Withdrawal by Subject|1
1036478|NCT01709695|2068435|FG001|Overall Study|Withdrawal by Subject|1
1036479|NCT01709708|2068443|FG000|Overall Study|Protocol Violation|1
1036480|NCT01709708|2068444|FG001|Overall Study|Protocol Violation|2
1036481|NCT01709721|2068454|FG000|Open Label Phase|Withdrawal by Subject|0
1036482|NCT01709721|2068455|FG001|Open Label Phase|Withdrawal by Subject|0
1036483|NCT01709721|2068456|FG002|Open Label Phase|Withdrawal by Subject|5
1036484|NCT01709721|2068454|FG000|Open Label Phase|Adverse Event|0
1036485|NCT01709721|2068455|FG001|Open Label Phase|Adverse Event|0
1036486|NCT01709721|2068456|FG002|Open Label Phase|Adverse Event|8
1036487|NCT01709721|2068454|FG000|Open Label Phase|Non-compliance With Study Drug|0
1036488|NCT01709721|2068455|FG001|Open Label Phase|Non-compliance With Study Drug|0
1036489|NCT01709721|2068456|FG002|Open Label Phase|Non-compliance With Study Drug|3
1036490|NCT01709721|2068454|FG000|Open Label Phase|Investigator Decision|0
1036491|NCT01709721|2068455|FG001|Open Label Phase|Investigator Decision|0
1036492|NCT01709721|2068456|FG002|Open Label Phase|Investigator Decision|1
1036493|NCT01709721|2068454|FG000|Open Label Phase|Sponsor Decision|0
1036494|NCT01709721|2068455|FG001|Open Label Phase|Sponsor Decision|0
1036495|NCT01709721|2068456|FG002|Open Label Phase|Sponsor Decision|2
1036496|NCT01709721|2068454|FG000|Open Label Phase|Protocol Violation|0
1036497|NCT01709721|2068455|FG001|Open Label Phase|Protocol Violation|0
1036498|NCT01709721|2068456|FG002|Open Label Phase|Protocol Violation|1
1036499|NCT01709721|2068454|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
1036500|NCT01709721|2068455|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
1036501|NCT01709721|2068456|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1
1036502|NCT01709721|2068454|FG000|Open Label Phase|Inadequate Pain Control|0
1036503|NCT01709721|2068455|FG001|Open Label Phase|Inadequate Pain Control|0
1036504|NCT01709721|2068456|FG002|Open Label Phase|Inadequate Pain Control|37
1036505|NCT01709721|2068454|FG000|Open Label Phase|Other, Specify in text field in database|0
1036506|NCT01709721|2068455|FG001|Open Label Phase|Other, Specify in text field in database|0
1036507|NCT01709721|2068456|FG002|Open Label Phase|Other, Specify in text field in database|14
1036508|NCT01709721|2068454|FG000|Randomized Phase|Adverse Event|0
1036509|NCT01709721|2068455|FG001|Randomized Phase|Adverse Event|1
1036510|NCT01709721|2068456|FG002|Randomized Phase|Adverse Event|0
1036511|NCT01709721|2068454|FG000|Randomized Phase|Lost to Follow-up|1
1036512|NCT01709721|2068455|FG001|Randomized Phase|Lost to Follow-up|0
1036513|NCT01709721|2068456|FG002|Randomized Phase|Lost to Follow-up|0
1036514|NCT01709721|2068454|FG000|Randomized Phase|Inadequate Pain Control|1
1036515|NCT01709721|2068455|FG001|Randomized Phase|Inadequate Pain Control|2
1036516|NCT01709721|2068456|FG002|Randomized Phase|Inadequate Pain Control|0
1036517|NCT01709721|2068454|FG000|Randomized Phase|Other, Specify text field in database|1
1036518|NCT01709721|2068455|FG001|Randomized Phase|Other, Specify text field in database|3
1036519|NCT01709721|2068456|FG002|Randomized Phase|Other, Specify text field in database|0
1036520|NCT01709838|2068488|FG000|Overall Study|Withdrawal by Subject|21
1036521|NCT01709838|2068488|FG000|Overall Study|Lost to Follow-up|16
1036522|NCT01709838|2068488|FG000|Overall Study|Pregnancy|10
1036523|NCT01709838|2068488|FG000|Overall Study|Subject/guardian decision|8
1036524|NCT01709838|2068488|FG000|Overall Study|Adverse Event|4
1036525|NCT01709838|2068488|FG000|Overall Study|Physician Decision|4
1036526|NCT01709838|2068488|FG000|Overall Study|Death|3
1036527|NCT01709838|2068488|FG000|Overall Study|Protocol Violation|1
1036528|NCT01709864|2068496|FG000|Overall Study|Physician Decision|0
1036529|NCT01709864|2068497|FG001|Overall Study|Physician Decision|1
1036530|NCT01709864|2068496|FG000|Overall Study|subject/guardian decision|5
1036531|NCT01709864|2068497|FG001|Overall Study|subject/guardian decision|6
1036532|NCT01709864|2068496|FG000|Overall Study|Lost to Follow-up|1
1036533|NCT01709864|2068497|FG001|Overall Study|Lost to Follow-up|0
1036534|NCT01709864|2068496|FG000|Overall Study|non-compliance with study treatment|1
1036535|NCT01709864|2068497|FG001|Overall Study|non-compliance with study treatment|1
1036536|NCT01709864|2068496|FG000|Overall Study|Adverse Event|0
1036537|NCT01709864|2068497|FG001|Overall Study|Adverse Event|2
1036538|NCT01709864|2068496|FG000|Overall Study|Death|0
1036539|NCT01709864|2068497|FG001|Overall Study|Death|1
1036540|NCT01709903|2068505|FG000|Overall Study|administrative problems|2
1036541|NCT01709903|2068506|FG001|Overall Study|administrative problems|6
1036542|NCT01709903|2068505|FG000|Overall Study|Abnormal test procedure results|1
1036543|NCT01709903|2068506|FG001|Overall Study|Abnormal test procedure results|0
1036544|NCT01709903|2068505|FG000|Overall Study|In ability to use device|1
1036545|NCT01709903|2068506|FG001|Overall Study|In ability to use device|1
1036546|NCT01709903|2068505|FG000|Overall Study|no longer needed study drug|0
1036547|NCT01709903|2068506|FG001|Overall Study|no longer needed study drug|1
1036548|NCT01709903|2068505|FG000|Overall Study|Lost to Follow-up|0
1036549|NCT01709903|2068506|FG001|Overall Study|Lost to Follow-up|2
906370|NCT00767806|1882006|FG000|Overall Study|Physician Decision|4
906371|NCT00767806|1882007|FG001|Overall Study|Physician Decision|3
1036550|NCT01709903|2068505|FG000|Overall Study|Death|2
1036551|NCT01709903|2068506|FG001|Overall Study|Death|0
1036552|NCT01709903|2068505|FG000|Overall Study|Protocol Violation|3
1036553|NCT01709903|2068506|FG001|Overall Study|Protocol Violation|2
1036554|NCT01709903|2068505|FG000|Overall Study|Lack of Efficacy|3
1036555|NCT01709903|2068506|FG001|Overall Study|Lack of Efficacy|3
1036556|NCT01709903|2068505|FG000|Overall Study|Withdrawal by Subject|6
1036557|NCT01709903|2068506|FG001|Overall Study|Withdrawal by Subject|6
1036558|NCT01709903|2068505|FG000|Overall Study|Adverse Event|11
1036559|NCT01709903|2068506|FG001|Overall Study|Adverse Event|18
1036560|NCT01710020|2068521|FG000|Period 1|Protocol Violation|1
1036561|NCT01710033|2068531|FG000|Stage 2|Adverse Event|0
1036562|NCT01710033|2068532|FG001|Stage 2|Adverse Event|0
1036563|NCT01710033|2068533|FG002|Stage 2|Adverse Event|0
1036564|NCT01710033|2068534|FG003|Stage 2|Adverse Event|0
1036565|NCT01710033|2068535|FG004|Stage 2|Adverse Event|1
1036566|NCT01710046|2068550|FG000|Overall Study|Lost to Follow-up|1
1036567|NCT01710046|2068551|FG001|Overall Study|Lost to Follow-up|0
1036568|NCT01710345|2068592|FG000|Overall Study|Adverse Event|0
1036569|NCT01710345|2068593|FG001|Overall Study|Adverse Event|2
1036570|NCT01710345|2068594|FG002|Overall Study|Adverse Event|0
1036571|NCT01710345|2068592|FG000|Overall Study|Lack of Efficacy|2
1036572|NCT01710345|2068593|FG001|Overall Study|Lack of Efficacy|3
1036573|NCT01710345|2068594|FG002|Overall Study|Lack of Efficacy|1
1036574|NCT01710345|2068592|FG000|Overall Study|Drug Dosing Error|1
1036575|NCT01710345|2068593|FG001|Overall Study|Drug Dosing Error|0
1036576|NCT01710345|2068594|FG002|Overall Study|Drug Dosing Error|0
1036577|NCT01710358|2068605|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
1036578|NCT01710358|2068606|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
1036579|NCT01710358|2068607|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
1036580|NCT01710358|2068605|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0
1036581|NCT01710358|2068606|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2
1036582|NCT01710358|2068607|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0
1036583|NCT01710358|2068605|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
1036584|NCT01710358|2068606|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
1036585|NCT01710358|2068607|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
1036586|NCT01710358|2068605|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
1036587|NCT01710358|2068606|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
1036588|NCT01710358|2068607|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
1036589|NCT01710358|2068605|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
1036590|NCT01710358|2068606|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
1036591|NCT01710358|2068607|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
1036592|NCT01710358|2068605|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
1036593|NCT01710358|2068606|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
1036594|NCT01710358|2068607|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
1036595|NCT01710358|2068605|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
1036596|NCT01710358|2068606|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
1036597|NCT01710358|2068607|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
1036598|NCT01710358|2068605|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
1036599|NCT01710358|2068606|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
1036600|NCT01710358|2068607|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
1036601|NCT01710358|2068605|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
1036602|NCT01710358|2068606|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
1036603|NCT01710358|2068607|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
1036604|NCT01710358|2068605|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
1036605|NCT01710358|2068606|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
1036606|NCT01710358|2068607|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
1036607|NCT01710358|2068605|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1
1036608|NCT01710358|2068606|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0
1036609|NCT01710358|2068607|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1
1036610|NCT01710358|2068605|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
1036611|NCT01710358|2068606|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
1036612|NCT01710358|2068607|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
1036613|NCT01710358|2068605|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
1036614|NCT01710358|2068606|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
1036615|NCT01710358|2068607|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
1036616|NCT01710358|2068605|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
1036617|NCT01710358|2068606|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
1036618|NCT01710358|2068607|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
1036619|NCT01710358|2068605|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
1036620|NCT01710358|2068606|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
1036621|NCT01710358|2068607|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
1036622|NCT01710358|2068605|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
1036623|NCT01710358|2068606|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
1036624|NCT01710358|2068607|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
1036625|NCT01710358|2068605|FG000|Rescue Period|Adverse Event|0
1036626|NCT01710358|2068606|FG001|Rescue Period|Adverse Event|15
1036627|NCT01710358|2068607|FG002|Rescue Period|Adverse Event|0
1036628|NCT01710358|2068605|FG000|Rescue Period|Death|0
1036629|NCT01710358|2068606|FG001|Rescue Period|Death|1
1036630|NCT01710358|2068607|FG002|Rescue Period|Death|0
1036631|NCT01710358|2068605|FG000|Rescue Period|Lack of Efficacy|0
1036632|NCT01710358|2068606|FG001|Rescue Period|Lack of Efficacy|7
1036633|NCT01710358|2068607|FG002|Rescue Period|Lack of Efficacy|0
1036634|NCT01710358|2068605|FG000|Rescue Period|Withdrawal by Subject|0
1036635|NCT01710358|2068606|FG001|Rescue Period|Withdrawal by Subject|8
1036636|NCT01710358|2068607|FG002|Rescue Period|Withdrawal by Subject|0
1036637|NCT01710501|2068631|FG000|Overall Study|Lost to Follow-up|2
1036638|NCT01710501|2068632|FG001|Overall Study|Lost to Follow-up|0
1036639|NCT01710501|2068633|FG002|Overall Study|Lost to Follow-up|0
1036640|NCT01710514|2068643|FG000|Overall Study|Adverse Event|6
1036641|NCT01710514|2068644|FG001|Overall Study|Adverse Event|7
1036642|NCT01710514|2068643|FG000|Overall Study|Withdrawal by Subject|1
1036643|NCT01710514|2068644|FG001|Overall Study|Withdrawal by Subject|0
1036644|NCT01710527|2068653|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0
1036645|NCT01710527|2068654|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1
1036646|NCT01710657|2068663|FG000|Overall Study|Lost to Follow-up|2
1036647|NCT01710657|2068664|FG001|Overall Study|Lost to Follow-up|0
1036648|NCT01710657|2068665|FG002|Overall Study|Lost to Follow-up|1
1036649|NCT01710657|2068663|FG000|Overall Study|Protocol Violation|2
1036650|NCT01710657|2068664|FG001|Overall Study|Protocol Violation|2
1036651|NCT01710657|2068665|FG002|Overall Study|Protocol Violation|0
1036652|NCT01710657|2068663|FG000|Overall Study|Adverse Event|14
1036653|NCT01710657|2068664|FG001|Overall Study|Adverse Event|8
1036654|NCT01710657|2068665|FG002|Overall Study|Adverse Event|28
1036655|NCT01710657|2068663|FG000|Overall Study|Withdrawal by Subject|0
1036656|NCT01710657|2068664|FG001|Overall Study|Withdrawal by Subject|1
1036657|NCT01710657|2068665|FG002|Overall Study|Withdrawal by Subject|2
1036658|NCT01710657|2068663|FG000|Overall Study|Lack of Efficacy|0
1036659|NCT01710657|2068664|FG001|Overall Study|Lack of Efficacy|1
1036660|NCT01710657|2068665|FG002|Overall Study|Lack of Efficacy|1
1036661|NCT01710709|2068673|FG000|Overall Study|Lost to Follow-up|29
1036662|NCT01710709|2068673|FG000|Overall Study|Adverse Event|48
1036663|NCT01710709|2068673|FG000|Overall Study|Participant met withdrawal criteria|33
1036664|NCT01710709|2068673|FG000|Overall Study|Participant withdrawn by investigator|2
1036665|NCT01710709|2068673|FG000|Overall Study|Withdrawal by Subject|53
1036666|NCT01710709|2068673|FG000|Overall Study|Protocol Violation|5
1036667|NCT01710709|2068673|FG000|Overall Study|Lack of Efficacy|3
1036668|NCT01710800|2068691|FG000|Overall Study|Withdrawal by Subject|21
1036669|NCT01710800|2068691|FG000|Overall Study|Protocol Violation|1
1036670|NCT01711216|2068728|FG000|Overall Study|Adverse Event|4
1036671|NCT01711216|2068728|FG000|Overall Study|Pregnancy|56
1036672|NCT01711216|2068728|FG000|Overall Study|Withdrawal by Subject|6
1036673|NCT01711216|2068728|FG000|Overall Study|Lost to Follow-up|46
1036674|NCT01711216|2068728|FG000|Overall Study|variety of other minor reasons|83
1036675|NCT01711216|2068728|FG000|Overall Study|no reason specified|22
1036676|NCT01711359|2068748|FG000|Treatment Period|Withdrawal by Subject|18
1036677|NCT01711359|2068749|FG001|Treatment Period|Withdrawal by Subject|7
1036678|NCT01711359|2068750|FG002|Treatment Period|Withdrawal by Subject|13
1036679|NCT01711359|2068748|FG000|Treatment Period|Lack of Efficacy|13
1036680|NCT01711359|2068749|FG001|Treatment Period|Lack of Efficacy|2
1036681|NCT01711359|2068750|FG002|Treatment Period|Lack of Efficacy|2
1036682|NCT01711359|2068748|FG000|Treatment Period|Adverse Event|8
1036683|NCT01711359|2068749|FG001|Treatment Period|Adverse Event|10
1036684|NCT01711359|2068750|FG002|Treatment Period|Adverse Event|24
1036685|NCT01711359|2068748|FG000|Treatment Period|Physician Decision|4
1036686|NCT01711359|2068749|FG001|Treatment Period|Physician Decision|3
1036687|NCT01711359|2068750|FG002|Treatment Period|Physician Decision|2
1036688|NCT01711359|2068748|FG000|Treatment Period|Death|3
1036689|NCT01711359|2068749|FG001|Treatment Period|Death|0
1036690|NCT01711359|2068750|FG002|Treatment Period|Death|0
1036691|NCT01711359|2068748|FG000|Treatment Period|Entry Criteria Not Met|1
1036692|NCT01711359|2068749|FG001|Treatment Period|Entry Criteria Not Met|0
1036693|NCT01711359|2068750|FG002|Treatment Period|Entry Criteria Not Met|0
1036694|NCT01711359|2068748|FG000|Treatment Period|Sponsor Decision|1
1036695|NCT01711359|2068749|FG001|Treatment Period|Sponsor Decision|0
1036696|NCT01711359|2068750|FG002|Treatment Period|Sponsor Decision|0
1036697|NCT01711359|2068748|FG000|Treatment Period|Lost to Follow-up|1
1036698|NCT01711359|2068749|FG001|Treatment Period|Lost to Follow-up|1
1036699|NCT01711359|2068750|FG002|Treatment Period|Lost to Follow-up|1
1036700|NCT01711359|2068748|FG000|Treatment Period|Randomized, Not Treated|3
1036701|NCT01711359|2068749|FG001|Treatment Period|Randomized, Not Treated|1
1036702|NCT01711359|2068750|FG002|Treatment Period|Randomized, Not Treated|0
1036713|NCT01711619|2068803|FG000|Overall Study|Early study termination|10
1036714|NCT01711619|2068804|FG001|Overall Study|Early study termination|14
1036715|NCT01711619|2068803|FG000|Overall Study|Withdrawal by Subject|3
1036716|NCT01711619|2068804|FG001|Overall Study|Withdrawal by Subject|7
1036717|NCT01711619|2068803|FG000|Overall Study|Protocol Violation|2
1036718|NCT01711619|2068804|FG001|Overall Study|Protocol Violation|3
1036719|NCT01711619|2068803|FG000|Overall Study|Adverse Event|2
1036720|NCT01711619|2068804|FG001|Overall Study|Adverse Event|0
1036721|NCT01711619|2068803|FG000|Overall Study|Lost to Follow-up|1
1036722|NCT01711619|2068804|FG001|Overall Study|Lost to Follow-up|0
1036723|NCT01711645|2068810|FG000|Overall Study|Withdrawal by Subject|8
1036724|NCT01711645|2068810|FG000|Overall Study|Lost to Follow-up|6
1036725|NCT01711645|2068810|FG000|Overall Study|Physician Decision|5
1036726|NCT01711736|2068825|FG000|Overall Study|Lost to Follow-up|4
1036727|NCT01711736|2068826|FG001|Overall Study|Lost to Follow-up|1
1036728|NCT01711736|2068825|FG000|Overall Study|Withdrawal by Subject|6
1036729|NCT01711736|2068826|FG001|Overall Study|Withdrawal by Subject|6
1036730|NCT01711736|2068825|FG000|Overall Study|Migrated/moved from study area|2
1036731|NCT01711736|2068826|FG001|Overall Study|Migrated/moved from study area|1
1036732|NCT01711853|2068833|FG000|Overall Study|Not treated|3
1036733|NCT01711866|2068837|FG000|Overall Study|Noncompliant|3
1036734|NCT01711866|2068837|FG000|Overall Study|Withdrawal by Subject|3
1036735|NCT01711866|2068837|FG000|Overall Study|Adverse Event|2
1036736|NCT01711879|2068843|FG000|Overall Study|Death|1
1036737|NCT01711879|2068844|FG001|Overall Study|Death|0
1036738|NCT01711983|2068856|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32
1036739|NCT01711983|2068856|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26
1036740|NCT01711983|2068856|FG000|36-Month Closure Evaluation|Test Device Removal|2
1036741|NCT01711983|2068856|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62
1036742|NCT01712009|2068863|FG000|Overall Study|Withdrawal by Subject|24
1036743|NCT01712009|2068864|FG001|Overall Study|Withdrawal by Subject|15
1036744|NCT01712009|2068865|FG002|Overall Study|Withdrawal by Subject|8
1036745|NCT01712009|2068863|FG000|Overall Study|Lost to Follow-up|2
1036746|NCT01712009|2068864|FG001|Overall Study|Lost to Follow-up|0
1036747|NCT01712009|2068865|FG002|Overall Study|Lost to Follow-up|1
1036748|NCT01712009|2068863|FG000|Overall Study|Decision by Sponsor|12
1036749|NCT01712009|2068864|FG001|Overall Study|Decision by Sponsor|14
1036750|NCT01712009|2068865|FG002|Overall Study|Decision by Sponsor|12
1036751|NCT01712061|2068875|FG000|Overall Study|Adverse Event|4
1036752|NCT01712061|2068876|FG001|Overall Study|Adverse Event|9
1036753|NCT01712061|2068877|FG002|Overall Study|Adverse Event|5
1036754|NCT01712061|2068875|FG000|Overall Study|Death|0
1036755|NCT01712061|2068876|FG001|Overall Study|Death|0
1036756|NCT01712061|2068877|FG002|Overall Study|Death|1
1036757|NCT01712061|2068875|FG000|Overall Study|Lost to Follow-up|1
1036758|NCT01712061|2068876|FG001|Overall Study|Lost to Follow-up|0
1036759|NCT01712061|2068877|FG002|Overall Study|Lost to Follow-up|1
1036760|NCT01712061|2068875|FG000|Overall Study|Did Not Meet Entrance Criteria|4
1036761|NCT01712061|2068876|FG001|Overall Study|Did Not Meet Entrance Criteria|6
1036762|NCT01712061|2068877|FG002|Overall Study|Did Not Meet Entrance Criteria|3
1036763|NCT01712061|2068875|FG000|Overall Study|Medication Error Without Associated AE|0
1036764|NCT01712061|2068876|FG001|Overall Study|Medication Error Without Associated AE|1
1036765|NCT01712061|2068877|FG002|Overall Study|Medication Error Without Associated AE|0
1036766|NCT01712061|2068875|FG000|Overall Study|Withdrawal by Subject|1
1036767|NCT01712061|2068876|FG001|Overall Study|Withdrawal by Subject|7
1036768|NCT01712061|2068877|FG002|Overall Study|Withdrawal by Subject|1
1036769|NCT01712061|2068875|FG000|Overall Study|Other|0
1036770|NCT01712061|2068876|FG001|Overall Study|Other|3
1036771|NCT01712061|2068877|FG002|Overall Study|Other|0
1036772|NCT01712074|2068889|FG000|Placebo Run-in Period|Adverse Event|2
1036773|NCT01712074|2068890|FG001|Placebo Run-in Period|Adverse Event|0
1036774|NCT01712074|2068891|FG002|Placebo Run-in Period|Adverse Event|0
1036775|NCT01712074|2068889|FG000|Placebo Run-in Period|Lost to Follow-up|1
1036776|NCT01712074|2068890|FG001|Placebo Run-in Period|Lost to Follow-up|0
1036777|NCT01712074|2068891|FG002|Placebo Run-in Period|Lost to Follow-up|0
1036778|NCT01712074|2068889|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5
1036779|NCT01712074|2068890|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0
1036780|NCT01712074|2068891|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0
1036781|NCT01712074|2068889|FG000|Placebo Run-in Period|Other|1
1036782|NCT01712074|2068890|FG001|Placebo Run-in Period|Other|0
1036783|NCT01712074|2068891|FG002|Placebo Run-in Period|Other|0
1036784|NCT01712074|2068889|FG000|Placebo Run-in Period|No longer willing to participate|1
1036785|NCT01712074|2068890|FG001|Placebo Run-in Period|No longer willing to participate|0
1036786|NCT01712074|2068891|FG002|Placebo Run-in Period|No longer willing to participate|0
1036787|NCT01712074|2068889|FG000|Double Blind Period|Adverse Event|0
1036788|NCT01712074|2068890|FG001|Double Blind Period|Adverse Event|2
1036789|NCT01712074|2068891|FG002|Double Blind Period|Adverse Event|1
1036790|NCT01712074|2068889|FG000|Double Blind Period|No longer willing to participate|0
1036791|NCT01712074|2068890|FG001|Double Blind Period|No longer willing to participate|2
1036792|NCT01712074|2068891|FG002|Double Blind Period|No longer willing to participate|4
1036793|NCT01712074|2068889|FG000|Double Blind Period|Death|0
1036794|NCT01712074|2068890|FG001|Double Blind Period|Death|1
1036795|NCT01712074|2068891|FG002|Double Blind Period|Death|0
1036796|NCT01712074|2068889|FG000|Double Blind Period|Lost to Follow-up|0
1036797|NCT01712074|2068890|FG001|Double Blind Period|Lost to Follow-up|2
1036798|NCT01712074|2068891|FG002|Double Blind Period|Lost to Follow-up|1
1036799|NCT01712074|2068889|FG000|Double Blind Period|Other|0
1036800|NCT01712074|2068890|FG001|Double Blind Period|Other|4
1036801|NCT01712074|2068891|FG002|Double Blind Period|Other|1
1036802|NCT01712074|2068889|FG000|Double Blind Period|Protocol Violation|0
1036803|NCT01712074|2068890|FG001|Double Blind Period|Protocol Violation|0
1036804|NCT01712074|2068891|FG002|Double Blind Period|Protocol Violation|1
1036805|NCT01712074|2068889|FG000|Double Blind Period|No longer met eligibility criteria|0
1036806|NCT01712074|2068890|FG001|Double Blind Period|No longer met eligibility criteria|3
1036807|NCT01712074|2068891|FG002|Double Blind Period|No longer met eligibility criteria|0
1036808|NCT01712178|2068908|FG000|Overall Study|Withdrew consent due to an adverse event|1
1036809|NCT01712178|2068909|FG001|Overall Study|Withdrew consent due to an adverse event|1
1036810|NCT01712178|2068908|FG000|Overall Study|Serious adverse event/withdrew consent|0
1036811|NCT01712178|2068909|FG001|Overall Study|Serious adverse event/withdrew consent|1
1036812|NCT01712178|2068908|FG000|Overall Study|Lost to Follow-up|0
1036813|NCT01712178|2068909|FG001|Overall Study|Lost to Follow-up|1
1036814|NCT01712204|2068917|FG000|Overall Study|Adverse Event|3
1036815|NCT01712204|2068918|FG001|Overall Study|Adverse Event|1
1036816|NCT01712204|2068917|FG000|Overall Study|Withdrawal by Subject|3
1036817|NCT01712204|2068918|FG001|Overall Study|Withdrawal by Subject|3
1036818|NCT01712204|2068917|FG000|Overall Study|Lost to Follow-up|1
1036819|NCT01712204|2068918|FG001|Overall Study|Lost to Follow-up|0
1036820|NCT01712204|2068917|FG000|Overall Study|Protocol Violation|1
1036821|NCT01712204|2068918|FG001|Overall Study|Protocol Violation|1
1036822|NCT01712256|2068937|FG000|Overall Study|Lost to Follow-up|1
1036823|NCT01712334|2068941|FG000|Treatment Period 1|Randomized in Error|0
1036824|NCT01712334|2068942|FG001|Treatment Period 1|Randomized in Error|2
1036825|NCT01712399|2068971|FG000|Overall Study|Lost to Follow-up|1
1036826|NCT01712399|2068971|FG000|Overall Study|Withdrawal by Subject|39
1036827|NCT01712399|2068971|FG000|Overall Study|Death|1
1036828|NCT01712399|2068971|FG000|Overall Study|Adverse Event|11
1036829|NCT01712399|2068971|FG000|Overall Study|Study closure|345
1036830|NCT01712438|2068975|FG000|Overall Study|Not treated with Human-cl rhFVIII|2
1036831|NCT01712438|2068975|FG000|Overall Study|Ongoing ITI treatment|6
1036832|NCT01712438|2068975|FG000|Overall Study|Violated inclusion & exclusion criteria|4
1036833|NCT01712438|2068975|FG000|Overall Study|Prematurely Discontinued|25
1036834|NCT01712490|2068986|FG000|Overall Study|Ongoing|601
1036835|NCT01712490|2068987|FG001|Overall Study|Ongoing|586
1036836|NCT01712490|2068986|FG000|Overall Study|Other|11
1036837|NCT01712490|2068987|FG001|Overall Study|Other|11
1036838|NCT01712490|2068986|FG000|Overall Study|Withdrawal by Subject|36
1036839|NCT01712490|2068987|FG001|Overall Study|Withdrawal by Subject|44
1036840|NCT01712490|2068986|FG000|Overall Study|Lost to Follow-up|16
1036841|NCT01712490|2068987|FG001|Overall Study|Lost to Follow-up|29
1036842|NCT01712516|2068997|FG000|Overall Study|Technical problems|0
1036843|NCT01712516|2068998|FG001|Overall Study|Technical problems|0
1036844|NCT01712516|2068999|FG002|Overall Study|Technical problems|0
1036845|NCT01712516|2069000|FG003|Overall Study|Technical problems|2
1036846|NCT01712516|2068997|FG000|Overall Study|Lost to Follow-up|0
1036847|NCT01712516|2068998|FG001|Overall Study|Lost to Follow-up|0
1036848|NCT01712516|2068999|FG002|Overall Study|Lost to Follow-up|2
1036849|NCT01712516|2069000|FG003|Overall Study|Lost to Follow-up|1
1036850|NCT01712516|2068997|FG000|Overall Study|Death|0
1036851|NCT01712516|2068998|FG001|Overall Study|Death|1
1036852|NCT01712516|2068999|FG002|Overall Study|Death|0
1036853|NCT01712516|2069000|FG003|Overall Study|Death|0
1036854|NCT01712516|2068997|FG000|Overall Study|Protocol deviation|1
1036855|NCT01712516|2068998|FG001|Overall Study|Protocol deviation|0
1036856|NCT01712516|2068999|FG002|Overall Study|Protocol deviation|1
1036857|NCT01712516|2069000|FG003|Overall Study|Protocol deviation|0
1036858|NCT01712516|2068997|FG000|Overall Study|Physician Decision|2
1036859|NCT01712516|2068998|FG001|Overall Study|Physician Decision|0
1036860|NCT01712516|2068999|FG002|Overall Study|Physician Decision|0
1036861|NCT01712516|2069000|FG003|Overall Study|Physician Decision|1
1036862|NCT01712516|2068997|FG000|Overall Study|Withdrawal by Subject|3
1036863|NCT01712516|2068998|FG001|Overall Study|Withdrawal by Subject|9
1036864|NCT01712516|2068999|FG002|Overall Study|Withdrawal by Subject|3
1036865|NCT01712516|2069000|FG003|Overall Study|Withdrawal by Subject|9
1036866|NCT01712685|2069010|FG000|Overall Study|pt declined to participate before trmt|1
1036867|NCT01712984|2069035|FG000|Overall Study|Adverse Event|0
1036868|NCT01712984|2069036|FG001|Overall Study|Adverse Event|0
1036869|NCT01712984|2069037|FG002|Overall Study|Adverse Event|1
1036870|NCT01712984|2069035|FG000|Overall Study|Protocol Violation|2
1036871|NCT01712984|2069036|FG001|Overall Study|Protocol Violation|0
1036872|NCT01712984|2069037|FG002|Overall Study|Protocol Violation|1
1036873|NCT01712984|2069035|FG000|Overall Study|Lost to Follow-up|8
1036874|NCT01712984|2069036|FG001|Overall Study|Lost to Follow-up|10
1036875|NCT01712984|2069037|FG002|Overall Study|Lost to Follow-up|1
1036876|NCT01712984|2069035|FG000|Overall Study|Withdrawal by Subject|6
1036877|NCT01712984|2069036|FG001|Overall Study|Withdrawal by Subject|6
1036878|NCT01712984|2069037|FG002|Overall Study|Withdrawal by Subject|7
1036879|NCT01713036|2069045|FG000|Overall Study|Death|1
1036880|NCT01713283|2069059|FG000|Overall Study|Lack of Efficacy|10
1036881|NCT01713283|2069060|FG001|Overall Study|Lack of Efficacy|2
1036882|NCT01713283|2069059|FG000|Overall Study|Lost to Follow-up|1
1036883|NCT01713283|2069060|FG001|Overall Study|Lost to Follow-up|1
1036884|NCT01713348|2069074|FG000|Overall Study|Withdrawal by Subject|3
1036885|NCT01713348|2069075|FG001|Overall Study|Withdrawal by Subject|2
1036886|NCT01713348|2069076|FG002|Overall Study|Withdrawal by Subject|2
1036887|NCT01713348|2069077|FG003|Overall Study|Withdrawal by Subject|0
1036888|NCT01713348|2069074|FG000|Overall Study|Lost to Follow-up|1
1036889|NCT01713348|2069075|FG001|Overall Study|Lost to Follow-up|0
1036890|NCT01713348|2069076|FG002|Overall Study|Lost to Follow-up|0
1036891|NCT01713348|2069077|FG003|Overall Study|Lost to Follow-up|0
1036892|NCT01713530|2069098|FG000|Overall Study|Adverse Event|0
1036893|NCT01713530|2069099|FG001|Overall Study|Adverse Event|5
1036894|NCT01713530|2069098|FG000|Overall Study|Withdrawal criteria|21
1036895|NCT01713530|2069099|FG001|Overall Study|Withdrawal criteria|12
1036896|NCT01713530|2069098|FG000|Overall Study|Unclassified|4
1036897|NCT01713530|2069099|FG001|Overall Study|Unclassified|2
1036898|NCT01713582|2069126|FG000|Overall Study|Disease progression|3
1036899|NCT01713582|2069127|FG001|Overall Study|Disease progression|3
1036900|NCT01713582|2069128|FG002|Overall Study|Disease progression|3
1036901|NCT01713582|2069129|FG003|Overall Study|Disease progression|2
1036902|NCT01713582|2069130|FG004|Overall Study|Disease progression|3
1036903|NCT01713582|2069131|FG005|Overall Study|Disease progression|3
1036904|NCT01713582|2069132|FG006|Overall Study|Disease progression|3
1036905|NCT01713582|2069133|FG007|Overall Study|Disease progression|3
1036906|NCT01713582|2069134|FG008|Overall Study|Disease progression|3
1036907|NCT01713582|2069135|FG009|Overall Study|Disease progression|11
1036908|NCT01713582|2069136|FG010|Overall Study|Disease progression|10
1036909|NCT01713582|2069137|FG011|Overall Study|Disease progression|5
1036910|NCT01713582|2069138|FG012|Overall Study|Disease progression|3
1036911|NCT01713582|2069139|FG013|Overall Study|Disease progression|3
1036912|NCT01713582|2069140|FG014|Overall Study|Disease progression|6
1036913|NCT01713582|2069141|FG015|Overall Study|Disease progression|6
1036914|NCT01713582|2069142|FG016|Overall Study|Disease progression|5
1036915|NCT01713582|2069143|FG017|Overall Study|Disease progression|2
1036916|NCT01713582|2069144|FG018|Overall Study|Disease progression|3
1036917|NCT01713582|2069145|FG019|Overall Study|Disease progression|5
1036918|NCT01713582|2069146|FG020|Overall Study|Disease progression|15
1036919|NCT01713582|2069126|FG000|Overall Study|Death|0
1036920|NCT01713582|2069127|FG001|Overall Study|Death|0
1036921|NCT01713582|2069128|FG002|Overall Study|Death|0
1036922|NCT01713582|2069129|FG003|Overall Study|Death|1
1036923|NCT01713582|2069130|FG004|Overall Study|Death|1
1036924|NCT01713582|2069131|FG005|Overall Study|Death|3
1036925|NCT01713582|2069132|FG006|Overall Study|Death|3
1036926|NCT01713582|2069133|FG007|Overall Study|Death|2
1036927|NCT01713582|2069134|FG008|Overall Study|Death|3
1036928|NCT01713582|2069135|FG009|Overall Study|Death|4
1036929|NCT01713582|2069136|FG010|Overall Study|Death|3
1036930|NCT01713582|2069137|FG011|Overall Study|Death|0
1036931|NCT01713582|2069138|FG012|Overall Study|Death|0
1036932|NCT01713582|2069139|FG013|Overall Study|Death|0
1036933|NCT01713582|2069140|FG014|Overall Study|Death|0
1036934|NCT01713582|2069141|FG015|Overall Study|Death|0
1036935|NCT01713582|2069142|FG016|Overall Study|Death|0
1036936|NCT01713582|2069143|FG017|Overall Study|Death|0
1036937|NCT01713582|2069144|FG018|Overall Study|Death|0
1036938|NCT01713582|2069145|FG019|Overall Study|Death|0
1036939|NCT01713582|2069146|FG020|Overall Study|Death|0
1036940|NCT01713582|2069126|FG000|Overall Study|Adverse event-related|0
1036941|NCT01713582|2069127|FG001|Overall Study|Adverse event-related|0
1036942|NCT01713582|2069128|FG002|Overall Study|Adverse event-related|0
1036943|NCT01713582|2069129|FG003|Overall Study|Adverse event-related|0
1036944|NCT01713582|2069130|FG004|Overall Study|Adverse event-related|0
1036945|NCT01713582|2069131|FG005|Overall Study|Adverse event-related|0
1036946|NCT01713582|2069132|FG006|Overall Study|Adverse event-related|0
1036947|NCT01713582|2069133|FG007|Overall Study|Adverse event-related|0
1036948|NCT01713582|2069134|FG008|Overall Study|Adverse event-related|0
1036949|NCT01713582|2069135|FG009|Overall Study|Adverse event-related|1
1036950|NCT01713582|2069136|FG010|Overall Study|Adverse event-related|1
1036951|NCT01713582|2069137|FG011|Overall Study|Adverse event-related|0
1036952|NCT01713582|2069138|FG012|Overall Study|Adverse event-related|0
1036953|NCT01713582|2069139|FG013|Overall Study|Adverse event-related|0
1036954|NCT01713582|2069140|FG014|Overall Study|Adverse event-related|0
1036955|NCT01713582|2069141|FG015|Overall Study|Adverse event-related|0
1036956|NCT01713582|2069142|FG016|Overall Study|Adverse event-related|0
1036957|NCT01713582|2069143|FG017|Overall Study|Adverse event-related|0
1036958|NCT01713582|2069144|FG018|Overall Study|Adverse event-related|1
1036959|NCT01713582|2069145|FG019|Overall Study|Adverse event-related|0
1036960|NCT01713582|2069146|FG020|Overall Study|Adverse event-related|0
1036961|NCT01713582|2069126|FG000|Overall Study|Adverse event-unrelated|0
1036962|NCT01713582|2069127|FG001|Overall Study|Adverse event-unrelated|0
1036963|NCT01713582|2069128|FG002|Overall Study|Adverse event-unrelated|0
1036964|NCT01713582|2069129|FG003|Overall Study|Adverse event-unrelated|0
1036965|NCT01713582|2069130|FG004|Overall Study|Adverse event-unrelated|0
1036966|NCT01713582|2069131|FG005|Overall Study|Adverse event-unrelated|1
1036967|NCT01713582|2069132|FG006|Overall Study|Adverse event-unrelated|1
1036968|NCT01713582|2069133|FG007|Overall Study|Adverse event-unrelated|1
1036969|NCT01713582|2069134|FG008|Overall Study|Adverse event-unrelated|0
1036970|NCT01713582|2069135|FG009|Overall Study|Adverse event-unrelated|0
1036971|NCT01713582|2069136|FG010|Overall Study|Adverse event-unrelated|0
1036972|NCT01713582|2069137|FG011|Overall Study|Adverse event-unrelated|0
1036973|NCT01713582|2069138|FG012|Overall Study|Adverse event-unrelated|0
1036974|NCT01713582|2069139|FG013|Overall Study|Adverse event-unrelated|1
1036975|NCT01713582|2069140|FG014|Overall Study|Adverse event-unrelated|1
1036976|NCT01713582|2069141|FG015|Overall Study|Adverse event-unrelated|0
1036977|NCT01713582|2069142|FG016|Overall Study|Adverse event-unrelated|0
1036978|NCT01713582|2069143|FG017|Overall Study|Adverse event-unrelated|0
1036979|NCT01713582|2069144|FG018|Overall Study|Adverse event-unrelated|0
1036980|NCT01713582|2069145|FG019|Overall Study|Adverse event-unrelated|0
1036981|NCT01713582|2069146|FG020|Overall Study|Adverse event-unrelated|0
1036982|NCT01713582|2069126|FG000|Overall Study|Withdrawal of consent|0
1036983|NCT01713582|2069127|FG001|Overall Study|Withdrawal of consent|0
1036984|NCT01713582|2069128|FG002|Overall Study|Withdrawal of consent|1
1036985|NCT01713582|2069129|FG003|Overall Study|Withdrawal of consent|0
1036986|NCT01713582|2069130|FG004|Overall Study|Withdrawal of consent|0
1036987|NCT01713582|2069131|FG005|Overall Study|Withdrawal of consent|1
1036988|NCT01713582|2069132|FG006|Overall Study|Withdrawal of consent|0
1036989|NCT01713582|2069133|FG007|Overall Study|Withdrawal of consent|0
1036990|NCT01713582|2069134|FG008|Overall Study|Withdrawal of consent|0
1036991|NCT01713582|2069135|FG009|Overall Study|Withdrawal of consent|1
1036992|NCT01713582|2069136|FG010|Overall Study|Withdrawal of consent|0
1036993|NCT01713582|2069137|FG011|Overall Study|Withdrawal of consent|0
1036994|NCT01713582|2069138|FG012|Overall Study|Withdrawal of consent|0
1036995|NCT01713582|2069139|FG013|Overall Study|Withdrawal of consent|0
1036996|NCT01713582|2069140|FG014|Overall Study|Withdrawal of consent|0
1036997|NCT01713582|2069141|FG015|Overall Study|Withdrawal of consent|0
1036998|NCT01713582|2069142|FG016|Overall Study|Withdrawal of consent|0
1036999|NCT01713582|2069143|FG017|Overall Study|Withdrawal of consent|0
1037000|NCT01713582|2069144|FG018|Overall Study|Withdrawal of consent|1
1037001|NCT01713582|2069145|FG019|Overall Study|Withdrawal of consent|0
1037002|NCT01713582|2069146|FG020|Overall Study|Withdrawal of consent|0
1037003|NCT01713582|2069126|FG000|Overall Study|Lack of Efficacy|0
1037004|NCT01713582|2069127|FG001|Overall Study|Lack of Efficacy|0
1037005|NCT01713582|2069128|FG002|Overall Study|Lack of Efficacy|0
1037006|NCT01713582|2069129|FG003|Overall Study|Lack of Efficacy|0
1037007|NCT01713582|2069130|FG004|Overall Study|Lack of Efficacy|0
1037008|NCT01713582|2069131|FG005|Overall Study|Lack of Efficacy|0
1037009|NCT01713582|2069132|FG006|Overall Study|Lack of Efficacy|0
1037010|NCT01713582|2069133|FG007|Overall Study|Lack of Efficacy|0
1037011|NCT01713582|2069134|FG008|Overall Study|Lack of Efficacy|0
1037012|NCT01713582|2069135|FG009|Overall Study|Lack of Efficacy|1
1037013|NCT01713582|2069136|FG010|Overall Study|Lack of Efficacy|2
1037014|NCT01713582|2069137|FG011|Overall Study|Lack of Efficacy|0
1037015|NCT01713582|2069138|FG012|Overall Study|Lack of Efficacy|0
1037016|NCT01713582|2069139|FG013|Overall Study|Lack of Efficacy|0
1037017|NCT01713582|2069140|FG014|Overall Study|Lack of Efficacy|0
1037018|NCT01713582|2069141|FG015|Overall Study|Lack of Efficacy|0
1037019|NCT01713582|2069142|FG016|Overall Study|Lack of Efficacy|0
1037020|NCT01713582|2069143|FG017|Overall Study|Lack of Efficacy|0
1037021|NCT01713582|2069144|FG018|Overall Study|Lack of Efficacy|0
1037022|NCT01713582|2069145|FG019|Overall Study|Lack of Efficacy|0
1037023|NCT01713582|2069146|FG020|Overall Study|Lack of Efficacy|0
1037024|NCT01713582|2069126|FG000|Overall Study|Withdrawal by Subject|0
1037025|NCT01713582|2069127|FG001|Overall Study|Withdrawal by Subject|0
1037026|NCT01713582|2069128|FG002|Overall Study|Withdrawal by Subject|0
1037027|NCT01713582|2069129|FG003|Overall Study|Withdrawal by Subject|0
1037028|NCT01713582|2069130|FG004|Overall Study|Withdrawal by Subject|0
1037029|NCT01713582|2069131|FG005|Overall Study|Withdrawal by Subject|0
1037030|NCT01713582|2069132|FG006|Overall Study|Withdrawal by Subject|0
1037031|NCT01713582|2069133|FG007|Overall Study|Withdrawal by Subject|0
1037032|NCT01713582|2069134|FG008|Overall Study|Withdrawal by Subject|0
1037033|NCT01713582|2069135|FG009|Overall Study|Withdrawal by Subject|0
1037034|NCT01713582|2069136|FG010|Overall Study|Withdrawal by Subject|0
1037035|NCT01713582|2069137|FG011|Overall Study|Withdrawal by Subject|0
1037036|NCT01713582|2069138|FG012|Overall Study|Withdrawal by Subject|0
1037037|NCT01713582|2069139|FG013|Overall Study|Withdrawal by Subject|0
1037038|NCT01713582|2069140|FG014|Overall Study|Withdrawal by Subject|0
1037039|NCT01713582|2069141|FG015|Overall Study|Withdrawal by Subject|0
1037040|NCT01713582|2069142|FG016|Overall Study|Withdrawal by Subject|0
1037041|NCT01713582|2069143|FG017|Overall Study|Withdrawal by Subject|1
1037042|NCT01713582|2069144|FG018|Overall Study|Withdrawal by Subject|0
1037043|NCT01713582|2069145|FG019|Overall Study|Withdrawal by Subject|0
1037044|NCT01713582|2069146|FG020|Overall Study|Withdrawal by Subject|0
1037045|NCT01713582|2069126|FG000|Overall Study|Stopped to receive bone marrow graft|0
1037046|NCT01713582|2069127|FG001|Overall Study|Stopped to receive bone marrow graft|0
1037047|NCT01713582|2069128|FG002|Overall Study|Stopped to receive bone marrow graft|0
1037048|NCT01713582|2069129|FG003|Overall Study|Stopped to receive bone marrow graft|0
1037049|NCT01713582|2069130|FG004|Overall Study|Stopped to receive bone marrow graft|0
1037050|NCT01713582|2069131|FG005|Overall Study|Stopped to receive bone marrow graft|0
1037051|NCT01713582|2069132|FG006|Overall Study|Stopped to receive bone marrow graft|0
1037052|NCT01713582|2069133|FG007|Overall Study|Stopped to receive bone marrow graft|0
1037053|NCT01713582|2069134|FG008|Overall Study|Stopped to receive bone marrow graft|0
1037054|NCT01713582|2069135|FG009|Overall Study|Stopped to receive bone marrow graft|0
1037055|NCT01713582|2069136|FG010|Overall Study|Stopped to receive bone marrow graft|0
1037056|NCT01713582|2069137|FG011|Overall Study|Stopped to receive bone marrow graft|0
1037057|NCT01713582|2069138|FG012|Overall Study|Stopped to receive bone marrow graft|0
1037058|NCT01713582|2069139|FG013|Overall Study|Stopped to receive bone marrow graft|0
1037059|NCT01713582|2069140|FG014|Overall Study|Stopped to receive bone marrow graft|0
1037060|NCT01713582|2069141|FG015|Overall Study|Stopped to receive bone marrow graft|0
1037061|NCT01713582|2069142|FG016|Overall Study|Stopped to receive bone marrow graft|1
1037062|NCT01713582|2069143|FG017|Overall Study|Stopped to receive bone marrow graft|0
1037063|NCT01713582|2069144|FG018|Overall Study|Stopped to receive bone marrow graft|0
1037064|NCT01713582|2069145|FG019|Overall Study|Stopped to receive bone marrow graft|0
1037065|NCT01713582|2069146|FG020|Overall Study|Stopped to receive bone marrow graft|0
1037066|NCT01713582|2069126|FG000|Overall Study|Disease progression and adverse event|0
1037067|NCT01713582|2069127|FG001|Overall Study|Disease progression and adverse event|0
1037068|NCT01713582|2069128|FG002|Overall Study|Disease progression and adverse event|0
1037069|NCT01713582|2069129|FG003|Overall Study|Disease progression and adverse event|0
1037070|NCT01713582|2069130|FG004|Overall Study|Disease progression and adverse event|0
1037071|NCT01713582|2069131|FG005|Overall Study|Disease progression and adverse event|0
1037072|NCT01713582|2069132|FG006|Overall Study|Disease progression and adverse event|0
1037073|NCT01713582|2069133|FG007|Overall Study|Disease progression and adverse event|0
1037074|NCT01713582|2069134|FG008|Overall Study|Disease progression and adverse event|0
1037075|NCT01713582|2069135|FG009|Overall Study|Disease progression and adverse event|0
1037076|NCT01713582|2069136|FG010|Overall Study|Disease progression and adverse event|0
1037077|NCT01713582|2069137|FG011|Overall Study|Disease progression and adverse event|0
1037078|NCT01713582|2069138|FG012|Overall Study|Disease progression and adverse event|0
1037079|NCT01713582|2069139|FG013|Overall Study|Disease progression and adverse event|0
1037080|NCT01713582|2069140|FG014|Overall Study|Disease progression and adverse event|0
1037081|NCT01713582|2069141|FG015|Overall Study|Disease progression and adverse event|0
1037082|NCT01713582|2069142|FG016|Overall Study|Disease progression and adverse event|1
1037083|NCT01713582|2069143|FG017|Overall Study|Disease progression and adverse event|0
1037084|NCT01713582|2069144|FG018|Overall Study|Disease progression and adverse event|0
1037085|NCT01713582|2069145|FG019|Overall Study|Disease progression and adverse event|0
1037086|NCT01713582|2069146|FG020|Overall Study|Disease progression and adverse event|0
1037087|NCT01713686|2069233|FG000|Overall Study|Lost to Follow-up|9
1037088|NCT01713686|2069233|FG000|Overall Study|Withdrawal by Subject|6
1037089|NCT01713933|2069256|FG000|Overall Study|Lost to Follow-up|2
1037090|NCT01713933|2069256|FG000|Overall Study|Withdrawal by Subject|3
1037091|NCT01713933|2069256|FG000|Overall Study|Excluded from analysis as a BMI outlier|1
1037092|NCT01713946|2069263|FG000|Overall Study|Death|0
1037093|NCT01713946|2069264|FG001|Overall Study|Death|2
1037094|NCT01713946|2069265|FG002|Overall Study|Death|2
1037095|NCT01713946|2069263|FG000|Overall Study|Adverse Event|19
1037096|NCT01713946|2069264|FG001|Overall Study|Adverse Event|14
1037097|NCT01713946|2069265|FG002|Overall Study|Adverse Event|13
1037098|NCT01713946|2069263|FG000|Overall Study|Withdrawal by Subject|12
1037099|NCT01713946|2069264|FG001|Overall Study|Withdrawal by Subject|12
1037100|NCT01713946|2069265|FG002|Overall Study|Withdrawal by Subject|8
1037101|NCT01713946|2069263|FG000|Overall Study|Lack of Efficacy|8
1037102|NCT01713946|2069264|FG001|Overall Study|Lack of Efficacy|8
1037103|NCT01713946|2069265|FG002|Overall Study|Lack of Efficacy|14
1037104|NCT01713946|2069263|FG000|Overall Study|Protocol Violation|2
1037105|NCT01713946|2069264|FG001|Overall Study|Protocol Violation|4
1037106|NCT01713946|2069265|FG002|Overall Study|Protocol Violation|1
1037107|NCT01713946|2069263|FG000|Overall Study|Lost to Follow-up|0
1037108|NCT01713946|2069264|FG001|Overall Study|Lost to Follow-up|0
1037109|NCT01713946|2069265|FG002|Overall Study|Lost to Follow-up|1
1037110|NCT01713946|2069263|FG000|Overall Study|Administrative problems|1
1037111|NCT01713946|2069264|FG001|Overall Study|Administrative problems|0
1037112|NCT01713946|2069265|FG002|Overall Study|Administrative problems|0
1037113|NCT01713946|2069263|FG000|Overall Study|Did not continue in Ext|0
1037114|NCT01713946|2069264|FG001|Overall Study|Did not continue in Ext|3
1037115|NCT01713946|2069265|FG002|Overall Study|Did not continue in Ext|0
1037116|NCT01713946|2069263|FG000|Overall Study|Did not continue in Post-Ext. Phase|1
1037117|NCT01713946|2069264|FG001|Overall Study|Did not continue in Post-Ext. Phase|2
1037118|NCT01713946|2069265|FG002|Overall Study|Did not continue in Post-Ext. Phase|0
1037119|NCT01713946|2069263|FG000|Overall Study|Patients never switched to everolimus|0
1037120|NCT01713946|2069264|FG001|Overall Study|Patients never switched to everolimus|0
1037121|NCT01713946|2069265|FG002|Overall Study|Patients never switched to everolimus|5
1037122|NCT01713998|2069294|FG000|Overall Study|Lost to Follow-up|2
1037123|NCT01713998|2069295|FG001|Overall Study|Lost to Follow-up|0
1037124|NCT01713998|2069296|FG002|Overall Study|Lost to Follow-up|2
1037125|NCT01713998|2069294|FG000|Overall Study|Withdrawal by Subject|1
1037126|NCT01713998|2069295|FG001|Overall Study|Withdrawal by Subject|0
1037127|NCT01713998|2069296|FG002|Overall Study|Withdrawal by Subject|0
1037128|NCT01714063|2069326|FG000|Overall Study|Equipment malfunction|2
1037129|NCT01714310|2069341|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0
1037130|NCT01714310|2069342|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0
1037131|NCT01714310|2069343|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1
1037132|NCT01714310|2069341|FG000|Open Lisdexamfetamine Titration|Adverse Event|0
1037133|NCT01714310|2069342|FG001|Open Lisdexamfetamine Titration|Adverse Event|0
1037134|NCT01714310|2069343|FG002|Open Lisdexamfetamine Titration|Adverse Event|3
1037135|NCT01714310|2069341|FG000|Double Blind Adjunctive Treatment|Adverse Event|1
1037136|NCT01714310|2069342|FG001|Double Blind Adjunctive Treatment|Adverse Event|1
1037137|NCT01714310|2069343|FG002|Double Blind Adjunctive Treatment|Adverse Event|0
1037138|NCT01714310|2069341|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1
1037139|NCT01714310|2069342|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2
1037140|NCT01714310|2069343|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0
1037141|NCT01714544|2069391|FG000|Overall Study|Lost to Follow-up|1
1037142|NCT01714544|2069391|FG000|Overall Study|Physician Decision|1
1037143|NCT01714544|2069391|FG000|Overall Study|Withdrawal by Subject|1
1037144|NCT01714609|2069397|FG000|Overall Study|Protocol Violation|1
1037145|NCT01714609|2069398|FG001|Overall Study|Protocol Violation|0
1037146|NCT01714635|2069407|FG000|Overall Study|Discontinued|1
1037147|NCT01714635|2069408|FG001|Overall Study|Discontinued|0
1037148|NCT01714635|2069409|FG002|Overall Study|Discontinued|2
1037149|NCT01714635|2069407|FG000|Overall Study|Missed 6-month exam|1
1037150|NCT01714635|2069408|FG001|Overall Study|Missed 6-month exam|0
1037151|NCT01714635|2069409|FG002|Overall Study|Missed 6-month exam|0
1037152|NCT01714687|2069419|FG000|Overall Study|Withdrawal by Subject|1
1037153|NCT01714687|2069420|FG001|Overall Study|Withdrawal by Subject|0
1037154|NCT01714687|2069419|FG000|Overall Study|Lost to Follow-up|2
1037155|NCT01714687|2069420|FG001|Overall Study|Lost to Follow-up|4
1037156|NCT01714726|2069430|FG000|Double-Blinded Induction Period|Subject not in open label period|3
1037157|NCT01714726|2069431|FG001|Double-Blinded Induction Period|Subject not in open label period|1
1037158|NCT01714726|2069432|FG002|Double-Blinded Induction Period|Subject not in open label period|0
1037159|NCT01714726|2069433|FG003|Double-Blinded Induction Period|Subject not in open label period|0
1037160|NCT01714726|2069430|FG000|Double-Blinded Induction Period|Adverse Event|0
1037161|NCT01714726|2069431|FG001|Double-Blinded Induction Period|Adverse Event|1
1037162|NCT01714726|2069432|FG002|Double-Blinded Induction Period|Adverse Event|0
1037163|NCT01714726|2069433|FG003|Double-Blinded Induction Period|Adverse Event|0
1037164|NCT01714726|2069430|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5
1037165|NCT01714726|2069431|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3
1037166|NCT01714726|2069432|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0
1037167|NCT01714726|2069433|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0
1037168|NCT01714726|2069430|FG000|Double-Blinded Induction Period|Lost to Follow-up|0
1037169|NCT01714726|2069431|FG001|Double-Blinded Induction Period|Lost to Follow-up|2
1037170|NCT01714726|2069432|FG002|Double-Blinded Induction Period|Lost to Follow-up|0
1037171|NCT01714726|2069433|FG003|Double-Blinded Induction Period|Lost to Follow-up|0
1037172|NCT01714726|2069430|FG000|Open-Label Period|Other|0
1037173|NCT01714726|2069431|FG001|Open-Label Period|Other|0
1037174|NCT01714726|2069432|FG002|Open-Label Period|Other|1
1037175|NCT01714726|2069433|FG003|Open-Label Period|Other|3
1037176|NCT01714726|2069430|FG000|Open-Label Period|Adverse Event|0
1037177|NCT01714726|2069431|FG001|Open-Label Period|Adverse Event|0
1037178|NCT01714726|2069432|FG002|Open-Label Period|Adverse Event|1
1037179|NCT01714726|2069433|FG003|Open-Label Period|Adverse Event|0
1037180|NCT01714726|2069430|FG000|Open-Label Period|Withdrawal by Subject|0
1037181|NCT01714726|2069431|FG001|Open-Label Period|Withdrawal by Subject|0
1037182|NCT01714726|2069432|FG002|Open-Label Period|Withdrawal by Subject|9
1037183|NCT01714726|2069433|FG003|Open-Label Period|Withdrawal by Subject|19
1037184|NCT01714726|2069430|FG000|Open-Label Period|Developed specific withdrawal criteria|0
1037185|NCT01714726|2069431|FG001|Open-Label Period|Developed specific withdrawal criteria|0
1037186|NCT01714726|2069432|FG002|Open-Label Period|Developed specific withdrawal criteria|5
1037187|NCT01714726|2069433|FG003|Open-Label Period|Developed specific withdrawal criteria|2
1037188|NCT01714726|2069430|FG000|Open-Label Period|Lost to Follow-up|0
1037189|NCT01714726|2069431|FG001|Open-Label Period|Lost to Follow-up|0
1037190|NCT01714726|2069432|FG002|Open-Label Period|Lost to Follow-up|3
1037191|NCT01714726|2069433|FG003|Open-Label Period|Lost to Follow-up|4
1037192|NCT01714947|2069470|FG000|Part B|Progressive Disease|3
1037193|NCT01715129|2069483|FG000|Overall Study|Adverse Event, fatal|1
1037194|NCT01715129|2069483|FG000|Overall Study|Lack of Efficacy|3
1037195|NCT01715129|2069483|FG000|Overall Study|Protocol Violation|1
1037196|NCT01715129|2069483|FG000|Overall Study|Consent Withdrawn|2
1037197|NCT01715129|2069483|FG000|Overall Study|Lost to Follow-up|1
1037198|NCT01715129|2069483|FG000|Overall Study|Other|1
1037232|NCT01715298|2069516|FG000|Overall Study|Lost to Follow-up|0
1037233|NCT01715298|2069517|FG001|Overall Study|Lost to Follow-up|2
1037234|NCT01715298|2069516|FG000|Overall Study|Patient/guardian decision|7
1037235|NCT01715298|2069517|FG001|Overall Study|Patient/guardian decision|9
1037236|NCT01715415|2069525|FG000|Double-blind Treatment|Did Not Receive Study Drug|0
1037237|NCT01715415|2069526|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
1037238|NCT01715415|2069525|FG000|Double-blind Treatment|Adverse Event|3
1037239|NCT01715415|2069526|FG001|Double-blind Treatment|Adverse Event|0
1037240|NCT01715415|2069525|FG000|Double-blind Treatment|Withdrawal by Subject|1
1037241|NCT01715415|2069526|FG001|Double-blind Treatment|Withdrawal by Subject|1
1037242|NCT01715415|2069525|FG000|Double-blind Treatment|Other|1
1037243|NCT01715415|2069526|FG001|Double-blind Treatment|Other|0
1037244|NCT01715415|2069525|FG000|Open-label Treatment|Adverse Event|0
1037245|NCT01715415|2069526|FG001|Open-label Treatment|Adverse Event|1
1037246|NCT01715415|2069525|FG000|Open-label Treatment|Subject Noncompliant|0
1037247|NCT01715415|2069526|FG001|Open-label Treatment|Subject Noncompliant|1
1037248|NCT01715571|2069533|FG000|Overall Study|Lost to Follow-up|8
1037249|NCT01715805|2069537|FG000|Placebo + ADT Lead-in Period|Adverse Event|41
1037250|NCT01715805|2069538|FG001|Placebo + ADT Lead-in Period|Adverse Event|0
1037251|NCT01715805|2069539|FG002|Placebo + ADT Lead-in Period|Adverse Event|0
1037252|NCT01715805|2069540|FG003|Placebo + ADT Lead-in Period|Adverse Event|0
1037253|NCT01715805|2069537|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
1037254|NCT01715805|2069538|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
1037255|NCT01715805|2069539|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
1037256|NCT01715805|2069540|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
1037257|NCT01715805|2069537|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74
1037258|NCT01715805|2069538|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0
1037259|NCT01715805|2069539|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0
1037260|NCT01715805|2069540|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0
1037261|NCT01715805|2069537|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
1037262|NCT01715805|2069538|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
1037263|NCT01715805|2069539|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
1037264|NCT01715805|2069540|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
1037265|NCT01715805|2069537|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34
1037266|NCT01715805|2069538|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0
1037267|NCT01715805|2069539|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0
1037268|NCT01715805|2069540|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0
1037269|NCT01715805|2069537|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
1037270|NCT01715805|2069538|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
1037271|NCT01715805|2069539|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
1037272|NCT01715805|2069540|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
1037273|NCT01715805|2069537|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
1037274|NCT01715805|2069538|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
1037275|NCT01715805|2069539|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
1037276|NCT01715805|2069540|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
1037277|NCT01715805|2069537|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
1037278|NCT01715805|2069538|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
1037279|NCT01715805|2069539|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
1037280|NCT01715805|2069540|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
1037281|NCT01715805|2069537|FG000|Double-Blind or Continued Treatment|Adverse Event|0
1037282|NCT01715805|2069538|FG001|Double-Blind or Continued Treatment|Adverse Event|3
1037283|NCT01715805|2069539|FG002|Double-Blind or Continued Treatment|Adverse Event|23
1037284|NCT01715805|2069540|FG003|Double-Blind or Continued Treatment|Adverse Event|2
1037285|NCT01715805|2069537|FG000|Double-Blind or Continued Treatment|Protocol Violation|0
1037286|NCT01715805|2069538|FG001|Double-Blind or Continued Treatment|Protocol Violation|14
1037287|NCT01715805|2069539|FG002|Double-Blind or Continued Treatment|Protocol Violation|12
1037288|NCT01715805|2069540|FG003|Double-Blind or Continued Treatment|Protocol Violation|19
1037289|NCT01715805|2069537|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0
1037290|NCT01715805|2069538|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11
1037291|NCT01715805|2069539|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11
1037292|NCT01715805|2069540|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13
1037293|NCT01715805|2069537|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0
1037294|NCT01715805|2069538|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7
1037295|NCT01715805|2069539|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10
1037296|NCT01715805|2069540|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10
1037297|NCT01715805|2069537|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0
1037298|NCT01715805|2069538|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1
1037299|NCT01715805|2069539|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0
1037300|NCT01715805|2069540|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3
1037301|NCT01715805|2069537|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
1037302|NCT01715805|2069538|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
1037303|NCT01715805|2069539|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
1037304|NCT01715805|2069540|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
1037305|NCT01715831|2069548|FG000|Overall Study|Adverse Event|1
1037306|NCT01715857|2069552|FG000|Overall Study|Did Not Meet Eligibility Criteria|96
1037307|NCT01715896|2069563|FG000|Overall Study|Lost to Follow-up|0
1037308|NCT01715896|2069564|FG001|Overall Study|Lost to Follow-up|2
1037309|NCT01715896|2069563|FG000|Overall Study|Withdrawal by Subject|1
1037310|NCT01715896|2069564|FG001|Overall Study|Withdrawal by Subject|4
1037311|NCT01715896|2069563|FG000|Overall Study|Other|2
1037312|NCT01715896|2069564|FG001|Overall Study|Other|5
1037313|NCT01716104|2069616|FG000|Overall Study|Do not meet inclusion criteria|6
1037314|NCT01716104|2069617|FG001|Overall Study|Do not meet inclusion criteria|7
1037315|NCT01716117|2069625|FG000|Overall Study|Death|5
1037316|NCT01716117|2069626|FG001|Overall Study|Death|2
1037317|NCT01716117|2069625|FG000|Overall Study|Withdrawal by Subject|2
1037318|NCT01716117|2069626|FG001|Overall Study|Withdrawal by Subject|0
1037319|NCT01716156|2069643|FG000|Overall Study|Protocol Violation|1
1037320|NCT01716156|2069644|FG001|Overall Study|Protocol Violation|0
1037321|NCT01716156|2069645|FG002|Overall Study|Protocol Violation|0
1037322|NCT01716156|2069643|FG000|Overall Study|Withdrawal by Subject|0
1037323|NCT01716156|2069644|FG001|Overall Study|Withdrawal by Subject|1
1037324|NCT01716156|2069645|FG002|Overall Study|Withdrawal by Subject|2
1037325|NCT01716156|2069643|FG000|Overall Study|Lost to Follow-up|1
1037326|NCT01716156|2069644|FG001|Overall Study|Lost to Follow-up|0
1037327|NCT01716156|2069645|FG002|Overall Study|Lost to Follow-up|0
1037328|NCT01716169|2069657|FG000|Overall Study|Adverse Event|1
1037329|NCT01716169|2069657|FG000|Overall Study|Lost to Follow-up|1
1037330|NCT01716169|2069657|FG000|Overall Study|Withdrawal by Subject|1
1037331|NCT01716169|2069657|FG000|Overall Study|inconsistent dressing application|1
1037332|NCT01716234|2069694|FG000|Overall Study|Protocol Violation|0
1037333|NCT01716234|2069695|FG001|Overall Study|Protocol Violation|0
1037334|NCT01716234|2069696|FG002|Overall Study|Protocol Violation|0
1037335|NCT01716234|2069697|FG003|Overall Study|Protocol Violation|1
1037336|NCT01716234|2069698|FG004|Overall Study|Protocol Violation|1
1037337|NCT01716234|2069699|FG005|Overall Study|Protocol Violation|1
1037338|NCT01716234|2069700|FG006|Overall Study|Protocol Violation|0
1037339|NCT01716234|2069694|FG000|Overall Study|Lack of Efficacy|0
1037340|NCT01716234|2069695|FG001|Overall Study|Lack of Efficacy|0
1037341|NCT01716234|2069696|FG002|Overall Study|Lack of Efficacy|0
1037342|NCT01716234|2069697|FG003|Overall Study|Lack of Efficacy|1
1037343|NCT01716234|2069698|FG004|Overall Study|Lack of Efficacy|0
1037344|NCT01716234|2069699|FG005|Overall Study|Lack of Efficacy|0
1037345|NCT01716234|2069700|FG006|Overall Study|Lack of Efficacy|0
1037346|NCT01716234|2069694|FG000|Overall Study|Did not meet protocol eligibility|0
1037347|NCT01716234|2069695|FG001|Overall Study|Did not meet protocol eligibility|0
1037348|NCT01716234|2069696|FG002|Overall Study|Did not meet protocol eligibility|1
1037349|NCT01716234|2069697|FG003|Overall Study|Did not meet protocol eligibility|0
1037350|NCT01716234|2069698|FG004|Overall Study|Did not meet protocol eligibility|0
1037351|NCT01716234|2069699|FG005|Overall Study|Did not meet protocol eligibility|4
1037352|NCT01716234|2069700|FG006|Overall Study|Did not meet protocol eligibility|0
1037353|NCT01716234|2069694|FG000|Overall Study|Adverse Event|7
1037354|NCT01716234|2069695|FG001|Overall Study|Adverse Event|10
1037355|NCT01716234|2069696|FG002|Overall Study|Adverse Event|2
1037356|NCT01716234|2069697|FG003|Overall Study|Adverse Event|8
1037357|NCT01716234|2069698|FG004|Overall Study|Adverse Event|3
1037358|NCT01716234|2069699|FG005|Overall Study|Adverse Event|6
1037359|NCT01716234|2069700|FG006|Overall Study|Adverse Event|0
1037360|NCT01716234|2069694|FG000|Overall Study|Withdrawal by Subject|3
1037361|NCT01716234|2069695|FG001|Overall Study|Withdrawal by Subject|0
1037362|NCT01716234|2069696|FG002|Overall Study|Withdrawal by Subject|2
1037363|NCT01716234|2069697|FG003|Overall Study|Withdrawal by Subject|2
1037364|NCT01716234|2069698|FG004|Overall Study|Withdrawal by Subject|1
1037365|NCT01716234|2069699|FG005|Overall Study|Withdrawal by Subject|3
1037366|NCT01716234|2069700|FG006|Overall Study|Withdrawal by Subject|0
1037367|NCT01716520|2069742|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
1037368|NCT01716520|2069743|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
1037369|NCT01716520|2069744|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
1037370|NCT01716520|2069745|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
1037371|NCT01716520|2069746|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
1037372|NCT01716520|2069747|FG005|Treatment Period 1 (14 Days)|Adverse Event|0
1037373|NCT01716520|2069742|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1037374|NCT01716520|2069743|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
1037375|NCT01716520|2069744|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
1037376|NCT01716520|2069745|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1037377|NCT01716520|2069746|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
1037378|NCT01716520|2069747|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1037379|NCT01716520|2069742|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1037380|NCT01716520|2069743|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1037381|NCT01716520|2069744|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1037382|NCT01716520|2069745|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1037383|NCT01716520|2069746|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1037384|NCT01716520|2069747|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1037385|NCT01716520|2069742|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1037386|NCT01716520|2069743|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1
1037387|NCT01716520|2069744|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1037388|NCT01716520|2069745|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1037389|NCT01716520|2069746|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1037390|NCT01716520|2069747|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1037391|NCT01716520|2069742|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1037392|NCT01716520|2069743|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1037393|NCT01716520|2069744|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1037394|NCT01716520|2069745|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1037395|NCT01716520|2069746|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1037396|NCT01716520|2069747|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
1037397|NCT01716520|2069742|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1037398|NCT01716520|2069743|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1037399|NCT01716520|2069744|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
1037400|NCT01716520|2069745|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1037401|NCT01716520|2069746|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1037402|NCT01716520|2069747|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
1037403|NCT01716520|2069742|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
1037404|NCT01716520|2069743|FG001|Treatment Period 2 (14 Days)|Adverse Event|0
1037405|NCT01716520|2069744|FG002|Treatment Period 2 (14 Days)|Adverse Event|0
1037406|NCT01716520|2069745|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
1037407|NCT01716520|2069746|FG004|Treatment Period 2 (14 Days)|Adverse Event|1
1037408|NCT01716520|2069747|FG005|Treatment Period 2 (14 Days)|Adverse Event|0
1037409|NCT01716520|2069742|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
1037410|NCT01716520|2069743|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
1037411|NCT01716520|2069744|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
1037412|NCT01716520|2069745|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0
1037413|NCT01716520|2069746|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1
1037414|NCT01716520|2069747|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
1037415|NCT01716520|2069742|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1037416|NCT01716520|2069743|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1037417|NCT01716520|2069744|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1037418|NCT01716520|2069745|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
1037419|NCT01716520|2069746|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1037420|NCT01716520|2069747|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1037421|NCT01716520|2069742|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1037422|NCT01716520|2069743|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1037423|NCT01716520|2069744|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1037424|NCT01716520|2069745|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1037425|NCT01716520|2069746|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1037426|NCT01716520|2069747|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1037427|NCT01716520|2069742|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
1037428|NCT01716520|2069743|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1037429|NCT01716520|2069744|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1037430|NCT01716520|2069745|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1037431|NCT01716520|2069746|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1037432|NCT01716520|2069747|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1037433|NCT01716520|2069742|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1037434|NCT01716520|2069743|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1037435|NCT01716520|2069744|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1037436|NCT01716520|2069745|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1037437|NCT01716520|2069746|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1037438|NCT01716520|2069747|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
1037439|NCT01716520|2069742|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1037440|NCT01716520|2069743|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
1037441|NCT01716520|2069744|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1037442|NCT01716520|2069745|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1037443|NCT01716520|2069746|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1037444|NCT01716520|2069747|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1037445|NCT01716520|2069742|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1037446|NCT01716520|2069743|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1037447|NCT01716520|2069744|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1037448|NCT01716520|2069745|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1037449|NCT01716520|2069746|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1037450|NCT01716520|2069747|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2
1037451|NCT01716520|2069742|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1037452|NCT01716520|2069743|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1037453|NCT01716520|2069744|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
1037454|NCT01716520|2069745|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1037455|NCT01716520|2069746|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1037456|NCT01716520|2069747|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1037457|NCT01716533|2069759|FG000|Overall Study|Failure of antibiotic treatment to treat|0
1037458|NCT01716533|2069760|FG001|Overall Study|Failure of antibiotic treatment to treat|0
1037459|NCT01716533|2069761|FG002|Overall Study|Failure of antibiotic treatment to treat|5
1037460|NCT01716533|2069762|FG003|Overall Study|Failure of antibiotic treatment to treat|0
1037461|NCT01716533|2069759|FG000|Overall Study|Withdrawal by Subject|0
1037462|NCT01716533|2069760|FG001|Overall Study|Withdrawal by Subject|0
1037463|NCT01716533|2069761|FG002|Overall Study|Withdrawal by Subject|0
1037464|NCT01716533|2069762|FG003|Overall Study|Withdrawal by Subject|5
1037465|NCT01716533|2069759|FG000|Overall Study|Death|0
1037466|NCT01716533|2069760|FG001|Overall Study|Death|0
1037467|NCT01716533|2069761|FG002|Overall Study|Death|0
1037468|NCT01716533|2069762|FG003|Overall Study|Death|2
1037469|NCT01716533|2069759|FG000|Overall Study|Immunosuppressants>14days past 6months|0
1037470|NCT01716533|2069760|FG001|Overall Study|Immunosuppressants>14days past 6months|0
1037471|NCT01716533|2069761|FG002|Overall Study|Immunosuppressants>14days past 6months|0
1037472|NCT01716533|2069762|FG003|Overall Study|Immunosuppressants>14days past 6months|1
1037473|NCT01716559|2069776|FG000|Overall Study|Adverse Event|11
1037474|NCT01716559|2069776|FG000|Overall Study|Death|21
1037475|NCT01716559|2069776|FG000|Overall Study|Withdrawal by Subject|4
1037476|NCT01716559|2069776|FG000|Overall Study|Other withdrawal reason|75
1037477|NCT01716585|2069782|FG000|Double-blind Treatment|Did Not Receive Study Drug|4
1037478|NCT01716585|2069783|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
1037479|NCT01716585|2069782|FG000|Double-blind Treatment|Adverse Event|2
1037480|NCT01716585|2069783|FG001|Double-blind Treatment|Adverse Event|1
1037481|NCT01716585|2069782|FG000|Double-blind Treatment|Withdrawal by Subject|3
1037482|NCT01716585|2069783|FG001|Double-blind Treatment|Withdrawal by Subject|0
1037483|NCT01716585|2069782|FG000|Double-blind Treatment|Lost to Follow-up|2
1037484|NCT01716585|2069783|FG001|Double-blind Treatment|Lost to Follow-up|0
1037485|NCT01716585|2069782|FG000|Double-blind Treatment|Subject Noncompliant|1
1037486|NCT01716585|2069783|FG001|Double-blind Treatment|Subject Noncompliant|0
1037487|NCT01716585|2069782|FG000|Double-blind Treatment|Other|1
1037488|NCT01716585|2069783|FG001|Double-blind Treatment|Other|0
1037489|NCT01716585|2069782|FG000|Open-label Treatment|Adverse Event|0
1037490|NCT01716585|2069783|FG001|Open-label Treatment|Adverse Event|2
1037491|NCT01716585|2069782|FG000|Open-label Treatment|Virologic Failure|0
1037492|NCT01716585|2069783|FG001|Open-label Treatment|Virologic Failure|2
1037493|NCT01716585|2069782|FG000|Open-label Treatment|Withdrawal by Subject|0
1037494|NCT01716585|2069783|FG001|Open-label Treatment|Withdrawal by Subject|3
1162029|NCT03381196|2283976|FG000|Overall Study|Withdrawal by Subject|7
1037495|NCT01716663|2069790|FG000|Overall Study|Withdrawn prior to procedure|4
1037496|NCT01716663|2069790|FG000|Overall Study|Treated with non-study catheter|2
1037497|NCT01716715|2069796|FG000|Overall Study|Never Treated|2
1037498|NCT01716715|2069797|FG001|Overall Study|Never Treated|4
1037499|NCT01716754|2069809|FG000|Overall Study|Death|0
1037500|NCT01716754|2069810|FG001|Overall Study|Death|0
1037501|NCT01716754|2069811|FG002|Overall Study|Death|0
1037502|NCT01716754|2069812|FG003|Overall Study|Death|1
1037503|NCT01716754|2069809|FG000|Overall Study|Protocol deviation|0
1037504|NCT01716754|2069810|FG001|Overall Study|Protocol deviation|2
1037505|NCT01716754|2069811|FG002|Overall Study|Protocol deviation|7
1037506|NCT01716754|2069812|FG003|Overall Study|Protocol deviation|2
1037507|NCT01716754|2069809|FG000|Overall Study|Non-compliance with study treatment|0
1037508|NCT01716754|2069810|FG001|Overall Study|Non-compliance with study treatment|0
1037509|NCT01716754|2069811|FG002|Overall Study|Non-compliance with study treatment|1
1037510|NCT01716754|2069812|FG003|Overall Study|Non-compliance with study treatment|0
1037511|NCT01716754|2069809|FG000|Overall Study|Physician Decision|1
1037512|NCT01716754|2069810|FG001|Overall Study|Physician Decision|0
1037513|NCT01716754|2069811|FG002|Overall Study|Physician Decision|0
1037514|NCT01716754|2069812|FG003|Overall Study|Physician Decision|0
1037515|NCT01716754|2069809|FG000|Overall Study|Lost to Follow-up|1
1037516|NCT01716754|2069810|FG001|Overall Study|Lost to Follow-up|0
1037517|NCT01716754|2069811|FG002|Overall Study|Lost to Follow-up|0
1037518|NCT01716754|2069812|FG003|Overall Study|Lost to Follow-up|1
1037519|NCT01716754|2069809|FG000|Overall Study|Adverse Event|4
1037520|NCT01716754|2069810|FG001|Overall Study|Adverse Event|2
1037521|NCT01716754|2069811|FG002|Overall Study|Adverse Event|2
1037522|NCT01716754|2069812|FG003|Overall Study|Adverse Event|1
1037523|NCT01716754|2069809|FG000|Overall Study|Withdrawal by Subject|5
1037524|NCT01716754|2069810|FG001|Overall Study|Withdrawal by Subject|0
1037525|NCT01716754|2069811|FG002|Overall Study|Withdrawal by Subject|4
1037526|NCT01716754|2069812|FG003|Overall Study|Withdrawal by Subject|3
1037527|NCT01717040|2069836|FG000|Overall Study|Lost to Follow-up|2
1037528|NCT01717040|2069837|FG001|Overall Study|Lost to Follow-up|3
1037529|NCT01717040|2069836|FG000|Overall Study|Lack of Efficacy|1
1037530|NCT01717040|2069837|FG001|Overall Study|Lack of Efficacy|1
1037531|NCT01717040|2069836|FG000|Overall Study|Adverse Event|1
1037532|NCT01717040|2069837|FG001|Overall Study|Adverse Event|0
1037533|NCT01717040|2069836|FG000|Overall Study|Required Medication Change|0
1037534|NCT01717040|2069837|FG001|Overall Study|Required Medication Change|1
1037535|NCT01717040|2069836|FG000|Overall Study|New Substance Use Disorder|1
1037536|NCT01717040|2069837|FG001|Overall Study|New Substance Use Disorder|0
1037537|NCT01717287|2069853|FG000|Overall Study|Lost to Follow-up|0
1037538|NCT01717287|2069854|FG001|Overall Study|Lost to Follow-up|2
1037539|NCT01717287|2069853|FG000|Overall Study|Protocol Violation|0
1037540|NCT01717287|2069854|FG001|Overall Study|Protocol Violation|1
1037541|NCT01717313|2069862|FG000|Phase A (Weeks 0 to 24)|Death|0
1037542|NCT01717313|2069863|FG001|Phase A (Weeks 0 to 24)|Death|1
1037543|NCT01717313|2069862|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
1037544|NCT01717313|2069863|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
1037545|NCT01717313|2069862|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
1037546|NCT01717313|2069863|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
1037547|NCT01717313|2069862|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4
1037548|NCT01717313|2069863|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2
1037549|NCT01717313|2069862|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
1037550|NCT01717313|2069863|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
1037551|NCT01717313|2069862|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1
1037552|NCT01717313|2069863|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0
1037553|NCT01717313|2069862|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
1037554|NCT01717313|2069863|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
1037555|NCT01717313|2069862|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
1037556|NCT01717313|2069863|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
1037557|NCT01717313|2069862|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
1037558|NCT01717313|2069863|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
1037559|NCT01717326|2069889|FG000|Overall Study|Death|0
1037560|NCT01717326|2069890|FG001|Overall Study|Death|0
1037561|NCT01717326|2069891|FG002|Overall Study|Death|0
1037562|NCT01717326|2069892|FG003|Overall Study|Death|0
1037563|NCT01717326|2069893|FG004|Overall Study|Death|0
1037564|NCT01717326|2069894|FG005|Overall Study|Death|0
1037565|NCT01717326|2069895|FG006|Overall Study|Death|0
1037566|NCT01717326|2069896|FG007|Overall Study|Death|0
1037567|NCT01717326|2069897|FG008|Overall Study|Death|0
1037568|NCT01717326|2069898|FG009|Overall Study|Death|0
1037569|NCT01717326|2069899|FG010|Overall Study|Death|1
1037570|NCT01717326|2069900|FG011|Overall Study|Death|0
1037571|NCT01717326|2069901|FG012|Overall Study|Death|0
1037572|NCT01717326|2069902|FG013|Overall Study|Death|0
1037573|NCT01717326|2069903|FG014|Overall Study|Death|0
1037574|NCT01717326|2069904|FG015|Overall Study|Death|0
1037575|NCT01717326|2069905|FG016|Overall Study|Death|0
1037576|NCT01717326|2069906|FG017|Overall Study|Death|0
1037577|NCT01717326|2069907|FG018|Overall Study|Death|0
1037578|NCT01717326|2069908|FG019|Overall Study|Death|0
1037579|NCT01717326|2069889|FG000|Overall Study|Lost to Follow-up|3
1037580|NCT01717326|2069890|FG001|Overall Study|Lost to Follow-up|0
1037581|NCT01717326|2069891|FG002|Overall Study|Lost to Follow-up|0
1037582|NCT01717326|2069892|FG003|Overall Study|Lost to Follow-up|2
1037583|NCT01717326|2069893|FG004|Overall Study|Lost to Follow-up|1
1037584|NCT01717326|2069894|FG005|Overall Study|Lost to Follow-up|0
1037585|NCT01717326|2069895|FG006|Overall Study|Lost to Follow-up|1
1037586|NCT01717326|2069896|FG007|Overall Study|Lost to Follow-up|0
1037587|NCT01717326|2069897|FG008|Overall Study|Lost to Follow-up|0
1037588|NCT01717326|2069898|FG009|Overall Study|Lost to Follow-up|0
1037589|NCT01717326|2069899|FG010|Overall Study|Lost to Follow-up|1
1037590|NCT01717326|2069900|FG011|Overall Study|Lost to Follow-up|0
1037591|NCT01717326|2069901|FG012|Overall Study|Lost to Follow-up|0
1037592|NCT01717326|2069902|FG013|Overall Study|Lost to Follow-up|0
1037593|NCT01717326|2069903|FG014|Overall Study|Lost to Follow-up|0
1037594|NCT01717326|2069904|FG015|Overall Study|Lost to Follow-up|2
1037595|NCT01717326|2069905|FG016|Overall Study|Lost to Follow-up|1
1037596|NCT01717326|2069906|FG017|Overall Study|Lost to Follow-up|0
1037597|NCT01717326|2069907|FG018|Overall Study|Lost to Follow-up|2
1037598|NCT01717326|2069908|FG019|Overall Study|Lost to Follow-up|3
1037599|NCT01717326|2069889|FG000|Overall Study|Physician Decision|0
1037600|NCT01717326|2069890|FG001|Overall Study|Physician Decision|0
1037601|NCT01717326|2069891|FG002|Overall Study|Physician Decision|0
1037602|NCT01717326|2069892|FG003|Overall Study|Physician Decision|0
1037603|NCT01717326|2069893|FG004|Overall Study|Physician Decision|0
1037604|NCT01717326|2069894|FG005|Overall Study|Physician Decision|0
1037605|NCT01717326|2069895|FG006|Overall Study|Physician Decision|0
1037606|NCT01717326|2069896|FG007|Overall Study|Physician Decision|0
1037607|NCT01717326|2069897|FG008|Overall Study|Physician Decision|0
1037608|NCT01717326|2069898|FG009|Overall Study|Physician Decision|1
1037609|NCT01717326|2069899|FG010|Overall Study|Physician Decision|0
1037610|NCT01717326|2069900|FG011|Overall Study|Physician Decision|0
1037611|NCT01717326|2069901|FG012|Overall Study|Physician Decision|0
1037612|NCT01717326|2069902|FG013|Overall Study|Physician Decision|0
1037613|NCT01717326|2069903|FG014|Overall Study|Physician Decision|0
1037614|NCT01717326|2069904|FG015|Overall Study|Physician Decision|0
1037615|NCT01717326|2069905|FG016|Overall Study|Physician Decision|0
1037616|NCT01717326|2069906|FG017|Overall Study|Physician Decision|0
1037617|NCT01717326|2069907|FG018|Overall Study|Physician Decision|0
1037618|NCT01717326|2069908|FG019|Overall Study|Physician Decision|0
1037619|NCT01717326|2069889|FG000|Overall Study|Protocol Violation|0
1037620|NCT01717326|2069890|FG001|Overall Study|Protocol Violation|0
1037621|NCT01717326|2069891|FG002|Overall Study|Protocol Violation|0
1037622|NCT01717326|2069892|FG003|Overall Study|Protocol Violation|0
1037623|NCT01717326|2069893|FG004|Overall Study|Protocol Violation|1
1037624|NCT01717326|2069894|FG005|Overall Study|Protocol Violation|0
1037625|NCT01717326|2069895|FG006|Overall Study|Protocol Violation|0
1037626|NCT01717326|2069896|FG007|Overall Study|Protocol Violation|0
1037627|NCT01717326|2069897|FG008|Overall Study|Protocol Violation|0
1037628|NCT01717326|2069898|FG009|Overall Study|Protocol Violation|0
1037629|NCT01717326|2069899|FG010|Overall Study|Protocol Violation|0
1037630|NCT01717326|2069900|FG011|Overall Study|Protocol Violation|0
1037631|NCT01717326|2069901|FG012|Overall Study|Protocol Violation|0
1037632|NCT01717326|2069902|FG013|Overall Study|Protocol Violation|0
1037633|NCT01717326|2069903|FG014|Overall Study|Protocol Violation|0
1037634|NCT01717326|2069904|FG015|Overall Study|Protocol Violation|0
1037635|NCT01717326|2069905|FG016|Overall Study|Protocol Violation|0
1037636|NCT01717326|2069906|FG017|Overall Study|Protocol Violation|0
1037637|NCT01717326|2069907|FG018|Overall Study|Protocol Violation|0
1037638|NCT01717326|2069908|FG019|Overall Study|Protocol Violation|0
1037639|NCT01717326|2069889|FG000|Overall Study|Withdrawal by Subject|0
1037640|NCT01717326|2069890|FG001|Overall Study|Withdrawal by Subject|1
1037641|NCT01717326|2069891|FG002|Overall Study|Withdrawal by Subject|0
1037642|NCT01717326|2069892|FG003|Overall Study|Withdrawal by Subject|0
1037643|NCT01717326|2069893|FG004|Overall Study|Withdrawal by Subject|0
1037644|NCT01717326|2069894|FG005|Overall Study|Withdrawal by Subject|0
1037645|NCT01717326|2069895|FG006|Overall Study|Withdrawal by Subject|0
1037646|NCT01717326|2069896|FG007|Overall Study|Withdrawal by Subject|0
1037647|NCT01717326|2069897|FG008|Overall Study|Withdrawal by Subject|0
1037648|NCT01717326|2069898|FG009|Overall Study|Withdrawal by Subject|1
1037649|NCT01717326|2069899|FG010|Overall Study|Withdrawal by Subject|0
1037650|NCT01717326|2069900|FG011|Overall Study|Withdrawal by Subject|0
1037651|NCT01717326|2069901|FG012|Overall Study|Withdrawal by Subject|1
1037652|NCT01717326|2069902|FG013|Overall Study|Withdrawal by Subject|0
1037653|NCT01717326|2069903|FG014|Overall Study|Withdrawal by Subject|0
1037654|NCT01717326|2069904|FG015|Overall Study|Withdrawal by Subject|1
1037655|NCT01717326|2069905|FG016|Overall Study|Withdrawal by Subject|0
1037656|NCT01717326|2069906|FG017|Overall Study|Withdrawal by Subject|0
1037657|NCT01717326|2069907|FG018|Overall Study|Withdrawal by Subject|2
1037658|NCT01717326|2069908|FG019|Overall Study|Withdrawal by Subject|3
1037659|NCT01717391|2069950|FG000|Overall Study|Withdrawal by Subject|5
1037660|NCT01717391|2069950|FG000|Overall Study|Physician Decision|1
1037661|NCT01717391|2069950|FG000|Overall Study|FLT technical failure|3
1037662|NCT01717456|2069958|FG000|End of Treatment|Physician Decision|0
1037663|NCT01717456|2069959|FG001|End of Treatment|Physician Decision|1
1037664|NCT01717456|2069958|FG000|End of Treatment|Lost to Follow-up|0
1037665|NCT01717456|2069959|FG001|End of Treatment|Lost to Follow-up|1
1037666|NCT01717456|2069958|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
1037667|NCT01717456|2069959|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
1037668|NCT01717638|2069983|FG000|Overall Study|Lost to Follow-up|0
1037669|NCT01717638|2069984|FG001|Overall Study|Lost to Follow-up|0
1037670|NCT01717638|2069985|FG002|Overall Study|Lost to Follow-up|0
1037671|NCT01717638|2069986|FG003|Overall Study|Lost to Follow-up|0
1037672|NCT01717638|2069987|FG004|Overall Study|Lost to Follow-up|0
1037673|NCT01717638|2069988|FG005|Overall Study|Lost to Follow-up|1
1037674|NCT01717638|2069989|FG006|Overall Study|Lost to Follow-up|0
1037675|NCT01717638|2069990|FG007|Overall Study|Lost to Follow-up|0
1037676|NCT01717638|2069991|FG008|Overall Study|Lost to Follow-up|0
1037677|NCT01717638|2069992|FG009|Overall Study|Lost to Follow-up|0
1037678|NCT01717638|2069993|FG010|Overall Study|Lost to Follow-up|0
1037679|NCT01717638|2069994|FG011|Overall Study|Lost to Follow-up|0
1037680|NCT01717638|2069995|FG012|Overall Study|Lost to Follow-up|0
1037681|NCT01717638|2069983|FG000|Overall Study|Father in hospital|0
1037682|NCT01717638|2069984|FG001|Overall Study|Father in hospital|0
1037683|NCT01717638|2069985|FG002|Overall Study|Father in hospital|0
1037684|NCT01717638|2069986|FG003|Overall Study|Father in hospital|0
1037685|NCT01717638|2069987|FG004|Overall Study|Father in hospital|0
1037686|NCT01717638|2069988|FG005|Overall Study|Father in hospital|0
1037687|NCT01717638|2069989|FG006|Overall Study|Father in hospital|0
1037688|NCT01717638|2069990|FG007|Overall Study|Father in hospital|0
1037689|NCT01717638|2069991|FG008|Overall Study|Father in hospital|0
1037690|NCT01717638|2069992|FG009|Overall Study|Father in hospital|0
1037691|NCT01717638|2069993|FG010|Overall Study|Father in hospital|0
1037692|NCT01717638|2069994|FG011|Overall Study|Father in hospital|0
1037693|NCT01717638|2069995|FG012|Overall Study|Father in hospital|1
1037694|NCT01717638|2069983|FG000|Overall Study|Withdrawal by Subject|0
1037695|NCT01717638|2069984|FG001|Overall Study|Withdrawal by Subject|1
1037696|NCT01717638|2069985|FG002|Overall Study|Withdrawal by Subject|1
1037697|NCT01717638|2069986|FG003|Overall Study|Withdrawal by Subject|0
1037698|NCT01717638|2069987|FG004|Overall Study|Withdrawal by Subject|1
1037699|NCT01717638|2069988|FG005|Overall Study|Withdrawal by Subject|0
1037700|NCT01717638|2069989|FG006|Overall Study|Withdrawal by Subject|2
1037701|NCT01717638|2069990|FG007|Overall Study|Withdrawal by Subject|1
1037702|NCT01717638|2069991|FG008|Overall Study|Withdrawal by Subject|2
1037703|NCT01717638|2069992|FG009|Overall Study|Withdrawal by Subject|1
1037704|NCT01717638|2069993|FG010|Overall Study|Withdrawal by Subject|0
1037705|NCT01717638|2069994|FG011|Overall Study|Withdrawal by Subject|0
1037706|NCT01717638|2069995|FG012|Overall Study|Withdrawal by Subject|18
1037707|NCT01717768|2070048|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1037708|NCT01717768|2070049|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
1037709|NCT01717768|2070050|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1037710|NCT01717768|2070051|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1037711|NCT01717768|2070052|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1037712|NCT01717768|2070053|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1037713|NCT01717768|2070054|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1037714|NCT01717768|2070055|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1037715|NCT01717768|2070056|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1037716|NCT01717768|2070057|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1037717|NCT01717768|2070058|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1037718|NCT01717768|2070059|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1037719|NCT01717768|2070048|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1037720|NCT01717768|2070049|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1037721|NCT01717768|2070050|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1037722|NCT01717768|2070051|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1037723|NCT01717768|2070052|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1037724|NCT01717768|2070053|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1037725|NCT01717768|2070054|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1037726|NCT01717768|2070055|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1037727|NCT01717768|2070056|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1037728|NCT01717768|2070057|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1037729|NCT01717768|2070058|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1037730|NCT01717768|2070059|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
1037731|NCT01717768|2070048|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1037732|NCT01717768|2070049|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1037733|NCT01717768|2070050|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1037734|NCT01717768|2070051|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1037735|NCT01717768|2070052|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1037736|NCT01717768|2070053|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1037737|NCT01717768|2070054|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1037738|NCT01717768|2070055|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
1037739|NCT01717768|2070056|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1037740|NCT01717768|2070057|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1037741|NCT01717768|2070058|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1037742|NCT01717768|2070059|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1037743|NCT01717768|2070048|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1037744|NCT01717768|2070049|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1037745|NCT01717768|2070050|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1037746|NCT01717768|2070051|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1037747|NCT01717768|2070052|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1037748|NCT01717768|2070053|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1037749|NCT01717768|2070054|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1037750|NCT01717768|2070055|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1037751|NCT01717768|2070056|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1037752|NCT01717768|2070057|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
1037753|NCT01717768|2070058|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1037754|NCT01717768|2070059|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1037755|NCT01717859|2070085|FG000|Overall Study|Adverse Event|5
1037756|NCT01717859|2070085|FG000|Overall Study|Moved out of state|1
1037757|NCT01717859|2070085|FG000|Overall Study|Patient concerned about mental health|1
1037758|NCT01717859|2070085|FG000|Overall Study|Lost to Follow-up|1
1037759|NCT01717859|2070085|FG000|Overall Study|Withdrawal by Subject|2
1037760|NCT01717976|2070124|FG000|Overall Study|Protocol Violation|0
1037761|NCT01717976|2070125|FG001|Overall Study|Protocol Violation|1
1037762|NCT01717989|2070131|FG000|Overall Study|Ineligibility determined|6
1037763|NCT01717989|2070131|FG000|Overall Study|Protocol deviation|6
1037764|NCT01717989|2070131|FG000|Overall Study|Withdrawal by Subject|11
1037765|NCT01717989|2070131|FG000|Overall Study|Physician Decision|2
1037766|NCT01717989|2070131|FG000|Overall Study|Lost to Follow-up|11
1037767|NCT01717989|2070131|FG000|Overall Study|Death|439
1037768|NCT01717989|2070131|FG000|Overall Study|Protocol-specified criteria|551
1037769|NCT01717989|2070131|FG000|Overall Study|Other|40
1037770|NCT01718353|2070161|FG000|Overall Study|Lost to Follow-up|0
1037771|NCT01718353|2070162|FG001|Overall Study|Lost to Follow-up|1
1037772|NCT01718353|2070161|FG000|Overall Study|Principal Investigator's Decision|10
1037773|NCT01718353|2070162|FG001|Overall Study|Principal Investigator's Decision|4
1037774|NCT01718353|2070161|FG000|Overall Study|Randomized but not treated|2
1037775|NCT01718353|2070162|FG001|Overall Study|Randomized but not treated|0
1037776|NCT01718483|2070172|FG000|Overall Study|Withdrawal by Subject|14
1037777|NCT01718483|2070173|FG001|Overall Study|Withdrawal by Subject|12
1037778|NCT01718483|2070172|FG000|Overall Study|Adverse Event|5
1037779|NCT01718483|2070173|FG001|Overall Study|Adverse Event|12
1037780|NCT01718483|2070172|FG000|Overall Study|Lost to Follow-up|8
1037781|NCT01718483|2070173|FG001|Overall Study|Lost to Follow-up|3
1037782|NCT01718483|2070172|FG000|Overall Study|Protocol Violation|4
1037783|NCT01718483|2070173|FG001|Overall Study|Protocol Violation|2
1037784|NCT01718483|2070172|FG000|Overall Study|Other|1
1037785|NCT01718483|2070173|FG001|Overall Study|Other|4
1037786|NCT01718483|2070172|FG000|Overall Study|Pregnancy|1
1037787|NCT01718483|2070173|FG001|Overall Study|Pregnancy|1
1037788|NCT01718483|2070172|FG000|Overall Study|Lack of Efficacy|1
1037789|NCT01718483|2070173|FG001|Overall Study|Lack of Efficacy|0
1037790|NCT01718509|2070181|FG000|Overall Study|Lost to Follow-up|18
1037791|NCT01718509|2070182|FG001|Overall Study|Lost to Follow-up|15
1037792|NCT01718509|2070181|FG000|Overall Study|Withdrawal by Subject|7
1037793|NCT01718509|2070182|FG001|Overall Study|Withdrawal by Subject|13
1037794|NCT01718509|2070181|FG000|Overall Study|Adverse Event|5
1037795|NCT01718509|2070182|FG001|Overall Study|Adverse Event|7
1037796|NCT01718509|2070181|FG000|Overall Study|Other|13
1037797|NCT01718509|2070182|FG001|Overall Study|Other|11
1037798|NCT01718509|2070181|FG000|Overall Study|Protocol Violation|4
1037799|NCT01718509|2070182|FG001|Overall Study|Protocol Violation|2
1037800|NCT01718509|2070181|FG000|Overall Study|Lack of Efficacy|1
1037801|NCT01718509|2070182|FG001|Overall Study|Lack of Efficacy|0
1037802|NCT01718535|2070205|FG000|Overall Study|Bidirectional Sequencing not possible|1
1037803|NCT01718535|2070206|FG001|Overall Study|Bidirectional Sequencing not possible|0
1037804|NCT01718535|2070207|FG002|Overall Study|Bidirectional Sequencing not possible|0
1037805|NCT01718535|2070208|FG003|Overall Study|Bidirectional Sequencing not possible|1
1037806|NCT01718535|2070209|FG004|Overall Study|Bidirectional Sequencing not possible|0
1037807|NCT01718535|2070210|FG005|Overall Study|Bidirectional Sequencing not possible|0
1037808|NCT01718535|2070211|FG006|Overall Study|Bidirectional Sequencing not possible|0
1037809|NCT01718535|2070212|FG007|Overall Study|Bidirectional Sequencing not possible|0
1037810|NCT01718535|2070213|FG008|Overall Study|Bidirectional Sequencing not possible|0
1037811|NCT01718535|2070214|FG009|Overall Study|Bidirectional Sequencing not possible|0
1037812|NCT01719003|2070258|FG000|Overall Study|Non compliant with protocol|1
1037813|NCT01719003|2070259|FG001|Overall Study|Non compliant with protocol|1
1037814|NCT01719003|2070260|FG002|Overall Study|Non compliant with protocol|0
1037815|NCT01719003|2070261|FG003|Overall Study|Non compliant with protocol|1
1037816|NCT01719003|2070262|FG004|Overall Study|Non compliant with protocol|2
1037817|NCT01719003|2070263|FG005|Overall Study|Non compliant with protocol|1
1037818|NCT01719003|2070264|FG006|Overall Study|Non compliant with protocol|2
1037819|NCT01719003|2070265|FG007|Overall Study|Non compliant with protocol|3
1037820|NCT01719003|2070266|FG008|Overall Study|Non compliant with protocol|0
906372|NCT00767806|1882006|FG000|Overall Study|Lost to Follow-up|1
906373|NCT00767806|1882007|FG001|Overall Study|Lost to Follow-up|4
906374|NCT00767806|1882006|FG000|Overall Study|Entry Criteria Not Met|1
1037821|NCT01719003|2070258|FG000|Overall Study|Adverse Event|6
1037822|NCT01719003|2070259|FG001|Overall Study|Adverse Event|5
1037823|NCT01719003|2070260|FG002|Overall Study|Adverse Event|4
1037824|NCT01719003|2070261|FG003|Overall Study|Adverse Event|3
1037825|NCT01719003|2070262|FG004|Overall Study|Adverse Event|4
1037826|NCT01719003|2070263|FG005|Overall Study|Adverse Event|3
1037827|NCT01719003|2070264|FG006|Overall Study|Adverse Event|6
1037828|NCT01719003|2070265|FG007|Overall Study|Adverse Event|5
1037829|NCT01719003|2070266|FG008|Overall Study|Adverse Event|0
1037830|NCT01719003|2070258|FG000|Overall Study|Lost to Follow-up|0
1037831|NCT01719003|2070259|FG001|Overall Study|Lost to Follow-up|6
1037832|NCT01719003|2070260|FG002|Overall Study|Lost to Follow-up|7
1037833|NCT01719003|2070261|FG003|Overall Study|Lost to Follow-up|2
1037834|NCT01719003|2070262|FG004|Overall Study|Lost to Follow-up|3
1037835|NCT01719003|2070263|FG005|Overall Study|Lost to Follow-up|4
1037836|NCT01719003|2070264|FG006|Overall Study|Lost to Follow-up|3
1037837|NCT01719003|2070265|FG007|Overall Study|Lost to Follow-up|2
1037838|NCT01719003|2070266|FG008|Overall Study|Lost to Follow-up|2
1037839|NCT01719003|2070258|FG000|Overall Study|Refusal to continue, not due to AE|2
1037840|NCT01719003|2070259|FG001|Overall Study|Refusal to continue, not due to AE|5
1037841|NCT01719003|2070260|FG002|Overall Study|Refusal to continue, not due to AE|4
1037842|NCT01719003|2070261|FG003|Overall Study|Refusal to continue, not due to AE|4
1037843|NCT01719003|2070262|FG004|Overall Study|Refusal to continue, not due to AE|4
1037844|NCT01719003|2070263|FG005|Overall Study|Refusal to continue, not due to AE|3
1037845|NCT01719003|2070264|FG006|Overall Study|Refusal to continue, not due to AE|8
1037846|NCT01719003|2070265|FG007|Overall Study|Refusal to continue, not due to AE|7
1037847|NCT01719003|2070266|FG008|Overall Study|Refusal to continue, not due to AE|1
1037848|NCT01719003|2070258|FG000|Overall Study|Reason other than those specified|0
1037849|NCT01719003|2070259|FG001|Overall Study|Reason other than those specified|0
1037850|NCT01719003|2070260|FG002|Overall Study|Reason other than those specified|2
1037851|NCT01719003|2070261|FG003|Overall Study|Reason other than those specified|3
1037852|NCT01719003|2070262|FG004|Overall Study|Reason other than those specified|4
1037853|NCT01719003|2070263|FG005|Overall Study|Reason other than those specified|1
1037854|NCT01719003|2070264|FG006|Overall Study|Reason other than those specified|0
1037855|NCT01719003|2070265|FG007|Overall Study|Reason other than those specified|3
1037856|NCT01719003|2070266|FG008|Overall Study|Reason other than those specified|1
1037857|NCT01719003|2070258|FG000|Overall Study|Lack of Efficacy|0
1037858|NCT01719003|2070259|FG001|Overall Study|Lack of Efficacy|0
1037859|NCT01719003|2070260|FG002|Overall Study|Lack of Efficacy|0
1037860|NCT01719003|2070261|FG003|Overall Study|Lack of Efficacy|0
1037861|NCT01719003|2070262|FG004|Overall Study|Lack of Efficacy|0
1037862|NCT01719003|2070263|FG005|Overall Study|Lack of Efficacy|0
1037863|NCT01719003|2070264|FG006|Overall Study|Lack of Efficacy|1
1037864|NCT01719003|2070265|FG007|Overall Study|Lack of Efficacy|0
1037865|NCT01719003|2070266|FG008|Overall Study|Lack of Efficacy|0
1037866|NCT01719172|2070285|FG000|Overall Study|Lost to Follow-up|1
1037867|NCT01719172|2070285|FG000|Overall Study|Death|1
1037868|NCT01719224|2070289|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
1037869|NCT01719224|2070290|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
1037870|NCT01719380|2070316|FG000|Overall Study|Adverse Event|0
1037871|NCT01719380|2070317|FG001|Overall Study|Adverse Event|0
1037872|NCT01719380|2070318|FG002|Overall Study|Adverse Event|1
1037873|NCT01719380|2070319|FG003|Overall Study|Adverse Event|2
1037874|NCT01719380|2070320|FG004|Overall Study|Adverse Event|0
1037875|NCT01719380|2070321|FG005|Overall Study|Adverse Event|1
1037876|NCT01719380|2070322|FG006|Overall Study|Adverse Event|0
1037877|NCT01719380|2070323|FG007|Overall Study|Adverse Event|1
1037878|NCT01719380|2070324|FG008|Overall Study|Adverse Event|4
1037879|NCT01719380|2070325|FG009|Overall Study|Adverse Event|3
1037880|NCT01719380|2070316|FG000|Overall Study|Death|0
1037881|NCT01719380|2070317|FG001|Overall Study|Death|1
1037882|NCT01719380|2070318|FG002|Overall Study|Death|0
1037883|NCT01719380|2070319|FG003|Overall Study|Death|0
1037884|NCT01719380|2070320|FG004|Overall Study|Death|0
1037885|NCT01719380|2070321|FG005|Overall Study|Death|0
1037886|NCT01719380|2070322|FG006|Overall Study|Death|0
1037887|NCT01719380|2070323|FG007|Overall Study|Death|0
1037888|NCT01719380|2070324|FG008|Overall Study|Death|3
1037889|NCT01719380|2070325|FG009|Overall Study|Death|3
1037890|NCT01719380|2070316|FG000|Overall Study|Participant/Guardian Decision|0
1037891|NCT01719380|2070317|FG001|Overall Study|Participant/Guardian Decision|0
1037892|NCT01719380|2070318|FG002|Overall Study|Participant/Guardian Decision|1
1037893|NCT01719380|2070319|FG003|Overall Study|Participant/Guardian Decision|0
1037894|NCT01719380|2070320|FG004|Overall Study|Participant/Guardian Decision|0
1037895|NCT01719380|2070321|FG005|Overall Study|Participant/Guardian Decision|0
1037896|NCT01719380|2070322|FG006|Overall Study|Participant/Guardian Decision|0
1037897|NCT01719380|2070323|FG007|Overall Study|Participant/Guardian Decision|0
1037898|NCT01719380|2070324|FG008|Overall Study|Participant/Guardian Decision|2
1037899|NCT01719380|2070325|FG009|Overall Study|Participant/Guardian Decision|2
1037900|NCT01719380|2070316|FG000|Overall Study|Physician Decision|0
1037901|NCT01719380|2070317|FG001|Overall Study|Physician Decision|0
1037902|NCT01719380|2070318|FG002|Overall Study|Physician Decision|2
1037903|NCT01719380|2070319|FG003|Overall Study|Physician Decision|0
1037904|NCT01719380|2070320|FG004|Overall Study|Physician Decision|0
1037905|NCT01719380|2070321|FG005|Overall Study|Physician Decision|0
1037906|NCT01719380|2070322|FG006|Overall Study|Physician Decision|0
1037907|NCT01719380|2070323|FG007|Overall Study|Physician Decision|0
1037908|NCT01719380|2070324|FG008|Overall Study|Physician Decision|1
1037909|NCT01719380|2070325|FG009|Overall Study|Physician Decision|1
1037910|NCT01719380|2070316|FG000|Overall Study|Lack of Efficacy|2
1037911|NCT01719380|2070317|FG001|Overall Study|Lack of Efficacy|6
1037912|NCT01719380|2070318|FG002|Overall Study|Lack of Efficacy|5
1037913|NCT01719380|2070319|FG003|Overall Study|Lack of Efficacy|6
1037914|NCT01719380|2070320|FG004|Overall Study|Lack of Efficacy|3
1037915|NCT01719380|2070321|FG005|Overall Study|Lack of Efficacy|7
1037916|NCT01719380|2070322|FG006|Overall Study|Lack of Efficacy|10
1037917|NCT01719380|2070323|FG007|Overall Study|Lack of Efficacy|6
1037918|NCT01719380|2070324|FG008|Overall Study|Lack of Efficacy|39
1037919|NCT01719380|2070325|FG009|Overall Study|Lack of Efficacy|42
1037920|NCT01719380|2070316|FG000|Overall Study|Progressive Disease|0
1037921|NCT01719380|2070317|FG001|Overall Study|Progressive Disease|0
1037922|NCT01719380|2070318|FG002|Overall Study|Progressive Disease|0
1037923|NCT01719380|2070319|FG003|Overall Study|Progressive Disease|0
1037924|NCT01719380|2070320|FG004|Overall Study|Progressive Disease|0
1037925|NCT01719380|2070321|FG005|Overall Study|Progressive Disease|0
1037926|NCT01719380|2070322|FG006|Overall Study|Progressive Disease|0
1037927|NCT01719380|2070323|FG007|Overall Study|Progressive Disease|0
1037928|NCT01719380|2070324|FG008|Overall Study|Progressive Disease|1
1037929|NCT01719380|2070325|FG009|Overall Study|Progressive Disease|0
1037930|NCT01719757|2070379|FG000|Overall Study|Adverse Event|38
1037931|NCT01719757|2070379|FG000|Overall Study|Withdrawal by Subject|15
1037932|NCT01719757|2070379|FG000|Overall Study|Lost to Follow-up|20
1037933|NCT01719757|2070379|FG000|Overall Study|Protocol Violation|1
1037934|NCT01719757|2070379|FG000|Overall Study|well controlled pain|27
1037935|NCT01719783|2070387|FG000|Dose 2|Physician Decision|1
1037936|NCT01719783|2070388|FG001|Dose 2|Physician Decision|0
1037937|NCT01719861|2070414|FG000|Cycle 1|Death|4
1037938|NCT01719861|2070414|FG000|Cycle 2|Death|1
1037939|NCT01720043|2070428|FG000|Overall Study|Withdrawal by Subject|1
1037940|NCT01720069|2070435|FG000|Overall Study|Could not use e-diary correctly|0
1037941|NCT01720069|2070436|FG001|Overall Study|Could not use e-diary correctly|1
1037942|NCT01720069|2070437|FG002|Overall Study|Could not use e-diary correctly|1
1037943|NCT01720069|2070435|FG000|Overall Study|Randomised without baseline values|0
1037944|NCT01720069|2070436|FG001|Overall Study|Randomised without baseline values|0
1037945|NCT01720069|2070437|FG002|Overall Study|Randomised without baseline values|1
1037946|NCT01720069|2070435|FG000|Overall Study|Adverse Event|0
1037947|NCT01720069|2070436|FG001|Overall Study|Adverse Event|0
1037948|NCT01720069|2070437|FG002|Overall Study|Adverse Event|1
1037949|NCT01720069|2070435|FG000|Overall Study|Lack of Efficacy|0
1037950|NCT01720069|2070436|FG001|Overall Study|Lack of Efficacy|4
1037951|NCT01720069|2070437|FG002|Overall Study|Lack of Efficacy|0
1037952|NCT01720069|2070435|FG000|Overall Study|Treatment period withdrawal criteria met|4
1037953|NCT01720069|2070436|FG001|Overall Study|Treatment period withdrawal criteria met|8
1037954|NCT01720069|2070437|FG002|Overall Study|Treatment period withdrawal criteria met|9
1037955|NCT01720069|2070435|FG000|Overall Study|Withdrawal by Subject|0
1037956|NCT01720069|2070436|FG001|Overall Study|Withdrawal by Subject|2
1037957|NCT01720069|2070437|FG002|Overall Study|Withdrawal by Subject|1
1037958|NCT01720069|2070435|FG000|Overall Study|OCS bursts occured, discontinued in line|1
1037959|NCT01720069|2070436|FG001|Overall Study|OCS bursts occured, discontinued in line|0
1037960|NCT01720069|2070437|FG002|Overall Study|OCS bursts occured, discontinued in line|0
1037961|NCT01720069|2070435|FG000|Overall Study|Non-compliance on using e-diary|0
1037962|NCT01720069|2070436|FG001|Overall Study|Non-compliance on using e-diary|0
1037963|NCT01720069|2070437|FG002|Overall Study|Non-compliance on using e-diary|1
1037964|NCT01720069|2070435|FG000|Overall Study|Lost to Follow-up|0
1037965|NCT01720069|2070436|FG001|Overall Study|Lost to Follow-up|0
1037966|NCT01720069|2070437|FG002|Overall Study|Lost to Follow-up|1
1037967|NCT01720225|2070451|FG000|Overall Study|Withdrawal by Subject|0
1037968|NCT01720225|2070452|FG001|Overall Study|Withdrawal by Subject|1
1037969|NCT01720225|2070451|FG000|Overall Study|Did not complete 2 cycles of therapy|3
1037970|NCT01720225|2070452|FG001|Overall Study|Did not complete 2 cycles of therapy|0
1037971|NCT01720264|2070471|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1
1037972|NCT01720264|2070471|FG000|Post-transplant (Day 16) to 1 Year|Death|8
1037973|NCT01720264|2070471|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4
1037974|NCT01720446|2070525|FG000|Overall Study|Lost to Follow-up|12
1037975|NCT01720446|2070526|FG001|Overall Study|Lost to Follow-up|6
1037976|NCT01720446|2070527|FG002|Overall Study|Lost to Follow-up|16
1037977|NCT01720446|2070528|FG003|Overall Study|Lost to Follow-up|16
1037978|NCT01720446|2070525|FG000|Overall Study|Withdrawal by Subject|2
1037979|NCT01720446|2070526|FG001|Overall Study|Withdrawal by Subject|5
1037980|NCT01720446|2070527|FG002|Overall Study|Withdrawal by Subject|4
1037981|NCT01720446|2070528|FG003|Overall Study|Withdrawal by Subject|4
1037982|NCT01720524|2070543|FG000|Part A|Insufficient Clinical Response|2
1037983|NCT01720524|2070544|FG001|Part A|Insufficient Clinical Response|4
1037984|NCT01720524|2070543|FG000|Part A|Adverse Event|2
1037985|NCT01720524|2070544|FG001|Part A|Adverse Event|2
1037986|NCT01720524|2070543|FG000|Part A|Death|2
1037987|NCT01720524|2070544|FG001|Part A|Death|1
1037988|NCT01720524|2070543|FG000|Part A|Lost to Follow-up|0
1037989|NCT01720524|2070544|FG001|Part A|Lost to Follow-up|1
1037990|NCT01720524|2070543|FG000|Part A|Missed 28 day follow-up visit|1
1037991|NCT01720524|2070544|FG001|Part A|Missed 28 day follow-up visit|1
1037992|NCT01720524|2070543|FG000|Part A|Withdrawal by Subject|0
1037993|NCT01720524|2070544|FG001|Part A|Withdrawal by Subject|1
1037994|NCT01720524|2070543|FG000|Part A|Other|0
1037995|NCT01720524|2070544|FG001|Part A|Other|1
1037996|NCT01720524|2070543|FG000|Part A|Lost to Follow-up|0
1037997|NCT01720524|2070544|FG001|Part A|Lost to Follow-up|1
1037998|NCT01720524|2070543|FG000|Part B|No longer willing to participate in study|1
1037999|NCT01720524|2070544|FG001|Part B|No longer willing to participate in study|4
1038000|NCT01720524|2070543|FG000|Part B|Other|2
1038001|NCT01720524|2070544|FG001|Part B|Other|0
1038002|NCT01720524|2070543|FG000|Part B|Lost to Follow-up|2
1038003|NCT01720524|2070544|FG001|Part B|Lost to Follow-up|3
1038004|NCT01720524|2070543|FG000|Part B|Death|0
1038005|NCT01720524|2070544|FG001|Part B|Death|2
1038006|NCT01720602|2070552|FG000|Overall Study|Adverse Event|3
1038007|NCT01720602|2070552|FG000|Overall Study|Progressive disease on therapy|2
1038008|NCT01720667|2070558|FG000|Overall Study|Adverse Event|1
1038009|NCT01720667|2070559|FG001|Overall Study|Adverse Event|1
1038010|NCT01720667|2070558|FG000|Overall Study|Withdrawal by Subject|3
1038011|NCT01720667|2070559|FG001|Overall Study|Withdrawal by Subject|0
1038012|NCT01720797|2070569|FG000|Overall Study|Withdrawal by Subject|3
1038013|NCT01720797|2070570|FG001|Overall Study|Withdrawal by Subject|0
1038014|NCT01721044|2070579|FG000|Treatment Period|Adverse Event|7
1038015|NCT01721044|2070580|FG001|Treatment Period|Adverse Event|7
1038016|NCT01721044|2070581|FG002|Treatment Period|Adverse Event|10
1038017|NCT01721044|2070579|FG000|Treatment Period|Death|0
1038018|NCT01721044|2070580|FG001|Treatment Period|Death|0
1038019|NCT01721044|2070581|FG002|Treatment Period|Death|1
1038020|NCT01721044|2070579|FG000|Treatment Period|Lack of Efficacy|16
1038021|NCT01721044|2070580|FG001|Treatment Period|Lack of Efficacy|4
1038022|NCT01721044|2070581|FG002|Treatment Period|Lack of Efficacy|4
1038023|NCT01721044|2070579|FG000|Treatment Period|Lost to Follow-up|0
1038024|NCT01721044|2070580|FG001|Treatment Period|Lost to Follow-up|0
1038025|NCT01721044|2070581|FG002|Treatment Period|Lost to Follow-up|1
1038026|NCT01721044|2070579|FG000|Treatment Period|Physician Decision|1
1038027|NCT01721044|2070580|FG001|Treatment Period|Physician Decision|0
1038028|NCT01721044|2070581|FG002|Treatment Period|Physician Decision|2
1038029|NCT01721044|2070579|FG000|Treatment Period|Protocol Violation|1
1038030|NCT01721044|2070580|FG001|Treatment Period|Protocol Violation|0
1038031|NCT01721044|2070581|FG002|Treatment Period|Protocol Violation|0
1038032|NCT01721044|2070579|FG000|Treatment Period|Withdrawal by Subject|7
1038033|NCT01721044|2070580|FG001|Treatment Period|Withdrawal by Subject|6
1038034|NCT01721044|2070581|FG002|Treatment Period|Withdrawal by Subject|1
1038035|NCT01721057|2070603|FG000|Treatment Period|Withdrawal by Subject|11
1038036|NCT01721057|2070604|FG001|Treatment Period|Withdrawal by Subject|5
1038037|NCT01721057|2070605|FG002|Treatment Period|Withdrawal by Subject|8
1038038|NCT01721057|2070606|FG003|Treatment Period|Withdrawal by Subject|0
1038039|NCT01721057|2070607|FG004|Treatment Period|Withdrawal by Subject|0
1038040|NCT01721057|2070608|FG005|Treatment Period|Withdrawal by Subject|0
1038041|NCT01721057|2070609|FG006|Treatment Period|Withdrawal by Subject|0
1038042|NCT01721057|2070603|FG000|Treatment Period|Adverse Event|7
1038043|NCT01721057|2070604|FG001|Treatment Period|Adverse Event|10
1038044|NCT01721057|2070605|FG002|Treatment Period|Adverse Event|12
1038045|NCT01721057|2070606|FG003|Treatment Period|Adverse Event|0
1038046|NCT01721057|2070607|FG004|Treatment Period|Adverse Event|0
1038047|NCT01721057|2070608|FG005|Treatment Period|Adverse Event|0
1038048|NCT01721057|2070609|FG006|Treatment Period|Adverse Event|0
1038049|NCT01721057|2070603|FG000|Treatment Period|Lack of Efficacy|7
1038050|NCT01721057|2070604|FG001|Treatment Period|Lack of Efficacy|3
1038051|NCT01721057|2070605|FG002|Treatment Period|Lack of Efficacy|0
1038052|NCT01721057|2070606|FG003|Treatment Period|Lack of Efficacy|0
1038053|NCT01721057|2070607|FG004|Treatment Period|Lack of Efficacy|0
1038054|NCT01721057|2070608|FG005|Treatment Period|Lack of Efficacy|0
1038055|NCT01721057|2070609|FG006|Treatment Period|Lack of Efficacy|0
1038056|NCT01721057|2070603|FG000|Treatment Period|Lost to Follow-up|1
1038057|NCT01721057|2070604|FG001|Treatment Period|Lost to Follow-up|0
1038058|NCT01721057|2070605|FG002|Treatment Period|Lost to Follow-up|0
1038059|NCT01721057|2070606|FG003|Treatment Period|Lost to Follow-up|0
1038060|NCT01721057|2070607|FG004|Treatment Period|Lost to Follow-up|0
1038061|NCT01721057|2070608|FG005|Treatment Period|Lost to Follow-up|0
1038062|NCT01721057|2070609|FG006|Treatment Period|Lost to Follow-up|0
1038063|NCT01721057|2070603|FG000|Treatment Period|Physician Decision|0
1038064|NCT01721057|2070604|FG001|Treatment Period|Physician Decision|1
1038065|NCT01721057|2070605|FG002|Treatment Period|Physician Decision|3
1038066|NCT01721057|2070606|FG003|Treatment Period|Physician Decision|0
1038067|NCT01721057|2070607|FG004|Treatment Period|Physician Decision|0
1038068|NCT01721057|2070608|FG005|Treatment Period|Physician Decision|0
1038069|NCT01721057|2070609|FG006|Treatment Period|Physician Decision|0
1038070|NCT01721057|2070603|FG000|Treatment Period|Death|2
1038071|NCT01721057|2070604|FG001|Treatment Period|Death|0
1038072|NCT01721057|2070605|FG002|Treatment Period|Death|0
1038073|NCT01721057|2070606|FG003|Treatment Period|Death|0
1038074|NCT01721057|2070607|FG004|Treatment Period|Death|0
1038075|NCT01721057|2070608|FG005|Treatment Period|Death|0
1038076|NCT01721057|2070609|FG006|Treatment Period|Death|0
1038077|NCT01721057|2070603|FG000|Rescue Period|Adverse Event|0
1038078|NCT01721057|2070604|FG001|Rescue Period|Adverse Event|0
1038079|NCT01721057|2070605|FG002|Rescue Period|Adverse Event|0
1038080|NCT01721057|2070606|FG003|Rescue Period|Adverse Event|1
1038081|NCT01721057|2070607|FG004|Rescue Period|Adverse Event|0
1038082|NCT01721057|2070608|FG005|Rescue Period|Adverse Event|0
1038083|NCT01721057|2070609|FG006|Rescue Period|Adverse Event|0
1038084|NCT01721057|2070603|FG000|Rescue Period|Lack of Efficacy|0
1038085|NCT01721057|2070604|FG001|Rescue Period|Lack of Efficacy|0
1038086|NCT01721057|2070605|FG002|Rescue Period|Lack of Efficacy|0
1038087|NCT01721057|2070606|FG003|Rescue Period|Lack of Efficacy|2
1038088|NCT01721057|2070607|FG004|Rescue Period|Lack of Efficacy|0
1038089|NCT01721057|2070608|FG005|Rescue Period|Lack of Efficacy|0
1038090|NCT01721057|2070609|FG006|Rescue Period|Lack of Efficacy|0
1038091|NCT01721070|2070636|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
1038092|NCT01721109|2070654|FG000|Overall Study|Lack of Efficacy|1
1038093|NCT01721109|2070654|FG000|Overall Study|Non- Compliance with Study Drug|3
1038094|NCT01721109|2070654|FG000|Overall Study|Withdrew Consent|1
1038095|NCT01721109|2070654|FG000|Overall Study|Lost to Follow-up|2
1038096|NCT01721161|2070660|FG000|Overall Study|Adverse Event|2
1038097|NCT01721161|2070661|FG001|Overall Study|Adverse Event|3
1038098|NCT01721161|2070660|FG000|Overall Study|Lost to Follow-up|1
1038099|NCT01721161|2070661|FG001|Overall Study|Lost to Follow-up|2
1038100|NCT01721161|2070660|FG000|Overall Study|Withdrawal by Subject|1
1038101|NCT01721161|2070661|FG001|Overall Study|Withdrawal by Subject|1
1038102|NCT01721161|2070660|FG000|Overall Study|Other|0
1038103|NCT01721161|2070661|FG001|Overall Study|Other|1
1038104|NCT01721200|2070670|FG000|Overall Study|Lost to Follow-up|3
1038105|NCT01721200|2070671|FG001|Overall Study|Lost to Follow-up|5
1038106|NCT01721317|2070693|FG000|Overall Study|Study Closed / Terminated|2
1038107|NCT01721317|2070694|FG001|Overall Study|Study Closed / Terminated|2
1038108|NCT01721317|2070693|FG000|Overall Study|Physician Decision|0
1038109|NCT01721317|2070694|FG001|Overall Study|Physician Decision|1
1038110|NCT01721317|2070693|FG000|Overall Study|Withdrawal by Subject|0
1038111|NCT01721317|2070694|FG001|Overall Study|Withdrawal by Subject|1
1038112|NCT01721330|2070702|FG000|Overall Study|Withdrawal by Subject|0
1038113|NCT01721330|2070703|FG001|Overall Study|Withdrawal by Subject|1
1038114|NCT01721369|2070709|FG000|Overall Study|Not initial etiological diagnosis|12
1038115|NCT01721408|2070715|FG000|Overall Study|Adverse Event|6
1038116|NCT01721408|2070716|FG001|Overall Study|Adverse Event|1
1038117|NCT01721408|2070715|FG000|Overall Study|Death|1
1038118|NCT01721408|2070716|FG001|Overall Study|Death|0
1038119|NCT01721408|2070715|FG000|Overall Study|Insufficient clinical response|15
1038120|NCT01721408|2070716|FG001|Overall Study|Insufficient clinical response|6
1038121|NCT01721408|2070715|FG000|Overall Study|No longer willing to participate study|9
1038122|NCT01721408|2070716|FG001|Overall Study|No longer willing to participate study|10
1038123|NCT01721408|2070715|FG000|Overall Study|Protocol Violation|0
1038124|NCT01721408|2070716|FG001|Overall Study|Protocol Violation|2
1038125|NCT01721408|2070715|FG000|Overall Study|Other|3
1038126|NCT01721408|2070716|FG001|Overall Study|Other|3
1038127|NCT01721408|2070715|FG000|Overall Study|Lost to Follow-up|1
1038128|NCT01721408|2070716|FG001|Overall Study|Lost to Follow-up|2
1038129|NCT01721408|2070715|FG000|Overall Study|Does not meet entrance criteria|1
1038130|NCT01721408|2070716|FG001|Overall Study|Does not meet entrance criteria|0
1038131|NCT01721486|2070755|FG000|Overall Study|Protocol Violation|1
1038132|NCT01721486|2070756|FG001|Overall Study|Protocol Violation|0
1038133|NCT01721486|2070755|FG000|Overall Study|Physician Decision|0
1038134|NCT01721486|2070756|FG001|Overall Study|Physician Decision|1
1038135|NCT01721746|2070776|FG000|Treatment Period|Disease Progression|182
1038136|NCT01721746|2070777|FG001|Treatment Period|Disease Progression|40
1038137|NCT01721746|2070778|FG002|Treatment Period|Disease Progression|34
1038138|NCT01721746|2070776|FG000|Treatment Period|Study Drug Toxicity|15
1038139|NCT01721746|2070777|FG001|Treatment Period|Study Drug Toxicity|2
1038140|NCT01721746|2070778|FG002|Treatment Period|Study Drug Toxicity|9
1038141|NCT01721746|2070776|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|6
1038142|NCT01721746|2070777|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|1
1038143|NCT01721746|2070778|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|2
1038144|NCT01721746|2070776|FG000|Treatment Period|Subject Request to Discontinue Treatment|19
1038145|NCT01721746|2070777|FG001|Treatment Period|Subject Request to Discontinue Treatment|1
1038146|NCT01721746|2070778|FG002|Treatment Period|Subject Request to Discontinue Treatment|6
1038147|NCT01721746|2070776|FG000|Treatment Period|Subject Withdrew Consent|3
1038148|NCT01721746|2070777|FG001|Treatment Period|Subject Withdrew Consent|0
1038149|NCT01721746|2070778|FG002|Treatment Period|Subject Withdrew Consent|2
1038150|NCT01721746|2070776|FG000|Treatment Period|Maximum Clinical Benefit|1
1038151|NCT01721746|2070777|FG001|Treatment Period|Maximum Clinical Benefit|0
1038152|NCT01721746|2070778|FG002|Treatment Period|Maximum Clinical Benefit|3
1038153|NCT01721746|2070776|FG000|Treatment Period|Poor/Non-compliance|1
1038154|NCT01721746|2070777|FG001|Treatment Period|Poor/Non-compliance|0
1038155|NCT01721746|2070778|FG002|Treatment Period|Poor/Non-compliance|0
1038156|NCT01721746|2070776|FG000|Treatment Period|Subject No Longer Met Study Criteria|4
1038157|NCT01721746|2070777|FG001|Treatment Period|Subject No Longer Met Study Criteria|0
1038158|NCT01721746|2070778|FG002|Treatment Period|Subject No Longer Met Study Criteria|0
1038159|NCT01721746|2070776|FG000|Treatment Period|Other|2
1038160|NCT01721746|2070777|FG001|Treatment Period|Other|1
1038161|NCT01721746|2070778|FG002|Treatment Period|Other|1
1038166|NCT01721772|2070790|FG000|Overall Study|Disease progression|96
1038167|NCT01721772|2070791|FG001|Overall Study|Disease progression|175
1038168|NCT01721772|2070790|FG000|Overall Study|Study drug toxicity|5
1038169|NCT01721772|2070791|FG001|Overall Study|Study drug toxicity|7
1038170|NCT01721772|2070790|FG000|Overall Study|Unrelated adverse event|2
1038171|NCT01721772|2070791|FG001|Overall Study|Unrelated adverse event|3
1038172|NCT01721772|2070790|FG000|Overall Study|Withdrawal by Subject|7
1038173|NCT01721772|2070791|FG001|Overall Study|Withdrawal by Subject|5
1038174|NCT01721772|2070790|FG000|Overall Study|Maximum clinical benefit|1
1038175|NCT01721772|2070791|FG001|Overall Study|Maximum clinical benefit|1
1038176|NCT01721772|2070790|FG000|Overall Study|Other|0
1038177|NCT01721772|2070791|FG001|Overall Study|Other|1
1038178|NCT01721876|2070803|FG000|Overall Study|Not treated|1
1038179|NCT01721876|2070804|FG001|Overall Study|Not treated|4
1038180|NCT01721876|2070803|FG000|Overall Study|Disease progression / relapse|123
1038181|NCT01721876|2070804|FG001|Overall Study|Disease progression / relapse|156
1038182|NCT01721876|2070803|FG000|Overall Study|Death|6
1038183|NCT01721876|2070804|FG001|Overall Study|Death|13
1038184|NCT01721876|2070803|FG000|Overall Study|Adverse Event|41
1038185|NCT01721876|2070804|FG001|Overall Study|Adverse Event|165
1038186|NCT01721876|2070803|FG000|Overall Study|Protocol Violation|2
1038187|NCT01721876|2070804|FG001|Overall Study|Protocol Violation|1
1038188|NCT01721876|2070803|FG000|Overall Study|Withdrawal by Subject|15
1038189|NCT01721876|2070804|FG001|Overall Study|Withdrawal by Subject|38
1038190|NCT01721876|2070803|FG000|Overall Study|Reason not listed|34
1038191|NCT01721876|2070804|FG001|Overall Study|Reason not listed|63
1038192|NCT01721876|2070803|FG000|Overall Study|Sponsor terminated trial|0
1038193|NCT01721876|2070804|FG001|Overall Study|Sponsor terminated trial|4
1038194|NCT01721954|2070812|FG000|Overall Study|Death|58
1038195|NCT01721954|2070813|FG001|Overall Study|Death|64
1038196|NCT01721954|2070812|FG000|Overall Study|Withdrawal by Subject|8
1038197|NCT01721954|2070813|FG001|Overall Study|Withdrawal by Subject|4
1038198|NCT01721954|2070812|FG000|Overall Study|Adverse Event|2
1038199|NCT01721954|2070813|FG001|Overall Study|Adverse Event|0
1038200|NCT01721954|2070812|FG000|Overall Study|Lost to Follow-up|2
1038201|NCT01721954|2070813|FG001|Overall Study|Lost to Follow-up|1
1038202|NCT01722045|2070823|FG000|Overall Study|Adverse Event|8
1038203|NCT01722045|2070823|FG000|Overall Study|Death|3
1038204|NCT01722045|2070823|FG000|Overall Study|Withdrawal by Subject|8
1038205|NCT01722045|2070823|FG000|Overall Study|Lost to Follow-up|4
1038206|NCT01722045|2070823|FG000|Overall Study|Protocol Deviation|1
1038207|NCT01722045|2070823|FG000|Overall Study|Physician Decision|3
1038208|NCT01722045|2070823|FG000|Overall Study|Relocation (did not wish to transfer)|1
1038209|NCT01722071|2070827|FG000|Overall Study|Protocol Violation|1
1038210|NCT01722071|2070828|FG001|Overall Study|Protocol Violation|0
1038211|NCT01722097|2070836|FG000|Overall Study|Patient sheets not returned|6
1038212|NCT01722097|2070837|FG001|Overall Study|Patient sheets not returned|5
1038213|NCT01722162|2070845|FG000|Overall Study|Withdrawal by Subject|1
1038214|NCT01722162|2070846|FG001|Overall Study|Withdrawal by Subject|1
1038215|NCT01722162|2070845|FG000|Overall Study|Found ineligible|1
1038216|NCT01722162|2070846|FG001|Overall Study|Found ineligible|0
1038217|NCT01722162|2070845|FG000|Overall Study|Unrelated to study adverse event|2
1038218|NCT01722162|2070846|FG001|Overall Study|Unrelated to study adverse event|2
1038219|NCT01722162|2070845|FG000|Overall Study|Adverse Event|1
1038220|NCT01722162|2070846|FG001|Overall Study|Adverse Event|1
1038221|NCT01722162|2070845|FG000|Overall Study|Insurance denial post enrollment|0
1038222|NCT01722162|2070846|FG001|Overall Study|Insurance denial post enrollment|1
1038223|NCT01722162|2070845|FG000|Overall Study|Noncompliance|0
1038224|NCT01722162|2070846|FG001|Overall Study|Noncompliance|1
1038225|NCT01722266|2070856|FG000|Overall Study|Withdrawal by Subject|1
1038226|NCT01722266|2070857|FG001|Overall Study|Withdrawal by Subject|2
1038227|NCT01722266|2070858|FG002|Overall Study|Withdrawal by Subject|0
1038228|NCT01722266|2070859|FG003|Overall Study|Withdrawal by Subject|0
1038229|NCT01722266|2070856|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0
1038230|NCT01722266|2070857|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1
1038231|NCT01722266|2070858|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3
1038232|NCT01722266|2070859|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0
1038233|NCT01722266|2070856|FG000|Overall Study|Dropped out due to Nausea|0
1038234|NCT01722266|2070857|FG001|Overall Study|Dropped out due to Nausea|0
1038235|NCT01722266|2070858|FG002|Overall Study|Dropped out due to Nausea|2
1038236|NCT01722266|2070859|FG003|Overall Study|Dropped out due to Nausea|0
1038237|NCT01722331|2070923|FG000|Part 1|Adverse Event|5
1038238|NCT01722331|2070924|FG001|Part 1|Adverse Event|0
1038239|NCT01722331|2070925|FG002|Part 1|Adverse Event|0
1038240|NCT01722331|2070926|FG003|Part 1|Adverse Event|0
1038241|NCT01722331|2070927|FG004|Part 1|Adverse Event|0
1038242|NCT01722331|2070928|FG005|Part 1|Adverse Event|0
1038243|NCT01722331|2070929|FG006|Part 1|Adverse Event|0
1038244|NCT01722331|2070923|FG000|Part 1|Lack of Efficacy|0
1038245|NCT01722331|2070924|FG001|Part 1|Lack of Efficacy|0
1038246|NCT01722331|2070925|FG002|Part 1|Lack of Efficacy|1
1038247|NCT01722331|2070926|FG003|Part 1|Lack of Efficacy|0
1038248|NCT01722331|2070927|FG004|Part 1|Lack of Efficacy|2
1038249|NCT01722331|2070928|FG005|Part 1|Lack of Efficacy|0
1038250|NCT01722331|2070929|FG006|Part 1|Lack of Efficacy|0
1038251|NCT01722331|2070923|FG000|Part 1|Lost to Follow-up|1
1038252|NCT01722331|2070924|FG001|Part 1|Lost to Follow-up|0
1038253|NCT01722331|2070925|FG002|Part 1|Lost to Follow-up|2
1038254|NCT01722331|2070926|FG003|Part 1|Lost to Follow-up|0
1038255|NCT01722331|2070927|FG004|Part 1|Lost to Follow-up|1
1038256|NCT01722331|2070928|FG005|Part 1|Lost to Follow-up|0
1038257|NCT01722331|2070929|FG006|Part 1|Lost to Follow-up|0
1038258|NCT01722331|2070923|FG000|Part 1|Physician Decision|0
1038259|NCT01722331|2070924|FG001|Part 1|Physician Decision|0
1038260|NCT01722331|2070925|FG002|Part 1|Physician Decision|3
1038261|NCT01722331|2070926|FG003|Part 1|Physician Decision|0
1038262|NCT01722331|2070927|FG004|Part 1|Physician Decision|1
1038263|NCT01722331|2070928|FG005|Part 1|Physician Decision|0
1038264|NCT01722331|2070929|FG006|Part 1|Physician Decision|0
1038265|NCT01722331|2070923|FG000|Part 1|Pregnancy|1
1038266|NCT01722331|2070924|FG001|Part 1|Pregnancy|0
1038267|NCT01722331|2070925|FG002|Part 1|Pregnancy|0
1038268|NCT01722331|2070926|FG003|Part 1|Pregnancy|0
1038269|NCT01722331|2070927|FG004|Part 1|Pregnancy|0
1038270|NCT01722331|2070928|FG005|Part 1|Pregnancy|0
1038271|NCT01722331|2070929|FG006|Part 1|Pregnancy|0
1038272|NCT01722331|2070923|FG000|Part 1|Progressive Disease|0
1038273|NCT01722331|2070924|FG001|Part 1|Progressive Disease|0
1038274|NCT01722331|2070925|FG002|Part 1|Progressive Disease|0
1038275|NCT01722331|2070926|FG003|Part 1|Progressive Disease|0
1038276|NCT01722331|2070927|FG004|Part 1|Progressive Disease|1
1038277|NCT01722331|2070928|FG005|Part 1|Progressive Disease|0
1038278|NCT01722331|2070929|FG006|Part 1|Progressive Disease|0
1038279|NCT01722331|2070923|FG000|Part 1|Protocol Violation|1
1038280|NCT01722331|2070924|FG001|Part 1|Protocol Violation|0
1038281|NCT01722331|2070925|FG002|Part 1|Protocol Violation|0
1038282|NCT01722331|2070926|FG003|Part 1|Protocol Violation|0
1038283|NCT01722331|2070927|FG004|Part 1|Protocol Violation|1
1038284|NCT01722331|2070928|FG005|Part 1|Protocol Violation|0
1038285|NCT01722331|2070929|FG006|Part 1|Protocol Violation|0
1038286|NCT01722331|2070923|FG000|Part 1|Withdrawal by Subject|2
1038287|NCT01722331|2070924|FG001|Part 1|Withdrawal by Subject|0
1038288|NCT01722331|2070925|FG002|Part 1|Withdrawal by Subject|3
1038289|NCT01722331|2070926|FG003|Part 1|Withdrawal by Subject|0
1038290|NCT01722331|2070927|FG004|Part 1|Withdrawal by Subject|3
1038291|NCT01722331|2070928|FG005|Part 1|Withdrawal by Subject|0
1038292|NCT01722331|2070929|FG006|Part 1|Withdrawal by Subject|0
1038293|NCT01722331|2070923|FG000|Part 2|Adverse Event|3
1038294|NCT01722331|2070924|FG001|Part 2|Adverse Event|0
1038295|NCT01722331|2070925|FG002|Part 2|Adverse Event|0
1038296|NCT01722331|2070926|FG003|Part 2|Adverse Event|0
1038297|NCT01722331|2070927|FG004|Part 2|Adverse Event|0
1038298|NCT01722331|2070928|FG005|Part 2|Adverse Event|1
1038299|NCT01722331|2070929|FG006|Part 2|Adverse Event|0
1038300|NCT01722331|2070923|FG000|Part 2|Lack of Efficacy|3
1038301|NCT01722331|2070924|FG001|Part 2|Lack of Efficacy|0
1038302|NCT01722331|2070925|FG002|Part 2|Lack of Efficacy|11
1038303|NCT01722331|2070926|FG003|Part 2|Lack of Efficacy|0
1038304|NCT01722331|2070927|FG004|Part 2|Lack of Efficacy|0
1038305|NCT01722331|2070928|FG005|Part 2|Lack of Efficacy|3
1038306|NCT01722331|2070929|FG006|Part 2|Lack of Efficacy|3
1038307|NCT01722331|2070923|FG000|Part 2|Lost to Follow-up|0
1038308|NCT01722331|2070924|FG001|Part 2|Lost to Follow-up|0
1038309|NCT01722331|2070925|FG002|Part 2|Lost to Follow-up|3
1038310|NCT01722331|2070926|FG003|Part 2|Lost to Follow-up|0
1038311|NCT01722331|2070927|FG004|Part 2|Lost to Follow-up|0
1038312|NCT01722331|2070928|FG005|Part 2|Lost to Follow-up|1
1038313|NCT01722331|2070929|FG006|Part 2|Lost to Follow-up|1
1038314|NCT01722331|2070923|FG000|Part 2|Non-Compliance with Study Drug|1
1038315|NCT01722331|2070924|FG001|Part 2|Non-Compliance with Study Drug|0
1038316|NCT01722331|2070925|FG002|Part 2|Non-Compliance with Study Drug|1
1038317|NCT01722331|2070926|FG003|Part 2|Non-Compliance with Study Drug|0
1038318|NCT01722331|2070927|FG004|Part 2|Non-Compliance with Study Drug|0
1038319|NCT01722331|2070928|FG005|Part 2|Non-Compliance with Study Drug|0
1038320|NCT01722331|2070929|FG006|Part 2|Non-Compliance with Study Drug|0
1038321|NCT01722331|2070923|FG000|Part 2|Physician Decision|0
1038322|NCT01722331|2070924|FG001|Part 2|Physician Decision|0
1038323|NCT01722331|2070925|FG002|Part 2|Physician Decision|2
1038324|NCT01722331|2070926|FG003|Part 2|Physician Decision|0
1038325|NCT01722331|2070927|FG004|Part 2|Physician Decision|0
1038326|NCT01722331|2070928|FG005|Part 2|Physician Decision|0
1038327|NCT01722331|2070929|FG006|Part 2|Physician Decision|0
1038328|NCT01722331|2070923|FG000|Part 2|Pregnancy|0
1038329|NCT01722331|2070924|FG001|Part 2|Pregnancy|0
1038330|NCT01722331|2070925|FG002|Part 2|Pregnancy|0
1038331|NCT01722331|2070926|FG003|Part 2|Pregnancy|0
1038332|NCT01722331|2070927|FG004|Part 2|Pregnancy|0
1038333|NCT01722331|2070928|FG005|Part 2|Pregnancy|1
1038334|NCT01722331|2070929|FG006|Part 2|Pregnancy|0
1038335|NCT01722331|2070923|FG000|Part 2|Progressive Disease|0
1038336|NCT01722331|2070924|FG001|Part 2|Progressive Disease|0
1038337|NCT01722331|2070925|FG002|Part 2|Progressive Disease|1
1038338|NCT01722331|2070926|FG003|Part 2|Progressive Disease|0
1038339|NCT01722331|2070927|FG004|Part 2|Progressive Disease|0
1038340|NCT01722331|2070928|FG005|Part 2|Progressive Disease|0
1038341|NCT01722331|2070929|FG006|Part 2|Progressive Disease|0
1038342|NCT01722331|2070923|FG000|Part 2|Protocol Violation|1
1038343|NCT01722331|2070924|FG001|Part 2|Protocol Violation|0
1038344|NCT01722331|2070925|FG002|Part 2|Protocol Violation|0
1038345|NCT01722331|2070926|FG003|Part 2|Protocol Violation|0
1038346|NCT01722331|2070927|FG004|Part 2|Protocol Violation|0
1038347|NCT01722331|2070928|FG005|Part 2|Protocol Violation|0
1038348|NCT01722331|2070929|FG006|Part 2|Protocol Violation|0
1038349|NCT01722331|2070923|FG000|Part 2|Withdrawal by Subject|5
1038350|NCT01722331|2070924|FG001|Part 2|Withdrawal by Subject|0
1038351|NCT01722331|2070925|FG002|Part 2|Withdrawal by Subject|3
1038352|NCT01722331|2070926|FG003|Part 2|Withdrawal by Subject|0
1038353|NCT01722331|2070927|FG004|Part 2|Withdrawal by Subject|0
1038354|NCT01722331|2070928|FG005|Part 2|Withdrawal by Subject|2
1038355|NCT01722331|2070929|FG006|Part 2|Withdrawal by Subject|2
1038356|NCT01722331|2070923|FG000|Part 2|Other Protocol Specified Criteria|6
1038357|NCT01722331|2070924|FG001|Part 2|Other Protocol Specified Criteria|0
1038358|NCT01722331|2070925|FG002|Part 2|Other Protocol Specified Criteria|10
1038359|NCT01722331|2070926|FG003|Part 2|Other Protocol Specified Criteria|0
1038360|NCT01722331|2070927|FG004|Part 2|Other Protocol Specified Criteria|0
1038361|NCT01722331|2070928|FG005|Part 2|Other Protocol Specified Criteria|2
1038362|NCT01722331|2070929|FG006|Part 2|Other Protocol Specified Criteria|1
1038363|NCT01722331|2070923|FG000|Part 3|Adverse Event|2
1038364|NCT01722331|2070924|FG001|Part 3|Adverse Event|2
1038365|NCT01722331|2070925|FG002|Part 3|Adverse Event|0
1038366|NCT01722331|2070926|FG003|Part 3|Adverse Event|1
1038367|NCT01722331|2070927|FG004|Part 3|Adverse Event|0
1038368|NCT01722331|2070928|FG005|Part 3|Adverse Event|0
1038369|NCT01722331|2070929|FG006|Part 3|Adverse Event|0
1038370|NCT01722331|2070923|FG000|Part 3|Death|1
1038371|NCT01722331|2070924|FG001|Part 3|Death|0
1038372|NCT01722331|2070925|FG002|Part 3|Death|0
1038373|NCT01722331|2070926|FG003|Part 3|Death|0
1038374|NCT01722331|2070927|FG004|Part 3|Death|0
1038375|NCT01722331|2070928|FG005|Part 3|Death|0
1038376|NCT01722331|2070929|FG006|Part 3|Death|0
1038377|NCT01722331|2070923|FG000|Part 3|Lack of Efficacy|1
1038378|NCT01722331|2070924|FG001|Part 3|Lack of Efficacy|0
1038379|NCT01722331|2070925|FG002|Part 3|Lack of Efficacy|0
1038380|NCT01722331|2070926|FG003|Part 3|Lack of Efficacy|0
1038381|NCT01722331|2070927|FG004|Part 3|Lack of Efficacy|0
1038382|NCT01722331|2070928|FG005|Part 3|Lack of Efficacy|0
1038383|NCT01722331|2070929|FG006|Part 3|Lack of Efficacy|0
1038384|NCT01722331|2070923|FG000|Part 3|Lost to Follow-up|3
1038385|NCT01722331|2070924|FG001|Part 3|Lost to Follow-up|4
1038386|NCT01722331|2070925|FG002|Part 3|Lost to Follow-up|0
1038387|NCT01722331|2070926|FG003|Part 3|Lost to Follow-up|0
1038388|NCT01722331|2070927|FG004|Part 3|Lost to Follow-up|0
1038389|NCT01722331|2070928|FG005|Part 3|Lost to Follow-up|1
1038390|NCT01722331|2070929|FG006|Part 3|Lost to Follow-up|0
1038391|NCT01722331|2070923|FG000|Part 3|Non-Compliance with Study Drug|0
1038392|NCT01722331|2070924|FG001|Part 3|Non-Compliance with Study Drug|1
1038393|NCT01722331|2070925|FG002|Part 3|Non-Compliance with Study Drug|0
1038394|NCT01722331|2070926|FG003|Part 3|Non-Compliance with Study Drug|0
1038395|NCT01722331|2070927|FG004|Part 3|Non-Compliance with Study Drug|0
1038396|NCT01722331|2070928|FG005|Part 3|Non-Compliance with Study Drug|0
1038397|NCT01722331|2070929|FG006|Part 3|Non-Compliance with Study Drug|0
1038398|NCT01722331|2070923|FG000|Part 3|Physician Decision|1
1038399|NCT01722331|2070924|FG001|Part 3|Physician Decision|1
1038400|NCT01722331|2070925|FG002|Part 3|Physician Decision|0
1038401|NCT01722331|2070926|FG003|Part 3|Physician Decision|0
1038402|NCT01722331|2070927|FG004|Part 3|Physician Decision|0
1038403|NCT01722331|2070928|FG005|Part 3|Physician Decision|0
1038404|NCT01722331|2070929|FG006|Part 3|Physician Decision|1
1038405|NCT01722331|2070923|FG000|Part 3|Protocol Violation|2
1038406|NCT01722331|2070924|FG001|Part 3|Protocol Violation|1
1038407|NCT01722331|2070925|FG002|Part 3|Protocol Violation|0
1038408|NCT01722331|2070926|FG003|Part 3|Protocol Violation|0
1038409|NCT01722331|2070927|FG004|Part 3|Protocol Violation|0
1038410|NCT01722331|2070928|FG005|Part 3|Protocol Violation|0
1038411|NCT01722331|2070929|FG006|Part 3|Protocol Violation|0
1038412|NCT01722331|2070923|FG000|Part 3|Withdrawal by Subject|4
1038413|NCT01722331|2070924|FG001|Part 3|Withdrawal by Subject|7
1038414|NCT01722331|2070925|FG002|Part 3|Withdrawal by Subject|0
1038415|NCT01722331|2070926|FG003|Part 3|Withdrawal by Subject|0
1038416|NCT01722331|2070927|FG004|Part 3|Withdrawal by Subject|0
1038417|NCT01722331|2070928|FG005|Part 3|Withdrawal by Subject|2
1038418|NCT01722331|2070929|FG006|Part 3|Withdrawal by Subject|1
1038419|NCT01722331|2070923|FG000|Part 3|Other Protocol Specified Criteria|1
1038420|NCT01722331|2070924|FG001|Part 3|Other Protocol Specified Criteria|1
1038421|NCT01722331|2070925|FG002|Part 3|Other Protocol Specified Criteria|0
1038422|NCT01722331|2070926|FG003|Part 3|Other Protocol Specified Criteria|0
1038423|NCT01722331|2070927|FG004|Part 3|Other Protocol Specified Criteria|0
1038424|NCT01722331|2070928|FG005|Part 3|Other Protocol Specified Criteria|0
1038425|NCT01722331|2070929|FG006|Part 3|Other Protocol Specified Criteria|0
1038426|NCT01722669|2070989|FG000|Overall Study|Withdrawal by Subject|0
1038427|NCT01722669|2070990|FG001|Overall Study|Withdrawal by Subject|0
1038428|NCT01722669|2070991|FG002|Overall Study|Withdrawal by Subject|0
1038429|NCT01722669|2070992|FG003|Overall Study|Withdrawal by Subject|0
1038430|NCT01722669|2070993|FG004|Overall Study|Withdrawal by Subject|0
1038431|NCT01722669|2070994|FG005|Overall Study|Withdrawal by Subject|2
1038432|NCT01722877|2071027|FG000|Overall Study|Death|1
1038433|NCT01722877|2071027|FG000|Overall Study|Lost to Follow-up|1
1038434|NCT01722994|2071040|FG000|Overall Study|Missing data|25
1038435|NCT01722994|2071041|FG001|Overall Study|Missing data|17
1038436|NCT01723072|2071051|FG000|Overall Study|Withdrawal by Subject|7
1038437|NCT01723072|2071052|FG001|Overall Study|Withdrawal by Subject|13
1038438|NCT01723072|2071051|FG000|Overall Study|Discon for rescue medication after wk 24|0
1038439|NCT01723072|2071052|FG001|Overall Study|Discon for rescue medication after wk 24|5
1038440|NCT01723072|2071051|FG000|Overall Study|Other|4
1038441|NCT01723072|2071052|FG001|Overall Study|Other|3
1038442|NCT01723163|2071060|FG000|Treatment Phase|Withdrawal by Subject|14
1038443|NCT01723163|2071061|FG001|Treatment Phase|Withdrawal by Subject|6
1038444|NCT01723163|2071060|FG000|Treatment Phase|Withdrawal by PI|5
1038445|NCT01723163|2071061|FG001|Treatment Phase|Withdrawal by PI|1
1038446|NCT01723163|2071060|FG000|3-Month Follow-up|Withdrawal by Subject|1
1038447|NCT01723163|2071061|FG001|3-Month Follow-up|Withdrawal by Subject|0
1038448|NCT01723163|2071060|FG000|3-Month Follow-up|Unable to Contact|12
1038449|NCT01723163|2071061|FG001|3-Month Follow-up|Unable to Contact|19
1038450|NCT01723163|2071060|FG000|6-Month Follow-up|Death|1
1038451|NCT01723163|2071061|FG001|6-Month Follow-up|Death|0
1038452|NCT01723163|2071060|FG000|6-Month Follow-up|Unable to Contact|17
1038453|NCT01723163|2071061|FG001|6-Month Follow-up|Unable to Contact|15
1038454|NCT01723163|2071060|FG000|12-Month Follow-up|Death|1
1038455|NCT01723163|2071061|FG001|12-Month Follow-up|Death|0
1038456|NCT01723163|2071060|FG000|12-Month Follow-up|Unable to Contact|23
1038457|NCT01723163|2071061|FG001|12-Month Follow-up|Unable to Contact|28
1038458|NCT01723228|2071069|FG000|Overall Study|Adverse Event|2
1038459|NCT01723228|2071070|FG001|Overall Study|Adverse Event|6
1038460|NCT01723228|2071069|FG000|Overall Study|Withdrawal by Subject|2
1038461|NCT01723228|2071070|FG001|Overall Study|Withdrawal by Subject|1
1038462|NCT01723228|2071069|FG000|Overall Study|Protocol Violation|0
1038463|NCT01723228|2071070|FG001|Overall Study|Protocol Violation|2
1038464|NCT01723228|2071069|FG000|Overall Study|Lost to Follow-up|2
1038465|NCT01723228|2071070|FG001|Overall Study|Lost to Follow-up|1
1038466|NCT01723228|2071069|FG000|Overall Study|Other|2
1038467|NCT01723228|2071070|FG001|Overall Study|Other|1
1038468|NCT01723254|2071084|FG000|Overall Study|Conflict with work schedule|0
1038469|NCT01723254|2071085|FG001|Overall Study|Conflict with work schedule|0
1038470|NCT01723254|2071086|FG002|Overall Study|Conflict with work schedule|0
1038471|NCT01723254|2071087|FG003|Overall Study|Conflict with work schedule|0
1038472|NCT01723254|2071088|FG004|Overall Study|Conflict with work schedule|0
1038473|NCT01723254|2071089|FG005|Overall Study|Conflict with work schedule|0
1038474|NCT01723254|2071090|FG006|Overall Study|Conflict with work schedule|0
1038475|NCT01723254|2071091|FG007|Overall Study|Conflict with work schedule|1
1038476|NCT01723254|2071084|FG000|Overall Study|Personal issues|0
1038477|NCT01723254|2071085|FG001|Overall Study|Personal issues|0
1038478|NCT01723254|2071086|FG002|Overall Study|Personal issues|0
1038479|NCT01723254|2071087|FG003|Overall Study|Personal issues|0
1038480|NCT01723254|2071088|FG004|Overall Study|Personal issues|0
1038481|NCT01723254|2071089|FG005|Overall Study|Personal issues|1
1038482|NCT01723254|2071090|FG006|Overall Study|Personal issues|0
1038483|NCT01723254|2071091|FG007|Overall Study|Personal issues|0
1038484|NCT01723254|2071084|FG000|Overall Study|No longer have time to participate|0
1038485|NCT01723254|2071085|FG001|Overall Study|No longer have time to participate|0
1038486|NCT01723254|2071086|FG002|Overall Study|No longer have time to participate|0
1038487|NCT01723254|2071087|FG003|Overall Study|No longer have time to participate|1
1038488|NCT01723254|2071088|FG004|Overall Study|No longer have time to participate|0
1038489|NCT01723254|2071089|FG005|Overall Study|No longer have time to participate|0
1038490|NCT01723254|2071090|FG006|Overall Study|No longer have time to participate|0
1038491|NCT01723254|2071091|FG007|Overall Study|No longer have time to participate|0
1038492|NCT01723254|2071084|FG000|Overall Study|Move/Left to another country/city|0
1038493|NCT01723254|2071085|FG001|Overall Study|Move/Left to another country/city|0
1038494|NCT01723254|2071086|FG002|Overall Study|Move/Left to another country/city|2
1038495|NCT01723254|2071087|FG003|Overall Study|Move/Left to another country/city|1
1038496|NCT01723254|2071088|FG004|Overall Study|Move/Left to another country/city|1
1038497|NCT01723254|2071089|FG005|Overall Study|Move/Left to another country/city|0
1038498|NCT01723254|2071090|FG006|Overall Study|Move/Left to another country/city|0
1038499|NCT01723254|2071091|FG007|Overall Study|Move/Left to another country/city|0
1038500|NCT01723254|2071084|FG000|Overall Study|Protocol Violation|0
1038501|NCT01723254|2071085|FG001|Overall Study|Protocol Violation|1
1038502|NCT01723254|2071086|FG002|Overall Study|Protocol Violation|0
1038503|NCT01723254|2071087|FG003|Overall Study|Protocol Violation|0
1038504|NCT01723254|2071088|FG004|Overall Study|Protocol Violation|0
1038505|NCT01723254|2071089|FG005|Overall Study|Protocol Violation|0
1038506|NCT01723254|2071090|FG006|Overall Study|Protocol Violation|0
1038507|NCT01723254|2071091|FG007|Overall Study|Protocol Violation|0
1038508|NCT01723254|2071084|FG000|Overall Study|Withdrawal by Subject|1
1038509|NCT01723254|2071085|FG001|Overall Study|Withdrawal by Subject|2
1038510|NCT01723254|2071086|FG002|Overall Study|Withdrawal by Subject|1
1038511|NCT01723254|2071087|FG003|Overall Study|Withdrawal by Subject|0
1038512|NCT01723254|2071088|FG004|Overall Study|Withdrawal by Subject|1
1038513|NCT01723254|2071089|FG005|Overall Study|Withdrawal by Subject|1
1038514|NCT01723254|2071090|FG006|Overall Study|Withdrawal by Subject|1
1038515|NCT01723254|2071091|FG007|Overall Study|Withdrawal by Subject|2
1038516|NCT01723397|2071120|FG000|Study Period 1|Protocol Violation|0
1038517|NCT01723397|2071121|FG001|Study Period 1|Protocol Violation|1
1038518|NCT01723397|2071120|FG000|Study Period 2|Protocol Violation|0
1038519|NCT01723397|2071121|FG001|Study Period 2|Protocol Violation|1
1038520|NCT01723826|2071184|FG000|Overall Study|Adverse Event|4
1038521|NCT01723826|2071185|FG001|Overall Study|Adverse Event|1
1038522|NCT01723826|2071186|FG002|Overall Study|Adverse Event|4
1038523|NCT01723826|2071187|FG003|Overall Study|Adverse Event|5
1038524|NCT01723826|2071184|FG000|Overall Study|Death according to AE eCRF|2
1038525|NCT01723826|2071185|FG001|Overall Study|Death according to AE eCRF|3
1038526|NCT01723826|2071186|FG002|Overall Study|Death according to AE eCRF|3
1038527|NCT01723826|2071187|FG003|Overall Study|Death according to AE eCRF|7
1038528|NCT01723826|2071184|FG000|Overall Study|Lost to Follow-up|1
1038529|NCT01723826|2071185|FG001|Overall Study|Lost to Follow-up|3
1038530|NCT01723826|2071186|FG002|Overall Study|Lost to Follow-up|1
1038531|NCT01723826|2071187|FG003|Overall Study|Lost to Follow-up|1
1038532|NCT01723826|2071184|FG000|Overall Study|Non-compliance|0
1038533|NCT01723826|2071185|FG001|Overall Study|Non-compliance|1
1038534|NCT01723826|2071186|FG002|Overall Study|Non-compliance|3
1038535|NCT01723826|2071187|FG003|Overall Study|Non-compliance|3
1038536|NCT01723826|2071184|FG000|Overall Study|Non-compliance With Study Drug|0
1038537|NCT01723826|2071185|FG001|Overall Study|Non-compliance With Study Drug|1
1038538|NCT01723826|2071186|FG002|Overall Study|Non-compliance With Study Drug|0
1038539|NCT01723826|2071187|FG003|Overall Study|Non-compliance With Study Drug|0
1038540|NCT01723826|2071184|FG000|Overall Study|Other Reason|8
1038541|NCT01723826|2071185|FG001|Overall Study|Other Reason|6
1038542|NCT01723826|2071186|FG002|Overall Study|Other Reason|12
1038543|NCT01723826|2071187|FG003|Overall Study|Other Reason|14
1038544|NCT01723826|2071184|FG000|Overall Study|Physician Decision|1
1038545|NCT01723826|2071185|FG001|Overall Study|Physician Decision|3
1038546|NCT01723826|2071186|FG002|Overall Study|Physician Decision|4
1038547|NCT01723826|2071187|FG003|Overall Study|Physician Decision|11
1038548|NCT01723826|2071184|FG000|Overall Study|Protocol Violation|1
1038549|NCT01723826|2071185|FG001|Overall Study|Protocol Violation|1
1038550|NCT01723826|2071186|FG002|Overall Study|Protocol Violation|3
1038551|NCT01723826|2071187|FG003|Overall Study|Protocol Violation|1
1038552|NCT01723826|2071184|FG000|Overall Study|Withdrawal by Subject|10
1038553|NCT01723826|2071185|FG001|Overall Study|Withdrawal by Subject|17
1038554|NCT01723826|2071186|FG002|Overall Study|Withdrawal by Subject|27
1038555|NCT01723826|2071187|FG003|Overall Study|Withdrawal by Subject|48
1038556|NCT01723904|2071197|FG000|Overall Study|Noncompliant|3
1038557|NCT01723904|2071197|FG000|Overall Study|Adverse Event|5
1038558|NCT01723904|2071197|FG000|Overall Study|Unable to follow protocol/ judged by inv|3
1038559|NCT01724021|2071203|FG000|Overall Study|Adverse Event|11
1038560|NCT01724021|2071204|FG001|Overall Study|Adverse Event|6
1038561|NCT01724021|2071203|FG000|Overall Study|Death|46
1038562|NCT01724021|2071204|FG001|Overall Study|Death|58
1038563|NCT01724021|2071203|FG000|Overall Study|Participant request/ Withdrew consent|18
1038564|NCT01724021|2071204|FG001|Overall Study|Participant request/ Withdrew consent|14
1038565|NCT01724021|2071203|FG000|Overall Study|Lost to Follow-up|15
1038566|NCT01724021|2071204|FG001|Overall Study|Lost to Follow-up|15
1038567|NCT01724021|2071203|FG000|Overall Study|Reason Not Specified|36
1038568|NCT01724021|2071204|FG001|Overall Study|Reason Not Specified|39
1038569|NCT01724021|2071203|FG000|Overall Study|Missing|1
1038570|NCT01724021|2071204|FG001|Overall Study|Missing|1
1038571|NCT01724177|2071245|FG000|Overall Study|Adverse Event|8
1038572|NCT01724177|2071245|FG000|Overall Study|Progressive disease or Relapsed Disease|16
1038573|NCT01724177|2071245|FG000|Overall Study|Nervous participant|1
1038574|NCT01724177|2071245|FG000|Overall Study|Serious Adverse Event Related|1
1038575|NCT01724216|2071250|FG000|Overall Study|Scan was not completed|1
1038576|NCT01724359|2071254|FG000|Overall Study|Adverse Event|10
1038577|NCT01724359|2071254|FG000|Overall Study|Death|1
1038578|NCT01724359|2071254|FG000|Overall Study|Other|20
1038579|NCT01724489|2071262|FG000|Overall Study|Adverse Event|8
1038580|NCT01724489|2071263|FG001|Overall Study|Adverse Event|3
1038581|NCT01724489|2071262|FG000|Overall Study|Surgery, medication|1
1038582|NCT01724489|2071263|FG001|Overall Study|Surgery, medication|1
1038583|NCT01724489|2071262|FG000|Overall Study|Lost to Follow-up|1
1038584|NCT01724489|2071263|FG001|Overall Study|Lost to Follow-up|2
1038585|NCT01724489|2071262|FG000|Overall Study|Withdrawal by Subject|6
1038586|NCT01724489|2071263|FG001|Overall Study|Withdrawal by Subject|6
1038587|NCT01724528|2071271|FG000|Overall Study|Death|3
1038588|NCT01724528|2071272|FG001|Overall Study|Death|0
1038589|NCT01724528|2071271|FG000|Overall Study|Withdrawal by Subject|0
1038590|NCT01724528|2071272|FG001|Overall Study|Withdrawal by Subject|2
1038591|NCT01724528|2071271|FG000|Overall Study|Protocol Violation|0
1038592|NCT01724528|2071272|FG001|Overall Study|Protocol Violation|1
1038593|NCT01724528|2071271|FG000|Overall Study|Patient refused to attend last visit|1
1038594|NCT01724528|2071272|FG001|Overall Study|Patient refused to attend last visit|0
1038595|NCT01725126|2071284|FG000|Overall Study|Protocol Violation|0
1038596|NCT01725126|2071285|FG001|Overall Study|Protocol Violation|1
1038597|NCT01725126|2071286|FG002|Overall Study|Protocol Violation|0
1038598|NCT01725126|2071287|FG003|Overall Study|Protocol Violation|0
1038599|NCT01725126|2071288|FG004|Overall Study|Protocol Violation|0
1038600|NCT01725126|2071289|FG005|Overall Study|Protocol Violation|0
1038601|NCT01725126|2071284|FG000|Overall Study|Withdrawal by Subject|0
1038602|NCT01725126|2071285|FG001|Overall Study|Withdrawal by Subject|0
1038603|NCT01725126|2071286|FG002|Overall Study|Withdrawal by Subject|0
1038604|NCT01725126|2071287|FG003|Overall Study|Withdrawal by Subject|1
1038605|NCT01725126|2071288|FG004|Overall Study|Withdrawal by Subject|0
1038606|NCT01725126|2071289|FG005|Overall Study|Withdrawal by Subject|0
1038607|NCT01725217|2071315|FG000|Overall Study|Withdrawal by Subject|1
1038608|NCT01725217|2071316|FG001|Overall Study|Withdrawal by Subject|0
1038609|NCT01725217|2071317|FG002|Overall Study|Withdrawal by Subject|0
1038610|NCT01725282|2071338|FG000|Overall Study|Adverse Event|1
1038611|NCT01725282|2071339|FG001|Overall Study|Adverse Event|3
1038612|NCT01725282|2071340|FG002|Overall Study|Adverse Event|6
1038613|NCT01725282|2071341|FG003|Overall Study|Adverse Event|4
1038614|NCT01725282|2071338|FG000|Overall Study|Exacerbation of Target Disease|1
1038615|NCT01725282|2071339|FG001|Overall Study|Exacerbation of Target Disease|0
1038616|NCT01725282|2071340|FG002|Overall Study|Exacerbation of Target Disease|0
1038617|NCT01725282|2071341|FG003|Overall Study|Exacerbation of Target Disease|1
1038618|NCT01725282|2071338|FG000|Overall Study|Met Exclusion Criteria|0
1038619|NCT01725282|2071339|FG001|Overall Study|Met Exclusion Criteria|0
1038620|NCT01725282|2071340|FG002|Overall Study|Met Exclusion Criteria|1
1038621|NCT01725282|2071341|FG003|Overall Study|Met Exclusion Criteria|0
1038622|NCT01725282|2071338|FG000|Overall Study|Study Site Withdrawal|0
1038623|NCT01725282|2071339|FG001|Overall Study|Study Site Withdrawal|1
1038624|NCT01725282|2071340|FG002|Overall Study|Study Site Withdrawal|0
1038625|NCT01725282|2071341|FG003|Overall Study|Study Site Withdrawal|0
1038626|NCT01725282|2071338|FG000|Overall Study|Withdrawal by Subject|0
1038627|NCT01725282|2071339|FG001|Overall Study|Withdrawal by Subject|0
1038628|NCT01725282|2071340|FG002|Overall Study|Withdrawal by Subject|1
1038629|NCT01725282|2071341|FG003|Overall Study|Withdrawal by Subject|1
1038630|NCT01725282|2071338|FG000|Overall Study|Lack of Efficacy|0
1038631|NCT01725282|2071339|FG001|Overall Study|Lack of Efficacy|1
1038632|NCT01725282|2071340|FG002|Overall Study|Lack of Efficacy|0
1038633|NCT01725282|2071341|FG003|Overall Study|Lack of Efficacy|1
1038634|NCT01725308|2071354|FG000|Treatment Period I|Did Not Receive Drug|1
1038635|NCT01725308|2071355|FG001|Treatment Period I|Did Not Receive Drug|0
1038636|NCT01725308|2071356|FG002|Treatment Period I|Did Not Receive Drug|0
1038637|NCT01725308|2071354|FG000|Treatment Period I|Adverse Event|5
1038638|NCT01725308|2071355|FG001|Treatment Period I|Adverse Event|4
1038639|NCT01725308|2071356|FG002|Treatment Period I|Adverse Event|21
1038640|NCT01725308|2071354|FG000|Treatment Period I|Insufficient Response|7
1038641|NCT01725308|2071355|FG001|Treatment Period I|Insufficient Response|0
1038642|NCT01725308|2071356|FG002|Treatment Period I|Insufficient Response|5
1038643|NCT01725308|2071354|FG000|Treatment Period I|Worsening of the Target Disease|8
1038644|NCT01725308|2071355|FG001|Treatment Period I|Worsening of the Target Disease|0
1038645|NCT01725308|2071356|FG002|Treatment Period I|Worsening of the Target Disease|2
1038646|NCT01725308|2071354|FG000|Treatment Period I|Changes in the Episodes|3
1038647|NCT01725308|2071355|FG001|Treatment Period I|Changes in the Episodes|0
1038648|NCT01725308|2071356|FG002|Treatment Period I|Changes in the Episodes|2
1038649|NCT01725308|2071354|FG000|Treatment Period I|Withdrawal of Consent|12
1038650|NCT01725308|2071355|FG001|Treatment Period I|Withdrawal of Consent|7
1038651|NCT01725308|2071356|FG002|Treatment Period I|Withdrawal of Consent|5
1038652|NCT01725308|2071354|FG000|Treatment Period I|Lost to Follow-up|3
1038653|NCT01725308|2071355|FG001|Treatment Period I|Lost to Follow-up|2
1038654|NCT01725308|2071356|FG002|Treatment Period I|Lost to Follow-up|2
1038655|NCT01725308|2071354|FG000|Treatment Period I|Protocol Deviations|3
1038656|NCT01725308|2071355|FG001|Treatment Period I|Protocol Deviations|1
1038657|NCT01725308|2071356|FG002|Treatment Period I|Protocol Deviations|1
1038658|NCT01725308|2071354|FG000|Treatment Period I|Miscellaneous|2
1038659|NCT01725308|2071355|FG001|Treatment Period I|Miscellaneous|0
1038660|NCT01725308|2071356|FG002|Treatment Period I|Miscellaneous|3
1038661|NCT01725308|2071354|FG000|Treatment Period II|Did Not Meet Transition Criteria|0
1038662|NCT01725308|2071355|FG001|Treatment Period II|Did Not Meet Transition Criteria|3
1038663|NCT01725308|2071356|FG002|Treatment Period II|Did Not Meet Transition Criteria|4
1038664|NCT01725308|2071354|FG000|Treatment Period II|Did Not Receive Drug|4
1038665|NCT01725308|2071355|FG001|Treatment Period II|Did Not Receive Drug|0
1038666|NCT01725308|2071356|FG002|Treatment Period II|Did Not Receive Drug|0
1038667|NCT01725308|2071354|FG000|Treatment Period II|Adverse Event|13
1038668|NCT01725308|2071355|FG001|Treatment Period II|Adverse Event|8
906375|NCT00767806|1882007|FG001|Overall Study|Entry Criteria Not Met|1
906376|NCT00767806|1882006|FG000|Overall Study|Sponsor Decision|0
906377|NCT00767806|1882007|FG001|Overall Study|Sponsor Decision|1
906378|NCT00767819|1882016|FG000|Overall Study|Unsatisfactory therapeutic effect|18
1038669|NCT01725308|2071356|FG002|Treatment Period II|Adverse Event|20
1038670|NCT01725308|2071354|FG000|Treatment Period II|Insufficient Response|2
1038671|NCT01725308|2071355|FG001|Treatment Period II|Insufficient Response|4
1038672|NCT01725308|2071356|FG002|Treatment Period II|Insufficient Response|6
1038673|NCT01725308|2071354|FG000|Treatment Period II|Worsening of the Target Disease|1
1038674|NCT01725308|2071355|FG001|Treatment Period II|Worsening of the Target Disease|4
1038675|NCT01725308|2071356|FG002|Treatment Period II|Worsening of the Target Disease|2
1038676|NCT01725308|2071354|FG000|Treatment Period II|Changes in the Episodes|1
1038677|NCT01725308|2071355|FG001|Treatment Period II|Changes in the Episodes|0
1038678|NCT01725308|2071356|FG002|Treatment Period II|Changes in the Episodes|5
1038679|NCT01725308|2071354|FG000|Treatment Period II|Withdrawal of Consent|28
1038680|NCT01725308|2071355|FG001|Treatment Period II|Withdrawal of Consent|2
1038681|NCT01725308|2071356|FG002|Treatment Period II|Withdrawal of Consent|16
1038682|NCT01725308|2071354|FG000|Treatment Period II|Lost to Follow-up|1
1038683|NCT01725308|2071355|FG001|Treatment Period II|Lost to Follow-up|5
1038684|NCT01725308|2071356|FG002|Treatment Period II|Lost to Follow-up|3
1038685|NCT01725308|2071354|FG000|Treatment Period II|Protocol Deviations|0
1038686|NCT01725308|2071355|FG001|Treatment Period II|Protocol Deviations|0
1038687|NCT01725308|2071356|FG002|Treatment Period II|Protocol Deviations|1
1038688|NCT01725308|2071354|FG000|Treatment Period II|Miscellaneous|5
1038689|NCT01725308|2071355|FG001|Treatment Period II|Miscellaneous|3
1038690|NCT01725308|2071356|FG002|Treatment Period II|Miscellaneous|7
1038691|NCT01725386|2071373|FG000|Overall Study|Death|84
1038692|NCT01725386|2071374|FG001|Overall Study|Death|40
1038693|NCT01725386|2071373|FG000|Overall Study|Lost to Follow-up|81
1038694|NCT01725386|2071374|FG001|Overall Study|Lost to Follow-up|6
1038695|NCT01725386|2071373|FG000|Overall Study|Withdrawal by Subject|10
1038696|NCT01725386|2071374|FG001|Overall Study|Withdrawal by Subject|0
1038697|NCT01725451|2071380|FG000|Period 1|Withdrawal by Subject|1
1038698|NCT01725451|2071381|FG001|Period 1|Withdrawal by Subject|0
1038699|NCT01725451|2071382|FG002|Period 1|Withdrawal by Subject|0
1038700|NCT01725451|2071383|FG003|Period 1|Withdrawal by Subject|0
1038701|NCT01725451|2071380|FG000|Washout From Period 3|Protocol Violation|0
1038702|NCT01725451|2071381|FG001|Washout From Period 3|Protocol Violation|0
1038703|NCT01725451|2071382|FG002|Washout From Period 3|Protocol Violation|1
1038704|NCT01725451|2071383|FG003|Washout From Period 3|Protocol Violation|0
1038705|NCT01725451|2071380|FG000|Washout From Period 3|Adverse Event|0
1038706|NCT01725451|2071381|FG001|Washout From Period 3|Adverse Event|1
1038707|NCT01725451|2071382|FG002|Washout From Period 3|Adverse Event|0
1038708|NCT01725451|2071383|FG003|Washout From Period 3|Adverse Event|0
1038709|NCT01725451|2071380|FG000|Period 4|Adverse Event|0
1038710|NCT01725451|2071381|FG001|Period 4|Adverse Event|0
1038711|NCT01725451|2071382|FG002|Period 4|Adverse Event|1
1038712|NCT01725451|2071383|FG003|Period 4|Adverse Event|0
1038713|NCT01725529|2071401|FG000|Overall Study|Adverse Event|1
1038714|NCT01725529|2071402|FG001|Overall Study|Adverse Event|0
1038715|NCT01725529|2071403|FG002|Overall Study|Adverse Event|0
1038716|NCT01725529|2071401|FG000|Overall Study|Lost to Follow-up|2
1038717|NCT01725529|2071402|FG001|Overall Study|Lost to Follow-up|1
1038718|NCT01725529|2071403|FG002|Overall Study|Lost to Follow-up|1
1038719|NCT01725529|2071401|FG000|Overall Study|Protocol Violation|0
1038720|NCT01725529|2071402|FG001|Overall Study|Protocol Violation|1
1038721|NCT01725529|2071403|FG002|Overall Study|Protocol Violation|1
1038722|NCT01725529|2071401|FG000|Overall Study|Withdrawal by Subject|12
1038723|NCT01725529|2071402|FG001|Overall Study|Withdrawal by Subject|14
1038724|NCT01725529|2071403|FG002|Overall Study|Withdrawal by Subject|8
1038725|NCT01725750|2071413|FG000|Overall Study|Adverse Event|1
1038726|NCT01725750|2071414|FG001|Overall Study|Adverse Event|0
1038727|NCT01725750|2071413|FG000|Overall Study|Lost to Follow-up|1
1038728|NCT01725750|2071414|FG001|Overall Study|Lost to Follow-up|1
1038729|NCT01725750|2071413|FG000|Overall Study|Withdrawal by Subject|0
1038730|NCT01725750|2071414|FG001|Overall Study|Withdrawal by Subject|9
1038731|NCT01726023|2071442|FG000|Overall Study|Death|1
1038732|NCT01726023|2071443|FG001|Overall Study|Death|1
1038733|NCT01726023|2071442|FG000|Overall Study|Lost to Follow-up|5
1038734|NCT01726023|2071443|FG001|Overall Study|Lost to Follow-up|10
1038735|NCT01726023|2071442|FG000|Overall Study|Other Eligibility criteria|7
1038736|NCT01726023|2071443|FG001|Overall Study|Other Eligibility criteria|7
1038737|NCT01726023|2071442|FG000|Overall Study|Withdrawal by Subject|16
1038738|NCT01726023|2071443|FG001|Overall Study|Withdrawal by Subject|8
1038739|NCT01726049|2071467|FG000|Overall Study|Death|1
1038740|NCT01726049|2071468|FG001|Overall Study|Death|1
1038741|NCT01726049|2071467|FG000|Overall Study|Adverse Event|4
1038742|NCT01726049|2071468|FG001|Overall Study|Adverse Event|1
1038743|NCT01726049|2071467|FG000|Overall Study|refused second HC|0
1038744|NCT01726049|2071468|FG001|Overall Study|refused second HC|2
1038745|NCT01726270|2071474|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10
1038746|NCT01726270|2071474|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20
1038747|NCT01726270|2071474|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21
1038748|NCT01726270|2071474|FG000|Part 2, Actual-Use Phase|Adverse Event|6
1038749|NCT01726270|2071474|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5
1038750|NCT01726270|2071474|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7
1038751|NCT01726335|2071480|FG000|Overall Study|Lost to Follow-up|2
1038752|NCT01726335|2071480|FG000|Overall Study|Withdrawal by Subject|15
1038753|NCT01726335|2071480|FG000|Overall Study|Adverse Event|4
1038754|NCT01726335|2071480|FG000|Overall Study|Lost to Follow-up|2
1038755|NCT01726335|2071480|FG000|Overall Study|Exacerbation of psychotic symptoms|1
1038756|NCT01726517|2071498|FG000|Overall Study|Withdrawal by Subject|0
1038757|NCT01726517|2071499|FG001|Overall Study|Withdrawal by Subject|0
1038758|NCT01726517|2071500|FG002|Overall Study|Withdrawal by Subject|1
1038759|NCT01726517|2071501|FG003|Overall Study|Withdrawal by Subject|0
1038760|NCT01726517|2071502|FG004|Overall Study|Withdrawal by Subject|0
1038761|NCT01726803|2071533|FG000|Overall Study|Lost to Follow-up|6
1038762|NCT01726803|2071534|FG001|Overall Study|Lost to Follow-up|1
1038763|NCT01726803|2071533|FG000|Overall Study|Withdrawal by Subject|1
1038764|NCT01726803|2071534|FG001|Overall Study|Withdrawal by Subject|0
1038765|NCT01727024|2071540|FG000|Period 1|Lost to Follow-up|1
1038766|NCT01727024|2071541|FG001|Period 1|Lost to Follow-up|1
1038767|NCT01727024|2071540|FG000|Period 1|Withdrawal by Subject|2
1038768|NCT01727024|2071541|FG001|Period 1|Withdrawal by Subject|3
1038769|NCT01727141|2071560|FG000|Overall Study|Physician Decision|0
1038770|NCT01727141|2071561|FG001|Overall Study|Physician Decision|1
1038771|NCT01727141|2071562|FG002|Overall Study|Physician Decision|0
1038772|NCT01727141|2071563|FG003|Overall Study|Physician Decision|2
1038773|NCT01727141|2071560|FG000|Overall Study|Lost to Follow-up|0
1038774|NCT01727141|2071561|FG001|Overall Study|Lost to Follow-up|2
1038775|NCT01727141|2071562|FG002|Overall Study|Lost to Follow-up|0
1038776|NCT01727141|2071563|FG003|Overall Study|Lost to Follow-up|0
1038777|NCT01727141|2071560|FG000|Overall Study|Death|0
1038778|NCT01727141|2071561|FG001|Overall Study|Death|1
1038779|NCT01727141|2071562|FG002|Overall Study|Death|1
1038780|NCT01727141|2071563|FG003|Overall Study|Death|1
1038781|NCT01727141|2071560|FG000|Overall Study|Protocol deviation|1
1038782|NCT01727141|2071561|FG001|Overall Study|Protocol deviation|1
1038783|NCT01727141|2071562|FG002|Overall Study|Protocol deviation|0
1038784|NCT01727141|2071563|FG003|Overall Study|Protocol deviation|1
1038785|NCT01727141|2071560|FG000|Overall Study|Withdrawal by Subject|4
1038786|NCT01727141|2071561|FG001|Overall Study|Withdrawal by Subject|4
1038787|NCT01727141|2071562|FG002|Overall Study|Withdrawal by Subject|2
1038788|NCT01727141|2071563|FG003|Overall Study|Withdrawal by Subject|11
1038789|NCT01727154|2071573|FG000|Overall Study|Death|17
1038790|NCT01727154|2071573|FG000|Overall Study|Withdrawal by Subject|14
1038791|NCT01727154|2071573|FG000|Overall Study|Subject Withdrew Consent|18
1038792|NCT01727154|2071573|FG000|Overall Study|Study Terminated|6
1038793|NCT01727154|2071573|FG000|Overall Study|No Discontinuation Documentation|4
1038794|NCT01727258|2071584|FG000|Overall Study|Adverse Event|0
1038795|NCT01727258|2071585|FG001|Overall Study|Adverse Event|2
1038796|NCT01727258|2071586|FG002|Overall Study|Adverse Event|0
1038797|NCT01727258|2071584|FG000|Overall Study|Noncompliance with Study Drug|0
1038798|NCT01727258|2071585|FG001|Overall Study|Noncompliance with Study Drug|0
1038799|NCT01727258|2071586|FG002|Overall Study|Noncompliance with Study Drug|1
1038800|NCT01727258|2071584|FG000|Overall Study|Withdrawal by Subject|1
1038801|NCT01727258|2071585|FG001|Overall Study|Withdrawal by Subject|1
1038802|NCT01727258|2071586|FG002|Overall Study|Withdrawal by Subject|0
1038803|NCT01727258|2071584|FG000|Overall Study|Lost to Follow-up|1
1038804|NCT01727258|2071585|FG001|Overall Study|Lost to Follow-up|0
1038805|NCT01727258|2071586|FG002|Overall Study|Lost to Follow-up|0
1038806|NCT01727297|2071594|FG000|Overall Study|Death|13
1038807|NCT01727297|2071595|FG001|Overall Study|Death|0
1038808|NCT01727297|2071594|FG000|Overall Study|Protocol Violation|1
1038809|NCT01727297|2071595|FG001|Overall Study|Protocol Violation|10
1038810|NCT01727297|2071594|FG000|Overall Study|Adverse Event|3
1038811|NCT01727297|2071595|FG001|Overall Study|Adverse Event|1
1038812|NCT01727297|2071594|FG000|Overall Study|Lost to Follow-up|11
1038813|NCT01727297|2071595|FG001|Overall Study|Lost to Follow-up|0
1038814|NCT01727297|2071594|FG000|Overall Study|Withdrawal by Subject|26
1038815|NCT01727297|2071595|FG001|Overall Study|Withdrawal by Subject|27
1038816|NCT01727297|2071594|FG000|Overall Study|Physician Decision|19
1038817|NCT01727297|2071595|FG001|Overall Study|Physician Decision|5
1038818|NCT01727297|2071594|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29
1038819|NCT01727297|2071595|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8
1038820|NCT01727336|2071614|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0
1038821|NCT01727336|2071615|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1
1038822|NCT01727336|2071616|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5
1038823|NCT01727336|2071617|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0
1038824|NCT01727336|2071618|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0
1038825|NCT01727336|2071619|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0
1038826|NCT01727336|2071614|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
1038827|NCT01727336|2071615|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1
1038828|NCT01727336|2071616|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
1038829|NCT01727336|2071617|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
1038830|NCT01727336|2071618|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
1038831|NCT01727336|2071619|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
1038832|NCT01727336|2071614|FG000|Part 2 Blinded|Death|0
1038833|NCT01727336|2071615|FG001|Part 2 Blinded|Death|0
1038834|NCT01727336|2071616|FG002|Part 2 Blinded|Death|0
1038835|NCT01727336|2071617|FG003|Part 2 Blinded|Death|0
1038836|NCT01727336|2071618|FG004|Part 2 Blinded|Death|20
1038837|NCT01727336|2071619|FG005|Part 2 Blinded|Death|16
1038838|NCT01727336|2071614|FG000|Part 2 Blinded|Lack of Efficacy|0
1038839|NCT01727336|2071615|FG001|Part 2 Blinded|Lack of Efficacy|0
1038840|NCT01727336|2071616|FG002|Part 2 Blinded|Lack of Efficacy|0
1038841|NCT01727336|2071617|FG003|Part 2 Blinded|Lack of Efficacy|0
1038842|NCT01727336|2071618|FG004|Part 2 Blinded|Lack of Efficacy|42
1038843|NCT01727336|2071619|FG005|Part 2 Blinded|Lack of Efficacy|44
1038844|NCT01727336|2071614|FG000|Part 2 Blinded|Lost to Follow-up|0
1038845|NCT01727336|2071615|FG001|Part 2 Blinded|Lost to Follow-up|0
1038846|NCT01727336|2071616|FG002|Part 2 Blinded|Lost to Follow-up|0
1038847|NCT01727336|2071617|FG003|Part 2 Blinded|Lost to Follow-up|0
1038848|NCT01727336|2071618|FG004|Part 2 Blinded|Lost to Follow-up|0
1038849|NCT01727336|2071619|FG005|Part 2 Blinded|Lost to Follow-up|1
1038850|NCT01727336|2071614|FG000|Part 2 Blinded|Withdrawal by Subject|0
1038851|NCT01727336|2071615|FG001|Part 2 Blinded|Withdrawal by Subject|0
1038852|NCT01727336|2071616|FG002|Part 2 Blinded|Withdrawal by Subject|0
1038853|NCT01727336|2071617|FG003|Part 2 Blinded|Withdrawal by Subject|0
1038854|NCT01727336|2071618|FG004|Part 2 Blinded|Withdrawal by Subject|0
1038855|NCT01727336|2071619|FG005|Part 2 Blinded|Withdrawal by Subject|4
1038856|NCT01727336|2071614|FG000|Part 2 Blinded|use of prohibited medications|0
1038857|NCT01727336|2071615|FG001|Part 2 Blinded|use of prohibited medications|0
1038858|NCT01727336|2071616|FG002|Part 2 Blinded|use of prohibited medications|0
1038859|NCT01727336|2071617|FG003|Part 2 Blinded|use of prohibited medications|0
1038860|NCT01727336|2071618|FG004|Part 2 Blinded|use of prohibited medications|1
1038861|NCT01727336|2071619|FG005|Part 2 Blinded|use of prohibited medications|3
1038862|NCT01727505|2071648|FG000|First 24 Hours|Adverse Event|0
1038863|NCT01727505|2071649|FG001|First 24 Hours|Adverse Event|1
1038864|NCT01727505|2071648|FG000|Second 24 Hours|Missing data|0
1038865|NCT01727505|2071649|FG001|Second 24 Hours|Missing data|1
1038866|NCT01727700|2071658|FG000|Overall Study|Adverse Event|0
1038867|NCT01727700|2071659|FG001|Overall Study|Adverse Event|7
1038868|NCT01727700|2071660|FG002|Overall Study|Adverse Event|1
1038869|NCT01727700|2071658|FG000|Overall Study|Particpant withdrew consent|0
1038870|NCT01727700|2071659|FG001|Overall Study|Particpant withdrew consent|3
1038871|NCT01727700|2071660|FG002|Overall Study|Particpant withdrew consent|1
1038872|NCT01727700|2071658|FG000|Overall Study|Protocol Violation|2
1038873|NCT01727700|2071659|FG001|Overall Study|Protocol Violation|0
1038874|NCT01727700|2071660|FG002|Overall Study|Protocol Violation|0
1038875|NCT01727713|2071668|FG000|Overall Study|Lost to Follow-up|5
1038876|NCT01727713|2071668|FG000|Overall Study|Adverse Event|10
1038877|NCT01727713|2071668|FG000|Overall Study|Participant Met Withdrawal Criteria|5
1038878|NCT01727713|2071668|FG000|Overall Study|Withdrawal by Subject|13
1038879|NCT01727713|2071668|FG000|Overall Study|Protocol Deviation|2
1038880|NCT01728077|2071709|FG000|Overall Study|Lack of Efficacy|3
1038881|NCT01728077|2071710|FG001|Overall Study|Lack of Efficacy|1
1038882|NCT01728077|2071709|FG000|Overall Study|Lost to Follow-up|1
1038883|NCT01728077|2071710|FG001|Overall Study|Lost to Follow-up|0
1038884|NCT01728077|2071709|FG000|Overall Study|Subject choice|2
1038885|NCT01728077|2071710|FG001|Overall Study|Subject choice|3
1038886|NCT01728077|2071709|FG000|Overall Study|Death|0
1038887|NCT01728077|2071710|FG001|Overall Study|Death|1
1038888|NCT01728077|2071709|FG000|Overall Study|Patient moving|1
1038889|NCT01728077|2071710|FG001|Overall Study|Patient moving|0
1038890|NCT01728077|2071709|FG000|Overall Study|Non compliance|1
1038891|NCT01728077|2071710|FG001|Overall Study|Non compliance|0
1038892|NCT01728116|2071719|FG000|Overall Study|Sponsor Terminated Study|106
1038893|NCT01728116|2071720|FG001|Overall Study|Sponsor Terminated Study|35
1038894|NCT01728116|2071719|FG000|Overall Study|Withdrawal by Subject|16
1038895|NCT01728116|2071720|FG001|Overall Study|Withdrawal by Subject|9
1038896|NCT01728116|2071719|FG000|Overall Study|Adverse Event|13
1038897|NCT01728116|2071720|FG001|Overall Study|Adverse Event|0
1038898|NCT01728116|2071719|FG000|Overall Study|Procedure/device failure|7
1038899|NCT01728116|2071720|FG001|Overall Study|Procedure/device failure|0
1038900|NCT01728116|2071719|FG000|Overall Study|Lost to Follow-up|9
1038901|NCT01728116|2071720|FG001|Overall Study|Lost to Follow-up|2
1038902|NCT01728116|2071719|FG000|Overall Study|Physician Decision|2
1038903|NCT01728116|2071720|FG001|Overall Study|Physician Decision|0
1038904|NCT01728116|2071719|FG000|Overall Study|Subject Non-Compliance|2
1038905|NCT01728116|2071720|FG001|Overall Study|Subject Non-Compliance|0
1038906|NCT01728116|2071719|FG000|Overall Study|Inter-current finding at procedure|1
1038907|NCT01728116|2071720|FG001|Overall Study|Inter-current finding at procedure|0
1038908|NCT01728116|2071719|FG000|Overall Study|Incorrectly enrolled in Study|0
1038909|NCT01728116|2071720|FG001|Overall Study|Incorrectly enrolled in Study|1
1038910|NCT01728116|2071719|FG000|Overall Study|various not noted previously|5
1038911|NCT01728116|2071720|FG001|Overall Study|various not noted previously|0
1038912|NCT01728194|2071729|FG000|Overall Study|Lost to Follow-up|4
1038913|NCT01728194|2071730|FG001|Overall Study|Lost to Follow-up|3
1038914|NCT01728194|2071729|FG000|Overall Study|Physician Decision|4
1038915|NCT01728194|2071730|FG001|Overall Study|Physician Decision|0
1038916|NCT01728194|2071729|FG000|Overall Study|Withdrawal by Subject|7
1038917|NCT01728194|2071730|FG001|Overall Study|Withdrawal by Subject|3
1038918|NCT01728194|2071729|FG000|Overall Study|Perceived Medication Side Effects|4
1038919|NCT01728194|2071730|FG001|Overall Study|Perceived Medication Side Effects|0
1038920|NCT01728194|2071729|FG000|Overall Study|Family Member Request|1
1038921|NCT01728194|2071730|FG001|Overall Study|Family Member Request|0
1038922|NCT01728246|2071738|FG000|Overall Study|Participant needed rescue medication|1
1038923|NCT01728246|2071739|FG001|Overall Study|Participant needed rescue medication|5
1038924|NCT01728246|2071738|FG000|Overall Study|Protocol Violation|1
1038925|NCT01728246|2071739|FG001|Overall Study|Protocol Violation|0
1038926|NCT01728246|2071738|FG000|Overall Study|Withdrawal by Subject|2
1038927|NCT01728246|2071739|FG001|Overall Study|Withdrawal by Subject|3
1038928|NCT01728246|2071738|FG000|Overall Study|Lost to Follow-up|23
1038929|NCT01728246|2071739|FG001|Overall Study|Lost to Follow-up|22
1038930|NCT01728246|2071738|FG000|Overall Study|Lack of Efficacy|1
1038931|NCT01728246|2071739|FG001|Overall Study|Lack of Efficacy|1
1038932|NCT01728246|2071738|FG000|Overall Study|Adverse Event|8
1038933|NCT01728246|2071739|FG001|Overall Study|Adverse Event|5
1038934|NCT01728324|2071748|FG000|Termination of DBV|Adverse Event|14
1038935|NCT01728324|2071749|FG001|Termination of DBV|Adverse Event|13
1038936|NCT01728324|2071750|FG002|Termination of DBV|Adverse Event|4
1038937|NCT01728324|2071748|FG000|Termination of DBV|Lack of Efficacy|14
1038938|NCT01728324|2071749|FG001|Termination of DBV|Lack of Efficacy|12
1038939|NCT01728324|2071750|FG002|Termination of DBV|Lack of Efficacy|8
1038940|NCT01728324|2071748|FG000|Termination of DBV|Withdrawal by Subject|9
1038941|NCT01728324|2071749|FG001|Termination of DBV|Withdrawal by Subject|6
1038942|NCT01728324|2071750|FG002|Termination of DBV|Withdrawal by Subject|2
1038943|NCT01728324|2071748|FG000|Termination of DBV|Other than stated|1
1038944|NCT01728324|2071749|FG001|Termination of DBV|Other than stated|3
1038945|NCT01728324|2071750|FG002|Termination of DBV|Other than stated|0
1038946|NCT01728324|2071748|FG000|Termination of DBV|Adverse Event (Placebo Period)|0
1038947|NCT01728324|2071749|FG001|Termination of DBV|Adverse Event (Placebo Period)|1
1038948|NCT01728324|2071750|FG002|Termination of DBV|Adverse Event (Placebo Period)|0
1038949|NCT01728324|2071748|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0
1038950|NCT01728324|2071749|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1
1038951|NCT01728324|2071750|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0
1038952|NCT01728324|2071748|FG000|Termination of FDV|Adverse Event|14
1038953|NCT01728324|2071749|FG001|Termination of FDV|Adverse Event|13
1038954|NCT01728324|2071750|FG002|Termination of FDV|Adverse Event|4
1038955|NCT01728324|2071748|FG000|Termination of FDV|Lack of Efficacy|14
1038956|NCT01728324|2071749|FG001|Termination of FDV|Lack of Efficacy|12
1038957|NCT01728324|2071750|FG002|Termination of FDV|Lack of Efficacy|8
1038958|NCT01728324|2071748|FG000|Termination of FDV|Withdrawal by Subject|9
1038959|NCT01728324|2071749|FG001|Termination of FDV|Withdrawal by Subject|6
1038960|NCT01728324|2071750|FG002|Termination of FDV|Withdrawal by Subject|2
1038961|NCT01728324|2071748|FG000|Termination of FDV|Other than stated|1
1038962|NCT01728324|2071749|FG001|Termination of FDV|Other than stated|3
1038963|NCT01728324|2071750|FG002|Termination of FDV|Other than stated|0
1038964|NCT01728324|2071748|FG000|Termination of FDV|Adverse Event (Placebo Period)|0
1038965|NCT01728324|2071749|FG001|Termination of FDV|Adverse Event (Placebo Period)|1
1038966|NCT01728324|2071750|FG002|Termination of FDV|Adverse Event (Placebo Period)|0
1038967|NCT01728324|2071748|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0
1038968|NCT01728324|2071749|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1
1038969|NCT01728324|2071750|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0
1038970|NCT01728324|2071748|FG000|Termination of RBV|Adverse Event|15
1038971|NCT01728324|2071749|FG001|Termination of RBV|Adverse Event|16
1038972|NCT01728324|2071750|FG002|Termination of RBV|Adverse Event|5
1038973|NCT01728324|2071748|FG000|Termination of RBV|Lack of Efficacy|14
1038974|NCT01728324|2071749|FG001|Termination of RBV|Lack of Efficacy|11
1038975|NCT01728324|2071750|FG002|Termination of RBV|Lack of Efficacy|7
1038976|NCT01728324|2071748|FG000|Termination of RBV|Withdrawal by Subject|9
1038977|NCT01728324|2071749|FG001|Termination of RBV|Withdrawal by Subject|5
1038978|NCT01728324|2071750|FG002|Termination of RBV|Withdrawal by Subject|2
1038979|NCT01728324|2071748|FG000|Termination of RBV|Other than stated|1
1038980|NCT01728324|2071749|FG001|Termination of RBV|Other than stated|3
1038981|NCT01728324|2071750|FG002|Termination of RBV|Other than stated|1
1038982|NCT01728324|2071748|FG000|Termination of RBV|Adverse Event (Placebo Period)|0
1038983|NCT01728324|2071749|FG001|Termination of RBV|Adverse Event (Placebo Period)|1
1038984|NCT01728324|2071750|FG002|Termination of RBV|Adverse Event (Placebo Period)|0
1038985|NCT01728324|2071748|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0
1038986|NCT01728324|2071749|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1
1038987|NCT01728324|2071750|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0
1038988|NCT01728376|2071772|FG000|Overall Study|Adverse Event|1
1038989|NCT01728376|2071773|FG001|Overall Study|Adverse Event|1
1038990|NCT01728376|2071774|FG002|Overall Study|Adverse Event|1
1038991|NCT01728376|2071775|FG003|Overall Study|Adverse Event|1
1038992|NCT01728376|2071776|FG004|Overall Study|Adverse Event|1
1038993|NCT01728376|2071777|FG005|Overall Study|Adverse Event|0
1038994|NCT01728376|2071772|FG000|Overall Study|Persistent Positive Blood Cultures|1
1038995|NCT01728376|2071773|FG001|Overall Study|Persistent Positive Blood Cultures|0
1038996|NCT01728376|2071774|FG002|Overall Study|Persistent Positive Blood Cultures|1
1038997|NCT01728376|2071775|FG003|Overall Study|Persistent Positive Blood Cultures|0
1038998|NCT01728376|2071776|FG004|Overall Study|Persistent Positive Blood Cultures|0
1038999|NCT01728376|2071777|FG005|Overall Study|Persistent Positive Blood Cultures|0
1039000|NCT01728376|2071772|FG000|Overall Study|No relevant bacteria|2
1039001|NCT01728376|2071773|FG001|Overall Study|No relevant bacteria|0
1039002|NCT01728376|2071774|FG002|Overall Study|No relevant bacteria|0
1039003|NCT01728376|2071775|FG003|Overall Study|No relevant bacteria|0
1039004|NCT01728376|2071776|FG004|Overall Study|No relevant bacteria|1
1039005|NCT01728376|2071777|FG005|Overall Study|No relevant bacteria|1
1039006|NCT01728376|2071772|FG000|Overall Study|Did not receive treatment|0
1039007|NCT01728376|2071773|FG001|Overall Study|Did not receive treatment|1
1039008|NCT01728376|2071774|FG002|Overall Study|Did not receive treatment|0
1039009|NCT01728376|2071775|FG003|Overall Study|Did not receive treatment|0
1039010|NCT01728376|2071776|FG004|Overall Study|Did not receive treatment|0
1039011|NCT01728376|2071777|FG005|Overall Study|Did not receive treatment|0
1039012|NCT01728376|2071772|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0
1039013|NCT01728376|2071773|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0
1039014|NCT01728376|2071774|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0
1039015|NCT01728376|2071775|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1
1039016|NCT01728376|2071776|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0
1039017|NCT01728376|2071777|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1
1039018|NCT01728454|2071794|FG000|Stage 1 and 2|Pregnancy|1
1039019|NCT01728454|2071795|FG001|Stage 1 and 2|Pregnancy|0
1039020|NCT01728454|2071796|FG002|Stage 1 and 2|Pregnancy|0
1039021|NCT01728454|2071794|FG000|Stage 1 and 2|Non-compliance with Protocol|0
1039022|NCT01728454|2071795|FG001|Stage 1 and 2|Non-compliance with Protocol|0
1039023|NCT01728454|2071796|FG002|Stage 1 and 2|Non-compliance with Protocol|1
1039024|NCT01728454|2071794|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
1039025|NCT01728454|2071795|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
1039026|NCT01728454|2071796|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
1039027|NCT01728454|2071794|FG000|Stage 1 and 2|Lost to Follow-up|1
1039028|NCT01728454|2071795|FG001|Stage 1 and 2|Lost to Follow-up|1
1039029|NCT01728454|2071796|FG002|Stage 1 and 2|Lost to Follow-up|0
1039030|NCT01728454|2071794|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
1039031|NCT01728454|2071795|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
1039032|NCT01728454|2071796|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
1039033|NCT01728454|2071794|FG000|Stage 3|Reason Missing|0
1039034|NCT01728454|2071795|FG001|Stage 3|Reason Missing|0
1039035|NCT01728454|2071796|FG002|Stage 3|Reason Missing|1
1039036|NCT01728454|2071794|FG000|Stage 3|Subject Required Other Treatment|0
1039037|NCT01728454|2071795|FG001|Stage 3|Subject Required Other Treatment|1
1039038|NCT01728454|2071796|FG002|Stage 3|Subject Required Other Treatment|0
1039039|NCT01728454|2071794|FG000|Stage 3|Pregnancy|1
1039040|NCT01728454|2071795|FG001|Stage 3|Pregnancy|0
1039041|NCT01728454|2071796|FG002|Stage 3|Pregnancy|0
1039042|NCT01728454|2071794|FG000|Stage 3|Withdrew Consent|1
1039043|NCT01728454|2071795|FG001|Stage 3|Withdrew Consent|0
1039044|NCT01728454|2071796|FG002|Stage 3|Withdrew Consent|1
1039045|NCT01728454|2071794|FG000|Stage 3|Non-compliance with Protocol|0
1039046|NCT01728454|2071795|FG001|Stage 3|Non-compliance with Protocol|0
1039047|NCT01728454|2071796|FG002|Stage 3|Non-compliance with Protocol|1
1039048|NCT01728454|2071794|FG000|Stage 3|Lost to Follow-up|0
1039049|NCT01728454|2071795|FG001|Stage 3|Lost to Follow-up|3
1039050|NCT01728454|2071796|FG002|Stage 3|Lost to Follow-up|1
1039051|NCT01728454|2071794|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1
1039052|NCT01728454|2071795|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0
1039053|NCT01728454|2071796|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0
1039054|NCT01728584|2071811|FG000|Overall Study|Adverse Event|1
1039055|NCT01728584|2071812|FG001|Overall Study|Adverse Event|0
1039056|NCT01728584|2071813|FG002|Overall Study|Adverse Event|0
1039057|NCT01728584|2071814|FG003|Overall Study|Adverse Event|0
1039058|NCT01728584|2071811|FG000|Overall Study|Physician Decision|4
1039059|NCT01728584|2071812|FG001|Overall Study|Physician Decision|0
1039060|NCT01728584|2071813|FG002|Overall Study|Physician Decision|1
1039061|NCT01728584|2071814|FG003|Overall Study|Physician Decision|0
1039062|NCT01728584|2071811|FG000|Overall Study|Withdrawal by Subject|1
1039063|NCT01728584|2071812|FG001|Overall Study|Withdrawal by Subject|0
1039064|NCT01728584|2071813|FG002|Overall Study|Withdrawal by Subject|0
1039065|NCT01728584|2071814|FG003|Overall Study|Withdrawal by Subject|0
1039066|NCT01728584|2071811|FG000|Overall Study|Screen failure|1
1039067|NCT01728584|2071812|FG001|Overall Study|Screen failure|0
1039068|NCT01728584|2071813|FG002|Overall Study|Screen failure|0
1039069|NCT01728584|2071814|FG003|Overall Study|Screen failure|0
1039070|NCT01728584|2071811|FG000|Overall Study|Other reason (not specified)|1
1039071|NCT01728584|2071812|FG001|Overall Study|Other reason (not specified)|0
1039072|NCT01728584|2071813|FG002|Overall Study|Other reason (not specified)|0
1039073|NCT01728584|2071814|FG003|Overall Study|Other reason (not specified)|1
1039074|NCT01728623|2071831|FG000|Overall Study|Disease progression|26
1039075|NCT01728623|2071831|FG000|Overall Study|Adverse Event|1
1039076|NCT01728623|2071831|FG000|Overall Study|Withdrawal by Subject|1
1039077|NCT01728779|2071847|FG000|Overall Study|Withdrawal by Subject|1
1039078|NCT01728792|2071856|FG000|Overall Study|Withdrawal of Consent|1
1039079|NCT01728792|2071857|FG001|Overall Study|Withdrawal of Consent|1
1039080|NCT01728792|2071858|FG002|Overall Study|Withdrawal of Consent|0
1039081|NCT01728792|2071859|FG003|Overall Study|Withdrawal of Consent|1
1039082|NCT01728792|2071860|FG004|Overall Study|Withdrawal of Consent|0
1039083|NCT01728792|2071856|FG000|Overall Study|Lost to Follow-up|2
1039084|NCT01728792|2071857|FG001|Overall Study|Lost to Follow-up|1
1039085|NCT01728792|2071858|FG002|Overall Study|Lost to Follow-up|4
1039086|NCT01728792|2071859|FG003|Overall Study|Lost to Follow-up|2
1039087|NCT01728792|2071860|FG004|Overall Study|Lost to Follow-up|0
1039088|NCT01729026|2071902|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2
1039089|NCT01729026|2071903|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2
1039090|NCT01729026|2071902|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
1039091|NCT01729026|2071903|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
1039092|NCT01729039|2071914|FG000|Overall Study|disqualified|2
1039093|NCT01729039|2071915|FG001|Overall Study|disqualified|5
1039094|NCT01729039|2071914|FG000|Overall Study|Withdrawal by Subject|8
1039095|NCT01729039|2071915|FG001|Overall Study|Withdrawal by Subject|7
1039096|NCT01729156|2071927|FG000|Overall Study|Withdrawal by Subject|1
1039097|NCT01729156|2071928|FG001|Overall Study|Withdrawal by Subject|0
1039098|NCT01729156|2071929|FG002|Overall Study|Withdrawal by Subject|0
1039099|NCT01729208|2071940|FG000|Baseline|Physician Decision|5
1039100|NCT01729208|2071941|FG001|Baseline|Physician Decision|4
1039101|NCT01729208|2071940|FG000|12 Months Follow-up|Withdrawal by Subject|4
1039102|NCT01729208|2071941|FG001|12 Months Follow-up|Withdrawal by Subject|7
1039103|NCT01729208|2071940|FG000|12 Months Follow-up|Lost to Follow-up|3
1039104|NCT01729208|2071941|FG001|12 Months Follow-up|Lost to Follow-up|3
1039105|NCT01729208|2071940|FG000|24 Months Follow-up|Lost to Follow-up|3
1039106|NCT01729208|2071941|FG001|24 Months Follow-up|Lost to Follow-up|0
1039107|NCT01729208|2071940|FG000|36 Months Follow-up|Physician Decision|1
1039108|NCT01729208|2071941|FG001|36 Months Follow-up|Physician Decision|0
1039109|NCT01729208|2071940|FG000|36 Months Follow-up|Withdrawal by Subject|2
1039110|NCT01729208|2071941|FG001|36 Months Follow-up|Withdrawal by Subject|4
1039111|NCT01729559|2071977|FG000|Overall Study|Protocol Violation|31
1039112|NCT01729559|2071978|FG001|Overall Study|Protocol Violation|28
1039113|NCT01729728|2071996|FG000|Overall Study|Adverse Event|0
1039114|NCT01729728|2071997|FG001|Overall Study|Adverse Event|6
1039115|NCT01729728|2071998|FG002|Overall Study|Adverse Event|0
1039116|NCT01729728|2071996|FG000|Overall Study|Protocol Violation|1
1039117|NCT01729728|2071997|FG001|Overall Study|Protocol Violation|0
1039118|NCT01729728|2071998|FG002|Overall Study|Protocol Violation|1
1039119|NCT01729754|2072133|FG000|Part 1|Adverse Event|2
1039120|NCT01729754|2072134|FG001|Part 1|Adverse Event|0
1039121|NCT01729754|2072135|FG002|Part 1|Adverse Event|0
1039122|NCT01729754|2072136|FG003|Part 1|Adverse Event|1
1039123|NCT01729754|2072137|FG004|Part 1|Adverse Event|0
1039124|NCT01729754|2072138|FG005|Part 1|Adverse Event|0
1039125|NCT01729754|2072139|FG006|Part 1|Adverse Event|2
1039126|NCT01729754|2072140|FG007|Part 1|Adverse Event|0
1039127|NCT01729754|2072141|FG008|Part 1|Adverse Event|0
1039128|NCT01729754|2072142|FG009|Part 1|Adverse Event|5
1039129|NCT01729754|2072133|FG000|Part 1|Lack of Efficacy|1
1039130|NCT01729754|2072134|FG001|Part 1|Lack of Efficacy|0
1039131|NCT01729754|2072135|FG002|Part 1|Lack of Efficacy|0
1039132|NCT01729754|2072136|FG003|Part 1|Lack of Efficacy|0
1039133|NCT01729754|2072137|FG004|Part 1|Lack of Efficacy|0
1039134|NCT01729754|2072138|FG005|Part 1|Lack of Efficacy|0
1039135|NCT01729754|2072139|FG006|Part 1|Lack of Efficacy|2
1039136|NCT01729754|2072140|FG007|Part 1|Lack of Efficacy|0
1039137|NCT01729754|2072141|FG008|Part 1|Lack of Efficacy|0
1039138|NCT01729754|2072142|FG009|Part 1|Lack of Efficacy|0
1039139|NCT01729754|2072133|FG000|Part 1|Lost to Follow-up|1
1039140|NCT01729754|2072134|FG001|Part 1|Lost to Follow-up|0
1039141|NCT01729754|2072135|FG002|Part 1|Lost to Follow-up|0
1039142|NCT01729754|2072136|FG003|Part 1|Lost to Follow-up|2
1039143|NCT01729754|2072137|FG004|Part 1|Lost to Follow-up|0
1039144|NCT01729754|2072138|FG005|Part 1|Lost to Follow-up|0
1039145|NCT01729754|2072139|FG006|Part 1|Lost to Follow-up|3
1039146|NCT01729754|2072140|FG007|Part 1|Lost to Follow-up|0
1039147|NCT01729754|2072141|FG008|Part 1|Lost to Follow-up|0
1039148|NCT01729754|2072142|FG009|Part 1|Lost to Follow-up|3
1039149|NCT01729754|2072133|FG000|Part 1|Non-compliance with Study Drug|1
1039150|NCT01729754|2072134|FG001|Part 1|Non-compliance with Study Drug|0
1039151|NCT01729754|2072135|FG002|Part 1|Non-compliance with Study Drug|0
1039152|NCT01729754|2072136|FG003|Part 1|Non-compliance with Study Drug|0
1039153|NCT01729754|2072137|FG004|Part 1|Non-compliance with Study Drug|0
1039154|NCT01729754|2072138|FG005|Part 1|Non-compliance with Study Drug|0
1039155|NCT01729754|2072139|FG006|Part 1|Non-compliance with Study Drug|0
1039156|NCT01729754|2072140|FG007|Part 1|Non-compliance with Study Drug|0
1039157|NCT01729754|2072141|FG008|Part 1|Non-compliance with Study Drug|0
1039158|NCT01729754|2072142|FG009|Part 1|Non-compliance with Study Drug|0
1039159|NCT01729754|2072133|FG000|Part 1|Physician Decision|0
1039160|NCT01729754|2072134|FG001|Part 1|Physician Decision|0
1039161|NCT01729754|2072135|FG002|Part 1|Physician Decision|0
1039162|NCT01729754|2072136|FG003|Part 1|Physician Decision|0
1039163|NCT01729754|2072137|FG004|Part 1|Physician Decision|0
1039164|NCT01729754|2072138|FG005|Part 1|Physician Decision|0
1039165|NCT01729754|2072139|FG006|Part 1|Physician Decision|0
1039166|NCT01729754|2072140|FG007|Part 1|Physician Decision|0
1039167|NCT01729754|2072141|FG008|Part 1|Physician Decision|0
1039168|NCT01729754|2072142|FG009|Part 1|Physician Decision|4
1039169|NCT01729754|2072133|FG000|Part 1|Pregnancy|0
1039170|NCT01729754|2072134|FG001|Part 1|Pregnancy|0
1039171|NCT01729754|2072135|FG002|Part 1|Pregnancy|0
1039172|NCT01729754|2072136|FG003|Part 1|Pregnancy|1
1039173|NCT01729754|2072137|FG004|Part 1|Pregnancy|0
1039174|NCT01729754|2072138|FG005|Part 1|Pregnancy|0
1039175|NCT01729754|2072139|FG006|Part 1|Pregnancy|0
1039176|NCT01729754|2072140|FG007|Part 1|Pregnancy|0
1039177|NCT01729754|2072141|FG008|Part 1|Pregnancy|0
1039178|NCT01729754|2072142|FG009|Part 1|Pregnancy|1
1039179|NCT01729754|2072133|FG000|Part 1|Progressive Disease|0
1039180|NCT01729754|2072134|FG001|Part 1|Progressive Disease|0
1039181|NCT01729754|2072135|FG002|Part 1|Progressive Disease|0
1039182|NCT01729754|2072136|FG003|Part 1|Progressive Disease|0
1039183|NCT01729754|2072137|FG004|Part 1|Progressive Disease|0
1039184|NCT01729754|2072138|FG005|Part 1|Progressive Disease|0
1039185|NCT01729754|2072139|FG006|Part 1|Progressive Disease|0
1039186|NCT01729754|2072140|FG007|Part 1|Progressive Disease|0
1039187|NCT01729754|2072141|FG008|Part 1|Progressive Disease|0
1039188|NCT01729754|2072142|FG009|Part 1|Progressive Disease|1
1039189|NCT01729754|2072133|FG000|Part 1|Protocol Violation|2
1039190|NCT01729754|2072134|FG001|Part 1|Protocol Violation|0
1039191|NCT01729754|2072135|FG002|Part 1|Protocol Violation|0
1039192|NCT01729754|2072136|FG003|Part 1|Protocol Violation|1
1039193|NCT01729754|2072137|FG004|Part 1|Protocol Violation|0
1039194|NCT01729754|2072138|FG005|Part 1|Protocol Violation|0
1039195|NCT01729754|2072139|FG006|Part 1|Protocol Violation|1
1039196|NCT01729754|2072140|FG007|Part 1|Protocol Violation|0
1039197|NCT01729754|2072141|FG008|Part 1|Protocol Violation|0
1039198|NCT01729754|2072142|FG009|Part 1|Protocol Violation|0
1039199|NCT01729754|2072133|FG000|Part 1|Withdrawal by Subject|5
1039200|NCT01729754|2072134|FG001|Part 1|Withdrawal by Subject|0
1039201|NCT01729754|2072135|FG002|Part 1|Withdrawal by Subject|0
1039202|NCT01729754|2072136|FG003|Part 1|Withdrawal by Subject|7
1039203|NCT01729754|2072137|FG004|Part 1|Withdrawal by Subject|0
1039204|NCT01729754|2072138|FG005|Part 1|Withdrawal by Subject|0
1039205|NCT01729754|2072139|FG006|Part 1|Withdrawal by Subject|5
1039206|NCT01729754|2072140|FG007|Part 1|Withdrawal by Subject|0
1039207|NCT01729754|2072141|FG008|Part 1|Withdrawal by Subject|0
1039208|NCT01729754|2072142|FG009|Part 1|Withdrawal by Subject|6
1039209|NCT01729754|2072133|FG000|Part 1|Other Protocol Specified Criteria|2
1039210|NCT01729754|2072134|FG001|Part 1|Other Protocol Specified Criteria|0
1039211|NCT01729754|2072135|FG002|Part 1|Other Protocol Specified Criteria|0
1039212|NCT01729754|2072136|FG003|Part 1|Other Protocol Specified Criteria|0
1039213|NCT01729754|2072137|FG004|Part 1|Other Protocol Specified Criteria|0
1039214|NCT01729754|2072138|FG005|Part 1|Other Protocol Specified Criteria|0
1039215|NCT01729754|2072139|FG006|Part 1|Other Protocol Specified Criteria|1
1039216|NCT01729754|2072140|FG007|Part 1|Other Protocol Specified Criteria|0
1039217|NCT01729754|2072141|FG008|Part 1|Other Protocol Specified Criteria|0
1039218|NCT01729754|2072142|FG009|Part 1|Other Protocol Specified Criteria|4
1039219|NCT01729754|2072133|FG000|Part 2|Adverse Event|2
1039220|NCT01729754|2072134|FG001|Part 2|Adverse Event|0
1039221|NCT01729754|2072135|FG002|Part 2|Adverse Event|0
1039222|NCT01729754|2072136|FG003|Part 2|Adverse Event|0
1039223|NCT01729754|2072137|FG004|Part 2|Adverse Event|0
1039224|NCT01729754|2072138|FG005|Part 2|Adverse Event|0
1039225|NCT01729754|2072139|FG006|Part 2|Adverse Event|0
1039226|NCT01729754|2072140|FG007|Part 2|Adverse Event|0
1039227|NCT01729754|2072141|FG008|Part 2|Adverse Event|1
1039228|NCT01729754|2072142|FG009|Part 2|Adverse Event|2
1039229|NCT01729754|2072133|FG000|Part 2|Lack of Efficacy|0
1039230|NCT01729754|2072134|FG001|Part 2|Lack of Efficacy|0
1039231|NCT01729754|2072135|FG002|Part 2|Lack of Efficacy|0
1039232|NCT01729754|2072136|FG003|Part 2|Lack of Efficacy|0
1039233|NCT01729754|2072137|FG004|Part 2|Lack of Efficacy|0
1039234|NCT01729754|2072138|FG005|Part 2|Lack of Efficacy|0
1039235|NCT01729754|2072139|FG006|Part 2|Lack of Efficacy|0
1039236|NCT01729754|2072140|FG007|Part 2|Lack of Efficacy|0
1039237|NCT01729754|2072141|FG008|Part 2|Lack of Efficacy|2
1039238|NCT01729754|2072142|FG009|Part 2|Lack of Efficacy|2
1039239|NCT01729754|2072133|FG000|Part 2|Lost to Follow-up|0
1039240|NCT01729754|2072134|FG001|Part 2|Lost to Follow-up|0
1039241|NCT01729754|2072135|FG002|Part 2|Lost to Follow-up|0
1039242|NCT01729754|2072136|FG003|Part 2|Lost to Follow-up|2
1039243|NCT01729754|2072137|FG004|Part 2|Lost to Follow-up|0
1039244|NCT01729754|2072138|FG005|Part 2|Lost to Follow-up|0
1039245|NCT01729754|2072139|FG006|Part 2|Lost to Follow-up|0
1039246|NCT01729754|2072140|FG007|Part 2|Lost to Follow-up|1
1039247|NCT01729754|2072141|FG008|Part 2|Lost to Follow-up|0
1039248|NCT01729754|2072142|FG009|Part 2|Lost to Follow-up|2
1039249|NCT01729754|2072133|FG000|Part 2|Non-Compliance with Study Drug|0
1039250|NCT01729754|2072134|FG001|Part 2|Non-Compliance with Study Drug|0
1039251|NCT01729754|2072135|FG002|Part 2|Non-Compliance with Study Drug|0
1039252|NCT01729754|2072136|FG003|Part 2|Non-Compliance with Study Drug|0
1039253|NCT01729754|2072137|FG004|Part 2|Non-Compliance with Study Drug|0
1039254|NCT01729754|2072138|FG005|Part 2|Non-Compliance with Study Drug|0
1039255|NCT01729754|2072139|FG006|Part 2|Non-Compliance with Study Drug|0
1039256|NCT01729754|2072140|FG007|Part 2|Non-Compliance with Study Drug|0
1039257|NCT01729754|2072141|FG008|Part 2|Non-Compliance with Study Drug|0
1039258|NCT01729754|2072142|FG009|Part 2|Non-Compliance with Study Drug|1
1039259|NCT01729754|2072133|FG000|Part 2|Pregnancy|0
1039260|NCT01729754|2072134|FG001|Part 2|Pregnancy|0
1039261|NCT01729754|2072135|FG002|Part 2|Pregnancy|0
1039262|NCT01729754|2072136|FG003|Part 2|Pregnancy|1
1039263|NCT01729754|2072137|FG004|Part 2|Pregnancy|0
1039264|NCT01729754|2072138|FG005|Part 2|Pregnancy|0
1039265|NCT01729754|2072139|FG006|Part 2|Pregnancy|0
1039266|NCT01729754|2072140|FG007|Part 2|Pregnancy|0
1039267|NCT01729754|2072141|FG008|Part 2|Pregnancy|0
1039268|NCT01729754|2072142|FG009|Part 2|Pregnancy|1
1039269|NCT01729754|2072133|FG000|Part 2|Withdrawal by Subject|3
1039270|NCT01729754|2072134|FG001|Part 2|Withdrawal by Subject|0
1039271|NCT01729754|2072135|FG002|Part 2|Withdrawal by Subject|0
1039272|NCT01729754|2072136|FG003|Part 2|Withdrawal by Subject|2
1039273|NCT01729754|2072137|FG004|Part 2|Withdrawal by Subject|0
1039274|NCT01729754|2072138|FG005|Part 2|Withdrawal by Subject|0
1039275|NCT01729754|2072139|FG006|Part 2|Withdrawal by Subject|0
1039276|NCT01729754|2072140|FG007|Part 2|Withdrawal by Subject|1
1039277|NCT01729754|2072141|FG008|Part 2|Withdrawal by Subject|1
1039278|NCT01729754|2072142|FG009|Part 2|Withdrawal by Subject|4
1039279|NCT01729754|2072133|FG000|Part 2|Other Protocol Specified Criteria|1
1039280|NCT01729754|2072134|FG001|Part 2|Other Protocol Specified Criteria|0
1039281|NCT01729754|2072135|FG002|Part 2|Other Protocol Specified Criteria|0
1039282|NCT01729754|2072136|FG003|Part 2|Other Protocol Specified Criteria|0
1039283|NCT01729754|2072137|FG004|Part 2|Other Protocol Specified Criteria|0
1039284|NCT01729754|2072138|FG005|Part 2|Other Protocol Specified Criteria|0
1039285|NCT01729754|2072139|FG006|Part 2|Other Protocol Specified Criteria|0
1039286|NCT01729754|2072140|FG007|Part 2|Other Protocol Specified Criteria|1
1039287|NCT01729754|2072141|FG008|Part 2|Other Protocol Specified Criteria|0
1039288|NCT01729754|2072142|FG009|Part 2|Other Protocol Specified Criteria|0
1039289|NCT01729754|2072133|FG000|Part 3|Adverse Event|0
1039290|NCT01729754|2072134|FG001|Part 3|Adverse Event|0
1039291|NCT01729754|2072135|FG002|Part 3|Adverse Event|1
1039292|NCT01729754|2072136|FG003|Part 3|Adverse Event|0
1039293|NCT01729754|2072137|FG004|Part 3|Adverse Event|0
1039294|NCT01729754|2072138|FG005|Part 3|Adverse Event|5
1039295|NCT01729754|2072139|FG006|Part 3|Adverse Event|0
1039296|NCT01729754|2072140|FG007|Part 3|Adverse Event|0
1039297|NCT01729754|2072141|FG008|Part 3|Adverse Event|0
1039298|NCT01729754|2072142|FG009|Part 3|Adverse Event|3
1039299|NCT01729754|2072133|FG000|Part 3|Death|0
1039300|NCT01729754|2072134|FG001|Part 3|Death|0
1039301|NCT01729754|2072135|FG002|Part 3|Death|0
1039302|NCT01729754|2072136|FG003|Part 3|Death|0
1039303|NCT01729754|2072137|FG004|Part 3|Death|0
1039304|NCT01729754|2072138|FG005|Part 3|Death|2
1039305|NCT01729754|2072139|FG006|Part 3|Death|0
1039306|NCT01729754|2072140|FG007|Part 3|Death|0
1039307|NCT01729754|2072141|FG008|Part 3|Death|0
1039308|NCT01729754|2072142|FG009|Part 3|Death|0
1039309|NCT01729754|2072133|FG000|Part 3|Lack of Efficacy|0
1039310|NCT01729754|2072134|FG001|Part 3|Lack of Efficacy|0
1039311|NCT01729754|2072135|FG002|Part 3|Lack of Efficacy|0
1039312|NCT01729754|2072136|FG003|Part 3|Lack of Efficacy|0
1039313|NCT01729754|2072137|FG004|Part 3|Lack of Efficacy|2
1039314|NCT01729754|2072138|FG005|Part 3|Lack of Efficacy|0
1039315|NCT01729754|2072139|FG006|Part 3|Lack of Efficacy|0
1039316|NCT01729754|2072140|FG007|Part 3|Lack of Efficacy|0
1039317|NCT01729754|2072141|FG008|Part 3|Lack of Efficacy|0
1039318|NCT01729754|2072142|FG009|Part 3|Lack of Efficacy|4
1039319|NCT01729754|2072133|FG000|Part 3|Lost to Follow-up|0
1039320|NCT01729754|2072134|FG001|Part 3|Lost to Follow-up|1
1039321|NCT01729754|2072135|FG002|Part 3|Lost to Follow-up|2
1039322|NCT01729754|2072136|FG003|Part 3|Lost to Follow-up|0
1039323|NCT01729754|2072137|FG004|Part 3|Lost to Follow-up|0
1039324|NCT01729754|2072138|FG005|Part 3|Lost to Follow-up|3
1039325|NCT01729754|2072139|FG006|Part 3|Lost to Follow-up|0
1039326|NCT01729754|2072140|FG007|Part 3|Lost to Follow-up|0
1039327|NCT01729754|2072141|FG008|Part 3|Lost to Follow-up|1
1039328|NCT01729754|2072142|FG009|Part 3|Lost to Follow-up|0
1039329|NCT01729754|2072133|FG000|Part 3|Physician Decision|0
1039330|NCT01729754|2072134|FG001|Part 3|Physician Decision|0
1039331|NCT01729754|2072135|FG002|Part 3|Physician Decision|1
1039332|NCT01729754|2072136|FG003|Part 3|Physician Decision|0
1039333|NCT01729754|2072137|FG004|Part 3|Physician Decision|0
1039334|NCT01729754|2072138|FG005|Part 3|Physician Decision|0
1039335|NCT01729754|2072139|FG006|Part 3|Physician Decision|0
1039336|NCT01729754|2072140|FG007|Part 3|Physician Decision|0
1039337|NCT01729754|2072141|FG008|Part 3|Physician Decision|0
1039338|NCT01729754|2072142|FG009|Part 3|Physician Decision|0
1039339|NCT01729754|2072133|FG000|Part 3|Withdrawal by Subject|0
1039340|NCT01729754|2072134|FG001|Part 3|Withdrawal by Subject|4
1039341|NCT01729754|2072135|FG002|Part 3|Withdrawal by Subject|1
1039342|NCT01729754|2072136|FG003|Part 3|Withdrawal by Subject|0
1039343|NCT01729754|2072137|FG004|Part 3|Withdrawal by Subject|2
1039344|NCT01729754|2072138|FG005|Part 3|Withdrawal by Subject|1
1039345|NCT01729754|2072139|FG006|Part 3|Withdrawal by Subject|0
1039346|NCT01729754|2072140|FG007|Part 3|Withdrawal by Subject|2
1039347|NCT01729754|2072141|FG008|Part 3|Withdrawal by Subject|0
1039348|NCT01729754|2072142|FG009|Part 3|Withdrawal by Subject|0
1039349|NCT01729754|2072133|FG000|Part 3|Other Protocol Specified Criteria|0
1039350|NCT01729754|2072134|FG001|Part 3|Other Protocol Specified Criteria|0
1039351|NCT01729754|2072135|FG002|Part 3|Other Protocol Specified Criteria|0
1039352|NCT01729754|2072136|FG003|Part 3|Other Protocol Specified Criteria|0
1039353|NCT01729754|2072137|FG004|Part 3|Other Protocol Specified Criteria|0
1039354|NCT01729754|2072138|FG005|Part 3|Other Protocol Specified Criteria|2
1039355|NCT01729754|2072139|FG006|Part 3|Other Protocol Specified Criteria|0
1039356|NCT01729754|2072140|FG007|Part 3|Other Protocol Specified Criteria|1
1039357|NCT01729754|2072141|FG008|Part 3|Other Protocol Specified Criteria|0
1039358|NCT01729754|2072142|FG009|Part 3|Other Protocol Specified Criteria|0
1039359|NCT01729819|2072174|FG000|Overall Study|Adverse Event|2
1039360|NCT01729819|2072175|FG001|Overall Study|Adverse Event|4
1039361|NCT01729819|2072174|FG000|Overall Study|Lack of Efficacy|1
1039362|NCT01729819|2072175|FG001|Overall Study|Lack of Efficacy|0
1039363|NCT01729819|2072174|FG000|Overall Study|Lost to Follow-up|2
1039364|NCT01729819|2072175|FG001|Overall Study|Lost to Follow-up|0
1039365|NCT01729819|2072174|FG000|Overall Study|Other reason|1
1039366|NCT01729819|2072175|FG001|Overall Study|Other reason|0
1039367|NCT01729819|2072174|FG000|Overall Study|Protocol Violation|0
1039368|NCT01729819|2072175|FG001|Overall Study|Protocol Violation|1
1039369|NCT01729819|2072174|FG000|Overall Study|Withdrawal by Subject|0
1039370|NCT01729819|2072175|FG001|Overall Study|Withdrawal by Subject|2
1039371|NCT01729871|2072201|FG000|Overall Study|Adverse Event|7
1039372|NCT01729871|2072202|FG001|Overall Study|Adverse Event|7
1039373|NCT01729871|2072201|FG000|Overall Study|Death|0
1039374|NCT01729871|2072202|FG001|Overall Study|Death|1
1039375|NCT01729871|2072201|FG000|Overall Study|Lack of Efficacy|0
1039376|NCT01729871|2072202|FG001|Overall Study|Lack of Efficacy|1
1039377|NCT01729871|2072201|FG000|Overall Study|Physician Decision|0
1039378|NCT01729871|2072202|FG001|Overall Study|Physician Decision|2
1039379|NCT01729871|2072201|FG000|Overall Study|Protocol Violation|1
1039380|NCT01729871|2072202|FG001|Overall Study|Protocol Violation|0
1039381|NCT01729871|2072201|FG000|Overall Study|Withdrawal by Subject|0
1039382|NCT01729871|2072202|FG001|Overall Study|Withdrawal by Subject|3
1039383|NCT01729871|2072201|FG000|Overall Study|Other|4
1039384|NCT01729871|2072202|FG001|Overall Study|Other|9
1039385|NCT01730040|2072219|FG000|Overall Study|Randomized but not treated|0
1039386|NCT01730040|2072220|FG001|Overall Study|Randomized but not treated|0
1039387|NCT01730040|2072221|FG002|Overall Study|Randomized but not treated|0
1039388|NCT01730040|2072222|FG003|Overall Study|Randomized but not treated|0
1039389|NCT01730040|2072223|FG004|Overall Study|Randomized but not treated|0
1039390|NCT01730040|2072224|FG005|Overall Study|Randomized but not treated|1
1039391|NCT01730040|2072225|FG006|Overall Study|Randomized but not treated|0
1039392|NCT01730040|2072219|FG000|Overall Study|Subject moved|0
1039393|NCT01730040|2072220|FG001|Overall Study|Subject moved|0
1039394|NCT01730040|2072221|FG002|Overall Study|Subject moved|1
1039395|NCT01730040|2072222|FG003|Overall Study|Subject moved|0
1039396|NCT01730040|2072223|FG004|Overall Study|Subject moved|0
1039397|NCT01730040|2072224|FG005|Overall Study|Subject moved|0
1039398|NCT01730040|2072225|FG006|Overall Study|Subject moved|1
1039399|NCT01730040|2072219|FG000|Overall Study|Physician Decision|0
1039400|NCT01730040|2072220|FG001|Overall Study|Physician Decision|0
1039401|NCT01730040|2072221|FG002|Overall Study|Physician Decision|0
1039402|NCT01730040|2072222|FG003|Overall Study|Physician Decision|0
1039403|NCT01730040|2072223|FG004|Overall Study|Physician Decision|0
1039404|NCT01730040|2072224|FG005|Overall Study|Physician Decision|1
1039405|NCT01730040|2072225|FG006|Overall Study|Physician Decision|1
1039406|NCT01730040|2072219|FG000|Overall Study|Other than specified|7
1039407|NCT01730040|2072220|FG001|Overall Study|Other than specified|8
1039408|NCT01730040|2072221|FG002|Overall Study|Other than specified|5
1039409|NCT01730040|2072222|FG003|Overall Study|Other than specified|5
1039410|NCT01730040|2072223|FG004|Overall Study|Other than specified|5
1039411|NCT01730040|2072224|FG005|Overall Study|Other than specified|4
1039412|NCT01730040|2072225|FG006|Overall Study|Other than specified|4
1039413|NCT01730040|2072219|FG000|Overall Study|Adverse Event|4
1039414|NCT01730040|2072220|FG001|Overall Study|Adverse Event|3
1039415|NCT01730040|2072221|FG002|Overall Study|Adverse Event|5
1039416|NCT01730040|2072222|FG003|Overall Study|Adverse Event|3
1039417|NCT01730040|2072223|FG004|Overall Study|Adverse Event|1
1039418|NCT01730040|2072224|FG005|Overall Study|Adverse Event|1
1039419|NCT01730040|2072225|FG006|Overall Study|Adverse Event|2
1039420|NCT01730040|2072219|FG000|Overall Study|Poor compliance to protocol|2
1039421|NCT01730040|2072220|FG001|Overall Study|Poor compliance to protocol|4
1039422|NCT01730040|2072221|FG002|Overall Study|Poor compliance to protocol|0
1039423|NCT01730040|2072222|FG003|Overall Study|Poor compliance to protocol|0
1039424|NCT01730040|2072223|FG004|Overall Study|Poor compliance to protocol|0
1039425|NCT01730040|2072224|FG005|Overall Study|Poor compliance to protocol|0
1039426|NCT01730040|2072225|FG006|Overall Study|Poor compliance to protocol|1
1039427|NCT01730053|2072247|FG000|Overall Study|Participant moved|0
1039428|NCT01730053|2072248|FG001|Overall Study|Participant moved|0
1039429|NCT01730053|2072249|FG002|Overall Study|Participant moved|1
1039430|NCT01730053|2072250|FG003|Overall Study|Participant moved|0
1039431|NCT01730053|2072251|FG004|Overall Study|Participant moved|0
1039432|NCT01730053|2072252|FG005|Overall Study|Participant moved|0
1039433|NCT01730053|2072247|FG000|Overall Study|Physician Decision|0
1039434|NCT01730053|2072248|FG001|Overall Study|Physician Decision|0
1039435|NCT01730053|2072249|FG002|Overall Study|Physician Decision|0
1039436|NCT01730053|2072250|FG003|Overall Study|Physician Decision|1
1039437|NCT01730053|2072251|FG004|Overall Study|Physician Decision|0
1039438|NCT01730053|2072252|FG005|Overall Study|Physician Decision|0
1039439|NCT01730053|2072247|FG000|Overall Study|Adverse Event|2
1039440|NCT01730053|2072248|FG001|Overall Study|Adverse Event|6
1039441|NCT01730053|2072249|FG002|Overall Study|Adverse Event|3
1039442|NCT01730053|2072250|FG003|Overall Study|Adverse Event|3
1039443|NCT01730053|2072251|FG004|Overall Study|Adverse Event|2
1039444|NCT01730053|2072252|FG005|Overall Study|Adverse Event|2
1039445|NCT01730053|2072247|FG000|Overall Study|Poor compliance to protocol|1
1039446|NCT01730053|2072248|FG001|Overall Study|Poor compliance to protocol|2
1039447|NCT01730053|2072249|FG002|Overall Study|Poor compliance to protocol|2
1039448|NCT01730053|2072250|FG003|Overall Study|Poor compliance to protocol|0
1039449|NCT01730053|2072251|FG004|Overall Study|Poor compliance to protocol|0
1039450|NCT01730053|2072252|FG005|Overall Study|Poor compliance to protocol|2
1039451|NCT01730053|2072247|FG000|Overall Study|Other than specified|2
1039452|NCT01730053|2072248|FG001|Overall Study|Other than specified|6
1039453|NCT01730053|2072249|FG002|Overall Study|Other than specified|5
1039454|NCT01730053|2072250|FG003|Overall Study|Other than specified|4
1039455|NCT01730053|2072251|FG004|Overall Study|Other than specified|7
1039456|NCT01730053|2072252|FG005|Overall Study|Other than specified|9
1039457|NCT01730339|2072269|FG000|Overall Study|Withdrawal by Subject|3
1039458|NCT01730339|2072270|FG001|Overall Study|Withdrawal by Subject|2
1039459|NCT01730339|2072269|FG000|Overall Study|Lost to Follow-up|1
1039460|NCT01730339|2072270|FG001|Overall Study|Lost to Follow-up|1
1039461|NCT01730339|2072269|FG000|Overall Study|Un-specified|1
1039462|NCT01730339|2072270|FG001|Overall Study|Un-specified|0
1039463|NCT01730378|2072288|FG000|Overall Study|Lost to Follow-up|1
1039464|NCT01730378|2072289|FG001|Overall Study|Lost to Follow-up|0
1039465|NCT01730534|2072298|FG000|Overall Study|Withdrawal by Subject|97
1039466|NCT01730534|2072299|FG001|Overall Study|Withdrawal by Subject|127
1039467|NCT01730534|2072298|FG000|Overall Study|Lost to Follow-up|12
1039468|NCT01730534|2072299|FG001|Overall Study|Lost to Follow-up|18
1039469|NCT01730586|2072305|FG000|Overall Study|Progressive Disease|2
1039470|NCT01730586|2072305|FG000|Overall Study|Inadequate Trial|8
1039471|NCT01730586|2072305|FG000|Overall Study|Adverse Event|2
1039472|NCT01730586|2072305|FG000|Overall Study|Hospice|1
1039473|NCT01730729|2072311|FG000|Overall Study|Adverse Event|1
1039474|NCT01730729|2072311|FG000|Overall Study|Death|1
1039475|NCT01730729|2072311|FG000|Overall Study|Progressive Disease|12
1039476|NCT01730950|2072342|FG000|Overall Study|Protocol Violation|6
1039477|NCT01730950|2072343|FG001|Overall Study|Protocol Violation|6
1039478|NCT01731002|2072353|FG000|Overall Study|Adverse Event|0
1039479|NCT01731002|2072354|FG001|Overall Study|Adverse Event|2
1039480|NCT01731002|2072355|FG002|Overall Study|Adverse Event|2
1039481|NCT01731002|2072353|FG000|Overall Study|Non-Compliant|0
1039482|NCT01731002|2072354|FG001|Overall Study|Non-Compliant|1
1039483|NCT01731002|2072355|FG002|Overall Study|Non-Compliant|0
1039484|NCT01731002|2072353|FG000|Overall Study|Lost to Follow-up|1
1039485|NCT01731002|2072354|FG001|Overall Study|Lost to Follow-up|0
1039486|NCT01731002|2072355|FG002|Overall Study|Lost to Follow-up|0
1039487|NCT01731002|2072353|FG000|Overall Study|Test Agent Discontinuation|0
1039488|NCT01731002|2072354|FG001|Overall Study|Test Agent Discontinuation|1
1039489|NCT01731002|2072355|FG002|Overall Study|Test Agent Discontinuation|0
1039490|NCT01731002|2072353|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
1039491|NCT01731002|2072354|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
1039492|NCT01731002|2072355|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
1039493|NCT01731002|2072353|FG000|Overall Study|Elevated IOP|1
1039494|NCT01731002|2072354|FG001|Overall Study|Elevated IOP|0
1039495|NCT01731002|2072355|FG002|Overall Study|Elevated IOP|0
1039496|NCT01731002|2072353|FG000|Overall Study|Inappropriate use of study medications|0
1039497|NCT01731002|2072354|FG001|Overall Study|Inappropriate use of study medications|0
1039498|NCT01731002|2072355|FG002|Overall Study|Inappropriate use of study medications|1
1039499|NCT01731171|2072378|FG000|Overall Study|Withdrawal by Subject|4
1039500|NCT01731171|2072379|FG001|Overall Study|Withdrawal by Subject|1
1039501|NCT01731171|2072378|FG000|Overall Study|Lost to Follow-up|3
1039502|NCT01731171|2072379|FG001|Overall Study|Lost to Follow-up|2
1039503|NCT01731171|2072378|FG000|Overall Study|Moved out of Area|0
1039504|NCT01731171|2072379|FG001|Overall Study|Moved out of Area|2
1039505|NCT01731171|2072378|FG000|Overall Study|Terminated for Lack of Adherence|0
1039506|NCT01731171|2072379|FG001|Overall Study|Terminated for Lack of Adherence|1
1039507|NCT01731171|2072378|FG000|Overall Study|Terminated for Safety Reasons|0
1039508|NCT01731171|2072379|FG001|Overall Study|Terminated for Safety Reasons|1
1039509|NCT01731470|2072385|FG000|Overall Study|Withdrawal by Subject|1
1039510|NCT01731470|2072385|FG000|Overall Study|Did not meet study criteria|1
1039511|NCT01731600|2072391|FG000|Overall Study|Adverse Event|2
1039512|NCT01731600|2072392|FG001|Overall Study|Adverse Event|0
1039513|NCT01731600|2072391|FG000|Overall Study|Withdrawal criteria|1
1039514|NCT01731600|2072392|FG001|Overall Study|Withdrawal criteria|0
1039515|NCT01731600|2072391|FG000|Overall Study|Other reasons|3
1039516|NCT01731600|2072392|FG001|Overall Study|Other reasons|0
1039517|NCT01731678|2072402|FG000|Overall Study|Withdrawal by Subject|3
1039518|NCT01731678|2072402|FG000|Overall Study|Did not meet inclusion criteria|1
1039519|NCT01731678|2072402|FG000|Overall Study|RMT too high, making TMS difficult|3
1039520|NCT01731886|2072424|FG000|Overall Study|Death|1
1039521|NCT01731886|2072425|FG001|Overall Study|Death|0
1039522|NCT01731886|2072424|FG000|Overall Study|Never started treatment|0
1039523|NCT01731886|2072425|FG001|Overall Study|Never started treatment|1
1039524|NCT01731886|2072424|FG000|Overall Study|Non-compliant|1
1039525|NCT01731886|2072425|FG001|Overall Study|Non-compliant|0
1039526|NCT01731912|2072432|FG000|Overall Study|noncompliance|2
1039527|NCT01731938|2072440|FG000|Preliminary Part I|Withdrawal by Subject|2
1039528|NCT01731938|2072441|FG001|Preliminary Part I|Withdrawal by Subject|2
1039529|NCT01731938|2072440|FG000|Preliminary Part I|Physician Decision|1
1039530|NCT01731938|2072441|FG001|Preliminary Part I|Physician Decision|0
1039531|NCT01731938|2072440|FG000|Preliminary Part I|Lost to Follow-up|0
1039532|NCT01731938|2072441|FG001|Preliminary Part I|Lost to Follow-up|3
1039533|NCT01731938|2072440|FG000|Preliminary Part I|Missed Week 6 visit|0
1039534|NCT01731938|2072441|FG001|Preliminary Part I|Missed Week 6 visit|3
1039535|NCT01731938|2072440|FG000|Primary Part II|Withdrawal by Subject|5
1039536|NCT01731938|2072441|FG001|Primary Part II|Withdrawal by Subject|4
1039537|NCT01731938|2072440|FG000|Primary Part II|Lost to Follow-up|4
1039538|NCT01731938|2072441|FG001|Primary Part II|Lost to Follow-up|5
1039539|NCT01731938|2072440|FG000|Primary Part II|Death|2
1039540|NCT01731938|2072441|FG001|Primary Part II|Death|1
1039541|NCT01731938|2072440|FG000|Primary Part II|Missed Week 6 visit|2
1039542|NCT01731938|2072441|FG001|Primary Part II|Missed Week 6 visit|3
1039543|NCT01731951|2072454|FG000|Overall Study|Documented Disease Progression|1
1039544|NCT01731951|2072455|FG001|Overall Study|Documented Disease Progression|0
1039545|NCT01731951|2072456|FG002|Overall Study|Documented Disease Progression|0
1039546|NCT01731951|2072457|FG003|Overall Study|Documented Disease Progression|0
1039547|NCT01731951|2072458|FG004|Overall Study|Documented Disease Progression|0
1039548|NCT01731951|2072459|FG005|Overall Study|Documented Disease Progression|0
1039549|NCT01731951|2072454|FG000|Overall Study|Lost to Follow-up|2
1039550|NCT01731951|2072455|FG001|Overall Study|Lost to Follow-up|0
1039551|NCT01731951|2072456|FG002|Overall Study|Lost to Follow-up|0
1039552|NCT01731951|2072457|FG003|Overall Study|Lost to Follow-up|1
1039553|NCT01731951|2072458|FG004|Overall Study|Lost to Follow-up|3
1039554|NCT01731951|2072459|FG005|Overall Study|Lost to Follow-up|1
1039555|NCT01731951|2072454|FG000|Overall Study|Withdrawal of Consent|1
1039556|NCT01731951|2072455|FG001|Overall Study|Withdrawal of Consent|0
1039557|NCT01731951|2072456|FG002|Overall Study|Withdrawal of Consent|0
1039558|NCT01731951|2072457|FG003|Overall Study|Withdrawal of Consent|0
1039559|NCT01731951|2072458|FG004|Overall Study|Withdrawal of Consent|0
1039560|NCT01731951|2072459|FG005|Overall Study|Withdrawal of Consent|2
1039561|NCT01731951|2072454|FG000|Overall Study|Death|13
1039562|NCT01731951|2072455|FG001|Overall Study|Death|15
1039563|NCT01731951|2072456|FG002|Overall Study|Death|9
1039564|NCT01731951|2072457|FG003|Overall Study|Death|8
1039565|NCT01731951|2072458|FG004|Overall Study|Death|9
1039566|NCT01731951|2072459|FG005|Overall Study|Death|6
1039567|NCT01731990|2072479|FG000|Overall Study|Adverse Event|1
1039568|NCT01731990|2072480|FG001|Overall Study|Adverse Event|5
1039569|NCT01731990|2072479|FG000|Overall Study|Withdrawal by Subject|1
1039570|NCT01731990|2072480|FG001|Overall Study|Withdrawal by Subject|1
1039571|NCT01731990|2072479|FG000|Overall Study|Protocol deviation|1
1039572|NCT01731990|2072480|FG001|Overall Study|Protocol deviation|2
1039573|NCT01731990|2072479|FG000|Overall Study|Death|1
1039574|NCT01731990|2072480|FG001|Overall Study|Death|0
1039575|NCT01732107|2072486|FG000|Overall Study|Adverse Event|2
1039576|NCT01732107|2072486|FG000|Overall Study|Disease Progression|8
1039577|NCT01732107|2072486|FG000|Overall Study|Physician Decision|1
1039578|NCT01732107|2072486|FG000|Overall Study|Withdrawal by Subject|2
1039579|NCT01732458|2072537|FG000|Overall Study|Lost to Follow-up|0
1039580|NCT01732458|2072538|FG001|Overall Study|Lost to Follow-up|2
1039581|NCT01732458|2072539|FG002|Overall Study|Lost to Follow-up|0
1039582|NCT01732458|2072540|FG003|Overall Study|Lost to Follow-up|0
1039583|NCT01732458|2072537|FG000|Overall Study|Non-Compliance With Study Drug|0
1039584|NCT01732458|2072538|FG001|Overall Study|Non-Compliance With Study Drug|0
1039585|NCT01732458|2072539|FG002|Overall Study|Non-Compliance With Study Drug|1
1039586|NCT01732458|2072540|FG003|Overall Study|Non-Compliance With Study Drug|0
1039587|NCT01732458|2072537|FG000|Overall Study|Physician Decision|1
1039588|NCT01732458|2072538|FG001|Overall Study|Physician Decision|2
1039589|NCT01732458|2072539|FG002|Overall Study|Physician Decision|2
1039590|NCT01732458|2072540|FG003|Overall Study|Physician Decision|0
1039591|NCT01732458|2072537|FG000|Overall Study|Protocol Violation|2
1039592|NCT01732458|2072538|FG001|Overall Study|Protocol Violation|0
1039593|NCT01732458|2072539|FG002|Overall Study|Protocol Violation|0
1039594|NCT01732458|2072540|FG003|Overall Study|Protocol Violation|2
1039595|NCT01732458|2072537|FG000|Overall Study|Screen Failure|0
1039596|NCT01732458|2072538|FG001|Overall Study|Screen Failure|1
1039597|NCT01732458|2072539|FG002|Overall Study|Screen Failure|0
1039598|NCT01732458|2072540|FG003|Overall Study|Screen Failure|0
1039599|NCT01732471|2072562|FG000|Overall Study|Withdrawal by Subject|1
1039600|NCT01732484|2072566|FG000|Overall Study|Death|7
1039601|NCT01732484|2072566|FG000|Overall Study|Lost to Follow-up|14
1039602|NCT01732484|2072566|FG000|Overall Study|chronical illness|5
1039603|NCT01732510|2072579|FG000|Overall Study|Adverse Event|0
1039604|NCT01732510|2072580|FG001|Overall Study|Adverse Event|1
1039605|NCT01732510|2072581|FG002|Overall Study|Adverse Event|1
1039606|NCT01732510|2072582|FG003|Overall Study|Adverse Event|0
1039607|NCT01732510|2072583|FG004|Overall Study|Adverse Event|0
1039608|NCT01732510|2072584|FG005|Overall Study|Adverse Event|0
1039609|NCT01732510|2072585|FG006|Overall Study|Adverse Event|1
1039610|NCT01732510|2072579|FG000|Overall Study|Protocol Violation|0
1039611|NCT01732510|2072580|FG001|Overall Study|Protocol Violation|0
1039612|NCT01732510|2072581|FG002|Overall Study|Protocol Violation|0
1039613|NCT01732510|2072582|FG003|Overall Study|Protocol Violation|1
1039614|NCT01732510|2072583|FG004|Overall Study|Protocol Violation|0
1039615|NCT01732510|2072584|FG005|Overall Study|Protocol Violation|0
1039616|NCT01732510|2072585|FG006|Overall Study|Protocol Violation|0
1039617|NCT01732510|2072579|FG000|Overall Study|Withdrawal by Subject|1
1039618|NCT01732510|2072580|FG001|Overall Study|Withdrawal by Subject|3
1039619|NCT01732510|2072581|FG002|Overall Study|Withdrawal by Subject|2
1039620|NCT01732510|2072582|FG003|Overall Study|Withdrawal by Subject|1
1039621|NCT01732510|2072583|FG004|Overall Study|Withdrawal by Subject|5
1039622|NCT01732510|2072584|FG005|Overall Study|Withdrawal by Subject|0
1039623|NCT01732510|2072585|FG006|Overall Study|Withdrawal by Subject|1
1039624|NCT01732510|2072579|FG000|Overall Study|Lost to Follow-up|0
1039625|NCT01732510|2072580|FG001|Overall Study|Lost to Follow-up|0
1039626|NCT01732510|2072581|FG002|Overall Study|Lost to Follow-up|1
1039627|NCT01732510|2072582|FG003|Overall Study|Lost to Follow-up|1
1039628|NCT01732510|2072583|FG004|Overall Study|Lost to Follow-up|0
1039629|NCT01732510|2072584|FG005|Overall Study|Lost to Follow-up|1
1039630|NCT01732510|2072585|FG006|Overall Study|Lost to Follow-up|0
1039631|NCT01732510|2072579|FG000|Overall Study|Physician Decision|0
1039632|NCT01732510|2072580|FG001|Overall Study|Physician Decision|1
1039633|NCT01732510|2072581|FG002|Overall Study|Physician Decision|0
1039634|NCT01732510|2072582|FG003|Overall Study|Physician Decision|0
1039635|NCT01732510|2072583|FG004|Overall Study|Physician Decision|0
1039636|NCT01732510|2072584|FG005|Overall Study|Physician Decision|0
1039637|NCT01732510|2072585|FG006|Overall Study|Physician Decision|0
1039638|NCT01732510|2072579|FG000|Overall Study|Pregnancy|0
1039639|NCT01732510|2072580|FG001|Overall Study|Pregnancy|0
1039640|NCT01732510|2072581|FG002|Overall Study|Pregnancy|0
1039641|NCT01732510|2072582|FG003|Overall Study|Pregnancy|1
1039642|NCT01732510|2072583|FG004|Overall Study|Pregnancy|0
1039643|NCT01732510|2072584|FG005|Overall Study|Pregnancy|0
1039644|NCT01732510|2072585|FG006|Overall Study|Pregnancy|0
1039645|NCT01732510|2072579|FG000|Overall Study|Study Terminated By Sponsor|0
1039646|NCT01732510|2072580|FG001|Overall Study|Study Terminated By Sponsor|0
1039647|NCT01732510|2072581|FG002|Overall Study|Study Terminated By Sponsor|0
1039648|NCT01732510|2072582|FG003|Overall Study|Study Terminated By Sponsor|1
1039649|NCT01732510|2072583|FG004|Overall Study|Study Terminated By Sponsor|0
1039650|NCT01732510|2072584|FG005|Overall Study|Study Terminated By Sponsor|12
1039651|NCT01732510|2072585|FG006|Overall Study|Study Terminated By Sponsor|6
1039652|NCT01732536|2072606|FG000|Overall Study|Withdrawal by Subject|1
1039653|NCT01732536|2072607|FG001|Overall Study|Withdrawal by Subject|1
1039654|NCT01732549|2072618|FG000|Overall Study|Adverse Event|13
1039655|NCT01732549|2072619|FG001|Overall Study|Adverse Event|3
1039656|NCT01732549|2072618|FG000|Overall Study|Consent withdrawn|13
1039657|NCT01732549|2072619|FG001|Overall Study|Consent withdrawn|6
1039658|NCT01732549|2072618|FG000|Overall Study|Disease progression|37
1039659|NCT01732549|2072619|FG001|Overall Study|Disease progression|50
1039660|NCT01732549|2072618|FG000|Overall Study|Other|8
1039661|NCT01732549|2072619|FG001|Overall Study|Other|14
1039662|NCT01732588|2072629|FG000|First Intervention (7 Days)|Adverse Event|0
1039663|NCT01732588|2072630|FG001|First Intervention (7 Days)|Adverse Event|1
1039664|NCT01732588|2072631|FG002|First Intervention (7 Days)|Adverse Event|0
1039665|NCT01732627|2072641|FG000|Overall Study|Withdrawal by Subject|1
1039666|NCT01732627|2072642|FG001|Overall Study|Withdrawal by Subject|0
1039667|NCT01732640|2072648|FG000|Overall Study|Adverse Event|0
1039668|NCT01732640|2072649|FG001|Overall Study|Adverse Event|1
1039669|NCT01732640|2072648|FG000|Overall Study|Death|0
1039670|NCT01732640|2072649|FG001|Overall Study|Death|1
1039671|NCT01732692|2072661|FG000|Overall Study|Adverse Event|0
1039672|NCT01732692|2072662|FG001|Overall Study|Adverse Event|1
1039673|NCT01732757|2072684|FG000|Overall Study|Lost to Follow-up|1
1039674|NCT01732757|2072685|FG001|Overall Study|Lost to Follow-up|0
1039675|NCT01732757|2072686|FG002|Overall Study|Lost to Follow-up|0
1039676|NCT01732770|2072696|FG000|Overall Study|Lost to Follow-up|2
1039677|NCT01732770|2072697|FG001|Overall Study|Lost to Follow-up|3
1039678|NCT01732770|2072696|FG000|Overall Study|Withdrawal by Subject|5
1039679|NCT01732770|2072697|FG001|Overall Study|Withdrawal by Subject|3
1039680|NCT01732770|2072696|FG000|Overall Study|Decision by Sponsor|2
1039681|NCT01732770|2072697|FG001|Overall Study|Decision by Sponsor|2
1039682|NCT01732770|2072696|FG000|Overall Study|Death|1
1039683|NCT01732770|2072697|FG001|Overall Study|Death|0
1039684|NCT01732783|2072706|FG000|Overall Study|Discontinued Panitumumab Treatment|106
1039685|NCT01732783|2072707|FG001|Overall Study|Discontinued Panitumumab Treatment|25
1039686|NCT01732783|2072708|FG002|Overall Study|Discontinued Panitumumab Treatment|7
1039687|NCT01732783|2072706|FG000|Overall Study|Death|13
1039688|NCT01732783|2072707|FG001|Overall Study|Death|4
1039689|NCT01732783|2072708|FG002|Overall Study|Death|1
1039690|NCT01732783|2072706|FG000|Overall Study|Lost to Follow-up|7
1039691|NCT01732783|2072707|FG001|Overall Study|Lost to Follow-up|1
1039692|NCT01732783|2072708|FG002|Overall Study|Lost to Follow-up|1
1039693|NCT01732783|2072706|FG000|Overall Study|Administrative Decision|8
1039694|NCT01732783|2072707|FG001|Overall Study|Administrative Decision|2
1039695|NCT01732783|2072708|FG002|Overall Study|Administrative Decision|1
1039696|NCT01732783|2072706|FG000|Overall Study|Withdrawal by Subject|1
1039697|NCT01732783|2072707|FG001|Overall Study|Withdrawal by Subject|0
1039698|NCT01732783|2072708|FG002|Overall Study|Withdrawal by Subject|0
1039699|NCT01732796|2072719|FG000|Overall Study|Adverse Event|16
1039700|NCT01732796|2072720|FG001|Overall Study|Adverse Event|16
1039701|NCT01732796|2072721|FG002|Overall Study|Adverse Event|4
1039702|NCT01732796|2072719|FG000|Overall Study|Lack of Efficacy|21
1039703|NCT01732796|2072720|FG001|Overall Study|Lack of Efficacy|18
1039704|NCT01732796|2072721|FG002|Overall Study|Lack of Efficacy|5
1039705|NCT01732796|2072719|FG000|Overall Study|Lost to Follow-up|2
1039706|NCT01732796|2072720|FG001|Overall Study|Lost to Follow-up|0
1039707|NCT01732796|2072721|FG002|Overall Study|Lost to Follow-up|0
1039708|NCT01732796|2072719|FG000|Overall Study|Withdrawal by Subject|6
1039709|NCT01732796|2072720|FG001|Overall Study|Withdrawal by Subject|8
1039710|NCT01732796|2072721|FG002|Overall Study|Withdrawal by Subject|2
1039711|NCT01732796|2072719|FG000|Overall Study|Other reason not defined above|1
1039712|NCT01732796|2072720|FG001|Overall Study|Other reason not defined above|0
1039713|NCT01732796|2072721|FG002|Overall Study|Other reason not defined above|2
1039714|NCT01732822|2072742|FG000|Overall Study|Withdrawal by Subject|123
1039715|NCT01732822|2072743|FG001|Overall Study|Withdrawal by Subject|113
1039716|NCT01732835|2072771|FG000|6-month Primary Endpoint|Did not receive device|19
1039717|NCT01732835|2072771|FG000|6-month Primary Endpoint|Withdrawal by Subject|2
1039718|NCT01732835|2072771|FG000|6-month Primary Endpoint|Adverse Event|3
1039719|NCT01732835|2072771|FG000|2-year Extended Follow-up|Withdrawal by Subject|1
1039720|NCT01732835|2072771|FG000|2-year Extended Follow-up|Adverse Event|3
1039721|NCT01732835|2072771|FG000|2-year Extended Follow-up|Death|1
1039722|NCT01732874|2072777|FG000|Overall Study|Withdrawal by Subject|5
1039723|NCT01732874|2072778|FG001|Overall Study|Withdrawal by Subject|1
1039724|NCT01732874|2072777|FG000|Overall Study|Death of Infant|3
1039725|NCT01732874|2072778|FG001|Overall Study|Death of Infant|2
1039726|NCT01733121|2072811|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2
1039727|NCT01733121|2072812|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
1039728|NCT01733121|2072811|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3
1039729|NCT01733121|2072812|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
1039730|NCT01733121|2072811|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
1039731|NCT01733121|2072812|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
1039732|NCT01733121|2072811|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1039733|NCT01733121|2072812|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
1039734|NCT01733316|2072851|FG000|RP103 Phase|Non-compliance|1
1039735|NCT01733316|2072851|FG000|Long Term Extension Phase|Adverse Event|1
1039736|NCT01733316|2072851|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2
1039737|NCT01733316|2072851|FG000|Long Term Extension Phase|Sponsor Decision|2
1039738|NCT01733329|2072864|FG000|Overall Study|Protocol Violation|1
1039739|NCT01733329|2072865|FG001|Overall Study|Protocol Violation|1
1039740|NCT01733329|2072864|FG000|Overall Study|Uterine artery injury|1
1039741|NCT01733329|2072865|FG001|Overall Study|Uterine artery injury|0
1039742|NCT01733680|2072902|FG000|Overall Study|Withdrawal by Subject|0
1039743|NCT01733680|2072903|FG001|Overall Study|Withdrawal by Subject|1
1039744|NCT01733732|2072915|FG000|Overall Study|Adverse Event|1
1039745|NCT01733732|2072916|FG001|Overall Study|Adverse Event|0
1039746|NCT01733732|2072915|FG000|Overall Study|Did not attend all study visits|1
1039747|NCT01733732|2072916|FG001|Overall Study|Did not attend all study visits|0
1039748|NCT01733758|2072945|FG000|Overall Study|Adverse Event|5
1039749|NCT01733758|2072946|FG001|Overall Study|Adverse Event|7
1039750|NCT01733758|2072947|FG002|Overall Study|Adverse Event|8
1039751|NCT01733758|2072948|FG003|Overall Study|Adverse Event|1
1039752|NCT01733758|2072945|FG000|Overall Study|Withdrawal by Subject|1
1039753|NCT01733758|2072946|FG001|Overall Study|Withdrawal by Subject|1
1039754|NCT01733758|2072947|FG002|Overall Study|Withdrawal by Subject|5
1039755|NCT01733758|2072948|FG003|Overall Study|Withdrawal by Subject|3
1039756|NCT01733758|2072945|FG000|Overall Study|Persistent Hyperglycemia|3
1039757|NCT01733758|2072946|FG001|Overall Study|Persistent Hyperglycemia|2
1039758|NCT01733758|2072947|FG002|Overall Study|Persistent Hyperglycemia|0
1039759|NCT01733758|2072948|FG003|Overall Study|Persistent Hyperglycemia|0
1039760|NCT01733758|2072945|FG000|Overall Study|Protocol Violation|0
1039761|NCT01733758|2072946|FG001|Overall Study|Protocol Violation|1
1039762|NCT01733758|2072947|FG002|Overall Study|Protocol Violation|2
1039763|NCT01733758|2072948|FG003|Overall Study|Protocol Violation|2
1039764|NCT01733758|2072945|FG000|Overall Study|Non-compliance|1
1039765|NCT01733758|2072946|FG001|Overall Study|Non-compliance|0
1039766|NCT01733758|2072947|FG002|Overall Study|Non-compliance|0
1039767|NCT01733758|2072948|FG003|Overall Study|Non-compliance|0
1039768|NCT01733758|2072945|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4
1039769|NCT01733758|2072946|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0
1039770|NCT01733758|2072947|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0
1039771|NCT01733758|2072948|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1
1039772|NCT01733758|2072945|FG000|Overall Study|Inv Decision, HbA1c not controlled|1
1039773|NCT01733758|2072946|FG001|Overall Study|Inv Decision, HbA1c not controlled|1
1039774|NCT01733758|2072947|FG002|Overall Study|Inv Decision, HbA1c not controlled|0
1039775|NCT01733758|2072948|FG003|Overall Study|Inv Decision, HbA1c not controlled|1
1039776|NCT01734382|2072994|FG000|Part 1|Adverse Event|2
1039777|NCT01734382|2072995|FG001|Part 1|Adverse Event|0
1039778|NCT01734382|2072996|FG002|Part 1|Adverse Event|0
1039779|NCT01734382|2072994|FG000|Part 2|Adverse Event|0
1039780|NCT01734382|2072995|FG001|Part 2|Adverse Event|0
1039781|NCT01734382|2072996|FG002|Part 2|Adverse Event|1
1039782|NCT01734382|2072994|FG000|Part 2|Lack of Efficacy|0
1039783|NCT01734382|2072995|FG001|Part 2|Lack of Efficacy|1
1039784|NCT01734382|2072996|FG002|Part 2|Lack of Efficacy|1
1039785|NCT01734382|2072994|FG000|Part 2|Other|0
1039786|NCT01734382|2072995|FG001|Part 2|Other|0
1039787|NCT01734382|2072996|FG002|Part 2|Other|1
1039788|NCT01734382|2072994|FG000|Part 2|Physician Decision|0
1039789|NCT01734382|2072995|FG001|Part 2|Physician Decision|0
1039790|NCT01734382|2072996|FG002|Part 2|Physician Decision|3
1039791|NCT01734382|2072994|FG000|Part 2|Protocol Violation|0
1039792|NCT01734382|2072995|FG001|Part 2|Protocol Violation|1
1039793|NCT01734382|2072996|FG002|Part 2|Protocol Violation|0
1039794|NCT01734382|2072994|FG000|Part 2|Withdrawal by Subject|0
1039795|NCT01734382|2072995|FG001|Part 2|Withdrawal by Subject|0
1039796|NCT01734382|2072996|FG002|Part 2|Withdrawal by Subject|1
1039797|NCT01734395|2073008|FG000|Overall Study|Other|65
1039798|NCT01734395|2073008|FG000|Overall Study|Lost to Follow-up|287
1039799|NCT01734395|2073008|FG000|Overall Study|Lack of Efficacy|5
1039800|NCT01734395|2073008|FG000|Overall Study|Adverse Event|40
1039801|NCT01734395|2073008|FG000|Overall Study|Withdrawal by Subject|10
1039802|NCT01734395|2073008|FG000|Overall Study|Missing the reasons for not completed|3
1039803|NCT01734434|2073016|FG000|Overall Study|Death Infant|3
1039804|NCT01734434|2073017|FG001|Overall Study|Death Infant|1
1039805|NCT01734434|2073018|FG002|Overall Study|Death Infant|17
1039806|NCT01734434|2073019|FG003|Overall Study|Death Infant|5
1039807|NCT01734434|2073016|FG000|Overall Study|Lost to Follow-up|2
1039808|NCT01734434|2073017|FG001|Overall Study|Lost to Follow-up|9
1039809|NCT01734434|2073018|FG002|Overall Study|Lost to Follow-up|67
1039810|NCT01734434|2073019|FG003|Overall Study|Lost to Follow-up|11
1039811|NCT01734434|2073016|FG000|Overall Study|No Live Birth|1
1039812|NCT01734434|2073017|FG001|Overall Study|No Live Birth|2
1039813|NCT01734434|2073018|FG002|Overall Study|No Live Birth|32
1039814|NCT01734434|2073019|FG003|Overall Study|No Live Birth|6
1039815|NCT01734434|2073016|FG000|Overall Study|Withdrawal by Subject|4
1039816|NCT01734434|2073017|FG001|Overall Study|Withdrawal by Subject|0
1039817|NCT01734434|2073018|FG002|Overall Study|Withdrawal by Subject|8
1039818|NCT01734434|2073019|FG003|Overall Study|Withdrawal by Subject|1
1039819|NCT01734434|2073016|FG000|Overall Study|Signed Adult Version of Consent Form|0
1039820|NCT01734434|2073017|FG001|Overall Study|Signed Adult Version of Consent Form|0
1039821|NCT01734434|2073018|FG002|Overall Study|Signed Adult Version of Consent Form|1
1039822|NCT01734434|2073019|FG003|Overall Study|Signed Adult Version of Consent Form|0
1039823|NCT01734434|2073016|FG000|Overall Study|Subject Not Reachable|0
1039824|NCT01734434|2073017|FG001|Overall Study|Subject Not Reachable|0
1039825|NCT01734434|2073018|FG002|Overall Study|Subject Not Reachable|1
1039826|NCT01734434|2073019|FG003|Overall Study|Subject Not Reachable|0
1039827|NCT01734434|2073016|FG000|Overall Study|Treatment Defaulter|0
1039828|NCT01734434|2073017|FG001|Overall Study|Treatment Defaulter|0
1039829|NCT01734434|2073018|FG002|Overall Study|Treatment Defaulter|1
1039830|NCT01734434|2073019|FG003|Overall Study|Treatment Defaulter|0
1039831|NCT01734434|2073016|FG000|Overall Study|Wrong Version of Consent Form Signed|0
1039832|NCT01734434|2073017|FG001|Overall Study|Wrong Version of Consent Form Signed|0
1039833|NCT01734434|2073018|FG002|Overall Study|Wrong Version of Consent Form Signed|1
1039834|NCT01734434|2073019|FG003|Overall Study|Wrong Version of Consent Form Signed|0
1039835|NCT01734434|2073016|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0
1039836|NCT01734434|2073017|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0
1039837|NCT01734434|2073018|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1
1039838|NCT01734434|2073019|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0
1039839|NCT01734772|2073068|FG000|Overall Study|Adverse Event|1
1039840|NCT01734772|2073069|FG001|Overall Study|Adverse Event|2
1039841|NCT01734772|2073068|FG000|Overall Study|Withdrawal by Subject|0
1039842|NCT01734772|2073069|FG001|Overall Study|Withdrawal by Subject|1
1039843|NCT01734785|2073084|FG000|Open-Label Period|Adverse Event|0
1039844|NCT01734785|2073085|FG001|Open-Label Period|Adverse Event|0
1039845|NCT01734785|2073086|FG002|Open-Label Period|Adverse Event|0
1039846|NCT01734785|2073087|FG003|Open-Label Period|Adverse Event|9
1039847|NCT01734785|2073084|FG000|Open-Label Period|Lack of Efficacy|0
1039848|NCT01734785|2073085|FG001|Open-Label Period|Lack of Efficacy|0
1039849|NCT01734785|2073086|FG002|Open-Label Period|Lack of Efficacy|0
1039850|NCT01734785|2073087|FG003|Open-Label Period|Lack of Efficacy|1
1039851|NCT01734785|2073084|FG000|Open-Label Period|Protocol Violation|0
1039852|NCT01734785|2073085|FG001|Open-Label Period|Protocol Violation|0
1039853|NCT01734785|2073086|FG002|Open-Label Period|Protocol Violation|0
1039854|NCT01734785|2073087|FG003|Open-Label Period|Protocol Violation|13
1039855|NCT01734785|2073084|FG000|Open-Label Period|Lost to Follow-up|0
1039856|NCT01734785|2073085|FG001|Open-Label Period|Lost to Follow-up|0
1039857|NCT01734785|2073086|FG002|Open-Label Period|Lost to Follow-up|0
1039858|NCT01734785|2073087|FG003|Open-Label Period|Lost to Follow-up|14
1039859|NCT01734785|2073084|FG000|Open-Label Period|Withdrawal by Subject|0
1039860|NCT01734785|2073085|FG001|Open-Label Period|Withdrawal by Subject|0
1039861|NCT01734785|2073086|FG002|Open-Label Period|Withdrawal by Subject|0
1039862|NCT01734785|2073087|FG003|Open-Label Period|Withdrawal by Subject|12
1039863|NCT01734785|2073084|FG000|Open-Label Period|Other Reasons|0
1039864|NCT01734785|2073085|FG001|Open-Label Period|Other Reasons|0
1039865|NCT01734785|2073086|FG002|Open-Label Period|Other Reasons|0
1039866|NCT01734785|2073087|FG003|Open-Label Period|Other Reasons|224
1039867|NCT01734785|2073084|FG000|Double-Blind Period|Adverse Event|0
1039868|NCT01734785|2073085|FG001|Double-Blind Period|Adverse Event|3
1039869|NCT01734785|2073086|FG002|Double-Blind Period|Adverse Event|2
1039870|NCT01734785|2073087|FG003|Double-Blind Period|Adverse Event|0
1039871|NCT01734785|2073084|FG000|Double-Blind Period|Lack of Efficacy|0
1039872|NCT01734785|2073085|FG001|Double-Blind Period|Lack of Efficacy|1
1039873|NCT01734785|2073086|FG002|Double-Blind Period|Lack of Efficacy|0
1039874|NCT01734785|2073087|FG003|Double-Blind Period|Lack of Efficacy|0
1039875|NCT01734785|2073084|FG000|Double-Blind Period|Protocol Violation|0
1039876|NCT01734785|2073085|FG001|Double-Blind Period|Protocol Violation|1
1039877|NCT01734785|2073086|FG002|Double-Blind Period|Protocol Violation|1
1039878|NCT01734785|2073087|FG003|Double-Blind Period|Protocol Violation|0
1039879|NCT01734785|2073084|FG000|Double-Blind Period|Lost to Follow-up|2
1039880|NCT01734785|2073085|FG001|Double-Blind Period|Lost to Follow-up|4
1039881|NCT01734785|2073086|FG002|Double-Blind Period|Lost to Follow-up|2
1039882|NCT01734785|2073087|FG003|Double-Blind Period|Lost to Follow-up|0
1039883|NCT01734785|2073084|FG000|Double-Blind Period|Withdrawal by Subject|2
1039884|NCT01734785|2073085|FG001|Double-Blind Period|Withdrawal by Subject|0
1039885|NCT01734785|2073086|FG002|Double-Blind Period|Withdrawal by Subject|0
1039886|NCT01734785|2073087|FG003|Double-Blind Period|Withdrawal by Subject|0
1039887|NCT01734785|2073084|FG000|Double-Blind Period|Not treated|1
1039888|NCT01734785|2073085|FG001|Double-Blind Period|Not treated|0
1039889|NCT01734785|2073086|FG002|Double-Blind Period|Not treated|0
1039890|NCT01734785|2073087|FG003|Double-Blind Period|Not treated|0
1039891|NCT01734811|2073098|FG000|Overall Study|Lost to Follow-up|2
1039892|NCT01734811|2073099|FG001|Overall Study|Lost to Follow-up|3
1039893|NCT01734811|2073098|FG000|Overall Study|Withdrawal by Subject|2
1039894|NCT01734811|2073099|FG001|Overall Study|Withdrawal by Subject|0
1039895|NCT01734850|2073108|FG000|Overall Study|Continued to Week 48 but recommenced ART|3
1039896|NCT01734850|2073109|FG001|Overall Study|Continued to Week 48 but recommenced ART|2
1039897|NCT01734850|2073110|FG002|Overall Study|Continued to Week 48 but recommenced ART|3
1039898|NCT01734850|2073108|FG000|Overall Study|Not infused due to manufacturing failure|0
1039899|NCT01734850|2073109|FG001|Overall Study|Not infused due to manufacturing failure|0
1039900|NCT01734850|2073110|FG002|Overall Study|Not infused due to manufacturing failure|1
1039901|NCT01734902|2073128|FG000|Overall Study|Other than listed|0
1039902|NCT01734902|2073129|FG001|Overall Study|Other than listed|2
1039903|NCT01734993|2073135|FG000|Overall Study|Adverse Event|1
1039904|NCT01734993|2073135|FG000|Overall Study|Lack of Efficacy|1
1039905|NCT01735175|2073142|FG000|Overall Study|Withdrawal by Subject|9
1039906|NCT01735175|2073143|FG001|Overall Study|Withdrawal by Subject|2
1039907|NCT01735175|2073142|FG000|Overall Study|Lost to Follow-up|4
1039908|NCT01735175|2073143|FG001|Overall Study|Lost to Follow-up|2
1039909|NCT01735175|2073142|FG000|Overall Study|Death|3
1039910|NCT01735175|2073143|FG001|Overall Study|Death|2
1039911|NCT01735175|2073142|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13
1039912|NCT01735175|2073143|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7
1039913|NCT01735201|2073157|FG000|Overall Study|Adverse Event|1
1039914|NCT01735201|2073158|FG001|Overall Study|Adverse Event|1
1039915|NCT01735201|2073159|FG002|Overall Study|Adverse Event|0
1039916|NCT01735201|2073160|FG003|Overall Study|Adverse Event|1
1039917|NCT01735201|2073161|FG004|Overall Study|Adverse Event|1
1039918|NCT01735201|2073162|FG005|Overall Study|Adverse Event|3
1039919|NCT01735201|2073163|FG006|Overall Study|Adverse Event|2
1039920|NCT01735201|2073164|FG007|Overall Study|Adverse Event|1
1039921|NCT01735201|2073157|FG000|Overall Study|Personal Reasons|1
1039922|NCT01735201|2073158|FG001|Overall Study|Personal Reasons|0
1039923|NCT01735201|2073159|FG002|Overall Study|Personal Reasons|0
1039924|NCT01735201|2073160|FG003|Overall Study|Personal Reasons|0
1039925|NCT01735201|2073161|FG004|Overall Study|Personal Reasons|0
1039926|NCT01735201|2073162|FG005|Overall Study|Personal Reasons|0
1039927|NCT01735201|2073163|FG006|Overall Study|Personal Reasons|0
1039928|NCT01735201|2073164|FG007|Overall Study|Personal Reasons|0
1039929|NCT01735201|2073157|FG000|Overall Study|Protocol Violation|1
1039930|NCT01735201|2073158|FG001|Overall Study|Protocol Violation|0
1039931|NCT01735201|2073159|FG002|Overall Study|Protocol Violation|0
1039932|NCT01735201|2073160|FG003|Overall Study|Protocol Violation|0
1039933|NCT01735201|2073161|FG004|Overall Study|Protocol Violation|0
1039934|NCT01735201|2073162|FG005|Overall Study|Protocol Violation|0
1039935|NCT01735201|2073163|FG006|Overall Study|Protocol Violation|0
1039936|NCT01735201|2073164|FG007|Overall Study|Protocol Violation|0
1039937|NCT01735201|2073157|FG000|Overall Study|Other Miscellaneous Reasons|0
1039938|NCT01735201|2073158|FG001|Overall Study|Other Miscellaneous Reasons|0
1039939|NCT01735201|2073159|FG002|Overall Study|Other Miscellaneous Reasons|0
1039940|NCT01735201|2073160|FG003|Overall Study|Other Miscellaneous Reasons|1
1039941|NCT01735201|2073161|FG004|Overall Study|Other Miscellaneous Reasons|0
1039942|NCT01735201|2073162|FG005|Overall Study|Other Miscellaneous Reasons|2
1039943|NCT01735201|2073163|FG006|Overall Study|Other Miscellaneous Reasons|1
1039944|NCT01735201|2073164|FG007|Overall Study|Other Miscellaneous Reasons|1
1039945|NCT01735279|2073188|FG000|Overall Study|Lost to Follow-up|11
1039946|NCT01735279|2073189|FG001|Overall Study|Lost to Follow-up|8
1039947|NCT01735396|2073195|FG000|Overall Study|not evaluable|1
1039948|NCT01735630|2073208|FG000|Overall Study|Adverse Event|8
1039949|NCT01735630|2073209|FG001|Overall Study|Adverse Event|7
1039950|NCT01735630|2073208|FG000|Overall Study|Lost to Follow-up|1
1039951|NCT01735630|2073209|FG001|Overall Study|Lost to Follow-up|0
1039952|NCT01735630|2073208|FG000|Overall Study|Physician Decision|0
1039953|NCT01735630|2073209|FG001|Overall Study|Physician Decision|1
1039954|NCT01735630|2073208|FG000|Overall Study|Sponsor Decision|2
1039955|NCT01735630|2073209|FG001|Overall Study|Sponsor Decision|1
1039956|NCT01735630|2073208|FG000|Overall Study|Withdrawal by Subject|7
1039957|NCT01735630|2073209|FG001|Overall Study|Withdrawal by Subject|9
1039958|NCT01735916|2073227|FG000|Overall Study|Subject not eligible to be randomized|11
1039959|NCT01735916|2073228|FG001|Overall Study|Subject not eligible to be randomized|0
1039960|NCT01735916|2073229|FG002|Overall Study|Subject not eligible to be randomized|0
1039961|NCT01735916|2073227|FG000|Overall Study|Early termination of study by sponsor|4
1039962|NCT01735916|2073228|FG001|Overall Study|Early termination of study by sponsor|19
1039963|NCT01735916|2073229|FG002|Overall Study|Early termination of study by sponsor|7
1039964|NCT01735916|2073227|FG000|Overall Study|Withdrawal by Subject|3
1039965|NCT01735916|2073228|FG001|Overall Study|Withdrawal by Subject|0
1039966|NCT01735916|2073229|FG002|Overall Study|Withdrawal by Subject|0
1039967|NCT01735994|2073249|FG000|Overall Study|Withdrawal by Subject|6
1039968|NCT01735994|2073250|FG001|Overall Study|Withdrawal by Subject|4
1039969|NCT01735994|2073249|FG000|Overall Study|Injury|2
1039970|NCT01735994|2073250|FG001|Overall Study|Injury|0
1039971|NCT01735994|2073249|FG000|Overall Study|Kicked off team|5
1039972|NCT01735994|2073250|FG001|Overall Study|Kicked off team|0
1039973|NCT01735994|2073249|FG000|Overall Study|Lost to Follow-up|50
1039974|NCT01735994|2073250|FG001|Overall Study|Lost to Follow-up|62
1039975|NCT01736124|2073280|FG000|Post-intervention Assessment|Death|2
1039976|NCT01736124|2073281|FG001|Post-intervention Assessment|Death|2
1039977|NCT01736124|2073280|FG000|Post-intervention Assessment|lost computer access|1
1039978|NCT01736124|2073281|FG001|Post-intervention Assessment|lost computer access|1
1039979|NCT01736124|2073280|FG000|Post-intervention Assessment|Moved away|3
1039980|NCT01736124|2073281|FG001|Post-intervention Assessment|Moved away|1
1039981|NCT01736124|2073280|FG000|Post-intervention Assessment|Withdrawal by Subject|11
1039982|NCT01736124|2073281|FG001|Post-intervention Assessment|Withdrawal by Subject|9
1039983|NCT01736124|2073280|FG000|Post-intervention Assessment|Illness|3
1039984|NCT01736124|2073281|FG001|Post-intervention Assessment|Illness|2
1039985|NCT01736124|2073280|FG000|Post-intervention Assessment|Lost to Follow-up|8
1039986|NCT01736124|2073281|FG001|Post-intervention Assessment|Lost to Follow-up|5
1039987|NCT01736124|2073280|FG000|Post-intervention Assessment|Temporarily away|3
1039988|NCT01736124|2073281|FG001|Post-intervention Assessment|Temporarily away|1
1039989|NCT01736124|2073280|FG000|6 Mo. Post-Intervention Assessment|Death|0
1039990|NCT01736124|2073281|FG001|6 Mo. Post-Intervention Assessment|Death|1
1039991|NCT01736124|2073280|FG000|6 Mo. Post-Intervention Assessment|Moved away|0
1039992|NCT01736124|2073281|FG001|6 Mo. Post-Intervention Assessment|Moved away|2
1039993|NCT01736124|2073280|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
1039994|NCT01736124|2073281|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
1039995|NCT01736124|2073280|FG000|6 Mo. Post-Intervention Assessment|Illness|1
1039996|NCT01736124|2073281|FG001|6 Mo. Post-Intervention Assessment|Illness|2
1039997|NCT01736124|2073280|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1
1039998|NCT01736124|2073281|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4
1039999|NCT01736124|2073280|FG000|12 Mo. Post-Intervention Assessment|Death|1
1040000|NCT01736124|2073281|FG001|12 Mo. Post-Intervention Assessment|Death|0
1040001|NCT01736124|2073280|FG000|12 Mo. Post-Intervention Assessment|Moved away|1
1040002|NCT01736124|2073281|FG001|12 Mo. Post-Intervention Assessment|Moved away|0
1040003|NCT01736124|2073280|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0
1040004|NCT01736124|2073281|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2
1040005|NCT01736124|2073280|FG000|12 Mo. Post-Intervention Assessment|End of study|10
1040006|NCT01736124|2073281|FG001|12 Mo. Post-Intervention Assessment|End of study|10
1040007|NCT01736176|2073289|FG000|Overall Study|Adverse Event|3
1040008|NCT01736176|2073289|FG000|Overall Study|Withdrawal by Subject|4
1040009|NCT01736176|2073289|FG000|Overall Study|Lack of Efficacy|3
1040010|NCT01736176|2073289|FG000|Overall Study|Unable to Complete PEG Placement|1
1040011|NCT01736189|2073297|FG000|Overall Study|Violation of registration criteria|41
1040012|NCT01736189|2073297|FG000|Overall Study|Protocol Violation|4
1040013|NCT01736189|2073297|FG000|Overall Study|Criteria and protocol violations|1
1040014|NCT01736215|2073301|FG000|Overall Study|Early termination of erythropoietin use|1
1040015|NCT01736215|2073301|FG000|Overall Study|Adverse Event|4
1040016|NCT01736215|2073301|FG000|Overall Study|Progressive disease stop chemotherapy|1
1040017|NCT01736215|2073301|FG000|Overall Study|Insufficient data to perform analysis|8
1040018|NCT01736254|2073335|FG000|Period 2 (Days 2 to 12)|Adverse Event|3
1040019|NCT01736254|2073335|FG000|Period 3 (Days 13 to 23)|Adverse Event|1
1040020|NCT01736397|2073358|FG000|Overall Study|Lack of Efficacy|1
1040021|NCT01736397|2073359|FG001|Overall Study|Lack of Efficacy|11
1040022|NCT01736397|2073358|FG000|Overall Study|Withdrawal by Subject|6
1040023|NCT01736397|2073359|FG001|Overall Study|Withdrawal by Subject|5
1040024|NCT01736397|2073358|FG000|Overall Study|Lost to Follow-up|0
1040025|NCT01736397|2073359|FG001|Overall Study|Lost to Follow-up|1
1040026|NCT01736397|2073358|FG000|Overall Study|Adverse Event|6
1040027|NCT01736397|2073359|FG001|Overall Study|Adverse Event|3
1040028|NCT01736397|2073358|FG000|Overall Study|Not stated|1
1040029|NCT01736397|2073359|FG001|Overall Study|Not stated|4
1040030|NCT01736475|2073367|FG000|Overall Study|Adverse Event|4
1040031|NCT01736475|2073368|FG001|Overall Study|Adverse Event|0
1040032|NCT01736475|2073367|FG000|Overall Study|Withdrawal by Subject|2
1040033|NCT01736475|2073368|FG001|Overall Study|Withdrawal by Subject|0
1040034|NCT01736475|2073367|FG000|Overall Study|Protocol Violation|4
1040035|NCT01736475|2073368|FG001|Overall Study|Protocol Violation|0
1040036|NCT01736475|2073367|FG000|Overall Study|Other - Screen failure|1
1040037|NCT01736475|2073368|FG001|Overall Study|Other - Screen failure|0
1040038|NCT01736475|2073367|FG000|Overall Study|Other - Surgical procedure|1
1040039|NCT01736475|2073368|FG001|Overall Study|Other - Surgical procedure|0
1040040|NCT01736540|2073389|FG000|Overall Study|Did not complete scan within 45 days|2
1040041|NCT01736540|2073389|FG000|Overall Study|Death|1
1040042|NCT01736540|2073389|FG000|Overall Study|Abnormal test procedure|1
1040043|NCT01736540|2073389|FG000|Overall Study|Withdrawal by Subject|5
1040044|NCT01736540|2073389|FG000|Overall Study|Protocol Violation|1
1040045|NCT01736540|2073389|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1
1040046|NCT01736540|2073389|FG000|Overall Study|No show for MRI appointment|1
1040047|NCT01736540|2073389|FG000|Overall Study|Unable to make MRI appointment|3
1040048|NCT01736553|2073402|FG000|Overall Study|Death|12
1040049|NCT01736553|2073403|FG001|Overall Study|Death|0
1040050|NCT01736553|2073402|FG000|Overall Study|Withdrawal by Subject|5
1040051|NCT01736553|2073403|FG001|Overall Study|Withdrawal by Subject|2
1040052|NCT01736553|2073402|FG000|Overall Study|Lost to Follow-up|2
1040053|NCT01736553|2073403|FG001|Overall Study|Lost to Follow-up|2
1040054|NCT01736566|2073432|FG000|Long Term Follow-up|Still collecting data|42
1040055|NCT01736566|2073433|FG001|Long Term Follow-up|Still collecting data|0
1040056|NCT01736566|2073434|FG002|Long Term Follow-up|Still collecting data|49
1040057|NCT01736566|2073435|FG003|Long Term Follow-up|Still collecting data|0
1040058|NCT01736566|2073436|FG004|Long Term Follow-up|Still collecting data|1
1040059|NCT01736579|2073463|FG000|Overall Study|Termination of Study by Sponsor|2
1040060|NCT01736579|2073464|FG001|Overall Study|Termination of Study by Sponsor|2
1040061|NCT01736657|2073470|FG000|Overall Study|insufficient vascular access|1
1040062|NCT01736683|2073479|FG000|Overall Study|Disease Relapse|0
1040063|NCT01736683|2073480|FG001|Overall Study|Disease Relapse|0
1040064|NCT01736683|2073481|FG002|Overall Study|Disease Relapse|2
1040065|NCT01736683|2073482|FG003|Overall Study|Disease Relapse|1
1040066|NCT01736683|2073483|FG004|Overall Study|Disease Relapse|0
1040067|NCT01736683|2073479|FG000|Overall Study|Adverse Event|0
1040068|NCT01736683|2073480|FG001|Overall Study|Adverse Event|2
1040069|NCT01736683|2073481|FG002|Overall Study|Adverse Event|2
1040070|NCT01736683|2073482|FG003|Overall Study|Adverse Event|3
1040071|NCT01736683|2073483|FG004|Overall Study|Adverse Event|2
1040072|NCT01736683|2073479|FG000|Overall Study|Withdrawal by Subject|0
1040073|NCT01736683|2073480|FG001|Overall Study|Withdrawal by Subject|0
1040074|NCT01736683|2073481|FG002|Overall Study|Withdrawal by Subject|3
1040075|NCT01736683|2073482|FG003|Overall Study|Withdrawal by Subject|1
1040076|NCT01736683|2073483|FG004|Overall Study|Withdrawal by Subject|1
1040077|NCT01736683|2073479|FG000|Overall Study|Lack of Therapeutic Effect|7
1040078|NCT01736683|2073480|FG001|Overall Study|Lack of Therapeutic Effect|4
1040079|NCT01736683|2073481|FG002|Overall Study|Lack of Therapeutic Effect|13
1040080|NCT01736683|2073482|FG003|Overall Study|Lack of Therapeutic Effect|20
1040081|NCT01736683|2073483|FG004|Overall Study|Lack of Therapeutic Effect|1
1040082|NCT01736683|2073479|FG000|Overall Study|Progressive Disease|0
1040083|NCT01736683|2073480|FG001|Overall Study|Progressive Disease|0
1040084|NCT01736683|2073481|FG002|Overall Study|Progressive Disease|0
1040085|NCT01736683|2073482|FG003|Overall Study|Progressive Disease|1
1040086|NCT01736683|2073483|FG004|Overall Study|Progressive Disease|0
1040087|NCT01736683|2073479|FG000|Overall Study|Other|0
1040088|NCT01736683|2073480|FG001|Overall Study|Other|0
1040089|NCT01736683|2073481|FG002|Overall Study|Other|1
1040090|NCT01736683|2073482|FG003|Overall Study|Other|9
1040091|NCT01736683|2073483|FG004|Overall Study|Other|1
1040092|NCT01736696|2073504|FG000|Overall Study|Withdrawal by Subject|0
1040093|NCT01736696|2073505|FG001|Overall Study|Withdrawal by Subject|0
1040094|NCT01736696|2073506|FG002|Overall Study|Withdrawal by Subject|1
1040095|NCT01736696|2073507|FG003|Overall Study|Withdrawal by Subject|0
1040096|NCT01736696|2073508|FG004|Overall Study|Withdrawal by Subject|0
1040097|NCT01736696|2073509|FG005|Overall Study|Withdrawal by Subject|0
1040098|NCT01736696|2073510|FG006|Overall Study|Withdrawal by Subject|0
1040099|NCT01736917|2073552|FG000|Overall Study|Adverse Event|1
1040100|NCT01736917|2073552|FG000|Overall Study|Protocol Violation|10
1040101|NCT01737021|2073570|FG000|Overall Study|Lost to Follow-up|5
1040102|NCT01737021|2073571|FG001|Overall Study|Lost to Follow-up|3
1040103|NCT01737268|2073577|FG000|Overall Study|Adverse Event|6
1040104|NCT01737268|2073577|FG000|Overall Study|Worsening of Target Disease|2
1040105|NCT01737268|2073577|FG000|Overall Study|In consideration of the patient's safety|1
1040106|NCT01737398|2073593|FG000|Overall Study|Adverse event or SAE|16
1040107|NCT01737398|2073594|FG001|Overall Study|Adverse event or SAE|1
1040108|NCT01737398|2073593|FG000|Overall Study|Stopping rule met|2
1040109|NCT01737398|2073594|FG001|Overall Study|Stopping rule met|1
1040110|NCT01737398|2073593|FG000|Overall Study|Voluntary withdrawal|2
1040111|NCT01737398|2073594|FG001|Overall Study|Voluntary withdrawal|3
1040112|NCT01737398|2073593|FG000|Overall Study|Ineligibility|1
1040113|NCT01737398|2073594|FG001|Overall Study|Ineligibility|0
1040114|NCT01737398|2073593|FG000|Overall Study|Liver transplant|1
1040115|NCT01737398|2073594|FG001|Overall Study|Liver transplant|0
1040116|NCT01737398|2073593|FG000|Overall Study|Disease progression|2
1040117|NCT01737398|2073594|FG001|Overall Study|Disease progression|3
1040118|NCT01737398|2073593|FG000|Overall Study|Sponsor's decision|2
1040119|NCT01737398|2073594|FG001|Overall Study|Sponsor's decision|0
1040120|NCT01737697|2073634|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0
1040121|NCT01737697|2073635|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1
1040122|NCT01737697|2073636|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0
1040123|NCT01737697|2073637|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1
1040124|NCT01737697|2073638|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1
1040125|NCT01737697|2073639|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0
1040126|NCT01737697|2073640|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0
1040127|NCT01737697|2073641|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0
1040128|NCT01737697|2073642|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0
1040129|NCT01737697|2073643|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0
1040130|NCT01737697|2073644|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0
1040131|NCT01737697|2073645|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0
1040132|NCT01737697|2073646|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0
1040133|NCT01737697|2073647|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0
1040134|NCT01737697|2073648|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0
1040135|NCT01737697|2073634|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
1040136|NCT01737697|2073635|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
1040137|NCT01737697|2073636|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
1040138|NCT01737697|2073637|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040139|NCT01737697|2073638|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040140|NCT01737697|2073639|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040141|NCT01737697|2073640|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040142|NCT01737697|2073641|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040143|NCT01737697|2073642|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040144|NCT01737697|2073643|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040145|NCT01737697|2073644|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040146|NCT01737697|2073645|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040147|NCT01737697|2073646|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040148|NCT01737697|2073647|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040149|NCT01737697|2073648|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1040150|NCT01737697|2073634|FG000|Acute Phase-Initial 48 Hours|Family emergency|0
1040151|NCT01737697|2073635|FG001|Acute Phase-Initial 48 Hours|Family emergency|0
1040152|NCT01737697|2073636|FG002|Acute Phase-Initial 48 Hours|Family emergency|0
1040153|NCT01737697|2073637|FG003|Acute Phase-Initial 48 Hours|Family emergency|1
1040154|NCT01737697|2073638|FG004|Acute Phase-Initial 48 Hours|Family emergency|0
1040155|NCT01737697|2073639|FG005|Acute Phase-Initial 48 Hours|Family emergency|0
1040156|NCT01737697|2073640|FG006|Acute Phase-Initial 48 Hours|Family emergency|0
1040157|NCT01737697|2073641|FG007|Acute Phase-Initial 48 Hours|Family emergency|0
1040158|NCT01737697|2073642|FG008|Acute Phase-Initial 48 Hours|Family emergency|0
1040159|NCT01737697|2073643|FG009|Acute Phase-Initial 48 Hours|Family emergency|0
1040160|NCT01737697|2073644|FG010|Acute Phase-Initial 48 Hours|Family emergency|0
1040161|NCT01737697|2073645|FG011|Acute Phase-Initial 48 Hours|Family emergency|0
1040162|NCT01737697|2073646|FG012|Acute Phase-Initial 48 Hours|Family emergency|0
1040163|NCT01737697|2073647|FG013|Acute Phase-Initial 48 Hours|Family emergency|0
1040164|NCT01737697|2073648|FG014|Acute Phase-Initial 48 Hours|Family emergency|0
1040165|NCT01737697|2073634|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040166|NCT01737697|2073635|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1
1040167|NCT01737697|2073636|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040168|NCT01737697|2073637|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040169|NCT01737697|2073638|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040170|NCT01737697|2073639|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040171|NCT01737697|2073640|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040172|NCT01737697|2073641|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040173|NCT01737697|2073642|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040174|NCT01737697|2073643|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040175|NCT01737697|2073644|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040176|NCT01737697|2073645|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040177|NCT01737697|2073646|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040178|NCT01737697|2073647|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040179|NCT01737697|2073648|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1040180|NCT01737697|2073634|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040181|NCT01737697|2073635|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040182|NCT01737697|2073636|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040183|NCT01737697|2073637|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040184|NCT01737697|2073638|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
1040185|NCT01737697|2073639|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040186|NCT01737697|2073640|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040187|NCT01737697|2073641|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040188|NCT01737697|2073642|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040189|NCT01737697|2073643|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040190|NCT01737697|2073644|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040191|NCT01737697|2073645|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040192|NCT01737697|2073646|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040193|NCT01737697|2073647|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040194|NCT01737697|2073648|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1040195|NCT01737697|2073634|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1040196|NCT01737697|2073635|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
1040197|NCT01737697|2073636|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
1040198|NCT01737697|2073637|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
1040199|NCT01737697|2073638|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
1040200|NCT01737697|2073639|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1040201|NCT01737697|2073640|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1040202|NCT01737697|2073641|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1040203|NCT01737697|2073642|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1040204|NCT01737697|2073643|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1040205|NCT01737697|2073644|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1040206|NCT01737697|2073645|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1040207|NCT01737697|2073646|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1040208|NCT01737697|2073647|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1040209|NCT01737697|2073648|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1040210|NCT01737697|2073634|FG000|Subacute Phase|Adverse Event|0
1040211|NCT01737697|2073635|FG001|Subacute Phase|Adverse Event|0
1040212|NCT01737697|2073636|FG002|Subacute Phase|Adverse Event|0
1040213|NCT01737697|2073637|FG003|Subacute Phase|Adverse Event|0
1040214|NCT01737697|2073638|FG004|Subacute Phase|Adverse Event|0
1040215|NCT01737697|2073639|FG005|Subacute Phase|Adverse Event|1
1040216|NCT01737697|2073640|FG006|Subacute Phase|Adverse Event|1
1040217|NCT01737697|2073641|FG007|Subacute Phase|Adverse Event|1
1040218|NCT01737697|2073642|FG008|Subacute Phase|Adverse Event|1
1040219|NCT01737697|2073643|FG009|Subacute Phase|Adverse Event|1
1040220|NCT01737697|2073644|FG010|Subacute Phase|Adverse Event|4
1040221|NCT01737697|2073645|FG011|Subacute Phase|Adverse Event|1
1040222|NCT01737697|2073646|FG012|Subacute Phase|Adverse Event|1
1040223|NCT01737697|2073647|FG013|Subacute Phase|Adverse Event|0
1040224|NCT01737697|2073648|FG014|Subacute Phase|Adverse Event|0
1040225|NCT01737697|2073634|FG000|Subacute Phase|Withdrawal by Subject|0
1040226|NCT01737697|2073635|FG001|Subacute Phase|Withdrawal by Subject|0
1040227|NCT01737697|2073636|FG002|Subacute Phase|Withdrawal by Subject|0
1040228|NCT01737697|2073637|FG003|Subacute Phase|Withdrawal by Subject|0
1040229|NCT01737697|2073638|FG004|Subacute Phase|Withdrawal by Subject|0
1040230|NCT01737697|2073639|FG005|Subacute Phase|Withdrawal by Subject|1
1040231|NCT01737697|2073640|FG006|Subacute Phase|Withdrawal by Subject|0
1040232|NCT01737697|2073641|FG007|Subacute Phase|Withdrawal by Subject|2
1040233|NCT01737697|2073642|FG008|Subacute Phase|Withdrawal by Subject|0
1040234|NCT01737697|2073643|FG009|Subacute Phase|Withdrawal by Subject|1
1040235|NCT01737697|2073644|FG010|Subacute Phase|Withdrawal by Subject|0
1040236|NCT01737697|2073645|FG011|Subacute Phase|Withdrawal by Subject|1
1040237|NCT01737697|2073646|FG012|Subacute Phase|Withdrawal by Subject|1
1040238|NCT01737697|2073647|FG013|Subacute Phase|Withdrawal by Subject|1
1040239|NCT01737697|2073648|FG014|Subacute Phase|Withdrawal by Subject|0
1040240|NCT01737697|2073634|FG000|Subacute Phase|Lost to Follow-up|0
1040241|NCT01737697|2073635|FG001|Subacute Phase|Lost to Follow-up|0
1040242|NCT01737697|2073636|FG002|Subacute Phase|Lost to Follow-up|0
1040243|NCT01737697|2073637|FG003|Subacute Phase|Lost to Follow-up|0
1040244|NCT01737697|2073638|FG004|Subacute Phase|Lost to Follow-up|0
1040245|NCT01737697|2073639|FG005|Subacute Phase|Lost to Follow-up|0
1040246|NCT01737697|2073640|FG006|Subacute Phase|Lost to Follow-up|0
1040247|NCT01737697|2073641|FG007|Subacute Phase|Lost to Follow-up|0
1040248|NCT01737697|2073642|FG008|Subacute Phase|Lost to Follow-up|0
1040249|NCT01737697|2073643|FG009|Subacute Phase|Lost to Follow-up|0
1040250|NCT01737697|2073644|FG010|Subacute Phase|Lost to Follow-up|0
1040251|NCT01737697|2073645|FG011|Subacute Phase|Lost to Follow-up|0
1040252|NCT01737697|2073646|FG012|Subacute Phase|Lost to Follow-up|0
1040253|NCT01737697|2073647|FG013|Subacute Phase|Lost to Follow-up|0
1040254|NCT01737697|2073648|FG014|Subacute Phase|Lost to Follow-up|1
1040255|NCT01737697|2073634|FG000|Subacute Phase|Hypo-or hyperkalemia|0
1040256|NCT01737697|2073635|FG001|Subacute Phase|Hypo-or hyperkalemia|0
1040257|NCT01737697|2073636|FG002|Subacute Phase|Hypo-or hyperkalemia|0
1040258|NCT01737697|2073637|FG003|Subacute Phase|Hypo-or hyperkalemia|0
1040259|NCT01737697|2073638|FG004|Subacute Phase|Hypo-or hyperkalemia|0
1040260|NCT01737697|2073639|FG005|Subacute Phase|Hypo-or hyperkalemia|0
1040261|NCT01737697|2073640|FG006|Subacute Phase|Hypo-or hyperkalemia|0
1040262|NCT01737697|2073641|FG007|Subacute Phase|Hypo-or hyperkalemia|0
1040263|NCT01737697|2073642|FG008|Subacute Phase|Hypo-or hyperkalemia|0
1040264|NCT01737697|2073643|FG009|Subacute Phase|Hypo-or hyperkalemia|0
1040265|NCT01737697|2073644|FG010|Subacute Phase|Hypo-or hyperkalemia|0
1040266|NCT01737697|2073645|FG011|Subacute Phase|Hypo-or hyperkalemia|1
1040267|NCT01737697|2073646|FG012|Subacute Phase|Hypo-or hyperkalemia|0
1040268|NCT01737697|2073647|FG013|Subacute Phase|Hypo-or hyperkalemia|1
1040269|NCT01737697|2073648|FG014|Subacute Phase|Hypo-or hyperkalemia|0
1040270|NCT01737697|2073634|FG000|Subacute Phase|Protocol Violation|0
1040271|NCT01737697|2073635|FG001|Subacute Phase|Protocol Violation|0
1040272|NCT01737697|2073636|FG002|Subacute Phase|Protocol Violation|0
1040273|NCT01737697|2073637|FG003|Subacute Phase|Protocol Violation|0
1040274|NCT01737697|2073638|FG004|Subacute Phase|Protocol Violation|0
1040275|NCT01737697|2073639|FG005|Subacute Phase|Protocol Violation|1
1040276|NCT01737697|2073640|FG006|Subacute Phase|Protocol Violation|0
1040277|NCT01737697|2073641|FG007|Subacute Phase|Protocol Violation|0
1040278|NCT01737697|2073642|FG008|Subacute Phase|Protocol Violation|0
1040279|NCT01737697|2073643|FG009|Subacute Phase|Protocol Violation|0
1040280|NCT01737697|2073644|FG010|Subacute Phase|Protocol Violation|1
1040281|NCT01737697|2073645|FG011|Subacute Phase|Protocol Violation|0
1040282|NCT01737697|2073646|FG012|Subacute Phase|Protocol Violation|0
1040283|NCT01737697|2073647|FG013|Subacute Phase|Protocol Violation|0
1040284|NCT01737697|2073648|FG014|Subacute Phase|Protocol Violation|0
1040285|NCT01737697|2073634|FG000|Subacute Phase|Physician Decision|0
1040286|NCT01737697|2073635|FG001|Subacute Phase|Physician Decision|0
1040287|NCT01737697|2073636|FG002|Subacute Phase|Physician Decision|0
1040288|NCT01737697|2073637|FG003|Subacute Phase|Physician Decision|0
1040289|NCT01737697|2073638|FG004|Subacute Phase|Physician Decision|0
1040290|NCT01737697|2073639|FG005|Subacute Phase|Physician Decision|0
1040291|NCT01737697|2073640|FG006|Subacute Phase|Physician Decision|0
1040292|NCT01737697|2073641|FG007|Subacute Phase|Physician Decision|0
1040293|NCT01737697|2073642|FG008|Subacute Phase|Physician Decision|1
1040294|NCT01737697|2073643|FG009|Subacute Phase|Physician Decision|0
1040295|NCT01737697|2073644|FG010|Subacute Phase|Physician Decision|0
1040296|NCT01737697|2073645|FG011|Subacute Phase|Physician Decision|0
1040297|NCT01737697|2073646|FG012|Subacute Phase|Physician Decision|0
1040298|NCT01737697|2073647|FG013|Subacute Phase|Physician Decision|0
1040299|NCT01737697|2073648|FG014|Subacute Phase|Physician Decision|0
1040300|NCT01737697|2073634|FG000|Subacute Phase|Death|0
1040301|NCT01737697|2073635|FG001|Subacute Phase|Death|0
1040302|NCT01737697|2073636|FG002|Subacute Phase|Death|0
1040303|NCT01737697|2073637|FG003|Subacute Phase|Death|0
1040304|NCT01737697|2073638|FG004|Subacute Phase|Death|0
1040305|NCT01737697|2073639|FG005|Subacute Phase|Death|0
1040306|NCT01737697|2073640|FG006|Subacute Phase|Death|0
1040307|NCT01737697|2073641|FG007|Subacute Phase|Death|0
1040308|NCT01737697|2073642|FG008|Subacute Phase|Death|0
1040309|NCT01737697|2073643|FG009|Subacute Phase|Death|0
1040310|NCT01737697|2073644|FG010|Subacute Phase|Death|1
1040311|NCT01737697|2073645|FG011|Subacute Phase|Death|0
1040312|NCT01737697|2073646|FG012|Subacute Phase|Death|0
1040313|NCT01737697|2073647|FG013|Subacute Phase|Death|0
1040314|NCT01737697|2073648|FG014|Subacute Phase|Death|0
1040315|NCT01737710|2073686|FG000|Overall Study|Lost to Follow-up|0
1040316|NCT01737710|2073687|FG001|Overall Study|Lost to Follow-up|2
1040317|NCT01737710|2073688|FG002|Overall Study|Lost to Follow-up|2
1040318|NCT01737710|2073689|FG003|Overall Study|Lost to Follow-up|0
1040319|NCT01737710|2073690|FG004|Overall Study|Lost to Follow-up|0
1040320|NCT01737710|2073686|FG000|Overall Study|Withdrawal by Subject|1
1040321|NCT01737710|2073687|FG001|Overall Study|Withdrawal by Subject|1
1040322|NCT01737710|2073688|FG002|Overall Study|Withdrawal by Subject|1
1040323|NCT01737710|2073689|FG003|Overall Study|Withdrawal by Subject|0
1040324|NCT01737710|2073690|FG004|Overall Study|Withdrawal by Subject|0
1040325|NCT01737710|2073686|FG000|Overall Study|Vaccinated in Error/Ineligible|1
1040326|NCT01737710|2073687|FG001|Overall Study|Vaccinated in Error/Ineligible|1
1040327|NCT01737710|2073688|FG002|Overall Study|Vaccinated in Error/Ineligible|0
1040328|NCT01737710|2073689|FG003|Overall Study|Vaccinated in Error/Ineligible|0
1040329|NCT01737710|2073690|FG004|Overall Study|Vaccinated in Error/Ineligible|0
1040330|NCT01737762|2073703|FG000|Overall Study|Adverse Event|2
1040331|NCT01737762|2073704|FG001|Overall Study|Adverse Event|2
1040332|NCT01737762|2073703|FG000|Overall Study|Lost to Follow-up|1
1040333|NCT01737762|2073704|FG001|Overall Study|Lost to Follow-up|0
1040334|NCT01737762|2073703|FG000|Overall Study|Withdrawal by Subject|2
1040335|NCT01737762|2073704|FG001|Overall Study|Withdrawal by Subject|2
1040336|NCT01737762|2073703|FG000|Overall Study|Progressive disease|1
1040337|NCT01737762|2073704|FG001|Overall Study|Progressive disease|2
1040338|NCT01737762|2073703|FG000|Overall Study|Physician Decision|1
1040339|NCT01737762|2073704|FG001|Overall Study|Physician Decision|1
1040340|NCT01737762|2073703|FG000|Overall Study|Moved from area|2
1040341|NCT01737762|2073704|FG001|Overall Study|Moved from area|1
1040342|NCT01737762|2073703|FG000|Overall Study|Trial termination|11
1040343|NCT01737762|2073704|FG001|Overall Study|Trial termination|9
1040344|NCT01737840|2073712|FG000|Overall Study|Diagnosed with an other pathology|2
1040345|NCT01737840|2073713|FG001|Overall Study|Diagnosed with an other pathology|2
1040346|NCT01737879|2073721|FG000|Overall Study|Death|1
1040347|NCT01737879|2073721|FG000|Overall Study|Sponsor decision|40
1040348|NCT01737931|2073728|FG000|Overall Study|Withdrawal by Subject|0
1040349|NCT01737931|2073729|FG001|Overall Study|Withdrawal by Subject|1
1040350|NCT01737931|2073730|FG002|Overall Study|Withdrawal by Subject|1
1040351|NCT01737931|2073728|FG000|Overall Study|Physician Decision|0
1040352|NCT01737931|2073729|FG001|Overall Study|Physician Decision|1
1040353|NCT01737931|2073730|FG002|Overall Study|Physician Decision|0
1040354|NCT01737996|2073755|FG000|Overall Study|Adverse Event|0
1040355|NCT01737996|2073756|FG001|Overall Study|Adverse Event|1
1040356|NCT01737996|2073757|FG002|Overall Study|Adverse Event|1
1040357|NCT01737996|2073755|FG000|Overall Study|Withdrawal by Subject|0
1040358|NCT01737996|2073756|FG001|Overall Study|Withdrawal by Subject|0
1040359|NCT01737996|2073757|FG002|Overall Study|Withdrawal by Subject|1
1040360|NCT01738191|2073767|FG000|Overall Study|Withdrawal by Subject|4
1040361|NCT01738191|2073768|FG001|Overall Study|Withdrawal by Subject|1
1040362|NCT01738438|2073783|FG000|Overall Study|Disease Progression|32
1040363|NCT01738438|2073783|FG000|Overall Study|Adverse Event|3
1040364|NCT01738477|2073789|FG000|Overall Study|Lost to Follow-up|1
1040365|NCT01738477|2073790|FG001|Overall Study|Lost to Follow-up|4
1040366|NCT01738503|2073804|FG000|Induction/Stabilization (Days -14 to -1)|Other|35
1040367|NCT01738503|2073805|FG001|Induction/Stabilization (Days -14 to -1)|Other|0
1040368|NCT01738503|2073806|FG002|Induction/Stabilization (Days -14 to -1)|Other|0
1040369|NCT01738503|2073807|FG003|Induction/Stabilization (Days -14 to -1)|Other|0
1040370|NCT01738503|2073808|FG004|Induction/Stabilization (Days -14 to -1)|Other|0
1040371|NCT01738503|2073809|FG005|Induction/Stabilization (Days -14 to -1)|Other|0
1040372|NCT01738503|2073810|FG006|Induction/Stabilization (Days -14 to -1)|Other|0
1040373|NCT01738503|2073804|FG000|Treatment Period|Adverse Event|0
1040374|NCT01738503|2073805|FG001|Treatment Period|Adverse Event|1
1040375|NCT01738503|2073806|FG002|Treatment Period|Adverse Event|0
1040376|NCT01738503|2073807|FG003|Treatment Period|Adverse Event|1
1040377|NCT01738503|2073808|FG004|Treatment Period|Adverse Event|2
1040378|NCT01738503|2073809|FG005|Treatment Period|Adverse Event|2
1040379|NCT01738503|2073810|FG006|Treatment Period|Adverse Event|2
1040380|NCT01738503|2073804|FG000|Treatment Period|Lost to Follow-up|0
1040381|NCT01738503|2073805|FG001|Treatment Period|Lost to Follow-up|0
1040382|NCT01738503|2073806|FG002|Treatment Period|Lost to Follow-up|3
1040383|NCT01738503|2073807|FG003|Treatment Period|Lost to Follow-up|4
1040384|NCT01738503|2073808|FG004|Treatment Period|Lost to Follow-up|1
1040385|NCT01738503|2073809|FG005|Treatment Period|Lost to Follow-up|1
1040386|NCT01738503|2073810|FG006|Treatment Period|Lost to Follow-up|5
1040387|NCT01738503|2073804|FG000|Treatment Period|Withdrawal by Subject|0
1040388|NCT01738503|2073805|FG001|Treatment Period|Withdrawal by Subject|1
1040389|NCT01738503|2073806|FG002|Treatment Period|Withdrawal by Subject|0
1040390|NCT01738503|2073807|FG003|Treatment Period|Withdrawal by Subject|1
1040391|NCT01738503|2073808|FG004|Treatment Period|Withdrawal by Subject|1
1040392|NCT01738503|2073809|FG005|Treatment Period|Withdrawal by Subject|1
1040393|NCT01738503|2073810|FG006|Treatment Period|Withdrawal by Subject|1
1040394|NCT01738503|2073804|FG000|Treatment Period|Protocol Violation|0
1040395|NCT01738503|2073805|FG001|Treatment Period|Protocol Violation|3
1040396|NCT01738503|2073806|FG002|Treatment Period|Protocol Violation|1
1040397|NCT01738503|2073807|FG003|Treatment Period|Protocol Violation|0
1040398|NCT01738503|2073808|FG004|Treatment Period|Protocol Violation|4
1040399|NCT01738503|2073809|FG005|Treatment Period|Protocol Violation|2
1040400|NCT01738503|2073810|FG006|Treatment Period|Protocol Violation|0
1040401|NCT01738503|2073804|FG000|Treatment Period|Other|0
1040402|NCT01738503|2073805|FG001|Treatment Period|Other|0
1040403|NCT01738503|2073806|FG002|Treatment Period|Other|1
1040404|NCT01738503|2073807|FG003|Treatment Period|Other|0
1040405|NCT01738503|2073808|FG004|Treatment Period|Other|0
1040406|NCT01738503|2073809|FG005|Treatment Period|Other|0
1040407|NCT01738503|2073810|FG006|Treatment Period|Other|0
1040408|NCT01738503|2073804|FG000|PET Imaging Sub-study|Adverse Event|0
1040409|NCT01738503|2073805|FG001|PET Imaging Sub-study|Adverse Event|0
1040410|NCT01738503|2073806|FG002|PET Imaging Sub-study|Adverse Event|0
1040411|NCT01738503|2073807|FG003|PET Imaging Sub-study|Adverse Event|0
1040412|NCT01738503|2073808|FG004|PET Imaging Sub-study|Adverse Event|0
1040413|NCT01738503|2073809|FG005|PET Imaging Sub-study|Adverse Event|1
1040414|NCT01738503|2073810|FG006|PET Imaging Sub-study|Adverse Event|0
1040415|NCT01738503|2073804|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1040416|NCT01738503|2073805|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1040417|NCT01738503|2073806|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1040418|NCT01738503|2073807|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1040419|NCT01738503|2073808|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1040420|NCT01738503|2073809|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1
1040421|NCT01738503|2073810|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1
1040422|NCT01738581|2073834|FG000|Overall Study|Lost to Follow-up|1
1040423|NCT01738581|2073835|FG001|Overall Study|Lost to Follow-up|0
1040424|NCT01738594|2073844|FG000|Registration and Treatment Start|Adverse Event|0
1040425|NCT01738594|2073845|FG001|Registration and Treatment Start|Adverse Event|1
1040426|NCT01738594|2073846|FG002|Registration and Treatment Start|Adverse Event|0
1040427|NCT01738594|2073847|FG003|Registration and Treatment Start|Adverse Event|0
1040428|NCT01738594|2073848|FG004|Registration and Treatment Start|Adverse Event|0
1040429|NCT01738594|2073849|FG005|Registration and Treatment Start|Adverse Event|0
1040430|NCT01738594|2073850|FG006|Registration and Treatment Start|Adverse Event|0
1040431|NCT01738594|2073851|FG007|Registration and Treatment Start|Adverse Event|0
1040432|NCT01738594|2073844|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1040433|NCT01738594|2073845|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1040434|NCT01738594|2073846|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1040435|NCT01738594|2073847|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1040436|NCT01738594|2073848|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1040437|NCT01738594|2073849|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
1040438|NCT01738594|2073850|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1040439|NCT01738594|2073851|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1040440|NCT01738594|2073844|FG000|Completed 4 Cycles of Treatment|Progressive disease|0
1040441|NCT01738594|2073845|FG001|Completed 4 Cycles of Treatment|Progressive disease|2
1040442|NCT01738594|2073846|FG002|Completed 4 Cycles of Treatment|Progressive disease|0
1040443|NCT01738594|2073847|FG003|Completed 4 Cycles of Treatment|Progressive disease|0
1040444|NCT01738594|2073848|FG004|Completed 4 Cycles of Treatment|Progressive disease|0
1040445|NCT01738594|2073849|FG005|Completed 4 Cycles of Treatment|Progressive disease|0
1040446|NCT01738594|2073850|FG006|Completed 4 Cycles of Treatment|Progressive disease|0
1040447|NCT01738594|2073851|FG007|Completed 4 Cycles of Treatment|Progressive disease|0
1040448|NCT01738594|2073844|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0
1040449|NCT01738594|2073845|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0
1040450|NCT01738594|2073846|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0
1040451|NCT01738594|2073847|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0
1040452|NCT01738594|2073848|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0
1040453|NCT01738594|2073849|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1
1040454|NCT01738594|2073850|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0
1040455|NCT01738594|2073851|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0
1040456|NCT01738594|2073844|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1040457|NCT01738594|2073845|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1040458|NCT01738594|2073846|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1040459|NCT01738594|2073847|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1040460|NCT01738594|2073848|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1040461|NCT01738594|2073849|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1
1040462|NCT01738594|2073850|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1040463|NCT01738594|2073851|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1040464|NCT01738594|2073844|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1040465|NCT01738594|2073845|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1040466|NCT01738594|2073846|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1040467|NCT01738594|2073847|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1040468|NCT01738594|2073848|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
1040469|NCT01738594|2073849|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1040470|NCT01738594|2073850|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1040471|NCT01738594|2073851|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1040472|NCT01738594|2073844|FG000|Follow up for 1 Year|Death|0
1040473|NCT01738594|2073845|FG001|Follow up for 1 Year|Death|0
1040474|NCT01738594|2073846|FG002|Follow up for 1 Year|Death|0
1040475|NCT01738594|2073847|FG003|Follow up for 1 Year|Death|0
1040476|NCT01738594|2073848|FG004|Follow up for 1 Year|Death|0
1040477|NCT01738594|2073849|FG005|Follow up for 1 Year|Death|1
1040478|NCT01738594|2073850|FG006|Follow up for 1 Year|Death|0
1040479|NCT01738594|2073851|FG007|Follow up for 1 Year|Death|0
1040480|NCT01738594|2073844|FG000|Follow up for 1 Year|Other|0
1040481|NCT01738594|2073845|FG001|Follow up for 1 Year|Other|0
1040482|NCT01738594|2073846|FG002|Follow up for 1 Year|Other|0
1040483|NCT01738594|2073847|FG003|Follow up for 1 Year|Other|0
1040484|NCT01738594|2073848|FG004|Follow up for 1 Year|Other|0
1040485|NCT01738594|2073849|FG005|Follow up for 1 Year|Other|2
1040486|NCT01738594|2073850|FG006|Follow up for 1 Year|Other|0
1040487|NCT01738594|2073851|FG007|Follow up for 1 Year|Other|0
1040488|NCT01738646|2073861|FG000|Overall Study|Still Receiving Treatment|2
1040489|NCT01738919|2073904|FG000|Overall Study|Lost to Follow-up|1
1040490|NCT01738919|2073905|FG001|Overall Study|Lost to Follow-up|0
1040491|NCT01738919|2073904|FG000|Overall Study|Immigrated|0
1040492|NCT01738919|2073905|FG001|Overall Study|Immigrated|1
1040493|NCT01738919|2073904|FG000|Overall Study|Withdrawal by Subject|0
1040494|NCT01738919|2073905|FG001|Overall Study|Withdrawal by Subject|1
1040495|NCT01738919|2073904|FG000|Overall Study|Not treated in accordance to guidelines|0
1040496|NCT01738919|2073905|FG001|Overall Study|Not treated in accordance to guidelines|1
1040497|NCT01738971|2073916|FG000|Overall Study|Lost to Follow-up|19
1040498|NCT01738971|2073917|FG001|Overall Study|Lost to Follow-up|30
1040499|NCT01738971|2073918|FG002|Overall Study|Lost to Follow-up|17
1040500|NCT01738984|2073928|FG000|Overall Study|Pregnancy|4
1040501|NCT01738984|2073929|FG001|Overall Study|Pregnancy|0
1040502|NCT01738984|2073928|FG000|Overall Study|Withdrawal by Subject|1
1040503|NCT01738984|2073929|FG001|Overall Study|Withdrawal by Subject|0
1040504|NCT01738984|2073928|FG000|Overall Study|Lost to Follow-up|59
1040505|NCT01738984|2073929|FG001|Overall Study|Lost to Follow-up|39
1040506|NCT01739309|2073962|FG000|Overall Study|On study treatment|3
1040507|NCT01739335|2073970|FG000|Overall Study|Lost to Follow-up|7
1040508|NCT01739335|2073971|FG001|Overall Study|Lost to Follow-up|4
1040509|NCT01739335|2073970|FG000|Overall Study|Ineligible patient randomized|0
1040510|NCT01739335|2073971|FG001|Overall Study|Ineligible patient randomized|1
1040511|NCT01739348|2073985|FG000|Part I (Base Study)|Adverse Event|41
1040512|NCT01739348|2073986|FG001|Part I (Base Study)|Adverse Event|52
1040513|NCT01739348|2073987|FG002|Part I (Base Study)|Adverse Event|8
1040514|NCT01739348|2073988|FG003|Part I (Base Study)|Adverse Event|33
1040515|NCT01739348|2073985|FG000|Part I (Base Study)|Death|10
1040516|NCT01739348|2073986|FG001|Part I (Base Study)|Death|7
1040517|NCT01739348|2073987|FG002|Part I (Base Study)|Death|2
1040518|NCT01739348|2073988|FG003|Part I (Base Study)|Death|8
1040519|NCT01739348|2073985|FG000|Part I (Base Study)|Lack of Efficacy|3
1040520|NCT01739348|2073986|FG001|Part I (Base Study)|Lack of Efficacy|8
1040521|NCT01739348|2073987|FG002|Part I (Base Study)|Lack of Efficacy|0
1040522|NCT01739348|2073988|FG003|Part I (Base Study)|Lack of Efficacy|7
1040523|NCT01739348|2073985|FG000|Part I (Base Study)|Lost to Follow-up|4
1040524|NCT01739348|2073986|FG001|Part I (Base Study)|Lost to Follow-up|2
1040525|NCT01739348|2073987|FG002|Part I (Base Study)|Lost to Follow-up|4
1040526|NCT01739348|2073988|FG003|Part I (Base Study)|Lost to Follow-up|4
1040527|NCT01739348|2073985|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3
1040528|NCT01739348|2073986|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2
1040529|NCT01739348|2073987|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0
1040530|NCT01739348|2073988|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0
1040531|NCT01739348|2073985|FG000|Part I (Base Study)|Physician Decision|10
1040532|NCT01739348|2073986|FG001|Part I (Base Study)|Physician Decision|7
1040533|NCT01739348|2073987|FG002|Part I (Base Study)|Physician Decision|1
1040534|NCT01739348|2073988|FG003|Part I (Base Study)|Physician Decision|4
1040535|NCT01739348|2073985|FG000|Part I (Base Study)|Protocol Violation|2
1040536|NCT01739348|2073986|FG001|Part I (Base Study)|Protocol Violation|0
1040537|NCT01739348|2073987|FG002|Part I (Base Study)|Protocol Violation|1
1040538|NCT01739348|2073988|FG003|Part I (Base Study)|Protocol Violation|2
1040539|NCT01739348|2073985|FG000|Part I (Base Study)|Screen Failure|2
1040540|NCT01739348|2073986|FG001|Part I (Base Study)|Screen Failure|0
1040541|NCT01739348|2073987|FG002|Part I (Base Study)|Screen Failure|0
1040542|NCT01739348|2073988|FG003|Part I (Base Study)|Screen Failure|0
1040543|NCT01739348|2073985|FG000|Part I (Base Study)|Site Discontinued Study Participation|1
1040544|NCT01739348|2073986|FG001|Part I (Base Study)|Site Discontinued Study Participation|3
1040545|NCT01739348|2073987|FG002|Part I (Base Study)|Site Discontinued Study Participation|0
1040546|NCT01739348|2073988|FG003|Part I (Base Study)|Site Discontinued Study Participation|0
1040547|NCT01739348|2073985|FG000|Part I (Base Study)|Study Terminated by Sponsor|72
1040548|NCT01739348|2073986|FG001|Part I (Base Study)|Study Terminated by Sponsor|73
1040549|NCT01739348|2073987|FG002|Part I (Base Study)|Study Terminated by Sponsor|0
1040550|NCT01739348|2073988|FG003|Part I (Base Study)|Study Terminated by Sponsor|86
1040551|NCT01739348|2073985|FG000|Part I (Base Study)|Participant Moved|4
1040552|NCT01739348|2073986|FG001|Part I (Base Study)|Participant Moved|3
1040553|NCT01739348|2073987|FG002|Part I (Base Study)|Participant Moved|1
1040554|NCT01739348|2073988|FG003|Part I (Base Study)|Participant Moved|7
1040555|NCT01739348|2073985|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
1040556|NCT01739348|2073986|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
1040557|NCT01739348|2073987|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
1040558|NCT01739348|2073988|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
1040559|NCT01739348|2073985|FG000|Part I (Base Study)|Withdrawal by Subject|23
1040560|NCT01739348|2073986|FG001|Part I (Base Study)|Withdrawal by Subject|21
1040561|NCT01739348|2073987|FG002|Part I (Base Study)|Withdrawal by Subject|7
1040562|NCT01739348|2073988|FG003|Part I (Base Study)|Withdrawal by Subject|20
1040563|NCT01739348|2073985|FG000|Part II (Extension Study)|Adverse Event|10
1040564|NCT01739348|2073986|FG001|Part II (Extension Study)|Adverse Event|11
1040565|NCT01739348|2073987|FG002|Part II (Extension Study)|Adverse Event|7
1040566|NCT01739348|2073988|FG003|Part II (Extension Study)|Adverse Event|26
1040567|NCT01739348|2073985|FG000|Part II (Extension Study)|Death|3
1040568|NCT01739348|2073986|FG001|Part II (Extension Study)|Death|3
1040569|NCT01739348|2073987|FG002|Part II (Extension Study)|Death|2
1040570|NCT01739348|2073988|FG003|Part II (Extension Study)|Death|6
1040571|NCT01739348|2073985|FG000|Part II (Extension Study)|Lack of Efficacy|1
1040572|NCT01739348|2073986|FG001|Part II (Extension Study)|Lack of Efficacy|5
1040573|NCT01739348|2073987|FG002|Part II (Extension Study)|Lack of Efficacy|0
1040574|NCT01739348|2073988|FG003|Part II (Extension Study)|Lack of Efficacy|1
1040575|NCT01739348|2073985|FG000|Part II (Extension Study)|Lost to Follow-up|3
1040576|NCT01739348|2073986|FG001|Part II (Extension Study)|Lost to Follow-up|4
1040577|NCT01739348|2073987|FG002|Part II (Extension Study)|Lost to Follow-up|0
1040578|NCT01739348|2073988|FG003|Part II (Extension Study)|Lost to Follow-up|1
1040579|NCT01739348|2073985|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0
1040580|NCT01739348|2073986|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0
1040581|NCT01739348|2073987|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0
1040582|NCT01739348|2073988|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1
1040583|NCT01739348|2073985|FG000|Part II (Extension Study)|Physician Decision|7
1040584|NCT01739348|2073986|FG001|Part II (Extension Study)|Physician Decision|11
1040585|NCT01739348|2073987|FG002|Part II (Extension Study)|Physician Decision|6
1040586|NCT01739348|2073988|FG003|Part II (Extension Study)|Physician Decision|12
1040587|NCT01739348|2073985|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329
1040588|NCT01739348|2073986|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315
1040589|NCT01739348|2073987|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34
1040590|NCT01739348|2073988|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323
1040591|NCT01739348|2073985|FG000|Part II (Extension Study)|Participant Moved|3
1040592|NCT01739348|2073986|FG001|Part II (Extension Study)|Participant Moved|3
1040593|NCT01739348|2073987|FG002|Part II (Extension Study)|Participant Moved|0
1040594|NCT01739348|2073988|FG003|Part II (Extension Study)|Participant Moved|3
1040595|NCT01739348|2073985|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
1040596|NCT01739348|2073986|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
1040597|NCT01739348|2073987|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
1040598|NCT01739348|2073988|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
1040599|NCT01739348|2073985|FG000|Part II (Extension Study)|Withdrawal by Subject|5
1040600|NCT01739348|2073986|FG001|Part II (Extension Study)|Withdrawal by Subject|2
1040601|NCT01739348|2073987|FG002|Part II (Extension Study)|Withdrawal by Subject|4
1040602|NCT01739348|2073988|FG003|Part II (Extension Study)|Withdrawal by Subject|7
1040603|NCT01739400|2074013|FG000|Overall Study|Physician Decision|3
1040604|NCT01739400|2074014|FG001|Overall Study|Physician Decision|0
1040605|NCT01739400|2074013|FG000|Overall Study|Lost to Follow-up|2
1040606|NCT01739400|2074014|FG001|Overall Study|Lost to Follow-up|0
1040607|NCT01739400|2074013|FG000|Overall Study|Death|5
1040608|NCT01739400|2074014|FG001|Overall Study|Death|2
1040609|NCT01739400|2074013|FG000|Overall Study|Withdrawal by Subject|7
1040610|NCT01739400|2074014|FG001|Overall Study|Withdrawal by Subject|7
1040611|NCT01739595|2074022|FG000|Overall Study|Adverse Event|3
1040612|NCT01739595|2074023|FG001|Overall Study|Adverse Event|0
1040613|NCT01739595|2074024|FG002|Overall Study|Adverse Event|0
1040614|NCT01739595|2074022|FG000|Overall Study|Lost to Follow-up|2
1040615|NCT01739595|2074023|FG001|Overall Study|Lost to Follow-up|0
1040616|NCT01739595|2074024|FG002|Overall Study|Lost to Follow-up|0
1040617|NCT01739595|2074022|FG000|Overall Study|Withdrawal by Subject|2
1040618|NCT01739595|2074023|FG001|Overall Study|Withdrawal by Subject|1
1040619|NCT01739595|2074024|FG002|Overall Study|Withdrawal by Subject|2
1040620|NCT01739595|2074022|FG000|Overall Study|Eligibility issue|3
1040621|NCT01739595|2074023|FG001|Overall Study|Eligibility issue|0
1040622|NCT01739595|2074024|FG002|Overall Study|Eligibility issue|0
1040623|NCT01739595|2074022|FG000|Overall Study|Protocol Violation|1
1040624|NCT01739595|2074023|FG001|Overall Study|Protocol Violation|0
1040625|NCT01739595|2074024|FG002|Overall Study|Protocol Violation|0
1040626|NCT01739595|2074022|FG000|Overall Study|Lab assessment|1
1040627|NCT01739595|2074023|FG001|Overall Study|Lab assessment|0
1040628|NCT01739595|2074024|FG002|Overall Study|Lab assessment|0
1040629|NCT01739595|2074022|FG000|Overall Study|Drug discrepancy|1
1040630|NCT01739595|2074023|FG001|Overall Study|Drug discrepancy|0
1040631|NCT01739595|2074024|FG002|Overall Study|Drug discrepancy|0
1040632|NCT01739764|2074043|FG000|Overall Study|Adverse Event|0
1040633|NCT01739764|2074044|FG001|Overall Study|Adverse Event|3
1040634|NCT01739764|2074045|FG002|Overall Study|Adverse Event|4
1040635|NCT01739764|2074043|FG000|Overall Study|Death|4
1040636|NCT01739764|2074044|FG001|Overall Study|Death|6
1040637|NCT01739764|2074045|FG002|Overall Study|Death|38
1040638|NCT01739764|2074043|FG000|Overall Study|Lost to Follow-up|0
1040639|NCT01739764|2074044|FG001|Overall Study|Lost to Follow-up|0
1040640|NCT01739764|2074045|FG002|Overall Study|Lost to Follow-up|5
1040641|NCT01739764|2074043|FG000|Overall Study|Non-Compliance|0
1040642|NCT01739764|2074044|FG001|Overall Study|Non-Compliance|0
1040643|NCT01739764|2074045|FG002|Overall Study|Non-Compliance|1
1040644|NCT01739764|2074043|FG000|Overall Study|Multiple Reasons|3
1040645|NCT01739764|2074044|FG001|Overall Study|Multiple Reasons|2
1040646|NCT01739764|2074045|FG002|Overall Study|Multiple Reasons|3
1040647|NCT01739764|2074043|FG000|Overall Study|Physician Decision|2
1040648|NCT01739764|2074044|FG001|Overall Study|Physician Decision|2
1040649|NCT01739764|2074045|FG002|Overall Study|Physician Decision|4
1040650|NCT01739764|2074043|FG000|Overall Study|Progressive Disease|3
1040651|NCT01739764|2074044|FG001|Overall Study|Progressive Disease|5
1040652|NCT01739764|2074045|FG002|Overall Study|Progressive Disease|16
1040653|NCT01739764|2074043|FG000|Overall Study|Protocol Violation|0
1040654|NCT01739764|2074044|FG001|Overall Study|Protocol Violation|0
1040655|NCT01739764|2074045|FG002|Overall Study|Protocol Violation|2
1040656|NCT01739764|2074043|FG000|Overall Study|Study Terminated by Sponsor|8
1040657|NCT01739764|2074044|FG001|Overall Study|Study Terminated by Sponsor|13
1040658|NCT01739764|2074045|FG002|Overall Study|Study Terminated by Sponsor|26
1040659|NCT01739764|2074043|FG000|Overall Study|Withdrawal by Subject|6
1040660|NCT01739764|2074044|FG001|Overall Study|Withdrawal by Subject|5
1040661|NCT01739764|2074045|FG002|Overall Study|Withdrawal by Subject|27
1040662|NCT01739790|2074055|FG000|Overall Study|Early Trial Termination|2
1040663|NCT01739790|2074056|FG001|Overall Study|Early Trial Termination|4
1040664|NCT01739803|2074064|FG000|Overall Study|Lost to Follow-up|9
1040665|NCT01739803|2074065|FG001|Overall Study|Lost to Follow-up|6
1040666|NCT01739933|2074073|FG000|Overall Study|Death|89
1040667|NCT01739933|2074074|FG001|Overall Study|Death|86
1040668|NCT01739933|2074073|FG000|Overall Study|Withdrawal by Subject|10
1040669|NCT01739933|2074074|FG001|Overall Study|Withdrawal by Subject|8
1040670|NCT01739933|2074073|FG000|Overall Study|Lost to Follow-up|3
1040671|NCT01739933|2074074|FG001|Overall Study|Lost to Follow-up|10
1040672|NCT01739933|2074073|FG000|Overall Study|Did not speak English required for neurospychological testing|4
1040673|NCT01739933|2074074|FG001|Overall Study|Did not speak English required for neurospychological testing|3
1040674|NCT01740089|2074083|FG000|First 12 Weeks of Treatment|Adverse Event|0
1040675|NCT01740089|2074084|FG001|First 12 Weeks of Treatment|Adverse Event|1
1040676|NCT01740089|2074085|FG002|First 12 Weeks of Treatment|Adverse Event|2
1040677|NCT01740089|2074083|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0
1040678|NCT01740089|2074084|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1
1040679|NCT01740089|2074085|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0
1040680|NCT01740089|2074083|FG000|After 12 Weeks|Lack of Efficacy|3
1040681|NCT01740089|2074084|FG001|After 12 Weeks|Lack of Efficacy|1
1040682|NCT01740089|2074085|FG002|After 12 Weeks|Lack of Efficacy|4
1040683|NCT01740089|2074083|FG000|After 12 Weeks|Adverse Event|2
1040684|NCT01740089|2074084|FG001|After 12 Weeks|Adverse Event|0
1040685|NCT01740089|2074085|FG002|After 12 Weeks|Adverse Event|5
1040686|NCT01740089|2074083|FG000|After 12 Weeks|Protocol Violation|1
1040687|NCT01740089|2074084|FG001|After 12 Weeks|Protocol Violation|1
1040688|NCT01740089|2074085|FG002|After 12 Weeks|Protocol Violation|1
1040689|NCT01740089|2074083|FG000|After 12 Weeks|Withdrawal by Subject|1
1040690|NCT01740089|2074084|FG001|After 12 Weeks|Withdrawal by Subject|1
1040691|NCT01740089|2074085|FG002|After 12 Weeks|Withdrawal by Subject|1
1040692|NCT01740128|2074096|FG000|Overall Study|Pregnancy|0
1040693|NCT01740128|2074097|FG001|Overall Study|Pregnancy|1
1040694|NCT01740128|2074096|FG000|Overall Study|Protocol Violation|1
1040695|NCT01740128|2074097|FG001|Overall Study|Protocol Violation|2
1040696|NCT01740128|2074096|FG000|Overall Study|Lost to Follow-up|2
1040697|NCT01740128|2074097|FG001|Overall Study|Lost to Follow-up|2
1040698|NCT01740128|2074096|FG000|Overall Study|Withdrawal by Subject|1
1040699|NCT01740128|2074097|FG001|Overall Study|Withdrawal by Subject|0
1040700|NCT01740128|2074096|FG000|Overall Study|Insufficient protocol compliance|2
1040701|NCT01740128|2074097|FG001|Overall Study|Insufficient protocol compliance|2
1040702|NCT01740297|2074119|FG000|Overall Study|Continuing Study|10
1040703|NCT01740297|2074120|FG001|Overall Study|Continuing Study|67
1040704|NCT01740297|2074121|FG002|Overall Study|Continuing Study|68
1040705|NCT01740297|2074119|FG000|Overall Study|Withdrawal by Subject|1
1040706|NCT01740297|2074120|FG001|Overall Study|Withdrawal by Subject|9
1040707|NCT01740297|2074121|FG002|Overall Study|Withdrawal by Subject|11
1040708|NCT01740297|2074119|FG000|Overall Study|Death|8
1040709|NCT01740297|2074120|FG001|Overall Study|Death|23
1040710|NCT01740297|2074121|FG002|Overall Study|Death|19
1040711|NCT01740297|2074119|FG000|Overall Study|Sponsor Decision|0
1040712|NCT01740297|2074120|FG001|Overall Study|Sponsor Decision|1
1040713|NCT01740297|2074121|FG002|Overall Study|Sponsor Decision|0
1040714|NCT01740323|2074133|FG000|Overall Study|Adverse Event|1
1040715|NCT01740323|2074134|FG001|Overall Study|Adverse Event|0
1040716|NCT01740323|2074133|FG000|Overall Study|Randomized but did not take study drug|1
1040717|NCT01740323|2074134|FG001|Overall Study|Randomized but did not take study drug|0
1040718|NCT01740388|2074159|FG000|Overall Study|Withdrawal by Subject|1
1040719|NCT01740388|2074160|FG001|Overall Study|Withdrawal by Subject|2
1040720|NCT01740388|2074159|FG000|Overall Study|Lost to Follow-up|2
1040721|NCT01740388|2074160|FG001|Overall Study|Lost to Follow-up|0
1040722|NCT01740388|2074159|FG000|Overall Study|Physician Decision|2
1040723|NCT01740388|2074160|FG001|Overall Study|Physician Decision|6
1040724|NCT01740388|2074159|FG000|Overall Study|Subjects missing data, completed|41
1040725|NCT01740388|2074160|FG001|Overall Study|Subjects missing data, completed|36
1040726|NCT01740401|2074166|FG000|Overall Study|Progression of disease|6
1040727|NCT01740401|2074166|FG000|Overall Study|Adverse Event|2
1040728|NCT01740401|2074166|FG000|Overall Study|Did not reach primary endpoint|2
1040729|NCT01740427|2074186|FG000|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
1040730|NCT01740427|2074187|FG001|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
1040731|NCT01740427|2074186|FG000|Overall Study|Objective progression or relapse|172
1040732|NCT01740427|2074187|FG001|Overall Study|Objective progression or relapse|125
1040733|NCT01740427|2074186|FG000|Overall Study|Adverse Event|20
1040734|NCT01740427|2074187|FG001|Overall Study|Adverse Event|9
1040735|NCT01740427|2074186|FG000|Overall Study|Global deterioration of health status|16
1040736|NCT01740427|2074187|FG001|Overall Study|Global deterioration of health status|9
1040737|NCT01740427|2074186|FG000|Overall Study|Subject refused continued treatment|12
1040738|NCT01740427|2074187|FG001|Overall Study|Subject refused continued treatment|9
1040739|NCT01740427|2074186|FG000|Overall Study|Unspecified reasons|6
1040740|NCT01740427|2074187|FG001|Overall Study|Unspecified reasons|4
1040741|NCT01740427|2074186|FG000|Overall Study|Death|6
1040742|NCT01740427|2074187|FG001|Overall Study|Death|2
1040743|NCT01740427|2074186|FG000|Overall Study|Protocol Violation|5
1040744|NCT01740427|2074187|FG001|Overall Study|Protocol Violation|3
1040745|NCT01740427|2074186|FG000|Overall Study|Lost to Follow-up|1
1040746|NCT01740427|2074187|FG001|Overall Study|Lost to Follow-up|0
1040747|NCT01740427|2074186|FG000|Overall Study|Study terminated by Sponsor|1
1040748|NCT01740427|2074187|FG001|Overall Study|Study terminated by Sponsor|0
1040749|NCT01740440|2074193|FG000|Overall Study|Lost to Follow-up|3
1040750|NCT01740791|2074228|FG000|Overall Study|Randomized but never treated|5
1040751|NCT01740791|2074229|FG001|Overall Study|Randomized but never treated|3
1040752|NCT01740791|2074230|FG002|Overall Study|Randomized but never treated|2
1040753|NCT01740791|2074231|FG003|Overall Study|Randomized but never treated|2
1040754|NCT01740791|2074232|FG004|Overall Study|Randomized but never treated|1
1040755|NCT01740791|2074233|FG005|Overall Study|Randomized but never treated|3
1040756|NCT01740791|2074228|FG000|Overall Study|Lost to Follow-up|2
1040757|NCT01740791|2074229|FG001|Overall Study|Lost to Follow-up|0
1040758|NCT01740791|2074230|FG002|Overall Study|Lost to Follow-up|2
1040759|NCT01740791|2074231|FG003|Overall Study|Lost to Follow-up|3
1040760|NCT01740791|2074232|FG004|Overall Study|Lost to Follow-up|2
1040761|NCT01740791|2074233|FG005|Overall Study|Lost to Follow-up|3
1040762|NCT01740791|2074228|FG000|Overall Study|Withdrew Consent|4
1040763|NCT01740791|2074229|FG001|Overall Study|Withdrew Consent|0
1040764|NCT01740791|2074230|FG002|Overall Study|Withdrew Consent|1
1040765|NCT01740791|2074231|FG003|Overall Study|Withdrew Consent|2
1040766|NCT01740791|2074232|FG004|Overall Study|Withdrew Consent|0
1040767|NCT01740791|2074233|FG005|Overall Study|Withdrew Consent|3
1040768|NCT01740791|2074228|FG000|Overall Study|Investigator's discretion|1
1040769|NCT01740791|2074229|FG001|Overall Study|Investigator's discretion|0
1040770|NCT01740791|2074230|FG002|Overall Study|Investigator's discretion|1
1040771|NCT01740791|2074231|FG003|Overall Study|Investigator's discretion|0
1040772|NCT01740791|2074232|FG004|Overall Study|Investigator's discretion|0
1040773|NCT01740791|2074233|FG005|Overall Study|Investigator's discretion|1
1040774|NCT01740791|2074228|FG000|Overall Study|Adverse Event|0
1040775|NCT01740791|2074229|FG001|Overall Study|Adverse Event|0
1040776|NCT01740791|2074230|FG002|Overall Study|Adverse Event|0
1040777|NCT01740791|2074231|FG003|Overall Study|Adverse Event|0
1040778|NCT01740791|2074232|FG004|Overall Study|Adverse Event|0
1040779|NCT01740791|2074233|FG005|Overall Study|Adverse Event|1
1040780|NCT01741012|2074295|FG000|Overall Study|Lost to Follow-up|1
1040781|NCT01741012|2074295|FG000|Overall Study|Withdrawal by Subject|2
1040782|NCT01741259|2074302|FG000|Overall Study|Protocol Violation|6
1040783|NCT01741259|2074303|FG001|Overall Study|Protocol Violation|4
1040784|NCT01741259|2074302|FG000|Overall Study|Withdrawal by Subject|0
1040785|NCT01741259|2074303|FG001|Overall Study|Withdrawal by Subject|2
1090863|NCT02249091|2158597|FG000|Overall Study|Stable disease with following SCT|0
1090864|NCT02249091|2158598|FG001|Overall Study|Stable disease with following SCT|1
1090865|NCT02249091|2158597|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0
1090866|NCT02249091|2158598|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1
1090867|NCT02249091|2158597|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1
1090868|NCT02249091|2158598|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0
1090869|NCT02249091|2158597|FG000|Overall Study|Refractory AML|1
1090870|NCT02249091|2158598|FG001|Overall Study|Refractory AML|1
1090871|NCT02249182|2158622|FG000|Treatment Phase|Lost to Follow-up|4
1090872|NCT02249182|2158623|FG001|Treatment Phase|Lost to Follow-up|0
1090873|NCT02249182|2158624|FG002|Treatment Phase|Lost to Follow-up|0
1090874|NCT02249182|2158625|FG003|Treatment Phase|Lost to Follow-up|0
1090875|NCT02249182|2158626|FG004|Treatment Phase|Lost to Follow-up|0
1090876|NCT02249767|2158674|FG000|Overall Study|Did not use medication|8
1090877|NCT02249767|2158675|FG001|Overall Study|Did not use medication|9
1090878|NCT02249767|2158676|FG002|Overall Study|Did not use medication|8
1090879|NCT02249832|2158696|FG000|Overall Study|Withdrawal by Subject|3
1090880|NCT02249832|2158696|FG000|Overall Study|Lost to Follow-up|10
1090881|NCT02249949|2158705|FG000|Overall Study|Cancelled prior to treatment|2
1090882|NCT02250183|2158718|FG000|Overall Study|Withdrawal by Subject|2
1090883|NCT02250183|2158718|FG000|Overall Study|Adverse Event|5
1090884|NCT02250183|2158718|FG000|Overall Study|Lost to Follow-up|1
1090885|NCT02250274|2158727|FG000|Overall Study|Insufficient blood draw amount|7
1090886|NCT02250274|2158728|FG001|Overall Study|Insufficient blood draw amount|6
1040786|NCT01741532|2074359|FG000|Overall Study|Adverse Event|4
1040787|NCT01741532|2074360|FG001|Overall Study|Adverse Event|0
1040788|NCT01741532|2074359|FG000|Overall Study|Withdrawal by Subject|1
1040789|NCT01741532|2074360|FG001|Overall Study|Withdrawal by Subject|1
1040790|NCT01741532|2074359|FG000|Overall Study|Protocol Violation|0
1040791|NCT01741532|2074360|FG001|Overall Study|Protocol Violation|1
1040792|NCT01741532|2074359|FG000|Overall Study|Worsening of the disease|3
1040793|NCT01741532|2074360|FG001|Overall Study|Worsening of the disease|1
1040794|NCT01741532|2074359|FG000|Overall Study|Sponsor decision|1
1040795|NCT01741532|2074360|FG001|Overall Study|Sponsor decision|0
1040796|NCT01741532|2074359|FG000|Overall Study|Medical event|1
1040797|NCT01741532|2074360|FG001|Overall Study|Medical event|0
1040798|NCT01741545|2074372|FG000|Treatment Period|Lack of Efficacy|0
1040799|NCT01741545|2074373|FG001|Treatment Period|Lack of Efficacy|1
1040800|NCT01741545|2074372|FG000|Treatment Period|Adverse event, non-fatal|1
1040801|NCT01741545|2074373|FG001|Treatment Period|Adverse event, non-fatal|3
1040802|NCT01741545|2074372|FG000|Follow-up Period (24 Weeks)|Other than specified|0
1040803|NCT01741545|2074373|FG001|Follow-up Period (24 Weeks)|Other than specified|1
1040804|NCT01741545|2074372|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
1040805|NCT01741545|2074373|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
1040806|NCT01741688|2074379|FG000|Overall Study|Lack of insurance coverage|2
1040807|NCT01741688|2074379|FG000|Overall Study|Withdrawal by Subject|1
1040808|NCT01741701|2074386|FG000|Overall Study|Adverse Event|5
1040809|NCT01741701|2074387|FG001|Overall Study|Adverse Event|1
1040810|NCT01741701|2074386|FG000|Overall Study|Withdrawal by Subject|0
1040811|NCT01741701|2074387|FG001|Overall Study|Withdrawal by Subject|1
1040812|NCT01741792|2074396|FG000|Overall Study|Death|6
1040813|NCT01741792|2074397|FG001|Overall Study|Death|1
1040814|NCT01741792|2074398|FG002|Overall Study|Death|12
1040815|NCT01742078|2074430|FG000|Overall Study|Withdrawal by Subject|0
1040816|NCT01742078|2074431|FG001|Overall Study|Withdrawal by Subject|0
1040817|NCT01742078|2074432|FG002|Overall Study|Withdrawal by Subject|0
1040818|NCT01742078|2074433|FG003|Overall Study|Withdrawal by Subject|1
1040819|NCT01742078|2074434|FG004|Overall Study|Withdrawal by Subject|0
1040820|NCT01742078|2074435|FG005|Overall Study|Withdrawal by Subject|0
1040821|NCT01742078|2074436|FG006|Overall Study|Withdrawal by Subject|0
1040822|NCT01742078|2074437|FG007|Overall Study|Withdrawal by Subject|0
1040823|NCT01742078|2074438|FG008|Overall Study|Withdrawal by Subject|0
1040824|NCT01742091|2074466|FG000|Overall Study|Adverse Event|0
1040825|NCT01742091|2074467|FG001|Overall Study|Adverse Event|0
1040826|NCT01742091|2074468|FG002|Overall Study|Adverse Event|0
1040827|NCT01742091|2074469|FG003|Overall Study|Adverse Event|0
1040828|NCT01742091|2074470|FG004|Overall Study|Adverse Event|1
1040829|NCT01742091|2074471|FG005|Overall Study|Adverse Event|0
1040830|NCT01742091|2074466|FG000|Overall Study|Physician Decision|0
1040831|NCT01742091|2074467|FG001|Overall Study|Physician Decision|0
1040832|NCT01742091|2074468|FG002|Overall Study|Physician Decision|0
1040833|NCT01742091|2074469|FG003|Overall Study|Physician Decision|0
1040834|NCT01742091|2074470|FG004|Overall Study|Physician Decision|0
1040835|NCT01742091|2074471|FG005|Overall Study|Physician Decision|1
1040836|NCT01742091|2074466|FG000|Overall Study|Withdrawal by Subject|0
1040837|NCT01742091|2074467|FG001|Overall Study|Withdrawal by Subject|0
1040838|NCT01742091|2074468|FG002|Overall Study|Withdrawal by Subject|0
1040839|NCT01742091|2074469|FG003|Overall Study|Withdrawal by Subject|1
1040840|NCT01742091|2074470|FG004|Overall Study|Withdrawal by Subject|0
1040841|NCT01742091|2074471|FG005|Overall Study|Withdrawal by Subject|0
1040842|NCT01742091|2074466|FG000|Overall Study|Lost to Follow-up|0
1040843|NCT01742091|2074467|FG001|Overall Study|Lost to Follow-up|0
1040844|NCT01742091|2074468|FG002|Overall Study|Lost to Follow-up|0
1040845|NCT01742091|2074469|FG003|Overall Study|Lost to Follow-up|0
1040846|NCT01742091|2074470|FG004|Overall Study|Lost to Follow-up|0
1040847|NCT01742091|2074471|FG005|Overall Study|Lost to Follow-up|1
1040848|NCT01742286|2074516|FG000|Escalation Phase|Administrative problems|1
1040849|NCT01742286|2074517|FG001|Escalation Phase|Administrative problems|1
1040850|NCT01742286|2074518|FG002|Escalation Phase|Administrative problems|0
1040851|NCT01742286|2074519|FG003|Escalation Phase|Administrative problems|0
1040852|NCT01742286|2074520|FG004|Escalation Phase|Administrative problems|0
1040853|NCT01742286|2074521|FG005|Escalation Phase|Administrative problems|0
1040854|NCT01742286|2074522|FG006|Escalation Phase|Administrative problems|2
1040855|NCT01742286|2074516|FG000|Escalation Phase|Adverse Event|0
1040856|NCT01742286|2074517|FG001|Escalation Phase|Adverse Event|1
1040857|NCT01742286|2074518|FG002|Escalation Phase|Adverse Event|2
1040858|NCT01742286|2074519|FG003|Escalation Phase|Adverse Event|0
1040859|NCT01742286|2074520|FG004|Escalation Phase|Adverse Event|0
1040860|NCT01742286|2074521|FG005|Escalation Phase|Adverse Event|1
1040861|NCT01742286|2074522|FG006|Escalation Phase|Adverse Event|0
1040862|NCT01742286|2074516|FG000|Escalation Phase|Disease progression|3
1040863|NCT01742286|2074517|FG001|Escalation Phase|Disease progression|7
1040864|NCT01742286|2074518|FG002|Escalation Phase|Disease progression|4
1040865|NCT01742286|2074519|FG003|Escalation Phase|Disease progression|1
1040866|NCT01742286|2074520|FG004|Escalation Phase|Disease progression|4
1040867|NCT01742286|2074521|FG005|Escalation Phase|Disease progression|3
1040868|NCT01742286|2074522|FG006|Escalation Phase|Disease progression|2
1040869|NCT01742286|2074516|FG000|Escalation Phase|Death|0
1040870|NCT01742286|2074517|FG001|Escalation Phase|Death|0
1040871|NCT01742286|2074518|FG002|Escalation Phase|Death|0
1040872|NCT01742286|2074519|FG003|Escalation Phase|Death|0
1040873|NCT01742286|2074520|FG004|Escalation Phase|Death|0
1040874|NCT01742286|2074521|FG005|Escalation Phase|Death|1
1040875|NCT01742286|2074522|FG006|Escalation Phase|Death|0
1040876|NCT01742286|2074516|FG000|Escalation Phase|Physician Decision|0
1040877|NCT01742286|2074517|FG001|Escalation Phase|Physician Decision|3
1040878|NCT01742286|2074518|FG002|Escalation Phase|Physician Decision|0
1040879|NCT01742286|2074519|FG003|Escalation Phase|Physician Decision|1
1040880|NCT01742286|2074520|FG004|Escalation Phase|Physician Decision|0
1040881|NCT01742286|2074521|FG005|Escalation Phase|Physician Decision|0
1040882|NCT01742286|2074522|FG006|Escalation Phase|Physician Decision|2
1040883|NCT01742286|2074516|FG000|Escalation Phase|Subject/guardian decision|1
1040884|NCT01742286|2074517|FG001|Escalation Phase|Subject/guardian decision|0
1040885|NCT01742286|2074518|FG002|Escalation Phase|Subject/guardian decision|0
1040886|NCT01742286|2074519|FG003|Escalation Phase|Subject/guardian decision|0
1040887|NCT01742286|2074520|FG004|Escalation Phase|Subject/guardian decision|0
1040888|NCT01742286|2074521|FG005|Escalation Phase|Subject/guardian decision|0
1040889|NCT01742286|2074522|FG006|Escalation Phase|Subject/guardian decision|0
1040890|NCT01742286|2074516|FG000|Expansion Phase|Administrative problems|0
1040891|NCT01742286|2074517|FG001|Expansion Phase|Administrative problems|0
1040892|NCT01742286|2074518|FG002|Expansion Phase|Administrative problems|0
1040893|NCT01742286|2074519|FG003|Expansion Phase|Administrative problems|0
1040894|NCT01742286|2074520|FG004|Expansion Phase|Administrative problems|0
1040895|NCT01742286|2074521|FG005|Expansion Phase|Administrative problems|0
1040896|NCT01742286|2074522|FG006|Expansion Phase|Administrative problems|5
1040897|NCT01742286|2074516|FG000|Expansion Phase|Physician Decision|0
1040898|NCT01742286|2074517|FG001|Expansion Phase|Physician Decision|0
1040899|NCT01742286|2074518|FG002|Expansion Phase|Physician Decision|4
1040900|NCT01742286|2074519|FG003|Expansion Phase|Physician Decision|0
1040901|NCT01742286|2074520|FG004|Expansion Phase|Physician Decision|0
1040902|NCT01742286|2074521|FG005|Expansion Phase|Physician Decision|0
1040903|NCT01742286|2074522|FG006|Expansion Phase|Physician Decision|9
1040904|NCT01742286|2074516|FG000|Expansion Phase|Adverse Event|0
1040905|NCT01742286|2074517|FG001|Expansion Phase|Adverse Event|0
1040906|NCT01742286|2074518|FG002|Expansion Phase|Adverse Event|0
1040907|NCT01742286|2074519|FG003|Expansion Phase|Adverse Event|0
1040908|NCT01742286|2074520|FG004|Expansion Phase|Adverse Event|0
1040909|NCT01742286|2074521|FG005|Expansion Phase|Adverse Event|0
1040910|NCT01742286|2074522|FG006|Expansion Phase|Adverse Event|6
1040911|NCT01742286|2074516|FG000|Expansion Phase|Disease progression|0
1040912|NCT01742286|2074517|FG001|Expansion Phase|Disease progression|0
1040913|NCT01742286|2074518|FG002|Expansion Phase|Disease progression|3
1040914|NCT01742286|2074519|FG003|Expansion Phase|Disease progression|0
1040915|NCT01742286|2074520|FG004|Expansion Phase|Disease progression|0
1040916|NCT01742286|2074521|FG005|Expansion Phase|Disease progression|0
1040917|NCT01742286|2074522|FG006|Expansion Phase|Disease progression|15
1040918|NCT01742286|2074516|FG000|Expansion Phase|Withdrawal by Subject|0
1040919|NCT01742286|2074517|FG001|Expansion Phase|Withdrawal by Subject|0
1040920|NCT01742286|2074518|FG002|Expansion Phase|Withdrawal by Subject|0
1040921|NCT01742286|2074519|FG003|Expansion Phase|Withdrawal by Subject|0
1040922|NCT01742286|2074520|FG004|Expansion Phase|Withdrawal by Subject|0
1040923|NCT01742286|2074521|FG005|Expansion Phase|Withdrawal by Subject|0
1040924|NCT01742286|2074522|FG006|Expansion Phase|Withdrawal by Subject|1
1040925|NCT01742897|2074572|FG000|Overall Study|Adverse Event|3
1040926|NCT01742897|2074572|FG000|Overall Study|Withdrawal by Subject|1
1040927|NCT01742897|2074572|FG000|Overall Study|Other|1
1040928|NCT01743001|2074597|FG000|Overall Study|Physician Decision|1
1040929|NCT01743001|2074598|FG001|Overall Study|Physician Decision|0
1040930|NCT01743001|2074597|FG000|Overall Study|Pregnancy|1
1040931|NCT01743001|2074598|FG001|Overall Study|Pregnancy|0
1040932|NCT01743001|2074597|FG000|Overall Study|Death|1
1040933|NCT01743001|2074598|FG001|Overall Study|Death|0
1040934|NCT01743027|2074608|FG000|Overall Study|Adverse Event|2
1040935|NCT01743027|2074609|FG001|Overall Study|Adverse Event|0
1040936|NCT01743027|2074610|FG002|Overall Study|Adverse Event|0
1040937|NCT01743027|2074611|FG003|Overall Study|Adverse Event|0
1040938|NCT01743027|2074608|FG000|Overall Study|Lost to Follow-up|0
1040939|NCT01743027|2074609|FG001|Overall Study|Lost to Follow-up|0
1040940|NCT01743027|2074610|FG002|Overall Study|Lost to Follow-up|2
1040941|NCT01743027|2074611|FG003|Overall Study|Lost to Follow-up|0
1040942|NCT01743027|2074608|FG000|Overall Study|Progressive Disease|1
1040943|NCT01743027|2074609|FG001|Overall Study|Progressive Disease|4
1040944|NCT01743027|2074610|FG002|Overall Study|Progressive Disease|3
1040945|NCT01743027|2074611|FG003|Overall Study|Progressive Disease|0
1040946|NCT01743027|2074608|FG000|Overall Study|Protocol Violation|1
1040947|NCT01743027|2074609|FG001|Overall Study|Protocol Violation|1
1040948|NCT01743027|2074610|FG002|Overall Study|Protocol Violation|1
1040949|NCT01743027|2074611|FG003|Overall Study|Protocol Violation|0
1040950|NCT01743027|2074608|FG000|Overall Study|Withdrawal by Subject|1
1040951|NCT01743027|2074609|FG001|Overall Study|Withdrawal by Subject|0
1040952|NCT01743027|2074610|FG002|Overall Study|Withdrawal by Subject|3
1040953|NCT01743027|2074611|FG003|Overall Study|Withdrawal by Subject|1
1040954|NCT01743040|2074621|FG000|Overall Study|Death|1
1040955|NCT01743040|2074621|FG000|Overall Study|Lost to Follow-up|66
1040956|NCT01743040|2074621|FG000|Overall Study|Physician Decision|40
1040957|NCT01743040|2074621|FG000|Overall Study|Protocol Violation|1
1040958|NCT01743040|2074621|FG000|Overall Study|Withdrawal by Subject|121
1040959|NCT01743092|2074627|FG000|Overall Study|Lost to Follow-up|14
1040960|NCT01743092|2074628|FG001|Overall Study|Lost to Follow-up|15
1040961|NCT01743469|2074655|FG000|Active Treatment Phase|Adverse Event|10
1040962|NCT01743469|2074656|FG001|Active Treatment Phase|Adverse Event|5
1040963|NCT01743469|2074657|FG002|Active Treatment Phase|Adverse Event|8
1040964|NCT01743469|2074658|FG003|Active Treatment Phase|Adverse Event|1
1040965|NCT01743469|2074655|FG000|Active Treatment Phase|Disease Progression|40
1040966|NCT01743469|2074656|FG001|Active Treatment Phase|Disease Progression|47
1040967|NCT01743469|2074657|FG002|Active Treatment Phase|Disease Progression|30
1040968|NCT01743469|2074658|FG003|Active Treatment Phase|Disease Progression|20
1040969|NCT01743469|2074655|FG000|Active Treatment Phase|Withdrawal by Subject|2
1040970|NCT01743469|2074656|FG001|Active Treatment Phase|Withdrawal by Subject|3
1040971|NCT01743469|2074657|FG002|Active Treatment Phase|Withdrawal by Subject|0
1040972|NCT01743469|2074658|FG003|Active Treatment Phase|Withdrawal by Subject|0
1040973|NCT01743469|2074655|FG000|Active Treatment Phase|Missing|1
1040974|NCT01743469|2074656|FG001|Active Treatment Phase|Missing|0
1040975|NCT01743469|2074657|FG002|Active Treatment Phase|Missing|0
1040976|NCT01743469|2074658|FG003|Active Treatment Phase|Missing|0
1040977|NCT01743469|2074655|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
1040978|NCT01743469|2074656|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
1040979|NCT01743469|2074657|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
1040980|NCT01743469|2074658|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
1040981|NCT01743469|2074655|FG000|Follow-up Period - Post-Treatment|Death|43
1040982|NCT01743469|2074656|FG001|Follow-up Period - Post-Treatment|Death|47
1040983|NCT01743469|2074657|FG002|Follow-up Period - Post-Treatment|Death|22
1040984|NCT01743469|2074658|FG003|Follow-up Period - Post-Treatment|Death|16
1040985|NCT01743469|2074655|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1
1040986|NCT01743469|2074656|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1
1040987|NCT01743469|2074657|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0
1040988|NCT01743469|2074658|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0
1040989|NCT01743560|2074683|FG000|Overall Study|Disease progression|26
1040990|NCT01743560|2074683|FG000|Overall Study|Adverse Event|8
1040991|NCT01743560|2074683|FG000|Overall Study|Death|3
1040992|NCT01743560|2074683|FG000|Overall Study|Withdrawal by Subject|2
1040993|NCT01743560|2074683|FG000|Overall Study|Protocol Violation|1
1040994|NCT01743560|2074683|FG000|Overall Study|>1 dose of study drug|3
1040995|NCT01743989|2074745|FG000|Treatment Phase|Unstable MR4.0|0
1040996|NCT01743989|2074746|FG001|Treatment Phase|Unstable MR4.0|6
1040997|NCT01743989|2074747|FG002|Treatment Phase|Unstable MR4.0|263
1040998|NCT01743989|2074745|FG000|Treatment Phase|Adverse Event|0
1040999|NCT01743989|2074746|FG001|Treatment Phase|Adverse Event|4
1041000|NCT01743989|2074747|FG002|Treatment Phase|Adverse Event|67
1041001|NCT01743989|2074745|FG000|Treatment Phase|Withdrawal by Subject|1
1041002|NCT01743989|2074746|FG001|Treatment Phase|Withdrawal by Subject|3
1041003|NCT01743989|2074747|FG002|Treatment Phase|Withdrawal by Subject|28
1041004|NCT01743989|2074745|FG000|Treatment Phase|Death|0
1041005|NCT01743989|2074746|FG001|Treatment Phase|Death|1
1041006|NCT01743989|2074747|FG002|Treatment Phase|Death|3
1041007|NCT01743989|2074745|FG000|Treatment Phase|Abnormal laboratory value(s)|0
1041008|NCT01743989|2074746|FG001|Treatment Phase|Abnormal laboratory value(s)|0
1041009|NCT01743989|2074747|FG002|Treatment Phase|Abnormal laboratory value(s)|3
1041010|NCT01743989|2074745|FG000|Treatment Phase|Protocol deviation|0
1041011|NCT01743989|2074746|FG001|Treatment Phase|Protocol deviation|0
1041012|NCT01743989|2074747|FG002|Treatment Phase|Protocol deviation|3
1041013|NCT01743989|2074745|FG000|Treatment Phase|Pregnancy|0
1041014|NCT01743989|2074746|FG001|Treatment Phase|Pregnancy|0
1041015|NCT01743989|2074747|FG002|Treatment Phase|Pregnancy|2
1041016|NCT01743989|2074745|FG000|Treatment Phase|Lost to Follow-up|0
1041017|NCT01743989|2074746|FG001|Treatment Phase|Lost to Follow-up|0
1041018|NCT01743989|2074747|FG002|Treatment Phase|Lost to Follow-up|2
1041019|NCT01743989|2074745|FG000|Treatment Phase|Abnormal test procedure result(s)|0
1041020|NCT01743989|2074746|FG001|Treatment Phase|Abnormal test procedure result(s)|0
1041021|NCT01743989|2074747|FG002|Treatment Phase|Abnormal test procedure result(s)|1
1041022|NCT01743989|2074745|FG000|Treatment Phase|Administrative problems|0
1041023|NCT01743989|2074746|FG001|Treatment Phase|Administrative problems|0
1041024|NCT01743989|2074747|FG002|Treatment Phase|Administrative problems|1
1041025|NCT01743989|2074745|FG000|Treatment Phase|New cancer (CML) therapy|0
1041026|NCT01743989|2074746|FG001|Treatment Phase|New cancer (CML) therapy|1
1041027|NCT01743989|2074747|FG002|Treatment Phase|New cancer (CML) therapy|0
1041028|NCT01743989|2074745|FG000|Treatment Phase|Physician Decision|0
1041029|NCT01743989|2074746|FG001|Treatment Phase|Physician Decision|0
1041030|NCT01743989|2074747|FG002|Treatment Phase|Physician Decision|3
1041031|NCT01743989|2074745|FG000|Treatment Phase|Patient non-compliance to treatment|0
1041032|NCT01743989|2074746|FG001|Treatment Phase|Patient non-compliance to treatment|0
1041033|NCT01743989|2074747|FG002|Treatment Phase|Patient non-compliance to treatment|3
1041034|NCT01743989|2074745|FG000|Treatment Phase|Not randomized by mistake|0
1041035|NCT01743989|2074746|FG001|Treatment Phase|Not randomized by mistake|0
1041036|NCT01743989|2074747|FG002|Treatment Phase|Not randomized by mistake|1
1041037|NCT01743989|2074745|FG000|Treatment Phase|Included by mistake|0
1041038|NCT01743989|2074746|FG001|Treatment Phase|Included by mistake|0
1041039|NCT01743989|2074747|FG002|Treatment Phase|Included by mistake|1
1041040|NCT01743989|2074745|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82
1041041|NCT01743989|2074746|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59
1041042|NCT01743989|2074747|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0
1041043|NCT01743989|2074745|FG000|TFR Phase|Adverse Event|0
1041044|NCT01743989|2074746|FG001|TFR Phase|Adverse Event|1
1041045|NCT01743989|2074747|FG002|TFR Phase|Adverse Event|0
1041046|NCT01743989|2074745|FG000|TFR Phase|Lost to Follow-up|0
1041047|NCT01743989|2074746|FG001|TFR Phase|Lost to Follow-up|2
1041048|NCT01743989|2074747|FG002|TFR Phase|Lost to Follow-up|0
1041049|NCT01743989|2074745|FG000|TFR Phase|Physician Decision|0
1041050|NCT01743989|2074746|FG001|TFR Phase|Physician Decision|1
1041051|NCT01743989|2074747|FG002|TFR Phase|Physician Decision|0
1041052|NCT01743989|2074745|FG000|TFR Phase|Logistical problems|0
1041053|NCT01743989|2074746|FG001|TFR Phase|Logistical problems|2
1041054|NCT01743989|2074747|FG002|TFR Phase|Logistical problems|0
1041055|NCT01743989|2074745|FG000|TFR Phase|Protocol deviation|0
1041056|NCT01743989|2074746|FG001|TFR Phase|Protocol deviation|1
1041057|NCT01743989|2074747|FG002|TFR Phase|Protocol deviation|0
1041058|NCT01743989|2074745|FG000|TFR Phase|Withdrawal by Subject|0
1041059|NCT01743989|2074746|FG001|TFR Phase|Withdrawal by Subject|2
1041060|NCT01743989|2074747|FG002|TFR Phase|Withdrawal by Subject|0
1041061|NCT01743989|2074745|FG000|Re-treatment Phase|Adverse Event|8
1041062|NCT01743989|2074746|FG001|Re-treatment Phase|Adverse Event|4
1041063|NCT01743989|2074747|FG002|Re-treatment Phase|Adverse Event|0
1041064|NCT01743989|2074745|FG000|Re-treatment Phase|Death|1
1041065|NCT01743989|2074746|FG001|Re-treatment Phase|Death|1
1041066|NCT01743989|2074747|FG002|Re-treatment Phase|Death|0
1041067|NCT01743989|2074745|FG000|Re-treatment Phase|Administrative problems|1
1041068|NCT01743989|2074746|FG001|Re-treatment Phase|Administrative problems|1
1041069|NCT01743989|2074747|FG002|Re-treatment Phase|Administrative problems|0
1041070|NCT01743989|2074745|FG000|Re-treatment Phase|Withdrawal by Subject|5
1041071|NCT01743989|2074746|FG001|Re-treatment Phase|Withdrawal by Subject|1
1041072|NCT01743989|2074747|FG002|Re-treatment Phase|Withdrawal by Subject|0
1041073|NCT01743989|2074745|FG000|Re-treatment Phase|Unstable MR|1
1041074|NCT01743989|2074746|FG001|Re-treatment Phase|Unstable MR|0
1041075|NCT01743989|2074747|FG002|Re-treatment Phase|Unstable MR|0
1041076|NCT01743989|2074745|FG000|Re-treatment Phase|Physician Decision|0
1041077|NCT01743989|2074746|FG001|Re-treatment Phase|Physician Decision|1
1041078|NCT01743989|2074747|FG002|Re-treatment Phase|Physician Decision|0
1041079|NCT01743989|2074745|FG000|Re-treatment Phase|Lost to Follow-up|0
1041080|NCT01743989|2074746|FG001|Re-treatment Phase|Lost to Follow-up|1
1041081|NCT01743989|2074747|FG002|Re-treatment Phase|Lost to Follow-up|0
1041082|NCT01744197|2074771|FG000|Overall Study|Received 1 patch|2
1041083|NCT01744197|2074772|FG001|Overall Study|Received 1 patch|1
1041084|NCT01744197|2074771|FG000|Overall Study|No patch received|2
1041085|NCT01744197|2074772|FG001|Overall Study|No patch received|2
1041086|NCT01744392|2074798|FG000|Overall Study|Physician Decision|1
1041087|NCT01744483|2074806|FG000|Overall Study|Death|9
1041088|NCT01744483|2074807|FG001|Overall Study|Death|4
1041089|NCT01744483|2074808|FG002|Overall Study|Death|11
1041090|NCT01744483|2074806|FG000|Overall Study|Lost to Follow-up|8
1041091|NCT01744483|2074807|FG001|Overall Study|Lost to Follow-up|9
1041092|NCT01744483|2074808|FG002|Overall Study|Lost to Follow-up|11
1041093|NCT01744483|2074806|FG000|Overall Study|Protocol Violation|1
1041094|NCT01744483|2074807|FG001|Overall Study|Protocol Violation|2
1041095|NCT01744483|2074808|FG002|Overall Study|Protocol Violation|1
1041096|NCT01744483|2074806|FG000|Overall Study|Withdrawal by Subject|4
1041097|NCT01744483|2074807|FG001|Overall Study|Withdrawal by Subject|6
1041098|NCT01744483|2074808|FG002|Overall Study|Withdrawal by Subject|2
1041099|NCT01744483|2074806|FG000|Overall Study|No ICU Admit|5
1041100|NCT01744483|2074807|FG001|Overall Study|No ICU Admit|1
1041101|NCT01744483|2074808|FG002|Overall Study|No ICU Admit|2
1041102|NCT01744483|2074806|FG000|Overall Study|Routed to OSH|2
1041103|NCT01744483|2074807|FG001|Overall Study|Routed to OSH|0
1041104|NCT01744483|2074808|FG002|Overall Study|Routed to OSH|1
1041105|NCT01744496|2074818|FG000|Titration Period|Adverse Event|2
1041106|NCT01744496|2074819|FG001|Titration Period|Adverse Event|1
1041107|NCT01744496|2074818|FG000|Titration Period|Personal reasons|0
1041108|NCT01744496|2074819|FG001|Titration Period|Personal reasons|1
1041109|NCT01744496|2074818|FG000|Maintenance Period|Adverse Event|1
1041110|NCT01744496|2074819|FG001|Maintenance Period|Adverse Event|3
1041111|NCT01744496|2074818|FG000|Maintenance Period|Protocol Violation|1
1041112|NCT01744496|2074819|FG001|Maintenance Period|Protocol Violation|0
1041113|NCT01744496|2074818|FG000|Maintenance Period|Withdrawal by Subject|1
1041114|NCT01744496|2074819|FG001|Maintenance Period|Withdrawal by Subject|1
1041115|NCT01744496|2074818|FG000|Maintenance Period|Subject left town|1
1041116|NCT01744496|2074819|FG001|Maintenance Period|Subject left town|0
1041117|NCT01744665|2074842|FG000|Monitoring Phase|Adverse Event|4
1041118|NCT01744665|2074842|FG000|Monitoring Phase|Abnormal laboratory value(s)|1
1041119|NCT01744665|2074842|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7
1041120|NCT01744665|2074842|FG000|Monitoring Phase|Withdrawal by Subject|5
1041121|NCT01744665|2074842|FG000|Monitoring Phase|Did not achieve MR4.5|1
1041122|NCT01744665|2074842|FG000|Consolidation Phase|Adverse Event|2
1041123|NCT01744665|2074842|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4
1041124|NCT01744665|2074842|FG000|Consolidation Phase|Withdrawal by Subject|4
1041125|NCT01744665|2074842|FG000|Consolidation Phase|Administrative problems|9
1041126|NCT01744665|2074842|FG000|Re-initiation Phase|Administrative problems|10
1041127|NCT01744665|2074842|FG000|Re-initiation Phase|Adverse Event|1
1041128|NCT01744665|2074842|FG000|Re-initiation Phase|No longer required treatment|1
1041129|NCT01744665|2074842|FG000|Re-initiation Phase|Withdrawal by Subject|1
1041130|NCT01744691|2074849|FG000|Overall Study|Progressive Disease|18
1041131|NCT01744691|2074849|FG000|Overall Study|Unacceptable toxicity, AE or death|18
1041132|NCT01744691|2074849|FG000|Overall Study|Withdrawal of consent for treatment|3
1041133|NCT01744691|2074849|FG000|Overall Study|Physician Decision|4
1041134|NCT01744782|2074925|FG000|Overall Study|Death|1
1041135|NCT01744977|2074960|FG000|Overall Study|Withdrawal by Subject|1
1041136|NCT01744977|2074961|FG001|Overall Study|Withdrawal by Subject|2
1041137|NCT01744977|2074960|FG000|Overall Study|Death|2
1041138|NCT01744977|2074961|FG001|Overall Study|Death|3
1041139|NCT01744977|2074960|FG000|Overall Study|Lost to Follow-up|2
1041140|NCT01744977|2074961|FG001|Overall Study|Lost to Follow-up|0
1041141|NCT01744977|2074960|FG000|Overall Study|No longer meets inclusion|6
1041142|NCT01744977|2074961|FG001|Overall Study|No longer meets inclusion|0
1041143|NCT01745094|2074980|FG000|Overall Study|Not Meeting the Eligibility Criteria|1
1041144|NCT01745094|2074981|FG001|Overall Study|Not Meeting the Eligibility Criteria|0
1041145|NCT01745094|2074982|FG002|Overall Study|Not Meeting the Eligibility Criteria|3
1041146|NCT01745094|2074983|FG003|Overall Study|Not Meeting the Eligibility Criteria|0
1041147|NCT01745094|2074980|FG000|Overall Study|Adverse Event|0
1041148|NCT01745094|2074981|FG001|Overall Study|Adverse Event|0
1041149|NCT01745094|2074982|FG002|Overall Study|Adverse Event|3
1041150|NCT01745094|2074983|FG003|Overall Study|Adverse Event|0
1041151|NCT01745094|2074980|FG000|Overall Study|Withdrawal by Subject|2
1041152|NCT01745094|2074981|FG001|Overall Study|Withdrawal by Subject|0
1041153|NCT01745094|2074982|FG002|Overall Study|Withdrawal by Subject|1
1041154|NCT01745094|2074983|FG003|Overall Study|Withdrawal by Subject|2
1041155|NCT01745094|2074980|FG000|Overall Study|Protocol Violation|1
1041156|NCT01745094|2074981|FG001|Overall Study|Protocol Violation|0
1041157|NCT01745094|2074982|FG002|Overall Study|Protocol Violation|3
1041158|NCT01745094|2074983|FG003|Overall Study|Protocol Violation|1
1041159|NCT01745094|2074980|FG000|Overall Study|Need Further Examinations Due to Biopsy|0
1041160|NCT01745094|2074981|FG001|Overall Study|Need Further Examinations Due to Biopsy|0
1041161|NCT01745094|2074982|FG002|Overall Study|Need Further Examinations Due to Biopsy|1
1041162|NCT01745094|2074983|FG003|Overall Study|Need Further Examinations Due to Biopsy|0
1041163|NCT01745094|2074980|FG000|Overall Study|Show no Stable Solifenacin Intake|0
1041164|NCT01745094|2074981|FG001|Overall Study|Show no Stable Solifenacin Intake|0
1041165|NCT01745094|2074982|FG002|Overall Study|Show no Stable Solifenacin Intake|1
1041166|NCT01745094|2074983|FG003|Overall Study|Show no Stable Solifenacin Intake|0
1041167|NCT01745094|2074980|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1
1041168|NCT01745094|2074981|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0
1041169|NCT01745094|2074982|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0
1041170|NCT01745094|2074983|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0
1041171|NCT01745120|2074998|FG000|Overall Study|Investigator decision|1
1041172|NCT01745120|2074999|FG001|Overall Study|Investigator decision|0
1041173|NCT01745146|2075023|FG000|Overall Study|Withdrawal by Subject|1
1041174|NCT01745146|2075024|FG001|Overall Study|Withdrawal by Subject|3
1041175|NCT01745146|2075023|FG000|Overall Study|Lost to Follow-up|2
1041176|NCT01745146|2075024|FG001|Overall Study|Lost to Follow-up|0
1041177|NCT01745367|2075037|FG000|Overall Study|Death|1
1041178|NCT01745367|2075038|FG001|Overall Study|Death|0
1041179|NCT01745367|2075037|FG000|Overall Study|Withdrawal by Subject|1
1041180|NCT01745367|2075038|FG001|Overall Study|Withdrawal by Subject|2
1041181|NCT01745367|2075037|FG000|Overall Study|Termination of The Study by The Sponsor|6
1041182|NCT01745367|2075038|FG001|Overall Study|Termination of The Study by The Sponsor|18
1041183|NCT01745367|2075037|FG000|Overall Study|Other Reasons Unspecified|0
1041184|NCT01745367|2075038|FG001|Overall Study|Other Reasons Unspecified|2
1041185|NCT01745380|2075046|FG000|Overall Study|Lost to Follow-up|1
1041186|NCT01745380|2075047|FG001|Overall Study|Lost to Follow-up|0
1041187|NCT01745380|2075046|FG000|Overall Study|Lack of Efficacy|0
1041188|NCT01745380|2075047|FG001|Overall Study|Lack of Efficacy|1
1041189|NCT01745393|2075055|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
1041190|NCT01745393|2075056|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
1041191|NCT01745393|2075055|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
1041192|NCT01745393|2075056|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
1041193|NCT01745393|2075055|FG000|12-month Follow-up|Lost to Follow-up|6
1041194|NCT01745393|2075056|FG001|12-month Follow-up|Lost to Follow-up|5
1041195|NCT01745848|2075075|FG000|Overall Study|Adverse Event|6
1041196|NCT01746017|2075106|FG000|Period 1|Withdrawal by Subject|0
1041197|NCT01746017|2075107|FG001|Period 1|Withdrawal by Subject|0
1041198|NCT01746017|2075108|FG002|Period 1|Withdrawal by Subject|0
1041199|NCT01746017|2075109|FG003|Period 1|Withdrawal by Subject|0
1041200|NCT01746017|2075110|FG004|Period 1|Withdrawal by Subject|0
1041201|NCT01746017|2075111|FG005|Period 1|Withdrawal by Subject|0
1041202|NCT01746017|2075112|FG006|Period 1|Withdrawal by Subject|1
1041203|NCT01746017|2075113|FG007|Period 1|Withdrawal by Subject|0
1041204|NCT01746017|2075114|FG008|Period 1|Withdrawal by Subject|0
1041205|NCT01746017|2075115|FG009|Period 1|Withdrawal by Subject|0
1041206|NCT01746017|2075116|FG010|Period 1|Withdrawal by Subject|0
1041207|NCT01746017|2075106|FG000|Period 3|Withdrawal by Subject|0
1041208|NCT01746017|2075107|FG001|Period 3|Withdrawal by Subject|0
1041209|NCT01746017|2075108|FG002|Period 3|Withdrawal by Subject|0
1041210|NCT01746017|2075109|FG003|Period 3|Withdrawal by Subject|0
1041211|NCT01746017|2075110|FG004|Period 3|Withdrawal by Subject|0
1041212|NCT01746017|2075111|FG005|Period 3|Withdrawal by Subject|1
1041213|NCT01746017|2075112|FG006|Period 3|Withdrawal by Subject|0
1041214|NCT01746017|2075113|FG007|Period 3|Withdrawal by Subject|0
1041215|NCT01746017|2075114|FG008|Period 3|Withdrawal by Subject|0
1041216|NCT01746017|2075115|FG009|Period 3|Withdrawal by Subject|0
1041217|NCT01746017|2075116|FG010|Period 3|Withdrawal by Subject|0
1041218|NCT01746108|2075192|FG000|Overall Study|Migrated /moved from study area|0
1041219|NCT01746108|2075193|FG001|Overall Study|Migrated /moved from study area|1
1041220|NCT01746108|2075194|FG002|Overall Study|Migrated /moved from study area|0
1041221|NCT01746108|2075192|FG000|Overall Study|Adverse event, non-fatal|0
1041222|NCT01746108|2075193|FG001|Overall Study|Adverse event, non-fatal|1
1041223|NCT01746108|2075194|FG002|Overall Study|Adverse event, non-fatal|0
1041224|NCT01746108|2075192|FG000|Overall Study|Withdrawal by Subject|0
1041225|NCT01746108|2075193|FG001|Overall Study|Withdrawal by Subject|1
1041226|NCT01746108|2075194|FG002|Overall Study|Withdrawal by Subject|0
1041227|NCT01746108|2075192|FG000|Overall Study|Lost to Follow-up|0
1041228|NCT01746108|2075193|FG001|Overall Study|Lost to Follow-up|1
1041229|NCT01746108|2075194|FG002|Overall Study|Lost to Follow-up|0
1041230|NCT01746173|2075210|FG000|Overall Study|Disease Progression|2
1041231|NCT01746225|2075217|FG000|Overall Study|Death|1
1041232|NCT01746225|2075218|FG001|Overall Study|Death|0
1041233|NCT01746225|2075219|FG002|Overall Study|Death|1
1041234|NCT01746225|2075217|FG000|Overall Study|Withdrawal by Subject|5
1041235|NCT01746225|2075218|FG001|Overall Study|Withdrawal by Subject|15
1041236|NCT01746225|2075219|FG002|Overall Study|Withdrawal by Subject|19
1041237|NCT01746225|2075217|FG000|Overall Study|Physician Decision|14
1041238|NCT01746225|2075218|FG001|Overall Study|Physician Decision|11
1041239|NCT01746225|2075219|FG002|Overall Study|Physician Decision|3
1041240|NCT01746225|2075217|FG000|Overall Study|Adverse Event|15
1041241|NCT01746225|2075218|FG001|Overall Study|Adverse Event|12
1041242|NCT01746225|2075219|FG002|Overall Study|Adverse Event|17
1041243|NCT01746225|2075217|FG000|Overall Study|Continuing Treatment|5
1041244|NCT01746225|2075218|FG001|Overall Study|Continuing Treatment|8
1041245|NCT01746225|2075219|FG002|Overall Study|Continuing Treatment|3
1041246|NCT01746368|2075233|FG000|Overall Study|Lost to Follow-up|2
1041247|NCT01746368|2075234|FG001|Overall Study|Lost to Follow-up|0
1041248|NCT01746368|2075233|FG000|Overall Study|Withdrawal by Subject|0
1041249|NCT01746368|2075234|FG001|Overall Study|Withdrawal by Subject|1
1041250|NCT01746732|2075271|FG000|Lead-In Period|Withdrawal by Subject|1
1041251|NCT01746732|2075272|FG001|Lead-In Period|Withdrawal by Subject|0
1041252|NCT01746732|2075273|FG002|Lead-In Period|Withdrawal by Subject|0
1041253|NCT01746732|2075271|FG000|Period 1|Physician Decision|0
1041254|NCT01746732|2075272|FG001|Period 1|Physician Decision|1
1041255|NCT01746732|2075273|FG002|Period 1|Physician Decision|0
1041256|NCT01746732|2075271|FG000|Period 2|Withdrawal by Subject|0
1041257|NCT01746732|2075272|FG001|Period 2|Withdrawal by Subject|0
1041258|NCT01746732|2075273|FG002|Period 2|Withdrawal by Subject|2
1041259|NCT01746732|2075271|FG000|Period 2|Adverse Event|0
1041260|NCT01746732|2075272|FG001|Period 2|Adverse Event|0
1041261|NCT01746732|2075273|FG002|Period 2|Adverse Event|1
1041262|NCT01746732|2075271|FG000|Period 2|Lost to Follow-up|0
1041263|NCT01746732|2075272|FG001|Period 2|Lost to Follow-up|0
1041264|NCT01746732|2075273|FG002|Period 2|Lost to Follow-up|1
1041265|NCT01746862|2075317|FG000|Overall Study|Withdrawal by Subject|1
1041266|NCT01746862|2075318|FG001|Overall Study|Withdrawal by Subject|1
1041267|NCT01746862|2075317|FG000|Overall Study|Protocol Violation|1
1041268|NCT01746862|2075318|FG001|Overall Study|Protocol Violation|0
1041269|NCT01746862|2075317|FG000|Overall Study|Consent withdrawal by parent's guardian|5
1041270|NCT01746862|2075318|FG001|Overall Study|Consent withdrawal by parent's guardian|2
1041271|NCT01746862|2075317|FG000|Overall Study|Entered puberty during the study|1
1041272|NCT01746862|2075318|FG001|Overall Study|Entered puberty during the study|0
1041273|NCT01746901|2075325|FG000|Naloxone Challenge Phase|Adverse Event|2
1041274|NCT01746901|2075326|FG001|Naloxone Challenge Phase|Adverse Event|0
1041275|NCT01746901|2075327|FG002|Naloxone Challenge Phase|Adverse Event|0
1041276|NCT01746901|2075328|FG003|Naloxone Challenge Phase|Adverse Event|0
1041277|NCT01746901|2075329|FG004|Naloxone Challenge Phase|Adverse Event|0
1041278|NCT01746901|2075330|FG005|Naloxone Challenge Phase|Adverse Event|0
1041279|NCT01746901|2075331|FG006|Naloxone Challenge Phase|Adverse Event|0
1041280|NCT01746901|2075332|FG007|Naloxone Challenge Phase|Adverse Event|0
1041281|NCT01746901|2075333|FG008|Naloxone Challenge Phase|Adverse Event|0
1041282|NCT01746901|2075325|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1
1162030|NCT03381196|2283977|FG001|Overall Study|Withdrawal by Subject|7
1041283|NCT01746901|2075326|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0
1041284|NCT01746901|2075327|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0
1041285|NCT01746901|2075328|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0
1041286|NCT01746901|2075329|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0
1041287|NCT01746901|2075330|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0
1041288|NCT01746901|2075331|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0
1041289|NCT01746901|2075332|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0
1041290|NCT01746901|2075333|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0
1041291|NCT01746901|2075325|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
1041292|NCT01746901|2075326|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
1041293|NCT01746901|2075327|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
1041294|NCT01746901|2075328|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
1041295|NCT01746901|2075329|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
1041296|NCT01746901|2075330|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
1041297|NCT01746901|2075331|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
1041298|NCT01746901|2075332|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0
1041299|NCT01746901|2075333|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0
1041300|NCT01746901|2075325|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0
1041301|NCT01746901|2075326|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2
1041302|NCT01746901|2075327|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1
1041303|NCT01746901|2075328|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0
1041304|NCT01746901|2075329|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0
1041305|NCT01746901|2075330|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0
1041306|NCT01746901|2075331|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0
1041307|NCT01746901|2075332|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0
1041308|NCT01746901|2075333|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0
1041309|NCT01746901|2075325|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1041310|NCT01746901|2075326|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
1041311|NCT01746901|2075327|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
1041312|NCT01746901|2075328|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1041313|NCT01746901|2075329|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1041314|NCT01746901|2075330|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1041315|NCT01746901|2075331|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1041316|NCT01746901|2075332|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1041317|NCT01746901|2075333|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1041318|NCT01746901|2075325|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
1041319|NCT01746901|2075326|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3
1041320|NCT01746901|2075327|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3
1041321|NCT01746901|2075328|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
1041322|NCT01746901|2075329|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
1041323|NCT01746901|2075330|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
1041324|NCT01746901|2075331|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
1041325|NCT01746901|2075332|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0
1041326|NCT01746901|2075333|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0
1041327|NCT01746901|2075325|FG000|Treatment Phase: First Intervention|Protocol Violation|0
1041328|NCT01746901|2075326|FG001|Treatment Phase: First Intervention|Protocol Violation|0
1041329|NCT01746901|2075327|FG002|Treatment Phase: First Intervention|Protocol Violation|0
1041330|NCT01746901|2075328|FG003|Treatment Phase: First Intervention|Protocol Violation|0
1041331|NCT01746901|2075329|FG004|Treatment Phase: First Intervention|Protocol Violation|0
1041332|NCT01746901|2075330|FG005|Treatment Phase: First Intervention|Protocol Violation|0
1041333|NCT01746901|2075331|FG006|Treatment Phase: First Intervention|Protocol Violation|1
1041334|NCT01746901|2075332|FG007|Treatment Phase: First Intervention|Protocol Violation|0
1041335|NCT01746901|2075333|FG008|Treatment Phase: First Intervention|Protocol Violation|0
1041336|NCT01746901|2075325|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1041337|NCT01746901|2075326|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1041338|NCT01746901|2075327|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1041339|NCT01746901|2075328|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1041340|NCT01746901|2075329|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1041341|NCT01746901|2075330|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1041342|NCT01746901|2075331|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1041343|NCT01746901|2075332|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1
1041344|NCT01746901|2075333|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1041345|NCT01746901|2075325|FG000|Treatment Phase: Third Intervention|Protocol Violation|0
1041346|NCT01746901|2075326|FG001|Treatment Phase: Third Intervention|Protocol Violation|0
1041347|NCT01746901|2075327|FG002|Treatment Phase: Third Intervention|Protocol Violation|0
1041348|NCT01746901|2075328|FG003|Treatment Phase: Third Intervention|Protocol Violation|0
1041349|NCT01746901|2075329|FG004|Treatment Phase: Third Intervention|Protocol Violation|0
1041350|NCT01746901|2075330|FG005|Treatment Phase: Third Intervention|Protocol Violation|1
1041351|NCT01746901|2075331|FG006|Treatment Phase: Third Intervention|Protocol Violation|1
1041352|NCT01746901|2075332|FG007|Treatment Phase: Third Intervention|Protocol Violation|0
1041353|NCT01746901|2075333|FG008|Treatment Phase: Third Intervention|Protocol Violation|0
1041354|NCT01746901|2075325|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1041355|NCT01746901|2075326|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1041356|NCT01746901|2075327|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1041357|NCT01746901|2075328|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
1041358|NCT01746901|2075329|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1041359|NCT01746901|2075330|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1041360|NCT01746901|2075331|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1041361|NCT01746901|2075332|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1041362|NCT01746901|2075333|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1041363|NCT01746901|2075325|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0
1041364|NCT01746901|2075326|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0
1041365|NCT01746901|2075327|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0
1041366|NCT01746901|2075328|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0
1041367|NCT01746901|2075329|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0
1041368|NCT01746901|2075330|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1
1041369|NCT01746901|2075331|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0
1041370|NCT01746901|2075332|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0
1041371|NCT01746901|2075333|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1
1041372|NCT01746901|2075325|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0
1041373|NCT01746901|2075326|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0
1041374|NCT01746901|2075327|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0
1041375|NCT01746901|2075328|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0
1041376|NCT01746901|2075329|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0
1041377|NCT01746901|2075330|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0
1041378|NCT01746901|2075331|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1
1041379|NCT01746901|2075332|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0
1041380|NCT01746901|2075333|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1
1041381|NCT01747486|2075412|FG000|Stage 1|Physician Decision|3
1041382|NCT01747486|2075413|FG001|Stage 1|Physician Decision|0
1041383|NCT01747486|2075412|FG000|Stage 1|Withdrawal by Subject|4
1041384|NCT01747486|2075413|FG001|Stage 1|Withdrawal by Subject|3
1041385|NCT01747486|2075412|FG000|Stage 1|Disease progression|4
1041386|NCT01747486|2075413|FG001|Stage 1|Disease progression|9
1041387|NCT01747486|2075412|FG000|Stage 1|Death|1
1041388|NCT01747486|2075413|FG001|Stage 1|Death|1
1041389|NCT01747486|2075412|FG000|Stage 2|Physician Decision|2
1041390|NCT01747486|2075413|FG001|Stage 2|Physician Decision|0
1041391|NCT01747486|2075412|FG000|Stage 2|Withdrawal by Subject|1
1041392|NCT01747486|2075413|FG001|Stage 2|Withdrawal by Subject|0
1041393|NCT01747486|2075412|FG000|Stage 2|New Cancer Therapy|3
1041394|NCT01747486|2075413|FG001|Stage 2|New Cancer Therapy|0
1041395|NCT01747486|2075412|FG000|Stage 2|Disease Progression|3
1041396|NCT01747486|2075413|FG001|Stage 2|Disease Progression|0
1041397|NCT01747499|2075424|FG000|Overall Study|Steroid refractory aGvHD|1
1041398|NCT01747499|2075425|FG001|Overall Study|Steroid refractory aGvHD|0
1041399|NCT01747499|2075426|FG002|Overall Study|Steroid refractory aGvHD|0
1041400|NCT01747499|2075427|FG003|Overall Study|Steroid refractory aGvHD|1
1041401|NCT01747499|2075428|FG004|Overall Study|Steroid refractory aGvHD|4
1041402|NCT01747499|2075424|FG000|Overall Study|Physician Decision|0
1041403|NCT01747499|2075425|FG001|Overall Study|Physician Decision|1
1041404|NCT01747499|2075426|FG002|Overall Study|Physician Decision|0
1041405|NCT01747499|2075427|FG003|Overall Study|Physician Decision|0
1041406|NCT01747499|2075428|FG004|Overall Study|Physician Decision|2
1041407|NCT01747499|2075424|FG000|Overall Study|Death|0
1041408|NCT01747499|2075425|FG001|Overall Study|Death|0
1041409|NCT01747499|2075426|FG002|Overall Study|Death|0
1041410|NCT01747499|2075427|FG003|Overall Study|Death|1
1041411|NCT01747499|2075428|FG004|Overall Study|Death|1
1041412|NCT01747499|2075424|FG000|Overall Study|Withdrawal by Subject|0
1041413|NCT01747499|2075425|FG001|Overall Study|Withdrawal by Subject|0
1041414|NCT01747499|2075426|FG002|Overall Study|Withdrawal by Subject|0
1041415|NCT01747499|2075427|FG003|Overall Study|Withdrawal by Subject|0
1041416|NCT01747499|2075428|FG004|Overall Study|Withdrawal by Subject|6
1041417|NCT01747499|2075424|FG000|Overall Study|Developed AML and death|0
1041418|NCT01747499|2075425|FG001|Overall Study|Developed AML and death|0
1041419|NCT01747499|2075426|FG002|Overall Study|Developed AML and death|0
1041420|NCT01747499|2075427|FG003|Overall Study|Developed AML and death|0
1041421|NCT01747499|2075428|FG004|Overall Study|Developed AML and death|1
1041422|NCT01747499|2075424|FG000|Overall Study|Determined not to be eligible|0
1041423|NCT01747499|2075425|FG001|Overall Study|Determined not to be eligible|0
1041424|NCT01747499|2075426|FG002|Overall Study|Determined not to be eligible|0
1041425|NCT01747499|2075427|FG003|Overall Study|Determined not to be eligible|0
1041426|NCT01747499|2075428|FG004|Overall Study|Determined not to be eligible|1
1041427|NCT01747551|2075444|FG000|Overall Study|Progressive Disease|24
1041428|NCT01747551|2075445|FG001|Overall Study|Progressive Disease|17
1041429|NCT01747551|2075444|FG000|Overall Study|Death|3
1041430|NCT01747551|2075445|FG001|Overall Study|Death|1
1041431|NCT01747551|2075444|FG000|Overall Study|Adverse Event|7
1041432|NCT01747551|2075445|FG001|Overall Study|Adverse Event|1
1041433|NCT01747551|2075444|FG000|Overall Study|Prolonged Treatment Delay|2
1041434|NCT01747551|2075445|FG001|Overall Study|Prolonged Treatment Delay|0
1041435|NCT01747551|2075444|FG000|Overall Study|Withdrawal by Subject|3
1041436|NCT01747551|2075445|FG001|Overall Study|Withdrawal by Subject|1
1041437|NCT01747551|2075444|FG000|Overall Study|Physician Decision|2
1041438|NCT01747551|2075445|FG001|Overall Study|Physician Decision|1
1041439|NCT01747551|2075444|FG000|Overall Study|Other|2
1041440|NCT01747551|2075445|FG001|Overall Study|Other|0
1041441|NCT01747629|2075453|FG000|Overall Study|Adverse Event|1
1041442|NCT01747629|2075454|FG001|Overall Study|Adverse Event|2
1041443|NCT01747629|2075453|FG000|Overall Study|Withdrawal by Subject|2
1041444|NCT01747629|2075454|FG001|Overall Study|Withdrawal by Subject|2
1041445|NCT01747629|2075453|FG000|Overall Study|Noncompliance|1
1041446|NCT01747629|2075454|FG001|Overall Study|Noncompliance|1
1041447|NCT01747629|2075453|FG000|Overall Study|Inclusion criteria not met|1
1041448|NCT01747629|2075454|FG001|Overall Study|Inclusion criteria not met|0
1041449|NCT01747629|2075453|FG000|Overall Study|Not treated|1
1041450|NCT01747629|2075454|FG001|Overall Study|Not treated|0
1041451|NCT01747629|2075453|FG000|Overall Study|Other|2
1041452|NCT01747629|2075454|FG001|Overall Study|Other|1
1041453|NCT01747655|2075460|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
1041454|NCT01747655|2075461|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
1041455|NCT01747655|2075460|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8
1041456|NCT01747655|2075461|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0
1041457|NCT01747655|2075460|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
1041458|NCT01747655|2075461|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
1041459|NCT01747772|2075467|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
1041460|NCT01747811|2075477|FG000|Overall Study|Lack of Efficacy|2
1041461|NCT01747811|2075478|FG001|Overall Study|Lack of Efficacy|4
1041462|NCT01747837|2075488|FG000|Overall Study|Lost to Follow-up|5
1041463|NCT01747837|2075489|FG001|Overall Study|Lost to Follow-up|2
1041464|NCT01747837|2075488|FG000|Overall Study|Death|4
1041465|NCT01747837|2075489|FG001|Overall Study|Death|4
1041466|NCT01747876|2075523|FG000|Overall Study|Adverse Event|1
1041467|NCT01747876|2075524|FG001|Overall Study|Adverse Event|0
1041468|NCT01747876|2075525|FG002|Overall Study|Adverse Event|2
1041469|NCT01747876|2075523|FG000|Overall Study|Withdrawal by Subject|0
1041470|NCT01747876|2075524|FG001|Overall Study|Withdrawal by Subject|1
1041471|NCT01747876|2075525|FG002|Overall Study|Withdrawal by Subject|1
1041472|NCT01747876|2075523|FG000|Overall Study|Disease progression|4
1041473|NCT01747876|2075524|FG001|Overall Study|Disease progression|13
1041474|NCT01747876|2075525|FG002|Overall Study|Disease progression|8
1041475|NCT01747876|2075523|FG000|Overall Study|Trtment duration compl. as per protocol|0
1041476|NCT01747876|2075524|FG001|Overall Study|Trtment duration compl. as per protocol|1
1041477|NCT01747876|2075525|FG002|Overall Study|Trtment duration compl. as per protocol|1
1041478|NCT01747915|2075539|FG000|Overall Study|Other|1
1041479|NCT01747915|2075540|FG001|Overall Study|Other|1
1041480|NCT01747915|2075541|FG002|Overall Study|Other|1
1041481|NCT01747915|2075539|FG000|Overall Study|Adverse Event|8
1041482|NCT01747915|2075540|FG001|Overall Study|Adverse Event|5
1041483|NCT01747915|2075541|FG002|Overall Study|Adverse Event|2
1041484|NCT01747915|2075539|FG000|Overall Study|Death|0
1041485|NCT01747915|2075540|FG001|Overall Study|Death|0
1041486|NCT01747915|2075541|FG002|Overall Study|Death|1
1041487|NCT01747915|2075539|FG000|Overall Study|Lack of Efficacy|0
1041488|NCT01747915|2075540|FG001|Overall Study|Lack of Efficacy|1
1041489|NCT01747915|2075541|FG002|Overall Study|Lack of Efficacy|0
1041490|NCT01747915|2075539|FG000|Overall Study|Lost to Follow-up|1
1041491|NCT01747915|2075540|FG001|Overall Study|Lost to Follow-up|0
1041492|NCT01747915|2075541|FG002|Overall Study|Lost to Follow-up|0
1041493|NCT01747915|2075539|FG000|Overall Study|Withdrawal by Subject|4
1041494|NCT01747915|2075540|FG001|Overall Study|Withdrawal by Subject|4
1041495|NCT01747915|2075541|FG002|Overall Study|Withdrawal by Subject|1
1041496|NCT01747915|2075539|FG000|Overall Study|Protocol Violation|1
1041497|NCT01747915|2075540|FG001|Overall Study|Protocol Violation|0
1041498|NCT01747915|2075541|FG002|Overall Study|Protocol Violation|0
1041499|NCT01747915|2075539|FG000|Overall Study|Pregnancy|0
1041500|NCT01747915|2075540|FG001|Overall Study|Pregnancy|0
1041501|NCT01747915|2075541|FG002|Overall Study|Pregnancy|1
1041502|NCT01748071|2075601|FG000|Overall Study|Adverse Event|2
1041503|NCT01748071|2075602|FG001|Overall Study|Adverse Event|2
1041504|NCT01748071|2075603|FG002|Overall Study|Adverse Event|0
1041505|NCT01748292|2075622|FG000|Overall Study|Adverse Event|2
1041506|NCT01748292|2075623|FG001|Overall Study|Adverse Event|4
1041507|NCT01748292|2075622|FG000|Overall Study|Lost to Follow-up|0
1041508|NCT01748292|2075623|FG001|Overall Study|Lost to Follow-up|3
1041509|NCT01748292|2075622|FG000|Overall Study|Death|0
1041510|NCT01748292|2075623|FG001|Overall Study|Death|3
1041511|NCT01748292|2075622|FG000|Overall Study|Withdrawal by Subject|0
1041512|NCT01748292|2075623|FG001|Overall Study|Withdrawal by Subject|2
1041513|NCT01748552|2075641|FG000|Intervention Period 2 and Washout|Physician Decision|0
1041514|NCT01748552|2075642|FG001|Intervention Period 2 and Washout|Physician Decision|0
1041515|NCT01748552|2075643|FG002|Intervention Period 2 and Washout|Physician Decision|1
1041516|NCT01748552|2075644|FG003|Intervention Period 2 and Washout|Physician Decision|0
1041517|NCT01748552|2075645|FG004|Intervention Period 2 and Washout|Physician Decision|0
1041518|NCT01748552|2075646|FG005|Intervention Period 2 and Washout|Physician Decision|0
1041519|NCT01748552|2075647|FG006|Intervention Period 2 and Washout|Physician Decision|0
1041520|NCT01748552|2075648|FG007|Intervention Period 2 and Washout|Physician Decision|0
1041521|NCT01748552|2075649|FG008|Intervention Period 2 and Washout|Physician Decision|0
1041522|NCT01748552|2075650|FG009|Intervention Period 2 and Washout|Physician Decision|0
1041523|NCT01748552|2075651|FG010|Intervention Period 2 and Washout|Physician Decision|0
1041524|NCT01748552|2075652|FG011|Intervention Period 2 and Washout|Physician Decision|0
1041525|NCT01748552|2075641|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0
1041526|NCT01748552|2075642|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0
1041527|NCT01748552|2075643|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0
1041528|NCT01748552|2075644|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0
1041529|NCT01748552|2075645|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0
1041530|NCT01748552|2075646|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0
1041531|NCT01748552|2075647|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3
1041532|NCT01748552|2075648|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3
1041533|NCT01748552|2075649|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3
1041534|NCT01748552|2075650|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0
1041535|NCT01748552|2075651|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0
1041536|NCT01748552|2075652|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0
1041537|NCT01748760|2075710|FG000|Overall Study|Withdrawal by Subject|1
1041538|NCT01748760|2075711|FG001|Overall Study|Withdrawal by Subject|1
1041539|NCT01748760|2075710|FG000|Overall Study|Lost to Follow-up|5
1041540|NCT01748760|2075711|FG001|Overall Study|Lost to Follow-up|1
1041541|NCT01748825|2075768|FG000|Dose Escalation|Refused further treatment|2
1041542|NCT01748825|2075769|FG001|Dose Escalation|Refused further treatment|2
1041543|NCT01748825|2075770|FG002|Dose Escalation|Refused further treatment|0
1041544|NCT01748825|2075771|FG003|Dose Escalation|Refused further treatment|0
1041545|NCT01748825|2075772|FG004|Dose Escalation|Refused further treatment|1
1041546|NCT01748825|2075773|FG005|Dose Escalation|Refused further treatment|2
1041547|NCT01748825|2075774|FG006|Dose Escalation|Refused further treatment|0
1041548|NCT01748825|2075775|FG007|Dose Escalation|Refused further treatment|0
1041549|NCT01748825|2075776|FG008|Dose Escalation|Refused further treatment|0
1041550|NCT01748825|2075777|FG009|Dose Escalation|Refused further treatment|0
1041551|NCT01748825|2075768|FG000|Dose Escalation|Switched to alternative treatment|0
1041552|NCT01748825|2075769|FG001|Dose Escalation|Switched to alternative treatment|0
1041553|NCT01748825|2075770|FG002|Dose Escalation|Switched to alternative treatment|0
1041554|NCT01748825|2075771|FG003|Dose Escalation|Switched to alternative treatment|1
1041555|NCT01748825|2075772|FG004|Dose Escalation|Switched to alternative treatment|0
1041556|NCT01748825|2075773|FG005|Dose Escalation|Switched to alternative treatment|0
1041557|NCT01748825|2075774|FG006|Dose Escalation|Switched to alternative treatment|0
1041558|NCT01748825|2075775|FG007|Dose Escalation|Switched to alternative treatment|0
1041559|NCT01748825|2075776|FG008|Dose Escalation|Switched to alternative treatment|0
1041560|NCT01748825|2075777|FG009|Dose Escalation|Switched to alternative treatment|0
1041561|NCT01748825|2075768|FG000|Dose Escalation|Adverse Event|0
1041562|NCT01748825|2075769|FG001|Dose Escalation|Adverse Event|0
1041563|NCT01748825|2075770|FG002|Dose Escalation|Adverse Event|0
1041564|NCT01748825|2075771|FG003|Dose Escalation|Adverse Event|0
1041565|NCT01748825|2075772|FG004|Dose Escalation|Adverse Event|0
1041566|NCT01748825|2075773|FG005|Dose Escalation|Adverse Event|0
1041567|NCT01748825|2075774|FG006|Dose Escalation|Adverse Event|1
1041568|NCT01748825|2075775|FG007|Dose Escalation|Adverse Event|0
1041569|NCT01748825|2075776|FG008|Dose Escalation|Adverse Event|0
1041570|NCT01748825|2075777|FG009|Dose Escalation|Adverse Event|0
1041571|NCT01748825|2075768|FG000|Dose Expansion|Refused further treatment|0
1041572|NCT01748825|2075769|FG001|Dose Expansion|Refused further treatment|0
1041573|NCT01748825|2075770|FG002|Dose Expansion|Refused further treatment|0
1041574|NCT01748825|2075771|FG003|Dose Expansion|Refused further treatment|0
1041575|NCT01748825|2075772|FG004|Dose Expansion|Refused further treatment|0
1041576|NCT01748825|2075773|FG005|Dose Expansion|Refused further treatment|0
1041577|NCT01748825|2075774|FG006|Dose Expansion|Refused further treatment|0
1041578|NCT01748825|2075775|FG007|Dose Expansion|Refused further treatment|0
1041579|NCT01748825|2075776|FG008|Dose Expansion|Refused further treatment|1
1041580|NCT01748825|2075777|FG009|Dose Expansion|Refused further treatment|1
1041581|NCT01748825|2075768|FG000|Dose Expansion|Switched to alternative treatment|0
1041582|NCT01748825|2075769|FG001|Dose Expansion|Switched to alternative treatment|0
1041583|NCT01748825|2075770|FG002|Dose Expansion|Switched to alternative treatment|0
1041584|NCT01748825|2075771|FG003|Dose Expansion|Switched to alternative treatment|0
1041585|NCT01748825|2075772|FG004|Dose Expansion|Switched to alternative treatment|0
1041586|NCT01748825|2075773|FG005|Dose Expansion|Switched to alternative treatment|0
1041587|NCT01748825|2075774|FG006|Dose Expansion|Switched to alternative treatment|0
1041588|NCT01748825|2075775|FG007|Dose Expansion|Switched to alternative treatment|0
1041589|NCT01748825|2075776|FG008|Dose Expansion|Switched to alternative treatment|0
1041590|NCT01748825|2075777|FG009|Dose Expansion|Switched to alternative treatment|1
1041591|NCT01748825|2075768|FG000|Dose Expansion|Adverse Event|0
1041592|NCT01748825|2075769|FG001|Dose Expansion|Adverse Event|0
1041593|NCT01748825|2075770|FG002|Dose Expansion|Adverse Event|0
1041594|NCT01748825|2075771|FG003|Dose Expansion|Adverse Event|0
1041595|NCT01748825|2075772|FG004|Dose Expansion|Adverse Event|0
1041596|NCT01748825|2075773|FG005|Dose Expansion|Adverse Event|0
1041597|NCT01748825|2075774|FG006|Dose Expansion|Adverse Event|0
1041598|NCT01748825|2075775|FG007|Dose Expansion|Adverse Event|0
1041599|NCT01748825|2075776|FG008|Dose Expansion|Adverse Event|0
1041600|NCT01748825|2075777|FG009|Dose Expansion|Adverse Event|3
1041601|NCT01748825|2075768|FG000|Dose Expansion|Physician Decision|0
1041602|NCT01748825|2075769|FG001|Dose Expansion|Physician Decision|0
1041603|NCT01748825|2075770|FG002|Dose Expansion|Physician Decision|0
1041604|NCT01748825|2075771|FG003|Dose Expansion|Physician Decision|0
1041605|NCT01748825|2075772|FG004|Dose Expansion|Physician Decision|0
1041606|NCT01748825|2075773|FG005|Dose Expansion|Physician Decision|0
1041607|NCT01748825|2075774|FG006|Dose Expansion|Physician Decision|0
1041608|NCT01748825|2075775|FG007|Dose Expansion|Physician Decision|0
1041609|NCT01748825|2075776|FG008|Dose Expansion|Physician Decision|1
1041610|NCT01748825|2075777|FG009|Dose Expansion|Physician Decision|0
1041611|NCT01748994|2075839|FG000|Overall Study|Lost to Follow-up|8
1041612|NCT01748994|2075840|FG001|Overall Study|Lost to Follow-up|6
1041613|NCT01749033|2075849|FG000|Overall Study|Did not receive allocated intervention|3
1041614|NCT01749033|2075850|FG001|Overall Study|Did not receive allocated intervention|3
1041615|NCT01749033|2075851|FG002|Overall Study|Did not receive allocated intervention|0
1041616|NCT01749033|2075849|FG000|Overall Study|Lost to Follow-up|0
1041617|NCT01749033|2075850|FG001|Overall Study|Lost to Follow-up|2
1041618|NCT01749033|2075851|FG002|Overall Study|Lost to Follow-up|1
1041619|NCT01749735|2075902|FG000|Overall Study|Withdrawal by Subject|1
1041620|NCT01749735|2075903|FG001|Overall Study|Withdrawal by Subject|0
1041621|NCT01749800|2075912|FG000|Overall Study|not meeting inclusion criteria|3
1041622|NCT01749800|2075913|FG001|Overall Study|not meeting inclusion criteria|0
1041623|NCT01749800|2075914|FG002|Overall Study|not meeting inclusion criteria|0
1041624|NCT01749800|2075912|FG000|Overall Study|Withdrawal by Subject|0
1041625|NCT01749800|2075913|FG001|Overall Study|Withdrawal by Subject|1
1041626|NCT01749800|2075914|FG002|Overall Study|Withdrawal by Subject|0
1041627|NCT01749982|2075957|FG000|Overall Study|Physician Decision|0
1041628|NCT01749982|2075958|FG001|Overall Study|Physician Decision|0
1041629|NCT01749982|2075959|FG002|Overall Study|Physician Decision|0
1041630|NCT01749982|2075960|FG003|Overall Study|Physician Decision|1
1041631|NCT01749982|2075957|FG000|Overall Study|Lost to Follow-up|0
1041632|NCT01749982|2075958|FG001|Overall Study|Lost to Follow-up|0
1041633|NCT01749982|2075959|FG002|Overall Study|Lost to Follow-up|0
1041634|NCT01749982|2075960|FG003|Overall Study|Lost to Follow-up|1
1041635|NCT01749982|2075957|FG000|Overall Study|Withdrawal by Subject|0
1041636|NCT01749982|2075958|FG001|Overall Study|Withdrawal by Subject|0
1041637|NCT01749982|2075959|FG002|Overall Study|Withdrawal by Subject|0
1041638|NCT01749982|2075960|FG003|Overall Study|Withdrawal by Subject|1
1041639|NCT01750190|2075985|FG000|Overall Study|Adverse Event|47
1041640|NCT01750190|2075986|FG001|Overall Study|Adverse Event|19
1041641|NCT01750190|2075985|FG000|Overall Study|Death|38
1041642|NCT01750190|2075986|FG001|Overall Study|Death|11
1041643|NCT01750190|2075985|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2
1041644|NCT01750190|2075986|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43
1041645|NCT01750190|2075985|FG000|Overall Study|Lost to Follow-up|28
1041646|NCT01750190|2075986|FG001|Overall Study|Lost to Follow-up|7
1041647|NCT01750190|2075985|FG000|Overall Study|Physician Decision|16
1041648|NCT01750190|2075986|FG001|Overall Study|Physician Decision|17
1041649|NCT01750190|2075985|FG000|Overall Study|Protocol Violation|6
1041650|NCT01750190|2075986|FG001|Overall Study|Protocol Violation|5
1041651|NCT01750190|2075985|FG000|Overall Study|Study/Site Terminated by Sponsor|4
1041652|NCT01750190|2075986|FG001|Overall Study|Study/Site Terminated by Sponsor|1
1041653|NCT01750190|2075985|FG000|Overall Study|Withdrawal by Subject|83
1041654|NCT01750190|2075986|FG001|Overall Study|Withdrawal by Subject|89
1041655|NCT01750190|2075985|FG000|Overall Study|Kidney Transplant|8
1041656|NCT01750190|2075986|FG001|Overall Study|Kidney Transplant|4
1041657|NCT01750190|2075985|FG000|Overall Study|Dialysis|22
1041658|NCT01750190|2075986|FG001|Overall Study|Dialysis|8
1041659|NCT01750190|2075985|FG000|Overall Study|Other than Specified|13
1041660|NCT01750190|2075986|FG001|Overall Study|Other than Specified|4
1041661|NCT01750229|2075992|FG000|Randomized Crossover Phase|Adverse Event|1
1041662|NCT01750229|2075992|FG000|Randomized Crossover Phase|Withdrawal by Subject|1
1041663|NCT01750229|2075992|FG000|Long-term Follow-up Phase|Adverse Event|2
1041664|NCT01750229|2075992|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1
1041665|NCT01750242|2076002|FG000|Overall Study|Unreadable Images|3
1041666|NCT01750268|2076019|FG000|Overall Study|Lost to Follow-up|0
1041667|NCT01750268|2076020|FG001|Overall Study|Lost to Follow-up|2
1041668|NCT01750268|2076019|FG000|Overall Study|Physician Decision|0
1041669|NCT01750268|2076020|FG001|Overall Study|Physician Decision|3
1041670|NCT01750268|2076019|FG000|Overall Study|Withdrawal by Subject|2
1041671|NCT01750268|2076020|FG001|Overall Study|Withdrawal by Subject|0
1041681|NCT01750294|2076039|FG000|Overall Study|Withdrawal by Subject|1
1041682|NCT01750294|2076039|FG000|Overall Study|Safety Endpoint|1
1041683|NCT01750346|2076046|FG000|Overall Study|Adverse Event|1
1041684|NCT01750346|2076047|FG001|Overall Study|Adverse Event|0
1041685|NCT01750346|2076048|FG002|Overall Study|Adverse Event|0
1041686|NCT01750684|2076076|FG000|Overall Study|Death|1
1041687|NCT01750684|2076077|FG001|Overall Study|Death|0
1041688|NCT01750684|2076076|FG000|Overall Study|Non-compliance with Study Drug|0
1041689|NCT01750684|2076077|FG001|Overall Study|Non-compliance with Study Drug|1
1041690|NCT01750684|2076076|FG000|Overall Study|Withdrawn by Sponsor|0
1041691|NCT01750684|2076077|FG001|Overall Study|Withdrawn by Sponsor|1
1041692|NCT01750684|2076076|FG000|Overall Study|Protocol Violation|1
1041693|NCT01750684|2076077|FG001|Overall Study|Protocol Violation|0
1041694|NCT01750697|2076084|FG000|Overall Study|Transferred Back to Local Hospital|1
1041695|NCT01750697|2076084|FG000|Overall Study|Physician and Family Decision|1
1041696|NCT01750697|2076084|FG000|Overall Study|Transferred to Adult Services|5
1041697|NCT01750697|2076084|FG000|Overall Study|Physician Decision|1
1041698|NCT01750697|2076084|FG000|Overall Study|Withdrawal by Subject|1
1041699|NCT01750840|2076091|FG000|Overall Study|Lost to Follow-up|4
1041700|NCT01750879|2076098|FG000|Overall Study|Adverse Event|8
1041701|NCT01750879|2076099|FG001|Overall Study|Adverse Event|0
1041702|NCT01750879|2076098|FG000|Overall Study|Lack of Efficacy|1
1041703|NCT01750879|2076099|FG001|Overall Study|Lack of Efficacy|0
1041704|NCT01750879|2076098|FG000|Overall Study|Withdrawal by Subject|1
1041705|NCT01750879|2076099|FG001|Overall Study|Withdrawal by Subject|0
1041706|NCT01750879|2076098|FG000|Overall Study|Did not complete per protocol|0
1041707|NCT01750879|2076099|FG001|Overall Study|Did not complete per protocol|3
1041708|NCT01750918|2076126|FG000|Overall Study|Last patient transitioned to a rollover protocol|0
1041709|NCT01750918|2076127|FG001|Overall Study|Last patient transitioned to a rollover protocol|0
1041710|NCT01750918|2076128|FG002|Overall Study|Last patient transitioned to a rollover protocol|5
1041711|NCT01750918|2076129|FG003|Overall Study|Last patient transitioned to a rollover protocol|2
1041712|NCT01750918|2076130|FG004|Overall Study|Last patient transitioned to a rollover protocol|0
1041713|NCT01750918|2076131|FG005|Overall Study|Last patient transitioned to a rollover protocol|2
1041714|NCT01750918|2076132|FG006|Overall Study|Last patient transitioned to a rollover protocol|1
1041715|NCT01750918|2076133|FG007|Overall Study|Last patient transitioned to a rollover protocol|1
1041716|NCT01750918|2076126|FG000|Overall Study|Lost to Follow-up|0
1041717|NCT01750918|2076127|FG001|Overall Study|Lost to Follow-up|0
1041718|NCT01750918|2076128|FG002|Overall Study|Lost to Follow-up|2
1041719|NCT01750918|2076129|FG003|Overall Study|Lost to Follow-up|2
1041720|NCT01750918|2076130|FG004|Overall Study|Lost to Follow-up|0
1041721|NCT01750918|2076131|FG005|Overall Study|Lost to Follow-up|0
1041722|NCT01750918|2076132|FG006|Overall Study|Lost to Follow-up|0
1041723|NCT01750918|2076133|FG007|Overall Study|Lost to Follow-up|1
1041724|NCT01750918|2076126|FG000|Overall Study|Withdrawal by Subject|0
1041725|NCT01750918|2076127|FG001|Overall Study|Withdrawal by Subject|0
1041726|NCT01750918|2076128|FG002|Overall Study|Withdrawal by Subject|1
1041727|NCT01750918|2076129|FG003|Overall Study|Withdrawal by Subject|2
1041728|NCT01750918|2076130|FG004|Overall Study|Withdrawal by Subject|1
1041729|NCT01750918|2076131|FG005|Overall Study|Withdrawal by Subject|1
1041730|NCT01750918|2076132|FG006|Overall Study|Withdrawal by Subject|2
1041731|NCT01750918|2076133|FG007|Overall Study|Withdrawal by Subject|2
1041732|NCT01751061|2076204|FG000|Overall Study|Death|1
1041733|NCT01751061|2076205|FG001|Overall Study|Death|0
1041734|NCT01751061|2076204|FG000|Overall Study|patient death|5
1041735|NCT01751061|2076205|FG001|Overall Study|patient death|0
1041736|NCT01751061|2076204|FG000|Overall Study|Lost to Follow-up|40
1041737|NCT01751061|2076205|FG001|Overall Study|Lost to Follow-up|25
1041738|NCT01751061|2076204|FG000|Overall Study|patient regained decisional capacity|4
1041739|NCT01751061|2076205|FG001|Overall Study|patient regained decisional capacity|8
1041740|NCT01751061|2076204|FG000|Overall Study|Withdrawal by Subject|4
1041741|NCT01751061|2076205|FG001|Overall Study|Withdrawal by Subject|1
1041742|NCT01751061|2076204|FG000|Overall Study|Physician Decision|2
1041743|NCT01751061|2076205|FG001|Overall Study|Physician Decision|0
1041744|NCT01751087|2076214|FG000|Overall Study|Withdrawal by Subject|1
1041745|NCT01751087|2076215|FG001|Overall Study|Withdrawal by Subject|0
1041746|NCT01751087|2076216|FG002|Overall Study|Withdrawal by Subject|0
1041747|NCT01751087|2076214|FG000|Overall Study|Physician Decision|0
1041748|NCT01751087|2076215|FG001|Overall Study|Physician Decision|0
1041749|NCT01751087|2076216|FG002|Overall Study|Physician Decision|1
1041750|NCT01751113|2076224|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
1041751|NCT01751113|2076225|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
1041752|NCT01751113|2076226|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0
1041753|NCT01751113|2076227|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1
1041754|NCT01751113|2076228|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1
1041755|NCT01751113|2076229|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0
1041756|NCT01751113|2076224|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0
1041757|NCT01751113|2076225|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0
1041758|NCT01751113|2076226|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0
1041759|NCT01751113|2076227|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0
1041760|NCT01751113|2076228|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0
1041761|NCT01751113|2076229|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1
1041762|NCT01751139|2076238|FG000|Overall Study|Other|135
1041763|NCT01751139|2076238|FG000|Overall Study|Sponsor study termination|1609
1041764|NCT01751139|2076238|FG000|Overall Study|Lost to Follow-up|240
1041765|NCT01751139|2076238|FG000|Overall Study|Withdrawal by Subject|251
1041766|NCT01751139|2076238|FG000|Overall Study|Adverse Event|1
1041767|NCT01751139|2076238|FG000|Overall Study|Death|31
1041768|NCT01751165|2076245|FG000|Overall Study|Adverse event, serious fatal|1
1041769|NCT01751165|2076246|FG001|Overall Study|Adverse event, serious fatal|0
1041770|NCT01751165|2076247|FG002|Overall Study|Adverse event, serious fatal|1
1041771|NCT01751165|2076245|FG000|Overall Study|Withdrawal by Subject|0
1041772|NCT01751165|2076246|FG001|Overall Study|Withdrawal by Subject|0
1041773|NCT01751165|2076247|FG002|Overall Study|Withdrawal by Subject|1
1041774|NCT01751165|2076245|FG000|Overall Study|Serious adverse event|0
1041775|NCT01751165|2076246|FG001|Overall Study|Serious adverse event|2
1041776|NCT01751165|2076247|FG002|Overall Study|Serious adverse event|0
1041777|NCT01751165|2076245|FG000|Overall Study|Lost to Follow-up|1
1041778|NCT01751165|2076246|FG001|Overall Study|Lost to Follow-up|1
1041779|NCT01751165|2076247|FG002|Overall Study|Lost to Follow-up|1
1041780|NCT01751178|2076260|FG000|Overall Study|Adverse Event|2
1041781|NCT01751178|2076261|FG001|Overall Study|Adverse Event|0
1041782|NCT01751178|2076262|FG002|Overall Study|Adverse Event|0
1041783|NCT01751178|2076260|FG000|Overall Study|Other Reason (unknown)|1
1041784|NCT01751178|2076261|FG001|Overall Study|Other Reason (unknown)|0
1041785|NCT01751178|2076262|FG002|Overall Study|Other Reason (unknown)|2
1041786|NCT01751412|2076338|FG000|Overall Study|Disease Progression Before Treatment|1
1041787|NCT01751568|2076358|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1
1041788|NCT01751568|2076359|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
1041789|NCT01751568|2076360|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
1041790|NCT01751646|2076370|FG000|Overall Study|Lost to Follow-up|5
1041791|NCT01751646|2076371|FG001|Overall Study|Lost to Follow-up|1
1041792|NCT01751646|2076370|FG000|Overall Study|Withdrawal by Subject|0
1041793|NCT01751646|2076371|FG001|Overall Study|Withdrawal by Subject|4
1041794|NCT01751646|2076370|FG000|Overall Study|Starting hormone therapy|1
1041795|NCT01751646|2076371|FG001|Overall Study|Starting hormone therapy|0
1041796|NCT01751646|2076370|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2
1041797|NCT01751646|2076371|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3
1041798|NCT01751646|2076370|FG000|Overall Study|Inadvertent enrollment|1
1041799|NCT01751646|2076371|FG001|Overall Study|Inadvertent enrollment|1
1041800|NCT01751646|2076370|FG000|Overall Study|Moved out of the area|1
1041801|NCT01751646|2076371|FG001|Overall Study|Moved out of the area|5
1041802|NCT01751646|2076370|FG000|Overall Study|Inability to attend required visits|0
1041803|NCT01751646|2076371|FG001|Overall Study|Inability to attend required visits|1
1041804|NCT01751646|2076370|FG000|Overall Study|Off study due to multiple obligations|0
1041805|NCT01751646|2076371|FG001|Overall Study|Off study due to multiple obligations|1
1041806|NCT01751646|2076370|FG000|Overall Study|Fails to comply with study requirements|0
1041807|NCT01751646|2076371|FG001|Overall Study|Fails to comply with study requirements|1
1041808|NCT01751646|2076370|FG000|Overall Study|Childcare issues|1
1041809|NCT01751646|2076371|FG001|Overall Study|Childcare issues|1
1041810|NCT01751724|2076383|FG000|Overall Study|extubated bef.start assigned treatment|1
1041811|NCT01751724|2076384|FG001|Overall Study|extubated bef.start assigned treatment|0
1041812|NCT01751724|2076383|FG000|Overall Study|withdrawn by parent|0
1041813|NCT01751724|2076384|FG001|Overall Study|withdrawn by parent|2
1041814|NCT01751802|2076392|FG000|Overall Study|Adverse Event|4
1041815|NCT01751802|2076393|FG001|Overall Study|Adverse Event|2
1041816|NCT01751867|2076407|FG000|Overall Study|Completed treatment,dropped in follow-up|4
1041817|NCT01751867|2076408|FG001|Overall Study|Completed treatment,dropped in follow-up|8
1041818|NCT01751867|2076407|FG000|Overall Study|Diease Progression|4
1041819|NCT01751867|2076408|FG001|Overall Study|Diease Progression|18
1041820|NCT01751867|2076407|FG000|Overall Study|Adverse Event|8
1041821|NCT01751867|2076408|FG001|Overall Study|Adverse Event|15
1041822|NCT01751867|2076407|FG000|Overall Study|Poor Compliance|0
1041823|NCT01751867|2076408|FG001|Overall Study|Poor Compliance|5
1041824|NCT01751867|2076407|FG000|Overall Study|Withdrawal by Subject|3
1041825|NCT01751867|2076408|FG001|Overall Study|Withdrawal by Subject|1
1041826|NCT01751867|2076407|FG000|Overall Study|Physician Decision|4
1041827|NCT01751867|2076408|FG001|Overall Study|Physician Decision|7
1041828|NCT01751867|2076407|FG000|Overall Study|Protocol Violation|0
1041829|NCT01751867|2076408|FG001|Overall Study|Protocol Violation|2
1041830|NCT01751867|2076407|FG000|Overall Study|Death|0
1041831|NCT01751867|2076408|FG001|Overall Study|Death|5
1041832|NCT01751867|2076407|FG000|Overall Study|Other|11
1041833|NCT01751867|2076408|FG001|Overall Study|Other|37
1041834|NCT01751867|2076407|FG000|Overall Study|Randomized but not treated.|2
1041835|NCT01751867|2076408|FG001|Overall Study|Randomized but not treated.|1
1041836|NCT01751906|2076416|FG000|Overall Study|Lost to Follow-up|151
1041837|NCT01751906|2076417|FG001|Overall Study|Lost to Follow-up|68
1041838|NCT01751906|2076416|FG000|Overall Study|Withdrawal by Subject|22
1041839|NCT01751906|2076417|FG001|Overall Study|Withdrawal by Subject|18
1041840|NCT01751906|2076416|FG000|Overall Study|Physician Decision|5
1041841|NCT01751906|2076417|FG001|Overall Study|Physician Decision|2
1041842|NCT01751906|2076416|FG000|Overall Study|Death|84
1041843|NCT01751906|2076417|FG001|Overall Study|Death|43
1041844|NCT01751906|2076416|FG000|Overall Study|Denied on premises for follow-up by law|1
1041845|NCT01751906|2076417|FG001|Overall Study|Denied on premises for follow-up by law|0
1041846|NCT01752036|2076438|FG000|Overall Study|Death|2
1041847|NCT01752634|2076466|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
1041848|NCT01752634|2076467|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
1041849|NCT01752634|2076468|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
1041850|NCT01752634|2076469|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
1041851|NCT01752634|2076470|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
1041852|NCT01752634|2076471|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
1041853|NCT01752634|2076466|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0
1041854|NCT01752634|2076467|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1
1041855|NCT01752634|2076468|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0
1041856|NCT01752634|2076469|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0
1041857|NCT01752634|2076470|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0
1041858|NCT01752634|2076471|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0
1041859|NCT01752634|2076466|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
1041860|NCT01752634|2076467|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
1041861|NCT01752634|2076468|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
1041862|NCT01752634|2076469|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
1041863|NCT01752634|2076470|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
1041864|NCT01752634|2076471|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
1041865|NCT01752634|2076466|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3
1041866|NCT01752634|2076467|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0
1041867|NCT01752634|2076468|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2
1041868|NCT01752634|2076469|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0
1041869|NCT01752634|2076470|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0
1041870|NCT01752634|2076471|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4
1041871|NCT01752634|2076466|FG000|Week 24 to Week 260|Lack of Efficacy|15
1041872|NCT01752634|2076467|FG001|Week 24 to Week 260|Lack of Efficacy|7
1041873|NCT01752634|2076468|FG002|Week 24 to Week 260|Lack of Efficacy|7
1041874|NCT01752634|2076469|FG003|Week 24 to Week 260|Lack of Efficacy|3
1041875|NCT01752634|2076470|FG004|Week 24 to Week 260|Lack of Efficacy|4
1041876|NCT01752634|2076471|FG005|Week 24 to Week 260|Lack of Efficacy|0
1041877|NCT01752634|2076466|FG000|Week 24 to Week 260|Subject/guardian decision|12
1041878|NCT01752634|2076467|FG001|Week 24 to Week 260|Subject/guardian decision|10
1041879|NCT01752634|2076468|FG002|Week 24 to Week 260|Subject/guardian decision|9
1041880|NCT01752634|2076469|FG003|Week 24 to Week 260|Subject/guardian decision|5
1041881|NCT01752634|2076470|FG004|Week 24 to Week 260|Subject/guardian decision|5
1041882|NCT01752634|2076471|FG005|Week 24 to Week 260|Subject/guardian decision|0
1041883|NCT01752634|2076466|FG000|Week 24 to Week 260|Physician Decision|1
1041884|NCT01752634|2076467|FG001|Week 24 to Week 260|Physician Decision|2
1041885|NCT01752634|2076468|FG002|Week 24 to Week 260|Physician Decision|4
1041886|NCT01752634|2076469|FG003|Week 24 to Week 260|Physician Decision|2
1041887|NCT01752634|2076470|FG004|Week 24 to Week 260|Physician Decision|1
1041888|NCT01752634|2076471|FG005|Week 24 to Week 260|Physician Decision|0
1041889|NCT01752634|2076466|FG000|Week 24 to Week 260|Death|0
1041890|NCT01752634|2076467|FG001|Week 24 to Week 260|Death|1
1041891|NCT01752634|2076468|FG002|Week 24 to Week 260|Death|0
1041892|NCT01752634|2076469|FG003|Week 24 to Week 260|Death|0
1041893|NCT01752634|2076470|FG004|Week 24 to Week 260|Death|0
1041894|NCT01752634|2076471|FG005|Week 24 to Week 260|Death|0
1041895|NCT01752634|2076466|FG000|Week 24 to Week 260|Pregnancy|0
1041896|NCT01752634|2076467|FG001|Week 24 to Week 260|Pregnancy|0
1041897|NCT01752634|2076468|FG002|Week 24 to Week 260|Pregnancy|1
1041898|NCT01752634|2076469|FG003|Week 24 to Week 260|Pregnancy|0
1041899|NCT01752634|2076470|FG004|Week 24 to Week 260|Pregnancy|0
1041900|NCT01752634|2076471|FG005|Week 24 to Week 260|Pregnancy|0
1041901|NCT01752634|2076466|FG000|Week 24 to Week 260|Noncompliance with study treatment|0
1041902|NCT01752634|2076467|FG001|Week 24 to Week 260|Noncompliance with study treatment|0
1041903|NCT01752634|2076468|FG002|Week 24 to Week 260|Noncompliance with study treatment|1
1041904|NCT01752634|2076469|FG003|Week 24 to Week 260|Noncompliance with study treatment|0
1041905|NCT01752634|2076470|FG004|Week 24 to Week 260|Noncompliance with study treatment|0
1041906|NCT01752634|2076471|FG005|Week 24 to Week 260|Noncompliance with study treatment|0
1041907|NCT01752634|2076466|FG000|Week 24 to Week 260|Lost to Follow-up|2
1041908|NCT01752634|2076467|FG001|Week 24 to Week 260|Lost to Follow-up|2
1041909|NCT01752634|2076468|FG002|Week 24 to Week 260|Lost to Follow-up|3
1041910|NCT01752634|2076469|FG003|Week 24 to Week 260|Lost to Follow-up|0
1041911|NCT01752634|2076470|FG004|Week 24 to Week 260|Lost to Follow-up|2
1041912|NCT01752634|2076471|FG005|Week 24 to Week 260|Lost to Follow-up|0
1041913|NCT01752634|2076466|FG000|Week 24 to Week 260|Adverse Event|4
1041914|NCT01752634|2076467|FG001|Week 24 to Week 260|Adverse Event|8
1041915|NCT01752634|2076468|FG002|Week 24 to Week 260|Adverse Event|8
1041916|NCT01752634|2076469|FG003|Week 24 to Week 260|Adverse Event|4
1041917|NCT01752634|2076470|FG004|Week 24 to Week 260|Adverse Event|2
1041918|NCT01752634|2076471|FG005|Week 24 to Week 260|Adverse Event|0
1041919|NCT01752842|2076492|FG000|Overall Study|Adverse Event|3
1041920|NCT01752842|2076493|FG001|Overall Study|Adverse Event|0
1041921|NCT01752842|2076492|FG000|Overall Study|Withdrawal by Subject|0
1041922|NCT01752842|2076493|FG001|Overall Study|Withdrawal by Subject|2
1041923|NCT01752855|2076501|FG000|Overall Study|Adverse Event|1
1041924|NCT01752855|2076502|FG001|Overall Study|Adverse Event|0
1041925|NCT01752855|2076501|FG000|Overall Study|Withdrew Consent|0
1041926|NCT01752855|2076502|FG001|Overall Study|Withdrew Consent|2
1041927|NCT01752855|2076501|FG000|Overall Study|Lack of Efficacy|0
1041928|NCT01752855|2076502|FG001|Overall Study|Lack of Efficacy|2
1041929|NCT01752907|2076510|FG000|Overall Study|Withdrawal by Subject|4
1041930|NCT01752907|2076511|FG001|Overall Study|Withdrawal by Subject|10
1041931|NCT01752907|2076510|FG000|Overall Study|Lost to Follow-up|2
1041932|NCT01752907|2076511|FG001|Overall Study|Lost to Follow-up|1
1041933|NCT01752907|2076510|FG000|Overall Study|Decision by Sponsor|6
1041934|NCT01752907|2076511|FG001|Overall Study|Decision by Sponsor|9
1041935|NCT01752920|2076521|FG000|Overall Study|Adverse Event|1
1041936|NCT01752920|2076522|FG001|Overall Study|Adverse Event|0
1041937|NCT01752920|2076523|FG002|Overall Study|Adverse Event|5
1041938|NCT01752920|2076524|FG003|Overall Study|Adverse Event|10
1041939|NCT01752920|2076521|FG000|Overall Study|Clinical Disease Progression|6
1041940|NCT01752920|2076522|FG001|Overall Study|Clinical Disease Progression|4
1041941|NCT01752920|2076523|FG002|Overall Study|Clinical Disease Progression|1
1041942|NCT01752920|2076524|FG003|Overall Study|Clinical Disease Progression|13
1041943|NCT01752920|2076521|FG000|Overall Study|Physician Decision|1
1041944|NCT01752920|2076522|FG001|Overall Study|Physician Decision|0
1041945|NCT01752920|2076523|FG002|Overall Study|Physician Decision|0
1041946|NCT01752920|2076524|FG003|Overall Study|Physician Decision|3
1041947|NCT01752920|2076521|FG000|Overall Study|Radiographic Disease Progression|20
1041948|NCT01752920|2076522|FG001|Overall Study|Radiographic Disease Progression|7
1041949|NCT01752920|2076523|FG002|Overall Study|Radiographic Disease Progression|12
1041950|NCT01752920|2076524|FG003|Overall Study|Radiographic Disease Progression|29
1041951|NCT01752920|2076521|FG000|Overall Study|Study Terminated by Sponsor|0
1041952|NCT01752920|2076522|FG001|Overall Study|Study Terminated by Sponsor|0
1041953|NCT01752920|2076523|FG002|Overall Study|Study Terminated by Sponsor|0
1041954|NCT01752920|2076524|FG003|Overall Study|Study Terminated by Sponsor|1
1041955|NCT01752920|2076521|FG000|Overall Study|Withdrawal by Subject|0
1041956|NCT01752920|2076522|FG001|Overall Study|Withdrawal by Subject|1
1041957|NCT01752920|2076523|FG002|Overall Study|Withdrawal by Subject|0
1041958|NCT01752920|2076524|FG003|Overall Study|Withdrawal by Subject|1
1041959|NCT01752920|2076521|FG000|Overall Study|Lack of clinical benefit|1
1041960|NCT01752920|2076522|FG001|Overall Study|Lack of clinical benefit|1
1041961|NCT01752920|2076523|FG002|Overall Study|Lack of clinical benefit|1
1041962|NCT01752920|2076524|FG003|Overall Study|Lack of clinical benefit|1
1041963|NCT01752933|2076538|FG000|Treatment|Disease Progression|3
1041964|NCT01752933|2076539|FG001|Treatment|Disease Progression|29
1041965|NCT01752933|2076538|FG000|Treatment|Withdrawal by Subject|0
1041966|NCT01752933|2076539|FG001|Treatment|Withdrawal by Subject|5
1041967|NCT01752933|2076538|FG000|Treatment|Adverse Event|1
1041968|NCT01752933|2076539|FG001|Treatment|Adverse Event|4
1041969|NCT01752933|2076538|FG000|Treatment|Physician Decision|0
1041970|NCT01752933|2076539|FG001|Treatment|Physician Decision|3
1041971|NCT01752933|2076538|FG000|Treatment|Death|0
1041972|NCT01752933|2076539|FG001|Treatment|Death|2
1041973|NCT01752933|2076538|FG000|Treatment|Hepatocellular carcinoma not confirmed|0
1041974|NCT01752933|2076539|FG001|Treatment|Hepatocellular carcinoma not confirmed|1
1041975|NCT01752933|2076538|FG000|Treatment|Patient noncompliant|0
1041976|NCT01752933|2076539|FG001|Treatment|Patient noncompliant|1
1041977|NCT01752933|2076538|FG000|Treatment|Patient unable to travel to appointments|0
1041978|NCT01752933|2076539|FG001|Treatment|Patient unable to travel to appointments|1
1041979|NCT01752933|2076538|FG000|Overall Study and Follow-up|Death|4
1041980|NCT01752933|2076539|FG001|Overall Study and Follow-up|Death|34
1041981|NCT01752933|2076538|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
1041982|NCT01752933|2076539|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
1041983|NCT01752933|2076538|FG000|Overall Study and Follow-up|Withdrawal by Subject|0
1041984|NCT01752933|2076539|FG001|Overall Study and Follow-up|Withdrawal by Subject|3
1041985|NCT01752933|2076538|FG000|Overall Study and Follow-up|Lost to Follow-up|0
1041986|NCT01752933|2076539|FG001|Overall Study and Follow-up|Lost to Follow-up|2
1041987|NCT01752985|2076549|FG000|Treatment Period|Subject request to discontinue treatment|1
1041988|NCT01752985|2076550|FG001|Treatment Period|Subject request to discontinue treatment|0
1041989|NCT01752985|2076551|FG002|Treatment Period|Subject request to discontinue treatment|1
1041990|NCT01752985|2076549|FG000|Treatment Period|Subject no longer meets study criteria|0
1041991|NCT01752985|2076550|FG001|Treatment Period|Subject no longer meets study criteria|1
1041992|NCT01752985|2076551|FG002|Treatment Period|Subject no longer meets study criteria|1
1041993|NCT01752985|2076549|FG000|Treatment Period|Adverse Event|2
1041994|NCT01752985|2076550|FG001|Treatment Period|Adverse Event|1
1041995|NCT01752985|2076551|FG002|Treatment Period|Adverse Event|2
1041996|NCT01752985|2076549|FG000|Treatment Period|Withdrawal by Subject|1
1041997|NCT01752985|2076550|FG001|Treatment Period|Withdrawal by Subject|1
1041998|NCT01752985|2076551|FG002|Treatment Period|Withdrawal by Subject|0
1041999|NCT01752985|2076549|FG000|Treatment Period|Lost to Follow-up|0
1042000|NCT01752985|2076550|FG001|Treatment Period|Lost to Follow-up|0
1042001|NCT01752985|2076551|FG002|Treatment Period|Lost to Follow-up|1
1042002|NCT01753076|2076561|FG000|Overall Study|Adverse Event|17
1042003|NCT01753076|2076562|FG001|Overall Study|Adverse Event|18
1042004|NCT01753076|2076561|FG000|Overall Study|Lack of Efficacy|3
1042005|NCT01753076|2076562|FG001|Overall Study|Lack of Efficacy|1
1042006|NCT01753076|2076561|FG000|Overall Study|Lost to Follow-up|2
1042007|NCT01753076|2076562|FG001|Overall Study|Lost to Follow-up|1
1042008|NCT01753076|2076561|FG000|Overall Study|Physician Decision|4
1042009|NCT01753076|2076562|FG001|Overall Study|Physician Decision|2
1042010|NCT01753076|2076561|FG000|Overall Study|Withdrawal by Subject|14
1042011|NCT01753076|2076562|FG001|Overall Study|Withdrawal by Subject|24
1042012|NCT01753076|2076561|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1
1042013|NCT01753076|2076562|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0
1042014|NCT01753115|2076573|FG000|Overall Study|Lost to Follow-up|3
1042015|NCT01753115|2076574|FG001|Overall Study|Lost to Follow-up|6
1042016|NCT01753115|2076575|FG002|Overall Study|Lost to Follow-up|8
1042017|NCT01753115|2076573|FG000|Overall Study|Withdrawal by Subject|6
1042018|NCT01753115|2076574|FG001|Overall Study|Withdrawal by Subject|5
1042019|NCT01753115|2076575|FG002|Overall Study|Withdrawal by Subject|6
1042020|NCT01753115|2076573|FG000|Overall Study|Subject non-compliant|3
1042021|NCT01753115|2076574|FG001|Overall Study|Subject non-compliant|3
1042022|NCT01753115|2076575|FG002|Overall Study|Subject non-compliant|0
1042023|NCT01753115|2076573|FG000|Overall Study|Used excluded drug|0
1042024|NCT01753115|2076574|FG001|Overall Study|Used excluded drug|1
1042025|NCT01753115|2076575|FG002|Overall Study|Used excluded drug|0
1042026|NCT01753193|2076583|FG000|Overall Study|Withdrawal by Subject|23
1042027|NCT01753193|2076583|FG000|Overall Study|Lost to Follow-up|6
1042028|NCT01753193|2076583|FG000|Overall Study|Death|1
1042029|NCT01753193|2076583|FG000|Overall Study|Other|16
1042030|NCT01753297|2076589|FG000|Overall Study|Lost to Follow-up|7
1042031|NCT01753297|2076590|FG001|Overall Study|Lost to Follow-up|2
1042032|NCT01753297|2076589|FG000|Overall Study|Withdrawal by Subject|26
1042033|NCT01753297|2076590|FG001|Overall Study|Withdrawal by Subject|23
1042034|NCT01753297|2076589|FG000|Overall Study|Adverse Event (up to Month 36)|1
1042035|NCT01753297|2076590|FG001|Overall Study|Adverse Event (up to Month 36)|1
1042036|NCT01753297|2076589|FG000|Overall Study|Death|0
1042037|NCT01753297|2076590|FG001|Overall Study|Death|2
1042038|NCT01753297|2076589|FG000|Overall Study|Did not attend end of study visit|7
1042039|NCT01753297|2076590|FG001|Overall Study|Did not attend end of study visit|8
1042040|NCT01753310|2076600|FG000|Overall Study|Entered into open label extension study|25
1042041|NCT01753310|2076601|FG001|Overall Study|Entered into open label extension study|22
1042042|NCT01753310|2076600|FG000|Overall Study|Adverse Event|1
1042043|NCT01753310|2076601|FG001|Overall Study|Adverse Event|0
1042044|NCT01753310|2076600|FG000|Overall Study|Lost to Follow-up|2
1042045|NCT01753310|2076601|FG001|Overall Study|Lost to Follow-up|0
1042046|NCT01753310|2076600|FG000|Overall Study|Subject decision|2
1042047|NCT01753310|2076601|FG001|Overall Study|Subject decision|2
1042048|NCT01753310|2076600|FG000|Overall Study|Sponsor decision|1
1042049|NCT01753310|2076601|FG001|Overall Study|Sponsor decision|0
1042050|NCT01753310|2076600|FG000|Overall Study|Withdrawal by Subject|1
1042051|NCT01753310|2076601|FG001|Overall Study|Withdrawal by Subject|0
1042052|NCT01753323|2076610|FG000|Overall Study|Lack of Efficacy|0
1042053|NCT01753323|2076611|FG001|Overall Study|Lack of Efficacy|0
1042054|NCT01753323|2076612|FG002|Overall Study|Lack of Efficacy|8
1042055|NCT01753323|2076610|FG000|Overall Study|Protocol deviation|1
1042056|NCT01753323|2076611|FG001|Overall Study|Protocol deviation|0
1042057|NCT01753323|2076612|FG002|Overall Study|Protocol deviation|0
1042058|NCT01753323|2076610|FG000|Overall Study|Adverse Event|0
1042059|NCT01753323|2076611|FG001|Overall Study|Adverse Event|0
1042060|NCT01753323|2076612|FG002|Overall Study|Adverse Event|1
1042061|NCT01753336|2076621|FG000|Overall Study|Patient decision|12
1042062|NCT01753336|2076621|FG000|Overall Study|Lost to Follow-up|3
1042063|NCT01753336|2076621|FG000|Overall Study|Physician Decision|2
1042064|NCT01753336|2076621|FG000|Overall Study|Sponsor's decision|2
1042065|NCT01753336|2076621|FG000|Overall Study|Withdrawal by Subject|1
1042066|NCT01753401|2076636|FG000|Double-blind Period (8 Weeks)|Adverse Event|0
1042067|NCT01753401|2076637|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
1042068|NCT01753401|2076638|FG002|Double-blind Period (8 Weeks)|Adverse Event|0
1042069|NCT01753401|2076639|FG003|Double-blind Period (8 Weeks)|Adverse Event|0
1042070|NCT01753401|2076636|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
1042071|NCT01753401|2076637|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
1042072|NCT01753401|2076638|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
1042073|NCT01753401|2076639|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
1042074|NCT01753401|2076636|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0
1042075|NCT01753401|2076637|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1
1042076|NCT01753401|2076638|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0
1042077|NCT01753401|2076639|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0
1042078|NCT01753401|2076636|FG000|Open Label Period (44 Weeks)|Adverse Event|0
1042079|NCT01753401|2076637|FG001|Open Label Period (44 Weeks)|Adverse Event|0
1042080|NCT01753401|2076638|FG002|Open Label Period (44 Weeks)|Adverse Event|3
1042081|NCT01753401|2076639|FG003|Open Label Period (44 Weeks)|Adverse Event|4
1042082|NCT01753401|2076636|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0
1042083|NCT01753401|2076637|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0
1042084|NCT01753401|2076638|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0
1042085|NCT01753401|2076639|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2
1042086|NCT01753401|2076636|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0
1042087|NCT01753401|2076637|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0
1042088|NCT01753401|2076638|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1
1042089|NCT01753401|2076639|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1
1042090|NCT01753401|2076636|FG000|Open Label Period (44 Weeks)|Reason not provided|0
1042091|NCT01753401|2076637|FG001|Open Label Period (44 Weeks)|Reason not provided|0
1042092|NCT01753401|2076638|FG002|Open Label Period (44 Weeks)|Reason not provided|0
1042093|NCT01753401|2076639|FG003|Open Label Period (44 Weeks)|Reason not provided|2
1042094|NCT01753518|2076651|FG000|Intention-to-Treat Analysis|Missing consent form|5
1042095|NCT01753518|2076652|FG001|Intention-to-Treat Analysis|Missing consent form|3
1042096|NCT01753518|2076651|FG000|Intention-to-Treat Analysis|Multifetal gestation|2
1042097|NCT01753518|2076652|FG001|Intention-to-Treat Analysis|Multifetal gestation|3
1042098|NCT01753518|2076651|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0
1042099|NCT01753518|2076652|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1
1042100|NCT01753518|2076651|FG000|Postpartum Follow-up|Lost to Follow-up|22
1042101|NCT01753518|2076652|FG001|Postpartum Follow-up|Lost to Follow-up|15
1042102|NCT01753570|2076671|FG000|Overall Study|Adverse Event|1
1042103|NCT01753570|2076672|FG001|Overall Study|Adverse Event|0
1042104|NCT01753570|2076673|FG002|Overall Study|Adverse Event|1
1042105|NCT01753570|2076671|FG000|Overall Study|Physician Decision|0
1042106|NCT01753570|2076672|FG001|Overall Study|Physician Decision|1
1042107|NCT01753570|2076673|FG002|Overall Study|Physician Decision|0
1042108|NCT01753570|2076671|FG000|Overall Study|Withdrawal by Subject|1
1042109|NCT01753570|2076672|FG001|Overall Study|Withdrawal by Subject|4
1042110|NCT01753570|2076673|FG002|Overall Study|Withdrawal by Subject|0
1042111|NCT01753856|2076723|FG000|Overall Study|Adverse Event|1
1042112|NCT01753856|2076724|FG001|Overall Study|Adverse Event|0
1042113|NCT01753856|2076723|FG000|Overall Study|Withdrawal by Subject|0
1042114|NCT01753856|2076724|FG001|Overall Study|Withdrawal by Subject|2
1042115|NCT01753856|2076723|FG000|Overall Study|Sponsor Decision|2
1042116|NCT01753856|2076724|FG001|Overall Study|Sponsor Decision|0
1042117|NCT01753999|2076733|FG000|Period 1 - Initial Assignment|Physician Decision|2
1042118|NCT01753999|2076734|FG001|Period 1 - Initial Assignment|Physician Decision|3
1042119|NCT01753999|2076733|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19
1042120|NCT01753999|2076734|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20
1042121|NCT01753999|2076733|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18
1042122|NCT01753999|2076734|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27
1042123|NCT01753999|2076733|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
1042124|NCT01753999|2076734|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
1042125|NCT01753999|2076733|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
1042126|NCT01753999|2076734|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
1042127|NCT01753999|2076733|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1
1042128|NCT01753999|2076734|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1
1042129|NCT01754129|2076745|FG000|Overall Study|Death|13
1042130|NCT01754129|2076745|FG000|Overall Study|Duodopa discontinuation|9
1042131|NCT01754129|2076745|FG000|Overall Study|Lost to Follow-up|7
1042132|NCT01754129|2076745|FG000|Overall Study|Withdrew consent|1
1042133|NCT01754129|2076745|FG000|Overall Study|Inclusion/exclusion criteria violation|3
1042134|NCT01754194|2076758|FG000|Overall Study|Lost to Follow-up|39
1042135|NCT01754194|2076759|FG001|Overall Study|Lost to Follow-up|14
1042136|NCT01754194|2076758|FG000|Overall Study|Withdrawal by Subject|4
1042137|NCT01754194|2076759|FG001|Overall Study|Withdrawal by Subject|5
1042138|NCT01754194|2076758|FG000|Overall Study|Other|9
1042139|NCT01754194|2076759|FG001|Overall Study|Other|8
1042140|NCT01754259|2076773|FG000|Overall Study|Withdrawal by Subject|2
1042141|NCT01754259|2076774|FG001|Overall Study|Withdrawal by Subject|4
1042142|NCT01754259|2076773|FG000|Overall Study|Adverse Event|3
1042143|NCT01754259|2076774|FG001|Overall Study|Adverse Event|1
1042144|NCT01754259|2076773|FG000|Overall Study|Lost to Follow-up|0
1042145|NCT01754259|2076774|FG001|Overall Study|Lost to Follow-up|1
1042146|NCT01754376|2076789|FG000|Overall Study|Adverse Event|1
1042147|NCT01754376|2076789|FG000|Overall Study|Lack of Efficacy|2
1042148|NCT01754402|2076810|FG000|Overall Study|Death|0
1042149|NCT01754402|2076811|FG001|Overall Study|Death|0
1042150|NCT01754402|2076812|FG002|Overall Study|Death|1
1042151|NCT01754402|2076810|FG000|Overall Study|Adverse Event|2
1042152|NCT01754402|2076811|FG001|Overall Study|Adverse Event|2
1042153|NCT01754402|2076812|FG002|Overall Study|Adverse Event|1
1042154|NCT01754402|2076810|FG000|Overall Study|Withdrawal by Subject|0
1042155|NCT01754402|2076811|FG001|Overall Study|Withdrawal by Subject|0
1042156|NCT01754402|2076812|FG002|Overall Study|Withdrawal by Subject|1
1042157|NCT01754402|2076810|FG000|Overall Study|Lack of Efficacy|0
1042158|NCT01754402|2076811|FG001|Overall Study|Lack of Efficacy|0
1042159|NCT01754402|2076812|FG002|Overall Study|Lack of Efficacy|1
1042160|NCT01754467|2076821|FG000|Overall Study|Lost to Follow-up|1
1042161|NCT01754493|2076835|FG000|Overall Study|Adverse Event|1
1042162|NCT01754493|2076835|FG000|Overall Study|Lost to Follow-up|3
1042163|NCT01754493|2076835|FG000|Overall Study|Withdrawal by Subject|1
1042164|NCT01754493|2076835|FG000|Overall Study|Moved out of town|1
1042165|NCT01754493|2076835|FG000|Overall Study|Scheduling conflict|1
1042166|NCT01754727|2076872|FG000|Overall Study|Adalimumab Treatment was not Documented|2
1042167|NCT01754753|2076878|FG000|Overall Study|Study close|43
1042168|NCT01754753|2076879|FG001|Overall Study|Study close|44
1042169|NCT01754753|2076878|FG000|Overall Study|Lost to Follow-up|9
1042170|NCT01754753|2076879|FG001|Overall Study|Lost to Follow-up|5
1042171|NCT01754766|2076888|FG000|Overall Study|Personal reasons|1
1042172|NCT01754766|2076889|FG001|Overall Study|Personal reasons|1
1042173|NCT01754766|2076890|FG002|Overall Study|Personal reasons|0
1042174|NCT01754922|2076909|FG000|Overall Study|Adverse Event|0
1042175|NCT01754922|2076910|FG001|Overall Study|Adverse Event|1
1042176|NCT01755026|2076919|FG000|Overall Study|Adverse Event|1
1042177|NCT01755026|2076920|FG001|Overall Study|Adverse Event|0
1042178|NCT01755026|2076919|FG000|Overall Study|Withdrawal by Subject|1
1042179|NCT01755026|2076920|FG001|Overall Study|Withdrawal by Subject|1
1042180|NCT01755091|2076929|FG000|Overall Study|Withdrawal by Subject|6
1042181|NCT01755091|2076930|FG001|Overall Study|Withdrawal by Subject|1
1042182|NCT01755091|2076931|FG002|Overall Study|Withdrawal by Subject|3
1042183|NCT01755091|2076929|FG000|Overall Study|Adverse Event|1
1042184|NCT01755091|2076930|FG001|Overall Study|Adverse Event|1
1042185|NCT01755091|2076931|FG002|Overall Study|Adverse Event|1
1042186|NCT01755091|2076929|FG000|Overall Study|Lost to Follow-up|1
1042187|NCT01755091|2076930|FG001|Overall Study|Lost to Follow-up|0
1042188|NCT01755091|2076931|FG002|Overall Study|Lost to Follow-up|1
1042189|NCT01755091|2076929|FG000|Overall Study|Physician Decision|1
1042190|NCT01755091|2076930|FG001|Overall Study|Physician Decision|1
1042191|NCT01755091|2076931|FG002|Overall Study|Physician Decision|2
1042192|NCT01755156|2076950|FG000|Phase A (Weeks 0-24)|Adverse Event|2
1042193|NCT01755156|2076951|FG001|Phase A (Weeks 0-24)|Adverse Event|3
1042194|NCT01755156|2076950|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1
1042195|NCT01755156|2076951|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0
1042196|NCT01755156|2076950|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5
1042197|NCT01755156|2076951|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3
1042198|NCT01755156|2076950|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1
1042199|NCT01755156|2076951|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0
1042200|NCT01755156|2076950|FG000|Phase A (Weeks 0-24)|Physician Decision|0
1042201|NCT01755156|2076951|FG001|Phase A (Weeks 0-24)|Physician Decision|1
1042202|NCT01755156|2076950|FG000|Phase A (Weeks 0-24)|Protocol Violation|1
1042203|NCT01755156|2076951|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
1042204|NCT01755156|2076950|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6
1042205|NCT01755156|2076951|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13
1042206|NCT01755156|2076950|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
1042207|NCT01755156|2076951|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
1042208|NCT01755156|2076950|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
1042209|NCT01755156|2076951|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
1042210|NCT01755156|2076950|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12
1042211|NCT01755156|2076951|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5
1042212|NCT01755156|2076950|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27
1042213|NCT01755156|2076951|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31
1042214|NCT01755195|2076978|FG000|Overall Study|Participant noncompliance|2
1042215|NCT01755195|2076978|FG000|Overall Study|Switched to alternative treatment|4
1042216|NCT01755195|2076978|FG000|Overall Study|Withdrawal by Subject|1
1042217|NCT01755195|2076978|FG000|Overall Study|Participant refused to start treatment|1
1042218|NCT01755195|2076978|FG000|Overall Study|Participant has been consented for another trial|1
1042219|NCT01755195|2076978|FG000|Overall Study|Refused further treatment|3
1042220|NCT01755195|2076978|FG000|Overall Study|Complicating disease/intercurrent illness|1
1042221|NCT01755234|2076984|FG000|Overall Study|Lost to Follow-up|11
1042222|NCT01755234|2076985|FG001|Overall Study|Lost to Follow-up|6
1042223|NCT01755234|2076984|FG000|Overall Study|Change in surgical case|2
1042224|NCT01755234|2076985|FG001|Overall Study|Change in surgical case|1
1042225|NCT01755234|2076984|FG000|Overall Study|case cancelled|1
1042226|NCT01755234|2076985|FG001|Overall Study|case cancelled|0
1042227|NCT01755234|2076984|FG000|Overall Study|Withdrawal by Subject|0
1042228|NCT01755234|2076985|FG001|Overall Study|Withdrawal by Subject|1
1042229|NCT01755234|2076984|FG000|Overall Study|unblinded|1
1042230|NCT01755234|2076985|FG001|Overall Study|unblinded|0
1042231|NCT01755416|2076991|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
1042232|NCT01755416|2076992|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
1162031|NCT03381196|2283976|FG000|Overall Study|Other|0
1042233|NCT01755546|2077005|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
1042234|NCT01755546|2077005|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
1042235|NCT01755546|2077005|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
1042236|NCT01755546|2077005|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
1042237|NCT01755546|2077005|FG000|Titration Phase|Adverse Event|11
1042238|NCT01755546|2077005|FG000|Titration Phase|Lack of Efficacy|18
1042239|NCT01755546|2077005|FG000|Titration Phase|Protocol Violation|9
1042240|NCT01755546|2077005|FG000|Titration Phase|Lost to Follow-up|2
1042241|NCT01755546|2077005|FG000|Titration Phase|Other and Continuing|22
1042242|NCT01755546|2077005|FG000|Titration Phase|Withdrawal by Subject|8
1042243|NCT01755546|2077005|FG000|Long Term Treatment|Adverse Event|12
1042244|NCT01755546|2077005|FG000|Long Term Treatment|Lack of Efficacy|6
1042245|NCT01755546|2077005|FG000|Long Term Treatment|Protocol Violation|10
1042246|NCT01755546|2077005|FG000|Long Term Treatment|Withdrawal by Subject|35
1042247|NCT01755546|2077005|FG000|Long Term Treatment|Lost to Follow-up|17
1042248|NCT01755546|2077005|FG000|Long Term Treatment|other and ongoing|41
1042249|NCT01755598|2077011|FG000|Overall Study|Other|109
1042250|NCT01755598|2077012|FG001|Overall Study|Other|109
1042251|NCT01755598|2077011|FG000|Overall Study|Lost to Follow-up|32
1042252|NCT01755598|2077012|FG001|Overall Study|Lost to Follow-up|43
1042253|NCT01755598|2077011|FG000|Overall Study|Migrated/moved from study area|76
1042254|NCT01755598|2077012|FG001|Overall Study|Migrated/moved from study area|65
1042255|NCT01755598|2077011|FG000|Overall Study|Withdrawal by Subject|22
1042256|NCT01755598|2077012|FG001|Overall Study|Withdrawal by Subject|31
1042257|NCT01755598|2077011|FG000|Overall Study|Protocol Violation|7
1042258|NCT01755598|2077012|FG001|Overall Study|Protocol Violation|7
1042259|NCT01755598|2077011|FG000|Overall Study|Adverse Event|19
1042260|NCT01755598|2077012|FG001|Overall Study|Adverse Event|28
1042261|NCT01755637|2077018|FG000|Period 1|Adverse Event|0
1042262|NCT01755637|2077019|FG001|Period 1|Adverse Event|1
1042263|NCT01755702|2077060|FG000|Wash Out Period I|Other Reason|3
1042264|NCT01755702|2077060|FG000|Washout Period II|Other Reason|5
1042265|NCT01755767|2077074|FG000|Overall Study|Progressive Disease|8
1042266|NCT01755767|2077075|FG001|Overall Study|Progressive Disease|7
1042267|NCT01755767|2077076|FG002|Overall Study|Progressive Disease|91
1042268|NCT01755767|2077077|FG003|Overall Study|Progressive Disease|43
1042269|NCT01755767|2077074|FG000|Overall Study|Clinical Disease Progression|4
1042270|NCT01755767|2077075|FG001|Overall Study|Clinical Disease Progression|2
1042271|NCT01755767|2077076|FG002|Overall Study|Clinical Disease Progression|29
1042272|NCT01755767|2077077|FG003|Overall Study|Clinical Disease Progression|20
1042273|NCT01755767|2077074|FG000|Overall Study|Radiographic Disease Progression|9
1042274|NCT01755767|2077075|FG001|Overall Study|Radiographic Disease Progression|4
1042275|NCT01755767|2077076|FG002|Overall Study|Radiographic Disease Progression|44
1042276|NCT01755767|2077077|FG003|Overall Study|Radiographic Disease Progression|27
1042277|NCT01755767|2077074|FG000|Overall Study|Adverse Event|6
1042278|NCT01755767|2077075|FG001|Overall Study|Adverse Event|0
1042279|NCT01755767|2077076|FG002|Overall Study|Adverse Event|28
1042280|NCT01755767|2077077|FG003|Overall Study|Adverse Event|11
1042281|NCT01755767|2077074|FG000|Overall Study|Death|1
1042282|NCT01755767|2077075|FG001|Overall Study|Death|2
1042283|NCT01755767|2077076|FG002|Overall Study|Death|15
1042284|NCT01755767|2077077|FG003|Overall Study|Death|4
1042285|NCT01755767|2077074|FG000|Overall Study|Subject Decision|0
1042286|NCT01755767|2077075|FG001|Overall Study|Subject Decision|0
1042287|NCT01755767|2077076|FG002|Overall Study|Subject Decision|10
1042288|NCT01755767|2077077|FG003|Overall Study|Subject Decision|3
1042289|NCT01755767|2077074|FG000|Overall Study|Withdrawal by Subject|0
1042290|NCT01755767|2077075|FG001|Overall Study|Withdrawal by Subject|0
1042291|NCT01755767|2077076|FG002|Overall Study|Withdrawal by Subject|2
1042292|NCT01755767|2077077|FG003|Overall Study|Withdrawal by Subject|1
1042293|NCT01755767|2077074|FG000|Overall Study|Other|0
1042294|NCT01755767|2077075|FG001|Overall Study|Other|0
1042295|NCT01755767|2077076|FG002|Overall Study|Other|2
1042296|NCT01755767|2077077|FG003|Overall Study|Other|3
1042297|NCT01755767|2077074|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
1042298|NCT01755767|2077075|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
1042299|NCT01755767|2077076|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5
1042300|NCT01755767|2077077|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2
1042301|NCT01755858|2077089|FG000|Overall Study|Adverse Event|1
1042302|NCT01755858|2077090|FG001|Overall Study|Adverse Event|1
1042303|NCT01756053|2077123|FG000|Period 1 (10 Days)|Protocol Violation|1
1042304|NCT01756053|2077124|FG001|Period 1 (10 Days)|Protocol Violation|1
1042305|NCT01756053|2077123|FG000|Period 2 (10 Days)|Protocol Violation|0
1042306|NCT01756053|2077124|FG001|Period 2 (10 Days)|Protocol Violation|2
1042307|NCT01756079|2077130|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
1042308|NCT01756079|2077130|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
1042309|NCT01756079|2077130|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2
1042310|NCT01756079|2077130|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
1042311|NCT01756079|2077130|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
1042312|NCT01756157|2077135|FG000|First Intervention Period|Withdrawal by Subject|1
1042313|NCT01756157|2077136|FG001|First Intervention Period|Withdrawal by Subject|0
1042314|NCT01756157|2077135|FG000|First Intervention Period|Lost to Follow-up|0
1042315|NCT01756157|2077136|FG001|First Intervention Period|Lost to Follow-up|2
1042316|NCT01756235|2077159|FG000|Overall Study|Adalimumab Treatment was not Documented|2
1042317|NCT01756274|2077163|FG000|Overall Study|Protocol Violation|2
1042318|NCT01756274|2077163|FG000|Overall Study|Laboratory error|1
1042319|NCT01756300|2077168|FG000|Overall Study|Death|1
1042320|NCT01756300|2077168|FG000|Overall Study|Withdrawal by Subject|1
1042321|NCT01756352|2077189|FG000|Overall Study|moved away and lost to followup|1
1042322|NCT01756456|2077203|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0
1042323|NCT01756456|2077204|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0
1042324|NCT01756456|2077205|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0
1042325|NCT01756456|2077206|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1
1042326|NCT01756456|2077207|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1
1042327|NCT01756456|2077208|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1
1042328|NCT01756456|2077203|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0
1042329|NCT01756456|2077204|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0
1042330|NCT01756456|2077205|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0
1042331|NCT01756456|2077206|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2
1042332|NCT01756456|2077207|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1
1042333|NCT01756456|2077208|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0
1042334|NCT01756456|2077203|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0
1042335|NCT01756456|2077204|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1
1042336|NCT01756456|2077205|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0
1042337|NCT01756456|2077206|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0
1042338|NCT01756456|2077207|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0
1042339|NCT01756456|2077208|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0
1042340|NCT01756456|2077203|FG000|Treatment Period: Phase I/II|Adverse Event|1
1042341|NCT01756456|2077204|FG001|Treatment Period: Phase I/II|Adverse Event|0
1042342|NCT01756456|2077205|FG002|Treatment Period: Phase I/II|Adverse Event|2
1042343|NCT01756456|2077206|FG003|Treatment Period: Phase I/II|Adverse Event|3
1042344|NCT01756456|2077207|FG004|Treatment Period: Phase I/II|Adverse Event|9
1042345|NCT01756456|2077208|FG005|Treatment Period: Phase I/II|Adverse Event|1
1042346|NCT01756456|2077203|FG000|Treatment Period: Phase I/II|Other causes|0
1042347|NCT01756456|2077204|FG001|Treatment Period: Phase I/II|Other causes|0
1042348|NCT01756456|2077205|FG002|Treatment Period: Phase I/II|Other causes|0
1042349|NCT01756456|2077206|FG003|Treatment Period: Phase I/II|Other causes|1
1042350|NCT01756456|2077207|FG004|Treatment Period: Phase I/II|Other causes|2
1042351|NCT01756456|2077208|FG005|Treatment Period: Phase I/II|Other causes|2
1042352|NCT01756456|2077203|FG000|Follow Up Period Phase I/II|still in study after week 20|0
1042353|NCT01756456|2077204|FG001|Follow Up Period Phase I/II|still in study after week 20|0
1042354|NCT01756456|2077205|FG002|Follow Up Period Phase I/II|still in study after week 20|0
1042355|NCT01756456|2077206|FG003|Follow Up Period Phase I/II|still in study after week 20|25
1042356|NCT01756456|2077207|FG004|Follow Up Period Phase I/II|still in study after week 20|23
1042357|NCT01756456|2077208|FG005|Follow Up Period Phase I/II|still in study after week 20|25
1042358|NCT01756456|2077203|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
1042359|NCT01756456|2077204|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
1042360|NCT01756456|2077205|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
1042361|NCT01756456|2077206|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
1042362|NCT01756456|2077207|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
1042363|NCT01756456|2077208|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
1042364|NCT01756456|2077203|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0
1042365|NCT01756456|2077204|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0
1042366|NCT01756456|2077205|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0
1042367|NCT01756456|2077206|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0
1042368|NCT01756456|2077207|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0
1042369|NCT01756456|2077208|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1
1042370|NCT01756456|2077203|FG000|Follow Up Period Phase I/II|Adverse Event|1
1042371|NCT01756456|2077204|FG001|Follow Up Period Phase I/II|Adverse Event|0
1042372|NCT01756456|2077205|FG002|Follow Up Period Phase I/II|Adverse Event|0
1042373|NCT01756456|2077206|FG003|Follow Up Period Phase I/II|Adverse Event|5
1042374|NCT01756456|2077207|FG004|Follow Up Period Phase I/II|Adverse Event|0
1042375|NCT01756456|2077208|FG005|Follow Up Period Phase I/II|Adverse Event|1
1042376|NCT01756456|2077203|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0
1042377|NCT01756456|2077204|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0
1042378|NCT01756456|2077205|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1
1042379|NCT01756456|2077206|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2
1042380|NCT01756456|2077207|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0
1042381|NCT01756456|2077208|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1
1042382|NCT01756456|2077203|FG000|Follow Up Period Phase I/II|Other causes|0
1042383|NCT01756456|2077204|FG001|Follow Up Period Phase I/II|Other causes|0
1042384|NCT01756456|2077205|FG002|Follow Up Period Phase I/II|Other causes|0
1042385|NCT01756456|2077206|FG003|Follow Up Period Phase I/II|Other causes|1
1042386|NCT01756456|2077207|FG004|Follow Up Period Phase I/II|Other causes|3
1042387|NCT01756456|2077208|FG005|Follow Up Period Phase I/II|Other causes|5
1042388|NCT01756833|2077233|FG000|Overall Study|Withdrawal by Subject|4
1042389|NCT01756833|2077234|FG001|Overall Study|Withdrawal by Subject|3
1042390|NCT01756846|2077242|FG000|Overall Study|Lost to Follow-up|5
1042391|NCT01756846|2077243|FG001|Overall Study|Lost to Follow-up|10
1042392|NCT01756846|2077242|FG000|Overall Study|Withdrawal by Subject|1
1042393|NCT01756846|2077243|FG001|Overall Study|Withdrawal by Subject|2
1042394|NCT01756898|2077262|FG000|Overall Study|Adverse Event|7
1042395|NCT01756898|2077263|FG001|Overall Study|Adverse Event|1
1042396|NCT01756898|2077264|FG002|Overall Study|Adverse Event|0
1042397|NCT01756898|2077265|FG003|Overall Study|Adverse Event|0
1042398|NCT01756898|2077262|FG000|Overall Study|Lack of Efficacy|4
1042399|NCT01756898|2077263|FG001|Overall Study|Lack of Efficacy|7
1042400|NCT01756898|2077264|FG002|Overall Study|Lack of Efficacy|6
1042401|NCT01756898|2077265|FG003|Overall Study|Lack of Efficacy|6
1042402|NCT01756898|2077262|FG000|Overall Study|Lost to Follow-up|2
1042403|NCT01756898|2077263|FG001|Overall Study|Lost to Follow-up|4
1042404|NCT01756898|2077264|FG002|Overall Study|Lost to Follow-up|2
1042405|NCT01756898|2077265|FG003|Overall Study|Lost to Follow-up|3
1042406|NCT01756898|2077262|FG000|Overall Study|Protocol Violation|1
1042407|NCT01756898|2077263|FG001|Overall Study|Protocol Violation|2
1042408|NCT01756898|2077264|FG002|Overall Study|Protocol Violation|2
1042409|NCT01756898|2077265|FG003|Overall Study|Protocol Violation|1
1042410|NCT01756898|2077262|FG000|Overall Study|Withdrew Consent|5
1042411|NCT01756898|2077263|FG001|Overall Study|Withdrew Consent|3
1042412|NCT01756898|2077264|FG002|Overall Study|Withdrew Consent|5
1042413|NCT01756898|2077265|FG003|Overall Study|Withdrew Consent|6
1042414|NCT01756898|2077262|FG000|Overall Study|Other|0
1042415|NCT01756898|2077263|FG001|Overall Study|Other|2
1042416|NCT01756898|2077264|FG002|Overall Study|Other|2
1042417|NCT01756898|2077265|FG003|Overall Study|Other|0
1042418|NCT01757171|2077298|FG000|Overall Study|Adverse Event|5
1042419|NCT01757171|2077299|FG001|Overall Study|Adverse Event|1
1042420|NCT01757171|2077298|FG000|Overall Study|Disease Progression|1
1042421|NCT01757171|2077299|FG001|Overall Study|Disease Progression|0
1042422|NCT01757171|2077298|FG000|Overall Study|Hospitalization|1
1042423|NCT01757171|2077299|FG001|Overall Study|Hospitalization|0
1042424|NCT01757171|2077298|FG000|Overall Study|ECOG decline|1
1042425|NCT01757171|2077299|FG001|Overall Study|ECOG decline|0
1042426|NCT01757184|2077307|FG000|Double-blind Period|Adverse Event|1
1042427|NCT01757184|2077308|FG001|Double-blind Period|Adverse Event|0
1042428|NCT01757184|2077309|FG002|Double-blind Period|Adverse Event|0
1042429|NCT01757184|2077310|FG003|Double-blind Period|Adverse Event|0
1042430|NCT01757184|2077307|FG000|Open-label Period|Lost to Follow-up|0
1042431|NCT01757184|2077308|FG001|Open-label Period|Lost to Follow-up|0
1042432|NCT01757184|2077309|FG002|Open-label Period|Lost to Follow-up|2
1042433|NCT01757184|2077310|FG003|Open-label Period|Lost to Follow-up|0
1042434|NCT01757184|2077307|FG000|Open-label Period|Withdrawal by Subject|0
1042435|NCT01757184|2077308|FG001|Open-label Period|Withdrawal by Subject|0
1042436|NCT01757184|2077309|FG002|Open-label Period|Withdrawal by Subject|1
1042437|NCT01757184|2077310|FG003|Open-label Period|Withdrawal by Subject|1
1042438|NCT01757184|2077307|FG000|Open-label Period|Discontinued by Sponsor|0
1042439|NCT01757184|2077308|FG001|Open-label Period|Discontinued by Sponsor|0
1042440|NCT01757184|2077309|FG002|Open-label Period|Discontinued by Sponsor|1
1042441|NCT01757184|2077310|FG003|Open-label Period|Discontinued by Sponsor|2
1042442|NCT01757197|2077324|FG000|Overall Study|Death|2
1042443|NCT01757275|2077330|FG000|Overall Study|Lost to Follow-up|1
1042444|NCT01757275|2077331|FG001|Overall Study|Lost to Follow-up|2
1042445|NCT01757275|2077330|FG000|Overall Study|Adverse Event|3
1042446|NCT01757275|2077331|FG001|Overall Study|Adverse Event|3
1042447|NCT01757275|2077330|FG000|Overall Study|Withdrawal by Subject|2
1042448|NCT01757275|2077331|FG001|Overall Study|Withdrawal by Subject|4
1042449|NCT01757275|2077330|FG000|Overall Study|Not treated|3
1042450|NCT01757275|2077331|FG001|Overall Study|Not treated|4
1042451|NCT01757288|2077340|FG000|Overall Study|Consent withdrawal|0
1042452|NCT01757288|2077341|FG001|Overall Study|Consent withdrawal|4
1042453|NCT01757288|2077342|FG002|Overall Study|Consent withdrawal|4
1042454|NCT01757288|2077340|FG000|Overall Study|Patient off study, IRB hold.|0
1042455|NCT01757288|2077341|FG001|Overall Study|Patient off study, IRB hold.|0
1042456|NCT01757288|2077342|FG002|Overall Study|Patient off study, IRB hold.|1
1042457|NCT01757288|2077340|FG000|Overall Study|Patient death prior to starting treatment|0
1042458|NCT01757288|2077341|FG001|Overall Study|Patient death prior to starting treatment|0
1042459|NCT01757288|2077342|FG002|Overall Study|Patient death prior to starting treatment|1
1042460|NCT01757288|2077340|FG000|Overall Study|Wrong medication administered|0
1042461|NCT01757288|2077341|FG001|Overall Study|Wrong medication administered|1
1042462|NCT01757288|2077342|FG002|Overall Study|Wrong medication administered|0
1042463|NCT01757288|2077340|FG000|Overall Study|Liver metastasis identified at CT simulation|0
1042464|NCT01757288|2077341|FG001|Overall Study|Liver metastasis identified at CT simulation|1
1042465|NCT01757288|2077342|FG002|Overall Study|Liver metastasis identified at CT simulation|0
1042466|NCT01757288|2077340|FG000|Overall Study|Not meeting protocol constraints|0
1042467|NCT01757288|2077341|FG001|Overall Study|Not meeting protocol constraints|1
1042468|NCT01757288|2077342|FG002|Overall Study|Not meeting protocol constraints|1
1042469|NCT01757288|2077340|FG000|Overall Study|Multiple missed appointments|0
1042470|NCT01757288|2077341|FG001|Overall Study|Multiple missed appointments|1
1042471|NCT01757288|2077342|FG002|Overall Study|Multiple missed appointments|0
1042472|NCT01757288|2077340|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
1042473|NCT01757288|2077341|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
1042474|NCT01757288|2077342|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1
1042475|NCT01757288|2077340|FG000|Overall Study|>2 weeks treatment break|0
1042476|NCT01757288|2077341|FG001|Overall Study|>2 weeks treatment break|0
1042477|NCT01757288|2077342|FG002|Overall Study|>2 weeks treatment break|1
1042478|NCT01757392|2077362|FG000|Overall Study|Withdrawal by Subject|1
1042479|NCT01757392|2077362|FG000|Overall Study|Screen Fail|3
1042480|NCT01757405|2077368|FG000|Overall Study|Lost to Follow-up|1
1042481|NCT01757405|2077369|FG001|Overall Study|Lost to Follow-up|1
1042482|NCT01757405|2077368|FG000|Overall Study|Withdrawal by Subject|0
1042483|NCT01757405|2077369|FG001|Overall Study|Withdrawal by Subject|1
1042512|NCT01757691|2077433|FG000|Overall Study|Administrative problems|2
1042513|NCT01757691|2077434|FG001|Overall Study|Administrative problems|0
1042514|NCT01757704|2077442|FG000|Overall Study|Protocol Violation|1
1042515|NCT01757704|2077443|FG001|Overall Study|Protocol Violation|3
1042516|NCT01757821|2077453|FG000|Overall Study|Adverse Event|1
1042517|NCT01757847|2077463|FG000|Overall Study|Withdrawal by Subject|3
1042518|NCT01757847|2077464|FG001|Overall Study|Withdrawal by Subject|4
1042519|NCT01758289|2077477|FG000|Overall Study|Premature Study Termination|44
1042520|NCT01758289|2077477|FG000|Overall Study|Adverse Event|9
1042521|NCT01758523|2077516|FG000|Overall Study|Adverse Event|2
1042522|NCT01758523|2077517|FG001|Overall Study|Adverse Event|1
1042523|NCT01758523|2077516|FG000|Overall Study|Lack of Efficacy|4
1042524|NCT01758523|2077517|FG001|Overall Study|Lack of Efficacy|2
1042525|NCT01758523|2077516|FG000|Overall Study|Lost to Follow-up|3
1042526|NCT01758523|2077517|FG001|Overall Study|Lost to Follow-up|4
1042527|NCT01758523|2077516|FG000|Overall Study|Withdrawal by Subject|12
1042528|NCT01758523|2077517|FG001|Overall Study|Withdrawal by Subject|7
1042529|NCT01758731|2077538|FG000|Overall Study|Physician Decision|1
1042530|NCT01758900|2077544|FG000|Overall Study|difficulty for further intubation|7
1042531|NCT01758900|2077545|FG001|Overall Study|difficulty for further intubation|8
1042532|NCT01759264|2077564|FG000|Overall Study|Serious Adverse Events (SAEs)|1
1042533|NCT01759264|2077564|FG000|Overall Study|Adverse Event|1
1042534|NCT01759264|2077564|FG000|Overall Study|Other|2
1042535|NCT01759264|2077564|FG000|Overall Study|Lost to Follow-up|2
1042536|NCT01759264|2077564|FG000|Overall Study|Withdrawal by Subject|3
1042537|NCT01759264|2077564|FG000|Overall Study|Discontinued Humira Due to Business Trip|1
1042538|NCT01759290|2077580|FG000|Overall Study|Subjects withdrawn consent|5
1042539|NCT01759290|2077580|FG000|Overall Study|Physician Decision|2
1042540|NCT01759290|2077580|FG000|Overall Study|Death|17
1042541|NCT01759290|2077580|FG000|Overall Study|Lost to Follow-up|53
1042542|NCT01759290|2077580|FG000|Overall Study|Unknown reason|4
1042543|NCT01759368|2077586|FG000|Overall Study|Lost to Follow-up|1
1042544|NCT01759368|2077587|FG001|Overall Study|Lost to Follow-up|0
1042545|NCT01759381|2077597|FG000|Overall Study|Death|1
1042546|NCT01759381|2077598|FG001|Overall Study|Death|0
1042547|NCT01759407|2077606|FG000|Overall Study|Protocol Violation|0
1042548|NCT01759407|2077607|FG001|Overall Study|Protocol Violation|2
1042549|NCT01759420|2077613|FG000|Overall Study|Screen failure|5
1042550|NCT01759420|2077613|FG000|Overall Study|Inaccurate EKG machine readings|1
1042551|NCT01759446|2077622|FG000|Overall Study|Protocol Violation|1
1042552|NCT01759446|2077623|FG001|Overall Study|Protocol Violation|0
1042553|NCT01759446|2077624|FG002|Overall Study|Protocol Violation|1
906379|NCT00767819|1882017|FG001|Overall Study|Unsatisfactory therapeutic effect|14
906380|NCT00767819|1882018|FG002|Overall Study|Unsatisfactory therapeutic effect|0
906381|NCT00767819|1882016|FG000|Overall Study|Withdrawal by Subject|1
906382|NCT00767819|1882017|FG001|Overall Study|Withdrawal by Subject|1
906383|NCT00767819|1882018|FG002|Overall Study|Withdrawal by Subject|0
906384|NCT00767819|1882016|FG000|Overall Study|Administrative problems|0
906385|NCT00767819|1882017|FG001|Overall Study|Administrative problems|1
906386|NCT00767819|1882018|FG002|Overall Study|Administrative problems|0
906387|NCT00767819|1882016|FG000|Overall Study|Death|2
906388|NCT00767819|1882017|FG001|Overall Study|Death|3
906389|NCT00767819|1882018|FG002|Overall Study|Death|0
906390|NCT00767819|1882016|FG000|Overall Study|Adverse Event|2
906391|NCT00767819|1882017|FG001|Overall Study|Adverse Event|0
906392|NCT00767819|1882018|FG002|Overall Study|Adverse Event|0
906393|NCT00767819|1882016|FG000|Overall Study|Abnormal lab values|1
906394|NCT00767819|1882017|FG001|Overall Study|Abnormal lab values|0
906395|NCT00767819|1882018|FG002|Overall Study|Abnormal lab values|0
906396|NCT00767819|1882016|FG000|Overall Study|Lost to Follow-up|1
906397|NCT00767819|1882017|FG001|Overall Study|Lost to Follow-up|0
906398|NCT00767819|1882018|FG002|Overall Study|Lost to Follow-up|0
906399|NCT00768053|1882026|FG000|Overall Study|Adverse Event|10
906400|NCT00768053|1882026|FG000|Overall Study|Lost to Follow-up|1
906401|NCT00768066|1882033|FG000|Overall Study|Did not receive study product injection.|3
906402|NCT00768066|1882034|FG001|Overall Study|Did not receive study product injection.|3
906403|NCT00768066|1882035|FG002|Overall Study|Did not receive study product injection.|0
906404|NCT00768079|1882046|FG000|Overall Study|Lost to Follow-up|2
906405|NCT00768079|1882047|FG001|Overall Study|Lost to Follow-up|0
906406|NCT00768079|1882048|FG002|Overall Study|Lost to Follow-up|4
1042554|NCT01759446|2077625|FG003|Overall Study|Protocol Violation|0
1042555|NCT01759446|2077626|FG004|Overall Study|Protocol Violation|0
1042556|NCT01759446|2077622|FG000|Overall Study|Withdrawal by Subject|0
1042557|NCT01759446|2077623|FG001|Overall Study|Withdrawal by Subject|1
1042558|NCT01759446|2077624|FG002|Overall Study|Withdrawal by Subject|0
1042559|NCT01759446|2077625|FG003|Overall Study|Withdrawal by Subject|1
1042560|NCT01759446|2077626|FG004|Overall Study|Withdrawal by Subject|0
1042561|NCT01759511|2077638|FG000|Overall Study|Adverse Event|4
1042562|NCT01759511|2077638|FG000|Overall Study|Death|2
1042563|NCT01759511|2077638|FG000|Overall Study|Lack of Efficacy|2
1042564|NCT01759511|2077638|FG000|Overall Study|Physician Decision|1
1042565|NCT01759511|2077638|FG000|Overall Study|Progressive Disease|5
1042566|NCT01759511|2077638|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4
1042567|NCT01759511|2077638|FG000|Overall Study|Study Terminated by Sponsor|13
1042568|NCT01759511|2077638|FG000|Overall Study|Withdrawal by Subject|3
1042569|NCT01759862|2077648|FG000|Overall Study|Physician Decision|3
1042570|NCT01759862|2077649|FG001|Overall Study|Physician Decision|1
1042571|NCT01759862|2077648|FG000|Overall Study|Adverse Event|0
1042572|NCT01759862|2077649|FG001|Overall Study|Adverse Event|1
1042573|NCT01760447|2077720|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
1042574|NCT01760447|2077721|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
1042575|NCT01760447|2077722|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1
1042576|NCT01760447|2077723|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3
1042577|NCT01760447|2077720|FG000|Weeks 0-20|Withdrawal by Subject|2
1042578|NCT01760447|2077721|FG001|Weeks 0-20|Withdrawal by Subject|0
1042579|NCT01760447|2077722|FG002|Weeks 0-20|Withdrawal by Subject|1
1042580|NCT01760447|2077723|FG003|Weeks 0-20|Withdrawal by Subject|0
1042581|NCT01760447|2077720|FG000|Weeks 0-20|Lost to Follow-up|1
1042582|NCT01760447|2077721|FG001|Weeks 0-20|Lost to Follow-up|0
1042583|NCT01760447|2077722|FG002|Weeks 0-20|Lost to Follow-up|1
1042584|NCT01760447|2077723|FG003|Weeks 0-20|Lost to Follow-up|1
1042585|NCT01760447|2077720|FG000|Weeks 0-20|Randomized but not treated|0
1042586|NCT01760447|2077721|FG001|Weeks 0-20|Randomized but not treated|0
1042587|NCT01760447|2077722|FG002|Weeks 0-20|Randomized but not treated|2
1042588|NCT01760447|2077723|FG003|Weeks 0-20|Randomized but not treated|0
1042589|NCT01760447|2077720|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
1042590|NCT01760447|2077721|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
1042591|NCT01760447|2077722|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
1042592|NCT01760447|2077723|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0
1042593|NCT01760447|2077720|FG000|Weeks 20-54|Withdrawal by Subject|2
1042594|NCT01760447|2077721|FG001|Weeks 20-54|Withdrawal by Subject|1
1042595|NCT01760447|2077722|FG002|Weeks 20-54|Withdrawal by Subject|1
1042596|NCT01760447|2077723|FG003|Weeks 20-54|Withdrawal by Subject|2
1042597|NCT01760447|2077720|FG000|Weeks 20-54|Lost to Follow-up|0
1042598|NCT01760447|2077721|FG001|Weeks 20-54|Lost to Follow-up|0
1042599|NCT01760447|2077722|FG002|Weeks 20-54|Lost to Follow-up|1
1042600|NCT01760447|2077723|FG003|Weeks 20-54|Lost to Follow-up|2
1042601|NCT01760733|2077751|FG000|Waiting List|Death|18
1042602|NCT01760733|2077751|FG000|Waiting List|Removed from waiting list|41
1042603|NCT01760733|2077751|FG000|Waiting List|Not received a transplant yet|13
1042604|NCT01760733|2077751|FG000|Transplanted|Not reached 10 years post transplant|184
1042605|NCT01760733|2077751|FG000|Transplanted|Death|26
1042606|NCT01760733|2077751|FG000|Transplanted|Graft loss|7
1042607|NCT01760876|2077765|FG000|Overall Study|Non-cardiac death (head injury)|1
1042608|NCT01760876|2077765|FG000|Overall Study|Carcinoma of prostate|1
906407|NCT00768079|1882046|FG000|Overall Study|Participant incarcerated|0
1042609|NCT01760876|2077765|FG000|Overall Study|Impaired renal function|1
1042610|NCT01760876|2077765|FG000|Overall Study|Major depression|1
1042611|NCT01760876|2077765|FG000|Overall Study|Very poor baseline OCT quality|2
1042612|NCT01760954|2077773|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8
1042613|NCT01760954|2077774|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8
1042614|NCT01760954|2077775|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4
1042615|NCT01760954|2077776|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5
1042616|NCT01760954|2077773|FG000|Treatment Period (6 Months)|Adverse Event|5
1042617|NCT01760954|2077774|FG001|Treatment Period (6 Months)|Adverse Event|3
1042618|NCT01760954|2077775|FG002|Treatment Period (6 Months)|Adverse Event|4
1042619|NCT01760954|2077776|FG003|Treatment Period (6 Months)|Adverse Event|10
1042620|NCT01760954|2077773|FG000|Treatment Period (6 Months)|Lost to Follow-up|9
1042621|NCT01760954|2077774|FG001|Treatment Period (6 Months)|Lost to Follow-up|1
1042622|NCT01760954|2077775|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
1042623|NCT01760954|2077776|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
1042624|NCT01760954|2077773|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
1042625|NCT01760954|2077774|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
1042626|NCT01760954|2077775|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
1042627|NCT01760954|2077776|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
1042628|NCT01760954|2077773|FG000|Treatment Period (6 Months)|Pregnancy|5
1042629|NCT01760954|2077774|FG001|Treatment Period (6 Months)|Pregnancy|0
1042630|NCT01760954|2077775|FG002|Treatment Period (6 Months)|Pregnancy|3
1042631|NCT01760954|2077776|FG003|Treatment Period (6 Months)|Pregnancy|2
1042632|NCT01760954|2077773|FG000|Treatment Period (6 Months)|Non-compliance|1
1042633|NCT01760954|2077774|FG001|Treatment Period (6 Months)|Non-compliance|4
1042634|NCT01760954|2077775|FG002|Treatment Period (6 Months)|Non-compliance|0
1042635|NCT01760954|2077776|FG003|Treatment Period (6 Months)|Non-compliance|3
1042636|NCT01760954|2077773|FG000|Treatment Period (6 Months)|Other|0
1042637|NCT01760954|2077774|FG001|Treatment Period (6 Months)|Other|3
1042638|NCT01760954|2077775|FG002|Treatment Period (6 Months)|Other|3
1042639|NCT01760954|2077776|FG003|Treatment Period (6 Months)|Other|1
1042640|NCT01760954|2077773|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
1042641|NCT01760954|2077774|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
1042642|NCT01760954|2077775|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
1042643|NCT01760954|2077776|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
1042644|NCT01760954|2077773|FG000|Treatment Period (6 Months)|Exclusionary Medication|1
1042645|NCT01760954|2077774|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
1042646|NCT01760954|2077775|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
1042647|NCT01760954|2077776|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
1042648|NCT01760954|2077773|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
1042649|NCT01760954|2077774|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
1042650|NCT01760954|2077775|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
1042651|NCT01760954|2077776|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
1042652|NCT01760954|2077773|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
1042653|NCT01760954|2077774|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
1042654|NCT01760954|2077775|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
1042655|NCT01760954|2077776|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
1042656|NCT01760954|2077773|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
1042657|NCT01760954|2077774|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
1042658|NCT01760954|2077775|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
1042659|NCT01760954|2077776|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
1042660|NCT01760954|2077773|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
1042661|NCT01760954|2077774|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
1042662|NCT01760954|2077775|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
1042663|NCT01760954|2077776|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
1042664|NCT01760954|2077773|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
1042665|NCT01760954|2077774|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
1042666|NCT01760954|2077775|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
1042667|NCT01760954|2077776|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
1042668|NCT01760954|2077773|FG000|Post-treatment Follow-up (12 Months)|Other|13
1042669|NCT01760954|2077774|FG001|Post-treatment Follow-up (12 Months)|Other|8
1042670|NCT01760954|2077775|FG002|Post-treatment Follow-up (12 Months)|Other|9
1042671|NCT01760954|2077776|FG003|Post-treatment Follow-up (12 Months)|Other|6
1042672|NCT01761162|2077800|FG000|Overall Study|Withdrawal by Subject|3
1042673|NCT01761266|2077816|FG000|Overall Study|Death|351
1042674|NCT01761266|2077817|FG001|Overall Study|Death|350
1042675|NCT01761266|2077816|FG000|Overall Study|Lost to Follow-up|5
1042676|NCT01761266|2077817|FG001|Overall Study|Lost to Follow-up|11
1042677|NCT01761266|2077816|FG000|Overall Study|Withdrawal by Subject|13
1042678|NCT01761266|2077817|FG001|Overall Study|Withdrawal by Subject|8
1042679|NCT01761266|2077816|FG000|Overall Study|Ongoing as of data-cut off|109
1042680|NCT01761266|2077817|FG001|Overall Study|Ongoing as of data-cut off|107
1042681|NCT01761292|2077835|FG000|Part 1|Adverse Event|1
1042682|NCT01761292|2077835|FG000|Part 1|not receiving treatment in Part 1|1
1042683|NCT01761292|2077835|FG000|Extension 1|Withdrawal by Subject|1
1042684|NCT01761565|2077846|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
1042685|NCT01762345|2077876|FG000|Overall Study|Adverse Event|5
1042686|NCT01762345|2077876|FG000|Overall Study|Protocol Violation|2
1042687|NCT01762800|2077920|FG000|Overall Study|Adverse Event|8
1042688|NCT01762800|2077921|FG001|Overall Study|Adverse Event|13
1042689|NCT01762800|2077920|FG000|Overall Study|Lack of Efficacy|3
1042690|NCT01762800|2077921|FG001|Overall Study|Lack of Efficacy|2
1042691|NCT01762800|2077920|FG000|Overall Study|Study Closed/Terminated|0
1042692|NCT01762800|2077921|FG001|Overall Study|Study Closed/Terminated|1
1042693|NCT01762800|2077920|FG000|Overall Study|Physician Decision|1
1042694|NCT01762800|2077921|FG001|Overall Study|Physician Decision|1
1042695|NCT01762800|2077920|FG000|Overall Study|Withdrawal by Subject|7
1042696|NCT01762800|2077921|FG001|Overall Study|Withdrawal by Subject|4
1042697|NCT01762943|2077942|FG000|Overall Study|Physician Decision|1
1042698|NCT01762943|2077943|FG001|Overall Study|Physician Decision|1
1042699|NCT01762943|2077942|FG000|Overall Study|Protocol Violation|1
1042700|NCT01762943|2077943|FG001|Overall Study|Protocol Violation|0
1042701|NCT01762943|2077942|FG000|Overall Study|Withdrawal by Subject|2
1042702|NCT01762943|2077943|FG001|Overall Study|Withdrawal by Subject|1
1042703|NCT01763047|2077959|FG000|Period 1|Test Article Not Available|4
1042704|NCT01763047|2077960|FG001|Period 1|Test Article Not Available|1
1042705|NCT01763047|2077959|FG000|Period 1|Protocol Violation|4
1042706|NCT01763047|2077960|FG001|Period 1|Protocol Violation|4
1042707|NCT01763047|2077959|FG000|Period 1|No Longer Meets Eligibility criteria|1
1042708|NCT01763047|2077960|FG001|Period 1|No Longer Meets Eligibility criteria|0
1042709|NCT01763047|2077959|FG000|Period 1|Adverse Event|0
1042710|NCT01763047|2077960|FG001|Period 1|Adverse Event|1
1042711|NCT01763047|2077959|FG000|Period 1|Unsatisfactory Visual Response|0
1042712|NCT01763047|2077960|FG001|Period 1|Unsatisfactory Visual Response|3
1042713|NCT01763047|2077959|FG000|Period 1|Lens Power Not Available|0
1042714|NCT01763047|2077960|FG001|Period 1|Lens Power Not Available|1
1042715|NCT01763047|2077959|FG000|Period 1|Study Site office Closed|0
1042716|NCT01763047|2077960|FG001|Period 1|Study Site office Closed|1
1042717|NCT01763047|2077959|FG000|Period 2|Lens Discomfort|1
1042718|NCT01763047|2077960|FG001|Period 2|Lens Discomfort|0
1042719|NCT01763047|2077959|FG000|Period 2|No longer meets Eligibility Criteria|1
1042720|NCT01763047|2077960|FG001|Period 2|No longer meets Eligibility Criteria|0
1042721|NCT01763047|2077959|FG000|Period 2|Study Site office Closed|1
1042722|NCT01763047|2077960|FG001|Period 2|Study Site office Closed|1
1042723|NCT01763047|2077959|FG000|Period 2|Unsatisfactory Visual Response|1
1042724|NCT01763047|2077960|FG001|Period 2|Unsatisfactory Visual Response|1
1042725|NCT01763047|2077959|FG000|Period 2|Protocol Violation|0
1042726|NCT01763047|2077960|FG001|Period 2|Protocol Violation|2
1042727|NCT01763047|2077959|FG000|Period 2|Unsatisfactory lens Fitting|0
1042728|NCT01763047|2077960|FG001|Period 2|Unsatisfactory lens Fitting|1
1042729|NCT01763164|2077971|FG000|Treatment Phase|Participant/Guardian decision|26
1042730|NCT01763164|2077972|FG001|Treatment Phase|Participant/Guardian decision|14
1042731|NCT01763164|2077971|FG000|Treatment Phase|Protocol Violation|1
1042732|NCT01763164|2077972|FG001|Treatment Phase|Protocol Violation|1
1042733|NCT01763164|2077971|FG000|Treatment Phase|Progressive Disease|142
1042734|NCT01763164|2077972|FG001|Treatment Phase|Progressive Disease|76
1042735|NCT01763164|2077971|FG000|Treatment Phase|Physician Decision|24
1042736|NCT01763164|2077972|FG001|Treatment Phase|Physician Decision|13
1042737|NCT01763164|2077971|FG000|Treatment Phase|Death|10
1042738|NCT01763164|2077972|FG001|Treatment Phase|Death|1
1042739|NCT01763164|2077971|FG000|Treatment Phase|Adverse Event|66
1042740|NCT01763164|2077972|FG001|Treatment Phase|Adverse Event|8
1042741|NCT01763164|2077971|FG000|Treatment Phase|Randomized but not Treated|0
1042742|NCT01763164|2077972|FG001|Treatment Phase|Randomized but not Treated|19
1042743|NCT01763164|2077971|FG000|Treatment Phase|Other|0
1042744|NCT01763164|2077972|FG001|Treatment Phase|Other|1
1042745|NCT01763164|2077971|FG000|Follow up Phase|New therapy for study indication|12
1042746|NCT01763164|2077972|FG001|Follow up Phase|New therapy for study indication|3
1042747|NCT01763164|2077971|FG000|Follow up Phase|Death|21
1042748|NCT01763164|2077972|FG001|Follow up Phase|Death|4
1042749|NCT01763164|2077971|FG000|Follow up Phase|Subject/guardian decision|9
1042750|NCT01763164|2077972|FG001|Follow up Phase|Subject/guardian decision|2
1042751|NCT01763164|2077971|FG000|Follow up Phase|Progressive disease|127
1042752|NCT01763164|2077972|FG001|Follow up Phase|Progressive disease|62
1042753|NCT01763164|2077971|FG000|Follow up Phase|Physician Decision|10
1042754|NCT01763164|2077972|FG001|Follow up Phase|Physician Decision|3
1042755|NCT01763164|2077971|FG000|Follow up Phase|Lost to Follow-up|1
1042756|NCT01763164|2077972|FG001|Follow up Phase|Lost to Follow-up|0
1042757|NCT01763164|2077971|FG000|Follow up Phase|Adverse Event|17
1042758|NCT01763164|2077972|FG001|Follow up Phase|Adverse Event|1
1042759|NCT01763203|2077980|FG000|Overall Study|Death|4
1042760|NCT01763203|2077981|FG001|Overall Study|Death|7
1042761|NCT01763203|2077980|FG000|Overall Study|Lost to Follow-up|12
1042762|NCT01763203|2077981|FG001|Overall Study|Lost to Follow-up|12
1042763|NCT01763203|2077980|FG000|Overall Study|Withdrawal by Subject|8
1042764|NCT01763203|2077981|FG001|Overall Study|Withdrawal by Subject|12
1042765|NCT01763203|2077980|FG000|Overall Study|Moved out of study region|7
1042766|NCT01763203|2077981|FG001|Overall Study|Moved out of study region|10
1042767|NCT01763203|2077980|FG000|Overall Study|Physician Decision|2
1042768|NCT01763203|2077981|FG001|Overall Study|Physician Decision|1
1042769|NCT01763684|2078083|FG000|Overall Study|Study terminated early due to low enrollment|126
1042770|NCT01763684|2078084|FG001|Overall Study|Study terminated early due to low enrollment|127
1042771|NCT01763684|2078083|FG000|Overall Study|Study surgery not performed|7
1042772|NCT01763684|2078084|FG001|Overall Study|Study surgery not performed|6
1042773|NCT01763827|2078113|FG000|Overall Study|Withdrawal by Subject|1
1042774|NCT01763827|2078114|FG001|Overall Study|Withdrawal by Subject|0
1042775|NCT01763827|2078115|FG002|Overall Study|Withdrawal by Subject|0
1042776|NCT01763827|2078116|FG003|Overall Study|Withdrawal by Subject|0
1042777|NCT01763827|2078117|FG004|Overall Study|Withdrawal by Subject|2
1042778|NCT01763827|2078118|FG005|Overall Study|Withdrawal by Subject|0
1042779|NCT01763827|2078113|FG000|Overall Study|Decision by sponsor|2
1042780|NCT01763827|2078114|FG001|Overall Study|Decision by sponsor|0
1042781|NCT01763827|2078115|FG002|Overall Study|Decision by sponsor|3
1042782|NCT01763827|2078116|FG003|Overall Study|Decision by sponsor|0
1042783|NCT01763827|2078117|FG004|Overall Study|Decision by sponsor|2
1042784|NCT01763827|2078118|FG005|Overall Study|Decision by sponsor|1
1042785|NCT01763827|2078113|FG000|Overall Study|Lost to Follow-up|0
1042786|NCT01763827|2078114|FG001|Overall Study|Lost to Follow-up|1
1042787|NCT01763827|2078115|FG002|Overall Study|Lost to Follow-up|1
1042788|NCT01763827|2078116|FG003|Overall Study|Lost to Follow-up|1
1042789|NCT01763827|2078117|FG004|Overall Study|Lost to Follow-up|2
1042790|NCT01763827|2078118|FG005|Overall Study|Lost to Follow-up|1
1042791|NCT01763866|2078156|FG000|Overall Study|Withdrawal by Subject|2
1042792|NCT01763866|2078157|FG001|Overall Study|Withdrawal by Subject|1
1042793|NCT01763866|2078158|FG002|Overall Study|Withdrawal by Subject|4
1042794|NCT01763866|2078159|FG003|Overall Study|Withdrawal by Subject|0
1042795|NCT01763866|2078160|FG004|Overall Study|Withdrawal by Subject|0
1042796|NCT01763866|2078161|FG005|Overall Study|Withdrawal by Subject|3
1042797|NCT01763866|2078162|FG006|Overall Study|Withdrawal by Subject|4
1042798|NCT01763866|2078163|FG007|Overall Study|Withdrawal by Subject|0
1042799|NCT01763866|2078164|FG008|Overall Study|Withdrawal by Subject|1
1042800|NCT01763866|2078165|FG009|Overall Study|Withdrawal by Subject|1
1042801|NCT01763866|2078166|FG010|Overall Study|Withdrawal by Subject|2
1042802|NCT01763866|2078167|FG011|Overall Study|Withdrawal by Subject|2
1042803|NCT01763866|2078168|FG012|Overall Study|Withdrawal by Subject|2
1042804|NCT01763866|2078169|FG013|Overall Study|Withdrawal by Subject|0
1042805|NCT01763866|2078170|FG014|Overall Study|Withdrawal by Subject|6
1042806|NCT01763866|2078171|FG015|Overall Study|Withdrawal by Subject|3
1042807|NCT01763866|2078172|FG016|Overall Study|Withdrawal by Subject|0
1042808|NCT01763866|2078173|FG017|Overall Study|Withdrawal by Subject|1
1042809|NCT01763866|2078174|FG018|Overall Study|Withdrawal by Subject|1
1042810|NCT01763866|2078175|FG019|Overall Study|Withdrawal by Subject|1
1042811|NCT01763866|2078176|FG020|Overall Study|Withdrawal by Subject|2
1042812|NCT01763866|2078177|FG021|Overall Study|Withdrawal by Subject|1
1042813|NCT01763866|2078178|FG022|Overall Study|Withdrawal by Subject|2
1042814|NCT01763866|2078179|FG023|Overall Study|Withdrawal by Subject|1
1042815|NCT01763866|2078156|FG000|Overall Study|Decision by sponsor|0
1042816|NCT01763866|2078157|FG001|Overall Study|Decision by sponsor|0
1042817|NCT01763866|2078158|FG002|Overall Study|Decision by sponsor|1
1042818|NCT01763866|2078159|FG003|Overall Study|Decision by sponsor|0
1042819|NCT01763866|2078160|FG004|Overall Study|Decision by sponsor|2
1042820|NCT01763866|2078161|FG005|Overall Study|Decision by sponsor|0
1042821|NCT01763866|2078162|FG006|Overall Study|Decision by sponsor|2
1042822|NCT01763866|2078163|FG007|Overall Study|Decision by sponsor|0
1042823|NCT01763866|2078164|FG008|Overall Study|Decision by sponsor|2
1042824|NCT01763866|2078165|FG009|Overall Study|Decision by sponsor|0
1042825|NCT01763866|2078166|FG010|Overall Study|Decision by sponsor|6
1042826|NCT01763866|2078167|FG011|Overall Study|Decision by sponsor|0
1042827|NCT01763866|2078168|FG012|Overall Study|Decision by sponsor|1
1042828|NCT01763866|2078169|FG013|Overall Study|Decision by sponsor|0
1042829|NCT01763866|2078170|FG014|Overall Study|Decision by sponsor|5
1042830|NCT01763866|2078171|FG015|Overall Study|Decision by sponsor|0
1042831|NCT01763866|2078172|FG016|Overall Study|Decision by sponsor|0
1042832|NCT01763866|2078173|FG017|Overall Study|Decision by sponsor|0
1042833|NCT01763866|2078174|FG018|Overall Study|Decision by sponsor|4
1042834|NCT01763866|2078175|FG019|Overall Study|Decision by sponsor|0
1042835|NCT01763866|2078176|FG020|Overall Study|Decision by sponsor|2
1042836|NCT01763866|2078177|FG021|Overall Study|Decision by sponsor|0
1042837|NCT01763866|2078178|FG022|Overall Study|Decision by sponsor|1
1042838|NCT01763866|2078179|FG023|Overall Study|Decision by sponsor|0
1042839|NCT01763866|2078156|FG000|Overall Study|Lost to Follow-up|0
1042840|NCT01763866|2078157|FG001|Overall Study|Lost to Follow-up|0
1042841|NCT01763866|2078158|FG002|Overall Study|Lost to Follow-up|0
1042842|NCT01763866|2078159|FG003|Overall Study|Lost to Follow-up|0
1042843|NCT01763866|2078160|FG004|Overall Study|Lost to Follow-up|0
1042844|NCT01763866|2078161|FG005|Overall Study|Lost to Follow-up|0
1042845|NCT01763866|2078162|FG006|Overall Study|Lost to Follow-up|1
1042846|NCT01763866|2078163|FG007|Overall Study|Lost to Follow-up|0
1042847|NCT01763866|2078164|FG008|Overall Study|Lost to Follow-up|0
1042848|NCT01763866|2078165|FG009|Overall Study|Lost to Follow-up|0
1042849|NCT01763866|2078166|FG010|Overall Study|Lost to Follow-up|0
1042850|NCT01763866|2078167|FG011|Overall Study|Lost to Follow-up|0
1042851|NCT01763866|2078168|FG012|Overall Study|Lost to Follow-up|1
1042852|NCT01763866|2078169|FG013|Overall Study|Lost to Follow-up|0
1042853|NCT01763866|2078170|FG014|Overall Study|Lost to Follow-up|1
1042854|NCT01763866|2078171|FG015|Overall Study|Lost to Follow-up|0
1042855|NCT01763866|2078172|FG016|Overall Study|Lost to Follow-up|0
1042856|NCT01763866|2078173|FG017|Overall Study|Lost to Follow-up|0
1042857|NCT01763866|2078174|FG018|Overall Study|Lost to Follow-up|1
1042858|NCT01763866|2078175|FG019|Overall Study|Lost to Follow-up|1
1042859|NCT01763866|2078176|FG020|Overall Study|Lost to Follow-up|0
1042860|NCT01763866|2078177|FG021|Overall Study|Lost to Follow-up|0
1042861|NCT01763866|2078178|FG022|Overall Study|Lost to Follow-up|0
1042862|NCT01763866|2078179|FG023|Overall Study|Lost to Follow-up|1
1042863|NCT01763866|2078156|FG000|Overall Study|Death|0
1042864|NCT01763866|2078157|FG001|Overall Study|Death|0
1042865|NCT01763866|2078158|FG002|Overall Study|Death|0
1042866|NCT01763866|2078159|FG003|Overall Study|Death|0
1042867|NCT01763866|2078160|FG004|Overall Study|Death|0
1042868|NCT01763866|2078161|FG005|Overall Study|Death|0
1042869|NCT01763866|2078162|FG006|Overall Study|Death|0
1042870|NCT01763866|2078163|FG007|Overall Study|Death|0
1042871|NCT01763866|2078164|FG008|Overall Study|Death|0
1042872|NCT01763866|2078165|FG009|Overall Study|Death|0
1042873|NCT01763866|2078166|FG010|Overall Study|Death|0
1042874|NCT01763866|2078167|FG011|Overall Study|Death|0
1042875|NCT01763866|2078168|FG012|Overall Study|Death|0
1042876|NCT01763866|2078169|FG013|Overall Study|Death|0
1042877|NCT01763866|2078170|FG014|Overall Study|Death|0
1042878|NCT01763866|2078171|FG015|Overall Study|Death|0
1042879|NCT01763866|2078172|FG016|Overall Study|Death|1
1042880|NCT01763866|2078173|FG017|Overall Study|Death|0
1042881|NCT01763866|2078174|FG018|Overall Study|Death|0
1042882|NCT01763866|2078175|FG019|Overall Study|Death|0
1042883|NCT01763866|2078176|FG020|Overall Study|Death|0
1042884|NCT01763866|2078177|FG021|Overall Study|Death|0
1042885|NCT01763866|2078178|FG022|Overall Study|Death|0
1042886|NCT01763866|2078179|FG023|Overall Study|Death|0
1042887|NCT01763905|2078233|FG000|Overall Study|Withdrawal by Subject|1
1042888|NCT01763905|2078234|FG001|Overall Study|Withdrawal by Subject|1
1042889|NCT01763905|2078235|FG002|Overall Study|Withdrawal by Subject|0
1042890|NCT01763905|2078236|FG003|Overall Study|Withdrawal by Subject|1
1042891|NCT01763905|2078233|FG000|Overall Study|Decision by sponsor|5
1042892|NCT01763905|2078234|FG001|Overall Study|Decision by sponsor|0
1042893|NCT01763905|2078235|FG002|Overall Study|Decision by sponsor|8
1042894|NCT01763905|2078236|FG003|Overall Study|Decision by sponsor|0
1042895|NCT01763905|2078233|FG000|Overall Study|Lost to Follow-up|0
1042896|NCT01763905|2078234|FG001|Overall Study|Lost to Follow-up|0
1042897|NCT01763905|2078235|FG002|Overall Study|Lost to Follow-up|1
1042898|NCT01763905|2078236|FG003|Overall Study|Lost to Follow-up|0
1042899|NCT01763918|2078250|FG000|Overall Study|Withdrawal by Subject|2
1042900|NCT01763918|2078251|FG001|Overall Study|Withdrawal by Subject|1
1042901|NCT01763918|2078252|FG002|Overall Study|Withdrawal by Subject|1
1042902|NCT01763918|2078253|FG003|Overall Study|Withdrawal by Subject|2
1042903|NCT01763918|2078250|FG000|Overall Study|Sponsor Decision|4
1042904|NCT01763918|2078251|FG001|Overall Study|Sponsor Decision|0
1042905|NCT01763918|2078252|FG002|Overall Study|Sponsor Decision|9
1042906|NCT01763918|2078253|FG003|Overall Study|Sponsor Decision|0
1042907|NCT01763996|2078279|FG000|Treatment Period 2|Adverse Event|0
1042908|NCT01763996|2078280|FG001|Treatment Period 2|Adverse Event|1
1042909|NCT01764022|2078288|FG000|Overall Study|Death|3
1042910|NCT01764022|2078289|FG001|Overall Study|Death|5
1042911|NCT01764022|2078288|FG000|Overall Study|Withdrawal by Subject|2
1042912|NCT01764022|2078289|FG001|Overall Study|Withdrawal by Subject|6
1042913|NCT01764022|2078288|FG000|Overall Study|Lack of Efficacy|0
1042914|NCT01764022|2078289|FG001|Overall Study|Lack of Efficacy|1
1042915|NCT01764022|2078288|FG000|Overall Study|Physician Decision|0
1042916|NCT01764022|2078289|FG001|Overall Study|Physician Decision|2
1042917|NCT01764022|2078288|FG000|Overall Study|Lost to Follow-up|2
1042918|NCT01764022|2078289|FG001|Overall Study|Lost to Follow-up|0
1042919|NCT01764022|2078288|FG000|Overall Study|Protocol Violation|1
1042920|NCT01764022|2078289|FG001|Overall Study|Protocol Violation|0
1042921|NCT01764256|2078301|FG000|Received All Vaccinations|Adverse Event|1
1042922|NCT01764256|2078302|FG001|Received All Vaccinations|Adverse Event|1
1042923|NCT01764256|2078303|FG002|Received All Vaccinations|Adverse Event|0
1042924|NCT01764256|2078304|FG003|Received All Vaccinations|Adverse Event|0
1042925|NCT01764256|2078301|FG000|Received All Vaccinations|Did not meet inclusion criteria|0
1042926|NCT01764256|2078302|FG001|Received All Vaccinations|Did not meet inclusion criteria|0
1042927|NCT01764256|2078303|FG002|Received All Vaccinations|Did not meet inclusion criteria|1
1042928|NCT01764256|2078304|FG003|Received All Vaccinations|Did not meet inclusion criteria|0
1042929|NCT01764256|2078301|FG000|Received All Vaccinations|Lost to Follow-up|1
1042930|NCT01764256|2078302|FG001|Received All Vaccinations|Lost to Follow-up|0
1042931|NCT01764256|2078303|FG002|Received All Vaccinations|Lost to Follow-up|0
1042932|NCT01764256|2078304|FG003|Received All Vaccinations|Lost to Follow-up|0
1042933|NCT01764256|2078301|FG000|Completed Study|Lost to Follow-up|0
1042934|NCT01764256|2078302|FG001|Completed Study|Lost to Follow-up|0
1042935|NCT01764256|2078303|FG002|Completed Study|Lost to Follow-up|0
1042936|NCT01764256|2078304|FG003|Completed Study|Lost to Follow-up|1
1042937|NCT01764386|2078320|FG000|Controlled Treatment Period (CTP)|Adverse Event|35
1042938|NCT01764386|2078321|FG001|Controlled Treatment Period (CTP)|Adverse Event|0
1042939|NCT01764386|2078320|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
1042940|NCT01764386|2078321|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
1042941|NCT01764386|2078320|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9
1042942|NCT01764386|2078321|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5
1042943|NCT01764386|2078320|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
1042944|NCT01764386|2078321|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
1042945|NCT01764386|2078320|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2
1042946|NCT01764386|2078321|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13
1042947|NCT01764386|2078320|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
1042948|NCT01764386|2078321|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
1042949|NCT01764386|2078320|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
1042950|NCT01764386|2078321|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
1042951|NCT01764386|2078320|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
1042952|NCT01764386|2078321|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
1042953|NCT01764464|2078330|FG000|First Intervention|Withdrawal by Subject|1
1042954|NCT01764464|2078331|FG001|First Intervention|Withdrawal by Subject|0
1042955|NCT01764464|2078330|FG000|First Intervention|Lost to Follow-up|1
1042956|NCT01764464|2078331|FG001|First Intervention|Lost to Follow-up|0
1042957|NCT01764464|2078330|FG000|First Intervention|Adverse Event|0
1042958|NCT01764464|2078331|FG001|First Intervention|Adverse Event|2
1042959|NCT01764464|2078330|FG000|First Intervention|did not receive study drug|0
1042960|NCT01764464|2078331|FG001|First Intervention|did not receive study drug|1
1042961|NCT01764464|2078330|FG000|Second Intervention (Cross-over)|Adverse Event|2
1042962|NCT01764464|2078331|FG001|Second Intervention (Cross-over)|Adverse Event|0
1042963|NCT01764633|2078343|FG000|Overall Study|Withdrawal by Subject|105
1042964|NCT01764633|2078344|FG001|Overall Study|Withdrawal by Subject|88
1042965|NCT01764633|2078343|FG000|Overall Study|Lost to Follow-up|13
1042966|NCT01764633|2078344|FG001|Overall Study|Lost to Follow-up|5
1042967|NCT01764659|2078350|FG000|Overall Study|Death|1
1042968|NCT01764659|2078350|FG000|Overall Study|Physician Decision|1
1042969|NCT01764841|2078369|FG000|Overall Study|Logistical Difficulties|0
1042970|NCT01764841|2078370|FG001|Overall Study|Logistical Difficulties|1
1042971|NCT01764841|2078371|FG002|Overall Study|Logistical Difficulties|0
1042972|NCT01764841|2078372|FG003|Overall Study|Logistical Difficulties|0
1042973|NCT01764841|2078369|FG000|Overall Study|Death|3
1042974|NCT01764841|2078370|FG001|Overall Study|Death|0
1042975|NCT01764841|2078371|FG002|Overall Study|Death|1
1042976|NCT01764841|2078372|FG003|Overall Study|Death|4
1042977|NCT01764841|2078369|FG000|Overall Study|No Follow Up|1
1042978|NCT01764841|2078370|FG001|Overall Study|No Follow Up|0
1042979|NCT01764841|2078371|FG002|Overall Study|No Follow Up|1
1042980|NCT01764841|2078372|FG003|Overall Study|No Follow Up|0
1042981|NCT01764841|2078369|FG000|Overall Study|Protocol Violation|0
1042982|NCT01764841|2078370|FG001|Overall Study|Protocol Violation|1
1042983|NCT01764841|2078371|FG002|Overall Study|Protocol Violation|0
1042984|NCT01764841|2078372|FG003|Overall Study|Protocol Violation|0
1042985|NCT01764841|2078369|FG000|Overall Study|Withdrawal by Subject|16
1042986|NCT01764841|2078370|FG001|Overall Study|Withdrawal by Subject|24
1042987|NCT01764841|2078371|FG002|Overall Study|Withdrawal by Subject|11
1042988|NCT01764841|2078372|FG003|Overall Study|Withdrawal by Subject|15
1042989|NCT01764841|2078369|FG000|Overall Study|Lost to Follow-up|3
1042990|NCT01764841|2078370|FG001|Overall Study|Lost to Follow-up|0
1042991|NCT01764841|2078371|FG002|Overall Study|Lost to Follow-up|1
1042992|NCT01764841|2078372|FG003|Overall Study|Lost to Follow-up|0
1042993|NCT01764854|2078386|FG000|Overall Study|Adverse Event|0
1042994|NCT01764854|2078387|FG001|Overall Study|Adverse Event|0
1042995|NCT01764854|2078388|FG002|Overall Study|Adverse Event|2
1042996|NCT01764854|2078389|FG003|Overall Study|Adverse Event|0
1042997|NCT01764854|2078386|FG000|Overall Study|Withdrawal by Subject|0
1042998|NCT01764854|2078387|FG001|Overall Study|Withdrawal by Subject|0
1042999|NCT01764854|2078388|FG002|Overall Study|Withdrawal by Subject|1
1043000|NCT01764854|2078389|FG003|Overall Study|Withdrawal by Subject|0
1043001|NCT01764854|2078386|FG000|Overall Study|relocation|0
1043002|NCT01764854|2078387|FG001|Overall Study|relocation|0
1043003|NCT01764854|2078388|FG002|Overall Study|relocation|2
1043004|NCT01764854|2078389|FG003|Overall Study|relocation|0
1043005|NCT01764854|2078386|FG000|Overall Study|Protocol Violation|0
1043006|NCT01764854|2078387|FG001|Overall Study|Protocol Violation|0
1043007|NCT01764854|2078388|FG002|Overall Study|Protocol Violation|1
1043008|NCT01764854|2078389|FG003|Overall Study|Protocol Violation|2
1043009|NCT01764945|2078411|FG000|Overall Study|Adverse Event|0
1043010|NCT01764945|2078412|FG001|Overall Study|Adverse Event|1
1043011|NCT01764945|2078413|FG002|Overall Study|Adverse Event|0
1043012|NCT01764945|2078414|FG003|Overall Study|Adverse Event|0
1043013|NCT01764945|2078415|FG004|Overall Study|Adverse Event|0
1043014|NCT01764945|2078416|FG005|Overall Study|Adverse Event|0
1043015|NCT01764945|2078417|FG006|Overall Study|Adverse Event|1
1043016|NCT01764945|2078418|FG007|Overall Study|Adverse Event|0
1043017|NCT01765153|2078438|FG000|Training Phase 1|Format of intervention differed|1
1043018|NCT01765153|2078439|FG001|Training Phase 1|Format of intervention differed|0
1043019|NCT01765153|2078438|FG000|Training Phase 1|Poor participation in intervention|0
1043020|NCT01765153|2078439|FG001|Training Phase 1|Poor participation in intervention|1
1043021|NCT01765153|2078438|FG000|Rest Phase 1|Withdrawal by Subject|0
1043022|NCT01765153|2078439|FG001|Rest Phase 1|Withdrawal by Subject|1
1043023|NCT01765153|2078438|FG000|Training Phase 2|Withdrawal by Subject|0
1043024|NCT01765153|2078439|FG001|Training Phase 2|Withdrawal by Subject|1
1043025|NCT01765153|2078438|FG000|Rest Phase 2|Lost to Follow-up|2
1043026|NCT01765153|2078439|FG001|Rest Phase 2|Lost to Follow-up|1
1043027|NCT01765179|2078449|FG000|Overall Study|Adverse Event|3
1043028|NCT01765179|2078449|FG000|Overall Study|Lost to Follow-up|5
1043029|NCT01765179|2078449|FG000|Overall Study|Non-compliance with study drug|2
1043030|NCT01765179|2078449|FG000|Overall Study|Protocol Violation|1
1043031|NCT01765179|2078449|FG000|Overall Study|Withdrawal by Subject|8
1043032|NCT01765179|2078449|FG000|Overall Study|Hematocrit >54%|3
1043033|NCT01765179|2078449|FG000|Overall Study|prohibited med|1
1043034|NCT01765179|2078449|FG000|Overall Study|Out of country unable to finish study|1
1043035|NCT01765179|2078449|FG000|Overall Study|lack of venous access|1
1043036|NCT01765179|2078449|FG000|Overall Study|work conflict|1
1043037|NCT01765179|2078449|FG000|Overall Study|Ca elevated 10.6|1
1043038|NCT01765192|2078455|FG000|Treatment Period 1|Adverse Event|0
1043039|NCT01765192|2078456|FG001|Treatment Period 1|Adverse Event|1
1043040|NCT01765192|2078455|FG000|Washout Period|Voluntary Withdrawal|1
1043041|NCT01765192|2078456|FG001|Washout Period|Voluntary Withdrawal|1
1043042|NCT01765192|2078455|FG000|Washout Period|Reason not specified|1
1043043|NCT01765192|2078456|FG001|Washout Period|Reason not specified|0
1043044|NCT01765192|2078455|FG000|Treatment Period 2|Reason not specified|0
1043045|NCT01765192|2078456|FG001|Treatment Period 2|Reason not specified|2
1043046|NCT01765192|2078455|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0
1043047|NCT01765192|2078456|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1
1043048|NCT01765270|2078464|FG000|Overall Study|Physician Decision|1
1043049|NCT01765270|2078465|FG001|Overall Study|Physician Decision|0
1043050|NCT01765270|2078464|FG000|Overall Study|Withdrawal by Subject|0
1043051|NCT01765270|2078465|FG001|Overall Study|Withdrawal by Subject|1
1043052|NCT01765426|2078476|FG000|Overall Study|Lost to Follow-up|0
1043053|NCT01765426|2078477|FG001|Overall Study|Lost to Follow-up|1
1043054|NCT01765426|2078478|FG002|Overall Study|Lost to Follow-up|0
1043055|NCT01765426|2078479|FG003|Overall Study|Lost to Follow-up|0
1043056|NCT01765543|2078509|FG000|Overall Study|Death|1
1043057|NCT01765543|2078509|FG000|Overall Study|Withdrawal by Subject|2
1043058|NCT01765569|2078517|FG000|Period B|Withdrawal by Subject|1
1043059|NCT01765569|2078517|FG000|Period C|Death|1
1043060|NCT01765582|2078527|FG000|Overall Study|Other|3
1043061|NCT01765582|2078528|FG001|Overall Study|Other|6
1043062|NCT01765582|2078529|FG002|Overall Study|Other|9
1043063|NCT01765582|2078527|FG000|Overall Study|Lost to Follow-up|2
1043064|NCT01765582|2078528|FG001|Overall Study|Lost to Follow-up|2
1043065|NCT01765582|2078529|FG002|Overall Study|Lost to Follow-up|1
1043066|NCT01765582|2078527|FG000|Overall Study|Death|31
1043067|NCT01765582|2078528|FG001|Overall Study|Death|36
1043068|NCT01765582|2078529|FG002|Overall Study|Death|33
1043069|NCT01765582|2078527|FG000|Overall Study|Sponsor Decision|46
1043070|NCT01765582|2078528|FG001|Overall Study|Sponsor Decision|42
1043071|NCT01765582|2078529|FG002|Overall Study|Sponsor Decision|42
1043072|NCT01765582|2078527|FG000|Overall Study|Withdrawal of Consent|11
1043073|NCT01765582|2078528|FG001|Overall Study|Withdrawal of Consent|6
1043074|NCT01765582|2078529|FG002|Overall Study|Withdrawal of Consent|10
1043075|NCT01765673|2078542|FG000|Overall Study|No transportation for 2nd/3rd visits|1
1043076|NCT01765751|2078561|FG000|Overall Study|Lost to Follow-up|0
1043077|NCT01765751|2078562|FG001|Overall Study|Lost to Follow-up|2
1043078|NCT01765751|2078563|FG002|Overall Study|Lost to Follow-up|1
1043079|NCT01765764|2078577|FG000|Treatment Period|Adverse Event|1
1043080|NCT01765764|2078578|FG001|Treatment Period|Adverse Event|2
1043081|NCT01765764|2078579|FG002|Treatment Period|Adverse Event|1
1043082|NCT01765764|2078577|FG000|Treatment Period|Lost to Follow-up|0
1043083|NCT01765764|2078578|FG001|Treatment Period|Lost to Follow-up|3
1043084|NCT01765764|2078579|FG002|Treatment Period|Lost to Follow-up|2
1043085|NCT01765764|2078577|FG000|Treatment Period|Personal Reasons|1
1043086|NCT01765764|2078578|FG001|Treatment Period|Personal Reasons|2
1043087|NCT01765764|2078579|FG002|Treatment Period|Personal Reasons|1
1043088|NCT01765764|2078577|FG000|Treatment Period|Other Miscellaneous Reasons|1
1043089|NCT01765764|2078578|FG001|Treatment Period|Other Miscellaneous Reasons|2
1043090|NCT01765764|2078579|FG002|Treatment Period|Other Miscellaneous Reasons|2
1043091|NCT01765920|2078593|FG000|Overall Study|Incorrect inclusion ineligible patient|2
1043092|NCT01765920|2078594|FG001|Overall Study|Incorrect inclusion ineligible patient|5
1043093|NCT01765920|2078593|FG000|Overall Study|Patient code disclosure|0
1043094|NCT01765920|2078594|FG001|Overall Study|Patient code disclosure|1
1043095|NCT01766037|2078626|FG000|Overall Study|Adverse Event|1
1043096|NCT01766037|2078627|FG001|Overall Study|Adverse Event|0
1043097|NCT01766037|2078626|FG000|Overall Study|Lack of Efficacy|1
1043098|NCT01766037|2078627|FG001|Overall Study|Lack of Efficacy|0
1043099|NCT01766037|2078626|FG000|Overall Study|Lost to Follow-up|0
1043100|NCT01766037|2078627|FG001|Overall Study|Lost to Follow-up|10
1043101|NCT01766037|2078626|FG000|Overall Study|Physician Decision|0
1043102|NCT01766037|2078627|FG001|Overall Study|Physician Decision|1
1043103|NCT01766037|2078626|FG000|Overall Study|Withdrawal by Subject|18
1043104|NCT01766037|2078627|FG001|Overall Study|Withdrawal by Subject|16
1043105|NCT01766037|2078626|FG000|Overall Study|Moved from area|5
1043106|NCT01766037|2078627|FG001|Overall Study|Moved from area|0
1043107|NCT01766037|2078626|FG000|Overall Study|medical - unrelated|1
1043108|NCT01766037|2078627|FG001|Overall Study|medical - unrelated|2
1043109|NCT01766037|2078626|FG000|Overall Study|nausea / discomfort|3
1043110|NCT01766037|2078627|FG001|Overall Study|nausea / discomfort|0
1043111|NCT01766050|2078633|FG000|Overall Study|Adverse Event|1
1043112|NCT01766050|2078633|FG000|Overall Study|Lost to Follow-up|1
1043113|NCT01766050|2078633|FG000|Overall Study|Withdrawal by Subject|2
1043114|NCT01766206|2078669|FG000|Overall Study|Withdrawal by Subject|22
1043115|NCT01766206|2078669|FG000|Overall Study|Lost to Follow-up|10
1043116|NCT01766206|2078669|FG000|Overall Study|Inappropriate enrollment|18
1043117|NCT01766206|2078669|FG000|Overall Study|Withdrawal and inappropriate enrollment|1
1043118|NCT01766310|2078689|FG000|Overall Study|Lost to Follow-up|1
1043119|NCT01766310|2078690|FG001|Overall Study|Lost to Follow-up|3
1043120|NCT01766336|2078698|FG000|Overall Study|Adverse Event|11
1043121|NCT01766336|2078699|FG001|Overall Study|Adverse Event|8
1043122|NCT01766336|2078698|FG000|Overall Study|Death|4
1043123|NCT01766336|2078699|FG001|Overall Study|Death|3
1043124|NCT01766336|2078698|FG000|Overall Study|Lost to Follow-up|1
1043125|NCT01766336|2078699|FG001|Overall Study|Lost to Follow-up|3
1043126|NCT01766336|2078698|FG000|Overall Study|Physician Decision|4
1043127|NCT01766336|2078699|FG001|Overall Study|Physician Decision|2
1043128|NCT01766336|2078698|FG000|Overall Study|Protocol Violation|0
1043129|NCT01766336|2078699|FG001|Overall Study|Protocol Violation|1
1043130|NCT01766336|2078698|FG000|Overall Study|Sponsor Decision|52
1043131|NCT01766336|2078699|FG001|Overall Study|Sponsor Decision|43
1043132|NCT01766336|2078698|FG000|Overall Study|Withdrawal by Subject|18
1043133|NCT01766336|2078699|FG001|Overall Study|Withdrawal by Subject|15
1043134|NCT01766401|2078707|FG000|Overall Study|Adverse Event|7
1043135|NCT01766401|2078708|FG001|Overall Study|Adverse Event|22
1043136|NCT01766401|2078707|FG000|Overall Study|Lack of Efficacy|1
1043137|NCT01766401|2078708|FG001|Overall Study|Lack of Efficacy|2
1043138|NCT01766401|2078707|FG000|Overall Study|Protocol Violation|3
1043139|NCT01766401|2078708|FG001|Overall Study|Protocol Violation|8
1043140|NCT01766401|2078707|FG000|Overall Study|Withdrawal by Subject|15
1043141|NCT01766401|2078708|FG001|Overall Study|Withdrawal by Subject|12
1043142|NCT01766401|2078707|FG000|Overall Study|Lost to Follow-up|10
1043143|NCT01766401|2078708|FG001|Overall Study|Lost to Follow-up|11
1043144|NCT01766401|2078707|FG000|Overall Study|Pregnancy|1
1043145|NCT01766401|2078708|FG001|Overall Study|Pregnancy|1
1043146|NCT01766778|2078743|FG000|Overall Study|Adverse Event|4
1043147|NCT01766778|2078744|FG001|Overall Study|Adverse Event|4
1043148|NCT01766778|2078743|FG000|Overall Study|Withdrawal by Subject|1
1043149|NCT01766778|2078744|FG001|Overall Study|Withdrawal by Subject|0
1043150|NCT01766817|2078753|FG000|Overall Study|Drug-related adverse event|1
1043151|NCT01766817|2078754|FG001|Overall Study|Drug-related adverse event|2
1043152|NCT01766817|2078755|FG002|Overall Study|Drug-related adverse event|1
1043153|NCT01766817|2078753|FG000|Overall Study|Drug-unrelated adverse event|3
1043154|NCT01766817|2078754|FG001|Overall Study|Drug-unrelated adverse event|3
1043155|NCT01766817|2078755|FG002|Overall Study|Drug-unrelated adverse event|3
1043156|NCT01766817|2078753|FG000|Overall Study|Death|1
1043157|NCT01766817|2078754|FG001|Overall Study|Death|1
1043158|NCT01766817|2078755|FG002|Overall Study|Death|0
1043159|NCT01766817|2078753|FG000|Overall Study|Unable to take study drug|0
1043160|NCT01766817|2078754|FG001|Overall Study|Unable to take study drug|1
1043161|NCT01766817|2078755|FG002|Overall Study|Unable to take study drug|0
1043162|NCT01766817|2078753|FG000|Overall Study|Withdrawal by Subject|2
1043163|NCT01766817|2078754|FG001|Overall Study|Withdrawal by Subject|0
1043164|NCT01766817|2078755|FG002|Overall Study|Withdrawal by Subject|3
1043165|NCT01766817|2078753|FG000|Overall Study|Subject non-compliance|0
1043166|NCT01766817|2078754|FG001|Overall Study|Subject non-compliance|1
1043167|NCT01766817|2078755|FG002|Overall Study|Subject non-compliance|2
1043168|NCT01766817|2078753|FG000|Overall Study|Physician Decision|3
1043169|NCT01766817|2078754|FG001|Overall Study|Physician Decision|3
1043170|NCT01766817|2078755|FG002|Overall Study|Physician Decision|4
1043171|NCT01766817|2078753|FG000|Overall Study|Other|1
1043172|NCT01766817|2078754|FG001|Overall Study|Other|0
1043173|NCT01766817|2078755|FG002|Overall Study|Other|0
1043174|NCT01766921|2078765|FG000|Overall Study|Administrative Reason|5
1043175|NCT01766921|2078766|FG001|Overall Study|Administrative Reason|5
1043176|NCT01766921|2078765|FG000|Overall Study|Death|1
1043177|NCT01766921|2078766|FG001|Overall Study|Death|1
1043178|NCT01766921|2078765|FG000|Overall Study|Lost to Follow-up|1
1043179|NCT01766921|2078766|FG001|Overall Study|Lost to Follow-up|3
1043180|NCT01766921|2078765|FG000|Overall Study|Unclassified|2
1043181|NCT01766921|2078766|FG001|Overall Study|Unclassified|2
1043182|NCT01766921|2078765|FG000|Overall Study|Protocol Violation|1
1043183|NCT01766921|2078766|FG001|Overall Study|Protocol Violation|1
1043184|NCT01766921|2078765|FG000|Overall Study|Withdrawal by Subject|14
1043185|NCT01766921|2078766|FG001|Overall Study|Withdrawal by Subject|5
1043186|NCT01767116|2078811|FG000|Overall Study|Lost to Follow-up|2
1043187|NCT01767116|2078812|FG001|Overall Study|Lost to Follow-up|2
1043188|NCT01767142|2078818|FG000|Overall Study|Lost to Follow-up|3
1043189|NCT01767194|2078833|FG000|Overall Study|Adverse Event|1
1043190|NCT01767194|2078834|FG001|Overall Study|Adverse Event|1
1043191|NCT01767194|2078833|FG000|Overall Study|Death|0
1043192|NCT01767194|2078834|FG001|Overall Study|Death|1
1043193|NCT01767194|2078833|FG000|Overall Study|Lack of Efficacy|12
1043194|NCT01767194|2078834|FG001|Overall Study|Lack of Efficacy|11
1043195|NCT01767194|2078833|FG000|Overall Study|Physician Decision|2
1043196|NCT01767194|2078834|FG001|Overall Study|Physician Decision|23
1043197|NCT01767194|2078833|FG000|Overall Study|Withdrawal by Subject|0
1043198|NCT01767194|2078834|FG001|Overall Study|Withdrawal by Subject|1
1043199|NCT01767194|2078833|FG000|Overall Study|Ineligible|1
1043200|NCT01767194|2078834|FG001|Overall Study|Ineligible|1
1043201|NCT01767194|2078833|FG000|Overall Study|Refusal by patient/parent|2
1043202|NCT01767194|2078834|FG001|Overall Study|Refusal by patient/parent|4
1043203|NCT01767194|2078833|FG000|Overall Study|Criteria not met on time for next cycle|0
1043204|NCT01767194|2078834|FG001|Overall Study|Criteria not met on time for next cycle|1
1043205|NCT01767376|2078853|FG000|Overall Study|Lost to Follow-up|3
1043206|NCT01767376|2078854|FG001|Overall Study|Lost to Follow-up|2
1043207|NCT01767376|2078855|FG002|Overall Study|Lost to Follow-up|0
1043208|NCT01767376|2078853|FG000|Overall Study|Withdrawal by Subject|1
1043209|NCT01767376|2078854|FG001|Overall Study|Withdrawal by Subject|1
1043210|NCT01767376|2078855|FG002|Overall Study|Withdrawal by Subject|0
1043211|NCT01767467|2078871|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8
1043212|NCT01767467|2078872|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8
1043213|NCT01767467|2078871|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1
1043214|NCT01767467|2078872|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0
1043215|NCT01767467|2078871|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
1043216|NCT01767467|2078872|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
1043217|NCT01767467|2078871|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
1043218|NCT01767467|2078872|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
1043219|NCT01767467|2078871|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1
1043220|NCT01767467|2078872|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0
1043221|NCT01767467|2078871|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0
1043222|NCT01767467|2078872|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1
1043223|NCT01767467|2078871|FG000|End of Study Phase (up to Month 13)|Adverse Event|29
1043224|NCT01767467|2078872|FG001|End of Study Phase (up to Month 13)|Adverse Event|39
1043225|NCT01767467|2078871|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2
1043226|NCT01767467|2078872|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0
1043227|NCT01767467|2078871|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
1043228|NCT01767467|2078872|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
1043229|NCT01767467|2078871|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
1043230|NCT01767467|2078872|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
1043231|NCT01767467|2078871|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6
1043232|NCT01767467|2078872|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4
1043233|NCT01767467|2078871|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
1043234|NCT01767467|2078872|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
1043235|NCT01767467|2078871|FG000|End of Study Phase (up to Month 13)|Physician Decision|1
1043236|NCT01767467|2078872|FG001|End of Study Phase (up to Month 13)|Physician Decision|0
1043237|NCT01767467|2078871|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0
1043238|NCT01767467|2078872|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2
1043239|NCT01767493|2078885|FG000|Overall Study|screen failures|3
1043240|NCT01767519|2078901|FG000|Overall Study|Other Reasons|4
1043241|NCT01767519|2078902|FG001|Overall Study|Other Reasons|4
1043242|NCT01767519|2078903|FG002|Overall Study|Other Reasons|2
1043243|NCT01767519|2078901|FG000|Overall Study|Protocol Violation|0
1043244|NCT01767519|2078902|FG001|Overall Study|Protocol Violation|3
1043245|NCT01767519|2078903|FG002|Overall Study|Protocol Violation|0
1043246|NCT01767519|2078901|FG000|Overall Study|Personal Reasons|1
1043247|NCT01767519|2078902|FG001|Overall Study|Personal Reasons|0
1043248|NCT01767519|2078903|FG002|Overall Study|Personal Reasons|0
1043249|NCT01767519|2078901|FG000|Overall Study|Lost to Follow-up|3
1043250|NCT01767519|2078902|FG001|Overall Study|Lost to Follow-up|1
1043251|NCT01767519|2078903|FG002|Overall Study|Lost to Follow-up|2
1043252|NCT01767519|2078901|FG000|Overall Study|Lack of Efficacy|1
1043253|NCT01767519|2078902|FG001|Overall Study|Lack of Efficacy|0
1043254|NCT01767519|2078903|FG002|Overall Study|Lack of Efficacy|0
1043255|NCT01767519|2078901|FG000|Overall Study|Adverse Event|5
1043256|NCT01767519|2078902|FG001|Overall Study|Adverse Event|5
1043257|NCT01767519|2078903|FG002|Overall Study|Adverse Event|1
1043258|NCT01767597|2078913|FG000|Overall Study|Incomplete intervention|3
1043259|NCT01767597|2078914|FG001|Overall Study|Incomplete intervention|1
1043260|NCT01767597|2078913|FG000|Overall Study|Withdrawal by Subject|1
1043261|NCT01767597|2078914|FG001|Overall Study|Withdrawal by Subject|0
1043262|NCT01767857|2078945|FG000|Overall Study|Adverse Event|27
1043263|NCT01767857|2078946|FG001|Overall Study|Adverse Event|7
1043264|NCT01767857|2078945|FG000|Overall Study|Death|28
1043265|NCT01767857|2078946|FG001|Overall Study|Death|13
1043266|NCT01767857|2078945|FG000|Overall Study|Lack of Efficacy|299
1043267|NCT01767857|2078946|FG001|Overall Study|Lack of Efficacy|151
1043268|NCT01767857|2078945|FG000|Overall Study|Lost to Follow-up|1
1043269|NCT01767857|2078946|FG001|Overall Study|Lost to Follow-up|1
1043270|NCT01767857|2078945|FG000|Overall Study|Withdrawal by Subject|38
1043271|NCT01767857|2078946|FG001|Overall Study|Withdrawal by Subject|18
1043272|NCT01767857|2078945|FG000|Overall Study|Physician Decision|17
1043273|NCT01767857|2078946|FG001|Overall Study|Physician Decision|10
1043274|NCT01767857|2078945|FG000|Overall Study|Protocol Terminated|1
1043275|NCT01767857|2078946|FG001|Overall Study|Protocol Terminated|0
1043276|NCT01767857|2078945|FG000|Overall Study|Randomized But Never Treated|19
1043277|NCT01767857|2078946|FG001|Overall Study|Randomized But Never Treated|13
1043278|NCT01767909|2078955|FG000|Overall Study|Withdrawal by Subject|4
1043279|NCT01767909|2078956|FG001|Overall Study|Withdrawal by Subject|7
1043280|NCT01767909|2078955|FG000|Overall Study|Adverse Event|3
1043281|NCT01767909|2078956|FG001|Overall Study|Adverse Event|1
1043282|NCT01767909|2078955|FG000|Overall Study|Withdrawal by Study Partner|3
1043283|NCT01767909|2078956|FG001|Overall Study|Withdrawal by Study Partner|1
1043284|NCT01767909|2078955|FG000|Overall Study|Non-Compliance|2
1043285|NCT01767909|2078956|FG001|Overall Study|Non-Compliance|0
1043286|NCT01767909|2078955|FG000|Overall Study|Perceived Lack of Efficacy|1
1043287|NCT01767909|2078956|FG001|Overall Study|Perceived Lack of Efficacy|0
1043288|NCT01767909|2078955|FG000|Overall Study|Investigator Recommendation|0
1043289|NCT01767909|2078956|FG001|Overall Study|Investigator Recommendation|1
1043290|NCT01767909|2078955|FG000|Overall Study|Lost to Follow-up|0
1043291|NCT01767909|2078956|FG001|Overall Study|Lost to Follow-up|1
1043292|NCT01767909|2078955|FG000|Overall Study|LP uncessessful|0
1043293|NCT01767909|2078956|FG001|Overall Study|LP uncessessful|1
1043294|NCT01767987|2078970|FG000|Overall Study|Physician Decision|4
1043295|NCT01767987|2078971|FG001|Overall Study|Physician Decision|1
1043296|NCT01768117|2079000|FG000|Overall Study|Lost to Follow-up|1
1043297|NCT01768117|2079000|FG000|Overall Study|Withdrawal by Subject|2
1043298|NCT01768117|2079000|FG000|Overall Study|Protocol Violation|3
1043299|NCT01768286|2079008|FG000|Overall Study|Randomized But Not Treated|0
1043300|NCT01768286|2079009|FG001|Overall Study|Randomized But Not Treated|0
1043301|NCT01768286|2079010|FG002|Overall Study|Randomized But Not Treated|1
1043302|NCT01768286|2079011|FG003|Overall Study|Randomized But Not Treated|0
1043303|NCT01768286|2079008|FG000|Overall Study|Lack of Efficacy|7
1043304|NCT01768286|2079009|FG001|Overall Study|Lack of Efficacy|4
1043305|NCT01768286|2079010|FG002|Overall Study|Lack of Efficacy|0
1043306|NCT01768286|2079011|FG003|Overall Study|Lack of Efficacy|1
1043307|NCT01768286|2079008|FG000|Overall Study|Withdrew Consent|0
1043308|NCT01768286|2079009|FG001|Overall Study|Withdrew Consent|0
1043309|NCT01768286|2079010|FG002|Overall Study|Withdrew Consent|1
1043310|NCT01768286|2079011|FG003|Overall Study|Withdrew Consent|0
1043311|NCT01768559|2079048|FG000|Overall Study|Randomized but not treated|0
1043312|NCT01768559|2079049|FG001|Overall Study|Randomized but not treated|0
1043313|NCT01768559|2079050|FG002|Overall Study|Randomized but not treated|1
1043314|NCT01768559|2079048|FG000|Overall Study|Adverse Event|15
1043315|NCT01768559|2079049|FG001|Overall Study|Adverse Event|2
1043316|NCT01768559|2079050|FG002|Overall Study|Adverse Event|5
1043317|NCT01768559|2079048|FG000|Overall Study|Lack of Efficacy|6
1043318|NCT01768559|2079049|FG001|Overall Study|Lack of Efficacy|4
1043319|NCT01768559|2079050|FG002|Overall Study|Lack of Efficacy|0
1043320|NCT01768559|2079048|FG000|Overall Study|Poor compliance to protocol|0
1043321|NCT01768559|2079049|FG001|Overall Study|Poor compliance to protocol|3
1043322|NCT01768559|2079050|FG002|Overall Study|Poor compliance to protocol|2
1043323|NCT01768559|2079048|FG000|Overall Study|Other than specified|9
1043324|NCT01768559|2079049|FG001|Overall Study|Other than specified|8
1043325|NCT01768559|2079050|FG002|Overall Study|Other than specified|5
1043326|NCT01768572|2079065|FG000|Overall Study|Adverse Event|7
1043327|NCT01768572|2079066|FG001|Overall Study|Adverse Event|8
1043328|NCT01768572|2079067|FG002|Overall Study|Adverse Event|4
1043329|NCT01768572|2079065|FG000|Overall Study|Lack of Efficacy|1
1043330|NCT01768572|2079066|FG001|Overall Study|Lack of Efficacy|3
1043331|NCT01768572|2079067|FG002|Overall Study|Lack of Efficacy|1
1043332|NCT01768572|2079065|FG000|Overall Study|Other, Not due to an adverse event|1
1043333|NCT01768572|2079066|FG001|Overall Study|Other, Not due to an adverse event|1
1043334|NCT01768572|2079067|FG002|Overall Study|Other, Not due to an adverse event|1
1043335|NCT01768637|2079077|FG000|Overall Study|Lost to Follow-up|2
1043336|NCT01768637|2079078|FG001|Overall Study|Lost to Follow-up|7
1043337|NCT01768637|2079077|FG000|Overall Study|Difficult blood draw|1
1043338|NCT01768637|2079078|FG001|Overall Study|Difficult blood draw|0
1043339|NCT01768676|2079086|FG000|Overall Study|Adverse Event|3
1043340|NCT01768676|2079087|FG001|Overall Study|Adverse Event|3
1043341|NCT01768676|2079086|FG000|Overall Study|Lost to Follow-up|13
1043342|NCT01768676|2079087|FG001|Overall Study|Lost to Follow-up|16
1043343|NCT01768676|2079086|FG000|Overall Study|Protocol Violation|1
1043344|NCT01768676|2079087|FG001|Overall Study|Protocol Violation|1
1043345|NCT01768676|2079086|FG000|Overall Study|Physician Decision|4
1043346|NCT01768676|2079087|FG001|Overall Study|Physician Decision|1
1043347|NCT01768676|2079086|FG000|Overall Study|Withdrawal by Subject|3
1043348|NCT01768676|2079087|FG001|Overall Study|Withdrawal by Subject|10
1043349|NCT01768858|2079110|FG000|Overall Study|Lost to Follow-up|9
1043350|NCT01768858|2079110|FG000|Overall Study|Lack of Efficacy|8
1043351|NCT01768858|2079110|FG000|Overall Study|Serious Adverse Event|1
1043352|NCT01768858|2079110|FG000|Overall Study|Participant moved to Germany|1
1043353|NCT01768858|2079110|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1
1043354|NCT01768858|2079110|FG000|Overall Study|Exanthema|1
1043355|NCT01768858|2079110|FG000|Overall Study|Withdrawal by Subject|1
1043356|NCT01769105|2079116|FG000|First Intervention|Protocol Violation|2
1043357|NCT01769105|2079117|FG001|First Intervention|Protocol Violation|2
1043358|NCT01769105|2079116|FG000|Cross-over|Lost to Follow-up|5
1043359|NCT01769105|2079117|FG001|Cross-over|Lost to Follow-up|0
1043360|NCT01769196|2079136|FG000|Overall Study|Adverse Event|24
1043361|NCT01769196|2079137|FG001|Overall Study|Adverse Event|20
1043362|NCT01769196|2079136|FG000|Overall Study|Death|21
1043363|NCT01769196|2079137|FG001|Overall Study|Death|26
1043364|NCT01769196|2079136|FG000|Overall Study|Investigator Discretion|7
1043365|NCT01769196|2079137|FG001|Overall Study|Investigator Discretion|3
1043366|NCT01769196|2079136|FG000|Overall Study|Lack of Efficacy|3
1043367|NCT01769196|2079137|FG001|Overall Study|Lack of Efficacy|2
1043368|NCT01769196|2079136|FG000|Overall Study|Progressive disease|11
1043369|NCT01769196|2079137|FG001|Overall Study|Progressive disease|6
1043370|NCT01769196|2079136|FG000|Overall Study|Protocol defined criteria for withdrawal|9
1043371|NCT01769196|2079137|FG001|Overall Study|Protocol defined criteria for withdrawal|11
1043372|NCT01769196|2079136|FG000|Overall Study|Protocol Violation|0
1043373|NCT01769196|2079137|FG001|Overall Study|Protocol Violation|3
1043374|NCT01769196|2079136|FG000|Overall Study|Study terminated by sponsor|160
1043375|NCT01769196|2079137|FG001|Overall Study|Study terminated by sponsor|161
1043376|NCT01769196|2079136|FG000|Overall Study|Participant never dosed with study drug|1
1043377|NCT01769196|2079137|FG001|Overall Study|Participant never dosed with study drug|0
1043378|NCT01769196|2079136|FG000|Overall Study|Withdrew consent|36
1043379|NCT01769196|2079137|FG001|Overall Study|Withdrew consent|40
1043380|NCT01769326|2079184|FG000|Overall Study|Lost to Follow-up|1
1043381|NCT01769326|2079185|FG001|Overall Study|Lost to Follow-up|2
1043382|NCT01769326|2079186|FG002|Overall Study|Lost to Follow-up|0
1043383|NCT01769326|2079187|FG003|Overall Study|Lost to Follow-up|0
1043384|NCT01769326|2079184|FG000|Overall Study|unrelated injry|1
1043385|NCT01769326|2079185|FG001|Overall Study|unrelated injry|1
1043386|NCT01769326|2079186|FG002|Overall Study|unrelated injry|0
1043387|NCT01769326|2079187|FG003|Overall Study|unrelated injry|0
1043388|NCT01769326|2079184|FG000|Overall Study|got a job|0
1043389|NCT01769326|2079185|FG001|Overall Study|got a job|1
1043390|NCT01769326|2079186|FG002|Overall Study|got a job|0
1043391|NCT01769326|2079187|FG003|Overall Study|got a job|0
1043392|NCT01769326|2079184|FG000|Overall Study|Got sick and could not complete study|0
1043393|NCT01769326|2079185|FG001|Overall Study|Got sick and could not complete study|0
1043394|NCT01769326|2079186|FG002|Overall Study|Got sick and could not complete study|1
1043395|NCT01769326|2079187|FG003|Overall Study|Got sick and could not complete study|0
1043396|NCT01769339|2079197|FG000|Overall Study|Lost to Follow-up|42
1043397|NCT01769339|2079197|FG000|Overall Study|Adverse Event|1
1043398|NCT01769378|2079234|FG000|Overall Study|Adverse Event|10
1043399|NCT01769378|2079235|FG001|Overall Study|Adverse Event|0
1043400|NCT01769378|2079234|FG000|Overall Study|Entry criteria not met|1
1043401|NCT01769378|2079235|FG001|Overall Study|Entry criteria not met|0
1043402|NCT01769378|2079234|FG000|Overall Study|Protocol Violation|1
1043403|NCT01769378|2079235|FG001|Overall Study|Protocol Violation|1
1043404|NCT01769378|2079234|FG000|Overall Study|Withdrawal by Subject|10
1043405|NCT01769378|2079235|FG001|Overall Study|Withdrawal by Subject|3
1043406|NCT01769378|2079234|FG000|Overall Study|Sponsor Decision|1
1043407|NCT01769378|2079235|FG001|Overall Study|Sponsor Decision|0
1043408|NCT01769378|2079234|FG000|Overall Study|Lost to Follow-up|2
1043409|NCT01769378|2079235|FG001|Overall Study|Lost to Follow-up|0
1043410|NCT01769391|2079243|FG000|Overall Study|Death|10
1043411|NCT01769391|2079244|FG001|Overall Study|Death|1
1043412|NCT01769391|2079243|FG000|Overall Study|Adverse Event|0
1043413|NCT01769391|2079244|FG001|Overall Study|Adverse Event|3
1043414|NCT01769391|2079243|FG000|Overall Study|Progressive Disease|1
1043415|NCT01769391|2079244|FG001|Overall Study|Progressive Disease|2
1043416|NCT01769391|2079243|FG000|Overall Study|Withdrawal by Subject|4
1043417|NCT01769391|2079244|FG001|Overall Study|Withdrawal by Subject|3
1043418|NCT01769391|2079243|FG000|Overall Study|Investigator Decision|2
1043419|NCT01769391|2079244|FG001|Overall Study|Investigator Decision|0
1043420|NCT01769404|2079256|FG000|Treatment Period 1|Did not meet eligibility criteria|1
1043421|NCT01769404|2079257|FG001|Treatment Period 1|Did not meet eligibility criteria|0
1043422|NCT01769404|2079256|FG000|Treatment Period 1|Withdrawal by Subject|3
1043423|NCT01769404|2079257|FG001|Treatment Period 1|Withdrawal by Subject|0
1043424|NCT01769404|2079256|FG000|Treatment Period 1|Sponsor decision|1
1043425|NCT01769404|2079257|FG001|Treatment Period 1|Sponsor decision|0
1043426|NCT01769404|2079256|FG000|Treatment Period 2|Sponsor decision|7
1043427|NCT01769404|2079257|FG001|Treatment Period 2|Sponsor decision|0
1043428|NCT01769456|2079265|FG000|Overall Study|Lost to Follow-up|19
1043429|NCT01769456|2079265|FG000|Overall Study|Withdrawal by Subject|3
1043430|NCT01769456|2079265|FG000|Overall Study|Did not receive PCC intervention|6
1043431|NCT01769456|2079265|FG000|Overall Study|Moved out of the area|3
1043432|NCT01769456|2079265|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5
1043433|NCT01769456|2079265|FG000|Overall Study|Parental request to youth to withdraw|1
1043434|NCT01769469|2079270|FG000|Overall Study|Consent Withdrawn|5
1043435|NCT01769469|2079270|FG000|Overall Study|Moved Out Of Area|3
1043436|NCT01769469|2079270|FG000|Overall Study|Lost to Follow-up|17
1043437|NCT01769469|2079270|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
1043438|NCT01769469|2079270|FG000|Overall Study|Subject Confirmed HIV Positive|3
1043439|NCT01769508|2079276|FG000|Overall Study|Death|3
1043440|NCT01769508|2079276|FG000|Overall Study|Withdrawal by Subject|1
1043441|NCT01769508|2079276|FG000|Overall Study|Adverse Event|1
1043442|NCT01769508|2079276|FG000|Overall Study|Lost to Follow-up|1
1043443|NCT01770145|2079316|FG000|Baseline|Adverse Event|20
1043444|NCT01770145|2079316|FG000|Baseline|Withdrawal by Subject|1
1043445|NCT01770145|2079316|FG000|Baseline|Lost to Follow-up|1
1043446|NCT01770145|2079316|FG000|Baseline|Unable to define optimal dose|4
1043447|NCT01770145|2079316|FG000|Treatment|Adverse Event|3
1043448|NCT01770145|2079316|FG000|Treatment|Withdrawal by Subject|1
1043449|NCT01770353|2079331|FG000|Overall Study|Progressive disease|2
1043450|NCT01770353|2079332|FG001|Overall Study|Progressive disease|1
1043451|NCT01770353|2079331|FG000|Overall Study|Adverse Event|0
1043452|NCT01770353|2079332|FG001|Overall Study|Adverse Event|1
1043453|NCT01770353|2079331|FG000|Overall Study|Protocol Violation|1
1043454|NCT01770353|2079332|FG001|Overall Study|Protocol Violation|0
1043455|NCT01770353|2079331|FG000|Overall Study|Physician Decision|0
1043456|NCT01770353|2079332|FG001|Overall Study|Physician Decision|3
1043457|NCT01770353|2079331|FG000|Overall Study|Clinical deterioration|3
1043458|NCT01770353|2079332|FG001|Overall Study|Clinical deterioration|6
1043459|NCT01770353|2079331|FG000|Overall Study|Toxicity related diarrhoea + progression|0
1043460|NCT01770353|2079332|FG001|Overall Study|Toxicity related diarrhoea + progression|1
1043461|NCT01770379|2079358|FG000|Overall Study|Technical issues|1
1043462|NCT01770379|2079359|FG001|Overall Study|Technical issues|0
1043463|NCT01770379|2079360|FG002|Overall Study|Technical issues|0
1043464|NCT01770379|2079358|FG000|Overall Study|Withdrawal by Subject|7
1043465|NCT01770379|2079359|FG001|Overall Study|Withdrawal by Subject|10
1043466|NCT01770379|2079360|FG002|Overall Study|Withdrawal by Subject|7
1043467|NCT01770379|2079358|FG000|Overall Study|study terminated by sponsor|22
1043468|NCT01770379|2079359|FG001|Overall Study|study terminated by sponsor|23
1043469|NCT01770379|2079360|FG002|Overall Study|study terminated by sponsor|22
1043470|NCT01770379|2079358|FG000|Overall Study|Protocol Violation|0
1043471|NCT01770379|2079359|FG001|Overall Study|Protocol Violation|1
1043472|NCT01770379|2079360|FG002|Overall Study|Protocol Violation|1
1043473|NCT01770379|2079358|FG000|Overall Study|Physician Decision|0
1043474|NCT01770379|2079359|FG001|Overall Study|Physician Decision|1
1043475|NCT01770379|2079360|FG002|Overall Study|Physician Decision|2
1043476|NCT01770379|2079358|FG000|Overall Study|Lost to Follow-up|0
1043477|NCT01770379|2079359|FG001|Overall Study|Lost to Follow-up|0
1043478|NCT01770379|2079360|FG002|Overall Study|Lost to Follow-up|2
1043479|NCT01770379|2079358|FG000|Overall Study|Lack of Efficacy|8
1043480|NCT01770379|2079359|FG001|Overall Study|Lack of Efficacy|6
1043481|NCT01770379|2079360|FG002|Overall Study|Lack of Efficacy|6
1043482|NCT01770379|2079358|FG000|Overall Study|Adverse Event|1
1043483|NCT01770379|2079359|FG001|Overall Study|Adverse Event|3
1043484|NCT01770379|2079360|FG002|Overall Study|Adverse Event|2
1043485|NCT01770392|2079370|FG000|Washout Period of at Least 14 Days|Adverse Event|1
1043486|NCT01770509|2079401|FG000|Overall Study|Injury|0
1043487|NCT01770509|2079402|FG001|Overall Study|Injury|1
1043488|NCT01770509|2079401|FG000|Overall Study|Lost to Follow-up|1
1043489|NCT01770509|2079402|FG001|Overall Study|Lost to Follow-up|2
1043490|NCT01770743|2079441|FG000|Overall Study|Adverse Event|1
1043491|NCT01770743|2079442|FG001|Overall Study|Adverse Event|0
1043492|NCT01770743|2079443|FG002|Overall Study|Adverse Event|0
1043493|NCT01770743|2079444|FG003|Overall Study|Adverse Event|0
1043494|NCT01770743|2079445|FG004|Overall Study|Adverse Event|0
1043495|NCT01770743|2079441|FG000|Overall Study|Withdrawal by Subject|0
1043496|NCT01770743|2079442|FG001|Overall Study|Withdrawal by Subject|0
1043497|NCT01770743|2079443|FG002|Overall Study|Withdrawal by Subject|1
1043498|NCT01770743|2079444|FG003|Overall Study|Withdrawal by Subject|1
1043499|NCT01770743|2079445|FG004|Overall Study|Withdrawal by Subject|1
1043500|NCT01770743|2079441|FG000|Overall Study|Lost to Follow-up|0
1043501|NCT01770743|2079442|FG001|Overall Study|Lost to Follow-up|2
1043502|NCT01770743|2079443|FG002|Overall Study|Lost to Follow-up|0
1043503|NCT01770743|2079444|FG003|Overall Study|Lost to Follow-up|0
1043504|NCT01770743|2079445|FG004|Overall Study|Lost to Follow-up|1
1043505|NCT01770743|2079441|FG000|Overall Study|Sponsor Terminated Subject|1
1043506|NCT01770743|2079442|FG001|Overall Study|Sponsor Terminated Subject|0
1043507|NCT01770743|2079443|FG002|Overall Study|Sponsor Terminated Subject|0
1043508|NCT01770743|2079444|FG003|Overall Study|Sponsor Terminated Subject|1
1043509|NCT01770743|2079445|FG004|Overall Study|Sponsor Terminated Subject|0
1043510|NCT01770743|2079441|FG000|Overall Study|Moving Out of State|0
1043511|NCT01770743|2079442|FG001|Overall Study|Moving Out of State|1
1043512|NCT01770743|2079443|FG002|Overall Study|Moving Out of State|0
1043513|NCT01770743|2079444|FG003|Overall Study|Moving Out of State|0
1043514|NCT01770743|2079445|FG004|Overall Study|Moving Out of State|0
1043515|NCT01770860|2079457|FG000|Overall Study|Withdrawal by Subject|4
1043516|NCT01770860|2079457|FG000|Overall Study|Lost to Follow-up|1
1043517|NCT01770860|2079457|FG000|Overall Study|Administrative decision made by the PI|1
1043518|NCT01770912|2079467|FG000|Overall Study|Lost to Follow-up|2
1043519|NCT01770912|2079468|FG001|Overall Study|Lost to Follow-up|0
1043520|NCT01771250|2079487|FG000|Period 1|Met exclusion criteria|1
1043521|NCT01771250|2079488|FG001|Period 1|Met exclusion criteria|0
1043522|NCT01771731|2079509|FG000|Overall Study|Physician Decision|1
1043523|NCT01771731|2079510|FG001|Overall Study|Physician Decision|0
1043524|NCT01771731|2079509|FG000|Overall Study|Protocol Violation|0
1043525|NCT01771731|2079510|FG001|Overall Study|Protocol Violation|1
1043526|NCT01771731|2079509|FG000|Overall Study|Adverse event: Pain Crisis|1
1043527|NCT01771731|2079510|FG001|Overall Study|Adverse event: Pain Crisis|1
1043528|NCT01771809|2079518|FG000|Overall Study|Adverse Event|4
1043529|NCT01771809|2079519|FG001|Overall Study|Adverse Event|12
1043530|NCT01771809|2079518|FG000|Overall Study|Protocol Violation|0
1043531|NCT01771809|2079519|FG001|Overall Study|Protocol Violation|1
1043532|NCT01771809|2079518|FG000|Overall Study|Withdrawal by Subject|34
1043533|NCT01771809|2079519|FG001|Overall Study|Withdrawal by Subject|42
1043534|NCT01771809|2079518|FG000|Overall Study|Lost to Follow-up|1
1043535|NCT01771809|2079519|FG001|Overall Study|Lost to Follow-up|3
1043536|NCT01771809|2079518|FG000|Overall Study|Other (Insufficient clinical response)|22
1043537|NCT01771809|2079519|FG001|Overall Study|Other (Insufficient clinical response)|20
1043538|NCT01771809|2079518|FG000|Overall Study|Death|1
1043539|NCT01771809|2079519|FG001|Overall Study|Death|0
1043540|NCT01771809|2079518|FG000|Overall Study|Other (other)|9
1043541|NCT01771809|2079519|FG001|Overall Study|Other (other)|5
1043542|NCT01771913|2079527|FG000|Overall Study|Withdrawal by Subject|1
1043543|NCT01771913|2079528|FG001|Overall Study|Withdrawal by Subject|0
1043544|NCT01772134|2079565|FG000|Overall Study|Adverse Event|6
1043545|NCT01772134|2079566|FG001|Overall Study|Adverse Event|5
1043546|NCT01772134|2079567|FG002|Overall Study|Adverse Event|10
1043547|NCT01772134|2079565|FG000|Overall Study|Withdrew Consent|3
1043548|NCT01772134|2079566|FG001|Overall Study|Withdrew Consent|1
1043549|NCT01772134|2079567|FG002|Overall Study|Withdrew Consent|5
1043550|NCT01772134|2079565|FG000|Overall Study|Lost to Follow-up|2
1043551|NCT01772134|2079566|FG001|Overall Study|Lost to Follow-up|0
1043552|NCT01772134|2079567|FG002|Overall Study|Lost to Follow-up|0
1043553|NCT01772134|2079565|FG000|Overall Study|Protocol Deviation|4
1043554|NCT01772134|2079566|FG001|Overall Study|Protocol Deviation|3
1043555|NCT01772134|2079567|FG002|Overall Study|Protocol Deviation|3
1043556|NCT01772134|2079565|FG000|Overall Study|Lack of Efficacy|11
1043557|NCT01772134|2079566|FG001|Overall Study|Lack of Efficacy|5
1043558|NCT01772134|2079567|FG002|Overall Study|Lack of Efficacy|3
1043559|NCT01772134|2079565|FG000|Overall Study|Protocol-defined Stopping Criteria|1
1043560|NCT01772134|2079566|FG001|Overall Study|Protocol-defined Stopping Criteria|0
1043561|NCT01772134|2079567|FG002|Overall Study|Protocol-defined Stopping Criteria|0
1043562|NCT01772134|2079565|FG000|Overall Study|Randomized Study Medication Not Received|2
1043563|NCT01772134|2079566|FG001|Overall Study|Randomized Study Medication Not Received|0
1043564|NCT01772134|2079567|FG002|Overall Study|Randomized Study Medication Not Received|1
1043565|NCT01772147|2079578|FG000|Overall Study|Adverse Event|13
1043566|NCT01772147|2079579|FG001|Overall Study|Adverse Event|10
1043567|NCT01772147|2079580|FG002|Overall Study|Adverse Event|6
1043568|NCT01772147|2079578|FG000|Overall Study|Withdrew Consent|7
1043569|NCT01772147|2079579|FG001|Overall Study|Withdrew Consent|8
1043570|NCT01772147|2079580|FG002|Overall Study|Withdrew Consent|4
1043571|NCT01772147|2079578|FG000|Overall Study|Lost to Follow-up|1
1043572|NCT01772147|2079579|FG001|Overall Study|Lost to Follow-up|0
1043573|NCT01772147|2079580|FG002|Overall Study|Lost to Follow-up|1
1043574|NCT01772147|2079578|FG000|Overall Study|Protocol Deviation|2
1043575|NCT01772147|2079579|FG001|Overall Study|Protocol Deviation|1
1043576|NCT01772147|2079580|FG002|Overall Study|Protocol Deviation|1
1043577|NCT01772147|2079578|FG000|Overall Study|Lack of Efficacy|8
1043578|NCT01772147|2079579|FG001|Overall Study|Lack of Efficacy|6
1043579|NCT01772147|2079580|FG002|Overall Study|Lack of Efficacy|6
1043580|NCT01772160|2079588|FG000|Overall Study|Death|3
1043581|NCT01772160|2079588|FG000|Overall Study|Eligibility criteria not fulfilled|3
1043582|NCT01772160|2079588|FG000|Overall Study|Consent withdrawal|3
1043583|NCT01772160|2079588|FG000|Overall Study|Migrated / moved from the study area|4
1043584|NCT01772160|2079588|FG000|Overall Study|Lost to Follow-up|30
1043585|NCT01772160|2079588|FG000|Overall Study|Other|5
1043586|NCT01772316|2079592|FG000|Overall Study|Serious adverse event|1
1043587|NCT01772316|2079592|FG000|Overall Study|Inform consent withdrawn|1
1043588|NCT01772316|2079592|FG000|Overall Study|Withdrawn by sponsor decision|5
1043589|NCT01772368|2079596|FG000|Overall Study|Adverse Event|1
1043590|NCT01772368|2079596|FG000|Overall Study|Withdrawal by Subject|3
1043591|NCT01772368|2079596|FG000|Overall Study|Protocol Violation|2
1043592|NCT01772368|2079596|FG000|Overall Study|Other|1
1043605|NCT01772537|2079624|FG000|Overall Study|unsuccessful lumbar drain placement|1
1043606|NCT01772537|2079625|FG001|Overall Study|unsuccessful lumbar drain placement|0
1043607|NCT01772537|2079626|FG002|Overall Study|unsuccessful lumbar drain placement|0
1043608|NCT01772550|2079639|FG000|Overall Study|Unable to insert IV in antecubital vein|1
1043609|NCT01772550|2079640|FG001|Overall Study|Unable to insert IV in antecubital vein|1
1043610|NCT01772550|2079641|FG002|Overall Study|Unable to insert IV in antecubital vein|5
1043611|NCT01772550|2079639|FG000|Overall Study|Adverse Event|0
1043612|NCT01772550|2079640|FG001|Overall Study|Adverse Event|0
1043613|NCT01772550|2079641|FG002|Overall Study|Adverse Event|1
1043614|NCT01772576|2079649|FG000|Overall Study|Death|15
1043615|NCT01772576|2079649|FG000|Overall Study|Protocol Violation|1
1043616|NCT01772576|2079649|FG000|Overall Study|Lost to Follow-up|3
1043617|NCT01772576|2079649|FG000|Overall Study|Study device not used|3
1043618|NCT01772576|2079649|FG000|Overall Study|Adverse Event|6
1043619|NCT01772576|2079649|FG000|Overall Study|Withdrawal by Subject|6
1043620|NCT01772693|2079664|FG000|Overall Study|Health Concerns Unrelated to Study|2
1043621|NCT01772693|2079665|FG001|Overall Study|Health Concerns Unrelated to Study|1
1043622|NCT01772693|2079664|FG000|Overall Study|Withdrawal by Subject|2
1043623|NCT01772693|2079665|FG001|Overall Study|Withdrawal by Subject|0
1043624|NCT01772693|2079664|FG000|Overall Study|Alternative Treatment|2
1043625|NCT01772693|2079665|FG001|Overall Study|Alternative Treatment|0
1043626|NCT01772823|2079690|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
1043627|NCT01772823|2079691|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
1043628|NCT01772823|2079690|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
1043629|NCT01772823|2079691|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
1043630|NCT01772823|2079690|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
1043631|NCT01772823|2079691|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
1043632|NCT01772823|2079690|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
1043633|NCT01772823|2079691|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
1043634|NCT01772823|2079690|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
1043635|NCT01772823|2079691|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
1043636|NCT01772823|2079690|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
1043637|NCT01772823|2079691|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
1043638|NCT01772823|2079690|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
1043639|NCT01772823|2079691|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
1043640|NCT01772823|2079690|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
1043641|NCT01772823|2079691|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
1043642|NCT01772823|2079690|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4
1043643|NCT01772823|2079691|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3
1043644|NCT01772823|2079690|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1
1043645|NCT01772823|2079691|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0
1043646|NCT01772823|2079690|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
1043647|NCT01772823|2079691|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
1043648|NCT01772823|2079690|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
1043649|NCT01772823|2079691|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
1043650|NCT01772823|2079690|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
1043651|NCT01772823|2079691|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
1043652|NCT01772823|2079690|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
1043653|NCT01772823|2079691|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
1043654|NCT01772823|2079690|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
1043655|NCT01772823|2079691|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
1043656|NCT01772823|2079690|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
1043657|NCT01772823|2079691|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
1043658|NCT01773070|2079702|FG000|Overall Study|Withdrawal by Subject|24
1043659|NCT01773070|2079702|FG000|Overall Study|Lost to Follow-up|39
1043660|NCT01773070|2079702|FG000|Overall Study|Other|15
1043661|NCT01773070|2079702|FG000|Overall Study|Death (unrelated to study procedures)|3
1043662|NCT01773109|2079706|FG000|Overall Study|Symptomatic Progression|2
1043663|NCT01773109|2079706|FG000|Overall Study|Death|1
1043664|NCT01773122|2079714|FG000|Overall Study|Due to amended age eligibility criteria|3
1043665|NCT01773122|2079715|FG001|Overall Study|Due to amended age eligibility criteria|1
1043666|NCT01773122|2079716|FG002|Overall Study|Due to amended age eligibility criteria|0
1043667|NCT01773122|2079717|FG003|Overall Study|Due to amended age eligibility criteria|1
1043668|NCT01773226|2079743|FG000|Overall Study|Withdrawal by Subject|1
1043669|NCT01773291|2079750|FG000|Overall Study|Protocol Violation|1
1043670|NCT01773291|2079751|FG001|Overall Study|Protocol Violation|0
1043671|NCT01773291|2079752|FG002|Overall Study|Protocol Violation|0
1043672|NCT01773291|2079750|FG000|Overall Study|Withdrawal by Subject|0
1043673|NCT01773291|2079751|FG001|Overall Study|Withdrawal by Subject|0
1043674|NCT01773291|2079752|FG002|Overall Study|Withdrawal by Subject|1
1043675|NCT01773421|2079765|FG000|Treatment Phase|Other|0
1043676|NCT01773421|2079766|FG001|Treatment Phase|Other|0
1043677|NCT01773421|2079767|FG002|Treatment Phase|Other|2
1043678|NCT01773421|2079768|FG003|Treatment Phase|Other|0
1043679|NCT01773421|2079769|FG004|Treatment Phase|Other|0
1043680|NCT01773421|2079770|FG005|Treatment Phase|Other|0
1043681|NCT01773421|2079771|FG006|Treatment Phase|Other|0
1043682|NCT01773421|2079765|FG000|Treatment Phase|Adverse Event|0
1043683|NCT01773421|2079766|FG001|Treatment Phase|Adverse Event|0
1043684|NCT01773421|2079767|FG002|Treatment Phase|Adverse Event|3
1043685|NCT01773421|2079768|FG003|Treatment Phase|Adverse Event|1
1043686|NCT01773421|2079769|FG004|Treatment Phase|Adverse Event|0
1043687|NCT01773421|2079770|FG005|Treatment Phase|Adverse Event|0
1043688|NCT01773421|2079771|FG006|Treatment Phase|Adverse Event|0
1043689|NCT01773421|2079765|FG000|Treatment Phase|Withdrawal by Subject|0
1043690|NCT01773421|2079766|FG001|Treatment Phase|Withdrawal by Subject|0
1043691|NCT01773421|2079767|FG002|Treatment Phase|Withdrawal by Subject|1
1043692|NCT01773421|2079768|FG003|Treatment Phase|Withdrawal by Subject|1
1043693|NCT01773421|2079769|FG004|Treatment Phase|Withdrawal by Subject|0
1043694|NCT01773421|2079770|FG005|Treatment Phase|Withdrawal by Subject|0
1043695|NCT01773421|2079771|FG006|Treatment Phase|Withdrawal by Subject|0
1043696|NCT01773421|2079765|FG000|Extension Phase|Other|0
1043697|NCT01773421|2079766|FG001|Extension Phase|Other|0
1043698|NCT01773421|2079767|FG002|Extension Phase|Other|0
1043699|NCT01773421|2079768|FG003|Extension Phase|Other|0
1043700|NCT01773421|2079769|FG004|Extension Phase|Other|1
1043701|NCT01773421|2079770|FG005|Extension Phase|Other|2
1043702|NCT01773421|2079771|FG006|Extension Phase|Other|0
1043703|NCT01773421|2079765|FG000|Extension Phase|Adverse Event|0
1043704|NCT01773421|2079766|FG001|Extension Phase|Adverse Event|0
1043705|NCT01773421|2079767|FG002|Extension Phase|Adverse Event|0
1043706|NCT01773421|2079768|FG003|Extension Phase|Adverse Event|0
1043707|NCT01773421|2079769|FG004|Extension Phase|Adverse Event|2
1043708|NCT01773421|2079770|FG005|Extension Phase|Adverse Event|0
1043709|NCT01773421|2079771|FG006|Extension Phase|Adverse Event|0
1043710|NCT01773473|2079789|FG000|Overall Study|Adverse Event|3
1043711|NCT01773473|2079790|FG001|Overall Study|Adverse Event|2
1043712|NCT01773473|2079789|FG000|Overall Study|Protocol Violation|0
1043713|NCT01773473|2079790|FG001|Overall Study|Protocol Violation|4
1043714|NCT01773473|2079789|FG000|Overall Study|Physician Decision|3
1043715|NCT01773473|2079790|FG001|Overall Study|Physician Decision|5
1043716|NCT01773473|2079789|FG000|Overall Study|Sponsor Decision|2
1043717|NCT01773473|2079790|FG001|Overall Study|Sponsor Decision|0
1043718|NCT01773473|2079789|FG000|Overall Study|Lack of Efficacy|0
1043719|NCT01773473|2079790|FG001|Overall Study|Lack of Efficacy|1
1043720|NCT01773473|2079789|FG000|Overall Study|Non-Compliance with study drug|1
1043721|NCT01773473|2079790|FG001|Overall Study|Non-Compliance with study drug|4
1043722|NCT01773473|2079789|FG000|Overall Study|Withdrawal by Subject|5
1043723|NCT01773473|2079790|FG001|Overall Study|Withdrawal by Subject|3
1043724|NCT01773473|2079789|FG000|Overall Study|Lost to Follow-up|2
1043725|NCT01773473|2079790|FG001|Overall Study|Lost to Follow-up|0
1043726|NCT01773889|2079796|FG000|Overall Study|lack of funding|2
1043727|NCT01773967|2079806|FG000|Overall Study|Lost to Follow-up|15
1043728|NCT01773967|2079807|FG001|Overall Study|Lost to Follow-up|13
1043729|NCT01773993|2079813|FG000|Overall Study|No Visit After Treatment|35
1043730|NCT01774084|2079829|FG000|Overall Study|Personal reasons|1
1043731|NCT01774084|2079830|FG001|Overall Study|Personal reasons|0
1043732|NCT01774097|2079838|FG000|Overall Study|Withdrawal by Subject|1
1043733|NCT01774097|2079839|FG001|Overall Study|Withdrawal by Subject|1
1043734|NCT01774097|2079838|FG000|Overall Study|Adverse Event|1
1043735|NCT01774097|2079839|FG001|Overall Study|Adverse Event|1
1043736|NCT01774110|2079847|FG000|Overall Study|Lost to Follow-up|7
1043737|NCT01774253|2079861|FG000|Overall Study|Lack of Efficacy|4
1043738|NCT01774253|2079861|FG000|Overall Study|Physician Decision|2
1043739|NCT01774253|2079861|FG000|Overall Study|Withdrawal by Subject|2
1043740|NCT01774253|2079861|FG000|Overall Study|Death|1
1043741|NCT01774305|2079867|FG000|Overall Study|Physician Decision|1
1043742|NCT01774305|2079868|FG001|Overall Study|Physician Decision|0
1043743|NCT01774344|2079876|FG000|Overall Study|Withdrawal by Subject|3
1043744|NCT01774344|2079877|FG001|Overall Study|Withdrawal by Subject|10
1043745|NCT01774344|2079876|FG000|Overall Study|Protocol Violation|0
1043746|NCT01774344|2079877|FG001|Overall Study|Protocol Violation|1
1043747|NCT01774344|2079876|FG000|Overall Study|Lost to Follow-up|4
1043748|NCT01774344|2079877|FG001|Overall Study|Lost to Follow-up|10
1043749|NCT01774344|2079876|FG000|Overall Study|End of survival follow-up not available|2
1043750|NCT01774344|2079877|FG001|Overall Study|End of survival follow-up not available|2
1043751|NCT01774344|2079876|FG000|Overall Study|Data collection finished|4
1043752|NCT01774344|2079877|FG001|Overall Study|Data collection finished|14
1043753|NCT01774344|2079876|FG000|Overall Study|Other|0
1043754|NCT01774344|2079877|FG001|Overall Study|Other|1
1043755|NCT01774344|2079876|FG000|Overall Study|Did not enter Survival Follow up|49
1043756|NCT01774344|2079877|FG001|Overall Study|Did not enter Survival Follow up|83
1043757|NCT01774591|2079889|FG000|Overall Study|Physician Decision|1
1043758|NCT01774591|2079890|FG001|Overall Study|Physician Decision|1
1043759|NCT01774591|2079889|FG000|Overall Study|Withdrawal by Subject|0
1043760|NCT01774591|2079890|FG001|Overall Study|Withdrawal by Subject|1
1043761|NCT01774591|2079889|FG000|Overall Study|Adverse Event|0
1043762|NCT01774591|2079890|FG001|Overall Study|Adverse Event|2
1043763|NCT01774721|2079907|FG000|Overall Study|Death|76
1043764|NCT01774721|2079908|FG001|Overall Study|Death|91
1043765|NCT01774721|2079907|FG000|Overall Study|Withdrawal by Subject|14
1043766|NCT01774721|2079908|FG001|Overall Study|Withdrawal by Subject|10
1043767|NCT01774721|2079907|FG000|Overall Study|Lost to Follow-up|1
1043768|NCT01774721|2079908|FG001|Overall Study|Lost to Follow-up|1
1043769|NCT01774721|2079907|FG000|Overall Study|Did not meet eligibility criteria|0
1043770|NCT01774721|2079908|FG001|Overall Study|Did not meet eligibility criteria|3
1043771|NCT01774721|2079907|FG000|Overall Study|Ongoing in study|136
1043772|NCT01774721|2079908|FG001|Overall Study|Ongoing in study|120
1043773|NCT01774786|2079922|FG000|Overall Study|Death|300
1043774|NCT01774786|2079923|FG001|Overall Study|Death|319
1043775|NCT01774786|2079922|FG000|Overall Study|Lost to Follow-up|6
1043776|NCT01774786|2079923|FG001|Overall Study|Lost to Follow-up|7
1043777|NCT01774786|2079922|FG000|Overall Study|Withdrawal by Subject|18
1043778|NCT01774786|2079923|FG001|Overall Study|Withdrawal by Subject|14
1043779|NCT01774786|2079922|FG000|Overall Study|Physician Decision|2
1043780|NCT01774786|2079923|FG001|Overall Study|Physician Decision|0
1043781|NCT01774786|2079922|FG000|Overall Study|Non-compliance|0
1043782|NCT01774786|2079923|FG001|Overall Study|Non-compliance|1
1043783|NCT01774786|2079922|FG000|Overall Study|Reason Not Specified|2
1043784|NCT01774786|2079923|FG001|Overall Study|Reason Not Specified|5
1043785|NCT01774799|2079933|FG000|Overall Study|Lost to Follow-up|1
1043786|NCT01774799|2079934|FG001|Overall Study|Lost to Follow-up|1
1043787|NCT01774799|2079935|FG002|Overall Study|Lost to Follow-up|0
1043788|NCT01774799|2079936|FG003|Overall Study|Lost to Follow-up|0
1043789|NCT01774903|2079951|FG000|Overall Study|Adverse Event|7
1043790|NCT01774903|2079951|FG000|Overall Study|Withdrawal by Subject|2
1043791|NCT01774903|2079951|FG000|Overall Study|Lack of Efficacy|1
1043792|NCT01774903|2079951|FG000|Overall Study|Ineligible to continue the trial|1
1043793|NCT01774929|2079956|FG000|Overall Study|Adverse Event|3
1043794|NCT01774968|2079962|FG000|Overall Study|Adverse Event|4
1043795|NCT01774968|2079963|FG001|Overall Study|Adverse Event|4
1043796|NCT01774968|2079962|FG000|Overall Study|Death|0
1043797|NCT01774968|2079963|FG001|Overall Study|Death|1
1043798|NCT01774968|2079962|FG000|Overall Study|Lost to Follow-up|1
1043799|NCT01774968|2079963|FG001|Overall Study|Lost to Follow-up|3
1043800|NCT01774968|2079962|FG000|Overall Study|Physician Decision|5
1043801|NCT01774968|2079963|FG001|Overall Study|Physician Decision|1
1043802|NCT01774968|2079962|FG000|Overall Study|Protocol Violation|14
1043803|NCT01774968|2079963|FG001|Overall Study|Protocol Violation|13
1043804|NCT01774968|2079962|FG000|Overall Study|Sponsor Decision|0
1043805|NCT01774968|2079963|FG001|Overall Study|Sponsor Decision|2
1043806|NCT01774968|2079962|FG000|Overall Study|Withdrawal by Subject|6
1043807|NCT01774968|2079963|FG001|Overall Study|Withdrawal by Subject|11
1043808|NCT01774981|2079977|FG000|Overall Study|Adverse Event|0
1043809|NCT01774981|2079978|FG001|Overall Study|Adverse Event|0
1043810|NCT01774981|2079979|FG002|Overall Study|Adverse Event|0
1043811|NCT01774981|2079980|FG003|Overall Study|Adverse Event|0
1043812|NCT01774981|2079981|FG004|Overall Study|Adverse Event|0
1043813|NCT01774981|2079982|FG005|Overall Study|Adverse Event|1
1043814|NCT01774981|2079983|FG006|Overall Study|Adverse Event|0
1043815|NCT01774981|2079984|FG007|Overall Study|Adverse Event|0
1043816|NCT01774981|2079977|FG000|Overall Study|Withdrawal by Subject|0
1043817|NCT01774981|2079978|FG001|Overall Study|Withdrawal by Subject|0
1043818|NCT01774981|2079979|FG002|Overall Study|Withdrawal by Subject|0
1043819|NCT01774981|2079980|FG003|Overall Study|Withdrawal by Subject|0
1043820|NCT01774981|2079981|FG004|Overall Study|Withdrawal by Subject|0
1043821|NCT01774981|2079982|FG005|Overall Study|Withdrawal by Subject|0
1043822|NCT01774981|2079983|FG006|Overall Study|Withdrawal by Subject|0
1043823|NCT01774981|2079984|FG007|Overall Study|Withdrawal by Subject|1
1043824|NCT01774981|2079977|FG000|Overall Study|Death|0
1043825|NCT01774981|2079978|FG001|Overall Study|Death|0
1043826|NCT01774981|2079979|FG002|Overall Study|Death|0
1043827|NCT01774981|2079980|FG003|Overall Study|Death|0
1043828|NCT01774981|2079981|FG004|Overall Study|Death|1
1043829|NCT01774981|2079982|FG005|Overall Study|Death|0
1043830|NCT01774981|2079983|FG006|Overall Study|Death|0
1043831|NCT01774981|2079984|FG007|Overall Study|Death|0
1043832|NCT01775124|2080009|FG000|Core Period|Disease Progression|0
1043833|NCT01775124|2080010|FG001|Core Period|Disease Progression|1
1043834|NCT01775124|2080009|FG000|Core Period|Physician Decision|1
1043835|NCT01775124|2080010|FG001|Core Period|Physician Decision|1
1043836|NCT01775124|2080009|FG000|Core Period|Death|0
1043837|NCT01775124|2080010|FG001|Core Period|Death|1
1043838|NCT01775124|2080009|FG000|Core Period|Administrative problems|1
1043839|NCT01775124|2080010|FG001|Core Period|Administrative problems|0
1043840|NCT01775124|2080009|FG000|Core Period|Withdrawal by Subject|4
1043841|NCT01775124|2080010|FG001|Core Period|Withdrawal by Subject|2
1043842|NCT01775124|2080009|FG000|Core Period|Adverse Event|5
1043843|NCT01775124|2080010|FG001|Core Period|Adverse Event|5
1043844|NCT01775124|2080009|FG000|Extension Period|Adverse Event|3
1043845|NCT01775124|2080010|FG001|Extension Period|Adverse Event|2
1043846|NCT01775124|2080009|FG000|Extension Period|Physician Decision|0
1043847|NCT01775124|2080010|FG001|Extension Period|Physician Decision|2
1043848|NCT01775124|2080009|FG000|Extension Period|Administrative problems|0
1043849|NCT01775124|2080010|FG001|Extension Period|Administrative problems|1
1043850|NCT01775124|2080009|FG000|Extension Period|Lost to Follow-up|0
1043851|NCT01775124|2080010|FG001|Extension Period|Lost to Follow-up|1
1043852|NCT01775124|2080009|FG000|Extension Period|Withdrawal by Subject|9
1043853|NCT01775124|2080010|FG001|Extension Period|Withdrawal by Subject|12
1043854|NCT01775137|2080017|FG000|Overall Study|Death|1
1043855|NCT01775137|2080017|FG000|Overall Study|Protocol deviation|2
1043856|NCT01775137|2080017|FG000|Overall Study|Unsatisfactory therapeutic effect|2
1043857|NCT01775137|2080017|FG000|Overall Study|Adverse Event|1
1043858|NCT01775137|2080017|FG000|Overall Study|Withdrawal by participants|5
1043859|NCT01775189|2080024|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
1043860|NCT01775189|2080025|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
1043861|NCT01775189|2080026|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
1043862|NCT01775189|2080027|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
1043863|NCT01775189|2080028|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
1043864|NCT01775189|2080029|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
1043865|NCT01775189|2080030|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
1043866|NCT01775189|2080024|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
1043867|NCT01775189|2080025|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1
1043868|NCT01775189|2080026|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0
1043869|NCT01775189|2080027|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
1043870|NCT01775189|2080028|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
1043871|NCT01775189|2080029|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
1043872|NCT01775189|2080030|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
1043873|NCT01775189|2080024|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1043874|NCT01775189|2080025|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
1043875|NCT01775189|2080026|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
1043876|NCT01775189|2080027|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1043877|NCT01775189|2080028|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1043878|NCT01775189|2080029|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1043879|NCT01775189|2080030|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1043880|NCT01775189|2080024|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0
1043881|NCT01775189|2080025|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0
1043882|NCT01775189|2080026|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0
1043883|NCT01775189|2080027|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0
1043884|NCT01775189|2080028|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0
1043885|NCT01775189|2080029|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1
1043886|NCT01775189|2080030|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0
1043887|NCT01775189|2080024|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0
1043888|NCT01775189|2080025|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0
1043889|NCT01775189|2080026|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0
1043890|NCT01775189|2080027|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1
1043891|NCT01775189|2080028|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0
1043892|NCT01775189|2080029|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0
1043893|NCT01775189|2080030|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0
1043894|NCT01775189|2080024|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0
1043895|NCT01775189|2080025|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0
1043896|NCT01775189|2080026|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0
1043897|NCT01775189|2080027|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1
1043898|NCT01775189|2080028|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0
1043899|NCT01775189|2080029|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0
1043900|NCT01775189|2080030|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1
1043901|NCT01775501|2080073|FG000|Overall Study|Discontinued prior to treatment|1
1043902|NCT01775553|2080077|FG000|Overall Study|Adverse Event|1
1043903|NCT01775553|2080077|FG000|Overall Study|Disease Progression|12
1043904|NCT01775670|2080083|FG000|Overall Study|Lost to Follow-up|1
1043905|NCT01775670|2080084|FG001|Overall Study|Lost to Follow-up|1
1043906|NCT01775787|2080118|FG000|First 7-10 Days|Adverse Event|0
1043907|NCT01775787|2080119|FG001|First 7-10 Days|Adverse Event|1
1043908|NCT01775787|2080118|FG000|First 7-10 Days|family emergency|0
1043909|NCT01775787|2080119|FG001|First 7-10 Days|family emergency|1
1043910|NCT01775787|2080118|FG000|First 7-10 Days|time commitment|0
1043911|NCT01775787|2080119|FG001|First 7-10 Days|time commitment|2
1043912|NCT01775787|2080118|FG000|First 7-10 Days|concerns with using IV|1
1043913|NCT01775787|2080119|FG001|First 7-10 Days|concerns with using IV|2
1043914|NCT01775787|2080118|FG000|Second 7-10 Days|time commitment|0
1043915|NCT01775787|2080119|FG001|Second 7-10 Days|time commitment|1
1043916|NCT01775787|2080118|FG000|Second 7-10 Days|concerns with using IV|0
1043917|NCT01775787|2080119|FG001|Second 7-10 Days|concerns with using IV|1
1043918|NCT01775904|2080164|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
1043919|NCT01775904|2080164|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1
1043920|NCT01775930|2080174|FG000|Overall Study|Futility stopping boundary met|1
1043921|NCT01775995|2080180|FG000|Overall Study|Lost to Follow-up|1
1043922|NCT01775995|2080181|FG001|Overall Study|Lost to Follow-up|1
1043923|NCT01776008|2080187|FG000|Overall Study|ineligible|2
1043924|NCT01776307|2080204|FG000|Overall Study|Not dosed|0
1043925|NCT01776307|2080205|FG001|Overall Study|Not dosed|0
1043926|NCT01776307|2080206|FG002|Overall Study|Not dosed|1
1043927|NCT01776424|2080238|FG000|Overall Study|Lost to Follow-up|10
1043928|NCT01776424|2080239|FG001|Overall Study|Lost to Follow-up|8
1043929|NCT01776424|2080240|FG002|Overall Study|Lost to Follow-up|9
1043930|NCT01776424|2080238|FG000|Overall Study|Withdrawal by Subject|10
1043931|NCT01776424|2080239|FG001|Overall Study|Withdrawal by Subject|11
1043932|NCT01776424|2080240|FG002|Overall Study|Withdrawal by Subject|15
1043933|NCT01776541|2080250|FG000|Overall Study|Administrative Reason|6
1043934|NCT01776541|2080251|FG001|Overall Study|Administrative Reason|2
1043935|NCT01776541|2080250|FG000|Overall Study|Death|4
1043936|NCT01776541|2080251|FG001|Overall Study|Death|0
1043937|NCT01776541|2080250|FG000|Overall Study|Lost to Follow-up|27
1043938|NCT01776541|2080251|FG001|Overall Study|Lost to Follow-up|48
1043939|NCT01776541|2080250|FG000|Overall Study|Unclassified|5
1043940|NCT01776541|2080251|FG001|Overall Study|Unclassified|4
1043941|NCT01776541|2080250|FG000|Overall Study|Protocol Violation|2
1043942|NCT01776541|2080251|FG001|Overall Study|Protocol Violation|1
1043943|NCT01776541|2080250|FG000|Overall Study|Withdrawal by Subject|12
1043944|NCT01776541|2080251|FG001|Overall Study|Withdrawal by Subject|20
1043945|NCT01776554|2080260|FG000|Overall Study|Adverse Event|1
1043946|NCT01776554|2080261|FG001|Overall Study|Adverse Event|0
1043947|NCT01776554|2080260|FG000|Overall Study|Withdrawal by Subject|3
1043948|NCT01776554|2080261|FG001|Overall Study|Withdrawal by Subject|8
1043949|NCT01776554|2080260|FG000|Overall Study|Lost to Follow-up|6
1043950|NCT01776554|2080261|FG001|Overall Study|Lost to Follow-up|9
1043951|NCT01776554|2080260|FG000|Overall Study|Administrative Reason|2
1043952|NCT01776554|2080261|FG001|Overall Study|Administrative Reason|5
1043953|NCT01776554|2080260|FG000|Overall Study|Protocol Violation|1
1043954|NCT01776554|2080261|FG001|Overall Study|Protocol Violation|0
1043955|NCT01776554|2080260|FG000|Overall Study|Unclassified|4
1043956|NCT01776554|2080261|FG001|Overall Study|Unclassified|1
1043957|NCT01777139|2080321|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
1043958|NCT01777139|2080322|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
1043959|NCT01777139|2080321|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
1043960|NCT01777139|2080322|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
1043961|NCT01777139|2080321|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
1043962|NCT01777139|2080322|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
1043963|NCT01777139|2080321|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
1043964|NCT01777139|2080322|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
1043965|NCT01777139|2080321|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
1043966|NCT01777139|2080322|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
1043967|NCT01777139|2080321|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
1043968|NCT01777139|2080322|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
1043969|NCT01777139|2080321|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
1043970|NCT01777139|2080322|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
1043971|NCT01777139|2080321|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
1043972|NCT01777139|2080322|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
1043973|NCT01777152|2080331|FG000|Overall Study|Withdrawal by Subject|22
1043974|NCT01777152|2080332|FG001|Overall Study|Withdrawal by Subject|16
1043975|NCT01777152|2080331|FG000|Overall Study|Lost to Follow-up|3
1043976|NCT01777152|2080332|FG001|Overall Study|Lost to Follow-up|5
1043977|NCT01777152|2080331|FG000|Overall Study|Death|68
1043978|NCT01777152|2080332|FG001|Overall Study|Death|89
1043979|NCT01777152|2080331|FG000|Overall Study|Not eligible, no study drug received|1
1043980|NCT01777152|2080332|FG001|Overall Study|Not eligible, no study drug received|0
1043981|NCT01777152|2080331|FG000|Overall Study|Change of diagnosis|1
1043982|NCT01777152|2080332|FG001|Overall Study|Change of diagnosis|0
1043983|NCT01777191|2080341|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
1043984|NCT01777191|2080342|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
1043985|NCT01777191|2080341|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
1043986|NCT01777191|2080342|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
1162032|NCT03381196|2283977|FG001|Overall Study|Other|1
1043987|NCT01777191|2080341|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
1043988|NCT01777191|2080342|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
1043989|NCT01777191|2080341|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
1043990|NCT01777191|2080342|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
1043991|NCT01777191|2080341|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
1043992|NCT01777191|2080342|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
1043993|NCT01777191|2080341|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
1043994|NCT01777191|2080342|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
1043995|NCT01777191|2080341|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
1043996|NCT01777191|2080342|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
1043997|NCT01777191|2080341|FG000|Safety Extension Per (Week 12-Week 48)|Death|0
1043998|NCT01777191|2080342|FG001|Safety Extension Per (Week 12-Week 48)|Death|1
1043999|NCT01777191|2080341|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
1044000|NCT01777191|2080342|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
1044001|NCT01777191|2080341|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
1044002|NCT01777191|2080342|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
1044003|NCT01777191|2080341|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
1044004|NCT01777191|2080342|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
1044005|NCT01777269|2080362|FG000|Overall Study|Adverse Event|24
1044006|NCT01777269|2080363|FG001|Overall Study|Adverse Event|33
1044007|NCT01777269|2080362|FG000|Overall Study|Lack of Efficacy|8
1044008|NCT01777269|2080363|FG001|Overall Study|Lack of Efficacy|10
1044009|NCT01777269|2080362|FG000|Overall Study|Protocol Violation|4
1044010|NCT01777269|2080363|FG001|Overall Study|Protocol Violation|4
1044011|NCT01777269|2080362|FG000|Overall Study|Participants reached stopping criteria|1
1044012|NCT01777269|2080363|FG001|Overall Study|Participants reached stopping criteria|1
1044013|NCT01777269|2080362|FG000|Overall Study|Lost to Follow-up|4
1044014|NCT01777269|2080363|FG001|Overall Study|Lost to Follow-up|0
1044015|NCT01777269|2080362|FG000|Overall Study|Physician Decision|5
1044016|NCT01777269|2080363|FG001|Overall Study|Physician Decision|2
1044017|NCT01777269|2080362|FG000|Overall Study|Withdrawal by Subject|9
1044018|NCT01777269|2080363|FG001|Overall Study|Withdrawal by Subject|9
1044019|NCT01777282|2080374|FG000|Overall Study|Persistent Hyperglycemia|0
1044020|NCT01777282|2080375|FG001|Overall Study|Persistent Hyperglycemia|0
1044021|NCT01777282|2080376|FG002|Overall Study|Persistent Hyperglycemia|1
1044022|NCT01777282|2080377|FG003|Overall Study|Persistent Hyperglycemia|0
1044023|NCT01777282|2080378|FG004|Overall Study|Persistent Hyperglycemia|0
1044024|NCT01777282|2080374|FG000|Overall Study|New Antidiabetic Medication|0
1044025|NCT01777282|2080375|FG001|Overall Study|New Antidiabetic Medication|0
1044026|NCT01777282|2080376|FG002|Overall Study|New Antidiabetic Medication|1
1044027|NCT01777282|2080377|FG003|Overall Study|New Antidiabetic Medication|0
1044028|NCT01777282|2080378|FG004|Overall Study|New Antidiabetic Medication|0
1044029|NCT01777282|2080374|FG000|Overall Study|Adverse Event|4
1044030|NCT01777282|2080375|FG001|Overall Study|Adverse Event|4
1044031|NCT01777282|2080376|FG002|Overall Study|Adverse Event|2
1044032|NCT01777282|2080377|FG003|Overall Study|Adverse Event|1
1044033|NCT01777282|2080378|FG004|Overall Study|Adverse Event|3
1044034|NCT01777282|2080374|FG000|Overall Study|Withdrawal by Subject|4
1044035|NCT01777282|2080375|FG001|Overall Study|Withdrawal by Subject|0
1044036|NCT01777282|2080376|FG002|Overall Study|Withdrawal by Subject|0
1044037|NCT01777282|2080377|FG003|Overall Study|Withdrawal by Subject|1
1044038|NCT01777282|2080378|FG004|Overall Study|Withdrawal by Subject|2
1044039|NCT01777282|2080374|FG000|Overall Study|Protocol Violation|2
1044040|NCT01777282|2080375|FG001|Overall Study|Protocol Violation|0
1044041|NCT01777282|2080376|FG002|Overall Study|Protocol Violation|1
1044042|NCT01777282|2080377|FG003|Overall Study|Protocol Violation|0
1044043|NCT01777282|2080378|FG004|Overall Study|Protocol Violation|2
1044044|NCT01777282|2080374|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1
1044045|NCT01777282|2080375|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0
1044046|NCT01777282|2080376|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1
1044047|NCT01777282|2080377|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0
1044048|NCT01777282|2080378|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0
1044049|NCT01777308|2080411|FG000|Overall Study|Withdrawal by Subject|5
1044050|NCT01777308|2080412|FG001|Overall Study|Withdrawal by Subject|1
1044051|NCT01777308|2080411|FG000|Overall Study|Migrated/moved from study area|1
1044052|NCT01777308|2080412|FG001|Overall Study|Migrated/moved from study area|0
1044053|NCT01777308|2080411|FG000|Overall Study|Lost to Follow-up|7
1044054|NCT01777308|2080412|FG001|Overall Study|Lost to Follow-up|2
1044055|NCT01777308|2080411|FG000|Overall Study|Blood draw refusal at Visit 3|1
1044056|NCT01777308|2080412|FG001|Overall Study|Blood draw refusal at Visit 3|0
1044057|NCT01777321|2080421|FG000|Overall Study|Withdrawal by Subject|0
1044058|NCT01777321|2080422|FG001|Overall Study|Withdrawal by Subject|1
1044059|NCT01777334|2080430|FG000|Overall Study|Adverse Event|18
1044060|NCT01777334|2080431|FG001|Overall Study|Adverse Event|14
1044061|NCT01777334|2080430|FG000|Overall Study|Lack of Efficacy|15
1044062|NCT01777334|2080431|FG001|Overall Study|Lack of Efficacy|29
1044063|NCT01777334|2080430|FG000|Overall Study|Protocol Violation|3
1044064|NCT01777334|2080431|FG001|Overall Study|Protocol Violation|7
1044065|NCT01777334|2080430|FG000|Overall Study|Lost to Follow-up|3
1044066|NCT01777334|2080431|FG001|Overall Study|Lost to Follow-up|2
1044067|NCT01777334|2080430|FG000|Overall Study|Withdrawal by Subject|14
1044068|NCT01777334|2080431|FG001|Overall Study|Withdrawal by Subject|11
1044069|NCT01777490|2080459|FG000|Overall Study|Dyad withdrew with data use prohibition|0
1044070|NCT01777490|2080460|FG001|Overall Study|Dyad withdrew with data use prohibition|0
1044071|NCT01777490|2080461|FG002|Overall Study|Dyad withdrew with data use prohibition|1
1044072|NCT01777490|2080462|FG003|Overall Study|Dyad withdrew with data use prohibition|1
1044073|NCT01777542|2080474|FG000|Second Intervention (20 Weeks)|Adverse Event|0
1044074|NCT01777542|2080475|FG001|Second Intervention (20 Weeks)|Adverse Event|1
1044075|NCT01777581|2080493|FG000|Overall Study|Lost to Follow-up|1
1044076|NCT01777581|2080494|FG001|Overall Study|Lost to Follow-up|1
1044077|NCT01777581|2080493|FG000|Overall Study|Adverse Event|2
1044078|NCT01777581|2080494|FG001|Overall Study|Adverse Event|0
1044079|NCT01777581|2080493|FG000|Overall Study|Lack of Efficacy|0
1044080|NCT01777581|2080494|FG001|Overall Study|Lack of Efficacy|1
1044081|NCT01777620|2080502|FG000|Overall Study|Subject Withdrawal|1
1044082|NCT01777620|2080503|FG001|Overall Study|Subject Withdrawal|0
1044083|NCT01777763|2080511|FG000|Overall Study|Adverse Event|2
1044084|NCT01777763|2080512|FG001|Overall Study|Adverse Event|32
1044085|NCT01777763|2080511|FG000|Overall Study|Protocol Violation|1
1044086|NCT01777763|2080512|FG001|Overall Study|Protocol Violation|7
1044087|NCT01777763|2080511|FG000|Overall Study|Withdrawal by Subject|0
1044088|NCT01777763|2080512|FG001|Overall Study|Withdrawal by Subject|2
1044089|NCT01777763|2080511|FG000|Overall Study|Treatment Failure|1
1044090|NCT01777763|2080512|FG001|Overall Study|Treatment Failure|6
1044091|NCT01777776|2080522|FG000|Overall Study|Adverse Event|2
1044092|NCT01777776|2080523|FG001|Overall Study|Adverse Event|4
1044093|NCT01777776|2080524|FG002|Overall Study|Adverse Event|0
1044094|NCT01777776|2080525|FG003|Overall Study|Adverse Event|0
1044095|NCT01777776|2080522|FG000|Overall Study|Disease Progression|4
1044096|NCT01777776|2080523|FG001|Overall Study|Disease Progression|8
1044097|NCT01777776|2080524|FG002|Overall Study|Disease Progression|6
1044098|NCT01777776|2080525|FG003|Overall Study|Disease Progression|3
1044099|NCT01777776|2080522|FG000|Overall Study|Withdrawal by Subject|0
1044100|NCT01777776|2080523|FG001|Overall Study|Withdrawal by Subject|0
1044101|NCT01777776|2080524|FG002|Overall Study|Withdrawal by Subject|0
1044102|NCT01777776|2080525|FG003|Overall Study|Withdrawal by Subject|1
1044103|NCT01777932|2080544|FG000|Overall Study|Disease progression|136
1044104|NCT01777932|2080544|FG000|Overall Study|Death|3
1044105|NCT01777932|2080544|FG000|Overall Study|Adverse Event|34
1044106|NCT01777932|2080544|FG000|Overall Study|Lost to Follow-up|3
1044107|NCT01777932|2080544|FG000|Overall Study|Investigator decision|10
1044108|NCT01777932|2080544|FG000|Overall Study|Reimbursement limit|9
1044109|NCT01777932|2080544|FG000|Overall Study|Patient refused further treatment|10
1044110|NCT01777997|2080552|FG000|12 Week lead-in of no ART|Severe debilitation|2
1044111|NCT01777997|2080552|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
1044112|NCT01777997|2080552|FG000|Weeks 48 to 72/96 on ART|Death|1
1044113|NCT01777997|2080552|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
1044114|NCT01778010|2080556|FG000|Overall Study|Withdrawal by Subject|2
1044115|NCT01778010|2080556|FG000|Overall Study|abnormal ECG before meds|1
1044116|NCT01778010|2080556|FG000|Overall Study|Arrested|1
1044117|NCT01778010|2080556|FG000|Overall Study|rash while on placebo|1
1044118|NCT01778023|2080575|FG000|Overall Study|Withdrawal by Subject|0
1044119|NCT01778023|2080576|FG001|Overall Study|Withdrawal by Subject|3
1044120|NCT01778049|2080584|FG000|Open Label Treatment Period|Adverse Event|5
1044121|NCT01778049|2080585|FG001|Open Label Treatment Period|Adverse Event|15
1044122|NCT01778049|2080586|FG002|Open Label Treatment Period|Adverse Event|0
1044123|NCT01778049|2080587|FG003|Open Label Treatment Period|Adverse Event|0
1044124|NCT01778049|2080588|FG004|Open Label Treatment Period|Adverse Event|0
1044125|NCT01778049|2080589|FG005|Open Label Treatment Period|Adverse Event|0
1044126|NCT01778049|2080584|FG000|Open Label Treatment Period|Lack of Efficacy|1
1044127|NCT01778049|2080585|FG001|Open Label Treatment Period|Lack of Efficacy|1
1044128|NCT01778049|2080586|FG002|Open Label Treatment Period|Lack of Efficacy|0
1044129|NCT01778049|2080587|FG003|Open Label Treatment Period|Lack of Efficacy|0
1044130|NCT01778049|2080588|FG004|Open Label Treatment Period|Lack of Efficacy|0
1044131|NCT01778049|2080589|FG005|Open Label Treatment Period|Lack of Efficacy|0
1044132|NCT01778049|2080584|FG000|Open Label Treatment Period|Protocol Violation|5
1044133|NCT01778049|2080585|FG001|Open Label Treatment Period|Protocol Violation|5
1044134|NCT01778049|2080586|FG002|Open Label Treatment Period|Protocol Violation|0
1044135|NCT01778049|2080587|FG003|Open Label Treatment Period|Protocol Violation|0
1044136|NCT01778049|2080588|FG004|Open Label Treatment Period|Protocol Violation|0
1044137|NCT01778049|2080589|FG005|Open Label Treatment Period|Protocol Violation|0
1044138|NCT01778049|2080584|FG000|Open Label Treatment Period|Lost to Follow-up|4
1044139|NCT01778049|2080585|FG001|Open Label Treatment Period|Lost to Follow-up|3
1044140|NCT01778049|2080586|FG002|Open Label Treatment Period|Lost to Follow-up|0
1044141|NCT01778049|2080587|FG003|Open Label Treatment Period|Lost to Follow-up|0
1044142|NCT01778049|2080588|FG004|Open Label Treatment Period|Lost to Follow-up|0
1044143|NCT01778049|2080589|FG005|Open Label Treatment Period|Lost to Follow-up|0
1044144|NCT01778049|2080584|FG000|Open Label Treatment Period|Withdrawal by Subject|4
1044145|NCT01778049|2080585|FG001|Open Label Treatment Period|Withdrawal by Subject|10
1044146|NCT01778049|2080586|FG002|Open Label Treatment Period|Withdrawal by Subject|0
1044147|NCT01778049|2080587|FG003|Open Label Treatment Period|Withdrawal by Subject|0
1044148|NCT01778049|2080588|FG004|Open Label Treatment Period|Withdrawal by Subject|0
1044149|NCT01778049|2080589|FG005|Open Label Treatment Period|Withdrawal by Subject|0
1044150|NCT01778049|2080584|FG000|Open Label Treatment Period|Not treated|2
1044151|NCT01778049|2080585|FG001|Open Label Treatment Period|Not treated|1
1044152|NCT01778049|2080586|FG002|Open Label Treatment Period|Not treated|0
1044153|NCT01778049|2080587|FG003|Open Label Treatment Period|Not treated|0
1044154|NCT01778049|2080588|FG004|Open Label Treatment Period|Not treated|0
1044155|NCT01778049|2080589|FG005|Open Label Treatment Period|Not treated|0
1044156|NCT01778049|2080584|FG000|Open Label Treatment Period|Other reason not defined above|77
1044157|NCT01778049|2080585|FG001|Open Label Treatment Period|Other reason not defined above|94
1044158|NCT01778049|2080586|FG002|Open Label Treatment Period|Other reason not defined above|0
1044159|NCT01778049|2080587|FG003|Open Label Treatment Period|Other reason not defined above|0
1044160|NCT01778049|2080588|FG004|Open Label Treatment Period|Other reason not defined above|0
1044161|NCT01778049|2080589|FG005|Open Label Treatment Period|Other reason not defined above|0
1044162|NCT01778049|2080584|FG000|Double Blind Treatment Period|Adverse Event|0
1044163|NCT01778049|2080585|FG001|Double Blind Treatment Period|Adverse Event|0
1044164|NCT01778049|2080586|FG002|Double Blind Treatment Period|Adverse Event|4
1044165|NCT01778049|2080587|FG003|Double Blind Treatment Period|Adverse Event|5
1044166|NCT01778049|2080588|FG004|Double Blind Treatment Period|Adverse Event|3
1044167|NCT01778049|2080589|FG005|Double Blind Treatment Period|Adverse Event|2
1044168|NCT01778049|2080584|FG000|Double Blind Treatment Period|Lack of Efficacy|0
1044169|NCT01778049|2080585|FG001|Double Blind Treatment Period|Lack of Efficacy|0
1044170|NCT01778049|2080586|FG002|Double Blind Treatment Period|Lack of Efficacy|0
1044171|NCT01778049|2080587|FG003|Double Blind Treatment Period|Lack of Efficacy|0
1044172|NCT01778049|2080588|FG004|Double Blind Treatment Period|Lack of Efficacy|0
1044173|NCT01778049|2080589|FG005|Double Blind Treatment Period|Lack of Efficacy|1
1044174|NCT01778049|2080584|FG000|Double Blind Treatment Period|Protocol Violation|0
1044175|NCT01778049|2080585|FG001|Double Blind Treatment Period|Protocol Violation|0
1044176|NCT01778049|2080586|FG002|Double Blind Treatment Period|Protocol Violation|2
1044177|NCT01778049|2080587|FG003|Double Blind Treatment Period|Protocol Violation|0
1044178|NCT01778049|2080588|FG004|Double Blind Treatment Period|Protocol Violation|0
1044179|NCT01778049|2080589|FG005|Double Blind Treatment Period|Protocol Violation|0
1044180|NCT01778049|2080584|FG000|Double Blind Treatment Period|Lost to Follow-up|0
1044181|NCT01778049|2080585|FG001|Double Blind Treatment Period|Lost to Follow-up|0
1044182|NCT01778049|2080586|FG002|Double Blind Treatment Period|Lost to Follow-up|4
1044183|NCT01778049|2080587|FG003|Double Blind Treatment Period|Lost to Follow-up|1
1044184|NCT01778049|2080588|FG004|Double Blind Treatment Period|Lost to Follow-up|5
1044185|NCT01778049|2080589|FG005|Double Blind Treatment Period|Lost to Follow-up|2
1044186|NCT01778049|2080584|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
1044187|NCT01778049|2080585|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
1044188|NCT01778049|2080586|FG002|Double Blind Treatment Period|Withdrawal by Subject|1
1044189|NCT01778049|2080587|FG003|Double Blind Treatment Period|Withdrawal by Subject|2
1044190|NCT01778049|2080588|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
1044191|NCT01778049|2080589|FG005|Double Blind Treatment Period|Withdrawal by Subject|1
1044192|NCT01778049|2080584|FG000|Double Blind Treatment Period|Not treated|0
1044193|NCT01778049|2080585|FG001|Double Blind Treatment Period|Not treated|0
1044194|NCT01778049|2080586|FG002|Double Blind Treatment Period|Not treated|0
1044195|NCT01778049|2080587|FG003|Double Blind Treatment Period|Not treated|2
1044196|NCT01778049|2080588|FG004|Double Blind Treatment Period|Not treated|2
1044197|NCT01778049|2080589|FG005|Double Blind Treatment Period|Not treated|0
1044198|NCT01778049|2080584|FG000|Double Blind Treatment Period|Other reason not defined above|0
1044199|NCT01778049|2080585|FG001|Double Blind Treatment Period|Other reason not defined above|0
1044200|NCT01778049|2080586|FG002|Double Blind Treatment Period|Other reason not defined above|4
1044201|NCT01778049|2080587|FG003|Double Blind Treatment Period|Other reason not defined above|2
1044202|NCT01778049|2080588|FG004|Double Blind Treatment Period|Other reason not defined above|2
1044203|NCT01778049|2080589|FG005|Double Blind Treatment Period|Other reason not defined above|1
1044204|NCT01778062|2080603|FG000|Overall Study|Adverse Event|1
1044205|NCT01778062|2080604|FG001|Overall Study|Adverse Event|3
1044206|NCT01778062|2080603|FG000|Overall Study|Consent Withdrawal|1
1044207|NCT01778062|2080604|FG001|Overall Study|Consent Withdrawal|5
1044208|NCT01778062|2080603|FG000|Overall Study|major protocol deviation|4
1044209|NCT01778062|2080604|FG001|Overall Study|major protocol deviation|3
1044210|NCT01778127|2080613|FG000|Overall Study|Lost to Follow-up|5
1044211|NCT01778127|2080614|FG001|Overall Study|Lost to Follow-up|1
1044212|NCT01778127|2080615|FG002|Overall Study|Lost to Follow-up|2
1044213|NCT01778127|2080613|FG000|Overall Study|Withdrawal by Subject|3
1044214|NCT01778127|2080614|FG001|Overall Study|Withdrawal by Subject|1
1044215|NCT01778127|2080615|FG002|Overall Study|Withdrawal by Subject|4
1044216|NCT01778530|2080658|FG000|Overall Study|Progression on study|1
1044217|NCT01778530|2080658|FG000|Overall Study|Adverse event/side effect|1
1044218|NCT01778556|2080664|FG000|Intervention 1 (5 Days)|Protocol Violation|0
1044219|NCT01778556|2080665|FG001|Intervention 1 (5 Days)|Protocol Violation|1
1044220|NCT01778556|2080664|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
1044221|NCT01778556|2080665|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1
1044222|NCT01778556|2080664|FG000|Intervention 2 (14 Days)|Protocol Violation|1
1044223|NCT01778556|2080665|FG001|Intervention 2 (14 Days)|Protocol Violation|0
1044224|NCT01778556|2080664|FG000|Long-term Follow-up|noncompliance with metreleptin|1
1044225|NCT01778556|2080665|FG001|Long-term Follow-up|noncompliance with metreleptin|0
1044226|NCT01778751|2080686|FG000|Overall Study|Lost to Follow-up|1
1044227|NCT01778751|2080687|FG001|Overall Study|Lost to Follow-up|0
1044228|NCT01778751|2080686|FG000|Overall Study|Withdrawal by Subject|0
1044229|NCT01778751|2080687|FG001|Overall Study|Withdrawal by Subject|2
1044230|NCT01778751|2080686|FG000|Overall Study|Transfered care|1
1044231|NCT01778751|2080687|FG001|Overall Study|Transfered care|0
1044232|NCT01778855|2080695|FG000|Overall Study|Death|0
1044233|NCT01778855|2080696|FG001|Overall Study|Death|1
1044234|NCT01778985|2080704|FG000|Overall Study|Lost to Follow-up|1
1044235|NCT01778985|2080705|FG001|Overall Study|Lost to Follow-up|0
1044236|NCT01778985|2080704|FG000|Overall Study|Physician Decision|2
1044237|NCT01778985|2080705|FG001|Overall Study|Physician Decision|2
1044238|NCT01778985|2080704|FG000|Overall Study|Protocol Violation|4
1044239|NCT01778985|2080705|FG001|Overall Study|Protocol Violation|1
1044240|NCT01779440|2080748|FG000|Overall Study|Withdrawal by Subject|3
1044241|NCT01779440|2080749|FG001|Overall Study|Withdrawal by Subject|5
1044242|NCT01779648|2080757|FG000|Overall Study|Protocol Violation|1
1044243|NCT01779648|2080758|FG001|Overall Study|Protocol Violation|0
1044244|NCT01779700|2080766|FG000|Overall Study|Adverse Event|4
1044245|NCT01779700|2080767|FG001|Overall Study|Adverse Event|3
1044246|NCT01779700|2080766|FG000|Overall Study|Withdrawal by Subject|0
1044247|NCT01779700|2080767|FG001|Overall Study|Withdrawal by Subject|2
1044248|NCT01779856|2080773|FG000|Overall Study|Withdrawal by Subject|15
1044249|NCT01779856|2080773|FG000|Overall Study|Death|3
1044250|NCT01779856|2080773|FG000|Overall Study|Physician Decision|1
1044251|NCT01779856|2080773|FG000|Overall Study|Inclusion/Exclusion Not Met|2
1044252|NCT01779856|2080773|FG000|Overall Study|Delays in scheduling implant|1
1044253|NCT01779856|2080773|FG000|Overall Study|Subject ineligible for Implant|2
1044254|NCT01779869|2080784|FG000|Overall Study|Physician Decision|2
1044255|NCT01780389|2080810|FG000|Overall Study|Adverse Event|1
1044256|NCT01780506|2080821|FG000|Double-Blind Phase|Randomized but not Treated|3
1044257|NCT01780506|2080822|FG001|Double-Blind Phase|Randomized but not Treated|2
1044258|NCT01780506|2080821|FG000|Double-Blind Phase|Adverse Event|4
1044259|NCT01780506|2080822|FG001|Double-Blind Phase|Adverse Event|14
1044260|NCT01780506|2080821|FG000|Double-Blind Phase|Death|1
1044261|NCT01780506|2080822|FG001|Double-Blind Phase|Death|2
1044262|NCT01780506|2080821|FG000|Double-Blind Phase|Pregnancy|2
1044263|NCT01780506|2080822|FG001|Double-Blind Phase|Pregnancy|1
1044264|NCT01780506|2080821|FG000|Double-Blind Phase|Lack of Efficacy|1
1044265|NCT01780506|2080822|FG001|Double-Blind Phase|Lack of Efficacy|1
1044266|NCT01780506|2080821|FG000|Double-Blind Phase|Investigator's Discretion|5
1044267|NCT01780506|2080822|FG001|Double-Blind Phase|Investigator's Discretion|2
1044268|NCT01780506|2080821|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
1044269|NCT01780506|2080822|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3
1044270|NCT01780506|2080821|FG000|Double-Blind Phase|Protocol Violation|4
1044271|NCT01780506|2080822|FG001|Double-Blind Phase|Protocol Violation|3
1044272|NCT01780506|2080821|FG000|Double-Blind Phase|Withdrew Consent|23
1044273|NCT01780506|2080822|FG001|Double-Blind Phase|Withdrew Consent|24
1044274|NCT01780506|2080821|FG000|Double-Blind Phase|Lost to Follow-up|23
1044275|NCT01780506|2080822|FG001|Double-Blind Phase|Lost to Follow-up|26
1044276|NCT01780506|2080821|FG000|Open-Label Extension Phase|Enrolled but not Treated|0
1044277|NCT01780506|2080822|FG001|Open-Label Extension Phase|Enrolled but not Treated|1
1044278|NCT01780545|2080832|FG000|Overall Study|Withdrawal by Subject|3
1044279|NCT01780545|2080833|FG001|Overall Study|Withdrawal by Subject|1
1044280|NCT01780545|2080832|FG000|Overall Study|Lost to Follow-up|1
1044281|NCT01780545|2080833|FG001|Overall Study|Lost to Follow-up|1
1044282|NCT01780584|2080845|FG000|Overall Study|Death|1
1044283|NCT01780584|2080846|FG001|Overall Study|Death|0
1044284|NCT01780584|2080847|FG002|Overall Study|Death|1
1044285|NCT01780584|2080845|FG000|Overall Study|Adverse Event|0
1044286|NCT01780584|2080846|FG001|Overall Study|Adverse Event|1
1044287|NCT01780584|2080847|FG002|Overall Study|Adverse Event|0
1044288|NCT01780584|2080845|FG000|Overall Study|Protocol Violation|0
1044289|NCT01780584|2080846|FG001|Overall Study|Protocol Violation|0
1044290|NCT01780584|2080847|FG002|Overall Study|Protocol Violation|1
1044291|NCT01780662|2080858|FG000|Overall Study|Adverse Event|1
1044292|NCT01780662|2080859|FG001|Overall Study|Adverse Event|0
1044293|NCT01780662|2080860|FG002|Overall Study|Adverse Event|2
1044294|NCT01780662|2080858|FG000|Overall Study|Physician Decision|0
1044295|NCT01780662|2080859|FG001|Overall Study|Physician Decision|5
1044296|NCT01780662|2080860|FG002|Overall Study|Physician Decision|7
1044297|NCT01780662|2080858|FG000|Overall Study|Protocol Violation|0
1044298|NCT01780662|2080859|FG001|Overall Study|Protocol Violation|1
1044299|NCT01780662|2080860|FG002|Overall Study|Protocol Violation|0
1044300|NCT01780662|2080858|FG000|Overall Study|Ineligible|0
1044301|NCT01780662|2080859|FG001|Overall Study|Ineligible|0
1044302|NCT01780662|2080860|FG002|Overall Study|Ineligible|1
1044303|NCT01780831|2080873|FG000|Overall Study|Withdrawal by Subject|0
1044304|NCT01780831|2080874|FG001|Overall Study|Withdrawal by Subject|0
1044305|NCT01780831|2080875|FG002|Overall Study|Withdrawal by Subject|4
1044306|NCT01780831|2080876|FG003|Overall Study|Withdrawal by Subject|0
1044307|NCT01780831|2080873|FG000|Overall Study|Lost to Follow-up|0
1044308|NCT01780831|2080874|FG001|Overall Study|Lost to Follow-up|0
1044309|NCT01780831|2080875|FG002|Overall Study|Lost to Follow-up|0
1044310|NCT01780831|2080876|FG003|Overall Study|Lost to Follow-up|1
1044311|NCT01780935|2080957|FG000|Overall Study|Admin problems due to early termination|321
1044312|NCT01780935|2080958|FG001|Overall Study|Admin problems due to early termination|309
1044313|NCT01780935|2080957|FG000|Overall Study|Adverse Event|2
1044314|NCT01780935|2080958|FG001|Overall Study|Adverse Event|4
1044315|NCT01780935|2080957|FG000|Overall Study|Death|1
1044316|NCT01780935|2080958|FG001|Overall Study|Death|6
1044317|NCT01780935|2080957|FG000|Overall Study|Lost to Follow-up|2
1044318|NCT01780935|2080958|FG001|Overall Study|Lost to Follow-up|6
1044319|NCT01780935|2080957|FG000|Overall Study|Physician Decision|1
1044320|NCT01780935|2080958|FG001|Overall Study|Physician Decision|1
1044321|NCT01780935|2080957|FG000|Overall Study|Protocol deviation|0
1044322|NCT01780935|2080958|FG001|Overall Study|Protocol deviation|1
1044323|NCT01780935|2080957|FG000|Overall Study|Patient withdrew consent|8
1044324|NCT01780935|2080958|FG001|Overall Study|Patient withdrew consent|9
1044325|NCT01780974|2080966|FG000|Overall Study|Death|1
1044326|NCT01780974|2080967|FG001|Overall Study|Death|0
1044327|NCT01780974|2080966|FG000|Overall Study|Adverse Event|1
1044328|NCT01780974|2080967|FG001|Overall Study|Adverse Event|3
1044329|NCT01780987|2080975|FG000|Overall Study|Adverse Event|0
1044330|NCT01780987|2080976|FG001|Overall Study|Adverse Event|4
1044331|NCT01780987|2080975|FG000|Overall Study|Withdrawal by Subject|2
1044332|NCT01780987|2080976|FG001|Overall Study|Withdrawal by Subject|0
1044333|NCT01780987|2080975|FG000|Overall Study|Request of Changing Hospital|0
1044334|NCT01780987|2080976|FG001|Overall Study|Request of Changing Hospital|1
1044335|NCT01780987|2080975|FG000|Overall Study|Changing Residence|1
1044336|NCT01780987|2080976|FG001|Overall Study|Changing Residence|0
1044337|NCT01780987|2080975|FG000|Overall Study|Not Receiving any Study Medication|0
1044338|NCT01780987|2080976|FG001|Overall Study|Not Receiving any Study Medication|1
1044339|NCT01781234|2081011|FG000|Overall Study|Adverse Event|2
1044340|NCT01781234|2081012|FG001|Overall Study|Adverse Event|0
1044341|NCT01781234|2081011|FG000|Overall Study|Protocol Violation|3
1044342|NCT01781234|2081012|FG001|Overall Study|Protocol Violation|0
1044343|NCT01781234|2081011|FG000|Overall Study|Withdrawal by Subject|4
1044344|NCT01781234|2081012|FG001|Overall Study|Withdrawal by Subject|3
1044345|NCT01781286|2081020|FG000|Overall Study|Lost to Follow-up|0
1044346|NCT01781286|2081021|FG001|Overall Study|Lost to Follow-up|0
1044347|NCT01781286|2081022|FG002|Overall Study|Lost to Follow-up|0
1044348|NCT01781286|2081023|FG003|Overall Study|Lost to Follow-up|0
1044349|NCT01781286|2081024|FG004|Overall Study|Lost to Follow-up|0
1044350|NCT01781286|2081025|FG005|Overall Study|Lost to Follow-up|1
1044351|NCT01781286|2081020|FG000|Overall Study|Time Constraints|2
1044352|NCT01781286|2081021|FG001|Overall Study|Time Constraints|0
1044353|NCT01781286|2081022|FG002|Overall Study|Time Constraints|2
1044354|NCT01781286|2081023|FG003|Overall Study|Time Constraints|0
1044355|NCT01781286|2081024|FG004|Overall Study|Time Constraints|0
1044356|NCT01781286|2081025|FG005|Overall Study|Time Constraints|0
1044357|NCT01781286|2081020|FG000|Overall Study|Noncompliance|0
1044358|NCT01781286|2081021|FG001|Overall Study|Noncompliance|0
1044359|NCT01781286|2081022|FG002|Overall Study|Noncompliance|0
1044360|NCT01781286|2081023|FG003|Overall Study|Noncompliance|1
1044361|NCT01781286|2081024|FG004|Overall Study|Noncompliance|0
1044362|NCT01781286|2081025|FG005|Overall Study|Noncompliance|0
1044363|NCT01781299|2081037|FG000|Overall Study|Withdrawal by Subject|0
1044364|NCT01781299|2081038|FG001|Overall Study|Withdrawal by Subject|1
1044365|NCT01781429|2081071|FG000|Overall Study|Death|0
1044366|NCT01781429|2081072|FG001|Overall Study|Death|0
1044367|NCT01781429|2081073|FG002|Overall Study|Death|0
1044368|NCT01781429|2081074|FG003|Overall Study|Death|0
1044369|NCT01781429|2081075|FG004|Overall Study|Death|0
1044370|NCT01781429|2081076|FG005|Overall Study|Death|0
1044371|NCT01781429|2081077|FG006|Overall Study|Death|0
1044372|NCT01781429|2081078|FG007|Overall Study|Death|0
1044373|NCT01781429|2081079|FG008|Overall Study|Death|0
1044374|NCT01781429|2081080|FG009|Overall Study|Death|1
1044375|NCT01781429|2081081|FG010|Overall Study|Death|0
1044376|NCT01781429|2081082|FG011|Overall Study|Death|0
1044377|NCT01781429|2081083|FG012|Overall Study|Death|1
1044378|NCT01781429|2081084|FG013|Overall Study|Death|0
1044379|NCT01781429|2081085|FG014|Overall Study|Death|1
1044380|NCT01781429|2081086|FG015|Overall Study|Death|0
1044381|NCT01781429|2081071|FG000|Overall Study|Withdrawal by Subject|0
1044382|NCT01781429|2081072|FG001|Overall Study|Withdrawal by Subject|0
1044383|NCT01781429|2081073|FG002|Overall Study|Withdrawal by Subject|0
1044384|NCT01781429|2081074|FG003|Overall Study|Withdrawal by Subject|0
1044385|NCT01781429|2081075|FG004|Overall Study|Withdrawal by Subject|0
1044386|NCT01781429|2081076|FG005|Overall Study|Withdrawal by Subject|0
1044387|NCT01781429|2081077|FG006|Overall Study|Withdrawal by Subject|0
1044388|NCT01781429|2081078|FG007|Overall Study|Withdrawal by Subject|0
1044389|NCT01781429|2081079|FG008|Overall Study|Withdrawal by Subject|1
1044390|NCT01781429|2081080|FG009|Overall Study|Withdrawal by Subject|3
1044391|NCT01781429|2081081|FG010|Overall Study|Withdrawal by Subject|1
1044392|NCT01781429|2081082|FG011|Overall Study|Withdrawal by Subject|1
1044393|NCT01781429|2081083|FG012|Overall Study|Withdrawal by Subject|5
1044394|NCT01781429|2081084|FG013|Overall Study|Withdrawal by Subject|2
1044395|NCT01781429|2081085|FG014|Overall Study|Withdrawal by Subject|3
1044396|NCT01781429|2081086|FG015|Overall Study|Withdrawal by Subject|0
1044397|NCT01781429|2081071|FG000|Overall Study|Disease Progression|1
1044398|NCT01781429|2081072|FG001|Overall Study|Disease Progression|0
1044399|NCT01781429|2081073|FG002|Overall Study|Disease Progression|1
1044400|NCT01781429|2081074|FG003|Overall Study|Disease Progression|1
1044401|NCT01781429|2081075|FG004|Overall Study|Disease Progression|1
1044402|NCT01781429|2081076|FG005|Overall Study|Disease Progression|4
1044403|NCT01781429|2081077|FG006|Overall Study|Disease Progression|7
1044404|NCT01781429|2081078|FG007|Overall Study|Disease Progression|4
1044405|NCT01781429|2081079|FG008|Overall Study|Disease Progression|6
1044406|NCT01781429|2081080|FG009|Overall Study|Disease Progression|15
1044407|NCT01781429|2081081|FG010|Overall Study|Disease Progression|15
1044408|NCT01781429|2081082|FG011|Overall Study|Disease Progression|15
1044409|NCT01781429|2081083|FG012|Overall Study|Disease Progression|15
1044410|NCT01781429|2081084|FG013|Overall Study|Disease Progression|4
1044411|NCT01781429|2081085|FG014|Overall Study|Disease Progression|11
1044412|NCT01781429|2081086|FG015|Overall Study|Disease Progression|0
1044413|NCT01781429|2081071|FG000|Overall Study|Unacceptable Toxicity|0
1044414|NCT01781429|2081072|FG001|Overall Study|Unacceptable Toxicity|0
1044415|NCT01781429|2081073|FG002|Overall Study|Unacceptable Toxicity|0
1044416|NCT01781429|2081074|FG003|Overall Study|Unacceptable Toxicity|0
1044417|NCT01781429|2081075|FG004|Overall Study|Unacceptable Toxicity|0
1044418|NCT01781429|2081076|FG005|Overall Study|Unacceptable Toxicity|0
1044419|NCT01781429|2081077|FG006|Overall Study|Unacceptable Toxicity|0
1044420|NCT01781429|2081078|FG007|Overall Study|Unacceptable Toxicity|0
1044421|NCT01781429|2081079|FG008|Overall Study|Unacceptable Toxicity|0
1044422|NCT01781429|2081080|FG009|Overall Study|Unacceptable Toxicity|0
1044423|NCT01781429|2081081|FG010|Overall Study|Unacceptable Toxicity|0
1044424|NCT01781429|2081082|FG011|Overall Study|Unacceptable Toxicity|2
1044425|NCT01781429|2081083|FG012|Overall Study|Unacceptable Toxicity|0
1044426|NCT01781429|2081084|FG013|Overall Study|Unacceptable Toxicity|0
1044427|NCT01781429|2081085|FG014|Overall Study|Unacceptable Toxicity|0
1044428|NCT01781429|2081086|FG015|Overall Study|Unacceptable Toxicity|0
1044429|NCT01781429|2081071|FG000|Overall Study|Patient Condition Changed|0
1044430|NCT01781429|2081072|FG001|Overall Study|Patient Condition Changed|0
1044431|NCT01781429|2081073|FG002|Overall Study|Patient Condition Changed|0
1044432|NCT01781429|2081074|FG003|Overall Study|Patient Condition Changed|0
1044433|NCT01781429|2081075|FG004|Overall Study|Patient Condition Changed|0
1044434|NCT01781429|2081076|FG005|Overall Study|Patient Condition Changed|0
1044435|NCT01781429|2081077|FG006|Overall Study|Patient Condition Changed|0
1044436|NCT01781429|2081078|FG007|Overall Study|Patient Condition Changed|0
1044437|NCT01781429|2081079|FG008|Overall Study|Patient Condition Changed|0
1044438|NCT01781429|2081080|FG009|Overall Study|Patient Condition Changed|4
1044439|NCT01781429|2081081|FG010|Overall Study|Patient Condition Changed|0
1044440|NCT01781429|2081082|FG011|Overall Study|Patient Condition Changed|1
1044441|NCT01781429|2081083|FG012|Overall Study|Patient Condition Changed|0
1044442|NCT01781429|2081084|FG013|Overall Study|Patient Condition Changed|1
1044443|NCT01781429|2081085|FG014|Overall Study|Patient Condition Changed|0
1044444|NCT01781429|2081086|FG015|Overall Study|Patient Condition Changed|0
1044445|NCT01781429|2081071|FG000|Overall Study|Other - as entered by PI in eCRF|0
1044446|NCT01781429|2081072|FG001|Overall Study|Other - as entered by PI in eCRF|1
1044447|NCT01781429|2081073|FG002|Overall Study|Other - as entered by PI in eCRF|0
1044448|NCT01781429|2081074|FG003|Overall Study|Other - as entered by PI in eCRF|0
1044449|NCT01781429|2081075|FG004|Overall Study|Other - as entered by PI in eCRF|0
1044450|NCT01781429|2081076|FG005|Overall Study|Other - as entered by PI in eCRF|0
1044451|NCT01781429|2081077|FG006|Overall Study|Other - as entered by PI in eCRF|0
1044452|NCT01781429|2081078|FG007|Overall Study|Other - as entered by PI in eCRF|0
1044453|NCT01781429|2081079|FG008|Overall Study|Other - as entered by PI in eCRF|0
1044454|NCT01781429|2081080|FG009|Overall Study|Other - as entered by PI in eCRF|1
1044455|NCT01781429|2081081|FG010|Overall Study|Other - as entered by PI in eCRF|1
1044456|NCT01781429|2081082|FG011|Overall Study|Other - as entered by PI in eCRF|2
1044457|NCT01781429|2081083|FG012|Overall Study|Other - as entered by PI in eCRF|1
1044458|NCT01781429|2081084|FG013|Overall Study|Other - as entered by PI in eCRF|1
1044459|NCT01781429|2081085|FG014|Overall Study|Other - as entered by PI in eCRF|1
1044460|NCT01781429|2081086|FG015|Overall Study|Other - as entered by PI in eCRF|0
1044461|NCT01781429|2081071|FG000|Overall Study|Enrolled, but not treated|0
1044462|NCT01781429|2081072|FG001|Overall Study|Enrolled, but not treated|0
1044463|NCT01781429|2081073|FG002|Overall Study|Enrolled, but not treated|0
1044464|NCT01781429|2081074|FG003|Overall Study|Enrolled, but not treated|0
1044465|NCT01781429|2081075|FG004|Overall Study|Enrolled, but not treated|0
1044466|NCT01781429|2081076|FG005|Overall Study|Enrolled, but not treated|0
1044467|NCT01781429|2081077|FG006|Overall Study|Enrolled, but not treated|0
1044468|NCT01781429|2081078|FG007|Overall Study|Enrolled, but not treated|0
1044469|NCT01781429|2081079|FG008|Overall Study|Enrolled, but not treated|0
1044470|NCT01781429|2081080|FG009|Overall Study|Enrolled, but not treated|0
1044471|NCT01781429|2081081|FG010|Overall Study|Enrolled, but not treated|1
1044472|NCT01781429|2081082|FG011|Overall Study|Enrolled, but not treated|0
1044473|NCT01781429|2081083|FG012|Overall Study|Enrolled, but not treated|0
1044474|NCT01781429|2081084|FG013|Overall Study|Enrolled, but not treated|0
1044475|NCT01781429|2081085|FG014|Overall Study|Enrolled, but not treated|0
1044476|NCT01781429|2081086|FG015|Overall Study|Enrolled, but not treated|0
1044477|NCT01781572|2081189|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7
1044478|NCT01781572|2081190|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0
1044479|NCT01781572|2081191|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11
1044480|NCT01781572|2081189|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8
1044481|NCT01781572|2081190|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6
1044482|NCT01781572|2081191|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23
1044483|NCT01781572|2081189|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1
1044484|NCT01781572|2081190|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0
1044485|NCT01781572|2081191|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2
1044486|NCT01781572|2081189|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
1044487|NCT01781572|2081190|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
1044488|NCT01781572|2081191|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4
1044489|NCT01781572|2081189|FG000|MEK162 45mg BID+LEE011 200mg|Death|0
1044490|NCT01781572|2081190|FG001|MEK162 45mg BID+LEE011 200mg|Death|0
1044491|NCT01781572|2081191|FG002|MEK162 45mg BID+LEE011 200mg|Death|1
1044492|NCT01781572|2081189|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2
1044493|NCT01781572|2081190|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
1044494|NCT01781572|2081191|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
1044495|NCT01781572|2081189|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1
1044496|NCT01781572|2081190|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
1044497|NCT01781572|2081191|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
1044498|NCT01781572|2081189|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1
1044499|NCT01781572|2081190|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
1044500|NCT01781572|2081191|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
1044501|NCT01781572|2081189|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3
1044502|NCT01781572|2081190|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2
1044503|NCT01781572|2081191|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0
1044504|NCT01781572|2081189|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
1044505|NCT01781572|2081190|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
1044506|NCT01781572|2081191|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0
1044507|NCT01781572|2081189|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4
1044508|NCT01781572|2081190|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3
1044509|NCT01781572|2081191|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0
1044510|NCT01781572|2081189|FG000|MEK162 45mg BID+LEE011 300mg|Death|1
1044511|NCT01781572|2081190|FG001|MEK162 45mg BID+LEE011 300mg|Death|0
1044512|NCT01781572|2081191|FG002|MEK162 45mg BID+LEE011 300mg|Death|0
1044513|NCT01781572|2081189|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0
1044514|NCT01781572|2081190|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5
1044515|NCT01781572|2081191|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0
1044516|NCT01781572|2081189|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0
1044517|NCT01781572|2081190|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1
1044518|NCT01781572|2081191|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0
1044519|NCT01781572|2081189|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0
1044520|NCT01781572|2081190|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2
1044521|NCT01781572|2081191|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0
1044522|NCT01781572|2081189|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0
1044523|NCT01781572|2081190|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6
1044524|NCT01781572|2081191|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0
1044525|NCT01781572|2081189|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0
1044526|NCT01781572|2081190|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1
1044527|NCT01781572|2081191|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0
1044528|NCT01781572|2081189|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0
1044529|NCT01781572|2081190|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5
1044530|NCT01781572|2081191|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0
1044531|NCT01781611|2081222|FG000|Overall Study|Adverse Event|4
1044532|NCT01781611|2081223|FG001|Overall Study|Adverse Event|0
1044539|NCT01781832|2081248|FG000|Overall Study|Withdrawal by Subject|1
1044540|NCT01781962|2081252|FG000|Overall Study|Other Miscellaneous Reasons|5
1044541|NCT01781975|2081258|FG000|Overall Study|Death|1
1044542|NCT01781975|2081259|FG001|Overall Study|Death|0
1044543|NCT01781975|2081258|FG000|Overall Study|Withdrawal by Subject|1
1044544|NCT01781975|2081259|FG001|Overall Study|Withdrawal by Subject|1
1044545|NCT01782131|2081267|FG000|Overall Study|Death|93
1044546|NCT01782131|2081268|FG001|Overall Study|Death|96
1044547|NCT01782131|2081267|FG000|Overall Study|Lost to Follow-up|1
1044548|NCT01782131|2081268|FG001|Overall Study|Lost to Follow-up|3
1044549|NCT01782131|2081267|FG000|Overall Study|Withdrawal by Subject|10
1044550|NCT01782131|2081268|FG001|Overall Study|Withdrawal by Subject|10
1044551|NCT01782131|2081267|FG000|Overall Study|Randomized but not treated|5
1044552|NCT01782131|2081268|FG001|Overall Study|Randomized but not treated|5
1044553|NCT01782131|2081267|FG000|Overall Study|Reason not provided|0
1044554|NCT01782131|2081268|FG001|Overall Study|Reason not provided|1
1044555|NCT01782222|2081281|FG000|Overall Study|Adverse Event|4
1044556|NCT01782222|2081282|FG001|Overall Study|Adverse Event|5
1044557|NCT01782222|2081283|FG002|Overall Study|Adverse Event|3
1044558|NCT01782222|2081281|FG000|Overall Study|Lack of Efficacy|2
1044559|NCT01782222|2081282|FG001|Overall Study|Lack of Efficacy|1
1044560|NCT01782222|2081283|FG002|Overall Study|Lack of Efficacy|0
1044561|NCT01782222|2081281|FG000|Overall Study|Protocol Violation|1
1044562|NCT01782222|2081282|FG001|Overall Study|Protocol Violation|0
1044563|NCT01782222|2081283|FG002|Overall Study|Protocol Violation|0
1044564|NCT01782222|2081281|FG000|Overall Study|Withdrawal by Subject|1
1044565|NCT01782222|2081282|FG001|Overall Study|Withdrawal by Subject|4
1044566|NCT01782222|2081283|FG002|Overall Study|Withdrawal by Subject|1
1044567|NCT01782222|2081281|FG000|Overall Study|Moved to other state|0
1044568|NCT01782222|2081282|FG001|Overall Study|Moved to other state|1
1044569|NCT01782222|2081283|FG002|Overall Study|Moved to other state|0
1044570|NCT01782313|2081291|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3
1044571|NCT01782313|2081291|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3
1044572|NCT01782313|2081291|FG000|Treated Cycle 3|Progressive Disease|21
1044573|NCT01782313|2081291|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
1044574|NCT01782313|2081291|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
1044575|NCT01782313|2081291|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6
1044576|NCT01782313|2081291|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
1044577|NCT01782313|2081291|FG000|Survival Follow up|Lost to Follow-up|1
1044578|NCT01782326|2081297|FG000|Planned Treatment Epoch|Subject/guardian decision|149
1044579|NCT01782326|2081298|FG001|Planned Treatment Epoch|Subject/guardian decision|151
1044580|NCT01782326|2081297|FG000|Planned Treatment Epoch|Death|29
1044581|NCT01782326|2081298|FG001|Planned Treatment Epoch|Death|30
1044582|NCT01782326|2081297|FG000|Planned Treatment Epoch|Physician Decision|18
1044583|NCT01782326|2081298|FG001|Planned Treatment Epoch|Physician Decision|16
1044584|NCT01782326|2081297|FG000|Planned Treatment Epoch|Protocol deviation|2
1044585|NCT01782326|2081298|FG001|Planned Treatment Epoch|Protocol deviation|3
1044586|NCT01782326|2081297|FG000|Planned Treatment Epoch|Lost to Follow-up|4
1044587|NCT01782326|2081298|FG001|Planned Treatment Epoch|Lost to Follow-up|4
1044588|NCT01782326|2081297|FG000|Planned Treatment Epoch|Technical problems|0
1044589|NCT01782326|2081298|FG001|Planned Treatment Epoch|Technical problems|4
1044590|NCT01782326|2081297|FG000|Double-blind Treatment|Adverse Event|129
1044591|NCT01782326|2081298|FG001|Double-blind Treatment|Adverse Event|145
1044592|NCT01782326|2081297|FG000|Double-blind Treatment|Subject/guardian decision|111
1044593|NCT01782326|2081298|FG001|Double-blind Treatment|Subject/guardian decision|125
1044594|NCT01782326|2081297|FG000|Double-blind Treatment|Lack of Efficacy|17
1044595|NCT01782326|2081298|FG001|Double-blind Treatment|Lack of Efficacy|22
1044596|NCT01782326|2081297|FG000|Double-blind Treatment|Physician Decision|13
1044597|NCT01782326|2081298|FG001|Double-blind Treatment|Physician Decision|16
1044598|NCT01782326|2081297|FG000|Double-blind Treatment|Protocol deviation|8
1044599|NCT01782326|2081298|FG001|Double-blind Treatment|Protocol deviation|7
1044600|NCT01782326|2081297|FG000|Double-blind Treatment|Technical problems|0
1044601|NCT01782326|2081298|FG001|Double-blind Treatment|Technical problems|5
1044602|NCT01782378|2081306|FG000|First Series|Lost to Follow-up|7
1044603|NCT01782378|2081307|FG001|First Series|Lost to Follow-up|8
1044604|NCT01782378|2081306|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0
1044605|NCT01782378|2081307|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25
1044606|NCT01782378|2081306|FG000|Second Series|Lost to Follow-up|8
1044607|NCT01782378|2081307|FG001|Second Series|Lost to Follow-up|7
1044608|NCT01782378|2081306|FG000|Second Series|Did not choose to complete S2 Optional|18
1044609|NCT01782378|2081307|FG001|Second Series|Did not choose to complete S2 Optional|0
1044610|NCT01782469|2081313|FG000|Overall Study|Lost to Follow-up|1
1044611|NCT01782482|2081319|FG000|Overall Study|Adverse Event|2
1044612|NCT01782482|2081320|FG001|Overall Study|Adverse Event|1
1044613|NCT01782482|2081319|FG000|Overall Study|Lost to Follow-up|2
1044614|NCT01782482|2081320|FG001|Overall Study|Lost to Follow-up|3
1044615|NCT01782482|2081319|FG000|Overall Study|Physician Decision|1
1044616|NCT01782482|2081320|FG001|Overall Study|Physician Decision|0
1044617|NCT01782482|2081319|FG000|Overall Study|Protocol Violation|1
1044618|NCT01782482|2081320|FG001|Overall Study|Protocol Violation|0
1044619|NCT01782482|2081319|FG000|Overall Study|Withdrawal by Subject|2
1044620|NCT01782482|2081320|FG001|Overall Study|Withdrawal by Subject|3
1044621|NCT01782482|2081319|FG000|Overall Study|Randomized in Error|2
1044622|NCT01782482|2081320|FG001|Overall Study|Randomized in Error|2
1044623|NCT01782482|2081319|FG000|Overall Study|Habitually wearing toric lens OS|0
1044624|NCT01782482|2081320|FG001|Overall Study|Habitually wearing toric lens OS|1
1044625|NCT01782495|2081337|FG000|Overall Study|Adverse Event|0
1044626|NCT01782495|2081338|FG001|Overall Study|Adverse Event|0
1044627|NCT01782495|2081339|FG002|Overall Study|Adverse Event|0
1044628|NCT01782495|2081340|FG003|Overall Study|Adverse Event|0
1044629|NCT01782495|2081341|FG004|Overall Study|Adverse Event|0
1044630|NCT01782495|2081342|FG005|Overall Study|Adverse Event|0
1044631|NCT01782495|2081343|FG006|Overall Study|Adverse Event|0
1044632|NCT01782495|2081344|FG007|Overall Study|Adverse Event|2
1044633|NCT01782495|2081345|FG008|Overall Study|Adverse Event|0
1044634|NCT01782495|2081346|FG009|Overall Study|Adverse Event|0
1044635|NCT01782495|2081347|FG010|Overall Study|Adverse Event|0
1044636|NCT01782495|2081337|FG000|Overall Study|Withdrew Consent|0
1044637|NCT01782495|2081338|FG001|Overall Study|Withdrew Consent|1
1044638|NCT01782495|2081339|FG002|Overall Study|Withdrew Consent|0
1044639|NCT01782495|2081340|FG003|Overall Study|Withdrew Consent|0
1044640|NCT01782495|2081341|FG004|Overall Study|Withdrew Consent|0
1044641|NCT01782495|2081342|FG005|Overall Study|Withdrew Consent|0
1044642|NCT01782495|2081343|FG006|Overall Study|Withdrew Consent|0
1044643|NCT01782495|2081344|FG007|Overall Study|Withdrew Consent|1
1044644|NCT01782495|2081345|FG008|Overall Study|Withdrew Consent|0
1044645|NCT01782495|2081346|FG009|Overall Study|Withdrew Consent|0
1044646|NCT01782495|2081347|FG010|Overall Study|Withdrew Consent|0
1044647|NCT01782664|2081377|FG000|Overall Study|Adverse Event|2
1044648|NCT01782664|2081378|FG001|Overall Study|Adverse Event|2
1044649|NCT01782664|2081379|FG002|Overall Study|Adverse Event|2
1044650|NCT01782664|2081380|FG003|Overall Study|Adverse Event|2
1044651|NCT01782664|2081381|FG004|Overall Study|Adverse Event|0
1044652|NCT01782664|2081382|FG005|Overall Study|Adverse Event|0
1044653|NCT01782664|2081377|FG000|Overall Study|Lack of Efficacy|2
1044654|NCT01782664|2081378|FG001|Overall Study|Lack of Efficacy|0
1044655|NCT01782664|2081379|FG002|Overall Study|Lack of Efficacy|2
1044656|NCT01782664|2081380|FG003|Overall Study|Lack of Efficacy|2
1044657|NCT01782664|2081381|FG004|Overall Study|Lack of Efficacy|0
1044658|NCT01782664|2081382|FG005|Overall Study|Lack of Efficacy|0
1044659|NCT01782664|2081377|FG000|Overall Study|Protocol Violation|0
1044660|NCT01782664|2081378|FG001|Overall Study|Protocol Violation|1
1044661|NCT01782664|2081379|FG002|Overall Study|Protocol Violation|0
1044662|NCT01782664|2081380|FG003|Overall Study|Protocol Violation|1
1044663|NCT01782664|2081381|FG004|Overall Study|Protocol Violation|0
1044664|NCT01782664|2081382|FG005|Overall Study|Protocol Violation|0
1044665|NCT01782664|2081377|FG000|Overall Study|Withdrawal by Subject|2
1044666|NCT01782664|2081378|FG001|Overall Study|Withdrawal by Subject|2
1044667|NCT01782664|2081379|FG002|Overall Study|Withdrawal by Subject|0
1044668|NCT01782664|2081380|FG003|Overall Study|Withdrawal by Subject|0
1044669|NCT01782664|2081381|FG004|Overall Study|Withdrawal by Subject|0
1044670|NCT01782664|2081382|FG005|Overall Study|Withdrawal by Subject|0
1044671|NCT01782690|2081396|FG000|Overall Study|Not reported|7
1044672|NCT01782690|2081396|FG000|Overall Study|Toxicity of gemcitabine|1
1044673|NCT01782690|2081396|FG000|Overall Study|Toxicity of erlotinib|1
1044674|NCT01782690|2081396|FG000|Overall Study|Lost to Follow-up|31
1044675|NCT01782690|2081396|FG000|Overall Study|Withdrawal of informed consent|2
1044676|NCT01782690|2081396|FG000|Overall Study|Absent rash|9
1044677|NCT01782690|2081396|FG000|Overall Study|Physician Decision|13
1044678|NCT01782690|2081396|FG000|Overall Study|Patient's wish|21
1044679|NCT01782690|2081396|FG000|Overall Study|Tumor progression|74
1044680|NCT01782690|2081396|FG000|Overall Study|Death|133
1044681|NCT01782690|2081396|FG000|Overall Study|Study completion unknown|7
1044682|NCT01782742|2081402|FG000|Double-blind Treatment Phase|Adverse Event|1
1044683|NCT01782742|2081403|FG001|Double-blind Treatment Phase|Adverse Event|0
1044684|NCT01782859|2081417|FG000|Overall Study|Protocol Violation|6
1044685|NCT01782859|2081418|FG001|Overall Study|Protocol Violation|6
1044686|NCT01782859|2081417|FG000|Overall Study|Withdrawal by Subject|0
1044687|NCT01782859|2081418|FG001|Overall Study|Withdrawal by Subject|1
1044688|NCT01782872|2081429|FG000|Overall Study|Protocol Violation|0
1044689|NCT01782872|2081430|FG001|Overall Study|Protocol Violation|0
1044690|NCT01782872|2081431|FG002|Overall Study|Protocol Violation|0
1044691|NCT01782872|2081432|FG003|Overall Study|Protocol Violation|1
1044692|NCT01782872|2081429|FG000|Overall Study|Withdrawal by Subject|0
1044693|NCT01782872|2081430|FG001|Overall Study|Withdrawal by Subject|1
1044694|NCT01782872|2081431|FG002|Overall Study|Withdrawal by Subject|0
1044695|NCT01782872|2081432|FG003|Overall Study|Withdrawal by Subject|0
1044696|NCT01782885|2081444|FG000|Overall Study|Lost to Follow-up|4
1044697|NCT01782885|2081445|FG001|Overall Study|Lost to Follow-up|6
1044698|NCT01783418|2081487|FG000|Overall Study|Withdrawal by Subject|1
1044699|NCT01783418|2081488|FG001|Overall Study|Withdrawal by Subject|0
1044700|NCT01783444|2081497|FG000|Treatment Phase|Adverse Event|9
1044701|NCT01783444|2081498|FG001|Treatment Phase|Adverse Event|20
1044702|NCT01783444|2081499|FG002|Treatment Phase|Adverse Event|19
1044703|NCT01783444|2081497|FG000|Treatment Phase|Disease Progression|76
1044704|NCT01783444|2081498|FG001|Treatment Phase|Disease Progression|66
1044705|NCT01783444|2081499|FG002|Treatment Phase|Disease Progression|64
1044706|NCT01783444|2081497|FG000|Treatment Phase|Death|2
1044707|NCT01783444|2081498|FG001|Treatment Phase|Death|2
1044708|NCT01783444|2081499|FG002|Treatment Phase|Death|2
1044709|NCT01783444|2081497|FG000|Treatment Phase|Protocol Violation|1
1044710|NCT01783444|2081498|FG001|Treatment Phase|Protocol Violation|1
1044711|NCT01783444|2081499|FG002|Treatment Phase|Protocol Violation|2
1044712|NCT01783444|2081497|FG000|Treatment Phase|Withdrawal by Subject|6
1044713|NCT01783444|2081498|FG001|Treatment Phase|Withdrawal by Subject|8
1044714|NCT01783444|2081499|FG002|Treatment Phase|Withdrawal by Subject|9
1044715|NCT01783444|2081497|FG000|Treatment Phase|Administrative problems|2
1044716|NCT01783444|2081498|FG001|Treatment Phase|Administrative problems|0
1044717|NCT01783444|2081499|FG002|Treatment Phase|Administrative problems|1
1044718|NCT01783444|2081497|FG000|Treatment Phase|Physician Decision|8
1044719|NCT01783444|2081498|FG001|Treatment Phase|Physician Decision|6
1044720|NCT01783444|2081499|FG002|Treatment Phase|Physician Decision|5
1044721|NCT01783444|2081497|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7
1044722|NCT01783444|2081498|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8
1044723|NCT01783444|2081499|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11
1044724|NCT01783444|2081497|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9
1044725|NCT01783444|2081498|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7
1044726|NCT01783444|2081499|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5
1044727|NCT01783444|2081497|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4
1044728|NCT01783444|2081498|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
1044729|NCT01783444|2081499|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
1044730|NCT01783444|2081497|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
1044731|NCT01783444|2081498|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1
1044732|NCT01783444|2081499|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
1044733|NCT01783444|2081497|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7
1044734|NCT01783444|2081498|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16
1044735|NCT01783444|2081499|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15
1044736|NCT01783444|2081497|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69
1044737|NCT01783444|2081498|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53
1044738|NCT01783444|2081499|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52
1044739|NCT01783483|2081518|FG000|Overall Study|Death|3
1044740|NCT01783483|2081519|FG001|Overall Study|Death|3
1044741|NCT01783483|2081518|FG000|Overall Study|Lost to Follow-up|14
1044742|NCT01783483|2081519|FG001|Overall Study|Lost to Follow-up|10
1044743|NCT01783483|2081518|FG000|Overall Study|Withdrawal by Subject|2
1044744|NCT01783483|2081519|FG001|Overall Study|Withdrawal by Subject|1
1044745|NCT01783483|2081518|FG000|Overall Study|Physician Decision|1
1044746|NCT01783483|2081519|FG001|Overall Study|Physician Decision|1
1044747|NCT01783496|2081531|FG000|Overall Study|Lost to Follow-up|0
1044748|NCT01783496|2081532|FG001|Overall Study|Lost to Follow-up|0
1044749|NCT01783496|2081533|FG002|Overall Study|Lost to Follow-up|0
1044750|NCT01783496|2081534|FG003|Overall Study|Lost to Follow-up|2
1044751|NCT01783496|2081535|FG004|Overall Study|Lost to Follow-up|0
1044752|NCT01783496|2081536|FG005|Overall Study|Lost to Follow-up|1
1044753|NCT01783496|2081531|FG000|Overall Study|Withdrawal by Subject|1
1044754|NCT01783496|2081532|FG001|Overall Study|Withdrawal by Subject|0
1044755|NCT01783496|2081533|FG002|Overall Study|Withdrawal by Subject|0
1044756|NCT01783496|2081534|FG003|Overall Study|Withdrawal by Subject|0
1044757|NCT01783496|2081535|FG004|Overall Study|Withdrawal by Subject|0
1044758|NCT01783496|2081536|FG005|Overall Study|Withdrawal by Subject|0
1044759|NCT01783548|2081561|FG000|Overall Study|Adverse Event|8
1044760|NCT01783548|2081562|FG001|Overall Study|Adverse Event|4
1044761|NCT01783548|2081561|FG000|Overall Study|Withdrawal by Subject|11
1044762|NCT01783548|2081562|FG001|Overall Study|Withdrawal by Subject|8
1044763|NCT01783548|2081561|FG000|Overall Study|Non-compliance|4
1044764|NCT01783548|2081562|FG001|Overall Study|Non-compliance|0
1044765|NCT01783548|2081561|FG000|Overall Study|Protocol Violation|2
1044766|NCT01783548|2081562|FG001|Overall Study|Protocol Violation|2
1044767|NCT01783548|2081561|FG000|Overall Study|Lost to Follow-up|8
1044768|NCT01783548|2081562|FG001|Overall Study|Lost to Follow-up|3
1044769|NCT01783548|2081561|FG000|Overall Study|Lack of Efficacy|1
1044770|NCT01783548|2081562|FG001|Overall Study|Lack of Efficacy|1
906408|NCT00768079|1882047|FG001|Overall Study|Participant incarcerated|1
906409|NCT00768079|1882048|FG002|Overall Study|Participant incarcerated|0
906410|NCT00768144|1882062|FG000|Overall Study|Adverse Event|13
906411|NCT00768144|1882062|FG000|Overall Study|Progressive Disease|21
906412|NCT00768144|1882062|FG000|Overall Study|Patient or MD Decision to End Treatment|1
906413|NCT00768144|1882062|FG000|Overall Study|Pt Withdrew Consent|1
906414|NCT00768222|1882068|FG000|Overall Study|Lost to Follow-up|1
906415|NCT00768222|1882069|FG001|Overall Study|Lost to Follow-up|1
906416|NCT00768222|1882068|FG000|Overall Study|Withdrawal by Subject|3
906417|NCT00768222|1882069|FG001|Overall Study|Withdrawal by Subject|1
906418|NCT00768222|1882068|FG000|Overall Study|Protocol Violation|0
906419|NCT00768222|1882069|FG001|Overall Study|Protocol Violation|2
906420|NCT00768300|1882114|FG000|Overall Study|Randomized but not treated|1
906421|NCT00768300|1882115|FG001|Overall Study|Randomized but not treated|1
1044771|NCT01783678|2081596|FG000|Overall Study|Randomized but Not Treated|0
1044772|NCT01783678|2081597|FG001|Overall Study|Randomized but Not Treated|0
1044773|NCT01783678|2081598|FG002|Overall Study|Randomized but Not Treated|0
1044774|NCT01783678|2081599|FG003|Overall Study|Randomized but Not Treated|1
1044775|NCT01783678|2081600|FG004|Overall Study|Randomized but Not Treated|0
1044776|NCT01783678|2081601|FG005|Overall Study|Randomized but Not Treated|0
1044777|NCT01783678|2081596|FG000|Overall Study|Lack of Efficacy|1
1044778|NCT01783678|2081597|FG001|Overall Study|Lack of Efficacy|13
1044779|NCT01783678|2081598|FG002|Overall Study|Lack of Efficacy|1
1044780|NCT01783678|2081599|FG003|Overall Study|Lack of Efficacy|3
1044781|NCT01783678|2081600|FG004|Overall Study|Lack of Efficacy|6
1044782|NCT01783678|2081601|FG005|Overall Study|Lack of Efficacy|5
1044783|NCT01783678|2081596|FG000|Overall Study|Lost to Follow-up|0
1044784|NCT01783678|2081597|FG001|Overall Study|Lost to Follow-up|4
1044785|NCT01783678|2081598|FG002|Overall Study|Lost to Follow-up|0
1044786|NCT01783678|2081599|FG003|Overall Study|Lost to Follow-up|2
1044787|NCT01783678|2081600|FG004|Overall Study|Lost to Follow-up|1
1044788|NCT01783678|2081601|FG005|Overall Study|Lost to Follow-up|0
1044789|NCT01783678|2081596|FG000|Overall Study|Withdrew Consent|1
1044790|NCT01783678|2081597|FG001|Overall Study|Withdrew Consent|1
1044791|NCT01783678|2081598|FG002|Overall Study|Withdrew Consent|0
1044792|NCT01783678|2081599|FG003|Overall Study|Withdrew Consent|2
1044793|NCT01783678|2081600|FG004|Overall Study|Withdrew Consent|0
1044794|NCT01783678|2081601|FG005|Overall Study|Withdrew Consent|0
1044795|NCT01783730|2081616|FG000|Overall Study|Failed to meet inclusion criteria|6
1044796|NCT01783743|2081622|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427
1044797|NCT01783743|2081623|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439
1044798|NCT01783743|2081622|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
1044799|NCT01783743|2081623|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
1044800|NCT01783743|2081622|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
1044801|NCT01783743|2081623|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
1044802|NCT01783821|2081631|FG000|Overall Study|Screen Failure|1
1044803|NCT01783821|2081632|FG001|Overall Study|Screen Failure|1
1044804|NCT01783886|2081666|FG000|Overall Study|Lost to Follow-up|0
1044805|NCT01783886|2081667|FG001|Overall Study|Lost to Follow-up|3
1044806|NCT01783886|2081668|FG002|Overall Study|Lost to Follow-up|0
1044807|NCT01783886|2081666|FG000|Overall Study|Protocol deviation|0
1044808|NCT01783886|2081667|FG001|Overall Study|Protocol deviation|0
1044809|NCT01783886|2081668|FG002|Overall Study|Protocol deviation|2
1044810|NCT01783886|2081666|FG000|Overall Study|Withdrawal of consent by participant|1
1044811|NCT01783886|2081667|FG001|Overall Study|Withdrawal of consent by participant|3
1044812|NCT01783886|2081668|FG002|Overall Study|Withdrawal of consent by participant|4
1044813|NCT01783886|2081666|FG000|Overall Study|Adverse Event|4
1044814|NCT01783886|2081667|FG001|Overall Study|Adverse Event|5
1044815|NCT01783886|2081668|FG002|Overall Study|Adverse Event|4
1044816|NCT01783938|2081691|FG000|Overall Study|Disease Progression|18
1044817|NCT01783938|2081692|FG001|Overall Study|Disease Progression|41
1044818|NCT01783938|2081691|FG000|Overall Study|Study Drug Toxicity|27
1044819|NCT01783938|2081692|FG001|Overall Study|Study Drug Toxicity|14
1044820|NCT01783938|2081691|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4
1044821|NCT01783938|2081692|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
1044822|NCT01783938|2081691|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2
1044823|NCT01783938|2081692|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3
1044824|NCT01783938|2081691|FG000|Overall Study|Participant Withdrew Consent|2
1044825|NCT01783938|2081692|FG001|Overall Study|Participant Withdrew Consent|0
1044826|NCT01783938|2081691|FG000|Overall Study|Maximum Clinical Benefit|1
1044827|NCT01783938|2081692|FG001|Overall Study|Maximum Clinical Benefit|0
1044828|NCT01783938|2081691|FG000|Overall Study|Other Reasons|3
1044829|NCT01783938|2081692|FG001|Overall Study|Other Reasons|1
1044830|NCT01784029|2081712|FG000|Overall Study|Lost to Follow-up|19
1044831|NCT01784029|2081713|FG001|Overall Study|Lost to Follow-up|20
1044832|NCT01784029|2081714|FG002|Overall Study|Lost to Follow-up|22
1044833|NCT01784068|2081726|FG000|NTCS Phase|Adverse Event|5
1044834|NCT01784068|2081727|FG001|NTCS Phase|Adverse Event|0
1044835|NCT01784068|2081726|FG000|NTCS Phase|Physician Decision|2
1044836|NCT01784068|2081727|FG001|NTCS Phase|Physician Decision|0
1044837|NCT01784068|2081726|FG000|NTCS Phase|Patient/guardian decision|3
1044838|NCT01784068|2081727|FG001|NTCS Phase|Patient/guardian decision|0
1044839|NCT01784068|2081726|FG000|NTCS Phase|Death|2
1044840|NCT01784068|2081727|FG001|NTCS Phase|Death|0
1044841|NCT01784068|2081726|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203
1044842|NCT01784068|2081727|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0
1044843|NCT01784068|2081726|FG000|TFR Phase|Physician Decision|0
1044844|NCT01784068|2081727|FG001|TFR Phase|Physician Decision|1
906422|NCT00768300|1882114|FG000|Overall Study|Adverse Event|10
906423|NCT00768300|1882115|FG001|Overall Study|Adverse Event|2
906424|NCT00768300|1882114|FG000|Overall Study|Protocol Violation|6
906425|NCT00768300|1882115|FG001|Overall Study|Protocol Violation|1
906426|NCT00768300|1882114|FG000|Overall Study|Withdrawal by Subject|13
906427|NCT00768300|1882115|FG001|Overall Study|Withdrawal by Subject|7
1044845|NCT01784068|2081726|FG000|TFR Phase|Patient/guardian decision|0
1044846|NCT01784068|2081727|FG001|TFR Phase|Patient/guardian decision|3
1044847|NCT01784068|2081726|FG000|TFR Phase|Death|0
1044848|NCT01784068|2081727|FG001|TFR Phase|Death|1
1044849|NCT01784068|2081726|FG000|TFR Phase|Lack of Efficacy|0
1044850|NCT01784068|2081727|FG001|TFR Phase|Lack of Efficacy|88
1044851|NCT01784211|2081740|FG000|Part A (Days 1-15)|Adverse Event|1
1044852|NCT01784211|2081741|FG001|Part A (Days 1-15)|Adverse Event|1
1044853|NCT01784211|2081742|FG002|Part A (Days 1-15)|Adverse Event|0
1044854|NCT01784211|2081743|FG003|Part A (Days 1-15)|Adverse Event|0
1044855|NCT01784211|2081744|FG004|Part A (Days 1-15)|Adverse Event|0
1044856|NCT01784211|2081745|FG005|Part A (Days 1-15)|Adverse Event|0
1044857|NCT01784211|2081740|FG000|Part A (Days 1-15)|Withdrawal by Subject|2
1044858|NCT01784211|2081741|FG001|Part A (Days 1-15)|Withdrawal by Subject|1
1044859|NCT01784211|2081742|FG002|Part A (Days 1-15)|Withdrawal by Subject|0
1044860|NCT01784211|2081743|FG003|Part A (Days 1-15)|Withdrawal by Subject|0
1044861|NCT01784211|2081744|FG004|Part A (Days 1-15)|Withdrawal by Subject|0
1044862|NCT01784211|2081745|FG005|Part A (Days 1-15)|Withdrawal by Subject|0
1044863|NCT01784419|2081757|FG000|Overall Study|Adverse Event|3
1044864|NCT01784523|2081763|FG000|Overall Study|Study closed early|7
1044865|NCT01784523|2081764|FG001|Overall Study|Study closed early|4
1044866|NCT01784861|2081848|FG000|Overall Study|Adverse Event|0
1044867|NCT01784861|2081849|FG001|Overall Study|Adverse Event|0
1044868|NCT01784861|2081850|FG002|Overall Study|Adverse Event|1
1044869|NCT01784861|2081851|FG003|Overall Study|Adverse Event|2
1044870|NCT01784861|2081852|FG004|Overall Study|Adverse Event|1
1044871|NCT01784861|2081853|FG005|Overall Study|Adverse Event|0
1044872|NCT01784861|2081848|FG000|Overall Study|Withdrawal by Subject|0
1044873|NCT01784861|2081849|FG001|Overall Study|Withdrawal by Subject|0
1044874|NCT01784861|2081850|FG002|Overall Study|Withdrawal by Subject|0
1044875|NCT01784861|2081851|FG003|Overall Study|Withdrawal by Subject|1
1044876|NCT01784861|2081852|FG004|Overall Study|Withdrawal by Subject|0
1044877|NCT01784861|2081853|FG005|Overall Study|Withdrawal by Subject|0
1044878|NCT01784861|2081848|FG000|Overall Study|Physician Decision|0
1044879|NCT01784861|2081849|FG001|Overall Study|Physician Decision|0
1044880|NCT01784861|2081850|FG002|Overall Study|Physician Decision|0
1044881|NCT01784861|2081851|FG003|Overall Study|Physician Decision|2
1044882|NCT01784861|2081852|FG004|Overall Study|Physician Decision|0
1044883|NCT01784861|2081853|FG005|Overall Study|Physician Decision|1
1044884|NCT01784965|2081880|FG000|Overall Study|Withdrawal by Subject|6
1044885|NCT01784965|2081881|FG001|Overall Study|Withdrawal by Subject|3
1044886|NCT01784965|2081880|FG000|Overall Study|Adverse Event|0
1044887|NCT01784965|2081881|FG001|Overall Study|Adverse Event|8
1044888|NCT01785069|2081893|FG000|Overall Study|Implanted with nonstudy device|1
1044889|NCT01785069|2081894|FG001|Overall Study|Implanted with nonstudy device|2
1044890|NCT01785069|2081895|FG002|Overall Study|Implanted with nonstudy device|1
1044891|NCT01785069|2081896|FG003|Overall Study|Implanted with nonstudy device|0
1044892|NCT01785069|2081893|FG000|Overall Study|Death|0
1044893|NCT01785069|2081894|FG001|Overall Study|Death|0
1044894|NCT01785069|2081895|FG002|Overall Study|Death|2
1044895|NCT01785069|2081896|FG003|Overall Study|Death|0
1044896|NCT01785069|2081893|FG000|Overall Study|Subject choice|2
1044897|NCT01785069|2081894|FG001|Overall Study|Subject choice|2
1044898|NCT01785069|2081895|FG002|Overall Study|Subject choice|0
1044899|NCT01785069|2081896|FG003|Overall Study|Subject choice|1
1044900|NCT01785069|2081893|FG000|Overall Study|Lost to Follow-up|1
1044901|NCT01785069|2081894|FG001|Overall Study|Lost to Follow-up|2
1044902|NCT01785069|2081895|FG002|Overall Study|Lost to Follow-up|4
1044903|NCT01785069|2081896|FG003|Overall Study|Lost to Follow-up|1
1044904|NCT01785069|2081893|FG000|Overall Study|Reason not Specified|1
1044905|NCT01785069|2081894|FG001|Overall Study|Reason not Specified|2
1044906|NCT01785069|2081895|FG002|Overall Study|Reason not Specified|1
1044907|NCT01785069|2081896|FG003|Overall Study|Reason not Specified|4
1044908|NCT01785069|2081893|FG000|Overall Study|Not evaluable|7
1044909|NCT01785069|2081894|FG001|Overall Study|Not evaluable|4
1044910|NCT01785069|2081895|FG002|Overall Study|Not evaluable|5
1044911|NCT01785069|2081896|FG003|Overall Study|Not evaluable|8
1044912|NCT01785160|2081922|FG000|Treatment Period 1: Raltegravir|Not treated|1
1044913|NCT01785160|2081922|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1
1044914|NCT01785472|2081963|FG000|Overall Study|Adverse Event|5
1044915|NCT01785472|2081964|FG001|Overall Study|Adverse Event|4
1044916|NCT01785472|2081965|FG002|Overall Study|Adverse Event|6
1044917|NCT01785472|2081963|FG000|Overall Study|Lack of Efficacy|2
1044918|NCT01785472|2081964|FG001|Overall Study|Lack of Efficacy|0
1044919|NCT01785472|2081965|FG002|Overall Study|Lack of Efficacy|1
1044920|NCT01785472|2081963|FG000|Overall Study|Lost to Follow-up|1
1044921|NCT01785472|2081964|FG001|Overall Study|Lost to Follow-up|2
1044922|NCT01785472|2081965|FG002|Overall Study|Lost to Follow-up|0
1044923|NCT01785472|2081963|FG000|Overall Study|Physician Decision|1
1044924|NCT01785472|2081964|FG001|Overall Study|Physician Decision|1
1044925|NCT01785472|2081965|FG002|Overall Study|Physician Decision|1
1044926|NCT01785472|2081963|FG000|Overall Study|Protocol deviation|0
1044927|NCT01785472|2081964|FG001|Overall Study|Protocol deviation|2
1044928|NCT01785472|2081965|FG002|Overall Study|Protocol deviation|2
1044929|NCT01785472|2081963|FG000|Overall Study|Subject/guardian decision|15
1044930|NCT01785472|2081964|FG001|Overall Study|Subject/guardian decision|10
1044931|NCT01785472|2081965|FG002|Overall Study|Subject/guardian decision|11
1044932|NCT01785472|2081963|FG000|Overall Study|Technical problems|0
1044933|NCT01785472|2081964|FG001|Overall Study|Technical problems|0
1044934|NCT01785472|2081965|FG002|Overall Study|Technical problems|1
1044935|NCT01785524|2081977|FG000|Overall Study|Withdrawal by Subject|2
1044936|NCT01785524|2081978|FG001|Overall Study|Withdrawal by Subject|2
1044937|NCT01785602|2081986|FG000|Overall Study|Withdrawal by Subject|2
1044938|NCT01785602|2081987|FG001|Overall Study|Withdrawal by Subject|0
1044939|NCT01785602|2081986|FG000|Overall Study|Lost to Follow-up|1
1044940|NCT01785602|2081987|FG001|Overall Study|Lost to Follow-up|1
1044941|NCT01785602|2081986|FG000|Overall Study|Adverse Event|3
1044942|NCT01785602|2081987|FG001|Overall Study|Adverse Event|5
1044943|NCT01785602|2081986|FG000|Overall Study|Administrative problems|7
1044944|NCT01785602|2081987|FG001|Overall Study|Administrative problems|3
1044945|NCT01785615|2081996|FG000|Dietary Phase|Lost to Follow-up|0
1044946|NCT01785615|2081997|FG001|Dietary Phase|Lost to Follow-up|0
1044947|NCT01785615|2081998|FG002|Dietary Phase|Lost to Follow-up|0
1044948|NCT01785615|2081999|FG003|Dietary Phase|Lost to Follow-up|24
1044949|NCT01785628|2082013|FG000|Overall Study|Lost to Follow-up|2
1044950|NCT01785628|2082014|FG001|Overall Study|Lost to Follow-up|3
1044951|NCT01785849|2082035|FG000|Overall Study|Death|7
1044952|NCT01785849|2082036|FG001|Overall Study|Death|9
1044953|NCT01785849|2082035|FG000|Overall Study|Protocol Specified Criteria|29
1044954|NCT01785849|2082036|FG001|Overall Study|Protocol Specified Criteria|1
1044955|NCT01785849|2082035|FG000|Overall Study|Withdrawal by Subject|15
1044956|NCT01785849|2082036|FG001|Overall Study|Withdrawal by Subject|12
1044957|NCT01785849|2082035|FG000|Overall Study|Sponsor Decision|0
1044958|NCT01785849|2082036|FG001|Overall Study|Sponsor Decision|1
1044959|NCT01785849|2082035|FG000|Overall Study|Lost to Follow-up|10
1044960|NCT01785849|2082036|FG001|Overall Study|Lost to Follow-up|11
1044961|NCT01785875|2082042|FG000|Overall Study|Withdrawal by Subject|41
1044962|NCT01785875|2082043|FG001|Overall Study|Withdrawal by Subject|34
1044963|NCT01785875|2082044|FG002|Overall Study|Withdrawal by Subject|36
1044964|NCT01785875|2082042|FG000|Overall Study|Lost to Follow-up|19
1044965|NCT01785875|2082043|FG001|Overall Study|Lost to Follow-up|22
1044966|NCT01785875|2082044|FG002|Overall Study|Lost to Follow-up|6
1044967|NCT01785875|2082042|FG000|Overall Study|Death|27
1044968|NCT01785875|2082043|FG001|Overall Study|Death|16
1044969|NCT01785875|2082044|FG002|Overall Study|Death|7
1044970|NCT01785875|2082042|FG000|Overall Study|Sponsor Decision|0
1044971|NCT01785875|2082043|FG001|Overall Study|Sponsor Decision|2
1044972|NCT01785875|2082044|FG002|Overall Study|Sponsor Decision|0
1044973|NCT01785875|2082042|FG000|Overall Study|Protocol Specified Criteria|207
1044974|NCT01785875|2082043|FG001|Overall Study|Protocol Specified Criteria|214
1044975|NCT01785875|2082044|FG002|Overall Study|Protocol Specified Criteria|55
1044976|NCT01785875|2082042|FG000|Overall Study|Missing|0
1044977|NCT01785875|2082043|FG001|Overall Study|Missing|1
1044978|NCT01785875|2082044|FG002|Overall Study|Missing|3
1044979|NCT01786109|2082058|FG000|Overall Study|fail manometry barostat tube placement|1
1044980|NCT01786109|2082059|FG001|Overall Study|fail manometry barostat tube placement|0
1044981|NCT01786109|2082060|FG002|Overall Study|fail manometry barostat tube placement|0
1044982|NCT01786109|2082058|FG000|Overall Study|unrelated illness|0
1044983|NCT01786109|2082059|FG001|Overall Study|unrelated illness|0
1044984|NCT01786109|2082060|FG002|Overall Study|unrelated illness|1
1044985|NCT01786109|2082058|FG000|Overall Study|adverse effects colon preparation|0
1044986|NCT01786109|2082059|FG001|Overall Study|adverse effects colon preparation|0
1044987|NCT01786109|2082060|FG002|Overall Study|adverse effects colon preparation|1
1044988|NCT01786148|2082070|FG000|Overall Study|Lost to Follow-up|21
1044989|NCT01786148|2082071|FG001|Overall Study|Lost to Follow-up|13
1044990|NCT01786148|2082070|FG000|Overall Study|Death|0
1044991|NCT01786148|2082071|FG001|Overall Study|Death|1
1044992|NCT01786148|2082070|FG000|Overall Study|Withdrawal by Subject|0
1044993|NCT01786148|2082071|FG001|Overall Study|Withdrawal by Subject|7
1044994|NCT01786148|2082070|FG000|Overall Study|Incarceration|1
1044995|NCT01786148|2082071|FG001|Overall Study|Incarceration|1
1044996|NCT01786174|2082090|FG000|Overall Study|Discontinued Study Drug|2
1044997|NCT01786174|2082091|FG001|Overall Study|Discontinued Study Drug|0
1044998|NCT01786330|2082129|FG000|Overall Study|Withdrawal by Subject|0
1044999|NCT01786330|2082130|FG001|Overall Study|Withdrawal by Subject|1
1045000|NCT01786330|2082129|FG000|Overall Study|Lost to Follow-up|0
1045001|NCT01786330|2082130|FG001|Overall Study|Lost to Follow-up|1
1045002|NCT01786330|2082129|FG000|Overall Study|Excluded intraoperatively|0
1045003|NCT01786330|2082130|FG001|Overall Study|Excluded intraoperatively|1
1045004|NCT01786330|2082129|FG000|Overall Study|Protocol Violation|1
1045005|NCT01786330|2082130|FG001|Overall Study|Protocol Violation|0
1045006|NCT01786512|2082156|FG000|Overall Study|Lost to Follow-up|0
1045007|NCT01786512|2082157|FG001|Overall Study|Lost to Follow-up|0
1045008|NCT01786512|2082158|FG002|Overall Study|Lost to Follow-up|0
1045009|NCT01786512|2082159|FG003|Overall Study|Lost to Follow-up|0
1045010|NCT01786512|2082160|FG004|Overall Study|Lost to Follow-up|0
1045011|NCT01786512|2082161|FG005|Overall Study|Lost to Follow-up|0
1045012|NCT01786512|2082162|FG006|Overall Study|Lost to Follow-up|0
1045013|NCT01786512|2082163|FG007|Overall Study|Lost to Follow-up|0
1045014|NCT01786512|2082164|FG008|Overall Study|Lost to Follow-up|0
1045015|NCT01786512|2082165|FG009|Overall Study|Lost to Follow-up|1
1045016|NCT01786512|2082166|FG010|Overall Study|Lost to Follow-up|0
1045017|NCT01786512|2082156|FG000|Overall Study|Decision by sponsor|0
1045018|NCT01786512|2082157|FG001|Overall Study|Decision by sponsor|0
1045019|NCT01786512|2082158|FG002|Overall Study|Decision by sponsor|0
1045020|NCT01786512|2082159|FG003|Overall Study|Decision by sponsor|0
1045021|NCT01786512|2082160|FG004|Overall Study|Decision by sponsor|0
1045022|NCT01786512|2082161|FG005|Overall Study|Decision by sponsor|0
1045023|NCT01786512|2082162|FG006|Overall Study|Decision by sponsor|0
1045024|NCT01786512|2082163|FG007|Overall Study|Decision by sponsor|0
1045025|NCT01786512|2082164|FG008|Overall Study|Decision by sponsor|0
1045026|NCT01786512|2082165|FG009|Overall Study|Decision by sponsor|0
1045027|NCT01786512|2082166|FG010|Overall Study|Decision by sponsor|2
1045028|NCT01786512|2082156|FG000|Overall Study|Withdrawal by Subject|0
1045029|NCT01786512|2082157|FG001|Overall Study|Withdrawal by Subject|1
1045030|NCT01786512|2082158|FG002|Overall Study|Withdrawal by Subject|0
1045031|NCT01786512|2082159|FG003|Overall Study|Withdrawal by Subject|0
1045032|NCT01786512|2082160|FG004|Overall Study|Withdrawal by Subject|0
1045033|NCT01786512|2082161|FG005|Overall Study|Withdrawal by Subject|0
1045034|NCT01786512|2082162|FG006|Overall Study|Withdrawal by Subject|1
1045035|NCT01786512|2082163|FG007|Overall Study|Withdrawal by Subject|0
1045036|NCT01786512|2082164|FG008|Overall Study|Withdrawal by Subject|0
1045037|NCT01786512|2082165|FG009|Overall Study|Withdrawal by Subject|3
1045038|NCT01786512|2082166|FG010|Overall Study|Withdrawal by Subject|7
1045039|NCT01786512|2082156|FG000|Overall Study|Death|0
1045040|NCT01786512|2082157|FG001|Overall Study|Death|0
1045041|NCT01786512|2082158|FG002|Overall Study|Death|0
1045042|NCT01786512|2082159|FG003|Overall Study|Death|0
1045043|NCT01786512|2082160|FG004|Overall Study|Death|0
1045044|NCT01786512|2082161|FG005|Overall Study|Death|0
1045045|NCT01786512|2082162|FG006|Overall Study|Death|0
1045046|NCT01786512|2082163|FG007|Overall Study|Death|0
1045047|NCT01786512|2082164|FG008|Overall Study|Death|4
1045048|NCT01786512|2082165|FG009|Overall Study|Death|1
1045049|NCT01786512|2082166|FG010|Overall Study|Death|3
1045050|NCT01786551|2082198|FG000|Overall Study|Participant withdrew consent|2
1045051|NCT01786564|2082202|FG000|Overall Study|Lost to Follow-up|47
1045052|NCT01786564|2082202|FG000|Overall Study|Ineligible|17
1045053|NCT01786603|2082208|FG000|Overall Study|Death|5
1045054|NCT01786603|2082209|FG001|Overall Study|Death|1
1045055|NCT01786603|2082208|FG000|Overall Study|Adverse Event|6
1045056|NCT01786603|2082209|FG001|Overall Study|Adverse Event|2
1045057|NCT01786603|2082208|FG000|Overall Study|Physician decision to withdraw|6
1045058|NCT01786603|2082209|FG001|Overall Study|Physician decision to withdraw|7
1045059|NCT01786603|2082208|FG000|Overall Study|Lost to Follow-up|1
1045060|NCT01786603|2082209|FG001|Overall Study|Lost to Follow-up|2
1045061|NCT01786629|2082217|FG000|Overall Study|Lack of Efficacy|0
1045062|NCT01786629|2082218|FG001|Overall Study|Lack of Efficacy|4
1045063|NCT01786629|2082217|FG000|Overall Study|Adverse Event|0
1045064|NCT01786629|2082218|FG001|Overall Study|Adverse Event|1
1045065|NCT01786668|2082228|FG000|Overall Study|Adverse Event|0
1045066|NCT01786668|2082229|FG001|Overall Study|Adverse Event|1
1045067|NCT01786668|2082230|FG002|Overall Study|Adverse Event|1
1045068|NCT01786668|2082231|FG003|Overall Study|Adverse Event|2
1045069|NCT01786668|2082228|FG000|Overall Study|Withdrawal by Subject|0
1045070|NCT01786668|2082229|FG001|Overall Study|Withdrawal by Subject|0
1045071|NCT01786668|2082230|FG002|Overall Study|Withdrawal by Subject|3
1045072|NCT01786668|2082231|FG003|Overall Study|Withdrawal by Subject|1
1045073|NCT01786668|2082228|FG000|Overall Study|Pregnancy|0
1045074|NCT01786668|2082229|FG001|Overall Study|Pregnancy|0
1045075|NCT01786668|2082230|FG002|Overall Study|Pregnancy|0
1045076|NCT01786668|2082231|FG003|Overall Study|Pregnancy|1
1045077|NCT01786668|2082228|FG000|Overall Study|Lost to Follow-up|1
1045078|NCT01786668|2082229|FG001|Overall Study|Lost to Follow-up|0
1045079|NCT01786668|2082230|FG002|Overall Study|Lost to Follow-up|1
1045080|NCT01786668|2082231|FG003|Overall Study|Lost to Follow-up|0
1045081|NCT01786707|2082243|FG000|Overall Study|Lost to Follow-up|1
1045082|NCT01786707|2082244|FG001|Overall Study|Lost to Follow-up|1
1045083|NCT01786993|2082285|FG000|Overall Study|Death|6
1045084|NCT01786993|2082286|FG001|Overall Study|Death|7
1045085|NCT01786993|2082285|FG000|Overall Study|Withdrawal by Subject|3
1045086|NCT01786993|2082286|FG001|Overall Study|Withdrawal by Subject|2
1045087|NCT01786993|2082285|FG000|Overall Study|Lost to Follow-up|0
1045088|NCT01786993|2082286|FG001|Overall Study|Lost to Follow-up|1
1045089|NCT01786993|2082285|FG000|Overall Study|Subject Non-Compliance|1
1045090|NCT01786993|2082286|FG001|Overall Study|Subject Non-Compliance|0
1045091|NCT01786993|2082285|FG000|Overall Study|System Explant|1
1045092|NCT01786993|2082286|FG001|Overall Study|System Explant|0
1045093|NCT01786993|2082285|FG000|Overall Study|Hospice Admission|1
1045094|NCT01786993|2082286|FG001|Overall Study|Hospice Admission|0
1045095|NCT01787032|2082308|FG000|Overall Study|Protocol Violation|0
1045096|NCT01787032|2082309|FG001|Overall Study|Protocol Violation|0
1045097|NCT01787032|2082310|FG002|Overall Study|Protocol Violation|0
1045098|NCT01787032|2082311|FG003|Overall Study|Protocol Violation|0
1045099|NCT01787032|2082312|FG004|Overall Study|Protocol Violation|1
1045100|NCT01787032|2082313|FG005|Overall Study|Protocol Violation|1
1045101|NCT01787097|2082323|FG000|Overall Study|Withdrawal by Subject|1
1045102|NCT01787097|2082324|FG001|Overall Study|Withdrawal by Subject|0
1045103|NCT01787097|2082325|FG002|Overall Study|Withdrawal by Subject|0
1045104|NCT01787097|2082326|FG003|Overall Study|Withdrawal by Subject|0
1045105|NCT01787188|2082358|FG000|Overall Study|Adverse Event|2
1045106|NCT01787188|2082359|FG001|Overall Study|Adverse Event|4
1045107|NCT01787188|2082360|FG002|Overall Study|Adverse Event|6
1045108|NCT01787188|2082358|FG000|Overall Study|Lack of Efficacy|7
1045109|NCT01787188|2082359|FG001|Overall Study|Lack of Efficacy|3
1045110|NCT01787188|2082360|FG002|Overall Study|Lack of Efficacy|5
1045111|NCT01787188|2082358|FG000|Overall Study|Non-compliance with Study Drug|0
1045112|NCT01787188|2082359|FG001|Overall Study|Non-compliance with Study Drug|1
1045113|NCT01787188|2082360|FG002|Overall Study|Non-compliance with Study Drug|0
1045114|NCT01787188|2082358|FG000|Overall Study|Withdrawal by Subject|4
1045115|NCT01787188|2082359|FG001|Overall Study|Withdrawal by Subject|3
1045116|NCT01787188|2082360|FG002|Overall Study|Withdrawal by Subject|2
1045117|NCT01787188|2082358|FG000|Overall Study|Protocol Violation|3
1045118|NCT01787188|2082359|FG001|Overall Study|Protocol Violation|2
1045119|NCT01787188|2082360|FG002|Overall Study|Protocol Violation|3
1045120|NCT01787188|2082358|FG000|Overall Study|Lost to Follow-up|1
1045121|NCT01787188|2082359|FG001|Overall Study|Lost to Follow-up|2
1045122|NCT01787188|2082360|FG002|Overall Study|Lost to Follow-up|2
1045123|NCT01787188|2082358|FG000|Overall Study|Other, including patient moved|0
1045124|NCT01787188|2082359|FG001|Overall Study|Other, including patient moved|3
1045125|NCT01787188|2082360|FG002|Overall Study|Other, including patient moved|0
1045126|NCT01787279|2082380|FG000|Overall Study|Lost to Follow-up|2
1045127|NCT01787279|2082380|FG000|Overall Study|Lack of Efficacy|1
1045128|NCT01787292|2082384|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2
1045129|NCT01787292|2082385|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2
1045130|NCT01787292|2082384|FG000|Home Based Exercise Program|Withdrawal by Subject|3
1045131|NCT01787292|2082385|FG001|Home Based Exercise Program|Withdrawal by Subject|1
1045132|NCT01787331|2082396|FG000|Overall Study|Physician Decision|1
1045133|NCT01787331|2082396|FG000|Overall Study|Withdrawal by Subject|1
1045134|NCT01787461|2082419|FG000|Overall Study|Adverse Event|4
1045135|NCT01787461|2082420|FG001|Overall Study|Adverse Event|3
1045136|NCT01787461|2082419|FG000|Overall Study|Lost to Follow-up|3
1045137|NCT01787461|2082420|FG001|Overall Study|Lost to Follow-up|2
1045138|NCT01787461|2082419|FG000|Overall Study|No longer met eligibility criteria|1
1045139|NCT01787461|2082420|FG001|Overall Study|No longer met eligibility criteria|0
1045140|NCT01787461|2082419|FG000|Overall Study|Withdrawal by Subject|3
1045141|NCT01787461|2082420|FG001|Overall Study|Withdrawal by Subject|4
1045142|NCT01787461|2082419|FG000|Overall Study|Protocol Violation|3
1045143|NCT01787461|2082420|FG001|Overall Study|Protocol Violation|0
1045144|NCT01787591|2082450|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1045145|NCT01787591|2082451|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1045146|NCT01787591|2082452|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1045147|NCT01787591|2082453|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
1045148|NCT01787760|2082476|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1
1045149|NCT01787760|2082477|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0
1045150|NCT01787760|2082478|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0
1045151|NCT01787760|2082476|FG000|Overall Study|Decompensated on left exotropia|0
1045152|NCT01787760|2082477|FG001|Overall Study|Decompensated on left exotropia|0
1045153|NCT01787760|2082478|FG002|Overall Study|Decompensated on left exotropia|1
1045154|NCT01787760|2082476|FG000|Overall Study|Dryness|0
1045155|NCT01787760|2082477|FG001|Overall Study|Dryness|1
1045156|NCT01787760|2082478|FG002|Overall Study|Dryness|0
1045157|NCT01787760|2082476|FG000|Overall Study|Relocation|1
1045158|NCT01787760|2082477|FG001|Overall Study|Relocation|1
1045159|NCT01787760|2082478|FG002|Overall Study|Relocation|0
1045160|NCT01787760|2082476|FG000|Overall Study|Lens discomfort|3
1045161|NCT01787760|2082477|FG001|Overall Study|Lens discomfort|0
1045162|NCT01787760|2082478|FG002|Overall Study|Lens discomfort|0
1045163|NCT01787760|2082476|FG000|Overall Study|Lens handling difficulty|1
1045164|NCT01787760|2082477|FG001|Overall Study|Lens handling difficulty|2
1045165|NCT01787760|2082478|FG002|Overall Study|Lens handling difficulty|0
1045166|NCT01787760|2082476|FG000|Overall Study|Protocol Violation|6
1045167|NCT01787760|2082477|FG001|Overall Study|Protocol Violation|0
1045168|NCT01787760|2082478|FG002|Overall Study|Protocol Violation|1
1045169|NCT01787760|2082476|FG000|Overall Study|Withdrawal by Subject|5
1045170|NCT01787760|2082477|FG001|Overall Study|Withdrawal by Subject|1
1045171|NCT01787760|2082478|FG002|Overall Study|Withdrawal by Subject|2
1045172|NCT01787760|2082476|FG000|Overall Study|Lost to Follow-up|1
1045173|NCT01787760|2082477|FG001|Overall Study|Lost to Follow-up|0
1045174|NCT01787760|2082478|FG002|Overall Study|Lost to Follow-up|1
1045175|NCT01787760|2082476|FG000|Overall Study|Stroke|1
1045176|NCT01787760|2082477|FG001|Overall Study|Stroke|0
1045177|NCT01787760|2082478|FG002|Overall Study|Stroke|0
1045178|NCT01787760|2082476|FG000|Overall Study|Unsatisfactory lens fitting performance|3
1045179|NCT01787760|2082477|FG001|Overall Study|Unsatisfactory lens fitting performance|6
1045180|NCT01787760|2082478|FG002|Overall Study|Unsatisfactory lens fitting performance|0
1045181|NCT01787760|2082476|FG000|Overall Study|Unsatisfactory physiological response|2
1045182|NCT01787760|2082477|FG001|Overall Study|Unsatisfactory physiological response|4
1045183|NCT01787760|2082478|FG002|Overall Study|Unsatisfactory physiological response|0
1045184|NCT01787760|2082476|FG000|Overall Study|Unsatisfactory visual response|1
1045185|NCT01787760|2082477|FG001|Overall Study|Unsatisfactory visual response|1
1045186|NCT01787760|2082478|FG002|Overall Study|Unsatisfactory visual response|0
1045187|NCT01787760|2082476|FG000|Overall Study|Near vision blur|1
1045188|NCT01787760|2082477|FG001|Overall Study|Near vision blur|0
1045189|NCT01787760|2082478|FG002|Overall Study|Near vision blur|0
1045190|NCT01787825|2082491|FG000|Overall Study|Subject Did Not Ingest Capsules|1
1045191|NCT01787825|2082492|FG001|Overall Study|Subject Did Not Ingest Capsules|0
1045192|NCT01787825|2082491|FG000|Overall Study|Data Not Analyzable|5
1045193|NCT01787825|2082492|FG001|Overall Study|Data Not Analyzable|1
1045194|NCT01787838|2082499|FG000|Overall Study|refused|1413
1045195|NCT01788046|2082512|FG000|Overall Study|Withdrawal by Subject|12
1045196|NCT01788046|2082513|FG001|Overall Study|Withdrawal by Subject|12
1045197|NCT01788046|2082512|FG000|Overall Study|Lost to Follow-up|12
1045198|NCT01788046|2082513|FG001|Overall Study|Lost to Follow-up|19
1045199|NCT01788046|2082512|FG000|Overall Study|Death|7
1045200|NCT01788046|2082513|FG001|Overall Study|Death|5
1045201|NCT01788046|2082512|FG000|Overall Study|Protocol Specified Criteria|25
1045202|NCT01788046|2082513|FG001|Overall Study|Protocol Specified Criteria|1
1045203|NCT01788163|2082537|FG000|Overall Study|Other|53
1045204|NCT01788163|2082538|FG001|Overall Study|Other|0
1045205|NCT01788163|2082539|FG002|Overall Study|Other|0
1045206|NCT01788163|2082540|FG003|Overall Study|Other|0
1045207|NCT01788163|2082541|FG004|Overall Study|Other|0
1045208|NCT01788163|2082542|FG005|Overall Study|Other|7
1045209|NCT01788163|2082543|FG006|Overall Study|Other|1
1045210|NCT01788163|2082544|FG007|Overall Study|Other|48
1045211|NCT01788163|2082545|FG008|Overall Study|Other|15
1045212|NCT01788163|2082537|FG000|Overall Study|Withdrawal by Subject|2
1045213|NCT01788163|2082538|FG001|Overall Study|Withdrawal by Subject|0
1045214|NCT01788163|2082539|FG002|Overall Study|Withdrawal by Subject|0
1045215|NCT01788163|2082540|FG003|Overall Study|Withdrawal by Subject|0
1045216|NCT01788163|2082541|FG004|Overall Study|Withdrawal by Subject|0
1045217|NCT01788163|2082542|FG005|Overall Study|Withdrawal by Subject|0
1045218|NCT01788163|2082543|FG006|Overall Study|Withdrawal by Subject|0
1045219|NCT01788163|2082544|FG007|Overall Study|Withdrawal by Subject|0
1045220|NCT01788163|2082545|FG008|Overall Study|Withdrawal by Subject|1
1045221|NCT01788215|2082626|FG000|Overall Study|Withdrawal by Subject|0
1045222|NCT01788215|2082627|FG001|Overall Study|Withdrawal by Subject|1
1045223|NCT01788215|2082626|FG000|Overall Study|Lost to Follow-up|2
1045224|NCT01788215|2082627|FG001|Overall Study|Lost to Follow-up|0
1045225|NCT01788228|2082635|FG000|Overall Study|Migrated/moved from study area|1
1045226|NCT01788228|2082636|FG001|Overall Study|Migrated/moved from study area|0
1045227|NCT01788358|2082645|FG000|Overall Study|Other|11
1045228|NCT01788358|2082645|FG000|Overall Study|Logistical difficulties|1
1045229|NCT01788358|2082645|FG000|Overall Study|Lost to Follow-up|5
1045230|NCT01788358|2082645|FG000|Overall Study|Protocol Violation|3
1045231|NCT01788358|2082645|FG000|Overall Study|Withdrawal by Subject|26
1045232|NCT01788358|2082645|FG000|Overall Study|Lack of Efficacy|1
1045233|NCT01788358|2082645|FG000|Overall Study|Adverse Event|51
1045234|NCT01788423|2082652|FG000|Overall Study|See Comments in Completed (above)|0
1045235|NCT01788423|2082653|FG001|Overall Study|See Comments in Completed (above)|4
1045236|NCT01788423|2082654|FG002|Overall Study|See Comments in Completed (above)|5
1045237|NCT01788566|2082662|FG000|Overall Study|Death|4
1045238|NCT01788566|2082662|FG000|Overall Study|Adverse Event|1
1045239|NCT01788566|2082662|FG000|Overall Study|Clinical Progressive Disease|3
1045240|NCT01788943|2082677|FG000|Overall Study|Withdrawal by Subject|1
1045241|NCT01788943|2082678|FG001|Overall Study|Withdrawal by Subject|0
1045242|NCT01789047|2082686|FG000|Overall Study|Adverse Event|3
1045243|NCT01789047|2082687|FG001|Overall Study|Adverse Event|2
1045244|NCT01789047|2082686|FG000|Overall Study|Withdrawal by Subject|1
1045245|NCT01789047|2082687|FG001|Overall Study|Withdrawal by Subject|2
1045246|NCT01789203|2082704|FG000|Overall Study|Adverse Event|2
1045247|NCT01789203|2082705|FG001|Overall Study|Adverse Event|2
1045248|NCT01789203|2082704|FG000|Overall Study|Withdrawal by Subject|1
1045249|NCT01789203|2082705|FG001|Overall Study|Withdrawal by Subject|0
1045250|NCT01789203|2082704|FG000|Overall Study|Death|1
1045251|NCT01789203|2082705|FG001|Overall Study|Death|0
1045252|NCT01789203|2082704|FG000|Overall Study|Protocol Violation|2
1045253|NCT01789203|2082705|FG001|Overall Study|Protocol Violation|1
1045254|NCT01789203|2082704|FG000|Overall Study|Other|1
1045255|NCT01789203|2082705|FG001|Overall Study|Other|1
1045256|NCT01789203|2082704|FG000|Overall Study|patient non-adherent|2
1045257|NCT01789203|2082705|FG001|Overall Study|patient non-adherent|0
1045258|NCT01789281|2082719|FG000|Overall Study|Disease progression|15
1045259|NCT01789281|2082720|FG001|Overall Study|Disease progression|4
1045260|NCT01789281|2082719|FG000|Overall Study|Adverse Event|5
1045261|NCT01789281|2082720|FG001|Overall Study|Adverse Event|5
1045262|NCT01789281|2082719|FG000|Overall Study|Withdrawal by Subject|1
1045263|NCT01789281|2082720|FG001|Overall Study|Withdrawal by Subject|0
1045264|NCT01789281|2082719|FG000|Overall Study|Lost to Follow-up|1
1045265|NCT01789281|2082720|FG001|Overall Study|Lost to Follow-up|0
1045266|NCT01789281|2082719|FG000|Overall Study|Administrative problems|0
1045267|NCT01789281|2082720|FG001|Overall Study|Administrative problems|1
1045268|NCT01789320|2082727|FG000|Overall Study|Re-enrolled into study|1
1045269|NCT01789320|2082727|FG000|Overall Study|Lost to Follow-up|1
1045270|NCT01789476|2082733|FG000|Overall Study|Lack of Efficacy|6
1045271|NCT01789476|2082734|FG001|Overall Study|Lack of Efficacy|2
1045272|NCT01789476|2082733|FG000|Overall Study|Adverse Event|1
1045273|NCT01789476|2082734|FG001|Overall Study|Adverse Event|0
1045274|NCT01789476|2082733|FG000|Overall Study|Unable to get IV access|1
1045275|NCT01789476|2082734|FG001|Overall Study|Unable to get IV access|0
1045276|NCT01789567|2082740|FG000|Overall Study|Death|6
1045277|NCT01789606|2082746|FG000|Overall Study|Participant not Purchased the Product|0
1045278|NCT01789606|2082747|FG001|Overall Study|Participant not Purchased the Product|20
1045279|NCT01789606|2082746|FG000|Overall Study|Withdrawal by Subject|0
1045280|NCT01789606|2082747|FG001|Overall Study|Withdrawal by Subject|1
1045281|NCT01789606|2082746|FG000|Overall Study|Ineligible|6
1045282|NCT01789606|2082747|FG001|Overall Study|Ineligible|2
1045283|NCT01789606|2082746|FG000|Overall Study|Administrative Reasons|17
1045284|NCT01789606|2082747|FG001|Overall Study|Administrative Reasons|6
1045285|NCT01789606|2082746|FG000|Overall Study|No Study Medication Taken|0
1045286|NCT01789606|2082747|FG001|Overall Study|No Study Medication Taken|1
1045287|NCT01789606|2082746|FG000|Overall Study|Protocol Violation|0
1045288|NCT01789606|2082747|FG001|Overall Study|Protocol Violation|55
1045289|NCT01789606|2082746|FG000|Overall Study|Adverse Event|0
1045290|NCT01789606|2082747|FG001|Overall Study|Adverse Event|3
1045291|NCT01789606|2082746|FG000|Overall Study|Lost to Follow-up|0
1045292|NCT01789606|2082747|FG001|Overall Study|Lost to Follow-up|14
1045293|NCT01789606|2082746|FG000|Overall Study|Ineligible or not Willing to Continue|0
1045294|NCT01789606|2082747|FG001|Overall Study|Ineligible or not Willing to Continue|348
1045295|NCT01789970|2082787|FG000|Open-label Titration Period|Adverse Event|68
1045296|NCT01789970|2082788|FG001|Open-label Titration Period|Adverse Event|0
1045297|NCT01789970|2082789|FG002|Open-label Titration Period|Adverse Event|0
1045298|NCT01789970|2082787|FG000|Open-label Titration Period|Lack of Efficacy|31
1045299|NCT01789970|2082788|FG001|Open-label Titration Period|Lack of Efficacy|0
1045300|NCT01789970|2082789|FG002|Open-label Titration Period|Lack of Efficacy|0
1045301|NCT01789970|2082787|FG000|Open-label Titration Period|Withdrawal by Subject|31
1045302|NCT01789970|2082788|FG001|Open-label Titration Period|Withdrawal by Subject|0
1045303|NCT01789970|2082789|FG002|Open-label Titration Period|Withdrawal by Subject|0
1045304|NCT01789970|2082787|FG000|Open-label Titration Period|Protocol Violation|18
1045305|NCT01789970|2082788|FG001|Open-label Titration Period|Protocol Violation|0
1045306|NCT01789970|2082789|FG002|Open-label Titration Period|Protocol Violation|0
1045307|NCT01789970|2082787|FG000|Open-label Titration Period|Lost to Follow-up|5
1045308|NCT01789970|2082788|FG001|Open-label Titration Period|Lost to Follow-up|0
1045309|NCT01789970|2082789|FG002|Open-label Titration Period|Lost to Follow-up|0
1045310|NCT01789970|2082787|FG000|Open-label Titration Period|Noncompliance to study drug admin|11
1045311|NCT01789970|2082788|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
1045312|NCT01789970|2082789|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
1045313|NCT01789970|2082787|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2
1045314|NCT01789970|2082788|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0
1045315|NCT01789970|2082789|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0
1045316|NCT01789970|2082787|FG000|Open-label Titration Period|Noncompliance with study procedures|8
1045317|NCT01789970|2082788|FG001|Open-label Titration Period|Noncompliance with study procedures|0
1045318|NCT01789970|2082789|FG002|Open-label Titration Period|Noncompliance with study procedures|0
1045319|NCT01789970|2082787|FG000|Open-label Titration Period|Pregnancy|2
1045320|NCT01789970|2082788|FG001|Open-label Titration Period|Pregnancy|0
1045321|NCT01789970|2082789|FG002|Open-label Titration Period|Pregnancy|0
1045322|NCT01789970|2082787|FG000|Open-label Titration Period|Other|76
1045323|NCT01789970|2082788|FG001|Open-label Titration Period|Other|0
1045324|NCT01789970|2082789|FG002|Open-label Titration Period|Other|0
1045325|NCT01789970|2082787|FG000|Open-label Titration Period|Dropped out prior to dosing|2
1045326|NCT01789970|2082788|FG001|Open-label Titration Period|Dropped out prior to dosing|0
1045327|NCT01789970|2082789|FG002|Open-label Titration Period|Dropped out prior to dosing|0
1045328|NCT01789970|2082787|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
1045329|NCT01789970|2082788|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
1045330|NCT01789970|2082789|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
1045331|NCT01789970|2082787|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1045332|NCT01789970|2082788|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
1045333|NCT01789970|2082789|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
1045334|NCT01789970|2082787|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1045335|NCT01789970|2082788|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
1045336|NCT01789970|2082789|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
1045337|NCT01789970|2082787|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
1045338|NCT01789970|2082788|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
1045339|NCT01789970|2082789|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
1045340|NCT01789970|2082787|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
1045341|NCT01789970|2082788|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
1045342|NCT01789970|2082789|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
1045343|NCT01789970|2082787|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
1045344|NCT01789970|2082788|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
1045345|NCT01789970|2082789|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
1045346|NCT01789970|2082787|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
1045347|NCT01789970|2082788|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
1045348|NCT01789970|2082789|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
1045349|NCT01789970|2082787|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
1045350|NCT01789970|2082788|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
1045351|NCT01789970|2082789|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
1045352|NCT01789970|2082787|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
906428|NCT00768300|1882114|FG000|Overall Study|Physician Decision|2
906429|NCT00768300|1882115|FG001|Overall Study|Physician Decision|3
906430|NCT00768300|1882114|FG000|Overall Study|Study discontinued by Sponsor|271
906431|NCT00768300|1882115|FG001|Overall Study|Study discontinued by Sponsor|140
906432|NCT00768300|1882114|FG000|Overall Study|Death|21
906433|NCT00768300|1882115|FG001|Overall Study|Death|5
906434|NCT00768300|1882114|FG000|Overall Study|Subject moved to pursue lung transplant|1
906435|NCT00768300|1882115|FG001|Overall Study|Subject moved to pursue lung transplant|1
906436|NCT00768300|1882114|FG000|Overall Study|Screen failure following randomization|1
906437|NCT00768300|1882115|FG001|Overall Study|Screen failure following randomization|0
906438|NCT00768300|1882114|FG000|Overall Study|Received lung transplant|1
906439|NCT00768300|1882115|FG001|Overall Study|Received lung transplant|1
906440|NCT00768300|1882114|FG000|Overall Study|Lost to Follow-up|0
906441|NCT00768300|1882115|FG001|Overall Study|Lost to Follow-up|1
906442|NCT00768300|1882114|FG000|Overall Study|Began prohibited concomitant medication|0
906443|NCT00768300|1882115|FG001|Overall Study|Began prohibited concomitant medication|1
906444|NCT00768300|1882114|FG000|Overall Study|Treated but never dosed with Study drug|1
906445|NCT00768300|1882115|FG001|Overall Study|Treated but never dosed with Study drug|0
906446|NCT00768300|1882114|FG000|Overall Study|Missing data|1
906447|NCT00768300|1882115|FG001|Overall Study|Missing data|0
906448|NCT00768430|1882123|FG000|7 Day Endpoint|Withdrawal by Subject|2
906449|NCT00768430|1882124|FG001|7 Day Endpoint|Withdrawal by Subject|3
906450|NCT00768469|1882132|FG000|Overall Study|Adverse Event|0
906451|NCT00768469|1882133|FG001|Overall Study|Adverse Event|2
906452|NCT00768469|1882132|FG000|Overall Study|Disease Progression|3
906453|NCT00768469|1882133|FG001|Overall Study|Disease Progression|4
906454|NCT00768469|1882132|FG000|Overall Study|Withdrawal by Subject|0
906455|NCT00768469|1882133|FG001|Overall Study|Withdrawal by Subject|1
906456|NCT00768560|1882153|FG000|Intervention Set 1|Adverse Event|0
906457|NCT00768560|1882154|FG001|Intervention Set 1|Adverse Event|1
906458|NCT00768560|1882155|FG002|Intervention Set 1|Adverse Event|0
906459|NCT00768560|1882156|FG003|Intervention Set 1|Adverse Event|0
906460|NCT00768560|1882157|FG004|Intervention Set 1|Adverse Event|0
906461|NCT00768560|1882158|FG005|Intervention Set 1|Adverse Event|0
906462|NCT00768651|1882179|FG000|Overall Study|Withdrawal by Subject|1
906463|NCT00768664|1882184|FG000|Overall Study|Death|57
906464|NCT00768664|1882184|FG000|Overall Study|Lost to Follow-up|2
906465|NCT00768664|1882184|FG000|Overall Study|Other|9
906466|NCT00768664|1882184|FG000|Overall Study|Participant refused|1
906467|NCT00768755|1882204|FG000|Phase 1|Death|6
906468|NCT00768755|1882205|FG001|Phase 1|Death|0
906469|NCT00768755|1882206|FG002|Phase 1|Death|0
906470|NCT00768755|1882207|FG003|Phase 1|Death|0
906471|NCT00768755|1882204|FG000|Phase 1|Other|4
906472|NCT00768755|1882205|FG001|Phase 1|Other|0
906473|NCT00768755|1882206|FG002|Phase 1|Other|0
906474|NCT00768755|1882207|FG003|Phase 1|Other|0
906475|NCT00768755|1882204|FG000|Phase 2|Death|0
906476|NCT00768755|1882205|FG001|Phase 2|Death|37
906477|NCT00768755|1882206|FG002|Phase 2|Death|48
906478|NCT00768755|1882207|FG003|Phase 2|Death|31
906479|NCT00768755|1882204|FG000|Phase 2|Protocol Violation|0
906480|NCT00768755|1882205|FG001|Phase 2|Protocol Violation|2
906481|NCT00768755|1882206|FG002|Phase 2|Protocol Violation|0
906482|NCT00768755|1882207|FG003|Phase 2|Protocol Violation|1
906483|NCT00768755|1882204|FG000|Phase 2|Lost to Follow-up|0
906484|NCT00768755|1882205|FG001|Phase 2|Lost to Follow-up|1
906485|NCT00768755|1882206|FG002|Phase 2|Lost to Follow-up|1
906486|NCT00768755|1882207|FG003|Phase 2|Lost to Follow-up|4
906487|NCT00768755|1882204|FG000|Phase 2|Withdrawal by Subject|0
906488|NCT00768755|1882205|FG001|Phase 2|Withdrawal by Subject|1
906489|NCT00768755|1882206|FG002|Phase 2|Withdrawal by Subject|0
906490|NCT00768755|1882207|FG003|Phase 2|Withdrawal by Subject|1
906491|NCT00768755|1882204|FG000|Phase 2|Other|0
906492|NCT00768755|1882205|FG001|Phase 2|Other|1
906493|NCT00768755|1882206|FG002|Phase 2|Other|2
906494|NCT00768755|1882207|FG003|Phase 2|Other|4
906495|NCT00768755|1882204|FG000|Phase 2|Study Terminated by Sponsor|0
906496|NCT00768755|1882205|FG001|Phase 2|Study Terminated by Sponsor|13
906497|NCT00768755|1882206|FG002|Phase 2|Study Terminated by Sponsor|7
906498|NCT00768755|1882207|FG003|Phase 2|Study Terminated by Sponsor|14
906499|NCT00768755|1882204|FG000|Phase 2|Randomized but not treated|0
906500|NCT00768755|1882205|FG001|Phase 2|Randomized but not treated|0
906501|NCT00768755|1882206|FG002|Phase 2|Randomized but not treated|0
906502|NCT00768755|1882207|FG003|Phase 2|Randomized but not treated|2
906503|NCT00768898|1882216|FG000|Overall Study|Unrelated injury|1
1045353|NCT01789970|2082788|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
1045354|NCT01789970|2082789|FG002|Double-blind Treatment Period (12 Weeks)|Other|3
1045355|NCT01789970|2082787|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
1045356|NCT01789970|2082788|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
1045357|NCT01789970|2082789|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
1045358|NCT01790048|2082805|FG000|Overall Study|Incorrect Age|9
1045359|NCT01790048|2082806|FG001|Overall Study|Incorrect Age|14
1045360|NCT01790048|2082805|FG000|Overall Study|data entry error|0
1045361|NCT01790048|2082806|FG001|Overall Study|data entry error|1
1045362|NCT01790048|2082805|FG000|Overall Study|Other|0
1045363|NCT01790048|2082806|FG001|Overall Study|Other|2
1045364|NCT01790048|2082805|FG000|Overall Study|SAM at Enrollment|2
1045365|NCT01790048|2082806|FG001|Overall Study|SAM at Enrollment|0
1045366|NCT01790048|2082805|FG000|Overall Study|Measurement error|1
1045367|NCT01790048|2082806|FG001|Overall Study|Measurement error|0
1045368|NCT01790113|2082816|FG000|Overall Study|Adverse Event|2
1045369|NCT01790113|2082817|FG001|Overall Study|Adverse Event|7
1045370|NCT01790113|2082816|FG000|Overall Study|Study ended due to FDA clearance|1
1045371|NCT01790113|2082817|FG001|Overall Study|Study ended due to FDA clearance|68
1045372|NCT01790126|2082826|FG000|Overall Study|PSA Progression|12
1045373|NCT01790126|2082827|FG001|Overall Study|PSA Progression|16
1045374|NCT01790126|2082828|FG002|Overall Study|PSA Progression|16
1045375|NCT01790126|2082826|FG000|Overall Study|Other|5
1045376|NCT01790126|2082827|FG001|Overall Study|Other|4
1045377|NCT01790126|2082828|FG002|Overall Study|Other|8
1045378|NCT01790126|2082826|FG000|Overall Study|Initiation of Non-Protocol Therapy|3
1045379|NCT01790126|2082827|FG001|Overall Study|Initiation of Non-Protocol Therapy|4
1045380|NCT01790126|2082828|FG002|Overall Study|Initiation of Non-Protocol Therapy|2
1045381|NCT01790126|2082826|FG000|Overall Study|Withdrawal by Physician|1
1045382|NCT01790126|2082827|FG001|Overall Study|Withdrawal by Physician|1
1045383|NCT01790126|2082828|FG002|Overall Study|Withdrawal by Physician|2
1045384|NCT01790126|2082826|FG000|Overall Study|Withdrawal by Subject|3
1045385|NCT01790126|2082827|FG001|Overall Study|Withdrawal by Subject|1
1045386|NCT01790126|2082828|FG002|Overall Study|Withdrawal by Subject|2
1045387|NCT01790126|2082826|FG000|Overall Study|Lost to Follow-up|1
1045388|NCT01790126|2082827|FG001|Overall Study|Lost to Follow-up|0
1045389|NCT01790126|2082828|FG002|Overall Study|Lost to Follow-up|1
1045390|NCT01790126|2082826|FG000|Overall Study|Adverse Event|0
1045391|NCT01790126|2082827|FG001|Overall Study|Adverse Event|2
1045392|NCT01790126|2082828|FG002|Overall Study|Adverse Event|0
1045393|NCT01790126|2082826|FG000|Overall Study|Death|2
1045394|NCT01790126|2082827|FG001|Overall Study|Death|0
1045395|NCT01790126|2082828|FG002|Overall Study|Death|0
1045396|NCT01790126|2082826|FG000|Overall Study|Radiographic Progression|3
1045397|NCT01790126|2082827|FG001|Overall Study|Radiographic Progression|1
1045398|NCT01790126|2082828|FG002|Overall Study|Radiographic Progression|0
1045399|NCT01790295|2082855|FG000|Overall Study|Adverse Event|1
1045400|NCT01790295|2082855|FG000|Overall Study|Death|4
1045401|NCT01790295|2082855|FG000|Overall Study|Lack of Efficacy|2
1045402|NCT01790295|2082855|FG000|Overall Study|Study closure|4
1045403|NCT01790438|2082862|FG000|Overall Study|Adverse Event|3
1045404|NCT01790438|2082863|FG001|Overall Study|Adverse Event|2
1045405|NCT01790438|2082862|FG000|Overall Study|Death|4
1045406|NCT01790438|2082863|FG001|Overall Study|Death|0
1045407|NCT01790438|2082862|FG000|Overall Study|Lost to Follow-up|5
1045408|NCT01790438|2082863|FG001|Overall Study|Lost to Follow-up|2
1045409|NCT01790438|2082862|FG000|Overall Study|Withdrawal by Subject|13
1045410|NCT01790438|2082863|FG001|Overall Study|Withdrawal by Subject|2
1045411|NCT01790438|2082862|FG000|Overall Study|Physician Decision|3
1045412|NCT01790438|2082863|FG001|Overall Study|Physician Decision|1
1045413|NCT01790438|2082862|FG000|Overall Study|Sponsor Decision|0
1045414|NCT01790438|2082863|FG001|Overall Study|Sponsor Decision|3
1045415|NCT01790438|2082862|FG000|Overall Study|Protocol Required Discontinuation|7
1045416|NCT01790438|2082863|FG001|Overall Study|Protocol Required Discontinuation|1
1045417|NCT01790503|2082898|FG000|Overall Study|Adverse Event|1
1045418|NCT01790503|2082899|FG001|Overall Study|Adverse Event|0
1045419|NCT01790503|2082900|FG002|Overall Study|Adverse Event|0
1045420|NCT01790503|2082901|FG003|Overall Study|Adverse Event|0
1045421|NCT01790503|2082902|FG004|Overall Study|Adverse Event|0
1045422|NCT01790503|2082903|FG005|Overall Study|Adverse Event|2
1045423|NCT01790503|2082904|FG006|Overall Study|Adverse Event|0
1045424|NCT01790503|2082905|FG007|Overall Study|Adverse Event|0
1045425|NCT01790503|2082906|FG008|Overall Study|Adverse Event|2
1045426|NCT01790503|2082907|FG009|Overall Study|Adverse Event|4
1045427|NCT01790503|2082908|FG010|Overall Study|Adverse Event|7
1045428|NCT01790503|2082898|FG000|Overall Study|Withdrawal by Subject|0
1045429|NCT01790503|2082899|FG001|Overall Study|Withdrawal by Subject|0
1045430|NCT01790503|2082900|FG002|Overall Study|Withdrawal by Subject|1
1045431|NCT01790503|2082901|FG003|Overall Study|Withdrawal by Subject|1
1045432|NCT01790503|2082902|FG004|Overall Study|Withdrawal by Subject|1
1045433|NCT01790503|2082903|FG005|Overall Study|Withdrawal by Subject|2
1045434|NCT01790503|2082904|FG006|Overall Study|Withdrawal by Subject|1
1045435|NCT01790503|2082905|FG007|Overall Study|Withdrawal by Subject|0
1045436|NCT01790503|2082906|FG008|Overall Study|Withdrawal by Subject|0
1045437|NCT01790503|2082907|FG009|Overall Study|Withdrawal by Subject|0
1045438|NCT01790503|2082908|FG010|Overall Study|Withdrawal by Subject|1
1045439|NCT01790503|2082898|FG000|Overall Study|Disease progression|2
1045440|NCT01790503|2082899|FG001|Overall Study|Disease progression|1
1045441|NCT01790503|2082900|FG002|Overall Study|Disease progression|0
1045442|NCT01790503|2082901|FG003|Overall Study|Disease progression|1
1045443|NCT01790503|2082902|FG004|Overall Study|Disease progression|2
1045444|NCT01790503|2082903|FG005|Overall Study|Disease progression|1
1045445|NCT01790503|2082904|FG006|Overall Study|Disease progression|0
1045446|NCT01790503|2082905|FG007|Overall Study|Disease progression|1
1045447|NCT01790503|2082906|FG008|Overall Study|Disease progression|0
1045448|NCT01790503|2082907|FG009|Overall Study|Disease progression|17
1045449|NCT01790503|2082908|FG010|Overall Study|Disease progression|7
1045450|NCT01790503|2082898|FG000|Overall Study|Protocol Violation|0
1045451|NCT01790503|2082899|FG001|Overall Study|Protocol Violation|0
1045452|NCT01790503|2082900|FG002|Overall Study|Protocol Violation|0
1045453|NCT01790503|2082901|FG003|Overall Study|Protocol Violation|0
1045454|NCT01790503|2082902|FG004|Overall Study|Protocol Violation|0
1045455|NCT01790503|2082903|FG005|Overall Study|Protocol Violation|0
1045456|NCT01790503|2082904|FG006|Overall Study|Protocol Violation|0
1045457|NCT01790503|2082905|FG007|Overall Study|Protocol Violation|0
1045458|NCT01790503|2082906|FG008|Overall Study|Protocol Violation|0
1045459|NCT01790503|2082907|FG009|Overall Study|Protocol Violation|1
1045460|NCT01790503|2082908|FG010|Overall Study|Protocol Violation|0
1045461|NCT01790503|2082898|FG000|Overall Study|Physician Decision|0
1045462|NCT01790503|2082899|FG001|Overall Study|Physician Decision|0
1045463|NCT01790503|2082900|FG002|Overall Study|Physician Decision|0
1045464|NCT01790503|2082901|FG003|Overall Study|Physician Decision|0
1045465|NCT01790503|2082902|FG004|Overall Study|Physician Decision|0
1045466|NCT01790503|2082903|FG005|Overall Study|Physician Decision|0
1045467|NCT01790503|2082904|FG006|Overall Study|Physician Decision|0
1045468|NCT01790503|2082905|FG007|Overall Study|Physician Decision|0
1045469|NCT01790503|2082906|FG008|Overall Study|Physician Decision|0
1045470|NCT01790503|2082907|FG009|Overall Study|Physician Decision|1
1045471|NCT01790503|2082908|FG010|Overall Study|Physician Decision|1
1045472|NCT01790503|2082898|FG000|Overall Study|Death|0
1045473|NCT01790503|2082899|FG001|Overall Study|Death|0
1045474|NCT01790503|2082900|FG002|Overall Study|Death|0
1045475|NCT01790503|2082901|FG003|Overall Study|Death|0
1045476|NCT01790503|2082902|FG004|Overall Study|Death|0
1045477|NCT01790503|2082903|FG005|Overall Study|Death|0
1045478|NCT01790503|2082904|FG006|Overall Study|Death|0
1045479|NCT01790503|2082905|FG007|Overall Study|Death|0
1045480|NCT01790503|2082906|FG008|Overall Study|Death|0
1045481|NCT01790503|2082907|FG009|Overall Study|Death|1
1045482|NCT01790503|2082908|FG010|Overall Study|Death|0
1045483|NCT01790503|2082898|FG000|Overall Study|Non Compliance|0
1045484|NCT01790503|2082899|FG001|Overall Study|Non Compliance|0
1045485|NCT01790503|2082900|FG002|Overall Study|Non Compliance|0
1045486|NCT01790503|2082901|FG003|Overall Study|Non Compliance|0
1045487|NCT01790503|2082902|FG004|Overall Study|Non Compliance|1
1045488|NCT01790503|2082903|FG005|Overall Study|Non Compliance|0
1045489|NCT01790503|2082904|FG006|Overall Study|Non Compliance|0
1045490|NCT01790503|2082905|FG007|Overall Study|Non Compliance|0
1045491|NCT01790503|2082906|FG008|Overall Study|Non Compliance|0
1045492|NCT01790503|2082907|FG009|Overall Study|Non Compliance|0
1045493|NCT01790503|2082908|FG010|Overall Study|Non Compliance|0
1045494|NCT01790503|2082898|FG000|Overall Study|Other|0
1045495|NCT01790503|2082899|FG001|Overall Study|Other|0
1045496|NCT01790503|2082900|FG002|Overall Study|Other|0
1045497|NCT01790503|2082901|FG003|Overall Study|Other|0
1045498|NCT01790503|2082902|FG004|Overall Study|Other|1
1045499|NCT01790503|2082903|FG005|Overall Study|Other|0
1045500|NCT01790503|2082904|FG006|Overall Study|Other|0
1045501|NCT01790503|2082905|FG007|Overall Study|Other|0
1045502|NCT01790503|2082906|FG008|Overall Study|Other|1
1045503|NCT01790503|2082907|FG009|Overall Study|Other|2
1045504|NCT01790503|2082908|FG010|Overall Study|Other|0
1045505|NCT01790516|2082947|FG000|Overall Study|Physician Decision|1
1045506|NCT01790516|2082948|FG001|Overall Study|Physician Decision|0
1045507|NCT01790568|2082954|FG000|Overall Study|Progression prior to transplant|0
1045508|NCT01790568|2082955|FG001|Overall Study|Progression prior to transplant|1
1045509|NCT01790594|2082970|FG000|Overall Study|Death|1
1045510|NCT01790594|2082971|FG001|Overall Study|Death|0
1045511|NCT01790594|2082972|FG002|Overall Study|Death|0
1045512|NCT01790594|2082970|FG000|Overall Study|Physician Decision|2
1045513|NCT01790594|2082971|FG001|Overall Study|Physician Decision|1
1045514|NCT01790594|2082972|FG002|Overall Study|Physician Decision|0
1045515|NCT01790594|2082970|FG000|Overall Study|Withdrawal by Subject|2
1045516|NCT01790594|2082971|FG001|Overall Study|Withdrawal by Subject|0
1045517|NCT01790594|2082972|FG002|Overall Study|Withdrawal by Subject|0
1045518|NCT01790594|2082970|FG000|Overall Study|Transplant was not done|0
1045519|NCT01790594|2082971|FG001|Overall Study|Transplant was not done|0
1045520|NCT01790594|2082972|FG002|Overall Study|Transplant was not done|3
1045521|NCT01790594|2082970|FG000|Overall Study|Terminated prior to week 76|0
1045522|NCT01790594|2082971|FG001|Overall Study|Terminated prior to week 76|2
1045523|NCT01790594|2082972|FG002|Overall Study|Terminated prior to week 76|0
1045524|NCT01790633|2082981|FG000|Overall Study|Protocol Violation|1
1045525|NCT01790633|2082982|FG001|Overall Study|Protocol Violation|2
1045526|NCT01790633|2082981|FG000|Overall Study|Did not have serology performed|47
1045527|NCT01790633|2082982|FG001|Overall Study|Did not have serology performed|0
1045528|NCT01790633|2082981|FG000|Overall Study|RT failure and no follow-up ELISA|0
1045529|NCT01790633|2082982|FG001|Overall Study|RT failure and no follow-up ELISA|3
1045530|NCT01790828|2083012|FG000|Overall Study|Other|34
1045531|NCT01790932|2083016|FG000|Overall Study|Disease Progression|41
1045532|NCT01790932|2083016|FG000|Overall Study|Adverse Event|7
1045533|NCT01790932|2083016|FG000|Overall Study|Physician Decision|1
1045534|NCT01790932|2083016|FG000|Overall Study|Withdrawal by Subject|1
1045535|NCT01790984|2083022|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
1045536|NCT01790984|2083023|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
1045537|NCT01790984|2083024|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
1045538|NCT01790984|2083025|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
1045539|NCT01791127|2083048|FG000|Overall Study|Death|356
1045540|NCT01791127|2083048|FG000|Overall Study|Patient has withdrawn from study|293
1045541|NCT01791127|2083048|FG000|Overall Study|Lost to Follow-up|42
1045542|NCT01791127|2083048|FG000|Overall Study|All Siello leads are explanted|31
1045543|NCT01791127|2083048|FG000|Overall Study|Completion of 30 day safety registry|1
1045544|NCT01791127|2083048|FG000|Overall Study|Study terminated for EP Passion|749
1045545|NCT01791153|2083069|FG000|Part 1: Blinded Period|Adverse Event|7
1045546|NCT01791153|2083070|FG001|Part 1: Blinded Period|Adverse Event|3
1045547|NCT01791153|2083071|FG002|Part 1: Blinded Period|Adverse Event|2
1045548|NCT01791153|2083072|FG003|Part 1: Blinded Period|Adverse Event|0
1045549|NCT01791153|2083073|FG004|Part 1: Blinded Period|Adverse Event|0
1045550|NCT01791153|2083074|FG005|Part 1: Blinded Period|Adverse Event|0
1045551|NCT01791153|2083075|FG006|Part 1: Blinded Period|Adverse Event|0
1045552|NCT01791153|2083076|FG007|Part 1: Blinded Period|Adverse Event|0
1045553|NCT01791153|2083069|FG000|Part 1: Blinded Period|Lack of Efficacy|1
1045554|NCT01791153|2083070|FG001|Part 1: Blinded Period|Lack of Efficacy|3
1045555|NCT01791153|2083071|FG002|Part 1: Blinded Period|Lack of Efficacy|2
1045556|NCT01791153|2083072|FG003|Part 1: Blinded Period|Lack of Efficacy|2
1045557|NCT01791153|2083073|FG004|Part 1: Blinded Period|Lack of Efficacy|0
1045558|NCT01791153|2083074|FG005|Part 1: Blinded Period|Lack of Efficacy|0
1045559|NCT01791153|2083075|FG006|Part 1: Blinded Period|Lack of Efficacy|0
1045560|NCT01791153|2083076|FG007|Part 1: Blinded Period|Lack of Efficacy|0
1045561|NCT01791153|2083069|FG000|Part 1: Blinded Period|Non-Compliance|1
1045562|NCT01791153|2083070|FG001|Part 1: Blinded Period|Non-Compliance|0
1045563|NCT01791153|2083071|FG002|Part 1: Blinded Period|Non-Compliance|0
1045564|NCT01791153|2083072|FG003|Part 1: Blinded Period|Non-Compliance|0
1045565|NCT01791153|2083073|FG004|Part 1: Blinded Period|Non-Compliance|0
1045566|NCT01791153|2083074|FG005|Part 1: Blinded Period|Non-Compliance|0
1045567|NCT01791153|2083075|FG006|Part 1: Blinded Period|Non-Compliance|0
1045568|NCT01791153|2083076|FG007|Part 1: Blinded Period|Non-Compliance|0
1045569|NCT01791153|2083069|FG000|Part 1: Blinded Period|Physician Decision|0
1045570|NCT01791153|2083070|FG001|Part 1: Blinded Period|Physician Decision|0
1045571|NCT01791153|2083071|FG002|Part 1: Blinded Period|Physician Decision|0
1045572|NCT01791153|2083072|FG003|Part 1: Blinded Period|Physician Decision|1
1045573|NCT01791153|2083073|FG004|Part 1: Blinded Period|Physician Decision|0
1045574|NCT01791153|2083074|FG005|Part 1: Blinded Period|Physician Decision|0
1045575|NCT01791153|2083075|FG006|Part 1: Blinded Period|Physician Decision|0
1045576|NCT01791153|2083076|FG007|Part 1: Blinded Period|Physician Decision|0
1045577|NCT01791153|2083069|FG000|Part 1: Blinded Period|Protocol Violation|0
1045578|NCT01791153|2083070|FG001|Part 1: Blinded Period|Protocol Violation|0
1045579|NCT01791153|2083071|FG002|Part 1: Blinded Period|Protocol Violation|0
1045580|NCT01791153|2083072|FG003|Part 1: Blinded Period|Protocol Violation|1
1045581|NCT01791153|2083073|FG004|Part 1: Blinded Period|Protocol Violation|0
1045582|NCT01791153|2083074|FG005|Part 1: Blinded Period|Protocol Violation|0
1045583|NCT01791153|2083075|FG006|Part 1: Blinded Period|Protocol Violation|0
1045584|NCT01791153|2083076|FG007|Part 1: Blinded Period|Protocol Violation|0
1045585|NCT01791153|2083069|FG000|Part 1: Blinded Period|Withdrawal by Subject|6
1045586|NCT01791153|2083070|FG001|Part 1: Blinded Period|Withdrawal by Subject|2
1045587|NCT01791153|2083071|FG002|Part 1: Blinded Period|Withdrawal by Subject|2
1045588|NCT01791153|2083072|FG003|Part 1: Blinded Period|Withdrawal by Subject|1
1045589|NCT01791153|2083073|FG004|Part 1: Blinded Period|Withdrawal by Subject|0
1045590|NCT01791153|2083074|FG005|Part 1: Blinded Period|Withdrawal by Subject|0
1045591|NCT01791153|2083075|FG006|Part 1: Blinded Period|Withdrawal by Subject|0
1045592|NCT01791153|2083076|FG007|Part 1: Blinded Period|Withdrawal by Subject|0
1045593|NCT01791153|2083069|FG000|Part 2: Open-label Period|Adverse Event|0
1045594|NCT01791153|2083070|FG001|Part 2: Open-label Period|Adverse Event|0
1045595|NCT01791153|2083071|FG002|Part 2: Open-label Period|Adverse Event|0
1045596|NCT01791153|2083072|FG003|Part 2: Open-label Period|Adverse Event|0
1045597|NCT01791153|2083073|FG004|Part 2: Open-label Period|Adverse Event|0
1045598|NCT01791153|2083074|FG005|Part 2: Open-label Period|Adverse Event|1
1045599|NCT01791153|2083075|FG006|Part 2: Open-label Period|Adverse Event|1
1045600|NCT01791153|2083076|FG007|Part 2: Open-label Period|Adverse Event|2
1045601|NCT01791153|2083069|FG000|Part 2: Open-label Period|Death|0
1045602|NCT01791153|2083070|FG001|Part 2: Open-label Period|Death|0
1045603|NCT01791153|2083071|FG002|Part 2: Open-label Period|Death|0
1045604|NCT01791153|2083072|FG003|Part 2: Open-label Period|Death|0
1045605|NCT01791153|2083073|FG004|Part 2: Open-label Period|Death|0
1045606|NCT01791153|2083074|FG005|Part 2: Open-label Period|Death|1
1045607|NCT01791153|2083075|FG006|Part 2: Open-label Period|Death|1
1045608|NCT01791153|2083076|FG007|Part 2: Open-label Period|Death|1
1045609|NCT01791153|2083069|FG000|Part 2: Open-label Period|Lost to Follow-up|0
1045610|NCT01791153|2083070|FG001|Part 2: Open-label Period|Lost to Follow-up|0
1045611|NCT01791153|2083071|FG002|Part 2: Open-label Period|Lost to Follow-up|0
1045612|NCT01791153|2083072|FG003|Part 2: Open-label Period|Lost to Follow-up|0
1045613|NCT01791153|2083073|FG004|Part 2: Open-label Period|Lost to Follow-up|0
1045614|NCT01791153|2083074|FG005|Part 2: Open-label Period|Lost to Follow-up|0
1045615|NCT01791153|2083075|FG006|Part 2: Open-label Period|Lost to Follow-up|1
1045616|NCT01791153|2083076|FG007|Part 2: Open-label Period|Lost to Follow-up|0
1045617|NCT01791153|2083069|FG000|Part 2: Open-label Period|Lack of Efficacy|0
1045618|NCT01791153|2083070|FG001|Part 2: Open-label Period|Lack of Efficacy|0
1045619|NCT01791153|2083071|FG002|Part 2: Open-label Period|Lack of Efficacy|0
1045620|NCT01791153|2083072|FG003|Part 2: Open-label Period|Lack of Efficacy|0
1045621|NCT01791153|2083073|FG004|Part 2: Open-label Period|Lack of Efficacy|0
1045622|NCT01791153|2083074|FG005|Part 2: Open-label Period|Lack of Efficacy|0
1045623|NCT01791153|2083075|FG006|Part 2: Open-label Period|Lack of Efficacy|0
1045624|NCT01791153|2083076|FG007|Part 2: Open-label Period|Lack of Efficacy|1
1045625|NCT01791153|2083069|FG000|Part 2: Open-label Period|Withdrawal by Subject|0
1045626|NCT01791153|2083070|FG001|Part 2: Open-label Period|Withdrawal by Subject|0
1045627|NCT01791153|2083071|FG002|Part 2: Open-label Period|Withdrawal by Subject|0
1045628|NCT01791153|2083072|FG003|Part 2: Open-label Period|Withdrawal by Subject|0
1045629|NCT01791153|2083073|FG004|Part 2: Open-label Period|Withdrawal by Subject|1
1045630|NCT01791153|2083074|FG005|Part 2: Open-label Period|Withdrawal by Subject|1
1045631|NCT01791153|2083075|FG006|Part 2: Open-label Period|Withdrawal by Subject|3
1045632|NCT01791153|2083076|FG007|Part 2: Open-label Period|Withdrawal by Subject|2
1045633|NCT01791153|2083069|FG000|Part 2: Open-label Period|Physician Decision|0
1045634|NCT01791153|2083070|FG001|Part 2: Open-label Period|Physician Decision|0
1045635|NCT01791153|2083071|FG002|Part 2: Open-label Period|Physician Decision|0
1045636|NCT01791153|2083072|FG003|Part 2: Open-label Period|Physician Decision|0
1045637|NCT01791153|2083073|FG004|Part 2: Open-label Period|Physician Decision|1
1045638|NCT01791153|2083074|FG005|Part 2: Open-label Period|Physician Decision|1
1045639|NCT01791153|2083075|FG006|Part 2: Open-label Period|Physician Decision|0
1045640|NCT01791153|2083076|FG007|Part 2: Open-label Period|Physician Decision|0
1045641|NCT01791205|2083093|FG000|Phase II|Lack of Efficacy|6
1045642|NCT01791205|2083094|FG001|Phase II|Lack of Efficacy|0
1045643|NCT01791205|2083093|FG000|Phase II|Adverse Event|2
1045644|NCT01791205|2083094|FG001|Phase II|Adverse Event|0
1045645|NCT01791205|2083093|FG000|Phase II|Safety|1
1045646|NCT01791205|2083094|FG001|Phase II|Safety|0
1045647|NCT01791205|2083093|FG000|Phase II|Lost to Follow-up|1
1045648|NCT01791205|2083094|FG001|Phase II|Lost to Follow-up|0
1045649|NCT01791205|2083093|FG000|Phase II|Remission of disease|1
1045650|NCT01791205|2083094|FG001|Phase II|Remission of disease|0
1045651|NCT01791205|2083093|FG000|Phase II|Physician's decision|1
1045652|NCT01791205|2083094|FG001|Phase II|Physician's decision|0
1045653|NCT01791244|2083102|FG000|Overall Study|Adverse Event|5
1045654|NCT01791244|2083103|FG001|Overall Study|Adverse Event|7
1045655|NCT01791244|2083102|FG000|Overall Study|Insufficient clinical response|10
1045656|NCT01791244|2083103|FG001|Overall Study|Insufficient clinical response|10
1045657|NCT01791244|2083102|FG000|Overall Study|Laboratory Abnormality|0
1045658|NCT01791244|2083103|FG001|Overall Study|Laboratory Abnormality|1
1045659|NCT01791413|2083113|FG000|Overall Study|Lost to Follow-up|5
1045660|NCT01791413|2083114|FG001|Overall Study|Lost to Follow-up|1
1045661|NCT01791517|2083133|FG000|Phase I: Period 1|Withdrawal by Subject|0
1045662|NCT01791517|2083134|FG001|Phase I: Period 1|Withdrawal by Subject|1
1045663|NCT01791517|2083135|FG002|Phase I: Period 1|Withdrawal by Subject|1
1045664|NCT01791517|2083136|FG003|Phase I: Period 1|Withdrawal by Subject|0
1045665|NCT01791517|2083137|FG004|Phase I: Period 1|Withdrawal by Subject|1
1045666|NCT01791517|2083138|FG005|Phase I: Period 1|Withdrawal by Subject|1
1045667|NCT01791517|2083139|FG006|Phase I: Period 1|Withdrawal by Subject|0
1045668|NCT01791517|2083140|FG007|Phase I: Period 1|Withdrawal by Subject|0
906504|NCT00768898|1882216|FG000|Overall Study|Headache|1
906505|NCT00768989|1882227|FG000|Prior to Week 24|Withdrawal by Subject|1
906506|NCT00768989|1882228|FG001|Prior to Week 24|Withdrawal by Subject|0
906507|NCT00768989|1882227|FG000|Prior to Week 24|Adverse Event|3
906508|NCT00768989|1882228|FG001|Prior to Week 24|Adverse Event|0
906509|NCT00768989|1882227|FG000|Prior to Week 24|Lost to Follow-up|0
906510|NCT00768989|1882228|FG001|Prior to Week 24|Lost to Follow-up|1
906511|NCT00768989|1882227|FG000|Prior to Week 24|Protocol Violation|0
1045669|NCT01791517|2083141|FG008|Phase I: Period 1|Withdrawal by Subject|0
1045670|NCT01791517|2083142|FG009|Phase I: Period 1|Withdrawal by Subject|0
1045671|NCT01791517|2083143|FG010|Phase I: Period 1|Withdrawal by Subject|0
1045672|NCT01791517|2083144|FG011|Phase I: Period 1|Withdrawal by Subject|0
1045673|NCT01791517|2083133|FG000|Phase I: Period 1|Adverse Event|0
1045674|NCT01791517|2083134|FG001|Phase I: Period 1|Adverse Event|0
1045675|NCT01791517|2083135|FG002|Phase I: Period 1|Adverse Event|1
1045676|NCT01791517|2083136|FG003|Phase I: Period 1|Adverse Event|1
1045677|NCT01791517|2083137|FG004|Phase I: Period 1|Adverse Event|0
1045678|NCT01791517|2083138|FG005|Phase I: Period 1|Adverse Event|0
1045679|NCT01791517|2083139|FG006|Phase I: Period 1|Adverse Event|0
1045680|NCT01791517|2083140|FG007|Phase I: Period 1|Adverse Event|0
1045681|NCT01791517|2083141|FG008|Phase I: Period 1|Adverse Event|0
1045682|NCT01791517|2083142|FG009|Phase I: Period 1|Adverse Event|0
1045683|NCT01791517|2083143|FG010|Phase I: Period 1|Adverse Event|0
1045684|NCT01791517|2083144|FG011|Phase I: Period 1|Adverse Event|0
1045685|NCT01791517|2083133|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1
1045686|NCT01791517|2083134|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1045687|NCT01791517|2083135|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1045688|NCT01791517|2083136|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1045689|NCT01791517|2083137|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1045690|NCT01791517|2083138|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1045691|NCT01791517|2083139|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1045692|NCT01791517|2083140|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1045693|NCT01791517|2083141|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1045694|NCT01791517|2083142|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1045695|NCT01791517|2083143|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1045696|NCT01791517|2083144|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1045697|NCT01791517|2083133|FG000|Phase I: Period 1|Protocol Violation|0
1045698|NCT01791517|2083134|FG001|Phase I: Period 1|Protocol Violation|1
1045699|NCT01791517|2083135|FG002|Phase I: Period 1|Protocol Violation|0
1045700|NCT01791517|2083136|FG003|Phase I: Period 1|Protocol Violation|0
1045701|NCT01791517|2083137|FG004|Phase I: Period 1|Protocol Violation|0
1045702|NCT01791517|2083138|FG005|Phase I: Period 1|Protocol Violation|0
1045703|NCT01791517|2083139|FG006|Phase I: Period 1|Protocol Violation|0
1045704|NCT01791517|2083140|FG007|Phase I: Period 1|Protocol Violation|0
1045705|NCT01791517|2083141|FG008|Phase I: Period 1|Protocol Violation|0
1045706|NCT01791517|2083142|FG009|Phase I: Period 1|Protocol Violation|0
1045707|NCT01791517|2083143|FG010|Phase I: Period 1|Protocol Violation|0
1045708|NCT01791517|2083144|FG011|Phase I: Period 1|Protocol Violation|0
1045709|NCT01791517|2083133|FG000|Phase I: Period 1|Lost to Follow-up|0
1045710|NCT01791517|2083134|FG001|Phase I: Period 1|Lost to Follow-up|0
1045711|NCT01791517|2083135|FG002|Phase I: Period 1|Lost to Follow-up|0
1045712|NCT01791517|2083136|FG003|Phase I: Period 1|Lost to Follow-up|1
1045713|NCT01791517|2083137|FG004|Phase I: Period 1|Lost to Follow-up|0
1045714|NCT01791517|2083138|FG005|Phase I: Period 1|Lost to Follow-up|0
1045715|NCT01791517|2083139|FG006|Phase I: Period 1|Lost to Follow-up|1
1045716|NCT01791517|2083140|FG007|Phase I: Period 1|Lost to Follow-up|0
1045717|NCT01791517|2083141|FG008|Phase I: Period 1|Lost to Follow-up|1
1045718|NCT01791517|2083142|FG009|Phase I: Period 1|Lost to Follow-up|1
1045719|NCT01791517|2083143|FG010|Phase I: Period 1|Lost to Follow-up|0
1045720|NCT01791517|2083144|FG011|Phase I: Period 1|Lost to Follow-up|0
1045721|NCT01791517|2083133|FG000|Phase I: Period 1|Lens Handling DIfficulties|0
1045722|NCT01791517|2083134|FG001|Phase I: Period 1|Lens Handling DIfficulties|0
1045723|NCT01791517|2083135|FG002|Phase I: Period 1|Lens Handling DIfficulties|0
1045724|NCT01791517|2083136|FG003|Phase I: Period 1|Lens Handling DIfficulties|0
1045725|NCT01791517|2083137|FG004|Phase I: Period 1|Lens Handling DIfficulties|0
1045726|NCT01791517|2083138|FG005|Phase I: Period 1|Lens Handling DIfficulties|0
1045727|NCT01791517|2083139|FG006|Phase I: Period 1|Lens Handling DIfficulties|0
1045728|NCT01791517|2083140|FG007|Phase I: Period 1|Lens Handling DIfficulties|0
1045729|NCT01791517|2083141|FG008|Phase I: Period 1|Lens Handling DIfficulties|0
1045730|NCT01791517|2083142|FG009|Phase I: Period 1|Lens Handling DIfficulties|0
1045731|NCT01791517|2083143|FG010|Phase I: Period 1|Lens Handling DIfficulties|0
1045732|NCT01791517|2083144|FG011|Phase I: Period 1|Lens Handling DIfficulties|1
1045733|NCT01791517|2083133|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1
1045734|NCT01791517|2083134|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0
1045735|NCT01791517|2083135|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0
1045736|NCT01791517|2083136|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0
1045737|NCT01791517|2083137|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0
1045738|NCT01791517|2083138|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0
1045739|NCT01791517|2083139|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0
1045740|NCT01791517|2083140|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0
1045741|NCT01791517|2083141|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0
1045742|NCT01791517|2083142|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0
1045743|NCT01791517|2083143|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0
1045744|NCT01791517|2083144|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0
1045745|NCT01791517|2083133|FG000|Phase I: Period 2|Protocol Violation|0
1045746|NCT01791517|2083134|FG001|Phase I: Period 2|Protocol Violation|0
1045747|NCT01791517|2083135|FG002|Phase I: Period 2|Protocol Violation|0
1045748|NCT01791517|2083136|FG003|Phase I: Period 2|Protocol Violation|1
1045749|NCT01791517|2083137|FG004|Phase I: Period 2|Protocol Violation|0
1045750|NCT01791517|2083138|FG005|Phase I: Period 2|Protocol Violation|0
1045751|NCT01791517|2083139|FG006|Phase I: Period 2|Protocol Violation|0
1045752|NCT01791517|2083140|FG007|Phase I: Period 2|Protocol Violation|0
1045753|NCT01791517|2083141|FG008|Phase I: Period 2|Protocol Violation|0
1045754|NCT01791517|2083142|FG009|Phase I: Period 2|Protocol Violation|0
1045755|NCT01791517|2083143|FG010|Phase I: Period 2|Protocol Violation|0
1045756|NCT01791517|2083144|FG011|Phase I: Period 2|Protocol Violation|0
1045757|NCT01791517|2083133|FG000|Phase I: Period 2|Withdrawal by Subject|0
1045758|NCT01791517|2083134|FG001|Phase I: Period 2|Withdrawal by Subject|0
1045759|NCT01791517|2083135|FG002|Phase I: Period 2|Withdrawal by Subject|0
1045760|NCT01791517|2083136|FG003|Phase I: Period 2|Withdrawal by Subject|0
1045761|NCT01791517|2083137|FG004|Phase I: Period 2|Withdrawal by Subject|0
1045762|NCT01791517|2083138|FG005|Phase I: Period 2|Withdrawal by Subject|0
1045763|NCT01791517|2083139|FG006|Phase I: Period 2|Withdrawal by Subject|0
1045764|NCT01791517|2083140|FG007|Phase I: Period 2|Withdrawal by Subject|0
1045765|NCT01791517|2083141|FG008|Phase I: Period 2|Withdrawal by Subject|0
1045766|NCT01791517|2083142|FG009|Phase I: Period 2|Withdrawal by Subject|1
1045767|NCT01791517|2083143|FG010|Phase I: Period 2|Withdrawal by Subject|1
1045768|NCT01791517|2083144|FG011|Phase I: Period 2|Withdrawal by Subject|0
1045769|NCT01791517|2083133|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0
1045770|NCT01791517|2083134|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0
1045771|NCT01791517|2083135|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0
1045772|NCT01791517|2083136|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0
1045773|NCT01791517|2083137|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0
1045774|NCT01791517|2083138|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0
1045775|NCT01791517|2083139|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0
1045776|NCT01791517|2083140|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0
1045777|NCT01791517|2083141|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0
1045778|NCT01791517|2083142|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0
1045779|NCT01791517|2083143|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1
1045780|NCT01791517|2083144|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0
1045781|NCT01791517|2083133|FG000|Phase I: Period 2|Lens Discomfort|0
1045782|NCT01791517|2083134|FG001|Phase I: Period 2|Lens Discomfort|0
1045783|NCT01791517|2083135|FG002|Phase I: Period 2|Lens Discomfort|0
1045784|NCT01791517|2083136|FG003|Phase I: Period 2|Lens Discomfort|0
1045785|NCT01791517|2083137|FG004|Phase I: Period 2|Lens Discomfort|0
1045786|NCT01791517|2083138|FG005|Phase I: Period 2|Lens Discomfort|1
1045787|NCT01791517|2083139|FG006|Phase I: Period 2|Lens Discomfort|0
1045788|NCT01791517|2083140|FG007|Phase I: Period 2|Lens Discomfort|0
1045789|NCT01791517|2083141|FG008|Phase I: Period 2|Lens Discomfort|0
1045790|NCT01791517|2083142|FG009|Phase I: Period 2|Lens Discomfort|0
1045791|NCT01791517|2083143|FG010|Phase I: Period 2|Lens Discomfort|0
1045792|NCT01791517|2083144|FG011|Phase I: Period 2|Lens Discomfort|0
1045793|NCT01791517|2083133|FG000|Phase I: Period 2|Lost to Follow-up|0
1045794|NCT01791517|2083134|FG001|Phase I: Period 2|Lost to Follow-up|3
1045795|NCT01791517|2083135|FG002|Phase I: Period 2|Lost to Follow-up|2
1045796|NCT01791517|2083136|FG003|Phase I: Period 2|Lost to Follow-up|0
1045797|NCT01791517|2083137|FG004|Phase I: Period 2|Lost to Follow-up|0
1045798|NCT01791517|2083138|FG005|Phase I: Period 2|Lost to Follow-up|0
1045799|NCT01791517|2083139|FG006|Phase I: Period 2|Lost to Follow-up|0
1045800|NCT01791517|2083140|FG007|Phase I: Period 2|Lost to Follow-up|0
1045801|NCT01791517|2083141|FG008|Phase I: Period 2|Lost to Follow-up|0
1045802|NCT01791517|2083142|FG009|Phase I: Period 2|Lost to Follow-up|0
1045803|NCT01791517|2083143|FG010|Phase I: Period 2|Lost to Follow-up|0
1045804|NCT01791517|2083144|FG011|Phase I: Period 2|Lost to Follow-up|0
1045805|NCT01791517|2083133|FG000|Phase I: Period 3|Lens Discomfort|0
1045806|NCT01791517|2083134|FG001|Phase I: Period 3|Lens Discomfort|0
1045807|NCT01791517|2083135|FG002|Phase I: Period 3|Lens Discomfort|0
1045808|NCT01791517|2083136|FG003|Phase I: Period 3|Lens Discomfort|0
1045809|NCT01791517|2083137|FG004|Phase I: Period 3|Lens Discomfort|0
1045810|NCT01791517|2083138|FG005|Phase I: Period 3|Lens Discomfort|0
1045811|NCT01791517|2083139|FG006|Phase I: Period 3|Lens Discomfort|0
1045812|NCT01791517|2083140|FG007|Phase I: Period 3|Lens Discomfort|0
1045813|NCT01791517|2083141|FG008|Phase I: Period 3|Lens Discomfort|0
1045814|NCT01791517|2083142|FG009|Phase I: Period 3|Lens Discomfort|0
1045815|NCT01791517|2083143|FG010|Phase I: Period 3|Lens Discomfort|0
1045816|NCT01791517|2083144|FG011|Phase I: Period 3|Lens Discomfort|1
1045817|NCT01791517|2083133|FG000|Phase I: Period 3|Lost to Follow-up|0
1045818|NCT01791517|2083134|FG001|Phase I: Period 3|Lost to Follow-up|1
1045819|NCT01791517|2083135|FG002|Phase I: Period 3|Lost to Follow-up|0
1045820|NCT01791517|2083136|FG003|Phase I: Period 3|Lost to Follow-up|0
1045821|NCT01791517|2083137|FG004|Phase I: Period 3|Lost to Follow-up|1
1045822|NCT01791517|2083138|FG005|Phase I: Period 3|Lost to Follow-up|0
1045823|NCT01791517|2083139|FG006|Phase I: Period 3|Lost to Follow-up|0
1045824|NCT01791517|2083140|FG007|Phase I: Period 3|Lost to Follow-up|0
1045825|NCT01791517|2083141|FG008|Phase I: Period 3|Lost to Follow-up|0
1045826|NCT01791517|2083142|FG009|Phase I: Period 3|Lost to Follow-up|0
1045827|NCT01791517|2083143|FG010|Phase I: Period 3|Lost to Follow-up|0
1045828|NCT01791517|2083144|FG011|Phase I: Period 3|Lost to Follow-up|0
1045829|NCT01791517|2083133|FG000|Phase I: Period 3|Adverse Event|0
1045830|NCT01791517|2083134|FG001|Phase I: Period 3|Adverse Event|0
1045831|NCT01791517|2083135|FG002|Phase I: Period 3|Adverse Event|0
1045832|NCT01791517|2083136|FG003|Phase I: Period 3|Adverse Event|1
1045833|NCT01791517|2083137|FG004|Phase I: Period 3|Adverse Event|0
1045834|NCT01791517|2083138|FG005|Phase I: Period 3|Adverse Event|0
1045835|NCT01791517|2083139|FG006|Phase I: Period 3|Adverse Event|0
1045836|NCT01791517|2083140|FG007|Phase I: Period 3|Adverse Event|0
1045837|NCT01791517|2083141|FG008|Phase I: Period 3|Adverse Event|0
1045838|NCT01791517|2083142|FG009|Phase I: Period 3|Adverse Event|0
1045839|NCT01791517|2083143|FG010|Phase I: Period 3|Adverse Event|0
1045840|NCT01791517|2083144|FG011|Phase I: Period 3|Adverse Event|0
1045841|NCT01791517|2083133|FG000|Phase II|Lost to Follow-up|1
1045842|NCT01791517|2083134|FG001|Phase II|Lost to Follow-up|0
1045843|NCT01791517|2083135|FG002|Phase II|Lost to Follow-up|1
1045844|NCT01791517|2083136|FG003|Phase II|Lost to Follow-up|0
1045845|NCT01791517|2083137|FG004|Phase II|Lost to Follow-up|1
1045846|NCT01791517|2083138|FG005|Phase II|Lost to Follow-up|2
1045847|NCT01791517|2083139|FG006|Phase II|Lost to Follow-up|0
1045848|NCT01791517|2083140|FG007|Phase II|Lost to Follow-up|1
1045849|NCT01791517|2083141|FG008|Phase II|Lost to Follow-up|1
1045850|NCT01791517|2083142|FG009|Phase II|Lost to Follow-up|1
1045851|NCT01791517|2083143|FG010|Phase II|Lost to Follow-up|0
1045852|NCT01791517|2083144|FG011|Phase II|Lost to Follow-up|0
1045853|NCT01791517|2083133|FG000|Phase II|Withdrawal by Subject|1
1045854|NCT01791517|2083134|FG001|Phase II|Withdrawal by Subject|0
1045855|NCT01791517|2083135|FG002|Phase II|Withdrawal by Subject|0
1045856|NCT01791517|2083136|FG003|Phase II|Withdrawal by Subject|0
1045857|NCT01791517|2083137|FG004|Phase II|Withdrawal by Subject|0
1045858|NCT01791517|2083138|FG005|Phase II|Withdrawal by Subject|2
1045859|NCT01791517|2083139|FG006|Phase II|Withdrawal by Subject|0
1045860|NCT01791517|2083140|FG007|Phase II|Withdrawal by Subject|1
1045861|NCT01791517|2083141|FG008|Phase II|Withdrawal by Subject|0
1045862|NCT01791517|2083142|FG009|Phase II|Withdrawal by Subject|0
1045863|NCT01791517|2083143|FG010|Phase II|Withdrawal by Subject|1
1045864|NCT01791517|2083144|FG011|Phase II|Withdrawal by Subject|0
1045865|NCT01791517|2083133|FG000|Phase II|Lack of Efficacy|0
1045866|NCT01791517|2083134|FG001|Phase II|Lack of Efficacy|0
1045867|NCT01791517|2083135|FG002|Phase II|Lack of Efficacy|0
1045868|NCT01791517|2083136|FG003|Phase II|Lack of Efficacy|0
1045869|NCT01791517|2083137|FG004|Phase II|Lack of Efficacy|1
1045870|NCT01791517|2083138|FG005|Phase II|Lack of Efficacy|0
1045871|NCT01791517|2083139|FG006|Phase II|Lack of Efficacy|0
1045872|NCT01791517|2083140|FG007|Phase II|Lack of Efficacy|0
1045873|NCT01791517|2083141|FG008|Phase II|Lack of Efficacy|0
1045874|NCT01791517|2083142|FG009|Phase II|Lack of Efficacy|0
1045875|NCT01791517|2083143|FG010|Phase II|Lack of Efficacy|0
1045876|NCT01791517|2083144|FG011|Phase II|Lack of Efficacy|0
1045877|NCT01791517|2083133|FG000|Phase II|Adverse Event|0
1045878|NCT01791517|2083134|FG001|Phase II|Adverse Event|0
1045879|NCT01791517|2083135|FG002|Phase II|Adverse Event|0
1045880|NCT01791517|2083136|FG003|Phase II|Adverse Event|0
1045881|NCT01791517|2083137|FG004|Phase II|Adverse Event|0
1045882|NCT01791517|2083138|FG005|Phase II|Adverse Event|0
1045883|NCT01791517|2083139|FG006|Phase II|Adverse Event|2
1045884|NCT01791517|2083140|FG007|Phase II|Adverse Event|1
1045885|NCT01791517|2083141|FG008|Phase II|Adverse Event|0
1045886|NCT01791517|2083142|FG009|Phase II|Adverse Event|1
1045887|NCT01791517|2083143|FG010|Phase II|Adverse Event|0
1045888|NCT01791517|2083144|FG011|Phase II|Adverse Event|0
1045889|NCT01791517|2083133|FG000|Phase II|Lens Handling Difficulties|0
1045890|NCT01791517|2083134|FG001|Phase II|Lens Handling Difficulties|0
1045891|NCT01791517|2083135|FG002|Phase II|Lens Handling Difficulties|0
1045892|NCT01791517|2083136|FG003|Phase II|Lens Handling Difficulties|0
1045893|NCT01791517|2083137|FG004|Phase II|Lens Handling Difficulties|0
1045894|NCT01791517|2083138|FG005|Phase II|Lens Handling Difficulties|0
1045895|NCT01791517|2083139|FG006|Phase II|Lens Handling Difficulties|0
1045896|NCT01791517|2083140|FG007|Phase II|Lens Handling Difficulties|0
1045897|NCT01791517|2083141|FG008|Phase II|Lens Handling Difficulties|1
1045898|NCT01791517|2083142|FG009|Phase II|Lens Handling Difficulties|0
1045899|NCT01791517|2083143|FG010|Phase II|Lens Handling Difficulties|0
1045900|NCT01791517|2083144|FG011|Phase II|Lens Handling Difficulties|0
1045901|NCT01791517|2083133|FG000|Phase II|Unsatisfactory Lens Fitting|0
1045902|NCT01791517|2083134|FG001|Phase II|Unsatisfactory Lens Fitting|0
1045903|NCT01791517|2083135|FG002|Phase II|Unsatisfactory Lens Fitting|0
1045904|NCT01791517|2083136|FG003|Phase II|Unsatisfactory Lens Fitting|0
1045905|NCT01791517|2083137|FG004|Phase II|Unsatisfactory Lens Fitting|0
1045906|NCT01791517|2083138|FG005|Phase II|Unsatisfactory Lens Fitting|0
1045907|NCT01791517|2083139|FG006|Phase II|Unsatisfactory Lens Fitting|0
1045908|NCT01791517|2083140|FG007|Phase II|Unsatisfactory Lens Fitting|0
1045909|NCT01791517|2083141|FG008|Phase II|Unsatisfactory Lens Fitting|0
1045910|NCT01791517|2083142|FG009|Phase II|Unsatisfactory Lens Fitting|1
1045911|NCT01791517|2083143|FG010|Phase II|Unsatisfactory Lens Fitting|0
1045912|NCT01791517|2083144|FG011|Phase II|Unsatisfactory Lens Fitting|0
1045913|NCT01791517|2083133|FG000|Phase II|Pre-Existing Ocular Issue|0
1045914|NCT01791517|2083134|FG001|Phase II|Pre-Existing Ocular Issue|0
1045915|NCT01791517|2083135|FG002|Phase II|Pre-Existing Ocular Issue|0
1045916|NCT01791517|2083136|FG003|Phase II|Pre-Existing Ocular Issue|0
1045917|NCT01791517|2083137|FG004|Phase II|Pre-Existing Ocular Issue|0
1045918|NCT01791517|2083138|FG005|Phase II|Pre-Existing Ocular Issue|0
1045919|NCT01791517|2083139|FG006|Phase II|Pre-Existing Ocular Issue|0
1045920|NCT01791517|2083140|FG007|Phase II|Pre-Existing Ocular Issue|0
1045921|NCT01791517|2083141|FG008|Phase II|Pre-Existing Ocular Issue|0
1045922|NCT01791517|2083142|FG009|Phase II|Pre-Existing Ocular Issue|0
1045923|NCT01791517|2083143|FG010|Phase II|Pre-Existing Ocular Issue|0
1045924|NCT01791517|2083144|FG011|Phase II|Pre-Existing Ocular Issue|1
1045925|NCT01791725|2083165|FG000|Overall Study|Withdrawal by Subject|0
1045926|NCT01791725|2083166|FG001|Overall Study|Withdrawal by Subject|1
1045927|NCT01791725|2083167|FG002|Overall Study|Withdrawal by Subject|0
1045928|NCT01791803|2083179|FG000|Overall Study|Withdrawal by Subject|0
1045929|NCT01791803|2083180|FG001|Overall Study|Withdrawal by Subject|0
1045930|NCT01791803|2083181|FG002|Overall Study|Withdrawal by Subject|0
1045931|NCT01791803|2083182|FG003|Overall Study|Withdrawal by Subject|2
1045932|NCT01791803|2083179|FG000|Overall Study|Physician Decision|0
1045933|NCT01791803|2083180|FG001|Overall Study|Physician Decision|2
1045934|NCT01791803|2083181|FG002|Overall Study|Physician Decision|0
1045935|NCT01791803|2083182|FG003|Overall Study|Physician Decision|1
1045936|NCT01791803|2083179|FG000|Overall Study|Death|0
1045937|NCT01791803|2083180|FG001|Overall Study|Death|0
1045938|NCT01791803|2083181|FG002|Overall Study|Death|2
1045939|NCT01791803|2083182|FG003|Overall Study|Death|2
1045940|NCT01791894|2083195|FG000|Overall Study|Adverse Event|1
1045941|NCT01792115|2083216|FG000|Overall Study|Lost to Follow-up|0
1045942|NCT01792115|2083217|FG001|Overall Study|Lost to Follow-up|1
1045943|NCT01792115|2083218|FG002|Overall Study|Lost to Follow-up|0
1045944|NCT01792284|2083226|FG000|Lead-in Period|Adverse Event|15
1045945|NCT01792284|2083227|FG001|Lead-in Period|Adverse Event|0
1045946|NCT01792284|2083228|FG002|Lead-in Period|Adverse Event|0
1045947|NCT01792284|2083226|FG000|Lead-in Period|Lost to Follow-up|2
1045948|NCT01792284|2083227|FG001|Lead-in Period|Lost to Follow-up|0
1045949|NCT01792284|2083228|FG002|Lead-in Period|Lost to Follow-up|0
1045950|NCT01792284|2083226|FG000|Lead-in Period|Protocol Violation|1
1045951|NCT01792284|2083227|FG001|Lead-in Period|Protocol Violation|0
1045952|NCT01792284|2083228|FG002|Lead-in Period|Protocol Violation|0
1045953|NCT01792284|2083226|FG000|Lead-in Period|Withdrawal by Subject|10
1045954|NCT01792284|2083227|FG001|Lead-in Period|Withdrawal by Subject|0
1045955|NCT01792284|2083228|FG002|Lead-in Period|Withdrawal by Subject|0
1045956|NCT01792284|2083226|FG000|Lead-in Period|Physician Decision|1
1045957|NCT01792284|2083227|FG001|Lead-in Period|Physician Decision|0
1045958|NCT01792284|2083228|FG002|Lead-in Period|Physician Decision|0
1045959|NCT01792284|2083226|FG000|Lead-in Period|Protocol Required Discontinuation|1
1045960|NCT01792284|2083227|FG001|Lead-in Period|Protocol Required Discontinuation|0
1045961|NCT01792284|2083228|FG002|Lead-in Period|Protocol Required Discontinuation|0
1045962|NCT01792284|2083226|FG000|Randomization Period 1|Withdrawal by Subject|0
1045963|NCT01792284|2083227|FG001|Randomization Period 1|Withdrawal by Subject|1
1045964|NCT01792284|2083228|FG002|Randomization Period 1|Withdrawal by Subject|1
1045965|NCT01792284|2083226|FG000|Randomization Period 1|Physician Decision|0
1045966|NCT01792284|2083227|FG001|Randomization Period 1|Physician Decision|1
1045967|NCT01792284|2083228|FG002|Randomization Period 1|Physician Decision|1
1045968|NCT01792284|2083226|FG000|Randomization Period 1|Adverse Event|0
1045969|NCT01792284|2083227|FG001|Randomization Period 1|Adverse Event|0
1045970|NCT01792284|2083228|FG002|Randomization Period 1|Adverse Event|2
1045971|NCT01792284|2083226|FG000|Randomization Period 1|Lost to Follow-up|0
1045972|NCT01792284|2083227|FG001|Randomization Period 1|Lost to Follow-up|0
1045973|NCT01792284|2083228|FG002|Randomization Period 1|Lost to Follow-up|1
1045974|NCT01792284|2083226|FG000|Randomization Period 2|Protocol Violation|0
1045975|NCT01792284|2083227|FG001|Randomization Period 2|Protocol Violation|1
1045976|NCT01792284|2083228|FG002|Randomization Period 2|Protocol Violation|0
1045977|NCT01792284|2083226|FG000|Randomization Period 2|Withdrawal by Subject|0
1045978|NCT01792284|2083227|FG001|Randomization Period 2|Withdrawal by Subject|2
1045979|NCT01792284|2083228|FG002|Randomization Period 2|Withdrawal by Subject|0
1045980|NCT01792518|2083238|FG000|Overall Study|Adverse Event|3
1045981|NCT01792518|2083239|FG001|Overall Study|Adverse Event|4
1045982|NCT01792518|2083238|FG000|Overall Study|Protocol Violation|0
1045983|NCT01792518|2083239|FG001|Overall Study|Protocol Violation|1
1045984|NCT01792518|2083238|FG000|Overall Study|Lost to Follow-up|3
1045985|NCT01792518|2083239|FG001|Overall Study|Lost to Follow-up|1
1045986|NCT01792518|2083238|FG000|Overall Study|Withdrawal by Subject|2
1045987|NCT01792518|2083239|FG001|Overall Study|Withdrawal by Subject|0
1045988|NCT01792518|2083238|FG000|Overall Study|Other Reason|0
1045989|NCT01792518|2083239|FG001|Overall Study|Other Reason|1
1045990|NCT01792635|2083248|FG000|Part B|Adverse Event|0
1045991|NCT01792635|2083249|FG001|Part B|Adverse Event|0
1045992|NCT01792635|2083250|FG002|Part B|Adverse Event|1
1045993|NCT01792635|2083248|FG000|Part B|Study terminated|0
1045994|NCT01792635|2083249|FG001|Part B|Study terminated|4
1045995|NCT01792635|2083250|FG002|Part B|Study terminated|3
1045996|NCT01792830|2083281|FG000|Overall Study|Withdrawal by Subject|22
1045997|NCT01792830|2083282|FG001|Overall Study|Withdrawal by Subject|0
1045998|NCT01792830|2083283|FG002|Overall Study|Withdrawal by Subject|0
1045999|NCT01792830|2083284|FG003|Overall Study|Withdrawal by Subject|2
1046000|NCT01792830|2083285|FG004|Overall Study|Withdrawal by Subject|1
1046001|NCT01792830|2083286|FG005|Overall Study|Withdrawal by Subject|1
1046002|NCT01792830|2083287|FG006|Overall Study|Withdrawal by Subject|1
1046003|NCT01792830|2083288|FG007|Overall Study|Withdrawal by Subject|1
1046004|NCT01792830|2083289|FG008|Overall Study|Withdrawal by Subject|7
1046005|NCT01792830|2083290|FG009|Overall Study|Withdrawal by Subject|0
1046006|NCT01792830|2083291|FG010|Overall Study|Withdrawal by Subject|2
1046007|NCT01792830|2083281|FG000|Overall Study|Death|3
1046008|NCT01792830|2083282|FG001|Overall Study|Death|0
1046009|NCT01792830|2083283|FG002|Overall Study|Death|0
1046010|NCT01792830|2083284|FG003|Overall Study|Death|1
1046011|NCT01792830|2083285|FG004|Overall Study|Death|0
1046012|NCT01792830|2083286|FG005|Overall Study|Death|0
1046013|NCT01792830|2083287|FG006|Overall Study|Death|1
1046014|NCT01792830|2083288|FG007|Overall Study|Death|0
1046015|NCT01792830|2083289|FG008|Overall Study|Death|1
1046016|NCT01792830|2083290|FG009|Overall Study|Death|0
1046017|NCT01792830|2083291|FG010|Overall Study|Death|1
1046018|NCT01792830|2083281|FG000|Overall Study|Adverse Event|0
1046019|NCT01792830|2083282|FG001|Overall Study|Adverse Event|0
1046020|NCT01792830|2083283|FG002|Overall Study|Adverse Event|0
1046021|NCT01792830|2083284|FG003|Overall Study|Adverse Event|0
1046022|NCT01792830|2083285|FG004|Overall Study|Adverse Event|0
1046023|NCT01792830|2083286|FG005|Overall Study|Adverse Event|0
1046024|NCT01792830|2083287|FG006|Overall Study|Adverse Event|0
1046025|NCT01792830|2083288|FG007|Overall Study|Adverse Event|0
1046026|NCT01792830|2083289|FG008|Overall Study|Adverse Event|1
1046027|NCT01792830|2083290|FG009|Overall Study|Adverse Event|0
1046028|NCT01792830|2083291|FG010|Overall Study|Adverse Event|0
1046029|NCT01793051|2083327|FG000|Overall Study|Withdrawal by Subject|6
1046030|NCT01793051|2083328|FG001|Overall Study|Withdrawal by Subject|4
1046031|NCT01793051|2083327|FG000|Overall Study|Adverse Event|0
1046032|NCT01793051|2083328|FG001|Overall Study|Adverse Event|2
1046033|NCT01793051|2083327|FG000|Overall Study|Too ill to continue|1
1046034|NCT01793051|2083328|FG001|Overall Study|Too ill to continue|0
1046035|NCT01793051|2083327|FG000|Overall Study|Switched chemo|1
1046036|NCT01793051|2083328|FG001|Overall Study|Switched chemo|1
1046037|NCT01793051|2083327|FG000|Overall Study|Lack of compliance|1
1046038|NCT01793051|2083328|FG001|Overall Study|Lack of compliance|0
1046039|NCT01793051|2083327|FG000|Overall Study|Requested to be removed from the study|1
1046040|NCT01793051|2083328|FG001|Overall Study|Requested to be removed from the study|1
1046041|NCT01793142|2083334|FG000|Overall Study|Randomized not treated|7
1046045|NCT01793688|2083358|FG000|Overall Study|Protocol Violation|2
1046046|NCT01793792|2083362|FG000|Overall Study|Death|5
1046047|NCT01793792|2083362|FG000|Overall Study|Lost to Follow-up|5
1046048|NCT01793792|2083362|FG000|Overall Study|Withdrawal by Subject|1
1046049|NCT01793792|2083362|FG000|Overall Study|Device Not Implanted|1
1046050|NCT01793883|2083369|FG000|Overall Study|Withdrawal by Subject|3
1046051|NCT01793883|2083370|FG001|Overall Study|Withdrawal by Subject|7
1046052|NCT01793883|2083371|FG002|Overall Study|Withdrawal by Subject|3
1046053|NCT01793883|2083369|FG000|Overall Study|Subject noncompliance|0
1046054|NCT01793883|2083370|FG001|Overall Study|Subject noncompliance|1
1046055|NCT01793883|2083371|FG002|Overall Study|Subject noncompliance|1
1046056|NCT01793883|2083369|FG000|Overall Study|Lost to Follow-up|5
1046057|NCT01793883|2083370|FG001|Overall Study|Lost to Follow-up|1
1046058|NCT01793883|2083371|FG002|Overall Study|Lost to Follow-up|3
1046059|NCT01793883|2083369|FG000|Overall Study|Randomized in error|1
1046060|NCT01793883|2083370|FG001|Overall Study|Randomized in error|0
1046061|NCT01793883|2083371|FG002|Overall Study|Randomized in error|0
1046062|NCT01793883|2083369|FG000|Overall Study|Unable to complete spriometry|1
1046063|NCT01793883|2083370|FG001|Overall Study|Unable to complete spriometry|0
1046064|NCT01793883|2083371|FG002|Overall Study|Unable to complete spriometry|0
1046065|NCT01793883|2083369|FG000|Overall Study|Unable to complete measurements|1
1046066|NCT01793883|2083370|FG001|Overall Study|Unable to complete measurements|0
1046067|NCT01793883|2083371|FG002|Overall Study|Unable to complete measurements|0
1046068|NCT01793883|2083369|FG000|Overall Study|Met exclusion criteria|1
1046069|NCT01793883|2083370|FG001|Overall Study|Met exclusion criteria|0
1046070|NCT01793883|2083371|FG002|Overall Study|Met exclusion criteria|0
1046071|NCT01793883|2083369|FG000|Overall Study|Dosing error|0
1046072|NCT01793883|2083370|FG001|Overall Study|Dosing error|1
1046073|NCT01793883|2083371|FG002|Overall Study|Dosing error|0
1046074|NCT01793883|2083369|FG000|Overall Study|Respiratory distress during spirometry|0
1046075|NCT01793883|2083370|FG001|Overall Study|Respiratory distress during spirometry|0
1046076|NCT01793883|2083371|FG002|Overall Study|Respiratory distress during spirometry|1
1046077|NCT01793935|2083390|FG000|Overall Study|Pregnancy|1
1046078|NCT01793935|2083391|FG001|Overall Study|Pregnancy|0
1046079|NCT01793935|2083390|FG000|Overall Study|Protocol Violation|2
1046080|NCT01793935|2083391|FG001|Overall Study|Protocol Violation|1
1046081|NCT01793935|2083390|FG000|Overall Study|Adverse Event|2
1046082|NCT01793935|2083391|FG001|Overall Study|Adverse Event|0
1046083|NCT01793935|2083390|FG000|Overall Study|Patient did not take study medication|1
1046084|NCT01793935|2083391|FG001|Overall Study|Patient did not take study medication|1
1046085|NCT01793935|2083390|FG000|Overall Study|Lost to Follow-up|0
906512|NCT00768989|1882228|FG001|Prior to Week 24|Protocol Violation|2
906513|NCT00768989|1882227|FG000|Week 24 to Prior to Week 36|Adverse Event|1
906514|NCT00768989|1882228|FG001|Week 24 to Prior to Week 36|Adverse Event|0
906515|NCT00768989|1882227|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6
906516|NCT00768989|1882228|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0
906517|NCT00768989|1882227|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1
906518|NCT00768989|1882228|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0
906519|NCT00768989|1882227|FG000|On or After Week 36|Lack of Efficacy|1
906520|NCT00768989|1882228|FG001|On or After Week 36|Lack of Efficacy|0
906521|NCT00768989|1882227|FG000|On or After Week 36|Adverse Event|0
906522|NCT00768989|1882228|FG001|On or After Week 36|Adverse Event|1
906523|NCT00768989|1882227|FG000|On or After Week 36|Lost to Follow-up|1
906524|NCT00768989|1882228|FG001|On or After Week 36|Lost to Follow-up|0
906525|NCT00768989|1882227|FG000|On or After Week 36|Poor Compliance|1
906526|NCT00768989|1882228|FG001|On or After Week 36|Poor Compliance|0
906527|NCT00768989|1882227|FG000|On or After Week 36|Protocol Violation|1
906528|NCT00768989|1882228|FG001|On or After Week 36|Protocol Violation|0
906529|NCT00768989|1882227|FG000|On or After Week 36|Did not attend termination visit|2
906530|NCT00768989|1882228|FG001|On or After Week 36|Did not attend termination visit|0
906531|NCT00768989|1882227|FG000|On or After Week 36|Sponsor Termination|45
906532|NCT00768989|1882228|FG001|On or After Week 36|Sponsor Termination|26
906533|NCT00769067|1882247|FG000|Overall Study|Death|89
906534|NCT00769067|1882248|FG001|Overall Study|Death|86
906535|NCT00769067|1882247|FG000|Overall Study|Lost to Follow-up|3
906536|NCT00769067|1882248|FG001|Overall Study|Lost to Follow-up|1
906537|NCT00769067|1882247|FG000|Overall Study|Study terminated by sponsor|1
906538|NCT00769067|1882248|FG001|Overall Study|Study terminated by sponsor|3
906539|NCT00769067|1882247|FG000|Overall Study|Other|1
906540|NCT00769067|1882248|FG001|Overall Study|Other|3
906541|NCT00769067|1882247|FG000|Overall Study|Withdrawal by Subject|0
906542|NCT00769067|1882248|FG001|Overall Study|Withdrawal by Subject|1
906543|NCT00769119|1882257|FG000|Overall Study|Voluntary discontinuation|0
906544|NCT00769119|1882258|FG001|Overall Study|Voluntary discontinuation|2
906545|NCT00769119|1882257|FG000|Overall Study|Adverse Event|1
906546|NCT00769119|1882258|FG001|Overall Study|Adverse Event|1
906547|NCT00769119|1882257|FG000|Overall Study|Disallowed medication|1
906548|NCT00769119|1882258|FG001|Overall Study|Disallowed medication|0
906549|NCT00769132|1882264|FG000|Period 1|Adverse Event|1
906550|NCT00769132|1882265|FG001|Period 1|Adverse Event|0
906551|NCT00769132|1882266|FG002|Period 1|Adverse Event|0
906552|NCT00769132|1882267|FG003|Period 1|Adverse Event|1
906553|NCT00769132|1882264|FG000|Period 2|Withdrawal by Subject|0
906554|NCT00769132|1882265|FG001|Period 2|Withdrawal by Subject|0
906555|NCT00769132|1882266|FG002|Period 2|Withdrawal by Subject|0
906556|NCT00769132|1882267|FG003|Period 2|Withdrawal by Subject|1
906557|NCT00769132|1882264|FG000|Period 3|Withdrawal by Subject|1
906558|NCT00769132|1882265|FG001|Period 3|Withdrawal by Subject|0
906559|NCT00769132|1882266|FG002|Period 3|Withdrawal by Subject|0
906560|NCT00769132|1882267|FG003|Period 3|Withdrawal by Subject|0
906561|NCT00769132|1882264|FG000|Period 4|Withdrawal by Subject|0
906562|NCT00769132|1882265|FG001|Period 4|Withdrawal by Subject|1
906563|NCT00769132|1882266|FG002|Period 4|Withdrawal by Subject|0
906564|NCT00769132|1882267|FG003|Period 4|Withdrawal by Subject|0
906565|NCT00769184|1882277|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
906566|NCT00769184|1882278|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
906567|NCT00769184|1882277|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
906568|NCT00769184|1882278|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
906569|NCT00769184|1882277|FG000|No Treatment (6 Weeks)|Adverse Event|1
906570|NCT00769184|1882278|FG001|No Treatment (6 Weeks)|Adverse Event|1
906571|NCT00769483|1882305|FG000|Overall Study|Withdrawal by Subject|0
906572|NCT00769483|1882306|FG001|Overall Study|Withdrawal by Subject|1
906573|NCT00769483|1882307|FG002|Overall Study|Withdrawal by Subject|0
906574|NCT00769483|1882308|FG003|Overall Study|Withdrawal by Subject|0
906575|NCT00769483|1882309|FG004|Overall Study|Withdrawal by Subject|1
906576|NCT00769483|1882310|FG005|Overall Study|Withdrawal by Subject|0
906577|NCT00769561|1882328|FG000|Overall Study|Withdrawal by Subject|2
906578|NCT00769561|1882329|FG001|Overall Study|Withdrawal by Subject|2
906579|NCT00769561|1882328|FG000|Overall Study|Lost to Follow-up|1
906580|NCT00769561|1882329|FG001|Overall Study|Lost to Follow-up|3
906581|NCT00769704|1882349|FG000|Overall Study|Lost to Follow-up|3
906582|NCT00769704|1882350|FG001|Overall Study|Lost to Follow-up|2
906583|NCT00769704|1882349|FG000|Overall Study|Death|95
906584|NCT00769704|1882350|FG001|Overall Study|Death|190
906585|NCT00769704|1882349|FG000|Overall Study|Withdrawal by Subject|12
906586|NCT00769704|1882350|FG001|Overall Study|Withdrawal by Subject|5
906587|NCT00769704|1882349|FG000|Overall Study|Other|1
906588|NCT00769704|1882350|FG001|Overall Study|Other|2
906589|NCT00769860|1882363|FG000|Overall Study|Withdrawal by Subject|2
906590|NCT00769860|1882364|FG001|Overall Study|Withdrawal by Subject|0
906591|NCT00770029|1882389|FG000|Overall Study|Lost to Follow-up|2
906592|NCT00770029|1882390|FG001|Overall Study|Lost to Follow-up|0
906593|NCT00770029|1882389|FG000|Overall Study|Withdrawal by Subject|3
906594|NCT00770029|1882390|FG001|Overall Study|Withdrawal by Subject|3
906595|NCT00770029|1882389|FG000|Overall Study|Adverse Event|1
906596|NCT00770029|1882390|FG001|Overall Study|Adverse Event|0
906597|NCT00770120|1882396|FG000|Overall Study|Progression|31
906598|NCT00770120|1882396|FG000|Overall Study|Adverse Event|11
906599|NCT00770120|1882396|FG000|Overall Study|Not Protocol Specified|11
906600|NCT00770120|1882396|FG000|Overall Study|Death|3
906601|NCT00770120|1882396|FG000|Overall Study|Withdrawal by Subject|2
906602|NCT00770120|1882396|FG000|Overall Study|Ineligible|1
906603|NCT00770120|1882396|FG000|Overall Study|Never Received Treatment/Not Analyzable|1
906604|NCT00770120|1882396|FG000|Overall Study|Reason under Review|1
906605|NCT00770146|1882420|FG000|Treatment Period|Withdrawal by Subject|6
906606|NCT00770146|1882421|FG001|Treatment Period|Withdrawal by Subject|13
906607|NCT00770146|1882420|FG000|Treatment Period|Adverse Event|2
906608|NCT00770146|1882421|FG001|Treatment Period|Adverse Event|26
906609|NCT00770146|1882420|FG000|Treatment Period|Other|1
906610|NCT00770146|1882421|FG001|Treatment Period|Other|5
906611|NCT00770146|1882420|FG000|Treatment Period|Protocol non-compliance|0
906612|NCT00770146|1882421|FG001|Treatment Period|Protocol non-compliance|1
906613|NCT00770146|1882420|FG000|Follow-up Period|Withdrawal by Subject|7
906614|NCT00770146|1882421|FG001|Follow-up Period|Withdrawal by Subject|13
906615|NCT00770146|1882420|FG000|Follow-up Period|Adverse Event|0
906616|NCT00770146|1882421|FG001|Follow-up Period|Adverse Event|2
906617|NCT00770146|1882420|FG000|Follow-up Period|Other|4
906618|NCT00770146|1882421|FG001|Follow-up Period|Other|5
906619|NCT00770211|1882429|FG000|Overall Study|Lost to Follow-up|1
906620|NCT00770211|1882430|FG001|Overall Study|Lost to Follow-up|0
906621|NCT00770211|1882429|FG000|Overall Study|Withdrawal by Subject|0
906622|NCT00770211|1882430|FG001|Overall Study|Withdrawal by Subject|2
906623|NCT00770224|1882436|FG000|Step 1: Induction|Adverse Event|3
906624|NCT00770224|1882437|FG001|Step 1: Induction|Adverse Event|0
1046086|NCT01793935|2083391|FG001|Overall Study|Lost to Follow-up|1
1046087|NCT01794000|2083399|FG000|Double-Blind Phase (DBP)|Adverse Event|5
1046088|NCT01794000|2083400|FG001|Double-Blind Phase (DBP)|Adverse Event|2
1046089|NCT01794000|2083399|FG000|Double-Blind Phase (DBP)|Death|1
1046090|NCT01794000|2083400|FG001|Double-Blind Phase (DBP)|Death|2
1046091|NCT01794000|2083399|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
1046092|NCT01794000|2083400|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
1046093|NCT01794000|2083399|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
1046094|NCT01794000|2083400|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
1046095|NCT01794000|2083399|FG000|Double-Blind Phase (DBP)|Physician Decision|2
1046096|NCT01794000|2083400|FG001|Double-Blind Phase (DBP)|Physician Decision|0
1046097|NCT01794000|2083399|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148
1046098|NCT01794000|2083400|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149
1046099|NCT01794000|2083399|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6
1046100|NCT01794000|2083400|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11
1046101|NCT01794000|2083399|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3
1046102|NCT01794000|2083400|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1046103|NCT01794117|2083422|FG000|Overall Study|Adverse Event|1
1046104|NCT01794117|2083423|FG001|Overall Study|Adverse Event|0
1046105|NCT01794117|2083424|FG002|Overall Study|Adverse Event|0
1046106|NCT01794117|2083425|FG003|Overall Study|Adverse Event|0
1046107|NCT01794117|2083422|FG000|Overall Study|Participant noncompliance|0
1046108|NCT01794117|2083423|FG001|Overall Study|Participant noncompliance|1
1046109|NCT01794117|2083424|FG002|Overall Study|Participant noncompliance|0
1046110|NCT01794117|2083425|FG003|Overall Study|Participant noncompliance|0
1046111|NCT01794117|2083422|FG000|Overall Study|Refused further treatment|0
1046112|NCT01794117|2083423|FG001|Overall Study|Refused further treatment|2
1046113|NCT01794117|2083424|FG002|Overall Study|Refused further treatment|0
1046114|NCT01794117|2083425|FG003|Overall Study|Refused further treatment|0
1046115|NCT01794299|2083436|FG000|Overall Study|ATIR manufacturing not possible|1
1046116|NCT01794299|2083436|FG000|Overall Study|Death|14
1046117|NCT01794299|2083436|FG000|Overall Study|Graft failure|1
1046118|NCT01794299|2083436|FG000|Overall Study|ATIR batch rejected|2
1046119|NCT01794299|2083436|FG000|Overall Study|Relapse|2
1046120|NCT01794299|2083436|FG000|Overall Study|Discontinued from active follow-up|1
1046121|NCT01794299|2083436|FG000|Overall Study|Relapse and rejection of ATIR batch|1
1046122|NCT01794689|2083462|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3
1046123|NCT01794689|2083463|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0
1046124|NCT01794689|2083464|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2
1046125|NCT01794689|2083465|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4
1046126|NCT01794689|2083462|FG000|Intervention 1 (2 Nights)|Protocol Violation|1
1046127|NCT01794689|2083463|FG001|Intervention 1 (2 Nights)|Protocol Violation|0
1046128|NCT01794689|2083464|FG002|Intervention 1 (2 Nights)|Protocol Violation|1
1046129|NCT01794689|2083465|FG003|Intervention 1 (2 Nights)|Protocol Violation|0
1046130|NCT01794689|2083462|FG000|Intervention 1 (2 Nights)|Physician Decision|1
1046131|NCT01794689|2083463|FG001|Intervention 1 (2 Nights)|Physician Decision|1
1046132|NCT01794689|2083464|FG002|Intervention 1 (2 Nights)|Physician Decision|0
1046133|NCT01794689|2083465|FG003|Intervention 1 (2 Nights)|Physician Decision|0
1046134|NCT01794689|2083462|FG000|Intervention 1 (2 Nights)|Adverse Event|0
1046135|NCT01794689|2083463|FG001|Intervention 1 (2 Nights)|Adverse Event|1
1046136|NCT01794689|2083464|FG002|Intervention 1 (2 Nights)|Adverse Event|0
1046137|NCT01794689|2083465|FG003|Intervention 1 (2 Nights)|Adverse Event|0
1046138|NCT01794780|2083511|FG000|Overall Study|Adverse Event|0
1046139|NCT01794780|2083512|FG001|Overall Study|Adverse Event|1
1046140|NCT01794780|2083513|FG002|Overall Study|Adverse Event|2
1046141|NCT01794780|2083514|FG003|Overall Study|Adverse Event|0
1046142|NCT01794780|2083515|FG004|Overall Study|Adverse Event|0
1046143|NCT01794780|2083516|FG005|Overall Study|Adverse Event|0
1046144|NCT01794780|2083517|FG006|Overall Study|Adverse Event|0
1046145|NCT01794780|2083518|FG007|Overall Study|Adverse Event|0
1046146|NCT01794780|2083511|FG000|Overall Study|Death|0
1046147|NCT01794780|2083512|FG001|Overall Study|Death|2
1046148|NCT01794780|2083513|FG002|Overall Study|Death|14
1046149|NCT01794780|2083514|FG003|Overall Study|Death|1
1046150|NCT01794780|2083515|FG004|Overall Study|Death|0
1046151|NCT01794780|2083516|FG005|Overall Study|Death|9
1046152|NCT01794780|2083517|FG006|Overall Study|Death|4
1046153|NCT01794780|2083518|FG007|Overall Study|Death|0
1046154|NCT01794780|2083511|FG000|Overall Study|Lost to Follow-up|10
1046155|NCT01794780|2083512|FG001|Overall Study|Lost to Follow-up|64
1046156|NCT01794780|2083513|FG002|Overall Study|Lost to Follow-up|165
1046157|NCT01794780|2083514|FG003|Overall Study|Lost to Follow-up|53
1046158|NCT01794780|2083515|FG004|Overall Study|Lost to Follow-up|2
1046159|NCT01794780|2083516|FG005|Overall Study|Lost to Follow-up|99
1046160|NCT01794780|2083517|FG006|Overall Study|Lost to Follow-up|30
1046161|NCT01794780|2083518|FG007|Overall Study|Lost to Follow-up|5
1046162|NCT01794780|2083511|FG000|Overall Study|Withdrew informed consent|7
1046163|NCT01794780|2083512|FG001|Overall Study|Withdrew informed consent|17
1046164|NCT01794780|2083513|FG002|Overall Study|Withdrew informed consent|36
1046165|NCT01794780|2083514|FG003|Overall Study|Withdrew informed consent|9
1046166|NCT01794780|2083515|FG004|Overall Study|Withdrew informed consent|0
1046167|NCT01794780|2083516|FG005|Overall Study|Withdrew informed consent|48
1046168|NCT01794780|2083517|FG006|Overall Study|Withdrew informed consent|4
1046169|NCT01794780|2083518|FG007|Overall Study|Withdrew informed consent|3
1046170|NCT01794780|2083511|FG000|Overall Study|Other|0
1046171|NCT01794780|2083512|FG001|Overall Study|Other|12
1046172|NCT01794780|2083513|FG002|Overall Study|Other|25
1046173|NCT01794780|2083514|FG003|Overall Study|Other|20
1046174|NCT01794780|2083515|FG004|Overall Study|Other|1
1046175|NCT01794780|2083516|FG005|Overall Study|Other|24
1046176|NCT01794780|2083517|FG006|Overall Study|Other|4
1046177|NCT01794780|2083518|FG007|Overall Study|Other|1
1046178|NCT01794845|2083552|FG000|Overall Study|Withdrawal by Subject|1
1046179|NCT01794923|2083559|FG000|Overall Study|Adverse Event|0
1046180|NCT01794923|2083560|FG001|Overall Study|Adverse Event|0
1046181|NCT01794923|2083561|FG002|Overall Study|Adverse Event|1
1046182|NCT01794949|2083571|FG000|Overall Study|Lost to Follow-up|1
1046183|NCT01794949|2083572|FG001|Overall Study|Lost to Follow-up|0
1046184|NCT01795495|2083595|FG000|Overall Study|Protocol Violation|1
1046185|NCT01795495|2083596|FG001|Overall Study|Protocol Violation|0
1046186|NCT01795495|2083597|FG002|Overall Study|Protocol Violation|1
1046187|NCT01795495|2083595|FG000|Overall Study|Physician Decision|0
1046188|NCT01795495|2083596|FG001|Overall Study|Physician Decision|0
1046189|NCT01795495|2083597|FG002|Overall Study|Physician Decision|1
1046190|NCT01795547|2083614|FG000|Overall Study|Adverse Event|16
1046191|NCT01795547|2083615|FG001|Overall Study|Adverse Event|27
1046192|NCT01795547|2083614|FG000|Overall Study|Lack of Efficacy|8
1046193|NCT01795547|2083615|FG001|Overall Study|Lack of Efficacy|3
1046194|NCT01795547|2083614|FG000|Overall Study|Protocol Violation|6
1046195|NCT01795547|2083615|FG001|Overall Study|Protocol Violation|4
1046196|NCT01795547|2083614|FG000|Overall Study|Lost to Follow-up|2
1046197|NCT01795547|2083615|FG001|Overall Study|Lost to Follow-up|5
1046198|NCT01795547|2083614|FG000|Overall Study|Withdrawal of consent|7
1046199|NCT01795547|2083615|FG001|Overall Study|Withdrawal of consent|12
1046200|NCT01795547|2083614|FG000|Overall Study|Not Treated|4
1046201|NCT01795547|2083615|FG001|Overall Study|Not Treated|10
1046202|NCT01795547|2083614|FG000|Overall Study|Non-compliance with IMP|1
1046203|NCT01795547|2083615|FG001|Overall Study|Non-compliance with IMP|1
1046204|NCT01795547|2083614|FG000|Overall Study|Others|4
1046205|NCT01795547|2083615|FG001|Overall Study|Others|1
1046206|NCT01795547|2083614|FG000|Overall Study|Not stated|0
1046207|NCT01795547|2083615|FG001|Overall Study|Not stated|1
1046208|NCT01795638|2083625|FG000|Overall Study|Death|0
1046209|NCT01795638|2083626|FG001|Overall Study|Death|3
1046210|NCT01795638|2083625|FG000|Overall Study|transferred to quaternary hospital|2
1046211|NCT01795638|2083626|FG001|Overall Study|transferred to quaternary hospital|3
1046212|NCT01795638|2083625|FG000|Overall Study|Protocol Violation|3
1046213|NCT01795638|2083626|FG001|Overall Study|Protocol Violation|0
1046214|NCT01795638|2083625|FG000|Overall Study|discharged from hospital|7
1046215|NCT01795638|2083626|FG001|Overall Study|discharged from hospital|5
1046216|NCT01795638|2083625|FG000|Overall Study|Withdrawal by Subject|1
1046217|NCT01795638|2083626|FG001|Overall Study|Withdrawal by Subject|0
1046218|NCT01795898|2083661|FG000|Overall Study|Adverse Event|27
1046219|NCT01795898|2083661|FG000|Overall Study|Lost to Follow-up|20
1046220|NCT01795898|2083661|FG000|Overall Study|Withdrawal of consent|6
1046221|NCT01795898|2083661|FG000|Overall Study|Diagnosed with metastasis|1
1046222|NCT01795898|2083661|FG000|Overall Study|No pain|1
1046223|NCT01795898|2083661|FG000|Overall Study|Death|1
1046224|NCT01795898|2083661|FG000|Overall Study|Withdrew consent & had adverse events|3
1046225|NCT01795898|2083661|FG000|Overall Study|Physician Decision|1
1046226|NCT01795937|2083668|FG000|Overall Study|Withdrawal by Subject|1
1046227|NCT01795937|2083669|FG001|Overall Study|Withdrawal by Subject|0
1046228|NCT01795937|2083670|FG002|Overall Study|Withdrawal by Subject|0
1046229|NCT01795937|2083668|FG000|Overall Study|Physician Decision|0
1046230|NCT01795937|2083669|FG001|Overall Study|Physician Decision|1
1046231|NCT01795937|2083670|FG002|Overall Study|Physician Decision|0
1046234|NCT01796301|2083702|FG000|Overall Study|Withdrawal by Subject|15
1046235|NCT01796301|2083703|FG001|Overall Study|Withdrawal by Subject|15
1046236|NCT01796301|2083702|FG000|Overall Study|Lost to Follow-up|3
1046237|NCT01796301|2083703|FG001|Overall Study|Lost to Follow-up|3
1046238|NCT01796301|2083702|FG000|Overall Study|Death|0
1046239|NCT01796301|2083703|FG001|Overall Study|Death|1
1046240|NCT01796301|2083702|FG000|Overall Study|Decision by Sponsor|0
1046241|NCT01796301|2083703|FG001|Overall Study|Decision by Sponsor|1
1046242|NCT01796392|2083711|FG000|Overall Study|Withdrawal by Subject|2
1046243|NCT01796392|2083712|FG001|Overall Study|Withdrawal by Subject|0
1046244|NCT01796392|2083711|FG000|Overall Study|Death|5
1046245|NCT01796392|2083712|FG001|Overall Study|Death|1
1046246|NCT01796392|2083711|FG000|Overall Study|Excluded for medical reasons|1
1046247|NCT01796392|2083712|FG001|Overall Study|Excluded for medical reasons|2
1046248|NCT01796392|2083711|FG000|Overall Study|Lost to Follow-up|1
1046249|NCT01796392|2083712|FG001|Overall Study|Lost to Follow-up|0
1046250|NCT01796470|2083723|FG000|Overall Study|Adverse Event|4
1046251|NCT01796470|2083724|FG001|Overall Study|Adverse Event|2
1046252|NCT01796470|2083725|FG002|Overall Study|Adverse Event|2
1046253|NCT01796470|2083726|FG003|Overall Study|Adverse Event|1
1046254|NCT01796470|2083727|FG004|Overall Study|Adverse Event|3
1046255|NCT01796470|2083723|FG000|Overall Study|Death|2
1046256|NCT01796470|2083724|FG001|Overall Study|Death|0
1046257|NCT01796470|2083725|FG002|Overall Study|Death|0
1046258|NCT01796470|2083726|FG003|Overall Study|Death|0
1046259|NCT01796470|2083727|FG004|Overall Study|Death|1
1046260|NCT01796470|2083723|FG000|Overall Study|Initiated New Therapy|9
1046261|NCT01796470|2083724|FG001|Overall Study|Initiated New Therapy|0
1046262|NCT01796470|2083725|FG002|Overall Study|Initiated New Therapy|0
1046263|NCT01796470|2083726|FG003|Overall Study|Initiated New Therapy|0
1046264|NCT01796470|2083727|FG004|Overall Study|Initiated New Therapy|2
1046265|NCT01796470|2083723|FG000|Overall Study|Lost to Follow-up|0
1046266|NCT01796470|2083724|FG001|Overall Study|Lost to Follow-up|1
1046267|NCT01796470|2083725|FG002|Overall Study|Lost to Follow-up|0
1046268|NCT01796470|2083726|FG003|Overall Study|Lost to Follow-up|0
1046269|NCT01796470|2083727|FG004|Overall Study|Lost to Follow-up|0
1046270|NCT01796470|2083723|FG000|Overall Study|Physician Decision|5
1046271|NCT01796470|2083724|FG001|Overall Study|Physician Decision|4
1046272|NCT01796470|2083725|FG002|Overall Study|Physician Decision|1
1046273|NCT01796470|2083726|FG003|Overall Study|Physician Decision|0
1046274|NCT01796470|2083727|FG004|Overall Study|Physician Decision|1
1046275|NCT01796470|2083723|FG000|Overall Study|Progressive Disease|7
1046276|NCT01796470|2083724|FG001|Overall Study|Progressive Disease|7
1046277|NCT01796470|2083725|FG002|Overall Study|Progressive Disease|3
1046278|NCT01796470|2083726|FG003|Overall Study|Progressive Disease|2
1046279|NCT01796470|2083727|FG004|Overall Study|Progressive Disease|0
1046280|NCT01796470|2083723|FG000|Overall Study|Protocol Criteria for Withdrawal|1
1046281|NCT01796470|2083724|FG001|Overall Study|Protocol Criteria for Withdrawal|0
1046282|NCT01796470|2083725|FG002|Overall Study|Protocol Criteria for Withdrawal|0
1046283|NCT01796470|2083726|FG003|Overall Study|Protocol Criteria for Withdrawal|0
1046284|NCT01796470|2083727|FG004|Overall Study|Protocol Criteria for Withdrawal|0
1046285|NCT01796470|2083723|FG000|Overall Study|Withdrawal by Subject|7
1046286|NCT01796470|2083724|FG001|Overall Study|Withdrawal by Subject|0
1046287|NCT01796470|2083725|FG002|Overall Study|Withdrawal by Subject|0
1046288|NCT01796470|2083726|FG003|Overall Study|Withdrawal by Subject|0
1046289|NCT01796470|2083727|FG004|Overall Study|Withdrawal by Subject|1
1046290|NCT01796548|2083743|FG000|Overall Study|Lost to Follow-up|1
1046291|NCT01796548|2083743|FG000|Overall Study|Other|2
1046292|NCT01796860|2083760|FG000|Overall Study|Withdrawal by Subject|3
1046293|NCT01796964|2083775|FG000|Overall Study|Adverse Event|1
1046294|NCT01796964|2083776|FG001|Overall Study|Adverse Event|1
1046295|NCT01796964|2083775|FG000|Overall Study|Death|1
1046296|NCT01796964|2083776|FG001|Overall Study|Death|0
1046297|NCT01796964|2083775|FG000|Overall Study|Protocol Violation|0
1046298|NCT01796964|2083776|FG001|Overall Study|Protocol Violation|1
1046299|NCT01796964|2083775|FG000|Overall Study|Withdrawal by Subject|1
1046300|NCT01796964|2083776|FG001|Overall Study|Withdrawal by Subject|1
1046301|NCT01797081|2083805|FG000|Overall Study|Adverse Event|1
1046302|NCT01797081|2083806|FG001|Overall Study|Adverse Event|0
1046303|NCT01797081|2083807|FG002|Overall Study|Adverse Event|1
1046304|NCT01797081|2083808|FG003|Overall Study|Adverse Event|0
1046305|NCT01797081|2083805|FG000|Overall Study|Pregnancy|1
1046306|NCT01797081|2083806|FG001|Overall Study|Pregnancy|0
1046307|NCT01797081|2083807|FG002|Overall Study|Pregnancy|0
1046308|NCT01797081|2083808|FG003|Overall Study|Pregnancy|0
1046309|NCT01797081|2083805|FG000|Overall Study|Personal Reasons|12
1046310|NCT01797081|2083806|FG001|Overall Study|Personal Reasons|4
1046311|NCT01797081|2083807|FG002|Overall Study|Personal Reasons|4
1046312|NCT01797081|2083808|FG003|Overall Study|Personal Reasons|8
1046313|NCT01797081|2083805|FG000|Overall Study|Protocol Violation|0
1046314|NCT01797081|2083806|FG001|Overall Study|Protocol Violation|0
1046315|NCT01797081|2083807|FG002|Overall Study|Protocol Violation|0
1046316|NCT01797081|2083808|FG003|Overall Study|Protocol Violation|1
1046317|NCT01797094|2083818|FG000|Overall Study|Adverse Event|1
1046318|NCT01797094|2083819|FG001|Overall Study|Adverse Event|1
1046319|NCT01797094|2083818|FG000|Overall Study|Personal Reasons|4
1046320|NCT01797094|2083819|FG001|Overall Study|Personal Reasons|0
1046321|NCT01797094|2083818|FG000|Overall Study|Protocol Violation|0
1046322|NCT01797094|2083819|FG001|Overall Study|Protocol Violation|1
1046323|NCT01797094|2083818|FG000|Overall Study|Other Miscellaneous Reasons|1
1046324|NCT01797094|2083819|FG001|Overall Study|Other Miscellaneous Reasons|0
1046325|NCT01797120|2083827|FG000|Overall Study|Disesae progression|37
1046326|NCT01797120|2083828|FG001|Overall Study|Disesae progression|49
1046327|NCT01797120|2083827|FG000|Overall Study|Adverse Event|13
1046328|NCT01797120|2083828|FG001|Overall Study|Adverse Event|5
1046329|NCT01797120|2083827|FG000|Overall Study|Withdrawal by Subject|6
1046330|NCT01797120|2083828|FG001|Overall Study|Withdrawal by Subject|6
1046331|NCT01797120|2083827|FG000|Overall Study|Symptomatic progression|2
1046332|NCT01797120|2083828|FG001|Overall Study|Symptomatic progression|1
1046333|NCT01797120|2083827|FG000|Overall Study|Non-compliance|1
1046334|NCT01797120|2083828|FG001|Overall Study|Non-compliance|0
1046335|NCT01797120|2083827|FG000|Overall Study|Physician Decision|3
1046336|NCT01797120|2083828|FG001|Overall Study|Physician Decision|0
1046337|NCT01797120|2083827|FG000|Overall Study|still on treatment|2
1046338|NCT01797120|2083828|FG001|Overall Study|still on treatment|4
1046339|NCT01797120|2083827|FG000|Overall Study|never start protocol therapy|2
1046340|NCT01797120|2083828|FG001|Overall Study|never start protocol therapy|0
1046341|NCT01797185|2083842|FG000|Overall Study|Adverse Event|5
1046342|NCT01797185|2083843|FG001|Overall Study|Adverse Event|15
906625|NCT00770224|1882436|FG000|Step 1: Induction|Refusal unrelated to adverse event|6
1046343|NCT01797185|2083844|FG002|Overall Study|Adverse Event|6
1046344|NCT01797185|2083842|FG000|Overall Study|Withdrawal by Subject|6
1046345|NCT01797185|2083843|FG001|Overall Study|Withdrawal by Subject|9
1046346|NCT01797185|2083844|FG002|Overall Study|Withdrawal by Subject|5
1046347|NCT01797185|2083842|FG000|Overall Study|Site terminated|8
1046348|NCT01797185|2083843|FG001|Overall Study|Site terminated|4
1046349|NCT01797185|2083844|FG002|Overall Study|Site terminated|0
1046350|NCT01797185|2083842|FG000|Overall Study|Lost to Follow-up|2
1046351|NCT01797185|2083843|FG001|Overall Study|Lost to Follow-up|6
1046352|NCT01797185|2083844|FG002|Overall Study|Lost to Follow-up|1
1046353|NCT01797185|2083842|FG000|Overall Study|Withdrawn per sponsor|5
1046354|NCT01797185|2083843|FG001|Overall Study|Withdrawn per sponsor|0
1046355|NCT01797185|2083844|FG002|Overall Study|Withdrawn per sponsor|0
1046356|NCT01797185|2083842|FG000|Overall Study|Physician Decision|1
1046357|NCT01797185|2083843|FG001|Overall Study|Physician Decision|3
1046358|NCT01797185|2083844|FG002|Overall Study|Physician Decision|0
1046359|NCT01797185|2083842|FG000|Overall Study|Protocol Violation|1
1046360|NCT01797185|2083843|FG001|Overall Study|Protocol Violation|1
1046361|NCT01797185|2083844|FG002|Overall Study|Protocol Violation|0
1046362|NCT01797263|2083854|FG000|Overall Study|Withdrawal by Subject|21
1046363|NCT01797263|2083855|FG001|Overall Study|Withdrawal by Subject|25
1046364|NCT01797263|2083854|FG000|Overall Study|Death|1
1046365|NCT01797263|2083855|FG001|Overall Study|Death|0
1046366|NCT01797263|2083854|FG000|Overall Study|Lost to Follow-up|15
1046367|NCT01797263|2083855|FG001|Overall Study|Lost to Follow-up|15
1046368|NCT01797302|2083864|FG000|Overall Study|Lost to Follow-up|16
1046369|NCT01797302|2083865|FG001|Overall Study|Lost to Follow-up|23
1046370|NCT01797302|2083866|FG002|Overall Study|Lost to Follow-up|22
1046371|NCT01797302|2083864|FG000|Overall Study|Withdrawal by Subject|1
1046372|NCT01797302|2083865|FG001|Overall Study|Withdrawal by Subject|3
1046373|NCT01797302|2083866|FG002|Overall Study|Withdrawal by Subject|4
1046374|NCT01797432|2083883|FG000|Overall Study|Lost to Follow-up|1
1046375|NCT01797432|2083883|FG000|Overall Study|Adverse Event|1
1046376|NCT01797432|2083883|FG000|Overall Study|Withdrawal by Subject|1
1046377|NCT01797432|2083883|FG000|Overall Study|lived too far from study site|1
1046378|NCT01797445|2083889|FG000|Double-Blind Phase|Randomized but Not Treated|4
1046379|NCT01797445|2083890|FG001|Double-Blind Phase|Randomized but Not Treated|2
1046380|NCT01797445|2083889|FG000|Double-Blind Phase|Adverse Event|3
1046381|NCT01797445|2083890|FG001|Double-Blind Phase|Adverse Event|0
1046382|NCT01797445|2083889|FG000|Double-Blind Phase|Death|5
1046383|NCT01797445|2083890|FG001|Double-Blind Phase|Death|4
1046384|NCT01797445|2083889|FG000|Double-Blind Phase|Pregnancy|0
1046385|NCT01797445|2083890|FG001|Double-Blind Phase|Pregnancy|1
1046386|NCT01797445|2083889|FG000|Double-Blind Phase|Lack of Efficacy|1
1046387|NCT01797445|2083890|FG001|Double-Blind Phase|Lack of Efficacy|2
1046388|NCT01797445|2083889|FG000|Double-Blind Phase|Investigator's Discretion|15
1046389|NCT01797445|2083890|FG001|Double-Blind Phase|Investigator's Discretion|17
1046390|NCT01797445|2083889|FG000|Double-Blind Phase|Noncompliance with Study Drug|5
1046391|NCT01797445|2083890|FG001|Double-Blind Phase|Noncompliance with Study Drug|1
1046392|NCT01797445|2083889|FG000|Double-Blind Phase|Protocol Violation|0
1046393|NCT01797445|2083890|FG001|Double-Blind Phase|Protocol Violation|1
1046394|NCT01797445|2083889|FG000|Double-Blind Phase|Withdrew Consent|20
1046395|NCT01797445|2083890|FG001|Double-Blind Phase|Withdrew Consent|35
1046396|NCT01797445|2083889|FG000|Double-Blind Phase|Lost to Follow-up|34
1046397|NCT01797445|2083890|FG001|Double-Blind Phase|Lost to Follow-up|26
1046398|NCT01797445|2083889|FG000|Open-Label Extension Phase|Investigator's Discretion|1
1046399|NCT01797445|2083890|FG001|Open-Label Extension Phase|Investigator's Discretion|0
1046400|NCT01797536|2083937|FG000|Overall Study|Adverse Event|0
1046401|NCT01797536|2083938|FG001|Overall Study|Adverse Event|1
1046402|NCT01797536|2083939|FG002|Overall Study|Adverse Event|0
1046403|NCT01797536|2083940|FG003|Overall Study|Adverse Event|0
1046404|NCT01797562|2083950|FG000|Overall Study|Protocol Violation|5
1046405|NCT01797705|2083976|FG000|Overall Study|Equipment anomalies during sleep studies|4
1046406|NCT01797705|2083976|FG000|Overall Study|Withdrawal by Subject|1
1046407|NCT01797731|2083982|FG000|Overall Study|Didn't have proper radiographs required|3
1046408|NCT01797731|2083983|FG001|Overall Study|Didn't have proper radiographs required|3
1046409|NCT01797783|2083991|FG000|Overall Study|Adverse Event|1
1046410|NCT01797783|2083992|FG001|Overall Study|Adverse Event|1
1046411|NCT01797783|2083991|FG000|Overall Study|Withdrawal by Subject|1
1046412|NCT01797783|2083992|FG001|Overall Study|Withdrawal by Subject|0
1046413|NCT01797835|2084014|FG000|Overall Study|Lost to Follow-up|31
1046414|NCT01797835|2084015|FG001|Overall Study|Lost to Follow-up|27
1046415|NCT01797965|2084025|FG000|Overall Study|Adverse Event|104
1046416|NCT01797965|2084026|FG001|Overall Study|Adverse Event|129
1046417|NCT01797965|2084027|FG002|Overall Study|Adverse Event|4
1046418|NCT01797965|2084028|FG003|Overall Study|Adverse Event|21
1046419|NCT01797965|2084025|FG000|Overall Study|Lost to Follow-up|9
1046420|NCT01797965|2084026|FG001|Overall Study|Lost to Follow-up|8
1046421|NCT01797965|2084027|FG002|Overall Study|Lost to Follow-up|1
1046422|NCT01797965|2084028|FG003|Overall Study|Lost to Follow-up|2
1046423|NCT01797965|2084025|FG000|Overall Study|Consent withdrawn|130
1046424|NCT01797965|2084026|FG001|Overall Study|Consent withdrawn|117
1046425|NCT01797965|2084027|FG002|Overall Study|Consent withdrawn|3
1046426|NCT01797965|2084028|FG003|Overall Study|Consent withdrawn|35
1046427|NCT01797965|2084025|FG000|Overall Study|Investigator decision|21
1046428|NCT01797965|2084026|FG001|Overall Study|Investigator decision|15
1046429|NCT01797965|2084027|FG002|Overall Study|Investigator decision|0
1046430|NCT01797965|2084028|FG003|Overall Study|Investigator decision|0
1046431|NCT01797965|2084025|FG000|Overall Study|Death|2
1046432|NCT01797965|2084026|FG001|Overall Study|Death|4
1046433|NCT01797965|2084027|FG002|Overall Study|Death|0
1046434|NCT01797965|2084028|FG003|Overall Study|Death|0
1046435|NCT01797965|2084025|FG000|Overall Study|Disease progression, defined by protocol|3
1046436|NCT01797965|2084026|FG001|Overall Study|Disease progression, defined by protocol|1
1046437|NCT01797965|2084027|FG002|Overall Study|Disease progression, defined by protocol|0
1046438|NCT01797965|2084028|FG003|Overall Study|Disease progression, defined by protocol|0
1046439|NCT01797965|2084025|FG000|Overall Study|Reason Not Specified|280
1046440|NCT01797965|2084026|FG001|Overall Study|Reason Not Specified|295
1046441|NCT01797965|2084027|FG002|Overall Study|Reason Not Specified|0
1046442|NCT01797965|2084028|FG003|Overall Study|Reason Not Specified|15
1046443|NCT01798004|2084039|FG000|Overall Study|Death|2
1046444|NCT01798004|2084039|FG000|Overall Study|Lack of Efficacy|8
1046445|NCT01798004|2084039|FG000|Overall Study|Physician Decision|25
1046446|NCT01798004|2084039|FG000|Overall Study|Withdrawal by Subject|4
1046447|NCT01798004|2084039|FG000|Overall Study|Ineligible|4
1046448|NCT01798004|2084039|FG000|Overall Study|Patient/parent refusal|7
1046449|NCT01798004|2084039|FG000|Overall Study|Initiation of other non-protocol therapy|5
1046450|NCT01798004|2084039|FG000|Overall Study|Enrollment another COG therapeutic trial|32
1046451|NCT01798056|2084045|FG000|Overall Study|Serious Adverse Event|13
1046452|NCT01798056|2084046|FG001|Overall Study|Serious Adverse Event|12
1046453|NCT01798056|2084045|FG000|Overall Study|Withdrawal by Subject|12
1046454|NCT01798056|2084046|FG001|Overall Study|Withdrawal by Subject|9
1046455|NCT01798056|2084045|FG000|Overall Study|Migrated/moved from study area|1
1046456|NCT01798056|2084046|FG001|Overall Study|Migrated/moved from study area|1
1046457|NCT01798056|2084045|FG000|Overall Study|Lost to Follow-up|1
1046458|NCT01798056|2084046|FG001|Overall Study|Lost to Follow-up|1
1046459|NCT01798056|2084045|FG000|Overall Study|Other|0
1046460|NCT01798056|2084046|FG001|Overall Study|Other|2
1046461|NCT01798134|2084054|FG000|Overall Study|Lost to Follow-up|1
1046462|NCT01798134|2084054|FG000|Overall Study|Withdrawal by Subject|3
1046463|NCT01798134|2084054|FG000|Overall Study|Death|2
1046464|NCT01798134|2084054|FG000|Overall Study|Adverse Event|3
1046465|NCT01798134|2084054|FG000|Overall Study|Physician Decision|3
1046466|NCT01798134|2084054|FG000|Overall Study|Liver transplant/surgery|4
1046467|NCT01798485|2084126|FG000|Overall Study|Adverse Event|32
1046468|NCT01798485|2084127|FG001|Overall Study|Adverse Event|40
1046469|NCT01798485|2084126|FG000|Overall Study|Withdrawal by Subject|27
1046470|NCT01798485|2084127|FG001|Overall Study|Withdrawal by Subject|31
1046471|NCT01798485|2084126|FG000|Overall Study|Lost to Follow-up|0
1046472|NCT01798485|2084127|FG001|Overall Study|Lost to Follow-up|3
1046473|NCT01798485|2084126|FG000|Overall Study|Physician Decision|14
1046474|NCT01798485|2084127|FG001|Overall Study|Physician Decision|10
1046475|NCT01798485|2084126|FG000|Overall Study|Objective Disease Progression|152
1046476|NCT01798485|2084127|FG001|Overall Study|Objective Disease Progression|106
1046477|NCT01798485|2084126|FG000|Overall Study|Death|25
1046478|NCT01798485|2084127|FG001|Overall Study|Death|22
1046479|NCT01798485|2084126|FG000|Overall Study|Sponsor Decision|61
1046480|NCT01798485|2084127|FG001|Overall Study|Sponsor Decision|54
1046481|NCT01798485|2084126|FG000|Overall Study|Clinical Progression|35
1046482|NCT01798485|2084127|FG001|Overall Study|Clinical Progression|24
1046483|NCT01798706|2084162|FG000|Overall Study|Adverse Event|15
1046484|NCT01798706|2084163|FG001|Overall Study|Adverse Event|10
1046485|NCT01798706|2084162|FG000|Overall Study|Lack of Efficacy|0
1046486|NCT01798706|2084163|FG001|Overall Study|Lack of Efficacy|2
1046487|NCT01798706|2084162|FG000|Overall Study|Poor compliance to protocol|1
1046488|NCT01798706|2084163|FG001|Overall Study|Poor compliance to protocol|0
1046489|NCT01798706|2084162|FG000|Overall Study|Other than specified above|5
1046490|NCT01798706|2084163|FG001|Overall Study|Other than specified above|9
1046491|NCT01798849|2084172|FG000|Overall Study|Physician Decision|0
1046492|NCT01798849|2084173|FG001|Overall Study|Physician Decision|0
1046493|NCT01798849|2084174|FG002|Overall Study|Physician Decision|1
1046494|NCT01798927|2084211|FG000|Overall Study|Withdrawal by Subject|1
1046495|NCT01798992|2084224|FG000|Overall Study|Administrative withdrawal|0
1046496|NCT01798992|2084225|FG001|Overall Study|Administrative withdrawal|1
1046497|NCT01798992|2084226|FG002|Overall Study|Administrative withdrawal|0
1046498|NCT01798992|2084227|FG003|Overall Study|Administrative withdrawal|1
1046499|NCT01798992|2084224|FG000|Overall Study|Lost to Follow-up|0
1046500|NCT01798992|2084225|FG001|Overall Study|Lost to Follow-up|1
1046501|NCT01798992|2084226|FG002|Overall Study|Lost to Follow-up|1
1046502|NCT01798992|2084227|FG003|Overall Study|Lost to Follow-up|0
1046503|NCT01798992|2084224|FG000|Overall Study|Insufficient biopsy tissue|0
1046504|NCT01798992|2084225|FG001|Overall Study|Insufficient biopsy tissue|0
1046505|NCT01798992|2084226|FG002|Overall Study|Insufficient biopsy tissue|1
1046506|NCT01798992|2084227|FG003|Overall Study|Insufficient biopsy tissue|0
1046507|NCT01799226|2084257|FG000|Overall Study|Withdrawal by Subject|1
1046508|NCT01799226|2084258|FG001|Overall Study|Withdrawal by Subject|0
1046509|NCT01799226|2084257|FG000|Overall Study|Disqualified at Day 14|1
1046510|NCT01799226|2084258|FG001|Overall Study|Disqualified at Day 14|0
1046511|NCT01799239|2084264|FG000|Period 1 (7 Days)|Lack of Efficacy|1
1046512|NCT01799239|2084265|FG001|Period 1 (7 Days)|Lack of Efficacy|0
1046513|NCT01799239|2084264|FG000|Period 1 (7 Days)|Withdrawal by Subject|2
1046514|NCT01799239|2084265|FG001|Period 1 (7 Days)|Withdrawal by Subject|0
1046515|NCT01799239|2084264|FG000|Period 1 (7 Days)|Protocol Violation|0
1046516|NCT01799239|2084265|FG001|Period 1 (7 Days)|Protocol Violation|1
1046517|NCT01799239|2084264|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
1046518|NCT01799239|2084265|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
1046519|NCT01799239|2084264|FG000|Period 2 (7 Days)|Protocol Violation|1
1046520|NCT01799239|2084265|FG001|Period 2 (7 Days)|Protocol Violation|0
1046521|NCT01799590|2084282|FG000|Overall Study|Adverse Event|13
1046522|NCT01799590|2084283|FG001|Overall Study|Adverse Event|7
1046523|NCT01799590|2084284|FG002|Overall Study|Adverse Event|5
1046524|NCT01799590|2084282|FG000|Overall Study|Pregnancy|2
1046525|NCT01799590|2084283|FG001|Overall Study|Pregnancy|0
1046526|NCT01799590|2084284|FG002|Overall Study|Pregnancy|0
1046527|NCT01799590|2084282|FG000|Overall Study|Lack of Efficacy|3
1046528|NCT01799590|2084283|FG001|Overall Study|Lack of Efficacy|1
1046529|NCT01799590|2084284|FG002|Overall Study|Lack of Efficacy|3
1046530|NCT01799590|2084282|FG000|Overall Study|Participants convenience|4
1046531|NCT01799590|2084283|FG001|Overall Study|Participants convenience|4
1046532|NCT01799590|2084284|FG002|Overall Study|Participants convenience|2
1046533|NCT01799590|2084282|FG000|Overall Study|Aggravation of complications|0
1046534|NCT01799590|2084283|FG001|Overall Study|Aggravation of complications|1
1046535|NCT01799590|2084284|FG002|Overall Study|Aggravation of complications|1
1046536|NCT01799590|2084282|FG000|Overall Study|Using drugs with restricted days of use|0
1046537|NCT01799590|2084283|FG001|Overall Study|Using drugs with restricted days of use|3
1046538|NCT01799590|2084284|FG002|Overall Study|Using drugs with restricted days of use|2
1046539|NCT01799590|2084282|FG000|Overall Study|Use of prohibited concomitant drugs|1
1046540|NCT01799590|2084283|FG001|Overall Study|Use of prohibited concomitant drugs|0
1046541|NCT01799590|2084284|FG002|Overall Study|Use of prohibited concomitant drugs|0
1046542|NCT01799590|2084282|FG000|Overall Study|Other|3
1046543|NCT01799590|2084283|FG001|Overall Study|Other|0
1046544|NCT01799590|2084284|FG002|Overall Study|Other|1
1046545|NCT01799720|2084295|FG000|Overall Study|Withdrawal by Subject|3
1046546|NCT01799720|2084296|FG001|Overall Study|Withdrawal by Subject|0
1046547|NCT01799720|2084297|FG002|Overall Study|Withdrawal by Subject|0
1046548|NCT01799720|2084295|FG000|Overall Study|Protocol Violation|0
1046549|NCT01799720|2084296|FG001|Overall Study|Protocol Violation|1
1046550|NCT01799720|2084297|FG002|Overall Study|Protocol Violation|0
1046551|NCT01799720|2084295|FG000|Overall Study|Pregnancy|0
1046552|NCT01799720|2084296|FG001|Overall Study|Pregnancy|0
1046553|NCT01799720|2084297|FG002|Overall Study|Pregnancy|1
1046554|NCT01799889|2084317|FG000|Overall Study|Adverse Event|4
1046555|NCT01799889|2084318|FG001|Overall Study|Adverse Event|4
1046556|NCT01799889|2084319|FG002|Overall Study|Adverse Event|5
1046557|NCT01799889|2084320|FG003|Overall Study|Adverse Event|1
1046558|NCT01799889|2084321|FG004|Overall Study|Adverse Event|11
1046559|NCT01799889|2084322|FG005|Overall Study|Adverse Event|1
1046560|NCT01799889|2084323|FG006|Overall Study|Adverse Event|5
1046561|NCT01799889|2084324|FG007|Overall Study|Adverse Event|2
1046562|NCT01799889|2084325|FG008|Overall Study|Adverse Event|3
1046563|NCT01799889|2084326|FG009|Overall Study|Adverse Event|1
1046564|NCT01799889|2084327|FG010|Overall Study|Adverse Event|1
1046565|NCT01799889|2084328|FG011|Overall Study|Adverse Event|0
1046566|NCT01799889|2084317|FG000|Overall Study|Death|1
1046567|NCT01799889|2084318|FG001|Overall Study|Death|0
1046568|NCT01799889|2084319|FG002|Overall Study|Death|5
1046569|NCT01799889|2084320|FG003|Overall Study|Death|3
1046570|NCT01799889|2084321|FG004|Overall Study|Death|1
1046571|NCT01799889|2084322|FG005|Overall Study|Death|0
1046572|NCT01799889|2084323|FG006|Overall Study|Death|0
1046573|NCT01799889|2084324|FG007|Overall Study|Death|0
1046574|NCT01799889|2084325|FG008|Overall Study|Death|1
1046575|NCT01799889|2084326|FG009|Overall Study|Death|0
1046576|NCT01799889|2084327|FG010|Overall Study|Death|1
1046577|NCT01799889|2084328|FG011|Overall Study|Death|0
1046578|NCT01799889|2084317|FG000|Overall Study|Lack of Efficacy|1
1046579|NCT01799889|2084318|FG001|Overall Study|Lack of Efficacy|1
1046580|NCT01799889|2084319|FG002|Overall Study|Lack of Efficacy|0
1046581|NCT01799889|2084320|FG003|Overall Study|Lack of Efficacy|1
1046582|NCT01799889|2084321|FG004|Overall Study|Lack of Efficacy|2
1046583|NCT01799889|2084322|FG005|Overall Study|Lack of Efficacy|2
1046584|NCT01799889|2084323|FG006|Overall Study|Lack of Efficacy|0
1046585|NCT01799889|2084324|FG007|Overall Study|Lack of Efficacy|0
1046586|NCT01799889|2084325|FG008|Overall Study|Lack of Efficacy|2
1046587|NCT01799889|2084326|FG009|Overall Study|Lack of Efficacy|0
1046588|NCT01799889|2084327|FG010|Overall Study|Lack of Efficacy|1
1046589|NCT01799889|2084328|FG011|Overall Study|Lack of Efficacy|0
1046590|NCT01799889|2084317|FG000|Overall Study|Lost to Follow-up|0
1046591|NCT01799889|2084318|FG001|Overall Study|Lost to Follow-up|1
1046592|NCT01799889|2084319|FG002|Overall Study|Lost to Follow-up|0
1046593|NCT01799889|2084320|FG003|Overall Study|Lost to Follow-up|0
1046594|NCT01799889|2084321|FG004|Overall Study|Lost to Follow-up|0
1046595|NCT01799889|2084322|FG005|Overall Study|Lost to Follow-up|0
1046596|NCT01799889|2084323|FG006|Overall Study|Lost to Follow-up|0
1046597|NCT01799889|2084324|FG007|Overall Study|Lost to Follow-up|0
1046598|NCT01799889|2084325|FG008|Overall Study|Lost to Follow-up|0
1046599|NCT01799889|2084326|FG009|Overall Study|Lost to Follow-up|0
1046600|NCT01799889|2084327|FG010|Overall Study|Lost to Follow-up|0
1046601|NCT01799889|2084328|FG011|Overall Study|Lost to Follow-up|0
1046602|NCT01799889|2084317|FG000|Overall Study|Physician Decision|3
1046603|NCT01799889|2084318|FG001|Overall Study|Physician Decision|2
1046604|NCT01799889|2084319|FG002|Overall Study|Physician Decision|4
1046605|NCT01799889|2084320|FG003|Overall Study|Physician Decision|4
1046606|NCT01799889|2084321|FG004|Overall Study|Physician Decision|5
1046607|NCT01799889|2084322|FG005|Overall Study|Physician Decision|5
1046608|NCT01799889|2084323|FG006|Overall Study|Physician Decision|5
1046609|NCT01799889|2084324|FG007|Overall Study|Physician Decision|2
1046610|NCT01799889|2084325|FG008|Overall Study|Physician Decision|6
1046611|NCT01799889|2084326|FG009|Overall Study|Physician Decision|0
1046612|NCT01799889|2084327|FG010|Overall Study|Physician Decision|0
1046613|NCT01799889|2084328|FG011|Overall Study|Physician Decision|1
1046614|NCT01799889|2084317|FG000|Overall Study|Progressive Disease|30
1046615|NCT01799889|2084318|FG001|Overall Study|Progressive Disease|26
1046616|NCT01799889|2084319|FG002|Overall Study|Progressive Disease|25
1046617|NCT01799889|2084320|FG003|Overall Study|Progressive Disease|30
1046618|NCT01799889|2084321|FG004|Overall Study|Progressive Disease|23
1046619|NCT01799889|2084322|FG005|Overall Study|Progressive Disease|9
1046620|NCT01799889|2084323|FG006|Overall Study|Progressive Disease|8
1046621|NCT01799889|2084324|FG007|Overall Study|Progressive Disease|13
1046622|NCT01799889|2084325|FG008|Overall Study|Progressive Disease|18
1046623|NCT01799889|2084326|FG009|Overall Study|Progressive Disease|5
1046624|NCT01799889|2084327|FG010|Overall Study|Progressive Disease|3
1046625|NCT01799889|2084328|FG011|Overall Study|Progressive Disease|1
1046626|NCT01799889|2084317|FG000|Overall Study|Specified Criteria for Withdrawal|0
1046627|NCT01799889|2084318|FG001|Overall Study|Specified Criteria for Withdrawal|1
1046628|NCT01799889|2084319|FG002|Overall Study|Specified Criteria for Withdrawal|1
1046629|NCT01799889|2084320|FG003|Overall Study|Specified Criteria for Withdrawal|0
1046630|NCT01799889|2084321|FG004|Overall Study|Specified Criteria for Withdrawal|0
1046631|NCT01799889|2084322|FG005|Overall Study|Specified Criteria for Withdrawal|0
1046632|NCT01799889|2084323|FG006|Overall Study|Specified Criteria for Withdrawal|0
1046633|NCT01799889|2084324|FG007|Overall Study|Specified Criteria for Withdrawal|0
1046634|NCT01799889|2084325|FG008|Overall Study|Specified Criteria for Withdrawal|0
1046635|NCT01799889|2084326|FG009|Overall Study|Specified Criteria for Withdrawal|0
1046636|NCT01799889|2084327|FG010|Overall Study|Specified Criteria for Withdrawal|0
1046637|NCT01799889|2084328|FG011|Overall Study|Specified Criteria for Withdrawal|0
1046638|NCT01799889|2084317|FG000|Overall Study|Study Terminated By Sponsor|1
1046639|NCT01799889|2084318|FG001|Overall Study|Study Terminated By Sponsor|0
1046640|NCT01799889|2084319|FG002|Overall Study|Study Terminated By Sponsor|0
1046641|NCT01799889|2084320|FG003|Overall Study|Study Terminated By Sponsor|0
1046642|NCT01799889|2084321|FG004|Overall Study|Study Terminated By Sponsor|2
1046643|NCT01799889|2084322|FG005|Overall Study|Study Terminated By Sponsor|1
1046644|NCT01799889|2084323|FG006|Overall Study|Study Terminated By Sponsor|0
1046645|NCT01799889|2084324|FG007|Overall Study|Study Terminated By Sponsor|2
1046646|NCT01799889|2084325|FG008|Overall Study|Study Terminated By Sponsor|1
1046647|NCT01799889|2084326|FG009|Overall Study|Study Terminated By Sponsor|1
1046648|NCT01799889|2084327|FG010|Overall Study|Study Terminated By Sponsor|0
1046649|NCT01799889|2084328|FG011|Overall Study|Study Terminated By Sponsor|0
1046650|NCT01799889|2084317|FG000|Overall Study|Withdrawal by Subject|1
1046651|NCT01799889|2084318|FG001|Overall Study|Withdrawal by Subject|6
1046652|NCT01799889|2084319|FG002|Overall Study|Withdrawal by Subject|4
1046653|NCT01799889|2084320|FG003|Overall Study|Withdrawal by Subject|0
1046654|NCT01799889|2084321|FG004|Overall Study|Withdrawal by Subject|5
1046655|NCT01799889|2084322|FG005|Overall Study|Withdrawal by Subject|1
1046656|NCT01799889|2084323|FG006|Overall Study|Withdrawal by Subject|3
1046657|NCT01799889|2084324|FG007|Overall Study|Withdrawal by Subject|1
1046658|NCT01799889|2084325|FG008|Overall Study|Withdrawal by Subject|2
1046659|NCT01799889|2084326|FG009|Overall Study|Withdrawal by Subject|1
1046660|NCT01799889|2084327|FG010|Overall Study|Withdrawal by Subject|1
1046661|NCT01799889|2084328|FG011|Overall Study|Withdrawal by Subject|1
1046662|NCT01799889|2084317|FG000|Overall Study|Non-Compliance With Study Drug|0
1046663|NCT01799889|2084318|FG001|Overall Study|Non-Compliance With Study Drug|0
1046664|NCT01799889|2084319|FG002|Overall Study|Non-Compliance With Study Drug|0
1046665|NCT01799889|2084320|FG003|Overall Study|Non-Compliance With Study Drug|0
1046666|NCT01799889|2084321|FG004|Overall Study|Non-Compliance With Study Drug|0
1046667|NCT01799889|2084322|FG005|Overall Study|Non-Compliance With Study Drug|1
1046668|NCT01799889|2084323|FG006|Overall Study|Non-Compliance With Study Drug|0
1046669|NCT01799889|2084324|FG007|Overall Study|Non-Compliance With Study Drug|0
1046670|NCT01799889|2084325|FG008|Overall Study|Non-Compliance With Study Drug|0
1046671|NCT01799889|2084326|FG009|Overall Study|Non-Compliance With Study Drug|0
1046672|NCT01799889|2084327|FG010|Overall Study|Non-Compliance With Study Drug|0
1046673|NCT01799889|2084328|FG011|Overall Study|Non-Compliance With Study Drug|0
1046674|NCT01799941|2084365|FG000|Overall Study|Adverse Event|34
1046675|NCT01799941|2084365|FG000|Overall Study|Withdrawal by Subject|21
1046676|NCT01799941|2084365|FG000|Overall Study|Death|2
1046677|NCT01799941|2084365|FG000|Overall Study|Investigator Decision|4
1046678|NCT01799941|2084365|FG000|Overall Study|Lack of Efficacy|3
1046679|NCT01799941|2084365|FG000|Overall Study|Lost to Follow-up|17
1046680|NCT01799941|2084365|FG000|Overall Study|Other|15
1046681|NCT01799993|2084377|FG000|Overall Study|"Didn't complete CRF page End of FU"|30
1046682|NCT01799993|2084378|FG001|Overall Study|"Didn't complete CRF page End of FU"|40
1046683|NCT01799993|2084377|FG000|Overall Study|Death|61
1046684|NCT01799993|2084378|FG001|Overall Study|Death|45
1046685|NCT01799993|2084377|FG000|Overall Study|Withdrawal by Subject|23
1046686|NCT01799993|2084378|FG001|Overall Study|Withdrawal by Subject|24
1046687|NCT01799993|2084377|FG000|Overall Study|Lost to Follow-up|5
1046688|NCT01799993|2084378|FG001|Overall Study|Lost to Follow-up|8
1046689|NCT01799993|2084377|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5
1046690|NCT01799993|2084378|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3
1046691|NCT01799993|2084377|FG000|Overall Study|Protocol driven decision point|0
1046692|NCT01799993|2084378|FG001|Overall Study|Protocol driven decision point|3
1046693|NCT01799993|2084377|FG000|Overall Study|Protocol Violation|1
1046694|NCT01799993|2084378|FG001|Overall Study|Protocol Violation|1
1046695|NCT01799993|2084377|FG000|Overall Study|Deterioration of general conditions|2
1046696|NCT01799993|2084378|FG001|Overall Study|Deterioration of general conditions|0
1046697|NCT01799993|2084377|FG000|Overall Study|Screen failure|0
1046698|NCT01799993|2084378|FG001|Overall Study|Screen failure|1
1046699|NCT01799993|2084377|FG000|Overall Study|Adverse Event|1
1046700|NCT01799993|2084378|FG001|Overall Study|Adverse Event|0
1046701|NCT01799993|2084377|FG000|Overall Study|Lack of Efficacy|1
1046702|NCT01799993|2084378|FG001|Overall Study|Lack of Efficacy|0
1046703|NCT01799993|2084377|FG000|Overall Study|Recovery|0
1046704|NCT01799993|2084378|FG001|Overall Study|Recovery|1
1046705|NCT01799993|2084377|FG000|Overall Study|Logistical difficulties|1
1046706|NCT01799993|2084378|FG001|Overall Study|Logistical difficulties|0
1046707|NCT01799993|2084377|FG000|Overall Study|Protocol deviation|1
1046708|NCT01799993|2084378|FG001|Overall Study|Protocol deviation|0
906626|NCT00770224|1882437|FG001|Step 1: Induction|Refusal unrelated to adverse event|0
906627|NCT00770224|1882436|FG000|Step 1: Induction|Other reason not protocol specified|2
906628|NCT00770224|1882437|FG001|Step 1: Induction|Other reason not protocol specified|0
906629|NCT00770224|1882436|FG000|Step 1: Induction|Ineligible|2
906630|NCT00770224|1882437|FG001|Step 1: Induction|Ineligible|0
906631|NCT00770224|1882436|FG000|Step 1: Induction|No protocol treatment given|1
906632|NCT00770224|1882437|FG001|Step 1: Induction|No protocol treatment given|0
906633|NCT00770224|1882436|FG000|Step 2: Maintenance|Adverse Event|0
906634|NCT00770224|1882437|FG001|Step 2: Maintenance|Adverse Event|10
906635|NCT00770224|1882436|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0
906636|NCT00770224|1882437|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8
906637|NCT00770224|1882436|FG000|Step 2: Maintenance|Progression/relapse|0
906638|NCT00770224|1882437|FG001|Step 2: Maintenance|Progression/relapse|1
906639|NCT00770224|1882436|FG000|Step 2: Maintenance|Death|0
906640|NCT00770224|1882437|FG001|Step 2: Maintenance|Death|2
906641|NCT00770224|1882436|FG000|Step 2: Maintenance|Other reason not protocol specified|0
906642|NCT00770224|1882437|FG001|Step 2: Maintenance|Other reason not protocol specified|7
906643|NCT00770224|1882436|FG000|Step 2: Maintenance|Ineligible|0
906644|NCT00770224|1882437|FG001|Step 2: Maintenance|Ineligible|2
1046709|NCT01799993|2084377|FG000|Overall Study|Non-compliance with medical device|1
1046710|NCT01799993|2084378|FG001|Overall Study|Non-compliance with medical device|0
1046711|NCT01799993|2084377|FG000|Overall Study|Withdrawal by parent/guardian|0
1046712|NCT01799993|2084378|FG001|Overall Study|Withdrawal by parent/guardian|1
1046713|NCT01799993|2084377|FG000|Overall Study|Other|1
1046714|NCT01799993|2084378|FG001|Overall Study|Other|0
1046715|NCT01799993|2084377|FG000|Overall Study|Subject didn't return for follow-up|0
1046716|NCT01799993|2084378|FG001|Overall Study|Subject didn't return for follow-up|1
1046717|NCT01800058|2084384|FG000|Overall Study|Lost to Follow-up|1
1046718|NCT01800201|2084391|FG000|Overall Study|Withdrawal by Subject|2
1046719|NCT01800201|2084392|FG001|Overall Study|Withdrawal by Subject|0
1046720|NCT01800201|2084391|FG000|Overall Study|patient privacy concerns|1
1046721|NCT01800201|2084392|FG001|Overall Study|patient privacy concerns|1
1046722|NCT01800201|2084391|FG000|Overall Study|did not want to use device|0
1046723|NCT01800201|2084392|FG001|Overall Study|did not want to use device|1
1046724|NCT01800201|2084391|FG000|Overall Study|PI withdrawal, cognitive concerns|0
1046725|NCT01800201|2084392|FG001|Overall Study|PI withdrawal, cognitive concerns|1
1046726|NCT01800903|2084467|FG000|Second Test Period|unable to catheterise|1
1046727|NCT01800903|2084468|FG001|Second Test Period|unable to catheterise|0
1046728|NCT01800903|2084469|FG002|Second Test Period|unable to catheterise|0
1046729|NCT01800903|2084470|FG003|Second Test Period|unable to catheterise|0
1046730|NCT01800903|2084471|FG004|Second Test Period|unable to catheterise|0
1046731|NCT01800903|2084472|FG005|Second Test Period|unable to catheterise|0
1046732|NCT01800916|2084478|FG000|Test Period 1 (1 Week)|Convex product user|0
1046733|NCT01800916|2084479|FG001|Test Period 1 (1 Week)|Convex product user|0
1046734|NCT01800916|2084480|FG002|Test Period 1 (1 Week)|Convex product user|0
1046735|NCT01800916|2084481|FG003|Test Period 1 (1 Week)|Convex product user|1
1046736|NCT01800916|2084482|FG004|Test Period 1 (1 Week)|Convex product user|0
1046737|NCT01800916|2084483|FG005|Test Period 1 (1 Week)|Convex product user|0
1046738|NCT01800916|2084484|FG006|Test Period 1 (1 Week)|Convex product user|0
1046739|NCT01800916|2084485|FG007|Test Period 1 (1 Week)|Convex product user|0
1046740|NCT01800916|2084486|FG008|Test Period 1 (1 Week)|Convex product user|0
1046741|NCT01800916|2084478|FG000|Test Period 1 (1 Week)|Adverse Event|0
1046742|NCT01800916|2084479|FG001|Test Period 1 (1 Week)|Adverse Event|0
1046743|NCT01800916|2084480|FG002|Test Period 1 (1 Week)|Adverse Event|0
1046744|NCT01800916|2084481|FG003|Test Period 1 (1 Week)|Adverse Event|0
1046745|NCT01800916|2084482|FG004|Test Period 1 (1 Week)|Adverse Event|1
1046746|NCT01800916|2084483|FG005|Test Period 1 (1 Week)|Adverse Event|0
1046747|NCT01800916|2084484|FG006|Test Period 1 (1 Week)|Adverse Event|0
1046748|NCT01800916|2084485|FG007|Test Period 1 (1 Week)|Adverse Event|0
1046749|NCT01800916|2084486|FG008|Test Period 1 (1 Week)|Adverse Event|0
1046750|NCT01800968|2084498|FG000|Overall Study|Death|23
1046751|NCT01800968|2084499|FG001|Overall Study|Death|16
1046752|NCT01800968|2084498|FG000|Overall Study|Lost to Follow-up|5
1046753|NCT01800968|2084499|FG001|Overall Study|Lost to Follow-up|7
1046754|NCT01800968|2084498|FG000|Overall Study|Withdrawal by Subject|7
1046755|NCT01800968|2084499|FG001|Overall Study|Withdrawal by Subject|9
1046756|NCT01800968|2084498|FG000|Overall Study|Physician Decision|1
1046757|NCT01800968|2084499|FG001|Overall Study|Physician Decision|0
1046758|NCT01801007|2084505|FG000|Overall Study|Adverse Event|2
1046759|NCT01801007|2084505|FG000|Overall Study|Lost to Follow-up|4
1046760|NCT01801007|2084505|FG000|Overall Study|Withdrawal by Subject|5
1046761|NCT01801111|2084509|FG000|Overall Study|Adverse Event|12
1046762|NCT01801111|2084509|FG000|Overall Study|Death|8
1046763|NCT01801111|2084509|FG000|Overall Study|Physician Decision|5
1046764|NCT01801111|2084509|FG000|Overall Study|Other|1
1046765|NCT01801111|2084509|FG000|Overall Study|Withdrawal by Subject|4
1046766|NCT01801111|2084509|FG000|Overall Study|Study Terminated by Sponsor|27
1046767|NCT01801111|2084509|FG000|Overall Study|Progressive Disease|81
1046768|NCT01801280|2084530|FG000|Period 1|Withdrawal by Subject|0
1046769|NCT01801280|2084531|FG001|Period 1|Withdrawal by Subject|1
1046770|NCT01801280|2084532|FG002|Period 1|Withdrawal by Subject|0
1046771|NCT01801280|2084533|FG003|Period 1|Withdrawal by Subject|0
1046772|NCT01801280|2084530|FG000|Period 2|Withdrawal by Subject|1
1046773|NCT01801280|2084531|FG001|Period 2|Withdrawal by Subject|0
1046774|NCT01801280|2084532|FG002|Period 2|Withdrawal by Subject|0
1046775|NCT01801280|2084533|FG003|Period 2|Withdrawal by Subject|0
1046776|NCT01801280|2084530|FG000|Period 4|Protocol Violation|0
1046777|NCT01801280|2084531|FG001|Period 4|Protocol Violation|0
1046778|NCT01801280|2084532|FG002|Period 4|Protocol Violation|1
1046779|NCT01801280|2084533|FG003|Period 4|Protocol Violation|0
1046780|NCT01801358|2084549|FG000|Overall Study|Adverse Event|0
1046781|NCT01801358|2084550|FG001|Overall Study|Adverse Event|2
1046782|NCT01801358|2084551|FG002|Overall Study|Adverse Event|1
1046783|NCT01801358|2084552|FG003|Overall Study|Adverse Event|0
1046784|NCT01801358|2084553|FG004|Overall Study|Adverse Event|0
1046785|NCT01801358|2084554|FG005|Overall Study|Adverse Event|1
1046786|NCT01801358|2084549|FG000|Overall Study|Physician Decision|0
1046787|NCT01801358|2084550|FG001|Overall Study|Physician Decision|0
1046788|NCT01801358|2084551|FG002|Overall Study|Physician Decision|1
1046789|NCT01801358|2084552|FG003|Overall Study|Physician Decision|0
1046790|NCT01801358|2084553|FG004|Overall Study|Physician Decision|0
1046791|NCT01801358|2084554|FG005|Overall Study|Physician Decision|0
1046792|NCT01801358|2084549|FG000|Overall Study|Progressive Disease|6
1046793|NCT01801358|2084550|FG001|Overall Study|Progressive Disease|4
1046794|NCT01801358|2084551|FG002|Overall Study|Progressive Disease|4
1046795|NCT01801358|2084552|FG003|Overall Study|Progressive Disease|5
1046796|NCT01801358|2084553|FG004|Overall Study|Progressive Disease|6
1046797|NCT01801358|2084554|FG005|Overall Study|Progressive Disease|5
1046798|NCT01801358|2084549|FG000|Overall Study|Withdrawal by Subject|0
1046799|NCT01801358|2084550|FG001|Overall Study|Withdrawal by Subject|0
1046800|NCT01801358|2084551|FG002|Overall Study|Withdrawal by Subject|0
1046801|NCT01801358|2084552|FG003|Overall Study|Withdrawal by Subject|1
1046802|NCT01801358|2084553|FG004|Overall Study|Withdrawal by Subject|0
1046803|NCT01801358|2084554|FG005|Overall Study|Withdrawal by Subject|2
1046804|NCT01801436|2084589|FG000|Overall Study|Withdrawal by Subject|3
1046805|NCT01801436|2084589|FG000|Overall Study|Adverse Event|2
1046806|NCT01801436|2084589|FG000|Overall Study|Progressive disease|4
1046807|NCT01801475|2084601|FG000|Overall Study|Withdrawal by Subject|0
1046808|NCT01801475|2084602|FG001|Overall Study|Withdrawal by Subject|0
1046809|NCT01801475|2084603|FG002|Overall Study|Withdrawal by Subject|0
1046810|NCT01801475|2084604|FG003|Overall Study|Withdrawal by Subject|0
1046811|NCT01801475|2084605|FG004|Overall Study|Withdrawal by Subject|1
1046812|NCT01801735|2084614|FG000|Overall Study|Adverse Event|79
1046813|NCT01801735|2084614|FG000|Overall Study|Lack of Efficacy|28
1046814|NCT01801735|2084614|FG000|Overall Study|Withdrawal by Subject|27
1046815|NCT01801735|2084614|FG000|Overall Study|Protocol Violation|25
1046816|NCT01801735|2084614|FG000|Overall Study|Lost to Follow-up|15
1046817|NCT01801735|2084614|FG000|Overall Study|Non-compliance with Trial Drug|13
1046818|NCT01801735|2084614|FG000|Overall Study|Physician Decision|3
1046819|NCT01801735|2084614|FG000|Overall Study|Death|1
1046820|NCT01801735|2084614|FG000|Overall Study|Other, including site closure|19
1046821|NCT01801865|2084618|FG000|Overall Study|Patients scanned on another MRI scanner|35
1046822|NCT01801865|2084618|FG000|Overall Study|Physician Decision|7
1046823|NCT01801917|2084626|FG000|Period 1 - Randomized|Adverse Event|1
1046824|NCT01801917|2084627|FG001|Period 1 - Randomized|Adverse Event|0
1046825|NCT01801917|2084628|FG002|Period 1 - Randomized|Adverse Event|1
1046826|NCT01801917|2084629|FG003|Period 1 - Randomized|Adverse Event|0
1046827|NCT01801930|2084644|FG000|Overall Study|Clear progression of the primary disease is observed|6
1046828|NCT01801930|2084645|FG001|Overall Study|Clear progression of the primary disease is observed|5
1046829|NCT01801930|2084646|FG002|Overall Study|Clear progression of the primary disease is observed|6
1046830|NCT01801930|2084647|FG003|Overall Study|Clear progression of the primary disease is observed|6
1046831|NCT01801930|2084644|FG000|Overall Study|DLT occurs|0
1046832|NCT01801930|2084645|FG001|Overall Study|DLT occurs|1
1046833|NCT01801930|2084646|FG002|Overall Study|DLT occurs|0
1046834|NCT01801930|2084647|FG003|Overall Study|DLT occurs|0
1046835|NCT01801982|2084657|FG000|Overall Study|Lost to Follow-up|1
1046836|NCT01802073|2084663|FG000|Overall Study|Lost to Follow-up|0
1046837|NCT01802073|2084664|FG001|Overall Study|Lost to Follow-up|1
1046838|NCT01802073|2084663|FG000|Overall Study|Non-compliant|4
1046839|NCT01802073|2084664|FG001|Overall Study|Non-compliant|2
1046840|NCT01802073|2084663|FG000|Overall Study|Withdrawal by Subject|1
1046841|NCT01802073|2084664|FG001|Overall Study|Withdrawal by Subject|1
1046842|NCT01802073|2084663|FG000|Overall Study|Physician Decision|0
1046843|NCT01802073|2084664|FG001|Overall Study|Physician Decision|7
1046844|NCT01802216|2084689|FG000|4 Month Visit|Participant did not show to visit|3
1046845|NCT01802216|2084690|FG001|4 Month Visit|Participant did not show to visit|4
1046846|NCT01802216|2084689|FG000|8 Month Visit|Participant did not show to visit|3
1046847|NCT01802216|2084690|FG001|8 Month Visit|Participant did not show to visit|5
1046848|NCT01802216|2084689|FG000|12 Month Visit|Participant did not show to visit|3
1046849|NCT01802216|2084690|FG001|12 Month Visit|Participant did not show to visit|4
1046850|NCT01802281|2084698|FG000|Overall Study|Death|1
1046851|NCT01802281|2084699|FG001|Overall Study|Death|2
1046852|NCT01802281|2084698|FG000|Overall Study|Withdrawal by Subject|2
1046853|NCT01802281|2084699|FG001|Overall Study|Withdrawal by Subject|1
1046854|NCT01802281|2084698|FG000|Overall Study|Ineligible|5
1046855|NCT01802281|2084699|FG001|Overall Study|Ineligible|3
1046856|NCT01802320|2084705|FG000|Overall Study|Death|1
1046857|NCT01802320|2084705|FG000|Overall Study|Withdrawal by Subject|1
1046858|NCT01802333|2084712|FG000|Overall Study|Ineligible|2
1046859|NCT01802333|2084713|FG001|Overall Study|Ineligible|6
1046860|NCT01802333|2084714|FG002|Overall Study|Ineligible|8
1046861|NCT01802333|2084712|FG000|Overall Study|Adverse Event|1
1046862|NCT01802333|2084713|FG001|Overall Study|Adverse Event|8
1046863|NCT01802333|2084714|FG002|Overall Study|Adverse Event|8
1046864|NCT01802333|2084712|FG000|Overall Study|Withdrawal by Subject|6
1046865|NCT01802333|2084713|FG001|Overall Study|Withdrawal by Subject|6
1046866|NCT01802333|2084714|FG002|Overall Study|Withdrawal by Subject|5
1046867|NCT01802333|2084712|FG000|Overall Study|Progression/relapse|1
1046868|NCT01802333|2084713|FG001|Overall Study|Progression/relapse|3
1046869|NCT01802333|2084714|FG002|Overall Study|Progression/relapse|0
1046870|NCT01802333|2084712|FG000|Overall Study|Death|7
1046871|NCT01802333|2084713|FG001|Overall Study|Death|14
1046872|NCT01802333|2084714|FG002|Overall Study|Death|13
1046873|NCT01802333|2084712|FG000|Overall Study|Other - not protocol specified|32
1046874|NCT01802333|2084713|FG001|Overall Study|Other - not protocol specified|22
1046875|NCT01802333|2084714|FG002|Overall Study|Other - not protocol specified|24
1046876|NCT01802333|2084712|FG000|Overall Study|Did not start treatment|0
1046877|NCT01802333|2084713|FG001|Overall Study|Did not start treatment|2
1046878|NCT01802333|2084714|FG002|Overall Study|Did not start treatment|5
1046879|NCT01802385|2084730|FG000|Overall Study|Death|106
1046880|NCT01802385|2084731|FG001|Overall Study|Death|120
1046881|NCT01802411|2084739|FG000|Overall Study|Death|2
1046882|NCT01802411|2084740|FG001|Overall Study|Death|1
1046883|NCT01802411|2084739|FG000|Overall Study|Adverse Event|2
1046884|NCT01802411|2084740|FG001|Overall Study|Adverse Event|7
1046885|NCT01802411|2084739|FG000|Overall Study|Lack of Efficacy|8
1046886|NCT01802411|2084740|FG001|Overall Study|Lack of Efficacy|10
1046887|NCT01802411|2084739|FG000|Overall Study|Withdrawal by Subject|0
1046888|NCT01802411|2084740|FG001|Overall Study|Withdrawal by Subject|2
1046889|NCT01802411|2084739|FG000|Overall Study|Planned pleurodesis as part of the proc|1
1046890|NCT01802411|2084740|FG001|Overall Study|Planned pleurodesis as part of the proc|0
1046891|NCT01802411|2084739|FG000|Overall Study|Surgery aborted after bronchoscopy|1
1046892|NCT01802411|2084740|FG001|Overall Study|Surgery aborted after bronchoscopy|0
1046893|NCT01802411|2084739|FG000|Overall Study|Proc changed to video-asst thorascopic|0
1046894|NCT01802411|2084740|FG001|Overall Study|Proc changed to video-asst thorascopic|1
1046895|NCT01802437|2084748|FG000|Overall Study|Lost to Follow-up|1
1046896|NCT01802437|2084749|FG001|Overall Study|Lost to Follow-up|0
1046897|NCT01802437|2084748|FG000|Overall Study|Withdrawal by Subject|3
1046898|NCT01802437|2084749|FG001|Overall Study|Withdrawal by Subject|4
1046899|NCT01802515|2084758|FG000|Overall Study|Withdrawal by Subject|3
1046900|NCT01802515|2084759|FG001|Overall Study|Withdrawal by Subject|0
1046901|NCT01802515|2084760|FG002|Overall Study|Withdrawal by Subject|0
1046902|NCT01802580|2084779|FG000|Overall Study|Physician Decision|1
1046903|NCT01802580|2084780|FG001|Overall Study|Physician Decision|0
1046904|NCT01802580|2084779|FG000|Overall Study|Protocol Violation|2
1046905|NCT01802580|2084780|FG001|Overall Study|Protocol Violation|0
1046906|NCT01802580|2084779|FG000|Overall Study|Withdrawal by Subject|5
1046907|NCT01802580|2084780|FG001|Overall Study|Withdrawal by Subject|6
1046908|NCT01802580|2084779|FG000|Overall Study|Other|1
1046909|NCT01802580|2084780|FG001|Overall Study|Other|3
1046910|NCT01802580|2084779|FG000|Overall Study|Lack of Efficacy|0
1046911|NCT01802580|2084780|FG001|Overall Study|Lack of Efficacy|2
1046912|NCT01802632|2084792|FG000|Overall Study|Death|28
1046913|NCT01802632|2084793|FG001|Overall Study|Death|1
1046914|NCT01802632|2084794|FG002|Overall Study|Death|38
1046915|NCT01802632|2084795|FG003|Overall Study|Death|0
1046916|NCT01802632|2084796|FG004|Overall Study|Death|2
1046917|NCT01802632|2084797|FG005|Overall Study|Death|0
1046918|NCT01802632|2084792|FG000|Overall Study|Withdrawal by Subject|4
1046919|NCT01802632|2084793|FG001|Overall Study|Withdrawal by Subject|2
1046920|NCT01802632|2084794|FG002|Overall Study|Withdrawal by Subject|7
1046921|NCT01802632|2084795|FG003|Overall Study|Withdrawal by Subject|3
1046922|NCT01802632|2084796|FG004|Overall Study|Withdrawal by Subject|0
1046923|NCT01802632|2084797|FG005|Overall Study|Withdrawal by Subject|1
1046924|NCT01802632|2084792|FG000|Overall Study|Objective Disease Progression|1
1046925|NCT01802632|2084793|FG001|Overall Study|Objective Disease Progression|12
1046926|NCT01802632|2084794|FG002|Overall Study|Objective Disease Progression|104
1046927|NCT01802632|2084795|FG003|Overall Study|Objective Disease Progression|6
1046928|NCT01802632|2084796|FG004|Overall Study|Objective Disease Progression|4
1046929|NCT01802632|2084797|FG005|Overall Study|Objective Disease Progression|4
1046930|NCT01802632|2084792|FG000|Overall Study|Ongoing Study at Data Cut-off|168
1046931|NCT01802632|2084793|FG001|Overall Study|Ongoing Study at Data Cut-off|16
1046932|NCT01802632|2084794|FG002|Overall Study|Ongoing Study at Data Cut-off|115
1046933|NCT01802632|2084795|FG003|Overall Study|Ongoing Study at Data Cut-off|50
1046934|NCT01802632|2084796|FG004|Overall Study|Ongoing Study at Data Cut-off|6
1046935|NCT01802632|2084797|FG005|Overall Study|Ongoing Study at Data Cut-off|22
1046936|NCT01802632|2084792|FG000|Overall Study|Other (not specified)|0
1046937|NCT01802632|2084793|FG001|Overall Study|Other (not specified)|0
1046938|NCT01802632|2084794|FG002|Overall Study|Other (not specified)|7
1046939|NCT01802632|2084795|FG003|Overall Study|Other (not specified)|1
1046940|NCT01802632|2084796|FG004|Overall Study|Other (not specified)|0
1046941|NCT01802632|2084797|FG005|Overall Study|Other (not specified)|1
1046942|NCT01802775|2084822|FG000|Overall Study|Death|0
1046943|NCT01802775|2084823|FG001|Overall Study|Death|3
1046944|NCT01802775|2084822|FG000|Overall Study|Reason not provided|0
1046945|NCT01802775|2084823|FG001|Overall Study|Reason not provided|1
1046946|NCT01802775|2084822|FG000|Overall Study|Physician Decision|1
1046947|NCT01802775|2084823|FG001|Overall Study|Physician Decision|0
1046948|NCT01802775|2084822|FG000|Overall Study|Adverse Event|1
1046949|NCT01802775|2084823|FG001|Overall Study|Adverse Event|1
1046950|NCT01802775|2084822|FG000|Overall Study|Withdrawal by Subject|3
1046951|NCT01802775|2084823|FG001|Overall Study|Withdrawal by Subject|5
1046952|NCT01802775|2084822|FG000|Overall Study|Lost to Follow-up|1
1046953|NCT01802775|2084823|FG001|Overall Study|Lost to Follow-up|2
1046954|NCT01802879|2084829|FG000|Overall Study|Administrative problems|2
1046955|NCT01802879|2084829|FG000|Overall Study|Disease progression|6
1046956|NCT01803269|2084911|FG000|Overall Study|Withdrawal by Subject|3
1046957|NCT01803269|2084912|FG001|Overall Study|Withdrawal by Subject|0
1046958|NCT01803269|2084913|FG002|Overall Study|Withdrawal by Subject|0
1046959|NCT01803282|2084933|FG000|Overall Study|Progressive Disease|4
1046960|NCT01803282|2084934|FG001|Overall Study|Progressive Disease|3
1046961|NCT01803282|2084935|FG002|Overall Study|Progressive Disease|6
1046962|NCT01803282|2084936|FG003|Overall Study|Progressive Disease|22
1046963|NCT01803282|2084937|FG004|Overall Study|Progressive Disease|5
1046964|NCT01803282|2084938|FG005|Overall Study|Progressive Disease|8
1046965|NCT01803282|2084939|FG006|Overall Study|Progressive Disease|23
1046966|NCT01803282|2084940|FG007|Overall Study|Progressive Disease|24
1046967|NCT01803282|2084941|FG008|Overall Study|Progressive Disease|3
1046968|NCT01803282|2084942|FG009|Overall Study|Progressive Disease|29
1046969|NCT01803282|2084943|FG010|Overall Study|Progressive Disease|6
1046970|NCT01803282|2084944|FG011|Overall Study|Progressive Disease|11
1046971|NCT01803282|2084933|FG000|Overall Study|Death|0
1046972|NCT01803282|2084934|FG001|Overall Study|Death|0
1046973|NCT01803282|2084935|FG002|Overall Study|Death|0
1046974|NCT01803282|2084936|FG003|Overall Study|Death|0
1046975|NCT01803282|2084937|FG004|Overall Study|Death|2
1046976|NCT01803282|2084938|FG005|Overall Study|Death|1
1046977|NCT01803282|2084939|FG006|Overall Study|Death|1
1046978|NCT01803282|2084940|FG007|Overall Study|Death|5
1046979|NCT01803282|2084941|FG008|Overall Study|Death|1
1046980|NCT01803282|2084942|FG009|Overall Study|Death|1
1046981|NCT01803282|2084943|FG010|Overall Study|Death|0
1046982|NCT01803282|2084944|FG011|Overall Study|Death|0
1046983|NCT01803282|2084933|FG000|Overall Study|Withdrew Consent|0
1046984|NCT01803282|2084934|FG001|Overall Study|Withdrew Consent|0
1046985|NCT01803282|2084935|FG002|Overall Study|Withdrew Consent|0
1046986|NCT01803282|2084936|FG003|Overall Study|Withdrew Consent|6
1046987|NCT01803282|2084937|FG004|Overall Study|Withdrew Consent|1
1046988|NCT01803282|2084938|FG005|Overall Study|Withdrew Consent|0
1046989|NCT01803282|2084939|FG006|Overall Study|Withdrew Consent|8
1046990|NCT01803282|2084940|FG007|Overall Study|Withdrew Consent|3
1046991|NCT01803282|2084941|FG008|Overall Study|Withdrew Consent|1
1046992|NCT01803282|2084942|FG009|Overall Study|Withdrew Consent|5
1046993|NCT01803282|2084943|FG010|Overall Study|Withdrew Consent|0
1046994|NCT01803282|2084944|FG011|Overall Study|Withdrew Consent|1
1046995|NCT01803282|2084933|FG000|Overall Study|Investigator's Discretion|0
1046996|NCT01803282|2084934|FG001|Overall Study|Investigator's Discretion|0
1046997|NCT01803282|2084935|FG002|Overall Study|Investigator's Discretion|0
1046998|NCT01803282|2084936|FG003|Overall Study|Investigator's Discretion|7
1046999|NCT01803282|2084937|FG004|Overall Study|Investigator's Discretion|2
1047000|NCT01803282|2084938|FG005|Overall Study|Investigator's Discretion|1
1047001|NCT01803282|2084939|FG006|Overall Study|Investigator's Discretion|7
1047002|NCT01803282|2084940|FG007|Overall Study|Investigator's Discretion|10
1047003|NCT01803282|2084941|FG008|Overall Study|Investigator's Discretion|6
1047004|NCT01803282|2084942|FG009|Overall Study|Investigator's Discretion|7
1047005|NCT01803282|2084943|FG010|Overall Study|Investigator's Discretion|1
1047006|NCT01803282|2084944|FG011|Overall Study|Investigator's Discretion|0
1047007|NCT01803282|2084933|FG000|Overall Study|Adverse Event|0
1047008|NCT01803282|2084934|FG001|Overall Study|Adverse Event|0
1047009|NCT01803282|2084935|FG002|Overall Study|Adverse Event|0
1047010|NCT01803282|2084936|FG003|Overall Study|Adverse Event|0
1047011|NCT01803282|2084937|FG004|Overall Study|Adverse Event|0
1047012|NCT01803282|2084938|FG005|Overall Study|Adverse Event|0
1047013|NCT01803282|2084939|FG006|Overall Study|Adverse Event|1
1047014|NCT01803282|2084940|FG007|Overall Study|Adverse Event|2
1047015|NCT01803282|2084941|FG008|Overall Study|Adverse Event|0
1047016|NCT01803282|2084942|FG009|Overall Study|Adverse Event|1
1047017|NCT01803282|2084943|FG010|Overall Study|Adverse Event|0
1047018|NCT01803282|2084944|FG011|Overall Study|Adverse Event|3
1047019|NCT01803282|2084933|FG000|Overall Study|Non-Compliance with Study Drug|0
1047020|NCT01803282|2084934|FG001|Overall Study|Non-Compliance with Study Drug|0
1047021|NCT01803282|2084935|FG002|Overall Study|Non-Compliance with Study Drug|0
1047022|NCT01803282|2084936|FG003|Overall Study|Non-Compliance with Study Drug|1
1047023|NCT01803282|2084937|FG004|Overall Study|Non-Compliance with Study Drug|0
1047024|NCT01803282|2084938|FG005|Overall Study|Non-Compliance with Study Drug|0
1047025|NCT01803282|2084939|FG006|Overall Study|Non-Compliance with Study Drug|0
1047026|NCT01803282|2084940|FG007|Overall Study|Non-Compliance with Study Drug|0
1047027|NCT01803282|2084941|FG008|Overall Study|Non-Compliance with Study Drug|0
1047028|NCT01803282|2084942|FG009|Overall Study|Non-Compliance with Study Drug|0
1047029|NCT01803282|2084943|FG010|Overall Study|Non-Compliance with Study Drug|0
1047030|NCT01803282|2084944|FG011|Overall Study|Non-Compliance with Study Drug|0
1047031|NCT01803282|2084933|FG000|Overall Study|Unknown Reason|0
1047032|NCT01803282|2084934|FG001|Overall Study|Unknown Reason|0
1047033|NCT01803282|2084935|FG002|Overall Study|Unknown Reason|0
1047034|NCT01803282|2084936|FG003|Overall Study|Unknown Reason|0
1047035|NCT01803282|2084937|FG004|Overall Study|Unknown Reason|0
1047036|NCT01803282|2084938|FG005|Overall Study|Unknown Reason|0
1047037|NCT01803282|2084939|FG006|Overall Study|Unknown Reason|0
906645|NCT00770289|1882444|FG000|Overall Study|Other|6
906646|NCT00770315|1882457|FG000|Overall Study|Adverse Event|11
906647|NCT00770315|1882458|FG001|Overall Study|Adverse Event|17
906648|NCT00770315|1882459|FG002|Overall Study|Adverse Event|16
906649|NCT00770315|1882460|FG003|Overall Study|Adverse Event|6
1047038|NCT01803282|2084940|FG007|Overall Study|Unknown Reason|1
1047039|NCT01803282|2084941|FG008|Overall Study|Unknown Reason|0
1047040|NCT01803282|2084942|FG009|Overall Study|Unknown Reason|0
1047041|NCT01803282|2084943|FG010|Overall Study|Unknown Reason|0
1047042|NCT01803282|2084944|FG011|Overall Study|Unknown Reason|0
1047043|NCT01803282|2084933|FG000|Overall Study|Specified Criteria for Withdrawal|0
1047044|NCT01803282|2084934|FG001|Overall Study|Specified Criteria for Withdrawal|0
1047045|NCT01803282|2084935|FG002|Overall Study|Specified Criteria for Withdrawal|0
1047046|NCT01803282|2084936|FG003|Overall Study|Specified Criteria for Withdrawal|0
1047047|NCT01803282|2084937|FG004|Overall Study|Specified Criteria for Withdrawal|0
1047048|NCT01803282|2084938|FG005|Overall Study|Specified Criteria for Withdrawal|0
1047049|NCT01803282|2084939|FG006|Overall Study|Specified Criteria for Withdrawal|0
1047050|NCT01803282|2084940|FG007|Overall Study|Specified Criteria for Withdrawal|0
1047051|NCT01803282|2084941|FG008|Overall Study|Specified Criteria for Withdrawal|0
1047052|NCT01803282|2084942|FG009|Overall Study|Specified Criteria for Withdrawal|1
1047053|NCT01803282|2084943|FG010|Overall Study|Specified Criteria for Withdrawal|1
1047054|NCT01803282|2084944|FG011|Overall Study|Specified Criteria for Withdrawal|0
1047055|NCT01803282|2084933|FG000|Overall Study|Enrolled but Never Treated|0
1047056|NCT01803282|2084934|FG001|Overall Study|Enrolled but Never Treated|0
1047057|NCT01803282|2084935|FG002|Overall Study|Enrolled but Never Treated|0
1047058|NCT01803282|2084936|FG003|Overall Study|Enrolled but Never Treated|0
1047059|NCT01803282|2084937|FG004|Overall Study|Enrolled but Never Treated|1
1047060|NCT01803282|2084938|FG005|Overall Study|Enrolled but Never Treated|0
1047061|NCT01803282|2084939|FG006|Overall Study|Enrolled but Never Treated|1
1047062|NCT01803282|2084940|FG007|Overall Study|Enrolled but Never Treated|1
1047063|NCT01803282|2084941|FG008|Overall Study|Enrolled but Never Treated|0
1047064|NCT01803282|2084942|FG009|Overall Study|Enrolled but Never Treated|1
1047065|NCT01803282|2084943|FG010|Overall Study|Enrolled but Never Treated|0
1047066|NCT01803282|2084944|FG011|Overall Study|Enrolled but Never Treated|0
1047067|NCT01803464|2084974|FG000|Overall Study|Incomplete data|0
1047068|NCT01803464|2084975|FG001|Overall Study|Incomplete data|0
1047069|NCT01803464|2084976|FG002|Overall Study|Incomplete data|4
1047070|NCT01803464|2084977|FG003|Overall Study|Incomplete data|0
1047071|NCT01803464|2084974|FG000|Overall Study|Withdrawal by Subject|1
1047072|NCT01803464|2084975|FG001|Overall Study|Withdrawal by Subject|0
1047073|NCT01803464|2084976|FG002|Overall Study|Withdrawal by Subject|0
1047074|NCT01803464|2084977|FG003|Overall Study|Withdrawal by Subject|0
1047075|NCT01803607|2084993|FG000|Overall Study|Adverse Event|5
1047076|NCT01803607|2084994|FG001|Overall Study|Adverse Event|3
1047077|NCT01803607|2084993|FG000|Overall Study|Lack of Efficacy|0
1047078|NCT01803607|2084994|FG001|Overall Study|Lack of Efficacy|1
1047079|NCT01803607|2084993|FG000|Overall Study|Protocol Violation|3
1047080|NCT01803607|2084994|FG001|Overall Study|Protocol Violation|2
1047081|NCT01803607|2084993|FG000|Overall Study|Study terminated by sponsor|54
1047082|NCT01803607|2084994|FG001|Overall Study|Study terminated by sponsor|56
1047083|NCT01803607|2084993|FG000|Overall Study|Withdrawal by Subject|6
1047084|NCT01803607|2084994|FG001|Overall Study|Withdrawal by Subject|5
1047085|NCT01803646|2085002|FG000|Overall Study|Protocol Violation|1
1047086|NCT01803646|2085003|FG001|Overall Study|Protocol Violation|0
1047087|NCT01803646|2085002|FG000|Overall Study|Adverse Event|1
1047088|NCT01803646|2085003|FG001|Overall Study|Adverse Event|1
1047089|NCT01803646|2085002|FG000|Overall Study|Withdrawal by Subject|9
1047090|NCT01803646|2085003|FG001|Overall Study|Withdrawal by Subject|6
1047091|NCT01803646|2085002|FG000|Overall Study|Randomization error|1
1047092|NCT01803646|2085003|FG001|Overall Study|Randomization error|2
1047093|NCT01803646|2085002|FG000|Overall Study|Lost to Follow-up|5
1047094|NCT01803646|2085003|FG001|Overall Study|Lost to Follow-up|1
1047095|NCT01803737|2085011|FG000|Overall Study|Lack of Time|1
1047096|NCT01803737|2085012|FG001|Overall Study|Lack of Time|0
1047097|NCT01803737|2085011|FG000|Overall Study|Medical Reason|0
1047098|NCT01803737|2085012|FG001|Overall Study|Medical Reason|1
1047099|NCT01803737|2085011|FG000|Overall Study|Lost to Follow-up|0
1047100|NCT01803737|2085012|FG001|Overall Study|Lost to Follow-up|2
1047101|NCT01803880|2085021|FG000|Overall Study|Adverse Event|1
1047102|NCT01803880|2085022|FG001|Overall Study|Adverse Event|0
1047103|NCT01803880|2085023|FG002|Overall Study|Adverse Event|0
1047104|NCT01803880|2085021|FG000|Overall Study|Withdrawal by Subject|1
1047105|NCT01803880|2085022|FG001|Overall Study|Withdrawal by Subject|1
1047106|NCT01803880|2085023|FG002|Overall Study|Withdrawal by Subject|4
1047107|NCT01803880|2085021|FG000|Overall Study|Physician Decision|0
1047108|NCT01803880|2085022|FG001|Overall Study|Physician Decision|0
1047109|NCT01803880|2085023|FG002|Overall Study|Physician Decision|1
1047110|NCT01803880|2085021|FG000|Overall Study|Unable to return for follow-up visits|0
1047111|NCT01803880|2085022|FG001|Overall Study|Unable to return for follow-up visits|1
1047112|NCT01803880|2085023|FG002|Overall Study|Unable to return for follow-up visits|2
1047113|NCT01803880|2085021|FG000|Overall Study|Lost to Follow-up|1
1047114|NCT01803880|2085022|FG001|Overall Study|Lost to Follow-up|2
1047115|NCT01803880|2085023|FG002|Overall Study|Lost to Follow-up|3
1047116|NCT01803880|2085021|FG000|Overall Study|Protocol Violation|1
1047117|NCT01803880|2085022|FG001|Overall Study|Protocol Violation|0
1047118|NCT01803880|2085023|FG002|Overall Study|Protocol Violation|0
1047119|NCT01803880|2085021|FG000|Overall Study|Early study termination|0
1047120|NCT01803880|2085022|FG001|Overall Study|Early study termination|6
1047121|NCT01803880|2085023|FG002|Overall Study|Early study termination|5
1047122|NCT01803880|2085021|FG000|Overall Study|Incomplete data entry by sites|2
1047123|NCT01803880|2085022|FG001|Overall Study|Incomplete data entry by sites|0
1047124|NCT01803880|2085023|FG002|Overall Study|Incomplete data entry by sites|0
1047125|NCT01804049|2085045|FG000|Overall Study|Adverse Event|2
1047126|NCT01804049|2085046|FG001|Overall Study|Adverse Event|10
1047127|NCT01804049|2085045|FG000|Overall Study|Lost to Follow-up|2
1047128|NCT01804049|2085046|FG001|Overall Study|Lost to Follow-up|1
1047129|NCT01804049|2085045|FG000|Overall Study|Decreased interest/personal|4
1047130|NCT01804049|2085046|FG001|Overall Study|Decreased interest/personal|5
1047131|NCT01804049|2085045|FG000|Overall Study|Other health concerns|2
1047132|NCT01804049|2085046|FG001|Overall Study|Other health concerns|7
1047133|NCT01804049|2085045|FG000|Overall Study|Moved out of area|0
1047134|NCT01804049|2085046|FG001|Overall Study|Moved out of area|7
1047135|NCT01804049|2085045|FG000|Overall Study|other MD recommended|1
1047136|NCT01804049|2085046|FG001|Overall Study|other MD recommended|1
1047137|NCT01804049|2085045|FG000|Overall Study|Enrollment in dual studies|0
1047138|NCT01804049|2085046|FG001|Overall Study|Enrollment in dual studies|1
1047139|NCT01804140|2085089|FG000|Overall Study|No sampling or biopsy procedures done|114
1047140|NCT01804582|2085108|FG000|Overall Study|Lost to Follow-up|47
1047141|NCT01804582|2085109|FG001|Overall Study|Lost to Follow-up|56
1047142|NCT01804582|2085108|FG000|Overall Study|Physician Decision|2
1047143|NCT01804582|2085109|FG001|Overall Study|Physician Decision|0
1047144|NCT01804673|2085116|FG000|Overall Study|Adverse Event|4
1047145|NCT01804673|2085116|FG000|Overall Study|Withdrawal by Subject|1
1047146|NCT01804673|2085116|FG000|Overall Study|Lack of Efficacy|9
1047147|NCT01804673|2085116|FG000|Overall Study|Change to Oral Therapy|37
1047148|NCT01804673|2085116|FG000|Overall Study|No Further Therapy Required|84
1047149|NCT01804673|2085116|FG000|Overall Study|Use of Prohibited Medication|1
1047150|NCT01804673|2085116|FG000|Overall Study|Other|4
1047153|NCT01804842|2085130|FG000|Overall Study|Adverse Event|1
1047154|NCT01804842|2085131|FG001|Overall Study|Adverse Event|1
1047155|NCT01804842|2085132|FG002|Overall Study|Adverse Event|0
1047156|NCT01804842|2085130|FG000|Overall Study|Lost to Follow-up|1
1047157|NCT01804842|2085131|FG001|Overall Study|Lost to Follow-up|0
1047158|NCT01804842|2085132|FG002|Overall Study|Lost to Follow-up|0
1047159|NCT01804842|2085130|FG000|Overall Study|Non-Compliance|1
1047160|NCT01804842|2085131|FG001|Overall Study|Non-Compliance|1
1047161|NCT01804842|2085132|FG002|Overall Study|Non-Compliance|0
1047162|NCT01804842|2085130|FG000|Overall Study|Personal Reason|0
1047163|NCT01804842|2085131|FG001|Overall Study|Personal Reason|0
1047164|NCT01804842|2085132|FG002|Overall Study|Personal Reason|1
1047165|NCT01804946|2085153|FG000|Overall Study|Protocol Violation|1
1047166|NCT01804946|2085154|FG001|Overall Study|Protocol Violation|0
1047167|NCT01804946|2085153|FG000|Overall Study|Adverse Event|0
1047168|NCT01804946|2085154|FG001|Overall Study|Adverse Event|1
1047169|NCT01804946|2085153|FG000|Overall Study|Insufficient data available|0
1047170|NCT01804946|2085154|FG001|Overall Study|Insufficient data available|1
1047171|NCT01804946|2085153|FG000|Overall Study|Do not meet inclusion criteria|1
1047172|NCT01804946|2085154|FG001|Overall Study|Do not meet inclusion criteria|2
1047173|NCT01805037|2085179|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0
1047174|NCT01805037|2085180|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2
1047175|NCT01805037|2085179|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0
1047176|NCT01805037|2085180|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2
1047177|NCT01805037|2085179|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0
1047178|NCT01805037|2085180|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1
1047179|NCT01805037|2085179|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0
1047180|NCT01805037|2085180|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1
1047181|NCT01805037|2085179|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0
1047182|NCT01805037|2085180|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10
1047183|NCT01805037|2085179|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0
1047184|NCT01805037|2085180|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1
1047185|NCT01805037|2085179|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0
1047186|NCT01805037|2085180|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1
1047187|NCT01805037|2085179|FG000|Follow Up (up to 3 Years)|Death|0
1047188|NCT01805037|2085180|FG001|Follow Up (up to 3 Years)|Death|2
1047189|NCT01805037|2085179|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0
1047190|NCT01805037|2085180|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3
1047191|NCT01805037|2085179|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0
1047192|NCT01805037|2085180|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1
1047193|NCT01805180|2085202|FG000|Lead-in Donor Phase|screen failure|1
1047194|NCT01805180|2085203|FG001|Lead-in Donor Phase|screen failure|0
1047195|NCT01805180|2085204|FG002|Lead-in Donor Phase|screen failure|0
1047196|NCT01806064|2085306|FG000|Overall Study|Randomized Not Enrolled|0
1047197|NCT01806064|2085307|FG001|Overall Study|Randomized Not Enrolled|0
1047198|NCT01806064|2085308|FG002|Overall Study|Randomized Not Enrolled|0
1047199|NCT01806064|2085309|FG003|Overall Study|Randomized Not Enrolled|1
1047200|NCT01806064|2085310|FG004|Overall Study|Randomized Not Enrolled|2
1047201|NCT01806168|2085329|FG000|Overall Study|Adverse Event|1
1047202|NCT01806168|2085330|FG001|Overall Study|Adverse Event|0
1047203|NCT01806168|2085331|FG002|Overall Study|Adverse Event|0
1047204|NCT01806168|2085329|FG000|Overall Study|Withdrawal by Subject|0
1047205|NCT01806168|2085330|FG001|Overall Study|Withdrawal by Subject|1
1047206|NCT01806168|2085331|FG002|Overall Study|Withdrawal by Subject|2
1047207|NCT01806168|2085329|FG000|Overall Study|Protocol Violation|0
1047208|NCT01806168|2085330|FG001|Overall Study|Protocol Violation|0
1047209|NCT01806168|2085331|FG002|Overall Study|Protocol Violation|1
1047210|NCT01806298|2085352|FG000|Overall Study|Adverse Event|3
1047211|NCT01806298|2085352|FG000|Overall Study|Protocol Non-compliance|1
1047212|NCT01806298|2085352|FG000|Overall Study|Withdrawal by Subject|1
1047213|NCT01806298|2085352|FG000|Overall Study|Other|5
1047214|NCT01806389|2085356|FG000|Overall Study|Withdrawal by Subject|4
1047215|NCT01806506|2085372|FG000|Overall Study|Lost to Follow-up|2
1047216|NCT01806506|2085373|FG001|Overall Study|Lost to Follow-up|1
1047217|NCT01806545|2085381|FG000|Overall Study|Adverse Event|2
1047218|NCT01806545|2085382|FG001|Overall Study|Adverse Event|3
1047219|NCT01806545|2085381|FG000|Overall Study|Lost to Follow-up|1
1047220|NCT01806545|2085382|FG001|Overall Study|Lost to Follow-up|0
1047221|NCT01806545|2085381|FG000|Overall Study|Withdrawal by Subject|3
1047222|NCT01806545|2085382|FG001|Overall Study|Withdrawal by Subject|2
1047223|NCT01806584|2085394|FG000|Overall Study|Adverse Event|2
1047224|NCT01806584|2085395|FG001|Overall Study|Adverse Event|1
1047225|NCT01806584|2085394|FG000|Overall Study|Death|1
1047226|NCT01806584|2085395|FG001|Overall Study|Death|0
1047227|NCT01806584|2085394|FG000|Overall Study|Lost to Follow-up|0
1047228|NCT01806584|2085395|FG001|Overall Study|Lost to Follow-up|2
1047229|NCT01806584|2085394|FG000|Overall Study|Study terminated by sponsor|9
1047230|NCT01806584|2085395|FG001|Overall Study|Study terminated by sponsor|14
1047231|NCT01806584|2085394|FG000|Overall Study|Withdrawal by Subject|1
1047232|NCT01806584|2085395|FG001|Overall Study|Withdrawal by Subject|1
1047233|NCT01806584|2085394|FG000|Overall Study|Other unspecified|1
1047234|NCT01806584|2085395|FG001|Overall Study|Other unspecified|0
1047235|NCT01806597|2085404|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1
1047236|NCT01806597|2085405|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1
1047237|NCT01806597|2085406|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0
1047238|NCT01806597|2085407|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0
1047239|NCT01806597|2085408|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2
1047240|NCT01806597|2085409|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0
1047241|NCT01806597|2085404|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
1047242|NCT01806597|2085405|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1047243|NCT01806597|2085406|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1047244|NCT01806597|2085407|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1047245|NCT01806597|2085408|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
1047246|NCT01806597|2085409|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1047247|NCT01806597|2085404|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0
1047248|NCT01806597|2085405|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1
1047249|NCT01806597|2085406|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0
1047250|NCT01806597|2085407|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0
1047251|NCT01806597|2085408|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0
1047252|NCT01806597|2085409|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0
1047253|NCT01806597|2085404|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
1047254|NCT01806597|2085405|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
1047255|NCT01806597|2085406|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1047256|NCT01806597|2085407|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1047257|NCT01806597|2085408|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
1047258|NCT01806597|2085409|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1047259|NCT01806597|2085404|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0
1047260|NCT01806597|2085405|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1
1047261|NCT01806597|2085406|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0
1047262|NCT01806597|2085407|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0
1047263|NCT01806597|2085408|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0
1047264|NCT01806597|2085409|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0
1047265|NCT01806597|2085404|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
1047266|NCT01806597|2085405|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
1047267|NCT01806597|2085406|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
1047268|NCT01806597|2085407|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
1047269|NCT01806597|2085408|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
1047270|NCT01806597|2085409|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
1047271|NCT01806597|2085404|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
1047272|NCT01806597|2085405|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
1047273|NCT01806597|2085406|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
1047274|NCT01806597|2085407|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
1047275|NCT01806597|2085408|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
1047276|NCT01806597|2085409|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
1047277|NCT01806597|2085404|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
1047278|NCT01806597|2085405|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1047279|NCT01806597|2085406|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1047280|NCT01806597|2085407|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1047281|NCT01806597|2085408|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1162033|NCT03381196|2283976|FG000|Overall Study|Lost to Follow-up|5
1047282|NCT01806597|2085409|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1047283|NCT01806597|2085404|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
1047284|NCT01806597|2085405|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
1047285|NCT01806597|2085406|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1047286|NCT01806597|2085407|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1047287|NCT01806597|2085408|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1047288|NCT01806597|2085409|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1047289|NCT01806597|2085404|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
1047290|NCT01806597|2085405|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1047291|NCT01806597|2085406|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1047292|NCT01806597|2085407|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1047293|NCT01806597|2085408|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1047294|NCT01806597|2085409|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1047295|NCT01806597|2085404|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1047296|NCT01806597|2085405|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
1047297|NCT01806597|2085406|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1047298|NCT01806597|2085407|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
1047299|NCT01806597|2085408|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1047300|NCT01806597|2085409|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1047301|NCT01806597|2085404|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
1047302|NCT01806597|2085405|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
1047303|NCT01806597|2085406|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
1047304|NCT01806597|2085407|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
1047305|NCT01806597|2085408|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
1047306|NCT01806597|2085409|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
1047307|NCT01806597|2085404|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
1047308|NCT01806597|2085405|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
1047309|NCT01806597|2085406|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
1047310|NCT01806597|2085407|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
1047311|NCT01806597|2085408|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
1047312|NCT01806597|2085409|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
1047313|NCT01806597|2085404|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1
1047314|NCT01806597|2085405|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0
1047315|NCT01806597|2085406|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0
1047316|NCT01806597|2085407|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0
1047317|NCT01806597|2085408|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0
1047318|NCT01806597|2085409|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0
1047319|NCT01806597|2085404|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1047320|NCT01806597|2085405|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1047321|NCT01806597|2085406|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1047322|NCT01806597|2085407|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1047323|NCT01806597|2085408|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1047324|NCT01806597|2085409|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
1047325|NCT01806597|2085404|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1047326|NCT01806597|2085405|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1047327|NCT01806597|2085406|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1047328|NCT01806597|2085407|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1047329|NCT01806597|2085408|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1047330|NCT01806597|2085409|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
1047331|NCT01806597|2085404|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1047332|NCT01806597|2085405|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1047333|NCT01806597|2085406|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1047334|NCT01806597|2085407|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1047335|NCT01806597|2085408|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1047336|NCT01806597|2085409|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
1047337|NCT01806597|2085404|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1047338|NCT01806597|2085405|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1047339|NCT01806597|2085406|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1047340|NCT01806597|2085407|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1047341|NCT01806597|2085408|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1047342|NCT01806597|2085409|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
1047343|NCT01806597|2085404|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1047344|NCT01806597|2085405|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1047345|NCT01806597|2085406|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1047346|NCT01806597|2085407|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1047347|NCT01806597|2085408|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1047348|NCT01806597|2085409|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
1047349|NCT01806623|2085423|FG000|Overall Study|Withdrawal by Subject|1
1047350|NCT01806623|2085423|FG000|Overall Study|Adverse Event|1
1047351|NCT01806623|2085423|FG000|Overall Study|Did not meet the inclusion criteria|56
1047352|NCT01806662|2085427|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
1047353|NCT01806662|2085428|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
1047354|NCT01806662|2085427|FG000|First Intervention (Weeks 0-16)|Adverse Event|0
1047355|NCT01806662|2085428|FG001|First Intervention (Weeks 0-16)|Adverse Event|1
1047356|NCT01806662|2085427|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
1047357|NCT01806662|2085428|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
1047358|NCT01806662|2085427|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
1047359|NCT01806662|2085428|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
1047360|NCT01806714|2085461|FG000|Overall Study|No functioning phone number|200
1047361|NCT01806714|2085462|FG001|Overall Study|No functioning phone number|170
1047362|NCT01806740|2085468|FG000|Overall Study|Withdrawal by Subject|4
1047363|NCT01806740|2085468|FG000|Overall Study|Physician Decision|1
1047364|NCT01806740|2085468|FG000|Overall Study|Patient's refusal of treatment|1
1047365|NCT01806779|2085477|FG000|Overall Study|Physician Decision|2
1047366|NCT01806779|2085478|FG001|Overall Study|Physician Decision|0
1047367|NCT01806779|2085479|FG002|Overall Study|Physician Decision|1
1047368|NCT01806779|2085477|FG000|Overall Study|Lack of Efficacy|1
1047369|NCT01806779|2085478|FG001|Overall Study|Lack of Efficacy|1
1047370|NCT01806779|2085479|FG002|Overall Study|Lack of Efficacy|0
1047371|NCT01806779|2085477|FG000|Overall Study|Lost to Follow-up|19
1047372|NCT01806779|2085478|FG001|Overall Study|Lost to Follow-up|20
1047373|NCT01806779|2085479|FG002|Overall Study|Lost to Follow-up|0
1047374|NCT01806779|2085477|FG000|Overall Study|Withdrawal by Subject|20
1047375|NCT01806779|2085478|FG001|Overall Study|Withdrawal by Subject|23
1047376|NCT01806779|2085479|FG002|Overall Study|Withdrawal by Subject|22
1047377|NCT01806896|2085496|FG000|Overall Study|Adverse Event|2
1047378|NCT01806896|2085497|FG001|Overall Study|Adverse Event|0
1047379|NCT01806896|2085496|FG000|Overall Study|Other|1
1047380|NCT01806896|2085497|FG001|Overall Study|Other|0
1047381|NCT01807065|2085539|FG000|Overall Study|Receive no sip-T due to IV access|1
1047382|NCT01807065|2085540|FG001|Overall Study|Receive no sip-T due to IV access|1
1047383|NCT01807156|2085565|FG000|Overall Study|Physician Decision|1
1047384|NCT01807221|2085575|FG000|Overall Study|Progressive disease|1
1047385|NCT01807221|2085576|FG001|Overall Study|Progressive disease|0
1047386|NCT01807221|2085577|FG002|Overall Study|Progressive disease|1
1047387|NCT01807221|2085578|FG003|Overall Study|Progressive disease|0
1047388|NCT01807221|2085579|FG004|Overall Study|Progressive disease|0
1047389|NCT01807221|2085580|FG005|Overall Study|Progressive disease|0
1047390|NCT01807221|2085575|FG000|Overall Study|Death|7
1047391|NCT01807221|2085576|FG001|Overall Study|Death|9
1047392|NCT01807221|2085577|FG002|Overall Study|Death|4
1047393|NCT01807221|2085578|FG003|Overall Study|Death|2
1047394|NCT01807221|2085579|FG004|Overall Study|Death|1
1047395|NCT01807221|2085580|FG005|Overall Study|Death|6
1047396|NCT01807221|2085575|FG000|Overall Study|Physician Decision|2
1047397|NCT01807221|2085576|FG001|Overall Study|Physician Decision|1
1047398|NCT01807221|2085577|FG002|Overall Study|Physician Decision|0
1047399|NCT01807221|2085578|FG003|Overall Study|Physician Decision|0
1047400|NCT01807221|2085579|FG004|Overall Study|Physician Decision|0
1047401|NCT01807221|2085580|FG005|Overall Study|Physician Decision|0
1047402|NCT01807221|2085575|FG000|Overall Study|Adverse Event|33
1047403|NCT01807221|2085576|FG001|Overall Study|Adverse Event|22
1047404|NCT01807221|2085577|FG002|Overall Study|Adverse Event|26
1047405|NCT01807221|2085578|FG003|Overall Study|Adverse Event|25
1047406|NCT01807221|2085579|FG004|Overall Study|Adverse Event|18
1047407|NCT01807221|2085580|FG005|Overall Study|Adverse Event|21
1047408|NCT01807221|2085575|FG000|Overall Study|Protocol Violation|0
1047409|NCT01807221|2085576|FG001|Overall Study|Protocol Violation|2
1047410|NCT01807221|2085577|FG002|Overall Study|Protocol Violation|1
1047411|NCT01807221|2085578|FG003|Overall Study|Protocol Violation|2
1047412|NCT01807221|2085579|FG004|Overall Study|Protocol Violation|0
1047413|NCT01807221|2085580|FG005|Overall Study|Protocol Violation|1
1047414|NCT01807221|2085575|FG000|Overall Study|Non-compliance|1
1047415|NCT01807221|2085576|FG001|Overall Study|Non-compliance|2
1047416|NCT01807221|2085577|FG002|Overall Study|Non-compliance|0
1047417|NCT01807221|2085578|FG003|Overall Study|Non-compliance|1
1047418|NCT01807221|2085579|FG004|Overall Study|Non-compliance|0
1047419|NCT01807221|2085580|FG005|Overall Study|Non-compliance|0
1047420|NCT01807221|2085575|FG000|Overall Study|Logistical difficulties|0
1047421|NCT01807221|2085576|FG001|Overall Study|Logistical difficulties|1
1047422|NCT01807221|2085577|FG002|Overall Study|Logistical difficulties|0
1047423|NCT01807221|2085578|FG003|Overall Study|Logistical difficulties|0
1047424|NCT01807221|2085579|FG004|Overall Study|Logistical difficulties|1
1047425|NCT01807221|2085580|FG005|Overall Study|Logistical difficulties|0
1047426|NCT01807221|2085575|FG000|Overall Study|Withdrawal by Subject|33
1047427|NCT01807221|2085576|FG001|Overall Study|Withdrawal by Subject|15
1047428|NCT01807221|2085577|FG002|Overall Study|Withdrawal by Subject|8
1047429|NCT01807221|2085578|FG003|Overall Study|Withdrawal by Subject|14
1047430|NCT01807221|2085579|FG004|Overall Study|Withdrawal by Subject|16
1047431|NCT01807221|2085580|FG005|Overall Study|Withdrawal by Subject|13
1047432|NCT01807221|2085575|FG000|Overall Study|Sponsor decision|2
1047433|NCT01807221|2085576|FG001|Overall Study|Sponsor decision|0
1047434|NCT01807221|2085577|FG002|Overall Study|Sponsor decision|1
1047435|NCT01807221|2085578|FG003|Overall Study|Sponsor decision|1
1047436|NCT01807221|2085579|FG004|Overall Study|Sponsor decision|0
1047437|NCT01807221|2085580|FG005|Overall Study|Sponsor decision|0
1047438|NCT01807221|2085575|FG000|Overall Study|Lost to Follow-up|1
1047439|NCT01807221|2085576|FG001|Overall Study|Lost to Follow-up|0
1047440|NCT01807221|2085577|FG002|Overall Study|Lost to Follow-up|2
1047441|NCT01807221|2085578|FG003|Overall Study|Lost to Follow-up|1
1047442|NCT01807221|2085579|FG004|Overall Study|Lost to Follow-up|0
1047443|NCT01807221|2085580|FG005|Overall Study|Lost to Follow-up|0
1047444|NCT01807234|2085600|FG000|Overall Study|Lost to Follow-up|2
1047445|NCT01807234|2085601|FG001|Overall Study|Lost to Follow-up|5
1047446|NCT01807234|2085602|FG002|Overall Study|Lost to Follow-up|1
1047447|NCT01807234|2085603|FG003|Overall Study|Lost to Follow-up|1
1047448|NCT01807234|2085604|FG004|Overall Study|Lost to Follow-up|1
1047449|NCT01807234|2085605|FG005|Overall Study|Lost to Follow-up|2
1047450|NCT01807234|2085600|FG000|Overall Study|Withdrawal by Subject|3
1047451|NCT01807234|2085601|FG001|Overall Study|Withdrawal by Subject|1
1047452|NCT01807234|2085602|FG002|Overall Study|Withdrawal by Subject|1
1047453|NCT01807234|2085603|FG003|Overall Study|Withdrawal by Subject|1
1047454|NCT01807234|2085604|FG004|Overall Study|Withdrawal by Subject|2
1047455|NCT01807234|2085605|FG005|Overall Study|Withdrawal by Subject|1
1047456|NCT01807234|2085600|FG000|Overall Study|Lack of Efficacy|0
1047457|NCT01807234|2085601|FG001|Overall Study|Lack of Efficacy|0
1047458|NCT01807234|2085602|FG002|Overall Study|Lack of Efficacy|0
1047459|NCT01807234|2085603|FG003|Overall Study|Lack of Efficacy|0
1047460|NCT01807234|2085604|FG004|Overall Study|Lack of Efficacy|1
1047461|NCT01807234|2085605|FG005|Overall Study|Lack of Efficacy|1
1047462|NCT01807299|2085619|FG000|Overall Study|Protocol Violation|3
1047463|NCT01807299|2085620|FG001|Overall Study|Protocol Violation|1
1047464|NCT01807299|2085621|FG002|Overall Study|Protocol Violation|0
1047465|NCT01807299|2085622|FG003|Overall Study|Protocol Violation|2
1047466|NCT01807520|2085639|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1047467|NCT01807520|2085640|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
1047468|NCT01807520|2085641|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
1047469|NCT01807520|2085642|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1047470|NCT01807520|2085643|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1047471|NCT01807520|2085644|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1047472|NCT01807520|2085645|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1047473|NCT01807520|2085639|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
1047474|NCT01807520|2085640|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1047475|NCT01807520|2085641|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
1047476|NCT01807520|2085642|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1047477|NCT01807520|2085643|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1047478|NCT01807520|2085644|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1047479|NCT01807520|2085645|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1047480|NCT01807520|2085639|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1047481|NCT01807520|2085640|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1047482|NCT01807520|2085641|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
1047483|NCT01807520|2085642|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1047484|NCT01807520|2085643|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1047485|NCT01807520|2085644|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1047486|NCT01807520|2085645|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1047487|NCT01807520|2085639|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
1047488|NCT01807520|2085640|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1047489|NCT01807520|2085641|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1047490|NCT01807520|2085642|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1047491|NCT01807520|2085643|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1047492|NCT01807520|2085644|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1047493|NCT01807520|2085645|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1047494|NCT01807520|2085639|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1047495|NCT01807520|2085640|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1047496|NCT01807520|2085641|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
1047497|NCT01807520|2085642|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1047498|NCT01807520|2085643|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1047499|NCT01807520|2085644|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1047500|NCT01807520|2085645|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1047501|NCT01807520|2085639|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
1047502|NCT01807520|2085640|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1047503|NCT01807520|2085641|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1047504|NCT01807520|2085642|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1047505|NCT01807520|2085643|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1047506|NCT01807520|2085644|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1047507|NCT01807520|2085645|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1047508|NCT01807520|2085639|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7
1047509|NCT01807520|2085640|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4
1047510|NCT01807520|2085641|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1047511|NCT01807520|2085642|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1047512|NCT01807520|2085643|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2
1047513|NCT01807520|2085644|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1047514|NCT01807520|2085645|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1047515|NCT01807520|2085639|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1047516|NCT01807520|2085640|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1047517|NCT01807520|2085641|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1047518|NCT01807520|2085642|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
1047519|NCT01807520|2085643|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1047520|NCT01807520|2085644|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1047521|NCT01807520|2085645|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1047522|NCT01807520|2085639|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
1047523|NCT01807520|2085640|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1047524|NCT01807520|2085641|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1047525|NCT01807520|2085642|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1047526|NCT01807520|2085643|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1047527|NCT01807520|2085644|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1047528|NCT01807520|2085645|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1047529|NCT01807520|2085639|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1047530|NCT01807520|2085640|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
1047531|NCT01807520|2085641|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1047532|NCT01807520|2085642|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1047533|NCT01807520|2085643|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1047534|NCT01807520|2085644|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1047535|NCT01807520|2085645|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1047536|NCT01807520|2085639|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
1047537|NCT01807520|2085640|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1047538|NCT01807520|2085641|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1047539|NCT01807520|2085642|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
1047540|NCT01807520|2085643|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1047541|NCT01807520|2085644|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1047542|NCT01807520|2085645|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1047543|NCT01807520|2085639|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
1047544|NCT01807520|2085640|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
1047545|NCT01807520|2085641|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1047546|NCT01807520|2085642|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1047547|NCT01807520|2085643|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
1047548|NCT01807520|2085644|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1047549|NCT01807520|2085645|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1047550|NCT01807520|2085639|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1047551|NCT01807520|2085640|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1047552|NCT01807520|2085641|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1047553|NCT01807520|2085642|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1047554|NCT01807520|2085643|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1047555|NCT01807520|2085644|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1047556|NCT01807520|2085645|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1047557|NCT01807520|2085639|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
1047558|NCT01807520|2085640|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
1047559|NCT01807520|2085641|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1047560|NCT01807520|2085642|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
1047561|NCT01807520|2085643|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
1047562|NCT01807520|2085644|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1047563|NCT01807520|2085645|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1047564|NCT01807520|2085639|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1047565|NCT01807520|2085640|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1047566|NCT01807520|2085641|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1047567|NCT01807520|2085642|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1047568|NCT01807520|2085643|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1047569|NCT01807520|2085644|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
1047570|NCT01807520|2085645|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1047571|NCT01807520|2085639|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0
1047572|NCT01807520|2085640|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0
1047573|NCT01807520|2085641|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0
1047574|NCT01807520|2085642|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0
1047575|NCT01807520|2085643|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0
1047576|NCT01807520|2085644|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1
1047577|NCT01807520|2085645|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0
1047578|NCT01807520|2085639|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1047579|NCT01807520|2085640|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1047580|NCT01807520|2085641|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1047581|NCT01807520|2085642|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1047582|NCT01807520|2085643|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1047583|NCT01807520|2085644|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
1047584|NCT01807520|2085645|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
1047585|NCT01807598|2085672|FG000|Overall Study|Withdrawal by Subject|4
1047586|NCT01807598|2085672|FG000|Overall Study|Adverse Event|1
1047587|NCT01807598|2085672|FG000|Overall Study|Other Physician Decision|1
1047588|NCT01807650|2085691|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13
1047589|NCT01807650|2085691|FG000|Overall Study|Adverse Event|5
1047590|NCT01807650|2085691|FG000|Overall Study|Other|2
1047591|NCT01807923|2085744|FG000|Overall Study|Adverse Event|2
1047592|NCT01807923|2085745|FG001|Overall Study|Adverse Event|1
1047593|NCT01807923|2085746|FG002|Overall Study|Adverse Event|2
1047594|NCT01807923|2085744|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
1047595|NCT01807923|2085745|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3
1047596|NCT01807923|2085746|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2
1047597|NCT01807923|2085744|FG000|Overall Study|Physician Decision|0
1047598|NCT01807923|2085745|FG001|Overall Study|Physician Decision|0
1047599|NCT01807923|2085746|FG002|Overall Study|Physician Decision|1
1047600|NCT01807923|2085744|FG000|Overall Study|Not Eligible (Genotype)|0
1047601|NCT01807923|2085745|FG001|Overall Study|Not Eligible (Genotype)|0
1047602|NCT01807923|2085746|FG002|Overall Study|Not Eligible (Genotype)|1
1047603|NCT01807923|2085744|FG000|Overall Study|Randomized But Not Treated|3
1047604|NCT01807923|2085745|FG001|Overall Study|Randomized But Not Treated|2
1047605|NCT01807923|2085746|FG002|Overall Study|Randomized But Not Treated|5
1047606|NCT01807949|2085759|FG000|Overall Study|Adverse Event|1
1047607|NCT01807949|2085760|FG001|Overall Study|Adverse Event|2
1047608|NCT01807949|2085761|FG002|Overall Study|Adverse Event|2
1047609|NCT01807949|2085759|FG000|Overall Study|Withdrawal by Subject|1
1047610|NCT01807949|2085760|FG001|Overall Study|Withdrawal by Subject|2
1047611|NCT01807949|2085761|FG002|Overall Study|Withdrawal by Subject|2
1047612|NCT01807949|2085759|FG000|Overall Study|Non-Compliance|0
1047613|NCT01807949|2085760|FG001|Overall Study|Non-Compliance|0
1047614|NCT01807949|2085761|FG002|Overall Study|Non-Compliance|1
1047615|NCT01807949|2085759|FG000|Overall Study|Undefined|0
1047616|NCT01807949|2085760|FG001|Overall Study|Undefined|1
1047617|NCT01807949|2085761|FG002|Overall Study|Undefined|2
1047618|NCT01807949|2085759|FG000|Overall Study|Randomized But Not Treated|0
1047619|NCT01807949|2085760|FG001|Overall Study|Randomized But Not Treated|2
1047620|NCT01807949|2085761|FG002|Overall Study|Randomized But Not Treated|2
1047621|NCT01808066|2085771|FG000|Overall Study|Withdrawal by Subject|15
1047622|NCT01808092|2085778|FG000|Overall Study|Death|39
1047623|NCT01808092|2085779|FG001|Overall Study|Death|29
1047624|NCT01808092|2085778|FG000|Overall Study|Lost to Follow-up|3
1047625|NCT01808092|2085779|FG001|Overall Study|Lost to Follow-up|7
1047626|NCT01808092|2085778|FG000|Overall Study|Withdrawal by Subject|9
1047627|NCT01808092|2085779|FG001|Overall Study|Withdrawal by Subject|4
1047628|NCT01808092|2085778|FG000|Overall Study|Other Eligibility criteria|3
1047629|NCT01808092|2085779|FG001|Overall Study|Other Eligibility criteria|5
1047630|NCT01808118|2085785|FG000|Period 1|Adverse Event|15
1047631|NCT01808118|2085786|FG001|Period 1|Adverse Event|0
1047632|NCT01808118|2085787|FG002|Period 1|Adverse Event|0
1047633|NCT01808118|2085785|FG000|Period 1|Withdrew consent|24
1047634|NCT01808118|2085786|FG001|Period 1|Withdrew consent|0
1047635|NCT01808118|2085787|FG002|Period 1|Withdrew consent|0
1047636|NCT01808118|2085785|FG000|Period 1|Lost to Follow-up|9
1047637|NCT01808118|2085786|FG001|Period 1|Lost to Follow-up|0
1047638|NCT01808118|2085787|FG002|Period 1|Lost to Follow-up|0
1047639|NCT01808118|2085785|FG000|Period 1|Did not meet criteria for remission|303
1047640|NCT01808118|2085786|FG001|Period 1|Did not meet criteria for remission|0
1047641|NCT01808118|2085787|FG002|Period 1|Did not meet criteria for remission|0
1047642|NCT01808118|2085785|FG000|Period 1|Enrolled in error|7
1047643|NCT01808118|2085786|FG001|Period 1|Enrolled in error|0
1047644|NCT01808118|2085787|FG002|Period 1|Enrolled in error|0
1047645|NCT01808118|2085785|FG000|Period 1|Did not meet inclusion criteria|3
1047646|NCT01808118|2085786|FG001|Period 1|Did not meet inclusion criteria|0
1047647|NCT01808118|2085787|FG002|Period 1|Did not meet inclusion criteria|0
1047648|NCT01808118|2085785|FG000|Period 1|Non-conformance with inclusion criteria|3
1047649|NCT01808118|2085786|FG001|Period 1|Non-conformance with inclusion criteria|0
1047650|NCT01808118|2085787|FG002|Period 1|Non-conformance with inclusion criteria|0
1047651|NCT01808118|2085785|FG000|Period 1|Investigator decision: site closure|2
1047652|NCT01808118|2085786|FG001|Period 1|Investigator decision: site closure|0
1047653|NCT01808118|2085787|FG002|Period 1|Investigator decision: site closure|0
1047654|NCT01808118|2085785|FG000|Period 1|Non-compliance per sponsor|1
1047655|NCT01808118|2085786|FG001|Period 1|Non-compliance per sponsor|0
1047656|NCT01808118|2085787|FG002|Period 1|Non-compliance per sponsor|0
1047657|NCT01808118|2085785|FG000|Period 1|Lack of Efficacy|1
1047658|NCT01808118|2085786|FG001|Period 1|Lack of Efficacy|0
1047659|NCT01808118|2085787|FG002|Period 1|Lack of Efficacy|0
1047660|NCT01808118|2085785|FG000|Period 2|Adverse Event|0
1047661|NCT01808118|2085786|FG001|Period 2|Adverse Event|4
1047662|NCT01808118|2085787|FG002|Period 2|Adverse Event|0
1047663|NCT01808118|2085785|FG000|Period 2|Withdrew consent|0
1047664|NCT01808118|2085786|FG001|Period 2|Withdrew consent|7
1047665|NCT01808118|2085787|FG002|Period 2|Withdrew consent|6
1047666|NCT01808118|2085785|FG000|Period 2|Lost to Follow-up|0
1047667|NCT01808118|2085786|FG001|Period 2|Lost to Follow-up|0
1047668|NCT01808118|2085787|FG002|Period 2|Lost to Follow-up|2
1047669|NCT01808118|2085785|FG000|Period 2|Investigator no longer conducting trials|0
1047670|NCT01808118|2085786|FG001|Period 2|Investigator no longer conducting trials|1
1047671|NCT01808118|2085787|FG002|Period 2|Investigator no longer conducting trials|0
1047672|NCT01808118|2085785|FG000|Period 2|Switched to other therapy|0
1047673|NCT01808118|2085786|FG001|Period 2|Switched to other therapy|1
1047674|NCT01808118|2085787|FG002|Period 2|Switched to other therapy|0
1047675|NCT01808144|2085803|FG000|Overall Study|Death|1
1047676|NCT01808144|2085804|FG001|Overall Study|Death|0
1047677|NCT01808144|2085803|FG000|Overall Study|Withdrawal by Subject|16
1047678|NCT01808144|2085804|FG001|Overall Study|Withdrawal by Subject|23
1047679|NCT01808144|2085803|FG000|Overall Study|Lost to Follow-up|6
1047680|NCT01808144|2085804|FG001|Overall Study|Lost to Follow-up|3
1047681|NCT01808144|2085803|FG000|Overall Study|Protocol Violation|6
1047682|NCT01808144|2085804|FG001|Overall Study|Protocol Violation|6
1047683|NCT01808144|2085803|FG000|Overall Study|Gout flare|0
1047684|NCT01808144|2085804|FG001|Overall Study|Gout flare|1
1047685|NCT01808144|2085803|FG000|Overall Study|Adverse Event|11
1047686|NCT01808144|2085804|FG001|Overall Study|Adverse Event|15
1047687|NCT01808196|2085810|FG000|Overall Study|Lost to Follow-up|1
1047688|NCT01808209|2085816|FG000|Overall Study|Lost to Follow-up|0
1047689|NCT01808209|2085817|FG001|Overall Study|Lost to Follow-up|1
1047690|NCT01808222|2085827|FG000|Overall Study|mpMR scan was not performed|1
1047691|NCT01808248|2085833|FG000|Overall Study|Lack of Efficacy|3
1047692|NCT01808248|2085833|FG000|Overall Study|Withdrawal by Subject|1
1047693|NCT01808248|2085833|FG000|Overall Study|Lost to Follow-up|1
1047694|NCT01808313|2085858|FG000|Overall Study|Adverse Event|5
1047695|NCT01808313|2085858|FG000|Overall Study|Protocol Violation|2
1047696|NCT01808313|2085858|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
1047697|NCT01808313|2085858|FG000|Overall Study|Lost to Follow-up|1
1047698|NCT01808313|2085858|FG000|Overall Study|Physician Decision|1
1047699|NCT01808339|2085866|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1047700|NCT01808339|2085867|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1047701|NCT01808339|2085868|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1047702|NCT01808339|2085869|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
1047703|NCT01808339|2085870|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
1047704|NCT01808339|2085871|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
1047705|NCT01808339|2085866|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1047706|NCT01808339|2085867|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1047707|NCT01808339|2085868|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1047708|NCT01808339|2085869|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1047709|NCT01808339|2085870|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1047710|NCT01808339|2085871|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1047711|NCT01808339|2085866|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1047712|NCT01808339|2085867|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1047713|NCT01808339|2085868|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
1047714|NCT01808339|2085869|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1047715|NCT01808339|2085870|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1047716|NCT01808339|2085871|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1047717|NCT01808508|2085882|FG000|Overall Study|Lost to Follow-up|1
1047718|NCT01808508|2085883|FG001|Overall Study|Lost to Follow-up|0
1047719|NCT01808508|2085884|FG002|Overall Study|Lost to Follow-up|0
1047720|NCT01808534|2085892|FG000|Overall Study|Disease progression|3
1047721|NCT01808534|2085892|FG000|Overall Study|Physician Decision|1
1047722|NCT01808573|2085920|FG000|Overall Study|Death|212
1047723|NCT01808573|2085921|FG001|Overall Study|Death|240
1047724|NCT01808573|2085920|FG000|Overall Study|Withdrawal by Subject|12
1047725|NCT01808573|2085921|FG001|Overall Study|Withdrawal by Subject|10
1047726|NCT01808573|2085920|FG000|Overall Study|Lost to Follow-up|3
1047727|NCT01808573|2085921|FG001|Overall Study|Lost to Follow-up|0
1047728|NCT01808573|2085920|FG000|Overall Study|Discontinuation of study by sponsor|79
1047729|NCT01808573|2085921|FG001|Overall Study|Discontinuation of study by sponsor|64
1047730|NCT01808573|2085920|FG000|Overall Study|Randomized in Error|1
1047731|NCT01808573|2085921|FG001|Overall Study|Randomized in Error|0
1047732|NCT01808612|2085930|FG000|Treatment Period|Adverse Event|8
1047733|NCT01808612|2085931|FG001|Treatment Period|Adverse Event|4
1047734|NCT01808612|2085932|FG002|Treatment Period|Adverse Event|3
1047735|NCT01808612|2085930|FG000|Treatment Period|Lost to Follow-up|2
1047736|NCT01808612|2085931|FG001|Treatment Period|Lost to Follow-up|2
1047737|NCT01808612|2085932|FG002|Treatment Period|Lost to Follow-up|1
1047738|NCT01808612|2085930|FG000|Treatment Period|Protocol Violation|1
1047739|NCT01808612|2085931|FG001|Treatment Period|Protocol Violation|0
1047740|NCT01808612|2085932|FG002|Treatment Period|Protocol Violation|0
1047741|NCT01808612|2085930|FG000|Treatment Period|Withdrawal by Subject|1
1047742|NCT01808612|2085931|FG001|Treatment Period|Withdrawal by Subject|0
1047743|NCT01808612|2085932|FG002|Treatment Period|Withdrawal by Subject|4
1047744|NCT01808612|2085930|FG000|Treatment Period|Physician Decision|1
1047745|NCT01808612|2085931|FG001|Treatment Period|Physician Decision|0
1047746|NCT01808612|2085932|FG002|Treatment Period|Physician Decision|4
1047747|NCT01808612|2085930|FG000|Treatment Period|Sponsor Decision|1
1047748|NCT01808612|2085931|FG001|Treatment Period|Sponsor Decision|0
1047749|NCT01808612|2085932|FG002|Treatment Period|Sponsor Decision|0
1047750|NCT01808612|2085930|FG000|Treatment Period|Lack of Efficacy|1
1047751|NCT01808612|2085931|FG001|Treatment Period|Lack of Efficacy|1
1047752|NCT01808612|2085932|FG002|Treatment Period|Lack of Efficacy|2
1047753|NCT01808612|2085930|FG000|Discontinuation Period|Adverse Event|1
1047754|NCT01808612|2085931|FG001|Discontinuation Period|Adverse Event|0
1047755|NCT01808612|2085932|FG002|Discontinuation Period|Adverse Event|0
1047756|NCT01808612|2085930|FG000|Discontinuation Period|Physician Decision|1
1047757|NCT01808612|2085931|FG001|Discontinuation Period|Physician Decision|0
1047758|NCT01808612|2085932|FG002|Discontinuation Period|Physician Decision|0
1047759|NCT01808612|2085930|FG000|Discontinuation Period|Lost to Follow-up|0
1047760|NCT01808612|2085931|FG001|Discontinuation Period|Lost to Follow-up|1
1047761|NCT01808612|2085932|FG002|Discontinuation Period|Lost to Follow-up|0
1047762|NCT01808651|2085946|FG000|Study Period 1|Lost to Follow-up|1
1047763|NCT01808651|2085947|FG001|Study Period 1|Lost to Follow-up|3
1047764|NCT01808651|2085948|FG002|Study Period 1|Lost to Follow-up|0
1047765|NCT01808651|2085946|FG000|Study Period 1|Protocol Violation|1
1047766|NCT01808651|2085947|FG001|Study Period 1|Protocol Violation|0
1047767|NCT01808651|2085948|FG002|Study Period 1|Protocol Violation|1
1047768|NCT01808651|2085946|FG000|Study Period 1|Physician Decision|3
1047769|NCT01808651|2085947|FG001|Study Period 1|Physician Decision|2
1047770|NCT01808651|2085948|FG002|Study Period 1|Physician Decision|0
1047771|NCT01808651|2085946|FG000|Study Period 1|Lack of Efficacy|2
1047772|NCT01808651|2085947|FG001|Study Period 1|Lack of Efficacy|1
1047773|NCT01808651|2085948|FG002|Study Period 1|Lack of Efficacy|0
1047774|NCT01808651|2085946|FG000|Study Period 1|Adverse Event|10
1047775|NCT01808651|2085947|FG001|Study Period 1|Adverse Event|4
1047776|NCT01808651|2085948|FG002|Study Period 1|Adverse Event|1
1047777|NCT01808651|2085946|FG000|Study Period 1|Participant Decision|9
1047778|NCT01808651|2085947|FG001|Study Period 1|Participant Decision|7
1047779|NCT01808651|2085948|FG002|Study Period 1|Participant Decision|3
1047780|NCT01808690|2085961|FG000|Overall Study|Withdrawal by Subject|1
1047781|NCT01808690|2085962|FG001|Overall Study|Withdrawal by Subject|2
1047782|NCT01809132|2086007|FG000|Overall Study|Withdrawal by Subject|0
1047783|NCT01809132|2086008|FG001|Overall Study|Withdrawal by Subject|0
1047784|NCT01809132|2086009|FG002|Overall Study|Withdrawal by Subject|1
1047785|NCT01809197|2086019|FG000|Overall Study|Lost to Follow-up|4
1047786|NCT01809197|2086020|FG001|Overall Study|Lost to Follow-up|2
1047787|NCT01809197|2086019|FG000|Overall Study|Adverse Event|2
1047788|NCT01809197|2086020|FG001|Overall Study|Adverse Event|3
1047789|NCT01809197|2086019|FG000|Overall Study|Failed slit lamp exam|1
1047790|NCT01809197|2086020|FG001|Overall Study|Failed slit lamp exam|0
1047791|NCT01809197|2086019|FG000|Overall Study|Non-Compliance|1
1047792|NCT01809197|2086020|FG001|Overall Study|Non-Compliance|1
1047793|NCT01809197|2086019|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
1047794|NCT01809197|2086020|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
1047795|NCT01809197|2086019|FG000|Overall Study|Withdrawal by Subject|1
1047796|NCT01809197|2086020|FG001|Overall Study|Withdrawal by Subject|1
1047797|NCT01809197|2086019|FG000|Overall Study|Product not available|0
1047798|NCT01809197|2086020|FG001|Overall Study|Product not available|1
1047799|NCT01809210|2086033|FG000|Overall Study|Withdrawal by Subject|0
1047800|NCT01809210|2086034|FG001|Overall Study|Withdrawal by Subject|0
1047801|NCT01809210|2086035|FG002|Overall Study|Withdrawal by Subject|1
1047802|NCT01809210|2086036|FG003|Overall Study|Withdrawal by Subject|1
1047803|NCT01809210|2086037|FG004|Overall Study|Withdrawal by Subject|1
1047804|NCT01809210|2086038|FG005|Overall Study|Withdrawal by Subject|0
1047805|NCT01809210|2086039|FG006|Overall Study|Withdrawal by Subject|4
1047806|NCT01809210|2086033|FG000|Overall Study|Death|1
1047807|NCT01809210|2086034|FG001|Overall Study|Death|1
1047808|NCT01809210|2086035|FG002|Overall Study|Death|2
1047809|NCT01809210|2086036|FG003|Overall Study|Death|0
1047810|NCT01809210|2086037|FG004|Overall Study|Death|1
1047811|NCT01809210|2086038|FG005|Overall Study|Death|3
1047812|NCT01809210|2086039|FG006|Overall Study|Death|1
1047813|NCT01809262|2086055|FG000|Period 1 (First Dose + Washout)|Adverse Event|0
906650|NCT00770315|1882457|FG000|Overall Study|Lost to Follow-up|9
906651|NCT00770315|1882458|FG001|Overall Study|Lost to Follow-up|5
906652|NCT00770315|1882459|FG002|Overall Study|Lost to Follow-up|10
906653|NCT00770315|1882460|FG003|Overall Study|Lost to Follow-up|3
906654|NCT00770315|1882457|FG000|Overall Study|Withdrawal by Subject|13
906655|NCT00770315|1882458|FG001|Overall Study|Withdrawal by Subject|17
906656|NCT00770315|1882459|FG002|Overall Study|Withdrawal by Subject|24
906657|NCT00770315|1882460|FG003|Overall Study|Withdrawal by Subject|20
906658|NCT00770315|1882457|FG000|Overall Study|Noncompliance with Protocol|7
1047814|NCT01809262|2086056|FG001|Period 1 (First Dose + Washout)|Adverse Event|0
1047815|NCT01809262|2086057|FG002|Period 1 (First Dose + Washout)|Adverse Event|0
1047816|NCT01809262|2086058|FG003|Period 1 (First Dose + Washout)|Adverse Event|0
1047817|NCT01809262|2086059|FG004|Period 1 (First Dose + Washout)|Adverse Event|1
1047818|NCT01809262|2086060|FG005|Period 1 (First Dose + Washout)|Adverse Event|0
1047819|NCT01809262|2086061|FG006|Period 1 (First Dose + Washout)|Adverse Event|0
1047820|NCT01809262|2086062|FG007|Period 1 (First Dose + Washout)|Adverse Event|0
1047821|NCT01809262|2086063|FG008|Period 1 (First Dose + Washout)|Adverse Event|0
1047822|NCT01809262|2086064|FG009|Period 1 (First Dose + Washout)|Adverse Event|0
1047823|NCT01809262|2086055|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0
1047824|NCT01809262|2086056|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1
1047825|NCT01809262|2086057|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0
1047826|NCT01809262|2086058|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0
1047827|NCT01809262|2086059|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0
1047828|NCT01809262|2086060|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0
1047829|NCT01809262|2086061|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0
1047830|NCT01809262|2086062|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0
1047831|NCT01809262|2086063|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0
1047832|NCT01809262|2086064|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0
1047833|NCT01809314|2086076|FG000|Overall Study|Withdrawal Prior to Treatment|1
1047834|NCT01809314|2086076|FG000|Overall Study|Adverse Event|6
1047835|NCT01809314|2086076|FG000|Overall Study|Insufficient Therapeutic Response|14
1047836|NCT01809314|2086076|FG000|Overall Study|Lost to Follow-up|724
1047837|NCT01809327|2086085|FG000|Overall Study|Lost to Follow-up|5
1047838|NCT01809327|2086086|FG001|Overall Study|Lost to Follow-up|2
1047839|NCT01809327|2086087|FG002|Overall Study|Lost to Follow-up|4
1047840|NCT01809327|2086088|FG003|Overall Study|Lost to Follow-up|2
1047841|NCT01809327|2086089|FG004|Overall Study|Lost to Follow-up|3
1047842|NCT01809327|2086085|FG000|Overall Study|Withdrawal by Subject|6
1047843|NCT01809327|2086086|FG001|Overall Study|Withdrawal by Subject|4
1047844|NCT01809327|2086087|FG002|Overall Study|Withdrawal by Subject|4
1047845|NCT01809327|2086088|FG003|Overall Study|Withdrawal by Subject|2
1047846|NCT01809327|2086089|FG004|Overall Study|Withdrawal by Subject|5
1047847|NCT01809327|2086085|FG000|Overall Study|Adverse Event|4
1047848|NCT01809327|2086086|FG001|Overall Study|Adverse Event|3
1047849|NCT01809327|2086087|FG002|Overall Study|Adverse Event|7
1047850|NCT01809327|2086088|FG003|Overall Study|Adverse Event|4
1047851|NCT01809327|2086089|FG004|Overall Study|Adverse Event|8
1047852|NCT01809327|2086085|FG000|Overall Study|Death|1
1047853|NCT01809327|2086086|FG001|Overall Study|Death|0
1047854|NCT01809327|2086087|FG002|Overall Study|Death|0
1047855|NCT01809327|2086088|FG003|Overall Study|Death|0
1047856|NCT01809327|2086089|FG004|Overall Study|Death|0
1047857|NCT01809327|2086085|FG000|Overall Study|Protocol Violation|0
1047858|NCT01809327|2086086|FG001|Overall Study|Protocol Violation|1
1047859|NCT01809327|2086087|FG002|Overall Study|Protocol Violation|0
1047860|NCT01809327|2086088|FG003|Overall Study|Protocol Violation|0
1047861|NCT01809327|2086089|FG004|Overall Study|Protocol Violation|0
1047862|NCT01809327|2086085|FG000|Overall Study|Physician Decision|1
1047863|NCT01809327|2086086|FG001|Overall Study|Physician Decision|1
1047864|NCT01809327|2086087|FG002|Overall Study|Physician Decision|0
1047865|NCT01809327|2086088|FG003|Overall Study|Physician Decision|0
1047866|NCT01809327|2086089|FG004|Overall Study|Physician Decision|0
1047867|NCT01809327|2086085|FG000|Overall Study|Pregnancy|1
1047868|NCT01809327|2086086|FG001|Overall Study|Pregnancy|0
1047869|NCT01809327|2086087|FG002|Overall Study|Pregnancy|0
1047870|NCT01809327|2086088|FG003|Overall Study|Pregnancy|0
1047871|NCT01809327|2086089|FG004|Overall Study|Pregnancy|0
1047872|NCT01809327|2086085|FG000|Overall Study|Other|14
1047873|NCT01809327|2086086|FG001|Overall Study|Other|15
1047874|NCT01809327|2086087|FG002|Overall Study|Other|7
1047875|NCT01809327|2086088|FG003|Overall Study|Other|4
1047876|NCT01809327|2086089|FG004|Overall Study|Other|9
1047877|NCT01810016|2086125|FG000|Overall Study|Progressive disease|1
1047878|NCT01810016|2086126|FG001|Overall Study|Progressive disease|1
1047879|NCT01810016|2086127|FG002|Overall Study|Progressive disease|0
1047880|NCT01810016|2086125|FG000|Overall Study|Death|0
1047881|NCT01810016|2086126|FG001|Overall Study|Death|0
1047882|NCT01810016|2086127|FG002|Overall Study|Death|1
1047883|NCT01810042|2086135|FG000|Overall Study|Lost to Follow-up|10
1047884|NCT01810263|2086141|FG000|Overall Study|Lost to Follow-up|8
1047885|NCT01810263|2086142|FG001|Overall Study|Lost to Follow-up|7
1047886|NCT01810380|2086160|FG000|Overall Study|Randomised not treated|2
1047887|NCT01810380|2086161|FG001|Overall Study|Randomised not treated|1
1047888|NCT01810380|2086162|FG002|Overall Study|Randomised not treated|1
1047889|NCT01810380|2086160|FG000|Overall Study|Adverse Event|11
1047890|NCT01810380|2086161|FG001|Overall Study|Adverse Event|14
1047891|NCT01810380|2086162|FG002|Overall Study|Adverse Event|4
1047892|NCT01810380|2086160|FG000|Overall Study|Lack of Efficacy|24
1047893|NCT01810380|2086161|FG001|Overall Study|Lack of Efficacy|10
1047894|NCT01810380|2086162|FG002|Overall Study|Lack of Efficacy|11
1047895|NCT01810380|2086160|FG000|Overall Study|Protocol Violation|1
1047896|NCT01810380|2086161|FG001|Overall Study|Protocol Violation|0
1047897|NCT01810380|2086162|FG002|Overall Study|Protocol Violation|1
1047898|NCT01810380|2086160|FG000|Overall Study|Withdrawal by Subject|6
1047899|NCT01810380|2086161|FG001|Overall Study|Withdrawal by Subject|0
1047900|NCT01810380|2086162|FG002|Overall Study|Withdrawal by Subject|6
1047901|NCT01810380|2086160|FG000|Overall Study|Administrative or other reasons|11
1047902|NCT01810380|2086161|FG001|Overall Study|Administrative or other reasons|13
1047903|NCT01810380|2086162|FG002|Overall Study|Administrative or other reasons|9
1047904|NCT01810432|2086170|FG000|Washout|Protocol Violation|0
1047905|NCT01810432|2086171|FG001|Washout|Protocol Violation|1
1047906|NCT01810432|2086170|FG000|Washout|Adverse Event|1
1047907|NCT01810432|2086171|FG001|Washout|Adverse Event|0
1047908|NCT01810432|2086170|FG000|Period 2|Withdrawal by Subject|2
1047909|NCT01810432|2086171|FG001|Period 2|Withdrawal by Subject|1
1047910|NCT01810432|2086170|FG000|Period 2|Physician Decision|1
1047911|NCT01810432|2086171|FG001|Period 2|Physician Decision|0
1047912|NCT01810432|2086170|FG000|Period 2|Lost to Follow-up|1
1047913|NCT01810432|2086171|FG001|Period 2|Lost to Follow-up|1
1047914|NCT01810783|2086190|FG000|Overall Study|Adverse Event|32
1047915|NCT01810783|2086190|FG000|Overall Study|Withdrawal by Subject|22
1047916|NCT01810783|2086190|FG000|Overall Study|Lack of Efficacy|12
1047917|NCT01810783|2086190|FG000|Overall Study|Lost to Follow-up|10
1047918|NCT01810783|2086190|FG000|Overall Study|Protocol Violation|5
1047919|NCT01810783|2086190|FG000|Overall Study|Non-compliance with IMP|4
1047920|NCT01810783|2086190|FG000|Overall Study|Adminstrative or other reason(s)|23
1047921|NCT01810783|2086190|FG000|Overall Study|Enrolled, not treated|1
1047922|NCT01810939|2086194|FG000|Part A Treatment Period|Non-compliance with Study Drug|1
1047923|NCT01810939|2086195|FG001|Part A Treatment Period|Non-compliance with Study Drug|0
1047924|NCT01810939|2086196|FG002|Part A Treatment Period|Non-compliance with Study Drug|0
1047925|NCT01810939|2086194|FG000|Part A Treatment Period|Protocol Violation|2
1047926|NCT01810939|2086195|FG001|Part A Treatment Period|Protocol Violation|0
1047927|NCT01810939|2086196|FG002|Part A Treatment Period|Protocol Violation|0
1047928|NCT01810939|2086194|FG000|Part A Treatment Period|Adverse Event|10
1047929|NCT01810939|2086195|FG001|Part A Treatment Period|Adverse Event|0
1047930|NCT01810939|2086196|FG002|Part A Treatment Period|Adverse Event|0
1047931|NCT01810939|2086194|FG000|Part A Treatment Period|Withdrawal by Subject|5
1047932|NCT01810939|2086195|FG001|Part A Treatment Period|Withdrawal by Subject|0
1047933|NCT01810939|2086196|FG002|Part A Treatment Period|Withdrawal by Subject|0
1047934|NCT01810939|2086194|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2
1047935|NCT01810939|2086195|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0
1047936|NCT01810939|2086196|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0
1047937|NCT01810939|2086194|FG000|Part A Treatment Period|Protocol-specified (High K+)|3
1047938|NCT01810939|2086195|FG001|Part A Treatment Period|Protocol-specified (High K+)|0
1047939|NCT01810939|2086196|FG002|Part A Treatment Period|Protocol-specified (High K+)|0
1047940|NCT01810939|2086194|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1
1047941|NCT01810939|2086195|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0
1047942|NCT01810939|2086196|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0
1047943|NCT01810939|2086194|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0
1047944|NCT01810939|2086195|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1
1047945|NCT01810939|2086196|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1
1047946|NCT01810939|2086194|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
1047947|NCT01810939|2086195|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
1047948|NCT01810939|2086196|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
1047949|NCT01810939|2086194|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0
1047950|NCT01810939|2086195|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1
1047951|NCT01810939|2086196|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1
1047952|NCT01810939|2086194|FG000|Part B Placebo-Controlled Withdrawal|Death|0
1047953|NCT01810939|2086195|FG001|Part B Placebo-Controlled Withdrawal|Death|0
1047954|NCT01810939|2086196|FG002|Part B Placebo-Controlled Withdrawal|Death|1
1047955|NCT01810939|2086194|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
1047956|NCT01810939|2086195|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
1047957|NCT01810939|2086196|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
1047958|NCT01810939|2086194|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
1047959|NCT01810939|2086195|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
1047960|NCT01810939|2086196|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
1047961|NCT01810939|2086194|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
1047962|NCT01810939|2086195|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
1047963|NCT01810939|2086196|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
1047964|NCT01810939|2086194|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
1047965|NCT01810939|2086195|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
1047966|NCT01810939|2086196|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
1047967|NCT01810939|2086194|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
1047968|NCT01810939|2086195|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
1047969|NCT01810939|2086196|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
1047970|NCT01810939|2086194|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
1047971|NCT01810939|2086195|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
1047972|NCT01810939|2086196|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
1047973|NCT01811186|2086258|FG000|Overall Study|Adverse Event|54
1047974|NCT01811186|2086259|FG001|Overall Study|Adverse Event|38
1047975|NCT01811186|2086258|FG000|Overall Study|Protocol Violation|5
1047976|NCT01811186|2086259|FG001|Overall Study|Protocol Violation|6
1047977|NCT01811186|2086258|FG000|Overall Study|Withdrawal by Subject|5
1047978|NCT01811186|2086259|FG001|Overall Study|Withdrawal by Subject|10
1047979|NCT01811186|2086258|FG000|Overall Study|Lack of Efficacy|3
1047980|NCT01811186|2086259|FG001|Overall Study|Lack of Efficacy|6
1047981|NCT01811186|2086258|FG000|Overall Study|Lost to Follow-up|4
1047982|NCT01811186|2086259|FG001|Overall Study|Lost to Follow-up|2
1047983|NCT01811225|2086273|FG000|Treatment Period 1|Adverse Event|2
1047984|NCT01811225|2086274|FG001|Treatment Period 1|Adverse Event|3
1047985|NCT01811225|2086273|FG000|Treatment Period 1|Lost to Follow-up|12
1047986|NCT01811225|2086274|FG001|Treatment Period 1|Lost to Follow-up|8
1047987|NCT01811225|2086273|FG000|Treatment Period 1|transporation|1
1047988|NCT01811225|2086274|FG001|Treatment Period 1|transporation|0
1047989|NCT01811225|2086273|FG000|Treatment Period 1|unable to remain smoke free overnight|10
1047990|NCT01811225|2086274|FG001|Treatment Period 1|unable to remain smoke free overnight|6
1047991|NCT01811225|2086273|FG000|Treatment Period 2|Lost to Follow-up|1
1047992|NCT01811225|2086274|FG001|Treatment Period 2|Lost to Follow-up|2
1047993|NCT01811225|2086273|FG000|Treatment Period 2|unable to remain smoke free overnight|3
1047994|NCT01811225|2086274|FG001|Treatment Period 2|unable to remain smoke free overnight|4
1047995|NCT01811238|2086280|FG000|Overall Study|Withdrawal by Subject|42
1047996|NCT01811238|2086280|FG000|Overall Study|Adverse Event|25
1047997|NCT01811238|2086280|FG000|Overall Study|Protocol Violation|4
1047998|NCT01811238|2086280|FG000|Overall Study|Lack of Efficacy|4
1047999|NCT01811238|2086280|FG000|Overall Study|subject refused study medication|6
1048000|NCT01811472|2086321|FG000|Overall Study|Adverse Event|1
1048001|NCT01811472|2086322|FG001|Overall Study|Adverse Event|0
1048002|NCT01811472|2086323|FG002|Overall Study|Adverse Event|4
1048003|NCT01811472|2086321|FG000|Overall Study|Lost to Follow-up|0
1048004|NCT01811472|2086322|FG001|Overall Study|Lost to Follow-up|0
1048005|NCT01811472|2086323|FG002|Overall Study|Lost to Follow-up|1
1048006|NCT01811472|2086321|FG000|Overall Study|Subject/guardian decision|1
1048007|NCT01811472|2086322|FG001|Overall Study|Subject/guardian decision|0
1048008|NCT01811472|2086323|FG002|Overall Study|Subject/guardian decision|0
1048009|NCT01811485|2086335|FG000|Overall Study|Adverse Event|1
1048010|NCT01811485|2086336|FG001|Overall Study|Adverse Event|3
1048011|NCT01811485|2086337|FG002|Overall Study|Adverse Event|2
1048012|NCT01811485|2086335|FG000|Overall Study|Unsatisfactory therapeutic effect|0
1048013|NCT01811485|2086336|FG001|Overall Study|Unsatisfactory therapeutic effect|0
1048014|NCT01811485|2086337|FG002|Overall Study|Unsatisfactory therapeutic effect|3
1048015|NCT01811485|2086335|FG000|Overall Study|Administrative problems|1
1048016|NCT01811485|2086336|FG001|Overall Study|Administrative problems|0
1048017|NCT01811485|2086337|FG002|Overall Study|Administrative problems|0
1048018|NCT01811485|2086335|FG000|Overall Study|Protocol Deviation|0
1048019|NCT01811485|2086336|FG001|Overall Study|Protocol Deviation|1
1048020|NCT01811485|2086337|FG002|Overall Study|Protocol Deviation|0
1048021|NCT01811563|2086350|FG000|Overall Study|Lost to Follow-up|5
1048022|NCT01811563|2086351|FG001|Overall Study|Lost to Follow-up|2
1048023|NCT01811563|2086350|FG000|Overall Study|Incorrect Randomization procedure|0
1048024|NCT01811563|2086351|FG001|Overall Study|Incorrect Randomization procedure|1
1048025|NCT01811706|2086380|FG000|First Intervention ( 4 Weeks)|Adverse Event|1
1048026|NCT01811706|2086381|FG001|First Intervention ( 4 Weeks)|Adverse Event|0
1048027|NCT01811732|2086391|FG000|Overall Study|Lost to Follow-up|24
1048028|NCT01811732|2086392|FG001|Overall Study|Lost to Follow-up|30
1048029|NCT01811732|2086391|FG000|Overall Study|Withdrawal by Subject|16
1048030|NCT01811732|2086392|FG001|Overall Study|Withdrawal by Subject|10
1048031|NCT01811732|2086391|FG000|Overall Study|Adverse Event|3
1048032|NCT01811732|2086392|FG001|Overall Study|Adverse Event|9
1048033|NCT01811732|2086391|FG000|Overall Study|Lack of Efficacy|3
1048034|NCT01811732|2086392|FG001|Overall Study|Lack of Efficacy|1
1048035|NCT01811732|2086391|FG000|Overall Study|Non-compliance with study drug/procedure|3
1048036|NCT01811732|2086392|FG001|Overall Study|Non-compliance with study drug/procedure|3
1048037|NCT01811732|2086391|FG000|Overall Study|Physician Decision|2
1048038|NCT01811732|2086392|FG001|Overall Study|Physician Decision|0
1048039|NCT01811732|2086391|FG000|Overall Study|Death|1
1048040|NCT01811732|2086392|FG001|Overall Study|Death|1
1048041|NCT01811732|2086391|FG000|Overall Study|Insufficient venous access|0
1048042|NCT01811732|2086392|FG001|Overall Study|Insufficient venous access|1
1048043|NCT01811732|2086391|FG000|Overall Study|Protocol Violation|0
1048044|NCT01811732|2086392|FG001|Overall Study|Protocol Violation|1
1048045|NCT01811732|2086391|FG000|Overall Study|Subject incarcerated|1
1048046|NCT01811732|2086392|FG001|Overall Study|Subject incarcerated|2
1048047|NCT01811732|2086391|FG000|Overall Study|Admitted to another facility|1
1048048|NCT01811732|2086392|FG001|Overall Study|Admitted to another facility|0
1048049|NCT01811732|2086391|FG000|Overall Study|Correct study drug not available on site|1
1048050|NCT01811732|2086392|FG001|Overall Study|Correct study drug not available on site|0
1048051|NCT01811953|2086418|FG000|Overall Study|Adverse Event|0
1048052|NCT01811953|2086419|FG001|Overall Study|Adverse Event|0
1048053|NCT01811953|2086420|FG002|Overall Study|Adverse Event|0
1048054|NCT01811953|2086421|FG003|Overall Study|Adverse Event|1
1048055|NCT01811953|2086422|FG004|Overall Study|Adverse Event|0
1048056|NCT01811953|2086423|FG005|Overall Study|Adverse Event|1
1048057|NCT01811953|2086418|FG000|Overall Study|Protocol Violation|0
1048058|NCT01811953|2086419|FG001|Overall Study|Protocol Violation|0
1048059|NCT01811953|2086420|FG002|Overall Study|Protocol Violation|0
1048060|NCT01811953|2086421|FG003|Overall Study|Protocol Violation|0
1048061|NCT01811953|2086422|FG004|Overall Study|Protocol Violation|1
1048062|NCT01811953|2086423|FG005|Overall Study|Protocol Violation|0
1048063|NCT01812057|2086461|FG000|Overall Study|Protocol Violation|1
1048064|NCT01812057|2086462|FG001|Overall Study|Protocol Violation|0
1048065|NCT01812057|2086461|FG000|Overall Study|Physician Decision|1
1048066|NCT01812057|2086462|FG001|Overall Study|Physician Decision|0
1048067|NCT01812109|2086472|FG000|Overall Study|research personnel delay|16
1048068|NCT01812109|2086472|FG000|Overall Study|NIRS Unattainable|17
1048069|NCT01812655|2086488|FG000|Overall Study|Protocol Violation|1
1048070|NCT01812655|2086489|FG001|Overall Study|Protocol Violation|1
1048071|NCT01812655|2086490|FG002|Overall Study|Protocol Violation|0
1048072|NCT01812707|2086518|FG000|Overall Study|Adverse Event|0
1048073|NCT01812707|2086519|FG001|Overall Study|Adverse Event|0
1048074|NCT01812707|2086520|FG002|Overall Study|Adverse Event|0
1048075|NCT01812707|2086521|FG003|Overall Study|Adverse Event|2
1048076|NCT01812707|2086518|FG000|Overall Study|Poor compliance to protocol|1
1048077|NCT01812707|2086519|FG001|Overall Study|Poor compliance to protocol|0
1048078|NCT01812707|2086520|FG002|Overall Study|Poor compliance to protocol|0
1048079|NCT01812707|2086521|FG003|Overall Study|Poor compliance to protocol|0
1048080|NCT01812707|2086518|FG000|Overall Study|Consent withdrawn by participant|1
1048081|NCT01812707|2086519|FG001|Overall Study|Consent withdrawn by participant|0
1048082|NCT01812707|2086520|FG002|Overall Study|Consent withdrawn by participant|0
1048083|NCT01812707|2086521|FG003|Overall Study|Consent withdrawn by participant|0
1048084|NCT01812759|2086535|FG000|Overall Study|Physician Decision|0
1048085|NCT01812759|2086536|FG001|Overall Study|Physician Decision|0
1048086|NCT01812759|2086537|FG002|Overall Study|Physician Decision|1
1048087|NCT01812837|2086548|FG000|Overall Study|Lost to Follow-up|1
1048088|NCT01812837|2086549|FG001|Overall Study|Lost to Follow-up|1
1048089|NCT01812837|2086550|FG002|Overall Study|Lost to Follow-up|0
1048090|NCT01812837|2086548|FG000|Overall Study|Protocol Violation|1
1048091|NCT01812837|2086549|FG001|Overall Study|Protocol Violation|0
1048092|NCT01812837|2086550|FG002|Overall Study|Protocol Violation|0
1048093|NCT01813019|2086560|FG000|Overall Study|Adverse Event|0
1048094|NCT01813019|2086561|FG001|Overall Study|Adverse Event|3
1048095|NCT01813019|2086560|FG000|Overall Study|Withdrawal by Subject|3
1048096|NCT01813019|2086561|FG001|Overall Study|Withdrawal by Subject|2
1048097|NCT01813019|2086560|FG000|Overall Study|administrative problems|2
1048098|NCT01813019|2086561|FG001|Overall Study|administrative problems|0
1048099|NCT01813019|2086560|FG000|Overall Study|Protocol Deviation|2
1048100|NCT01813019|2086561|FG001|Overall Study|Protocol Deviation|1
1048101|NCT01813058|2086569|FG000|Overall Study|Withdrawal by Subject|5
1048102|NCT01813058|2086570|FG001|Overall Study|Withdrawal by Subject|4
1048103|NCT01813071|2086585|FG000|Overall Study|Protocol Violation|0
1048104|NCT01813071|2086586|FG001|Overall Study|Protocol Violation|0
1048105|NCT01813071|2086587|FG002|Overall Study|Protocol Violation|0
1048106|NCT01813071|2086588|FG003|Overall Study|Protocol Violation|0
1048107|NCT01813071|2086589|FG004|Overall Study|Protocol Violation|1
1048108|NCT01813071|2086590|FG005|Overall Study|Protocol Violation|4
1048109|NCT01813071|2086591|FG006|Overall Study|Protocol Violation|2
1048110|NCT01813071|2086592|FG007|Overall Study|Protocol Violation|4
1048111|NCT01813071|2086593|FG008|Overall Study|Protocol Violation|2
1048112|NCT01813071|2086585|FG000|Overall Study|Withdrawal by Subject|0
1048113|NCT01813071|2086586|FG001|Overall Study|Withdrawal by Subject|0
1048114|NCT01813071|2086587|FG002|Overall Study|Withdrawal by Subject|0
1048115|NCT01813071|2086588|FG003|Overall Study|Withdrawal by Subject|0
1048116|NCT01813071|2086589|FG004|Overall Study|Withdrawal by Subject|0
1048117|NCT01813071|2086590|FG005|Overall Study|Withdrawal by Subject|1
1048118|NCT01813071|2086591|FG006|Overall Study|Withdrawal by Subject|0
1048119|NCT01813071|2086592|FG007|Overall Study|Withdrawal by Subject|0
1048120|NCT01813071|2086593|FG008|Overall Study|Withdrawal by Subject|0
1048121|NCT01813071|2086585|FG000|Overall Study|Adverse Event|0
1048122|NCT01813071|2086586|FG001|Overall Study|Adverse Event|0
1048123|NCT01813071|2086587|FG002|Overall Study|Adverse Event|0
1048124|NCT01813071|2086588|FG003|Overall Study|Adverse Event|0
1048125|NCT01813071|2086589|FG004|Overall Study|Adverse Event|0
1048126|NCT01813071|2086590|FG005|Overall Study|Adverse Event|1
1048127|NCT01813071|2086591|FG006|Overall Study|Adverse Event|0
1048128|NCT01813071|2086592|FG007|Overall Study|Adverse Event|0
1048129|NCT01813071|2086593|FG008|Overall Study|Adverse Event|0
1048130|NCT01813071|2086585|FG000|Overall Study|Physician Decision|0
1048131|NCT01813071|2086586|FG001|Overall Study|Physician Decision|0
1048132|NCT01813071|2086587|FG002|Overall Study|Physician Decision|0
1048133|NCT01813071|2086588|FG003|Overall Study|Physician Decision|0
1048134|NCT01813071|2086589|FG004|Overall Study|Physician Decision|0
1048135|NCT01813071|2086590|FG005|Overall Study|Physician Decision|0
1048136|NCT01813071|2086591|FG006|Overall Study|Physician Decision|1
1048137|NCT01813071|2086592|FG007|Overall Study|Physician Decision|0
1048138|NCT01813071|2086593|FG008|Overall Study|Physician Decision|0
1048139|NCT01813071|2086585|FG000|Overall Study|Met inc/exc criteria|0
1048140|NCT01813071|2086586|FG001|Overall Study|Met inc/exc criteria|0
1048141|NCT01813071|2086587|FG002|Overall Study|Met inc/exc criteria|0
1048142|NCT01813071|2086588|FG003|Overall Study|Met inc/exc criteria|0
1048143|NCT01813071|2086589|FG004|Overall Study|Met inc/exc criteria|0
1048144|NCT01813071|2086590|FG005|Overall Study|Met inc/exc criteria|1
1048145|NCT01813071|2086591|FG006|Overall Study|Met inc/exc criteria|0
1048146|NCT01813071|2086592|FG007|Overall Study|Met inc/exc criteria|1
1048147|NCT01813071|2086593|FG008|Overall Study|Met inc/exc criteria|1
1048148|NCT01813357|2086660|FG000|Overall Study|Lost to Follow-up|5
1048149|NCT01813357|2086661|FG001|Overall Study|Lost to Follow-up|6
1048150|NCT01813422|2086669|FG000|Overall Study|Withdrawal by Subject|14
1048151|NCT01813422|2086670|FG001|Overall Study|Withdrawal by Subject|8
1048152|NCT01813422|2086669|FG000|Overall Study|Death|2
1048153|NCT01813422|2086670|FG001|Overall Study|Death|3
1048154|NCT01813422|2086669|FG000|Overall Study|Sponsor Decision|2
1048155|NCT01813422|2086670|FG001|Overall Study|Sponsor Decision|1
1048156|NCT01813422|2086669|FG000|Overall Study|Lost to Follow-up|2
1048157|NCT01813422|2086670|FG001|Overall Study|Lost to Follow-up|4
1048158|NCT01813435|2086678|FG000|Overall Study|did not finish experimental regimen|1902
1048159|NCT01813435|2086679|FG001|Overall Study|did not finish experimental regimen|770
1048160|NCT01813435|2086678|FG000|Overall Study|Lost to Follow-up|268
1048161|NCT01813435|2086679|FG001|Overall Study|Lost to Follow-up|237
1048162|NCT01813474|2086688|FG000|Overall Study|Withdrawal by Subject|0
1048163|NCT01813474|2086689|FG001|Overall Study|Withdrawal by Subject|0
1048164|NCT01813474|2086690|FG002|Overall Study|Withdrawal by Subject|1
1048165|NCT01813474|2086688|FG000|Overall Study|Adverse Event|1
1048166|NCT01813474|2086689|FG001|Overall Study|Adverse Event|1
1048167|NCT01813474|2086690|FG002|Overall Study|Adverse Event|0
1048168|NCT01813474|2086688|FG000|Overall Study|Lack of Efficacy|2
1048169|NCT01813474|2086689|FG001|Overall Study|Lack of Efficacy|6
1048170|NCT01813474|2086690|FG002|Overall Study|Lack of Efficacy|9
1048171|NCT01813474|2086688|FG000|Overall Study|Death|0
1048172|NCT01813474|2086689|FG001|Overall Study|Death|0
1048173|NCT01813474|2086690|FG002|Overall Study|Death|1
1048174|NCT01813721|2086699|FG000|Overall Study|Ineligibility determined|63
1048175|NCT01813721|2086699|FG000|Overall Study|Withdrawal by Subject|1
1048176|NCT01813890|2086728|FG000|Overall Study|Adverse Event|0
1048177|NCT01813890|2086729|FG001|Overall Study|Adverse Event|3
1048178|NCT01813890|2086730|FG002|Overall Study|Adverse Event|4
1048179|NCT01813890|2086728|FG000|Overall Study|Lack of Efficacy|9
1048180|NCT01813890|2086729|FG001|Overall Study|Lack of Efficacy|1
1048181|NCT01813890|2086730|FG002|Overall Study|Lack of Efficacy|2
1048182|NCT01814007|2086738|FG000|Overall Study|Withdrawal by Subject|1
1048183|NCT01814046|2086745|FG000|Drug Administration|Death due to complications of RSV|1
1048184|NCT01814046|2086746|FG001|Drug Administration|Death due to complications of RSV|0
1048185|NCT01814046|2086747|FG002|Drug Administration|Death due to complications of RSV|0
1048186|NCT01814072|2086786|FG000|Overall Study|Lost to Follow-up|2
1048187|NCT01814072|2086787|FG001|Overall Study|Lost to Follow-up|2
1048188|NCT01814072|2086788|FG002|Overall Study|Lost to Follow-up|2
1048189|NCT01814072|2086789|FG003|Overall Study|Lost to Follow-up|0
1048190|NCT01814072|2086790|FG004|Overall Study|Lost to Follow-up|2
1048191|NCT01814072|2086791|FG005|Overall Study|Lost to Follow-up|3
1048192|NCT01814072|2086792|FG006|Overall Study|Lost to Follow-up|3
1048193|NCT01814072|2086793|FG007|Overall Study|Lost to Follow-up|1
1048194|NCT01814072|2086794|FG008|Overall Study|Lost to Follow-up|2
1048195|NCT01814072|2086795|FG009|Overall Study|Lost to Follow-up|3
1048196|NCT01814072|2086796|FG010|Overall Study|Lost to Follow-up|1
1048197|NCT01814072|2086797|FG011|Overall Study|Lost to Follow-up|2
1048198|NCT01814072|2086798|FG012|Overall Study|Lost to Follow-up|2
1048199|NCT01814072|2086799|FG013|Overall Study|Lost to Follow-up|1
1048200|NCT01814072|2086800|FG014|Overall Study|Lost to Follow-up|2
1048201|NCT01814072|2086801|FG015|Overall Study|Lost to Follow-up|1
1048202|NCT01814072|2086802|FG016|Overall Study|Lost to Follow-up|3
1048203|NCT01814072|2086803|FG017|Overall Study|Lost to Follow-up|1
1048204|NCT01814072|2086804|FG018|Overall Study|Lost to Follow-up|3
1048205|NCT01814072|2086805|FG019|Overall Study|Lost to Follow-up|3
1048206|NCT01814072|2086806|FG020|Overall Study|Lost to Follow-up|2
1048207|NCT01814072|2086807|FG021|Overall Study|Lost to Follow-up|1
1048208|NCT01814072|2086808|FG022|Overall Study|Lost to Follow-up|3
1048209|NCT01814072|2086809|FG023|Overall Study|Lost to Follow-up|1
1048210|NCT01814072|2086810|FG024|Overall Study|Lost to Follow-up|4
1048211|NCT01814072|2086811|FG025|Overall Study|Lost to Follow-up|1
1048212|NCT01814072|2086812|FG026|Overall Study|Lost to Follow-up|1
1048213|NCT01814072|2086813|FG027|Overall Study|Lost to Follow-up|2
1048214|NCT01814072|2086814|FG028|Overall Study|Lost to Follow-up|3
1048215|NCT01814072|2086815|FG029|Overall Study|Lost to Follow-up|3
1048216|NCT01814072|2086816|FG030|Overall Study|Lost to Follow-up|2
1048217|NCT01814072|2086817|FG031|Overall Study|Lost to Follow-up|0
1048218|NCT01814072|2086786|FG000|Overall Study|Withdrawal by Subject|2
1048219|NCT01814072|2086787|FG001|Overall Study|Withdrawal by Subject|0
1048220|NCT01814072|2086788|FG002|Overall Study|Withdrawal by Subject|1
1048221|NCT01814072|2086789|FG003|Overall Study|Withdrawal by Subject|0
1048222|NCT01814072|2086790|FG004|Overall Study|Withdrawal by Subject|2
1048223|NCT01814072|2086791|FG005|Overall Study|Withdrawal by Subject|3
1048224|NCT01814072|2086792|FG006|Overall Study|Withdrawal by Subject|1
1048225|NCT01814072|2086793|FG007|Overall Study|Withdrawal by Subject|0
1048226|NCT01814072|2086794|FG008|Overall Study|Withdrawal by Subject|1
1048227|NCT01814072|2086795|FG009|Overall Study|Withdrawal by Subject|2
1048228|NCT01814072|2086796|FG010|Overall Study|Withdrawal by Subject|0
1048229|NCT01814072|2086797|FG011|Overall Study|Withdrawal by Subject|0
1048230|NCT01814072|2086798|FG012|Overall Study|Withdrawal by Subject|1
1048231|NCT01814072|2086799|FG013|Overall Study|Withdrawal by Subject|1
1048232|NCT01814072|2086800|FG014|Overall Study|Withdrawal by Subject|1
1048233|NCT01814072|2086801|FG015|Overall Study|Withdrawal by Subject|1
1048234|NCT01814072|2086802|FG016|Overall Study|Withdrawal by Subject|0
1048235|NCT01814072|2086803|FG017|Overall Study|Withdrawal by Subject|0
1048236|NCT01814072|2086804|FG018|Overall Study|Withdrawal by Subject|0
1048237|NCT01814072|2086805|FG019|Overall Study|Withdrawal by Subject|2
1048238|NCT01814072|2086806|FG020|Overall Study|Withdrawal by Subject|0
1048239|NCT01814072|2086807|FG021|Overall Study|Withdrawal by Subject|0
1048240|NCT01814072|2086808|FG022|Overall Study|Withdrawal by Subject|1
1048241|NCT01814072|2086809|FG023|Overall Study|Withdrawal by Subject|0
1048242|NCT01814072|2086810|FG024|Overall Study|Withdrawal by Subject|2
1048243|NCT01814072|2086811|FG025|Overall Study|Withdrawal by Subject|1
1048244|NCT01814072|2086812|FG026|Overall Study|Withdrawal by Subject|1
1048245|NCT01814072|2086813|FG027|Overall Study|Withdrawal by Subject|2
1048246|NCT01814072|2086814|FG028|Overall Study|Withdrawal by Subject|1
1048247|NCT01814072|2086815|FG029|Overall Study|Withdrawal by Subject|0
1048248|NCT01814072|2086816|FG030|Overall Study|Withdrawal by Subject|0
1048249|NCT01814072|2086817|FG031|Overall Study|Withdrawal by Subject|0
1048250|NCT01814137|2086859|FG000|Overall Study|Adverse Event|0
1048251|NCT01814137|2086860|FG001|Overall Study|Adverse Event|1
1048252|NCT01814137|2086859|FG000|Overall Study|Withdrawal by Subject|2
1048253|NCT01814137|2086860|FG001|Overall Study|Withdrawal by Subject|2
1048254|NCT01814137|2086859|FG000|Overall Study|Physician Decision|1
1048255|NCT01814137|2086860|FG001|Overall Study|Physician Decision|1
1048256|NCT01814137|2086859|FG000|Overall Study|Unclassified|2
1048257|NCT01814137|2086860|FG001|Overall Study|Unclassified|1
1048258|NCT01814332|2086873|FG000|Overall Study|Adverse Event|8
1048259|NCT01814332|2086874|FG001|Overall Study|Adverse Event|3
1048260|NCT01814332|2086873|FG000|Overall Study|Withdrawal by Subject|3
1048261|NCT01814332|2086874|FG001|Overall Study|Withdrawal by Subject|8
1048262|NCT01814332|2086873|FG000|Overall Study|Protocol Violation|0
1048263|NCT01814332|2086874|FG001|Overall Study|Protocol Violation|4
1048264|NCT01814332|2086873|FG000|Overall Study|Lost to Follow-up|5
1048265|NCT01814332|2086874|FG001|Overall Study|Lost to Follow-up|1
1048266|NCT01814371|2086882|FG000|Overall Study|Lost to Follow-up|30
1048267|NCT01814371|2086883|FG001|Overall Study|Lost to Follow-up|27
1048268|NCT01814397|2086892|FG000|Overall Study|Adverse Event|7
1048269|NCT01814397|2086892|FG000|Overall Study|Withdrawal by Subject|7
1048270|NCT01814553|2086898|FG000|Overall Study|PD per clinical progression|6
1048271|NCT01814553|2086899|FG001|Overall Study|PD per clinical progression|8
1048272|NCT01814553|2086898|FG000|Overall Study|Other Adverse Event|4
1048273|NCT01814553|2086899|FG001|Overall Study|Other Adverse Event|5
1048274|NCT01814553|2086898|FG000|Overall Study|Withdrawal by Subject|1
1048275|NCT01814553|2086899|FG001|Overall Study|Withdrawal by Subject|1
1048276|NCT01814553|2086898|FG000|Overall Study|Other than stated|7
1048277|NCT01814553|2086899|FG001|Overall Study|Other than stated|8
1048278|NCT01814670|2086905|FG000|Overall Study|Protocol Violation|12
1048279|NCT01814696|2086911|FG000|Overall Study|Withdrawal by Subject|1
1048280|NCT01814696|2086912|FG001|Overall Study|Withdrawal by Subject|0
1048281|NCT01814696|2086911|FG000|Overall Study|Randomized to wrong group|1
1048282|NCT01814696|2086912|FG001|Overall Study|Randomized to wrong group|0
1048283|NCT01814748|2086920|FG000|Overall Study|Lost to Follow-up|1
1048284|NCT01814748|2086921|FG001|Overall Study|Lost to Follow-up|2
1048285|NCT01814748|2086920|FG000|Overall Study|Study site terminated by sponsor|1
1048286|NCT01814748|2086921|FG001|Overall Study|Study site terminated by sponsor|1
1048287|NCT01814748|2086920|FG000|Overall Study|Withdrawal by Subject|6
1048288|NCT01814748|2086921|FG001|Overall Study|Withdrawal by Subject|4
1048289|NCT01814761|2086929|FG000|Overall Study|Other Reasons|1
1048290|NCT01814761|2086930|FG001|Overall Study|Other Reasons|10
1048291|NCT01814761|2086929|FG000|Overall Study|Ocular Adverse Event|6
1048292|NCT01814761|2086930|FG001|Overall Study|Ocular Adverse Event|15
1048293|NCT01814761|2086929|FG000|Overall Study|Lost to Follow-up|1
1048294|NCT01814761|2086930|FG001|Overall Study|Lost to Follow-up|5
1048295|NCT01814800|2086951|FG000|Overall Study|Adverse Event|2
1048296|NCT01814800|2086951|FG000|Overall Study|Pregnancy|1
1048297|NCT01814800|2086951|FG000|Overall Study|Sponsor decision|1
1048298|NCT01814800|2086951|FG000|Overall Study|Subject relocation|1
1048299|NCT01814878|2086984|FG000|Overall Study|Adverse Event|16
1048300|NCT01814878|2086985|FG001|Overall Study|Adverse Event|5
1048301|NCT01814878|2086984|FG000|Overall Study|Withdrawal by Subject|20
1048302|NCT01814878|2086985|FG001|Overall Study|Withdrawal by Subject|16
1048303|NCT01814878|2086984|FG000|Overall Study|Protocol Violation|5
1048304|NCT01814878|2086985|FG001|Overall Study|Protocol Violation|5
1048305|NCT01814878|2086984|FG000|Overall Study|Physician Decision|3
1048306|NCT01814878|2086985|FG001|Overall Study|Physician Decision|1
1048307|NCT01814878|2086984|FG000|Overall Study|Screening failure (drop-out)|0
906659|NCT00770315|1882458|FG001|Overall Study|Noncompliance with Protocol|4
906660|NCT00770315|1882459|FG002|Overall Study|Noncompliance with Protocol|7
1048308|NCT01814878|2086985|FG001|Overall Study|Screening failure (drop-out)|3
1048309|NCT01814878|2086984|FG000|Overall Study|Other|2
1048310|NCT01814878|2086985|FG001|Overall Study|Other|0
1048311|NCT01815099|2086997|FG000|Overall Study|Lack of Efficacy|1
1048312|NCT01815099|2086997|FG000|Overall Study|unable to attend study visits|1
1048313|NCT01815138|2087004|FG000|Overall Study|Withdrawal by Subject|0
1048314|NCT01815138|2087005|FG001|Overall Study|Withdrawal by Subject|1
1048315|NCT01815138|2087004|FG000|Overall Study|Physician Decision|8
1048316|NCT01815138|2087005|FG001|Overall Study|Physician Decision|5
1048317|NCT01815424|2087030|FG000|Week 0 to 16|Adverse Event|1
1048318|NCT01815424|2087031|FG001|Week 0 to 16|Adverse Event|3
1048319|NCT01815424|2087032|FG002|Week 0 to 16|Adverse Event|3
1048320|NCT01815424|2087033|FG003|Week 0 to 16|Adverse Event|0
1048321|NCT01815424|2087034|FG004|Week 0 to 16|Adverse Event|0
1048322|NCT01815424|2087030|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2
1048323|NCT01815424|2087031|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0
1048324|NCT01815424|2087032|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0
1048325|NCT01815424|2087033|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0
1048326|NCT01815424|2087034|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0
1048327|NCT01815424|2087030|FG000|Week 0 to 16|Lost to Follow-up|0
1048328|NCT01815424|2087031|FG001|Week 0 to 16|Lost to Follow-up|1
1048329|NCT01815424|2087032|FG002|Week 0 to 16|Lost to Follow-up|0
1048330|NCT01815424|2087033|FG003|Week 0 to 16|Lost to Follow-up|0
1048331|NCT01815424|2087034|FG004|Week 0 to 16|Lost to Follow-up|0
1048332|NCT01815424|2087030|FG000|Week 0 to 16|Withdrawal by Subject|0
1048333|NCT01815424|2087031|FG001|Week 0 to 16|Withdrawal by Subject|0
1048334|NCT01815424|2087032|FG002|Week 0 to 16|Withdrawal by Subject|1
1048335|NCT01815424|2087033|FG003|Week 0 to 16|Withdrawal by Subject|0
1048336|NCT01815424|2087034|FG004|Week 0 to 16|Withdrawal by Subject|0
1048337|NCT01815424|2087030|FG000|Week 0 to 16|Other|1
1048338|NCT01815424|2087031|FG001|Week 0 to 16|Other|0
1048339|NCT01815424|2087032|FG002|Week 0 to 16|Other|3
1048340|NCT01815424|2087033|FG003|Week 0 to 16|Other|0
1048341|NCT01815424|2087034|FG004|Week 0 to 16|Other|0
1048342|NCT01815424|2087030|FG000|Week 0 to 16|Protocol Violation|1
1048343|NCT01815424|2087031|FG001|Week 0 to 16|Protocol Violation|0
1048344|NCT01815424|2087032|FG002|Week 0 to 16|Protocol Violation|0
1048345|NCT01815424|2087033|FG003|Week 0 to 16|Protocol Violation|0
1048346|NCT01815424|2087034|FG004|Week 0 to 16|Protocol Violation|0
1048347|NCT01815424|2087030|FG000|Week 0 to 16|Insufficient Clinical Response|2
1048348|NCT01815424|2087031|FG001|Week 0 to 16|Insufficient Clinical Response|0
1048349|NCT01815424|2087032|FG002|Week 0 to 16|Insufficient Clinical Response|4
1048350|NCT01815424|2087033|FG003|Week 0 to 16|Insufficient Clinical Response|0
1048351|NCT01815424|2087034|FG004|Week 0 to 16|Insufficient Clinical Response|0
1048352|NCT01815424|2087030|FG000|Week 16 to 52|Other|0
1048353|NCT01815424|2087031|FG001|Week 16 to 52|Other|1
1048354|NCT01815424|2087032|FG002|Week 16 to 52|Other|0
1048355|NCT01815424|2087033|FG003|Week 16 to 52|Other|0
1048356|NCT01815424|2087034|FG004|Week 16 to 52|Other|0
1048357|NCT01815424|2087030|FG000|Week 16 to 52|Adverse Event|0
1048358|NCT01815424|2087031|FG001|Week 16 to 52|Adverse Event|0
1048359|NCT01815424|2087032|FG002|Week 16 to 52|Adverse Event|0
1048360|NCT01815424|2087033|FG003|Week 16 to 52|Adverse Event|0
1048361|NCT01815424|2087034|FG004|Week 16 to 52|Adverse Event|1
1048362|NCT01815424|2087030|FG000|Week 16 to 52|Insufficient Clinical Response|1
1048363|NCT01815424|2087031|FG001|Week 16 to 52|Insufficient Clinical Response|0
1048364|NCT01815424|2087032|FG002|Week 16 to 52|Insufficient Clinical Response|0
1048365|NCT01815424|2087033|FG003|Week 16 to 52|Insufficient Clinical Response|1
1048366|NCT01815424|2087034|FG004|Week 16 to 52|Insufficient Clinical Response|1
1048367|NCT01815424|2087030|FG000|Week 16 to 52|Lost to Follow-up|0
1048368|NCT01815424|2087031|FG001|Week 16 to 52|Lost to Follow-up|2
1048369|NCT01815424|2087032|FG002|Week 16 to 52|Lost to Follow-up|0
1048370|NCT01815424|2087033|FG003|Week 16 to 52|Lost to Follow-up|2
1048371|NCT01815424|2087034|FG004|Week 16 to 52|Lost to Follow-up|1
1048372|NCT01815424|2087030|FG000|Week 16 to 52|Withdrawal by Subject|1
1048373|NCT01815424|2087031|FG001|Week 16 to 52|Withdrawal by Subject|2
1048374|NCT01815424|2087032|FG002|Week 16 to 52|Withdrawal by Subject|0
1048375|NCT01815424|2087033|FG003|Week 16 to 52|Withdrawal by Subject|0
1048376|NCT01815424|2087034|FG004|Week 16 to 52|Withdrawal by Subject|0
1048377|NCT01815736|2087085|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11
1048378|NCT01815736|2087086|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17
1048379|NCT01815736|2087085|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10
1048380|NCT01815736|2087086|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9
1048381|NCT01815736|2087085|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11
1048382|NCT01815736|2087086|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2
1048383|NCT01815736|2087085|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7
1048384|NCT01815736|2087086|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4
1048385|NCT01815736|2087085|FG000|Randomized Treatment Phase-Up to Week 96|Death|4
1048386|NCT01815736|2087086|FG001|Randomized Treatment Phase-Up to Week 96|Death|0
1048387|NCT01815736|2087085|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1
1048388|NCT01815736|2087086|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0
1048389|NCT01815736|2087085|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1
1048390|NCT01815736|2087086|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0
1048391|NCT01815736|2087085|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4
1048392|NCT01815736|2087086|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3
1048393|NCT01815736|2087085|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31
1048394|NCT01815736|2087086|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15
1048395|NCT01815736|2087085|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13
1048396|NCT01815736|2087086|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9
1048397|NCT01815736|2087085|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5
1048398|NCT01815736|2087086|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1
1048399|NCT01815736|2087085|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1
1048400|NCT01815736|2087086|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1
1048401|NCT01815736|2087085|FG000|Extension Treatment Phase- After Week 96|Death|1
1048402|NCT01815736|2087086|FG001|Extension Treatment Phase- After Week 96|Death|0
1048403|NCT01815840|2087096|FG000|Overall Study|Missing|1
1048404|NCT01815840|2087097|FG001|Overall Study|Missing|0
1048405|NCT01815840|2087096|FG000|Overall Study|Withdrew Consent|31
1048406|NCT01815840|2087097|FG001|Overall Study|Withdrew Consent|30
1048407|NCT01815840|2087096|FG000|Overall Study|Administrative/Other|1
1048408|NCT01815840|2087097|FG001|Overall Study|Administrative/Other|3
1048409|NCT01815840|2087096|FG000|Overall Study|Adverse Event|10
1048410|NCT01815840|2087097|FG001|Overall Study|Adverse Event|16
1048411|NCT01815840|2087096|FG000|Overall Study|Death|2
1048412|NCT01815840|2087097|FG001|Overall Study|Death|2
1048413|NCT01815840|2087096|FG000|Overall Study|Disease progression|3
1048414|NCT01815840|2087097|FG001|Overall Study|Disease progression|2
1048415|NCT01815840|2087096|FG000|Overall Study|Investigators Decision|2
1048416|NCT01815840|2087097|FG001|Overall Study|Investigators Decision|3
1048417|NCT01815840|2087096|FG000|Overall Study|Lost to Follow-up|3
1048418|NCT01815840|2087097|FG001|Overall Study|Lost to Follow-up|6
1048419|NCT01815840|2087096|FG000|Overall Study|Refused Treatment|5
1048420|NCT01815840|2087097|FG001|Overall Study|Refused Treatment|1
1048421|NCT01815840|2087096|FG000|Overall Study|Sponsor Termination Treatment|1
1048422|NCT01815840|2087097|FG001|Overall Study|Sponsor Termination Treatment|0
1048423|NCT01815918|2087105|FG000|Overall Study|Patient samples not analyzable|3
1048424|NCT01815918|2087106|FG001|Overall Study|Patient samples not analyzable|4
1048425|NCT01815918|2087105|FG000|Overall Study|Lack of Efficacy|15
1048426|NCT01815918|2087106|FG001|Overall Study|Lack of Efficacy|15
1048427|NCT01816048|2087116|FG000|Overall Study|Adverse Event|1
1048428|NCT01816048|2087116|FG000|Overall Study|Death|1
1048429|NCT01816048|2087116|FG000|Overall Study|Withdrawal by Subject|1
1048430|NCT01816048|2087116|FG000|Overall Study|Disease Progression|3
1048431|NCT01816061|2087123|FG000|Overall Study|Lost to Follow-up|13
1048432|NCT01816061|2087124|FG001|Overall Study|Lost to Follow-up|24
1048433|NCT01816074|2087134|FG000|Phase 1|Time commitment issues|0
1048434|NCT01816074|2087135|FG001|Phase 1|Time commitment issues|0
1048435|NCT01816074|2087136|FG002|Phase 1|Time commitment issues|1
1048436|NCT01816074|2087137|FG003|Phase 1|Time commitment issues|0
1048437|NCT01816074|2087134|FG000|Phase 2|Time commitment Issues|0
1048438|NCT01816074|2087135|FG001|Phase 2|Time commitment Issues|2
1048439|NCT01816074|2087136|FG002|Phase 2|Time commitment Issues|0
1048440|NCT01816074|2087137|FG003|Phase 2|Time commitment Issues|0
1048441|NCT01816074|2087134|FG000|Phase 2|Unsatisfied with Randomization assignmen|1
1048442|NCT01816074|2087135|FG001|Phase 2|Unsatisfied with Randomization assignmen|0
1048443|NCT01816074|2087136|FG002|Phase 2|Unsatisfied with Randomization assignmen|0
1048444|NCT01816074|2087137|FG003|Phase 2|Unsatisfied with Randomization assignmen|0
1048445|NCT01816074|2087134|FG000|Phase 2|Physician Decision|0
1048446|NCT01816074|2087135|FG001|Phase 2|Physician Decision|0
1048447|NCT01816074|2087136|FG002|Phase 2|Physician Decision|0
1048448|NCT01816074|2087137|FG003|Phase 2|Physician Decision|1
1048449|NCT01816074|2087134|FG000|Phase 2|Withdrawal by Subject|1
1048450|NCT01816074|2087135|FG001|Phase 2|Withdrawal by Subject|0
1048451|NCT01816074|2087136|FG002|Phase 2|Withdrawal by Subject|0
1048452|NCT01816074|2087137|FG003|Phase 2|Withdrawal by Subject|0
1048453|NCT01816243|2087165|FG000|Overall Study|Adverse Event|6
1048454|NCT01816243|2087165|FG000|Overall Study|Lost to Follow-up|1
1048455|NCT01816243|2087165|FG000|Overall Study|Lack of Efficacy|1
1048456|NCT01816243|2087165|FG000|Overall Study|Not eligible for the study|1
1048457|NCT01816243|2087165|FG000|Overall Study|Amputation|3
1048458|NCT01816295|2087171|FG000|Double Blind Phase|Adverse Event|11
1048459|NCT01816295|2087172|FG001|Double Blind Phase|Adverse Event|8
1048460|NCT01816295|2087171|FG000|Double Blind Phase|Entry Criteria Not Met|0
1048461|NCT01816295|2087172|FG001|Double Blind Phase|Entry Criteria Not Met|2
1048462|NCT01816295|2087171|FG000|Double Blind Phase|Lost to Follow-up|3
1048463|NCT01816295|2087172|FG001|Double Blind Phase|Lost to Follow-up|5
1048464|NCT01816295|2087171|FG000|Double Blind Phase|Physician Decision|2
1048465|NCT01816295|2087172|FG001|Double Blind Phase|Physician Decision|2
1048466|NCT01816295|2087171|FG000|Double Blind Phase|Protocol Violation|17
1048467|NCT01816295|2087172|FG001|Double Blind Phase|Protocol Violation|11
1048468|NCT01816295|2087171|FG000|Double Blind Phase|Sponsor Decision|8
1048469|NCT01816295|2087172|FG001|Double Blind Phase|Sponsor Decision|8
1048470|NCT01816295|2087171|FG000|Double Blind Phase|Withdrawal by Subject|22
906661|NCT00770315|1882460|FG003|Overall Study|Noncompliance with Protocol|9
906662|NCT00770328|1882472|FG000|Overall Study|Adverse Event|11
906663|NCT00770328|1882473|FG001|Overall Study|Adverse Event|2
906664|NCT00770328|1882472|FG000|Overall Study|Lost to Follow-up|2
906665|NCT00770328|1882473|FG001|Overall Study|Lost to Follow-up|2
906666|NCT00770341|1882482|FG000|Overall Study|Did not meet eligibility criteria|1
906667|NCT00770341|1882483|FG001|Overall Study|Did not meet eligibility criteria|0
906668|NCT00770341|1882484|FG002|Overall Study|Did not meet eligibility criteria|0
906669|NCT00770341|1882482|FG000|Overall Study|Withdrawal by Subject|0
906670|NCT00770341|1882483|FG001|Overall Study|Withdrawal by Subject|1
906671|NCT00770341|1882484|FG002|Overall Study|Withdrawal by Subject|0
906672|NCT00770341|1882482|FG000|Overall Study|Clinical Adverse Event|3
906673|NCT00770341|1882483|FG001|Overall Study|Clinical Adverse Event|1
906674|NCT00770341|1882484|FG002|Overall Study|Clinical Adverse Event|2
906675|NCT00770341|1882482|FG000|Overall Study|Laboratory adverse event|3
906676|NCT00770341|1882483|FG001|Overall Study|Laboratory adverse event|3
906677|NCT00770341|1882484|FG002|Overall Study|Laboratory adverse event|0
906678|NCT00770341|1882482|FG000|Overall Study|Lack of Efficacy|3
906679|NCT00770341|1882483|FG001|Overall Study|Lack of Efficacy|0
906680|NCT00770341|1882484|FG002|Overall Study|Lack of Efficacy|1
906681|NCT00770341|1882482|FG000|Overall Study|Other|1
906682|NCT00770341|1882483|FG001|Overall Study|Other|0
906683|NCT00770341|1882484|FG002|Overall Study|Other|0
906684|NCT00770341|1882482|FG000|Overall Study|Not treated|1
906685|NCT00770341|1882483|FG001|Overall Study|Not treated|0
906686|NCT00770341|1882484|FG002|Overall Study|Not treated|0
906687|NCT00770367|1882495|FG000|First Intervention|Withdrawal by Subject|0
906688|NCT00770367|1882496|FG001|First Intervention|Withdrawal by Subject|2
906689|NCT00770367|1882495|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0
906690|NCT00770367|1882496|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1
906691|NCT00770367|1882495|FG000|Second Intervention|Lost to Follow-up|2
906692|NCT00770367|1882496|FG001|Second Intervention|Lost to Follow-up|0
906693|NCT00770432|1882506|FG000|Overall Study|Other|4
906694|NCT00770432|1882507|FG001|Overall Study|Other|6
906695|NCT00770432|1882506|FG000|Overall Study|Non-compliance|0
906696|NCT00770432|1882507|FG001|Overall Study|Non-compliance|1
906697|NCT00770484|1882515|FG000|Overall Study|Withdrawal by Subject|1
906698|NCT00770484|1882516|FG001|Overall Study|Withdrawal by Subject|0
906699|NCT00770510|1882522|FG000|Overall Study|Lost to Follow-up|2
906700|NCT00770510|1882522|FG000|Overall Study|Pregnancy|1
906701|NCT00770510|1882522|FG000|Overall Study|Withdrawal by Subject|2
906702|NCT00770562|1882536|FG000|Overall Study|Did not take treatment|1
906703|NCT00770562|1882537|FG001|Overall Study|Did not take treatment|1
906704|NCT00770588|1882546|FG000|Overall Study|Adverse Event|9
906705|NCT00770588|1882547|FG001|Overall Study|Adverse Event|2
906706|NCT00770588|1882546|FG000|Overall Study|Death caused by progression of disease|70
906707|NCT00770588|1882547|FG001|Overall Study|Death caused by progression of disease|91
906708|NCT00770588|1882546|FG000|Overall Study|Lost to Follow-up|1
1048471|NCT01816295|2087172|FG001|Double Blind Phase|Withdrawal by Subject|20
1048472|NCT01816295|2087171|FG000|OLE Phase|Adverse Event|17
1048473|NCT01816295|2087172|FG001|OLE Phase|Adverse Event|15
1048474|NCT01816295|2087171|FG000|OLE Phase|Death|1
1048475|NCT01816295|2087172|FG001|OLE Phase|Death|0
1048476|NCT01816295|2087171|FG000|OLE Phase|Entry Criteria Not Met|3
1048477|NCT01816295|2087172|FG001|OLE Phase|Entry Criteria Not Met|5
1048478|NCT01816295|2087171|FG000|OLE Phase|Lost to Follow-up|5
1048479|NCT01816295|2087172|FG001|OLE Phase|Lost to Follow-up|5
1048480|NCT01816295|2087171|FG000|OLE Phase|Physician Decision|3
1048481|NCT01816295|2087172|FG001|OLE Phase|Physician Decision|1
1048482|NCT01816295|2087171|FG000|OLE Phase|Protocol Violation|4
1048483|NCT01816295|2087172|FG001|OLE Phase|Protocol Violation|4
1048484|NCT01816295|2087171|FG000|OLE Phase|Sponsor Decision|7
1048485|NCT01816295|2087172|FG001|OLE Phase|Sponsor Decision|9
1048486|NCT01816295|2087171|FG000|OLE Phase|Withdrawal by Subject|10
1048487|NCT01816295|2087172|FG001|OLE Phase|Withdrawal by Subject|10
1048488|NCT01816295|2087171|FG000|OLE Phase|Lack of Efficacy|3
1048489|NCT01816295|2087172|FG001|OLE Phase|Lack of Efficacy|7
1048490|NCT01816477|2087196|FG000|Overall Study|Withdrawal by Subject|13
1048491|NCT01816477|2087197|FG001|Overall Study|Withdrawal by Subject|1
1048492|NCT01816477|2087196|FG000|Overall Study|Unable to tolerate catheter placement|3
1048493|NCT01816477|2087197|FG001|Overall Study|Unable to tolerate catheter placement|0
1048494|NCT01816594|2087205|FG000|Overall Study|Local Progress|0
1048495|NCT01816594|2087206|FG001|Overall Study|Local Progress|2
1048496|NCT01816594|2087205|FG000|Overall Study|Adverse Event|9
1048497|NCT01816594|2087206|FG001|Overall Study|Adverse Event|0
1048498|NCT01816594|2087205|FG000|Overall Study|Withdrawal by Subject|1
1048499|NCT01816594|2087206|FG001|Overall Study|Withdrawal by Subject|0
1048500|NCT01816594|2087205|FG000|Overall Study|Physician Decision|1
1048501|NCT01816594|2087206|FG001|Overall Study|Physician Decision|0
1048502|NCT01816685|2087220|FG000|Overall Study|Lost to Follow-up|7
1048503|NCT01816685|2087221|FG001|Overall Study|Lost to Follow-up|9
1048504|NCT01816685|2087220|FG000|Overall Study|Surgery Cancelled|3
1048505|NCT01816685|2087221|FG001|Overall Study|Surgery Cancelled|2
1048506|NCT01816763|2087239|FG000|Overall Study|The main reason for an incomplete survey|4
906709|NCT00770588|1882547|FG001|Overall Study|Lost to Follow-up|1
906710|NCT00770588|1882546|FG000|Overall Study|Withdrawal by Subject|1
906711|NCT00770588|1882547|FG001|Overall Study|Withdrawal by Subject|1
1048507|NCT01816763|2087240|FG001|Overall Study|The main reason for an incomplete survey|15
1048508|NCT01816763|2087241|FG002|Overall Study|The main reason for an incomplete survey|11
1048509|NCT01816893|2087263|FG000|Washout Period|Withdrawal by Subject|2
1048510|NCT01816893|2087264|FG001|Washout Period|Withdrawal by Subject|0
1048511|NCT01816906|2087272|FG000|Six Months|Did Not Show Up for Baseline Measurement|7
1048512|NCT01816906|2087273|FG001|Six Months|Did Not Show Up for Baseline Measurement|6
1048513|NCT01816906|2087272|FG000|Six Months|Lost to Follow-up|14
1048514|NCT01816906|2087273|FG001|Six Months|Lost to Follow-up|16
1048515|NCT01816906|2087272|FG000|12 Months|Adverse Event|2
1048516|NCT01816906|2087273|FG001|12 Months|Adverse Event|2
1048517|NCT01816906|2087272|FG000|12 Months|Death|0
1048518|NCT01816906|2087273|FG001|12 Months|Death|2
1048519|NCT01816906|2087272|FG000|12 Months|Lost to Follow-up|2
1048520|NCT01816906|2087273|FG001|12 Months|Lost to Follow-up|1
1048521|NCT01816984|2087289|FG000|Overall Study|declining health status|1
1048522|NCT01817075|2087295|FG000|Overall Study|Adverse Event|7
1048523|NCT01817075|2087296|FG001|Overall Study|Adverse Event|5
1048524|NCT01817075|2087295|FG000|Overall Study|Physician Decision|9
1048525|NCT01817075|2087296|FG001|Overall Study|Physician Decision|12
1048526|NCT01817075|2087295|FG000|Overall Study|Withdrawal by Subject|31
1048527|NCT01817075|2087296|FG001|Overall Study|Withdrawal by Subject|15
1048528|NCT01817075|2087295|FG000|Overall Study|Received Sorafenib after enrollment|0
1048529|NCT01817075|2087296|FG001|Overall Study|Received Sorafenib after enrollment|1
1048530|NCT01817075|2087295|FG000|Overall Study|Ineligible|0
1048531|NCT01817075|2087296|FG001|Overall Study|Ineligible|2
1048532|NCT01817530|2087326|FG000|Overall Study|Exclusionary Medication Received|0
1048533|NCT01817530|2087327|FG001|Overall Study|Exclusionary Medication Received|0
1048534|NCT01817530|2087328|FG002|Overall Study|Exclusionary Medication Received|0
1048535|NCT01817530|2087329|FG003|Overall Study|Exclusionary Medication Received|0
1048536|NCT01817530|2087330|FG004|Overall Study|Exclusionary Medication Received|1
1048537|NCT01817530|2087331|FG005|Overall Study|Exclusionary Medication Received|0
1048538|NCT01817530|2087332|FG006|Overall Study|Exclusionary Medication Received|0
1048539|NCT01817530|2087333|FG007|Overall Study|Exclusionary Medication Received|0
1048540|NCT01817530|2087326|FG000|Overall Study|Adverse Event|6
1048541|NCT01817530|2087327|FG001|Overall Study|Adverse Event|3
1048542|NCT01817530|2087328|FG002|Overall Study|Adverse Event|2
1048543|NCT01817530|2087329|FG003|Overall Study|Adverse Event|5
1048544|NCT01817530|2087330|FG004|Overall Study|Adverse Event|0
1048545|NCT01817530|2087331|FG005|Overall Study|Adverse Event|10
1048546|NCT01817530|2087332|FG006|Overall Study|Adverse Event|5
1048547|NCT01817530|2087333|FG007|Overall Study|Adverse Event|8
1048548|NCT01817530|2087326|FG000|Overall Study|Subject Noncompliant|3
1048549|NCT01817530|2087327|FG001|Overall Study|Subject Noncompliant|1
1048550|NCT01817530|2087328|FG002|Overall Study|Subject Noncompliant|0
1048551|NCT01817530|2087329|FG003|Overall Study|Subject Noncompliant|4
1048552|NCT01817530|2087330|FG004|Overall Study|Subject Noncompliant|0
1048553|NCT01817530|2087331|FG005|Overall Study|Subject Noncompliant|1
1048554|NCT01817530|2087332|FG006|Overall Study|Subject Noncompliant|1
1048555|NCT01817530|2087333|FG007|Overall Study|Subject Noncompliant|1
1048556|NCT01817530|2087326|FG000|Overall Study|Lack of Efficacy|1
1048557|NCT01817530|2087327|FG001|Overall Study|Lack of Efficacy|0
1048558|NCT01817530|2087328|FG002|Overall Study|Lack of Efficacy|0
1048559|NCT01817530|2087329|FG003|Overall Study|Lack of Efficacy|0
1048560|NCT01817530|2087330|FG004|Overall Study|Lack of Efficacy|0
1048561|NCT01817530|2087331|FG005|Overall Study|Lack of Efficacy|1
1048562|NCT01817530|2087332|FG006|Overall Study|Lack of Efficacy|0
1048563|NCT01817530|2087333|FG007|Overall Study|Lack of Efficacy|1
1048564|NCT01817530|2087326|FG000|Overall Study|Pregnancy|0
1048565|NCT01817530|2087327|FG001|Overall Study|Pregnancy|0
1048566|NCT01817530|2087328|FG002|Overall Study|Pregnancy|0
1048567|NCT01817530|2087329|FG003|Overall Study|Pregnancy|0
1048568|NCT01817530|2087330|FG004|Overall Study|Pregnancy|0
1048569|NCT01817530|2087331|FG005|Overall Study|Pregnancy|1
1048570|NCT01817530|2087332|FG006|Overall Study|Pregnancy|0
1048571|NCT01817530|2087333|FG007|Overall Study|Pregnancy|0
1048572|NCT01817530|2087326|FG000|Overall Study|Other|0
1048573|NCT01817530|2087327|FG001|Overall Study|Other|1
1048574|NCT01817530|2087328|FG002|Overall Study|Other|0
1048575|NCT01817530|2087329|FG003|Overall Study|Other|0
1048576|NCT01817530|2087330|FG004|Overall Study|Other|1
1048577|NCT01817530|2087331|FG005|Overall Study|Other|0
1048578|NCT01817530|2087332|FG006|Overall Study|Other|5
1048579|NCT01817530|2087333|FG007|Overall Study|Other|0
1048580|NCT01817530|2087326|FG000|Overall Study|Surgery or Invasive Intervention|1
1048581|NCT01817530|2087327|FG001|Overall Study|Surgery or Invasive Intervention|0
1048582|NCT01817530|2087328|FG002|Overall Study|Surgery or Invasive Intervention|0
1048583|NCT01817530|2087329|FG003|Overall Study|Surgery or Invasive Intervention|0
1048584|NCT01817530|2087330|FG004|Overall Study|Surgery or Invasive Intervention|1
1048585|NCT01817530|2087331|FG005|Overall Study|Surgery or Invasive Intervention|1
1048586|NCT01817530|2087332|FG006|Overall Study|Surgery or Invasive Intervention|1
1048587|NCT01817530|2087333|FG007|Overall Study|Surgery or Invasive Intervention|0
1048588|NCT01817530|2087326|FG000|Overall Study|Consent Withdrawn by Subject|3
1048589|NCT01817530|2087327|FG001|Overall Study|Consent Withdrawn by Subject|4
1048590|NCT01817530|2087328|FG002|Overall Study|Consent Withdrawn by Subject|7
1048591|NCT01817530|2087329|FG003|Overall Study|Consent Withdrawn by Subject|3
1048592|NCT01817530|2087330|FG004|Overall Study|Consent Withdrawn by Subject|5
1048593|NCT01817530|2087331|FG005|Overall Study|Consent Withdrawn by Subject|3
1048594|NCT01817530|2087332|FG006|Overall Study|Consent Withdrawn by Subject|3
1048595|NCT01817530|2087333|FG007|Overall Study|Consent Withdrawn by Subject|10
1048596|NCT01817530|2087326|FG000|Overall Study|Lost to Follow-up|1
1048597|NCT01817530|2087327|FG001|Overall Study|Lost to Follow-up|4
1048598|NCT01817530|2087328|FG002|Overall Study|Lost to Follow-up|2
1048599|NCT01817530|2087329|FG003|Overall Study|Lost to Follow-up|1
1048600|NCT01817530|2087330|FG004|Overall Study|Lost to Follow-up|3
1048601|NCT01817530|2087331|FG005|Overall Study|Lost to Follow-up|2
1048602|NCT01817530|2087332|FG006|Overall Study|Lost to Follow-up|8
1048603|NCT01817530|2087333|FG007|Overall Study|Lost to Follow-up|4
1048604|NCT01817582|2087354|FG000|Overall Study|Withdrawal by Subject|0
1048605|NCT01817582|2087355|FG001|Overall Study|Withdrawal by Subject|1
1048606|NCT01817582|2087356|FG002|Overall Study|Withdrawal by Subject|0
1048607|NCT01817582|2087354|FG000|Overall Study|Participant revealed masked treatment|1
1048608|NCT01817582|2087355|FG001|Overall Study|Participant revealed masked treatment|0
1048609|NCT01817582|2087356|FG002|Overall Study|Participant revealed masked treatment|0
1048610|NCT01817582|2087354|FG000|Overall Study|Randomized but exclusion criteria met|1
1048611|NCT01817582|2087355|FG001|Overall Study|Randomized but exclusion criteria met|0
1048612|NCT01817582|2087356|FG002|Overall Study|Randomized but exclusion criteria met|0
1048613|NCT01817725|2087373|FG000|Overall Study|Withdrawal by Subject|1
1048614|NCT01817751|2087377|FG000|Overall Study|Physician Decision|1
1048615|NCT01817764|2087383|FG000|Overall Study|Adverse Event|7
1048616|NCT01817764|2087384|FG001|Overall Study|Adverse Event|10
1048617|NCT01817764|2087383|FG000|Overall Study|Lack of Efficacy|9
1048618|NCT01817764|2087384|FG001|Overall Study|Lack of Efficacy|7
1048619|NCT01817764|2087383|FG000|Overall Study|Protocol Violation|7
1048620|NCT01817764|2087384|FG001|Overall Study|Protocol Violation|5
1048621|NCT01817764|2087383|FG000|Overall Study|Lost to Follow-up|1
1048622|NCT01817764|2087384|FG001|Overall Study|Lost to Follow-up|4
1048623|NCT01817764|2087383|FG000|Overall Study|Withdrawal by Subject|10
1048624|NCT01817764|2087384|FG001|Overall Study|Withdrawal by Subject|12
1048625|NCT01817777|2087392|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3
1048626|NCT01817777|2087393|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0
1048627|NCT01817777|2087394|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0
1048628|NCT01817777|2087392|FG000|Observational Phase (8 Weeks)|Early Study Termination|2
1048629|NCT01817777|2087393|FG001|Observational Phase (8 Weeks)|Early Study Termination|0
1048630|NCT01817777|2087394|FG002|Observational Phase (8 Weeks)|Early Study Termination|0
1048631|NCT01817777|2087392|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
1048632|NCT01817777|2087393|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
1048633|NCT01817777|2087394|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
1048634|NCT01817777|2087392|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0
1048635|NCT01817777|2087393|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1
1048636|NCT01817777|2087394|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2
1048637|NCT01817777|2087392|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0
1048638|NCT01817777|2087393|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1
1048639|NCT01817777|2087394|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3
1048640|NCT01817790|2087402|FG000|Overall Study|Adverse Event|0
1048641|NCT01817790|2087403|FG001|Overall Study|Adverse Event|2
1048642|NCT01817790|2087402|FG000|Overall Study|Lost to Follow-up|0
1048643|NCT01817790|2087403|FG001|Overall Study|Lost to Follow-up|1
1048644|NCT01817790|2087402|FG000|Overall Study|Protocol Violation|2
1048645|NCT01817790|2087403|FG001|Overall Study|Protocol Violation|1
1048646|NCT01817790|2087402|FG000|Overall Study|Withdrawal by Subject|1
1048647|NCT01817790|2087403|FG001|Overall Study|Withdrawal by Subject|3
1048648|NCT01817790|2087402|FG000|Overall Study|Other: Could not attend appointment|1
1048649|NCT01817790|2087403|FG001|Overall Study|Other: Could not attend appointment|1
1048650|NCT01817959|2087445|FG000|Overall Study|Graft loss|1
1048651|NCT01817959|2087446|FG001|Overall Study|Graft loss|1
1048652|NCT01817959|2087445|FG000|Overall Study|forbidden medication|1
1048653|NCT01817959|2087446|FG001|Overall Study|forbidden medication|1
1048654|NCT01817959|2087445|FG000|Overall Study|Adverse Event|1
1048655|NCT01817959|2087446|FG001|Overall Study|Adverse Event|0
1048656|NCT01817959|2087445|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1
1048657|NCT01817959|2087446|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1
1048658|NCT01818141|2087463|FG000|Overall Study|Withdrawal by Subject|2
1048659|NCT01818141|2087464|FG001|Overall Study|Withdrawal by Subject|0
1048660|NCT01818141|2087463|FG000|Overall Study|No baseline C.diff colonies|1
1048661|NCT01818141|2087464|FG001|Overall Study|No baseline C.diff colonies|1
1048662|NCT01818141|2087463|FG000|Overall Study|Lost to Follow-up|0
1048663|NCT01818141|2087464|FG001|Overall Study|Lost to Follow-up|2
1048664|NCT01818258|2087486|FG000|Overall Study|Death|3
1048665|NCT01818258|2087487|FG001|Overall Study|Death|0
1048666|NCT01818258|2087486|FG000|Overall Study|Withdrawal by Subject|0
1048667|NCT01818258|2087487|FG001|Overall Study|Withdrawal by Subject|1
1048668|NCT01818258|2087486|FG000|Overall Study|Lost to Follow-up|0
1048669|NCT01818258|2087487|FG001|Overall Study|Lost to Follow-up|1
1048670|NCT01818258|2087486|FG000|Overall Study|Unable to Travel to Clinic|0
1048671|NCT01818258|2087487|FG001|Overall Study|Unable to Travel to Clinic|1
1048672|NCT01818284|2087496|FG000|Overall Study|Not eligible due to White Blood Counts|4
1048673|NCT01818284|2087497|FG001|Overall Study|Not eligible due to White Blood Counts|4
1048674|NCT01818284|2087496|FG000|Overall Study|Death|0
1048675|NCT01818284|2087497|FG001|Overall Study|Death|2
1048676|NCT01818297|2087504|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
1048677|NCT01818297|2087505|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
1048678|NCT01818297|2087504|FG000|Open Label Phase (3-12 Months)|Physician Decision|1
1048679|NCT01818297|2087505|FG001|Open Label Phase (3-12 Months)|Physician Decision|0
1048680|NCT01818297|2087504|FG000|Open Label Phase (3-12 Months)|Early study closure|17
1048681|NCT01818297|2087505|FG001|Open Label Phase (3-12 Months)|Early study closure|10
1048682|NCT01818336|2087511|FG000|Overall Study|Declined retest visit|0
1048683|NCT01818336|2087512|FG001|Overall Study|Declined retest visit|11
1048684|NCT01818336|2087511|FG000|Overall Study|Lost to Follow-up|0
1048685|NCT01818336|2087512|FG001|Overall Study|Lost to Follow-up|1
1048686|NCT01818492|2087538|FG000|Overall Study|Adverse Event|2
1048687|NCT01818492|2087538|FG000|Overall Study|Death|3
1048688|NCT01818492|2087538|FG000|Overall Study|Withdrawal by Subject|1
1048689|NCT01818492|2087538|FG000|Overall Study|Additional therapy when not allowed PP|4
1048690|NCT01818531|2087570|FG000|Overall Study|Withdrawn for case delay after block|1
1048691|NCT01818531|2087571|FG001|Overall Study|Withdrawn for case delay after block|0
1048692|NCT01818531|2087570|FG000|Overall Study|Withdrawn for long-acting opioid patch|0
1048693|NCT01818531|2087571|FG001|Overall Study|Withdrawn for long-acting opioid patch|1
1048694|NCT01818531|2087570|FG000|Overall Study|Withdrawn for failure to place block|0
1048695|NCT01818531|2087571|FG001|Overall Study|Withdrawn for failure to place block|1
1048696|NCT01818596|2087579|FG000|Overall Study|Enrolled but Not Treated|4
1048697|NCT01818596|2087580|FG001|Overall Study|Enrolled but Not Treated|0
1048698|NCT01818596|2087579|FG000|Overall Study|Adverse Event|7
1048699|NCT01818596|2087580|FG001|Overall Study|Adverse Event|0
1048700|NCT01818596|2087579|FG000|Overall Study|Death|3
1048701|NCT01818596|2087580|FG001|Overall Study|Death|0
1048702|NCT01818596|2087579|FG000|Overall Study|Investigator's Discretion|4
1048703|NCT01818596|2087580|FG001|Overall Study|Investigator's Discretion|0
1048704|NCT01818596|2087579|FG000|Overall Study|Protocol Violation|1
1048705|NCT01818596|2087580|FG001|Overall Study|Protocol Violation|0
1048706|NCT01818596|2087579|FG000|Overall Study|Withdrew Consent|5
1048707|NCT01818596|2087580|FG001|Overall Study|Withdrew Consent|0
1048708|NCT01818596|2087579|FG000|Overall Study|Lost to Follow-up|7
1048709|NCT01818596|2087580|FG001|Overall Study|Lost to Follow-up|0
1048710|NCT01818700|2087587|FG000|Overall Study|Adverse Event|67
1048711|NCT01818700|2087587|FG000|Overall Study|Lack of Efficacy|2
1048712|NCT01818700|2087587|FG000|Overall Study|Lost to Follow-up|5
1048713|NCT01818700|2087587|FG000|Overall Study|Withdrawal by Subject|27
1048714|NCT01818700|2087587|FG000|Overall Study|Protocol Violation|2
1048715|NCT01818700|2087587|FG000|Overall Study|Other|1
1048716|NCT01818726|2087595|FG000|Overall Study|Administrative reasons|5
1048717|NCT01818726|2087596|FG001|Overall Study|Administrative reasons|1
1048718|NCT01818726|2087595|FG000|Overall Study|Withdrawal by Subject|0
1048719|NCT01818726|2087596|FG001|Overall Study|Withdrawal by Subject|1
1048720|NCT01818726|2087595|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1
1048721|NCT01818726|2087596|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0
1048722|NCT01818752|2087609|FG000|Overall Study|Adverse Event|64
1048723|NCT01818752|2087610|FG001|Overall Study|Adverse Event|74
1048724|NCT01818752|2087609|FG000|Overall Study|Death|14
1048725|NCT01818752|2087610|FG001|Overall Study|Death|18
1048726|NCT01818752|2087609|FG000|Overall Study|Non-compliance|16
1048727|NCT01818752|2087610|FG001|Overall Study|Non-compliance|20
1048728|NCT01818752|2087609|FG000|Overall Study|Withdrawal by Subject|15
1048729|NCT01818752|2087610|FG001|Overall Study|Withdrawal by Subject|14
1048730|NCT01818752|2087609|FG000|Overall Study|Physician Decision|9
1048731|NCT01818752|2087610|FG001|Overall Study|Physician Decision|8
1048732|NCT01818752|2087609|FG000|Overall Study|Disease Progression|54
1048733|NCT01818752|2087610|FG001|Overall Study|Disease Progression|48
1048734|NCT01818752|2087609|FG000|Overall Study|Other|7
1048735|NCT01818752|2087610|FG001|Overall Study|Other|8
1048736|NCT01818752|2087609|FG000|Overall Study|Continuing Treatment|1
1048737|NCT01818752|2087610|FG001|Overall Study|Continuing Treatment|4
1048738|NCT01818752|2087609|FG000|Overall Study|Randomized but not Dosed|7
1048739|NCT01818752|2087610|FG001|Overall Study|Randomized but not Dosed|4
1048740|NCT01818765|2087616|FG000|Overall Study|Death|2
1048741|NCT01819129|2087632|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
1048742|NCT01819129|2087633|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
1048743|NCT01819129|2087632|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1
1048744|NCT01819129|2087633|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0
1048745|NCT01819129|2087632|FG000|Overall Study|Other, Subject moved out of the country|0
1048746|NCT01819129|2087633|FG001|Overall Study|Other, Subject moved out of the country|1
1048747|NCT01819129|2087632|FG000|Overall Study|Withdrawal by Subject|15
1048748|NCT01819129|2087633|FG001|Overall Study|Withdrawal by Subject|15
1048749|NCT01819129|2087632|FG000|Overall Study|Lost to Follow-up|5
1048750|NCT01819129|2087633|FG001|Overall Study|Lost to Follow-up|2
1048751|NCT01819129|2087632|FG000|Overall Study|Lack of Efficacy|0
1048752|NCT01819129|2087633|FG001|Overall Study|Lack of Efficacy|1
1048753|NCT01819129|2087632|FG000|Overall Study|Adverse Event|1
1048754|NCT01819129|2087633|FG001|Overall Study|Adverse Event|4
1048755|NCT01819129|2087632|FG000|Overall Study|Death|1
1048756|NCT01819129|2087633|FG001|Overall Study|Death|1
1048757|NCT01819129|2087632|FG000|Overall Study|Withdrawal Criteria|20
1048758|NCT01819129|2087633|FG001|Overall Study|Withdrawal Criteria|15
1048759|NCT01819194|2087639|FG000|Overall Study|Loss of study articles|2
1048760|NCT01819272|2087653|FG000|Overall Study|Adverse Event|1
1048761|NCT01819272|2087654|FG001|Overall Study|Adverse Event|0
1048762|NCT01819272|2087655|FG002|Overall Study|Adverse Event|0
1048763|NCT01819272|2087656|FG003|Overall Study|Adverse Event|2
1048764|NCT01819272|2087657|FG004|Overall Study|Adverse Event|0
1048765|NCT01819272|2087658|FG005|Overall Study|Adverse Event|0
1048766|NCT01819272|2087653|FG000|Overall Study|Lost to Follow-up|3
1048767|NCT01819272|2087654|FG001|Overall Study|Lost to Follow-up|0
1048768|NCT01819272|2087655|FG002|Overall Study|Lost to Follow-up|1
1048769|NCT01819272|2087656|FG003|Overall Study|Lost to Follow-up|0
1048770|NCT01819272|2087657|FG004|Overall Study|Lost to Follow-up|0
1048771|NCT01819272|2087658|FG005|Overall Study|Lost to Follow-up|3
1048772|NCT01819272|2087653|FG000|Overall Study|Protocol Violation|0
1048773|NCT01819272|2087654|FG001|Overall Study|Protocol Violation|0
1048774|NCT01819272|2087655|FG002|Overall Study|Protocol Violation|0
1048775|NCT01819272|2087656|FG003|Overall Study|Protocol Violation|1
1048776|NCT01819272|2087657|FG004|Overall Study|Protocol Violation|2
1048777|NCT01819272|2087658|FG005|Overall Study|Protocol Violation|3
1048778|NCT01819272|2087653|FG000|Overall Study|Physician Decision|0
1048779|NCT01819272|2087654|FG001|Overall Study|Physician Decision|1
1048780|NCT01819272|2087655|FG002|Overall Study|Physician Decision|0
1048781|NCT01819272|2087656|FG003|Overall Study|Physician Decision|0
1048782|NCT01819272|2087657|FG004|Overall Study|Physician Decision|0
906712|NCT00770601|1882554|FG000|Overall Study|Withdrawal by Subject|1
906713|NCT00770653|1882560|FG000|Overall Study|Adverse Event|13
906714|NCT00770653|1882561|FG001|Overall Study|Adverse Event|5
906715|NCT00770653|1882560|FG000|Overall Study|Protocol Violation|8
906716|NCT00770653|1882561|FG001|Overall Study|Protocol Violation|6
906717|NCT00770653|1882560|FG000|Overall Study|Withdrawal by Subject|4
906718|NCT00770653|1882561|FG001|Overall Study|Withdrawal by Subject|7
906719|NCT00770653|1882560|FG000|Overall Study|Lack of Compliance|1
906720|NCT00770653|1882561|FG001|Overall Study|Lack of Compliance|4
906721|NCT00770653|1882560|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2
906722|NCT00770653|1882561|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2
906723|NCT00770653|1882560|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2
906724|NCT00770653|1882561|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1
906725|NCT00770653|1882560|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0
906726|NCT00770653|1882561|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2
906727|NCT00770653|1882560|FG000|Overall Study|Lost to Follow-up|1
906728|NCT00770653|1882561|FG001|Overall Study|Lost to Follow-up|2
906729|NCT00770653|1882560|FG000|Overall Study|Physician Decision|1
906730|NCT00770653|1882561|FG001|Overall Study|Physician Decision|0
906731|NCT00770679|1882567|FG000|Overall Study|Lost to Follow-up|3
906732|NCT00770679|1882567|FG000|Overall Study|Follow-up LDL measurement not collected|3
906733|NCT00770692|1882575|FG000|Overall Study|Withdrawal by Subject|7
906734|NCT00770692|1882576|FG001|Overall Study|Withdrawal by Subject|9
906735|NCT00770692|1882577|FG002|Overall Study|Withdrawal by Subject|9
906736|NCT00770692|1882578|FG003|Overall Study|Withdrawal by Subject|6
906737|NCT00770692|1882575|FG000|Overall Study|Adverse Event|3
906738|NCT00770692|1882576|FG001|Overall Study|Adverse Event|0
906739|NCT00770692|1882577|FG002|Overall Study|Adverse Event|4
906740|NCT00770692|1882578|FG003|Overall Study|Adverse Event|4
906741|NCT00770692|1882575|FG000|Overall Study|Investigator judgment|2
906742|NCT00770692|1882576|FG001|Overall Study|Investigator judgment|0
906743|NCT00770692|1882577|FG002|Overall Study|Investigator judgment|1
906744|NCT00770692|1882578|FG003|Overall Study|Investigator judgment|1
906745|NCT00770770|1882594|FG000|Overall Study|Lost to Follow-up|1
906746|NCT00770770|1882595|FG001|Overall Study|Lost to Follow-up|0
906747|NCT00770770|1882594|FG000|Overall Study|Withdrawal by Subject|1
906748|NCT00770770|1882595|FG001|Overall Study|Withdrawal by Subject|0
906749|NCT00770770|1882594|FG000|Overall Study|Death|0
906750|NCT00770770|1882595|FG001|Overall Study|Death|1
906751|NCT00770770|1882594|FG000|Overall Study|Study Terminated|8
906752|NCT00770770|1882595|FG001|Overall Study|Study Terminated|0
906753|NCT00770809|1882604|FG000|Overall Study|Adverse Event|9
906754|NCT00770809|1882605|FG001|Overall Study|Adverse Event|1
906755|NCT00770809|1882606|FG002|Overall Study|Adverse Event|12
906756|NCT00770809|1882604|FG000|Overall Study|Death|1
906757|NCT00770809|1882605|FG001|Overall Study|Death|0
906758|NCT00770809|1882606|FG002|Overall Study|Death|0
906759|NCT00770809|1882604|FG000|Overall Study|Withdrawal by Subject|3
906760|NCT00770809|1882605|FG001|Overall Study|Withdrawal by Subject|3
906761|NCT00770809|1882606|FG002|Overall Study|Withdrawal by Subject|7
1048783|NCT01819272|2087658|FG005|Overall Study|Physician Decision|0
1048784|NCT01819272|2087653|FG000|Overall Study|Withdrawal of Consent|0
1048785|NCT01819272|2087654|FG001|Overall Study|Withdrawal of Consent|1
1048786|NCT01819272|2087655|FG002|Overall Study|Withdrawal of Consent|2
1048787|NCT01819272|2087656|FG003|Overall Study|Withdrawal of Consent|1
1048788|NCT01819272|2087657|FG004|Overall Study|Withdrawal of Consent|0
1048789|NCT01819272|2087658|FG005|Overall Study|Withdrawal of Consent|1
1048790|NCT01819272|2087653|FG000|Overall Study|Loss of Glucose Control|2
1048791|NCT01819272|2087654|FG001|Overall Study|Loss of Glucose Control|1
1048792|NCT01819272|2087655|FG002|Overall Study|Loss of Glucose Control|0
1048793|NCT01819272|2087656|FG003|Overall Study|Loss of Glucose Control|1
1048794|NCT01819272|2087657|FG004|Overall Study|Loss of Glucose Control|2
1048795|NCT01819272|2087658|FG005|Overall Study|Loss of Glucose Control|0
1048796|NCT01819506|2087700|FG000|Overall Study|Physician Decision|5
1048797|NCT01819506|2087701|FG001|Overall Study|Physician Decision|2
1048798|NCT01819506|2087700|FG000|Overall Study|Withdrawal by Subject|3
1048799|NCT01819506|2087701|FG001|Overall Study|Withdrawal by Subject|3
1048800|NCT01819727|2087713|FG000|Overall Study|Adverse Event|8
1048801|NCT01819727|2087714|FG001|Overall Study|Adverse Event|9
1048802|NCT01819727|2087713|FG000|Overall Study|Death|1
1048803|NCT01819727|2087714|FG001|Overall Study|Death|0
1048804|NCT01819727|2087713|FG000|Overall Study|Lost to Follow-up|1
1048805|NCT01819727|2087714|FG001|Overall Study|Lost to Follow-up|1
1048806|NCT01819727|2087713|FG000|Overall Study|Physician Decision|3
1048807|NCT01819727|2087714|FG001|Overall Study|Physician Decision|2
1048808|NCT01819727|2087713|FG000|Overall Study|Pregnancy|1
1048809|NCT01819727|2087714|FG001|Overall Study|Pregnancy|0
1048810|NCT01819727|2087713|FG000|Overall Study|Protocol Violation|0
1048811|NCT01819727|2087714|FG001|Overall Study|Protocol Violation|2
1048812|NCT01819727|2087713|FG000|Overall Study|Study Terminated by Sponsor|0
1048813|NCT01819727|2087714|FG001|Overall Study|Study Terminated by Sponsor|1
1048814|NCT01819727|2087713|FG000|Overall Study|Withdrawal by Subject|6
1048815|NCT01819727|2087714|FG001|Overall Study|Withdrawal by Subject|11
1048816|NCT01819727|2087713|FG000|Overall Study|Unable to demostrate ability self-inject|0
1048817|NCT01819727|2087714|FG001|Overall Study|Unable to demostrate ability self-inject|1
1048818|NCT01819727|2087713|FG000|Overall Study|Quit due to lack of health benifits|0
1048819|NCT01819727|2087714|FG001|Overall Study|Quit due to lack of health benifits|1
1048820|NCT01820260|2087763|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048821|NCT01820260|2087764|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048822|NCT01820260|2087765|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048823|NCT01820260|2087766|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048824|NCT01820260|2087767|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048825|NCT01820260|2087768|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048826|NCT01820260|2087769|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1
1048827|NCT01820260|2087770|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048828|NCT01820260|2087771|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048829|NCT01820260|2087772|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048830|NCT01820260|2087773|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048831|NCT01820260|2087774|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048832|NCT01820260|2087775|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048833|NCT01820260|2087776|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
1048834|NCT01820260|2087763|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0
1048835|NCT01820260|2087764|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0
1048836|NCT01820260|2087765|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0
1048837|NCT01820260|2087766|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0
1048838|NCT01820260|2087767|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0
1048839|NCT01820260|2087768|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0
1048840|NCT01820260|2087769|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0
1048841|NCT01820260|2087770|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0
1048842|NCT01820260|2087771|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0
1048843|NCT01820260|2087772|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1
1048844|NCT01820260|2087773|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0
1048845|NCT01820260|2087774|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0
1048846|NCT01820260|2087775|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0
1048847|NCT01820260|2087776|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0
1048848|NCT01820364|2087812|FG000|Part I: LGX818|Death|1
1048849|NCT01820364|2087813|FG001|Part I: LGX818|Death|0
1048850|NCT01820364|2087812|FG000|Part I: LGX818|Administrative Problems|3
1048851|NCT01820364|2087813|FG001|Part I: LGX818|Administrative Problems|0
1048852|NCT01820364|2087812|FG000|Part I: LGX818|Adverse Event|6
1048853|NCT01820364|2087813|FG001|Part I: LGX818|Adverse Event|0
1048854|NCT01820364|2087812|FG000|Part I: LGX818|Disease Progression|4
1048855|NCT01820364|2087813|FG001|Part I: LGX818|Disease Progression|0
1048856|NCT01820364|2087812|FG000|Part II: LGX818 + MEK162|Study Termination|0
1048857|NCT01820364|2087813|FG001|Part II: LGX818 + MEK162|Study Termination|1
1048858|NCT01820559|2087835|FG000|Overall Study|Adverse Event|4
1048859|NCT01820559|2087836|FG001|Overall Study|Adverse Event|6
1048860|NCT01820559|2087837|FG002|Overall Study|Adverse Event|13
1048861|NCT01820559|2087835|FG000|Overall Study|Withdrawal by Subject|1
1048862|NCT01820559|2087836|FG001|Overall Study|Withdrawal by Subject|2
1048863|NCT01820559|2087837|FG002|Overall Study|Withdrawal by Subject|5
1048864|NCT01820559|2087835|FG000|Overall Study|Protocol Violation|2
1048865|NCT01820559|2087836|FG001|Overall Study|Protocol Violation|1
1048866|NCT01820559|2087837|FG002|Overall Study|Protocol Violation|3
1048867|NCT01820559|2087835|FG000|Overall Study|Subject's non-compliance|1
1048868|NCT01820559|2087836|FG001|Overall Study|Subject's non-compliance|0
1048869|NCT01820559|2087837|FG002|Overall Study|Subject's non-compliance|2
1048870|NCT01820559|2087835|FG000|Overall Study|Lost to Follow-up|3
1048871|NCT01820559|2087836|FG001|Overall Study|Lost to Follow-up|2
1048872|NCT01820559|2087837|FG002|Overall Study|Lost to Follow-up|2
1048873|NCT01820559|2087835|FG000|Overall Study|At sponsor request|0
1048874|NCT01820559|2087836|FG001|Overall Study|At sponsor request|0
1048875|NCT01820559|2087837|FG002|Overall Study|At sponsor request|1
1048876|NCT01820559|2087835|FG000|Overall Study|Lack of Efficacy|3
1048877|NCT01820559|2087836|FG001|Overall Study|Lack of Efficacy|2
1048878|NCT01820559|2087837|FG002|Overall Study|Lack of Efficacy|3
1048879|NCT01820572|2087847|FG000|Randomization|Not Treated|2
1048880|NCT01820572|2087848|FG001|Randomization|Not Treated|1
1048881|NCT01820572|2087847|FG000|Treatment Period|Adverse Event|12
1048882|NCT01820572|2087848|FG001|Treatment Period|Adverse Event|7
1048883|NCT01820572|2087847|FG000|Treatment Period|Death|3
1048884|NCT01820572|2087848|FG001|Treatment Period|Death|3
1048885|NCT01820572|2087847|FG000|Treatment Period|Lack of Efficacy|1
1048886|NCT01820572|2087848|FG001|Treatment Period|Lack of Efficacy|0
1048887|NCT01820572|2087847|FG000|Treatment Period|poor/non compliance|0
1048888|NCT01820572|2087848|FG001|Treatment Period|poor/non compliance|3
1048889|NCT01820572|2087847|FG000|Treatment Period|request to discontinue|6
1048890|NCT01820572|2087848|FG001|Treatment Period|request to discontinue|11
1048891|NCT01820572|2087847|FG000|Treatment Period|No longer meets study criteria|3
1048892|NCT01820572|2087848|FG001|Treatment Period|No longer meets study criteria|10
1048893|NCT01820572|2087847|FG000|Treatment Period|withdrew consent|1
1048894|NCT01820572|2087848|FG001|Treatment Period|withdrew consent|2
1048895|NCT01820585|2087858|FG000|Overall Study|Adverse Event|9
1048896|NCT01820585|2087859|FG001|Overall Study|Adverse Event|13
1048897|NCT01820585|2087860|FG002|Overall Study|Adverse Event|23
1048898|NCT01820585|2087861|FG003|Overall Study|Adverse Event|34
1048899|NCT01820585|2087858|FG000|Overall Study|Lack of Efficacy|9
1048900|NCT01820585|2087859|FG001|Overall Study|Lack of Efficacy|7
1048901|NCT01820585|2087860|FG002|Overall Study|Lack of Efficacy|5
1048902|NCT01820585|2087861|FG003|Overall Study|Lack of Efficacy|1
1048903|NCT01820585|2087858|FG000|Overall Study|Withdrawal by Subject|3
1048904|NCT01820585|2087859|FG001|Overall Study|Withdrawal by Subject|7
1048905|NCT01820585|2087860|FG002|Overall Study|Withdrawal by Subject|3
1048906|NCT01820585|2087861|FG003|Overall Study|Withdrawal by Subject|8
1048907|NCT01820585|2087858|FG000|Overall Study|Lost to Follow-up|3
1048908|NCT01820585|2087859|FG001|Overall Study|Lost to Follow-up|3
1048909|NCT01820585|2087860|FG002|Overall Study|Lost to Follow-up|0
1048910|NCT01820585|2087861|FG003|Overall Study|Lost to Follow-up|3
1048911|NCT01820585|2087858|FG000|Overall Study|Protocol Violation|3
1048912|NCT01820585|2087859|FG001|Overall Study|Protocol Violation|1
1048913|NCT01820585|2087860|FG002|Overall Study|Protocol Violation|1
1048914|NCT01820585|2087861|FG003|Overall Study|Protocol Violation|1
1048915|NCT01820585|2087858|FG000|Overall Study|Subject non-compliance|0
1048916|NCT01820585|2087859|FG001|Overall Study|Subject non-compliance|0
1048917|NCT01820585|2087860|FG002|Overall Study|Subject non-compliance|1
1048918|NCT01820585|2087861|FG003|Overall Study|Subject non-compliance|2
1048919|NCT01820585|2087858|FG000|Overall Study|at sponsor request|0
1048920|NCT01820585|2087859|FG001|Overall Study|at sponsor request|0
1048921|NCT01820585|2087860|FG002|Overall Study|at sponsor request|1
1048922|NCT01820585|2087861|FG003|Overall Study|at sponsor request|0
1048923|NCT01820585|2087858|FG000|Overall Study|Pregnancy|0
1048924|NCT01820585|2087859|FG001|Overall Study|Pregnancy|1
1048925|NCT01820585|2087860|FG002|Overall Study|Pregnancy|0
1048926|NCT01820585|2087861|FG003|Overall Study|Pregnancy|0
1048927|NCT01820637|2087871|FG000|Overall Study|Death|2
1048928|NCT01820637|2087871|FG000|Overall Study|Withdrawal by Subject|1
1048929|NCT01821118|2087885|FG000|Overall Study|Death|0
1048930|NCT01821118|2087886|FG001|Overall Study|Death|1
1048931|NCT01821391|2087940|FG000|Overall Study|Adverse Event|1
1048932|NCT01821391|2087941|FG001|Overall Study|Adverse Event|0
1048933|NCT01821560|2087964|FG000|Overall Study|Lost to Follow-up|5
906762|NCT00770809|1882604|FG000|Overall Study|Progression|2
906763|NCT00770809|1882605|FG001|Overall Study|Progression|2
906764|NCT00770809|1882606|FG002|Overall Study|Progression|0
906765|NCT00770809|1882604|FG000|Overall Study|Complicating illness|0
906766|NCT00770809|1882605|FG001|Overall Study|Complicating illness|0
906767|NCT00770809|1882606|FG002|Overall Study|Complicating illness|1
906768|NCT00770809|1882604|FG000|Overall Study|Other Medical Reasons|2
906769|NCT00770809|1882605|FG001|Overall Study|Other Medical Reasons|4
906770|NCT00770809|1882606|FG002|Overall Study|Other Medical Reasons|3
906771|NCT00770913|1882635|FG000|Overall Study|Adverse Event|1
906772|NCT00770913|1882636|FG001|Overall Study|Adverse Event|3
906773|NCT00770913|1882637|FG002|Overall Study|Adverse Event|6
906774|NCT00770913|1882635|FG000|Overall Study|Refusal to continue participation|6
1048934|NCT01821560|2087965|FG001|Overall Study|Lost to Follow-up|5
1048935|NCT01821560|2087964|FG000|Overall Study|Withdrawal by Subject|1
1048936|NCT01821560|2087965|FG001|Overall Study|Withdrawal by Subject|1
1048937|NCT01821560|2087964|FG000|Overall Study|Protocol Violation|0
1048938|NCT01821560|2087965|FG001|Overall Study|Protocol Violation|1
1048939|NCT01821625|2087971|FG000|Overall Study|Withdrawal by Subject|2
1048940|NCT01821625|2087971|FG000|Overall Study|Lack of Efficacy|2
1048941|NCT01821625|2087971|FG000|Overall Study|Adverse Event|1
1048942|NCT01821625|2087971|FG000|Overall Study|Medical contraindication|1
1048943|NCT01821729|2087975|FG000|Overall Study|Withdrawal by Subject|1
1048944|NCT01821807|2087981|FG000|Overall Study|Lost to Follow-up|3
1048945|NCT01821807|2087982|FG001|Overall Study|Lost to Follow-up|1
1048946|NCT01821937|2087990|FG000|Overall Study|Adverse Event|0
1048947|NCT01821937|2087991|FG001|Overall Study|Adverse Event|3
1048948|NCT01822132|2088005|FG000|Overall Study|Lost to Follow-up|4
1048949|NCT01822132|2088006|FG001|Overall Study|Lost to Follow-up|2
1048950|NCT01822223|2088024|FG000|Overall Study|Death|0
1048951|NCT01822223|2088025|FG001|Overall Study|Death|1
1048952|NCT01822353|2088046|FG000|Overall Study|Adverse Event|1
1048953|NCT01822353|2088047|FG001|Overall Study|Adverse Event|3
1048954|NCT01822353|2088048|FG002|Overall Study|Adverse Event|1
1048955|NCT01822353|2088046|FG000|Overall Study|Pregnancy|0
1048956|NCT01822353|2088047|FG001|Overall Study|Pregnancy|1
1048957|NCT01822353|2088048|FG002|Overall Study|Pregnancy|0
1048958|NCT01822353|2088046|FG000|Overall Study|Withdrawal by Subject|3
1048959|NCT01822353|2088047|FG001|Overall Study|Withdrawal by Subject|1
1048960|NCT01822353|2088048|FG002|Overall Study|Withdrawal by Subject|0
1048961|NCT01822366|2088063|FG000|Overall Study|Lost to Follow-up|5
1048962|NCT01822366|2088064|FG001|Overall Study|Lost to Follow-up|1
1048963|NCT01822366|2088065|FG002|Overall Study|Lost to Follow-up|5
1048964|NCT01822366|2088066|FG003|Overall Study|Lost to Follow-up|1
1048965|NCT01822366|2088063|FG000|Overall Study|Withdrawal by Subject|0
1048966|NCT01822366|2088064|FG001|Overall Study|Withdrawal by Subject|6
1048967|NCT01822366|2088065|FG002|Overall Study|Withdrawal by Subject|0
1048968|NCT01822366|2088066|FG003|Overall Study|Withdrawal by Subject|6
1048969|NCT01822366|2088063|FG000|Overall Study|Partial Intervention Completion|0
1048970|NCT01822366|2088064|FG001|Overall Study|Partial Intervention Completion|15
1048971|NCT01822366|2088065|FG002|Overall Study|Partial Intervention Completion|0
1048972|NCT01822366|2088066|FG003|Overall Study|Partial Intervention Completion|15
1048973|NCT01822496|2088107|FG000|Overall Study|Protocol Violation|2
1048974|NCT01822496|2088108|FG001|Overall Study|Protocol Violation|2
1048975|NCT01822496|2088109|FG002|Overall Study|Protocol Violation|0
1048976|NCT01822496|2088110|FG003|Overall Study|Protocol Violation|1
1048977|NCT01822496|2088107|FG000|Overall Study|Withdrawal by Subject|0
1048978|NCT01822496|2088108|FG001|Overall Study|Withdrawal by Subject|0
1048979|NCT01822496|2088109|FG002|Overall Study|Withdrawal by Subject|0
1048980|NCT01822496|2088110|FG003|Overall Study|Withdrawal by Subject|3
1048981|NCT01822535|2088122|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
1048982|NCT01822535|2088123|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
1048983|NCT01822535|2088122|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
1048984|NCT01822535|2088123|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
1048985|NCT01822535|2088122|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
1048986|NCT01822535|2088123|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
1048987|NCT01822561|2088141|FG000|Overall Study|Withdrawal by Subject|2
1048988|NCT01822587|2088165|FG000|Overall Study|Lost to Follow-up|7
1048989|NCT01822587|2088166|FG001|Overall Study|Lost to Follow-up|9
1048990|NCT01822587|2088167|FG002|Overall Study|Lost to Follow-up|12
1048991|NCT01822587|2088165|FG000|Overall Study|Physician Decision|9
1048992|NCT01822587|2088166|FG001|Overall Study|Physician Decision|6
1048993|NCT01822587|2088167|FG002|Overall Study|Physician Decision|6
1048994|NCT01822665|2088175|FG000|Overall Study|Adverse Event|3
1048995|NCT01822665|2088175|FG000|Overall Study|Other Reason|5
1048996|NCT01822678|2088196|FG000|Overall Study|Withdrawal by Subject|5
1048997|NCT01822678|2088197|FG001|Overall Study|Withdrawal by Subject|4
1048998|NCT01822678|2088198|FG002|Overall Study|Withdrawal by Subject|4
1048999|NCT01822678|2088196|FG000|Overall Study|Adverse Event|4
1049000|NCT01822678|2088197|FG001|Overall Study|Adverse Event|3
1049001|NCT01822678|2088198|FG002|Overall Study|Adverse Event|1
1049002|NCT01822678|2088196|FG000|Overall Study|Lack of Efficacy|3
1049003|NCT01822678|2088197|FG001|Overall Study|Lack of Efficacy|6
1049004|NCT01822678|2088198|FG002|Overall Study|Lack of Efficacy|5
1049005|NCT01822678|2088196|FG000|Overall Study|Lost to Follow-up|0
1049006|NCT01822678|2088197|FG001|Overall Study|Lost to Follow-up|2
1049007|NCT01822678|2088198|FG002|Overall Study|Lost to Follow-up|1
1049008|NCT01822691|2088206|FG000|Overall Study|Withdrawal by Subject|2
1049009|NCT01822756|2088215|FG000|Overall Study|Adverse Event|0
1049010|NCT01822756|2088216|FG001|Overall Study|Adverse Event|0
1049011|NCT01822756|2088217|FG002|Overall Study|Adverse Event|0
1049012|NCT01822756|2088218|FG003|Overall Study|Adverse Event|2
1049013|NCT01822756|2088219|FG004|Overall Study|Adverse Event|0
1049014|NCT01822756|2088215|FG000|Overall Study|Disease progression|11
1049015|NCT01822756|2088216|FG001|Overall Study|Disease progression|1
1049016|NCT01822756|2088217|FG002|Overall Study|Disease progression|7
1049017|NCT01822756|2088218|FG003|Overall Study|Disease progression|2
1049018|NCT01822756|2088219|FG004|Overall Study|Disease progression|6
1049019|NCT01822756|2088215|FG000|Overall Study|Death|2
1049020|NCT01822756|2088216|FG001|Overall Study|Death|2
1049021|NCT01822756|2088217|FG002|Overall Study|Death|1
1049022|NCT01822756|2088218|FG003|Overall Study|Death|0
1049023|NCT01822756|2088219|FG004|Overall Study|Death|0
1049024|NCT01822756|2088215|FG000|Overall Study|Lost to Follow-up|1
1049025|NCT01822756|2088216|FG001|Overall Study|Lost to Follow-up|0
1049026|NCT01822756|2088217|FG002|Overall Study|Lost to Follow-up|1
1049027|NCT01822756|2088218|FG003|Overall Study|Lost to Follow-up|0
1049028|NCT01822756|2088219|FG004|Overall Study|Lost to Follow-up|1
1049029|NCT01822756|2088215|FG000|Overall Study|Physician Decision|0
1049030|NCT01822756|2088216|FG001|Overall Study|Physician Decision|1
1049031|NCT01822756|2088217|FG002|Overall Study|Physician Decision|0
1049032|NCT01822756|2088218|FG003|Overall Study|Physician Decision|0
1049033|NCT01822756|2088219|FG004|Overall Study|Physician Decision|0
1049034|NCT01822756|2088215|FG000|Overall Study|disease progression & patient preference|2
1049035|NCT01822756|2088216|FG001|Overall Study|disease progression & patient preference|0
1049036|NCT01822756|2088217|FG002|Overall Study|disease progression & patient preference|1
1049037|NCT01822756|2088218|FG003|Overall Study|disease progression & patient preference|0
1049038|NCT01822756|2088219|FG004|Overall Study|disease progression & patient preference|0
1049039|NCT01822821|2088233|FG000|Overall Study|Eligible surgery cancelled|1
1049040|NCT01822821|2088234|FG001|Overall Study|Eligible surgery cancelled|1
1049041|NCT01822821|2088233|FG000|Overall Study|Other reasons|1
1049042|NCT01822821|2088234|FG001|Overall Study|Other reasons|0
1049043|NCT01822899|2088246|FG000|Overall Study|Adverse Event|6
1049044|NCT01822899|2088247|FG001|Overall Study|Adverse Event|5
1049045|NCT01822899|2088246|FG000|Overall Study|Lack of Efficacy|6
1049046|NCT01822899|2088247|FG001|Overall Study|Lack of Efficacy|3
1049047|NCT01822899|2088246|FG000|Overall Study|Protocol Violation|6
1049048|NCT01822899|2088247|FG001|Overall Study|Protocol Violation|3
1049049|NCT01822899|2088246|FG000|Overall Study|Lost to Follow-up|1
1049050|NCT01822899|2088247|FG001|Overall Study|Lost to Follow-up|0
1049051|NCT01822899|2088246|FG000|Overall Study|Withdrawal by Subject|5
1049052|NCT01822899|2088247|FG001|Overall Study|Withdrawal by Subject|7
1049053|NCT01822925|2088257|FG000|Overall Study|Adverse Event|1
1049054|NCT01822925|2088258|FG001|Overall Study|Adverse Event|1
1049055|NCT01822925|2088259|FG002|Overall Study|Adverse Event|1
1049056|NCT01822925|2088260|FG003|Overall Study|Adverse Event|1
1049057|NCT01822925|2088257|FG000|Overall Study|Lost to Follow-up|0
1049058|NCT01822925|2088258|FG001|Overall Study|Lost to Follow-up|1
1049059|NCT01822925|2088259|FG002|Overall Study|Lost to Follow-up|0
1049060|NCT01822925|2088260|FG003|Overall Study|Lost to Follow-up|0
1049061|NCT01822925|2088257|FG000|Overall Study|Protocol Violation|1
1049062|NCT01822925|2088258|FG001|Overall Study|Protocol Violation|0
1049063|NCT01822925|2088259|FG002|Overall Study|Protocol Violation|0
1049064|NCT01822925|2088260|FG003|Overall Study|Protocol Violation|1
1049065|NCT01822925|2088257|FG000|Overall Study|Withdrawal by Subject|2
1049066|NCT01822925|2088258|FG001|Overall Study|Withdrawal by Subject|0
1049067|NCT01822925|2088259|FG002|Overall Study|Withdrawal by Subject|2
1049068|NCT01822925|2088260|FG003|Overall Study|Withdrawal by Subject|2
1049069|NCT01822925|2088257|FG000|Overall Study|Taking prohibited medication|2
1049070|NCT01822925|2088258|FG001|Overall Study|Taking prohibited medication|0
1049071|NCT01822925|2088259|FG002|Overall Study|Taking prohibited medication|0
1049072|NCT01822925|2088260|FG003|Overall Study|Taking prohibited medication|1
1049073|NCT01823107|2088270|FG000|Overall Study|Withdrawal by Subject|1
1049074|NCT01823146|2088276|FG000|Overall Study|Withdrawal by Subject|0
1049075|NCT01823146|2088277|FG001|Overall Study|Withdrawal by Subject|1
1049076|NCT01823146|2088276|FG000|Overall Study|Lost to Follow-up|2
1049077|NCT01823146|2088277|FG001|Overall Study|Lost to Follow-up|1
1049078|NCT01823224|2088285|FG000|Overall Study|Lost to Follow-up|5
1049079|NCT01823224|2088286|FG001|Overall Study|Lost to Follow-up|6
1049080|NCT01823224|2088285|FG000|Overall Study|didn't qualify|1
1049081|NCT01823224|2088286|FG001|Overall Study|didn't qualify|2
1049082|NCT01823224|2088285|FG000|Overall Study|pharmacy error|0
1049083|NCT01823224|2088286|FG001|Overall Study|pharmacy error|1
1049084|NCT01823224|2088285|FG000|Overall Study|missed med dose|0
1049085|NCT01823224|2088286|FG001|Overall Study|missed med dose|1
1049086|NCT01823224|2088285|FG000|Overall Study|Withdrawal by Subject|0
1049087|NCT01823224|2088286|FG001|Overall Study|Withdrawal by Subject|1
1049088|NCT01823289|2088294|FG000|Overall Study|Lost to Follow-up|5
1049089|NCT01823289|2088294|FG000|Overall Study|Adverse Event|5
1049090|NCT01823289|2088294|FG000|Overall Study|Lack of Efficacy|1
1049091|NCT01823289|2088294|FG000|Overall Study|Physician Decision|9
1049092|NCT01823289|2088294|FG000|Overall Study|Administered contraindicated medicine|1
1049093|NCT01823289|2088294|FG000|Overall Study|Transaminase increased more than 3 times|1
1049094|NCT01823289|2088294|FG000|Overall Study|Drug affected efficacy and safety|1
1049095|NCT01823289|2088294|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1
1049096|NCT01823328|2088300|FG000|Overall Study|Withdrawal by Subject|8
1049097|NCT01823328|2088301|FG001|Overall Study|Withdrawal by Subject|6
1049098|NCT01823341|2088307|FG000|Overall Study|Failed run-in|7
1049099|NCT01823341|2088307|FG000|Overall Study|Withdrawal by Subject|7
1049100|NCT01823341|2088307|FG000|Overall Study|Adverse Event|1
1049101|NCT01823536|2088336|FG000|Overall Study|Lost to Follow-up|1
1049102|NCT01823536|2088337|FG001|Overall Study|Lost to Follow-up|0
1049103|NCT01823536|2088338|FG002|Overall Study|Lost to Follow-up|0
1049104|NCT01823536|2088339|FG003|Overall Study|Lost to Follow-up|1
1049105|NCT01823536|2088340|FG004|Overall Study|Lost to Follow-up|1
1049106|NCT01823536|2088341|FG005|Overall Study|Lost to Follow-up|0
1049107|NCT01823536|2088336|FG000|Overall Study|Protocol Violation|0
1049108|NCT01823536|2088337|FG001|Overall Study|Protocol Violation|1
1049109|NCT01823536|2088338|FG002|Overall Study|Protocol Violation|0
1049110|NCT01823536|2088339|FG003|Overall Study|Protocol Violation|0
1049111|NCT01823536|2088340|FG004|Overall Study|Protocol Violation|0
1049112|NCT01823536|2088341|FG005|Overall Study|Protocol Violation|0
1049113|NCT01823536|2088336|FG000|Overall Study|Withdrawal by Subject|1
1049114|NCT01823536|2088337|FG001|Overall Study|Withdrawal by Subject|1
1049115|NCT01823536|2088338|FG002|Overall Study|Withdrawal by Subject|0
1049116|NCT01823536|2088339|FG003|Overall Study|Withdrawal by Subject|0
1049117|NCT01823536|2088340|FG004|Overall Study|Withdrawal by Subject|0
1049118|NCT01823536|2088341|FG005|Overall Study|Withdrawal by Subject|0
1049119|NCT01823536|2088336|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0
1049120|NCT01823536|2088337|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0
1049121|NCT01823536|2088338|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1
1049122|NCT01823536|2088339|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0
1049123|NCT01823536|2088340|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0
1049124|NCT01823536|2088341|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0
1049125|NCT01823536|2088336|FG000|Overall Study|Met exclusion criterion No 6|0
1049126|NCT01823536|2088337|FG001|Overall Study|Met exclusion criterion No 6|0
1049127|NCT01823536|2088338|FG002|Overall Study|Met exclusion criterion No 6|0
1049128|NCT01823536|2088339|FG003|Overall Study|Met exclusion criterion No 6|1
1049129|NCT01823536|2088340|FG004|Overall Study|Met exclusion criterion No 6|0
1049130|NCT01823536|2088341|FG005|Overall Study|Met exclusion criterion No 6|0
1049131|NCT01823536|2088336|FG000|Overall Study|Subject moved out of the state|0
1049132|NCT01823536|2088337|FG001|Overall Study|Subject moved out of the state|0
1049133|NCT01823536|2088338|FG002|Overall Study|Subject moved out of the state|0
1049134|NCT01823536|2088339|FG003|Overall Study|Subject moved out of the state|0
1049135|NCT01823536|2088340|FG004|Overall Study|Subject moved out of the state|1
1049136|NCT01823536|2088341|FG005|Overall Study|Subject moved out of the state|0
1049137|NCT01823679|2088392|FG000|Overall Study|Death|1
1049138|NCT01823835|2088412|FG000|Overall Study|Adverse Event|0
1049139|NCT01823835|2088413|FG001|Overall Study|Adverse Event|0
1049140|NCT01823835|2088414|FG002|Overall Study|Adverse Event|0
1049141|NCT01823835|2088415|FG003|Overall Study|Adverse Event|0
1049142|NCT01823835|2088416|FG004|Overall Study|Adverse Event|1
1049143|NCT01823835|2088417|FG005|Overall Study|Adverse Event|0
1049144|NCT01823835|2088418|FG006|Overall Study|Adverse Event|1
1049145|NCT01823835|2088419|FG007|Overall Study|Adverse Event|0
1049146|NCT01823835|2088420|FG008|Overall Study|Adverse Event|0
1049147|NCT01823835|2088421|FG009|Overall Study|Adverse Event|0
1049148|NCT01823835|2088422|FG010|Overall Study|Adverse Event|1
1049149|NCT01823835|2088423|FG011|Overall Study|Adverse Event|2
1049150|NCT01823835|2088424|FG012|Overall Study|Adverse Event|0
1049151|NCT01823835|2088425|FG013|Overall Study|Adverse Event|0
1049152|NCT01823835|2088426|FG014|Overall Study|Adverse Event|0
1049153|NCT01823835|2088412|FG000|Overall Study|Physician Decision|0
1049154|NCT01823835|2088413|FG001|Overall Study|Physician Decision|0
1049155|NCT01823835|2088414|FG002|Overall Study|Physician Decision|0
1049156|NCT01823835|2088415|FG003|Overall Study|Physician Decision|0
1049157|NCT01823835|2088416|FG004|Overall Study|Physician Decision|0
1049158|NCT01823835|2088417|FG005|Overall Study|Physician Decision|0
1049159|NCT01823835|2088418|FG006|Overall Study|Physician Decision|0
1049160|NCT01823835|2088419|FG007|Overall Study|Physician Decision|0
1049161|NCT01823835|2088420|FG008|Overall Study|Physician Decision|0
1049162|NCT01823835|2088421|FG009|Overall Study|Physician Decision|0
1049163|NCT01823835|2088422|FG010|Overall Study|Physician Decision|0
1049164|NCT01823835|2088423|FG011|Overall Study|Physician Decision|2
1049165|NCT01823835|2088424|FG012|Overall Study|Physician Decision|0
1049166|NCT01823835|2088425|FG013|Overall Study|Physician Decision|0
1049167|NCT01823835|2088426|FG014|Overall Study|Physician Decision|0
1049168|NCT01823835|2088412|FG000|Overall Study|Progressive Disease|3
1049169|NCT01823835|2088413|FG001|Overall Study|Progressive Disease|4
1049170|NCT01823835|2088414|FG002|Overall Study|Progressive Disease|3
1049171|NCT01823835|2088415|FG003|Overall Study|Progressive Disease|6
1049172|NCT01823835|2088416|FG004|Overall Study|Progressive Disease|4
1049173|NCT01823835|2088417|FG005|Overall Study|Progressive Disease|6
1049174|NCT01823835|2088418|FG006|Overall Study|Progressive Disease|5
1049175|NCT01823835|2088419|FG007|Overall Study|Progressive Disease|3
1049176|NCT01823835|2088420|FG008|Overall Study|Progressive Disease|3
1049177|NCT01823835|2088421|FG009|Overall Study|Progressive Disease|18
1049178|NCT01823835|2088422|FG010|Overall Study|Progressive Disease|8
1049179|NCT01823835|2088423|FG011|Overall Study|Progressive Disease|46
1049180|NCT01823835|2088424|FG012|Overall Study|Progressive Disease|18
1049181|NCT01823835|2088425|FG013|Overall Study|Progressive Disease|4
1049182|NCT01823835|2088426|FG014|Overall Study|Progressive Disease|6
1049183|NCT01823835|2088412|FG000|Overall Study|Study Termination|0
1049184|NCT01823835|2088413|FG001|Overall Study|Study Termination|0
1049185|NCT01823835|2088414|FG002|Overall Study|Study Termination|0
1049186|NCT01823835|2088415|FG003|Overall Study|Study Termination|0
1049187|NCT01823835|2088416|FG004|Overall Study|Study Termination|1
1049188|NCT01823835|2088417|FG005|Overall Study|Study Termination|0
1049189|NCT01823835|2088418|FG006|Overall Study|Study Termination|0
1049190|NCT01823835|2088419|FG007|Overall Study|Study Termination|0
1049191|NCT01823835|2088420|FG008|Overall Study|Study Termination|0
1049192|NCT01823835|2088421|FG009|Overall Study|Study Termination|0
1049193|NCT01823835|2088422|FG010|Overall Study|Study Termination|0
1049194|NCT01823835|2088423|FG011|Overall Study|Study Termination|1
1049195|NCT01823835|2088424|FG012|Overall Study|Study Termination|0
1049196|NCT01823835|2088425|FG013|Overall Study|Study Termination|0
1049197|NCT01823835|2088426|FG014|Overall Study|Study Termination|0
1049198|NCT01823835|2088412|FG000|Overall Study|Withdrawal by Subject|0
1049199|NCT01823835|2088413|FG001|Overall Study|Withdrawal by Subject|0
1049200|NCT01823835|2088414|FG002|Overall Study|Withdrawal by Subject|1
1049201|NCT01823835|2088415|FG003|Overall Study|Withdrawal by Subject|0
1049202|NCT01823835|2088416|FG004|Overall Study|Withdrawal by Subject|0
1049203|NCT01823835|2088417|FG005|Overall Study|Withdrawal by Subject|0
1049204|NCT01823835|2088418|FG006|Overall Study|Withdrawal by Subject|0
1049205|NCT01823835|2088419|FG007|Overall Study|Withdrawal by Subject|0
1049206|NCT01823835|2088420|FG008|Overall Study|Withdrawal by Subject|0
1049207|NCT01823835|2088421|FG009|Overall Study|Withdrawal by Subject|1
1049208|NCT01823835|2088422|FG010|Overall Study|Withdrawal by Subject|1
1049209|NCT01823835|2088423|FG011|Overall Study|Withdrawal by Subject|2
1049210|NCT01823835|2088424|FG012|Overall Study|Withdrawal by Subject|1
1049211|NCT01823835|2088425|FG013|Overall Study|Withdrawal by Subject|0
1049212|NCT01823835|2088426|FG014|Overall Study|Withdrawal by Subject|0
1049213|NCT01823991|2088477|FG000|Overall Study|Withdrawal by Subject|8
1049214|NCT01823991|2088478|FG001|Overall Study|Withdrawal by Subject|5
1049215|NCT01824290|2088507|FG000|Period 1: Double Blind|Entry Criteria Not Met|1
1049216|NCT01824290|2088508|FG001|Period 1: Double Blind|Entry Criteria Not Met|0
1049217|NCT01824290|2088509|FG002|Period 1: Double Blind|Entry Criteria Not Met|0
1049218|NCT01824290|2088510|FG003|Period 1: Double Blind|Entry Criteria Not Met|0
1049219|NCT01824290|2088507|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1
1049220|NCT01824290|2088508|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1
1049221|NCT01824290|2088509|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0
1049222|NCT01824290|2088510|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0
1049223|NCT01824290|2088507|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
1049224|NCT01824290|2088508|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
1049225|NCT01824290|2088509|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
1049226|NCT01824290|2088510|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
1049227|NCT01824290|2088507|FG000|Period 2: Open-Label Treatment|Adverse Event|0
1049228|NCT01824290|2088508|FG001|Period 2: Open-Label Treatment|Adverse Event|0
1049229|NCT01824290|2088509|FG002|Period 2: Open-Label Treatment|Adverse Event|0
1049230|NCT01824290|2088510|FG003|Period 2: Open-Label Treatment|Adverse Event|1
1049231|NCT01824290|2088507|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
1049232|NCT01824290|2088508|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
1049233|NCT01824290|2088509|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
1049234|NCT01824290|2088510|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
1049235|NCT01824290|2088507|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0
1049236|NCT01824290|2088508|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0
1049237|NCT01824290|2088509|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2
1049238|NCT01824290|2088510|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1
1049239|NCT01824303|2088524|FG000|Randomized Study|Withdrawal by Subject|1
1049240|NCT01824303|2088525|FG001|Randomized Study|Withdrawal by Subject|1
1049241|NCT01824303|2088524|FG000|Randomized Study|Other Miscellaneous Reasons|1
1049242|NCT01824303|2088525|FG001|Randomized Study|Other Miscellaneous Reasons|0
1049243|NCT01824342|2088535|FG000|Overall Study|Withdrawal by Subject|0
1049244|NCT01824342|2088536|FG001|Overall Study|Withdrawal by Subject|3
1049245|NCT01824342|2088535|FG000|Overall Study|Adverse Event|1
1049246|NCT01824342|2088536|FG001|Overall Study|Adverse Event|1
1049247|NCT01824342|2088535|FG000|Overall Study|Disease Progression|1
1049248|NCT01824342|2088536|FG001|Overall Study|Disease Progression|1
1049249|NCT01824342|2088535|FG000|Overall Study|Physician Decision|5
1049250|NCT01824342|2088536|FG001|Overall Study|Physician Decision|0
1049251|NCT01824342|2088535|FG000|Overall Study|Death|2
1049252|NCT01824342|2088536|FG001|Overall Study|Death|0
1049253|NCT01824355|2088542|FG000|Overall Study|Adverse Event|2
1049254|NCT01824355|2088542|FG000|Overall Study|unevaluable reference method results per|1
1049255|NCT01824394|2088549|FG000|Overall Study|Early Termination|1
1049256|NCT01824394|2088550|FG001|Overall Study|Early Termination|1
1049257|NCT01824394|2088551|FG002|Overall Study|Early Termination|3
1049258|NCT01824394|2088549|FG000|Overall Study|Withdrawn due to Study Termination|91
1049259|NCT01824394|2088550|FG001|Overall Study|Withdrawn due to Study Termination|83
1049260|NCT01824394|2088551|FG002|Overall Study|Withdrawn due to Study Termination|41
1049261|NCT01824394|2088549|FG000|Overall Study|Lost to Follow-up|0
1049262|NCT01824394|2088550|FG001|Overall Study|Lost to Follow-up|9
1049263|NCT01824394|2088551|FG002|Overall Study|Lost to Follow-up|3
1049264|NCT01824394|2088549|FG000|Overall Study|Death|3
1049265|NCT01824394|2088550|FG001|Overall Study|Death|2
1049266|NCT01824394|2088551|FG002|Overall Study|Death|4
1049267|NCT01824394|2088549|FG000|Overall Study|Discontinued Subjects|1
1049268|NCT01824394|2088550|FG001|Overall Study|Discontinued Subjects|1
1049269|NCT01824394|2088551|FG002|Overall Study|Discontinued Subjects|2
1049270|NCT01824394|2088549|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23
1049271|NCT01824394|2088550|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20
1049272|NCT01824394|2088551|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21
1049273|NCT01824472|2088566|FG000|Overall Study|Lost to Follow-up|0
1049274|NCT01824472|2088567|FG001|Overall Study|Lost to Follow-up|0
1049275|NCT01824472|2088568|FG002|Overall Study|Lost to Follow-up|1
1049276|NCT01824472|2088566|FG000|Overall Study|Withdrawal by Subject|1
1049277|NCT01824472|2088567|FG001|Overall Study|Withdrawal by Subject|5
1049278|NCT01824472|2088568|FG002|Overall Study|Withdrawal by Subject|3
1049279|NCT01824472|2088566|FG000|Overall Study|Ineligible post randomization&screening|0
1049280|NCT01824472|2088567|FG001|Overall Study|Ineligible post randomization&screening|2
1049281|NCT01824472|2088568|FG002|Overall Study|Ineligible post randomization&screening|0
1049282|NCT01824498|2088582|FG000|Washout (8 Weeks)|Withdrawal by Subject|2
1049283|NCT01824498|2088583|FG001|Washout (8 Weeks)|Withdrawal by Subject|0
1049284|NCT01824498|2088584|FG002|Washout (8 Weeks)|Withdrawal by Subject|2
1049285|NCT01824498|2088585|FG003|Washout (8 Weeks)|Withdrawal by Subject|1
1049286|NCT01824498|2088586|FG004|Washout (8 Weeks)|Withdrawal by Subject|1
1049287|NCT01824498|2088587|FG005|Washout (8 Weeks)|Withdrawal by Subject|0
1049288|NCT01824576|2088595|FG000|Overall Study|Device deficiency|2
1049289|NCT01824602|2088620|FG000|Overall Study|Withdrawal by Subject|0
1049290|NCT01824602|2088621|FG001|Overall Study|Withdrawal by Subject|0
1049291|NCT01824602|2088622|FG002|Overall Study|Withdrawal by Subject|1
1049292|NCT01824602|2088623|FG003|Overall Study|Withdrawal by Subject|2
1049293|NCT01824602|2088620|FG000|Overall Study|Patient non-compliance|0
1049294|NCT01824602|2088621|FG001|Overall Study|Patient non-compliance|0
1049295|NCT01824602|2088622|FG002|Overall Study|Patient non-compliance|1
1049296|NCT01824602|2088623|FG003|Overall Study|Patient non-compliance|0
1049297|NCT01824602|2088620|FG000|Overall Study|Adverse Event|1
1049298|NCT01824602|2088621|FG001|Overall Study|Adverse Event|0
1049299|NCT01824602|2088622|FG002|Overall Study|Adverse Event|2
1049300|NCT01824602|2088623|FG003|Overall Study|Adverse Event|2
1049301|NCT01824602|2088620|FG000|Overall Study|Treatment failure|0
1049302|NCT01824602|2088621|FG001|Overall Study|Treatment failure|0
1049303|NCT01824602|2088622|FG002|Overall Study|Treatment failure|0
1049304|NCT01824602|2088623|FG003|Overall Study|Treatment failure|1
1049305|NCT01824693|2088636|FG000|Overall Study|Death|0
1049306|NCT01824693|2088637|FG001|Overall Study|Death|1
1049307|NCT01824693|2088638|FG002|Overall Study|Death|0
1049308|NCT01824693|2088636|FG000|Overall Study|Physician Decision|1
1049309|NCT01824693|2088637|FG001|Overall Study|Physician Decision|1
1049310|NCT01824693|2088638|FG002|Overall Study|Physician Decision|1
1049311|NCT01824693|2088636|FG000|Overall Study|Withdrawal by Subject|0
1049312|NCT01824693|2088637|FG001|Overall Study|Withdrawal by Subject|0
1049313|NCT01824693|2088638|FG002|Overall Study|Withdrawal by Subject|1
1049314|NCT01824693|2088636|FG000|Overall Study|Progressive Disease|0
1049315|NCT01824693|2088637|FG001|Overall Study|Progressive Disease|5
1049316|NCT01824693|2088638|FG002|Overall Study|Progressive Disease|0
1049317|NCT01824693|2088636|FG000|Overall Study|Ineligible|0
1049318|NCT01824693|2088637|FG001|Overall Study|Ineligible|0
1049319|NCT01824693|2088638|FG002|Overall Study|Ineligible|3
1049320|NCT01824693|2088636|FG000|Overall Study|No Transplant Planned|0
1049321|NCT01824693|2088637|FG001|Overall Study|No Transplant Planned|0
1049322|NCT01824693|2088638|FG002|Overall Study|No Transplant Planned|10
1049323|NCT01824823|2088647|FG000|Overall Study|Lack of Efficacy|1
1049324|NCT01824823|2088648|FG001|Overall Study|Lack of Efficacy|1
1049325|NCT01824823|2088647|FG000|Overall Study|Off-treatment reason not submitted|1
1049326|NCT01824823|2088648|FG001|Overall Study|Off-treatment reason not submitted|0
1049327|NCT01824979|2088663|FG000|Overall Study|Withdrawal by Subject|5
1049328|NCT01824979|2088664|FG001|Overall Study|Withdrawal by Subject|0
1049329|NCT01824979|2088663|FG000|Overall Study|Physician Decision|2
1049330|NCT01824979|2088664|FG001|Overall Study|Physician Decision|0
1049331|NCT01824979|2088663|FG000|Overall Study|Protocol Violation|6
1049332|NCT01824979|2088664|FG001|Overall Study|Protocol Violation|13
1049333|NCT01825200|2088697|FG000|Overall Study|Lost to Follow-up|5
1049334|NCT01825200|2088698|FG001|Overall Study|Lost to Follow-up|6
1049335|NCT01825200|2088697|FG000|Overall Study|Withdrawal by Subject|0
1049336|NCT01825200|2088698|FG001|Overall Study|Withdrawal by Subject|1
1049337|NCT01825577|2088730|FG000|Overall Study|Physician Decision|2
1049338|NCT01825577|2088730|FG000|Overall Study|Withdrawal by Subject|1
1049339|NCT01825577|2088730|FG000|Overall Study|Withdrawn by family members|2
1049340|NCT01825577|2088730|FG000|Overall Study|Lack of Efficacy|3
1049341|NCT01825785|2088750|FG000|Overall Study|Adverse Event|0
1049342|NCT01825785|2088751|FG001|Overall Study|Adverse Event|0
1049343|NCT01825785|2088752|FG002|Overall Study|Adverse Event|0
1049344|NCT01825785|2088753|FG003|Overall Study|Adverse Event|0
1049345|NCT01825785|2088754|FG004|Overall Study|Adverse Event|1
1049346|NCT01825785|2088755|FG005|Overall Study|Adverse Event|0
1049347|NCT01825785|2088756|FG006|Overall Study|Adverse Event|0
1049348|NCT01825785|2088750|FG000|Overall Study|Withdrawal by Subject|0
1049349|NCT01825785|2088751|FG001|Overall Study|Withdrawal by Subject|0
1049350|NCT01825785|2088752|FG002|Overall Study|Withdrawal by Subject|0
1049351|NCT01825785|2088753|FG003|Overall Study|Withdrawal by Subject|0
1049352|NCT01825785|2088754|FG004|Overall Study|Withdrawal by Subject|1
1049353|NCT01825785|2088755|FG005|Overall Study|Withdrawal by Subject|1
1049354|NCT01825785|2088756|FG006|Overall Study|Withdrawal by Subject|0
1049355|NCT01825798|2088780|FG000|Overall Study|Adverse Event|1
1049356|NCT01825798|2088781|FG001|Overall Study|Adverse Event|5
1049357|NCT01825798|2088780|FG000|Overall Study|Lost to Follow-up|1
1049358|NCT01825798|2088781|FG001|Overall Study|Lost to Follow-up|0
1049359|NCT01825837|2088791|FG000|PART I|Withdrawal by Subject|0
1049360|NCT01825837|2088792|FG001|PART I|Withdrawal by Subject|0
1049361|NCT01825837|2088793|FG002|PART I|Withdrawal by Subject|0
1049362|NCT01825837|2088794|FG003|PART I|Withdrawal by Subject|6
1049363|NCT01825837|2088791|FG000|PART I|Patient non-compliance|0
1049364|NCT01825837|2088792|FG001|PART I|Patient non-compliance|0
1049365|NCT01825837|2088793|FG002|PART I|Patient non-compliance|0
1049366|NCT01825837|2088794|FG003|PART I|Patient non-compliance|1
1049367|NCT01825837|2088791|FG000|PART I|Treatment failure|0
1049368|NCT01825837|2088792|FG001|PART I|Treatment failure|0
1049369|NCT01825837|2088793|FG002|PART I|Treatment failure|0
1049370|NCT01825837|2088794|FG003|PART I|Treatment failure|7
1049371|NCT01825837|2088791|FG000|PART I|reason unspecified|0
1049372|NCT01825837|2088792|FG001|PART I|reason unspecified|0
1049373|NCT01825837|2088793|FG002|PART I|reason unspecified|0
1049374|NCT01825837|2088794|FG003|PART I|reason unspecified|3
1049375|NCT01825837|2088791|FG000|PART II|Withdrawal by Subject|3
1049376|NCT01825837|2088792|FG001|PART II|Withdrawal by Subject|3
1049377|NCT01825837|2088793|FG002|PART II|Withdrawal by Subject|7
1049378|NCT01825837|2088794|FG003|PART II|Withdrawal by Subject|0
1049379|NCT01825837|2088791|FG000|PART II|Patient non-compliance|5
1049380|NCT01825837|2088792|FG001|PART II|Patient non-compliance|2
1049381|NCT01825837|2088793|FG002|PART II|Patient non-compliance|4
1049382|NCT01825837|2088794|FG003|PART II|Patient non-compliance|0
1049383|NCT01825837|2088791|FG000|PART II|Adverse Event|3
1049384|NCT01825837|2088792|FG001|PART II|Adverse Event|3
1049385|NCT01825837|2088793|FG002|PART II|Adverse Event|1
1049386|NCT01825837|2088794|FG003|PART II|Adverse Event|0
1049387|NCT01825837|2088791|FG000|PART II|Treatment failure|6
1049388|NCT01825837|2088792|FG001|PART II|Treatment failure|4
1049389|NCT01825837|2088793|FG002|PART II|Treatment failure|5
1049390|NCT01825837|2088794|FG003|PART II|Treatment failure|0
1049391|NCT01825837|2088791|FG000|PART II|reason unspecified|2
1049392|NCT01825837|2088792|FG001|PART II|reason unspecified|2
1049393|NCT01825837|2088793|FG002|PART II|reason unspecified|2
1049394|NCT01825837|2088794|FG003|PART II|reason unspecified|0
1049395|NCT01825876|2088802|FG000|Period 2|Withdrawal by Subject|0
1049396|NCT01825876|2088803|FG001|Period 2|Withdrawal by Subject|1
1049397|NCT01825941|2088823|FG000|Overall Study|Lost to Follow-up|4
1049398|NCT01825941|2088824|FG001|Overall Study|Lost to Follow-up|1
1049399|NCT01826201|2088830|FG000|Overall Study|Non compliance with protocol|4
1049400|NCT01826214|2088838|FG000|Overall Study|Adverse Event|7
1049401|NCT01826214|2088839|FG001|Overall Study|Adverse Event|6
1049402|NCT01826214|2088838|FG000|Overall Study|Death|3
1049403|NCT01826214|2088839|FG001|Overall Study|Death|1
1049404|NCT01826214|2088838|FG000|Overall Study|Lost to Follow-up|1
1049405|NCT01826214|2088839|FG001|Overall Study|Lost to Follow-up|0
1049406|NCT01826214|2088838|FG000|Overall Study|Physician Decision|0
1049407|NCT01826214|2088839|FG001|Overall Study|Physician Decision|2
1049408|NCT01826214|2088838|FG000|Overall Study|Progressive disease|22
1049409|NCT01826214|2088839|FG001|Overall Study|Progressive disease|21
1049410|NCT01826214|2088838|FG000|Overall Study|Study terminated by Sponsor|0
1049411|NCT01826214|2088839|FG001|Overall Study|Study terminated by Sponsor|1
1049412|NCT01826214|2088838|FG000|Overall Study|Subject/guardian decision|2
1049413|NCT01826214|2088839|FG001|Overall Study|Subject/guardian decision|3
1049414|NCT01826370|2088849|FG000|Overall Study|Protocol Violation|6
1049415|NCT01826370|2088849|FG000|Overall Study|Lost to Follow-up|12
1049416|NCT01826370|2088849|FG000|Overall Study|Other reason not defined above|2
1049417|NCT01826422|2088855|FG000|Overall Study|Withdrawal by Subject|1
1049418|NCT01826422|2088856|FG001|Overall Study|Withdrawal by Subject|3
1049419|NCT01826448|2088864|FG000|Overall Study|Adverse Event|1
1049420|NCT01826448|2088865|FG001|Overall Study|Adverse Event|3
1049421|NCT01826448|2088864|FG000|Overall Study|Disease progression|2
1049422|NCT01826448|2088865|FG001|Overall Study|Disease progression|4
1049423|NCT01826448|2088864|FG000|Overall Study|Withdrawal by Subject|1
1049424|NCT01826448|2088865|FG001|Overall Study|Withdrawal by Subject|0
1049425|NCT01826448|2088864|FG000|Overall Study|Physician Decision|0
1049426|NCT01826448|2088865|FG001|Overall Study|Physician Decision|1
1049427|NCT01826448|2088864|FG000|Overall Study|2 active cancers|0
1049428|NCT01826448|2088865|FG001|Overall Study|2 active cancers|1
1049429|NCT01826487|2088873|FG000|Overall Study|Adverse Event|1
1049430|NCT01826487|2088874|FG001|Overall Study|Adverse Event|1
1049431|NCT01826487|2088873|FG000|Overall Study|Lost to Follow-up|1
1049432|NCT01826487|2088874|FG001|Overall Study|Lost to Follow-up|0
1049433|NCT01826487|2088873|FG000|Overall Study|Withdrawal by Subject|1
1049434|NCT01826487|2088874|FG001|Overall Study|Withdrawal by Subject|3
1049435|NCT01826487|2088873|FG000|Overall Study|Protocol Violation|1
1049436|NCT01826487|2088874|FG001|Overall Study|Protocol Violation|1
1049437|NCT01826604|2088895|FG000|Overall Study|Lost to Follow-up|8
1049438|NCT01826604|2088896|FG001|Overall Study|Lost to Follow-up|9
1049439|NCT01826825|2088915|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0
1049440|NCT01826825|2088916|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2
1049441|NCT01826981|2088948|FG000|Overall Study|Lack of Efficacy|0
1049442|NCT01826981|2088949|FG001|Overall Study|Lack of Efficacy|1
1049443|NCT01826981|2088950|FG002|Overall Study|Lack of Efficacy|0
1049444|NCT01826981|2088951|FG003|Overall Study|Lack of Efficacy|0
1049445|NCT01826981|2088952|FG004|Overall Study|Lack of Efficacy|5
1049446|NCT01826981|2088953|FG005|Overall Study|Lack of Efficacy|0
1049447|NCT01826981|2088954|FG006|Overall Study|Lack of Efficacy|0
1049448|NCT01826981|2088955|FG007|Overall Study|Lack of Efficacy|8
1049449|NCT01826981|2088956|FG008|Overall Study|Lack of Efficacy|7
1049450|NCT01826981|2088957|FG009|Overall Study|Lack of Efficacy|0
1049451|NCT01826981|2088958|FG010|Overall Study|Lack of Efficacy|1
1049452|NCT01826981|2088959|FG011|Overall Study|Lack of Efficacy|0
1049453|NCT01826981|2088960|FG012|Overall Study|Lack of Efficacy|0
1049454|NCT01826981|2088961|FG013|Overall Study|Lack of Efficacy|3
1049455|NCT01826981|2088962|FG014|Overall Study|Lack of Efficacy|0
1049456|NCT01826981|2088948|FG000|Overall Study|Lost to Follow-up|0
1049457|NCT01826981|2088949|FG001|Overall Study|Lost to Follow-up|0
1049458|NCT01826981|2088950|FG002|Overall Study|Lost to Follow-up|0
1049459|NCT01826981|2088951|FG003|Overall Study|Lost to Follow-up|0
1049460|NCT01826981|2088952|FG004|Overall Study|Lost to Follow-up|1
1049461|NCT01826981|2088953|FG005|Overall Study|Lost to Follow-up|1
1049462|NCT01826981|2088954|FG006|Overall Study|Lost to Follow-up|0
1049463|NCT01826981|2088955|FG007|Overall Study|Lost to Follow-up|1
1049464|NCT01826981|2088956|FG008|Overall Study|Lost to Follow-up|0
1049465|NCT01826981|2088957|FG009|Overall Study|Lost to Follow-up|1
1049466|NCT01826981|2088958|FG010|Overall Study|Lost to Follow-up|1
1049467|NCT01826981|2088959|FG011|Overall Study|Lost to Follow-up|1
1049468|NCT01826981|2088960|FG012|Overall Study|Lost to Follow-up|1
1049469|NCT01826981|2088961|FG013|Overall Study|Lost to Follow-up|0
1049470|NCT01826981|2088962|FG014|Overall Study|Lost to Follow-up|0
1049471|NCT01826981|2088948|FG000|Overall Study|Withdrew Consent|0
1049472|NCT01826981|2088949|FG001|Overall Study|Withdrew Consent|0
1049473|NCT01826981|2088950|FG002|Overall Study|Withdrew Consent|0
1049474|NCT01826981|2088951|FG003|Overall Study|Withdrew Consent|0
1049475|NCT01826981|2088952|FG004|Overall Study|Withdrew Consent|0
1049476|NCT01826981|2088953|FG005|Overall Study|Withdrew Consent|0
1049477|NCT01826981|2088954|FG006|Overall Study|Withdrew Consent|1
1049478|NCT01826981|2088955|FG007|Overall Study|Withdrew Consent|1
1049479|NCT01826981|2088956|FG008|Overall Study|Withdrew Consent|0
1049480|NCT01826981|2088957|FG009|Overall Study|Withdrew Consent|0
1049481|NCT01826981|2088958|FG010|Overall Study|Withdrew Consent|0
1049482|NCT01826981|2088959|FG011|Overall Study|Withdrew Consent|1
1049483|NCT01826981|2088960|FG012|Overall Study|Withdrew Consent|0
1049484|NCT01826981|2088961|FG013|Overall Study|Withdrew Consent|1
1049485|NCT01826981|2088962|FG014|Overall Study|Withdrew Consent|0
1049486|NCT01826981|2088948|FG000|Overall Study|Adverse Event|0
1049487|NCT01826981|2088949|FG001|Overall Study|Adverse Event|0
1049488|NCT01826981|2088950|FG002|Overall Study|Adverse Event|0
1049489|NCT01826981|2088951|FG003|Overall Study|Adverse Event|0
1049490|NCT01826981|2088952|FG004|Overall Study|Adverse Event|1
1049491|NCT01826981|2088953|FG005|Overall Study|Adverse Event|0
1049492|NCT01826981|2088954|FG006|Overall Study|Adverse Event|0
1049493|NCT01826981|2088955|FG007|Overall Study|Adverse Event|0
1049494|NCT01826981|2088956|FG008|Overall Study|Adverse Event|0
1049495|NCT01826981|2088957|FG009|Overall Study|Adverse Event|0
1049496|NCT01826981|2088958|FG010|Overall Study|Adverse Event|0
1049497|NCT01826981|2088959|FG011|Overall Study|Adverse Event|0
1049498|NCT01826981|2088960|FG012|Overall Study|Adverse Event|0
1049499|NCT01826981|2088961|FG013|Overall Study|Adverse Event|0
1049500|NCT01826981|2088962|FG014|Overall Study|Adverse Event|0
1049501|NCT01826981|2088948|FG000|Overall Study|Upper G-I Haemorrhage|0
1049502|NCT01826981|2088949|FG001|Overall Study|Upper G-I Haemorrhage|0
1049503|NCT01826981|2088950|FG002|Overall Study|Upper G-I Haemorrhage|0
1049504|NCT01826981|2088951|FG003|Overall Study|Upper G-I Haemorrhage|0
1049505|NCT01826981|2088952|FG004|Overall Study|Upper G-I Haemorrhage|0
1049506|NCT01826981|2088953|FG005|Overall Study|Upper G-I Haemorrhage|0
1049507|NCT01826981|2088954|FG006|Overall Study|Upper G-I Haemorrhage|0
1049508|NCT01826981|2088955|FG007|Overall Study|Upper G-I Haemorrhage|0
1049509|NCT01826981|2088956|FG008|Overall Study|Upper G-I Haemorrhage|0
1049510|NCT01826981|2088957|FG009|Overall Study|Upper G-I Haemorrhage|0
1049511|NCT01826981|2088958|FG010|Overall Study|Upper G-I Haemorrhage|0
1049512|NCT01826981|2088959|FG011|Overall Study|Upper G-I Haemorrhage|0
1049513|NCT01826981|2088960|FG012|Overall Study|Upper G-I Haemorrhage|0
1049514|NCT01826981|2088961|FG013|Overall Study|Upper G-I Haemorrhage|1
1049515|NCT01826981|2088962|FG014|Overall Study|Upper G-I Haemorrhage|0
1049516|NCT01826981|2088948|FG000|Overall Study|Enrolled/Randomized but Not Treated|0
1049517|NCT01826981|2088949|FG001|Overall Study|Enrolled/Randomized but Not Treated|0
1049518|NCT01826981|2088950|FG002|Overall Study|Enrolled/Randomized but Not Treated|0
1049519|NCT01826981|2088951|FG003|Overall Study|Enrolled/Randomized but Not Treated|0
1049520|NCT01826981|2088952|FG004|Overall Study|Enrolled/Randomized but Not Treated|0
1049521|NCT01826981|2088953|FG005|Overall Study|Enrolled/Randomized but Not Treated|0
906775|NCT00770913|1882636|FG001|Overall Study|Refusal to continue participation|4
906776|NCT00770913|1882637|FG002|Overall Study|Refusal to continue participation|5
906777|NCT00770913|1882635|FG000|Overall Study|Physician Decision|0
906778|NCT00770913|1882636|FG001|Overall Study|Physician Decision|1
1049522|NCT01826981|2088954|FG006|Overall Study|Enrolled/Randomized but Not Treated|0
1049523|NCT01826981|2088955|FG007|Overall Study|Enrolled/Randomized but Not Treated|1
1049524|NCT01826981|2088956|FG008|Overall Study|Enrolled/Randomized but Not Treated|0
1049525|NCT01826981|2088957|FG009|Overall Study|Enrolled/Randomized but Not Treated|0
1049526|NCT01826981|2088958|FG010|Overall Study|Enrolled/Randomized but Not Treated|0
1049527|NCT01826981|2088959|FG011|Overall Study|Enrolled/Randomized but Not Treated|0
1049528|NCT01826981|2088960|FG012|Overall Study|Enrolled/Randomized but Not Treated|0
1049529|NCT01826981|2088961|FG013|Overall Study|Enrolled/Randomized but Not Treated|0
1049530|NCT01826981|2088962|FG014|Overall Study|Enrolled/Randomized but Not Treated|0
1049531|NCT01827046|2089000|FG000|Overall Study|Lost to Follow-up|1
1049532|NCT01827046|2089001|FG001|Overall Study|Lost to Follow-up|5
1049533|NCT01827046|2089000|FG000|Overall Study|Withdrawal by Subject|0
1049534|NCT01827046|2089001|FG001|Overall Study|Withdrawal by Subject|4
1049535|NCT01827163|2089007|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2
1049536|NCT01827163|2089007|FG000|Overall Study|Adverse Event|9
1049537|NCT01827254|2089011|FG000|Overall Study|Death|10
1049538|NCT01827254|2089011|FG000|Overall Study|Case report form not completed|4
1049539|NCT01827254|2089011|FG000|Overall Study|Invalidated centre|3
1049540|NCT01827254|2089011|FG000|Overall Study|Discontinued prior initiation: sunitinib|1
1049541|NCT01827254|2089011|FG000|Overall Study|Did not complete re-challenge|1
1049542|NCT01827254|2089011|FG000|Overall Study|Disease progression|36
1049543|NCT01827254|2089011|FG000|Overall Study|Intolerance to treatment|4
1049544|NCT01827267|2089021|FG000|Overall Study|Did not receive study drug|1
1049545|NCT01827267|2089022|FG001|Overall Study|Did not receive study drug|1
1049546|NCT01827267|2089021|FG000|Overall Study|Physician Decision|1
1049547|NCT01827267|2089022|FG001|Overall Study|Physician Decision|0
1049548|NCT01827267|2089021|FG000|Overall Study|Disease Progression|1
1049549|NCT01827267|2089022|FG001|Overall Study|Disease Progression|1
1049550|NCT01827267|2089021|FG000|Overall Study|Sponsor Discontinued Study|2
1049551|NCT01827267|2089022|FG001|Overall Study|Sponsor Discontinued Study|8
1049552|NCT01827267|2089021|FG000|Overall Study|Still on study|0
1049553|NCT01827267|2089022|FG001|Overall Study|Still on study|2
1049554|NCT01827319|2089038|FG000|Overall Study|Lost to Follow-up|3
1049555|NCT01827332|2089044|FG000|Overall Study|Lost to Follow-up|2
1049556|NCT01827332|2089045|FG001|Overall Study|Lost to Follow-up|1
1049557|NCT01827371|2089064|FG000|Overall Study|Adverse Event|0
1049558|NCT01827371|2089065|FG001|Overall Study|Adverse Event|0
1049559|NCT01827371|2089066|FG002|Overall Study|Adverse Event|4
1049560|NCT01827371|2089067|FG003|Overall Study|Adverse Event|2
1049561|NCT01827371|2089064|FG000|Overall Study|Lost to Follow-up|0
1049562|NCT01827371|2089065|FG001|Overall Study|Lost to Follow-up|2
1049563|NCT01827371|2089066|FG002|Overall Study|Lost to Follow-up|0
1049564|NCT01827371|2089067|FG003|Overall Study|Lost to Follow-up|4
1049565|NCT01827371|2089064|FG000|Overall Study|Protocol Violation|1
1049566|NCT01827371|2089065|FG001|Overall Study|Protocol Violation|0
1049567|NCT01827371|2089066|FG002|Overall Study|Protocol Violation|0
1049568|NCT01827371|2089067|FG003|Overall Study|Protocol Violation|0
1049569|NCT01827371|2089064|FG000|Overall Study|Withdrawal by Subject|1
1049570|NCT01827371|2089065|FG001|Overall Study|Withdrawal by Subject|2
1049571|NCT01827371|2089066|FG002|Overall Study|Withdrawal by Subject|2
1049572|NCT01827371|2089067|FG003|Overall Study|Withdrawal by Subject|3
1049573|NCT01827371|2089064|FG000|Overall Study|Physician Decision|0
1049574|NCT01827371|2089065|FG001|Overall Study|Physician Decision|1
1049575|NCT01827371|2089066|FG002|Overall Study|Physician Decision|0
1049576|NCT01827371|2089067|FG003|Overall Study|Physician Decision|1
1049577|NCT01827371|2089064|FG000|Overall Study|Temporary study halt to vaccinations|11
1049578|NCT01827371|2089065|FG001|Overall Study|Temporary study halt to vaccinations|2
1049579|NCT01827371|2089066|FG002|Overall Study|Temporary study halt to vaccinations|5
1049580|NCT01827371|2089067|FG003|Overall Study|Temporary study halt to vaccinations|13
1049581|NCT01827592|2089109|FG000|Overall Study|Adverse Event|11
1049582|NCT01827592|2089110|FG001|Overall Study|Adverse Event|9
1049583|NCT01827592|2089111|FG002|Overall Study|Adverse Event|2
1049584|NCT01827592|2089109|FG000|Overall Study|Physician Decision|0
1049585|NCT01827592|2089110|FG001|Overall Study|Physician Decision|2
1049586|NCT01827592|2089111|FG002|Overall Study|Physician Decision|1
1049587|NCT01827592|2089109|FG000|Overall Study|Protocol Violation|2
1049588|NCT01827592|2089110|FG001|Overall Study|Protocol Violation|1
1049589|NCT01827592|2089111|FG002|Overall Study|Protocol Violation|0
1049590|NCT01827592|2089109|FG000|Overall Study|Lost to Follow-up|1
1049591|NCT01827592|2089110|FG001|Overall Study|Lost to Follow-up|2
1049592|NCT01827592|2089111|FG002|Overall Study|Lost to Follow-up|2
1049593|NCT01827592|2089109|FG000|Overall Study|Withdrawal by Subject|12
1049594|NCT01827592|2089110|FG001|Overall Study|Withdrawal by Subject|11
1049595|NCT01827592|2089111|FG002|Overall Study|Withdrawal by Subject|11
1049596|NCT01827592|2089109|FG000|Overall Study|Patient's substantial non-compliance|1
1049597|NCT01827592|2089110|FG001|Overall Study|Patient's substantial non-compliance|1
1049598|NCT01827592|2089111|FG002|Overall Study|Patient's substantial non-compliance|6
1049599|NCT01827592|2089109|FG000|Overall Study|Trial terminated by Sponsor|47
1049600|NCT01827592|2089110|FG001|Overall Study|Trial terminated by Sponsor|53
1049601|NCT01827592|2089111|FG002|Overall Study|Trial terminated by Sponsor|51
1049602|NCT01827592|2089109|FG000|Overall Study|Others|0
1049603|NCT01827592|2089110|FG001|Overall Study|Others|1
1049604|NCT01827592|2089111|FG002|Overall Study|Others|3
1049605|NCT01827670|2089121|FG000|Overall Study|Withdrawal of Consent|3
1049606|NCT01827670|2089122|FG001|Overall Study|Withdrawal of Consent|2
1049607|NCT01827670|2089121|FG000|Overall Study|Lost to Follow-up|0
1049608|NCT01827670|2089122|FG001|Overall Study|Lost to Follow-up|1
1049609|NCT01827839|2089145|FG000|Overall Study|Adverse Event|1
1049610|NCT01827839|2089145|FG000|Overall Study|Consent Withdrawal|2
1049611|NCT01827943|2089169|FG000|Overall Study|Protocol Violation|8
1049612|NCT01827943|2089169|FG000|Overall Study|Never treated because of an rapid progression|1
1049613|NCT01828021|2089173|FG000|Overall Study|Adverse Event|5
1049614|NCT01828021|2089173|FG000|Overall Study|Lack of Efficacy|17
1049615|NCT01828021|2089173|FG000|Overall Study|Withdrawal by Subject|2
1049616|NCT01828021|2089173|FG000|Overall Study|Ileal obstruction, unrelated|1
1049617|NCT01828034|2089181|FG000|Overall Study|Withdrawal by Subject|0
1049618|NCT01828034|2089182|FG001|Overall Study|Withdrawal by Subject|0
1049619|NCT01828034|2089183|FG002|Overall Study|Withdrawal by Subject|0
1049620|NCT01828034|2089184|FG003|Overall Study|Withdrawal by Subject|1
1049621|NCT01828073|2089193|FG000|Overall Study|Lost to Follow-up|1
1049622|NCT01828073|2089194|FG001|Overall Study|Lost to Follow-up|2
1049639|NCT01828112|2089217|FG000|Overall Study|Adverse Event|6
1049640|NCT01828112|2089218|FG001|Overall Study|Adverse Event|8
1049641|NCT01828112|2089217|FG000|Overall Study|Death|9
1049642|NCT01828112|2089218|FG001|Overall Study|Death|5
1049643|NCT01828112|2089217|FG000|Overall Study|Physician Decision|5
1049644|NCT01828112|2089218|FG001|Overall Study|Physician Decision|5
1049645|NCT01828112|2089217|FG000|Overall Study|Progressive disease|56
1049646|NCT01828112|2089218|FG001|Overall Study|Progressive disease|82
1049647|NCT01828112|2089217|FG000|Overall Study|Subject/guardian decision|6
1049648|NCT01828112|2089218|FG001|Overall Study|Subject/guardian decision|8
1049649|NCT01828281|2089256|FG000|Overall Study|Withdrawal by Subject|1
1049650|NCT01828281|2089257|FG001|Overall Study|Withdrawal by Subject|0
1049651|NCT01828567|2089288|FG000|Overall Study|Lost to Follow-up|27
1049652|NCT01828567|2089289|FG001|Overall Study|Lost to Follow-up|9
1049653|NCT01828567|2089288|FG000|Overall Study|Excluded - did not meet criteria|4
1049654|NCT01828567|2089289|FG001|Overall Study|Excluded - did not meet criteria|1
1049655|NCT01829048|2089325|FG000|Overall Study|Withdrawal by Subject|0
1049656|NCT01829048|2089326|FG001|Overall Study|Withdrawal by Subject|0
1049657|NCT01829048|2089327|FG002|Overall Study|Withdrawal by Subject|0
1049658|NCT01829048|2089328|FG003|Overall Study|Withdrawal by Subject|2
1049659|NCT01829048|2089329|FG004|Overall Study|Withdrawal by Subject|0
1049660|NCT01829113|2089344|FG000|Overall Study|Disease Progression|37
1049661|NCT01829113|2089345|FG001|Overall Study|Disease Progression|48
1049662|NCT01829113|2089344|FG000|Overall Study|Adverse Event|14
1049663|NCT01829113|2089345|FG001|Overall Study|Adverse Event|10
1049664|NCT01829113|2089344|FG000|Overall Study|Withdrawal by Subject|17
1049665|NCT01829113|2089345|FG001|Overall Study|Withdrawal by Subject|10
1049666|NCT01829113|2089344|FG000|Overall Study|Death|4
1049667|NCT01829113|2089345|FG001|Overall Study|Death|6
1049668|NCT01829113|2089344|FG000|Overall Study|Sponsor Decision|1
1049669|NCT01829113|2089345|FG001|Overall Study|Sponsor Decision|1
1049670|NCT01829113|2089344|FG000|Overall Study|No Study Treatment Received|3
1049671|NCT01829113|2089345|FG001|Overall Study|No Study Treatment Received|2
1049672|NCT01829113|2089344|FG000|Overall Study|Physician Decision|1
1049673|NCT01829113|2089345|FG001|Overall Study|Physician Decision|1
1049674|NCT01829165|2089355|FG000|Overall Study|Did not complete intervention|2
1049675|NCT01829165|2089356|FG001|Overall Study|Did not complete intervention|0
1049676|NCT01829191|2089364|FG000|Overall Study|Relocation|0
1049677|NCT01829191|2089365|FG001|Overall Study|Relocation|1
1049678|NCT01829191|2089364|FG000|Overall Study|Lens discomfort|0
1049679|NCT01829191|2089365|FG001|Overall Study|Lens discomfort|3
1049680|NCT01829191|2089364|FG000|Overall Study|Lens handling difficulty|1
1049681|NCT01829191|2089365|FG001|Overall Study|Lens handling difficulty|4
1049682|NCT01829191|2089364|FG000|Overall Study|Protocol Violation|4
1049683|NCT01829191|2089365|FG001|Overall Study|Protocol Violation|1
1049684|NCT01829191|2089364|FG000|Overall Study|Withdrawal by Subject|2
1049685|NCT01829191|2089365|FG001|Overall Study|Withdrawal by Subject|3
1049686|NCT01829191|2089364|FG000|Overall Study|Lost to Follow-up|0
1049687|NCT01829191|2089365|FG001|Overall Study|Lost to Follow-up|1
1049688|NCT01829191|2089364|FG000|Overall Study|Subject was fit for ortho - k|0
1049689|NCT01829191|2089365|FG001|Overall Study|Subject was fit for ortho - k|1
1049690|NCT01829230|2089376|FG000|Overall Study|Protocol Violation|0
1049691|NCT01829230|2089377|FG001|Overall Study|Protocol Violation|2
1049692|NCT01829230|2089376|FG000|Overall Study|Withdrawal by Subject|0
1049693|NCT01829230|2089377|FG001|Overall Study|Withdrawal by Subject|1
1049694|NCT01829230|2089376|FG000|Overall Study|Lost to Follow-up|1
1049695|NCT01829230|2089377|FG001|Overall Study|Lost to Follow-up|1
1049696|NCT01829243|2089383|FG000|First Intervention|Screen Failure|4
1049697|NCT01829243|2089384|FG001|First Intervention|Screen Failure|2
1049698|NCT01829295|2089394|FG000|6-12 Months|Did not want to switch antimetabolites|0
1049699|NCT01829295|2089395|FG001|6-12 Months|Did not want to switch antimetabolites|0
1049700|NCT01829295|2089396|FG002|6-12 Months|Did not want to switch antimetabolites|9
1049701|NCT01829295|2089397|FG003|6-12 Months|Did not want to switch antimetabolites|11
1049702|NCT01829295|2089394|FG000|6-12 Months|Adverse Event|0
1049703|NCT01829295|2089395|FG001|6-12 Months|Adverse Event|0
1049704|NCT01829295|2089396|FG002|6-12 Months|Adverse Event|3
1049705|NCT01829295|2089397|FG003|6-12 Months|Adverse Event|2
1049706|NCT01829295|2089394|FG000|6-12 Months|Lost to Follow-up|2
1049707|NCT01829295|2089395|FG001|6-12 Months|Lost to Follow-up|0
1049708|NCT01829295|2089396|FG002|6-12 Months|Lost to Follow-up|0
1049709|NCT01829295|2089397|FG003|6-12 Months|Lost to Follow-up|0
1049710|NCT01829295|2089394|FG000|6-12 Months|Withdrawal by Subject|2
1049711|NCT01829295|2089395|FG001|6-12 Months|Withdrawal by Subject|2
1049712|NCT01829295|2089396|FG002|6-12 Months|Withdrawal by Subject|0
1049713|NCT01829295|2089397|FG003|6-12 Months|Withdrawal by Subject|0
1049714|NCT01829347|2089409|FG000|VTI-210|Death|5
1049715|NCT01829347|2089410|FG001|VTI-210|Death|3
1049716|NCT01829347|2089409|FG000|VTI-210|Withdrawal by Subject|1
1049717|NCT01829347|2089410|FG001|VTI-210|Withdrawal by Subject|0
1049718|NCT01829347|2089409|FG000|VTI-210E|Death|2
1049719|NCT01829347|2089410|FG001|VTI-210E|Death|1
1049720|NCT01829347|2089409|FG000|VTI-210E|Study terminated prematurely|1
1049721|NCT01829347|2089410|FG001|VTI-210E|Study terminated prematurely|5
1049722|NCT01829360|2089420|FG000|Overall Study|Protocol Violation|0
1049723|NCT01829360|2089421|FG001|Overall Study|Protocol Violation|0
1049724|NCT01829360|2089422|FG002|Overall Study|Protocol Violation|1
1049725|NCT01829360|2089423|FG003|Overall Study|Protocol Violation|0
1049726|NCT01829425|2089450|FG000|Overall Study|Withdrawal by Subject|4
1049727|NCT01829425|2089451|FG001|Overall Study|Withdrawal by Subject|3
1049728|NCT01829425|2089450|FG000|Overall Study|Lost to Follow-up|2
1049729|NCT01829425|2089451|FG001|Overall Study|Lost to Follow-up|1
1049730|NCT01829464|2089460|FG000|Overall Study|Adverse Event|1
1049731|NCT01829464|2089461|FG001|Overall Study|Adverse Event|0
1049732|NCT01829464|2089462|FG002|Overall Study|Adverse Event|0
1049733|NCT01829464|2089460|FG000|Overall Study|Lost to Follow-up|0
1049734|NCT01829464|2089461|FG001|Overall Study|Lost to Follow-up|0
1049735|NCT01829464|2089462|FG002|Overall Study|Lost to Follow-up|1
1049736|NCT01829464|2089460|FG000|Overall Study|Withdrawal by Subject|2
1049737|NCT01829464|2089461|FG001|Overall Study|Withdrawal by Subject|0
1049738|NCT01829464|2089462|FG002|Overall Study|Withdrawal by Subject|0
1049739|NCT01829464|2089460|FG000|Overall Study|Study terminated by sponsor|25
1049740|NCT01829464|2089461|FG001|Overall Study|Study terminated by sponsor|28
1049741|NCT01829464|2089462|FG002|Overall Study|Study terminated by sponsor|25
1049742|NCT01829464|2089460|FG000|Overall Study|Lack of Efficacy|0
1049743|NCT01829464|2089461|FG001|Overall Study|Lack of Efficacy|1
1049744|NCT01829464|2089462|FG002|Overall Study|Lack of Efficacy|0
1049745|NCT01830127|2089499|FG000|Overall Study|Adverse Event|1
1049746|NCT01830127|2089500|FG001|Overall Study|Adverse Event|6
1049747|NCT01830127|2089499|FG000|Overall Study|Lack of Efficacy|3
1049748|NCT01830127|2089500|FG001|Overall Study|Lack of Efficacy|0
1049749|NCT01830127|2089499|FG000|Overall Study|Withdrawal by Subject|1
1049750|NCT01830127|2089500|FG001|Overall Study|Withdrawal by Subject|1
1049751|NCT01830127|2089499|FG000|Overall Study|Other reason not defined above|0
1049752|NCT01830127|2089500|FG001|Overall Study|Other reason not defined above|2
1049753|NCT01830543|2089546|FG000|Overall Study|Subject Decision|19
1049754|NCT01830543|2089547|FG001|Overall Study|Subject Decision|21
1049755|NCT01830543|2089548|FG002|Overall Study|Subject Decision|57
1049756|NCT01830543|2089546|FG000|Overall Study|Adverse Event|91
1049757|NCT01830543|2089547|FG001|Overall Study|Adverse Event|77
1049758|NCT01830543|2089548|FG002|Overall Study|Adverse Event|76
1049759|NCT01830543|2089546|FG000|Overall Study|Death|20
1049760|NCT01830543|2089547|FG001|Overall Study|Death|22
1049761|NCT01830543|2089548|FG002|Overall Study|Death|22
1049762|NCT01830543|2089546|FG000|Overall Study|Protocol Violation|3
1049763|NCT01830543|2089547|FG001|Overall Study|Protocol Violation|7
1049764|NCT01830543|2089548|FG002|Overall Study|Protocol Violation|7
1049765|NCT01830543|2089546|FG000|Overall Study|Physician Decision|11
1049766|NCT01830543|2089547|FG001|Overall Study|Physician Decision|5
1049767|NCT01830543|2089548|FG002|Overall Study|Physician Decision|12
1049768|NCT01830543|2089546|FG000|Overall Study|Withdrawal by consent|3
1049769|NCT01830543|2089547|FG001|Overall Study|Withdrawal by consent|3
906779|NCT00770913|1882637|FG002|Overall Study|Physician Decision|1
906780|NCT00770913|1882635|FG000|Overall Study|Protocol Violation|3
906781|NCT00770913|1882636|FG001|Overall Study|Protocol Violation|0
1049770|NCT01830543|2089548|FG002|Overall Study|Withdrawal by consent|3
1049771|NCT01830543|2089546|FG000|Overall Study|Other|12
1049772|NCT01830543|2089547|FG001|Overall Study|Other|17
1049773|NCT01830543|2089548|FG002|Overall Study|Other|37
1049774|NCT01830595|2089556|FG000|First Period|Withdrawal by Subject|1
1049775|NCT01830595|2089557|FG001|First Period|Withdrawal by Subject|3
1049776|NCT01830595|2089556|FG000|Washout|Withdrawal by Subject|2
1049777|NCT01830595|2089557|FG001|Washout|Withdrawal by Subject|2
1049778|NCT01830816|2089584|FG000|Overall Study|Progressive Disease|12
1049779|NCT01830816|2089585|FG001|Overall Study|Progressive Disease|7
1049780|NCT01830816|2089586|FG002|Overall Study|Progressive Disease|7
1049781|NCT01830816|2089584|FG000|Overall Study|Adverse Event|3
1049782|NCT01830816|2089585|FG001|Overall Study|Adverse Event|4
1049783|NCT01830816|2089586|FG002|Overall Study|Adverse Event|0
1049784|NCT01830816|2089584|FG000|Overall Study|Study Terminated by Sponsor|1
1049785|NCT01830816|2089585|FG001|Overall Study|Study Terminated by Sponsor|1
1049786|NCT01830816|2089586|FG002|Overall Study|Study Terminated by Sponsor|0
1049787|NCT01830816|2089584|FG000|Overall Study|Withdrawal by Subject|1
1049788|NCT01830816|2089585|FG001|Overall Study|Withdrawal by Subject|1
1049789|NCT01830816|2089586|FG002|Overall Study|Withdrawal by Subject|0
1049790|NCT01830816|2089584|FG000|Overall Study|Lost to Follow-up|0
1049791|NCT01830816|2089585|FG001|Overall Study|Lost to Follow-up|1
1049792|NCT01830816|2089586|FG002|Overall Study|Lost to Follow-up|0
1049793|NCT01830816|2089584|FG000|Overall Study|Symptomatic Deterioration|1
1049794|NCT01830816|2089585|FG001|Overall Study|Symptomatic Deterioration|0
1049795|NCT01830816|2089586|FG002|Overall Study|Symptomatic Deterioration|0
1049796|NCT01830816|2089584|FG000|Overall Study|Reason not Specified|2
1049797|NCT01830816|2089585|FG001|Overall Study|Reason not Specified|0
1049798|NCT01830816|2089586|FG002|Overall Study|Reason not Specified|0
1049799|NCT01830855|2089610|FG000|Overall Study|Other|7
1049800|NCT01830855|2089611|FG001|Overall Study|Other|1
1049801|NCT01830855|2089612|FG002|Overall Study|Other|4
1049802|NCT01830855|2089613|FG003|Overall Study|Other|4
1049803|NCT01830855|2089610|FG000|Overall Study|Medication error without associated AE|1
1049804|NCT01830855|2089611|FG001|Overall Study|Medication error without associated AE|0
1049805|NCT01830855|2089612|FG002|Overall Study|Medication error without associated AE|0
1049806|NCT01830855|2089613|FG003|Overall Study|Medication error without associated AE|1
1049807|NCT01830855|2089610|FG000|Overall Study|Pregnancy|3
1049808|NCT01830855|2089611|FG001|Overall Study|Pregnancy|1
1049809|NCT01830855|2089612|FG002|Overall Study|Pregnancy|2
1049810|NCT01830855|2089613|FG003|Overall Study|Pregnancy|1
1049811|NCT01830855|2089610|FG000|Overall Study|No longer meets eligibility criteria|11
1049812|NCT01830855|2089611|FG001|Overall Study|No longer meets eligibility criteria|2
1049813|NCT01830855|2089612|FG002|Overall Study|No longer meets eligibility criteria|3
1049814|NCT01830855|2089613|FG003|Overall Study|No longer meets eligibility criteria|5
1049815|NCT01830855|2089610|FG000|Overall Study|Adverse Event|11
1049816|NCT01830855|2089611|FG001|Overall Study|Adverse Event|5
1049817|NCT01830855|2089612|FG002|Overall Study|Adverse Event|6
1049818|NCT01830855|2089613|FG003|Overall Study|Adverse Event|3
1049819|NCT01830855|2089610|FG000|Overall Study|Protocol deviation|10
1049820|NCT01830855|2089611|FG001|Overall Study|Protocol deviation|5
1049821|NCT01830855|2089612|FG002|Overall Study|Protocol deviation|6
1049822|NCT01830855|2089613|FG003|Overall Study|Protocol deviation|6
1049823|NCT01830855|2089610|FG000|Overall Study|Withdrawal by Subject|33
1049824|NCT01830855|2089611|FG001|Overall Study|Withdrawal by Subject|14
1049825|NCT01830855|2089612|FG002|Overall Study|Withdrawal by Subject|10
1049826|NCT01830855|2089613|FG003|Overall Study|Withdrawal by Subject|12
1049827|NCT01830855|2089610|FG000|Overall Study|No longer willing to participate|32
1049828|NCT01830855|2089611|FG001|Overall Study|No longer willing to participate|13
1049829|NCT01830855|2089612|FG002|Overall Study|No longer willing to participate|12
1049830|NCT01830855|2089613|FG003|Overall Study|No longer willing to participate|17
1049831|NCT01830855|2089610|FG000|Overall Study|Lost to Follow-up|47
1049832|NCT01830855|2089611|FG001|Overall Study|Lost to Follow-up|20
1049833|NCT01830855|2089612|FG002|Overall Study|Lost to Follow-up|23
1049834|NCT01830855|2089613|FG003|Overall Study|Lost to Follow-up|33
1049835|NCT01830881|2089630|FG000|Overall Study|Changed decision to have an abortion|0
1049836|NCT01830881|2089631|FG001|Overall Study|Changed decision to have an abortion|1
1049837|NCT01830920|2089644|FG000|Overall Study|Adverse Event|1
1049838|NCT01830920|2089645|FG001|Overall Study|Adverse Event|0
1049839|NCT01830920|2089646|FG002|Overall Study|Adverse Event|1
1049840|NCT01830920|2089647|FG003|Overall Study|Adverse Event|0
1049841|NCT01830920|2089648|FG004|Overall Study|Adverse Event|0
1049842|NCT01830920|2089644|FG000|Overall Study|Withdrawal by Subject|2
1049843|NCT01830920|2089645|FG001|Overall Study|Withdrawal by Subject|2
1049844|NCT01830920|2089646|FG002|Overall Study|Withdrawal by Subject|1
1049845|NCT01830920|2089647|FG003|Overall Study|Withdrawal by Subject|7
1049846|NCT01830920|2089648|FG004|Overall Study|Withdrawal by Subject|1
1049847|NCT01830920|2089644|FG000|Overall Study|Death|3
1049848|NCT01830920|2089645|FG001|Overall Study|Death|3
1049849|NCT01830920|2089646|FG002|Overall Study|Death|5
1049850|NCT01830920|2089647|FG003|Overall Study|Death|4
1049851|NCT01830920|2089648|FG004|Overall Study|Death|4
1049852|NCT01830920|2089644|FG000|Overall Study|Other|15
1049853|NCT01830920|2089645|FG001|Overall Study|Other|1
1049854|NCT01830920|2089646|FG002|Overall Study|Other|1
1049855|NCT01830920|2089647|FG003|Overall Study|Other|5
1049856|NCT01830920|2089648|FG004|Overall Study|Other|3
1049857|NCT01830972|2089671|FG000|Part II|Withdrawal by Subject|2
1049858|NCT01830972|2089672|FG001|Part II|Withdrawal by Subject|2
1049859|NCT01830972|2089671|FG000|Part III|Withdrawal by Subject|1
1049860|NCT01830972|2089672|FG001|Part III|Withdrawal by Subject|0
1049861|NCT01830972|2089671|FG000|Part III|Noncompliance|1
1049862|NCT01830972|2089672|FG001|Part III|Noncompliance|0
1049863|NCT01830972|2089671|FG000|Part IV|Withdrawal by Subject|2
1049864|NCT01830972|2089672|FG001|Part IV|Withdrawal by Subject|1
1049865|NCT01830972|2089671|FG000|Part IV|Non-Compliance|1
1049866|NCT01830972|2089672|FG001|Part IV|Non-Compliance|0
1049867|NCT01831089|2089703|FG000|Cohort I: Dose Level 1|Progressive disease|3
1049868|NCT01831089|2089704|FG001|Cohort I: Dose Level 1|Progressive disease|0
1049869|NCT01831089|2089705|FG002|Cohort I: Dose Level 1|Progressive disease|0
1049870|NCT01831089|2089706|FG003|Cohort I: Dose Level 1|Progressive disease|0
1049871|NCT01831089|2089707|FG004|Cohort I: Dose Level 1|Progressive disease|0
1049872|NCT01831089|2089708|FG005|Cohort I: Dose Level 1|Progressive disease|0
1049873|NCT01831089|2089703|FG000|Cohort II: Dose Level 2|Progressive disease|0
1049874|NCT01831089|2089704|FG001|Cohort II: Dose Level 2|Progressive disease|2
1049875|NCT01831089|2089705|FG002|Cohort II: Dose Level 2|Progressive disease|0
1049876|NCT01831089|2089706|FG003|Cohort II: Dose Level 2|Progressive disease|0
1049877|NCT01831089|2089707|FG004|Cohort II: Dose Level 2|Progressive disease|0
1049878|NCT01831089|2089708|FG005|Cohort II: Dose Level 2|Progressive disease|0
1049879|NCT01831089|2089703|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0
1049880|NCT01831089|2089704|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1
1049881|NCT01831089|2089705|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0
1049882|NCT01831089|2089706|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0
1049883|NCT01831089|2089707|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0
1049884|NCT01831089|2089708|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0
1049885|NCT01831089|2089703|FG000|Cohort III: Dose Level 3|Progressive disease|0
1049886|NCT01831089|2089704|FG001|Cohort III: Dose Level 3|Progressive disease|0
1049887|NCT01831089|2089705|FG002|Cohort III: Dose Level 3|Progressive disease|3
1049888|NCT01831089|2089706|FG003|Cohort III: Dose Level 3|Progressive disease|0
1049889|NCT01831089|2089707|FG004|Cohort III: Dose Level 3|Progressive disease|0
1049890|NCT01831089|2089708|FG005|Cohort III: Dose Level 3|Progressive disease|0
1049891|NCT01831089|2089703|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0
1049892|NCT01831089|2089704|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0
1049893|NCT01831089|2089705|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1
1049894|NCT01831089|2089706|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0
1049895|NCT01831089|2089707|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0
1049896|NCT01831089|2089708|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0
1049897|NCT01831089|2089703|FG000|Cohort III: Dose Level 3|Adverse Event|0
1049898|NCT01831089|2089704|FG001|Cohort III: Dose Level 3|Adverse Event|0
1049899|NCT01831089|2089705|FG002|Cohort III: Dose Level 3|Adverse Event|1
1049900|NCT01831089|2089706|FG003|Cohort III: Dose Level 3|Adverse Event|0
1049901|NCT01831089|2089707|FG004|Cohort III: Dose Level 3|Adverse Event|0
1049902|NCT01831089|2089708|FG005|Cohort III: Dose Level 3|Adverse Event|0
1049903|NCT01831089|2089703|FG000|Cohort III: Dose Level 3|Global end of study|0
1049904|NCT01831089|2089704|FG001|Cohort III: Dose Level 3|Global end of study|0
1049905|NCT01831089|2089705|FG002|Cohort III: Dose Level 3|Global end of study|1
1049906|NCT01831089|2089706|FG003|Cohort III: Dose Level 3|Global end of study|0
1049907|NCT01831089|2089707|FG004|Cohort III: Dose Level 3|Global end of study|0
1049908|NCT01831089|2089708|FG005|Cohort III: Dose Level 3|Global end of study|0
1049909|NCT01831089|2089703|FG000|Cohort IV: Dose Level 4|Progressive disease|0
1049910|NCT01831089|2089704|FG001|Cohort IV: Dose Level 4|Progressive disease|0
1049911|NCT01831089|2089705|FG002|Cohort IV: Dose Level 4|Progressive disease|0
1049912|NCT01831089|2089706|FG003|Cohort IV: Dose Level 4|Progressive disease|6
1049913|NCT01831089|2089707|FG004|Cohort IV: Dose Level 4|Progressive disease|0
1049914|NCT01831089|2089708|FG005|Cohort IV: Dose Level 4|Progressive disease|0
1049915|NCT01831089|2089703|FG000|Cohort V: Dose Level 5|Progressive disease|0
1049916|NCT01831089|2089704|FG001|Cohort V: Dose Level 5|Progressive disease|0
1049917|NCT01831089|2089705|FG002|Cohort V: Dose Level 5|Progressive disease|0
1049918|NCT01831089|2089706|FG003|Cohort V: Dose Level 5|Progressive disease|0
1049919|NCT01831089|2089707|FG004|Cohort V: Dose Level 5|Progressive disease|30
1049920|NCT01831089|2089708|FG005|Cohort V: Dose Level 5|Progressive disease|0
1049921|NCT01831089|2089703|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0
1049922|NCT01831089|2089704|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0
1049923|NCT01831089|2089705|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0
1049924|NCT01831089|2089706|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0
1049925|NCT01831089|2089707|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3
1049926|NCT01831089|2089708|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0
1049927|NCT01831089|2089703|FG000|Cohort V: Dose Level 5|Death|0
1049928|NCT01831089|2089704|FG001|Cohort V: Dose Level 5|Death|0
1049929|NCT01831089|2089705|FG002|Cohort V: Dose Level 5|Death|0
1049930|NCT01831089|2089706|FG003|Cohort V: Dose Level 5|Death|0
1049931|NCT01831089|2089707|FG004|Cohort V: Dose Level 5|Death|1
1049932|NCT01831089|2089708|FG005|Cohort V: Dose Level 5|Death|0
1049933|NCT01831089|2089703|FG000|Cohort V: Dose Level 5|Global end of study|0
1049934|NCT01831089|2089704|FG001|Cohort V: Dose Level 5|Global end of study|0
1049935|NCT01831089|2089705|FG002|Cohort V: Dose Level 5|Global end of study|0
1049936|NCT01831089|2089706|FG003|Cohort V: Dose Level 5|Global end of study|0
1049937|NCT01831089|2089707|FG004|Cohort V: Dose Level 5|Global end of study|2
1049938|NCT01831089|2089708|FG005|Cohort V: Dose Level 5|Global end of study|0
1049939|NCT01831089|2089703|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0
1049940|NCT01831089|2089704|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0
1049941|NCT01831089|2089705|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0
1049942|NCT01831089|2089706|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0
1049943|NCT01831089|2089707|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1
1049944|NCT01831089|2089708|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0
1049945|NCT01831089|2089703|FG000|Cohort B: Arm B|Progressive disease|0
1049946|NCT01831089|2089704|FG001|Cohort B: Arm B|Progressive disease|0
1049947|NCT01831089|2089705|FG002|Cohort B: Arm B|Progressive disease|0
1049948|NCT01831089|2089706|FG003|Cohort B: Arm B|Progressive disease|0
1049949|NCT01831089|2089707|FG004|Cohort B: Arm B|Progressive disease|0
1049950|NCT01831089|2089708|FG005|Cohort B: Arm B|Progressive disease|8
1049951|NCT01831089|2089703|FG000|Cohort B: Arm B|Physician Decision|0
1049952|NCT01831089|2089704|FG001|Cohort B: Arm B|Physician Decision|0
1049953|NCT01831089|2089705|FG002|Cohort B: Arm B|Physician Decision|0
1049954|NCT01831089|2089706|FG003|Cohort B: Arm B|Physician Decision|0
1049955|NCT01831089|2089707|FG004|Cohort B: Arm B|Physician Decision|0
1049956|NCT01831089|2089708|FG005|Cohort B: Arm B|Physician Decision|2
1049957|NCT01831089|2089703|FG000|Cohort B: Arm B|Never treated|0
1049958|NCT01831089|2089704|FG001|Cohort B: Arm B|Never treated|0
1049959|NCT01831089|2089705|FG002|Cohort B: Arm B|Never treated|0
1049960|NCT01831089|2089706|FG003|Cohort B: Arm B|Never treated|0
1049961|NCT01831089|2089707|FG004|Cohort B: Arm B|Never treated|0
1049962|NCT01831089|2089708|FG005|Cohort B: Arm B|Never treated|2
1049963|NCT01831089|2089703|FG000|Cohort B: Arm B|Adverse Event|0
1049964|NCT01831089|2089704|FG001|Cohort B: Arm B|Adverse Event|0
1049965|NCT01831089|2089705|FG002|Cohort B: Arm B|Adverse Event|0
1049966|NCT01831089|2089706|FG003|Cohort B: Arm B|Adverse Event|0
1049967|NCT01831089|2089707|FG004|Cohort B: Arm B|Adverse Event|0
1049968|NCT01831089|2089708|FG005|Cohort B: Arm B|Adverse Event|1
1049969|NCT01831089|2089703|FG000|Cohort B: Arm B|Global end of study|0
1049970|NCT01831089|2089704|FG001|Cohort B: Arm B|Global end of study|0
1049971|NCT01831089|2089705|FG002|Cohort B: Arm B|Global end of study|0
1049972|NCT01831089|2089706|FG003|Cohort B: Arm B|Global end of study|0
1049973|NCT01831089|2089707|FG004|Cohort B: Arm B|Global end of study|0
1049974|NCT01831089|2089708|FG005|Cohort B: Arm B|Global end of study|1
1049975|NCT01831258|2089749|FG000|Overall Study|Withdrawal by Subject|2
1049976|NCT01831258|2089750|FG001|Overall Study|Withdrawal by Subject|1
1049977|NCT01831258|2089749|FG000|Overall Study|Lost to Follow-up|3
1049978|NCT01831258|2089750|FG001|Overall Study|Lost to Follow-up|2
1049979|NCT01831427|2089769|FG000|Overall Study|Adverse Event|0
1049980|NCT01831427|2089770|FG001|Overall Study|Adverse Event|1
1049981|NCT01831427|2089771|FG002|Overall Study|Adverse Event|0
1049982|NCT01831427|2089772|FG003|Overall Study|Adverse Event|0
1049983|NCT01831427|2089773|FG004|Overall Study|Adverse Event|0
1049984|NCT01831427|2089774|FG005|Overall Study|Adverse Event|1
1049985|NCT01831427|2089775|FG006|Overall Study|Adverse Event|0
1049986|NCT01831427|2089776|FG007|Overall Study|Adverse Event|1
1049987|NCT01831427|2089777|FG008|Overall Study|Adverse Event|0
1049988|NCT01831427|2089778|FG009|Overall Study|Adverse Event|0
1049989|NCT01831427|2089779|FG010|Overall Study|Adverse Event|2
1049990|NCT01831427|2089769|FG000|Overall Study|Investigator's Discretion|0
1049991|NCT01831427|2089770|FG001|Overall Study|Investigator's Discretion|0
1049992|NCT01831427|2089771|FG002|Overall Study|Investigator's Discretion|0
1049993|NCT01831427|2089772|FG003|Overall Study|Investigator's Discretion|1
1049994|NCT01831427|2089773|FG004|Overall Study|Investigator's Discretion|0
1049995|NCT01831427|2089774|FG005|Overall Study|Investigator's Discretion|0
1049996|NCT01831427|2089775|FG006|Overall Study|Investigator's Discretion|0
1049997|NCT01831427|2089776|FG007|Overall Study|Investigator's Discretion|0
1049998|NCT01831427|2089777|FG008|Overall Study|Investigator's Discretion|0
1049999|NCT01831427|2089778|FG009|Overall Study|Investigator's Discretion|0
1050000|NCT01831427|2089779|FG010|Overall Study|Investigator's Discretion|0
1050001|NCT01831427|2089769|FG000|Overall Study|Withdrew Consent|0
1050002|NCT01831427|2089770|FG001|Overall Study|Withdrew Consent|0
1050003|NCT01831427|2089771|FG002|Overall Study|Withdrew Consent|0
1050004|NCT01831427|2089772|FG003|Overall Study|Withdrew Consent|0
1050005|NCT01831427|2089773|FG004|Overall Study|Withdrew Consent|0
1050006|NCT01831427|2089774|FG005|Overall Study|Withdrew Consent|0
1050007|NCT01831427|2089775|FG006|Overall Study|Withdrew Consent|2
1050008|NCT01831427|2089776|FG007|Overall Study|Withdrew Consent|0
1050009|NCT01831427|2089777|FG008|Overall Study|Withdrew Consent|0
1050010|NCT01831427|2089778|FG009|Overall Study|Withdrew Consent|1
1050011|NCT01831427|2089779|FG010|Overall Study|Withdrew Consent|1
1050012|NCT01831466|2089826|FG000|Overall Study|Protocol Violation|1
1050013|NCT01831466|2089827|FG001|Overall Study|Protocol Violation|1
1050014|NCT01831466|2089828|FG002|Overall Study|Protocol Violation|2
1050015|NCT01831466|2089829|FG003|Overall Study|Protocol Violation|0
1050016|NCT01831466|2089830|FG004|Overall Study|Protocol Violation|0
1050017|NCT01831466|2089831|FG005|Overall Study|Protocol Violation|1
1050018|NCT01831466|2089832|FG006|Overall Study|Protocol Violation|0
1050019|NCT01831466|2089833|FG007|Overall Study|Protocol Violation|0
1050020|NCT01831466|2089834|FG008|Overall Study|Protocol Violation|0
1050021|NCT01831466|2089835|FG009|Overall Study|Protocol Violation|0
1050022|NCT01831466|2089836|FG010|Overall Study|Protocol Violation|0
1050023|NCT01831466|2089837|FG011|Overall Study|Protocol Violation|0
1050024|NCT01831466|2089826|FG000|Overall Study|Other|2
1050025|NCT01831466|2089827|FG001|Overall Study|Other|3
1050026|NCT01831466|2089828|FG002|Overall Study|Other|2
1050027|NCT01831466|2089829|FG003|Overall Study|Other|2
1050028|NCT01831466|2089830|FG004|Overall Study|Other|2
1050029|NCT01831466|2089831|FG005|Overall Study|Other|1
1050030|NCT01831466|2089832|FG006|Overall Study|Other|0
1050031|NCT01831466|2089833|FG007|Overall Study|Other|0
1050032|NCT01831466|2089834|FG008|Overall Study|Other|0
1050033|NCT01831466|2089835|FG009|Overall Study|Other|0
1050034|NCT01831466|2089836|FG010|Overall Study|Other|0
1050035|NCT01831466|2089837|FG011|Overall Study|Other|0
1050036|NCT01831466|2089826|FG000|Overall Study|Non-compliance with study treatment|2
1050037|NCT01831466|2089827|FG001|Overall Study|Non-compliance with study treatment|1
1050038|NCT01831466|2089828|FG002|Overall Study|Non-compliance with study treatment|1
1050039|NCT01831466|2089829|FG003|Overall Study|Non-compliance with study treatment|0
1050040|NCT01831466|2089830|FG004|Overall Study|Non-compliance with study treatment|0
1050041|NCT01831466|2089831|FG005|Overall Study|Non-compliance with study treatment|1
1050042|NCT01831466|2089832|FG006|Overall Study|Non-compliance with study treatment|0
1050043|NCT01831466|2089833|FG007|Overall Study|Non-compliance with study treatment|0
1050044|NCT01831466|2089834|FG008|Overall Study|Non-compliance with study treatment|0
1050045|NCT01831466|2089835|FG009|Overall Study|Non-compliance with study treatment|0
1050046|NCT01831466|2089836|FG010|Overall Study|Non-compliance with study treatment|0
1050047|NCT01831466|2089837|FG011|Overall Study|Non-compliance with study treatment|0
1050048|NCT01831466|2089826|FG000|Overall Study|Death|0
1050049|NCT01831466|2089827|FG001|Overall Study|Death|1
1050050|NCT01831466|2089828|FG002|Overall Study|Death|0
1050051|NCT01831466|2089829|FG003|Overall Study|Death|0
1050052|NCT01831466|2089830|FG004|Overall Study|Death|0
1050053|NCT01831466|2089831|FG005|Overall Study|Death|0
1050054|NCT01831466|2089832|FG006|Overall Study|Death|0
1050055|NCT01831466|2089833|FG007|Overall Study|Death|0
1050056|NCT01831466|2089834|FG008|Overall Study|Death|0
1050057|NCT01831466|2089835|FG009|Overall Study|Death|0
1050058|NCT01831466|2089836|FG010|Overall Study|Death|0
1050059|NCT01831466|2089837|FG011|Overall Study|Death|0
1050060|NCT01831466|2089826|FG000|Overall Study|Withdrawal by Subject|6
1050061|NCT01831466|2089827|FG001|Overall Study|Withdrawal by Subject|3
1050062|NCT01831466|2089828|FG002|Overall Study|Withdrawal by Subject|3
1050063|NCT01831466|2089829|FG003|Overall Study|Withdrawal by Subject|3
1050064|NCT01831466|2089830|FG004|Overall Study|Withdrawal by Subject|3
1050065|NCT01831466|2089831|FG005|Overall Study|Withdrawal by Subject|5
1050066|NCT01831466|2089832|FG006|Overall Study|Withdrawal by Subject|0
1050067|NCT01831466|2089833|FG007|Overall Study|Withdrawal by Subject|0
1050068|NCT01831466|2089834|FG008|Overall Study|Withdrawal by Subject|0
1050069|NCT01831466|2089835|FG009|Overall Study|Withdrawal by Subject|1
1050070|NCT01831466|2089836|FG010|Overall Study|Withdrawal by Subject|0
1050071|NCT01831466|2089837|FG011|Overall Study|Withdrawal by Subject|1
1050072|NCT01831466|2089826|FG000|Overall Study|Lost to Follow-up|0
1050073|NCT01831466|2089827|FG001|Overall Study|Lost to Follow-up|1
1050074|NCT01831466|2089828|FG002|Overall Study|Lost to Follow-up|4
1050075|NCT01831466|2089829|FG003|Overall Study|Lost to Follow-up|2
1050076|NCT01831466|2089830|FG004|Overall Study|Lost to Follow-up|0
1050077|NCT01831466|2089831|FG005|Overall Study|Lost to Follow-up|3
1050078|NCT01831466|2089832|FG006|Overall Study|Lost to Follow-up|0
1050079|NCT01831466|2089833|FG007|Overall Study|Lost to Follow-up|0
1050080|NCT01831466|2089834|FG008|Overall Study|Lost to Follow-up|0
1050081|NCT01831466|2089835|FG009|Overall Study|Lost to Follow-up|1
1050082|NCT01831466|2089836|FG010|Overall Study|Lost to Follow-up|0
1050083|NCT01831466|2089837|FG011|Overall Study|Lost to Follow-up|1
1050084|NCT01831466|2089826|FG000|Overall Study|Lack of Efficacy|5
1050085|NCT01831466|2089827|FG001|Overall Study|Lack of Efficacy|8
1050086|NCT01831466|2089828|FG002|Overall Study|Lack of Efficacy|7
1050087|NCT01831466|2089829|FG003|Overall Study|Lack of Efficacy|6
1050088|NCT01831466|2089830|FG004|Overall Study|Lack of Efficacy|9
1050089|NCT01831466|2089831|FG005|Overall Study|Lack of Efficacy|8
1050090|NCT01831466|2089832|FG006|Overall Study|Lack of Efficacy|1
1050091|NCT01831466|2089833|FG007|Overall Study|Lack of Efficacy|1
1050092|NCT01831466|2089834|FG008|Overall Study|Lack of Efficacy|2
1050093|NCT01831466|2089835|FG009|Overall Study|Lack of Efficacy|2
1050094|NCT01831466|2089836|FG010|Overall Study|Lack of Efficacy|2
1050095|NCT01831466|2089837|FG011|Overall Study|Lack of Efficacy|0
1050096|NCT01831466|2089826|FG000|Overall Study|Adverse Event|0
1050097|NCT01831466|2089827|FG001|Overall Study|Adverse Event|0
1050098|NCT01831466|2089828|FG002|Overall Study|Adverse Event|4
1050099|NCT01831466|2089829|FG003|Overall Study|Adverse Event|6
1050100|NCT01831466|2089830|FG004|Overall Study|Adverse Event|3
1050101|NCT01831466|2089831|FG005|Overall Study|Adverse Event|7
1050102|NCT01831466|2089832|FG006|Overall Study|Adverse Event|0
1050103|NCT01831466|2089833|FG007|Overall Study|Adverse Event|1
1050104|NCT01831466|2089834|FG008|Overall Study|Adverse Event|1
1050105|NCT01831466|2089835|FG009|Overall Study|Adverse Event|1
1050106|NCT01831466|2089836|FG010|Overall Study|Adverse Event|0
1050107|NCT01831466|2089837|FG011|Overall Study|Adverse Event|2
1050108|NCT01831544|2089857|FG000|Overall Study|Death|1
1050109|NCT01831544|2089857|FG000|Overall Study|Still on original MVAD device|2
1050110|NCT01831726|2089861|FG000|Overall Study|Adverse Event|16
1050111|NCT01831726|2089861|FG000|Overall Study|Death|7
1050112|NCT01831726|2089861|FG000|Overall Study|Disease Progression|49
1050113|NCT01831726|2089861|FG000|Overall Study|Physician Decision|1
1050114|NCT01831726|2089861|FG000|Overall Study|Subject/guardian decision|7
1050115|NCT01831765|2089868|FG000|Overall Study|Lack of Efficacy|1
1050116|NCT01831765|2089869|FG001|Overall Study|Lack of Efficacy|0
1050117|NCT01831765|2089870|FG002|Overall Study|Lack of Efficacy|0
1050118|NCT01831765|2089868|FG000|Overall Study|Other, sponsor withdrew subject|0
1050119|NCT01831765|2089869|FG001|Overall Study|Other, sponsor withdrew subject|1
1050120|NCT01831765|2089870|FG002|Overall Study|Other, sponsor withdrew subject|0
1050121|NCT01831765|2089868|FG000|Overall Study|Pregnancy|1
1050122|NCT01831765|2089869|FG001|Overall Study|Pregnancy|1
1050123|NCT01831765|2089870|FG002|Overall Study|Pregnancy|2
1050124|NCT01831765|2089868|FG000|Overall Study|Death|0
1050125|NCT01831765|2089869|FG001|Overall Study|Death|1
1050126|NCT01831765|2089870|FG002|Overall Study|Death|1
1050127|NCT01831765|2089868|FG000|Overall Study|Other, site closed|1
1050128|NCT01831765|2089869|FG001|Overall Study|Other, site closed|1
1050129|NCT01831765|2089870|FG002|Overall Study|Other, site closed|0
1050130|NCT01831765|2089868|FG000|Overall Study|Adverse Event|5
1050131|NCT01831765|2089869|FG001|Overall Study|Adverse Event|3
1050132|NCT01831765|2089870|FG002|Overall Study|Adverse Event|3
1050133|NCT01831765|2089868|FG000|Overall Study|Withdrawal by Subject|22
1050134|NCT01831765|2089869|FG001|Overall Study|Withdrawal by Subject|7
1050135|NCT01831765|2089870|FG002|Overall Study|Withdrawal by Subject|17
1050136|NCT01831765|2089868|FG000|Overall Study|Withdrawal criteria|12
1050137|NCT01831765|2089869|FG001|Overall Study|Withdrawal criteria|10
1050138|NCT01831765|2089870|FG002|Overall Study|Withdrawal criteria|16
1050139|NCT01831765|2089868|FG000|Overall Study|Lost to Follow-up|2
1050140|NCT01831765|2089869|FG001|Overall Study|Lost to Follow-up|3
1050141|NCT01831765|2089870|FG002|Overall Study|Lost to Follow-up|3
1050142|NCT01831791|2089880|FG000|Overall Study|Withdrawal by Subject|10
1050143|NCT01831804|2089893|FG000|Overall Study|Adverse Event|0
1050144|NCT01831804|2089894|FG001|Overall Study|Adverse Event|0
1050145|NCT01831804|2089895|FG002|Overall Study|Adverse Event|0
1050146|NCT01831804|2089896|FG003|Overall Study|Adverse Event|0
1050147|NCT01831804|2089897|FG004|Overall Study|Adverse Event|0
1050148|NCT01831804|2089898|FG005|Overall Study|Adverse Event|0
1050149|NCT01831804|2089899|FG006|Overall Study|Adverse Event|1
1050150|NCT01831804|2089900|FG007|Overall Study|Adverse Event|0
1050151|NCT01831804|2089901|FG008|Overall Study|Adverse Event|1
1050152|NCT01831804|2089893|FG000|Overall Study|Protocol Violation|0
1050153|NCT01831804|2089894|FG001|Overall Study|Protocol Violation|0
1050154|NCT01831804|2089895|FG002|Overall Study|Protocol Violation|2
1050155|NCT01831804|2089896|FG003|Overall Study|Protocol Violation|0
1050156|NCT01831804|2089897|FG004|Overall Study|Protocol Violation|0
1050157|NCT01831804|2089898|FG005|Overall Study|Protocol Violation|0
1050158|NCT01831804|2089899|FG006|Overall Study|Protocol Violation|0
1050159|NCT01831804|2089900|FG007|Overall Study|Protocol Violation|0
1050160|NCT01831804|2089901|FG008|Overall Study|Protocol Violation|0
1050161|NCT01831804|2089893|FG000|Overall Study|Protocol defined stopping criteria|1
1050162|NCT01831804|2089894|FG001|Overall Study|Protocol defined stopping criteria|1
1050163|NCT01831804|2089895|FG002|Overall Study|Protocol defined stopping criteria|3
1050164|NCT01831804|2089896|FG003|Overall Study|Protocol defined stopping criteria|0
1050165|NCT01831804|2089897|FG004|Overall Study|Protocol defined stopping criteria|1
1050166|NCT01831804|2089898|FG005|Overall Study|Protocol defined stopping criteria|0
1050167|NCT01831804|2089899|FG006|Overall Study|Protocol defined stopping criteria|0
1050168|NCT01831804|2089900|FG007|Overall Study|Protocol defined stopping criteria|0
1050169|NCT01831804|2089901|FG008|Overall Study|Protocol defined stopping criteria|0
1050170|NCT01831804|2089893|FG000|Overall Study|Lost to Follow-up|0
1050171|NCT01831804|2089894|FG001|Overall Study|Lost to Follow-up|0
1050172|NCT01831804|2089895|FG002|Overall Study|Lost to Follow-up|1
1050173|NCT01831804|2089896|FG003|Overall Study|Lost to Follow-up|0
1050174|NCT01831804|2089897|FG004|Overall Study|Lost to Follow-up|0
1050175|NCT01831804|2089898|FG005|Overall Study|Lost to Follow-up|0
1050176|NCT01831804|2089899|FG006|Overall Study|Lost to Follow-up|0
1050177|NCT01831804|2089900|FG007|Overall Study|Lost to Follow-up|0
1050178|NCT01831804|2089901|FG008|Overall Study|Lost to Follow-up|1
1050179|NCT01831804|2089893|FG000|Overall Study|Investigator discretion|0
1050180|NCT01831804|2089894|FG001|Overall Study|Investigator discretion|0
1050181|NCT01831804|2089895|FG002|Overall Study|Investigator discretion|0
1050182|NCT01831804|2089896|FG003|Overall Study|Investigator discretion|0
1050183|NCT01831804|2089897|FG004|Overall Study|Investigator discretion|1
1050184|NCT01831804|2089898|FG005|Overall Study|Investigator discretion|0
1050185|NCT01831804|2089899|FG006|Overall Study|Investigator discretion|0
1050186|NCT01831804|2089900|FG007|Overall Study|Investigator discretion|1
1050187|NCT01831804|2089901|FG008|Overall Study|Investigator discretion|0
1050188|NCT01831804|2089893|FG000|Overall Study|Withdrew Consent|0
1050189|NCT01831804|2089894|FG001|Overall Study|Withdrew Consent|1
1050190|NCT01831804|2089895|FG002|Overall Study|Withdrew Consent|0
1050191|NCT01831804|2089896|FG003|Overall Study|Withdrew Consent|0
1050192|NCT01831804|2089897|FG004|Overall Study|Withdrew Consent|0
1050193|NCT01831804|2089898|FG005|Overall Study|Withdrew Consent|0
1050194|NCT01831804|2089899|FG006|Overall Study|Withdrew Consent|0
1050195|NCT01831804|2089900|FG007|Overall Study|Withdrew Consent|2
1050196|NCT01831804|2089901|FG008|Overall Study|Withdrew Consent|0
1050197|NCT01831817|2089934|FG000|Overall Study|Lost to Follow-up|1
1050198|NCT01831817|2089935|FG001|Overall Study|Lost to Follow-up|0
1050199|NCT01831817|2089936|FG002|Overall Study|Lost to Follow-up|0
1050200|NCT01831817|2089937|FG003|Overall Study|Lost to Follow-up|0
1050201|NCT01831817|2089934|FG000|Overall Study|Withdrawl of Consent|3
1050202|NCT01831817|2089935|FG001|Overall Study|Withdrawl of Consent|0
1050203|NCT01831817|2089936|FG002|Overall Study|Withdrawl of Consent|0
1050204|NCT01831817|2089937|FG003|Overall Study|Withdrawl of Consent|0
1050205|NCT01831856|2089949|FG000|Overall Study|Adverse Event|5
1050206|NCT01831856|2089950|FG001|Overall Study|Adverse Event|8
1050207|NCT01831856|2089949|FG000|Overall Study|Lack of Efficacy|13
1050208|NCT01831856|2089950|FG001|Overall Study|Lack of Efficacy|11
1050209|NCT01831856|2089949|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16
1050210|NCT01831856|2089950|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18
1050211|NCT01832038|2089987|FG000|Overall Study|Death|5
1050212|NCT01832038|2089987|FG000|Overall Study|Adverse Event|50
1050213|NCT01832038|2089987|FG000|Overall Study|Lack of Efficacy|81
1050214|NCT01832038|2089987|FG000|Overall Study|Protocol Violation|7
1050215|NCT01832038|2089987|FG000|Overall Study|Lost to Follow-up|10
1050216|NCT01832038|2089987|FG000|Overall Study|Withdrawal by Subject|49
1050217|NCT01832038|2089987|FG000|Overall Study|Visit non-compliance|2
1050218|NCT01832038|2089987|FG000|Overall Study|Subject refused to return visit|2
1050219|NCT01832038|2089987|FG000|Overall Study|Not convenient to come back to site|2
1050220|NCT01832038|2089987|FG000|Overall Study|Participant was asked to quit|5
1050221|NCT01832038|2089987|FG000|Overall Study|Back home|1
1050222|NCT01832038|2089987|FG000|Overall Study|Pregnancy|1
1050223|NCT01832038|2089987|FG000|Overall Study|Low compliance|3
1050224|NCT01832038|2089987|FG000|Overall Study|Prohibit procedure|2
1050225|NCT01832038|2089987|FG000|Overall Study|Not possible to visit the hospital|1
1050226|NCT01832038|2089987|FG000|Overall Study|Changes of implementation system|3
1050227|NCT01832038|2089987|FG000|Overall Study|Plan to pregnancy|7
1050228|NCT01832038|2089987|FG000|Overall Study|Bad mood and has suicidal thought|1
1050229|NCT01832038|2089987|FG000|Overall Study|Prohibited concomitant medication|1
1050230|NCT01832038|2089987|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1
1050231|NCT01832038|2089987|FG000|Overall Study|Subject considered the efficacy was poor|1
1050232|NCT01832155|2090023|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
1050233|NCT01832155|2090024|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
1050234|NCT01832155|2090023|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
1050235|NCT01832155|2090024|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
1050236|NCT01832402|2090047|FG000|Overall Study|Lost to Follow-up|2
1050237|NCT01832402|2090048|FG001|Overall Study|Lost to Follow-up|0
1050238|NCT01832402|2090047|FG000|Overall Study|Withdrawal by Subject|3
1050239|NCT01832402|2090048|FG001|Overall Study|Withdrawal by Subject|3
1050240|NCT01832402|2090047|FG000|Overall Study|Declining Performance status|2
1050241|NCT01832402|2090048|FG001|Overall Study|Declining Performance status|1
1050242|NCT01832480|2090060|FG000|Overall Study|Lost to Follow-up|33
1050243|NCT01832480|2090061|FG001|Overall Study|Lost to Follow-up|30
1050244|NCT01832480|2090060|FG000|Overall Study|Withdrawal by Subject|0
1050245|NCT01832480|2090061|FG001|Overall Study|Withdrawal by Subject|2
1050246|NCT01832480|2090060|FG000|Overall Study|post randomization ineligible|8
1050247|NCT01832480|2090061|FG001|Overall Study|post randomization ineligible|10
1050248|NCT01832493|2090067|FG000|Overall Study|Physician Decision|2
1050249|NCT01832493|2090067|FG000|Overall Study|Protocol Violation|4
1050250|NCT01832493|2090067|FG000|Overall Study|Unable to place LV lead|2
1050251|NCT01832532|2090091|FG000|Overall Study|Withdrawal by Subject|5
1050252|NCT01832532|2090092|FG001|Overall Study|Withdrawal by Subject|2
1050253|NCT01832727|2090111|FG000|Overall Study|Adverse Event|4
1050254|NCT01832727|2090112|FG001|Overall Study|Adverse Event|6
1050255|NCT01832727|2090113|FG002|Overall Study|Adverse Event|1
906782|NCT00770913|1882637|FG002|Overall Study|Protocol Violation|1
1050256|NCT01832727|2090114|FG003|Overall Study|Adverse Event|0
1050257|NCT01832727|2090115|FG004|Overall Study|Adverse Event|1
1050258|NCT01832727|2090116|FG005|Overall Study|Adverse Event|1
1050259|NCT01832727|2090117|FG006|Overall Study|Adverse Event|2
1050260|NCT01832727|2090118|FG007|Overall Study|Adverse Event|1
1050261|NCT01832727|2090119|FG008|Overall Study|Adverse Event|9
1050262|NCT01832727|2090111|FG000|Overall Study|Disease progression|3
1050263|NCT01832727|2090112|FG001|Overall Study|Disease progression|0
1050264|NCT01832727|2090113|FG002|Overall Study|Disease progression|2
1050265|NCT01832727|2090114|FG003|Overall Study|Disease progression|1
1050266|NCT01832727|2090115|FG004|Overall Study|Disease progression|3
1050267|NCT01832727|2090116|FG005|Overall Study|Disease progression|3
1050268|NCT01832727|2090117|FG006|Overall Study|Disease progression|6
1050269|NCT01832727|2090118|FG007|Overall Study|Disease progression|2
1050270|NCT01832727|2090119|FG008|Overall Study|Disease progression|7
1050271|NCT01832727|2090111|FG000|Overall Study|Lost to Follow-up|0
1050272|NCT01832727|2090112|FG001|Overall Study|Lost to Follow-up|0
1050273|NCT01832727|2090113|FG002|Overall Study|Lost to Follow-up|0
1050274|NCT01832727|2090114|FG003|Overall Study|Lost to Follow-up|1
1050275|NCT01832727|2090115|FG004|Overall Study|Lost to Follow-up|0
1050276|NCT01832727|2090116|FG005|Overall Study|Lost to Follow-up|0
1050277|NCT01832727|2090117|FG006|Overall Study|Lost to Follow-up|0
1050278|NCT01832727|2090118|FG007|Overall Study|Lost to Follow-up|0
1050279|NCT01832727|2090119|FG008|Overall Study|Lost to Follow-up|0
1050280|NCT01832727|2090111|FG000|Overall Study|Physician Decision|1
1050281|NCT01832727|2090112|FG001|Overall Study|Physician Decision|0
1050282|NCT01832727|2090113|FG002|Overall Study|Physician Decision|0
1050283|NCT01832727|2090114|FG003|Overall Study|Physician Decision|1
1050284|NCT01832727|2090115|FG004|Overall Study|Physician Decision|0
1050285|NCT01832727|2090116|FG005|Overall Study|Physician Decision|1
1050286|NCT01832727|2090117|FG006|Overall Study|Physician Decision|0
1050287|NCT01832727|2090118|FG007|Overall Study|Physician Decision|0
1050288|NCT01832727|2090119|FG008|Overall Study|Physician Decision|0
1050289|NCT01832727|2090111|FG000|Overall Study|Withdrawal by Subject|1
1050290|NCT01832727|2090112|FG001|Overall Study|Withdrawal by Subject|1
1050291|NCT01832727|2090113|FG002|Overall Study|Withdrawal by Subject|0
1050292|NCT01832727|2090114|FG003|Overall Study|Withdrawal by Subject|1
1050293|NCT01832727|2090115|FG004|Overall Study|Withdrawal by Subject|0
1050294|NCT01832727|2090116|FG005|Overall Study|Withdrawal by Subject|1
1050295|NCT01832727|2090117|FG006|Overall Study|Withdrawal by Subject|0
1050296|NCT01832727|2090118|FG007|Overall Study|Withdrawal by Subject|2
1050297|NCT01832727|2090119|FG008|Overall Study|Withdrawal by Subject|1
1050298|NCT01832727|2090111|FG000|Overall Study|Study terminated by sponsor|0
1050299|NCT01832727|2090112|FG001|Overall Study|Study terminated by sponsor|0
1050300|NCT01832727|2090113|FG002|Overall Study|Study terminated by sponsor|0
1050301|NCT01832727|2090114|FG003|Overall Study|Study terminated by sponsor|0
1050302|NCT01832727|2090115|FG004|Overall Study|Study terminated by sponsor|0
1050303|NCT01832727|2090116|FG005|Overall Study|Study terminated by sponsor|0
1050304|NCT01832727|2090117|FG006|Overall Study|Study terminated by sponsor|0
1050305|NCT01832727|2090118|FG007|Overall Study|Study terminated by sponsor|1
1050306|NCT01832727|2090119|FG008|Overall Study|Study terminated by sponsor|1
1050307|NCT01832766|2090162|FG000|Washout|Lost to Follow-up|0
1050308|NCT01832766|2090163|FG001|Washout|Lost to Follow-up|1
1050309|NCT01832818|2090169|FG000|Overall Study|Lost to Follow-up|6
1050310|NCT01833065|2090201|FG000|Overall Study|Adverse Event|6
1050311|NCT01833065|2090202|FG001|Overall Study|Adverse Event|1
1050312|NCT01833065|2090203|FG002|Overall Study|Adverse Event|0
1050313|NCT01833065|2090204|FG003|Overall Study|Adverse Event|2
1050314|NCT01833065|2090205|FG004|Overall Study|Adverse Event|3
1050315|NCT01833065|2090201|FG000|Overall Study|Protocol Violation|1
1050316|NCT01833065|2090202|FG001|Overall Study|Protocol Violation|0
1050317|NCT01833065|2090203|FG002|Overall Study|Protocol Violation|0
1050318|NCT01833065|2090204|FG003|Overall Study|Protocol Violation|0
906783|NCT00770913|1882635|FG000|Overall Study|Incorrect drug was allocated|1
906784|NCT00770913|1882636|FG001|Overall Study|Incorrect drug was allocated|0
1050319|NCT01833065|2090205|FG004|Overall Study|Protocol Violation|2
1050320|NCT01833065|2090201|FG000|Overall Study|Lost to Follow-up|1
1050321|NCT01833065|2090202|FG001|Overall Study|Lost to Follow-up|0
1050322|NCT01833065|2090203|FG002|Overall Study|Lost to Follow-up|0
1050323|NCT01833065|2090204|FG003|Overall Study|Lost to Follow-up|0
1050324|NCT01833065|2090205|FG004|Overall Study|Lost to Follow-up|3
1050325|NCT01833065|2090201|FG000|Overall Study|Withdrawal by Subject|6
1050326|NCT01833065|2090202|FG001|Overall Study|Withdrawal by Subject|2
1050327|NCT01833065|2090203|FG002|Overall Study|Withdrawal by Subject|4
1050328|NCT01833065|2090204|FG003|Overall Study|Withdrawal by Subject|3
1050329|NCT01833065|2090205|FG004|Overall Study|Withdrawal by Subject|11
1050330|NCT01833065|2090201|FG000|Overall Study|Subject's substantial non-compliance|0
1050331|NCT01833065|2090202|FG001|Overall Study|Subject's substantial non-compliance|1
1050332|NCT01833065|2090203|FG002|Overall Study|Subject's substantial non-compliance|0
1050333|NCT01833065|2090204|FG003|Overall Study|Subject's substantial non-compliance|0
1050334|NCT01833065|2090205|FG004|Overall Study|Subject's substantial non-compliance|0
1050335|NCT01833065|2090201|FG000|Overall Study|Trial terminated by sponsor|8
1050336|NCT01833065|2090202|FG001|Overall Study|Trial terminated by sponsor|8
1050337|NCT01833065|2090203|FG002|Overall Study|Trial terminated by sponsor|7
1050338|NCT01833065|2090204|FG003|Overall Study|Trial terminated by sponsor|3
1050339|NCT01833065|2090205|FG004|Overall Study|Trial terminated by sponsor|13
1050340|NCT01833065|2090201|FG000|Overall Study|Others|2
1050341|NCT01833065|2090202|FG001|Overall Study|Others|1
1050342|NCT01833065|2090203|FG002|Overall Study|Others|1
1050343|NCT01833065|2090204|FG003|Overall Study|Others|1
1050344|NCT01833065|2090205|FG004|Overall Study|Others|4
1050345|NCT01833143|2090237|FG000|Overall Study|Not Treated|1
1050346|NCT01833169|2090241|FG000|Overall Study|Disease Progression|99
1050347|NCT01833169|2090241|FG000|Overall Study|Adverse Event|33
1050348|NCT01833169|2090241|FG000|Overall Study|Withdrawal by Subject|9
1050349|NCT01833169|2090241|FG000|Overall Study|Death|3
906785|NCT00770913|1882637|FG002|Overall Study|Incorrect drug was allocated|0
906786|NCT00770991|1882647|FG000|Overall Study|Physician Decision|2
906787|NCT00770991|1882648|FG001|Overall Study|Physician Decision|0
906788|NCT00770991|1882647|FG000|Overall Study|Withdrawal by Subject|1
906789|NCT00770991|1882648|FG001|Overall Study|Withdrawal by Subject|0
1050350|NCT01833169|2090241|FG000|Overall Study|Physician Decision|2
1050351|NCT01833455|2090256|FG000|Overall Study|Withdrawal by Subject|1
1050352|NCT01833455|2090257|FG001|Overall Study|Withdrawal by Subject|0
1050353|NCT01833494|2090288|FG000|Overall Study|Adverse Event|24
1050354|NCT01833494|2090288|FG000|Overall Study|Physician Decision|6
1050355|NCT01833494|2090288|FG000|Overall Study|Withdrawal by Subject|6
1050356|NCT01833494|2090288|FG000|Overall Study|Decrease in serum phosphorus|4
1050357|NCT01833494|2090288|FG000|Overall Study|Decrease in serum calcium|4
1050358|NCT01833494|2090288|FG000|Overall Study|Increase in serum ferritin|1
1050359|NCT01833520|2090294|FG000|Overall Study|Lack of Efficacy|3
1050360|NCT01833520|2090295|FG001|Overall Study|Lack of Efficacy|3
1050361|NCT01833520|2090296|FG002|Overall Study|Lack of Efficacy|8
1050362|NCT01833520|2090297|FG003|Overall Study|Lack of Efficacy|3
1050363|NCT01833533|2090311|FG000|Overall Study|Adverse Event|0
1050364|NCT01833533|2090312|FG001|Overall Study|Adverse Event|1
1050365|NCT01833533|2090311|FG000|Overall Study|Lost to Follow-up|4
1050366|NCT01833533|2090312|FG001|Overall Study|Lost to Follow-up|9
1050367|NCT01833533|2090311|FG000|Overall Study|To Enter an Extension Study|0
1050368|NCT01833533|2090312|FG001|Overall Study|To Enter an Extension Study|4
1050369|NCT01833533|2090311|FG000|Overall Study|Other|2
1050370|NCT01833533|2090312|FG001|Overall Study|Other|7
1050371|NCT01833832|2090353|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1
1050372|NCT01833897|2090361|FG000|Overall Study|Lack of Efficacy|1
1050373|NCT01834222|2090395|FG000|Overall Study|Not meet inclusion/exclusion criteria|1
1050374|NCT01834274|2090410|FG000|Overall Study|Study Termination|41
1050375|NCT01834274|2090411|FG001|Overall Study|Study Termination|38
1050376|NCT01834274|2090410|FG000|Overall Study|Withdrawal by Subject|1
1050377|NCT01834274|2090411|FG001|Overall Study|Withdrawal by Subject|1
1050378|NCT01834274|2090410|FG000|Overall Study|Lost to Follow-up|3
1050379|NCT01834274|2090411|FG001|Overall Study|Lost to Follow-up|1
1050380|NCT01834274|2090410|FG000|Overall Study|Other|2
1050381|NCT01834274|2090411|FG001|Overall Study|Other|1
1050382|NCT01834586|2090435|FG000|Overall Study|Adverse Event|1
1050383|NCT01834729|2090458|FG000|Overall Study|Did not return bowel diaries|0
1050384|NCT01834729|2090459|FG001|Overall Study|Did not return bowel diaries|0
1050385|NCT01834729|2090460|FG002|Overall Study|Did not return bowel diaries|3
1050386|NCT01834729|2090461|FG003|Overall Study|Did not return bowel diaries|0
1050387|NCT01834729|2090458|FG000|Overall Study|Withdrawal by Subject|1
1050388|NCT01834729|2090459|FG001|Overall Study|Withdrawal by Subject|1
1050389|NCT01834729|2090460|FG002|Overall Study|Withdrawal by Subject|0
1050390|NCT01834729|2090461|FG003|Overall Study|Withdrawal by Subject|0
1050391|NCT01834729|2090458|FG000|Overall Study|Adverse Event|0
1050392|NCT01834729|2090459|FG001|Overall Study|Adverse Event|0
1050393|NCT01834729|2090460|FG002|Overall Study|Adverse Event|0
1050394|NCT01834729|2090461|FG003|Overall Study|Adverse Event|2
1050395|NCT01835015|2090477|FG000|Overall Study|Adverse Event|0
1050396|NCT01835015|2090478|FG001|Overall Study|Adverse Event|0
1050397|NCT01835015|2090479|FG002|Overall Study|Adverse Event|1
1050398|NCT01835015|2090480|FG003|Overall Study|Adverse Event|0
1050399|NCT01835015|2090481|FG004|Overall Study|Adverse Event|0
1050400|NCT01835132|2090494|FG000|Initial Phase|Insufficient Therapeutic Response|2
1050403|NCT01835158|2090511|FG000|Overall Study|Withdrawal by Subject|1
1050404|NCT01835158|2090512|FG001|Overall Study|Withdrawal by Subject|6
1050405|NCT01835223|2090520|FG000|Overall Study|Adverse Event|1
1050406|NCT01835223|2090521|FG001|Overall Study|Adverse Event|0
1050407|NCT01835223|2090520|FG000|Overall Study|Withdrawal by Subject|2
1050408|NCT01835223|2090521|FG001|Overall Study|Withdrawal by Subject|0
1050409|NCT01835223|2090520|FG000|Overall Study|Disease progression|2
906790|NCT00770991|1882647|FG000|Overall Study|Adverse Event|1
906791|NCT00770991|1882648|FG001|Overall Study|Adverse Event|5
906792|NCT00770991|1882647|FG000|Overall Study|Pregnancy|1
906793|NCT00770991|1882648|FG001|Overall Study|Pregnancy|0
906794|NCT00771030|1882666|FG000|Overall Study|Adverse Event|0
906795|NCT00771030|1882667|FG001|Overall Study|Adverse Event|1
906796|NCT00771030|1882668|FG002|Overall Study|Adverse Event|0
906797|NCT00771030|1882669|FG003|Overall Study|Adverse Event|0
906798|NCT00771030|1882670|FG004|Overall Study|Adverse Event|0
906799|NCT00771030|1882671|FG005|Overall Study|Adverse Event|0
906800|NCT00771030|1882672|FG006|Overall Study|Adverse Event|0
906801|NCT00771472|1882737|FG000|Overall Study|Physician Decision|2
906802|NCT00771472|1882738|FG001|Overall Study|Physician Decision|3
906803|NCT00771472|1882737|FG000|Overall Study|Progressive Disease|3
906804|NCT00771472|1882738|FG001|Overall Study|Progressive Disease|1
906805|NCT00771472|1882737|FG000|Overall Study|Protocol Violation|1
906806|NCT00771472|1882738|FG001|Overall Study|Protocol Violation|0
906807|NCT00771615|1882809|FG000|Overall Study|Withdrawal by Subject|0
906808|NCT00771615|1882810|FG001|Overall Study|Withdrawal by Subject|1
906809|NCT00771615|1882811|FG002|Overall Study|Withdrawal by Subject|0
1050410|NCT01835223|2090521|FG001|Overall Study|Disease progression|1
1050411|NCT01835223|2090520|FG000|Overall Study|Became Inelligible|4
1050412|NCT01835223|2090521|FG001|Overall Study|Became Inelligible|0
1050413|NCT01835431|2090549|FG000|Overall Study|Adverse Event|1
1050414|NCT01835431|2090550|FG001|Overall Study|Adverse Event|0
1050415|NCT01835431|2090549|FG000|Overall Study|other|0
1050416|NCT01835431|2090550|FG001|Overall Study|other|2
1050417|NCT01835431|2090549|FG000|Overall Study|Withdrawal by Subject|6
1050418|NCT01835431|2090550|FG001|Overall Study|Withdrawal by Subject|10
1050419|NCT01835431|2090549|FG000|Overall Study|Protocol Violation|1
1050420|NCT01835431|2090550|FG001|Overall Study|Protocol Violation|0
1050421|NCT01835470|2090556|FG000|Long Term Treatment Period|Subject Request to Discontinue|1
1050422|NCT01835470|2090556|FG000|Long Term Treatment Period|Lack of Efficacy|3
1050423|NCT01835548|2090567|FG000|Dose Optimization Period|Adverse Event|0
1050424|NCT01835548|2090568|FG001|Dose Optimization Period|Adverse Event|0
1050425|NCT01835548|2090569|FG002|Dose Optimization Period|Adverse Event|1
1050426|NCT01835548|2090567|FG000|Dose Optimization Period|Withdrawal by Subject|0
1050427|NCT01835548|2090568|FG001|Dose Optimization Period|Withdrawal by Subject|0
1050428|NCT01835548|2090569|FG002|Dose Optimization Period|Withdrawal by Subject|1
1050429|NCT01835548|2090567|FG000|Double-Blind Treatment Period|Adverse Event|0
1050430|NCT01835548|2090568|FG001|Double-Blind Treatment Period|Adverse Event|1
1050431|NCT01835548|2090569|FG002|Double-Blind Treatment Period|Adverse Event|0
1050432|NCT01835548|2090567|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
1050433|NCT01835548|2090568|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
1050434|NCT01835548|2090569|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0
1050435|NCT01835587|2090585|FG000|Overall Study|Disease Recurrence or Relapse|0
1050436|NCT01835587|2090586|FG001|Overall Study|Disease Recurrence or Relapse|3
1050437|NCT01835587|2090587|FG002|Overall Study|Disease Recurrence or Relapse|0
1050438|NCT01835587|2090588|FG003|Overall Study|Disease Recurrence or Relapse|3
1050439|NCT01835587|2090585|FG000|Overall Study|Withdrawal by Subject|2
1050440|NCT01835587|2090586|FG001|Overall Study|Withdrawal by Subject|0
1050441|NCT01835587|2090587|FG002|Overall Study|Withdrawal by Subject|0
1050442|NCT01835587|2090588|FG003|Overall Study|Withdrawal by Subject|3
1050443|NCT01835587|2090585|FG000|Overall Study|Adverse Event|0
1050444|NCT01835587|2090586|FG001|Overall Study|Adverse Event|0
1050445|NCT01835587|2090587|FG002|Overall Study|Adverse Event|2
1050446|NCT01835587|2090588|FG003|Overall Study|Adverse Event|2
1050447|NCT01835587|2090585|FG000|Overall Study|Death|0
1050448|NCT01835587|2090586|FG001|Overall Study|Death|0
1050449|NCT01835587|2090587|FG002|Overall Study|Death|0
1050450|NCT01835587|2090588|FG003|Overall Study|Death|1
1050451|NCT01835587|2090585|FG000|Overall Study|Miscellaneous|0
1050452|NCT01835587|2090586|FG001|Overall Study|Miscellaneous|1
1050453|NCT01835587|2090587|FG002|Overall Study|Miscellaneous|0
1050454|NCT01835587|2090588|FG003|Overall Study|Miscellaneous|0
1050455|NCT01835899|2090632|FG000|Overall Study|Adverse Event|0
1050456|NCT01835899|2090633|FG001|Overall Study|Adverse Event|0
1050457|NCT01835899|2090634|FG002|Overall Study|Adverse Event|1
1050458|NCT01835899|2090632|FG000|Overall Study|Other than stated above|0
1050459|NCT01835899|2090633|FG001|Overall Study|Other than stated above|1
1050460|NCT01835899|2090634|FG002|Overall Study|Other than stated above|0
1050461|NCT01836198|2090699|FG000|Part A, Period 2|Protocol Violation|0
1050462|NCT01836198|2090700|FG001|Part A, Period 2|Protocol Violation|1
1050463|NCT01836198|2090701|FG002|Part A, Period 2|Protocol Violation|0
1050464|NCT01836276|2090719|FG000|Overall Study|Lost to Follow-up|28
1050465|NCT01836276|2090720|FG001|Overall Study|Lost to Follow-up|51
1050466|NCT01836458|2090739|FG000|Overall Study|Unsatisfactory therapeutic effect|3
1050467|NCT01836458|2090740|FG001|Overall Study|Unsatisfactory therapeutic effect|2
1050468|NCT01836458|2090741|FG002|Overall Study|Unsatisfactory therapeutic effect|5
1050469|NCT01836458|2090742|FG003|Overall Study|Unsatisfactory therapeutic effect|6
1050470|NCT01836471|2090757|FG000|Overall Study|Pregnancy|1
1050471|NCT01836471|2090758|FG001|Overall Study|Pregnancy|0
1050472|NCT01836471|2090759|FG002|Overall Study|Pregnancy|0
1050473|NCT01836471|2090760|FG003|Overall Study|Pregnancy|0
1050474|NCT01836471|2090761|FG004|Overall Study|Pregnancy|0
1050475|NCT01836471|2090757|FG000|Overall Study|Withdrawal by Subject|3
1050476|NCT01836471|2090758|FG001|Overall Study|Withdrawal by Subject|4
1050477|NCT01836471|2090759|FG002|Overall Study|Withdrawal by Subject|1
1050478|NCT01836471|2090760|FG003|Overall Study|Withdrawal by Subject|0
1050479|NCT01836471|2090761|FG004|Overall Study|Withdrawal by Subject|2
1050480|NCT01836471|2090757|FG000|Overall Study|Physician Decision|0
1050481|NCT01836471|2090758|FG001|Overall Study|Physician Decision|1
1050482|NCT01836471|2090759|FG002|Overall Study|Physician Decision|0
1050483|NCT01836471|2090760|FG003|Overall Study|Physician Decision|0
1050484|NCT01836471|2090761|FG004|Overall Study|Physician Decision|0
1050485|NCT01836471|2090757|FG000|Overall Study|Lost to Follow-up|0
1050486|NCT01836471|2090758|FG001|Overall Study|Lost to Follow-up|0
1050487|NCT01836471|2090759|FG002|Overall Study|Lost to Follow-up|0
1050488|NCT01836471|2090760|FG003|Overall Study|Lost to Follow-up|1
1050489|NCT01836471|2090761|FG004|Overall Study|Lost to Follow-up|1
1050490|NCT01836471|2090757|FG000|Overall Study|Adverse Event|6
1050491|NCT01836471|2090758|FG001|Overall Study|Adverse Event|3
1050492|NCT01836471|2090759|FG002|Overall Study|Adverse Event|1
1050493|NCT01836471|2090760|FG003|Overall Study|Adverse Event|1
1050494|NCT01836471|2090761|FG004|Overall Study|Adverse Event|2
1050495|NCT01836471|2090757|FG000|Overall Study|Non compliance with tx|1
1050496|NCT01836471|2090758|FG001|Overall Study|Non compliance with tx|1
1050497|NCT01836471|2090759|FG002|Overall Study|Non compliance with tx|0
1050498|NCT01836471|2090760|FG003|Overall Study|Non compliance with tx|0
1050499|NCT01836471|2090761|FG004|Overall Study|Non compliance with tx|0
1050500|NCT01836523|2090778|FG000|Overall Study|Adverse Event|15
1050501|NCT01836523|2090779|FG001|Overall Study|Adverse Event|41
1050502|NCT01836523|2090780|FG002|Overall Study|Adverse Event|49
1050503|NCT01836523|2090781|FG003|Overall Study|Adverse Event|14
1050504|NCT01836523|2090778|FG000|Overall Study|Protocol Violation|6
1050505|NCT01836523|2090779|FG001|Overall Study|Protocol Violation|3
1050506|NCT01836523|2090780|FG002|Overall Study|Protocol Violation|2
1050507|NCT01836523|2090781|FG003|Overall Study|Protocol Violation|4
1050508|NCT01836523|2090778|FG000|Overall Study|Met Withdrawal Criteria|13
1050509|NCT01836523|2090779|FG001|Overall Study|Met Withdrawal Criteria|13
1050510|NCT01836523|2090780|FG002|Overall Study|Met Withdrawal Criteria|21
1050511|NCT01836523|2090781|FG003|Overall Study|Met Withdrawal Criteria|27
1050512|NCT01836523|2090778|FG000|Overall Study|Unclassified|17
1050513|NCT01836523|2090779|FG001|Overall Study|Unclassified|28
1050514|NCT01836523|2090780|FG002|Overall Study|Unclassified|19
1050515|NCT01836523|2090781|FG003|Overall Study|Unclassified|29
1050516|NCT01836549|2090797|FG000|Overall Study|Did not receive study drug|0
1050517|NCT01836549|2090798|FG001|Overall Study|Did not receive study drug|0
1050518|NCT01836549|2090799|FG002|Overall Study|Did not receive study drug|1
1050519|NCT01836549|2090800|FG003|Overall Study|Did not receive study drug|0
1050520|NCT01836549|2090801|FG004|Overall Study|Did not receive study drug|0
1050521|NCT01836549|2090802|FG005|Overall Study|Did not receive study drug|0
1050522|NCT01836549|2090803|FG006|Overall Study|Did not receive study drug|0
1050523|NCT01836549|2090797|FG000|Overall Study|Patient declared ineligible|0
1050524|NCT01836549|2090798|FG001|Overall Study|Patient declared ineligible|0
1050525|NCT01836549|2090799|FG002|Overall Study|Patient declared ineligible|0
1050526|NCT01836549|2090800|FG003|Overall Study|Patient declared ineligible|1
1050527|NCT01836549|2090801|FG004|Overall Study|Patient declared ineligible|0
1050528|NCT01836549|2090802|FG005|Overall Study|Patient declared ineligible|0
1050529|NCT01836549|2090803|FG006|Overall Study|Patient declared ineligible|0
1050530|NCT01836549|2090797|FG000|Overall Study|Patient inevaluable to start therapy|0
1050531|NCT01836549|2090798|FG001|Overall Study|Patient inevaluable to start therapy|0
1050532|NCT01836549|2090799|FG002|Overall Study|Patient inevaluable to start therapy|0
1050533|NCT01836549|2090800|FG003|Overall Study|Patient inevaluable to start therapy|0
1050534|NCT01836549|2090801|FG004|Overall Study|Patient inevaluable to start therapy|0
1050535|NCT01836549|2090802|FG005|Overall Study|Patient inevaluable to start therapy|0
1050536|NCT01836549|2090803|FG006|Overall Study|Patient inevaluable to start therapy|1
1050537|NCT01837680|2090861|FG000|Overall Study|Lost to Follow-up|2
1050538|NCT01837680|2090862|FG001|Overall Study|Lost to Follow-up|2
1050539|NCT01837680|2090861|FG000|Overall Study|lack of insurance|0
1050540|NCT01837680|2090862|FG001|Overall Study|lack of insurance|2
1050541|NCT01837680|2090861|FG000|Overall Study|allergic reaction|6
1050542|NCT01837680|2090862|FG001|Overall Study|allergic reaction|0
1050543|NCT01837680|2090861|FG000|Overall Study|switched to oral hypoglycemic or diet|2
1050544|NCT01837680|2090862|FG001|Overall Study|switched to oral hypoglycemic or diet|4
1050545|NCT01837719|2090868|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
1050546|NCT01837719|2090868|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
1050547|NCT01837797|2090886|FG000|Period 1|Adverse Event|9
1050548|NCT01837797|2090887|FG001|Period 1|Adverse Event|0
1050549|NCT01837797|2090888|FG002|Period 1|Adverse Event|0
1050550|NCT01837797|2090889|FG003|Period 1|Adverse Event|0
1050551|NCT01837797|2090890|FG004|Period 1|Adverse Event|0
1050552|NCT01837797|2090886|FG000|Period 1|Withdrawal by Subject|6
1050553|NCT01837797|2090887|FG001|Period 1|Withdrawal by Subject|0
1050554|NCT01837797|2090888|FG002|Period 1|Withdrawal by Subject|0
1050555|NCT01837797|2090889|FG003|Period 1|Withdrawal by Subject|0
1050556|NCT01837797|2090890|FG004|Period 1|Withdrawal by Subject|0
1050557|NCT01837797|2090886|FG000|Period 1|Administrative reasons|76
1050558|NCT01837797|2090887|FG001|Period 1|Administrative reasons|0
1050559|NCT01837797|2090888|FG002|Period 1|Administrative reasons|0
1050560|NCT01837797|2090889|FG003|Period 1|Administrative reasons|0
1050561|NCT01837797|2090890|FG004|Period 1|Administrative reasons|0
1050562|NCT01837797|2090886|FG000|Period 1|Withdrawal of consent before treatment|1
1050563|NCT01837797|2090887|FG001|Period 1|Withdrawal of consent before treatment|0
1050564|NCT01837797|2090888|FG002|Period 1|Withdrawal of consent before treatment|0
1050565|NCT01837797|2090889|FG003|Period 1|Withdrawal of consent before treatment|0
1050566|NCT01837797|2090890|FG004|Period 1|Withdrawal of consent before treatment|0
1050567|NCT01837797|2090886|FG000|Period 1|Other|10
1050568|NCT01837797|2090887|FG001|Period 1|Other|0
1050569|NCT01837797|2090888|FG002|Period 1|Other|0
1050570|NCT01837797|2090889|FG003|Period 1|Other|0
1050571|NCT01837797|2090890|FG004|Period 1|Other|0
1050572|NCT01837797|2090886|FG000|Period 2|Administrative or other reasons|0
1050573|NCT01837797|2090887|FG001|Period 2|Administrative or other reasons|5
1050574|NCT01837797|2090888|FG002|Period 2|Administrative or other reasons|2
1050575|NCT01837797|2090889|FG003|Period 2|Administrative or other reasons|4
1050576|NCT01837797|2090890|FG004|Period 2|Administrative or other reasons|0
1050577|NCT01837797|2090886|FG000|Period 2|Adverse Event|0
1050578|NCT01837797|2090887|FG001|Period 2|Adverse Event|0
1050579|NCT01837797|2090888|FG002|Period 2|Adverse Event|0
1050580|NCT01837797|2090889|FG003|Period 2|Adverse Event|1
1050581|NCT01837797|2090890|FG004|Period 2|Adverse Event|0
1050582|NCT01837797|2090886|FG000|Period 3|Adverse Event|0
1050583|NCT01837797|2090887|FG001|Period 3|Adverse Event|0
1050584|NCT01837797|2090888|FG002|Period 3|Adverse Event|0
1050585|NCT01837797|2090889|FG003|Period 3|Adverse Event|0
1050586|NCT01837797|2090890|FG004|Period 3|Adverse Event|1
1050587|NCT01837797|2090886|FG000|Period 3|Administrative reasons|0
1050588|NCT01837797|2090887|FG001|Period 3|Administrative reasons|0
1050589|NCT01837797|2090888|FG002|Period 3|Administrative reasons|0
1050590|NCT01837797|2090889|FG003|Period 3|Administrative reasons|0
1050591|NCT01837797|2090890|FG004|Period 3|Administrative reasons|20
1050592|NCT01837797|2090886|FG000|Period 3|Other|0
1050593|NCT01837797|2090887|FG001|Period 3|Other|0
1050594|NCT01837797|2090888|FG002|Period 3|Other|0
1050595|NCT01837797|2090889|FG003|Period 3|Other|0
1050596|NCT01837797|2090890|FG004|Period 3|Other|2
1050597|NCT01837823|2090898|FG000|Overall Study|Lost to Follow-up|6
1050598|NCT01837966|2090921|FG000|Overall Study|Withdrawal by Subject|2
1050599|NCT01837966|2090922|FG001|Overall Study|Withdrawal by Subject|1
1050600|NCT01838044|2090930|FG000|Overall Study|Adverse Event|4
1050601|NCT01838044|2090931|FG001|Overall Study|Adverse Event|6
1050602|NCT01838044|2090930|FG000|Overall Study|Protocol Violation|3
1050603|NCT01838044|2090931|FG001|Overall Study|Protocol Violation|3
1050604|NCT01838044|2090930|FG000|Overall Study|Withdrawal by Subject|0
1050605|NCT01838044|2090931|FG001|Overall Study|Withdrawal by Subject|2
1050606|NCT01838044|2090930|FG000|Overall Study|Insufficient clinical response|1
1050607|NCT01838044|2090931|FG001|Overall Study|Insufficient clinical response|2
1050608|NCT01838044|2090930|FG000|Overall Study|Medication error without associated AE|0
1050609|NCT01838044|2090931|FG001|Overall Study|Medication error without associated AE|1
1050610|NCT01838044|2090930|FG000|Overall Study|Lost to Follow-up|0
1050611|NCT01838044|2090931|FG001|Overall Study|Lost to Follow-up|2
1050612|NCT01838200|2090940|FG000|Overall Study|Adverse Event|0
1050613|NCT01838200|2090941|FG001|Overall Study|Adverse Event|2
1050614|NCT01838200|2090940|FG000|Overall Study|Progressive disease|3
1050615|NCT01838200|2090941|FG001|Overall Study|Progressive disease|0
1050616|NCT01838213|2090949|FG000|Overall Study|Ineligible|166
1050617|NCT01838213|2090950|FG001|Overall Study|Ineligible|191
1050618|NCT01838447|2090985|FG000|Overall Study|Change in surgical plan|1
1050619|NCT01838447|2090986|FG001|Overall Study|Change in surgical plan|2
1050620|NCT01838447|2090985|FG000|Overall Study|Withdrawal by Subject|1
1050621|NCT01838447|2090986|FG001|Overall Study|Withdrawal by Subject|1
1050622|NCT01838499|2090994|FG000|Overall Study|Protocol Violation|0
1050623|NCT01838499|2090995|FG001|Overall Study|Protocol Violation|1
1050624|NCT01838499|2090994|FG000|Overall Study|Lost to Follow-up|2
1050625|NCT01838499|2090995|FG001|Overall Study|Lost to Follow-up|4
1050626|NCT01838499|2090994|FG000|Overall Study|Lack of Efficacy|1
1050627|NCT01838499|2090995|FG001|Overall Study|Lack of Efficacy|2
1050628|NCT01838499|2090994|FG000|Overall Study|Adverse Event|2
1050629|NCT01838499|2090995|FG001|Overall Study|Adverse Event|1
1050630|NCT01838499|2090994|FG000|Overall Study|Withdrawal by Subject|19
1050631|NCT01838499|2090995|FG001|Overall Study|Withdrawal by Subject|9
1050632|NCT01838551|2091001|FG000|Overall Study|Adverse Event|16
1050633|NCT01838551|2091001|FG000|Overall Study|Death|1
1050634|NCT01838551|2091001|FG000|Overall Study|Lack of Efficacy|10
1050635|NCT01838551|2091001|FG000|Overall Study|Physician Decision|4
1050636|NCT01838551|2091001|FG000|Overall Study|Withdrawal by Subject|10
1050637|NCT01838551|2091001|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7
1050638|NCT01838590|2091009|FG000|Overall Study|Lack of Efficacy|12
1050639|NCT01838590|2091010|FG001|Overall Study|Lack of Efficacy|4
1050640|NCT01838590|2091009|FG000|Overall Study|Lost to Follow-up|0
1050641|NCT01838590|2091010|FG001|Overall Study|Lost to Follow-up|1
1050642|NCT01838616|2091022|FG000|Titration Period|Adverse Event|18
1050643|NCT01838616|2091023|FG001|Titration Period|Adverse Event|48
1050644|NCT01838616|2091022|FG000|Titration Period|Lack of Efficacy|5
1050645|NCT01838616|2091023|FG001|Titration Period|Lack of Efficacy|12
1050646|NCT01838616|2091022|FG000|Titration Period|Withdrawal by Subject|5
1050647|NCT01838616|2091023|FG001|Titration Period|Withdrawal by Subject|5
1050648|NCT01838616|2091022|FG000|Titration Period|Technical problems|1
1050649|NCT01838616|2091023|FG001|Titration Period|Technical problems|0
1050650|NCT01838616|2091022|FG000|Titration Period|Other|1
1050651|NCT01838616|2091023|FG001|Titration Period|Other|0
1050652|NCT01838616|2091022|FG000|Titration Period|Protocol Violation|0
1050653|NCT01838616|2091023|FG001|Titration Period|Protocol Violation|1
1050654|NCT01838616|2091022|FG000|Continuation Period|Lack of Efficacy|3
1050655|NCT01838616|2091023|FG001|Continuation Period|Lack of Efficacy|5
1050656|NCT01838616|2091022|FG000|Continuation Period|Adverse Event|8
1050657|NCT01838616|2091023|FG001|Continuation Period|Adverse Event|4
1050658|NCT01838616|2091022|FG000|Continuation Period|Protocol Violation|2
1050659|NCT01838616|2091023|FG001|Continuation Period|Protocol Violation|0
1050660|NCT01838616|2091022|FG000|Continuation Period|Lost to Follow-up|1
1050661|NCT01838616|2091023|FG001|Continuation Period|Lost to Follow-up|0
1050662|NCT01838616|2091022|FG000|Continuation Period|Withdrawal by Subject|0
1050663|NCT01838616|2091023|FG001|Continuation Period|Withdrawal by Subject|4
1050664|NCT01838616|2091022|FG000|Continuation Period|Technical problems|0
1050665|NCT01838616|2091023|FG001|Continuation Period|Technical problems|1
1050666|NCT01838616|2091022|FG000|Pick-up Arm|Lack of Efficacy|4
1050667|NCT01838616|2091023|FG001|Pick-up Arm|Lack of Efficacy|0
1050668|NCT01838616|2091022|FG000|Pick-up Arm|Adverse Event|9
1050669|NCT01838616|2091023|FG001|Pick-up Arm|Adverse Event|0
1050670|NCT01838616|2091022|FG000|Pick-up Arm|Withdrawal by Subject|1
1050671|NCT01838616|2091023|FG001|Pick-up Arm|Withdrawal by Subject|0
1050672|NCT01838616|2091022|FG000|Pick-up Arm|Technical problems|1
1050673|NCT01838616|2091023|FG001|Pick-up Arm|Technical problems|0
1050674|NCT01838642|2091034|FG000|Overall Study|Died on study|1
1050675|NCT01838681|2091043|FG000|Period A|Adverse Event|39
1050676|NCT01838681|2091044|FG001|Period A|Adverse Event|0
1050677|NCT01838681|2091045|FG002|Period A|Adverse Event|0
1050678|NCT01838681|2091046|FG003|Period A|Adverse Event|0
1050679|NCT01838681|2091043|FG000|Period A|Lack of Efficacy|21
1050680|NCT01838681|2091044|FG001|Period A|Lack of Efficacy|0
1050681|NCT01838681|2091045|FG002|Period A|Lack of Efficacy|0
1050682|NCT01838681|2091046|FG003|Period A|Lack of Efficacy|0
1050683|NCT01838681|2091043|FG000|Period A|Early response|148
1050684|NCT01838681|2091044|FG001|Period A|Early response|0
1050685|NCT01838681|2091045|FG002|Period A|Early response|0
1050686|NCT01838681|2091046|FG003|Period A|Early response|0
1050687|NCT01838681|2091043|FG000|Period A|Withdrawal by Subject|70
1050688|NCT01838681|2091044|FG001|Period A|Withdrawal by Subject|0
1050689|NCT01838681|2091045|FG002|Period A|Withdrawal by Subject|0
1050690|NCT01838681|2091046|FG003|Period A|Withdrawal by Subject|0
1050691|NCT01838681|2091043|FG000|Period A|Protocol Violation|16
1050692|NCT01838681|2091044|FG001|Period A|Protocol Violation|0
1050693|NCT01838681|2091045|FG002|Period A|Protocol Violation|0
1050694|NCT01838681|2091046|FG003|Period A|Protocol Violation|0
1050695|NCT01838681|2091043|FG000|Period A|Non-compliance with IMP|6
1050696|NCT01838681|2091044|FG001|Period A|Non-compliance with IMP|0
1050697|NCT01838681|2091045|FG002|Period A|Non-compliance with IMP|0
1050698|NCT01838681|2091046|FG003|Period A|Non-compliance with IMP|0
1050699|NCT01838681|2091043|FG000|Period A|Lost to Follow-up|4
1050700|NCT01838681|2091044|FG001|Period A|Lost to Follow-up|0
1050701|NCT01838681|2091045|FG002|Period A|Lost to Follow-up|0
1050702|NCT01838681|2091046|FG003|Period A|Lost to Follow-up|0
1050703|NCT01838681|2091043|FG000|Period A|Withdrawal before treatment|4
1050704|NCT01838681|2091044|FG001|Period A|Withdrawal before treatment|0
1050705|NCT01838681|2091045|FG002|Period A|Withdrawal before treatment|0
1050706|NCT01838681|2091046|FG003|Period A|Withdrawal before treatment|0
1050707|NCT01838681|2091043|FG000|Period A|Administrative or other reasons|17
1050708|NCT01838681|2091044|FG001|Period A|Administrative or other reasons|0
1050709|NCT01838681|2091045|FG002|Period A|Administrative or other reasons|0
1050710|NCT01838681|2091046|FG003|Period A|Administrative or other reasons|0
1050711|NCT01838681|2091043|FG000|Period B/A+|Adverse Event|0
1050712|NCT01838681|2091044|FG001|Period B/A+|Adverse Event|13
1050713|NCT01838681|2091045|FG002|Period B/A+|Adverse Event|27
1050714|NCT01838681|2091046|FG003|Period B/A+|Adverse Event|16
1050715|NCT01838681|2091043|FG000|Period B/A+|Lack of Efficacy|0
1050716|NCT01838681|2091044|FG001|Period B/A+|Lack of Efficacy|9
1050717|NCT01838681|2091045|FG002|Period B/A+|Lack of Efficacy|11
1050718|NCT01838681|2091046|FG003|Period B/A+|Lack of Efficacy|6
1050719|NCT01838681|2091043|FG000|Period B/A+|Withdrawal by Subject|0
1050720|NCT01838681|2091044|FG001|Period B/A+|Withdrawal by Subject|28
1050721|NCT01838681|2091045|FG002|Period B/A+|Withdrawal by Subject|35
1050722|NCT01838681|2091046|FG003|Period B/A+|Withdrawal by Subject|47
1050723|NCT01838681|2091043|FG000|Period B/A+|Protocol Violation|0
1050724|NCT01838681|2091044|FG001|Period B/A+|Protocol Violation|1
1050725|NCT01838681|2091045|FG002|Period B/A+|Protocol Violation|4
1050726|NCT01838681|2091046|FG003|Period B/A+|Protocol Violation|6
1050727|NCT01838681|2091043|FG000|Period B/A+|Non-compliance with IMP|0
1050728|NCT01838681|2091044|FG001|Period B/A+|Non-compliance with IMP|2
1050729|NCT01838681|2091045|FG002|Period B/A+|Non-compliance with IMP|3
1050730|NCT01838681|2091046|FG003|Period B/A+|Non-compliance with IMP|3
1050731|NCT01838681|2091043|FG000|Period B/A+|Lost to Follow-up|0
1050732|NCT01838681|2091044|FG001|Period B/A+|Lost to Follow-up|2
1050733|NCT01838681|2091045|FG002|Period B/A+|Lost to Follow-up|5
1050734|NCT01838681|2091046|FG003|Period B/A+|Lost to Follow-up|11
1050735|NCT01838681|2091043|FG000|Period B/A+|Withdrawal before treatment|0
1050736|NCT01838681|2091044|FG001|Period B/A+|Withdrawal before treatment|1
1050737|NCT01838681|2091045|FG002|Period B/A+|Withdrawal before treatment|0
1050738|NCT01838681|2091046|FG003|Period B/A+|Withdrawal before treatment|0
1050739|NCT01838681|2091043|FG000|Period B/A+|Administrative or other reasons|0
1050740|NCT01838681|2091044|FG001|Period B/A+|Administrative or other reasons|6
1050741|NCT01838681|2091045|FG002|Period B/A+|Administrative or other reasons|10
1050742|NCT01838681|2091046|FG003|Period B/A+|Administrative or other reasons|28
1050743|NCT01838694|2091054|FG000|Overall Study|Adverse Event|0
1050744|NCT01838694|2091055|FG001|Overall Study|Adverse Event|1
1050745|NCT01838876|2091077|FG000|Overall Study|Adverse Event|49
1050746|NCT01838876|2091077|FG000|Overall Study|Insufficient Therapeutic Response|10
1050747|NCT01838876|2091077|FG000|Overall Study|Protocol Violation|34
1050748|NCT01838876|2091077|FG000|Overall Study|Withdrawal of Consent|33
1050749|NCT01838876|2091077|FG000|Overall Study|Lost to Follow-up|21
1050750|NCT01838876|2091077|FG000|Overall Study|Study or Site Terminated by Sponsor|1
1050751|NCT01838876|2091077|FG000|Overall Study|Reason not Specified|7
1050752|NCT01838876|2091077|FG000|Overall Study|Did not meet eligibility criteria|78
1050753|NCT01838941|2091083|FG000|Overall Study|Adverse Event|1
1050754|NCT01838941|2091083|FG000|Overall Study|Withdrawal by Subject|1
1050755|NCT01839188|2091114|FG000|Overall Study|Withdrawal by Subject|1
1050756|NCT01839279|2091126|FG000|Overall Study|Adverse Event|4
1050757|NCT01839279|2091127|FG001|Overall Study|Adverse Event|1
1050758|NCT01839279|2091128|FG002|Overall Study|Adverse Event|1
1050759|NCT01839279|2091126|FG000|Overall Study|Withdrawal by Subject|4
1050760|NCT01839279|2091127|FG001|Overall Study|Withdrawal by Subject|1
1050761|NCT01839279|2091128|FG002|Overall Study|Withdrawal by Subject|1
1050762|NCT01839279|2091126|FG000|Overall Study|Classified as 'Other'|5
1050763|NCT01839279|2091127|FG001|Overall Study|Classified as 'Other'|0
1050764|NCT01839279|2091128|FG002|Overall Study|Classified as 'Other'|0
1050765|NCT01839487|2091167|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1
1050766|NCT01839487|2091168|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
1050767|NCT01839487|2091169|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
1050768|NCT01839487|2091170|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
1050769|NCT01839487|2091171|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
1050770|NCT01839487|2091172|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
1050771|NCT01839487|2091167|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14
1050772|NCT01839487|2091168|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6
1050773|NCT01839487|2091169|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0
1050774|NCT01839487|2091170|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0
1050775|NCT01839487|2091171|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0
1050776|NCT01839487|2091172|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0
1050777|NCT01839487|2091167|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
1050778|NCT01839487|2091168|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1
1050779|NCT01839487|2091169|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
1050780|NCT01839487|2091170|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
1050781|NCT01839487|2091171|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
1050782|NCT01839487|2091172|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
1050783|NCT01839487|2091167|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1
1050784|NCT01839487|2091168|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
1050785|NCT01839487|2091169|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
1050786|NCT01839487|2091170|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
1050787|NCT01839487|2091171|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
1050788|NCT01839487|2091172|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
1050789|NCT01839487|2091167|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
1050790|NCT01839487|2091168|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
1050791|NCT01839487|2091169|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12
1050792|NCT01839487|2091170|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9
1050793|NCT01839487|2091171|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4
1050794|NCT01839487|2091172|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8
1050795|NCT01839487|2091167|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0
1050796|NCT01839487|2091168|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0
1050797|NCT01839487|2091169|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46
1050798|NCT01839487|2091170|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49
1050799|NCT01839487|2091171|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71
1050800|NCT01839487|2091172|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32
1050801|NCT01839487|2091167|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
1050802|NCT01839487|2091168|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
1050803|NCT01839487|2091169|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2
1050804|NCT01839487|2091170|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
1050805|NCT01839487|2091171|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1
1050806|NCT01839487|2091172|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
1050807|NCT01839487|2091167|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
1050808|NCT01839487|2091168|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
1050809|NCT01839487|2091169|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
1050810|NCT01839487|2091170|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1
1050811|NCT01839487|2091171|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10
1050812|NCT01839487|2091172|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3
1050813|NCT01839487|2091167|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
1050814|NCT01839487|2091168|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
1050815|NCT01839487|2091169|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
1050816|NCT01839487|2091170|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3
1050817|NCT01839487|2091171|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2
1050818|NCT01839487|2091172|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
1050819|NCT01839656|2091203|FG000|Overall Study|Withdrawal by Subject|1
1050820|NCT01839656|2091204|FG001|Overall Study|Withdrawal by Subject|1
1050821|NCT01839656|2091203|FG000|Overall Study|Adverse event, serious fatal|1
1050822|NCT01839656|2091204|FG001|Overall Study|Adverse event, serious fatal|4
1050823|NCT01839656|2091203|FG000|Overall Study|Early study closure|0
1050824|NCT01839656|2091204|FG001|Overall Study|Early study closure|11
1050825|NCT01839656|2091203|FG000|Overall Study|Adverse Event|1
1050826|NCT01839656|2091204|FG001|Overall Study|Adverse Event|0
1050827|NCT01839916|2091232|FG000|Overall Study|Death|9
1050828|NCT01839916|2091232|FG000|Overall Study|Physician Decision|17
1050829|NCT01839916|2091232|FG000|Overall Study|Relapse|12
1050830|NCT01839916|2091232|FG000|Overall Study|GVHD|2
1050831|NCT01839916|2091232|FG000|Overall Study|Graft Failure|1
1050832|NCT01840163|2091249|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19
1050833|NCT01840163|2091250|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16
1050834|NCT01840163|2091249|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
1050835|NCT01840163|2091250|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
1050836|NCT01840163|2091249|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
1050837|NCT01840163|2091250|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
1050838|NCT01840228|2091258|FG000|Overall Study|Lost to Follow-up|1
1050839|NCT01840228|2091259|FG001|Overall Study|Lost to Follow-up|1
1050840|NCT01840410|2091279|FG000|Overall Study|Physician Decision|1
1050841|NCT01840410|2091280|FG001|Overall Study|Physician Decision|2
1050842|NCT01840410|2091279|FG000|Overall Study|Pregnancy|1
1050843|NCT01840410|2091280|FG001|Overall Study|Pregnancy|0
1050844|NCT01840410|2091279|FG000|Overall Study|Protocol deviation|1
1050845|NCT01840410|2091280|FG001|Overall Study|Protocol deviation|0
1050846|NCT01840410|2091279|FG000|Overall Study|Lost to Follow-up|1
1050847|NCT01840410|2091280|FG001|Overall Study|Lost to Follow-up|0
1050848|NCT01840410|2091279|FG000|Overall Study|Withdrawal by Subject|2
1050849|NCT01840410|2091280|FG001|Overall Study|Withdrawal by Subject|1
1050850|NCT01840410|2091279|FG000|Overall Study|Adverse Event|1
1050851|NCT01840410|2091280|FG001|Overall Study|Adverse Event|1
1050852|NCT01840579|2091298|FG000|Overall Study|Status not recorded|0
1050853|NCT01840579|2091299|FG001|Overall Study|Status not recorded|0
1050854|NCT01840579|2091300|FG002|Overall Study|Status not recorded|2
1050855|NCT01840579|2091301|FG003|Overall Study|Status not recorded|3
1050856|NCT01840579|2091302|FG004|Overall Study|Status not recorded|4
1050857|NCT01840579|2091303|FG005|Overall Study|Status not recorded|3
1050858|NCT01840579|2091304|FG006|Overall Study|Status not recorded|0
1050859|NCT01840579|2091305|FG007|Overall Study|Status not recorded|3
1050860|NCT01840579|2091306|FG008|Overall Study|Status not recorded|3
1050861|NCT01840579|2091307|FG009|Overall Study|Status not recorded|3
1050862|NCT01840579|2091298|FG000|Overall Study|Progressive disease|3
1050863|NCT01840579|2091299|FG001|Overall Study|Progressive disease|5
1050864|NCT01840579|2091300|FG002|Overall Study|Progressive disease|0
1050865|NCT01840579|2091301|FG003|Overall Study|Progressive disease|0
1050866|NCT01840579|2091302|FG004|Overall Study|Progressive disease|0
1050867|NCT01840579|2091303|FG005|Overall Study|Progressive disease|0
1050868|NCT01840579|2091304|FG006|Overall Study|Progressive disease|0
1050869|NCT01840579|2091305|FG007|Overall Study|Progressive disease|0
1050870|NCT01840579|2091306|FG008|Overall Study|Progressive disease|0
1050871|NCT01840579|2091307|FG009|Overall Study|Progressive disease|0
1050872|NCT01840579|2091298|FG000|Overall Study|Ongoing in study|0
1050873|NCT01840579|2091299|FG001|Overall Study|Ongoing in study|1
1050874|NCT01840579|2091300|FG002|Overall Study|Ongoing in study|0
1050875|NCT01840579|2091301|FG003|Overall Study|Ongoing in study|0
1050876|NCT01840579|2091302|FG004|Overall Study|Ongoing in study|0
1050877|NCT01840579|2091303|FG005|Overall Study|Ongoing in study|0
1050878|NCT01840579|2091304|FG006|Overall Study|Ongoing in study|0
1050879|NCT01840579|2091305|FG007|Overall Study|Ongoing in study|0
1050880|NCT01840579|2091306|FG008|Overall Study|Ongoing in study|0
1050881|NCT01840579|2091307|FG009|Overall Study|Ongoing in study|0
1050882|NCT01840579|2091298|FG000|Overall Study|Death|0
1050883|NCT01840579|2091299|FG001|Overall Study|Death|0
1050884|NCT01840579|2091300|FG002|Overall Study|Death|0
1050885|NCT01840579|2091301|FG003|Overall Study|Death|0
1050886|NCT01840579|2091302|FG004|Overall Study|Death|0
1050887|NCT01840579|2091303|FG005|Overall Study|Death|1
1050888|NCT01840579|2091304|FG006|Overall Study|Death|0
1050889|NCT01840579|2091305|FG007|Overall Study|Death|0
1050890|NCT01840579|2091306|FG008|Overall Study|Death|0
1050891|NCT01840579|2091307|FG009|Overall Study|Death|0
1050892|NCT01840579|2091298|FG000|Overall Study|Adverse Event|0
1050893|NCT01840579|2091299|FG001|Overall Study|Adverse Event|1
1050894|NCT01840579|2091300|FG002|Overall Study|Adverse Event|0
1050895|NCT01840579|2091301|FG003|Overall Study|Adverse Event|0
1050896|NCT01840579|2091302|FG004|Overall Study|Adverse Event|0
1050897|NCT01840579|2091303|FG005|Overall Study|Adverse Event|0
1050898|NCT01840579|2091304|FG006|Overall Study|Adverse Event|0
1050899|NCT01840579|2091305|FG007|Overall Study|Adverse Event|0
1050900|NCT01840579|2091306|FG008|Overall Study|Adverse Event|0
1050901|NCT01840579|2091307|FG009|Overall Study|Adverse Event|0
1050902|NCT01840579|2091298|FG000|Overall Study|Follow-up ended by Sponsor|0
1050903|NCT01840579|2091299|FG001|Overall Study|Follow-up ended by Sponsor|0
1050904|NCT01840579|2091300|FG002|Overall Study|Follow-up ended by Sponsor|0
1050905|NCT01840579|2091301|FG003|Overall Study|Follow-up ended by Sponsor|0
1050906|NCT01840579|2091302|FG004|Overall Study|Follow-up ended by Sponsor|0
1050907|NCT01840579|2091303|FG005|Overall Study|Follow-up ended by Sponsor|0
1050908|NCT01840579|2091304|FG006|Overall Study|Follow-up ended by Sponsor|2
1050909|NCT01840579|2091305|FG007|Overall Study|Follow-up ended by Sponsor|0
1050910|NCT01840579|2091306|FG008|Overall Study|Follow-up ended by Sponsor|0
1050911|NCT01840579|2091307|FG009|Overall Study|Follow-up ended by Sponsor|0
1050912|NCT01840605|2091343|FG000|Overall Study|Adverse Event|0
1050913|NCT01840605|2091344|FG001|Overall Study|Adverse Event|1
1050914|NCT01840605|2091343|FG000|Overall Study|Physician Decision|2
1050915|NCT01840605|2091344|FG001|Overall Study|Physician Decision|1
1050916|NCT01840943|2091361|FG000|Overall Study|Withdrawal by Subject|5
1050917|NCT01840943|2091362|FG001|Overall Study|Withdrawal by Subject|6
1050918|NCT01840943|2091361|FG000|Overall Study|Physician Decision|4
1050919|NCT01840943|2091362|FG001|Overall Study|Physician Decision|2
1050920|NCT01840943|2091361|FG000|Overall Study|Lost to Follow-up|4
1050921|NCT01840943|2091362|FG001|Overall Study|Lost to Follow-up|4
1050922|NCT01841060|2091376|FG000|Overall Study|Protocol Violation|10
1050923|NCT01841073|2091382|FG000|Overall Study|Adverse Event|1
1050924|NCT01841073|2091383|FG001|Overall Study|Adverse Event|1
1050925|NCT01841073|2091382|FG000|Overall Study|Physician Decision|1
1050926|NCT01841073|2091383|FG001|Overall Study|Physician Decision|0
1050927|NCT01841073|2091382|FG000|Overall Study|Lost to Follow-up|0
1050928|NCT01841073|2091383|FG001|Overall Study|Lost to Follow-up|2
1050929|NCT01841554|2091421|FG000|Overall Study|Death|7
1050930|NCT01841554|2091421|FG000|Overall Study|No Implantation|1
1050931|NCT01841554|2091421|FG000|Overall Study|Discontinued Follow Up|5
1050932|NCT01841554|2091421|FG000|Overall Study|Study exit due to secondary intervention|6
1050933|NCT01841567|2091425|FG000|Overall Study|Adverse Event|3
1050934|NCT01841593|2091431|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0
1050935|NCT01841593|2091432|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1
1050936|NCT01841593|2091431|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1
1050937|NCT01841593|2091432|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0
1050938|NCT01841697|2091461|FG000|Overall Study|Death|0
1050939|NCT01841697|2091462|FG001|Overall Study|Death|1
1050940|NCT01841697|2091461|FG000|Overall Study|Lost to Follow-up|4
1050941|NCT01841697|2091462|FG001|Overall Study|Lost to Follow-up|1
1050942|NCT01841697|2091461|FG000|Overall Study|Withdrawal by Subject|16
1050943|NCT01841697|2091462|FG001|Overall Study|Withdrawal by Subject|16
1050944|NCT01841762|2091468|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
1050945|NCT01841762|2091468|FG000|Treatment Period|Adverse Event|16
1050946|NCT01841762|2091468|FG000|Treatment Period|Death|1
1050947|NCT01841762|2091468|FG000|Treatment Period|Withdrawal by Subject|7
1050948|NCT01841762|2091468|FG000|Treatment Period|Lost to Follow-up|1
1050949|NCT01841762|2091468|FG000|Treatment Period|Physician Decision|2
1050950|NCT01841762|2091468|FG000|Treatment Period|Other, including non-compliance|5
1050951|NCT01841762|2091468|FG000|Post-Treatment Safety Follow-Up Period|Death|1
1050952|NCT01841762|2091468|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
1050953|NCT01841762|2091468|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
1050954|NCT01841762|2091468|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
1050955|NCT01841970|2091472|FG000|Overall Study|Withdrawal by Subject|1
1050956|NCT01841970|2091472|FG000|Overall Study|Physician Decision|2
1050957|NCT01841970|2091472|FG000|Overall Study|Lost to Follow-up|8
1050958|NCT01842308|2091493|FG000|Overall Study|Withdrawal by Subject|0
1050959|NCT01842308|2091494|FG001|Overall Study|Withdrawal by Subject|0
1050960|NCT01842308|2091495|FG002|Overall Study|Withdrawal by Subject|0
1050961|NCT01842308|2091496|FG003|Overall Study|Withdrawal by Subject|0
1050962|NCT01842308|2091497|FG004|Overall Study|Withdrawal by Subject|1
1050963|NCT01842334|2091512|FG000|Overall Study|Withdrawal by Subject|3
1050964|NCT01842334|2091513|FG001|Overall Study|Withdrawal by Subject|3
1050965|NCT01842334|2091512|FG000|Overall Study|Moved away mid-study|0
1050966|NCT01842334|2091513|FG001|Overall Study|Moved away mid-study|1
1050967|NCT01842438|2091521|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6
1050968|NCT01842438|2091522|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8
1050969|NCT01842438|2091521|FG000|T2: 6month Follow-up|Withdrawal by Subject|4
1050970|NCT01842438|2091522|FG001|T2: 6month Follow-up|Withdrawal by Subject|3
1050971|NCT01842438|2091521|FG000|T2: 6month Follow-up|Death|0
1050972|NCT01842438|2091522|FG001|T2: 6month Follow-up|Death|1
1050973|NCT01842581|2091539|FG000|Overall Study|Adverse Event|6
1050974|NCT01842581|2091540|FG001|Overall Study|Adverse Event|4
1050975|NCT01842581|2091539|FG000|Overall Study|HE breakthrough|26
1050976|NCT01842581|2091540|FG001|Overall Study|HE breakthrough|13
1050977|NCT01842581|2091539|FG000|Overall Study|Liver transplant|2
1050978|NCT01842581|2091540|FG001|Overall Study|Liver transplant|0
1050979|NCT01842581|2091539|FG000|Overall Study|Lost to Follow-up|2
1050980|NCT01842581|2091540|FG001|Overall Study|Lost to Follow-up|5
1050981|NCT01842581|2091539|FG000|Overall Study|Withdrawal by Subject|5
1050982|NCT01842581|2091540|FG001|Overall Study|Withdrawal by Subject|7
1050983|NCT01842581|2091539|FG000|Overall Study|Other than specified|3
1050984|NCT01842581|2091540|FG001|Overall Study|Other than specified|1
1050985|NCT01842607|2091550|FG000|Overall Study|Adverse Event|11
1050986|NCT01842607|2091550|FG000|Overall Study|Lack of Efficacy|19
1050987|NCT01842607|2091550|FG000|Overall Study|Protocol Violation|8
1050988|NCT01842607|2091550|FG000|Overall Study|Protocol defined stopping criteria|2
1050989|NCT01842607|2091550|FG000|Overall Study|Lost to Follow-up|3
1050990|NCT01842607|2091550|FG000|Overall Study|Physician Decision|9
1050991|NCT01842607|2091550|FG000|Overall Study|Withdrawal by Subject|14
1050992|NCT01842620|2091554|FG000|Period 1|Withdrawal by Subject|1
1050993|NCT01842620|2091555|FG001|Period 1|Withdrawal by Subject|0
1050994|NCT01842633|2091564|FG000|Overall Study|Screen Failure|1
1050995|NCT01842633|2091565|FG001|Overall Study|Screen Failure|0
1050996|NCT01842633|2091566|FG002|Overall Study|Screen Failure|0
1050997|NCT01842633|2091564|FG000|Overall Study|Adverse Event|1
1050998|NCT01842633|2091565|FG001|Overall Study|Adverse Event|1
1050999|NCT01842633|2091566|FG002|Overall Study|Adverse Event|0
1051000|NCT01842633|2091564|FG000|Overall Study|Withdrawal by Subject|0
1051001|NCT01842633|2091565|FG001|Overall Study|Withdrawal by Subject|1
1051002|NCT01842633|2091566|FG002|Overall Study|Withdrawal by Subject|0
1051003|NCT01842633|2091564|FG000|Overall Study|Technical issues|1
1051004|NCT01842633|2091565|FG001|Overall Study|Technical issues|0
1051005|NCT01842633|2091566|FG002|Overall Study|Technical issues|0
1051006|NCT01842958|2091610|FG000|Overall Study|Lost to Follow-up|1
1051007|NCT01842958|2091611|FG001|Overall Study|Lost to Follow-up|1
1051008|NCT01843023|2091619|FG000|Overall Study|Death|1
1051009|NCT01843023|2091620|FG001|Overall Study|Death|0
1051010|NCT01843023|2091619|FG000|Overall Study|Lost to Follow-up|24
1051011|NCT01843023|2091620|FG001|Overall Study|Lost to Follow-up|29
1051012|NCT01843023|2091619|FG000|Overall Study|Withdrawal by Subject|8
1051013|NCT01843023|2091620|FG001|Overall Study|Withdrawal by Subject|6
1051014|NCT01843062|2091628|FG000|Overall Study|Protocol Violation|1
1051015|NCT01843062|2091629|FG001|Overall Study|Protocol Violation|0
1051016|NCT01843062|2091628|FG000|Overall Study|New treatment following progression|2
1051017|NCT01843062|2091629|FG001|Overall Study|New treatment following progression|0
1051018|NCT01843062|2091628|FG000|Overall Study|Pregnancy|1
1051019|NCT01843062|2091629|FG001|Overall Study|Pregnancy|0
1051020|NCT01843062|2091628|FG000|Overall Study|Adverse Event|2
1051021|NCT01843062|2091629|FG001|Overall Study|Adverse Event|0
1051022|NCT01843062|2091628|FG000|Overall Study|Incorrect randomisation|1
1051023|NCT01843062|2091629|FG001|Overall Study|Incorrect randomisation|0
1051024|NCT01843062|2091628|FG000|Overall Study|Withdrawal by Subject|12
1051025|NCT01843062|2091629|FG001|Overall Study|Withdrawal by Subject|3
1051026|NCT01843062|2091628|FG000|Overall Study|Death|1
1051027|NCT01843062|2091629|FG001|Overall Study|Death|2
1051028|NCT01843062|2091628|FG000|Overall Study|Lost to Follow-up|2
1051029|NCT01843062|2091629|FG001|Overall Study|Lost to Follow-up|4
1051030|NCT01843192|2091638|FG000|Overall Study|Intra-operative exclusions per protocol|2
1051031|NCT01843192|2091639|FG001|Overall Study|Intra-operative exclusions per protocol|6
1051032|NCT01843192|2091640|FG002|Overall Study|Intra-operative exclusions per protocol|2
1051033|NCT01843205|2091648|FG000|First Treatment (11 Days)|Withdrawal by Subject|1
1051034|NCT01843205|2091649|FG001|First Treatment (11 Days)|Withdrawal by Subject|0
1051035|NCT01843348|2091658|FG000|Overall Study|Withdrawal by Subject|4
1051036|NCT01843348|2091659|FG001|Overall Study|Withdrawal by Subject|16
1051037|NCT01843348|2091660|FG002|Overall Study|Withdrawal by Subject|18
1051038|NCT01843348|2091658|FG000|Overall Study|Lost to Follow-up|5
1051039|NCT01843348|2091659|FG001|Overall Study|Lost to Follow-up|4
1051040|NCT01843348|2091660|FG002|Overall Study|Lost to Follow-up|2
1051041|NCT01843348|2091658|FG000|Overall Study|Death|5
1051042|NCT01843348|2091659|FG001|Overall Study|Death|3
1051043|NCT01843348|2091660|FG002|Overall Study|Death|4
1051044|NCT01843348|2091658|FG000|Overall Study|Graft loss/retransplantation|5
1051045|NCT01843348|2091659|FG001|Overall Study|Graft loss/retransplantation|8
1051046|NCT01843348|2091660|FG002|Overall Study|Graft loss/retransplantation|11
1051047|NCT01843348|2091658|FG000|Overall Study|Various reasons|4
1051048|NCT01843348|2091659|FG001|Overall Study|Various reasons|9
1051049|NCT01843348|2091660|FG002|Overall Study|Various reasons|6
1051050|NCT01843374|2091672|FG000|Overall Study|Death|155
1051051|NCT01843374|2091673|FG001|Overall Study|Death|313
1051052|NCT01843374|2091672|FG000|Overall Study|Withdrawal by Subject|14
1051053|NCT01843374|2091673|FG001|Overall Study|Withdrawal by Subject|20
1051054|NCT01843374|2091672|FG000|Overall Study|Withdrawing due to Other reason|20
1051055|NCT01843374|2091673|FG001|Overall Study|Withdrawing due to Other reason|46
1051056|NCT01843660|2091698|FG000|Overall Study|Other|30
1051057|NCT01843673|2091702|FG000|Overall Study|Lack of Efficacy|2
1051058|NCT01843673|2091702|FG000|Overall Study|Withdrawal by Subject|4
1051059|NCT01843777|2091719|FG000|Overall Study|Withdrawal by Subject|1
1051060|NCT01843777|2091720|FG001|Overall Study|Withdrawal by Subject|0
1051061|NCT01843803|2091728|FG000|Overall Study|not a Veteran, did not see provider|1
1051062|NCT01843803|2091729|FG001|Overall Study|not a Veteran, did not see provider|3
1051063|NCT01843842|2091737|FG000|Overall Study|Do not meet inclusion criteria|1
1051064|NCT01843842|2091738|FG001|Overall Study|Do not meet inclusion criteria|1
906810|NCT00771615|1882812|FG003|Overall Study|Withdrawal by Subject|0
906811|NCT00771615|1882813|FG004|Overall Study|Withdrawal by Subject|0
906812|NCT00771615|1882814|FG005|Overall Study|Withdrawal by Subject|0
906813|NCT00771615|1882815|FG006|Overall Study|Withdrawal by Subject|0
906814|NCT00771615|1882816|FG007|Overall Study|Withdrawal by Subject|1
906815|NCT00771615|1882817|FG008|Overall Study|Withdrawal by Subject|0
906816|NCT00771615|1882809|FG000|Overall Study|Lost to Follow-up|1
906817|NCT00771615|1882810|FG001|Overall Study|Lost to Follow-up|1
906818|NCT00771615|1882811|FG002|Overall Study|Lost to Follow-up|1
906819|NCT00771615|1882812|FG003|Overall Study|Lost to Follow-up|1
906820|NCT00771615|1882813|FG004|Overall Study|Lost to Follow-up|0
906821|NCT00771615|1882814|FG005|Overall Study|Lost to Follow-up|1
906822|NCT00771615|1882815|FG006|Overall Study|Lost to Follow-up|1
906823|NCT00771615|1882816|FG007|Overall Study|Lost to Follow-up|0
906824|NCT00771615|1882817|FG008|Overall Study|Lost to Follow-up|0
906825|NCT00771667|1882850|FG000|Induction Phase|Adverse Event|5
906826|NCT00771667|1882851|FG001|Induction Phase|Adverse Event|2
906827|NCT00771667|1882852|FG002|Induction Phase|Adverse Event|4
906828|NCT00771667|1882853|FG003|Induction Phase|Adverse Event|1
906829|NCT00771667|1882854|FG004|Induction Phase|Adverse Event|0
906830|NCT00771667|1882855|FG005|Induction Phase|Adverse Event|0
906831|NCT00771667|1882856|FG006|Induction Phase|Adverse Event|0
906832|NCT00771667|1882857|FG007|Induction Phase|Adverse Event|0
906833|NCT00771667|1882858|FG008|Induction Phase|Adverse Event|0
906834|NCT00771667|1882859|FG009|Induction Phase|Adverse Event|0
906835|NCT00771667|1882850|FG000|Induction Phase|Lack of Efficacy|9
906836|NCT00771667|1882851|FG001|Induction Phase|Lack of Efficacy|2
906837|NCT00771667|1882852|FG002|Induction Phase|Lack of Efficacy|4
906838|NCT00771667|1882853|FG003|Induction Phase|Lack of Efficacy|3
906839|NCT00771667|1882854|FG004|Induction Phase|Lack of Efficacy|0
906840|NCT00771667|1882855|FG005|Induction Phase|Lack of Efficacy|0
906841|NCT00771667|1882856|FG006|Induction Phase|Lack of Efficacy|0
906842|NCT00771667|1882857|FG007|Induction Phase|Lack of Efficacy|0
906843|NCT00771667|1882858|FG008|Induction Phase|Lack of Efficacy|0
906844|NCT00771667|1882859|FG009|Induction Phase|Lack of Efficacy|0
906845|NCT00771667|1882850|FG000|Induction Phase|Lost to Follow-up|1
906846|NCT00771667|1882851|FG001|Induction Phase|Lost to Follow-up|0
906847|NCT00771667|1882852|FG002|Induction Phase|Lost to Follow-up|1
906848|NCT00771667|1882853|FG003|Induction Phase|Lost to Follow-up|0
906849|NCT00771667|1882854|FG004|Induction Phase|Lost to Follow-up|0
906850|NCT00771667|1882855|FG005|Induction Phase|Lost to Follow-up|0
906851|NCT00771667|1882856|FG006|Induction Phase|Lost to Follow-up|0
906852|NCT00771667|1882857|FG007|Induction Phase|Lost to Follow-up|0
906853|NCT00771667|1882858|FG008|Induction Phase|Lost to Follow-up|0
906854|NCT00771667|1882859|FG009|Induction Phase|Lost to Follow-up|0
906855|NCT00771667|1882850|FG000|Induction Phase|Other|4
906856|NCT00771667|1882851|FG001|Induction Phase|Other|6
906857|NCT00771667|1882852|FG002|Induction Phase|Other|3
906858|NCT00771667|1882853|FG003|Induction Phase|Other|4
906859|NCT00771667|1882854|FG004|Induction Phase|Other|0
906860|NCT00771667|1882855|FG005|Induction Phase|Other|0
906861|NCT00771667|1882856|FG006|Induction Phase|Other|0
906862|NCT00771667|1882857|FG007|Induction Phase|Other|0
906863|NCT00771667|1882858|FG008|Induction Phase|Other|0
906864|NCT00771667|1882859|FG009|Induction Phase|Other|0
906865|NCT00771667|1882850|FG000|Maintenance Phase|Adverse Event|0
906866|NCT00771667|1882851|FG001|Maintenance Phase|Adverse Event|0
906867|NCT00771667|1882852|FG002|Maintenance Phase|Adverse Event|0
906868|NCT00771667|1882853|FG003|Maintenance Phase|Adverse Event|0
1051065|NCT01843933|2091755|FG000|Overall Study|Data lost|6
1051066|NCT01843933|2091756|FG001|Overall Study|Data lost|4
1051067|NCT01843972|2091772|FG000|Overall Study|Withdrawal by Subject|0
1051068|NCT01843972|2091773|FG001|Overall Study|Withdrawal by Subject|0
1051069|NCT01843972|2091774|FG002|Overall Study|Withdrawal by Subject|0
1051070|NCT01843972|2091775|FG003|Overall Study|Withdrawal by Subject|0
1051071|NCT01843972|2091776|FG004|Overall Study|Withdrawal by Subject|1
1051072|NCT01843972|2091777|FG005|Overall Study|Withdrawal by Subject|0
1051073|NCT01843972|2091778|FG006|Overall Study|Withdrawal by Subject|0
1051074|NCT01843972|2091779|FG007|Overall Study|Withdrawal by Subject|0
1051075|NCT01843972|2091780|FG008|Overall Study|Withdrawal by Subject|0
1051076|NCT01843972|2091781|FG009|Overall Study|Withdrawal by Subject|0
1051077|NCT01844076|2091821|FG000|Overall Study|Adverse Event|1
1051078|NCT01844076|2091822|FG001|Overall Study|Adverse Event|0
1051079|NCT01844076|2091823|FG002|Overall Study|Adverse Event|0
1051080|NCT01844076|2091824|FG003|Overall Study|Adverse Event|0
1051081|NCT01844076|2091821|FG000|Overall Study|Withdrawal by Subject|1
1051082|NCT01844076|2091822|FG001|Overall Study|Withdrawal by Subject|0
1051083|NCT01844076|2091823|FG002|Overall Study|Withdrawal by Subject|0
1051084|NCT01844076|2091824|FG003|Overall Study|Withdrawal by Subject|0
1051085|NCT01844115|2091836|FG000|Overall Study|Adverse Event|4
1051086|NCT01844115|2091837|FG001|Overall Study|Adverse Event|22
1051087|NCT01844115|2091836|FG000|Overall Study|Lack of Efficacy|1
1051088|NCT01844115|2091837|FG001|Overall Study|Lack of Efficacy|4
1051089|NCT01844115|2091836|FG000|Overall Study|Protocol Violation|12
1051090|NCT01844115|2091837|FG001|Overall Study|Protocol Violation|10
1051091|NCT01844115|2091836|FG000|Overall Study|Withdrawal by Subject|11
1051092|NCT01844115|2091837|FG001|Overall Study|Withdrawal by Subject|11
1051093|NCT01844115|2091836|FG000|Overall Study|Lost to Follow-up|11
1051094|NCT01844115|2091837|FG001|Overall Study|Lost to Follow-up|10
1051095|NCT01844115|2091836|FG000|Overall Study|Pregnancy|0
1051096|NCT01844115|2091837|FG001|Overall Study|Pregnancy|1
1051097|NCT01844284|2091854|FG000|Overall Study|Lost to Follow-up|12
1051098|NCT01844284|2091855|FG001|Overall Study|Lost to Follow-up|7
1051099|NCT01844375|2091863|FG000|Overall Study|Protocol Violation|1
1051100|NCT01844375|2091864|FG001|Overall Study|Protocol Violation|1
1051145|NCT01844531|2091912|FG000|Overall Study|Withdrawal by Subject|0
1051146|NCT01844531|2091913|FG001|Overall Study|Withdrawal by Subject|1
1051147|NCT01844531|2091914|FG002|Overall Study|Withdrawal by Subject|0
1051148|NCT01844531|2091915|FG003|Overall Study|Withdrawal by Subject|0
1051149|NCT01844583|2091927|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8
1051150|NCT01844583|2091928|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10
1051151|NCT01844687|2091939|FG000|Visit 1|Protocol Violation|3
1051152|NCT01844687|2091939|FG000|Visit 1|Lost to Follow-up|5
1051153|NCT01844687|2091939|FG000|Visit 2|Withdrawal by Subject|1
1051154|NCT01844687|2091939|FG000|Visit 2|Protocol Violation|1
1051155|NCT01844687|2091939|FG000|Visit 3|Lost to Follow-up|1
1051156|NCT01844687|2091939|FG000|Visit 3|Withdrawal by Subject|3
1051157|NCT01844687|2091939|FG000|Visit 3|child care problems|1
1051158|NCT01844687|2091939|FG000|Visit 4|Pregnancy|1
1051159|NCT01844687|2091939|FG000|Visit 4|Lost to Follow-up|1
1051160|NCT01844687|2091939|FG000|Visit 4|Withdrawal by Subject|2
1051161|NCT01844700|2091963|FG000|Overall Study|Lack of Efficacy|1
1051162|NCT01844700|2091964|FG001|Overall Study|Lack of Efficacy|0
1051163|NCT01844700|2091963|FG000|Overall Study|refused medication switch|1
1051164|NCT01844700|2091964|FG001|Overall Study|refused medication switch|0
1051165|NCT01844700|2091963|FG000|Overall Study|Withdrawal by Subject|1
1051166|NCT01844700|2091964|FG001|Overall Study|Withdrawal by Subject|0
1051167|NCT01844700|2091963|FG000|Overall Study|stopped taking meds|0
1051168|NCT01844700|2091964|FG001|Overall Study|stopped taking meds|1
1051169|NCT01844765|2091972|FG000|Overall Study|Adverse Event|6
1051170|NCT01844765|2091973|FG001|Overall Study|Adverse Event|8
1051171|NCT01844765|2091972|FG000|Overall Study|Withdrawal by Subject|2
1051172|NCT01844765|2091973|FG001|Overall Study|Withdrawal by Subject|3
1051173|NCT01844765|2091972|FG000|Overall Study|Disease progression|1
1051174|NCT01844765|2091973|FG001|Overall Study|Disease progression|0
1051175|NCT01844765|2091972|FG000|Overall Study|Administrative problems|3
1051176|NCT01844765|2091973|FG001|Overall Study|Administrative problems|4
1051177|NCT01844765|2091972|FG000|Overall Study|Protocol deviation|2
1051178|NCT01844765|2091973|FG001|Overall Study|Protocol deviation|0
1051179|NCT01844765|2091972|FG000|Overall Study|Untreated|1
1051180|NCT01844765|2091973|FG001|Overall Study|Untreated|0
1051181|NCT01844778|2091987|FG000|Overall Study|Protocol deviation|0
1051182|NCT01844778|2091988|FG001|Overall Study|Protocol deviation|1
1051183|NCT01844778|2091989|FG002|Overall Study|Protocol deviation|2
1051184|NCT01844778|2091987|FG000|Overall Study|Withdrawal by Subject|2
1051185|NCT01844778|2091988|FG001|Overall Study|Withdrawal by Subject|0
1051186|NCT01844778|2091989|FG002|Overall Study|Withdrawal by Subject|0
1051187|NCT01844778|2091987|FG000|Overall Study|Adverse Event|0
1051188|NCT01844778|2091988|FG001|Overall Study|Adverse Event|2
1051189|NCT01844778|2091989|FG002|Overall Study|Adverse Event|2
1051190|NCT01844817|2092003|FG000|Enrolled and Randomized|Withdrawal by Subject|2
1051191|NCT01844817|2092004|FG001|Enrolled and Randomized|Withdrawal by Subject|3
1051192|NCT01844817|2092003|FG000|Treatment|Progressive Disease|27
1051193|NCT01844817|2092004|FG001|Treatment|Progressive Disease|36
1051194|NCT01844817|2092003|FG000|Treatment|Adverse Event|17
1051195|NCT01844817|2092004|FG001|Treatment|Adverse Event|9
1051196|NCT01844817|2092003|FG000|Treatment|Withdrawal by Subject|10
1051197|NCT01844817|2092004|FG001|Treatment|Withdrawal by Subject|6
1051198|NCT01844817|2092003|FG000|Treatment|Death|10
1051199|NCT01844817|2092004|FG001|Treatment|Death|8
1051200|NCT01844817|2092003|FG000|Treatment|Lost to Follow-up|0
1051201|NCT01844817|2092004|FG001|Treatment|Lost to Follow-up|1
906869|NCT00771667|1882854|FG004|Maintenance Phase|Adverse Event|1
906870|NCT00771667|1882855|FG005|Maintenance Phase|Adverse Event|3
906871|NCT00771667|1882856|FG006|Maintenance Phase|Adverse Event|5
906872|NCT00771667|1882857|FG007|Maintenance Phase|Adverse Event|1
906873|NCT00771667|1882858|FG008|Maintenance Phase|Adverse Event|8
906874|NCT00771667|1882859|FG009|Maintenance Phase|Adverse Event|7
906875|NCT00771667|1882850|FG000|Maintenance Phase|Lack of Efficacy|0
906876|NCT00771667|1882851|FG001|Maintenance Phase|Lack of Efficacy|0
906877|NCT00771667|1882852|FG002|Maintenance Phase|Lack of Efficacy|0
906878|NCT00771667|1882853|FG003|Maintenance Phase|Lack of Efficacy|0
906879|NCT00771667|1882854|FG004|Maintenance Phase|Lack of Efficacy|1
906880|NCT00771667|1882855|FG005|Maintenance Phase|Lack of Efficacy|3
906881|NCT00771667|1882856|FG006|Maintenance Phase|Lack of Efficacy|3
1051202|NCT01844817|2092003|FG000|Treatment|Other|0
1051203|NCT01844817|2092004|FG001|Treatment|Other|3
1051204|NCT01844830|2092013|FG000|Overall Study|Withdrawal by Subject|1
1051205|NCT01844830|2092014|FG001|Overall Study|Withdrawal by Subject|0
1051220|NCT01844895|2092029|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
1162034|NCT03381196|2283977|FG001|Overall Study|Lost to Follow-up|4
1051221|NCT01844895|2092029|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
1051222|NCT01844895|2092029|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
1051223|NCT01844895|2092029|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1
1051224|NCT01844895|2092029|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
1051225|NCT01844895|2092029|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3
1051226|NCT01844895|2092029|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1
1051227|NCT01844986|2092044|FG000|Overall Study|Severe non-compliance to protocol|1
1051228|NCT01844986|2092045|FG001|Overall Study|Severe non-compliance to protocol|0
1051229|NCT01844986|2092044|FG000|Overall Study|Withdrawal by Subject|21
1051230|NCT01844986|2092045|FG001|Overall Study|Withdrawal by Subject|14
1051231|NCT01844986|2092044|FG000|Overall Study|Death|55
1051232|NCT01844986|2092045|FG001|Overall Study|Death|26
1051233|NCT01845025|2092053|FG000|Overall Study|Adverse Event|6
1051234|NCT01845025|2092054|FG001|Overall Study|Adverse Event|3
1051235|NCT01845025|2092053|FG000|Overall Study|Unsatisfactory therapeutic effect|4
1051236|NCT01845025|2092054|FG001|Overall Study|Unsatisfactory therapeutic effect|2
1051237|NCT01845025|2092053|FG000|Overall Study|Withdrawal by Subject|48
1051238|NCT01845025|2092054|FG001|Overall Study|Withdrawal by Subject|44
1051239|NCT01845025|2092053|FG000|Overall Study|Lost to Follow-up|13
1051240|NCT01845025|2092054|FG001|Overall Study|Lost to Follow-up|13
1051241|NCT01845025|2092053|FG000|Overall Study|Administrative problems|8
1051242|NCT01845025|2092054|FG001|Overall Study|Administrative problems|8
1051243|NCT01845025|2092053|FG000|Overall Study|Death|2
1051244|NCT01845025|2092054|FG001|Overall Study|Death|0
1051245|NCT01845025|2092053|FG000|Overall Study|Protocol deviation|3
1051246|NCT01845025|2092054|FG001|Overall Study|Protocol deviation|6
1051247|NCT01845025|2092053|FG000|Overall Study|Missing|1
1051248|NCT01845025|2092054|FG001|Overall Study|Missing|1
1051249|NCT01845077|2092063|FG000|Washout Period|Lost to Follow-up|0
1051250|NCT01845077|2092064|FG001|Washout Period|Lost to Follow-up|1
1051251|NCT01845077|2092065|FG002|Washout Period|Lost to Follow-up|0
1051252|NCT01845077|2092066|FG003|Washout Period|Lost to Follow-up|1
1051253|NCT01845077|2092067|FG004|Washout Period|Lost to Follow-up|0
1051254|NCT01845077|2092068|FG005|Washout Period|Lost to Follow-up|1
1051255|NCT01845077|2092063|FG000|Washout Period|Adverse Event|1
1051256|NCT01845077|2092064|FG001|Washout Period|Adverse Event|0
1051257|NCT01845077|2092065|FG002|Washout Period|Adverse Event|0
1051258|NCT01845077|2092066|FG003|Washout Period|Adverse Event|0
1051259|NCT01845077|2092067|FG004|Washout Period|Adverse Event|0
1051260|NCT01845077|2092068|FG005|Washout Period|Adverse Event|0
1051261|NCT01845077|2092063|FG000|Washout Period|elevated lab values (not clinic. sign.)|0
1051262|NCT01845077|2092064|FG001|Washout Period|elevated lab values (not clinic. sign.)|0
1051263|NCT01845077|2092065|FG002|Washout Period|elevated lab values (not clinic. sign.)|1
1051264|NCT01845077|2092066|FG003|Washout Period|elevated lab values (not clinic. sign.)|0
1051265|NCT01845077|2092067|FG004|Washout Period|elevated lab values (not clinic. sign.)|0
1051266|NCT01845077|2092068|FG005|Washout Period|elevated lab values (not clinic. sign.)|0
1051267|NCT01845077|2092063|FG000|Washout Period|Protocol Violation|0
1051268|NCT01845077|2092064|FG001|Washout Period|Protocol Violation|0
1051269|NCT01845077|2092065|FG002|Washout Period|Protocol Violation|0
1051270|NCT01845077|2092066|FG003|Washout Period|Protocol Violation|1
1051271|NCT01845077|2092067|FG004|Washout Period|Protocol Violation|1
1051272|NCT01845077|2092068|FG005|Washout Period|Protocol Violation|0
1051273|NCT01845818|2092118|FG000|Overall Study|Withdrawal by Subject|0
1051274|NCT01845818|2092119|FG001|Overall Study|Withdrawal by Subject|1
1051275|NCT01845818|2092118|FG000|Overall Study|Lost to Follow-up|7
1051276|NCT01845818|2092119|FG001|Overall Study|Lost to Follow-up|5
1051277|NCT01845818|2092118|FG000|Overall Study|Administrative Reasons|3
1051278|NCT01845818|2092119|FG001|Overall Study|Administrative Reasons|1
1051279|NCT01845818|2092118|FG000|Overall Study|Serious Adverse Event|1
1051280|NCT01845818|2092119|FG001|Overall Study|Serious Adverse Event|1
1051281|NCT01845818|2092118|FG000|Overall Study|Other|25
1051282|NCT01845818|2092119|FG001|Overall Study|Other|8
1051283|NCT01845818|2092118|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5
1051284|NCT01845818|2092119|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0
1051285|NCT01845818|2092118|FG000|Overall Study|No Follow-Up Data Available|4
1051286|NCT01845818|2092119|FG001|Overall Study|No Follow-Up Data Available|1
1051287|NCT01845831|2092129|FG000|Inpatient Phase|Withdrawal by Subject|1
1051288|NCT01845831|2092130|FG001|Inpatient Phase|Withdrawal by Subject|1
1051289|NCT01845831|2092131|FG002|Inpatient Phase|Withdrawal by Subject|0
1051290|NCT01845831|2092132|FG003|Inpatient Phase|Withdrawal by Subject|0
1051291|NCT01845831|2092133|FG004|Inpatient Phase|Withdrawal by Subject|0
1051292|NCT01845974|2092146|FG000|Overall Study|screen failure|1
1051293|NCT01845974|2092147|FG001|Overall Study|screen failure|0
1051294|NCT01846039|2092153|FG000|Overall Study|Protocol Violation|1
1051295|NCT01846039|2092153|FG000|Overall Study|Subject Withdrew Consent|1
1051296|NCT01846104|2092157|FG000|Overall Study|Withdrawal by Subject|1
1051297|NCT01846208|2092164|FG000|Overall Study|Withdrew prior to treatment|1
1051298|NCT01846208|2092165|FG001|Overall Study|Withdrew prior to treatment|1
1051299|NCT01846208|2092166|FG002|Overall Study|Withdrew prior to treatment|1
1051300|NCT01846208|2092164|FG000|Overall Study|Dosing Symptoms|1
1051301|NCT01846208|2092165|FG001|Overall Study|Dosing Symptoms|2
1051302|NCT01846208|2092166|FG002|Overall Study|Dosing Symptoms|6
1051303|NCT01846208|2092164|FG000|Overall Study|Withdrawal by Subject|5
1051304|NCT01846208|2092165|FG001|Overall Study|Withdrawal by Subject|0
1051305|NCT01846208|2092166|FG002|Overall Study|Withdrawal by Subject|0
1051306|NCT01846208|2092164|FG000|Overall Study|Non-compliance|1
1051307|NCT01846208|2092165|FG001|Overall Study|Non-compliance|1
1051308|NCT01846208|2092166|FG002|Overall Study|Non-compliance|0
1051309|NCT01846208|2092164|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
1051310|NCT01846208|2092165|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
1051311|NCT01846208|2092166|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
1051312|NCT01846208|2092164|FG000|Overall Study|Refused SU OFC|0
1051313|NCT01846208|2092165|FG001|Overall Study|Refused SU OFC|0
1051314|NCT01846208|2092166|FG002|Overall Study|Refused SU OFC|1
1051315|NCT01846221|2092176|FG000|Overall Study|Catheter Failure|2
1051316|NCT01846221|2092177|FG001|Overall Study|Catheter Failure|0
1051317|NCT01846221|2092176|FG000|Overall Study|Age Exclusion|1
1051318|NCT01846221|2092177|FG001|Overall Study|Age Exclusion|0
1051319|NCT01846299|2092198|FG000|Overall Study|Physician Decision|4
1051320|NCT01846299|2092199|FG001|Overall Study|Physician Decision|2
1051321|NCT01846299|2092198|FG000|Overall Study|Protocol deviation|1
1051322|NCT01846299|2092199|FG001|Overall Study|Protocol deviation|0
1051323|NCT01846299|2092198|FG000|Overall Study|Death|1
1051324|NCT01846299|2092199|FG001|Overall Study|Death|2
1051325|NCT01846299|2092198|FG000|Overall Study|Lost to Follow-up|3
1051326|NCT01846299|2092199|FG001|Overall Study|Lost to Follow-up|0
1051327|NCT01846299|2092198|FG000|Overall Study|Withdrawal by Subject|1
1051328|NCT01846299|2092199|FG001|Overall Study|Withdrawal by Subject|6
1051329|NCT01846299|2092198|FG000|Overall Study|Adverse Event|2
1051330|NCT01846299|2092199|FG001|Overall Study|Adverse Event|0
1051331|NCT01846416|2092210|FG000|Treatment Phase|Death|2
1051332|NCT01846416|2092211|FG001|Treatment Phase|Death|9
1051333|NCT01846416|2092212|FG002|Treatment Phase|Death|1
1051334|NCT01846416|2092210|FG000|Treatment Phase|Withdrawal by Subject|2
1051335|NCT01846416|2092211|FG001|Treatment Phase|Withdrawal by Subject|4
1051336|NCT01846416|2092212|FG002|Treatment Phase|Withdrawal by Subject|2
1051337|NCT01846416|2092210|FG000|Treatment Phase|Other|1
1051338|NCT01846416|2092211|FG001|Treatment Phase|Other|5
1051339|NCT01846416|2092212|FG002|Treatment Phase|Other|1
1051340|NCT01846416|2092210|FG000|Treatment Phase|Physician Decision|1
1051341|NCT01846416|2092211|FG001|Treatment Phase|Physician Decision|2
1051342|NCT01846416|2092212|FG002|Treatment Phase|Physician Decision|0
1051343|NCT01846416|2092210|FG000|Treatment Phase|Adverse Event|3
1051344|NCT01846416|2092211|FG001|Treatment Phase|Adverse Event|4
1051345|NCT01846416|2092212|FG002|Treatment Phase|Adverse Event|0
1051346|NCT01846416|2092210|FG000|Treatment Phase|Non-compliance|0
1051347|NCT01846416|2092211|FG001|Treatment Phase|Non-compliance|2
1051348|NCT01846416|2092212|FG002|Treatment Phase|Non-compliance|0
1051349|NCT01846416|2092210|FG000|Treatment Phase|Study Terminated by Sponsor|1
1051350|NCT01846416|2092211|FG001|Treatment Phase|Study Terminated by Sponsor|4
1051351|NCT01846416|2092212|FG002|Treatment Phase|Study Terminated by Sponsor|0
1051352|NCT01846416|2092210|FG000|Treatment Phase|Progressive Disease|21
1051353|NCT01846416|2092211|FG001|Treatment Phase|Progressive Disease|63
1051354|NCT01846416|2092212|FG002|Treatment Phase|Progressive Disease|9
1051355|NCT01846416|2092210|FG000|Survival Follow-up|Death|21
1051356|NCT01846416|2092211|FG001|Survival Follow-up|Death|62
1051357|NCT01846416|2092212|FG002|Survival Follow-up|Death|9
1051358|NCT01846416|2092210|FG000|Survival Follow-up|Lost to Follow-up|0
1051359|NCT01846416|2092211|FG001|Survival Follow-up|Lost to Follow-up|2
1051360|NCT01846416|2092212|FG002|Survival Follow-up|Lost to Follow-up|2
1051361|NCT01846416|2092210|FG000|Survival Follow-up|Withdrawal by Subject|2
1051362|NCT01846416|2092211|FG001|Survival Follow-up|Withdrawal by Subject|7
1051363|NCT01846416|2092212|FG002|Survival Follow-up|Withdrawal by Subject|0
1051364|NCT01846416|2092210|FG000|Survival Follow-up|Study Terminated by Sponsor|2
1051365|NCT01846416|2092211|FG001|Survival Follow-up|Study Terminated by Sponsor|8
1051366|NCT01846416|2092212|FG002|Survival Follow-up|Study Terminated by Sponsor|0
1051367|NCT01846416|2092210|FG000|Survival Follow-up|Other|3
1051368|NCT01846416|2092211|FG001|Survival Follow-up|Other|1
1051369|NCT01846416|2092212|FG002|Survival Follow-up|Other|1
906882|NCT00771667|1882857|FG007|Maintenance Phase|Lack of Efficacy|2
906883|NCT00771667|1882858|FG008|Maintenance Phase|Lack of Efficacy|11
906884|NCT00771667|1882859|FG009|Maintenance Phase|Lack of Efficacy|7
906885|NCT00771667|1882850|FG000|Maintenance Phase|Other|0
906886|NCT00771667|1882851|FG001|Maintenance Phase|Other|0
906887|NCT00771667|1882852|FG002|Maintenance Phase|Other|0
906888|NCT00771667|1882853|FG003|Maintenance Phase|Other|0
906889|NCT00771667|1882854|FG004|Maintenance Phase|Other|0
906890|NCT00771667|1882855|FG005|Maintenance Phase|Other|1
906891|NCT00771667|1882856|FG006|Maintenance Phase|Other|2
906892|NCT00771667|1882857|FG007|Maintenance Phase|Other|2
906893|NCT00771667|1882858|FG008|Maintenance Phase|Other|3
906894|NCT00771667|1882859|FG009|Maintenance Phase|Other|3
906895|NCT00771758|1882889|FG000|Overall Study|Adverse Event|2
906896|NCT00771758|1882890|FG001|Overall Study|Adverse Event|8
906897|NCT00771758|1882891|FG002|Overall Study|Adverse Event|1
906898|NCT00771758|1882889|FG000|Overall Study|Lack of Efficacy|0
906899|NCT00771758|1882890|FG001|Overall Study|Lack of Efficacy|2
906900|NCT00771758|1882891|FG002|Overall Study|Lack of Efficacy|1
1051370|NCT01846442|2092225|FG000|Overall Study|Adverse Event|2
1051371|NCT01846442|2092226|FG001|Overall Study|Adverse Event|4
1051372|NCT01846442|2092227|FG002|Overall Study|Adverse Event|2
1051373|NCT01846442|2092228|FG003|Overall Study|Adverse Event|1
1051374|NCT01846442|2092225|FG000|Overall Study|Lost to Follow-up|0
1051375|NCT01846442|2092226|FG001|Overall Study|Lost to Follow-up|0
1051376|NCT01846442|2092227|FG002|Overall Study|Lost to Follow-up|1
1051377|NCT01846442|2092228|FG003|Overall Study|Lost to Follow-up|0
1051378|NCT01846442|2092225|FG000|Overall Study|Withdrawal by Subject|3
1051379|NCT01846442|2092226|FG001|Overall Study|Withdrawal by Subject|2
1051380|NCT01846442|2092227|FG002|Overall Study|Withdrawal by Subject|0
1051381|NCT01846442|2092228|FG003|Overall Study|Withdrawal by Subject|1
1051382|NCT01846442|2092225|FG000|Overall Study|Left the city/Lost medication|1
1051383|NCT01846442|2092226|FG001|Overall Study|Left the city/Lost medication|0
1051384|NCT01846442|2092227|FG002|Overall Study|Left the city/Lost medication|1
1051385|NCT01846442|2092228|FG003|Overall Study|Left the city/Lost medication|1
1051386|NCT01846507|2092268|FG000|Overall Study|Lost to Follow-up|4
1051387|NCT01846507|2092268|FG000|Overall Study|Protocol Violation|1
1051388|NCT01846507|2092268|FG000|Overall Study|Missing data|2
1051389|NCT01846611|2092276|FG000|Overall Study|Lost to Follow-up|4
1051390|NCT01846611|2092277|FG001|Overall Study|Lost to Follow-up|6
1051391|NCT01846611|2092276|FG000|Overall Study|Withdrawal by Subject|15
1051392|NCT01846611|2092277|FG001|Overall Study|Withdrawal by Subject|19
1051393|NCT01846611|2092276|FG000|Overall Study|Other|19
1051394|NCT01846611|2092277|FG001|Overall Study|Other|18
1051395|NCT01846624|2092283|FG000|Overall Study|Died during induction, no midostaurin|1
1051396|NCT01846741|2092328|FG000|Baseline Visit|Subject did not meet entry criteria|2
1051397|NCT01847092|2092417|FG000|Overall Study|Adverse Event|12
1051398|NCT01847092|2092418|FG001|Overall Study|Adverse Event|3
1051399|NCT01847092|2092417|FG000|Overall Study|Withdrawal by Subject|5
1051400|NCT01847092|2092418|FG001|Overall Study|Withdrawal by Subject|5
1051401|NCT01847092|2092417|FG000|Overall Study|Protocol Specified|8
1051402|NCT01847092|2092418|FG001|Overall Study|Protocol Specified|0
1051403|NCT01847092|2092417|FG000|Overall Study|Physician Decision|1
1051404|NCT01847092|2092418|FG001|Overall Study|Physician Decision|1
1051405|NCT01847092|2092417|FG000|Overall Study|Protocol Violation|0
1051406|NCT01847092|2092418|FG001|Overall Study|Protocol Violation|2
1051407|NCT01847209|2092437|FG000|Overall Study|Withdrawal by Subject|1
1051408|NCT01847209|2092437|FG000|Overall Study|No lung nodule found on intraop CT scan|1
1051409|NCT01847274|2092445|FG000|Overall Study|Adverse Event|17
1051410|NCT01847274|2092446|FG001|Overall Study|Adverse Event|1
1051411|NCT01847274|2092447|FG002|Overall Study|Adverse Event|33
1051412|NCT01847274|2092448|FG003|Overall Study|Adverse Event|2
1051413|NCT01847274|2092445|FG000|Overall Study|Withdrawal by Subject|8
1051414|NCT01847274|2092446|FG001|Overall Study|Withdrawal by Subject|8
1051415|NCT01847274|2092447|FG002|Overall Study|Withdrawal by Subject|11
1051416|NCT01847274|2092448|FG003|Overall Study|Withdrawal by Subject|1
1051417|NCT01847274|2092445|FG000|Overall Study|Disease Progression|63
1051418|NCT01847274|2092446|FG001|Overall Study|Disease Progression|49
1051419|NCT01847274|2092447|FG002|Overall Study|Disease Progression|129
1051420|NCT01847274|2092448|FG003|Overall Study|Disease Progression|98
1051421|NCT01847274|2092445|FG000|Overall Study|Treatment Associated Risk|0
1051422|NCT01847274|2092446|FG001|Overall Study|Treatment Associated Risk|2
1051423|NCT01847274|2092447|FG002|Overall Study|Treatment Associated Risk|2
1051424|NCT01847274|2092448|FG003|Overall Study|Treatment Associated Risk|0
1051425|NCT01847274|2092445|FG000|Overall Study|Other Reasons|3
1051426|NCT01847274|2092446|FG001|Overall Study|Other Reasons|1
1051427|NCT01847274|2092447|FG002|Overall Study|Other Reasons|11
1051428|NCT01847274|2092448|FG003|Overall Study|Other Reasons|3
1051429|NCT01847274|2092445|FG000|Overall Study|Non Compliance|0
1051430|NCT01847274|2092446|FG001|Overall Study|Non Compliance|0
1051431|NCT01847274|2092447|FG002|Overall Study|Non Compliance|2
1051432|NCT01847274|2092448|FG003|Overall Study|Non Compliance|0
1051433|NCT01847313|2092460|FG000|Overall Study|Death|0
1051434|NCT01847313|2092461|FG001|Overall Study|Death|1
1051435|NCT01847313|2092460|FG000|Overall Study|Withdrawal by Subject|0
1051436|NCT01847313|2092461|FG001|Overall Study|Withdrawal by Subject|1
1051437|NCT01847443|2092471|FG000|Study Period 1|Withdrawal by Subject|0
1051438|NCT01847443|2092472|FG001|Study Period 1|Withdrawal by Subject|1
1051439|NCT01847443|2092473|FG002|Study Period 1|Withdrawal by Subject|0
1051440|NCT01847443|2092474|FG003|Study Period 1|Withdrawal by Subject|0
1051441|NCT01847443|2092471|FG000|Washout Period Before Study Period 2|Adverse Event|1
1051442|NCT01847443|2092472|FG001|Washout Period Before Study Period 2|Adverse Event|1
1051443|NCT01847443|2092473|FG002|Washout Period Before Study Period 2|Adverse Event|0
1051444|NCT01847443|2092474|FG003|Washout Period Before Study Period 2|Adverse Event|0
1051445|NCT01847443|2092471|FG000|Washout Period Before Study Period 2|Other reason|1
1051446|NCT01847443|2092472|FG001|Washout Period Before Study Period 2|Other reason|0
1051447|NCT01847443|2092473|FG002|Washout Period Before Study Period 2|Other reason|0
1051448|NCT01847443|2092474|FG003|Washout Period Before Study Period 2|Other reason|0
1051449|NCT01847443|2092471|FG000|Washout Period Before Study Period 3|Other reason|1
1051450|NCT01847443|2092472|FG001|Washout Period Before Study Period 3|Other reason|0
1051451|NCT01847443|2092473|FG002|Washout Period Before Study Period 3|Other reason|0
1051452|NCT01847443|2092474|FG003|Washout Period Before Study Period 3|Other reason|0
1051453|NCT01847443|2092471|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1
1051454|NCT01847443|2092472|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0
1051455|NCT01847443|2092473|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0
1051456|NCT01847443|2092474|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0
1051457|NCT01847443|2092471|FG000|Washout Period Before Study Period 4|Positive alcohol test|1
1051458|NCT01847443|2092472|FG001|Washout Period Before Study Period 4|Positive alcohol test|0
1051459|NCT01847443|2092473|FG002|Washout Period Before Study Period 4|Positive alcohol test|0
1051460|NCT01847443|2092474|FG003|Washout Period Before Study Period 4|Positive alcohol test|0
1051461|NCT01847755|2092575|FG000|Overall Study|Adverse Event|2
1051462|NCT01847755|2092575|FG000|Overall Study|Withdrawal by Subject|2
1051463|NCT01847755|2092575|FG000|Overall Study|Physician Decision|1
1051464|NCT01847885|2092581|FG000|Initial Enrollment (Consented)|Protocol Violation|1
1051465|NCT01847885|2092582|FG001|Initial Enrollment (Consented)|Protocol Violation|0
1051466|NCT01847885|2092583|FG002|Initial Enrollment (Consented)|Protocol Violation|0
1051467|NCT01847885|2092581|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2
1051468|NCT01847885|2092582|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0
1051469|NCT01847885|2092583|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0
1051470|NCT01847885|2092581|FG000|Initial Enrollment (Consented)|Screen failure|39
1051471|NCT01847885|2092582|FG001|Initial Enrollment (Consented)|Screen failure|0
1051472|NCT01847885|2092583|FG002|Initial Enrollment (Consented)|Screen failure|0
1051473|NCT01847885|2092581|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
1051474|NCT01847885|2092582|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
1051475|NCT01847885|2092583|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
1051476|NCT01847885|2092581|FG000|Randomization|Protocol Violation|0
1051477|NCT01847885|2092582|FG001|Randomization|Protocol Violation|1
1051478|NCT01847885|2092583|FG002|Randomization|Protocol Violation|0
1051479|NCT01847885|2092581|FG000|Randomization|Withdrawal by Subject|0
1051480|NCT01847885|2092582|FG001|Randomization|Withdrawal by Subject|0
1051481|NCT01847885|2092583|FG002|Randomization|Withdrawal by Subject|2
1051482|NCT01847885|2092581|FG000|Randomization|Screen Failure|0
1051483|NCT01847885|2092582|FG001|Randomization|Screen Failure|3
1051484|NCT01847885|2092583|FG002|Randomization|Screen Failure|0
1051485|NCT01848145|2092628|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
1051486|NCT01848145|2092628|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
906901|NCT00771758|1882889|FG000|Overall Study|Lost to Follow-up|1
906902|NCT00771758|1882890|FG001|Overall Study|Lost to Follow-up|0
906903|NCT00771758|1882891|FG002|Overall Study|Lost to Follow-up|0
906904|NCT00771758|1882889|FG000|Overall Study|Protocol Violation|1
906905|NCT00771758|1882890|FG001|Overall Study|Protocol Violation|0
906906|NCT00771758|1882891|FG002|Overall Study|Protocol Violation|0
906907|NCT00771758|1882889|FG000|Overall Study|Withdrawal by Subject|1
906908|NCT00771758|1882890|FG001|Overall Study|Withdrawal by Subject|0
906909|NCT00771758|1882891|FG002|Overall Study|Withdrawal by Subject|0
906910|NCT00771758|1882889|FG000|Overall Study|Other|3
906911|NCT00771758|1882890|FG001|Overall Study|Other|2
906912|NCT00771758|1882891|FG002|Overall Study|Other|0
906913|NCT00771810|1882919|FG000|Overall Study|Adverse Event|3
906914|NCT00771810|1882920|FG001|Overall Study|Adverse Event|0
906915|NCT00771810|1882921|FG002|Overall Study|Adverse Event|2
906916|NCT00771810|1882919|FG000|Overall Study|Lost to Follow-up|0
906917|NCT00771810|1882920|FG001|Overall Study|Lost to Follow-up|0
906918|NCT00771810|1882921|FG002|Overall Study|Lost to Follow-up|1
906919|NCT00771810|1882919|FG000|Overall Study|Physician Decision|1
906920|NCT00771810|1882920|FG001|Overall Study|Physician Decision|2
906921|NCT00771810|1882921|FG002|Overall Study|Physician Decision|2
906922|NCT00771810|1882919|FG000|Overall Study|Protocol Violation|0
906923|NCT00771810|1882920|FG001|Overall Study|Protocol Violation|1
906924|NCT00771810|1882921|FG002|Overall Study|Protocol Violation|1
906925|NCT00771810|1882919|FG000|Overall Study|Withdrawal by Subject|1
906926|NCT00771810|1882920|FG001|Overall Study|Withdrawal by Subject|2
906927|NCT00771810|1882921|FG002|Overall Study|Withdrawal by Subject|0
906928|NCT00771810|1882919|FG000|Overall Study|Other|0
906929|NCT00771810|1882920|FG001|Overall Study|Other|0
906930|NCT00771810|1882921|FG002|Overall Study|Other|1
906931|NCT00771849|1882932|FG000|Overall Study|Lost to Follow-up|1
1051487|NCT01848145|2092628|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
1051488|NCT01848145|2092628|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
1051489|NCT01848145|2092628|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6
1051490|NCT01848145|2092628|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
1051491|NCT01848145|2092628|FG000|Subsequent Infusions: Weeks 3-8|Death|1
1051492|NCT01848210|2092653|FG000|Overall Study|Informed Consent Form Withdrawal|28
1051493|NCT01848210|2092654|FG001|Overall Study|Informed Consent Form Withdrawal|24
1051494|NCT01848210|2092653|FG000|Overall Study|Lost to Follow-up|24
1051495|NCT01848210|2092654|FG001|Overall Study|Lost to Follow-up|12
1051496|NCT01848210|2092653|FG000|Overall Study|Protocol Violation|3
1051497|NCT01848210|2092654|FG001|Overall Study|Protocol Violation|5
1051498|NCT01848210|2092653|FG000|Overall Study|Use of Forbidden Drugs|9
1051499|NCT01848210|2092654|FG001|Overall Study|Use of Forbidden Drugs|10
1051500|NCT01848210|2092653|FG000|Overall Study|Impedition Condition|5
1051501|NCT01848210|2092654|FG001|Overall Study|Impedition Condition|9
1051502|NCT01848210|2092653|FG000|Overall Study|Adverse Event|7
1051503|NCT01848210|2092654|FG001|Overall Study|Adverse Event|9
1051504|NCT01848210|2092653|FG000|Overall Study|Discontinuation Criterion|5
1051505|NCT01848210|2092654|FG001|Overall Study|Discontinuation Criterion|7
1051506|NCT01848210|2092653|FG000|Overall Study|Hypesensitivity|1
1051507|NCT01848210|2092654|FG001|Overall Study|Hypesensitivity|0
1051508|NCT01848210|2092653|FG000|Overall Study|Hepatic Function Alteration|4
1051509|NCT01848210|2092654|FG001|Overall Study|Hepatic Function Alteration|0
1051510|NCT01848210|2092653|FG000|Overall Study|Chronic Venous Insufficiency Course|1
1051511|NCT01848210|2092654|FG001|Overall Study|Chronic Venous Insufficiency Course|2
1051512|NCT01848210|2092653|FG000|Overall Study|Administrative|1
1051513|NCT01848210|2092654|FG001|Overall Study|Administrative|0
1051514|NCT01848288|2092660|FG000|Overall Study|Death|1
1051515|NCT01848288|2092660|FG000|Overall Study|Protocol Violation|1
1051516|NCT01848288|2092660|FG000|Overall Study|Withdrawal by Subject|1
1051517|NCT01848353|2092669|FG000|Phase 1|Withdrawal by Subject|3
1051518|NCT01848353|2092670|FG001|Phase 1|Withdrawal by Subject|1
1051519|NCT01848353|2092671|FG002|Phase 1|Withdrawal by Subject|0
1051520|NCT01848353|2092672|FG003|Phase 1|Withdrawal by Subject|0
1051521|NCT01848353|2092669|FG000|Phase 2|Withdrawal by Subject|3
1051522|NCT01848353|2092670|FG001|Phase 2|Withdrawal by Subject|2
1051523|NCT01848353|2092671|FG002|Phase 2|Withdrawal by Subject|0
1051524|NCT01848353|2092672|FG003|Phase 2|Withdrawal by Subject|0
1051525|NCT01848353|2092669|FG000|Phase 3|Withdrawal by Subject|1
1051526|NCT01848353|2092670|FG001|Phase 3|Withdrawal by Subject|1
1051527|NCT01848353|2092671|FG002|Phase 3|Withdrawal by Subject|0
1051528|NCT01848353|2092672|FG003|Phase 3|Withdrawal by Subject|0
1051529|NCT01848457|2092698|FG000|Overall Study|Death|1
1051530|NCT01848457|2092699|FG001|Overall Study|Death|0
1051531|NCT01848457|2092700|FG002|Overall Study|Death|0
1051532|NCT01848457|2092701|FG003|Overall Study|Death|0
1051533|NCT01848483|2092721|FG000|Overall Study|Death|2
1051534|NCT01848483|2092722|FG001|Overall Study|Death|1
1051535|NCT01848483|2092721|FG000|Overall Study|Lost to Follow-up|6
1051536|NCT01848483|2092722|FG001|Overall Study|Lost to Follow-up|8
1051537|NCT01848483|2092721|FG000|Overall Study|Withdrawal by Subject|1
1051538|NCT01848483|2092722|FG001|Overall Study|Withdrawal by Subject|0
1051539|NCT01848483|2092721|FG000|Overall Study|Incarceration|2
1051540|NCT01848483|2092722|FG001|Overall Study|Incarceration|2
1051541|NCT01848756|2092729|FG000|Overall Study|Adverse Event|1
1051542|NCT01848756|2092729|FG000|Overall Study|Withdrawal by Subject|1
1051543|NCT01848756|2092729|FG000|Overall Study|Enrolled in Error|1
1051544|NCT01848834|2092748|FG000|Overall Study|Adverse Event|3
1051545|NCT01848834|2092749|FG001|Overall Study|Adverse Event|11
1051546|NCT01848834|2092750|FG002|Overall Study|Adverse Event|3
1051547|NCT01848834|2092751|FG003|Overall Study|Adverse Event|5
1051548|NCT01848834|2092752|FG004|Overall Study|Adverse Event|9
1051549|NCT01848834|2092748|FG000|Overall Study|Death|2
1051550|NCT01848834|2092749|FG001|Overall Study|Death|11
1051551|NCT01848834|2092750|FG002|Overall Study|Death|1
1051552|NCT01848834|2092751|FG003|Overall Study|Death|8
1051553|NCT01848834|2092752|FG004|Overall Study|Death|27
1051554|NCT01848834|2092748|FG000|Overall Study|Excluded Medication|5
1051555|NCT01848834|2092749|FG001|Overall Study|Excluded Medication|4
1051556|NCT01848834|2092750|FG002|Overall Study|Excluded Medication|3
1051557|NCT01848834|2092751|FG003|Overall Study|Excluded Medication|6
1051558|NCT01848834|2092752|FG004|Overall Study|Excluded Medication|6
1051559|NCT01848834|2092748|FG000|Overall Study|Lost to Follow-up|5
1051560|NCT01848834|2092749|FG001|Overall Study|Lost to Follow-up|5
1051561|NCT01848834|2092750|FG002|Overall Study|Lost to Follow-up|3
1051562|NCT01848834|2092751|FG003|Overall Study|Lost to Follow-up|0
1051563|NCT01848834|2092752|FG004|Overall Study|Lost to Follow-up|3
1051564|NCT01848834|2092748|FG000|Overall Study|Physician Decision|1
1051565|NCT01848834|2092749|FG001|Overall Study|Physician Decision|3
1051566|NCT01848834|2092750|FG002|Overall Study|Physician Decision|4
1051567|NCT01848834|2092751|FG003|Overall Study|Physician Decision|0
1051568|NCT01848834|2092752|FG004|Overall Study|Physician Decision|11
1051569|NCT01848834|2092748|FG000|Overall Study|Protocol Violation|0
1051570|NCT01848834|2092749|FG001|Overall Study|Protocol Violation|0
1051571|NCT01848834|2092750|FG002|Overall Study|Protocol Violation|0
1051572|NCT01848834|2092751|FG003|Overall Study|Protocol Violation|0
1051573|NCT01848834|2092752|FG004|Overall Study|Protocol Violation|1
1051574|NCT01848834|2092748|FG000|Overall Study|Sponsor Decision|1
1051575|NCT01848834|2092749|FG001|Overall Study|Sponsor Decision|1
1051576|NCT01848834|2092750|FG002|Overall Study|Sponsor Decision|0
1051577|NCT01848834|2092751|FG003|Overall Study|Sponsor Decision|1
1051578|NCT01848834|2092752|FG004|Overall Study|Sponsor Decision|1
1051579|NCT01848834|2092748|FG000|Overall Study|Withdrawal by Subject|2
1051580|NCT01848834|2092749|FG001|Overall Study|Withdrawal by Subject|13
1051581|NCT01848834|2092750|FG002|Overall Study|Withdrawal by Subject|10
1051582|NCT01848834|2092751|FG003|Overall Study|Withdrawal by Subject|6
1051583|NCT01848834|2092752|FG004|Overall Study|Withdrawal by Subject|36
1051584|NCT01848938|2092788|FG000|Overall Study|Lost to Follow-up|1
1051585|NCT01848938|2092789|FG001|Overall Study|Lost to Follow-up|1
1051586|NCT01848990|2092807|FG000|Overall Study|Adverse Event|6
1051587|NCT01848990|2092808|FG001|Overall Study|Adverse Event|2
1051588|NCT01848990|2092809|FG002|Overall Study|Adverse Event|0
1051589|NCT01848990|2092807|FG000|Overall Study|Lost to Follow-up|6
1051590|NCT01848990|2092808|FG001|Overall Study|Lost to Follow-up|2
1051591|NCT01848990|2092809|FG002|Overall Study|Lost to Follow-up|2
1051592|NCT01848990|2092807|FG000|Overall Study|Protocol Violation|1
1051593|NCT01848990|2092808|FG001|Overall Study|Protocol Violation|1
1051594|NCT01848990|2092809|FG002|Overall Study|Protocol Violation|0
1051595|NCT01848990|2092807|FG000|Overall Study|Withdrawal by Subject|29
1051596|NCT01848990|2092808|FG001|Overall Study|Withdrawal by Subject|10
1051597|NCT01848990|2092809|FG002|Overall Study|Withdrawal by Subject|11
1051598|NCT01848990|2092807|FG000|Overall Study|Physician Decision|1
1051599|NCT01848990|2092808|FG001|Overall Study|Physician Decision|1
1051600|NCT01848990|2092809|FG002|Overall Study|Physician Decision|0
1051601|NCT01848990|2092807|FG000|Overall Study|Non Compliance|1
1051602|NCT01848990|2092808|FG001|Overall Study|Non Compliance|0
1051603|NCT01848990|2092809|FG002|Overall Study|Non Compliance|0
1051604|NCT01848990|2092807|FG000|Overall Study|Death|1
1051605|NCT01848990|2092808|FG001|Overall Study|Death|0
1051606|NCT01848990|2092809|FG002|Overall Study|Death|1
1051607|NCT01848990|2092807|FG000|Overall Study|Other|1
1051608|NCT01848990|2092808|FG001|Overall Study|Other|4
1051609|NCT01848990|2092809|FG002|Overall Study|Other|2
1051610|NCT01849055|2092827|FG000|Overall Study|Withdrawal by Subject|0
1051611|NCT01849055|2092828|FG001|Overall Study|Withdrawal by Subject|0
1051612|NCT01849055|2092829|FG002|Overall Study|Withdrawal by Subject|1
1051613|NCT01849055|2092830|FG003|Overall Study|Withdrawal by Subject|0
1051614|NCT01849055|2092831|FG004|Overall Study|Withdrawal by Subject|0
1051615|NCT01849055|2092832|FG005|Overall Study|Withdrawal by Subject|0
1051616|NCT01849276|2092872|FG000|Followed for Survival for 5 Years|Death|1
1051617|NCT01849276|2092872|FG000|Followed for Survival for 5 Years|Early termination of the study|1
1051618|NCT01849289|2092878|FG000|Overall Study|Adverse Event|3
1051619|NCT01849289|2092879|FG001|Overall Study|Adverse Event|3
1051620|NCT01849289|2092878|FG000|Overall Study|Protocol Violation|3
1051621|NCT01849289|2092879|FG001|Overall Study|Protocol Violation|3
1051622|NCT01849289|2092878|FG000|Overall Study|Withdrawal criteria|1
1051623|NCT01849289|2092879|FG001|Overall Study|Withdrawal criteria|0
1051624|NCT01849289|2092878|FG000|Overall Study|Unclassified|25
1051625|NCT01849289|2092879|FG001|Overall Study|Unclassified|18
1051626|NCT01849458|2092890|FG000|Overall Study|Lost to Follow-up|4
1051627|NCT01849497|2092896|FG000|Overall Study|Withdrawal by Subject|1
1051628|NCT01849497|2092897|FG001|Overall Study|Withdrawal by Subject|2
1051629|NCT01849497|2092896|FG000|Overall Study|Sponsor Decision|0
1051630|NCT01849497|2092897|FG001|Overall Study|Sponsor Decision|1
1051631|NCT01849497|2092896|FG000|Overall Study|Lost to Follow-up|0
1051632|NCT01849497|2092897|FG001|Overall Study|Lost to Follow-up|1
1051633|NCT01849562|2092906|FG000|Overall Study|Lost to Follow-up|1
1051634|NCT01849562|2092907|FG001|Overall Study|Lost to Follow-up|0
1051635|NCT01849562|2092908|FG002|Overall Study|Lost to Follow-up|0
1051636|NCT01849562|2092906|FG000|Overall Study|Non-compliance with Study Drug|1
1051637|NCT01849562|2092907|FG001|Overall Study|Non-compliance with Study Drug|0
1051638|NCT01849562|2092908|FG002|Overall Study|Non-compliance with Study Drug|0
1051639|NCT01849588|2092928|FG000|Overall Study|Lack of Efficacy|3
1051640|NCT01849848|2092981|FG000|Overall Study|Physician Decision|1
1051641|NCT01849848|2092981|FG000|Overall Study|Progression of the primary disease|3
1051642|NCT01849874|2092987|FG000|Overall Study|Death|34
1051643|NCT01849874|2092988|FG001|Overall Study|Death|16
1051644|NCT01849874|2092987|FG000|Overall Study|Withdrawal by Subject|4
1051645|NCT01849874|2092988|FG001|Overall Study|Withdrawal by Subject|8
1051646|NCT01849874|2092987|FG000|Overall Study|Lost to Follow-up|0
1051647|NCT01849874|2092988|FG001|Overall Study|Lost to Follow-up|1
1051648|NCT01849874|2092987|FG000|Overall Study|Randomized but Never Treated|1
1051649|NCT01849874|2092988|FG001|Overall Study|Randomized but Never Treated|8
1051650|NCT01849874|2092987|FG000|Overall Study|Ongoing|162
1051651|NCT01849874|2092988|FG001|Overall Study|Ongoing|69
1051657|NCT01850030|2093001|FG000|Overall Study|Adverse Event|64
1051658|NCT01850030|2093002|FG001|Overall Study|Adverse Event|82
1051659|NCT01850030|2093001|FG000|Overall Study|Lack of Efficacy|3
1051660|NCT01850030|2093002|FG001|Overall Study|Lack of Efficacy|1
1051661|NCT01850030|2093001|FG000|Overall Study|Lost to Follow-up|5
1051662|NCT01850030|2093002|FG001|Overall Study|Lost to Follow-up|5
1051663|NCT01850030|2093001|FG000|Overall Study|Withdrawal by Subject|3
1051664|NCT01850030|2093002|FG001|Overall Study|Withdrawal by Subject|4
1051665|NCT01850030|2093001|FG000|Overall Study|Protocol Violation|24
1051666|NCT01850030|2093002|FG001|Overall Study|Protocol Violation|28
1051667|NCT01850030|2093001|FG000|Overall Study|pregnancy not confirmed at visit 4|248
1051668|NCT01850030|2093002|FG001|Overall Study|pregnancy not confirmed at visit 4|249
1051669|NCT01850446|2093032|FG000|Overall Study|Lack of Efficacy|1
1051670|NCT01850446|2093033|FG001|Overall Study|Lack of Efficacy|0
1051671|NCT01850446|2093032|FG000|Overall Study|Withdrawal by Subject|4
1051672|NCT01850446|2093033|FG001|Overall Study|Withdrawal by Subject|0
1051673|NCT01850446|2093032|FG000|Overall Study|Protocol Violation|0
1051674|NCT01850446|2093033|FG001|Overall Study|Protocol Violation|2
1051675|NCT01850524|2093050|FG000|Overall Study|Ongoing on Treatment|57
1051676|NCT01850524|2093051|FG001|Overall Study|Ongoing on Treatment|54
1051677|NCT01850524|2093050|FG000|Overall Study|Adverse Event|96
1051678|NCT01850524|2093051|FG001|Overall Study|Adverse Event|122
1051679|NCT01850524|2093050|FG000|Overall Study|Lost to Follow-up|2
1051680|NCT01850524|2093051|FG001|Overall Study|Lost to Follow-up|0
1051681|NCT01850524|2093050|FG000|Overall Study|Progressive Disease|166
1051682|NCT01850524|2093051|FG001|Overall Study|Progressive Disease|123
1051683|NCT01850524|2093050|FG000|Overall Study|Protocol Violation|1
1051684|NCT01850524|2093051|FG001|Overall Study|Protocol Violation|2
1051685|NCT01850524|2093050|FG000|Overall Study|Withdrawal by Subject|8
1051686|NCT01850524|2093051|FG001|Overall Study|Withdrawal by Subject|19
1051687|NCT01850524|2093050|FG000|Overall Study|Participant Wished to Discontinue Treatment|15
1051688|NCT01850524|2093051|FG001|Overall Study|Participant Wished to Discontinue Treatment|22
1051689|NCT01850524|2093050|FG000|Overall Study|Investigator Decision|4
1051690|NCT01850524|2093051|FG001|Overall Study|Investigator Decision|4
1051691|NCT01850524|2093050|FG000|Overall Study|Participants Removed From Study|0
1051692|NCT01850524|2093051|FG001|Overall Study|Participants Removed From Study|1
906932|NCT00771849|1882933|FG001|Overall Study|Lost to Follow-up|2
906933|NCT00771849|1882932|FG000|Overall Study|Withdrawal by Subject|1
906934|NCT00771849|1882933|FG001|Overall Study|Withdrawal by Subject|1
906935|NCT00771849|1882932|FG000|Overall Study|Not vaccinated|0
906936|NCT00771849|1882933|FG001|Overall Study|Not vaccinated|1
906937|NCT00771901|1882955|FG000|Overall Study|Dissat w/# of study medication (40/day)|0
906938|NCT00771901|1882956|FG001|Overall Study|Dissat w/# of study medication (40/day)|0
906939|NCT00771901|1882957|FG002|Overall Study|Dissat w/# of study medication (40/day)|4
906940|NCT00771914|1882969|FG000|Overall Study|Physician Decision|0
906941|NCT00771914|1882970|FG001|Overall Study|Physician Decision|0
906942|NCT00771914|1882971|FG002|Overall Study|Physician Decision|0
906943|NCT00771914|1882972|FG003|Overall Study|Physician Decision|1
906944|NCT00771914|1882969|FG000|Overall Study|Lost to Follow-up|0
906945|NCT00771914|1882970|FG001|Overall Study|Lost to Follow-up|0
906946|NCT00771914|1882971|FG002|Overall Study|Lost to Follow-up|0
906947|NCT00771914|1882972|FG003|Overall Study|Lost to Follow-up|1
906948|NCT00771927|1882984|FG000|Overall Study|Adverse Event|100
906949|NCT00771927|1882985|FG001|Overall Study|Adverse Event|105
906950|NCT00771927|1882984|FG000|Overall Study|Lack of Efficacy|70
906951|NCT00771927|1882985|FG001|Overall Study|Lack of Efficacy|42
906952|NCT00771927|1882984|FG000|Overall Study|Lost to Follow-up|46
906953|NCT00771927|1882985|FG001|Overall Study|Lost to Follow-up|46
906954|NCT00771927|1882984|FG000|Overall Study|Withdrawal by Subject|16
906955|NCT00771927|1882985|FG001|Overall Study|Withdrawal by Subject|17
906956|NCT00771927|1882984|FG000|Overall Study|Other reason|23
906957|NCT00771927|1882985|FG001|Overall Study|Other reason|27
906958|NCT00771953|1882993|FG000|Overall Study|Adverse Event|5
906959|NCT00771953|1882994|FG001|Overall Study|Adverse Event|3
906960|NCT00771953|1882993|FG000|Overall Study|Death|2
906961|NCT00771953|1882994|FG001|Overall Study|Death|2
906962|NCT00771953|1882993|FG000|Overall Study|Progression before active Tx|1
906963|NCT00771953|1882994|FG001|Overall Study|Progression before active Tx|2
906964|NCT00771953|1882993|FG000|Overall Study|Sponsor decision|1
906965|NCT00771953|1882994|FG001|Overall Study|Sponsor decision|0
906966|NCT00771953|1882993|FG000|Overall Study|Other complicating disease|1
906967|NCT00771953|1882994|FG001|Overall Study|Other complicating disease|0
906968|NCT00771953|1882993|FG000|Overall Study|Withdrawal by Subject|0
906969|NCT00771953|1882994|FG001|Overall Study|Withdrawal by Subject|3
906970|NCT00772005|1883006|FG000|Overall Study|Adverse Event|9
906971|NCT00772005|1883007|FG001|Overall Study|Adverse Event|14
906972|NCT00772005|1883008|FG002|Overall Study|Adverse Event|10
906973|NCT00772005|1883009|FG003|Overall Study|Adverse Event|13
906974|NCT00772005|1883006|FG000|Overall Study|Lack of Efficacy|0
906975|NCT00772005|1883007|FG001|Overall Study|Lack of Efficacy|1
906976|NCT00772005|1883008|FG002|Overall Study|Lack of Efficacy|0
906977|NCT00772005|1883009|FG003|Overall Study|Lack of Efficacy|0
906978|NCT00772005|1883006|FG000|Overall Study|Withdrawal by Subject|3
906979|NCT00772005|1883007|FG001|Overall Study|Withdrawal by Subject|7
906980|NCT00772005|1883008|FG002|Overall Study|Withdrawal by Subject|10
906981|NCT00772005|1883009|FG003|Overall Study|Withdrawal by Subject|2
906982|NCT00772005|1883006|FG000|Overall Study|Protocol Violation|2
906983|NCT00772005|1883007|FG001|Overall Study|Protocol Violation|4
906984|NCT00772005|1883008|FG002|Overall Study|Protocol Violation|1
906985|NCT00772005|1883009|FG003|Overall Study|Protocol Violation|6
906986|NCT00772005|1883006|FG000|Overall Study|Lost to Follow-up|7
906987|NCT00772005|1883007|FG001|Overall Study|Lost to Follow-up|3
906988|NCT00772005|1883008|FG002|Overall Study|Lost to Follow-up|6
906989|NCT00772005|1883009|FG003|Overall Study|Lost to Follow-up|3
906990|NCT00772005|1883006|FG000|Overall Study|Non-compliance with study procedures|1
1051693|NCT01850524|2093050|FG000|Overall Study|Medical Monitor Decision|0
1051694|NCT01850524|2093051|FG001|Overall Study|Medical Monitor Decision|1
1051695|NCT01850524|2093050|FG000|Overall Study|Participants Decision|2
1051696|NCT01850524|2093051|FG001|Overall Study|Participants Decision|2
1051697|NCT01850524|2093050|FG000|Overall Study|Progressive Disease Per Local Lab|1
1051698|NCT01850524|2093051|FG001|Overall Study|Progressive Disease Per Local Lab|0
1051699|NCT01850524|2093050|FG000|Overall Study|Lack of Improvement|0
1051700|NCT01850524|2093051|FG001|Overall Study|Lack of Improvement|1
1051701|NCT01850524|2093050|FG000|Overall Study|Minimal Response|1
1051702|NCT01850524|2093051|FG001|Overall Study|Minimal Response|0
1051703|NCT01850524|2093050|FG000|Overall Study|Comorbidities|1
1051704|NCT01850524|2093051|FG001|Overall Study|Comorbidities|0
1051705|NCT01850563|2093070|FG000|Overall Study|Death|8
1051706|NCT01850563|2093071|FG001|Overall Study|Death|0
1051707|NCT01850563|2093070|FG000|Overall Study|Withdrawal by Subject|3
1051708|NCT01850563|2093071|FG001|Overall Study|Withdrawal by Subject|0
1051709|NCT01850563|2093070|FG000|Overall Study|Physician Decision|4
1051710|NCT01850563|2093071|FG001|Overall Study|Physician Decision|0
1051711|NCT01850563|2093070|FG000|Overall Study|Not eligible|3
1051712|NCT01850563|2093071|FG001|Overall Study|Not eligible|0
1051713|NCT01850589|2093080|FG000|Overall Study|Withdrawal by Subject|8
1051714|NCT01850589|2093081|FG001|Overall Study|Withdrawal by Subject|0
1051715|NCT01850602|2093089|FG000|Overall Study|Adverse Event|7
1051716|NCT01850602|2093090|FG001|Overall Study|Adverse Event|10
1051717|NCT01850602|2093089|FG000|Overall Study|Physician Decision|2
1051718|NCT01850602|2093090|FG001|Overall Study|Physician Decision|1
1051719|NCT01850602|2093089|FG000|Overall Study|Withdrawal by Subject|2
1051720|NCT01850602|2093090|FG001|Overall Study|Withdrawal by Subject|4
1051721|NCT01850602|2093089|FG000|Overall Study|Decrease in serum calcium|2
1051722|NCT01850602|2093090|FG001|Overall Study|Decrease in serum calcium|3
1051723|NCT01850602|2093089|FG000|Overall Study|Increase in serum ferritin|1
1051724|NCT01850602|2093090|FG001|Overall Study|Increase in serum ferritin|0
1051725|NCT01850615|2093098|FG000|Overall Study|Protocol Violation|4
1051726|NCT01850615|2093099|FG001|Overall Study|Protocol Violation|1
1051727|NCT01850615|2093098|FG000|Overall Study|Adverse Event|2
1051728|NCT01850615|2093099|FG001|Overall Study|Adverse Event|1
1051729|NCT01850615|2093098|FG000|Overall Study|Withdrawal by Subject|3
1051730|NCT01850615|2093099|FG001|Overall Study|Withdrawal by Subject|1
1051731|NCT01850615|2093098|FG000|Overall Study|Lost to Follow-up|0
1051732|NCT01850615|2093099|FG001|Overall Study|Lost to Follow-up|1
1051733|NCT01850615|2093098|FG000|Overall Study|Unclassified|0
1051734|NCT01850615|2093099|FG001|Overall Study|Unclassified|1
1051735|NCT01850641|2093105|FG000|Overall Study|Physician Decision|1
1051736|NCT01850641|2093105|FG000|Overall Study|Decrease in serum phosphorus|1
1051737|NCT01850641|2093105|FG000|Overall Study|Decrease in serum calcium|2
1051738|NCT01850641|2093105|FG000|Overall Study|Increase in serum ferritin|1
1051739|NCT01850823|2093125|FG000|Overall Study|Early Visit Window|0
1051740|NCT01850823|2093126|FG001|Overall Study|Early Visit Window|1
1051741|NCT01850823|2093127|FG002|Overall Study|Early Visit Window|4
906991|NCT00772005|1883007|FG001|Overall Study|Non-compliance with study procedures|1
906992|NCT00772005|1883008|FG002|Overall Study|Non-compliance with study procedures|0
906993|NCT00772005|1883009|FG003|Overall Study|Non-compliance with study procedures|1
906994|NCT00772005|1883006|FG000|Overall Study|Non-compliance with drug administration|3
906995|NCT00772005|1883007|FG001|Overall Study|Non-compliance with drug administration|0
906996|NCT00772005|1883008|FG002|Overall Study|Non-compliance with drug administration|1
906997|NCT00772005|1883009|FG003|Overall Study|Non-compliance with drug administration|1
906998|NCT00772031|1883021|FG000|Overall Study|Early termination of trial|12
906999|NCT00772031|1883022|FG001|Overall Study|Early termination of trial|10
907000|NCT00772031|1883021|FG000|Overall Study|Lost to Follow-up|20
907001|NCT00772031|1883022|FG001|Overall Study|Lost to Follow-up|33
907002|NCT00772070|1883036|FG000|Overall Study|Lost to Follow-up|0
907003|NCT00772070|1883037|FG001|Overall Study|Lost to Follow-up|8
907004|NCT00772070|1883036|FG000|Overall Study|Withdrawal by Subject|0
907005|NCT00772070|1883037|FG001|Overall Study|Withdrawal by Subject|2
907006|NCT00772070|1883036|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2
907007|NCT00772070|1883037|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0
907008|NCT00772109|1883047|FG000|Overall Study|Serious adverse event|1
907009|NCT00772109|1883048|FG001|Overall Study|Serious adverse event|0
907010|NCT00772109|1883049|FG002|Overall Study|Serious adverse event|1
907011|NCT00772109|1883050|FG003|Overall Study|Serious adverse event|0
907012|NCT00772109|1883047|FG000|Overall Study|Protocol Violation|5
907013|NCT00772109|1883048|FG001|Overall Study|Protocol Violation|8
1051742|NCT01850823|2093125|FG000|Overall Study|Enrolled in Error|0
1051743|NCT01850823|2093126|FG001|Overall Study|Enrolled in Error|1
1051744|NCT01850823|2093127|FG002|Overall Study|Enrolled in Error|2
1051745|NCT01850823|2093125|FG000|Overall Study|Lack of Efficacy|1
1051746|NCT01850823|2093126|FG001|Overall Study|Lack of Efficacy|0
1051747|NCT01850823|2093127|FG002|Overall Study|Lack of Efficacy|0
1051748|NCT01850823|2093125|FG000|Overall Study|Lost to Follow-up|0
1051749|NCT01850823|2093126|FG001|Overall Study|Lost to Follow-up|0
1051750|NCT01850823|2093127|FG002|Overall Study|Lost to Follow-up|1
1051751|NCT01850823|2093125|FG000|Overall Study|Restricted Medication|0
1051752|NCT01850823|2093126|FG001|Overall Study|Restricted Medication|0
1051753|NCT01850823|2093127|FG002|Overall Study|Restricted Medication|2
1051754|NCT01850823|2093125|FG000|Overall Study|Significant worstening of SAR|0
1051755|NCT01850823|2093126|FG001|Overall Study|Significant worstening of SAR|1
1051756|NCT01850823|2093127|FG002|Overall Study|Significant worstening of SAR|0
1051757|NCT01850823|2093125|FG000|Overall Study|Withdrawal by Subject|2
1051758|NCT01850823|2093126|FG001|Overall Study|Withdrawal by Subject|0
1051759|NCT01850823|2093127|FG002|Overall Study|Withdrawal by Subject|1
1051760|NCT01851330|2093140|FG000|Overall Study|Lack of Efficacy|10
1051761|NCT01851330|2093141|FG001|Overall Study|Lack of Efficacy|9
1051762|NCT01851330|2093142|FG002|Overall Study|Lack of Efficacy|2
1051763|NCT01851330|2093140|FG000|Overall Study|Lost to Follow-up|1
1051764|NCT01851330|2093141|FG001|Overall Study|Lost to Follow-up|6
1051765|NCT01851330|2093142|FG002|Overall Study|Lost to Follow-up|9
1051766|NCT01851330|2093140|FG000|Overall Study|Withdrew Consent|2
1051767|NCT01851330|2093141|FG001|Overall Study|Withdrew Consent|1
1051768|NCT01851330|2093142|FG002|Overall Study|Withdrew Consent|0
1051769|NCT01851330|2093140|FG000|Overall Study|Investigator's Discretion|0
1051770|NCT01851330|2093141|FG001|Overall Study|Investigator's Discretion|0
1051771|NCT01851330|2093142|FG002|Overall Study|Investigator's Discretion|1
1051772|NCT01851590|2093153|FG000|Overall Study|Withdrawal by Subject|0
1051773|NCT01851590|2093154|FG001|Overall Study|Withdrawal by Subject|0
1051774|NCT01851590|2093155|FG002|Overall Study|Withdrawal by Subject|1
1051775|NCT01851590|2093153|FG000|Overall Study|Adverse Event|0
907014|NCT00772109|1883049|FG002|Overall Study|Protocol Violation|7
907015|NCT00772109|1883050|FG003|Overall Study|Protocol Violation|6
907016|NCT00772109|1883047|FG000|Overall Study|Lost to Follow-up|7
907017|NCT00772109|1883048|FG001|Overall Study|Lost to Follow-up|3
907018|NCT00772109|1883049|FG002|Overall Study|Lost to Follow-up|5
907019|NCT00772109|1883050|FG003|Overall Study|Lost to Follow-up|9
907020|NCT00772109|1883047|FG000|Overall Study|Withdrawal by Subject|8
907021|NCT00772109|1883048|FG001|Overall Study|Withdrawal by Subject|8
907022|NCT00772109|1883049|FG002|Overall Study|Withdrawal by Subject|6
907023|NCT00772109|1883050|FG003|Overall Study|Withdrawal by Subject|16
907024|NCT00772148|1883062|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3
907025|NCT00772148|1883063|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1
907026|NCT00772148|1883062|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
907027|NCT00772148|1883063|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
907028|NCT00772148|1883062|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2
907029|NCT00772148|1883063|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0
907030|NCT00772148|1883062|FG000|Maintenance Phase (Week 52)|Death|2
907031|NCT00772148|1883063|FG001|Maintenance Phase (Week 52)|Death|2
907032|NCT00772148|1883062|FG000|Maintenance Phase (Week 52)|Adverse Event|1
907033|NCT00772148|1883063|FG001|Maintenance Phase (Week 52)|Adverse Event|0
907034|NCT00772148|1883062|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0
907035|NCT00772148|1883063|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1
907036|NCT00772148|1883062|FG000|Maintenance Phase (Week 52)|Administrative/other|1
907037|NCT00772148|1883063|FG001|Maintenance Phase (Week 52)|Administrative/other|2
907038|NCT00772330|1883073|FG000|Overall Study|Lost to Follow-up|3
907039|NCT00772369|1883080|FG000|Overall Study|Did not return record release form|1
907040|NCT00772382|1883084|FG000|Overall Study|Adverse Event|19
907041|NCT00772382|1883084|FG000|Overall Study|Death|6
907042|NCT00772382|1883084|FG000|Overall Study|Lack of Efficacy|4
907043|NCT00772382|1883084|FG000|Overall Study|Physician Decision|5
907044|NCT00772382|1883084|FG000|Overall Study|Protocol Violation|1
907045|NCT00772382|1883084|FG000|Overall Study|Withdrawal by Subject|10
907046|NCT00772382|1883084|FG000|Overall Study|Other Reasons|10
907047|NCT00772447|1883090|FG000|Overall Study|Withdrawal by Subject|9
907048|NCT00772447|1883091|FG001|Overall Study|Withdrawal by Subject|5
907049|NCT00772447|1883090|FG000|Overall Study|Physician Decision|4
907050|NCT00772447|1883091|FG001|Overall Study|Physician Decision|8
907051|NCT00772447|1883090|FG000|Overall Study|Lost to Follow-up|2
907052|NCT00772447|1883091|FG001|Overall Study|Lost to Follow-up|4
907053|NCT00772447|1883090|FG000|Overall Study|incorrect enrolment|3
907054|NCT00772447|1883091|FG001|Overall Study|incorrect enrolment|4
907055|NCT00772447|1883090|FG000|Overall Study|Protocol Violation|0
907056|NCT00772447|1883091|FG001|Overall Study|Protocol Violation|1
907057|NCT00772447|1883090|FG000|Overall Study|all others|2
907058|NCT00772447|1883091|FG001|Overall Study|all others|2
907059|NCT00772538|1883100|FG000|Overall Study|Adverse Event|6
907060|NCT00772538|1883101|FG001|Overall Study|Adverse Event|6
907061|NCT00772538|1883100|FG000|Overall Study|Protocol Violation|3
907062|NCT00772538|1883101|FG001|Overall Study|Protocol Violation|3
907063|NCT00772538|1883100|FG000|Overall Study|Lost to Follow-up|1
1051776|NCT01851590|2093154|FG001|Overall Study|Adverse Event|0
1051777|NCT01851590|2093155|FG002|Overall Study|Adverse Event|2
1051778|NCT01851590|2093153|FG000|Overall Study|Lack of Efficacy|0
1051779|NCT01851590|2093154|FG001|Overall Study|Lack of Efficacy|1
1051780|NCT01851590|2093155|FG002|Overall Study|Lack of Efficacy|0
1051781|NCT01851720|2093178|FG000|Overall Study|Lost to Follow-up|0
1051782|NCT01851720|2093179|FG001|Overall Study|Lost to Follow-up|1
1051783|NCT01851863|2093193|FG000|Overall Study|Did not receive study medication|2
1051784|NCT01851863|2093194|FG001|Overall Study|Did not receive study medication|5
1051785|NCT01851863|2093195|FG002|Overall Study|Did not receive study medication|3
1051786|NCT01851863|2093196|FG003|Overall Study|Did not receive study medication|0
1051787|NCT01851863|2093193|FG000|Overall Study|Lost to Follow-up|3
1051788|NCT01851863|2093194|FG001|Overall Study|Lost to Follow-up|4
1051789|NCT01851863|2093195|FG002|Overall Study|Lost to Follow-up|2
1051790|NCT01851863|2093196|FG003|Overall Study|Lost to Follow-up|3
1051791|NCT01852045|2093244|FG000|Overall Study|Adverse Event|1
1051792|NCT01852045|2093245|FG001|Overall Study|Adverse Event|0
1051793|NCT01852045|2093246|FG002|Overall Study|Adverse Event|0
1051794|NCT01852045|2093244|FG000|Overall Study|Lack of Efficacy|3
1051795|NCT01852045|2093245|FG001|Overall Study|Lack of Efficacy|0
1051796|NCT01852045|2093246|FG002|Overall Study|Lack of Efficacy|0
1051797|NCT01852045|2093244|FG000|Overall Study|Lost to Follow-up|0
1051798|NCT01852045|2093245|FG001|Overall Study|Lost to Follow-up|1
1051799|NCT01852045|2093246|FG002|Overall Study|Lost to Follow-up|1
1051800|NCT01852045|2093244|FG000|Overall Study|Withdrawal by Subject|1
1051801|NCT01852045|2093245|FG001|Overall Study|Withdrawal by Subject|0
1051802|NCT01852045|2093246|FG002|Overall Study|Withdrawal by Subject|1
1051803|NCT01852045|2093244|FG000|Overall Study|Other Miscellaneous Reasons|1
1051804|NCT01852045|2093245|FG001|Overall Study|Other Miscellaneous Reasons|3
1051805|NCT01852045|2093246|FG002|Overall Study|Other Miscellaneous Reasons|2
1051806|NCT01852058|2093257|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
1051807|NCT01852058|2093258|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
1051808|NCT01852058|2093259|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
1051809|NCT01852058|2093260|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
1051810|NCT01852058|2093261|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
1051811|NCT01852058|2093262|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
1051812|NCT01852058|2093263|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
1051813|NCT01852058|2093264|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
1051814|NCT01852058|2093265|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
1051815|NCT01852058|2093266|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
1051816|NCT01852058|2093267|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
1051817|NCT01852058|2093268|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
1051818|NCT01852058|2093257|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
1051819|NCT01852058|2093258|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
1051820|NCT01852058|2093259|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
1051821|NCT01852058|2093260|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
1051822|NCT01852058|2093261|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
1051823|NCT01852058|2093262|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
1051824|NCT01852058|2093263|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
1051825|NCT01852058|2093264|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
1051826|NCT01852058|2093265|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
1051827|NCT01852058|2093266|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
1051828|NCT01852058|2093267|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
1051829|NCT01852058|2093268|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
1051830|NCT01852058|2093257|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
1051831|NCT01852058|2093258|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
1051832|NCT01852058|2093259|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
1051833|NCT01852058|2093260|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
1051834|NCT01852058|2093261|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
1051835|NCT01852058|2093262|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
1051836|NCT01852058|2093263|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
1051837|NCT01852058|2093264|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
1051838|NCT01852058|2093265|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
1051839|NCT01852058|2093266|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
1051840|NCT01852058|2093267|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
1051841|NCT01852058|2093268|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
1051842|NCT01852058|2093257|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
1051843|NCT01852058|2093258|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
1051844|NCT01852058|2093259|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
1051845|NCT01852058|2093260|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
1051846|NCT01852058|2093261|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
1051847|NCT01852058|2093262|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
1051848|NCT01852058|2093263|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
1162035|NCT03381196|2283976|FG000|Overall Study|Death|0
1051849|NCT01852058|2093264|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
1051850|NCT01852058|2093265|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
1051851|NCT01852058|2093266|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
1051852|NCT01852058|2093267|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
1051853|NCT01852058|2093268|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
1051854|NCT01852058|2093257|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
1051855|NCT01852058|2093258|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
1051856|NCT01852058|2093259|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
1051857|NCT01852058|2093260|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
1051858|NCT01852058|2093261|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
1051859|NCT01852058|2093262|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
1051860|NCT01852058|2093263|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
1051861|NCT01852058|2093264|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
1051862|NCT01852058|2093265|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
1051863|NCT01852058|2093266|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
1051864|NCT01852058|2093267|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
1051865|NCT01852058|2093268|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
1051866|NCT01852058|2093257|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
1051867|NCT01852058|2093258|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
1051868|NCT01852058|2093259|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
1051869|NCT01852058|2093260|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
1051870|NCT01852058|2093261|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
1051871|NCT01852058|2093262|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
1051872|NCT01852058|2093263|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
1051873|NCT01852058|2093264|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
1051874|NCT01852058|2093265|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
1051875|NCT01852058|2093266|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
1051876|NCT01852058|2093267|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
1051877|NCT01852058|2093268|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
1051878|NCT01852058|2093257|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
1051879|NCT01852058|2093258|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
1051880|NCT01852058|2093259|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
1051881|NCT01852058|2093260|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
1051882|NCT01852058|2093261|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
1051883|NCT01852058|2093262|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
1051884|NCT01852058|2093263|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
1051885|NCT01852058|2093264|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
1051886|NCT01852058|2093265|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
1051887|NCT01852058|2093266|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
1051888|NCT01852058|2093267|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
1051889|NCT01852058|2093268|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
1051890|NCT01852058|2093257|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
1051891|NCT01852058|2093258|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
1051892|NCT01852058|2093259|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
1051893|NCT01852058|2093260|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
1051894|NCT01852058|2093261|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
1051895|NCT01852058|2093262|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
1051896|NCT01852058|2093263|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
1051897|NCT01852058|2093264|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
1051898|NCT01852058|2093265|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
1051899|NCT01852058|2093266|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
1051900|NCT01852058|2093267|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
1051901|NCT01852058|2093268|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
1051902|NCT01852058|2093257|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
1051903|NCT01852058|2093258|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
1051904|NCT01852058|2093259|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
1051905|NCT01852058|2093260|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
1051906|NCT01852058|2093261|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
1051907|NCT01852058|2093262|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
1051908|NCT01852058|2093263|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
907064|NCT00772538|1883101|FG001|Overall Study|Lost to Follow-up|1
907065|NCT00772538|1883100|FG000|Overall Study|Withdrawal by Subject|3
907066|NCT00772538|1883101|FG001|Overall Study|Withdrawal by Subject|8
907067|NCT00772538|1883100|FG000|Overall Study|Lack of Efficacy|0
907068|NCT00772538|1883101|FG001|Overall Study|Lack of Efficacy|1
1051909|NCT01852058|2093264|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
1051910|NCT01852058|2093265|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
1051911|NCT01852058|2093266|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
1051912|NCT01852058|2093267|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
1051913|NCT01852058|2093268|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
1051914|NCT01852110|2093337|FG000|Overall Study|Adverse Event|12
1051915|NCT01852110|2093338|FG001|Overall Study|Adverse Event|5
1051916|NCT01852110|2093339|FG002|Overall Study|Adverse Event|0
1051917|NCT01852110|2093340|FG003|Overall Study|Adverse Event|0
1051918|NCT01852110|2093341|FG004|Overall Study|Adverse Event|0
1051919|NCT01852110|2093342|FG005|Overall Study|Adverse Event|0
1051920|NCT01852110|2093337|FG000|Overall Study|Lost to Follow-up|1
1051921|NCT01852110|2093338|FG001|Overall Study|Lost to Follow-up|3
1051922|NCT01852110|2093339|FG002|Overall Study|Lost to Follow-up|0
1051923|NCT01852110|2093340|FG003|Overall Study|Lost to Follow-up|0
1051924|NCT01852110|2093341|FG004|Overall Study|Lost to Follow-up|0
1051925|NCT01852110|2093342|FG005|Overall Study|Lost to Follow-up|0
1051926|NCT01852110|2093337|FG000|Overall Study|Non-compliance with Study Drug|2
1051927|NCT01852110|2093338|FG001|Overall Study|Non-compliance with Study Drug|1
1051928|NCT01852110|2093339|FG002|Overall Study|Non-compliance with Study Drug|0
1051929|NCT01852110|2093340|FG003|Overall Study|Non-compliance with Study Drug|0
1051930|NCT01852110|2093341|FG004|Overall Study|Non-compliance with Study Drug|0
1051931|NCT01852110|2093342|FG005|Overall Study|Non-compliance with Study Drug|0
1051932|NCT01852110|2093337|FG000|Overall Study|Physician Decision|1
1051933|NCT01852110|2093338|FG001|Overall Study|Physician Decision|0
1051934|NCT01852110|2093339|FG002|Overall Study|Physician Decision|0
1051935|NCT01852110|2093340|FG003|Overall Study|Physician Decision|0
1051936|NCT01852110|2093341|FG004|Overall Study|Physician Decision|0
1051937|NCT01852110|2093342|FG005|Overall Study|Physician Decision|0
1051938|NCT01852110|2093337|FG000|Overall Study|Protocol Violation|0
1051939|NCT01852110|2093338|FG001|Overall Study|Protocol Violation|1
1051940|NCT01852110|2093339|FG002|Overall Study|Protocol Violation|0
1051941|NCT01852110|2093340|FG003|Overall Study|Protocol Violation|0
1051942|NCT01852110|2093341|FG004|Overall Study|Protocol Violation|0
1051943|NCT01852110|2093342|FG005|Overall Study|Protocol Violation|0
1051944|NCT01852110|2093337|FG000|Overall Study|Study Terminated by Sponsor|30
1051945|NCT01852110|2093338|FG001|Overall Study|Study Terminated by Sponsor|32
1051946|NCT01852110|2093339|FG002|Overall Study|Study Terminated by Sponsor|0
1051947|NCT01852110|2093340|FG003|Overall Study|Study Terminated by Sponsor|0
1051948|NCT01852110|2093341|FG004|Overall Study|Study Terminated by Sponsor|0
1051949|NCT01852110|2093342|FG005|Overall Study|Study Terminated by Sponsor|0
1051950|NCT01852110|2093337|FG000|Overall Study|Withdrawal by Subject|4
1051951|NCT01852110|2093338|FG001|Overall Study|Withdrawal by Subject|4
1051952|NCT01852110|2093339|FG002|Overall Study|Withdrawal by Subject|0
1051953|NCT01852110|2093340|FG003|Overall Study|Withdrawal by Subject|0
1051954|NCT01852110|2093341|FG004|Overall Study|Withdrawal by Subject|0
1051955|NCT01852110|2093342|FG005|Overall Study|Withdrawal by Subject|0
1051956|NCT01852162|2093358|FG000|Overall Study|Adverse Event|1
1051957|NCT01852162|2093359|FG001|Overall Study|Adverse Event|0
1051958|NCT01852162|2093358|FG000|Overall Study|Withdrawal by Subject|3
1051959|NCT01852162|2093359|FG001|Overall Study|Withdrawal by Subject|1
1051960|NCT01852214|2093384|FG000|Period 1|Adverse Event|1
1051961|NCT01852214|2093385|FG001|Period 1|Adverse Event|2
1051962|NCT01852214|2093384|FG000|Period 1|Withdrawal by Subject|0
1051963|NCT01852214|2093385|FG001|Period 1|Withdrawal by Subject|1
1051964|NCT01852214|2093384|FG000|Washout Period|Withdrawal by Subject|0
1051965|NCT01852214|2093385|FG001|Washout Period|Withdrawal by Subject|1
1051966|NCT01852292|2093394|FG000|Overall Study|Untreated - did not receive study drug|3
1051967|NCT01852292|2093395|FG001|Overall Study|Untreated - did not receive study drug|1
1051968|NCT01852292|2093394|FG000|Overall Study|Death|9
1051969|NCT01852292|2093395|FG001|Overall Study|Death|8
1051970|NCT01852292|2093394|FG000|Overall Study|Patient/guardian decision|8
1051971|NCT01852292|2093395|FG001|Overall Study|Patient/guardian decision|4
1051972|NCT01852292|2093394|FG000|Overall Study|Adverse Event|8
1051973|NCT01852292|2093395|FG001|Overall Study|Adverse Event|11
1051974|NCT01852292|2093394|FG000|Overall Study|Physician Decision|6
1051975|NCT01852292|2093395|FG001|Overall Study|Physician Decision|2
907069|NCT00772538|1883100|FG000|Overall Study|Other|7
907070|NCT00772538|1883101|FG001|Overall Study|Other|7
907071|NCT00772577|1883109|FG000|Overall Study|Adverse Event|6
907072|NCT00772577|1883110|FG001|Overall Study|Adverse Event|3
907073|NCT00772577|1883109|FG000|Overall Study|Abnormal laboratory values|0
907074|NCT00772577|1883110|FG001|Overall Study|Abnormal laboratory values|1
907075|NCT00772577|1883109|FG000|Overall Study|Unsatisfactory therapeutic effect|0
907076|NCT00772577|1883110|FG001|Overall Study|Unsatisfactory therapeutic effect|8
907077|NCT00772577|1883109|FG000|Overall Study|Patient withdrew consent|8
907078|NCT00772577|1883110|FG001|Overall Study|Patient withdrew consent|5
907079|NCT00772577|1883109|FG000|Overall Study|Lost to Follow-up|4
907080|NCT00772577|1883110|FG001|Overall Study|Lost to Follow-up|3
907081|NCT00772577|1883109|FG000|Overall Study|Administrative problems|2
907082|NCT00772577|1883110|FG001|Overall Study|Administrative problems|1
907083|NCT00772577|1883109|FG000|Overall Study|Protocol Deviation|3
907084|NCT00772577|1883110|FG001|Overall Study|Protocol Deviation|2
1051976|NCT01852292|2093394|FG000|Overall Study|Protocol Violation|2
1051977|NCT01852292|2093395|FG001|Overall Study|Protocol Violation|0
1051978|NCT01852292|2093394|FG000|Overall Study|Non-compliance with study treatment|1
1051979|NCT01852292|2093395|FG001|Overall Study|Non-compliance with study treatment|0
1051980|NCT01852292|2093394|FG000|Overall Study|Study terminated by Sponsor|0
1051981|NCT01852292|2093395|FG001|Overall Study|Study terminated by Sponsor|1
1051982|NCT01852292|2093394|FG000|Overall Study|Progressive disease|42
1051983|NCT01852292|2093395|FG001|Overall Study|Progressive disease|52
1051984|NCT01852591|2093433|FG000|Overall Study|Withdrawal by Subject|2
1051985|NCT01852591|2093433|FG000|Overall Study|Not Evaluable at Time of Analysis|1
1051986|NCT01852812|2093453|FG000|Overall Study|Adverse Event|0
1051987|NCT01852812|2093454|FG001|Overall Study|Adverse Event|0
1051988|NCT01852812|2093455|FG002|Overall Study|Adverse Event|1
1051989|NCT01852812|2093453|FG000|Overall Study|Non-compliance With Study Drug|0
1051990|NCT01852812|2093454|FG001|Overall Study|Non-compliance With Study Drug|1
1051991|NCT01852812|2093455|FG002|Overall Study|Non-compliance With Study Drug|0
1051992|NCT01852825|2093466|FG000|Overall Study|Withdrawal by Subject|2
1051993|NCT01852825|2093467|FG001|Overall Study|Withdrawal by Subject|0
1051994|NCT01852825|2093468|FG002|Overall Study|Withdrawal by Subject|0
1051995|NCT01852942|2093478|FG000|Overall Study|Physician Decision|1
1051996|NCT01852942|2093479|FG001|Overall Study|Physician Decision|0
1051997|NCT01852942|2093478|FG000|Overall Study|Death|1
1051998|NCT01852942|2093479|FG001|Overall Study|Death|1
1051999|NCT01852942|2093478|FG000|Overall Study|Withdrawal by Subject|2
1052000|NCT01852942|2093479|FG001|Overall Study|Withdrawal by Subject|3
1052001|NCT01852942|2093478|FG000|Overall Study|Lost to Follow-up|1
1052002|NCT01852942|2093479|FG001|Overall Study|Lost to Follow-up|2
1052003|NCT01853046|2093497|FG000|Overall Study|Withdrawal by Subject|1
1052004|NCT01853046|2093498|FG001|Overall Study|Withdrawal by Subject|1
1052005|NCT01853046|2093497|FG000|Overall Study|Adverse Event|4
1052006|NCT01853046|2093498|FG001|Overall Study|Adverse Event|2
1052007|NCT01853046|2093497|FG000|Overall Study|Disease progression|13
1052008|NCT01853046|2093498|FG001|Overall Study|Disease progression|3
1052009|NCT01853072|2093507|FG000|Overall Study|Adverse event prior to treatment|0
1052010|NCT01853072|2093508|FG001|Overall Study|Adverse event prior to treatment|1
1052011|NCT01853072|2093507|FG000|Overall Study|Adverse Event|0
1052012|NCT01853072|2093508|FG001|Overall Study|Adverse Event|3
1052013|NCT01853072|2093507|FG000|Overall Study|Death|1
1052014|NCT01853072|2093508|FG001|Overall Study|Death|4
1052015|NCT01853072|2093507|FG000|Overall Study|Lost to Follow-up|0
1052016|NCT01853072|2093508|FG001|Overall Study|Lost to Follow-up|3
1052017|NCT01853072|2093507|FG000|Overall Study|Non-compliance with study drug|0
1052018|NCT01853072|2093508|FG001|Overall Study|Non-compliance with study drug|1
1052019|NCT01853072|2093507|FG000|Overall Study|Physician Decision|1
1052020|NCT01853072|2093508|FG001|Overall Study|Physician Decision|1
1052021|NCT01853072|2093507|FG000|Overall Study|Withdrawal by Subject|1
1052022|NCT01853072|2093508|FG001|Overall Study|Withdrawal by Subject|2
1052023|NCT01853072|2093507|FG000|Overall Study|Reason not specified|9
1052024|NCT01853072|2093508|FG001|Overall Study|Reason not specified|6
1052025|NCT01853137|2093522|FG000|Overall Study|Lost to Follow-up|4
1052026|NCT01853137|2093523|FG001|Overall Study|Lost to Follow-up|1
1052027|NCT01853228|2093535|FG000|Phase 1|Lack of Efficacy|8
1052028|NCT01853228|2093536|FG001|Phase 1|Lack of Efficacy|0
1052029|NCT01853228|2093535|FG000|Phase 1|Other|1
1052030|NCT01853228|2093536|FG001|Phase 1|Other|0
1052031|NCT01853228|2093535|FG000|Phase 2|Physician Decision|0
1052032|NCT01853228|2093536|FG001|Phase 2|Physician Decision|1
1052033|NCT01853228|2093535|FG000|Phase 2|Proceed To Transplant|0
1052034|NCT01853228|2093536|FG001|Phase 2|Proceed To Transplant|3
1052035|NCT01853228|2093535|FG000|Phase 2|Lack of Efficacy|0
1052036|NCT01853228|2093536|FG001|Phase 2|Lack of Efficacy|4
1052037|NCT01853254|2093541|FG000|Overall Study|Abnormal Laboratory Test|1
1052038|NCT01853254|2093541|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
1052039|NCT01853254|2093541|FG000|Overall Study|Death|1
1052040|NCT01853254|2093541|FG000|Overall Study|Failure to Return|43
1052041|NCT01853254|2093541|FG000|Overall Study|Insufficient Therapeutic Response|22
1052042|NCT01853254|2093541|FG000|Overall Study|Refusal of Treatment|1
1052043|NCT01853254|2093541|FG000|Overall Study|Other Protocol Violation|1
1052044|NCT01853254|2093541|FG000|Overall Study|Withdrawal of Consent|16
1052045|NCT01853254|2093541|FG000|Overall Study|Administrative/Other|16
1052046|NCT01853280|2093547|FG000|Overall Study|Lack of Efficacy|2
1052047|NCT01853280|2093548|FG001|Overall Study|Lack of Efficacy|2
1052048|NCT01853280|2093547|FG000|Overall Study|Lost to Follow-up|0
1052049|NCT01853280|2093548|FG001|Overall Study|Lost to Follow-up|1
1052050|NCT01853280|2093547|FG000|Overall Study|Physician Decision|0
1052051|NCT01853280|2093548|FG001|Overall Study|Physician Decision|1
1052052|NCT01853280|2093547|FG000|Overall Study|Withdrawal by Subject|0
1052053|NCT01853280|2093548|FG001|Overall Study|Withdrawal by Subject|1
1052054|NCT01853280|2093547|FG000|Overall Study|Ineligible|0
1052055|NCT01853280|2093548|FG001|Overall Study|Ineligible|1
1052056|NCT01853384|2093570|FG000|Randomized|Adverse Event|5
1052057|NCT01853384|2093571|FG001|Randomized|Adverse Event|3
1052058|NCT01853384|2093570|FG000|Randomized|Death|1
1052059|NCT01853384|2093571|FG001|Randomized|Death|2
1052060|NCT01853384|2093570|FG000|Randomized|Lost to Follow-up|1
1052061|NCT01853384|2093571|FG001|Randomized|Lost to Follow-up|1
1052062|NCT01853384|2093570|FG000|Randomized|Withdrawal by Subject|5
1052063|NCT01853384|2093571|FG001|Randomized|Withdrawal by Subject|3
1052064|NCT01853384|2093570|FG000|Randomized|Sponsor Decision|47
1052065|NCT01853384|2093571|FG001|Randomized|Sponsor Decision|34
1052066|NCT01853384|2093570|FG000|Randomized|Other|3
1052067|NCT01853384|2093571|FG001|Randomized|Other|3
1052068|NCT01853384|2093570|FG000|Completed Follow up Visit 1|Early Termination|13
1052069|NCT01853384|2093571|FG001|Completed Follow up Visit 1|Early Termination|9
1052070|NCT01853384|2093570|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1
1052071|NCT01853384|2093571|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0
1052072|NCT01853384|2093570|FG000|Completed Follow up Visit 2|Adverse Event|1
1052073|NCT01853384|2093571|FG001|Completed Follow up Visit 2|Adverse Event|0
1052074|NCT01853384|2093570|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1
1052075|NCT01853384|2093571|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2
1052076|NCT01853384|2093570|FG000|Completed Follow up Visit 2|Death|1
1052077|NCT01853384|2093571|FG001|Completed Follow up Visit 2|Death|0
1052078|NCT01853384|2093570|FG000|Completed Follow up Visit 2|Lost to Follow-up|0
1052079|NCT01853384|2093571|FG001|Completed Follow up Visit 2|Lost to Follow-up|1
1052080|NCT01853397|2093581|FG000|Overall Study|Withdrawal by Subject|0
1052081|NCT01853397|2093582|FG001|Overall Study|Withdrawal by Subject|0
1052082|NCT01853397|2093583|FG002|Overall Study|Withdrawal by Subject|0
1052083|NCT01853397|2093584|FG003|Overall Study|Withdrawal by Subject|1
1052084|NCT01853397|2093581|FG000|Overall Study|Subject Noncompliance|0
1052085|NCT01853397|2093582|FG001|Overall Study|Subject Noncompliance|0
1052086|NCT01853397|2093583|FG002|Overall Study|Subject Noncompliance|0
1052087|NCT01853397|2093584|FG003|Overall Study|Subject Noncompliance|1
1052088|NCT01853462|2093596|FG000|Overall Study|Withdrawal by Subject|1
1052089|NCT01853462|2093597|FG001|Overall Study|Withdrawal by Subject|1
1052090|NCT01853475|2093608|FG000|Overall Study|Withdrawal by Subject|0
1052091|NCT01853475|2093609|FG001|Overall Study|Withdrawal by Subject|1
1052092|NCT01853475|2093610|FG002|Overall Study|Withdrawal by Subject|0
1052093|NCT01853618|2093649|FG000|Overall Study|Bile duct stent blockage/progressive dis|1
1052094|NCT01853618|2093650|FG001|Overall Study|Bile duct stent blockage/progressive dis|0
1052095|NCT01853618|2093651|FG002|Overall Study|Bile duct stent blockage/progressive dis|0
1052096|NCT01853618|2093652|FG003|Overall Study|Bile duct stent blockage/progressive dis|0
1052097|NCT01853618|2093653|FG004|Overall Study|Bile duct stent blockage/progressive dis|0
1052098|NCT01853618|2093649|FG000|Overall Study|Progressive disease|1
1052099|NCT01853618|2093650|FG001|Overall Study|Progressive disease|1
1052100|NCT01853618|2093651|FG002|Overall Study|Progressive disease|1
1052101|NCT01853618|2093652|FG003|Overall Study|Progressive disease|1
1052102|NCT01853618|2093653|FG004|Overall Study|Progressive disease|2
1052103|NCT01853618|2093649|FG000|Overall Study|Physician Decision|0
1052104|NCT01853618|2093650|FG001|Overall Study|Physician Decision|1
1052105|NCT01853618|2093651|FG002|Overall Study|Physician Decision|1
1052106|NCT01853618|2093652|FG003|Overall Study|Physician Decision|0
1052107|NCT01853618|2093653|FG004|Overall Study|Physician Decision|0
1052108|NCT01853618|2093649|FG000|Overall Study|Refused further treatment|0
1052109|NCT01853618|2093650|FG001|Overall Study|Refused further treatment|0
1052110|NCT01853618|2093651|FG002|Overall Study|Refused further treatment|0
1052111|NCT01853618|2093652|FG003|Overall Study|Refused further treatment|0
1052112|NCT01853618|2093653|FG004|Overall Study|Refused further treatment|1
1052113|NCT01853644|2093666|FG000|Registration and Treatment Start|Did not start treatment|1
1052114|NCT01853644|2093666|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2
1052115|NCT01853644|2093666|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
1052116|NCT01853644|2093666|FG000|Reached First Response/Complete 2 Cycles|Other|1
1052117|NCT01853644|2093666|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2
1052118|NCT01853644|2093666|FG000|Continued Treatment After First Response|Adverse Event|2
1052119|NCT01853644|2093666|FG000|Continued Treatment After First Response|Progressive Diseaes|10
1052120|NCT01853696|2093672|FG000|Overall Study|Withdrawal by Subject|1
1052121|NCT01853696|2093673|FG001|Overall Study|Withdrawal by Subject|1
1052122|NCT01853696|2093672|FG000|Overall Study|Lost to Follow-up|5
1052123|NCT01853696|2093673|FG001|Overall Study|Lost to Follow-up|4
1052124|NCT01853839|2093690|FG000|Overall Study|Violated inclusion criteria|2
1052125|NCT01853839|2093690|FG000|Overall Study|Not meet ITT population definition|58
1052126|NCT01853839|2093690|FG000|Overall Study|End of treatment visit too early|33
1052127|NCT01853839|2093690|FG000|Overall Study|Lost to follow-up or no valid BP measure|336
1052128|NCT01853878|2093700|FG000|Overall Study|Recurrence|2
1052129|NCT01853878|2093701|FG001|Overall Study|Recurrence|0
1052130|NCT01853878|2093700|FG000|Overall Study|Adverse Event|2
1052131|NCT01853878|2093701|FG001|Overall Study|Adverse Event|0
1052132|NCT01853878|2093700|FG000|Overall Study|Withdrawal by Subject|3
1052133|NCT01853878|2093701|FG001|Overall Study|Withdrawal by Subject|1
1052134|NCT01853878|2093700|FG000|Overall Study|Migrated/moved from the study area|1
1052135|NCT01853878|2093701|FG001|Overall Study|Migrated/moved from the study area|0
1052136|NCT01853878|2093700|FG000|Overall Study|Other|55
1052137|NCT01853878|2093701|FG001|Overall Study|Other|43
1052138|NCT01854047|2093725|FG000|Overall Study|Lack of Efficacy|1
1052139|NCT01854047|2093726|FG001|Overall Study|Lack of Efficacy|0
1052140|NCT01854047|2093727|FG002|Overall Study|Lack of Efficacy|0
1052141|NCT01854047|2093728|FG003|Overall Study|Lack of Efficacy|0
1052142|NCT01854047|2093729|FG004|Overall Study|Lack of Efficacy|0
1052143|NCT01854047|2093725|FG000|Overall Study|Poor compliance to protocol|3
1052144|NCT01854047|2093726|FG001|Overall Study|Poor compliance to protocol|0
1052145|NCT01854047|2093727|FG002|Overall Study|Poor compliance to protocol|2
1052146|NCT01854047|2093728|FG003|Overall Study|Poor compliance to protocol|0
1052147|NCT01854047|2093729|FG004|Overall Study|Poor compliance to protocol|0
1052148|NCT01854047|2093725|FG000|Overall Study|Adverse Event|5
1052149|NCT01854047|2093726|FG001|Overall Study|Adverse Event|4
1052150|NCT01854047|2093727|FG002|Overall Study|Adverse Event|6
1052151|NCT01854047|2093728|FG003|Overall Study|Adverse Event|10
1052152|NCT01854047|2093729|FG004|Overall Study|Adverse Event|7
1052153|NCT01854047|2093725|FG000|Overall Study|Randomized but not treated|0
1052154|NCT01854047|2093726|FG001|Overall Study|Randomized but not treated|1
1052155|NCT01854047|2093727|FG002|Overall Study|Randomized but not treated|2
1052156|NCT01854047|2093728|FG003|Overall Study|Randomized but not treated|0
1052157|NCT01854047|2093729|FG004|Overall Study|Randomized but not treated|4
1052158|NCT01854047|2093725|FG000|Overall Study|Other than specified above|3
1052159|NCT01854047|2093726|FG001|Overall Study|Other than specified above|3
1052160|NCT01854047|2093727|FG002|Overall Study|Other than specified above|3
1052161|NCT01854047|2093728|FG003|Overall Study|Other than specified above|5
1052162|NCT01854047|2093729|FG004|Overall Study|Other than specified above|8
1052163|NCT01854528|2093801|FG000|Overall Study|Adverse Event|0
1052164|NCT01854528|2093802|FG001|Overall Study|Adverse Event|4
1052165|NCT01854528|2093801|FG000|Overall Study|Withdrawal by Subject|0
1052166|NCT01854528|2093802|FG001|Overall Study|Withdrawal by Subject|2
1052167|NCT01854528|2093801|FG000|Overall Study|Virologic Failure|0
1052168|NCT01854528|2093802|FG001|Overall Study|Virologic Failure|9
1052169|NCT01854645|2093832|FG000|Overall Study|Protocol-Specified Criteria|13
1052170|NCT01854645|2093833|FG001|Overall Study|Protocol-Specified Criteria|10
1052171|NCT01854645|2093834|FG002|Overall Study|Protocol-Specified Criteria|8
1052172|NCT01854645|2093835|FG003|Overall Study|Protocol-Specified Criteria|5
1052173|NCT01854645|2093836|FG004|Overall Study|Protocol-Specified Criteria|7
1052174|NCT01854645|2093832|FG000|Overall Study|Administrative Reasons / Missing|0
1052175|NCT01854645|2093833|FG001|Overall Study|Administrative Reasons / Missing|0
1052176|NCT01854645|2093834|FG002|Overall Study|Administrative Reasons / Missing|0
1052177|NCT01854645|2093835|FG003|Overall Study|Administrative Reasons / Missing|1
1052178|NCT01854645|2093836|FG004|Overall Study|Administrative Reasons / Missing|1
1052179|NCT01854645|2093832|FG000|Overall Study|Protocol Violation|3
1052180|NCT01854645|2093833|FG001|Overall Study|Protocol Violation|0
1052181|NCT01854645|2093834|FG002|Overall Study|Protocol Violation|5
1052182|NCT01854645|2093835|FG003|Overall Study|Protocol Violation|4
1052183|NCT01854645|2093836|FG004|Overall Study|Protocol Violation|1
1052184|NCT01854645|2093832|FG000|Overall Study|Lost to Follow-up|10
1052185|NCT01854645|2093833|FG001|Overall Study|Lost to Follow-up|7
1052186|NCT01854645|2093834|FG002|Overall Study|Lost to Follow-up|8
1052187|NCT01854645|2093835|FG003|Overall Study|Lost to Follow-up|5
1052188|NCT01854645|2093836|FG004|Overall Study|Lost to Follow-up|0
1052189|NCT01854645|2093832|FG000|Overall Study|Physician Decision|1
1052190|NCT01854645|2093833|FG001|Overall Study|Physician Decision|5
1052191|NCT01854645|2093834|FG002|Overall Study|Physician Decision|3
1052192|NCT01854645|2093835|FG003|Overall Study|Physician Decision|3
1052193|NCT01854645|2093836|FG004|Overall Study|Physician Decision|7
1052194|NCT01854645|2093832|FG000|Overall Study|Withdrawal by Subject|31
1052195|NCT01854645|2093833|FG001|Overall Study|Withdrawal by Subject|41
1052196|NCT01854645|2093834|FG002|Overall Study|Withdrawal by Subject|30
1052197|NCT01854645|2093835|FG003|Overall Study|Withdrawal by Subject|21
1052198|NCT01854645|2093836|FG004|Overall Study|Withdrawal by Subject|24
1052199|NCT01854645|2093832|FG000|Overall Study|Lack of Efficacy|7
1052200|NCT01854645|2093833|FG001|Overall Study|Lack of Efficacy|12
1052201|NCT01854645|2093834|FG002|Overall Study|Lack of Efficacy|9
1052202|NCT01854645|2093835|FG003|Overall Study|Lack of Efficacy|3
1052203|NCT01854645|2093836|FG004|Overall Study|Lack of Efficacy|9
1052204|NCT01854645|2093832|FG000|Overall Study|Adverse Event|33
1052205|NCT01854645|2093833|FG001|Overall Study|Adverse Event|31
1052206|NCT01854645|2093834|FG002|Overall Study|Adverse Event|19
1052207|NCT01854645|2093835|FG003|Overall Study|Adverse Event|20
1052208|NCT01854645|2093836|FG004|Overall Study|Adverse Event|11
1052209|NCT01854658|2093852|FG000|Overall Study|Protocol Violation|6
1052210|NCT01854658|2093853|FG001|Overall Study|Protocol Violation|2
1052211|NCT01854658|2093854|FG002|Overall Study|Protocol Violation|2
1052212|NCT01854658|2093855|FG003|Overall Study|Protocol Violation|1
1052213|NCT01854658|2093852|FG000|Overall Study|Physician Decision|7
1052214|NCT01854658|2093853|FG001|Overall Study|Physician Decision|5
1052215|NCT01854658|2093854|FG002|Overall Study|Physician Decision|2
1052216|NCT01854658|2093855|FG003|Overall Study|Physician Decision|4
1052217|NCT01854658|2093852|FG000|Overall Study|Lost to Follow-up|8
1052218|NCT01854658|2093853|FG001|Overall Study|Lost to Follow-up|9
1052219|NCT01854658|2093854|FG002|Overall Study|Lost to Follow-up|8
1052220|NCT01854658|2093855|FG003|Overall Study|Lost to Follow-up|4
1052221|NCT01854658|2093852|FG000|Overall Study|Withdrawal by Subject|28
1052222|NCT01854658|2093853|FG001|Overall Study|Withdrawal by Subject|21
1052223|NCT01854658|2093854|FG002|Overall Study|Withdrawal by Subject|29
1052224|NCT01854658|2093855|FG003|Overall Study|Withdrawal by Subject|15
1052225|NCT01854658|2093852|FG000|Overall Study|Protocol-specified criteria|15
1052226|NCT01854658|2093853|FG001|Overall Study|Protocol-specified criteria|15
1052227|NCT01854658|2093854|FG002|Overall Study|Protocol-specified criteria|10
1052228|NCT01854658|2093855|FG003|Overall Study|Protocol-specified criteria|7
1052229|NCT01854658|2093852|FG000|Overall Study|Lack of Efficacy|3
1052230|NCT01854658|2093853|FG001|Overall Study|Lack of Efficacy|8
1052231|NCT01854658|2093854|FG002|Overall Study|Lack of Efficacy|4
1052232|NCT01854658|2093855|FG003|Overall Study|Lack of Efficacy|7
1052233|NCT01854658|2093852|FG000|Overall Study|Adverse Event|21
1052234|NCT01854658|2093853|FG001|Overall Study|Adverse Event|14
1052235|NCT01854658|2093854|FG002|Overall Study|Adverse Event|23
1052236|NCT01854658|2093855|FG003|Overall Study|Adverse Event|19
1052237|NCT01854658|2093852|FG000|Overall Study|Administrative reasons|5
1052238|NCT01854658|2093853|FG001|Overall Study|Administrative reasons|1
1052239|NCT01854658|2093854|FG002|Overall Study|Administrative reasons|2
1052240|NCT01854658|2093855|FG003|Overall Study|Administrative reasons|2
1052241|NCT01854697|2093870|FG000|Overall Study|Adverse Event|1
1052242|NCT01854697|2093871|FG001|Overall Study|Adverse Event|0
1052243|NCT01854697|2093872|FG002|Overall Study|Adverse Event|0
1052244|NCT01854697|2093873|FG003|Overall Study|Adverse Event|0
1052245|NCT01854697|2093874|FG004|Overall Study|Adverse Event|1
1052246|NCT01854697|2093870|FG000|Overall Study|Lost to Follow-up|4
1052247|NCT01854697|2093871|FG001|Overall Study|Lost to Follow-up|1
1052248|NCT01854697|2093872|FG002|Overall Study|Lost to Follow-up|1
1052249|NCT01854697|2093873|FG003|Overall Study|Lost to Follow-up|2
1052250|NCT01854697|2093874|FG004|Overall Study|Lost to Follow-up|0
1052251|NCT01854697|2093870|FG000|Overall Study|To enter another AbbVie study|1
1052252|NCT01854697|2093871|FG001|Overall Study|To enter another AbbVie study|0
1052253|NCT01854697|2093872|FG002|Overall Study|To enter another AbbVie study|0
1052254|NCT01854697|2093873|FG003|Overall Study|To enter another AbbVie study|0
1052255|NCT01854697|2093874|FG004|Overall Study|To enter another AbbVie study|1
1052256|NCT01854697|2093870|FG000|Overall Study|Withdrew Consent|0
1052257|NCT01854697|2093871|FG001|Overall Study|Withdrew Consent|1
1052258|NCT01854697|2093872|FG002|Overall Study|Withdrew Consent|0
1052259|NCT01854697|2093873|FG003|Overall Study|Withdrew Consent|1
1052260|NCT01854697|2093874|FG004|Overall Study|Withdrew Consent|0
1052261|NCT01854697|2093870|FG000|Overall Study|Other|0
1052262|NCT01854697|2093871|FG001|Overall Study|Other|1
1052263|NCT01854697|2093872|FG002|Overall Study|Other|1
1052264|NCT01854697|2093873|FG003|Overall Study|Other|0
1052265|NCT01854697|2093874|FG004|Overall Study|Other|0
1052266|NCT01854710|2093884|FG000|Overall Study|Withdrawal by Subject|2
1052267|NCT01854710|2093885|FG001|Overall Study|Withdrawal by Subject|1
1052268|NCT01854710|2093886|FG002|Overall Study|Withdrawal by Subject|0
1052269|NCT01854710|2093887|FG003|Overall Study|Withdrawal by Subject|0
1052270|NCT01854710|2093888|FG004|Overall Study|Withdrawal by Subject|0
1052271|NCT01854710|2093889|FG005|Overall Study|Withdrawal by Subject|0
1052272|NCT01854710|2093884|FG000|Overall Study|CRI procedural error|2
1052273|NCT01854710|2093885|FG001|Overall Study|CRI procedural error|2
1052274|NCT01854710|2093886|FG002|Overall Study|CRI procedural error|2
1052275|NCT01854710|2093887|FG003|Overall Study|CRI procedural error|2
1052276|NCT01854710|2093888|FG004|Overall Study|CRI procedural error|2
1052277|NCT01854710|2093889|FG005|Overall Study|CRI procedural error|2
1052278|NCT01854775|2093902|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
1052279|NCT01854775|2093903|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
1052280|NCT01854775|2093904|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0
1052281|NCT01854775|2093902|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1
1052282|NCT01854775|2093903|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0
1052283|NCT01854775|2093904|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0
1052284|NCT01854775|2093902|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
1052285|NCT01854775|2093903|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
1052286|NCT01854775|2093904|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9
1052287|NCT01854775|2093902|FG000|Extension Phase|Pregnancy|3
1052288|NCT01854775|2093903|FG001|Extension Phase|Pregnancy|0
1052289|NCT01854775|2093904|FG002|Extension Phase|Pregnancy|0
1052290|NCT01854775|2093902|FG000|Extension Phase|Investigator's Discretion|1
1052291|NCT01854775|2093903|FG001|Extension Phase|Investigator's Discretion|0
1052292|NCT01854775|2093904|FG002|Extension Phase|Investigator's Discretion|0
1052293|NCT01854775|2093902|FG000|Extension Phase|Non-Compliance with Study Drug|1
1052294|NCT01854775|2093903|FG001|Extension Phase|Non-Compliance with Study Drug|0
1052295|NCT01854775|2093904|FG002|Extension Phase|Non-Compliance with Study Drug|0
1052296|NCT01854775|2093902|FG000|Extension Phase|Lost to Follow-up|2
1052297|NCT01854775|2093903|FG001|Extension Phase|Lost to Follow-up|0
1052298|NCT01854775|2093904|FG002|Extension Phase|Lost to Follow-up|0
1052299|NCT01854775|2093902|FG000|Extension Phase|Still on Study|32
1052300|NCT01854775|2093903|FG001|Extension Phase|Still on Study|47
907085|NCT00772603|1883136|FG000|Overall Study|Withdrawal by Subject|11
907086|NCT00772603|1883137|FG001|Overall Study|Withdrawal by Subject|10
907087|NCT00772603|1883138|FG002|Overall Study|Withdrawal by Subject|6
907088|NCT00772603|1883136|FG000|Overall Study|Adverse Event|37
1052301|NCT01854775|2093904|FG002|Extension Phase|Still on Study|18
1052302|NCT01854827|2093912|FG000|Overall Study|Death|1
1052303|NCT01854879|2093916|FG000|Overall Study|Could not complete testing within the scheduled time.|1
1052304|NCT01854879|2093916|FG000|Overall Study|screen fail|3
1052305|NCT01854879|2093916|FG000|Overall Study|incomplete data set|1
1052306|NCT01854918|2093926|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
1052307|NCT01854918|2093927|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
1052308|NCT01854918|2093926|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2
1052309|NCT01854918|2093927|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1
1052310|NCT01854918|2093926|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3
1052311|NCT01854918|2093927|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8
1052312|NCT01854918|2093926|FG000|SOC-controlled Period (Year 1)|Death|5
1052313|NCT01854918|2093927|FG001|SOC-controlled Period (Year 1)|Death|5
1052314|NCT01854918|2093926|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
1052315|NCT01854918|2093927|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
1052316|NCT01854918|2093926|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
1052317|NCT01854918|2093927|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
1052318|NCT01854918|2093926|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
1052319|NCT01854918|2093927|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
1052320|NCT01854918|2093926|FG000|All-IP Period (Years 2 and 3)|Death|5
1052321|NCT01854918|2093927|FG001|All-IP Period (Years 2 and 3)|Death|16
1052322|NCT01854944|2093943|FG000|Overall Study|Withdrawal by Subject|0
1052323|NCT01854944|2093944|FG001|Overall Study|Withdrawal by Subject|0
1052324|NCT01854944|2093945|FG002|Overall Study|Withdrawal by Subject|1
1052325|NCT01855048|2093973|FG000|Overall Study|Withdrawal by Subject|0
1052326|NCT01855048|2093974|FG001|Overall Study|Withdrawal by Subject|1
1052327|NCT01855048|2093975|FG002|Overall Study|Withdrawal by Subject|0
1052328|NCT01855048|2093976|FG003|Overall Study|Withdrawal by Subject|0
1052329|NCT01855048|2093977|FG004|Overall Study|Withdrawal by Subject|1
1052330|NCT01855048|2093978|FG005|Overall Study|Withdrawal by Subject|0
1052331|NCT01855074|2094002|FG000|Overall Study|Adverse Event|1
1052332|NCT01855074|2094002|FG000|Overall Study|Lost to Follow-up|4
1052333|NCT01855074|2094002|FG000|Overall Study|Withdrawal by Subject|8
1052334|NCT01855074|2094002|FG000|Overall Study|Started but not treated|1
1052335|NCT01855126|2094008|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4
1052336|NCT01855126|2094009|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6
1052337|NCT01855126|2094008|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
1052338|NCT01855126|2094009|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2
1052339|NCT01855243|2094022|FG000|Overall Study|develpoed diabetic ketoacidosis|1
1052340|NCT01855243|2094023|FG001|Overall Study|develpoed diabetic ketoacidosis|0
1052341|NCT01855243|2094024|FG002|Overall Study|develpoed diabetic ketoacidosis|0
1052342|NCT01855399|2094038|FG000|6 Month|Lost to Follow-up|12
1052343|NCT01855399|2094039|FG001|6 Month|Lost to Follow-up|9
1052344|NCT01855399|2094038|FG000|6 Month|Withdrawal by Subject|8
907089|NCT00772603|1883137|FG001|Overall Study|Adverse Event|18
907090|NCT00772603|1883138|FG002|Overall Study|Adverse Event|10
907091|NCT00772603|1883136|FG000|Overall Study|Subject Non-compliance|1
907092|NCT00772603|1883137|FG001|Overall Study|Subject Non-compliance|6
907093|NCT00772603|1883138|FG002|Overall Study|Subject Non-compliance|4
907094|NCT00772603|1883136|FG000|Overall Study|Protocol Violation|0
907095|NCT00772603|1883137|FG001|Overall Study|Protocol Violation|1
907096|NCT00772603|1883138|FG002|Overall Study|Protocol Violation|1
907097|NCT00772603|1883136|FG000|Overall Study|Lost to Follow-up|1
907098|NCT00772603|1883137|FG001|Overall Study|Lost to Follow-up|5
907099|NCT00772603|1883138|FG002|Overall Study|Lost to Follow-up|2
907100|NCT00772603|1883136|FG000|Overall Study|Physician Decision|0
907101|NCT00772603|1883137|FG001|Overall Study|Physician Decision|0
907102|NCT00772603|1883138|FG002|Overall Study|Physician Decision|1
907103|NCT00772603|1883136|FG000|Overall Study|Other|2
907104|NCT00772603|1883137|FG001|Overall Study|Other|0
907105|NCT00772603|1883138|FG002|Overall Study|Other|2
907106|NCT00772629|1883151|FG000|Overall Study|Subject was not vaccinated|1
907107|NCT00772629|1883152|FG001|Overall Study|Subject was not vaccinated|0
907108|NCT00772668|1883158|FG000|Overall Study|Physician Decision|3
907109|NCT00772707|1883163|FG000|Overall Study|Withdrawn|3
907110|NCT00772889|1883175|FG000|Overall Study|Adverse Event|7
907111|NCT00772889|1883176|FG001|Overall Study|Adverse Event|4
907112|NCT00772889|1883177|FG002|Overall Study|Adverse Event|0
907113|NCT00772889|1883175|FG000|Overall Study|Withdrawal by Subject|9
907114|NCT00772889|1883176|FG001|Overall Study|Withdrawal by Subject|8
907115|NCT00772889|1883177|FG002|Overall Study|Withdrawal by Subject|9
907116|NCT00772889|1883175|FG000|Overall Study|Lost to Follow-up|6
907117|NCT00772889|1883176|FG001|Overall Study|Lost to Follow-up|6
907118|NCT00772889|1883177|FG002|Overall Study|Lost to Follow-up|7
907119|NCT00772928|1883191|FG000|Overall Study|Lost to Follow-up|9
907120|NCT00772928|1883192|FG001|Overall Study|Lost to Follow-up|6
907121|NCT00772928|1883191|FG000|Overall Study|Protocol Violation|10
907122|NCT00772928|1883192|FG001|Overall Study|Protocol Violation|12
907123|NCT00772928|1883191|FG000|Overall Study|Withdrawal by Subject|25
1052345|NCT01855399|2094039|FG001|6 Month|Withdrawal by Subject|6
1052346|NCT01855399|2094038|FG000|12 Month|Lost to Follow-up|7
1052347|NCT01855399|2094039|FG001|12 Month|Lost to Follow-up|11
1052348|NCT01855412|2094048|FG000|Overall Study|Death|77
1052349|NCT01855412|2094049|FG001|Overall Study|Death|123
1052350|NCT01855412|2094050|FG002|Overall Study|Death|30
1052351|NCT01855412|2094048|FG000|Overall Study|Lost to Follow-up|28
1052352|NCT01855412|2094049|FG001|Overall Study|Lost to Follow-up|46
1052353|NCT01855412|2094050|FG002|Overall Study|Lost to Follow-up|15
1052354|NCT01855412|2094048|FG000|Overall Study|Withdrawal by Subject|77
1052355|NCT01855412|2094049|FG001|Overall Study|Withdrawal by Subject|123
1052356|NCT01855412|2094050|FG002|Overall Study|Withdrawal by Subject|24
1052357|NCT01855412|2094048|FG000|Overall Study|Physician Decision|25
1052358|NCT01855412|2094049|FG001|Overall Study|Physician Decision|31
1052359|NCT01855412|2094050|FG002|Overall Study|Physician Decision|3
1052360|NCT01855412|2094048|FG000|Overall Study|Site Closure|4
1052361|NCT01855412|2094049|FG001|Overall Study|Site Closure|18
1052362|NCT01855412|2094050|FG002|Overall Study|Site Closure|1
1052363|NCT01855412|2094048|FG000|Overall Study|Reason not Specified|1
1052364|NCT01855412|2094049|FG001|Overall Study|Reason not Specified|2
1052365|NCT01855412|2094050|FG002|Overall Study|Reason not Specified|3
1052366|NCT01855425|2094064|FG000|Overall Study|Physician Decision|20
1052367|NCT01855750|2094070|FG000|Overall Study|Death|78
1052368|NCT01855750|2094071|FG001|Overall Study|Death|78
1052369|NCT01855750|2094070|FG000|Overall Study|Lost to Follow-up|9
1052370|NCT01855750|2094071|FG001|Overall Study|Lost to Follow-up|23
1052371|NCT01855750|2094070|FG000|Overall Study|Withdrawal by Subject|35
1052372|NCT01855750|2094071|FG001|Overall Study|Withdrawal by Subject|28
1052373|NCT01855750|2094070|FG000|Overall Study|Sponsor ends the study|297
1052374|NCT01855750|2094071|FG001|Overall Study|Sponsor ends the study|290
1052375|NCT01855789|2094077|FG000|1) Baseline up to Week 24|Adverse Event|37
1052376|NCT01855789|2094078|FG001|1) Baseline up to Week 24|Adverse Event|0
1052377|NCT01855789|2094079|FG002|1) Baseline up to Week 24|Adverse Event|0
1052378|NCT01855789|2094080|FG003|1) Baseline up to Week 24|Adverse Event|0
907124|NCT00772928|1883192|FG001|Overall Study|Withdrawal by Subject|22
907125|NCT00772928|1883191|FG000|Overall Study|Did not receive vaccine|0
907126|NCT00772928|1883192|FG001|Overall Study|Did not receive vaccine|1
907127|NCT00772941|1883198|FG000|Overall Study|CRFs not available|195
907128|NCT00772941|1883198|FG000|Overall Study|Study not completed|16
907129|NCT00772941|1883198|FG000|Overall Study|Missed Visits|374
907130|NCT00772941|1883198|FG000|Overall Study|Poor Compliance|7
907131|NCT00772941|1883198|FG000|Overall Study|GPSP Violation|90
907132|NCT00772954|1883228|FG000|Overall Study|Adverse Event|0
907133|NCT00772954|1883229|FG001|Overall Study|Adverse Event|0
907134|NCT00772954|1883230|FG002|Overall Study|Adverse Event|1
907135|NCT00772967|1883238|FG000|Crossover Treatment 1|Adverse Event (Pain)|0
907136|NCT00772967|1883239|FG001|Crossover Treatment 1|Adverse Event (Pain)|0
907137|NCT00772967|1883240|FG002|Crossover Treatment 1|Adverse Event (Pain)|0
907138|NCT00772967|1883241|FG003|Crossover Treatment 1|Adverse Event (Pain)|1
907139|NCT00772967|1883242|FG004|Crossover Treatment 1|Adverse Event (Pain)|0
907140|NCT00772967|1883243|FG005|Crossover Treatment 1|Adverse Event (Pain)|0
907141|NCT00772967|1883238|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0
907142|NCT00772967|1883239|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1
907143|NCT00772967|1883240|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0
907144|NCT00772967|1883241|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0
907145|NCT00772967|1883242|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0
907146|NCT00772967|1883243|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0
907147|NCT00772967|1883238|FG000|Crossover Treatment 3|Adverse Event|0
907148|NCT00772967|1883239|FG001|Crossover Treatment 3|Adverse Event|0
907149|NCT00772967|1883240|FG002|Crossover Treatment 3|Adverse Event|0
907150|NCT00772967|1883241|FG003|Crossover Treatment 3|Adverse Event|0
907151|NCT00772967|1883242|FG004|Crossover Treatment 3|Adverse Event|1
907152|NCT00772967|1883243|FG005|Crossover Treatment 3|Adverse Event|0
907153|NCT00773097|1883251|FG000|Overall Study|Withdrawal by Subject|1
907154|NCT00773097|1883251|FG000|Overall Study|Physician Decision|6
907155|NCT00773136|1883255|FG000|Overall Study|Physician Decision|2
907156|NCT00773175|1883262|FG000|Overall Study|Adverse Event|2
907157|NCT00773175|1883263|FG001|Overall Study|Adverse Event|0
907158|NCT00773175|1883262|FG000|Overall Study|Consent Withdrawn|0
907159|NCT00773175|1883263|FG001|Overall Study|Consent Withdrawn|2
907160|NCT00773253|1883276|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0
907161|NCT00773253|1883277|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1
907162|NCT00773279|1883285|FG000|Period 1|Adverse Event|2
907163|NCT00773279|1883286|FG001|Period 1|Adverse Event|1
907164|NCT00773279|1883285|FG000|Period 1|Lack of Efficacy|0
907165|NCT00773279|1883286|FG001|Period 1|Lack of Efficacy|2
907166|NCT00773279|1883285|FG000|Period 1|Unclassified|5
907167|NCT00773279|1883286|FG001|Period 1|Unclassified|1
907168|NCT00773279|1883285|FG000|Period 2|Adverse Event|0
907169|NCT00773279|1883286|FG001|Period 2|Adverse Event|1
907170|NCT00773279|1883285|FG000|Period 2|Lack of Efficacy|1
907171|NCT00773279|1883286|FG001|Period 2|Lack of Efficacy|0
907172|NCT00773279|1883285|FG000|Period 2|Protocol Violation|0
907173|NCT00773279|1883286|FG001|Period 2|Protocol Violation|3
907174|NCT00773279|1883285|FG000|Period 2|Unclassified|2
1052379|NCT01855789|2094077|FG000|1) Baseline up to Week 24|Death|2
1052380|NCT01855789|2094078|FG001|1) Baseline up to Week 24|Death|0
1052381|NCT01855789|2094079|FG002|1) Baseline up to Week 24|Death|0
1052382|NCT01855789|2094080|FG003|1) Baseline up to Week 24|Death|0
1052383|NCT01855789|2094077|FG000|1) Baseline up to Week 24|Lack of Efficacy|16
1052384|NCT01855789|2094078|FG001|1) Baseline up to Week 24|Lack of Efficacy|0
1052385|NCT01855789|2094079|FG002|1) Baseline up to Week 24|Lack of Efficacy|0
1052386|NCT01855789|2094080|FG003|1) Baseline up to Week 24|Lack of Efficacy|0
1052387|NCT01855789|2094077|FG000|1) Baseline up to Week 24|Lost to Follow-up|11
1052388|NCT01855789|2094078|FG001|1) Baseline up to Week 24|Lost to Follow-up|0
1052389|NCT01855789|2094079|FG002|1) Baseline up to Week 24|Lost to Follow-up|0
1052390|NCT01855789|2094080|FG003|1) Baseline up to Week 24|Lost to Follow-up|0
1052391|NCT01855789|2094077|FG000|1) Baseline up to Week 24|Protocol Violation|4
1052392|NCT01855789|2094078|FG001|1) Baseline up to Week 24|Protocol Violation|0
1052393|NCT01855789|2094079|FG002|1) Baseline up to Week 24|Protocol Violation|0
1052394|NCT01855789|2094080|FG003|1) Baseline up to Week 24|Protocol Violation|0
1052395|NCT01855789|2094077|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31
1052396|NCT01855789|2094078|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0
1052397|NCT01855789|2094079|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0
1052398|NCT01855789|2094080|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0
1052399|NCT01855789|2094077|FG000|1) Baseline up to Week 24|Physician Decision|4
1052400|NCT01855789|2094078|FG001|1) Baseline up to Week 24|Physician Decision|0
1052401|NCT01855789|2094079|FG002|1) Baseline up to Week 24|Physician Decision|0
1052402|NCT01855789|2094080|FG003|1) Baseline up to Week 24|Physician Decision|0
1052403|NCT01855789|2094077|FG000|1) Baseline up to Week 24|Pregnancy|1
1052404|NCT01855789|2094078|FG001|1) Baseline up to Week 24|Pregnancy|0
1052405|NCT01855789|2094079|FG002|1) Baseline up to Week 24|Pregnancy|0
1052406|NCT01855789|2094080|FG003|1) Baseline up to Week 24|Pregnancy|0
1052407|NCT01855789|2094077|FG000|1) Baseline up to Week 24|Participant Non-compliance|3
1052408|NCT01855789|2094078|FG001|1) Baseline up to Week 24|Participant Non-compliance|0
1052409|NCT01855789|2094079|FG002|1) Baseline up to Week 24|Participant Non-compliance|0
1052410|NCT01855789|2094080|FG003|1) Baseline up to Week 24|Participant Non-compliance|0
1052411|NCT01855789|2094077|FG000|1) Baseline up to Week 24|Sponsor Decision|3
1052412|NCT01855789|2094078|FG001|1) Baseline up to Week 24|Sponsor Decision|0
1052413|NCT01855789|2094079|FG002|1) Baseline up to Week 24|Sponsor Decision|0
1052414|NCT01855789|2094080|FG003|1) Baseline up to Week 24|Sponsor Decision|0
1052415|NCT01855789|2094077|FG000|1) Baseline up to Week 24|Other|4
1052416|NCT01855789|2094078|FG001|1) Baseline up to Week 24|Other|0
1052417|NCT01855789|2094079|FG002|1) Baseline up to Week 24|Other|0
1052418|NCT01855789|2094080|FG003|1) Baseline up to Week 24|Other|0
1052419|NCT01855789|2094077|FG000|2) Week 24 up to End of Study|Adverse Event|0
1052420|NCT01855789|2094078|FG001|2) Week 24 up to End of Study|Adverse Event|4
1052421|NCT01855789|2094079|FG002|2) Week 24 up to End of Study|Adverse Event|5
1052422|NCT01855789|2094080|FG003|2) Week 24 up to End of Study|Adverse Event|21
1052423|NCT01855789|2094077|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1052424|NCT01855789|2094078|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1052425|NCT01855789|2094079|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1052426|NCT01855789|2094080|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
1052427|NCT01855789|2094077|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0
1052428|NCT01855789|2094078|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2
1052429|NCT01855789|2094079|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5
1052430|NCT01855789|2094080|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16
1052431|NCT01855789|2094077|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0
1052432|NCT01855789|2094078|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1
1052433|NCT01855789|2094079|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1
1052434|NCT01855789|2094080|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4
907175|NCT00773279|1883286|FG001|Period 2|Unclassified|2
907176|NCT00773292|1883293|FG000|Treatment 48 Weeks|Adverse Event|1
907177|NCT00773292|1883293|FG000|Treatment 48 Weeks|Lack of Efficacy|1
907178|NCT00773383|1883306|FG000|Overall Study|Adverse Event|4
907179|NCT00773383|1883306|FG000|Overall Study|Death|1
907180|NCT00773383|1883306|FG000|Overall Study|Progression of Disease|23
907181|NCT00773383|1883306|FG000|Overall Study|Other|2
907182|NCT00773383|1883306|FG000|Overall Study|No study dose received|1
907183|NCT00773461|1883329|FG000|Overall Study|Adverse Event|1
907184|NCT00773461|1883330|FG001|Overall Study|Adverse Event|3
907185|NCT00773461|1883329|FG000|Overall Study|Withdrawal by Subject|4
907186|NCT00773461|1883330|FG001|Overall Study|Withdrawal by Subject|1
907187|NCT00773513|1883343|FG000|Overall Study|Renal Transplant|254
907188|NCT00773513|1883344|FG001|Overall Study|Renal Transplant|263
907189|NCT00773513|1883343|FG000|Overall Study|Adverse Event / Intercurrent Illness|40
907190|NCT00773513|1883344|FG001|Overall Study|Adverse Event / Intercurrent Illness|48
907191|NCT00773513|1883343|FG000|Overall Study|Withdrew Consent|68
907192|NCT00773513|1883344|FG001|Overall Study|Withdrew Consent|69
907193|NCT00773513|1883343|FG000|Overall Study|Refused Treatment / Did not Cooperate|26
907194|NCT00773513|1883344|FG001|Overall Study|Refused Treatment / Did not Cooperate|32
907195|NCT00773513|1883343|FG000|Overall Study|Failure to Return|22
907196|NCT00773513|1883344|FG001|Overall Study|Failure to Return|8
1052435|NCT01855789|2094077|FG000|2) Week 24 up to End of Study|Protocol Violation|0
1052436|NCT01855789|2094078|FG001|2) Week 24 up to End of Study|Protocol Violation|0
1052437|NCT01855789|2094079|FG002|2) Week 24 up to End of Study|Protocol Violation|0
1052438|NCT01855789|2094080|FG003|2) Week 24 up to End of Study|Protocol Violation|1
1052439|NCT01855789|2094077|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0
1052440|NCT01855789|2094078|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7
1052441|NCT01855789|2094079|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5
1052442|NCT01855789|2094080|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8
1052443|NCT01855789|2094077|FG000|2) Week 24 up to End of Study|Physician Decision|0
1052444|NCT01855789|2094078|FG001|2) Week 24 up to End of Study|Physician Decision|0
1052445|NCT01855789|2094079|FG002|2) Week 24 up to End of Study|Physician Decision|2
1052446|NCT01855789|2094080|FG003|2) Week 24 up to End of Study|Physician Decision|4
1052447|NCT01855789|2094077|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0
1052448|NCT01855789|2094078|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1
1052449|NCT01855789|2094079|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0
1052450|NCT01855789|2094080|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1
1052451|NCT01855789|2094077|FG000|2) Week 24 up to End of Study|Sponsor Decision|0
1052452|NCT01855789|2094078|FG001|2) Week 24 up to End of Study|Sponsor Decision|0
1052453|NCT01855789|2094079|FG002|2) Week 24 up to End of Study|Sponsor Decision|0
1052454|NCT01855789|2094080|FG003|2) Week 24 up to End of Study|Sponsor Decision|1
1052455|NCT01855789|2094077|FG000|2) Week 24 up to End of Study|Other|0
1052456|NCT01855789|2094078|FG001|2) Week 24 up to End of Study|Other|0
1052457|NCT01855789|2094079|FG002|2) Week 24 up to End of Study|Other|0
1052458|NCT01855789|2094080|FG003|2) Week 24 up to End of Study|Other|1
1052459|NCT01855828|2094086|FG000|Overall Study|Adverse Event|1
1052460|NCT01855828|2094086|FG000|Overall Study|Withdrawal by Subject|1
1052461|NCT01855919|2094097|FG000|Overall Study|Adverse Event|16
1052462|NCT01855919|2094098|FG001|Overall Study|Adverse Event|8
1052463|NCT01855919|2094097|FG000|Overall Study|Lack of Efficacy|1
1052464|NCT01855919|2094098|FG001|Overall Study|Lack of Efficacy|3
1052465|NCT01855919|2094097|FG000|Overall Study|Withdrawal by Subject|4
1052466|NCT01855919|2094098|FG001|Overall Study|Withdrawal by Subject|10
1052467|NCT01855919|2094097|FG000|Overall Study|Entry Criteria Not Met|1
1052468|NCT01855919|2094098|FG001|Overall Study|Entry Criteria Not Met|1
1052469|NCT01855919|2094097|FG000|Overall Study|Protocol Violation|1
1052470|NCT01855919|2094098|FG001|Overall Study|Protocol Violation|4
1052471|NCT01855945|2094117|FG000|Overall Study|Adverse Event|0
1052472|NCT01855945|2094118|FG001|Overall Study|Adverse Event|0
1052473|NCT01855945|2094119|FG002|Overall Study|Adverse Event|0
1052474|NCT01855945|2094120|FG003|Overall Study|Adverse Event|0
1052475|NCT01855945|2094121|FG004|Overall Study|Adverse Event|0
1052476|NCT01855945|2094122|FG005|Overall Study|Adverse Event|0
1052477|NCT01855945|2094123|FG006|Overall Study|Adverse Event|1
1052478|NCT01855945|2094124|FG007|Overall Study|Adverse Event|0
1052479|NCT01855945|2094125|FG008|Overall Study|Adverse Event|0
1052480|NCT01855945|2094126|FG009|Overall Study|Adverse Event|0
1052481|NCT01855945|2094127|FG010|Overall Study|Adverse Event|0
1052482|NCT01855945|2094128|FG011|Overall Study|Adverse Event|0
1052483|NCT01855945|2094117|FG000|Overall Study|Death|0
1052484|NCT01855945|2094118|FG001|Overall Study|Death|0
1052485|NCT01855945|2094119|FG002|Overall Study|Death|0
1052486|NCT01855945|2094120|FG003|Overall Study|Death|0
1052487|NCT01855945|2094121|FG004|Overall Study|Death|0
1052488|NCT01855945|2094122|FG005|Overall Study|Death|0
1052489|NCT01855945|2094123|FG006|Overall Study|Death|2
1052490|NCT01855945|2094124|FG007|Overall Study|Death|0
1052491|NCT01855945|2094125|FG008|Overall Study|Death|0
1052492|NCT01855945|2094126|FG009|Overall Study|Death|0
1052493|NCT01855945|2094127|FG010|Overall Study|Death|0
1052494|NCT01855945|2094128|FG011|Overall Study|Death|0
1052495|NCT01855945|2094117|FG000|Overall Study|Lost to Follow-up|11
1052496|NCT01855945|2094118|FG001|Overall Study|Lost to Follow-up|10
1052497|NCT01855945|2094119|FG002|Overall Study|Lost to Follow-up|7
1052498|NCT01855945|2094120|FG003|Overall Study|Lost to Follow-up|3
1052499|NCT01855945|2094121|FG004|Overall Study|Lost to Follow-up|0
1052500|NCT01855945|2094122|FG005|Overall Study|Lost to Follow-up|3
1052501|NCT01855945|2094123|FG006|Overall Study|Lost to Follow-up|4
1052502|NCT01855945|2094124|FG007|Overall Study|Lost to Follow-up|7
1052503|NCT01855945|2094125|FG008|Overall Study|Lost to Follow-up|2
1052504|NCT01855945|2094126|FG009|Overall Study|Lost to Follow-up|0
1052505|NCT01855945|2094127|FG010|Overall Study|Lost to Follow-up|0
1052506|NCT01855945|2094128|FG011|Overall Study|Lost to Follow-up|2
1052507|NCT01855945|2094117|FG000|Overall Study|Other - Unclassified|1
1052508|NCT01855945|2094118|FG001|Overall Study|Other - Unclassified|1
1052509|NCT01855945|2094119|FG002|Overall Study|Other - Unclassified|1
1052510|NCT01855945|2094120|FG003|Overall Study|Other - Unclassified|0
1052511|NCT01855945|2094121|FG004|Overall Study|Other - Unclassified|0
1052512|NCT01855945|2094122|FG005|Overall Study|Other - Unclassified|0
1052513|NCT01855945|2094123|FG006|Overall Study|Other - Unclassified|2
1052514|NCT01855945|2094124|FG007|Overall Study|Other - Unclassified|1
1052515|NCT01855945|2094125|FG008|Overall Study|Other - Unclassified|0
1052516|NCT01855945|2094126|FG009|Overall Study|Other - Unclassified|0
1052517|NCT01855945|2094127|FG010|Overall Study|Other - Unclassified|1
1052518|NCT01855945|2094128|FG011|Overall Study|Other - Unclassified|0
1052519|NCT01855945|2094117|FG000|Overall Study|Withdrawal by Subject|4
1052520|NCT01855945|2094118|FG001|Overall Study|Withdrawal by Subject|0
1052521|NCT01855945|2094119|FG002|Overall Study|Withdrawal by Subject|4
1052522|NCT01855945|2094120|FG003|Overall Study|Withdrawal by Subject|1
1052523|NCT01855945|2094121|FG004|Overall Study|Withdrawal by Subject|1
1052524|NCT01855945|2094122|FG005|Overall Study|Withdrawal by Subject|0
1052525|NCT01855945|2094123|FG006|Overall Study|Withdrawal by Subject|1
1052526|NCT01855945|2094124|FG007|Overall Study|Withdrawal by Subject|0
1052527|NCT01855945|2094125|FG008|Overall Study|Withdrawal by Subject|0
1052528|NCT01855945|2094126|FG009|Overall Study|Withdrawal by Subject|2
1052529|NCT01855945|2094127|FG010|Overall Study|Withdrawal by Subject|4
1052530|NCT01855945|2094128|FG011|Overall Study|Withdrawal by Subject|1
1052531|NCT01855958|2094193|FG000|Overall Study|Withdrawal by Subject|1
1052532|NCT01855958|2094194|FG001|Overall Study|Withdrawal by Subject|0
1052533|NCT01856114|2094216|FG000|Overall Study|Withdrawal by Subject|1
1052534|NCT01856114|2094217|FG001|Overall Study|Withdrawal by Subject|0
1052535|NCT01856114|2094216|FG000|Overall Study|Adverse Event|1
1052536|NCT01856114|2094217|FG001|Overall Study|Adverse Event|0
1052537|NCT01856192|2094225|FG000|Overall Study|Adverse Event|12
1052538|NCT01856192|2094226|FG001|Overall Study|Adverse Event|4
1052539|NCT01856192|2094225|FG000|Overall Study|Alternative therapy|0
1052540|NCT01856192|2094226|FG001|Overall Study|Alternative therapy|3
1052541|NCT01856192|2094225|FG000|Overall Study|Death|3
1052542|NCT01856192|2094226|FG001|Overall Study|Death|5
1052543|NCT01856192|2094225|FG000|Overall Study|Lack of Efficacy|0
1052544|NCT01856192|2094226|FG001|Overall Study|Lack of Efficacy|5
1052545|NCT01856192|2094225|FG000|Overall Study|Withdrawal by Subject|1
1052546|NCT01856192|2094226|FG001|Overall Study|Withdrawal by Subject|1
1052547|NCT01856192|2094225|FG000|Overall Study|Other diseases|1
1052548|NCT01856192|2094226|FG001|Overall Study|Other diseases|0
1052549|NCT01856192|2094225|FG000|Overall Study|Never started treatment|7
1052550|NCT01856192|2094226|FG001|Overall Study|Never started treatment|5
1052551|NCT01856192|2094225|FG000|Overall Study|Path ineligible|20
1052552|NCT01856192|2094226|FG001|Overall Study|Path ineligible|34
1052553|NCT01856192|2094225|FG000|Overall Study|Non-path ineligible|2
1052554|NCT01856192|2094226|FG001|Overall Study|Non-path ineligible|2
1052555|NCT01856192|2094225|FG000|Overall Study|Physician Decision|1
1052556|NCT01856192|2094226|FG001|Overall Study|Physician Decision|1
1052557|NCT01856192|2094225|FG000|Overall Study|Suspicion of progressive disease|1
1052558|NCT01856192|2094226|FG001|Overall Study|Suspicion of progressive disease|0
1052559|NCT01856192|2094225|FG000|Overall Study|Non-compliance|1
1052560|NCT01856192|2094226|FG001|Overall Study|Non-compliance|0
1052561|NCT01856257|2094239|FG000|Overall Study|Death|2
1052562|NCT01856257|2094240|FG001|Overall Study|Death|0
1052563|NCT01856257|2094241|FG002|Overall Study|Death|0
1052564|NCT01856257|2094242|FG003|Overall Study|Death|0
1052565|NCT01856257|2094239|FG000|Overall Study|Physician Decision|0
1052566|NCT01856257|2094240|FG001|Overall Study|Physician Decision|0
1052567|NCT01856257|2094241|FG002|Overall Study|Physician Decision|0
1052568|NCT01856257|2094242|FG003|Overall Study|Physician Decision|1
1052569|NCT01856257|2094239|FG000|Overall Study|Withdrawal by Subject|1
1052570|NCT01856257|2094240|FG001|Overall Study|Withdrawal by Subject|1
1052571|NCT01856257|2094241|FG002|Overall Study|Withdrawal by Subject|0
1052572|NCT01856257|2094242|FG003|Overall Study|Withdrawal by Subject|0
1052573|NCT01856257|2094239|FG000|Overall Study|Donor complication|0
1052574|NCT01856257|2094240|FG001|Overall Study|Donor complication|0
1052575|NCT01856257|2094241|FG002|Overall Study|Donor complication|0
1052576|NCT01856257|2094242|FG003|Overall Study|Donor complication|1
1052577|NCT01856309|2094266|FG000|Overall Study|Death|4
1052578|NCT01856309|2094267|FG001|Overall Study|Death|6
907197|NCT00773513|1883343|FG000|Overall Study|Insufficient Therapeutic Response|1
907198|NCT00773513|1883344|FG001|Overall Study|Insufficient Therapeutic Response|18
907199|NCT00773513|1883343|FG000|Overall Study|Reason Not Specified|159
907200|NCT00773513|1883344|FG001|Overall Study|Reason Not Specified|126
907201|NCT00773513|1883343|FG000|Overall Study|Death|531
907202|NCT00773513|1883344|FG001|Overall Study|Death|545
907203|NCT00773734|1883358|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
907204|NCT00773734|1883359|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
907205|NCT00773734|1883360|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
907206|NCT00773734|1883361|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
907207|NCT00773734|1883362|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
907208|NCT00773734|1883363|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
907209|NCT00773734|1883358|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
907210|NCT00773734|1883359|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
907211|NCT00773734|1883360|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
907212|NCT00773734|1883361|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
907213|NCT00773734|1883362|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
907214|NCT00773734|1883363|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
907215|NCT00773734|1883358|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
907216|NCT00773734|1883359|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
907217|NCT00773734|1883360|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
1052579|NCT01856309|2094268|FG002|Overall Study|Death|11
1052580|NCT01856309|2094269|FG003|Overall Study|Death|6
1052581|NCT01856309|2094266|FG000|Overall Study|Lost to Follow-up|6
1052582|NCT01856309|2094267|FG001|Overall Study|Lost to Follow-up|2
1052583|NCT01856309|2094268|FG002|Overall Study|Lost to Follow-up|4
1052584|NCT01856309|2094269|FG003|Overall Study|Lost to Follow-up|8
1052585|NCT01856309|2094266|FG000|Overall Study|Withdrawal by Subject|11
1052586|NCT01856309|2094267|FG001|Overall Study|Withdrawal by Subject|13
1052587|NCT01856309|2094268|FG002|Overall Study|Withdrawal by Subject|28
1052588|NCT01856309|2094269|FG003|Overall Study|Withdrawal by Subject|26
1052589|NCT01856309|2094266|FG000|Overall Study|Other|227
1052590|NCT01856309|2094267|FG001|Overall Study|Other|225
1052591|NCT01856309|2094268|FG002|Overall Study|Other|447
1052592|NCT01856309|2094269|FG003|Overall Study|Other|469
1052593|NCT01856309|2094266|FG000|Overall Study|Lack of Efficacy|14
1052594|NCT01856309|2094267|FG001|Overall Study|Lack of Efficacy|9
1052595|NCT01856309|2094268|FG002|Overall Study|Lack of Efficacy|40
1052596|NCT01856309|2094269|FG003|Overall Study|Lack of Efficacy|25
1052597|NCT01856309|2094266|FG000|Overall Study|Adverse Event|31
1052598|NCT01856309|2094267|FG001|Overall Study|Adverse Event|31
1052599|NCT01856309|2094268|FG002|Overall Study|Adverse Event|55
1052600|NCT01856309|2094269|FG003|Overall Study|Adverse Event|65
1052601|NCT01856309|2094266|FG000|Overall Study|Pregnancy|0
1052602|NCT01856309|2094267|FG001|Overall Study|Pregnancy|0
1052603|NCT01856309|2094268|FG002|Overall Study|Pregnancy|0
1052604|NCT01856309|2094269|FG003|Overall Study|Pregnancy|1
1052605|NCT01856309|2094266|FG000|Overall Study|Physician Decision|6
1052606|NCT01856309|2094267|FG001|Overall Study|Physician Decision|1
1052607|NCT01856309|2094268|FG002|Overall Study|Physician Decision|6
1052608|NCT01856309|2094269|FG003|Overall Study|Physician Decision|8
1052609|NCT01856309|2094266|FG000|Overall Study|Noncompliance With Study Drug|0
1052610|NCT01856309|2094267|FG001|Overall Study|Noncompliance With Study Drug|1
1052611|NCT01856309|2094268|FG002|Overall Study|Noncompliance With Study Drug|4
1052612|NCT01856309|2094269|FG003|Overall Study|Noncompliance With Study Drug|1
1052613|NCT01856543|2094294|FG000|Overall Study|Treatment discontinued|6
1052614|NCT01856543|2094295|FG001|Overall Study|Treatment discontinued|3
1052615|NCT01856543|2094294|FG000|Overall Study|Withdrawn before start|7
1052616|NCT01856543|2094295|FG001|Overall Study|Withdrawn before start|3
1052617|NCT01856569|2094302|FG000|Overall Study|Other|1
1052618|NCT01856569|2094302|FG000|Overall Study|Changed Site/Structure|1
1052619|NCT01856569|2094302|FG000|Overall Study|Lost to Follow-up|3
1052620|NCT01856569|2094302|FG000|Overall Study|Did not met inclusion criteria|8
1052621|NCT01856582|2094306|FG000|Overall Study|Died prior to Boost infusion|1
1052622|NCT01856595|2094319|FG000|Overall Study|Withdrawal by Subject|0
1052623|NCT01856595|2094320|FG001|Overall Study|Withdrawal by Subject|1
1052624|NCT01856595|2094321|FG002|Overall Study|Withdrawal by Subject|0
1052625|NCT01856595|2094322|FG003|Overall Study|Withdrawal by Subject|0
1052626|NCT01856595|2094323|FG004|Overall Study|Withdrawal by Subject|0
1052627|NCT01856595|2094324|FG005|Overall Study|Withdrawal by Subject|0
1052628|NCT01856595|2094325|FG006|Overall Study|Withdrawal by Subject|1
1052629|NCT01856595|2094326|FG007|Overall Study|Withdrawal by Subject|0
1052630|NCT01856595|2094327|FG008|Overall Study|Withdrawal by Subject|0
1052631|NCT01856673|2094365|FG000|Overall Study|Withdrawal by Subject|44
1052632|NCT01856673|2094366|FG001|Overall Study|Withdrawal by Subject|50
1052633|NCT01856673|2094367|FG002|Overall Study|Withdrawal by Subject|33
1052634|NCT01856673|2094365|FG000|Overall Study|Lost to Follow-up|31
1052635|NCT01856673|2094366|FG001|Overall Study|Lost to Follow-up|34
1052636|NCT01856673|2094367|FG002|Overall Study|Lost to Follow-up|0
1052637|NCT01856673|2094365|FG000|Overall Study|Unknown reasons|9
1052638|NCT01856673|2094366|FG001|Overall Study|Unknown reasons|0
1052639|NCT01856673|2094367|FG002|Overall Study|Unknown reasons|0
1052640|NCT01856673|2094365|FG000|Overall Study|Psychologist decision|1
1052641|NCT01856673|2094366|FG001|Overall Study|Psychologist decision|0
1052642|NCT01856673|2094367|FG002|Overall Study|Psychologist decision|0
1052643|NCT01856673|2094365|FG000|Overall Study|Paperwork errors|8
1052644|NCT01856673|2094366|FG001|Overall Study|Paperwork errors|0
1052645|NCT01856673|2094367|FG002|Overall Study|Paperwork errors|0
1052646|NCT01856673|2094365|FG000|Overall Study|Death|1
1052647|NCT01856673|2094366|FG001|Overall Study|Death|1
1052648|NCT01856673|2094367|FG002|Overall Study|Death|0
907218|NCT00773734|1883361|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
907219|NCT00773734|1883362|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
907220|NCT00773734|1883363|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
907221|NCT00773734|1883358|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1
907222|NCT00773734|1883359|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0
907223|NCT00773734|1883360|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0
907224|NCT00773734|1883361|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0
907225|NCT00773734|1883362|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0
907226|NCT00773734|1883363|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0
907227|NCT00773734|1883358|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
907228|NCT00773734|1883359|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
907229|NCT00773734|1883360|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1052649|NCT01856673|2094365|FG000|Overall Study|Protocol Violation|1
1052650|NCT01856673|2094366|FG001|Overall Study|Protocol Violation|0
1052651|NCT01856673|2094367|FG002|Overall Study|Protocol Violation|1
1052652|NCT01856686|2094377|FG000|Overall Study|Lost to Follow-up|5
1052653|NCT01856686|2094378|FG001|Overall Study|Lost to Follow-up|11
1052654|NCT01856790|2094406|FG000|Closed Loop Control|Withdrawal by Subject|2
1052655|NCT01856790|2094406|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
1052656|NCT01856907|2094420|FG000|Overall Study|Pregnancy|0
1052657|NCT01856907|2094421|FG001|Overall Study|Pregnancy|1
1052658|NCT01856907|2094422|FG002|Overall Study|Pregnancy|0
1052659|NCT01856907|2094420|FG000|Overall Study|Pregnancy|0
1052660|NCT01856907|2094421|FG001|Overall Study|Pregnancy|1
1052661|NCT01856907|2094422|FG002|Overall Study|Pregnancy|0
1052662|NCT01856907|2094420|FG000|Overall Study|Withdrawal by Subject|0
1052663|NCT01856907|2094421|FG001|Overall Study|Withdrawal by Subject|1
1052664|NCT01856907|2094422|FG002|Overall Study|Withdrawal by Subject|0
1052665|NCT01857063|2094439|FG000|Period 1 (7 Days)|Adverse Event|0
1052666|NCT01857063|2094440|FG001|Period 1 (7 Days)|Adverse Event|1
1052667|NCT01857063|2094439|FG000|Period 1 (7 Days)|Physician Decision|1
1052668|NCT01857063|2094440|FG001|Period 1 (7 Days)|Physician Decision|0
1052669|NCT01857063|2094439|FG000|Period 1 (7 Days)|Withdrawal by Subject|1
1052670|NCT01857063|2094440|FG001|Period 1 (7 Days)|Withdrawal by Subject|3
1052671|NCT01857063|2094439|FG000|Period 2 (7 Days)|Adverse Event|2
1052672|NCT01857063|2094440|FG001|Period 2 (7 Days)|Adverse Event|1
1052673|NCT01857063|2094439|FG000|Period 2 (7 Days)|Physician Decision|1
1052674|NCT01857063|2094440|FG001|Period 2 (7 Days)|Physician Decision|1
1052675|NCT01857063|2094439|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
1052676|NCT01857063|2094440|FG001|Period 2 (7 Days)|Withdrawal by Subject|0
1052677|NCT01857102|2094446|FG000|Period 1|No longer meets Eligibility Criteria|0
1052678|NCT01857102|2094447|FG001|Period 1|No longer meets Eligibility Criteria|2
1052679|NCT01857102|2094446|FG000|Period 1|Lost to Follow-up|0
1052680|NCT01857102|2094447|FG001|Period 1|Lost to Follow-up|3
1052681|NCT01857102|2094446|FG000|Period 1|Unsatisfactory Lens Fit|1
907230|NCT00773734|1883361|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
907231|NCT00773734|1883362|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
907232|NCT00773734|1883363|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
907233|NCT00773734|1883358|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
907234|NCT00773734|1883359|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
907235|NCT00773734|1883360|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
907236|NCT00773734|1883361|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
907237|NCT00773734|1883362|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
907238|NCT00773734|1883363|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
907239|NCT00773734|1883358|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1
907240|NCT00773734|1883359|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1
907241|NCT00773734|1883360|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1
907242|NCT00773734|1883361|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1
907243|NCT00773734|1883362|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0
907244|NCT00773734|1883363|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0
907245|NCT00773734|1883358|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0
907246|NCT00773734|1883359|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4
907247|NCT00773734|1883360|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0
907248|NCT00773734|1883361|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0
907249|NCT00773734|1883362|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1
907250|NCT00773734|1883363|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2
907251|NCT00773734|1883358|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
907252|NCT00773734|1883359|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
907253|NCT00773734|1883360|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
907254|NCT00773734|1883361|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
907255|NCT00773734|1883362|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
907256|NCT00773734|1883363|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
907257|NCT00773734|1883358|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
907258|NCT00773734|1883359|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
907259|NCT00773734|1883360|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
907260|NCT00773734|1883361|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
907261|NCT00773734|1883362|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
907262|NCT00773734|1883363|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
907263|NCT00773734|1883358|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
907264|NCT00773734|1883359|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
907265|NCT00773734|1883360|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
907266|NCT00773734|1883361|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
907267|NCT00773734|1883362|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
907268|NCT00773734|1883363|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
907269|NCT00773734|1883358|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
907270|NCT00773734|1883359|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
907271|NCT00773734|1883360|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
907272|NCT00773734|1883361|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1052682|NCT01857102|2094447|FG001|Period 1|Unsatisfactory Lens Fit|0
1052683|NCT01857102|2094446|FG000|Period 1|Unsatisfactory Visual Response|1
1052684|NCT01857102|2094447|FG001|Period 1|Unsatisfactory Visual Response|0
1052685|NCT01857102|2094446|FG000|Period 1|Physician Decision|1
1052686|NCT01857102|2094447|FG001|Period 1|Physician Decision|0
1052687|NCT01857102|2094446|FG000|Period 2|Lens Discomfort|1
1052688|NCT01857102|2094447|FG001|Period 2|Lens Discomfort|0
1052689|NCT01857102|2094446|FG000|Period 2|Unsatisfactory Lens Fit|1
1052690|NCT01857102|2094447|FG001|Period 2|Unsatisfactory Lens Fit|0
1052691|NCT01857206|2094457|FG000|Overall Study|ADMINISTRATIVE REASON|0
1052692|NCT01857206|2094458|FG001|Overall Study|ADMINISTRATIVE REASON|1
1052693|NCT01857206|2094457|FG000|Overall Study|Lost to Follow-up|9
1052694|NCT01857206|2094458|FG001|Overall Study|Lost to Follow-up|6
1052695|NCT01857206|2094457|FG000|Overall Study|Unclassified|3
1052696|NCT01857206|2094458|FG001|Overall Study|Unclassified|3
1052697|NCT01857206|2094457|FG000|Overall Study|Withdrawal by Subject|1
1052698|NCT01857206|2094458|FG001|Overall Study|Withdrawal by Subject|0
1052699|NCT01857310|2094512|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315
1052700|NCT01857310|2094513|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282
1052701|NCT01857323|2094519|FG000|Overall Study|Adverse Event|1
1052702|NCT01857323|2094519|FG000|Overall Study|Withdrawal by Subject|3
1052703|NCT01857323|2094519|FG000|Overall Study|Non-compliance|1
1052704|NCT01857323|2094519|FG000|Overall Study|Protocol Violation|6
1052705|NCT01857323|2094519|FG000|Overall Study|Lost to Follow-up|1
1052706|NCT01857323|2094519|FG000|Overall Study|Other|4
1052707|NCT01857323|2094519|FG000|Overall Study|Did not complete 180 doses|48
1052708|NCT01857531|2094530|FG000|Overall Study|Withdrawal by Subject|4
1052709|NCT01857583|2094538|FG000|Overall Study|Adverse Event|0
1052710|NCT01857583|2094539|FG001|Overall Study|Adverse Event|0
1052711|NCT01857583|2094540|FG002|Overall Study|Adverse Event|1
1052712|NCT01857583|2094541|FG003|Overall Study|Adverse Event|1
1052713|NCT01857583|2094538|FG000|Overall Study|Death|0
1052714|NCT01857583|2094539|FG001|Overall Study|Death|1
1052715|NCT01857583|2094540|FG002|Overall Study|Death|1
1052716|NCT01857583|2094541|FG003|Overall Study|Death|0
907273|NCT00773734|1883362|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
907274|NCT00773734|1883363|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
907275|NCT00773734|1883358|FG000|Core: Active Treatment Phase Week 16-24|Other|0
907276|NCT00773734|1883359|FG001|Core: Active Treatment Phase Week 16-24|Other|1
907277|NCT00773734|1883360|FG002|Core: Active Treatment Phase Week 16-24|Other|0
907278|NCT00773734|1883361|FG003|Core: Active Treatment Phase Week 16-24|Other|0
907279|NCT00773734|1883362|FG004|Core: Active Treatment Phase Week 16-24|Other|0
907280|NCT00773734|1883363|FG005|Core: Active Treatment Phase Week 16-24|Other|0
907281|NCT00773734|1883358|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0
907282|NCT00773734|1883359|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0
907283|NCT00773734|1883360|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0
907284|NCT00773734|1883361|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0
907285|NCT00773734|1883362|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2
907286|NCT00773734|1883363|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1
907287|NCT00773734|1883358|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
907288|NCT00773734|1883359|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
907289|NCT00773734|1883360|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
907290|NCT00773734|1883361|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
907291|NCT00773734|1883362|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
907292|NCT00773734|1883363|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
907293|NCT00773734|1883358|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
907294|NCT00773734|1883359|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
907295|NCT00773734|1883360|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
907296|NCT00773734|1883361|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
907297|NCT00773734|1883362|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
907298|NCT00773734|1883363|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
907299|NCT00773734|1883358|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
907300|NCT00773734|1883359|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
907301|NCT00773734|1883360|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
907302|NCT00773734|1883361|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
907303|NCT00773734|1883362|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
907304|NCT00773734|1883363|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
907305|NCT00773734|1883358|FG000|Extension: Active Treatment Week 24-52|Other|0
907306|NCT00773734|1883359|FG001|Extension: Active Treatment Week 24-52|Other|0
907307|NCT00773734|1883360|FG002|Extension: Active Treatment Week 24-52|Other|1
907308|NCT00773734|1883361|FG003|Extension: Active Treatment Week 24-52|Other|2
907309|NCT00773734|1883362|FG004|Extension: Active Treatment Week 24-52|Other|0
907310|NCT00773734|1883363|FG005|Extension: Active Treatment Week 24-52|Other|1
907311|NCT00773734|1883358|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0
907312|NCT00773734|1883359|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0
907313|NCT00773734|1883360|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0
907314|NCT00773734|1883361|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1
1052717|NCT01857583|2094538|FG000|Overall Study|Physician Decision|0
1052718|NCT01857583|2094539|FG001|Overall Study|Physician Decision|0
1052719|NCT01857583|2094540|FG002|Overall Study|Physician Decision|0
1052720|NCT01857583|2094541|FG003|Overall Study|Physician Decision|1
1052721|NCT01857583|2094538|FG000|Overall Study|Withdrawal by Subject|1
1052722|NCT01857583|2094539|FG001|Overall Study|Withdrawal by Subject|0
1052723|NCT01857583|2094540|FG002|Overall Study|Withdrawal by Subject|1
1052724|NCT01857583|2094541|FG003|Overall Study|Withdrawal by Subject|2
1052725|NCT01857622|2094554|FG000|Overall Study|Adverse Event|5
1052726|NCT01857622|2094555|FG001|Overall Study|Adverse Event|0
1052727|NCT01857622|2094556|FG002|Overall Study|Adverse Event|2
1052728|NCT01857622|2094554|FG000|Overall Study|Physician Decision|1
1052729|NCT01857622|2094555|FG001|Overall Study|Physician Decision|0
1052730|NCT01857622|2094556|FG002|Overall Study|Physician Decision|0
1052731|NCT01857622|2094554|FG000|Overall Study|Protocol Violation|4
1052732|NCT01857622|2094555|FG001|Overall Study|Protocol Violation|1
1052733|NCT01857622|2094556|FG002|Overall Study|Protocol Violation|0
1052734|NCT01857622|2094554|FG000|Overall Study|Withdrawal by Subject|1
1052735|NCT01857622|2094555|FG001|Overall Study|Withdrawal by Subject|0
1052736|NCT01857622|2094556|FG002|Overall Study|Withdrawal by Subject|0
1052737|NCT01857869|2094580|FG000|Primary/Challenge Phase|Lost to Follow-up|2
1052738|NCT01857869|2094581|FG001|Primary/Challenge Phase|Lost to Follow-up|0
1052739|NCT01857869|2094582|FG002|Primary/Challenge Phase|Lost to Follow-up|0
1052740|NCT01857869|2094583|FG003|Primary/Challenge Phase|Lost to Follow-up|0
1052741|NCT01857869|2094584|FG004|Primary/Challenge Phase|Lost to Follow-up|0
1052742|NCT01857869|2094585|FG005|Primary/Challenge Phase|Lost to Follow-up|0
1052743|NCT01857869|2094586|FG006|Primary/Challenge Phase|Lost to Follow-up|0
907315|NCT00773734|1883362|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0
907316|NCT00773734|1883363|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0
907317|NCT00773734|1883358|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
907318|NCT00773734|1883359|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
907319|NCT00773734|1883360|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
907320|NCT00773734|1883361|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
907321|NCT00773734|1883362|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
907322|NCT00773734|1883363|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
907323|NCT00773734|1883358|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
907324|NCT00773734|1883359|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
907325|NCT00773734|1883360|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
907326|NCT00773734|1883361|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
907327|NCT00773734|1883362|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
907328|NCT00773734|1883363|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
907329|NCT00773734|1883358|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
907330|NCT00773734|1883359|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
907331|NCT00773734|1883360|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
907332|NCT00773734|1883361|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
907333|NCT00773734|1883362|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
907334|NCT00773734|1883363|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
907335|NCT00773747|1883422|FG000|Overall Study|Lack of Efficacy|112
907336|NCT00773747|1883423|FG001|Overall Study|Lack of Efficacy|144
907337|NCT00773747|1883422|FG000|Overall Study|Physician Decision|26
907338|NCT00773747|1883423|FG001|Overall Study|Physician Decision|18
907339|NCT00773747|1883422|FG000|Overall Study|Lost to Follow-up|0
907340|NCT00773747|1883423|FG001|Overall Study|Lost to Follow-up|1
907341|NCT00773747|1883422|FG000|Overall Study|Protocol Violation|2
907342|NCT00773747|1883423|FG001|Overall Study|Protocol Violation|2
907343|NCT00773747|1883422|FG000|Overall Study|Withdrawal by Subject|89
907344|NCT00773747|1883423|FG001|Overall Study|Withdrawal by Subject|61
907345|NCT00773747|1883422|FG000|Overall Study|Adverse Event|61
907346|NCT00773747|1883423|FG001|Overall Study|Adverse Event|62
907347|NCT00773747|1883422|FG000|Overall Study|Death|5
907348|NCT00773747|1883423|FG001|Overall Study|Death|8
907349|NCT00773747|1883422|FG000|Overall Study|Not Treated|2
907350|NCT00773747|1883423|FG001|Overall Study|Not Treated|0
907351|NCT00773838|1883437|FG000|Overall Study|Adverse Event|29
907352|NCT00773838|1883437|FG000|Overall Study|Lost to Follow-up|1
907353|NCT00773838|1883437|FG000|Overall Study|Physician Decision|8
907354|NCT00773838|1883437|FG000|Overall Study|Progressive Disease|82
907355|NCT00773838|1883437|FG000|Overall Study|Protocol Violation|2
907356|NCT00773838|1883437|FG000|Overall Study|Withdrawal by Subject|21
907357|NCT00773968|1883445|FG000|Overall Study|Adverse Event|2
907358|NCT00773968|1883445|FG000|Overall Study|Death|1
907359|NCT00773968|1883445|FG000|Overall Study|Failure to Return|2
907360|NCT00773968|1883445|FG000|Overall Study|Lack of Efficacy|3
907361|NCT00773968|1883445|FG000|Overall Study|Protocol Violation|1
907362|NCT00773968|1883445|FG000|Overall Study|Withdrawal by Subject|11
907363|NCT00773968|1883445|FG000|Overall Study|Screen Failure|17
907364|NCT00773968|1883445|FG000|Overall Study|Other|8
907365|NCT00774046|1883449|FG000|Screening|Not eligible|56
907366|NCT00774046|1883449|FG000|Enrollment|Desired other therapy/refused|28
907367|NCT00774046|1883449|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
907368|NCT00774397|1883499|FG000|Overall Study|Adverse Event|1
907369|NCT00774397|1883500|FG001|Overall Study|Adverse Event|3
907370|NCT00774397|1883501|FG002|Overall Study|Adverse Event|16
1052744|NCT01857869|2094587|FG007|Primary/Challenge Phase|Lost to Follow-up|0
1052745|NCT01857869|2094588|FG008|Primary/Challenge Phase|Lost to Follow-up|0
1052746|NCT01857869|2094589|FG009|Primary/Challenge Phase|Lost to Follow-up|0
1052747|NCT01857869|2094580|FG000|Primary/Challenge Phase|Pregnancy|1
1052748|NCT01857869|2094581|FG001|Primary/Challenge Phase|Pregnancy|0
1052749|NCT01857869|2094582|FG002|Primary/Challenge Phase|Pregnancy|0
1052750|NCT01857869|2094583|FG003|Primary/Challenge Phase|Pregnancy|0
1052751|NCT01857869|2094584|FG004|Primary/Challenge Phase|Pregnancy|0
1052752|NCT01857869|2094585|FG005|Primary/Challenge Phase|Pregnancy|0
1052753|NCT01857869|2094586|FG006|Primary/Challenge Phase|Pregnancy|0
1052754|NCT01857869|2094587|FG007|Primary/Challenge Phase|Pregnancy|0
1052755|NCT01857869|2094588|FG008|Primary/Challenge Phase|Pregnancy|0
1052756|NCT01857869|2094589|FG009|Primary/Challenge Phase|Pregnancy|0
1052757|NCT01857869|2094580|FG000|Primary/Challenge Phase|Protocol Violation|1
1052758|NCT01857869|2094581|FG001|Primary/Challenge Phase|Protocol Violation|0
907371|NCT00774397|1883502|FG003|Overall Study|Adverse Event|8
907372|NCT00774397|1883503|FG004|Overall Study|Adverse Event|8
907373|NCT00774397|1883504|FG005|Overall Study|Adverse Event|3
907374|NCT00774397|1883505|FG006|Overall Study|Adverse Event|16
907375|NCT00774397|1883499|FG000|Overall Study|Lack of Efficacy|11
907376|NCT00774397|1883500|FG001|Overall Study|Lack of Efficacy|4
907377|NCT00774397|1883501|FG002|Overall Study|Lack of Efficacy|5
907378|NCT00774397|1883502|FG003|Overall Study|Lack of Efficacy|3
907379|NCT00774397|1883503|FG004|Overall Study|Lack of Efficacy|27
907380|NCT00774397|1883504|FG005|Overall Study|Lack of Efficacy|15
907381|NCT00774397|1883505|FG006|Overall Study|Lack of Efficacy|9
907382|NCT00774397|1883499|FG000|Overall Study|Protocol Violation|0
907383|NCT00774397|1883500|FG001|Overall Study|Protocol Violation|1
907384|NCT00774397|1883501|FG002|Overall Study|Protocol Violation|3
907385|NCT00774397|1883502|FG003|Overall Study|Protocol Violation|1
907386|NCT00774397|1883503|FG004|Overall Study|Protocol Violation|2
907387|NCT00774397|1883504|FG005|Overall Study|Protocol Violation|1
907388|NCT00774397|1883505|FG006|Overall Study|Protocol Violation|0
907389|NCT00774397|1883499|FG000|Overall Study|Lost to Follow-up|0
907390|NCT00774397|1883500|FG001|Overall Study|Lost to Follow-up|1
907391|NCT00774397|1883501|FG002|Overall Study|Lost to Follow-up|1
907392|NCT00774397|1883502|FG003|Overall Study|Lost to Follow-up|1
907393|NCT00774397|1883503|FG004|Overall Study|Lost to Follow-up|0
907394|NCT00774397|1883504|FG005|Overall Study|Lost to Follow-up|1
907395|NCT00774397|1883505|FG006|Overall Study|Lost to Follow-up|0
907396|NCT00774397|1883499|FG000|Overall Study|Refused to continue trial medication|1
907397|NCT00774397|1883500|FG001|Overall Study|Refused to continue trial medication|3
907398|NCT00774397|1883501|FG002|Overall Study|Refused to continue trial medication|2
907399|NCT00774397|1883502|FG003|Overall Study|Refused to continue trial medication|2
907400|NCT00774397|1883503|FG004|Overall Study|Refused to continue trial medication|6
907401|NCT00774397|1883504|FG005|Overall Study|Refused to continue trial medication|2
907402|NCT00774397|1883505|FG006|Overall Study|Refused to continue trial medication|3
907403|NCT00774397|1883499|FG000|Overall Study|Not treated|0
907404|NCT00774397|1883500|FG001|Overall Study|Not treated|0
907405|NCT00774397|1883501|FG002|Overall Study|Not treated|0
907406|NCT00774397|1883502|FG003|Overall Study|Not treated|0
907407|NCT00774397|1883503|FG004|Overall Study|Not treated|1
907408|NCT00774397|1883504|FG005|Overall Study|Not treated|0
907409|NCT00774397|1883505|FG006|Overall Study|Not treated|1
907410|NCT00774397|1883499|FG000|Overall Study|Other than those stated above|1
907411|NCT00774397|1883500|FG001|Overall Study|Other than those stated above|1
907412|NCT00774397|1883501|FG002|Overall Study|Other than those stated above|3
907413|NCT00774397|1883502|FG003|Overall Study|Other than those stated above|2
907414|NCT00774397|1883503|FG004|Overall Study|Other than those stated above|2
907415|NCT00774397|1883504|FG005|Overall Study|Other than those stated above|0
907416|NCT00774397|1883505|FG006|Overall Study|Other than those stated above|1
907417|NCT00774566|1883530|FG000|Overall Study|Protocol Violation|18
907418|NCT00774566|1883531|FG001|Overall Study|Protocol Violation|15
907419|NCT00774748|1883546|FG000|Overall Study|Lost to Follow-up|3
907420|NCT00774787|1883554|FG000|Overall Study|Lost to Follow-up|1
907421|NCT00774800|1883558|FG000|Intervention 4|Withdrawal by Subject|1
907422|NCT00774852|1883570|FG000|Overall Study|Adverse Event|9
907423|NCT00774852|1883571|FG001|Overall Study|Adverse Event|6
907424|NCT00774852|1883570|FG000|Overall Study|Death|2
907425|NCT00774852|1883571|FG001|Overall Study|Death|1
907426|NCT00774852|1883570|FG000|Overall Study|Lack of Efficacy|3
907427|NCT00774852|1883571|FG001|Overall Study|Lack of Efficacy|7
907428|NCT00774852|1883570|FG000|Overall Study|Lost to Follow-up|9
907429|NCT00774852|1883571|FG001|Overall Study|Lost to Follow-up|5
907430|NCT00774852|1883570|FG000|Overall Study|Physician Decision|2
907431|NCT00774852|1883571|FG001|Overall Study|Physician Decision|6
907432|NCT00774852|1883570|FG000|Overall Study|Pregnancy|1
907433|NCT00774852|1883571|FG001|Overall Study|Pregnancy|2
907434|NCT00774852|1883570|FG000|Overall Study|Withdrawal by Subject|2
907435|NCT00774852|1883571|FG001|Overall Study|Withdrawal by Subject|2
907436|NCT00774852|1883570|FG000|Overall Study|Non-responder|15
907437|NCT00774852|1883571|FG001|Overall Study|Non-responder|11
907438|NCT00774852|1883570|FG000|Overall Study|Subject non-compliance|0
907439|NCT00774852|1883571|FG001|Overall Study|Subject non-compliance|1
907440|NCT00774852|1883570|FG000|Overall Study|Protocol Violation|1
1052759|NCT01857869|2094582|FG002|Primary/Challenge Phase|Protocol Violation|0
1052760|NCT01857869|2094583|FG003|Primary/Challenge Phase|Protocol Violation|0
1052761|NCT01857869|2094584|FG004|Primary/Challenge Phase|Protocol Violation|0
1052762|NCT01857869|2094585|FG005|Primary/Challenge Phase|Protocol Violation|0
907441|NCT00774852|1883571|FG001|Overall Study|Protocol Violation|0
907442|NCT00774852|1883570|FG000|Overall Study|Subject received prohibited medication|1
907443|NCT00774852|1883571|FG001|Overall Study|Subject received prohibited medication|0
907444|NCT00774930|1883589|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11
907445|NCT00774930|1883590|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12
907446|NCT00774930|1883589|FG000|DB Phase|Adverse Event|1
907447|NCT00774930|1883590|FG001|DB Phase|Adverse Event|2
907448|NCT00774930|1883589|FG000|DB Phase|Subject Decision|1
907449|NCT00774930|1883590|FG001|DB Phase|Subject Decision|5
907450|NCT00774930|1883589|FG000|DB Phase|Sponsor Decision|0
907451|NCT00774930|1883590|FG001|DB Phase|Sponsor Decision|1
907452|NCT00774930|1883589|FG000|DB Phase|Disease Progression|1
907453|NCT00774930|1883590|FG001|DB Phase|Disease Progression|1
907454|NCT00774930|1883589|FG000|DB Phase|Started Nonprotocol Radiation therapy|0
907455|NCT00774930|1883590|FG001|DB Phase|Started Nonprotocol Radiation therapy|1
907456|NCT00774930|1883589|FG000|IOL Phase|Adverse Event|1
907457|NCT00774930|1883590|FG001|IOL Phase|Adverse Event|1
907458|NCT00774930|1883589|FG000|IOL Phase|Subject Decision|4
907459|NCT00774930|1883590|FG001|IOL Phase|Subject Decision|3
907460|NCT00774930|1883589|FG000|IOL Phase|Physician Decision|3
907461|NCT00774930|1883590|FG001|IOL Phase|Physician Decision|2
907462|NCT00774930|1883589|FG000|IOL Phase|Sponsor Decision|1
907463|NCT00774930|1883590|FG001|IOL Phase|Sponsor Decision|0
907464|NCT00774930|1883589|FG000|IOL Phase|Disease Progression|2
907465|NCT00774930|1883590|FG001|IOL Phase|Disease Progression|1
907466|NCT00774930|1883589|FG000|IOL Phase|Subject Consumed Prohibited Medication|1
907467|NCT00774930|1883590|FG001|IOL Phase|Subject Consumed Prohibited Medication|0
907468|NCT00774930|1883589|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0
907469|NCT00774930|1883590|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1
907470|NCT00774930|1883589|FG000|IOL Phase|Other|1
907471|NCT00774930|1883590|FG001|IOL Phase|Other|0
907472|NCT00774930|1883589|FG000|IOL Phase|Brain radiation|0
907473|NCT00774930|1883590|FG001|IOL Phase|Brain radiation|1
907474|NCT00774930|1883589|FG000|LTOLE Phase|Adverse Event|7
907475|NCT00774930|1883590|FG001|LTOLE Phase|Adverse Event|3
907476|NCT00774930|1883589|FG000|LTOLE Phase|Subject decision|0
907477|NCT00774930|1883590|FG001|LTOLE Phase|Subject decision|5
907478|NCT00774930|1883589|FG000|LTOLE Phase|Physician Decision|4
907479|NCT00774930|1883590|FG001|LTOLE Phase|Physician Decision|1
907480|NCT00774930|1883589|FG000|LTOLE Phase|Sponsor decision|2
907481|NCT00774930|1883590|FG001|LTOLE Phase|Sponsor decision|1
907482|NCT00774930|1883589|FG000|LTOLE Phase|Disease Progression|2
907483|NCT00774930|1883590|FG001|LTOLE Phase|Disease Progression|5
907484|NCT00774930|1883589|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
907485|NCT00774930|1883590|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
907486|NCT00774930|1883589|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
907487|NCT00774930|1883590|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
907488|NCT00774995|1883602|FG000|Overall Study|Protocol Violation|0
907489|NCT00774995|1883603|FG001|Overall Study|Protocol Violation|0
907490|NCT00774995|1883604|FG002|Overall Study|Protocol Violation|1
907491|NCT00774995|1883605|FG003|Overall Study|Protocol Violation|0
907492|NCT00775021|1883615|FG000|First Intervention|Lost to Follow-up|1
907493|NCT00775021|1883616|FG001|First Intervention|Lost to Follow-up|0
907494|NCT00775021|1883615|FG000|Second Intervention|Adverse Event|0
907495|NCT00775021|1883616|FG001|Second Intervention|Adverse Event|1
907496|NCT00775138|1883626|FG000|Overall Study|Withdrawal by Subject|0
907497|NCT00775138|1883627|FG001|Overall Study|Withdrawal by Subject|0
907498|NCT00775138|1883628|FG002|Overall Study|Withdrawal by Subject|2
907499|NCT00775138|1883629|FG003|Overall Study|Withdrawal by Subject|2
907500|NCT00775138|1883626|FG000|Overall Study|Adverse Event|0
907501|NCT00775138|1883627|FG001|Overall Study|Adverse Event|0
907502|NCT00775138|1883628|FG002|Overall Study|Adverse Event|1
907503|NCT00775138|1883629|FG003|Overall Study|Adverse Event|0
907504|NCT00775203|1883643|FG000|Overall Study|Adverse Event|25
907505|NCT00775203|1883644|FG001|Overall Study|Adverse Event|6
907506|NCT00775203|1883643|FG000|Overall Study|Lack of Efficacy|8
907507|NCT00775203|1883644|FG001|Overall Study|Lack of Efficacy|9
907508|NCT00775203|1883643|FG000|Overall Study|Withdrawal by Subject|11
907509|NCT00775203|1883644|FG001|Overall Study|Withdrawal by Subject|9
907510|NCT00775203|1883643|FG000|Overall Study|Lost to Follow-up|11
907511|NCT00775203|1883644|FG001|Overall Study|Lost to Follow-up|15
907512|NCT00775203|1883643|FG000|Overall Study|Administrative reason|2
907513|NCT00775203|1883644|FG001|Overall Study|Administrative reason|0
907514|NCT00775203|1883643|FG000|Overall Study|Noncompliance|4
907515|NCT00775203|1883644|FG001|Overall Study|Noncompliance|2
907516|NCT00775203|1883643|FG000|Overall Study|Protocol Violation|0
907517|NCT00775203|1883644|FG001|Overall Study|Protocol Violation|1
907518|NCT00775203|1883643|FG000|Overall Study|Entered other study|1
907519|NCT00775203|1883644|FG001|Overall Study|Entered other study|0
907520|NCT00775203|1883643|FG000|Overall Study|Physician Decision|0
907521|NCT00775203|1883644|FG001|Overall Study|Physician Decision|1
1052763|NCT01857869|2094586|FG006|Primary/Challenge Phase|Protocol Violation|0
907522|NCT00775268|1883661|FG000|Baseline|Drug not synthesize dose|1
907523|NCT00775268|1883662|FG001|Baseline|Drug not synthesize dose|0
907524|NCT00775268|1883661|FG000|Baseline|Not treated-ineligible per CT|0
907525|NCT00775268|1883662|FG001|Baseline|Not treated-ineligible per CT|1
907526|NCT00775268|1883661|FG000|After 2 Cycles|Participant refused to be scanned further|1
907527|NCT00775268|1883662|FG001|After 2 Cycles|Participant refused to be scanned further|0
907528|NCT00775268|1883661|FG000|After Completion|Participant missed scan appointment|1
907529|NCT00775268|1883662|FG001|After Completion|Participant missed scan appointment|0
907530|NCT00775437|1883687|FG000|Overall Study|Loss of efficacy|2
907531|NCT00775437|1883687|FG000|Overall Study|Withdrawal by Subject|3
907532|NCT00775437|1883687|FG000|Overall Study|Lost to Follow-up|1
907533|NCT00775450|1883696|FG000|Overall Study|Serious Adverse Event|2
907534|NCT00775450|1883697|FG001|Overall Study|Serious Adverse Event|0
907535|NCT00775450|1883698|FG002|Overall Study|Serious Adverse Event|0
907536|NCT00775450|1883699|FG003|Overall Study|Serious Adverse Event|0
907537|NCT00775450|1883700|FG004|Overall Study|Serious Adverse Event|0
907538|NCT00775450|1883696|FG000|Overall Study|Protocol Violation|0
907539|NCT00775450|1883697|FG001|Overall Study|Protocol Violation|0
907540|NCT00775450|1883698|FG002|Overall Study|Protocol Violation|0
907541|NCT00775450|1883699|FG003|Overall Study|Protocol Violation|0
907542|NCT00775450|1883700|FG004|Overall Study|Protocol Violation|1
907543|NCT00775450|1883696|FG000|Overall Study|Withdrawal by Subject|1
907544|NCT00775450|1883697|FG001|Overall Study|Withdrawal by Subject|0
907545|NCT00775450|1883698|FG002|Overall Study|Withdrawal by Subject|0
907546|NCT00775450|1883699|FG003|Overall Study|Withdrawal by Subject|0
907547|NCT00775450|1883700|FG004|Overall Study|Withdrawal by Subject|1
907548|NCT00775463|1883714|FG000|Overall Study|Withdrawal by Subject|0
907549|NCT00775463|1883715|FG001|Overall Study|Withdrawal by Subject|1
907550|NCT00775463|1883714|FG000|Overall Study|Adverse Event|7
907551|NCT00775463|1883715|FG001|Overall Study|Adverse Event|9
907552|NCT00775463|1883714|FG000|Overall Study|Protocol Violation|2
907553|NCT00775463|1883715|FG001|Overall Study|Protocol Violation|2
907554|NCT00775463|1883714|FG000|Overall Study|Lost to Follow-up|1
907555|NCT00775463|1883715|FG001|Overall Study|Lost to Follow-up|0
907556|NCT00775463|1883714|FG000|Overall Study|Lack of Efficacy|1
907557|NCT00775463|1883715|FG001|Overall Study|Lack of Efficacy|1
907558|NCT00775528|1883728|FG000|Overall Study|Protocol Violation|1
907559|NCT00775593|1883732|FG000|Overall Study|Unmet eligibility criteria|6
907560|NCT00775593|1883732|FG000|Overall Study|Death|1
907561|NCT00775606|1883738|FG000|Overall Study|Study sponsor terminated funding|3
907562|NCT00775606|1883739|FG001|Overall Study|Study sponsor terminated funding|0
907563|NCT00775983|1883822|FG000|Overall Study|Protocol Violation|1
907564|NCT00775983|1883823|FG001|Overall Study|Protocol Violation|2
907565|NCT00776009|1883835|FG000|Period 1: First Intervention|Withdrawal by Subject|0
907566|NCT00776009|1883836|FG001|Period 1: First Intervention|Withdrawal by Subject|0
907567|NCT00776009|1883837|FG002|Period 1: First Intervention|Withdrawal by Subject|1
907568|NCT00776009|1883838|FG003|Period 1: First Intervention|Withdrawal by Subject|0
907569|NCT00776009|1883839|FG004|Period 1: First Intervention|Withdrawal by Subject|1
907570|NCT00776009|1883840|FG005|Period 1: First Intervention|Withdrawal by Subject|0
907571|NCT00776009|1883835|FG000|Period 1: First Intervention|Protocol Violation|0
907572|NCT00776009|1883836|FG001|Period 1: First Intervention|Protocol Violation|1
907573|NCT00776009|1883837|FG002|Period 1: First Intervention|Protocol Violation|0
907574|NCT00776009|1883838|FG003|Period 1: First Intervention|Protocol Violation|0
907575|NCT00776009|1883839|FG004|Period 1: First Intervention|Protocol Violation|1
907576|NCT00776009|1883840|FG005|Period 1: First Intervention|Protocol Violation|0
907577|NCT00776009|1883835|FG000|Period 2: Second Intervention|Withdrawal by Subject|0
907578|NCT00776009|1883836|FG001|Period 2: Second Intervention|Withdrawal by Subject|0
907579|NCT00776009|1883837|FG002|Period 2: Second Intervention|Withdrawal by Subject|0
907580|NCT00776009|1883838|FG003|Period 2: Second Intervention|Withdrawal by Subject|0
907581|NCT00776009|1883839|FG004|Period 2: Second Intervention|Withdrawal by Subject|0
907582|NCT00776009|1883840|FG005|Period 2: Second Intervention|Withdrawal by Subject|1
907583|NCT00776009|1883835|FG000|Period 2: Second Intervention|Protocol Violation|1
907584|NCT00776009|1883836|FG001|Period 2: Second Intervention|Protocol Violation|0
907585|NCT00776009|1883837|FG002|Period 2: Second Intervention|Protocol Violation|1
907586|NCT00776009|1883838|FG003|Period 2: Second Intervention|Protocol Violation|0
907587|NCT00776009|1883839|FG004|Period 2: Second Intervention|Protocol Violation|0
907588|NCT00776009|1883840|FG005|Period 2: Second Intervention|Protocol Violation|0
907589|NCT00776009|1883835|FG000|Period 3: Third Intervention|Withdrawal by Subject|1
907590|NCT00776009|1883836|FG001|Period 3: Third Intervention|Withdrawal by Subject|0
907591|NCT00776009|1883837|FG002|Period 3: Third Intervention|Withdrawal by Subject|0
907592|NCT00776009|1883838|FG003|Period 3: Third Intervention|Withdrawal by Subject|0
907593|NCT00776009|1883839|FG004|Period 3: Third Intervention|Withdrawal by Subject|0
907594|NCT00776009|1883840|FG005|Period 3: Third Intervention|Withdrawal by Subject|0
907595|NCT00776230|1883851|FG000|Overall Study|Lost to Follow-up|2
907596|NCT00776230|1883852|FG001|Overall Study|Lost to Follow-up|1
907597|NCT00776230|1883853|FG002|Overall Study|Lost to Follow-up|5
907598|NCT00776230|1883851|FG000|Overall Study|Not vaccinated at Day 0|1
1052764|NCT01857869|2094587|FG007|Primary/Challenge Phase|Protocol Violation|0
1052765|NCT01857869|2094588|FG008|Primary/Challenge Phase|Protocol Violation|0
907599|NCT00776230|1883852|FG001|Overall Study|Not vaccinated at Day 0|0
907600|NCT00776230|1883853|FG002|Overall Study|Not vaccinated at Day 0|0
907601|NCT00776230|1883851|FG000|Overall Study|Withdrawal by Subject|0
907602|NCT00776230|1883852|FG001|Overall Study|Withdrawal by Subject|1
907603|NCT00776230|1883853|FG002|Overall Study|Withdrawal by Subject|0
907604|NCT00776230|1883851|FG000|Overall Study|Subject missed Visit 4|0
907605|NCT00776230|1883852|FG001|Overall Study|Subject missed Visit 4|1
907606|NCT00776230|1883853|FG002|Overall Study|Subject missed Visit 4|0
907607|NCT00776659|1883876|FG000|Overall Study|Lost to Follow-up|15
907608|NCT00776659|1883876|FG000|Overall Study|Withdrawal by Subject|10
907609|NCT00776659|1883876|FG000|Overall Study|Study Terminated by Sponsor|1
907610|NCT00776789|1883882|FG000|Overall Study|Consent refusal|2
907611|NCT00776789|1883883|FG001|Overall Study|Consent refusal|2
907612|NCT00776789|1883882|FG000|Overall Study|Poor quality video|1
907613|NCT00776789|1883883|FG001|Overall Study|Poor quality video|1
907614|NCT00776919|1883895|FG000|Overall Study|Withdrawal by Subject|16
907615|NCT00776919|1883896|FG001|Overall Study|Withdrawal by Subject|14
907616|NCT00776919|1883897|FG002|Overall Study|Withdrawal by Subject|15
907617|NCT00776919|1883898|FG003|Overall Study|Withdrawal by Subject|26
907618|NCT00776919|1883895|FG000|Overall Study|Lost to Follow-up|8
907619|NCT00776919|1883896|FG001|Overall Study|Lost to Follow-up|12
907620|NCT00776919|1883897|FG002|Overall Study|Lost to Follow-up|11
907621|NCT00776919|1883898|FG003|Overall Study|Lost to Follow-up|8
907622|NCT00776919|1883895|FG000|Overall Study|Adverse Event|1
907623|NCT00776919|1883896|FG001|Overall Study|Adverse Event|0
907624|NCT00776919|1883897|FG002|Overall Study|Adverse Event|2
907625|NCT00776919|1883898|FG003|Overall Study|Adverse Event|2
907626|NCT00776919|1883895|FG000|Overall Study|Protocol Violation|1
907627|NCT00776919|1883896|FG001|Overall Study|Protocol Violation|2
907628|NCT00776919|1883897|FG002|Overall Study|Protocol Violation|0
907629|NCT00776919|1883898|FG003|Overall Study|Protocol Violation|1
907630|NCT00776919|1883895|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1
907631|NCT00776919|1883896|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5
907632|NCT00776919|1883897|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4
907633|NCT00776919|1883898|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2
907634|NCT00776984|1883910|FG000|Overall Study|Adverse Event|8
907635|NCT00776984|1883911|FG001|Overall Study|Adverse Event|2
907636|NCT00776984|1883910|FG000|Overall Study|Protocol Violation|4
907637|NCT00776984|1883911|FG001|Overall Study|Protocol Violation|2
907638|NCT00776984|1883910|FG000|Overall Study|Lost to Follow-up|2
907639|NCT00776984|1883911|FG001|Overall Study|Lost to Follow-up|0
907640|NCT00776984|1883910|FG000|Overall Study|Withdrawal by Subject|12
907641|NCT00776984|1883911|FG001|Overall Study|Withdrawal by Subject|7
907642|NCT00776984|1883910|FG000|Overall Study|Lack of Efficacy|0
907643|NCT00776984|1883911|FG001|Overall Study|Lack of Efficacy|1
907644|NCT00776984|1883910|FG000|Overall Study|Other|5
907645|NCT00776984|1883911|FG001|Overall Study|Other|9
907646|NCT00776997|1883917|FG000|Overall Study|Adverse Event|2
907647|NCT00777023|1883924|FG000|Overall Study|Adverse Event|15
907648|NCT00777023|1883925|FG001|Overall Study|Adverse Event|21
907649|NCT00777023|1883926|FG002|Overall Study|Adverse Event|8
907650|NCT00777023|1883924|FG000|Overall Study|Lack of Efficacy|1
907651|NCT00777023|1883925|FG001|Overall Study|Lack of Efficacy|0
907652|NCT00777023|1883926|FG002|Overall Study|Lack of Efficacy|14
907653|NCT00777023|1883924|FG000|Overall Study|Protocol Violation|2
907654|NCT00777023|1883925|FG001|Overall Study|Protocol Violation|1
907655|NCT00777023|1883926|FG002|Overall Study|Protocol Violation|1
907656|NCT00777023|1883924|FG000|Overall Study|Lost to Follow-up|2
907657|NCT00777023|1883925|FG001|Overall Study|Lost to Follow-up|3
907658|NCT00777023|1883926|FG002|Overall Study|Lost to Follow-up|3
907659|NCT00777023|1883924|FG000|Overall Study|Death|0
907660|NCT00777023|1883925|FG001|Overall Study|Death|1
907661|NCT00777023|1883926|FG002|Overall Study|Death|0
907662|NCT00777023|1883924|FG000|Overall Study|Withdrawal by Subject|7
907663|NCT00777023|1883925|FG001|Overall Study|Withdrawal by Subject|7
907664|NCT00777023|1883926|FG002|Overall Study|Withdrawal by Subject|8
907665|NCT00777023|1883924|FG000|Overall Study|Missing data|1
907666|NCT00777023|1883925|FG001|Overall Study|Missing data|1
907667|NCT00777023|1883926|FG002|Overall Study|Missing data|0
907668|NCT00777023|1883924|FG000|Overall Study|Reasons not specified|4
907669|NCT00777023|1883925|FG001|Overall Study|Reasons not specified|4
907670|NCT00777023|1883926|FG002|Overall Study|Reasons not specified|2
907671|NCT00777023|1883924|FG000|Overall Study|Last dose date unknown|3
907672|NCT00777023|1883925|FG001|Overall Study|Last dose date unknown|3
907673|NCT00777023|1883926|FG002|Overall Study|Last dose date unknown|1
907674|NCT00777036|1883937|FG000|On Treatment|Reason Not Specified|4
907675|NCT00777036|1883938|FG001|On Treatment|Reason Not Specified|7
907676|NCT00777036|1883939|FG002|On Treatment|Reason Not Specified|12
907677|NCT00777036|1883937|FG000|On Treatment|Failure to Meet Study Criteria|0
907678|NCT00777036|1883938|FG001|On Treatment|Failure to Meet Study Criteria|1
907679|NCT00777036|1883939|FG002|On Treatment|Failure to Meet Study Criteria|0
907680|NCT00777036|1883937|FG000|On Treatment|Non-compliance with Study Drug|1
1052766|NCT01857869|2094589|FG009|Primary/Challenge Phase|Protocol Violation|0
1052767|NCT01857869|2094580|FG000|Primary/Challenge Phase|Other|1
1052768|NCT01857869|2094581|FG001|Primary/Challenge Phase|Other|1
1052769|NCT01857869|2094582|FG002|Primary/Challenge Phase|Other|0
1052770|NCT01857869|2094583|FG003|Primary/Challenge Phase|Other|0
1052771|NCT01857869|2094584|FG004|Primary/Challenge Phase|Other|0
1052772|NCT01857869|2094585|FG005|Primary/Challenge Phase|Other|0
1052773|NCT01857869|2094586|FG006|Primary/Challenge Phase|Other|0
1052774|NCT01857869|2094587|FG007|Primary/Challenge Phase|Other|0
1052775|NCT01857869|2094588|FG008|Primary/Challenge Phase|Other|0
1052776|NCT01857869|2094589|FG009|Primary/Challenge Phase|Other|0
1052777|NCT01857869|2094580|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0
1052778|NCT01857869|2094581|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0
1052779|NCT01857869|2094582|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0
1052780|NCT01857869|2094583|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1
1052781|NCT01857869|2094584|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0
1052782|NCT01857869|2094585|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0
1052783|NCT01857869|2094586|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0
1052784|NCT01857869|2094587|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0
1052785|NCT01857869|2094588|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0
1052786|NCT01857869|2094589|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0
1052787|NCT01857869|2094580|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1052788|NCT01857869|2094581|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1052789|NCT01857869|2094582|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1052790|NCT01857869|2094583|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
1052791|NCT01857869|2094584|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1052792|NCT01857869|2094585|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1052793|NCT01857869|2094586|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1052794|NCT01857869|2094587|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1052795|NCT01857869|2094588|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1052796|NCT01857869|2094589|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1052797|NCT01857973|2094621|FG000|Overall Study|Subject did not meet required BG range|3
1052798|NCT01857973|2094621|FG000|Overall Study|drop out after 3 failed attempts|1
1052799|NCT01857973|2094621|FG000|Overall Study|Physician Decision|1
907681|NCT00777036|1883938|FG001|On Treatment|Non-compliance with Study Drug|0
907682|NCT00777036|1883939|FG002|On Treatment|Non-compliance with Study Drug|0
907683|NCT00777036|1883937|FG000|On Treatment|Maximum Clinical Benefit|2
907684|NCT00777036|1883938|FG001|On Treatment|Maximum Clinical Benefit|0
907685|NCT00777036|1883939|FG002|On Treatment|Maximum Clinical Benefit|1
907686|NCT00777036|1883937|FG000|On Treatment|Withdrawal by Subject|3
907687|NCT00777036|1883938|FG001|On Treatment|Withdrawal by Subject|2
907688|NCT00777036|1883939|FG002|On Treatment|Withdrawal by Subject|3
907689|NCT00777036|1883937|FG000|On Treatment|Death|0
907690|NCT00777036|1883938|FG001|On Treatment|Death|2
907691|NCT00777036|1883939|FG002|On Treatment|Death|0
907692|NCT00777036|1883937|FG000|On Treatment|Study Drug Toxicity|0
907693|NCT00777036|1883938|FG001|On Treatment|Study Drug Toxicity|0
907694|NCT00777036|1883939|FG002|On Treatment|Study Drug Toxicity|1
907695|NCT00777036|1883937|FG000|On Treatment|Progressive Disease|5
907696|NCT00777036|1883938|FG001|On Treatment|Progressive Disease|4
907697|NCT00777036|1883939|FG002|On Treatment|Progressive Disease|6
907698|NCT00777036|1883937|FG000|Follow-Up|Lost to Follow-up|1
907699|NCT00777036|1883938|FG001|Follow-Up|Lost to Follow-up|0
907700|NCT00777036|1883939|FG002|Follow-Up|Lost to Follow-up|0
907701|NCT00777036|1883937|FG000|Follow-Up|Reason Not Specified|2
907702|NCT00777036|1883938|FG001|Follow-Up|Reason Not Specified|0
907703|NCT00777036|1883939|FG002|Follow-Up|Reason Not Specified|0
907704|NCT00777036|1883937|FG000|Follow-Up|Withdrawal by Subject|1
907705|NCT00777036|1883938|FG001|Follow-Up|Withdrawal by Subject|0
907706|NCT00777036|1883939|FG002|Follow-Up|Withdrawal by Subject|4
907707|NCT00777036|1883937|FG000|Follow-Up|Death|1
907708|NCT00777036|1883938|FG001|Follow-Up|Death|8
907709|NCT00777036|1883939|FG002|Follow-Up|Death|0
907710|NCT00777049|1883956|FG000|Overall Study|Withdrawal by Subject|1
907711|NCT00777049|1883957|FG001|Overall Study|Withdrawal by Subject|0
907712|NCT00777049|1883956|FG000|Overall Study|No treatment (elevated liver enzymes)|0
907713|NCT00777049|1883957|FG001|Overall Study|No treatment (elevated liver enzymes)|1
907714|NCT00777088|1883972|FG000|Overall Study|PED Treatment not attempted|1
907715|NCT00777101|1883979|FG000|Overall Study|Death|48
907716|NCT00777101|1883980|FG001|Overall Study|Death|43
907717|NCT00777101|1883979|FG000|Overall Study|Withdrawal by Subject|11
907718|NCT00777101|1883980|FG001|Overall Study|Withdrawal by Subject|6
907719|NCT00777101|1883979|FG000|Overall Study|Lost to Follow-up|2
907720|NCT00777101|1883980|FG001|Overall Study|Lost to Follow-up|1
907721|NCT00777101|1883979|FG000|Overall Study|Discontinuation of Study by Sponsor|1
907722|NCT00777101|1883980|FG001|Overall Study|Discontinuation of Study by Sponsor|0
907723|NCT00777101|1883979|FG000|Overall Study|Failed to Return|0
907724|NCT00777101|1883980|FG001|Overall Study|Failed to Return|1
907725|NCT00777153|1883990|FG000|Overall Study|Lost to Follow-up|1
907726|NCT00777153|1883991|FG001|Overall Study|Lost to Follow-up|1
907727|NCT00777153|1883992|FG002|Overall Study|Lost to Follow-up|0
1052800|NCT01858194|2094636|FG000|Overall Study|Total Artificial Heart Implant|0
1052801|NCT01858194|2094637|FG001|Overall Study|Total Artificial Heart Implant|1
1052802|NCT01858194|2094636|FG000|Overall Study|Lost to Follow-up|0
1052803|NCT01858194|2094637|FG001|Overall Study|Lost to Follow-up|1
1052804|NCT01858363|2094647|FG000|Overall Study|Death|35
1052805|NCT01858363|2094648|FG001|Overall Study|Death|9
1052806|NCT01858363|2094647|FG000|Overall Study|Withdrawal by Subject|28
1052807|NCT01858363|2094648|FG001|Overall Study|Withdrawal by Subject|14
1052808|NCT01858363|2094647|FG000|Overall Study|Lost to Follow-up|13
1052809|NCT01858363|2094648|FG001|Overall Study|Lost to Follow-up|3
1052810|NCT01858376|2094654|FG000|Overall Study|Dropped d/t lab work not fitting criter|4
1052811|NCT01858389|2094660|FG000|Overall Study|Death|1
1052812|NCT01858389|2094661|FG001|Overall Study|Death|3
1052813|NCT01858389|2094660|FG000|Overall Study|Study terminated by sponsor|0
1052814|NCT01858389|2094661|FG001|Overall Study|Study terminated by sponsor|2
1052815|NCT01858389|2094660|FG000|Overall Study|Withdrawal by Subject|0
1052816|NCT01858389|2094661|FG001|Overall Study|Withdrawal by Subject|1
1052817|NCT01858389|2094660|FG000|Overall Study|Progressive disease|10
1052818|NCT01858389|2094661|FG001|Overall Study|Progressive disease|11
1052819|NCT01858389|2094660|FG000|Overall Study|Other|2
907728|NCT00777153|1883990|FG000|Overall Study|Death|85
907729|NCT00777153|1883991|FG001|Overall Study|Death|73
907730|NCT00777153|1883992|FG002|Overall Study|Death|33
907731|NCT00777153|1883990|FG000|Overall Study|Withdrawal by Subject|3
907732|NCT00777153|1883991|FG001|Overall Study|Withdrawal by Subject|4
907733|NCT00777153|1883992|FG002|Overall Study|Withdrawal by Subject|3
907734|NCT00777153|1883990|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1
907735|NCT00777153|1883991|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5
907736|NCT00777153|1883992|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1
907737|NCT00777205|1884015|FG000|Overall Study|Lost to Follow-up|25
907738|NCT00777205|1884016|FG001|Overall Study|Lost to Follow-up|9
907739|NCT00777205|1884015|FG000|Overall Study|Withdrawal by Subject|6
907740|NCT00777205|1884016|FG001|Overall Study|Withdrawal by Subject|4
907741|NCT00777205|1884015|FG000|Overall Study|Death|0
907742|NCT00777205|1884016|FG001|Overall Study|Death|2
907743|NCT00777205|1884015|FG000|Overall Study|Protocol Violation|0
907744|NCT00777205|1884016|FG001|Overall Study|Protocol Violation|56
907745|NCT00777257|1884027|FG000|Overall Study|Adverse Event|3
907746|NCT00777257|1884028|FG001|Overall Study|Adverse Event|1
907747|NCT00777257|1884029|FG002|Overall Study|Adverse Event|0
907748|NCT00777257|1884027|FG000|Overall Study|Lost to Follow-up|3
907749|NCT00777257|1884028|FG001|Overall Study|Lost to Follow-up|3
907750|NCT00777257|1884029|FG002|Overall Study|Lost to Follow-up|2
907751|NCT00777257|1884027|FG000|Overall Study|Protocol Violation|2
907752|NCT00777257|1884028|FG001|Overall Study|Protocol Violation|2
907753|NCT00777257|1884029|FG002|Overall Study|Protocol Violation|2
907754|NCT00777257|1884027|FG000|Overall Study|Withdrawal by Subject|3
907755|NCT00777257|1884028|FG001|Overall Study|Withdrawal by Subject|6
907756|NCT00777257|1884029|FG002|Overall Study|Withdrawal by Subject|5
907757|NCT00777296|1884041|FG000|Overall Study|Adverse Event|0
907758|NCT00777296|1884042|FG001|Overall Study|Adverse Event|1
907759|NCT00777296|1884043|FG002|Overall Study|Adverse Event|0
907760|NCT00777296|1884044|FG003|Overall Study|Adverse Event|1
907761|NCT00777296|1884041|FG000|Overall Study|Withdrawal by Subject|1
907762|NCT00777296|1884042|FG001|Overall Study|Withdrawal by Subject|0
907763|NCT00777296|1884043|FG002|Overall Study|Withdrawal by Subject|0
907764|NCT00777296|1884044|FG003|Overall Study|Withdrawal by Subject|0
907765|NCT00777296|1884041|FG000|Overall Study|CRF form not completed|0
907766|NCT00777296|1884042|FG001|Overall Study|CRF form not completed|0
907767|NCT00777296|1884043|FG002|Overall Study|CRF form not completed|2
907768|NCT00777296|1884044|FG003|Overall Study|CRF form not completed|0
907769|NCT00777491|1884077|FG000|Overall Study|Protocol Violation|0
907770|NCT00777491|1884078|FG001|Overall Study|Protocol Violation|2
907771|NCT00777491|1884077|FG000|Overall Study|Did not receive any protocol treatment|2
907772|NCT00777491|1884078|FG001|Overall Study|Did not receive any protocol treatment|0
907773|NCT00777556|1884084|FG000|Overall Study|Inappropriate self-selection|34
907774|NCT00777556|1884084|FG000|Overall Study|Dispensed but did not use product|12
907775|NCT00777556|1884084|FG000|Overall Study|Did not complete all 3 follow-up visits|20
907776|NCT00777608|1884090|FG000|Overall Study|Lost to Follow-up|1
907777|NCT00777608|1884091|FG001|Overall Study|Lost to Follow-up|1
907778|NCT00777608|1884090|FG000|Overall Study|Withdrawal by Subject|1
907779|NCT00777608|1884091|FG001|Overall Study|Withdrawal by Subject|3
907780|NCT00777608|1884090|FG000|Overall Study|Protocol Violation|1
907781|NCT00777608|1884091|FG001|Overall Study|Protocol Violation|0
907782|NCT00777608|1884090|FG000|Overall Study|Investigator Decision|1
907783|NCT00777608|1884091|FG001|Overall Study|Investigator Decision|2
907784|NCT00777803|1884132|FG000|Overall Study|Lost to Follow-up|12
907785|NCT00777803|1884133|FG001|Overall Study|Lost to Follow-up|5
907786|NCT00777803|1884132|FG000|Overall Study|Adverse Event|1
907787|NCT00777803|1884133|FG001|Overall Study|Adverse Event|0
907788|NCT00777803|1884132|FG000|Overall Study|Non-compliance|2
907789|NCT00777803|1884133|FG001|Overall Study|Non-compliance|2
907790|NCT00777829|1884139|FG000|Overall Study|Withdrawal by Subject|0
907791|NCT00777829|1884140|FG001|Overall Study|Withdrawal by Subject|2
1052820|NCT01858389|2094661|FG001|Overall Study|Other|4
1052821|NCT01858389|2094660|FG000|Overall Study|Adverse Event|3
1052822|NCT01858389|2094661|FG001|Overall Study|Adverse Event|1
1052823|NCT01858389|2094660|FG000|Overall Study|Did not receive treatment|0
1052824|NCT01858389|2094661|FG001|Overall Study|Did not receive treatment|3
1052825|NCT01858532|2094682|FG000|Overall Study|Adverse Event|58
1052826|NCT01858532|2094683|FG001|Overall Study|Adverse Event|50
1052827|NCT01858532|2094684|FG002|Overall Study|Adverse Event|23
1052828|NCT01858532|2094685|FG003|Overall Study|Adverse Event|28
1052829|NCT01858532|2094682|FG000|Overall Study|Withdrew consent|71
1052830|NCT01858532|2094683|FG001|Overall Study|Withdrew consent|93
1052831|NCT01858532|2094684|FG002|Overall Study|Withdrew consent|46
1052832|NCT01858532|2094685|FG003|Overall Study|Withdrew consent|27
1052833|NCT01858532|2094682|FG000|Overall Study|Lost to Follow-up|17
1052834|NCT01858532|2094683|FG001|Overall Study|Lost to Follow-up|26
1052835|NCT01858532|2094684|FG002|Overall Study|Lost to Follow-up|11
1052836|NCT01858532|2094685|FG003|Overall Study|Lost to Follow-up|14
1052837|NCT01858532|2094682|FG000|Overall Study|Deterioration of medical status|3
1052838|NCT01858532|2094683|FG001|Overall Study|Deterioration of medical status|4
1052839|NCT01858532|2094684|FG002|Overall Study|Deterioration of medical status|3
1052840|NCT01858532|2094685|FG003|Overall Study|Deterioration of medical status|7
1052841|NCT01858532|2094682|FG000|Overall Study|Investigator request|3
1052842|NCT01858532|2094683|FG001|Overall Study|Investigator request|4
1052843|NCT01858532|2094684|FG002|Overall Study|Investigator request|2
1052844|NCT01858532|2094685|FG003|Overall Study|Investigator request|6
1052845|NCT01858532|2094682|FG000|Overall Study|Other, not specified|29
1052846|NCT01858532|2094683|FG001|Overall Study|Other, not specified|15
1052847|NCT01858532|2094684|FG002|Overall Study|Other, not specified|13
1052848|NCT01858532|2094685|FG003|Overall Study|Other, not specified|11
1052849|NCT01858558|2094706|FG000|Overall Study|Death|1
1052850|NCT01858558|2094707|FG001|Overall Study|Death|1
1052851|NCT01858558|2094706|FG000|Overall Study|Lost to Follow-up|1
1052852|NCT01858558|2094707|FG001|Overall Study|Lost to Follow-up|0
1052853|NCT01858558|2094706|FG000|Overall Study|Disease progression|3
1052854|NCT01858558|2094707|FG001|Overall Study|Disease progression|1
1052855|NCT01858558|2094706|FG000|Overall Study|Product contamination|2
1052856|NCT01858558|2094707|FG001|Overall Study|Product contamination|0
1052857|NCT01858558|2094706|FG000|Overall Study|Failed expansion of cell product|2
1052858|NCT01858558|2094707|FG001|Overall Study|Failed expansion of cell product|0
1052859|NCT01858636|2094713|FG000|Overall Study|No Device Deployment Attempted|24
1052860|NCT01858636|2094713|FG000|Overall Study|Physician Decision|1
1052861|NCT01858636|2094713|FG000|Overall Study|Death|1
1052862|NCT01858636|2094713|FG000|Overall Study|Lost to Follow-up|1
1052863|NCT01858636|2094713|FG000|Overall Study|Withdrawal by Subject|1
1052864|NCT01858701|2094718|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
1052865|NCT01858701|2094719|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
1052866|NCT01858701|2094718|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
1052867|NCT01858701|2094719|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
1052868|NCT01858701|2094718|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1
1052869|NCT01858701|2094719|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2
1052870|NCT01858701|2094718|FG000|Period 2, Second 30 Days of Wear|Comfort|0
1052871|NCT01858701|2094719|FG001|Period 2, Second 30 Days of Wear|Comfort|1
1052872|NCT01858766|2094753|FG000|Overall Study|Randomized but Never Treated|0
1052873|NCT01858766|2094754|FG001|Overall Study|Randomized but Never Treated|0
1052874|NCT01858766|2094755|FG002|Overall Study|Randomized but Never Treated|0
1052875|NCT01858766|2094756|FG003|Overall Study|Randomized but Never Treated|0
1052876|NCT01858766|2094757|FG004|Overall Study|Randomized but Never Treated|0
1052877|NCT01858766|2094758|FG005|Overall Study|Randomized but Never Treated|1
1052878|NCT01858766|2094759|FG006|Overall Study|Randomized but Never Treated|0
1052879|NCT01858766|2094760|FG007|Overall Study|Randomized but Never Treated|0
1052880|NCT01858766|2094761|FG008|Overall Study|Randomized but Never Treated|0
1052881|NCT01858766|2094762|FG009|Overall Study|Randomized but Never Treated|0
1052882|NCT01858766|2094763|FG010|Overall Study|Randomized but Never Treated|0
1052883|NCT01858766|2094764|FG011|Overall Study|Randomized but Never Treated|0
1052884|NCT01858766|2094765|FG012|Overall Study|Randomized but Never Treated|0
1052885|NCT01858766|2094766|FG013|Overall Study|Randomized but Never Treated|0
1052886|NCT01858766|2094767|FG014|Overall Study|Randomized but Never Treated|0
1052887|NCT01858766|2094768|FG015|Overall Study|Randomized but Never Treated|0
1052888|NCT01858766|2094769|FG016|Overall Study|Randomized but Never Treated|0
1052889|NCT01858766|2094770|FG017|Overall Study|Randomized but Never Treated|1
1052890|NCT01858766|2094771|FG018|Overall Study|Randomized but Never Treated|0
1052891|NCT01858766|2094753|FG000|Overall Study|Death|0
1052892|NCT01858766|2094754|FG001|Overall Study|Death|0
1052893|NCT01858766|2094755|FG002|Overall Study|Death|1
1052894|NCT01858766|2094756|FG003|Overall Study|Death|0
1052895|NCT01858766|2094757|FG004|Overall Study|Death|0
1052896|NCT01858766|2094758|FG005|Overall Study|Death|0
1052897|NCT01858766|2094759|FG006|Overall Study|Death|0
1052898|NCT01858766|2094760|FG007|Overall Study|Death|0
1052899|NCT01858766|2094761|FG008|Overall Study|Death|0
1052900|NCT01858766|2094762|FG009|Overall Study|Death|0
1052901|NCT01858766|2094763|FG010|Overall Study|Death|0
1052902|NCT01858766|2094764|FG011|Overall Study|Death|0
1052903|NCT01858766|2094765|FG012|Overall Study|Death|0
1052904|NCT01858766|2094766|FG013|Overall Study|Death|0
1052905|NCT01858766|2094767|FG014|Overall Study|Death|0
1052906|NCT01858766|2094768|FG015|Overall Study|Death|0
1052907|NCT01858766|2094769|FG016|Overall Study|Death|0
1052908|NCT01858766|2094770|FG017|Overall Study|Death|0
1052909|NCT01858766|2094771|FG018|Overall Study|Death|0
1052910|NCT01858766|2094753|FG000|Overall Study|Lack of Efficacy|1
1052911|NCT01858766|2094754|FG001|Overall Study|Lack of Efficacy|0
1052912|NCT01858766|2094755|FG002|Overall Study|Lack of Efficacy|0
1052913|NCT01858766|2094756|FG003|Overall Study|Lack of Efficacy|0
1052914|NCT01858766|2094757|FG004|Overall Study|Lack of Efficacy|1
1052915|NCT01858766|2094758|FG005|Overall Study|Lack of Efficacy|2
907792|NCT00777920|1884154|FG000|Overall Study|Adverse Event|39
907793|NCT00777920|1884154|FG000|Overall Study|Withdrawal of Consent|4
907794|NCT00777920|1884154|FG000|Overall Study|Lost to Follow-up|1
907795|NCT00777920|1884154|FG000|Overall Study|Investigator's discretion|1
907796|NCT00777920|1884154|FG000|Overall Study|Clinical status did not improve|1
907797|NCT00777920|1884154|FG000|Overall Study|Other, not specified|4
907798|NCT00777946|1884161|FG000|Overall Study|Adverse Event|11
907799|NCT00777946|1884162|FG001|Overall Study|Adverse Event|1
907800|NCT00777946|1884163|FG002|Overall Study|Adverse Event|3
907801|NCT00777946|1884161|FG000|Overall Study|Lack of Efficacy|0
907802|NCT00777946|1884162|FG001|Overall Study|Lack of Efficacy|0
907803|NCT00777946|1884163|FG002|Overall Study|Lack of Efficacy|9
907804|NCT00777946|1884161|FG000|Overall Study|Condition no longer required study drug|1
907805|NCT00777946|1884162|FG001|Overall Study|Condition no longer required study drug|0
907806|NCT00777946|1884163|FG002|Overall Study|Condition no longer required study drug|0
907807|NCT00777946|1884161|FG000|Overall Study|Patient withdrew consent|3
907808|NCT00777946|1884162|FG001|Overall Study|Patient withdrew consent|2
907809|NCT00777946|1884163|FG002|Overall Study|Patient withdrew consent|3
907810|NCT00777946|1884161|FG000|Overall Study|Lost to Follow-up|3
907811|NCT00777946|1884162|FG001|Overall Study|Lost to Follow-up|1
907812|NCT00777946|1884163|FG002|Overall Study|Lost to Follow-up|0
907813|NCT00777946|1884161|FG000|Overall Study|Protocol deviation|2
907814|NCT00777946|1884162|FG001|Overall Study|Protocol deviation|1
907815|NCT00777946|1884163|FG002|Overall Study|Protocol deviation|1
907816|NCT00777946|1884161|FG000|Overall Study|Randomized in error|1
907817|NCT00777946|1884162|FG001|Overall Study|Randomized in error|1
907818|NCT00777946|1884163|FG002|Overall Study|Randomized in error|0
907819|NCT00778102|1884173|FG000|Overall Study|Adverse Event|8
907820|NCT00778102|1884174|FG001|Overall Study|Adverse Event|5
907821|NCT00778102|1884173|FG000|Overall Study|Death|1
907822|NCT00778102|1884174|FG001|Overall Study|Death|1
907823|NCT00778102|1884173|FG000|Overall Study|Lost to Follow-up|1
907824|NCT00778102|1884174|FG001|Overall Study|Lost to Follow-up|0
907825|NCT00778102|1884173|FG000|Overall Study|Violation of Selection Criteria|1
907826|NCT00778102|1884174|FG001|Overall Study|Violation of Selection Criteria|1
907827|NCT00778102|1884173|FG000|Overall Study|Protocol Violation|0
907828|NCT00778102|1884174|FG001|Overall Study|Protocol Violation|1
907829|NCT00778102|1884173|FG000|Overall Study|Refused Treatment|2
907830|NCT00778102|1884174|FG001|Overall Study|Refused Treatment|3
907831|NCT00778102|1884173|FG000|Overall Study|Withdrawal by Subject|1
907832|NCT00778102|1884174|FG001|Overall Study|Withdrawal by Subject|1
907833|NCT00778102|1884173|FG000|Overall Study|Administrative Reason|7
907834|NCT00778102|1884174|FG001|Overall Study|Administrative Reason|10
907835|NCT00778258|1884202|FG000|Overall Study|Adverse Event|1
907836|NCT00778258|1884203|FG001|Overall Study|Adverse Event|0
907837|NCT00778258|1884204|FG002|Overall Study|Adverse Event|0
907838|NCT00778258|1884205|FG003|Overall Study|Adverse Event|0
907839|NCT00778258|1884206|FG004|Overall Study|Adverse Event|0
907840|NCT00778258|1884207|FG005|Overall Study|Adverse Event|1
907841|NCT00778258|1884208|FG006|Overall Study|Adverse Event|0
907842|NCT00778258|1884209|FG007|Overall Study|Adverse Event|0
907843|NCT00778258|1884210|FG008|Overall Study|Adverse Event|0
907844|NCT00778258|1884202|FG000|Overall Study|Lost to Follow-up|0
907845|NCT00778258|1884203|FG001|Overall Study|Lost to Follow-up|0
907846|NCT00778258|1884204|FG002|Overall Study|Lost to Follow-up|2
907847|NCT00778258|1884205|FG003|Overall Study|Lost to Follow-up|0
907848|NCT00778258|1884206|FG004|Overall Study|Lost to Follow-up|0
907849|NCT00778258|1884207|FG005|Overall Study|Lost to Follow-up|3
907850|NCT00778258|1884208|FG006|Overall Study|Lost to Follow-up|2
907851|NCT00778258|1884209|FG007|Overall Study|Lost to Follow-up|2
907852|NCT00778258|1884210|FG008|Overall Study|Lost to Follow-up|0
907853|NCT00778258|1884202|FG000|Overall Study|Withdrawal by Subject|6
907854|NCT00778258|1884203|FG001|Overall Study|Withdrawal by Subject|2
907855|NCT00778258|1884204|FG002|Overall Study|Withdrawal by Subject|8
907856|NCT00778258|1884205|FG003|Overall Study|Withdrawal by Subject|2
907857|NCT00778258|1884206|FG004|Overall Study|Withdrawal by Subject|0
907858|NCT00778258|1884207|FG005|Overall Study|Withdrawal by Subject|6
907859|NCT00778258|1884208|FG006|Overall Study|Withdrawal by Subject|12
907860|NCT00778258|1884209|FG007|Overall Study|Withdrawal by Subject|12
907861|NCT00778258|1884210|FG008|Overall Study|Withdrawal by Subject|4
1052916|NCT01858766|2094759|FG006|Overall Study|Lack of Efficacy|0
1052917|NCT01858766|2094760|FG007|Overall Study|Lack of Efficacy|0
1052918|NCT01858766|2094761|FG008|Overall Study|Lack of Efficacy|0
1052919|NCT01858766|2094762|FG009|Overall Study|Lack of Efficacy|0
1052920|NCT01858766|2094763|FG010|Overall Study|Lack of Efficacy|0
1052921|NCT01858766|2094764|FG011|Overall Study|Lack of Efficacy|3
1052922|NCT01858766|2094765|FG012|Overall Study|Lack of Efficacy|5
1052923|NCT01858766|2094766|FG013|Overall Study|Lack of Efficacy|3
1052924|NCT01858766|2094767|FG014|Overall Study|Lack of Efficacy|5
1052925|NCT01858766|2094768|FG015|Overall Study|Lack of Efficacy|5
1052926|NCT01858766|2094769|FG016|Overall Study|Lack of Efficacy|2
1052927|NCT01858766|2094770|FG017|Overall Study|Lack of Efficacy|3
1052928|NCT01858766|2094771|FG018|Overall Study|Lack of Efficacy|3
1052929|NCT01858766|2094753|FG000|Overall Study|Lost to Follow-up|0
1052930|NCT01858766|2094754|FG001|Overall Study|Lost to Follow-up|0
1052931|NCT01858766|2094755|FG002|Overall Study|Lost to Follow-up|0
1052932|NCT01858766|2094756|FG003|Overall Study|Lost to Follow-up|0
1052933|NCT01858766|2094757|FG004|Overall Study|Lost to Follow-up|0
1052934|NCT01858766|2094758|FG005|Overall Study|Lost to Follow-up|1
1052935|NCT01858766|2094759|FG006|Overall Study|Lost to Follow-up|0
1052936|NCT01858766|2094760|FG007|Overall Study|Lost to Follow-up|2
1052937|NCT01858766|2094761|FG008|Overall Study|Lost to Follow-up|0
1052938|NCT01858766|2094762|FG009|Overall Study|Lost to Follow-up|0
1052939|NCT01858766|2094763|FG010|Overall Study|Lost to Follow-up|0
1052940|NCT01858766|2094764|FG011|Overall Study|Lost to Follow-up|1
1052941|NCT01858766|2094765|FG012|Overall Study|Lost to Follow-up|0
1052942|NCT01858766|2094766|FG013|Overall Study|Lost to Follow-up|0
1052943|NCT01858766|2094767|FG014|Overall Study|Lost to Follow-up|3
1052944|NCT01858766|2094768|FG015|Overall Study|Lost to Follow-up|1
1052945|NCT01858766|2094769|FG016|Overall Study|Lost to Follow-up|1
1052946|NCT01858766|2094770|FG017|Overall Study|Lost to Follow-up|0
1052947|NCT01858766|2094771|FG018|Overall Study|Lost to Follow-up|1
1052948|NCT01858766|2094753|FG000|Overall Study|Withdrew Consent|0
1052949|NCT01858766|2094754|FG001|Overall Study|Withdrew Consent|0
1052950|NCT01858766|2094755|FG002|Overall Study|Withdrew Consent|0
1052951|NCT01858766|2094756|FG003|Overall Study|Withdrew Consent|0
1052952|NCT01858766|2094757|FG004|Overall Study|Withdrew Consent|0
1052953|NCT01858766|2094758|FG005|Overall Study|Withdrew Consent|0
1052954|NCT01858766|2094759|FG006|Overall Study|Withdrew Consent|0
907862|NCT00778258|1884202|FG000|Overall Study|New Contraindication|0
907863|NCT00778258|1884203|FG001|Overall Study|New Contraindication|0
907864|NCT00778258|1884204|FG002|Overall Study|New Contraindication|0
907865|NCT00778258|1884205|FG003|Overall Study|New Contraindication|0
907866|NCT00778258|1884206|FG004|Overall Study|New Contraindication|0
907867|NCT00778258|1884207|FG005|Overall Study|New Contraindication|0
907868|NCT00778258|1884208|FG006|Overall Study|New Contraindication|0
907869|NCT00778258|1884209|FG007|Overall Study|New Contraindication|1
907870|NCT00778258|1884210|FG008|Overall Study|New Contraindication|0
907871|NCT00778258|1884202|FG000|Overall Study|Non-compliance|0
907872|NCT00778258|1884203|FG001|Overall Study|Non-compliance|0
907873|NCT00778258|1884204|FG002|Overall Study|Non-compliance|0
907874|NCT00778258|1884205|FG003|Overall Study|Non-compliance|1
907875|NCT00778258|1884206|FG004|Overall Study|Non-compliance|0
907876|NCT00778258|1884207|FG005|Overall Study|Non-compliance|0
907877|NCT00778258|1884208|FG006|Overall Study|Non-compliance|0
907878|NCT00778258|1884209|FG007|Overall Study|Non-compliance|0
907879|NCT00778258|1884210|FG008|Overall Study|Non-compliance|0
907880|NCT00778258|1884202|FG000|Overall Study|Other|0
907881|NCT00778258|1884203|FG001|Overall Study|Other|0
907882|NCT00778258|1884204|FG002|Overall Study|Other|0
907883|NCT00778258|1884205|FG003|Overall Study|Other|0
907884|NCT00778258|1884206|FG004|Overall Study|Other|0
907885|NCT00778258|1884207|FG005|Overall Study|Other|0
907886|NCT00778258|1884208|FG006|Overall Study|Other|1
907887|NCT00778258|1884209|FG007|Overall Study|Other|0
907888|NCT00778258|1884210|FG008|Overall Study|Other|0
907889|NCT00778336|1884251|FG000|Index Procedure-Discharge|Death|6
907890|NCT00778336|1884252|FG001|Index Procedure-Discharge|Death|3
907891|NCT00778336|1884253|FG002|Index Procedure-Discharge|Death|2
907892|NCT00778336|1884254|FG003|Index Procedure-Discharge|Death|0
907893|NCT00778336|1884251|FG000|3 Month Follow Up|Lost to Follow-up|15
907894|NCT00778336|1884252|FG001|3 Month Follow Up|Lost to Follow-up|20
907895|NCT00778336|1884253|FG002|3 Month Follow Up|Lost to Follow-up|3
907896|NCT00778336|1884254|FG003|3 Month Follow Up|Lost to Follow-up|0
907897|NCT00778336|1884251|FG000|3 Month Follow Up|Death|8
907898|NCT00778336|1884252|FG001|3 Month Follow Up|Death|3
907899|NCT00778336|1884253|FG002|3 Month Follow Up|Death|2
907900|NCT00778336|1884254|FG003|3 Month Follow Up|Death|0
907901|NCT00778375|1884264|FG000|Overall Study|Ineligible|3
907902|NCT00778622|1884273|FG000|Overall Study|Adverse Event|5
907903|NCT00778622|1884274|FG001|Overall Study|Adverse Event|4
907904|NCT00778622|1884275|FG002|Overall Study|Adverse Event|7
907905|NCT00778622|1884273|FG000|Overall Study|Withdrawal by Subject|4
907906|NCT00778622|1884274|FG001|Overall Study|Withdrawal by Subject|5
907907|NCT00778622|1884275|FG002|Overall Study|Withdrawal by Subject|5
907908|NCT00778622|1884273|FG000|Overall Study|Lost to Follow-up|3
907909|NCT00778622|1884274|FG001|Overall Study|Lost to Follow-up|3
1052955|NCT01858766|2094760|FG007|Overall Study|Withdrew Consent|0
1052956|NCT01858766|2094761|FG008|Overall Study|Withdrew Consent|0
1052957|NCT01858766|2094762|FG009|Overall Study|Withdrew Consent|0
1052958|NCT01858766|2094763|FG010|Overall Study|Withdrew Consent|0
1052959|NCT01858766|2094764|FG011|Overall Study|Withdrew Consent|1
1052960|NCT01858766|2094765|FG012|Overall Study|Withdrew Consent|0
1052961|NCT01858766|2094766|FG013|Overall Study|Withdrew Consent|0
1052962|NCT01858766|2094767|FG014|Overall Study|Withdrew Consent|0
1052963|NCT01858766|2094768|FG015|Overall Study|Withdrew Consent|0
1052964|NCT01858766|2094769|FG016|Overall Study|Withdrew Consent|0
1052965|NCT01858766|2094770|FG017|Overall Study|Withdrew Consent|0
1052966|NCT01858766|2094771|FG018|Overall Study|Withdrew Consent|0
1052967|NCT01859143|2094821|FG000|Overall Study|Lost to Follow-up|2
1052968|NCT01859143|2094822|FG001|Overall Study|Lost to Follow-up|0
1052969|NCT01859390|2094891|FG000|Overall Study|Insufficient Sputum Collected|1
1052970|NCT01859390|2094892|FG001|Overall Study|Insufficient Sputum Collected|3
1052971|NCT01859390|2094891|FG000|Overall Study|Sample Missing Collection Date|0
1052972|NCT01859390|2094892|FG001|Overall Study|Sample Missing Collection Date|1
1052973|NCT01859390|2094891|FG000|Overall Study|Tube Cracked|0
1052974|NCT01859390|2094892|FG001|Overall Study|Tube Cracked|2
1052975|NCT01859390|2094891|FG000|Overall Study|Shipment Error|0
1052976|NCT01859390|2094892|FG001|Overall Study|Shipment Error|1
1052977|NCT01859403|2094900|FG000|Primary Endpoint Measure|Lost to Follow-up|0
1052978|NCT01859403|2094901|FG001|Primary Endpoint Measure|Lost to Follow-up|2
1052979|NCT01859403|2094900|FG000|Primary Endpoint Measure|Withdrawal by Subject|1
1052980|NCT01859403|2094901|FG001|Primary Endpoint Measure|Withdrawal by Subject|1
1052981|NCT01859403|2094900|FG000|Primary Endpoint Measure|Physician Decision|0
1052982|NCT01859403|2094901|FG001|Primary Endpoint Measure|Physician Decision|1
1052983|NCT01859403|2094900|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6
1052984|NCT01859403|2094901|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8
1052985|NCT01859494|2094907|FG000|Overall Study|Adverse Event|1
1052986|NCT01859507|2094911|FG000|Overall Study|left the country|4
1052987|NCT01859598|2094916|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742
1052988|NCT01859702|2094930|FG000|Overall Study|Protocol deviation|3
1052989|NCT01859702|2094930|FG000|Overall Study|Adverse Event|2
1052990|NCT01859715|2094937|FG000|Overall Study|No 2nd VAS|16
1052991|NCT01859715|2094938|FG001|Overall Study|No 2nd VAS|8
1052992|NCT01859715|2094939|FG002|Overall Study|No 2nd VAS|23
1052993|NCT01859741|2094957|FG000|Overall Study|Death|3
1052994|NCT01859741|2094958|FG001|Overall Study|Death|2
1052995|NCT01859741|2094959|FG002|Overall Study|Death|4
1052996|NCT01859741|2094960|FG003|Overall Study|Death|3
1052997|NCT01859741|2094961|FG004|Overall Study|Death|5
1052998|NCT01859741|2094962|FG005|Overall Study|Death|4
1052999|NCT01859741|2094963|FG006|Overall Study|Death|51
1053000|NCT01859741|2094964|FG007|Overall Study|Death|51
1053001|NCT01859741|2094957|FG000|Overall Study|Lost to Follow-up|0
1053002|NCT01859741|2094958|FG001|Overall Study|Lost to Follow-up|0
1053003|NCT01859741|2094959|FG002|Overall Study|Lost to Follow-up|0
1053004|NCT01859741|2094960|FG003|Overall Study|Lost to Follow-up|0
1053005|NCT01859741|2094961|FG004|Overall Study|Lost to Follow-up|0
1053006|NCT01859741|2094962|FG005|Overall Study|Lost to Follow-up|1
1053007|NCT01859741|2094963|FG006|Overall Study|Lost to Follow-up|0
1053008|NCT01859741|2094964|FG007|Overall Study|Lost to Follow-up|4
1053009|NCT01859741|2094957|FG000|Overall Study|Withdrawal by Subject|0
1053010|NCT01859741|2094958|FG001|Overall Study|Withdrawal by Subject|1
1053011|NCT01859741|2094959|FG002|Overall Study|Withdrawal by Subject|2
1053012|NCT01859741|2094960|FG003|Overall Study|Withdrawal by Subject|0
1053013|NCT01859741|2094961|FG004|Overall Study|Withdrawal by Subject|0
1053014|NCT01859741|2094962|FG005|Overall Study|Withdrawal by Subject|1
1053015|NCT01859741|2094963|FG006|Overall Study|Withdrawal by Subject|1
1053016|NCT01859741|2094964|FG007|Overall Study|Withdrawal by Subject|1
1053017|NCT01859741|2094957|FG000|Overall Study|Study Terminated by Sponsor|0
1053018|NCT01859741|2094958|FG001|Overall Study|Study Terminated by Sponsor|0
1053019|NCT01859741|2094959|FG002|Overall Study|Study Terminated by Sponsor|0
1053020|NCT01859741|2094960|FG003|Overall Study|Study Terminated by Sponsor|0
1053021|NCT01859741|2094961|FG004|Overall Study|Study Terminated by Sponsor|1
1053022|NCT01859741|2094962|FG005|Overall Study|Study Terminated by Sponsor|0
1053023|NCT01859741|2094963|FG006|Overall Study|Study Terminated by Sponsor|16
1053024|NCT01859741|2094964|FG007|Overall Study|Study Terminated by Sponsor|14
1053025|NCT01859741|2094957|FG000|Overall Study|Other|0
1053026|NCT01859741|2094958|FG001|Overall Study|Other|0
1053027|NCT01859741|2094959|FG002|Overall Study|Other|0
1053028|NCT01859741|2094960|FG003|Overall Study|Other|0
1053029|NCT01859741|2094961|FG004|Overall Study|Other|0
1053030|NCT01859741|2094962|FG005|Overall Study|Other|0
1053031|NCT01859741|2094963|FG006|Overall Study|Other|2
1053032|NCT01859741|2094964|FG007|Overall Study|Other|0
1053033|NCT01859793|2094984|FG000|First Intervention (8 Weeks)|Protocol Violation|2
1053034|NCT01859793|2094985|FG001|First Intervention (8 Weeks)|Protocol Violation|0
1053035|NCT01859793|2094984|FG000|First Intervention (8 Weeks)|Adverse Event|1
1053036|NCT01859793|2094985|FG001|First Intervention (8 Weeks)|Adverse Event|0
1053037|NCT01859793|2094984|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
907910|NCT00778622|1884275|FG002|Overall Study|Lost to Follow-up|2
1053038|NCT01859793|2094985|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
1053039|NCT01859793|2094984|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1
1053040|NCT01859793|2094985|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
1053041|NCT01859923|2094995|FG000|Overall Study|Adverse Event|0
1053042|NCT01859923|2094996|FG001|Overall Study|Adverse Event|0
1053043|NCT01859923|2094997|FG002|Overall Study|Adverse Event|1
1053044|NCT01859923|2094998|FG003|Overall Study|Adverse Event|1
907911|NCT00778622|1884273|FG000|Overall Study|Protocol Violation|0
907912|NCT00778622|1884274|FG001|Overall Study|Protocol Violation|3
907913|NCT00778622|1884275|FG002|Overall Study|Protocol Violation|0
907914|NCT00778622|1884273|FG000|Overall Study|Lack of Efficacy|2
907915|NCT00778622|1884274|FG001|Overall Study|Lack of Efficacy|0
907916|NCT00778622|1884275|FG002|Overall Study|Lack of Efficacy|0
907917|NCT00778622|1884273|FG000|Overall Study|immigration|1
907918|NCT00778622|1884274|FG001|Overall Study|immigration|0
907919|NCT00778622|1884275|FG002|Overall Study|immigration|0
907920|NCT00778622|1884273|FG000|Overall Study|Other|1
907921|NCT00778622|1884274|FG001|Overall Study|Other|0
907922|NCT00778622|1884275|FG002|Overall Study|Other|1
907923|NCT00778817|1884296|FG000|Overall Study|Adverse Event|2
907924|NCT00778817|1884296|FG000|Overall Study|Withdrawal by Subject|2
907925|NCT00778830|1884302|FG000|Overall Study|Ongoing at data cut-off|0
907926|NCT00778830|1884303|FG001|Overall Study|Ongoing at data cut-off|1
907927|NCT00778895|1884316|FG000|Active Phase|Adverse Event|3
907928|NCT00778895|1884317|FG001|Active Phase|Adverse Event|1
907929|NCT00778895|1884318|FG002|Active Phase|Adverse Event|0
907930|NCT00778895|1884316|FG000|Active Phase|Withdrawal by Subject|1
907931|NCT00778895|1884317|FG001|Active Phase|Withdrawal by Subject|4
907932|NCT00778895|1884318|FG002|Active Phase|Withdrawal by Subject|0
907933|NCT00778895|1884316|FG000|Active Phase|Lost to Follow-up|1
907934|NCT00778895|1884317|FG001|Active Phase|Lost to Follow-up|1
907935|NCT00778895|1884318|FG002|Active Phase|Lost to Follow-up|0
907936|NCT00778895|1884316|FG000|Active Phase|Other|2
907937|NCT00778895|1884317|FG001|Active Phase|Other|0
907938|NCT00778895|1884318|FG002|Active Phase|Other|0
907939|NCT00778895|1884316|FG000|ESFU Phase|Adverse Event|2
907940|NCT00778895|1884317|FG001|ESFU Phase|Adverse Event|1
907941|NCT00778895|1884318|FG002|ESFU Phase|Adverse Event|0
907942|NCT00778895|1884316|FG000|ESFU Phase|Withdrawal by Subject|1
907943|NCT00778895|1884317|FG001|ESFU Phase|Withdrawal by Subject|4
907944|NCT00778895|1884318|FG002|ESFU Phase|Withdrawal by Subject|0
907945|NCT00778895|1884316|FG000|ESFU Phase|Lost to Follow-up|6
907946|NCT00778895|1884317|FG001|ESFU Phase|Lost to Follow-up|7
907947|NCT00778895|1884318|FG002|ESFU Phase|Lost to Follow-up|2
907948|NCT00778895|1884316|FG000|ESFU Phase|Other|2
907949|NCT00778895|1884317|FG001|ESFU Phase|Other|0
907950|NCT00778895|1884318|FG002|ESFU Phase|Other|0
907951|NCT00778921|1884330|FG000|Overall Study|Adverse Event|9
907952|NCT00778921|1884331|FG001|Overall Study|Adverse Event|10
907953|NCT00778921|1884332|FG002|Overall Study|Adverse Event|14
907954|NCT00778921|1884330|FG000|Overall Study|Abnormal Laboratory Value(s)|1
907955|NCT00778921|1884331|FG001|Overall Study|Abnormal Laboratory Value(s)|0
907956|NCT00778921|1884332|FG002|Overall Study|Abnormal Laboratory Value(s)|0
907957|NCT00778921|1884330|FG000|Overall Study|Abnormal Test Procedure Result(s)|0
907958|NCT00778921|1884331|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
907959|NCT00778921|1884332|FG002|Overall Study|Abnormal Test Procedure Result(s)|2
907960|NCT00778921|1884330|FG000|Overall Study|Unsatisfactory therapeutic response|1
907961|NCT00778921|1884331|FG001|Overall Study|Unsatisfactory therapeutic response|1
907962|NCT00778921|1884332|FG002|Overall Study|Unsatisfactory therapeutic response|1
907963|NCT00778921|1884330|FG000|Overall Study|Patient No Longer Requires Study Drug|0
907964|NCT00778921|1884331|FG001|Overall Study|Patient No Longer Requires Study Drug|1
907965|NCT00778921|1884332|FG002|Overall Study|Patient No Longer Requires Study Drug|0
907966|NCT00778921|1884330|FG000|Overall Study|Patient withdrew request|3
907967|NCT00778921|1884331|FG001|Overall Study|Patient withdrew request|1
907968|NCT00778921|1884332|FG002|Overall Study|Patient withdrew request|6
907969|NCT00778921|1884330|FG000|Overall Study|Lost to Follow-up|0
907970|NCT00778921|1884331|FG001|Overall Study|Lost to Follow-up|2
907971|NCT00778921|1884332|FG002|Overall Study|Lost to Follow-up|1
907972|NCT00778921|1884330|FG000|Overall Study|Administrative Problems|1
907973|NCT00778921|1884331|FG001|Overall Study|Administrative Problems|2
907974|NCT00778921|1884332|FG002|Overall Study|Administrative Problems|0
907975|NCT00778921|1884330|FG000|Overall Study|Protocol Violation|3
907976|NCT00778921|1884331|FG001|Overall Study|Protocol Violation|0
907977|NCT00778921|1884332|FG002|Overall Study|Protocol Violation|2
907978|NCT00778921|1884330|FG000|Overall Study|Not treated|0
907979|NCT00778921|1884331|FG001|Overall Study|Not treated|2
907980|NCT00778921|1884332|FG002|Overall Study|Not treated|2
907981|NCT00778999|1884342|FG000|Overall Study|Discontinuation: no embryo transfer|14
907982|NCT00778999|1884343|FG001|Overall Study|Discontinuation: no embryo transfer|14
907983|NCT00778999|1884342|FG000|Overall Study|Did not receive recFSH|14
907984|NCT00778999|1884343|FG001|Overall Study|Did not receive recFSH|20
907985|NCT00779025|1884349|FG000|Overall Study|Withdrawal by Subject|1
907986|NCT00779142|1884370|FG000|Overall Study|Screen Failures|3
907987|NCT00779246|1884386|FG000|Overall Study|Missing sufficient data for analysis|33
907988|NCT00779246|1884387|FG001|Overall Study|Missing sufficient data for analysis|53
907989|NCT00779259|1884393|FG000|Quinine Alone|Adverse Event|2
907990|NCT00779324|1884438|FG000|Overall Study|Lost to Follow-up|2
907991|NCT00779324|1884439|FG001|Overall Study|Lost to Follow-up|1
907992|NCT00779324|1884438|FG000|Overall Study|Withdrawal by Subject|4
1053045|NCT01859949|2095013|FG000|Overall Study|Family Matters|0
1053046|NCT01859949|2095014|FG001|Overall Study|Family Matters|1
1053047|NCT01859949|2095013|FG000|Overall Study|Physician Decision|2
1053048|NCT01859949|2095014|FG001|Overall Study|Physician Decision|4
907993|NCT00779324|1884439|FG001|Overall Study|Withdrawal by Subject|2
907994|NCT00779324|1884438|FG000|Overall Study|Missed visit|1
907995|NCT00779324|1884439|FG001|Overall Study|Missed visit|1
907996|NCT00779402|1884447|FG000|Treatment Phase 1|Disease Progression|1
907997|NCT00779402|1884448|FG001|Treatment Phase 1|Disease Progression|0
907998|NCT00779402|1884447|FG000|Treatment Phase 1|Adverse Event|2
907999|NCT00779402|1884448|FG001|Treatment Phase 1|Adverse Event|0
908000|NCT00779402|1884447|FG000|Treatment Phase 1|Protocol Violation|1
908001|NCT00779402|1884448|FG001|Treatment Phase 1|Protocol Violation|0
908002|NCT00779402|1884447|FG000|Treatment Phase 1|Patient Refused to Continue|17
908003|NCT00779402|1884448|FG001|Treatment Phase 1|Patient Refused to Continue|2
908004|NCT00779402|1884447|FG000|Treatment Phase 1|Lost to Follow-up|0
908005|NCT00779402|1884448|FG001|Treatment Phase 1|Lost to Follow-up|1
908006|NCT00779402|1884447|FG000|Treatment Phase 1|Death|0
908007|NCT00779402|1884448|FG001|Treatment Phase 1|Death|1
908008|NCT00779402|1884447|FG000|Treatment Phase 1|Intercurrent Illness|1
908009|NCT00779402|1884448|FG001|Treatment Phase 1|Intercurrent Illness|1
908010|NCT00779402|1884447|FG000|Treatment Phase 1|Withdrawal by Subject|1
908011|NCT00779402|1884448|FG001|Treatment Phase 1|Withdrawal by Subject|0
908012|NCT00779402|1884447|FG000|Treatment Phase 1|Other|4
908013|NCT00779402|1884448|FG001|Treatment Phase 1|Other|2
908014|NCT00779402|1884447|FG000|Treatment Phase 1|Closure of Study|3
908015|NCT00779402|1884448|FG001|Treatment Phase 1|Closure of Study|2
908016|NCT00779402|1884447|FG000|Treatment Phase 1|Completed Protocol Visits|3
908017|NCT00779402|1884448|FG001|Treatment Phase 1|Completed Protocol Visits|6
908018|NCT00779402|1884447|FG000|Surveillance Phase|Protocol Violation|0
908019|NCT00779402|1884448|FG001|Surveillance Phase|Protocol Violation|1
908020|NCT00779402|1884447|FG000|Surveillance Phase|Patient refused to continue|22
908021|NCT00779402|1884448|FG001|Surveillance Phase|Patient refused to continue|14
908022|NCT00779402|1884447|FG000|Surveillance Phase|Lost to Follow-up|2
908023|NCT00779402|1884448|FG001|Surveillance Phase|Lost to Follow-up|1
908024|NCT00779402|1884447|FG000|Surveillance Phase|Death|0
908025|NCT00779402|1884448|FG001|Surveillance Phase|Death|1
908026|NCT00779402|1884447|FG000|Surveillance Phase|Intercurrent Illness|2
908027|NCT00779402|1884448|FG001|Surveillance Phase|Intercurrent Illness|0
908028|NCT00779402|1884447|FG000|Surveillance Phase|Other|5
908029|NCT00779402|1884448|FG001|Surveillance Phase|Other|5
908030|NCT00779402|1884447|FG000|Surveillance Phase|Withdrawal by Subject|4
908031|NCT00779402|1884448|FG001|Surveillance Phase|Withdrawal by Subject|1
908032|NCT00779402|1884447|FG000|Surveillance Phase|Closure of study|5
908033|NCT00779402|1884448|FG001|Surveillance Phase|Closure of study|6
908034|NCT00779402|1884447|FG000|Surveillance Phase|Completed Protocol Visits|3
908035|NCT00779402|1884448|FG001|Surveillance Phase|Completed Protocol Visits|2
908036|NCT00779402|1884447|FG000|Long-term Follow-up|Patient refused to continue|2
908037|NCT00779402|1884448|FG001|Long-term Follow-up|Patient refused to continue|0
908038|NCT00779402|1884447|FG000|Long-term Follow-up|Other|5
908039|NCT00779402|1884448|FG001|Long-term Follow-up|Other|0
908040|NCT00779402|1884447|FG000|Long-term Follow-up|Closure of Study|8
908041|NCT00779402|1884448|FG001|Long-term Follow-up|Closure of Study|4
908042|NCT00779402|1884447|FG000|Long-term Follow-up|Completed Protocol Visits|6
908043|NCT00779402|1884448|FG001|Long-term Follow-up|Completed Protocol Visits|2
908044|NCT00779467|1884458|FG000|Overall Study|Lack of Efficacy|11
908045|NCT00779467|1884459|FG001|Overall Study|Lack of Efficacy|2
908046|NCT00779467|1884460|FG002|Overall Study|Lack of Efficacy|6
908047|NCT00779467|1884461|FG003|Overall Study|Lack of Efficacy|11
908048|NCT00779467|1884458|FG000|Overall Study|failed inclusion criteria|3
908049|NCT00779467|1884459|FG001|Overall Study|failed inclusion criteria|3
908050|NCT00779467|1884460|FG002|Overall Study|failed inclusion criteria|1
908051|NCT00779467|1884461|FG003|Overall Study|failed inclusion criteria|2
908052|NCT00779467|1884458|FG000|Overall Study|missing data|1
908053|NCT00779467|1884459|FG001|Overall Study|missing data|0
908054|NCT00779467|1884460|FG002|Overall Study|missing data|1
908055|NCT00779467|1884461|FG003|Overall Study|missing data|4
908056|NCT00779467|1884458|FG000|Overall Study|technical issue|0
908057|NCT00779467|1884459|FG001|Overall Study|technical issue|0
908058|NCT00779467|1884460|FG002|Overall Study|technical issue|2
908059|NCT00779467|1884461|FG003|Overall Study|technical issue|1
908060|NCT00779467|1884458|FG000|Overall Study|unavailable research staff|0
908061|NCT00779467|1884459|FG001|Overall Study|unavailable research staff|0
908062|NCT00779467|1884460|FG002|Overall Study|unavailable research staff|0
908063|NCT00779467|1884461|FG003|Overall Study|unavailable research staff|1
908064|NCT00779506|1884471|FG000|Overall Study|Screening Failed|2
908065|NCT00779506|1884471|FG000|Overall Study|Adverse Event|4
908066|NCT00779506|1884471|FG000|Overall Study|Lack of Efficacy|11
908067|NCT00779506|1884471|FG000|Overall Study|Protocol Violation|5
908068|NCT00779506|1884471|FG000|Overall Study|Withdrawal by Subject|6
908069|NCT00779506|1884471|FG000|Overall Study|Lost to Follow-up|1
908070|NCT00779584|1884493|FG000|Overall Study|Protocol Violation|0
908071|NCT00779584|1884494|FG001|Overall Study|Protocol Violation|0
908072|NCT00779584|1884495|FG002|Overall Study|Protocol Violation|0
1053049|NCT01859949|2095013|FG000|Overall Study|Withdrawal by Subject|11
1053050|NCT01859949|2095014|FG001|Overall Study|Withdrawal by Subject|10
1053051|NCT01859949|2095013|FG000|Overall Study|Protocol Violation|1
1053052|NCT01859949|2095014|FG001|Overall Study|Protocol Violation|1
1053053|NCT01859949|2095013|FG000|Overall Study|Adverse Event|0
1053054|NCT01859949|2095014|FG001|Overall Study|Adverse Event|1
1053055|NCT01859988|2095026|FG000|Overall Study|Withdrawal by Subject|6
1053056|NCT01859988|2095027|FG001|Overall Study|Withdrawal by Subject|3
908073|NCT00779584|1884496|FG003|Overall Study|Protocol Violation|0
908074|NCT00779584|1884497|FG004|Overall Study|Protocol Violation|0
908075|NCT00779584|1884498|FG005|Overall Study|Protocol Violation|1
908076|NCT00779584|1884499|FG006|Overall Study|Protocol Violation|0
908077|NCT00779584|1884500|FG007|Overall Study|Protocol Violation|0
908078|NCT00779584|1884501|FG008|Overall Study|Protocol Violation|0
908079|NCT00779584|1884493|FG000|Overall Study|Withdrawal by Subject|1
908080|NCT00779584|1884494|FG001|Overall Study|Withdrawal by Subject|1
908081|NCT00779584|1884495|FG002|Overall Study|Withdrawal by Subject|2
908082|NCT00779584|1884496|FG003|Overall Study|Withdrawal by Subject|0
908083|NCT00779584|1884497|FG004|Overall Study|Withdrawal by Subject|0
908084|NCT00779584|1884498|FG005|Overall Study|Withdrawal by Subject|2
908085|NCT00779584|1884499|FG006|Overall Study|Withdrawal by Subject|1
908086|NCT00779584|1884500|FG007|Overall Study|Withdrawal by Subject|0
908087|NCT00779584|1884501|FG008|Overall Study|Withdrawal by Subject|0
908088|NCT00779584|1884493|FG000|Overall Study|Lost to Follow-up|0
908089|NCT00779584|1884494|FG001|Overall Study|Lost to Follow-up|0
908090|NCT00779584|1884495|FG002|Overall Study|Lost to Follow-up|0
908091|NCT00779584|1884496|FG003|Overall Study|Lost to Follow-up|0
908092|NCT00779584|1884497|FG004|Overall Study|Lost to Follow-up|1
908093|NCT00779584|1884498|FG005|Overall Study|Lost to Follow-up|0
908094|NCT00779584|1884499|FG006|Overall Study|Lost to Follow-up|0
908095|NCT00779584|1884500|FG007|Overall Study|Lost to Follow-up|0
908096|NCT00779584|1884501|FG008|Overall Study|Lost to Follow-up|0
908097|NCT00779584|1884493|FG000|Overall Study|Progression of Disease|0
908098|NCT00779584|1884494|FG001|Overall Study|Progression of Disease|1
908099|NCT00779584|1884495|FG002|Overall Study|Progression of Disease|2
908100|NCT00779584|1884496|FG003|Overall Study|Progression of Disease|6
908101|NCT00779584|1884497|FG004|Overall Study|Progression of Disease|5
908102|NCT00779584|1884498|FG005|Overall Study|Progression of Disease|1
908103|NCT00779584|1884499|FG006|Overall Study|Progression of Disease|4
908104|NCT00779584|1884500|FG007|Overall Study|Progression of Disease|2
908105|NCT00779584|1884501|FG008|Overall Study|Progression of Disease|1
908106|NCT00779584|1884493|FG000|Overall Study|Adverse Event|1
908107|NCT00779584|1884494|FG001|Overall Study|Adverse Event|0
908108|NCT00779584|1884495|FG002|Overall Study|Adverse Event|2
908109|NCT00779584|1884496|FG003|Overall Study|Adverse Event|0
908110|NCT00779584|1884497|FG004|Overall Study|Adverse Event|0
908111|NCT00779584|1884498|FG005|Overall Study|Adverse Event|0
908112|NCT00779584|1884499|FG006|Overall Study|Adverse Event|2
908113|NCT00779584|1884500|FG007|Overall Study|Adverse Event|1
908114|NCT00779584|1884501|FG008|Overall Study|Adverse Event|1
908115|NCT00779584|1884493|FG000|Overall Study|Symptomatic Deterioration|1
908116|NCT00779584|1884494|FG001|Overall Study|Symptomatic Deterioration|1
908117|NCT00779584|1884495|FG002|Overall Study|Symptomatic Deterioration|1
908118|NCT00779584|1884496|FG003|Overall Study|Symptomatic Deterioration|0
908119|NCT00779584|1884497|FG004|Overall Study|Symptomatic Deterioration|0
908120|NCT00779584|1884498|FG005|Overall Study|Symptomatic Deterioration|1
908121|NCT00779584|1884499|FG006|Overall Study|Symptomatic Deterioration|1
908122|NCT00779584|1884500|FG007|Overall Study|Symptomatic Deterioration|0
908123|NCT00779584|1884501|FG008|Overall Study|Symptomatic Deterioration|0
908124|NCT00779584|1884493|FG000|Overall Study|Ongoing in Study|0
908125|NCT00779584|1884494|FG001|Overall Study|Ongoing in Study|0
908126|NCT00779584|1884495|FG002|Overall Study|Ongoing in Study|0
908127|NCT00779584|1884496|FG003|Overall Study|Ongoing in Study|0
908128|NCT00779584|1884497|FG004|Overall Study|Ongoing in Study|1
908129|NCT00779584|1884498|FG005|Overall Study|Ongoing in Study|1
908130|NCT00779584|1884499|FG006|Overall Study|Ongoing in Study|0
908131|NCT00779584|1884500|FG007|Overall Study|Ongoing in Study|0
908132|NCT00779584|1884501|FG008|Overall Study|Ongoing in Study|0
908133|NCT00779675|1884521|FG000|Treatment Period|Adverse Event|87
908134|NCT00779675|1884521|FG000|Treatment Period|Treatment Failure|80
908135|NCT00779675|1884521|FG000|Treatment Period|Transferred to Another Study|38
908136|NCT00779675|1884521|FG000|Treatment Period|Lost to Follow-up|23
908137|NCT00779675|1884521|FG000|Treatment Period|Withdrawal by Subject|46
908138|NCT00779675|1884521|FG000|Treatment Period|Protocol Violation|54
908139|NCT00779675|1884521|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1
908140|NCT00779675|1884521|FG000|Treatment Period|Administrative|3
908141|NCT00779675|1884521|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9
908142|NCT00779675|1884521|FG000|Extended Treatment Period|Protocol Violation|13
908143|NCT00779675|1884521|FG000|Extended Treatment Period|Adverse Event|6
908144|NCT00779675|1884521|FG000|Extended Treatment Period|Treatment Failure|11
908145|NCT00779675|1884521|FG000|Extended Treatment Period|Protocol defined clinical event|1
908146|NCT00779675|1884521|FG000|Extended Treatment Period|Lost to Follow-up|6
908147|NCT00779766|1884535|FG000|Month 24|Serious Adverse Event|2
908148|NCT00779766|1884536|FG001|Month 24|Serious Adverse Event|3
1053057|NCT01859988|2095028|FG002|Overall Study|Withdrawal by Subject|4
1053058|NCT01859988|2095029|FG003|Overall Study|Withdrawal by Subject|3
1053059|NCT01859988|2095030|FG004|Overall Study|Withdrawal by Subject|2
1053060|NCT01859988|2095031|FG005|Overall Study|Withdrawal by Subject|2
1053061|NCT01859988|2095026|FG000|Overall Study|Lack of Efficacy|1
1053062|NCT01859988|2095027|FG001|Overall Study|Lack of Efficacy|1
1053063|NCT01859988|2095028|FG002|Overall Study|Lack of Efficacy|5
1053064|NCT01859988|2095029|FG003|Overall Study|Lack of Efficacy|0
1053065|NCT01859988|2095030|FG004|Overall Study|Lack of Efficacy|7
1053066|NCT01859988|2095031|FG005|Overall Study|Lack of Efficacy|9
1053067|NCT01859988|2095026|FG000|Overall Study|Physician Decision|1
1053068|NCT01859988|2095027|FG001|Overall Study|Physician Decision|3
1053069|NCT01859988|2095028|FG002|Overall Study|Physician Decision|1
1053070|NCT01859988|2095029|FG003|Overall Study|Physician Decision|3
1053071|NCT01859988|2095030|FG004|Overall Study|Physician Decision|4
1053072|NCT01859988|2095031|FG005|Overall Study|Physician Decision|1
1053073|NCT01859988|2095026|FG000|Overall Study|Adverse Event|2
1053074|NCT01859988|2095027|FG001|Overall Study|Adverse Event|1
1053075|NCT01859988|2095028|FG002|Overall Study|Adverse Event|3
1053076|NCT01859988|2095029|FG003|Overall Study|Adverse Event|1
1053077|NCT01859988|2095030|FG004|Overall Study|Adverse Event|2
1053078|NCT01859988|2095031|FG005|Overall Study|Adverse Event|2
1053079|NCT01859988|2095026|FG000|Overall Study|Lost to Follow-up|1
1053080|NCT01859988|2095027|FG001|Overall Study|Lost to Follow-up|2
1053081|NCT01859988|2095028|FG002|Overall Study|Lost to Follow-up|3
1053082|NCT01859988|2095029|FG003|Overall Study|Lost to Follow-up|0
1053083|NCT01859988|2095030|FG004|Overall Study|Lost to Follow-up|3
1053084|NCT01859988|2095031|FG005|Overall Study|Lost to Follow-up|2
1053085|NCT01859988|2095026|FG000|Overall Study|Protocol Violation|0
1053086|NCT01859988|2095027|FG001|Overall Study|Protocol Violation|0
1053087|NCT01859988|2095028|FG002|Overall Study|Protocol Violation|1
1053088|NCT01859988|2095029|FG003|Overall Study|Protocol Violation|0
1053089|NCT01859988|2095030|FG004|Overall Study|Protocol Violation|0
1053090|NCT01859988|2095031|FG005|Overall Study|Protocol Violation|0
1053091|NCT01859988|2095026|FG000|Overall Study|Other than specified above|0
1053092|NCT01859988|2095027|FG001|Overall Study|Other than specified above|2
1053093|NCT01859988|2095028|FG002|Overall Study|Other than specified above|11
1053094|NCT01859988|2095029|FG003|Overall Study|Other than specified above|3
1053095|NCT01859988|2095030|FG004|Overall Study|Other than specified above|5
1053096|NCT01859988|2095031|FG005|Overall Study|Other than specified above|3
1053097|NCT01860079|2095047|FG000|Overall Study|Physician Decision|14
1053098|NCT01860079|2095048|FG001|Overall Study|Physician Decision|22
1053099|NCT01860534|2095091|FG000|ROP #1|Needed treatment for ROP|0
1053100|NCT01860534|2095092|FG001|ROP #1|Needed treatment for ROP|1
1053101|NCT01860534|2095091|FG000|ROP #2|discharged prior to ROP #2|1
1053102|NCT01860534|2095092|FG001|ROP #2|discharged prior to ROP #2|0
1053103|NCT01860677|2095129|FG000|Second Intervention (1 Day)|Lost to Follow-up|7
1053104|NCT01860677|2095130|FG001|Second Intervention (1 Day)|Lost to Follow-up|0
1053105|NCT01860703|2095137|FG000|Overall Study|Adverse Event|1
1053106|NCT01860703|2095138|FG001|Overall Study|Adverse Event|4
1053107|NCT01860703|2095139|FG002|Overall Study|Adverse Event|0
1053108|NCT01860703|2095140|FG003|Overall Study|Adverse Event|2
1053109|NCT01860703|2095137|FG000|Overall Study|Withdrawal by Subject|0
1053110|NCT01860703|2095138|FG001|Overall Study|Withdrawal by Subject|1
1053111|NCT01860703|2095139|FG002|Overall Study|Withdrawal by Subject|0
1053112|NCT01860703|2095140|FG003|Overall Study|Withdrawal by Subject|0
1053113|NCT01860703|2095137|FG000|Overall Study|Personal reason|1
1053114|NCT01860703|2095138|FG001|Overall Study|Personal reason|0
1053115|NCT01860703|2095139|FG002|Overall Study|Personal reason|1
1053116|NCT01860703|2095140|FG003|Overall Study|Personal reason|0
1053117|NCT01860846|2095165|FG000|Overall Study|Lost to Follow-up|33
1053118|NCT01860976|2095197|FG000|Blinded Treatment|Adverse Event|1
1053119|NCT01860976|2095198|FG001|Blinded Treatment|Adverse Event|3
1053120|NCT01860976|2095197|FG000|Blinded Treatment|Lack of Efficacy|5
1053121|NCT01860976|2095198|FG001|Blinded Treatment|Lack of Efficacy|12
1053122|NCT01860976|2095197|FG000|Blinded Treatment|Subject request to discontinue treatment|2
1053123|NCT01860976|2095198|FG001|Blinded Treatment|Subject request to discontinue treatment|3
1053124|NCT01860976|2095197|FG000|Blinded Treatment|Withdrawal by Subject|3
1053125|NCT01860976|2095198|FG001|Blinded Treatment|Withdrawal by Subject|5
1053126|NCT01860976|2095197|FG000|Blinded Treatment|Subject no longer met criteria|1
1053127|NCT01860976|2095198|FG001|Blinded Treatment|Subject no longer met criteria|0
1053128|NCT01860976|2095197|FG000|Blinded Treatment|Entered Open-Label in error|0
1053129|NCT01860976|2095198|FG001|Blinded Treatment|Entered Open-Label in error|1
1053130|NCT01860976|2095197|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76
1053131|NCT01860976|2095198|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89
1053132|NCT01860976|2095197|FG000|Open-Label|Adverse Event|2
1053133|NCT01860976|2095198|FG001|Open-Label|Adverse Event|4
1053134|NCT01860976|2095197|FG000|Open-Label|Lack of Efficacy|16
1053135|NCT01860976|2095198|FG001|Open-Label|Lack of Efficacy|8
1053136|NCT01860976|2095197|FG000|Open-Label|Lost to Follow-up|1
1053137|NCT01860976|2095198|FG001|Open-Label|Lost to Follow-up|2
1053138|NCT01860976|2095197|FG000|Open-Label|Subject request discontinue treatment|4
1053139|NCT01860976|2095198|FG001|Open-Label|Subject request discontinue treatment|3
1053140|NCT01860976|2095197|FG000|Open-Label|Withdrawal by Subject|4
1053141|NCT01860976|2095198|FG001|Open-Label|Withdrawal by Subject|1
1053142|NCT01860976|2095197|FG000|Open-Label|Other Reasons|1
1053143|NCT01860976|2095198|FG001|Open-Label|Other Reasons|1
1053144|NCT01860976|2095197|FG000|Open-Label|Ongoing OL treatment at time of analysis|46
1053145|NCT01860976|2095198|FG001|Open-Label|Ongoing OL treatment at time of analysis|45
1053146|NCT01860976|2095197|FG000|Long Term Extension|Adverse Event|1
1053147|NCT01860976|2095198|FG001|Long Term Extension|Adverse Event|0
1053148|NCT01860976|2095197|FG000|Long Term Extension|Lack of Efficacy|3
1053149|NCT01860976|2095198|FG001|Long Term Extension|Lack of Efficacy|7
1053150|NCT01860976|2095197|FG000|Long Term Extension|Subject request to discontinue treatment|2
1053151|NCT01860976|2095198|FG001|Long Term Extension|Subject request to discontinue treatment|0
1053152|NCT01860976|2095197|FG000|Long Term Extension|Withdrawal by Subject|1
1053153|NCT01860976|2095198|FG001|Long Term Extension|Withdrawal by Subject|0
1053154|NCT01860976|2095197|FG000|Long Term Extension|Ongoing treatment at time of analysis|106
1053155|NCT01860976|2095198|FG001|Long Term Extension|Ongoing treatment at time of analysis|100
1053156|NCT01860989|2095204|FG000|Overall Study|Unsatisfactory therapeutic|5
1053157|NCT01861522|2095249|FG000|Overall Study|Adverse Event|1
1053158|NCT01861522|2095250|FG001|Overall Study|Adverse Event|0
1053159|NCT01861522|2095249|FG000|Overall Study|Withdrawal by Subject|2
1053160|NCT01861522|2095250|FG001|Overall Study|Withdrawal by Subject|0
1053161|NCT01862029|2095330|FG000|Overall Study|Physician Decision|1
1053162|NCT01862250|2095346|FG000|Overall Study|Adverse Event|4
1053163|NCT01862328|2095357|FG000|Overall Study|Progressive Disease|3
1053164|NCT01862328|2095358|FG001|Overall Study|Progressive Disease|11
1053165|NCT01862328|2095359|FG002|Overall Study|Progressive Disease|5
1053166|NCT01862328|2095360|FG003|Overall Study|Progressive Disease|6
1053167|NCT01862328|2095361|FG004|Overall Study|Progressive Disease|7
1053168|NCT01862328|2095362|FG005|Overall Study|Progressive Disease|4
1053169|NCT01862328|2095363|FG006|Overall Study|Progressive Disease|3
1053170|NCT01862328|2095357|FG000|Overall Study|Adverse Event|0
1053171|NCT01862328|2095358|FG001|Overall Study|Adverse Event|4
1053172|NCT01862328|2095359|FG002|Overall Study|Adverse Event|0
1053173|NCT01862328|2095360|FG003|Overall Study|Adverse Event|1
1053174|NCT01862328|2095361|FG004|Overall Study|Adverse Event|0
1053175|NCT01862328|2095362|FG005|Overall Study|Adverse Event|2
1053176|NCT01862328|2095363|FG006|Overall Study|Adverse Event|4
1053177|NCT01862328|2095357|FG000|Overall Study|Other|0
1053178|NCT01862328|2095358|FG001|Overall Study|Other|2
1053179|NCT01862328|2095359|FG002|Overall Study|Other|1
1053180|NCT01862328|2095360|FG003|Overall Study|Other|0
1053181|NCT01862328|2095361|FG004|Overall Study|Other|4
1053182|NCT01862328|2095362|FG005|Overall Study|Other|0
1053183|NCT01862328|2095363|FG006|Overall Study|Other|1
1053184|NCT01862328|2095357|FG000|Overall Study|Withdrawal by Subject|1
1053185|NCT01862328|2095358|FG001|Overall Study|Withdrawal by Subject|1
1053186|NCT01862328|2095359|FG002|Overall Study|Withdrawal by Subject|0
1053187|NCT01862328|2095360|FG003|Overall Study|Withdrawal by Subject|0
1053188|NCT01862328|2095361|FG004|Overall Study|Withdrawal by Subject|1
1053189|NCT01862328|2095362|FG005|Overall Study|Withdrawal by Subject|1
1053190|NCT01862328|2095363|FG006|Overall Study|Withdrawal by Subject|1
1053191|NCT01862328|2095357|FG000|Overall Study|Symptomatic Deterioration|0
1053192|NCT01862328|2095358|FG001|Overall Study|Symptomatic Deterioration|0
1053193|NCT01862328|2095359|FG002|Overall Study|Symptomatic Deterioration|0
1053194|NCT01862328|2095360|FG003|Overall Study|Symptomatic Deterioration|0
1053195|NCT01862328|2095361|FG004|Overall Study|Symptomatic Deterioration|0
1053196|NCT01862328|2095362|FG005|Overall Study|Symptomatic Deterioration|0
1053197|NCT01862328|2095363|FG006|Overall Study|Symptomatic Deterioration|1
1053198|NCT01862484|2095396|FG000|Overall Study|Lack of Efficacy|1
1053199|NCT01862484|2095397|FG001|Overall Study|Lack of Efficacy|1
1053200|NCT01862484|2095396|FG000|Overall Study|Lost to Follow-up|1
1053201|NCT01862484|2095397|FG001|Overall Study|Lost to Follow-up|2
1053202|NCT01862484|2095396|FG000|Overall Study|Protocol Violation|0
1053203|NCT01862484|2095397|FG001|Overall Study|Protocol Violation|2
1053204|NCT01862484|2095396|FG000|Overall Study|Withdrawal by Subject|0
1053205|NCT01862484|2095397|FG001|Overall Study|Withdrawal by Subject|3
1053206|NCT01862640|2095425|FG000|Overall Study|Adverse Event|4
1053207|NCT01862640|2095426|FG001|Overall Study|Adverse Event|10
1053208|NCT01862640|2095427|FG002|Overall Study|Adverse Event|6
1053209|NCT01862640|2095428|FG003|Overall Study|Adverse Event|8
1053210|NCT01862640|2095425|FG000|Overall Study|Participant Met Withdrawal Criteria|1
1053211|NCT01862640|2095426|FG001|Overall Study|Participant Met Withdrawal Criteria|1
1053212|NCT01862640|2095427|FG002|Overall Study|Participant Met Withdrawal Criteria|2
1053213|NCT01862640|2095428|FG003|Overall Study|Participant Met Withdrawal Criteria|1
1053214|NCT01862640|2095425|FG000|Overall Study|Participant Withdrawn by Investigator|0
1053215|NCT01862640|2095426|FG001|Overall Study|Participant Withdrawn by Investigator|1
1053216|NCT01862640|2095427|FG002|Overall Study|Participant Withdrawn by Investigator|1
1053217|NCT01862640|2095428|FG003|Overall Study|Participant Withdrawn by Investigator|1
1053218|NCT01862640|2095425|FG000|Overall Study|Withdrawal by Subject|2
1053219|NCT01862640|2095426|FG001|Overall Study|Withdrawal by Subject|4
1053220|NCT01862640|2095427|FG002|Overall Study|Withdrawal by Subject|8
1053221|NCT01862640|2095428|FG003|Overall Study|Withdrawal by Subject|5
1053222|NCT01862640|2095425|FG000|Overall Study|Protocol Deviation|0
1053223|NCT01862640|2095426|FG001|Overall Study|Protocol Deviation|0
1053224|NCT01862640|2095427|FG002|Overall Study|Protocol Deviation|1
1053225|NCT01862640|2095428|FG003|Overall Study|Protocol Deviation|0
1053226|NCT01862796|2095440|FG000|Overall Study|Prohibited medications|0
1053227|NCT01862796|2095441|FG001|Overall Study|Prohibited medications|0
1053228|NCT01862796|2095442|FG002|Overall Study|Prohibited medications|1
1053229|NCT01862874|2095452|FG000|Overall Study|Randomized not treated|1
1053230|NCT01862874|2095453|FG001|Overall Study|Randomized not treated|0
1053231|NCT01862874|2095452|FG000|Overall Study|Adverse Event|0
1053232|NCT01862874|2095453|FG001|Overall Study|Adverse Event|3
1053233|NCT01862874|2095452|FG000|Overall Study|Lost to Follow-up|26
1053234|NCT01862874|2095453|FG001|Overall Study|Lost to Follow-up|29
1053235|NCT01862874|2095452|FG000|Overall Study|Physician Decision|5
1053236|NCT01862874|2095453|FG001|Overall Study|Physician Decision|3
1053237|NCT01862874|2095452|FG000|Overall Study|Withdrawn by parent/guardian|1
1053238|NCT01862874|2095453|FG001|Overall Study|Withdrawn by parent/guardian|1
1053239|NCT01862874|2095452|FG000|Overall Study|Withdrawal by Subject|46
1053240|NCT01862874|2095453|FG001|Overall Study|Withdrawal by Subject|40
1053241|NCT01862874|2095452|FG000|Overall Study|Death|0
1053242|NCT01862874|2095453|FG001|Overall Study|Death|1
1053243|NCT01862991|2095462|FG000|Overall Study|Lost to Follow-up|2
1053244|NCT01862991|2095463|FG001|Overall Study|Lost to Follow-up|1
1053245|NCT01862991|2095464|FG002|Overall Study|Lost to Follow-up|1
1053246|NCT01862991|2095462|FG000|Overall Study|Protocol Violation|1
1053247|NCT01862991|2095463|FG001|Overall Study|Protocol Violation|0
1053248|NCT01862991|2095464|FG002|Overall Study|Protocol Violation|0
1053249|NCT01863368|2095512|FG000|Phase I, Day 0 to Day 35|Adverse Event|2
1053250|NCT01863368|2095513|FG001|Phase I, Day 0 to Day 35|Adverse Event|4
1053251|NCT01863368|2095512|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1
1053252|NCT01863368|2095513|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0
1053253|NCT01863368|2095512|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
1053254|NCT01863368|2095513|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
1053255|NCT01863368|2095512|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
1053256|NCT01863368|2095513|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
1053257|NCT01863368|2095512|FG000|Phase II, Day 35 to Day 90|Adverse Event|1
1053258|NCT01863368|2095513|FG001|Phase II, Day 35 to Day 90|Adverse Event|0
1053259|NCT01863368|2095512|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1
1053260|NCT01863368|2095513|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0
1053261|NCT01863433|2095520|FG000|Overall Study|Protocol Violation|1
1053262|NCT01863667|2095539|FG000|Overall Study|Adverse Event|1
1053263|NCT01863667|2095540|FG001|Overall Study|Adverse Event|0
1053264|NCT01863667|2095539|FG000|Overall Study|Study terminated by Sponsor|30
1053265|NCT01863667|2095540|FG001|Overall Study|Study terminated by Sponsor|30
1053266|NCT01863667|2095539|FG000|Overall Study|Withdrawal by Subject|2
1053267|NCT01863667|2095540|FG001|Overall Study|Withdrawal by Subject|2
1053268|NCT01863680|2095546|FG000|Overall Study|Adverse Event|17
1053269|NCT01863680|2095546|FG000|Overall Study|Risk of OHSS|17
1053270|NCT01863680|2095546|FG000|Overall Study|Spontaneous pregnancy|2
1053271|NCT01863680|2095546|FG000|Overall Study|Withdrawal by Subject|1
1053272|NCT01863680|2095546|FG000|Overall Study|Did not undergo IVF/ET|14
1053273|NCT01863680|2095546|FG000|Overall Study|Other|6
1053274|NCT01863732|2095554|FG000|Overall Study|Adverse Event|2
1053275|NCT01863732|2095555|FG001|Overall Study|Adverse Event|0
1053276|NCT01863732|2095556|FG002|Overall Study|Adverse Event|3
1053277|NCT01863732|2095557|FG003|Overall Study|Adverse Event|3
1053278|NCT01863732|2095554|FG000|Overall Study|Lack of Efficacy|1
1053279|NCT01863732|2095555|FG001|Overall Study|Lack of Efficacy|0
1053280|NCT01863732|2095556|FG002|Overall Study|Lack of Efficacy|2
1053281|NCT01863732|2095557|FG003|Overall Study|Lack of Efficacy|1
1053282|NCT01863732|2095554|FG000|Overall Study|Lost to Follow-up|2
1053283|NCT01863732|2095555|FG001|Overall Study|Lost to Follow-up|2
1053284|NCT01863732|2095556|FG002|Overall Study|Lost to Follow-up|1
1053285|NCT01863732|2095557|FG003|Overall Study|Lost to Follow-up|1
1053286|NCT01863732|2095554|FG000|Overall Study|Physician Decision|1
1053287|NCT01863732|2095555|FG001|Overall Study|Physician Decision|0
1053288|NCT01863732|2095556|FG002|Overall Study|Physician Decision|1
1053289|NCT01863732|2095557|FG003|Overall Study|Physician Decision|0
1053290|NCT01863732|2095554|FG000|Overall Study|Pregnancy|0
1053291|NCT01863732|2095555|FG001|Overall Study|Pregnancy|0
1053292|NCT01863732|2095556|FG002|Overall Study|Pregnancy|0
1053293|NCT01863732|2095557|FG003|Overall Study|Pregnancy|1
1053294|NCT01863732|2095554|FG000|Overall Study|Technical problems|0
1053295|NCT01863732|2095555|FG001|Overall Study|Technical problems|1
1053296|NCT01863732|2095556|FG002|Overall Study|Technical problems|1
1053297|NCT01863732|2095557|FG003|Overall Study|Technical problems|0
1053298|NCT01863732|2095554|FG000|Overall Study|Subject/guardian decision|6
1053299|NCT01863732|2095555|FG001|Overall Study|Subject/guardian decision|9
1053300|NCT01863732|2095556|FG002|Overall Study|Subject/guardian decision|3
1053301|NCT01863732|2095557|FG003|Overall Study|Subject/guardian decision|1
1053302|NCT01863732|2095554|FG000|Overall Study|Death|1
1053303|NCT01863732|2095555|FG001|Overall Study|Death|0
1053304|NCT01863732|2095556|FG002|Overall Study|Death|0
1053305|NCT01863732|2095557|FG003|Overall Study|Death|1
1053306|NCT01863758|2095566|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
1053307|NCT01863758|2095566|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1
1053308|NCT01863771|2095570|FG000|Induction Phase|Adverse Event|9
1053309|NCT01863771|2095571|FG001|Induction Phase|Adverse Event|0
1053310|NCT01863771|2095572|FG002|Induction Phase|Adverse Event|0
1053311|NCT01863771|2095573|FG003|Induction Phase|Adverse Event|0
1053312|NCT01863771|2095570|FG000|Induction Phase|Lack of Efficacy|10
1053313|NCT01863771|2095571|FG001|Induction Phase|Lack of Efficacy|0
1053314|NCT01863771|2095572|FG002|Induction Phase|Lack of Efficacy|0
1053315|NCT01863771|2095573|FG003|Induction Phase|Lack of Efficacy|0
1053316|NCT01863771|2095570|FG000|Induction Phase|Withdrawal by Subject|2
1053317|NCT01863771|2095571|FG001|Induction Phase|Withdrawal by Subject|0
1053318|NCT01863771|2095572|FG002|Induction Phase|Withdrawal by Subject|0
1053319|NCT01863771|2095573|FG003|Induction Phase|Withdrawal by Subject|0
1053320|NCT01863771|2095570|FG000|Maintenance Phase|Adverse Event|0
1053321|NCT01863771|2095571|FG001|Maintenance Phase|Adverse Event|0
1053322|NCT01863771|2095572|FG002|Maintenance Phase|Adverse Event|1
1053323|NCT01863771|2095573|FG003|Maintenance Phase|Adverse Event|1
1053324|NCT01863771|2095570|FG000|Maintenance Phase|Lack of Efficacy|0
1053325|NCT01863771|2095571|FG001|Maintenance Phase|Lack of Efficacy|3
1053326|NCT01863771|2095572|FG002|Maintenance Phase|Lack of Efficacy|7
1053327|NCT01863771|2095573|FG003|Maintenance Phase|Lack of Efficacy|38
1053328|NCT01863771|2095570|FG000|Maintenance Phase|Physician Decision|0
1053329|NCT01863771|2095571|FG001|Maintenance Phase|Physician Decision|0
1053330|NCT01863771|2095572|FG002|Maintenance Phase|Physician Decision|2
1053331|NCT01863771|2095573|FG003|Maintenance Phase|Physician Decision|1
1053332|NCT01863771|2095570|FG000|Maintenance Phase|Pregnancy|0
1053333|NCT01863771|2095571|FG001|Maintenance Phase|Pregnancy|1
1053334|NCT01863771|2095572|FG002|Maintenance Phase|Pregnancy|0
1053335|NCT01863771|2095573|FG003|Maintenance Phase|Pregnancy|0
1053336|NCT01863771|2095570|FG000|Maintenance Phase|Withdrawal by Subject|0
1053337|NCT01863771|2095571|FG001|Maintenance Phase|Withdrawal by Subject|1
1053338|NCT01863771|2095572|FG002|Maintenance Phase|Withdrawal by Subject|2
1053339|NCT01863771|2095573|FG003|Maintenance Phase|Withdrawal by Subject|3
1053340|NCT01863849|2095583|FG000|Overall Study|Lost to Follow-up|1
1053341|NCT01863849|2095584|FG001|Overall Study|Lost to Follow-up|0
1053342|NCT01863953|2095594|FG000|Overall Study|Adverse Event|0
1053343|NCT01863953|2095595|FG001|Overall Study|Adverse Event|0
1053344|NCT01863953|2095596|FG002|Overall Study|Adverse Event|1
1053345|NCT01864005|2095606|FG000|Overall Study|Protocol Violation|0
1053346|NCT01864005|2095607|FG001|Overall Study|Protocol Violation|1
1053347|NCT01864005|2095606|FG000|Overall Study|Withdrawal by Subject|0
1053348|NCT01864005|2095607|FG001|Overall Study|Withdrawal by Subject|1
1053349|NCT01864005|2095606|FG000|Overall Study|Incorrect enrolment|1
1053350|NCT01864005|2095607|FG001|Overall Study|Incorrect enrolment|0
1053351|NCT01864005|2095606|FG000|Overall Study|Disease need|1
1053352|NCT01864005|2095607|FG001|Overall Study|Disease need|1
1053353|NCT01864005|2095606|FG000|Overall Study|Need GP IIb/IIIa|1
1053354|NCT01864005|2095607|FG001|Overall Study|Need GP IIb/IIIa|3
1053355|NCT01864148|2095618|FG000|Overall Study|Other|2
1053356|NCT01864148|2095619|FG001|Overall Study|Other|1
1053357|NCT01864148|2095620|FG002|Overall Study|Other|1
1053358|NCT01864148|2095621|FG003|Overall Study|Other|3
1053359|NCT01864148|2095622|FG004|Overall Study|Other|1
1053360|NCT01864148|2095618|FG000|Overall Study|Death|0
1053361|NCT01864148|2095619|FG001|Overall Study|Death|0
1053362|NCT01864148|2095620|FG002|Overall Study|Death|0
1053363|NCT01864148|2095621|FG003|Overall Study|Death|1
1053364|NCT01864148|2095622|FG004|Overall Study|Death|0
1053365|NCT01864148|2095618|FG000|Overall Study|Investigator Decision|5
1053366|NCT01864148|2095619|FG001|Overall Study|Investigator Decision|0
1053367|NCT01864148|2095620|FG002|Overall Study|Investigator Decision|0
1053368|NCT01864148|2095621|FG003|Overall Study|Investigator Decision|4
1053369|NCT01864148|2095622|FG004|Overall Study|Investigator Decision|6
1053370|NCT01864148|2095618|FG000|Overall Study|Withdrawal by Subject|9
1053371|NCT01864148|2095619|FG001|Overall Study|Withdrawal by Subject|2
1053372|NCT01864148|2095620|FG002|Overall Study|Withdrawal by Subject|6
1053373|NCT01864148|2095621|FG003|Overall Study|Withdrawal by Subject|8
1053374|NCT01864148|2095622|FG004|Overall Study|Withdrawal by Subject|8
1053375|NCT01864148|2095618|FG000|Overall Study|Lost to Follow-up|0
1053376|NCT01864148|2095619|FG001|Overall Study|Lost to Follow-up|0
1053377|NCT01864148|2095620|FG002|Overall Study|Lost to Follow-up|0
1053378|NCT01864148|2095621|FG003|Overall Study|Lost to Follow-up|2
1053379|NCT01864148|2095622|FG004|Overall Study|Lost to Follow-up|1
1053380|NCT01864148|2095618|FG000|Overall Study|Adverse Event|4
1053381|NCT01864148|2095619|FG001|Overall Study|Adverse Event|2
1053382|NCT01864148|2095620|FG002|Overall Study|Adverse Event|4
1053383|NCT01864148|2095621|FG003|Overall Study|Adverse Event|7
1053384|NCT01864148|2095622|FG004|Overall Study|Adverse Event|7
1053385|NCT01864148|2095618|FG000|Overall Study|Not Dosed|0
1053386|NCT01864148|2095619|FG001|Overall Study|Not Dosed|0
1053387|NCT01864148|2095620|FG002|Overall Study|Not Dosed|0
1053388|NCT01864148|2095621|FG003|Overall Study|Not Dosed|1
1053389|NCT01864148|2095622|FG004|Overall Study|Not Dosed|0
1053390|NCT01864174|2095641|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
1053391|NCT01864174|2095642|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
1053392|NCT01864174|2095641|FG000|Double Blind - Compliant Randomized|Adverse Event|6
1053393|NCT01864174|2095642|FG001|Double Blind - Compliant Randomized|Adverse Event|1
1053394|NCT01864174|2095641|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
1053395|NCT01864174|2095642|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
1053396|NCT01864174|2095641|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
1053397|NCT01864174|2095642|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
1053398|NCT01864174|2095641|FG000|Double Blind - Compliant Randomized|Death|1
1053399|NCT01864174|2095642|FG001|Double Blind - Compliant Randomized|Death|0
1053400|NCT01864174|2095641|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3
1053401|NCT01864174|2095642|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10
1053402|NCT01864174|2095641|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1
1053403|NCT01864174|2095642|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0
1053404|NCT01864174|2095641|FG000|Double Blind - Compliant Randomized|Other|6
1053405|NCT01864174|2095642|FG001|Double Blind - Compliant Randomized|Other|10
1053406|NCT01864174|2095641|FG000|Off Treatment Follow-Up|Other|2
1053407|NCT01864174|2095642|FG001|Off Treatment Follow-Up|Other|0
1053408|NCT01864174|2095641|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1
1053409|NCT01864174|2095642|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0
1053410|NCT01864200|2095650|FG000|Overall Study|Lost to Follow-up|1
1053411|NCT01864200|2095651|FG001|Overall Study|Lost to Follow-up|3
1053412|NCT01864200|2095650|FG000|Overall Study|Protocol Violation|1
1053413|NCT01864200|2095651|FG001|Overall Study|Protocol Violation|0
1053414|NCT01864291|2095657|FG000|Overall Study|need for revision surgery|2
1053415|NCT01864525|2095672|FG000|Overall Study|Adverse Event|1
1053416|NCT01864525|2095673|FG001|Overall Study|Adverse Event|0
1053417|NCT01864564|2095685|FG000|Overall Study|Lost to Follow-up|17
1053418|NCT01864564|2095686|FG001|Overall Study|Lost to Follow-up|23
1053419|NCT01864564|2095685|FG000|Overall Study|Withdrawal by Subject|20
1053420|NCT01864564|2095686|FG001|Overall Study|Withdrawal by Subject|11
1053421|NCT01864564|2095685|FG000|Overall Study|Protocol Violation|0
1053422|NCT01864564|2095686|FG001|Overall Study|Protocol Violation|27
1053423|NCT01864564|2095685|FG000|Overall Study|not reported|0
1053424|NCT01864564|2095686|FG001|Overall Study|not reported|34
1053425|NCT01865084|2095695|FG000|Double Blind Period (DB)|Adverse Event|2
1053426|NCT01865084|2095696|FG001|Double Blind Period (DB)|Adverse Event|2
1053427|NCT01865084|2095697|FG002|Double Blind Period (DB)|Adverse Event|1
1053428|NCT01865084|2095695|FG000|Double Blind Period (DB)|Protocol Violation|0
1053429|NCT01865084|2095696|FG001|Double Blind Period (DB)|Protocol Violation|0
1053430|NCT01865084|2095697|FG002|Double Blind Period (DB)|Protocol Violation|1
1053431|NCT01865084|2095695|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
1053432|NCT01865084|2095696|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
1053433|NCT01865084|2095697|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
1053434|NCT01865084|2095695|FG000|Double Blind Period (DB)|Withdrawal by Subject|1
1053435|NCT01865084|2095696|FG001|Double Blind Period (DB)|Withdrawal by Subject|0
1053436|NCT01865084|2095697|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
1053437|NCT01865084|2095695|FG000|Open Label Extension (OLE) Period|Adverse Event|0
1053438|NCT01865084|2095696|FG001|Open Label Extension (OLE) Period|Adverse Event|0
1053439|NCT01865084|2095697|FG002|Open Label Extension (OLE) Period|Adverse Event|1
1053440|NCT01865084|2095695|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0
1053441|NCT01865084|2095696|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0
1053442|NCT01865084|2095697|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2
1053443|NCT01865084|2095695|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0
1053444|NCT01865084|2095696|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1
1053445|NCT01865084|2095697|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0
1053446|NCT01865084|2095695|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
1053447|NCT01865084|2095696|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
1053448|NCT01865084|2095697|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
1053449|NCT01865084|2095695|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
1053450|NCT01865084|2095696|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2
1053451|NCT01865084|2095697|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2
1053452|NCT01865448|2095711|FG000|Overall Study|Adverse Event|1
1053453|NCT01865448|2095712|FG001|Overall Study|Adverse Event|1
1053454|NCT01865448|2095711|FG000|Overall Study|Pregnancy|0
1053455|NCT01865448|2095712|FG001|Overall Study|Pregnancy|1
1053456|NCT01865448|2095711|FG000|Overall Study|dropout unrelated to study|1
1053457|NCT01865448|2095712|FG001|Overall Study|dropout unrelated to study|1
1053458|NCT01865487|2095725|FG000|Overall Study|Lost to Follow-up|0
1053459|NCT01865487|2095726|FG001|Overall Study|Lost to Follow-up|0
1053460|NCT01865487|2095727|FG002|Overall Study|Lost to Follow-up|0
1053461|NCT01865487|2095728|FG003|Overall Study|Lost to Follow-up|1
1053462|NCT01865487|2095729|FG004|Overall Study|Lost to Follow-up|0
1053463|NCT01865487|2095730|FG005|Overall Study|Lost to Follow-up|0
1053464|NCT01865487|2095731|FG006|Overall Study|Lost to Follow-up|1
1053465|NCT01865487|2095732|FG007|Overall Study|Lost to Follow-up|0
1053466|NCT01865487|2095733|FG008|Overall Study|Lost to Follow-up|0
1053467|NCT01865487|2095734|FG009|Overall Study|Lost to Follow-up|0
1053468|NCT01865487|2095725|FG000|Overall Study|Withdrawal by Subject|0
1053469|NCT01865487|2095726|FG001|Overall Study|Withdrawal by Subject|0
1053470|NCT01865487|2095727|FG002|Overall Study|Withdrawal by Subject|0
1053471|NCT01865487|2095728|FG003|Overall Study|Withdrawal by Subject|0
1053472|NCT01865487|2095729|FG004|Overall Study|Withdrawal by Subject|1
1053473|NCT01865487|2095730|FG005|Overall Study|Withdrawal by Subject|0
1053474|NCT01865487|2095731|FG006|Overall Study|Withdrawal by Subject|0
1053475|NCT01865487|2095732|FG007|Overall Study|Withdrawal by Subject|0
1053476|NCT01865487|2095733|FG008|Overall Study|Withdrawal by Subject|0
1053477|NCT01865487|2095734|FG009|Overall Study|Withdrawal by Subject|0
1053478|NCT01865552|2095768|FG000|Period 1|Adverse Event|1
1053479|NCT01865552|2095769|FG001|Period 1|Adverse Event|0
1053480|NCT01865552|2095770|FG002|Period 1|Adverse Event|0
1053481|NCT01865552|2095771|FG003|Period 1|Adverse Event|1
1053482|NCT01865552|2095772|FG004|Period 1|Adverse Event|1
1053483|NCT01865552|2095773|FG005|Period 1|Adverse Event|1
1053484|NCT01865552|2095768|FG000|Period 1|Pathological lab|0
1053485|NCT01865552|2095769|FG001|Period 1|Pathological lab|0
1053486|NCT01865552|2095770|FG002|Period 1|Pathological lab|0
1053487|NCT01865552|2095771|FG003|Period 1|Pathological lab|0
1053488|NCT01865552|2095772|FG004|Period 1|Pathological lab|1
1053489|NCT01865552|2095773|FG005|Period 1|Pathological lab|0
1053490|NCT01865552|2095768|FG000|Period 1|Other|0
1053491|NCT01865552|2095769|FG001|Period 1|Other|0
1053492|NCT01865552|2095770|FG002|Period 1|Other|0
1053493|NCT01865552|2095771|FG003|Period 1|Other|0
1053494|NCT01865552|2095772|FG004|Period 1|Other|1
1053495|NCT01865552|2095773|FG005|Period 1|Other|0
1053496|NCT01865747|2095793|FG000|Overall Study (ITT)|Adverse Event|32
1053497|NCT01865747|2095794|FG001|Overall Study (ITT)|Adverse Event|31
1053498|NCT01865747|2095793|FG000|Overall Study (ITT)|Clinical Deterioration|29
1053499|NCT01865747|2095794|FG001|Overall Study (ITT)|Clinical Deterioration|50
1053500|NCT01865747|2095793|FG000|Overall Study (ITT)|Lack of Efficacy|3
1053501|NCT01865747|2095794|FG001|Overall Study (ITT)|Lack of Efficacy|0
1053502|NCT01865747|2095793|FG000|Overall Study (ITT)|Protocol Violation|1
1053503|NCT01865747|2095794|FG001|Overall Study (ITT)|Protocol Violation|1
1053504|NCT01865747|2095793|FG000|Overall Study (ITT)|Physician Decision|5
1053505|NCT01865747|2095794|FG001|Overall Study (ITT)|Physician Decision|2
1053506|NCT01865747|2095793|FG000|Overall Study (ITT)|Withdrawal by Subject|6
1053507|NCT01865747|2095794|FG001|Overall Study (ITT)|Withdrawal by Subject|11
1053508|NCT01865747|2095793|FG000|Overall Study (ITT)|Sponsor Decision|0
1053509|NCT01865747|2095794|FG001|Overall Study (ITT)|Sponsor Decision|1
1053510|NCT01865747|2095793|FG000|Overall Study (ITT)|Progressive Disease|122
1053511|NCT01865747|2095794|FG001|Overall Study (ITT)|Progressive Disease|158
1053512|NCT01865747|2095793|FG000|Overall Study (ITT)|Reason Not Provided|0
1053513|NCT01865747|2095794|FG001|Overall Study (ITT)|Reason Not Provided|1
1053514|NCT01865747|2095793|FG000|Primary Intent to Treat (PITT)|Adverse Event|21
1053515|NCT01865747|2095794|FG001|Primary Intent to Treat (PITT)|Adverse Event|20
1053516|NCT01865747|2095793|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18
1053517|NCT01865747|2095794|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29
1053518|NCT01865747|2095793|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2
1053519|NCT01865747|2095794|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0
1053520|NCT01865747|2095793|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1
1053521|NCT01865747|2095794|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1
1053522|NCT01865747|2095793|FG000|Primary Intent to Treat (PITT)|Physician Decision|4
1053523|NCT01865747|2095794|FG001|Primary Intent to Treat (PITT)|Physician Decision|2
1053524|NCT01865747|2095793|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
1053525|NCT01865747|2095794|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
1053526|NCT01865747|2095793|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82
1053527|NCT01865747|2095794|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92
1053528|NCT01865747|2095793|FG000|Primary Intent to Treat (PITT)|Other|0
1053529|NCT01865747|2095794|FG001|Primary Intent to Treat (PITT)|Other|1
1053530|NCT01865812|2095800|FG000|Overall Study|Adverse Event|2
1053531|NCT01866098|2095807|FG000|Overall Study|Lost to Follow-up|11
1053532|NCT01866098|2095808|FG001|Overall Study|Lost to Follow-up|18
1053533|NCT01866098|2095809|FG002|Overall Study|Lost to Follow-up|13
1053534|NCT01866098|2095807|FG000|Overall Study|Physician Decision|0
1053535|NCT01866098|2095808|FG001|Overall Study|Physician Decision|1
1053536|NCT01866098|2095809|FG002|Overall Study|Physician Decision|2
1053537|NCT01866098|2095807|FG000|Overall Study|Adverse Event|1
1053538|NCT01866098|2095808|FG001|Overall Study|Adverse Event|5
1053539|NCT01866098|2095809|FG002|Overall Study|Adverse Event|4
1053540|NCT01866098|2095807|FG000|Overall Study|Protocol Violation|1
1053541|NCT01866098|2095808|FG001|Overall Study|Protocol Violation|0
1053542|NCT01866098|2095809|FG002|Overall Study|Protocol Violation|0
1053543|NCT01866098|2095807|FG000|Overall Study|Withdrawal by Subject|1
1053544|NCT01866098|2095808|FG001|Overall Study|Withdrawal by Subject|2
1053545|NCT01866098|2095809|FG002|Overall Study|Withdrawal by Subject|0
1053546|NCT01866098|2095807|FG000|Overall Study|Unrelated Hospitalization|2
1053547|NCT01866098|2095808|FG001|Overall Study|Unrelated Hospitalization|0
1053548|NCT01866098|2095809|FG002|Overall Study|Unrelated Hospitalization|1
1053549|NCT01866098|2095807|FG000|Overall Study|Non-compliance|1
1053550|NCT01866098|2095808|FG001|Overall Study|Non-compliance|0
1053551|NCT01866098|2095809|FG002|Overall Study|Non-compliance|1
1053552|NCT01866098|2095807|FG000|Overall Study|Pregnancy|2
1053553|NCT01866098|2095808|FG001|Overall Study|Pregnancy|0
1053554|NCT01866098|2095809|FG002|Overall Study|Pregnancy|0
1053555|NCT01866098|2095807|FG000|Overall Study|Death|0
1053556|NCT01866098|2095808|FG001|Overall Study|Death|1
1053557|NCT01866098|2095809|FG002|Overall Study|Death|0
1053558|NCT01866293|2095833|FG000|Overall Study|Adverse Event|2
1053559|NCT01866319|2095869|FG000|Overall Study|Adverse Event|12
1053560|NCT01866319|2095870|FG001|Overall Study|Adverse Event|5
1053561|NCT01866319|2095871|FG002|Overall Study|Adverse Event|9
1053562|NCT01866319|2095869|FG000|Overall Study|Clinical progression|3
1053563|NCT01866319|2095870|FG001|Overall Study|Clinical progression|2
1053564|NCT01866319|2095871|FG002|Overall Study|Clinical progression|2
1053565|NCT01866319|2095869|FG000|Overall Study|Death|153
1053566|NCT01866319|2095870|FG001|Overall Study|Death|154
1053567|NCT01866319|2095871|FG002|Overall Study|Death|147
1053568|NCT01866319|2095869|FG000|Overall Study|Lost to Follow-up|6
1053569|NCT01866319|2095870|FG001|Overall Study|Lost to Follow-up|3
1053570|NCT01866319|2095871|FG002|Overall Study|Lost to Follow-up|8
1053571|NCT01866319|2095869|FG000|Overall Study|Physician Decision|1
1053572|NCT01866319|2095870|FG001|Overall Study|Physician Decision|0
1053573|NCT01866319|2095871|FG002|Overall Study|Physician Decision|1
1053574|NCT01866319|2095869|FG000|Overall Study|Protocol Violation|0
1053575|NCT01866319|2095870|FG001|Overall Study|Protocol Violation|0
1053576|NCT01866319|2095871|FG002|Overall Study|Protocol Violation|1
1053577|NCT01866319|2095869|FG000|Overall Study|Withdrawal by Subject|32
1053578|NCT01866319|2095870|FG001|Overall Study|Withdrawal by Subject|14
1053579|NCT01866319|2095871|FG002|Overall Study|Withdrawal by Subject|12
1053580|NCT01866423|2095886|FG000|Overall Study|Lack of Efficacy|3
1053581|NCT01866423|2095886|FG000|Overall Study|Sponsor Decision|1
1053582|NCT01866826|2095894|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
1053583|NCT01866826|2095895|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
1053584|NCT01866826|2095894|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
1053585|NCT01866826|2095895|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
1053586|NCT01866826|2095894|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
1053587|NCT01866826|2095895|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
1053588|NCT01866917|2095907|FG000|Overall Study|Pharmacist stopped dispensing treatment|4
1053589|NCT01866917|2095908|FG001|Overall Study|Pharmacist stopped dispensing treatment|6
1053590|NCT01867008|2095926|FG000|Overall Study|Withdrawal by Subject|1
1053591|NCT01867021|2095932|FG000|Overall Study|Adverse Event|0
1053592|NCT01867021|2095933|FG001|Overall Study|Adverse Event|1
1053593|NCT01867021|2095932|FG000|Overall Study|Not Eligible|0
1053594|NCT01867021|2095933|FG001|Overall Study|Not Eligible|1
1053595|NCT01867021|2095932|FG000|Overall Study|Death|1
1053596|NCT01867021|2095933|FG001|Overall Study|Death|0
1053597|NCT01867021|2095932|FG000|Overall Study|Lost to Follow-up|0
1053598|NCT01867021|2095933|FG001|Overall Study|Lost to Follow-up|2
1053599|NCT01867021|2095932|FG000|Overall Study|Withdrawal by Subject|1
1053600|NCT01867021|2095933|FG001|Overall Study|Withdrawal by Subject|6
1053601|NCT01867047|2095946|FG000|Overall Study|Lost to Follow-up|3
1053602|NCT01867047|2095947|FG001|Overall Study|Lost to Follow-up|3
1053603|NCT01867047|2095946|FG000|Overall Study|Withdrawal by Subject|2
1053604|NCT01867047|2095947|FG001|Overall Study|Withdrawal by Subject|0
1053605|NCT01867047|2095946|FG000|Overall Study|Physician Decision|2
1053606|NCT01867047|2095947|FG001|Overall Study|Physician Decision|0
1053607|NCT01867047|2095946|FG000|Overall Study|surgery not indicated in protocol|1
1053608|NCT01867047|2095947|FG001|Overall Study|surgery not indicated in protocol|2
1053609|NCT01867086|2095957|FG000|Overall Study|Disease Progression|1
1053610|NCT01867216|2095977|FG000|Overall Study|Withdrawal by Subject|2
1053611|NCT01867216|2095978|FG001|Overall Study|Withdrawal by Subject|0
1053612|NCT01867216|2095979|FG002|Overall Study|Withdrawal by Subject|0
1053613|NCT01867216|2095980|FG003|Overall Study|Withdrawal by Subject|0
1053614|NCT01867216|2095981|FG004|Overall Study|Withdrawal by Subject|1
1053615|NCT01867216|2095982|FG005|Overall Study|Withdrawal by Subject|0
1053616|NCT01867216|2095983|FG006|Overall Study|Withdrawal by Subject|1
1053617|NCT01867216|2095977|FG000|Overall Study|Physician Decision|1
1053618|NCT01867216|2095978|FG001|Overall Study|Physician Decision|0
1053619|NCT01867216|2095979|FG002|Overall Study|Physician Decision|0
1053620|NCT01867216|2095980|FG003|Overall Study|Physician Decision|0
1053621|NCT01867216|2095981|FG004|Overall Study|Physician Decision|0
1053622|NCT01867216|2095982|FG005|Overall Study|Physician Decision|0
1053623|NCT01867216|2095983|FG006|Overall Study|Physician Decision|0
1053624|NCT01867216|2095977|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1
1053625|NCT01867216|2095978|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0
1053626|NCT01867216|2095979|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0
1053627|NCT01867216|2095980|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0
1053628|NCT01867216|2095981|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0
1053629|NCT01867216|2095982|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0
1053630|NCT01867216|2095983|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0
1053631|NCT01867294|2096009|FG000|Overall Study|Withdrawal by Subject|1
1053632|NCT01867294|2096010|FG001|Overall Study|Withdrawal by Subject|1
1053633|NCT01867294|2096011|FG002|Overall Study|Withdrawal by Subject|0
1053634|NCT01867294|2096012|FG003|Overall Study|Withdrawal by Subject|0
1053635|NCT01867307|2096022|FG000|Overall Study|Protocol Violation|2
1053636|NCT01867307|2096023|FG001|Overall Study|Protocol Violation|0
1053637|NCT01867307|2096022|FG000|Overall Study|Other Adverse Event|1
1053638|NCT01867307|2096023|FG001|Overall Study|Other Adverse Event|3
1053639|NCT01867424|2096031|FG000|Overall Study|Patient noncompliance|2
1053640|NCT01867424|2096032|FG001|Overall Study|Patient noncompliance|1
1053641|NCT01867580|2096053|FG000|Overall Study|Withdrawal by Subject|2
1053642|NCT01867580|2096054|FG001|Overall Study|Withdrawal by Subject|3
1053643|NCT01867580|2096053|FG000|Overall Study|Physician Decision|17
1053644|NCT01867580|2096054|FG001|Overall Study|Physician Decision|12
1053645|NCT01867580|2096053|FG000|Overall Study|Lost to Follow-up|3
1053646|NCT01867580|2096054|FG001|Overall Study|Lost to Follow-up|5
1053647|NCT01867580|2096053|FG000|Overall Study|Sponsor terminated study|1
1053648|NCT01867580|2096054|FG001|Overall Study|Sponsor terminated study|0
1053649|NCT01867580|2096053|FG000|Overall Study|Missed follow-up assessment|2
1053650|NCT01867580|2096054|FG001|Overall Study|Missed follow-up assessment|1
1053651|NCT01867580|2096053|FG000|Overall Study|Interruption to therapy|3
1053652|NCT01867580|2096054|FG001|Overall Study|Interruption to therapy|0
1053653|NCT01867580|2096053|FG000|Overall Study|Osteomyelitis|0
1053654|NCT01867580|2096054|FG001|Overall Study|Osteomyelitis|1
1053655|NCT01867580|2096053|FG000|Overall Study|Continuation of therapy|0
1053656|NCT01867580|2096054|FG001|Overall Study|Continuation of therapy|1
1053657|NCT01867580|2096053|FG000|Overall Study|Wound recurrence|0
1053658|NCT01867580|2096054|FG001|Overall Study|Wound recurrence|1
1053659|NCT01867606|2096062|FG000|Overall Study|Withdrawal by Subject|10
1053660|NCT01867606|2096063|FG001|Overall Study|Withdrawal by Subject|14
1053661|NCT01867606|2096062|FG000|Overall Study|Protocol Violation|0
1053662|NCT01867606|2096063|FG001|Overall Study|Protocol Violation|1
1053663|NCT01867658|2096084|FG000|Overall Study|Withdrawal by Subject|6
1053664|NCT01867658|2096084|FG000|Overall Study|Death|2
1053665|NCT01867658|2096084|FG000|Overall Study|Subject could not be contacted|1
1053666|NCT01867671|2096090|FG000|Overall Study|Adverse Event|5
1053667|NCT01867671|2096091|FG001|Overall Study|Adverse Event|3
1053668|NCT01867671|2096090|FG000|Overall Study|Anaphylaxis|0
1053669|NCT01867671|2096091|FG001|Overall Study|Anaphylaxis|1
1053670|NCT01867671|2096090|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2
1053671|NCT01867671|2096091|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0
1053672|NCT01867671|2096090|FG000|Overall Study|Lost to Follow-up|0
1053673|NCT01867671|2096091|FG001|Overall Study|Lost to Follow-up|1
1053674|NCT01867671|2096090|FG000|Overall Study|Non-compliance with Study Drug|1
1053675|NCT01867671|2096091|FG001|Overall Study|Non-compliance with Study Drug|2
1053676|NCT01867671|2096090|FG000|Overall Study|Withdrawal by Subject|21
1053677|NCT01867671|2096091|FG001|Overall Study|Withdrawal by Subject|21
1053678|NCT01867710|2096101|FG000|Overall Study|Death|25
1053679|NCT01867710|2096102|FG001|Overall Study|Death|15
1053680|NCT01867710|2096103|FG002|Overall Study|Death|27
1053681|NCT01867710|2096104|FG003|Overall Study|Death|20
1053682|NCT01867710|2096101|FG000|Overall Study|Lost to Follow-up|3
1053683|NCT01867710|2096102|FG001|Overall Study|Lost to Follow-up|4
1053684|NCT01867710|2096103|FG002|Overall Study|Lost to Follow-up|3
1053685|NCT01867710|2096104|FG003|Overall Study|Lost to Follow-up|2
1053686|NCT01867710|2096101|FG000|Overall Study|Withdrawal of consent|2
1053687|NCT01867710|2096102|FG001|Overall Study|Withdrawal of consent|5
1053688|NCT01867710|2096103|FG002|Overall Study|Withdrawal of consent|1
1053689|NCT01867710|2096104|FG003|Overall Study|Withdrawal of consent|2
1053690|NCT01867710|2096101|FG000|Overall Study|Study Terminated by Sponsor|9
1053691|NCT01867710|2096102|FG001|Overall Study|Study Terminated by Sponsor|13
1053692|NCT01867710|2096103|FG002|Overall Study|Study Terminated by Sponsor|8
1053693|NCT01867710|2096104|FG003|Overall Study|Study Terminated by Sponsor|16
1053694|NCT01867710|2096101|FG000|Overall Study|Biochemical progression|0
1053695|NCT01867710|2096102|FG001|Overall Study|Biochemical progression|1
1053696|NCT01867710|2096103|FG002|Overall Study|Biochemical progression|0
1053697|NCT01867710|2096104|FG003|Overall Study|Biochemical progression|0
1053698|NCT01867710|2096101|FG000|Overall Study|Clinical progression|0
1053699|NCT01867710|2096102|FG001|Overall Study|Clinical progression|0
1053700|NCT01867710|2096103|FG002|Overall Study|Clinical progression|1
1053701|NCT01867710|2096104|FG003|Overall Study|Clinical progression|0
1053702|NCT01867710|2096101|FG000|Overall Study|Disease progression|1
1053703|NCT01867710|2096102|FG001|Overall Study|Disease progression|0
1053704|NCT01867710|2096103|FG002|Overall Study|Disease progression|0
1053705|NCT01867710|2096104|FG003|Overall Study|Disease progression|0
1053706|NCT01867710|2096101|FG000|Overall Study|Patient decision|0
1053707|NCT01867710|2096102|FG001|Overall Study|Patient decision|0
1053708|NCT01867710|2096103|FG002|Overall Study|Patient decision|0
1053709|NCT01867710|2096104|FG003|Overall Study|Patient decision|1
1053710|NCT01867710|2096101|FG000|Overall Study|Patient to follow subsequent treatment|0
1162036|NCT03381196|2283977|FG001|Overall Study|Death|1
1053711|NCT01867710|2096102|FG001|Overall Study|Patient to follow subsequent treatment|1
1053712|NCT01867710|2096103|FG002|Overall Study|Patient to follow subsequent treatment|0
1053713|NCT01867710|2096104|FG003|Overall Study|Patient to follow subsequent treatment|0
1053714|NCT01867710|2096101|FG000|Overall Study|Progressive disease|1
1053715|NCT01867710|2096102|FG001|Overall Study|Progressive disease|0
1053716|NCT01867710|2096103|FG002|Overall Study|Progressive disease|0
1053717|NCT01867710|2096104|FG003|Overall Study|Progressive disease|0
1053718|NCT01867710|2096101|FG000|Overall Study|Protocol Violation|0
1053719|NCT01867710|2096102|FG001|Overall Study|Protocol Violation|0
1053720|NCT01867710|2096103|FG002|Overall Study|Protocol Violation|0
1053721|NCT01867710|2096104|FG003|Overall Study|Protocol Violation|1
1053722|NCT01867710|2096101|FG000|Overall Study|PSA-progression|0
1053723|NCT01867710|2096102|FG001|Overall Study|PSA-progression|1
1053724|NCT01867710|2096103|FG002|Overall Study|PSA-progression|0
1053725|NCT01867710|2096104|FG003|Overall Study|PSA-progression|0
1053726|NCT01867710|2096101|FG000|Overall Study|Study medication no longer effective|0
1053727|NCT01867710|2096102|FG001|Overall Study|Study medication no longer effective|1
1053728|NCT01867710|2096103|FG002|Overall Study|Study medication no longer effective|0
1053729|NCT01867710|2096104|FG003|Overall Study|Study medication no longer effective|0
1053730|NCT01868009|2096114|FG000|Period 1 (5-9 Days)|Adverse Event|0
1053731|NCT01868009|2096115|FG001|Period 1 (5-9 Days)|Adverse Event|2
1053732|NCT01868009|2096114|FG000|Period 2 (5-9 Days)|Adverse Event|1
1053733|NCT01868009|2096115|FG001|Period 2 (5-9 Days)|Adverse Event|0
1053734|NCT01868009|2096114|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
1053735|NCT01868009|2096115|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
1053736|NCT01868022|2096130|FG000|Overall Study|Withdrawal by Subject|0
1053737|NCT01868022|2096131|FG001|Overall Study|Withdrawal by Subject|0
1053738|NCT01868022|2096132|FG002|Overall Study|Withdrawal by Subject|1
1053739|NCT01868022|2096133|FG003|Overall Study|Withdrawal by Subject|1
1053740|NCT01868022|2096134|FG004|Overall Study|Withdrawal by Subject|0
1053741|NCT01868022|2096135|FG005|Overall Study|Withdrawal by Subject|0
1053742|NCT01868022|2096136|FG006|Overall Study|Withdrawal by Subject|0
1053743|NCT01868022|2096137|FG007|Overall Study|Withdrawal by Subject|1
1053744|NCT01868022|2096138|FG008|Overall Study|Withdrawal by Subject|0
1053745|NCT01868022|2096130|FG000|Overall Study|Adverse Event|0
1053746|NCT01868022|2096131|FG001|Overall Study|Adverse Event|0
1053747|NCT01868022|2096132|FG002|Overall Study|Adverse Event|0
1053748|NCT01868022|2096133|FG003|Overall Study|Adverse Event|0
1053749|NCT01868022|2096134|FG004|Overall Study|Adverse Event|2
1053750|NCT01868022|2096135|FG005|Overall Study|Adverse Event|0
1053751|NCT01868022|2096136|FG006|Overall Study|Adverse Event|0
1053752|NCT01868022|2096137|FG007|Overall Study|Adverse Event|2
1053753|NCT01868022|2096138|FG008|Overall Study|Adverse Event|2
1053754|NCT01868022|2096130|FG000|Overall Study|Physician Decision|0
1053755|NCT01868022|2096131|FG001|Overall Study|Physician Decision|0
1053756|NCT01868022|2096132|FG002|Overall Study|Physician Decision|0
1053757|NCT01868022|2096133|FG003|Overall Study|Physician Decision|0
1053758|NCT01868022|2096134|FG004|Overall Study|Physician Decision|0
1053759|NCT01868022|2096135|FG005|Overall Study|Physician Decision|1
1053760|NCT01868022|2096136|FG006|Overall Study|Physician Decision|0
1053761|NCT01868022|2096137|FG007|Overall Study|Physician Decision|2
1053762|NCT01868022|2096138|FG008|Overall Study|Physician Decision|0
1053763|NCT01868022|2096130|FG000|Overall Study|Study closed/terminated|0
1053764|NCT01868022|2096131|FG001|Overall Study|Study closed/terminated|0
1053765|NCT01868022|2096132|FG002|Overall Study|Study closed/terminated|0
1053766|NCT01868022|2096133|FG003|Overall Study|Study closed/terminated|0
1053767|NCT01868022|2096134|FG004|Overall Study|Study closed/terminated|0
1053768|NCT01868022|2096135|FG005|Overall Study|Study closed/terminated|0
1053769|NCT01868022|2096136|FG006|Overall Study|Study closed/terminated|0
1053770|NCT01868022|2096137|FG007|Overall Study|Study closed/terminated|1
1053771|NCT01868022|2096138|FG008|Overall Study|Study closed/terminated|0
1053772|NCT01868022|2096130|FG000|Overall Study|Ongoing|0
1053773|NCT01868022|2096131|FG001|Overall Study|Ongoing|0
1053774|NCT01868022|2096132|FG002|Overall Study|Ongoing|0
1053775|NCT01868022|2096133|FG003|Overall Study|Ongoing|0
1053776|NCT01868022|2096134|FG004|Overall Study|Ongoing|0
1053777|NCT01868022|2096135|FG005|Overall Study|Ongoing|0
1053778|NCT01868022|2096136|FG006|Overall Study|Ongoing|0
1053779|NCT01868022|2096137|FG007|Overall Study|Ongoing|3
1053780|NCT01868022|2096138|FG008|Overall Study|Ongoing|0
1053781|NCT01868035|2096164|FG000|Overall Study|Lost to Follow-up|3
1053782|NCT01868035|2096164|FG000|Overall Study|Withdrawal by Subject|1
1053783|NCT01868035|2096164|FG000|Overall Study|Progressive Disease|2
1053784|NCT01868035|2096164|FG000|Overall Study|Non-compliance|1
1053785|NCT01868074|2096170|FG000|Overall Study|Lost to Follow-up|3
1053786|NCT01868074|2096171|FG001|Overall Study|Lost to Follow-up|2
1053787|NCT01868074|2096170|FG000|Overall Study|Withdrawal by Subject|4
1053788|NCT01868074|2096171|FG001|Overall Study|Withdrawal by Subject|2
1053789|NCT01868165|2096177|FG000|Overall Study|Withdrawal by Subject|36
1053790|NCT01868165|2096177|FG000|Overall Study|Physician Decision|2
1053791|NCT01868165|2096177|FG000|Overall Study|Lost to Follow-up|3
1053792|NCT01868165|2096177|FG000|Overall Study|Death|4
1053793|NCT01868243|2096183|FG000|Overall Study|Death|0
1053794|NCT01868243|2096184|FG001|Overall Study|Death|1
1053795|NCT01868477|2096246|FG000|Overall Study|Adverse Event|2
1053796|NCT01868477|2096247|FG001|Overall Study|Adverse Event|4
1053797|NCT01868477|2096246|FG000|Overall Study|Disease progression|1
1053798|NCT01868477|2096247|FG001|Overall Study|Disease progression|1
1053799|NCT01868477|2096246|FG000|Overall Study|Withdrawal by Subject|1
1053800|NCT01868477|2096247|FG001|Overall Study|Withdrawal by Subject|0
1053801|NCT01868503|2096260|FG000|Overall Study|Withdrawal by Subject|1
1053802|NCT01868503|2096260|FG000|Overall Study|Protocol Violation|1
1053803|NCT01868542|2096268|FG000|Overall Study|Protocol Violation|0
1053804|NCT01868542|2096269|FG001|Overall Study|Protocol Violation|1
1053805|NCT01868542|2096268|FG000|Overall Study|Unclassified|0
1053806|NCT01868542|2096269|FG001|Overall Study|Unclassified|1
1053807|NCT01868594|2096277|FG000|Overall Study|Do not meet inclusion criteria|4
1053808|NCT01868594|2096278|FG001|Overall Study|Do not meet inclusion criteria|3
1053809|NCT01868646|2096297|FG000|Overall Study|Do not meet inclusion criteria|3
1053810|NCT01868646|2096298|FG001|Overall Study|Do not meet inclusion criteria|5
1053811|NCT01868893|2096322|FG000|Overall Study|Adverse Event|2
1053812|NCT01868893|2096322|FG000|Overall Study|Commercial availability of study drug|17
1053813|NCT01868893|2096322|FG000|Overall Study|Neutropenia|1
1053814|NCT01868997|2096330|FG000|Overall Study|Adverse Event|2
1053815|NCT01868997|2096331|FG001|Overall Study|Adverse Event|5
1053816|NCT01868997|2096330|FG000|Overall Study|Lack of Efficacy|2
1053817|NCT01868997|2096331|FG001|Overall Study|Lack of Efficacy|0
1053818|NCT01868997|2096330|FG000|Overall Study|Other|3
1053819|NCT01868997|2096331|FG001|Overall Study|Other|1
1053820|NCT01869192|2096364|FG000|Preoperative Chemotherapy to Surgery|patient choice|2
1053821|NCT01869192|2096365|FG001|Preoperative Chemotherapy to Surgery|patient choice|1
1053822|NCT01869192|2096364|FG000|Postoperative Chemotherapy|Physician Decision|0
1053823|NCT01869192|2096365|FG001|Postoperative Chemotherapy|Physician Decision|2
1053824|NCT01869348|2096373|FG000|Overall Study|Withdrawal by Subject|1
1053825|NCT01869348|2096374|FG001|Overall Study|Withdrawal by Subject|1
1053826|NCT01869699|2096421|FG000|Overall Study|Withdrawal by Subject|1
1053827|NCT01869699|2096422|FG001|Overall Study|Withdrawal by Subject|0
1053828|NCT01869725|2096428|FG000|Overall Study|ineligible after registration|1
1053829|NCT01869725|2096428|FG000|Overall Study|Death|1
1053830|NCT01869725|2096428|FG000|Overall Study|Lost to Follow-up|2
1053831|NCT01869764|2096434|FG000|Overall Study|Withdrawal by Subject|0
1053832|NCT01869764|2096435|FG001|Overall Study|Withdrawal by Subject|2
1053833|NCT01869777|2096441|FG000|Overall Study|Excluded from the analysis, ineligible|1
1053834|NCT01869959|2096449|FG000|Randomization Period|Physician Decision|0
1053835|NCT01869959|2096450|FG001|Randomization Period|Physician Decision|0
1053836|NCT01869959|2096451|FG002|Randomization Period|Physician Decision|0
1053837|NCT01869959|2096452|FG003|Randomization Period|Physician Decision|0
1053838|NCT01869959|2096453|FG004|Randomization Period|Physician Decision|1
1053839|NCT01869959|2096449|FG000|Treatment Period|Adverse Event|1
1053840|NCT01869959|2096450|FG001|Treatment Period|Adverse Event|0
1053841|NCT01869959|2096451|FG002|Treatment Period|Adverse Event|3
1053842|NCT01869959|2096452|FG003|Treatment Period|Adverse Event|1
1053843|NCT01869959|2096453|FG004|Treatment Period|Adverse Event|0
1053844|NCT01869959|2096449|FG000|Treatment Period|Sponsor decision|0
1053845|NCT01869959|2096450|FG001|Treatment Period|Sponsor decision|1
1053846|NCT01869959|2096451|FG002|Treatment Period|Sponsor decision|0
1053847|NCT01869959|2096452|FG003|Treatment Period|Sponsor decision|1
1053848|NCT01869959|2096453|FG004|Treatment Period|Sponsor decision|0
1053849|NCT01869959|2096449|FG000|Treatment Period|Withdrawal by Subject|0
1053850|NCT01869959|2096450|FG001|Treatment Period|Withdrawal by Subject|1
1053851|NCT01869959|2096451|FG002|Treatment Period|Withdrawal by Subject|0
1053852|NCT01869959|2096452|FG003|Treatment Period|Withdrawal by Subject|0
1053853|NCT01869959|2096453|FG004|Treatment Period|Withdrawal by Subject|0
1053854|NCT01870076|2096467|FG000|Overall Study|Withdrawal by Subject|1
1053855|NCT01870076|2096468|FG001|Overall Study|Withdrawal by Subject|0
1053856|NCT01870076|2096469|FG002|Overall Study|Withdrawal by Subject|1
1053857|NCT01870076|2096470|FG003|Overall Study|Withdrawal by Subject|0
1053858|NCT01870297|2096487|FG000|Overall Study|Adverse Event|0
1053859|NCT01870297|2096488|FG001|Overall Study|Adverse Event|0
1053860|NCT01870297|2096489|FG002|Overall Study|Adverse Event|0
1053861|NCT01870297|2096490|FG003|Overall Study|Adverse Event|0
1053862|NCT01870297|2096491|FG004|Overall Study|Adverse Event|2
1053863|NCT01870297|2096492|FG005|Overall Study|Adverse Event|0
1053864|NCT01870297|2096493|FG006|Overall Study|Adverse Event|0
1053865|NCT01870297|2096487|FG000|Overall Study|Lost to Follow-up|0
1053866|NCT01870297|2096488|FG001|Overall Study|Lost to Follow-up|1
1053867|NCT01870297|2096489|FG002|Overall Study|Lost to Follow-up|1
1053868|NCT01870297|2096490|FG003|Overall Study|Lost to Follow-up|0
1053869|NCT01870297|2096491|FG004|Overall Study|Lost to Follow-up|0
1053870|NCT01870297|2096492|FG005|Overall Study|Lost to Follow-up|0
1053871|NCT01870297|2096493|FG006|Overall Study|Lost to Follow-up|0
1053872|NCT01870297|2096487|FG000|Overall Study|Withdrawal by Subject|0
1053873|NCT01870297|2096488|FG001|Overall Study|Withdrawal by Subject|0
1053874|NCT01870297|2096489|FG002|Overall Study|Withdrawal by Subject|0
1053875|NCT01870297|2096490|FG003|Overall Study|Withdrawal by Subject|0
1053876|NCT01870297|2096491|FG004|Overall Study|Withdrawal by Subject|1
1053877|NCT01870297|2096492|FG005|Overall Study|Withdrawal by Subject|1
1053878|NCT01870297|2096493|FG006|Overall Study|Withdrawal by Subject|1
1053879|NCT01870297|2096487|FG000|Overall Study|Sponsor Decision|0
1053880|NCT01870297|2096488|FG001|Overall Study|Sponsor Decision|6
1053881|NCT01870297|2096489|FG002|Overall Study|Sponsor Decision|0
1053882|NCT01870297|2096490|FG003|Overall Study|Sponsor Decision|0
1053883|NCT01870297|2096491|FG004|Overall Study|Sponsor Decision|0
1053884|NCT01870297|2096492|FG005|Overall Study|Sponsor Decision|0
1053885|NCT01870297|2096493|FG006|Overall Study|Sponsor Decision|1
1053886|NCT01870401|2096531|FG000|Overall Study|Death|48
1053887|NCT01870401|2096532|FG001|Overall Study|Death|24
1053888|NCT01870401|2096531|FG000|Overall Study|Withdrawal by Subject|39
1053889|NCT01870401|2096532|FG001|Overall Study|Withdrawal by Subject|26
1053890|NCT01870401|2096531|FG000|Overall Study|Lost to Follow-up|19
1053891|NCT01870401|2096532|FG001|Overall Study|Lost to Follow-up|14
1053892|NCT01870401|2096531|FG000|Overall Study|Other|9
1053893|NCT01870401|2096532|FG001|Overall Study|Other|7
1053894|NCT01870401|2096531|FG000|Overall Study|On-going in the Study|35
1053895|NCT01870401|2096532|FG001|Overall Study|On-going in the Study|25
1053896|NCT01870583|2096543|FG000|Overall Study|Protocol Violation|0
1053897|NCT01870583|2096544|FG001|Overall Study|Protocol Violation|5
1053898|NCT01870583|2096545|FG002|Overall Study|Protocol Violation|3
1053899|NCT01870583|2096543|FG000|Overall Study|Lost to Follow-up|11
1053900|NCT01870583|2096544|FG001|Overall Study|Lost to Follow-up|13
1053901|NCT01870583|2096545|FG002|Overall Study|Lost to Follow-up|5
1053902|NCT01870726|2096569|FG000|Overall Study|Withdrawal of informed consent|0
1053903|NCT01870726|2096570|FG001|Overall Study|Withdrawal of informed consent|0
1053904|NCT01870726|2096571|FG002|Overall Study|Withdrawal of informed consent|0
1053905|NCT01870726|2096572|FG003|Overall Study|Withdrawal of informed consent|1
1053906|NCT01870726|2096573|FG004|Overall Study|Withdrawal of informed consent|0
1053907|NCT01870726|2096574|FG005|Overall Study|Withdrawal of informed consent|0
1053908|NCT01870726|2096575|FG006|Overall Study|Withdrawal of informed consent|0
1053909|NCT01870726|2096569|FG000|Overall Study|Withdrawal by Subject|0
1053910|NCT01870726|2096570|FG001|Overall Study|Withdrawal by Subject|1
1053911|NCT01870726|2096571|FG002|Overall Study|Withdrawal by Subject|0
1053912|NCT01870726|2096572|FG003|Overall Study|Withdrawal by Subject|0
1053913|NCT01870726|2096573|FG004|Overall Study|Withdrawal by Subject|0
1053914|NCT01870726|2096574|FG005|Overall Study|Withdrawal by Subject|0
1053915|NCT01870726|2096575|FG006|Overall Study|Withdrawal by Subject|0
1053916|NCT01870726|2096569|FG000|Overall Study|Adverse Event|0
1053917|NCT01870726|2096570|FG001|Overall Study|Adverse Event|0
1053918|NCT01870726|2096571|FG002|Overall Study|Adverse Event|0
1053919|NCT01870726|2096572|FG003|Overall Study|Adverse Event|0
1053920|NCT01870726|2096573|FG004|Overall Study|Adverse Event|1
1053921|NCT01870726|2096574|FG005|Overall Study|Adverse Event|1
1053922|NCT01870726|2096575|FG006|Overall Study|Adverse Event|0
1053923|NCT01870726|2096569|FG000|Overall Study|Progressive disease|5
1053924|NCT01870726|2096570|FG001|Overall Study|Progressive disease|5
1053925|NCT01870726|2096571|FG002|Overall Study|Progressive disease|4
1053926|NCT01870726|2096572|FG003|Overall Study|Progressive disease|5
1053927|NCT01870726|2096573|FG004|Overall Study|Progressive disease|6
1053928|NCT01870726|2096574|FG005|Overall Study|Progressive disease|4
1053929|NCT01870726|2096575|FG006|Overall Study|Progressive disease|10
1053930|NCT01870739|2096602|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0
1053931|NCT01870739|2096603|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1
1053932|NCT01870739|2096602|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0
1053933|NCT01870739|2096603|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1
1053934|NCT01870739|2096602|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3
1053935|NCT01870739|2096603|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2
1053936|NCT01870739|2096602|FG000|Add-on Period (40 Weeks)|Adverse Event|0
1053937|NCT01870739|2096603|FG001|Add-on Period (40 Weeks)|Adverse Event|1
1053938|NCT01870739|2096602|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
1053939|NCT01870739|2096603|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
1053940|NCT01870739|2096602|FG000|Add-on Period (40 Weeks)|Protocol deviation|1
1053941|NCT01870739|2096603|FG001|Add-on Period (40 Weeks)|Protocol deviation|1
1053942|NCT01870739|2096602|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1
1053943|NCT01870739|2096603|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0
1053944|NCT01870778|2096621|FG000|Overall Study|Withdrawal by Subject|8
1053945|NCT01870778|2096622|FG001|Overall Study|Withdrawal by Subject|7
1053946|NCT01870778|2096621|FG000|Overall Study|Lost to Follow-up|0
1053947|NCT01870778|2096622|FG001|Overall Study|Lost to Follow-up|2
1053948|NCT01870843|2096628|FG000|Overall Study|Adverse Event|10
1053949|NCT01870843|2096628|FG000|Overall Study|Lost to Follow-up|24
1053950|NCT01870843|2096628|FG000|Overall Study|Death|1
1053951|NCT01870843|2096628|FG000|Overall Study|Withdrawal by Subject|18
1053952|NCT01870869|2096647|FG000|Overall Study|Implanted with nonstudy device|1
1053953|NCT01870869|2096648|FG001|Overall Study|Implanted with nonstudy device|3
1053954|NCT01870869|2096649|FG002|Overall Study|Implanted with nonstudy device|14
1053955|NCT01870869|2096650|FG003|Overall Study|Implanted with nonstudy device|4
1053956|NCT01870869|2096647|FG000|Overall Study|Death|0
1053957|NCT01870869|2096648|FG001|Overall Study|Death|0
1053958|NCT01870869|2096649|FG002|Overall Study|Death|7
1053959|NCT01870869|2096650|FG003|Overall Study|Death|1
1053960|NCT01870869|2096647|FG000|Overall Study|Subject choice|6
1053961|NCT01870869|2096648|FG001|Overall Study|Subject choice|2
1053962|NCT01870869|2096649|FG002|Overall Study|Subject choice|22
1053963|NCT01870869|2096650|FG003|Overall Study|Subject choice|8
1053964|NCT01870869|2096647|FG000|Overall Study|Lost to Follow-up|10
1053965|NCT01870869|2096648|FG001|Overall Study|Lost to Follow-up|2
1053966|NCT01870869|2096649|FG002|Overall Study|Lost to Follow-up|25
1053967|NCT01870869|2096650|FG003|Overall Study|Lost to Follow-up|3
1053968|NCT01870869|2096647|FG000|Overall Study|Reason not Specified|1
1053969|NCT01870869|2096648|FG001|Overall Study|Reason not Specified|2
1053970|NCT01870869|2096649|FG002|Overall Study|Reason not Specified|20
1053971|NCT01870869|2096650|FG003|Overall Study|Reason not Specified|4
1053972|NCT01870869|2096647|FG000|Overall Study|Not evaluable|10
1053973|NCT01870869|2096648|FG001|Overall Study|Not evaluable|5
1053974|NCT01870869|2096649|FG002|Overall Study|Not evaluable|42
1053975|NCT01870869|2096650|FG003|Overall Study|Not evaluable|10
1053976|NCT01870921|2096660|FG000|Overall Study|Subject decision|80
1053977|NCT01870921|2096660|FG000|Overall Study|Severe non-compliance to protocol|7
1053978|NCT01870921|2096660|FG000|Overall Study|Subject Lost to Follow up|2
1053979|NCT01870921|2096660|FG000|Overall Study|Other|1
1053980|NCT01870973|2096666|FG000|Overall Study|Lost to Follow-up|10
1053981|NCT01870973|2096667|FG001|Overall Study|Lost to Follow-up|3
1053982|NCT01870999|2096676|FG000|Overall Study|Adverse Event|0
1053983|NCT01870999|2096677|FG001|Overall Study|Adverse Event|4
1053984|NCT01870999|2096678|FG002|Overall Study|Adverse Event|1
1053985|NCT01870999|2096676|FG000|Overall Study|Subject met withdrawal criteria|3
1053986|NCT01870999|2096677|FG001|Overall Study|Subject met withdrawal criteria|2
1053987|NCT01870999|2096678|FG002|Overall Study|Subject met withdrawal criteria|0
1053988|NCT01870999|2096676|FG000|Overall Study|Subject withdrawn by Investigator|1
1053989|NCT01870999|2096677|FG001|Overall Study|Subject withdrawn by Investigator|0
1053990|NCT01870999|2096678|FG002|Overall Study|Subject withdrawn by Investigator|0
1053991|NCT01870999|2096676|FG000|Overall Study|Withdrawal by Subject|0
1053992|NCT01870999|2096677|FG001|Overall Study|Withdrawal by Subject|2
1053993|NCT01870999|2096678|FG002|Overall Study|Withdrawal by Subject|5
1053994|NCT01870999|2096676|FG000|Overall Study|Protocol Violation|0
1053995|NCT01870999|2096677|FG001|Overall Study|Protocol Violation|0
1053996|NCT01870999|2096678|FG002|Overall Study|Protocol Violation|1
1053997|NCT01871090|2096692|FG000|Overall Study|Interrogation not done in Emergency Room|1
1053998|NCT01871090|2096693|FG001|Overall Study|Interrogation not done in Emergency Room|22
1053999|NCT01871090|2096692|FG000|Overall Study|Interrogation not completed correctly|1
1054000|NCT01871090|2096693|FG001|Overall Study|Interrogation not completed correctly|0
1054001|NCT01871090|2096692|FG000|Overall Study|Subject Non-Compliance|0
1054002|NCT01871090|2096693|FG001|Overall Study|Subject Non-Compliance|1
1054003|NCT01871142|2096699|FG000|Overall Study|Adverse Event|1
1054004|NCT01871285|2096715|FG000|First Intervention (1 Day)|Adverse Event|1
1054005|NCT01871285|2096716|FG001|First Intervention (1 Day)|Adverse Event|0
1054006|NCT01871285|2096717|FG002|First Intervention (1 Day)|Adverse Event|0
1054007|NCT01871285|2096718|FG003|First Intervention (1 Day)|Adverse Event|0
1054008|NCT01871285|2096715|FG000|First Intervention (1 Day)|Lost to Follow-up|0
1054009|NCT01871285|2096716|FG001|First Intervention (1 Day)|Lost to Follow-up|1
1054010|NCT01871285|2096717|FG002|First Intervention (1 Day)|Lost to Follow-up|1
1054011|NCT01871285|2096718|FG003|First Intervention (1 Day)|Lost to Follow-up|0
1054012|NCT01871402|2096730|FG000|Overall Study|Lost to Follow-up|1
1054013|NCT01871402|2096731|FG001|Overall Study|Lost to Follow-up|0
1054014|NCT01871402|2096730|FG000|Overall Study|Withdrawal by Subject|0
1054015|NCT01871402|2096731|FG001|Overall Study|Withdrawal by Subject|2
1054016|NCT01871402|2096730|FG000|Overall Study|Non-compliance|0
1054017|NCT01871402|2096731|FG001|Overall Study|Non-compliance|1
1054018|NCT01871519|2096764|FG000|Overall Study|Death|26
1054019|NCT01871519|2096764|FG000|Overall Study|Lost to Follow-up|15
1054020|NCT01871519|2096764|FG000|Overall Study|Withdrawal by Subject|49
1054021|NCT01871532|2096771|FG000|Overall Study|Withdrawal by Subject|1
1054022|NCT01871532|2096772|FG001|Overall Study|Withdrawal by Subject|2
1054023|NCT01871545|2096780|FG000|Overall Study|Death|2
1054024|NCT01871545|2096781|FG001|Overall Study|Death|0
1054025|NCT01871545|2096780|FG000|Overall Study|Lack of Efficacy|11
1054026|NCT01871545|2096781|FG001|Overall Study|Lack of Efficacy|2
1054027|NCT01871545|2096780|FG000|Overall Study|Physician Decision|4
1054028|NCT01871545|2096781|FG001|Overall Study|Physician Decision|0
1054029|NCT01871545|2096780|FG000|Overall Study|Withdrawal by Subject|0
1054030|NCT01871545|2096781|FG001|Overall Study|Withdrawal by Subject|1
1054031|NCT01871558|2096792|FG000|Overall Study|Other reason|0
1054032|NCT01871558|2096793|FG001|Overall Study|Other reason|1
1054033|NCT01871558|2096792|FG000|Overall Study|antidiabetic drug prematurely stopped|1
1054034|NCT01871558|2096793|FG001|Overall Study|antidiabetic drug prematurely stopped|1
1054035|NCT01871558|2096792|FG000|Overall Study|Withdrawal by Subject|2
1054036|NCT01871558|2096793|FG001|Overall Study|Withdrawal by Subject|0
1054037|NCT01871805|2096805|FG000|Phase I|Death|7
1054038|NCT01871805|2096806|FG001|Phase I|Death|4
1054039|NCT01871805|2096807|FG002|Phase I|Death|6
1054040|NCT01871805|2096808|FG003|Phase I|Death|2
1054041|NCT01871805|2096809|FG004|Phase I|Death|9
1054042|NCT01871805|2096810|FG005|Phase I|Death|0
1054043|NCT01871805|2096805|FG000|Phase I|Alive in Survival Follow-up|0
1054044|NCT01871805|2096806|FG001|Phase I|Alive in Survival Follow-up|2
1054045|NCT01871805|2096807|FG002|Phase I|Alive in Survival Follow-up|4
1054046|NCT01871805|2096808|FG003|Phase I|Alive in Survival Follow-up|5
1054047|NCT01871805|2096809|FG004|Phase I|Alive in Survival Follow-up|4
1054048|NCT01871805|2096810|FG005|Phase I|Alive in Survival Follow-up|0
1054049|NCT01871805|2096805|FG000|Phase I|Lost to Follow-up|0
1054050|NCT01871805|2096806|FG001|Phase I|Lost to Follow-up|1
1054051|NCT01871805|2096807|FG002|Phase I|Lost to Follow-up|3
1054052|NCT01871805|2096808|FG003|Phase I|Lost to Follow-up|0
1054053|NCT01871805|2096809|FG004|Phase I|Lost to Follow-up|0
1054054|NCT01871805|2096810|FG005|Phase I|Lost to Follow-up|0
1054055|NCT01871805|2096805|FG000|Phase II|Death|0
1054056|NCT01871805|2096806|FG001|Phase II|Death|0
1054057|NCT01871805|2096807|FG002|Phase II|Death|0
1054058|NCT01871805|2096808|FG003|Phase II|Death|0
1054059|NCT01871805|2096809|FG004|Phase II|Death|0
1054060|NCT01871805|2096810|FG005|Phase II|Death|45
1054061|NCT01871805|2096805|FG000|Phase II|Alive in Survival Follow-up|0
1054062|NCT01871805|2096806|FG001|Phase II|Alive in Survival Follow-up|0
1054063|NCT01871805|2096807|FG002|Phase II|Alive in Survival Follow-up|0
1054064|NCT01871805|2096808|FG003|Phase II|Alive in Survival Follow-up|0
1054065|NCT01871805|2096809|FG004|Phase II|Alive in Survival Follow-up|0
1054066|NCT01871805|2096810|FG005|Phase II|Alive in Survival Follow-up|29
1054067|NCT01871805|2096805|FG000|Phase II|Lost to Follow-up|0
1054068|NCT01871805|2096806|FG001|Phase II|Lost to Follow-up|0
1054069|NCT01871805|2096807|FG002|Phase II|Lost to Follow-up|0
1054070|NCT01871805|2096808|FG003|Phase II|Lost to Follow-up|0
1054071|NCT01871805|2096809|FG004|Phase II|Lost to Follow-up|0
1054072|NCT01871805|2096810|FG005|Phase II|Lost to Follow-up|13
1054073|NCT01871870|2096841|FG000|Overall Study|Hardware issues|7
1054074|NCT01871870|2096841|FG000|Overall Study|hyperglycemia|2
1054075|NCT01872078|2096849|FG000|Overall Study|Adverse Event|0
1054076|NCT01872078|2096850|FG001|Overall Study|Adverse Event|0
1054077|NCT01872078|2096851|FG002|Overall Study|Adverse Event|1
1054078|NCT01872078|2096852|FG003|Overall Study|Adverse Event|0
1054079|NCT01872078|2096849|FG000|Overall Study|Dose administration non-compliance|0
1054080|NCT01872078|2096850|FG001|Overall Study|Dose administration non-compliance|0
1054081|NCT01872078|2096851|FG002|Overall Study|Dose administration non-compliance|0
1054082|NCT01872078|2096852|FG003|Overall Study|Dose administration non-compliance|1
1054083|NCT01872078|2096849|FG000|Overall Study|Protocol Violation|0
1054084|NCT01872078|2096850|FG001|Overall Study|Protocol Violation|0
1054085|NCT01872078|2096851|FG002|Overall Study|Protocol Violation|1
1054086|NCT01872078|2096852|FG003|Overall Study|Protocol Violation|0
1054087|NCT01872078|2096849|FG000|Overall Study|Withdrawal by Subject|0
1054088|NCT01872078|2096850|FG001|Overall Study|Withdrawal by Subject|0
1054089|NCT01872078|2096851|FG002|Overall Study|Withdrawal by Subject|1
1054090|NCT01872078|2096852|FG003|Overall Study|Withdrawal by Subject|0
1054091|NCT01872078|2096849|FG000|Overall Study|Patient met exclusion criterion 16.|0
1054092|NCT01872078|2096850|FG001|Overall Study|Patient met exclusion criterion 16.|0
1054093|NCT01872078|2096851|FG002|Overall Study|Patient met exclusion criterion 16.|0
1054094|NCT01872078|2096852|FG003|Overall Study|Patient met exclusion criterion 16.|1
1054095|NCT01872611|2096882|FG000|Overall Study|Adverse Event|3
1054096|NCT01872611|2096883|FG001|Overall Study|Adverse Event|1
1054097|NCT01872611|2096882|FG000|Overall Study|Adverse Event, prior to treatment|0
1054098|NCT01872611|2096883|FG001|Overall Study|Adverse Event, prior to treatment|1
1054099|NCT01872611|2096882|FG000|Overall Study|Death|0
1054100|NCT01872611|2096883|FG001|Overall Study|Death|1
1054101|NCT01872611|2096882|FG000|Overall Study|Death, prior to treatment|0
1054102|NCT01872611|2096883|FG001|Overall Study|Death, prior to treatment|1
1054103|NCT01872611|2096882|FG000|Overall Study|Lost to Follow-up|8
1054104|NCT01872611|2096883|FG001|Overall Study|Lost to Follow-up|1
1054105|NCT01872611|2096882|FG000|Overall Study|Physician Decision|1
1054106|NCT01872611|2096883|FG001|Overall Study|Physician Decision|0
1054107|NCT01872611|2096882|FG000|Overall Study|Withdrawal by Subject|6
1054108|NCT01872611|2096883|FG001|Overall Study|Withdrawal by Subject|1
1054109|NCT01872611|2096882|FG000|Overall Study|Reason not provided|6
1054110|NCT01872611|2096883|FG001|Overall Study|Reason not provided|6
1054111|NCT01872689|2096895|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1054112|NCT01872689|2096896|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
1054113|NCT01872689|2096897|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1054114|NCT01872689|2096898|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1054115|NCT01872689|2096895|FG000|Double-Blind/Placebo-Controlled Period|Other|1
1054116|NCT01872689|2096896|FG001|Double-Blind/Placebo-Controlled Period|Other|1
1054117|NCT01872689|2096897|FG002|Double-Blind/Placebo-Controlled Period|Other|6
1054118|NCT01872689|2096898|FG003|Double-Blind/Placebo-Controlled Period|Other|3
1054119|NCT01872689|2096895|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
1054120|NCT01872689|2096896|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
1054121|NCT01872689|2096897|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
1054122|NCT01872689|2096898|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
1054123|NCT01872689|2096895|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
1054124|NCT01872689|2096896|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
1054125|NCT01872689|2096897|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
1054126|NCT01872689|2096898|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
1054127|NCT01872689|2096895|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0
1054128|NCT01872689|2096896|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3
1054129|NCT01872689|2096897|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3
1054130|NCT01872689|2096898|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1
1054131|NCT01872689|2096895|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
1054132|NCT01872689|2096896|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
1054133|NCT01872689|2096897|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
1054134|NCT01872689|2096898|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
1054135|NCT01872689|2096895|FG000|Double-Blind/Placebo-Controlled Period|Death|3
1054136|NCT01872689|2096896|FG001|Double-Blind/Placebo-Controlled Period|Death|4
1054137|NCT01872689|2096897|FG002|Double-Blind/Placebo-Controlled Period|Death|14
1054138|NCT01872689|2096898|FG003|Double-Blind/Placebo-Controlled Period|Death|9
1054139|NCT01872689|2096895|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6
1054140|NCT01872689|2096896|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3
1054141|NCT01872689|2096897|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10
1054142|NCT01872689|2096898|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7
1054143|NCT01872689|2096895|FG000|Open-Label Period (Only For Monotherapy)|Other|2
1054144|NCT01872689|2096896|FG001|Open-Label Period (Only For Monotherapy)|Other|3
1054145|NCT01872689|2096897|FG002|Open-Label Period (Only For Monotherapy)|Other|0
1054146|NCT01872689|2096898|FG003|Open-Label Period (Only For Monotherapy)|Other|0
1054147|NCT01872689|2096895|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
1054148|NCT01872689|2096896|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
1054149|NCT01872689|2096897|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
1054150|NCT01872689|2096898|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
1054151|NCT01872689|2096895|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1054152|NCT01872689|2096896|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1
1054153|NCT01872689|2096897|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1054154|NCT01872689|2096898|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1054155|NCT01872689|2096895|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
1054156|NCT01872689|2096896|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
1054157|NCT01872689|2096897|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
1054158|NCT01872689|2096898|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
1054159|NCT01872689|2096895|FG000|Open-Label Period (Only For Monotherapy)|Death|5
1054160|NCT01872689|2096896|FG001|Open-Label Period (Only For Monotherapy)|Death|3
1054161|NCT01872689|2096897|FG002|Open-Label Period (Only For Monotherapy)|Death|0
1054162|NCT01872689|2096898|FG003|Open-Label Period (Only For Monotherapy)|Death|0
1054163|NCT01872689|2096895|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2
1054164|NCT01872689|2096896|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1
1054165|NCT01872689|2096897|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0
1054166|NCT01872689|2096898|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0
1054167|NCT01872715|2096911|FG000|Overall Study|Adverse Event|1
1054168|NCT01872715|2096911|FG000|Overall Study|Protocol Violation|1
1054169|NCT01872715|2096911|FG000|Overall Study|Withdrawal by Subject|2
1054170|NCT01872910|2096936|FG000|Overall Study|Lost to Follow-up|2
1054171|NCT01872910|2096937|FG001|Overall Study|Lost to Follow-up|0
1054172|NCT01872910|2096938|FG002|Overall Study|Lost to Follow-up|2
1054173|NCT01872910|2096939|FG003|Overall Study|Lost to Follow-up|0
1054174|NCT01872910|2096940|FG004|Overall Study|Lost to Follow-up|0
1054175|NCT01872910|2096941|FG005|Overall Study|Lost to Follow-up|0
1054176|NCT01873417|2096965|FG000|Overall Study|Did Not Receive Any Study Drug|4
1054177|NCT01873417|2096965|FG000|Overall Study|Adverse Event|24
1054178|NCT01873417|2096965|FG000|Overall Study|Lost to Follow-up|2
1054179|NCT01873417|2096965|FG000|Overall Study|Withdrawal by Subject|2
1054180|NCT01873417|2096965|FG000|Overall Study|Physician Decision|3
1054181|NCT01873495|2096969|FG000|Overall Study|Withdrawal by Subject|1
1054182|NCT01873495|2096969|FG000|Overall Study|Physician Decision|3
1054183|NCT01873495|2096969|FG000|Overall Study|Adverse Event|1
1054184|NCT01873495|2096969|FG000|Overall Study|Removed for Transplantation|1
1054185|NCT01873495|2096969|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
1054186|NCT01873586|2096973|FG000|Overall Study|Lost to Follow-up|3
1054187|NCT01873729|2096980|FG000|Overall Study|Withdrawal by Subject|1
1054188|NCT01873742|2096986|FG000|Overall Study|Lost to Follow-up|68
1054189|NCT01873742|2096987|FG001|Overall Study|Lost to Follow-up|76
1054190|NCT01873859|2096999|FG000|Overall Study|Withdrawal by Subject|0
1054191|NCT01873859|2097000|FG001|Overall Study|Withdrawal by Subject|4
1054192|NCT01873950|2097007|FG000|Period 5|Withdrawal by Subject|0
1054193|NCT01873950|2097008|FG001|Period 5|Withdrawal by Subject|0
1054194|NCT01873950|2097009|FG002|Period 5|Withdrawal by Subject|0
1054195|NCT01873950|2097010|FG003|Period 5|Withdrawal by Subject|1
1054196|NCT01873950|2097011|FG004|Period 5|Withdrawal by Subject|0
1054197|NCT01874054|2097034|FG000|Overall Study|Withdrawal by Subject|3
1054198|NCT01874054|2097034|FG000|Overall Study|Study Termination by Sponsor|42
1054199|NCT01874054|2097034|FG000|Overall Study|Lost to Follow-up|5
1054200|NCT01874054|2097034|FG000|Overall Study|Death|5
1054201|NCT01874145|2097060|FG000|Core Period|Non-compliance|1
1054202|NCT01874145|2097061|FG001|Core Period|Non-compliance|0
1054203|NCT01874145|2097060|FG000|Core Period|Protocol Violation|1
1054204|NCT01874145|2097061|FG001|Core Period|Protocol Violation|1
1054205|NCT01874145|2097060|FG000|Core Period|Physician Decision|1
1054206|NCT01874145|2097061|FG001|Core Period|Physician Decision|1
1054207|NCT01874145|2097060|FG000|Core Period|Adverse Event|0
1054208|NCT01874145|2097061|FG001|Core Period|Adverse Event|1
1054209|NCT01874145|2097060|FG000|Core Period|Withdrawal by Subject|0
1054210|NCT01874145|2097061|FG001|Core Period|Withdrawal by Subject|4
1054211|NCT01874145|2097060|FG000|Extension Period|Adverse Event|3
1054212|NCT01874145|2097061|FG001|Extension Period|Adverse Event|2
1054213|NCT01874145|2097060|FG000|Extension Period|Withdrawal by Subject|2
1054214|NCT01874145|2097061|FG001|Extension Period|Withdrawal by Subject|1
1054215|NCT01874145|2097060|FG000|Extension Period|Lost to Follow-up|1
1054216|NCT01874145|2097061|FG001|Extension Period|Lost to Follow-up|1
1054217|NCT01874275|2097082|FG000|Overall Study|Lost to Follow-up|1
1054218|NCT01874275|2097083|FG001|Overall Study|Lost to Follow-up|0
1054219|NCT01874288|2097100|FG000|Overall Study|Withdrawal by Subject|1
1054220|NCT01874288|2097101|FG001|Overall Study|Withdrawal by Subject|0
1054221|NCT01874288|2097102|FG002|Overall Study|Withdrawal by Subject|2
1054222|NCT01874288|2097103|FG003|Overall Study|Withdrawal by Subject|1
1054223|NCT01874288|2097104|FG004|Overall Study|Withdrawal by Subject|1
1054224|NCT01874288|2097100|FG000|Overall Study|Physician Decision|0
1054225|NCT01874288|2097101|FG001|Overall Study|Physician Decision|0
1054226|NCT01874288|2097102|FG002|Overall Study|Physician Decision|0
1054227|NCT01874288|2097103|FG003|Overall Study|Physician Decision|1
1054228|NCT01874288|2097104|FG004|Overall Study|Physician Decision|0
1054229|NCT01874288|2097100|FG000|Overall Study|Progressive disease|2
1054230|NCT01874288|2097101|FG001|Overall Study|Progressive disease|0
1054231|NCT01874288|2097102|FG002|Overall Study|Progressive disease|3
1054232|NCT01874288|2097103|FG003|Overall Study|Progressive disease|5
1054233|NCT01874288|2097104|FG004|Overall Study|Progressive disease|1
1054234|NCT01874340|2097121|FG000|Overall Study|Study terminated by Sponsor|6
1054235|NCT01874340|2097122|FG001|Overall Study|Study terminated by Sponsor|8
1054236|NCT01874340|2097123|FG002|Overall Study|Study terminated by Sponsor|8
1054237|NCT01874340|2097124|FG003|Overall Study|Study terminated by Sponsor|4
1054238|NCT01874340|2097121|FG000|Overall Study|Withdrawal by Subject|0
1054239|NCT01874340|2097122|FG001|Overall Study|Withdrawal by Subject|0
1054240|NCT01874340|2097123|FG002|Overall Study|Withdrawal by Subject|0
1054241|NCT01874340|2097124|FG003|Overall Study|Withdrawal by Subject|1
1054242|NCT01874431|2097146|FG000|Overall Study|Physician Decision|0
1054243|NCT01874431|2097147|FG001|Overall Study|Physician Decision|0
1054244|NCT01874431|2097148|FG002|Overall Study|Physician Decision|1
1054245|NCT01874431|2097149|FG003|Overall Study|Physician Decision|0
1054246|NCT01874431|2097150|FG004|Overall Study|Physician Decision|0
1054247|NCT01874431|2097151|FG005|Overall Study|Physician Decision|0
1054248|NCT01874431|2097152|FG006|Overall Study|Physician Decision|0
1054249|NCT01874431|2097153|FG007|Overall Study|Physician Decision|0
1054250|NCT01874431|2097146|FG000|Overall Study|Adverse Event|5
1054251|NCT01874431|2097147|FG001|Overall Study|Adverse Event|4
1054252|NCT01874431|2097148|FG002|Overall Study|Adverse Event|6
1054253|NCT01874431|2097149|FG003|Overall Study|Adverse Event|5
1054254|NCT01874431|2097150|FG004|Overall Study|Adverse Event|2
1054255|NCT01874431|2097151|FG005|Overall Study|Adverse Event|8
1054256|NCT01874431|2097152|FG006|Overall Study|Adverse Event|2
1054257|NCT01874431|2097153|FG007|Overall Study|Adverse Event|3
1054258|NCT01874431|2097146|FG000|Overall Study|Protocol Violation|1
1054259|NCT01874431|2097147|FG001|Overall Study|Protocol Violation|1
1054260|NCT01874431|2097148|FG002|Overall Study|Protocol Violation|1
1054261|NCT01874431|2097149|FG003|Overall Study|Protocol Violation|0
1054262|NCT01874431|2097150|FG004|Overall Study|Protocol Violation|3
1054263|NCT01874431|2097151|FG005|Overall Study|Protocol Violation|2
1054264|NCT01874431|2097152|FG006|Overall Study|Protocol Violation|1
1054265|NCT01874431|2097153|FG007|Overall Study|Protocol Violation|1
1054266|NCT01874431|2097146|FG000|Overall Study|Non-compliance|0
1054267|NCT01874431|2097147|FG001|Overall Study|Non-compliance|0
1054268|NCT01874431|2097148|FG002|Overall Study|Non-compliance|0
1054269|NCT01874431|2097149|FG003|Overall Study|Non-compliance|0
1054270|NCT01874431|2097150|FG004|Overall Study|Non-compliance|1
1054271|NCT01874431|2097151|FG005|Overall Study|Non-compliance|0
1054272|NCT01874431|2097152|FG006|Overall Study|Non-compliance|1
1054273|NCT01874431|2097153|FG007|Overall Study|Non-compliance|0
1054274|NCT01874431|2097146|FG000|Overall Study|Logistical difficulties|0
1054275|NCT01874431|2097147|FG001|Overall Study|Logistical difficulties|0
1054276|NCT01874431|2097148|FG002|Overall Study|Logistical difficulties|0
1054277|NCT01874431|2097149|FG003|Overall Study|Logistical difficulties|0
1054278|NCT01874431|2097150|FG004|Overall Study|Logistical difficulties|0
1054279|NCT01874431|2097151|FG005|Overall Study|Logistical difficulties|0
1054280|NCT01874431|2097152|FG006|Overall Study|Logistical difficulties|1
1054281|NCT01874431|2097153|FG007|Overall Study|Logistical difficulties|0
1054282|NCT01874431|2097146|FG000|Overall Study|Withdrawal by Subject|0
1054283|NCT01874431|2097147|FG001|Overall Study|Withdrawal by Subject|0
1054284|NCT01874431|2097148|FG002|Overall Study|Withdrawal by Subject|1
1054285|NCT01874431|2097149|FG003|Overall Study|Withdrawal by Subject|2
1054286|NCT01874431|2097150|FG004|Overall Study|Withdrawal by Subject|1
1054287|NCT01874431|2097151|FG005|Overall Study|Withdrawal by Subject|1
1054288|NCT01874431|2097152|FG006|Overall Study|Withdrawal by Subject|3
1054289|NCT01874431|2097153|FG007|Overall Study|Withdrawal by Subject|0
1054290|NCT01874431|2097146|FG000|Overall Study|Sponsor decision|0
1054291|NCT01874431|2097147|FG001|Overall Study|Sponsor decision|0
1054292|NCT01874431|2097148|FG002|Overall Study|Sponsor decision|0
1054293|NCT01874431|2097149|FG003|Overall Study|Sponsor decision|0
1054294|NCT01874431|2097150|FG004|Overall Study|Sponsor decision|1
1054295|NCT01874431|2097151|FG005|Overall Study|Sponsor decision|0
1054296|NCT01874431|2097152|FG006|Overall Study|Sponsor decision|0
1054297|NCT01874431|2097153|FG007|Overall Study|Sponsor decision|0
1054298|NCT01874431|2097146|FG000|Overall Study|Lost to Follow-up|0
1054299|NCT01874431|2097147|FG001|Overall Study|Lost to Follow-up|0
1054300|NCT01874431|2097148|FG002|Overall Study|Lost to Follow-up|1
1054301|NCT01874431|2097149|FG003|Overall Study|Lost to Follow-up|0
1054302|NCT01874431|2097150|FG004|Overall Study|Lost to Follow-up|0
1054303|NCT01874431|2097151|FG005|Overall Study|Lost to Follow-up|0
1054304|NCT01874431|2097152|FG006|Overall Study|Lost to Follow-up|0
1054305|NCT01874431|2097153|FG007|Overall Study|Lost to Follow-up|0
1054306|NCT01874535|2097173|FG000|Overall Study|Lost to Follow-up|10
1054307|NCT01874535|2097174|FG001|Overall Study|Lost to Follow-up|9
1054308|NCT01874535|2097173|FG000|Overall Study|incomplete symptom resolution|45
1054309|NCT01874535|2097174|FG001|Overall Study|incomplete symptom resolution|35
1054310|NCT01874665|2097182|FG000|Overall Study|Adverse Event|6
1054311|NCT01874665|2097183|FG001|Overall Study|Adverse Event|2
1054312|NCT01874665|2097182|FG000|Overall Study|Withdrawal by Subject|4
1054313|NCT01874665|2097183|FG001|Overall Study|Withdrawal by Subject|1
1054314|NCT01874665|2097182|FG000|Overall Study|Physician Decision|3
1054315|NCT01874665|2097183|FG001|Overall Study|Physician Decision|0
1054316|NCT01874665|2097182|FG000|Overall Study|Clinical Progressive Disease|4
1054317|NCT01874665|2097183|FG001|Overall Study|Clinical Progressive Disease|3
1054318|NCT01874665|2097182|FG000|Overall Study|Study Terminated by Sponsor|0
1054319|NCT01874665|2097183|FG001|Overall Study|Study Terminated by Sponsor|2
1054320|NCT01874665|2097182|FG000|Overall Study|Documented Progressive Disease|11
1054321|NCT01874665|2097183|FG001|Overall Study|Documented Progressive Disease|7
1054322|NCT01874665|2097182|FG000|Overall Study|Other|2
1054323|NCT01874665|2097183|FG001|Overall Study|Other|0
1054324|NCT01875237|2097243|FG000|Overall Study|GVDH before DLI|1
1054325|NCT01875237|2097244|FG001|Overall Study|GVDH before DLI|0
1054326|NCT01875237|2097243|FG000|Overall Study|DLI cells could not be produced|1
1054327|NCT01875237|2097244|FG001|Overall Study|DLI cells could not be produced|0
1054328|NCT01875250|2097254|FG000|Overall Study|Adverse Event|2
1054329|NCT01875250|2097255|FG001|Overall Study|Adverse Event|0
1054330|NCT01875367|2097265|FG000|Overall Study|Not complete at least 2 questionaries|4
1054331|NCT01875367|2097266|FG001|Overall Study|Not complete at least 2 questionaries|2
1054332|NCT01875367|2097265|FG000|Overall Study|Not receive study treatment|1
1054333|NCT01875367|2097266|FG001|Overall Study|Not receive study treatment|0
1054334|NCT01875445|2097278|FG000|Overall Study|Lost to Follow-up|5
1054335|NCT01875445|2097279|FG001|Overall Study|Lost to Follow-up|0
1054336|NCT01875445|2097278|FG000|Overall Study|Withdrawal by Subject|2
1054337|NCT01875445|2097279|FG001|Overall Study|Withdrawal by Subject|0
1054338|NCT01875471|2097287|FG000|Overall Study|Adverse Event|0
1054339|NCT01875471|2097288|FG001|Overall Study|Adverse Event|1
1054340|NCT01875471|2097287|FG000|Overall Study|Unsatisfactory Lens Fitting|1
1054341|NCT01875471|2097288|FG001|Overall Study|Unsatisfactory Lens Fitting|0
1054342|NCT01875731|2097305|FG000|Overall Study|Fail to obtain lab sample|1
1054343|NCT01875731|2097306|FG001|Overall Study|Fail to obtain lab sample|0
1054344|NCT01875848|2097320|FG000|Overall Study|Withdrawal by Subject|2
1054345|NCT01875848|2097321|FG001|Overall Study|Withdrawal by Subject|0
1054346|NCT01875874|2097337|FG000|Overall Study|Death|3
1054347|NCT01875991|2097355|FG000|Overall Study|Withdrawal by Subject|6
1054348|NCT01875991|2097356|FG001|Overall Study|Withdrawal by Subject|6
1054349|NCT01875991|2097355|FG000|Overall Study|Sponsor Decision|1
1054350|NCT01875991|2097356|FG001|Overall Study|Sponsor Decision|0
1054351|NCT01876043|2097365|FG000|Overall Study|Death|1
1054352|NCT01876043|2097365|FG000|Overall Study|Withdrawal by Subject|1
1054353|NCT01876082|2097371|FG000|Overall Study|Withdrawal by Subject|0
1054354|NCT01876082|2097372|FG001|Overall Study|Withdrawal by Subject|2
1054355|NCT01876082|2097371|FG000|Overall Study|Protocol Violation|1
1054356|NCT01876082|2097372|FG001|Overall Study|Protocol Violation|0
1054357|NCT01876082|2097371|FG000|Overall Study|Adverse Event|1
1054358|NCT01876082|2097372|FG001|Overall Study|Adverse Event|1
1054359|NCT01876082|2097371|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0
1054360|NCT01876082|2097372|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1
1054361|NCT01876251|2097390|FG000|Overall Study|Clinical progression|1
1054362|NCT01876251|2097391|FG001|Overall Study|Clinical progression|0
1054363|NCT01876251|2097392|FG002|Overall Study|Clinical progression|0
1054364|NCT01876251|2097390|FG000|Overall Study|Death|2
1054365|NCT01876251|2097391|FG001|Overall Study|Death|0
1054366|NCT01876251|2097392|FG002|Overall Study|Death|1
1054367|NCT01876251|2097390|FG000|Overall Study|Participant started new treatment|1
1054368|NCT01876251|2097391|FG001|Overall Study|Participant started new treatment|0
1054369|NCT01876251|2097392|FG002|Overall Study|Participant started new treatment|1
1054370|NCT01876251|2097390|FG000|Overall Study|Participant refused further follow-up|0
1054371|NCT01876251|2097391|FG001|Overall Study|Participant refused further follow-up|0
1054372|NCT01876251|2097392|FG002|Overall Study|Participant refused further follow-up|1
1054373|NCT01876251|2097390|FG000|Overall Study|Study terminated|1
1054374|NCT01876251|2097391|FG001|Overall Study|Study terminated|0
1054375|NCT01876251|2097392|FG002|Overall Study|Study terminated|0
1054376|NCT01876251|2097390|FG000|Overall Study|Objective progression or relapse|10
1054377|NCT01876251|2097391|FG001|Overall Study|Objective progression or relapse|3
1054378|NCT01876251|2097392|FG002|Overall Study|Objective progression or relapse|8
1054379|NCT01876368|2097416|FG000|Overall Study|Adverse Event|2
1054380|NCT01876368|2097417|FG001|Overall Study|Adverse Event|5
1054381|NCT01876368|2097416|FG000|Overall Study|Lack of Efficacy|1
1054382|NCT01876368|2097417|FG001|Overall Study|Lack of Efficacy|0
1054383|NCT01876368|2097416|FG000|Overall Study|Lost to Follow-up|0
1054384|NCT01876368|2097417|FG001|Overall Study|Lost to Follow-up|1
1054385|NCT01876368|2097416|FG000|Overall Study|Non-compliance with study treatment|0
1054386|NCT01876368|2097417|FG001|Overall Study|Non-compliance with study treatment|1
1054387|NCT01876368|2097416|FG000|Overall Study|Physician Decision|0
1054388|NCT01876368|2097417|FG001|Overall Study|Physician Decision|2
1054389|NCT01876368|2097416|FG000|Overall Study|Protocol deviation|3
1054390|NCT01876368|2097417|FG001|Overall Study|Protocol deviation|3
1054391|NCT01876368|2097416|FG000|Overall Study|Subject/guardian decision|3
1054392|NCT01876368|2097417|FG001|Overall Study|Subject/guardian decision|1
1054393|NCT01876381|2097423|FG000|Overall Study|Lack of Efficacy|5
1054394|NCT01876381|2097423|FG000|Overall Study|Physician Decision|1
1054395|NCT01876381|2097423|FG000|Overall Study|Withdrawal by Subject|1
1054396|NCT01876420|2097427|FG000|Overall Study|Missed 30 day visit|1
1054397|NCT01876446|2097433|FG000|Overall Study|Death|0
1054398|NCT01876446|2097434|FG001|Overall Study|Death|1
1054399|NCT01876446|2097433|FG000|Overall Study|Withdrawal by Subject|1
1054400|NCT01876446|2097434|FG001|Overall Study|Withdrawal by Subject|2
1054401|NCT01876446|2097433|FG000|Overall Study|Physician Decision|1
1054402|NCT01876446|2097434|FG001|Overall Study|Physician Decision|3
1054403|NCT01876511|2097452|FG000|Overall Study|Disease Progression-clinical/radiologic|11
1054404|NCT01876511|2097453|FG001|Overall Study|Disease Progression-clinical/radiologic|24
1054405|NCT01876511|2097454|FG002|Overall Study|Disease Progression-clinical/radiologic|16
1054406|NCT01876511|2097452|FG000|Overall Study|Death (unrelated)|3
1054407|NCT01876511|2097453|FG001|Overall Study|Death (unrelated)|0
1054408|NCT01876511|2097454|FG002|Overall Study|Death (unrelated)|2
1054409|NCT01876511|2097452|FG000|Overall Study|Drug-related Toxicity|5
1054410|NCT01876511|2097453|FG001|Overall Study|Drug-related Toxicity|1
1054411|NCT01876511|2097454|FG002|Overall Study|Drug-related Toxicity|6
1054412|NCT01876511|2097452|FG000|Overall Study|Patient Decision|3
1054413|NCT01876511|2097453|FG001|Overall Study|Patient Decision|0
1054414|NCT01876511|2097454|FG002|Overall Study|Patient Decision|6
1054415|NCT01876511|2097452|FG000|Overall Study|Physician Decision|1
1054416|NCT01876511|2097453|FG001|Overall Study|Physician Decision|0
1054417|NCT01876511|2097454|FG002|Overall Study|Physician Decision|1
1054418|NCT01876706|2097464|FG000|Overall Study|BPH Intervention|9
1054419|NCT01876706|2097464|FG000|Overall Study|Lost to Follow-up|7
1054420|NCT01876706|2097464|FG000|Overall Study|Withdrawals|6
1054421|NCT01876706|2097464|FG000|Overall Study|Death|3
1054422|NCT01876732|2097468|FG000|Overall Study|MMA was not over 800mg/dL|75
1054423|NCT01876784|2097475|FG000|Overall Study|Withdrawal by Subject|17
1054424|NCT01876784|2097476|FG001|Overall Study|Withdrawal by Subject|2
1054425|NCT01876784|2097475|FG000|Overall Study|Adverse Event|15
1054426|NCT01876784|2097476|FG001|Overall Study|Adverse Event|2
1054427|NCT01876784|2097475|FG000|Overall Study|Protocol Violation|1
1054428|NCT01876784|2097476|FG001|Overall Study|Protocol Violation|0
1054429|NCT01876784|2097475|FG000|Overall Study|Disease progression|37
1054430|NCT01876784|2097476|FG001|Overall Study|Disease progression|67
1054431|NCT01876784|2097475|FG000|Overall Study|Lost to Follow-up|0
1054432|NCT01876784|2097476|FG001|Overall Study|Lost to Follow-up|1
1054433|NCT01876784|2097475|FG000|Overall Study|Death|1
1054434|NCT01876784|2097476|FG001|Overall Study|Death|0
1054435|NCT01876784|2097475|FG000|Overall Study|Randomized but not treated|2
1054436|NCT01876784|2097476|FG001|Overall Study|Randomized but not treated|1
1054437|NCT01876784|2097475|FG000|Overall Study|Other than specified above|5
1054438|NCT01876784|2097476|FG001|Overall Study|Other than specified above|6
1054439|NCT01876784|2097475|FG000|Overall Study|Ongoing|41
1054440|NCT01876784|2097476|FG001|Overall Study|Ongoing|40
1054441|NCT01876810|2097482|FG000|Overall Study|Physician Decision|0
1054442|NCT01876810|2097483|FG001|Overall Study|Physician Decision|1
1054443|NCT01876823|2097492|FG000|Overall Study|Withdrawal by Subject|5
1054444|NCT01876823|2097492|FG000|Overall Study|Physician Decision|2
1054445|NCT01876823|2097492|FG000|Overall Study|Patients moved|2
1054446|NCT01876901|2097498|FG000|Overall Study|Protocol Violation|10
1054447|NCT01876901|2097499|FG001|Overall Study|Protocol Violation|2
1054448|NCT01876901|2097498|FG000|Overall Study|No or other surgical intervention|7
1054449|NCT01876901|2097499|FG001|Overall Study|No or other surgical intervention|5
1054450|NCT01876979|2097517|FG000|Overall Study|Physician Decision|2
1054451|NCT01876979|2097518|FG001|Overall Study|Physician Decision|3
1054452|NCT01877083|2097534|FG000|Treatment Phase|Disease Progression|10
1054453|NCT01877083|2097534|FG000|Treatment Phase|Clinical Progression|1
1054454|NCT01877083|2097534|FG000|Treatment Phase|Adverse Event|6
1054455|NCT01877083|2097534|FG000|Treatment Phase|Withdrawal by Subject|2
1054456|NCT01877083|2097534|FG000|Treatment Phase|Lost to Follow-up|1
1054457|NCT01877083|2097534|FG000|Extension Phase|Disease Progression|3
1054458|NCT01877083|2097534|FG000|Extension Phase|Adverse Event|2
1054459|NCT01877187|2097555|FG000|Overall Study|Death|2
1054460|NCT01877187|2097555|FG000|Overall Study|Withdrawal by Subject|4
1054461|NCT01877187|2097555|FG000|Overall Study|Lost to Follow-up|3
1054462|NCT01877187|2097555|FG000|Overall Study|Declining clinical status|11
1054463|NCT01877187|2097555|FG000|Overall Study|Liver transplant|2
1054464|NCT01877239|2097562|FG000|Overall Study|Adverse Event|4
1054465|NCT01877239|2097562|FG000|Overall Study|Disease Remission|1
1054466|NCT01877239|2097562|FG000|Overall Study|Withdrawal by Subject|4
1054467|NCT01877239|2097562|FG000|Overall Study|Other|2
1054468|NCT01877239|2097562|FG000|Overall Study|Lack of Efficacy|4
1054469|NCT01877239|2097562|FG000|Overall Study|Data not available|35
1054470|NCT01877265|2097566|FG000|Treatment Period 1|Sponsor Decision|0
1054471|NCT01877265|2097567|FG001|Treatment Period 1|Sponsor Decision|0
1054472|NCT01877265|2097568|FG002|Treatment Period 1|Sponsor Decision|1
1054473|NCT01877265|2097569|FG003|Treatment Period 1|Sponsor Decision|0
1054474|NCT01877265|2097570|FG004|Treatment Period 1|Sponsor Decision|0
1054475|NCT01877265|2097571|FG005|Treatment Period 1|Sponsor Decision|0
1054476|NCT01877265|2097566|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1054477|NCT01877265|2097567|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1054478|NCT01877265|2097568|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1054479|NCT01877265|2097569|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1054480|NCT01877265|2097570|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1054481|NCT01877265|2097571|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
1054482|NCT01877265|2097566|FG000|Treatment Period 3|Lost to Follow-up|1
1054483|NCT01877265|2097567|FG001|Treatment Period 3|Lost to Follow-up|0
1054484|NCT01877265|2097568|FG002|Treatment Period 3|Lost to Follow-up|0
1054485|NCT01877265|2097569|FG003|Treatment Period 3|Lost to Follow-up|0
1054486|NCT01877265|2097570|FG004|Treatment Period 3|Lost to Follow-up|0
1054487|NCT01877265|2097571|FG005|Treatment Period 3|Lost to Follow-up|0
1054488|NCT01877278|2097584|FG000|Overall Study|Lost to Follow-up|3
1054489|NCT01877278|2097585|FG001|Overall Study|Lost to Follow-up|3
1054490|NCT01877408|2097593|FG000|Overall Study|Lost to Follow-up|0
1054491|NCT01877408|2097594|FG001|Overall Study|Lost to Follow-up|2
1054492|NCT01877421|2097633|FG000|Phase 2|Lost to Follow-up|0
1054493|NCT01877421|2097634|FG001|Phase 2|Lost to Follow-up|0
1054494|NCT01877421|2097635|FG002|Phase 2|Lost to Follow-up|0
1054495|NCT01877421|2097636|FG003|Phase 2|Lost to Follow-up|0
1054496|NCT01877421|2097637|FG004|Phase 2|Lost to Follow-up|0
1054497|NCT01877421|2097638|FG005|Phase 2|Lost to Follow-up|0
1054498|NCT01877421|2097639|FG006|Phase 2|Lost to Follow-up|1
1054499|NCT01877421|2097640|FG007|Phase 2|Lost to Follow-up|0
1054500|NCT01877421|2097641|FG008|Phase 2|Lost to Follow-up|0
1054501|NCT01877421|2097642|FG009|Phase 2|Lost to Follow-up|0
1054502|NCT01877421|2097643|FG010|Phase 2|Lost to Follow-up|0
1054503|NCT01877421|2097644|FG011|Phase 2|Lost to Follow-up|0
1054504|NCT01877421|2097645|FG012|Phase 2|Lost to Follow-up|0
1054505|NCT01877421|2097646|FG013|Phase 2|Lost to Follow-up|0
1054506|NCT01877421|2097647|FG014|Phase 2|Lost to Follow-up|0
1054507|NCT01877421|2097648|FG015|Phase 2|Lost to Follow-up|0
1054508|NCT01877421|2097649|FG016|Phase 2|Lost to Follow-up|0
1054509|NCT01877421|2097650|FG017|Phase 2|Lost to Follow-up|0
1054510|NCT01877421|2097633|FG000|Phase 2|Withdrawal by Subject|0
1054511|NCT01877421|2097634|FG001|Phase 2|Withdrawal by Subject|0
1054512|NCT01877421|2097635|FG002|Phase 2|Withdrawal by Subject|0
1054513|NCT01877421|2097636|FG003|Phase 2|Withdrawal by Subject|0
1054514|NCT01877421|2097637|FG004|Phase 2|Withdrawal by Subject|0
1054515|NCT01877421|2097638|FG005|Phase 2|Withdrawal by Subject|0
1054516|NCT01877421|2097639|FG006|Phase 2|Withdrawal by Subject|0
1054517|NCT01877421|2097640|FG007|Phase 2|Withdrawal by Subject|0
1054518|NCT01877421|2097641|FG008|Phase 2|Withdrawal by Subject|1
1054519|NCT01877421|2097642|FG009|Phase 2|Withdrawal by Subject|0
1054520|NCT01877421|2097643|FG010|Phase 2|Withdrawal by Subject|1
1054521|NCT01877421|2097644|FG011|Phase 2|Withdrawal by Subject|0
1054522|NCT01877421|2097645|FG012|Phase 2|Withdrawal by Subject|1
1054523|NCT01877421|2097646|FG013|Phase 2|Withdrawal by Subject|0
1054524|NCT01877421|2097647|FG014|Phase 2|Withdrawal by Subject|0
1054525|NCT01877421|2097648|FG015|Phase 2|Withdrawal by Subject|1
1054526|NCT01877421|2097649|FG016|Phase 2|Withdrawal by Subject|0
1054527|NCT01877421|2097650|FG017|Phase 2|Withdrawal by Subject|0
1054528|NCT01877421|2097633|FG000|Phase 2|Protocol Violation|0
1054529|NCT01877421|2097634|FG001|Phase 2|Protocol Violation|0
1054530|NCT01877421|2097635|FG002|Phase 2|Protocol Violation|0
1054531|NCT01877421|2097636|FG003|Phase 2|Protocol Violation|0
1054532|NCT01877421|2097637|FG004|Phase 2|Protocol Violation|0
1054533|NCT01877421|2097638|FG005|Phase 2|Protocol Violation|0
1054534|NCT01877421|2097639|FG006|Phase 2|Protocol Violation|0
1054535|NCT01877421|2097640|FG007|Phase 2|Protocol Violation|0
1054536|NCT01877421|2097641|FG008|Phase 2|Protocol Violation|0
1054537|NCT01877421|2097642|FG009|Phase 2|Protocol Violation|0
1054538|NCT01877421|2097643|FG010|Phase 2|Protocol Violation|1
1054539|NCT01877421|2097644|FG011|Phase 2|Protocol Violation|0
1054540|NCT01877421|2097645|FG012|Phase 2|Protocol Violation|0
1054541|NCT01877421|2097646|FG013|Phase 2|Protocol Violation|0
1054542|NCT01877421|2097647|FG014|Phase 2|Protocol Violation|0
1054543|NCT01877421|2097648|FG015|Phase 2|Protocol Violation|0
1054544|NCT01877421|2097649|FG016|Phase 2|Protocol Violation|0
1054545|NCT01877421|2097650|FG017|Phase 2|Protocol Violation|0
1054546|NCT01877551|2097736|FG000|Overall Study|Physician Decision|0
1054547|NCT01877551|2097737|FG001|Overall Study|Physician Decision|1
1054558|NCT01877668|2097774|FG000|Overall Study|Death|0
1054559|NCT01877668|2097775|FG001|Overall Study|Death|0
1054560|NCT01877668|2097776|FG002|Overall Study|Death|0
1054561|NCT01877668|2097777|FG003|Overall Study|Death|1
1054562|NCT01877668|2097778|FG004|Overall Study|Death|0
1054563|NCT01877668|2097774|FG000|Overall Study|No longer met study criteria|1
1054564|NCT01877668|2097775|FG001|Overall Study|No longer met study criteria|0
1054565|NCT01877668|2097776|FG002|Overall Study|No longer met study criteria|1
1054566|NCT01877668|2097777|FG003|Overall Study|No longer met study criteria|0
1054567|NCT01877668|2097778|FG004|Overall Study|No longer met study criteria|0
1054568|NCT01877668|2097774|FG000|Overall Study|Insufficient clinical response|0
1054569|NCT01877668|2097775|FG001|Overall Study|Insufficient clinical response|1
1054570|NCT01877668|2097776|FG002|Overall Study|Insufficient clinical response|2
1054571|NCT01877668|2097777|FG003|Overall Study|Insufficient clinical response|2
1054572|NCT01877668|2097778|FG004|Overall Study|Insufficient clinical response|0
1054573|NCT01877668|2097774|FG000|Overall Study|Lost to Follow-up|0
1054574|NCT01877668|2097775|FG001|Overall Study|Lost to Follow-up|2
1054575|NCT01877668|2097776|FG002|Overall Study|Lost to Follow-up|1
1054576|NCT01877668|2097777|FG003|Overall Study|Lost to Follow-up|0
1054577|NCT01877668|2097778|FG004|Overall Study|Lost to Follow-up|0
1054578|NCT01877668|2097774|FG000|Overall Study|Withdrawal by Subject|2
1054579|NCT01877668|2097775|FG001|Overall Study|Withdrawal by Subject|0
1054580|NCT01877668|2097776|FG002|Overall Study|Withdrawal by Subject|3
1054581|NCT01877668|2097777|FG003|Overall Study|Withdrawal by Subject|2
1054582|NCT01877668|2097778|FG004|Overall Study|Withdrawal by Subject|2
1054583|NCT01877668|2097774|FG000|Overall Study|Other|1
1054584|NCT01877668|2097775|FG001|Overall Study|Other|1
1054585|NCT01877668|2097776|FG002|Overall Study|Other|1
1054586|NCT01877668|2097777|FG003|Overall Study|Other|1
1054587|NCT01877668|2097778|FG004|Overall Study|Other|3
1054588|NCT01877668|2097774|FG000|Overall Study|Protocol Violation|1
1054589|NCT01877668|2097775|FG001|Overall Study|Protocol Violation|1
1054590|NCT01877668|2097776|FG002|Overall Study|Protocol Violation|0
1054591|NCT01877668|2097777|FG003|Overall Study|Protocol Violation|0
1054592|NCT01877668|2097778|FG004|Overall Study|Protocol Violation|3
1054593|NCT01877668|2097774|FG000|Overall Study|Adverse event related to study drug|2
1054594|NCT01877668|2097775|FG001|Overall Study|Adverse event related to study drug|2
1054595|NCT01877668|2097776|FG002|Overall Study|Adverse event related to study drug|2
1054596|NCT01877668|2097777|FG003|Overall Study|Adverse event related to study drug|2
1054597|NCT01877668|2097778|FG004|Overall Study|Adverse event related to study drug|1
1054598|NCT01877668|2097774|FG000|Overall Study|Adverse event unrelated to study drug|4
1054599|NCT01877668|2097775|FG001|Overall Study|Adverse event unrelated to study drug|1
1054600|NCT01877668|2097776|FG002|Overall Study|Adverse event unrelated to study drug|2
1054601|NCT01877668|2097777|FG003|Overall Study|Adverse event unrelated to study drug|0
1054602|NCT01877668|2097778|FG004|Overall Study|Adverse event unrelated to study drug|1
1054603|NCT01877720|2097794|FG000|Overall Study|Adverse Event|1
1054604|NCT01877720|2097795|FG001|Overall Study|Adverse Event|0
1054605|NCT01877915|2097803|FG000|Overall Study|Lost to Follow-up|10
1054606|NCT01877915|2097804|FG001|Overall Study|Lost to Follow-up|9
1054607|NCT01877915|2097803|FG000|Overall Study|Withdrawal by Subject|42
1054608|NCT01877915|2097804|FG001|Overall Study|Withdrawal by Subject|55
1054609|NCT01877915|2097803|FG000|Overall Study|Other|2
1054610|NCT01877915|2097804|FG001|Overall Study|Other|4
1054611|NCT01878084|2097822|FG000|Overall Study|Physician Decision|2
1054612|NCT01878097|2097829|FG000|Baseline|Surveys not fully completed|2497
1054613|NCT01878097|2097830|FG001|Baseline|Surveys not fully completed|1800
1054614|NCT01878097|2097829|FG000|Implementation Year 1|Surveys not fully completed|3202
1054615|NCT01878097|2097830|FG001|Implementation Year 1|Surveys not fully completed|2549
1054616|NCT01878097|2097829|FG000|Implementation Year 2|Surveys not fully completed|3281
1054617|NCT01878097|2097830|FG001|Implementation Year 2|Surveys not fully completed|2841
1054618|NCT01878097|2097829|FG000|Implementation Year 3|Surveys not fully completed|3494
1054619|NCT01878097|2097830|FG001|Implementation Year 3|Surveys not fully completed|2980
1054620|NCT01878097|2097829|FG000|Implementation Year 4|Surveys not fully completed|3604
1054621|NCT01878097|2097830|FG001|Implementation Year 4|Surveys not fully completed|3007
1054622|NCT01878149|2097838|FG000|Overall Study|Did Not Meet Eligibility Criteria|2
1054623|NCT01878149|2097839|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
1054624|NCT01878175|2097845|FG000|Overall Study|Developed contraindicated health problem|2
1054625|NCT01878214|2097852|FG000|Overall Study|Withdrawal by Subject|18
1054626|NCT01878214|2097853|FG001|Overall Study|Withdrawal by Subject|7
1054627|NCT01878214|2097852|FG000|Overall Study|Death|0
1054628|NCT01878214|2097853|FG001|Overall Study|Death|1
1054629|NCT01878214|2097852|FG000|Overall Study|Lost to Follow-up|35
1054630|NCT01878214|2097853|FG001|Overall Study|Lost to Follow-up|36
1054631|NCT01878253|2097859|FG000|Overall Study|Death|1
1054632|NCT01878253|2097859|FG000|Overall Study|SIdus System Removal|3
1054633|NCT01878253|2097859|FG000|Overall Study|Withdrawal by Subject|1
1054634|NCT01878253|2097859|FG000|Overall Study|Lost to Follow-up|2
1054635|NCT01878253|2097859|FG000|Overall Study|Completed Study w/o Follow-up Data|2
1054636|NCT01878292|2097871|FG000|Randomized|Protocol Violation|1
1054637|NCT01878292|2097872|FG001|Randomized|Protocol Violation|0
1054638|NCT01878292|2097873|FG002|Randomized|Protocol Violation|0
1054639|NCT01878292|2097871|FG000|Randomized|Lost to Follow-up|1
1054640|NCT01878292|2097872|FG001|Randomized|Lost to Follow-up|0
1054641|NCT01878292|2097873|FG002|Randomized|Lost to Follow-up|0
1054642|NCT01878292|2097871|FG000|Randomized|Adverse Event|1
1054643|NCT01878292|2097872|FG001|Randomized|Adverse Event|0
1054644|NCT01878292|2097873|FG002|Randomized|Adverse Event|0
1054645|NCT01878292|2097871|FG000|Double-blind Treatment Period|Other Reasons|2
1054646|NCT01878292|2097872|FG001|Double-blind Treatment Period|Other Reasons|0
1054647|NCT01878292|2097873|FG002|Double-blind Treatment Period|Other Reasons|0
1054648|NCT01878292|2097871|FG000|Double-blind Treatment Period|Lost to Follow-up|6
1054649|NCT01878292|2097872|FG001|Double-blind Treatment Period|Lost to Follow-up|3
1054650|NCT01878292|2097873|FG002|Double-blind Treatment Period|Lost to Follow-up|1
1054651|NCT01878292|2097871|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
1054652|NCT01878292|2097872|FG001|Double-blind Treatment Period|Withdrawal by Subject|7
1054653|NCT01878292|2097873|FG002|Double-blind Treatment Period|Withdrawal by Subject|8
1054654|NCT01878292|2097871|FG000|Double-blind Treatment Period|Protocol Violation|3
1054655|NCT01878292|2097872|FG001|Double-blind Treatment Period|Protocol Violation|4
1054656|NCT01878292|2097873|FG002|Double-blind Treatment Period|Protocol Violation|2
1054657|NCT01878292|2097871|FG000|Double-blind Treatment Period|Lack of Efficacy|5
1054658|NCT01878292|2097872|FG001|Double-blind Treatment Period|Lack of Efficacy|3
1054659|NCT01878292|2097873|FG002|Double-blind Treatment Period|Lack of Efficacy|0
1054660|NCT01878292|2097871|FG000|Double-blind Treatment Period|Adverse Event|4
1054661|NCT01878292|2097872|FG001|Double-blind Treatment Period|Adverse Event|9
1054662|NCT01878292|2097873|FG002|Double-blind Treatment Period|Adverse Event|8
1054663|NCT01878292|2097871|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5
1054664|NCT01878292|2097872|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8
1054665|NCT01878292|2097873|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4
1054666|NCT01878383|2097883|FG000|Overall Study|Lost to Follow-up|0
1054667|NCT01878383|2097884|FG001|Overall Study|Lost to Follow-up|1499
1054668|NCT01878890|2097954|FG000|Overall Study|Protocol Violation|0
1054669|NCT01878890|2097955|FG001|Overall Study|Protocol Violation|1
1054670|NCT01878890|2097956|FG002|Overall Study|Protocol Violation|0
1054671|NCT01878890|2097957|FG003|Overall Study|Protocol Violation|0
1054672|NCT01879072|2097972|FG000|Overall Study|Withdrawal by Subject|121
1054673|NCT01879072|2097972|FG000|Overall Study|Not Transplanted|30
1054674|NCT01879319|2097987|FG000|Overall Study|Withdrawal by Subject|1
1054675|NCT01879319|2097988|FG001|Overall Study|Withdrawal by Subject|0
1054676|NCT01879319|2097987|FG000|Overall Study|Lost to Follow-up|1
1054677|NCT01879319|2097988|FG001|Overall Study|Lost to Follow-up|5
1054678|NCT01879410|2098043|FG000|Overall Study|Adverse Event|9
1054679|NCT01879410|2098044|FG001|Overall Study|Adverse Event|14
1054680|NCT01879410|2098043|FG000|Overall Study|Lack of Efficacy|4
1054681|NCT01879410|2098044|FG001|Overall Study|Lack of Efficacy|6
1054682|NCT01879410|2098043|FG000|Overall Study|Protocol Violation|1
1054683|NCT01879410|2098044|FG001|Overall Study|Protocol Violation|7
1054684|NCT01879410|2098043|FG000|Overall Study|Lost to Follow-up|2
1054685|NCT01879410|2098044|FG001|Overall Study|Lost to Follow-up|1
1054686|NCT01879410|2098043|FG000|Overall Study|Withdrawal by Subject|7
1054687|NCT01879410|2098044|FG001|Overall Study|Withdrawal by Subject|8
1054688|NCT01879410|2098043|FG000|Overall Study|Randomised in Error|1
1054689|NCT01879410|2098044|FG001|Overall Study|Randomised in Error|2
1054690|NCT01879553|2098056|FG000|Overall Study|Withdrawal by Subject|1
1054691|NCT01879553|2098057|FG001|Overall Study|Withdrawal by Subject|0
1054692|NCT01879579|2098066|FG000|Overall Study|Phone incompatible with texting platform|3
1054693|NCT01879579|2098067|FG001|Overall Study|Phone incompatible with texting platform|0
1054694|NCT01879579|2098066|FG000|Overall Study|Did not enroll in texting platform|1
1054695|NCT01879579|2098067|FG001|Overall Study|Did not enroll in texting platform|0
1054696|NCT01879579|2098066|FG000|Overall Study|Did not initiate insulin treatment|1
1054697|NCT01879579|2098067|FG001|Overall Study|Did not initiate insulin treatment|0
1054698|NCT01879579|2098066|FG000|Overall Study|Phenotypic type 1 diabetes|0
1054699|NCT01879579|2098067|FG001|Overall Study|Phenotypic type 1 diabetes|1
1054700|NCT01879579|2098066|FG000|Overall Study|Discontinued insulin - possible allergy|0
1054701|NCT01879579|2098067|FG001|Overall Study|Discontinued insulin - possible allergy|1
1054702|NCT01879618|2098076|FG000|Overall Study|Does not meet entrance criteria|1
1054703|NCT01879618|2098076|FG000|Overall Study|Withdrawal by Subject|1
1054704|NCT01879618|2098076|FG000|Overall Study|Surgery;changed schedule; not available|8
1054705|NCT01879618|2098076|FG000|Overall Study|Protocol Violation|6
1054706|NCT01879618|2098076|FG000|Overall Study|Adverse Event|5
1054707|NCT01879683|2098080|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1
1054708|NCT01879722|2098094|FG000|Overall Study|Pretreatment Event/Adverse Event|0
1054709|NCT01879722|2098095|FG001|Overall Study|Pretreatment Event/Adverse Event|1
1054710|NCT01879722|2098096|FG002|Overall Study|Pretreatment Event/Adverse Event|0
1054711|NCT01879722|2098097|FG003|Overall Study|Pretreatment Event/Adverse Event|1
1054712|NCT01879722|2098098|FG004|Overall Study|Pretreatment Event/Adverse Event|1
1054713|NCT01879722|2098099|FG005|Overall Study|Pretreatment Event/Adverse Event|0
1054714|NCT01879722|2098100|FG006|Overall Study|Pretreatment Event/Adverse Event|0
1054715|NCT01879722|2098101|FG007|Overall Study|Pretreatment Event/Adverse Event|1
1054716|NCT01879722|2098102|FG008|Overall Study|Pretreatment Event/Adverse Event|1
1054717|NCT01879722|2098103|FG009|Overall Study|Pretreatment Event/Adverse Event|0
1054718|NCT01879722|2098094|FG000|Overall Study|Voluntary Withdrawal|0
1054719|NCT01879722|2098095|FG001|Overall Study|Voluntary Withdrawal|0
1054720|NCT01879722|2098096|FG002|Overall Study|Voluntary Withdrawal|0
1054721|NCT01879722|2098097|FG003|Overall Study|Voluntary Withdrawal|0
1054722|NCT01879722|2098098|FG004|Overall Study|Voluntary Withdrawal|0
1054723|NCT01879722|2098099|FG005|Overall Study|Voluntary Withdrawal|0
1054724|NCT01879722|2098100|FG006|Overall Study|Voluntary Withdrawal|0
1054725|NCT01879722|2098101|FG007|Overall Study|Voluntary Withdrawal|0
1054726|NCT01879722|2098102|FG008|Overall Study|Voluntary Withdrawal|1
1054727|NCT01879722|2098103|FG009|Overall Study|Voluntary Withdrawal|0
1054728|NCT01879852|2098157|FG000|Overall Study|Withdrawal by Subject|2
1054729|NCT01879852|2098158|FG001|Overall Study|Withdrawal by Subject|0
1054730|NCT01880086|2098194|FG000|Overall Study|Lost to Follow-up|1
1054731|NCT01880086|2098195|FG001|Overall Study|Lost to Follow-up|1
1054732|NCT01880424|2098229|FG000|Overall Study|Adverse Event|7
1054733|NCT01880424|2098230|FG001|Overall Study|Adverse Event|6
1054734|NCT01880424|2098229|FG000|Overall Study|Lack of Efficacy|1
1054735|NCT01880424|2098230|FG001|Overall Study|Lack of Efficacy|4
1054736|NCT01880424|2098229|FG000|Overall Study|Lost to Follow-up|3
1054737|NCT01880424|2098230|FG001|Overall Study|Lost to Follow-up|2
1054738|NCT01880424|2098229|FG000|Overall Study|Protocol Violation|11
1054739|NCT01880424|2098230|FG001|Overall Study|Protocol Violation|13
1054740|NCT01880424|2098229|FG000|Overall Study|Withdrawal by Subject|10
1054741|NCT01880424|2098230|FG001|Overall Study|Withdrawal by Subject|30
1054742|NCT01880424|2098229|FG000|Overall Study|Other|1
1054743|NCT01880424|2098230|FG001|Overall Study|Other|0
1054744|NCT01880437|2098239|FG000|Overall Study|Death|12
1054745|NCT01880437|2098240|FG001|Overall Study|Death|4
1054746|NCT01880437|2098241|FG002|Overall Study|Death|17
1054747|NCT01880437|2098239|FG000|Overall Study|Study terminated by Sponsor|3
1054748|NCT01880437|2098240|FG001|Overall Study|Study terminated by Sponsor|0
1054749|NCT01880437|2098241|FG002|Overall Study|Study terminated by Sponsor|2
1054750|NCT01880515|2098253|FG000|Overall Study|Lost to Follow-up|3
1054751|NCT01880515|2098254|FG001|Overall Study|Lost to Follow-up|2
1054752|NCT01880515|2098253|FG000|Overall Study|Disease Progression|5
1054753|NCT01880515|2098254|FG001|Overall Study|Disease Progression|7
1054754|NCT01880528|2098263|FG000|Overall Study|Other|1
1054755|NCT01880528|2098264|FG001|Overall Study|Other|1
1054756|NCT01880554|2098270|FG000|Overall Study|Protocol Violation|14
1054757|NCT01880554|2098270|FG000|Overall Study|Simon's design requirements|2
1054758|NCT01880593|2098277|FG000|Overall Study|Adverse Event|1
1054759|NCT01880593|2098278|FG001|Overall Study|Adverse Event|0
1054760|NCT01880593|2098277|FG000|Overall Study|Lack of Efficacy|1
1054761|NCT01880593|2098278|FG001|Overall Study|Lack of Efficacy|5
1054762|NCT01880593|2098277|FG000|Overall Study|Withdrawal by Subject|6
1054763|NCT01880593|2098278|FG001|Overall Study|Withdrawal by Subject|1
1054764|NCT01880736|2098306|FG000|Overall Study|Adverse Event|0
1054765|NCT01880736|2098307|FG001|Overall Study|Adverse Event|0
1054766|NCT01880736|2098308|FG002|Overall Study|Adverse Event|0
1054767|NCT01880736|2098309|FG003|Overall Study|Adverse Event|1
1054768|NCT01880736|2098306|FG000|Overall Study|Withdrawal Criteria|1
1054769|NCT01880736|2098307|FG001|Overall Study|Withdrawal Criteria|2
1054770|NCT01880736|2098308|FG002|Overall Study|Withdrawal Criteria|1
1054771|NCT01880736|2098309|FG003|Overall Study|Withdrawal Criteria|5
1054772|NCT01881009|2098330|FG000|Summer Camp Session (6 Days)|Unable to wear device|0
1054773|NCT01881009|2098331|FG001|Summer Camp Session (6 Days)|Unable to wear device|1
1054774|NCT01881126|2098362|FG000|Overall Study|Non-compliance|1
1054775|NCT01881126|2098363|FG001|Overall Study|Non-compliance|1
1054776|NCT01881126|2098362|FG000|Overall Study|Adverse Event|0
1054777|NCT01881126|2098363|FG001|Overall Study|Adverse Event|1
1054778|NCT01881230|2098372|FG000|Overall Study|Death|2
1054779|NCT01881230|2098373|FG001|Overall Study|Death|0
1054780|NCT01881230|2098374|FG002|Overall Study|Death|1
1054781|NCT01881230|2098372|FG000|Overall Study|Adverse Event|9
1054782|NCT01881230|2098373|FG001|Overall Study|Adverse Event|13
1054783|NCT01881230|2098374|FG002|Overall Study|Adverse Event|12
1054784|NCT01881230|2098372|FG000|Overall Study|Progressive Disease|31
1054785|NCT01881230|2098373|FG001|Overall Study|Progressive Disease|35
1054786|NCT01881230|2098374|FG002|Overall Study|Progressive Disease|36
1054787|NCT01881230|2098372|FG000|Overall Study|Symptomatic Deterioration|3
1054788|NCT01881230|2098373|FG001|Overall Study|Symptomatic Deterioration|3
1054789|NCT01881230|2098374|FG002|Overall Study|Symptomatic Deterioration|1
1054790|NCT01881230|2098372|FG000|Overall Study|Withdrawal by Subject|6
1054791|NCT01881230|2098373|FG001|Overall Study|Withdrawal by Subject|4
1054792|NCT01881230|2098374|FG002|Overall Study|Withdrawal by Subject|6
1054793|NCT01881230|2098372|FG000|Overall Study|Physician Decision|4
1054794|NCT01881230|2098373|FG001|Overall Study|Physician Decision|3
1054795|NCT01881230|2098374|FG002|Overall Study|Physician Decision|6
1054796|NCT01881230|2098372|FG000|Overall Study|Non-Compliance with Study Drug|1
1054797|NCT01881230|2098373|FG001|Overall Study|Non-Compliance with Study Drug|2
1054798|NCT01881230|2098374|FG002|Overall Study|Non-Compliance with Study Drug|0
1054799|NCT01881230|2098372|FG000|Overall Study|Given Commercially Available Drug|0
1054800|NCT01881230|2098373|FG001|Overall Study|Given Commercially Available Drug|0
1054801|NCT01881230|2098374|FG002|Overall Study|Given Commercially Available Drug|2
1054802|NCT01881230|2098372|FG000|Overall Study|Protocol Violation|1
1054803|NCT01881230|2098373|FG001|Overall Study|Protocol Violation|1
1054804|NCT01881230|2098374|FG002|Overall Study|Protocol Violation|0
1054805|NCT01881230|2098372|FG000|Overall Study|Miscellaneous|3
1054806|NCT01881230|2098373|FG001|Overall Study|Miscellaneous|3
1054807|NCT01881230|2098374|FG002|Overall Study|Miscellaneous|0
1054808|NCT01881230|2098372|FG000|Overall Study|Untreated: Other|0
1054809|NCT01881230|2098373|FG001|Overall Study|Untreated: Other|0
1054810|NCT01881230|2098374|FG002|Overall Study|Untreated: Other|1
1054811|NCT01881230|2098372|FG000|Overall Study|Untreated: Death|0
1054812|NCT01881230|2098373|FG001|Overall Study|Untreated: Death|0
1054813|NCT01881230|2098374|FG002|Overall Study|Untreated: Death|1
1054814|NCT01881230|2098372|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1
1054815|NCT01881230|2098373|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0
1054816|NCT01881230|2098374|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0
1054817|NCT01881620|2098408|FG000|Overall Study|Protocol Violation|4
1054818|NCT01881737|2098412|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
1054819|NCT01881737|2098412|FG000|Overall Study|Withdrawal by Subject|1
1054820|NCT01881737|2098412|FG000|Overall Study|Worsening of baseline behavior|1
1054821|NCT01881750|2098420|FG000|Overall Study|Changes in concomitant therapies|2
1054822|NCT01881750|2098421|FG001|Overall Study|Changes in concomitant therapies|3
1054823|NCT01881750|2098420|FG000|Overall Study|Lost to Follow-up|0
1054824|NCT01881750|2098421|FG001|Overall Study|Lost to Follow-up|1
1054825|NCT01881776|2098432|FG000|Overall Study|Lost to Follow-up|1
1054826|NCT01881776|2098433|FG001|Overall Study|Lost to Follow-up|2
1054827|NCT01881776|2098434|FG002|Overall Study|Lost to Follow-up|1
1054828|NCT01881776|2098432|FG000|Overall Study|Protocol Violation|0
1054829|NCT01881776|2098433|FG001|Overall Study|Protocol Violation|2
1054830|NCT01881776|2098434|FG002|Overall Study|Protocol Violation|1
1054831|NCT01881789|2098448|FG000|Overall Study|Withdrawal by Subject|0
1054832|NCT01881789|2098449|FG001|Overall Study|Withdrawal by Subject|2
1054833|NCT01881789|2098450|FG002|Overall Study|Withdrawal by Subject|1
1054834|NCT01881789|2098451|FG003|Overall Study|Withdrawal by Subject|0
1054835|NCT01881789|2098452|FG004|Overall Study|Withdrawal by Subject|1
1054836|NCT01881789|2098453|FG005|Overall Study|Withdrawal by Subject|1
1054837|NCT01881789|2098448|FG000|Overall Study|Study Terminated by Sponsor|0
1054838|NCT01881789|2098449|FG001|Overall Study|Study Terminated by Sponsor|0
1054839|NCT01881789|2098450|FG002|Overall Study|Study Terminated by Sponsor|0
1054840|NCT01881789|2098451|FG003|Overall Study|Study Terminated by Sponsor|0
1054841|NCT01881789|2098452|FG004|Overall Study|Study Terminated by Sponsor|0
1054842|NCT01881789|2098453|FG005|Overall Study|Study Terminated by Sponsor|1
1054843|NCT01881789|2098448|FG000|Overall Study|Other|3
1054844|NCT01881789|2098449|FG001|Overall Study|Other|5
1054845|NCT01881789|2098450|FG002|Overall Study|Other|2
1054846|NCT01881789|2098451|FG003|Overall Study|Other|3
1054847|NCT01881789|2098452|FG004|Overall Study|Other|1
1054848|NCT01881789|2098453|FG005|Overall Study|Other|1
1054849|NCT01882088|2098492|FG000|Overall Study|Intolerance of esophageal manometry|1
1054850|NCT01882088|2098492|FG000|Overall Study|no possibility to place the catheter|1
1054851|NCT01882088|2098492|FG000|Overall Study|Protocol Violation|1
1054852|NCT01882088|2098492|FG000|Overall Study|inadequate pH-impedance tracings|2
1054853|NCT01882257|2098499|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0
1054854|NCT01882257|2098500|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2
1054855|NCT01882257|2098501|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1
1054856|NCT01882257|2098499|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
1054857|NCT01882257|2098500|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
1054858|NCT01882257|2098501|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
1054859|NCT01882439|2098516|FG000|Overall Study|Adverse event related to study drug|3
1054860|NCT01882439|2098517|FG001|Overall Study|Adverse event related to study drug|8
1054861|NCT01882439|2098518|FG002|Overall Study|Adverse event related to study drug|1
1054862|NCT01882439|2098519|FG003|Overall Study|Adverse event related to study drug|2
1054863|NCT01882439|2098516|FG000|Overall Study|Pregnancy|0
1054864|NCT01882439|2098517|FG001|Overall Study|Pregnancy|1
1054865|NCT01882439|2098518|FG002|Overall Study|Pregnancy|0
1054866|NCT01882439|2098519|FG003|Overall Study|Pregnancy|0
1054867|NCT01882439|2098516|FG000|Overall Study|Protocol Violation|2
1054868|NCT01882439|2098517|FG001|Overall Study|Protocol Violation|2
1054869|NCT01882439|2098518|FG002|Overall Study|Protocol Violation|0
1054870|NCT01882439|2098519|FG003|Overall Study|Protocol Violation|1
1054871|NCT01882439|2098516|FG000|Overall Study|No longer willing to participate|1
1054872|NCT01882439|2098517|FG001|Overall Study|No longer willing to participate|4
1054873|NCT01882439|2098518|FG002|Overall Study|No longer willing to participate|2
1054874|NCT01882439|2098519|FG003|Overall Study|No longer willing to participate|3
1054875|NCT01882439|2098516|FG000|Overall Study|Medication error with no associated AE|0
1054876|NCT01882439|2098517|FG001|Overall Study|Medication error with no associated AE|0
1054877|NCT01882439|2098518|FG002|Overall Study|Medication error with no associated AE|2
1054878|NCT01882439|2098519|FG003|Overall Study|Medication error with no associated AE|0
1054879|NCT01882439|2098516|FG000|Overall Study|Insufficient clinical response|1
1054880|NCT01882439|2098517|FG001|Overall Study|Insufficient clinical response|4
1054881|NCT01882439|2098518|FG002|Overall Study|Insufficient clinical response|4
1054882|NCT01882439|2098519|FG003|Overall Study|Insufficient clinical response|2
1054883|NCT01882439|2098516|FG000|Overall Study|Adverse event unrelated to study drug|2
1054884|NCT01882439|2098517|FG001|Overall Study|Adverse event unrelated to study drug|2
1054885|NCT01882439|2098518|FG002|Overall Study|Adverse event unrelated to study drug|1
1054886|NCT01882439|2098519|FG003|Overall Study|Adverse event unrelated to study drug|1
1054887|NCT01882465|2098534|FG000|Period 1|Lens Discomfort|0
1054888|NCT01882465|2098535|FG001|Period 1|Lens Discomfort|0
1054889|NCT01882465|2098536|FG002|Period 1|Lens Discomfort|0
1054890|NCT01882465|2098537|FG003|Period 1|Lens Discomfort|1
1054891|NCT01882465|2098538|FG004|Period 1|Lens Discomfort|0
1054892|NCT01882465|2098539|FG005|Period 1|Lens Discomfort|0
1054893|NCT01882465|2098540|FG006|Period 1|Lens Discomfort|0
1054894|NCT01882465|2098534|FG000|Period 1|Withdrawal by Subject|0
1054895|NCT01882465|2098535|FG001|Period 1|Withdrawal by Subject|0
1054896|NCT01882465|2098536|FG002|Period 1|Withdrawal by Subject|0
1054897|NCT01882465|2098537|FG003|Period 1|Withdrawal by Subject|0
1054898|NCT01882465|2098538|FG004|Period 1|Withdrawal by Subject|0
1054899|NCT01882465|2098539|FG005|Period 1|Withdrawal by Subject|0
1054900|NCT01882465|2098540|FG006|Period 1|Withdrawal by Subject|1
1054901|NCT01882465|2098534|FG000|Period 2|Protocol Violation|0
1054902|NCT01882465|2098535|FG001|Period 2|Protocol Violation|0
1054903|NCT01882465|2098536|FG002|Period 2|Protocol Violation|0
1054904|NCT01882465|2098537|FG003|Period 2|Protocol Violation|0
1054905|NCT01882465|2098538|FG004|Period 2|Protocol Violation|1
1054906|NCT01882465|2098539|FG005|Period 2|Protocol Violation|0
1054907|NCT01882465|2098540|FG006|Period 2|Protocol Violation|0
1054908|NCT01882647|2098560|FG000|Overall Study|Lost to Follow-up|2
1054909|NCT01882647|2098561|FG001|Overall Study|Lost to Follow-up|2
1054910|NCT01882647|2098560|FG000|Overall Study|Withdrawal by Subject|0
1054911|NCT01882647|2098561|FG001|Overall Study|Withdrawal by Subject|4
1054912|NCT01882803|2098580|FG000|Overall Study|Disease Progression|53
1054913|NCT01882803|2098580|FG000|Overall Study|Adverse Event|22
1054914|NCT01882803|2098580|FG000|Overall Study|Death|7
1054915|NCT01882803|2098580|FG000|Overall Study|Physician Decision|7
1054916|NCT01882803|2098580|FG000|Overall Study|Protocol Violation|1
1054917|NCT01882803|2098580|FG000|Overall Study|Withdrawal by Subject|4
1054918|NCT01882829|2098585|FG000|Overall Study|Adverse Event|4
1054919|NCT01882829|2098585|FG000|Overall Study|Protocol Violation|1
1054920|NCT01882829|2098585|FG000|Overall Study|Withdrawal by Subject|1
1054921|NCT01882907|2098595|FG000|Overall Study|Adverse Event|3
1054922|NCT01882907|2098596|FG001|Overall Study|Adverse Event|1
1054923|NCT01882907|2098595|FG000|Overall Study|Lack of Efficacy|0
1054924|NCT01882907|2098596|FG001|Overall Study|Lack of Efficacy|3
1054925|NCT01882907|2098595|FG000|Overall Study|Lost to Follow-up|1
1054926|NCT01882907|2098596|FG001|Overall Study|Lost to Follow-up|4
1054927|NCT01882907|2098595|FG000|Overall Study|Protocol Violation|10
1054928|NCT01882907|2098596|FG001|Overall Study|Protocol Violation|14
1054929|NCT01882907|2098595|FG000|Overall Study|Withdrawal by Subject|0
1054930|NCT01882907|2098596|FG001|Overall Study|Withdrawal by Subject|6
1054931|NCT01882985|2098604|FG000|Overall Study|Lost to Follow-up|1
1054932|NCT01882985|2098604|FG000|Overall Study|Withdrawal by Subject|1
1054933|NCT01883362|2098614|FG000|Treatment|Adverse Event|1
1054934|NCT01883362|2098615|FG001|Treatment|Adverse Event|8
1054935|NCT01883362|2098614|FG000|Treatment|Withdrawal by Subject|6
1054936|NCT01883362|2098615|FG001|Treatment|Withdrawal by Subject|2
1054937|NCT01883362|2098614|FG000|Treatment|Administrative problems|4
1054938|NCT01883362|2098615|FG001|Treatment|Administrative problems|1
1054939|NCT01883362|2098614|FG000|Treatment|Relapse|4
1054940|NCT01883362|2098615|FG001|Treatment|Relapse|2
1054941|NCT01883362|2098614|FG000|Treatment|Randomized, not treated|1
1054942|NCT01883362|2098615|FG001|Treatment|Randomized, not treated|1
1054943|NCT01883362|2098614|FG000|Post Treatment Follow-up|Protocol Violation|0
1054944|NCT01883362|2098615|FG001|Post Treatment Follow-up|Protocol Violation|1
1054945|NCT01883362|2098614|FG000|Post Treatment Follow-up|Withdrawal by Subject|4
1054946|NCT01883362|2098615|FG001|Post Treatment Follow-up|Withdrawal by Subject|3
1054947|NCT01883362|2098614|FG000|Post Treatment Follow-up|Lost to Follow-up|1
1054948|NCT01883362|2098615|FG001|Post Treatment Follow-up|Lost to Follow-up|4
1054949|NCT01883362|2098614|FG000|Post Treatment Follow-up|Administrative problems|2
1054950|NCT01883362|2098615|FG001|Post Treatment Follow-up|Administrative problems|0
1054951|NCT01883362|2098614|FG000|Post Treatment Follow-up|Death|8
1054952|NCT01883362|2098615|FG001|Post Treatment Follow-up|Death|4
1054953|NCT01883362|2098614|FG000|Post Treatment Follow-up|Relapse|1
1054954|NCT01883362|2098615|FG001|Post Treatment Follow-up|Relapse|2
1054955|NCT01883453|2098646|FG000|Overall Study|No episode of common cold|25
1054956|NCT01883453|2098647|FG001|Overall Study|No episode of common cold|23
1054957|NCT01883492|2098655|FG000|Overall Study|Lost to Follow-up|3
1054958|NCT01883492|2098656|FG001|Overall Study|Lost to Follow-up|4
1054959|NCT01883492|2098655|FG000|Overall Study|Surgery on contra-lateral hip|0
1054960|NCT01883492|2098656|FG001|Overall Study|Surgery on contra-lateral hip|1
1054961|NCT01883492|2098655|FG000|Overall Study|Poor X-ray quality|7
1054962|NCT01883492|2098656|FG001|Overall Study|Poor X-ray quality|4
1054963|NCT01883492|2098655|FG000|Overall Study|Withdrawal by Subject|1
1054964|NCT01883492|2098656|FG001|Overall Study|Withdrawal by Subject|0
1054965|NCT01883492|2098655|FG000|Overall Study|inappropriate implant used|1
1054966|NCT01883492|2098656|FG001|Overall Study|inappropriate implant used|1
1054967|NCT01883492|2098655|FG000|Overall Study|bone anatomy did not meet study criteria|1
1054968|NCT01883492|2098656|FG001|Overall Study|bone anatomy did not meet study criteria|1
1054969|NCT01883635|2098664|FG000|Overall Study|Withdrawal by Subject|4
1054970|NCT01883635|2098665|FG001|Overall Study|Withdrawal by Subject|0
1054971|NCT01883895|2098686|FG000|Overall Study|Lost to Follow-up|2
1054972|NCT01884025|2098705|FG000|Overall Study|Lost to Follow-up|3
1054973|NCT01884025|2098706|FG001|Overall Study|Lost to Follow-up|4
1054974|NCT01884311|2098721|FG000|Overall Study|Withdrawal by Subject|3
1054975|NCT01884311|2098721|FG000|Overall Study|withdrew consent due to AEs|1
1054976|NCT01884311|2098721|FG000|Overall Study|Precautionary measure|1
1054977|NCT01884337|2098730|FG000|Treatment|Adverse Event|2
1054978|NCT01884337|2098731|FG001|Treatment|Adverse Event|2
1054979|NCT01884337|2098730|FG000|Treatment|Subj. request to discont. treatment|2
1054980|NCT01884337|2098731|FG001|Treatment|Subj. request to discont. treatment|0
1054981|NCT01884337|2098730|FG000|Follow-up Period|Lost to Follow-up|1
1054982|NCT01884337|2098731|FG001|Follow-up Period|Lost to Follow-up|1
1054983|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
1054984|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
1054985|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
1054986|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6
1054987|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4
1054988|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0
1054989|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
1054990|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
1054991|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
1054992|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
1054993|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
1054994|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
1054995|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
1054996|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
1054997|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
1054998|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
1054999|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
1055000|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
1055001|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
1055002|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
1055003|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
1055004|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
1055005|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
1055006|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
1055007|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
1055008|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
1055009|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
1055010|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
1055011|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
1055012|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
1055013|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
1055014|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
1055015|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
1055016|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
1055017|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
1055018|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
1055019|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7
1055020|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3
1055021|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3
1055022|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
1055023|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
1055024|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
1055025|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
1055026|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
1055027|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
1055028|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
1055029|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
1055030|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
1055031|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
1055032|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
1055033|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
1055034|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
1055035|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
1055036|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
1055037|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
1055038|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
1055039|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
1055040|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
1055041|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
1055042|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
1055043|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
1055044|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
1055045|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
1055046|NCT01884350|2098739|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
1055047|NCT01884350|2098740|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
1055048|NCT01884350|2098741|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
1055049|NCT01884545|2098772|FG000|Overall Study|Lost to Follow-up|6
1055050|NCT01884545|2098773|FG001|Overall Study|Lost to Follow-up|4
1055051|NCT01884545|2098774|FG002|Overall Study|Lost to Follow-up|9
1055052|NCT01884545|2098775|FG003|Overall Study|Lost to Follow-up|4
1055053|NCT01884545|2098772|FG000|Overall Study|Patient withdrawn|7
1055054|NCT01884545|2098773|FG001|Overall Study|Patient withdrawn|12
1055055|NCT01884545|2098774|FG002|Overall Study|Patient withdrawn|5
1055056|NCT01884545|2098775|FG003|Overall Study|Patient withdrawn|5
1055057|NCT01884545|2098772|FG000|Overall Study|Non-adherence|0
1055058|NCT01884545|2098773|FG001|Overall Study|Non-adherence|2
1055059|NCT01884545|2098774|FG002|Overall Study|Non-adherence|0
1055060|NCT01884545|2098775|FG003|Overall Study|Non-adherence|0
1055061|NCT01884571|2098785|FG000|Overall Study|Adverse Event|1
1055062|NCT01884571|2098785|FG000|Overall Study|Death|2
1055063|NCT01884571|2098785|FG000|Overall Study|Withdrawal by Subject|2
1055064|NCT01884571|2098785|FG000|Overall Study|Disease progression|3
1055065|NCT01884597|2098792|FG000|Overall Study|Adverse Event|0
1055066|NCT01884597|2098793|FG001|Overall Study|Adverse Event|0
1055067|NCT01884597|2098794|FG002|Overall Study|Adverse Event|1
1055068|NCT01884597|2098792|FG000|Overall Study|Lack of Efficacy|1
1055069|NCT01884597|2098793|FG001|Overall Study|Lack of Efficacy|0
1055070|NCT01884597|2098794|FG002|Overall Study|Lack of Efficacy|0
1055071|NCT01884597|2098792|FG000|Overall Study|Death|0
1055072|NCT01884597|2098793|FG001|Overall Study|Death|1
1055073|NCT01884597|2098794|FG002|Overall Study|Death|0
1055074|NCT01884675|2098810|FG000|Overall Study|Study closed/terminated|3
1055075|NCT01884675|2098811|FG001|Overall Study|Study closed/terminated|2
1055076|NCT01884688|2098819|FG000|Overall Study|Screen Failure|2
1055077|NCT01885000|2098834|FG000|Overall Study|Adverse Event|1
1055078|NCT01885000|2098835|FG001|Overall Study|Adverse Event|0
1055079|NCT01885000|2098834|FG000|Overall Study|Withdrawal by Subject|1
1055080|NCT01885000|2098835|FG001|Overall Study|Withdrawal by Subject|1
1055081|NCT01885000|2098834|FG000|Overall Study|Protocol Violation|0
1055082|NCT01885000|2098835|FG001|Overall Study|Protocol Violation|1
1055083|NCT01885104|2098843|FG000|Overall Study|Withdrawal of Consent|1
1055084|NCT01885104|2098844|FG001|Overall Study|Withdrawal of Consent|0
1055085|NCT01885104|2098843|FG000|Overall Study|Lost to Follow-up|0
1055086|NCT01885104|2098844|FG001|Overall Study|Lost to Follow-up|1
1055087|NCT01885104|2098843|FG000|Overall Study|Physician Decision|1
1055088|NCT01885104|2098844|FG001|Overall Study|Physician Decision|0
1055089|NCT01885182|2098861|FG000|Overall Study|Adverse Event|11
1055090|NCT01885182|2098862|FG001|Overall Study|Adverse Event|13
1055091|NCT01885182|2098861|FG000|Overall Study|Withdrawal by Subject|13
1055092|NCT01885182|2098862|FG001|Overall Study|Withdrawal by Subject|6
1055093|NCT01885182|2098861|FG000|Overall Study|Lost to Follow-up|2
1055094|NCT01885182|2098862|FG001|Overall Study|Lost to Follow-up|2
1055095|NCT01885182|2098861|FG000|Overall Study|Lack of Efficacy|8
1055096|NCT01885182|2098862|FG001|Overall Study|Lack of Efficacy|1
1055097|NCT01885195|2098870|FG000|Overall Study|Adverse Event|29
1055098|NCT01885195|2098870|FG000|Overall Study|Death|1
1055099|NCT01885195|2098870|FG000|Overall Study|Disease Progression|67
1055100|NCT01885195|2098870|FG000|Overall Study|Protocol Deviation|2
1055101|NCT01885195|2098870|FG000|Overall Study|Physician Decision|3
1055102|NCT01885195|2098870|FG000|Overall Study|Patient/guardian decision|8
1055103|NCT01885208|2098876|FG000|Overall Study|Unclassified|32
1055104|NCT01885208|2098877|FG001|Overall Study|Unclassified|38
1055105|NCT01885559|2098885|FG000|Overall Study|Lost to Follow-up|15
1055106|NCT01885559|2098886|FG001|Overall Study|Lost to Follow-up|16
1055107|NCT01885559|2098885|FG000|Overall Study|Less than full participation|9
1055108|NCT01885559|2098886|FG001|Overall Study|Less than full participation|19
1055109|NCT01885559|2098885|FG000|Overall Study|Protocol Violation|0
1055110|NCT01885559|2098886|FG001|Overall Study|Protocol Violation|1
1055111|NCT01885936|2098929|FG000|Overall Study|Withdrawal by Subject|1
1055112|NCT01885936|2098930|FG001|Overall Study|Withdrawal by Subject|0
1055113|NCT01886105|2098936|FG000|Overall Study|Lack of Efficacy|3
1055114|NCT01886287|2098945|FG000|Overall Study|Radiographic disease progression|1
1055115|NCT01886287|2098945|FG000|Overall Study|Clinical progression due to disease|1
1055116|NCT01886300|2098949|FG000|Overall Study|Trial terminated by sponsor|16
1055117|NCT01886313|2098955|FG000|Overall Study|Adverse Event|1
1055118|NCT01886313|2098956|FG001|Overall Study|Adverse Event|1
1055119|NCT01886378|2098962|FG000|Overall Study|Adverse Event|1
1055120|NCT01886378|2098962|FG000|Overall Study|Withdrawal by Subject|4
1055121|NCT01886690|2098968|FG000|Overall Study|Protocol Violation|0
1055122|NCT01886690|2098969|FG001|Overall Study|Protocol Violation|1
1055123|NCT01886690|2098968|FG000|Overall Study|Personal Reasons|0
1055124|NCT01886690|2098969|FG001|Overall Study|Personal Reasons|1
1055125|NCT01886716|2098979|FG000|Week 1|Lost to Follow-up|0
1055126|NCT01886716|2098980|FG001|Week 1|Lost to Follow-up|0
1055127|NCT01886716|2098981|FG002|Week 1|Lost to Follow-up|2
1055128|NCT01886716|2098982|FG003|Week 1|Lost to Follow-up|2
1055129|NCT01886716|2098979|FG000|Week 2|Lost to Follow-up|3
1055130|NCT01886716|2098980|FG001|Week 2|Lost to Follow-up|2
1055131|NCT01886716|2098981|FG002|Week 2|Lost to Follow-up|1
1055132|NCT01886716|2098982|FG003|Week 2|Lost to Follow-up|3
1055133|NCT01886716|2098979|FG000|Week 3|Lost to Follow-up|1
1055134|NCT01886716|2098980|FG001|Week 3|Lost to Follow-up|1
1055135|NCT01886716|2098981|FG002|Week 3|Lost to Follow-up|0
1055136|NCT01886716|2098982|FG003|Week 3|Lost to Follow-up|1
1055137|NCT01886781|2098994|FG000|Overall Study|Protocol Violation|5
1055138|NCT01886781|2098995|FG001|Overall Study|Protocol Violation|0
1055139|NCT01886781|2098994|FG000|Overall Study|Adverse Event|1
1055140|NCT01886781|2098995|FG001|Overall Study|Adverse Event|0
1055141|NCT01886781|2098994|FG000|Overall Study|Lost to Follow-up|5
1055142|NCT01886781|2098995|FG001|Overall Study|Lost to Follow-up|0
1055143|NCT01886781|2098994|FG000|Overall Study|Withdrawal by Subject|2
1055144|NCT01886781|2098995|FG001|Overall Study|Withdrawal by Subject|1
1055145|NCT01886781|2098994|FG000|Overall Study|Worsening of symptoms|1
1055146|NCT01886781|2098995|FG001|Overall Study|Worsening of symptoms|1
1055147|NCT01886833|2099017|FG000|Overall Study|IgA not available from both periods|204
1055151|NCT01887210|2099071|FG000|Overall Study|Withdrawal by Subject|1
1055152|NCT01887210|2099072|FG001|Overall Study|Withdrawal by Subject|3
1055153|NCT01887210|2099071|FG000|Overall Study|Lost to Follow-up|0
1055154|NCT01887210|2099072|FG001|Overall Study|Lost to Follow-up|1
1055155|NCT01887353|2099094|FG000|Overall Study|Study stopped early|4
1055156|NCT01887353|2099095|FG001|Overall Study|Study stopped early|3
1055157|NCT01887418|2099104|FG000|Overall Study|Travelling difficulties|0
1055158|NCT01887418|2099105|FG001|Overall Study|Travelling difficulties|0
1055159|NCT01887418|2099106|FG002|Overall Study|Travelling difficulties|1
1055160|NCT01887600|2099138|FG000|Overall Study|Death|39
1055161|NCT01887600|2099139|FG001|Overall Study|Death|16
1055162|NCT01887600|2099138|FG000|Overall Study|Lack of Efficacy|3
1055163|NCT01887600|2099139|FG001|Overall Study|Lack of Efficacy|26
1055164|NCT01887600|2099138|FG000|Overall Study|Lost to Follow-up|5
1055165|NCT01887600|2099139|FG001|Overall Study|Lost to Follow-up|1
1055166|NCT01887600|2099138|FG000|Overall Study|Physician Decision|7
1055167|NCT01887600|2099139|FG001|Overall Study|Physician Decision|8
1055168|NCT01887600|2099138|FG000|Overall Study|Protocol Deviation|3
1055169|NCT01887600|2099139|FG001|Overall Study|Protocol Deviation|0
1055170|NCT01887600|2099138|FG000|Overall Study|Withdrawal by Subject|58
1055171|NCT01887600|2099139|FG001|Overall Study|Withdrawal by Subject|52
1055172|NCT01887600|2099138|FG000|Overall Study|Adverse Event|21
1055173|NCT01887600|2099139|FG001|Overall Study|Adverse Event|9
1055174|NCT01887600|2099138|FG000|Overall Study|Non-compliance with study drug|3
1055175|NCT01887600|2099139|FG001|Overall Study|Non-compliance with study drug|0
1055176|NCT01887600|2099138|FG000|Overall Study|Miscellaneous|6
1055177|NCT01887600|2099139|FG001|Overall Study|Miscellaneous|2
1055178|NCT01887600|2099138|FG000|Overall Study|Progressive Disease|1
1055179|NCT01887600|2099139|FG001|Overall Study|Progressive Disease|0
1055180|NCT01887678|2099148|FG000|Overall Study|Adverse Event|4
1055181|NCT01887678|2099149|FG001|Overall Study|Adverse Event|6
1055182|NCT01887678|2099148|FG000|Overall Study|Exceeded rescue medication dosage|4
1055183|NCT01887678|2099149|FG001|Overall Study|Exceeded rescue medication dosage|5
1055184|NCT01887678|2099148|FG000|Overall Study|Withdrawal of consent|3
1055185|NCT01887678|2099149|FG001|Overall Study|Withdrawal of consent|4
1055186|NCT01887678|2099148|FG000|Overall Study|Lost to Follow-up|4
1055187|NCT01887678|2099149|FG001|Overall Study|Lost to Follow-up|2
1055188|NCT01887678|2099148|FG000|Overall Study|Deterioration of clinical condition|0
1055189|NCT01887678|2099149|FG001|Overall Study|Deterioration of clinical condition|4
1055190|NCT01887678|2099148|FG000|Overall Study|Lack of Efficacy|1
1055191|NCT01887678|2099149|FG001|Overall Study|Lack of Efficacy|2
1055192|NCT01887678|2099148|FG000|Overall Study|Non-compliance|0
1055193|NCT01887678|2099149|FG001|Overall Study|Non-compliance|3
1055194|NCT01887678|2099148|FG000|Overall Study|Specified|1
1055195|NCT01887678|2099149|FG001|Overall Study|Specified|2
1055196|NCT01887717|2099157|FG000|Overall Study|Withdrawal by Subject|1
1055197|NCT01887717|2099158|FG001|Overall Study|Withdrawal by Subject|7
1055198|NCT01887717|2099157|FG000|Overall Study|Physician Decision|0
1055199|NCT01887717|2099158|FG001|Overall Study|Physician Decision|2
1055200|NCT01887717|2099157|FG000|Overall Study|Administrative reasons|5
1055201|NCT01887717|2099158|FG001|Overall Study|Administrative reasons|2
1055202|NCT01887912|2099166|FG000|Overall Study|Serious adverse event|400
1055203|NCT01887912|2099167|FG001|Overall Study|Serious adverse event|198
1055204|NCT01887912|2099166|FG000|Overall Study|Other Adverse Event|34
1055205|NCT01887912|2099167|FG001|Overall Study|Other Adverse Event|15
1055206|NCT01887912|2099166|FG000|Overall Study|Protocol Violation|67
1055207|NCT01887912|2099167|FG001|Overall Study|Protocol Violation|37
1055208|NCT01887912|2099166|FG000|Overall Study|Lost to Follow-up|163
1055209|NCT01887912|2099167|FG001|Overall Study|Lost to Follow-up|74
1055210|NCT01887912|2099166|FG000|Overall Study|Withdrawal by Subject|606
1055211|NCT01887912|2099167|FG001|Overall Study|Withdrawal by Subject|349
1055212|NCT01887912|2099166|FG000|Overall Study|Other|122
1055213|NCT01887912|2099167|FG001|Overall Study|Other|58
1055214|NCT01888003|2099195|FG000|Overall Study|Study Terminated|5
1055215|NCT01888003|2099196|FG001|Overall Study|Study Terminated|6
1055216|NCT01888003|2099197|FG002|Overall Study|Study Terminated|40
1055217|NCT01888367|2099208|FG000|Overall Study|Physician Decision|3
1055218|NCT01888367|2099209|FG001|Overall Study|Physician Decision|4
1055219|NCT01888367|2099210|FG002|Overall Study|Physician Decision|2
1055220|NCT01888367|2099208|FG000|Overall Study|Death|2
1055221|NCT01888367|2099209|FG001|Overall Study|Death|0
1055222|NCT01888367|2099210|FG002|Overall Study|Death|1
1055223|NCT01888367|2099208|FG000|Overall Study|Withdrawal by Subject|1
1055224|NCT01888367|2099209|FG001|Overall Study|Withdrawal by Subject|0
1055225|NCT01888367|2099210|FG002|Overall Study|Withdrawal by Subject|1
1055226|NCT01888367|2099208|FG000|Overall Study|Lost to Follow-up|1
1055227|NCT01888367|2099209|FG001|Overall Study|Lost to Follow-up|1
1055228|NCT01888367|2099210|FG002|Overall Study|Lost to Follow-up|0
1055229|NCT01888367|2099208|FG000|Overall Study|Protocol Violation|0
1055230|NCT01888367|2099209|FG001|Overall Study|Protocol Violation|0
1055231|NCT01888367|2099210|FG002|Overall Study|Protocol Violation|1
1055232|NCT01888367|2099208|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1
1055233|NCT01888367|2099209|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0
1055234|NCT01888367|2099210|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0
1055235|NCT01888432|2099220|FG000|12-month Analysis (FAS)|Lost to Follow-up|0
1055236|NCT01888432|2099221|FG001|12-month Analysis (FAS)|Lost to Follow-up|2
1055237|NCT01888432|2099220|FG000|12-month Analysis (FAS)|Physician Decision|1
1055238|NCT01888432|2099221|FG001|12-month Analysis (FAS)|Physician Decision|1
1055239|NCT01888432|2099220|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6
1055240|NCT01888432|2099221|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3
1055241|NCT01888432|2099220|FG000|12-month Analysis (FAS)|Death|4
1055242|NCT01888432|2099221|FG001|12-month Analysis (FAS)|Death|3
1055243|NCT01888432|2099220|FG000|24-month Analysis (FAS)|Graft loss|0
1055244|NCT01888432|2099221|FG001|24-month Analysis (FAS)|Graft loss|1
1055245|NCT01888432|2099220|FG000|24-month Analysis (FAS)|Lost to Follow-up|0
1055246|NCT01888432|2099221|FG001|24-month Analysis (FAS)|Lost to Follow-up|2
1055247|NCT01888432|2099220|FG000|24-month Analysis (FAS)|Physician Decision|2
1055248|NCT01888432|2099221|FG001|24-month Analysis (FAS)|Physician Decision|4
1055249|NCT01888432|2099220|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7
1055250|NCT01888432|2099221|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6
1055251|NCT01888432|2099220|FG000|24-month Analysis (FAS)|Death|8
1055252|NCT01888432|2099221|FG001|24-month Analysis (FAS)|Death|4
1055253|NCT01888432|2099220|FG000|36-month Analysis (Extension)|Death|1
1055254|NCT01888432|2099221|FG001|36-month Analysis (Extension)|Death|0
1055255|NCT01888497|2099237|FG000|Washout Period 1|Withdrawal by Subject|0
1055256|NCT01888497|2099238|FG001|Washout Period 1|Withdrawal by Subject|0
1055257|NCT01888497|2099239|FG002|Washout Period 1|Withdrawal by Subject|1
1055258|NCT01888497|2099240|FG003|Washout Period 1|Withdrawal by Subject|1
1055259|NCT01888497|2099237|FG000|Washout Period 2|Adverse Event|0
1055260|NCT01888497|2099238|FG001|Washout Period 2|Adverse Event|0
1055261|NCT01888497|2099239|FG002|Washout Period 2|Adverse Event|0
1055262|NCT01888497|2099240|FG003|Washout Period 2|Adverse Event|1
1055263|NCT01888497|2099237|FG000|Washout Period 2|Withdrawal by Subject|0
1055264|NCT01888497|2099238|FG001|Washout Period 2|Withdrawal by Subject|0
1055265|NCT01888497|2099239|FG002|Washout Period 2|Withdrawal by Subject|0
1055266|NCT01888497|2099240|FG003|Washout Period 2|Withdrawal by Subject|1
1055267|NCT01888640|2099253|FG000|Overall Study|Lost to Follow-up|1
1055268|NCT01888640|2099254|FG001|Overall Study|Lost to Follow-up|2
1055269|NCT01888640|2099255|FG002|Overall Study|Lost to Follow-up|0
1055270|NCT01888640|2099253|FG000|Overall Study|Withdrawal by Subject|15
1055271|NCT01888640|2099254|FG001|Overall Study|Withdrawal by Subject|11
1055272|NCT01888640|2099255|FG002|Overall Study|Withdrawal by Subject|4
1055273|NCT01888640|2099253|FG000|Overall Study|Minimum dose not met|10
1055274|NCT01888640|2099254|FG001|Overall Study|Minimum dose not met|16
1055275|NCT01888640|2099255|FG002|Overall Study|Minimum dose not met|0
1055276|NCT01888640|2099253|FG000|Overall Study|Given wrong unit (placebo)|1
1055277|NCT01888640|2099254|FG001|Overall Study|Given wrong unit (placebo)|0
1055278|NCT01888640|2099255|FG002|Overall Study|Given wrong unit (placebo)|0
1055279|NCT01888640|2099253|FG000|Overall Study|Excluded for prior TENS|0
1055280|NCT01888640|2099254|FG001|Overall Study|Excluded for prior TENS|1
1055281|NCT01888640|2099255|FG002|Overall Study|Excluded for prior TENS|0
1055282|NCT01888640|2099253|FG000|Overall Study|Researcher Termination of Participant|0
1055283|NCT01888640|2099254|FG001|Overall Study|Researcher Termination of Participant|1
1055284|NCT01888640|2099255|FG002|Overall Study|Researcher Termination of Participant|1
1055285|NCT01888874|2099273|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
1055286|NCT01888874|2099274|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
1055287|NCT01888874|2099275|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
1055288|NCT01888874|2099276|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4
1055289|NCT01888874|2099277|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
1055290|NCT01888874|2099278|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
1055291|NCT01888874|2099279|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
908149|NCT00779766|1884535|FG000|Month 24|Adverse Event|3
908150|NCT00779766|1884536|FG001|Month 24|Adverse Event|3
908151|NCT00779766|1884535|FG000|Month 24|Protocol Violation|3
908152|NCT00779766|1884536|FG001|Month 24|Protocol Violation|1
1055292|NCT01888874|2099273|FG000|Period 1 (Baseline up to Week 12)|Other|1
1055293|NCT01888874|2099274|FG001|Period 1 (Baseline up to Week 12)|Other|0
1055294|NCT01888874|2099275|FG002|Period 1 (Baseline up to Week 12)|Other|1
1055295|NCT01888874|2099276|FG003|Period 1 (Baseline up to Week 12)|Other|1
1055296|NCT01888874|2099277|FG004|Period 1 (Baseline up to Week 12)|Other|3
1055297|NCT01888874|2099278|FG005|Period 1 (Baseline up to Week 12)|Other|3
1055298|NCT01888874|2099279|FG006|Period 1 (Baseline up to Week 12)|Other|0
1055299|NCT01888874|2099273|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0
1055300|NCT01888874|2099274|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0
1055301|NCT01888874|2099275|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0
1055302|NCT01888874|2099276|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0
1055303|NCT01888874|2099277|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0
1055304|NCT01888874|2099278|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0
1055305|NCT01888874|2099279|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1
1055306|NCT01888874|2099273|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0
1055307|NCT01888874|2099274|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2
1055308|NCT01888874|2099275|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3
1055309|NCT01888874|2099276|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
1055310|NCT01888874|2099277|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2
1055311|NCT01888874|2099278|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1
1055312|NCT01888874|2099279|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0
1055313|NCT01888874|2099273|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
908153|NCT00779766|1884535|FG000|Month 24|Withdrawal by Subject|159
908154|NCT00779766|1884536|FG001|Month 24|Withdrawal by Subject|127
908155|NCT00779766|1884535|FG000|Month 24|Migrated/moved from study area|138
908156|NCT00779766|1884536|FG001|Month 24|Migrated/moved from study area|162
908157|NCT00779766|1884535|FG000|Month 24|Lost to Follow-up|9
1055314|NCT01888874|2099274|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
1055315|NCT01888874|2099275|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
1055316|NCT01888874|2099276|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
1055317|NCT01888874|2099277|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1
1055318|NCT01888874|2099278|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
1055319|NCT01888874|2099279|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
1055320|NCT01888874|2099273|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
1055321|NCT01888874|2099274|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1
1055322|NCT01888874|2099275|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
1055323|NCT01888874|2099276|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
1055324|NCT01888874|2099277|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
1055325|NCT01888874|2099278|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
1055326|NCT01888874|2099279|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
1055327|NCT01888874|2099273|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
1055328|NCT01888874|2099274|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
1055329|NCT01888874|2099275|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
1055330|NCT01888874|2099276|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
1055331|NCT01888874|2099277|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
1055332|NCT01888874|2099278|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
1055333|NCT01888874|2099279|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
1055334|NCT01888874|2099273|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
1055335|NCT01888874|2099274|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
1055336|NCT01888874|2099275|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
1055337|NCT01888874|2099276|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
1055338|NCT01888874|2099277|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
1055339|NCT01888874|2099278|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
1055340|NCT01888874|2099279|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
1055341|NCT01888874|2099273|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
1055342|NCT01888874|2099274|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
1055343|NCT01888874|2099275|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
1055344|NCT01888874|2099276|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
1055345|NCT01888874|2099277|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1
1055346|NCT01888874|2099278|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
1055347|NCT01888874|2099279|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
1055348|NCT01888874|2099273|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
1055349|NCT01888874|2099274|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
1055350|NCT01888874|2099275|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2
1055351|NCT01888874|2099276|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
1055352|NCT01888874|2099277|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
1055353|NCT01888874|2099278|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1
1055354|NCT01888874|2099279|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
1055355|NCT01888874|2099273|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0
1055356|NCT01888874|2099274|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0
1055357|NCT01888874|2099275|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1
1055358|NCT01888874|2099276|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0
1055359|NCT01888874|2099277|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0
1055360|NCT01888874|2099278|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0
1055361|NCT01888874|2099279|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0
1055362|NCT01888874|2099273|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2
1055363|NCT01888874|2099274|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0
1055364|NCT01888874|2099275|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
1055365|NCT01888874|2099276|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2
1055366|NCT01888874|2099277|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1
1055367|NCT01888874|2099278|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1
1055368|NCT01888874|2099279|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3
1055369|NCT01888874|2099273|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
1055370|NCT01888874|2099274|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
1055371|NCT01888874|2099275|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
1055372|NCT01888874|2099276|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
1055373|NCT01888874|2099277|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
1055374|NCT01888874|2099278|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
1055375|NCT01888874|2099279|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
1055376|NCT01888900|2099298|FG000|Overall Study|failed treatment|0
1055377|NCT01888900|2099299|FG001|Overall Study|failed treatment|2
1055378|NCT01888965|2099311|FG000|Overall Study|Adverse Event|5
1055379|NCT01888965|2099311|FG000|Overall Study|Lack of Efficacy|4
1055380|NCT01889069|2099317|FG000|Overall Study|Death|18
1055381|NCT01889069|2099317|FG000|Overall Study|Progression of Disease|14
1055382|NCT01889069|2099317|FG000|Overall Study|Lost to Follow-up|6
1055383|NCT01889069|2099317|FG000|Overall Study|Other|4
1055384|NCT01889069|2099317|FG000|Overall Study|Consent Withdrawal|3
1055385|NCT01889238|2099327|FG000|Overall Study|Treatment ongoing|9
1055386|NCT01889251|2099333|FG000|Overall Study|Adverse Event|1
1055387|NCT01889251|2099334|FG001|Overall Study|Adverse Event|0
1055388|NCT01889602|2099356|FG000|First Intervention|Adverse Event|1
1055389|NCT01889602|2099357|FG001|First Intervention|Adverse Event|1
1055390|NCT01889602|2099358|FG002|First Intervention|Adverse Event|1
1055391|NCT01889602|2099356|FG000|First Intervention|Protocol Violation|0
1055392|NCT01889602|2099357|FG001|First Intervention|Protocol Violation|1
1055393|NCT01889602|2099358|FG002|First Intervention|Protocol Violation|1
1055394|NCT01889602|2099356|FG000|First Intervention|Study ending|0
1055395|NCT01889602|2099357|FG001|First Intervention|Study ending|1
1055396|NCT01889602|2099358|FG002|First Intervention|Study ending|0
1055397|NCT01889602|2099356|FG000|Second Intervention|Adverse Event|0
1055398|NCT01889602|2099357|FG001|Second Intervention|Adverse Event|0
1055399|NCT01889602|2099358|FG002|Second Intervention|Adverse Event|1
1055400|NCT01889602|2099356|FG000|Second Intervention|Study ending|1
1055401|NCT01889602|2099357|FG001|Second Intervention|Study ending|0
1055402|NCT01889602|2099358|FG002|Second Intervention|Study ending|0
1055403|NCT01889602|2099356|FG000|Second Intervention|Withdrawal by Subject|0
1055404|NCT01889602|2099357|FG001|Second Intervention|Withdrawal by Subject|0
1055405|NCT01889602|2099358|FG002|Second Intervention|Withdrawal by Subject|1
1055406|NCT01889602|2099356|FG000|Third Intervention|Protocol Violation|1
1055407|NCT01889602|2099357|FG001|Third Intervention|Protocol Violation|0
1055408|NCT01889602|2099358|FG002|Third Intervention|Protocol Violation|0
1055409|NCT01889602|2099356|FG000|Third Intervention|Withdrawal by Subject|2
1055410|NCT01889602|2099357|FG001|Third Intervention|Withdrawal by Subject|2
1055411|NCT01889602|2099358|FG002|Third Intervention|Withdrawal by Subject|0
1055412|NCT01889862|2099398|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4
1055413|NCT01889862|2099399|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0
1055414|NCT01889862|2099400|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0
1055415|NCT01889862|2099401|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0
1055416|NCT01889862|2099402|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0
1055417|NCT01889862|2099398|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2
1055418|NCT01889862|2099399|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
1055419|NCT01889862|2099400|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
1055420|NCT01889862|2099401|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
1055421|NCT01889862|2099402|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
1055422|NCT01889862|2099398|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4
1055423|NCT01889862|2099399|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
1055424|NCT01889862|2099400|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
1055425|NCT01889862|2099401|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
1055426|NCT01889862|2099402|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
1055427|NCT01889862|2099398|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2
1055428|NCT01889862|2099399|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0
1055429|NCT01889862|2099400|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0
1055430|NCT01889862|2099401|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0
1055431|NCT01889862|2099402|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0
1055432|NCT01889862|2099398|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0
1055433|NCT01889862|2099399|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0
1055434|NCT01889862|2099400|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1
1055435|NCT01889862|2099401|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0
1055436|NCT01889862|2099402|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0
1055437|NCT01889862|2099398|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0
1055438|NCT01889862|2099399|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0
1055439|NCT01889862|2099400|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0
1055440|NCT01889862|2099401|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0
1055441|NCT01889862|2099402|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5
1055442|NCT01889862|2099398|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
1055443|NCT01889862|2099399|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
1055444|NCT01889862|2099400|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
1055445|NCT01889862|2099401|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
1055446|NCT01889862|2099402|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14
1055447|NCT01889862|2099398|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
1055448|NCT01889862|2099399|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
1055449|NCT01889862|2099400|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
1055450|NCT01889862|2099401|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
1055451|NCT01889862|2099402|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4
1055452|NCT01889862|2099398|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0
1055453|NCT01889862|2099399|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0
1055454|NCT01889862|2099400|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0
1055455|NCT01889862|2099401|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0
1055456|NCT01889862|2099402|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5
1055457|NCT01889862|2099398|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0
1055458|NCT01889862|2099399|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0
1055459|NCT01889862|2099400|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0
1055460|NCT01889862|2099401|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0
1055461|NCT01889862|2099402|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2
1055462|NCT01890109|2099450|FG000|Overall Study|Withdrawal by Subject|0
1055463|NCT01890109|2099451|FG001|Overall Study|Withdrawal by Subject|3
1055464|NCT01890109|2099450|FG000|Overall Study|Lost to Follow-up|1
1055465|NCT01890109|2099451|FG001|Overall Study|Lost to Follow-up|2
1055466|NCT01890122|2099462|FG000|Overall Study|Adverse Event|1
1055467|NCT01890122|2099463|FG001|Overall Study|Adverse Event|1
1055468|NCT01890122|2099464|FG002|Overall Study|Adverse Event|1
1055469|NCT01890122|2099465|FG003|Overall Study|Adverse Event|2
1055470|NCT01890122|2099462|FG000|Overall Study|Major Protocol Deviation|3
1055471|NCT01890122|2099463|FG001|Overall Study|Major Protocol Deviation|1
1055472|NCT01890122|2099464|FG002|Overall Study|Major Protocol Deviation|0
1055473|NCT01890122|2099465|FG003|Overall Study|Major Protocol Deviation|1
1055474|NCT01890122|2099462|FG000|Overall Study|Lost to Follow-up|0
1055475|NCT01890122|2099463|FG001|Overall Study|Lost to Follow-up|1
1055476|NCT01890122|2099464|FG002|Overall Study|Lost to Follow-up|2
1055477|NCT01890122|2099465|FG003|Overall Study|Lost to Follow-up|2
1055478|NCT01890122|2099462|FG000|Overall Study|Voluntary Withdrawal|8
1055479|NCT01890122|2099463|FG001|Overall Study|Voluntary Withdrawal|8
1055480|NCT01890122|2099464|FG002|Overall Study|Voluntary Withdrawal|2
1055481|NCT01890122|2099465|FG003|Overall Study|Voluntary Withdrawal|11
1055482|NCT01890122|2099462|FG000|Overall Study|Lack of Efficacy|14
1055483|NCT01890122|2099463|FG001|Overall Study|Lack of Efficacy|24
1055484|NCT01890122|2099464|FG002|Overall Study|Lack of Efficacy|7
1055485|NCT01890122|2099465|FG003|Overall Study|Lack of Efficacy|41
1055486|NCT01890122|2099462|FG000|Overall Study|Reason not Specified|0
1055487|NCT01890122|2099463|FG001|Overall Study|Reason not Specified|1
1055488|NCT01890122|2099464|FG002|Overall Study|Reason not Specified|1
1055489|NCT01890122|2099465|FG003|Overall Study|Reason not Specified|2
1055490|NCT01890122|2099462|FG000|Overall Study|Randomized but not Treated|1
1055491|NCT01890122|2099463|FG001|Overall Study|Randomized but not Treated|1
1055492|NCT01890122|2099464|FG002|Overall Study|Randomized but not Treated|0
1055493|NCT01890122|2099465|FG003|Overall Study|Randomized but not Treated|0
1055494|NCT01890148|2099475|FG000|Overall Study|Adverse Event|1
1055495|NCT01890265|2099494|FG000|Overall Study|Other (Unspecified reason)|0
1055496|NCT01890265|2099495|FG001|Overall Study|Other (Unspecified reason)|1
1055497|NCT01890265|2099496|FG002|Overall Study|Other (Unspecified reason)|0
1055498|NCT01890265|2099497|FG003|Overall Study|Other (Unspecified reason)|0
1055499|NCT01890265|2099498|FG004|Overall Study|Other (Unspecified reason)|0
1055500|NCT01890265|2099499|FG005|Overall Study|Other (Unspecified reason)|0
1055501|NCT01890265|2099494|FG000|Overall Study|Progressive disease|6
1055502|NCT01890265|2099495|FG001|Overall Study|Progressive disease|6
1055503|NCT01890265|2099496|FG002|Overall Study|Progressive disease|0
1055504|NCT01890265|2099497|FG003|Overall Study|Progressive disease|0
1055505|NCT01890265|2099498|FG004|Overall Study|Progressive disease|0
1055506|NCT01890265|2099499|FG005|Overall Study|Progressive disease|0
1055507|NCT01890265|2099494|FG000|Overall Study|Adverse Event|2
1055508|NCT01890265|2099495|FG001|Overall Study|Adverse Event|1
1055509|NCT01890265|2099496|FG002|Overall Study|Adverse Event|0
1055510|NCT01890265|2099497|FG003|Overall Study|Adverse Event|0
1055511|NCT01890265|2099498|FG004|Overall Study|Adverse Event|0
1055512|NCT01890265|2099499|FG005|Overall Study|Adverse Event|0
1055513|NCT01890265|2099494|FG000|Overall Study|Death|2
1055514|NCT01890265|2099495|FG001|Overall Study|Death|3
1055515|NCT01890265|2099496|FG002|Overall Study|Death|1
1055516|NCT01890265|2099497|FG003|Overall Study|Death|0
1055517|NCT01890265|2099498|FG004|Overall Study|Death|0
1055518|NCT01890265|2099499|FG005|Overall Study|Death|0
1055519|NCT01890265|2099494|FG000|Overall Study|Withdrawal by Subject|0
1055520|NCT01890265|2099495|FG001|Overall Study|Withdrawal by Subject|2
1055521|NCT01890265|2099496|FG002|Overall Study|Withdrawal by Subject|3
1055522|NCT01890265|2099497|FG003|Overall Study|Withdrawal by Subject|0
1055523|NCT01890265|2099498|FG004|Overall Study|Withdrawal by Subject|2
1055524|NCT01890265|2099499|FG005|Overall Study|Withdrawal by Subject|0
1055525|NCT01890421|2099522|FG000|Overall Study|Adverse Event|1
1055526|NCT01890421|2099522|FG000|Overall Study|Other reason|10
1055527|NCT01890434|2099526|FG000|Overall Study|Adverse Event|8
1055528|NCT01890434|2099526|FG000|Overall Study|PCI at external hospital|1
1055529|NCT01890434|2099526|FG000|Overall Study|Assessment discrepancy|1
1055530|NCT01890434|2099526|FG000|Overall Study|CRC didn't contact participant for FU|1
1055531|NCT01890434|2099526|FG000|Overall Study|Could not get whole set of images|1
1055532|NCT01890434|2099526|FG000|Overall Study|Decline to return for GSPECT|1
1055533|NCT01890434|2099526|FG000|Overall Study|GSPECT at rest was not done|1
1055534|NCT01890434|2099526|FG000|Overall Study|Participant didn't complete MRI|1
1055535|NCT01890434|2099526|FG000|Overall Study|Uncontactable by phone|1
1055536|NCT01890434|2099526|FG000|Overall Study|Moved out of position|1
1055537|NCT01890434|2099526|FG000|Overall Study|Unable to contact|1
1055538|NCT01890434|2099526|FG000|Overall Study|Withdrawal by PI for ICA not performed|2
1055539|NCT01890473|2099532|FG000|Overall Study|Lost to Follow-up|1
1055540|NCT01890473|2099533|FG001|Overall Study|Lost to Follow-up|0
1055541|NCT01890473|2099532|FG000|Overall Study|Poor/non-compliance|1
1055542|NCT01890473|2099533|FG001|Overall Study|Poor/non-compliance|0
1055543|NCT01890512|2099541|FG000|Overall Study|Physician Decision|1
1055544|NCT01890512|2099541|FG000|Overall Study|Withdrawal by Subject|1
1055545|NCT01890512|2099541|FG000|Overall Study|Protocol Violation|1
1055546|NCT01890707|2099560|FG000|Overall Study|Lost to Follow-up|1
1055547|NCT01890707|2099561|FG001|Overall Study|Lost to Follow-up|1
1055548|NCT01890746|2099569|FG000|Overall Study|Death|39
1055549|NCT01890746|2099570|FG001|Overall Study|Death|30
1055550|NCT01890746|2099569|FG000|Overall Study|Adverse Event|1
1055551|NCT01890746|2099570|FG001|Overall Study|Adverse Event|0
1055552|NCT01890746|2099569|FG000|Overall Study|Lost to Follow-up|4
1055553|NCT01890746|2099570|FG001|Overall Study|Lost to Follow-up|1
1055554|NCT01890746|2099569|FG000|Overall Study|Physician Decision|3
1055555|NCT01890746|2099570|FG001|Overall Study|Physician Decision|2
1055556|NCT01890746|2099569|FG000|Overall Study|Withdrawal by Subject|5
1055557|NCT01890746|2099570|FG001|Overall Study|Withdrawal by Subject|8
1055558|NCT01890759|2099578|FG000|Overall Study|Protocol Violation|0
1055559|NCT01890759|2099579|FG001|Overall Study|Protocol Violation|2
1055560|NCT01890759|2099578|FG000|Overall Study|Lost to Follow-up|0
1055561|NCT01890759|2099579|FG001|Overall Study|Lost to Follow-up|2
1055562|NCT01890759|2099578|FG000|Overall Study|Withdrawal by Subject|2
1055563|NCT01890759|2099579|FG001|Overall Study|Withdrawal by Subject|8
1055564|NCT01890785|2099591|FG000|Third Intervention|Withdrawal by Subject|0
1055565|NCT01890785|2099592|FG001|Third Intervention|Withdrawal by Subject|1
1055566|NCT01890785|2099593|FG002|Third Intervention|Withdrawal by Subject|0
1055567|NCT01890785|2099594|FG003|Third Intervention|Withdrawal by Subject|0
1055568|NCT01890785|2099595|FG004|Third Intervention|Withdrawal by Subject|0
1055569|NCT01890785|2099596|FG005|Third Intervention|Withdrawal by Subject|0
1055570|NCT01890915|2099607|FG000|Overall Study|Adverse Event|1
1055571|NCT01890915|2099608|FG001|Overall Study|Adverse Event|0
1055572|NCT01890915|2099607|FG000|Overall Study|Protocol Violation|2
1055573|NCT01890915|2099608|FG001|Overall Study|Protocol Violation|0
1055574|NCT01890915|2099607|FG000|Overall Study|Equipment Malfunction|0
1055575|NCT01890915|2099608|FG001|Overall Study|Equipment Malfunction|1
1055576|NCT01890967|2099629|FG000|Overall Study|Adverse Event|3
1055577|NCT01890967|2099630|FG001|Overall Study|Adverse Event|3
1055578|NCT01890967|2099631|FG002|Overall Study|Adverse Event|3
1055579|NCT01890967|2099632|FG003|Overall Study|Adverse Event|2
1055580|NCT01890967|2099633|FG004|Overall Study|Adverse Event|1
1055581|NCT01890967|2099634|FG005|Overall Study|Adverse Event|7
1055582|NCT01890967|2099629|FG000|Overall Study|Death|1
1055583|NCT01890967|2099630|FG001|Overall Study|Death|0
1055584|NCT01890967|2099631|FG002|Overall Study|Death|0
1055585|NCT01890967|2099632|FG003|Overall Study|Death|0
1055586|NCT01890967|2099633|FG004|Overall Study|Death|0
1055587|NCT01890967|2099634|FG005|Overall Study|Death|0
1055588|NCT01890967|2099629|FG000|Overall Study|Lost to Follow-up|1
1055589|NCT01890967|2099630|FG001|Overall Study|Lost to Follow-up|1
1055590|NCT01890967|2099631|FG002|Overall Study|Lost to Follow-up|1
1055591|NCT01890967|2099632|FG003|Overall Study|Lost to Follow-up|1
1055592|NCT01890967|2099633|FG004|Overall Study|Lost to Follow-up|0
1055593|NCT01890967|2099634|FG005|Overall Study|Lost to Follow-up|1
1055594|NCT01890967|2099629|FG000|Overall Study|Protocol Violation|0
1055595|NCT01890967|2099630|FG001|Overall Study|Protocol Violation|3
1055596|NCT01890967|2099631|FG002|Overall Study|Protocol Violation|3
1055597|NCT01890967|2099632|FG003|Overall Study|Protocol Violation|2
1055598|NCT01890967|2099633|FG004|Overall Study|Protocol Violation|4
1055599|NCT01890967|2099634|FG005|Overall Study|Protocol Violation|1
1055600|NCT01890967|2099629|FG000|Overall Study|Sponsor Decision|2
1055601|NCT01890967|2099630|FG001|Overall Study|Sponsor Decision|0
1055602|NCT01890967|2099631|FG002|Overall Study|Sponsor Decision|1
1055603|NCT01890967|2099632|FG003|Overall Study|Sponsor Decision|3
1055604|NCT01890967|2099633|FG004|Overall Study|Sponsor Decision|2
1055605|NCT01890967|2099634|FG005|Overall Study|Sponsor Decision|3
1055606|NCT01890967|2099629|FG000|Overall Study|Withdrawal by Subject|3
1055607|NCT01890967|2099630|FG001|Overall Study|Withdrawal by Subject|4
1055608|NCT01890967|2099631|FG002|Overall Study|Withdrawal by Subject|2
1055609|NCT01890967|2099632|FG003|Overall Study|Withdrawal by Subject|3
1055610|NCT01890967|2099633|FG004|Overall Study|Withdrawal by Subject|3
1055611|NCT01890967|2099634|FG005|Overall Study|Withdrawal by Subject|1
1055612|NCT01891344|2099691|FG000|Overall Study|Ongoing|6
1055613|NCT01891344|2099692|FG001|Overall Study|Ongoing|2
1055614|NCT01891344|2099693|FG002|Overall Study|Ongoing|0
1055615|NCT01891344|2099694|FG003|Overall Study|Ongoing|1
1055616|NCT01891344|2099695|FG004|Overall Study|Ongoing|4
1055617|NCT01891344|2099696|FG005|Overall Study|Ongoing|1
1055618|NCT01891344|2099697|FG006|Overall Study|Ongoing|0
1055619|NCT01891344|2099698|FG007|Overall Study|Ongoing|0
1055620|NCT01891357|2099716|FG000|Overall Study|Protocol Violation|3
1055621|NCT01891669|2099739|FG000|Overall Study|Death|0
1055622|NCT01891669|2099740|FG001|Overall Study|Death|0
1055623|NCT01891669|2099741|FG002|Overall Study|Death|0
1055624|NCT01891669|2099742|FG003|Overall Study|Death|0
1055625|NCT01891669|2099743|FG004|Overall Study|Death|0
1055626|NCT01891669|2099744|FG005|Overall Study|Death|0
1055627|NCT01891669|2099745|FG006|Overall Study|Death|0
1055628|NCT01891669|2099746|FG007|Overall Study|Death|1
1055629|NCT01891669|2099747|FG008|Overall Study|Death|0
1055630|NCT01891669|2099748|FG009|Overall Study|Death|1
1055631|NCT01891669|2099739|FG000|Overall Study|Withdrawal by Subject|1
1055632|NCT01891669|2099740|FG001|Overall Study|Withdrawal by Subject|1
1055633|NCT01891669|2099741|FG002|Overall Study|Withdrawal by Subject|0
1055634|NCT01891669|2099742|FG003|Overall Study|Withdrawal by Subject|0
1055635|NCT01891669|2099743|FG004|Overall Study|Withdrawal by Subject|0
1055636|NCT01891669|2099744|FG005|Overall Study|Withdrawal by Subject|0
1055637|NCT01891669|2099745|FG006|Overall Study|Withdrawal by Subject|1
1055638|NCT01891669|2099746|FG007|Overall Study|Withdrawal by Subject|2
1055639|NCT01891669|2099747|FG008|Overall Study|Withdrawal by Subject|1
1055640|NCT01891669|2099748|FG009|Overall Study|Withdrawal by Subject|1
1055641|NCT01891669|2099739|FG000|Overall Study|Other|1
1055642|NCT01891669|2099740|FG001|Overall Study|Other|0
1055643|NCT01891669|2099741|FG002|Overall Study|Other|0
1055644|NCT01891669|2099742|FG003|Overall Study|Other|0
1055645|NCT01891669|2099743|FG004|Overall Study|Other|0
1055646|NCT01891669|2099744|FG005|Overall Study|Other|0
1055647|NCT01891669|2099745|FG006|Overall Study|Other|0
1055648|NCT01891669|2099746|FG007|Overall Study|Other|1
1055649|NCT01891669|2099747|FG008|Overall Study|Other|0
1055650|NCT01891669|2099748|FG009|Overall Study|Other|0
1055651|NCT01891721|2099782|FG000|Overall Study|Lost to Follow-up|10
1055652|NCT01891721|2099783|FG001|Overall Study|Lost to Follow-up|5
1055653|NCT01891721|2099784|FG002|Overall Study|Lost to Follow-up|1
1055654|NCT01891864|2099805|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1
1055655|NCT01891864|2099806|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1
1055656|NCT01891864|2099807|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1055657|NCT01891864|2099808|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1055658|NCT01891864|2099809|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1055659|NCT01891864|2099810|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1055660|NCT01891864|2099805|FG000|Treatment Period 1|Physician Decision|0
1055661|NCT01891864|2099806|FG001|Treatment Period 1|Physician Decision|1
1055662|NCT01891864|2099807|FG002|Treatment Period 1|Physician Decision|0
1055663|NCT01891864|2099808|FG003|Treatment Period 1|Physician Decision|0
1055664|NCT01891864|2099809|FG004|Treatment Period 1|Physician Decision|0
1055665|NCT01891864|2099810|FG005|Treatment Period 1|Physician Decision|0
1055666|NCT01891864|2099805|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0
1055667|NCT01891864|2099806|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1
1055668|NCT01891864|2099807|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0
1055669|NCT01891864|2099808|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0
1055670|NCT01891864|2099809|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0
1055671|NCT01891864|2099810|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0
1055672|NCT01891864|2099805|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4
1055673|NCT01891864|2099806|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4
1055674|NCT01891864|2099807|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1055675|NCT01891864|2099808|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1055676|NCT01891864|2099809|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1055677|NCT01891864|2099810|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1055678|NCT01891864|2099805|FG000|Treatment Period 1|Withdrawal by Subject|2
1055679|NCT01891864|2099806|FG001|Treatment Period 1|Withdrawal by Subject|5
1055680|NCT01891864|2099807|FG002|Treatment Period 1|Withdrawal by Subject|0
1055681|NCT01891864|2099808|FG003|Treatment Period 1|Withdrawal by Subject|0
1055682|NCT01891864|2099809|FG004|Treatment Period 1|Withdrawal by Subject|0
1055683|NCT01891864|2099810|FG005|Treatment Period 1|Withdrawal by Subject|0
1055684|NCT01891864|2099805|FG000|Treatment Period 1|Lost to Follow-up|1
1055685|NCT01891864|2099806|FG001|Treatment Period 1|Lost to Follow-up|0
1055686|NCT01891864|2099807|FG002|Treatment Period 1|Lost to Follow-up|0
1055687|NCT01891864|2099808|FG003|Treatment Period 1|Lost to Follow-up|0
1055688|NCT01891864|2099809|FG004|Treatment Period 1|Lost to Follow-up|0
1055689|NCT01891864|2099810|FG005|Treatment Period 1|Lost to Follow-up|0
1055690|NCT01891864|2099805|FG000|Treatment Period 2|Protocol Violation|0
1055691|NCT01891864|2099806|FG001|Treatment Period 2|Protocol Violation|0
1055692|NCT01891864|2099807|FG002|Treatment Period 2|Protocol Violation|0
1055693|NCT01891864|2099808|FG003|Treatment Period 2|Protocol Violation|1
1055694|NCT01891864|2099809|FG004|Treatment Period 2|Protocol Violation|0
1055695|NCT01891864|2099810|FG005|Treatment Period 2|Protocol Violation|0
1055696|NCT01891864|2099805|FG000|Treatment Period 2|Physician Decision|0
1055697|NCT01891864|2099806|FG001|Treatment Period 2|Physician Decision|0
1055698|NCT01891864|2099807|FG002|Treatment Period 2|Physician Decision|1
1055699|NCT01891864|2099808|FG003|Treatment Period 2|Physician Decision|0
1055700|NCT01891864|2099809|FG004|Treatment Period 2|Physician Decision|0
1055701|NCT01891864|2099810|FG005|Treatment Period 2|Physician Decision|0
1055702|NCT01891864|2099805|FG000|Treatment Period 2|Site Termination|0
1055703|NCT01891864|2099806|FG001|Treatment Period 2|Site Termination|0
1055704|NCT01891864|2099807|FG002|Treatment Period 2|Site Termination|1
1055705|NCT01891864|2099808|FG003|Treatment Period 2|Site Termination|2
1055706|NCT01891864|2099809|FG004|Treatment Period 2|Site Termination|0
1055707|NCT01891864|2099810|FG005|Treatment Period 2|Site Termination|0
1055708|NCT01891864|2099805|FG000|Treatment Period 2|Lack of Efficacy|0
1055709|NCT01891864|2099806|FG001|Treatment Period 2|Lack of Efficacy|0
1055710|NCT01891864|2099807|FG002|Treatment Period 2|Lack of Efficacy|1
1055711|NCT01891864|2099808|FG003|Treatment Period 2|Lack of Efficacy|0
1055712|NCT01891864|2099809|FG004|Treatment Period 2|Lack of Efficacy|1
1055713|NCT01891864|2099810|FG005|Treatment Period 2|Lack of Efficacy|0
1055714|NCT01891864|2099805|FG000|Treatment Period 2|Adverse Event|0
1055715|NCT01891864|2099806|FG001|Treatment Period 2|Adverse Event|0
1055716|NCT01891864|2099807|FG002|Treatment Period 2|Adverse Event|1
1055717|NCT01891864|2099808|FG003|Treatment Period 2|Adverse Event|2
1055718|NCT01891864|2099809|FG004|Treatment Period 2|Adverse Event|0
1055719|NCT01891864|2099810|FG005|Treatment Period 2|Adverse Event|4
1055720|NCT01891864|2099805|FG000|Treatment Period 2|Termination of Site|0
1055721|NCT01891864|2099806|FG001|Treatment Period 2|Termination of Site|0
1055722|NCT01891864|2099807|FG002|Treatment Period 2|Termination of Site|0
1055723|NCT01891864|2099808|FG003|Treatment Period 2|Termination of Site|0
1055724|NCT01891864|2099809|FG004|Treatment Period 2|Termination of Site|2
1055725|NCT01891864|2099810|FG005|Treatment Period 2|Termination of Site|0
1055726|NCT01891864|2099805|FG000|Treatment Period 2|Withdrawal by Subject|0
1055727|NCT01891864|2099806|FG001|Treatment Period 2|Withdrawal by Subject|0
1055728|NCT01891864|2099807|FG002|Treatment Period 2|Withdrawal by Subject|3
1055729|NCT01891864|2099808|FG003|Treatment Period 2|Withdrawal by Subject|4
1055730|NCT01891864|2099809|FG004|Treatment Period 2|Withdrawal by Subject|1
1055731|NCT01891864|2099810|FG005|Treatment Period 2|Withdrawal by Subject|1
1055732|NCT01891864|2099805|FG000|Extension Period|Lack of Efficacy|0
1055733|NCT01891864|2099806|FG001|Extension Period|Lack of Efficacy|0
1055734|NCT01891864|2099807|FG002|Extension Period|Lack of Efficacy|0
1055735|NCT01891864|2099808|FG003|Extension Period|Lack of Efficacy|1
1055736|NCT01891864|2099809|FG004|Extension Period|Lack of Efficacy|1
1055737|NCT01891864|2099810|FG005|Extension Period|Lack of Efficacy|0
1055738|NCT01891864|2099805|FG000|Extension Period|Pregnancy|0
1055739|NCT01891864|2099806|FG001|Extension Period|Pregnancy|0
1055740|NCT01891864|2099807|FG002|Extension Period|Pregnancy|1
1055741|NCT01891864|2099808|FG003|Extension Period|Pregnancy|0
1055742|NCT01891864|2099809|FG004|Extension Period|Pregnancy|0
1055743|NCT01891864|2099810|FG005|Extension Period|Pregnancy|0
1055744|NCT01891864|2099805|FG000|Extension Period|Adverse Event|0
1055745|NCT01891864|2099806|FG001|Extension Period|Adverse Event|0
1055746|NCT01891864|2099807|FG002|Extension Period|Adverse Event|4
1055747|NCT01891864|2099808|FG003|Extension Period|Adverse Event|2
1055748|NCT01891864|2099809|FG004|Extension Period|Adverse Event|2
1055749|NCT01891864|2099810|FG005|Extension Period|Adverse Event|0
1055750|NCT01891864|2099805|FG000|Extension Period|Withdrawal by Subject|0
1055751|NCT01891864|2099806|FG001|Extension Period|Withdrawal by Subject|0
1055752|NCT01891864|2099807|FG002|Extension Period|Withdrawal by Subject|1
1055753|NCT01891864|2099808|FG003|Extension Period|Withdrawal by Subject|2
1055754|NCT01891864|2099809|FG004|Extension Period|Withdrawal by Subject|4
1055755|NCT01891864|2099810|FG005|Extension Period|Withdrawal by Subject|0
1055756|NCT01891864|2099805|FG000|Extension Period|Lost to Follow-up|0
1055757|NCT01891864|2099806|FG001|Extension Period|Lost to Follow-up|0
1055758|NCT01891864|2099807|FG002|Extension Period|Lost to Follow-up|2
1055759|NCT01891864|2099808|FG003|Extension Period|Lost to Follow-up|0
1055760|NCT01891864|2099809|FG004|Extension Period|Lost to Follow-up|0
1055761|NCT01891864|2099810|FG005|Extension Period|Lost to Follow-up|0
1055762|NCT01891890|2099825|FG000|Overall Study|Lost to Follow-up|0
1055763|NCT01891890|2099826|FG001|Overall Study|Lost to Follow-up|0
1055764|NCT01891890|2099827|FG002|Overall Study|Lost to Follow-up|1
1055765|NCT01891890|2099825|FG000|Overall Study|Study ended before endpoint reached|7
1055766|NCT01891890|2099826|FG001|Overall Study|Study ended before endpoint reached|3
1055767|NCT01891890|2099827|FG002|Overall Study|Study ended before endpoint reached|6
1055768|NCT01892020|2099852|FG000|Period 1|Adverse Event|1
1055769|NCT01892020|2099853|FG001|Period 1|Adverse Event|1
1055770|NCT01892020|2099852|FG000|Period 1|Protocol Violation|2
1055771|NCT01892020|2099853|FG001|Period 1|Protocol Violation|4
1055772|NCT01892020|2099852|FG000|Period 1|Unclassified|0
1055773|NCT01892020|2099853|FG001|Period 1|Unclassified|1
1055774|NCT01892020|2099852|FG000|Period 2|Protocol Violation|1
1055775|NCT01892020|2099853|FG001|Period 2|Protocol Violation|0
1055776|NCT01892163|2099861|FG000|Overall Study|Death|1
1055777|NCT01892163|2099862|FG001|Overall Study|Death|1
1055778|NCT01892163|2099861|FG000|Overall Study|Lost to Follow-up|1
1055779|NCT01892163|2099862|FG001|Overall Study|Lost to Follow-up|0
1055780|NCT01892189|2099877|FG000|Washout Period 1 (7 Days)|Adverse Event|0
1055781|NCT01892189|2099878|FG001|Washout Period 1 (7 Days)|Adverse Event|0
1055782|NCT01892189|2099879|FG002|Washout Period 1 (7 Days)|Adverse Event|0
1055783|NCT01892189|2099880|FG003|Washout Period 1 (7 Days)|Adverse Event|0
1055784|NCT01892189|2099881|FG004|Washout Period 1 (7 Days)|Adverse Event|0
1055785|NCT01892189|2099882|FG005|Washout Period 1 (7 Days)|Adverse Event|0
1055786|NCT01892189|2099883|FG006|Washout Period 1 (7 Days)|Adverse Event|0
1055787|NCT01892189|2099884|FG007|Washout Period 1 (7 Days)|Adverse Event|0
1055788|NCT01892189|2099885|FG008|Washout Period 1 (7 Days)|Adverse Event|1
1055789|NCT01892189|2099877|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1055790|NCT01892189|2099878|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1055791|NCT01892189|2099879|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2
1055792|NCT01892189|2099880|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1055793|NCT01892189|2099881|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1055794|NCT01892189|2099882|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1055795|NCT01892189|2099883|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1055796|NCT01892189|2099884|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1055797|NCT01892189|2099885|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1055798|NCT01892189|2099877|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1055799|NCT01892189|2099878|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1055800|NCT01892189|2099879|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1055801|NCT01892189|2099880|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1055802|NCT01892189|2099881|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1055803|NCT01892189|2099882|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
1055804|NCT01892189|2099883|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1055805|NCT01892189|2099884|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1055806|NCT01892189|2099885|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1055807|NCT01892293|2099909|FG000|Overall Study|Apheresed but not treated|4
1055808|NCT01892345|2099924|FG000|Overall Study|Adverse Event|0
1055809|NCT01892345|2099925|FG001|Overall Study|Adverse Event|2
1055810|NCT01892345|2099924|FG000|Overall Study|Death|1
1055811|NCT01892345|2099925|FG001|Overall Study|Death|0
1055812|NCT01892345|2099924|FG000|Overall Study|Lost to Follow-up|3
1055813|NCT01892345|2099925|FG001|Overall Study|Lost to Follow-up|0
1055814|NCT01892345|2099924|FG000|Overall Study|Withdrawal by Subject|12
1055815|NCT01892345|2099925|FG001|Overall Study|Withdrawal by Subject|1
1055816|NCT01892436|2099935|FG000|Overall Study|Withdrawal by Subject|8
1055817|NCT01892436|2099936|FG001|Overall Study|Withdrawal by Subject|15
1055818|NCT01892436|2099937|FG002|Overall Study|Withdrawal by Subject|4
1055819|NCT01892436|2099938|FG003|Overall Study|Withdrawal by Subject|4
1055820|NCT01892436|2099935|FG000|Overall Study|Death|1
1055821|NCT01892436|2099936|FG001|Overall Study|Death|1
1055822|NCT01892436|2099937|FG002|Overall Study|Death|0
1055823|NCT01892436|2099938|FG003|Overall Study|Death|0
1055824|NCT01892436|2099935|FG000|Overall Study|Physician Decision|2
1055825|NCT01892436|2099936|FG001|Overall Study|Physician Decision|1
1055826|NCT01892436|2099937|FG002|Overall Study|Physician Decision|0
1055827|NCT01892436|2099938|FG003|Overall Study|Physician Decision|1
1055828|NCT01892436|2099935|FG000|Overall Study|Pregnancy|0
1055829|NCT01892436|2099936|FG001|Overall Study|Pregnancy|2
1055830|NCT01892436|2099937|FG002|Overall Study|Pregnancy|1
1055831|NCT01892436|2099938|FG003|Overall Study|Pregnancy|0
1055832|NCT01892436|2099935|FG000|Overall Study|Technical problems|2
1055833|NCT01892436|2099936|FG001|Overall Study|Technical problems|1
1055834|NCT01892436|2099937|FG002|Overall Study|Technical problems|1
1055835|NCT01892436|2099938|FG003|Overall Study|Technical problems|1
1055836|NCT01892436|2099935|FG000|Overall Study|Lack of Efficacy|1
1055837|NCT01892436|2099936|FG001|Overall Study|Lack of Efficacy|2
1055838|NCT01892436|2099937|FG002|Overall Study|Lack of Efficacy|2
1055839|NCT01892436|2099938|FG003|Overall Study|Lack of Efficacy|2
1055840|NCT01892436|2099935|FG000|Overall Study|Lost to Follow-up|1
1055841|NCT01892436|2099936|FG001|Overall Study|Lost to Follow-up|1
1055842|NCT01892436|2099937|FG002|Overall Study|Lost to Follow-up|1
1055843|NCT01892436|2099938|FG003|Overall Study|Lost to Follow-up|3
1055844|NCT01892436|2099935|FG000|Overall Study|non-compliance with treatment|1
1055845|NCT01892436|2099936|FG001|Overall Study|non-compliance with treatment|0
1055846|NCT01892436|2099937|FG002|Overall Study|non-compliance with treatment|0
1055847|NCT01892436|2099938|FG003|Overall Study|non-compliance with treatment|0
1055848|NCT01892436|2099935|FG000|Overall Study|Adverse Event|7
1055849|NCT01892436|2099936|FG001|Overall Study|Adverse Event|6
1055850|NCT01892436|2099937|FG002|Overall Study|Adverse Event|2
1055851|NCT01892436|2099938|FG003|Overall Study|Adverse Event|3
1055852|NCT01892501|2099948|FG000|Overall Study|Protocol Violation|2
1055853|NCT01892501|2099948|FG000|Overall Study|Puncture not carried out|9
1055854|NCT01892501|2099948|FG000|Overall Study|Radiological monitoring not carried out|5
1055855|NCT01892501|2099948|FG000|Overall Study|Non-contributory histological result|12
1055856|NCT01892540|2099955|FG000|Overall Study|Did not complete PET/MRI|0
1055857|NCT01892540|2099956|FG001|Overall Study|Did not complete PET/MRI|0
1055858|NCT01892540|2099957|FG002|Overall Study|Did not complete PET/MRI|2
1055859|NCT01892540|2099955|FG000|Overall Study|Did not fit in scanner|0
1055860|NCT01892540|2099956|FG001|Overall Study|Did not fit in scanner|0
1055861|NCT01892540|2099957|FG002|Overall Study|Did not fit in scanner|1
1055862|NCT01892657|2099965|FG000|Overall Study|Withdrawal by Subject|6
1055863|NCT01892657|2099965|FG000|Overall Study|Protocol Violation|12
1055864|NCT01892722|2099991|FG000|Overall Study|Protocol deviation|0
1055865|NCT01892722|2099992|FG001|Overall Study|Protocol deviation|1
1055866|NCT01892722|2099991|FG000|Overall Study|Administrative problems|0
1055867|NCT01892722|2099992|FG001|Overall Study|Administrative problems|1
1055868|NCT01892722|2099991|FG000|Overall Study|Patient/guardian decision|0
1055869|NCT01892722|2099992|FG001|Overall Study|Patient/guardian decision|2
1055870|NCT01892722|2099991|FG000|Overall Study|Physician Decision|1
1055871|NCT01892722|2099992|FG001|Overall Study|Physician Decision|2
1055872|NCT01892722|2099991|FG000|Overall Study|Adverse Event|3
1055873|NCT01892722|2099992|FG001|Overall Study|Adverse Event|2
1055874|NCT01892722|2099991|FG000|Overall Study|Lack of Efficacy|0
1055875|NCT01892722|2099992|FG001|Overall Study|Lack of Efficacy|7
1055876|NCT01892722|2099991|FG000|Overall Study|Withdrawal by Subject|3
1055877|NCT01892722|2099992|FG001|Overall Study|Withdrawal by Subject|5
1055878|NCT01893203|2100007|FG000|Overall Study|Withdrawal by Subject|1
1055879|NCT01893281|2100011|FG000|Overall Study|Adverse Event|1
1055880|NCT01893281|2100011|FG000|Overall Study|Protocol Violation|1
1055881|NCT01893281|2100011|FG000|Overall Study|Withdrawal by Subject|1
1055882|NCT01893346|2100019|FG000|Overall Study|Lost to Follow-up|0
1055883|NCT01893346|2100020|FG001|Overall Study|Lost to Follow-up|1
1055884|NCT01893346|2100021|FG002|Overall Study|Lost to Follow-up|0
1055885|NCT01893346|2100022|FG003|Overall Study|Lost to Follow-up|0
1055886|NCT01893346|2100019|FG000|Overall Study|Protocol Violation|1
1055887|NCT01893346|2100020|FG001|Overall Study|Protocol Violation|0
1055888|NCT01893346|2100021|FG002|Overall Study|Protocol Violation|0
1055889|NCT01893346|2100022|FG003|Overall Study|Protocol Violation|0
1055890|NCT01893346|2100019|FG000|Overall Study|Withdrawal by Subject|2
1055891|NCT01893346|2100020|FG001|Overall Study|Withdrawal by Subject|0
1055892|NCT01893346|2100021|FG002|Overall Study|Withdrawal by Subject|0
1055893|NCT01893346|2100022|FG003|Overall Study|Withdrawal by Subject|0
1055894|NCT01893411|2100044|FG000|Overall Study|Protocol Violation|1
1055895|NCT01893411|2100045|FG001|Overall Study|Protocol Violation|0
1055896|NCT01893411|2100046|FG002|Overall Study|Protocol Violation|0
1055897|NCT01893411|2100044|FG000|Overall Study|Physician Decision|1
1055898|NCT01893411|2100045|FG001|Overall Study|Physician Decision|1
1055899|NCT01893411|2100046|FG002|Overall Study|Physician Decision|2
1055900|NCT01893411|2100044|FG000|Overall Study|Lack of Efficacy|2
1055901|NCT01893411|2100045|FG001|Overall Study|Lack of Efficacy|1
1055902|NCT01893411|2100046|FG002|Overall Study|Lack of Efficacy|0
1055903|NCT01893411|2100044|FG000|Overall Study|Other|3
1055904|NCT01893411|2100045|FG001|Overall Study|Other|1
1055905|NCT01893411|2100046|FG002|Overall Study|Other|3
1055906|NCT01893411|2100044|FG000|Overall Study|Adverse Event|1
1055907|NCT01893411|2100045|FG001|Overall Study|Adverse Event|0
1055908|NCT01893411|2100046|FG002|Overall Study|Adverse Event|0
1055909|NCT01893411|2100044|FG000|Overall Study|Withdrawal by Subject|7
1055910|NCT01893411|2100045|FG001|Overall Study|Withdrawal by Subject|4
1055911|NCT01893411|2100046|FG002|Overall Study|Withdrawal by Subject|3
1055912|NCT01893411|2100044|FG000|Overall Study|Lost to Follow-up|2
1055913|NCT01893411|2100045|FG001|Overall Study|Lost to Follow-up|0
1055914|NCT01893411|2100046|FG002|Overall Study|Lost to Follow-up|1
1055915|NCT01893827|2100075|FG000|Overall Study|Lost to Follow-up|19
1055916|NCT01893827|2100076|FG001|Overall Study|Lost to Follow-up|26
1055917|NCT01893905|2100093|FG000|Overall Study|Withdrawal by Subject|1
1055918|NCT01893905|2100094|FG001|Overall Study|Withdrawal by Subject|0
1055919|NCT01893905|2100093|FG000|Overall Study|Adverse Event|9
1055920|NCT01893905|2100094|FG001|Overall Study|Adverse Event|3
1055921|NCT01893905|2100093|FG000|Overall Study|Lack of Efficacy|5
1055922|NCT01893905|2100094|FG001|Overall Study|Lack of Efficacy|7
1055923|NCT01893905|2100093|FG000|Overall Study|Lost to Follow-up|1
1055924|NCT01893905|2100094|FG001|Overall Study|Lost to Follow-up|0
1055925|NCT01893905|2100093|FG000|Overall Study|Protocol Violation|6
1055926|NCT01893905|2100094|FG001|Overall Study|Protocol Violation|1
1055927|NCT01893905|2100093|FG000|Overall Study|Lack of adherence to treatment|2
1055928|NCT01893905|2100094|FG001|Overall Study|Lack of adherence to treatment|0
1055929|NCT01893905|2100093|FG000|Overall Study|Other reason|1
1055930|NCT01893905|2100094|FG001|Overall Study|Other reason|3
1055931|NCT01894022|2100111|FG000|Overall Study|Death|1
1055932|NCT01894022|2100112|FG001|Overall Study|Death|0
1055933|NCT01894022|2100111|FG000|Overall Study|Adverse Event, non-fatal|1
1055934|NCT01894022|2100112|FG001|Overall Study|Adverse Event, non-fatal|0
1055935|NCT01894022|2100111|FG000|Overall Study|Study Closed/terminated|7
1055936|NCT01894022|2100112|FG001|Overall Study|Study Closed/terminated|10
1055937|NCT01894100|2100130|FG000|Overall Study|Lost to Follow-up|0
1055938|NCT01894100|2100131|FG001|Overall Study|Lost to Follow-up|1
1055939|NCT01894100|2100130|FG000|Overall Study|Withdrawal by Subject|3
1055940|NCT01894100|2100131|FG001|Overall Study|Withdrawal by Subject|0
1055941|NCT01894152|2100137|FG000|Overall Study|No DMR and no Stent thrombosis|151
1055942|NCT01894230|2100152|FG000|Overall Study|Lost to Follow-up|2
1055943|NCT01894230|2100153|FG001|Overall Study|Lost to Follow-up|2
1055944|NCT01894230|2100152|FG000|Overall Study|Withdrawal by Subject|4
1055945|NCT01894230|2100153|FG001|Overall Study|Withdrawal by Subject|4
1055946|NCT01894230|2100152|FG000|Overall Study|Non-adherent|0
1055947|NCT01894230|2100153|FG001|Overall Study|Non-adherent|1
1055948|NCT01894230|2100152|FG000|Overall Study|Death|1
1055949|NCT01894230|2100153|FG001|Overall Study|Death|0
1055950|NCT01894243|2100162|FG000|Overall Study|Adverse Event|0
1055951|NCT01894243|2100163|FG001|Overall Study|Adverse Event|1
1055952|NCT01894243|2100164|FG002|Overall Study|Adverse Event|2
1055953|NCT01894243|2100162|FG000|Overall Study|Death|0
1055954|NCT01894243|2100163|FG001|Overall Study|Death|0
1055955|NCT01894243|2100164|FG002|Overall Study|Death|3
1055956|NCT01894243|2100162|FG000|Overall Study|Lack of Efficacy|3
1055957|NCT01894243|2100163|FG001|Overall Study|Lack of Efficacy|3
1055958|NCT01894243|2100164|FG002|Overall Study|Lack of Efficacy|1
1055959|NCT01894243|2100162|FG000|Overall Study|Condition under investigation worsened|8
1055960|NCT01894243|2100163|FG001|Overall Study|Condition under investigation worsened|6
1055961|NCT01894243|2100164|FG002|Overall Study|Condition under investigation worsened|2
1055962|NCT01894243|2100162|FG000|Overall Study|Subject decision|1
1055963|NCT01894243|2100163|FG001|Overall Study|Subject decision|0
1055964|NCT01894243|2100164|FG002|Overall Study|Subject decision|0
1055965|NCT01894243|2100162|FG000|Overall Study|Other|1
1055966|NCT01894243|2100163|FG001|Overall Study|Other|0
1055967|NCT01894243|2100164|FG002|Overall Study|Other|0
1055968|NCT01894256|2100182|FG000|Part A|Adverse Event|0
1055969|NCT01894256|2100183|FG001|Part A|Adverse Event|1
1055970|NCT01894256|2100184|FG002|Part A|Adverse Event|0
1055971|NCT01894256|2100182|FG000|Part B|Death|0
1055972|NCT01894256|2100183|FG001|Part B|Death|1
1055973|NCT01894256|2100184|FG002|Part B|Death|1
1055974|NCT01894256|2100182|FG000|Part B|Withdrawal by Subject|0
1055975|NCT01894256|2100183|FG001|Part B|Withdrawal by Subject|1
1055976|NCT01894256|2100184|FG002|Part B|Withdrawal by Subject|0
1055977|NCT01894256|2100182|FG000|Part B|Lack of Efficacy|15
1055978|NCT01894256|2100183|FG001|Part B|Lack of Efficacy|12
1055979|NCT01894256|2100184|FG002|Part B|Lack of Efficacy|13
1055980|NCT01894477|2100197|FG000|Overall Study|Protocol Violation|0
1055981|NCT01894477|2100198|FG001|Overall Study|Protocol Violation|1
1055982|NCT01894477|2100197|FG000|Overall Study|protocol changed due SC changed to cord|0
1055983|NCT01894477|2100198|FG001|Overall Study|protocol changed due SC changed to cord|1
1055984|NCT01894516|2100213|FG000|Period 1 (Baseline up to Week 12)|Other|0
1055985|NCT01894516|2100214|FG001|Period 1 (Baseline up to Week 12)|Other|1
1055986|NCT01894516|2100215|FG002|Period 1 (Baseline up to Week 12)|Other|1
1055987|NCT01894516|2100216|FG003|Period 1 (Baseline up to Week 12)|Other|0
1055988|NCT01894516|2100213|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2
1055989|NCT01894516|2100214|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
1055990|NCT01894516|2100215|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
1055991|NCT01894516|2100216|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
1055992|NCT01894516|2100213|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
1055993|NCT01894516|2100214|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
1055994|NCT01894516|2100215|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
1055995|NCT01894516|2100216|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
1055996|NCT01894516|2100213|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0
1055997|NCT01894516|2100214|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0
1055998|NCT01894516|2100215|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1
1055999|NCT01894516|2100216|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0
1056000|NCT01894516|2100213|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2
1056001|NCT01894516|2100214|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0
1056002|NCT01894516|2100215|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0
1056003|NCT01894516|2100216|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
1056004|NCT01894516|2100213|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
1056005|NCT01894516|2100214|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
1056006|NCT01894516|2100215|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1
1056007|NCT01894516|2100216|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
1056008|NCT01894516|2100213|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0
1056009|NCT01894516|2100214|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2
1056010|NCT01894516|2100215|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
1056011|NCT01894516|2100216|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1
1056012|NCT01894516|2100213|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
1056013|NCT01894516|2100214|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
1056014|NCT01894516|2100215|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
1056015|NCT01894516|2100216|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
1056016|NCT01894568|2100236|FG000|Overall Study|Adverse Event|2
1056017|NCT01894568|2100237|FG001|Overall Study|Adverse Event|3
1056018|NCT01894568|2100236|FG000|Overall Study|Protocol required discontinuation|2
1056019|NCT01894568|2100237|FG001|Overall Study|Protocol required discontinuation|1
1056020|NCT01894568|2100236|FG000|Overall Study|Withdrawal by Subject|5
1056021|NCT01894568|2100237|FG001|Overall Study|Withdrawal by Subject|5
1056022|NCT01894568|2100236|FG000|Overall Study|Physician Decision|1
1056023|NCT01894568|2100237|FG001|Overall Study|Physician Decision|0
1056024|NCT01894568|2100236|FG000|Overall Study|Lost to Follow-up|0
1056025|NCT01894568|2100237|FG001|Overall Study|Lost to Follow-up|1
1056026|NCT01894581|2100246|FG000|Overall Study|Withdrawal by Subject|2
1056027|NCT01894581|2100247|FG001|Overall Study|Withdrawal by Subject|3
1056028|NCT01894581|2100246|FG000|Overall Study|Screen Failure|3
1056029|NCT01894581|2100247|FG001|Overall Study|Screen Failure|4
1056030|NCT01894607|2100253|FG000|Overall Study|Ineligible|1
1056031|NCT01894620|2100259|FG000|Overall Study|Withdrawal by Subject|0
1056032|NCT01894620|2100260|FG001|Overall Study|Withdrawal by Subject|1
1056033|NCT01894776|2100273|FG000|Overall Study|Withdrawal by Subject|1
1056034|NCT01894841|2100279|FG000|Overall Study|Withdrawal by Subject|9
1056035|NCT01894841|2100280|FG001|Overall Study|Withdrawal by Subject|4
1056036|NCT01894841|2100279|FG000|Overall Study|Withdrawn by investigator|2
1056037|NCT01894841|2100280|FG001|Overall Study|Withdrawn by investigator|2
1056038|NCT01894841|2100279|FG000|Overall Study|Lost to Follow-up|7
1056039|NCT01894841|2100280|FG001|Overall Study|Lost to Follow-up|3
1056040|NCT01894919|2100324|FG000|Overall Study|Withdrawal by Subject|1
1056041|NCT01894919|2100325|FG001|Overall Study|Withdrawal by Subject|0
1056042|NCT01894919|2100326|FG002|Overall Study|Withdrawal by Subject|0
1056043|NCT01894919|2100327|FG003|Overall Study|Withdrawal by Subject|0
1056044|NCT01894919|2100328|FG004|Overall Study|Withdrawal by Subject|1
1056045|NCT01894919|2100329|FG005|Overall Study|Withdrawal by Subject|0
1056046|NCT01894919|2100330|FG006|Overall Study|Withdrawal by Subject|0
1056047|NCT01894919|2100331|FG007|Overall Study|Withdrawal by Subject|0
1056048|NCT01894919|2100332|FG008|Overall Study|Withdrawal by Subject|0
1056049|NCT01894919|2100333|FG009|Overall Study|Withdrawal by Subject|1
1056050|NCT01894919|2100334|FG010|Overall Study|Withdrawal by Subject|1
1056051|NCT01894919|2100335|FG011|Overall Study|Withdrawal by Subject|0
1056052|NCT01894919|2100336|FG012|Overall Study|Withdrawal by Subject|0
1056053|NCT01894919|2100324|FG000|Overall Study|Adverse Event|0
1056054|NCT01894919|2100325|FG001|Overall Study|Adverse Event|0
1056055|NCT01894919|2100326|FG002|Overall Study|Adverse Event|0
1056056|NCT01894919|2100327|FG003|Overall Study|Adverse Event|0
1056057|NCT01894919|2100328|FG004|Overall Study|Adverse Event|0
1056058|NCT01894919|2100329|FG005|Overall Study|Adverse Event|0
1056059|NCT01894919|2100330|FG006|Overall Study|Adverse Event|0
1056060|NCT01894919|2100331|FG007|Overall Study|Adverse Event|0
1056061|NCT01894919|2100332|FG008|Overall Study|Adverse Event|0
1056062|NCT01894919|2100333|FG009|Overall Study|Adverse Event|0
1056063|NCT01894919|2100334|FG010|Overall Study|Adverse Event|1
1056064|NCT01894919|2100335|FG011|Overall Study|Adverse Event|0
1056065|NCT01894919|2100336|FG012|Overall Study|Adverse Event|0
1056066|NCT01894919|2100324|FG000|Overall Study|Other-Unspecified|1
1056067|NCT01894919|2100325|FG001|Overall Study|Other-Unspecified|0
1056068|NCT01894919|2100326|FG002|Overall Study|Other-Unspecified|0
1056069|NCT01894919|2100327|FG003|Overall Study|Other-Unspecified|0
1056070|NCT01894919|2100328|FG004|Overall Study|Other-Unspecified|0
1056071|NCT01894919|2100329|FG005|Overall Study|Other-Unspecified|0
1056072|NCT01894919|2100330|FG006|Overall Study|Other-Unspecified|0
1056073|NCT01894919|2100331|FG007|Overall Study|Other-Unspecified|0
1056074|NCT01894919|2100332|FG008|Overall Study|Other-Unspecified|0
1056075|NCT01894919|2100333|FG009|Overall Study|Other-Unspecified|0
1056076|NCT01894919|2100334|FG010|Overall Study|Other-Unspecified|0
1056077|NCT01894919|2100335|FG011|Overall Study|Other-Unspecified|0
1056078|NCT01894919|2100336|FG012|Overall Study|Other-Unspecified|0
1056079|NCT01894919|2100324|FG000|Overall Study|Lost to Follow-up|0
1056080|NCT01894919|2100325|FG001|Overall Study|Lost to Follow-up|0
1056081|NCT01894919|2100326|FG002|Overall Study|Lost to Follow-up|0
1056082|NCT01894919|2100327|FG003|Overall Study|Lost to Follow-up|0
1056083|NCT01894919|2100328|FG004|Overall Study|Lost to Follow-up|2
1056084|NCT01894919|2100329|FG005|Overall Study|Lost to Follow-up|0
1056085|NCT01894919|2100330|FG006|Overall Study|Lost to Follow-up|0
1056086|NCT01894919|2100331|FG007|Overall Study|Lost to Follow-up|0
1056087|NCT01894919|2100332|FG008|Overall Study|Lost to Follow-up|0
1056088|NCT01894919|2100333|FG009|Overall Study|Lost to Follow-up|0
1056089|NCT01894919|2100334|FG010|Overall Study|Lost to Follow-up|0
1056090|NCT01894919|2100335|FG011|Overall Study|Lost to Follow-up|0
1056091|NCT01894919|2100336|FG012|Overall Study|Lost to Follow-up|0
1056092|NCT01894984|2100380|FG000|Overall Study|Other|314
1056093|NCT01894984|2100381|FG001|Overall Study|Other|175
1056094|NCT01895101|2100407|FG000|Overall Study|OPCAB procedure|1
1056095|NCT01895101|2100408|FG001|Overall Study|OPCAB procedure|1
1056096|NCT01895101|2100409|FG002|Overall Study|OPCAB procedure|3
1056097|NCT01895101|2100407|FG000|Overall Study|Withdrawal by Subject|0
1056098|NCT01895101|2100408|FG001|Overall Study|Withdrawal by Subject|1
1056099|NCT01895101|2100409|FG002|Overall Study|Withdrawal by Subject|2
1056100|NCT01895101|2100407|FG000|Overall Study|another study, enrolled in other study|0
1056101|NCT01895101|2100408|FG001|Overall Study|another study, enrolled in other study|1
1056102|NCT01895101|2100409|FG002|Overall Study|another study, enrolled in other study|0
1056103|NCT01895101|2100407|FG000|Overall Study|Death|0
1056104|NCT01895101|2100408|FG001|Overall Study|Death|1
1056105|NCT01895101|2100409|FG002|Overall Study|Death|0
1056106|NCT01895101|2100407|FG000|Overall Study|coagulation disorder|0
1056107|NCT01895101|2100408|FG001|Overall Study|coagulation disorder|1
1056108|NCT01895101|2100409|FG002|Overall Study|coagulation disorder|0
1056109|NCT01895270|2100429|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0
1056110|NCT01895270|2100430|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2
1056111|NCT01895270|2100429|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
1056112|NCT01895270|2100430|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
1056113|NCT01895270|2100429|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3
1056114|NCT01895270|2100430|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1
1056115|NCT01895270|2100429|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0
1056116|NCT01895270|2100430|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1
1056117|NCT01895270|2100429|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
1056118|NCT01895270|2100430|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
1056119|NCT01895270|2100429|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0
1056120|NCT01895270|2100430|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1
1056121|NCT01895270|2100429|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0
1056122|NCT01895270|2100430|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1
1056123|NCT01895309|2100438|FG000|Overall Study|Adverse Event|13
1056124|NCT01895309|2100439|FG001|Overall Study|Adverse Event|17
1056125|NCT01895309|2100438|FG000|Overall Study|Protocol Violation|1
1056126|NCT01895309|2100439|FG001|Overall Study|Protocol Violation|0
1056127|NCT01895309|2100438|FG000|Overall Study|Lack of Efficacy|1
1056128|NCT01895309|2100439|FG001|Overall Study|Lack of Efficacy|3
1056129|NCT01895309|2100438|FG000|Overall Study|Lost to Follow-up|1
1056130|NCT01895309|2100439|FG001|Overall Study|Lost to Follow-up|3
1056131|NCT01895309|2100438|FG000|Overall Study|Physician Decision|15
1056132|NCT01895309|2100439|FG001|Overall Study|Physician Decision|10
1056133|NCT01895309|2100438|FG000|Overall Study|Withdrawal by Subject|9
1056134|NCT01895309|2100439|FG001|Overall Study|Withdrawal by Subject|18
1056135|NCT01895322|2100449|FG000|Overall Study|Adverse Event|1
1056136|NCT01895322|2100449|FG000|Overall Study|Withdrawal by Subject|2
1056137|NCT01895322|2100449|FG000|Overall Study|Protocol Violation|10
1056138|NCT01895335|2100454|FG000|Overall Study|Adverse Event|106
1056139|NCT01895335|2100454|FG000|Overall Study|Lack of Efficacy|53
1056140|NCT01895335|2100454|FG000|Overall Study|Poor Compliance to Protocol|11
1056141|NCT01895335|2100454|FG000|Overall Study|Included But Not treated|1
1056142|NCT01895335|2100454|FG000|Overall Study|Other than Specified Above|44
1056143|NCT01895361|2100461|FG000|Overall Study|Adverse Event|1
1056144|NCT01895361|2100462|FG001|Overall Study|Adverse Event|1
1056145|NCT01895361|2100463|FG002|Overall Study|Adverse Event|3
1056146|NCT01895361|2100461|FG000|Overall Study|Death|2
1056147|NCT01895361|2100462|FG001|Overall Study|Death|1
1056148|NCT01895361|2100463|FG002|Overall Study|Death|2
1056149|NCT01895361|2100461|FG000|Overall Study|Lost to Follow-up|4
1056150|NCT01895361|2100462|FG001|Overall Study|Lost to Follow-up|4
1056151|NCT01895361|2100463|FG002|Overall Study|Lost to Follow-up|6
1056152|NCT01895361|2100461|FG000|Overall Study|Non-compliance with study|1
1056153|NCT01895361|2100462|FG001|Overall Study|Non-compliance with study|3
1056154|NCT01895361|2100463|FG002|Overall Study|Non-compliance with study|1
1056155|NCT01895361|2100461|FG000|Overall Study|Physician Decision|2
1056156|NCT01895361|2100462|FG001|Overall Study|Physician Decision|2
1056157|NCT01895361|2100463|FG002|Overall Study|Physician Decision|2
1056158|NCT01895361|2100461|FG000|Overall Study|Withdrawal by Subject|7
1056159|NCT01895361|2100462|FG001|Overall Study|Withdrawal by Subject|6
1056160|NCT01895361|2100463|FG002|Overall Study|Withdrawal by Subject|6
1056161|NCT01895361|2100461|FG000|Overall Study|Lack of Efficacy|0
1056162|NCT01895361|2100462|FG001|Overall Study|Lack of Efficacy|1
1056163|NCT01895361|2100463|FG002|Overall Study|Lack of Efficacy|0
1056164|NCT01895361|2100461|FG000|Overall Study|Reasons different from categories above|7
1056165|NCT01895361|2100462|FG001|Overall Study|Reasons different from categories above|3
1056166|NCT01895361|2100463|FG002|Overall Study|Reasons different from categories above|4
1056167|NCT01895452|2100473|FG000|Overall Study|Adverse Event|1
1056168|NCT01895452|2100474|FG001|Overall Study|Adverse Event|4
1056169|NCT01895452|2100473|FG000|Overall Study|Lost to Follow-up|1
1056170|NCT01895452|2100474|FG001|Overall Study|Lost to Follow-up|5
1056171|NCT01895452|2100473|FG000|Overall Study|Pregnancy|0
1056172|NCT01895452|2100474|FG001|Overall Study|Pregnancy|1
1056173|NCT01895452|2100473|FG000|Overall Study|Withdrawal by Subject|2
1056174|NCT01895452|2100474|FG001|Overall Study|Withdrawal by Subject|14
1056175|NCT01895452|2100473|FG000|Overall Study|Underlying disease|0
1056176|NCT01895452|2100474|FG001|Overall Study|Underlying disease|3
1056177|NCT01895452|2100473|FG000|Overall Study|Noncompliance with study drug|0
1056178|NCT01895452|2100474|FG001|Overall Study|Noncompliance with study drug|1
1056179|NCT01895543|2100480|FG000|Overall Study|Withdrawal by Subject|43
1056180|NCT01895543|2100480|FG000|Overall Study|Lost to Follow-up|25
1056181|NCT01895543|2100480|FG000|Overall Study|Adverse Event|28
1056182|NCT01895543|2100480|FG000|Overall Study|Subject's substantial non-compliance|6
1056183|NCT01895543|2100480|FG000|Overall Study|Protocol Violation|1
1056184|NCT01895543|2100480|FG000|Overall Study|Physician Decision|2
1056185|NCT01895543|2100480|FG000|Overall Study|Other (Not fulfilling above criteria)|24
1056186|NCT01895608|2100488|FG000|Overall Study|change in health status|0
1056187|NCT01895608|2100489|FG001|Overall Study|change in health status|1
1056188|NCT01895608|2100490|FG002|Overall Study|change in health status|1
1056189|NCT01895608|2100491|FG003|Overall Study|change in health status|0
1056190|NCT01895608|2100488|FG000|Overall Study|Withdrawal by Subject|0
1056191|NCT01895608|2100489|FG001|Overall Study|Withdrawal by Subject|0
1056192|NCT01895608|2100490|FG002|Overall Study|Withdrawal by Subject|2
1056193|NCT01895608|2100491|FG003|Overall Study|Withdrawal by Subject|0
1056194|NCT01895777|2100520|FG000|Overall Study|Adverse Event|1
1056195|NCT01895777|2100521|FG001|Overall Study|Adverse Event|2
1056196|NCT01895777|2100520|FG000|Overall Study|Lost to Follow-up|2
1056197|NCT01895777|2100521|FG001|Overall Study|Lost to Follow-up|0
1056198|NCT01895777|2100520|FG000|Overall Study|Not treated|1
1056199|NCT01895777|2100521|FG001|Overall Study|Not treated|0
1056200|NCT01895777|2100520|FG000|Overall Study|Other reasons|3
1056201|NCT01895777|2100521|FG001|Overall Study|Other reasons|2
1056202|NCT01895777|2100520|FG000|Overall Study|Non-compliance with the CTP|2
1056203|NCT01895777|2100521|FG001|Overall Study|Non-compliance with the CTP|1
1056204|NCT01896050|2100558|FG000|Overall Study|Adverse Event|37
1056205|NCT01896050|2100559|FG001|Overall Study|Adverse Event|2
1056206|NCT01896050|2100558|FG000|Overall Study|Death|1
1056207|NCT01896050|2100559|FG001|Overall Study|Death|0
1056208|NCT01896128|2100583|FG000|Overall Study|Withdrawal by Subject|3
1056209|NCT01896128|2100584|FG001|Overall Study|Withdrawal by Subject|3
1056210|NCT01896193|2100594|FG000|Overall Study|Lack of Efficacy|20
1056211|NCT01896193|2100595|FG001|Overall Study|Lack of Efficacy|11
1056212|NCT01896193|2100594|FG000|Overall Study|Protocol Violation|0
1056213|NCT01896193|2100595|FG001|Overall Study|Protocol Violation|1
1056214|NCT01896193|2100594|FG000|Overall Study|Withdrew Consent|1
1056215|NCT01896193|2100595|FG001|Overall Study|Withdrew Consent|0
1056216|NCT01896232|2100609|FG000|Overall Study|Death|6
1056217|NCT01896232|2100610|FG001|Overall Study|Death|10
1056218|NCT01896232|2100609|FG000|Overall Study|Withdrawal by Subject|32
1056219|NCT01896232|2100610|FG001|Overall Study|Withdrawal by Subject|31
1056220|NCT01896232|2100609|FG000|Overall Study|Sponsor Decision|2
1056221|NCT01896232|2100610|FG001|Overall Study|Sponsor Decision|0
1056222|NCT01896232|2100609|FG000|Overall Study|Lost to Follow-up|9
1056223|NCT01896232|2100610|FG001|Overall Study|Lost to Follow-up|12
1056224|NCT01896271|2100616|FG000|Overall Study|Physician Decision|10
1056225|NCT01896297|2100620|FG000|Overall Study|Died in post treatment phase|1
1056226|NCT01896557|2100642|FG000|Clopidogrel Alone|Adverse Event|1
1056227|NCT01896557|2100643|FG001|Clopidogrel Alone|Adverse Event|0
1056228|NCT01896557|2100642|FG000|Clopidogrel + GI Protector|low adherence|1
1056229|NCT01896557|2100643|FG001|Clopidogrel + GI Protector|low adherence|1
1056230|NCT01896557|2100642|FG000|Clopidogrel + GI Protector|Reading error|1
1056231|NCT01896557|2100643|FG001|Clopidogrel + GI Protector|Reading error|3
1056232|NCT01896700|2100660|FG000|Overall Study|Adverse Event|4
1056233|NCT01896700|2100661|FG001|Overall Study|Adverse Event|5
1056234|NCT01896700|2100660|FG000|Overall Study|Withdrawal by Subject|0
1056235|NCT01896700|2100661|FG001|Overall Study|Withdrawal by Subject|1
1056236|NCT01896726|2100667|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1
1056237|NCT01896726|2100667|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
1056238|NCT01896856|2100680|FG000|Overall Study|Transportation issues / Non-compliance|0
1056239|NCT01896856|2100681|FG001|Overall Study|Transportation issues / Non-compliance|0
1056240|NCT01896856|2100682|FG002|Overall Study|Transportation issues / Non-compliance|1
1056241|NCT01896856|2100683|FG003|Overall Study|Transportation issues / Non-compliance|0
1056242|NCT01896856|2100684|FG004|Overall Study|Transportation issues / Non-compliance|0
1056243|NCT01896856|2100685|FG005|Overall Study|Transportation issues / Non-compliance|0
1056244|NCT01896869|2100702|FG000|Overall Study|Withdrawal by Subject|0
1056245|NCT01896869|2100703|FG001|Overall Study|Withdrawal by Subject|6
1056246|NCT01896869|2100702|FG000|Overall Study|Lost to Follow-up|1
1056247|NCT01896869|2100703|FG001|Overall Study|Lost to Follow-up|0
1056248|NCT01896895|2100714|FG000|Double-blind MP|Physician Decision|0
1056249|NCT01896895|2100715|FG001|Double-blind MP|Physician Decision|0
1056250|NCT01896895|2100716|FG002|Double-blind MP|Physician Decision|1
1056251|NCT01896895|2100717|FG003|Double-blind MP|Physician Decision|0
1056252|NCT01896895|2100714|FG000|Double-blind MP|Withdrawal by Subject|0
1056253|NCT01896895|2100715|FG001|Double-blind MP|Withdrawal by Subject|2
1056254|NCT01896895|2100716|FG002|Double-blind MP|Withdrawal by Subject|1
1056255|NCT01896895|2100717|FG003|Double-blind MP|Withdrawal by Subject|0
1056256|NCT01896895|2100714|FG000|Double-blind MP|Lost to Follow-up|1
1056257|NCT01896895|2100715|FG001|Double-blind MP|Lost to Follow-up|0
1056258|NCT01896895|2100716|FG002|Double-blind MP|Lost to Follow-up|1
1056259|NCT01896895|2100717|FG003|Double-blind MP|Lost to Follow-up|0
1056260|NCT01896934|2100730|FG000|Overall Study|Adverse Event|1
1056261|NCT01896934|2100730|FG000|Overall Study|Withdrawal by Subject|1
1056262|NCT01896986|2100736|FG000|Overall Study|samples lost|14
1056263|NCT01896986|2100737|FG001|Overall Study|samples lost|23
1056264|NCT01897233|2100761|FG000|Part B (24 Weeks)|Adverse Event|1
1056265|NCT01897233|2100761|FG000|Part B (24 Weeks)|Withdrawal by Subject|2
1056266|NCT01897233|2100761|FG000|Part B (24 Weeks)|Physician Decision|1
1056267|NCT01897493|2100790|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
1056268|NCT01897532|2100799|FG000|Discontinuation From Treatment|Not Treated|7
1056269|NCT01897532|2100800|FG001|Discontinuation From Treatment|Not Treated|5
1056270|NCT01897532|2100799|FG000|Discontinuation From Treatment|Other reason than specified|196
1056271|NCT01897532|2100800|FG001|Discontinuation From Treatment|Other reason than specified|176
1056272|NCT01897532|2100799|FG000|Discontinuation From Treatment|Withdrawal by Subject|333
1056273|NCT01897532|2100800|FG001|Discontinuation From Treatment|Withdrawal by Subject|281
1056274|NCT01897532|2100799|FG000|Discontinuation From Treatment|Non compliance|24
1056275|NCT01897532|2100800|FG001|Discontinuation From Treatment|Non compliance|15
1056276|NCT01897532|2100799|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402
1056277|NCT01897532|2100800|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362
1056278|NCT01897532|2100799|FG000|Discontinuation From Trial|Not Treated|7
1056279|NCT01897532|2100800|FG001|Discontinuation From Trial|Not Treated|5
1056280|NCT01897532|2100799|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55
1056281|NCT01897532|2100800|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36
1056282|NCT01897714|2100812|FG000|Phase I (Dose Escalation)|Disease progression|3
1056283|NCT01897714|2100813|FG001|Phase I (Dose Escalation)|Disease progression|5
1056284|NCT01897714|2100814|FG002|Phase I (Dose Escalation)|Disease progression|1
1056285|NCT01897714|2100815|FG003|Phase I (Dose Escalation)|Disease progression|3
1056286|NCT01897714|2100816|FG004|Phase I (Dose Escalation)|Disease progression|0
1056287|NCT01897714|2100817|FG005|Phase I (Dose Escalation)|Disease progression|0
1056288|NCT01897714|2100812|FG000|Phase I (Dose Escalation)|Adverse Event|0
1056289|NCT01897714|2100813|FG001|Phase I (Dose Escalation)|Adverse Event|1
1056290|NCT01897714|2100814|FG002|Phase I (Dose Escalation)|Adverse Event|4
1056291|NCT01897714|2100815|FG003|Phase I (Dose Escalation)|Adverse Event|3
1056292|NCT01897714|2100816|FG004|Phase I (Dose Escalation)|Adverse Event|0
1056293|NCT01897714|2100817|FG005|Phase I (Dose Escalation)|Adverse Event|0
1056294|NCT01897714|2100812|FG000|Phase I (Dose Escalation)|Other|0
1056295|NCT01897714|2100813|FG001|Phase I (Dose Escalation)|Other|1
1056296|NCT01897714|2100814|FG002|Phase I (Dose Escalation)|Other|0
1056297|NCT01897714|2100815|FG003|Phase I (Dose Escalation)|Other|0
1056298|NCT01897714|2100816|FG004|Phase I (Dose Escalation)|Other|0
1056299|NCT01897714|2100817|FG005|Phase I (Dose Escalation)|Other|0
1056300|NCT01897714|2100812|FG000|Phase II (MTD)|Withdrawal by Subject|0
1056301|NCT01897714|2100813|FG001|Phase II (MTD)|Withdrawal by Subject|0
1056302|NCT01897714|2100814|FG002|Phase II (MTD)|Withdrawal by Subject|0
1056303|NCT01897714|2100815|FG003|Phase II (MTD)|Withdrawal by Subject|0
1056304|NCT01897714|2100816|FG004|Phase II (MTD)|Withdrawal by Subject|0
1056305|NCT01897714|2100817|FG005|Phase II (MTD)|Withdrawal by Subject|1
1056306|NCT01897714|2100812|FG000|Phase II (MTD)|Lost to Follow-up|0
1056307|NCT01897714|2100813|FG001|Phase II (MTD)|Lost to Follow-up|0
1056308|NCT01897714|2100814|FG002|Phase II (MTD)|Lost to Follow-up|0
1056309|NCT01897714|2100815|FG003|Phase II (MTD)|Lost to Follow-up|0
1056310|NCT01897714|2100816|FG004|Phase II (MTD)|Lost to Follow-up|1
1056311|NCT01897714|2100817|FG005|Phase II (MTD)|Lost to Follow-up|0
1056312|NCT01897714|2100812|FG000|Phase II (MTD)|Death|0
1056313|NCT01897714|2100813|FG001|Phase II (MTD)|Death|0
1056314|NCT01897714|2100814|FG002|Phase II (MTD)|Death|0
1056315|NCT01897714|2100815|FG003|Phase II (MTD)|Death|0
1056316|NCT01897714|2100816|FG004|Phase II (MTD)|Death|25
1056317|NCT01897714|2100817|FG005|Phase II (MTD)|Death|10
1056318|NCT01897714|2100812|FG000|Phase II (MTD)|Study terminated with patient alive|0
1056319|NCT01897714|2100813|FG001|Phase II (MTD)|Study terminated with patient alive|0
1056320|NCT01897714|2100814|FG002|Phase II (MTD)|Study terminated with patient alive|0
1056321|NCT01897714|2100815|FG003|Phase II (MTD)|Study terminated with patient alive|0
1056322|NCT01897714|2100816|FG004|Phase II (MTD)|Study terminated with patient alive|1
1056323|NCT01897714|2100817|FG005|Phase II (MTD)|Study terminated with patient alive|0
1056324|NCT01897714|2100812|FG000|Phase II (MTD)|Other|0
1056325|NCT01897714|2100813|FG001|Phase II (MTD)|Other|0
1056326|NCT01897714|2100814|FG002|Phase II (MTD)|Other|0
1056327|NCT01897714|2100815|FG003|Phase II (MTD)|Other|0
1056328|NCT01897714|2100816|FG004|Phase II (MTD)|Other|3
1056329|NCT01897714|2100817|FG005|Phase II (MTD)|Other|0
1056330|NCT01897727|2100835|FG000|Overall Study|Exclusion: central sleep apnea|0
1056331|NCT01897727|2100836|FG001|Overall Study|Exclusion: central sleep apnea|1
1056332|NCT01897896|2100861|FG000|Overall Study|Death|1
1056333|NCT01897896|2100862|FG001|Overall Study|Death|0
1056334|NCT01897896|2100861|FG000|Overall Study|Adverse Event|11
1056335|NCT01897896|2100862|FG001|Overall Study|Adverse Event|1
1056336|NCT01897896|2100861|FG000|Overall Study|Lost to Follow-up|1
1056337|NCT01897896|2100862|FG001|Overall Study|Lost to Follow-up|0
1056338|NCT01897896|2100861|FG000|Overall Study|Non-compliance with study drug dosing|1
1056339|NCT01897896|2100862|FG001|Overall Study|Non-compliance with study drug dosing|1
1056340|NCT01897896|2100861|FG000|Overall Study|Withdrawal by Subject|7
1056341|NCT01897896|2100862|FG001|Overall Study|Withdrawal by Subject|1
1056342|NCT01897896|2100861|FG000|Overall Study|Require drug that interfere with study|1
1056343|NCT01897896|2100862|FG001|Overall Study|Require drug that interfere with study|4
1056344|NCT01897896|2100861|FG000|Overall Study|Protocol Violation|1
1056345|NCT01897896|2100862|FG001|Overall Study|Protocol Violation|1
1056346|NCT01897896|2100861|FG000|Overall Study|Withdrawal per Investigator's judgement|1
1056347|NCT01897896|2100862|FG001|Overall Study|Withdrawal per Investigator's judgement|1
1056348|NCT01897896|2100861|FG000|Overall Study|Caregiver can no longer participate|0
1056349|NCT01897896|2100862|FG001|Overall Study|Caregiver can no longer participate|2
1056350|NCT01897896|2100861|FG000|Overall Study|Other than specified|2
1056351|NCT01897896|2100862|FG001|Overall Study|Other than specified|1
1056352|NCT01898078|2100881|FG000|Overall Study|Progressive Disease|1
1056353|NCT01898078|2100882|FG001|Overall Study|Progressive Disease|5
1056354|NCT01898078|2100881|FG000|Overall Study|Adverse Event|2
1056355|NCT01898078|2100882|FG001|Overall Study|Adverse Event|1
1056356|NCT01898078|2100881|FG000|Overall Study|Withdrawal by Subject|1
1056357|NCT01898078|2100882|FG001|Overall Study|Withdrawal by Subject|1
1056358|NCT01898078|2100881|FG000|Overall Study|Symptomatic Deterioration|2
1056359|NCT01898078|2100882|FG001|Overall Study|Symptomatic Deterioration|0
1056360|NCT01898078|2100881|FG000|Overall Study|Reason not Specified|0
1056361|NCT01898078|2100882|FG001|Overall Study|Reason not Specified|1
1056362|NCT01898091|2100892|FG000|Overall Study|Lost to Follow-up|1
1056363|NCT01898091|2100893|FG001|Overall Study|Lost to Follow-up|1
1056364|NCT01898091|2100892|FG000|Overall Study|Withdrawal by Subject|1
1056365|NCT01898091|2100893|FG001|Overall Study|Withdrawal by Subject|5
1056366|NCT01898130|2100899|FG000|Treatment|Withdrawal by Subject|2
1056367|NCT01898130|2100899|FG000|Treatment|Progressive Disease|4
1056368|NCT01898130|2100899|FG000|Follow up Until PD or Death|Lost to Follow-up|1
1056369|NCT01898195|2100906|FG000|Smoking Abstinence|Did not have good measurements|35
1056370|NCT01898195|2100907|FG001|Smoking Abstinence|Did not have good measurements|38
1056371|NCT01898195|2100908|FG002|Smoking Abstinence|Did not have good measurements|36
1056372|NCT01898208|2100919|FG000|Overall Study|Positive blood culture|17
1056373|NCT01898208|2100920|FG001|Overall Study|Positive blood culture|23
1056374|NCT01898208|2100921|FG002|Overall Study|Positive blood culture|15
1056375|NCT01898208|2100919|FG000|Overall Study|Death/comfort care within 24 hours|10
1056376|NCT01898208|2100920|FG001|Overall Study|Death/comfort care within 24 hours|9
1056377|NCT01898208|2100921|FG002|Overall Study|Death/comfort care within 24 hours|8
1056378|NCT01898208|2100919|FG000|Overall Study|Negative Gram Stain|6
1056379|NCT01898208|2100920|FG001|Overall Study|Negative Gram Stain|9
1056380|NCT01898208|2100921|FG002|Overall Study|Negative Gram Stain|6
1056381|NCT01898208|2100919|FG000|Overall Study|Non-Blood Specimens in Bottles|3
1056382|NCT01898208|2100920|FG001|Overall Study|Non-Blood Specimens in Bottles|5
1056383|NCT01898208|2100921|FG002|Overall Study|Non-Blood Specimens in Bottles|4
1056384|NCT01898208|2100919|FG000|Overall Study|System/Technical Error|1
1056385|NCT01898208|2100920|FG001|Overall Study|System/Technical Error|2
1056386|NCT01898208|2100921|FG002|Overall Study|System/Technical Error|3
1056387|NCT01898208|2100919|FG000|Overall Study|Lost to Follow-up|3
1056388|NCT01898208|2100920|FG001|Overall Study|Lost to Follow-up|1
1056389|NCT01898208|2100921|FG002|Overall Study|Lost to Follow-up|1
1056390|NCT01898286|2100929|FG000|Overall Study|Withdrawal by Subject|1
1056391|NCT01898286|2100929|FG000|Overall Study|Protocol Violation|1
1056392|NCT01898286|2100929|FG000|Overall Study|Lost to Follow-up|1
1056393|NCT01898299|2100935|FG000|Post Treatment (One Month)|Lost to Follow-up|3
1056394|NCT01898299|2100936|FG001|Post Treatment (One Month)|Lost to Follow-up|4
1056395|NCT01898442|2100957|FG000|Overall Study|Hemolysis/technical problems|1
1056396|NCT01898442|2100958|FG001|Overall Study|Hemolysis/technical problems|2
1056397|NCT01898442|2100959|FG002|Overall Study|Hemolysis/technical problems|2
1056398|NCT01898442|2100957|FG000|Overall Study|Patient vomited pills|0
1056399|NCT01898442|2100958|FG001|Overall Study|Patient vomited pills|0
1056400|NCT01898442|2100959|FG002|Overall Study|Patient vomited pills|1
1056401|NCT01898598|2100969|FG000|Overall Study|Adverse Event|1
1056402|NCT01898598|2100970|FG001|Overall Study|Adverse Event|0
1056403|NCT01898598|2100969|FG000|Overall Study|Withdrawal by Subject|3
1056404|NCT01898598|2100970|FG001|Overall Study|Withdrawal by Subject|0
1056405|NCT01898598|2100969|FG000|Overall Study|Lost to Follow-up|0
1056406|NCT01898598|2100970|FG001|Overall Study|Lost to Follow-up|1
1056407|NCT01898598|2100969|FG000|Overall Study|Other|0
1056408|NCT01898598|2100970|FG001|Overall Study|Other|1
1056409|NCT01898806|2101005|FG000|Overall Study|Withdrawal by Subject|2
1056410|NCT01898806|2101005|FG000|Overall Study|Physician Decision|1
1056411|NCT01898884|2101014|FG000|Multiple Dose Period|Adverse Event|0
1056412|NCT01898884|2101015|FG001|Multiple Dose Period|Adverse Event|0
1056413|NCT01898884|2101016|FG002|Multiple Dose Period|Adverse Event|0
1056414|NCT01898884|2101017|FG003|Multiple Dose Period|Adverse Event|0
1056415|NCT01898884|2101018|FG004|Multiple Dose Period|Adverse Event|0
1056416|NCT01898884|2101019|FG005|Multiple Dose Period|Adverse Event|0
1056417|NCT01898884|2101020|FG006|Multiple Dose Period|Adverse Event|1
1056418|NCT01898884|2101021|FG007|Multiple Dose Period|Adverse Event|0
1056419|NCT01898884|2101022|FG008|Multiple Dose Period|Adverse Event|0
1056420|NCT01898884|2101014|FG000|Multiple Dose Period|Randomized Not Treated|0
1056421|NCT01898884|2101015|FG001|Multiple Dose Period|Randomized Not Treated|0
1056422|NCT01898884|2101016|FG002|Multiple Dose Period|Randomized Not Treated|0
1056423|NCT01898884|2101017|FG003|Multiple Dose Period|Randomized Not Treated|0
1056424|NCT01898884|2101018|FG004|Multiple Dose Period|Randomized Not Treated|0
1056425|NCT01898884|2101019|FG005|Multiple Dose Period|Randomized Not Treated|0
1056426|NCT01898884|2101020|FG006|Multiple Dose Period|Randomized Not Treated|0
1056427|NCT01898884|2101021|FG007|Multiple Dose Period|Randomized Not Treated|0
1056428|NCT01898884|2101022|FG008|Multiple Dose Period|Randomized Not Treated|1
1056429|NCT01898923|2101060|FG000|Overall Study|Lack of Efficacy|5
1056430|NCT01898923|2101061|FG001|Overall Study|Lack of Efficacy|6
1056431|NCT01898923|2101060|FG000|Overall Study|Adverse Event|3
1056432|NCT01898923|2101061|FG001|Overall Study|Adverse Event|1
1056433|NCT01898923|2101060|FG000|Overall Study|Lost to Follow-up|0
1056434|NCT01898923|2101061|FG001|Overall Study|Lost to Follow-up|1
1056435|NCT01898923|2101060|FG000|Overall Study|Withdrawal by Subject|4
1056436|NCT01898923|2101061|FG001|Overall Study|Withdrawal by Subject|7
1056437|NCT01898923|2101060|FG000|Overall Study|Physician Decision|3
1056438|NCT01898923|2101061|FG001|Overall Study|Physician Decision|4
1056439|NCT01898923|2101060|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1
1056440|NCT01898923|2101061|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2
1056441|NCT01899053|2101081|FG000|Overall Study|Progressive Disease|4
1056442|NCT01899053|2101082|FG001|Overall Study|Progressive Disease|0
1056443|NCT01899053|2101083|FG002|Overall Study|Progressive Disease|3
1056444|NCT01899053|2101084|FG003|Overall Study|Progressive Disease|0
1056445|NCT01899053|2101085|FG004|Overall Study|Progressive Disease|3
1056446|NCT01899053|2101086|FG005|Overall Study|Progressive Disease|1
1056447|NCT01899053|2101087|FG006|Overall Study|Progressive Disease|1
1056448|NCT01899053|2101088|FG007|Overall Study|Progressive Disease|1
1056449|NCT01899053|2101089|FG008|Overall Study|Progressive Disease|4
1056450|NCT01899053|2101090|FG009|Overall Study|Progressive Disease|3
1056451|NCT01899053|2101091|FG010|Overall Study|Progressive Disease|12
1056452|NCT01899053|2101092|FG011|Overall Study|Progressive Disease|5
1056453|NCT01899053|2101093|FG012|Overall Study|Progressive Disease|8
1056454|NCT01899053|2101094|FG013|Overall Study|Progressive Disease|17
1056455|NCT01899053|2101081|FG000|Overall Study|Adverse Event|1
1056456|NCT01899053|2101082|FG001|Overall Study|Adverse Event|1
1056457|NCT01899053|2101083|FG002|Overall Study|Adverse Event|1
1056458|NCT01899053|2101084|FG003|Overall Study|Adverse Event|3
1056459|NCT01899053|2101085|FG004|Overall Study|Adverse Event|1
1056460|NCT01899053|2101086|FG005|Overall Study|Adverse Event|1
1056461|NCT01899053|2101087|FG006|Overall Study|Adverse Event|1
1056462|NCT01899053|2101088|FG007|Overall Study|Adverse Event|0
1056463|NCT01899053|2101089|FG008|Overall Study|Adverse Event|2
1056464|NCT01899053|2101090|FG009|Overall Study|Adverse Event|0
1056465|NCT01899053|2101091|FG010|Overall Study|Adverse Event|3
1056466|NCT01899053|2101092|FG011|Overall Study|Adverse Event|1
1056467|NCT01899053|2101093|FG012|Overall Study|Adverse Event|2
1056468|NCT01899053|2101094|FG013|Overall Study|Adverse Event|2
1056469|NCT01899053|2101081|FG000|Overall Study|Reason Not Specified|0
1056470|NCT01899053|2101082|FG001|Overall Study|Reason Not Specified|0
1056471|NCT01899053|2101083|FG002|Overall Study|Reason Not Specified|0
1056472|NCT01899053|2101084|FG003|Overall Study|Reason Not Specified|0
1056473|NCT01899053|2101085|FG004|Overall Study|Reason Not Specified|0
1056474|NCT01899053|2101086|FG005|Overall Study|Reason Not Specified|0
1056475|NCT01899053|2101087|FG006|Overall Study|Reason Not Specified|1
1056476|NCT01899053|2101088|FG007|Overall Study|Reason Not Specified|0
1056477|NCT01899053|2101089|FG008|Overall Study|Reason Not Specified|0
1056478|NCT01899053|2101090|FG009|Overall Study|Reason Not Specified|0
1056479|NCT01899053|2101091|FG010|Overall Study|Reason Not Specified|0
1056480|NCT01899053|2101092|FG011|Overall Study|Reason Not Specified|0
1056481|NCT01899053|2101093|FG012|Overall Study|Reason Not Specified|1
1056482|NCT01899053|2101094|FG013|Overall Study|Reason Not Specified|0
1056483|NCT01899053|2101081|FG000|Overall Study|Withdrawal by Subject|1
1056484|NCT01899053|2101082|FG001|Overall Study|Withdrawal by Subject|1
1056485|NCT01899053|2101083|FG002|Overall Study|Withdrawal by Subject|2
1056486|NCT01899053|2101084|FG003|Overall Study|Withdrawal by Subject|0
1056487|NCT01899053|2101085|FG004|Overall Study|Withdrawal by Subject|2
1056488|NCT01899053|2101086|FG005|Overall Study|Withdrawal by Subject|0
1056489|NCT01899053|2101087|FG006|Overall Study|Withdrawal by Subject|0
1056490|NCT01899053|2101088|FG007|Overall Study|Withdrawal by Subject|1
1056491|NCT01899053|2101089|FG008|Overall Study|Withdrawal by Subject|0
1056492|NCT01899053|2101090|FG009|Overall Study|Withdrawal by Subject|0
1056493|NCT01899053|2101091|FG010|Overall Study|Withdrawal by Subject|0
1056494|NCT01899053|2101092|FG011|Overall Study|Withdrawal by Subject|0
1056495|NCT01899053|2101093|FG012|Overall Study|Withdrawal by Subject|1
1056496|NCT01899053|2101094|FG013|Overall Study|Withdrawal by Subject|1
1056497|NCT01899053|2101081|FG000|Overall Study|Protocol Violation|0
1056498|NCT01899053|2101082|FG001|Overall Study|Protocol Violation|0
1056499|NCT01899053|2101083|FG002|Overall Study|Protocol Violation|1
1056500|NCT01899053|2101084|FG003|Overall Study|Protocol Violation|0
1056501|NCT01899053|2101085|FG004|Overall Study|Protocol Violation|0
1056502|NCT01899053|2101086|FG005|Overall Study|Protocol Violation|0
1056503|NCT01899053|2101087|FG006|Overall Study|Protocol Violation|0
1056504|NCT01899053|2101088|FG007|Overall Study|Protocol Violation|0
1056505|NCT01899053|2101089|FG008|Overall Study|Protocol Violation|0
1056506|NCT01899053|2101090|FG009|Overall Study|Protocol Violation|0
1056507|NCT01899053|2101091|FG010|Overall Study|Protocol Violation|0
1056508|NCT01899053|2101092|FG011|Overall Study|Protocol Violation|0
1056509|NCT01899053|2101093|FG012|Overall Study|Protocol Violation|0
1056510|NCT01899053|2101094|FG013|Overall Study|Protocol Violation|0
1056511|NCT01899053|2101081|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
1056512|NCT01899053|2101082|FG001|Overall Study|Unsatisfactory Therapeutic Response|1
1056513|NCT01899053|2101083|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
1056514|NCT01899053|2101084|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
1056515|NCT01899053|2101085|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
1056516|NCT01899053|2101086|FG005|Overall Study|Unsatisfactory Therapeutic Response|0
1056517|NCT01899053|2101087|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
1056518|NCT01899053|2101088|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
1056519|NCT01899053|2101089|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
1056520|NCT01899053|2101090|FG009|Overall Study|Unsatisfactory Therapeutic Response|0
1056521|NCT01899053|2101091|FG010|Overall Study|Unsatisfactory Therapeutic Response|1
1056522|NCT01899053|2101092|FG011|Overall Study|Unsatisfactory Therapeutic Response|0
1056523|NCT01899053|2101093|FG012|Overall Study|Unsatisfactory Therapeutic Response|0
1056524|NCT01899053|2101094|FG013|Overall Study|Unsatisfactory Therapeutic Response|0
1056525|NCT01899053|2101081|FG000|Overall Study|Symptomatic Deterioration|0
1056526|NCT01899053|2101082|FG001|Overall Study|Symptomatic Deterioration|0
1056527|NCT01899053|2101083|FG002|Overall Study|Symptomatic Deterioration|0
1056528|NCT01899053|2101084|FG003|Overall Study|Symptomatic Deterioration|0
1056529|NCT01899053|2101085|FG004|Overall Study|Symptomatic Deterioration|0
1056530|NCT01899053|2101086|FG005|Overall Study|Symptomatic Deterioration|1
1056531|NCT01899053|2101087|FG006|Overall Study|Symptomatic Deterioration|0
1056532|NCT01899053|2101088|FG007|Overall Study|Symptomatic Deterioration|1
1056533|NCT01899053|2101089|FG008|Overall Study|Symptomatic Deterioration|0
1056534|NCT01899053|2101090|FG009|Overall Study|Symptomatic Deterioration|0
1056535|NCT01899053|2101091|FG010|Overall Study|Symptomatic Deterioration|0
1056536|NCT01899053|2101092|FG011|Overall Study|Symptomatic Deterioration|1
1056537|NCT01899053|2101093|FG012|Overall Study|Symptomatic Deterioration|2
1056538|NCT01899053|2101094|FG013|Overall Study|Symptomatic Deterioration|0
1056542|NCT01899729|2101163|FG000|Overall Study|Adverse Event|1
1056543|NCT01899729|2101164|FG001|Overall Study|Adverse Event|0
1056544|NCT01899729|2101165|FG002|Overall Study|Adverse Event|0
1056545|NCT01899729|2101166|FG003|Overall Study|Adverse Event|0
1056546|NCT01899729|2101167|FG004|Overall Study|Adverse Event|1
1056547|NCT01899729|2101163|FG000|Overall Study|Withdrawal by Subject|1
1056548|NCT01899729|2101164|FG001|Overall Study|Withdrawal by Subject|2
1056549|NCT01899729|2101165|FG002|Overall Study|Withdrawal by Subject|0
1056550|NCT01899729|2101166|FG003|Overall Study|Withdrawal by Subject|0
1056551|NCT01899729|2101167|FG004|Overall Study|Withdrawal by Subject|0
1056552|NCT01899729|2101163|FG000|Overall Study|Lack of Efficacy|0
1056553|NCT01899729|2101164|FG001|Overall Study|Lack of Efficacy|0
1056554|NCT01899729|2101165|FG002|Overall Study|Lack of Efficacy|2
1056555|NCT01899729|2101166|FG003|Overall Study|Lack of Efficacy|0
1056556|NCT01899729|2101167|FG004|Overall Study|Lack of Efficacy|1
1056557|NCT01899742|2101181|FG000|Overall Study|Adverse Event|5
1056558|NCT01899742|2101182|FG001|Overall Study|Adverse Event|4
1056559|NCT01899742|2101181|FG000|Overall Study|Lack of Efficacy|1
1056560|NCT01899742|2101182|FG001|Overall Study|Lack of Efficacy|5
1056561|NCT01899742|2101181|FG000|Overall Study|Protocol Violation|2
1056562|NCT01899742|2101182|FG001|Overall Study|Protocol Violation|2
1056563|NCT01899742|2101181|FG000|Overall Study|Withdrawal by Subject|9
1056564|NCT01899742|2101182|FG001|Overall Study|Withdrawal by Subject|5
1056565|NCT01899768|2101188|FG000|Part A|Adverse Event|2
1056566|NCT01899768|2101188|FG000|Part A|Withdrawal by Subject|1
1056567|NCT01899768|2101188|FG000|Part B|Adverse Event|1
1056568|NCT01899768|2101188|FG000|Part B|Withdrawal by Subject|1
1056569|NCT01900054|2101200|FG000|Overall Study|Physician Decision|1
1056570|NCT01900054|2101200|FG000|Overall Study|Withdrawal by Subject|1
1056571|NCT01900314|2101228|FG000|Overall Study|Lost to Follow-up|1
1056572|NCT01900314|2101229|FG001|Overall Study|Lost to Follow-up|0
1056573|NCT01900314|2101228|FG000|Overall Study|Protocol Violation|0
1056574|NCT01900314|2101229|FG001|Overall Study|Protocol Violation|1
1056575|NCT01900314|2101228|FG000|Overall Study|Withdrawal by Subject|3
1056576|NCT01900314|2101229|FG001|Overall Study|Withdrawal by Subject|3
1056577|NCT01900431|2101251|FG000|Principal Treatment Period (Part A)|Adverse Event|1
1056578|NCT01900431|2101252|FG001|Principal Treatment Period (Part A)|Adverse Event|3
1056579|NCT01900431|2101253|FG002|Principal Treatment Period (Part A)|Adverse Event|0
1056580|NCT01900431|2101251|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6
1056581|NCT01900431|2101252|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6
1056582|NCT01900431|2101253|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0
1056583|NCT01900431|2101251|FG000|Principal Treatment Period (Part A)|Other than specified above|0
1056584|NCT01900431|2101252|FG001|Principal Treatment Period (Part A)|Other than specified above|1
1056585|NCT01900431|2101253|FG002|Principal Treatment Period (Part A)|Other than specified above|0
1056586|NCT01900431|2101251|FG000|Extended Treatment Period (Part B)|Adverse Event|0
1056587|NCT01900431|2101252|FG001|Extended Treatment Period (Part B)|Adverse Event|2
1056588|NCT01900431|2101253|FG002|Extended Treatment Period (Part B)|Adverse Event|0
1056589|NCT01900431|2101251|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1
1056590|NCT01900431|2101252|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7
1056591|NCT01900431|2101253|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0
1056592|NCT01900431|2101251|FG000|Extended Treatment Period (Part B)|Other than specified above|0
1056593|NCT01900431|2101252|FG001|Extended Treatment Period (Part B)|Other than specified above|1
1056594|NCT01900431|2101253|FG002|Extended Treatment Period (Part B)|Other than specified above|0
1056595|NCT01900431|2101251|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0
1056596|NCT01900431|2101252|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0
1056597|NCT01900431|2101253|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2
1056598|NCT01900431|2101251|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
1056599|NCT01900431|2101252|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
1056600|NCT01900431|2101253|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
1056601|NCT01900431|2101251|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
1056602|NCT01900431|2101252|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
1056603|NCT01900431|2101253|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
1056604|NCT01900444|2101261|FG000|Overall Study|Protocol Violation|2
1056605|NCT01900444|2101261|FG000|Overall Study|Lost to Follow-up|1
1056606|NCT01900652|2101276|FG000|Overall Study|Progressive Disease|1
1056607|NCT01900652|2101277|FG001|Overall Study|Progressive Disease|0
1056608|NCT01900652|2101276|FG000|Overall Study|Consent withdrawn by subject|1
1056609|NCT01900652|2101277|FG001|Overall Study|Consent withdrawn by subject|1
1056610|NCT01900652|2101276|FG000|Overall Study|Death|3
1056611|NCT01900652|2101277|FG001|Overall Study|Death|0
1056612|NCT01900652|2101276|FG000|Overall Study|Adverse Event|2
1056613|NCT01900652|2101277|FG001|Overall Study|Adverse Event|1
1056614|NCT01900652|2101276|FG000|Overall Study|Physician Decision|1
1056615|NCT01900652|2101277|FG001|Overall Study|Physician Decision|1
1056616|NCT01900665|2101290|FG000|Placebo Controlled Period|Death|9
1056617|NCT01900665|2101291|FG001|Placebo Controlled Period|Death|16
1056618|NCT01900665|2101290|FG000|Placebo Controlled Period|Adverse Event|48
1056619|NCT01900665|2101291|FG001|Placebo Controlled Period|Adverse Event|39
1056620|NCT01900665|2101290|FG000|Placebo Controlled Period|Protocol Violation|1
1056621|NCT01900665|2101291|FG001|Placebo Controlled Period|Protocol Violation|7
1056622|NCT01900665|2101290|FG000|Placebo Controlled Period|Withdrawal by Subject|33
1056623|NCT01900665|2101291|FG001|Placebo Controlled Period|Withdrawal by Subject|45
1056624|NCT01900665|2101290|FG000|Placebo Controlled Period|Physician Decision|11
1056625|NCT01900665|2101291|FG001|Placebo Controlled Period|Physician Decision|7
908158|NCT00779766|1884536|FG001|Month 24|Lost to Follow-up|9
908159|NCT00779766|1884535|FG000|Month 24|Other|18
908160|NCT00779766|1884536|FG001|Month 24|Other|27
908161|NCT00779766|1884535|FG000|Month 48|Withdrawal by Subject|68
908162|NCT00779766|1884536|FG001|Month 48|Withdrawal by Subject|63
908163|NCT00779766|1884535|FG000|Month 48|Migrated/moved from study area|76
908164|NCT00779766|1884536|FG001|Month 48|Migrated/moved from study area|75
908165|NCT00779766|1884535|FG000|Month 48|Lost to Follow-up|29
908166|NCT00779766|1884536|FG001|Month 48|Lost to Follow-up|30
908167|NCT00779766|1884535|FG000|Month 48|Other|1
908168|NCT00779766|1884536|FG001|Month 48|Other|0
908169|NCT00779766|1884535|FG000|Month 72|Withdrawal by Subject|55
908170|NCT00779766|1884536|FG001|Month 72|Withdrawal by Subject|71
908171|NCT00779766|1884535|FG000|Month 72|Migrated/moved from study area|124
908172|NCT00779766|1884536|FG001|Month 72|Migrated/moved from study area|109
908173|NCT00779766|1884535|FG000|Month 72|Lost to Follow-up|6
908174|NCT00779766|1884536|FG001|Month 72|Lost to Follow-up|8
908175|NCT00779766|1884535|FG000|Month 72|Other|0
1056626|NCT01900665|2101290|FG000|Placebo Controlled Period|Lost to Follow-up|3
1056627|NCT01900665|2101291|FG001|Placebo Controlled Period|Lost to Follow-up|0
1056628|NCT01900665|2101290|FG000|Placebo Controlled Period|Caregiver Decision|33
1056629|NCT01900665|2101291|FG001|Placebo Controlled Period|Caregiver Decision|41
1056630|NCT01900665|2101290|FG000|Placebo Controlled Period|Entry Criteria Not Met|5
1056631|NCT01900665|2101291|FG001|Placebo Controlled Period|Entry Criteria Not Met|9
1056632|NCT01900665|2101290|FG000|Open Label Period|Adverse Event|16
1056633|NCT01900665|2101291|FG001|Open Label Period|Adverse Event|20
1056634|NCT01900665|2101290|FG000|Open Label Period|Death|5
1056635|NCT01900665|2101291|FG001|Open Label Period|Death|6
1056636|NCT01900665|2101290|FG000|Open Label Period|Lost to Follow-up|1
1056637|NCT01900665|2101291|FG001|Open Label Period|Lost to Follow-up|1
1056638|NCT01900665|2101290|FG000|Open Label Period|Parent/Caregiver Decision|33
1056639|NCT01900665|2101291|FG001|Open Label Period|Parent/Caregiver Decision|34
1056640|NCT01900665|2101290|FG000|Open Label Period|Physician Decision|4
1056641|NCT01900665|2101291|FG001|Open Label Period|Physician Decision|4
1056642|NCT01900665|2101290|FG000|Open Label Period|Protocol Violation|0
1056643|NCT01900665|2101291|FG001|Open Label Period|Protocol Violation|1
1056644|NCT01900665|2101290|FG000|Open Label Period|Sponsor Decision|802
1056645|NCT01900665|2101291|FG001|Open Label Period|Sponsor Decision|765
1056646|NCT01900665|2101290|FG000|Open Label Period|Withdrawal by Subject|20
1056647|NCT01900665|2101291|FG001|Open Label Period|Withdrawal by Subject|28
1056648|NCT01900899|2101316|FG000|Overall Study|Withdrawal by Subject|7
1056649|NCT01900899|2101317|FG001|Overall Study|Withdrawal by Subject|1
1056650|NCT01900899|2101316|FG000|Overall Study|Migrated from study area|2
1056651|NCT01900899|2101317|FG001|Overall Study|Migrated from study area|0
1056652|NCT01901055|2101325|FG000|Randomization But Not Titrated|Did not come to titration study|1
1056653|NCT01901055|2101326|FG001|Randomization But Not Titrated|Did not come to titration study|1
1056654|NCT01901055|2101325|FG000|Randomization But Not Titrated|Physician Decision|0
1056655|NCT01901055|2101326|FG001|Randomization But Not Titrated|Physician Decision|1
1056656|NCT01901055|2101325|FG000|Started Protocol to Week 6|Physician Decision|2
1056657|NCT01901055|2101326|FG001|Started Protocol to Week 6|Physician Decision|1
1056658|NCT01901055|2101325|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0
1056659|NCT01901055|2101326|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2
1056660|NCT01901055|2101325|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1
1056661|NCT01901055|2101326|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0
1056662|NCT01901055|2101325|FG000|Started Protocol to Week 6|Withdrawal by Subject|0
1056663|NCT01901055|2101326|FG001|Started Protocol to Week 6|Withdrawal by Subject|1
1056664|NCT01901055|2101325|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1
1056665|NCT01901055|2101326|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0
1056666|NCT01901055|2101325|FG000|Week 12 Assessment|Withdrawal by Subject|0
1056667|NCT01901055|2101326|FG001|Week 12 Assessment|Withdrawal by Subject|4
1056668|NCT01901055|2101325|FG000|Week 24|Withdrawal by Subject|13
1056669|NCT01901055|2101326|FG001|Week 24|Withdrawal by Subject|19
1056670|NCT01901055|2101325|FG000|Week 24|Physician Decision|1
1056671|NCT01901055|2101326|FG001|Week 24|Physician Decision|0
1056672|NCT01901055|2101325|FG000|Week 36|Withdrawal by Subject|0
1056673|NCT01901055|2101326|FG001|Week 36|Withdrawal by Subject|5
1056674|NCT01901146|2101337|FG000|Neoadjuvant Phase|Death|1
1056675|NCT01901146|2101338|FG001|Neoadjuvant Phase|Death|2
1056676|NCT01901146|2101339|FG002|Neoadjuvant Phase|Death|0
1056677|NCT01901146|2101340|FG003|Neoadjuvant Phase|Death|0
1056678|NCT01901146|2101341|FG004|Neoadjuvant Phase|Death|0
1056679|NCT01901146|2101337|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2
1056680|NCT01901146|2101338|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3
1056681|NCT01901146|2101339|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0
1056682|NCT01901146|2101340|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0
1056683|NCT01901146|2101341|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0
1056684|NCT01901146|2101337|FG000|Neoadjuvant Phase|Lost to Follow-up|0
1056685|NCT01901146|2101338|FG001|Neoadjuvant Phase|Lost to Follow-up|1
1056686|NCT01901146|2101339|FG002|Neoadjuvant Phase|Lost to Follow-up|0
1056687|NCT01901146|2101340|FG003|Neoadjuvant Phase|Lost to Follow-up|0
1056688|NCT01901146|2101341|FG004|Neoadjuvant Phase|Lost to Follow-up|0
1056689|NCT01901146|2101337|FG000|Neoadjuvant Phase|Physician Decision|1
1056690|NCT01901146|2101338|FG001|Neoadjuvant Phase|Physician Decision|2
1056691|NCT01901146|2101339|FG002|Neoadjuvant Phase|Physician Decision|0
1056692|NCT01901146|2101340|FG003|Neoadjuvant Phase|Physician Decision|0
1056693|NCT01901146|2101341|FG004|Neoadjuvant Phase|Physician Decision|0
1056694|NCT01901146|2101337|FG000|Neoadjuvant Phase|Withdrawal by Subject|2
1056695|NCT01901146|2101338|FG001|Neoadjuvant Phase|Withdrawal by Subject|5
1056696|NCT01901146|2101339|FG002|Neoadjuvant Phase|Withdrawal by Subject|0
1056697|NCT01901146|2101340|FG003|Neoadjuvant Phase|Withdrawal by Subject|0
1056698|NCT01901146|2101341|FG004|Neoadjuvant Phase|Withdrawal by Subject|0
1056699|NCT01901146|2101337|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0
1056700|NCT01901146|2101338|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1
1056701|NCT01901146|2101339|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0
1056702|NCT01901146|2101340|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0
1056703|NCT01901146|2101341|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0
1056704|NCT01901146|2101337|FG000|Adjuvant Phase|Other|0
1056705|NCT01901146|2101338|FG001|Adjuvant Phase|Other|0
1056706|NCT01901146|2101339|FG002|Adjuvant Phase|Other|1
1056707|NCT01901146|2101340|FG003|Adjuvant Phase|Other|0
1056708|NCT01901146|2101341|FG004|Adjuvant Phase|Other|0
1056709|NCT01901146|2101337|FG000|Adjuvant Phase|Death|0
1056710|NCT01901146|2101338|FG001|Adjuvant Phase|Death|0
1056711|NCT01901146|2101339|FG002|Adjuvant Phase|Death|0
1056712|NCT01901146|2101340|FG003|Adjuvant Phase|Death|0
1056713|NCT01901146|2101341|FG004|Adjuvant Phase|Death|3
1056714|NCT01901146|2101337|FG000|Adjuvant Phase|Disease Progression or Recurrence|0
1056715|NCT01901146|2101338|FG001|Adjuvant Phase|Disease Progression or Recurrence|0
1056716|NCT01901146|2101339|FG002|Adjuvant Phase|Disease Progression or Recurrence|12
1056717|NCT01901146|2101340|FG003|Adjuvant Phase|Disease Progression or Recurrence|4
1056718|NCT01901146|2101341|FG004|Adjuvant Phase|Disease Progression or Recurrence|3
1056719|NCT01901146|2101337|FG000|Adjuvant Phase|Physician Decision|0
1056720|NCT01901146|2101338|FG001|Adjuvant Phase|Physician Decision|0
1056721|NCT01901146|2101339|FG002|Adjuvant Phase|Physician Decision|9
1056722|NCT01901146|2101340|FG003|Adjuvant Phase|Physician Decision|2
1056723|NCT01901146|2101341|FG004|Adjuvant Phase|Physician Decision|4
1056724|NCT01901146|2101337|FG000|Adjuvant Phase|Withdrawal by Subject|0
1056725|NCT01901146|2101338|FG001|Adjuvant Phase|Withdrawal by Subject|0
1056726|NCT01901146|2101339|FG002|Adjuvant Phase|Withdrawal by Subject|4
1056727|NCT01901146|2101340|FG003|Adjuvant Phase|Withdrawal by Subject|1
1056728|NCT01901146|2101341|FG004|Adjuvant Phase|Withdrawal by Subject|4
1056729|NCT01901185|2101350|FG000|Overall Study|Withdrawal by Subject|2
1056730|NCT01901302|2101378|FG000|Overall Study|Adverse Event|2
1056731|NCT01901302|2101379|FG001|Overall Study|Adverse Event|1
1056732|NCT01901302|2101378|FG000|Overall Study|Lack of Efficacy|0
1056733|NCT01901302|2101379|FG001|Overall Study|Lack of Efficacy|2
1056734|NCT01901302|2101378|FG000|Overall Study|Study Terminated by Sponsor|23
1056735|NCT01901302|2101379|FG001|Overall Study|Study Terminated by Sponsor|20
1056736|NCT01901302|2101378|FG000|Overall Study|Withdrawal by Subject|2
1056737|NCT01901302|2101379|FG001|Overall Study|Withdrawal by Subject|0
1056738|NCT01901328|2101387|FG000|Overall Study|Lost to Follow-up|1
1056739|NCT01901328|2101388|FG001|Overall Study|Lost to Follow-up|0
1056740|NCT01901328|2101387|FG000|Overall Study|Physician Decision|0
1056741|NCT01901328|2101388|FG001|Overall Study|Physician Decision|1
1056742|NCT01901328|2101387|FG000|Overall Study|Protocol Violation|1
1056743|NCT01901328|2101388|FG001|Overall Study|Protocol Violation|1
1056744|NCT01901328|2101387|FG000|Overall Study|Study Terminated by Sponsor|19
1056745|NCT01901328|2101388|FG001|Overall Study|Study Terminated by Sponsor|16
1056746|NCT01901328|2101387|FG000|Overall Study|Withdrawal by Subject|1
1056747|NCT01901328|2101388|FG001|Overall Study|Withdrawal by Subject|2
1056748|NCT01901328|2101387|FG000|Overall Study|Lack of Efficacy|0
1056749|NCT01901328|2101388|FG001|Overall Study|Lack of Efficacy|1
1056750|NCT01901341|2101397|FG000|Overall Study|Adverse Event|4
1056751|NCT01901341|2101398|FG001|Overall Study|Adverse Event|2
1056752|NCT01901341|2101397|FG000|Overall Study|Lack of Efficacy|0
1056753|NCT01901341|2101398|FG001|Overall Study|Lack of Efficacy|2
1056754|NCT01901341|2101397|FG000|Overall Study|Lost to Follow-up|0
1056755|NCT01901341|2101398|FG001|Overall Study|Lost to Follow-up|1
1056756|NCT01901341|2101397|FG000|Overall Study|Protocol Violation|2
1056757|NCT01901341|2101398|FG001|Overall Study|Protocol Violation|0
1056758|NCT01901341|2101397|FG000|Overall Study|Study Terminated by Sponsor|13
1056759|NCT01901341|2101398|FG001|Overall Study|Study Terminated by Sponsor|15
1056760|NCT01901341|2101397|FG000|Overall Study|Withdrawal by Subject|1
1056761|NCT01901341|2101398|FG001|Overall Study|Withdrawal by Subject|1
1056762|NCT01901393|2101407|FG000|Overall Study|Adverse Event|1
1056763|NCT01901393|2101408|FG001|Overall Study|Adverse Event|0
1056764|NCT01901419|2101416|FG000|Overall Study|Protocol Violation|2
1056765|NCT01901419|2101417|FG001|Overall Study|Protocol Violation|6
1056766|NCT01901419|2101416|FG000|Overall Study|unavailable researchers|6
1056767|NCT01901419|2101417|FG001|Overall Study|unavailable researchers|3
1056768|NCT01901614|2101467|FG000|Overall Study|Adverse Event|0
1056769|NCT01901614|2101468|FG001|Overall Study|Adverse Event|1
1056770|NCT01901614|2101467|FG000|Overall Study|Lost to Follow-up|1
1056771|NCT01901614|2101468|FG001|Overall Study|Lost to Follow-up|0
1056772|NCT01901614|2101467|FG000|Overall Study|Screen Fail|1
1056773|NCT01901614|2101468|FG001|Overall Study|Screen Fail|0
1056774|NCT01901653|2101487|FG000|Overall Study|Death|2
1056775|NCT01901653|2101488|FG001|Overall Study|Death|1
1056776|NCT01901653|2101489|FG002|Overall Study|Death|8
1056777|NCT01901653|2101490|FG003|Overall Study|Death|3
1056778|NCT01901653|2101491|FG004|Overall Study|Death|2
1056779|NCT01901653|2101492|FG005|Overall Study|Death|2
1056780|NCT01901653|2101493|FG006|Overall Study|Death|6
1056781|NCT01901653|2101494|FG007|Overall Study|Death|9
1056782|NCT01901653|2101495|FG008|Overall Study|Death|1
1056783|NCT01901653|2101496|FG009|Overall Study|Death|16
1056784|NCT01901653|2101497|FG010|Overall Study|Death|2
1056785|NCT01901653|2101498|FG011|Overall Study|Death|15
1056786|NCT01901653|2101499|FG012|Overall Study|Death|4
1056787|NCT01901653|2101487|FG000|Overall Study|Lost to Follow-up|1
1056788|NCT01901653|2101488|FG001|Overall Study|Lost to Follow-up|0
1056789|NCT01901653|2101489|FG002|Overall Study|Lost to Follow-up|2
1056790|NCT01901653|2101490|FG003|Overall Study|Lost to Follow-up|0
1056791|NCT01901653|2101491|FG004|Overall Study|Lost to Follow-up|0
1056792|NCT01901653|2101492|FG005|Overall Study|Lost to Follow-up|1
1056793|NCT01901653|2101493|FG006|Overall Study|Lost to Follow-up|0
1056794|NCT01901653|2101494|FG007|Overall Study|Lost to Follow-up|1
1056795|NCT01901653|2101495|FG008|Overall Study|Lost to Follow-up|0
1056796|NCT01901653|2101496|FG009|Overall Study|Lost to Follow-up|0
1056797|NCT01901653|2101497|FG010|Overall Study|Lost to Follow-up|0
1056798|NCT01901653|2101498|FG011|Overall Study|Lost to Follow-up|0
1056799|NCT01901653|2101499|FG012|Overall Study|Lost to Follow-up|0
1056800|NCT01901653|2101487|FG000|Overall Study|Withdrawal by Subject|0
1056801|NCT01901653|2101488|FG001|Overall Study|Withdrawal by Subject|0
1056802|NCT01901653|2101489|FG002|Overall Study|Withdrawal by Subject|0
1056803|NCT01901653|2101490|FG003|Overall Study|Withdrawal by Subject|0
1056804|NCT01901653|2101491|FG004|Overall Study|Withdrawal by Subject|0
1056805|NCT01901653|2101492|FG005|Overall Study|Withdrawal by Subject|0
1056806|NCT01901653|2101493|FG006|Overall Study|Withdrawal by Subject|1
1056807|NCT01901653|2101494|FG007|Overall Study|Withdrawal by Subject|0
1056808|NCT01901653|2101495|FG008|Overall Study|Withdrawal by Subject|0
1056809|NCT01901653|2101496|FG009|Overall Study|Withdrawal by Subject|0
1056810|NCT01901653|2101497|FG010|Overall Study|Withdrawal by Subject|0
1056811|NCT01901653|2101498|FG011|Overall Study|Withdrawal by Subject|0
1056812|NCT01901653|2101499|FG012|Overall Study|Withdrawal by Subject|0
1056813|NCT01901653|2101487|FG000|Overall Study|Alive at Study Termination by Sponsor|0
1056814|NCT01901653|2101488|FG001|Overall Study|Alive at Study Termination by Sponsor|0
1056815|NCT01901653|2101489|FG002|Overall Study|Alive at Study Termination by Sponsor|1
1056816|NCT01901653|2101490|FG003|Overall Study|Alive at Study Termination by Sponsor|0
1056817|NCT01901653|2101491|FG004|Overall Study|Alive at Study Termination by Sponsor|0
1056818|NCT01901653|2101492|FG005|Overall Study|Alive at Study Termination by Sponsor|0
1056819|NCT01901653|2101493|FG006|Overall Study|Alive at Study Termination by Sponsor|0
1056820|NCT01901653|2101494|FG007|Overall Study|Alive at Study Termination by Sponsor|0
1056821|NCT01901653|2101495|FG008|Overall Study|Alive at Study Termination by Sponsor|0
1056822|NCT01901653|2101496|FG009|Overall Study|Alive at Study Termination by Sponsor|2
1056823|NCT01901653|2101497|FG010|Overall Study|Alive at Study Termination by Sponsor|0
1056824|NCT01901653|2101498|FG011|Overall Study|Alive at Study Termination by Sponsor|1
1056825|NCT01901653|2101499|FG012|Overall Study|Alive at Study Termination by Sponsor|1
1056826|NCT01901848|2101548|FG000|Randomized and Treated|Lost to Follow-up|3
1056827|NCT01901848|2101549|FG001|Randomized and Treated|Lost to Follow-up|6
1056828|NCT01901848|2101548|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10
1056829|NCT01901848|2101549|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0
1056830|NCT01901874|2101555|FG000|Screening Committee Retrospective Review|Protocol Violation|47
1056831|NCT01901874|2101555|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1
1056832|NCT01901874|2101555|FG000|1-Year (365-Day) MAE Evaluation|Death|7
1056833|NCT01901874|2101555|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
1056834|NCT01901874|2101555|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
1056835|NCT01901874|2101555|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
1056836|NCT01902134|2101574|FG000|Overall Study|Adverse Event|3
1056837|NCT01902134|2101575|FG001|Overall Study|Adverse Event|1
1056838|NCT01902134|2101576|FG002|Overall Study|Adverse Event|2
1056839|NCT01902134|2101577|FG003|Overall Study|Adverse Event|1
1056840|NCT01902134|2101578|FG004|Overall Study|Adverse Event|1
1056841|NCT01902134|2101579|FG005|Overall Study|Adverse Event|3
1056842|NCT01902134|2101574|FG000|Overall Study|Lack of Efficacy|0
1056843|NCT01902134|2101575|FG001|Overall Study|Lack of Efficacy|0
1056844|NCT01902134|2101576|FG002|Overall Study|Lack of Efficacy|2
1056845|NCT01902134|2101577|FG003|Overall Study|Lack of Efficacy|0
1056846|NCT01902134|2101578|FG004|Overall Study|Lack of Efficacy|0
1056847|NCT01902134|2101579|FG005|Overall Study|Lack of Efficacy|1
1056848|NCT01902134|2101574|FG000|Overall Study|Physician Decision|0
1056849|NCT01902134|2101575|FG001|Overall Study|Physician Decision|1
1056850|NCT01902134|2101576|FG002|Overall Study|Physician Decision|0
1056851|NCT01902134|2101577|FG003|Overall Study|Physician Decision|0
1056852|NCT01902134|2101578|FG004|Overall Study|Physician Decision|0
1056853|NCT01902134|2101579|FG005|Overall Study|Physician Decision|0
1056854|NCT01902134|2101574|FG000|Overall Study|Protocol Violation|0
1056855|NCT01902134|2101575|FG001|Overall Study|Protocol Violation|0
1056856|NCT01902134|2101576|FG002|Overall Study|Protocol Violation|0
1056857|NCT01902134|2101577|FG003|Overall Study|Protocol Violation|0
1056858|NCT01902134|2101578|FG004|Overall Study|Protocol Violation|0
1056859|NCT01902134|2101579|FG005|Overall Study|Protocol Violation|1
1056860|NCT01902134|2101574|FG000|Overall Study|Withdrawal by Subject|4
1056861|NCT01902134|2101575|FG001|Overall Study|Withdrawal by Subject|8
1056862|NCT01902134|2101576|FG002|Overall Study|Withdrawal by Subject|9
1056863|NCT01902134|2101577|FG003|Overall Study|Withdrawal by Subject|1
1056864|NCT01902134|2101578|FG004|Overall Study|Withdrawal by Subject|5
1056865|NCT01902134|2101579|FG005|Overall Study|Withdrawal by Subject|4
1056866|NCT01902134|2101574|FG000|Overall Study|no compliance|1
1056867|NCT01902134|2101575|FG001|Overall Study|no compliance|0
1056868|NCT01902134|2101576|FG002|Overall Study|no compliance|0
1056869|NCT01902134|2101577|FG003|Overall Study|no compliance|0
1056870|NCT01902134|2101578|FG004|Overall Study|no compliance|0
1056871|NCT01902134|2101579|FG005|Overall Study|no compliance|0
1056872|NCT01902134|2101574|FG000|Overall Study|Other|0
1056873|NCT01902134|2101575|FG001|Overall Study|Other|1
1056874|NCT01902134|2101576|FG002|Overall Study|Other|2
1056875|NCT01902134|2101577|FG003|Overall Study|Other|0
1056876|NCT01902134|2101578|FG004|Overall Study|Other|1
1056877|NCT01902134|2101579|FG005|Overall Study|Other|0
1056878|NCT01902173|2101601|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1
1056879|NCT01902173|2101602|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
1056880|NCT01902173|2101603|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
1056881|NCT01902173|2101604|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
1056882|NCT01902173|2101605|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
1056883|NCT01902173|2101606|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
1056884|NCT01902173|2101601|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2
1056885|NCT01902173|2101602|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
1056886|NCT01902173|2101603|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
1056887|NCT01902173|2101604|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
1056888|NCT01902173|2101605|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
1056889|NCT01902173|2101606|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
1056890|NCT01902173|2101601|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
1056891|NCT01902173|2101602|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5
1056892|NCT01902173|2101603|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
1056893|NCT01902173|2101604|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
1056894|NCT01902173|2101605|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
1056895|NCT01902173|2101606|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
1056896|NCT01902173|2101601|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
1056897|NCT01902173|2101602|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1
1056898|NCT01902173|2101603|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
1056899|NCT01902173|2101604|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
1056900|NCT01902173|2101605|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
1056901|NCT01902173|2101606|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
1056902|NCT01902173|2101601|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0
1056903|NCT01902173|2101602|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3
1056904|NCT01902173|2101603|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0
1056905|NCT01902173|2101604|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0
1056906|NCT01902173|2101605|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0
1056907|NCT01902173|2101606|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0
1056908|NCT01902173|2101601|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
1056909|NCT01902173|2101602|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
1056910|NCT01902173|2101603|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3
1056911|NCT01902173|2101604|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
1056912|NCT01902173|2101605|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
1056913|NCT01902173|2101606|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
1056914|NCT01902173|2101601|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
1056915|NCT01902173|2101602|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
1056916|NCT01902173|2101603|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1
1056917|NCT01902173|2101604|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
1056918|NCT01902173|2101605|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
1056919|NCT01902173|2101606|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
1056920|NCT01902173|2101601|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
1056921|NCT01902173|2101602|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
1056922|NCT01902173|2101603|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
1056923|NCT01902173|2101604|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1
1056924|NCT01902173|2101605|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
1056925|NCT01902173|2101606|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
1056926|NCT01902173|2101601|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
1056927|NCT01902173|2101602|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
1056928|NCT01902173|2101603|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
1056929|NCT01902173|2101604|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2
1056930|NCT01902173|2101605|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
1056931|NCT01902173|2101606|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
1056932|NCT01902173|2101601|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
1056933|NCT01902173|2101602|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
1056934|NCT01902173|2101603|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
1056935|NCT01902173|2101604|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
1056936|NCT01902173|2101605|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1
1056937|NCT01902173|2101606|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
1056938|NCT01902173|2101601|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
1056939|NCT01902173|2101602|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
1056940|NCT01902173|2101603|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
1056941|NCT01902173|2101604|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
1056942|NCT01902173|2101605|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2
1056943|NCT01902173|2101606|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
1056944|NCT01902173|2101601|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
1056945|NCT01902173|2101602|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
1056946|NCT01902173|2101603|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
1056947|NCT01902173|2101604|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
1056948|NCT01902173|2101605|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
1056949|NCT01902173|2101606|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1
1056950|NCT01902173|2101601|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
1056951|NCT01902173|2101602|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
1056952|NCT01902173|2101603|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
1056953|NCT01902173|2101604|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
1056954|NCT01902173|2101605|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
1056955|NCT01902173|2101606|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3
1056956|NCT01902173|2101601|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0
1056957|NCT01902173|2101602|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0
1056958|NCT01902173|2101603|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0
1056959|NCT01902173|2101604|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0
1056960|NCT01902173|2101605|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0
1056961|NCT01902173|2101606|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1
1056962|NCT01902303|2101625|FG000|Overall Study|Adverse Event|0
1056963|NCT01902303|2101626|FG001|Overall Study|Adverse Event|1
1056964|NCT01902303|2101625|FG000|Overall Study|Lost to Follow-up|0
1056965|NCT01902303|2101626|FG001|Overall Study|Lost to Follow-up|1
1056966|NCT01902303|2101625|FG000|Overall Study|Protocol Violation|2
1056967|NCT01902303|2101626|FG001|Overall Study|Protocol Violation|2
1056968|NCT01902303|2101625|FG000|Overall Study|subject lost investigational product|0
1056969|NCT01902303|2101626|FG001|Overall Study|subject lost investigational product|1
1056970|NCT01902303|2101625|FG000|Overall Study|Did not develop a cold sore|21
1056971|NCT01902303|2101626|FG001|Overall Study|Did not develop a cold sore|19
1056972|NCT01902628|2101643|FG000|Overall Study|Withdrawal of participant's consent|7
1056973|NCT01902628|2101643|FG000|Overall Study|Adverse Event|41
1056974|NCT01902628|2101643|FG000|Overall Study|Lost to Follow-up|35
1056975|NCT01903031|2101679|FG000|Overall Study|Not Able to Attend Clinic|1
1056976|NCT01903031|2101680|FG001|Overall Study|Not Able to Attend Clinic|1
1056977|NCT01903031|2101681|FG002|Overall Study|Not Able to Attend Clinic|0
1056978|NCT01903031|2101679|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1
1056979|NCT01903031|2101680|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0
1056980|NCT01903031|2101681|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0
1056981|NCT01903031|2101679|FG000|Overall Study|Adverse Event|0
1056982|NCT01903031|2101680|FG001|Overall Study|Adverse Event|1
1056983|NCT01903031|2101681|FG002|Overall Study|Adverse Event|0
1056984|NCT01903031|2101679|FG000|Overall Study|Withdrawal by Subject|0
1056985|NCT01903031|2101680|FG001|Overall Study|Withdrawal by Subject|1
1056986|NCT01903031|2101681|FG002|Overall Study|Withdrawal by Subject|1
1056987|NCT01903031|2101679|FG000|Overall Study|Protocol Violation|0
1056988|NCT01903031|2101680|FG001|Overall Study|Protocol Violation|0
1056989|NCT01903031|2101681|FG002|Overall Study|Protocol Violation|2
1056990|NCT01903031|2101679|FG000|Overall Study|Lost to Follow-up|0
1056991|NCT01903031|2101680|FG001|Overall Study|Lost to Follow-up|0
1056992|NCT01903031|2101681|FG002|Overall Study|Lost to Follow-up|1
1056993|NCT01903031|2101679|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0
1056994|NCT01903031|2101680|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0
1056995|NCT01903031|2101681|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1
1056996|NCT01903252|2101712|FG000|Double-Blind Induction|Adverse Event|20
1056997|NCT01903252|2101713|FG001|Double-Blind Induction|Adverse Event|18
1056998|NCT01903252|2101714|FG002|Double-Blind Induction|Adverse Event|0
1056999|NCT01903252|2101715|FG003|Double-Blind Induction|Adverse Event|0
1057000|NCT01903252|2101716|FG004|Double-Blind Induction|Adverse Event|0
1057001|NCT01903252|2101717|FG005|Double-Blind Induction|Adverse Event|0
1057002|NCT01903252|2101712|FG000|Double-Blind Induction|Withdrawal by Subject|10
1057003|NCT01903252|2101713|FG001|Double-Blind Induction|Withdrawal by Subject|13
1057004|NCT01903252|2101714|FG002|Double-Blind Induction|Withdrawal by Subject|0
1057005|NCT01903252|2101715|FG003|Double-Blind Induction|Withdrawal by Subject|0
1057006|NCT01903252|2101716|FG004|Double-Blind Induction|Withdrawal by Subject|0
1162037|NCT03381196|2283976|FG000|Overall Study|Adverse Event|1
1057007|NCT01903252|2101717|FG005|Double-Blind Induction|Withdrawal by Subject|0
1057008|NCT01903252|2101712|FG000|Double-Blind Induction|Physician Decision|2
1057009|NCT01903252|2101713|FG001|Double-Blind Induction|Physician Decision|3
1057010|NCT01903252|2101714|FG002|Double-Blind Induction|Physician Decision|0
1057011|NCT01903252|2101715|FG003|Double-Blind Induction|Physician Decision|0
1057012|NCT01903252|2101716|FG004|Double-Blind Induction|Physician Decision|0
1057013|NCT01903252|2101717|FG005|Double-Blind Induction|Physician Decision|0
1057014|NCT01903252|2101712|FG000|Double-Blind Induction|non-compliance,|7
1057015|NCT01903252|2101713|FG001|Double-Blind Induction|non-compliance,|7
1057016|NCT01903252|2101714|FG002|Double-Blind Induction|non-compliance,|0
1057017|NCT01903252|2101715|FG003|Double-Blind Induction|non-compliance,|0
1057018|NCT01903252|2101716|FG004|Double-Blind Induction|non-compliance,|0
1057019|NCT01903252|2101717|FG005|Double-Blind Induction|non-compliance,|0
1057020|NCT01903252|2101712|FG000|Extended Induction, Open-Label|Adverse Event|0
1057021|NCT01903252|2101713|FG001|Extended Induction, Open-Label|Adverse Event|0
1057022|NCT01903252|2101714|FG002|Extended Induction, Open-Label|Adverse Event|17
1057023|NCT01903252|2101715|FG003|Extended Induction, Open-Label|Adverse Event|0
1057024|NCT01903252|2101716|FG004|Extended Induction, Open-Label|Adverse Event|0
1057025|NCT01903252|2101717|FG005|Extended Induction, Open-Label|Adverse Event|0
1057026|NCT01903252|2101712|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0
1057027|NCT01903252|2101713|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0
1057028|NCT01903252|2101714|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5
1057029|NCT01903252|2101715|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0
1057030|NCT01903252|2101716|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0
1057031|NCT01903252|2101717|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0
1057032|NCT01903252|2101712|FG000|Extended Induction, Open-Label|Physician Decision|0
1057033|NCT01903252|2101713|FG001|Extended Induction, Open-Label|Physician Decision|0
1057034|NCT01903252|2101714|FG002|Extended Induction, Open-Label|Physician Decision|1
1057035|NCT01903252|2101715|FG003|Extended Induction, Open-Label|Physician Decision|0
1057036|NCT01903252|2101716|FG004|Extended Induction, Open-Label|Physician Decision|0
1057037|NCT01903252|2101717|FG005|Extended Induction, Open-Label|Physician Decision|0
1057038|NCT01903252|2101712|FG000|Maintenance, Open-Label|Adverse Event|0
1057039|NCT01903252|2101713|FG001|Maintenance, Open-Label|Adverse Event|0
1057040|NCT01903252|2101714|FG002|Maintenance, Open-Label|Adverse Event|0
1057041|NCT01903252|2101715|FG003|Maintenance, Open-Label|Adverse Event|3
1057042|NCT01903252|2101716|FG004|Maintenance, Open-Label|Adverse Event|9
1057043|NCT01903252|2101717|FG005|Maintenance, Open-Label|Adverse Event|14
1057044|NCT01903252|2101712|FG000|Maintenance, Open-Label|Withdrawal by Subject|0
1057045|NCT01903252|2101713|FG001|Maintenance, Open-Label|Withdrawal by Subject|0
1057046|NCT01903252|2101714|FG002|Maintenance, Open-Label|Withdrawal by Subject|0
1057047|NCT01903252|2101715|FG003|Maintenance, Open-Label|Withdrawal by Subject|1
1057048|NCT01903252|2101716|FG004|Maintenance, Open-Label|Withdrawal by Subject|6
1057049|NCT01903252|2101717|FG005|Maintenance, Open-Label|Withdrawal by Subject|2
1057050|NCT01903252|2101712|FG000|Maintenance, Open-Label|Other|0
1057051|NCT01903252|2101713|FG001|Maintenance, Open-Label|Other|0
1057052|NCT01903252|2101714|FG002|Maintenance, Open-Label|Other|0
1057053|NCT01903252|2101715|FG003|Maintenance, Open-Label|Other|2
1057054|NCT01903252|2101716|FG004|Maintenance, Open-Label|Other|6
1057055|NCT01903252|2101717|FG005|Maintenance, Open-Label|Other|2
1057056|NCT01903356|2101744|FG000|Overall Study|Lost to Follow-up|7
1057057|NCT01903356|2101744|FG000|Overall Study|Violated inclusion/exclusion criteria|5
1057058|NCT01903356|2101744|FG000|Overall Study|Violated the dosage and administration|3
1057059|NCT01903434|2101748|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1
1057060|NCT01903434|2101749|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0
1057061|NCT01903434|2101748|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
1057062|NCT01903434|2101749|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
1057063|NCT01903460|2101759|FG000|Overall Study|Adverse Event|0
1057064|NCT01903460|2101760|FG001|Overall Study|Adverse Event|0
1057065|NCT01903460|2101761|FG002|Overall Study|Adverse Event|0
1057066|NCT01903460|2101762|FG003|Overall Study|Adverse Event|1
1057067|NCT01903525|2101773|FG000|Overall Study|Lost to Follow-up|5
1057068|NCT01903525|2101774|FG001|Overall Study|Lost to Follow-up|9
1057069|NCT01903525|2101773|FG000|Overall Study|Adverse Event|0
1057070|NCT01903525|2101774|FG001|Overall Study|Adverse Event|1
1057071|NCT01903720|2101789|FG000|Overall Study|Inclusion / exclusion criteria not met|6
1057072|NCT01903720|2101789|FG000|Overall Study|Adverse Event|1
1057073|NCT01903720|2101789|FG000|Overall Study|Rescinding of informed consent|2
1057074|NCT01903720|2101789|FG000|Overall Study|Lost to Follow-up|2
1057075|NCT01903720|2101789|FG000|Overall Study|Treatment with alternative drug|1
1057076|NCT01903733|2101797|FG000|Overall Study|Death|23
1057077|NCT01903733|2101798|FG001|Overall Study|Death|54
1057078|NCT01903733|2101799|FG002|Overall Study|Death|30
1057079|NCT01903733|2101800|FG003|Overall Study|Death|98
1057080|NCT01903733|2101797|FG000|Overall Study|Participant refused further follow-up|35
1057081|NCT01903733|2101798|FG001|Overall Study|Participant refused further follow-up|38
1057082|NCT01903733|2101799|FG002|Overall Study|Participant refused further follow-up|13
1057083|NCT01903733|2101800|FG003|Overall Study|Participant refused further follow-up|9
1057084|NCT01903733|2101797|FG000|Overall Study|Lost to Follow-up|18
1057085|NCT01903733|2101798|FG001|Overall Study|Lost to Follow-up|19
1057086|NCT01903733|2101799|FG002|Overall Study|Lost to Follow-up|6
1057087|NCT01903733|2101800|FG003|Overall Study|Lost to Follow-up|9
1057088|NCT01903733|2101797|FG000|Overall Study|Other|10
1057089|NCT01903733|2101798|FG001|Overall Study|Other|15
1057090|NCT01903733|2101799|FG002|Overall Study|Other|12
1057091|NCT01903733|2101800|FG003|Overall Study|Other|3
1057092|NCT01903733|2101797|FG000|Overall Study|Missing|2
1057093|NCT01903733|2101798|FG001|Overall Study|Missing|0
1057094|NCT01903733|2101799|FG002|Overall Study|Missing|0
1057095|NCT01903733|2101800|FG003|Overall Study|Missing|0
1057096|NCT01903733|2101797|FG000|Overall Study|Investigator request|18
1057097|NCT01903733|2101798|FG001|Overall Study|Investigator request|0
1057098|NCT01903733|2101799|FG002|Overall Study|Investigator request|0
1057099|NCT01903733|2101800|FG003|Overall Study|Investigator request|0
1057100|NCT01903811|2101839|FG000|Overall Study|No measurable disease|1
1057101|NCT01903811|2101840|FG001|Overall Study|No measurable disease|1
1057102|NCT01903811|2101839|FG000|Overall Study|Incomplete/discontinued prior therapy|1
1057103|NCT01903811|2101840|FG001|Overall Study|Incomplete/discontinued prior therapy|1
1057104|NCT01903811|2101839|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6
1057105|NCT01903811|2101840|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11
1057106|NCT01903811|2101839|FG000|Overall Study|Withdrawal by Subject|0
1057107|NCT01903811|2101840|FG001|Overall Study|Withdrawal by Subject|1
1057108|NCT01903837|2101853|FG000|Part A|Withdrawal by Subject|4
1057109|NCT01903837|2101854|FG001|Part A|Withdrawal by Subject|9
1057110|NCT01903837|2101855|FG002|Part A|Withdrawal by Subject|8
1057111|NCT01903837|2101856|FG003|Part A|Withdrawal by Subject|5
908176|NCT00779766|1884536|FG001|Month 72|Other|1
908177|NCT00779779|1884543|FG000|Overall Study|Adverse Event|1
908178|NCT00779779|1884543|FG000|Overall Study|Protocol Violation|14
908179|NCT00779779|1884543|FG000|Overall Study|Withdrawal by Subject|4
908180|NCT00779779|1884543|FG000|Overall Study|Lost to Follow-up|5
908181|NCT00779857|1884547|FG000|Overall Study|Death|1
1057112|NCT01903837|2101853|FG000|Part A|Adverse Event|3
1057113|NCT01903837|2101854|FG001|Part A|Adverse Event|6
1057114|NCT01903837|2101855|FG002|Part A|Adverse Event|9
1057115|NCT01903837|2101856|FG003|Part A|Adverse Event|6
1057116|NCT01903837|2101853|FG000|Part A|Lost to Follow-up|9
1057117|NCT01903837|2101854|FG001|Part A|Lost to Follow-up|7
1057118|NCT01903837|2101855|FG002|Part A|Lost to Follow-up|7
1057119|NCT01903837|2101856|FG003|Part A|Lost to Follow-up|2
1057120|NCT01903837|2101853|FG000|Part A|Non-compliance with study drug|1
1057121|NCT01903837|2101854|FG001|Part A|Non-compliance with study drug|4
1057122|NCT01903837|2101855|FG002|Part A|Non-compliance with study drug|4
1057123|NCT01903837|2101856|FG003|Part A|Non-compliance with study drug|0
1057124|NCT01903837|2101853|FG000|Part A|Physician Decision|1
1057125|NCT01903837|2101854|FG001|Part A|Physician Decision|1
1057126|NCT01903837|2101855|FG002|Part A|Physician Decision|0
1057127|NCT01903837|2101856|FG003|Part A|Physician Decision|0
1057128|NCT01903837|2101853|FG000|Part A|Protocol Violation|1
1057129|NCT01903837|2101854|FG001|Part A|Protocol Violation|1
1057130|NCT01903837|2101855|FG002|Part A|Protocol Violation|0
1057131|NCT01903837|2101856|FG003|Part A|Protocol Violation|0
1057132|NCT01903837|2101853|FG000|Part B|Lost to Follow-up|0
1057133|NCT01903837|2101854|FG001|Part B|Lost to Follow-up|3
1057134|NCT01903837|2101855|FG002|Part B|Lost to Follow-up|3
1057135|NCT01903837|2101856|FG003|Part B|Lost to Follow-up|4
1057136|NCT01903837|2101853|FG000|Part B|Withdrawal by Subject|1
1057137|NCT01903837|2101854|FG001|Part B|Withdrawal by Subject|2
1057138|NCT01903837|2101855|FG002|Part B|Withdrawal by Subject|0
1057139|NCT01903837|2101856|FG003|Part B|Withdrawal by Subject|3
1057140|NCT01903837|2101853|FG000|Part B|Adverse Event|3
1057141|NCT01903837|2101854|FG001|Part B|Adverse Event|0
1057142|NCT01903837|2101855|FG002|Part B|Adverse Event|2
1057143|NCT01903837|2101856|FG003|Part B|Adverse Event|0
1057144|NCT01903837|2101853|FG000|Part B|Non-compliance with study drug|2
1057145|NCT01903837|2101854|FG001|Part B|Non-compliance with study drug|0
1057146|NCT01903837|2101855|FG002|Part B|Non-compliance with study drug|0
1057147|NCT01903837|2101856|FG003|Part B|Non-compliance with study drug|1
1057148|NCT01903837|2101853|FG000|Part B|Incarceration|2
1057149|NCT01903837|2101854|FG001|Part B|Incarceration|0
1057150|NCT01903837|2101855|FG002|Part B|Incarceration|0
1057151|NCT01903837|2101856|FG003|Part B|Incarceration|1
1057152|NCT01903837|2101853|FG000|Part B|Physician Decision|1
1057153|NCT01903837|2101854|FG001|Part B|Physician Decision|0
1057154|NCT01903837|2101855|FG002|Part B|Physician Decision|0
1057155|NCT01903837|2101856|FG003|Part B|Physician Decision|2
1057156|NCT01903837|2101853|FG000|Part B|Lack of Efficacy|0
1057157|NCT01903837|2101854|FG001|Part B|Lack of Efficacy|1
1057158|NCT01903837|2101855|FG002|Part B|Lack of Efficacy|0
1057159|NCT01903837|2101856|FG003|Part B|Lack of Efficacy|0
1057160|NCT01903863|2101889|FG000|Overall Study|Physician Decision|2
1057161|NCT01903863|2101890|FG001|Overall Study|Physician Decision|0
1057162|NCT01903876|2101898|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184
1057163|NCT01903876|2101899|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108
1057164|NCT01903876|2101898|FG000|Six-Month Follow-up Period|Lost to Follow-up|91
1057165|NCT01903876|2101899|FG001|Six-Month Follow-up Period|Lost to Follow-up|145
1057166|NCT01903993|2101907|FG000|Overall Study|Death|118
1057167|NCT01903993|2101908|FG001|Overall Study|Death|121
1057168|NCT01903993|2101907|FG000|Overall Study|Withdrawal by Subject|15
1057169|NCT01903993|2101908|FG001|Overall Study|Withdrawal by Subject|4
1057170|NCT01903993|2101907|FG000|Overall Study|Lost to Follow-up|2
1057171|NCT01903993|2101908|FG001|Overall Study|Lost to Follow-up|3
1057172|NCT01903993|2101907|FG000|Overall Study|Study Terminated by Sponsor|8
1057173|NCT01903993|2101908|FG001|Overall Study|Study Terminated by Sponsor|14
1057174|NCT01903993|2101907|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
1057175|NCT01903993|2101908|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
1057176|NCT01904019|2101915|FG000|1 Year Follow-up|Withdrawal by Subject|4
1057177|NCT01904019|2101915|FG000|1 Year Follow-up|Impossibility to contact patient|5
1057178|NCT01904019|2101915|FG000|3 Year Follow-up|Withdrawal by Subject|1
1057179|NCT01904019|2101915|FG000|3 Year Follow-up|Impossibility to contact patient|14
1057180|NCT01904019|2101915|FG000|5 Year Follow-up|Withdrawal by Subject|2
1057181|NCT01904019|2101915|FG000|5 Year Follow-up|Impossibility to contact patient|4
1057182|NCT01904058|2101923|FG000|Overall Study|Adverse Event|2
1057183|NCT01904058|2101924|FG001|Overall Study|Adverse Event|0
1057184|NCT01904058|2101925|FG002|Overall Study|Adverse Event|0
1057185|NCT01904058|2101926|FG003|Overall Study|Adverse Event|0
1057186|NCT01904058|2101923|FG000|Overall Study|Withdrawal by Subject|1
1057187|NCT01904058|2101924|FG001|Overall Study|Withdrawal by Subject|0
1057188|NCT01904058|2101925|FG002|Overall Study|Withdrawal by Subject|1
1057189|NCT01904058|2101926|FG003|Overall Study|Withdrawal by Subject|0
1057190|NCT01904058|2101923|FG000|Overall Study|Pregnancy|0
1057191|NCT01904058|2101924|FG001|Overall Study|Pregnancy|0
1057192|NCT01904058|2101925|FG002|Overall Study|Pregnancy|0
1057193|NCT01904058|2101926|FG003|Overall Study|Pregnancy|1
1057194|NCT01904149|2101961|FG000|Overall Study|Adverse Event|3
1057195|NCT01904149|2101962|FG001|Overall Study|Adverse Event|4
1057196|NCT01904149|2101963|FG002|Overall Study|Adverse Event|0
1057197|NCT01904149|2101964|FG003|Overall Study|Adverse Event|1
1057198|NCT01904149|2101965|FG004|Overall Study|Adverse Event|1
1057199|NCT01904149|2101966|FG005|Overall Study|Adverse Event|2
1057200|NCT01904149|2101961|FG000|Overall Study|Lack of Efficacy|0
1057201|NCT01904149|2101962|FG001|Overall Study|Lack of Efficacy|3
1057202|NCT01904149|2101963|FG002|Overall Study|Lack of Efficacy|1
1057203|NCT01904149|2101964|FG003|Overall Study|Lack of Efficacy|3
1057204|NCT01904149|2101965|FG004|Overall Study|Lack of Efficacy|3
1057205|NCT01904149|2101966|FG005|Overall Study|Lack of Efficacy|1
1057206|NCT01904149|2101961|FG000|Overall Study|Withdrawal by Subject|1
1057207|NCT01904149|2101962|FG001|Overall Study|Withdrawal by Subject|3
1057208|NCT01904149|2101963|FG002|Overall Study|Withdrawal by Subject|1
1057209|NCT01904149|2101964|FG003|Overall Study|Withdrawal by Subject|0
1057210|NCT01904149|2101965|FG004|Overall Study|Withdrawal by Subject|1
1057211|NCT01904149|2101966|FG005|Overall Study|Withdrawal by Subject|0
1057212|NCT01904149|2101961|FG000|Overall Study|Protocol Violation|0
1057213|NCT01904149|2101962|FG001|Overall Study|Protocol Violation|1
1057214|NCT01904149|2101963|FG002|Overall Study|Protocol Violation|0
1057215|NCT01904149|2101964|FG003|Overall Study|Protocol Violation|0
1057216|NCT01904149|2101965|FG004|Overall Study|Protocol Violation|0
1057217|NCT01904149|2101966|FG005|Overall Study|Protocol Violation|0
1057218|NCT01904149|2101961|FG000|Overall Study|non compliance with study drug|1
1057219|NCT01904149|2101962|FG001|Overall Study|non compliance with study drug|0
1057220|NCT01904149|2101963|FG002|Overall Study|non compliance with study drug|0
1057221|NCT01904149|2101964|FG003|Overall Study|non compliance with study drug|0
1057222|NCT01904149|2101965|FG004|Overall Study|non compliance with study drug|0
1057223|NCT01904149|2101966|FG005|Overall Study|non compliance with study drug|0
1057224|NCT01904383|2101992|FG000|Overall Study|CRF not collected|117
1057225|NCT01904383|2101992|FG000|Overall Study|Reason not listed|147
1057226|NCT01904383|2101992|FG000|Overall Study|Lost to Follow-up|674
1057227|NCT01904383|2101992|FG000|Overall Study|Lack of Efficacy|370
1057228|NCT01904383|2101992|FG000|Overall Study|Improvement|141
1057229|NCT01904383|2101992|FG000|Overall Study|Adverse Event|271
1057230|NCT01904383|2101992|FG000|Overall Study|No patient visit after entry|54
1057231|NCT01904604|2102012|FG000|Overall Study|Withdrew before receiving dosing|0
1057232|NCT01904604|2102013|FG001|Overall Study|Withdrew before receiving dosing|1
1057233|NCT01904604|2102014|FG002|Overall Study|Withdrew before receiving dosing|0
1057234|NCT01904604|2102012|FG000|Overall Study|Non-compliance|1
1057235|NCT01904604|2102013|FG001|Overall Study|Non-compliance|0
1057236|NCT01904604|2102014|FG002|Overall Study|Non-compliance|0
1057237|NCT01904604|2102012|FG000|Overall Study|Anxiety about OFC/Refused OFC|2
1057238|NCT01904604|2102013|FG001|Overall Study|Anxiety about OFC/Refused OFC|0
1057239|NCT01904604|2102014|FG002|Overall Study|Anxiety about OFC/Refused OFC|0
1057240|NCT01904604|2102012|FG000|Overall Study|Patch site reactions|1
1057241|NCT01904604|2102013|FG001|Overall Study|Patch site reactions|1
1057242|NCT01904604|2102014|FG002|Overall Study|Patch site reactions|0
1057243|NCT01904604|2102012|FG000|Overall Study|Increased syncope|0
1057244|NCT01904604|2102013|FG001|Overall Study|Increased syncope|1
1057245|NCT01904604|2102014|FG002|Overall Study|Increased syncope|0
1057246|NCT01904604|2102012|FG000|Overall Study|Unrelated illness|0
1057247|NCT01904604|2102013|FG001|Overall Study|Unrelated illness|1
1057248|NCT01904604|2102014|FG002|Overall Study|Unrelated illness|0
1057249|NCT01904604|2102012|FG000|Overall Study|Passed Week 52 OFC|1
1057250|NCT01904604|2102013|FG001|Overall Study|Passed Week 52 OFC|0
1057251|NCT01904604|2102014|FG002|Overall Study|Passed Week 52 OFC|0
1057252|NCT01904604|2102012|FG000|Overall Study|Withdrawal by Subject|1
1057253|NCT01904604|2102013|FG001|Overall Study|Withdrawal by Subject|2
1057254|NCT01904604|2102014|FG002|Overall Study|Withdrawal by Subject|0
1057255|NCT01904604|2102012|FG000|Overall Study|Participant Relocated|1
1057256|NCT01904604|2102013|FG001|Overall Study|Participant Relocated|1
1057257|NCT01904604|2102014|FG002|Overall Study|Participant Relocated|1
1057258|NCT01904604|2102012|FG000|Overall Study|Lost to Follow-up|0
1057259|NCT01904604|2102013|FG001|Overall Study|Lost to Follow-up|0
1057260|NCT01904604|2102014|FG002|Overall Study|Lost to Follow-up|1
1057261|NCT01904721|2102032|FG000|Overall Study|Other Reasons|0
1057262|NCT01904721|2102033|FG001|Overall Study|Other Reasons|0
1057263|NCT01904721|2102034|FG002|Overall Study|Other Reasons|1
1057264|NCT01904721|2102035|FG003|Overall Study|Other Reasons|1
1057265|NCT01904721|2102036|FG004|Overall Study|Other Reasons|2
1057266|NCT01904721|2102037|FG005|Overall Study|Other Reasons|2
1057267|NCT01904721|2102038|FG006|Overall Study|Other Reasons|2
1057268|NCT01904721|2102032|FG000|Overall Study|Personal Reasons|0
1057269|NCT01904721|2102033|FG001|Overall Study|Personal Reasons|0
1057270|NCT01904721|2102034|FG002|Overall Study|Personal Reasons|0
1057271|NCT01904721|2102035|FG003|Overall Study|Personal Reasons|0
1057272|NCT01904721|2102036|FG004|Overall Study|Personal Reasons|2
1057273|NCT01904721|2102037|FG005|Overall Study|Personal Reasons|3
1057274|NCT01904721|2102038|FG006|Overall Study|Personal Reasons|3
1057275|NCT01904721|2102032|FG000|Overall Study|Lost to Follow-up|0
1057276|NCT01904721|2102033|FG001|Overall Study|Lost to Follow-up|0
1057277|NCT01904721|2102034|FG002|Overall Study|Lost to Follow-up|0
1057278|NCT01904721|2102035|FG003|Overall Study|Lost to Follow-up|0
1057279|NCT01904721|2102036|FG004|Overall Study|Lost to Follow-up|1
1057280|NCT01904721|2102037|FG005|Overall Study|Lost to Follow-up|3
1057281|NCT01904721|2102038|FG006|Overall Study|Lost to Follow-up|1
1057282|NCT01904721|2102032|FG000|Overall Study|Lack of Efficacy|0
1057283|NCT01904721|2102033|FG001|Overall Study|Lack of Efficacy|0
1057284|NCT01904721|2102034|FG002|Overall Study|Lack of Efficacy|0
1057285|NCT01904721|2102035|FG003|Overall Study|Lack of Efficacy|0
1057286|NCT01904721|2102036|FG004|Overall Study|Lack of Efficacy|0
1057287|NCT01904721|2102037|FG005|Overall Study|Lack of Efficacy|0
1057288|NCT01904721|2102038|FG006|Overall Study|Lack of Efficacy|1
1057289|NCT01904721|2102032|FG000|Overall Study|Adverse Event|0
1057290|NCT01904721|2102033|FG001|Overall Study|Adverse Event|0
1057291|NCT01904721|2102034|FG002|Overall Study|Adverse Event|0
1057292|NCT01904721|2102035|FG003|Overall Study|Adverse Event|0
1057293|NCT01904721|2102036|FG004|Overall Study|Adverse Event|3
1057294|NCT01904721|2102037|FG005|Overall Study|Adverse Event|1
1057295|NCT01904721|2102038|FG006|Overall Study|Adverse Event|0
1057296|NCT01904760|2102052|FG000|Overall Study|Protocol Violation|1
1057297|NCT01904760|2102053|FG001|Overall Study|Protocol Violation|0
1057298|NCT01904773|2102059|FG000|Screen|Screen failure|3
1057299|NCT01904773|2102060|FG001|Screen|Screen failure|0
1057300|NCT01904773|2102061|FG002|Screen|Screen failure|0
1057301|NCT01904773|2102062|FG003|Screen|Screen failure|0
1057302|NCT01904773|2102063|FG004|Screen|Screen failure|0
1057303|NCT01904773|2102064|FG005|Screen|Screen failure|0
1057304|NCT01904773|2102065|FG006|Screen|Screen failure|0
1057305|NCT01904773|2102066|FG007|Screen|Screen failure|0
1057306|NCT01904773|2102067|FG008|Screen|Screen failure|0
1057307|NCT01904773|2102059|FG000|Screen|Withdrawal by Subject|1
1057308|NCT01904773|2102060|FG001|Screen|Withdrawal by Subject|0
1057309|NCT01904773|2102061|FG002|Screen|Withdrawal by Subject|0
1057310|NCT01904773|2102062|FG003|Screen|Withdrawal by Subject|0
1057311|NCT01904773|2102063|FG004|Screen|Withdrawal by Subject|0
1057312|NCT01904773|2102064|FG005|Screen|Withdrawal by Subject|0
1057313|NCT01904773|2102065|FG006|Screen|Withdrawal by Subject|0
1057314|NCT01904773|2102066|FG007|Screen|Withdrawal by Subject|0
1057315|NCT01904773|2102067|FG008|Screen|Withdrawal by Subject|0
1057316|NCT01904773|2102059|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
1057317|NCT01904773|2102060|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1057318|NCT01904773|2102061|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1057319|NCT01904773|2102062|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1057320|NCT01904773|2102063|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1057321|NCT01904773|2102064|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1057322|NCT01904773|2102065|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1057323|NCT01904773|2102066|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1057324|NCT01904773|2102067|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1057325|NCT01904773|2102059|FG000|First Intervention|Adverse Event|0
1057326|NCT01904773|2102060|FG001|First Intervention|Adverse Event|0
1057327|NCT01904773|2102061|FG002|First Intervention|Adverse Event|0
1057328|NCT01904773|2102062|FG003|First Intervention|Adverse Event|0
1057329|NCT01904773|2102063|FG004|First Intervention|Adverse Event|0
1057330|NCT01904773|2102064|FG005|First Intervention|Adverse Event|0
1057331|NCT01904773|2102065|FG006|First Intervention|Adverse Event|1
1057332|NCT01904773|2102066|FG007|First Intervention|Adverse Event|0
1057333|NCT01904773|2102067|FG008|First Intervention|Adverse Event|0
1057334|NCT01904773|2102059|FG000|Placebo Washout First Intervention|Condition worsened|0
1057335|NCT01904773|2102060|FG001|Placebo Washout First Intervention|Condition worsened|1
1057336|NCT01904773|2102061|FG002|Placebo Washout First Intervention|Condition worsened|0
1057337|NCT01904773|2102062|FG003|Placebo Washout First Intervention|Condition worsened|0
1057338|NCT01904773|2102063|FG004|Placebo Washout First Intervention|Condition worsened|0
1057339|NCT01904773|2102064|FG005|Placebo Washout First Intervention|Condition worsened|0
1057340|NCT01904773|2102065|FG006|Placebo Washout First Intervention|Condition worsened|0
1057341|NCT01904773|2102066|FG007|Placebo Washout First Intervention|Condition worsened|0
1057342|NCT01904773|2102067|FG008|Placebo Washout First Intervention|Condition worsened|0
1057343|NCT01904773|2102059|FG000|Fifth Intervention|Adverse Event|0
1057344|NCT01904773|2102060|FG001|Fifth Intervention|Adverse Event|0
1057345|NCT01904773|2102061|FG002|Fifth Intervention|Adverse Event|0
1057346|NCT01904773|2102062|FG003|Fifth Intervention|Adverse Event|0
1057347|NCT01904773|2102063|FG004|Fifth Intervention|Adverse Event|0
1057348|NCT01904773|2102064|FG005|Fifth Intervention|Adverse Event|0
1057349|NCT01904773|2102065|FG006|Fifth Intervention|Adverse Event|0
1057350|NCT01904773|2102066|FG007|Fifth Intervention|Adverse Event|1
1057351|NCT01904773|2102067|FG008|Fifth Intervention|Adverse Event|0
1057352|NCT01904773|2102059|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1057353|NCT01904773|2102060|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
1057354|NCT01904773|2102061|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1057355|NCT01904773|2102062|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1057356|NCT01904773|2102063|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1057357|NCT01904773|2102064|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1057358|NCT01904773|2102065|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1057359|NCT01904773|2102066|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1057360|NCT01904773|2102067|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1057361|NCT01904903|2102088|FG000|Overall Study|Withdrawal by Subject|1
1057362|NCT01905267|2102102|FG000|Overall Study|Physician Decision|2
1057363|NCT01905267|2102103|FG001|Overall Study|Physician Decision|2
1057364|NCT01905540|2102134|FG000|Period 3|Other|1
1057365|NCT01905540|2102135|FG001|Period 3|Other|0
1057366|NCT01905540|2102136|FG002|Period 3|Other|1
1057367|NCT01905540|2102137|FG003|Period 3|Other|1
1057368|NCT01905553|2102149|FG000|Period 2|Adverse Event|1
1057369|NCT01905553|2102150|FG001|Period 2|Adverse Event|0
1057370|NCT01905592|2102158|FG000|Overall Study|Disease Progression|51
1057371|NCT01905592|2102159|FG001|Overall Study|Disease Progression|104
1057372|NCT01905592|2102158|FG000|Overall Study|Toxicity|1
1057373|NCT01905592|2102159|FG001|Overall Study|Toxicity|16
1057374|NCT01905592|2102158|FG000|Overall Study|Physician Decision|0
1057375|NCT01905592|2102159|FG001|Overall Study|Physician Decision|2
1057376|NCT01905592|2102158|FG000|Overall Study|New anti-cancer|1
1057377|NCT01905592|2102159|FG001|Overall Study|New anti-cancer|0
1057378|NCT01905592|2102158|FG000|Overall Study|Protocol Violation|0
1057379|NCT01905592|2102159|FG001|Overall Study|Protocol Violation|1
1057380|NCT01905592|2102158|FG000|Overall Study|Sponsor's decision|1
1057381|NCT01905592|2102159|FG001|Overall Study|Sponsor's decision|0
1057382|NCT01905592|2102158|FG000|Overall Study|Not treated|7
1057383|NCT01905592|2102159|FG001|Overall Study|Not treated|3
1057384|NCT01905592|2102158|FG000|Overall Study|Ongoing in Study|0
1057385|NCT01905592|2102159|FG001|Overall Study|Ongoing in Study|7
1057386|NCT01905592|2102158|FG000|Overall Study|Withdrawal by Subject|10
1057387|NCT01905592|2102159|FG001|Overall Study|Withdrawal by Subject|2
1057388|NCT01905657|2102168|FG000|Overall Study|Adverse Event|23
1057389|NCT01905657|2102169|FG001|Overall Study|Adverse Event|17
1057390|NCT01905657|2102170|FG002|Overall Study|Adverse Event|18
1057391|NCT01905657|2102168|FG000|Overall Study|Clinical Progression|103
1057392|NCT01905657|2102169|FG001|Overall Study|Clinical Progression|78
1057393|NCT01905657|2102170|FG002|Overall Study|Clinical Progression|59
1057394|NCT01905657|2102168|FG000|Overall Study|Death|40
1057395|NCT01905657|2102169|FG001|Overall Study|Death|43
1057396|NCT01905657|2102170|FG002|Overall Study|Death|47
1057397|NCT01905657|2102168|FG000|Overall Study|Excluded Medication|13
1057398|NCT01905657|2102169|FG001|Overall Study|Excluded Medication|16
1057399|NCT01905657|2102170|FG002|Overall Study|Excluded Medication|9
1057400|NCT01905657|2102168|FG000|Overall Study|Lost to Follow-up|1
1057401|NCT01905657|2102169|FG001|Overall Study|Lost to Follow-up|2
1057402|NCT01905657|2102170|FG002|Overall Study|Lost to Follow-up|1
1057403|NCT01905657|2102168|FG000|Overall Study|Physician Decision|5
1057404|NCT01905657|2102169|FG001|Overall Study|Physician Decision|8
1057405|NCT01905657|2102170|FG002|Overall Study|Physician Decision|12
1057406|NCT01905657|2102168|FG000|Overall Study|Protocol Violation|2
1057407|NCT01905657|2102169|FG001|Overall Study|Protocol Violation|1
1057408|NCT01905657|2102170|FG002|Overall Study|Protocol Violation|1
1057409|NCT01905657|2102168|FG000|Overall Study|Screen Failure|0
1057410|NCT01905657|2102169|FG001|Overall Study|Screen Failure|1
1057411|NCT01905657|2102170|FG002|Overall Study|Screen Failure|0
1057412|NCT01905657|2102168|FG000|Overall Study|Withdrawal by Subject|15
1057413|NCT01905657|2102169|FG001|Overall Study|Withdrawal by Subject|21
1057414|NCT01905657|2102170|FG002|Overall Study|Withdrawal by Subject|53
1057415|NCT01905657|2102168|FG000|Overall Study|Sponsor Decision|1
1057416|NCT01905657|2102169|FG001|Overall Study|Sponsor Decision|0
1057417|NCT01905657|2102170|FG002|Overall Study|Sponsor Decision|0
1057418|NCT01905683|2102181|FG000|Overall Study|Protocol Violation|1
1057419|NCT01905683|2102181|FG000|Overall Study|Re-injection criteria not met; others|13
1057420|NCT01905683|2102181|FG000|Overall Study|Physician Decision|1
1057421|NCT01905683|2102181|FG000|Overall Study|Lack of Efficacy|8
1057422|NCT01905683|2102181|FG000|Overall Study|Withdrawal by Subject|20
1057423|NCT01905683|2102181|FG000|Overall Study|Adverse Event|4
1057424|NCT01905683|2102181|FG000|Overall Study|Lost to Follow-up|4
1057425|NCT01905943|2102185|FG000|Overall Study|Withdrawal of consent|90
1057426|NCT01905943|2102185|FG000|Overall Study|Lost to Follow-up|16
1057427|NCT01905943|2102185|FG000|Overall Study|Investigator discretion|7
1057428|NCT01905943|2102185|FG000|Overall Study|Death|186
1057429|NCT01905943|2102185|FG000|Overall Study|Adverse Event|3
1057430|NCT01905943|2102185|FG000|Overall Study|Other|12
1057431|NCT01906008|2102215|FG000|Overall Study|Lost to Follow-up|2
1057432|NCT01906008|2102216|FG001|Overall Study|Lost to Follow-up|0
1057433|NCT01906008|2102215|FG000|Overall Study|Oxaliplatin toxicity|2
1057434|NCT01906008|2102216|FG001|Overall Study|Oxaliplatin toxicity|0
1057435|NCT01906008|2102215|FG000|Overall Study|Protocol Violation|0
1057436|NCT01906008|2102216|FG001|Overall Study|Protocol Violation|1
1057437|NCT01906008|2102215|FG000|Overall Study|Withdrawal by Subject|1
1057438|NCT01906008|2102216|FG001|Overall Study|Withdrawal by Subject|5
1057439|NCT01906008|2102215|FG000|Overall Study|Did not start study med|3
1057440|NCT01906008|2102216|FG001|Overall Study|Did not start study med|4
1057441|NCT01906008|2102215|FG000|Overall Study|Oxaliplatin stops|10
1057442|NCT01906008|2102216|FG001|Overall Study|Oxaliplatin stops|8
1057443|NCT01906008|2102215|FG000|Overall Study|Hospice|1
1057444|NCT01906008|2102216|FG001|Overall Study|Hospice|0
1057445|NCT01906008|2102215|FG000|Overall Study|Physician Decision|3
1057446|NCT01906008|2102216|FG001|Overall Study|Physician Decision|3
1057447|NCT01906008|2102215|FG000|Overall Study|Lack of compliance of study med|5
1057448|NCT01906008|2102216|FG001|Overall Study|Lack of compliance of study med|3
1057449|NCT01906008|2102215|FG000|Overall Study|Adverse Event|0
1057450|NCT01906008|2102216|FG001|Overall Study|Adverse Event|3
1057451|NCT01906346|2102222|FG000|Overall Study|AEs|1
1057452|NCT01906372|2102228|FG000|Overall Study|Withdrawal by Subject|2
1057453|NCT01906476|2102235|FG000|Overall Study|Lost to Follow-up|17
1057454|NCT01906476|2102236|FG001|Overall Study|Lost to Follow-up|16
1057455|NCT01907087|2102281|FG000|Overall Study|Withdrawal by Subject|1
1057456|NCT01907100|2102289|FG000|Overall Study|PD based on modified RECIST criteria|31
1057457|NCT01907100|2102290|FG001|Overall Study|PD based on modified RECIST criteria|32
1057458|NCT01907100|2102291|FG002|Overall Study|PD based on modified RECIST criteria|95
1057459|NCT01907100|2102292|FG003|Overall Study|PD based on modified RECIST criteria|92
1057460|NCT01907100|2102289|FG000|Overall Study|Withdrawal by Subject|2
1057461|NCT01907100|2102290|FG001|Overall Study|Withdrawal by Subject|5
1057462|NCT01907100|2102291|FG002|Overall Study|Withdrawal by Subject|10
1057463|NCT01907100|2102292|FG003|Overall Study|Withdrawal by Subject|13
1057464|NCT01907100|2102289|FG000|Overall Study|Protocol Violation|0
1057465|NCT01907100|2102290|FG001|Overall Study|Protocol Violation|0
1057466|NCT01907100|2102291|FG002|Overall Study|Protocol Violation|1
1057467|NCT01907100|2102292|FG003|Overall Study|Protocol Violation|1
1057468|NCT01907100|2102289|FG000|Overall Study|Lost to Follow-up|0
1057469|NCT01907100|2102290|FG001|Overall Study|Lost to Follow-up|0
1057470|NCT01907100|2102291|FG002|Overall Study|Lost to Follow-up|0
1057471|NCT01907100|2102292|FG003|Overall Study|Lost to Follow-up|1
1057472|NCT01907100|2102289|FG000|Overall Study|Not treated|2
1057473|NCT01907100|2102290|FG001|Overall Study|Not treated|0
1057474|NCT01907100|2102291|FG002|Overall Study|Not treated|1
1057475|NCT01907100|2102292|FG003|Overall Study|Not treated|2
1057476|NCT01907100|2102289|FG000|Overall Study|Other than reasons specified|1
1057477|NCT01907100|2102290|FG001|Overall Study|Other than reasons specified|0
1057478|NCT01907100|2102291|FG002|Overall Study|Other than reasons specified|10
1057479|NCT01907100|2102292|FG003|Overall Study|Other than reasons specified|6
1057480|NCT01907100|2102289|FG000|Overall Study|Adverse event (AE)|6
1057481|NCT01907100|2102290|FG001|Overall Study|Adverse event (AE)|3
1057482|NCT01907100|2102291|FG002|Overall Study|Adverse event (AE)|22
1057483|NCT01907100|2102292|FG003|Overall Study|Adverse event (AE)|23
1057484|NCT01907100|2102289|FG000|Overall Study|Worsening/AE underlying cancer disease|0
1057485|NCT01907100|2102290|FG001|Overall Study|Worsening/AE underlying cancer disease|0
1057486|NCT01907100|2102291|FG002|Overall Study|Worsening/AE underlying cancer disease|8
1057487|NCT01907100|2102292|FG003|Overall Study|Worsening/AE underlying cancer disease|8
1057488|NCT01907217|2102323|FG000|Overall Study|Withdrawal by Subject|0
1057489|NCT01907217|2102324|FG001|Overall Study|Withdrawal by Subject|2
1057490|NCT01907516|2102367|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5
1057491|NCT01907516|2102368|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9
1057492|NCT01907516|2102367|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
1057493|NCT01907516|2102368|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3
1057494|NCT01907516|2102367|FG000|First Intervention (3 Weeks)|Delivered before second arm|3
1057495|NCT01907516|2102368|FG001|First Intervention (3 Weeks)|Delivered before second arm|4
1057496|NCT01907516|2102367|FG000|First Intervention (3 Weeks)|Developed DKA during study|1
1057497|NCT01907516|2102368|FG001|First Intervention (3 Weeks)|Developed DKA during study|0
1057498|NCT01907737|2102379|FG000|Overall Study|Withdrawal by Subject|1
1057499|NCT01907815|2102391|FG000|Overall Study|Withdrawal by Subject|1
1057500|NCT01907815|2102392|FG001|Overall Study|Withdrawal by Subject|0
1057501|NCT01907828|2102402|FG000|Overall Study|Exclusion criteria not met|0
1057502|NCT01907828|2102403|FG001|Overall Study|Exclusion criteria not met|1
1057503|NCT01907828|2102402|FG000|Overall Study|Withdrawal by Subject|3
1057504|NCT01907828|2102403|FG001|Overall Study|Withdrawal by Subject|4
1057505|NCT01907828|2102402|FG000|Overall Study|Lost to Follow-up|3
1057506|NCT01907828|2102403|FG001|Overall Study|Lost to Follow-up|0
1057507|NCT01907828|2102402|FG000|Overall Study|Participant refused 24-month follow-up|1
1057508|NCT01907828|2102403|FG001|Overall Study|Participant refused 24-month follow-up|0
1057509|NCT01907828|2102402|FG000|Overall Study|Participant met exclusion criteria|0
1057510|NCT01907828|2102403|FG001|Overall Study|Participant met exclusion criteria|1
1057511|NCT01907854|2102411|FG000|Overall Study|Protocol Violation|1
1057512|NCT01907854|2102412|FG001|Overall Study|Protocol Violation|1
1057513|NCT01907854|2102411|FG000|Overall Study|Withdrawal by Subject|9
1057514|NCT01907854|2102412|FG001|Overall Study|Withdrawal by Subject|7
1057515|NCT01907854|2102411|FG000|Overall Study|Lost to Follow-up|2
1057516|NCT01907854|2102412|FG001|Overall Study|Lost to Follow-up|2
1057517|NCT01907854|2102411|FG000|Overall Study|Unclassified|4
1057518|NCT01907854|2102412|FG001|Overall Study|Unclassified|3
1057519|NCT01907906|2102420|FG000|Overall Study|Withdrawal by Subject|1
1057520|NCT01907906|2102421|FG001|Overall Study|Withdrawal by Subject|0
1057521|NCT01907906|2102420|FG000|Overall Study|Physician Decision|3
1057522|NCT01907906|2102421|FG001|Overall Study|Physician Decision|1
1057523|NCT01908101|2102441|FG000|Overall Study|Physician Decision|1
1057524|NCT01908101|2102441|FG000|Overall Study|Withdrawal by Subject|1
1057525|NCT01908101|2102441|FG000|Overall Study|Incorrect Diagnosis|2
1057526|NCT01908101|2102441|FG000|Overall Study|Incorrect Starting Dose|1
1057527|NCT01908101|2102441|FG000|Overall Study|Did not complete the first cycle|4
1057528|NCT01908140|2102456|FG000|Overall Study|Other or Progressive Disease|5
1057529|NCT01908140|2102457|FG001|Overall Study|Other or Progressive Disease|12
1057530|NCT01908140|2102456|FG000|Overall Study|Lack of Efficacy|7
1057531|NCT01908140|2102457|FG001|Overall Study|Lack of Efficacy|5
1057532|NCT01908140|2102456|FG000|Overall Study|Withdrawal by Subject|23
1057533|NCT01908140|2102457|FG001|Overall Study|Withdrawal by Subject|24
1057534|NCT01908140|2102456|FG000|Overall Study|Lost to Follow-up|1
1057535|NCT01908140|2102457|FG001|Overall Study|Lost to Follow-up|6
1057536|NCT01908140|2102456|FG000|Overall Study|Protocol Violation|8
1057537|NCT01908140|2102457|FG001|Overall Study|Protocol Violation|9
1057538|NCT01908140|2102456|FG000|Overall Study|Adverse Event|22
1057539|NCT01908140|2102457|FG001|Overall Study|Adverse Event|23
1057540|NCT01908205|2102465|FG000|Overall Study|Lost to Follow-up|2
1057541|NCT01908205|2102466|FG001|Overall Study|Lost to Follow-up|0
1057542|NCT01908205|2102465|FG000|Overall Study|Withdrawal by Subject|3
1057543|NCT01908205|2102466|FG001|Overall Study|Withdrawal by Subject|1
1057544|NCT01908426|2102487|FG000|Overall Study|Adverse Event|98
1057545|NCT01908426|2102488|FG001|Overall Study|Adverse Event|11
1057546|NCT01908426|2102487|FG000|Overall Study|Clinical Deterioration|72
1057547|NCT01908426|2102488|FG001|Overall Study|Clinical Deterioration|38
1057548|NCT01908426|2102487|FG000|Overall Study|Lack of Efficacy|3
1057549|NCT01908426|2102488|FG001|Overall Study|Lack of Efficacy|0
1057550|NCT01908426|2102487|FG000|Overall Study|Lost to Follow-up|0
1057551|NCT01908426|2102488|FG001|Overall Study|Lost to Follow-up|1
1057552|NCT01908426|2102487|FG000|Overall Study|Physician Decision|3
1057553|NCT01908426|2102488|FG001|Overall Study|Physician Decision|3
1057554|NCT01908426|2102487|FG000|Overall Study|Withdrawal by Subject|11
1057555|NCT01908426|2102488|FG001|Overall Study|Withdrawal by Subject|6
1057556|NCT01908426|2102487|FG000|Overall Study|Progressive Disease|206
1057557|NCT01908426|2102488|FG001|Overall Study|Progressive Disease|152
1057558|NCT01908426|2102487|FG000|Overall Study|Protocol Violation|1
1057559|NCT01908426|2102488|FG001|Overall Study|Protocol Violation|0
1057560|NCT01908426|2102487|FG000|Overall Study|No Study Treatment Given|3
1057561|NCT01908426|2102488|FG001|Overall Study|No Study Treatment Given|0
1057562|NCT01908582|2102510|FG000|Period 2|Physician Decision|1
1057563|NCT01908582|2102510|FG000|Period 2|Withdrawal by Subject|1
1057564|NCT01908634|2102517|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1
1057565|NCT01908634|2102517|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5
1057566|NCT01908699|2102527|FG000|Overall Study|Adverse Event|8
1057567|NCT01908699|2102528|FG001|Overall Study|Adverse Event|12
1057568|NCT01908699|2102527|FG000|Overall Study|Lack of Efficacy|2
1057569|NCT01908699|2102528|FG001|Overall Study|Lack of Efficacy|2
1057570|NCT01908699|2102527|FG000|Overall Study|Lost to Follow-up|2
1057571|NCT01908699|2102528|FG001|Overall Study|Lost to Follow-up|4
1057572|NCT01908699|2102527|FG000|Overall Study|Physician Decision|8
1057573|NCT01908699|2102528|FG001|Overall Study|Physician Decision|8
1057574|NCT01908699|2102527|FG000|Overall Study|Withdrawal by Subject|15
1057575|NCT01908699|2102528|FG001|Overall Study|Withdrawal by Subject|10
1057576|NCT01908699|2102527|FG000|Overall Study|Pregnancy|0
1057577|NCT01908699|2102528|FG001|Overall Study|Pregnancy|1
1057578|NCT01908699|2102527|FG000|Overall Study|Randomized in Error|1
1057579|NCT01908699|2102528|FG001|Overall Study|Randomized in Error|0
1057580|NCT01908699|2102527|FG000|Overall Study|Death|9
1057581|NCT01908699|2102528|FG001|Overall Study|Death|12
1057582|NCT01908699|2102527|FG000|Overall Study|Progressive Disease|30
1057583|NCT01908699|2102528|FG001|Overall Study|Progressive Disease|29
1057584|NCT01908803|2102553|FG000|Overall Study|Adverse Event|1
1057585|NCT01908803|2102554|FG001|Overall Study|Adverse Event|0
1057586|NCT01908803|2102553|FG000|Overall Study|Physician Decision|0
1057587|NCT01908803|2102554|FG001|Overall Study|Physician Decision|1
1057588|NCT01908803|2102553|FG000|Overall Study|Withdrawal by Subject|1
1057589|NCT01908803|2102554|FG001|Overall Study|Withdrawal by Subject|0
1057590|NCT01908803|2102553|FG000|Overall Study|Randomization Error|1
1057591|NCT01908803|2102554|FG001|Overall Study|Randomization Error|0
1057592|NCT01908803|2102553|FG000|Overall Study|Adverse Event (pre-treatment)|1
1057593|NCT01908803|2102554|FG001|Overall Study|Adverse Event (pre-treatment)|0
1057594|NCT01908816|2102565|FG000|Overall Study|Subject's no longer requires study drug|0
1057595|NCT01908816|2102566|FG001|Overall Study|Subject's no longer requires study drug|0
1057596|NCT01908816|2102567|FG002|Overall Study|Subject's no longer requires study drug|0
1057597|NCT01908816|2102568|FG003|Overall Study|Subject's no longer requires study drug|1
1057598|NCT01908816|2102565|FG000|Overall Study|Protocol deviation|1
1057599|NCT01908816|2102566|FG001|Overall Study|Protocol deviation|2
1057600|NCT01908816|2102567|FG002|Overall Study|Protocol deviation|1
1057601|NCT01908816|2102568|FG003|Overall Study|Protocol deviation|1
1057602|NCT01908816|2102565|FG000|Overall Study|Withdrawal by Subject|0
1057603|NCT01908816|2102566|FG001|Overall Study|Withdrawal by Subject|4
1057604|NCT01908816|2102567|FG002|Overall Study|Withdrawal by Subject|2
1057605|NCT01908816|2102568|FG003|Overall Study|Withdrawal by Subject|2
1057606|NCT01908816|2102565|FG000|Overall Study|Lost to Follow-up|3
1057607|NCT01908816|2102566|FG001|Overall Study|Lost to Follow-up|5
1057608|NCT01908816|2102567|FG002|Overall Study|Lost to Follow-up|4
1057609|NCT01908816|2102568|FG003|Overall Study|Lost to Follow-up|2
1057610|NCT01908816|2102565|FG000|Overall Study|Death|1
1057611|NCT01908816|2102566|FG001|Overall Study|Death|0
1057612|NCT01908816|2102567|FG002|Overall Study|Death|7
1057613|NCT01908816|2102568|FG003|Overall Study|Death|1
1057614|NCT01908816|2102565|FG000|Overall Study|Unsatisfactory therapeutic effect|1
1057615|NCT01908816|2102566|FG001|Overall Study|Unsatisfactory therapeutic effect|13
1057616|NCT01908816|2102567|FG002|Overall Study|Unsatisfactory therapeutic effect|1
1057617|NCT01908816|2102568|FG003|Overall Study|Unsatisfactory therapeutic effect|0
1057618|NCT01908816|2102565|FG000|Overall Study|Early termination|87
1057619|NCT01908816|2102566|FG001|Overall Study|Early termination|60
1057620|NCT01908816|2102567|FG002|Overall Study|Early termination|43
1057621|NCT01908816|2102568|FG003|Overall Study|Early termination|28
1057622|NCT01908829|2102584|FG000|Overall Study|Adverse Event|13
1057623|NCT01908829|2102585|FG001|Overall Study|Adverse Event|11
1057624|NCT01908829|2102586|FG002|Overall Study|Adverse Event|13
1057625|NCT01908829|2102584|FG000|Overall Study|Lost to Follow-up|4
1057626|NCT01908829|2102585|FG001|Overall Study|Lost to Follow-up|2
1057627|NCT01908829|2102586|FG002|Overall Study|Lost to Follow-up|1
1057628|NCT01908829|2102584|FG000|Overall Study|Randomized no double-blind drug received|1
1057629|NCT01908829|2102585|FG001|Overall Study|Randomized no double-blind drug received|0
1057630|NCT01908829|2102586|FG002|Overall Study|Randomized no double-blind drug received|1
1057631|NCT01908829|2102584|FG000|Overall Study|Discontinued (no EoT page)|2
1057632|NCT01908829|2102585|FG001|Overall Study|Discontinued (no EoT page)|0
1057633|NCT01908829|2102586|FG002|Overall Study|Discontinued (no EoT page)|0
1057634|NCT01908829|2102584|FG000|Overall Study|Miscellaneous|0
1057635|NCT01908829|2102585|FG001|Overall Study|Miscellaneous|2
1057636|NCT01908829|2102586|FG002|Overall Study|Miscellaneous|0
1057637|NCT01908829|2102584|FG000|Overall Study|Protocol Violation|2
1057638|NCT01908829|2102585|FG001|Overall Study|Protocol Violation|2
1057639|NCT01908829|2102586|FG002|Overall Study|Protocol Violation|0
1057640|NCT01908829|2102584|FG000|Overall Study|Lack of Efficacy|1
1057641|NCT01908829|2102585|FG001|Overall Study|Lack of Efficacy|3
1057642|NCT01908829|2102586|FG002|Overall Study|Lack of Efficacy|2
1057643|NCT01908829|2102584|FG000|Overall Study|Withdrawal by Subject|26
1057644|NCT01908829|2102585|FG001|Overall Study|Withdrawal by Subject|29
1057645|NCT01908829|2102586|FG002|Overall Study|Withdrawal by Subject|22
1057646|NCT01908907|2102605|FG000|Overall Study|Physician Decision|1
1057647|NCT01908907|2102606|FG001|Overall Study|Physician Decision|0
1057648|NCT01908907|2102605|FG000|Overall Study|Protocol Violation|1
1057649|NCT01908907|2102606|FG001|Overall Study|Protocol Violation|0
1057650|NCT01909336|2102658|FG000|Overall Study|Lost to Follow-up|4
1057651|NCT01909336|2102659|FG001|Overall Study|Lost to Follow-up|2
1057652|NCT01909336|2102660|FG002|Overall Study|Lost to Follow-up|2
1057653|NCT01909336|2102658|FG000|Overall Study|Physician Decision|0
1057654|NCT01909336|2102659|FG001|Overall Study|Physician Decision|1
1057655|NCT01909336|2102660|FG002|Overall Study|Physician Decision|1
1057656|NCT01909453|2102673|FG000|Overall Study|Ongoing|118
1057657|NCT01909453|2102674|FG001|Overall Study|Ongoing|103
1057658|NCT01909453|2102675|FG002|Overall Study|Ongoing|83
1057659|NCT01909453|2102676|FG003|Overall Study|Ongoing|164
1057660|NCT01909453|2102677|FG004|Overall Study|Ongoing|50
1057661|NCT01909453|2102673|FG000|Overall Study|Death|69
1057662|NCT01909453|2102674|FG001|Overall Study|Death|74
1057663|NCT01909453|2102675|FG002|Overall Study|Death|88
1057664|NCT01909453|2102676|FG003|Overall Study|Death|86
1057665|NCT01909453|2102677|FG004|Overall Study|Death|29
1057666|NCT01909453|2102673|FG000|Overall Study|Lost to Follow-up|3
1057667|NCT01909453|2102674|FG001|Overall Study|Lost to Follow-up|4
1057668|NCT01909453|2102675|FG002|Overall Study|Lost to Follow-up|4
1057669|NCT01909453|2102676|FG003|Overall Study|Lost to Follow-up|3
1057670|NCT01909453|2102677|FG004|Overall Study|Lost to Follow-up|3
1057671|NCT01909453|2102673|FG000|Overall Study|Withdrawal by Subject|2
1057672|NCT01909453|2102674|FG001|Overall Study|Withdrawal by Subject|13
1057673|NCT01909453|2102675|FG002|Overall Study|Withdrawal by Subject|16
1057674|NCT01909453|2102676|FG003|Overall Study|Withdrawal by Subject|5
1057675|NCT01909453|2102677|FG004|Overall Study|Withdrawal by Subject|4
1057676|NCT01909466|2102695|FG000|Overall Study|Lost to Follow-up|5
1057677|NCT01909466|2102696|FG001|Overall Study|Lost to Follow-up|7
1057678|NCT01909466|2102695|FG000|Overall Study|Adverse Event|3
1057679|NCT01909466|2102696|FG001|Overall Study|Adverse Event|4
1057680|NCT01909466|2102695|FG000|Overall Study|Met Withdrawal Criteria|0
1057681|NCT01909466|2102696|FG001|Overall Study|Met Withdrawal Criteria|3
1057682|NCT01909466|2102695|FG000|Overall Study|Physician Decision|2
1057683|NCT01909466|2102696|FG001|Overall Study|Physician Decision|0
1057684|NCT01909466|2102695|FG000|Overall Study|Withdrawal by Subject|11
1057685|NCT01909466|2102696|FG001|Overall Study|Withdrawal by Subject|9
1057686|NCT01909466|2102695|FG000|Overall Study|Lack of Efficacy|1
1057687|NCT01909466|2102696|FG001|Overall Study|Lack of Efficacy|0
1057688|NCT01909674|2102711|FG000|Overall Study|Withdrawal by Subject|5
1057689|NCT01909674|2102712|FG001|Overall Study|Withdrawal by Subject|2
1057690|NCT01909778|2102743|FG000|Overall Study|failed screening|1
1057691|NCT01909791|2102752|FG000|Overall Study|Death|9
1057692|NCT01909791|2102753|FG001|Overall Study|Death|8
1057693|NCT01909791|2102754|FG002|Overall Study|Death|4
1057694|NCT01909791|2102752|FG000|Overall Study|Withdrawal by Subject|5
1057695|NCT01909791|2102753|FG001|Overall Study|Withdrawal by Subject|9
1057696|NCT01909791|2102754|FG002|Overall Study|Withdrawal by Subject|13
1057697|NCT01909791|2102752|FG000|Overall Study|Lost to Follow-up|5
1057698|NCT01909791|2102753|FG001|Overall Study|Lost to Follow-up|11
1057699|NCT01909791|2102754|FG002|Overall Study|Lost to Follow-up|10
1057700|NCT01909791|2102752|FG000|Overall Study|Missed Visit|2
1057701|NCT01909791|2102753|FG001|Overall Study|Missed Visit|0
1057702|NCT01909791|2102754|FG002|Overall Study|Missed Visit|1
1057703|NCT01909804|2102779|FG000|Overall Study|Randomized but Never Treated|0
1057704|NCT01909804|2102780|FG001|Overall Study|Randomized but Never Treated|0
1057705|NCT01909804|2102781|FG002|Overall Study|Randomized but Never Treated|0
1057706|NCT01909804|2102782|FG003|Overall Study|Randomized but Never Treated|0
1057707|NCT01909804|2102783|FG004|Overall Study|Randomized but Never Treated|0
1057708|NCT01909804|2102784|FG005|Overall Study|Randomized but Never Treated|0
1057709|NCT01909804|2102785|FG006|Overall Study|Randomized but Never Treated|1
1057710|NCT01909804|2102786|FG007|Overall Study|Randomized but Never Treated|0
1057711|NCT01909804|2102787|FG008|Overall Study|Randomized but Never Treated|0
1057712|NCT01909804|2102788|FG009|Overall Study|Randomized but Never Treated|0
1057713|NCT01909804|2102789|FG010|Overall Study|Randomized but Never Treated|0
1057714|NCT01909804|2102790|FG011|Overall Study|Randomized but Never Treated|1
1057715|NCT01909804|2102779|FG000|Overall Study|Death|0
1057716|NCT01909804|2102780|FG001|Overall Study|Death|0
1057717|NCT01909804|2102781|FG002|Overall Study|Death|0
1057718|NCT01909804|2102782|FG003|Overall Study|Death|0
1057719|NCT01909804|2102783|FG004|Overall Study|Death|0
1057720|NCT01909804|2102784|FG005|Overall Study|Death|0
1057721|NCT01909804|2102785|FG006|Overall Study|Death|0
1057722|NCT01909804|2102786|FG007|Overall Study|Death|0
1057723|NCT01909804|2102787|FG008|Overall Study|Death|0
1057724|NCT01909804|2102788|FG009|Overall Study|Death|0
1057725|NCT01909804|2102789|FG010|Overall Study|Death|1
1057726|NCT01909804|2102790|FG011|Overall Study|Death|0
1057727|NCT01909804|2102779|FG000|Overall Study|Lack of Efficacy|4
1057728|NCT01909804|2102780|FG001|Overall Study|Lack of Efficacy|1
1057729|NCT01909804|2102781|FG002|Overall Study|Lack of Efficacy|0
1057730|NCT01909804|2102782|FG003|Overall Study|Lack of Efficacy|0
1057731|NCT01909804|2102783|FG004|Overall Study|Lack of Efficacy|7
1057732|NCT01909804|2102784|FG005|Overall Study|Lack of Efficacy|3
1057733|NCT01909804|2102785|FG006|Overall Study|Lack of Efficacy|1
1057734|NCT01909804|2102786|FG007|Overall Study|Lack of Efficacy|1
1057735|NCT01909804|2102787|FG008|Overall Study|Lack of Efficacy|0
1057736|NCT01909804|2102788|FG009|Overall Study|Lack of Efficacy|1
1057737|NCT01909804|2102789|FG010|Overall Study|Lack of Efficacy|0
1057738|NCT01909804|2102790|FG011|Overall Study|Lack of Efficacy|1
1057739|NCT01909804|2102779|FG000|Overall Study|Withdrew Consent|0
1057740|NCT01909804|2102780|FG001|Overall Study|Withdrew Consent|0
1057741|NCT01909804|2102781|FG002|Overall Study|Withdrew Consent|0
1057742|NCT01909804|2102782|FG003|Overall Study|Withdrew Consent|0
1057743|NCT01909804|2102783|FG004|Overall Study|Withdrew Consent|1
1057744|NCT01909804|2102784|FG005|Overall Study|Withdrew Consent|1
1057745|NCT01909804|2102785|FG006|Overall Study|Withdrew Consent|0
1057746|NCT01909804|2102786|FG007|Overall Study|Withdrew Consent|0
1057747|NCT01909804|2102787|FG008|Overall Study|Withdrew Consent|0
1057748|NCT01909804|2102788|FG009|Overall Study|Withdrew Consent|0
1057749|NCT01909804|2102789|FG010|Overall Study|Withdrew Consent|0
1057750|NCT01909804|2102790|FG011|Overall Study|Withdrew Consent|0
1057751|NCT01909804|2102779|FG000|Overall Study|Protocol Violation|0
1057752|NCT01909804|2102780|FG001|Overall Study|Protocol Violation|0
1057753|NCT01909804|2102781|FG002|Overall Study|Protocol Violation|0
1057754|NCT01909804|2102782|FG003|Overall Study|Protocol Violation|0
1057755|NCT01909804|2102783|FG004|Overall Study|Protocol Violation|0
1057756|NCT01909804|2102784|FG005|Overall Study|Protocol Violation|0
1057757|NCT01909804|2102785|FG006|Overall Study|Protocol Violation|0
1057758|NCT01909804|2102786|FG007|Overall Study|Protocol Violation|0
1057759|NCT01909804|2102787|FG008|Overall Study|Protocol Violation|0
1057760|NCT01909804|2102788|FG009|Overall Study|Protocol Violation|0
1057761|NCT01909804|2102789|FG010|Overall Study|Protocol Violation|0
1057762|NCT01909804|2102790|FG011|Overall Study|Protocol Violation|1
1057763|NCT01909973|2102814|FG000|Overall Study|Lost to Follow-up|1
1057764|NCT01909973|2102815|FG001|Overall Study|Lost to Follow-up|0
1057765|NCT01910116|2102827|FG000|Overall Study|Adverse Event|0
1057766|NCT01910116|2102828|FG001|Overall Study|Adverse Event|3
1057767|NCT01910116|2102827|FG000|Overall Study|Lack of Efficacy|3
1057768|NCT01910116|2102828|FG001|Overall Study|Lack of Efficacy|4
1057769|NCT01910116|2102827|FG000|Overall Study|Lost to Follow-up|1
1057770|NCT01910116|2102828|FG001|Overall Study|Lost to Follow-up|0
1057771|NCT01910116|2102827|FG000|Overall Study|Protocol Violation|1
1057772|NCT01910116|2102828|FG001|Overall Study|Protocol Violation|2
1057773|NCT01910116|2102827|FG000|Overall Study|Withdrawal by Subject|8
1057774|NCT01910116|2102828|FG001|Overall Study|Withdrawal by Subject|3
1057775|NCT01910116|2102827|FG000|Overall Study|uncertain allocation|1
1057776|NCT01910116|2102828|FG001|Overall Study|uncertain allocation|3
1057777|NCT01910116|2102827|FG000|Overall Study|incomplete data|0
1057778|NCT01910116|2102828|FG001|Overall Study|incomplete data|1
1057779|NCT01910129|2102836|FG000|Randomized Phase 2|Withdrawal by Subject|2
1057780|NCT01910129|2102837|FG001|Randomized Phase 2|Withdrawal by Subject|1
1057781|NCT01910129|2102838|FG002|Randomized Phase 2|Withdrawal by Subject|0
1057782|NCT01910129|2102836|FG000|Randomized Phase 3|Withdrawal by Subject|0
1057783|NCT01910129|2102837|FG001|Randomized Phase 3|Withdrawal by Subject|1
1057784|NCT01910129|2102838|FG002|Randomized Phase 3|Withdrawal by Subject|0
1057785|NCT01910181|2102856|FG000|Overall Study|Death|37
1057786|NCT01910181|2102856|FG000|Overall Study|Lost to Follow-up|3
1057787|NCT01910181|2102856|FG000|Overall Study|Study Terminated by Sponsor|6
1057788|NCT01910298|2102863|FG000|Overall Study|Adverse Event|1
1057789|NCT01910298|2102864|FG001|Overall Study|Adverse Event|0
1057790|NCT01910298|2102863|FG000|Overall Study|Withdrawal by Subject|2
1057791|NCT01910298|2102864|FG001|Overall Study|Withdrawal by Subject|7
1057792|NCT01910298|2102863|FG000|Overall Study|Protocol Deviation|0
1057793|NCT01910298|2102864|FG001|Overall Study|Protocol Deviation|5
1057794|NCT01910298|2102863|FG000|Overall Study|Lost to Follow-up|1
1057795|NCT01910298|2102864|FG001|Overall Study|Lost to Follow-up|1
1057796|NCT01910298|2102863|FG000|Overall Study|Study Terminated by Sponsor|1
1057797|NCT01910298|2102864|FG001|Overall Study|Study Terminated by Sponsor|17
1057798|NCT01910298|2102863|FG000|Overall Study|Other Miscellaneous Reasons|0
1057799|NCT01910298|2102864|FG001|Overall Study|Other Miscellaneous Reasons|2
1057820|NCT01910519|2102891|FG000|Overall Study|Withdrawal by Subject|2
1057821|NCT01910519|2102892|FG001|Overall Study|Withdrawal by Subject|0
1057822|NCT01910519|2102891|FG000|Overall Study|Adverse Event|2
1057823|NCT01910519|2102892|FG001|Overall Study|Adverse Event|0
1057824|NCT01911260|2102951|FG000|Supplementation Period|transference or evasion of school|7
1057825|NCT01911260|2102952|FG001|Supplementation Period|transference or evasion of school|9
1057826|NCT01911260|2102953|FG002|Supplementation Period|transference or evasion of school|7
1057827|NCT01911260|2102954|FG003|Supplementation Period|transference or evasion of school|6
1057828|NCT01911260|2102951|FG000|Supplementation Period|Adverse Event|2
1057829|NCT01911260|2102952|FG001|Supplementation Period|Adverse Event|0
1057830|NCT01911260|2102953|FG002|Supplementation Period|Adverse Event|1
1057831|NCT01911260|2102954|FG003|Supplementation Period|Adverse Event|0
1057832|NCT01911260|2102951|FG000|Supplementation Period|refused to receive supplement|1
1057833|NCT01911260|2102952|FG001|Supplementation Period|refused to receive supplement|0
1057834|NCT01911260|2102953|FG002|Supplementation Period|refused to receive supplement|1
1057835|NCT01911260|2102954|FG003|Supplementation Period|refused to receive supplement|0
1057836|NCT01911260|2102951|FG000|Supplementation Period|less than 12 weeks supplementation|0
1162038|NCT03381196|2283977|FG001|Overall Study|Adverse Event|0
1057837|NCT01911260|2102952|FG001|Supplementation Period|less than 12 weeks supplementation|3
1057838|NCT01911260|2102953|FG002|Supplementation Period|less than 12 weeks supplementation|1
1057839|NCT01911260|2102954|FG003|Supplementation Period|less than 12 weeks supplementation|2
1057840|NCT01911260|2102951|FG000|Follow-up Period|transference or evasion of school|13
1057841|NCT01911260|2102952|FG001|Follow-up Period|transference or evasion of school|20
1057842|NCT01911260|2102953|FG002|Follow-up Period|transference or evasion of school|15
1057843|NCT01911260|2102954|FG003|Follow-up Period|transference or evasion of school|12
1057844|NCT01911273|2102966|FG000|Overall Study|Progression of Disease|1
1057845|NCT01911273|2102967|FG001|Overall Study|Progression of Disease|0
1057846|NCT01911273|2102966|FG000|Overall Study|Withdrawal by Subject|0
1057847|NCT01911273|2102967|FG001|Overall Study|Withdrawal by Subject|2
1057848|NCT01911429|2103011|FG000|Overall Study|Adverse Event|5
1057849|NCT01911429|2103012|FG001|Overall Study|Adverse Event|3
1057850|NCT01911429|2103013|FG002|Overall Study|Adverse Event|9
1057851|NCT01911429|2103011|FG000|Overall Study|Lack of Efficacy|1
1057852|NCT01911429|2103012|FG001|Overall Study|Lack of Efficacy|2
1057853|NCT01911429|2103013|FG002|Overall Study|Lack of Efficacy|4
1057854|NCT01911429|2103011|FG000|Overall Study|Lost to Follow-up|0
1057855|NCT01911429|2103012|FG001|Overall Study|Lost to Follow-up|0
1057856|NCT01911429|2103013|FG002|Overall Study|Lost to Follow-up|1
1057857|NCT01911429|2103011|FG000|Overall Study|Protocol Violation|0
1057858|NCT01911429|2103012|FG001|Overall Study|Protocol Violation|0
1057859|NCT01911429|2103013|FG002|Overall Study|Protocol Violation|1
1057860|NCT01911429|2103011|FG000|Overall Study|Withdrawal by Subject|5
1057861|NCT01911429|2103012|FG001|Overall Study|Withdrawal by Subject|5
1057862|NCT01911429|2103013|FG002|Overall Study|Withdrawal by Subject|4
1057863|NCT01911429|2103011|FG000|Overall Study|Accidental randomization|0
1057864|NCT01911429|2103012|FG001|Overall Study|Accidental randomization|0
1057865|NCT01911429|2103013|FG002|Overall Study|Accidental randomization|1
1057866|NCT01911429|2103011|FG000|Overall Study|subject left study|1
1057867|NCT01911429|2103012|FG001|Overall Study|subject left study|0
1057868|NCT01911429|2103013|FG002|Overall Study|subject left study|0
1057869|NCT01911442|2103024|FG000|Overall Study|Adverse Event|2
1057870|NCT01911442|2103025|FG001|Overall Study|Adverse Event|2
1057871|NCT01911442|2103026|FG002|Overall Study|Adverse Event|4
1057872|NCT01911442|2103024|FG000|Overall Study|Lack of Efficacy|1
1057873|NCT01911442|2103025|FG001|Overall Study|Lack of Efficacy|1
1057874|NCT01911442|2103026|FG002|Overall Study|Lack of Efficacy|1
1057875|NCT01911442|2103024|FG000|Overall Study|Lost to Follow-up|2
1057876|NCT01911442|2103025|FG001|Overall Study|Lost to Follow-up|0
1057877|NCT01911442|2103026|FG002|Overall Study|Lost to Follow-up|1
1057878|NCT01911442|2103024|FG000|Overall Study|Withdrawal by Subject|1
1057879|NCT01911442|2103025|FG001|Overall Study|Withdrawal by Subject|0
1057880|NCT01911442|2103026|FG002|Overall Study|Withdrawal by Subject|6
1057881|NCT01911442|2103024|FG000|Overall Study|Mother's Work Schedule|0
1057882|NCT01911442|2103025|FG001|Overall Study|Mother's Work Schedule|1
1057883|NCT01911442|2103026|FG002|Overall Study|Mother's Work Schedule|0
1057884|NCT01911546|2103038|FG000|Overall Study|Lost to Follow-up|1
1057885|NCT01911546|2103038|FG000|Overall Study|Everolimus was discontinued|5
1057886|NCT01911780|2103060|FG000|Double-blind Period (8 Weeks)|Adverse Event|1
1057887|NCT01911780|2103061|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
1057888|NCT01911780|2103060|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
1057889|NCT01911780|2103061|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
1057890|NCT01911780|2103060|FG000|Double-blind Period (8 Weeks)|Personal reason|1
1057891|NCT01911780|2103061|FG001|Double-blind Period (8 Weeks)|Personal reason|0
1057892|NCT01911780|2103060|FG000|Extension Period (52 Weeks)|Adverse Event|3
1057893|NCT01911780|2103061|FG001|Extension Period (52 Weeks)|Adverse Event|0
1057894|NCT01911780|2103060|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
1057895|NCT01911780|2103061|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
1057896|NCT01911780|2103060|FG000|Extension Period (52 Weeks)|Personal reason|1
1057897|NCT01911780|2103061|FG001|Extension Period (52 Weeks)|Personal reason|1
1057898|NCT01911819|2103074|FG000|Overall Study|Adverse Event|0
1057899|NCT01911819|2103075|FG001|Overall Study|Adverse Event|1
1057900|NCT01911819|2103076|FG002|Overall Study|Adverse Event|0
1057901|NCT01911819|2103074|FG000|Overall Study|Withdrawal by Subject|1
1057902|NCT01911819|2103075|FG001|Overall Study|Withdrawal by Subject|1
1057903|NCT01911819|2103076|FG002|Overall Study|Withdrawal by Subject|0
1057904|NCT01911845|2103084|FG000|Overall Study|Adverse Event|2
1057905|NCT01911845|2103084|FG000|Overall Study|Lost to Follow-up|1
1057906|NCT01911845|2103084|FG000|Overall Study|Other (not specified)|3
1057907|NCT01912222|2103102|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
1057908|NCT01912222|2103103|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
1057909|NCT01912222|2103104|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
1057910|NCT01912222|2103102|FG000|Part B: Treatment Period|Progressive disease|10
1057911|NCT01912222|2103103|FG001|Part B: Treatment Period|Progressive disease|12
1057912|NCT01912222|2103104|FG002|Part B: Treatment Period|Progressive disease|15
1057913|NCT01912222|2103102|FG000|Part B: Treatment Period|Adverse Event|1
1057914|NCT01912222|2103103|FG001|Part B: Treatment Period|Adverse Event|2
1057915|NCT01912222|2103104|FG002|Part B: Treatment Period|Adverse Event|3
1057916|NCT01912222|2103102|FG000|Part B: Treatment Period|Withdrawal by Subject|2
1057917|NCT01912222|2103103|FG001|Part B: Treatment Period|Withdrawal by Subject|1
1057918|NCT01912222|2103104|FG002|Part B: Treatment Period|Withdrawal by Subject|2
1057919|NCT01912287|2103120|FG000|Overall Study|Ineligible|1
1057920|NCT01912287|2103121|FG001|Overall Study|Ineligible|0
1057921|NCT01912287|2103122|FG002|Overall Study|Ineligible|1
1057922|NCT01912287|2103120|FG000|Overall Study|No-show|0
1057923|NCT01912287|2103121|FG001|Overall Study|No-show|0
1057924|NCT01912287|2103122|FG002|Overall Study|No-show|1
1057925|NCT01912287|2103120|FG000|Overall Study|Dissatisfaction with assigned treatment|4
1057926|NCT01912287|2103121|FG001|Overall Study|Dissatisfaction with assigned treatment|2
1057927|NCT01912287|2103122|FG002|Overall Study|Dissatisfaction with assigned treatment|1
1057928|NCT01912287|2103120|FG000|Overall Study|Felt treatment no longer needed|0
1057929|NCT01912287|2103121|FG001|Overall Study|Felt treatment no longer needed|1
1057930|NCT01912287|2103122|FG002|Overall Study|Felt treatment no longer needed|0
1057931|NCT01912287|2103120|FG000|Overall Study|Life circumstances|4
1057932|NCT01912287|2103121|FG001|Overall Study|Life circumstances|2
1057933|NCT01912287|2103122|FG002|Overall Study|Life circumstances|0
1057934|NCT01912287|2103120|FG000|Overall Study|Lost Interest|1
1057935|NCT01912287|2103121|FG001|Overall Study|Lost Interest|0
1057936|NCT01912287|2103122|FG002|Overall Study|Lost Interest|0
1057937|NCT01912287|2103120|FG000|Overall Study|Uknown reason - subject drop out|5
1057938|NCT01912287|2103121|FG001|Overall Study|Uknown reason - subject drop out|7
1057939|NCT01912287|2103122|FG002|Overall Study|Uknown reason - subject drop out|3
1057940|NCT01912287|2103120|FG000|Overall Study|Missed Assesment|1
1057941|NCT01912287|2103121|FG001|Overall Study|Missed Assesment|1
1057942|NCT01912287|2103122|FG002|Overall Study|Missed Assesment|1
1057943|NCT01912287|2103120|FG000|Overall Study|Scheduling/change in availability|17
1057944|NCT01912287|2103121|FG001|Overall Study|Scheduling/change in availability|10
1057945|NCT01912287|2103122|FG002|Overall Study|Scheduling/change in availability|8
1057946|NCT01912339|2103132|FG000|Blinded (0 to 3 Months)|Declined to participate|1
1057947|NCT01912339|2103133|FG001|Blinded (0 to 3 Months)|Declined to participate|0
1057948|NCT01912339|2103134|FG002|Blinded (0 to 3 Months)|Declined to participate|0
1057949|NCT01912339|2103132|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1
1057950|NCT01912339|2103133|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0
1057951|NCT01912339|2103134|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0
1057952|NCT01912339|2103132|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
1057953|NCT01912339|2103133|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
1057954|NCT01912339|2103134|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
1057955|NCT01912339|2103132|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
1057956|NCT01912339|2103133|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
1057957|NCT01912339|2103134|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
1057958|NCT01912339|2103132|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
1057959|NCT01912339|2103133|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
1057960|NCT01912339|2103134|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
1057961|NCT01912339|2103132|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
1057962|NCT01912339|2103133|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
1057963|NCT01912339|2103134|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
1057964|NCT01912339|2103132|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
1057965|NCT01912339|2103133|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
1057966|NCT01912339|2103134|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
1057967|NCT01912339|2103132|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
1057968|NCT01912339|2103133|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
1057969|NCT01912339|2103134|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
1057970|NCT01912339|2103132|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
1057971|NCT01912339|2103133|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
1057972|NCT01912339|2103134|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
1057973|NCT01912339|2103132|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
1057974|NCT01912339|2103133|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
1057975|NCT01912339|2103134|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
1057976|NCT01912339|2103132|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
1057977|NCT01912339|2103133|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
1057978|NCT01912339|2103134|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
1057979|NCT01912339|2103132|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
1057980|NCT01912339|2103133|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
1057981|NCT01912339|2103134|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
1057982|NCT01912339|2103132|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
1057983|NCT01912339|2103133|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
1057984|NCT01912339|2103134|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
1057985|NCT01912456|2103146|FG000|Period 1|Physician Decision|0
1057986|NCT01912456|2103147|FG001|Period 1|Physician Decision|0
1057987|NCT01912456|2103148|FG002|Period 1|Physician Decision|1
1057988|NCT01912456|2103149|FG003|Period 1|Physician Decision|0
1057989|NCT01912456|2103146|FG000|Period 1|non-compliance|1
1057990|NCT01912456|2103147|FG001|Period 1|non-compliance|0
1057991|NCT01912456|2103148|FG002|Period 1|non-compliance|0
1057992|NCT01912456|2103149|FG003|Period 1|non-compliance|1
1057993|NCT01912456|2103146|FG000|Period 1|Adverse Event|1
1057994|NCT01912456|2103147|FG001|Period 1|Adverse Event|0
1057995|NCT01912456|2103148|FG002|Period 1|Adverse Event|0
1057996|NCT01912456|2103149|FG003|Period 1|Adverse Event|1
1057997|NCT01912456|2103146|FG000|Period 1|Withdrawal by Subject|0
1057998|NCT01912456|2103147|FG001|Period 1|Withdrawal by Subject|1
1057999|NCT01912456|2103148|FG002|Period 1|Withdrawal by Subject|1
1058000|NCT01912456|2103149|FG003|Period 1|Withdrawal by Subject|1
1058001|NCT01912456|2103146|FG000|Period 2|Lack of Efficacy|0
1058002|NCT01912456|2103147|FG001|Period 2|Lack of Efficacy|2
1058003|NCT01912456|2103148|FG002|Period 2|Lack of Efficacy|0
1058004|NCT01912456|2103149|FG003|Period 2|Lack of Efficacy|0
1058005|NCT01912456|2103146|FG000|Period 2|Adverse Event|0
1058006|NCT01912456|2103147|FG001|Period 2|Adverse Event|0
1058007|NCT01912456|2103148|FG002|Period 2|Adverse Event|0
1058008|NCT01912456|2103149|FG003|Period 2|Adverse Event|1
1058009|NCT01912599|2103168|FG000|Overall Study|Withdrawal by Subject|0
1058010|NCT01912599|2103169|FG001|Overall Study|Withdrawal by Subject|1
1058011|NCT01912612|2103177|FG000|Overall Study|Adverse Event|4
1058012|NCT01912612|2103178|FG001|Overall Study|Adverse Event|0
1058013|NCT01912612|2103179|FG002|Overall Study|Adverse Event|0
1058014|NCT01912612|2103177|FG000|Overall Study|Withdrew consent|1
1058015|NCT01912612|2103178|FG001|Overall Study|Withdrew consent|0
1058016|NCT01912612|2103179|FG002|Overall Study|Withdrew consent|0
1058017|NCT01912612|2103177|FG000|Overall Study|Study design change|0
1058018|NCT01912612|2103178|FG001|Overall Study|Study design change|0
1058019|NCT01912612|2103179|FG002|Overall Study|Study design change|3
1058020|NCT01912729|2103198|FG000|Overall Study|Withdrawal by Subject|0
1058021|NCT01912729|2103199|FG001|Overall Study|Withdrawal by Subject|1
1058022|NCT01912768|2103207|FG000|Overall Study|Adverse Event|2
1058023|NCT01912768|2103208|FG001|Overall Study|Adverse Event|0
1058024|NCT01912768|2103207|FG000|Overall Study|Lost to Follow-up|2
1058025|NCT01912768|2103208|FG001|Overall Study|Lost to Follow-up|1
1058026|NCT01912768|2103207|FG000|Overall Study|Withdrawal by Subject|5
1058027|NCT01912768|2103208|FG001|Overall Study|Withdrawal by Subject|3
1058028|NCT01912768|2103207|FG000|Overall Study|Randomized in error|1
1058029|NCT01912768|2103208|FG001|Overall Study|Randomized in error|0
1058030|NCT01912781|2103217|FG000|Overall Study|Withdrawal by Subject|2
1058031|NCT01912781|2103218|FG001|Overall Study|Withdrawal by Subject|0
1058032|NCT01912807|2103227|FG000|Overall Study|Did not meet elegibility criteria|6
1058033|NCT01912807|2103228|FG001|Overall Study|Did not meet elegibility criteria|4
1058034|NCT01912807|2103227|FG000|Overall Study|Lost to Follow-up|36
1058035|NCT01912807|2103228|FG001|Overall Study|Lost to Follow-up|37
1058036|NCT01912872|2103238|FG000|Overall Study|Lost to Follow-up|2
1058037|NCT01912872|2103239|FG001|Overall Study|Lost to Follow-up|3
1058038|NCT01912872|2103240|FG002|Overall Study|Lost to Follow-up|5
1058039|NCT01912872|2103241|FG003|Overall Study|Lost to Follow-up|5
1058040|NCT01912872|2103238|FG000|Overall Study|Other unspecified|3
1058041|NCT01912872|2103239|FG001|Overall Study|Other unspecified|1
1058042|NCT01912872|2103240|FG002|Overall Study|Other unspecified|3
1058043|NCT01912872|2103241|FG003|Overall Study|Other unspecified|0
1058044|NCT01912872|2103238|FG000|Overall Study|Informed consent withdrawn|0
1058045|NCT01912872|2103239|FG001|Overall Study|Informed consent withdrawn|0
1058046|NCT01912872|2103240|FG002|Overall Study|Informed consent withdrawn|1
1058047|NCT01912872|2103241|FG003|Overall Study|Informed consent withdrawn|1
1058048|NCT01912872|2103238|FG000|Overall Study|Non-compliance with lab inc/exclusion|0
1058049|NCT01912872|2103239|FG001|Overall Study|Non-compliance with lab inc/exclusion|0
1058050|NCT01912872|2103240|FG002|Overall Study|Non-compliance with lab inc/exclusion|0
1058051|NCT01912872|2103241|FG003|Overall Study|Non-compliance with lab inc/exclusion|1
1058052|NCT01912872|2103238|FG000|Overall Study|Protocol Violation|0
1058053|NCT01912872|2103239|FG001|Overall Study|Protocol Violation|0
1058054|NCT01912872|2103240|FG002|Overall Study|Protocol Violation|1
1058055|NCT01912872|2103241|FG003|Overall Study|Protocol Violation|0
1058056|NCT01912872|2103238|FG000|Overall Study|Unsatisfactory therapeutic effect|0
1058057|NCT01912872|2103239|FG001|Overall Study|Unsatisfactory therapeutic effect|0
1058058|NCT01912872|2103240|FG002|Overall Study|Unsatisfactory therapeutic effect|0
1058059|NCT01912872|2103241|FG003|Overall Study|Unsatisfactory therapeutic effect|2
1058060|NCT01912872|2103238|FG000|Overall Study|Withdrawal of study medication|0
1058061|NCT01912872|2103239|FG001|Overall Study|Withdrawal of study medication|0
1058062|NCT01912872|2103240|FG002|Overall Study|Withdrawal of study medication|0
1058063|NCT01912872|2103241|FG003|Overall Study|Withdrawal of study medication|2
1058064|NCT01912872|2103238|FG000|Overall Study|Missing|0
1058065|NCT01912872|2103239|FG001|Overall Study|Missing|0
1058066|NCT01912872|2103240|FG002|Overall Study|Missing|0
1058067|NCT01912872|2103241|FG003|Overall Study|Missing|1
1058068|NCT01912963|2103255|FG000|Overall Study|Disease Progression (RECIST1.1)|6
1058069|NCT01912963|2103256|FG001|Overall Study|Disease Progression (RECIST1.1)|9
1058070|NCT01912963|2103257|FG002|Overall Study|Disease Progression (RECIST1.1)|5
1058071|NCT01912963|2103255|FG000|Overall Study|Disease Progression (not RECIST1.1)|0
1058072|NCT01912963|2103256|FG001|Overall Study|Disease Progression (not RECIST1.1)|7
1058073|NCT01912963|2103257|FG002|Overall Study|Disease Progression (not RECIST1.1)|1
1058074|NCT01912963|2103255|FG000|Overall Study|Adverse Event|0
1058075|NCT01912963|2103256|FG001|Overall Study|Adverse Event|1
1058076|NCT01912963|2103257|FG002|Overall Study|Adverse Event|1
1058077|NCT01912963|2103255|FG000|Overall Study|Withdrawal by Subject|0
1058078|NCT01912963|2103256|FG001|Overall Study|Withdrawal by Subject|1
1058079|NCT01912963|2103257|FG002|Overall Study|Withdrawal by Subject|0
1058080|NCT01912963|2103255|FG000|Overall Study|Sought treatment locally|0
1058081|NCT01912963|2103256|FG001|Overall Study|Sought treatment locally|1
1058082|NCT01912963|2103257|FG002|Overall Study|Sought treatment locally|0
1058083|NCT01913041|2103265|FG000|Overall Study|Protocol Violation|35
1058084|NCT01913041|2103265|FG000|Overall Study|Withdrawal by Subject|3
1058085|NCT01913041|2103265|FG000|Overall Study|Physician Decision|1
1058086|NCT01913340|2103275|FG000|Overall Study|Death|2
1058087|NCT01913340|2103276|FG001|Overall Study|Death|5
1058088|NCT01913340|2103275|FG000|Overall Study|Lost to Follow-up|1
1058089|NCT01913340|2103276|FG001|Overall Study|Lost to Follow-up|1
1058090|NCT01913353|2103284|FG000|Overall Study|Adverse Event|2
1058091|NCT01913353|2103285|FG001|Overall Study|Adverse Event|0
1058092|NCT01913353|2103284|FG000|Overall Study|Physician Decision|0
1058093|NCT01913353|2103285|FG001|Overall Study|Physician Decision|2
1058094|NCT01913353|2103284|FG000|Overall Study|Withdrawal by Subject|20
1058095|NCT01913353|2103285|FG001|Overall Study|Withdrawal by Subject|6
1058096|NCT01913353|2103284|FG000|Overall Study|multiple reasons|10
1058097|NCT01913353|2103285|FG001|Overall Study|multiple reasons|7
1058098|NCT01913405|2103298|FG000|Overall Study|Withdrawal by Subject|1
1058099|NCT01913405|2103298|FG000|Overall Study|Adverse Event|1
1058100|NCT01913470|2103317|FG000|Overall Study|Lost to Follow-up|0
1058101|NCT01913470|2103318|FG001|Overall Study|Lost to Follow-up|1
1058102|NCT01913470|2103317|FG000|Overall Study|Physician Decision|0
1058103|NCT01913470|2103318|FG001|Overall Study|Physician Decision|1
1058104|NCT01913470|2103317|FG000|Overall Study|Withdrawal by Subject|0
1058105|NCT01913470|2103318|FG001|Overall Study|Withdrawal by Subject|1
1058106|NCT01913483|2103327|FG000|Overall Study|Withdrawal by Subject|1
1058107|NCT01913483|2103328|FG001|Overall Study|Withdrawal by Subject|2
1058108|NCT01913483|2103327|FG000|Overall Study|Lost to Follow-up|6
1058109|NCT01913483|2103328|FG001|Overall Study|Lost to Follow-up|3
1058110|NCT01913483|2103327|FG000|Overall Study|Death|14
1058111|NCT01913483|2103328|FG001|Overall Study|Death|17
1058112|NCT01913639|2103360|FG000|Overall Study|Not Eligible|3
1058113|NCT01914393|2103397|FG000|Overall Study|Protocol Violation|11
1058114|NCT01914393|2103398|FG001|Overall Study|Protocol Violation|3
1058115|NCT01914393|2103399|FG002|Overall Study|Protocol Violation|19
1058116|NCT01914393|2103397|FG000|Overall Study|Lack of Efficacy|11
1058117|NCT01914393|2103398|FG001|Overall Study|Lack of Efficacy|16
1058118|NCT01914393|2103399|FG002|Overall Study|Lack of Efficacy|5
1058119|NCT01914393|2103397|FG000|Overall Study|no reason given|14
1058120|NCT01914393|2103398|FG001|Overall Study|no reason given|8
1058121|NCT01914393|2103399|FG002|Overall Study|no reason given|16
1058122|NCT01914393|2103397|FG000|Overall Study|Adverse Event|29
1058123|NCT01914393|2103398|FG001|Overall Study|Adverse Event|18
1058124|NCT01914393|2103399|FG002|Overall Study|Adverse Event|31
1058125|NCT01914393|2103397|FG000|Overall Study|Withdrawal by Subject|38
1058126|NCT01914393|2103398|FG001|Overall Study|Withdrawal by Subject|20
1058127|NCT01914393|2103399|FG002|Overall Study|Withdrawal by Subject|47
1058128|NCT01914393|2103397|FG000|Overall Study|Lost to Follow-up|12
1058129|NCT01914393|2103398|FG001|Overall Study|Lost to Follow-up|6
1058130|NCT01914393|2103399|FG002|Overall Study|Lost to Follow-up|19
1058131|NCT01914393|2103397|FG000|Overall Study|subject never dosed|0
1058132|NCT01914393|2103398|FG001|Overall Study|subject never dosed|0
1058133|NCT01914393|2103399|FG002|Overall Study|subject never dosed|1
1058134|NCT01914666|2103419|FG000|Treatment Period|Lack of Efficacy|0
1058135|NCT01914666|2103420|FG001|Treatment Period|Lack of Efficacy|0
1058136|NCT01914666|2103421|FG002|Treatment Period|Lack of Efficacy|2
1058137|NCT01914666|2103419|FG000|Treatment Period|Adverse Event|10
1058138|NCT01914666|2103420|FG001|Treatment Period|Adverse Event|4
1058139|NCT01914666|2103421|FG002|Treatment Period|Adverse Event|2
1058140|NCT01914666|2103419|FG000|Treatment Period|Withdrawal by Subject|3
1058141|NCT01914666|2103420|FG001|Treatment Period|Withdrawal by Subject|2
1058142|NCT01914666|2103421|FG002|Treatment Period|Withdrawal by Subject|2
1058143|NCT01914666|2103419|FG000|Treatment Period|Physician Decision|0
1058144|NCT01914666|2103420|FG001|Treatment Period|Physician Decision|0
1058145|NCT01914666|2103421|FG002|Treatment Period|Physician Decision|2
1058146|NCT01914679|2103427|FG000|Overall Study|Lack of Efficacy|1
1058147|NCT01914679|2103427|FG000|Overall Study|Sponsor terminated study|4
1058148|NCT01914757|2103434|FG000|Overall Study|Severe non-compliance to protocol|3
1058149|NCT01914757|2103435|FG001|Overall Study|Severe non-compliance to protocol|1
1058150|NCT01914757|2103436|FG002|Overall Study|Severe non-compliance to protocol|2
1058151|NCT01914757|2103434|FG000|Overall Study|Lost to Follow-up|5
1058152|NCT01914757|2103435|FG001|Overall Study|Lost to Follow-up|8
1058153|NCT01914757|2103436|FG002|Overall Study|Lost to Follow-up|6
1058154|NCT01914757|2103434|FG000|Overall Study|Withdrawal by Subject|15
1058155|NCT01914757|2103435|FG001|Overall Study|Withdrawal by Subject|27
1058156|NCT01914757|2103436|FG002|Overall Study|Withdrawal by Subject|19
1058157|NCT01914757|2103434|FG000|Overall Study|Death|2
1058158|NCT01914757|2103435|FG001|Overall Study|Death|2
1058159|NCT01914757|2103436|FG002|Overall Study|Death|1
1058160|NCT01914757|2103434|FG000|Overall Study|Adverse Event|4
1058161|NCT01914757|2103435|FG001|Overall Study|Adverse Event|3
1058162|NCT01914757|2103436|FG002|Overall Study|Adverse Event|4
1058163|NCT01914757|2103434|FG000|Overall Study|Study specific withdrawal criteria|0
1058164|NCT01914757|2103435|FG001|Overall Study|Study specific withdrawal criteria|1
1058165|NCT01914757|2103436|FG002|Overall Study|Study specific withdrawal criteria|0
1058166|NCT01914757|2103434|FG000|Overall Study|Eligibility criteria not fulfilled|2
1058167|NCT01914757|2103435|FG001|Overall Study|Eligibility criteria not fulfilled|0
1058168|NCT01914757|2103436|FG002|Overall Study|Eligibility criteria not fulfilled|2
1058169|NCT01914757|2103434|FG000|Overall Study|Other reasons|5
1058170|NCT01914757|2103435|FG001|Overall Study|Other reasons|9
1058171|NCT01914757|2103436|FG002|Overall Study|Other reasons|4
1058172|NCT01914926|2103446|FG000|Overall Study|Adverse Event|1
1058173|NCT01914926|2103447|FG001|Overall Study|Adverse Event|0
1058174|NCT01914926|2103446|FG000|Overall Study|uncooperative, agitated and removed|0
1058175|NCT01914926|2103447|FG001|Overall Study|uncooperative, agitated and removed|1
1058176|NCT01915095|2103460|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
1058177|NCT01915095|2103461|FG001|Overall Study|Some subjects were unable to commit to the training study.|0
1058178|NCT01915095|2103462|FG002|Overall Study|Some subjects were unable to commit to the training study.|0
1058179|NCT01915095|2103463|FG003|Overall Study|Some subjects were unable to commit to the training study.|4
1058180|NCT01915095|2103464|FG004|Overall Study|Some subjects were unable to commit to the training study.|6
1058181|NCT01915303|2103519|FG000|Core Phase|Adverse Event|7
1058182|NCT01915303|2103519|FG000|Core Phase|Unsatisfactory therapeutic effect|3
1058183|NCT01915303|2103519|FG000|Core Phase|Death|2
1058184|NCT01915303|2103519|FG000|Core Phase|Protocol Violation|2
1058185|NCT01915303|2103519|FG000|Core Phase|Abnormal lab value|1
1058186|NCT01915303|2103519|FG000|Core Phase|Withdrawal by Subject|1
1058187|NCT01915303|2103519|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
1058188|NCT01915303|2103519|FG000|Extension Phase|Withdrawal by Subject|4
1058189|NCT01915303|2103519|FG000|Extension Phase|Adverse Event|3
1058190|NCT01915303|2103519|FG000|Extension Phase|Death|1
1058191|NCT01915303|2103519|FG000|Extension Phase|Protocol Violation|1
1058192|NCT01915732|2103658|FG000|Overall Study|Withdrawal by Subject|18
1058193|NCT01915732|2103659|FG001|Overall Study|Withdrawal by Subject|18
1058194|NCT01915732|2103658|FG000|Overall Study|Failure to Meet Randomization Criteria|1
1058195|NCT01915732|2103659|FG001|Overall Study|Failure to Meet Randomization Criteria|0
1058196|NCT01915732|2103658|FG000|Overall Study|Adverse Event|12
1058197|NCT01915732|2103659|FG001|Overall Study|Adverse Event|4
1058198|NCT01915732|2103658|FG000|Overall Study|Protocol Violation|5
1058199|NCT01915732|2103659|FG001|Overall Study|Protocol Violation|5
1058200|NCT01915732|2103658|FG000|Overall Study|Lack of Efficacy|6
1058201|NCT01915732|2103659|FG001|Overall Study|Lack of Efficacy|11
1058202|NCT01915732|2103658|FG000|Overall Study|Lost to Follow-up|22
1058203|NCT01915732|2103659|FG001|Overall Study|Lost to Follow-up|26
1058204|NCT01915732|2103658|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1
1058205|NCT01915732|2103659|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0
1058206|NCT01915732|2103658|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1
1058207|NCT01915732|2103659|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0
1058208|NCT01915732|2103658|FG000|Overall Study|Drug Release Error|1
1058209|NCT01915732|2103659|FG001|Overall Study|Drug Release Error|0
1058210|NCT01915732|2103658|FG000|Overall Study|Recovered|1
1058211|NCT01915732|2103659|FG001|Overall Study|Recovered|0
1058212|NCT01915732|2103658|FG000|Overall Study|Pregnancy|1
1058213|NCT01915732|2103659|FG001|Overall Study|Pregnancy|0
1058214|NCT01915732|2103658|FG000|Overall Study|Poor Perceived Efficacy|1
1058215|NCT01915732|2103659|FG001|Overall Study|Poor Perceived Efficacy|0
1058216|NCT01915732|2103658|FG000|Overall Study|Par. Unable to Come to the Hospital|0
1058217|NCT01915732|2103659|FG001|Overall Study|Par. Unable to Come to the Hospital|1
1058218|NCT01915732|2103658|FG000|Overall Study|Got Well|0
1058219|NCT01915732|2103659|FG001|Overall Study|Got Well|1
1058220|NCT01915732|2103658|FG000|Overall Study|Par. not Willing to Continue Treatment|0
1058221|NCT01915732|2103659|FG001|Overall Study|Par. not Willing to Continue Treatment|1
1058222|NCT01915732|2103658|FG000|Overall Study|Par. Refused to Hospital Visits|0
1058223|NCT01915732|2103659|FG001|Overall Study|Par. Refused to Hospital Visits|1
1058224|NCT01915732|2103658|FG000|Overall Study|Job Transfer|0
1058225|NCT01915732|2103659|FG001|Overall Study|Job Transfer|1
1058226|NCT01915732|2103658|FG000|Overall Study|Improper Facial Procedure|0
1058227|NCT01915732|2103659|FG001|Overall Study|Improper Facial Procedure|1
1058228|NCT01915732|2103658|FG000|Overall Study|Poor Conscious Effect|0
1058229|NCT01915732|2103659|FG001|Overall Study|Poor Conscious Effect|1
1058230|NCT01915771|2103665|FG000|Day 1|Withdrawal by Subject|1
1058231|NCT01915771|2103665|FG000|Day 15|Withdrawal by Subject|1
1058232|NCT01915849|2103686|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1
1058233|NCT01915849|2103687|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0
1058234|NCT01915849|2103688|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0
1058235|NCT01915849|2103689|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0
1058236|NCT01915849|2103686|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1058237|NCT01915849|2103687|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1058238|NCT01915849|2103688|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1058239|NCT01915849|2103689|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1058240|NCT01915914|2103699|FG000|Acute Phase|Withdrawal by Subject|4
1058241|NCT01915914|2103700|FG001|Acute Phase|Withdrawal by Subject|0
1058242|NCT01915914|2103701|FG002|Acute Phase|Withdrawal by Subject|0
1058243|NCT01915914|2103702|FG003|Acute Phase|Withdrawal by Subject|0
1058244|NCT01915914|2103699|FG000|Acute Phase|Lost to Follow-up|4
1058245|NCT01915914|2103700|FG001|Acute Phase|Lost to Follow-up|0
1058246|NCT01915914|2103701|FG002|Acute Phase|Lost to Follow-up|0
1058247|NCT01915914|2103702|FG003|Acute Phase|Lost to Follow-up|0
1058248|NCT01915914|2103699|FG000|Acute Phase|Physician Decision|1
1058249|NCT01915914|2103700|FG001|Acute Phase|Physician Decision|0
1058250|NCT01915914|2103701|FG002|Acute Phase|Physician Decision|0
1058251|NCT01915914|2103702|FG003|Acute Phase|Physician Decision|0
1058252|NCT01915914|2103699|FG000|Acute Phase|Accepted Other Topic Therapies|1
1058253|NCT01915914|2103700|FG001|Acute Phase|Accepted Other Topic Therapies|0
1058254|NCT01915914|2103701|FG002|Acute Phase|Accepted Other Topic Therapies|0
1058255|NCT01915914|2103702|FG003|Acute Phase|Accepted Other Topic Therapies|0
1058256|NCT01915914|2103699|FG000|Acute Phase|"Not Achieved treatment success"|1
1058257|NCT01915914|2103700|FG001|Acute Phase|"Not Achieved treatment success"|0
1058258|NCT01915914|2103701|FG002|Acute Phase|"Not Achieved treatment success"|0
1058259|NCT01915914|2103702|FG003|Acute Phase|"Not Achieved treatment success"|0
1058260|NCT01915914|2103699|FG000|Acute Phase|Missing|1
1058261|NCT01915914|2103700|FG001|Acute Phase|Missing|0
1058262|NCT01915914|2103701|FG002|Acute Phase|Missing|0
1058263|NCT01915914|2103702|FG003|Acute Phase|Missing|0
1058264|NCT01915914|2103699|FG000|Maintenance Phase|Withdrawal by Subject|0
1058265|NCT01915914|2103700|FG001|Maintenance Phase|Withdrawal by Subject|1
1058266|NCT01915914|2103701|FG002|Maintenance Phase|Withdrawal by Subject|1
1058267|NCT01915914|2103702|FG003|Maintenance Phase|Withdrawal by Subject|0
1058268|NCT01915914|2103699|FG000|Maintenance Phase|Lost to Follow-up|0
1058269|NCT01915914|2103700|FG001|Maintenance Phase|Lost to Follow-up|4
1058270|NCT01915914|2103701|FG002|Maintenance Phase|Lost to Follow-up|1
1058271|NCT01915914|2103702|FG003|Maintenance Phase|Lost to Follow-up|0
1058272|NCT01915914|2103699|FG000|Maintenance Phase|Missing|0
1058273|NCT01915914|2103700|FG001|Maintenance Phase|Missing|1
1058274|NCT01915914|2103701|FG002|Maintenance Phase|Missing|0
1058275|NCT01915914|2103702|FG003|Maintenance Phase|Missing|0
1058276|NCT01915914|2103699|FG000|Follow-up Phase|Withdrawal by Subject|0
1058277|NCT01915914|2103700|FG001|Follow-up Phase|Withdrawal by Subject|0
1058278|NCT01915914|2103701|FG002|Follow-up Phase|Withdrawal by Subject|0
1058279|NCT01915914|2103702|FG003|Follow-up Phase|Withdrawal by Subject|1
1058280|NCT01915914|2103699|FG000|Follow-up Phase|Physician Decision|0
1058281|NCT01915914|2103700|FG001|Follow-up Phase|Physician Decision|0
1058282|NCT01915914|2103701|FG002|Follow-up Phase|Physician Decision|0
1058283|NCT01915914|2103702|FG003|Follow-up Phase|Physician Decision|1
1058284|NCT01915940|2103722|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39
1058285|NCT01915940|2103723|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0
1058286|NCT01915940|2103724|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0
1058287|NCT01915940|2103722|FG000|Treatment Period|Decision of Participant|0
1058288|NCT01915940|2103723|FG001|Treatment Period|Decision of Participant|1
1058289|NCT01915940|2103724|FG002|Treatment Period|Decision of Participant|3
1058290|NCT01915940|2103722|FG000|Treatment Period|Adverse Event|0
1058291|NCT01915940|2103723|FG001|Treatment Period|Adverse Event|9
1058292|NCT01915940|2103724|FG002|Treatment Period|Adverse Event|1
1058293|NCT01915940|2103722|FG000|Treatment Period|Other Miscellaneous Reasons|0
1058294|NCT01915940|2103723|FG001|Treatment Period|Other Miscellaneous Reasons|1
1058295|NCT01915940|2103724|FG002|Treatment Period|Other Miscellaneous Reasons|0
1058296|NCT01916109|2103730|FG000|Overall Study|Withdrawal by Subject|1
1058297|NCT01916226|2103738|FG000|Overall Study|Adverse Event|1
1058298|NCT01916226|2103739|FG001|Overall Study|Adverse Event|0
1058299|NCT01916226|2103740|FG002|Overall Study|Adverse Event|1
1058300|NCT01916226|2103741|FG003|Overall Study|Adverse Event|1
1058301|NCT01916226|2103738|FG000|Overall Study|Lack of Efficacy|0
1058302|NCT01916226|2103739|FG001|Overall Study|Lack of Efficacy|0
1058303|NCT01916226|2103740|FG002|Overall Study|Lack of Efficacy|2
1058304|NCT01916226|2103741|FG003|Overall Study|Lack of Efficacy|1
1058305|NCT01916226|2103738|FG000|Overall Study|Protocol Violation|0
1058306|NCT01916226|2103739|FG001|Overall Study|Protocol Violation|1
1058307|NCT01916226|2103740|FG002|Overall Study|Protocol Violation|0
1058308|NCT01916226|2103741|FG003|Overall Study|Protocol Violation|1
1058309|NCT01916226|2103738|FG000|Overall Study|Physician Decision|0
1058310|NCT01916226|2103739|FG001|Overall Study|Physician Decision|0
1058311|NCT01916226|2103740|FG002|Overall Study|Physician Decision|0
1058312|NCT01916226|2103741|FG003|Overall Study|Physician Decision|1
1058313|NCT01916304|2103752|FG000|Overall Study|Screening failure|17
1058314|NCT01916824|2103798|FG000|Overall Study|Lost to Follow-up|3
1058315|NCT01916824|2103799|FG001|Overall Study|Lost to Follow-up|6
1058316|NCT01916824|2103798|FG000|Overall Study|Physician Decision|2
1058317|NCT01916824|2103799|FG001|Overall Study|Physician Decision|0
1058318|NCT01916824|2103798|FG000|Overall Study|Withdrawal by Subject|2
1058319|NCT01916824|2103799|FG001|Overall Study|Withdrawal by Subject|3
1058320|NCT01916967|2103821|FG000|Overall Study|Adverse Event|0
1058321|NCT01916967|2103822|FG001|Overall Study|Adverse Event|0
1058322|NCT01916967|2103823|FG002|Overall Study|Adverse Event|2
1058323|NCT01916967|2103821|FG000|Overall Study|Lack of Efficacy|0
1058324|NCT01916967|2103822|FG001|Overall Study|Lack of Efficacy|0
1058325|NCT01916967|2103823|FG002|Overall Study|Lack of Efficacy|6
1058326|NCT01916967|2103821|FG000|Overall Study|Physician Decision|0
1058327|NCT01916967|2103822|FG001|Overall Study|Physician Decision|0
1058328|NCT01916967|2103823|FG002|Overall Study|Physician Decision|1
1058329|NCT01916967|2103821|FG000|Overall Study|Protocol Violation|0
1058330|NCT01916967|2103822|FG001|Overall Study|Protocol Violation|1
1058331|NCT01916967|2103823|FG002|Overall Study|Protocol Violation|0
1058332|NCT01916980|2103835|FG000|Overall Study|Adverse Event|4
1058333|NCT01916980|2103836|FG001|Overall Study|Adverse Event|2
1058334|NCT01916980|2103835|FG000|Overall Study|Lack of Efficacy|2
1058335|NCT01916980|2103836|FG001|Overall Study|Lack of Efficacy|2
1058336|NCT01916980|2103835|FG000|Overall Study|Withdrawal by Subject|1
1058337|NCT01916980|2103836|FG001|Overall Study|Withdrawal by Subject|0
1058338|NCT01917006|2103849|FG000|Randomized-treatment Period|Lost to Follow-up|1
1058339|NCT01917006|2103850|FG001|Randomized-treatment Period|Lost to Follow-up|0
1058340|NCT01917006|2103851|FG002|Randomized-treatment Period|Lost to Follow-up|0
1058341|NCT01917006|2103852|FG003|Randomized-treatment Period|Lost to Follow-up|1
1058342|NCT01917006|2103853|FG004|Randomized-treatment Period|Lost to Follow-up|0
1058343|NCT01917006|2103854|FG005|Randomized-treatment Period|Lost to Follow-up|0
1058344|NCT01917006|2103855|FG006|Randomized-treatment Period|Lost to Follow-up|0
1058345|NCT01917006|2103856|FG007|Randomized-treatment Period|Lost to Follow-up|0
1058346|NCT01917006|2103849|FG000|Randomized-treatment Period|Personal Reasons|0
1058347|NCT01917006|2103850|FG001|Randomized-treatment Period|Personal Reasons|0
1058348|NCT01917006|2103851|FG002|Randomized-treatment Period|Personal Reasons|0
1058349|NCT01917006|2103852|FG003|Randomized-treatment Period|Personal Reasons|0
1058350|NCT01917006|2103853|FG004|Randomized-treatment Period|Personal Reasons|0
1058351|NCT01917006|2103854|FG005|Randomized-treatment Period|Personal Reasons|1
1058352|NCT01917006|2103855|FG006|Randomized-treatment Period|Personal Reasons|0
1058353|NCT01917006|2103856|FG007|Randomized-treatment Period|Personal Reasons|0
1058354|NCT01917006|2103849|FG000|Randomized-treatment Period|Protocol Violation|1
1058355|NCT01917006|2103850|FG001|Randomized-treatment Period|Protocol Violation|0
1058356|NCT01917006|2103851|FG002|Randomized-treatment Period|Protocol Violation|0
1058357|NCT01917006|2103852|FG003|Randomized-treatment Period|Protocol Violation|0
1058358|NCT01917006|2103853|FG004|Randomized-treatment Period|Protocol Violation|0
1058359|NCT01917006|2103854|FG005|Randomized-treatment Period|Protocol Violation|0
1058360|NCT01917006|2103855|FG006|Randomized-treatment Period|Protocol Violation|0
1058361|NCT01917006|2103856|FG007|Randomized-treatment Period|Protocol Violation|0
1058362|NCT01917006|2103849|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0
1058363|NCT01917006|2103850|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0
1058364|NCT01917006|2103851|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0
1058365|NCT01917006|2103852|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0
1058366|NCT01917006|2103853|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0
1058367|NCT01917006|2103854|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0
1058368|NCT01917006|2103855|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1
1058369|NCT01917006|2103856|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0
1058370|NCT01917006|2103849|FG000|Open-label Period|Adverse Event|0
1058371|NCT01917006|2103850|FG001|Open-label Period|Adverse Event|0
1058372|NCT01917006|2103851|FG002|Open-label Period|Adverse Event|0
1058373|NCT01917006|2103852|FG003|Open-label Period|Adverse Event|0
1058374|NCT01917006|2103853|FG004|Open-label Period|Adverse Event|0
1058375|NCT01917006|2103854|FG005|Open-label Period|Adverse Event|0
1058376|NCT01917006|2103855|FG006|Open-label Period|Adverse Event|0
1058377|NCT01917006|2103856|FG007|Open-label Period|Adverse Event|1
1058378|NCT01917006|2103849|FG000|Open-label Period|Lost to Follow-up|0
1058379|NCT01917006|2103850|FG001|Open-label Period|Lost to Follow-up|0
1058380|NCT01917006|2103851|FG002|Open-label Period|Lost to Follow-up|0
1058381|NCT01917006|2103852|FG003|Open-label Period|Lost to Follow-up|0
1058382|NCT01917006|2103853|FG004|Open-label Period|Lost to Follow-up|0
1058383|NCT01917006|2103854|FG005|Open-label Period|Lost to Follow-up|0
1058384|NCT01917006|2103855|FG006|Open-label Period|Lost to Follow-up|0
1058385|NCT01917006|2103856|FG007|Open-label Period|Lost to Follow-up|1
1058386|NCT01917084|2103873|FG000|Overall Study|Withdrawal by Subject|1
1058387|NCT01917344|2103908|FG000|Overall Study|Withdrawal by Subject|1
1058388|NCT01917526|2103923|FG000|Overall Study|Protocol Violation|1
1058389|NCT01917526|2103924|FG001|Overall Study|Protocol Violation|1
1058390|NCT01917656|2103932|FG000|Overall Study|Adverse Event|11
1058391|NCT01917656|2103933|FG001|Overall Study|Adverse Event|0
1058392|NCT01917656|2103932|FG000|Overall Study|Withdrawal criteria|8
1058393|NCT01917656|2103933|FG001|Overall Study|Withdrawal criteria|14
1058394|NCT01917656|2103932|FG000|Overall Study|Unclassified|0
1058395|NCT01917656|2103933|FG001|Overall Study|Unclassified|3
1058396|NCT01917656|2103932|FG000|Overall Study|Withdrawal by Subject|4
1058397|NCT01917656|2103933|FG001|Overall Study|Withdrawal by Subject|3
1058398|NCT01917656|2103932|FG000|Overall Study|Lost to Follow-up|3
1058399|NCT01917656|2103933|FG001|Overall Study|Lost to Follow-up|4
1058400|NCT01917747|2103946|FG000|Overall Study|Withdrawal by Subject|1
1058401|NCT01917747|2103947|FG001|Overall Study|Withdrawal by Subject|2
1058402|NCT01917747|2103946|FG000|Overall Study|Lost to Follow-up|18
1058403|NCT01917747|2103947|FG001|Overall Study|Lost to Follow-up|9
1058404|NCT01917968|2103978|FG000|Overall Study|Death|3
1058405|NCT01917968|2103979|FG001|Overall Study|Death|2
1058406|NCT01917968|2103978|FG000|Overall Study|Lost to Follow-up|21
1058407|NCT01917968|2103979|FG001|Overall Study|Lost to Follow-up|39
1058408|NCT01917968|2103978|FG000|Overall Study|Physician Decision|1
1058409|NCT01917968|2103979|FG001|Overall Study|Physician Decision|2
1058410|NCT01917968|2103978|FG000|Overall Study|Withdrawal by Subject|20
1058411|NCT01917968|2103979|FG001|Overall Study|Withdrawal by Subject|35
1058412|NCT01917968|2103978|FG000|Overall Study|Subject Relocation|5
1058413|NCT01917968|2103979|FG001|Overall Study|Subject Relocation|1
1058414|NCT01917968|2103978|FG000|Overall Study|36M Missed Visit|3
1058415|NCT01917968|2103979|FG001|Overall Study|36M Missed Visit|2
1058416|NCT01917968|2103978|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1
1058417|NCT01917968|2103979|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0
1058418|NCT01917968|2103978|FG000|Overall Study|Change in Family Circumstances|0
1058419|NCT01917968|2103979|FG001|Overall Study|Change in Family Circumstances|1
1058420|NCT01917968|2103978|FG000|Overall Study|No Data Available|0
1058421|NCT01917968|2103979|FG001|Overall Study|No Data Available|2
1058422|NCT01918033|2103995|FG000|Overall Study|Adverse Event|1
1058423|NCT01918033|2103996|FG001|Overall Study|Adverse Event|0
1058424|NCT01918033|2103997|FG002|Overall Study|Adverse Event|2
1058425|NCT01918033|2103995|FG000|Overall Study|Lost to Follow-up|0
1058426|NCT01918033|2103996|FG001|Overall Study|Lost to Follow-up|1
1058427|NCT01918033|2103997|FG002|Overall Study|Lost to Follow-up|0
1058428|NCT01918033|2103995|FG000|Overall Study|Protocol Violation|2
1058429|NCT01918033|2103996|FG001|Overall Study|Protocol Violation|0
1058430|NCT01918033|2103997|FG002|Overall Study|Protocol Violation|1
1058431|NCT01918033|2103995|FG000|Overall Study|Withdrawal by Subject|2
1058432|NCT01918033|2103996|FG001|Overall Study|Withdrawal by Subject|1
1058433|NCT01918033|2103997|FG002|Overall Study|Withdrawal by Subject|0
1058434|NCT01918085|2104019|FG000|Test Period 1: Strata Strip|Adverse Event|0
1058435|NCT01918085|2104020|FG001|Test Period 1: Strata Strip|Adverse Event|1
1058436|NCT01918306|2104035|FG000|Overall Study|progresive disease|4
1058437|NCT01918306|2104036|FG001|Overall Study|progresive disease|0
1058438|NCT01918306|2104037|FG002|Overall Study|progresive disease|1
1058439|NCT01918306|2104038|FG003|Overall Study|progresive disease|1
1058440|NCT01918306|2104035|FG000|Overall Study|Withdrawal by Subject|0
1058441|NCT01918306|2104036|FG001|Overall Study|Withdrawal by Subject|0
1058442|NCT01918306|2104037|FG002|Overall Study|Withdrawal by Subject|0
1058443|NCT01918306|2104038|FG003|Overall Study|Withdrawal by Subject|2
1058444|NCT01918306|2104035|FG000|Overall Study|neutropenia|1
1058445|NCT01918306|2104036|FG001|Overall Study|neutropenia|0
1058446|NCT01918306|2104037|FG002|Overall Study|neutropenia|0
1058447|NCT01918306|2104038|FG003|Overall Study|neutropenia|0
1058448|NCT01918306|2104035|FG000|Overall Study|Lack of Efficacy|1
1058449|NCT01918306|2104036|FG001|Overall Study|Lack of Efficacy|0
1058450|NCT01918306|2104037|FG002|Overall Study|Lack of Efficacy|0
1058451|NCT01918306|2104038|FG003|Overall Study|Lack of Efficacy|0
1058452|NCT01918306|2104035|FG000|Overall Study|progress disease, crossover|0
1058453|NCT01918306|2104036|FG001|Overall Study|progress disease, crossover|0
1058454|NCT01918306|2104037|FG002|Overall Study|progress disease, crossover|1
1058455|NCT01918306|2104038|FG003|Overall Study|progress disease, crossover|0
1058456|NCT01918332|2104062|FG000|Overall Study|Adverse Event|0
1058457|NCT01918332|2104063|FG001|Overall Study|Adverse Event|0
1058458|NCT01918332|2104064|FG002|Overall Study|Adverse Event|0
1058459|NCT01918332|2104065|FG003|Overall Study|Adverse Event|1
1058460|NCT01918332|2104062|FG000|Overall Study|Withdrawal by Subject|2
1058461|NCT01918332|2104063|FG001|Overall Study|Withdrawal by Subject|3
1058462|NCT01918332|2104064|FG002|Overall Study|Withdrawal by Subject|2
1058463|NCT01918332|2104065|FG003|Overall Study|Withdrawal by Subject|3
1058464|NCT01918332|2104062|FG000|Overall Study|Protocol Violation|6
1058465|NCT01918332|2104063|FG001|Overall Study|Protocol Violation|2
1058466|NCT01918332|2104064|FG002|Overall Study|Protocol Violation|6
1058467|NCT01918332|2104065|FG003|Overall Study|Protocol Violation|3
1058468|NCT01918332|2104062|FG000|Overall Study|lipid result by central lab did not meet|0
1058469|NCT01918332|2104063|FG001|Overall Study|lipid result by central lab did not meet|0
1058470|NCT01918332|2104064|FG002|Overall Study|lipid result by central lab did not meet|1
1058471|NCT01918332|2104065|FG003|Overall Study|lipid result by central lab did not meet|0
1058472|NCT01918371|2104077|FG000|Overall Study|Missing Data|1
1058473|NCT01918371|2104078|FG001|Overall Study|Missing Data|1
1058474|NCT01918774|2104088|FG000|Overall Study|Lost prior to first CBTw session|4
1058475|NCT01918774|2104088|FG000|Overall Study|Lost to Follow-up|1
1058476|NCT01919112|2104104|FG000|Secondary Analysis-day 30|Death|1
1058477|NCT01919112|2104105|FG001|Secondary Analysis-day 30|Death|1
1058478|NCT01919112|2104106|FG002|Secondary Analysis-day 30|Death|1
1058479|NCT01919112|2104104|FG000|Secondary Analysis-day 30|Lost to Follow-up|1
1058480|NCT01919112|2104105|FG001|Secondary Analysis-day 30|Lost to Follow-up|0
1058481|NCT01919112|2104106|FG002|Secondary Analysis-day 30|Lost to Follow-up|0
1058482|NCT01919164|2104119|FG000|Overall Study|Adverse Event|6
1058483|NCT01919164|2104120|FG001|Overall Study|Adverse Event|4
1058484|NCT01919164|2104121|FG002|Overall Study|Adverse Event|9
1058485|NCT01919164|2104122|FG003|Overall Study|Adverse Event|3
1058486|NCT01919164|2104123|FG004|Overall Study|Adverse Event|2
1058487|NCT01919164|2104119|FG000|Overall Study|Lost to Follow-up|2
1058488|NCT01919164|2104120|FG001|Overall Study|Lost to Follow-up|2
1058489|NCT01919164|2104121|FG002|Overall Study|Lost to Follow-up|2
1058490|NCT01919164|2104122|FG003|Overall Study|Lost to Follow-up|0
1058491|NCT01919164|2104123|FG004|Overall Study|Lost to Follow-up|4
1058492|NCT01919164|2104119|FG000|Overall Study|Death|1
1058493|NCT01919164|2104120|FG001|Overall Study|Death|0
1058494|NCT01919164|2104121|FG002|Overall Study|Death|0
1058495|NCT01919164|2104122|FG003|Overall Study|Death|0
1058496|NCT01919164|2104123|FG004|Overall Study|Death|0
1058497|NCT01919164|2104119|FG000|Overall Study|Protocol Violation|6
1058498|NCT01919164|2104120|FG001|Overall Study|Protocol Violation|0
1058499|NCT01919164|2104121|FG002|Overall Study|Protocol Violation|3
1058500|NCT01919164|2104122|FG003|Overall Study|Protocol Violation|2
1058501|NCT01919164|2104123|FG004|Overall Study|Protocol Violation|2
1058502|NCT01919164|2104119|FG000|Overall Study|Disease progression|2
1058503|NCT01919164|2104120|FG001|Overall Study|Disease progression|2
1058504|NCT01919164|2104121|FG002|Overall Study|Disease progression|1
1058505|NCT01919164|2104122|FG003|Overall Study|Disease progression|2
1058506|NCT01919164|2104123|FG004|Overall Study|Disease progression|1
1058507|NCT01919164|2104119|FG000|Overall Study|Withdrew consent|13
1058508|NCT01919164|2104120|FG001|Overall Study|Withdrew consent|13
1058509|NCT01919164|2104121|FG002|Overall Study|Withdrew consent|14
1058510|NCT01919164|2104122|FG003|Overall Study|Withdrew consent|14
1058511|NCT01919164|2104123|FG004|Overall Study|Withdrew consent|9
1058512|NCT01919164|2104119|FG000|Overall Study|Other Un-specified|13
1058513|NCT01919164|2104120|FG001|Overall Study|Other Un-specified|9
1058514|NCT01919164|2104121|FG002|Overall Study|Other Un-specified|8
1058515|NCT01919164|2104122|FG003|Overall Study|Other Un-specified|7
1058516|NCT01919164|2104123|FG004|Overall Study|Other Un-specified|15
1058517|NCT01919190|2104137|FG000|Overall Study|Intra-op findings, etc.|3
1058518|NCT01919190|2104138|FG001|Overall Study|Intra-op findings, etc.|0
1058519|NCT01919229|2104161|FG000|Overall Study|Subject/guardian decision|0
1058520|NCT01919229|2104162|FG001|Overall Study|Subject/guardian decision|0
1058521|NCT01919229|2104163|FG002|Overall Study|Subject/guardian decision|1
1058522|NCT01919307|2104171|FG000|Overall Study|Withdrawal by Subject|9
1058523|NCT01919398|2104178|FG000|Overall Study|Progressive Disease|0
1058524|NCT01919398|2104179|FG001|Overall Study|Progressive Disease|0
1058525|NCT01919398|2104180|FG002|Overall Study|Progressive Disease|4
1058526|NCT01919411|2104190|FG000|Overall Study|Lost to Follow-up|2
1058527|NCT01919411|2104191|FG001|Overall Study|Lost to Follow-up|4
1058528|NCT01919411|2104190|FG000|Overall Study|Physician Decision|1
1058529|NCT01919411|2104191|FG001|Overall Study|Physician Decision|0
1058530|NCT01919411|2104190|FG000|Overall Study|Protocol Violation|2
1058531|NCT01919411|2104191|FG001|Overall Study|Protocol Violation|1
1058532|NCT01919489|2104216|FG000|Overall Study|Rejected the need of injections|4
1058533|NCT01919489|2104217|FG001|Overall Study|Rejected the need of injections|7
1058534|NCT01919489|2104216|FG000|Overall Study|Adverse Event|10
1058535|NCT01919489|2104217|FG001|Overall Study|Adverse Event|0
1058536|NCT01919489|2104216|FG000|Overall Study|Hospital readmission|2
1058537|NCT01919489|2104217|FG001|Overall Study|Hospital readmission|9
1058538|NCT01919489|2104216|FG000|Overall Study|Death|2
1058539|NCT01919489|2104217|FG001|Overall Study|Death|1
1058540|NCT01919489|2104216|FG000|Overall Study|Lost to Follow-up|38
1058541|NCT01919489|2104217|FG001|Overall Study|Lost to Follow-up|27
1058542|NCT01919723|2104244|FG000|Overall Study|Blood Samples Hemolyzed|2
1058543|NCT01919723|2104245|FG001|Overall Study|Blood Samples Hemolyzed|2
1058544|NCT01919801|2104253|FG000|Overall Study|Withdrawal by Subject|1
1058545|NCT01919801|2104254|FG001|Overall Study|Withdrawal by Subject|0
1058546|NCT01919801|2104253|FG000|Overall Study|Physician Decision|0
1058547|NCT01919801|2104254|FG001|Overall Study|Physician Decision|1
1058548|NCT01919801|2104253|FG000|Overall Study|Lost to Follow-up|0
1058549|NCT01919801|2104254|FG001|Overall Study|Lost to Follow-up|1
1058550|NCT01919801|2104253|FG000|Overall Study|Other|0
1058551|NCT01919801|2104254|FG001|Overall Study|Other|1
1058552|NCT01919814|2104260|FG000|Overall Study|Adverse Event|1
1058553|NCT01919814|2104261|FG001|Overall Study|Adverse Event|0
1058554|NCT01919814|2104260|FG000|Overall Study|Protocol Violation|1
1058555|NCT01919814|2104261|FG001|Overall Study|Protocol Violation|0
1058556|NCT01919814|2104260|FG000|Overall Study|Withdrawal by Subject|1
1058557|NCT01919814|2104261|FG001|Overall Study|Withdrawal by Subject|0
1058558|NCT01919970|2104269|FG000|Overall Study|Withdrawal by Subject|3
1058559|NCT01919970|2104270|FG001|Overall Study|Withdrawal by Subject|0
1058560|NCT01920061|2104300|FG000|Overall Study|Death|1
1058561|NCT01920061|2104301|FG001|Overall Study|Death|1
1058562|NCT01920061|2104302|FG002|Overall Study|Death|0
1058563|NCT01920061|2104303|FG003|Overall Study|Death|1
1058564|NCT01920061|2104304|FG004|Overall Study|Death|1
1058565|NCT01920061|2104305|FG005|Overall Study|Death|0
1058566|NCT01920061|2104306|FG006|Overall Study|Death|0
1058567|NCT01920061|2104307|FG007|Overall Study|Death|1
1058568|NCT01920061|2104308|FG008|Overall Study|Death|0
1058569|NCT01920061|2104309|FG009|Overall Study|Death|1
1058570|NCT01920061|2104310|FG010|Overall Study|Death|0
1058571|NCT01920061|2104311|FG011|Overall Study|Death|1
1058572|NCT01920061|2104312|FG012|Overall Study|Death|0
1058573|NCT01920061|2104313|FG013|Overall Study|Death|2
1058574|NCT01920061|2104314|FG014|Overall Study|Death|0
1058575|NCT01920061|2104315|FG015|Overall Study|Death|0
1058576|NCT01920061|2104316|FG016|Overall Study|Death|0
1058577|NCT01920061|2104317|FG017|Overall Study|Death|0
1058578|NCT01920061|2104318|FG018|Overall Study|Death|1
1058579|NCT01920061|2104319|FG019|Overall Study|Death|0
1058580|NCT01920061|2104300|FG000|Overall Study|Lost to Follow-up|0
1058581|NCT01920061|2104301|FG001|Overall Study|Lost to Follow-up|2
1058582|NCT01920061|2104302|FG002|Overall Study|Lost to Follow-up|0
1058583|NCT01920061|2104303|FG003|Overall Study|Lost to Follow-up|0
1058584|NCT01920061|2104304|FG004|Overall Study|Lost to Follow-up|0
1058585|NCT01920061|2104305|FG005|Overall Study|Lost to Follow-up|0
1058586|NCT01920061|2104306|FG006|Overall Study|Lost to Follow-up|1
1058587|NCT01920061|2104307|FG007|Overall Study|Lost to Follow-up|0
1058588|NCT01920061|2104308|FG008|Overall Study|Lost to Follow-up|0
1058589|NCT01920061|2104309|FG009|Overall Study|Lost to Follow-up|0
1058590|NCT01920061|2104310|FG010|Overall Study|Lost to Follow-up|3
1058591|NCT01920061|2104311|FG011|Overall Study|Lost to Follow-up|0
1058592|NCT01920061|2104312|FG012|Overall Study|Lost to Follow-up|0
1058593|NCT01920061|2104313|FG013|Overall Study|Lost to Follow-up|0
1058594|NCT01920061|2104314|FG014|Overall Study|Lost to Follow-up|0
1058595|NCT01920061|2104315|FG015|Overall Study|Lost to Follow-up|0
1058596|NCT01920061|2104316|FG016|Overall Study|Lost to Follow-up|0
1058597|NCT01920061|2104317|FG017|Overall Study|Lost to Follow-up|1
1058598|NCT01920061|2104318|FG018|Overall Study|Lost to Follow-up|4
1058599|NCT01920061|2104319|FG019|Overall Study|Lost to Follow-up|3
1058600|NCT01920061|2104300|FG000|Overall Study|Other|1
1058601|NCT01920061|2104301|FG001|Overall Study|Other|1
1058602|NCT01920061|2104302|FG002|Overall Study|Other|2
1058603|NCT01920061|2104303|FG003|Overall Study|Other|1
1058604|NCT01920061|2104304|FG004|Overall Study|Other|0
1058605|NCT01920061|2104305|FG005|Overall Study|Other|1
1058606|NCT01920061|2104306|FG006|Overall Study|Other|0
1058607|NCT01920061|2104307|FG007|Overall Study|Other|0
1058608|NCT01920061|2104308|FG008|Overall Study|Other|0
1058609|NCT01920061|2104309|FG009|Overall Study|Other|1
1058610|NCT01920061|2104310|FG010|Overall Study|Other|1
1058611|NCT01920061|2104311|FG011|Overall Study|Other|2
1058612|NCT01920061|2104312|FG012|Overall Study|Other|1
1058613|NCT01920061|2104313|FG013|Overall Study|Other|4
1058614|NCT01920061|2104314|FG014|Overall Study|Other|0
1058615|NCT01920061|2104315|FG015|Overall Study|Other|1
1058616|NCT01920061|2104316|FG016|Overall Study|Other|1
1058617|NCT01920061|2104317|FG017|Overall Study|Other|0
1058618|NCT01920061|2104318|FG018|Overall Study|Other|1
1058619|NCT01920061|2104319|FG019|Overall Study|Other|1
1058620|NCT01920061|2104300|FG000|Overall Study|Participant refused further follow-up|0
1058621|NCT01920061|2104301|FG001|Overall Study|Participant refused further follow-up|0
1058622|NCT01920061|2104302|FG002|Overall Study|Participant refused further follow-up|0
1058623|NCT01920061|2104303|FG003|Overall Study|Participant refused further follow-up|0
1058624|NCT01920061|2104304|FG004|Overall Study|Participant refused further follow-up|1
1058625|NCT01920061|2104305|FG005|Overall Study|Participant refused further follow-up|1
1058626|NCT01920061|2104306|FG006|Overall Study|Participant refused further follow-up|0
1058627|NCT01920061|2104307|FG007|Overall Study|Participant refused further follow-up|0
1058628|NCT01920061|2104308|FG008|Overall Study|Participant refused further follow-up|1
1058629|NCT01920061|2104309|FG009|Overall Study|Participant refused further follow-up|0
1058630|NCT01920061|2104310|FG010|Overall Study|Participant refused further follow-up|1
1058631|NCT01920061|2104311|FG011|Overall Study|Participant refused further follow-up|0
1058632|NCT01920061|2104312|FG012|Overall Study|Participant refused further follow-up|1
1058633|NCT01920061|2104313|FG013|Overall Study|Participant refused further follow-up|0
1058634|NCT01920061|2104314|FG014|Overall Study|Participant refused further follow-up|1
1058635|NCT01920061|2104315|FG015|Overall Study|Participant refused further follow-up|2
1058636|NCT01920061|2104316|FG016|Overall Study|Participant refused further follow-up|1
1058637|NCT01920061|2104317|FG017|Overall Study|Participant refused further follow-up|1
1058638|NCT01920061|2104318|FG018|Overall Study|Participant refused further follow-up|0
1058639|NCT01920061|2104319|FG019|Overall Study|Participant refused further follow-up|0
1058640|NCT01920152|2104384|FG000|Overall Study|Withdrawal by Subject|1
1058641|NCT01920152|2104385|FG001|Overall Study|Withdrawal by Subject|2
1058642|NCT01920178|2104393|FG000|Overall Study|Lost to Follow-up|2
1058643|NCT01920178|2104394|FG001|Overall Study|Lost to Follow-up|1
1058644|NCT01920477|2104415|FG000|Overall Study|Adverse Event|0
1058645|NCT01920477|2104416|FG001|Overall Study|Adverse Event|1
1058646|NCT01920477|2104415|FG000|Overall Study|Lack of Efficacy|1
1058647|NCT01920477|2104416|FG001|Overall Study|Lack of Efficacy|0
1058648|NCT01920477|2104415|FG000|Overall Study|Study closed/terminated|14
1058649|NCT01920477|2104416|FG001|Overall Study|Study closed/terminated|15
1058650|NCT01920477|2104415|FG000|Overall Study|Withdrawal by Subject|0
1058651|NCT01920477|2104416|FG001|Overall Study|Withdrawal by Subject|1
1058652|NCT01920555|2104427|FG000|Overall Study|Physician Decision|1
1058653|NCT01920555|2104428|FG001|Overall Study|Physician Decision|2
1058654|NCT01920555|2104429|FG002|Overall Study|Physician Decision|1
1058655|NCT01920555|2104430|FG003|Overall Study|Physician Decision|2
1058656|NCT01920555|2104431|FG004|Overall Study|Physician Decision|0
1058657|NCT01920555|2104427|FG000|Overall Study|Lack of Efficacy|2
1058658|NCT01920555|2104428|FG001|Overall Study|Lack of Efficacy|0
1058659|NCT01920555|2104429|FG002|Overall Study|Lack of Efficacy|0
1058660|NCT01920555|2104430|FG003|Overall Study|Lack of Efficacy|0
1058661|NCT01920555|2104431|FG004|Overall Study|Lack of Efficacy|0
1058662|NCT01920555|2104427|FG000|Overall Study|Travel Difficulties|1
1058663|NCT01920555|2104428|FG001|Overall Study|Travel Difficulties|1
1058664|NCT01920555|2104429|FG002|Overall Study|Travel Difficulties|0
1058665|NCT01920555|2104430|FG003|Overall Study|Travel Difficulties|0
1058666|NCT01920555|2104431|FG004|Overall Study|Travel Difficulties|1
1058667|NCT01920555|2104427|FG000|Overall Study|Lost to Follow-up|0
1058668|NCT01920555|2104428|FG001|Overall Study|Lost to Follow-up|1
1058669|NCT01920555|2104429|FG002|Overall Study|Lost to Follow-up|0
1058670|NCT01920555|2104430|FG003|Overall Study|Lost to Follow-up|1
1058671|NCT01920555|2104431|FG004|Overall Study|Lost to Follow-up|0
1058672|NCT01920568|2104445|FG000|Overall Study|Adverse Event|27
1058673|NCT01920568|2104446|FG001|Overall Study|Adverse Event|8
1058674|NCT01920568|2104445|FG000|Overall Study|Protocol Violation|5
1058675|NCT01920568|2104446|FG001|Overall Study|Protocol Violation|3
1058676|NCT01920568|2104445|FG000|Overall Study|Lost to Follow-up|2
1058677|NCT01920568|2104446|FG001|Overall Study|Lost to Follow-up|2
1058678|NCT01920568|2104445|FG000|Overall Study|Physician Decision|13
1058679|NCT01920568|2104446|FG001|Overall Study|Physician Decision|4
1058680|NCT01920568|2104445|FG000|Overall Study|Withdrawal by Subject|79
1058681|NCT01920568|2104446|FG001|Overall Study|Withdrawal by Subject|55
1058682|NCT01920568|2104445|FG000|Overall Study|Death due to disease progression|25
1058683|NCT01920568|2104446|FG001|Overall Study|Death due to disease progression|12
1058684|NCT01920594|2104455|FG000|Overall Study|Adverse Event|4
1058685|NCT01920594|2104456|FG001|Overall Study|Adverse Event|2
1058686|NCT01920594|2104455|FG000|Overall Study|Lost to Follow-up|1
1058687|NCT01920594|2104456|FG001|Overall Study|Lost to Follow-up|0
1058688|NCT01920594|2104455|FG000|Overall Study|Recovery|2
1058689|NCT01920594|2104456|FG001|Overall Study|Recovery|0
1058690|NCT01920594|2104455|FG000|Overall Study|Investigator discretion|0
1058691|NCT01920594|2104456|FG001|Overall Study|Investigator discretion|1
1058692|NCT01920711|2104464|FG000|Overall Study|Death|347
1058693|NCT01920711|2104465|FG001|Overall Study|Death|356
1058694|NCT01920711|2104464|FG000|Overall Study|Lost to Follow-up|13
1058695|NCT01920711|2104465|FG001|Overall Study|Lost to Follow-up|14
1058696|NCT01920711|2104464|FG000|Overall Study|Withdrawal by Subject|4
1058697|NCT01920711|2104465|FG001|Overall Study|Withdrawal by Subject|3
1058698|NCT01920854|2104492|FG000|Overall Study|Withdrawal by Subject|1
1058699|NCT01920854|2104493|FG001|Overall Study|Withdrawal by Subject|0
1058700|NCT01920854|2104494|FG002|Overall Study|Withdrawal by Subject|0
1058701|NCT01920854|2104495|FG003|Overall Study|Withdrawal by Subject|0
1058702|NCT01920854|2104496|FG004|Overall Study|Withdrawal by Subject|1
1058703|NCT01920854|2104497|FG005|Overall Study|Withdrawal by Subject|0
1058704|NCT01920854|2104498|FG006|Overall Study|Withdrawal by Subject|1
1058705|NCT01920893|2104535|FG000|Overall Study|Adverse Event|5
1058706|NCT01920893|2104536|FG001|Overall Study|Adverse Event|2
1058707|NCT01920893|2104535|FG000|Overall Study|Lack of Efficacy|2
1058708|NCT01920893|2104536|FG001|Overall Study|Lack of Efficacy|0
1058709|NCT01920958|2104543|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5
1058710|NCT01921101|2104549|FG000|Overall Study|Death|16
1058711|NCT01921101|2104550|FG001|Overall Study|Death|6
1058712|NCT01921179|2104567|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
1058713|NCT01921179|2104568|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
1058714|NCT01921179|2104567|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
1058715|NCT01921179|2104568|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
1058716|NCT01921205|2104577|FG000|Overall Study|Adverse Event|12
1058717|NCT01921205|2104578|FG001|Overall Study|Adverse Event|7
1058718|NCT01921205|2104577|FG000|Overall Study|Lack of Efficacy|1
1058719|NCT01921205|2104578|FG001|Overall Study|Lack of Efficacy|0
1058720|NCT01921205|2104577|FG000|Overall Study|Protocol Violation|1
1058721|NCT01921205|2104578|FG001|Overall Study|Protocol Violation|3
1058722|NCT01921205|2104577|FG000|Overall Study|Lost to Follow-up|1
1058723|NCT01921205|2104578|FG001|Overall Study|Lost to Follow-up|1
1058724|NCT01921205|2104577|FG000|Overall Study|Withdrawal by Subject|6
1058725|NCT01921205|2104578|FG001|Overall Study|Withdrawal by Subject|5
1058726|NCT01921205|2104577|FG000|Overall Study|Use Of Prohibited Medication|0
1058727|NCT01921205|2104578|FG001|Overall Study|Use Of Prohibited Medication|1
1058728|NCT01921205|2104577|FG000|Overall Study|The Excessive Use Of Rescue Medication|0
1058729|NCT01921205|2104578|FG001|Overall Study|The Excessive Use Of Rescue Medication|1
1058730|NCT01921205|2104577|FG000|Overall Study|Non Compliance Of The Parent|0
1058731|NCT01921205|2104578|FG001|Overall Study|Non Compliance Of The Parent|1
1058732|NCT01921205|2104577|FG000|Overall Study|Non Compliance Of Child|0
1058733|NCT01921205|2104578|FG001|Overall Study|Non Compliance Of Child|1
1058734|NCT01921257|2104593|FG000|Overall Study|Adverse Event|1
1058735|NCT01921257|2104593|FG000|Overall Study|Protocol Violation|1
1058736|NCT01921257|2104593|FG000|Overall Study|Withdrawal by Subject|1
1058737|NCT01921270|2104598|FG000|Overall Study|Withdrawal by Subject|1
1058738|NCT01921348|2104617|FG000|Overall Study|Withdrawal by Subject|1
1058739|NCT01921348|2104618|FG001|Overall Study|Withdrawal by Subject|0
1058740|NCT01921348|2104617|FG000|Overall Study|Lost to Follow-up|0
1058741|NCT01921348|2104618|FG001|Overall Study|Lost to Follow-up|2
1058742|NCT01921387|2104624|FG000|Overall Study|Adverse Event|1
1058743|NCT01921517|2104635|FG000|Overall Study|Lost to Follow-up|5
1058744|NCT01921517|2104636|FG001|Overall Study|Lost to Follow-up|0
1058745|NCT01921517|2104635|FG000|Overall Study|Newly diagnosed health concern|2
1058746|NCT01921517|2104636|FG001|Overall Study|Newly diagnosed health concern|0
1058747|NCT01921517|2104635|FG000|Overall Study|Physician Decision|0
1058748|NCT01921517|2104636|FG001|Overall Study|Physician Decision|2
1058749|NCT01921517|2104635|FG000|Overall Study|Withdrawal by Subject|7
1058750|NCT01921517|2104636|FG001|Overall Study|Withdrawal by Subject|3
1058751|NCT01921517|2104635|FG000|Overall Study|Subject missed final imaging|1
1058752|NCT01921517|2104636|FG001|Overall Study|Subject missed final imaging|4
1058753|NCT01921829|2104663|FG000|Overall Study|Withdrawal by Subject|0
1058754|NCT01921829|2104664|FG001|Overall Study|Withdrawal by Subject|1
1058755|NCT01922011|2104697|FG000|Overall Study|Protocol Violation|0
1058756|NCT01922011|2104698|FG001|Overall Study|Protocol Violation|1
1058757|NCT01922011|2104697|FG000|Overall Study|Physician Decision|0
1058758|NCT01922011|2104698|FG001|Overall Study|Physician Decision|1
1058759|NCT01922011|2104697|FG000|Overall Study|Parent/Guardian Decision|3
1058760|NCT01922011|2104698|FG001|Overall Study|Parent/Guardian Decision|0
1058761|NCT01922011|2104697|FG000|Overall Study|Lost to Follow-up|0
1058762|NCT01922011|2104698|FG001|Overall Study|Lost to Follow-up|1
1058763|NCT01922011|2104697|FG000|Overall Study|Missed Test-of-Cure Visit|0
1058764|NCT01922011|2104698|FG001|Overall Study|Missed Test-of-Cure Visit|2
1058765|NCT01922011|2104697|FG000|Overall Study|Not Treated|1
1058766|NCT01922011|2104698|FG001|Overall Study|Not Treated|0
1058767|NCT01922011|2104697|FG000|Overall Study|Lack of willing home health agency|1
1058768|NCT01922011|2104698|FG001|Overall Study|Lack of willing home health agency|0
1058769|NCT01922011|2104697|FG000|Overall Study|Randomized in error|1
1058770|NCT01922011|2104698|FG001|Overall Study|Randomized in error|0
1058771|NCT01922037|2104721|FG000|Overall Study|Withdrawal by Subject|2
1058772|NCT01922037|2104722|FG001|Overall Study|Withdrawal by Subject|44
1058773|NCT01922037|2104721|FG000|Overall Study|Adverse Event|1
1058774|NCT01922037|2104722|FG001|Overall Study|Adverse Event|7
1058775|NCT01922037|2104721|FG000|Overall Study|Death|0
1058776|NCT01922037|2104722|FG001|Overall Study|Death|5
1058777|NCT01922037|2104721|FG000|Overall Study|Pregnancy|0
1058778|NCT01922037|2104722|FG001|Overall Study|Pregnancy|2
1058779|NCT01922037|2104721|FG000|Overall Study|Participant non-compliance|4
1058780|NCT01922037|2104722|FG001|Overall Study|Participant non-compliance|46
1058781|NCT01922037|2104721|FG000|Overall Study|Investigator/Sponsor decision|1
1058782|NCT01922037|2104722|FG001|Overall Study|Investigator/Sponsor decision|4
1058783|NCT01922037|2104721|FG000|Overall Study|Other unspecified|2
1058784|NCT01922037|2104722|FG001|Overall Study|Other unspecified|66
1058785|NCT01922089|2104789|FG000|Overall Study|Adverse Event|18
1058786|NCT01922089|2104790|FG001|Overall Study|Adverse Event|13
1058787|NCT01922089|2104789|FG000|Overall Study|Protocol Deviation|10
1058788|NCT01922089|2104790|FG001|Overall Study|Protocol Deviation|7
1058789|NCT01922089|2104789|FG000|Overall Study|Withdrawal by Subject|3
1058790|NCT01922089|2104790|FG001|Overall Study|Withdrawal by Subject|4
1058791|NCT01922089|2104789|FG000|Overall Study|administrative problems|4
1058792|NCT01922089|2104790|FG001|Overall Study|administrative problems|1
1058793|NCT01922089|2104789|FG000|Overall Study|Physician Decision|2
1058794|NCT01922089|2104790|FG001|Overall Study|Physician Decision|3
1058795|NCT01922089|2104789|FG000|Overall Study|Death|2
1058796|NCT01922089|2104790|FG001|Overall Study|Death|1
1058797|NCT01922089|2104789|FG000|Overall Study|Lost to Follow-up|0
1058798|NCT01922089|2104790|FG001|Overall Study|Lost to Follow-up|1
1058799|NCT01922102|2104799|FG000|Overall Study|Withdrawal by Subject|7
1058800|NCT01922102|2104800|FG001|Overall Study|Withdrawal by Subject|3
1058801|NCT01922102|2104801|FG002|Overall Study|Withdrawal by Subject|7
1058802|NCT01922102|2104799|FG000|Overall Study|Physician Decision|0
1058803|NCT01922102|2104800|FG001|Overall Study|Physician Decision|2
1058804|NCT01922102|2104801|FG002|Overall Study|Physician Decision|1
1058805|NCT01922102|2104799|FG000|Overall Study|Adverse Event|1
1058806|NCT01922102|2104800|FG001|Overall Study|Adverse Event|2
1058807|NCT01922102|2104801|FG002|Overall Study|Adverse Event|0
1058808|NCT01922102|2104799|FG000|Overall Study|Lost to Follow-up|1
1058809|NCT01922102|2104800|FG001|Overall Study|Lost to Follow-up|0
1058810|NCT01922102|2104801|FG002|Overall Study|Lost to Follow-up|0
1058811|NCT01922102|2104799|FG000|Overall Study|Administrative problems|0
1058812|NCT01922102|2104800|FG001|Overall Study|Administrative problems|2
1058813|NCT01922102|2104801|FG002|Overall Study|Administrative problems|0
1058814|NCT01922258|2104828|FG000|Overall Study|Lost to Follow-up|1
1058815|NCT01922258|2104829|FG001|Overall Study|Lost to Follow-up|1
1058816|NCT01922258|2104828|FG000|Overall Study|Adverse Event|9
1058817|NCT01922258|2104829|FG001|Overall Study|Adverse Event|2
1058818|NCT01922258|2104828|FG000|Overall Study|Met Withdrawal Criteria|0
1058819|NCT01922258|2104829|FG001|Overall Study|Met Withdrawal Criteria|4
1058820|NCT01922258|2104828|FG000|Overall Study|Withdrawn by the Investigator|1
1058821|NCT01922258|2104829|FG001|Overall Study|Withdrawn by the Investigator|4
1058822|NCT01922258|2104828|FG000|Overall Study|Withdrawal by participant|5
1058823|NCT01922258|2104829|FG001|Overall Study|Withdrawal by participant|5
1058824|NCT01922271|2104837|FG000|WASHOUT Period|Withdrawal by Subject|1
1058825|NCT01922271|2104838|FG001|WASHOUT Period|Withdrawal by Subject|0
1058826|NCT01922349|2104861|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0
1058827|NCT01922349|2104862|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0
1058828|NCT01922349|2104863|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0
1058829|NCT01922349|2104864|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1
1058830|NCT01922739|2104900|FG000|Titration/Adjustment Period|Adverse Event|3
1058831|NCT01922739|2104900|FG000|Titration/Adjustment Period|Withdrawal by Subject|5
1058832|NCT01922739|2104900|FG000|Titration/Adjustment Period|Lost to Follow-up|1
1058833|NCT01922739|2104900|FG000|Titration/Adjustment Period|Lack of Efficacy|3
1058834|NCT01922739|2104900|FG000|Open-label Treatment Period|Adverse Event|6
1058835|NCT01922739|2104900|FG000|Open-label Treatment Period|Withdrawal by Subject|14
1058836|NCT01922739|2104900|FG000|Open-label Treatment Period|Noncompliance to study medication|3
1058837|NCT01922739|2104900|FG000|Open-label Treatment Period|Protocol Violation|5
1058838|NCT01922739|2104900|FG000|Open-label Treatment Period|Pregnancy|1
1058839|NCT01922739|2104900|FG000|Open-label Treatment Period|Noncompliance to study procedures|1
1058840|NCT01922739|2104900|FG000|Open-label Treatment Period|Lost to Follow-up|2
1058841|NCT01922739|2104900|FG000|Open-label Treatment Period|Physician Decision|1
1058842|NCT01922739|2104900|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1
1058843|NCT01922934|2104918|FG000|Eligible Patients|Death|0
1058844|NCT01922934|2104919|FG001|Eligible Patients|Death|7
1058845|NCT01922934|2104918|FG000|Eligible Patients|Physician Decision|17
1058846|NCT01922934|2104919|FG001|Eligible Patients|Physician Decision|0
1058847|NCT01922934|2104918|FG000|Eligible Patients|Did not meet inclusion criteria|36
1058848|NCT01922934|2104919|FG001|Eligible Patients|Did not meet inclusion criteria|81
1058849|NCT01922934|2104918|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
1058850|NCT01922934|2104919|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
1058851|NCT01922934|2104918|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
1058852|NCT01922934|2104919|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
1058853|NCT01922934|2104918|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
1058854|NCT01922934|2104919|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
1058855|NCT01923181|2104967|FG000|Overall Study|Protocol Violation|2
1058856|NCT01923181|2104968|FG001|Overall Study|Protocol Violation|2
1058857|NCT01923181|2104969|FG002|Overall Study|Protocol Violation|0
1058858|NCT01923181|2104970|FG003|Overall Study|Protocol Violation|2
1058859|NCT01923181|2104971|FG004|Overall Study|Protocol Violation|2
1058860|NCT01923181|2104972|FG005|Overall Study|Protocol Violation|1
1058861|NCT01923181|2104973|FG006|Overall Study|Protocol Violation|1
1058862|NCT01923181|2104974|FG007|Overall Study|Protocol Violation|2
1058863|NCT01923181|2104975|FG008|Overall Study|Protocol Violation|1
1058864|NCT01923181|2104967|FG000|Overall Study|Withdrawal by Subject|0
1058865|NCT01923181|2104968|FG001|Overall Study|Withdrawal by Subject|1
1058866|NCT01923181|2104969|FG002|Overall Study|Withdrawal by Subject|0
1058867|NCT01923181|2104970|FG003|Overall Study|Withdrawal by Subject|1
1058868|NCT01923181|2104971|FG004|Overall Study|Withdrawal by Subject|4
1058869|NCT01923181|2104972|FG005|Overall Study|Withdrawal by Subject|2
1058870|NCT01923181|2104973|FG006|Overall Study|Withdrawal by Subject|4
1058871|NCT01923181|2104974|FG007|Overall Study|Withdrawal by Subject|3
1058872|NCT01923181|2104975|FG008|Overall Study|Withdrawal by Subject|1
1058873|NCT01923181|2104967|FG000|Overall Study|Other|1
1058874|NCT01923181|2104968|FG001|Overall Study|Other|0
1058875|NCT01923181|2104969|FG002|Overall Study|Other|0
1058876|NCT01923181|2104970|FG003|Overall Study|Other|1
1058877|NCT01923181|2104971|FG004|Overall Study|Other|0
1058878|NCT01923181|2104972|FG005|Overall Study|Other|0
1058879|NCT01923181|2104973|FG006|Overall Study|Other|0
1058880|NCT01923181|2104974|FG007|Overall Study|Other|0
1058881|NCT01923181|2104975|FG008|Overall Study|Other|0
1058882|NCT01923181|2104967|FG000|Overall Study|Lost to Follow-up|0
1058883|NCT01923181|2104968|FG001|Overall Study|Lost to Follow-up|3
1058884|NCT01923181|2104969|FG002|Overall Study|Lost to Follow-up|2
1058885|NCT01923181|2104970|FG003|Overall Study|Lost to Follow-up|1
1058886|NCT01923181|2104971|FG004|Overall Study|Lost to Follow-up|2
1058887|NCT01923181|2104972|FG005|Overall Study|Lost to Follow-up|1
1058888|NCT01923181|2104973|FG006|Overall Study|Lost to Follow-up|3
1058889|NCT01923181|2104974|FG007|Overall Study|Lost to Follow-up|3
1058890|NCT01923181|2104975|FG008|Overall Study|Lost to Follow-up|1
1058891|NCT01923285|2105000|FG000|Overall Study|Withdrawal by Subject|7
1058892|NCT01923285|2105001|FG001|Overall Study|Withdrawal by Subject|6
1058893|NCT01923311|2105009|FG000|Overall Study|Pregnancy|1
1058894|NCT01923311|2105010|FG001|Overall Study|Pregnancy|0
1058895|NCT01923311|2105009|FG000|Overall Study|Investigator's Discretion|1
1058896|NCT01923311|2105010|FG001|Overall Study|Investigator's Discretion|0
1058897|NCT01923311|2105009|FG000|Overall Study|Non-Compliance with Study Drug|2
1058898|NCT01923311|2105010|FG001|Overall Study|Non-Compliance with Study Drug|1
1058899|NCT01923311|2105009|FG000|Overall Study|Withdrew Consent|1
1058900|NCT01923311|2105010|FG001|Overall Study|Withdrew Consent|0
1058901|NCT01923311|2105009|FG000|Overall Study|Study Terminated by Sponsor|12
1058902|NCT01923311|2105010|FG001|Overall Study|Study Terminated by Sponsor|0
1058903|NCT01923363|2105017|FG000|Overall Study|Protocol Violation|1
1058904|NCT01923389|2105023|FG000|Overall Study|Protocol Violation|1
1058905|NCT01923389|2105024|FG001|Overall Study|Protocol Violation|0
1058906|NCT01923428|2105035|FG000|Overall Study|Adverse Event|8
1058907|NCT01923428|2105036|FG001|Overall Study|Adverse Event|6
1058908|NCT01923428|2105037|FG002|Overall Study|Adverse Event|3
1058909|NCT01923428|2105038|FG003|Overall Study|Adverse Event|3
1058910|NCT01923428|2105035|FG000|Overall Study|Withdrawal by Subject|5
1058911|NCT01923428|2105036|FG001|Overall Study|Withdrawal by Subject|3
1058912|NCT01923428|2105037|FG002|Overall Study|Withdrawal by Subject|0
1058913|NCT01923428|2105038|FG003|Overall Study|Withdrawal by Subject|4
1058914|NCT01923428|2105035|FG000|Overall Study|Lost to Follow-up|2
1058915|NCT01923428|2105036|FG001|Overall Study|Lost to Follow-up|1
1058916|NCT01923428|2105037|FG002|Overall Study|Lost to Follow-up|5
1058917|NCT01923428|2105038|FG003|Overall Study|Lost to Follow-up|0
1058918|NCT01923428|2105035|FG000|Overall Study|Protocol Violation|3
1058919|NCT01923428|2105036|FG001|Overall Study|Protocol Violation|0
1058920|NCT01923428|2105037|FG002|Overall Study|Protocol Violation|2
1058921|NCT01923428|2105038|FG003|Overall Study|Protocol Violation|1
1058922|NCT01923428|2105035|FG000|Overall Study|Non Compliance to treatment|1
1058923|NCT01923428|2105036|FG001|Overall Study|Non Compliance to treatment|2
1058924|NCT01923428|2105037|FG002|Overall Study|Non Compliance to treatment|0
1058925|NCT01923428|2105038|FG003|Overall Study|Non Compliance to treatment|1
1058926|NCT01923428|2105035|FG000|Overall Study|Lack of Efficacy|0
1058927|NCT01923428|2105036|FG001|Overall Study|Lack of Efficacy|0
1058928|NCT01923428|2105037|FG002|Overall Study|Lack of Efficacy|1
1058929|NCT01923428|2105038|FG003|Overall Study|Lack of Efficacy|1
1058930|NCT01923467|2105048|FG000|Overall Study|Lost to Follow-up|62
1058931|NCT01923467|2105048|FG000|Overall Study|Subject non-interest|479
1058932|NCT01923740|2105074|FG000|Overall Study|Lost to Follow-up|4
1058933|NCT01923740|2105075|FG001|Overall Study|Lost to Follow-up|9
1058934|NCT01923740|2105074|FG000|Overall Study|Withdrawal by Subject|2
1058935|NCT01923740|2105075|FG001|Overall Study|Withdrawal by Subject|0
1058936|NCT01923896|2105092|FG000|Overall Study|Adverse Event|1
1058937|NCT01923896|2105093|FG001|Overall Study|Adverse Event|0
1058938|NCT01924182|2105118|FG000|Overall Study|Withdrawal by Subject|1
1058939|NCT01924182|2105119|FG001|Overall Study|Withdrawal by Subject|0
1058940|NCT01924299|2105127|FG000|Period 2|Withdrawal by Subject|1
1058941|NCT01924299|2105128|FG001|Period 2|Withdrawal by Subject|0
1058942|NCT01924299|2105127|FG000|Period 2|Adverse Event|0
1058943|NCT01924299|2105128|FG001|Period 2|Adverse Event|1
1058944|NCT01924364|2105140|FG000|Overall Study|Physician Decision|3
1058945|NCT01924429|2105166|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3
1058946|NCT01924429|2105167|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
1058947|NCT01924533|2105186|FG000|Overall Study|Death|181
1058948|NCT01924533|2105187|FG001|Overall Study|Death|200
1058949|NCT01924533|2105186|FG000|Overall Study|Lost to Follow-up|0
1058950|NCT01924533|2105187|FG001|Overall Study|Lost to Follow-up|1
1058951|NCT01924533|2105186|FG000|Overall Study|Withdrawal by Subject|7
1058952|NCT01924533|2105187|FG001|Overall Study|Withdrawal by Subject|3
1058953|NCT01924533|2105186|FG000|Overall Study|Other Eligibility criteria|1
1058954|NCT01924533|2105187|FG001|Overall Study|Other Eligibility criteria|1
1058955|NCT01924689|2105213|FG000|Overall Study|Death|0
1058956|NCT01924689|2105214|FG001|Overall Study|Death|1
1058957|NCT01924689|2105215|FG002|Overall Study|Death|0
1058958|NCT01924689|2105216|FG003|Overall Study|Death|1
1058959|NCT01924689|2105217|FG004|Overall Study|Death|0
1058960|NCT01924689|2105218|FG005|Overall Study|Death|0
1058961|NCT01924689|2105213|FG000|Overall Study|Disease progression|0
1058962|NCT01924689|2105214|FG001|Overall Study|Disease progression|0
1058963|NCT01924689|2105215|FG002|Overall Study|Disease progression|2
1058964|NCT01924689|2105216|FG003|Overall Study|Disease progression|0
1058965|NCT01924689|2105217|FG004|Overall Study|Disease progression|3
1058966|NCT01924689|2105218|FG005|Overall Study|Disease progression|2
1058967|NCT01924689|2105213|FG000|Overall Study|New therapy or study|3
1058968|NCT01924689|2105214|FG001|Overall Study|New therapy or study|2
1058969|NCT01924689|2105215|FG002|Overall Study|New therapy or study|1
1058970|NCT01924689|2105216|FG003|Overall Study|New therapy or study|4
1058971|NCT01924689|2105217|FG004|Overall Study|New therapy or study|2
1058972|NCT01924689|2105218|FG005|Overall Study|New therapy or study|0
1058973|NCT01924689|2105213|FG000|Overall Study|Withdrawal of consent|0
1058974|NCT01924689|2105214|FG001|Overall Study|Withdrawal of consent|0
1058975|NCT01924689|2105215|FG002|Overall Study|Withdrawal of consent|1
1058976|NCT01924689|2105216|FG003|Overall Study|Withdrawal of consent|1
1058977|NCT01924689|2105217|FG004|Overall Study|Withdrawal of consent|0
1058978|NCT01924689|2105218|FG005|Overall Study|Withdrawal of consent|0
1058979|NCT01924689|2105213|FG000|Overall Study|Other|0
1058980|NCT01924689|2105214|FG001|Overall Study|Other|0
1058981|NCT01924689|2105215|FG002|Overall Study|Other|0
1058982|NCT01924689|2105216|FG003|Overall Study|Other|0
1058983|NCT01924689|2105217|FG004|Overall Study|Other|1
1058984|NCT01924689|2105218|FG005|Overall Study|Other|0
1058985|NCT01924754|2105239|FG000|Overall Study|Lost to Follow-up|1
1058986|NCT01924754|2105240|FG001|Overall Study|Lost to Follow-up|2
1058987|NCT01924754|2105241|FG002|Overall Study|Lost to Follow-up|1
1058988|NCT01924754|2105239|FG000|Overall Study|Pregnancy|0
1058989|NCT01924754|2105240|FG001|Overall Study|Pregnancy|1
1058990|NCT01924754|2105241|FG002|Overall Study|Pregnancy|2
1058991|NCT01924767|2105257|FG000|Overall Study|Adverse Event|1
1058992|NCT01924767|2105258|FG001|Overall Study|Adverse Event|0
1058993|NCT01924767|2105259|FG002|Overall Study|Adverse Event|1
1058994|NCT01924767|2105260|FG003|Overall Study|Adverse Event|0
1058995|NCT01924767|2105261|FG004|Overall Study|Adverse Event|0
1058996|NCT01924806|2105280|FG000|Overall Study|Physician Decision|2
1058997|NCT01924806|2105281|FG001|Overall Study|Physician Decision|1
1058998|NCT01924845|2105287|FG000|Overall Study|Adverse Event|3
1058999|NCT01924845|2105287|FG000|Overall Study|Withdrawal by Subject|2
1059000|NCT01924845|2105287|FG000|Overall Study|Protocol Violation|1
1059001|NCT01925014|2105322|FG000|Overall Study|Inappropriate enrollment|4
1059002|NCT01925014|2105323|FG001|Overall Study|Inappropriate enrollment|6
1059003|NCT01925014|2105322|FG000|Overall Study|Withdrawal by Subject|5
1059004|NCT01925014|2105323|FG001|Overall Study|Withdrawal by Subject|13
1059005|NCT01925170|2105336|FG000|Overall Study|Unverified cancer status|53
1059006|NCT01925183|2105344|FG000|Overall Study|Adverse Event|1
1059007|NCT01925183|2105345|FG001|Overall Study|Adverse Event|0
1059008|NCT01925209|2105355|FG000|Treatment Epoch|Physician Decision|1
1059009|NCT01925209|2105356|FG001|Treatment Epoch|Physician Decision|0
1059010|NCT01925209|2105357|FG002|Treatment Epoch|Physician Decision|0
1059011|NCT01925209|2105358|FG003|Treatment Epoch|Physician Decision|0
1059012|NCT01925209|2105355|FG000|Treatment Epoch|Non-compliance with study treatment|0
1059013|NCT01925209|2105356|FG001|Treatment Epoch|Non-compliance with study treatment|0
1059014|NCT01925209|2105357|FG002|Treatment Epoch|Non-compliance with study treatment|0
1059015|NCT01925209|2105358|FG003|Treatment Epoch|Non-compliance with study treatment|1
1059016|NCT01925209|2105355|FG000|Treatment Epoch|Death|1
1059017|NCT01925209|2105356|FG001|Treatment Epoch|Death|0
1059018|NCT01925209|2105357|FG002|Treatment Epoch|Death|0
1059019|NCT01925209|2105358|FG003|Treatment Epoch|Death|0
1059020|NCT01925209|2105355|FG000|Treatment Epoch|Protocol deviation|0
1059021|NCT01925209|2105356|FG001|Treatment Epoch|Protocol deviation|0
1059022|NCT01925209|2105357|FG002|Treatment Epoch|Protocol deviation|1
1059023|NCT01925209|2105358|FG003|Treatment Epoch|Protocol deviation|1
1059024|NCT01925209|2105355|FG000|Treatment Epoch|Withdrawal by Subject|4
1059025|NCT01925209|2105356|FG001|Treatment Epoch|Withdrawal by Subject|3
1059026|NCT01925209|2105357|FG002|Treatment Epoch|Withdrawal by Subject|3
1059027|NCT01925209|2105358|FG003|Treatment Epoch|Withdrawal by Subject|2
1059028|NCT01925209|2105355|FG000|Treatment Epoch|Adverse Event|3
1059029|NCT01925209|2105356|FG001|Treatment Epoch|Adverse Event|5
1059030|NCT01925209|2105357|FG002|Treatment Epoch|Adverse Event|3
1059031|NCT01925209|2105358|FG003|Treatment Epoch|Adverse Event|1
1059032|NCT01925209|2105355|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0
1059033|NCT01925209|2105356|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1
1059034|NCT01925209|2105357|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1
1059035|NCT01925209|2105358|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2
1059036|NCT01925209|2105355|FG000|Maintenance Treatment Epoch|Adverse Event|0
1059037|NCT01925209|2105356|FG001|Maintenance Treatment Epoch|Adverse Event|0
1059038|NCT01925209|2105357|FG002|Maintenance Treatment Epoch|Adverse Event|1
1059039|NCT01925209|2105358|FG003|Maintenance Treatment Epoch|Adverse Event|0
1059040|NCT01925209|2105355|FG000|Follow-up|Adverse Event|1
1059041|NCT01925209|2105356|FG001|Follow-up|Adverse Event|4
1059042|NCT01925209|2105357|FG002|Follow-up|Adverse Event|0
1059043|NCT01925209|2105358|FG003|Follow-up|Adverse Event|1
1059044|NCT01925209|2105355|FG000|Follow-up|Physician Decision|0
1059045|NCT01925209|2105356|FG001|Follow-up|Physician Decision|0
1059046|NCT01925209|2105357|FG002|Follow-up|Physician Decision|1
1059047|NCT01925209|2105358|FG003|Follow-up|Physician Decision|0
1059048|NCT01925209|2105355|FG000|Follow-up|Non-compliance with study treatment|0
1059049|NCT01925209|2105356|FG001|Follow-up|Non-compliance with study treatment|0
1059050|NCT01925209|2105357|FG002|Follow-up|Non-compliance with study treatment|0
1059051|NCT01925209|2105358|FG003|Follow-up|Non-compliance with study treatment|1
1059052|NCT01925209|2105355|FG000|Follow-up|Withdrawal by Subject|0
1059053|NCT01925209|2105356|FG001|Follow-up|Withdrawal by Subject|2
1059054|NCT01925209|2105357|FG002|Follow-up|Withdrawal by Subject|0
1059055|NCT01925209|2105358|FG003|Follow-up|Withdrawal by Subject|2
1059056|NCT01925274|2105371|FG000|Overall Study|Death|1
1059057|NCT01925274|2105372|FG001|Overall Study|Death|0
1059058|NCT01925274|2105373|FG002|Overall Study|Death|0
1059059|NCT01925274|2105371|FG000|Overall Study|Lost to Follow-up|0
1059060|NCT01925274|2105372|FG001|Overall Study|Lost to Follow-up|1
1059061|NCT01925274|2105373|FG002|Overall Study|Lost to Follow-up|0
1059062|NCT01925274|2105371|FG000|Overall Study|Withdrawal by Subject|1
1059063|NCT01925274|2105372|FG001|Overall Study|Withdrawal by Subject|2
1059064|NCT01925274|2105373|FG002|Overall Study|Withdrawal by Subject|0
1059065|NCT01925274|2105371|FG000|Overall Study|Study terminated by sponsor|4
1059066|NCT01925274|2105372|FG001|Overall Study|Study terminated by sponsor|0
1059067|NCT01925274|2105373|FG002|Overall Study|Study terminated by sponsor|0
1059068|NCT01925274|2105371|FG000|Overall Study|Protocol amendment|1
1059069|NCT01925274|2105372|FG001|Overall Study|Protocol amendment|3
1059070|NCT01925274|2105373|FG002|Overall Study|Protocol amendment|6
1059071|NCT01925339|2105385|FG000|Overall Study|Adverse Event|2
1059072|NCT01925339|2105386|FG001|Overall Study|Adverse Event|0
1059073|NCT01925417|2105409|FG000|Overall Study|Withdrawal by Subject|2
1059074|NCT01925417|2105409|FG000|Overall Study|Death|1
1059075|NCT01925612|2105428|FG000|Overall Study|Progressive Disease|1
1059076|NCT01925612|2105429|FG001|Overall Study|Progressive Disease|1
1059077|NCT01925612|2105430|FG002|Overall Study|Progressive Disease|1
1059078|NCT01925612|2105431|FG003|Overall Study|Progressive Disease|0
1059079|NCT01925612|2105432|FG004|Overall Study|Progressive Disease|0
1059080|NCT01925612|2105428|FG000|Overall Study|Adverse Event|3
1059081|NCT01925612|2105429|FG001|Overall Study|Adverse Event|3
1059082|NCT01925612|2105430|FG002|Overall Study|Adverse Event|0
1059083|NCT01925612|2105431|FG003|Overall Study|Adverse Event|1
1059084|NCT01925612|2105432|FG004|Overall Study|Adverse Event|2
1059085|NCT01925703|2105448|FG000|Overall Study|Physician Decision|1
1059086|NCT01925703|2105448|FG000|Overall Study|Lost to Follow-up|2
1059087|NCT01925703|2105448|FG000|Overall Study|Discharge prior to full iron repletion|1
1059088|NCT01925768|2105454|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1059089|NCT01925768|2105455|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1059090|NCT01925768|2105454|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1059091|NCT01925768|2105455|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
1059092|NCT01925768|2105454|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
1059093|NCT01925768|2105455|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
1059094|NCT01925768|2105454|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
1059095|NCT01925768|2105455|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
1059096|NCT01925768|2105454|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
1059097|NCT01925768|2105455|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
1059098|NCT01925768|2105454|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
1059099|NCT01925768|2105455|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
1059100|NCT01925768|2105454|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
1059101|NCT01925768|2105455|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
1059102|NCT01925768|2105454|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
1059103|NCT01925768|2105455|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
1059104|NCT01925768|2105454|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
1059105|NCT01925768|2105455|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
1059106|NCT01925768|2105454|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0
1059107|NCT01925768|2105455|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1
1059108|NCT01925768|2105454|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
1059109|NCT01925768|2105455|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
1059110|NCT01925950|2105476|FG000|Part 2|Withdrawal by Subject|1
1059111|NCT01925950|2105477|FG001|Part 2|Withdrawal by Subject|0
1059112|NCT01925989|2105485|FG000|Period 1|Sponsor Decision|1
1059113|NCT01925989|2105486|FG001|Period 1|Sponsor Decision|1
1059114|NCT01925989|2105487|FG002|Period 1|Sponsor Decision|0
1059115|NCT01925989|2105485|FG000|Period 1|Withdrawal by Subject|0
1059116|NCT01925989|2105486|FG001|Period 1|Withdrawal by Subject|1
1059117|NCT01925989|2105487|FG002|Period 1|Withdrawal by Subject|0
1059118|NCT01926015|2105501|FG000|Overall Study|Withdrawal by parent/guardian|0
1059119|NCT01926015|2105502|FG001|Overall Study|Withdrawal by parent/guardian|1
1059120|NCT01926015|2105501|FG000|Overall Study|Randomized not treated|2
1059121|NCT01926015|2105502|FG001|Overall Study|Randomized not treated|0
1059122|NCT01926028|2105511|FG000|Overall Study|Lost to Follow-up|7
1059123|NCT01926028|2105512|FG001|Overall Study|Lost to Follow-up|6
1059124|NCT01926028|2105513|FG002|Overall Study|Lost to Follow-up|0
1059125|NCT01926028|2105511|FG000|Overall Study|Physician Decision|1
1059126|NCT01926028|2105512|FG001|Overall Study|Physician Decision|5
1059127|NCT01926028|2105513|FG002|Overall Study|Physician Decision|0
1059128|NCT01926028|2105511|FG000|Overall Study|Withdrawal by Subject|9
1059129|NCT01926028|2105512|FG001|Overall Study|Withdrawal by Subject|9
1059130|NCT01926028|2105513|FG002|Overall Study|Withdrawal by Subject|2
1059131|NCT01926028|2105511|FG000|Overall Study|Non compliance or other reasons|4
1059132|NCT01926028|2105512|FG001|Overall Study|Non compliance or other reasons|2
1059133|NCT01926028|2105513|FG002|Overall Study|Non compliance or other reasons|0
1059134|NCT01926119|2105522|FG000|Overall Study|Withdrawal by Subject|1
1059135|NCT01926444|2105530|FG000|Overall Study|Colonoscopy not performed|0
1059136|NCT01926444|2105531|FG001|Overall Study|Colonoscopy not performed|0
1059137|NCT01926444|2105532|FG002|Overall Study|Colonoscopy not performed|4
1059138|NCT01926444|2105533|FG003|Overall Study|Colonoscopy not performed|2
1059139|NCT01926509|2105560|FG000|Overall Study|vital sign met discontinuation criteria|1
1059140|NCT01926509|2105561|FG001|Overall Study|vital sign met discontinuation criteria|0
1059141|NCT01926509|2105562|FG002|Overall Study|vital sign met discontinuation criteria|0
1059142|NCT01926509|2105563|FG003|Overall Study|vital sign met discontinuation criteria|0
1059143|NCT01926626|2105573|FG000|Overall Study|Withdrawal by Subject|15
1059144|NCT01926626|2105573|FG000|Overall Study|Lost to Follow-up|7
1059145|NCT01926782|2105583|FG000|Overall Study|Participant moved|2
1059146|NCT01926782|2105584|FG001|Overall Study|Participant moved|0
1059147|NCT01926782|2105585|FG002|Overall Study|Participant moved|1
1059148|NCT01926782|2105586|FG003|Overall Study|Participant moved|1
1059149|NCT01926782|2105587|FG004|Overall Study|Participant moved|0
1059150|NCT01926782|2105588|FG005|Overall Study|Participant moved|3
1059151|NCT01926782|2105583|FG000|Overall Study|Physician Decision|0
1059152|NCT01926782|2105584|FG001|Overall Study|Physician Decision|2
1059153|NCT01926782|2105585|FG002|Overall Study|Physician Decision|1
1059154|NCT01926782|2105586|FG003|Overall Study|Physician Decision|1
1059155|NCT01926782|2105587|FG004|Overall Study|Physician Decision|0
1059156|NCT01926782|2105588|FG005|Overall Study|Physician Decision|0
1059157|NCT01926782|2105583|FG000|Overall Study|Other than specified|2
1059158|NCT01926782|2105584|FG001|Overall Study|Other than specified|3
1059159|NCT01926782|2105585|FG002|Overall Study|Other than specified|5
1059160|NCT01926782|2105586|FG003|Overall Study|Other than specified|12
1059161|NCT01926782|2105587|FG004|Overall Study|Other than specified|4
1059162|NCT01926782|2105588|FG005|Overall Study|Other than specified|11
1059163|NCT01926782|2105583|FG000|Overall Study|Adverse Event|13
1059164|NCT01926782|2105584|FG001|Overall Study|Adverse Event|4
1059165|NCT01926782|2105585|FG002|Overall Study|Adverse Event|17
1059166|NCT01926782|2105586|FG003|Overall Study|Adverse Event|4
1059167|NCT01926782|2105587|FG004|Overall Study|Adverse Event|3
1059168|NCT01926782|2105588|FG005|Overall Study|Adverse Event|14
1059169|NCT01926782|2105583|FG000|Overall Study|Poor compliance to protocol|5
1059170|NCT01926782|2105584|FG001|Overall Study|Poor compliance to protocol|3
1059171|NCT01926782|2105585|FG002|Overall Study|Poor compliance to protocol|8
1059172|NCT01926782|2105586|FG003|Overall Study|Poor compliance to protocol|0
1059173|NCT01926782|2105587|FG004|Overall Study|Poor compliance to protocol|1
1059174|NCT01926782|2105588|FG005|Overall Study|Poor compliance to protocol|6
1059175|NCT01926782|2105583|FG000|Overall Study|Randomized and not treated|0
1059176|NCT01926782|2105584|FG001|Overall Study|Randomized and not treated|0
1059177|NCT01926782|2105585|FG002|Overall Study|Randomized and not treated|0
1059178|NCT01926782|2105586|FG003|Overall Study|Randomized and not treated|1
1059179|NCT01926782|2105587|FG004|Overall Study|Randomized and not treated|0
1059180|NCT01926782|2105588|FG005|Overall Study|Randomized and not treated|0
1059181|NCT01926782|2105583|FG000|Overall Study|Withdrawal by Subject|6
1059182|NCT01926782|2105584|FG001|Overall Study|Withdrawal by Subject|1
1059183|NCT01926782|2105585|FG002|Overall Study|Withdrawal by Subject|8
1059184|NCT01926782|2105586|FG003|Overall Study|Withdrawal by Subject|1
1059185|NCT01926782|2105587|FG004|Overall Study|Withdrawal by Subject|0
1059186|NCT01926782|2105588|FG005|Overall Study|Withdrawal by Subject|5
1059187|NCT01926782|2105583|FG000|Overall Study|Related to study drug administration|0
1059188|NCT01926782|2105584|FG001|Overall Study|Related to study drug administration|0
1059189|NCT01926782|2105585|FG002|Overall Study|Related to study drug administration|0
1059190|NCT01926782|2105586|FG003|Overall Study|Related to study drug administration|0
1059191|NCT01926782|2105587|FG004|Overall Study|Related to study drug administration|0
1059192|NCT01926782|2105588|FG005|Overall Study|Related to study drug administration|2
1059193|NCT01926886|2105603|FG000|Overall Study|Administrative/other|1
1059194|NCT01926886|2105604|FG001|Overall Study|Administrative/other|0
1059195|NCT01926886|2105603|FG000|Overall Study|Adverse event/intercurrent illness|4
1059196|NCT01926886|2105604|FG001|Overall Study|Adverse event/intercurrent illness|0
1059197|NCT01926886|2105603|FG000|Overall Study|Disease progression/recurrence|4
1059198|NCT01926886|2105604|FG001|Overall Study|Disease progression/recurrence|0
1059199|NCT01926886|2105603|FG000|Overall Study|Withdrawal by Subject|15
1059200|NCT01926886|2105604|FG001|Overall Study|Withdrawal by Subject|0
1059201|NCT01926886|2105603|FG000|Overall Study|Failure to return|3
1059202|NCT01926886|2105604|FG001|Overall Study|Failure to return|0
1059203|NCT01926886|2105603|FG000|Overall Study|Recurrence of disease|1
1059204|NCT01926886|2105604|FG001|Overall Study|Recurrence of disease|0
1059205|NCT01926886|2105603|FG000|Overall Study|Progression of disease|2
1059206|NCT01926886|2105604|FG001|Overall Study|Progression of disease|0
1059207|NCT01926886|2105603|FG000|Overall Study|Death|1
1059208|NCT01926886|2105604|FG001|Overall Study|Death|0
1059209|NCT01926886|2105603|FG000|Overall Study|Did not cooperate|1
1059210|NCT01926886|2105604|FG001|Overall Study|Did not cooperate|0
1059211|NCT01927055|2105622|FG000|Open-label|Adverse Event|6
1059212|NCT01927055|2105623|FG001|Open-label|Adverse Event|0
1059213|NCT01927055|2105624|FG002|Open-label|Adverse Event|0
1059214|NCT01927055|2105622|FG000|Open-label|Withdrawal by Subject|1
1059215|NCT01927055|2105623|FG001|Open-label|Withdrawal by Subject|0
1059216|NCT01927055|2105624|FG002|Open-label|Withdrawal by Subject|0
1059217|NCT01927055|2105622|FG000|Open-label|Study Stopped|4
1059218|NCT01927055|2105623|FG001|Open-label|Study Stopped|0
1059219|NCT01927055|2105624|FG002|Open-label|Study Stopped|0
1059220|NCT01927055|2105622|FG000|Open-label|Supine Hypertension|4
1059221|NCT01927055|2105623|FG001|Open-label|Supine Hypertension|0
1059222|NCT01927055|2105624|FG002|Open-label|Supine Hypertension|0
1059223|NCT01927055|2105622|FG000|Open-label|Difficulty attending study visits|1
1059224|NCT01927055|2105623|FG001|Open-label|Difficulty attending study visits|0
1059225|NCT01927055|2105624|FG002|Open-label|Difficulty attending study visits|0
1059226|NCT01927055|2105622|FG000|Double-Blind|Adverse Event|0
1059227|NCT01927055|2105623|FG001|Double-Blind|Adverse Event|1
1059228|NCT01927055|2105624|FG002|Double-Blind|Adverse Event|1
1059229|NCT01927055|2105622|FG000|Double-Blind|Protocol Violation|0
1059230|NCT01927055|2105623|FG001|Double-Blind|Protocol Violation|0
1059231|NCT01927055|2105624|FG002|Double-Blind|Protocol Violation|1
1059232|NCT01927055|2105622|FG000|Double-Blind|Withdrawal by Subject|0
1059233|NCT01927055|2105623|FG001|Double-Blind|Withdrawal by Subject|2
1059234|NCT01927055|2105624|FG002|Double-Blind|Withdrawal by Subject|3
1059235|NCT01927055|2105622|FG000|Double-Blind|Study Stopped|0
1059236|NCT01927055|2105623|FG001|Double-Blind|Study Stopped|7
1059237|NCT01927055|2105624|FG002|Double-Blind|Study Stopped|7
1059238|NCT01927055|2105622|FG000|Double-Blind|Supine Hypertension|0
1059239|NCT01927055|2105623|FG001|Double-Blind|Supine Hypertension|0
1059240|NCT01927055|2105624|FG002|Double-Blind|Supine Hypertension|1
1059241|NCT01927055|2105622|FG000|Double-Blind|Extended Vacation|0
1059242|NCT01927055|2105623|FG001|Double-Blind|Extended Vacation|1
1059243|NCT01927055|2105624|FG002|Double-Blind|Extended Vacation|0
1059244|NCT01927341|2105640|FG000|Phase 1b|Lost to Follow-up|1
1059245|NCT01927341|2105641|FG001|Phase 1b|Lost to Follow-up|0
1059246|NCT01927341|2105642|FG002|Phase 1b|Lost to Follow-up|0
1059247|NCT01927341|2105643|FG003|Phase 1b|Lost to Follow-up|0
1059248|NCT01927341|2105644|FG004|Phase 1b|Lost to Follow-up|0
1059249|NCT01927341|2105640|FG000|Phase 1b|Death|2
1059250|NCT01927341|2105641|FG001|Phase 1b|Death|0
1059251|NCT01927341|2105642|FG002|Phase 1b|Death|0
1059252|NCT01927341|2105643|FG003|Phase 1b|Death|0
1059253|NCT01927341|2105644|FG004|Phase 1b|Death|0
1059254|NCT01927341|2105640|FG000|Phase 1b|Follow-up completed|7
1059255|NCT01927341|2105641|FG001|Phase 1b|Follow-up completed|0
1059256|NCT01927341|2105642|FG002|Phase 1b|Follow-up completed|0
1059257|NCT01927341|2105643|FG003|Phase 1b|Follow-up completed|0
1059258|NCT01927341|2105644|FG004|Phase 1b|Follow-up completed|0
1059259|NCT01927341|2105640|FG000|Phase 2|Lost to Follow-up|0
1059260|NCT01927341|2105641|FG001|Phase 2|Lost to Follow-up|1
1059261|NCT01927341|2105642|FG002|Phase 2|Lost to Follow-up|0
1059262|NCT01927341|2105643|FG003|Phase 2|Lost to Follow-up|0
1059263|NCT01927341|2105644|FG004|Phase 2|Lost to Follow-up|0
1059264|NCT01927341|2105640|FG000|Phase 2|Participant withdrew consent|0
1059265|NCT01927341|2105641|FG001|Phase 2|Participant withdrew consent|2
1059266|NCT01927341|2105642|FG002|Phase 2|Participant withdrew consent|1
1059267|NCT01927341|2105643|FG003|Phase 2|Participant withdrew consent|2
1059268|NCT01927341|2105644|FG004|Phase 2|Participant withdrew consent|3
1059269|NCT01927341|2105640|FG000|Phase 2|Death|0
1059270|NCT01927341|2105641|FG001|Phase 2|Death|4
1059271|NCT01927341|2105642|FG002|Phase 2|Death|0
1059272|NCT01927341|2105643|FG003|Phase 2|Death|3
1059273|NCT01927341|2105644|FG004|Phase 2|Death|2
1059274|NCT01927341|2105640|FG000|Phase 2|New cancer therapy|0
1059275|NCT01927341|2105641|FG001|Phase 2|New cancer therapy|1
1059276|NCT01927341|2105642|FG002|Phase 2|New cancer therapy|0
1059277|NCT01927341|2105643|FG003|Phase 2|New cancer therapy|4
1059278|NCT01927341|2105644|FG004|Phase 2|New cancer therapy|1
1059279|NCT01927341|2105640|FG000|Phase 2|Disease progression|0
1059280|NCT01927341|2105641|FG001|Phase 2|Disease progression|1
1059281|NCT01927341|2105642|FG002|Phase 2|Disease progression|1
1059282|NCT01927341|2105643|FG003|Phase 2|Disease progression|1
1059283|NCT01927341|2105644|FG004|Phase 2|Disease progression|0
1059284|NCT01927341|2105640|FG000|Phase 2|Follow-up completed|0
1059285|NCT01927341|2105641|FG001|Phase 2|Follow-up completed|6
1059286|NCT01927341|2105642|FG002|Phase 2|Follow-up completed|3
1059287|NCT01927341|2105643|FG003|Phase 2|Follow-up completed|5
1059288|NCT01927341|2105644|FG004|Phase 2|Follow-up completed|2
1059289|NCT01927367|2105662|FG000|Overall Study|Withdrawal by Subject|7
1059290|NCT01927367|2105663|FG001|Overall Study|Withdrawal by Subject|4
1059291|NCT01927367|2105662|FG000|Overall Study|No baseline data|0
1059292|NCT01927367|2105663|FG001|Overall Study|No baseline data|1
1059307|NCT01927497|2105682|FG000|Overall Study|Death|0
1059308|NCT01927497|2105683|FG001|Overall Study|Death|1
1059309|NCT01927497|2105682|FG000|Overall Study|Protocol Violation|2
1059310|NCT01927497|2105683|FG001|Overall Study|Protocol Violation|0
1059311|NCT01927562|2105689|FG000|Overall Study|Lost to Follow-up|30
1059312|NCT01927562|2105689|FG000|Overall Study|Withdrawal by Subject|3
1059313|NCT01927562|2105689|FG000|Overall Study|Physician Decision|5
1059314|NCT01927627|2105701|FG000|Overall Study|Adverse Event|3
1059315|NCT01927627|2105701|FG000|Overall Study|Lack of Efficacy|1
1059316|NCT01927627|2105701|FG000|Overall Study|Financial Concerns|1
1059317|NCT01927757|2105709|FG000|Overall Study|Withdrawal by Subject|14
1059318|NCT01927757|2105709|FG000|Overall Study|Lost to Follow-up|2
1059319|NCT01927757|2105709|FG000|Overall Study|Decision by Sponsor|2
1059320|NCT01927757|2105709|FG000|Overall Study|Other|1
1059321|NCT01927757|2105709|FG000|Overall Study|Ethical Reasons|4
1059322|NCT01927861|2105719|FG000|Extension Phase (104 Weeks)|Adverse Event|0
1059323|NCT01927861|2105720|FG001|Extension Phase (104 Weeks)|Adverse Event|2
1059324|NCT01927861|2105719|FG000|Extension Phase (104 Weeks)|Unclassified|0
1059325|NCT01927861|2105720|FG001|Extension Phase (104 Weeks)|Unclassified|1
1059326|NCT01928225|2105755|FG000|Overall Study|Pregnancy|1
1059327|NCT01928225|2105756|FG001|Overall Study|Pregnancy|0
1059328|NCT01928225|2105755|FG000|Overall Study|basaloid cervical cancer|1
1059329|NCT01928225|2105756|FG001|Overall Study|basaloid cervical cancer|0
1059330|NCT01928225|2105755|FG000|Overall Study|Lost to Follow-up|1
1059331|NCT01928225|2105756|FG001|Overall Study|Lost to Follow-up|3
1059332|NCT01928329|2105774|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1
1059333|NCT01928329|2105775|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3
1059334|NCT01928329|2105774|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0
1059335|NCT01928329|2105775|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1
1059336|NCT01928329|2105774|FG000|Overall Study|Adverse Event|5
1059337|NCT01928329|2105775|FG001|Overall Study|Adverse Event|3
1059338|NCT01928329|2105774|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4
1059339|NCT01928329|2105775|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1
1059340|NCT01928329|2105774|FG000|Overall Study|Withdrawal by Subject|1
1059341|NCT01928329|2105775|FG001|Overall Study|Withdrawal by Subject|5
1059342|NCT01928329|2105774|FG000|Overall Study|Physician Decision|1
1059343|NCT01928329|2105775|FG001|Overall Study|Physician Decision|1
1059344|NCT01928381|2105781|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
1059345|NCT01928381|2105782|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1059346|NCT01928381|2105783|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1059347|NCT01928381|2105784|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1059348|NCT01928381|2105785|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1059349|NCT01928381|2105786|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1059350|NCT01928381|2105787|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1059351|NCT01928381|2105781|FG000|Part 1 - Pain Training|Pain training criteria not met|29
1059352|NCT01928381|2105782|FG001|Part 1 - Pain Training|Pain training criteria not met|0
1059353|NCT01928381|2105783|FG002|Part 1 - Pain Training|Pain training criteria not met|0
1059354|NCT01928381|2105784|FG003|Part 1 - Pain Training|Pain training criteria not met|0
1059355|NCT01928381|2105785|FG004|Part 1 - Pain Training|Pain training criteria not met|0
1059356|NCT01928381|2105786|FG005|Part 1 - Pain Training|Pain training criteria not met|0
1059357|NCT01928381|2105787|FG006|Part 1 - Pain Training|Pain training criteria not met|0
1059358|NCT01928381|2105781|FG000|Part 1 - Pain Training|Withdrawal by Subject|1
1059359|NCT01928381|2105782|FG001|Part 1 - Pain Training|Withdrawal by Subject|0
1059360|NCT01928381|2105783|FG002|Part 1 - Pain Training|Withdrawal by Subject|0
1059361|NCT01928381|2105784|FG003|Part 1 - Pain Training|Withdrawal by Subject|0
1059362|NCT01928381|2105785|FG004|Part 1 - Pain Training|Withdrawal by Subject|0
1059363|NCT01928381|2105786|FG005|Part 1 - Pain Training|Withdrawal by Subject|0
1059364|NCT01928381|2105787|FG006|Part 1 - Pain Training|Withdrawal by Subject|0
1059365|NCT01928381|2105781|FG000|Part 1 - Pain Training|Lost to Follow-up|4
1059366|NCT01928381|2105782|FG001|Part 1 - Pain Training|Lost to Follow-up|0
1059367|NCT01928381|2105783|FG002|Part 1 - Pain Training|Lost to Follow-up|0
1059368|NCT01928381|2105784|FG003|Part 1 - Pain Training|Lost to Follow-up|0
1059369|NCT01928381|2105785|FG004|Part 1 - Pain Training|Lost to Follow-up|0
1059370|NCT01928381|2105786|FG005|Part 1 - Pain Training|Lost to Follow-up|0
1059371|NCT01928381|2105787|FG006|Part 1 - Pain Training|Lost to Follow-up|0
1059372|NCT01928381|2105781|FG000|Part 1 - Pain Training|Protocol Violation|1
1059373|NCT01928381|2105782|FG001|Part 1 - Pain Training|Protocol Violation|0
1059374|NCT01928381|2105783|FG002|Part 1 - Pain Training|Protocol Violation|0
1059375|NCT01928381|2105784|FG003|Part 1 - Pain Training|Protocol Violation|0
1059376|NCT01928381|2105785|FG004|Part 1 - Pain Training|Protocol Violation|0
1059377|NCT01928381|2105786|FG005|Part 1 - Pain Training|Protocol Violation|0
1059378|NCT01928381|2105787|FG006|Part 1 - Pain Training|Protocol Violation|0
1059379|NCT01928381|2105781|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1
1059380|NCT01928381|2105782|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1059381|NCT01928381|2105783|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1059382|NCT01928381|2105784|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1059383|NCT01928381|2105785|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1059384|NCT01928381|2105786|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1059385|NCT01928381|2105787|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1059386|NCT01928381|2105781|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
1059387|NCT01928381|2105782|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1059388|NCT01928381|2105783|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1059389|NCT01928381|2105784|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1059390|NCT01928381|2105785|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1059391|NCT01928381|2105786|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1059392|NCT01928381|2105787|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1059393|NCT01928381|2105781|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
1059394|NCT01928381|2105782|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1059395|NCT01928381|2105783|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1059396|NCT01928381|2105784|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1059397|NCT01928381|2105785|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1059398|NCT01928381|2105786|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1059399|NCT01928381|2105787|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1059400|NCT01928381|2105781|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
1059401|NCT01928381|2105782|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1059402|NCT01928381|2105783|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1059403|NCT01928381|2105784|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1059404|NCT01928381|2105785|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1059405|NCT01928381|2105786|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1059406|NCT01928381|2105787|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1059407|NCT01928381|2105781|FG000|Part 2 - First Intervention|Withdrawal by Subject|0
1059408|NCT01928381|2105782|FG001|Part 2 - First Intervention|Withdrawal by Subject|0
1059409|NCT01928381|2105783|FG002|Part 2 - First Intervention|Withdrawal by Subject|1
1059410|NCT01928381|2105784|FG003|Part 2 - First Intervention|Withdrawal by Subject|0
1059411|NCT01928381|2105785|FG004|Part 2 - First Intervention|Withdrawal by Subject|0
1059412|NCT01928381|2105786|FG005|Part 2 - First Intervention|Withdrawal by Subject|0
1059413|NCT01928381|2105787|FG006|Part 2 - First Intervention|Withdrawal by Subject|0
1059414|NCT01928381|2105781|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0
1059415|NCT01928381|2105782|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0
1059416|NCT01928381|2105783|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1
1059417|NCT01928381|2105784|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0
1059418|NCT01928381|2105785|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0
1059419|NCT01928381|2105786|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0
1059420|NCT01928381|2105787|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0
1059421|NCT01928381|2105781|FG000|Part 2 - First Intervention|Eligibility criterion not met|0
1059422|NCT01928381|2105782|FG001|Part 2 - First Intervention|Eligibility criterion not met|0
1059423|NCT01928381|2105783|FG002|Part 2 - First Intervention|Eligibility criterion not met|0
1059424|NCT01928381|2105784|FG003|Part 2 - First Intervention|Eligibility criterion not met|0
1059425|NCT01928381|2105785|FG004|Part 2 - First Intervention|Eligibility criterion not met|0
1059426|NCT01928381|2105786|FG005|Part 2 - First Intervention|Eligibility criterion not met|1
1059427|NCT01928381|2105787|FG006|Part 2 - First Intervention|Eligibility criterion not met|1
1059428|NCT01928381|2105781|FG000|Part 2 - First Intervention|Lost to Follow-up|0
1059429|NCT01928381|2105782|FG001|Part 2 - First Intervention|Lost to Follow-up|0
1059430|NCT01928381|2105783|FG002|Part 2 - First Intervention|Lost to Follow-up|0
1059431|NCT01928381|2105784|FG003|Part 2 - First Intervention|Lost to Follow-up|1
1059432|NCT01928381|2105785|FG004|Part 2 - First Intervention|Lost to Follow-up|0
1059433|NCT01928381|2105786|FG005|Part 2 - First Intervention|Lost to Follow-up|0
1059434|NCT01928381|2105787|FG006|Part 2 - First Intervention|Lost to Follow-up|0
1059435|NCT01928381|2105781|FG000|Washout First Intervention|Protocol Violation|0
1059436|NCT01928381|2105782|FG001|Washout First Intervention|Protocol Violation|0
1059437|NCT01928381|2105783|FG002|Washout First Intervention|Protocol Violation|0
1059438|NCT01928381|2105784|FG003|Washout First Intervention|Protocol Violation|0
1059439|NCT01928381|2105785|FG004|Washout First Intervention|Protocol Violation|1
1059440|NCT01928381|2105786|FG005|Washout First Intervention|Protocol Violation|0
1059441|NCT01928381|2105787|FG006|Washout First Intervention|Protocol Violation|0
1059442|NCT01928381|2105781|FG000|Part 2 - Second Intervention|Lost to Follow-up|0
1059443|NCT01928381|2105782|FG001|Part 2 - Second Intervention|Lost to Follow-up|1
1059444|NCT01928381|2105783|FG002|Part 2 - Second Intervention|Lost to Follow-up|0
1059445|NCT01928381|2105784|FG003|Part 2 - Second Intervention|Lost to Follow-up|1
1059446|NCT01928381|2105785|FG004|Part 2 - Second Intervention|Lost to Follow-up|0
1059447|NCT01928381|2105786|FG005|Part 2 - Second Intervention|Lost to Follow-up|0
1059448|NCT01928381|2105787|FG006|Part 2 - Second Intervention|Lost to Follow-up|0
1059449|NCT01928381|2105781|FG000|Part 2 - Post Third Intervention|Protocol Violation|0
1059450|NCT01928381|2105782|FG001|Part 2 - Post Third Intervention|Protocol Violation|0
1059451|NCT01928381|2105783|FG002|Part 2 - Post Third Intervention|Protocol Violation|1
1059452|NCT01928381|2105784|FG003|Part 2 - Post Third Intervention|Protocol Violation|0
1059453|NCT01928381|2105785|FG004|Part 2 - Post Third Intervention|Protocol Violation|0
1059454|NCT01928381|2105786|FG005|Part 2 - Post Third Intervention|Protocol Violation|0
1059455|NCT01928381|2105787|FG006|Part 2 - Post Third Intervention|Protocol Violation|0
1059456|NCT01928394|2105820|FG000|Treatment Period|Disease progression|17
1059457|NCT01928394|2105821|FG001|Treatment Period|Disease progression|2
1059458|NCT01928394|2105822|FG002|Treatment Period|Disease progression|12
1059459|NCT01928394|2105823|FG003|Treatment Period|Disease progression|48
1059460|NCT01928394|2105824|FG004|Treatment Period|Disease progression|3
1059461|NCT01928394|2105825|FG005|Treatment Period|Disease progression|25
1059462|NCT01928394|2105826|FG006|Treatment Period|Disease progression|38
1059463|NCT01928394|2105827|FG007|Treatment Period|Disease progression|16
1059464|NCT01928394|2105828|FG008|Treatment Period|Disease progression|3
1059465|NCT01928394|2105829|FG009|Treatment Period|Disease progression|11
1059466|NCT01928394|2105830|FG010|Treatment Period|Disease progression|22
1059467|NCT01928394|2105831|FG011|Treatment Period|Disease progression|73
1059468|NCT01928394|2105832|FG012|Treatment Period|Disease progression|38
1059469|NCT01928394|2105833|FG013|Treatment Period|Disease progression|118
1059470|NCT01928394|2105834|FG014|Treatment Period|Disease progression|59
1059471|NCT01928394|2105835|FG015|Treatment Period|Disease progression|1
1059472|NCT01928394|2105836|FG016|Treatment Period|Disease progression|43
1059473|NCT01928394|2105837|FG017|Treatment Period|Disease progression|56
1059474|NCT01928394|2105838|FG018|Treatment Period|Disease progression|50
1059475|NCT01928394|2105839|FG019|Treatment Period|Disease progression|71
1059476|NCT01928394|2105840|FG020|Treatment Period|Disease progression|30
1059477|NCT01928394|2105841|FG021|Treatment Period|Disease progression|31
1059478|NCT01928394|2105842|FG022|Treatment Period|Disease progression|31
1059479|NCT01928394|2105820|FG000|Treatment Period|Study drug toxicity|1
1059480|NCT01928394|2105821|FG001|Treatment Period|Study drug toxicity|1
1059481|NCT01928394|2105822|FG002|Treatment Period|Study drug toxicity|3
1059482|NCT01928394|2105823|FG003|Treatment Period|Study drug toxicity|3
1059483|NCT01928394|2105824|FG004|Treatment Period|Study drug toxicity|0
1059484|NCT01928394|2105825|FG005|Treatment Period|Study drug toxicity|9
1059485|NCT01928394|2105826|FG006|Treatment Period|Study drug toxicity|7
1059486|NCT01928394|2105827|FG007|Treatment Period|Study drug toxicity|1
1059487|NCT01928394|2105828|FG008|Treatment Period|Study drug toxicity|0
1059488|NCT01928394|2105829|FG009|Treatment Period|Study drug toxicity|5
1059489|NCT01928394|2105830|FG010|Treatment Period|Study drug toxicity|2
1059490|NCT01928394|2105831|FG011|Treatment Period|Study drug toxicity|3
1059491|NCT01928394|2105832|FG012|Treatment Period|Study drug toxicity|7
1059492|NCT01928394|2105833|FG013|Treatment Period|Study drug toxicity|5
1059493|NCT01928394|2105834|FG014|Treatment Period|Study drug toxicity|12
1059494|NCT01928394|2105835|FG015|Treatment Period|Study drug toxicity|0
1059495|NCT01928394|2105836|FG016|Treatment Period|Study drug toxicity|3
1059496|NCT01928394|2105837|FG017|Treatment Period|Study drug toxicity|3
1059497|NCT01928394|2105838|FG018|Treatment Period|Study drug toxicity|12
1059498|NCT01928394|2105839|FG019|Treatment Period|Study drug toxicity|15
1059499|NCT01928394|2105840|FG020|Treatment Period|Study drug toxicity|4
1059500|NCT01928394|2105841|FG021|Treatment Period|Study drug toxicity|7
1059501|NCT01928394|2105842|FG022|Treatment Period|Study drug toxicity|4
1059502|NCT01928394|2105820|FG000|Treatment Period|AE unrelated to study drug|0
1059503|NCT01928394|2105821|FG001|Treatment Period|AE unrelated to study drug|0
1059504|NCT01928394|2105822|FG002|Treatment Period|AE unrelated to study drug|2
1059505|NCT01928394|2105823|FG003|Treatment Period|AE unrelated to study drug|3
1059506|NCT01928394|2105824|FG004|Treatment Period|AE unrelated to study drug|0
1059507|NCT01928394|2105825|FG005|Treatment Period|AE unrelated to study drug|5
1059508|NCT01928394|2105826|FG006|Treatment Period|AE unrelated to study drug|1
1059509|NCT01928394|2105827|FG007|Treatment Period|AE unrelated to study drug|0
1059510|NCT01928394|2105828|FG008|Treatment Period|AE unrelated to study drug|0
1059511|NCT01928394|2105829|FG009|Treatment Period|AE unrelated to study drug|2
1059512|NCT01928394|2105830|FG010|Treatment Period|AE unrelated to study drug|0
1059513|NCT01928394|2105831|FG011|Treatment Period|AE unrelated to study drug|12
1059514|NCT01928394|2105832|FG012|Treatment Period|AE unrelated to study drug|6
1059515|NCT01928394|2105833|FG013|Treatment Period|AE unrelated to study drug|13
1059516|NCT01928394|2105834|FG014|Treatment Period|AE unrelated to study drug|6
1059517|NCT01928394|2105835|FG015|Treatment Period|AE unrelated to study drug|1
1059518|NCT01928394|2105836|FG016|Treatment Period|AE unrelated to study drug|1
1059519|NCT01928394|2105837|FG017|Treatment Period|AE unrelated to study drug|6
1059520|NCT01928394|2105838|FG018|Treatment Period|AE unrelated to study drug|3
1059521|NCT01928394|2105839|FG019|Treatment Period|AE unrelated to study drug|5
1059522|NCT01928394|2105840|FG020|Treatment Period|AE unrelated to study drug|1
1059523|NCT01928394|2105841|FG021|Treatment Period|AE unrelated to study drug|1
1059524|NCT01928394|2105842|FG022|Treatment Period|AE unrelated to study drug|0
1059525|NCT01928394|2105820|FG000|Treatment Period|Participant request to stop therapy|0
1059526|NCT01928394|2105821|FG001|Treatment Period|Participant request to stop therapy|0
1059527|NCT01928394|2105822|FG002|Treatment Period|Participant request to stop therapy|0
1059528|NCT01928394|2105823|FG003|Treatment Period|Participant request to stop therapy|0
1059529|NCT01928394|2105824|FG004|Treatment Period|Participant request to stop therapy|0
1059530|NCT01928394|2105825|FG005|Treatment Period|Participant request to stop therapy|3
1059531|NCT01928394|2105826|FG006|Treatment Period|Participant request to stop therapy|3
1059532|NCT01928394|2105827|FG007|Treatment Period|Participant request to stop therapy|0
1059533|NCT01928394|2105828|FG008|Treatment Period|Participant request to stop therapy|0
1059534|NCT01928394|2105829|FG009|Treatment Period|Participant request to stop therapy|0
1059535|NCT01928394|2105830|FG010|Treatment Period|Participant request to stop therapy|3
1059536|NCT01928394|2105831|FG011|Treatment Period|Participant request to stop therapy|2
1059537|NCT01928394|2105832|FG012|Treatment Period|Participant request to stop therapy|1
1059538|NCT01928394|2105833|FG013|Treatment Period|Participant request to stop therapy|2
1059539|NCT01928394|2105834|FG014|Treatment Period|Participant request to stop therapy|4
1059540|NCT01928394|2105835|FG015|Treatment Period|Participant request to stop therapy|0
1059541|NCT01928394|2105836|FG016|Treatment Period|Participant request to stop therapy|1
1059542|NCT01928394|2105837|FG017|Treatment Period|Participant request to stop therapy|3
1059543|NCT01928394|2105838|FG018|Treatment Period|Participant request to stop therapy|1
1059544|NCT01928394|2105839|FG019|Treatment Period|Participant request to stop therapy|1
1059545|NCT01928394|2105840|FG020|Treatment Period|Participant request to stop therapy|3
1059546|NCT01928394|2105841|FG021|Treatment Period|Participant request to stop therapy|1
1059547|NCT01928394|2105842|FG022|Treatment Period|Participant request to stop therapy|3
1059548|NCT01928394|2105820|FG000|Treatment Period|Participant withdrew consent|0
1059549|NCT01928394|2105821|FG001|Treatment Period|Participant withdrew consent|0
1059550|NCT01928394|2105822|FG002|Treatment Period|Participant withdrew consent|1
1059551|NCT01928394|2105823|FG003|Treatment Period|Participant withdrew consent|1
1059552|NCT01928394|2105824|FG004|Treatment Period|Participant withdrew consent|0
1059553|NCT01928394|2105825|FG005|Treatment Period|Participant withdrew consent|1
1059554|NCT01928394|2105826|FG006|Treatment Period|Participant withdrew consent|0
1059555|NCT01928394|2105827|FG007|Treatment Period|Participant withdrew consent|1
1059556|NCT01928394|2105828|FG008|Treatment Period|Participant withdrew consent|0
1059557|NCT01928394|2105829|FG009|Treatment Period|Participant withdrew consent|0
1059558|NCT01928394|2105830|FG010|Treatment Period|Participant withdrew consent|1
1059559|NCT01928394|2105831|FG011|Treatment Period|Participant withdrew consent|1
1059560|NCT01928394|2105832|FG012|Treatment Period|Participant withdrew consent|1
1059561|NCT01928394|2105833|FG013|Treatment Period|Participant withdrew consent|0
1059562|NCT01928394|2105834|FG014|Treatment Period|Participant withdrew consent|2
1059563|NCT01928394|2105835|FG015|Treatment Period|Participant withdrew consent|0
1059564|NCT01928394|2105836|FG016|Treatment Period|Participant withdrew consent|2
1059565|NCT01928394|2105837|FG017|Treatment Period|Participant withdrew consent|1
1059566|NCT01928394|2105838|FG018|Treatment Period|Participant withdrew consent|1
1059567|NCT01928394|2105839|FG019|Treatment Period|Participant withdrew consent|1
1059568|NCT01928394|2105840|FG020|Treatment Period|Participant withdrew consent|0
1059569|NCT01928394|2105841|FG021|Treatment Period|Participant withdrew consent|2
1059570|NCT01928394|2105842|FG022|Treatment Period|Participant withdrew consent|0
1059571|NCT01928394|2105820|FG000|Treatment Period|Poor/non-compliance|0
1059572|NCT01928394|2105821|FG001|Treatment Period|Poor/non-compliance|0
1059573|NCT01928394|2105822|FG002|Treatment Period|Poor/non-compliance|0
1059574|NCT01928394|2105823|FG003|Treatment Period|Poor/non-compliance|1
1059575|NCT01928394|2105824|FG004|Treatment Period|Poor/non-compliance|0
1059576|NCT01928394|2105825|FG005|Treatment Period|Poor/non-compliance|0
1059577|NCT01928394|2105826|FG006|Treatment Period|Poor/non-compliance|0
1059578|NCT01928394|2105827|FG007|Treatment Period|Poor/non-compliance|0
1059579|NCT01928394|2105828|FG008|Treatment Period|Poor/non-compliance|0
1059580|NCT01928394|2105829|FG009|Treatment Period|Poor/non-compliance|0
1059581|NCT01928394|2105830|FG010|Treatment Period|Poor/non-compliance|0
1059582|NCT01928394|2105831|FG011|Treatment Period|Poor/non-compliance|0
1059583|NCT01928394|2105832|FG012|Treatment Period|Poor/non-compliance|1
1059584|NCT01928394|2105833|FG013|Treatment Period|Poor/non-compliance|0
1059585|NCT01928394|2105834|FG014|Treatment Period|Poor/non-compliance|1
1059586|NCT01928394|2105835|FG015|Treatment Period|Poor/non-compliance|0
1059587|NCT01928394|2105836|FG016|Treatment Period|Poor/non-compliance|0
1059588|NCT01928394|2105837|FG017|Treatment Period|Poor/non-compliance|1
1059589|NCT01928394|2105838|FG018|Treatment Period|Poor/non-compliance|0
1059590|NCT01928394|2105839|FG019|Treatment Period|Poor/non-compliance|1
1059591|NCT01928394|2105840|FG020|Treatment Period|Poor/non-compliance|0
1059592|NCT01928394|2105841|FG021|Treatment Period|Poor/non-compliance|0
1059593|NCT01928394|2105842|FG022|Treatment Period|Poor/non-compliance|0
1059594|NCT01928394|2105820|FG000|Treatment Period|other reason|0
1059595|NCT01928394|2105821|FG001|Treatment Period|other reason|0
1059596|NCT01928394|2105822|FG002|Treatment Period|other reason|0
1059597|NCT01928394|2105823|FG003|Treatment Period|other reason|0
1059598|NCT01928394|2105824|FG004|Treatment Period|other reason|0
1059599|NCT01928394|2105825|FG005|Treatment Period|other reason|0
1059600|NCT01928394|2105826|FG006|Treatment Period|other reason|0
1059601|NCT01928394|2105827|FG007|Treatment Period|other reason|0
1059602|NCT01928394|2105828|FG008|Treatment Period|other reason|0
1059603|NCT01928394|2105829|FG009|Treatment Period|other reason|0
1059604|NCT01928394|2105830|FG010|Treatment Period|other reason|1
1059605|NCT01928394|2105831|FG011|Treatment Period|other reason|1
1059606|NCT01928394|2105832|FG012|Treatment Period|other reason|1
1059607|NCT01928394|2105833|FG013|Treatment Period|other reason|0
1059608|NCT01928394|2105834|FG014|Treatment Period|other reason|1
1059609|NCT01928394|2105835|FG015|Treatment Period|other reason|0
1059610|NCT01928394|2105836|FG016|Treatment Period|other reason|0
1059611|NCT01928394|2105837|FG017|Treatment Period|other reason|0
1059612|NCT01928394|2105838|FG018|Treatment Period|other reason|2
1059613|NCT01928394|2105839|FG019|Treatment Period|other reason|2
1059614|NCT01928394|2105840|FG020|Treatment Period|other reason|0
1059615|NCT01928394|2105841|FG021|Treatment Period|other reason|0
1059616|NCT01928394|2105842|FG022|Treatment Period|other reason|0
1059617|NCT01928394|2105820|FG000|Treatment Period|Maximum clinical benefit|0
1059618|NCT01928394|2105821|FG001|Treatment Period|Maximum clinical benefit|0
1059619|NCT01928394|2105822|FG002|Treatment Period|Maximum clinical benefit|0
1059620|NCT01928394|2105823|FG003|Treatment Period|Maximum clinical benefit|0
1059621|NCT01928394|2105824|FG004|Treatment Period|Maximum clinical benefit|0
1059622|NCT01928394|2105825|FG005|Treatment Period|Maximum clinical benefit|0
1059623|NCT01928394|2105826|FG006|Treatment Period|Maximum clinical benefit|0
1059624|NCT01928394|2105827|FG007|Treatment Period|Maximum clinical benefit|0
1059625|NCT01928394|2105828|FG008|Treatment Period|Maximum clinical benefit|0
1059626|NCT01928394|2105829|FG009|Treatment Period|Maximum clinical benefit|0
1059627|NCT01928394|2105830|FG010|Treatment Period|Maximum clinical benefit|1
1059628|NCT01928394|2105831|FG011|Treatment Period|Maximum clinical benefit|1
1059629|NCT01928394|2105832|FG012|Treatment Period|Maximum clinical benefit|0
1059630|NCT01928394|2105833|FG013|Treatment Period|Maximum clinical benefit|0
1059631|NCT01928394|2105834|FG014|Treatment Period|Maximum clinical benefit|1
1059632|NCT01928394|2105835|FG015|Treatment Period|Maximum clinical benefit|0
1059633|NCT01928394|2105836|FG016|Treatment Period|Maximum clinical benefit|0
1059634|NCT01928394|2105837|FG017|Treatment Period|Maximum clinical benefit|1
1059635|NCT01928394|2105838|FG018|Treatment Period|Maximum clinical benefit|1
1059636|NCT01928394|2105839|FG019|Treatment Period|Maximum clinical benefit|0
1059637|NCT01928394|2105840|FG020|Treatment Period|Maximum clinical benefit|2
1059638|NCT01928394|2105841|FG021|Treatment Period|Maximum clinical benefit|0
1059639|NCT01928394|2105842|FG022|Treatment Period|Maximum clinical benefit|0
1059640|NCT01928394|2105820|FG000|Treatment Period|Lost to Follow-up|0
1059641|NCT01928394|2105821|FG001|Treatment Period|Lost to Follow-up|0
1059642|NCT01928394|2105822|FG002|Treatment Period|Lost to Follow-up|0
1059643|NCT01928394|2105823|FG003|Treatment Period|Lost to Follow-up|0
1059644|NCT01928394|2105824|FG004|Treatment Period|Lost to Follow-up|0
1059645|NCT01928394|2105825|FG005|Treatment Period|Lost to Follow-up|0
1059646|NCT01928394|2105826|FG006|Treatment Period|Lost to Follow-up|0
1059647|NCT01928394|2105827|FG007|Treatment Period|Lost to Follow-up|0
1059648|NCT01928394|2105828|FG008|Treatment Period|Lost to Follow-up|0
1059649|NCT01928394|2105829|FG009|Treatment Period|Lost to Follow-up|0
1059650|NCT01928394|2105830|FG010|Treatment Period|Lost to Follow-up|0
1059651|NCT01928394|2105831|FG011|Treatment Period|Lost to Follow-up|0
1059652|NCT01928394|2105832|FG012|Treatment Period|Lost to Follow-up|0
1059653|NCT01928394|2105833|FG013|Treatment Period|Lost to Follow-up|0
1059654|NCT01928394|2105834|FG014|Treatment Period|Lost to Follow-up|0
1059655|NCT01928394|2105835|FG015|Treatment Period|Lost to Follow-up|0
1059656|NCT01928394|2105836|FG016|Treatment Period|Lost to Follow-up|0
1059657|NCT01928394|2105837|FG017|Treatment Period|Lost to Follow-up|0
1059658|NCT01928394|2105838|FG018|Treatment Period|Lost to Follow-up|0
1059659|NCT01928394|2105839|FG019|Treatment Period|Lost to Follow-up|0
1059660|NCT01928394|2105840|FG020|Treatment Period|Lost to Follow-up|0
1059661|NCT01928394|2105841|FG021|Treatment Period|Lost to Follow-up|0
1059662|NCT01928394|2105842|FG022|Treatment Period|Lost to Follow-up|1
1059663|NCT01928394|2105820|FG000|Treatment Period|Death|0
1059664|NCT01928394|2105821|FG001|Treatment Period|Death|0
1059665|NCT01928394|2105822|FG002|Treatment Period|Death|0
1059666|NCT01928394|2105823|FG003|Treatment Period|Death|0
1059667|NCT01928394|2105824|FG004|Treatment Period|Death|0
1059668|NCT01928394|2105825|FG005|Treatment Period|Death|0
1059669|NCT01928394|2105826|FG006|Treatment Period|Death|0
1059670|NCT01928394|2105827|FG007|Treatment Period|Death|0
1059671|NCT01928394|2105828|FG008|Treatment Period|Death|0
1059672|NCT01928394|2105829|FG009|Treatment Period|Death|0
1059673|NCT01928394|2105830|FG010|Treatment Period|Death|0
1059674|NCT01928394|2105831|FG011|Treatment Period|Death|0
1059675|NCT01928394|2105832|FG012|Treatment Period|Death|0
1059676|NCT01928394|2105833|FG013|Treatment Period|Death|1
1059677|NCT01928394|2105834|FG014|Treatment Period|Death|2
1059678|NCT01928394|2105835|FG015|Treatment Period|Death|0
1059679|NCT01928394|2105836|FG016|Treatment Period|Death|0
1059680|NCT01928394|2105837|FG017|Treatment Period|Death|0
1059681|NCT01928394|2105838|FG018|Treatment Period|Death|0
1059682|NCT01928394|2105839|FG019|Treatment Period|Death|0
1059683|NCT01928394|2105840|FG020|Treatment Period|Death|0
1059684|NCT01928394|2105841|FG021|Treatment Period|Death|0
1059685|NCT01928394|2105842|FG022|Treatment Period|Death|0
1059686|NCT01928394|2105820|FG000|Follow-up Period|Participant withdrew consent|3
1059687|NCT01928394|2105821|FG001|Follow-up Period|Participant withdrew consent|0
1059688|NCT01928394|2105822|FG002|Follow-up Period|Participant withdrew consent|1
1059689|NCT01928394|2105823|FG003|Follow-up Period|Participant withdrew consent|4
1059690|NCT01928394|2105824|FG004|Follow-up Period|Participant withdrew consent|0
1059691|NCT01928394|2105825|FG005|Follow-up Period|Participant withdrew consent|2
1059692|NCT01928394|2105826|FG006|Follow-up Period|Participant withdrew consent|5
1059693|NCT01928394|2105827|FG007|Follow-up Period|Participant withdrew consent|1
1059694|NCT01928394|2105828|FG008|Follow-up Period|Participant withdrew consent|0
1059695|NCT01928394|2105829|FG009|Follow-up Period|Participant withdrew consent|0
1059696|NCT01928394|2105830|FG010|Follow-up Period|Participant withdrew consent|5
1059697|NCT01928394|2105831|FG011|Follow-up Period|Participant withdrew consent|8
1059698|NCT01928394|2105832|FG012|Follow-up Period|Participant withdrew consent|2
1059699|NCT01928394|2105833|FG013|Follow-up Period|Participant withdrew consent|12
1059700|NCT01928394|2105834|FG014|Follow-up Period|Participant withdrew consent|7
1059701|NCT01928394|2105835|FG015|Follow-up Period|Participant withdrew consent|0
1059702|NCT01928394|2105836|FG016|Follow-up Period|Participant withdrew consent|5
1059703|NCT01928394|2105837|FG017|Follow-up Period|Participant withdrew consent|3
1059704|NCT01928394|2105838|FG018|Follow-up Period|Participant withdrew consent|2
1059705|NCT01928394|2105839|FG019|Follow-up Period|Participant withdrew consent|7
1059706|NCT01928394|2105840|FG020|Follow-up Period|Participant withdrew consent|4
1059707|NCT01928394|2105841|FG021|Follow-up Period|Participant withdrew consent|6
1059708|NCT01928394|2105842|FG022|Follow-up Period|Participant withdrew consent|2
1059709|NCT01928394|2105820|FG000|Follow-up Period|Death|0
1059710|NCT01928394|2105821|FG001|Follow-up Period|Death|0
1059711|NCT01928394|2105822|FG002|Follow-up Period|Death|2
1059712|NCT01928394|2105823|FG003|Follow-up Period|Death|6
1059713|NCT01928394|2105824|FG004|Follow-up Period|Death|0
1059714|NCT01928394|2105825|FG005|Follow-up Period|Death|6
1059715|NCT01928394|2105826|FG006|Follow-up Period|Death|6
1059716|NCT01928394|2105827|FG007|Follow-up Period|Death|2
1059717|NCT01928394|2105828|FG008|Follow-up Period|Death|1
1059718|NCT01928394|2105829|FG009|Follow-up Period|Death|2
1059719|NCT01928394|2105830|FG010|Follow-up Period|Death|4
1059720|NCT01928394|2105831|FG011|Follow-up Period|Death|12
1059721|NCT01928394|2105832|FG012|Follow-up Period|Death|11
1059722|NCT01928394|2105833|FG013|Follow-up Period|Death|25
1059723|NCT01928394|2105834|FG014|Follow-up Period|Death|18
1059724|NCT01928394|2105835|FG015|Follow-up Period|Death|0
1059725|NCT01928394|2105836|FG016|Follow-up Period|Death|6
1059726|NCT01928394|2105837|FG017|Follow-up Period|Death|5
1059727|NCT01928394|2105838|FG018|Follow-up Period|Death|13
1059728|NCT01928394|2105839|FG019|Follow-up Period|Death|13
1059729|NCT01928394|2105840|FG020|Follow-up Period|Death|5
1059730|NCT01928394|2105841|FG021|Follow-up Period|Death|3
1059731|NCT01928394|2105842|FG022|Follow-up Period|Death|2
1059732|NCT01928394|2105820|FG000|Follow-up Period|other reason|0
1059733|NCT01928394|2105821|FG001|Follow-up Period|other reason|0
1059734|NCT01928394|2105822|FG002|Follow-up Period|other reason|0
1059735|NCT01928394|2105823|FG003|Follow-up Period|other reason|0
1059736|NCT01928394|2105824|FG004|Follow-up Period|other reason|0
1059737|NCT01928394|2105825|FG005|Follow-up Period|other reason|0
1059738|NCT01928394|2105826|FG006|Follow-up Period|other reason|1
1059739|NCT01928394|2105827|FG007|Follow-up Period|other reason|3
1059740|NCT01928394|2105828|FG008|Follow-up Period|other reason|0
1059741|NCT01928394|2105829|FG009|Follow-up Period|other reason|0
1059742|NCT01928394|2105830|FG010|Follow-up Period|other reason|2
1059743|NCT01928394|2105831|FG011|Follow-up Period|other reason|1
1059744|NCT01928394|2105832|FG012|Follow-up Period|other reason|0
1059745|NCT01928394|2105833|FG013|Follow-up Period|other reason|1
1059746|NCT01928394|2105834|FG014|Follow-up Period|other reason|4
1059747|NCT01928394|2105835|FG015|Follow-up Period|other reason|0
1059748|NCT01928394|2105836|FG016|Follow-up Period|other reason|2
1059749|NCT01928394|2105837|FG017|Follow-up Period|other reason|0
1059750|NCT01928394|2105838|FG018|Follow-up Period|other reason|1
1059751|NCT01928394|2105839|FG019|Follow-up Period|other reason|1
1059752|NCT01928394|2105840|FG020|Follow-up Period|other reason|0
1059753|NCT01928394|2105841|FG021|Follow-up Period|other reason|0
1059754|NCT01928394|2105842|FG022|Follow-up Period|other reason|1
1059755|NCT01928394|2105820|FG000|Follow-up Period|Lost to Follow-up|0
1059756|NCT01928394|2105821|FG001|Follow-up Period|Lost to Follow-up|0
1059757|NCT01928394|2105822|FG002|Follow-up Period|Lost to Follow-up|0
1059758|NCT01928394|2105823|FG003|Follow-up Period|Lost to Follow-up|0
1059759|NCT01928394|2105824|FG004|Follow-up Period|Lost to Follow-up|0
1059760|NCT01928394|2105825|FG005|Follow-up Period|Lost to Follow-up|0
1059761|NCT01928394|2105826|FG006|Follow-up Period|Lost to Follow-up|0
1059762|NCT01928394|2105827|FG007|Follow-up Period|Lost to Follow-up|0
1059763|NCT01928394|2105828|FG008|Follow-up Period|Lost to Follow-up|0
1059764|NCT01928394|2105829|FG009|Follow-up Period|Lost to Follow-up|0
1059765|NCT01928394|2105830|FG010|Follow-up Period|Lost to Follow-up|0
1059766|NCT01928394|2105831|FG011|Follow-up Period|Lost to Follow-up|1
1059767|NCT01928394|2105832|FG012|Follow-up Period|Lost to Follow-up|1
1059768|NCT01928394|2105833|FG013|Follow-up Period|Lost to Follow-up|0
1059769|NCT01928394|2105834|FG014|Follow-up Period|Lost to Follow-up|1
1059770|NCT01928394|2105835|FG015|Follow-up Period|Lost to Follow-up|0
1059771|NCT01928394|2105836|FG016|Follow-up Period|Lost to Follow-up|1
1059772|NCT01928394|2105837|FG017|Follow-up Period|Lost to Follow-up|0
1059773|NCT01928394|2105838|FG018|Follow-up Period|Lost to Follow-up|0
1059774|NCT01928394|2105839|FG019|Follow-up Period|Lost to Follow-up|0
1059775|NCT01928394|2105840|FG020|Follow-up Period|Lost to Follow-up|0
1059776|NCT01928394|2105841|FG021|Follow-up Period|Lost to Follow-up|0
1059777|NCT01928394|2105842|FG022|Follow-up Period|Lost to Follow-up|1
1059778|NCT01928433|2105893|FG000|Overall Study|Adverse Event|5
1059779|NCT01928433|2105894|FG001|Overall Study|Adverse Event|2
1059780|NCT01928433|2105895|FG002|Overall Study|Adverse Event|5
1059781|NCT01928433|2105893|FG000|Overall Study|Protocol Violation|0
1059782|NCT01928433|2105894|FG001|Overall Study|Protocol Violation|0
1059783|NCT01928433|2105895|FG002|Overall Study|Protocol Violation|2
1059784|NCT01928433|2105893|FG000|Overall Study|Lack of Efficacy|5
1059785|NCT01928433|2105894|FG001|Overall Study|Lack of Efficacy|4
1059786|NCT01928433|2105895|FG002|Overall Study|Lack of Efficacy|4
1059787|NCT01928433|2105893|FG000|Overall Study|Withdrawal by Subject|0
1059788|NCT01928433|2105894|FG001|Overall Study|Withdrawal by Subject|4
1059789|NCT01928433|2105895|FG002|Overall Study|Withdrawal by Subject|0
1059790|NCT01928433|2105893|FG000|Overall Study|Negative screening urine culture|7
1059791|NCT01928433|2105894|FG001|Overall Study|Negative screening urine culture|6
1059792|NCT01928433|2105895|FG002|Overall Study|Negative screening urine culture|10
1059793|NCT01928433|2105893|FG000|Overall Study|Lost to Follow-up|0
1059794|NCT01928433|2105894|FG001|Overall Study|Lost to Follow-up|2
1059795|NCT01928433|2105895|FG002|Overall Study|Lost to Follow-up|3
1059796|NCT01928433|2105893|FG000|Overall Study|Other reasons|3
1059797|NCT01928433|2105894|FG001|Overall Study|Other reasons|3
1059798|NCT01928433|2105895|FG002|Overall Study|Other reasons|4
1059799|NCT01928472|2105921|FG000|Overall Study|Death|0
1059800|NCT01928472|2105922|FG001|Overall Study|Death|0
1059801|NCT01928472|2105923|FG002|Overall Study|Death|1
1059802|NCT01928472|2105924|FG003|Overall Study|Death|0
1059803|NCT01928472|2105921|FG000|Overall Study|Withdrawal by Subject|4
1059804|NCT01928472|2105922|FG001|Overall Study|Withdrawal by Subject|4
1059805|NCT01928472|2105923|FG002|Overall Study|Withdrawal by Subject|1
1059806|NCT01928472|2105924|FG003|Overall Study|Withdrawal by Subject|2
1059807|NCT01928472|2105921|FG000|Overall Study|Lost to Follow-up|2
1059808|NCT01928472|2105922|FG001|Overall Study|Lost to Follow-up|3
1059809|NCT01928472|2105923|FG002|Overall Study|Lost to Follow-up|4
1059810|NCT01928472|2105924|FG003|Overall Study|Lost to Follow-up|0
1059811|NCT01928472|2105921|FG000|Overall Study|Administrative Reason|2
1059812|NCT01928472|2105922|FG001|Overall Study|Administrative Reason|1
1059813|NCT01928472|2105923|FG002|Overall Study|Administrative Reason|0
1059814|NCT01928472|2105924|FG003|Overall Study|Administrative Reason|0
1059815|NCT01928472|2105921|FG000|Overall Study|Unclassified|0
1059816|NCT01928472|2105922|FG001|Overall Study|Unclassified|0
1059817|NCT01928472|2105923|FG002|Overall Study|Unclassified|1
1059818|NCT01928472|2105924|FG003|Overall Study|Unclassified|0
1059819|NCT01928485|2105937|FG000|Overall Study|Physician Decision|0
1059820|NCT01928485|2105938|FG001|Overall Study|Physician Decision|1
1059821|NCT01928719|2105992|FG000|Overall Study|Lost to Follow-up|26
1059822|NCT01928719|2105993|FG001|Overall Study|Lost to Follow-up|11
1059823|NCT01928719|2105992|FG000|Overall Study|Withdrawal by Subject|22
1059824|NCT01928719|2105993|FG001|Overall Study|Withdrawal by Subject|7
1059825|NCT01928719|2105992|FG000|Overall Study|Protocol Violation|3
1059826|NCT01928719|2105993|FG001|Overall Study|Protocol Violation|1
1059827|NCT01928719|2105992|FG000|Overall Study|Adverse Event|1
1059828|NCT01928719|2105993|FG001|Overall Study|Adverse Event|0
1059829|NCT01928758|2106003|FG000|Overall Study|Lost to Follow-up|14
1059830|NCT01928758|2106004|FG001|Overall Study|Lost to Follow-up|9
1059831|NCT01928758|2106003|FG000|Overall Study|Withdrawal by Subject|5
1059832|NCT01928758|2106004|FG001|Overall Study|Withdrawal by Subject|2
1059833|NCT01928758|2106003|FG000|Overall Study|Adverse Event|3
1059834|NCT01928758|2106004|FG001|Overall Study|Adverse Event|5
1059835|NCT01928758|2106003|FG000|Overall Study|Protocol Violation|3
1059836|NCT01928758|2106004|FG001|Overall Study|Protocol Violation|4
1059837|NCT01928771|2106014|FG000|Overall Study|Adverse Event|6
1059838|NCT01928771|2106015|FG001|Overall Study|Adverse Event|5
1059839|NCT01928771|2106016|FG002|Overall Study|Adverse Event|1
1059840|NCT01928771|2106014|FG000|Overall Study|Death|2
1059841|NCT01928771|2106015|FG001|Overall Study|Death|2
1059842|NCT01928771|2106016|FG002|Overall Study|Death|2
1059843|NCT01928771|2106014|FG000|Overall Study|Lost to Follow-up|5
1059844|NCT01928771|2106015|FG001|Overall Study|Lost to Follow-up|6
1059845|NCT01928771|2106016|FG002|Overall Study|Lost to Follow-up|3
1059846|NCT01928771|2106014|FG000|Overall Study|Withdrawal by Subject|20
1059847|NCT01928771|2106015|FG001|Overall Study|Withdrawal by Subject|15
1059848|NCT01928771|2106016|FG002|Overall Study|Withdrawal by Subject|17
1059849|NCT01928771|2106014|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
1059850|NCT01928771|2106015|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
1059851|NCT01928771|2106016|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
1059852|NCT01928771|2106014|FG000|Overall Study|Other Reasons|9
1059853|NCT01928771|2106015|FG001|Overall Study|Other Reasons|9
1059854|NCT01928771|2106016|FG002|Overall Study|Other Reasons|14
1059855|NCT01928771|2106014|FG000|Overall Study|Severe Non-Compliance to Protocol|4
1059856|NCT01928771|2106015|FG001|Overall Study|Severe Non-Compliance to Protocol|2
1059857|NCT01928771|2106016|FG002|Overall Study|Severe Non-Compliance to Protocol|2
1059858|NCT01928862|2106049|FG000|Overall Study|Lost to Follow-up|1
1059859|NCT01928862|2106050|FG001|Overall Study|Lost to Follow-up|0
1059860|NCT01928862|2106051|FG002|Overall Study|Lost to Follow-up|0
1059861|NCT01928862|2106052|FG003|Overall Study|Lost to Follow-up|0
1059862|NCT01928862|2106053|FG004|Overall Study|Lost to Follow-up|1
1059863|NCT01928927|2106068|FG000|Overall Study|Lost to Follow-up|1
1059864|NCT01928927|2106069|FG001|Overall Study|Lost to Follow-up|0
1059865|NCT01928927|2106068|FG000|Overall Study|Withdrawal by Subject|1
1059866|NCT01928927|2106069|FG001|Overall Study|Withdrawal by Subject|1
1059867|NCT01928940|2106081|FG000|Overall Study|Adverse Event|0
1059868|NCT01928940|2106082|FG001|Overall Study|Adverse Event|1
1059869|NCT01929018|2106091|FG000|Overall Study|Lost to Follow-up|1
1059870|NCT01929018|2106092|FG001|Overall Study|Lost to Follow-up|0
1059871|NCT01929018|2106091|FG000|Overall Study|Hospitalization|0
1059872|NCT01929018|2106092|FG001|Overall Study|Hospitalization|1
1059873|NCT01929031|2106102|FG000|Overall Study|Adverse Event|3
1059874|NCT01929031|2106103|FG001|Overall Study|Adverse Event|1
1059875|NCT01929031|2106104|FG002|Overall Study|Adverse Event|1
1059876|NCT01929031|2106105|FG003|Overall Study|Adverse Event|0
1059877|NCT01929031|2106106|FG004|Overall Study|Adverse Event|0
1059878|NCT01929031|2106107|FG005|Overall Study|Adverse Event|0
1059879|NCT01929031|2106102|FG000|Overall Study|Protocol Violation|1
1059880|NCT01929031|2106103|FG001|Overall Study|Protocol Violation|0
1059881|NCT01929031|2106104|FG002|Overall Study|Protocol Violation|0
1059882|NCT01929031|2106105|FG003|Overall Study|Protocol Violation|0
1059883|NCT01929031|2106106|FG004|Overall Study|Protocol Violation|0
1059884|NCT01929031|2106107|FG005|Overall Study|Protocol Violation|1
1059885|NCT01929031|2106102|FG000|Overall Study|Reason other than specified above|0
1059886|NCT01929031|2106103|FG001|Overall Study|Reason other than specified above|1
1059887|NCT01929031|2106104|FG002|Overall Study|Reason other than specified above|0
1059888|NCT01929031|2106105|FG003|Overall Study|Reason other than specified above|0
1059889|NCT01929031|2106106|FG004|Overall Study|Reason other than specified above|1
1059890|NCT01929031|2106107|FG005|Overall Study|Reason other than specified above|0
1059891|NCT01929044|2106119|FG000|Overall Study|Adverse Event|1
1059892|NCT01929044|2106120|FG001|Overall Study|Adverse Event|0
1059893|NCT01929044|2106119|FG000|Overall Study|Protocol Violation|9
1059894|NCT01929044|2106120|FG001|Overall Study|Protocol Violation|14
1059895|NCT01929044|2106119|FG000|Overall Study|Not Treated|1
1059896|NCT01929044|2106120|FG001|Overall Study|Not Treated|3
1059897|NCT01929083|2106137|FG000|Intervention 1|Lost to Follow-up|2
1059898|NCT01929083|2106138|FG001|Intervention 1|Lost to Follow-up|0
1059899|NCT01929083|2106137|FG000|Intervention 1|Nonadherent to study medications|1
1059900|NCT01929083|2106138|FG001|Intervention 1|Nonadherent to study medications|0
1059901|NCT01929083|2106137|FG000|Intervention 2|Adverse Event|0
1059902|NCT01929083|2106138|FG001|Intervention 2|Adverse Event|1
1059903|NCT01929109|2106149|FG000|Period 1 (All Groups)|Deviation from protocol|0
1059904|NCT01929109|2106150|FG001|Period 1 (All Groups)|Deviation from protocol|0
1059905|NCT01929109|2106151|FG002|Period 1 (All Groups)|Deviation from protocol|1
1059906|NCT01929109|2106152|FG003|Period 1 (All Groups)|Deviation from protocol|0
1059907|NCT01929109|2106153|FG004|Period 1 (All Groups)|Deviation from protocol|0
1059908|NCT01929135|2106170|FG000|Overall Study|Lost to Follow-up|1
1059909|NCT01929135|2106171|FG001|Overall Study|Lost to Follow-up|1
1059910|NCT01929226|2106181|FG000|Overall Study|Lost to Follow-up|4
1059911|NCT01929226|2106182|FG001|Overall Study|Lost to Follow-up|0
1059912|NCT01929226|2106181|FG000|Overall Study|Withdrawal by Subject|1
1059913|NCT01929226|2106182|FG001|Overall Study|Withdrawal by Subject|1
1059914|NCT01929317|2106195|FG000|Dose Increase Effect Verification Phase|Adverse Event|5
1059915|NCT01929317|2106196|FG001|Dose Increase Effect Verification Phase|Adverse Event|1
1059916|NCT01929317|2106195|FG000|Dose Increase Effect Verification Phase|Physician Decision|1
1059917|NCT01929317|2106196|FG001|Dose Increase Effect Verification Phase|Physician Decision|0
1059918|NCT01929317|2106195|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
1059919|NCT01929317|2106196|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
1059920|NCT01929317|2106195|FG000|Long-term Phase|Adverse Event|5
1059921|NCT01929317|2106196|FG001|Long-term Phase|Adverse Event|1
1059922|NCT01929317|2106195|FG000|Long-term Phase|Physician Decision|3
1059923|NCT01929317|2106196|FG001|Long-term Phase|Physician Decision|0
1059924|NCT01929317|2106195|FG000|Long-term Phase|Withdrawal by Subject|4
1059925|NCT01929317|2106196|FG001|Long-term Phase|Withdrawal by Subject|0
1059926|NCT01929317|2106195|FG000|Long-term Phase|Protocol Violation|1
1059927|NCT01929317|2106196|FG001|Long-term Phase|Protocol Violation|0
1059928|NCT01929317|2106195|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1
1059929|NCT01929317|2106196|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0
1059930|NCT01929317|2106195|FG000|Long-term Phase|Study Closed/Terminated|5
1059931|NCT01929317|2106196|FG001|Long-term Phase|Study Closed/Terminated|3
1059932|NCT01929343|2106211|FG000|Overall Study|Physician Decision|0
1059933|NCT01929343|2106212|FG001|Overall Study|Physician Decision|2
1059934|NCT01929343|2106213|FG002|Overall Study|Physician Decision|0
1059935|NCT01929343|2106211|FG000|Overall Study|Withdrawal by Subject|1
1059936|NCT01929343|2106212|FG001|Overall Study|Withdrawal by Subject|0
1059937|NCT01929343|2106213|FG002|Overall Study|Withdrawal by Subject|0
1059938|NCT01929395|2106224|FG000|Overall Study|Did not complete - non-related toxicity|1
1059939|NCT01929395|2106225|FG001|Overall Study|Did not complete - non-related toxicity|0
1059940|NCT01929395|2106226|FG002|Overall Study|Did not complete - non-related toxicity|0
1059941|NCT01929395|2106224|FG000|Overall Study|Withdrawal by Subject|0
1059942|NCT01929395|2106225|FG001|Overall Study|Withdrawal by Subject|1
1059943|NCT01929395|2106226|FG002|Overall Study|Withdrawal by Subject|0
1059944|NCT01929395|2106224|FG000|Overall Study|Screen Fail|0
1059945|NCT01929395|2106225|FG001|Overall Study|Screen Fail|0
1059946|NCT01929395|2106226|FG002|Overall Study|Screen Fail|1
1059947|NCT01929408|2106234|FG000|Overall Study|received HCT as initial treatment|8
1059948|NCT01929681|2106259|FG000|Overall Study|Withdrawal by Subject|1
1059949|NCT01929681|2106260|FG001|Overall Study|Withdrawal by Subject|0
1059950|NCT01929681|2106259|FG000|Overall Study|Physician Decision|1
1059951|NCT01929681|2106260|FG001|Overall Study|Physician Decision|1
1059952|NCT01929707|2106266|FG000|Intervention Period 1|Lost to Follow-up|0
1059953|NCT01929707|2106267|FG001|Intervention Period 1|Lost to Follow-up|0
1059954|NCT01929707|2106268|FG002|Intervention Period 1|Lost to Follow-up|0
1059955|NCT01929707|2106269|FG003|Intervention Period 1|Lost to Follow-up|1
1059956|NCT01929707|2106270|FG004|Intervention Period 1|Lost to Follow-up|0
1059957|NCT01929707|2106271|FG005|Intervention Period 1|Lost to Follow-up|0
1059958|NCT01929707|2106272|FG006|Intervention Period 1|Lost to Follow-up|0
1059959|NCT01929707|2106273|FG007|Intervention Period 1|Lost to Follow-up|0
1059960|NCT01929707|2106266|FG000|Intervention Period 1|Withdrawal by Subject|0
1059961|NCT01929707|2106267|FG001|Intervention Period 1|Withdrawal by Subject|0
1059962|NCT01929707|2106268|FG002|Intervention Period 1|Withdrawal by Subject|0
1059963|NCT01929707|2106269|FG003|Intervention Period 1|Withdrawal by Subject|2
1059964|NCT01929707|2106270|FG004|Intervention Period 1|Withdrawal by Subject|0
1059965|NCT01929707|2106271|FG005|Intervention Period 1|Withdrawal by Subject|0
1059966|NCT01929707|2106272|FG006|Intervention Period 1|Withdrawal by Subject|0
1059967|NCT01929707|2106273|FG007|Intervention Period 1|Withdrawal by Subject|0
1059968|NCT01929707|2106266|FG000|Intervention Period 2|Withdrawal by Subject|0
1059969|NCT01929707|2106267|FG001|Intervention Period 2|Withdrawal by Subject|0
1059970|NCT01929707|2106268|FG002|Intervention Period 2|Withdrawal by Subject|0
1059971|NCT01929707|2106269|FG003|Intervention Period 2|Withdrawal by Subject|0
1059972|NCT01929707|2106270|FG004|Intervention Period 2|Withdrawal by Subject|0
1059973|NCT01929707|2106271|FG005|Intervention Period 2|Withdrawal by Subject|2
1059974|NCT01929707|2106272|FG006|Intervention Period 2|Withdrawal by Subject|0
1059975|NCT01929707|2106273|FG007|Intervention Period 2|Withdrawal by Subject|0
1059976|NCT01929863|2106298|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
1059977|NCT01929863|2106299|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
1059978|NCT01929863|2106298|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
1059979|NCT01929863|2106299|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
1059980|NCT01929863|2106298|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
1059981|NCT01929863|2106299|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
1059982|NCT01929876|2106310|FG000|Period 2|Non-Compliance|1
1059983|NCT01929980|2106318|FG000|Overall Study|Physician Decision|1
1059984|NCT01929993|2106324|FG000|Overall Study|Protocol Violation|4
1059985|NCT01929993|2106325|FG001|Overall Study|Protocol Violation|6
1059986|NCT01929993|2106324|FG000|Overall Study|Absent CIN, invasion present or artifact|26
1059987|NCT01929993|2106325|FG001|Overall Study|Absent CIN, invasion present or artifact|22
1059988|NCT01930045|2106331|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0
1059989|NCT01930045|2106332|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0
1059990|NCT01930045|2106333|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0
1059991|NCT01930045|2106334|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0
1059992|NCT01930045|2106335|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0
1059993|NCT01930045|2106336|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1
1059994|NCT01930045|2106331|FG000|Pause (up to 37 Days)|Protocol Violation|0
1059995|NCT01930045|2106332|FG001|Pause (up to 37 Days)|Protocol Violation|0
1059996|NCT01930045|2106333|FG002|Pause (up to 37 Days)|Protocol Violation|0
1059997|NCT01930045|2106334|FG003|Pause (up to 37 Days)|Protocol Violation|0
1059998|NCT01930045|2106335|FG004|Pause (up to 37 Days)|Protocol Violation|0
1059999|NCT01930045|2106336|FG005|Pause (up to 37 Days)|Protocol Violation|1
1060000|NCT01930162|2106360|FG000|Overall Study|Abnormal test procedure result(s)|4
1060001|NCT01930162|2106360|FG000|Overall Study|Death|1
1060002|NCT01930175|2106368|FG000|Core Study|Lost to Follow-up|0
1060003|NCT01930175|2106369|FG001|Core Study|Lost to Follow-up|1
1060004|NCT01930175|2106370|FG002|Core Study|Lost to Follow-up|0
1060005|NCT01930175|2106368|FG000|Core Study|Adverse Event|0
1060006|NCT01930175|2106369|FG001|Core Study|Adverse Event|0
1060007|NCT01930175|2106370|FG002|Core Study|Adverse Event|1
1060008|NCT01930188|2106382|FG000|Overall Study|unclassified|4
1060009|NCT01930188|2106383|FG001|Overall Study|unclassified|5
1060010|NCT01930188|2106384|FG002|Overall Study|unclassified|3
1060011|NCT01930188|2106382|FG000|Overall Study|Missing follow-up information|2
1060012|NCT01930188|2106383|FG001|Overall Study|Missing follow-up information|2
1060013|NCT01930188|2106384|FG002|Overall Study|Missing follow-up information|3
1060014|NCT01930188|2106382|FG000|Overall Study|Lost to Follow-up|5
1060015|NCT01930188|2106383|FG001|Overall Study|Lost to Follow-up|2
1060016|NCT01930188|2106384|FG002|Overall Study|Lost to Follow-up|2
1060017|NCT01930188|2106382|FG000|Overall Study|Death|2
1060018|NCT01930188|2106383|FG001|Overall Study|Death|1
1060019|NCT01930188|2106384|FG002|Overall Study|Death|3
1060020|NCT01930188|2106382|FG000|Overall Study|Withdrawal by Subject|9
1060021|NCT01930188|2106383|FG001|Overall Study|Withdrawal by Subject|11
1060022|NCT01930188|2106384|FG002|Overall Study|Withdrawal by Subject|8
1060023|NCT01930214|2106396|FG000|Overall Study|Death|4
1060024|NCT01930214|2106397|FG001|Overall Study|Death|4
1060025|NCT01930214|2106398|FG002|Overall Study|Death|11
1060026|NCT01930214|2106396|FG000|Overall Study|Lost to Follow-up|12
1060027|NCT01930214|2106397|FG001|Overall Study|Lost to Follow-up|13
1060028|NCT01930214|2106398|FG002|Overall Study|Lost to Follow-up|12
1060029|NCT01930214|2106396|FG000|Overall Study|Voluntary withdrawal of infomed consent|2
1060030|NCT01930214|2106397|FG001|Overall Study|Voluntary withdrawal of infomed consent|4
1060031|NCT01930214|2106398|FG002|Overall Study|Voluntary withdrawal of infomed consent|2
1060032|NCT01930214|2106396|FG000|Overall Study|Physician Decision|2
1060033|NCT01930214|2106397|FG001|Overall Study|Physician Decision|0
1060034|NCT01930214|2106398|FG002|Overall Study|Physician Decision|0
1060035|NCT01930799|2106440|FG000|Overall Study|Withdrawal by Subject|3
1060036|NCT01930799|2106440|FG000|Overall Study|Lost to Follow-up|5
1060037|NCT01930890|2106448|FG000|Overall Study|Study Termination|14
1060038|NCT01930890|2106449|FG001|Overall Study|Study Termination|28
1060039|NCT01930890|2106450|FG002|Overall Study|Study Termination|13
1060040|NCT01930890|2106451|FG003|Overall Study|Study Termination|25
1060041|NCT01930890|2106448|FG000|Overall Study|Death|0
1060042|NCT01930890|2106449|FG001|Overall Study|Death|0
1060043|NCT01930890|2106450|FG002|Overall Study|Death|0
1060044|NCT01930890|2106451|FG003|Overall Study|Death|1
1060045|NCT01930890|2106448|FG000|Overall Study|Investigator Decision|0
1060046|NCT01930890|2106449|FG001|Overall Study|Investigator Decision|1
1060047|NCT01930890|2106450|FG002|Overall Study|Investigator Decision|0
1060048|NCT01930890|2106451|FG003|Overall Study|Investigator Decision|0
1060049|NCT01930890|2106448|FG000|Overall Study|Consent Withdrawn|0
1060050|NCT01930890|2106449|FG001|Overall Study|Consent Withdrawn|3
1060051|NCT01930890|2106450|FG002|Overall Study|Consent Withdrawn|0
1060052|NCT01930890|2106451|FG003|Overall Study|Consent Withdrawn|1
1060053|NCT01930890|2106448|FG000|Overall Study|Adverse Event|0
1060054|NCT01930890|2106449|FG001|Overall Study|Adverse Event|1
1060055|NCT01930890|2106450|FG002|Overall Study|Adverse Event|0
1060056|NCT01930890|2106451|FG003|Overall Study|Adverse Event|0
1060057|NCT01931059|2106463|FG000|Day 1|Pregnancy|0
1060058|NCT01931059|2106464|FG001|Day 1|Pregnancy|1
1060059|NCT01931059|2106463|FG000|Day3|Lost to Follow-up|1
1060060|NCT01931059|2106464|FG001|Day3|Lost to Follow-up|0
1060061|NCT01931150|2106489|FG000|Overall Study|Withdrawal by Subject|1
1060062|NCT01931150|2106490|FG001|Overall Study|Withdrawal by Subject|2
1060063|NCT01931202|2106503|FG000|Overall Study|Withdrawal by Subject|0
1060064|NCT01931202|2106504|FG001|Overall Study|Withdrawal by Subject|0
1060065|NCT01931202|2106505|FG002|Overall Study|Withdrawal by Subject|2
1060066|NCT01931202|2106503|FG000|Overall Study|Lost to Follow-up|0
1060067|NCT01931202|2106504|FG001|Overall Study|Lost to Follow-up|5
1060068|NCT01931202|2106505|FG002|Overall Study|Lost to Follow-up|2
1060069|NCT01931397|2106516|FG000|Overall Study|Physician Decision|2
1060070|NCT01931397|2106516|FG000|Overall Study|Withdrawal by Subject|8
1060071|NCT01931397|2106516|FG000|Overall Study|moved out of state|1
1060072|NCT01931462|2106524|FG000|Overall Study|Withdrawal by Subject|1
1060073|NCT01931475|2106530|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20
1060074|NCT01931475|2106531|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10
1060075|NCT01931475|2106530|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
1060076|NCT01931475|2106531|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
1060077|NCT01931475|2106530|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
1060078|NCT01931475|2106531|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
1060079|NCT01931475|2106530|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
1060080|NCT01931475|2106531|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
1060081|NCT01931475|2106530|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0
1060082|NCT01931475|2106531|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1
1060083|NCT01931475|2106530|FG000|Period 2: Extension Treatment Phase|Adverse Event|0
1060084|NCT01931475|2106531|FG001|Period 2: Extension Treatment Phase|Adverse Event|8
1060085|NCT01931475|2106530|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1
1060086|NCT01931475|2106531|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0
1060087|NCT01931475|2106530|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
1060088|NCT01931475|2106531|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
1060089|NCT01931475|2106530|FG000|Period 2: Extension Treatment Phase|Physician Decision|1
1060090|NCT01931475|2106531|FG001|Period 2: Extension Treatment Phase|Physician Decision|1
1060091|NCT01931475|2106530|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
1060092|NCT01931475|2106531|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
1060093|NCT01931475|2106530|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1
1060094|NCT01931475|2106531|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1
1060095|NCT01931566|2106558|FG000|Overall Study|Randomized But Not Treated|6
1060096|NCT01931566|2106559|FG001|Overall Study|Randomized But Not Treated|9
1060097|NCT01931566|2106560|FG002|Overall Study|Randomized But Not Treated|14
1060098|NCT01931566|2106558|FG000|Overall Study|Adverse Event|37
1060099|NCT01931566|2106559|FG001|Overall Study|Adverse Event|167
1060100|NCT01931566|2106560|FG002|Overall Study|Adverse Event|132
1060101|NCT01931566|2106558|FG000|Overall Study|Major Protocol Deviation|5
1060102|NCT01931566|2106559|FG001|Overall Study|Major Protocol Deviation|14
1060103|NCT01931566|2106560|FG002|Overall Study|Major Protocol Deviation|21
1060104|NCT01931566|2106558|FG000|Overall Study|Lost to Follow-up|3
1060105|NCT01931566|2106559|FG001|Overall Study|Lost to Follow-up|26
1060106|NCT01931566|2106560|FG002|Overall Study|Lost to Follow-up|23
1060107|NCT01931566|2106558|FG000|Overall Study|Voluntary Withdrawal|78
1060108|NCT01931566|2106559|FG001|Overall Study|Voluntary Withdrawal|245
1060109|NCT01931566|2106560|FG002|Overall Study|Voluntary Withdrawal|225
1060110|NCT01931566|2106558|FG000|Overall Study|Study Termination|289
1060111|NCT01931566|2106559|FG001|Overall Study|Study Termination|968
1060112|NCT01931566|2106560|FG002|Overall Study|Study Termination|1037
1060113|NCT01931566|2106558|FG000|Overall Study|Reason Not Specified|11
1060114|NCT01931566|2106559|FG001|Overall Study|Reason Not Specified|47
1060115|NCT01931566|2106560|FG002|Overall Study|Reason Not Specified|53
1060116|NCT01931566|2106558|FG000|Overall Study|Missing|0
1060117|NCT01931566|2106559|FG001|Overall Study|Missing|0
1060118|NCT01931566|2106560|FG002|Overall Study|Missing|1
1060119|NCT01931670|2106572|FG000|Treatment Period|Exclusionary Medication Received|1
1060120|NCT01931670|2106573|FG001|Treatment Period|Exclusionary Medication Received|1
1060121|NCT01931670|2106574|FG002|Treatment Period|Exclusionary Medication Received|1
1060122|NCT01931670|2106572|FG000|Treatment Period|Surgery/Invasive Intervention|4
1060123|NCT01931670|2106573|FG001|Treatment Period|Surgery/Invasive Intervention|2
1060124|NCT01931670|2106574|FG002|Treatment Period|Surgery/Invasive Intervention|0
1060125|NCT01931670|2106572|FG000|Treatment Period|Subject Noncompliant|4
1060126|NCT01931670|2106573|FG001|Treatment Period|Subject Noncompliant|9
1060127|NCT01931670|2106574|FG002|Treatment Period|Subject Noncompliant|5
1060128|NCT01931670|2106572|FG000|Treatment Period|Adverse Event|19
1060129|NCT01931670|2106573|FG001|Treatment Period|Adverse Event|8
1060130|NCT01931670|2106574|FG002|Treatment Period|Adverse Event|21
1060131|NCT01931670|2106572|FG000|Treatment Period|Lack of Efficacy|11
1060132|NCT01931670|2106573|FG001|Treatment Period|Lack of Efficacy|2
1060133|NCT01931670|2106574|FG002|Treatment Period|Lack of Efficacy|2
1060134|NCT01931670|2106572|FG000|Treatment Period|Pregnancy|7
1060135|NCT01931670|2106573|FG001|Treatment Period|Pregnancy|2
1060136|NCT01931670|2106574|FG002|Treatment Period|Pregnancy|0
1060137|NCT01931670|2106572|FG000|Treatment Period|Other|8
1060138|NCT01931670|2106573|FG001|Treatment Period|Other|7
1060139|NCT01931670|2106574|FG002|Treatment Period|Other|2
1060140|NCT01931670|2106572|FG000|Treatment Period|Consent Withdrawn by Subject|17
1060141|NCT01931670|2106573|FG001|Treatment Period|Consent Withdrawn by Subject|12
1060142|NCT01931670|2106574|FG002|Treatment Period|Consent Withdrawn by Subject|7
1060143|NCT01931670|2106572|FG000|Treatment Period|Lost to Follow-up|19
1060144|NCT01931670|2106573|FG001|Treatment Period|Lost to Follow-up|5
1060145|NCT01931670|2106574|FG002|Treatment Period|Lost to Follow-up|7
1060146|NCT01931670|2106572|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
1060147|NCT01931670|2106573|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
1060148|NCT01931670|2106574|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
1060149|NCT01931670|2106572|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
1060150|NCT01931670|2106573|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
1060151|NCT01931670|2106574|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
1060152|NCT01931670|2106572|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
1060153|NCT01931670|2106573|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
1060154|NCT01931670|2106574|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
1060155|NCT01931670|2106572|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6
1060156|NCT01931670|2106573|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3
1060157|NCT01931670|2106574|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3
1060158|NCT01931670|2106572|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
1060159|NCT01931670|2106573|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
1060160|NCT01931670|2106574|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
1060161|NCT01931670|2106572|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
1060162|NCT01931670|2106573|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
1060163|NCT01931670|2106574|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
1060164|NCT01931735|2106592|FG000|Randomized Phase|Lost to Follow-up|2
1060165|NCT01931735|2106593|FG001|Randomized Phase|Lost to Follow-up|2
1060166|NCT01931735|2106594|FG002|Randomized Phase|Lost to Follow-up|5
1060167|NCT01931735|2106595|FG003|Randomized Phase|Lost to Follow-up|0
1060168|NCT01931735|2106592|FG000|Observational Non-Randomized Phase|Adverse Event|0
1060169|NCT01931735|2106593|FG001|Observational Non-Randomized Phase|Adverse Event|0
1060170|NCT01931735|2106594|FG002|Observational Non-Randomized Phase|Adverse Event|0
1060171|NCT01931735|2106595|FG003|Observational Non-Randomized Phase|Adverse Event|1
1060172|NCT01931735|2106592|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0
1060173|NCT01931735|2106593|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0
1060174|NCT01931735|2106594|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0
1060175|NCT01931735|2106595|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1
1060176|NCT01931839|2106612|FG000|Overall Study|Death|0
1060177|NCT01931839|2106613|FG001|Overall Study|Death|1
1060178|NCT01931839|2106614|FG002|Overall Study|Death|2
1060179|NCT01931839|2106615|FG003|Overall Study|Death|0
1060180|NCT01931839|2106616|FG004|Overall Study|Death|0
1060181|NCT01931839|2106617|FG005|Overall Study|Death|0
1060182|NCT01931839|2106618|FG006|Overall Study|Death|0
1060183|NCT01931839|2106612|FG000|Overall Study|Physician Decision|1
1060184|NCT01931839|2106613|FG001|Overall Study|Physician Decision|0
1060185|NCT01931839|2106614|FG002|Overall Study|Physician Decision|1
1060186|NCT01931839|2106615|FG003|Overall Study|Physician Decision|0
1060187|NCT01931839|2106616|FG004|Overall Study|Physician Decision|0
1060188|NCT01931839|2106617|FG005|Overall Study|Physician Decision|0
1060189|NCT01931839|2106618|FG006|Overall Study|Physician Decision|1
1060190|NCT01931839|2106612|FG000|Overall Study|Withdrawal of consent|0
1060191|NCT01931839|2106613|FG001|Overall Study|Withdrawal of consent|0
1060192|NCT01931839|2106614|FG002|Overall Study|Withdrawal of consent|0
1060193|NCT01931839|2106615|FG003|Overall Study|Withdrawal of consent|0
1060194|NCT01931839|2106616|FG004|Overall Study|Withdrawal of consent|1
1060195|NCT01931839|2106617|FG005|Overall Study|Withdrawal of consent|0
1060196|NCT01931839|2106618|FG006|Overall Study|Withdrawal of consent|0
1060197|NCT01931839|2106612|FG000|Overall Study|Adverse Event|9
1060198|NCT01931839|2106613|FG001|Overall Study|Adverse Event|4
1060199|NCT01931839|2106614|FG002|Overall Study|Adverse Event|1
1060200|NCT01931839|2106615|FG003|Overall Study|Adverse Event|3
1060201|NCT01931839|2106616|FG004|Overall Study|Adverse Event|0
1060202|NCT01931839|2106617|FG005|Overall Study|Adverse Event|0
1060203|NCT01931839|2106618|FG006|Overall Study|Adverse Event|1
1060204|NCT01931839|2106612|FG000|Overall Study|Withdrawal of consent (not due to AE)|11
1060205|NCT01931839|2106613|FG001|Overall Study|Withdrawal of consent (not due to AE)|8
1060206|NCT01931839|2106614|FG002|Overall Study|Withdrawal of consent (not due to AE)|13
1060207|NCT01931839|2106615|FG003|Overall Study|Withdrawal of consent (not due to AE)|3
1060208|NCT01931839|2106616|FG004|Overall Study|Withdrawal of consent (not due to AE)|0
1060209|NCT01931839|2106617|FG005|Overall Study|Withdrawal of consent (not due to AE)|2
1060210|NCT01931839|2106618|FG006|Overall Study|Withdrawal of consent (not due to AE)|2
1060211|NCT01931839|2106612|FG000|Overall Study|Other non-compliance|15
1060212|NCT01931839|2106613|FG001|Overall Study|Other non-compliance|9
1060213|NCT01931839|2106614|FG002|Overall Study|Other non-compliance|12
1060214|NCT01931839|2106615|FG003|Overall Study|Other non-compliance|3
1060215|NCT01931839|2106616|FG004|Overall Study|Other non-compliance|0
1060216|NCT01931839|2106617|FG005|Overall Study|Other non-compliance|3
1060217|NCT01931839|2106618|FG006|Overall Study|Other non-compliance|0
1060218|NCT01931839|2106612|FG000|Overall Study|Lost to Follow-up|1
1060219|NCT01931839|2106613|FG001|Overall Study|Lost to Follow-up|2
1060220|NCT01931839|2106614|FG002|Overall Study|Lost to Follow-up|4
1060221|NCT01931839|2106615|FG003|Overall Study|Lost to Follow-up|5
1060222|NCT01931839|2106616|FG004|Overall Study|Lost to Follow-up|0
1060223|NCT01931839|2106617|FG005|Overall Study|Lost to Follow-up|0
1060224|NCT01931839|2106618|FG006|Overall Study|Lost to Follow-up|0
1060225|NCT01931839|2106612|FG000|Overall Study|Other|4
1060226|NCT01931839|2106613|FG001|Overall Study|Other|2
1060227|NCT01931839|2106614|FG002|Overall Study|Other|6
1060228|NCT01931839|2106615|FG003|Overall Study|Other|0
1060229|NCT01931839|2106616|FG004|Overall Study|Other|0
1060230|NCT01931839|2106617|FG005|Overall Study|Other|0
1060231|NCT01931839|2106618|FG006|Overall Study|Other|0
1060232|NCT01931865|2106638|FG000|Overall Study|Lost to Follow-up|2
1060233|NCT01931865|2106638|FG000|Overall Study|Withdrawal by Subject|2
1060234|NCT01931956|2106658|FG000|Overall Study|Death|42
1060235|NCT01931956|2106659|FG001|Overall Study|Death|7
1060236|NCT01931956|2106660|FG002|Overall Study|Death|379
1060237|NCT01931956|2106661|FG003|Overall Study|Death|96
1060238|NCT01931956|2106658|FG000|Overall Study|Withdrawal by Subject|5
1060239|NCT01931956|2106659|FG001|Overall Study|Withdrawal by Subject|0
1060240|NCT01931956|2106660|FG002|Overall Study|Withdrawal by Subject|70
1060241|NCT01931956|2106661|FG003|Overall Study|Withdrawal by Subject|30
1060242|NCT01931956|2106658|FG000|Overall Study|Lost to Follow-up|2
1060243|NCT01931956|2106659|FG001|Overall Study|Lost to Follow-up|0
1060244|NCT01931956|2106660|FG002|Overall Study|Lost to Follow-up|11
1060245|NCT01931956|2106661|FG003|Overall Study|Lost to Follow-up|7
1060246|NCT01931956|2106658|FG000|Overall Study|Expected|2
1060247|NCT01931956|2106659|FG001|Overall Study|Expected|0
1060248|NCT01931956|2106660|FG002|Overall Study|Expected|6
1060249|NCT01931956|2106661|FG003|Overall Study|Expected|0
1060250|NCT01931956|2106658|FG000|Overall Study|Not due|0
1060251|NCT01931956|2106659|FG001|Overall Study|Not due|0
1060252|NCT01931956|2106660|FG002|Overall Study|Not due|21
1060253|NCT01931956|2106661|FG003|Overall Study|Not due|0
1060254|NCT01931995|2106686|FG000|First Intervention (1 Day)|Withdrawal by Subject|2
1060255|NCT01931995|2106687|FG001|First Intervention (1 Day)|Withdrawal by Subject|2
1060256|NCT01931995|2106686|FG000|First Intervention (1 Day)|Physician Decision|1
1060257|NCT01931995|2106687|FG001|First Intervention (1 Day)|Physician Decision|1
1060258|NCT01931995|2106686|FG000|First Intervention (1 Day)|Lost to Follow-up|1
1060259|NCT01931995|2106687|FG001|First Intervention (1 Day)|Lost to Follow-up|1
1060260|NCT01932294|2106719|FG000|Overall Study|Death|43
1060261|NCT01932294|2106719|FG000|Overall Study|Lost to Follow-up|8
1060262|NCT01932294|2106719|FG000|Overall Study|VAD Implantation|20
1060263|NCT01932294|2106719|FG000|Overall Study|Heart Transplantation|16
1060264|NCT01932294|2106719|FG000|Overall Study|Transferred to other hospitals|12
1060265|NCT01932437|2106726|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
1060266|NCT01932437|2106727|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
1060267|NCT01932437|2106728|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
1060268|NCT01932437|2106729|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
1060269|NCT01932437|2106730|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
1060270|NCT01932437|2106731|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
1060271|NCT01932697|2106763|FG000|Overall Study|Received a different amount of tx|1
1060272|NCT01932697|2106764|FG001|Overall Study|Received a different amount of tx|0
1060273|NCT01932697|2106763|FG000|Overall Study|Ineligible|1
1060274|NCT01932697|2106764|FG001|Overall Study|Ineligible|0
1060275|NCT01932762|2106776|FG000|Overall Study|Withdrawal by Subject|1
1060276|NCT01932762|2106777|FG001|Overall Study|Withdrawal by Subject|2
1060277|NCT01932762|2106778|FG002|Overall Study|Withdrawal by Subject|0
1060278|NCT01932762|2106779|FG003|Overall Study|Withdrawal by Subject|0
1060279|NCT01932762|2106776|FG000|Overall Study|Lost to Follow-up|4
1060280|NCT01932762|2106777|FG001|Overall Study|Lost to Follow-up|0
1060281|NCT01932762|2106778|FG002|Overall Study|Lost to Follow-up|0
1060282|NCT01932762|2106779|FG003|Overall Study|Lost to Follow-up|1
1060283|NCT01932762|2106776|FG000|Overall Study|Physician Decision|1
1060284|NCT01932762|2106777|FG001|Overall Study|Physician Decision|0
1060285|NCT01932762|2106778|FG002|Overall Study|Physician Decision|0
1060286|NCT01932762|2106779|FG003|Overall Study|Physician Decision|0
1060287|NCT01932788|2106791|FG000|Overall Study|Protocol Violation|18
1060288|NCT01932788|2106792|FG001|Overall Study|Protocol Violation|0
1060289|NCT01932788|2106791|FG000|Overall Study|Lost to Follow-up|18
1060290|NCT01932788|2106792|FG001|Overall Study|Lost to Follow-up|46
1060291|NCT01932788|2106791|FG000|Overall Study|Lack of Efficacy|2
1060292|NCT01932788|2106792|FG001|Overall Study|Lack of Efficacy|0
1060293|NCT01932788|2106791|FG000|Overall Study|Withdrawal by Subject|0
1060294|NCT01932788|2106792|FG001|Overall Study|Withdrawal by Subject|5
1060295|NCT01932970|2106798|FG000|Overall Study|Withdrawal by Subject|5
1060296|NCT01932970|2106798|FG000|Overall Study|Death|1
1060297|NCT01932970|2106798|FG000|Overall Study|Lost to Follow-up|2
1060298|NCT01932970|2106798|FG000|Overall Study|Protocol Specified Criteria|10
1060299|NCT01932996|2106804|FG000|Overall Study|Protocol Violation|2
1060300|NCT01932996|2106805|FG001|Overall Study|Protocol Violation|0
1060301|NCT01933048|2106813|FG000|Overall Study|Lost to Follow-up|15
1060302|NCT01933048|2106814|FG001|Overall Study|Lost to Follow-up|18
1060303|NCT01933048|2106813|FG000|Overall Study|personal reasons|1
1060304|NCT01933048|2106814|FG001|Overall Study|personal reasons|1
1060305|NCT01933048|2106813|FG000|Overall Study|Protocol Violation|7
1060306|NCT01933048|2106814|FG001|Overall Study|Protocol Violation|8
1060307|NCT01933048|2106813|FG000|Overall Study|Physician Decision|1
1060308|NCT01933048|2106814|FG001|Overall Study|Physician Decision|0
1060309|NCT01933048|2106813|FG000|Overall Study|unknown reasons|1
1060310|NCT01933048|2106814|FG001|Overall Study|unknown reasons|1
1060311|NCT01933113|2106823|FG000|Overall Study|Fractured nonfunctioning lead.|1
1060312|NCT01933217|2106829|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1
1060313|NCT01933217|2106830|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3
1060314|NCT01933217|2106829|FG000|Randomization (4 Weeks)|Lost to Follow-up|1
1060315|NCT01933217|2106830|FG001|Randomization (4 Weeks)|Lost to Follow-up|1
1060316|NCT01933334|2106853|FG000|Overall Study|Adverse Event|5
1060317|NCT01933334|2106854|FG001|Overall Study|Adverse Event|1
1060318|NCT01933334|2106853|FG000|Overall Study|Withdrawal by Subject|0
1060319|NCT01933334|2106854|FG001|Overall Study|Withdrawal by Subject|1
1060320|NCT01933594|2106897|FG000|Overall Study|Lost to Follow-up|1
1060321|NCT01933594|2106898|FG001|Overall Study|Lost to Follow-up|0
1060322|NCT01933594|2106899|FG002|Overall Study|Lost to Follow-up|0
1060323|NCT01933594|2106900|FG003|Overall Study|Lost to Follow-up|0
1060324|NCT01933594|2106901|FG004|Overall Study|Lost to Follow-up|1
1060325|NCT01933594|2106902|FG005|Overall Study|Lost to Follow-up|0
1060326|NCT01933594|2106897|FG000|Overall Study|Ineligible for subsequent study step|0
1060327|NCT01933594|2106898|FG001|Overall Study|Ineligible for subsequent study step|0
1060328|NCT01933594|2106899|FG002|Overall Study|Ineligible for subsequent study step|0
1060329|NCT01933594|2106900|FG003|Overall Study|Ineligible for subsequent study step|0
1060330|NCT01933594|2106901|FG004|Overall Study|Ineligible for subsequent study step|1
1060331|NCT01933594|2106902|FG005|Overall Study|Ineligible for subsequent study step|0
1060332|NCT01933672|2106920|FG000|Metformin Run-in Period|Adverse Event|1
1060333|NCT01933672|2106921|FG001|Metformin Run-in Period|Adverse Event|0
1060334|NCT01933672|2106922|FG002|Metformin Run-in Period|Adverse Event|0
1060335|NCT01933672|2106923|FG003|Metformin Run-in Period|Adverse Event|0
1060336|NCT01933672|2106924|FG004|Metformin Run-in Period|Adverse Event|0
1060337|NCT01933672|2106925|FG005|Metformin Run-in Period|Adverse Event|0
1060338|NCT01933672|2106926|FG006|Metformin Run-in Period|Adverse Event|0
1060339|NCT01933672|2106920|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4
1060340|NCT01933672|2106921|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0
1060341|NCT01933672|2106922|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0
1060342|NCT01933672|2106923|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0
1060343|NCT01933672|2106924|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0
1060344|NCT01933672|2106925|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0
1060345|NCT01933672|2106926|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0
1060346|NCT01933672|2106920|FG000|Metformin Run-in Period|Other|5
1060347|NCT01933672|2106921|FG001|Metformin Run-in Period|Other|0
1060348|NCT01933672|2106922|FG002|Metformin Run-in Period|Other|0
1060349|NCT01933672|2106923|FG003|Metformin Run-in Period|Other|0
1060350|NCT01933672|2106924|FG004|Metformin Run-in Period|Other|0
1060351|NCT01933672|2106925|FG005|Metformin Run-in Period|Other|0
1060352|NCT01933672|2106926|FG006|Metformin Run-in Period|Other|0
1060353|NCT01933672|2106920|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1060354|NCT01933672|2106921|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1060355|NCT01933672|2106922|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1060356|NCT01933672|2106923|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1060357|NCT01933672|2106924|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1
1060358|NCT01933672|2106925|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1060359|NCT01933672|2106926|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1060360|NCT01933672|2106920|FG000|First Intervention Period (12-16 Days)|Other|0
1060361|NCT01933672|2106921|FG001|First Intervention Period (12-16 Days)|Other|0
1060362|NCT01933672|2106922|FG002|First Intervention Period (12-16 Days)|Other|1
1060363|NCT01933672|2106923|FG003|First Intervention Period (12-16 Days)|Other|0
1060364|NCT01933672|2106924|FG004|First Intervention Period (12-16 Days)|Other|0
1060365|NCT01933672|2106925|FG005|First Intervention Period (12-16 Days)|Other|1
1060366|NCT01933672|2106926|FG006|First Intervention Period (12-16 Days)|Other|0
1060367|NCT01933672|2106920|FG000|Second Intervention Period (12-16 Days)|Other|0
1060368|NCT01933672|2106921|FG001|Second Intervention Period (12-16 Days)|Other|1
1060369|NCT01933672|2106922|FG002|Second Intervention Period (12-16 Days)|Other|1
1060370|NCT01933672|2106923|FG003|Second Intervention Period (12-16 Days)|Other|0
1060371|NCT01933672|2106924|FG004|Second Intervention Period (12-16 Days)|Other|0
1060372|NCT01933672|2106925|FG005|Second Intervention Period (12-16 Days)|Other|0
1060373|NCT01933672|2106926|FG006|Second Intervention Period (12-16 Days)|Other|0
1060374|NCT01933672|2106920|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1060375|NCT01933672|2106921|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1060376|NCT01933672|2106922|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1060377|NCT01933672|2106923|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
1060378|NCT01933672|2106924|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1060379|NCT01933672|2106925|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1060380|NCT01933672|2106926|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1060381|NCT01933672|2106920|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1060382|NCT01933672|2106921|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
1060383|NCT01933672|2106922|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1060384|NCT01933672|2106923|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1060385|NCT01933672|2106924|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1060386|NCT01933672|2106925|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1060387|NCT01933672|2106926|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1060388|NCT01933789|2106957|FG000|Overall Study|Death|0
1060389|NCT01933789|2106958|FG001|Overall Study|Death|0
1060390|NCT01933789|2106959|FG002|Overall Study|Death|0
1060391|NCT01933789|2106960|FG003|Overall Study|Death|0
1060392|NCT01933789|2106961|FG004|Overall Study|Death|21
1060393|NCT01933789|2106962|FG005|Overall Study|Death|32
1060394|NCT01933789|2106963|FG006|Overall Study|Death|0
1060395|NCT01933789|2106964|FG007|Overall Study|Death|0
1060396|NCT01933789|2106965|FG008|Overall Study|Death|0
1060397|NCT01933789|2106957|FG000|Overall Study|Lost to Follow-up|0
1060398|NCT01933789|2106958|FG001|Overall Study|Lost to Follow-up|0
1060399|NCT01933789|2106959|FG002|Overall Study|Lost to Follow-up|0
1060400|NCT01933789|2106960|FG003|Overall Study|Lost to Follow-up|1
1060401|NCT01933789|2106961|FG004|Overall Study|Lost to Follow-up|8
1060402|NCT01933789|2106962|FG005|Overall Study|Lost to Follow-up|9
1060403|NCT01933789|2106963|FG006|Overall Study|Lost to Follow-up|1
1060404|NCT01933789|2106964|FG007|Overall Study|Lost to Follow-up|4
1060405|NCT01933789|2106965|FG008|Overall Study|Lost to Follow-up|0
1060406|NCT01933789|2106957|FG000|Overall Study|Withdrawal by Subject|2
1060407|NCT01933789|2106958|FG001|Overall Study|Withdrawal by Subject|1
1060408|NCT01933789|2106959|FG002|Overall Study|Withdrawal by Subject|0
1060409|NCT01933789|2106960|FG003|Overall Study|Withdrawal by Subject|0
1060410|NCT01933789|2106961|FG004|Overall Study|Withdrawal by Subject|17
1060411|NCT01933789|2106962|FG005|Overall Study|Withdrawal by Subject|16
1060412|NCT01933789|2106963|FG006|Overall Study|Withdrawal by Subject|1
1060413|NCT01933789|2106964|FG007|Overall Study|Withdrawal by Subject|4
1060414|NCT01933789|2106965|FG008|Overall Study|Withdrawal by Subject|0
1060415|NCT01933789|2106957|FG000|Overall Study|Became Ineligible|4
1060416|NCT01933789|2106958|FG001|Overall Study|Became Ineligible|0
1060417|NCT01933789|2106959|FG002|Overall Study|Became Ineligible|0
1060418|NCT01933789|2106960|FG003|Overall Study|Became Ineligible|0
1060419|NCT01933789|2106961|FG004|Overall Study|Became Ineligible|13
1060420|NCT01933789|2106962|FG005|Overall Study|Became Ineligible|10
1060421|NCT01933789|2106963|FG006|Overall Study|Became Ineligible|13
1060422|NCT01933789|2106964|FG007|Overall Study|Became Ineligible|6
1060423|NCT01933789|2106965|FG008|Overall Study|Became Ineligible|0
1060424|NCT01933880|2106987|FG000|Overall Study|Withdrawal by Subject|5
1060425|NCT01933880|2106988|FG001|Overall Study|Withdrawal by Subject|0
1060426|NCT01933880|2106987|FG000|Overall Study|Lack of Efficacy|1
1060427|NCT01933880|2106988|FG001|Overall Study|Lack of Efficacy|0
1060428|NCT01933880|2106987|FG000|Overall Study|Concomitant medication Interference|0
1060429|NCT01933880|2106988|FG001|Overall Study|Concomitant medication Interference|1
1060430|NCT01933880|2106987|FG000|Overall Study|Followup exceeded 4 days to visit window|19
1060431|NCT01933880|2106988|FG001|Overall Study|Followup exceeded 4 days to visit window|0
1060432|NCT01933880|2106987|FG000|Overall Study|Other|4
1060433|NCT01933880|2106988|FG001|Overall Study|Other|0
1060434|NCT01933880|2106987|FG000|Overall Study|Protocol Violation|1
1060435|NCT01933880|2106988|FG001|Overall Study|Protocol Violation|0
1090917|NCT02250443|2158764|FG000|Overall Study|Administrative problems|7
1090918|NCT02250443|2158764|FG000|Overall Study|Adverse Event|3
1090919|NCT02250651|2158803|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0
1090920|NCT02250651|2158804|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
1090921|NCT02250651|2158805|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
1060436|NCT01933919|2107001|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0
1060437|NCT01933919|2107002|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1
1060438|NCT01933919|2107001|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
1060439|NCT01933919|2107002|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
1060440|NCT01933919|2107001|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
1060441|NCT01933919|2107002|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
1060442|NCT01933919|2107001|FG000|Open-label Long-term Phase|Adverse Event|2
1060443|NCT01933919|2107002|FG001|Open-label Long-term Phase|Adverse Event|0
1060444|NCT01933919|2107001|FG000|Open-label Long-term Phase|Withdrawal by Subject|3
1060445|NCT01933919|2107002|FG001|Open-label Long-term Phase|Withdrawal by Subject|4
1060446|NCT01933919|2107001|FG000|Open-label Long-term Phase|Lost to Follow-up|1
1060447|NCT01933919|2107002|FG001|Open-label Long-term Phase|Lost to Follow-up|0
1060448|NCT01933919|2107001|FG000|Open-label Long-term Phase|Other|1
1060449|NCT01933919|2107002|FG001|Open-label Long-term Phase|Other|2
1060456|NCT01934010|2107045|FG000|Overall Study|Adverse Event|1
1060457|NCT01934010|2107046|FG001|Overall Study|Adverse Event|1
1060458|NCT01934010|2107047|FG002|Overall Study|Adverse Event|0
1060459|NCT01934010|2107045|FG000|Overall Study|Withdrawal by Subject|15
1060460|NCT01934010|2107046|FG001|Overall Study|Withdrawal by Subject|6
1060461|NCT01934010|2107047|FG002|Overall Study|Withdrawal by Subject|2
1060462|NCT01934010|2107045|FG000|Overall Study|Lost to Follow-up|7
1060463|NCT01934010|2107046|FG001|Overall Study|Lost to Follow-up|4
1060464|NCT01934010|2107047|FG002|Overall Study|Lost to Follow-up|0
1060465|NCT01934140|2107066|FG000|Persistence Phase (Year 6-10)|Other|24
1060466|NCT01934140|2107067|FG001|Persistence Phase (Year 6-10)|Other|6
1060467|NCT01934140|2107066|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5
1060468|NCT01934140|2107067|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2
1060469|NCT01934140|2107066|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
1060470|NCT01934140|2107067|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
1060471|NCT01934140|2107066|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
1060472|NCT01934140|2107067|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
1060473|NCT01934140|2107066|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
1060474|NCT01934140|2107067|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
1060475|NCT01934140|2107066|FG000|Booster Phase (6 Months)|Lost to Follow-up|1
1060476|NCT01934140|2107067|FG001|Booster Phase (6 Months)|Lost to Follow-up|0
1060477|NCT01934140|2107066|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2
1060478|NCT01934140|2107067|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1
1060479|NCT01934140|2107066|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2
1060480|NCT01934140|2107067|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2
1060481|NCT01934192|2107079|FG000|Overall Study|Protocol Violation|0
1060482|NCT01934192|2107080|FG001|Overall Study|Protocol Violation|0
1060483|NCT01934192|2107081|FG002|Overall Study|Protocol Violation|0
1060484|NCT01934192|2107082|FG003|Overall Study|Protocol Violation|1
1060485|NCT01934192|2107079|FG000|Overall Study|Other: reached stopping criteria|6
1060486|NCT01934192|2107080|FG001|Overall Study|Other: reached stopping criteria|5
1060487|NCT01934192|2107081|FG002|Overall Study|Other: reached stopping criteria|1
1060488|NCT01934192|2107082|FG003|Overall Study|Other: reached stopping criteria|0
1060489|NCT01934192|2107079|FG000|Overall Study|Physician Decision|3
1060490|NCT01934192|2107080|FG001|Overall Study|Physician Decision|2
1060491|NCT01934192|2107081|FG002|Overall Study|Physician Decision|0
1060492|NCT01934192|2107082|FG003|Overall Study|Physician Decision|0
1060493|NCT01934218|2107105|FG000|Double-blind Phase|Adverse Event|8
1060494|NCT01934218|2107106|FG001|Double-blind Phase|Adverse Event|8
1060495|NCT01934218|2107105|FG000|Double-blind Phase|Lack of Efficacy|6
1060496|NCT01934218|2107106|FG001|Double-blind Phase|Lack of Efficacy|7
1060497|NCT01934218|2107105|FG000|Double-blind Phase|Lost to Follow-up|7
1060498|NCT01934218|2107106|FG001|Double-blind Phase|Lost to Follow-up|14
1060499|NCT01934218|2107105|FG000|Double-blind Phase|Physician Decision|1
1060500|NCT01934218|2107106|FG001|Double-blind Phase|Physician Decision|2
1060501|NCT01934218|2107105|FG000|Double-blind Phase|Protocol Violation|4
1060502|NCT01934218|2107106|FG001|Double-blind Phase|Protocol Violation|0
1060503|NCT01934218|2107105|FG000|Double-blind Phase|Withdrawal by Subject|16
1060504|NCT01934218|2107106|FG001|Double-blind Phase|Withdrawal by Subject|13
1060505|NCT01934218|2107105|FG000|Double-blind Phase|Noncompliance with Study Protocol|5
1060506|NCT01934218|2107106|FG001|Double-blind Phase|Noncompliance with Study Protocol|8
1060507|NCT01934218|2107105|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1
1060508|NCT01934218|2107106|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2
1060509|NCT01934218|2107105|FG000|Open-Label Phase|Adverse Event|2
1060510|NCT01934218|2107106|FG001|Open-Label Phase|Adverse Event|4
1060511|NCT01934218|2107105|FG000|Open-Label Phase|Lack of Efficacy|1
1060512|NCT01934218|2107106|FG001|Open-Label Phase|Lack of Efficacy|4
1060513|NCT01934218|2107105|FG000|Open-Label Phase|Lost to Follow-up|4
1060514|NCT01934218|2107106|FG001|Open-Label Phase|Lost to Follow-up|2
1060515|NCT01934218|2107105|FG000|Open-Label Phase|Physician Decision|1
1060516|NCT01934218|2107106|FG001|Open-Label Phase|Physician Decision|0
1060517|NCT01934218|2107105|FG000|Open-Label Phase|Protocol Violation|1
1060518|NCT01934218|2107106|FG001|Open-Label Phase|Protocol Violation|0
1060519|NCT01934218|2107105|FG000|Open-Label Phase|Withdrawal by Subject|13
1060520|NCT01934218|2107106|FG001|Open-Label Phase|Withdrawal by Subject|11
1060521|NCT01934218|2107105|FG000|Open-Label Phase|Noncompliance with Study Protocol|4
1060522|NCT01934218|2107106|FG001|Open-Label Phase|Noncompliance with Study Protocol|2
1060523|NCT01934218|2107105|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0
1060524|NCT01934218|2107106|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1
1060525|NCT01934335|2107118|FG000|Overall Study|Withdrawal by Subject|1
1060526|NCT01934335|2107119|FG001|Overall Study|Withdrawal by Subject|1
1060527|NCT01934556|2107136|FG000|Overall Study|Withdrawal by Subject|0
1060528|NCT01934556|2107137|FG001|Overall Study|Withdrawal by Subject|1
1060529|NCT01934556|2107138|FG002|Overall Study|Withdrawal by Subject|1
1060530|NCT01934556|2107136|FG000|Overall Study|Lost to Follow-up|4
1060531|NCT01934556|2107137|FG001|Overall Study|Lost to Follow-up|10
1060532|NCT01934556|2107138|FG002|Overall Study|Lost to Follow-up|7
1060533|NCT01934556|2107136|FG000|Overall Study|Death|1
1060534|NCT01934556|2107137|FG001|Overall Study|Death|5
1060535|NCT01934556|2107138|FG002|Overall Study|Death|2
1060536|NCT01934790|2107152|FG000|Treatment|Adverse Event|3
1060537|NCT01934790|2107152|FG000|Treatment|Clinical progression|6
1060538|NCT01934790|2107152|FG000|Treatment|Radiological progression|4
1060539|NCT01934790|2107152|FG000|Treatment|Withdrawal by Subject|2
1060540|NCT01934790|2107152|FG000|Treatment|Study drug never administered|1
1060541|NCT01934790|2107152|FG000|Active Follow up|Death|20
1060542|NCT01934790|2107152|FG000|Active Follow up|Physician Decision|2
1060543|NCT01934790|2107152|FG000|Active Follow up|Progressive disease|1
1060544|NCT01934790|2107152|FG000|Active Follow up|Other reason|1
1060545|NCT01934894|2107158|FG000|Overall Study|Adverse Event|1
1060546|NCT01934894|2107159|FG001|Overall Study|Adverse Event|2
1060547|NCT01934894|2107158|FG000|Overall Study|Death|2
1060548|NCT01934894|2107159|FG001|Overall Study|Death|0
1060549|NCT01934894|2107158|FG000|Overall Study|Withdrawal by Subject|0
1060550|NCT01934894|2107159|FG001|Overall Study|Withdrawal by Subject|1
1060551|NCT01934894|2107158|FG000|Overall Study|Progressive Disease|3
1060552|NCT01934894|2107159|FG001|Overall Study|Progressive Disease|2
1060553|NCT01934972|2107170|FG000|Overall Study|Withdrawal by Subject|9
1060554|NCT01934972|2107171|FG001|Overall Study|Withdrawal by Subject|6
1060555|NCT01935700|2107201|FG000|Overall Study|Withdrawal by Subject|1
1060556|NCT01935700|2107202|FG001|Overall Study|Withdrawal by Subject|0
1060557|NCT01935700|2107201|FG000|Overall Study|Physician Decision|4
1060558|NCT01935700|2107202|FG001|Overall Study|Physician Decision|0
1060559|NCT01936181|2107242|FG000|Randomised, Double-blind|Adverse Event|27
1060560|NCT01936181|2107243|FG001|Randomised, Double-blind|Adverse Event|21
1060561|NCT01936181|2107244|FG002|Randomised, Double-blind|Adverse Event|0
1060562|NCT01936181|2107245|FG003|Randomised, Double-blind|Adverse Event|0
1060563|NCT01936181|2107242|FG000|Randomised, Double-blind|Protocol Violation|1
1060564|NCT01936181|2107243|FG001|Randomised, Double-blind|Protocol Violation|5
1060565|NCT01936181|2107244|FG002|Randomised, Double-blind|Protocol Violation|0
1060566|NCT01936181|2107245|FG003|Randomised, Double-blind|Protocol Violation|0
1060567|NCT01936181|2107242|FG000|Randomised, Double-blind|Lack of Efficacy|5
1060568|NCT01936181|2107243|FG001|Randomised, Double-blind|Lack of Efficacy|6
1060569|NCT01936181|2107244|FG002|Randomised, Double-blind|Lack of Efficacy|0
1060570|NCT01936181|2107245|FG003|Randomised, Double-blind|Lack of Efficacy|0
1060571|NCT01936181|2107242|FG000|Randomised, Double-blind|Lost to Follow-up|0
1060572|NCT01936181|2107243|FG001|Randomised, Double-blind|Lost to Follow-up|1
1060573|NCT01936181|2107244|FG002|Randomised, Double-blind|Lost to Follow-up|0
1060574|NCT01936181|2107245|FG003|Randomised, Double-blind|Lost to Follow-up|0
1060575|NCT01936181|2107242|FG000|Randomised, Double-blind|Pregnancy|0
1060576|NCT01936181|2107243|FG001|Randomised, Double-blind|Pregnancy|1
1060577|NCT01936181|2107244|FG002|Randomised, Double-blind|Pregnancy|0
1060578|NCT01936181|2107245|FG003|Randomised, Double-blind|Pregnancy|0
1060579|NCT01936181|2107242|FG000|Randomised, Double-blind|Physician Decision|4
1060580|NCT01936181|2107243|FG001|Randomised, Double-blind|Physician Decision|4
1060581|NCT01936181|2107244|FG002|Randomised, Double-blind|Physician Decision|0
1060582|NCT01936181|2107245|FG003|Randomised, Double-blind|Physician Decision|0
1060583|NCT01936181|2107242|FG000|Randomised, Double-blind|Withdrawal by Subject|23
1060584|NCT01936181|2107243|FG001|Randomised, Double-blind|Withdrawal by Subject|26
1060585|NCT01936181|2107244|FG002|Randomised, Double-blind|Withdrawal by Subject|0
1060586|NCT01936181|2107245|FG003|Randomised, Double-blind|Withdrawal by Subject|0
1060587|NCT01936181|2107242|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
1060588|NCT01936181|2107243|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
1060589|NCT01936181|2107244|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
1060590|NCT01936181|2107245|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
1060591|NCT01936181|2107242|FG000|Transition-extension|Adverse Event|3
1060592|NCT01936181|2107243|FG001|Transition-extension|Adverse Event|0
1060593|NCT01936181|2107244|FG002|Transition-extension|Adverse Event|3
1060594|NCT01936181|2107245|FG003|Transition-extension|Adverse Event|1
1060595|NCT01936181|2107242|FG000|Transition-extension|Lost to Follow-up|3
1060596|NCT01936181|2107243|FG001|Transition-extension|Lost to Follow-up|0
1060597|NCT01936181|2107244|FG002|Transition-extension|Lost to Follow-up|1
1060598|NCT01936181|2107245|FG003|Transition-extension|Lost to Follow-up|2
1060599|NCT01936181|2107242|FG000|Transition-extension|Physician Decision|2
1060600|NCT01936181|2107243|FG001|Transition-extension|Physician Decision|0
1060601|NCT01936181|2107244|FG002|Transition-extension|Physician Decision|0
1060602|NCT01936181|2107245|FG003|Transition-extension|Physician Decision|1
1060603|NCT01936181|2107242|FG000|Transition-extension|Withdrawal by Subject|7
1060604|NCT01936181|2107243|FG001|Transition-extension|Withdrawal by Subject|0
1060605|NCT01936181|2107244|FG002|Transition-extension|Withdrawal by Subject|2
1060606|NCT01936181|2107245|FG003|Transition-extension|Withdrawal by Subject|1
1060607|NCT01936623|2107322|FG000|Overall Study|Lost to Follow-up|0
1060608|NCT01936623|2107323|FG001|Overall Study|Lost to Follow-up|5
1060609|NCT01936649|2107329|FG000|Overall Study|Withdrawal by Subject|4
1060610|NCT01936649|2107329|FG000|Overall Study|Physician Decision|2
1060611|NCT01936649|2107329|FG000|Overall Study|Protocol Violation|2
1060612|NCT01936649|2107329|FG000|Overall Study|Other than specified above|5
1060613|NCT01936857|2107355|FG000|Overall Study|Sent to prison or 06 center|11
1060614|NCT01936857|2107356|FG001|Overall Study|Sent to prison or 06 center|12
1060615|NCT01936857|2107355|FG000|Overall Study|Lost to Follow-up|10
1060616|NCT01936857|2107356|FG001|Overall Study|Lost to Follow-up|7
1060617|NCT01936857|2107355|FG000|Overall Study|Death|7
1060618|NCT01936857|2107356|FG001|Overall Study|Death|3
1060619|NCT01936857|2107355|FG000|Overall Study|Moved|2
1060620|NCT01936857|2107356|FG001|Overall Study|Moved|1
1060621|NCT01936857|2107355|FG000|Overall Study|Withdrawal by Subject|1
1060622|NCT01936857|2107356|FG001|Overall Study|Withdrawal by Subject|0
1060623|NCT01936857|2107355|FG000|Overall Study|Side effect of medication|1
1060624|NCT01936857|2107356|FG001|Overall Study|Side effect of medication|0
1060625|NCT01936857|2107355|FG000|Overall Study|Other|2
1060626|NCT01936857|2107356|FG001|Overall Study|Other|2
1060627|NCT01936870|2107362|FG000|Overall Study|No Visit After Treatment|176
1060628|NCT01936870|2107362|FG000|Overall Study|Protocol Violation|12
1060629|NCT01936870|2107362|FG000|Overall Study|No Drug Administration|1
1060630|NCT01936948|2107387|FG000|Overall Study|no 30-day follow-up data|0
1060631|NCT01936948|2107388|FG001|Overall Study|no 30-day follow-up data|3
1060632|NCT01936948|2107389|FG002|Overall Study|no 30-day follow-up data|3
1060633|NCT01936948|2107390|FG003|Overall Study|no 30-day follow-up data|3
1060634|NCT01937117|2107405|FG000|Overall Study|Disease Progression|7
1060635|NCT01937117|2107405|FG000|Overall Study|Physician Decision|4
1060636|NCT01937117|2107405|FG000|Overall Study|Adverse Event|2
1060637|NCT01937130|2107413|FG000|Overall Study|Withdrawal by Subject|0
1060638|NCT01937130|2107414|FG001|Overall Study|Withdrawal by Subject|0
1060639|NCT01937130|2107415|FG002|Overall Study|Withdrawal by Subject|0
1060640|NCT01937130|2107416|FG003|Overall Study|Withdrawal by Subject|1
1060641|NCT01937130|2107413|FG000|Overall Study|Adverse Event|0
1060642|NCT01937130|2107414|FG001|Overall Study|Adverse Event|1
1060643|NCT01937130|2107415|FG002|Overall Study|Adverse Event|0
1060644|NCT01937130|2107416|FG003|Overall Study|Adverse Event|1
1060645|NCT01937130|2107413|FG000|Overall Study|Death|1
1060646|NCT01937130|2107414|FG001|Overall Study|Death|1
1060647|NCT01937130|2107415|FG002|Overall Study|Death|1
1060648|NCT01937130|2107416|FG003|Overall Study|Death|0
1060649|NCT01937130|2107413|FG000|Overall Study|Lost to Follow-up|2
1060650|NCT01937130|2107414|FG001|Overall Study|Lost to Follow-up|0
1060651|NCT01937130|2107415|FG002|Overall Study|Lost to Follow-up|2
1060652|NCT01937130|2107416|FG003|Overall Study|Lost to Follow-up|0
1060653|NCT01937130|2107413|FG000|Overall Study|Physician Decision|0
1060654|NCT01937130|2107414|FG001|Overall Study|Physician Decision|1
1060655|NCT01937130|2107415|FG002|Overall Study|Physician Decision|0
1060656|NCT01937130|2107416|FG003|Overall Study|Physician Decision|0
1060657|NCT01937130|2107413|FG000|Overall Study|Patients unable to swallow|0
1060658|NCT01937130|2107414|FG001|Overall Study|Patients unable to swallow|1
1060659|NCT01937130|2107415|FG002|Overall Study|Patients unable to swallow|0
1060660|NCT01937130|2107416|FG003|Overall Study|Patients unable to swallow|0
1060661|NCT01937130|2107413|FG000|Overall Study|Patient lost to FU due to death|2
1060662|NCT01937130|2107414|FG001|Overall Study|Patient lost to FU due to death|0
1060663|NCT01937130|2107415|FG002|Overall Study|Patient lost to FU due to death|0
1060664|NCT01937130|2107416|FG003|Overall Study|Patient lost to FU due to death|0
1060665|NCT01937299|2107441|FG000|Overall Study|Adverse Event|13
1060666|NCT01937299|2107442|FG001|Overall Study|Adverse Event|0
1060667|NCT01937299|2107441|FG000|Overall Study|Lack of Efficacy|0
1060668|NCT01937299|2107442|FG001|Overall Study|Lack of Efficacy|4
1060669|NCT01937299|2107441|FG000|Overall Study|Withdrawal by Subject|1
1060670|NCT01937299|2107442|FG001|Overall Study|Withdrawal by Subject|0
1060671|NCT01937312|2107451|FG000|Overall Study|Adverse Event|10
1060672|NCT01937312|2107452|FG001|Overall Study|Adverse Event|1
1060673|NCT01937312|2107451|FG000|Overall Study|Lack of Efficacy|0
1060674|NCT01937312|2107452|FG001|Overall Study|Lack of Efficacy|1
1060675|NCT01937312|2107451|FG000|Overall Study|Withdrawal of subject prior to treatment|1
1060676|NCT01937312|2107452|FG001|Overall Study|Withdrawal of subject prior to treatment|1
1060677|NCT01937351|2107461|FG000|Overall Study|Withdrawal by Subject|4
1060678|NCT01937351|2107462|FG001|Overall Study|Withdrawal by Subject|2
1060679|NCT01937351|2107461|FG000|Overall Study|Death|1
1060680|NCT01937351|2107462|FG001|Overall Study|Death|0
1060681|NCT01937351|2107461|FG000|Overall Study|Not treated w device, per protocol fail|4
1060682|NCT01937351|2107462|FG001|Overall Study|Not treated w device, per protocol fail|0
1060683|NCT01937364|2107469|FG000|Overall Study|Adverse Event|2
1060684|NCT01937364|2107470|FG001|Overall Study|Adverse Event|1
1060685|NCT01937390|2107476|FG000|Overall Study|Death|2
1060686|NCT01937390|2107476|FG000|Overall Study|Lost to Follow-up|7
1060687|NCT01937390|2107476|FG000|Overall Study|Withdrawal by Subject|5
1060688|NCT01937390|2107476|FG000|Overall Study|Fail to return|21
1060689|NCT01937559|2107493|FG000|Overall Study|Physician Decision|3
1060690|NCT01937559|2107494|FG001|Overall Study|Physician Decision|3
1060691|NCT01937559|2107495|FG002|Overall Study|Physician Decision|0
1060692|NCT01937559|2107493|FG000|Overall Study|Withdrawal by Subject|6
1060693|NCT01937559|2107494|FG001|Overall Study|Withdrawal by Subject|4
1060694|NCT01937559|2107495|FG002|Overall Study|Withdrawal by Subject|0
1060695|NCT01937559|2107493|FG000|Overall Study|screen fail|2
1060696|NCT01937559|2107494|FG001|Overall Study|screen fail|4
1060697|NCT01937559|2107495|FG002|Overall Study|screen fail|0
1060698|NCT01937715|2107523|FG000|Overall Study|Death|0
1060699|NCT01937715|2107524|FG001|Overall Study|Death|0
1060700|NCT01937715|2107525|FG002|Overall Study|Death|0
1060701|NCT01937715|2107526|FG003|Overall Study|Death|1
1060702|NCT01937715|2107527|FG004|Overall Study|Death|0
1060703|NCT01937715|2107523|FG000|Overall Study|Withdrawal by Subject|0
1060704|NCT01937715|2107524|FG001|Overall Study|Withdrawal by Subject|1
1060705|NCT01937715|2107525|FG002|Overall Study|Withdrawal by Subject|0
1060706|NCT01937715|2107526|FG003|Overall Study|Withdrawal by Subject|0
1060707|NCT01937715|2107527|FG004|Overall Study|Withdrawal by Subject|2
1060708|NCT01937715|2107523|FG000|Overall Study|Other|0
1060709|NCT01937715|2107524|FG001|Overall Study|Other|0
1060710|NCT01937715|2107525|FG002|Overall Study|Other|0
1060711|NCT01937715|2107526|FG003|Overall Study|Other|3
1060712|NCT01937715|2107527|FG004|Overall Study|Other|0
1060713|NCT01937871|2107542|FG000|Overall Study|Adverse Event|6
1060714|NCT01937871|2107543|FG001|Overall Study|Adverse Event|6
1060715|NCT01937871|2107544|FG002|Overall Study|Adverse Event|2
1060716|NCT01937871|2107542|FG000|Overall Study|Lost to Follow-up|8
1060717|NCT01937871|2107543|FG001|Overall Study|Lost to Follow-up|2
1060718|NCT01937871|2107544|FG002|Overall Study|Lost to Follow-up|4
1060719|NCT01937871|2107542|FG000|Overall Study|Withdrawal by Subject|9
1060720|NCT01937871|2107543|FG001|Overall Study|Withdrawal by Subject|6
1060721|NCT01937871|2107544|FG002|Overall Study|Withdrawal by Subject|4
1060722|NCT01937871|2107542|FG000|Overall Study|Physician Decision|0
1060723|NCT01937871|2107543|FG001|Overall Study|Physician Decision|1
1060724|NCT01937871|2107544|FG002|Overall Study|Physician Decision|0
1060725|NCT01937871|2107542|FG000|Overall Study|Entry Criteria Not Met|1
1060726|NCT01937871|2107543|FG001|Overall Study|Entry Criteria Not Met|2
1060727|NCT01937871|2107544|FG002|Overall Study|Entry Criteria Not Met|1
1060728|NCT01937884|2107557|FG000|Overall Study|Withdrawal by Subject|1
1060729|NCT01937884|2107558|FG001|Overall Study|Withdrawal by Subject|0
1060730|NCT01938001|2107585|FG000|Overall Study|Withdrawal by Subject|25
1060731|NCT01938001|2107586|FG001|Overall Study|Withdrawal by Subject|17
1060732|NCT01938001|2107585|FG000|Overall Study|Non-compliant|1
1060733|NCT01938001|2107586|FG001|Overall Study|Non-compliant|0
1060734|NCT01938001|2107585|FG000|Overall Study|Participant Moved|0
1060735|NCT01938001|2107586|FG001|Overall Study|Participant Moved|1
1060736|NCT01938001|2107585|FG000|Overall Study|Lost to Follow-up|1
1060737|NCT01938001|2107586|FG001|Overall Study|Lost to Follow-up|3
1060738|NCT01938001|2107585|FG000|Overall Study|Death|16
1060739|NCT01938001|2107586|FG001|Overall Study|Death|26
1060740|NCT01938391|2107650|FG000|6 Month Follow up|Withdrawal by Subject|1
1060741|NCT01938391|2107650|FG000|12 Month Follow up|Physician Decision|1
1060742|NCT01938391|2107650|FG000|12 Month Follow up|Withdrawal by Subject|1
1060743|NCT01938430|2107668|FG000|Overall Study|Randomized but Not Treated|0
1060744|NCT01938430|2107669|FG001|Overall Study|Randomized but Not Treated|0
1060745|NCT01938430|2107670|FG002|Overall Study|Randomized but Not Treated|0
1060746|NCT01938430|2107671|FG003|Overall Study|Randomized but Not Treated|0
1060747|NCT01938430|2107672|FG004|Overall Study|Randomized but Not Treated|0
1060748|NCT01938430|2107673|FG005|Overall Study|Randomized but Not Treated|0
1060749|NCT01938430|2107674|FG006|Overall Study|Randomized but Not Treated|0
1060750|NCT01938430|2107675|FG007|Overall Study|Randomized but Not Treated|0
1060751|NCT01938430|2107676|FG008|Overall Study|Randomized but Not Treated|0
1060752|NCT01938430|2107677|FG009|Overall Study|Randomized but Not Treated|0
1060753|NCT01938430|2107678|FG010|Overall Study|Randomized but Not Treated|1
1060754|NCT01938430|2107679|FG011|Overall Study|Randomized but Not Treated|0
1060755|NCT01938430|2107680|FG012|Overall Study|Randomized but Not Treated|0
1060756|NCT01938430|2107681|FG013|Overall Study|Randomized but Not Treated|1
1060757|NCT01938430|2107668|FG000|Overall Study|Adverse Event|0
1060758|NCT01938430|2107669|FG001|Overall Study|Adverse Event|0
1060759|NCT01938430|2107670|FG002|Overall Study|Adverse Event|0
1060760|NCT01938430|2107671|FG003|Overall Study|Adverse Event|0
1060761|NCT01938430|2107672|FG004|Overall Study|Adverse Event|0
1060762|NCT01938430|2107673|FG005|Overall Study|Adverse Event|0
1060763|NCT01938430|2107674|FG006|Overall Study|Adverse Event|1
1060764|NCT01938430|2107675|FG007|Overall Study|Adverse Event|0
1060765|NCT01938430|2107676|FG008|Overall Study|Adverse Event|0
1060766|NCT01938430|2107677|FG009|Overall Study|Adverse Event|0
1060767|NCT01938430|2107678|FG010|Overall Study|Adverse Event|0
1060768|NCT01938430|2107679|FG011|Overall Study|Adverse Event|0
1060769|NCT01938430|2107680|FG012|Overall Study|Adverse Event|0
1060770|NCT01938430|2107681|FG013|Overall Study|Adverse Event|0
1060771|NCT01938430|2107668|FG000|Overall Study|Death|1
1060772|NCT01938430|2107669|FG001|Overall Study|Death|2
1060773|NCT01938430|2107670|FG002|Overall Study|Death|2
1060774|NCT01938430|2107671|FG003|Overall Study|Death|1
1060775|NCT01938430|2107672|FG004|Overall Study|Death|0
1060776|NCT01938430|2107673|FG005|Overall Study|Death|0
1060777|NCT01938430|2107674|FG006|Overall Study|Death|1
1060778|NCT01938430|2107675|FG007|Overall Study|Death|1
1060779|NCT01938430|2107676|FG008|Overall Study|Death|2
1060780|NCT01938430|2107677|FG009|Overall Study|Death|3
1060781|NCT01938430|2107678|FG010|Overall Study|Death|0
1060782|NCT01938430|2107679|FG011|Overall Study|Death|0
1060783|NCT01938430|2107680|FG012|Overall Study|Death|0
1060784|NCT01938430|2107681|FG013|Overall Study|Death|0
1060785|NCT01938430|2107668|FG000|Overall Study|Investigator's Discretion|0
1060786|NCT01938430|2107669|FG001|Overall Study|Investigator's Discretion|0
1060787|NCT01938430|2107670|FG002|Overall Study|Investigator's Discretion|1
1060788|NCT01938430|2107671|FG003|Overall Study|Investigator's Discretion|0
1060789|NCT01938430|2107672|FG004|Overall Study|Investigator's Discretion|0
1060790|NCT01938430|2107673|FG005|Overall Study|Investigator's Discretion|0
1060791|NCT01938430|2107674|FG006|Overall Study|Investigator's Discretion|0
1060792|NCT01938430|2107675|FG007|Overall Study|Investigator's Discretion|0
1060793|NCT01938430|2107676|FG008|Overall Study|Investigator's Discretion|0
1060794|NCT01938430|2107677|FG009|Overall Study|Investigator's Discretion|0
1060795|NCT01938430|2107678|FG010|Overall Study|Investigator's Discretion|0
1060796|NCT01938430|2107679|FG011|Overall Study|Investigator's Discretion|0
1060797|NCT01938430|2107680|FG012|Overall Study|Investigator's Discretion|0
1060798|NCT01938430|2107681|FG013|Overall Study|Investigator's Discretion|0
1060799|NCT01938430|2107668|FG000|Overall Study|Lack of Efficacy|3
1060800|NCT01938430|2107669|FG001|Overall Study|Lack of Efficacy|1
1060801|NCT01938430|2107670|FG002|Overall Study|Lack of Efficacy|1
1060802|NCT01938430|2107671|FG003|Overall Study|Lack of Efficacy|1
1060803|NCT01938430|2107672|FG004|Overall Study|Lack of Efficacy|0
1060804|NCT01938430|2107673|FG005|Overall Study|Lack of Efficacy|0
1060805|NCT01938430|2107674|FG006|Overall Study|Lack of Efficacy|0
1060806|NCT01938430|2107675|FG007|Overall Study|Lack of Efficacy|0
1060807|NCT01938430|2107676|FG008|Overall Study|Lack of Efficacy|1
1060808|NCT01938430|2107677|FG009|Overall Study|Lack of Efficacy|0
1060809|NCT01938430|2107678|FG010|Overall Study|Lack of Efficacy|2
1060810|NCT01938430|2107679|FG011|Overall Study|Lack of Efficacy|1
1060811|NCT01938430|2107680|FG012|Overall Study|Lack of Efficacy|0
1060812|NCT01938430|2107681|FG013|Overall Study|Lack of Efficacy|0
1060813|NCT01938430|2107668|FG000|Overall Study|Lost to Follow-up|0
1060814|NCT01938430|2107669|FG001|Overall Study|Lost to Follow-up|0
1060815|NCT01938430|2107670|FG002|Overall Study|Lost to Follow-up|1
1060816|NCT01938430|2107671|FG003|Overall Study|Lost to Follow-up|0
1060817|NCT01938430|2107672|FG004|Overall Study|Lost to Follow-up|0
1060818|NCT01938430|2107673|FG005|Overall Study|Lost to Follow-up|1
1060819|NCT01938430|2107674|FG006|Overall Study|Lost to Follow-up|0
1060820|NCT01938430|2107675|FG007|Overall Study|Lost to Follow-up|0
1060821|NCT01938430|2107676|FG008|Overall Study|Lost to Follow-up|0
1060822|NCT01938430|2107677|FG009|Overall Study|Lost to Follow-up|0
1060823|NCT01938430|2107678|FG010|Overall Study|Lost to Follow-up|0
1060824|NCT01938430|2107679|FG011|Overall Study|Lost to Follow-up|0
1060825|NCT01938430|2107680|FG012|Overall Study|Lost to Follow-up|0
1060826|NCT01938430|2107681|FG013|Overall Study|Lost to Follow-up|0
1060827|NCT01938430|2107668|FG000|Overall Study|Withdrew Consent|0
1060828|NCT01938430|2107669|FG001|Overall Study|Withdrew Consent|0
1060829|NCT01938430|2107670|FG002|Overall Study|Withdrew Consent|0
1060830|NCT01938430|2107671|FG003|Overall Study|Withdrew Consent|0
1060831|NCT01938430|2107672|FG004|Overall Study|Withdrew Consent|0
1060832|NCT01938430|2107673|FG005|Overall Study|Withdrew Consent|0
1060833|NCT01938430|2107674|FG006|Overall Study|Withdrew Consent|0
1060834|NCT01938430|2107675|FG007|Overall Study|Withdrew Consent|0
1060835|NCT01938430|2107676|FG008|Overall Study|Withdrew Consent|1
1060836|NCT01938430|2107677|FG009|Overall Study|Withdrew Consent|0
1060837|NCT01938430|2107678|FG010|Overall Study|Withdrew Consent|0
1060838|NCT01938430|2107679|FG011|Overall Study|Withdrew Consent|0
1060839|NCT01938430|2107680|FG012|Overall Study|Withdrew Consent|0
1060840|NCT01938430|2107681|FG013|Overall Study|Withdrew Consent|0
1060841|NCT01938573|2107736|FG000|Overall Study|Lack of Efficacy|1
1060842|NCT01938573|2107737|FG001|Overall Study|Lack of Efficacy|0
1060843|NCT01938573|2107736|FG000|Overall Study|Operation at other hospital|1
1060844|NCT01938573|2107737|FG001|Overall Study|Operation at other hospital|0
1060845|NCT01938625|2107744|FG000|Overall Study|Withdrawal by Subject|0
1060846|NCT01938625|2107745|FG001|Overall Study|Withdrawal by Subject|1
1060847|NCT01938625|2107744|FG000|Overall Study|Adverse Event|0
1060848|NCT01938625|2107745|FG001|Overall Study|Adverse Event|1
1060849|NCT01938846|2107763|FG000|Overall Study|Progressive disease|26
1060850|NCT01938846|2107764|FG001|Overall Study|Progressive disease|18
1060851|NCT01938846|2107765|FG002|Overall Study|Progressive disease|16
1060852|NCT01938846|2107763|FG000|Overall Study|Adverse Event|8
1060853|NCT01938846|2107764|FG001|Overall Study|Adverse Event|4
1060854|NCT01938846|2107765|FG002|Overall Study|Adverse Event|3
1060855|NCT01938846|2107763|FG000|Overall Study|Withdrawal by Subject|2
1060856|NCT01938846|2107764|FG001|Overall Study|Withdrawal by Subject|2
1060857|NCT01938846|2107765|FG002|Overall Study|Withdrawal by Subject|1
1060858|NCT01938846|2107763|FG000|Overall Study|Other than listed|5
1060859|NCT01938846|2107764|FG001|Overall Study|Other than listed|1
1060860|NCT01938846|2107765|FG002|Overall Study|Other than listed|4
1060861|NCT01939002|2107815|FG000|Overall Study|Adverse Event|13
1060862|NCT01939002|2107816|FG001|Overall Study|Adverse Event|13
1060863|NCT01939002|2107815|FG000|Overall Study|Withdrawal by Subject|5
1060864|NCT01939002|2107816|FG001|Overall Study|Withdrawal by Subject|3
1060865|NCT01939002|2107815|FG000|Overall Study|Other|1
1060866|NCT01939002|2107816|FG001|Overall Study|Other|2
1060867|NCT01939028|2107827|FG000|Overall Study|Withdrawal by Subject|5
1060868|NCT01939028|2107827|FG000|Overall Study|Physician Decision|7
1060869|NCT01939158|2107844|FG000|Overall Study|Adverse Event|1
1060870|NCT01939158|2107845|FG001|Overall Study|Adverse Event|0
1060871|NCT01939158|2107846|FG002|Overall Study|Adverse Event|0
1060872|NCT01939158|2107847|FG003|Overall Study|Adverse Event|0
1060873|NCT01939158|2107844|FG000|Overall Study|Withdrawal by Subject|22
1060874|NCT01939158|2107845|FG001|Overall Study|Withdrawal by Subject|25
1060875|NCT01939158|2107846|FG002|Overall Study|Withdrawal by Subject|15
1060876|NCT01939158|2107847|FG003|Overall Study|Withdrawal by Subject|17
1060877|NCT01939158|2107844|FG000|Overall Study|Migrated/moved from study area|5
1060878|NCT01939158|2107845|FG001|Overall Study|Migrated/moved from study area|7
1060879|NCT01939158|2107846|FG002|Overall Study|Migrated/moved from study area|3
1060880|NCT01939158|2107847|FG003|Overall Study|Migrated/moved from study area|6
1060881|NCT01939158|2107844|FG000|Overall Study|Lost to Follow-up|18
1060882|NCT01939158|2107845|FG001|Overall Study|Lost to Follow-up|17
1060883|NCT01939158|2107846|FG002|Overall Study|Lost to Follow-up|17
1060884|NCT01939158|2107847|FG003|Overall Study|Lost to Follow-up|17
1060885|NCT01939158|2107844|FG000|Overall Study|Death|0
1060886|NCT01939158|2107845|FG001|Overall Study|Death|0
1060887|NCT01939158|2107846|FG002|Overall Study|Death|1
1060888|NCT01939158|2107847|FG003|Overall Study|Death|1
1060889|NCT01939158|2107844|FG000|Overall Study|No longer meets eligibility criteria|0
1060890|NCT01939158|2107845|FG001|Overall Study|No longer meets eligibility criteria|0
1060891|NCT01939158|2107846|FG002|Overall Study|No longer meets eligibility criteria|1
1060892|NCT01939158|2107847|FG003|Overall Study|No longer meets eligibility criteria|0
1060893|NCT01939158|2107844|FG000|Overall Study|Other|1
1060894|NCT01939158|2107845|FG001|Overall Study|Other|3
1060895|NCT01939158|2107846|FG002|Overall Study|Other|4
1060896|NCT01939158|2107847|FG003|Overall Study|Other|3
1060897|NCT01939197|2107868|FG000|Overall Study|Withdrawal by Subject|1
1060898|NCT01939197|2107869|FG001|Overall Study|Withdrawal by Subject|0
1060899|NCT01939197|2107870|FG002|Overall Study|Withdrawal by Subject|0
1060900|NCT01939197|2107871|FG003|Overall Study|Withdrawal by Subject|0
1060901|NCT01939197|2107872|FG004|Overall Study|Withdrawal by Subject|1
1060902|NCT01939197|2107873|FG005|Overall Study|Withdrawal by Subject|0
1060903|NCT01939197|2107874|FG006|Overall Study|Withdrawal by Subject|0
1060904|NCT01939197|2107868|FG000|Overall Study|Lost to Follow-up|0
1060905|NCT01939197|2107869|FG001|Overall Study|Lost to Follow-up|1
1060906|NCT01939197|2107870|FG002|Overall Study|Lost to Follow-up|0
1060907|NCT01939197|2107871|FG003|Overall Study|Lost to Follow-up|1
1060908|NCT01939197|2107872|FG004|Overall Study|Lost to Follow-up|3
1060909|NCT01939197|2107873|FG005|Overall Study|Lost to Follow-up|1
1060910|NCT01939197|2107874|FG006|Overall Study|Lost to Follow-up|2
1060911|NCT01939314|2107927|FG000|Overall Study|Withdrawal by Subject|3
1060912|NCT01939314|2107928|FG001|Overall Study|Withdrawal by Subject|1
1060913|NCT01939314|2107927|FG000|Overall Study|Protocol Violation|1
1060914|NCT01939314|2107928|FG001|Overall Study|Protocol Violation|0
1060915|NCT01939314|2107927|FG000|Overall Study|Pregnancy|0
1060916|NCT01939314|2107928|FG001|Overall Study|Pregnancy|1
1060917|NCT01939314|2107927|FG000|Overall Study|Lost to Follow-up|5
1060918|NCT01939314|2107928|FG001|Overall Study|Lost to Follow-up|6
1060919|NCT01939353|2107936|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3
1060920|NCT01939353|2107936|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1
1060921|NCT01939353|2107936|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2
1060922|NCT01939353|2107936|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1
1060923|NCT01939353|2107936|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1
1060924|NCT01939366|2107945|FG000|Overall Study|Adverse Event|8
1060925|NCT01939366|2107946|FG001|Overall Study|Adverse Event|17
1060926|NCT01939366|2107947|FG002|Overall Study|Adverse Event|30
1060927|NCT01939366|2107948|FG003|Overall Study|Adverse Event|8
1060928|NCT01939366|2107949|FG004|Overall Study|Adverse Event|5
1060929|NCT01939366|2107945|FG000|Overall Study|Lack of Efficacy|2
1060930|NCT01939366|2107946|FG001|Overall Study|Lack of Efficacy|1
1060931|NCT01939366|2107947|FG002|Overall Study|Lack of Efficacy|1
1060932|NCT01939366|2107948|FG003|Overall Study|Lack of Efficacy|1
1060933|NCT01939366|2107949|FG004|Overall Study|Lack of Efficacy|3
1060934|NCT01939366|2107945|FG000|Overall Study|Lost to Follow-up|1
1060935|NCT01939366|2107946|FG001|Overall Study|Lost to Follow-up|1
1060936|NCT01939366|2107947|FG002|Overall Study|Lost to Follow-up|0
1060937|NCT01939366|2107948|FG003|Overall Study|Lost to Follow-up|0
1060938|NCT01939366|2107949|FG004|Overall Study|Lost to Follow-up|0
1060939|NCT01939366|2107945|FG000|Overall Study|Withdrawal by Subject|1
1060940|NCT01939366|2107946|FG001|Overall Study|Withdrawal by Subject|0
1060941|NCT01939366|2107947|FG002|Overall Study|Withdrawal by Subject|2
1060942|NCT01939366|2107948|FG003|Overall Study|Withdrawal by Subject|2
1060943|NCT01939366|2107949|FG004|Overall Study|Withdrawal by Subject|3
1060944|NCT01939366|2107945|FG000|Overall Study|Inclusion criteria not met|0
1060945|NCT01939366|2107946|FG001|Overall Study|Inclusion criteria not met|1
1060946|NCT01939366|2107947|FG002|Overall Study|Inclusion criteria not met|1
1060947|NCT01939366|2107948|FG003|Overall Study|Inclusion criteria not met|0
1060948|NCT01939366|2107949|FG004|Overall Study|Inclusion criteria not met|1
1060949|NCT01939366|2107945|FG000|Overall Study|Other|0
1060950|NCT01939366|2107946|FG001|Overall Study|Other|0
1060951|NCT01939366|2107947|FG002|Overall Study|Other|2
1060952|NCT01939366|2107948|FG003|Overall Study|Other|2
1060953|NCT01939366|2107949|FG004|Overall Study|Other|1
1060954|NCT01939366|2107945|FG000|Overall Study|Protocol Violation|0
1060955|NCT01939366|2107946|FG001|Overall Study|Protocol Violation|0
1060956|NCT01939366|2107947|FG002|Overall Study|Protocol Violation|0
1060957|NCT01939366|2107948|FG003|Overall Study|Protocol Violation|1
1060958|NCT01939366|2107949|FG004|Overall Study|Protocol Violation|0
1060959|NCT01939366|2107945|FG000|Overall Study|Sponsor decision|0
1060960|NCT01939366|2107946|FG001|Overall Study|Sponsor decision|0
1060961|NCT01939366|2107947|FG002|Overall Study|Sponsor decision|0
1060962|NCT01939366|2107948|FG003|Overall Study|Sponsor decision|0
1060963|NCT01939366|2107949|FG004|Overall Study|Sponsor decision|2
1060964|NCT01939366|2107945|FG000|Overall Study|GCP non-compliance at site|2
1060965|NCT01939366|2107946|FG001|Overall Study|GCP non-compliance at site|3
1060966|NCT01939366|2107947|FG002|Overall Study|GCP non-compliance at site|2
1060967|NCT01939366|2107948|FG003|Overall Study|GCP non-compliance at site|3
1060968|NCT01939366|2107949|FG004|Overall Study|GCP non-compliance at site|3
1060969|NCT01939496|2107973|FG000|Overall Study|Adverse Event|2
1060970|NCT01939496|2107974|FG001|Overall Study|Adverse Event|0
1060971|NCT01939496|2107975|FG002|Overall Study|Adverse Event|0
1060972|NCT01939496|2107973|FG000|Overall Study|Lost to Follow-up|1
1060973|NCT01939496|2107974|FG001|Overall Study|Lost to Follow-up|1
1060974|NCT01939496|2107975|FG002|Overall Study|Lost to Follow-up|0
1060975|NCT01939496|2107973|FG000|Overall Study|Physician Decision|1
1060976|NCT01939496|2107974|FG001|Overall Study|Physician Decision|0
1060977|NCT01939496|2107975|FG002|Overall Study|Physician Decision|0
1060978|NCT01939496|2107973|FG000|Overall Study|Protocol Violation|3
1060979|NCT01939496|2107974|FG001|Overall Study|Protocol Violation|0
1060980|NCT01939496|2107975|FG002|Overall Study|Protocol Violation|0
1060981|NCT01939496|2107973|FG000|Overall Study|Withdrawal by Subject|0
1060982|NCT01939496|2107974|FG001|Overall Study|Withdrawal by Subject|1
1060983|NCT01939496|2107975|FG002|Overall Study|Withdrawal by Subject|1
1060984|NCT01939496|2107973|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0
1060985|NCT01939496|2107974|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1
1060986|NCT01939496|2107975|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0
1060987|NCT01939496|2107973|FG000|Overall Study|Other|2
1060988|NCT01939496|2107974|FG001|Overall Study|Other|0
1060989|NCT01939496|2107975|FG002|Overall Study|Other|1
1060990|NCT01939548|2107986|FG000|Overall Study|Non compliance|0
1060991|NCT01939548|2107987|FG001|Overall Study|Non compliance|2
1060992|NCT01939548|2107988|FG002|Overall Study|Non compliance|0
1060993|NCT01939548|2107986|FG000|Overall Study|Study Terminated by Sponsor|17
1060994|NCT01939548|2107987|FG001|Overall Study|Study Terminated by Sponsor|19
1060995|NCT01939548|2107988|FG002|Overall Study|Study Terminated by Sponsor|12
1060996|NCT01939548|2107986|FG000|Overall Study|Insufficient Clinical Response|1
1060997|NCT01939548|2107987|FG001|Overall Study|Insufficient Clinical Response|0
1060998|NCT01939548|2107988|FG002|Overall Study|Insufficient Clinical Response|0
1060999|NCT01939548|2107986|FG000|Overall Study|Did Not Meet Entrance Criteria|1
1061000|NCT01939548|2107987|FG001|Overall Study|Did Not Meet Entrance Criteria|0
1061001|NCT01939548|2107988|FG002|Overall Study|Did Not Meet Entrance Criteria|0
1061002|NCT01939548|2107986|FG000|Overall Study|Withdrawal by Subject|4
1061003|NCT01939548|2107987|FG001|Overall Study|Withdrawal by Subject|4
1061004|NCT01939548|2107988|FG002|Overall Study|Withdrawal by Subject|1
1061005|NCT01939548|2107986|FG000|Overall Study|Protocol Violation|7
1061006|NCT01939548|2107987|FG001|Overall Study|Protocol Violation|6
1061007|NCT01939548|2107988|FG002|Overall Study|Protocol Violation|5
1061008|NCT01939548|2107986|FG000|Overall Study|Lost to Follow-up|5
1061009|NCT01939548|2107987|FG001|Overall Study|Lost to Follow-up|5
1061010|NCT01939548|2107988|FG002|Overall Study|Lost to Follow-up|3
1061011|NCT01939548|2107986|FG000|Overall Study|Adverse Event|2
1061012|NCT01939548|2107987|FG001|Overall Study|Adverse Event|9
1061013|NCT01939548|2107988|FG002|Overall Study|Adverse Event|7
1061014|NCT01939548|2107986|FG000|Overall Study|Death|0
1061015|NCT01939548|2107987|FG001|Overall Study|Death|0
1061016|NCT01939548|2107988|FG002|Overall Study|Death|1
1061017|NCT01939548|2107986|FG000|Overall Study|Participant dropped|0
1061018|NCT01939548|2107987|FG001|Overall Study|Participant dropped|0
1061019|NCT01939548|2107988|FG002|Overall Study|Participant dropped|1
1061020|NCT01939548|2107986|FG000|Overall Study|Participant unwilling to continue|0
1061021|NCT01939548|2107987|FG001|Overall Study|Participant unwilling to continue|1
1061022|NCT01939548|2107988|FG002|Overall Study|Participant unwilling to continue|0
1061023|NCT01939548|2107986|FG000|Overall Study|Participant withdrew consent|0
1061024|NCT01939548|2107987|FG001|Overall Study|Participant withdrew consent|2
1061025|NCT01939548|2107988|FG002|Overall Study|Participant withdrew consent|0
1061026|NCT01939548|2107986|FG000|Overall Study|Did not complete follow-up|0
1061027|NCT01939548|2107987|FG001|Overall Study|Did not complete follow-up|1
1061028|NCT01939548|2107988|FG002|Overall Study|Did not complete follow-up|0
1061029|NCT01939899|2108001|FG000|Lead-in Dose Finding Phase|Death|0
1061030|NCT01939899|2108002|FG001|Lead-in Dose Finding Phase|Death|3
1061031|NCT01939899|2108003|FG002|Lead-in Dose Finding Phase|Death|1
1061032|NCT01939899|2108004|FG003|Lead-in Dose Finding Phase|Death|0
1061033|NCT01939899|2108005|FG004|Lead-in Dose Finding Phase|Death|0
1061034|NCT01939899|2108001|FG000|Lead-in Dose Finding Phase|Disease Progression|2
1061035|NCT01939899|2108002|FG001|Lead-in Dose Finding Phase|Disease Progression|4
1061036|NCT01939899|2108003|FG002|Lead-in Dose Finding Phase|Disease Progression|3
1061037|NCT01939899|2108004|FG003|Lead-in Dose Finding Phase|Disease Progression|0
1061038|NCT01939899|2108005|FG004|Lead-in Dose Finding Phase|Disease Progression|0
1061039|NCT01939899|2108001|FG000|Lead-in Dose Finding Phase|Other|0
1061040|NCT01939899|2108002|FG001|Lead-in Dose Finding Phase|Other|0
1061041|NCT01939899|2108003|FG002|Lead-in Dose Finding Phase|Other|1
1061042|NCT01939899|2108004|FG003|Lead-in Dose Finding Phase|Other|0
1061043|NCT01939899|2108005|FG004|Lead-in Dose Finding Phase|Other|0
1061044|NCT01939899|2108001|FG000|Phase 2|Withdrawal by Subject|0
1061045|NCT01939899|2108002|FG001|Phase 2|Withdrawal by Subject|0
1061046|NCT01939899|2108003|FG002|Phase 2|Withdrawal by Subject|0
1061047|NCT01939899|2108004|FG003|Phase 2|Withdrawal by Subject|2
1061048|NCT01939899|2108005|FG004|Phase 2|Withdrawal by Subject|0
1061049|NCT01939899|2108001|FG000|Phase 2|Disease Progression|0
1061050|NCT01939899|2108002|FG001|Phase 2|Disease Progression|0
1061051|NCT01939899|2108003|FG002|Phase 2|Disease Progression|0
1061052|NCT01939899|2108004|FG003|Phase 2|Disease Progression|9
1061053|NCT01939899|2108005|FG004|Phase 2|Disease Progression|1
1061054|NCT01939977|2108031|FG000|Overall Study|Adverse Event|4
1061055|NCT01939977|2108032|FG001|Overall Study|Adverse Event|3
1061056|NCT01939977|2108031|FG000|Overall Study|Lack of Efficacy|3
1061057|NCT01939977|2108032|FG001|Overall Study|Lack of Efficacy|0
1061058|NCT01939977|2108031|FG000|Overall Study|Physician Decision|1
1061059|NCT01939977|2108032|FG001|Overall Study|Physician Decision|1
1061060|NCT01939977|2108031|FG000|Overall Study|Withdrawal by Subject|0
1061061|NCT01939977|2108032|FG001|Overall Study|Withdrawal by Subject|2
1061062|NCT01939977|2108031|FG000|Overall Study|Did not meet inclusion criteria|1
1061063|NCT01939977|2108032|FG001|Overall Study|Did not meet inclusion criteria|0
1061064|NCT01939977|2108031|FG000|Overall Study|Did not receive study medication|0
1061065|NCT01939977|2108032|FG001|Overall Study|Did not receive study medication|1
1061066|NCT01940120|2108038|FG000|Overall Study|Death|40
1061067|NCT01940120|2108038|FG000|Overall Study|Withdrawal by Subject|8
1061088|NCT01940354|2108082|FG000|Overall Study|Withdrawal by Subject|4
1061089|NCT01940354|2108083|FG001|Overall Study|Withdrawal by Subject|2
1061090|NCT01940471|2108091|FG000|Double-Blind Phase|Randomized but Never Treated|1
1061091|NCT01940471|2108092|FG001|Double-Blind Phase|Randomized but Never Treated|1
1061092|NCT01940471|2108091|FG000|Double-Blind Phase|Withdrew Consent|13
1061093|NCT01940471|2108092|FG001|Double-Blind Phase|Withdrew Consent|7
1061094|NCT01940471|2108091|FG000|Double-Blind Phase|Adverse Event|1
1061095|NCT01940471|2108092|FG001|Double-Blind Phase|Adverse Event|2
1061096|NCT01940471|2108091|FG000|Double-Blind Phase|Lost to Follow-up|3
1061097|NCT01940471|2108092|FG001|Double-Blind Phase|Lost to Follow-up|2
1061098|NCT01940471|2108091|FG000|Double-Blind Phase|Pregnancy|2
1061099|NCT01940471|2108092|FG001|Double-Blind Phase|Pregnancy|1
1061100|NCT01940471|2108091|FG000|Double-Blind Phase|Investigator's Discretion|5
1061101|NCT01940471|2108092|FG001|Double-Blind Phase|Investigator's Discretion|0
1061102|NCT01940471|2108091|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
1061103|NCT01940471|2108092|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
1061104|NCT01940471|2108091|FG000|Double-Blind Phase|Protocol-Specified Criteria|1
1061105|NCT01940471|2108092|FG001|Double-Blind Phase|Protocol-Specified Criteria|0
1061106|NCT01940471|2108091|FG000|Double-Blind Phase|Death|1
1061107|NCT01940471|2108092|FG001|Double-Blind Phase|Death|0
1061108|NCT01940471|2108091|FG000|Double-Blind Phase|Lack of Efficacy|1
1061109|NCT01940471|2108092|FG001|Double-Blind Phase|Lack of Efficacy|0
1061110|NCT01940471|2108091|FG000|Double-Blind Phase|Protocol Violation|0
1061111|NCT01940471|2108092|FG001|Double-Blind Phase|Protocol Violation|1
1061112|NCT01940471|2108091|FG000|Double-Blind Phase|Still in Double-Blind Phase|539
1061113|NCT01940471|2108092|FG001|Double-Blind Phase|Still in Double-Blind Phase|270
1061114|NCT01940471|2108091|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14
1061115|NCT01940471|2108092|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8
1061116|NCT01940484|2108099|FG000|Overall Study|Withdrawal by Subject|3
1061117|NCT01940484|2108099|FG000|Overall Study|Underwent transplantation|4
1061118|NCT01940484|2108099|FG000|Overall Study|Death|2
1061119|NCT01940484|2108099|FG000|Overall Study|Adverse Event|1
1061120|NCT01940497|2108105|FG000|Overall Study|Adverse Event/Intercurrent Illness|11
1061121|NCT01940497|2108106|FG001|Overall Study|Adverse Event/Intercurrent Illness|8
1061122|NCT01940497|2108105|FG000|Overall Study|Recurrence of Disease Postsurgery|1
1061123|NCT01940497|2108106|FG001|Overall Study|Recurrence of Disease Postsurgery|3
1061124|NCT01940497|2108105|FG000|Overall Study|Violation of Entry Criteria|1
1061125|NCT01940497|2108106|FG001|Overall Study|Violation of Entry Criteria|1
1061126|NCT01940497|2108105|FG000|Overall Study|Refused Treatment|1
1061127|NCT01940497|2108106|FG001|Overall Study|Refused Treatment|3
1061128|NCT01940497|2108105|FG000|Overall Study|Withdrew Consent|6
1061129|NCT01940497|2108106|FG001|Overall Study|Withdrew Consent|2
1061130|NCT01940497|2108105|FG000|Overall Study|Administrative/Other|1
1061131|NCT01940497|2108106|FG001|Overall Study|Administrative/Other|1
1061132|NCT01940705|2108145|FG000|Overall Study|Lost to Follow-up|1
1061133|NCT01940705|2108146|FG001|Overall Study|Lost to Follow-up|3
1061134|NCT01940705|2108147|FG002|Overall Study|Lost to Follow-up|2
1061135|NCT01940705|2108148|FG003|Overall Study|Lost to Follow-up|2
1061136|NCT01940705|2108145|FG000|Overall Study|Withdrawal by Subject|2
1061137|NCT01940705|2108146|FG001|Overall Study|Withdrawal by Subject|2
1061138|NCT01940705|2108147|FG002|Overall Study|Withdrawal by Subject|3
1061139|NCT01940705|2108148|FG003|Overall Study|Withdrawal by Subject|2
1061140|NCT01940705|2108145|FG000|Overall Study|Intervention not given|0
1061141|NCT01940705|2108146|FG001|Overall Study|Intervention not given|3
1061142|NCT01940705|2108147|FG002|Overall Study|Intervention not given|3
1061143|NCT01940705|2108148|FG003|Overall Study|Intervention not given|0
1061144|NCT01940705|2108145|FG000|Overall Study|Withdrawal by team - hearing aid change|1
1061145|NCT01940705|2108146|FG001|Overall Study|Withdrawal by team - hearing aid change|0
1061146|NCT01940705|2108147|FG002|Overall Study|Withdrawal by team - hearing aid change|0
1061147|NCT01940705|2108148|FG003|Overall Study|Withdrawal by team - hearing aid change|0
1061148|NCT01940887|2108163|FG000|Year 1|Protocol Violation|0
1061149|NCT01940887|2108164|FG001|Year 1|Protocol Violation|1
1061150|NCT01940887|2108163|FG000|Year 1|Physician Decision|7
1061151|NCT01940887|2108164|FG001|Year 1|Physician Decision|3
1061152|NCT01940887|2108163|FG000|Year 1|Death|5
1061153|NCT01940887|2108164|FG001|Year 1|Death|3
1061154|NCT01940887|2108163|FG000|Year 1|Adverse Event|7
1061155|NCT01940887|2108164|FG001|Year 1|Adverse Event|6
1061156|NCT01940887|2108163|FG000|Year 1|Withdrawal by Subject|18
1061157|NCT01940887|2108164|FG001|Year 1|Withdrawal by Subject|9
1061158|NCT01940887|2108163|FG000|Year 1|Lost to Follow-up|2
1061159|NCT01940887|2108164|FG001|Year 1|Lost to Follow-up|1
1061160|NCT01940887|2108163|FG000|Year 2|Physician Decision|8
1061161|NCT01940887|2108164|FG001|Year 2|Physician Decision|1
1061162|NCT01940887|2108163|FG000|Year 2|Death|0
1061163|NCT01940887|2108164|FG001|Year 2|Death|2
1061164|NCT01940887|2108163|FG000|Year 2|Sponsor Decision, early termination|192
1061165|NCT01940887|2108164|FG001|Year 2|Sponsor Decision, early termination|203
1061166|NCT01940887|2108163|FG000|Year 2|Adverse Event|8
1061167|NCT01940887|2108164|FG001|Year 2|Adverse Event|2
1061168|NCT01940887|2108163|FG000|Year 2|Withdrawal by Subject|8
1061169|NCT01940887|2108164|FG001|Year 2|Withdrawal by Subject|8
1061170|NCT01940887|2108163|FG000|Year 2|Lost to Follow-up|1
1061171|NCT01940887|2108164|FG001|Year 2|Lost to Follow-up|6
1061172|NCT01940900|2108172|FG000|Overall Study|Physician Decision|4
1061173|NCT01940900|2108173|FG001|Overall Study|Physician Decision|0
1061174|NCT01940900|2108172|FG000|Overall Study|Adverse Event|10
1061175|NCT01940900|2108173|FG001|Overall Study|Adverse Event|15
1061176|NCT01940900|2108172|FG000|Overall Study|Withdrawal by Subject|11
1061177|NCT01940900|2108173|FG001|Overall Study|Withdrawal by Subject|15
1061178|NCT01940900|2108172|FG000|Overall Study|Lost to Follow-up|1
1061179|NCT01940900|2108173|FG001|Overall Study|Lost to Follow-up|0
1061180|NCT01940900|2108172|FG000|Overall Study|Sponsor Decision|1
1061181|NCT01940900|2108173|FG001|Overall Study|Sponsor Decision|0
1061182|NCT01940900|2108172|FG000|Overall Study|subject non-compliance|1
1061183|NCT01940900|2108173|FG001|Overall Study|subject non-compliance|1
1061184|NCT01940900|2108172|FG000|Overall Study|other|1
1061185|NCT01940900|2108173|FG001|Overall Study|other|0
1061186|NCT01940939|2108181|FG000|Overall Study|Withdrawal by Subject|2
1061187|NCT01940939|2108182|FG001|Overall Study|Withdrawal by Subject|8
1061188|NCT01941030|2108190|FG000|Overall Study|Death|3
1061189|NCT01941030|2108191|FG001|Overall Study|Death|2
1061190|NCT01941030|2108190|FG000|Overall Study|Lost to Follow-up|6
1061191|NCT01941030|2108191|FG001|Overall Study|Lost to Follow-up|5
1061192|NCT01941030|2108190|FG000|Overall Study|Withdrawal by Subject|4
1061193|NCT01941030|2108191|FG001|Overall Study|Withdrawal by Subject|6
1061194|NCT01941095|2108197|FG000|Overall Study|Insufficient therapeutic response|13
1061195|NCT01941095|2108197|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2
1061196|NCT01941095|2108197|FG000|Overall Study|Adverse Event|11
1061197|NCT01941095|2108197|FG000|Overall Study|Physician Decision|3
1061198|NCT01941095|2108197|FG000|Overall Study|Withdrawal by Subject|17
1061199|NCT01941095|2108197|FG000|Overall Study|Lost to Follow-up|10
1061200|NCT01941186|2108204|FG000|Follow-up|Lost to Follow-up|1
1061201|NCT01941186|2108205|FG001|Follow-up|Lost to Follow-up|0
1061202|NCT01941498|2108250|FG000|Overall Study|Relocated out of state|1
1061203|NCT01941537|2108271|FG000|Overall Study|Lack of Efficacy|1
1061204|NCT01941537|2108272|FG001|Overall Study|Lack of Efficacy|2
1061205|NCT01941537|2108271|FG000|Overall Study|Lost to Follow-up|1
1061206|NCT01941537|2108272|FG001|Overall Study|Lost to Follow-up|0
1061207|NCT01941537|2108271|FG000|Overall Study|Pregnancy|1
1061208|NCT01941537|2108272|FG001|Overall Study|Pregnancy|0
1061209|NCT01941537|2108271|FG000|Overall Study|Adverse Event|1
1061210|NCT01941537|2108272|FG001|Overall Study|Adverse Event|0
1061211|NCT01941537|2108271|FG000|Overall Study|Withdrawal by Subject|0
1061212|NCT01941537|2108272|FG001|Overall Study|Withdrawal by Subject|1
1061213|NCT01941940|2108317|FG000|Overall Study|Adverse Event|11
1061214|NCT01941940|2108317|FG000|Overall Study|Lost to Follow-up|2
1061215|NCT01941940|2108317|FG000|Overall Study|Physician Decision|2
1061216|NCT01941940|2108317|FG000|Overall Study|Withdrawal by Subject|15
1061217|NCT01941940|2108317|FG000|Overall Study|Death|1
1061218|NCT01941940|2108317|FG000|Overall Study|Other|1
1061219|NCT01941940|2108317|FG000|Overall Study|Other|1
1061236|NCT01942148|2108330|FG000|Overall Study|Adverse Event|4
1061237|NCT01942148|2108330|FG000|Overall Study|Lack of Efficacy|2
1061238|NCT01942148|2108330|FG000|Overall Study|Physician Decision|11
1061239|NCT01942148|2108330|FG000|Overall Study|Protocol Violation|1
1061240|NCT01942148|2108330|FG000|Overall Study|Withdrawal by Subject|8
1061241|NCT01942148|2108330|FG000|Overall Study|Use of the prohibition medicine|1
1061242|NCT01942161|2108337|FG000|Overall Study|Adverse Event|1
1061243|NCT01942161|2108338|FG001|Overall Study|Adverse Event|2
1061244|NCT01942161|2108339|FG002|Overall Study|Adverse Event|5
1061245|NCT01942161|2108337|FG000|Overall Study|Physician Decision|3
1061246|NCT01942161|2108338|FG001|Overall Study|Physician Decision|1
1061247|NCT01942161|2108339|FG002|Overall Study|Physician Decision|0
1061248|NCT01942161|2108337|FG000|Overall Study|Protocol Violation|1
1061249|NCT01942161|2108338|FG001|Overall Study|Protocol Violation|0
1061250|NCT01942161|2108339|FG002|Overall Study|Protocol Violation|0
1061251|NCT01942161|2108337|FG000|Overall Study|Withdrawal by Subject|3
1061252|NCT01942161|2108338|FG001|Overall Study|Withdrawal by Subject|3
1061253|NCT01942161|2108339|FG002|Overall Study|Withdrawal by Subject|1
1061254|NCT01942486|2108347|FG000|Overall Study|Lost to Follow-up|27
1061255|NCT01942590|2108353|FG000|Overall Study|Withdrawal by Subject|0
1061256|NCT01942590|2108354|FG001|Overall Study|Withdrawal by Subject|1
1061257|NCT01942590|2108353|FG000|Overall Study|Adverse Event|1
1061258|NCT01942590|2108354|FG001|Overall Study|Adverse Event|0
1061259|NCT01942733|2108409|FG000|Overall Study|Lost to Follow-up|1
1061260|NCT01942733|2108409|FG000|Overall Study|Non-compliance with IMP|1
1061261|NCT01942733|2108409|FG000|Overall Study|Administrative|1
1061262|NCT01942785|2108413|FG000|Overall Study|Adverse Event|2
1061263|NCT01942785|2108413|FG000|Overall Study|Withdrawal by Subject|1
1061264|NCT01942785|2108413|FG000|Overall Study|Protocol Violation|1
1061265|NCT01942993|2108419|FG000|Overall Study|Lost to Follow-up|1
1061266|NCT01942993|2108419|FG000|Overall Study|Physician Decision|1
1061267|NCT01943292|2108451|FG000|Overall Study|Withdrawal by Subject|1
1061268|NCT01943292|2108452|FG001|Overall Study|Withdrawal by Subject|0
1061269|NCT01943292|2108453|FG002|Overall Study|Withdrawal by Subject|0
1061270|NCT01943435|2108470|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4
1061271|NCT01943435|2108471|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12
1061272|NCT01943435|2108472|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3
1061273|NCT01943435|2108470|FG000|Intervention Period|Withdrawal by Subject|3
1061274|NCT01943435|2108471|FG001|Intervention Period|Withdrawal by Subject|3
1061275|NCT01943435|2108472|FG002|Intervention Period|Withdrawal by Subject|4
1061276|NCT01943435|2108470|FG000|2 Month Follow up|Lost to Follow-up|2
1061277|NCT01943435|2108471|FG001|2 Month Follow up|Lost to Follow-up|3
1061278|NCT01943435|2108472|FG002|2 Month Follow up|Lost to Follow-up|0
1061279|NCT01943435|2108470|FG000|6 Month Follow up|Lost to Follow-up|12
1061280|NCT01943435|2108471|FG001|6 Month Follow up|Lost to Follow-up|7
1061281|NCT01943435|2108472|FG002|6 Month Follow up|Lost to Follow-up|15
1061282|NCT01943539|2108506|FG000|Overall Study|Non-compliance with at-home intervention|4
1061283|NCT01943539|2108507|FG001|Overall Study|Non-compliance with at-home intervention|0
1061284|NCT01943552|2108516|FG000|Overall Study|Adverse Event|3
1061285|NCT01943552|2108517|FG001|Overall Study|Adverse Event|2
1061286|NCT01943552|2108516|FG000|Overall Study|Withdrawal by Subject|6
1061287|NCT01943552|2108517|FG001|Overall Study|Withdrawal by Subject|6
1061288|NCT01943552|2108516|FG000|Overall Study|Other Reasons|16
1061289|NCT01943552|2108517|FG001|Overall Study|Other Reasons|17
1061290|NCT01943591|2108538|FG000|Overall Study|Lost to Follow-up|3
1061291|NCT01943591|2108539|FG001|Overall Study|Lost to Follow-up|4
1061292|NCT01943591|2108538|FG000|Overall Study|Death|2
1061293|NCT01943591|2108539|FG001|Overall Study|Death|7
1061294|NCT01943799|2108549|FG000|Overall Study|Lost to Follow-up|0
1061295|NCT01943799|2108550|FG001|Overall Study|Lost to Follow-up|1
1061296|NCT01943799|2108551|FG002|Overall Study|Lost to Follow-up|1
1061297|NCT01943799|2108552|FG003|Overall Study|Lost to Follow-up|0
1061298|NCT01943799|2108549|FG000|Overall Study|Protocol Violation|1
1061299|NCT01943799|2108550|FG001|Overall Study|Protocol Violation|0
1061300|NCT01943799|2108551|FG002|Overall Study|Protocol Violation|0
1061301|NCT01943799|2108552|FG003|Overall Study|Protocol Violation|0
1061302|NCT01943799|2108549|FG000|Overall Study|Withdrawal by Subject|4
1061303|NCT01943799|2108550|FG001|Overall Study|Withdrawal by Subject|2
1061304|NCT01943799|2108551|FG002|Overall Study|Withdrawal by Subject|1
1061305|NCT01943799|2108552|FG003|Overall Study|Withdrawal by Subject|0
1061306|NCT01943825|2108566|FG000|Overall Study|Lost to Follow-up|9
1061307|NCT01943825|2108567|FG001|Overall Study|Lost to Follow-up|3
1061308|NCT01943825|2108568|FG002|Overall Study|Lost to Follow-up|12
1061309|NCT01943825|2108569|FG003|Overall Study|Lost to Follow-up|8
1061310|NCT01943825|2108566|FG000|Overall Study|Withdrawal by Subject|1
1061311|NCT01943825|2108567|FG001|Overall Study|Withdrawal by Subject|0
1061312|NCT01943825|2108568|FG002|Overall Study|Withdrawal by Subject|3
1061313|NCT01943825|2108569|FG003|Overall Study|Withdrawal by Subject|2
1061314|NCT01943825|2108566|FG000|Overall Study|Other than specified above|0
1061315|NCT01943825|2108567|FG001|Overall Study|Other than specified above|1
1061316|NCT01943825|2108568|FG002|Overall Study|Other than specified above|0
1061317|NCT01943825|2108569|FG003|Overall Study|Other than specified above|1
1061318|NCT01943851|2108601|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061319|NCT01943851|2108602|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061320|NCT01943851|2108603|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061321|NCT01943851|2108604|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
1061322|NCT01943851|2108605|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061323|NCT01943851|2108606|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061324|NCT01943851|2108607|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
1061325|NCT01943851|2108608|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
1061326|NCT01943851|2108609|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
1061327|NCT01943851|2108610|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061328|NCT01943851|2108611|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061329|NCT01943851|2108612|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061330|NCT01943851|2108613|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061331|NCT01943851|2108614|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061332|NCT01943851|2108615|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061333|NCT01943851|2108616|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061334|NCT01943851|2108617|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061335|NCT01943851|2108618|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
1061336|NCT01943851|2108601|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061337|NCT01943851|2108602|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061338|NCT01943851|2108603|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061339|NCT01943851|2108604|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061340|NCT01943851|2108605|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
1061341|NCT01943851|2108606|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061342|NCT01943851|2108607|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061343|NCT01943851|2108608|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
1061344|NCT01943851|2108609|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061345|NCT01943851|2108610|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061346|NCT01943851|2108611|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061347|NCT01943851|2108612|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061348|NCT01943851|2108613|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061349|NCT01943851|2108614|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061350|NCT01943851|2108615|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061351|NCT01943851|2108616|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061352|NCT01943851|2108617|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061353|NCT01943851|2108618|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
1061354|NCT01943851|2108601|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061355|NCT01943851|2108602|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061356|NCT01943851|2108603|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061357|NCT01943851|2108604|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061358|NCT01943851|2108605|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061359|NCT01943851|2108606|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061360|NCT01943851|2108607|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061361|NCT01943851|2108608|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061362|NCT01943851|2108609|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061363|NCT01943851|2108610|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061364|NCT01943851|2108611|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061365|NCT01943851|2108612|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061366|NCT01943851|2108613|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061367|NCT01943851|2108614|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1
1061368|NCT01943851|2108615|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061369|NCT01943851|2108616|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061370|NCT01943851|2108617|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061371|NCT01943851|2108618|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
1061372|NCT01943851|2108601|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061373|NCT01943851|2108602|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061374|NCT01943851|2108603|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061375|NCT01943851|2108604|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061376|NCT01943851|2108605|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061377|NCT01943851|2108606|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061378|NCT01943851|2108607|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061379|NCT01943851|2108608|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061380|NCT01943851|2108609|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061381|NCT01943851|2108610|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061382|NCT01943851|2108611|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061383|NCT01943851|2108612|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061384|NCT01943851|2108613|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061385|NCT01943851|2108614|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061386|NCT01943851|2108615|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061387|NCT01943851|2108616|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2
1061388|NCT01943851|2108617|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061389|NCT01943851|2108618|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
1061390|NCT01943851|2108601|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061391|NCT01943851|2108602|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061392|NCT01943851|2108603|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061393|NCT01943851|2108604|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061394|NCT01943851|2108605|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061395|NCT01943851|2108606|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061396|NCT01943851|2108607|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061397|NCT01943851|2108608|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061398|NCT01943851|2108609|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061399|NCT01943851|2108610|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061400|NCT01943851|2108611|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061401|NCT01943851|2108612|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061402|NCT01943851|2108613|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061403|NCT01943851|2108614|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061404|NCT01943851|2108615|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
1061405|NCT01943851|2108616|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4
1061406|NCT01943851|2108617|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3
1061407|NCT01943851|2108618|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1
1061408|NCT01943916|2108663|FG000|Overall Study|Technically invalid images|10
1061409|NCT01943916|2108663|FG000|Overall Study|Enrollment Failure|23
1061410|NCT01943916|2108663|FG000|Overall Study|Pilot Phase exclusion|100
1061411|NCT01943916|2108663|FG000|Overall Study|Quality Assurance Reader Fail|130
1061412|NCT01943916|2108663|FG000|Overall Study|Technical Failure|39
1061413|NCT01943916|2108663|FG000|Overall Study|Protocol Deviation No Biopsy|25
1061414|NCT01943916|2108663|FG000|Overall Study|No Truth Panel Review|38
1061415|NCT01943916|2108663|FG000|Overall Study|Protocol Deviation|1
1061416|NCT01944046|2108674|FG000|Randomized to DB|Adverse Event|5
1061417|NCT01944046|2108675|FG001|Randomized to DB|Adverse Event|2
1061418|NCT01944046|2108674|FG000|Randomized to DB|Clinical Worsening|3
1061419|NCT01944046|2108675|FG001|Randomized to DB|Clinical Worsening|2
1061420|NCT01944046|2108674|FG000|Randomized to DB|Lost to Follow-up|3
1061421|NCT01944046|2108675|FG001|Randomized to DB|Lost to Follow-up|3
1061422|NCT01944046|2108674|FG000|Randomized to DB|Withdrawal by Subject|2
1061423|NCT01944046|2108675|FG001|Randomized to DB|Withdrawal by Subject|4
1061424|NCT01944046|2108674|FG000|Randomized to DB|Physician Decision|1
1061425|NCT01944046|2108675|FG001|Randomized to DB|Physician Decision|2
1061426|NCT01944046|2108674|FG000|Randomized to DB|Did not have baseline ABC-SW|2
1061427|NCT01944046|2108675|FG001|Randomized to DB|Did not have baseline ABC-SW|0
1061428|NCT01944046|2108674|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5
1061429|NCT01944046|2108675|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6
1061430|NCT01944046|2108674|FG000|Open Label Eligible and Consented|Lost to Follow-up|3
1061431|NCT01944046|2108675|FG001|Open Label Eligible and Consented|Lost to Follow-up|5
1061432|NCT01944046|2108674|FG000|Open Label Eligible and Consented|Adverse Event|6
1061433|NCT01944046|2108675|FG001|Open Label Eligible and Consented|Adverse Event|1
1061434|NCT01944046|2108674|FG000|Open Label Eligible and Consented|Clinical Worsening|4
1061435|NCT01944046|2108675|FG001|Open Label Eligible and Consented|Clinical Worsening|2
1061436|NCT01944046|2108674|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1
1061437|NCT01944046|2108675|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0
1061438|NCT01944098|2108687|FG000|Overall Study|Physician Decision|1
1061439|NCT01944098|2108688|FG001|Overall Study|Physician Decision|0
1061440|NCT01944462|2108739|FG000|PPPP Educational Program|Lost to Follow-up|60
1061441|NCT01944631|2108746|FG000|Overall Study|Adverse Event|1
1061442|NCT01944631|2108747|FG001|Overall Study|Adverse Event|0
1061443|NCT01944631|2108746|FG000|Overall Study|Lost to Follow-up|3
1061444|NCT01944631|2108747|FG001|Overall Study|Lost to Follow-up|1
1061445|NCT01944631|2108746|FG000|Overall Study|Withdrawal by Subject|0
1061446|NCT01944631|2108747|FG001|Overall Study|Withdrawal by Subject|1
1061447|NCT01944670|2108762|FG000|Overall Study|Lost to Follow-up|2
1061448|NCT01944722|2108768|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
1061449|NCT01944722|2108768|FG000|Overall Study|Specimen Shipping Issues|34
1061450|NCT01944722|2108768|FG000|Overall Study|Improper Storage/Transport|5
1061451|NCT01944722|2108768|FG000|Overall Study|Insufficient Volume for Test|1
1061452|NCT01944722|2108768|FG000|Overall Study|Missing Specimens|3
1061453|NCT01944722|2108768|FG000|Overall Study|Specimens Mislabeled|2
1061454|NCT01944722|2108768|FG000|Overall Study|Withdrawal by Subject|8
1061455|NCT01944722|2108768|FG000|Overall Study|NILM Subjects <30 years old|8106
1061456|NCT01944722|2108768|FG000|Overall Study|Unsatisfactory Cytology Result|63
1061457|NCT01944722|2108768|FG000|Overall Study|>ASCUS Cytology|1122
1061458|NCT01944774|2108780|FG000|Overall Study|Withdrawal by Subject|2
1061459|NCT01944774|2108781|FG001|Overall Study|Withdrawal by Subject|3
1061460|NCT01944774|2108782|FG002|Overall Study|Withdrawal by Subject|3
1061461|NCT01944774|2108780|FG000|Overall Study|Adverse Event|3
1061462|NCT01944774|2108781|FG001|Overall Study|Adverse Event|2
1061463|NCT01944774|2108782|FG002|Overall Study|Adverse Event|3
1061464|NCT01944774|2108780|FG000|Overall Study|Lack of Efficacy|1
1061465|NCT01944774|2108781|FG001|Overall Study|Lack of Efficacy|2
1061466|NCT01944774|2108782|FG002|Overall Study|Lack of Efficacy|2
1061467|NCT01944774|2108780|FG000|Overall Study|Lost to Follow-up|0
1061468|NCT01944774|2108781|FG001|Overall Study|Lost to Follow-up|1
1061469|NCT01944774|2108782|FG002|Overall Study|Lost to Follow-up|0
1061470|NCT01944839|2108795|FG000|Overall Study|Physician Decision|2
1061471|NCT01944839|2108796|FG001|Overall Study|Physician Decision|2
1061472|NCT01944839|2108795|FG000|Overall Study|Protocol Violation|0
1061473|NCT01944839|2108796|FG001|Overall Study|Protocol Violation|1
1061474|NCT01944839|2108795|FG000|Overall Study|Adverse Event|10
1061475|NCT01944839|2108796|FG001|Overall Study|Adverse Event|5
1061476|NCT01944839|2108795|FG000|Overall Study|Withdrawal by Subject|9
1061477|NCT01944839|2108796|FG001|Overall Study|Withdrawal by Subject|17
1061478|NCT01944839|2108795|FG000|Overall Study|Lost to Follow-up|1
1061479|NCT01944839|2108796|FG001|Overall Study|Lost to Follow-up|0
1061480|NCT01944839|2108795|FG000|Overall Study|Subject non-compliance|0
1061481|NCT01944839|2108796|FG001|Overall Study|Subject non-compliance|3
1061482|NCT01944969|2108822|FG000|Overall Study|Adverse Event|1
1061483|NCT01944969|2108822|FG000|Overall Study|Lack of Efficacy|1
1061484|NCT01944969|2108822|FG000|Overall Study|Non-compliance with IMP|1
1061485|NCT01944969|2108822|FG000|Overall Study|Administrative or other reasons|23
1061486|NCT01945034|2108835|FG000|Overall Study|Medication Error|0
1061487|NCT01945034|2108836|FG001|Overall Study|Medication Error|1
1061488|NCT01945034|2108837|FG002|Overall Study|Medication Error|0
1061489|NCT01945034|2108835|FG000|Overall Study|Withdrawal by Subject|0
1061490|NCT01945034|2108836|FG001|Overall Study|Withdrawal by Subject|3
1061491|NCT01945034|2108837|FG002|Overall Study|Withdrawal by Subject|1
1061492|NCT01945034|2108835|FG000|Overall Study|Other|0
1061493|NCT01945034|2108836|FG001|Overall Study|Other|1
1061494|NCT01945034|2108837|FG002|Overall Study|Other|3
1061495|NCT01945034|2108835|FG000|Overall Study|Lost to Follow-up|0
1061496|NCT01945034|2108836|FG001|Overall Study|Lost to Follow-up|0
1061497|NCT01945034|2108837|FG002|Overall Study|Lost to Follow-up|2
1061498|NCT01945034|2108835|FG000|Overall Study|Protocol Violation|1
1061499|NCT01945034|2108836|FG001|Overall Study|Protocol Violation|0
1061500|NCT01945034|2108837|FG002|Overall Study|Protocol Violation|1
1061501|NCT01945086|2108848|FG000|Overall Study|Withdrawal by Subject|1
1061502|NCT01945086|2108849|FG001|Overall Study|Withdrawal by Subject|0
1061503|NCT01945086|2108850|FG002|Overall Study|Withdrawal by Subject|1
1061504|NCT01945086|2108848|FG000|Overall Study|Adverse Event|0
1061505|NCT01945086|2108849|FG001|Overall Study|Adverse Event|0
1061506|NCT01945086|2108850|FG002|Overall Study|Adverse Event|1
1061507|NCT01945216|2108876|FG000|Overall Study|Case report forms (CRF) uncollected|52
1061508|NCT01945216|2108876|FG000|Overall Study|Protocol Violation|42
1061509|NCT01945216|2108876|FG000|Overall Study|CRF not assured by investigators|5
1061510|NCT01945242|2108886|FG000|Overall Study|Physician Decision|3
1061511|NCT01945242|2108887|FG001|Overall Study|Physician Decision|3
1061512|NCT01945281|2108896|FG000|Overall Study|Adverse Event|1
1061513|NCT01945281|2108897|FG001|Overall Study|Adverse Event|0
1061514|NCT01945281|2108896|FG000|Overall Study|Death|3
1061515|NCT01945281|2108897|FG001|Overall Study|Death|3
1061516|NCT01945281|2108896|FG000|Overall Study|Physician Decision|1
1061517|NCT01945281|2108897|FG001|Overall Study|Physician Decision|1
1061518|NCT01945281|2108896|FG000|Overall Study|Technical Problems|1
1061519|NCT01945281|2108897|FG001|Overall Study|Technical Problems|0
1061520|NCT01945489|2108920|FG000|Cycle 1|Adverse Event|2
1061521|NCT01945489|2108921|FG001|Cycle 1|Adverse Event|0
1061522|NCT01945489|2108920|FG000|Cycle 1|Lost to Follow-up|4
1061523|NCT01945489|2108921|FG001|Cycle 1|Lost to Follow-up|0
1061524|NCT01945489|2108920|FG000|Cycle 1|Personal Reasons|4
1061525|NCT01945489|2108921|FG001|Cycle 1|Personal Reasons|2
1061526|NCT01945489|2108920|FG000|Cycle 1|Protocol Violation|0
1061527|NCT01945489|2108921|FG001|Cycle 1|Protocol Violation|1
1061528|NCT01945489|2108920|FG000|Cycle 1|Other Miscellaneous Reasons|3
1061529|NCT01945489|2108921|FG001|Cycle 1|Other Miscellaneous Reasons|1
1061530|NCT01945489|2108920|FG000|Cycle 2|Adverse Event|1
1061531|NCT01945489|2108921|FG001|Cycle 2|Adverse Event|0
1061532|NCT01945489|2108920|FG000|Cycle 2|Lost to Follow-up|0
1061533|NCT01945489|2108921|FG001|Cycle 2|Lost to Follow-up|1
1061534|NCT01945580|2108930|FG000|Overall Study|Withdrawal by Subject|13
1061535|NCT01945580|2108931|FG001|Overall Study|Withdrawal by Subject|35
1061536|NCT01945580|2108930|FG000|Overall Study|Physician Decision|3
1061537|NCT01945580|2108931|FG001|Overall Study|Physician Decision|2
1061538|NCT01945580|2108930|FG000|Overall Study|Lost to Follow-up|26
1061539|NCT01945580|2108931|FG001|Overall Study|Lost to Follow-up|39
1061540|NCT01945580|2108930|FG000|Overall Study|Death|7
1061541|NCT01945580|2108931|FG001|Overall Study|Death|2
1061542|NCT01945580|2108930|FG000|Overall Study|Patient moved out of state|0
1061543|NCT01945580|2108931|FG001|Overall Study|Patient moved out of state|1
1061544|NCT01945580|2108930|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1
1061545|NCT01945580|2108931|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0
1061546|NCT01945580|2108930|FG000|Overall Study|Family illness - unable to return|0
1061547|NCT01945580|2108931|FG001|Overall Study|Family illness - unable to return|1
1061548|NCT01945580|2108930|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0
1061549|NCT01945580|2108931|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1
1061550|NCT01945580|2108930|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0
1061551|NCT01945580|2108931|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1
1061552|NCT01945580|2108930|FG000|Overall Study|Noncompliance with 36 month visit|1
1061553|NCT01945580|2108931|FG001|Overall Study|Noncompliance with 36 month visit|0
1061554|NCT01945580|2108930|FG000|Overall Study|The patient moved.|1
1061555|NCT01945580|2108931|FG001|Overall Study|The patient moved.|0
1061556|NCT01945580|2108930|FG000|Overall Study|No data available|0
1061557|NCT01945580|2108931|FG001|Overall Study|No data available|2
1061558|NCT01945593|2108945|FG000|Overall Study|Adverse Event|0
1061559|NCT01945593|2108946|FG001|Overall Study|Adverse Event|0
1061560|NCT01945593|2108947|FG002|Overall Study|Adverse Event|0
1061561|NCT01945593|2108948|FG003|Overall Study|Adverse Event|5
1061562|NCT01945593|2108945|FG000|Overall Study|Physician Decision|0
1061563|NCT01945593|2108946|FG001|Overall Study|Physician Decision|0
1061564|NCT01945593|2108947|FG002|Overall Study|Physician Decision|1
1061565|NCT01945593|2108948|FG003|Overall Study|Physician Decision|1
1061566|NCT01945593|2108945|FG000|Overall Study|Withdrawal by Subject|0
1061567|NCT01945593|2108946|FG001|Overall Study|Withdrawal by Subject|2
1061568|NCT01945593|2108947|FG002|Overall Study|Withdrawal by Subject|0
1061569|NCT01945593|2108948|FG003|Overall Study|Withdrawal by Subject|4
1061570|NCT01945593|2108945|FG000|Overall Study|Protocol Violation|0
1061571|NCT01945593|2108946|FG001|Overall Study|Protocol Violation|2
1061572|NCT01945593|2108947|FG002|Overall Study|Protocol Violation|1
1061573|NCT01945593|2108948|FG003|Overall Study|Protocol Violation|3
1061574|NCT01945593|2108945|FG000|Overall Study|Death|0
1061575|NCT01945593|2108946|FG001|Overall Study|Death|0
1061576|NCT01945593|2108947|FG002|Overall Study|Death|1
1061577|NCT01945593|2108948|FG003|Overall Study|Death|0
1061578|NCT01945593|2108945|FG000|Overall Study|Other: Terminated|0
1061579|NCT01945593|2108946|FG001|Overall Study|Other: Terminated|0
1061580|NCT01945593|2108947|FG002|Overall Study|Other: Terminated|0
1061581|NCT01945593|2108948|FG003|Overall Study|Other: Terminated|1
1061582|NCT01945593|2108945|FG000|Overall Study|Other: Surgical Procedure|0
1061583|NCT01945593|2108946|FG001|Overall Study|Other: Surgical Procedure|2
1061584|NCT01945593|2108947|FG002|Overall Study|Other: Surgical Procedure|0
1061585|NCT01945593|2108948|FG003|Overall Study|Other: Surgical Procedure|6
1061586|NCT01945593|2108945|FG000|Overall Study|Other: Screen Failure|0
1061587|NCT01945593|2108946|FG001|Overall Study|Other: Screen Failure|2
1061588|NCT01945593|2108947|FG002|Overall Study|Other: Screen Failure|0
1061589|NCT01945593|2108948|FG003|Overall Study|Other: Screen Failure|0
1061590|NCT01945710|2108970|FG000|Overall Study|Progressive Disease|5
1061591|NCT01945710|2108971|FG001|Overall Study|Progressive Disease|4
1061592|NCT01945710|2108972|FG002|Overall Study|Progressive Disease|3
1061593|NCT01945710|2108973|FG003|Overall Study|Progressive Disease|2
1061594|NCT01945710|2108974|FG004|Overall Study|Progressive Disease|7
1061595|NCT01945710|2108975|FG005|Overall Study|Progressive Disease|3
1061596|NCT01945710|2108976|FG006|Overall Study|Progressive Disease|19
1061597|NCT01945710|2108970|FG000|Overall Study|Adverse Event|0
1061598|NCT01945710|2108971|FG001|Overall Study|Adverse Event|1
1061599|NCT01945710|2108972|FG002|Overall Study|Adverse Event|0
1061600|NCT01945710|2108973|FG003|Overall Study|Adverse Event|0
1061601|NCT01945710|2108974|FG004|Overall Study|Adverse Event|0
1061602|NCT01945710|2108975|FG005|Overall Study|Adverse Event|0
1061603|NCT01945710|2108976|FG006|Overall Study|Adverse Event|0
1061604|NCT01945710|2108970|FG000|Overall Study|Other|2
1061605|NCT01945710|2108971|FG001|Overall Study|Other|0
1061606|NCT01945710|2108972|FG002|Overall Study|Other|3
1061607|NCT01945710|2108973|FG003|Overall Study|Other|1
1061608|NCT01945710|2108974|FG004|Overall Study|Other|1
1061609|NCT01945710|2108975|FG005|Overall Study|Other|0
1061610|NCT01945710|2108976|FG006|Overall Study|Other|4
1061611|NCT01945710|2108970|FG000|Overall Study|Withdrawal by Subject|0
1061612|NCT01945710|2108971|FG001|Overall Study|Withdrawal by Subject|1
1061613|NCT01945710|2108972|FG002|Overall Study|Withdrawal by Subject|1
1061614|NCT01945710|2108973|FG003|Overall Study|Withdrawal by Subject|0
1061615|NCT01945710|2108974|FG004|Overall Study|Withdrawal by Subject|1
1061616|NCT01945710|2108975|FG005|Overall Study|Withdrawal by Subject|0
1061617|NCT01945710|2108976|FG006|Overall Study|Withdrawal by Subject|0
1061626|NCT01945866|2109005|FG000|Overall Study|Eyes did not complete or were dropped|2
1061627|NCT01945866|2109006|FG001|Overall Study|Eyes did not complete or were dropped|0
1061628|NCT01945944|2109015|FG000|Overall Study|Adverse Event|0
1061629|NCT01945944|2109016|FG001|Overall Study|Adverse Event|2
1061630|NCT01945944|2109015|FG000|Overall Study|Physician Decision|1
1061631|NCT01945944|2109016|FG001|Overall Study|Physician Decision|0
1061632|NCT01945944|2109015|FG000|Overall Study|Withdrawal by Subject|0
1061633|NCT01945944|2109016|FG001|Overall Study|Withdrawal by Subject|1
1061634|NCT01945996|2109041|FG000|Overall Study|Lost to Follow-up|3
1061635|NCT01945996|2109042|FG001|Overall Study|Lost to Follow-up|5
1061636|NCT01946152|2109063|FG000|Overall Study|Adverse Event|1
1061637|NCT01946152|2109064|FG001|Overall Study|Adverse Event|0
1061638|NCT01946152|2109065|FG002|Overall Study|Adverse Event|0
1061639|NCT01946152|2109066|FG003|Overall Study|Adverse Event|0
1061640|NCT01946152|2109063|FG000|Overall Study|Withdrawal by Subject|0
1061641|NCT01946152|2109064|FG001|Overall Study|Withdrawal by Subject|2
1061642|NCT01946152|2109065|FG002|Overall Study|Withdrawal by Subject|0
1061643|NCT01946152|2109066|FG003|Overall Study|Withdrawal by Subject|0
1061644|NCT01946152|2109063|FG000|Overall Study|Progression|0
1061645|NCT01946152|2109064|FG001|Overall Study|Progression|1
1061646|NCT01946152|2109065|FG002|Overall Study|Progression|4
1061647|NCT01946152|2109066|FG003|Overall Study|Progression|7
1061648|NCT01946152|2109063|FG000|Overall Study|Physician Decision|0
1061649|NCT01946152|2109064|FG001|Overall Study|Physician Decision|0
1061650|NCT01946152|2109065|FG002|Overall Study|Physician Decision|1
1061651|NCT01946152|2109066|FG003|Overall Study|Physician Decision|0
1061652|NCT01946152|2109063|FG000|Overall Study|Second malignancy|0
1061653|NCT01946152|2109064|FG001|Overall Study|Second malignancy|0
1061654|NCT01946152|2109065|FG002|Overall Study|Second malignancy|1
1061655|NCT01946152|2109066|FG003|Overall Study|Second malignancy|0
1061656|NCT01946152|2109063|FG000|Overall Study|Adverse Event|0
1061657|NCT01946152|2109064|FG001|Overall Study|Adverse Event|0
1061658|NCT01946152|2109065|FG002|Overall Study|Adverse Event|0
1061659|NCT01946152|2109066|FG003|Overall Study|Adverse Event|1
1061660|NCT01946165|2109080|FG000|Overall Study|Physician Decision|2
1061661|NCT01946165|2109081|FG001|Overall Study|Physician Decision|0
1061662|NCT01946165|2109080|FG000|Overall Study|Withdrawal by Subject|0
1061663|NCT01946165|2109081|FG001|Overall Study|Withdrawal by Subject|2
1061664|NCT01946178|2109088|FG000|Overall Study|Pregnancy|1
1061665|NCT01946178|2109088|FG000|Overall Study|Lost to Follow-up|1
1061666|NCT01946191|2109098|FG000|Allocation|Did not complete orientation|1
1061667|NCT01946191|2109099|FG001|Allocation|Did not complete orientation|1
1061668|NCT01946191|2109098|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4
1061669|NCT01946191|2109099|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2
1061670|NCT01946191|2109098|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0
1061671|NCT01946191|2109099|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1
1061672|NCT01946191|2109098|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13
1061673|NCT01946191|2109099|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15
1061684|NCT01946282|2109124|FG000|Year 1|Did not return FIT kit|4186
1061685|NCT01946282|2109125|FG001|Year 1|Did not return FIT kit|608
1061686|NCT01946282|2109126|FG002|Year 1|Did not return FIT kit|654
1061687|NCT01946282|2109124|FG000|Year 2|Did not return FIT kit|803
1061688|NCT01946282|2109125|FG001|Year 2|Did not return FIT kit|131
1061689|NCT01946282|2109126|FG002|Year 2|Did not return FIT kit|115
1061690|NCT01946282|2109124|FG000|Year 3|Did not return FIT kit|288
1061691|NCT01946282|2109125|FG001|Year 3|Did not return FIT kit|43
1061692|NCT01946282|2109126|FG002|Year 3|Did not return FIT kit|30
1061693|NCT01946412|2109136|FG000|Overall Study|Adverse Event|1
1061694|NCT01946412|2109136|FG000|Overall Study|Non-Compliance|1
1061695|NCT01946412|2109136|FG000|Overall Study|Continued with commercial Kalydeco|2
1061696|NCT01946412|2109136|FG000|Overall Study|Difficulty in swallowing|1
1061697|NCT01946425|2109144|FG000|Overall Study|Protocol Violation|1
1061698|NCT01946425|2109145|FG001|Overall Study|Protocol Violation|0
1061699|NCT01946425|2109144|FG000|Overall Study|Withdrawal by Subject|1
1061700|NCT01946425|2109145|FG001|Overall Study|Withdrawal by Subject|0
1061701|NCT01946438|2109156|FG000|Overall Study|Adverse Event|0
1061702|NCT01946438|2109157|FG001|Overall Study|Adverse Event|0
1061703|NCT01946438|2109158|FG002|Overall Study|Adverse Event|0
1061704|NCT01946438|2109159|FG003|Overall Study|Adverse Event|1
1061705|NCT01946438|2109156|FG000|Overall Study|Serious Adverse event|1
1061706|NCT01946438|2109157|FG001|Overall Study|Serious Adverse event|0
1061707|NCT01946438|2109158|FG002|Overall Study|Serious Adverse event|0
1061708|NCT01946438|2109159|FG003|Overall Study|Serious Adverse event|0
1061709|NCT01946438|2109156|FG000|Overall Study|Protocol Violation|0
1061710|NCT01946438|2109157|FG001|Overall Study|Protocol Violation|0
1061711|NCT01946438|2109158|FG002|Overall Study|Protocol Violation|1
1061712|NCT01946438|2109159|FG003|Overall Study|Protocol Violation|0
1061713|NCT01946438|2109156|FG000|Overall Study|Withdrawal by Subject|1
1061714|NCT01946438|2109157|FG001|Overall Study|Withdrawal by Subject|0
1061715|NCT01946438|2109158|FG002|Overall Study|Withdrawal by Subject|0
1061716|NCT01946438|2109159|FG003|Overall Study|Withdrawal by Subject|0
1061717|NCT01946529|2109178|FG000|End of Window Therapy (2 Courses)|Physician Decision|0
1061718|NCT01946529|2109179|FG001|End of Window Therapy (2 Courses)|Physician Decision|1
1061719|NCT01946529|2109180|FG002|End of Window Therapy (2 Courses)|Physician Decision|0
1061720|NCT01946529|2109178|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1
1061721|NCT01946529|2109179|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16
1061722|NCT01946529|2109180|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6
1061723|NCT01946802|2109187|FG000|Overall Study|Death|1
1061724|NCT01946802|2109187|FG000|Overall Study|Withdrawal by Subject|2
1061725|NCT01946802|2109187|FG000|Overall Study|Combined septic shock|1
1061726|NCT01946802|2109187|FG000|Overall Study|Protocol Violation|1
1061727|NCT01946880|2109193|FG000|Overall Study|Lost to Follow-up|1
1061728|NCT01946880|2109194|FG001|Overall Study|Lost to Follow-up|0
1061729|NCT01946880|2109193|FG000|Overall Study|Physician Decision|1
1061730|NCT01946880|2109194|FG001|Overall Study|Physician Decision|1
1061731|NCT01946880|2109193|FG000|Overall Study|Withdrawal by Subject|3
1061732|NCT01946880|2109194|FG001|Overall Study|Withdrawal by Subject|2
1061733|NCT01946880|2109193|FG000|Overall Study|Met Primary Endpoint|1
1061734|NCT01946880|2109194|FG001|Overall Study|Met Primary Endpoint|0
1061735|NCT01946880|2109193|FG000|Overall Study|Personal and Family Issues|1
1061736|NCT01946880|2109194|FG001|Overall Study|Personal and Family Issues|0
1061737|NCT01947127|2109202|FG000|Overall Study|Protocol Violation|18
1061738|NCT01947127|2109203|FG001|Overall Study|Protocol Violation|38
1061739|NCT01947127|2109202|FG000|Overall Study|Withdrawal by Subject|1
1061740|NCT01947127|2109203|FG001|Overall Study|Withdrawal by Subject|1
1061741|NCT01947127|2109202|FG000|Overall Study|Data loss|4
1061742|NCT01947127|2109203|FG001|Overall Study|Data loss|4
1061743|NCT01947283|2109223|FG000|Overall Study|Death|1
1061744|NCT01947283|2109224|FG001|Overall Study|Death|1
1061745|NCT01947283|2109225|FG002|Overall Study|Death|1
1061746|NCT01947283|2109226|FG003|Overall Study|Death|0
1061747|NCT01947283|2109227|FG004|Overall Study|Death|0
1061748|NCT01947283|2109228|FG005|Overall Study|Death|0
1061749|NCT01947283|2109229|FG006|Overall Study|Death|0
1061750|NCT01947283|2109223|FG000|Overall Study|Lost to Follow-up|4
1061751|NCT01947283|2109224|FG001|Overall Study|Lost to Follow-up|6
1061752|NCT01947283|2109225|FG002|Overall Study|Lost to Follow-up|5
1061753|NCT01947283|2109226|FG003|Overall Study|Lost to Follow-up|5
1061754|NCT01947283|2109227|FG004|Overall Study|Lost to Follow-up|0
1061755|NCT01947283|2109228|FG005|Overall Study|Lost to Follow-up|2
1061756|NCT01947283|2109229|FG006|Overall Study|Lost to Follow-up|5
1061757|NCT01947283|2109223|FG000|Overall Study|Withdrawal by Subject|10
1061758|NCT01947283|2109224|FG001|Overall Study|Withdrawal by Subject|8
1061759|NCT01947283|2109225|FG002|Overall Study|Withdrawal by Subject|4
1061760|NCT01947283|2109226|FG003|Overall Study|Withdrawal by Subject|1
1061761|NCT01947283|2109227|FG004|Overall Study|Withdrawal by Subject|0
1061762|NCT01947283|2109228|FG005|Overall Study|Withdrawal by Subject|0
1061763|NCT01947283|2109229|FG006|Overall Study|Withdrawal by Subject|2
1061764|NCT01947283|2109223|FG000|Overall Study|No Clinical Recording|12
1061765|NCT01947283|2109224|FG001|Overall Study|No Clinical Recording|6
1061766|NCT01947283|2109225|FG002|Overall Study|No Clinical Recording|8
1061767|NCT01947283|2109226|FG003|Overall Study|No Clinical Recording|10
1061768|NCT01947283|2109227|FG004|Overall Study|No Clinical Recording|0
1061769|NCT01947283|2109228|FG005|Overall Study|No Clinical Recording|0
1061770|NCT01947283|2109229|FG006|Overall Study|No Clinical Recording|0
1061771|NCT01947283|2109223|FG000|Overall Study|Non-coding Clinical Recording language|0
1061772|NCT01947283|2109224|FG001|Overall Study|Non-coding Clinical Recording language|0
1061773|NCT01947283|2109225|FG002|Overall Study|Non-coding Clinical Recording language|0
1061774|NCT01947283|2109226|FG003|Overall Study|Non-coding Clinical Recording language|1
1061775|NCT01947283|2109227|FG004|Overall Study|Non-coding Clinical Recording language|0
1061776|NCT01947283|2109228|FG005|Overall Study|Non-coding Clinical Recording language|0
1061777|NCT01947283|2109229|FG006|Overall Study|Non-coding Clinical Recording language|0
1061778|NCT01947283|2109223|FG000|Overall Study|Missing Follow-up Assessment|2
1061779|NCT01947283|2109224|FG001|Overall Study|Missing Follow-up Assessment|2
1061780|NCT01947283|2109225|FG002|Overall Study|Missing Follow-up Assessment|3
1061781|NCT01947283|2109226|FG003|Overall Study|Missing Follow-up Assessment|0
1061782|NCT01947283|2109227|FG004|Overall Study|Missing Follow-up Assessment|0
1061783|NCT01947283|2109228|FG005|Overall Study|Missing Follow-up Assessment|2
1061784|NCT01947283|2109229|FG006|Overall Study|Missing Follow-up Assessment|0
1061785|NCT01947283|2109223|FG000|Overall Study|No patients were enrolled in study|0
1061786|NCT01947283|2109224|FG001|Overall Study|No patients were enrolled in study|0
1061787|NCT01947283|2109225|FG002|Overall Study|No patients were enrolled in study|0
1061788|NCT01947283|2109226|FG003|Overall Study|No patients were enrolled in study|0
1061789|NCT01947283|2109227|FG004|Overall Study|No patients were enrolled in study|0
1061790|NCT01947283|2109228|FG005|Overall Study|No patients were enrolled in study|3
1061791|NCT01947283|2109229|FG006|Overall Study|No patients were enrolled in study|1
1061792|NCT01947491|2109259|FG000|Overall Study|Lost to Follow-up|5
1061793|NCT01947491|2109260|FG001|Overall Study|Lost to Follow-up|3
1061794|NCT01947491|2109261|FG002|Overall Study|Lost to Follow-up|1
1061795|NCT01947491|2109262|FG003|Overall Study|Lost to Follow-up|2
1061796|NCT01947491|2109259|FG000|Overall Study|Lack of Efficacy|1
1061797|NCT01947491|2109260|FG001|Overall Study|Lack of Efficacy|0
1061798|NCT01947491|2109261|FG002|Overall Study|Lack of Efficacy|0
1061799|NCT01947491|2109262|FG003|Overall Study|Lack of Efficacy|1
1061800|NCT01947491|2109259|FG000|Overall Study|Protocol Violation|1
1061801|NCT01947491|2109260|FG001|Overall Study|Protocol Violation|0
1061802|NCT01947491|2109261|FG002|Overall Study|Protocol Violation|0
1061803|NCT01947491|2109262|FG003|Overall Study|Protocol Violation|0
1061804|NCT01947491|2109259|FG000|Overall Study|Withdrawal by Subject|1
1061805|NCT01947491|2109260|FG001|Overall Study|Withdrawal by Subject|1
1061806|NCT01947491|2109261|FG002|Overall Study|Withdrawal by Subject|1
1061807|NCT01947491|2109262|FG003|Overall Study|Withdrawal by Subject|0
1061808|NCT01947491|2109259|FG000|Overall Study|Worsening of condition|0
1061809|NCT01947491|2109260|FG001|Overall Study|Worsening of condition|1
1061810|NCT01947491|2109261|FG002|Overall Study|Worsening of condition|0
1061811|NCT01947491|2109262|FG003|Overall Study|Worsening of condition|0
1061812|NCT01947491|2109259|FG000|Overall Study|Adverse Event|0
1061813|NCT01947491|2109260|FG001|Overall Study|Adverse Event|1
1061814|NCT01947491|2109261|FG002|Overall Study|Adverse Event|0
1061815|NCT01947491|2109262|FG003|Overall Study|Adverse Event|2
1061816|NCT01947517|2109274|FG000|Overall Study|Withdrawal by Subject|1
1061817|NCT01947517|2109275|FG001|Overall Study|Withdrawal by Subject|1
1061818|NCT01947582|2109281|FG000|Overall Study|Withdrawal by Subject|1
1061819|NCT01947855|2109301|FG000|Overall Study|Withdrawal by Subject|1
1061820|NCT01947855|2109302|FG001|Overall Study|Withdrawal by Subject|0
1061821|NCT01947855|2109303|FG002|Overall Study|Withdrawal by Subject|0
1061822|NCT01947894|2109314|FG000|Overall Study|Other|3
1061823|NCT01947894|2109315|FG001|Overall Study|Other|4
1061824|NCT01947894|2109316|FG002|Overall Study|Other|3
1061825|NCT01947894|2109314|FG000|Overall Study|Withdrawal by Subject|12
1061826|NCT01947894|2109315|FG001|Overall Study|Withdrawal by Subject|4
1061827|NCT01947894|2109316|FG002|Overall Study|Withdrawal by Subject|1
1061828|NCT01947894|2109314|FG000|Overall Study|Death|12
1061829|NCT01947894|2109315|FG001|Overall Study|Death|1
1061830|NCT01947894|2109316|FG002|Overall Study|Death|0
1061831|NCT01947894|2109314|FG000|Overall Study|Physician Decision|2
1061832|NCT01947894|2109315|FG001|Overall Study|Physician Decision|0
1061833|NCT01947894|2109316|FG002|Overall Study|Physician Decision|0
1061834|NCT01947894|2109314|FG000|Overall Study|Adverse Event|5
1061835|NCT01947894|2109315|FG001|Overall Study|Adverse Event|1
1061836|NCT01947894|2109316|FG002|Overall Study|Adverse Event|0
1061837|NCT01947894|2109314|FG000|Overall Study|Switched to other growth hormone brand|53
1061838|NCT01947894|2109315|FG001|Overall Study|Switched to other growth hormone brand|8
1061839|NCT01947894|2109316|FG002|Overall Study|Switched to other growth hormone brand|23
1061840|NCT01948050|2109356|FG000|Overall Study|Withdrawal by Subject|0
1061841|NCT01948050|2109357|FG001|Overall Study|Withdrawal by Subject|1
1061842|NCT01948063|2109365|FG000|Overall Study|Boston MCI halted research protocol|0
1061843|NCT01948063|2109366|FG001|Overall Study|Boston MCI halted research protocol|1
1061844|NCT01948063|2109365|FG000|Overall Study|Discovered an enrollment in other study|0
1061845|NCT01948063|2109366|FG001|Overall Study|Discovered an enrollment in other study|1
1061846|NCT01948063|2109365|FG000|Overall Study|Blood samples were accidentally thawed|1
1061847|NCT01948063|2109366|FG001|Overall Study|Blood samples were accidentally thawed|0
1061848|NCT01948076|2109374|FG000|Overall Study|Withdrawal by Subject|0
1061849|NCT01948076|2109375|FG001|Overall Study|Withdrawal by Subject|1
1061850|NCT01948193|2109387|FG000|Overall Study|Serious event|2
1061851|NCT01948193|2109387|FG000|Overall Study|Lost to Follow-up|7
1061852|NCT01948258|2109392|FG000|Overall Study|Pregnancy|41
1061853|NCT01948258|2109392|FG000|Overall Study|Did not complete by cut-off date|35
1061854|NCT01948258|2109392|FG000|Overall Study|Lost to Follow-up|27
1061855|NCT01948258|2109392|FG000|Overall Study|Withdrawal by SPD|8
1061856|NCT01948258|2109392|FG000|Overall Study|Withdrawal by Subject|6
1061857|NCT01948258|2109392|FG000|Overall Study|Health Care Professional|43
1061858|NCT01948258|2109392|FG000|Overall Study|Removed from statistical analysis|2
1061859|NCT01948427|2109432|FG000|Overall Study|Serious Adverse Event|3
1061860|NCT01948427|2109433|FG001|Overall Study|Serious Adverse Event|0
1061861|NCT01948427|2109434|FG002|Overall Study|Serious Adverse Event|0
1061862|NCT01948427|2109435|FG003|Overall Study|Serious Adverse Event|0
1061863|NCT01948427|2109436|FG004|Overall Study|Serious Adverse Event|1
1061864|NCT01948427|2109432|FG000|Overall Study|Investigator Request|0
1061865|NCT01948427|2109433|FG001|Overall Study|Investigator Request|8
1061866|NCT01948427|2109434|FG002|Overall Study|Investigator Request|0
1061867|NCT01948427|2109435|FG003|Overall Study|Investigator Request|0
1061868|NCT01948427|2109436|FG004|Overall Study|Investigator Request|6
1061869|NCT01948427|2109432|FG000|Overall Study|Lost to Follow-up|1
1061870|NCT01948427|2109433|FG001|Overall Study|Lost to Follow-up|0
1061871|NCT01948427|2109434|FG002|Overall Study|Lost to Follow-up|0
1061872|NCT01948427|2109435|FG003|Overall Study|Lost to Follow-up|0
1061873|NCT01948427|2109436|FG004|Overall Study|Lost to Follow-up|4
1061874|NCT01948427|2109432|FG000|Overall Study|Withdrawal by Subject|2
1061875|NCT01948427|2109433|FG001|Overall Study|Withdrawal by Subject|0
1061876|NCT01948427|2109434|FG002|Overall Study|Withdrawal by Subject|0
1061877|NCT01948427|2109435|FG003|Overall Study|Withdrawal by Subject|0
1061878|NCT01948427|2109436|FG004|Overall Study|Withdrawal by Subject|1
1061879|NCT01948427|2109432|FG000|Overall Study|Other, Not Specified|1
1061880|NCT01948427|2109433|FG001|Overall Study|Other, Not Specified|9
1061881|NCT01948427|2109434|FG002|Overall Study|Other, Not Specified|0
1061882|NCT01948427|2109435|FG003|Overall Study|Other, Not Specified|0
1061883|NCT01948427|2109436|FG004|Overall Study|Other, Not Specified|2
1061884|NCT01948791|2109461|FG000|Overall Study|Adverse Event|12
1061885|NCT01948791|2109461|FG000|Overall Study|Lack of Efficacy|3
1061886|NCT01948791|2109461|FG000|Overall Study|Protocol Violation|2
1061887|NCT01948791|2109461|FG000|Overall Study|Withdrawal by Subject|5
1061888|NCT01948791|2109461|FG000|Overall Study|Lost to Follow-up|6
1061889|NCT01948791|2109461|FG000|Overall Study|Management issues|1
1061890|NCT01948791|2109461|FG000|Overall Study|Others|7
1061891|NCT01948791|2109461|FG000|Overall Study|Screening failure|35
1061892|NCT01948830|2109467|FG000|Overall Study|Physician Decision|1
1061893|NCT01948830|2109468|FG001|Overall Study|Physician Decision|3
1061894|NCT01948830|2109467|FG000|Overall Study|Protocol deviation|1
1061895|NCT01948830|2109468|FG001|Overall Study|Protocol deviation|2
1061896|NCT01948830|2109467|FG000|Overall Study|Lost to Follow-up|5
1061897|NCT01948830|2109468|FG001|Overall Study|Lost to Follow-up|4
1061898|NCT01948830|2109467|FG000|Overall Study|Withdrawal by Subject|14
1061899|NCT01948830|2109468|FG001|Overall Study|Withdrawal by Subject|17
1061900|NCT01948830|2109467|FG000|Overall Study|Adverse Event|9
1061901|NCT01948830|2109468|FG001|Overall Study|Adverse Event|2
1061902|NCT01948830|2109467|FG000|Overall Study|Death|3
1061903|NCT01948830|2109468|FG001|Overall Study|Death|4
1061904|NCT01948908|2109477|FG000|Overall Study|Protocol Violation|1
1061905|NCT01948908|2109478|FG001|Overall Study|Protocol Violation|0
1061906|NCT01948908|2109479|FG002|Overall Study|Protocol Violation|2
1061907|NCT01949051|2109517|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1
1061908|NCT01949051|2109518|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0
1061909|NCT01949051|2109519|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0
1061910|NCT01949051|2109520|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1
1061911|NCT01949051|2109521|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0
1061912|NCT01949051|2109522|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0
1061913|NCT01949051|2109517|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1
1061914|NCT01949051|2109518|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1061915|NCT01949051|2109519|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1061916|NCT01949051|2109520|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1061917|NCT01949051|2109521|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1061918|NCT01949051|2109522|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1061919|NCT01949051|2109517|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0
1061920|NCT01949051|2109518|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0
1061921|NCT01949051|2109519|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0
1061922|NCT01949051|2109520|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0
1061923|NCT01949051|2109521|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0
1061924|NCT01949051|2109522|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1
1061925|NCT01949051|2109517|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1061926|NCT01949051|2109518|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1
1061927|NCT01949051|2109519|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1061928|NCT01949051|2109520|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1061929|NCT01949051|2109521|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1061930|NCT01949051|2109522|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1061931|NCT01949051|2109517|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1061932|NCT01949051|2109518|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1061933|NCT01949051|2109519|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
1061934|NCT01949051|2109520|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1061935|NCT01949051|2109521|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1061936|NCT01949051|2109522|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1061937|NCT01949090|2109535|FG000|Overall Study|Serious Adverse Event|0
1061938|NCT01949090|2109536|FG001|Overall Study|Serious Adverse Event|1
1061939|NCT01949090|2109537|FG002|Overall Study|Serious Adverse Event|2
1061940|NCT01949090|2109538|FG003|Overall Study|Serious Adverse Event|0
1061941|NCT01949090|2109539|FG004|Overall Study|Serious Adverse Event|1
1061942|NCT01949090|2109535|FG000|Overall Study|Withdrawal by Subject|2
1061943|NCT01949090|2109536|FG001|Overall Study|Withdrawal by Subject|0
1061944|NCT01949090|2109537|FG002|Overall Study|Withdrawal by Subject|0
1061945|NCT01949090|2109538|FG003|Overall Study|Withdrawal by Subject|0
1061946|NCT01949090|2109539|FG004|Overall Study|Withdrawal by Subject|1
1061947|NCT01949090|2109535|FG000|Overall Study|Protocol non-compliance|0
1061948|NCT01949090|2109536|FG001|Overall Study|Protocol non-compliance|0
1061949|NCT01949090|2109537|FG002|Overall Study|Protocol non-compliance|0
1061950|NCT01949090|2109538|FG003|Overall Study|Protocol non-compliance|0
1061951|NCT01949090|2109539|FG004|Overall Study|Protocol non-compliance|1
1061952|NCT01949090|2109535|FG000|Overall Study|Lost to Follow-up|2
1061953|NCT01949090|2109536|FG001|Overall Study|Lost to Follow-up|1
1061954|NCT01949090|2109537|FG002|Overall Study|Lost to Follow-up|0
1061955|NCT01949090|2109538|FG003|Overall Study|Lost to Follow-up|1
1061956|NCT01949090|2109539|FG004|Overall Study|Lost to Follow-up|1
1061957|NCT01949116|2109554|FG000|Overall Study|Death|2
1061958|NCT01949116|2109555|FG001|Overall Study|Death|0
1061959|NCT01949116|2109554|FG000|Overall Study|Lost to Follow-up|1
1061960|NCT01949116|2109555|FG001|Overall Study|Lost to Follow-up|3
1061961|NCT01949116|2109554|FG000|Overall Study|Withdrawal by Subject|5
1061962|NCT01949116|2109555|FG001|Overall Study|Withdrawal by Subject|3
1061963|NCT01949142|2109567|FG000|Overall Study|Withdrawal of consent|1
1061964|NCT01949142|2109568|FG001|Overall Study|Withdrawal of consent|0
1061965|NCT01949142|2109567|FG000|Overall Study|Lost to Follow-up|1
1061966|NCT01949142|2109568|FG001|Overall Study|Lost to Follow-up|1
1061967|NCT01949142|2109567|FG000|Overall Study|Parent changed their mind|1
1061968|NCT01949142|2109568|FG001|Overall Study|Parent changed their mind|0
1061969|NCT01949155|2109577|FG000|Overall Study|Lost to Follow-up|1
1061970|NCT01949155|2109578|FG001|Overall Study|Lost to Follow-up|0
1061971|NCT01949155|2109577|FG000|Overall Study|Protocol Violation|1
1061972|NCT01949155|2109578|FG001|Overall Study|Protocol Violation|0
1061973|NCT01949480|2109600|FG000|Overall Study|Physician Decision|5
1061974|NCT01949480|2109601|FG001|Overall Study|Physician Decision|8
1061975|NCT01949532|2109609|FG000|Overall Study|On-study at the Data Cut-off Date|3
1061976|NCT01949532|2109610|FG001|Overall Study|On-study at the Data Cut-off Date|3
1061977|NCT01949662|2109635|FG000|Overall Study|Death|9
1061978|NCT01949662|2109636|FG001|Overall Study|Death|7
1061979|NCT01949662|2109635|FG000|Overall Study|Discharged before an agitation event|8
1061980|NCT01949662|2109636|FG001|Overall Study|Discharged before an agitation event|3
1061981|NCT01949662|2109635|FG000|Overall Study|Dropped out|1
1061982|NCT01949662|2109636|FG001|Overall Study|Dropped out|3
1061983|NCT01949662|2109635|FG000|Overall Study|Ineligible|0
1061984|NCT01949662|2109636|FG001|Overall Study|Ineligible|1
1061985|NCT01949870|2109650|FG000|Overall Study|Lack of Efficacy|2
1061986|NCT01949870|2109650|FG000|Overall Study|Adverse Event|1
1061987|NCT01949870|2109650|FG000|Overall Study|Study termination|1
1061988|NCT01949870|2109650|FG000|Overall Study|Eligibility requirements not fulfilled|2
1061989|NCT01950013|2109657|FG000|Overall Study|Withdrawal by Subject|0
1061990|NCT01950013|2109658|FG001|Overall Study|Withdrawal by Subject|2
1061991|NCT01950013|2109659|FG002|Overall Study|Withdrawal by Subject|0
1061992|NCT01950169|2109688|FG000|Overall Study|Withdrawal by Subject|2
1061993|NCT01950169|2109689|FG001|Overall Study|Withdrawal by Subject|8
1061994|NCT01950169|2109690|FG002|Overall Study|Withdrawal by Subject|1
1061995|NCT01950169|2109688|FG000|Overall Study|Death|1
1061996|NCT01950169|2109689|FG001|Overall Study|Death|0
1061997|NCT01950169|2109690|FG002|Overall Study|Death|0
1061998|NCT01950273|2109710|FG000|Overall Study|Protocol Violation|1
1061999|NCT01950273|2109711|FG001|Overall Study|Protocol Violation|0
1062000|NCT01950273|2109710|FG000|Overall Study|Withdrawal by Subject|2
1062001|NCT01950273|2109711|FG001|Overall Study|Withdrawal by Subject|0
1062002|NCT01950273|2109710|FG000|Overall Study|Other not defined above|1
1062003|NCT01950273|2109711|FG001|Overall Study|Other not defined above|0
1062004|NCT01950364|2109732|FG000|Overall Study|Adverse Event|3
1062005|NCT01950364|2109733|FG001|Overall Study|Adverse Event|0
1062006|NCT01950364|2109732|FG000|Overall Study|Stem Cell Transplant|2
1062007|NCT01950364|2109733|FG001|Overall Study|Stem Cell Transplant|6
1062008|NCT01950364|2109732|FG000|Overall Study|Disease Progression|5
1062009|NCT01950364|2109733|FG001|Overall Study|Disease Progression|2
1062010|NCT01950364|2109732|FG000|Overall Study|Withdrawal by Subject|0
1062011|NCT01950364|2109733|FG001|Overall Study|Withdrawal by Subject|1
1062012|NCT01950364|2109732|FG000|Overall Study|Protocol Violation|0
1062013|NCT01950364|2109733|FG001|Overall Study|Protocol Violation|1
1062014|NCT01950741|2109743|FG000|Overall Study|Lost to Follow-up|1
1062015|NCT01950741|2109743|FG000|Overall Study|Death|1
1062016|NCT01950741|2109743|FG000|Overall Study|Withdrawal by Subject|1
1062017|NCT01950819|2109754|FG000|Overall Study|Graft Loss|35
1062018|NCT01950819|2109755|FG001|Overall Study|Graft Loss|30
1062019|NCT01950819|2109754|FG000|Overall Study|Death|29
1062020|NCT01950819|2109755|FG001|Overall Study|Death|34
1062021|NCT01950819|2109754|FG000|Overall Study|Subject / Gardian decision|54
1062022|NCT01950819|2109755|FG001|Overall Study|Subject / Gardian decision|51
1062023|NCT01950819|2109754|FG000|Overall Study|technical problems|2
1062024|NCT01950819|2109755|FG001|Overall Study|technical problems|0
1062025|NCT01950819|2109754|FG000|Overall Study|Pregnancy|0
1062026|NCT01950819|2109755|FG001|Overall Study|Pregnancy|2
1062027|NCT01950819|2109754|FG000|Overall Study|Lost to Follow-up|9
1062028|NCT01950819|2109755|FG001|Overall Study|Lost to Follow-up|17
1062029|NCT01951092|2109767|FG000|Overall Study|Lost to Follow-up|10
1062030|NCT01951092|2109767|FG000|Overall Study|Incarceration|1
1062031|NCT01951092|2109767|FG000|Overall Study|Transfer of Care|1
1062032|NCT01951105|2109774|FG000|Overall Study|Adverse Event|0
1062033|NCT01951105|2109775|FG001|Overall Study|Adverse Event|5
1062034|NCT01951105|2109776|FG002|Overall Study|Adverse Event|0
1062035|NCT01951105|2109774|FG000|Overall Study|Lost to Follow-up|0
1062036|NCT01951105|2109775|FG001|Overall Study|Lost to Follow-up|1
1062037|NCT01951105|2109776|FG002|Overall Study|Lost to Follow-up|0
1062038|NCT01951105|2109774|FG000|Overall Study|Protocol Violation|1
1062039|NCT01951105|2109775|FG001|Overall Study|Protocol Violation|1
1062040|NCT01951105|2109776|FG002|Overall Study|Protocol Violation|1
1062041|NCT01951105|2109774|FG000|Overall Study|Withdrawal by Subject|0
1062042|NCT01951105|2109775|FG001|Overall Study|Withdrawal by Subject|3
1062043|NCT01951105|2109776|FG002|Overall Study|Withdrawal by Subject|1
1062044|NCT01951157|2109802|FG000|Overall Study|Progressive Disease|12
1062045|NCT01951157|2109803|FG001|Overall Study|Progressive Disease|13
1062046|NCT01951157|2109804|FG002|Overall Study|Progressive Disease|10
1062047|NCT01951157|2109802|FG000|Overall Study|Treatment-unrelated AE|1
1062048|NCT01951157|2109803|FG001|Overall Study|Treatment-unrelated AE|0
1062049|NCT01951157|2109804|FG002|Overall Study|Treatment-unrelated AE|3
1062050|NCT01951157|2109802|FG000|Overall Study|Study Termination|0
1062051|NCT01951157|2109803|FG001|Overall Study|Study Termination|0
1062052|NCT01951157|2109804|FG002|Overall Study|Study Termination|1
1062053|NCT01951157|2109802|FG000|Overall Study|Physician Decision|5
1062054|NCT01951157|2109803|FG001|Overall Study|Physician Decision|3
1062055|NCT01951157|2109804|FG002|Overall Study|Physician Decision|2
1062056|NCT01951157|2109802|FG000|Overall Study|Non-treatmentrelated death|2
1062057|NCT01951157|2109803|FG001|Overall Study|Non-treatmentrelated death|2
1062058|NCT01951157|2109804|FG002|Overall Study|Non-treatmentrelated death|2
1062059|NCT01951157|2109802|FG000|Overall Study|No treated|0
1062060|NCT01951157|2109803|FG001|Overall Study|No treated|1
1062061|NCT01951157|2109804|FG002|Overall Study|No treated|0
1062062|NCT01951157|2109802|FG000|Overall Study|Treatment-related AE|2
1062063|NCT01951157|2109803|FG001|Overall Study|Treatment-related AE|0
1062064|NCT01951157|2109804|FG002|Overall Study|Treatment-related AE|4
1062065|NCT01951157|2109802|FG000|Overall Study|Consent withdrawn by subject|0
1062066|NCT01951157|2109803|FG001|Overall Study|Consent withdrawn by subject|1
1062067|NCT01951157|2109804|FG002|Overall Study|Consent withdrawn by subject|3
1062068|NCT01951157|2109802|FG000|Overall Study|Treatment-related death|0
1062069|NCT01951157|2109803|FG001|Overall Study|Treatment-related death|2
1062070|NCT01951157|2109804|FG002|Overall Study|Treatment-related death|0
1062071|NCT01951170|2109813|FG000|Overall Study|Investigator decision|1
1062072|NCT01951261|2109819|FG000|Overall Study|Death|1
1062073|NCT01951261|2109820|FG001|Overall Study|Death|0
1062074|NCT01951261|2109819|FG000|Overall Study|Lost to Follow-up|4
1062075|NCT01951261|2109820|FG001|Overall Study|Lost to Follow-up|3
1062076|NCT01951261|2109819|FG000|Overall Study|Protocol Violation|4
1062077|NCT01951261|2109820|FG001|Overall Study|Protocol Violation|3
1062078|NCT01951417|2109860|FG000|Overall Study|Withdrawal by Subject|1
1062079|NCT01951417|2109860|FG000|Overall Study|Protocol Violation|2
1062080|NCT01951417|2109860|FG000|Overall Study|Lost to Follow-up|6
1062081|NCT01951573|2109868|FG000|Washout Period|Adverse Event|0
1062082|NCT01951573|2109869|FG001|Washout Period|Adverse Event|1
1062083|NCT01951586|2109877|FG000|Overall Study|Death|61
1062084|NCT01951586|2109878|FG001|Overall Study|Death|120
1062085|NCT01951586|2109877|FG000|Overall Study|Withdrawal by Subject|8
1062086|NCT01951586|2109878|FG001|Overall Study|Withdrawal by Subject|17
1062087|NCT01951586|2109877|FG000|Overall Study|Lost to Follow-up|0
1062088|NCT01951586|2109878|FG001|Overall Study|Lost to Follow-up|1
1062089|NCT01951586|2109877|FG000|Overall Study|Sponsor Decision|9
1062090|NCT01951586|2109878|FG001|Overall Study|Sponsor Decision|10
1062091|NCT01951625|2109890|FG000|Treatment Period|Protocol Violation|2
1062092|NCT01951625|2109891|FG001|Treatment Period|Protocol Violation|0
1062093|NCT01951625|2109892|FG002|Treatment Period|Protocol Violation|1
1062094|NCT01951625|2109893|FG003|Treatment Period|Protocol Violation|3
1062095|NCT01951625|2109894|FG004|Treatment Period|Protocol Violation|2
1062096|NCT01951625|2109890|FG000|Treatment Period|Physician Decision|0
1062097|NCT01951625|2109891|FG001|Treatment Period|Physician Decision|0
1062098|NCT01951625|2109892|FG002|Treatment Period|Physician Decision|0
1062099|NCT01951625|2109893|FG003|Treatment Period|Physician Decision|0
1062100|NCT01951625|2109894|FG004|Treatment Period|Physician Decision|1
1062101|NCT01951625|2109890|FG000|Treatment Period|Protocol driven decision point|0
1062102|NCT01951625|2109891|FG001|Treatment Period|Protocol driven decision point|5
1062103|NCT01951625|2109892|FG002|Treatment Period|Protocol driven decision point|0
1062104|NCT01951625|2109893|FG003|Treatment Period|Protocol driven decision point|2
1062105|NCT01951625|2109894|FG004|Treatment Period|Protocol driven decision point|1
1062106|NCT01951625|2109890|FG000|Treatment Period|Non compliance with study drug|1
1062107|NCT01951625|2109891|FG001|Treatment Period|Non compliance with study drug|2
1062108|NCT01951625|2109892|FG002|Treatment Period|Non compliance with study drug|2
1062109|NCT01951625|2109893|FG003|Treatment Period|Non compliance with study drug|0
1062110|NCT01951625|2109894|FG004|Treatment Period|Non compliance with study drug|0
1062111|NCT01951625|2109890|FG000|Treatment Period|Death|3
1062112|NCT01951625|2109891|FG001|Treatment Period|Death|2
1062113|NCT01951625|2109892|FG002|Treatment Period|Death|2
1062114|NCT01951625|2109893|FG003|Treatment Period|Death|1
1062115|NCT01951625|2109894|FG004|Treatment Period|Death|2
1062116|NCT01951625|2109890|FG000|Treatment Period|Adverse Event|7
1062117|NCT01951625|2109891|FG001|Treatment Period|Adverse Event|10
1062118|NCT01951625|2109892|FG002|Treatment Period|Adverse Event|9
1062119|NCT01951625|2109893|FG003|Treatment Period|Adverse Event|8
1062120|NCT01951625|2109894|FG004|Treatment Period|Adverse Event|8
1062121|NCT01951625|2109890|FG000|Treatment Period|Withdrawal by Subject|5
1062122|NCT01951625|2109891|FG001|Treatment Period|Withdrawal by Subject|2
1062123|NCT01951625|2109892|FG002|Treatment Period|Withdrawal by Subject|1
1062124|NCT01951625|2109893|FG003|Treatment Period|Withdrawal by Subject|7
1062125|NCT01951625|2109894|FG004|Treatment Period|Withdrawal by Subject|3
1062126|NCT01951625|2109890|FG000|Treatment Period|Lost to Follow-up|1
1062127|NCT01951625|2109891|FG001|Treatment Period|Lost to Follow-up|0
1062128|NCT01951625|2109892|FG002|Treatment Period|Lost to Follow-up|0
1062129|NCT01951625|2109893|FG003|Treatment Period|Lost to Follow-up|1
1062130|NCT01951625|2109894|FG004|Treatment Period|Lost to Follow-up|0
1062131|NCT01951625|2109890|FG000|Follow Up Period|Non-compliance with study drug|1
1062132|NCT01951625|2109891|FG001|Follow Up Period|Non-compliance with study drug|0
1062133|NCT01951625|2109892|FG002|Follow Up Period|Non-compliance with study drug|0
1062134|NCT01951625|2109893|FG003|Follow Up Period|Non-compliance with study drug|0
1062135|NCT01951625|2109894|FG004|Follow Up Period|Non-compliance with study drug|0
1062136|NCT01951625|2109890|FG000|Follow Up Period|Death|1
1062137|NCT01951625|2109891|FG001|Follow Up Period|Death|3
1062138|NCT01951625|2109892|FG002|Follow Up Period|Death|2
1062139|NCT01951625|2109893|FG003|Follow Up Period|Death|2
1062140|NCT01951625|2109894|FG004|Follow Up Period|Death|1
1062141|NCT01951625|2109890|FG000|Follow Up Period|Logistical difficulties|1
1062142|NCT01951625|2109891|FG001|Follow Up Period|Logistical difficulties|2
1062143|NCT01951625|2109892|FG002|Follow Up Period|Logistical difficulties|0
1062144|NCT01951625|2109893|FG003|Follow Up Period|Logistical difficulties|0
1062145|NCT01951625|2109894|FG004|Follow Up Period|Logistical difficulties|0
1062146|NCT01951625|2109890|FG000|Follow Up Period|Adverse Event|0
1062147|NCT01951625|2109891|FG001|Follow Up Period|Adverse Event|3
1062148|NCT01951625|2109892|FG002|Follow Up Period|Adverse Event|2
1062149|NCT01951625|2109893|FG003|Follow Up Period|Adverse Event|3
1062150|NCT01951625|2109894|FG004|Follow Up Period|Adverse Event|5
1062151|NCT01951625|2109890|FG000|Follow Up Period|Withdrawal by Subject|4
1062152|NCT01951625|2109891|FG001|Follow Up Period|Withdrawal by Subject|1
1062153|NCT01951625|2109892|FG002|Follow Up Period|Withdrawal by Subject|0
1062154|NCT01951625|2109893|FG003|Follow Up Period|Withdrawal by Subject|5
1062155|NCT01951625|2109894|FG004|Follow Up Period|Withdrawal by Subject|3
1062156|NCT01951625|2109890|FG000|Follow Up Period|Lost to Follow-up|1
1062157|NCT01951625|2109891|FG001|Follow Up Period|Lost to Follow-up|0
1062158|NCT01951625|2109892|FG002|Follow Up Period|Lost to Follow-up|0
1062159|NCT01951625|2109893|FG003|Follow Up Period|Lost to Follow-up|1
1062160|NCT01951625|2109894|FG004|Follow Up Period|Lost to Follow-up|1
1062161|NCT01951638|2109912|FG000|Treatment Period|Protocol Violation|0
1062162|NCT01951638|2109913|FG001|Treatment Period|Protocol Violation|0
1062163|NCT01951638|2109914|FG002|Treatment Period|Protocol Violation|0
1062164|NCT01951638|2109915|FG003|Treatment Period|Protocol Violation|2
1062165|NCT01951638|2109916|FG004|Treatment Period|Protocol Violation|0
1062166|NCT01951638|2109912|FG000|Treatment Period|Protocol-driven decision point|1
1062167|NCT01951638|2109913|FG001|Treatment Period|Protocol-driven decision point|3
1062168|NCT01951638|2109914|FG002|Treatment Period|Protocol-driven decision point|0
1062169|NCT01951638|2109915|FG003|Treatment Period|Protocol-driven decision point|0
1062170|NCT01951638|2109916|FG004|Treatment Period|Protocol-driven decision point|0
1062171|NCT01951638|2109912|FG000|Treatment Period|Logistical difficulties|0
1062172|NCT01951638|2109913|FG001|Treatment Period|Logistical difficulties|1
1062173|NCT01951638|2109914|FG002|Treatment Period|Logistical difficulties|1
1062174|NCT01951638|2109915|FG003|Treatment Period|Logistical difficulties|0
1062175|NCT01951638|2109916|FG004|Treatment Period|Logistical difficulties|0
1062176|NCT01951638|2109912|FG000|Treatment Period|Withdrawal by Subject|9
1062177|NCT01951638|2109913|FG001|Treatment Period|Withdrawal by Subject|6
1062178|NCT01951638|2109914|FG002|Treatment Period|Withdrawal by Subject|4
1062179|NCT01951638|2109915|FG003|Treatment Period|Withdrawal by Subject|5
1062180|NCT01951638|2109916|FG004|Treatment Period|Withdrawal by Subject|4
1062181|NCT01951638|2109912|FG000|Treatment Period|Death|0
1062182|NCT01951638|2109913|FG001|Treatment Period|Death|0
1062183|NCT01951638|2109914|FG002|Treatment Period|Death|0
1062184|NCT01951638|2109915|FG003|Treatment Period|Death|3
1062185|NCT01951638|2109916|FG004|Treatment Period|Death|1
1062186|NCT01951638|2109912|FG000|Treatment Period|Adverse Event|3
1062187|NCT01951638|2109913|FG001|Treatment Period|Adverse Event|4
1062188|NCT01951638|2109914|FG002|Treatment Period|Adverse Event|8
1062189|NCT01951638|2109915|FG003|Treatment Period|Adverse Event|6
1062190|NCT01951638|2109916|FG004|Treatment Period|Adverse Event|5
1062191|NCT01951638|2109912|FG000|Follow-up Period|Protocol Violation|0
1062192|NCT01951638|2109913|FG001|Follow-up Period|Protocol Violation|0
1062193|NCT01951638|2109914|FG002|Follow-up Period|Protocol Violation|0
1062194|NCT01951638|2109915|FG003|Follow-up Period|Protocol Violation|1
1062195|NCT01951638|2109916|FG004|Follow-up Period|Protocol Violation|0
1062196|NCT01951638|2109912|FG000|Follow-up Period|Logistical difficulties|0
1062197|NCT01951638|2109913|FG001|Follow-up Period|Logistical difficulties|2
1062198|NCT01951638|2109914|FG002|Follow-up Period|Logistical difficulties|0
1062199|NCT01951638|2109915|FG003|Follow-up Period|Logistical difficulties|0
1062200|NCT01951638|2109916|FG004|Follow-up Period|Logistical difficulties|1
1062201|NCT01951638|2109912|FG000|Follow-up Period|Withdrawal by Subject|1
1062202|NCT01951638|2109913|FG001|Follow-up Period|Withdrawal by Subject|5
1062203|NCT01951638|2109914|FG002|Follow-up Period|Withdrawal by Subject|2
1062204|NCT01951638|2109915|FG003|Follow-up Period|Withdrawal by Subject|1
1062205|NCT01951638|2109916|FG004|Follow-up Period|Withdrawal by Subject|2
1062206|NCT01951638|2109912|FG000|Follow-up Period|Lost to Follow-up|0
1062207|NCT01951638|2109913|FG001|Follow-up Period|Lost to Follow-up|1
1062208|NCT01951638|2109914|FG002|Follow-up Period|Lost to Follow-up|0
1062209|NCT01951638|2109915|FG003|Follow-up Period|Lost to Follow-up|1
1062210|NCT01951638|2109916|FG004|Follow-up Period|Lost to Follow-up|0
1062211|NCT01951638|2109912|FG000|Follow-up Period|Death|1
1062212|NCT01951638|2109913|FG001|Follow-up Period|Death|0
1062213|NCT01951638|2109914|FG002|Follow-up Period|Death|1
1062214|NCT01951638|2109915|FG003|Follow-up Period|Death|4
1062215|NCT01951638|2109916|FG004|Follow-up Period|Death|1
1062216|NCT01951638|2109912|FG000|Follow-up Period|Adverse Event|0
1062217|NCT01951638|2109913|FG001|Follow-up Period|Adverse Event|1
1062218|NCT01951638|2109914|FG002|Follow-up Period|Adverse Event|2
1062219|NCT01951638|2109915|FG003|Follow-up Period|Adverse Event|1
1062220|NCT01951638|2109916|FG004|Follow-up Period|Adverse Event|1
1062221|NCT01951703|2109939|FG000|First Intervention|Withdrawal by Subject|1
1062222|NCT01951703|2109940|FG001|First Intervention|Withdrawal by Subject|0
1062223|NCT01951703|2109939|FG000|First Intervention|Subject was not compliant|1
1062224|NCT01951703|2109940|FG001|First Intervention|Subject was not compliant|1
1062225|NCT01951703|2109939|FG000|First Intervention|Physician Decision|1
1062226|NCT01951703|2109940|FG001|First Intervention|Physician Decision|0
1062227|NCT01951703|2109939|FG000|Second Intervention|Protocol Violation|0
1062228|NCT01951703|2109940|FG001|Second Intervention|Protocol Violation|1
1062229|NCT01951703|2109939|FG000|Second Intervention|Unsatisfactory Lens fitting|0
1062230|NCT01951703|2109940|FG001|Second Intervention|Unsatisfactory Lens fitting|1
1062231|NCT01952015|2109987|FG000|Induction|Protocol Violation|1
1062232|NCT01952015|2109987|FG000|Maintenance|Adverse Event|2
1062233|NCT01952015|2109987|FG000|Treatment Period 3|Physician Decision|9
1062234|NCT01952041|2110005|FG000|Overall Study|Lost to Follow-up|9
1062235|NCT01952041|2110006|FG001|Overall Study|Lost to Follow-up|16
1062236|NCT01952041|2110005|FG000|Overall Study|Withdrawal by Subject|7
1062237|NCT01952041|2110006|FG001|Overall Study|Withdrawal by Subject|5
1062238|NCT01952041|2110005|FG000|Overall Study|Death|1
1062239|NCT01952041|2110006|FG001|Overall Study|Death|0
1062240|NCT01952054|2110012|FG000|Overall Study|Physician Decision|1
1062241|NCT01952080|2110020|FG000|Overall Study|Withdrawal by Subject|0
1062242|NCT01952080|2110021|FG001|Overall Study|Withdrawal by Subject|0
1062243|NCT01952080|2110022|FG002|Overall Study|Withdrawal by Subject|0
1062244|NCT01952080|2110023|FG003|Overall Study|Withdrawal by Subject|1
1062245|NCT01952080|2110020|FG000|Overall Study|Protocol Non-compliance|0
1062246|NCT01952080|2110021|FG001|Overall Study|Protocol Non-compliance|1
1062247|NCT01952080|2110022|FG002|Overall Study|Protocol Non-compliance|0
1062248|NCT01952080|2110023|FG003|Overall Study|Protocol Non-compliance|0
1062249|NCT01952145|2110035|FG000|Overall Study|Protocol Violation|2
1062250|NCT01952145|2110036|FG001|Overall Study|Protocol Violation|1
1062251|NCT01952145|2110035|FG000|Overall Study|Death|0
1062252|NCT01952145|2110036|FG001|Overall Study|Death|1
1062253|NCT01952145|2110035|FG000|Overall Study|Adverse Event|9
1062254|NCT01952145|2110036|FG001|Overall Study|Adverse Event|0
1062255|NCT01952145|2110035|FG000|Overall Study|Withdrawal Criteria|16
1062256|NCT01952145|2110036|FG001|Overall Study|Withdrawal Criteria|11
1062257|NCT01952145|2110035|FG000|Overall Study|Unclassified|1
1062258|NCT01952145|2110036|FG001|Overall Study|Unclassified|1
1062259|NCT01952366|2110048|FG000|Overall Study|Death|22
1062260|NCT01952366|2110048|FG000|Overall Study|Withdrawal by Subject|9
1062261|NCT01952574|2110091|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9
1062262|NCT01952574|2110092|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3
1062263|NCT01952574|2110093|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3
1062264|NCT01952574|2110094|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4
1062265|NCT01952574|2110095|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
1062266|NCT01952574|2110096|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0
1062267|NCT01952574|2110097|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0
1062268|NCT01952574|2110091|FG000|Double-blind Treatment Phase|Sponsor Decision|6
1062269|NCT01952574|2110092|FG001|Double-blind Treatment Phase|Sponsor Decision|0
1062270|NCT01952574|2110093|FG002|Double-blind Treatment Phase|Sponsor Decision|5
1062271|NCT01952574|2110094|FG003|Double-blind Treatment Phase|Sponsor Decision|2
1062272|NCT01952574|2110095|FG004|Double-blind Treatment Phase|Sponsor Decision|0
1062273|NCT01952574|2110096|FG005|Double-blind Treatment Phase|Sponsor Decision|0
1062274|NCT01952574|2110097|FG006|Double-blind Treatment Phase|Sponsor Decision|0
1062275|NCT01952574|2110091|FG000|Double-blind Treatment Phase|Lost to Follow-up|2
1062276|NCT01952574|2110092|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
1062277|NCT01952574|2110093|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
1062278|NCT01952574|2110094|FG003|Double-blind Treatment Phase|Lost to Follow-up|0
1062279|NCT01952574|2110095|FG004|Double-blind Treatment Phase|Lost to Follow-up|0
1062280|NCT01952574|2110096|FG005|Double-blind Treatment Phase|Lost to Follow-up|0
1062281|NCT01952574|2110097|FG006|Double-blind Treatment Phase|Lost to Follow-up|0
1062282|NCT01952574|2110091|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
1062283|NCT01952574|2110092|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
1062284|NCT01952574|2110093|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
1062285|NCT01952574|2110094|FG003|Open-label Treatment Phase|Withdrawal by Subject|0
1062286|NCT01952574|2110095|FG004|Open-label Treatment Phase|Withdrawal by Subject|121
1062287|NCT01952574|2110096|FG005|Open-label Treatment Phase|Withdrawal by Subject|0
1062288|NCT01952574|2110097|FG006|Open-label Treatment Phase|Withdrawal by Subject|0
1062289|NCT01952574|2110091|FG000|Open-label Treatment Phase|Decision by Sponsor|0
1062290|NCT01952574|2110092|FG001|Open-label Treatment Phase|Decision by Sponsor|0
1062291|NCT01952574|2110093|FG002|Open-label Treatment Phase|Decision by Sponsor|0
1062292|NCT01952574|2110094|FG003|Open-label Treatment Phase|Decision by Sponsor|0
1062293|NCT01952574|2110095|FG004|Open-label Treatment Phase|Decision by Sponsor|17
1062294|NCT01952574|2110096|FG005|Open-label Treatment Phase|Decision by Sponsor|0
1062295|NCT01952574|2110097|FG006|Open-label Treatment Phase|Decision by Sponsor|0
1062296|NCT01952574|2110091|FG000|Open-label Treatment Phase|Missing|0
1062297|NCT01952574|2110092|FG001|Open-label Treatment Phase|Missing|0
1062298|NCT01952574|2110093|FG002|Open-label Treatment Phase|Missing|0
1062299|NCT01952574|2110094|FG003|Open-label Treatment Phase|Missing|0
1062300|NCT01952574|2110095|FG004|Open-label Treatment Phase|Missing|4
1062301|NCT01952574|2110096|FG005|Open-label Treatment Phase|Missing|0
1062302|NCT01952574|2110097|FG006|Open-label Treatment Phase|Missing|0
1062303|NCT01952574|2110091|FG000|Open-label Treatment Phase|Lost to Follow-up|0
1062304|NCT01952574|2110092|FG001|Open-label Treatment Phase|Lost to Follow-up|0
1062305|NCT01952574|2110093|FG002|Open-label Treatment Phase|Lost to Follow-up|0
1062306|NCT01952574|2110094|FG003|Open-label Treatment Phase|Lost to Follow-up|0
1062307|NCT01952574|2110095|FG004|Open-label Treatment Phase|Lost to Follow-up|19
1062308|NCT01952574|2110096|FG005|Open-label Treatment Phase|Lost to Follow-up|0
1062309|NCT01952574|2110097|FG006|Open-label Treatment Phase|Lost to Follow-up|0
1062310|NCT01952574|2110091|FG000|Open-label Treatment Phase|Death|0
1062311|NCT01952574|2110092|FG001|Open-label Treatment Phase|Death|0
1062312|NCT01952574|2110093|FG002|Open-label Treatment Phase|Death|0
1062313|NCT01952574|2110094|FG003|Open-label Treatment Phase|Death|0
1062314|NCT01952574|2110095|FG004|Open-label Treatment Phase|Death|1
1062315|NCT01952574|2110096|FG005|Open-label Treatment Phase|Death|0
1062316|NCT01952574|2110097|FG006|Open-label Treatment Phase|Death|0
1062317|NCT01952574|2110091|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0
1062318|NCT01952574|2110092|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0
1062319|NCT01952574|2110093|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0
1062320|NCT01952574|2110094|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0
1062321|NCT01952574|2110095|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0
1062322|NCT01952574|2110096|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1
1062323|NCT01952574|2110097|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0
1062324|NCT01952574|2110091|FG000|Clinical Home Use Substudy|Decision by Sponsor|0
1062325|NCT01952574|2110092|FG001|Clinical Home Use Substudy|Decision by Sponsor|0
1062326|NCT01952574|2110093|FG002|Clinical Home Use Substudy|Decision by Sponsor|0
1062327|NCT01952574|2110094|FG003|Clinical Home Use Substudy|Decision by Sponsor|0
1062328|NCT01952574|2110095|FG004|Clinical Home Use Substudy|Decision by Sponsor|0
1062329|NCT01952574|2110096|FG005|Clinical Home Use Substudy|Decision by Sponsor|2
1062330|NCT01952574|2110097|FG006|Clinical Home Use Substudy|Decision by Sponsor|1
1062331|NCT01952665|2110137|FG000|Overall Study|Physician Decision|3
1062332|NCT01952665|2110138|FG001|Overall Study|Physician Decision|2
1062333|NCT01952665|2110137|FG000|Overall Study|Lost to Follow-up|1
1062334|NCT01952665|2110138|FG001|Overall Study|Lost to Follow-up|2
1062335|NCT01952665|2110137|FG000|Overall Study|Adverse Event|2
1062336|NCT01952665|2110138|FG001|Overall Study|Adverse Event|1
1062337|NCT01952665|2110137|FG000|Overall Study|Protocol Violation|0
1062338|NCT01952665|2110138|FG001|Overall Study|Protocol Violation|1
1062339|NCT01952691|2110166|FG000|Overall Study|Lost to Follow-up|2
1062340|NCT01952834|2110170|FG000|Overall Study|Adverse Event|1
1062341|NCT01953003|2110177|FG000|Overall Study|Not treated|0
1062342|NCT01953003|2110178|FG001|Overall Study|Not treated|1
1062343|NCT01953003|2110177|FG000|Overall Study|Progressive disease|35
1062344|NCT01953003|2110178|FG001|Overall Study|Progressive disease|45
1062345|NCT01953003|2110177|FG000|Overall Study|Related Adverse events|7
1062346|NCT01953003|2110178|FG001|Overall Study|Related Adverse events|2
1062347|NCT01953003|2110177|FG000|Overall Study|Non-related adverse events|0
1062348|NCT01953003|2110178|FG001|Overall Study|Non-related adverse events|2
1062349|NCT01953003|2110177|FG000|Overall Study|Protocol Violation|0
1062350|NCT01953003|2110178|FG001|Overall Study|Protocol Violation|1
1062351|NCT01953003|2110177|FG000|Overall Study|Withdrawal by Subject|14
1062352|NCT01953003|2110178|FG001|Overall Study|Withdrawal by Subject|4
1062353|NCT01953224|2110201|FG000|Overall Study|Lost to Follow-up|1
1062354|NCT01953224|2110202|FG001|Overall Study|Lost to Follow-up|1
1062355|NCT01953224|2110201|FG000|Overall Study|Withdrawal by Subject|1
1062356|NCT01953224|2110202|FG001|Overall Study|Withdrawal by Subject|2
1062357|NCT01953328|2110225|FG000|Overall Study|Withdrawal by Subject|0
1062358|NCT01953328|2110226|FG001|Overall Study|Withdrawal by Subject|0
1062359|NCT01953328|2110227|FG002|Overall Study|Withdrawal by Subject|0
1062360|NCT01953328|2110228|FG003|Overall Study|Withdrawal by Subject|0
1062361|NCT01953328|2110229|FG004|Overall Study|Withdrawal by Subject|1
1062362|NCT01953328|2110230|FG005|Overall Study|Withdrawal by Subject|0
1062363|NCT01953328|2110231|FG006|Overall Study|Withdrawal by Subject|0
1062364|NCT01953328|2110232|FG007|Overall Study|Withdrawal by Subject|0
1062365|NCT01953328|2110225|FG000|Overall Study|Lost to Follow-up|0
1062366|NCT01953328|2110226|FG001|Overall Study|Lost to Follow-up|0
1062367|NCT01953328|2110227|FG002|Overall Study|Lost to Follow-up|0
1062368|NCT01953328|2110228|FG003|Overall Study|Lost to Follow-up|0
1062369|NCT01953328|2110229|FG004|Overall Study|Lost to Follow-up|1
1062370|NCT01953328|2110230|FG005|Overall Study|Lost to Follow-up|0
1062371|NCT01953328|2110231|FG006|Overall Study|Lost to Follow-up|0
1062372|NCT01953328|2110232|FG007|Overall Study|Lost to Follow-up|0
1062373|NCT01953354|2110252|FG000|Overall Study|Withdrawal by Subject|0
1062374|NCT01953354|2110253|FG001|Overall Study|Withdrawal by Subject|1
1062375|NCT01953354|2110252|FG000|Overall Study|Decision of Sponsor|0
1062376|NCT01953354|2110253|FG001|Overall Study|Decision of Sponsor|1
1062377|NCT01953354|2110252|FG000|Overall Study|Disease Exacerbation|1
1062378|NCT01953354|2110253|FG001|Overall Study|Disease Exacerbation|0
1062379|NCT01953601|2110284|FG000|Part 1 (Base Study)|Adverse Event|24
1062380|NCT01953601|2110285|FG001|Part 1 (Base Study)|Adverse Event|37
1062381|NCT01953601|2110286|FG002|Part 1 (Base Study)|Adverse Event|15
1062382|NCT01953601|2110284|FG000|Part 1 (Base Study)|Death|2
1062383|NCT01953601|2110285|FG001|Part 1 (Base Study)|Death|0
1062384|NCT01953601|2110286|FG002|Part 1 (Base Study)|Death|3
1062385|NCT01953601|2110284|FG000|Part 1 (Base Study)|Lack of Efficacy|3
1062386|NCT01953601|2110285|FG001|Part 1 (Base Study)|Lack of Efficacy|1
1062387|NCT01953601|2110286|FG002|Part 1 (Base Study)|Lack of Efficacy|4
1062388|NCT01953601|2110284|FG000|Part 1 (Base Study)|Lost to Follow-up|1
1062389|NCT01953601|2110285|FG001|Part 1 (Base Study)|Lost to Follow-up|3
1062390|NCT01953601|2110286|FG002|Part 1 (Base Study)|Lost to Follow-up|6
1062391|NCT01953601|2110284|FG000|Part 1 (Base Study)|Non-compliance with study drug|0
1062392|NCT01953601|2110285|FG001|Part 1 (Base Study)|Non-compliance with study drug|3
1062393|NCT01953601|2110286|FG002|Part 1 (Base Study)|Non-compliance with study drug|1
1062394|NCT01953601|2110284|FG000|Part 1 (Base Study)|Physician Decision|3
1062395|NCT01953601|2110285|FG001|Part 1 (Base Study)|Physician Decision|7
1062396|NCT01953601|2110286|FG002|Part 1 (Base Study)|Physician Decision|4
1062397|NCT01953601|2110284|FG000|Part 1 (Base Study)|Screen failure|1
1062398|NCT01953601|2110285|FG001|Part 1 (Base Study)|Screen failure|0
1062399|NCT01953601|2110286|FG002|Part 1 (Base Study)|Screen failure|1
1062400|NCT01953601|2110284|FG000|Part 1 (Base Study)|Site discontinued study participation|2
1062401|NCT01953601|2110285|FG001|Part 1 (Base Study)|Site discontinued study participation|0
1062402|NCT01953601|2110286|FG002|Part 1 (Base Study)|Site discontinued study participation|0
1062403|NCT01953601|2110284|FG000|Part 1 (Base Study)|Study terminated by sponsor|174
1062404|NCT01953601|2110285|FG001|Part 1 (Base Study)|Study terminated by sponsor|169
1062405|NCT01953601|2110286|FG002|Part 1 (Base Study)|Study terminated by sponsor|179
1062406|NCT01953601|2110284|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
1062407|NCT01953601|2110285|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
1062408|NCT01953601|2110286|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
1062409|NCT01953601|2110284|FG000|Part 1 (Base Study)|Subject moved|2
1062410|NCT01953601|2110285|FG001|Part 1 (Base Study)|Subject moved|2
1062411|NCT01953601|2110286|FG002|Part 1 (Base Study)|Subject moved|1
1062412|NCT01953601|2110284|FG000|Part 1 (Base Study)|Withdrawal by Subject|32
1062413|NCT01953601|2110285|FG001|Part 1 (Base Study)|Withdrawal by Subject|23
1062414|NCT01953601|2110286|FG002|Part 1 (Base Study)|Withdrawal by Subject|22
1062415|NCT01953601|2110284|FG000|Part 2 (Extension Study)|Adverse Event|1
1062416|NCT01953601|2110285|FG001|Part 2 (Extension Study)|Adverse Event|1
1062417|NCT01953601|2110286|FG002|Part 2 (Extension Study)|Adverse Event|10
1062418|NCT01953601|2110284|FG000|Part 2 (Extension Study)|Death|0
1062419|NCT01953601|2110285|FG001|Part 2 (Extension Study)|Death|3
1062420|NCT01953601|2110286|FG002|Part 2 (Extension Study)|Death|0
1062421|NCT01953601|2110284|FG000|Part 2 (Extension Study)|Lack of Efficacy|2
1062422|NCT01953601|2110285|FG001|Part 2 (Extension Study)|Lack of Efficacy|0
1062423|NCT01953601|2110286|FG002|Part 2 (Extension Study)|Lack of Efficacy|0
1062424|NCT01953601|2110284|FG000|Part 2 (Extension Study)|Lost to Follow-up|2
1062425|NCT01953601|2110285|FG001|Part 2 (Extension Study)|Lost to Follow-up|1
1062426|NCT01953601|2110286|FG002|Part 2 (Extension Study)|Lost to Follow-up|1
1062427|NCT01953601|2110284|FG000|Part 2 (Extension Study)|Physician Decision|2
1062428|NCT01953601|2110285|FG001|Part 2 (Extension Study)|Physician Decision|0
1062429|NCT01953601|2110286|FG002|Part 2 (Extension Study)|Physician Decision|2
1062430|NCT01953601|2110284|FG000|Part 2 (Extension Study)|Site discontinued study participation|0
1062431|NCT01953601|2110285|FG001|Part 2 (Extension Study)|Site discontinued study participation|1
1062432|NCT01953601|2110286|FG002|Part 2 (Extension Study)|Site discontinued study participation|1
1062433|NCT01953601|2110284|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185
1062434|NCT01953601|2110285|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178
1062435|NCT01953601|2110286|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187
1062436|NCT01953601|2110284|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
1062437|NCT01953601|2110285|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
1062438|NCT01953601|2110286|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
1062439|NCT01953601|2110284|FG000|Part 2 (Extension Study)|Subject moved|0
1062440|NCT01953601|2110285|FG001|Part 2 (Extension Study)|Subject moved|0
1062441|NCT01953601|2110286|FG002|Part 2 (Extension Study)|Subject moved|1
1062442|NCT01953601|2110284|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5
1062443|NCT01953601|2110285|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4
1062444|NCT01953601|2110286|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2
1062445|NCT01953692|2110306|FG000|Overall Study|Adverse Event|5
1062446|NCT01953692|2110307|FG001|Overall Study|Adverse Event|2
1062447|NCT01953692|2110308|FG002|Overall Study|Adverse Event|4
1062448|NCT01953692|2110309|FG003|Overall Study|Adverse Event|2
1062449|NCT01953692|2110310|FG004|Overall Study|Adverse Event|1
1062450|NCT01953692|2110311|FG005|Overall Study|Adverse Event|2
1062451|NCT01953692|2110312|FG006|Overall Study|Adverse Event|0
1062452|NCT01953692|2110313|FG007|Overall Study|Adverse Event|0
1062453|NCT01953692|2110314|FG008|Overall Study|Adverse Event|0
1062454|NCT01953692|2110306|FG000|Overall Study|Clinical Progression|0
1062455|NCT01953692|2110307|FG001|Overall Study|Clinical Progression|15
1062456|NCT01953692|2110308|FG002|Overall Study|Clinical Progression|7
1062457|NCT01953692|2110309|FG003|Overall Study|Clinical Progression|5
1062458|NCT01953692|2110310|FG004|Overall Study|Clinical Progression|0
1062459|NCT01953692|2110311|FG005|Overall Study|Clinical Progression|7
1062460|NCT01953692|2110312|FG006|Overall Study|Clinical Progression|20
1062461|NCT01953692|2110313|FG007|Overall Study|Clinical Progression|3
1062462|NCT01953692|2110314|FG008|Overall Study|Clinical Progression|3
1062463|NCT01953692|2110306|FG000|Overall Study|Death|5
1062464|NCT01953692|2110307|FG001|Overall Study|Death|0
1062465|NCT01953692|2110308|FG002|Overall Study|Death|2
1062466|NCT01953692|2110309|FG003|Overall Study|Death|2
1062467|NCT01953692|2110310|FG004|Overall Study|Death|1
1062468|NCT01953692|2110311|FG005|Overall Study|Death|3
1062469|NCT01953692|2110312|FG006|Overall Study|Death|6
1062470|NCT01953692|2110313|FG007|Overall Study|Death|2
1062471|NCT01953692|2110314|FG008|Overall Study|Death|1
1062472|NCT01953692|2110306|FG000|Overall Study|Excluded Medication|1
1062473|NCT01953692|2110307|FG001|Overall Study|Excluded Medication|0
1062474|NCT01953692|2110308|FG002|Overall Study|Excluded Medication|0
1062475|NCT01953692|2110309|FG003|Overall Study|Excluded Medication|0
1062476|NCT01953692|2110310|FG004|Overall Study|Excluded Medication|0
1062477|NCT01953692|2110311|FG005|Overall Study|Excluded Medication|0
1062478|NCT01953692|2110312|FG006|Overall Study|Excluded Medication|0
1062479|NCT01953692|2110313|FG007|Overall Study|Excluded Medication|0
1062480|NCT01953692|2110314|FG008|Overall Study|Excluded Medication|0
1062481|NCT01953692|2110306|FG000|Overall Study|Lost to Follow-up|1
1062482|NCT01953692|2110307|FG001|Overall Study|Lost to Follow-up|0
1062483|NCT01953692|2110308|FG002|Overall Study|Lost to Follow-up|3
1062484|NCT01953692|2110309|FG003|Overall Study|Lost to Follow-up|1
1062485|NCT01953692|2110310|FG004|Overall Study|Lost to Follow-up|0
1062486|NCT01953692|2110311|FG005|Overall Study|Lost to Follow-up|1
1062487|NCT01953692|2110312|FG006|Overall Study|Lost to Follow-up|0
1062488|NCT01953692|2110313|FG007|Overall Study|Lost to Follow-up|0
1062489|NCT01953692|2110314|FG008|Overall Study|Lost to Follow-up|0
1062490|NCT01953692|2110306|FG000|Overall Study|Physician Decision|11
1062491|NCT01953692|2110307|FG001|Overall Study|Physician Decision|4
1062492|NCT01953692|2110308|FG002|Overall Study|Physician Decision|2
1062493|NCT01953692|2110309|FG003|Overall Study|Physician Decision|2
1062494|NCT01953692|2110310|FG004|Overall Study|Physician Decision|1
1062495|NCT01953692|2110311|FG005|Overall Study|Physician Decision|2
1062496|NCT01953692|2110312|FG006|Overall Study|Physician Decision|4
1062497|NCT01953692|2110313|FG007|Overall Study|Physician Decision|1
1062498|NCT01953692|2110314|FG008|Overall Study|Physician Decision|0
1062499|NCT01953692|2110306|FG000|Overall Study|Protocol Violation|0
1062500|NCT01953692|2110307|FG001|Overall Study|Protocol Violation|2
1062501|NCT01953692|2110308|FG002|Overall Study|Protocol Violation|1
1062502|NCT01953692|2110309|FG003|Overall Study|Protocol Violation|0
1062503|NCT01953692|2110310|FG004|Overall Study|Protocol Violation|0
1062504|NCT01953692|2110311|FG005|Overall Study|Protocol Violation|0
1062505|NCT01953692|2110312|FG006|Overall Study|Protocol Violation|0
1062506|NCT01953692|2110313|FG007|Overall Study|Protocol Violation|1
1062507|NCT01953692|2110314|FG008|Overall Study|Protocol Violation|0
1062508|NCT01953692|2110306|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
1062509|NCT01953692|2110307|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
1062510|NCT01953692|2110308|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
1062511|NCT01953692|2110309|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
1062512|NCT01953692|2110310|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
1062513|NCT01953692|2110311|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
1062514|NCT01953692|2110312|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
1062515|NCT01953692|2110313|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2
1062516|NCT01953692|2110314|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
1062517|NCT01953692|2110306|FG000|Overall Study|Withdrawal by Subject|4
1062518|NCT01953692|2110307|FG001|Overall Study|Withdrawal by Subject|2
1062519|NCT01953692|2110308|FG002|Overall Study|Withdrawal by Subject|1
1062520|NCT01953692|2110309|FG003|Overall Study|Withdrawal by Subject|2
1062521|NCT01953692|2110310|FG004|Overall Study|Withdrawal by Subject|0
1062522|NCT01953692|2110311|FG005|Overall Study|Withdrawal by Subject|3
1062523|NCT01953692|2110312|FG006|Overall Study|Withdrawal by Subject|2
1062524|NCT01953692|2110313|FG007|Overall Study|Withdrawal by Subject|1
1062525|NCT01953692|2110314|FG008|Overall Study|Withdrawal by Subject|1
1062526|NCT01953783|2110344|FG000|Overall Study|Progressive disease|2
1062527|NCT01953913|2110358|FG000|Overall Study|Disease Progression|349
1062528|NCT01953913|2110358|FG000|Overall Study|Worsening of underlying cancer|22
1062529|NCT01953913|2110358|FG000|Overall Study|Adverse Event|20
1062530|NCT01953913|2110358|FG000|Overall Study|Protocol Violation|6
1062531|NCT01953913|2110358|FG000|Overall Study|Lost to Follow-up|4
1062532|NCT01953913|2110358|FG000|Overall Study|Withdrawal by Subject|32
1062533|NCT01953913|2110358|FG000|Overall Study|Other than listed|108
1062534|NCT01953913|2110358|FG000|Overall Study|Not Treated|1
1062535|NCT01954017|2110365|FG000|Overall Study|Adverse Event|0
1062536|NCT01954017|2110366|FG001|Overall Study|Adverse Event|0
1062537|NCT01954017|2110367|FG002|Overall Study|Adverse Event|1
1062538|NCT01954017|2110365|FG000|Overall Study|Death|2
1062539|NCT01954017|2110366|FG001|Overall Study|Death|1
1062540|NCT01954017|2110367|FG002|Overall Study|Death|1
1062541|NCT01954017|2110365|FG000|Overall Study|Withdrawal by Subject|0
1062542|NCT01954017|2110366|FG001|Overall Study|Withdrawal by Subject|1
1062543|NCT01954017|2110367|FG002|Overall Study|Withdrawal by Subject|0
1062544|NCT01954017|2110365|FG000|Overall Study|Protocol Violation|0
1062545|NCT01954017|2110366|FG001|Overall Study|Protocol Violation|3
1062546|NCT01954017|2110367|FG002|Overall Study|Protocol Violation|2
1062547|NCT01954017|2110365|FG000|Overall Study|Necrotizing enterocolitis|1
1062548|NCT01954017|2110366|FG001|Overall Study|Necrotizing enterocolitis|0
1062549|NCT01954017|2110367|FG002|Overall Study|Necrotizing enterocolitis|1
1062550|NCT01954017|2110365|FG000|Overall Study|Enteral intake stopped >7 days|0
1062551|NCT01954017|2110366|FG001|Overall Study|Enteral intake stopped >7 days|1
1062552|NCT01954017|2110367|FG002|Overall Study|Enteral intake stopped >7 days|1
1062553|NCT01954017|2110365|FG000|Overall Study|All other reasons|2
1062554|NCT01954017|2110366|FG001|Overall Study|All other reasons|2
1062555|NCT01954017|2110367|FG002|Overall Study|All other reasons|7
1062556|NCT01954056|2110403|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
1062557|NCT01954056|2110404|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
1062558|NCT01954082|2110412|FG000|Overall Study|Study Suspension|42
1062559|NCT01954082|2110413|FG001|Overall Study|Study Suspension|36
1062560|NCT01954082|2110412|FG000|Overall Study|Adverse Event|10
1062561|NCT01954082|2110413|FG001|Overall Study|Adverse Event|4
1062562|NCT01954082|2110412|FG000|Overall Study|Intolerance|0
1062563|NCT01954082|2110413|FG001|Overall Study|Intolerance|1
1062564|NCT01954082|2110412|FG000|Overall Study|Non-compliance|6
1062565|NCT01954082|2110413|FG001|Overall Study|Non-compliance|4
1062566|NCT01954082|2110412|FG000|Overall Study|Physician Decision|2
1062567|NCT01954082|2110413|FG001|Overall Study|Physician Decision|0
1062568|NCT01954082|2110412|FG000|Overall Study|Parent Decision|1
1062569|NCT01954082|2110413|FG001|Overall Study|Parent Decision|0
1062570|NCT01954082|2110412|FG000|Overall Study|Withdrawal by Subject|0
1062571|NCT01954082|2110413|FG001|Overall Study|Withdrawal by Subject|1
1062572|NCT01954082|2110412|FG000|Overall Study|Discontinued Early Prior to Transfer|3
1062573|NCT01954082|2110413|FG001|Overall Study|Discontinued Early Prior to Transfer|2
1062574|NCT01954082|2110412|FG000|Overall Study|Redirection of Care|0
1062575|NCT01954082|2110413|FG001|Overall Study|Redirection of Care|2
1062576|NCT01954082|2110412|FG000|Overall Study|Miscalculation of Final Dose Day|0
1062577|NCT01954082|2110413|FG001|Overall Study|Miscalculation of Final Dose Day|3
1062578|NCT01954082|2110412|FG000|Overall Study|Comfort Care|0
1062579|NCT01954082|2110413|FG001|Overall Study|Comfort Care|1
1062580|NCT01954082|2110412|FG000|Overall Study|Infant Moved|0
1062581|NCT01954082|2110413|FG001|Overall Study|Infant Moved|1
1062582|NCT01954082|2110412|FG000|Overall Study|Randomized not Treated|4
1062583|NCT01954082|2110413|FG001|Overall Study|Randomized not Treated|2
1062584|NCT01954121|2110421|FG000|Overall Study|Lack of Efficacy|94
1062585|NCT01954121|2110422|FG001|Overall Study|Lack of Efficacy|41
1062586|NCT01954121|2110421|FG000|Overall Study|Protocol Violation|0
1062587|NCT01954121|2110422|FG001|Overall Study|Protocol Violation|2
1062588|NCT01954121|2110421|FG000|Overall Study|Lost to Follow-up|5
1062589|NCT01954121|2110422|FG001|Overall Study|Lost to Follow-up|6
1062590|NCT01954121|2110421|FG000|Overall Study|Withdrawal by Subject|18
1062591|NCT01954121|2110422|FG001|Overall Study|Withdrawal by Subject|12
1062592|NCT01954121|2110421|FG000|Overall Study|Pregnancy|1
1062593|NCT01954121|2110422|FG001|Overall Study|Pregnancy|1
1062594|NCT01954121|2110421|FG000|Overall Study|AE, serious fatal|1
1062595|NCT01954121|2110422|FG001|Overall Study|AE, serious fatal|0
1062596|NCT01954121|2110421|FG000|Overall Study|AE, non-serious non-fatal|5
1062597|NCT01954121|2110422|FG001|Overall Study|AE, non-serious non-fatal|22
1062598|NCT01954121|2110421|FG000|Overall Study|SAE, non-fatal|1
1062599|NCT01954121|2110422|FG001|Overall Study|SAE, non-fatal|4
1062600|NCT01954121|2110421|FG000|Overall Study|Non-compliant with study procedures|1
1062601|NCT01954121|2110422|FG001|Overall Study|Non-compliant with study procedures|0
1062602|NCT01954121|2110421|FG000|Overall Study|Non-compliant patient|1
1062603|NCT01954121|2110422|FG001|Overall Study|Non-compliant patient|1
1062604|NCT01954121|2110421|FG000|Overall Study|Subject did not follow instructions|0
1062605|NCT01954121|2110422|FG001|Overall Study|Subject did not follow instructions|2
1062606|NCT01954251|2110430|FG000|Overall Study|Adverse Event|5
1062607|NCT01954251|2110431|FG001|Overall Study|Adverse Event|7
1062608|NCT01954251|2110430|FG000|Overall Study|Lost to Follow-up|6
1062609|NCT01954251|2110431|FG001|Overall Study|Lost to Follow-up|6
1062610|NCT01954251|2110430|FG000|Overall Study|Withdrawal by Subject|2
1062611|NCT01954251|2110431|FG001|Overall Study|Withdrawal by Subject|6
1062612|NCT01954342|2110459|FG000|Overall Study|Missing data from 13-16week study visit|0
1062613|NCT01954342|2110460|FG001|Overall Study|Missing data from 13-16week study visit|0
1062614|NCT01954342|2110461|FG002|Overall Study|Missing data from 13-16week study visit|0
1062615|NCT01954342|2110462|FG003|Overall Study|Missing data from 13-16week study visit|1
1062616|NCT01954342|2110459|FG000|Overall Study|Miscarriage|0
1062617|NCT01954342|2110460|FG001|Overall Study|Miscarriage|0
1062618|NCT01954342|2110461|FG002|Overall Study|Miscarriage|0
1062619|NCT01954342|2110462|FG003|Overall Study|Miscarriage|3
1062620|NCT01954342|2110459|FG000|Overall Study|Lost to Follow-up|0
1062621|NCT01954342|2110460|FG001|Overall Study|Lost to Follow-up|0
1062622|NCT01954342|2110461|FG002|Overall Study|Lost to Follow-up|0
1062623|NCT01954342|2110462|FG003|Overall Study|Lost to Follow-up|5
1062624|NCT01954342|2110459|FG000|Overall Study|Preterm delivery|0
1062625|NCT01954342|2110460|FG001|Overall Study|Preterm delivery|0
1062626|NCT01954342|2110461|FG002|Overall Study|Preterm delivery|0
1062627|NCT01954342|2110462|FG003|Overall Study|Preterm delivery|3
1062628|NCT01954342|2110459|FG000|Overall Study|Pre-eclampsia|0
1062629|NCT01954342|2110460|FG001|Overall Study|Pre-eclampsia|0
1062630|NCT01954342|2110461|FG002|Overall Study|Pre-eclampsia|0
1062631|NCT01954342|2110462|FG003|Overall Study|Pre-eclampsia|4
1062632|NCT01954342|2110459|FG000|Overall Study|Unreliable Data|0
1062633|NCT01954342|2110460|FG001|Overall Study|Unreliable Data|0
1062634|NCT01954342|2110461|FG002|Overall Study|Unreliable Data|0
1062635|NCT01954342|2110462|FG003|Overall Study|Unreliable Data|2
1062636|NCT01954394|2110474|FG000|Overall Study|Enrolled but not treated|1
1062637|NCT01954394|2110475|FG001|Overall Study|Enrolled but not treated|0
1062638|NCT01954394|2110474|FG000|Overall Study|Adverse Event|10
1062639|NCT01954394|2110475|FG001|Overall Study|Adverse Event|23
1062640|NCT01954394|2110474|FG000|Overall Study|Poor compliance to protocol|7
1062641|NCT01954394|2110475|FG001|Overall Study|Poor compliance to protocol|7
1062642|NCT01954394|2110474|FG000|Overall Study|Participant Moved|0
1062643|NCT01954394|2110475|FG001|Overall Study|Participant Moved|4
1062644|NCT01954394|2110474|FG000|Overall Study|Related to Study Drug administration|2
1062645|NCT01954394|2110475|FG001|Overall Study|Related to Study Drug administration|2
1062646|NCT01954394|2110474|FG000|Overall Study|Other than specified above|10
1062647|NCT01954394|2110475|FG001|Overall Study|Other than specified above|21
1062648|NCT01954745|2110496|FG000|Overall Study|Radiological Progression|11
1062649|NCT01954745|2110496|FG000|Overall Study|Clinical Progression|5
1062650|NCT01954745|2110496|FG000|Overall Study|Adverse Event|2
1062651|NCT01954745|2110496|FG000|Overall Study|Death|1
1062652|NCT01954771|2110503|FG000|Overall Study|Missing HbA1c of end-point|1
1062653|NCT01954771|2110504|FG001|Overall Study|Missing HbA1c of end-point|1
1062654|NCT01954771|2110505|FG002|Overall Study|Missing HbA1c of end-point|0
1062655|NCT01954771|2110503|FG000|Overall Study|Missing CGMS of end-point|1
1062656|NCT01954771|2110504|FG001|Overall Study|Missing CGMS of end-point|1
1062657|NCT01954771|2110505|FG002|Overall Study|Missing CGMS of end-point|0
1062658|NCT01954771|2110503|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5
1062659|NCT01954771|2110504|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1
1062660|NCT01954771|2110505|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3
1062661|NCT01954927|2110518|FG000|Overall Study|Withdrawal by Subject|3
1062662|NCT01954927|2110519|FG001|Overall Study|Withdrawal by Subject|1
1062663|NCT01955005|2110527|FG000|Overall Study|Withdrawal by Subject|3
1062664|NCT01955005|2110528|FG001|Overall Study|Withdrawal by Subject|5
1062665|NCT01955044|2110537|FG000|Overall Study|Death|1
1062666|NCT01955044|2110538|FG001|Overall Study|Death|1
1062667|NCT01955044|2110539|FG002|Overall Study|Death|0
1062668|NCT01955083|2110549|FG000|Overall Study|Lost to Follow-up|1
1062669|NCT01955083|2110550|FG001|Overall Study|Lost to Follow-up|1
1062670|NCT01955122|2110582|FG000|Overall Study|Physician Decision|5
1062671|NCT01955122|2110583|FG001|Overall Study|Physician Decision|5
1062672|NCT01955161|2110598|FG000|Overall Study|Withdrawal before treatment|2
1062673|NCT01955161|2110599|FG001|Overall Study|Withdrawal before treatment|0
1062674|NCT01955161|2110600|FG002|Overall Study|Withdrawal before treatment|1
1062675|NCT01955161|2110598|FG000|Overall Study|Adverse Event|10
1062676|NCT01955161|2110599|FG001|Overall Study|Adverse Event|14
1062677|NCT01955161|2110600|FG002|Overall Study|Adverse Event|15
1062678|NCT01955161|2110598|FG000|Overall Study|Death|1
1062679|NCT01955161|2110599|FG001|Overall Study|Death|1
1062680|NCT01955161|2110600|FG002|Overall Study|Death|3
1062681|NCT01955161|2110598|FG000|Overall Study|Withdrawal by Subject|9
1062682|NCT01955161|2110599|FG001|Overall Study|Withdrawal by Subject|8
1062683|NCT01955161|2110600|FG002|Overall Study|Withdrawal by Subject|12
1062684|NCT01955161|2110598|FG000|Overall Study|Protocol Violation|2
1062685|NCT01955161|2110599|FG001|Overall Study|Protocol Violation|0
1062686|NCT01955161|2110600|FG002|Overall Study|Protocol Violation|0
1062687|NCT01955161|2110598|FG000|Overall Study|Other reason: physician decision|0
1062688|NCT01955161|2110599|FG001|Overall Study|Other reason: physician decision|1
1062689|NCT01955161|2110600|FG002|Overall Study|Other reason: physician decision|1
1062690|NCT01955161|2110598|FG000|Overall Study|Other reason: disallowed medication|1
1062691|NCT01955161|2110599|FG001|Overall Study|Other reason: disallowed medication|0
1062692|NCT01955161|2110600|FG002|Overall Study|Other reason: disallowed medication|1
1062693|NCT01955161|2110598|FG000|Overall Study|Other reason: caregiver unavailable|1
1062694|NCT01955161|2110599|FG001|Overall Study|Other reason: caregiver unavailable|0
1062695|NCT01955161|2110600|FG002|Overall Study|Other reason: caregiver unavailable|0
1062696|NCT01955161|2110598|FG000|Overall Study|Other reason: moved to nursing home|0
1062697|NCT01955161|2110599|FG001|Overall Study|Other reason: moved to nursing home|1
1062698|NCT01955161|2110600|FG002|Overall Study|Other reason: moved to nursing home|0
1062699|NCT01955161|2110598|FG000|Overall Study|Other reason: insufficient compliance|0
1062700|NCT01955161|2110599|FG001|Overall Study|Other reason: insufficient compliance|0
1062701|NCT01955161|2110600|FG002|Overall Study|Other reason: insufficient compliance|1
1062702|NCT01955161|2110598|FG000|Overall Study|Other reason: primary biliary cirrhosis|1
1062703|NCT01955161|2110599|FG001|Overall Study|Other reason: primary biliary cirrhosis|0
1062704|NCT01955161|2110600|FG002|Overall Study|Other reason: primary biliary cirrhosis|0
1062705|NCT01955161|2110598|FG000|Overall Study|Other reason: patient's will|0
1062706|NCT01955161|2110599|FG001|Overall Study|Other reason: patient's will|0
1062707|NCT01955161|2110600|FG002|Overall Study|Other reason: patient's will|1
1062708|NCT01955707|2110692|FG000|Overall Study|Adverse Event|1
1062709|NCT01955707|2110693|FG001|Overall Study|Adverse Event|2
1062710|NCT01955707|2110692|FG000|Overall Study|Lost to Follow-up|2
1062711|NCT01955707|2110693|FG001|Overall Study|Lost to Follow-up|1
1062712|NCT01955707|2110692|FG000|Overall Study|Withdrawal by Subject|0
1062713|NCT01955707|2110693|FG001|Overall Study|Withdrawal by Subject|3
1062714|NCT01955707|2110692|FG000|Overall Study|Death|13
1062715|NCT01955707|2110693|FG001|Overall Study|Death|14
1062716|NCT01955707|2110692|FG000|Overall Study|Other|4
1062717|NCT01955707|2110693|FG001|Overall Study|Other|2
1062718|NCT01955733|2110753|FG000|Period 1|Lost to Follow-up|1
1062719|NCT01955733|2110754|FG001|Period 1|Lost to Follow-up|0
1062720|NCT01955733|2110755|FG002|Period 1|Lost to Follow-up|0
1062721|NCT01955733|2110753|FG000|Period 2|Adverse Event|1
1062722|NCT01955733|2110754|FG001|Period 2|Adverse Event|0
1062723|NCT01955733|2110755|FG002|Period 2|Adverse Event|0
1062724|NCT01955733|2110753|FG000|Period 2|Physician Decision|0
1062725|NCT01955733|2110754|FG001|Period 2|Physician Decision|0
1062726|NCT01955733|2110755|FG002|Period 2|Physician Decision|1
1062727|NCT01955733|2110753|FG000|Period 2|Withdrawal by Subject|1
1062728|NCT01955733|2110754|FG001|Period 2|Withdrawal by Subject|3
1062729|NCT01955733|2110755|FG002|Period 2|Withdrawal by Subject|2
1062730|NCT01955733|2110753|FG000|Period 2|Study terminated by sponsor|8
1062731|NCT01955733|2110754|FG001|Period 2|Study terminated by sponsor|14
1062732|NCT01955733|2110755|FG002|Period 2|Study terminated by sponsor|16
1062733|NCT01955733|2110753|FG000|Period 2|Lost to Follow-up|2
1062734|NCT01955733|2110754|FG001|Period 2|Lost to Follow-up|0
1062735|NCT01955733|2110755|FG002|Period 2|Lost to Follow-up|0
1062736|NCT01955733|2110753|FG000|Period 2|Other not defined above|0
1062737|NCT01955733|2110754|FG001|Period 2|Other not defined above|2
1062738|NCT01955733|2110755|FG002|Period 2|Other not defined above|2
1062745|NCT01956123|2110809|FG000|COS Cycle 2|Protocol Violation|8
1062746|NCT01956123|2110810|FG001|COS Cycle 2|Protocol Violation|3
1062747|NCT01956123|2110811|FG002|COS Cycle 2|Protocol Violation|0
1062748|NCT01956123|2110812|FG003|COS Cycle 2|Protocol Violation|0
1062749|NCT01956123|2110809|FG000|COS Cycle 2|Adverse Event|3
1062750|NCT01956123|2110810|FG001|COS Cycle 2|Adverse Event|4
1062751|NCT01956123|2110811|FG002|COS Cycle 2|Adverse Event|0
1062752|NCT01956123|2110812|FG003|COS Cycle 2|Adverse Event|0
1062753|NCT01956123|2110809|FG000|COS Cycle 2|Personal Reasons|2
1062754|NCT01956123|2110810|FG001|COS Cycle 2|Personal Reasons|0
1062755|NCT01956123|2110811|FG002|COS Cycle 2|Personal Reasons|0
1062756|NCT01956123|2110812|FG003|COS Cycle 2|Personal Reasons|0
1062757|NCT01956123|2110809|FG000|COS Cycle 2|Withdrawal by Subject|1
1062758|NCT01956123|2110810|FG001|COS Cycle 2|Withdrawal by Subject|0
1062759|NCT01956123|2110811|FG002|COS Cycle 2|Withdrawal by Subject|0
1062760|NCT01956123|2110812|FG003|COS Cycle 2|Withdrawal by Subject|0
1062761|NCT01956123|2110809|FG000|COS Cycle 3|Protocol Violation|0
1062762|NCT01956123|2110810|FG001|COS Cycle 3|Protocol Violation|0
1062763|NCT01956123|2110811|FG002|COS Cycle 3|Protocol Violation|2
1062764|NCT01956123|2110812|FG003|COS Cycle 3|Protocol Violation|1
1062765|NCT01956123|2110809|FG000|COS Cycle 3|Adverse Event|0
1062766|NCT01956123|2110810|FG001|COS Cycle 3|Adverse Event|0
1062767|NCT01956123|2110811|FG002|COS Cycle 3|Adverse Event|3
1062768|NCT01956123|2110812|FG003|COS Cycle 3|Adverse Event|0
1062769|NCT01956123|2110809|FG000|COS Cycle 3|Personal Reasons|0
1062770|NCT01956123|2110810|FG001|COS Cycle 3|Personal Reasons|0
1062771|NCT01956123|2110811|FG002|COS Cycle 3|Personal Reasons|1
1062772|NCT01956123|2110812|FG003|COS Cycle 3|Personal Reasons|0
1062773|NCT01956123|2110809|FG000|COS Cycle 3|Withdrawal by Subject|0
1062774|NCT01956123|2110810|FG001|COS Cycle 3|Withdrawal by Subject|0
1062775|NCT01956123|2110811|FG002|COS Cycle 3|Withdrawal by Subject|0
1062776|NCT01956123|2110812|FG003|COS Cycle 3|Withdrawal by Subject|1
1062777|NCT01956240|2110825|FG000|Overall Study|Lost to Follow-up|6
1062778|NCT01956240|2110826|FG001|Overall Study|Lost to Follow-up|20
1062779|NCT01956240|2110825|FG000|Overall Study|Adverse Event|17
1062780|NCT01956240|2110826|FG001|Overall Study|Adverse Event|4
1062781|NCT01956773|2110889|FG000|Overall Study|Lost to Follow-up|628
1062782|NCT01956773|2110890|FG001|Overall Study|Lost to Follow-up|1
1062783|NCT01957111|2110903|FG000|Overall Study|Withdrawal by Subject|1
1062784|NCT01957111|2110904|FG001|Overall Study|Withdrawal by Subject|1
1062785|NCT01957137|2110910|FG000|Randomized Portion|Adverse Event|1
1062786|NCT01957137|2110910|FG000|Randomized Portion|Withdrawal by Subject|1
1062787|NCT01957150|2110924|FG000|Overall Study|Adverse Event|23
1062788|NCT01957150|2110925|FG001|Overall Study|Adverse Event|20
1062789|NCT01957150|2110924|FG000|Overall Study|Withdrawal by Subject|13
1062790|NCT01957150|2110925|FG001|Overall Study|Withdrawal by Subject|17
1062791|NCT01957150|2110924|FG000|Overall Study|Physician Decision|3
1062792|NCT01957150|2110925|FG001|Overall Study|Physician Decision|6
1062793|NCT01957150|2110924|FG000|Overall Study|Lost to Follow-up|4
1062794|NCT01957150|2110925|FG001|Overall Study|Lost to Follow-up|4
1062795|NCT01957150|2110924|FG000|Overall Study|Protocol Violation|1
1062796|NCT01957150|2110925|FG001|Overall Study|Protocol Violation|0
1062797|NCT01957150|2110924|FG000|Overall Study|Lack of Efficacy|11
1062798|NCT01957150|2110925|FG001|Overall Study|Lack of Efficacy|11
1062799|NCT01957163|2110934|FG000|Overall Study|Adverse Event|5
1062800|NCT01957163|2110935|FG001|Overall Study|Adverse Event|2
1062801|NCT01957163|2110936|FG002|Overall Study|Adverse Event|4
1062802|NCT01957163|2110934|FG000|Overall Study|Lack of Efficacy|5
1062803|NCT01957163|2110935|FG001|Overall Study|Lack of Efficacy|4
1062804|NCT01957163|2110936|FG002|Overall Study|Lack of Efficacy|9
1062805|NCT01957163|2110934|FG000|Overall Study|Protocol Violation|1
1062806|NCT01957163|2110935|FG001|Overall Study|Protocol Violation|2
1062807|NCT01957163|2110936|FG002|Overall Study|Protocol Violation|0
1062808|NCT01957163|2110934|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0
1062809|NCT01957163|2110935|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0
1062810|NCT01957163|2110936|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1
1062811|NCT01957163|2110934|FG000|Overall Study|Lost to Follow-up|0
1062812|NCT01957163|2110935|FG001|Overall Study|Lost to Follow-up|1
1062813|NCT01957163|2110936|FG002|Overall Study|Lost to Follow-up|0
1062814|NCT01957163|2110934|FG000|Overall Study|Withdrawal by Subject|4
1062815|NCT01957163|2110935|FG001|Overall Study|Withdrawal by Subject|2
1062816|NCT01957163|2110936|FG002|Overall Study|Withdrawal by Subject|4
1062817|NCT01957202|2110944|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062818|NCT01957202|2110945|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
1062819|NCT01957202|2110946|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062820|NCT01957202|2110947|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062821|NCT01957202|2110948|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062822|NCT01957202|2110949|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062823|NCT01957202|2110950|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062824|NCT01957202|2110951|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062825|NCT01957202|2110952|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062826|NCT01957202|2110953|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062827|NCT01957202|2110954|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062828|NCT01957202|2110955|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062829|NCT01957202|2110956|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062830|NCT01957202|2110957|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062831|NCT01957202|2110958|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062832|NCT01957202|2110959|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062833|NCT01957202|2110960|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
1062834|NCT01957202|2110961|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1062835|NCT01957202|2110944|FG000|Treatment Period 3 (8 Days)|Adverse Event|0
1062836|NCT01957202|2110945|FG001|Treatment Period 3 (8 Days)|Adverse Event|0
1062837|NCT01957202|2110946|FG002|Treatment Period 3 (8 Days)|Adverse Event|0
1062838|NCT01957202|2110947|FG003|Treatment Period 3 (8 Days)|Adverse Event|0
1062839|NCT01957202|2110948|FG004|Treatment Period 3 (8 Days)|Adverse Event|0
1062840|NCT01957202|2110949|FG005|Treatment Period 3 (8 Days)|Adverse Event|0
1062841|NCT01957202|2110950|FG006|Treatment Period 3 (8 Days)|Adverse Event|0
1062842|NCT01957202|2110951|FG007|Treatment Period 3 (8 Days)|Adverse Event|0
1062843|NCT01957202|2110952|FG008|Treatment Period 3 (8 Days)|Adverse Event|0
1062844|NCT01957202|2110953|FG009|Treatment Period 3 (8 Days)|Adverse Event|0
1062845|NCT01957202|2110954|FG010|Treatment Period 3 (8 Days)|Adverse Event|0
1062846|NCT01957202|2110955|FG011|Treatment Period 3 (8 Days)|Adverse Event|0
1062847|NCT01957202|2110956|FG012|Treatment Period 3 (8 Days)|Adverse Event|0
1062848|NCT01957202|2110957|FG013|Treatment Period 3 (8 Days)|Adverse Event|0
1062849|NCT01957202|2110958|FG014|Treatment Period 3 (8 Days)|Adverse Event|0
1062850|NCT01957202|2110959|FG015|Treatment Period 3 (8 Days)|Adverse Event|0
1062851|NCT01957202|2110960|FG016|Treatment Period 3 (8 Days)|Adverse Event|1
1062852|NCT01957202|2110961|FG017|Treatment Period 3 (8 Days)|Adverse Event|0
1062853|NCT01957215|2110973|FG000|Overall Study|Adverse Event|2
1062854|NCT01957215|2110974|FG001|Overall Study|Adverse Event|2
1062855|NCT01957215|2110973|FG000|Overall Study|Lost to Follow-up|3
1062856|NCT01957215|2110974|FG001|Overall Study|Lost to Follow-up|3
1062857|NCT01957215|2110973|FG000|Overall Study|Protocol Violation|1
1062858|NCT01957215|2110974|FG001|Overall Study|Protocol Violation|2
1062859|NCT01957215|2110973|FG000|Overall Study|Withdrawal by Subject|7
1062860|NCT01957215|2110974|FG001|Overall Study|Withdrawal by Subject|5
1062861|NCT01957397|2110997|FG000|Test Period 1|sudden leakage/small bag|1
1062862|NCT01957397|2110998|FG001|Test Period 1|sudden leakage/small bag|1
1062863|NCT01957397|2110997|FG000|Test Period 1|Withdrawal by Subject|1
1062864|NCT01957397|2110998|FG001|Test Period 1|Withdrawal by Subject|0
1062865|NCT01957397|2110997|FG000|Test Period 2|Adverse Event|0
1062866|NCT01957397|2110998|FG001|Test Period 2|Adverse Event|1
1062867|NCT01957397|2110997|FG000|Test Period 3|Adverse Event|1
1062868|NCT01957397|2110998|FG001|Test Period 3|Adverse Event|2
1062869|NCT01957397|2110997|FG000|Test Period 3|the adhesive did not work|1
1062870|NCT01957397|2110998|FG001|Test Period 3|the adhesive did not work|0
1062871|NCT01957462|2111012|FG000|Test Period 1|Withdrawal by Subject|1
1062872|NCT01957462|2111013|FG001|Test Period 1|Withdrawal by Subject|0
1062873|NCT01957462|2111012|FG000|Test Period 1|Adverse Event|1
1062874|NCT01957462|2111013|FG001|Test Period 1|Adverse Event|0
1062875|NCT01957475|2111019|FG000|Test Period 1|Withdrawal by Subject|1
1062876|NCT01957475|2111020|FG001|Test Period 1|Withdrawal by Subject|0
1062877|NCT01957475|2111019|FG000|Test Period 1|Other|1
1062878|NCT01957475|2111020|FG001|Test Period 1|Other|0
1062879|NCT01957475|2111019|FG000|Test Period 1|Lack of Efficacy|0
1062880|NCT01957475|2111020|FG001|Test Period 1|Lack of Efficacy|1
1062881|NCT01957475|2111019|FG000|Test Period 2|Adverse Event|1
1062882|NCT01957475|2111020|FG001|Test Period 2|Adverse Event|0
1062883|NCT01957488|2111026|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2
1062884|NCT01957488|2111027|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0
1062885|NCT01957488|2111028|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1
1062886|NCT01957488|2111029|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1
1062887|NCT01957488|2111030|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0
1062888|NCT01957488|2111031|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0
1062889|NCT01957488|2111026|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1
1062890|NCT01957488|2111027|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2
1062891|NCT01957488|2111028|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2
1062892|NCT01957488|2111029|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1
1062893|NCT01957488|2111030|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0
1062894|NCT01957488|2111031|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3
1062895|NCT01957488|2111026|FG000|Test Period 1 (2 Weeks)|Adverse Event|0
1062896|NCT01957488|2111027|FG001|Test Period 1 (2 Weeks)|Adverse Event|1
1062897|NCT01957488|2111028|FG002|Test Period 1 (2 Weeks)|Adverse Event|1
1062898|NCT01957488|2111029|FG003|Test Period 1 (2 Weeks)|Adverse Event|0
1062899|NCT01957488|2111030|FG004|Test Period 1 (2 Weeks)|Adverse Event|1
1062900|NCT01957488|2111031|FG005|Test Period 1 (2 Weeks)|Adverse Event|0
1062901|NCT01957488|2111026|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
1062902|NCT01957488|2111027|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
1062903|NCT01957488|2111028|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
1062904|NCT01957488|2111029|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
1062905|NCT01957488|2111030|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
1062906|NCT01957488|2111031|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2
1062907|NCT01957488|2111026|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
1162039|NCT03381196|2283976|FG000|Overall Study|Randomized, not treated|3
1062908|NCT01957488|2111027|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
1062909|NCT01957488|2111028|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
1062910|NCT01957488|2111029|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
1062911|NCT01957488|2111030|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1
1062912|NCT01957488|2111031|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
1062913|NCT01957488|2111026|FG000|Test Period 1 (2 Weeks)|screen failure|0
1062914|NCT01957488|2111027|FG001|Test Period 1 (2 Weeks)|screen failure|0
1062915|NCT01957488|2111028|FG002|Test Period 1 (2 Weeks)|screen failure|0
1062916|NCT01957488|2111029|FG003|Test Period 1 (2 Weeks)|screen failure|0
1062917|NCT01957488|2111030|FG004|Test Period 1 (2 Weeks)|screen failure|0
1062918|NCT01957488|2111031|FG005|Test Period 1 (2 Weeks)|screen failure|1
1062919|NCT01957488|2111026|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2
1062920|NCT01957488|2111027|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0
1062921|NCT01957488|2111028|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1
1062922|NCT01957488|2111029|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1
1062923|NCT01957488|2111030|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0
1062924|NCT01957488|2111031|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0
1062925|NCT01957488|2111026|FG000|Test Period 2 (2 Weeks)|Other|1
1062926|NCT01957488|2111027|FG001|Test Period 2 (2 Weeks)|Other|0
1062927|NCT01957488|2111028|FG002|Test Period 2 (2 Weeks)|Other|0
1062928|NCT01957488|2111029|FG003|Test Period 2 (2 Weeks)|Other|0
1062929|NCT01957488|2111030|FG004|Test Period 2 (2 Weeks)|Other|0
1062930|NCT01957488|2111031|FG005|Test Period 2 (2 Weeks)|Other|0
1062931|NCT01957488|2111026|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
1062932|NCT01957488|2111027|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1
1062933|NCT01957488|2111028|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
1062934|NCT01957488|2111029|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
1062935|NCT01957488|2111030|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
1062936|NCT01957488|2111031|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
1062937|NCT01957488|2111026|FG000|Test Period 2 (2 Weeks)|Adverse Event|0
1062938|NCT01957488|2111027|FG001|Test Period 2 (2 Weeks)|Adverse Event|0
1062939|NCT01957488|2111028|FG002|Test Period 2 (2 Weeks)|Adverse Event|0
1062940|NCT01957488|2111029|FG003|Test Period 2 (2 Weeks)|Adverse Event|0
1062941|NCT01957488|2111030|FG004|Test Period 2 (2 Weeks)|Adverse Event|2
1062942|NCT01957488|2111031|FG005|Test Period 2 (2 Weeks)|Adverse Event|0
1062943|NCT01957488|2111026|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
1062944|NCT01957488|2111027|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
1062945|NCT01957488|2111028|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
1062946|NCT01957488|2111029|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
1062947|NCT01957488|2111030|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
1062948|NCT01957488|2111031|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1
1062949|NCT01957488|2111026|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1
1062950|NCT01957488|2111027|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
1062951|NCT01957488|2111028|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
1062952|NCT01957488|2111029|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
1062953|NCT01957488|2111030|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
1062954|NCT01957488|2111031|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
1062955|NCT01957488|2111026|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0
1062956|NCT01957488|2111027|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1
1062957|NCT01957488|2111028|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0
1062958|NCT01957488|2111029|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0
1062959|NCT01957488|2111030|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0
1062960|NCT01957488|2111031|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0
1062961|NCT01957553|2111039|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
1062962|NCT01957553|2111040|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
1062963|NCT01957553|2111039|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2
1062964|NCT01957553|2111040|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0
1062965|NCT01957553|2111039|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
1062966|NCT01957553|2111040|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
1062967|NCT01957553|2111039|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1
1062968|NCT01957553|2111040|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0
1062969|NCT01957553|2111039|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1
1062970|NCT01957553|2111040|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3
1062971|NCT01957553|2111039|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
1062972|NCT01957553|2111040|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
1062973|NCT01957553|2111039|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
1062974|NCT01957553|2111040|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
1062975|NCT01957553|2111039|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
1062976|NCT01957553|2111040|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
1062977|NCT01957553|2111039|FG000|Test Period 2 (21 +- 1 Days)|Other|1
1062978|NCT01957553|2111040|FG001|Test Period 2 (21 +- 1 Days)|Other|0
1062979|NCT01957579|2111050|FG000|Overall Study|Withdrawal of concent|0
1062980|NCT01957579|2111051|FG001|Overall Study|Withdrawal of concent|1
1062981|NCT01957579|2111052|FG002|Overall Study|Withdrawal of concent|0
1062982|NCT01957579|2111053|FG003|Overall Study|Withdrawal of concent|0
1062983|NCT01957579|2111050|FG000|Overall Study|Death|0
1062984|NCT01957579|2111051|FG001|Overall Study|Death|0
1062985|NCT01957579|2111052|FG002|Overall Study|Death|2
1062986|NCT01957579|2111053|FG003|Overall Study|Death|0
1062987|NCT01957644|2111085|FG000|Overall Study|Adverse Event|4
1062988|NCT01957644|2111086|FG001|Overall Study|Adverse Event|2
1062989|NCT01957644|2111087|FG002|Overall Study|Adverse Event|0
1062990|NCT01957644|2111088|FG003|Overall Study|Adverse Event|0
1062991|NCT01957644|2111089|FG004|Overall Study|Adverse Event|1
1062992|NCT01957644|2111085|FG000|Overall Study|Progressive disease / relapse|0
1062993|NCT01957644|2111086|FG001|Overall Study|Progressive disease / relapse|1
1062994|NCT01957644|2111087|FG002|Overall Study|Progressive disease / relapse|0
1062995|NCT01957644|2111088|FG003|Overall Study|Progressive disease / relapse|1
1062996|NCT01957644|2111089|FG004|Overall Study|Progressive disease / relapse|0
1062997|NCT01957644|2111085|FG000|Overall Study|Other reason|1
1062998|NCT01957644|2111086|FG001|Overall Study|Other reason|2
1062999|NCT01957644|2111087|FG002|Overall Study|Other reason|1
1063000|NCT01957644|2111088|FG003|Overall Study|Other reason|1
1063001|NCT01957644|2111089|FG004|Overall Study|Other reason|0
1063002|NCT01957644|2111085|FG000|Overall Study|Withdrawal by Subject|1
1063003|NCT01957644|2111086|FG001|Overall Study|Withdrawal by Subject|0
1063004|NCT01957644|2111087|FG002|Overall Study|Withdrawal by Subject|0
1063005|NCT01957644|2111088|FG003|Overall Study|Withdrawal by Subject|0
1063006|NCT01957644|2111089|FG004|Overall Study|Withdrawal by Subject|0
1063007|NCT01957644|2111085|FG000|Overall Study|Protocol Violation|0
1063008|NCT01957644|2111086|FG001|Overall Study|Protocol Violation|1
1063009|NCT01957644|2111087|FG002|Overall Study|Protocol Violation|0
1063010|NCT01957644|2111088|FG003|Overall Study|Protocol Violation|0
1063011|NCT01957644|2111089|FG004|Overall Study|Protocol Violation|0
1063012|NCT01957709|2111107|FG000|Overall Study|Patient refused to complete post-tx bx|1
1063013|NCT01957787|2111115|FG000|Overall Study|Death|18
1063014|NCT01957787|2111115|FG000|Overall Study|Lost to Follow-up|3
1063015|NCT01957787|2111115|FG000|Overall Study|Withdrawal by Subject|3
1063016|NCT01957787|2111115|FG000|Overall Study|Entered Hospice or Similar Program|2
1063017|NCT01957787|2111115|FG000|Overall Study|Index Tumor(s) Resected|2
1063018|NCT01957787|2111115|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2
1063019|NCT01957787|2111115|FG000|Overall Study|Local therapy, not cryoablation|6
1063020|NCT01957865|2111122|FG000|Overall Study|Found HIV negative|0
1063021|NCT01957865|2111123|FG001|Overall Study|Found HIV negative|0
1063022|NCT01957865|2111124|FG002|Overall Study|Found HIV negative|1
1063023|NCT01957865|2111122|FG000|Overall Study|Lost to Follow-up|0
1063024|NCT01957865|2111123|FG001|Overall Study|Lost to Follow-up|2
1063025|NCT01957865|2111124|FG002|Overall Study|Lost to Follow-up|2
1063026|NCT01958008|2111149|FG000|Overall Study|Worsening of disease under study|0
1063027|NCT01958008|2111150|FG001|Overall Study|Worsening of disease under study|0
1063028|NCT01958008|2111151|FG002|Overall Study|Worsening of disease under study|1
1063029|NCT01958008|2111152|FG003|Overall Study|Worsening of disease under study|0
1063030|NCT01958008|2111149|FG000|Overall Study|Other adverse event|1
1063031|NCT01958008|2111150|FG001|Overall Study|Other adverse event|0
1063032|NCT01958008|2111151|FG002|Overall Study|Other adverse event|0
1063033|NCT01958008|2111152|FG003|Overall Study|Other adverse event|0
1063046|NCT01958060|2111180|FG000|Overall Study|Not treated|2
1063047|NCT01958060|2111181|FG001|Overall Study|Not treated|0
1063048|NCT01958060|2111182|FG002|Overall Study|Not treated|0
1063049|NCT01958060|2111183|FG003|Overall Study|Not treated|0
1063050|NCT01958060|2111184|FG004|Overall Study|Not treated|1
1063051|NCT01958060|2111185|FG005|Overall Study|Not treated|0
1063052|NCT01958125|2111232|FG000|Overall Study|Missing diary data|2
1063053|NCT01958125|2111233|FG001|Overall Study|Missing diary data|6
1063054|NCT01958125|2111232|FG000|Overall Study|No headache attacks|0
1063055|NCT01958125|2111233|FG001|Overall Study|No headache attacks|2
1063056|NCT01958164|2111241|FG000|Overall Study|Adverse Event|0
1063057|NCT01958164|2111242|FG001|Overall Study|Adverse Event|2
1063058|NCT01958164|2111241|FG000|Overall Study|Lost to Follow-up|2
1063059|NCT01958164|2111242|FG001|Overall Study|Lost to Follow-up|3
1063060|NCT01958281|2111251|FG000|Overall Study|Lack of Efficacy|5
1063061|NCT01958281|2111252|FG001|Overall Study|Lack of Efficacy|2
1063062|NCT01958281|2111253|FG002|Overall Study|Lack of Efficacy|0
1063063|NCT01958281|2111251|FG000|Overall Study|Adverse Event|0
1063064|NCT01958281|2111252|FG001|Overall Study|Adverse Event|2
1063065|NCT01958281|2111253|FG002|Overall Study|Adverse Event|0
1063066|NCT01958281|2111251|FG000|Overall Study|Withdrew Consent|1
1063067|NCT01958281|2111252|FG001|Overall Study|Withdrew Consent|0
1063068|NCT01958281|2111253|FG002|Overall Study|Withdrew Consent|0
1063069|NCT01958294|2111262|FG000|Overall Study|Clinical Circumstances|2
1063070|NCT01958437|2111288|FG000|Overall Study|Incidental MRI findings|0
1063071|NCT01958437|2111289|FG001|Overall Study|Incidental MRI findings|0
1063072|NCT01958437|2111290|FG002|Overall Study|Incidental MRI findings|1
1063073|NCT01958437|2111291|FG003|Overall Study|Incidental MRI findings|1
1063074|NCT01958476|2111310|FG000|Overall Study|Parent requested exclusion from analysis|1
1063075|NCT01958476|2111311|FG001|Overall Study|Parent requested exclusion from analysis|0
1063076|NCT01958489|2111317|FG000|Period 2|Adverse Event|0
1063077|NCT01958489|2111318|FG001|Period 2|Adverse Event|1
1063078|NCT01958619|2111351|FG000|Overall Study|Protocol Violation|2
1063079|NCT01958619|2111352|FG001|Overall Study|Protocol Violation|0
1063080|NCT01958619|2111353|FG002|Overall Study|Protocol Violation|1
1063081|NCT01958619|2111354|FG003|Overall Study|Protocol Violation|0
1063082|NCT01958671|2111382|FG000|Overall Study|Adverse Event|1
1063083|NCT01958671|2111383|FG001|Overall Study|Adverse Event|1
1063084|NCT01958671|2111384|FG002|Overall Study|Adverse Event|5
1063085|NCT01958671|2111382|FG000|Overall Study|Death|1
1063086|NCT01958671|2111383|FG001|Overall Study|Death|0
1063087|NCT01958671|2111384|FG002|Overall Study|Death|0
1063088|NCT01958671|2111382|FG000|Overall Study|Excluded medication|0
1063089|NCT01958671|2111383|FG001|Overall Study|Excluded medication|0
1063090|NCT01958671|2111384|FG002|Overall Study|Excluded medication|1
1063091|NCT01958671|2111382|FG000|Overall Study|Hyperglycemia|0
1063092|NCT01958671|2111383|FG001|Overall Study|Hyperglycemia|0
1063093|NCT01958671|2111384|FG002|Overall Study|Hyperglycemia|2
1063094|NCT01958671|2111382|FG000|Overall Study|Lost to Follow-up|7
1063095|NCT01958671|2111383|FG001|Overall Study|Lost to Follow-up|11
1063096|NCT01958671|2111384|FG002|Overall Study|Lost to Follow-up|7
1063097|NCT01958671|2111382|FG000|Overall Study|Non-compliance with study drug|1
1063098|NCT01958671|2111383|FG001|Overall Study|Non-compliance with study drug|1
1063099|NCT01958671|2111384|FG002|Overall Study|Non-compliance with study drug|1
1063100|NCT01958671|2111382|FG000|Overall Study|Pregnancy|0
1063101|NCT01958671|2111383|FG001|Overall Study|Pregnancy|0
1063102|NCT01958671|2111384|FG002|Overall Study|Pregnancy|1
1063103|NCT01958671|2111382|FG000|Overall Study|Protocol Violation|0
1063104|NCT01958671|2111383|FG001|Overall Study|Protocol Violation|1
1063105|NCT01958671|2111384|FG002|Overall Study|Protocol Violation|0
1063106|NCT01958671|2111382|FG000|Overall Study|Study site terminated by sponsor|1
1063107|NCT01958671|2111383|FG001|Overall Study|Study site terminated by sponsor|0
1063108|NCT01958671|2111384|FG002|Overall Study|Study site terminated by sponsor|1
1063109|NCT01958671|2111382|FG000|Overall Study|Participant moved|0
1063110|NCT01958671|2111383|FG001|Overall Study|Participant moved|0
1063111|NCT01958671|2111384|FG002|Overall Study|Participant moved|1
1063112|NCT01958671|2111382|FG000|Overall Study|Withdrawal by Subject|8
1063113|NCT01958671|2111383|FG001|Overall Study|Withdrawal by Subject|10
1063114|NCT01958671|2111384|FG002|Overall Study|Withdrawal by Subject|13
1063115|NCT01958827|2111400|FG000|Overall Study|Adverse Event|3
1063116|NCT01958827|2111400|FG000|Overall Study|Lack of Efficacy|6
1063117|NCT01958827|2111400|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1
1063118|NCT01958918|2111406|FG000|Overall Study|Death|1
1063119|NCT01958918|2111407|FG001|Overall Study|Death|3
1063120|NCT01958918|2111406|FG000|Overall Study|Lost to Follow-up|4
1063121|NCT01958918|2111407|FG001|Overall Study|Lost to Follow-up|7
1063122|NCT01958918|2111406|FG000|Overall Study|Withdrawal by Subject|13
1063123|NCT01958918|2111407|FG001|Overall Study|Withdrawal by Subject|8
1063124|NCT01958918|2111406|FG000|Overall Study|Lack of Efficacy|13
1063125|NCT01958918|2111407|FG001|Overall Study|Lack of Efficacy|10
1063126|NCT01958918|2111406|FG000|Overall Study|Adverse Event|12
1063127|NCT01958918|2111407|FG001|Overall Study|Adverse Event|12
1063128|NCT01958918|2111406|FG000|Overall Study|administrative problems|0
1063129|NCT01958918|2111407|FG001|Overall Study|administrative problems|2
1063130|NCT01959035|2111413|FG000|Overall Study|Adverse Event|5
1063131|NCT01959035|2111413|FG000|Overall Study|Withdrawal by Subject|4
1063132|NCT01959035|2111413|FG000|Overall Study|Lost to Follow-up|1
1063133|NCT01959035|2111413|FG000|Overall Study|Other (no primary reason given)|1
1063134|NCT01959165|2111431|FG000|Overall Study|Adverse Event|0
1063135|NCT01959165|2111432|FG001|Overall Study|Adverse Event|0
1063136|NCT01959165|2111433|FG002|Overall Study|Adverse Event|0
1063137|NCT01959165|2111434|FG003|Overall Study|Adverse Event|1
1063138|NCT01959165|2111431|FG000|Overall Study|Lack of Efficacy|1
1063139|NCT01959165|2111432|FG001|Overall Study|Lack of Efficacy|0
1063140|NCT01959165|2111433|FG002|Overall Study|Lack of Efficacy|0
1063141|NCT01959165|2111434|FG003|Overall Study|Lack of Efficacy|0
1063142|NCT01959165|2111431|FG000|Overall Study|overdose|0
1063143|NCT01959165|2111432|FG001|Overall Study|overdose|0
1063144|NCT01959165|2111433|FG002|Overall Study|overdose|0
1063145|NCT01959165|2111434|FG003|Overall Study|overdose|1
1063146|NCT01959165|2111431|FG000|Overall Study|Welfare recipient|0
1063147|NCT01959165|2111432|FG001|Overall Study|Welfare recipient|1
1063148|NCT01959165|2111433|FG002|Overall Study|Welfare recipient|0
1063149|NCT01959165|2111434|FG003|Overall Study|Welfare recipient|0
1063150|NCT01959230|2111453|FG000|Overall Study|Failure to follow study procedures|0
1063151|NCT01959230|2111454|FG001|Overall Study|Failure to follow study procedures|1
1063152|NCT01959230|2111453|FG000|Overall Study|Administrative reasons|2
1063153|NCT01959230|2111454|FG001|Overall Study|Administrative reasons|0
1063154|NCT01959230|2111453|FG000|Overall Study|Withdrawal by Subject|2
1063155|NCT01959230|2111454|FG001|Overall Study|Withdrawal by Subject|0
1063156|NCT01959243|2111462|FG000|Overall Study|Investigator Decision|3
1063157|NCT01959243|2111463|FG001|Overall Study|Investigator Decision|0
1063158|NCT01959243|2111462|FG000|Overall Study|Adverse Event|5
1063159|NCT01959243|2111463|FG001|Overall Study|Adverse Event|2
1063160|NCT01959243|2111462|FG000|Overall Study|Administrative reasons|2
1063161|NCT01959243|2111463|FG001|Overall Study|Administrative reasons|1
1063162|NCT01959243|2111462|FG000|Overall Study|Lost to Follow-up|3
1063163|NCT01959243|2111463|FG001|Overall Study|Lost to Follow-up|1
1063164|NCT01959334|2111471|FG000|Second Dose|Adverse Event|1
1063165|NCT01959334|2111472|FG001|Second Dose|Adverse Event|0
1063166|NCT01959334|2111471|FG000|Third Dose|Adverse Event|0
1063167|NCT01959334|2111472|FG001|Third Dose|Adverse Event|1
1063168|NCT01959347|2111480|FG000|Overall Study|Protocol Violation|9
1063169|NCT01959347|2111481|FG001|Overall Study|Protocol Violation|7
1063170|NCT01959412|2111487|FG000|Overall Study|Protocol deviation|1
1063171|NCT01959412|2111488|FG001|Overall Study|Protocol deviation|1
1063172|NCT01959412|2111489|FG002|Overall Study|Protocol deviation|0
1063173|NCT01959412|2111490|FG003|Overall Study|Protocol deviation|1
1063174|NCT01959412|2111491|FG004|Overall Study|Protocol deviation|3
1063175|NCT01959412|2111492|FG005|Overall Study|Protocol deviation|0
1063176|NCT01959412|2111487|FG000|Overall Study|Adverse Event|0
1063177|NCT01959412|2111488|FG001|Overall Study|Adverse Event|0
1063178|NCT01959412|2111489|FG002|Overall Study|Adverse Event|0
1063179|NCT01959412|2111490|FG003|Overall Study|Adverse Event|1
1063180|NCT01959412|2111491|FG004|Overall Study|Adverse Event|0
1063181|NCT01959412|2111492|FG005|Overall Study|Adverse Event|0
1063182|NCT01959425|2111508|FG000|Overall Study|Withdrawal by Subject|5
1063183|NCT01959425|2111509|FG001|Overall Study|Withdrawal by Subject|4
1063184|NCT01959425|2111508|FG000|Overall Study|Lost to Follow-up|1
1063185|NCT01959425|2111509|FG001|Overall Study|Lost to Follow-up|0
1063186|NCT01959425|2111508|FG000|Overall Study|Discontinued Subjects|6
1063187|NCT01959425|2111509|FG001|Overall Study|Discontinued Subjects|4
1063188|NCT01959503|2111539|FG000|Overall Study|Death|2
1063189|NCT01959503|2111540|FG001|Overall Study|Death|1
1063190|NCT01959503|2111539|FG000|Overall Study|Randomized but not treated|1
1063191|NCT01959503|2111540|FG001|Overall Study|Randomized but not treated|1
1063192|NCT01959516|2111546|FG000|Epoch 1|Adverse Event|4
1063193|NCT01959516|2111547|FG001|Epoch 1|Adverse Event|1
1063194|NCT01959516|2111546|FG000|Epoch 1|unsatisfactory therapeutic effect|1
1063195|NCT01959516|2111547|FG001|Epoch 1|unsatisfactory therapeutic effect|0
1063196|NCT01959516|2111546|FG000|Epoch 1|Subject withdrew consent|3
1063197|NCT01959516|2111547|FG001|Epoch 1|Subject withdrew consent|2
1063198|NCT01959516|2111546|FG000|Epoch 1|Administrative problems|1
1063199|NCT01959516|2111547|FG001|Epoch 1|Administrative problems|0
1063200|NCT01959516|2111546|FG000|Epoch 1|Use of prohibited treatment|1
1063201|NCT01959516|2111547|FG001|Epoch 1|Use of prohibited treatment|0
1063202|NCT01959516|2111546|FG000|Epoch 1|Moderate or severe COPD exacerbation|0
1063203|NCT01959516|2111547|FG001|Epoch 1|Moderate or severe COPD exacerbation|1
1063204|NCT01959516|2111546|FG000|Epoch 1|Protocol deviation|0
1063205|NCT01959516|2111547|FG001|Epoch 1|Protocol deviation|1
1063206|NCT01959516|2111546|FG000|Epoch 2|unsatisfactory therapeutic effect|1
1063207|NCT01959516|2111547|FG001|Epoch 2|unsatisfactory therapeutic effect|0
1063208|NCT01959516|2111546|FG000|Epoch 2|Subject withdrew consent|1
1063209|NCT01959516|2111547|FG001|Epoch 2|Subject withdrew consent|0
1063210|NCT01959516|2111546|FG000|Epoch 2|Moderate or severe COPD exacerbation|0
1063211|NCT01959516|2111547|FG001|Epoch 2|Moderate or severe COPD exacerbation|1
1063212|NCT01959529|2111555|FG000|Overall Study|Adverse event (not hypoglycaemia)|0
1063213|NCT01959529|2111556|FG001|Overall Study|Adverse event (not hypoglycaemia)|1
1063214|NCT01959529|2111555|FG000|Overall Study|Lost to Follow-up|4
1063215|NCT01959529|2111556|FG001|Overall Study|Lost to Follow-up|1
1063216|NCT01959529|2111555|FG000|Overall Study|Other|70
1063217|NCT01959529|2111556|FG001|Overall Study|Other|68
1063218|NCT01959529|2111555|FG000|Overall Study|Hypoglycaemia|1
1063219|NCT01959529|2111556|FG001|Overall Study|Hypoglycaemia|1
1063220|NCT01959529|2111555|FG000|Overall Study|Lack of glycaemic control|1
1063221|NCT01959529|2111556|FG001|Overall Study|Lack of glycaemic control|1
1063222|NCT01959581|2111567|FG000|Overall Study|Lost to Follow-up|5
1063223|NCT01959607|2111573|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
1063224|NCT01959607|2111574|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
1063225|NCT01959607|2111575|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
1063226|NCT01959607|2111576|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
1063227|NCT01959672|2111585|FG000|Overall Study|Death|1
1063228|NCT01959698|2111603|FG000|Overall Study|Adverse Event|0
1063229|NCT01959698|2111604|FG001|Overall Study|Adverse Event|0
1063230|NCT01959698|2111605|FG002|Overall Study|Adverse Event|0
1063231|NCT01959698|2111606|FG003|Overall Study|Adverse Event|0
1063232|NCT01959698|2111607|FG004|Overall Study|Adverse Event|0
1063233|NCT01959698|2111608|FG005|Overall Study|Adverse Event|0
1063234|NCT01959698|2111609|FG006|Overall Study|Adverse Event|1
1063235|NCT01959698|2111603|FG000|Overall Study|Physician Decision|1
1063236|NCT01959698|2111604|FG001|Overall Study|Physician Decision|0
1063237|NCT01959698|2111605|FG002|Overall Study|Physician Decision|1
1063238|NCT01959698|2111606|FG003|Overall Study|Physician Decision|2
1063239|NCT01959698|2111607|FG004|Overall Study|Physician Decision|0
1063240|NCT01959698|2111608|FG005|Overall Study|Physician Decision|3
1063241|NCT01959698|2111609|FG006|Overall Study|Physician Decision|3
1063242|NCT01959841|2111629|FG000|Overall Study|Adverse Event|1
1063243|NCT01959841|2111630|FG001|Overall Study|Adverse Event|3
1063244|NCT01959841|2111631|FG002|Overall Study|Adverse Event|2
1063245|NCT01959841|2111629|FG000|Overall Study|Lack of Efficacy|5
1063246|NCT01959841|2111630|FG001|Overall Study|Lack of Efficacy|0
1063247|NCT01959841|2111631|FG002|Overall Study|Lack of Efficacy|0
1063248|NCT01959841|2111629|FG000|Overall Study|Lost to Follow-up|1
1063249|NCT01959841|2111630|FG001|Overall Study|Lost to Follow-up|1
1063250|NCT01959841|2111631|FG002|Overall Study|Lost to Follow-up|0
1063251|NCT01959841|2111629|FG000|Overall Study|Physician Decision|0
1063252|NCT01959841|2111630|FG001|Overall Study|Physician Decision|2
1063253|NCT01959841|2111631|FG002|Overall Study|Physician Decision|3
1063254|NCT01959841|2111629|FG000|Overall Study|Protocol Violation|16
1063255|NCT01959841|2111630|FG001|Overall Study|Protocol Violation|23
1063256|NCT01959841|2111631|FG002|Overall Study|Protocol Violation|16
1063257|NCT01959841|2111629|FG000|Overall Study|Withdrawal by Subject|7
1063258|NCT01959841|2111630|FG001|Overall Study|Withdrawal by Subject|7
1063259|NCT01959841|2111631|FG002|Overall Study|Withdrawal by Subject|5
1063260|NCT01959841|2111629|FG000|Overall Study|Clinical laboratory value|2
1063261|NCT01959841|2111630|FG001|Overall Study|Clinical laboratory value|6
1063262|NCT01959841|2111631|FG002|Overall Study|Clinical laboratory value|6
1063263|NCT01959841|2111629|FG000|Overall Study|Platelet count below on day1 or 4|11
1063264|NCT01959841|2111630|FG001|Overall Study|Platelet count below on day1 or 4|15
1063265|NCT01959841|2111631|FG002|Overall Study|Platelet count below on day1 or 4|11
1063266|NCT01959880|2111643|FG000|Overall Study|Withdrawal by Subject|11
1063267|NCT01959880|2111644|FG001|Overall Study|Withdrawal by Subject|13
1063268|NCT01959880|2111645|FG002|Overall Study|Withdrawal by Subject|8
1063269|NCT01959880|2111646|FG003|Overall Study|Withdrawal by Subject|7
1063270|NCT01959880|2111643|FG000|Overall Study|Death|1
1063271|NCT01959880|2111644|FG001|Overall Study|Death|10
1063272|NCT01959880|2111645|FG002|Overall Study|Death|1
1063273|NCT01959880|2111646|FG003|Overall Study|Death|2
1063274|NCT01959880|2111643|FG000|Overall Study|Lost to Follow-up|95
1063275|NCT01959880|2111644|FG001|Overall Study|Lost to Follow-up|18
1063276|NCT01959880|2111645|FG002|Overall Study|Lost to Follow-up|15
1063277|NCT01959880|2111646|FG003|Overall Study|Lost to Follow-up|8
1063278|NCT01959880|2111643|FG000|Overall Study|Explantation w/o study device reimplant.|22
1063279|NCT01959880|2111644|FG001|Overall Study|Explantation w/o study device reimplant.|17
1063280|NCT01959880|2111645|FG002|Overall Study|Explantation w/o study device reimplant.|5
1063281|NCT01959880|2111646|FG003|Overall Study|Explantation w/o study device reimplant.|12
1063282|NCT01959880|2111643|FG000|Overall Study|Study completed early-FDA approved|1003
1063283|NCT01959880|2111644|FG001|Overall Study|Study completed early-FDA approved|311
1063284|NCT01959880|2111645|FG002|Overall Study|Study completed early-FDA approved|179
1063285|NCT01959880|2111646|FG003|Overall Study|Study completed early-FDA approved|152
1063286|NCT01959919|2111656|FG000|Overall Study|Did not meet the eligibility criteria|2
1063287|NCT01959932|2111663|FG000|Overall Study|Withdrawal by Subject|1
1063288|NCT01959932|2111664|FG001|Overall Study|Withdrawal by Subject|0
1063289|NCT01959932|2111665|FG002|Overall Study|Withdrawal by Subject|0
1063290|NCT01960114|2111708|FG000|Overall Study|Adverse Event|1
1063291|NCT01960114|2111709|FG001|Overall Study|Adverse Event|0
1063292|NCT01960114|2111708|FG000|Overall Study|Could not swallow study medication|0
1063293|NCT01960114|2111709|FG001|Overall Study|Could not swallow study medication|1
1063294|NCT01960140|2111715|FG000|Period 2 (Days 3-18)|Adverse Event|2
1063295|NCT01960257|2111723|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12
1063296|NCT01960257|2111724|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
1063297|NCT01960257|2111725|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
1063298|NCT01960257|2111723|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3
1063299|NCT01960257|2111724|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
1063300|NCT01960257|2111725|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
1063301|NCT01960257|2111723|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1
1063302|NCT01960257|2111724|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0
1063303|NCT01960257|2111725|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0
1063304|NCT01960296|2111737|FG000|Overall Study|Postponed surgery|1
1063305|NCT01960296|2111738|FG001|Overall Study|Postponed surgery|0
1063306|NCT01960296|2111737|FG000|Overall Study|Received different procedure|1
1063307|NCT01960296|2111738|FG001|Overall Study|Received different procedure|3
1063308|NCT01960348|2111746|FG000|Overall Study|Adverse event, not serious|2
1063309|NCT01960348|2111747|FG001|Overall Study|Adverse event, not serious|2
1063310|NCT01960348|2111746|FG000|Overall Study|Adverse event, serious fatal|6
1063311|NCT01960348|2111747|FG001|Overall Study|Adverse event, serious fatal|5
1063312|NCT01960348|2111746|FG000|Overall Study|Adverse event, serious non-fatal|0
1063313|NCT01960348|2111747|FG001|Overall Study|Adverse event, serious non-fatal|3
1063314|NCT01960348|2111746|FG000|Overall Study|Withdrawal by Subject|1
1063315|NCT01960348|2111747|FG001|Overall Study|Withdrawal by Subject|11
1063316|NCT01960348|2111746|FG000|Overall Study|Physician Decision|0
1063317|NCT01960348|2111747|FG001|Overall Study|Physician Decision|1
1063318|NCT01960348|2111746|FG000|Overall Study|Protocol Violation|1
1063319|NCT01960348|2111747|FG001|Overall Study|Protocol Violation|0
1063320|NCT01960413|2111768|FG000|Overall Study|Withdrawal by Subject|1
1063321|NCT01960413|2111769|FG001|Overall Study|Withdrawal by Subject|1
1063322|NCT01960413|2111768|FG000|Overall Study|Physician Decision|1
1063323|NCT01960413|2111769|FG001|Overall Study|Physician Decision|0
1063324|NCT01960413|2111768|FG000|Overall Study|Lost to Follow-up|2
1063325|NCT01960413|2111769|FG001|Overall Study|Lost to Follow-up|0
1063326|NCT01960725|2111801|FG000|Overall Study|Lost to Follow-up|4
1063327|NCT01960725|2111802|FG001|Overall Study|Lost to Follow-up|3
1063328|NCT01960725|2111801|FG000|Overall Study|Withdrawal by Subject|1
1063329|NCT01960725|2111802|FG001|Overall Study|Withdrawal by Subject|0
1063330|NCT01960725|2111801|FG000|Overall Study|unable to obtain blood sample|1
1063331|NCT01960725|2111802|FG001|Overall Study|unable to obtain blood sample|2
1063332|NCT01960790|2111808|FG000|Overall Study|Survey forms could not be recovered|3
1063333|NCT01960790|2111808|FG000|Overall Study|Treat with Humira outside survey period|3
1063334|NCT01960790|2111808|FG000|Overall Study|Transferred to another hospital|4
1063335|NCT01960790|2111808|FG000|Overall Study|Unevaluable for safety|1
1063336|NCT01960816|2111812|FG000|Overall Study|Lost to Follow-up|1
1063337|NCT01960842|2111816|FG000|Overall Study|Adverse Event|1
1063338|NCT01960842|2111816|FG000|Overall Study|Withdrawal by Subject|2
1063339|NCT01960855|2111825|FG000|Overall Study|Subject noncompliant|1
1063340|NCT01960855|2111826|FG001|Overall Study|Subject noncompliant|0
1063341|NCT01960855|2111827|FG002|Overall Study|Subject noncompliant|0
1063342|NCT01960855|2111828|FG003|Overall Study|Subject noncompliant|0
1063343|NCT01960855|2111829|FG004|Overall Study|Subject noncompliant|0
1063344|NCT01960855|2111825|FG000|Overall Study|Adverse Event|2
1063345|NCT01960855|2111826|FG001|Overall Study|Adverse Event|0
1063346|NCT01960855|2111827|FG002|Overall Study|Adverse Event|6
1063347|NCT01960855|2111828|FG003|Overall Study|Adverse Event|2
1063348|NCT01960855|2111829|FG004|Overall Study|Adverse Event|2
1063349|NCT01960855|2111825|FG000|Overall Study|Lack of Efficacy|1
1063350|NCT01960855|2111826|FG001|Overall Study|Lack of Efficacy|1
1063351|NCT01960855|2111827|FG002|Overall Study|Lack of Efficacy|0
1063352|NCT01960855|2111828|FG003|Overall Study|Lack of Efficacy|0
1063353|NCT01960855|2111829|FG004|Overall Study|Lack of Efficacy|0
1063354|NCT01960855|2111825|FG000|Overall Study|Other|2
1063355|NCT01960855|2111826|FG001|Overall Study|Other|1
1063356|NCT01960855|2111827|FG002|Overall Study|Other|1
1063357|NCT01960855|2111828|FG003|Overall Study|Other|1
1063358|NCT01960855|2111829|FG004|Overall Study|Other|0
1063359|NCT01960855|2111825|FG000|Overall Study|Consent withdrawn by subject|3
1063360|NCT01960855|2111826|FG001|Overall Study|Consent withdrawn by subject|1
1063361|NCT01960855|2111827|FG002|Overall Study|Consent withdrawn by subject|2
1063362|NCT01960855|2111828|FG003|Overall Study|Consent withdrawn by subject|1
1063363|NCT01960855|2111829|FG004|Overall Study|Consent withdrawn by subject|1
1063364|NCT01960855|2111825|FG000|Overall Study|Lost to Follow-up|2
1063365|NCT01960855|2111826|FG001|Overall Study|Lost to Follow-up|1
1063366|NCT01960855|2111827|FG002|Overall Study|Lost to Follow-up|0
1063367|NCT01960855|2111828|FG003|Overall Study|Lost to Follow-up|0
1063368|NCT01960855|2111829|FG004|Overall Study|Lost to Follow-up|2
1063369|NCT01960907|2111843|FG000|Overall Study|Death|4
1063370|NCT01960907|2111844|FG001|Overall Study|Death|3
1063371|NCT01960907|2111843|FG000|Overall Study|Withdrawal by Subject|32
1063372|NCT01960907|2111844|FG001|Overall Study|Withdrawal by Subject|42
1063373|NCT01960998|2111855|FG000|Overall Study|Lost to Follow-up|3
1063374|NCT01960998|2111856|FG001|Overall Study|Lost to Follow-up|7
1063375|NCT01960998|2111855|FG000|Overall Study|Death|0
1063376|NCT01960998|2111856|FG001|Overall Study|Death|1
1063377|NCT01960998|2111855|FG000|Overall Study|Withdrawal by Subject|8
1063378|NCT01960998|2111856|FG001|Overall Study|Withdrawal by Subject|2
1063379|NCT01960998|2111855|FG000|Overall Study|lost computer access|0
1063380|NCT01960998|2111856|FG001|Overall Study|lost computer access|1
1063381|NCT01961115|2111871|FG000|Overall Study|Disease Progression|1
1063382|NCT01961115|2111872|FG001|Overall Study|Disease Progression|0
1063383|NCT01961115|2111873|FG002|Overall Study|Disease Progression|3
1063384|NCT01961115|2111871|FG000|Overall Study|Adverse Event|1
1063385|NCT01961115|2111872|FG001|Overall Study|Adverse Event|0
1063386|NCT01961115|2111873|FG002|Overall Study|Adverse Event|1
1063387|NCT01961297|2111891|FG000|Overall Study|unconfirmed diagnosis of SD|2
1063388|NCT01961297|2111892|FG001|Overall Study|unconfirmed diagnosis of SD|1
1063389|NCT01961323|2111898|FG000|Overall Study|Withdrawal by Subject|7
1063390|NCT01961323|2111898|FG000|Overall Study|Lost to Follow-up|8
1063391|NCT01961323|2111898|FG000|Overall Study|screen failure|34
1063392|NCT01961349|2111905|FG000|Overall Study|Withdrawal by Subject|1
1063393|NCT01961349|2111906|FG001|Overall Study|Withdrawal by Subject|4
1063394|NCT01961349|2111907|FG002|Overall Study|Withdrawal by Subject|0
1063395|NCT01961349|2111905|FG000|Overall Study|Adverse Event|0
1063396|NCT01961349|2111906|FG001|Overall Study|Adverse Event|0
1063397|NCT01961349|2111907|FG002|Overall Study|Adverse Event|1
1063398|NCT01961349|2111905|FG000|Overall Study|registration error, personal reason etc|2
1063399|NCT01961349|2111906|FG001|Overall Study|registration error, personal reason etc|2
1063400|NCT01961349|2111907|FG002|Overall Study|registration error, personal reason etc|1
1063401|NCT01961544|2111923|FG000|Overall Study|Protocol Violation|1
1063402|NCT01961544|2111923|FG000|Overall Study|Withdrawal by Subject|7
1063403|NCT01961544|2111923|FG000|Overall Study|Adverse Event|1
1063404|NCT01961544|2111923|FG000|Overall Study|Physician Decision|2
1063405|NCT01961544|2111923|FG000|Overall Study|Poor Tolerance|1
1063406|NCT01961544|2111923|FG000|Overall Study|Aggravation of Steral Pain|1
1063407|NCT01961609|2111929|FG000|Initiation|Missing|3
1063408|NCT01961609|2111930|FG001|Initiation|Missing|2
1063409|NCT01961609|2111931|FG002|Initiation|Missing|0
1063410|NCT01961609|2111932|FG003|Initiation|Missing|0
1063411|NCT01961609|2111929|FG000|Initiation|Protocol deviation|1
1063412|NCT01961609|2111930|FG001|Initiation|Protocol deviation|0
1063413|NCT01961609|2111931|FG002|Initiation|Protocol deviation|0
1063414|NCT01961609|2111932|FG003|Initiation|Protocol deviation|0
1063415|NCT01961609|2111929|FG000|Initiation|Death|0
1063416|NCT01961609|2111930|FG001|Initiation|Death|1
1063417|NCT01961609|2111931|FG002|Initiation|Death|0
1063418|NCT01961609|2111932|FG003|Initiation|Death|0
1063419|NCT01961609|2111929|FG000|Initiation|Administrative problems|1
1063420|NCT01961609|2111930|FG001|Initiation|Administrative problems|0
1063421|NCT01961609|2111931|FG002|Initiation|Administrative problems|0
1063422|NCT01961609|2111932|FG003|Initiation|Administrative problems|0
1063423|NCT01961609|2111929|FG000|Initiation|Withdrawal by Subject|1
1063424|NCT01961609|2111930|FG001|Initiation|Withdrawal by Subject|2
1063425|NCT01961609|2111931|FG002|Initiation|Withdrawal by Subject|0
1063426|NCT01961609|2111932|FG003|Initiation|Withdrawal by Subject|0
1063427|NCT01961609|2111929|FG000|Initiation|Lack of Efficacy|2
1063428|NCT01961609|2111930|FG001|Initiation|Lack of Efficacy|1
1063429|NCT01961609|2111931|FG002|Initiation|Lack of Efficacy|0
1063430|NCT01961609|2111932|FG003|Initiation|Lack of Efficacy|0
1063431|NCT01961609|2111929|FG000|Initiation|Abnormal lab values|0
1063432|NCT01961609|2111930|FG001|Initiation|Abnormal lab values|1
1063433|NCT01961609|2111931|FG002|Initiation|Abnormal lab values|0
1063434|NCT01961609|2111932|FG003|Initiation|Abnormal lab values|0
1063435|NCT01961609|2111929|FG000|Initiation|Adverse Event|3
1063436|NCT01961609|2111930|FG001|Initiation|Adverse Event|5
1063437|NCT01961609|2111931|FG002|Initiation|Adverse Event|0
1063438|NCT01961609|2111932|FG003|Initiation|Adverse Event|0
1063439|NCT01961609|2111929|FG000|Initiation|Randomized but not treated|1
1063440|NCT01961609|2111930|FG001|Initiation|Randomized but not treated|1
1063441|NCT01961609|2111931|FG002|Initiation|Randomized but not treated|0
1063442|NCT01961609|2111932|FG003|Initiation|Randomized but not treated|0
1063443|NCT01961609|2111929|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
1063444|NCT01961609|2111930|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
1063445|NCT01961609|2111931|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
1063446|NCT01961609|2111932|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
1063447|NCT01961609|2111929|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
1063448|NCT01961609|2111930|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
1063449|NCT01961609|2111931|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
1063450|NCT01961609|2111932|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
1063451|NCT01961609|2111929|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
1063452|NCT01961609|2111930|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
1063453|NCT01961609|2111931|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
1063454|NCT01961609|2111932|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
1063455|NCT01961609|2111929|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
1063456|NCT01961609|2111930|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
1063457|NCT01961609|2111931|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
1063458|NCT01961609|2111932|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
1063459|NCT01961609|2111929|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
1063460|NCT01961609|2111930|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
1063461|NCT01961609|2111931|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
1063462|NCT01961609|2111932|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
1063463|NCT01961609|2111929|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
1063464|NCT01961609|2111930|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
1063465|NCT01961609|2111931|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
1063466|NCT01961609|2111932|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
1063467|NCT01961609|2111929|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
1063468|NCT01961609|2111930|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
1063469|NCT01961609|2111931|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
1063470|NCT01961609|2111932|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
1063471|NCT01961609|2111929|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
1063472|NCT01961609|2111930|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
1063473|NCT01961609|2111931|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
1063474|NCT01961609|2111932|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
1063475|NCT01961609|2111929|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
1063476|NCT01961609|2111930|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
1063477|NCT01961609|2111931|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
1063478|NCT01961609|2111932|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
1063479|NCT01961609|2111929|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
1063480|NCT01961609|2111930|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
1063481|NCT01961609|2111931|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
1063482|NCT01961609|2111932|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
1063483|NCT01961609|2111929|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
1063484|NCT01961609|2111930|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
1063485|NCT01961609|2111931|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
1063486|NCT01961609|2111932|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
1063487|NCT01961609|2111929|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
1063488|NCT01961609|2111930|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
1063489|NCT01961609|2111931|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
1063490|NCT01961609|2111932|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
1063491|NCT01961687|2111949|FG000|Overall Study|Lost to Follow-up|19
1063492|NCT01961687|2111949|FG000|Overall Study|Re-operation|17
1063493|NCT01961687|2111949|FG000|Overall Study|Death|7
1063494|NCT01961687|2111949|FG000|Overall Study|Withdrawal by Subject|6
1063495|NCT01961687|2111949|FG000|Overall Study|Adverse Event|6
1063496|NCT01961687|2111949|FG000|Overall Study|Moved to area without study site|2
1063497|NCT01961687|2111949|FG000|Overall Study|Sponsor decision|2
1063498|NCT01961687|2111949|FG000|Overall Study|Physician Decision|1
1063499|NCT01961687|2111949|FG000|Overall Study|Unable to meet follow-up requirements|1
1063500|NCT01961882|2111955|FG000|Overall Study|Adverse Event|3
1063501|NCT01961882|2111956|FG001|Overall Study|Adverse Event|2
1063502|NCT01961882|2111955|FG000|Overall Study|Physician Decision|1
1063503|NCT01961882|2111956|FG001|Overall Study|Physician Decision|0
1063504|NCT01961882|2111955|FG000|Overall Study|Withdrawal by Subject|4
1063505|NCT01961882|2111956|FG001|Overall Study|Withdrawal by Subject|1
1063506|NCT01961882|2111955|FG000|Overall Study|Relapse of AML|39
1063507|NCT01961882|2111956|FG001|Overall Study|Relapse of AML|37
1063508|NCT01961882|2111955|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2
1063509|NCT01961882|2111956|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2
1063510|NCT01961882|2111955|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1
1063511|NCT01961882|2111956|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0
1063512|NCT01962103|2111986|FG000|Phase 1|Adverse Event|4
1063513|NCT01962103|2111987|FG001|Phase 1|Adverse Event|0
1063514|NCT01962103|2111988|FG002|Phase 1|Adverse Event|2
1063515|NCT01962103|2111989|FG003|Phase 1|Adverse Event|1
1063516|NCT01962103|2111990|FG004|Phase 1|Adverse Event|2
1063517|NCT01962103|2111991|FG005|Phase 1|Adverse Event|2
1063518|NCT01962103|2111992|FG006|Phase 1|Adverse Event|0
1063519|NCT01962103|2111993|FG007|Phase 1|Adverse Event|0
1063520|NCT01962103|2111994|FG008|Phase 1|Adverse Event|0
1063521|NCT01962103|2111986|FG000|Phase 1|Progressive Disease|8
1063522|NCT01962103|2111987|FG001|Phase 1|Progressive Disease|6
1063523|NCT01962103|2111988|FG002|Phase 1|Progressive Disease|8
1063524|NCT01962103|2111989|FG003|Phase 1|Progressive Disease|4
1063525|NCT01962103|2111990|FG004|Phase 1|Progressive Disease|5
1063526|NCT01962103|2111991|FG005|Phase 1|Progressive Disease|4
1063527|NCT01962103|2111992|FG006|Phase 1|Progressive Disease|0
1063528|NCT01962103|2111993|FG007|Phase 1|Progressive Disease|0
1063529|NCT01962103|2111994|FG008|Phase 1|Progressive Disease|0
1063530|NCT01962103|2111986|FG000|Phase 1|Withdrawal by Subject|0
1063531|NCT01962103|2111987|FG001|Phase 1|Withdrawal by Subject|0
1063532|NCT01962103|2111988|FG002|Phase 1|Withdrawal by Subject|0
1063533|NCT01962103|2111989|FG003|Phase 1|Withdrawal by Subject|2
1063534|NCT01962103|2111990|FG004|Phase 1|Withdrawal by Subject|0
1063535|NCT01962103|2111991|FG005|Phase 1|Withdrawal by Subject|0
1063536|NCT01962103|2111992|FG006|Phase 1|Withdrawal by Subject|0
1063537|NCT01962103|2111993|FG007|Phase 1|Withdrawal by Subject|0
1063538|NCT01962103|2111994|FG008|Phase 1|Withdrawal by Subject|0
1063539|NCT01962103|2111986|FG000|Phase 1|Withdrawal by Parent/Guardian|0
1063540|NCT01962103|2111987|FG001|Phase 1|Withdrawal by Parent/Guardian|0
1063541|NCT01962103|2111988|FG002|Phase 1|Withdrawal by Parent/Guardian|2
1063542|NCT01962103|2111989|FG003|Phase 1|Withdrawal by Parent/Guardian|1
1063543|NCT01962103|2111990|FG004|Phase 1|Withdrawal by Parent/Guardian|0
1063544|NCT01962103|2111991|FG005|Phase 1|Withdrawal by Parent/Guardian|0
1063545|NCT01962103|2111992|FG006|Phase 1|Withdrawal by Parent/Guardian|0
1063546|NCT01962103|2111993|FG007|Phase 1|Withdrawal by Parent/Guardian|0
1063547|NCT01962103|2111994|FG008|Phase 1|Withdrawal by Parent/Guardian|0
1063548|NCT01962103|2111986|FG000|Phase 1|Physician Decision|0
1063549|NCT01962103|2111987|FG001|Phase 1|Physician Decision|0
1063550|NCT01962103|2111988|FG002|Phase 1|Physician Decision|0
1063551|NCT01962103|2111989|FG003|Phase 1|Physician Decision|1
1063552|NCT01962103|2111990|FG004|Phase 1|Physician Decision|0
1063553|NCT01962103|2111991|FG005|Phase 1|Physician Decision|0
1063554|NCT01962103|2111992|FG006|Phase 1|Physician Decision|0
1063555|NCT01962103|2111993|FG007|Phase 1|Physician Decision|0
1063556|NCT01962103|2111994|FG008|Phase 1|Physician Decision|0
1063557|NCT01962103|2111986|FG000|Phase 1|Symptomatic Deterioration|3
1063558|NCT01962103|2111987|FG001|Phase 1|Symptomatic Deterioration|2
1063559|NCT01962103|2111988|FG002|Phase 1|Symptomatic Deterioration|2
1063560|NCT01962103|2111989|FG003|Phase 1|Symptomatic Deterioration|2
1063561|NCT01962103|2111990|FG004|Phase 1|Symptomatic Deterioration|1
1063562|NCT01962103|2111991|FG005|Phase 1|Symptomatic Deterioration|1
1063563|NCT01962103|2111992|FG006|Phase 1|Symptomatic Deterioration|0
1063564|NCT01962103|2111993|FG007|Phase 1|Symptomatic Deterioration|0
1063565|NCT01962103|2111994|FG008|Phase 1|Symptomatic Deterioration|0
1063566|NCT01962103|2111986|FG000|Phase 1|Miscellaneous|1
1063567|NCT01962103|2111987|FG001|Phase 1|Miscellaneous|0
1063568|NCT01962103|2111988|FG002|Phase 1|Miscellaneous|0
1063569|NCT01962103|2111989|FG003|Phase 1|Miscellaneous|0
1063570|NCT01962103|2111990|FG004|Phase 1|Miscellaneous|0
1063571|NCT01962103|2111991|FG005|Phase 1|Miscellaneous|0
1063572|NCT01962103|2111992|FG006|Phase 1|Miscellaneous|0
1063573|NCT01962103|2111993|FG007|Phase 1|Miscellaneous|0
1063574|NCT01962103|2111994|FG008|Phase 1|Miscellaneous|0
1063575|NCT01962103|2111986|FG000|Phase 2|Adverse Event|0
1063576|NCT01962103|2111987|FG001|Phase 2|Adverse Event|0
1063577|NCT01962103|2111988|FG002|Phase 2|Adverse Event|0
1063578|NCT01962103|2111989|FG003|Phase 2|Adverse Event|0
1063579|NCT01962103|2111990|FG004|Phase 2|Adverse Event|0
1063580|NCT01962103|2111991|FG005|Phase 2|Adverse Event|0
1063581|NCT01962103|2111992|FG006|Phase 2|Adverse Event|1
1063582|NCT01962103|2111993|FG007|Phase 2|Adverse Event|0
1063583|NCT01962103|2111994|FG008|Phase 2|Adverse Event|3
1063584|NCT01962103|2111986|FG000|Phase 2|Progressive Disease|0
1063585|NCT01962103|2111987|FG001|Phase 2|Progressive Disease|0
1063586|NCT01962103|2111988|FG002|Phase 2|Progressive Disease|0
1063587|NCT01962103|2111989|FG003|Phase 2|Progressive Disease|0
1063588|NCT01962103|2111990|FG004|Phase 2|Progressive Disease|0
1063589|NCT01962103|2111991|FG005|Phase 2|Progressive Disease|0
1063590|NCT01962103|2111992|FG006|Phase 2|Progressive Disease|11
1063591|NCT01962103|2111993|FG007|Phase 2|Progressive Disease|12
1063592|NCT01962103|2111994|FG008|Phase 2|Progressive Disease|11
1063593|NCT01962103|2111986|FG000|Phase 2|Symptomatic Deterioration|0
1063594|NCT01962103|2111987|FG001|Phase 2|Symptomatic Deterioration|0
1063595|NCT01962103|2111988|FG002|Phase 2|Symptomatic Deterioration|0
1063596|NCT01962103|2111989|FG003|Phase 2|Symptomatic Deterioration|0
1063597|NCT01962103|2111990|FG004|Phase 2|Symptomatic Deterioration|0
1063598|NCT01962103|2111991|FG005|Phase 2|Symptomatic Deterioration|0
1063599|NCT01962103|2111992|FG006|Phase 2|Symptomatic Deterioration|2
1063600|NCT01962103|2111993|FG007|Phase 2|Symptomatic Deterioration|2
1063601|NCT01962103|2111994|FG008|Phase 2|Symptomatic Deterioration|0
1063602|NCT01962207|2112018|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2
1063603|NCT01962207|2112019|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1
1063604|NCT01962207|2112020|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5
1063605|NCT01962207|2112021|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2
1063606|NCT01962207|2112018|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2
1063607|NCT01962207|2112019|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0
1063608|NCT01962207|2112020|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4
1063609|NCT01962207|2112021|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0
1063610|NCT01962207|2112018|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4
1063611|NCT01962207|2112019|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5
1063612|NCT01962207|2112020|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18
1063613|NCT01962207|2112021|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4
1063614|NCT01962207|2112018|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
1063615|NCT01962207|2112019|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
1063616|NCT01962207|2112020|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
1063617|NCT01962207|2112021|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
1063618|NCT01962207|2112018|FG000|Persistence Phase (5 Years)|Adverse Event|0
1063619|NCT01962207|2112019|FG001|Persistence Phase (5 Years)|Adverse Event|0
1063620|NCT01962207|2112020|FG002|Persistence Phase (5 Years)|Adverse Event|1
1063621|NCT01962207|2112021|FG003|Persistence Phase (5 Years)|Adverse Event|0
1063622|NCT01962207|2112018|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
1063623|NCT01962207|2112019|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
1063624|NCT01962207|2112020|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
1063625|NCT01962207|2112021|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
1063626|NCT01962298|2112040|FG000|Overall Study|Protocol Violation|1
1063627|NCT01962298|2112041|FG001|Overall Study|Protocol Violation|0
1063628|NCT01962298|2112042|FG002|Overall Study|Protocol Violation|1
1063629|NCT01962298|2112043|FG003|Overall Study|Protocol Violation|1
1063630|NCT01962298|2112044|FG004|Overall Study|Protocol Violation|0
1063631|NCT01962298|2112040|FG000|Overall Study|Data quality insufficient|2
1063632|NCT01962298|2112041|FG001|Overall Study|Data quality insufficient|0
1063633|NCT01962298|2112042|FG002|Overall Study|Data quality insufficient|3
1063634|NCT01962298|2112043|FG003|Overall Study|Data quality insufficient|1
1063635|NCT01962298|2112044|FG004|Overall Study|Data quality insufficient|4
1063636|NCT01962298|2112040|FG000|Overall Study|Insufficient data|0
1063637|NCT01962298|2112041|FG001|Overall Study|Insufficient data|2
1063638|NCT01962298|2112042|FG002|Overall Study|Insufficient data|1
1063639|NCT01962298|2112043|FG003|Overall Study|Insufficient data|0
1063640|NCT01962298|2112044|FG004|Overall Study|Insufficient data|1
1063641|NCT01962298|2112040|FG000|Overall Study|Incorrect data recorded|0
1063642|NCT01962298|2112041|FG001|Overall Study|Incorrect data recorded|1
1063643|NCT01962298|2112042|FG002|Overall Study|Incorrect data recorded|0
1063644|NCT01962298|2112043|FG003|Overall Study|Incorrect data recorded|0
1063645|NCT01962298|2112044|FG004|Overall Study|Incorrect data recorded|0
1063646|NCT01962298|2112040|FG000|Overall Study|Physician Decision|0
1063647|NCT01962298|2112041|FG001|Overall Study|Physician Decision|1
1063648|NCT01962298|2112042|FG002|Overall Study|Physician Decision|0
1063649|NCT01962298|2112043|FG003|Overall Study|Physician Decision|0
1063650|NCT01962298|2112044|FG004|Overall Study|Physician Decision|1
1063651|NCT01962441|2112068|FG000|Randomized Period|Randomized but Never Treated|4
1063652|NCT01962441|2112069|FG001|Randomized Period|Randomized but Never Treated|2
1063653|NCT01962441|2112070|FG002|Randomized Period|Randomized but Never Treated|3
1063654|NCT01962441|2112068|FG000|Randomized Period|Lost to Follow-up|2
1063655|NCT01962441|2112069|FG001|Randomized Period|Lost to Follow-up|4
1063656|NCT01962441|2112070|FG002|Randomized Period|Lost to Follow-up|4
1063657|NCT01962441|2112068|FG000|Randomized Period|Withdrew Consent|3
1063658|NCT01962441|2112069|FG001|Randomized Period|Withdrew Consent|3
1063659|NCT01962441|2112070|FG002|Randomized Period|Withdrew Consent|2
1063660|NCT01962441|2112068|FG000|Randomized Period|Adverse Event|1
1063661|NCT01962441|2112069|FG001|Randomized Period|Adverse Event|1
1063662|NCT01962441|2112070|FG002|Randomized Period|Adverse Event|0
1063663|NCT01962441|2112068|FG000|Randomized Period|Death|0
1063664|NCT01962441|2112069|FG001|Randomized Period|Death|0
1063665|NCT01962441|2112070|FG002|Randomized Period|Death|2
1063666|NCT01962441|2112068|FG000|Randomized Period|Protocol Violation|0
1063667|NCT01962441|2112069|FG001|Randomized Period|Protocol Violation|1
1063668|NCT01962441|2112070|FG002|Randomized Period|Protocol Violation|0
1063669|NCT01962441|2112068|FG000|Retreatment Substudy|Lack of Efficacy|1
1063670|NCT01962441|2112069|FG001|Retreatment Substudy|Lack of Efficacy|0
1063671|NCT01962441|2112070|FG002|Retreatment Substudy|Lack of Efficacy|0
1063672|NCT01962441|2112068|FG000|Retreatment Substudy|Lost to Follow-up|1
1063673|NCT01962441|2112069|FG001|Retreatment Substudy|Lost to Follow-up|0
1063674|NCT01962441|2112070|FG002|Retreatment Substudy|Lost to Follow-up|0
1063675|NCT01962493|2112081|FG000|Overall Study|Adverse Event|1
1063676|NCT01962493|2112082|FG001|Overall Study|Adverse Event|2
1063677|NCT01962493|2112081|FG000|Overall Study|Protocol Violation|0
1063678|NCT01962493|2112082|FG001|Overall Study|Protocol Violation|1
1063679|NCT01962493|2112081|FG000|Overall Study|Withdrawal by Subject|4
1063680|NCT01962493|2112082|FG001|Overall Study|Withdrawal by Subject|2
1063681|NCT01962896|2112124|FG000|Overall Study|Lack of Efficacy|4
1063682|NCT01962922|2112131|FG000|PK Portion Day 7|Withdrawal by Subject|3
1063683|NCT01962922|2112132|FG001|PK Portion Day 7|Withdrawal by Subject|0
1063684|NCT01962922|2112131|FG000|PK Portion Day 7|non-compliance|1
1063685|NCT01962922|2112132|FG001|PK Portion Day 7|non-compliance|0
1063686|NCT01962922|2112131|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
1063687|NCT01962922|2112132|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
1063688|NCT01962922|2112131|FG000|Extendion Portion (up to Month 6)|Physician Decision|1
1063689|NCT01962922|2112132|FG001|Extendion Portion (up to Month 6)|Physician Decision|0
1063690|NCT01962987|2112154|FG000|Overall Study|Adverse Event|4
1063691|NCT01962987|2112155|FG001|Overall Study|Adverse Event|4
1063692|NCT01962987|2112156|FG002|Overall Study|Adverse Event|0
1063693|NCT01962987|2112154|FG000|Overall Study|Lost to Follow-up|0
1063694|NCT01962987|2112155|FG001|Overall Study|Lost to Follow-up|0
1063695|NCT01962987|2112156|FG002|Overall Study|Lost to Follow-up|1
1063696|NCT01962987|2112154|FG000|Overall Study|Non compliance with dosing requirements|4
1063697|NCT01962987|2112155|FG001|Overall Study|Non compliance with dosing requirements|2
1063698|NCT01962987|2112156|FG002|Overall Study|Non compliance with dosing requirements|0
1063699|NCT01962987|2112154|FG000|Overall Study|Miscellaneous|1
1063700|NCT01962987|2112155|FG001|Overall Study|Miscellaneous|9
1063701|NCT01962987|2112156|FG002|Overall Study|Miscellaneous|2
1063702|NCT01962987|2112154|FG000|Overall Study|Restricted medication|5
1063703|NCT01962987|2112155|FG001|Overall Study|Restricted medication|1
1063704|NCT01962987|2112156|FG002|Overall Study|Restricted medication|1
1063705|NCT01962987|2112154|FG000|Overall Study|Serious Adverse Event|1
1063706|NCT01962987|2112155|FG001|Overall Study|Serious Adverse Event|0
1063707|NCT01962987|2112156|FG002|Overall Study|Serious Adverse Event|0
1063708|NCT01962987|2112154|FG000|Overall Study|Withdrawal by Subject|11
1063709|NCT01962987|2112155|FG001|Overall Study|Withdrawal by Subject|10
1063710|NCT01962987|2112156|FG002|Overall Study|Withdrawal by Subject|6
1063711|NCT01962987|2112154|FG000|Overall Study|Randomized in Error|4
1063712|NCT01962987|2112155|FG001|Overall Study|Randomized in Error|2
1063713|NCT01962987|2112156|FG002|Overall Study|Randomized in Error|2
1063714|NCT01963117|2112190|FG000|Overall Study|Death|1
1063715|NCT01963260|2112244|FG000|Overall Study|Withdrawal by Subject|2
1063716|NCT01963260|2112245|FG001|Overall Study|Withdrawal by Subject|0
1063717|NCT01963260|2112246|FG002|Overall Study|Withdrawal by Subject|0
1063718|NCT01963260|2112247|FG003|Overall Study|Withdrawal by Subject|1
1063719|NCT01963260|2112248|FG004|Overall Study|Withdrawal by Subject|2
1063720|NCT01963260|2112249|FG005|Overall Study|Withdrawal by Subject|0
1063721|NCT01963260|2112250|FG006|Overall Study|Withdrawal by Subject|0
1063722|NCT01963260|2112251|FG007|Overall Study|Withdrawal by Subject|0
1063723|NCT01963260|2112252|FG008|Overall Study|Withdrawal by Subject|0
1063724|NCT01963260|2112253|FG009|Overall Study|Withdrawal by Subject|0
1063725|NCT01963403|2112284|FG000|Overall Study|Lost to Follow-up|2
1063726|NCT01963403|2112285|FG001|Overall Study|Lost to Follow-up|3
1063727|NCT01963403|2112284|FG000|Overall Study|Implant removal|0
1063728|NCT01963403|2112285|FG001|Overall Study|Implant removal|1
1063729|NCT01963611|2112302|FG000|Overall Study|Adverse Event|1
1063730|NCT01963611|2112303|FG001|Overall Study|Adverse Event|1
1063731|NCT01963611|2112304|FG002|Overall Study|Adverse Event|3
1063732|NCT01963611|2112305|FG003|Overall Study|Adverse Event|4
1063733|NCT01963611|2112306|FG004|Overall Study|Adverse Event|3
1063734|NCT01963611|2112302|FG000|Overall Study|Protocol Violation|0
1063735|NCT01963611|2112303|FG001|Overall Study|Protocol Violation|0
1063736|NCT01963611|2112304|FG002|Overall Study|Protocol Violation|0
1063737|NCT01963611|2112305|FG003|Overall Study|Protocol Violation|1
1063738|NCT01963611|2112306|FG004|Overall Study|Protocol Violation|0
1063739|NCT01963611|2112302|FG000|Overall Study|Lack of Efficacy|0
1063740|NCT01963611|2112303|FG001|Overall Study|Lack of Efficacy|0
1063741|NCT01963611|2112304|FG002|Overall Study|Lack of Efficacy|0
1063742|NCT01963611|2112305|FG003|Overall Study|Lack of Efficacy|1
1063743|NCT01963611|2112306|FG004|Overall Study|Lack of Efficacy|0
1063744|NCT01963611|2112302|FG000|Overall Study|Withdrawal by Subject|3
1063745|NCT01963611|2112303|FG001|Overall Study|Withdrawal by Subject|2
1063746|NCT01963611|2112304|FG002|Overall Study|Withdrawal by Subject|1
1063747|NCT01963611|2112305|FG003|Overall Study|Withdrawal by Subject|1
1063748|NCT01963611|2112306|FG004|Overall Study|Withdrawal by Subject|3
1063749|NCT01963611|2112302|FG000|Overall Study|Other|47
1063750|NCT01963611|2112303|FG001|Overall Study|Other|46
1063751|NCT01963611|2112304|FG002|Overall Study|Other|48
1063752|NCT01963611|2112305|FG003|Overall Study|Other|45
1063753|NCT01963611|2112306|FG004|Overall Study|Other|45
1063754|NCT01963676|2112321|FG000|Overall Study|Withdrawal by Subject|1
1063755|NCT01963676|2112322|FG001|Overall Study|Withdrawal by Subject|0
1063756|NCT01963767|2112330|FG000|Overall Study|Withdrawal by Subject|4
1063757|NCT01963767|2112331|FG001|Overall Study|Withdrawal by Subject|2
1063758|NCT01963767|2112330|FG000|Overall Study|Adverse Event|2
1063759|NCT01963767|2112331|FG001|Overall Study|Adverse Event|0
1063760|NCT01964105|2112389|FG000|Overall Study|Lost to Follow-up|2
1063761|NCT01964105|2112390|FG001|Overall Study|Lost to Follow-up|13
1063762|NCT01964105|2112391|FG002|Overall Study|Lost to Follow-up|0
1063763|NCT01964222|2112401|FG000|Overall Study|Lost to Follow-up|7
1063764|NCT01964222|2112402|FG001|Overall Study|Lost to Follow-up|5
1063765|NCT01964222|2112401|FG000|Overall Study|Withdrawal by Subject|6
1063766|NCT01964222|2112402|FG001|Overall Study|Withdrawal by Subject|6
1063767|NCT01964222|2112401|FG000|Overall Study|Screening Failure|2
1063768|NCT01964222|2112402|FG001|Overall Study|Screening Failure|0
1063769|NCT01964300|2112410|FG000|Overall Study|Ineligible after enrollment|0
1063770|NCT01964300|2112411|FG001|Overall Study|Ineligible after enrollment|1
1063771|NCT01964300|2112410|FG000|Overall Study|Adverse Event|1
1063772|NCT01964300|2112411|FG001|Overall Study|Adverse Event|1
1063773|NCT01964300|2112410|FG000|Overall Study|Lack of Efficacy|3
1063774|NCT01964300|2112411|FG001|Overall Study|Lack of Efficacy|5
1063775|NCT01964300|2112410|FG000|Overall Study|Withdrawal by Subject|0
1063776|NCT01964300|2112411|FG001|Overall Study|Withdrawal by Subject|1
1063777|NCT01964300|2112410|FG000|Overall Study|To receive alternative therapy|1
1063778|NCT01964300|2112411|FG001|Overall Study|To receive alternative therapy|2
1063779|NCT01964300|2112410|FG000|Overall Study|Enlargement of cyst requiring drainage|1
1063780|NCT01964300|2112411|FG001|Overall Study|Enlargement of cyst requiring drainage|0
1063781|NCT01964300|2112410|FG000|Overall Study|Weight criteria not met|0
1063782|NCT01964300|2112411|FG001|Overall Study|Weight criteria not met|1
1063783|NCT01964326|2112417|FG000|Overall Study|Adverse Event|48
1063784|NCT01964326|2112417|FG000|Overall Study|Death|2
1063785|NCT01964326|2112417|FG000|Overall Study|Protocol Violation|4
1063786|NCT01964326|2112417|FG000|Overall Study|Lost to Follow-up|88
1063787|NCT01964326|2112417|FG000|Overall Study|Withdrawal by Subject|87
1063788|NCT01964326|2112417|FG000|Overall Study|Pregnancy|1
1063789|NCT01964326|2112417|FG000|Overall Study|No Longer Meets Eligibility Criteria|1
1063790|NCT01964326|2112417|FG000|Overall Study|Physician Decision|55
1063791|NCT01964326|2112417|FG000|Overall Study|Investigator Discretion|1
1063792|NCT01964326|2112417|FG000|Overall Study|Other|9
1063793|NCT01964326|2112417|FG000|Overall Study|Did not meet eligibility criteria|1
1063794|NCT01964352|2112425|FG000|Overall Study|Adverse Event|13
1063795|NCT01964352|2112426|FG001|Overall Study|Adverse Event|3
1063796|NCT01964352|2112427|FG002|Overall Study|Adverse Event|4
1063797|NCT01964352|2112428|FG003|Overall Study|Adverse Event|3
1063798|NCT01964352|2112425|FG000|Overall Study|Lack of Efficacy|6
1063799|NCT01964352|2112426|FG001|Overall Study|Lack of Efficacy|0
1063800|NCT01964352|2112427|FG002|Overall Study|Lack of Efficacy|0
1063801|NCT01964352|2112428|FG003|Overall Study|Lack of Efficacy|0
1063802|NCT01964352|2112425|FG000|Overall Study|Protocol Violation|2
1063803|NCT01964352|2112426|FG001|Overall Study|Protocol Violation|4
1063804|NCT01964352|2112427|FG002|Overall Study|Protocol Violation|0
1063805|NCT01964352|2112428|FG003|Overall Study|Protocol Violation|2
1063806|NCT01964352|2112425|FG000|Overall Study|Lost to Follow-up|1
1063807|NCT01964352|2112426|FG001|Overall Study|Lost to Follow-up|0
1063808|NCT01964352|2112427|FG002|Overall Study|Lost to Follow-up|0
1063809|NCT01964352|2112428|FG003|Overall Study|Lost to Follow-up|1
1063810|NCT01964352|2112425|FG000|Overall Study|Withdrawal by Subject|4
1063811|NCT01964352|2112426|FG001|Overall Study|Withdrawal by Subject|2
1063812|NCT01964352|2112427|FG002|Overall Study|Withdrawal by Subject|1
1063813|NCT01964352|2112428|FG003|Overall Study|Withdrawal by Subject|0
1063814|NCT01964352|2112425|FG000|Overall Study|Other than stated above|0
1063815|NCT01964352|2112426|FG001|Overall Study|Other than stated above|2
1063816|NCT01964352|2112427|FG002|Overall Study|Other than stated above|1
1063817|NCT01964352|2112428|FG003|Overall Study|Other than stated above|2
1063818|NCT01964378|2112440|FG000|Overall Study|Disc. due to death before first dosing|0
1063819|NCT01964378|2112441|FG001|Overall Study|Disc. due to death before first dosing|1
1063820|NCT01964378|2112440|FG000|Overall Study|Disc. due to AE before first dosing|1
1063821|NCT01964378|2112441|FG001|Overall Study|Disc. due to AE before first dosing|0
1063822|NCT01964378|2112440|FG000|Overall Study|Death|3
1063823|NCT01964378|2112441|FG001|Overall Study|Death|2
1063824|NCT01964378|2112440|FG000|Overall Study|Adverse Event|12
1063825|NCT01964378|2112441|FG001|Overall Study|Adverse Event|5
1063826|NCT01964378|2112440|FG000|Overall Study|Lack of Efficacy|0
1063827|NCT01964378|2112441|FG001|Overall Study|Lack of Efficacy|1
1063828|NCT01964378|2112440|FG000|Overall Study|Protocol Violation|0
1063829|NCT01964378|2112441|FG001|Overall Study|Protocol Violation|1
1063830|NCT01964378|2112440|FG000|Overall Study|Lost to Follow-up|0
1063831|NCT01964378|2112441|FG001|Overall Study|Lost to Follow-up|1
1063832|NCT01964378|2112440|FG000|Overall Study|Withdrawal by Subject|7
1063833|NCT01964378|2112441|FG001|Overall Study|Withdrawal by Subject|5
1063834|NCT01964378|2112440|FG000|Overall Study|Inclusion/exclusion criteria not met|1
1063835|NCT01964378|2112441|FG001|Overall Study|Inclusion/exclusion criteria not met|3
1063836|NCT01964378|2112440|FG000|Overall Study|Other|1
1063837|NCT01964378|2112441|FG001|Overall Study|Other|2
1063838|NCT01964430|2112449|FG000|Overall Study|Adverse Event|71
1063839|NCT01964430|2112450|FG001|Overall Study|Adverse Event|37
1063840|NCT01964430|2112449|FG000|Overall Study|Withdrawal by Subject|36
1063841|NCT01964430|2112450|FG001|Overall Study|Withdrawal by Subject|27
1063842|NCT01964430|2112449|FG000|Overall Study|Death|1
1063843|NCT01964430|2112450|FG001|Overall Study|Death|3
1063844|NCT01964430|2112449|FG000|Overall Study|Protocol Deviation|0
1063845|NCT01964430|2112450|FG001|Overall Study|Protocol Deviation|1
1063846|NCT01964430|2112449|FG000|Overall Study|Physician Decision|5
1063847|NCT01964430|2112450|FG001|Overall Study|Physician Decision|4
1063848|NCT01964430|2112449|FG000|Overall Study|Disease Relapse|28
1063849|NCT01964430|2112450|FG001|Overall Study|Disease Relapse|38
1063850|NCT01964430|2112449|FG000|Overall Study|Miscellaneous|1
1063851|NCT01964430|2112450|FG001|Overall Study|Miscellaneous|3
1063852|NCT01964430|2112449|FG000|Overall Study|Randomized but not Treated|3
1063853|NCT01964430|2112450|FG001|Overall Study|Randomized but not Treated|11
1063854|NCT01964521|2112456|FG000|Overall Study|Lost to Follow-up|4
1063855|NCT01964547|2112463|FG000|Overall Study|Adverse Event|8
1063856|NCT01964547|2112464|FG001|Overall Study|Adverse Event|2
1063857|NCT01964547|2112463|FG000|Overall Study|Withdrawal by Subject|4
1063858|NCT01964547|2112464|FG001|Overall Study|Withdrawal by Subject|7
1063859|NCT01964547|2112463|FG000|Overall Study|Lost to Follow-up|0
1063860|NCT01964547|2112464|FG001|Overall Study|Lost to Follow-up|1
1063861|NCT01964547|2112463|FG000|Overall Study|Withdrawal by Investigator|0
1063862|NCT01964547|2112464|FG001|Overall Study|Withdrawal by Investigator|1
1063863|NCT01964716|2112472|FG000|Overall Study|Withdrawal by Subject|2
1063864|NCT01964716|2112473|FG001|Overall Study|Withdrawal by Subject|3
1063865|NCT01964716|2112472|FG000|Overall Study|Lost to Follow-up|1
1063866|NCT01964716|2112473|FG001|Overall Study|Lost to Follow-up|2
1063867|NCT01964716|2112472|FG000|Overall Study|No longer met eligibility criteria|1
1063868|NCT01964716|2112473|FG001|Overall Study|No longer met eligibility criteria|1
1063869|NCT01964716|2112472|FG000|Overall Study|Death|1
1063870|NCT01964716|2112473|FG001|Overall Study|Death|0
1063871|NCT01964755|2112487|FG000|Overall Study|Death|2
1063872|NCT01964898|2112493|FG000|Overall Study|ineligible post-randomization|1
1063873|NCT01964898|2112494|FG001|Overall Study|ineligible post-randomization|1
1063874|NCT01964898|2112493|FG000|Overall Study|did not receive the allocated interventi|2
1063875|NCT01964898|2112494|FG001|Overall Study|did not receive the allocated interventi|1
1063876|NCT01964898|2112493|FG000|Overall Study|Lost to Follow-up|3
1063877|NCT01964898|2112494|FG001|Overall Study|Lost to Follow-up|5
1063878|NCT01964898|2112493|FG000|Overall Study|Withdrawal by Subject|1
1063879|NCT01964898|2112494|FG001|Overall Study|Withdrawal by Subject|0
1063880|NCT01964924|2112500|FG000|Trametinib Monotherapy|Progression|19
1063881|NCT01964924|2112501|FG001|Trametinib Monotherapy|Progression|0
1063882|NCT01964950|2112512|FG000|Overall Study|Protocol Violation|25
1063883|NCT01964963|2112519|FG000|Overall Study|Case Report Forms Uncollected|888
1063884|NCT01964963|2112519|FG000|Overall Study|Protocol Deviation|50
1063885|NCT01964963|2112519|FG000|Overall Study|Data Reliability was not Assured|5
1063886|NCT01964976|2112525|FG000|Overall Study|Protocol Violation|31
1063887|NCT01965158|2112549|FG000|Overall Study|Adverse Event|14
1063888|NCT01965158|2112550|FG001|Overall Study|Adverse Event|5
1063889|NCT01965158|2112549|FG000|Overall Study|Withdrawal by Subject|16
1063890|NCT01965158|2112550|FG001|Overall Study|Withdrawal by Subject|24
1063891|NCT01965158|2112549|FG000|Overall Study|Lost to Follow-up|7
1063892|NCT01965158|2112550|FG001|Overall Study|Lost to Follow-up|5
1063893|NCT01965158|2112549|FG000|Overall Study|Protocol Violation|1
1063894|NCT01965158|2112550|FG001|Overall Study|Protocol Violation|1
1063895|NCT01965158|2112549|FG000|Overall Study|Other - Miscellaneous|3
1063896|NCT01965158|2112550|FG001|Overall Study|Other - Miscellaneous|0
1063897|NCT01965262|2112556|FG000|Second Intervention (7 Days)|Discontinued|0
1063898|NCT01965262|2112557|FG001|Second Intervention (7 Days)|Discontinued|1
1063899|NCT01965262|2112556|FG000|Second Intervention (7 Days)|Poor lens fit|0
1063900|NCT01965262|2112557|FG001|Second Intervention (7 Days)|Poor lens fit|9
1063901|NCT01965262|2112556|FG000|Second Intervention (7 Days)|Poor visual acuity|1
1063902|NCT01965262|2112557|FG001|Second Intervention (7 Days)|Poor visual acuity|0
1063903|NCT01965327|2112584|FG000|Overall Study|Physician Decision|2
1063904|NCT01965431|2112597|FG000|Overall Study|Adverse Event|0
1063905|NCT01965431|2112598|FG001|Overall Study|Adverse Event|1
1063906|NCT01965431|2112599|FG002|Overall Study|Adverse Event|0
1063907|NCT01965431|2112600|FG003|Overall Study|Adverse Event|0
1063908|NCT01965431|2112601|FG004|Overall Study|Adverse Event|0
1063909|NCT01965431|2112602|FG005|Overall Study|Adverse Event|0
1063910|NCT01965431|2112597|FG000|Overall Study|Other than stated above|6
1063911|NCT01965431|2112598|FG001|Overall Study|Other than stated above|5
1063912|NCT01965431|2112599|FG002|Overall Study|Other than stated above|6
1063913|NCT01965431|2112600|FG003|Overall Study|Other than stated above|6
1063914|NCT01965431|2112601|FG004|Overall Study|Other than stated above|6
1063915|NCT01965431|2112602|FG005|Overall Study|Other than stated above|6
1063916|NCT01965535|2112614|FG000|Overall Study|Lack of Efficacy|2
1063917|NCT01965535|2112615|FG001|Overall Study|Lack of Efficacy|1
1063918|NCT01965600|2112628|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
1063919|NCT01965600|2112629|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
1063920|NCT01965600|2112630|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
1063921|NCT01965600|2112631|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
1063922|NCT01965600|2112628|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1063923|NCT01965600|2112629|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
1063924|NCT01965600|2112630|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1063925|NCT01965600|2112631|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1063926|NCT01965600|2112628|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
1063927|NCT01965600|2112629|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1063928|NCT01965600|2112630|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1063929|NCT01965600|2112631|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1063930|NCT01965600|2112628|FG000|Washout Period of Approximately 15 Days|Adverse Event|0
1063931|NCT01965600|2112629|FG001|Washout Period of Approximately 15 Days|Adverse Event|0
1063932|NCT01965600|2112630|FG002|Washout Period of Approximately 15 Days|Adverse Event|0
1063933|NCT01965600|2112631|FG003|Washout Period of Approximately 15 Days|Adverse Event|1
1063934|NCT01965600|2112628|FG000|Second Intervention|Study terminated by Sponsor|0
1063935|NCT01965600|2112629|FG001|Second Intervention|Study terminated by Sponsor|0
1063936|NCT01965600|2112630|FG002|Second Intervention|Study terminated by Sponsor|2
1063937|NCT01965600|2112631|FG003|Second Intervention|Study terminated by Sponsor|2
1063938|NCT01965652|2112641|FG000|Overall Study|Adverse Event|40
1063939|NCT01965652|2112642|FG001|Overall Study|Adverse Event|37
1063940|NCT01965652|2112641|FG000|Overall Study|Withdrawal by Subject|62
1063941|NCT01965652|2112642|FG001|Overall Study|Withdrawal by Subject|69
1063942|NCT01965652|2112641|FG000|Overall Study|Lost to Follow-up|53
1063943|NCT01965652|2112642|FG001|Overall Study|Lost to Follow-up|40
1063944|NCT01965652|2112641|FG000|Overall Study|Protocol Violation|34
1063945|NCT01965652|2112642|FG001|Overall Study|Protocol Violation|38
1063946|NCT01965652|2112641|FG000|Overall Study|Death|3
1063947|NCT01965652|2112642|FG001|Overall Study|Death|4
1063948|NCT01965652|2112641|FG000|Overall Study|Other - Miscellaneous|18
1063949|NCT01965652|2112642|FG001|Overall Study|Other - Miscellaneous|21
1063950|NCT01965652|2112641|FG000|Overall Study|Pregnancy|0
1063951|NCT01965652|2112642|FG001|Overall Study|Pregnancy|1
1063952|NCT01965834|2112665|FG000|Overall Study|Lack of Efficacy|4
1063953|NCT01965860|2112672|FG000|Overall Study|Pregnancy|1
1063954|NCT01965860|2112673|FG001|Overall Study|Pregnancy|0
1063955|NCT01965860|2112674|FG002|Overall Study|Pregnancy|1
1063956|NCT01965860|2112672|FG000|Overall Study|Logistics|1
1063957|NCT01965860|2112673|FG001|Overall Study|Logistics|0
1063958|NCT01965860|2112674|FG002|Overall Study|Logistics|0
1063959|NCT01965938|2112689|FG000|Overall Study|Withdrawal by Subject|1
1063960|NCT01965938|2112690|FG001|Overall Study|Withdrawal by Subject|0
1063961|NCT01966003|2112700|FG000|Overall Study|Death|43
1063962|NCT01966003|2112701|FG001|Overall Study|Death|36
1063963|NCT01966003|2112700|FG000|Overall Study|Protocol Violation|6
1063964|NCT01966003|2112701|FG001|Overall Study|Protocol Violation|4
1063965|NCT01966003|2112700|FG000|Overall Study|Lost to Follow-up|4
1063966|NCT01966003|2112701|FG001|Overall Study|Lost to Follow-up|3
1063967|NCT01966003|2112700|FG000|Overall Study|Physician Decision|12
1063968|NCT01966003|2112701|FG001|Overall Study|Physician Decision|13
1063969|NCT01966003|2112700|FG000|Overall Study|Withdrawal by Subject|29
1063970|NCT01966003|2112701|FG001|Overall Study|Withdrawal by Subject|19
1063971|NCT01966003|2112700|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131
1063972|NCT01966003|2112701|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127
1063973|NCT01966003|2112700|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44
1063974|NCT01966003|2112701|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67
1063975|NCT01966003|2112700|FG000|Overall Study|Other|1
1063976|NCT01966003|2112701|FG001|Overall Study|Other|1
1063977|NCT01966042|2112707|FG000|Overall Study|Death|2
1063978|NCT01966068|2112713|FG000|Overall Study|Withdrawal by Subject|57
1063979|NCT01966068|2112713|FG000|Overall Study|Lost to Follow-up|81
1063980|NCT01966107|2112720|FG000|Overall Study|excluded from FAS|21
1063981|NCT01966107|2112721|FG001|Overall Study|excluded from FAS|20
1063982|NCT01966107|2112720|FG000|Overall Study|discontinued treatment|345
1063983|NCT01966107|2112721|FG001|Overall Study|discontinued treatment|372
1063984|NCT01966107|2112720|FG000|Overall Study|due to study closure|164
1063985|NCT01966107|2112721|FG001|Overall Study|due to study closure|186
1063986|NCT01966107|2112720|FG000|Overall Study|withdrew from the study|272
1063987|NCT01966107|2112721|FG001|Overall Study|withdrew from the study|303
1063988|NCT01966120|2112729|FG000|Overall Study|Withdrawal by Subject|0
1063989|NCT01966120|2112730|FG001|Overall Study|Withdrawal by Subject|5
1063990|NCT01966120|2112729|FG000|Overall Study|Lost to Follow-up|1
1063991|NCT01966120|2112730|FG001|Overall Study|Lost to Follow-up|1
1063992|NCT01966432|2112777|FG000|Overall Study|Lost to Follow-up|3
1063993|NCT01966432|2112778|FG001|Overall Study|Lost to Follow-up|2
1063994|NCT01966432|2112779|FG002|Overall Study|Lost to Follow-up|5
1063995|NCT01966432|2112777|FG000|Overall Study|Withdrawal by Subject|1
1063996|NCT01966432|2112778|FG001|Overall Study|Withdrawal by Subject|3
1063997|NCT01966432|2112779|FG002|Overall Study|Withdrawal by Subject|0
1063998|NCT01966432|2112777|FG000|Overall Study|Subject Incarcerated|0
1063999|NCT01966432|2112778|FG001|Overall Study|Subject Incarcerated|0
1064000|NCT01966432|2112779|FG002|Overall Study|Subject Incarcerated|1
1064001|NCT01966432|2112777|FG000|Overall Study|SBIRT program ended|1
1064002|NCT01966432|2112778|FG001|Overall Study|SBIRT program ended|8
1064003|NCT01966432|2112779|FG002|Overall Study|SBIRT program ended|20
1064004|NCT01966445|2112795|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
1064005|NCT01966445|2112796|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
1064006|NCT01966445|2112797|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
1064007|NCT01966445|2112798|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
1064008|NCT01966445|2112799|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
1064009|NCT01966445|2112800|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
1064010|NCT01966445|2112801|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
1064011|NCT01966445|2112795|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
1064012|NCT01966445|2112796|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
1064013|NCT01966445|2112797|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
1064014|NCT01966445|2112798|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
1064015|NCT01966445|2112799|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
1064016|NCT01966445|2112800|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
1064017|NCT01966445|2112801|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
1064018|NCT01966445|2112795|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
1064019|NCT01966445|2112796|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
1064020|NCT01966445|2112797|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
1064021|NCT01966445|2112798|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
1064022|NCT01966445|2112799|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
1064023|NCT01966445|2112800|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
1064024|NCT01966445|2112801|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
1064025|NCT01966445|2112795|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
1064026|NCT01966445|2112796|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
1064027|NCT01966445|2112797|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
1064028|NCT01966445|2112798|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
1064029|NCT01966445|2112799|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
908182|NCT00779857|1884547|FG000|Overall Study|Withdrawal by Subject|3
908183|NCT00779857|1884547|FG000|Overall Study|Missed Visit|2
908184|NCT00779909|1884568|FG000|Overall Study|Lost to Follow-up|1
908185|NCT00779909|1884569|FG001|Overall Study|Lost to Follow-up|0
908186|NCT00779909|1884570|FG002|Overall Study|Lost to Follow-up|0
908187|NCT00779909|1884571|FG003|Overall Study|Lost to Follow-up|1
908188|NCT00779909|1884568|FG000|Overall Study|Withdrawal by Subject|0
908189|NCT00779909|1884569|FG001|Overall Study|Withdrawal by Subject|1
908190|NCT00779909|1884570|FG002|Overall Study|Withdrawal by Subject|0
908191|NCT00779909|1884571|FG003|Overall Study|Withdrawal by Subject|0
908192|NCT00780143|1884597|FG000|Overall Study|Progressive disease|1
908193|NCT00780143|1884597|FG000|Overall Study|Toxicity|1
908194|NCT00780143|1884597|FG000|Overall Study|Adverse Event|1
908195|NCT00780273|1884614|FG000|Overall Study|Death|1
908196|NCT00780273|1884614|FG000|Overall Study|Lost to Follow-up|1
908197|NCT00780416|1884642|FG000|Overall Study|Physician Decision|3
908198|NCT00780416|1884643|FG001|Overall Study|Physician Decision|3
908199|NCT00780416|1884642|FG000|Overall Study|Protocol Violation|1
908200|NCT00780416|1884643|FG001|Overall Study|Protocol Violation|0
908201|NCT00780416|1884642|FG000|Overall Study|Withdrawal by Subject|8
908202|NCT00780416|1884643|FG001|Overall Study|Withdrawal by Subject|6
908203|NCT00780559|1884664|FG000|Overall Study|Lost to Follow-up|2
908204|NCT00780559|1884665|FG001|Overall Study|Lost to Follow-up|7
1064030|NCT01966445|2112800|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
1064031|NCT01966445|2112801|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
1064032|NCT01966445|2112795|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1064033|NCT01966445|2112796|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1064034|NCT01966445|2112797|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1064035|NCT01966445|2112798|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1064036|NCT01966445|2112799|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1064037|NCT01966445|2112800|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1064038|NCT01966445|2112801|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
1064045|NCT01967069|2112933|FG000|Overall Study|Adverse Event|2
1064046|NCT01967069|2112934|FG001|Overall Study|Adverse Event|2
1064047|NCT01967069|2112933|FG000|Overall Study|Lost to Follow-up|5
1064048|NCT01967069|2112934|FG001|Overall Study|Lost to Follow-up|2
1064049|NCT01967069|2112933|FG000|Overall Study|Withdrawal by Subject|1
1064050|NCT01967069|2112934|FG001|Overall Study|Withdrawal by Subject|3
1064051|NCT01967069|2112933|FG000|Overall Study|Lack of Efficacy|0
1064052|NCT01967069|2112934|FG001|Overall Study|Lack of Efficacy|1
1064053|NCT01967134|2112956|FG000|Overall Study|Lost to Follow-up|0
1064054|NCT01967134|2112957|FG001|Overall Study|Lost to Follow-up|1
1064055|NCT01967134|2112958|FG002|Overall Study|Lost to Follow-up|0
1064056|NCT01967147|2112968|FG000|Overall Study|Adverse Event|5
1064057|NCT01967147|2112969|FG001|Overall Study|Adverse Event|2
1064058|NCT01967147|2112968|FG000|Overall Study|Lack of Efficacy|1
1064059|NCT01967147|2112969|FG001|Overall Study|Lack of Efficacy|4
1064060|NCT01967147|2112968|FG000|Overall Study|Lost to Follow-up|1
1064061|NCT01967147|2112969|FG001|Overall Study|Lost to Follow-up|2
1064062|NCT01967147|2112968|FG000|Overall Study|Withdrawal by Subject|2
1064063|NCT01967147|2112969|FG001|Overall Study|Withdrawal by Subject|4
1064064|NCT01967147|2112968|FG000|Overall Study|Non-compliance with Study Drug|0
1064065|NCT01967147|2112969|FG001|Overall Study|Non-compliance with Study Drug|3
1064066|NCT01967147|2112968|FG000|Overall Study|Other|4
1064067|NCT01967147|2112969|FG001|Overall Study|Other|5
1064068|NCT01967173|2112984|FG000|Overall Study|Lost to Follow-up|5
1064069|NCT01967173|2112985|FG001|Overall Study|Lost to Follow-up|3
1064070|NCT01967173|2112986|FG002|Overall Study|Lost to Follow-up|2
1064071|NCT01967173|2112987|FG003|Overall Study|Lost to Follow-up|4
1064072|NCT01967173|2112988|FG004|Overall Study|Lost to Follow-up|8
1064073|NCT01967173|2112989|FG005|Overall Study|Lost to Follow-up|12
1064074|NCT01967173|2112990|FG006|Overall Study|Lost to Follow-up|6
1064075|NCT01967173|2112991|FG007|Overall Study|Lost to Follow-up|8
1064076|NCT01967173|2112984|FG000|Overall Study|Physician Decision|2
1064077|NCT01967173|2112985|FG001|Overall Study|Physician Decision|0
1064078|NCT01967173|2112986|FG002|Overall Study|Physician Decision|2
1064079|NCT01967173|2112987|FG003|Overall Study|Physician Decision|1
1064080|NCT01967173|2112988|FG004|Overall Study|Physician Decision|1
1064081|NCT01967173|2112989|FG005|Overall Study|Physician Decision|1
1064082|NCT01967173|2112990|FG006|Overall Study|Physician Decision|1
1064083|NCT01967173|2112991|FG007|Overall Study|Physician Decision|0
1064084|NCT01967173|2112984|FG000|Overall Study|Lack of Efficacy|2
1064085|NCT01967173|2112985|FG001|Overall Study|Lack of Efficacy|0
1064086|NCT01967173|2112986|FG002|Overall Study|Lack of Efficacy|2
1064087|NCT01967173|2112987|FG003|Overall Study|Lack of Efficacy|2
1064088|NCT01967173|2112988|FG004|Overall Study|Lack of Efficacy|0
1064089|NCT01967173|2112989|FG005|Overall Study|Lack of Efficacy|1
1064090|NCT01967173|2112990|FG006|Overall Study|Lack of Efficacy|0
1064091|NCT01967173|2112991|FG007|Overall Study|Lack of Efficacy|2
1064092|NCT01967173|2112984|FG000|Overall Study|Pregnancy|0
1064093|NCT01967173|2112985|FG001|Overall Study|Pregnancy|0
1064094|NCT01967173|2112986|FG002|Overall Study|Pregnancy|0
1064095|NCT01967173|2112987|FG003|Overall Study|Pregnancy|0
1064096|NCT01967173|2112988|FG004|Overall Study|Pregnancy|0
1064097|NCT01967173|2112989|FG005|Overall Study|Pregnancy|0
1064098|NCT01967173|2112990|FG006|Overall Study|Pregnancy|1
1064099|NCT01967173|2112991|FG007|Overall Study|Pregnancy|1
1064100|NCT01967173|2112984|FG000|Overall Study|Adverse Event|0
1064101|NCT01967173|2112985|FG001|Overall Study|Adverse Event|0
1064102|NCT01967173|2112986|FG002|Overall Study|Adverse Event|0
1064103|NCT01967173|2112987|FG003|Overall Study|Adverse Event|0
1064104|NCT01967173|2112988|FG004|Overall Study|Adverse Event|0
1064105|NCT01967173|2112989|FG005|Overall Study|Adverse Event|0
1064106|NCT01967173|2112990|FG006|Overall Study|Adverse Event|0
1064107|NCT01967173|2112991|FG007|Overall Study|Adverse Event|1
1064108|NCT01967173|2112984|FG000|Overall Study|Withdrawal by Subject|15
1064109|NCT01967173|2112985|FG001|Overall Study|Withdrawal by Subject|14
908205|NCT00780559|1884664|FG000|Overall Study|Death|1
908206|NCT00780559|1884665|FG001|Overall Study|Death|0
908207|NCT00780910|1884724|FG000|Overall Study|Adverse Event|2
908208|NCT00780975|1884737|FG000|Overall Study|Progressive disease|3
908209|NCT00780975|1884737|FG000|Overall Study|Toxicity|5
1064110|NCT01967173|2112986|FG002|Overall Study|Withdrawal by Subject|10
1064111|NCT01967173|2112987|FG003|Overall Study|Withdrawal by Subject|7
1064112|NCT01967173|2112988|FG004|Overall Study|Withdrawal by Subject|8
1064113|NCT01967173|2112989|FG005|Overall Study|Withdrawal by Subject|9
1064114|NCT01967173|2112990|FG006|Overall Study|Withdrawal by Subject|10
1064115|NCT01967173|2112991|FG007|Overall Study|Withdrawal by Subject|12
1064116|NCT01967225|2113007|FG000|Overall Study|Adverse Event|3
1064117|NCT01967225|2113008|FG001|Overall Study|Adverse Event|1
1064118|NCT01967225|2113007|FG000|Overall Study|Withdrawal by Subject|2
1064119|NCT01967225|2113008|FG001|Overall Study|Withdrawal by Subject|1
1064120|NCT01967225|2113007|FG000|Overall Study|Lack of Efficacy|1
1064121|NCT01967225|2113008|FG001|Overall Study|Lack of Efficacy|1
1064122|NCT01967225|2113007|FG000|Overall Study|Switching to other therapy|2
1064123|NCT01967225|2113008|FG001|Overall Study|Switching to other therapy|0
1064124|NCT01967225|2113007|FG000|Overall Study|Protocol driven decision point|1
1064125|NCT01967225|2113008|FG001|Overall Study|Protocol driven decision point|0
1064126|NCT01967225|2113007|FG000|Overall Study|Logistical difficulties|1
1064127|NCT01967225|2113008|FG001|Overall Study|Logistical difficulties|0
1064128|NCT01967225|2113007|FG000|Overall Study|Protocol Violation|2
1064129|NCT01967225|2113008|FG001|Overall Study|Protocol Violation|0
1064130|NCT01967277|2113018|FG000|Overall Study|Lost to Follow-up|1
1064131|NCT01967277|2113019|FG001|Overall Study|Lost to Follow-up|2
1064132|NCT01967277|2113018|FG000|Overall Study|Unrelated illness|0
1064133|NCT01967277|2113019|FG001|Overall Study|Unrelated illness|1
1064134|NCT01967537|2113053|FG000|Overall Study|Withdrawal by Subject|52
1064135|NCT01967537|2113053|FG000|Overall Study|Refuse treatment|2
1064136|NCT01967537|2113053|FG000|Overall Study|Lost to Follow-up|6
1064137|NCT01967550|2113059|FG000|Overall Study|Withdrawal by Subject|1
1064138|NCT01967550|2113060|FG001|Overall Study|Withdrawal by Subject|0
1064139|NCT01967550|2113059|FG000|Overall Study|Adverse Event|2
1064140|NCT01967550|2113060|FG001|Overall Study|Adverse Event|0
1064141|NCT01967550|2113059|FG000|Overall Study|Protocol Violation|2
1064142|NCT01967550|2113060|FG001|Overall Study|Protocol Violation|1
1064143|NCT01967550|2113059|FG000|Overall Study|Non Compliance|0
1064144|NCT01967550|2113060|FG001|Overall Study|Non Compliance|1
1064145|NCT01967576|2113066|FG000|Overall Study|Withdrawal by Subject|3
1064146|NCT01967576|2113066|FG000|Overall Study|Progressed/Removed from treatment|1
1064147|NCT01967576|2113066|FG000|Overall Study|Study closing at site|1
1064148|NCT01967576|2113066|FG000|Overall Study|Adverse Event|1
1064149|NCT01967576|2113066|FG000|Overall Study|Refused further treatment|1
1064150|NCT01967628|2113072|FG000|Overall Study|Withdrawal by Subject|2
1064151|NCT01967628|2113073|FG001|Overall Study|Withdrawal by Subject|0
1064152|NCT01967628|2113072|FG000|Overall Study|Unable to complete bronchoscopy|4
1064153|NCT01967628|2113073|FG001|Overall Study|Unable to complete bronchoscopy|6
1064154|NCT01967628|2113072|FG000|Overall Study|Lost to Follow-up|1
1064155|NCT01967628|2113073|FG001|Overall Study|Lost to Follow-up|0
1064156|NCT01967628|2113072|FG000|Overall Study|Low protein concentration in sample|20
1064157|NCT01967628|2113073|FG001|Overall Study|Low protein concentration in sample|25
1064158|NCT01967706|2113086|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
1064159|NCT01967706|2113087|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
1064160|NCT01967706|2113088|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
1064161|NCT01967706|2113089|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
1064162|NCT01967719|2113100|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
1064163|NCT01967719|2113101|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
1064164|NCT01967719|2113102|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
1064165|NCT01967719|2113103|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
1064166|NCT01967719|2113100|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0
1064167|NCT01967719|2113101|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1
1064168|NCT01967719|2113102|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0
1064169|NCT01967719|2113103|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0
1064170|NCT01967732|2113115|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1064171|NCT01967732|2113116|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
1064172|NCT01967732|2113117|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1064173|NCT01967732|2113118|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1064174|NCT01967732|2113115|FG000|First Intervention (Day 1)|Poor venous access|0
1064175|NCT01967732|2113116|FG001|First Intervention (Day 1)|Poor venous access|1
1064176|NCT01967732|2113117|FG002|First Intervention (Day 1)|Poor venous access|0
1064177|NCT01967732|2113118|FG003|First Intervention (Day 1)|Poor venous access|0
1064178|NCT01967888|2113149|FG000|Overall Study|Lost to Follow-up|6
1064179|NCT01967888|2113150|FG001|Overall Study|Lost to Follow-up|4
1064180|NCT01967888|2113149|FG000|Overall Study|Withdrawal by Subject|1
1064181|NCT01967888|2113150|FG001|Overall Study|Withdrawal by Subject|1
1064182|NCT01967888|2113149|FG000|Overall Study|Did Not Have Transplant|1
1064183|NCT01967888|2113150|FG001|Overall Study|Did Not Have Transplant|0
1064184|NCT01967888|2113149|FG000|Overall Study|Research visit not done, data recorded|1
1064185|NCT01967888|2113150|FG001|Overall Study|Research visit not done, data recorded|0
1064186|NCT01967888|2113149|FG000|Overall Study|Subject excluded after randomization|1
1064187|NCT01967888|2113150|FG001|Overall Study|Subject excluded after randomization|0
1064188|NCT01967888|2113149|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0
1064189|NCT01967888|2113150|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1
1064190|NCT01967888|2113149|FG000|Overall Study|Subject Unable To Comply With Final Day|0
1064191|NCT01967888|2113150|FG001|Overall Study|Subject Unable To Comply With Final Day|1
1064192|NCT01967940|2113159|FG000|Part 2|Enrolled in Part 2 and Never Treated|0
1064193|NCT01967940|2113160|FG001|Part 2|Enrolled in Part 2 and Never Treated|0
1064194|NCT01967940|2113161|FG002|Part 2|Enrolled in Part 2 and Never Treated|0
1064195|NCT01967940|2113162|FG003|Part 2|Enrolled in Part 2 and Never Treated|1
1064196|NCT01967940|2113159|FG000|Part 2|Adverse Event|0
1064197|NCT01967940|2113160|FG001|Part 2|Adverse Event|0
1064198|NCT01967940|2113161|FG002|Part 2|Adverse Event|0
1064199|NCT01967940|2113162|FG003|Part 2|Adverse Event|1
1064200|NCT01967940|2113159|FG000|Part 2|Unknown Reason|0
1064201|NCT01967940|2113160|FG001|Part 2|Unknown Reason|0
1064202|NCT01967940|2113161|FG002|Part 2|Unknown Reason|0
1064203|NCT01967940|2113162|FG003|Part 2|Unknown Reason|1
1064204|NCT01968031|2113175|FG000|Overall Study|Adverse Event|13
1064205|NCT01968031|2113176|FG001|Overall Study|Adverse Event|10
1064206|NCT01968031|2113177|FG002|Overall Study|Adverse Event|22
1064207|NCT01968031|2113175|FG000|Overall Study|Withdrawal by Subject|3
1064208|NCT01968031|2113176|FG001|Overall Study|Withdrawal by Subject|7
1064209|NCT01968031|2113177|FG002|Overall Study|Withdrawal by Subject|3
1064210|NCT01968031|2113175|FG000|Overall Study|Did not meet entry criteria|1
1064211|NCT01968031|2113176|FG001|Overall Study|Did not meet entry criteria|1
1064212|NCT01968031|2113177|FG002|Overall Study|Did not meet entry criteria|1
1064213|NCT01968031|2113175|FG000|Overall Study|Noncompliance|0
1064214|NCT01968031|2113176|FG001|Overall Study|Noncompliance|0
1064215|NCT01968031|2113177|FG002|Overall Study|Noncompliance|2
1064216|NCT01968031|2113175|FG000|Overall Study|Failed inclusion criteria|0
1064217|NCT01968031|2113176|FG001|Overall Study|Failed inclusion criteria|2
1064218|NCT01968031|2113177|FG002|Overall Study|Failed inclusion criteria|0
1064219|NCT01968031|2113175|FG000|Overall Study|Death|0
1064220|NCT01968031|2113176|FG001|Overall Study|Death|0
1064221|NCT01968031|2113177|FG002|Overall Study|Death|1
1064222|NCT01968031|2113175|FG000|Overall Study|Prohibited concomitant medication|1
1064223|NCT01968031|2113176|FG001|Overall Study|Prohibited concomitant medication|0
1064224|NCT01968031|2113177|FG002|Overall Study|Prohibited concomitant medication|0
1064225|NCT01968070|2113209|FG000|Period 1|Withdrawal by Subject|0
1064226|NCT01968070|2113210|FG001|Period 1|Withdrawal by Subject|1
1064227|NCT01968070|2113211|FG002|Period 1|Withdrawal by Subject|0
1064228|NCT01968070|2113212|FG003|Period 1|Withdrawal by Subject|0
1064229|NCT01968070|2113213|FG004|Period 1|Withdrawal by Subject|0
1064230|NCT01968070|2113214|FG005|Period 1|Withdrawal by Subject|0
1064231|NCT01968070|2113215|FG006|Period 1|Withdrawal by Subject|1
1064232|NCT01968070|2113216|FG007|Period 1|Withdrawal by Subject|0
1064233|NCT01968070|2113217|FG008|Period 1|Withdrawal by Subject|0
1064234|NCT01968070|2113218|FG009|Period 1|Withdrawal by Subject|0
1064235|NCT01968070|2113219|FG010|Period 1|Withdrawal by Subject|0
1064236|NCT01968070|2113220|FG011|Period 1|Withdrawal by Subject|0
1064237|NCT01968070|2113221|FG012|Period 1|Withdrawal by Subject|0
1064238|NCT01968070|2113222|FG013|Period 1|Withdrawal by Subject|0
1064239|NCT01968070|2113223|FG014|Period 1|Withdrawal by Subject|0
1064240|NCT01968070|2113224|FG015|Period 1|Withdrawal by Subject|1
1064241|NCT01968070|2113225|FG016|Period 1|Withdrawal by Subject|0
1064242|NCT01968070|2113226|FG017|Period 1|Withdrawal by Subject|0
1064243|NCT01968070|2113209|FG000|Period 1|Protocol Violation|0
1064244|NCT01968070|2113210|FG001|Period 1|Protocol Violation|0
1064245|NCT01968070|2113211|FG002|Period 1|Protocol Violation|0
1064246|NCT01968070|2113212|FG003|Period 1|Protocol Violation|1
1064247|NCT01968070|2113213|FG004|Period 1|Protocol Violation|1
1064248|NCT01968070|2113214|FG005|Period 1|Protocol Violation|0
1064249|NCT01968070|2113215|FG006|Period 1|Protocol Violation|0
1064250|NCT01968070|2113216|FG007|Period 1|Protocol Violation|0
1064251|NCT01968070|2113217|FG008|Period 1|Protocol Violation|0
1064252|NCT01968070|2113218|FG009|Period 1|Protocol Violation|0
1064253|NCT01968070|2113219|FG010|Period 1|Protocol Violation|0
1064254|NCT01968070|2113220|FG011|Period 1|Protocol Violation|0
1064255|NCT01968070|2113221|FG012|Period 1|Protocol Violation|0
1064256|NCT01968070|2113222|FG013|Period 1|Protocol Violation|0
1064257|NCT01968070|2113223|FG014|Period 1|Protocol Violation|0
1064258|NCT01968070|2113224|FG015|Period 1|Protocol Violation|0
1064259|NCT01968070|2113225|FG016|Period 1|Protocol Violation|0
1064260|NCT01968070|2113226|FG017|Period 1|Protocol Violation|0
1064261|NCT01968070|2113209|FG000|Period 1|Lost to Follow-up|0
1064262|NCT01968070|2113210|FG001|Period 1|Lost to Follow-up|0
1064263|NCT01968070|2113211|FG002|Period 1|Lost to Follow-up|0
1064264|NCT01968070|2113212|FG003|Period 1|Lost to Follow-up|1
1064265|NCT01968070|2113213|FG004|Period 1|Lost to Follow-up|0
1064266|NCT01968070|2113214|FG005|Period 1|Lost to Follow-up|0
1064267|NCT01968070|2113215|FG006|Period 1|Lost to Follow-up|0
1064268|NCT01968070|2113216|FG007|Period 1|Lost to Follow-up|0
1064269|NCT01968070|2113217|FG008|Period 1|Lost to Follow-up|0
1064270|NCT01968070|2113218|FG009|Period 1|Lost to Follow-up|0
1064271|NCT01968070|2113219|FG010|Period 1|Lost to Follow-up|0
1064272|NCT01968070|2113220|FG011|Period 1|Lost to Follow-up|0
1064273|NCT01968070|2113221|FG012|Period 1|Lost to Follow-up|0
1064274|NCT01968070|2113222|FG013|Period 1|Lost to Follow-up|0
1064275|NCT01968070|2113223|FG014|Period 1|Lost to Follow-up|0
1064276|NCT01968070|2113224|FG015|Period 1|Lost to Follow-up|0
1064277|NCT01968070|2113225|FG016|Period 1|Lost to Follow-up|0
1064278|NCT01968070|2113226|FG017|Period 1|Lost to Follow-up|0
1064279|NCT01968070|2113209|FG000|Period 1|Adverse Event|0
1064280|NCT01968070|2113210|FG001|Period 1|Adverse Event|0
1064281|NCT01968070|2113211|FG002|Period 1|Adverse Event|0
1064282|NCT01968070|2113212|FG003|Period 1|Adverse Event|0
1064283|NCT01968070|2113213|FG004|Period 1|Adverse Event|0
1064284|NCT01968070|2113214|FG005|Period 1|Adverse Event|0
1064285|NCT01968070|2113215|FG006|Period 1|Adverse Event|1
1064286|NCT01968070|2113216|FG007|Period 1|Adverse Event|0
1064287|NCT01968070|2113217|FG008|Period 1|Adverse Event|0
1064288|NCT01968070|2113218|FG009|Period 1|Adverse Event|0
1064289|NCT01968070|2113219|FG010|Period 1|Adverse Event|0
1064290|NCT01968070|2113220|FG011|Period 1|Adverse Event|0
1064291|NCT01968070|2113221|FG012|Period 1|Adverse Event|0
1064292|NCT01968070|2113222|FG013|Period 1|Adverse Event|0
1064293|NCT01968070|2113223|FG014|Period 1|Adverse Event|0
1064294|NCT01968070|2113224|FG015|Period 1|Adverse Event|0
1064295|NCT01968070|2113225|FG016|Period 1|Adverse Event|0
1064296|NCT01968070|2113226|FG017|Period 1|Adverse Event|0
1064297|NCT01968070|2113209|FG000|Period 1|Physician Decision|0
1064298|NCT01968070|2113210|FG001|Period 1|Physician Decision|0
1064299|NCT01968070|2113211|FG002|Period 1|Physician Decision|0
1064300|NCT01968070|2113212|FG003|Period 1|Physician Decision|0
1064301|NCT01968070|2113213|FG004|Period 1|Physician Decision|0
1064302|NCT01968070|2113214|FG005|Period 1|Physician Decision|0
1064303|NCT01968070|2113215|FG006|Period 1|Physician Decision|0
1064304|NCT01968070|2113216|FG007|Period 1|Physician Decision|0
1064305|NCT01968070|2113217|FG008|Period 1|Physician Decision|0
1064306|NCT01968070|2113218|FG009|Period 1|Physician Decision|0
1064307|NCT01968070|2113219|FG010|Period 1|Physician Decision|0
1064308|NCT01968070|2113220|FG011|Period 1|Physician Decision|1
1064309|NCT01968070|2113221|FG012|Period 1|Physician Decision|0
1064310|NCT01968070|2113222|FG013|Period 1|Physician Decision|0
1064311|NCT01968070|2113223|FG014|Period 1|Physician Decision|0
1064312|NCT01968070|2113224|FG015|Period 1|Physician Decision|0
1064313|NCT01968070|2113225|FG016|Period 1|Physician Decision|0
1064314|NCT01968070|2113226|FG017|Period 1|Physician Decision|0
1064315|NCT01968070|2113209|FG000|Period 2|Withdrawal by Subject|0
1064316|NCT01968070|2113210|FG001|Period 2|Withdrawal by Subject|0
1064317|NCT01968070|2113211|FG002|Period 2|Withdrawal by Subject|0
1064318|NCT01968070|2113212|FG003|Period 2|Withdrawal by Subject|0
1064319|NCT01968070|2113213|FG004|Period 2|Withdrawal by Subject|1
1064320|NCT01968070|2113214|FG005|Period 2|Withdrawal by Subject|0
1064321|NCT01968070|2113215|FG006|Period 2|Withdrawal by Subject|0
1064322|NCT01968070|2113216|FG007|Period 2|Withdrawal by Subject|0
1064323|NCT01968070|2113217|FG008|Period 2|Withdrawal by Subject|0
1064324|NCT01968070|2113218|FG009|Period 2|Withdrawal by Subject|0
1064325|NCT01968070|2113219|FG010|Period 2|Withdrawal by Subject|0
1064326|NCT01968070|2113220|FG011|Period 2|Withdrawal by Subject|0
1064327|NCT01968070|2113221|FG012|Period 2|Withdrawal by Subject|0
1064328|NCT01968070|2113222|FG013|Period 2|Withdrawal by Subject|0
1064329|NCT01968070|2113223|FG014|Period 2|Withdrawal by Subject|0
1064330|NCT01968070|2113224|FG015|Period 2|Withdrawal by Subject|0
1064331|NCT01968070|2113225|FG016|Period 2|Withdrawal by Subject|0
1064332|NCT01968070|2113226|FG017|Period 2|Withdrawal by Subject|0
1064333|NCT01968213|2113275|FG000|Overall Study|Ongoing|90
1064334|NCT01968213|2113276|FG001|Overall Study|Ongoing|9
1064335|NCT01968434|2113356|FG000|Overall Study|Lost to Follow-up|3
1064336|NCT01968434|2113357|FG001|Overall Study|Lost to Follow-up|6
1064337|NCT01968551|2113375|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
1064338|NCT01968551|2113376|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
1064339|NCT01968551|2113377|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
1064340|NCT01968551|2113375|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0
1064341|NCT01968551|2113376|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1
1064342|NCT01968551|2113377|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0
1064343|NCT01968551|2113375|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1
1064344|NCT01968551|2113376|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1
1064345|NCT01968551|2113377|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3
1064346|NCT01968551|2113375|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0
1064347|NCT01968551|2113376|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0
1064348|NCT01968551|2113377|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2
1064349|NCT01968551|2113375|FG000|Extension Phase|Adverse Event|0
1064350|NCT01968551|2113376|FG001|Extension Phase|Adverse Event|0
1064351|NCT01968551|2113377|FG002|Extension Phase|Adverse Event|2
1064352|NCT01968551|2113375|FG000|Extension Phase|Death|0
1064353|NCT01968551|2113376|FG001|Extension Phase|Death|1
1064354|NCT01968551|2113377|FG002|Extension Phase|Death|0
1064355|NCT01968551|2113375|FG000|Extension Phase|Withdrew Consent|0
1064356|NCT01968551|2113376|FG001|Extension Phase|Withdrew Consent|0
1064357|NCT01968551|2113377|FG002|Extension Phase|Withdrew Consent|1
1064358|NCT01968551|2113375|FG000|Extension Phase|Lost to Follow-up|1
1064359|NCT01968551|2113376|FG001|Extension Phase|Lost to Follow-up|0
1064360|NCT01968551|2113377|FG002|Extension Phase|Lost to Follow-up|1
1064361|NCT01968694|2113391|FG000|Washout (1 Month)|Lost to Follow-up|0
1064362|NCT01968694|2113392|FG001|Washout (1 Month)|Lost to Follow-up|1
1064363|NCT01968707|2113408|FG000|Overall Study|Did not meet treatment day baseline|49
1064364|NCT01968707|2113409|FG001|Overall Study|Did not meet treatment day baseline|12
1064365|NCT01968707|2113410|FG002|Overall Study|Did not meet treatment day baseline|41
1064366|NCT01968707|2113411|FG003|Overall Study|Did not meet treatment day baseline|44
1064367|NCT01968707|2113412|FG004|Overall Study|Did not meet treatment day baseline|36
1064368|NCT01968707|2113413|FG005|Overall Study|Did not meet treatment day baseline|11
1064369|NCT01968707|2113414|FG006|Overall Study|Did not meet treatment day baseline|34
1064370|NCT01968707|2113415|FG007|Overall Study|Did not meet treatment day baseline|35
1064371|NCT01968811|2113448|FG000|Overall Study|Protocol Violation|4
1064372|NCT01968811|2113448|FG000|Overall Study|post op.ref. of subject to other hospita|1
1064373|NCT01968954|2113454|FG000|Overall Study|Adverse Event|6
1064374|NCT01968954|2113455|FG001|Overall Study|Adverse Event|3
1064375|NCT01968954|2113454|FG000|Overall Study|Death|1
1064376|NCT01968954|2113455|FG001|Overall Study|Death|2
1064377|NCT01968954|2113454|FG000|Overall Study|Lost to Follow-up|6
1064378|NCT01968954|2113455|FG001|Overall Study|Lost to Follow-up|4
1064379|NCT01968954|2113454|FG000|Overall Study|Withdrawal by Subject|20
1064380|NCT01968954|2113455|FG001|Overall Study|Withdrawal by Subject|23
1064381|NCT01968954|2113454|FG000|Overall Study|Other|7
1064382|NCT01968954|2113455|FG001|Overall Study|Other|8
1064383|NCT01968954|2113454|FG000|Overall Study|Protocol Violation|0
1064384|NCT01968954|2113455|FG001|Overall Study|Protocol Violation|1
1064385|NCT01968954|2113454|FG000|Overall Study|Did not met inclusion criteria|0
1064386|NCT01968954|2113455|FG001|Overall Study|Did not met inclusion criteria|2
1064387|NCT01968967|2113464|FG000|Treatment Period|Other|22
1064388|NCT01968967|2113465|FG001|Treatment Period|Other|22
1064389|NCT01968967|2113466|FG002|Treatment Period|Other|0
1064390|NCT01968967|2113467|FG003|Treatment Period|Other|0
1064391|NCT01968967|2113468|FG004|Treatment Period|Other|0
1064392|NCT01968967|2113464|FG000|Treatment Period|Withdrawal by Subject|71
1064393|NCT01968967|2113465|FG001|Treatment Period|Withdrawal by Subject|61
1064394|NCT01968967|2113466|FG002|Treatment Period|Withdrawal by Subject|0
1064395|NCT01968967|2113467|FG003|Treatment Period|Withdrawal by Subject|0
1064396|NCT01968967|2113468|FG004|Treatment Period|Withdrawal by Subject|0
1064397|NCT01968967|2113464|FG000|Treatment Period|Did Not Meet Entrance Criteria|2
1064398|NCT01968967|2113465|FG001|Treatment Period|Did Not Meet Entrance Criteria|3
1064399|NCT01968967|2113466|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
1064400|NCT01968967|2113467|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
1064401|NCT01968967|2113468|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
1064402|NCT01968967|2113464|FG000|Treatment Period|Lost to Follow-up|26
1064403|NCT01968967|2113465|FG001|Treatment Period|Lost to Follow-up|31
1064404|NCT01968967|2113466|FG002|Treatment Period|Lost to Follow-up|0
1064405|NCT01968967|2113467|FG003|Treatment Period|Lost to Follow-up|0
1064406|NCT01968967|2113468|FG004|Treatment Period|Lost to Follow-up|0
1064407|NCT01968967|2113464|FG000|Treatment Period|Protocol Violation|1
1064408|NCT01968967|2113465|FG001|Treatment Period|Protocol Violation|2
1064409|NCT01968967|2113466|FG002|Treatment Period|Protocol Violation|0
1064410|NCT01968967|2113467|FG003|Treatment Period|Protocol Violation|0
1064411|NCT01968967|2113468|FG004|Treatment Period|Protocol Violation|0
1064412|NCT01968967|2113464|FG000|Treatment Period|Adverse Event|9
1064413|NCT01968967|2113465|FG001|Treatment Period|Adverse Event|8
1064414|NCT01968967|2113466|FG002|Treatment Period|Adverse Event|0
1064415|NCT01968967|2113467|FG003|Treatment Period|Adverse Event|0
1064416|NCT01968967|2113468|FG004|Treatment Period|Adverse Event|0
1064417|NCT01968967|2113464|FG000|Treatment Period|Death|9
1064418|NCT01968967|2113465|FG001|Treatment Period|Death|2
1064419|NCT01968967|2113466|FG002|Treatment Period|Death|0
1064420|NCT01968967|2113467|FG003|Treatment Period|Death|0
1064421|NCT01968967|2113468|FG004|Treatment Period|Death|0
1064422|NCT01968967|2113464|FG000|Treatment Period|Randomized Not Treated|6
1064423|NCT01968967|2113465|FG001|Treatment Period|Randomized Not Treated|5
1064424|NCT01968967|2113466|FG002|Treatment Period|Randomized Not Treated|0
1064425|NCT01968967|2113467|FG003|Treatment Period|Randomized Not Treated|0
1064426|NCT01968967|2113468|FG004|Treatment Period|Randomized Not Treated|0
1064427|NCT01968967|2113464|FG000|Extension Period|Withdrew Consent|0
1064428|NCT01968967|2113465|FG001|Extension Period|Withdrew Consent|0
1064429|NCT01968967|2113466|FG002|Extension Period|Withdrew Consent|2
1064430|NCT01968967|2113467|FG003|Extension Period|Withdrew Consent|0
1064431|NCT01968967|2113468|FG004|Extension Period|Withdrew Consent|5
1064432|NCT01968980|2113484|FG000|Overall Study|Death|0
1064433|NCT01968980|2113485|FG001|Overall Study|Death|1
1064434|NCT01968980|2113484|FG000|Overall Study|Adverse Event|1
1064435|NCT01968980|2113485|FG001|Overall Study|Adverse Event|3
1064436|NCT01968980|2113484|FG000|Overall Study|Does not meet entry criteria|1
1064437|NCT01968980|2113485|FG001|Overall Study|Does not meet entry criteria|3
1064438|NCT01968980|2113484|FG000|Overall Study|Withdrawal by Subject|13
1064439|NCT01968980|2113485|FG001|Overall Study|Withdrawal by Subject|5
1064440|NCT01968980|2113484|FG000|Overall Study|Other unspecified|1
1064441|NCT01968980|2113485|FG001|Overall Study|Other unspecified|2
1064442|NCT01969058|2113494|FG000|Overall Study|Withdrawal by Subject|2
1064443|NCT01969058|2113495|FG001|Overall Study|Withdrawal by Subject|0
1064444|NCT01969058|2113494|FG000|Overall Study|Adverse Event|1
1064445|NCT01969058|2113495|FG001|Overall Study|Adverse Event|0
1064446|NCT01969084|2113503|FG000|Overall Study|Adverse Event|0
1064447|NCT01969084|2113504|FG001|Overall Study|Adverse Event|1
1064454|NCT01969500|2113570|FG000|Overall Study|Death|0
1064455|NCT01969500|2113571|FG001|Overall Study|Death|1
1064456|NCT01969500|2113570|FG000|Overall Study|extended hospitalization|1
1064457|NCT01969500|2113571|FG001|Overall Study|extended hospitalization|1
1064458|NCT01969721|2113590|FG000|Overall Study|Adverse Event|3
1064459|NCT01969721|2113591|FG001|Overall Study|Adverse Event|8
1064460|NCT01969721|2113592|FG002|Overall Study|Adverse Event|3
1064461|NCT01969721|2113593|FG003|Overall Study|Adverse Event|2
1064462|NCT01969721|2113590|FG000|Overall Study|Lack of Efficacy|0
1064463|NCT01969721|2113591|FG001|Overall Study|Lack of Efficacy|0
1064464|NCT01969721|2113592|FG002|Overall Study|Lack of Efficacy|1
1064465|NCT01969721|2113593|FG003|Overall Study|Lack of Efficacy|0
1064466|NCT01969721|2113590|FG000|Overall Study|Non compliant with protocol|1
1064467|NCT01969721|2113591|FG001|Overall Study|Non compliant with protocol|1
1064468|NCT01969721|2113592|FG002|Overall Study|Non compliant with protocol|0
1064469|NCT01969721|2113593|FG003|Overall Study|Non compliant with protocol|2
1064470|NCT01969721|2113590|FG000|Overall Study|Other not defined above|0
1064471|NCT01969721|2113591|FG001|Overall Study|Other not defined above|2
1064472|NCT01969721|2113592|FG002|Overall Study|Other not defined above|0
1064473|NCT01969721|2113593|FG003|Overall Study|Other not defined above|0
1064474|NCT01969721|2113590|FG000|Overall Study|Discontinued during washout periods.|0
1064475|NCT01969721|2113591|FG001|Overall Study|Discontinued during washout periods.|1
1064476|NCT01969721|2113592|FG002|Overall Study|Discontinued during washout periods.|1
1064477|NCT01969721|2113593|FG003|Overall Study|Discontinued during washout periods.|2
1064478|NCT01969799|2113622|FG000|Overall Study|Adverse Event|0
1064479|NCT01969799|2113623|FG001|Overall Study|Adverse Event|1
1064480|NCT01969799|2113622|FG000|Overall Study|Death|16
1064481|NCT01969799|2113623|FG001|Overall Study|Death|11
1064482|NCT01969799|2113622|FG000|Overall Study|Lost to Follow-up|0
1064483|NCT01969799|2113623|FG001|Overall Study|Lost to Follow-up|2
1064484|NCT01969799|2113622|FG000|Overall Study|Physician Decision|1
1064485|NCT01969799|2113623|FG001|Overall Study|Physician Decision|0
1064486|NCT01969851|2113641|FG000|Overall Study|Adverse Event|0
1064487|NCT01969851|2113642|FG001|Overall Study|Adverse Event|0
1064488|NCT01969851|2113643|FG002|Overall Study|Adverse Event|3
1064489|NCT01969851|2113641|FG000|Overall Study|Lack of Efficacy|0
1064490|NCT01969851|2113642|FG001|Overall Study|Lack of Efficacy|3
1064491|NCT01969851|2113643|FG002|Overall Study|Lack of Efficacy|1
1064492|NCT01969851|2113641|FG000|Overall Study|Withdrawal by Subject|1
1064493|NCT01969851|2113642|FG001|Overall Study|Withdrawal by Subject|0
1064494|NCT01969851|2113643|FG002|Overall Study|Withdrawal by Subject|1
1064495|NCT01969851|2113641|FG000|Overall Study|No effective dose in Titration period|0
1064496|NCT01969851|2113642|FG001|Overall Study|No effective dose in Titration period|0
1064497|NCT01969851|2113643|FG002|Overall Study|No effective dose in Titration period|1
1064498|NCT01969851|2113641|FG000|Overall Study|Sponsor decision|0
1064499|NCT01969851|2113642|FG001|Overall Study|Sponsor decision|0
1064500|NCT01969851|2113643|FG002|Overall Study|Sponsor decision|1
1064501|NCT01970007|2113655|FG000|Overall Study|Death|5
1064502|NCT01970007|2113655|FG000|Overall Study|Withdrawal by Subject|23
1064503|NCT01970007|2113655|FG000|Overall Study|Lost to Follow-up|24
1064504|NCT01970007|2113655|FG000|Overall Study|"Other endpoint"|3
1064505|NCT01970241|2113670|FG000|Overall Study|Withdrawal by Subject|2
1064506|NCT01970241|2113671|FG001|Overall Study|Withdrawal by Subject|0
1064507|NCT01970241|2113670|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15
1064508|NCT01970241|2113671|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8
1064509|NCT01970371|2113682|FG000|Overall Study|Death|8
1064510|NCT01970371|2113683|FG001|Overall Study|Death|13
1064511|NCT01970371|2113684|FG002|Overall Study|Death|12
1064512|NCT01970371|2113682|FG000|Overall Study|Lost to Follow-up|0
1064513|NCT01970371|2113683|FG001|Overall Study|Lost to Follow-up|0
1064514|NCT01970371|2113684|FG002|Overall Study|Lost to Follow-up|1
1064515|NCT01970397|2113696|FG000|Overall Study|Adverse Event|0
1064516|NCT01970397|2113697|FG001|Overall Study|Adverse Event|1
1064517|NCT01970397|2113696|FG000|Overall Study|Lost to Follow-up|0
1064518|NCT01970397|2113697|FG001|Overall Study|Lost to Follow-up|1
1064519|NCT01970397|2113696|FG000|Overall Study|Personal Reasons|1
1064520|NCT01970397|2113697|FG001|Overall Study|Personal Reasons|2
1064521|NCT01970397|2113696|FG000|Overall Study|Protocol Violation|1
1064522|NCT01970397|2113697|FG001|Overall Study|Protocol Violation|1
1064523|NCT01970475|2113705|FG000|Overall Study|Withdrawal by Subject|11
1064524|NCT01970475|2113706|FG001|Overall Study|Withdrawal by Subject|6
1064525|NCT01970475|2113705|FG000|Overall Study|Adverse Event|7
1064526|NCT01970475|2113706|FG001|Overall Study|Adverse Event|3
1064527|NCT01970475|2113705|FG000|Overall Study|Lost to Follow-up|2
1064528|NCT01970475|2113706|FG001|Overall Study|Lost to Follow-up|2
1064529|NCT01970475|2113705|FG000|Overall Study|Protocol Violation|1
1064530|NCT01970475|2113706|FG001|Overall Study|Protocol Violation|0
1064531|NCT01970488|2113714|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1
1064532|NCT01970488|2113715|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2
1064533|NCT01970488|2113716|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0
1064534|NCT01970488|2113717|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0
1064535|NCT01970488|2113718|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0
1064536|NCT01970488|2113714|FG000|Part 1: Through Week 16|Protocol Violation|1
1064537|NCT01970488|2113715|FG001|Part 1: Through Week 16|Protocol Violation|2
1064538|NCT01970488|2113716|FG002|Part 1: Through Week 16|Protocol Violation|0
1064539|NCT01970488|2113717|FG003|Part 1: Through Week 16|Protocol Violation|0
1064540|NCT01970488|2113718|FG004|Part 1: Through Week 16|Protocol Violation|0
1064541|NCT01970488|2113714|FG000|Part 1: Through Week 16|Adverse Event|6
1064542|NCT01970488|2113715|FG001|Part 1: Through Week 16|Adverse Event|5
1064543|NCT01970488|2113716|FG002|Part 1: Through Week 16|Adverse Event|0
1064544|NCT01970488|2113717|FG003|Part 1: Through Week 16|Adverse Event|0
1064545|NCT01970488|2113718|FG004|Part 1: Through Week 16|Adverse Event|0
1064546|NCT01970488|2113714|FG000|Part 1: Through Week 16|Withdrawal by Subject|3
1064547|NCT01970488|2113715|FG001|Part 1: Through Week 16|Withdrawal by Subject|2
1064548|NCT01970488|2113716|FG002|Part 1: Through Week 16|Withdrawal by Subject|0
1064549|NCT01970488|2113717|FG003|Part 1: Through Week 16|Withdrawal by Subject|0
1064550|NCT01970488|2113718|FG004|Part 1: Through Week 16|Withdrawal by Subject|0
1064551|NCT01970488|2113714|FG000|Part 1: Through Week 16|Lost to Follow-up|0
1064552|NCT01970488|2113715|FG001|Part 1: Through Week 16|Lost to Follow-up|2
1064553|NCT01970488|2113716|FG002|Part 1: Through Week 16|Lost to Follow-up|0
1064554|NCT01970488|2113717|FG003|Part 1: Through Week 16|Lost to Follow-up|0
1064555|NCT01970488|2113718|FG004|Part 1: Through Week 16|Lost to Follow-up|0
1064556|NCT01970488|2113714|FG000|Part 2: Post Week 16|Physician Decision|0
1064557|NCT01970488|2113715|FG001|Part 2: Post Week 16|Physician Decision|0
1064558|NCT01970488|2113716|FG002|Part 2: Post Week 16|Physician Decision|0
1064559|NCT01970488|2113717|FG003|Part 2: Post Week 16|Physician Decision|0
1064560|NCT01970488|2113718|FG004|Part 2: Post Week 16|Physician Decision|1
1064561|NCT01970488|2113714|FG000|Part 2: Post Week 16|Non-compliance|0
1064562|NCT01970488|2113715|FG001|Part 2: Post Week 16|Non-compliance|0
1064563|NCT01970488|2113716|FG002|Part 2: Post Week 16|Non-compliance|1
1064564|NCT01970488|2113717|FG003|Part 2: Post Week 16|Non-compliance|0
1064565|NCT01970488|2113718|FG004|Part 2: Post Week 16|Non-compliance|0
1064566|NCT01970488|2113714|FG000|Part 2: Post Week 16|Lack of Efficacy|0
1064567|NCT01970488|2113715|FG001|Part 2: Post Week 16|Lack of Efficacy|0
1064568|NCT01970488|2113716|FG002|Part 2: Post Week 16|Lack of Efficacy|2
1064569|NCT01970488|2113717|FG003|Part 2: Post Week 16|Lack of Efficacy|3
1064570|NCT01970488|2113718|FG004|Part 2: Post Week 16|Lack of Efficacy|1
1064571|NCT01970488|2113714|FG000|Part 2: Post Week 16|Adverse Event|0
1064572|NCT01970488|2113715|FG001|Part 2: Post Week 16|Adverse Event|0
1064573|NCT01970488|2113716|FG002|Part 2: Post Week 16|Adverse Event|5
1064574|NCT01970488|2113717|FG003|Part 2: Post Week 16|Adverse Event|1
1064575|NCT01970488|2113718|FG004|Part 2: Post Week 16|Adverse Event|1
1064576|NCT01970488|2113714|FG000|Part 2: Post Week 16|Withdrawal by Subject|0
1064577|NCT01970488|2113715|FG001|Part 2: Post Week 16|Withdrawal by Subject|0
1064578|NCT01970488|2113716|FG002|Part 2: Post Week 16|Withdrawal by Subject|8
1064579|NCT01970488|2113717|FG003|Part 2: Post Week 16|Withdrawal by Subject|3
1064580|NCT01970488|2113718|FG004|Part 2: Post Week 16|Withdrawal by Subject|3
1064581|NCT01970488|2113714|FG000|Part 2: Post Week 16|Lost to Follow-up|0
1064582|NCT01970488|2113715|FG001|Part 2: Post Week 16|Lost to Follow-up|0
1064583|NCT01970488|2113716|FG002|Part 2: Post Week 16|Lost to Follow-up|1
1064584|NCT01970488|2113717|FG003|Part 2: Post Week 16|Lost to Follow-up|1
1064585|NCT01970488|2113718|FG004|Part 2: Post Week 16|Lost to Follow-up|2
1064586|NCT01970527|2113735|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
1064587|NCT01970527|2113736|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
1064588|NCT01970527|2113735|FG000|Treatment|Disease progression|0
1064589|NCT01970527|2113736|FG001|Treatment|Disease progression|1
1064590|NCT01970527|2113735|FG000|Treatment|Participant did not tolerate Ipilimumab|0
1064591|NCT01970527|2113736|FG001|Treatment|Participant did not tolerate Ipilimumab|1
1064592|NCT01970527|2113735|FG000|Treatment|Death|0
1064593|NCT01970527|2113736|FG001|Treatment|Death|1
1064594|NCT01970527|2113735|FG000|Follow-up Clinic Visit|Disease progression|1
1064595|NCT01970527|2113736|FG001|Follow-up Clinic Visit|Disease progression|1
1064596|NCT01970527|2113735|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0
1064597|NCT01970527|2113736|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1
1064598|NCT01970527|2113735|FG000|Follow-up Clinic Visit|Lost to Follow-up|0
1064599|NCT01970527|2113736|FG001|Follow-up Clinic Visit|Lost to Follow-up|1
1064600|NCT01970540|2113748|FG000|Overall Study|Non-treatment-related AE|0
1064601|NCT01970540|2113749|FG001|Overall Study|Non-treatment-related AE|0
1064602|NCT01970540|2113750|FG002|Overall Study|Non-treatment-related AE|1
1064603|NCT01970540|2113748|FG000|Overall Study|Progressive disease|55
1064604|NCT01970540|2113749|FG001|Overall Study|Progressive disease|23
1064605|NCT01970540|2113750|FG002|Overall Study|Progressive disease|10
1064606|NCT01970540|2113748|FG000|Overall Study|Treatment delay over protocol|0
1064607|NCT01970540|2113749|FG001|Overall Study|Treatment delay over protocol|0
1064608|NCT01970540|2113750|FG002|Overall Study|Treatment delay over protocol|1
1064609|NCT01970540|2113748|FG000|Overall Study|Physician Decision|7
1064610|NCT01970540|2113749|FG001|Overall Study|Physician Decision|2
1064611|NCT01970540|2113750|FG002|Overall Study|Physician Decision|0
1064612|NCT01970540|2113748|FG000|Overall Study|Clinical progression|0
1064613|NCT01970540|2113749|FG001|Overall Study|Clinical progression|1
1064614|NCT01970540|2113750|FG002|Overall Study|Clinical progression|1
1064615|NCT01970540|2113748|FG000|Overall Study|End of study|2
1064616|NCT01970540|2113749|FG001|Overall Study|End of study|0
1064617|NCT01970540|2113750|FG002|Overall Study|End of study|2
1064618|NCT01970540|2113748|FG000|Overall Study|Adverse Event|0
1064619|NCT01970540|2113749|FG001|Overall Study|Adverse Event|2
1064620|NCT01970540|2113750|FG002|Overall Study|Adverse Event|1
1064621|NCT01970540|2113748|FG000|Overall Study|Treatment-related AE|4
1064622|NCT01970540|2113749|FG001|Overall Study|Treatment-related AE|0
1064623|NCT01970540|2113750|FG002|Overall Study|Treatment-related AE|2
1064624|NCT01970540|2113748|FG000|Overall Study|Withdrawal by Subject|4
1064625|NCT01970540|2113749|FG001|Overall Study|Withdrawal by Subject|0
1064626|NCT01970540|2113750|FG002|Overall Study|Withdrawal by Subject|1
1064627|NCT01970540|2113748|FG000|Overall Study|Clinical deterioration|1
1064628|NCT01970540|2113749|FG001|Overall Study|Clinical deterioration|0
1064629|NCT01970540|2113750|FG002|Overall Study|Clinical deterioration|0
1064630|NCT01970592|2113769|FG000|Overall Study|Withdrawal by Subject|4
1064631|NCT01970592|2113769|FG000|Overall Study|Physician Decision|1
1064632|NCT01970592|2113769|FG000|Overall Study|Adverse Event|1
1064633|NCT01970865|2113794|FG000|Overall Study|Death|3
1064634|NCT01970865|2113795|FG001|Overall Study|Death|1
1064635|NCT01970865|2113796|FG002|Overall Study|Death|3
1064636|NCT01970865|2113797|FG003|Overall Study|Death|4
1064637|NCT01970865|2113798|FG004|Overall Study|Death|6
1064638|NCT01970865|2113799|FG005|Overall Study|Death|3
1064639|NCT01970865|2113800|FG006|Overall Study|Death|1
1064640|NCT01970865|2113801|FG007|Overall Study|Death|3
1064641|NCT01970865|2113802|FG008|Overall Study|Death|2
1064642|NCT01970865|2113803|FG009|Overall Study|Death|1
1064643|NCT01970865|2113804|FG010|Overall Study|Death|1
1064644|NCT01970865|2113805|FG011|Overall Study|Death|4
1064645|NCT01970865|2113806|FG012|Overall Study|Death|14
1064646|NCT01970865|2113807|FG013|Overall Study|Death|19
1064647|NCT01970865|2113808|FG014|Overall Study|Death|15
1064648|NCT01970865|2113809|FG015|Overall Study|Death|10
1064649|NCT01970865|2113810|FG016|Overall Study|Death|1
1064650|NCT01970865|2113794|FG000|Overall Study|Lost to Follow-up|0
1064651|NCT01970865|2113795|FG001|Overall Study|Lost to Follow-up|0
1064652|NCT01970865|2113796|FG002|Overall Study|Lost to Follow-up|0
1064653|NCT01970865|2113797|FG003|Overall Study|Lost to Follow-up|1
1064654|NCT01970865|2113798|FG004|Overall Study|Lost to Follow-up|1
1064655|NCT01970865|2113799|FG005|Overall Study|Lost to Follow-up|0
1064656|NCT01970865|2113800|FG006|Overall Study|Lost to Follow-up|0
1064657|NCT01970865|2113801|FG007|Overall Study|Lost to Follow-up|0
1064658|NCT01970865|2113802|FG008|Overall Study|Lost to Follow-up|0
1064659|NCT01970865|2113803|FG009|Overall Study|Lost to Follow-up|0
1064660|NCT01970865|2113804|FG010|Overall Study|Lost to Follow-up|0
1064661|NCT01970865|2113805|FG011|Overall Study|Lost to Follow-up|0
1064662|NCT01970865|2113806|FG012|Overall Study|Lost to Follow-up|1
1064663|NCT01970865|2113807|FG013|Overall Study|Lost to Follow-up|0
1064664|NCT01970865|2113808|FG014|Overall Study|Lost to Follow-up|0
1064665|NCT01970865|2113809|FG015|Overall Study|Lost to Follow-up|0
1064666|NCT01970865|2113810|FG016|Overall Study|Lost to Follow-up|0
1064667|NCT01970865|2113794|FG000|Overall Study|Withdrawal by Subject|0
1064668|NCT01970865|2113795|FG001|Overall Study|Withdrawal by Subject|0
1064669|NCT01970865|2113796|FG002|Overall Study|Withdrawal by Subject|0
1064670|NCT01970865|2113797|FG003|Overall Study|Withdrawal by Subject|1
1064671|NCT01970865|2113798|FG004|Overall Study|Withdrawal by Subject|2
1064672|NCT01970865|2113799|FG005|Overall Study|Withdrawal by Subject|0
1064673|NCT01970865|2113800|FG006|Overall Study|Withdrawal by Subject|0
1064674|NCT01970865|2113801|FG007|Overall Study|Withdrawal by Subject|0
1064675|NCT01970865|2113802|FG008|Overall Study|Withdrawal by Subject|0
1064676|NCT01970865|2113803|FG009|Overall Study|Withdrawal by Subject|0
1064677|NCT01970865|2113804|FG010|Overall Study|Withdrawal by Subject|0
1064678|NCT01970865|2113805|FG011|Overall Study|Withdrawal by Subject|1
1064679|NCT01970865|2113806|FG012|Overall Study|Withdrawal by Subject|2
1064680|NCT01970865|2113807|FG013|Overall Study|Withdrawal by Subject|5
1064681|NCT01970865|2113808|FG014|Overall Study|Withdrawal by Subject|2
1064682|NCT01970865|2113809|FG015|Overall Study|Withdrawal by Subject|7
1064683|NCT01970865|2113810|FG016|Overall Study|Withdrawal by Subject|0
1064684|NCT01970865|2113794|FG000|Overall Study|Other|0
1064685|NCT01970865|2113795|FG001|Overall Study|Other|0
1064686|NCT01970865|2113796|FG002|Overall Study|Other|0
1064687|NCT01970865|2113797|FG003|Overall Study|Other|1
1064688|NCT01970865|2113798|FG004|Overall Study|Other|0
1064689|NCT01970865|2113799|FG005|Overall Study|Other|0
1064690|NCT01970865|2113800|FG006|Overall Study|Other|0
1064691|NCT01970865|2113801|FG007|Overall Study|Other|0
1064692|NCT01970865|2113802|FG008|Overall Study|Other|0
1064693|NCT01970865|2113803|FG009|Overall Study|Other|0
1064694|NCT01970865|2113804|FG010|Overall Study|Other|0
1064695|NCT01970865|2113805|FG011|Overall Study|Other|0
1064696|NCT01970865|2113806|FG012|Overall Study|Other|0
1064697|NCT01970865|2113807|FG013|Overall Study|Other|1
1064698|NCT01970865|2113808|FG014|Overall Study|Other|0
1064699|NCT01970865|2113809|FG015|Overall Study|Other|1
1064700|NCT01970865|2113810|FG016|Overall Study|Other|0
1064701|NCT01970865|2113794|FG000|Overall Study|Study ongoing|0
1064702|NCT01970865|2113795|FG001|Overall Study|Study ongoing|2
1064703|NCT01970865|2113796|FG002|Overall Study|Study ongoing|0
1064704|NCT01970865|2113797|FG003|Overall Study|Study ongoing|6
1064705|NCT01970865|2113798|FG004|Overall Study|Study ongoing|8
1064706|NCT01970865|2113799|FG005|Overall Study|Study ongoing|0
1064707|NCT01970865|2113800|FG006|Overall Study|Study ongoing|2
1064708|NCT01970865|2113801|FG007|Overall Study|Study ongoing|0
1064709|NCT01970865|2113802|FG008|Overall Study|Study ongoing|1
1064710|NCT01970865|2113803|FG009|Overall Study|Study ongoing|3
1064711|NCT01970865|2113804|FG010|Overall Study|Study ongoing|29
1064712|NCT01970865|2113805|FG011|Overall Study|Study ongoing|22
1064713|NCT01970865|2113806|FG012|Overall Study|Study ongoing|43
1064714|NCT01970865|2113807|FG013|Overall Study|Study ongoing|41
1064715|NCT01970865|2113808|FG014|Overall Study|Study ongoing|29
1064716|NCT01970865|2113809|FG015|Overall Study|Study ongoing|29
1064717|NCT01970865|2113810|FG016|Overall Study|Study ongoing|2
1064718|NCT01970878|2113875|FG000|Overall Study|Withdrawal by Subject|11
1064719|NCT01970878|2113876|FG001|Overall Study|Withdrawal by Subject|10
1064720|NCT01970878|2113877|FG002|Overall Study|Withdrawal by Subject|14
1064721|NCT01970878|2113878|FG003|Overall Study|Withdrawal by Subject|7
1064722|NCT01970878|2113875|FG000|Overall Study|Lost to Follow-up|1
1064723|NCT01970878|2113876|FG001|Overall Study|Lost to Follow-up|3
1064724|NCT01970878|2113877|FG002|Overall Study|Lost to Follow-up|2
1064725|NCT01970878|2113878|FG003|Overall Study|Lost to Follow-up|4
1064726|NCT01970878|2113875|FG000|Overall Study|Administrative Reasons|1
1064727|NCT01970878|2113876|FG001|Overall Study|Administrative Reasons|0
1064728|NCT01970878|2113877|FG002|Overall Study|Administrative Reasons|0
1064729|NCT01970878|2113878|FG003|Overall Study|Administrative Reasons|4
1064730|NCT01970878|2113875|FG000|Overall Study|Lack of Efficacy|2
1064731|NCT01970878|2113876|FG001|Overall Study|Lack of Efficacy|1
1064732|NCT01970878|2113877|FG002|Overall Study|Lack of Efficacy|2
1064733|NCT01970878|2113878|FG003|Overall Study|Lack of Efficacy|0
1064734|NCT01970878|2113875|FG000|Overall Study|Adverse Event|12
1064735|NCT01970878|2113876|FG001|Overall Study|Adverse Event|7
1064736|NCT01970878|2113877|FG002|Overall Study|Adverse Event|4
1064737|NCT01970878|2113878|FG003|Overall Study|Adverse Event|3
1064738|NCT01970878|2113875|FG000|Overall Study|Protocol Specified Criteria|10
1064739|NCT01970878|2113876|FG001|Overall Study|Protocol Specified Criteria|4
1064740|NCT01970878|2113877|FG002|Overall Study|Protocol Specified Criteria|3
1064741|NCT01970878|2113878|FG003|Overall Study|Protocol Specified Criteria|6
1064742|NCT01970878|2113875|FG000|Overall Study|Physician Decision|0
1064743|NCT01970878|2113876|FG001|Overall Study|Physician Decision|1
1064744|NCT01970878|2113877|FG002|Overall Study|Physician Decision|1
1064745|NCT01970878|2113878|FG003|Overall Study|Physician Decision|0
1064746|NCT01970878|2113875|FG000|Overall Study|No Completion Status|0
1064747|NCT01970878|2113876|FG001|Overall Study|No Completion Status|1
1064748|NCT01970878|2113877|FG002|Overall Study|No Completion Status|0
1064749|NCT01970878|2113878|FG003|Overall Study|No Completion Status|0
1064750|NCT01970982|2113898|FG000|Overall Study|Withdrawal by Subject|0
1064751|NCT01970982|2113899|FG001|Overall Study|Withdrawal by Subject|0
1064752|NCT01970982|2113900|FG002|Overall Study|Withdrawal by Subject|2
1064753|NCT01970995|2113912|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1064754|NCT01970995|2113913|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1064755|NCT01970995|2113914|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1064756|NCT01970995|2113912|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1
1064757|NCT01970995|2113913|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0
1064758|NCT01970995|2113914|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1
1064759|NCT01971203|2113929|FG000|Overall Study|Protocol Violation|3
1064760|NCT01971203|2113930|FG001|Overall Study|Protocol Violation|2
1064761|NCT01971203|2113929|FG000|Overall Study|Withdrawal by Subject|5
1064762|NCT01971203|2113930|FG001|Overall Study|Withdrawal by Subject|6
1064763|NCT01971203|2113929|FG000|Overall Study|Adverse Event|1
1064764|NCT01971203|2113930|FG001|Overall Study|Adverse Event|0
1064765|NCT01971346|2113945|FG000|Overall Study|Protocol Violation|3
1064766|NCT01971346|2113945|FG000|Overall Study|Lost to Follow-up|2
1064767|NCT01971346|2113945|FG000|Overall Study|Withdrawal by Subject|2
1064768|NCT01971346|2113945|FG000|Overall Study|Physician Decision|1
1064769|NCT01971476|2113976|FG000|Cohort 1: 2 to <12 Years|Other not defined|3
1064770|NCT01971476|2113977|FG001|Cohort 1: 2 to <12 Years|Other not defined|3
1064771|NCT01971476|2113978|FG002|Cohort 1: 2 to <12 Years|Other not defined|6
1064772|NCT01971476|2113976|FG000|Cohort 2: 12 to <18 Years|Other not defined|6
1064773|NCT01971476|2113977|FG001|Cohort 2: 12 to <18 Years|Other not defined|3
1064774|NCT01971476|2113978|FG002|Cohort 2: 12 to <18 Years|Other not defined|0
1064775|NCT01971476|2113976|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0
1064776|NCT01971476|2113977|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1
1064777|NCT01971476|2113978|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0
1064778|NCT01971554|2113999|FG000|Overall Study|Lost to Follow-up|1
1064779|NCT01971554|2114000|FG001|Overall Study|Lost to Follow-up|0
1064780|NCT01971554|2114001|FG002|Overall Study|Lost to Follow-up|0
1064781|NCT01971554|2114002|FG003|Overall Study|Lost to Follow-up|0
1064782|NCT01971567|2114014|FG000|Overall Study|Withdrawal by Subject|3
1064783|NCT01971567|2114015|FG001|Overall Study|Withdrawal by Subject|2
1064784|NCT01971567|2114014|FG000|Overall Study|Lost to Follow-up|1
1064785|NCT01971567|2114015|FG001|Overall Study|Lost to Follow-up|0
1064786|NCT01971645|2114040|FG000|Overall Study|Adverse Event|1
1064787|NCT01971645|2114041|FG001|Overall Study|Adverse Event|0
1064788|NCT01971645|2114042|FG002|Overall Study|Adverse Event|0
1064789|NCT01971645|2114040|FG000|Overall Study|Lost to Follow-up|1
1064790|NCT01971645|2114041|FG001|Overall Study|Lost to Follow-up|0
1064791|NCT01971645|2114042|FG002|Overall Study|Lost to Follow-up|1
1064792|NCT01971645|2114040|FG000|Overall Study|Protocol Violation|0
1064793|NCT01971645|2114041|FG001|Overall Study|Protocol Violation|0
1064794|NCT01971645|2114042|FG002|Overall Study|Protocol Violation|1
1064795|NCT01971723|2114052|FG000|Overall Study|Withdrawal by Subject|1
1064796|NCT01971723|2114053|FG001|Overall Study|Withdrawal by Subject|1
1064797|NCT01971723|2114052|FG000|Overall Study|Protocol Violation|1
1064798|NCT01971723|2114053|FG001|Overall Study|Protocol Violation|2
1064799|NCT01972074|2114075|FG000|Overall Study|Adverse Event|4
1064800|NCT01972074|2114076|FG001|Overall Study|Adverse Event|1
1064801|NCT01972074|2114077|FG002|Overall Study|Adverse Event|0
1064802|NCT01972074|2114075|FG000|Overall Study|Lack of Efficacy|1
1064803|NCT01972074|2114076|FG001|Overall Study|Lack of Efficacy|1
1064804|NCT01972074|2114077|FG002|Overall Study|Lack of Efficacy|0
1064805|NCT01972074|2114075|FG000|Overall Study|Lost to Follow-up|0
1064806|NCT01972074|2114076|FG001|Overall Study|Lost to Follow-up|1
1064807|NCT01972074|2114077|FG002|Overall Study|Lost to Follow-up|1
1064808|NCT01972074|2114075|FG000|Overall Study|Withdrawal by Subject|1
1064809|NCT01972074|2114076|FG001|Overall Study|Withdrawal by Subject|1
1064810|NCT01972074|2114077|FG002|Overall Study|Withdrawal by Subject|1
1064811|NCT01972074|2114075|FG000|Overall Study|Scanner Unavailable|0
1064812|NCT01972074|2114076|FG001|Overall Study|Scanner Unavailable|0
1064813|NCT01972074|2114077|FG002|Overall Study|Scanner Unavailable|1
1064814|NCT01972152|2114084|FG000|First Treatment Visit|Lost to Follow-up|0
1064815|NCT01972152|2114085|FG001|First Treatment Visit|Lost to Follow-up|1
1064816|NCT01972152|2114086|FG002|First Treatment Visit|Lost to Follow-up|0
1064817|NCT01972152|2114087|FG003|First Treatment Visit|Lost to Follow-up|0
1064818|NCT01972152|2114088|FG004|First Treatment Visit|Lost to Follow-up|0
1064819|NCT01972152|2114089|FG005|First Treatment Visit|Lost to Follow-up|0
1064820|NCT01972152|2114084|FG000|Second Treatment Visit|Protocol Violation|0
1064821|NCT01972152|2114085|FG001|Second Treatment Visit|Protocol Violation|1
1064822|NCT01972152|2114086|FG002|Second Treatment Visit|Protocol Violation|0
1064823|NCT01972152|2114087|FG003|Second Treatment Visit|Protocol Violation|0
1064824|NCT01972152|2114088|FG004|Second Treatment Visit|Protocol Violation|0
1064825|NCT01972152|2114089|FG005|Second Treatment Visit|Protocol Violation|0
1162040|NCT03381196|2283977|FG001|Overall Study|Randomized, not treated|6
1064862|NCT01972308|2114134|FG000|Overall Study|Withdrawal by Subject|0
1064863|NCT01972308|2114135|FG001|Overall Study|Withdrawal by Subject|1
1064864|NCT01972308|2114134|FG000|Overall Study|Lost to Follow-up|4
1064865|NCT01972308|2114135|FG001|Overall Study|Lost to Follow-up|6
1064866|NCT01972308|2114134|FG000|Overall Study|Death|4
1064867|NCT01972308|2114135|FG001|Overall Study|Death|1
1064868|NCT01972438|2114145|FG000|Baseline-Month 3 Crossover Period|Death|1
1064869|NCT01972438|2114146|FG001|Baseline-Month 3 Crossover Period|Death|0
1064870|NCT01972438|2114145|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
1064871|NCT01972438|2114146|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
1064872|NCT01972438|2114145|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0
1064873|NCT01972438|2114146|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1
1064874|NCT01972438|2114145|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
1064875|NCT01972438|2114146|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
1064876|NCT01972438|2114145|FG000|Months 3-6 Crossover Period|Early Study Closure|0
1064877|NCT01972438|2114146|FG001|Months 3-6 Crossover Period|Early Study Closure|1
1064878|NCT01972438|2114145|FG000|Months 6-12 Study Period|Death|1
1064879|NCT01972438|2114146|FG001|Months 6-12 Study Period|Death|0
1064880|NCT01972438|2114145|FG000|Months 6-12 Study Period|Early Study Closure|2
1064881|NCT01972438|2114146|FG001|Months 6-12 Study Period|Early Study Closure|2
1064882|NCT01972438|2114145|FG000|Post Month 12 Study Period|Early Study Closure|3
1064883|NCT01972438|2114146|FG001|Post Month 12 Study Period|Early Study Closure|4
1064884|NCT01972464|2114156|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
1064885|NCT01972464|2114157|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
1064886|NCT01972464|2114156|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
1064887|NCT01972464|2114157|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
1064888|NCT01972464|2114156|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
1064889|NCT01972464|2114157|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
1064890|NCT01972464|2114156|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
1064891|NCT01972464|2114157|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
1064892|NCT01972529|2114177|FG000|Overall Study|Adverse Event|0
1064893|NCT01972529|2114178|FG001|Overall Study|Adverse Event|1
1064894|NCT01972529|2114179|FG002|Overall Study|Adverse Event|0
1064895|NCT01972529|2114180|FG003|Overall Study|Adverse Event|0
1064896|NCT01972529|2114177|FG000|Overall Study|Lost to Follow-up|1
1064897|NCT01972529|2114178|FG001|Overall Study|Lost to Follow-up|0
1064898|NCT01972529|2114179|FG002|Overall Study|Lost to Follow-up|0
1064899|NCT01972529|2114180|FG003|Overall Study|Lost to Follow-up|0
1064900|NCT01972529|2114177|FG000|Overall Study|Participant Choice|0
1064901|NCT01972529|2114178|FG001|Overall Study|Participant Choice|1
1064902|NCT01972529|2114179|FG002|Overall Study|Participant Choice|0
1064903|NCT01972529|2114180|FG003|Overall Study|Participant Choice|0
1064904|NCT01972529|2114177|FG000|Overall Study|Withdrawl of Consent|1
1064905|NCT01972529|2114178|FG001|Overall Study|Withdrawl of Consent|2
1064906|NCT01972529|2114179|FG002|Overall Study|Withdrawl of Consent|0
1064907|NCT01972529|2114180|FG003|Overall Study|Withdrawl of Consent|1
1064908|NCT01972529|2114177|FG000|Overall Study|Other|0
1064909|NCT01972529|2114178|FG001|Overall Study|Other|0
1064910|NCT01972529|2114179|FG002|Overall Study|Other|0
1064911|NCT01972529|2114180|FG003|Overall Study|Other|2
1064912|NCT01972529|2114177|FG000|Overall Study|Not treated|0
1064913|NCT01972529|2114178|FG001|Overall Study|Not treated|1
1064914|NCT01972529|2114179|FG002|Overall Study|Not treated|2
1064915|NCT01972529|2114180|FG003|Overall Study|Not treated|1
1064916|NCT01972568|2114194|FG000|Overall Study|Other events|3
1064917|NCT01972568|2114195|FG001|Overall Study|Other events|0
1064918|NCT01972568|2114196|FG002|Overall Study|Other events|0
1064919|NCT01972568|2114194|FG000|Overall Study|Lack of Efficacy|0
1064920|NCT01972568|2114195|FG001|Overall Study|Lack of Efficacy|1
1064921|NCT01972568|2114196|FG002|Overall Study|Lack of Efficacy|2
1064922|NCT01972568|2114194|FG000|Overall Study|Protocol Violation|1
1064923|NCT01972568|2114195|FG001|Overall Study|Protocol Violation|2
1064924|NCT01972568|2114196|FG002|Overall Study|Protocol Violation|2
1064925|NCT01972568|2114194|FG000|Overall Study|Withdrawal by Subject|6
1064926|NCT01972568|2114195|FG001|Overall Study|Withdrawal by Subject|3
1064927|NCT01972568|2114196|FG002|Overall Study|Withdrawal by Subject|7
1064928|NCT01972568|2114194|FG000|Overall Study|Lost to Follow-up|1
1064929|NCT01972568|2114195|FG001|Overall Study|Lost to Follow-up|0
1064930|NCT01972568|2114196|FG002|Overall Study|Lost to Follow-up|0
1064931|NCT01972568|2114194|FG000|Overall Study|Adverse Event|5
1064932|NCT01972568|2114195|FG001|Overall Study|Adverse Event|6
1064933|NCT01972568|2114196|FG002|Overall Study|Adverse Event|5
1064934|NCT01972659|2114206|FG000|Overall Study|Protocol Violation|2
1064935|NCT01972659|2114207|FG001|Overall Study|Protocol Violation|2
1064936|NCT01972659|2114206|FG000|Overall Study|problems realted to acceleromyograph|2
1064937|NCT01972659|2114207|FG001|Overall Study|problems realted to acceleromyograph|1
1064938|NCT01972724|2114216|FG000|Double-Blind|Rescue Criteria Met|1
1064939|NCT01972724|2114217|FG001|Double-Blind|Rescue Criteria Met|0
1064940|NCT01972724|2114218|FG002|Double-Blind|Rescue Criteria Met|0
1064941|NCT01972724|2114216|FG000|Double-Blind|Adverse Event|1
1064942|NCT01972724|2114217|FG001|Double-Blind|Adverse Event|0
1064943|NCT01972724|2114218|FG002|Double-Blind|Adverse Event|0
1064944|NCT01972724|2114216|FG000|Double-Blind|Withdrawal of Consent|2
1064945|NCT01972724|2114217|FG001|Double-Blind|Withdrawal of Consent|1
1064946|NCT01972724|2114218|FG002|Double-Blind|Withdrawal of Consent|0
1064947|NCT01972724|2114216|FG000|Double-Blind|Significant Protocol Deviation|5
1064948|NCT01972724|2114217|FG001|Double-Blind|Significant Protocol Deviation|8
1064949|NCT01972724|2114218|FG002|Double-Blind|Significant Protocol Deviation|0
1064950|NCT01972724|2114216|FG000|Open-Label|Withdrew Consent|0
1064951|NCT01972724|2114217|FG001|Open-Label|Withdrew Consent|0
1064952|NCT01972724|2114218|FG002|Open-Label|Withdrew Consent|3
1064953|NCT01972724|2114216|FG000|Open-Label|Significant Protocol Deviation|0
1064954|NCT01972724|2114217|FG001|Open-Label|Significant Protocol Deviation|0
1064955|NCT01972724|2114218|FG002|Open-Label|Significant Protocol Deviation|2
1064956|NCT01972776|2114232|FG000|Part 1|Withdrawal by Subject|0
1064957|NCT01972776|2114233|FG001|Part 1|Withdrawal by Subject|0
1064958|NCT01972776|2114234|FG002|Part 1|Withdrawal by Subject|1
1064959|NCT01972776|2114235|FG003|Part 1|Withdrawal by Subject|0
1064960|NCT01972776|2114236|FG004|Part 1|Withdrawal by Subject|0
1064961|NCT01972776|2114237|FG005|Part 1|Withdrawal by Subject|0
1064962|NCT01972776|2114232|FG000|Part 1|Adverse Event|0
1064963|NCT01972776|2114233|FG001|Part 1|Adverse Event|0
1064964|NCT01972776|2114234|FG002|Part 1|Adverse Event|1
1064965|NCT01972776|2114235|FG003|Part 1|Adverse Event|1
1064966|NCT01972776|2114236|FG004|Part 1|Adverse Event|0
1064967|NCT01972776|2114237|FG005|Part 1|Adverse Event|0
1064968|NCT01972776|2114232|FG000|Part 2|Adverse Event|0
1064969|NCT01972776|2114233|FG001|Part 2|Adverse Event|0
1064970|NCT01972776|2114234|FG002|Part 2|Adverse Event|0
1064971|NCT01972776|2114235|FG003|Part 2|Adverse Event|0
1064972|NCT01972776|2114236|FG004|Part 2|Adverse Event|3
1064973|NCT01972776|2114237|FG005|Part 2|Adverse Event|0
1064974|NCT01972776|2114232|FG000|Part 2|Administrative problems|0
1064975|NCT01972776|2114233|FG001|Part 2|Administrative problems|0
1064976|NCT01972776|2114234|FG002|Part 2|Administrative problems|0
1064977|NCT01972776|2114235|FG003|Part 2|Administrative problems|0
1064978|NCT01972776|2114236|FG004|Part 2|Administrative problems|10
1064979|NCT01972776|2114237|FG005|Part 2|Administrative problems|7
1064980|NCT01972789|2114253|FG000|Overall Study|Adverse Event|11
1064981|NCT01972789|2114254|FG001|Overall Study|Adverse Event|4
1064982|NCT01972789|2114253|FG000|Overall Study|Subject withdrew consent|14
1064983|NCT01972789|2114254|FG001|Overall Study|Subject withdrew consent|12
1064984|NCT01972789|2114253|FG000|Overall Study|Lost to Follow-up|4
1064985|NCT01972789|2114254|FG001|Overall Study|Lost to Follow-up|7
1064986|NCT01972789|2114253|FG000|Overall Study|Death|7
1064987|NCT01972789|2114254|FG001|Overall Study|Death|5
1064988|NCT01972789|2114253|FG000|Overall Study|Protocol deviation|1
1064989|NCT01972789|2114254|FG001|Overall Study|Protocol deviation|0
1064990|NCT01972789|2114253|FG000|Overall Study|Physician Decision|3
1064991|NCT01972789|2114254|FG001|Overall Study|Physician Decision|2
1064992|NCT01972841|2114266|FG000|Overall Study|Randomized but Never Received Treatment|2
1064993|NCT01972841|2114267|FG001|Overall Study|Randomized but Never Received Treatment|5
1064994|NCT01972841|2114268|FG002|Overall Study|Randomized but Never Received Treatment|4
1064995|NCT01972841|2114269|FG003|Overall Study|Randomized but Never Received Treatment|2
1064996|NCT01972841|2114270|FG004|Overall Study|Randomized but Never Received Treatment|6
1064997|NCT01972841|2114271|FG005|Overall Study|Randomized but Never Received Treatment|13
1064998|NCT01972841|2114266|FG000|Overall Study|Adverse Event|13
1064999|NCT01972841|2114267|FG001|Overall Study|Adverse Event|8
1065000|NCT01972841|2114268|FG002|Overall Study|Adverse Event|12
1065001|NCT01972841|2114269|FG003|Overall Study|Adverse Event|9
1065002|NCT01972841|2114270|FG004|Overall Study|Adverse Event|21
1065003|NCT01972841|2114271|FG005|Overall Study|Adverse Event|26
1065004|NCT01972841|2114266|FG000|Overall Study|Lack of Efficacy|1
1065005|NCT01972841|2114267|FG001|Overall Study|Lack of Efficacy|0
1065006|NCT01972841|2114268|FG002|Overall Study|Lack of Efficacy|0
1065007|NCT01972841|2114269|FG003|Overall Study|Lack of Efficacy|2
1065008|NCT01972841|2114270|FG004|Overall Study|Lack of Efficacy|4
1065009|NCT01972841|2114271|FG005|Overall Study|Lack of Efficacy|1
1065010|NCT01972841|2114266|FG000|Overall Study|Lost to Follow-up|4
1065011|NCT01972841|2114267|FG001|Overall Study|Lost to Follow-up|2
1065012|NCT01972841|2114268|FG002|Overall Study|Lost to Follow-up|4
1065013|NCT01972841|2114269|FG003|Overall Study|Lost to Follow-up|2
1065014|NCT01972841|2114270|FG004|Overall Study|Lost to Follow-up|9
1065015|NCT01972841|2114271|FG005|Overall Study|Lost to Follow-up|3
1065016|NCT01972841|2114266|FG000|Overall Study|Protocol Violation|2
1065017|NCT01972841|2114267|FG001|Overall Study|Protocol Violation|2
1065018|NCT01972841|2114268|FG002|Overall Study|Protocol Violation|3
1065019|NCT01972841|2114269|FG003|Overall Study|Protocol Violation|5
1065020|NCT01972841|2114270|FG004|Overall Study|Protocol Violation|9
1065021|NCT01972841|2114271|FG005|Overall Study|Protocol Violation|4
1065022|NCT01972841|2114266|FG000|Overall Study|Withdrawal by participants|21
1065023|NCT01972841|2114267|FG001|Overall Study|Withdrawal by participants|27
1065024|NCT01972841|2114268|FG002|Overall Study|Withdrawal by participants|23
1065025|NCT01972841|2114269|FG003|Overall Study|Withdrawal by participants|16
1065026|NCT01972841|2114270|FG004|Overall Study|Withdrawal by participants|33
1065027|NCT01972841|2114271|FG005|Overall Study|Withdrawal by participants|34
1065028|NCT01972841|2114266|FG000|Overall Study|Miscellaneous|0
1065029|NCT01972841|2114267|FG001|Overall Study|Miscellaneous|0
1065030|NCT01972841|2114268|FG002|Overall Study|Miscellaneous|4
1065031|NCT01972841|2114269|FG003|Overall Study|Miscellaneous|1
1065032|NCT01972841|2114270|FG004|Overall Study|Miscellaneous|0
1065033|NCT01972841|2114271|FG005|Overall Study|Miscellaneous|4
1065034|NCT01972841|2114266|FG000|Overall Study|Did not have end of treatment page|0
1065035|NCT01972841|2114267|FG001|Overall Study|Did not have end of treatment page|0
1065036|NCT01972841|2114268|FG002|Overall Study|Did not have end of treatment page|0
1065037|NCT01972841|2114269|FG003|Overall Study|Did not have end of treatment page|0
1065038|NCT01972841|2114270|FG004|Overall Study|Did not have end of treatment page|1
1065039|NCT01972841|2114271|FG005|Overall Study|Did not have end of treatment page|0
1065040|NCT01973218|2114306|FG000|Overall Study|Adverse Event|1
1065041|NCT01973218|2114307|FG001|Overall Study|Adverse Event|0
1065042|NCT01973218|2114306|FG000|Overall Study|Withdrawal by Subject|1
1065043|NCT01973218|2114307|FG001|Overall Study|Withdrawal by Subject|0
1065044|NCT01973231|2114317|FG000|Overall Study|Protocol Violation|1
1065045|NCT01973231|2114318|FG001|Overall Study|Protocol Violation|1
1065046|NCT01973231|2114317|FG000|Overall Study|Lost to Follow-up|1
1065047|NCT01973231|2114318|FG001|Overall Study|Lost to Follow-up|1
1065048|NCT01973231|2114317|FG000|Overall Study|unclassified|2
1065049|NCT01973231|2114318|FG001|Overall Study|unclassified|1
1065050|NCT01973231|2114317|FG000|Overall Study|Withdrawal by Subject|7
1065051|NCT01973231|2114318|FG001|Overall Study|Withdrawal by Subject|9
1065052|NCT01973283|2114324|FG000|Overall Study|Lost to Follow-up|4
1065053|NCT01973387|2114366|FG000|Overall Study|Adverse Event|14
1065054|NCT01973387|2114367|FG001|Overall Study|Adverse Event|4
1065055|NCT01973387|2114366|FG000|Overall Study|Withdrawal by Subject|7
1065056|NCT01973387|2114367|FG001|Overall Study|Withdrawal by Subject|4
1065057|NCT01973387|2114366|FG000|Overall Study|Study terminated by sponsor|63
1065058|NCT01973387|2114367|FG001|Overall Study|Study terminated by sponsor|0
1065059|NCT01973387|2114366|FG000|Overall Study|Progressive disease or relapse|16
1065060|NCT01973387|2114367|FG001|Overall Study|Progressive disease or relapse|5
1065061|NCT01973387|2114366|FG000|Overall Study|Death|4
1065062|NCT01973387|2114367|FG001|Overall Study|Death|3
1065063|NCT01973387|2114366|FG000|Overall Study|Randomized, not treated|2
1065064|NCT01973387|2114367|FG001|Overall Study|Randomized, not treated|2
1065065|NCT01973439|2114383|FG000|Overall Study|Lost samples from one PK Day|2
1065066|NCT01973439|2114383|FG000|Overall Study|Vomiting after commencing once daily|1
1065067|NCT01973439|2114383|FG000|Overall Study|PK curve incomplete|2
1065068|NCT01973491|2114387|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
1065069|NCT01973491|2114387|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
1065070|NCT01973491|2114387|FG000|Treatment Period (16 Weeks)|Adverse Event|1
1065071|NCT01973569|2114394|FG000|Overall Study|Adverse Event|9
1065072|NCT01973569|2114395|FG001|Overall Study|Adverse Event|2
1065073|NCT01973569|2114396|FG002|Overall Study|Adverse Event|4
1065074|NCT01973569|2114394|FG000|Overall Study|Protocol Violation|2
1065075|NCT01973569|2114395|FG001|Overall Study|Protocol Violation|1
1065076|NCT01973569|2114396|FG002|Overall Study|Protocol Violation|3
1065077|NCT01973569|2114394|FG000|Overall Study|Withdrawal by Subject|7
1065078|NCT01973569|2114395|FG001|Overall Study|Withdrawal by Subject|5
1065079|NCT01973569|2114396|FG002|Overall Study|Withdrawal by Subject|2
1065080|NCT01973569|2114394|FG000|Overall Study|Invasive dental treatment|3
1065081|NCT01973569|2114395|FG001|Overall Study|Invasive dental treatment|5
1065082|NCT01973569|2114396|FG002|Overall Study|Invasive dental treatment|6
1065083|NCT01973569|2114394|FG000|Overall Study|Prohibited concomitant d|1
1065084|NCT01973569|2114395|FG001|Overall Study|Prohibited concomitant d|5
1065085|NCT01973569|2114396|FG002|Overall Study|Prohibited concomitant d|0
1065086|NCT01973569|2114394|FG000|Overall Study|Disease progression|0
1065087|NCT01973569|2114395|FG001|Overall Study|Disease progression|3
1065088|NCT01973569|2114396|FG002|Overall Study|Disease progression|0
1065089|NCT01973569|2114394|FG000|Overall Study|Other|1
1065090|NCT01973569|2114395|FG001|Overall Study|Other|1
1065091|NCT01973569|2114396|FG002|Overall Study|Other|0
1065092|NCT01973569|2114394|FG000|Overall Study|Did not receive study drug|6
1065093|NCT01973569|2114395|FG001|Overall Study|Did not receive study drug|3
1065094|NCT01973569|2114396|FG002|Overall Study|Did not receive study drug|3
1065095|NCT01973595|2114408|FG000|Washout|Withdrawal by Subject|1
1065096|NCT01973595|2114409|FG001|Washout|Withdrawal by Subject|0
1065097|NCT01973595|2114410|FG002|Washout|Withdrawal by Subject|1
1065098|NCT01973595|2114411|FG003|Washout|Withdrawal by Subject|0
1065099|NCT01973998|2114458|FG000|Overall Study|Death|2
1065100|NCT01973998|2114459|FG001|Overall Study|Death|2
1065101|NCT01974141|2114493|FG000|Overall Study|Other Reasons|28
1065102|NCT01974141|2114494|FG001|Overall Study|Other Reasons|18
1065103|NCT01974141|2114493|FG000|Overall Study|Protocol Violation|2
1065104|NCT01974141|2114494|FG001|Overall Study|Protocol Violation|6
1065105|NCT01974141|2114493|FG000|Overall Study|Personal Reasons|21
1065106|NCT01974141|2114494|FG001|Overall Study|Personal Reasons|20
1065107|NCT01974141|2114493|FG000|Overall Study|Lost to Follow-up|38
1065108|NCT01974141|2114494|FG001|Overall Study|Lost to Follow-up|29
1065109|NCT01974141|2114493|FG000|Overall Study|Pregnancy|3
1065110|NCT01974141|2114494|FG001|Overall Study|Pregnancy|3
1065111|NCT01974141|2114493|FG000|Overall Study|Lack of Efficacy|0
1065112|NCT01974141|2114494|FG001|Overall Study|Lack of Efficacy|1
1065113|NCT01974141|2114493|FG000|Overall Study|Adverse Event|4
1065114|NCT01974141|2114494|FG001|Overall Study|Adverse Event|5
1065115|NCT01974323|2114511|FG000|Overall Study|Other Reasons|25
1065116|NCT01974323|2114512|FG001|Overall Study|Other Reasons|28
1065117|NCT01974323|2114511|FG000|Overall Study|Protocol Violation|2
1065118|NCT01974323|2114512|FG001|Overall Study|Protocol Violation|2
1065119|NCT01974323|2114511|FG000|Overall Study|Personal Reasons|15
1065120|NCT01974323|2114512|FG001|Overall Study|Personal Reasons|19
1065121|NCT01974323|2114511|FG000|Overall Study|Lost to Follow-up|45
1065122|NCT01974323|2114512|FG001|Overall Study|Lost to Follow-up|40
1065123|NCT01974323|2114511|FG000|Overall Study|Pregnancy|2
1065124|NCT01974323|2114512|FG001|Overall Study|Pregnancy|1
1065125|NCT01974323|2114511|FG000|Overall Study|Lack of Efficacy|1
1065126|NCT01974323|2114512|FG001|Overall Study|Lack of Efficacy|1
1065127|NCT01974323|2114511|FG000|Overall Study|Adverse Event|2
1065128|NCT01974323|2114512|FG001|Overall Study|Adverse Event|2
1065129|NCT01974752|2114658|FG000|Overall Study|Death|33
1065130|NCT01974752|2114659|FG001|Overall Study|Death|11
1065131|NCT01974752|2114658|FG000|Overall Study|Lost to Follow-up|2
1065132|NCT01974752|2114659|FG001|Overall Study|Lost to Follow-up|0
1065133|NCT01974752|2114658|FG000|Overall Study|Withdrawal by Subject|2
1065134|NCT01974752|2114659|FG001|Overall Study|Withdrawal by Subject|3
1065135|NCT01974752|2114658|FG000|Overall Study|Other Eligibility Criteria|0
1065136|NCT01974752|2114659|FG001|Overall Study|Other Eligibility Criteria|1
1065137|NCT01974817|2114665|FG000|Overall Study|Death|4
1065138|NCT01974817|2114665|FG000|Overall Study|Lost to Follow-up|2
1065139|NCT01974817|2114665|FG000|Overall Study|Protocol Violation|2
1065140|NCT01974895|2114671|FG000|Overall Study|Protocol Violation|1
1065141|NCT01974895|2114672|FG001|Overall Study|Protocol Violation|0
1065142|NCT01974895|2114671|FG000|Overall Study|Lost to Follow-up|4
1065143|NCT01974895|2114672|FG001|Overall Study|Lost to Follow-up|6
1065144|NCT01974895|2114671|FG000|Overall Study|Withdrawal by Subject|0
1065145|NCT01974895|2114672|FG001|Overall Study|Withdrawal by Subject|1
1065146|NCT01974895|2114671|FG000|Overall Study|Other (Missed Visit)|1
1065147|NCT01974895|2114672|FG001|Overall Study|Other (Missed Visit)|0
1065148|NCT01974895|2114671|FG000|Overall Study|Other (Reason unknown)|9
1065149|NCT01974895|2114672|FG001|Overall Study|Other (Reason unknown)|8
1065150|NCT01975220|2114691|FG000|Test Period 1|Not treated|0
1065151|NCT01975220|2114692|FG001|Test Period 1|Not treated|1
1065152|NCT01975220|2114693|FG002|Test Period 1|Not treated|0
1065153|NCT01975220|2114694|FG003|Test Period 1|Not treated|0
1065154|NCT01975220|2114695|FG004|Test Period 1|Not treated|0
1065155|NCT01975220|2114696|FG005|Test Period 1|Not treated|0
1065156|NCT01975246|2114713|FG000|Overall Study|Adverse Event|2
1065157|NCT01975246|2114714|FG001|Overall Study|Adverse Event|1
1065158|NCT01975246|2114713|FG000|Overall Study|Lack of Efficacy|1
1065159|NCT01975246|2114714|FG001|Overall Study|Lack of Efficacy|0
1065160|NCT01975246|2114713|FG000|Overall Study|Protocol Violation|1
1065161|NCT01975246|2114714|FG001|Overall Study|Protocol Violation|0
1065162|NCT01975246|2114713|FG000|Overall Study|Other than stated|0
1065163|NCT01975246|2114714|FG001|Overall Study|Other than stated|1
1065164|NCT01975285|2114722|FG000|Overall Study|Failed Block and follow up|2
1065165|NCT01975285|2114723|FG001|Overall Study|Failed Block and follow up|2
1065166|NCT01975376|2114731|FG000|Overall Study|Adverse Event|5
1065167|NCT01975376|2114732|FG001|Overall Study|Adverse Event|5
1065168|NCT01975376|2114731|FG000|Overall Study|Death|65
1065169|NCT01975376|2114732|FG001|Overall Study|Death|72
1065170|NCT01975376|2114731|FG000|Overall Study|Lost to Follow-up|70
1065171|NCT01975376|2114732|FG001|Overall Study|Lost to Follow-up|66
1065172|NCT01975376|2114731|FG000|Overall Study|Withdrew consent|68
1065173|NCT01975376|2114732|FG001|Overall Study|Withdrew consent|62
1065174|NCT01975376|2114731|FG000|Overall Study|Other|2
1065175|NCT01975376|2114732|FG001|Overall Study|Other|4
1065176|NCT01975376|2114731|FG000|Overall Study|Randomized, Not Treated|16
1065177|NCT01975376|2114732|FG001|Overall Study|Randomized, Not Treated|8
1065178|NCT01975389|2114740|FG000|Overall Study|Adverse Event|10
1065179|NCT01975389|2114741|FG001|Overall Study|Adverse Event|6
1065180|NCT01975389|2114740|FG000|Overall Study|Death|61
1065181|NCT01975389|2114741|FG001|Overall Study|Death|54
1065182|NCT01975389|2114740|FG000|Overall Study|Lost to Follow-up|81
1065183|NCT01975389|2114741|FG001|Overall Study|Lost to Follow-up|86
1065184|NCT01975389|2114740|FG000|Overall Study|Withdrawal by Subject|90
1065185|NCT01975389|2114741|FG001|Overall Study|Withdrawal by Subject|76
1065186|NCT01975389|2114740|FG000|Overall Study|Other|6
1065187|NCT01975389|2114741|FG001|Overall Study|Other|9
1065188|NCT01975389|2114740|FG000|Overall Study|Randomized, not treated|4
1065189|NCT01975389|2114741|FG001|Overall Study|Randomized, not treated|5
1065190|NCT01975428|2114749|FG000|Overall Study|Lost to Follow-up|17
1065191|NCT01975428|2114750|FG001|Overall Study|Lost to Follow-up|4
1065192|NCT01975428|2114749|FG000|Overall Study|Withdrawal by Subject|3
1065193|NCT01975428|2114750|FG001|Overall Study|Withdrawal by Subject|10
1065194|NCT01975675|2114777|FG000|Overall Study|Death|0
1065195|NCT01975675|2114778|FG001|Overall Study|Death|1
1065196|NCT01975675|2114779|FG002|Overall Study|Death|0
1065197|NCT01975675|2114780|FG003|Overall Study|Death|0
1065198|NCT01975701|2114790|FG000|Overall Study|Lost to Follow-up|1
1065199|NCT01975701|2114790|FG000|Overall Study|Death|23
1065200|NCT01975701|2114790|FG000|Overall Study|Physician Decision|1
1065201|NCT01975831|2114803|FG000|Overall Study|Adverse Event|1
1065202|NCT01975831|2114804|FG001|Overall Study|Adverse Event|2
1065203|NCT01975831|2114805|FG002|Overall Study|Adverse Event|2
1065204|NCT01975831|2114806|FG003|Overall Study|Adverse Event|0
1065205|NCT01975831|2114807|FG004|Overall Study|Adverse Event|1
1065206|NCT01975831|2114808|FG005|Overall Study|Adverse Event|1
1065207|NCT01975831|2114809|FG006|Overall Study|Adverse Event|3
1065208|NCT01975831|2114810|FG007|Overall Study|Adverse Event|4
1065209|NCT01975831|2114811|FG008|Overall Study|Adverse Event|1
1065210|NCT01975831|2114803|FG000|Overall Study|Death|1
1065211|NCT01975831|2114804|FG001|Overall Study|Death|1
1065212|NCT01975831|2114805|FG002|Overall Study|Death|0
1065213|NCT01975831|2114806|FG003|Overall Study|Death|0
1065214|NCT01975831|2114807|FG004|Overall Study|Death|1
1065215|NCT01975831|2114808|FG005|Overall Study|Death|0
1065216|NCT01975831|2114809|FG006|Overall Study|Death|1
1065217|NCT01975831|2114810|FG007|Overall Study|Death|0
1065218|NCT01975831|2114811|FG008|Overall Study|Death|0
1065219|NCT01975831|2114803|FG000|Overall Study|Progressive Disease|1
1065220|NCT01975831|2114804|FG001|Overall Study|Progressive Disease|3
1065221|NCT01975831|2114805|FG002|Overall Study|Progressive Disease|2
1065222|NCT01975831|2114806|FG003|Overall Study|Progressive Disease|4
1065223|NCT01975831|2114807|FG004|Overall Study|Progressive Disease|13
1065224|NCT01975831|2114808|FG005|Overall Study|Progressive Disease|9
1065225|NCT01975831|2114809|FG006|Overall Study|Progressive Disease|10
1065226|NCT01975831|2114810|FG007|Overall Study|Progressive Disease|8
1065227|NCT01975831|2114811|FG008|Overall Study|Progressive Disease|10
1065228|NCT01975831|2114803|FG000|Overall Study|Withdrawal by Subject|0
1065229|NCT01975831|2114804|FG001|Overall Study|Withdrawal by Subject|3
1065230|NCT01975831|2114805|FG002|Overall Study|Withdrawal by Subject|0
1065231|NCT01975831|2114806|FG003|Overall Study|Withdrawal by Subject|0
1065232|NCT01975831|2114807|FG004|Overall Study|Withdrawal by Subject|3
1065233|NCT01975831|2114808|FG005|Overall Study|Withdrawal by Subject|1
1065234|NCT01975831|2114809|FG006|Overall Study|Withdrawal by Subject|1
1065235|NCT01975831|2114810|FG007|Overall Study|Withdrawal by Subject|0
1065236|NCT01975831|2114811|FG008|Overall Study|Withdrawal by Subject|0
1065237|NCT01975831|2114803|FG000|Overall Study|Physician Decision|0
1065238|NCT01975831|2114804|FG001|Overall Study|Physician Decision|0
1065239|NCT01975831|2114805|FG002|Overall Study|Physician Decision|0
1065240|NCT01975831|2114806|FG003|Overall Study|Physician Decision|0
1065241|NCT01975831|2114807|FG004|Overall Study|Physician Decision|0
1065242|NCT01975831|2114808|FG005|Overall Study|Physician Decision|1
1065243|NCT01975831|2114809|FG006|Overall Study|Physician Decision|0
1065244|NCT01975831|2114810|FG007|Overall Study|Physician Decision|1
1065245|NCT01975831|2114811|FG008|Overall Study|Physician Decision|0
1065246|NCT01975831|2114803|FG000|Overall Study|Initiation of Subsequent Therapy|0
1065247|NCT01975831|2114804|FG001|Overall Study|Initiation of Subsequent Therapy|0
1065248|NCT01975831|2114805|FG002|Overall Study|Initiation of Subsequent Therapy|0
1065249|NCT01975831|2114806|FG003|Overall Study|Initiation of Subsequent Therapy|0
1065250|NCT01975831|2114807|FG004|Overall Study|Initiation of Subsequent Therapy|0
1065251|NCT01975831|2114808|FG005|Overall Study|Initiation of Subsequent Therapy|1
1065252|NCT01975831|2114809|FG006|Overall Study|Initiation of Subsequent Therapy|0
1065253|NCT01975831|2114810|FG007|Overall Study|Initiation of Subsequent Therapy|2
1065254|NCT01975831|2114811|FG008|Overall Study|Initiation of Subsequent Therapy|0
1065255|NCT01975831|2114803|FG000|Overall Study|Entered Hospice|0
1065256|NCT01975831|2114804|FG001|Overall Study|Entered Hospice|0
1065257|NCT01975831|2114805|FG002|Overall Study|Entered Hospice|0
1065258|NCT01975831|2114806|FG003|Overall Study|Entered Hospice|0
1065259|NCT01975831|2114807|FG004|Overall Study|Entered Hospice|0
1065260|NCT01975831|2114808|FG005|Overall Study|Entered Hospice|1
1065261|NCT01975831|2114809|FG006|Overall Study|Entered Hospice|0
1065262|NCT01975831|2114810|FG007|Overall Study|Entered Hospice|0
1065263|NCT01975831|2114811|FG008|Overall Study|Entered Hospice|0
1065264|NCT01975831|2114803|FG000|Overall Study|Unable to Treat Within Protocol Windows|0
1065265|NCT01975831|2114804|FG001|Overall Study|Unable to Treat Within Protocol Windows|0
1065266|NCT01975831|2114805|FG002|Overall Study|Unable to Treat Within Protocol Windows|0
1065267|NCT01975831|2114806|FG003|Overall Study|Unable to Treat Within Protocol Windows|0
1065268|NCT01975831|2114807|FG004|Overall Study|Unable to Treat Within Protocol Windows|0
1065269|NCT01975831|2114808|FG005|Overall Study|Unable to Treat Within Protocol Windows|0
1065270|NCT01975831|2114809|FG006|Overall Study|Unable to Treat Within Protocol Windows|1
1065271|NCT01975831|2114810|FG007|Overall Study|Unable to Treat Within Protocol Windows|0
1065272|NCT01975831|2114811|FG008|Overall Study|Unable to Treat Within Protocol Windows|1
1065273|NCT01975948|2114862|FG000|Overall Study|Withdrawal by Subject|17
1065274|NCT01975948|2114863|FG001|Overall Study|Withdrawal by Subject|21
1065275|NCT01975948|2114864|FG002|Overall Study|Withdrawal by Subject|7
1065276|NCT01975948|2114865|FG003|Overall Study|Withdrawal by Subject|6
1065277|NCT01976104|2114883|FG000|Overall Study|Adverse Event|0
1065278|NCT01976104|2114884|FG001|Overall Study|Adverse Event|0
1065279|NCT01976104|2114885|FG002|Overall Study|Adverse Event|1
1065280|NCT01976104|2114886|FG003|Overall Study|Adverse Event|0
1065281|NCT01976104|2114883|FG000|Overall Study|Lost to Follow-up|3
1065282|NCT01976104|2114884|FG001|Overall Study|Lost to Follow-up|0
1065283|NCT01976104|2114885|FG002|Overall Study|Lost to Follow-up|1
1065284|NCT01976104|2114886|FG003|Overall Study|Lost to Follow-up|1
1065285|NCT01976104|2114883|FG000|Overall Study|Subject Choice|0
1065286|NCT01976104|2114884|FG001|Overall Study|Subject Choice|1
1065287|NCT01976104|2114885|FG002|Overall Study|Subject Choice|0
1065288|NCT01976104|2114886|FG003|Overall Study|Subject Choice|1
1065289|NCT01976104|2114883|FG000|Overall Study|Withdrawal by Subject|3
1065290|NCT01976104|2114884|FG001|Overall Study|Withdrawal by Subject|0
1065291|NCT01976104|2114885|FG002|Overall Study|Withdrawal by Subject|0
1065292|NCT01976104|2114886|FG003|Overall Study|Withdrawal by Subject|1
1065293|NCT01976104|2114883|FG000|Overall Study|Other|0
1065294|NCT01976104|2114884|FG001|Overall Study|Other|1
1065295|NCT01976104|2114885|FG002|Overall Study|Other|0
1065296|NCT01976104|2114886|FG003|Overall Study|Other|0
1065297|NCT01976299|2114908|FG000|Overall Study|Withdrawal by Subject|3
1065298|NCT01976299|2114909|FG001|Overall Study|Withdrawal by Subject|1
1065299|NCT01976299|2114908|FG000|Overall Study|Death|4
1065300|NCT01976299|2114909|FG001|Overall Study|Death|2
1065301|NCT01976299|2114908|FG000|Overall Study|Lost to Follow-up|7
1065302|NCT01976299|2114909|FG001|Overall Study|Lost to Follow-up|1
1065303|NCT01976299|2114908|FG000|Overall Study|See clarification above in comments|9
1065304|NCT01976299|2114909|FG001|Overall Study|See clarification above in comments|2
1065305|NCT01976312|2114917|FG000|Overall Study|Pregnancy|0
1065306|NCT01976312|2114918|FG001|Overall Study|Pregnancy|1
1065307|NCT01976312|2114917|FG000|Overall Study|Lost to Follow-up|2
1065308|NCT01976312|2114918|FG001|Overall Study|Lost to Follow-up|0
1065309|NCT01976312|2114917|FG000|Overall Study|Withdrawal by Subject|7
1065310|NCT01976312|2114918|FG001|Overall Study|Withdrawal by Subject|2
1065311|NCT01976312|2114917|FG000|Overall Study|Adverse Event|6
1065312|NCT01976312|2114918|FG001|Overall Study|Adverse Event|6
1065313|NCT01976312|2114917|FG000|Overall Study|Protocol Violation|2
1065314|NCT01976312|2114918|FG001|Overall Study|Protocol Violation|0
1065315|NCT01976338|2114927|FG000|Overall Study|Physician Decision|0
1065316|NCT01976338|2114928|FG001|Overall Study|Physician Decision|1
1065317|NCT01976338|2114927|FG000|Overall Study|Lost to Follow-up|3
1065318|NCT01976338|2114928|FG001|Overall Study|Lost to Follow-up|0
1065319|NCT01976338|2114927|FG000|Overall Study|Withdrawal by Subject|5
1065320|NCT01976338|2114928|FG001|Overall Study|Withdrawal by Subject|2
1065321|NCT01976338|2114927|FG000|Overall Study|Adverse Event|5
1065322|NCT01976338|2114928|FG001|Overall Study|Adverse Event|1
1065323|NCT01976364|2114935|FG000|Main Study (36 Months)|Adverse Event|63
1065324|NCT01976364|2114936|FG001|Main Study (36 Months)|Adverse Event|0
1065325|NCT01976364|2114937|FG002|Main Study (36 Months)|Adverse Event|0
1065326|NCT01976364|2114935|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5
1065327|NCT01976364|2114936|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0
1065328|NCT01976364|2114937|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0
1065329|NCT01976364|2114935|FG000|Main Study (36 Months)|Other|13
1065330|NCT01976364|2114936|FG001|Main Study (36 Months)|Other|0
1065331|NCT01976364|2114937|FG002|Main Study (36 Months)|Other|0
1065332|NCT01976364|2114935|FG000|Main Study (36 Months)|No longer met eligibility criteria|2
1065333|NCT01976364|2114936|FG001|Main Study (36 Months)|No longer met eligibility criteria|0
1065334|NCT01976364|2114937|FG002|Main Study (36 Months)|No longer met eligibility criteria|0
1065335|NCT01976364|2114935|FG000|Main Study (36 Months)|Medication error|1
1065336|NCT01976364|2114936|FG001|Main Study (36 Months)|Medication error|0
1065337|NCT01976364|2114937|FG002|Main Study (36 Months)|Medication error|0
1065338|NCT01976364|2114935|FG000|Main Study (36 Months)|Lost to Follow-up|10
1065339|NCT01976364|2114936|FG001|Main Study (36 Months)|Lost to Follow-up|0
1065340|NCT01976364|2114937|FG002|Main Study (36 Months)|Lost to Follow-up|0
1065341|NCT01976364|2114935|FG000|Main Study (36 Months)|Lack of Efficacy|40
1065342|NCT01976364|2114936|FG001|Main Study (36 Months)|Lack of Efficacy|0
1065343|NCT01976364|2114937|FG002|Main Study (36 Months)|Lack of Efficacy|0
1065344|NCT01976364|2114935|FG000|Main Study (36 Months)|Protocol Violation|13
1065345|NCT01976364|2114936|FG001|Main Study (36 Months)|Protocol Violation|0
1065346|NCT01976364|2114937|FG002|Main Study (36 Months)|Protocol Violation|0
1162041|NCT03381248|2283985|FG000|Overall Study|Withdrawal by Subject|5
1065347|NCT01976364|2114935|FG000|Main Study (36 Months)|Withdrawal by Subject|69
1065348|NCT01976364|2114936|FG001|Main Study (36 Months)|Withdrawal by Subject|0
1065349|NCT01976364|2114937|FG002|Main Study (36 Months)|Withdrawal by Subject|0
1065350|NCT01976364|2114935|FG000|Main Study (36 Months)|Death|5
1065351|NCT01976364|2114936|FG001|Main Study (36 Months)|Death|0
1065352|NCT01976364|2114937|FG002|Main Study (36 Months)|Death|0
1065353|NCT01976364|2114935|FG000|Sub-study (12 Months)|Lost to Follow-up|0
1065354|NCT01976364|2114936|FG001|Sub-study (12 Months)|Lost to Follow-up|1
1065355|NCT01976364|2114937|FG002|Sub-study (12 Months)|Lost to Follow-up|0
1065356|NCT01976364|2114935|FG000|Sub-study (12 Months)|Withdrawal by Subject|0
1065357|NCT01976364|2114936|FG001|Sub-study (12 Months)|Withdrawal by Subject|0
1065358|NCT01976364|2114937|FG002|Sub-study (12 Months)|Withdrawal by Subject|1
1065359|NCT01976364|2114935|FG000|Sub-study (12 Months)|Protocol Violation|0
1065360|NCT01976364|2114936|FG001|Sub-study (12 Months)|Protocol Violation|1
1065361|NCT01976364|2114937|FG002|Sub-study (12 Months)|Protocol Violation|1
1065362|NCT01976364|2114935|FG000|Sub-study (12 Months)|Adverse Event|0
1065363|NCT01976364|2114936|FG001|Sub-study (12 Months)|Adverse Event|4
1065364|NCT01976364|2114937|FG002|Sub-study (12 Months)|Adverse Event|3
1065365|NCT01976507|2114973|FG000|Overall Study|Adverse Event|6
1065366|NCT01976507|2114973|FG000|Overall Study|ablation not done, drug not given|1
1065367|NCT01976624|2114988|FG000|Overall Study|Participants contraindicated|2
1065368|NCT01976624|2114988|FG000|Overall Study|Participants age less than 19 years|12
1065369|NCT01976663|2114996|FG000|Overall Study|Completed 18 mos but no repeat treatment|24
1065370|NCT01976663|2114996|FG000|Overall Study|Personal Reasons|6
1065371|NCT01976663|2114996|FG000|Overall Study|Withdrawal by Subject|4
1065372|NCT01976663|2114996|FG000|Overall Study|Screen Failure|3
1065373|NCT01976663|2114996|FG000|Overall Study|Adverse Event|2
1065374|NCT01976663|2114996|FG000|Overall Study|Lost to Follow-up|3
1065375|NCT01976728|2115008|FG000|Overall Study|Subject missed multiple doses of IMP|1
1065376|NCT01976728|2115009|FG001|Overall Study|Subject missed multiple doses of IMP|0
1065377|NCT01976728|2115010|FG002|Overall Study|Subject missed multiple doses of IMP|0
1065378|NCT01976728|2115011|FG003|Overall Study|Subject missed multiple doses of IMP|0
1065379|NCT01976741|2115047|FG000|Overall Study|Withdrawal by Subject|1
1065380|NCT01976741|2115048|FG001|Overall Study|Withdrawal by Subject|0
1065381|NCT01976741|2115049|FG002|Overall Study|Withdrawal by Subject|1
1065382|NCT01976741|2115050|FG003|Overall Study|Withdrawal by Subject|1
1065383|NCT01976741|2115051|FG004|Overall Study|Withdrawal by Subject|0
1065384|NCT01976741|2115052|FG005|Overall Study|Withdrawal by Subject|0
1065385|NCT01976741|2115053|FG006|Overall Study|Withdrawal by Subject|1
1065386|NCT01976741|2115054|FG007|Overall Study|Withdrawal by Subject|4
1065387|NCT01976741|2115055|FG008|Overall Study|Withdrawal by Subject|0
1065388|NCT01976741|2115056|FG009|Overall Study|Withdrawal by Subject|0
1065389|NCT01976741|2115047|FG000|Overall Study|Adverse Event|0
1065390|NCT01976741|2115048|FG001|Overall Study|Adverse Event|0
1065391|NCT01976741|2115049|FG002|Overall Study|Adverse Event|2
1065392|NCT01976741|2115050|FG003|Overall Study|Adverse Event|0
1065393|NCT01976741|2115051|FG004|Overall Study|Adverse Event|0
1065394|NCT01976741|2115052|FG005|Overall Study|Adverse Event|0
1065395|NCT01976741|2115053|FG006|Overall Study|Adverse Event|3
1065396|NCT01976741|2115054|FG007|Overall Study|Adverse Event|8
1065397|NCT01976741|2115055|FG008|Overall Study|Adverse Event|1
1065398|NCT01976741|2115056|FG009|Overall Study|Adverse Event|4
1065399|NCT01976806|2115092|FG000|Overall Study|Lost to Follow-up|1
1065400|NCT01976806|2115093|FG001|Overall Study|Lost to Follow-up|4
1065401|NCT01976806|2115092|FG000|Overall Study|Adverse Event|1
1065402|NCT01976806|2115093|FG001|Overall Study|Adverse Event|1
1065403|NCT01976806|2115092|FG000|Overall Study|Withdrawal by Subject|1
1065404|NCT01976806|2115093|FG001|Overall Study|Withdrawal by Subject|1
1065405|NCT01976845|2115111|FG000|Overall Study|Physician Decision|8
1065406|NCT01976845|2115112|FG001|Overall Study|Physician Decision|8
1065407|NCT01976845|2115113|FG002|Overall Study|Physician Decision|3
1065408|NCT01977040|2115145|FG000|Overall Study|Vasa previa not confirmed|2
1065409|NCT01977092|2115155|FG000|Overall Study|Death|3
1065410|NCT01977092|2115156|FG001|Overall Study|Death|4
1065411|NCT01977092|2115155|FG000|Overall Study|Lost to Follow-up|23
1065412|NCT01977092|2115156|FG001|Overall Study|Lost to Follow-up|14
1065413|NCT01977092|2115155|FG000|Overall Study|Withdrawal by Subject|2
1065414|NCT01977092|2115156|FG001|Overall Study|Withdrawal by Subject|1
1065415|NCT01977092|2115155|FG000|Overall Study|In prison|3
1065416|NCT01977092|2115156|FG001|Overall Study|In prison|11
1065417|NCT01977222|2115162|FG000|Overall Study|Withdrawal by Subject|1
1065418|NCT01977352|2115168|FG000|Overall Study|Lost to Follow-up|1
1065419|NCT01977352|2115169|FG001|Overall Study|Lost to Follow-up|2
1065420|NCT01977456|2115175|FG000|Overall Study|Death|5
1065421|NCT01977482|2115185|FG000|Overall Study|Adverse Event|0
1065422|NCT01977482|2115186|FG001|Overall Study|Adverse Event|1
1065423|NCT01977482|2115187|FG002|Overall Study|Adverse Event|1
1065424|NCT01977482|2115188|FG003|Overall Study|Adverse Event|0
1065425|NCT01977482|2115189|FG004|Overall Study|Adverse Event|2
1065426|NCT01977482|2115190|FG005|Overall Study|Adverse Event|0
1065427|NCT01977482|2115185|FG000|Overall Study|Lost to Follow-up|1
1065428|NCT01977482|2115186|FG001|Overall Study|Lost to Follow-up|0
1065429|NCT01977482|2115187|FG002|Overall Study|Lost to Follow-up|0
1065430|NCT01977482|2115188|FG003|Overall Study|Lost to Follow-up|0
1065431|NCT01977482|2115189|FG004|Overall Study|Lost to Follow-up|0
1065432|NCT01977482|2115190|FG005|Overall Study|Lost to Follow-up|0
1065433|NCT01977482|2115185|FG000|Overall Study|Physician Decision|0
1065434|NCT01977482|2115186|FG001|Overall Study|Physician Decision|1
1065435|NCT01977482|2115187|FG002|Overall Study|Physician Decision|0
1065436|NCT01977482|2115188|FG003|Overall Study|Physician Decision|0
1065437|NCT01977482|2115189|FG004|Overall Study|Physician Decision|0
1065438|NCT01977482|2115190|FG005|Overall Study|Physician Decision|0
1065439|NCT01977482|2115185|FG000|Overall Study|Protocol Violation|0
1065440|NCT01977482|2115186|FG001|Overall Study|Protocol Violation|0
1065441|NCT01977482|2115187|FG002|Overall Study|Protocol Violation|1
1065442|NCT01977482|2115188|FG003|Overall Study|Protocol Violation|0
1065443|NCT01977482|2115189|FG004|Overall Study|Protocol Violation|0
1065444|NCT01977482|2115190|FG005|Overall Study|Protocol Violation|0
1065445|NCT01977482|2115185|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0
1065446|NCT01977482|2115186|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3
1065447|NCT01977482|2115187|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2
1065448|NCT01977482|2115188|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1
1065449|NCT01977482|2115189|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0
1065450|NCT01977482|2115190|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0
1065451|NCT01977482|2115185|FG000|Overall Study|Withdrawal by Subject|2
1065452|NCT01977482|2115186|FG001|Overall Study|Withdrawal by Subject|4
1065453|NCT01977482|2115187|FG002|Overall Study|Withdrawal by Subject|1
1065454|NCT01977482|2115188|FG003|Overall Study|Withdrawal by Subject|3
1065455|NCT01977482|2115189|FG004|Overall Study|Withdrawal by Subject|1
1065456|NCT01977482|2115190|FG005|Overall Study|Withdrawal by Subject|5
1065457|NCT01977573|2115222|FG000|Overall Study|Adverse Event|7
1065458|NCT01977573|2115223|FG001|Overall Study|Adverse Event|0
1065459|NCT01977573|2115224|FG002|Overall Study|Adverse Event|2
1065460|NCT01977573|2115225|FG003|Overall Study|Adverse Event|1
1065461|NCT01977573|2115222|FG000|Overall Study|Lost to Follow-up|1
1065462|NCT01977573|2115223|FG001|Overall Study|Lost to Follow-up|0
1065463|NCT01977573|2115224|FG002|Overall Study|Lost to Follow-up|0
1065464|NCT01977573|2115225|FG003|Overall Study|Lost to Follow-up|1
1065465|NCT01977573|2115222|FG000|Overall Study|Physician Decision|1
1065466|NCT01977573|2115223|FG001|Overall Study|Physician Decision|0
1065467|NCT01977573|2115224|FG002|Overall Study|Physician Decision|0
1065468|NCT01977573|2115225|FG003|Overall Study|Physician Decision|0
1065469|NCT01977573|2115222|FG000|Overall Study|Protocol Violation|3
1065470|NCT01977573|2115223|FG001|Overall Study|Protocol Violation|1
1065471|NCT01977573|2115224|FG002|Overall Study|Protocol Violation|0
1065472|NCT01977573|2115225|FG003|Overall Study|Protocol Violation|0
1065473|NCT01977573|2115222|FG000|Overall Study|Reached Defined Stopping Criteria|2
1065474|NCT01977573|2115223|FG001|Overall Study|Reached Defined Stopping Criteria|1
1065475|NCT01977573|2115224|FG002|Overall Study|Reached Defined Stopping Criteria|1
1065476|NCT01977573|2115225|FG003|Overall Study|Reached Defined Stopping Criteria|0
1065477|NCT01977573|2115222|FG000|Overall Study|Withdrawal by Subject|6
1065478|NCT01977573|2115223|FG001|Overall Study|Withdrawal by Subject|1
1065479|NCT01977573|2115224|FG002|Overall Study|Withdrawal by Subject|1
1065480|NCT01977573|2115225|FG003|Overall Study|Withdrawal by Subject|1
1065481|NCT01977612|2115247|FG000|Overall Study|Lost to Follow-up|1
1065482|NCT01977612|2115248|FG001|Overall Study|Lost to Follow-up|1
1065483|NCT01977625|2115254|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3
1065484|NCT01977625|2115255|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0
1065485|NCT01977625|2115254|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1065486|NCT01977625|2115255|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1065487|NCT01977651|2115263|FG000|4 Month Treatment Period|Adverse Event|34
1065488|NCT01977651|2115263|FG000|4 Month Treatment Period|Death|3
1065489|NCT01977651|2115263|FG000|4 Month Treatment Period|Progressive Disease|43
1065490|NCT01977651|2115263|FG000|4 Month Treatment Period|Withdrawal by Subject|17
1065491|NCT01977651|2115263|FG000|4 Month Treatment Period|Physician Decision|4
1065492|NCT01977651|2115263|FG000|1 Year Extension Period|Adverse Event|14
1065493|NCT01977651|2115263|FG000|1 Year Extension Period|Death|10
1065494|NCT01977651|2115263|FG000|1 Year Extension Period|Lost to Follow-up|2
1065495|NCT01977651|2115263|FG000|1 Year Extension Period|Progressive Disease|86
1065496|NCT01977651|2115263|FG000|1 Year Extension Period|Withdrawal by Subject|11
1065497|NCT01977651|2115263|FG000|1 Year Extension Period|Physician Decision|6
1065498|NCT01977651|2115263|FG000|1 Year Extension Period|Miscellaneous|1
1065499|NCT01977651|2115263|FG000|Post 1 Year Extension Period|Adverse Event|5
1065500|NCT01977651|2115263|FG000|Post 1 Year Extension Period|Death|13
1065501|NCT01977651|2115263|FG000|Post 1 Year Extension Period|Progressive Disease|60
1065502|NCT01977651|2115263|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13
1065503|NCT01977651|2115263|FG000|Post 1 Year Extension Period|Physician Decision|4
1065504|NCT01977651|2115263|FG000|Post 1 Year Extension Period|Miscellaneous|49
1065505|NCT01977677|2115270|FG000|Overall Study|Unrelated Adverse Event|0
1065506|NCT01977677|2115271|FG001|Overall Study|Unrelated Adverse Event|0
1065507|NCT01977677|2115272|FG002|Overall Study|Unrelated Adverse Event|1
1065508|NCT01977690|2115282|FG000|Overall Study|Withdrawal by Subject|0
1065509|NCT01977690|2115283|FG001|Overall Study|Withdrawal by Subject|4
1065510|NCT01977794|2115300|FG000|Overall Study|Adverse Event|2
1065511|NCT01977794|2115301|FG001|Overall Study|Adverse Event|2
1065512|NCT01977794|2115300|FG000|Overall Study|Lost to Follow-up|2
1065513|NCT01977794|2115301|FG001|Overall Study|Lost to Follow-up|1
1065514|NCT01977794|2115300|FG000|Overall Study|Protocol Violation|1
1065515|NCT01977794|2115301|FG001|Overall Study|Protocol Violation|0
1065516|NCT01977794|2115300|FG000|Overall Study|Death|1
1065517|NCT01977794|2115301|FG001|Overall Study|Death|1
1065518|NCT01977794|2115300|FG000|Overall Study|Withdrew consent|2
1065519|NCT01977794|2115301|FG001|Overall Study|Withdrew consent|1
1065520|NCT01977794|2115300|FG000|Overall Study|Other|0
1065521|NCT01977794|2115301|FG001|Overall Study|Other|1
1065522|NCT01977820|2115309|FG000|Overall Study|Sponsor terminated the study|1
1065523|NCT01977820|2115310|FG001|Overall Study|Sponsor terminated the study|1
1065524|NCT01977846|2115318|FG000|Total Study - Prospective|Death|0
1065525|NCT01977846|2115319|FG001|Total Study - Prospective|Death|1
1065526|NCT01977846|2115318|FG000|Total Study - Prospective|Lost to Follow-up|0
1065527|NCT01977846|2115319|FG001|Total Study - Prospective|Lost to Follow-up|8
1065528|NCT01977846|2115318|FG000|Total Study - Prospective|Withdrawal by Subject|0
1065529|NCT01977846|2115319|FG001|Total Study - Prospective|Withdrawal by Subject|13
1065530|NCT01977846|2115318|FG000|Total Study - Prospective|Not available at time of visit|0
1065531|NCT01977846|2115319|FG001|Total Study - Prospective|Not available at time of visit|5
1065532|NCT01977846|2115318|FG000|Total Study - Prospective|No show|0
1065533|NCT01977846|2115319|FG001|Total Study - Prospective|No show|1
1065534|NCT01977846|2115318|FG000|Total Study - Prospective|Protocol Violation|0
1065535|NCT01977846|2115319|FG001|Total Study - Prospective|Protocol Violation|1
1065536|NCT01977898|2115328|FG000|Overall Study|Non functioning catheter|1
1065537|NCT01977898|2115329|FG001|Overall Study|Non functioning catheter|1
1065538|NCT01977937|2115337|FG000|Overall Study|Withdrawal by Subject|2
1065539|NCT01977937|2115338|FG001|Overall Study|Withdrawal by Subject|1
1065540|NCT01977937|2115337|FG000|Overall Study|Adverse Event|1
1065541|NCT01977937|2115338|FG001|Overall Study|Adverse Event|0
1065542|NCT01977937|2115337|FG000|Overall Study|Physician Decision|0
1065543|NCT01977937|2115338|FG001|Overall Study|Physician Decision|1
1065544|NCT01978093|2115346|FG000|Overall Study|Death|1
1065545|NCT01978093|2115347|FG001|Overall Study|Death|0
1065546|NCT01978093|2115346|FG000|Overall Study|Adverse Event|0
1065547|NCT01978093|2115347|FG001|Overall Study|Adverse Event|5
1065548|NCT01978093|2115346|FG000|Overall Study|Protocol Violation|8
1065549|NCT01978093|2115347|FG001|Overall Study|Protocol Violation|2
1065550|NCT01978093|2115346|FG000|Overall Study|Withdrawal by Subject|29
1065551|NCT01978093|2115347|FG001|Overall Study|Withdrawal by Subject|25
1065552|NCT01978093|2115346|FG000|Overall Study|Lost to Follow-up|11
1065553|NCT01978093|2115347|FG001|Overall Study|Lost to Follow-up|15
1065554|NCT01978093|2115346|FG000|Overall Study|Migrated/moved from study area|11
1065555|NCT01978093|2115347|FG001|Overall Study|Migrated/moved from study area|13
1065556|NCT01978093|2115346|FG000|Overall Study|Loss of kaiser coverage|4
1065557|NCT01978093|2115347|FG001|Overall Study|Loss of kaiser coverage|10
1065558|NCT01978093|2115346|FG000|Overall Study|Lost kaiser health plan unable to contac|1
1065559|NCT01978093|2115347|FG001|Overall Study|Lost kaiser health plan unable to contac|0
1065560|NCT01978093|2115346|FG000|Overall Study|Mother lost custody of child|0
1065561|NCT01978093|2115347|FG001|Overall Study|Mother lost custody of child|1
1065562|NCT01978093|2115346|FG000|Overall Study|Child was in care of grandmother|0
1065563|NCT01978093|2115347|FG001|Overall Study|Child was in care of grandmother|1
1065564|NCT01978093|2115346|FG000|Overall Study|N/A for vaccine administration|0
1065565|NCT01978093|2115347|FG001|Overall Study|N/A for vaccine administration|1
1065566|NCT01978119|2115356|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
1065567|NCT01978119|2115357|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
1065568|NCT01978119|2115356|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1065569|NCT01978119|2115357|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1065570|NCT01978119|2115356|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1065571|NCT01978119|2115357|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
1065572|NCT01978145|2115363|FG000|Treatment Period 1|Adverse Event|1
1065573|NCT01978145|2115364|FG001|Treatment Period 1|Adverse Event|9
1065574|NCT01978145|2115363|FG000|Treatment Period 1|Physician Decision|1
1065575|NCT01978145|2115364|FG001|Treatment Period 1|Physician Decision|0
1065576|NCT01978145|2115363|FG000|Treatment Period 1|Withdrawal by Subject|5
1065577|NCT01978145|2115364|FG001|Treatment Period 1|Withdrawal by Subject|4
1065578|NCT01978145|2115363|FG000|Treatment Period 1|Par. reached defined stopping criteria|2
1065579|NCT01978145|2115364|FG001|Treatment Period 1|Par. reached defined stopping criteria|3
1065580|NCT01978145|2115363|FG000|Washout Period 1|Adverse Event|0
1065581|NCT01978145|2115364|FG001|Washout Period 1|Adverse Event|1
1065582|NCT01978145|2115363|FG000|Washout Period 1|Withdrawal by Subject|1
1065583|NCT01978145|2115364|FG001|Washout Period 1|Withdrawal by Subject|1
1065584|NCT01978145|2115363|FG000|Washout Period 1|Par. reached defined stopping criteria|0
1065585|NCT01978145|2115364|FG001|Washout Period 1|Par. reached defined stopping criteria|1
1065586|NCT01978145|2115363|FG000|Treatment Period 2|Adverse Event|3
1065587|NCT01978145|2115364|FG001|Treatment Period 2|Adverse Event|3
1065588|NCT01978145|2115363|FG000|Treatment Period 2|Protocol Violation|0
1065589|NCT01978145|2115364|FG001|Treatment Period 2|Protocol Violation|1
1065590|NCT01978145|2115363|FG000|Treatment Period 2|Lost to Follow-up|1
1065591|NCT01978145|2115364|FG001|Treatment Period 2|Lost to Follow-up|1
1065592|NCT01978145|2115363|FG000|Treatment Period 2|Withdrawal by Subject|7
1065593|NCT01978145|2115364|FG001|Treatment Period 2|Withdrawal by Subject|4
1065594|NCT01978145|2115363|FG000|Treatment Period 2|Par. reached defined stopping criteria|8
1065595|NCT01978145|2115364|FG001|Treatment Period 2|Par. reached defined stopping criteria|5
1065596|NCT01978184|2115372|FG000|Overall Study|Progressive disease|5
1065597|NCT01978184|2115373|FG001|Overall Study|Progressive disease|5
1065598|NCT01978184|2115372|FG000|Overall Study|Other than PDA|2
1065599|NCT01978184|2115373|FG001|Overall Study|Other than PDA|2
1065600|NCT01978184|2115372|FG000|Overall Study|Physician Decision|0
1065601|NCT01978184|2115373|FG001|Overall Study|Physician Decision|3
1065602|NCT01978184|2115372|FG000|Overall Study|Noncompliance|1
1065603|NCT01978184|2115373|FG001|Overall Study|Noncompliance|2
1065604|NCT01978184|2115372|FG000|Overall Study|Death|1
1065605|NCT01978184|2115373|FG001|Overall Study|Death|0
1065606|NCT01978184|2115372|FG000|Overall Study|Withdrew- toxicities or physical decline|4
1065607|NCT01978184|2115373|FG001|Overall Study|Withdrew- toxicities or physical decline|8
1065608|NCT01978236|2115379|FG000|Overall Study|Discontinued due to study close|2
1065609|NCT01978262|2115383|FG000|Overall Study|Withdrawal by Subject|9
1065610|NCT01978262|2115383|FG000|Overall Study|Lost to Follow-up|2
1065611|NCT01978912|2115451|FG000|Overall Study|Adverse Event|0
1065612|NCT01978912|2115452|FG001|Overall Study|Adverse Event|1
1065613|NCT01978912|2115453|FG002|Overall Study|Adverse Event|0
1065614|NCT01978912|2115454|FG003|Overall Study|Adverse Event|0
1065615|NCT01978912|2115451|FG000|Overall Study|Lost to Follow-up|1
1065616|NCT01978912|2115452|FG001|Overall Study|Lost to Follow-up|1
1065617|NCT01978912|2115453|FG002|Overall Study|Lost to Follow-up|0
1065618|NCT01978912|2115454|FG003|Overall Study|Lost to Follow-up|1
1065619|NCT01978912|2115451|FG000|Overall Study|Withdrawal by Subject|1
1065620|NCT01978912|2115452|FG001|Overall Study|Withdrawal by Subject|0
1065621|NCT01978912|2115453|FG002|Overall Study|Withdrawal by Subject|2
1065622|NCT01978912|2115454|FG003|Overall Study|Withdrawal by Subject|2
1065623|NCT01978912|2115451|FG000|Overall Study|Lumbar Surgery|1
1065624|NCT01978912|2115452|FG001|Overall Study|Lumbar Surgery|0
1065625|NCT01978912|2115453|FG002|Overall Study|Lumbar Surgery|1
1065626|NCT01978912|2115454|FG003|Overall Study|Lumbar Surgery|0
1065627|NCT01978912|2115451|FG000|Overall Study|Intradiscal Steroid Injection|0
1065628|NCT01978912|2115452|FG001|Overall Study|Intradiscal Steroid Injection|1
1065629|NCT01978912|2115453|FG002|Overall Study|Intradiscal Steroid Injection|0
1065630|NCT01978912|2115454|FG003|Overall Study|Intradiscal Steroid Injection|0
1065643|NCT01979016|2115475|FG000|Overall Study|Withdrawal by Subject|2
1065644|NCT01979016|2115476|FG001|Overall Study|Withdrawal by Subject|0
1065645|NCT01979016|2115475|FG000|Overall Study|Adverse Event|0
1065646|NCT01979016|2115476|FG001|Overall Study|Adverse Event|1
1065647|NCT01979185|2115516|FG000|Period 2|Other|0
1065648|NCT01979185|2115517|FG001|Period 2|Other|1
1065649|NCT01979523|2115552|FG000|Overall Study|Withdrawal by Subject|1
1065650|NCT01979523|2115553|FG001|Overall Study|Withdrawal by Subject|0
1065651|NCT01979614|2115562|FG000|Overall Study|Adverse Event|1
1065652|NCT01979614|2115563|FG001|Overall Study|Adverse Event|1
1065653|NCT01979835|2115569|FG000|Primary Outcome SA Measurment|failed insertion|18
1065654|NCT01979835|2115569|FG000|Follow-up|Lost to Follow-up|32
1065655|NCT01979952|2115575|FG000|Overall Study|Adverse Event|4
1065656|NCT01979952|2115576|FG001|Overall Study|Adverse Event|5
1065657|NCT01979952|2115575|FG000|Overall Study|Protocol Violation|1
1065658|NCT01979952|2115576|FG001|Overall Study|Protocol Violation|0
1065659|NCT01979952|2115575|FG000|Overall Study|Withdrawal by Subject|2
1065660|NCT01979952|2115576|FG001|Overall Study|Withdrawal by Subject|1
1065661|NCT01979952|2115575|FG000|Overall Study|Other than specified above|1
1065662|NCT01979952|2115576|FG001|Overall Study|Other than specified above|0
1065663|NCT01980056|2115585|FG000|Overall Study|Death|1
1065664|NCT01980056|2115586|FG001|Overall Study|Death|1
1065665|NCT01980056|2115587|FG002|Overall Study|Death|0
1065666|NCT01980095|2115601|FG000|Overall Study|Lost to Follow-up|6
1065667|NCT01980095|2115602|FG001|Overall Study|Lost to Follow-up|7
1065668|NCT01980095|2115601|FG000|Overall Study|Withdrawal by Subject|2
1065669|NCT01980095|2115602|FG001|Overall Study|Withdrawal by Subject|3
1065670|NCT01980095|2115601|FG000|Overall Study|Poor compliance|5
1065671|NCT01980095|2115602|FG001|Overall Study|Poor compliance|0
1065672|NCT01980095|2115601|FG000|Overall Study|Safety issue|0
1065673|NCT01980095|2115602|FG001|Overall Study|Safety issue|1
1065674|NCT01980095|2115601|FG000|Overall Study|Study drug discontinued|1
1065675|NCT01980095|2115602|FG001|Overall Study|Study drug discontinued|0
1065676|NCT01980095|2115601|FG000|Overall Study|Randomized by mistake|1
1065677|NCT01980095|2115602|FG001|Overall Study|Randomized by mistake|0
1065678|NCT01980628|2115641|FG000|Overall Study|Adverse Event|12
1065679|NCT01980628|2115641|FG000|Overall Study|Physician Decision|5
1065680|NCT01980628|2115641|FG000|Overall Study|Withdrawal by Subject|4
1065681|NCT01980628|2115641|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42
1065682|NCT01980706|2115658|FG000|Overall Study|Withdrawal by Subject|9
1065683|NCT01980706|2115659|FG001|Overall Study|Withdrawal by Subject|6
1065684|NCT01980706|2115660|FG002|Overall Study|Withdrawal by Subject|2
1065685|NCT01980706|2115658|FG000|Overall Study|Adverse Event|1
1065686|NCT01980706|2115659|FG001|Overall Study|Adverse Event|2
1065687|NCT01980706|2115660|FG002|Overall Study|Adverse Event|5
1065688|NCT01980706|2115658|FG000|Overall Study|Lost to Follow-up|3
1065689|NCT01980706|2115659|FG001|Overall Study|Lost to Follow-up|4
1065690|NCT01980706|2115660|FG002|Overall Study|Lost to Follow-up|3
1065691|NCT01980706|2115658|FG000|Overall Study|miscellaneous|4
1065692|NCT01980706|2115659|FG001|Overall Study|miscellaneous|5
1065693|NCT01980706|2115660|FG002|Overall Study|miscellaneous|3
1065694|NCT01980888|2115679|FG000|Overall Study|Study Terminated by Sponsor|116
1065695|NCT01980888|2115680|FG001|Overall Study|Study Terminated by Sponsor|122
1065696|NCT01980888|2115679|FG000|Overall Study|Withdrew Consent|17
1065697|NCT01980888|2115680|FG001|Overall Study|Withdrew Consent|6
1065698|NCT01980888|2115679|FG000|Overall Study|Investigator's Discretion|8
1065699|NCT01980888|2115680|FG001|Overall Study|Investigator's Discretion|3
1065700|NCT01980888|2115679|FG000|Overall Study|Non-Compliance with Study Drug|3
1065701|NCT01980888|2115680|FG001|Overall Study|Non-Compliance with Study Drug|2
1065702|NCT01980940|2115699|FG000|Overall Study|Protocol Violation|0
1065703|NCT01980940|2115700|FG001|Overall Study|Protocol Violation|0
1065704|NCT01980940|2115701|FG002|Overall Study|Protocol Violation|0
1065705|NCT01980940|2115702|FG003|Overall Study|Protocol Violation|0
1065706|NCT01980940|2115703|FG004|Overall Study|Protocol Violation|0
1065707|NCT01980940|2115704|FG005|Overall Study|Protocol Violation|2
1065708|NCT01980940|2115705|FG006|Overall Study|Protocol Violation|0
1065709|NCT01980940|2115706|FG007|Overall Study|Protocol Violation|0
1065710|NCT01980992|2115732|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
1065711|NCT01980992|2115733|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
1065712|NCT01980992|2115732|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
1065713|NCT01980992|2115733|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
1065714|NCT01980992|2115732|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1
1065715|NCT01980992|2115733|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0
1065716|NCT01980992|2115732|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
1065717|NCT01980992|2115733|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
1065718|NCT01980992|2115732|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
1065719|NCT01980992|2115733|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
1065720|NCT01980992|2115732|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
1065721|NCT01980992|2115733|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
1065722|NCT01981096|2115757|FG000|Overall Study|Parent illness|1
1065723|NCT01981096|2115758|FG001|Overall Study|Parent illness|0
1065724|NCT01981096|2115757|FG000|Overall Study|Withdrawal by Subject|0
1065725|NCT01981096|2115758|FG001|Overall Study|Withdrawal by Subject|1
1065726|NCT01981096|2115757|FG000|Overall Study|Lost to Follow-up|2
1065727|NCT01981096|2115758|FG001|Overall Study|Lost to Follow-up|0
1065728|NCT01981109|2115764|FG000|Overall Study|Death|36
1065729|NCT01981109|2115764|FG000|Overall Study|Withdrawal by Subject|40
1065730|NCT01981109|2115764|FG000|Overall Study|Lost to Follow-up|9
1065731|NCT01981109|2115764|FG000|Overall Study|No Discontinuation Documentation|37
1065732|NCT01981109|2115764|FG000|Overall Study|Study Termination|100
1065733|NCT01981109|2115764|FG000|Overall Study|No data available|2
1065734|NCT01981122|2115771|FG000|Overall Study|Withdrawal by Subject|0
1065735|NCT01981122|2115772|FG001|Overall Study|Withdrawal by Subject|2
1065736|NCT01981122|2115771|FG000|Overall Study|Protocol Violation|0
1065737|NCT01981122|2115772|FG001|Overall Study|Protocol Violation|1
1065738|NCT01981122|2115771|FG000|Overall Study|Lost to Follow-up|0
1065739|NCT01981122|2115772|FG001|Overall Study|Lost to Follow-up|1
1065740|NCT01981122|2115771|FG000|Overall Study|Investigator Or Dendreon Discretion|0
1065741|NCT01981122|2115772|FG001|Overall Study|Investigator Or Dendreon Discretion|1
1065742|NCT01981122|2115771|FG000|Overall Study|Death|14
1065743|NCT01981122|2115772|FG001|Overall Study|Death|15
1065744|NCT01981187|2115778|FG000|Overall Study|Participant/guardian decision|2
1065745|NCT01981187|2115778|FG000|Overall Study|Physician Decision|1
1065746|NCT01981187|2115778|FG000|Overall Study|Disease progression|2
1065747|NCT01981187|2115778|FG000|Overall Study|Adverse Event|7
1065748|NCT01981356|2115784|FG000|Overall Study|Lost to Follow-up|4
1065749|NCT01981356|2115785|FG001|Overall Study|Lost to Follow-up|1
1065750|NCT01981356|2115784|FG000|Overall Study|Withdrawal by Subject|1
1065751|NCT01981356|2115785|FG001|Overall Study|Withdrawal by Subject|1
1065752|NCT01981356|2115784|FG000|Overall Study|Protocol Violation|2
1065753|NCT01981356|2115785|FG001|Overall Study|Protocol Violation|0
1065754|NCT01981473|2115795|FG000|Overall Study|Incorrect diagnosis of RA|0
1065755|NCT01981473|2115796|FG001|Overall Study|Incorrect diagnosis of RA|0
1065756|NCT01981473|2115797|FG002|Overall Study|Incorrect diagnosis of RA|1
1065757|NCT01981473|2115795|FG000|Overall Study|Received treatment for < 6 months|0
1065758|NCT01981473|2115796|FG001|Overall Study|Received treatment for < 6 months|0
1065759|NCT01981473|2115797|FG002|Overall Study|Received treatment for < 6 months|1
1065760|NCT01981473|2115795|FG000|Overall Study|Received treatment for >24 months|2
1065761|NCT01981473|2115796|FG001|Overall Study|Received treatment for >24 months|0
1065762|NCT01981473|2115797|FG002|Overall Study|Received treatment for >24 months|6
1065765|NCT01981616|2115829|FG000|Overall Study|Adverse Event|0
1065766|NCT01981616|2115830|FG001|Overall Study|Adverse Event|1
1065767|NCT01981616|2115829|FG000|Overall Study|Protocol Violation|1
1065768|NCT01981616|2115830|FG001|Overall Study|Protocol Violation|0
1065769|NCT01981954|2115863|FG000|Titration Period|Protocol Deviation|1
1065770|NCT01981954|2115863|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1
1065771|NCT01982292|2115899|FG000|Overall Study|Adverse Event|2
1065772|NCT01982292|2115900|FG001|Overall Study|Adverse Event|0
1065773|NCT01982292|2115899|FG000|Overall Study|Death|1
1065774|NCT01982292|2115900|FG001|Overall Study|Death|0
1065775|NCT01982292|2115899|FG000|Overall Study|Lost to Follow-up|2
1065776|NCT01982292|2115900|FG001|Overall Study|Lost to Follow-up|0
1065777|NCT01982292|2115899|FG000|Overall Study|Non-Compliance With Study Treatment|1
1065778|NCT01982292|2115900|FG001|Overall Study|Non-Compliance With Study Treatment|0
1065779|NCT01982292|2115899|FG000|Overall Study|Protocol Deviation|1
1065780|NCT01982292|2115900|FG001|Overall Study|Protocol Deviation|0
1065781|NCT01982292|2115899|FG000|Overall Study|Patient/Guardian Decision|3
1065782|NCT01982292|2115900|FG001|Overall Study|Patient/Guardian Decision|1
1065783|NCT01982292|2115899|FG000|Overall Study|Technical Problems|2
1065784|NCT01982292|2115900|FG001|Overall Study|Technical Problems|0
1065785|NCT01982331|2115908|FG000|Received Vaccination 2|Adverse Event|1
1065786|NCT01982331|2115909|FG001|Received Vaccination 2|Adverse Event|2
1065787|NCT01982331|2115908|FG000|Received Vaccination 2|Withdrawal by Subject|0
1065788|NCT01982331|2115909|FG001|Received Vaccination 2|Withdrawal by Subject|1
1065789|NCT01982331|2115908|FG000|Completed Study (Day 112)|Withdrawal by Subject|2
1065790|NCT01982331|2115909|FG001|Completed Study (Day 112)|Withdrawal by Subject|0
1065791|NCT01982435|2115917|FG000|Overall Study|Adverse Event|1
1065792|NCT01982435|2115918|FG001|Overall Study|Adverse Event|0
1065793|NCT01982448|2115926|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
1065794|NCT01982448|2115927|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2
1065795|NCT01982448|2115926|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1
1065796|NCT01982448|2115927|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0
1065797|NCT01982448|2115926|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0
1065798|NCT01982448|2115927|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2
1065799|NCT01982448|2115926|FG000|Preoperative Chemotherapy|Lost to Follow-up|0
1065800|NCT01982448|2115927|FG001|Preoperative Chemotherapy|Lost to Follow-up|1
1065801|NCT01982682|2115945|FG000|Overall Study|Physician Decision|1
1065802|NCT01982773|2115961|FG000|Overall Study|Withdrawal by Subject|1
1065803|NCT01982773|2115962|FG001|Overall Study|Withdrawal by Subject|3
1065804|NCT01982773|2115961|FG000|Overall Study|Lost to Follow-up|7
1065805|NCT01982773|2115962|FG001|Overall Study|Lost to Follow-up|1
1065806|NCT01982812|2115979|FG000|Overall Study|Death|1
1065807|NCT01982812|2115980|FG001|Overall Study|Death|5
1065808|NCT01982812|2115979|FG000|Overall Study|Adverse Event|0
1065809|NCT01982812|2115980|FG001|Overall Study|Adverse Event|5
1065810|NCT01982942|2115988|FG000|Overall Study|Adverse Event|10
1065811|NCT01982942|2115989|FG001|Overall Study|Adverse Event|5
1065812|NCT01982942|2115988|FG000|Overall Study|Lost to Follow-up|4
1065813|NCT01982942|2115989|FG001|Overall Study|Lost to Follow-up|3
1065814|NCT01982942|2115988|FG000|Overall Study|Multiple sclerosis progression|3
1065815|NCT01982942|2115989|FG001|Overall Study|Multiple sclerosis progression|2
1065816|NCT01982942|2115988|FG000|Overall Study|Wanted to try therapy not permitted|1
1065817|NCT01982942|2115989|FG001|Overall Study|Wanted to try therapy not permitted|0
1065818|NCT01982942|2115988|FG000|Overall Study|Subject declined future visits|0
1065819|NCT01982942|2115989|FG001|Overall Study|Subject declined future visits|1
1065820|NCT01982942|2115988|FG000|Overall Study|Left geographical area|2
1065821|NCT01982942|2115989|FG001|Overall Study|Left geographical area|0
1065822|NCT01982942|2115988|FG000|Overall Study|Too many pills|1
1065823|NCT01982942|2115989|FG001|Overall Study|Too many pills|0
1065824|NCT01982942|2115988|FG000|Overall Study|MS Relapse|0
1065825|NCT01982942|2115989|FG001|Overall Study|MS Relapse|1
1065826|NCT01982942|2115988|FG000|Overall Study|Chose to join a stem cell trial|0
1065827|NCT01982942|2115989|FG001|Overall Study|Chose to join a stem cell trial|1
1065828|NCT01982942|2115988|FG000|Overall Study|Subject bedridden, rapidly declining|0
1065829|NCT01982942|2115989|FG001|Overall Study|Subject bedridden, rapidly declining|1
1065830|NCT01982955|2116000|FG000|Overall Study|Randomized but not treated|0
1065831|NCT01982955|2116001|FG001|Overall Study|Randomized but not treated|0
1065832|NCT01982955|2116002|FG002|Overall Study|Randomized but not treated|0
1065833|NCT01982955|2116003|FG003|Overall Study|Randomized but not treated|1
1065834|NCT01982955|2116004|FG004|Overall Study|Randomized but not treated|0
1065835|NCT01982955|2116000|FG000|Overall Study|Ongoing|0
1065836|NCT01982955|2116001|FG001|Overall Study|Ongoing|0
1065837|NCT01982955|2116002|FG002|Overall Study|Ongoing|4
1065838|NCT01982955|2116003|FG003|Overall Study|Ongoing|0
1065839|NCT01982955|2116004|FG004|Overall Study|Ongoing|0
1065840|NCT01983111|2116045|FG000|Overall Study|Withdrawal by Subject|8
1065841|NCT01983111|2116046|FG001|Overall Study|Withdrawal by Subject|6
1065842|NCT01983111|2116045|FG000|Overall Study|Adverse Event|4
1065843|NCT01983111|2116046|FG001|Overall Study|Adverse Event|0
1065844|NCT01983111|2116045|FG000|Overall Study|Protocol Violation|0
1065845|NCT01983111|2116046|FG001|Overall Study|Protocol Violation|1
1065846|NCT01983254|2116065|FG000|Overall Study|Death|6
1065847|NCT01983254|2116066|FG001|Overall Study|Death|6
1065848|NCT01983254|2116065|FG000|Overall Study|Lost to Follow-up|17
1065849|NCT01983254|2116066|FG001|Overall Study|Lost to Follow-up|16
1065850|NCT01983254|2116065|FG000|Overall Study|too ill|11
1065851|NCT01983254|2116066|FG001|Overall Study|too ill|8
1065852|NCT01983293|2116074|FG000|Overall Study|Withdrawal by Subject|29
1065853|NCT01983293|2116075|FG001|Overall Study|Withdrawal by Subject|15
1065854|NCT01983293|2116074|FG000|Overall Study|Missing 12-month visit|3
1065855|NCT01983293|2116075|FG001|Overall Study|Missing 12-month visit|3
1065856|NCT01983293|2116074|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1
1065857|NCT01983293|2116075|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1
1065858|NCT01983683|2116110|FG000|Overall Study|Withdrawal by Subject|14
1065859|NCT01983683|2116111|FG001|Overall Study|Withdrawal by Subject|18
1065860|NCT01983683|2116110|FG000|Overall Study|Death|11
1065861|NCT01983683|2116111|FG001|Overall Study|Death|15
1065862|NCT01983683|2116110|FG000|Overall Study|Physician Decision|8
1065863|NCT01983683|2116111|FG001|Overall Study|Physician Decision|9
1065864|NCT01983683|2116110|FG000|Overall Study|Lost to Follow-up|4
1065865|NCT01983683|2116111|FG001|Overall Study|Lost to Follow-up|8
1065866|NCT01983683|2116110|FG000|Overall Study|Sponsor Decision|1
1065867|NCT01983683|2116111|FG001|Overall Study|Sponsor Decision|1
1065868|NCT01983930|2116164|FG000|Overall Study|Withdrawal by Subject|9
1065869|NCT01983930|2116165|FG001|Overall Study|Withdrawal by Subject|8
1065870|NCT01983930|2116164|FG000|Overall Study|Adverse Event|0
1065871|NCT01983930|2116165|FG001|Overall Study|Adverse Event|1
1065872|NCT01983969|2116175|FG000|Overall Study|Disease Progression|0
1065873|NCT01983969|2116176|FG001|Overall Study|Disease Progression|1
1065874|NCT01983969|2116177|FG002|Overall Study|Disease Progression|0
1065875|NCT01984164|2116191|FG000|Overall Study|Withdrawal by Subject|4
1065876|NCT01984164|2116192|FG001|Overall Study|Withdrawal by Subject|3
1065877|NCT01984164|2116191|FG000|Overall Study|Adverse Event|5
1065878|NCT01984164|2116192|FG001|Overall Study|Adverse Event|19
1065879|NCT01984164|2116191|FG000|Overall Study|Lost to Follow-up|1
1065880|NCT01984164|2116192|FG001|Overall Study|Lost to Follow-up|3
1065881|NCT01984229|2116200|FG000|Safety Follow-up Period|Adverse Event|1
1065882|NCT01984229|2116201|FG001|Safety Follow-up Period|Adverse Event|1
1065883|NCT01984229|2116200|FG000|Safety Follow-up Period|Lost to Follow-up|1
1065884|NCT01984229|2116201|FG001|Safety Follow-up Period|Lost to Follow-up|0
1065885|NCT01984242|2116216|FG000|Overall Study|Death|52
1065886|NCT01984242|2116217|FG001|Overall Study|Death|50
1065887|NCT01984242|2116218|FG002|Overall Study|Death|52
1065888|NCT01984242|2116216|FG000|Overall Study|Withdrawal by Subject|5
1065889|NCT01984242|2116217|FG001|Overall Study|Withdrawal by Subject|3
1065890|NCT01984242|2116218|FG002|Overall Study|Withdrawal by Subject|10
1065891|NCT01984242|2116216|FG000|Overall Study|Physician Decision|0
1065892|NCT01984242|2116217|FG001|Overall Study|Physician Decision|0
1065893|NCT01984242|2116218|FG002|Overall Study|Physician Decision|1
1065894|NCT01984242|2116216|FG000|Overall Study|Lost to Follow-up|4
1065895|NCT01984242|2116217|FG001|Overall Study|Lost to Follow-up|0
1065896|NCT01984242|2116218|FG002|Overall Study|Lost to Follow-up|3
1065897|NCT01984242|2116216|FG000|Overall Study|Sponsor Decision|1
1065898|NCT01984242|2116217|FG001|Overall Study|Sponsor Decision|0
1065899|NCT01984242|2116218|FG002|Overall Study|Sponsor Decision|0
1065900|NCT01984242|2116216|FG000|Overall Study|Non-Compliance|1
1065901|NCT01984242|2116217|FG001|Overall Study|Non-Compliance|0
1065902|NCT01984242|2116218|FG002|Overall Study|Non-Compliance|0
1065903|NCT01984242|2116216|FG000|Overall Study|Study terminated by Sponsor|38
1065904|NCT01984242|2116217|FG001|Overall Study|Study terminated by Sponsor|50
1065905|NCT01984242|2116218|FG002|Overall Study|Study terminated by Sponsor|34
1065906|NCT01984242|2116216|FG000|Overall Study|Disease Progression|0
1065907|NCT01984242|2116217|FG001|Overall Study|Disease Progression|0
1065908|NCT01984242|2116218|FG002|Overall Study|Disease Progression|1
1065909|NCT01984294|2116237|FG000|Overall Study|Randomized but Never Treated|0
1065910|NCT01984294|2116238|FG001|Overall Study|Randomized but Never Treated|0
1065911|NCT01984294|2116239|FG002|Overall Study|Randomized but Never Treated|1
1065912|NCT01984294|2116237|FG000|Overall Study|Lack of Efficacy|4
1065913|NCT01984294|2116238|FG001|Overall Study|Lack of Efficacy|2
1065914|NCT01984294|2116239|FG002|Overall Study|Lack of Efficacy|6
1065915|NCT01984294|2116237|FG000|Overall Study|Adverse Event|0
1065916|NCT01984294|2116238|FG001|Overall Study|Adverse Event|1
1065917|NCT01984294|2116239|FG002|Overall Study|Adverse Event|0
1065918|NCT01984424|2116264|FG000|Overall Study|Withdrawal by Subject|3
1065919|NCT01984424|2116265|FG001|Overall Study|Withdrawal by Subject|5
1065920|NCT01984424|2116264|FG000|Overall Study|Sponsor Decision|0
1065921|NCT01984424|2116265|FG001|Overall Study|Sponsor Decision|1
1065922|NCT01984424|2116264|FG000|Overall Study|Lost to Follow-up|0
1065923|NCT01984424|2116265|FG001|Overall Study|Lost to Follow-up|1
1065924|NCT01984684|2116277|FG000|Overall Study|Lost to Follow-up|25
1065925|NCT01984684|2116278|FG001|Overall Study|Lost to Follow-up|24
1065926|NCT01984684|2116277|FG000|Overall Study|Adverse Event|8
1065927|NCT01984684|2116278|FG001|Overall Study|Adverse Event|12
1065928|NCT01984684|2116277|FG000|Overall Study|Withdrawal by Subject|9
1065929|NCT01984684|2116278|FG001|Overall Study|Withdrawal by Subject|9
1065930|NCT01984684|2116277|FG000|Overall Study|Lack of Efficacy|3
1065931|NCT01984684|2116278|FG001|Overall Study|Lack of Efficacy|6
1065932|NCT01984684|2116277|FG000|Overall Study|Physician Decision|4
1065933|NCT01984684|2116278|FG001|Overall Study|Physician Decision|2
1065934|NCT01984684|2116277|FG000|Overall Study|Protocol Violation|4
1065935|NCT01984684|2116278|FG001|Overall Study|Protocol Violation|2
1065936|NCT01984684|2116277|FG000|Overall Study|Death|0
1065937|NCT01984684|2116278|FG001|Overall Study|Death|1
1065938|NCT01984684|2116277|FG000|Overall Study|Noncompliance with study drug|2
1065939|NCT01984684|2116278|FG001|Overall Study|Noncompliance with study drug|1
1065940|NCT01984684|2116277|FG000|Overall Study|Subject incarcerated|1
1065941|NCT01984684|2116278|FG001|Overall Study|Subject incarcerated|0
1065942|NCT01984684|2116277|FG000|Overall Study|Study drug not available at site|1
1065943|NCT01984684|2116278|FG001|Overall Study|Study drug not available at site|1
1065944|NCT01984684|2116277|FG000|Overall Study|Subject had inadequate IV access|0
1065945|NCT01984684|2116278|FG001|Overall Study|Subject had inadequate IV access|1
1065946|NCT01984697|2116289|FG000|Overall Study|Adverse Event|0
1065947|NCT01984697|2116290|FG001|Overall Study|Adverse Event|0
1065948|NCT01984697|2116291|FG002|Overall Study|Adverse Event|2
1065949|NCT01984697|2116292|FG003|Overall Study|Adverse Event|0
1065950|NCT01984697|2116293|FG004|Overall Study|Adverse Event|0
1065951|NCT01984697|2116289|FG000|Overall Study|Lost to Follow-up|14
1065952|NCT01984697|2116290|FG001|Overall Study|Lost to Follow-up|5
1065953|NCT01984697|2116291|FG002|Overall Study|Lost to Follow-up|10
1065954|NCT01984697|2116292|FG003|Overall Study|Lost to Follow-up|6
1065955|NCT01984697|2116293|FG004|Overall Study|Lost to Follow-up|21
1065956|NCT01984697|2116289|FG000|Overall Study|Physician Decision|3
1065957|NCT01984697|2116290|FG001|Overall Study|Physician Decision|0
1065958|NCT01984697|2116291|FG002|Overall Study|Physician Decision|0
1065959|NCT01984697|2116292|FG003|Overall Study|Physician Decision|1
1065960|NCT01984697|2116293|FG004|Overall Study|Physician Decision|0
1065961|NCT01984697|2116289|FG000|Overall Study|Protocol Violation|8
1065962|NCT01984697|2116290|FG001|Overall Study|Protocol Violation|5
1065963|NCT01984697|2116291|FG002|Overall Study|Protocol Violation|3
1065964|NCT01984697|2116292|FG003|Overall Study|Protocol Violation|2
1065965|NCT01984697|2116293|FG004|Overall Study|Protocol Violation|0
1065966|NCT01984697|2116289|FG000|Overall Study|Withdrawal by Subject|15
1065967|NCT01984697|2116290|FG001|Overall Study|Withdrawal by Subject|21
1065968|NCT01984697|2116291|FG002|Overall Study|Withdrawal by Subject|13
1065969|NCT01984697|2116292|FG003|Overall Study|Withdrawal by Subject|11
1065970|NCT01984697|2116293|FG004|Overall Study|Withdrawal by Subject|13
1065971|NCT01984697|2116289|FG000|Overall Study|Missed last follow-up visit|1
1065972|NCT01984697|2116290|FG001|Overall Study|Missed last follow-up visit|0
1065973|NCT01984697|2116291|FG002|Overall Study|Missed last follow-up visit|0
1065974|NCT01984697|2116292|FG003|Overall Study|Missed last follow-up visit|0
1065975|NCT01984697|2116293|FG004|Overall Study|Missed last follow-up visit|0
1065976|NCT01984697|2116289|FG000|Overall Study|Death|0
1065977|NCT01984697|2116290|FG001|Overall Study|Death|0
1065978|NCT01984697|2116291|FG002|Overall Study|Death|0
1065979|NCT01984697|2116292|FG003|Overall Study|Death|1
1065980|NCT01984697|2116293|FG004|Overall Study|Death|0
1065981|NCT01984697|2116289|FG000|Overall Study|Pregnancy|2
1065982|NCT01984697|2116290|FG001|Overall Study|Pregnancy|0
1065983|NCT01984697|2116291|FG002|Overall Study|Pregnancy|1
1065984|NCT01984697|2116292|FG003|Overall Study|Pregnancy|0
1065985|NCT01984697|2116293|FG004|Overall Study|Pregnancy|1
1065986|NCT01984892|2116305|FG000|Overall Study|Progressive disease|7
1065987|NCT01985126|2116311|FG000|Overall Study|Death|15
1065988|NCT01985126|2116312|FG001|Overall Study|Death|69
1065989|NCT01985126|2116311|FG000|Overall Study|Lost to Follow-up|0
1065990|NCT01985126|2116312|FG001|Overall Study|Lost to Follow-up|8
1065991|NCT01985126|2116311|FG000|Overall Study|Study Terminated By Sponsor|1
1065992|NCT01985126|2116312|FG001|Overall Study|Study Terminated By Sponsor|22
1065993|NCT01985126|2116311|FG000|Overall Study|Withdrawal by Subject|2
1065994|NCT01985126|2116312|FG001|Overall Study|Withdrawal by Subject|7
1065995|NCT01985321|2116320|FG000|Overall Study|Protocol Violation|4
1065996|NCT01985321|2116321|FG001|Overall Study|Protocol Violation|3
1065997|NCT01985321|2116320|FG000|Overall Study|Withdrawal by Subject|1
1065998|NCT01985321|2116321|FG001|Overall Study|Withdrawal by Subject|0
1065999|NCT01985321|2116320|FG000|Overall Study|Lost to Follow-up|5
1066000|NCT01985321|2116321|FG001|Overall Study|Lost to Follow-up|2
1066001|NCT01985321|2116320|FG000|Overall Study|Subject treated wrong type of sore|1
1066002|NCT01985321|2116321|FG001|Overall Study|Subject treated wrong type of sore|0
1066003|NCT01985334|2116335|FG000|Overall Study|Administrative problems|1
1066004|NCT01985334|2116336|FG001|Overall Study|Administrative problems|1
1066005|NCT01985334|2116337|FG002|Overall Study|Administrative problems|0
1066006|NCT01985334|2116338|FG003|Overall Study|Administrative problems|2
1066007|NCT01985334|2116339|FG004|Overall Study|Administrative problems|0
1066008|NCT01985334|2116340|FG005|Overall Study|Administrative problems|1
1066009|NCT01985334|2116341|FG006|Overall Study|Administrative problems|1
1066010|NCT01985334|2116342|FG007|Overall Study|Administrative problems|3
1066011|NCT01985334|2116335|FG000|Overall Study|Death|1
1066012|NCT01985334|2116336|FG001|Overall Study|Death|0
1066013|NCT01985334|2116337|FG002|Overall Study|Death|0
1066014|NCT01985334|2116338|FG003|Overall Study|Death|3
1066015|NCT01985334|2116339|FG004|Overall Study|Death|0
1066016|NCT01985334|2116340|FG005|Overall Study|Death|0
1066017|NCT01985334|2116341|FG006|Overall Study|Death|1
1066018|NCT01985334|2116342|FG007|Overall Study|Death|2
1066019|NCT01985334|2116335|FG000|Overall Study|Worsening of disease|0
1066020|NCT01985334|2116336|FG001|Overall Study|Worsening of disease|0
1066021|NCT01985334|2116337|FG002|Overall Study|Worsening of disease|0
1066022|NCT01985334|2116338|FG003|Overall Study|Worsening of disease|1
1066023|NCT01985334|2116339|FG004|Overall Study|Worsening of disease|0
1066024|NCT01985334|2116340|FG005|Overall Study|Worsening of disease|3
1066025|NCT01985334|2116341|FG006|Overall Study|Worsening of disease|0
1066026|NCT01985334|2116342|FG007|Overall Study|Worsening of disease|1
1066027|NCT01985334|2116335|FG000|Overall Study|Other|2
1066028|NCT01985334|2116336|FG001|Overall Study|Other|9
1066029|NCT01985334|2116337|FG002|Overall Study|Other|7
1066030|NCT01985334|2116338|FG003|Overall Study|Other|17
1066031|NCT01985334|2116339|FG004|Overall Study|Other|4
1066032|NCT01985334|2116340|FG005|Overall Study|Other|8
1066033|NCT01985334|2116341|FG006|Overall Study|Other|4
1066034|NCT01985334|2116342|FG007|Overall Study|Other|7
1066035|NCT01985334|2116335|FG000|Overall Study|Protocol deviation|6
1066036|NCT01985334|2116336|FG001|Overall Study|Protocol deviation|31
1066037|NCT01985334|2116337|FG002|Overall Study|Protocol deviation|25
1066038|NCT01985334|2116338|FG003|Overall Study|Protocol deviation|84
1066039|NCT01985334|2116339|FG004|Overall Study|Protocol deviation|17
1066040|NCT01985334|2116340|FG005|Overall Study|Protocol deviation|47
1066041|NCT01985334|2116341|FG006|Overall Study|Protocol deviation|15
1066042|NCT01985334|2116342|FG007|Overall Study|Protocol deviation|42
1066043|NCT01985334|2116335|FG000|Overall Study|Moderate / severe COPD exacerbation|5
1066044|NCT01985334|2116336|FG001|Overall Study|Moderate / severe COPD exacerbation|14
1066045|NCT01985334|2116337|FG002|Overall Study|Moderate / severe COPD exacerbation|12
1066046|NCT01985334|2116338|FG003|Overall Study|Moderate / severe COPD exacerbation|40
1066047|NCT01985334|2116339|FG004|Overall Study|Moderate / severe COPD exacerbation|6
1066048|NCT01985334|2116340|FG005|Overall Study|Moderate / severe COPD exacerbation|40
1066049|NCT01985334|2116341|FG006|Overall Study|Moderate / severe COPD exacerbation|8
1066050|NCT01985334|2116342|FG007|Overall Study|Moderate / severe COPD exacerbation|19
1066051|NCT01985334|2116335|FG000|Overall Study|Subject withdrawal of consent|3
1066052|NCT01985334|2116336|FG001|Overall Study|Subject withdrawal of consent|6
1066053|NCT01985334|2116337|FG002|Overall Study|Subject withdrawal of consent|2
1066054|NCT01985334|2116338|FG003|Overall Study|Subject withdrawal of consent|28
1066055|NCT01985334|2116339|FG004|Overall Study|Subject withdrawal of consent|4
1066056|NCT01985334|2116340|FG005|Overall Study|Subject withdrawal of consent|19
1066057|NCT01985334|2116341|FG006|Overall Study|Subject withdrawal of consent|0
1066058|NCT01985334|2116342|FG007|Overall Study|Subject withdrawal of consent|20
1066059|NCT01985334|2116335|FG000|Overall Study|Adverse Event|0
1066060|NCT01985334|2116336|FG001|Overall Study|Adverse Event|8
1066061|NCT01985334|2116337|FG002|Overall Study|Adverse Event|2
1066062|NCT01985334|2116338|FG003|Overall Study|Adverse Event|26
1066063|NCT01985334|2116339|FG004|Overall Study|Adverse Event|3
1066064|NCT01985334|2116340|FG005|Overall Study|Adverse Event|18
1066065|NCT01985334|2116341|FG006|Overall Study|Adverse Event|3
1066066|NCT01985334|2116342|FG007|Overall Study|Adverse Event|15
1066067|NCT01985334|2116335|FG000|Overall Study|Other|4
1066068|NCT01985334|2116336|FG001|Overall Study|Other|2
1066069|NCT01985334|2116337|FG002|Overall Study|Other|3
1066070|NCT01985334|2116338|FG003|Overall Study|Other|10
1066071|NCT01985334|2116339|FG004|Overall Study|Other|1
1066072|NCT01985334|2116340|FG005|Overall Study|Other|6
1066073|NCT01985334|2116341|FG006|Overall Study|Other|2
1066074|NCT01985334|2116342|FG007|Overall Study|Other|2
1066075|NCT01985334|2116335|FG000|Overall Study|Medication non-compliance|0
1066076|NCT01985334|2116336|FG001|Overall Study|Medication non-compliance|4
1066077|NCT01985334|2116337|FG002|Overall Study|Medication non-compliance|1
1066078|NCT01985334|2116338|FG003|Overall Study|Medication non-compliance|6
1066079|NCT01985334|2116339|FG004|Overall Study|Medication non-compliance|2
1066080|NCT01985334|2116340|FG005|Overall Study|Medication non-compliance|3
1066081|NCT01985334|2116341|FG006|Overall Study|Medication non-compliance|1
1066082|NCT01985334|2116342|FG007|Overall Study|Medication non-compliance|3
1066083|NCT01985334|2116335|FG000|Overall Study|Use of prohibited treatment|1
1066084|NCT01985334|2116336|FG001|Overall Study|Use of prohibited treatment|4
1066085|NCT01985334|2116337|FG002|Overall Study|Use of prohibited treatment|1
1066086|NCT01985334|2116338|FG003|Overall Study|Use of prohibited treatment|2
1066087|NCT01985334|2116339|FG004|Overall Study|Use of prohibited treatment|1
1066088|NCT01985334|2116340|FG005|Overall Study|Use of prohibited treatment|6
1066089|NCT01985334|2116341|FG006|Overall Study|Use of prohibited treatment|2
1066090|NCT01985334|2116342|FG007|Overall Study|Use of prohibited treatment|0
1066091|NCT01985334|2116335|FG000|Overall Study|Investigator decision|0
1066092|NCT01985334|2116336|FG001|Overall Study|Investigator decision|3
1066093|NCT01985334|2116337|FG002|Overall Study|Investigator decision|0
1066094|NCT01985334|2116338|FG003|Overall Study|Investigator decision|7
1066095|NCT01985334|2116339|FG004|Overall Study|Investigator decision|1
1066096|NCT01985334|2116340|FG005|Overall Study|Investigator decision|1
1066097|NCT01985334|2116341|FG006|Overall Study|Investigator decision|0
1066098|NCT01985334|2116342|FG007|Overall Study|Investigator decision|4
1066099|NCT01985334|2116335|FG000|Overall Study|Lost to Follow-up|0
1066100|NCT01985334|2116336|FG001|Overall Study|Lost to Follow-up|2
1066101|NCT01985334|2116337|FG002|Overall Study|Lost to Follow-up|0
1066102|NCT01985334|2116338|FG003|Overall Study|Lost to Follow-up|3
1066103|NCT01985334|2116339|FG004|Overall Study|Lost to Follow-up|1
1066104|NCT01985334|2116340|FG005|Overall Study|Lost to Follow-up|4
1066105|NCT01985334|2116341|FG006|Overall Study|Lost to Follow-up|0
1066106|NCT01985334|2116342|FG007|Overall Study|Lost to Follow-up|3
1066107|NCT01985360|2116376|FG000|Overall Study|Withdrawal by Subject|4
1066108|NCT01985360|2116377|FG001|Overall Study|Withdrawal by Subject|0
1066109|NCT01985360|2116376|FG000|Overall Study|Lost to Follow-up|5
1066110|NCT01985360|2116377|FG001|Overall Study|Lost to Follow-up|3
1066111|NCT01986010|2116465|FG000|Overall Study|Adverse Event|0
1066112|NCT01986010|2116466|FG001|Overall Study|Adverse Event|1
1066113|NCT01986010|2116467|FG002|Overall Study|Adverse Event|0
1066114|NCT01986010|2116468|FG003|Overall Study|Adverse Event|0
1066115|NCT01986010|2116469|FG004|Overall Study|Adverse Event|0
1066116|NCT01986010|2116470|FG005|Overall Study|Adverse Event|0
1066117|NCT01986010|2116471|FG006|Overall Study|Adverse Event|0
1066118|NCT01986010|2116472|FG007|Overall Study|Adverse Event|0
1066119|NCT01986010|2116473|FG008|Overall Study|Adverse Event|0
1066120|NCT01986010|2116474|FG009|Overall Study|Adverse Event|0
1066121|NCT01986010|2116475|FG010|Overall Study|Adverse Event|0
1066122|NCT01986010|2116476|FG011|Overall Study|Adverse Event|0
1066123|NCT01986010|2116477|FG012|Overall Study|Adverse Event|0
1066124|NCT01986010|2116478|FG013|Overall Study|Adverse Event|0
1066125|NCT01986010|2116479|FG014|Overall Study|Adverse Event|0
1066126|NCT01986010|2116480|FG015|Overall Study|Adverse Event|1
1066127|NCT01986010|2116481|FG016|Overall Study|Adverse Event|0
1066128|NCT01986010|2116465|FG000|Overall Study|Lost to Follow-up|2
1066129|NCT01986010|2116466|FG001|Overall Study|Lost to Follow-up|1
1066130|NCT01986010|2116467|FG002|Overall Study|Lost to Follow-up|2
1066131|NCT01986010|2116468|FG003|Overall Study|Lost to Follow-up|2
1066132|NCT01986010|2116469|FG004|Overall Study|Lost to Follow-up|2
1066133|NCT01986010|2116470|FG005|Overall Study|Lost to Follow-up|2
1066134|NCT01986010|2116471|FG006|Overall Study|Lost to Follow-up|0
1066135|NCT01986010|2116472|FG007|Overall Study|Lost to Follow-up|0
1066136|NCT01986010|2116473|FG008|Overall Study|Lost to Follow-up|4
1066137|NCT01986010|2116474|FG009|Overall Study|Lost to Follow-up|2
1066138|NCT01986010|2116475|FG010|Overall Study|Lost to Follow-up|0
1066139|NCT01986010|2116476|FG011|Overall Study|Lost to Follow-up|1
1066140|NCT01986010|2116477|FG012|Overall Study|Lost to Follow-up|1
1066141|NCT01986010|2116478|FG013|Overall Study|Lost to Follow-up|1
1066142|NCT01986010|2116479|FG014|Overall Study|Lost to Follow-up|2
1066143|NCT01986010|2116480|FG015|Overall Study|Lost to Follow-up|0
1066144|NCT01986010|2116481|FG016|Overall Study|Lost to Follow-up|0
1066145|NCT01986010|2116465|FG000|Overall Study|Physician Decision|0
1066146|NCT01986010|2116466|FG001|Overall Study|Physician Decision|0
1066147|NCT01986010|2116467|FG002|Overall Study|Physician Decision|0
1066148|NCT01986010|2116468|FG003|Overall Study|Physician Decision|0
1066149|NCT01986010|2116469|FG004|Overall Study|Physician Decision|0
1066150|NCT01986010|2116470|FG005|Overall Study|Physician Decision|0
1066151|NCT01986010|2116471|FG006|Overall Study|Physician Decision|0
1066152|NCT01986010|2116472|FG007|Overall Study|Physician Decision|0
1066153|NCT01986010|2116473|FG008|Overall Study|Physician Decision|0
1066154|NCT01986010|2116474|FG009|Overall Study|Physician Decision|0
1066155|NCT01986010|2116475|FG010|Overall Study|Physician Decision|0
1066156|NCT01986010|2116476|FG011|Overall Study|Physician Decision|0
1066157|NCT01986010|2116477|FG012|Overall Study|Physician Decision|0
1066158|NCT01986010|2116478|FG013|Overall Study|Physician Decision|0
1066159|NCT01986010|2116479|FG014|Overall Study|Physician Decision|1
1066160|NCT01986010|2116480|FG015|Overall Study|Physician Decision|0
1066161|NCT01986010|2116481|FG016|Overall Study|Physician Decision|0
1066162|NCT01986010|2116465|FG000|Overall Study|Withdrawal by Subject|2
1066163|NCT01986010|2116466|FG001|Overall Study|Withdrawal by Subject|2
1066164|NCT01986010|2116467|FG002|Overall Study|Withdrawal by Subject|3
1066165|NCT01986010|2116468|FG003|Overall Study|Withdrawal by Subject|0
1066166|NCT01986010|2116469|FG004|Overall Study|Withdrawal by Subject|2
1066167|NCT01986010|2116470|FG005|Overall Study|Withdrawal by Subject|4
1066168|NCT01986010|2116471|FG006|Overall Study|Withdrawal by Subject|0
1066169|NCT01986010|2116472|FG007|Overall Study|Withdrawal by Subject|0
1066170|NCT01986010|2116473|FG008|Overall Study|Withdrawal by Subject|0
1066171|NCT01986010|2116474|FG009|Overall Study|Withdrawal by Subject|0
1066172|NCT01986010|2116475|FG010|Overall Study|Withdrawal by Subject|0
1066173|NCT01986010|2116476|FG011|Overall Study|Withdrawal by Subject|2
1066174|NCT01986010|2116477|FG012|Overall Study|Withdrawal by Subject|0
1066175|NCT01986010|2116478|FG013|Overall Study|Withdrawal by Subject|1
1066176|NCT01986010|2116479|FG014|Overall Study|Withdrawal by Subject|2
1066177|NCT01986010|2116480|FG015|Overall Study|Withdrawal by Subject|0
1066178|NCT01986010|2116481|FG016|Overall Study|Withdrawal by Subject|0
1066179|NCT01986010|2116465|FG000|Overall Study|Status Not Recorded|2
1066180|NCT01986010|2116466|FG001|Overall Study|Status Not Recorded|4
1066181|NCT01986010|2116467|FG002|Overall Study|Status Not Recorded|2
1066182|NCT01986010|2116468|FG003|Overall Study|Status Not Recorded|0
1066183|NCT01986010|2116469|FG004|Overall Study|Status Not Recorded|1
1066184|NCT01986010|2116470|FG005|Overall Study|Status Not Recorded|2
1066185|NCT01986010|2116471|FG006|Overall Study|Status Not Recorded|0
1066186|NCT01986010|2116472|FG007|Overall Study|Status Not Recorded|0
1066187|NCT01986010|2116473|FG008|Overall Study|Status Not Recorded|2
1066188|NCT01986010|2116474|FG009|Overall Study|Status Not Recorded|1
1066189|NCT01986010|2116475|FG010|Overall Study|Status Not Recorded|7
1066190|NCT01986010|2116476|FG011|Overall Study|Status Not Recorded|7
1066191|NCT01986010|2116477|FG012|Overall Study|Status Not Recorded|9
1066192|NCT01986010|2116478|FG013|Overall Study|Status Not Recorded|9
1066193|NCT01986010|2116479|FG014|Overall Study|Status Not Recorded|5
1066194|NCT01986010|2116480|FG015|Overall Study|Status Not Recorded|10
1066195|NCT01986010|2116481|FG016|Overall Study|Status Not Recorded|4
1066196|NCT01986062|2116529|FG000|Overall Study|Lost to Follow-up|1
1066197|NCT01986062|2116530|FG001|Overall Study|Lost to Follow-up|0
1066198|NCT01986062|2116529|FG000|Overall Study|Withdrawal by Subject|0
1066199|NCT01986062|2116530|FG001|Overall Study|Withdrawal by Subject|1
1066200|NCT01986114|2116552|FG000|Overall Study|Adverse Event|59
1066201|NCT01986114|2116552|FG000|Overall Study|Lack of Efficacy|23
1066202|NCT01986114|2116552|FG000|Overall Study|Withdrawal by Subject|58
1066203|NCT01986114|2116552|FG000|Overall Study|Noncompliance|3
1066204|NCT01986114|2116552|FG000|Overall Study|Protocol Violation|1
1066205|NCT01986114|2116552|FG000|Overall Study|Lost to Follow-up|5
1066206|NCT01986114|2116552|FG000|Overall Study|Other reason|7
1066207|NCT01986140|2116560|FG000|Overall Study|Withdrawal by Subject|31
1066208|NCT01986140|2116561|FG001|Overall Study|Withdrawal by Subject|25
1066209|NCT01986140|2116560|FG000|Overall Study|alternative treatment|1
1066210|NCT01986140|2116561|FG001|Overall Study|alternative treatment|1
1066211|NCT01986140|2116560|FG000|Overall Study|found not eligible|3
1066212|NCT01986140|2116561|FG001|Overall Study|found not eligible|0
1066213|NCT01986140|2116560|FG000|Overall Study|Adverse Event|0
1066214|NCT01986140|2116561|FG001|Overall Study|Adverse Event|1
1066215|NCT01986140|2116560|FG000|Overall Study|progression disease|0
1066216|NCT01986140|2116561|FG001|Overall Study|progression disease|1
1066217|NCT01986231|2116567|FG000|Overall Study|Adverse Event|1
1066218|NCT01986348|2116575|FG000|Overall Study|Death|8
1066219|NCT01986348|2116576|FG001|Overall Study|Death|22
1066220|NCT01986348|2116577|FG002|Overall Study|Death|10
1066221|NCT01986348|2116578|FG003|Overall Study|Death|21
1066222|NCT01986348|2116575|FG000|Overall Study|Lost to Follow-up|0
1066223|NCT01986348|2116576|FG001|Overall Study|Lost to Follow-up|0
1066224|NCT01986348|2116577|FG002|Overall Study|Lost to Follow-up|0
1066225|NCT01986348|2116578|FG003|Overall Study|Lost to Follow-up|2
1066226|NCT01986348|2116575|FG000|Overall Study|Physician Decision|0
1066227|NCT01986348|2116576|FG001|Overall Study|Physician Decision|0
1066228|NCT01986348|2116577|FG002|Overall Study|Physician Decision|0
1066229|NCT01986348|2116578|FG003|Overall Study|Physician Decision|1
1066230|NCT01986348|2116575|FG000|Overall Study|Progressive Disease|0
1066231|NCT01986348|2116576|FG001|Overall Study|Progressive Disease|0
1066232|NCT01986348|2116577|FG002|Overall Study|Progressive Disease|2
1066233|NCT01986348|2116578|FG003|Overall Study|Progressive Disease|0
1066234|NCT01986348|2116575|FG000|Overall Study|Withdrawal by Participant|0
1066235|NCT01986348|2116576|FG001|Overall Study|Withdrawal by Participant|1
1066236|NCT01986348|2116577|FG002|Overall Study|Withdrawal by Participant|2
1066237|NCT01986348|2116578|FG003|Overall Study|Withdrawal by Participant|1
1066238|NCT01986348|2116575|FG000|Overall Study|Study Terminated by Sponsor|0
1066239|NCT01986348|2116576|FG001|Overall Study|Study Terminated by Sponsor|0
1066240|NCT01986348|2116577|FG002|Overall Study|Study Terminated by Sponsor|0
1066241|NCT01986348|2116578|FG003|Overall Study|Study Terminated by Sponsor|3
1066242|NCT01986348|2116575|FG000|Overall Study|Other-unspecified|0
1066243|NCT01986348|2116576|FG001|Overall Study|Other-unspecified|1
1066244|NCT01986348|2116577|FG002|Overall Study|Other-unspecified|0
1066245|NCT01986348|2116578|FG003|Overall Study|Other-unspecified|2
1066246|NCT01986647|2116604|FG000|Overall Study|Lost to Follow-up|4
1066247|NCT01986647|2116605|FG001|Overall Study|Lost to Follow-up|1
1066248|NCT01986647|2116606|FG002|Overall Study|Lost to Follow-up|4
1066249|NCT01986647|2116607|FG003|Overall Study|Lost to Follow-up|4
1066250|NCT01986647|2116604|FG000|Overall Study|Withdrawal by Subject|1
1066251|NCT01986647|2116605|FG001|Overall Study|Withdrawal by Subject|3
1066252|NCT01986647|2116606|FG002|Overall Study|Withdrawal by Subject|2
1066253|NCT01986647|2116607|FG003|Overall Study|Withdrawal by Subject|3
1066254|NCT01986647|2116604|FG000|Overall Study|Health|5
1066255|NCT01986647|2116605|FG001|Overall Study|Health|3
1066256|NCT01986647|2116606|FG002|Overall Study|Health|6
1066257|NCT01986647|2116607|FG003|Overall Study|Health|4
1066258|NCT01986829|2116643|FG000|Overall Study|Death|1
1066259|NCT01986855|2116653|FG000|Overall Study|Adverse Event|1
1066260|NCT01986855|2116654|FG001|Overall Study|Adverse Event|0
1066261|NCT01986855|2116655|FG002|Overall Study|Adverse Event|0
1066262|NCT01986855|2116653|FG000|Overall Study|Death|3
1066263|NCT01986855|2116654|FG001|Overall Study|Death|4
1066264|NCT01986855|2116655|FG002|Overall Study|Death|4
1066265|NCT01986855|2116653|FG000|Overall Study|Lost to Follow-up|2
1066266|NCT01986855|2116654|FG001|Overall Study|Lost to Follow-up|1
1066267|NCT01986855|2116655|FG002|Overall Study|Lost to Follow-up|0
1066268|NCT01986855|2116653|FG000|Overall Study|Screen Failure|0
1066269|NCT01986855|2116654|FG001|Overall Study|Screen Failure|1
1066270|NCT01986855|2116655|FG002|Overall Study|Screen Failure|0
1066271|NCT01986855|2116653|FG000|Overall Study|Participant Moved|0
1066272|NCT01986855|2116654|FG001|Overall Study|Participant Moved|0
1066273|NCT01986855|2116655|FG002|Overall Study|Participant Moved|2
1066274|NCT01986855|2116653|FG000|Overall Study|Withdrawal by Subject|7
1066275|NCT01986855|2116654|FG001|Overall Study|Withdrawal by Subject|8
1066276|NCT01986855|2116655|FG002|Overall Study|Withdrawal by Subject|5
1066277|NCT01986881|2116666|FG000|Overall Study|Death|228
1066278|NCT01986881|2116667|FG001|Overall Study|Death|233
1066279|NCT01986881|2116668|FG002|Overall Study|Death|247
1066280|NCT01986881|2116666|FG000|Overall Study|Lost to Follow-up|51
1066281|NCT01986881|2116667|FG001|Overall Study|Lost to Follow-up|44
1066282|NCT01986881|2116668|FG002|Overall Study|Lost to Follow-up|55
1066283|NCT01986881|2116666|FG000|Overall Study|Physician Decision|7
1066284|NCT01986881|2116667|FG001|Overall Study|Physician Decision|4
1066285|NCT01986881|2116668|FG002|Overall Study|Physician Decision|6
1066286|NCT01986881|2116666|FG000|Overall Study|Study Site Terminated by Sponsor|2
1066287|NCT01986881|2116667|FG001|Overall Study|Study Site Terminated by Sponsor|2
1066288|NCT01986881|2116668|FG002|Overall Study|Study Site Terminated by Sponsor|3
1066289|NCT01986881|2116666|FG000|Overall Study|Withdrawal by Subject|41
1066290|NCT01986881|2116667|FG001|Overall Study|Withdrawal by Subject|60
1066291|NCT01986881|2116668|FG002|Overall Study|Withdrawal by Subject|45
1066292|NCT01986881|2116666|FG000|Overall Study|Subject Moved|0
1066293|NCT01986881|2116667|FG001|Overall Study|Subject Moved|1
1066294|NCT01986881|2116668|FG002|Overall Study|Subject Moved|0
1066295|NCT01986881|2116666|FG000|Overall Study|Other|1
1066296|NCT01986881|2116667|FG001|Overall Study|Other|2
1066297|NCT01986881|2116668|FG002|Overall Study|Other|2
1066298|NCT01986907|2116699|FG000|Overall Study|Adverse Event|11
1066299|NCT01986907|2116699|FG000|Overall Study|Unsatisfactory therapeutic effect|24
1066300|NCT01986907|2116699|FG000|Overall Study|Protocol Violation|4
1066301|NCT01986907|2116699|FG000|Overall Study|Withdrawal by Subject|76
1066302|NCT01986907|2116699|FG000|Overall Study|Lost to Follow-up|38
1066303|NCT01986907|2116699|FG000|Overall Study|Death|9
1066304|NCT01986920|2116706|FG000|A- 101 25%|Withdrawal by Subject|1
1066305|NCT01986920|2116707|FG001|A- 101 25%|Withdrawal by Subject|0
1066306|NCT01986920|2116708|FG002|A- 101 25%|Withdrawal by Subject|0
1066307|NCT01986920|2116709|FG003|A- 101 25%|Withdrawal by Subject|0
1066308|NCT01986920|2116706|FG000|A-101 32.5%|Withdrawal by Subject|0
1066309|NCT01986920|2116707|FG001|A-101 32.5%|Withdrawal by Subject|1
1066310|NCT01986920|2116708|FG002|A-101 32.5%|Withdrawal by Subject|0
1066311|NCT01986920|2116709|FG003|A-101 32.5%|Withdrawal by Subject|0
1066312|NCT01986920|2116706|FG000|A-101 40%|Withdrawal by Subject|0
908210|NCT00781274|1884750|FG000|Overall Study|Withdrawal by Subject|2
908211|NCT00781326|1884754|FG000|Phase I|Adverse Event|1
908212|NCT00781326|1884754|FG000|Phase I|Withdrawal by Subject|1
908213|NCT00781326|1884754|FG000|Phase I|Physician Decision|2
908214|NCT00781365|1884760|FG000|Overall Study|Withdrawal by Subject|13
908215|NCT00781365|1884761|FG001|Overall Study|Withdrawal by Subject|8
908216|NCT00781365|1884760|FG000|Overall Study|Did Not Attend Visit|20
908217|NCT00781365|1884761|FG001|Overall Study|Did Not Attend Visit|28
1066313|NCT01986920|2116707|FG001|A-101 40%|Withdrawal by Subject|0
1066314|NCT01986920|2116708|FG002|A-101 40%|Withdrawal by Subject|1
1066315|NCT01986920|2116709|FG003|A-101 40%|Withdrawal by Subject|0
1066316|NCT01986920|2116706|FG000|Placebo|Withdrawal by Subject|0
1066317|NCT01986920|2116707|FG001|Placebo|Withdrawal by Subject|0
1066318|NCT01986920|2116708|FG002|Placebo|Withdrawal by Subject|0
1066319|NCT01986920|2116709|FG003|Placebo|Withdrawal by Subject|1
1066405|NCT01986985|2116756|FG000|Overall Study|Withdrawal by Subject|4
1162042|NCT03381248|2283986|FG001|Overall Study|Withdrawal by Subject|3
1066406|NCT01986985|2116756|FG000|Overall Study|Scan not completed due to malfunction|3
1066407|NCT01987102|2116771|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
1066408|NCT01987102|2116772|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
1066409|NCT01987102|2116771|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
1066410|NCT01987102|2116772|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
1066411|NCT01987102|2116771|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
1066412|NCT01987102|2116772|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
1066413|NCT01987102|2116771|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
1066414|NCT01987102|2116772|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
1066415|NCT01987102|2116771|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
1066416|NCT01987102|2116772|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
1066417|NCT01987102|2116771|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
1066418|NCT01987102|2116772|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
1066419|NCT01987232|2116803|FG000|Overall Study|Ongoing in Study|0
1066420|NCT01987232|2116804|FG001|Overall Study|Ongoing in Study|0
1066421|NCT01987232|2116805|FG002|Overall Study|Ongoing in Study|0
1066422|NCT01987232|2116806|FG003|Overall Study|Ongoing in Study|1
1066423|NCT01987232|2116807|FG004|Overall Study|Ongoing in Study|0
1066424|NCT01987427|2116883|FG000|Overall Study|Adverse Event|4
1066425|NCT01987427|2116884|FG001|Overall Study|Adverse Event|2
1066426|NCT01987427|2116885|FG002|Overall Study|Adverse Event|8
1066427|NCT01987427|2116883|FG000|Overall Study|Lost to Follow-up|6
1066428|NCT01987427|2116884|FG001|Overall Study|Lost to Follow-up|6
1066429|NCT01987427|2116885|FG002|Overall Study|Lost to Follow-up|9
1066430|NCT01987427|2116883|FG000|Overall Study|Withdrawal by Subject|2
1066431|NCT01987427|2116884|FG001|Overall Study|Withdrawal by Subject|1
1066432|NCT01987427|2116885|FG002|Overall Study|Withdrawal by Subject|3
1066433|NCT01987427|2116883|FG000|Overall Study|Lack of Efficacy|1
1066434|NCT01987427|2116884|FG001|Overall Study|Lack of Efficacy|0
1066435|NCT01987427|2116885|FG002|Overall Study|Lack of Efficacy|0
1066436|NCT01987427|2116883|FG000|Overall Study|Other|1
1066437|NCT01987427|2116884|FG001|Overall Study|Other|1
1066438|NCT01987427|2116885|FG002|Overall Study|Other|0
1066439|NCT01987453|2116896|FG000|Overall Study|Death|0
1066440|NCT01987453|2116897|FG001|Overall Study|Death|0
1066441|NCT01987453|2116898|FG002|Overall Study|Death|1
1066442|NCT01987453|2116896|FG000|Overall Study|Lack of Efficacy|1
1066443|NCT01987453|2116897|FG001|Overall Study|Lack of Efficacy|12
1066444|NCT01987453|2116898|FG002|Overall Study|Lack of Efficacy|0
1066445|NCT01987479|2116910|FG000|Overall Study|Protocol Violation|1
1066446|NCT01987479|2116910|FG000|Overall Study|Physician Decision|2
1066447|NCT01987479|2116910|FG000|Overall Study|Participant/legal guardian decision|1
1066448|NCT01987479|2116910|FG000|Overall Study|Other|5
1066449|NCT01987479|2116910|FG000|Overall Study|Lost to Follow-up|1
1066450|NCT01987479|2116910|FG000|Overall Study|Adverse Event|7
1066451|NCT01987505|2116916|FG000|Overall Study|Other|9
1066452|NCT01987505|2116916|FG000|Overall Study|Withdrawal by Subject|2
1066453|NCT01987505|2116916|FG000|Overall Study|Other Reason|2
1066454|NCT01987505|2116916|FG000|Overall Study|Lost to Follow-up|15
1066455|NCT01987505|2116916|FG000|Overall Study|Investigator Decision|2
1066456|NCT01987505|2116916|FG000|Overall Study|Death|4
1066457|NCT01987557|2116925|FG000|Overall Study|Protocol Violation|1
1066458|NCT01987557|2116926|FG001|Overall Study|Protocol Violation|0
1066459|NCT01987557|2116927|FG002|Overall Study|Protocol Violation|1
1066460|NCT01987557|2116925|FG000|Overall Study|Withdrawal by Subject|2
1066461|NCT01987557|2116926|FG001|Overall Study|Withdrawal by Subject|1
1066462|NCT01987557|2116927|FG002|Overall Study|Withdrawal by Subject|2
1066463|NCT01987557|2116925|FG000|Overall Study|Adverse Event|0
1066464|NCT01987557|2116926|FG001|Overall Study|Adverse Event|2
1066465|NCT01987557|2116927|FG002|Overall Study|Adverse Event|0
1066466|NCT01987596|2116946|FG000|Overall Study|Physician Decision|1
1066467|NCT01987596|2116947|FG001|Overall Study|Physician Decision|0
1066468|NCT01987596|2116946|FG000|Overall Study|Progressive Disease; missing all period|0
1066469|NCT01987596|2116947|FG001|Overall Study|Progressive Disease; missing all period|1
1066470|NCT01987609|2116959|FG000|Overall Study|Adverse Event|1
1066471|NCT01987765|2116977|FG000|Overall Study|Protocol Violation|65
1066472|NCT01987765|2116977|FG000|Overall Study|Lost to Follow-up|37
1066473|NCT01987817|2116983|FG000|Overall Study|Adverse Event|4
1066474|NCT01987817|2116984|FG001|Overall Study|Adverse Event|0
1066475|NCT01987817|2116983|FG000|Overall Study|Withdrawal by Subject|1
1066476|NCT01987817|2116984|FG001|Overall Study|Withdrawal by Subject|1
1066477|NCT01987817|2116983|FG000|Overall Study|Physician Decision|1
1066478|NCT01987817|2116984|FG001|Overall Study|Physician Decision|0
1066479|NCT01987830|2116991|FG000|Overall Study|Never received baseline scan|1
1066480|NCT01987895|2116997|FG000|Overall Study|Withdrawal by Subject|12
1066481|NCT01987895|2116998|FG001|Overall Study|Withdrawal by Subject|7
1066482|NCT01987895|2116997|FG000|Overall Study|Physician Decision|8
1066483|NCT01987895|2116998|FG001|Overall Study|Physician Decision|10
1066484|NCT01987895|2116997|FG000|Overall Study|Death|7
1066485|NCT01987895|2116998|FG001|Overall Study|Death|7
1066486|NCT01987895|2116997|FG000|Overall Study|Lost to Follow-up|3
1066487|NCT01987895|2116998|FG001|Overall Study|Lost to Follow-up|5
1066488|NCT01987895|2116997|FG000|Overall Study|randomized before giving IC|0
1066489|NCT01987895|2116998|FG001|Overall Study|randomized before giving IC|1
1066490|NCT01987908|2117004|FG000|Placebo Lead-in Period|Adverse Event|2
1066491|NCT01987908|2117005|FG001|Placebo Lead-in Period|Adverse Event|0
1066492|NCT01987908|2117006|FG002|Placebo Lead-in Period|Adverse Event|0
1066493|NCT01987908|2117004|FG000|Placebo Lead-in Period|Physician Decision|2
1066494|NCT01987908|2117005|FG001|Placebo Lead-in Period|Physician Decision|0
1066495|NCT01987908|2117006|FG002|Placebo Lead-in Period|Physician Decision|0
1066496|NCT01987908|2117004|FG000|Placebo Lead-in Period|Withdrawal by Subject|1
1066497|NCT01987908|2117005|FG001|Placebo Lead-in Period|Withdrawal by Subject|0
1066498|NCT01987908|2117006|FG002|Placebo Lead-in Period|Withdrawal by Subject|0
1066499|NCT01987908|2117004|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
1066500|NCT01987908|2117005|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
1066501|NCT01987908|2117006|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
1066502|NCT01987908|2117004|FG000|Treatment Period|Adverse Event|0
1066503|NCT01987908|2117005|FG001|Treatment Period|Adverse Event|1
1066504|NCT01987908|2117006|FG002|Treatment Period|Adverse Event|1
1066505|NCT01987908|2117004|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
1066506|NCT01987908|2117005|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
1066507|NCT01987908|2117006|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
1066508|NCT01987908|2117004|FG000|Post-Treatment Observation Period|Other: Bad Veins|0
1066509|NCT01987908|2117005|FG001|Post-Treatment Observation Period|Other: Bad Veins|1
1066510|NCT01987908|2117006|FG002|Post-Treatment Observation Period|Other: Bad Veins|0
1066511|NCT01987960|2117032|FG000|Period 1|Adverse Event|24
1066512|NCT01987960|2117033|FG001|Period 1|Adverse Event|0
1066513|NCT01987960|2117034|FG002|Period 1|Adverse Event|0
1066514|NCT01987960|2117035|FG003|Period 1|Adverse Event|0
1066515|NCT01987960|2117032|FG000|Period 1|Lack of Efficacy|4
1066516|NCT01987960|2117033|FG001|Period 1|Lack of Efficacy|0
1066517|NCT01987960|2117034|FG002|Period 1|Lack of Efficacy|0
1066518|NCT01987960|2117035|FG003|Period 1|Lack of Efficacy|0
1066519|NCT01987960|2117032|FG000|Period 1|Non-compliance with IMP|6
1066520|NCT01987960|2117033|FG001|Period 1|Non-compliance with IMP|0
1066521|NCT01987960|2117034|FG002|Period 1|Non-compliance with IMP|0
1066522|NCT01987960|2117035|FG003|Period 1|Non-compliance with IMP|0
1066523|NCT01987960|2117032|FG000|Period 1|Protocol Violation|12
1066524|NCT01987960|2117033|FG001|Period 1|Protocol Violation|0
1066525|NCT01987960|2117034|FG002|Period 1|Protocol Violation|0
1066526|NCT01987960|2117035|FG003|Period 1|Protocol Violation|0
1066527|NCT01987960|2117032|FG000|Period 1|Withdrawal by Subject|21
1066528|NCT01987960|2117033|FG001|Period 1|Withdrawal by Subject|0
1066529|NCT01987960|2117034|FG002|Period 1|Withdrawal by Subject|0
908218|NCT00781365|1884760|FG000|Overall Study|Language barrier|1
908219|NCT00781365|1884761|FG001|Overall Study|Language barrier|0
908220|NCT00781391|1884770|FG000|Overall Study|never received study drug|24
908221|NCT00781391|1884771|FG001|Overall Study|never received study drug|23
1066530|NCT01987960|2117035|FG003|Period 1|Withdrawal by Subject|0
1066531|NCT01987960|2117032|FG000|Period 1|Lost to Follow-up|40
1066532|NCT01987960|2117033|FG001|Period 1|Lost to Follow-up|0
1066533|NCT01987960|2117034|FG002|Period 1|Lost to Follow-up|0
1066534|NCT01987960|2117035|FG003|Period 1|Lost to Follow-up|0
1066535|NCT01987960|2117032|FG000|Period 1|administrative or other reason|75
1066536|NCT01987960|2117033|FG001|Period 1|administrative or other reason|0
1066537|NCT01987960|2117034|FG002|Period 1|administrative or other reason|0
1066538|NCT01987960|2117035|FG003|Period 1|administrative or other reason|0
1066539|NCT01987960|2117032|FG000|Period 1|Withdrawal of consent before treatment|4
1066540|NCT01987960|2117033|FG001|Period 1|Withdrawal of consent before treatment|0
1066541|NCT01987960|2117034|FG002|Period 1|Withdrawal of consent before treatment|0
1066542|NCT01987960|2117035|FG003|Period 1|Withdrawal of consent before treatment|0
1066543|NCT01987960|2117032|FG000|Period 2|Adverse Event|0
1066544|NCT01987960|2117033|FG001|Period 2|Adverse Event|0
1066545|NCT01987960|2117034|FG002|Period 2|Adverse Event|1
1066546|NCT01987960|2117035|FG003|Period 2|Adverse Event|0
1066547|NCT01987960|2117032|FG000|Period 2|Withdrawal by Subject|0
1066548|NCT01987960|2117033|FG001|Period 2|Withdrawal by Subject|0
1066549|NCT01987960|2117034|FG002|Period 2|Withdrawal by Subject|1
1066550|NCT01987960|2117035|FG003|Period 2|Withdrawal by Subject|0
1066551|NCT01987960|2117032|FG000|Period 2|Administrative or other reason|0
1066552|NCT01987960|2117033|FG001|Period 2|Administrative or other reason|5
1066553|NCT01987960|2117034|FG002|Period 2|Administrative or other reason|7
1066554|NCT01987960|2117035|FG003|Period 2|Administrative or other reason|0
1066555|NCT01987960|2117032|FG000|Period 3|Adverse Event|0
1066556|NCT01987960|2117033|FG001|Period 3|Adverse Event|0
1066557|NCT01987960|2117034|FG002|Period 3|Adverse Event|0
1066558|NCT01987960|2117035|FG003|Period 3|Adverse Event|7
1066559|NCT01987960|2117032|FG000|Period 3|Non-compliance with IMP|0
1066560|NCT01987960|2117033|FG001|Period 3|Non-compliance with IMP|0
1066561|NCT01987960|2117034|FG002|Period 3|Non-compliance with IMP|0
1066562|NCT01987960|2117035|FG003|Period 3|Non-compliance with IMP|1
1066563|NCT01987960|2117032|FG000|Period 3|Protocol Violation|0
1066564|NCT01987960|2117033|FG001|Period 3|Protocol Violation|0
1066565|NCT01987960|2117034|FG002|Period 3|Protocol Violation|0
1066566|NCT01987960|2117035|FG003|Period 3|Protocol Violation|6
1066567|NCT01987960|2117032|FG000|Period 3|Withdrawal by Subject|0
1066568|NCT01987960|2117033|FG001|Period 3|Withdrawal by Subject|0
1066569|NCT01987960|2117034|FG002|Period 3|Withdrawal by Subject|0
1066570|NCT01987960|2117035|FG003|Period 3|Withdrawal by Subject|9
1066571|NCT01987960|2117032|FG000|Period 3|Lost to Follow-up|0
1066572|NCT01987960|2117033|FG001|Period 3|Lost to Follow-up|0
1066573|NCT01987960|2117034|FG002|Period 3|Lost to Follow-up|0
1066574|NCT01987960|2117035|FG003|Period 3|Lost to Follow-up|5
1066575|NCT01987960|2117032|FG000|Period 3|Administrative or other reason|0
1066576|NCT01987960|2117033|FG001|Period 3|Administrative or other reason|0
1066577|NCT01987960|2117034|FG002|Period 3|Administrative or other reason|0
1066578|NCT01987960|2117035|FG003|Period 3|Administrative or other reason|43
1066579|NCT01987986|2117049|FG000|Overall Study|Lost to Follow-up|1
1066580|NCT01987986|2117050|FG001|Overall Study|Lost to Follow-up|0
1066581|NCT01987986|2117051|FG002|Overall Study|Lost to Follow-up|0
1066582|NCT01987986|2117052|FG003|Overall Study|Lost to Follow-up|0
1066583|NCT01987986|2117049|FG000|Overall Study|Adverse Event|1
1066584|NCT01987986|2117050|FG001|Overall Study|Adverse Event|0
1066585|NCT01987986|2117051|FG002|Overall Study|Adverse Event|2
1066586|NCT01987986|2117052|FG003|Overall Study|Adverse Event|0
1066587|NCT01988012|2117062|FG000|Overall Study|Adverse Event|5
1066588|NCT01988012|2117062|FG000|Overall Study|Insufficient Therapeutic Response|3
1066589|NCT01988012|2117062|FG000|Overall Study|Patient Withdrawal of Consent|4
1066590|NCT01988012|2117062|FG000|Overall Study|Lost to Follow-up|1
1066591|NCT01988012|2117062|FG000|Overall Study|Physician Decision|1
1066592|NCT01988012|2117062|FG000|Overall Study|Protocol Violation|1
1066593|NCT01988090|2117068|FG000|Start Treament After Randomization|Withdrawal by Subject|2
1066594|NCT01988090|2117069|FG001|Start Treament After Randomization|Withdrawal by Subject|3
1066595|NCT01988090|2117068|FG000|Start Treament After Randomization|Protocol Violation|0
1066596|NCT01988090|2117069|FG001|Start Treament After Randomization|Protocol Violation|1
1066597|NCT01988090|2117068|FG000|Complete Study After Start|Withdrawal by Subject|2
1066598|NCT01988090|2117069|FG001|Complete Study After Start|Withdrawal by Subject|0
1066599|NCT01988090|2117068|FG000|Complete Study After Start|Protocol Violation|1
1066600|NCT01988090|2117069|FG001|Complete Study After Start|Protocol Violation|1
1066601|NCT01988103|2117078|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3
1066602|NCT01988103|2117079|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10
1066603|NCT01988103|2117080|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6
1066604|NCT01988103|2117081|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0
1066605|NCT01988103|2117082|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0
1066606|NCT01988103|2117078|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
1066607|NCT01988103|2117079|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
1066608|NCT01988103|2117080|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
1066609|NCT01988103|2117081|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
1066610|NCT01988103|2117082|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
1066611|NCT01988103|2117078|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
1066612|NCT01988103|2117079|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
1066613|NCT01988103|2117080|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
1066614|NCT01988103|2117081|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
1066615|NCT01988103|2117082|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
1066616|NCT01988103|2117078|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
1066617|NCT01988103|2117079|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
1066618|NCT01988103|2117080|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
1066619|NCT01988103|2117081|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
1066620|NCT01988103|2117082|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
1066621|NCT01988103|2117078|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
1066622|NCT01988103|2117079|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
1066623|NCT01988103|2117080|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
1066624|NCT01988103|2117081|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
1066625|NCT01988103|2117082|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
1066626|NCT01988103|2117078|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
1066627|NCT01988103|2117079|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
1066628|NCT01988103|2117080|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
1066629|NCT01988103|2117081|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
1066630|NCT01988103|2117082|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
1066631|NCT01988103|2117078|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
1066632|NCT01988103|2117079|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
1066633|NCT01988103|2117080|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
1066634|NCT01988103|2117081|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
1066635|NCT01988103|2117082|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
1066636|NCT01988402|2117129|FG000|Overall Study|Adverse Event|1
1066637|NCT01988402|2117130|FG001|Overall Study|Adverse Event|2
1066638|NCT01988402|2117129|FG000|Overall Study|Withdrawal by Subject|1
1066639|NCT01988402|2117130|FG001|Overall Study|Withdrawal by Subject|0
1066640|NCT01988493|2117147|FG000|Overall Study|Randomized but not treated|0
1066641|NCT01988493|2117148|FG001|Overall Study|Randomized but not treated|0
1066642|NCT01988493|2117149|FG002|Overall Study|Randomized but not treated|0
1066643|NCT01988493|2117150|FG003|Overall Study|Randomized but not treated|0
1066644|NCT01988493|2117151|FG004|Overall Study|Randomized but not treated|1
1066645|NCT01988493|2117147|FG000|Overall Study|Ongoing|0
1066646|NCT01988493|2117148|FG001|Overall Study|Ongoing|0
1066647|NCT01988493|2117149|FG002|Overall Study|Ongoing|0
1066648|NCT01988493|2117150|FG003|Overall Study|Ongoing|2
1066649|NCT01988493|2117151|FG004|Overall Study|Ongoing|0
1066650|NCT01988662|2117165|FG000|Overall Study|Subject/guardian decision|1
1066651|NCT01988662|2117166|FG001|Overall Study|Subject/guardian decision|1
1066652|NCT01988662|2117165|FG000|Overall Study|Adverse Event|3
1066653|NCT01988662|2117166|FG001|Overall Study|Adverse Event|1
1066654|NCT01988779|2117175|FG000|Overall Study|Withdrawal by Subject|2
1066655|NCT01988779|2117176|FG001|Overall Study|Withdrawal by Subject|2
1066656|NCT01988779|2117175|FG000|Overall Study|Protocol Violation|1
1066657|NCT01988779|2117176|FG001|Overall Study|Protocol Violation|0
1066658|NCT01989156|2117214|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
1066659|NCT01989156|2117215|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1066660|NCT01989156|2117216|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
1066661|NCT01989156|2117214|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0
1066662|NCT01989156|2117215|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0
1066663|NCT01989156|2117216|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1
1066664|NCT01989156|2117214|FG000|Confinement Period (Population at Day 5)|Adverse Event|0
1066665|NCT01989156|2117215|FG001|Confinement Period (Population at Day 5)|Adverse Event|0
1066666|NCT01989156|2117216|FG002|Confinement Period (Population at Day 5)|Adverse Event|1
1066667|NCT01989156|2117214|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2
1066668|NCT01989156|2117215|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2
1066669|NCT01989156|2117216|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2
1066670|NCT01989156|2117214|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3
1066671|NCT01989156|2117215|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2
1066672|NCT01989156|2117216|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0
1066673|NCT01989156|2117214|FG000|End of Study (Population at Day 90)|Physician Decision|1
1066674|NCT01989156|2117215|FG001|End of Study (Population at Day 90)|Physician Decision|0
1066675|NCT01989156|2117216|FG002|End of Study (Population at Day 90)|Physician Decision|1
1066676|NCT01989156|2117214|FG000|End of Study (Population at Day 90)|Moved out of state|1
1066677|NCT01989156|2117215|FG001|End of Study (Population at Day 90)|Moved out of state|0
1066678|NCT01989156|2117216|FG002|End of Study (Population at Day 90)|Moved out of state|0
1066679|NCT01989156|2117214|FG000|End of Study (Population at Day 90)|Employment Conflict|0
1066680|NCT01989156|2117215|FG001|End of Study (Population at Day 90)|Employment Conflict|1
1066681|NCT01989156|2117216|FG002|End of Study (Population at Day 90)|Employment Conflict|0
1066682|NCT01989169|2117226|FG000|Period 2|Adverse Event|0
1066683|NCT01989169|2117227|FG001|Period 2|Adverse Event|1
1066684|NCT01989208|2117242|FG000|200 mg (7 Days)|Protocol Violation|0
1066685|NCT01989208|2117243|FG001|200 mg (7 Days)|Protocol Violation|1
1066686|NCT01989455|2117270|FG000|Overall Study|Adverse Event|0
1066687|NCT01989455|2117271|FG001|Overall Study|Adverse Event|1
1066688|NCT01989455|2117272|FG002|Overall Study|Adverse Event|0
1066689|NCT01989455|2117273|FG003|Overall Study|Adverse Event|0
1066690|NCT01989455|2117274|FG004|Overall Study|Adverse Event|0
1066691|NCT01989455|2117270|FG000|Overall Study|Withdrawal by Subject|0
1066692|NCT01989455|2117271|FG001|Overall Study|Withdrawal by Subject|1
1066693|NCT01989455|2117272|FG002|Overall Study|Withdrawal by Subject|0
1066694|NCT01989455|2117273|FG003|Overall Study|Withdrawal by Subject|0
1066695|NCT01989455|2117274|FG004|Overall Study|Withdrawal by Subject|0
1066696|NCT01989455|2117270|FG000|Overall Study|Technical problems with infusion|0
1066697|NCT01989455|2117271|FG001|Overall Study|Technical problems with infusion|0
1066698|NCT01989455|2117272|FG002|Overall Study|Technical problems with infusion|1
1066699|NCT01989455|2117273|FG003|Overall Study|Technical problems with infusion|0
1066700|NCT01989455|2117274|FG004|Overall Study|Technical problems with infusion|1
1066701|NCT01989468|2117293|FG000|Overall Study|Adverse Event|10
1066702|NCT01989468|2117294|FG001|Overall Study|Adverse Event|15
1066703|NCT01989468|2117295|FG002|Overall Study|Adverse Event|4
1066704|NCT01989468|2117296|FG003|Overall Study|Adverse Event|5
1066705|NCT01989468|2117297|FG004|Overall Study|Adverse Event|4
1066706|NCT01989468|2117293|FG000|Overall Study|Lack of Efficacy|11
1066707|NCT01989468|2117294|FG001|Overall Study|Lack of Efficacy|11
1066708|NCT01989468|2117295|FG002|Overall Study|Lack of Efficacy|7
1066709|NCT01989468|2117296|FG003|Overall Study|Lack of Efficacy|4
1066710|NCT01989468|2117297|FG004|Overall Study|Lack of Efficacy|2
1066711|NCT01989468|2117293|FG000|Overall Study|Lost to Follow-up|5
1066712|NCT01989468|2117294|FG001|Overall Study|Lost to Follow-up|2
1066713|NCT01989468|2117295|FG002|Overall Study|Lost to Follow-up|0
1066714|NCT01989468|2117296|FG003|Overall Study|Lost to Follow-up|1
1066715|NCT01989468|2117297|FG004|Overall Study|Lost to Follow-up|1
1066716|NCT01989468|2117293|FG000|Overall Study|Physician Decision|4
1066717|NCT01989468|2117294|FG001|Overall Study|Physician Decision|1
1066718|NCT01989468|2117295|FG002|Overall Study|Physician Decision|0
1066719|NCT01989468|2117296|FG003|Overall Study|Physician Decision|1
1066720|NCT01989468|2117297|FG004|Overall Study|Physician Decision|0
1066721|NCT01989468|2117293|FG000|Overall Study|Pregnancy|0
1066722|NCT01989468|2117294|FG001|Overall Study|Pregnancy|1
1066723|NCT01989468|2117295|FG002|Overall Study|Pregnancy|0
1066724|NCT01989468|2117296|FG003|Overall Study|Pregnancy|0
1066725|NCT01989468|2117297|FG004|Overall Study|Pregnancy|0
1066726|NCT01989468|2117293|FG000|Overall Study|Technical Problems|3
1066727|NCT01989468|2117294|FG001|Overall Study|Technical Problems|1
1066728|NCT01989468|2117295|FG002|Overall Study|Technical Problems|3
1066729|NCT01989468|2117296|FG003|Overall Study|Technical Problems|1
1066730|NCT01989468|2117297|FG004|Overall Study|Technical Problems|0
1066731|NCT01989468|2117293|FG000|Overall Study|Subject Guardian Decision|11
1066732|NCT01989468|2117294|FG001|Overall Study|Subject Guardian Decision|6
1066733|NCT01989468|2117295|FG002|Overall Study|Subject Guardian Decision|4
1066734|NCT01989468|2117296|FG003|Overall Study|Subject Guardian Decision|4
1066735|NCT01989468|2117297|FG004|Overall Study|Subject Guardian Decision|1
1066736|NCT01989468|2117293|FG000|Overall Study|Death|3
1066737|NCT01989468|2117294|FG001|Overall Study|Death|0
1066738|NCT01989468|2117295|FG002|Overall Study|Death|1
1066739|NCT01989468|2117296|FG003|Overall Study|Death|0
1066740|NCT01989468|2117297|FG004|Overall Study|Death|0
1066741|NCT01989546|2117310|FG000|Overall Study|Clinical Progression|1
1066742|NCT01989546|2117310|FG000|Overall Study|Disease progression on study|8
1066743|NCT01989572|2117320|FG000|Overall Study|Lack of Efficacy|35
1066744|NCT01989572|2117321|FG001|Overall Study|Lack of Efficacy|48
1066745|NCT01989572|2117322|FG002|Overall Study|Lack of Efficacy|48
1066746|NCT01989572|2117323|FG003|Overall Study|Lack of Efficacy|43
1066747|NCT01989572|2117324|FG004|Overall Study|Lack of Efficacy|71
1066748|NCT01989572|2117325|FG005|Overall Study|Lack of Efficacy|79
1066749|NCT01989572|2117320|FG000|Overall Study|Adverse Event|2
1066750|NCT01989572|2117321|FG001|Overall Study|Adverse Event|1
1066751|NCT01989572|2117322|FG002|Overall Study|Adverse Event|3
1066752|NCT01989572|2117323|FG003|Overall Study|Adverse Event|0
1066753|NCT01989572|2117324|FG004|Overall Study|Adverse Event|3
1066754|NCT01989572|2117325|FG005|Overall Study|Adverse Event|0
1066755|NCT01989572|2117320|FG000|Overall Study|Death|0
1066756|NCT01989572|2117321|FG001|Overall Study|Death|0
1066757|NCT01989572|2117322|FG002|Overall Study|Death|0
1066758|NCT01989572|2117323|FG003|Overall Study|Death|0
1066759|NCT01989572|2117324|FG004|Overall Study|Death|1
1066760|NCT01989572|2117325|FG005|Overall Study|Death|0
1066761|NCT01989572|2117320|FG000|Overall Study|Withdrawal by Subject|4
1066762|NCT01989572|2117321|FG001|Overall Study|Withdrawal by Subject|1
1066763|NCT01989572|2117322|FG002|Overall Study|Withdrawal by Subject|5
1066764|NCT01989572|2117323|FG003|Overall Study|Withdrawal by Subject|1
1066765|NCT01989572|2117324|FG004|Overall Study|Withdrawal by Subject|12
1066766|NCT01989572|2117325|FG005|Overall Study|Withdrawal by Subject|4
1066767|NCT01989572|2117320|FG000|Overall Study|complicating disease|1
1066768|NCT01989572|2117321|FG001|Overall Study|complicating disease|1
1066769|NCT01989572|2117322|FG002|Overall Study|complicating disease|2
1066770|NCT01989572|2117323|FG003|Overall Study|complicating disease|0
1066771|NCT01989572|2117324|FG004|Overall Study|complicating disease|1
1066772|NCT01989572|2117325|FG005|Overall Study|complicating disease|0
1066773|NCT01989572|2117320|FG000|Overall Study|error|2
1066774|NCT01989572|2117321|FG001|Overall Study|error|1
1066775|NCT01989572|2117322|FG002|Overall Study|error|1
1066776|NCT01989572|2117323|FG003|Overall Study|error|1
1066777|NCT01989572|2117324|FG004|Overall Study|error|1
1066778|NCT01989572|2117325|FG005|Overall Study|error|1
1066779|NCT01989572|2117320|FG000|Overall Study|maximum dose reached|0
1066780|NCT01989572|2117321|FG001|Overall Study|maximum dose reached|1
1066781|NCT01989572|2117322|FG002|Overall Study|maximum dose reached|0
1066782|NCT01989572|2117323|FG003|Overall Study|maximum dose reached|0
1066783|NCT01989572|2117324|FG004|Overall Study|maximum dose reached|1
1066784|NCT01989572|2117325|FG005|Overall Study|maximum dose reached|0
1066785|NCT01989572|2117320|FG000|Overall Study|unknown/not specify|3
1066786|NCT01989572|2117321|FG001|Overall Study|unknown/not specify|4
1066787|NCT01989572|2117322|FG002|Overall Study|unknown/not specify|1
1066788|NCT01989572|2117323|FG003|Overall Study|unknown/not specify|3
1066789|NCT01989572|2117324|FG004|Overall Study|unknown/not specify|3
1066790|NCT01989572|2117325|FG005|Overall Study|unknown/not specify|5
1066791|NCT01989572|2117320|FG000|Overall Study|not start protocol therapy|5
1066792|NCT01989572|2117321|FG001|Overall Study|not start protocol therapy|1
1066793|NCT01989572|2117322|FG002|Overall Study|not start protocol therapy|2
1066794|NCT01989572|2117323|FG003|Overall Study|not start protocol therapy|3
1066795|NCT01989572|2117324|FG004|Overall Study|not start protocol therapy|4
1066796|NCT01989572|2117325|FG005|Overall Study|not start protocol therapy|18
1066797|NCT01989572|2117320|FG000|Overall Study|alternative therapy|3
1066798|NCT01989572|2117321|FG001|Overall Study|alternative therapy|0
1066799|NCT01989572|2117322|FG002|Overall Study|alternative therapy|0
1066800|NCT01989572|2117323|FG003|Overall Study|alternative therapy|0
1066801|NCT01989572|2117324|FG004|Overall Study|alternative therapy|1
1066802|NCT01989572|2117325|FG005|Overall Study|alternative therapy|3
1066803|NCT01989689|2117355|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
1066804|NCT01989689|2117356|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
1066805|NCT01989689|2117355|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
1066806|NCT01989689|2117356|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
1066807|NCT01989754|2117366|FG000|Overall Study|Withdrawal by Subject|10
1066808|NCT01989754|2117367|FG001|Overall Study|Withdrawal by Subject|14
1066809|NCT01989754|2117366|FG000|Overall Study|Lost to Follow-up|28
1066810|NCT01989754|2117367|FG001|Overall Study|Lost to Follow-up|20
1066811|NCT01989754|2117366|FG000|Overall Study|Closed Site|1
1066812|NCT01989754|2117367|FG001|Overall Study|Closed Site|1
1066813|NCT01990261|2117395|FG000|Overall Study|Death Before Treatment Start|2
1066814|NCT01990261|2117395|FG000|Overall Study|Death due to Disease Progression (PD)|10
1066815|NCT01990261|2117395|FG000|Overall Study|Death From other Causes|1
1066816|NCT01990261|2117395|FG000|Overall Study|Disease Progression (PD)|8
1066817|NCT01990261|2117395|FG000|Overall Study|PD Before Treatment Start|1
1066818|NCT01990261|2117395|FG000|Overall Study|Dossier not Approved|1
1066819|NCT01990261|2117395|FG000|Overall Study|Lost to Follow-up|2
1066820|NCT01990300|2117399|FG000|Overall Study|Case Report Forms Uncollected|89
1066821|NCT01990300|2117399|FG000|Overall Study|Protocol Deviation|53
1066822|NCT01990313|2117403|FG000|Overall Study|Lost to Follow-up|1
1066823|NCT01990339|2117407|FG000|Overall Study|Data Not Available|49
1066824|NCT01990339|2117407|FG000|Overall Study|Voluntary Withdrawal|1402
1066825|NCT01990339|2117407|FG000|Overall Study|Lost to Follow-up|861
1066826|NCT01990495|2117413|FG000|Overall Study|Physician Decision|5
1066827|NCT01990495|2117414|FG001|Overall Study|Physician Decision|4
1066828|NCT01990534|2117422|FG000|Overall Study|Death|22
1066829|NCT01990534|2117422|FG000|Overall Study|Progressive disease|3
1066830|NCT01990534|2117422|FG000|Overall Study|Protocol Violation|1
1066831|NCT01990534|2117422|FG000|Overall Study|Withdrawal of Informed Consent|2
1066832|NCT01990534|2117422|FG000|Overall Study|Symptomatic Deterioration|1
1066833|NCT01990534|2117422|FG000|Overall Study|Withdrawal by Subject|3
1066834|NCT01990534|2117422|FG000|Overall Study|Reason not Specified|2
1066835|NCT01990534|2117422|FG000|Overall Study|Lost to Follow-up|1
1066836|NCT01990560|2117426|FG000|Overall Study|Withdrawal by Subject|1
1066837|NCT01990573|2117433|FG000|Overall Study|Physician Decision|0
1066838|NCT01990573|2117434|FG001|Overall Study|Physician Decision|0
1066839|NCT01990573|2117435|FG002|Overall Study|Physician Decision|1
1066840|NCT01990612|2117445|FG000|Overall Study|Lost to Follow-up|2
1066841|NCT01990612|2117446|FG001|Overall Study|Lost to Follow-up|1
1066842|NCT01990612|2117445|FG000|Overall Study|Withdrawal by Subject|5
1066843|NCT01990612|2117446|FG001|Overall Study|Withdrawal by Subject|2
1066844|NCT01990664|2117454|FG000|Overall Study|Lost to Follow-up|2
1066845|NCT01990664|2117455|FG001|Overall Study|Lost to Follow-up|6
1066846|NCT01990664|2117454|FG000|Overall Study|Withdrawal by Subject|2
1066847|NCT01990664|2117455|FG001|Overall Study|Withdrawal by Subject|3
1066848|NCT01990664|2117454|FG000|Overall Study|Protocol Violation|1
1066849|NCT01990664|2117455|FG001|Overall Study|Protocol Violation|0
1066850|NCT01990664|2117454|FG000|Overall Study|Lens Discomfort|1
1066851|NCT01990664|2117455|FG001|Overall Study|Lens Discomfort|1
1066852|NCT01990664|2117454|FG000|Overall Study|Lens Handling Difficulties|1
1066853|NCT01990664|2117455|FG001|Overall Study|Lens Handling Difficulties|0
1066854|NCT01990664|2117454|FG000|Overall Study|Unsatisfactory Visual Response|0
1066855|NCT01990664|2117455|FG001|Overall Study|Unsatisfactory Visual Response|1
1066856|NCT01990742|2117481|FG000|Overall Study|Withdrawal by facility|407
1066857|NCT01990742|2117482|FG001|Overall Study|Withdrawal by facility|1083
1066858|NCT01990742|2117481|FG000|Overall Study|Facility closed|0
1066859|NCT01990742|2117482|FG001|Overall Study|Facility closed|270
1066860|NCT01990768|2117491|FG000|Intervention Started|Found to be ineligible|14
1066861|NCT01990768|2117492|FG001|Intervention Started|Found to be ineligible|13
1066862|NCT01990768|2117493|FG002|Intervention Started|Found to be ineligible|11
1066863|NCT01990768|2117491|FG000|Intervention Started|Study drug issue or kit malfunction|9
1066864|NCT01990768|2117492|FG001|Intervention Started|Study drug issue or kit malfunction|6
1066865|NCT01990768|2117493|FG002|Intervention Started|Study drug issue or kit malfunction|7
1066866|NCT01990768|2117491|FG000|Intervention Started|Patient became ineligible due to vitals|5
1066867|NCT01990768|2117492|FG001|Intervention Started|Patient became ineligible due to vitals|5
1066868|NCT01990768|2117493|FG002|Intervention Started|Patient became ineligible due to vitals|2
1066869|NCT01990768|2117491|FG000|Intervention Started|Not enough time for EMS to enroll|4
1066870|NCT01990768|2117492|FG001|Intervention Started|Not enough time for EMS to enroll|3
1066871|NCT01990768|2117493|FG002|Intervention Started|Not enough time for EMS to enroll|0
1066872|NCT01990768|2117491|FG000|Intervention Started|Patient care priority|1
1066873|NCT01990768|2117492|FG001|Intervention Started|Patient care priority|2
1066874|NCT01990768|2117493|FG002|Intervention Started|Patient care priority|3
1066875|NCT01990768|2117491|FG000|Intervention Started|IV lost|2
1066876|NCT01990768|2117492|FG001|Intervention Started|IV lost|2
1066877|NCT01990768|2117493|FG002|Intervention Started|IV lost|2
1066878|NCT01990768|2117491|FG000|Intervention Started|Required CPR|1
1066879|NCT01990768|2117492|FG001|Intervention Started|Required CPR|1
1066880|NCT01990768|2117493|FG002|Intervention Started|Required CPR|0
1066881|NCT01990768|2117491|FG000|Intervention Started|Seizure or hx of seizure|0
1066882|NCT01990768|2117492|FG001|Intervention Started|Seizure or hx of seizure|0
1066883|NCT01990768|2117493|FG002|Intervention Started|Seizure or hx of seizure|2
1066884|NCT01990768|2117491|FG000|Intervention Started|Discovered to be pregnant|0
1066885|NCT01990768|2117492|FG001|Intervention Started|Discovered to be pregnant|1
1066886|NCT01990768|2117493|FG002|Intervention Started|Discovered to be pregnant|0
1066887|NCT01990768|2117491|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4
1066888|NCT01990768|2117492|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11
1066889|NCT01990768|2117493|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10
1066890|NCT01990768|2117491|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
1066891|NCT01990768|2117492|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
1066892|NCT01990768|2117493|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
1066893|NCT01990768|2117491|FG000|Prehospital Study Drug Infusion|Required CPR|2
1066894|NCT01990768|2117492|FG001|Prehospital Study Drug Infusion|Required CPR|6
1066895|NCT01990768|2117493|FG002|Prehospital Study Drug Infusion|Required CPR|0
1066896|NCT01990768|2117491|FG000|Prehospital Study Drug Infusion|Other safety concern|2
1066897|NCT01990768|2117492|FG001|Prehospital Study Drug Infusion|Other safety concern|1
1066898|NCT01990768|2117493|FG002|Prehospital Study Drug Infusion|Other safety concern|1
1066899|NCT01990768|2117491|FG000|Prehospital Study Drug Infusion|Death|3
1066900|NCT01990768|2117492|FG001|Prehospital Study Drug Infusion|Death|1
1066901|NCT01990768|2117493|FG002|Prehospital Study Drug Infusion|Death|1
1066902|NCT01990768|2117491|FG000|Prehospital Study Drug Infusion|Discharged|2
1066903|NCT01990768|2117492|FG001|Prehospital Study Drug Infusion|Discharged|1
1066904|NCT01990768|2117493|FG002|Prehospital Study Drug Infusion|Discharged|0
1066905|NCT01990768|2117491|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1
1066906|NCT01990768|2117492|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0
1066907|NCT01990768|2117493|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0
1066908|NCT01990768|2117491|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0
1066909|NCT01990768|2117492|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0
1066910|NCT01990768|2117493|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1
1066911|NCT01990768|2117491|FG000|Prehospital Study Drug Infusion|Unknown if completed|1
1066912|NCT01990768|2117492|FG001|Prehospital Study Drug Infusion|Unknown if completed|4
1066913|NCT01990768|2117493|FG002|Prehospital Study Drug Infusion|Unknown if completed|2
1066914|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Discharged|19
1066915|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Discharged|18
1066916|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Discharged|13
1066917|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14
1066918|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17
1066919|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10
1066920|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
1066921|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
1066922|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
1066923|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12
1066924|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11
1066925|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6
1066926|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11
1066927|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4
1066928|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7
1066929|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
1066930|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
1066931|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
1066932|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
1066933|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
1066934|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
1066935|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Required CPR|3
1066936|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Required CPR|7
1066937|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Required CPR|1
1066938|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Other safety concern|4
1066939|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Other safety concern|2
1066940|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Other safety concern|3
1066941|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4
1066942|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0
1066943|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3
1066944|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1
1066945|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1
1066946|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1
1066947|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
1066948|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
1066949|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
1066950|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0
1066951|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1
1066952|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2
1066953|NCT01990768|2117491|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0
1066954|NCT01990768|2117492|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0
1066955|NCT01990768|2117493|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1
1066956|NCT01990768|2117491|FG000|6-Month Follow-up|Withdrawal by Subject|25
1066957|NCT01990768|2117492|FG001|6-Month Follow-up|Withdrawal by Subject|25
1066958|NCT01990768|2117493|FG002|6-Month Follow-up|Withdrawal by Subject|26
1066959|NCT01990768|2117491|FG000|6-Month Follow-up|Calls unreturned or refused contact|4
1066960|NCT01990768|2117492|FG001|6-Month Follow-up|Calls unreturned or refused contact|15
1066961|NCT01990768|2117493|FG002|6-Month Follow-up|Calls unreturned or refused contact|20
1066962|NCT01990768|2117491|FG000|6-Month Follow-up|No contact information|5
1066963|NCT01990768|2117492|FG001|6-Month Follow-up|No contact information|6
1066964|NCT01990768|2117493|FG002|6-Month Follow-up|No contact information|5
1066965|NCT01990768|2117491|FG000|6-Month Follow-up|Homeless|4
1066966|NCT01990768|2117492|FG001|6-Month Follow-up|Homeless|3
1066967|NCT01990768|2117493|FG002|6-Month Follow-up|Homeless|6
1066968|NCT01990768|2117491|FG000|6-Month Follow-up|Prisoner at time of enrollment|0
1066969|NCT01990768|2117492|FG001|6-Month Follow-up|Prisoner at time of enrollment|0
1066970|NCT01990768|2117493|FG002|6-Month Follow-up|Prisoner at time of enrollment|1
1066971|NCT01990768|2117491|FG000|6-Month Follow-up|Prisoner at time of follow-up|0
1066972|NCT01990768|2117492|FG001|6-Month Follow-up|Prisoner at time of follow-up|2
1066973|NCT01990768|2117493|FG002|6-Month Follow-up|Prisoner at time of follow-up|0
1066974|NCT01990768|2117491|FG000|6-Month Follow-up|Patient at psychiatric hospital|1
1066975|NCT01990768|2117492|FG001|6-Month Follow-up|Patient at psychiatric hospital|0
1066976|NCT01990768|2117493|FG002|6-Month Follow-up|Patient at psychiatric hospital|0
1066977|NCT01990859|2117598|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
1066978|NCT01990859|2117598|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
1066979|NCT01990950|2117607|FG000|Overall Study|Death|3
1066980|NCT01990950|2117607|FG000|Overall Study|Lost to Follow-up|2
1066981|NCT01990950|2117607|FG000|Overall Study|Withdrawal by Subject|6
1066984|NCT01991197|2117622|FG000|Overall Study|Lost to Follow-up|1
1066985|NCT01991197|2117623|FG001|Overall Study|Lost to Follow-up|1
1066986|NCT01991197|2117622|FG000|Overall Study|Physician Decision|0
1066987|NCT01991197|2117623|FG001|Overall Study|Physician Decision|2
1066988|NCT01991197|2117622|FG000|Overall Study|Withdrawal by Subject|2
1066989|NCT01991197|2117623|FG001|Overall Study|Withdrawal by Subject|0
1066990|NCT01991314|2117636|FG000|Overall Study|Adverse Event|5
1066991|NCT01991314|2117637|FG001|Overall Study|Adverse Event|1
1066992|NCT01991314|2117636|FG000|Overall Study|Lost to Follow-up|6
1066993|NCT01991314|2117637|FG001|Overall Study|Lost to Follow-up|10
1066994|NCT01991470|2117643|FG000|Enlite 1 Period|Withdrawal by Subject|18
1066995|NCT01991470|2117643|FG000|Enlite 1 Period|Adverse Event|1
1066996|NCT01991470|2117643|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1
1066997|NCT01991470|2117643|FG000|Enlite 3 Period|Lost to Follow-up|1
1066998|NCT01991470|2117643|FG000|Enlite 3 Period|Physician Decision|2
1066999|NCT01991470|2117643|FG000|Enlite 3 Period|Physician Decision|8
1067000|NCT01991470|2117643|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
1067001|NCT01991483|2117659|FG000|Dose Level 600 mg|Withdrawal by Subject|0
1067002|NCT01991483|2117660|FG001|Dose Level 600 mg|Withdrawal by Subject|0
1067003|NCT01991483|2117661|FG002|Dose Level 600 mg|Withdrawal by Subject|1
1067004|NCT01991483|2117662|FG003|Dose Level 600 mg|Withdrawal by Subject|0
1067005|NCT01991483|2117659|FG000|Dose Level 600 mg|Physician Decision|0
1067006|NCT01991483|2117660|FG001|Dose Level 600 mg|Physician Decision|0
1067007|NCT01991483|2117661|FG002|Dose Level 600 mg|Physician Decision|1
1067008|NCT01991483|2117662|FG003|Dose Level 600 mg|Physician Decision|0
1067009|NCT01991483|2117659|FG000|Dose Level 1000 mg|Protocol Violation|0
1067010|NCT01991483|2117660|FG001|Dose Level 1000 mg|Protocol Violation|0
1067011|NCT01991483|2117661|FG002|Dose Level 1000 mg|Protocol Violation|0
1067012|NCT01991483|2117662|FG003|Dose Level 1000 mg|Protocol Violation|1
1067013|NCT01991743|2117692|FG000|Overall Study|external cephalic version not performed|0
1162043|NCT03381248|2283985|FG000|Overall Study|Lost to Follow-up|3
1067014|NCT01991743|2117693|FG001|Overall Study|external cephalic version not performed|0
1067015|NCT01991743|2117694|FG002|Overall Study|external cephalic version not performed|1
1067016|NCT01991743|2117695|FG003|Overall Study|external cephalic version not performed|0
1067017|NCT01991795|2117707|FG000|Overall Study|Lost to Follow-up|6
1067018|NCT01991795|2117708|FG001|Overall Study|Lost to Follow-up|4
1067019|NCT01991795|2117707|FG000|Overall Study|Withdrawal by Subject|117
1067020|NCT01991795|2117708|FG001|Overall Study|Withdrawal by Subject|94
1067021|NCT01991795|2117707|FG000|Overall Study|Site prematurely closed by sponsor|26
1067022|NCT01991795|2117708|FG001|Overall Study|Site prematurely closed by sponsor|25
1067023|NCT01991977|2117738|FG000|Overall Study|Withdrew prior to receiving treatment|7
1067024|NCT01991977|2117738|FG000|Overall Study|Withdrew after start of treatment|5
1067025|NCT01992094|2117767|FG000|Overall Study|ADMINISTRATIVE REASON|6
1067026|NCT01992094|2117768|FG001|Overall Study|ADMINISTRATIVE REASON|7
1067027|NCT01992094|2117769|FG002|Overall Study|ADMINISTRATIVE REASON|1
1067028|NCT01992094|2117767|FG000|Overall Study|Adverse Event|1
1067029|NCT01992094|2117768|FG001|Overall Study|Adverse Event|0
1067030|NCT01992094|2117769|FG002|Overall Study|Adverse Event|0
1067031|NCT01992094|2117767|FG000|Overall Study|Death|5
1067032|NCT01992094|2117768|FG001|Overall Study|Death|5
1067033|NCT01992094|2117769|FG002|Overall Study|Death|2
1067034|NCT01992094|2117767|FG000|Overall Study|Lost to Follow-up|26
1067035|NCT01992094|2117768|FG001|Overall Study|Lost to Follow-up|9
1067036|NCT01992094|2117769|FG002|Overall Study|Lost to Follow-up|13
1067037|NCT01992094|2117767|FG000|Overall Study|OTHER|4
1067038|NCT01992094|2117768|FG001|Overall Study|OTHER|0
1067039|NCT01992094|2117769|FG002|Overall Study|OTHER|0
1067040|NCT01992094|2117767|FG000|Overall Study|Protocol Violation|1
1067041|NCT01992094|2117768|FG001|Overall Study|Protocol Violation|0
1067042|NCT01992094|2117769|FG002|Overall Study|Protocol Violation|1
1067043|NCT01992094|2117767|FG000|Overall Study|Withdrawal by Subject|7
1067044|NCT01992094|2117768|FG001|Overall Study|Withdrawal by Subject|3
1067045|NCT01992094|2117769|FG002|Overall Study|Withdrawal by Subject|4
1067046|NCT01992107|2117796|FG000|Overall Study|Administrative reasons|2
1067047|NCT01992107|2117797|FG001|Overall Study|Administrative reasons|0
1067048|NCT01992107|2117798|FG002|Overall Study|Administrative reasons|0
1067049|NCT01992107|2117796|FG000|Overall Study|Adverse Event|0
1067050|NCT01992107|2117797|FG001|Overall Study|Adverse Event|1
1067051|NCT01992107|2117798|FG002|Overall Study|Adverse Event|0
1067052|NCT01992107|2117796|FG000|Overall Study|Lost to Follow-up|46
1067053|NCT01992107|2117797|FG001|Overall Study|Lost to Follow-up|22
1067054|NCT01992107|2117798|FG002|Overall Study|Lost to Follow-up|26
1067055|NCT01992107|2117796|FG000|Overall Study|noncompliance and were unavailable|7
1067056|NCT01992107|2117797|FG001|Overall Study|noncompliance and were unavailable|3
1067057|NCT01992107|2117798|FG002|Overall Study|noncompliance and were unavailable|2
1067058|NCT01992107|2117796|FG000|Overall Study|Withdrawal by Subject|13
1067059|NCT01992107|2117797|FG001|Overall Study|Withdrawal by Subject|7
1067060|NCT01992107|2117798|FG002|Overall Study|Withdrawal by Subject|8
1067061|NCT01992159|2117827|FG000|Overall Study|Withdrawal by Subject|4
1067062|NCT01992159|2117828|FG001|Overall Study|Withdrawal by Subject|7
1067063|NCT01992159|2117829|FG002|Overall Study|Withdrawal by Subject|0
1067064|NCT01992159|2117830|FG003|Overall Study|Withdrawal by Subject|3
1067065|NCT01992159|2117827|FG000|Overall Study|Adverse Event|0
1067066|NCT01992159|2117828|FG001|Overall Study|Adverse Event|1
1067067|NCT01992159|2117829|FG002|Overall Study|Adverse Event|0
1067068|NCT01992159|2117830|FG003|Overall Study|Adverse Event|1
1067069|NCT01992159|2117827|FG000|Overall Study|Death|0
1067070|NCT01992159|2117828|FG001|Overall Study|Death|0
1067071|NCT01992159|2117829|FG002|Overall Study|Death|1
1067072|NCT01992159|2117830|FG003|Overall Study|Death|0
1067073|NCT01992536|2117895|FG000|Overall Study|Administrative Reason|0
1067074|NCT01992536|2117896|FG001|Overall Study|Administrative Reason|0
1067075|NCT01992536|2117897|FG002|Overall Study|Administrative Reason|0
1067076|NCT01992536|2117898|FG003|Overall Study|Administrative Reason|0
1067077|NCT01992536|2117899|FG004|Overall Study|Administrative Reason|0
1067078|NCT01992536|2117900|FG005|Overall Study|Administrative Reason|0
1067079|NCT01992536|2117901|FG006|Overall Study|Administrative Reason|7
1067080|NCT01992536|2117902|FG007|Overall Study|Administrative Reason|0
1067081|NCT01992536|2117903|FG008|Overall Study|Administrative Reason|0
1067082|NCT01992536|2117904|FG009|Overall Study|Administrative Reason|0
1067083|NCT01992536|2117895|FG000|Overall Study|Lost to Follow-up|4
1067084|NCT01992536|2117896|FG001|Overall Study|Lost to Follow-up|2
1067085|NCT01992536|2117897|FG002|Overall Study|Lost to Follow-up|1
1067086|NCT01992536|2117898|FG003|Overall Study|Lost to Follow-up|0
1067087|NCT01992536|2117899|FG004|Overall Study|Lost to Follow-up|0
1067088|NCT01992536|2117900|FG005|Overall Study|Lost to Follow-up|1
1067089|NCT01992536|2117901|FG006|Overall Study|Lost to Follow-up|0
1067090|NCT01992536|2117902|FG007|Overall Study|Lost to Follow-up|0
1067091|NCT01992536|2117903|FG008|Overall Study|Lost to Follow-up|1
1067092|NCT01992536|2117904|FG009|Overall Study|Lost to Follow-up|1
1067093|NCT01992536|2117895|FG000|Overall Study|Withdrawal by Subject|0
1067094|NCT01992536|2117896|FG001|Overall Study|Withdrawal by Subject|1
1067095|NCT01992536|2117897|FG002|Overall Study|Withdrawal by Subject|0
1067096|NCT01992536|2117898|FG003|Overall Study|Withdrawal by Subject|2
1067097|NCT01992536|2117899|FG004|Overall Study|Withdrawal by Subject|0
1067098|NCT01992536|2117900|FG005|Overall Study|Withdrawal by Subject|0
1067099|NCT01992536|2117901|FG006|Overall Study|Withdrawal by Subject|0
1067100|NCT01992536|2117902|FG007|Overall Study|Withdrawal by Subject|0
1067101|NCT01992536|2117903|FG008|Overall Study|Withdrawal by Subject|0
1067102|NCT01992536|2117904|FG009|Overall Study|Withdrawal by Subject|0
1067103|NCT01992549|2117946|FG000|Overall Study|Lost to Follow-up|2
1067104|NCT01992549|2117946|FG000|Overall Study|Serious Adverse Event|1
1067105|NCT01992549|2117946|FG000|Overall Study|Product Switch to Extend Half Life|1
1067106|NCT01992757|2117989|FG000|Overall Study|2 patients excluded due to FFP given.|2
1067107|NCT01993017|2118009|FG000|Overall Study|Death|23
1067108|NCT01993017|2118010|FG001|Overall Study|Death|26
1067109|NCT01993017|2118011|FG002|Overall Study|Death|18
1067110|NCT01993017|2118009|FG000|Overall Study|Could not be contacted|43
1067111|NCT01993017|2118010|FG001|Overall Study|Could not be contacted|42
1067112|NCT01993017|2118011|FG002|Overall Study|Could not be contacted|38
1067113|NCT01993017|2118009|FG000|Overall Study|Dropped out|19
1067114|NCT01993017|2118010|FG001|Overall Study|Dropped out|6
1067115|NCT01993017|2118011|FG002|Overall Study|Dropped out|11
1067116|NCT01993017|2118009|FG000|Overall Study|Other reasons|17
1067117|NCT01993017|2118010|FG001|Overall Study|Other reasons|11
1067118|NCT01993017|2118011|FG002|Overall Study|Other reasons|7
1067119|NCT01993017|2118009|FG000|Overall Study|Ineligible after randomization|4
1067120|NCT01993017|2118010|FG001|Overall Study|Ineligible after randomization|5
1067121|NCT01993017|2118011|FG002|Overall Study|Ineligible after randomization|5
1067122|NCT01993030|2118022|FG000|Overall Study|Adverse Event|0
1067123|NCT01993030|2118023|FG001|Overall Study|Adverse Event|4
1067124|NCT01993186|2118052|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1
1067125|NCT01993186|2118053|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
1067126|NCT01993186|2118052|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
1067127|NCT01993186|2118053|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
1067128|NCT01993186|2118052|FG000|Open-Label Extension Period|Other, Not Specified|0
1067129|NCT01993186|2118053|FG001|Open-Label Extension Period|Other, Not Specified|1
1067130|NCT01993186|2118052|FG000|Open-Label Extension Period|Adverse Event|1
1067131|NCT01993186|2118053|FG001|Open-Label Extension Period|Adverse Event|0
1067132|NCT01993186|2118052|FG000|Open-Label Extension Period|Principal Investigator Decision|1
1067133|NCT01993186|2118053|FG001|Open-Label Extension Period|Principal Investigator Decision|0
1067134|NCT01993186|2118052|FG000|Open-Label Extension Period|Withdrawal by Subject|4
1067135|NCT01993186|2118053|FG001|Open-Label Extension Period|Withdrawal by Subject|5
1067136|NCT01993186|2118052|FG000|Open-Label Extension Period|Subject Non-Compliance|1
1067137|NCT01993186|2118053|FG001|Open-Label Extension Period|Subject Non-Compliance|0
1067138|NCT01993329|2118070|FG000|Period 2|Adverse Event|0
1067139|NCT01993329|2118071|FG001|Period 2|Adverse Event|0
1067140|NCT01993329|2118072|FG002|Period 2|Adverse Event|0
1067141|NCT01993329|2118073|FG003|Period 2|Adverse Event|0
1067142|NCT01993329|2118074|FG004|Period 2|Adverse Event|0
1067143|NCT01993329|2118075|FG005|Period 2|Adverse Event|1
1067144|NCT01993329|2118070|FG000|Wash-out|Personal reasons|0
1067145|NCT01993329|2118071|FG001|Wash-out|Personal reasons|1
1067146|NCT01993329|2118072|FG002|Wash-out|Personal reasons|0
1067147|NCT01993329|2118073|FG003|Wash-out|Personal reasons|0
1067148|NCT01993329|2118074|FG004|Wash-out|Personal reasons|0
1067149|NCT01993329|2118075|FG005|Wash-out|Personal reasons|0
1067150|NCT01993615|2118089|FG000|Overall Study|Death|1
1067151|NCT01993615|2118090|FG001|Overall Study|Death|0
1067152|NCT01993667|2118098|FG000|Overall Study|Insufficient data to analyze|16
1067153|NCT01993667|2118099|FG001|Overall Study|Insufficient data to analyze|16
1067154|NCT01993667|2118098|FG000|Overall Study|Insufficient altitude reached|3
1067155|NCT01993667|2118099|FG001|Overall Study|Insufficient altitude reached|1
1067156|NCT01993667|2118098|FG000|Overall Study|Lost to Follow-up|2
1067157|NCT01993667|2118099|FG001|Overall Study|Lost to Follow-up|2
1067158|NCT01993823|2118107|FG000|Overall Study|Requested by the patient|6
1067159|NCT01993823|2118108|FG001|Overall Study|Requested by the patient|11
1067160|NCT01993823|2118107|FG000|Overall Study|Protocol Violation|0
1067161|NCT01993823|2118108|FG001|Overall Study|Protocol Violation|1
1067162|NCT01993823|2118107|FG000|Overall Study|Lost to Follow-up|1
1067163|NCT01993823|2118108|FG001|Overall Study|Lost to Follow-up|4
1067164|NCT01993836|2118117|FG000|Overall Study|Surgery Cancelled|3
1067165|NCT01993836|2118118|FG001|Overall Study|Surgery Cancelled|0
1067166|NCT01993836|2118119|FG002|Overall Study|Surgery Cancelled|0
1067167|NCT01993836|2118117|FG000|Overall Study|Physician Decision|2
1067168|NCT01993836|2118118|FG001|Overall Study|Physician Decision|1
1067169|NCT01993836|2118119|FG002|Overall Study|Physician Decision|0
1067170|NCT01993836|2118117|FG000|Overall Study|Death|0
1067171|NCT01993836|2118118|FG001|Overall Study|Death|2
1067172|NCT01993836|2118119|FG002|Overall Study|Death|0
1067173|NCT01993836|2118117|FG000|Overall Study|Withdrawal by Subject|12
1067174|NCT01993836|2118118|FG001|Overall Study|Withdrawal by Subject|10
1067175|NCT01993836|2118119|FG002|Overall Study|Withdrawal by Subject|5
1067176|NCT01993888|2118150|FG000|Overall Study|Death|1
1067177|NCT01993888|2118151|FG001|Overall Study|Death|1
1067178|NCT01993888|2118150|FG000|Overall Study|Lost to Follow-up|1
1067179|NCT01993888|2118151|FG001|Overall Study|Lost to Follow-up|1
1067180|NCT01993888|2118150|FG000|Overall Study|Withdrawal by Subject|0
1067181|NCT01993888|2118151|FG001|Overall Study|Withdrawal by Subject|1
1067182|NCT01993927|2118157|FG000|Overall Study|Case Report Forms Uncollected|18
1067183|NCT01993927|2118157|FG000|Overall Study|Protocol Violation|11
1067184|NCT01993940|2118163|FG000|Overall Study|Adverse Event|16
1067185|NCT01993940|2118164|FG001|Overall Study|Adverse Event|11
1067186|NCT01993940|2118163|FG000|Overall Study|Withdrawal by Subject|15
1067187|NCT01993940|2118164|FG001|Overall Study|Withdrawal by Subject|19
1067188|NCT01993940|2118163|FG000|Overall Study|Lost to Follow-up|2
1067189|NCT01993940|2118164|FG001|Overall Study|Lost to Follow-up|5
1067190|NCT01993940|2118163|FG000|Overall Study|Protocol Violation|5
1067191|NCT01993940|2118164|FG001|Overall Study|Protocol Violation|8
1067192|NCT01993940|2118163|FG000|Overall Study|Death|1
1067193|NCT01993940|2118164|FG001|Overall Study|Death|0
1067194|NCT01993940|2118163|FG000|Overall Study|Other - Miscellaneous|1
1067195|NCT01993940|2118164|FG001|Overall Study|Other - Miscellaneous|1
1067196|NCT01994226|2118188|FG000|Overall Study|Protocol Violation|13
1067197|NCT01994226|2118189|FG001|Overall Study|Protocol Violation|10
1067198|NCT01994226|2118188|FG000|Overall Study|Early Cessation of treatment|6
1067199|NCT01994226|2118189|FG001|Overall Study|Early Cessation of treatment|11
1067200|NCT01994291|2118198|FG000|Overall Study|Adverse Event|4
1067201|NCT01994291|2118199|FG001|Overall Study|Adverse Event|1
1067202|NCT01994291|2118200|FG002|Overall Study|Adverse Event|3
1067203|NCT01994291|2118198|FG000|Overall Study|Lost to Follow-up|1
1067204|NCT01994291|2118199|FG001|Overall Study|Lost to Follow-up|1
1067205|NCT01994291|2118200|FG002|Overall Study|Lost to Follow-up|0
1067206|NCT01994291|2118198|FG000|Overall Study|Does not meet entrance criteria|1
1067207|NCT01994291|2118199|FG001|Overall Study|Does not meet entrance criteria|0
1067208|NCT01994291|2118200|FG002|Overall Study|Does not meet entrance criteria|0
1067209|NCT01994291|2118198|FG000|Overall Study|Medication error without associated AE|1
1067210|NCT01994291|2118199|FG001|Overall Study|Medication error without associated AE|0
1067211|NCT01994291|2118200|FG002|Overall Study|Medication error without associated AE|1
1067212|NCT01994291|2118198|FG000|Overall Study|Protocol Violation|1
1067213|NCT01994291|2118199|FG001|Overall Study|Protocol Violation|0
1067214|NCT01994291|2118200|FG002|Overall Study|Protocol Violation|0
1067215|NCT01994291|2118198|FG000|Overall Study|Withdrawal by Subject|6
1067216|NCT01994291|2118199|FG001|Overall Study|Withdrawal by Subject|3
1067217|NCT01994291|2118200|FG002|Overall Study|Withdrawal by Subject|5
1067218|NCT01994291|2118198|FG000|Overall Study|Other|1
1067219|NCT01994291|2118199|FG001|Overall Study|Other|2
1067220|NCT01994291|2118200|FG002|Overall Study|Other|0
1067221|NCT01994395|2118211|FG000|Overall Study|Withdrawal by Subject|1
1067222|NCT01994395|2118212|FG001|Overall Study|Withdrawal by Subject|2
1067223|NCT01994590|2118233|FG000|Overall Study|Adverse Event|1
1067224|NCT01994590|2118233|FG000|Overall Study|Trial Terminated|1
1067225|NCT01994629|2118239|FG000|Overall Study|Withdrawal by Subject|1
1067226|NCT01994629|2118240|FG001|Overall Study|Withdrawal by Subject|0
1067227|NCT01994629|2118239|FG000|Overall Study|Lost to Follow-up|0
1067228|NCT01994629|2118240|FG001|Overall Study|Lost to Follow-up|3
1067229|NCT01994720|2118248|FG000|Overall Study|Withdrawal by Subject|46
1067230|NCT01994720|2118249|FG001|Overall Study|Withdrawal by Subject|56
1067231|NCT01994837|2118279|FG000|Overall Study|Progressive disease per protocol|23
1067232|NCT01994837|2118279|FG000|Overall Study|Adv event related to progressive disease|3
1067233|NCT01994837|2118279|FG000|Overall Study|Fatal progressive disease|2
1067234|NCT01994837|2118279|FG000|Overall Study|Adverse event not related to progression|1
1067235|NCT01994837|2118279|FG000|Overall Study|Chose palliative care|1
1067236|NCT01994837|2118279|FG000|Overall Study|Proceeded to transplant|1
1067237|NCT01994837|2118279|FG000|Overall Study|Removed from study due to no response|1
1067238|NCT01994850|2118283|FG000|Overall Study|Physician Decision|1
1067239|NCT01994850|2118283|FG000|Overall Study|Withdrawal by Subject|1
1067240|NCT01994863|2118287|FG000|Period 1|Adverse Event|4
1067241|NCT01994863|2118288|FG001|Period 1|Adverse Event|0
1067242|NCT01994863|2118287|FG000|Period 1|Withdrawal by Subject|1
1067243|NCT01994863|2118288|FG001|Period 1|Withdrawal by Subject|0
1067244|NCT01994863|2118287|FG000|Period 1|Trial stopped by sponsor|1
1067245|NCT01994863|2118288|FG001|Period 1|Trial stopped by sponsor|3
1067246|NCT01994863|2118287|FG000|Period 1|Lack of Efficacy|1
1067247|NCT01994863|2118288|FG001|Period 1|Lack of Efficacy|0
1067248|NCT01994863|2118287|FG000|Period 2|Adverse Event|0
1067249|NCT01994863|2118288|FG001|Period 2|Adverse Event|1
1067250|NCT01994863|2118287|FG000|Period 2|Lack of Efficacy|0
1067251|NCT01994863|2118288|FG001|Period 2|Lack of Efficacy|2
1067252|NCT01994863|2118287|FG000|Period 2|Withdrawal by Subject|1
1067253|NCT01994863|2118288|FG001|Period 2|Withdrawal by Subject|1
1067254|NCT01994876|2118294|FG000|Test Period 1|Withdrawal by Subject|0
1067255|NCT01994876|2118295|FG001|Test Period 1|Withdrawal by Subject|1
1067256|NCT01994876|2118294|FG000|Test Period 1|Adverse Event|0
1067257|NCT01994876|2118295|FG001|Test Period 1|Adverse Event|1
1067258|NCT01994876|2118294|FG000|Test Period 2|Adverse Event|1
1067259|NCT01994876|2118295|FG001|Test Period 2|Adverse Event|0
1067260|NCT01994876|2118294|FG000|Test Period 2|Protocol Violation|0
1067261|NCT01994876|2118295|FG001|Test Period 2|Protocol Violation|1
1067262|NCT01994889|2118306|FG000|Overall Study|Adverse Event|5
1067263|NCT01994889|2118307|FG001|Overall Study|Adverse Event|12
1067264|NCT01994889|2118308|FG002|Overall Study|Adverse Event|11
1067265|NCT01994889|2118306|FG000|Overall Study|Cardiac Device Implantation|0
1067266|NCT01994889|2118307|FG001|Overall Study|Cardiac Device Implantation|2
1067267|NCT01994889|2118308|FG002|Overall Study|Cardiac Device Implantation|0
1067268|NCT01994889|2118306|FG000|Overall Study|Organ Transplantation|1
1067269|NCT01994889|2118307|FG001|Overall Study|Organ Transplantation|5
1067270|NCT01994889|2118308|FG002|Overall Study|Organ Transplantation|5
1067271|NCT01994889|2118306|FG000|Overall Study|No longer willing to participate|8
1067272|NCT01994889|2118307|FG001|Overall Study|No longer willing to participate|17
1067273|NCT01994889|2118308|FG002|Overall Study|No longer willing to participate|37
1067274|NCT01994889|2118306|FG000|Overall Study|Lost to Follow-up|0
1067275|NCT01994889|2118307|FG001|Overall Study|Lost to Follow-up|1
1067276|NCT01994889|2118308|FG002|Overall Study|Lost to Follow-up|0
1067277|NCT01994889|2118306|FG000|Overall Study|Protocol Violation|0
1067278|NCT01994889|2118307|FG001|Overall Study|Protocol Violation|1
1067279|NCT01994889|2118308|FG002|Overall Study|Protocol Violation|1
1067280|NCT01994889|2118306|FG000|Overall Study|Death|14
1067281|NCT01994889|2118307|FG001|Overall Study|Death|25
1067282|NCT01994889|2118308|FG002|Overall Study|Death|38
1067283|NCT01994902|2118315|FG000|Test Period 1|Withdrawal by Subject|3
1067284|NCT01994902|2118316|FG001|Test Period 1|Withdrawal by Subject|0
1067285|NCT01994902|2118315|FG000|Test Period 1|device deficiency with adverse event|0
1067286|NCT01994902|2118316|FG001|Test Period 1|device deficiency with adverse event|1
1067287|NCT01994902|2118315|FG000|Test Period 1|Adverse Event|2
1067288|NCT01994902|2118316|FG001|Test Period 1|Adverse Event|1
1067289|NCT01994902|2118315|FG000|Test Period 1|Lack of Efficacy|0
1067290|NCT01994902|2118316|FG001|Test Period 1|Lack of Efficacy|1
1067291|NCT01994902|2118315|FG000|Test Period 1|bag too small|1
1067292|NCT01994902|2118316|FG001|Test Period 1|bag too small|0
1067293|NCT01994902|2118315|FG000|Test Period 2|Withdrawal by Subject|0
1067294|NCT01994902|2118316|FG001|Test Period 2|Withdrawal by Subject|2
1067295|NCT01994902|2118315|FG000|Test Period 2|Lack of Efficacy|0
1067296|NCT01994902|2118316|FG001|Test Period 2|Lack of Efficacy|1
1067297|NCT01994902|2118315|FG000|Test Period 2|Other|0
1067298|NCT01994902|2118316|FG001|Test Period 2|Other|3
1067299|NCT01994954|2118324|FG000|Overall Study|Death|1
1067300|NCT01994954|2118325|FG001|Overall Study|Death|0
1067301|NCT01994954|2118324|FG000|Overall Study|Withdrawal by Subject|9
1067302|NCT01994954|2118325|FG001|Overall Study|Withdrawal by Subject|14
1067303|NCT01994954|2118324|FG000|Overall Study|Physician Decision|2
1067304|NCT01994954|2118325|FG001|Overall Study|Physician Decision|2
1067305|NCT01994954|2118324|FG000|Overall Study|Lost to Follow-up|8
1067306|NCT01994954|2118325|FG001|Overall Study|Lost to Follow-up|10
1067307|NCT01994954|2118324|FG000|Overall Study|6 Month Follow-up Not Complete|5
1067308|NCT01994954|2118325|FG001|Overall Study|6 Month Follow-up Not Complete|4
1067309|NCT01995071|2118379|FG000|Overall Study|Adverse Event|0
1067310|NCT01995071|2118380|FG001|Overall Study|Adverse Event|0
1067311|NCT01995071|2118381|FG002|Overall Study|Adverse Event|0
1067312|NCT01995071|2118382|FG003|Overall Study|Adverse Event|0
1067313|NCT01995071|2118383|FG004|Overall Study|Adverse Event|0
1067314|NCT01995071|2118384|FG005|Overall Study|Adverse Event|0
1067315|NCT01995071|2118385|FG006|Overall Study|Adverse Event|1
1067316|NCT01995071|2118386|FG007|Overall Study|Adverse Event|0
1067317|NCT01995071|2118387|FG008|Overall Study|Adverse Event|0
1067318|NCT01995071|2118388|FG009|Overall Study|Adverse Event|0
1067319|NCT01995071|2118389|FG010|Overall Study|Adverse Event|0
1067320|NCT01995071|2118390|FG011|Overall Study|Adverse Event|0
1067321|NCT01995071|2118379|FG000|Overall Study|Moved|0
1067322|NCT01995071|2118380|FG001|Overall Study|Moved|0
1067323|NCT01995071|2118381|FG002|Overall Study|Moved|1
1067324|NCT01995071|2118382|FG003|Overall Study|Moved|0
1067325|NCT01995071|2118383|FG004|Overall Study|Moved|1
1067326|NCT01995071|2118384|FG005|Overall Study|Moved|0
1067327|NCT01995071|2118385|FG006|Overall Study|Moved|0
1067328|NCT01995071|2118386|FG007|Overall Study|Moved|0
1067329|NCT01995071|2118387|FG008|Overall Study|Moved|0
1067330|NCT01995071|2118388|FG009|Overall Study|Moved|0
1067331|NCT01995071|2118389|FG010|Overall Study|Moved|1
1067332|NCT01995071|2118390|FG011|Overall Study|Moved|0
1067333|NCT01995071|2118379|FG000|Overall Study|Lost to Follow-up|1
1067334|NCT01995071|2118380|FG001|Overall Study|Lost to Follow-up|0
1067335|NCT01995071|2118381|FG002|Overall Study|Lost to Follow-up|0
1067336|NCT01995071|2118382|FG003|Overall Study|Lost to Follow-up|0
1067337|NCT01995071|2118383|FG004|Overall Study|Lost to Follow-up|0
1067338|NCT01995071|2118384|FG005|Overall Study|Lost to Follow-up|0
1067339|NCT01995071|2118385|FG006|Overall Study|Lost to Follow-up|0
1067340|NCT01995071|2118386|FG007|Overall Study|Lost to Follow-up|1
1067341|NCT01995071|2118387|FG008|Overall Study|Lost to Follow-up|1
1067342|NCT01995071|2118388|FG009|Overall Study|Lost to Follow-up|0
1067343|NCT01995071|2118389|FG010|Overall Study|Lost to Follow-up|0
1067344|NCT01995071|2118390|FG011|Overall Study|Lost to Follow-up|0
1067345|NCT01995071|2118379|FG000|Overall Study|Incarcerated|0
1067346|NCT01995071|2118380|FG001|Overall Study|Incarcerated|0
1067347|NCT01995071|2118381|FG002|Overall Study|Incarcerated|0
1067348|NCT01995071|2118382|FG003|Overall Study|Incarcerated|0
1067349|NCT01995071|2118383|FG004|Overall Study|Incarcerated|0
1067350|NCT01995071|2118384|FG005|Overall Study|Incarcerated|0
1067351|NCT01995071|2118385|FG006|Overall Study|Incarcerated|0
1067352|NCT01995071|2118386|FG007|Overall Study|Incarcerated|1
1067353|NCT01995071|2118387|FG008|Overall Study|Incarcerated|0
1067354|NCT01995071|2118388|FG009|Overall Study|Incarcerated|0
1067355|NCT01995071|2118389|FG010|Overall Study|Incarcerated|0
1067356|NCT01995071|2118390|FG011|Overall Study|Incarcerated|0
1067357|NCT01995136|2118431|FG000|Overall Study|Change in residence|1
1067362|NCT01995201|2118441|FG000|From Baseline Until Week 24|Adverse Event|4
1067363|NCT01995201|2118442|FG001|From Baseline Until Week 24|Adverse Event|15
1067364|NCT01995201|2118443|FG002|From Baseline Until Week 24|Adverse Event|0
1067365|NCT01995201|2118444|FG003|From Baseline Until Week 24|Adverse Event|0
1067366|NCT01995201|2118445|FG004|From Baseline Until Week 24|Adverse Event|0
1067367|NCT01995201|2118446|FG005|From Baseline Until Week 24|Adverse Event|0
1067368|NCT01995201|2118447|FG006|From Baseline Until Week 24|Adverse Event|0
1067369|NCT01995201|2118441|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1067370|NCT01995201|2118442|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
1067371|NCT01995201|2118443|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1067372|NCT01995201|2118444|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1067373|NCT01995201|2118445|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1067374|NCT01995201|2118446|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1067375|NCT01995201|2118447|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1067376|NCT01995201|2118441|FG000|From Baseline Until Week 24|Death|0
1067377|NCT01995201|2118442|FG001|From Baseline Until Week 24|Death|1
1067378|NCT01995201|2118443|FG002|From Baseline Until Week 24|Death|0
1067379|NCT01995201|2118444|FG003|From Baseline Until Week 24|Death|0
1067380|NCT01995201|2118445|FG004|From Baseline Until Week 24|Death|0
1067381|NCT01995201|2118446|FG005|From Baseline Until Week 24|Death|0
1067382|NCT01995201|2118447|FG006|From Baseline Until Week 24|Death|0
1067383|NCT01995201|2118441|FG000|From Baseline Until Week 24|Lack of Efficacy|2
1067384|NCT01995201|2118442|FG001|From Baseline Until Week 24|Lack of Efficacy|5
1067385|NCT01995201|2118443|FG002|From Baseline Until Week 24|Lack of Efficacy|0
1067386|NCT01995201|2118444|FG003|From Baseline Until Week 24|Lack of Efficacy|0
1067387|NCT01995201|2118445|FG004|From Baseline Until Week 24|Lack of Efficacy|0
1067388|NCT01995201|2118446|FG005|From Baseline Until Week 24|Lack of Efficacy|0
1067389|NCT01995201|2118447|FG006|From Baseline Until Week 24|Lack of Efficacy|0
1067390|NCT01995201|2118441|FG000|From Baseline Until Week 24|Lost to Follow-up|2
1067391|NCT01995201|2118442|FG001|From Baseline Until Week 24|Lost to Follow-up|3
1067392|NCT01995201|2118443|FG002|From Baseline Until Week 24|Lost to Follow-up|0
1067393|NCT01995201|2118444|FG003|From Baseline Until Week 24|Lost to Follow-up|0
1067394|NCT01995201|2118445|FG004|From Baseline Until Week 24|Lost to Follow-up|0
1067395|NCT01995201|2118446|FG005|From Baseline Until Week 24|Lost to Follow-up|0
1067396|NCT01995201|2118447|FG006|From Baseline Until Week 24|Lost to Follow-up|0
1067397|NCT01995201|2118441|FG000|From Baseline Until Week 24|Withdrawal by Subject|2
1067398|NCT01995201|2118442|FG001|From Baseline Until Week 24|Withdrawal by Subject|8
1067399|NCT01995201|2118443|FG002|From Baseline Until Week 24|Withdrawal by Subject|0
1067400|NCT01995201|2118444|FG003|From Baseline Until Week 24|Withdrawal by Subject|0
1067401|NCT01995201|2118445|FG004|From Baseline Until Week 24|Withdrawal by Subject|0
1067402|NCT01995201|2118446|FG005|From Baseline Until Week 24|Withdrawal by Subject|0
1067403|NCT01995201|2118447|FG006|From Baseline Until Week 24|Withdrawal by Subject|0
1067404|NCT01995201|2118441|FG000|From Baseline Until Week 24|Physician Decision|0
1067405|NCT01995201|2118442|FG001|From Baseline Until Week 24|Physician Decision|2
1067406|NCT01995201|2118443|FG002|From Baseline Until Week 24|Physician Decision|0
1067407|NCT01995201|2118444|FG003|From Baseline Until Week 24|Physician Decision|0
1067408|NCT01995201|2118445|FG004|From Baseline Until Week 24|Physician Decision|0
1067409|NCT01995201|2118446|FG005|From Baseline Until Week 24|Physician Decision|0
1067410|NCT01995201|2118447|FG006|From Baseline Until Week 24|Physician Decision|0
1067411|NCT01995201|2118441|FG000|From Baseline Until Week 24|Protocol Violation|0
1067412|NCT01995201|2118442|FG001|From Baseline Until Week 24|Protocol Violation|9
1067413|NCT01995201|2118443|FG002|From Baseline Until Week 24|Protocol Violation|0
1067414|NCT01995201|2118444|FG003|From Baseline Until Week 24|Protocol Violation|0
1067415|NCT01995201|2118445|FG004|From Baseline Until Week 24|Protocol Violation|0
1067416|NCT01995201|2118446|FG005|From Baseline Until Week 24|Protocol Violation|0
1067417|NCT01995201|2118447|FG006|From Baseline Until Week 24|Protocol Violation|0
1067418|NCT01995201|2118441|FG000|From Week 24 Until Week 48|Adverse Event|0
1067419|NCT01995201|2118442|FG001|From Week 24 Until Week 48|Adverse Event|0
1067420|NCT01995201|2118443|FG002|From Week 24 Until Week 48|Adverse Event|2
1067421|NCT01995201|2118444|FG003|From Week 24 Until Week 48|Adverse Event|1
1067422|NCT01995201|2118445|FG004|From Week 24 Until Week 48|Adverse Event|1
1067423|NCT01995201|2118446|FG005|From Week 24 Until Week 48|Adverse Event|3
1067424|NCT01995201|2118447|FG006|From Week 24 Until Week 48|Adverse Event|1
1067425|NCT01995201|2118441|FG000|From Week 24 Until Week 48|Death|0
1067426|NCT01995201|2118442|FG001|From Week 24 Until Week 48|Death|0
1067427|NCT01995201|2118443|FG002|From Week 24 Until Week 48|Death|0
1067428|NCT01995201|2118444|FG003|From Week 24 Until Week 48|Death|0
1067429|NCT01995201|2118445|FG004|From Week 24 Until Week 48|Death|0
1067430|NCT01995201|2118446|FG005|From Week 24 Until Week 48|Death|2
1067431|NCT01995201|2118447|FG006|From Week 24 Until Week 48|Death|0
1067432|NCT01995201|2118441|FG000|From Week 24 Until Week 48|Lack of Efficacy|0
1067433|NCT01995201|2118442|FG001|From Week 24 Until Week 48|Lack of Efficacy|0
1067434|NCT01995201|2118443|FG002|From Week 24 Until Week 48|Lack of Efficacy|1
1067435|NCT01995201|2118444|FG003|From Week 24 Until Week 48|Lack of Efficacy|0
1067436|NCT01995201|2118445|FG004|From Week 24 Until Week 48|Lack of Efficacy|0
1067437|NCT01995201|2118446|FG005|From Week 24 Until Week 48|Lack of Efficacy|2
1067438|NCT01995201|2118447|FG006|From Week 24 Until Week 48|Lack of Efficacy|1
1067439|NCT01995201|2118441|FG000|From Week 24 Until Week 48|Lost to Follow-up|0
1067440|NCT01995201|2118442|FG001|From Week 24 Until Week 48|Lost to Follow-up|0
1067441|NCT01995201|2118443|FG002|From Week 24 Until Week 48|Lost to Follow-up|0
1067442|NCT01995201|2118444|FG003|From Week 24 Until Week 48|Lost to Follow-up|0
1067443|NCT01995201|2118445|FG004|From Week 24 Until Week 48|Lost to Follow-up|1
1067444|NCT01995201|2118446|FG005|From Week 24 Until Week 48|Lost to Follow-up|1
1067445|NCT01995201|2118447|FG006|From Week 24 Until Week 48|Lost to Follow-up|0
1067446|NCT01995201|2118441|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0
1067447|NCT01995201|2118442|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0
1067448|NCT01995201|2118443|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1
1067449|NCT01995201|2118444|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0
1067450|NCT01995201|2118445|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1
1067451|NCT01995201|2118446|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0
1067452|NCT01995201|2118447|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0
1067453|NCT01995201|2118441|FG000|From Week 24 Until Week 48|Physician Decision|0
1067454|NCT01995201|2118442|FG001|From Week 24 Until Week 48|Physician Decision|0
1067455|NCT01995201|2118443|FG002|From Week 24 Until Week 48|Physician Decision|0
1067456|NCT01995201|2118444|FG003|From Week 24 Until Week 48|Physician Decision|0
1067457|NCT01995201|2118445|FG004|From Week 24 Until Week 48|Physician Decision|1
1067458|NCT01995201|2118446|FG005|From Week 24 Until Week 48|Physician Decision|0
1067459|NCT01995201|2118447|FG006|From Week 24 Until Week 48|Physician Decision|0
1067460|NCT01995201|2118441|FG000|From Week 24 Until Week 48|Protocol Violation|0
1067461|NCT01995201|2118442|FG001|From Week 24 Until Week 48|Protocol Violation|0
1067462|NCT01995201|2118443|FG002|From Week 24 Until Week 48|Protocol Violation|1
1067463|NCT01995201|2118444|FG003|From Week 24 Until Week 48|Protocol Violation|0
1067464|NCT01995201|2118445|FG004|From Week 24 Until Week 48|Protocol Violation|2
1067465|NCT01995201|2118446|FG005|From Week 24 Until Week 48|Protocol Violation|0
1067466|NCT01995201|2118447|FG006|From Week 24 Until Week 48|Protocol Violation|0
1067467|NCT01995266|2118468|FG000|Overall Study|Death|1
1067468|NCT01995266|2118468|FG000|Overall Study|Lack of Efficacy|6
1067469|NCT01995266|2118468|FG000|Overall Study|Adverse Event|2
1067470|NCT01995357|2118472|FG000|Period 5|Lack of Efficacy|1
1067471|NCT01995357|2118473|FG001|Period 5|Lack of Efficacy|0
1067472|NCT01995357|2118474|FG002|Period 5|Lack of Efficacy|0
1067473|NCT01995357|2118475|FG003|Period 5|Lack of Efficacy|0
1067474|NCT01995357|2118476|FG004|Period 5|Lack of Efficacy|0
1067475|NCT01995357|2118477|FG005|Period 5|Lack of Efficacy|0
1067476|NCT01995357|2118472|FG000|Period 5|Adverse Event|1
1067477|NCT01995357|2118473|FG001|Period 5|Adverse Event|0
1067478|NCT01995357|2118474|FG002|Period 5|Adverse Event|1
1067479|NCT01995357|2118475|FG003|Period 5|Adverse Event|0
1067480|NCT01995357|2118476|FG004|Period 5|Adverse Event|0
1067481|NCT01995357|2118477|FG005|Period 5|Adverse Event|0
1067482|NCT01995461|2118493|FG000|Overall Study|Death|1
1067483|NCT01995461|2118493|FG000|Overall Study|Lost to Follow-up|2
1067484|NCT01995461|2118493|FG000|Overall Study|Withdrawal by Subject|2
1067485|NCT01995513|2118506|FG000|Open Label Treatment Period|Other|9
1067486|NCT01995513|2118507|FG001|Open Label Treatment Period|Other|0
1067487|NCT01995513|2118508|FG002|Open Label Treatment Period|Other|0
1067488|NCT01995513|2118506|FG000|Open Label Treatment Period|Withdrawal by Subject|14
1067489|NCT01995513|2118507|FG001|Open Label Treatment Period|Withdrawal by Subject|0
1067490|NCT01995513|2118508|FG002|Open Label Treatment Period|Withdrawal by Subject|0
1067491|NCT01995513|2118506|FG000|Open Label Treatment Period|Protocol Violation|1
1067492|NCT01995513|2118507|FG001|Open Label Treatment Period|Protocol Violation|0
1067493|NCT01995513|2118508|FG002|Open Label Treatment Period|Protocol Violation|0
1067494|NCT01995513|2118506|FG000|Open Label Treatment Period|Disease Progression|64
1067495|NCT01995513|2118507|FG001|Open Label Treatment Period|Disease Progression|0
1067496|NCT01995513|2118508|FG002|Open Label Treatment Period|Disease Progression|0
1067497|NCT01995513|2118506|FG000|Open Label Treatment Period|No PSA response at week 13|43
1067498|NCT01995513|2118507|FG001|Open Label Treatment Period|No PSA response at week 13|0
1067499|NCT01995513|2118508|FG002|Open Label Treatment Period|No PSA response at week 13|0
1067500|NCT01995513|2118506|FG000|Open Label Treatment Period|Adverse Event|35
1067501|NCT01995513|2118507|FG001|Open Label Treatment Period|Adverse Event|0
1067502|NCT01995513|2118508|FG002|Open Label Treatment Period|Adverse Event|0
1067503|NCT01995513|2118506|FG000|Open Label Treatment Period|Death|8
1067504|NCT01995513|2118507|FG001|Open Label Treatment Period|Death|0
1067505|NCT01995513|2118508|FG002|Open Label Treatment Period|Death|0
1067506|NCT01995513|2118506|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
1067507|NCT01995513|2118507|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1067508|NCT01995513|2118508|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1067509|NCT01995513|2118506|FG000|Double Blind Treatment Period|Adverse Event|0
1067510|NCT01995513|2118507|FG001|Double Blind Treatment Period|Adverse Event|12
1067511|NCT01995513|2118508|FG002|Double Blind Treatment Period|Adverse Event|5
1067512|NCT01995513|2118506|FG000|Double Blind Treatment Period|Other|0
1067513|NCT01995513|2118507|FG001|Double Blind Treatment Period|Other|1
1067514|NCT01995513|2118508|FG002|Double Blind Treatment Period|Other|2
1067515|NCT01995513|2118506|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
1067516|NCT01995513|2118507|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
1067517|NCT01995513|2118508|FG002|Double Blind Treatment Period|Withdrawal by Subject|6
1067518|NCT01995513|2118506|FG000|Double Blind Treatment Period|Death|0
1067519|NCT01995513|2118507|FG001|Double Blind Treatment Period|Death|0
1067520|NCT01995513|2118508|FG002|Double Blind Treatment Period|Death|1
1067521|NCT01995513|2118506|FG000|Double Blind Treatment Period|Disease Progression|0
1067522|NCT01995513|2118507|FG001|Double Blind Treatment Period|Disease Progression|82
1067523|NCT01995513|2118508|FG002|Double Blind Treatment Period|Disease Progression|93
1067524|NCT01995513|2118506|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1067525|NCT01995513|2118507|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
1067526|NCT01995513|2118508|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
1067527|NCT01995526|2118518|FG000|Overall Study|Physician Decision|1
1067528|NCT01995539|2118522|FG000|Overall Study|Screening Failure|1
1067529|NCT01995539|2118522|FG000|Overall Study|Withdrawal by Investigator|15
1067530|NCT01995539|2118522|FG000|Overall Study|Withdrawal by Subject|11
1067531|NCT01995539|2118522|FG000|Overall Study|Lost to Follow-up|5
1067532|NCT01995539|2118522|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1
1067533|NCT01995552|2118526|FG000|Overall Study|Protocol Violation|1
1067534|NCT01995552|2118526|FG000|Overall Study|Lack of Efficacy|15
1067535|NCT01995552|2118526|FG000|Overall Study|Death|1
1067536|NCT01995825|2118534|FG000|Overall Study|Withdrawal by Subject|1
1067537|NCT01995825|2118535|FG001|Overall Study|Withdrawal by Subject|0
1067538|NCT01995838|2118548|FG000|Overall Study|Lost to Follow-up|0
1067539|NCT01995838|2118549|FG001|Overall Study|Lost to Follow-up|1
1067540|NCT01995838|2118550|FG002|Overall Study|Lost to Follow-up|0
1067541|NCT01995838|2118551|FG003|Overall Study|Lost to Follow-up|0
1067542|NCT01995838|2118552|FG004|Overall Study|Lost to Follow-up|0
1067543|NCT01995838|2118553|FG005|Overall Study|Lost to Follow-up|0
1067544|NCT01995838|2118554|FG006|Overall Study|Lost to Follow-up|1
1067545|NCT01995838|2118548|FG000|Overall Study|Participant choice|2
1067546|NCT01995838|2118549|FG001|Overall Study|Participant choice|0
1067547|NCT01995838|2118550|FG002|Overall Study|Participant choice|0
1067548|NCT01995838|2118551|FG003|Overall Study|Participant choice|0
1067549|NCT01995838|2118552|FG004|Overall Study|Participant choice|0
1067550|NCT01995838|2118553|FG005|Overall Study|Participant choice|1
1067551|NCT01995838|2118554|FG006|Overall Study|Participant choice|1
1067552|NCT01995838|2118548|FG000|Overall Study|Adverse Event|0
1067553|NCT01995838|2118549|FG001|Overall Study|Adverse Event|0
1067554|NCT01995838|2118550|FG002|Overall Study|Adverse Event|0
1067555|NCT01995838|2118551|FG003|Overall Study|Adverse Event|0
1067556|NCT01995838|2118552|FG004|Overall Study|Adverse Event|0
1067557|NCT01995838|2118553|FG005|Overall Study|Adverse Event|0
1067558|NCT01995838|2118554|FG006|Overall Study|Adverse Event|1
1067559|NCT01995838|2118548|FG000|Overall Study|Withdrawal by Subject|0
1067560|NCT01995838|2118549|FG001|Overall Study|Withdrawal by Subject|0
1067561|NCT01995838|2118550|FG002|Overall Study|Withdrawal by Subject|0
1067562|NCT01995838|2118551|FG003|Overall Study|Withdrawal by Subject|0
1067563|NCT01995838|2118552|FG004|Overall Study|Withdrawal by Subject|1
1067564|NCT01995838|2118553|FG005|Overall Study|Withdrawal by Subject|0
1067565|NCT01995838|2118554|FG006|Overall Study|Withdrawal by Subject|0
1067566|NCT01995838|2118548|FG000|Overall Study|Other|3
1067567|NCT01995838|2118549|FG001|Overall Study|Other|1
1067568|NCT01995838|2118550|FG002|Overall Study|Other|0
1067569|NCT01995838|2118551|FG003|Overall Study|Other|2
1067570|NCT01995838|2118552|FG004|Overall Study|Other|1
1067571|NCT01995838|2118553|FG005|Overall Study|Other|1
1067572|NCT01995838|2118554|FG006|Overall Study|Other|2
1067573|NCT01996033|2118571|FG000|Overall Study|Death|1
1067574|NCT01996033|2118571|FG000|Overall Study|Physician Decision|1
1067575|NCT01996033|2118571|FG000|Overall Study|Withdrawal by Subject|4
1067576|NCT01996033|2118571|FG000|Overall Study|Lost to Follow-up|3
1067577|NCT01996241|2118577|FG000|Overall Study|Lost to Follow-up|252
1067578|NCT01996241|2118578|FG001|Overall Study|Lost to Follow-up|235
1067579|NCT01996254|2118588|FG000|Overall Study|Change in Eligibility|0
1067580|NCT01996254|2118589|FG001|Overall Study|Change in Eligibility|2
1067581|NCT01996254|2118590|FG002|Overall Study|Change in Eligibility|0
1067582|NCT01996254|2118588|FG000|Overall Study|Withdrawal by Subject|0
1067583|NCT01996254|2118589|FG001|Overall Study|Withdrawal by Subject|3
1067584|NCT01996254|2118590|FG002|Overall Study|Withdrawal by Subject|4
1067585|NCT01996254|2118588|FG000|Overall Study|Lost to Follow-up|1
1067586|NCT01996254|2118589|FG001|Overall Study|Lost to Follow-up|0
1067587|NCT01996254|2118590|FG002|Overall Study|Lost to Follow-up|4
1067588|NCT01996319|2118602|FG000|Overall Study|Protocol Violation|1
1067589|NCT01996319|2118603|FG001|Overall Study|Protocol Violation|0
1067590|NCT01996319|2118602|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5
1067591|NCT01996319|2118603|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1
1067592|NCT01996319|2118602|FG000|Overall Study|Adverse Event|2
1067593|NCT01996319|2118603|FG001|Overall Study|Adverse Event|2
1067594|NCT01996332|2118609|FG000|Overall Study|Adverse Event|117
1067595|NCT01996332|2118609|FG000|Overall Study|Lack of Efficacy|1245
1067596|NCT01996332|2118609|FG000|Overall Study|Death|264
1067597|NCT01996332|2118609|FG000|Overall Study|Protocol Violation|9
1067598|NCT01996332|2118609|FG000|Overall Study|Withdrawal by Subject|71
1067599|NCT01996332|2118609|FG000|Overall Study|Other|20
1067600|NCT01996332|2118609|FG000|Overall Study|Clinical Deterioration|28
1067601|NCT01996332|2118609|FG000|Overall Study|Physician Decision|17
1067602|NCT01996332|2118609|FG000|Overall Study|Lost to Follow-up|34
1067603|NCT01996592|2118613|FG000|Overall Study|no response to text/no diary entry|32
1067604|NCT01996592|2118613|FG000|Overall Study|change in surgical date|4
1067605|NCT01996592|2118613|FG000|Overall Study|Withdrawal by Subject|5
1067606|NCT01996592|2118613|FG000|Overall Study|change in mode of delivery|4
1067607|NCT01996709|2118649|FG000|Overall Study|Withdrawal by Subject|1
1067608|NCT01996709|2118650|FG001|Overall Study|Withdrawal by Subject|0
1067609|NCT01996709|2118649|FG000|Overall Study|Lost to Follow-up|3
1067610|NCT01996709|2118650|FG001|Overall Study|Lost to Follow-up|0
1067611|NCT01996709|2118649|FG000|Overall Study|Subject Non-Compliant|1
1067612|NCT01996709|2118650|FG001|Overall Study|Subject Non-Compliant|0
1067613|NCT01996709|2118649|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
1067614|NCT01996709|2118650|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
1067615|NCT01996748|2118662|FG000|Overall Study|Personal reason|1
1067616|NCT01996748|2118663|FG001|Overall Study|Personal reason|0
1067617|NCT01996748|2118662|FG000|Overall Study|Physician Decision|2
1067618|NCT01996748|2118663|FG001|Overall Study|Physician Decision|0
1067619|NCT01996748|2118662|FG000|Overall Study|Adverse Event|1
1067620|NCT01996748|2118663|FG001|Overall Study|Adverse Event|4
1067621|NCT01996748|2118662|FG000|Overall Study|Withdrawal by Subject|0
1067622|NCT01996748|2118663|FG001|Overall Study|Withdrawal by Subject|1
1067623|NCT01996748|2118662|FG000|Overall Study|Lost to Follow-up|4
1067624|NCT01996748|2118663|FG001|Overall Study|Lost to Follow-up|1
1067625|NCT01996826|2118682|FG000|Overall Study|Lost to Follow-up|6
1067626|NCT01996826|2118683|FG001|Overall Study|Lost to Follow-up|2
1067627|NCT01996826|2118682|FG000|Overall Study|Physician Decision|1
1067628|NCT01996826|2118683|FG001|Overall Study|Physician Decision|1
1067629|NCT01996904|2118704|FG000|Overall Study|Lost to Follow-up|38
1067630|NCT01996904|2118705|FG001|Overall Study|Lost to Follow-up|27
1067631|NCT01997281|2118747|FG000|Overall Study|Withdrawal by Subject|1
1067632|NCT01997281|2118748|FG001|Overall Study|Withdrawal by Subject|0
1067633|NCT01997333|2118756|FG000|Randomization and Treatment|Disease Progression|70
1067634|NCT01997333|2118757|FG001|Randomization and Treatment|Disease Progression|159
1067635|NCT01997333|2118756|FG000|Randomization and Treatment|Adverse Event|10
1067636|NCT01997333|2118757|FG001|Randomization and Treatment|Adverse Event|32
1067637|NCT01997333|2118756|FG000|Randomization and Treatment|Physician Decision|0
1067638|NCT01997333|2118757|FG001|Randomization and Treatment|Physician Decision|4
1067639|NCT01997333|2118756|FG000|Randomization and Treatment|Withdrawal by Subject|6
1067640|NCT01997333|2118757|FG001|Randomization and Treatment|Withdrawal by Subject|3
1067641|NCT01997333|2118756|FG000|Randomization and Treatment|Did not receive treatment|17
1067642|NCT01997333|2118757|FG001|Randomization and Treatment|Did not receive treatment|5
1067643|NCT01997333|2118756|FG000|Survival Follow up|Withdrawal by Subject|15
1067644|NCT01997333|2118757|FG001|Survival Follow up|Withdrawal by Subject|6
1067645|NCT01997333|2118756|FG000|Survival Follow up|Lost to Follow-up|0
1067646|NCT01997333|2118757|FG001|Survival Follow up|Lost to Follow-up|6
1067647|NCT01997333|2118756|FG000|Survival Follow up|Various|1
1067648|NCT01997333|2118757|FG001|Survival Follow up|Various|2
1067649|NCT01997892|2118821|FG000|Overall Study|Physician Decision|2
1067650|NCT01997892|2118821|FG000|Overall Study|Lost to Follow-up|6
1067651|NCT01997892|2118821|FG000|Overall Study|Death|14
1067652|NCT01997892|2118821|FG000|Overall Study|Renal transplant|8
1067653|NCT01997892|2118821|FG000|Overall Study|Other|3
1067654|NCT01997892|2118821|FG000|Overall Study|Study completion data not recorded|35
1067655|NCT01998243|2118836|FG000|Overall Study|Pregnancy|0
1067656|NCT01998243|2118837|FG001|Overall Study|Pregnancy|1
1067657|NCT01998243|2118836|FG000|Overall Study|Protocol Violation|5
1067658|NCT01998243|2118837|FG001|Overall Study|Protocol Violation|2
1067659|NCT01998243|2118836|FG000|Overall Study|Withdrawal by Subject|3
1067660|NCT01998243|2118837|FG001|Overall Study|Withdrawal by Subject|4
1067661|NCT01998399|2118860|FG000|Overall Study|Lost to Follow-up|1
1067662|NCT01998399|2118861|FG001|Overall Study|Lost to Follow-up|3
1067663|NCT01998399|2118860|FG000|Overall Study|Death|4
1067664|NCT01998399|2118861|FG001|Overall Study|Death|2
1067665|NCT01998399|2118860|FG000|Overall Study|Study stopped before dosing completed|3
1067666|NCT01998399|2118861|FG001|Overall Study|Study stopped before dosing completed|3
1067667|NCT01998399|2118860|FG000|Overall Study|Withdrawal by Subject|0
1067668|NCT01998399|2118861|FG001|Overall Study|Withdrawal by Subject|1
1067669|NCT01998477|2118882|FG000|Overall Study|Lost to Follow-up|4
1067670|NCT01998477|2118883|FG001|Overall Study|Lost to Follow-up|5
1067671|NCT01998477|2118882|FG000|Overall Study|Withdrawal by Subject|6
1067672|NCT01998477|2118883|FG001|Overall Study|Withdrawal by Subject|0
1067673|NCT01998581|2118916|FG000|Overall Study|Refused repeat treatment|20
1067674|NCT01998581|2118917|FG001|Overall Study|Refused repeat treatment|4
1067675|NCT01998581|2118916|FG000|Overall Study|Protocol Violation|1
908222|NCT00781391|1884772|FG002|Overall Study|never received study drug|32
908223|NCT00781391|1884770|FG000|Overall Study|Protocol Violation|19
908224|NCT00781391|1884771|FG001|Overall Study|Protocol Violation|17
1067676|NCT01998581|2118917|FG001|Overall Study|Protocol Violation|0
1067677|NCT01998581|2118916|FG000|Overall Study|Withdrawal by Subject|8
1067678|NCT01998581|2118917|FG001|Overall Study|Withdrawal by Subject|1
1067679|NCT01998581|2118916|FG000|Overall Study|Lost to Follow-up|12
1067680|NCT01998581|2118917|FG001|Overall Study|Lost to Follow-up|4
1067681|NCT01998581|2118916|FG000|Overall Study|Adverse Event|1
1067682|NCT01998581|2118917|FG001|Overall Study|Adverse Event|1
1067683|NCT01998581|2118916|FG000|Overall Study|Other reasons|3
1067684|NCT01998581|2118917|FG001|Overall Study|Other reasons|2
1067685|NCT01998581|2118916|FG000|Overall Study|Randomized but withdrew before treatment|1
1067686|NCT01998581|2118917|FG001|Overall Study|Randomized but withdrew before treatment|0
1067687|NCT01998633|2118926|FG000|Overall Study|Death|1
1067688|NCT01998737|2118936|FG000|Overall Study|Corrupted database|23
1067689|NCT01998737|2118937|FG001|Overall Study|Corrupted database|0
1067690|NCT01998880|2118945|FG000|Overall Study|Adverse Events or Intercurrent Illness|16
1067691|NCT01998880|2118946|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
1067692|NCT01998880|2118945|FG000|Overall Study|Disease Progression|1
1067693|NCT01998880|2118946|FG001|Overall Study|Disease Progression|8
1067694|NCT01998880|2118945|FG000|Overall Study|Withdrew Consent|2
1067695|NCT01998880|2118946|FG001|Overall Study|Withdrew Consent|1
1067696|NCT01998880|2118945|FG000|Overall Study|Death|3
1067697|NCT01998880|2118946|FG001|Overall Study|Death|6
1067698|NCT01998880|2118945|FG000|Overall Study|Insufficient Therapeutic Response|1
1067699|NCT01998880|2118946|FG001|Overall Study|Insufficient Therapeutic Response|5
1067700|NCT01998880|2118945|FG000|Overall Study|Administrative/Other|1
1067701|NCT01998880|2118946|FG001|Overall Study|Administrative/Other|1
1067702|NCT01998880|2118945|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
1067703|NCT01998880|2118946|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
1067704|NCT01998880|2118945|FG000|Overall Study|Violation of Selection Criteria at Entry|0
1067705|NCT01998880|2118946|FG001|Overall Study|Violation of Selection Criteria at Entry|1
1067706|NCT01998880|2118945|FG000|Overall Study|Did Not Receive Treatment|3
1067707|NCT01998880|2118946|FG001|Overall Study|Did Not Receive Treatment|2
1067708|NCT01998893|2118952|FG000|Overall Study|Adverse Event|2
1067709|NCT01998893|2118952|FG000|Overall Study|Death|1
1067710|NCT01998893|2118952|FG000|Overall Study|Lost to Follow-up|8
1067711|NCT01998893|2118952|FG000|Overall Study|Physician Decision|2
1067712|NCT01998893|2118952|FG000|Overall Study|Protocol Violation|2
1067713|NCT01998893|2118952|FG000|Overall Study|Withdrawal by Subject|1
1067714|NCT01998893|2118952|FG000|Overall Study|Transformation to high-grade lymphoma|1
1067715|NCT01998906|2118959|FG000|Overall Study|Participants ongoing in follow-up|77
1067716|NCT01998906|2118960|FG001|Overall Study|Participants ongoing in follow-up|60
1067717|NCT01998906|2118961|FG002|Overall Study|Participants ongoing in follow-up|58
1067718|NCT01998906|2118959|FG000|Overall Study|Death|21
1067719|NCT01998906|2118960|FG001|Overall Study|Death|30
1067720|NCT01998906|2118961|FG002|Overall Study|Death|17
1067721|NCT01998906|2118959|FG000|Overall Study|Lack of Efficacy|10
1067722|NCT01998906|2118960|FG001|Overall Study|Lack of Efficacy|9
1067723|NCT01998906|2118961|FG002|Overall Study|Lack of Efficacy|8
1067724|NCT01998906|2118959|FG000|Overall Study|Failure to return|0
1067725|NCT01998906|2118960|FG001|Overall Study|Failure to return|2
1067726|NCT01998906|2118961|FG002|Overall Study|Failure to return|4
1067727|NCT01998906|2118959|FG000|Overall Study|Violation of Selection Criteria|0
1067728|NCT01998906|2118960|FG001|Overall Study|Violation of Selection Criteria|0
1067729|NCT01998906|2118961|FG002|Overall Study|Violation of Selection Criteria|1
1067730|NCT01998906|2118959|FG000|Overall Study|Withdrawal by Subject|1
1067731|NCT01998906|2118960|FG001|Overall Study|Withdrawal by Subject|4
1067732|NCT01998906|2118961|FG002|Overall Study|Withdrawal by Subject|3
1067733|NCT01998906|2118959|FG000|Overall Study|Administrative/Other|2
1067734|NCT01998906|2118960|FG001|Overall Study|Administrative/Other|1
1067735|NCT01998906|2118961|FG002|Overall Study|Administrative/Other|3
1067736|NCT01998906|2118959|FG000|Overall Study|Other|3
1067737|NCT01998906|2118960|FG001|Overall Study|Other|8
1067738|NCT01998906|2118961|FG002|Overall Study|Other|4
1067739|NCT01998919|2118974|FG000|Overall Study|Death|2
1067740|NCT01998919|2118975|FG001|Overall Study|Death|2
1067741|NCT01998919|2118974|FG000|Overall Study|Adverse Event|0
1067742|NCT01998919|2118975|FG001|Overall Study|Adverse Event|5
1067743|NCT01998919|2118974|FG000|Overall Study|Disease progression|31
1067744|NCT01998919|2118975|FG001|Overall Study|Disease progression|22
1067745|NCT01998919|2118974|FG000|Overall Study|Withdrawal by Subject|2
1067746|NCT01998919|2118975|FG001|Overall Study|Withdrawal by Subject|4
1067747|NCT01998919|2118974|FG000|Overall Study|Lost to Follow-up|2
1067748|NCT01998919|2118975|FG001|Overall Study|Lost to Follow-up|0
1067749|NCT01998919|2118974|FG000|Overall Study|Other|5
1067750|NCT01998919|2118975|FG001|Overall Study|Other|2
1067751|NCT01998958|2118988|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067752|NCT01998958|2118989|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1
1067753|NCT01998958|2118990|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067754|NCT01998958|2118991|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067755|NCT01998958|2118992|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067756|NCT01998958|2118993|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067757|NCT01998958|2118994|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067758|NCT01998958|2118995|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067759|NCT01998958|2118996|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067760|NCT01998958|2118997|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067761|NCT01998958|2118998|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067762|NCT01998958|2118999|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067763|NCT01998958|2119000|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067764|NCT01998958|2119001|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067765|NCT01998958|2119002|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067766|NCT01998958|2119003|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067767|NCT01998958|2119004|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067768|NCT01998958|2119005|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067769|NCT01998958|2119006|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067770|NCT01998958|2119007|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067771|NCT01998958|2119008|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067772|NCT01998958|2119009|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067773|NCT01998958|2119010|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067774|NCT01998958|2119011|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067775|NCT01998958|2119012|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067776|NCT01998958|2119013|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067777|NCT01998958|2119014|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067778|NCT01998958|2119015|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067779|NCT01998958|2119016|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067780|NCT01998958|2119017|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067781|NCT01998958|2119018|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067782|NCT01998958|2119019|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0
1067783|NCT01998958|2118988|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0
1067784|NCT01998958|2118989|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1
1067785|NCT01998958|2118990|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0
1067786|NCT01998958|2118991|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0
1067787|NCT01998958|2118992|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0
1067788|NCT01998958|2118993|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0
1067789|NCT01998958|2118994|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0
1067790|NCT01998958|2118995|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0
1067791|NCT01998958|2118996|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0
1067792|NCT01998958|2118997|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0
1067793|NCT01998958|2118998|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0
1067794|NCT01998958|2118999|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0
1067795|NCT01998958|2119000|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0
1067796|NCT01998958|2119001|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0
1067797|NCT01998958|2119002|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0
1067798|NCT01998958|2119003|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0
1067799|NCT01998958|2119004|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0
1067800|NCT01998958|2119005|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0
1067801|NCT01998958|2119006|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0
1067802|NCT01998958|2119007|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0
1067803|NCT01998958|2119008|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0
1067804|NCT01998958|2119009|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0
1067805|NCT01998958|2119010|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0
1067806|NCT01998958|2119011|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0
1067807|NCT01998958|2119012|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0
1067808|NCT01998958|2119013|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0
1067809|NCT01998958|2119014|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0
1067810|NCT01998958|2119015|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0
1067811|NCT01998958|2119016|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0
1067812|NCT01998958|2119017|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0
1067813|NCT01998958|2119018|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0
1067814|NCT01998958|2119019|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0
1067815|NCT01998958|2118988|FG000|Period 1 (Panel A and B)|Adverse Event|0
1067816|NCT01998958|2118989|FG001|Period 1 (Panel A and B)|Adverse Event|1
1067817|NCT01998958|2118990|FG002|Period 1 (Panel A and B)|Adverse Event|0
1067818|NCT01998958|2118991|FG003|Period 1 (Panel A and B)|Adverse Event|0
1067819|NCT01998958|2118992|FG004|Period 1 (Panel A and B)|Adverse Event|0
1067820|NCT01998958|2118993|FG005|Period 1 (Panel A and B)|Adverse Event|0
1067821|NCT01998958|2118994|FG006|Period 1 (Panel A and B)|Adverse Event|0
1067822|NCT01998958|2118995|FG007|Period 1 (Panel A and B)|Adverse Event|0
1067823|NCT01998958|2118996|FG008|Period 1 (Panel A and B)|Adverse Event|0
1067824|NCT01998958|2118997|FG009|Period 1 (Panel A and B)|Adverse Event|0
1067825|NCT01998958|2118998|FG010|Period 1 (Panel A and B)|Adverse Event|0
1067826|NCT01998958|2118999|FG011|Period 1 (Panel A and B)|Adverse Event|0
1067827|NCT01998958|2119000|FG012|Period 1 (Panel A and B)|Adverse Event|0
1067828|NCT01998958|2119001|FG013|Period 1 (Panel A and B)|Adverse Event|0
1067829|NCT01998958|2119002|FG014|Period 1 (Panel A and B)|Adverse Event|0
1067830|NCT01998958|2119003|FG015|Period 1 (Panel A and B)|Adverse Event|0
1067831|NCT01998958|2119004|FG016|Period 1 (Panel A and B)|Adverse Event|0
1067832|NCT01998958|2119005|FG017|Period 1 (Panel A and B)|Adverse Event|0
1067833|NCT01998958|2119006|FG018|Period 1 (Panel A and B)|Adverse Event|0
1067834|NCT01998958|2119007|FG019|Period 1 (Panel A and B)|Adverse Event|0
1067835|NCT01998958|2119008|FG020|Period 1 (Panel A and B)|Adverse Event|0
1067836|NCT01998958|2119009|FG021|Period 1 (Panel A and B)|Adverse Event|0
1067837|NCT01998958|2119010|FG022|Period 1 (Panel A and B)|Adverse Event|0
1067838|NCT01998958|2119011|FG023|Period 1 (Panel A and B)|Adverse Event|0
1067839|NCT01998958|2119012|FG024|Period 1 (Panel A and B)|Adverse Event|0
1067840|NCT01998958|2119013|FG025|Period 1 (Panel A and B)|Adverse Event|0
1067841|NCT01998958|2119014|FG026|Period 1 (Panel A and B)|Adverse Event|0
1067842|NCT01998958|2119015|FG027|Period 1 (Panel A and B)|Adverse Event|0
1067843|NCT01998958|2119016|FG028|Period 1 (Panel A and B)|Adverse Event|0
1067844|NCT01998958|2119017|FG029|Period 1 (Panel A and B)|Adverse Event|0
1067845|NCT01998958|2119018|FG030|Period 1 (Panel A and B)|Adverse Event|0
1067846|NCT01998958|2119019|FG031|Period 1 (Panel A and B)|Adverse Event|0
1067847|NCT01998958|2118988|FG000|Period 1 (Panel A and B)|Other|1
1067848|NCT01998958|2118989|FG001|Period 1 (Panel A and B)|Other|0
1067849|NCT01998958|2118990|FG002|Period 1 (Panel A and B)|Other|0
1067850|NCT01998958|2118991|FG003|Period 1 (Panel A and B)|Other|0
1067851|NCT01998958|2118992|FG004|Period 1 (Panel A and B)|Other|0
1067852|NCT01998958|2118993|FG005|Period 1 (Panel A and B)|Other|0
1067853|NCT01998958|2118994|FG006|Period 1 (Panel A and B)|Other|0
1067854|NCT01998958|2118995|FG007|Period 1 (Panel A and B)|Other|0
1067855|NCT01998958|2118996|FG008|Period 1 (Panel A and B)|Other|0
1067856|NCT01998958|2118997|FG009|Period 1 (Panel A and B)|Other|0
1067857|NCT01998958|2118998|FG010|Period 1 (Panel A and B)|Other|0
1067858|NCT01998958|2118999|FG011|Period 1 (Panel A and B)|Other|0
1067859|NCT01998958|2119000|FG012|Period 1 (Panel A and B)|Other|0
1067860|NCT01998958|2119001|FG013|Period 1 (Panel A and B)|Other|0
1067861|NCT01998958|2119002|FG014|Period 1 (Panel A and B)|Other|0
1067862|NCT01998958|2119003|FG015|Period 1 (Panel A and B)|Other|0
1067863|NCT01998958|2119004|FG016|Period 1 (Panel A and B)|Other|0
1067864|NCT01998958|2119005|FG017|Period 1 (Panel A and B)|Other|0
1067865|NCT01998958|2119006|FG018|Period 1 (Panel A and B)|Other|0
1067866|NCT01998958|2119007|FG019|Period 1 (Panel A and B)|Other|0
1067867|NCT01998958|2119008|FG020|Period 1 (Panel A and B)|Other|0
1067868|NCT01998958|2119009|FG021|Period 1 (Panel A and B)|Other|0
1067869|NCT01998958|2119010|FG022|Period 1 (Panel A and B)|Other|0
1067870|NCT01998958|2119011|FG023|Period 1 (Panel A and B)|Other|0
1067871|NCT01998958|2119012|FG024|Period 1 (Panel A and B)|Other|0
1067872|NCT01998958|2119013|FG025|Period 1 (Panel A and B)|Other|0
1067873|NCT01998958|2119014|FG026|Period 1 (Panel A and B)|Other|0
1067874|NCT01998958|2119015|FG027|Period 1 (Panel A and B)|Other|0
1067875|NCT01998958|2119016|FG028|Period 1 (Panel A and B)|Other|0
1067876|NCT01998958|2119017|FG029|Period 1 (Panel A and B)|Other|0
1067877|NCT01998958|2119018|FG030|Period 1 (Panel A and B)|Other|0
1067878|NCT01998958|2119019|FG031|Period 1 (Panel A and B)|Other|0
1067879|NCT01998958|2118988|FG000|Period 2 (Panel A and B)|Adverse Event|0
1067880|NCT01998958|2118989|FG001|Period 2 (Panel A and B)|Adverse Event|0
1067881|NCT01998958|2118990|FG002|Period 2 (Panel A and B)|Adverse Event|0
1067882|NCT01998958|2118991|FG003|Period 2 (Panel A and B)|Adverse Event|0
1067883|NCT01998958|2118992|FG004|Period 2 (Panel A and B)|Adverse Event|0
1067884|NCT01998958|2118993|FG005|Period 2 (Panel A and B)|Adverse Event|0
1067885|NCT01998958|2118994|FG006|Period 2 (Panel A and B)|Adverse Event|0
1067886|NCT01998958|2118995|FG007|Period 2 (Panel A and B)|Adverse Event|0
1067887|NCT01998958|2118996|FG008|Period 2 (Panel A and B)|Adverse Event|0
1067888|NCT01998958|2118997|FG009|Period 2 (Panel A and B)|Adverse Event|0
1067889|NCT01998958|2118998|FG010|Period 2 (Panel A and B)|Adverse Event|1
1067890|NCT01998958|2118999|FG011|Period 2 (Panel A and B)|Adverse Event|0
1067891|NCT01998958|2119000|FG012|Period 2 (Panel A and B)|Adverse Event|0
1067892|NCT01998958|2119001|FG013|Period 2 (Panel A and B)|Adverse Event|0
1067893|NCT01998958|2119002|FG014|Period 2 (Panel A and B)|Adverse Event|1
1067894|NCT01998958|2119003|FG015|Period 2 (Panel A and B)|Adverse Event|0
1067895|NCT01998958|2119004|FG016|Period 2 (Panel A and B)|Adverse Event|0
1067896|NCT01998958|2119005|FG017|Period 2 (Panel A and B)|Adverse Event|0
1067897|NCT01998958|2119006|FG018|Period 2 (Panel A and B)|Adverse Event|0
1067898|NCT01998958|2119007|FG019|Period 2 (Panel A and B)|Adverse Event|0
1067899|NCT01998958|2119008|FG020|Period 2 (Panel A and B)|Adverse Event|0
1067900|NCT01998958|2119009|FG021|Period 2 (Panel A and B)|Adverse Event|0
1067901|NCT01998958|2119010|FG022|Period 2 (Panel A and B)|Adverse Event|0
1067902|NCT01998958|2119011|FG023|Period 2 (Panel A and B)|Adverse Event|0
1067903|NCT01998958|2119012|FG024|Period 2 (Panel A and B)|Adverse Event|0
1067904|NCT01998958|2119013|FG025|Period 2 (Panel A and B)|Adverse Event|0
1067905|NCT01998958|2119014|FG026|Period 2 (Panel A and B)|Adverse Event|0
1067906|NCT01998958|2119015|FG027|Period 2 (Panel A and B)|Adverse Event|0
1067907|NCT01998958|2119016|FG028|Period 2 (Panel A and B)|Adverse Event|0
1067908|NCT01998958|2119017|FG029|Period 2 (Panel A and B)|Adverse Event|0
1067909|NCT01998958|2119018|FG030|Period 2 (Panel A and B)|Adverse Event|0
1067910|NCT01998958|2119019|FG031|Period 2 (Panel A and B)|Adverse Event|0
1067911|NCT01998958|2118988|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067912|NCT01998958|2118989|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067913|NCT01998958|2118990|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067914|NCT01998958|2118991|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067915|NCT01998958|2118992|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067916|NCT01998958|2118993|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067917|NCT01998958|2118994|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067918|NCT01998958|2118995|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067919|NCT01998958|2118996|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067920|NCT01998958|2118997|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067921|NCT01998958|2118998|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067922|NCT01998958|2118999|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067923|NCT01998958|2119000|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067924|NCT01998958|2119001|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067925|NCT01998958|2119002|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1
1067926|NCT01998958|2119003|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067927|NCT01998958|2119004|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067928|NCT01998958|2119005|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067929|NCT01998958|2119006|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1
1067930|NCT01998958|2119007|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067931|NCT01998958|2119008|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067932|NCT01998958|2119009|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067933|NCT01998958|2119010|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067934|NCT01998958|2119011|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067935|NCT01998958|2119012|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067936|NCT01998958|2119013|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067937|NCT01998958|2119014|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067938|NCT01998958|2119015|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067939|NCT01998958|2119016|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067940|NCT01998958|2119017|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067941|NCT01998958|2119018|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067942|NCT01998958|2119019|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0
1067943|NCT01998958|2118988|FG000|Open Label Phase (Optional)|Adverse Event|0
1067944|NCT01998958|2118989|FG001|Open Label Phase (Optional)|Adverse Event|0
1067945|NCT01998958|2118990|FG002|Open Label Phase (Optional)|Adverse Event|0
1067946|NCT01998958|2118991|FG003|Open Label Phase (Optional)|Adverse Event|0
1067947|NCT01998958|2118992|FG004|Open Label Phase (Optional)|Adverse Event|0
1067948|NCT01998958|2118993|FG005|Open Label Phase (Optional)|Adverse Event|0
1067949|NCT01998958|2118994|FG006|Open Label Phase (Optional)|Adverse Event|0
1067950|NCT01998958|2118995|FG007|Open Label Phase (Optional)|Adverse Event|0
1067951|NCT01998958|2118996|FG008|Open Label Phase (Optional)|Adverse Event|0
1067952|NCT01998958|2118997|FG009|Open Label Phase (Optional)|Adverse Event|0
1067953|NCT01998958|2118998|FG010|Open Label Phase (Optional)|Adverse Event|0
1067954|NCT01998958|2118999|FG011|Open Label Phase (Optional)|Adverse Event|0
1067955|NCT01998958|2119000|FG012|Open Label Phase (Optional)|Adverse Event|0
1067956|NCT01998958|2119001|FG013|Open Label Phase (Optional)|Adverse Event|0
1067957|NCT01998958|2119002|FG014|Open Label Phase (Optional)|Adverse Event|0
1067958|NCT01998958|2119003|FG015|Open Label Phase (Optional)|Adverse Event|0
1067959|NCT01998958|2119004|FG016|Open Label Phase (Optional)|Adverse Event|0
1067960|NCT01998958|2119005|FG017|Open Label Phase (Optional)|Adverse Event|0
1067961|NCT01998958|2119006|FG018|Open Label Phase (Optional)|Adverse Event|0
1067962|NCT01998958|2119007|FG019|Open Label Phase (Optional)|Adverse Event|0
1067963|NCT01998958|2119008|FG020|Open Label Phase (Optional)|Adverse Event|0
1067964|NCT01998958|2119009|FG021|Open Label Phase (Optional)|Adverse Event|0
1067965|NCT01998958|2119010|FG022|Open Label Phase (Optional)|Adverse Event|0
1067966|NCT01998958|2119011|FG023|Open Label Phase (Optional)|Adverse Event|1
1067967|NCT01998958|2119012|FG024|Open Label Phase (Optional)|Adverse Event|0
1067968|NCT01998958|2119013|FG025|Open Label Phase (Optional)|Adverse Event|0
1067969|NCT01998958|2119014|FG026|Open Label Phase (Optional)|Adverse Event|0
1067970|NCT01998958|2119015|FG027|Open Label Phase (Optional)|Adverse Event|0
1067971|NCT01998958|2119016|FG028|Open Label Phase (Optional)|Adverse Event|0
1067972|NCT01998958|2119017|FG029|Open Label Phase (Optional)|Adverse Event|0
1067973|NCT01998958|2119018|FG030|Open Label Phase (Optional)|Adverse Event|0
1067974|NCT01998958|2119019|FG031|Open Label Phase (Optional)|Adverse Event|0
1067975|NCT01998958|2118988|FG000|Open Label Phase (Optional)|Other|0
1067976|NCT01998958|2118989|FG001|Open Label Phase (Optional)|Other|0
1067977|NCT01998958|2118990|FG002|Open Label Phase (Optional)|Other|0
1067978|NCT01998958|2118991|FG003|Open Label Phase (Optional)|Other|0
1067979|NCT01998958|2118992|FG004|Open Label Phase (Optional)|Other|0
1067980|NCT01998958|2118993|FG005|Open Label Phase (Optional)|Other|0
1067981|NCT01998958|2118994|FG006|Open Label Phase (Optional)|Other|0
1067982|NCT01998958|2118995|FG007|Open Label Phase (Optional)|Other|0
1067983|NCT01998958|2118996|FG008|Open Label Phase (Optional)|Other|0
1067984|NCT01998958|2118997|FG009|Open Label Phase (Optional)|Other|0
1067985|NCT01998958|2118998|FG010|Open Label Phase (Optional)|Other|0
1067986|NCT01998958|2118999|FG011|Open Label Phase (Optional)|Other|0
1067987|NCT01998958|2119000|FG012|Open Label Phase (Optional)|Other|0
1067988|NCT01998958|2119001|FG013|Open Label Phase (Optional)|Other|0
1067989|NCT01998958|2119002|FG014|Open Label Phase (Optional)|Other|0
1067990|NCT01998958|2119003|FG015|Open Label Phase (Optional)|Other|0
1067991|NCT01998958|2119004|FG016|Open Label Phase (Optional)|Other|0
1067992|NCT01998958|2119005|FG017|Open Label Phase (Optional)|Other|0
1067993|NCT01998958|2119006|FG018|Open Label Phase (Optional)|Other|0
1067994|NCT01998958|2119007|FG019|Open Label Phase (Optional)|Other|0
1067995|NCT01998958|2119008|FG020|Open Label Phase (Optional)|Other|0
1067996|NCT01998958|2119009|FG021|Open Label Phase (Optional)|Other|0
1067997|NCT01998958|2119010|FG022|Open Label Phase (Optional)|Other|5
1067998|NCT01998958|2119011|FG023|Open Label Phase (Optional)|Other|1
1067999|NCT01998958|2119012|FG024|Open Label Phase (Optional)|Other|0
1068000|NCT01998958|2119013|FG025|Open Label Phase (Optional)|Other|0
1068001|NCT01998958|2119014|FG026|Open Label Phase (Optional)|Other|0
1068002|NCT01998958|2119015|FG027|Open Label Phase (Optional)|Other|0
1068003|NCT01998958|2119016|FG028|Open Label Phase (Optional)|Other|0
1068004|NCT01998958|2119017|FG029|Open Label Phase (Optional)|Other|0
1068005|NCT01998958|2119018|FG030|Open Label Phase (Optional)|Other|0
1068006|NCT01998958|2119019|FG031|Open Label Phase (Optional)|Other|0
1068007|NCT01998958|2118988|FG000|Open Label Phase (Optional)|Lost to Follow-up|0
1068008|NCT01998958|2118989|FG001|Open Label Phase (Optional)|Lost to Follow-up|0
1068009|NCT01998958|2118990|FG002|Open Label Phase (Optional)|Lost to Follow-up|0
1068010|NCT01998958|2118991|FG003|Open Label Phase (Optional)|Lost to Follow-up|0
1068011|NCT01998958|2118992|FG004|Open Label Phase (Optional)|Lost to Follow-up|0
1068012|NCT01998958|2118993|FG005|Open Label Phase (Optional)|Lost to Follow-up|0
1068013|NCT01998958|2118994|FG006|Open Label Phase (Optional)|Lost to Follow-up|0
1068014|NCT01998958|2118995|FG007|Open Label Phase (Optional)|Lost to Follow-up|0
1068015|NCT01998958|2118996|FG008|Open Label Phase (Optional)|Lost to Follow-up|0
1068016|NCT01998958|2118997|FG009|Open Label Phase (Optional)|Lost to Follow-up|0
1068017|NCT01998958|2118998|FG010|Open Label Phase (Optional)|Lost to Follow-up|0
1068018|NCT01998958|2118999|FG011|Open Label Phase (Optional)|Lost to Follow-up|0
1068019|NCT01998958|2119000|FG012|Open Label Phase (Optional)|Lost to Follow-up|0
1068020|NCT01998958|2119001|FG013|Open Label Phase (Optional)|Lost to Follow-up|0
1068021|NCT01998958|2119002|FG014|Open Label Phase (Optional)|Lost to Follow-up|0
1068022|NCT01998958|2119003|FG015|Open Label Phase (Optional)|Lost to Follow-up|0
1068023|NCT01998958|2119004|FG016|Open Label Phase (Optional)|Lost to Follow-up|0
1068024|NCT01998958|2119005|FG017|Open Label Phase (Optional)|Lost to Follow-up|0
1068025|NCT01998958|2119006|FG018|Open Label Phase (Optional)|Lost to Follow-up|0
1068026|NCT01998958|2119007|FG019|Open Label Phase (Optional)|Lost to Follow-up|0
1068027|NCT01998958|2119008|FG020|Open Label Phase (Optional)|Lost to Follow-up|0
1068028|NCT01998958|2119009|FG021|Open Label Phase (Optional)|Lost to Follow-up|0
908225|NCT00781391|1884772|FG002|Overall Study|Protocol Violation|20
908226|NCT00781391|1884770|FG000|Overall Study|Death|789
908227|NCT00781391|1884771|FG001|Overall Study|Death|730
908228|NCT00781391|1884772|FG002|Overall Study|Death|706
908229|NCT00781391|1884770|FG000|Overall Study|Withdrawal by Subject|47
1068029|NCT01998958|2119010|FG022|Open Label Phase (Optional)|Lost to Follow-up|1
1068030|NCT01998958|2119011|FG023|Open Label Phase (Optional)|Lost to Follow-up|0
1068031|NCT01998958|2119012|FG024|Open Label Phase (Optional)|Lost to Follow-up|0
1068032|NCT01998958|2119013|FG025|Open Label Phase (Optional)|Lost to Follow-up|0
1068033|NCT01998958|2119014|FG026|Open Label Phase (Optional)|Lost to Follow-up|0
1068034|NCT01998958|2119015|FG027|Open Label Phase (Optional)|Lost to Follow-up|0
1068035|NCT01998958|2119016|FG028|Open Label Phase (Optional)|Lost to Follow-up|0
1068036|NCT01998958|2119017|FG029|Open Label Phase (Optional)|Lost to Follow-up|0
1068037|NCT01998958|2119018|FG030|Open Label Phase (Optional)|Lost to Follow-up|0
1068038|NCT01998958|2119019|FG031|Open Label Phase (Optional)|Lost to Follow-up|0
1068039|NCT01998958|2118988|FG000|Open Label Phase (Optional)|Lack of Efficacy|0
1068040|NCT01998958|2118989|FG001|Open Label Phase (Optional)|Lack of Efficacy|0
1068041|NCT01998958|2118990|FG002|Open Label Phase (Optional)|Lack of Efficacy|0
1068042|NCT01998958|2118991|FG003|Open Label Phase (Optional)|Lack of Efficacy|0
1068043|NCT01998958|2118992|FG004|Open Label Phase (Optional)|Lack of Efficacy|0
1068044|NCT01998958|2118993|FG005|Open Label Phase (Optional)|Lack of Efficacy|0
1068045|NCT01998958|2118994|FG006|Open Label Phase (Optional)|Lack of Efficacy|0
1068046|NCT01998958|2118995|FG007|Open Label Phase (Optional)|Lack of Efficacy|0
1068047|NCT01998958|2118996|FG008|Open Label Phase (Optional)|Lack of Efficacy|0
1068048|NCT01998958|2118997|FG009|Open Label Phase (Optional)|Lack of Efficacy|0
1068049|NCT01998958|2118998|FG010|Open Label Phase (Optional)|Lack of Efficacy|0
1068050|NCT01998958|2118999|FG011|Open Label Phase (Optional)|Lack of Efficacy|0
1068051|NCT01998958|2119000|FG012|Open Label Phase (Optional)|Lack of Efficacy|0
1068052|NCT01998958|2119001|FG013|Open Label Phase (Optional)|Lack of Efficacy|0
1068053|NCT01998958|2119002|FG014|Open Label Phase (Optional)|Lack of Efficacy|0
1068054|NCT01998958|2119003|FG015|Open Label Phase (Optional)|Lack of Efficacy|0
1068055|NCT01998958|2119004|FG016|Open Label Phase (Optional)|Lack of Efficacy|0
1068056|NCT01998958|2119005|FG017|Open Label Phase (Optional)|Lack of Efficacy|0
1068057|NCT01998958|2119006|FG018|Open Label Phase (Optional)|Lack of Efficacy|0
1068058|NCT01998958|2119007|FG019|Open Label Phase (Optional)|Lack of Efficacy|0
1068059|NCT01998958|2119008|FG020|Open Label Phase (Optional)|Lack of Efficacy|0
1068060|NCT01998958|2119009|FG021|Open Label Phase (Optional)|Lack of Efficacy|1
1068061|NCT01998958|2119010|FG022|Open Label Phase (Optional)|Lack of Efficacy|2
1068062|NCT01998958|2119011|FG023|Open Label Phase (Optional)|Lack of Efficacy|0
1068063|NCT01998958|2119012|FG024|Open Label Phase (Optional)|Lack of Efficacy|0
1068064|NCT01998958|2119013|FG025|Open Label Phase (Optional)|Lack of Efficacy|0
1068065|NCT01998958|2119014|FG026|Open Label Phase (Optional)|Lack of Efficacy|0
1068066|NCT01998958|2119015|FG027|Open Label Phase (Optional)|Lack of Efficacy|0
1068067|NCT01998958|2119016|FG028|Open Label Phase (Optional)|Lack of Efficacy|0
1068068|NCT01998958|2119017|FG029|Open Label Phase (Optional)|Lack of Efficacy|0
1068069|NCT01998958|2119018|FG030|Open Label Phase (Optional)|Lack of Efficacy|0
1068070|NCT01998958|2119019|FG031|Open Label Phase (Optional)|Lack of Efficacy|0
1068071|NCT01998958|2118988|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0
1068072|NCT01998958|2118989|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0
1068073|NCT01998958|2118990|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0
1068074|NCT01998958|2118991|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0
1068075|NCT01998958|2118992|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0
1068076|NCT01998958|2118993|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0
1068077|NCT01998958|2118994|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0
1068078|NCT01998958|2118995|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0
1068079|NCT01998958|2118996|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0
1068080|NCT01998958|2118997|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0
1068081|NCT01998958|2118998|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0
1068082|NCT01998958|2118999|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0
1068083|NCT01998958|2119000|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0
1068084|NCT01998958|2119001|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0
1068085|NCT01998958|2119002|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0
1068086|NCT01998958|2119003|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0
1068087|NCT01998958|2119004|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0
1068088|NCT01998958|2119005|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0
1068089|NCT01998958|2119006|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0
1068090|NCT01998958|2119007|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0
1068091|NCT01998958|2119008|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0
1068092|NCT01998958|2119009|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2
1068093|NCT01998958|2119010|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1
1068094|NCT01998958|2119011|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2
1068095|NCT01998958|2119012|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0
1068096|NCT01998958|2119013|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0
1068097|NCT01998958|2119014|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0
1068098|NCT01998958|2119015|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0
1068099|NCT01998958|2119016|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0
1068100|NCT01998958|2119017|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0
1068101|NCT01998958|2119018|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0
1068102|NCT01998958|2119019|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0
1068103|NCT01998984|2119073|FG000|Overall Study|Adverse Event|0
1068104|NCT01998984|2119074|FG001|Overall Study|Adverse Event|0
1068105|NCT01998984|2119075|FG002|Overall Study|Adverse Event|0
1068106|NCT01998984|2119076|FG003|Overall Study|Adverse Event|1
1068107|NCT01998984|2119073|FG000|Overall Study|Lost to Follow-up|0
1068108|NCT01998984|2119074|FG001|Overall Study|Lost to Follow-up|1
1068109|NCT01998984|2119075|FG002|Overall Study|Lost to Follow-up|0
1068110|NCT01998984|2119076|FG003|Overall Study|Lost to Follow-up|1
1068111|NCT01998984|2119073|FG000|Overall Study|Withdrawal by Subject|0
1068112|NCT01998984|2119074|FG001|Overall Study|Withdrawal by Subject|0
1068113|NCT01998984|2119075|FG002|Overall Study|Withdrawal by Subject|1
1068114|NCT01998984|2119076|FG003|Overall Study|Withdrawal by Subject|0
1068115|NCT01998984|2119073|FG000|Overall Study|Other|0
1068116|NCT01998984|2119074|FG001|Overall Study|Other|0
1068117|NCT01998984|2119075|FG002|Overall Study|Other|0
1068118|NCT01998984|2119076|FG003|Overall Study|Other|1
1068119|NCT01999114|2119091|FG000|Overall Study|Adverse Event|8
1068120|NCT01999114|2119092|FG001|Overall Study|Adverse Event|7
1068121|NCT01999114|2119093|FG002|Overall Study|Adverse Event|2
1068122|NCT01999114|2119094|FG003|Overall Study|Adverse Event|2
1068123|NCT01999114|2119095|FG004|Overall Study|Adverse Event|1
1068124|NCT01999114|2119091|FG000|Overall Study|Withdrawal by Subject|0
1068125|NCT01999114|2119092|FG001|Overall Study|Withdrawal by Subject|0
1068126|NCT01999114|2119093|FG002|Overall Study|Withdrawal by Subject|1
1068127|NCT01999114|2119094|FG003|Overall Study|Withdrawal by Subject|0
1068128|NCT01999114|2119095|FG004|Overall Study|Withdrawal by Subject|1
1068129|NCT01999114|2119091|FG000|Overall Study|Lost to Follow-up|0
1068130|NCT01999114|2119092|FG001|Overall Study|Lost to Follow-up|0
1068131|NCT01999114|2119093|FG002|Overall Study|Lost to Follow-up|1
1068132|NCT01999114|2119094|FG003|Overall Study|Lost to Follow-up|0
1068133|NCT01999114|2119095|FG004|Overall Study|Lost to Follow-up|0
1068134|NCT01999114|2119091|FG000|Overall Study|Administrative|0
1068135|NCT01999114|2119092|FG001|Overall Study|Administrative|0
1068136|NCT01999114|2119093|FG002|Overall Study|Administrative|1
1068137|NCT01999114|2119094|FG003|Overall Study|Administrative|1
1068138|NCT01999114|2119095|FG004|Overall Study|Administrative|2
1068139|NCT01999218|2119141|FG000|Overall Study|Hyperglycemia|18
1068140|NCT01999218|2119142|FG001|Overall Study|Hyperglycemia|17
1068141|NCT01999218|2119143|FG002|Overall Study|Hyperglycemia|17
1068142|NCT01999218|2119141|FG000|Overall Study|Lack of Efficacy|1
1068143|NCT01999218|2119142|FG001|Overall Study|Lack of Efficacy|0
1068144|NCT01999218|2119143|FG002|Overall Study|Lack of Efficacy|1
1068145|NCT01999218|2119141|FG000|Overall Study|Lost to Follow-up|22
1068146|NCT01999218|2119142|FG001|Overall Study|Lost to Follow-up|17
1068147|NCT01999218|2119143|FG002|Overall Study|Lost to Follow-up|18
1068148|NCT01999218|2119141|FG000|Overall Study|Non-Compliance With Study Drug|6
1068149|NCT01999218|2119142|FG001|Overall Study|Non-Compliance With Study Drug|4
1068150|NCT01999218|2119143|FG002|Overall Study|Non-Compliance With Study Drug|1
1068151|NCT01999218|2119141|FG000|Overall Study|Physician Decision|1
1068152|NCT01999218|2119142|FG001|Overall Study|Physician Decision|4
1068153|NCT01999218|2119143|FG002|Overall Study|Physician Decision|6
1068154|NCT01999218|2119141|FG000|Overall Study|Protocol Violation|4
1068155|NCT01999218|2119142|FG001|Overall Study|Protocol Violation|5
1068156|NCT01999218|2119143|FG002|Overall Study|Protocol Violation|4
1068157|NCT01999218|2119141|FG000|Overall Study|Screen failure|0
1068158|NCT01999218|2119142|FG001|Overall Study|Screen failure|1
1068159|NCT01999218|2119143|FG002|Overall Study|Screen failure|0
1068160|NCT01999218|2119141|FG000|Overall Study|Study Terminated By Sponsor|7
908230|NCT00781391|1884771|FG001|Overall Study|Withdrawal by Subject|37
908231|NCT00781391|1884772|FG002|Overall Study|Withdrawal by Subject|25
908232|NCT00781391|1884770|FG000|Overall Study|Lost to Follow-up|0
908233|NCT00781391|1884771|FG001|Overall Study|Lost to Follow-up|0
908234|NCT00781391|1884772|FG002|Overall Study|Lost to Follow-up|1
908235|NCT00781456|1884782|FG000|Overall Study|Adverse Event|3
908236|NCT00781456|1884783|FG001|Overall Study|Adverse Event|3
908237|NCT00781456|1884782|FG000|Overall Study|Withdrawal by Subject|3
908238|NCT00781456|1884783|FG001|Overall Study|Withdrawal by Subject|5
908239|NCT00781456|1884782|FG000|Overall Study|Protocol Violation|4
908240|NCT00781456|1884783|FG001|Overall Study|Protocol Violation|1
908241|NCT00781456|1884782|FG000|Overall Study|Noncompliance With Protocol|1
908242|NCT00781456|1884783|FG001|Overall Study|Noncompliance With Protocol|1
908243|NCT00781456|1884782|FG000|Overall Study|Lost to Follow-up|10
908244|NCT00781456|1884783|FG001|Overall Study|Lost to Follow-up|5
908245|NCT00781456|1884782|FG000|Overall Study|Other Reason, Unknown|0
908246|NCT00781456|1884783|FG001|Overall Study|Other Reason, Unknown|1
908247|NCT00781599|1884802|FG000|Overall Study|Lost to Follow-up|7
908248|NCT00781599|1884803|FG001|Overall Study|Lost to Follow-up|4
908249|NCT00781768|1884811|FG000|Overall Study|Not transplanted.|0
908250|NCT00781768|1884812|FG001|Overall Study|Not transplanted.|2
1068161|NCT01999218|2119142|FG001|Overall Study|Study Terminated By Sponsor|5
1068162|NCT01999218|2119143|FG002|Overall Study|Study Terminated By Sponsor|12
1068163|NCT01999218|2119141|FG000|Overall Study|Participant moves|2
1068164|NCT01999218|2119142|FG001|Overall Study|Participant moves|5
1068165|NCT01999218|2119143|FG002|Overall Study|Participant moves|3
1068166|NCT01999218|2119141|FG000|Overall Study|Withdrawal by Subject|28
1068167|NCT01999218|2119142|FG001|Overall Study|Withdrawal by Subject|29
1068168|NCT01999218|2119143|FG002|Overall Study|Withdrawal by Subject|34
1068169|NCT01999218|2119141|FG000|Overall Study|Creatinine/eGFR|0
1068170|NCT01999218|2119142|FG001|Overall Study|Creatinine/eGFR|0
1068171|NCT01999218|2119143|FG002|Overall Study|Creatinine/eGFR|1
1068172|NCT01999218|2119141|FG000|Overall Study|Death|7
1068173|NCT01999218|2119142|FG001|Overall Study|Death|1
1068174|NCT01999218|2119143|FG002|Overall Study|Death|2
1068175|NCT01999218|2119141|FG000|Overall Study|Excluded Medication|1
1068176|NCT01999218|2119142|FG001|Overall Study|Excluded Medication|1
1068177|NCT01999218|2119143|FG002|Overall Study|Excluded Medication|2
1068178|NCT01999218|2119141|FG000|Overall Study|Adverse Event|9
1068179|NCT01999218|2119142|FG001|Overall Study|Adverse Event|7
1068180|NCT01999218|2119143|FG002|Overall Study|Adverse Event|7
1068181|NCT01999218|2119141|FG000|Overall Study|Treated but excluded at 1 trial site|3
1068182|NCT01999218|2119142|FG001|Overall Study|Treated but excluded at 1 trial site|5
1068183|NCT01999218|2119143|FG002|Overall Study|Treated but excluded at 1 trial site|2
1068184|NCT01999322|2119172|FG000|Overall Study|Adverse Event|1
1068185|NCT01999322|2119173|FG001|Overall Study|Adverse Event|0
1068186|NCT01999335|2119184|FG000|Overall Study|Discontinued before receiving treatment|0
1068187|NCT01999335|2119185|FG001|Overall Study|Discontinued before receiving treatment|0
1068188|NCT01999335|2119186|FG002|Overall Study|Discontinued before receiving treatment|0
1068189|NCT01999335|2119187|FG003|Overall Study|Discontinued before receiving treatment|0
1068190|NCT01999335|2119188|FG004|Overall Study|Discontinued before receiving treatment|2
1068191|NCT01999465|2119224|FG000|Overall Study|Lost to Follow-up|0
1068192|NCT01999465|2119225|FG001|Overall Study|Lost to Follow-up|2
1068193|NCT01999465|2119224|FG000|Overall Study|Protocol Violation|0
1068194|NCT01999465|2119225|FG001|Overall Study|Protocol Violation|1
1068195|NCT01999868|2119263|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
1068196|NCT01999868|2119264|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
1068197|NCT01999868|2119265|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5
1068198|NCT01999868|2119263|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
1068199|NCT01999868|2119264|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
1068200|NCT01999868|2119265|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0
1068201|NCT01999868|2119263|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3
1068202|NCT01999868|2119264|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4
1068203|NCT01999868|2119265|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0
1068204|NCT01999868|2119263|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
1068205|NCT01999868|2119264|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1
1068206|NCT01999868|2119265|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
1068207|NCT01999868|2119263|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
1068208|NCT01999868|2119264|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2
1068209|NCT01999868|2119265|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
1068210|NCT01999868|2119263|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1
1068211|NCT01999868|2119264|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2
1068212|NCT01999868|2119265|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0
1068213|NCT01999868|2119263|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8
1068214|NCT01999868|2119264|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1
1068215|NCT01999868|2119265|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0
1068216|NCT01999868|2119263|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1
1068217|NCT01999868|2119264|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
1068218|NCT01999868|2119265|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
1068219|NCT01999868|2119263|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4
1068220|NCT01999868|2119264|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
1068221|NCT01999868|2119265|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
1068222|NCT01999868|2119263|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
1068223|NCT01999868|2119264|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1
1068224|NCT01999868|2119265|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
1068225|NCT01999868|2119263|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
1068226|NCT01999868|2119264|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1
1068227|NCT01999868|2119265|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
1068228|NCT01999868|2119263|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1
1068229|NCT01999868|2119264|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2
1068230|NCT01999868|2119265|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0
1068231|NCT01999868|2119263|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10
1068232|NCT01999868|2119264|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19
1068233|NCT01999868|2119265|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0
1068234|NCT01999868|2119263|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
1068235|NCT01999868|2119264|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2
1068236|NCT01999868|2119265|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
1068237|NCT01999868|2119263|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12
1068238|NCT01999868|2119264|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4
1068239|NCT01999868|2119265|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0
1068240|NCT01999894|2119273|FG000|Overall Study|Adverse Event|9
1068241|NCT01999894|2119273|FG000|Overall Study|Lack of Efficacy|5
1068242|NCT01999894|2119273|FG000|Overall Study|Protocol Violation|1
1068243|NCT01999894|2119273|FG000|Overall Study|Withdrawal by Subject|7
1068244|NCT01999894|2119273|FG000|Overall Study|Lost to Follow-up|10
1068245|NCT01999894|2119273|FG000|Overall Study|Other Reason|3
1068246|NCT01999894|2119273|FG000|Overall Study|Inclusion/exclusion criteria not met|1
1068247|NCT01999946|2119290|FG000|Overall Study|Participant not released from jail|2
1068248|NCT01999946|2119291|FG001|Overall Study|Participant not released from jail|2
1068249|NCT01999946|2119292|FG002|Overall Study|Participant not released from jail|0
1068250|NCT01999946|2119290|FG000|Overall Study|Not included in primary outcome analysis|0
1068251|NCT01999946|2119291|FG001|Overall Study|Not included in primary outcome analysis|0
1068252|NCT01999946|2119292|FG002|Overall Study|Not included in primary outcome analysis|79
1068253|NCT01999972|2119305|FG000|Dose Escalation Part|Participant refused further follow-up|1
1068254|NCT01999972|2119306|FG001|Dose Escalation Part|Participant refused further follow-up|0
1068255|NCT01999972|2119307|FG002|Dose Escalation Part|Participant refused further follow-up|1
1068256|NCT01999972|2119308|FG003|Dose Escalation Part|Participant refused further follow-up|1
1068257|NCT01999972|2119309|FG004|Dose Escalation Part|Participant refused further follow-up|0
1068258|NCT01999972|2119310|FG005|Dose Escalation Part|Participant refused further follow-up|0
1068259|NCT01999972|2119305|FG000|Dose Escalation Part|Death|0
1068260|NCT01999972|2119306|FG001|Dose Escalation Part|Death|1
1068261|NCT01999972|2119307|FG002|Dose Escalation Part|Death|0
1068262|NCT01999972|2119308|FG003|Dose Escalation Part|Death|0
1068263|NCT01999972|2119309|FG004|Dose Escalation Part|Death|0
1068264|NCT01999972|2119310|FG005|Dose Escalation Part|Death|0
1068265|NCT01999972|2119305|FG000|Dose Escalation Part|Enrolled but not treated|0
1068266|NCT01999972|2119306|FG001|Dose Escalation Part|Enrolled but not treated|0
1068267|NCT01999972|2119307|FG002|Dose Escalation Part|Enrolled but not treated|1
1068268|NCT01999972|2119308|FG003|Dose Escalation Part|Enrolled but not treated|1
1068269|NCT01999972|2119309|FG004|Dose Escalation Part|Enrolled but not treated|0
1068270|NCT01999972|2119310|FG005|Dose Escalation Part|Enrolled but not treated|0
1068271|NCT01999972|2119305|FG000|Dose Escalation Part|Disease progression|3
1068272|NCT01999972|2119306|FG001|Dose Escalation Part|Disease progression|2
1068273|NCT01999972|2119307|FG002|Dose Escalation Part|Disease progression|3
1068274|NCT01999972|2119308|FG003|Dose Escalation Part|Disease progression|6
1068275|NCT01999972|2119309|FG004|Dose Escalation Part|Disease progression|0
1068276|NCT01999972|2119310|FG005|Dose Escalation Part|Disease progression|0
1068277|NCT01999972|2119305|FG000|Dose Escalation Part|Adverse Event|0
1068278|NCT01999972|2119306|FG001|Dose Escalation Part|Adverse Event|0
1068279|NCT01999972|2119307|FG002|Dose Escalation Part|Adverse Event|0
1068280|NCT01999972|2119308|FG003|Dose Escalation Part|Adverse Event|2
1068281|NCT01999972|2119309|FG004|Dose Escalation Part|Adverse Event|0
1068282|NCT01999972|2119310|FG005|Dose Escalation Part|Adverse Event|0
908251|NCT00781859|1884820|FG000|Overall Study|Adverse Event|2
908252|NCT00781859|1884821|FG001|Overall Study|Adverse Event|2
1068283|NCT01999972|2119305|FG000|Dose Escalation Part|Global deterioration of health status|1
1068284|NCT01999972|2119306|FG001|Dose Escalation Part|Global deterioration of health status|0
1068285|NCT01999972|2119307|FG002|Dose Escalation Part|Global deterioration of health status|0
1068286|NCT01999972|2119308|FG003|Dose Escalation Part|Global deterioration of health status|1
1068287|NCT01999972|2119309|FG004|Dose Escalation Part|Global deterioration of health status|0
1068288|NCT01999972|2119310|FG005|Dose Escalation Part|Global deterioration of health status|0
1068289|NCT01999972|2119305|FG000|Dose Expansion Part|Death|0
1068290|NCT01999972|2119306|FG001|Dose Expansion Part|Death|0
1068291|NCT01999972|2119307|FG002|Dose Expansion Part|Death|0
1068292|NCT01999972|2119308|FG003|Dose Expansion Part|Death|0
1068293|NCT01999972|2119309|FG004|Dose Expansion Part|Death|2
1068294|NCT01999972|2119310|FG005|Dose Expansion Part|Death|1
1068295|NCT01999972|2119305|FG000|Dose Expansion Part|Disease progression|0
1068296|NCT01999972|2119306|FG001|Dose Expansion Part|Disease progression|0
1068297|NCT01999972|2119307|FG002|Dose Expansion Part|Disease progression|0
1068298|NCT01999972|2119308|FG003|Dose Expansion Part|Disease progression|0
1068299|NCT01999972|2119309|FG004|Dose Expansion Part|Disease progression|9
1068300|NCT01999972|2119310|FG005|Dose Expansion Part|Disease progression|3
1068301|NCT01999972|2119305|FG000|Dose Expansion Part|Sponsor decision|0
1068302|NCT01999972|2119306|FG001|Dose Expansion Part|Sponsor decision|0
1068303|NCT01999972|2119307|FG002|Dose Expansion Part|Sponsor decision|0
1068304|NCT01999972|2119308|FG003|Dose Expansion Part|Sponsor decision|0
1068305|NCT01999972|2119309|FG004|Dose Expansion Part|Sponsor decision|1
1068306|NCT01999972|2119310|FG005|Dose Expansion Part|Sponsor decision|0
1068307|NCT01999972|2119305|FG000|Dose Expansion Part|Adverse Event|0
1068308|NCT01999972|2119306|FG001|Dose Expansion Part|Adverse Event|0
1068309|NCT01999972|2119307|FG002|Dose Expansion Part|Adverse Event|0
1068310|NCT01999972|2119308|FG003|Dose Expansion Part|Adverse Event|0
1068311|NCT01999972|2119309|FG004|Dose Expansion Part|Adverse Event|4
1068312|NCT01999972|2119310|FG005|Dose Expansion Part|Adverse Event|2
1068313|NCT01999972|2119305|FG000|Dose Expansion Part|Participant's non-compliance|0
1068314|NCT01999972|2119306|FG001|Dose Expansion Part|Participant's non-compliance|0
1068315|NCT01999972|2119307|FG002|Dose Expansion Part|Participant's non-compliance|0
1068316|NCT01999972|2119308|FG003|Dose Expansion Part|Participant's non-compliance|0
1068317|NCT01999972|2119309|FG004|Dose Expansion Part|Participant's non-compliance|0
1068318|NCT01999972|2119310|FG005|Dose Expansion Part|Participant's non-compliance|1
1068319|NCT01999972|2119305|FG000|Dose Expansion Part|Participant refused further follow-up|0
1068320|NCT01999972|2119306|FG001|Dose Expansion Part|Participant refused further follow-up|0
1068321|NCT01999972|2119307|FG002|Dose Expansion Part|Participant refused further follow-up|0
1068322|NCT01999972|2119308|FG003|Dose Expansion Part|Participant refused further follow-up|0
1068323|NCT01999972|2119309|FG004|Dose Expansion Part|Participant refused further follow-up|4
1068324|NCT01999972|2119310|FG005|Dose Expansion Part|Participant refused further follow-up|0
1068325|NCT01999972|2119305|FG000|Dose Expansion Part|Changed to standard of care|0
1068326|NCT01999972|2119306|FG001|Dose Expansion Part|Changed to standard of care|0
1068327|NCT01999972|2119307|FG002|Dose Expansion Part|Changed to standard of care|0
1068328|NCT01999972|2119308|FG003|Dose Expansion Part|Changed to standard of care|0
1068329|NCT01999972|2119309|FG004|Dose Expansion Part|Changed to standard of care|1
1068330|NCT01999972|2119310|FG005|Dose Expansion Part|Changed to standard of care|0
1068331|NCT02000115|2119337|FG000|Overall Study|Death|56
1068332|NCT02000115|2119338|FG001|Overall Study|Death|45
1068333|NCT02000115|2119339|FG002|Overall Study|Death|0
1068334|NCT02000115|2119340|FG003|Overall Study|Death|0
1068335|NCT02000115|2119337|FG000|Overall Study|Missed Visit|6
1068336|NCT02000115|2119338|FG001|Overall Study|Missed Visit|8
1068337|NCT02000115|2119339|FG002|Overall Study|Missed Visit|1
1068338|NCT02000115|2119340|FG003|Overall Study|Missed Visit|0
1068339|NCT02000115|2119337|FG000|Overall Study|Protocol Violation|2
1068340|NCT02000115|2119338|FG001|Overall Study|Protocol Violation|1
1068341|NCT02000115|2119339|FG002|Overall Study|Protocol Violation|0
1068342|NCT02000115|2119340|FG003|Overall Study|Protocol Violation|0
1068343|NCT02000115|2119337|FG000|Overall Study|Physician Decision|2
1068344|NCT02000115|2119338|FG001|Overall Study|Physician Decision|0
1068345|NCT02000115|2119339|FG002|Overall Study|Physician Decision|0
1068346|NCT02000115|2119340|FG003|Overall Study|Physician Decision|0
1068347|NCT02000115|2119337|FG000|Overall Study|Withdrawal by Subject|11
1068348|NCT02000115|2119338|FG001|Overall Study|Withdrawal by Subject|11
1068349|NCT02000115|2119339|FG002|Overall Study|Withdrawal by Subject|0
1068350|NCT02000115|2119340|FG003|Overall Study|Withdrawal by Subject|0
1068351|NCT02000115|2119337|FG000|Overall Study|Lost to Follow-up|0
1068352|NCT02000115|2119338|FG001|Overall Study|Lost to Follow-up|1
1068353|NCT02000115|2119339|FG002|Overall Study|Lost to Follow-up|0
1068354|NCT02000115|2119340|FG003|Overall Study|Lost to Follow-up|0
1068355|NCT02000115|2119337|FG000|Overall Study|Non-compliance|2
1068356|NCT02000115|2119338|FG001|Overall Study|Non-compliance|1
1068357|NCT02000115|2119339|FG002|Overall Study|Non-compliance|0
1068358|NCT02000115|2119340|FG003|Overall Study|Non-compliance|0
1068359|NCT02000115|2119337|FG000|Overall Study|Withdrawn on day of randomization|0
1068360|NCT02000115|2119338|FG001|Overall Study|Withdrawn on day of randomization|1
1068361|NCT02000115|2119339|FG002|Overall Study|Withdrawn on day of randomization|0
1068362|NCT02000115|2119340|FG003|Overall Study|Withdrawn on day of randomization|0
1068363|NCT02000115|2119337|FG000|Overall Study|Still on Study|0
1068364|NCT02000115|2119338|FG001|Overall Study|Still on Study|0
1068365|NCT02000115|2119339|FG002|Overall Study|Still on Study|0
1068366|NCT02000115|2119340|FG003|Overall Study|Still on Study|53
1068368|NCT02000440|2119366|FG000|Overall Study|Adverse Event|3
1068369|NCT02000440|2119366|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1
1068370|NCT02000531|2119372|FG000|Overall Study|Lost to Follow-up|1
1068371|NCT02000531|2119373|FG001|Overall Study|Lost to Follow-up|0
1068372|NCT02000531|2119372|FG000|Overall Study|Discontinued due to data cut-off|3
1068373|NCT02000531|2119373|FG001|Overall Study|Discontinued due to data cut-off|8
1068374|NCT02000622|2119390|FG000|Overall Study|Withdrawal by Subject|5
1068375|NCT02000622|2119391|FG001|Overall Study|Withdrawal by Subject|7
1068376|NCT02000622|2119390|FG000|Overall Study|Lost to Follow-up|4
1068377|NCT02000622|2119391|FG001|Overall Study|Lost to Follow-up|0
1068378|NCT02000622|2119390|FG000|Overall Study|Death|159
1068379|NCT02000622|2119391|FG001|Overall Study|Death|73
1068380|NCT02000622|2119390|FG000|Overall Study|Withdrawn due to site closure|1
1068381|NCT02000622|2119391|FG001|Overall Study|Withdrawn due to site closure|0
1068382|NCT02000752|2119399|FG000|Overall Study|Dystocic delivery|19
1068383|NCT02000752|2119400|FG001|Overall Study|Dystocic delivery|8
1068384|NCT02000752|2119399|FG000|Overall Study|Shift Changes|12
1068385|NCT02000752|2119400|FG001|Overall Study|Shift Changes|5
1068386|NCT02000817|2119410|FG000|Overall Study|Withdrawal by Subject|2
1068387|NCT02000817|2119411|FG001|Overall Study|Withdrawal by Subject|0
1068388|NCT02000817|2119412|FG002|Overall Study|Withdrawal by Subject|0
1068389|NCT02000817|2119413|FG003|Overall Study|Withdrawal by Subject|0
1068390|NCT02000817|2119410|FG000|Overall Study|Adverse Event|0
1068391|NCT02000817|2119411|FG001|Overall Study|Adverse Event|1
1068392|NCT02000817|2119412|FG002|Overall Study|Adverse Event|0
1068393|NCT02000817|2119413|FG003|Overall Study|Adverse Event|0
1068394|NCT02000817|2119410|FG000|Overall Study|Lost to Follow-up|0
1068395|NCT02000817|2119411|FG001|Overall Study|Lost to Follow-up|0
1068396|NCT02000817|2119412|FG002|Overall Study|Lost to Follow-up|1
1068397|NCT02000817|2119413|FG003|Overall Study|Lost to Follow-up|0
1068398|NCT02000921|2119438|FG000|Overall Study|Withdrawal by Subject|3
1068399|NCT02000921|2119439|FG001|Overall Study|Withdrawal by Subject|10
1068400|NCT02000921|2119440|FG002|Overall Study|Withdrawal by Subject|5
1068401|NCT02000921|2119438|FG000|Overall Study|Lost to Follow-up|2
1068402|NCT02000921|2119439|FG001|Overall Study|Lost to Follow-up|4
1068403|NCT02000921|2119440|FG002|Overall Study|Lost to Follow-up|5
1068404|NCT02000921|2119438|FG000|Overall Study|Physician Decision|0
1068405|NCT02000921|2119439|FG001|Overall Study|Physician Decision|2
1068406|NCT02000921|2119440|FG002|Overall Study|Physician Decision|0
1068407|NCT02001051|2119467|FG000|Overall Study|Deemed not eligible following enrollment|0
1068408|NCT02001051|2119468|FG001|Overall Study|Deemed not eligible following enrollment|1
1068409|NCT02001064|2119476|FG000|Overall Study|Withdrawal by Subject|2
1068410|NCT02001064|2119477|FG001|Overall Study|Withdrawal by Subject|1
1068411|NCT02001181|2119485|FG000|Overall Study|Adverse Event|0
1068412|NCT02001181|2119486|FG001|Overall Study|Adverse Event|2
1068413|NCT02001181|2119485|FG000|Overall Study|Lost to Follow-up|1
1068414|NCT02001181|2119486|FG001|Overall Study|Lost to Follow-up|0
1068415|NCT02001181|2119485|FG000|Overall Study|Withdrawal by Subject|0
1068416|NCT02001181|2119486|FG001|Overall Study|Withdrawal by Subject|1
1068417|NCT02001194|2119496|FG000|Intervention Period (13 Weeks)|No longer interested|1
1068418|NCT02001194|2119497|FG001|Intervention Period (13 Weeks)|No longer interested|0
1068419|NCT02001194|2119498|FG002|Intervention Period (13 Weeks)|No longer interested|2
1068420|NCT02001194|2119499|FG003|Intervention Period (13 Weeks)|No longer interested|2
1068421|NCT02001194|2119496|FG000|Follow-Up Period (13 Weeks)|No longer interested|3
1068422|NCT02001194|2119497|FG001|Follow-Up Period (13 Weeks)|No longer interested|2
1068423|NCT02001194|2119498|FG002|Follow-Up Period (13 Weeks)|No longer interested|1
1068424|NCT02001194|2119499|FG003|Follow-Up Period (13 Weeks)|No longer interested|0
1068425|NCT02001558|2119511|FG000|Overall Study|Lost to Follow-up|8
1068426|NCT02001558|2119512|FG001|Overall Study|Lost to Follow-up|14
1068427|NCT02001688|2119521|FG000|Overall Study|Withdrawal by Subject|0
1068428|NCT02001688|2119522|FG001|Overall Study|Withdrawal by Subject|0
1068429|NCT02001688|2119523|FG002|Overall Study|Withdrawal by Subject|1
1068430|NCT02001688|2119521|FG000|Overall Study|Adverse Event|0
1068431|NCT02001688|2119522|FG001|Overall Study|Adverse Event|1
1068432|NCT02001688|2119523|FG002|Overall Study|Adverse Event|0
1068433|NCT02001987|2119554|FG000|Core Study Period (24 Weeks)|Adverse Event|9
1068434|NCT02001987|2119554|FG000|Core Study Period (24 Weeks)|Death|1
1068435|NCT02001987|2119554|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
1068436|NCT02001987|2119554|FG000|Core Study Period (24 Weeks)|Physician Decision|1
1068437|NCT02001987|2119554|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4
1068438|NCT02001987|2119554|FG000|Core Study Period (24 Weeks)|Protocol Violation|3
1068439|NCT02001987|2119554|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3
1068440|NCT02001987|2119554|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2
1068441|NCT02001987|2119554|FG000|LTE Period (52 Weeks)|Physician Decision|2
1068442|NCT02001987|2119554|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1
1068443|NCT02001987|2119554|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1
1068444|NCT02001987|2119554|FG000|LTE Period (52 Weeks)|Other|3
1068445|NCT02002091|2119565|FG000|Screening|Lost to Follow-up|10
1068446|NCT02002091|2119566|FG001|Screening|Lost to Follow-up|12
1068447|NCT02002091|2119565|FG000|Screening|Death|3
1068448|NCT02002091|2119566|FG001|Screening|Death|2
1068449|NCT02002182|2119603|FG000|Overall Study|Withdraw from study|3
1068450|NCT02002182|2119604|FG001|Overall Study|Withdraw from study|1
1068451|NCT02002182|2119603|FG000|Overall Study|Health Reasons|1
1068452|NCT02002182|2119604|FG001|Overall Study|Health Reasons|0
1068453|NCT02002182|2119603|FG000|Overall Study|Death|1
1068454|NCT02002182|2119604|FG001|Overall Study|Death|0
1068455|NCT02002221|2119621|FG000|Overall Study|Adverse Event|2
1068456|NCT02002221|2119622|FG001|Overall Study|Adverse Event|1
1068457|NCT02002221|2119621|FG000|Overall Study|Unsatisfactory therapeutic effect|0
1068458|NCT02002221|2119622|FG001|Overall Study|Unsatisfactory therapeutic effect|1
1068459|NCT02002221|2119621|FG000|Overall Study|Patient withdrew consent|0
1068460|NCT02002221|2119622|FG001|Overall Study|Patient withdrew consent|1
1068461|NCT02002533|2119645|FG000|Overall Study|Withdrawal by Subject|6
1068462|NCT02002533|2119646|FG001|Overall Study|Withdrawal by Subject|13
1068463|NCT02002533|2119645|FG000|Overall Study|Protocol Violation|0
1068464|NCT02002533|2119646|FG001|Overall Study|Protocol Violation|1
1068465|NCT02002533|2119645|FG000|Overall Study|Adverse Event|0
1068466|NCT02002533|2119646|FG001|Overall Study|Adverse Event|3
1068467|NCT02002533|2119645|FG000|Overall Study|Lost to Follow-up|0
1068468|NCT02002533|2119646|FG001|Overall Study|Lost to Follow-up|1
1068469|NCT02002689|2119663|FG000|Overall Study|Disease Progression|7
1068470|NCT02002689|2119663|FG000|Overall Study|Adverse Event|3
1068471|NCT02002884|2119707|FG000|Main Period (MP)|Other|0
1068472|NCT02002884|2119708|FG001|Main Period (MP)|Other|3
1068473|NCT02002884|2119709|FG002|Main Period (MP)|Other|3
1068474|NCT02002884|2119710|FG003|Main Period (MP)|Other|0
1068475|NCT02002884|2119707|FG000|Main Period (MP)|Adverse Event|0
1068476|NCT02002884|2119708|FG001|Main Period (MP)|Adverse Event|1
1068477|NCT02002884|2119709|FG002|Main Period (MP)|Adverse Event|1
1068478|NCT02002884|2119710|FG003|Main Period (MP)|Adverse Event|0
1068479|NCT02002884|2119707|FG000|Main Period (MP)|Withdrawal by Subject|6
1068480|NCT02002884|2119708|FG001|Main Period (MP)|Withdrawal by Subject|2
1068481|NCT02002884|2119709|FG002|Main Period (MP)|Withdrawal by Subject|2
1068482|NCT02002884|2119710|FG003|Main Period (MP)|Withdrawal by Subject|0
1068483|NCT02002884|2119707|FG000|Main Period (MP)|Lost to Follow-up|0
1068484|NCT02002884|2119708|FG001|Main Period (MP)|Lost to Follow-up|0
1068485|NCT02002884|2119709|FG002|Main Period (MP)|Lost to Follow-up|2
1068486|NCT02002884|2119710|FG003|Main Period (MP)|Lost to Follow-up|0
1068487|NCT02002884|2119707|FG000|Open-Label Extension Period (OLEX)|Other|0
1068488|NCT02002884|2119708|FG001|Open-Label Extension Period (OLEX)|Other|0
1068489|NCT02002884|2119709|FG002|Open-Label Extension Period (OLEX)|Other|0
1068490|NCT02002884|2119710|FG003|Open-Label Extension Period (OLEX)|Other|24
1068491|NCT02002884|2119707|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0
1068492|NCT02002884|2119708|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0
1068493|NCT02002884|2119709|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0
1068494|NCT02002884|2119710|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1
1068495|NCT02002884|2119707|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0
1068496|NCT02002884|2119708|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0
1068497|NCT02002884|2119709|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0
1068498|NCT02002884|2119710|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5
1068499|NCT02002884|2119707|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
1068500|NCT02002884|2119708|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
1068501|NCT02002884|2119709|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
1068502|NCT02002884|2119710|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10
1068503|NCT02002884|2119707|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
1068504|NCT02002884|2119708|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
1068505|NCT02002884|2119709|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
1162044|NCT03381248|2283986|FG001|Overall Study|Lost to Follow-up|2
908253|NCT00781859|1884820|FG000|Overall Study|Withdrawal by Subject|8
908254|NCT00781859|1884821|FG001|Overall Study|Withdrawal by Subject|4
908255|NCT00781859|1884820|FG000|Overall Study|Lost to Follow-up|6
908256|NCT00781859|1884821|FG001|Overall Study|Lost to Follow-up|3
908257|NCT00781859|1884820|FG000|Overall Study|Death|3
908258|NCT00781859|1884821|FG001|Overall Study|Death|0
908259|NCT00781885|1884827|FG000|Overall Study|Physician Decision|1
908260|NCT00781911|1884842|FG000|Overall Study|Adverse Event|4
908261|NCT00781911|1884843|FG001|Overall Study|Adverse Event|4
908262|NCT00781911|1884842|FG000|Overall Study|Withdrawal by Subject|1
908263|NCT00781911|1884843|FG001|Overall Study|Withdrawal by Subject|2
908264|NCT00781911|1884842|FG000|Overall Study|Physician Decision|0
908265|NCT00781911|1884843|FG001|Overall Study|Physician Decision|2
908266|NCT00781911|1884842|FG000|Overall Study|Sponsor Decision|1
908267|NCT00781911|1884843|FG001|Overall Study|Sponsor Decision|0
908268|NCT00781937|1884853|FG000|Main Trial Period Through Week 56|Adverse Event|18
908269|NCT00781937|1884854|FG001|Main Trial Period Through Week 56|Adverse Event|18
908270|NCT00781937|1884853|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0
908271|NCT00781937|1884854|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2
1068506|NCT02002884|2119710|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10
1068507|NCT02002975|2119724|FG000|Overall Study|Case Report Forms Uncollected|135
1068508|NCT02002975|2119724|FG000|Overall Study|Protocol Deviation|437
1068509|NCT02003014|2119728|FG000|Overall Study|Case report forms uncollected|9
1068510|NCT02003014|2119728|FG000|Overall Study|Treatment started after contract period|1
1068511|NCT02003014|2119728|FG000|Overall Study|Patient did not visit the study site|5
1068512|NCT02003014|2119728|FG000|Overall Study|Investigator's transfer|4
1068513|NCT02003183|2119743|FG000|Overall Study|Lost to Follow-up|0
1068514|NCT02003183|2119744|FG001|Overall Study|Lost to Follow-up|2
1068515|NCT02003365|2119757|FG000|Overall Study|Lost to Follow-up|0
1068516|NCT02003365|2119758|FG001|Overall Study|Lost to Follow-up|0
1068517|NCT02003365|2119759|FG002|Overall Study|Lost to Follow-up|1
1068518|NCT02003391|2119769|FG000|Overall Study|Withdrawal by Subject|2
1068519|NCT02003391|2119770|FG001|Overall Study|Withdrawal by Subject|1
1068520|NCT02003391|2119769|FG000|Overall Study|Protocol Violation|0
1068521|NCT02003391|2119770|FG001|Overall Study|Protocol Violation|1
1068522|NCT02003391|2119769|FG000|Overall Study|Adverse Event|1
1068523|NCT02003391|2119770|FG001|Overall Study|Adverse Event|0
1068524|NCT02003534|2119791|FG000|Overall Study|Lost to Follow-up|47
1068525|NCT02003573|2119798|FG000|Overall Study|Progressive disease|2
1068526|NCT02003573|2119799|FG001|Overall Study|Progressive disease|0
1068527|NCT02003573|2119800|FG002|Overall Study|Progressive disease|1
1068528|NCT02003573|2119798|FG000|Overall Study|Other Adverse event|0
1068529|NCT02003573|2119799|FG001|Overall Study|Other Adverse event|1
1068530|NCT02003573|2119800|FG002|Overall Study|Other Adverse event|1
1068531|NCT02003573|2119798|FG000|Overall Study|Refuse to take trial medication|0
1068532|NCT02003573|2119799|FG001|Overall Study|Refuse to take trial medication|1
1068533|NCT02003573|2119800|FG002|Overall Study|Refuse to take trial medication|1
1068534|NCT02003573|2119798|FG000|Overall Study|Other than specified|1
1068535|NCT02003573|2119799|FG001|Overall Study|Other than specified|2
1068536|NCT02003573|2119800|FG002|Overall Study|Other than specified|3
1068537|NCT02003638|2119821|FG000|Overall Study|Withdrawal by Subject|1
1068538|NCT02003638|2119822|FG001|Overall Study|Withdrawal by Subject|0
1068539|NCT02003898|2119828|FG000|Overall Study|Death|3
1068540|NCT02003898|2119828|FG000|Overall Study|Lost to Follow-up|12
1068541|NCT02003898|2119828|FG000|Overall Study|Withdrawal by Subject|52
1068590|NCT02003963|2119854|FG000|Overall Study|Lost to Follow-up|2
1068591|NCT02003963|2119855|FG001|Overall Study|Lost to Follow-up|1
1068592|NCT02004093|2119865|FG000|Overall Study|Death|2
1068593|NCT02004093|2119866|FG001|Overall Study|Death|1
1068594|NCT02004093|2119865|FG000|Overall Study|Lack of Efficacy|66
1068595|NCT02004093|2119866|FG001|Overall Study|Lack of Efficacy|62
1068596|NCT02004093|2119865|FG000|Overall Study|Protocol Violation|0
1068597|NCT02004093|2119866|FG001|Overall Study|Protocol Violation|1
1068598|NCT02004093|2119865|FG000|Overall Study|Lost to Follow-up|0
1068599|NCT02004093|2119866|FG001|Overall Study|Lost to Follow-up|1
1068600|NCT02004093|2119865|FG000|Overall Study|Withdrawal by Subject|3
1068601|NCT02004093|2119866|FG001|Overall Study|Withdrawal by Subject|7
1068602|NCT02004093|2119865|FG000|Overall Study|Other|3
1068603|NCT02004093|2119866|FG001|Overall Study|Other|1
1068604|NCT02004236|2119888|FG000|Overall Study|Lack of Efficacy|0
1068605|NCT02004236|2119889|FG001|Overall Study|Lack of Efficacy|0
1068606|NCT02004236|2119890|FG002|Overall Study|Lack of Efficacy|16
1068607|NCT02004262|2119905|FG000|Overall Study|Death|67
1068608|NCT02004262|2119906|FG001|Overall Study|Death|64
1068609|NCT02004262|2119907|FG002|Overall Study|Death|66
1068610|NCT02004262|2119908|FG003|Overall Study|Death|28
1068611|NCT02004262|2119909|FG004|Overall Study|Death|29
1068612|NCT02004262|2119910|FG005|Overall Study|Death|22
1068613|NCT02004262|2119905|FG000|Overall Study|Withdrawal by Subject|1
1068614|NCT02004262|2119906|FG001|Overall Study|Withdrawal by Subject|0
1068615|NCT02004262|2119907|FG002|Overall Study|Withdrawal by Subject|4
1068616|NCT02004262|2119908|FG003|Overall Study|Withdrawal by Subject|0
1068617|NCT02004262|2119909|FG004|Overall Study|Withdrawal by Subject|1
1068618|NCT02004262|2119910|FG005|Overall Study|Withdrawal by Subject|3
1068619|NCT02004262|2119905|FG000|Overall Study|Lost to Follow-up|1
1068620|NCT02004262|2119906|FG001|Overall Study|Lost to Follow-up|1
1068621|NCT02004262|2119907|FG002|Overall Study|Lost to Follow-up|0
1068622|NCT02004262|2119908|FG003|Overall Study|Lost to Follow-up|0
1068623|NCT02004262|2119909|FG004|Overall Study|Lost to Follow-up|0
1068624|NCT02004262|2119910|FG005|Overall Study|Lost to Follow-up|0
1068625|NCT02004262|2119905|FG000|Overall Study|Study Terminated by Sponsor|4
1068626|NCT02004262|2119906|FG001|Overall Study|Study Terminated by Sponsor|3
1068627|NCT02004262|2119907|FG002|Overall Study|Study Terminated by Sponsor|2
1068628|NCT02004262|2119908|FG003|Overall Study|Study Terminated by Sponsor|1
1068629|NCT02004262|2119909|FG004|Overall Study|Study Terminated by Sponsor|1
1068630|NCT02004262|2119910|FG005|Overall Study|Study Terminated by Sponsor|5
1068631|NCT02004353|2119933|FG000|Overall Study|Voluntary participation|1334
1068650|NCT02004847|2119979|FG000|Overall Study|Protocol Violation|1
1068651|NCT02004847|2119980|FG001|Overall Study|Protocol Violation|1
1068652|NCT02004873|2119995|FG000|Overall Study|Implant unsuccessful|6
1068653|NCT02004873|2119995|FG000|Overall Study|Awaiting 6-month visit|390
1068654|NCT02004873|2119995|FG000|Overall Study|Missed 6-month visit|4
1068655|NCT02004873|2119995|FG000|Overall Study|Death|23
1068656|NCT02004873|2119995|FG000|Overall Study|Withdrawal by Subject|1
1068657|NCT02004886|2120006|FG000|Overall Study|Adverse Event|0
1068658|NCT02004886|2120007|FG001|Overall Study|Adverse Event|1
1068659|NCT02004886|2120008|FG002|Overall Study|Adverse Event|0
1068660|NCT02004886|2120009|FG003|Overall Study|Adverse Event|0
1068661|NCT02004886|2120006|FG000|Overall Study|Unable to attend future visits|1
1068662|NCT02004886|2120007|FG001|Overall Study|Unable to attend future visits|0
1068663|NCT02004886|2120008|FG002|Overall Study|Unable to attend future visits|0
1068664|NCT02004886|2120009|FG003|Overall Study|Unable to attend future visits|0
1068665|NCT02005029|2120038|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1
1068666|NCT02005029|2120039|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0
1068667|NCT02005211|2120070|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1068668|NCT02005211|2120071|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1068669|NCT02005211|2120072|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1068670|NCT02005211|2120073|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1068671|NCT02005211|2120074|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
1068672|NCT02005211|2120075|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1068673|NCT02005211|2120076|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1068674|NCT02005250|2120101|FG000|Overall Study|Lost to Follow-up|15
1068675|NCT02005250|2120102|FG001|Overall Study|Lost to Follow-up|5
1068676|NCT02005276|2120112|FG000|Overall Study|No longer interested|5
1068677|NCT02005276|2120113|FG001|Overall Study|No longer interested|2
1068678|NCT02005276|2120114|FG002|Overall Study|No longer interested|3
1068679|NCT02005276|2120115|FG003|Overall Study|No longer interested|3
1068680|NCT02005471|2120142|FG000|Overall Study|Ongoing in Study|144
1068681|NCT02005471|2120143|FG001|Overall Study|Ongoing in Study|171
1068682|NCT02005471|2120142|FG000|Overall Study|Adverse Event|1
1068683|NCT02005471|2120143|FG001|Overall Study|Adverse Event|0
1068684|NCT02005471|2120142|FG000|Overall Study|Death|26
1068685|NCT02005471|2120143|FG001|Overall Study|Death|15
1068686|NCT02005471|2120142|FG000|Overall Study|Lost to Follow-up|1
1068687|NCT02005471|2120143|FG001|Overall Study|Lost to Follow-up|0
1068688|NCT02005471|2120142|FG000|Overall Study|Physician Decision|2
1068689|NCT02005471|2120143|FG001|Overall Study|Physician Decision|1
1068690|NCT02005471|2120142|FG000|Overall Study|Progressive Disease|3
1068691|NCT02005471|2120143|FG001|Overall Study|Progressive Disease|0
1068692|NCT02005471|2120142|FG000|Overall Study|Withdrawal by Subject|18
1068693|NCT02005471|2120143|FG001|Overall Study|Withdrawal by Subject|7
1068694|NCT02005484|2120152|FG000|Overall Study|Death|1
1068695|NCT02005484|2120152|FG000|Overall Study|Disease progression|1
1068696|NCT02005484|2120152|FG000|Overall Study|Changed to a Different Study|1
1068697|NCT02005484|2120152|FG000|Overall Study|Sponsor decision|1
1068698|NCT02005562|2120175|FG000|Overall Study|Death|2
1068699|NCT02005562|2120176|FG001|Overall Study|Death|2
1068700|NCT02005562|2120175|FG000|Overall Study|Graft loss|7
1068701|NCT02005562|2120176|FG001|Overall Study|Graft loss|6
1068702|NCT02005562|2120175|FG000|Overall Study|Withdrawal by Subject|2
1068703|NCT02005562|2120176|FG001|Overall Study|Withdrawal by Subject|2
1068704|NCT02005562|2120175|FG000|Overall Study|No transplant|1
1068705|NCT02005562|2120176|FG001|Overall Study|No transplant|4
1068706|NCT02005562|2120175|FG000|Overall Study|Physician Decision|0
1068707|NCT02005562|2120176|FG001|Overall Study|Physician Decision|1
1068708|NCT02005627|2120193|FG000|Overall Study|Lost to Follow-up|1
1068709|NCT02005627|2120194|FG001|Overall Study|Lost to Follow-up|2
1068710|NCT02005627|2120193|FG000|Overall Study|Withdrawal by Subject|1
1068711|NCT02005627|2120194|FG001|Overall Study|Withdrawal by Subject|2
1068712|NCT02005692|2120214|FG000|Overall Study|Protocol Violation|1
1068713|NCT02005692|2120214|FG000|Overall Study|Withdrawal by Subject|1
1068714|NCT02005692|2120214|FG000|Overall Study|Discharged earlier than anticipated|5
1068715|NCT02005887|2120221|FG000|Overall Study|Protocol Violation|0
1068716|NCT02005887|2120222|FG001|Overall Study|Protocol Violation|2
1068717|NCT02006121|2120243|FG000|Double Blind Phase|Adverse Event|6
1068718|NCT02006121|2120244|FG001|Double Blind Phase|Adverse Event|0
1068719|NCT02006121|2120243|FG000|Double Blind Phase|Lack of Efficacy|1
1068720|NCT02006121|2120244|FG001|Double Blind Phase|Lack of Efficacy|16
1068721|NCT02006121|2120243|FG000|Double Blind Phase|Withdrawal by Subject|3
1068722|NCT02006121|2120244|FG001|Double Blind Phase|Withdrawal by Subject|4
1068723|NCT02006121|2120243|FG000|Double Blind Phase|Non-compliance with study drug|1
1068724|NCT02006121|2120244|FG001|Double Blind Phase|Non-compliance with study drug|3
1068725|NCT02006121|2120243|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1
1068726|NCT02006121|2120244|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0
1068727|NCT02006121|2120243|FG000|Double Blind Phase|Inconvenience of infusion system|0
1068728|NCT02006121|2120244|FG001|Double Blind Phase|Inconvenience of infusion system|1
1068729|NCT02006121|2120243|FG000|Open Label Phase|Adverse Event|15
1068730|NCT02006121|2120244|FG001|Open Label Phase|Adverse Event|0
1068731|NCT02006121|2120243|FG000|Open Label Phase|Lack of Efficacy|2
1068732|NCT02006121|2120244|FG001|Open Label Phase|Lack of Efficacy|0
1068733|NCT02006121|2120243|FG000|Open Label Phase|Protocol Violation|2
1068734|NCT02006121|2120244|FG001|Open Label Phase|Protocol Violation|0
1068735|NCT02006121|2120243|FG000|Open Label Phase|Withdrawal by Subject|3
1068736|NCT02006121|2120244|FG001|Open Label Phase|Withdrawal by Subject|0
1068737|NCT02006121|2120243|FG000|Open Label Phase|Non-compliance with study drug|3
1068738|NCT02006121|2120244|FG001|Open Label Phase|Non-compliance with study drug|0
1068739|NCT02006472|2120301|FG000|Period 1 (Through Week 26)|Protocol Violation|1
1068740|NCT02006472|2120302|FG001|Period 1 (Through Week 26)|Protocol Violation|1
1068741|NCT02006472|2120303|FG002|Period 1 (Through Week 26)|Protocol Violation|1
1068742|NCT02006472|2120304|FG003|Period 1 (Through Week 26)|Protocol Violation|1
1068743|NCT02006472|2120305|FG004|Period 1 (Through Week 26)|Protocol Violation|0
1068744|NCT02006472|2120301|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0
1068745|NCT02006472|2120302|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0
1068746|NCT02006472|2120303|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1
1068747|NCT02006472|2120304|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0
1068748|NCT02006472|2120305|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0
1068749|NCT02006472|2120301|FG000|Period 1 (Through Week 26)|Noncompliance|2
1068750|NCT02006472|2120302|FG001|Period 1 (Through Week 26)|Noncompliance|1
1068751|NCT02006472|2120303|FG002|Period 1 (Through Week 26)|Noncompliance|1
1068752|NCT02006472|2120304|FG003|Period 1 (Through Week 26)|Noncompliance|0
1068753|NCT02006472|2120305|FG004|Period 1 (Through Week 26)|Noncompliance|0
1068754|NCT02006472|2120301|FG000|Period 1 (Through Week 26)|Other|1
1068755|NCT02006472|2120302|FG001|Period 1 (Through Week 26)|Other|5
1068756|NCT02006472|2120303|FG002|Period 1 (Through Week 26)|Other|0
1068757|NCT02006472|2120304|FG003|Period 1 (Through Week 26)|Other|2
1068758|NCT02006472|2120305|FG004|Period 1 (Through Week 26)|Other|3
1068759|NCT02006472|2120301|FG000|Period 1 (Through Week 26)|Adverse Event|5
1068760|NCT02006472|2120302|FG001|Period 1 (Through Week 26)|Adverse Event|6
1068761|NCT02006472|2120303|FG002|Period 1 (Through Week 26)|Adverse Event|11
1068762|NCT02006472|2120304|FG003|Period 1 (Through Week 26)|Adverse Event|11
1068763|NCT02006472|2120305|FG004|Period 1 (Through Week 26)|Adverse Event|14
1068764|NCT02006472|2120301|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3
1068765|NCT02006472|2120302|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9
1068766|NCT02006472|2120303|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3
1068767|NCT02006472|2120304|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0
1068768|NCT02006472|2120305|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3
1068769|NCT02006472|2120301|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1
1068770|NCT02006472|2120302|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0
1068771|NCT02006472|2120303|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0
1068772|NCT02006472|2120304|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1
1068773|NCT02006472|2120305|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1
1068774|NCT02006472|2120301|FG000|Period 2 (Through Week 52)|Noncompliance|1
1068775|NCT02006472|2120302|FG001|Period 2 (Through Week 52)|Noncompliance|0
1068776|NCT02006472|2120303|FG002|Period 2 (Through Week 52)|Noncompliance|0
1068777|NCT02006472|2120304|FG003|Period 2 (Through Week 52)|Noncompliance|0
1068778|NCT02006472|2120305|FG004|Period 2 (Through Week 52)|Noncompliance|0
1068779|NCT02006472|2120301|FG000|Period 2 (Through Week 52)|Adverse Event|1
1068780|NCT02006472|2120302|FG001|Period 2 (Through Week 52)|Adverse Event|4
1068781|NCT02006472|2120303|FG002|Period 2 (Through Week 52)|Adverse Event|5
1068782|NCT02006472|2120304|FG003|Period 2 (Through Week 52)|Adverse Event|1
1068783|NCT02006472|2120305|FG004|Period 2 (Through Week 52)|Adverse Event|1
1068784|NCT02006472|2120301|FG000|Period 2 (Through Week 52)|Other|0
1068785|NCT02006472|2120302|FG001|Period 2 (Through Week 52)|Other|1
1068786|NCT02006472|2120303|FG002|Period 2 (Through Week 52)|Other|0
1068787|NCT02006472|2120304|FG003|Period 2 (Through Week 52)|Other|1
1068788|NCT02006472|2120305|FG004|Period 2 (Through Week 52)|Other|0
1068789|NCT02006472|2120301|FG000|Period 2 (Through Week 52)|Not treated|0
1068790|NCT02006472|2120302|FG001|Period 2 (Through Week 52)|Not treated|0
1068791|NCT02006472|2120303|FG002|Period 2 (Through Week 52)|Not treated|2
1068792|NCT02006472|2120304|FG003|Period 2 (Through Week 52)|Not treated|0
1068793|NCT02006472|2120305|FG004|Period 2 (Through Week 52)|Not treated|0
1068794|NCT02006472|2120301|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2
1068795|NCT02006472|2120302|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1
1068796|NCT02006472|2120303|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2
1068797|NCT02006472|2120304|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0
1068798|NCT02006472|2120305|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0
1068799|NCT02006472|2120301|FG000|Period 2 (Through Week 52)|Sponsor decision|0
1068800|NCT02006472|2120302|FG001|Period 2 (Through Week 52)|Sponsor decision|0
1068801|NCT02006472|2120303|FG002|Period 2 (Through Week 52)|Sponsor decision|1
1068802|NCT02006472|2120304|FG003|Period 2 (Through Week 52)|Sponsor decision|0
1068803|NCT02006472|2120305|FG004|Period 2 (Through Week 52)|Sponsor decision|0
1068804|NCT02006576|2120325|FG000|Overall Study|Withdrawal by Subject|4
1068805|NCT02006576|2120326|FG001|Overall Study|Withdrawal by Subject|6
1068806|NCT02006576|2120327|FG002|Overall Study|Withdrawal by Subject|2
1068807|NCT02006576|2120325|FG000|Overall Study|Death|0
1068808|NCT02006576|2120326|FG001|Overall Study|Death|0
1068809|NCT02006576|2120327|FG002|Overall Study|Death|1
1068810|NCT02006576|2120325|FG000|Overall Study|Lost to Follow-up|1
1068811|NCT02006576|2120326|FG001|Overall Study|Lost to Follow-up|0
1068812|NCT02006576|2120327|FG002|Overall Study|Lost to Follow-up|1
1068813|NCT02006576|2120325|FG000|Overall Study|Screen Failure, too sick, other|13
1068814|NCT02006576|2120326|FG001|Overall Study|Screen Failure, too sick, other|1
1068815|NCT02006576|2120327|FG002|Overall Study|Screen Failure, too sick, other|13
1068816|NCT02006628|2120337|FG000|Overall Study|Adverse Event|1
1068817|NCT02006628|2120338|FG001|Overall Study|Adverse Event|1
1068818|NCT02006628|2120337|FG000|Overall Study|Withdrawal by Subject|2
1068819|NCT02006628|2120338|FG001|Overall Study|Withdrawal by Subject|1
1068820|NCT02006641|2120347|FG000|Overall Study|Withdrawal before treatment|2
1068821|NCT02006641|2120348|FG001|Overall Study|Withdrawal before treatment|5
1068822|NCT02006641|2120349|FG002|Overall Study|Withdrawal before treatment|3
1068823|NCT02006641|2120347|FG000|Overall Study|Adverse Event|15
1068824|NCT02006641|2120348|FG001|Overall Study|Adverse Event|11
1068825|NCT02006641|2120349|FG002|Overall Study|Adverse Event|15
1068826|NCT02006641|2120347|FG000|Overall Study|Protocol Violation|0
1068827|NCT02006641|2120348|FG001|Overall Study|Protocol Violation|2
1068828|NCT02006641|2120349|FG002|Overall Study|Protocol Violation|2
1068829|NCT02006641|2120347|FG000|Overall Study|Lost to Follow-up|0
1068830|NCT02006641|2120348|FG001|Overall Study|Lost to Follow-up|1
1068831|NCT02006641|2120349|FG002|Overall Study|Lost to Follow-up|0
1068832|NCT02006641|2120347|FG000|Overall Study|Withdrawal by Subject|7
1068833|NCT02006641|2120348|FG001|Overall Study|Withdrawal by Subject|12
1068834|NCT02006641|2120349|FG002|Overall Study|Withdrawal by Subject|11
1068835|NCT02006641|2120347|FG000|Overall Study|Other reason: patient didn't show up|1
1068836|NCT02006641|2120348|FG001|Overall Study|Other reason: patient didn't show up|0
1068837|NCT02006641|2120349|FG002|Overall Study|Other reason: patient didn't show up|0
1068838|NCT02006641|2120347|FG000|Overall Study|Other reason:patient didn't want to come|0
1068839|NCT02006641|2120348|FG001|Overall Study|Other reason:patient didn't want to come|0
1068840|NCT02006641|2120349|FG002|Overall Study|Other reason:patient didn't want to come|1
1068841|NCT02006641|2120347|FG000|Overall Study|Other reason: patient has moved|1
1068842|NCT02006641|2120348|FG001|Overall Study|Other reason: patient has moved|0
1068843|NCT02006641|2120349|FG002|Overall Study|Other reason: patient has moved|1
1068844|NCT02006641|2120347|FG000|Overall Study|Other reason: caregiver in hospital|0
1068845|NCT02006641|2120348|FG001|Overall Study|Other reason: caregiver in hospital|1
1068846|NCT02006641|2120349|FG002|Overall Study|Other reason: caregiver in hospital|0
1068847|NCT02006641|2120347|FG000|Overall Study|Other reason: patient's wife has died|0
1068848|NCT02006641|2120348|FG001|Overall Study|Other reason: patient's wife has died|0
1068849|NCT02006641|2120349|FG002|Overall Study|Other reason: patient's wife has died|1
1068850|NCT02006641|2120347|FG000|Overall Study|Other reason: hospitalisation|0
1068851|NCT02006641|2120348|FG001|Overall Study|Other reason: hospitalisation|1
1068852|NCT02006641|2120349|FG002|Overall Study|Other reason: hospitalisation|0
1068853|NCT02006641|2120347|FG000|Overall Study|Other reason: caregiver impossibility|0
1068854|NCT02006641|2120348|FG001|Overall Study|Other reason: caregiver impossibility|0
1068855|NCT02006641|2120349|FG002|Overall Study|Other reason: caregiver impossibility|1
1068856|NCT02006641|2120347|FG000|Overall Study|Other reason: protocol non-compliance|0
1068857|NCT02006641|2120348|FG001|Overall Study|Other reason: protocol non-compliance|0
1068858|NCT02006641|2120349|FG002|Overall Study|Other reason: protocol non-compliance|1
1068859|NCT02006654|2120359|FG000|Overall Study|Withdrawal before treatment|4
1068860|NCT02006654|2120360|FG001|Overall Study|Withdrawal before treatment|2
1068861|NCT02006654|2120359|FG000|Overall Study|Adverse Event|16
1068862|NCT02006654|2120360|FG001|Overall Study|Adverse Event|17
1068863|NCT02006654|2120359|FG000|Overall Study|Death|1
1068864|NCT02006654|2120360|FG001|Overall Study|Death|0
1068865|NCT02006654|2120359|FG000|Overall Study|Withdrawal by Subject|14
1068866|NCT02006654|2120360|FG001|Overall Study|Withdrawal by Subject|12
1068867|NCT02006654|2120359|FG000|Overall Study|Protocol Violation|5
1068868|NCT02006654|2120360|FG001|Overall Study|Protocol Violation|8
1068869|NCT02006654|2120359|FG000|Overall Study|Lost to Follow-up|1
1068870|NCT02006654|2120360|FG001|Overall Study|Lost to Follow-up|0
1068871|NCT02006654|2120359|FG000|Overall Study|patient's will|2
1068872|NCT02006654|2120360|FG001|Overall Study|patient's will|1
1068873|NCT02006654|2120359|FG000|Overall Study|insufficient compliance|1
1068874|NCT02006654|2120360|FG001|Overall Study|insufficient compliance|0
1068875|NCT02006654|2120359|FG000|Overall Study|worsening cognitive condition|0
1068876|NCT02006654|2120360|FG001|Overall Study|worsening cognitive condition|1
1068877|NCT02006654|2120359|FG000|Overall Study|faecal incontinence|0
1068878|NCT02006654|2120360|FG001|Overall Study|faecal incontinence|1
1068879|NCT02006654|2120359|FG000|Overall Study|mood disorder|0
1068880|NCT02006654|2120360|FG001|Overall Study|mood disorder|1
1068881|NCT02006654|2120359|FG000|Overall Study|disallowed medication|1
1068882|NCT02006654|2120360|FG001|Overall Study|disallowed medication|0
1068883|NCT02006654|2120359|FG000|Overall Study|moving out of state|0
1068884|NCT02006654|2120360|FG001|Overall Study|moving out of state|1
1068885|NCT02006667|2120367|FG000|Overall Study|Adverse Event|3
1068886|NCT02006667|2120367|FG000|Overall Study|Death|2
1068887|NCT02006667|2120367|FG000|Overall Study|Withdrawal by Subject|1
1068888|NCT02006693|2120373|FG000|Overall Study|No Reason Specified|6
1068889|NCT02006693|2120374|FG001|Overall Study|No Reason Specified|8
1068890|NCT02006693|2120373|FG000|Overall Study|Another Glaucoma-related Surgery|12
1068891|NCT02006693|2120374|FG001|Overall Study|Another Glaucoma-related Surgery|1
1068892|NCT02006693|2120373|FG000|Overall Study|XEN Implant Explantation|0
1068893|NCT02006693|2120374|FG001|Overall Study|XEN Implant Explantation|1
1068894|NCT02006693|2120373|FG000|Overall Study|Death|2
1068895|NCT02006693|2120374|FG001|Overall Study|Death|2
1068896|NCT02006693|2120373|FG000|Overall Study|Lost to Follow-up|4
1068897|NCT02006693|2120374|FG001|Overall Study|Lost to Follow-up|1
1068898|NCT02006693|2120373|FG000|Overall Study|Patient Decision|4
1068899|NCT02006693|2120374|FG001|Overall Study|Patient Decision|0
1068900|NCT02006706|2120380|FG000|Overall Study|Lost to Follow-up|1
1068901|NCT02006719|2120386|FG000|Overall Study|Withdrawal by Subject|10
1068902|NCT02006719|2120387|FG001|Overall Study|Withdrawal by Subject|2
1068903|NCT02006719|2120386|FG000|Overall Study|Lost to Follow-up|5
1068904|NCT02006719|2120387|FG001|Overall Study|Lost to Follow-up|1
1068905|NCT02006719|2120386|FG000|Overall Study|Protocol Violation|2
1068906|NCT02006719|2120387|FG001|Overall Study|Protocol Violation|0
1068907|NCT02006719|2120386|FG000|Overall Study|Adverse Event|1
1068908|NCT02006719|2120387|FG001|Overall Study|Adverse Event|1
1068909|NCT02006719|2120386|FG000|Overall Study|Other/Unknown|0
1068910|NCT02006719|2120387|FG001|Overall Study|Other/Unknown|1
1068911|NCT02006732|2120397|FG000|Overall Study|Adverse Event|10
1068912|NCT02006732|2120398|FG001|Overall Study|Adverse Event|7
1068913|NCT02006732|2120399|FG002|Overall Study|Adverse Event|4
1068914|NCT02006732|2120400|FG003|Overall Study|Adverse Event|2
1068915|NCT02006732|2120397|FG000|Overall Study|Lack of Efficacy|6
1068916|NCT02006732|2120398|FG001|Overall Study|Lack of Efficacy|3
1068917|NCT02006732|2120399|FG002|Overall Study|Lack of Efficacy|1
1068918|NCT02006732|2120400|FG003|Overall Study|Lack of Efficacy|1
1068919|NCT02006732|2120397|FG000|Overall Study|Protocol Violation|1
1068920|NCT02006732|2120398|FG001|Overall Study|Protocol Violation|1
1068921|NCT02006732|2120399|FG002|Overall Study|Protocol Violation|0
1068922|NCT02006732|2120400|FG003|Overall Study|Protocol Violation|0
1068923|NCT02006732|2120397|FG000|Overall Study|Lost to Follow-up|0
1068924|NCT02006732|2120398|FG001|Overall Study|Lost to Follow-up|1
1068925|NCT02006732|2120399|FG002|Overall Study|Lost to Follow-up|0
1068926|NCT02006732|2120400|FG003|Overall Study|Lost to Follow-up|0
1068927|NCT02006732|2120397|FG000|Overall Study|Withdrawal by Subject|3
1068928|NCT02006732|2120398|FG001|Overall Study|Withdrawal by Subject|0
1068929|NCT02006732|2120399|FG002|Overall Study|Withdrawal by Subject|4
1068930|NCT02006732|2120400|FG003|Overall Study|Withdrawal by Subject|1
1068931|NCT02006758|2120410|FG000|Overall Study|Protocol Violation|1
1068932|NCT02006758|2120410|FG000|Overall Study|Death|1
1068933|NCT02006758|2120410|FG000|Overall Study|Lost to Follow-up|4
1068934|NCT02006758|2120410|FG000|Overall Study|Withdrawal by Subject|4
1068935|NCT02006758|2120410|FG000|Overall Study|Procedurally excluded|1
1068936|NCT02006758|2120410|FG000|Overall Study|Other|2
1068937|NCT02006979|2120445|FG000|Overall Study|Withdrawal by Subject|1
1068938|NCT02006979|2120446|FG001|Overall Study|Withdrawal by Subject|1
1068939|NCT02006979|2120445|FG000|Overall Study|Protocol Violation|0
1068940|NCT02006979|2120446|FG001|Overall Study|Protocol Violation|1
1068941|NCT02007070|2120452|FG000|Overall Study|Adverse Event|4
1068942|NCT02007070|2120452|FG000|Overall Study|Clinical Progression|4
1068943|NCT02007070|2120452|FG000|Overall Study|Death|1
1068944|NCT02007070|2120452|FG000|Overall Study|Protocol Violation|2
1068945|NCT02007070|2120452|FG000|Overall Study|Physician Decision|1
1068946|NCT02007070|2120452|FG000|Overall Study|Progressive Disease|21
1068947|NCT02007096|2120458|FG000|Overall Study|medication not available|2
1068948|NCT02007096|2120459|FG001|Overall Study|medication not available|0
1068949|NCT02007096|2120458|FG000|Overall Study|did not inject saline|0
1068950|NCT02007096|2120459|FG001|Overall Study|did not inject saline|3
1068951|NCT02007096|2120458|FG000|Overall Study|did not follow postoperative protocol|8
1068952|NCT02007096|2120459|FG001|Overall Study|did not follow postoperative protocol|11
1068953|NCT02007096|2120458|FG000|Overall Study|converted to open surgery|1
1068954|NCT02007096|2120459|FG001|Overall Study|converted to open surgery|1
1068955|NCT02007096|2120458|FG000|Overall Study|no mesh placed|0
1068956|NCT02007096|2120459|FG001|Overall Study|no mesh placed|1
1068957|NCT02007109|2120465|FG000|Overall Study|Diary not returned or excluded|102
1068958|NCT02007109|2120465|FG000|Overall Study|Excluded - Age<7yo|9
1068959|NCT02007252|2120478|FG000|Overall Study|Administrative problems|3
1068960|NCT02007252|2120479|FG001|Overall Study|Administrative problems|7
1068961|NCT02007252|2120478|FG000|Overall Study|Abnormal laboratory value(s)|1
1068962|NCT02007252|2120479|FG001|Overall Study|Abnormal laboratory value(s)|0
1068963|NCT02007252|2120478|FG000|Overall Study|Adverse Event|7
1068964|NCT02007252|2120479|FG001|Overall Study|Adverse Event|4
1068965|NCT02007278|2120487|FG000|Overall Study|Failure to comply with an eligibility|0
1068966|NCT02007278|2120488|FG001|Overall Study|Failure to comply with an eligibility|1
1068967|NCT02007278|2120487|FG000|Overall Study|Ingestion of drugs not allowed in study|0
1068968|NCT02007278|2120488|FG001|Overall Study|Ingestion of drugs not allowed in study|1
1068969|NCT02007278|2120487|FG000|Overall Study|Incorrect medication administration|1
1068970|NCT02007278|2120488|FG001|Overall Study|Incorrect medication administration|0
1068971|NCT02007278|2120487|FG000|Overall Study|Mis-randomization|1
1068972|NCT02007278|2120488|FG001|Overall Study|Mis-randomization|1
1068973|NCT02007434|2120522|FG000|Overall Study|Lost to Follow-up|0
1068974|NCT02007434|2120523|FG001|Overall Study|Lost to Follow-up|1
1068975|NCT02007434|2120524|FG002|Overall Study|Lost to Follow-up|0
1068976|NCT02007434|2120525|FG003|Overall Study|Lost to Follow-up|0
1068977|NCT02007434|2120526|FG004|Overall Study|Lost to Follow-up|0
1068978|NCT02007434|2120527|FG005|Overall Study|Lost to Follow-up|0
1068979|NCT02007434|2120528|FG006|Overall Study|Lost to Follow-up|0
1068980|NCT02007434|2120529|FG007|Overall Study|Lost to Follow-up|0
1068981|NCT02007434|2120522|FG000|Overall Study|Non-compliance|1
1068982|NCT02007434|2120523|FG001|Overall Study|Non-compliance|0
1068983|NCT02007434|2120524|FG002|Overall Study|Non-compliance|1
1068984|NCT02007434|2120525|FG003|Overall Study|Non-compliance|0
1068985|NCT02007434|2120526|FG004|Overall Study|Non-compliance|0
1068986|NCT02007434|2120527|FG005|Overall Study|Non-compliance|0
1068987|NCT02007434|2120528|FG006|Overall Study|Non-compliance|0
1068988|NCT02007434|2120529|FG007|Overall Study|Non-compliance|0
1068989|NCT02007577|2120570|FG000|Overall Study|Adverse Event|1
1068990|NCT02007577|2120571|FG001|Overall Study|Adverse Event|0
1068991|NCT02007577|2120570|FG000|Overall Study|Withdrawal by Subject|0
1068992|NCT02007577|2120571|FG001|Overall Study|Withdrawal by Subject|1
1068993|NCT02007720|2120579|FG000|Overall Study|Withdrawal by Subject|9
1068994|NCT02007720|2120580|FG001|Overall Study|Withdrawal by Subject|11
1068995|NCT02007720|2120579|FG000|Overall Study|study terminated by sponsor|58
1068996|NCT02007720|2120580|FG001|Overall Study|study terminated by sponsor|54
1068997|NCT02007720|2120579|FG000|Overall Study|technical problem|4
1068998|NCT02007720|2120580|FG001|Overall Study|technical problem|2
1068999|NCT02007720|2120579|FG000|Overall Study|patient followd less than 165 days|11
1069000|NCT02007720|2120580|FG001|Overall Study|patient followd less than 165 days|5
1069001|NCT02007954|2120591|FG000|Overall Study|Received liver transplant|3
1069002|NCT02007954|2120591|FG000|Overall Study|Switch in treatment modality|2
1069003|NCT02007954|2120591|FG000|Overall Study|Disease progression and unrelated AE|1
1069004|NCT02007954|2120591|FG000|Overall Study|Death|1
1069005|NCT02008227|2120610|FG000|Overall Study|Lost to Follow-up|7
1069006|NCT02008227|2120611|FG001|Overall Study|Lost to Follow-up|9
1069007|NCT02008227|2120610|FG000|Overall Study|Death|494
1069008|NCT02008227|2120611|FG001|Overall Study|Death|485
1069009|NCT02008227|2120610|FG000|Overall Study|Withdrawal by Subject|67
1069010|NCT02008227|2120611|FG001|Overall Study|Withdrawal by Subject|36
1069011|NCT02008227|2120610|FG000|Overall Study|Study Terminated By Sponsor|44
1069012|NCT02008227|2120611|FG001|Overall Study|Study Terminated By Sponsor|83
1069013|NCT02008318|2120620|FG000|Overall Study|Adverse Event|4
1069014|NCT02008318|2120621|FG001|Overall Study|Adverse Event|0
1069015|NCT02008318|2120620|FG000|Overall Study|Physician Decision|2
1069016|NCT02008318|2120621|FG001|Overall Study|Physician Decision|0
1069017|NCT02008318|2120620|FG000|Overall Study|Progressive Disease|2
1069018|NCT02008318|2120621|FG001|Overall Study|Progressive Disease|0
1069019|NCT02008318|2120620|FG000|Overall Study|Protocol Violation|1
1069020|NCT02008318|2120621|FG001|Overall Study|Protocol Violation|1
1069021|NCT02008318|2120620|FG000|Overall Study|Withdrawal by Subject|3
1069022|NCT02008318|2120621|FG001|Overall Study|Withdrawal by Subject|0
1069025|NCT02008526|2120642|FG000|Overall Study|Death|0
1069026|NCT02008526|2120643|FG001|Overall Study|Death|2
1069027|NCT02008526|2120644|FG002|Overall Study|Death|1
1069028|NCT02008526|2120642|FG000|Overall Study|Withdrawal by Subject|3
1069029|NCT02008526|2120643|FG001|Overall Study|Withdrawal by Subject|3
1069030|NCT02008526|2120644|FG002|Overall Study|Withdrawal by Subject|2
1069031|NCT02008526|2120642|FG000|Overall Study|Lost to Follow-up|5
1069032|NCT02008526|2120643|FG001|Overall Study|Lost to Follow-up|9
1069033|NCT02008526|2120644|FG002|Overall Study|Lost to Follow-up|6
1069034|NCT02008565|2120656|FG000|Overall Study|Protocol Violation|1
1069035|NCT02008565|2120657|FG001|Overall Study|Protocol Violation|1
1069036|NCT02008565|2120658|FG002|Overall Study|Protocol Violation|2
1069037|NCT02008565|2120659|FG003|Overall Study|Protocol Violation|0
1069038|NCT02008773|2120693|FG000|Overall Study|Adverse Event|3
1069039|NCT02008773|2120694|FG001|Overall Study|Adverse Event|3
1069040|NCT02008773|2120695|FG002|Overall Study|Adverse Event|1
1069041|NCT02008773|2120696|FG003|Overall Study|Adverse Event|2
1069042|NCT02008773|2120693|FG000|Overall Study|Medication Non-compliance|2
1069043|NCT02008773|2120694|FG001|Overall Study|Medication Non-compliance|1
1069044|NCT02008773|2120695|FG002|Overall Study|Medication Non-compliance|3
1069045|NCT02008773|2120696|FG003|Overall Study|Medication Non-compliance|2
1069046|NCT02008773|2120693|FG000|Overall Study|Withdrawal by Subject|8
1069047|NCT02008773|2120694|FG001|Overall Study|Withdrawal by Subject|4
1069048|NCT02008773|2120695|FG002|Overall Study|Withdrawal by Subject|7
1069049|NCT02008773|2120696|FG003|Overall Study|Withdrawal by Subject|6
1069050|NCT02008773|2120693|FG000|Overall Study|Lost to Follow-up|0
1069051|NCT02008773|2120694|FG001|Overall Study|Lost to Follow-up|1
1069052|NCT02008773|2120695|FG002|Overall Study|Lost to Follow-up|3
1069053|NCT02008773|2120696|FG003|Overall Study|Lost to Follow-up|2
1069054|NCT02008877|2120704|FG000|Overall Study|Inevaluable|0
1069055|NCT02008877|2120705|FG001|Overall Study|Inevaluable|1
1069056|NCT02008877|2120706|FG002|Overall Study|Inevaluable|0
1069057|NCT02008890|2120718|FG000|Period 1|Withdrawal by Subject|7
1069058|NCT02008890|2120719|FG001|Period 1|Withdrawal by Subject|7
1069059|NCT02008890|2120720|FG002|Period 1|Withdrawal by Subject|5
1069060|NCT02008890|2120721|FG003|Period 1|Withdrawal by Subject|0
1069061|NCT02008890|2120722|FG004|Period 1|Withdrawal by Subject|0
1069062|NCT02008890|2120718|FG000|Period 1|Pregnancy|1
1069063|NCT02008890|2120719|FG001|Period 1|Pregnancy|0
1069064|NCT02008890|2120720|FG002|Period 1|Pregnancy|0
1069065|NCT02008890|2120721|FG003|Period 1|Pregnancy|0
1069066|NCT02008890|2120722|FG004|Period 1|Pregnancy|0
1069067|NCT02008890|2120718|FG000|Period 1|Physician Decision|1
1069068|NCT02008890|2120719|FG001|Period 1|Physician Decision|0
1069069|NCT02008890|2120720|FG002|Period 1|Physician Decision|1
1069070|NCT02008890|2120721|FG003|Period 1|Physician Decision|0
1069071|NCT02008890|2120722|FG004|Period 1|Physician Decision|0
1069072|NCT02008890|2120718|FG000|Period 1|Adverse Event|6
1069073|NCT02008890|2120719|FG001|Period 1|Adverse Event|8
1069074|NCT02008890|2120720|FG002|Period 1|Adverse Event|6
1069075|NCT02008890|2120721|FG003|Period 1|Adverse Event|0
1069076|NCT02008890|2120722|FG004|Period 1|Adverse Event|0
1069077|NCT02008890|2120718|FG000|Period 2|Adverse Event|12
1069078|NCT02008890|2120719|FG001|Period 2|Adverse Event|7
1069079|NCT02008890|2120720|FG002|Period 2|Adverse Event|0
1069080|NCT02008890|2120721|FG003|Period 2|Adverse Event|5
1069081|NCT02008890|2120722|FG004|Period 2|Adverse Event|5
1069082|NCT02008890|2120718|FG000|Period 2|Withdrawal by Subject|11
1069083|NCT02008890|2120719|FG001|Period 2|Withdrawal by Subject|8
1069084|NCT02008890|2120720|FG002|Period 2|Withdrawal by Subject|0
1069085|NCT02008890|2120721|FG003|Period 2|Withdrawal by Subject|7
1069086|NCT02008890|2120722|FG004|Period 2|Withdrawal by Subject|2
1069087|NCT02008890|2120718|FG000|Period 2|Physician Decision|4
1069088|NCT02008890|2120719|FG001|Period 2|Physician Decision|0
1069089|NCT02008890|2120720|FG002|Period 2|Physician Decision|0
1069090|NCT02008890|2120721|FG003|Period 2|Physician Decision|2
1069091|NCT02008890|2120722|FG004|Period 2|Physician Decision|1
1069092|NCT02008890|2120718|FG000|Period 2|Lost to Follow-up|0
1069093|NCT02008890|2120719|FG001|Period 2|Lost to Follow-up|0
1069094|NCT02008890|2120720|FG002|Period 2|Lost to Follow-up|1
1069095|NCT02008890|2120721|FG003|Period 2|Lost to Follow-up|0
1069096|NCT02008890|2120722|FG004|Period 2|Lost to Follow-up|0
1069097|NCT02008890|2120718|FG000|Extension Period|Withdrawal by Subject|3
1069098|NCT02008890|2120719|FG001|Extension Period|Withdrawal by Subject|2
1069099|NCT02008890|2120720|FG002|Extension Period|Withdrawal by Subject|0
1069100|NCT02008890|2120721|FG003|Extension Period|Withdrawal by Subject|4
1069101|NCT02008890|2120722|FG004|Extension Period|Withdrawal by Subject|2
1069102|NCT02008890|2120718|FG000|Extension Period|Lost to Follow-up|1
1069103|NCT02008890|2120719|FG001|Extension Period|Lost to Follow-up|0
1069104|NCT02008890|2120720|FG002|Extension Period|Lost to Follow-up|0
1069105|NCT02008890|2120721|FG003|Extension Period|Lost to Follow-up|0
1069106|NCT02008890|2120722|FG004|Extension Period|Lost to Follow-up|0
1069107|NCT02008890|2120718|FG000|Extension Period|Adverse Event|1
1069108|NCT02008890|2120719|FG001|Extension Period|Adverse Event|3
1069109|NCT02008890|2120720|FG002|Extension Period|Adverse Event|0
1069110|NCT02008890|2120721|FG003|Extension Period|Adverse Event|0
1069111|NCT02008890|2120722|FG004|Extension Period|Adverse Event|2
1069112|NCT02008916|2120740|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
1069113|NCT02008916|2120741|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
1069114|NCT02008916|2120742|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
1069115|NCT02008916|2120740|FG000|Week 16 - 156|Adverse Event|4
1069116|NCT02008916|2120741|FG001|Week 16 - 156|Adverse Event|2
1069117|NCT02008916|2120742|FG002|Week 16 - 156|Adverse Event|3
1069118|NCT02008916|2120740|FG000|Week 16 - 156|Withdrawal by Subject|7
1069119|NCT02008916|2120741|FG001|Week 16 - 156|Withdrawal by Subject|3
1069120|NCT02008916|2120742|FG002|Week 16 - 156|Withdrawal by Subject|5
1069121|NCT02008916|2120740|FG000|Week 16 - 156|No longer requires treatment|0
1069122|NCT02008916|2120741|FG001|Week 16 - 156|No longer requires treatment|1
1069123|NCT02008916|2120742|FG002|Week 16 - 156|No longer requires treatment|0
1069124|NCT02008916|2120740|FG000|Week 16 - 156|Lost to Follow-up|5
1069125|NCT02008916|2120741|FG001|Week 16 - 156|Lost to Follow-up|0
1069126|NCT02008916|2120742|FG002|Week 16 - 156|Lost to Follow-up|0
1069127|NCT02008916|2120740|FG000|Week 16 - 156|Lack of Efficacy|3
1069128|NCT02008916|2120741|FG001|Week 16 - 156|Lack of Efficacy|5
1069129|NCT02008916|2120742|FG002|Week 16 - 156|Lack of Efficacy|2
1069130|NCT02008916|2120740|FG000|Week 16 - 156|Pregnancy|0
1069131|NCT02008916|2120741|FG001|Week 16 - 156|Pregnancy|1
1069132|NCT02008916|2120742|FG002|Week 16 - 156|Pregnancy|0
1069133|NCT02008916|2120740|FG000|Week 16 - 156|Physician Decision|0
1069134|NCT02008916|2120741|FG001|Week 16 - 156|Physician Decision|1
1069135|NCT02008916|2120742|FG002|Week 16 - 156|Physician Decision|0
1069136|NCT02009046|2120760|FG000|Overall Study|Lost to Follow-up|256
1069137|NCT02009046|2120761|FG001|Overall Study|Lost to Follow-up|206
1069138|NCT02009163|2120775|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
1069139|NCT02009163|2120776|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
1069140|NCT02009163|2120777|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
1069141|NCT02009163|2120775|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29
1069142|NCT02009163|2120776|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0
1069143|NCT02009163|2120777|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0
1069144|NCT02009163|2120775|FG000|Open-label Period (Non-randomized)|Adverse Event|22
1069145|NCT02009163|2120776|FG001|Open-label Period (Non-randomized)|Adverse Event|0
1069146|NCT02009163|2120777|FG002|Open-label Period (Non-randomized)|Adverse Event|0
1069147|NCT02009163|2120775|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20
1069148|NCT02009163|2120776|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0
1069149|NCT02009163|2120777|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0
1069150|NCT02009163|2120775|FG000|Open-label Period (Non-randomized)|Protocol Violation|10
1069151|NCT02009163|2120776|FG001|Open-label Period (Non-randomized)|Protocol Violation|0
908272|NCT00781937|1884853|FG000|Main Trial Period Through Week 56|Protocol Violation|8
908273|NCT00781937|1884854|FG001|Main Trial Period Through Week 56|Protocol Violation|5
908274|NCT00781937|1884853|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17
908275|NCT00781937|1884854|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24
908276|NCT00781937|1884853|FG000|Main Trial Period Through Week 56|Unclassified|10
908277|NCT00781937|1884854|FG001|Main Trial Period Through Week 56|Unclassified|15
908278|NCT00781937|1884853|FG000|Follow up Period (Week 56-68)|Protocol Violation|1
908279|NCT00781937|1884854|FG001|Follow up Period (Week 56-68)|Protocol Violation|1
908280|NCT00781937|1884853|FG000|Follow up Period (Week 56-68)|Unclassified|5
908281|NCT00781937|1884854|FG001|Follow up Period (Week 56-68)|Unclassified|4
908282|NCT00781963|1884872|FG000|Overall Study|Death|3
908283|NCT00781963|1884873|FG001|Overall Study|Death|0
908284|NCT00781963|1884872|FG000|Overall Study|Lost to Follow-up|2
908285|NCT00781963|1884873|FG001|Overall Study|Lost to Follow-up|1
908286|NCT00781963|1884872|FG000|Overall Study|Withdrawal by Subject|3
908287|NCT00781963|1884873|FG001|Overall Study|Withdrawal by Subject|1
908288|NCT00781963|1884872|FG000|Overall Study|Refused follow-up|9
1069152|NCT02009163|2120777|FG002|Open-label Period (Non-randomized)|Protocol Violation|0
1069153|NCT02009163|2120775|FG000|Open-label Period (Non-randomized)|Pregnancy|1
1069154|NCT02009163|2120776|FG001|Open-label Period (Non-randomized)|Pregnancy|0
1069155|NCT02009163|2120777|FG002|Open-label Period (Non-randomized)|Pregnancy|0
1069156|NCT02009163|2120775|FG000|Open-label Period (Non-randomized)|Other|13
1069157|NCT02009163|2120776|FG001|Open-label Period (Non-randomized)|Other|0
1069158|NCT02009163|2120777|FG002|Open-label Period (Non-randomized)|Other|0
1069159|NCT02009163|2120775|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0
1069160|NCT02009163|2120776|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25
1069161|NCT02009163|2120777|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9
1069162|NCT02009163|2120775|FG000|Randomized-withdrawal Period|Lost to Follow-up|0
1069163|NCT02009163|2120776|FG001|Randomized-withdrawal Period|Lost to Follow-up|13
1069164|NCT02009163|2120777|FG002|Randomized-withdrawal Period|Lost to Follow-up|6
1069165|NCT02009163|2120775|FG000|Randomized-withdrawal Period|Adverse Event|0
1069166|NCT02009163|2120776|FG001|Randomized-withdrawal Period|Adverse Event|0
1069167|NCT02009163|2120777|FG002|Randomized-withdrawal Period|Adverse Event|6
1069168|NCT02009163|2120775|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0
1069169|NCT02009163|2120776|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40
1069170|NCT02009163|2120777|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5
1069171|NCT02009163|2120775|FG000|Randomized-withdrawal Period|Protocol Violation|0
1069172|NCT02009163|2120776|FG001|Randomized-withdrawal Period|Protocol Violation|1
1069173|NCT02009163|2120777|FG002|Randomized-withdrawal Period|Protocol Violation|2
1069174|NCT02009163|2120775|FG000|Randomized-withdrawal Period|Pregnancy|0
1069175|NCT02009163|2120776|FG001|Randomized-withdrawal Period|Pregnancy|0
1069176|NCT02009163|2120777|FG002|Randomized-withdrawal Period|Pregnancy|2
1069177|NCT02009163|2120775|FG000|Randomized-withdrawal Period|Other|0
1069178|NCT02009163|2120776|FG001|Randomized-withdrawal Period|Other|9
1069179|NCT02009163|2120777|FG002|Randomized-withdrawal Period|Other|5
1069180|NCT02009332|2120793|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
1069181|NCT02009332|2120794|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1
1069182|NCT02009332|2120795|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
1069183|NCT02009332|2120796|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
1069184|NCT02009332|2120797|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
1069185|NCT02009332|2120798|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
1069186|NCT02009332|2120793|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
1069187|NCT02009332|2120794|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
1069188|NCT02009332|2120795|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
1069189|NCT02009332|2120796|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
1069190|NCT02009332|2120797|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1
1069191|NCT02009332|2120798|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
1069192|NCT02009332|2120793|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
1069193|NCT02009332|2120794|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
1069194|NCT02009332|2120795|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
1069195|NCT02009332|2120796|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
1069196|NCT02009332|2120797|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
1069197|NCT02009332|2120798|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1
1069198|NCT02009397|2120812|FG000|Overall Study|Protocol Violation|6
1069199|NCT02009397|2120812|FG000|Overall Study|Death|8
1069200|NCT02009397|2120812|FG000|Overall Study|Lost to Follow-up|6
1069201|NCT02009696|2120825|FG000|Overall Study|Withdrawal by Subject|2
1069202|NCT02009722|2120831|FG000|Overall Study|Protocol Violation|1
1069203|NCT02009722|2120832|FG001|Overall Study|Protocol Violation|2
1069204|NCT02009722|2120831|FG000|Overall Study|Did not receive intervention|0
1069205|NCT02009722|2120832|FG001|Overall Study|Did not receive intervention|1
1069206|NCT02009865|2120840|FG000|Overall Study|Adverse Event|0
1069207|NCT02009865|2120841|FG001|Overall Study|Adverse Event|2
1069208|NCT02009865|2120840|FG000|Overall Study|Protocol Violation|0
1069209|NCT02009865|2120841|FG001|Overall Study|Protocol Violation|2
1069210|NCT02009865|2120840|FG000|Overall Study|Withdrawal by Subject|1
1069211|NCT02009865|2120841|FG001|Overall Study|Withdrawal by Subject|1
1069212|NCT02009878|2120850|FG000|Overall Study|Participant Met Withdrawal Criteria|0
1069213|NCT02009878|2120851|FG001|Overall Study|Participant Met Withdrawal Criteria|1
1069214|NCT02009878|2120852|FG002|Overall Study|Participant Met Withdrawal Criteria|0
1069215|NCT02009930|2120860|FG000|Overall Study|withdrawn|5
1069216|NCT02010255|2120928|FG000|Overall Study|Death|0
1069217|NCT02010255|2120929|FG001|Overall Study|Death|1
1069218|NCT02010255|2120930|FG002|Overall Study|Death|4
1069219|NCT02010255|2120931|FG003|Overall Study|Death|4
1069220|NCT02010255|2120932|FG004|Overall Study|Death|2
1069221|NCT02010255|2120933|FG005|Overall Study|Death|0
1069222|NCT02010255|2120934|FG006|Overall Study|Death|1
1069223|NCT02010255|2120935|FG007|Overall Study|Death|1
1069224|NCT02010255|2120936|FG008|Overall Study|Death|1
1069225|NCT02010255|2120937|FG009|Overall Study|Death|0
1069226|NCT02010255|2120938|FG010|Overall Study|Death|1
1069227|NCT02010255|2120939|FG011|Overall Study|Death|1
1069228|NCT02010255|2120940|FG012|Overall Study|Death|0
1069229|NCT02010255|2120941|FG013|Overall Study|Death|0
1069230|NCT02010255|2120928|FG000|Overall Study|Lack of Efficacy|4
1069231|NCT02010255|2120929|FG001|Overall Study|Lack of Efficacy|1
1069232|NCT02010255|2120930|FG002|Overall Study|Lack of Efficacy|2
1069233|NCT02010255|2120931|FG003|Overall Study|Lack of Efficacy|1
1069234|NCT02010255|2120932|FG004|Overall Study|Lack of Efficacy|1
1069235|NCT02010255|2120933|FG005|Overall Study|Lack of Efficacy|0
1069236|NCT02010255|2120934|FG006|Overall Study|Lack of Efficacy|0
1069237|NCT02010255|2120935|FG007|Overall Study|Lack of Efficacy|0
1069238|NCT02010255|2120936|FG008|Overall Study|Lack of Efficacy|0
1069239|NCT02010255|2120937|FG009|Overall Study|Lack of Efficacy|0
1069240|NCT02010255|2120938|FG010|Overall Study|Lack of Efficacy|1
1069241|NCT02010255|2120939|FG011|Overall Study|Lack of Efficacy|0
1069242|NCT02010255|2120940|FG012|Overall Study|Lack of Efficacy|0
1069243|NCT02010255|2120941|FG013|Overall Study|Lack of Efficacy|0
1069244|NCT02010255|2120928|FG000|Overall Study|Withdrew Consent|1
1069245|NCT02010255|2120929|FG001|Overall Study|Withdrew Consent|0
1069246|NCT02010255|2120930|FG002|Overall Study|Withdrew Consent|0
1069247|NCT02010255|2120931|FG003|Overall Study|Withdrew Consent|1
1069248|NCT02010255|2120932|FG004|Overall Study|Withdrew Consent|0
1069249|NCT02010255|2120933|FG005|Overall Study|Withdrew Consent|0
1069250|NCT02010255|2120934|FG006|Overall Study|Withdrew Consent|0
1069251|NCT02010255|2120935|FG007|Overall Study|Withdrew Consent|0
1069252|NCT02010255|2120936|FG008|Overall Study|Withdrew Consent|0
1069253|NCT02010255|2120937|FG009|Overall Study|Withdrew Consent|0
1069254|NCT02010255|2120938|FG010|Overall Study|Withdrew Consent|0
1069255|NCT02010255|2120939|FG011|Overall Study|Withdrew Consent|0
1069256|NCT02010255|2120940|FG012|Overall Study|Withdrew Consent|0
1069257|NCT02010255|2120941|FG013|Overall Study|Withdrew Consent|0
1069258|NCT02010255|2120928|FG000|Overall Study|Adverse Event|1
1069259|NCT02010255|2120929|FG001|Overall Study|Adverse Event|0
1069260|NCT02010255|2120930|FG002|Overall Study|Adverse Event|0
1069261|NCT02010255|2120931|FG003|Overall Study|Adverse Event|0
1069262|NCT02010255|2120932|FG004|Overall Study|Adverse Event|0
1069263|NCT02010255|2120933|FG005|Overall Study|Adverse Event|0
1069264|NCT02010255|2120934|FG006|Overall Study|Adverse Event|0
1069265|NCT02010255|2120935|FG007|Overall Study|Adverse Event|0
1069266|NCT02010255|2120936|FG008|Overall Study|Adverse Event|0
1069267|NCT02010255|2120937|FG009|Overall Study|Adverse Event|0
1069268|NCT02010255|2120938|FG010|Overall Study|Adverse Event|0
1069269|NCT02010255|2120939|FG011|Overall Study|Adverse Event|0
1069270|NCT02010255|2120940|FG012|Overall Study|Adverse Event|0
1069271|NCT02010255|2120941|FG013|Overall Study|Adverse Event|0
1069272|NCT02010255|2120928|FG000|Overall Study|Lost to Follow-up|0
1069273|NCT02010255|2120929|FG001|Overall Study|Lost to Follow-up|0
1069274|NCT02010255|2120930|FG002|Overall Study|Lost to Follow-up|1
1069275|NCT02010255|2120931|FG003|Overall Study|Lost to Follow-up|0
1069276|NCT02010255|2120932|FG004|Overall Study|Lost to Follow-up|1
1069277|NCT02010255|2120933|FG005|Overall Study|Lost to Follow-up|0
1069278|NCT02010255|2120934|FG006|Overall Study|Lost to Follow-up|0
1069279|NCT02010255|2120935|FG007|Overall Study|Lost to Follow-up|0
1069280|NCT02010255|2120936|FG008|Overall Study|Lost to Follow-up|0
1069281|NCT02010255|2120937|FG009|Overall Study|Lost to Follow-up|0
1069282|NCT02010255|2120938|FG010|Overall Study|Lost to Follow-up|0
1069283|NCT02010255|2120939|FG011|Overall Study|Lost to Follow-up|0
1069284|NCT02010255|2120940|FG012|Overall Study|Lost to Follow-up|0
1069285|NCT02010255|2120941|FG013|Overall Study|Lost to Follow-up|0
1069286|NCT02010255|2120928|FG000|Overall Study|Randomized but Not Treated|0
1069287|NCT02010255|2120929|FG001|Overall Study|Randomized but Not Treated|0
1069288|NCT02010255|2120930|FG002|Overall Study|Randomized but Not Treated|0
1069289|NCT02010255|2120931|FG003|Overall Study|Randomized but Not Treated|0
1069290|NCT02010255|2120932|FG004|Overall Study|Randomized but Not Treated|0
1069291|NCT02010255|2120933|FG005|Overall Study|Randomized but Not Treated|0
1069292|NCT02010255|2120934|FG006|Overall Study|Randomized but Not Treated|0
1069293|NCT02010255|2120935|FG007|Overall Study|Randomized but Not Treated|0
1069294|NCT02010255|2120936|FG008|Overall Study|Randomized but Not Treated|0
1069295|NCT02010255|2120937|FG009|Overall Study|Randomized but Not Treated|0
1069296|NCT02010255|2120938|FG010|Overall Study|Randomized but Not Treated|0
1069297|NCT02010255|2120939|FG011|Overall Study|Randomized but Not Treated|0
1069298|NCT02010255|2120940|FG012|Overall Study|Randomized but Not Treated|0
1069299|NCT02010255|2120941|FG013|Overall Study|Randomized but Not Treated|1
1069300|NCT02010567|2121010|FG000|Overall Study|Adverse Event|0
1069301|NCT02010567|2121011|FG001|Overall Study|Adverse Event|0
1069302|NCT02010567|2121012|FG002|Overall Study|Adverse Event|1
1069303|NCT02010567|2121013|FG003|Overall Study|Adverse Event|0
1069304|NCT02010567|2121014|FG004|Overall Study|Adverse Event|1
1069305|NCT02010632|2121024|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
1069306|NCT02010632|2121025|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
1069307|NCT02010684|2121037|FG000|Overall Study|Lost to Follow-up|8
1069308|NCT02010684|2121038|FG001|Overall Study|Lost to Follow-up|18
1069309|NCT02010684|2121037|FG000|Overall Study|Withdrawal by Subject|4
1069310|NCT02010684|2121038|FG001|Overall Study|Withdrawal by Subject|5
1069311|NCT02010775|2121062|FG000|Overall Study|Adverse Event|0
1069312|NCT02010775|2121063|FG001|Overall Study|Adverse Event|0
1069313|NCT02010775|2121064|FG002|Overall Study|Adverse Event|0
1069314|NCT02010775|2121065|FG003|Overall Study|Adverse Event|0
1069315|NCT02010775|2121066|FG004|Overall Study|Adverse Event|1
1069316|NCT02010775|2121062|FG000|Overall Study|Pregnancy|0
1069317|NCT02010775|2121063|FG001|Overall Study|Pregnancy|0
1069318|NCT02010775|2121064|FG002|Overall Study|Pregnancy|2
1069319|NCT02010775|2121065|FG003|Overall Study|Pregnancy|0
1069320|NCT02010775|2121066|FG004|Overall Study|Pregnancy|0
1069321|NCT02010775|2121062|FG000|Overall Study|Lost to Follow-up|2
1069322|NCT02010775|2121063|FG001|Overall Study|Lost to Follow-up|0
1069323|NCT02010775|2121064|FG002|Overall Study|Lost to Follow-up|0
1069324|NCT02010775|2121065|FG003|Overall Study|Lost to Follow-up|1
1069325|NCT02010775|2121066|FG004|Overall Study|Lost to Follow-up|1
1069326|NCT02010775|2121062|FG000|Overall Study|Personal Reasons|3
1069327|NCT02010775|2121063|FG001|Overall Study|Personal Reasons|3
1069328|NCT02010775|2121064|FG002|Overall Study|Personal Reasons|1
1069329|NCT02010775|2121065|FG003|Overall Study|Personal Reasons|2
1069330|NCT02010775|2121066|FG004|Overall Study|Personal Reasons|4
1069331|NCT02011113|2121091|FG000|Overall Study|Adverse Event|4
1069332|NCT02011113|2121091|FG000|Overall Study|Disease Progression (DP)|16
1069333|NCT02011113|2121091|FG000|Overall Study|Death|1
1069334|NCT02011113|2121091|FG000|Overall Study|Insufficient effect of Pomalidomide|1
1069335|NCT02011113|2121091|FG000|Overall Study|Investigator's judgement- DP|3
1069336|NCT02011113|2121091|FG000|Overall Study|Study terminated by sponsor|11
1069337|NCT02011386|2121096|FG000|Overall Study|Non-compliance|2
1069338|NCT02011386|2121096|FG000|Overall Study|Lack of Efficacy|3
1069339|NCT02011893|2121152|FG000|Enrollment to Randomization|Adverse Event|2
1069340|NCT02011893|2121153|FG001|Enrollment to Randomization|Adverse Event|0
1069341|NCT02011893|2121154|FG002|Enrollment to Randomization|Adverse Event|0
1069342|NCT02011893|2121152|FG000|Enrollment to Randomization|Physician Decision|10
1069343|NCT02011893|2121153|FG001|Enrollment to Randomization|Physician Decision|0
1069344|NCT02011893|2121154|FG002|Enrollment to Randomization|Physician Decision|0
1069345|NCT02011893|2121152|FG000|Enrollment to Randomization|Withdrawal by Subject|21
1069346|NCT02011893|2121153|FG001|Enrollment to Randomization|Withdrawal by Subject|0
1069347|NCT02011893|2121154|FG002|Enrollment to Randomization|Withdrawal by Subject|0
1069348|NCT02011893|2121152|FG000|Enrollment to Randomization|Screening Failure|29
1069349|NCT02011893|2121153|FG001|Enrollment to Randomization|Screening Failure|0
1069350|NCT02011893|2121154|FG002|Enrollment to Randomization|Screening Failure|0
1069351|NCT02011893|2121152|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
1069352|NCT02011893|2121153|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
1069353|NCT02011893|2121154|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
1069354|NCT02011893|2121152|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2
1069355|NCT02011893|2121153|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0
1069356|NCT02011893|2121154|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0
1069357|NCT02011893|2121152|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
1069358|NCT02011893|2121153|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
1069359|NCT02011893|2121154|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
1069360|NCT02011893|2121152|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
1069361|NCT02011893|2121153|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
1069362|NCT02011893|2121154|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
1069363|NCT02011893|2121152|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
1069364|NCT02011893|2121153|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
1069365|NCT02011893|2121154|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
1069366|NCT02011945|2121162|FG000|Overall Study|Participant requested to Discontinue|0
1069367|NCT02011945|2121163|FG001|Overall Study|Participant requested to Discontinue|1
1069368|NCT02011945|2121164|FG002|Overall Study|Participant requested to Discontinue|1
1069369|NCT02011945|2121162|FG000|Overall Study|Adverse Event unrelated to Drug|0
1069370|NCT02011945|2121163|FG001|Overall Study|Adverse Event unrelated to Drug|2
1069371|NCT02011945|2121164|FG002|Overall Study|Adverse Event unrelated to Drug|1
1069372|NCT02011945|2121162|FG000|Overall Study|Study Drug Toxicity|0
1069373|NCT02011945|2121163|FG001|Overall Study|Study Drug Toxicity|0
1069374|NCT02011945|2121164|FG002|Overall Study|Study Drug Toxicity|1
1069375|NCT02011945|2121162|FG000|Overall Study|Treatment Failure|0
1069376|NCT02011945|2121163|FG001|Overall Study|Treatment Failure|7
1069377|NCT02011945|2121164|FG002|Overall Study|Treatment Failure|6
1069378|NCT02011945|2121162|FG000|Overall Study|No Longer Meets Study Criteria|1
1069379|NCT02011945|2121163|FG001|Overall Study|No Longer Meets Study Criteria|0
1069380|NCT02011945|2121164|FG002|Overall Study|No Longer Meets Study Criteria|0
1069381|NCT02011945|2121162|FG000|Overall Study|Proceeded to stem cell transplant|0
1069382|NCT02011945|2121163|FG001|Overall Study|Proceeded to stem cell transplant|0
1069383|NCT02011945|2121164|FG002|Overall Study|Proceeded to stem cell transplant|1
1069384|NCT02011945|2121162|FG000|Overall Study|Sub-Optimal Response to dasatinib|1
1069385|NCT02011945|2121163|FG001|Overall Study|Sub-Optimal Response to dasatinib|0
1069386|NCT02011945|2121164|FG002|Overall Study|Sub-Optimal Response to dasatinib|0
1069387|NCT02012218|2121186|FG000|Overall Study|Withdrawal by Subject|1
1069388|NCT02012218|2121187|FG001|Overall Study|Withdrawal by Subject|0
1069389|NCT02012218|2121188|FG002|Overall Study|Withdrawal by Subject|1
1069390|NCT02012218|2121189|FG003|Overall Study|Withdrawal by Subject|1
1069391|NCT02012218|2121190|FG004|Overall Study|Withdrawal by Subject|1
1069392|NCT02012218|2121186|FG000|Overall Study|Adverse Event|1
1069393|NCT02012218|2121187|FG001|Overall Study|Adverse Event|0
1069394|NCT02012218|2121188|FG002|Overall Study|Adverse Event|0
1069395|NCT02012218|2121189|FG003|Overall Study|Adverse Event|1
1069396|NCT02012218|2121190|FG004|Overall Study|Adverse Event|0
1069397|NCT02012218|2121186|FG000|Overall Study|Lost to Follow-up|0
1069398|NCT02012218|2121187|FG001|Overall Study|Lost to Follow-up|1
1069399|NCT02012218|2121188|FG002|Overall Study|Lost to Follow-up|1
1069400|NCT02012218|2121189|FG003|Overall Study|Lost to Follow-up|0
1069401|NCT02012218|2121190|FG004|Overall Study|Lost to Follow-up|0
1069402|NCT02012218|2121186|FG000|Overall Study|Protocol Specified|1
1069403|NCT02012218|2121187|FG001|Overall Study|Protocol Specified|0
1069404|NCT02012218|2121188|FG002|Overall Study|Protocol Specified|0
1069405|NCT02012218|2121189|FG003|Overall Study|Protocol Specified|0
1069406|NCT02012218|2121190|FG004|Overall Study|Protocol Specified|0
1069407|NCT02012218|2121186|FG000|Overall Study|Protocol Deviation|1
1069408|NCT02012218|2121187|FG001|Overall Study|Protocol Deviation|0
1069409|NCT02012218|2121188|FG002|Overall Study|Protocol Deviation|0
1069410|NCT02012218|2121189|FG003|Overall Study|Protocol Deviation|0
1069411|NCT02012218|2121190|FG004|Overall Study|Protocol Deviation|0
1069412|NCT02012452|2121231|FG000|Overall Study|Lost to Follow-up|2
1069413|NCT02012452|2121232|FG001|Overall Study|Lost to Follow-up|1
1069414|NCT02012452|2121231|FG000|Overall Study|Withdrawal by Subject|4
1069415|NCT02012452|2121232|FG001|Overall Study|Withdrawal by Subject|0
1069416|NCT02012491|2121240|FG000|Overall Study|Lost to Follow-up|1
1069417|NCT02012491|2121241|FG001|Overall Study|Lost to Follow-up|0
1069418|NCT02012491|2121240|FG000|Overall Study|Protocol Violation|0
1069419|NCT02012491|2121241|FG001|Overall Study|Protocol Violation|1
1069420|NCT02012491|2121240|FG000|Overall Study|Withdrawal by Subject|1
1069421|NCT02012491|2121241|FG001|Overall Study|Withdrawal by Subject|0
1069422|NCT02012686|2121270|FG000|Overall Study|muscle contraction|0
1069423|NCT02012686|2121271|FG001|Overall Study|muscle contraction|1
1069424|NCT02012686|2121270|FG000|Overall Study|electrocardiography monitoring noise|0
1069425|NCT02012686|2121271|FG001|Overall Study|electrocardiography monitoring noise|1
1069426|NCT02012959|2121277|FG000|Treatment Phase A|Adverse Event|2
1069427|NCT02012959|2121278|FG001|Treatment Phase A|Adverse Event|0
1069428|NCT02012959|2121279|FG002|Treatment Phase A|Adverse Event|0
1069429|NCT02012959|2121280|FG003|Treatment Phase A|Adverse Event|0
1069430|NCT02012959|2121281|FG004|Treatment Phase A|Adverse Event|0
1069431|NCT02013037|2121291|FG000|Overall Study|Death|6
1069432|NCT02013037|2121291|FG000|Overall Study|Withdrawal by Subject|1
1069433|NCT02013037|2121291|FG000|Overall Study|Awaiting Transplantation|7
1069434|NCT02013037|2121291|FG000|Overall Study|Transplanted without DSA|2
1069443|NCT02013206|2121334|FG000|Overall Study|Progressive disease (PD)|14
1069444|NCT02013206|2121335|FG001|Overall Study|Progressive disease (PD)|17
1069445|NCT02013206|2121334|FG000|Overall Study|Symptomatic deterioration|3
1069446|NCT02013206|2121335|FG001|Overall Study|Symptomatic deterioration|1
1069447|NCT02013206|2121334|FG000|Overall Study|Adverse Event|1
1069448|NCT02013206|2121335|FG001|Overall Study|Adverse Event|0
1069449|NCT02013206|2121334|FG000|Overall Study|Patient refusal|2
1069450|NCT02013206|2121335|FG001|Overall Study|Patient refusal|0
1069451|NCT02013206|2121334|FG000|Overall Study|Patient non-compliance|1
1069452|NCT02013206|2121335|FG001|Overall Study|Patient non-compliance|0
1069453|NCT02013206|2121334|FG000|Overall Study|Death|1
1069454|NCT02013206|2121335|FG001|Overall Study|Death|2
1069455|NCT02013206|2121334|FG000|Overall Study|Other reasons off treatment|5
1069456|NCT02013206|2121335|FG001|Overall Study|Other reasons off treatment|2
1069457|NCT02013375|2121358|FG000|Overall Study|Did not engraft|1
1069458|NCT02013375|2121358|FG000|Overall Study|Did not engraft|1
1069459|NCT02013388|2121371|FG000|Overall Study|work emergency|1
1069460|NCT02013388|2121372|FG001|Overall Study|work emergency|0
1069461|NCT02013388|2121373|FG002|Overall Study|work emergency|0
1069462|NCT02013388|2121374|FG003|Overall Study|work emergency|0
1069463|NCT02013388|2121375|FG004|Overall Study|work emergency|1
1069464|NCT02013388|2121376|FG005|Overall Study|work emergency|0
1069465|NCT02013388|2121377|FG006|Overall Study|work emergency|0
1069466|NCT02013388|2121378|FG007|Overall Study|work emergency|0
1069467|NCT02013531|2121400|FG000|Overall Study|Lost to Follow-up|3
1069468|NCT02013531|2121400|FG000|Overall Study|Met Withdrawal Criteria|1
1069469|NCT02013531|2121400|FG000|Overall Study|Withdrawal by Subject|1
1069470|NCT02013544|2121406|FG000|Overall Study|Adverse Event|5
1069471|NCT02013544|2121407|FG001|Overall Study|Adverse Event|5
1069472|NCT02013544|2121406|FG000|Overall Study|Lost to Follow-up|2
1069473|NCT02013544|2121407|FG001|Overall Study|Lost to Follow-up|3
1069474|NCT02013544|2121406|FG000|Overall Study|Withdrawal by Subject|2
1069475|NCT02013544|2121407|FG001|Overall Study|Withdrawal by Subject|8
1069476|NCT02013544|2121406|FG000|Overall Study|Physician Decision|0
1069477|NCT02013544|2121407|FG001|Overall Study|Physician Decision|1
1069478|NCT02013544|2121406|FG000|Overall Study|Entry criteria not met/non-compliance|2
1069479|NCT02013544|2121407|FG001|Overall Study|Entry criteria not met/non-compliance|3
1069480|NCT02013609|2121413|FG000|Overall Study|Withdrawal by Subject|9
1069481|NCT02013609|2121413|FG000|Overall Study|Lost to Follow-up|3
1069482|NCT02013609|2121413|FG000|Overall Study|Adverse Event|3
1069483|NCT02013609|2121413|FG000|Overall Study|Met Withdrawal Criteria|3
1069484|NCT02013622|2121417|FG000|Overall Study|Lost to Follow-up|10
1069485|NCT02013622|2121417|FG000|Overall Study|Adverse Event|3
1069486|NCT02013622|2121417|FG000|Overall Study|Met Withdrawal Criteria|3
1069487|NCT02013622|2121417|FG000|Overall Study|Withdrawal by Subject|6
1069488|NCT02013622|2121417|FG000|Overall Study|Protocol Deviation|1
1069489|NCT02013622|2121417|FG000|Overall Study|Lack of Efficacy|1
1069490|NCT02013674|2121423|FG000|Overall Study|Death|0
1069491|NCT02013674|2121424|FG001|Overall Study|Death|1
1069492|NCT02013674|2121423|FG000|Overall Study|Lost to Follow-up|1
1069493|NCT02013674|2121424|FG001|Overall Study|Lost to Follow-up|0
1069494|NCT02013687|2121434|FG000|Overall Study|Lost to Follow-up|0
1069495|NCT02013687|2121435|FG001|Overall Study|Lost to Follow-up|0
1069496|NCT02013687|2121436|FG002|Overall Study|Lost to Follow-up|1
1069497|NCT02013687|2121437|FG003|Overall Study|Lost to Follow-up|0
1069498|NCT02013687|2121434|FG000|Overall Study|Protocol Violation|0
1069499|NCT02013687|2121435|FG001|Overall Study|Protocol Violation|0
1069500|NCT02013687|2121436|FG002|Overall Study|Protocol Violation|0
1069501|NCT02013687|2121437|FG003|Overall Study|Protocol Violation|1
1069502|NCT02013687|2121434|FG000|Overall Study|Withdrawal by Subject|0
1069503|NCT02013687|2121435|FG001|Overall Study|Withdrawal by Subject|0
1069504|NCT02013687|2121436|FG002|Overall Study|Withdrawal by Subject|0
1069505|NCT02013687|2121437|FG003|Overall Study|Withdrawal by Subject|1
1069506|NCT02013687|2121434|FG000|Overall Study|Missed visits due to patient travel|0
1069507|NCT02013687|2121435|FG001|Overall Study|Missed visits due to patient travel|0
1069508|NCT02013687|2121436|FG002|Overall Study|Missed visits due to patient travel|1
1069509|NCT02013687|2121437|FG003|Overall Study|Missed visits due to patient travel|0
1069510|NCT02013765|2121451|FG000|Overall Study|Trial was terminated by sponsor|1
1069511|NCT02013778|2121455|FG000|Overall Study|Death|4
1069512|NCT02013778|2121455|FG000|Overall Study|Withdrawal by Subject|1
1069513|NCT02013778|2121455|FG000|Overall Study|Physician Decision|1
1069514|NCT02013778|2121455|FG000|Overall Study|Adverse Event|1
1069515|NCT02013791|2121468|FG000|Period 1|Lost to Follow-up|0
1069516|NCT02013791|2121469|FG001|Period 1|Lost to Follow-up|0
1069517|NCT02013791|2121470|FG002|Period 1|Lost to Follow-up|0
1069518|NCT02013791|2121471|FG003|Period 1|Lost to Follow-up|1
1069519|NCT02013791|2121472|FG004|Period 1|Lost to Follow-up|0
1069520|NCT02013791|2121473|FG005|Period 1|Lost to Follow-up|0
1069521|NCT02013791|2121474|FG006|Period 1|Lost to Follow-up|1
1069522|NCT02013791|2121475|FG007|Period 1|Lost to Follow-up|1
1069523|NCT02013791|2121476|FG008|Period 1|Lost to Follow-up|0
1069524|NCT02013791|2121468|FG000|Period 1|Other Miscellaneous Reasons|0
1069525|NCT02013791|2121469|FG001|Period 1|Other Miscellaneous Reasons|2
1069526|NCT02013791|2121470|FG002|Period 1|Other Miscellaneous Reasons|0
1069527|NCT02013791|2121471|FG003|Period 1|Other Miscellaneous Reasons|0
1069528|NCT02013791|2121472|FG004|Period 1|Other Miscellaneous Reasons|0
1069529|NCT02013791|2121473|FG005|Period 1|Other Miscellaneous Reasons|0
1069530|NCT02013791|2121474|FG006|Period 1|Other Miscellaneous Reasons|0
1069531|NCT02013791|2121475|FG007|Period 1|Other Miscellaneous Reasons|0
1069532|NCT02013791|2121476|FG008|Period 1|Other Miscellaneous Reasons|0
1069533|NCT02013817|2121497|FG000|Overall Study|Adverse Event|12
1069534|NCT02013817|2121497|FG000|Overall Study|Withdrawal by Subject|4
1069535|NCT02013817|2121497|FG000|Overall Study|Death|2
1069536|NCT02013817|2121497|FG000|Overall Study|Other|9
1069537|NCT02013830|2121501|FG000|Overall Study|Adverse Event|3
1069538|NCT02013830|2121501|FG000|Overall Study|Death|1
1069539|NCT02013830|2121501|FG000|Overall Study|Insufficient therapeutic response|25
1069540|NCT02013830|2121501|FG000|Overall Study|Refused treatment|1
1069541|NCT02014116|2121522|FG000|Overall Study|Progressive Disease|3
1069542|NCT02014116|2121523|FG001|Overall Study|Progressive Disease|4
1069543|NCT02014116|2121524|FG002|Overall Study|Progressive Disease|2
1069544|NCT02014116|2121525|FG003|Overall Study|Progressive Disease|6
1069545|NCT02014116|2121526|FG004|Overall Study|Progressive Disease|1
1069546|NCT02014116|2121527|FG005|Overall Study|Progressive Disease|13
1069547|NCT02014116|2121528|FG006|Overall Study|Progressive Disease|1
1069548|NCT02014116|2121529|FG007|Overall Study|Progressive Disease|3
1069549|NCT02014116|2121530|FG008|Overall Study|Progressive Disease|7
908289|NCT00781963|1884873|FG001|Overall Study|Refused follow-up|0
908290|NCT00782067|1884879|FG000|Overall Study|Adverse Event|35
908291|NCT00782067|1884879|FG000|Overall Study|Subject withdrew consent|11
908292|NCT00782067|1884879|FG000|Overall Study|Lost to Follow-up|2
908293|NCT00782067|1884879|FG000|Overall Study|Administrative problems|14
908294|NCT00782067|1884879|FG000|Overall Study|Death|9
908295|NCT00782067|1884879|FG000|Overall Study|Disease progression|43
908296|NCT00782067|1884879|FG000|Overall Study|Protocol deviation|2
908297|NCT00782171|1884885|FG000|Overall Study|Lost to Follow-up|2
908298|NCT00782171|1884886|FG001|Overall Study|Lost to Follow-up|2
908299|NCT00782171|1884885|FG000|Overall Study|Withdrawal by Subject|2
1069550|NCT02014116|2121522|FG000|Overall Study|Adverse Event|0
1069551|NCT02014116|2121523|FG001|Overall Study|Adverse Event|0
1069552|NCT02014116|2121524|FG002|Overall Study|Adverse Event|0
1069553|NCT02014116|2121525|FG003|Overall Study|Adverse Event|0
1069554|NCT02014116|2121526|FG004|Overall Study|Adverse Event|1
1069555|NCT02014116|2121527|FG005|Overall Study|Adverse Event|0
1069556|NCT02014116|2121528|FG006|Overall Study|Adverse Event|0
1069557|NCT02014116|2121529|FG007|Overall Study|Adverse Event|1
1069558|NCT02014116|2121530|FG008|Overall Study|Adverse Event|0
1069559|NCT02014116|2121522|FG000|Overall Study|Lost to Follow-up|0
1069560|NCT02014116|2121523|FG001|Overall Study|Lost to Follow-up|0
1069561|NCT02014116|2121524|FG002|Overall Study|Lost to Follow-up|0
1069562|NCT02014116|2121525|FG003|Overall Study|Lost to Follow-up|0
1069563|NCT02014116|2121526|FG004|Overall Study|Lost to Follow-up|0
1069564|NCT02014116|2121527|FG005|Overall Study|Lost to Follow-up|1
1069565|NCT02014116|2121528|FG006|Overall Study|Lost to Follow-up|0
1069566|NCT02014116|2121529|FG007|Overall Study|Lost to Follow-up|0
1069567|NCT02014116|2121530|FG008|Overall Study|Lost to Follow-up|1
1069568|NCT02014116|2121522|FG000|Overall Study|Death|0
1069569|NCT02014116|2121523|FG001|Overall Study|Death|0
1069570|NCT02014116|2121524|FG002|Overall Study|Death|0
1069571|NCT02014116|2121525|FG003|Overall Study|Death|0
1069572|NCT02014116|2121526|FG004|Overall Study|Death|0
1069573|NCT02014116|2121527|FG005|Overall Study|Death|0
1069574|NCT02014116|2121528|FG006|Overall Study|Death|0
1069575|NCT02014116|2121529|FG007|Overall Study|Death|1
1069576|NCT02014116|2121530|FG008|Overall Study|Death|1
1069577|NCT02014116|2121522|FG000|Overall Study|Withdrawal by Subject|0
1069578|NCT02014116|2121523|FG001|Overall Study|Withdrawal by Subject|0
1069579|NCT02014116|2121524|FG002|Overall Study|Withdrawal by Subject|1
1069580|NCT02014116|2121525|FG003|Overall Study|Withdrawal by Subject|1
1069581|NCT02014116|2121526|FG004|Overall Study|Withdrawal by Subject|0
1069582|NCT02014116|2121527|FG005|Overall Study|Withdrawal by Subject|1
1069583|NCT02014116|2121528|FG006|Overall Study|Withdrawal by Subject|0
1069584|NCT02014116|2121529|FG007|Overall Study|Withdrawal by Subject|0
1069585|NCT02014116|2121530|FG008|Overall Study|Withdrawal by Subject|0
1069586|NCT02014116|2121522|FG000|Overall Study|Withdrawal Caregiver Decision|0
1069587|NCT02014116|2121523|FG001|Overall Study|Withdrawal Caregiver Decision|0
1069588|NCT02014116|2121524|FG002|Overall Study|Withdrawal Caregiver Decision|0
1069589|NCT02014116|2121525|FG003|Overall Study|Withdrawal Caregiver Decision|0
1069590|NCT02014116|2121526|FG004|Overall Study|Withdrawal Caregiver Decision|0
1069591|NCT02014116|2121527|FG005|Overall Study|Withdrawal Caregiver Decision|1
1069592|NCT02014116|2121528|FG006|Overall Study|Withdrawal Caregiver Decision|0
1069593|NCT02014116|2121529|FG007|Overall Study|Withdrawal Caregiver Decision|0
1069594|NCT02014116|2121530|FG008|Overall Study|Withdrawal Caregiver Decision|0
1069595|NCT02014116|2121522|FG000|Overall Study|Physician Decision|0
1069596|NCT02014116|2121523|FG001|Overall Study|Physician Decision|0
1069597|NCT02014116|2121524|FG002|Overall Study|Physician Decision|0
1069598|NCT02014116|2121525|FG003|Overall Study|Physician Decision|0
1069599|NCT02014116|2121526|FG004|Overall Study|Physician Decision|0
1069600|NCT02014116|2121527|FG005|Overall Study|Physician Decision|0
1069601|NCT02014116|2121528|FG006|Overall Study|Physician Decision|0
1069602|NCT02014116|2121529|FG007|Overall Study|Physician Decision|0
1069603|NCT02014116|2121530|FG008|Overall Study|Physician Decision|1
1069604|NCT02014272|2121566|FG000|Intervention Period 1|Withdrawal by Subject|1
1069605|NCT02014272|2121567|FG001|Intervention Period 1|Withdrawal by Subject|0
1069606|NCT02014272|2121566|FG000|Intervention Period 1|Adverse Event|0
1069607|NCT02014272|2121567|FG001|Intervention Period 1|Adverse Event|1
1069608|NCT02014376|2121589|FG000|Overall Study|Adverse Event|1
1069609|NCT02014376|2121590|FG001|Overall Study|Adverse Event|1
1069610|NCT02014376|2121591|FG002|Overall Study|Adverse Event|0
1069611|NCT02014376|2121589|FG000|Overall Study|Lost to Follow-up|2
1069612|NCT02014376|2121590|FG001|Overall Study|Lost to Follow-up|0
1069613|NCT02014376|2121591|FG002|Overall Study|Lost to Follow-up|0
1069614|NCT02014402|2121603|FG000|Overall Study|Adverse Event|1
1069615|NCT02014402|2121604|FG001|Overall Study|Adverse Event|0
1069616|NCT02014402|2121605|FG002|Overall Study|Adverse Event|0
1069617|NCT02014402|2121606|FG003|Overall Study|Adverse Event|0
1069618|NCT02014402|2121603|FG000|Overall Study|Withdrawal by Subject|1
1069619|NCT02014402|2121604|FG001|Overall Study|Withdrawal by Subject|2
1069620|NCT02014402|2121605|FG002|Overall Study|Withdrawal by Subject|2
1069621|NCT02014402|2121606|FG003|Overall Study|Withdrawal by Subject|1
1069622|NCT02014402|2121603|FG000|Overall Study|Subject did not have transportation|0
1069623|NCT02014402|2121604|FG001|Overall Study|Subject did not have transportation|1
1069624|NCT02014402|2121605|FG002|Overall Study|Subject did not have transportation|0
1069625|NCT02014402|2121606|FG003|Overall Study|Subject did not have transportation|0
1069626|NCT02014402|2121603|FG000|Overall Study|Lost to Follow-up|0
1069627|NCT02014402|2121604|FG001|Overall Study|Lost to Follow-up|0
1069628|NCT02014402|2121605|FG002|Overall Study|Lost to Follow-up|1
1069629|NCT02014402|2121606|FG003|Overall Study|Lost to Follow-up|2
1069630|NCT02014441|2121623|FG000|Overall Study|Withdrawal by Subject|12
1069631|NCT02014467|2121631|FG000|Overall Study|Adverse Event|4
1069632|NCT02014467|2121632|FG001|Overall Study|Adverse Event|0
1069633|NCT02014467|2121631|FG000|Overall Study|Protocol Violation|3
1069634|NCT02014467|2121632|FG001|Overall Study|Protocol Violation|0
1069635|NCT02014467|2121631|FG000|Overall Study|Physician Decision|2
1069636|NCT02014467|2121632|FG001|Overall Study|Physician Decision|3
1069637|NCT02014467|2121631|FG000|Overall Study|Withdrawal by Subject|16
1069638|NCT02014467|2121632|FG001|Overall Study|Withdrawal by Subject|4
1069639|NCT02014480|2121638|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1069640|NCT02014480|2121639|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1069641|NCT02014480|2121640|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1
1069642|NCT02014480|2121641|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1069643|NCT02014480|2121642|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1069644|NCT02014480|2121643|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1069645|NCT02014480|2121638|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1069646|NCT02014480|2121639|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1069647|NCT02014480|2121640|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1069648|NCT02014480|2121641|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
1069649|NCT02014480|2121642|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1069650|NCT02014480|2121643|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1069651|NCT02014480|2121638|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1069652|NCT02014480|2121639|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1069653|NCT02014480|2121640|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
1069654|NCT02014480|2121641|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1069655|NCT02014480|2121642|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1069656|NCT02014480|2121643|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1069657|NCT02014480|2121638|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1
1069658|NCT02014480|2121639|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1
1069659|NCT02014480|2121640|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2
1069660|NCT02014480|2121641|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
1069661|NCT02014480|2121642|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
1069662|NCT02014480|2121643|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
1069663|NCT02014480|2121638|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1069664|NCT02014480|2121639|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
1069665|NCT02014480|2121640|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1069666|NCT02014480|2121641|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1069667|NCT02014480|2121642|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1069668|NCT02014480|2121643|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1069669|NCT02014480|2121638|FG000|Treatment Period 3 (14 Days)|Adverse Event|0
1069670|NCT02014480|2121639|FG001|Treatment Period 3 (14 Days)|Adverse Event|0
1069671|NCT02014480|2121640|FG002|Treatment Period 3 (14 Days)|Adverse Event|1
1069672|NCT02014480|2121641|FG003|Treatment Period 3 (14 Days)|Adverse Event|0
1069673|NCT02014480|2121642|FG004|Treatment Period 3 (14 Days)|Adverse Event|0
1069674|NCT02014480|2121643|FG005|Treatment Period 3 (14 Days)|Adverse Event|1
1069675|NCT02014480|2121638|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1069676|NCT02014480|2121639|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1069677|NCT02014480|2121640|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1069678|NCT02014480|2121641|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1069679|NCT02014480|2121642|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1069680|NCT02014480|2121643|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1
1069681|NCT02014584|2121732|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0
1069682|NCT02014584|2121733|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1
1069683|NCT02014584|2121734|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0
1069684|NCT02014584|2121735|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0
1069685|NCT02014584|2121736|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0
1069686|NCT02014584|2121737|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0
1069687|NCT02014584|2121732|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
1069688|NCT02014584|2121733|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
1069689|NCT02014584|2121734|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1069690|NCT02014584|2121735|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1069691|NCT02014584|2121736|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1069692|NCT02014584|2121737|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1069693|NCT02014584|2121732|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1069694|NCT02014584|2121733|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1069695|NCT02014584|2121734|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2
1069696|NCT02014584|2121735|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1069697|NCT02014584|2121736|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1069698|NCT02014584|2121737|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1069699|NCT02014584|2121732|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1069700|NCT02014584|2121733|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1069701|NCT02014584|2121734|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
1069702|NCT02014584|2121735|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
1069703|NCT02014584|2121736|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1069704|NCT02014584|2121737|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1069705|NCT02014584|2121732|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1069706|NCT02014584|2121733|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1069707|NCT02014584|2121734|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1069708|NCT02014584|2121735|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1069709|NCT02014584|2121736|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
1069710|NCT02014584|2121737|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1069711|NCT02014597|2121751|FG000|Overall Study|Unable to record log contrast sensitivity|2
1069712|NCT02014597|2121752|FG001|Overall Study|Unable to record log contrast sensitivity|1
1069713|NCT02014740|2121760|FG000|Overall Study|Lost to Follow-up|4
1069714|NCT02014740|2121761|FG001|Overall Study|Lost to Follow-up|4
1069715|NCT02014740|2121760|FG000|Overall Study|Withdrawal by Subject|2
1069716|NCT02014740|2121761|FG001|Overall Study|Withdrawal by Subject|1
1069717|NCT02015039|2121769|FG000|Overall Study|Not eligible|0
1069718|NCT02015039|2121770|FG001|Overall Study|Not eligible|1
1069719|NCT02015065|2121779|FG000|Overall Study|Death on study|1
1069720|NCT02015065|2121780|FG001|Overall Study|Death on study|2
1069721|NCT02015065|2121781|FG002|Overall Study|Death on study|1
1069722|NCT02015104|2121791|FG000|Overall Study|Withdrew consent after first dose drug|1
1069723|NCT02015104|2121792|FG001|Overall Study|Withdrew consent after first dose drug|0
1069724|NCT02015104|2121791|FG000|Overall Study|Withdrew consent prior to treatment|0
1069725|NCT02015104|2121792|FG001|Overall Study|Withdrew consent prior to treatment|1
1069726|NCT02015195|2121808|FG000|Overall Study|Adverse Event|0
1069727|NCT02015195|2121809|FG001|Overall Study|Adverse Event|0
1069728|NCT02015195|2121810|FG002|Overall Study|Adverse Event|0
1069729|NCT02015195|2121811|FG003|Overall Study|Adverse Event|1
1069730|NCT02015195|2121812|FG004|Overall Study|Adverse Event|0
1069731|NCT02015195|2121813|FG005|Overall Study|Adverse Event|0
1069732|NCT02015195|2121814|FG006|Overall Study|Adverse Event|0
1069733|NCT02015221|2121831|FG000|Overall Study|Withdrawal by Subject|8
1069734|NCT02015221|2121832|FG001|Overall Study|Withdrawal by Subject|6
1069735|NCT02015221|2121831|FG000|Overall Study|Lost to Follow-up|1
1069736|NCT02015221|2121832|FG001|Overall Study|Lost to Follow-up|0
1069737|NCT02015390|2121851|FG000|Overall Study|Lost to Follow-up|1
1069738|NCT02015390|2121852|FG001|Overall Study|Lost to Follow-up|0
1069739|NCT02015390|2121851|FG000|Overall Study|Adverse Event|0
1069740|NCT02015390|2121852|FG001|Overall Study|Adverse Event|3
1069741|NCT02015390|2121851|FG000|Overall Study|Physician Decision|0
1069742|NCT02015390|2121852|FG001|Overall Study|Physician Decision|1
1069743|NCT02015481|2121866|FG000|Overall Study|Death|1
1069744|NCT02015520|2121875|FG000|Overall Study|Lack of Efficacy|1
1069745|NCT02015520|2121876|FG001|Overall Study|Lack of Efficacy|0
1069746|NCT02015520|2121877|FG002|Overall Study|Lack of Efficacy|3
1069747|NCT02015520|2121878|FG003|Overall Study|Lack of Efficacy|2
1069748|NCT02015520|2121875|FG000|Overall Study|Adverse Event|0
1069749|NCT02015520|2121876|FG001|Overall Study|Adverse Event|0
1069750|NCT02015520|2121877|FG002|Overall Study|Adverse Event|0
1069751|NCT02015520|2121878|FG003|Overall Study|Adverse Event|1
1069752|NCT02015520|2121875|FG000|Overall Study|Withdrawal by Subject|2
1069753|NCT02015520|2121876|FG001|Overall Study|Withdrawal by Subject|2
1069754|NCT02015520|2121877|FG002|Overall Study|Withdrawal by Subject|1
1069755|NCT02015520|2121878|FG003|Overall Study|Withdrawal by Subject|0
1069756|NCT02015520|2121875|FG000|Overall Study|Death|1
1069757|NCT02015520|2121876|FG001|Overall Study|Death|0
1069758|NCT02015520|2121877|FG002|Overall Study|Death|0
1069759|NCT02015520|2121878|FG003|Overall Study|Death|0
1069760|NCT02015520|2121875|FG000|Overall Study|Lost to Follow-up|0
1069761|NCT02015520|2121876|FG001|Overall Study|Lost to Follow-up|0
1069762|NCT02015520|2121877|FG002|Overall Study|Lost to Follow-up|1
1069763|NCT02015520|2121878|FG003|Overall Study|Lost to Follow-up|0
1069764|NCT02015520|2121875|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1
1069765|NCT02015520|2121876|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1
1069766|NCT02015520|2121877|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2
1069767|NCT02015520|2121878|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1
1069768|NCT02015520|2121875|FG000|Overall Study|Subject no Longer Meets Study Criteria|0
1069769|NCT02015520|2121876|FG001|Overall Study|Subject no Longer Meets Study Criteria|1
1069770|NCT02015520|2121877|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
1069771|NCT02015520|2121878|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
1069772|NCT02015546|2121891|FG000|Overall Study|Withdrawal by Subject|1
1069773|NCT02015546|2121892|FG001|Overall Study|Withdrawal by Subject|1
1069774|NCT02015546|2121893|FG002|Overall Study|Withdrawal by Subject|1
1069775|NCT02015546|2121891|FG000|Overall Study|Screem Failure|2
1069776|NCT02015546|2121892|FG001|Overall Study|Screem Failure|1
1069777|NCT02015546|2121893|FG002|Overall Study|Screem Failure|3
1069778|NCT02015637|2121903|FG000|Overall Study|Lost to Follow-up|3
1069779|NCT02015637|2121904|FG001|Overall Study|Lost to Follow-up|5
1069780|NCT02015637|2121903|FG000|Overall Study|Adverse Event|3
1069781|NCT02015637|2121904|FG001|Overall Study|Adverse Event|0
1069782|NCT02015637|2121903|FG000|Overall Study|Did not take study drug|2
1069783|NCT02015637|2121904|FG001|Overall Study|Did not take study drug|0
908300|NCT00782171|1884886|FG001|Overall Study|Withdrawal by Subject|1
908301|NCT00782171|1884885|FG000|Overall Study|complications|3
908302|NCT00782171|1884886|FG001|Overall Study|complications|1
1069784|NCT02015676|2121913|FG000|Overall Study|Adverse Event|2
1069785|NCT02015676|2121914|FG001|Overall Study|Adverse Event|18
1069786|NCT02015676|2121915|FG002|Overall Study|Adverse Event|0
1069787|NCT02015676|2121913|FG000|Overall Study|Lack of Efficacy|2
1069788|NCT02015676|2121914|FG001|Overall Study|Lack of Efficacy|4
1069789|NCT02015676|2121915|FG002|Overall Study|Lack of Efficacy|0
1069790|NCT02015676|2121913|FG000|Overall Study|Protocol Violation|1
1069791|NCT02015676|2121914|FG001|Overall Study|Protocol Violation|0
1069792|NCT02015676|2121915|FG002|Overall Study|Protocol Violation|0
1069793|NCT02015676|2121913|FG000|Overall Study|Withdrawal by Subject|1
1069794|NCT02015676|2121914|FG001|Overall Study|Withdrawal by Subject|7
1069795|NCT02015676|2121915|FG002|Overall Study|Withdrawal by Subject|1
1069796|NCT02015676|2121913|FG000|Overall Study|Administrative reasons|0
1069797|NCT02015676|2121914|FG001|Overall Study|Administrative reasons|3
1069798|NCT02015676|2121915|FG002|Overall Study|Administrative reasons|1
1069799|NCT02015676|2121913|FG000|Overall Study|Death|0
1069800|NCT02015676|2121914|FG001|Overall Study|Death|1
1069801|NCT02015676|2121915|FG002|Overall Study|Death|0
1069802|NCT02015676|2121913|FG000|Overall Study|Disease progression|3
1069803|NCT02015676|2121914|FG001|Overall Study|Disease progression|1
1069804|NCT02015676|2121915|FG002|Overall Study|Disease progression|1
1069805|NCT02015754|2121919|FG000|Overall Study|Disease progression|5
1069806|NCT02015754|2121919|FG000|Overall Study|Change in treatment modality|5
1069807|NCT02015754|2121919|FG000|Overall Study|Lost to Follow-up|1
1069808|NCT02015793|2121925|FG000|Overall Study|Adverse Event|3
1069809|NCT02015793|2121926|FG001|Overall Study|Adverse Event|3
1069810|NCT02015793|2121925|FG000|Overall Study|Withdrawal by Subject|1
1069811|NCT02015793|2121926|FG001|Overall Study|Withdrawal by Subject|1
1069812|NCT02015819|2121942|FG000|Overall Study|Rickham catheter was misaligned|0
1069813|NCT02015819|2121943|FG001|Overall Study|Rickham catheter was misaligned|0
1069814|NCT02015819|2121944|FG002|Overall Study|Rickham catheter was misaligned|0
1069815|NCT02015819|2121945|FG003|Overall Study|Rickham catheter was misaligned|1
1069816|NCT02016105|2121961|FG000|TREATMENT PERIOD 1|Protocol Violation|2
1069817|NCT02016105|2121962|FG001|TREATMENT PERIOD 1|Protocol Violation|8
1069818|NCT02016105|2121963|FG002|TREATMENT PERIOD 1|Protocol Violation|0
1069819|NCT02016105|2121964|FG003|TREATMENT PERIOD 1|Protocol Violation|0
1069820|NCT02016105|2121965|FG004|TREATMENT PERIOD 1|Protocol Violation|0
1069821|NCT02016105|2121966|FG005|TREATMENT PERIOD 1|Protocol Violation|0
1069822|NCT02016105|2121961|FG000|TREATMENT PERIOD 1|Physician Decision|0
1069823|NCT02016105|2121962|FG001|TREATMENT PERIOD 1|Physician Decision|2
1069824|NCT02016105|2121963|FG002|TREATMENT PERIOD 1|Physician Decision|0
1069825|NCT02016105|2121964|FG003|TREATMENT PERIOD 1|Physician Decision|0
1069826|NCT02016105|2121965|FG004|TREATMENT PERIOD 1|Physician Decision|0
1069827|NCT02016105|2121966|FG005|TREATMENT PERIOD 1|Physician Decision|0
1069828|NCT02016105|2121961|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4
1069829|NCT02016105|2121962|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2
1069830|NCT02016105|2121963|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0
1069831|NCT02016105|2121964|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0
1069832|NCT02016105|2121965|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0
1069833|NCT02016105|2121966|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0
1069834|NCT02016105|2121961|FG000|TREATMENT PERIOD 1|Pregnancy|0
1069835|NCT02016105|2121962|FG001|TREATMENT PERIOD 1|Pregnancy|1
1069836|NCT02016105|2121963|FG002|TREATMENT PERIOD 1|Pregnancy|0
1069837|NCT02016105|2121964|FG003|TREATMENT PERIOD 1|Pregnancy|0
1069838|NCT02016105|2121965|FG004|TREATMENT PERIOD 1|Pregnancy|0
1069839|NCT02016105|2121966|FG005|TREATMENT PERIOD 1|Pregnancy|0
1069840|NCT02016105|2121961|FG000|TREATMENT PERIOD 1|Adverse Event|3
1069841|NCT02016105|2121962|FG001|TREATMENT PERIOD 1|Adverse Event|5
1069842|NCT02016105|2121963|FG002|TREATMENT PERIOD 1|Adverse Event|0
1069843|NCT02016105|2121964|FG003|TREATMENT PERIOD 1|Adverse Event|0
1069844|NCT02016105|2121965|FG004|TREATMENT PERIOD 1|Adverse Event|0
1069845|NCT02016105|2121966|FG005|TREATMENT PERIOD 1|Adverse Event|0
1069846|NCT02016105|2121961|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15
1069847|NCT02016105|2121962|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11
1069848|NCT02016105|2121963|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0
1069849|NCT02016105|2121964|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0
1069850|NCT02016105|2121965|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0
1069851|NCT02016105|2121966|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0
1069852|NCT02016105|2121961|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6
1069853|NCT02016105|2121962|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4
1069854|NCT02016105|2121963|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0
1069855|NCT02016105|2121964|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0
1069856|NCT02016105|2121965|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0
1069857|NCT02016105|2121966|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0
1069858|NCT02016105|2121961|FG000|TREATMENT PERIOD 2|Non compliance study medication|0
1069859|NCT02016105|2121962|FG001|TREATMENT PERIOD 2|Non compliance study medication|0
1069860|NCT02016105|2121963|FG002|TREATMENT PERIOD 2|Non compliance study medication|0
1069861|NCT02016105|2121964|FG003|TREATMENT PERIOD 2|Non compliance study medication|0
1069862|NCT02016105|2121965|FG004|TREATMENT PERIOD 2|Non compliance study medication|0
1069863|NCT02016105|2121966|FG005|TREATMENT PERIOD 2|Non compliance study medication|1
1069864|NCT02016105|2121961|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0
1069865|NCT02016105|2121962|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0
1069866|NCT02016105|2121963|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2
1069867|NCT02016105|2121964|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6
1069868|NCT02016105|2121965|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3
1069869|NCT02016105|2121966|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2
1069870|NCT02016105|2121961|FG000|TREATMENT PERIOD 2|Pregnancy|0
1069871|NCT02016105|2121962|FG001|TREATMENT PERIOD 2|Pregnancy|0
1069872|NCT02016105|2121963|FG002|TREATMENT PERIOD 2|Pregnancy|0
1069873|NCT02016105|2121964|FG003|TREATMENT PERIOD 2|Pregnancy|0
1069874|NCT02016105|2121965|FG004|TREATMENT PERIOD 2|Pregnancy|0
1069875|NCT02016105|2121966|FG005|TREATMENT PERIOD 2|Pregnancy|1
1069876|NCT02016105|2121961|FG000|TREATMENT PERIOD 2|Death|0
1069877|NCT02016105|2121962|FG001|TREATMENT PERIOD 2|Death|0
1069878|NCT02016105|2121963|FG002|TREATMENT PERIOD 2|Death|0
1069879|NCT02016105|2121964|FG003|TREATMENT PERIOD 2|Death|0
1069880|NCT02016105|2121965|FG004|TREATMENT PERIOD 2|Death|0
1069881|NCT02016105|2121966|FG005|TREATMENT PERIOD 2|Death|1
1069882|NCT02016105|2121961|FG000|TREATMENT PERIOD 2|Adverse Event|0
1069883|NCT02016105|2121962|FG001|TREATMENT PERIOD 2|Adverse Event|0
1069884|NCT02016105|2121963|FG002|TREATMENT PERIOD 2|Adverse Event|0
1069885|NCT02016105|2121964|FG003|TREATMENT PERIOD 2|Adverse Event|4
1069886|NCT02016105|2121965|FG004|TREATMENT PERIOD 2|Adverse Event|0
1069887|NCT02016105|2121966|FG005|TREATMENT PERIOD 2|Adverse Event|1
1069888|NCT02016105|2121961|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0
1069889|NCT02016105|2121962|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0
1069890|NCT02016105|2121963|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3
1069891|NCT02016105|2121964|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1
1069892|NCT02016105|2121965|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1
1069893|NCT02016105|2121966|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7
1069894|NCT02016105|2121961|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0
1069895|NCT02016105|2121962|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0
1069896|NCT02016105|2121963|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1
1069897|NCT02016105|2121964|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0
1069898|NCT02016105|2121965|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0
1069899|NCT02016105|2121966|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1
1069900|NCT02016105|2121961|FG000|EXTENSION PERIOD|New therapy for study indication|0
1069901|NCT02016105|2121962|FG001|EXTENSION PERIOD|New therapy for study indication|0
1069902|NCT02016105|2121963|FG002|EXTENSION PERIOD|New therapy for study indication|0
1069903|NCT02016105|2121964|FG003|EXTENSION PERIOD|New therapy for study indication|0
1069904|NCT02016105|2121965|FG004|EXTENSION PERIOD|New therapy for study indication|1
1069905|NCT02016105|2121966|FG005|EXTENSION PERIOD|New therapy for study indication|1
1069906|NCT02016105|2121961|FG000|EXTENSION PERIOD|Lack of Efficacy|0
1069907|NCT02016105|2121962|FG001|EXTENSION PERIOD|Lack of Efficacy|0
1069908|NCT02016105|2121963|FG002|EXTENSION PERIOD|Lack of Efficacy|1
1069909|NCT02016105|2121964|FG003|EXTENSION PERIOD|Lack of Efficacy|3
1069910|NCT02016105|2121965|FG004|EXTENSION PERIOD|Lack of Efficacy|1
1069911|NCT02016105|2121966|FG005|EXTENSION PERIOD|Lack of Efficacy|1
1069912|NCT02016105|2121961|FG000|EXTENSION PERIOD|Adverse Event|0
1069913|NCT02016105|2121962|FG001|EXTENSION PERIOD|Adverse Event|0
1069914|NCT02016105|2121963|FG002|EXTENSION PERIOD|Adverse Event|2
1069915|NCT02016105|2121964|FG003|EXTENSION PERIOD|Adverse Event|0
1069916|NCT02016105|2121965|FG004|EXTENSION PERIOD|Adverse Event|1
1069917|NCT02016105|2121966|FG005|EXTENSION PERIOD|Adverse Event|0
1069918|NCT02016105|2121961|FG000|EXTENSION PERIOD|Withdrawal by Subject|0
1069919|NCT02016105|2121962|FG001|EXTENSION PERIOD|Withdrawal by Subject|0
1069920|NCT02016105|2121963|FG002|EXTENSION PERIOD|Withdrawal by Subject|2
1069921|NCT02016105|2121964|FG003|EXTENSION PERIOD|Withdrawal by Subject|2
1069922|NCT02016105|2121965|FG004|EXTENSION PERIOD|Withdrawal by Subject|2
1069923|NCT02016105|2121966|FG005|EXTENSION PERIOD|Withdrawal by Subject|2
1069924|NCT02016105|2121961|FG000|EXTENSION PERIOD|Non-compliance with study indication|0
1069925|NCT02016105|2121962|FG001|EXTENSION PERIOD|Non-compliance with study indication|0
1069926|NCT02016105|2121963|FG002|EXTENSION PERIOD|Non-compliance with study indication|0
1069927|NCT02016105|2121964|FG003|EXTENSION PERIOD|Non-compliance with study indication|0
1069928|NCT02016105|2121965|FG004|EXTENSION PERIOD|Non-compliance with study indication|1
1069929|NCT02016105|2121966|FG005|EXTENSION PERIOD|Non-compliance with study indication|0
1069930|NCT02016105|2121961|FG000|EXTENSION PERIOD|Lost to Follow-up|0
1069931|NCT02016105|2121962|FG001|EXTENSION PERIOD|Lost to Follow-up|0
1069932|NCT02016105|2121963|FG002|EXTENSION PERIOD|Lost to Follow-up|0
1069933|NCT02016105|2121964|FG003|EXTENSION PERIOD|Lost to Follow-up|0
1069934|NCT02016105|2121965|FG004|EXTENSION PERIOD|Lost to Follow-up|0
1069935|NCT02016105|2121966|FG005|EXTENSION PERIOD|Lost to Follow-up|2
1069936|NCT02016170|2121983|FG000|Overall Study|Adverse Event|1
1069937|NCT02016170|2121984|FG001|Overall Study|Adverse Event|1
1069938|NCT02016170|2121985|FG002|Overall Study|Adverse Event|0
1069939|NCT02016170|2121983|FG000|Overall Study|Protocol Violation|1
1069940|NCT02016170|2121984|FG001|Overall Study|Protocol Violation|0
1069941|NCT02016170|2121985|FG002|Overall Study|Protocol Violation|0
1069942|NCT02016183|2121992|FG000|Overall Study|Case Report Forms Uncollected|13
1069943|NCT02016183|2121992|FG000|Overall Study|Protocol Violation|52
1069944|NCT02016300|2122011|FG000|Overall Study|Lost to Follow-up|0
1069945|NCT02016300|2122012|FG001|Overall Study|Lost to Follow-up|3
1069946|NCT02016482|2122020|FG000|Period A|Adverse Event|3
1069947|NCT02016482|2122021|FG001|Period A|Adverse Event|5
1069948|NCT02016482|2122020|FG000|Period A|Withdrawal by Subject|3
1069949|NCT02016482|2122021|FG001|Period A|Withdrawal by Subject|4
1069950|NCT02016482|2122020|FG000|Period A|Lost to Follow-up|3
1069951|NCT02016482|2122021|FG001|Period A|Lost to Follow-up|3
1069952|NCT02016482|2122020|FG000|Period A|Lack of Efficacy|2
1069953|NCT02016482|2122021|FG001|Period A|Lack of Efficacy|1
1069954|NCT02016482|2122020|FG000|Period A|Other|3
1069955|NCT02016482|2122021|FG001|Period A|Other|0
1069956|NCT02016482|2122020|FG000|Period A|Protocol Violation|0
1069957|NCT02016482|2122021|FG001|Period A|Protocol Violation|1
1069958|NCT02016482|2122020|FG000|Period A|Required Alternative/Prohibited Therapy|0
1069959|NCT02016482|2122021|FG001|Period A|Required Alternative/Prohibited Therapy|1
1069960|NCT02016482|2122020|FG000|Period B|Withdrawal by Subject|1
1069961|NCT02016482|2122021|FG001|Period B|Withdrawal by Subject|1
1069962|NCT02016482|2122020|FG000|Period B|Lost to Follow-up|2
1069963|NCT02016482|2122021|FG001|Period B|Lost to Follow-up|0
1069964|NCT02016482|2122020|FG000|Period B|Lack of Efficacy|6
1069965|NCT02016482|2122021|FG001|Period B|Lack of Efficacy|4
1069966|NCT02016482|2122020|FG000|Period B|Other|4
1069967|NCT02016482|2122021|FG001|Period B|Other|0
1069968|NCT02016482|2122020|FG000|Period B|Required Alternative/Prohibited Therapy|0
1069969|NCT02016482|2122021|FG001|Period B|Required Alternative/Prohibited Therapy|2
1069970|NCT02016625|2122081|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0
1069971|NCT02016625|2122082|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1
1069972|NCT02016625|2122081|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
1069973|NCT02016625|2122082|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
1069974|NCT02016625|2122081|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
1069975|NCT02016625|2122082|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
1069976|NCT02016690|2122098|FG000|Overall Study|Excluded from SAS: Enrollment violation|2
1069977|NCT02016690|2122098|FG000|Overall Study|Excluded from SAS: Duplication|2
1069978|NCT02016690|2122098|FG000|Overall Study|Excluded from SAS: Early treatment|2
1069979|NCT02016690|2122098|FG000|Overall Study|Excluded from SAS: Ineligible for study|2
1069980|NCT02016690|2122098|FG000|Overall Study|Did not meet inclusion criteria|13
1069981|NCT02016690|2122098|FG000|Overall Study|Hospitalized for RSV at study start|3
1069982|NCT02016716|2122105|FG000|Overall Study|Withdrawal by Subject|5
1069983|NCT02016716|2122106|FG001|Overall Study|Withdrawal by Subject|5
1069984|NCT02016716|2122107|FG002|Overall Study|Withdrawal by Subject|5
1069985|NCT02016716|2122105|FG000|Overall Study|Protocol-specified Criteria|0
1069986|NCT02016716|2122106|FG001|Overall Study|Protocol-specified Criteria|1
1069987|NCT02016716|2122107|FG002|Overall Study|Protocol-specified Criteria|0
1069988|NCT02016716|2122105|FG000|Overall Study|Lost to Follow-up|1
1069989|NCT02016716|2122106|FG001|Overall Study|Lost to Follow-up|2
1069990|NCT02016716|2122107|FG002|Overall Study|Lost to Follow-up|1
1069991|NCT02016755|2122116|FG000|Overall Study|Major amputation of index limb|2
1069992|NCT02016755|2122116|FG000|Overall Study|Adverse Event|2
1069993|NCT02016755|2122116|FG000|Overall Study|Physician Decision|1
1069994|NCT02016755|2122116|FG000|Overall Study|Death|2
1069995|NCT02016898|2122143|FG000|Overall Study|Death|1
1069996|NCT02016898|2122144|FG001|Overall Study|Death|1
1069997|NCT02016898|2122143|FG000|Overall Study|Lost to Follow-up|4
1069998|NCT02016898|2122144|FG001|Overall Study|Lost to Follow-up|4
1069999|NCT02017015|2122155|FG000|Overall Study|Adverse Event|9
1070000|NCT02017015|2122155|FG000|Overall Study|Withdrawal by Subject|21
1070001|NCT02017015|2122155|FG000|Overall Study|Death|4
1070002|NCT02017015|2122155|FG000|Overall Study|Progressive Disease|31
1070003|NCT02017015|2122155|FG000|Overall Study|Non-compliance with study drug|2
1070004|NCT02017015|2122155|FG000|Overall Study|Physician Decision|2
1070005|NCT02017171|2122173|FG000|Overall Study|Death|10
1070006|NCT02017171|2122174|FG001|Overall Study|Death|4
1070007|NCT02017171|2122173|FG000|Overall Study|Withdrawal by Subject|23
1070008|NCT02017171|2122174|FG001|Overall Study|Withdrawal by Subject|17
1070009|NCT02017171|2122173|FG000|Overall Study|Lost to Follow-up|21
1070010|NCT02017171|2122174|FG001|Overall Study|Lost to Follow-up|20
1070011|NCT02017171|2122173|FG000|Overall Study|ESKD|6
1070012|NCT02017171|2122174|FG001|Overall Study|ESKD|2
1070013|NCT02017171|2122173|FG000|Overall Study|Miscellaneous|2
1070014|NCT02017171|2122174|FG001|Overall Study|Miscellaneous|3
1070015|NCT02017223|2122197|FG000|Overall Study|Algorithm problems|2
1070016|NCT02017444|2122216|FG000|Overall Study|Physician Decision|1
1070017|NCT02017444|2122217|FG001|Overall Study|Physician Decision|0
1070018|NCT02017444|2122216|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1
1070019|NCT02017444|2122217|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0
1070020|NCT02017535|2122227|FG000|Overall Study|Withdrawal by Subject|1
1070021|NCT02017535|2122228|FG001|Overall Study|Withdrawal by Subject|0
1070022|NCT02017535|2122229|FG002|Overall Study|Withdrawal by Subject|0
1070023|NCT02017535|2122230|FG003|Overall Study|Withdrawal by Subject|0
1070024|NCT02017860|2122249|FG000|Overall Study|Adverse Event|1
1070025|NCT02017860|2122249|FG000|Overall Study|Withdrawal by Subject|1
1070026|NCT02017899|2122259|FG000|Overall Study|Withdrawal by Subject|0
1070027|NCT02017899|2122260|FG001|Overall Study|Withdrawal by Subject|0
1070028|NCT02017899|2122261|FG002|Overall Study|Withdrawal by Subject|0
1070029|NCT02017899|2122262|FG003|Overall Study|Withdrawal by Subject|1
1070030|NCT02017899|2122263|FG004|Overall Study|Withdrawal by Subject|1
1070031|NCT02017899|2122264|FG005|Overall Study|Withdrawal by Subject|0
1070033|NCT02018042|2122282|FG000|Overall Study|Withdrawal by Subject|1
908303|NCT00782171|1884885|FG000|Overall Study|others|7
1070034|NCT02018458|2122301|FG000|Overall Study|Death|4
1070035|NCT02018562|2122307|FG000|Overall Study|Withdrawal by Subject|2
1070036|NCT02018562|2122308|FG001|Overall Study|Withdrawal by Subject|0
1070037|NCT02018562|2122307|FG000|Overall Study|Discharged prior to study completion|1
1070038|NCT02018562|2122308|FG001|Overall Study|Discharged prior to study completion|0
1070039|NCT02018822|2122351|FG000|Overall Study|filling replaced by crown|0
1070040|NCT02018822|2122352|FG001|Overall Study|filling replaced by crown|1
1070041|NCT02018822|2122353|FG002|Overall Study|filling replaced by crown|0
1070042|NCT02018822|2122351|FG000|Overall Study|Physician Decision|0
1070043|NCT02018822|2122352|FG001|Overall Study|Physician Decision|1
1070044|NCT02018822|2122353|FG002|Overall Study|Physician Decision|1
1070045|NCT02018822|2122351|FG000|Overall Study|Lost to Follow-up|6
1070046|NCT02018822|2122352|FG001|Overall Study|Lost to Follow-up|6
1070047|NCT02018822|2122353|FG002|Overall Study|Lost to Follow-up|5
1070048|NCT02018887|2122372|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1
1070049|NCT02018887|2122373|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1070050|NCT02018887|2122374|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1070051|NCT02018887|2122375|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1070052|NCT02018887|2122376|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1070053|NCT02018887|2122377|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1070054|NCT02018887|2122378|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1070055|NCT02018887|2122379|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1070056|NCT02018887|2122380|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1070057|NCT02018887|2122381|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1070058|NCT02018887|2122382|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1070059|NCT02018887|2122372|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0
1070060|NCT02018887|2122373|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0
1070061|NCT02018887|2122374|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0
1070062|NCT02018887|2122375|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0
1070063|NCT02018887|2122376|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1
1070064|NCT02018887|2122377|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0
1070065|NCT02018887|2122378|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1
1070066|NCT02018887|2122379|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4
1070067|NCT02018887|2122380|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0
1070068|NCT02018887|2122381|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0
1070069|NCT02018887|2122382|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0
1070070|NCT02018887|2122372|FG000|Part C: Cohort 8 Overall|Adverse Event|0
1070071|NCT02018887|2122373|FG001|Part C: Cohort 8 Overall|Adverse Event|0
1070072|NCT02018887|2122374|FG002|Part C: Cohort 8 Overall|Adverse Event|0
1070073|NCT02018887|2122375|FG003|Part C: Cohort 8 Overall|Adverse Event|0
1070074|NCT02018887|2122376|FG004|Part C: Cohort 8 Overall|Adverse Event|0
1070075|NCT02018887|2122377|FG005|Part C: Cohort 8 Overall|Adverse Event|0
1070076|NCT02018887|2122378|FG006|Part C: Cohort 8 Overall|Adverse Event|0
1070077|NCT02018887|2122379|FG007|Part C: Cohort 8 Overall|Adverse Event|0
1070078|NCT02018887|2122380|FG008|Part C: Cohort 8 Overall|Adverse Event|1
1070079|NCT02018887|2122381|FG009|Part C: Cohort 8 Overall|Adverse Event|3
1070080|NCT02018887|2122382|FG010|Part C: Cohort 8 Overall|Adverse Event|0
1070081|NCT02018887|2122372|FG000|Part C: Cohort 8 Overall|Physician Decision|0
1070082|NCT02018887|2122373|FG001|Part C: Cohort 8 Overall|Physician Decision|0
1070083|NCT02018887|2122374|FG002|Part C: Cohort 8 Overall|Physician Decision|0
1070084|NCT02018887|2122375|FG003|Part C: Cohort 8 Overall|Physician Decision|0
1070085|NCT02018887|2122376|FG004|Part C: Cohort 8 Overall|Physician Decision|0
1070086|NCT02018887|2122377|FG005|Part C: Cohort 8 Overall|Physician Decision|0
1070087|NCT02018887|2122378|FG006|Part C: Cohort 8 Overall|Physician Decision|0
1070088|NCT02018887|2122379|FG007|Part C: Cohort 8 Overall|Physician Decision|0
908304|NCT00782171|1884886|FG001|Overall Study|others|9
908305|NCT00782171|1884885|FG000|Overall Study|not eligible|8
908306|NCT00782171|1884886|FG001|Overall Study|not eligible|6
908307|NCT00782184|1884894|FG000|Overall Study|Adverse Event|1
908308|NCT00782184|1884895|FG001|Overall Study|Adverse Event|2
908309|NCT00782184|1884894|FG000|Overall Study|Protocol Violation|0
908310|NCT00782184|1884895|FG001|Overall Study|Protocol Violation|1
908311|NCT00782184|1884894|FG000|Overall Study|Withdrawal by Subject|3
908312|NCT00782184|1884895|FG001|Overall Study|Withdrawal by Subject|2
908313|NCT00782210|1884905|FG000|Overall Study|Adverse Event|21
908314|NCT00782210|1884906|FG001|Overall Study|Adverse Event|17
908315|NCT00782210|1884907|FG002|Overall Study|Adverse Event|16
908316|NCT00782210|1884905|FG000|Overall Study|Lost to Follow-up|2
908317|NCT00782210|1884906|FG001|Overall Study|Lost to Follow-up|1
908318|NCT00782210|1884907|FG002|Overall Study|Lost to Follow-up|2
908319|NCT00782210|1884905|FG000|Overall Study|Withdrawal by Subject|11
908320|NCT00782210|1884906|FG001|Overall Study|Withdrawal by Subject|8
908321|NCT00782210|1884907|FG002|Overall Study|Withdrawal by Subject|11
908322|NCT00782210|1884905|FG000|Overall Study|Non compliance with protocol|0
908323|NCT00782210|1884906|FG001|Overall Study|Non compliance with protocol|3
908324|NCT00782210|1884907|FG002|Overall Study|Non compliance with protocol|2
908325|NCT00782210|1884905|FG000|Overall Study|Lack of Efficacy|13
908326|NCT00782210|1884906|FG001|Overall Study|Lack of Efficacy|4
908327|NCT00782210|1884907|FG002|Overall Study|Lack of Efficacy|1
908328|NCT00782210|1884905|FG000|Overall Study|Other reason not described above|3
908329|NCT00782210|1884906|FG001|Overall Study|Other reason not described above|2
1070089|NCT02018887|2122380|FG008|Part C: Cohort 8 Overall|Physician Decision|2
1070090|NCT02018887|2122381|FG009|Part C: Cohort 8 Overall|Physician Decision|0
1070091|NCT02018887|2122382|FG010|Part C: Cohort 8 Overall|Physician Decision|1
1070092|NCT02019108|2122454|FG000|Overall Study|Lost to Follow-up|5
1070093|NCT02019108|2122455|FG001|Overall Study|Lost to Follow-up|7
1070094|NCT02019264|2122463|FG000|Overall Study|Not treated|6
1070095|NCT02019264|2122464|FG001|Overall Study|Not treated|4
1070096|NCT02019264|2122463|FG000|Overall Study|Lost to Follow-up|50
1070097|NCT02019264|2122464|FG001|Overall Study|Lost to Follow-up|47
1070098|NCT02019264|2122463|FG000|Overall Study|Withdrawal by Subject|142
1070099|NCT02019264|2122464|FG001|Overall Study|Withdrawal by Subject|117
1070100|NCT02019264|2122463|FG000|Overall Study|Administrative reason|36
1070101|NCT02019264|2122464|FG001|Overall Study|Administrative reason|28
1070102|NCT02019264|2122463|FG000|Overall Study|Missing|14
1070103|NCT02019264|2122464|FG001|Overall Study|Missing|11
1070104|NCT02019277|2122470|FG000|Overall Study|Withdrawal by Subject|3
1070105|NCT02019277|2122470|FG000|Overall Study|Death|7
1070106|NCT02019277|2122470|FG000|Overall Study|Did no Cooperate|1
1070107|NCT02019277|2122470|FG000|Overall Study|Adverse Event|1
1070108|NCT02019420|2122476|FG000|Overall Study|Did not receive study drug|2
1070109|NCT02019420|2122477|FG001|Overall Study|Did not receive study drug|2
1070110|NCT02019420|2122476|FG000|Overall Study|Withdrawal by Subject|1
1070111|NCT02019420|2122477|FG001|Overall Study|Withdrawal by Subject|3
1070112|NCT02019420|2122476|FG000|Overall Study|At request of sponsor or investigator|0
1070113|NCT02019420|2122477|FG001|Overall Study|At request of sponsor or investigator|1
1070114|NCT02019420|2122476|FG000|Overall Study|Death|104
1070115|NCT02019420|2122477|FG001|Overall Study|Death|99
1070116|NCT02019420|2122476|FG000|Overall Study|Transferred to other care facility|1
1070117|NCT02019420|2122477|FG001|Overall Study|Transferred to other care facility|1
1070118|NCT02019472|2122486|FG000|Overall Study|Adverse Event|14
1070119|NCT02019472|2122487|FG001|Overall Study|Adverse Event|23
1070120|NCT02019472|2122488|FG002|Overall Study|Adverse Event|17
1070121|NCT02019472|2122486|FG000|Overall Study|Death|0
1070122|NCT02019472|2122487|FG001|Overall Study|Death|1
1070123|NCT02019472|2122488|FG002|Overall Study|Death|1
1070124|NCT02019472|2122486|FG000|Overall Study|Lack of Efficacy|7
1070125|NCT02019472|2122487|FG001|Overall Study|Lack of Efficacy|4
1070126|NCT02019472|2122488|FG002|Overall Study|Lack of Efficacy|4
1070127|NCT02019472|2122486|FG000|Overall Study|Lost to Follow-up|0
1070128|NCT02019472|2122487|FG001|Overall Study|Lost to Follow-up|2
1070129|NCT02019472|2122488|FG002|Overall Study|Lost to Follow-up|1
1070130|NCT02019472|2122486|FG000|Overall Study|Physician Decision|1
1070131|NCT02019472|2122487|FG001|Overall Study|Physician Decision|2
1070132|NCT02019472|2122488|FG002|Overall Study|Physician Decision|0
1070133|NCT02019472|2122486|FG000|Overall Study|Pregnancy|1
1070134|NCT02019472|2122487|FG001|Overall Study|Pregnancy|2
1070135|NCT02019472|2122488|FG002|Overall Study|Pregnancy|2
1070136|NCT02019472|2122486|FG000|Overall Study|Withdrawal by Subject|11
1070137|NCT02019472|2122487|FG001|Overall Study|Withdrawal by Subject|10
1070138|NCT02019472|2122488|FG002|Overall Study|Withdrawal by Subject|11
1070139|NCT02019472|2122486|FG000|Overall Study|Other|3
1070140|NCT02019472|2122487|FG001|Overall Study|Other|8
1070141|NCT02019472|2122488|FG002|Overall Study|Other|6
1070142|NCT02019550|2122502|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
1070143|NCT02019550|2122503|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1
1070144|NCT02019602|2122524|FG000|Screening Period|Ineligibility|4
1070145|NCT02019602|2122525|FG001|Screening Period|Ineligibility|0
1070146|NCT02019602|2122524|FG000|Screening Period|Adverse Event|1
1070147|NCT02019602|2122525|FG001|Screening Period|Adverse Event|0
1070148|NCT02019667|2122532|FG000|First Intervention (6 Months)|Adverse Event|0
1070149|NCT02019667|2122533|FG001|First Intervention (6 Months)|Adverse Event|1
1070150|NCT02019667|2122532|FG000|2nd Intervention (6 Months)|Adverse Event|0
1070151|NCT02019667|2122533|FG001|2nd Intervention (6 Months)|Adverse Event|1
1070152|NCT02019667|2122532|FG000|2nd Intervention (6 Months)|Physician Decision|0
1070153|NCT02019667|2122533|FG001|2nd Intervention (6 Months)|Physician Decision|1
1070154|NCT02019719|2122546|FG000|Overall Study|Adverse Event|1
1070155|NCT02019719|2122547|FG001|Overall Study|Adverse Event|0
1070156|NCT02019719|2122548|FG002|Overall Study|Adverse Event|0
1070157|NCT02019719|2122549|FG003|Overall Study|Adverse Event|1
1070158|NCT02019719|2122550|FG004|Overall Study|Adverse Event|1
1070159|NCT02019719|2122546|FG000|Overall Study|Protocol Violation|1
1070160|NCT02019719|2122547|FG001|Overall Study|Protocol Violation|1
1070161|NCT02019719|2122548|FG002|Overall Study|Protocol Violation|0
1070162|NCT02019719|2122549|FG003|Overall Study|Protocol Violation|0
1070163|NCT02019719|2122550|FG004|Overall Study|Protocol Violation|0
1070164|NCT02019719|2122546|FG000|Overall Study|Protocol defined stopping criteria|2
1070165|NCT02019719|2122547|FG001|Overall Study|Protocol defined stopping criteria|0
1070166|NCT02019719|2122548|FG002|Overall Study|Protocol defined stopping criteria|0
1070167|NCT02019719|2122549|FG003|Overall Study|Protocol defined stopping criteria|1
1070168|NCT02019719|2122550|FG004|Overall Study|Protocol defined stopping criteria|1
1070169|NCT02019719|2122546|FG000|Overall Study|Physician Decision|2
1070170|NCT02019719|2122547|FG001|Overall Study|Physician Decision|0
1070171|NCT02019719|2122548|FG002|Overall Study|Physician Decision|0
1070172|NCT02019719|2122549|FG003|Overall Study|Physician Decision|0
1070173|NCT02019719|2122550|FG004|Overall Study|Physician Decision|0
1070174|NCT02019927|2122597|FG000|Overall Study|Lost to Follow-up|2
1070175|NCT02019927|2122598|FG001|Overall Study|Lost to Follow-up|4
1070176|NCT02019927|2122599|FG002|Overall Study|Lost to Follow-up|1
1070177|NCT02019927|2122600|FG003|Overall Study|Lost to Follow-up|2
1070178|NCT02019927|2122601|FG004|Overall Study|Lost to Follow-up|3
1070179|NCT02019927|2122602|FG005|Overall Study|Lost to Follow-up|1
1070180|NCT02019979|2122624|FG000|Overall Study|study terminated|14
1070181|NCT02020031|2122639|FG000|Overall Study|Physician Decision|1
1070182|NCT02020031|2122640|FG001|Overall Study|Physician Decision|1
1070183|NCT02020512|2122695|FG000|Overall Study|Adverse Event|1
1070184|NCT02020512|2122695|FG000|Overall Study|Lost to Follow-up|3
1070185|NCT02020512|2122695|FG000|Overall Study|Protocol Violation|4
1070186|NCT02020577|2122701|FG000|Overall Study|Progressive disease|3
1070187|NCT02020577|2122702|FG001|Overall Study|Progressive disease|38
1070188|NCT02020577|2122701|FG000|Overall Study|Other AE or clinical progression|0
1070189|NCT02020577|2122702|FG001|Overall Study|Other AE or clinical progression|15
1070190|NCT02020577|2122701|FG000|Overall Study|Withdrawal by Subject|0
1070191|NCT02020577|2122702|FG001|Overall Study|Withdrawal by Subject|1
1070192|NCT02020577|2122701|FG000|Overall Study|Other than stated above|0
1070193|NCT02020577|2122702|FG001|Overall Study|Other than stated above|1
1070194|NCT02020616|2122721|FG000|Overall Study|Adverse Event|0
1070195|NCT02020616|2122722|FG001|Overall Study|Adverse Event|0
1070196|NCT02020616|2122723|FG002|Overall Study|Adverse Event|0
1070197|NCT02020616|2122724|FG003|Overall Study|Adverse Event|0
1070198|NCT02020616|2122725|FG004|Overall Study|Adverse Event|0
1070199|NCT02020616|2122726|FG005|Overall Study|Adverse Event|1
1070200|NCT02020616|2122727|FG006|Overall Study|Adverse Event|1
1070201|NCT02020616|2122721|FG000|Overall Study|Physician Decision|0
1070202|NCT02020616|2122722|FG001|Overall Study|Physician Decision|0
1070203|NCT02020616|2122723|FG002|Overall Study|Physician Decision|0
1070204|NCT02020616|2122724|FG003|Overall Study|Physician Decision|0
1070205|NCT02020616|2122725|FG004|Overall Study|Physician Decision|0
1070206|NCT02020616|2122726|FG005|Overall Study|Physician Decision|1
1070207|NCT02020616|2122727|FG006|Overall Study|Physician Decision|2
1070208|NCT02020616|2122721|FG000|Overall Study|Withdrawal by Subject|0
1070209|NCT02020616|2122722|FG001|Overall Study|Withdrawal by Subject|0
1070210|NCT02020616|2122723|FG002|Overall Study|Withdrawal by Subject|1
1070211|NCT02020616|2122724|FG003|Overall Study|Withdrawal by Subject|0
1070212|NCT02020616|2122725|FG004|Overall Study|Withdrawal by Subject|0
1070213|NCT02020616|2122726|FG005|Overall Study|Withdrawal by Subject|1
1070214|NCT02020616|2122727|FG006|Overall Study|Withdrawal by Subject|1
1070215|NCT02020616|2122721|FG000|Overall Study|Lost to Follow-up|0
1070216|NCT02020616|2122722|FG001|Overall Study|Lost to Follow-up|1
1070217|NCT02020616|2122723|FG002|Overall Study|Lost to Follow-up|0
1070218|NCT02020616|2122724|FG003|Overall Study|Lost to Follow-up|1
1070219|NCT02020616|2122725|FG004|Overall Study|Lost to Follow-up|1
1070220|NCT02020616|2122726|FG005|Overall Study|Lost to Follow-up|1
1070221|NCT02020616|2122727|FG006|Overall Study|Lost to Follow-up|0
1070222|NCT02020616|2122721|FG000|Overall Study|Early Termination Criteria Met|0
1070223|NCT02020616|2122722|FG001|Overall Study|Early Termination Criteria Met|0
1070224|NCT02020616|2122723|FG002|Overall Study|Early Termination Criteria Met|1
1070225|NCT02020616|2122724|FG003|Overall Study|Early Termination Criteria Met|0
1070226|NCT02020616|2122725|FG004|Overall Study|Early Termination Criteria Met|0
1070227|NCT02020616|2122726|FG005|Overall Study|Early Termination Criteria Met|1
1070228|NCT02020616|2122727|FG006|Overall Study|Early Termination Criteria Met|0
1070229|NCT02020616|2122721|FG000|Overall Study|Randomized in Error|0
1070230|NCT02020616|2122722|FG001|Overall Study|Randomized in Error|0
1070231|NCT02020616|2122723|FG002|Overall Study|Randomized in Error|0
1070232|NCT02020616|2122724|FG003|Overall Study|Randomized in Error|1
1070233|NCT02020616|2122725|FG004|Overall Study|Randomized in Error|0
1070234|NCT02020616|2122726|FG005|Overall Study|Randomized in Error|0
1070235|NCT02020616|2122727|FG006|Overall Study|Randomized in Error|0
1070236|NCT02020616|2122721|FG000|Overall Study|Lack of Efficacy|0
1070237|NCT02020616|2122722|FG001|Overall Study|Lack of Efficacy|0
1070238|NCT02020616|2122723|FG002|Overall Study|Lack of Efficacy|0
1070239|NCT02020616|2122724|FG003|Overall Study|Lack of Efficacy|0
1070240|NCT02020616|2122725|FG004|Overall Study|Lack of Efficacy|1
1070241|NCT02020616|2122726|FG005|Overall Study|Lack of Efficacy|0
1070242|NCT02020616|2122727|FG006|Overall Study|Lack of Efficacy|0
1070243|NCT02020863|2122766|FG000|Overall Study|Discovery of Metastatic disease|4
1070244|NCT02020863|2122766|FG000|Overall Study|Team chose not to place an a line|1
1070245|NCT02020889|2122772|FG000|Overall Study|Adverse Event|0
1070246|NCT02020889|2122773|FG001|Overall Study|Adverse Event|1
1070247|NCT02020889|2122772|FG000|Overall Study|Lack of Efficacy|1
1070248|NCT02020889|2122773|FG001|Overall Study|Lack of Efficacy|0
1070249|NCT02020889|2122772|FG000|Overall Study|Lost to Follow-up|1
1070250|NCT02020889|2122773|FG001|Overall Study|Lost to Follow-up|0
1070251|NCT02020889|2122772|FG000|Overall Study|Physician Decision|2
1070252|NCT02020889|2122773|FG001|Overall Study|Physician Decision|0
1070253|NCT02020889|2122772|FG000|Overall Study|Withdrawal by Subject|3
1070254|NCT02020889|2122773|FG001|Overall Study|Withdrawal by Subject|2
1070255|NCT02020941|2122779|FG000|Overall Study|Adverse Event|1
1070256|NCT02020941|2122779|FG000|Overall Study|Physician Decision|2
1070257|NCT02020941|2122779|FG000|Overall Study|Withdrawal by Subject|1
1070258|NCT02020941|2122779|FG000|Overall Study|Disease Progression|4
1070259|NCT02020967|2122785|FG000|Overall Study|Withdrawal by Subject|51
1070260|NCT02021292|2122803|FG000|Overall Study|Physician Decision|0
1070261|NCT02021292|2122804|FG001|Overall Study|Physician Decision|1
1070262|NCT02021292|2122803|FG000|Overall Study|Lost to Follow-up|0
1070263|NCT02021292|2122804|FG001|Overall Study|Lost to Follow-up|1
1070264|NCT02021292|2122803|FG000|Overall Study|Death|0
1070265|NCT02021292|2122804|FG001|Overall Study|Death|1
1070266|NCT02021318|2122814|FG000|Overall Study|Adverse Event|2
1070267|NCT02021318|2122815|FG001|Overall Study|Adverse Event|1
1070268|NCT02021318|2122814|FG000|Overall Study|Death|33
1070269|NCT02021318|2122815|FG001|Overall Study|Death|34
1070270|NCT02021318|2122814|FG000|Overall Study|Lost to Follow-up|3
1070271|NCT02021318|2122815|FG001|Overall Study|Lost to Follow-up|3
1070272|NCT02021318|2122814|FG000|Overall Study|Progressive Disease|0
1070273|NCT02021318|2122815|FG001|Overall Study|Progressive Disease|1
1070274|NCT02021318|2122814|FG000|Overall Study|Withdrawal by Subject|30
1070275|NCT02021318|2122815|FG001|Overall Study|Withdrawal by Subject|18
1070276|NCT02021318|2122814|FG000|Overall Study|Physician Decision|3
1070277|NCT02021318|2122815|FG001|Overall Study|Physician Decision|3
1070278|NCT02021318|2122814|FG000|Overall Study|Miscellaneous|2
1070279|NCT02021318|2122815|FG001|Overall Study|Miscellaneous|3
1070280|NCT02021331|2122824|FG000|Overall Study|Adverse Event|0
1070281|NCT02021331|2122825|FG001|Overall Study|Adverse Event|2
1070282|NCT02021565|2122839|FG000|Baseline Through Intervention|Death|0
1070283|NCT02021565|2122840|FG001|Baseline Through Intervention|Death|1
1070284|NCT02021565|2122839|FG000|Baseline Through Intervention|Withdrawal by Subject|8
1070285|NCT02021565|2122840|FG001|Baseline Through Intervention|Withdrawal by Subject|8
1070286|NCT02021565|2122839|FG000|Baseline Through Intervention|Protocol Violation|0
1070287|NCT02021565|2122840|FG001|Baseline Through Intervention|Protocol Violation|7
1070288|NCT02021565|2122839|FG000|Baseline Through Intervention|Lost to Follow-up|4
1070289|NCT02021565|2122840|FG001|Baseline Through Intervention|Lost to Follow-up|2
1070290|NCT02021565|2122839|FG000|3-month Follow-up|Death|3
1070291|NCT02021565|2122840|FG001|3-month Follow-up|Death|0
1070292|NCT02021565|2122839|FG000|3-month Follow-up|Withdrawal by Subject|4
1070293|NCT02021565|2122840|FG001|3-month Follow-up|Withdrawal by Subject|0
1070294|NCT02021565|2122839|FG000|3-month Follow-up|Protocol Violation|3
1070295|NCT02021565|2122840|FG001|3-month Follow-up|Protocol Violation|2
1070296|NCT02021643|2122854|FG000|Overall Study|Enrolled but Never Treated|1
1070297|NCT02021643|2122855|FG001|Overall Study|Enrolled but Never Treated|0
1070298|NCT02021643|2122856|FG002|Overall Study|Enrolled but Never Treated|0
1070299|NCT02021643|2122857|FG003|Overall Study|Enrolled but Never Treated|0
1070300|NCT02021643|2122854|FG000|Overall Study|Adverse Event|0
1070301|NCT02021643|2122855|FG001|Overall Study|Adverse Event|1
1070302|NCT02021643|2122856|FG002|Overall Study|Adverse Event|0
1070303|NCT02021643|2122857|FG003|Overall Study|Adverse Event|0
1070304|NCT02021643|2122854|FG000|Overall Study|Death|0
1070305|NCT02021643|2122855|FG001|Overall Study|Death|1
1070306|NCT02021643|2122856|FG002|Overall Study|Death|0
1070307|NCT02021643|2122857|FG003|Overall Study|Death|0
1070308|NCT02021643|2122854|FG000|Overall Study|Investigator's Discretion|1
1070309|NCT02021643|2122855|FG001|Overall Study|Investigator's Discretion|0
1070310|NCT02021643|2122856|FG002|Overall Study|Investigator's Discretion|0
1070311|NCT02021643|2122857|FG003|Overall Study|Investigator's Discretion|0
1070312|NCT02021643|2122854|FG000|Overall Study|Lack of Efficacy|7
1070313|NCT02021643|2122855|FG001|Overall Study|Lack of Efficacy|6
1070314|NCT02021643|2122856|FG002|Overall Study|Lack of Efficacy|0
1070315|NCT02021643|2122857|FG003|Overall Study|Lack of Efficacy|12
1070316|NCT02021643|2122854|FG000|Overall Study|Lost to Follow-up|0
1070317|NCT02021643|2122855|FG001|Overall Study|Lost to Follow-up|1
1070318|NCT02021643|2122856|FG002|Overall Study|Lost to Follow-up|0
1070319|NCT02021643|2122857|FG003|Overall Study|Lost to Follow-up|0
1070320|NCT02021643|2122854|FG000|Overall Study|Withdrew Consent|0
1070321|NCT02021643|2122855|FG001|Overall Study|Withdrew Consent|1
1070322|NCT02021643|2122856|FG002|Overall Study|Withdrew Consent|0
1070323|NCT02021643|2122857|FG003|Overall Study|Withdrew Consent|0
1070324|NCT02021656|2122873|FG000|Overall Study|Adverse Event|1
1070325|NCT02021656|2122873|FG000|Overall Study|Lack of Efficacy|2
1070326|NCT02021656|2122873|FG000|Overall Study|Lost to Follow-up|1
1070327|NCT02021656|2122873|FG000|Overall Study|Withdrew Consent|2
1070346|NCT02021812|2122903|FG000|Overall Study|Death|8
1070347|NCT02021812|2122903|FG000|Overall Study|Withdrawal by Subject|3
1070348|NCT02021812|2122903|FG000|Overall Study|Lost to Follow-up|1
1070349|NCT02021812|2122903|FG000|Overall Study|Refuse to return, COVD 19, in hospice, and didn't return for visit|4
1070350|NCT02021812|2122903|FG000|Overall Study|Still in study|6
1070351|NCT02022007|2122933|FG000|Overall Study|Withdrawal by Subject|1
1070352|NCT02022007|2122934|FG001|Overall Study|Withdrawal by Subject|1
1070353|NCT02022007|2122935|FG002|Overall Study|Withdrawal by Subject|1
1070354|NCT02022007|2122933|FG000|Overall Study|Noncompliant|0
1070355|NCT02022007|2122934|FG001|Overall Study|Noncompliant|0
1070356|NCT02022007|2122935|FG002|Overall Study|Noncompliant|1
1070357|NCT02022033|2122947|FG000|Overall Study|Physician Decision|1
1070358|NCT02022657|2122966|FG000|Overall Study|Withdrawal by Subject|2
1070359|NCT02022657|2122967|FG001|Overall Study|Withdrawal by Subject|0
1070360|NCT02022657|2122968|FG002|Overall Study|Withdrawal by Subject|1
1070361|NCT02022657|2122969|FG003|Overall Study|Withdrawal by Subject|0
1070362|NCT02022657|2122970|FG004|Overall Study|Withdrawal by Subject|0
1070363|NCT02022657|2122971|FG005|Overall Study|Withdrawal by Subject|0
1070364|NCT02022657|2122966|FG000|Overall Study|Physician Decision|0
1070365|NCT02022657|2122967|FG001|Overall Study|Physician Decision|0
1070366|NCT02022657|2122968|FG002|Overall Study|Physician Decision|0
1070367|NCT02022657|2122969|FG003|Overall Study|Physician Decision|0
1070368|NCT02022657|2122970|FG004|Overall Study|Physician Decision|0
1070369|NCT02022657|2122971|FG005|Overall Study|Physician Decision|1
1070370|NCT02022670|2122980|FG000|Overall Study|Adverse Event|1
1070371|NCT02022670|2122981|FG001|Overall Study|Adverse Event|0
1070372|NCT02022670|2122982|FG002|Overall Study|Adverse Event|1
1070373|NCT02022748|2123003|FG000|Overall Study|Adverse Event|1
1070374|NCT02022748|2123004|FG001|Overall Study|Adverse Event|1
1070375|NCT02022748|2123005|FG002|Overall Study|Adverse Event|0
1070376|NCT02022748|2123003|FG000|Overall Study|Withdrawal by Subject|0
1070377|NCT02022748|2123004|FG001|Overall Study|Withdrawal by Subject|1
1070378|NCT02022748|2123005|FG002|Overall Study|Withdrawal by Subject|0
1070379|NCT02023099|2123020|FG000|Overall Study|Non-fatal Adverse Event (AE)|0
1070380|NCT02023099|2123021|FG001|Overall Study|Non-fatal Adverse Event (AE)|0
1070381|NCT02023099|2123022|FG002|Overall Study|Non-fatal Adverse Event (AE)|1
1070382|NCT02023099|2123020|FG000|Overall Study|Withdrawn Consent|3
1070383|NCT02023099|2123021|FG001|Overall Study|Withdrawn Consent|0
1070384|NCT02023099|2123022|FG002|Overall Study|Withdrawn Consent|1
1070385|NCT02023099|2123020|FG000|Overall Study|Non-treatment-emergent Fatal AE|0
1070386|NCT02023099|2123021|FG001|Overall Study|Non-treatment-emergent Fatal AE|0
1070387|NCT02023099|2123022|FG002|Overall Study|Non-treatment-emergent Fatal AE|1
1070388|NCT02023112|2123032|FG000|Overall Study|Withdrawal by Subject|2
1070389|NCT02023112|2123033|FG001|Overall Study|Withdrawal by Subject|1
1070390|NCT02023151|2123057|FG000|Overall Study|Lost to Follow-up|4
1070391|NCT02023242|2123063|FG000|Overall Study|Lost to Follow-up|3
1070392|NCT02023242|2123064|FG001|Overall Study|Lost to Follow-up|1
1070393|NCT02023242|2123063|FG000|Overall Study|Death|0
1070394|NCT02023242|2123064|FG001|Overall Study|Death|1
1070395|NCT02023268|2123072|FG000|Overall Study|Lack of Efficacy|0
1070396|NCT02023268|2123073|FG001|Overall Study|Lack of Efficacy|1
1070397|NCT02023268|2123072|FG000|Overall Study|Adverse Event|0
1070398|NCT02023268|2123073|FG001|Overall Study|Adverse Event|2
1070399|NCT02023268|2123072|FG000|Overall Study|Withdrawal by Subject|0
1070400|NCT02023268|2123073|FG001|Overall Study|Withdrawal by Subject|1
1070401|NCT02023697|2123101|FG000|Treatment Period|Radiological progression|13
1070402|NCT02023697|2123102|FG001|Treatment Period|Radiological progression|17
1070403|NCT02023697|2123103|FG002|Treatment Period|Radiological progression|26
1070404|NCT02023697|2123101|FG000|Treatment Period|Never Treated|5
1070405|NCT02023697|2123102|FG001|Treatment Period|Never Treated|6
1070406|NCT02023697|2123103|FG002|Treatment Period|Never Treated|10
1070407|NCT02023697|2123101|FG000|Treatment Period|Adverse Event|13
1070408|NCT02023697|2123102|FG001|Treatment Period|Adverse Event|25
1070409|NCT02023697|2123103|FG002|Treatment Period|Adverse Event|23
1070410|NCT02023697|2123101|FG000|Treatment Period|Logistical difficulties|1
1070411|NCT02023697|2123102|FG001|Treatment Period|Logistical difficulties|1
1070412|NCT02023697|2123103|FG002|Treatment Period|Logistical difficulties|1
1070413|NCT02023697|2123101|FG000|Treatment Period|Clinical progression|10
1070414|NCT02023697|2123102|FG001|Treatment Period|Clinical progression|8
1070415|NCT02023697|2123103|FG002|Treatment Period|Clinical progression|28
1070416|NCT02023697|2123101|FG000|Treatment Period|Withdrawal by Subject|4
1070417|NCT02023697|2123102|FG001|Treatment Period|Withdrawal by Subject|5
1070418|NCT02023697|2123103|FG002|Treatment Period|Withdrawal by Subject|13
1070419|NCT02023697|2123101|FG000|Treatment Period|Safety outcome reached|0
1070420|NCT02023697|2123102|FG001|Treatment Period|Safety outcome reached|1
1070421|NCT02023697|2123103|FG002|Treatment Period|Safety outcome reached|0
1070422|NCT02023697|2123101|FG000|Treatment Period|Physician Decision|0
1070423|NCT02023697|2123102|FG001|Treatment Period|Physician Decision|0
1070424|NCT02023697|2123103|FG002|Treatment Period|Physician Decision|1
1070425|NCT02023697|2123101|FG000|Active Follow-up Period|Withdrawal by Subject|5
1070426|NCT02023697|2123102|FG001|Active Follow-up Period|Withdrawal by Subject|13
1070427|NCT02023697|2123103|FG002|Active Follow-up Period|Withdrawal by Subject|7
1070428|NCT02023697|2123101|FG000|Active Follow-up Period|Lost to Follow-up|1
1070429|NCT02023697|2123102|FG001|Active Follow-up Period|Lost to Follow-up|1
1070430|NCT02023697|2123103|FG002|Active Follow-up Period|Lost to Follow-up|1
1070431|NCT02023697|2123101|FG000|Active Follow-up Period|Deterioration of general condition|1
1070432|NCT02023697|2123102|FG001|Active Follow-up Period|Deterioration of general condition|1
1070433|NCT02023697|2123103|FG002|Active Follow-up Period|Deterioration of general condition|1
1070434|NCT02023697|2123101|FG000|Active Follow-up Period|Other unspecified|2
1070435|NCT02023697|2123102|FG001|Active Follow-up Period|Other unspecified|0
1070436|NCT02023697|2123103|FG002|Active Follow-up Period|Other unspecified|1
1070437|NCT02023697|2123101|FG000|Active Follow-up Period|Clinical progression|0
1070438|NCT02023697|2123102|FG001|Active Follow-up Period|Clinical progression|2
1070439|NCT02023697|2123103|FG002|Active Follow-up Period|Clinical progression|1
1070440|NCT02023697|2123101|FG000|Active Follow-up Period|Radiological progression|0
1070441|NCT02023697|2123102|FG001|Active Follow-up Period|Radiological progression|0
1070442|NCT02023697|2123103|FG002|Active Follow-up Period|Radiological progression|1
1070443|NCT02023697|2123101|FG000|Active Follow-up Period|Death|83
1070444|NCT02023697|2123102|FG001|Active Follow-up Period|Death|82
1070445|NCT02023697|2123103|FG002|Active Follow-up Period|Death|87
1070446|NCT02023697|2123101|FG000|Long-term Follow-up Period|Death|9
1070447|NCT02023697|2123102|FG001|Long-term Follow-up Period|Death|6
1070448|NCT02023697|2123103|FG002|Long-term Follow-up Period|Death|4
1070449|NCT02023697|2123101|FG000|Long-term Follow-up Period|Withdrawal by Subject|6
1070450|NCT02023697|2123102|FG001|Long-term Follow-up Period|Withdrawal by Subject|3
1070451|NCT02023697|2123103|FG002|Long-term Follow-up Period|Withdrawal by Subject|0
1070452|NCT02023697|2123101|FG000|Long-term Follow-up Period|Lost to Follow-up|1
1070453|NCT02023697|2123102|FG001|Long-term Follow-up Period|Lost to Follow-up|0
1070454|NCT02023697|2123103|FG002|Long-term Follow-up Period|Lost to Follow-up|1
1070455|NCT02023697|2123101|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6
1070456|NCT02023697|2123102|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9
1070457|NCT02023697|2123103|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6
1070458|NCT02023697|2123101|FG000|Long-term Follow-up Period|Technical problems|0
1070459|NCT02023697|2123102|FG001|Long-term Follow-up Period|Technical problems|0
1070460|NCT02023697|2123103|FG002|Long-term Follow-up Period|Technical problems|1
1070461|NCT02023697|2123101|FG000|Long-term Follow-up Period|Other unspecified|6
1070462|NCT02023697|2123102|FG001|Long-term Follow-up Period|Other unspecified|3
1070463|NCT02023697|2123103|FG002|Long-term Follow-up Period|Other unspecified|5
1070464|NCT02023866|2123122|FG000|Overall Study|Non-compliance|2
1070465|NCT02023866|2123122|FG000|Overall Study|Adverse Event|3
1070466|NCT02023866|2123122|FG000|Overall Study|Withdrawal by Subject|1
1070467|NCT02023879|2123129|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
1070468|NCT02023879|2123130|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
1070469|NCT02023879|2123131|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
1070470|NCT02023879|2123129|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
1070471|NCT02023879|2123130|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
1070472|NCT02023879|2123131|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
1070473|NCT02023879|2123129|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
1070474|NCT02023879|2123130|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
1070475|NCT02023879|2123131|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
1070476|NCT02023879|2123129|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
1070477|NCT02023879|2123130|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
1070478|NCT02023879|2123131|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
1070479|NCT02023879|2123129|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
1070480|NCT02023879|2123130|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
1070481|NCT02023879|2123131|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
1070482|NCT02023879|2123129|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
1070483|NCT02023879|2123130|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
1070484|NCT02023879|2123131|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
1070485|NCT02023879|2123129|FG000|Extension Open Label Treatment|Adverse Event|1
1070486|NCT02023879|2123130|FG001|Extension Open Label Treatment|Adverse Event|7
1070487|NCT02023879|2123131|FG002|Extension Open Label Treatment|Adverse Event|3
1070488|NCT02023879|2123129|FG000|Extension Open Label Treatment|Poor compliance to protocol|1
1070489|NCT02023879|2123130|FG001|Extension Open Label Treatment|Poor compliance to protocol|1
1070490|NCT02023879|2123131|FG002|Extension Open Label Treatment|Poor compliance to protocol|0
1070491|NCT02023879|2123129|FG000|Extension Open Label Treatment|Participant moved|1
1070492|NCT02023879|2123130|FG001|Extension Open Label Treatment|Participant moved|2
1070493|NCT02023879|2123131|FG002|Extension Open Label Treatment|Participant moved|0
1070494|NCT02023879|2123129|FG000|Extension Open Label Treatment|Other than specified above|2
1070495|NCT02023879|2123130|FG001|Extension Open Label Treatment|Other than specified above|7
1070496|NCT02023879|2123131|FG002|Extension Open Label Treatment|Other than specified above|2
1070497|NCT02024698|2123285|FG000|First Intervention (7 Days)|Withdrawal by Subject|0
1070498|NCT02024698|2123286|FG001|First Intervention (7 Days)|Withdrawal by Subject|1
1070499|NCT02024750|2123312|FG000|Overall Study|Withdrawal by Subject|2
1070500|NCT02024750|2123313|FG001|Overall Study|Withdrawal by Subject|1
1070501|NCT02024867|2123321|FG000|Overall Study|Protocol Violation|3
1070502|NCT02024867|2123322|FG001|Overall Study|Protocol Violation|3
1070503|NCT02024867|2123321|FG000|Overall Study|Lost to Follow-up|6
1070504|NCT02024867|2123322|FG001|Overall Study|Lost to Follow-up|4
1070505|NCT02024932|2123334|FG000|Overall Study|Adverse Event|2
1070506|NCT02024932|2123335|FG001|Overall Study|Adverse Event|3
1070507|NCT02024932|2123336|FG002|Overall Study|Adverse Event|0
1070508|NCT02024932|2123337|FG003|Overall Study|Adverse Event|0
1070509|NCT02024932|2123338|FG004|Overall Study|Adverse Event|2
1070510|NCT02024932|2123339|FG005|Overall Study|Adverse Event|0
1070511|NCT02024932|2123334|FG000|Overall Study|Abnormal laboratory value|0
1070512|NCT02024932|2123335|FG001|Overall Study|Abnormal laboratory value|0
1070513|NCT02024932|2123336|FG002|Overall Study|Abnormal laboratory value|0
1070514|NCT02024932|2123337|FG003|Overall Study|Abnormal laboratory value|2
1070515|NCT02024932|2123338|FG004|Overall Study|Abnormal laboratory value|0
1070516|NCT02024932|2123339|FG005|Overall Study|Abnormal laboratory value|0
1070517|NCT02024971|2123359|FG000|Overall Study|Data Not Available|30
1070518|NCT02024971|2123359|FG000|Overall Study|Lost to Follow-up|6
1070519|NCT02025179|2123381|FG000|Overall Study|Lost to Follow-up|0
1070520|NCT02025179|2123382|FG001|Overall Study|Lost to Follow-up|0
1070521|NCT02025179|2123383|FG002|Overall Study|Lost to Follow-up|1
1070522|NCT02025205|2123393|FG000|Overall Study|Withdrawal by Subject|1
1070523|NCT02025205|2123394|FG001|Overall Study|Withdrawal by Subject|1
1070524|NCT02025205|2123393|FG000|Overall Study|Protocol Violation|2
1070525|NCT02025205|2123394|FG001|Overall Study|Protocol Violation|1
1070526|NCT02025205|2123393|FG000|Overall Study|Death|0
1070527|NCT02025205|2123394|FG001|Overall Study|Death|1
1070528|NCT02025530|2123422|FG000|Overall Study|No longer met elligibility criteria|5
1070529|NCT02025530|2123423|FG001|Overall Study|No longer met elligibility criteria|1
1070530|NCT02025621|2123431|FG000|Overall Study|Withdrawal by Subject|1
1070531|NCT02025621|2123432|FG001|Overall Study|Withdrawal by Subject|0
1070532|NCT02025621|2123431|FG000|Overall Study|Death|0
1070533|NCT02025621|2123432|FG001|Overall Study|Death|1
1070534|NCT02025621|2123431|FG000|Overall Study|No longer eligible|10
1070535|NCT02025621|2123432|FG001|Overall Study|No longer eligible|15
1070536|NCT02025621|2123431|FG000|Overall Study|Surgery initiated before infusion|3
1070537|NCT02025621|2123432|FG001|Overall Study|Surgery initiated before infusion|3
1070538|NCT02025725|2123453|FG000|Overall Study|Adverse Event|5
1070539|NCT02025725|2123454|FG001|Overall Study|Adverse Event|0
1070540|NCT02025725|2123453|FG000|Overall Study|Lost to Follow-up|2
1070541|NCT02025725|2123454|FG001|Overall Study|Lost to Follow-up|0
1070542|NCT02025725|2123453|FG000|Overall Study|Protocol Violation|1
1070543|NCT02025725|2123454|FG001|Overall Study|Protocol Violation|1
1070544|NCT02025725|2123453|FG000|Overall Study|Withdrawal by Subject|3
1070545|NCT02025725|2123454|FG001|Overall Study|Withdrawal by Subject|2
1070546|NCT02025725|2123453|FG000|Overall Study|Post-dose QTcB > 270 msec|0
1070547|NCT02025725|2123454|FG001|Overall Study|Post-dose QTcB > 270 msec|1
1070548|NCT02025751|2123464|FG000|Overall Study|Lost to Follow-up|1
1070549|NCT02025751|2123465|FG001|Overall Study|Lost to Follow-up|0
1070550|NCT02025751|2123464|FG000|Overall Study|Adverse Event|0
1070551|NCT02025751|2123465|FG001|Overall Study|Adverse Event|1
1070552|NCT02025751|2123464|FG000|Overall Study|Physician Decision|0
1070553|NCT02025751|2123465|FG001|Overall Study|Physician Decision|1
1070554|NCT02025751|2123464|FG000|Overall Study|Withdrawal by Subject|0
1070555|NCT02025751|2123465|FG001|Overall Study|Withdrawal by Subject|1
1070556|NCT02025907|2123483|FG000|Overall Study|Lack of Efficacy|1
1070557|NCT02025907|2123484|FG001|Overall Study|Lack of Efficacy|0
1070558|NCT02025907|2123483|FG000|Overall Study|Withdrawal by Subject|15
1070559|NCT02025907|2123484|FG001|Overall Study|Withdrawal by Subject|8
1070560|NCT02025907|2123483|FG000|Overall Study|Protocol Violation|2
1070561|NCT02025907|2123484|FG001|Overall Study|Protocol Violation|0
1070562|NCT02025907|2123483|FG000|Overall Study|Physician Decision|2
1070563|NCT02025907|2123484|FG001|Overall Study|Physician Decision|0
1070564|NCT02025907|2123483|FG000|Overall Study|Lost to Follow-up|2
1070565|NCT02025907|2123484|FG001|Overall Study|Lost to Follow-up|2
1070566|NCT02025907|2123483|FG000|Overall Study|Adverse Event|3
1070567|NCT02025907|2123484|FG001|Overall Study|Adverse Event|1
1070568|NCT02025907|2123483|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2
1070569|NCT02025907|2123484|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1
1070570|NCT02025985|2123495|FG000|Overall Study|Consent withdrawn|0
1070571|NCT02025985|2123496|FG001|Overall Study|Consent withdrawn|0
1070572|NCT02025985|2123497|FG002|Overall Study|Consent withdrawn|1
1070573|NCT02025985|2123498|FG003|Overall Study|Consent withdrawn|0
1070574|NCT02025985|2123499|FG004|Overall Study|Consent withdrawn|0
1070575|NCT02025985|2123495|FG000|Overall Study|Termination of study by Sponsor|4
1070576|NCT02025985|2123496|FG001|Overall Study|Termination of study by Sponsor|3
1070577|NCT02025985|2123497|FG002|Overall Study|Termination of study by Sponsor|1
1070578|NCT02025985|2123498|FG003|Overall Study|Termination of study by Sponsor|1
1070579|NCT02025985|2123499|FG004|Overall Study|Termination of study by Sponsor|3
1070580|NCT02025985|2123495|FG000|Overall Study|Death|21
1070581|NCT02025985|2123496|FG001|Overall Study|Death|20
1070582|NCT02025985|2123497|FG002|Overall Study|Death|23
1070583|NCT02025985|2123498|FG003|Overall Study|Death|20
1070584|NCT02025985|2123499|FG004|Overall Study|Death|17
1070585|NCT02026011|2123515|FG000|Allocation 1 (First Set of Medication)|Side Effects|6
1070586|NCT02026011|2123516|FG001|Allocation 1 (First Set of Medication)|Side Effects|0
1070587|NCT02026011|2123515|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
1070588|NCT02026011|2123516|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
1070589|NCT02026011|2123515|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
1070590|NCT02026011|2123516|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
1070591|NCT02026011|2123515|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
1070592|NCT02026011|2123516|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
1070593|NCT02026063|2123527|FG000|Overall Study|Physician Decision|0
1070594|NCT02026063|2123528|FG001|Overall Study|Physician Decision|10
1070595|NCT02026063|2123527|FG000|Overall Study|Noncompliance with Study Drug|1
1070596|NCT02026063|2123528|FG001|Overall Study|Noncompliance with Study Drug|1
1070597|NCT02026063|2123527|FG000|Overall Study|Withdrawal of Consent|1
1070598|NCT02026063|2123528|FG001|Overall Study|Withdrawal of Consent|6
1070599|NCT02026063|2123527|FG000|Overall Study|Adverse Event|5
1070600|NCT02026063|2123528|FG001|Overall Study|Adverse Event|20
1070601|NCT02026063|2123527|FG000|Overall Study|Lack of Efficacy|0
1070602|NCT02026063|2123528|FG001|Overall Study|Lack of Efficacy|4
1070603|NCT02026063|2123527|FG000|Overall Study|Lost to Follow-up|0
1070604|NCT02026063|2123528|FG001|Overall Study|Lost to Follow-up|1
1070605|NCT02026063|2123527|FG000|Overall Study|Reason not Specified|2
1070606|NCT02026063|2123528|FG001|Overall Study|Reason not Specified|7
1070607|NCT02026141|2123537|FG000|Overall Study|Protocol Violation|0
1070608|NCT02026141|2123538|FG001|Overall Study|Protocol Violation|1
1070609|NCT02026258|2123564|FG000|Randomized|Did not start treatment|2
1070610|NCT02026258|2123565|FG001|Randomized|Did not start treatment|1
1070611|NCT02026258|2123564|FG000|Randomized|Change in treatment plan|1
1070612|NCT02026258|2123565|FG001|Randomized|Change in treatment plan|0
1070613|NCT02026258|2123564|FG000|Randomized|Presence of periodontal disease|1
1070614|NCT02026258|2123565|FG001|Randomized|Presence of periodontal disease|1
1070615|NCT02026258|2123564|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1
1070616|NCT02026258|2123565|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1
1070617|NCT02026258|2123564|FG000|Recieved Allocated Intervention|Lost to Follow-up|0
1070618|NCT02026258|2123565|FG001|Recieved Allocated Intervention|Lost to Follow-up|1
1070619|NCT02027025|2123606|FG000|Overall Study|Adverse Event|0
1070620|NCT02027025|2123607|FG001|Overall Study|Adverse Event|1
1070621|NCT02027025|2123608|FG002|Overall Study|Adverse Event|1
1070622|NCT02027025|2123606|FG000|Overall Study|Protocol Violation|1
1070623|NCT02027025|2123607|FG001|Overall Study|Protocol Violation|0
1070624|NCT02027025|2123608|FG002|Overall Study|Protocol Violation|0
1070625|NCT02027025|2123606|FG000|Overall Study|Lost to Follow-up|0
1070626|NCT02027025|2123607|FG001|Overall Study|Lost to Follow-up|2
1070627|NCT02027025|2123608|FG002|Overall Study|Lost to Follow-up|0
1070628|NCT02027025|2123606|FG000|Overall Study|Withdrawal by Subject|0
1070629|NCT02027025|2123607|FG001|Overall Study|Withdrawal by Subject|1
1070630|NCT02027025|2123608|FG002|Overall Study|Withdrawal by Subject|0
1070631|NCT02027025|2123606|FG000|Overall Study|Sponsor's decision|0
1070632|NCT02027025|2123607|FG001|Overall Study|Sponsor's decision|1
1070633|NCT02027025|2123608|FG002|Overall Study|Sponsor's decision|0
1070634|NCT02027311|2123629|FG000|Overall Study|Protocol Violation|3
1070635|NCT02027311|2123630|FG001|Overall Study|Protocol Violation|2
1070636|NCT02027376|2123638|FG000|Overall Study|Death|1
1070637|NCT02027376|2123639|FG001|Overall Study|Death|0
1070638|NCT02027376|2123640|FG002|Overall Study|Death|0
1070639|NCT02027402|2123652|FG000|Overall Study|Withdrawal by Subject|4
1070640|NCT02027402|2123653|FG001|Overall Study|Withdrawal by Subject|1
1070641|NCT02027428|2123663|FG000|Induction|Never treated|7
1070642|NCT02027428|2123664|FG001|Induction|Never treated|0
1070643|NCT02027428|2123665|FG002|Induction|Never treated|0
1070644|NCT02027428|2123663|FG000|Induction|Progressive disease|77
1070645|NCT02027428|2123664|FG001|Induction|Progressive disease|0
1070646|NCT02027428|2123665|FG002|Induction|Progressive disease|0
1070647|NCT02027428|2123663|FG000|Induction|Adverse Event|51
1070648|NCT02027428|2123664|FG001|Induction|Adverse Event|0
1070649|NCT02027428|2123665|FG002|Induction|Adverse Event|0
1070650|NCT02027428|2123663|FG000|Induction|Withdrawal by Subject|22
1070651|NCT02027428|2123664|FG001|Induction|Withdrawal by Subject|0
1070652|NCT02027428|2123665|FG002|Induction|Withdrawal by Subject|0
1070653|NCT02027428|2123663|FG000|Induction|Death|21
1070654|NCT02027428|2123664|FG001|Induction|Death|0
1070655|NCT02027428|2123665|FG002|Induction|Death|0
1070656|NCT02027428|2123663|FG000|Induction|Symptomatic deterioration|16
1070657|NCT02027428|2123664|FG001|Induction|Symptomatic deterioration|0
1070658|NCT02027428|2123665|FG002|Induction|Symptomatic deterioration|0
1070659|NCT02027428|2123663|FG000|Induction|Study terminated by sponsor|12
1070660|NCT02027428|2123664|FG001|Induction|Study terminated by sponsor|0
1070661|NCT02027428|2123665|FG002|Induction|Study terminated by sponsor|0
1070662|NCT02027428|2123663|FG000|Induction|Protocol Violation|1
1070663|NCT02027428|2123664|FG001|Induction|Protocol Violation|0
1070664|NCT02027428|2123665|FG002|Induction|Protocol Violation|0
1070665|NCT02027428|2123663|FG000|Induction|Miscellaneous|14
1070666|NCT02027428|2123664|FG001|Induction|Miscellaneous|0
1070667|NCT02027428|2123665|FG002|Induction|Miscellaneous|0
1070668|NCT02027428|2123663|FG000|Induction|Induction Treatment Ongoing|4
1070669|NCT02027428|2123664|FG001|Induction|Induction Treatment Ongoing|0
1070670|NCT02027428|2123665|FG002|Induction|Induction Treatment Ongoing|0
1070671|NCT02027428|2123663|FG000|Maintenance|Death|0
1070672|NCT02027428|2123664|FG001|Maintenance|Death|3
1070673|NCT02027428|2123665|FG002|Maintenance|Death|2
1070674|NCT02027428|2123663|FG000|Maintenance|Adverse Event|0
1070675|NCT02027428|2123664|FG001|Maintenance|Adverse Event|21
1070676|NCT02027428|2123665|FG002|Maintenance|Adverse Event|1
1070677|NCT02027428|2123663|FG000|Maintenance|Progressive disease|0
1070678|NCT02027428|2123664|FG001|Maintenance|Progressive disease|84
1070679|NCT02027428|2123665|FG002|Maintenance|Progressive disease|47
1070680|NCT02027428|2123663|FG000|Maintenance|Symptomatic deterioration|0
1070681|NCT02027428|2123664|FG001|Maintenance|Symptomatic deterioration|4
1070682|NCT02027428|2123665|FG002|Maintenance|Symptomatic deterioration|1
1070683|NCT02027428|2123663|FG000|Maintenance|Withdrawal by Subject|0
1070684|NCT02027428|2123664|FG001|Maintenance|Withdrawal by Subject|6
1070685|NCT02027428|2123665|FG002|Maintenance|Withdrawal by Subject|5
1070686|NCT02027428|2123663|FG000|Maintenance|Protocol Violation|0
1070687|NCT02027428|2123664|FG001|Maintenance|Protocol Violation|0
1070688|NCT02027428|2123665|FG002|Maintenance|Protocol Violation|1
1070689|NCT02027428|2123663|FG000|Maintenance|Other|0
1070690|NCT02027428|2123664|FG001|Maintenance|Other|6
1070691|NCT02027428|2123665|FG002|Maintenance|Other|3
1070692|NCT02027428|2123663|FG000|Survival Follow-up|Death|0
1070693|NCT02027428|2123664|FG001|Survival Follow-up|Death|78
1070694|NCT02027428|2123665|FG002|Survival Follow-up|Death|45
1070695|NCT02027428|2123663|FG000|Survival Follow-up|Lost to Follow-up|0
1070696|NCT02027428|2123664|FG001|Survival Follow-up|Lost to Follow-up|1
1070697|NCT02027428|2123665|FG002|Survival Follow-up|Lost to Follow-up|1
1070698|NCT02027545|2123690|FG000|Overall Study|Failed to sign HIPAA|0
1070699|NCT02027545|2123691|FG001|Overall Study|Failed to sign HIPAA|2
1070700|NCT02027545|2123690|FG000|Overall Study|Failed to attend study visit|2
1070701|NCT02027545|2123691|FG001|Overall Study|Failed to attend study visit|0
1070702|NCT02027558|2123699|FG000|Overall Study|Death|0
1070703|NCT02027558|2123700|FG001|Overall Study|Death|1
1070704|NCT02027558|2123699|FG000|Overall Study|Withdrawal by Subject|2
1070705|NCT02027558|2123700|FG001|Overall Study|Withdrawal by Subject|0
1070706|NCT02027558|2123699|FG000|Overall Study|Lost to Follow-up|4
1070707|NCT02027558|2123700|FG001|Overall Study|Lost to Follow-up|1
1070708|NCT02027558|2123699|FG000|Overall Study|Refused assessment|3
1070709|NCT02027558|2123700|FG001|Overall Study|Refused assessment|0
1070710|NCT02027623|2123710|FG000|Overall Study|Lost to Follow-up|3
1070711|NCT02027623|2123711|FG001|Overall Study|Lost to Follow-up|3
1070712|NCT02027623|2123710|FG000|Overall Study|Withdrawal by Subject|6
1070713|NCT02027623|2123711|FG001|Overall Study|Withdrawal by Subject|9
1070714|NCT02027701|2123718|FG000|Overall Study|Adverse Event|3
1070715|NCT02027701|2123718|FG000|Overall Study|Lack of Efficacy|8
1070716|NCT02027701|2123718|FG000|Overall Study|Physician Decision|2
1070717|NCT02027701|2123718|FG000|Overall Study|Withdrawal by Subject|3
1070718|NCT02027844|2123727|FG000|Overall Study|Withdrawal by Subject|3
1070719|NCT02027844|2123728|FG001|Overall Study|Withdrawal by Subject|2
1070720|NCT02027844|2123729|FG002|Overall Study|Withdrawal by Subject|1
1070721|NCT02027844|2123727|FG000|Overall Study|Lost to Follow-up|0
1070722|NCT02027844|2123728|FG001|Overall Study|Lost to Follow-up|2
1070723|NCT02027844|2123729|FG002|Overall Study|Lost to Follow-up|1
1070724|NCT02027844|2123727|FG000|Overall Study|Protocol Violation|0
1070725|NCT02027844|2123728|FG001|Overall Study|Protocol Violation|2
1070726|NCT02027844|2123729|FG002|Overall Study|Protocol Violation|0
1070727|NCT02027844|2123727|FG000|Overall Study|Incomlete data|2
1070728|NCT02027844|2123728|FG001|Overall Study|Incomlete data|0
1070729|NCT02027844|2123729|FG002|Overall Study|Incomlete data|0
1070730|NCT02028065|2123753|FG000|Randomization Through Start Treatment|Not treated|1
1070731|NCT02028065|2123754|FG001|Randomization Through Start Treatment|Not treated|3
1070732|NCT02028065|2123755|FG002|Randomization Through Start Treatment|Not treated|3
1070733|NCT02028065|2123753|FG000|Treatment Through Study Completion|Lost to Follow-up|2
1070734|NCT02028065|2123754|FG001|Treatment Through Study Completion|Lost to Follow-up|4
1070735|NCT02028065|2123755|FG002|Treatment Through Study Completion|Lost to Follow-up|6
1070736|NCT02028065|2123753|FG000|Treatment Through Study Completion|Physician Decision|1
1070737|NCT02028065|2123754|FG001|Treatment Through Study Completion|Physician Decision|0
1070738|NCT02028065|2123755|FG002|Treatment Through Study Completion|Physician Decision|0
1070739|NCT02028065|2123753|FG000|Treatment Through Study Completion|Protocol Violation|1
1070740|NCT02028065|2123754|FG001|Treatment Through Study Completion|Protocol Violation|4
1070741|NCT02028065|2123755|FG002|Treatment Through Study Completion|Protocol Violation|0
1070742|NCT02028065|2123753|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
1070743|NCT02028065|2123754|FG001|Treatment Through Study Completion|Withdrawal by Subject|4
1070744|NCT02028065|2123755|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
1070745|NCT02028065|2123753|FG000|Treatment Through Study Completion|Adverse Event|3
908330|NCT00782210|1884907|FG002|Overall Study|Other reason not described above|3
908331|NCT00782275|1884924|FG000|Overall Study|Adverse Event|11
908332|NCT00782275|1884924|FG000|Overall Study|Withdrawal by Subject|1
908333|NCT00782275|1884924|FG000|Overall Study|Progressive Disease|21
908334|NCT00782275|1884924|FG000|Overall Study|Physician Decision|4
1070746|NCT02028065|2123754|FG001|Treatment Through Study Completion|Adverse Event|3
1070747|NCT02028065|2123755|FG002|Treatment Through Study Completion|Adverse Event|5
1070748|NCT02028169|2123763|FG000|Overall Study|Lost to Follow-up|21
1070749|NCT02028169|2123763|FG000|Overall Study|Lack of Efficacy|2
1070750|NCT02028169|2123763|FG000|Overall Study|Withdrawal by Subject|2
1070751|NCT02028169|2123763|FG000|Overall Study|Adverse Event|1
1070752|NCT02028169|2123763|FG000|Overall Study|Cessation of Drug|1
1070753|NCT02028169|2123763|FG000|Overall Study|Concomitant Medication Usage|1
1070754|NCT02028182|2123767|FG000|Overall Study|Protocol Violation|2
1070755|NCT02028715|2123854|FG000|Overall Study|Adverse Event|2
1070756|NCT02028715|2123855|FG001|Overall Study|Adverse Event|2
1070757|NCT02028715|2123854|FG000|Overall Study|Physician Decision|1
1070758|NCT02028715|2123855|FG001|Overall Study|Physician Decision|0
1070759|NCT02028715|2123854|FG000|Overall Study|Did not complete satisfaction surveys|2
1070760|NCT02028715|2123855|FG001|Overall Study|Did not complete satisfaction surveys|2
1070761|NCT02028767|2123870|FG000|Treatment Period 2|Non compliant with protocol|1
1070762|NCT02028767|2123871|FG001|Treatment Period 2|Non compliant with protocol|0
1070763|NCT02028767|2123870|FG000|Treatment Period 2|Reason other than those specified above|1
1070764|NCT02028767|2123871|FG001|Treatment Period 2|Reason other than those specified above|0
1070765|NCT02028871|2123946|FG000|Overall Study|Positive urine drug screen|1
1070766|NCT02028871|2123947|FG001|Overall Study|Positive urine drug screen|1
1070767|NCT02028871|2123946|FG000|Overall Study|Withdrawal by Subject|1
1070768|NCT02028871|2123947|FG001|Overall Study|Withdrawal by Subject|2
1070769|NCT02028871|2123946|FG000|Overall Study|IV placement difficulty|1
1070770|NCT02028871|2123947|FG001|Overall Study|IV placement difficulty|0
1070771|NCT02028871|2123946|FG000|Overall Study|Current Illness|1
1070772|NCT02028871|2123947|FG001|Overall Study|Current Illness|0
1070793|NCT02029235|2123988|FG000|Overall Study|Non-compliance with study meds or diary|4
1070794|NCT02029235|2123989|FG001|Overall Study|Non-compliance with study meds or diary|1
1070795|NCT02029274|2123999|FG000|Overall Study|Adverse Event|1
1070796|NCT02029274|2124000|FG001|Overall Study|Adverse Event|0
1070797|NCT02029274|2124001|FG002|Overall Study|Adverse Event|2
1070798|NCT02029274|2124002|FG003|Overall Study|Adverse Event|2
1070799|NCT02029417|2124016|FG000|Overall Study|Death|1
1070800|NCT02029417|2124016|FG000|Overall Study|Adverse Event|1
1070801|NCT02029521|2124035|FG000|Overall Study|Protocol Violation|1
1070802|NCT02029521|2124036|FG001|Overall Study|Protocol Violation|0
1070803|NCT02029521|2124035|FG000|Overall Study|Withdrawal by Subject|1
1070804|NCT02029521|2124036|FG001|Overall Study|Withdrawal by Subject|1
1070805|NCT02029638|2124048|FG000|Overall Study|Death|0
1070806|NCT02029638|2124049|FG001|Overall Study|Death|0
1070807|NCT02029638|2124050|FG002|Overall Study|Death|1
1070808|NCT02029638|2124048|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2
1070809|NCT02029638|2124049|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0
1070810|NCT02029638|2124050|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0
1070811|NCT02029976|2124095|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12
1070812|NCT02029976|2124096|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8
1070813|NCT02029976|2124095|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8
1070814|NCT02029976|2124096|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4
908335|NCT00782275|1884924|FG000|Overall Study|Not started treatment|1
908336|NCT00782275|1884924|FG000|Overall Study|Other|3
908337|NCT00782340|1884946|FG000|Open Label Titration|Adverse Event|12
908338|NCT00782340|1884947|FG001|Open Label Titration|Adverse Event|0
908339|NCT00782340|1884948|FG002|Open Label Titration|Adverse Event|0
908340|NCT00782340|1884946|FG000|Open Label Titration|Treatment failure|50
908341|NCT00782340|1884947|FG001|Open Label Titration|Treatment failure|0
908342|NCT00782340|1884948|FG002|Open Label Titration|Treatment failure|0
908343|NCT00782340|1884946|FG000|Open Label Titration|Protocol Violation|5
1070815|NCT02029976|2124095|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
1070816|NCT02029976|2124096|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
1070817|NCT02029976|2124095|FG000|YR-2 Follow Up vs Baseline|Moved from area|0
1070818|NCT02029976|2124096|FG001|YR-2 Follow Up vs Baseline|Moved from area|2
1070819|NCT02029989|2124104|FG000|Overall Study|Withdrawal by Subject|1
1070820|NCT02029989|2124105|FG001|Overall Study|Withdrawal by Subject|0
1070821|NCT02029989|2124104|FG000|Overall Study|Withdrawal: Fear of needles|1
1070822|NCT02029989|2124105|FG001|Overall Study|Withdrawal: Fear of needles|0
1070823|NCT02029989|2124104|FG000|Overall Study|Change of location|2
1070824|NCT02029989|2124105|FG001|Overall Study|Change of location|3
1070825|NCT02029989|2124104|FG000|Overall Study|Physician Decision|2
1070826|NCT02029989|2124105|FG001|Overall Study|Physician Decision|0
1070827|NCT02029989|2124104|FG000|Overall Study|Lost to Follow-up|9
1070828|NCT02029989|2124105|FG001|Overall Study|Lost to Follow-up|7
1070829|NCT02029989|2124104|FG000|Overall Study|Death|0
1070830|NCT02029989|2124105|FG001|Overall Study|Death|1
1070831|NCT02029989|2124104|FG000|Overall Study|Protocol Violation|1
1070832|NCT02029989|2124105|FG001|Overall Study|Protocol Violation|0
1070833|NCT02030002|2124111|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1
1070834|NCT02030002|2124111|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4
1070835|NCT02030002|2124111|FG000|Follow-up|Lost to Follow-up|2
1070836|NCT02030041|2124120|FG000|Overall Study|Withdrawal by Subject|2
1070837|NCT02030041|2124121|FG001|Overall Study|Withdrawal by Subject|2
1070838|NCT02030041|2124122|FG002|Overall Study|Withdrawal by Subject|1
1070839|NCT02030119|2124151|FG000|Overall Study|Withdrawal by Subject|3
1070840|NCT02030119|2124152|FG001|Overall Study|Withdrawal by Subject|1
1070841|NCT02030119|2124153|FG002|Overall Study|Withdrawal by Subject|5
1070842|NCT02030119|2124154|FG003|Overall Study|Withdrawal by Subject|3
1070843|NCT02030119|2124151|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0
1070844|NCT02030119|2124152|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1
1070845|NCT02030119|2124153|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1
1070846|NCT02030119|2124154|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0
1070847|NCT02030405|2124177|FG000|Overall Study|Withdrawal by Subject|1
1070848|NCT02030405|2124177|FG000|Overall Study|Lost to Follow-up|1
1070849|NCT02030535|2124182|FG000|Washout Period 1 (21 Days)|Adverse Event|1
1070850|NCT02030600|2124202|FG000|Treatment Period 1|Adverse Event|5
1070851|NCT02030600|2124203|FG001|Treatment Period 1|Adverse Event|7
1070852|NCT02030600|2124202|FG000|Treatment Period 1|Lack of Efficacy|0
1070853|NCT02030600|2124203|FG001|Treatment Period 1|Lack of Efficacy|1
1070854|NCT02030600|2124202|FG000|Treatment Period 1|Lost to Follow-up|11
1070855|NCT02030600|2124203|FG001|Treatment Period 1|Lost to Follow-up|3
1070856|NCT02030600|2124202|FG000|Treatment Period 1|Protocol Violation|22
1070857|NCT02030600|2124203|FG001|Treatment Period 1|Protocol Violation|17
1070858|NCT02030600|2124202|FG000|Treatment Period 1|Withdrawal by Subject|13
1070859|NCT02030600|2124203|FG001|Treatment Period 1|Withdrawal by Subject|17
1070860|NCT02030600|2124202|FG000|Treatment Period 1|Casebook Unsigned|1
1070861|NCT02030600|2124203|FG001|Treatment Period 1|Casebook Unsigned|0
1070862|NCT02030600|2124202|FG000|Treatment Period 1|Unclassified|1
1070863|NCT02030600|2124203|FG001|Treatment Period 1|Unclassified|0
1070864|NCT02030600|2124202|FG000|Treatment Period 2|Adverse Event|4
1070865|NCT02030600|2124203|FG001|Treatment Period 2|Adverse Event|4
1070866|NCT02030600|2124202|FG000|Treatment Period 2|Lack of Efficacy|2
1070867|NCT02030600|2124203|FG001|Treatment Period 2|Lack of Efficacy|1
1070868|NCT02030600|2124202|FG000|Treatment Period 2|Lost to Follow-up|4
1070869|NCT02030600|2124203|FG001|Treatment Period 2|Lost to Follow-up|2
1070870|NCT02030600|2124202|FG000|Treatment Period 2|Protocol Violation|1
1070871|NCT02030600|2124203|FG001|Treatment Period 2|Protocol Violation|2
1070872|NCT02030600|2124202|FG000|Treatment Period 2|Withdrawal by Subject|13
1070873|NCT02030600|2124203|FG001|Treatment Period 2|Withdrawal by Subject|9
1070874|NCT02030600|2124202|FG000|Treatment Period 2|Unclassified|1
1070875|NCT02030600|2124203|FG001|Treatment Period 2|Unclassified|0
1070876|NCT02030821|2124215|FG000|Overall Study|Physician Decision|2
1070877|NCT02030821|2124216|FG001|Overall Study|Physician Decision|2
1070878|NCT02030821|2124217|FG002|Overall Study|Physician Decision|5
1070879|NCT02030821|2124218|FG003|Overall Study|Physician Decision|2
1070880|NCT02030834|2124231|FG000|Overall Study|Death|4
1070881|NCT02030834|2124232|FG001|Overall Study|Death|0
1070882|NCT02030834|2124233|FG002|Overall Study|Death|0
1070883|NCT02030834|2124231|FG000|Overall Study|Manufacturing failure|2
1070884|NCT02030834|2124232|FG001|Overall Study|Manufacturing failure|0
1070885|NCT02030834|2124233|FG002|Overall Study|Manufacturing failure|1
1070886|NCT02030834|2124231|FG000|Overall Study|Disease progression|2
1070887|NCT02030834|2124232|FG001|Overall Study|Disease progression|0
1070888|NCT02030834|2124233|FG002|Overall Study|Disease progression|2
1070889|NCT02030834|2124231|FG000|Overall Study|Lost to Follow-up|1
1070890|NCT02030834|2124232|FG001|Overall Study|Lost to Follow-up|0
1070891|NCT02030834|2124233|FG002|Overall Study|Lost to Follow-up|0
1070892|NCT02030834|2124231|FG000|Overall Study|Withdrawal by Subject|1
1070893|NCT02030834|2124232|FG001|Overall Study|Withdrawal by Subject|0
1070894|NCT02030834|2124233|FG002|Overall Study|Withdrawal by Subject|0
1070895|NCT02030834|2124231|FG000|Overall Study|Lack of funding|1
1070896|NCT02030834|2124232|FG001|Overall Study|Lack of funding|0
1070897|NCT02030834|2124233|FG002|Overall Study|Lack of funding|0
1070898|NCT02030847|2124241|FG000|Overall Study|Death|10
1070899|NCT02030847|2124241|FG000|Overall Study|Disease Progression|15
1070900|NCT02030847|2124241|FG000|Overall Study|New Cancer Therapy|8
1070901|NCT02030847|2124241|FG000|Overall Study|Physician Decision|3
1070902|NCT02030847|2124241|FG000|Overall Study|Withdrawal by Subject|1
1070903|NCT02031146|2124259|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0
1070904|NCT02031146|2124260|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0
1070905|NCT02031146|2124261|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0
1070906|NCT02031146|2124262|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100
1070907|NCT02031146|2124263|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26
1070908|NCT02031146|2124264|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4
1070909|NCT02031146|2124265|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5
1070910|NCT02031237|2124277|FG000|Overall Study|Death|1
1070911|NCT02031237|2124278|FG001|Overall Study|Death|5
1070912|NCT02031237|2124279|FG002|Overall Study|Death|0
1070913|NCT02031237|2124277|FG000|Overall Study|Physician Decision|0
1070914|NCT02031237|2124278|FG001|Overall Study|Physician Decision|1
1070915|NCT02031237|2124279|FG002|Overall Study|Physician Decision|0
1070916|NCT02031237|2124277|FG000|Overall Study|Withdrawal by Subject|2
1070917|NCT02031237|2124278|FG001|Overall Study|Withdrawal by Subject|2
1070918|NCT02031237|2124279|FG002|Overall Study|Withdrawal by Subject|0
1070919|NCT02031237|2124277|FG000|Overall Study|Protocol Violation|2
1070920|NCT02031237|2124278|FG001|Overall Study|Protocol Violation|6
1070921|NCT02031237|2124279|FG002|Overall Study|Protocol Violation|0
1070922|NCT02031237|2124277|FG000|Overall Study|Alternate Treatment Given|0
1070923|NCT02031237|2124278|FG001|Overall Study|Alternate Treatment Given|0
1070924|NCT02031237|2124279|FG002|Overall Study|Alternate Treatment Given|3
1070925|NCT02031276|2124289|FG000|Period 1 Double-blind IV|Adverse Event|6
1070926|NCT02031276|2124290|FG001|Period 1 Double-blind IV|Adverse Event|5
1070927|NCT02031276|2124291|FG002|Period 1 Double-blind IV|Adverse Event|1
1070928|NCT02031276|2124289|FG000|Period 1 Double-blind IV|Other|0
1070929|NCT02031276|2124290|FG001|Period 1 Double-blind IV|Other|1
1070930|NCT02031276|2124291|FG002|Period 1 Double-blind IV|Other|0
1070931|NCT02031276|2124289|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1
1070932|NCT02031276|2124290|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0
1070933|NCT02031276|2124291|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0
908344|NCT00782340|1884947|FG001|Open Label Titration|Protocol Violation|0
908345|NCT00782340|1884948|FG002|Open Label Titration|Protocol Violation|0
908346|NCT00782340|1884946|FG000|Open Label Titration|Withdrawal by Subject|5
908347|NCT00782340|1884947|FG001|Open Label Titration|Withdrawal by Subject|0
908348|NCT00782340|1884948|FG002|Open Label Titration|Withdrawal by Subject|0
908349|NCT00782340|1884946|FG000|Open Label Titration|Enrollment capped|16
908350|NCT00782340|1884947|FG001|Open Label Titration|Enrollment capped|0
908351|NCT00782340|1884948|FG002|Open Label Titration|Enrollment capped|0
908352|NCT00782340|1884946|FG000|Open Label Titration|Did not meet responder criteria|2
908353|NCT00782340|1884947|FG001|Open Label Titration|Did not meet responder criteria|0
908354|NCT00782340|1884948|FG002|Open Label Titration|Did not meet responder criteria|0
908355|NCT00782340|1884946|FG000|Open Label Titration|Lost to Follow-up|5
908356|NCT00782340|1884947|FG001|Open Label Titration|Lost to Follow-up|0
908357|NCT00782340|1884948|FG002|Open Label Titration|Lost to Follow-up|0
908358|NCT00782340|1884946|FG000|Open Label Titration|Randomized in error|6
908359|NCT00782340|1884947|FG001|Open Label Titration|Randomized in error|0
908360|NCT00782340|1884948|FG002|Open Label Titration|Randomized in error|0
908361|NCT00782418|1884959|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1
908362|NCT00782418|1884960|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0
908363|NCT00782418|1884961|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0
908364|NCT00782418|1884962|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0
908365|NCT00782418|1884963|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0
908366|NCT00782418|1884964|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0
908367|NCT00782418|1884965|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0
908368|NCT00782418|1884959|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
908369|NCT00782418|1884960|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
908370|NCT00782418|1884961|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
908371|NCT00782418|1884962|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
908372|NCT00782418|1884963|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
908373|NCT00782418|1884964|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
908374|NCT00782418|1884965|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
908375|NCT00782496|1884981|FG000|Overall Study|Lost to Follow-up|14
908376|NCT00782496|1884982|FG001|Overall Study|Lost to Follow-up|15
908377|NCT00782509|1884992|FG000|Overall Study|Adverse Event|20
908378|NCT00782509|1884993|FG001|Overall Study|Adverse Event|10
908379|NCT00782509|1884994|FG002|Overall Study|Adverse Event|20
908380|NCT00782509|1884992|FG000|Overall Study|Lost to Follow-up|1
908381|NCT00782509|1884993|FG001|Overall Study|Lost to Follow-up|2
908382|NCT00782509|1884994|FG002|Overall Study|Lost to Follow-up|3
908383|NCT00782509|1884992|FG000|Overall Study|Withdrawal by Subject|3
1070934|NCT02031276|2124289|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
1070935|NCT02031276|2124290|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
1070936|NCT02031276|2124291|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
1070937|NCT02031276|2124289|FG000|Period 2 Open-label Risankizumab IV|Other|0
1070938|NCT02031276|2124290|FG001|Period 2 Open-label Risankizumab IV|Other|2
1070939|NCT02031276|2124291|FG002|Period 2 Open-label Risankizumab IV|Other|1
1070940|NCT02031276|2124289|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0
1070941|NCT02031276|2124290|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2
1070942|NCT02031276|2124291|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0
1070943|NCT02031276|2124289|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2
1070944|NCT02031276|2124290|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0
1070945|NCT02031276|2124291|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0
1070946|NCT02031276|2124289|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
1070947|NCT02031276|2124290|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
1070948|NCT02031276|2124291|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
1070949|NCT02031276|2124289|FG000|Period 3 Open-label Risankizumab SC|Other|0
1070950|NCT02031276|2124290|FG001|Period 3 Open-label Risankizumab SC|Other|0
1070951|NCT02031276|2124291|FG002|Period 3 Open-label Risankizumab SC|Other|1
1070952|NCT02031302|2124305|FG000|Overall Study|Death|115
1070953|NCT02031302|2124306|FG001|Overall Study|Death|0
1070954|NCT02031302|2124305|FG000|Overall Study|Not treated with study valve system|18
1070955|NCT02031302|2124306|FG001|Overall Study|Not treated with study valve system|0
1070956|NCT02031302|2124305|FG000|Overall Study|Missed Follow Up|27
1070957|NCT02031302|2124306|FG001|Overall Study|Missed Follow Up|0
1070958|NCT02031302|2124305|FG000|Overall Study|Lost to Follow-up|4
1070959|NCT02031302|2124306|FG001|Overall Study|Lost to Follow-up|0
1070960|NCT02031432|2124313|FG000|Overall Study|Protocol Violation|1
1070961|NCT02031432|2124313|FG000|Overall Study|Lack of Efficacy|5
1070962|NCT02031432|2124313|FG000|Overall Study|Cancer Progression|2
1070963|NCT02031432|2124313|FG000|Overall Study|Withdrawn as forbidden meds required|1
1070964|NCT02031432|2124313|FG000|Overall Study|Adverse Event|8
1070965|NCT02031432|2124313|FG000|Overall Study|Withdrawal by Subject|5
1070966|NCT02031432|2124313|FG000|Overall Study|Lost to Follow-up|1
1070967|NCT02031432|2124313|FG000|Overall Study|Inclusion/Exclusion criteria not met|5
1070968|NCT02031432|2124313|FG000|Overall Study|Death|10
1070969|NCT02031458|2124320|FG000|May 8, 2015 to January 11, 2019|Death|89
1070970|NCT02031458|2124321|FG001|May 8, 2015 to January 11, 2019|Death|193
1070971|NCT02031458|2124322|FG002|May 8, 2015 to January 11, 2019|Death|198
1070972|NCT02031458|2124320|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
1070973|NCT02031458|2124321|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
1070974|NCT02031458|2124322|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
1070975|NCT02031458|2124320|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
1070976|NCT02031458|2124321|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
1070977|NCT02031458|2124322|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
1070978|NCT02031458|2124320|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2
1070979|NCT02031458|2124321|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3
1070980|NCT02031458|2124322|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3
1070981|NCT02031458|2124320|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7
1070982|NCT02031458|2124321|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4
1070983|NCT02031458|2124322|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0
1070984|NCT02031458|2124320|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
1070985|NCT02031458|2124321|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
1070986|NCT02031458|2124322|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
1070987|NCT02031458|2124320|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
1070988|NCT02031458|2124321|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
1070989|NCT02031458|2124322|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
1070990|NCT02031458|2124320|FG000|Baseline to May 8, 2015|Death|36
1070991|NCT02031458|2124321|FG001|Baseline to May 8, 2015|Death|87
1070992|NCT02031458|2124322|FG002|Baseline to May 8, 2015|Death|100
1070993|NCT02031458|2124320|FG000|Baseline to May 8, 2015|Protocol Violation|7
1070994|NCT02031458|2124321|FG001|Baseline to May 8, 2015|Protocol Violation|4
1070995|NCT02031458|2124322|FG002|Baseline to May 8, 2015|Protocol Violation|0
1070996|NCT02031458|2124320|FG000|Baseline to May 8, 2015|Physician Decision|0
1070997|NCT02031458|2124321|FG001|Baseline to May 8, 2015|Physician Decision|1
1070998|NCT02031458|2124322|FG002|Baseline to May 8, 2015|Physician Decision|0
1070999|NCT02031458|2124320|FG000|Baseline to May 8, 2015|Unknown Reason|0
1071000|NCT02031458|2124321|FG001|Baseline to May 8, 2015|Unknown Reason|1
1071001|NCT02031458|2124322|FG002|Baseline to May 8, 2015|Unknown Reason|2
1071002|NCT02031458|2124320|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6
908384|NCT00782509|1884993|FG001|Overall Study|Withdrawal by Subject|5
908385|NCT00782509|1884994|FG002|Overall Study|Withdrawal by Subject|8
908386|NCT00782509|1884992|FG000|Overall Study|Non compliance with protocol|2
908387|NCT00782509|1884993|FG001|Overall Study|Non compliance with protocol|0
908388|NCT00782509|1884994|FG002|Overall Study|Non compliance with protocol|0
1071003|NCT02031458|2124321|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9
1071004|NCT02031458|2124322|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3
1071005|NCT02031458|2124320|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46
1071006|NCT02031458|2124321|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83
1071007|NCT02031458|2124322|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73
1071008|NCT02031458|2124320|FG000|Baseline to May 8, 2015|On Treatment|43
1071009|NCT02031458|2124321|FG001|Baseline to May 8, 2015|On Treatment|81
1071010|NCT02031458|2124322|FG002|Baseline to May 8, 2015|On Treatment|73
1071011|NCT02031458|2124320|FG000|Baseline to May 8, 2015|Lost to Follow-up|1
1071012|NCT02031458|2124321|FG001|Baseline to May 8, 2015|Lost to Follow-up|1
1071013|NCT02031458|2124322|FG002|Baseline to May 8, 2015|Lost to Follow-up|2
1071014|NCT02031471|2124332|FG000|24 Week Treatment Period|Adverse Event|6
1071015|NCT02031471|2124332|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2
1071016|NCT02031471|2124332|FG000|24 Week Treatment Period|Protocol Violation|1
1071017|NCT02031471|2124332|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1
1071018|NCT02031471|2124332|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1
1071019|NCT02031471|2124332|FG000|Long Term Extension (LTE) Period|Adverse Event|1
1071020|NCT02031471|2124332|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
1071021|NCT02031536|2124338|FG000|Overall Study|ineligible|1
1071022|NCT02031536|2124339|FG001|Overall Study|ineligible|0
1071023|NCT02031640|2124363|FG000|Screening Period|Adverse Event|1
1071024|NCT02031640|2124364|FG001|Screening Period|Adverse Event|0
1071025|NCT02031640|2124365|FG002|Screening Period|Adverse Event|0
1071026|NCT02031640|2124366|FG003|Screening Period|Adverse Event|0
1071027|NCT02031640|2124367|FG004|Screening Period|Adverse Event|0
1071028|NCT02031640|2124368|FG005|Screening Period|Adverse Event|0
1071029|NCT02031640|2124363|FG000|Screening Period|Withdrawal by Subject|29
1071030|NCT02031640|2124364|FG001|Screening Period|Withdrawal by Subject|0
1071031|NCT02031640|2124365|FG002|Screening Period|Withdrawal by Subject|0
1071032|NCT02031640|2124366|FG003|Screening Period|Withdrawal by Subject|0
1071033|NCT02031640|2124367|FG004|Screening Period|Withdrawal by Subject|0
1071034|NCT02031640|2124368|FG005|Screening Period|Withdrawal by Subject|0
1071035|NCT02031640|2124363|FG000|Screening Period|Inclusion criteria not met|312
908389|NCT00782509|1884992|FG000|Overall Study|Other reasons not stated above|5
908390|NCT00782509|1884993|FG001|Overall Study|Other reasons not stated above|2
908391|NCT00782509|1884994|FG002|Overall Study|Other reasons not stated above|3
908392|NCT00782509|1884992|FG000|Overall Study|Lack of Efficacy|10
908393|NCT00782509|1884993|FG001|Overall Study|Lack of Efficacy|5
908394|NCT00782509|1884994|FG002|Overall Study|Lack of Efficacy|2
908395|NCT00782626|1885009|FG000|Overall Study|Adverse Event|1
908396|NCT00782626|1885009|FG000|Overall Study|Progressive Disease|5
908397|NCT00782626|1885009|FG000|Overall Study|Other Complicating Disease|1
908398|NCT00782717|1885026|FG000|Overall Study|Adverse Event|2
908399|NCT00782717|1885027|FG001|Overall Study|Adverse Event|5
908400|NCT00782717|1885026|FG000|Overall Study|Patient decision unrelated to AE|6
908401|NCT00782717|1885027|FG001|Overall Study|Patient decision unrelated to AE|3
908402|NCT00782717|1885026|FG000|Overall Study|Noncompliance|2
908403|NCT00782717|1885027|FG001|Overall Study|Noncompliance|1
908404|NCT00782717|1885026|FG000|Overall Study|Treatment failure|3
908405|NCT00782717|1885027|FG001|Overall Study|Treatment failure|14
908406|NCT00782717|1885026|FG000|Overall Study|Enrollment close prior to surgery|1
908407|NCT00782717|1885027|FG001|Overall Study|Enrollment close prior to surgery|0
908408|NCT00782717|1885026|FG000|Overall Study|Did not meet entrance criteria|1
908409|NCT00782717|1885027|FG001|Overall Study|Did not meet entrance criteria|3
908410|NCT00782717|1885026|FG000|Overall Study|Exited in error|0
908411|NCT00782717|1885027|FG001|Overall Study|Exited in error|2
908412|NCT00782795|1885039|FG000|Overall Study|Withdrawal by Subject|1
908413|NCT00782795|1885040|FG001|Overall Study|Withdrawal by Subject|2
908414|NCT00782834|1885070|FG000|Treatment Phase|fibrous tumor not GIST|1
908415|NCT00783094|1885077|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4
908416|NCT00783094|1885078|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5
908417|NCT00783094|1885079|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5
908418|NCT00783094|1885077|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
908419|NCT00783094|1885078|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
908420|NCT00783094|1885079|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
908421|NCT00783094|1885077|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0
908422|NCT00783094|1885078|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2
908423|NCT00783094|1885079|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0
908424|NCT00783094|1885077|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1
908425|NCT00783094|1885078|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2
908426|NCT00783094|1885079|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1
908427|NCT00783094|1885077|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
908428|NCT00783094|1885078|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
908429|NCT00783094|1885079|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
908430|NCT00783094|1885077|FG000|Open-Label Extension Period|Adverse Event|12
908431|NCT00783094|1885078|FG001|Open-Label Extension Period|Adverse Event|7
908432|NCT00783094|1885079|FG002|Open-Label Extension Period|Adverse Event|16
1071036|NCT02031640|2124364|FG001|Screening Period|Inclusion criteria not met|0
1071037|NCT02031640|2124365|FG002|Screening Period|Inclusion criteria not met|0
1071038|NCT02031640|2124366|FG003|Screening Period|Inclusion criteria not met|0
1071039|NCT02031640|2124367|FG004|Screening Period|Inclusion criteria not met|0
1071040|NCT02031640|2124368|FG005|Screening Period|Inclusion criteria not met|0
1071041|NCT02031640|2124363|FG000|Screening Period|Exclusion criteria met|30
1071042|NCT02031640|2124364|FG001|Screening Period|Exclusion criteria met|0
1071043|NCT02031640|2124365|FG002|Screening Period|Exclusion criteria met|0
1071044|NCT02031640|2124366|FG003|Screening Period|Exclusion criteria met|0
1071045|NCT02031640|2124367|FG004|Screening Period|Exclusion criteria met|0
1071046|NCT02031640|2124368|FG005|Screening Period|Exclusion criteria met|0
1071047|NCT02031640|2124363|FG000|Screening Period|Lost to Follow-up|14
1071048|NCT02031640|2124364|FG001|Screening Period|Lost to Follow-up|0
1071049|NCT02031640|2124365|FG002|Screening Period|Lost to Follow-up|0
1071050|NCT02031640|2124366|FG003|Screening Period|Lost to Follow-up|0
1071051|NCT02031640|2124367|FG004|Screening Period|Lost to Follow-up|0
1071052|NCT02031640|2124368|FG005|Screening Period|Lost to Follow-up|0
1071053|NCT02031640|2124363|FG000|Screening Period|Enrollment closed|26
1071054|NCT02031640|2124364|FG001|Screening Period|Enrollment closed|0
1071055|NCT02031640|2124365|FG002|Screening Period|Enrollment closed|0
1071056|NCT02031640|2124366|FG003|Screening Period|Enrollment closed|0
1071057|NCT02031640|2124367|FG004|Screening Period|Enrollment closed|0
1071058|NCT02031640|2124368|FG005|Screening Period|Enrollment closed|0
1071059|NCT02031640|2124363|FG000|Run-In Period|Adverse Event|4
1071060|NCT02031640|2124364|FG001|Run-In Period|Adverse Event|0
1071061|NCT02031640|2124365|FG002|Run-In Period|Adverse Event|0
1071062|NCT02031640|2124366|FG003|Run-In Period|Adverse Event|0
1071063|NCT02031640|2124367|FG004|Run-In Period|Adverse Event|0
1071064|NCT02031640|2124368|FG005|Run-In Period|Adverse Event|0
1071065|NCT02031640|2124363|FG000|Run-In Period|Withdrawal by Subject|17
1071066|NCT02031640|2124364|FG001|Run-In Period|Withdrawal by Subject|0
1071067|NCT02031640|2124365|FG002|Run-In Period|Withdrawal by Subject|0
1071068|NCT02031640|2124366|FG003|Run-In Period|Withdrawal by Subject|0
1071069|NCT02031640|2124367|FG004|Run-In Period|Withdrawal by Subject|0
1071070|NCT02031640|2124368|FG005|Run-In Period|Withdrawal by Subject|0
1071071|NCT02031640|2124363|FG000|Run-In Period|Inclusion criteria not met|38
1071072|NCT02031640|2124364|FG001|Run-In Period|Inclusion criteria not met|0
1071073|NCT02031640|2124365|FG002|Run-In Period|Inclusion criteria not met|0
1071074|NCT02031640|2124366|FG003|Run-In Period|Inclusion criteria not met|0
1071075|NCT02031640|2124367|FG004|Run-In Period|Inclusion criteria not met|0
1071076|NCT02031640|2124368|FG005|Run-In Period|Inclusion criteria not met|0
1071077|NCT02031640|2124363|FG000|Run-In Period|Exclusion criteria met|8
1071078|NCT02031640|2124364|FG001|Run-In Period|Exclusion criteria met|0
1071079|NCT02031640|2124365|FG002|Run-In Period|Exclusion criteria met|0
1071080|NCT02031640|2124366|FG003|Run-In Period|Exclusion criteria met|0
1071081|NCT02031640|2124367|FG004|Run-In Period|Exclusion criteria met|0
1071082|NCT02031640|2124368|FG005|Run-In Period|Exclusion criteria met|0
1071083|NCT02031640|2124363|FG000|Run-In Period|Randomization criteria not met|85
1071084|NCT02031640|2124364|FG001|Run-In Period|Randomization criteria not met|0
1071085|NCT02031640|2124365|FG002|Run-In Period|Randomization criteria not met|0
1071086|NCT02031640|2124366|FG003|Run-In Period|Randomization criteria not met|0
1071087|NCT02031640|2124367|FG004|Run-In Period|Randomization criteria not met|0
1071088|NCT02031640|2124368|FG005|Run-In Period|Randomization criteria not met|0
1071089|NCT02031640|2124363|FG000|Run-In Period|Various administrative reasons|17
1071090|NCT02031640|2124364|FG001|Run-In Period|Various administrative reasons|0
1071091|NCT02031640|2124365|FG002|Run-In Period|Various administrative reasons|0
1071092|NCT02031640|2124366|FG003|Run-In Period|Various administrative reasons|0
1071093|NCT02031640|2124367|FG004|Run-In Period|Various administrative reasons|0
1071094|NCT02031640|2124368|FG005|Run-In Period|Various administrative reasons|0
1071095|NCT02031640|2124363|FG000|Double-blind Treatment Period|Protocol deviation|0
1071096|NCT02031640|2124364|FG001|Double-blind Treatment Period|Protocol deviation|2
1071097|NCT02031640|2124365|FG002|Double-blind Treatment Period|Protocol deviation|0
1071098|NCT02031640|2124366|FG003|Double-blind Treatment Period|Protocol deviation|1
1071099|NCT02031640|2124367|FG004|Double-blind Treatment Period|Protocol deviation|3
1071100|NCT02031640|2124368|FG005|Double-blind Treatment Period|Protocol deviation|1
1071101|NCT02031640|2124363|FG000|Double-blind Treatment Period|Lack of Efficacy|0
1071102|NCT02031640|2124364|FG001|Double-blind Treatment Period|Lack of Efficacy|14
1071103|NCT02031640|2124365|FG002|Double-blind Treatment Period|Lack of Efficacy|3
1071104|NCT02031640|2124366|FG003|Double-blind Treatment Period|Lack of Efficacy|2
1071105|NCT02031640|2124367|FG004|Double-blind Treatment Period|Lack of Efficacy|5
1071106|NCT02031640|2124368|FG005|Double-blind Treatment Period|Lack of Efficacy|1
1071107|NCT02031640|2124363|FG000|Double-blind Treatment Period|Non-compliance|0
1071108|NCT02031640|2124364|FG001|Double-blind Treatment Period|Non-compliance|1
1071109|NCT02031640|2124365|FG002|Double-blind Treatment Period|Non-compliance|0
1071110|NCT02031640|2124366|FG003|Double-blind Treatment Period|Non-compliance|1
1071111|NCT02031640|2124367|FG004|Double-blind Treatment Period|Non-compliance|1
1071112|NCT02031640|2124368|FG005|Double-blind Treatment Period|Non-compliance|0
1071113|NCT02031640|2124363|FG000|Double-blind Treatment Period|Adverse Event|0
1071114|NCT02031640|2124364|FG001|Double-blind Treatment Period|Adverse Event|0
1071115|NCT02031640|2124365|FG002|Double-blind Treatment Period|Adverse Event|0
1071116|NCT02031640|2124366|FG003|Double-blind Treatment Period|Adverse Event|2
1071117|NCT02031640|2124367|FG004|Double-blind Treatment Period|Adverse Event|0
1071118|NCT02031640|2124368|FG005|Double-blind Treatment Period|Adverse Event|0
1071119|NCT02031640|2124363|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
1071120|NCT02031640|2124364|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
1071121|NCT02031640|2124365|FG002|Double-blind Treatment Period|Withdrawal by Subject|3
1071122|NCT02031640|2124366|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
1071123|NCT02031640|2124367|FG004|Double-blind Treatment Period|Withdrawal by Subject|1
1071124|NCT02031640|2124368|FG005|Double-blind Treatment Period|Withdrawal by Subject|1
1071125|NCT02031640|2124363|FG000|Double-blind Treatment Period|Lost to Follow-up|0
1071126|NCT02031640|2124364|FG001|Double-blind Treatment Period|Lost to Follow-up|3
1071127|NCT02031640|2124365|FG002|Double-blind Treatment Period|Lost to Follow-up|0
1071128|NCT02031640|2124366|FG003|Double-blind Treatment Period|Lost to Follow-up|0
1071129|NCT02031640|2124367|FG004|Double-blind Treatment Period|Lost to Follow-up|1
1071130|NCT02031640|2124368|FG005|Double-blind Treatment Period|Lost to Follow-up|0
1071131|NCT02031679|2124389|FG000|Overall Study|Protocol Violation|0
1071132|NCT02031679|2124390|FG001|Overall Study|Protocol Violation|1
1071133|NCT02031679|2124389|FG000|Overall Study|Lack of Efficacy|0
1071134|NCT02031679|2124390|FG001|Overall Study|Lack of Efficacy|1
1071135|NCT02032173|2124407|FG000|Overall Study|Discontinuation due to sponsor decision|31
1071136|NCT02032238|2124430|FG000|Overall Study|Lost to Follow-up|2
1071137|NCT02032238|2124431|FG001|Overall Study|Lost to Follow-up|0
1071138|NCT02032407|2124437|FG000|Overall Study|Lost to Follow-up|2
1071139|NCT02032407|2124437|FG000|Overall Study|Pregnancy|1
1071140|NCT02032407|2124437|FG000|Overall Study|Other Miscellaneous Reasons|2
1071141|NCT02032706|2124483|FG000|Overall Study|Did not qualify|5
1071142|NCT02032706|2124483|FG000|Overall Study|Protocol Violation|1
1071143|NCT02032875|2124511|FG000|Treatment Period|Adverse Event|1
1071144|NCT02032875|2124512|FG001|Treatment Period|Adverse Event|0
1071145|NCT02032875|2124511|FG000|Treatment Period|Liver transplant, No extension needed|0
1071146|NCT02032875|2124512|FG001|Treatment Period|Liver transplant, No extension needed|1
1071147|NCT02032875|2124511|FG000|Treatment Period|Liver transplant, Treatment extension|0
1071148|NCT02032875|2124512|FG001|Treatment Period|Liver transplant, Treatment extension|3
1071149|NCT02032875|2124511|FG000|Follow-up Period|Death|0
1071150|NCT02032875|2124512|FG001|Follow-up Period|Death|1
1071151|NCT02032875|2124511|FG000|Follow-up Period|Virologic Relapse|3
1071152|NCT02032875|2124512|FG001|Follow-up Period|Virologic Relapse|10
1071153|NCT02032888|2124522|FG000|Treatment Period|Poor compliance/noncompliance|1
1071154|NCT02032888|2124523|FG001|Treatment Period|Poor compliance/noncompliance|1
1071155|NCT02032888|2124524|FG002|Treatment Period|Poor compliance/noncompliance|0
1071156|NCT02032888|2124522|FG000|Treatment Period|Other|1
1071157|NCT02032888|2124523|FG001|Treatment Period|Other|1
1071158|NCT02032888|2124524|FG002|Treatment Period|Other|0
1071159|NCT02032888|2124522|FG000|Follow-up Period|Lost to Follow-up|1
1071160|NCT02032888|2124523|FG001|Follow-up Period|Lost to Follow-up|1
1071161|NCT02032888|2124524|FG002|Follow-up Period|Lost to Follow-up|0
1071162|NCT02032888|2124522|FG000|Follow-up Period|Death|1
1071163|NCT02032888|2124523|FG001|Follow-up Period|Death|1
1071164|NCT02032888|2124524|FG002|Follow-up Period|Death|0
1071165|NCT02032888|2124522|FG000|Follow-up Period|Other|1
1071166|NCT02032888|2124523|FG001|Follow-up Period|Other|0
1071167|NCT02032888|2124524|FG002|Follow-up Period|Other|0
1071168|NCT02032901|2124543|FG000|Treatment Period (12 Weeks)|Pregnancy|1
1071169|NCT02032901|2124544|FG001|Treatment Period (12 Weeks)|Pregnancy|0
1071170|NCT02032901|2124543|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
1071171|NCT02032901|2124544|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
1071172|NCT02033369|2124608|FG000|Overall Study|Physician Decision|1
1071173|NCT02033369|2124609|FG001|Overall Study|Physician Decision|2
1071174|NCT02033369|2124608|FG000|Overall Study|Not a good demographic match|0
1071175|NCT02033369|2124609|FG001|Overall Study|Not a good demographic match|2
1071176|NCT02033369|2124608|FG000|Overall Study|Withdrawal by Subject|1
1071177|NCT02033369|2124609|FG001|Overall Study|Withdrawal by Subject|1
1071178|NCT02033369|2124608|FG000|Overall Study|Lost to Follow-up|1
1071179|NCT02033369|2124609|FG001|Overall Study|Lost to Follow-up|0
1071180|NCT02033369|2124608|FG000|Overall Study|Protocol Violation|2
1071181|NCT02033369|2124609|FG001|Overall Study|Protocol Violation|0
1071182|NCT02033759|2124647|FG000|Overall Study|Withdrawal by Subject|2
1071183|NCT02033759|2124648|FG001|Overall Study|Withdrawal by Subject|1
1071184|NCT02033759|2124647|FG000|Overall Study|Protocol Violation|1
1071185|NCT02033759|2124648|FG001|Overall Study|Protocol Violation|1
1071186|NCT02033850|2124656|FG000|Overall Study|Death|1
1071187|NCT02033850|2124657|FG001|Overall Study|Death|0
1071188|NCT02033850|2124656|FG000|Overall Study|unrelated medical reason|1
1071189|NCT02033850|2124657|FG001|Overall Study|unrelated medical reason|1
1071190|NCT02033889|2124675|FG000|Overall Study|Adverse Event|3
1071191|NCT02033889|2124676|FG001|Overall Study|Adverse Event|1
1071192|NCT02033889|2124677|FG002|Overall Study|Adverse Event|3
1071193|NCT02033889|2124675|FG000|Overall Study|Death|3
1071194|NCT02033889|2124676|FG001|Overall Study|Death|1
1071195|NCT02033889|2124677|FG002|Overall Study|Death|2
1071196|NCT02033889|2124675|FG000|Overall Study|Excluded Medication|1
1071197|NCT02033889|2124676|FG001|Overall Study|Excluded Medication|1
1071198|NCT02033889|2124677|FG002|Overall Study|Excluded Medication|0
1071199|NCT02033889|2124675|FG000|Overall Study|Lost to Follow-up|8
1071200|NCT02033889|2124676|FG001|Overall Study|Lost to Follow-up|5
1071201|NCT02033889|2124677|FG002|Overall Study|Lost to Follow-up|6
1071202|NCT02033889|2124675|FG000|Overall Study|Non-Compliance With Study Drug|1
1071203|NCT02033889|2124676|FG001|Overall Study|Non-Compliance With Study Drug|0
1071204|NCT02033889|2124677|FG002|Overall Study|Non-Compliance With Study Drug|0
1071205|NCT02033889|2124675|FG000|Overall Study|Physician Decision|0
1071206|NCT02033889|2124676|FG001|Overall Study|Physician Decision|1
1071207|NCT02033889|2124677|FG002|Overall Study|Physician Decision|1
1071208|NCT02033889|2124675|FG000|Overall Study|Participant moved|0
1071209|NCT02033889|2124676|FG001|Overall Study|Participant moved|1
1071210|NCT02033889|2124677|FG002|Overall Study|Participant moved|0
1071211|NCT02033889|2124675|FG000|Overall Study|Withdrawal by Subject|18
1071212|NCT02033889|2124676|FG001|Overall Study|Withdrawal by Subject|10
1071213|NCT02033889|2124677|FG002|Overall Study|Withdrawal by Subject|13
1071214|NCT02034006|2124696|FG000|Overall Study|Withdrawal by Subject|7
1071215|NCT02034006|2124696|FG000|Overall Study|Lost to Follow-up|5
1071216|NCT02034006|2124696|FG000|Overall Study|Death|1
1071217|NCT02034006|2124696|FG000|Overall Study|Pregnancy|1
1071218|NCT02034058|2124712|FG000|Overall Study|Death|3
1071219|NCT02034162|2124796|FG000|Double-blind|Lost to Follow-up|3
1071220|NCT02034162|2124797|FG001|Double-blind|Lost to Follow-up|0
1071221|NCT02034162|2124798|FG002|Double-blind|Lost to Follow-up|0
1071222|NCT02034162|2124796|FG000|Double-blind|Physician Decision|1
1071223|NCT02034162|2124797|FG001|Double-blind|Physician Decision|0
1071224|NCT02034162|2124798|FG002|Double-blind|Physician Decision|0
1071225|NCT02034162|2124796|FG000|Double-blind|Protocol Violation|0
1071226|NCT02034162|2124797|FG001|Double-blind|Protocol Violation|1
1071227|NCT02034162|2124798|FG002|Double-blind|Protocol Violation|0
1071228|NCT02034162|2124796|FG000|Double-blind|Withdrawal by Subject|5
1071229|NCT02034162|2124797|FG001|Double-blind|Withdrawal by Subject|7
1071230|NCT02034162|2124798|FG002|Double-blind|Withdrawal by Subject|0
1071231|NCT02034409|2124815|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4
1071232|NCT02034409|2124816|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0
1071233|NCT02034409|2124815|FG000|Sham-Controlled Treatment Period|Adverse Event|1
1071234|NCT02034409|2124816|FG001|Sham-Controlled Treatment Period|Adverse Event|1
1071235|NCT02034409|2124815|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0
1071236|NCT02034409|2124816|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1
1071237|NCT02034409|2124815|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8
1071238|NCT02034409|2124816|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8
1071239|NCT02034409|2124815|FG000|Sham-Controlled Treatment Period|Physician Decision|1
1071240|NCT02034409|2124816|FG001|Sham-Controlled Treatment Period|Physician Decision|3
1071241|NCT02034409|2124815|FG000|Sham-Controlled Treatment Period|misrandomized|2
1071242|NCT02034409|2124816|FG001|Sham-Controlled Treatment Period|misrandomized|2
1071243|NCT02034435|2124824|FG000|Overall Study|Withdrawal by Subject|1
1071244|NCT02034435|2124825|FG001|Overall Study|Withdrawal by Subject|0
1071245|NCT02034435|2124826|FG002|Overall Study|Withdrawal by Subject|0
1071246|NCT02034435|2124827|FG003|Overall Study|Withdrawal by Subject|0
1071247|NCT02034435|2124824|FG000|Overall Study|Illness|0
1071248|NCT02034435|2124825|FG001|Overall Study|Illness|2
1071249|NCT02034435|2124826|FG002|Overall Study|Illness|0
1071250|NCT02034435|2124827|FG003|Overall Study|Illness|0
1071251|NCT02034435|2124824|FG000|Overall Study|Inadequate IV access|1
1071252|NCT02034435|2124825|FG001|Overall Study|Inadequate IV access|0
1071253|NCT02034435|2124826|FG002|Overall Study|Inadequate IV access|0
1071254|NCT02034435|2124827|FG003|Overall Study|Inadequate IV access|1
908433|NCT00783094|1885077|FG000|Open-Label Extension Period|Death|0
908434|NCT00783094|1885078|FG001|Open-Label Extension Period|Death|0
908435|NCT00783094|1885079|FG002|Open-Label Extension Period|Death|1
908436|NCT00783094|1885077|FG000|Open-Label Extension Period|Protocol Violation|4
908437|NCT00783094|1885078|FG001|Open-Label Extension Period|Protocol Violation|5
908438|NCT00783094|1885079|FG002|Open-Label Extension Period|Protocol Violation|7
908439|NCT00783094|1885077|FG000|Open-Label Extension Period|Withdrawal by Subject|1
908440|NCT00783094|1885078|FG001|Open-Label Extension Period|Withdrawal by Subject|1
908441|NCT00783094|1885079|FG002|Open-Label Extension Period|Withdrawal by Subject|3
908442|NCT00783094|1885077|FG000|Open-Label Extension Period|Physician Decision|4
908443|NCT00783094|1885078|FG001|Open-Label Extension Period|Physician Decision|2
908444|NCT00783094|1885079|FG002|Open-Label Extension Period|Physician Decision|3
908445|NCT00783094|1885077|FG000|Open-Label Extension Period|Lack of Efficacy|1
908446|NCT00783094|1885078|FG001|Open-Label Extension Period|Lack of Efficacy|4
908447|NCT00783094|1885079|FG002|Open-Label Extension Period|Lack of Efficacy|0
908448|NCT00783198|1885093|FG000|Overall Study|Adverse Event|15
908449|NCT00783198|1885094|FG001|Overall Study|Adverse Event|19
908450|NCT00783198|1885095|FG002|Overall Study|Adverse Event|3
908451|NCT00783198|1885093|FG000|Overall Study|Lost to Follow-up|11
908452|NCT00783198|1885094|FG001|Overall Study|Lost to Follow-up|1
908453|NCT00783198|1885095|FG002|Overall Study|Lost to Follow-up|7
908454|NCT00783198|1885093|FG000|Overall Study|Withdrawal by Subject|22
908455|NCT00783198|1885094|FG001|Overall Study|Withdrawal by Subject|14
1071255|NCT02034474|2124839|FG000|Overall Study|Adverse Event|3
1071256|NCT02034474|2124840|FG001|Overall Study|Adverse Event|2
1071257|NCT02034474|2124839|FG000|Overall Study|Withdrawal by Subject|1
1071258|NCT02034474|2124840|FG001|Overall Study|Withdrawal by Subject|2
1071259|NCT02034513|2124850|FG000|Overall Study|Adverse Event|11
1071260|NCT02034513|2124851|FG001|Overall Study|Adverse Event|10
1071261|NCT02034513|2124850|FG000|Overall Study|Lack of Efficacy|0
1071262|NCT02034513|2124851|FG001|Overall Study|Lack of Efficacy|1
1071263|NCT02034513|2124850|FG000|Overall Study|Lost to Follow-up|6
1071264|NCT02034513|2124851|FG001|Overall Study|Lost to Follow-up|7
1071265|NCT02034513|2124850|FG000|Overall Study|Pregnancy|0
1071266|NCT02034513|2124851|FG001|Overall Study|Pregnancy|3
1071267|NCT02034513|2124850|FG000|Overall Study|Protocol Violation|7
1071268|NCT02034513|2124851|FG001|Overall Study|Protocol Violation|10
1071269|NCT02034513|2124850|FG000|Overall Study|Withdrawal by Subject|25
1071270|NCT02034513|2124851|FG001|Overall Study|Withdrawal by Subject|25
1071271|NCT02034513|2124850|FG000|Overall Study|Unclassified|0
1071272|NCT02034513|2124851|FG001|Overall Study|Unclassified|1
1071273|NCT02034552|2124862|FG000|Overall Study|Never treated|3
1071274|NCT02034552|2124863|FG001|Overall Study|Never treated|2
1071275|NCT02034552|2124864|FG002|Overall Study|Never treated|0
1071276|NCT02034552|2124862|FG000|Overall Study|Radiological progression|3
1071277|NCT02034552|2124863|FG001|Overall Study|Radiological progression|5
1071278|NCT02034552|2124864|FG002|Overall Study|Radiological progression|4
1071279|NCT02034552|2124862|FG000|Overall Study|AE not assoc. with disease progression|1
1071280|NCT02034552|2124863|FG001|Overall Study|AE not assoc. with disease progression|4
1071281|NCT02034552|2124864|FG002|Overall Study|AE not assoc. with disease progression|2
1071282|NCT02034552|2124862|FG000|Overall Study|AE associated with disease progression|0
1071283|NCT02034552|2124863|FG001|Overall Study|AE associated with disease progression|1
1071284|NCT02034552|2124864|FG002|Overall Study|AE associated with disease progression|0
908456|NCT00783198|1885095|FG002|Overall Study|Withdrawal by Subject|20
908457|NCT00783198|1885093|FG000|Overall Study|Noncompliance with protocol|7
908458|NCT00783198|1885094|FG001|Overall Study|Noncompliance with protocol|7
908459|NCT00783198|1885095|FG002|Overall Study|Noncompliance with protocol|10
908460|NCT00783198|1885093|FG000|Overall Study|Did not meet protocol eligibility|0
908461|NCT00783198|1885094|FG001|Overall Study|Did not meet protocol eligibility|1
908462|NCT00783198|1885095|FG002|Overall Study|Did not meet protocol eligibility|0
908463|NCT00783198|1885093|FG000|Overall Study|Administrative|2
908464|NCT00783198|1885094|FG001|Overall Study|Administrative|1
908465|NCT00783198|1885095|FG002|Overall Study|Administrative|2
908466|NCT00783224|1885107|FG000|Overall Study|Adverse Event|0
908467|NCT00783224|1885108|FG001|Overall Study|Adverse Event|0
908468|NCT00783224|1885109|FG002|Overall Study|Adverse Event|1
908469|NCT00783224|1885110|FG003|Overall Study|Adverse Event|0
908470|NCT00783224|1885107|FG000|Overall Study|Discarded the Investigational Drug Used|0
908471|NCT00783224|1885108|FG001|Overall Study|Discarded the Investigational Drug Used|0
908472|NCT00783224|1885109|FG002|Overall Study|Discarded the Investigational Drug Used|0
908473|NCT00783224|1885110|FG003|Overall Study|Discarded the Investigational Drug Used|1
908474|NCT00783224|1885107|FG000|Overall Study|Inappropriate as a study subject|0
908475|NCT00783224|1885108|FG001|Overall Study|Inappropriate as a study subject|0
908476|NCT00783224|1885109|FG002|Overall Study|Inappropriate as a study subject|0
908477|NCT00783224|1885110|FG003|Overall Study|Inappropriate as a study subject|1
908478|NCT00783263|1885123|FG000|Overall Study|Adverse Event|3
908479|NCT00783263|1885124|FG001|Overall Study|Adverse Event|0
908480|NCT00783263|1885125|FG002|Overall Study|Adverse Event|2
908481|NCT00783263|1885126|FG003|Overall Study|Adverse Event|1
908482|NCT00783263|1885123|FG000|Overall Study|Lost to Follow-up|1
908483|NCT00783263|1885124|FG001|Overall Study|Lost to Follow-up|1
908484|NCT00783263|1885125|FG002|Overall Study|Lost to Follow-up|0
908485|NCT00783263|1885126|FG003|Overall Study|Lost to Follow-up|0
908486|NCT00783263|1885123|FG000|Overall Study|Withdrawal by Subject|0
908487|NCT00783263|1885124|FG001|Overall Study|Withdrawal by Subject|1
908488|NCT00783263|1885125|FG002|Overall Study|Withdrawal by Subject|1
908489|NCT00783263|1885126|FG003|Overall Study|Withdrawal by Subject|2
908490|NCT00783289|1885153|FG000|Overall Study|Protocol Violation|0
908491|NCT00783289|1885154|FG001|Overall Study|Protocol Violation|1
908492|NCT00783289|1885155|FG002|Overall Study|Protocol Violation|0
908493|NCT00783289|1885156|FG003|Overall Study|Protocol Violation|0
908494|NCT00783302|1885169|FG000|Overall Study|Lost to Follow-up|17
908495|NCT00783302|1885169|FG000|Overall Study|Technical Problems|11
908496|NCT00783302|1885169|FG000|Overall Study|Protocol Violation|3
908497|NCT00783302|1885169|FG000|Overall Study|Physician Decision|1
908498|NCT00783302|1885169|FG000|Overall Study|Withdrawal by Subject|3
908499|NCT00783432|1885198|FG000|Overall Study|Adverse Event|22
908500|NCT00783432|1885199|FG001|Overall Study|Adverse Event|17
908501|NCT00783432|1885198|FG000|Overall Study|Lack of Efficacy|20
908502|NCT00783432|1885199|FG001|Overall Study|Lack of Efficacy|21
908503|NCT00783432|1885198|FG000|Overall Study|Lost to Follow-up|11
908504|NCT00783432|1885199|FG001|Overall Study|Lost to Follow-up|6
908505|NCT00783432|1885198|FG000|Overall Study|Withdrawal by Subject|23
908506|NCT00783432|1885199|FG001|Overall Study|Withdrawal by Subject|20
908507|NCT00783432|1885198|FG000|Overall Study|subject moved|3
908508|NCT00783432|1885199|FG001|Overall Study|subject moved|5
1071285|NCT02034552|2124862|FG000|Overall Study|Withdrawal by Subject|2
1071286|NCT02034552|2124863|FG001|Overall Study|Withdrawal by Subject|1
1071287|NCT02034552|2124864|FG002|Overall Study|Withdrawal by Subject|1
1071288|NCT02034552|2124862|FG000|Overall Study|Non-compliance with study drug|0
1071289|NCT02034552|2124863|FG001|Overall Study|Non-compliance with study drug|0
1071290|NCT02034552|2124864|FG002|Overall Study|Non-compliance with study drug|1
1071291|NCT02034552|2124862|FG000|Overall Study|Clinical progression|5
1071292|NCT02034552|2124863|FG001|Overall Study|Clinical progression|7
1071293|NCT02034552|2124864|FG002|Overall Study|Clinical progression|9
1071294|NCT02034565|2124872|FG000|Overall Study|Adverse Event|1
1071295|NCT02034565|2124873|FG001|Overall Study|Adverse Event|0
1071296|NCT02034591|2124895|FG000|Overall Study|Withdrawal by Subject|0
1071297|NCT02034591|2124896|FG001|Overall Study|Withdrawal by Subject|0
1071298|NCT02034591|2124897|FG002|Overall Study|Withdrawal by Subject|0
1071299|NCT02034591|2124898|FG003|Overall Study|Withdrawal by Subject|0
1071300|NCT02034591|2124899|FG004|Overall Study|Withdrawal by Subject|1
1071301|NCT02034591|2124900|FG005|Overall Study|Withdrawal by Subject|0
1071302|NCT02034708|2124911|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
1071303|NCT02034708|2124912|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
1071304|NCT02034708|2124911|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
1071305|NCT02034708|2124912|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
1071306|NCT02034708|2124911|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
1071307|NCT02034708|2124912|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
1071308|NCT02034708|2124911|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3
1071309|NCT02034708|2124912|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2
1071310|NCT02034799|2124925|FG000|Overall Study|Withdrawal by Subject|0
1071311|NCT02034799|2124926|FG001|Overall Study|Withdrawal by Subject|2
1071312|NCT02034799|2124925|FG000|Overall Study|Lost to Follow-up|0
1071313|NCT02034799|2124926|FG001|Overall Study|Lost to Follow-up|1
1071314|NCT02034799|2124925|FG000|Overall Study|Death|2
1071315|NCT02034799|2124926|FG001|Overall Study|Death|1
1071316|NCT02034877|2124934|FG000|Overall Study|Lost to Follow-up|0
1071317|NCT02034877|2124935|FG001|Overall Study|Lost to Follow-up|3
1071318|NCT02034877|2124934|FG000|Overall Study|No Longer Willing to Participate|0
1071319|NCT02034877|2124935|FG001|Overall Study|No Longer Willing to Participate|3
1071320|NCT02034916|2124943|FG000|Overall Study|Death|39
1071321|NCT02034916|2124944|FG001|Overall Study|Death|28
1071322|NCT02034916|2124943|FG000|Overall Study|Withdrawal by Subject|2
1071323|NCT02034916|2124944|FG001|Overall Study|Withdrawal by Subject|1
1071324|NCT02034916|2124943|FG000|Overall Study|Lost to Follow-up|4
1071325|NCT02034916|2124944|FG001|Overall Study|Lost to Follow-up|1
1071326|NCT02034916|2124943|FG000|Overall Study|Study terminated by sponsor|4
1071327|NCT02034916|2124944|FG001|Overall Study|Study terminated by sponsor|5
1071328|NCT02035202|2124954|FG000|Overall Study|Lost to Follow-up|8
1071329|NCT02035202|2124955|FG001|Overall Study|Lost to Follow-up|16
1071330|NCT02035202|2124956|FG002|Overall Study|Lost to Follow-up|2
1071331|NCT02035267|2124968|FG000|Overall Study|Withdrawal consent-subject convenience|0
1071332|NCT02035267|2124969|FG001|Overall Study|Withdrawal consent-subject convenience|0
1071333|NCT02035267|2124970|FG002|Overall Study|Withdrawal consent-subject convenience|1
1071334|NCT02035267|2124971|FG003|Overall Study|Withdrawal consent-subject convenience|0
1071335|NCT02035267|2124968|FG000|Overall Study|Adverse Event|0
1071336|NCT02035267|2124969|FG001|Overall Study|Adverse Event|0
1071337|NCT02035267|2124970|FG002|Overall Study|Adverse Event|1
1071338|NCT02035267|2124971|FG003|Overall Study|Adverse Event|0
1071339|NCT02035267|2124968|FG000|Overall Study|Lost to Follow-up|0
1071340|NCT02035267|2124969|FG001|Overall Study|Lost to Follow-up|0
1071341|NCT02035267|2124970|FG002|Overall Study|Lost to Follow-up|0
1071342|NCT02035267|2124971|FG003|Overall Study|Lost to Follow-up|1
1071343|NCT02035267|2124968|FG000|Overall Study|Other unspecified|0
1071344|NCT02035267|2124969|FG001|Overall Study|Other unspecified|1
1071345|NCT02035267|2124970|FG002|Overall Study|Other unspecified|0
1071346|NCT02035267|2124971|FG003|Overall Study|Other unspecified|0
1071347|NCT02035332|2124983|FG000|Overall Study|Procedure Aborted due to Uterine Width|1
1071348|NCT02035475|2124992|FG000|Overall Study|Withdrawal by Subject|4
1071349|NCT02035475|2124992|FG000|Overall Study|Physician Decision|1
1071350|NCT02035475|2124992|FG000|Overall Study|Equipment Error|1
1071351|NCT02035553|2125000|FG000|Overall Study|Death (See All-Cause Mortality Table)|0
1071352|NCT02035553|2125001|FG001|Overall Study|Death (See All-Cause Mortality Table)|1
1071353|NCT02035553|2125000|FG000|Overall Study|Adverse Event|10
1071354|NCT02035553|2125001|FG001|Overall Study|Adverse Event|6
1071355|NCT02035553|2125000|FG000|Overall Study|Physician Decision|3
1071356|NCT02035553|2125001|FG001|Overall Study|Physician Decision|2
1071357|NCT02035553|2125000|FG000|Overall Study|Lack of Efficacy|1
1071358|NCT02035553|2125001|FG001|Overall Study|Lack of Efficacy|1
1071359|NCT02035553|2125000|FG000|Overall Study|Withdrawal by Subject|4
1071360|NCT02035553|2125001|FG001|Overall Study|Withdrawal by Subject|7
1071361|NCT02035553|2125000|FG000|Overall Study|Non-compliance with Study Drug|0
1071362|NCT02035553|2125001|FG001|Overall Study|Non-compliance with Study Drug|1
1071363|NCT02035553|2125000|FG000|Overall Study|Lost to Follow-up|0
1071364|NCT02035553|2125001|FG001|Overall Study|Lost to Follow-up|1
1071365|NCT02035553|2125000|FG000|Overall Study|Other Reason|0
1071366|NCT02035553|2125001|FG001|Overall Study|Other Reason|4
1071367|NCT02035696|2125011|FG000|Overall Study|Lost to Follow-up|0
1071368|NCT02035696|2125012|FG001|Overall Study|Lost to Follow-up|3
1071369|NCT02035696|2125013|FG002|Overall Study|Lost to Follow-up|1
1071370|NCT02035696|2125014|FG003|Overall Study|Lost to Follow-up|2
1071371|NCT02035696|2125011|FG000|Overall Study|Withdrawal by Subject|3
1071372|NCT02035696|2125012|FG001|Overall Study|Withdrawal by Subject|0
1071373|NCT02035696|2125013|FG002|Overall Study|Withdrawal by Subject|2
1071374|NCT02035696|2125014|FG003|Overall Study|Withdrawal by Subject|1
1071375|NCT02035748|2125028|FG000|Overall Study|Adverse Event|5
1071376|NCT02035748|2125028|FG000|Overall Study|Death|3
1071377|NCT02035748|2125028|FG000|Overall Study|Lost to Follow-up|2
1071378|NCT02035748|2125028|FG000|Overall Study|Physician Decision|3
1071379|NCT02035748|2125028|FG000|Overall Study|Withdrawal by Subject|6
1071380|NCT02035748|2125028|FG000|Overall Study|Progressive Disease|1
1071381|NCT02036294|2125035|FG000|Overall Study|Death|7
1071382|NCT02036294|2125036|FG001|Overall Study|Death|8
1071383|NCT02036294|2125035|FG000|Overall Study|Withdrawal by Subject|2
1071384|NCT02036294|2125036|FG001|Overall Study|Withdrawal by Subject|3
1071385|NCT02036502|2125066|FG000|Part 1:Dose Determination/Escalation|Death|3
1071386|NCT02036502|2125067|FG001|Part 1:Dose Determination/Escalation|Death|2
1071387|NCT02036502|2125068|FG002|Part 1:Dose Determination/Escalation|Death|0
1071388|NCT02036502|2125069|FG003|Part 1:Dose Determination/Escalation|Death|0
1071389|NCT02036502|2125070|FG004|Part 1:Dose Determination/Escalation|Death|0
1071390|NCT02036502|2125071|FG005|Part 1:Dose Determination/Escalation|Death|0
1071391|NCT02036502|2125072|FG006|Part 1:Dose Determination/Escalation|Death|0
1071392|NCT02036502|2125073|FG007|Part 1:Dose Determination/Escalation|Death|0
1071393|NCT02036502|2125066|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3
1071394|NCT02036502|2125067|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
1071395|NCT02036502|2125068|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
1071396|NCT02036502|2125069|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
1071397|NCT02036502|2125070|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
1071398|NCT02036502|2125071|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
1071399|NCT02036502|2125072|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
908509|NCT00783432|1885198|FG000|Overall Study|Protocol Violation|6
908510|NCT00783432|1885199|FG001|Overall Study|Protocol Violation|9
908511|NCT00783692|1885225|FG000|Induction Phase|Adverse Event|7
908512|NCT00783692|1885226|FG001|Induction Phase|Adverse Event|9
908513|NCT00783692|1885227|FG002|Induction Phase|Adverse Event|24
908514|NCT00783692|1885228|FG003|Induction Phase|Adverse Event|0
908515|NCT00783692|1885229|FG004|Induction Phase|Adverse Event|0
908516|NCT00783692|1885230|FG005|Induction Phase|Adverse Event|0
908517|NCT00783692|1885231|FG006|Induction Phase|Adverse Event|0
908518|NCT00783692|1885225|FG000|Induction Phase|Protocol Violation|0
908519|NCT00783692|1885226|FG001|Induction Phase|Protocol Violation|0
908520|NCT00783692|1885227|FG002|Induction Phase|Protocol Violation|1
908521|NCT00783692|1885228|FG003|Induction Phase|Protocol Violation|0
908522|NCT00783692|1885229|FG004|Induction Phase|Protocol Violation|0
908523|NCT00783692|1885230|FG005|Induction Phase|Protocol Violation|0
908524|NCT00783692|1885231|FG006|Induction Phase|Protocol Violation|0
908525|NCT00783692|1885225|FG000|Induction Phase|Lack of Efficacy|1
908526|NCT00783692|1885226|FG001|Induction Phase|Lack of Efficacy|3
908527|NCT00783692|1885227|FG002|Induction Phase|Lack of Efficacy|28
908528|NCT00783692|1885228|FG003|Induction Phase|Lack of Efficacy|0
908529|NCT00783692|1885229|FG004|Induction Phase|Lack of Efficacy|0
908530|NCT00783692|1885230|FG005|Induction Phase|Lack of Efficacy|0
908531|NCT00783692|1885231|FG006|Induction Phase|Lack of Efficacy|0
908532|NCT00783692|1885225|FG000|Induction Phase|Withdrawal by Subject|3
908533|NCT00783692|1885226|FG001|Induction Phase|Withdrawal by Subject|9
908534|NCT00783692|1885227|FG002|Induction Phase|Withdrawal by Subject|16
908535|NCT00783692|1885228|FG003|Induction Phase|Withdrawal by Subject|0
908536|NCT00783692|1885229|FG004|Induction Phase|Withdrawal by Subject|0
908537|NCT00783692|1885230|FG005|Induction Phase|Withdrawal by Subject|0
908538|NCT00783692|1885231|FG006|Induction Phase|Withdrawal by Subject|0
908539|NCT00783692|1885225|FG000|Induction Phase|Lost to Follow-up|0
908540|NCT00783692|1885226|FG001|Induction Phase|Lost to Follow-up|0
908541|NCT00783692|1885227|FG002|Induction Phase|Lost to Follow-up|3
908542|NCT00783692|1885228|FG003|Induction Phase|Lost to Follow-up|0
908543|NCT00783692|1885229|FG004|Induction Phase|Lost to Follow-up|0
908544|NCT00783692|1885230|FG005|Induction Phase|Lost to Follow-up|0
908545|NCT00783692|1885231|FG006|Induction Phase|Lost to Follow-up|0
908546|NCT00783692|1885225|FG000|Induction Phase|Other|0
908547|NCT00783692|1885226|FG001|Induction Phase|Other|0
908548|NCT00783692|1885227|FG002|Induction Phase|Other|2
908549|NCT00783692|1885228|FG003|Induction Phase|Other|0
908550|NCT00783692|1885229|FG004|Induction Phase|Other|0
908551|NCT00783692|1885230|FG005|Induction Phase|Other|0
908552|NCT00783692|1885231|FG006|Induction Phase|Other|0
908553|NCT00783692|1885225|FG000|Maintenance Phase|Adverse Event|7
908554|NCT00783692|1885226|FG001|Maintenance Phase|Adverse Event|0
908555|NCT00783692|1885227|FG002|Maintenance Phase|Adverse Event|0
908556|NCT00783692|1885228|FG003|Maintenance Phase|Adverse Event|15
908557|NCT00783692|1885229|FG004|Maintenance Phase|Adverse Event|12
908558|NCT00783692|1885230|FG005|Maintenance Phase|Adverse Event|9
1071400|NCT02036502|2125073|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
1071401|NCT02036502|2125066|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0
1071402|NCT02036502|2125067|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1
1071403|NCT02036502|2125068|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0
1071404|NCT02036502|2125069|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0
1071405|NCT02036502|2125070|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0
1071406|NCT02036502|2125071|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0
1071407|NCT02036502|2125072|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0
1071408|NCT02036502|2125073|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0
1071409|NCT02036502|2125066|FG000|Part 1:Dose Determination/Escalation|Not treated|0
1071410|NCT02036502|2125067|FG001|Part 1:Dose Determination/Escalation|Not treated|1
1071411|NCT02036502|2125068|FG002|Part 1:Dose Determination/Escalation|Not treated|0
1071412|NCT02036502|2125069|FG003|Part 1:Dose Determination/Escalation|Not treated|0
1071413|NCT02036502|2125070|FG004|Part 1:Dose Determination/Escalation|Not treated|0
1071414|NCT02036502|2125071|FG005|Part 1:Dose Determination/Escalation|Not treated|0
1071415|NCT02036502|2125072|FG006|Part 1:Dose Determination/Escalation|Not treated|0
1071416|NCT02036502|2125073|FG007|Part 1:Dose Determination/Escalation|Not treated|0
1071417|NCT02036502|2125066|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
1071418|NCT02036502|2125067|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
1071419|NCT02036502|2125068|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2
1071420|NCT02036502|2125069|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
1071421|NCT02036502|2125070|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
1071422|NCT02036502|2125071|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
1071423|NCT02036502|2125072|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
1071424|NCT02036502|2125073|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
1071425|NCT02036502|2125066|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0
1071426|NCT02036502|2125067|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0
1071427|NCT02036502|2125068|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3
908559|NCT00783692|1885231|FG006|Maintenance Phase|Adverse Event|38
908560|NCT00783692|1885225|FG000|Maintenance Phase|Protocol Violation|0
908561|NCT00783692|1885226|FG001|Maintenance Phase|Protocol Violation|0
908562|NCT00783692|1885227|FG002|Maintenance Phase|Protocol Violation|0
908563|NCT00783692|1885228|FG003|Maintenance Phase|Protocol Violation|1
908564|NCT00783692|1885229|FG004|Maintenance Phase|Protocol Violation|2
908565|NCT00783692|1885230|FG005|Maintenance Phase|Protocol Violation|3
908566|NCT00783692|1885231|FG006|Maintenance Phase|Protocol Violation|4
908567|NCT00783692|1885225|FG000|Maintenance Phase|Lack of Efficacy|79
908568|NCT00783692|1885226|FG001|Maintenance Phase|Lack of Efficacy|0
908569|NCT00783692|1885227|FG002|Maintenance Phase|Lack of Efficacy|0
908570|NCT00783692|1885228|FG003|Maintenance Phase|Lack of Efficacy|64
908571|NCT00783692|1885229|FG004|Maintenance Phase|Lack of Efficacy|58
908572|NCT00783692|1885230|FG005|Maintenance Phase|Lack of Efficacy|48
908573|NCT00783692|1885231|FG006|Maintenance Phase|Lack of Efficacy|177
908574|NCT00783692|1885225|FG000|Maintenance Phase|Withdrawal by Subject|7
908575|NCT00783692|1885226|FG001|Maintenance Phase|Withdrawal by Subject|0
908576|NCT00783692|1885227|FG002|Maintenance Phase|Withdrawal by Subject|0
908577|NCT00783692|1885228|FG003|Maintenance Phase|Withdrawal by Subject|7
908578|NCT00783692|1885229|FG004|Maintenance Phase|Withdrawal by Subject|6
908579|NCT00783692|1885230|FG005|Maintenance Phase|Withdrawal by Subject|9
908580|NCT00783692|1885231|FG006|Maintenance Phase|Withdrawal by Subject|24
908581|NCT00783692|1885225|FG000|Maintenance Phase|Lost to Follow-up|2
908582|NCT00783692|1885226|FG001|Maintenance Phase|Lost to Follow-up|0
908583|NCT00783692|1885227|FG002|Maintenance Phase|Lost to Follow-up|0
908584|NCT00783692|1885228|FG003|Maintenance Phase|Lost to Follow-up|1
908585|NCT00783692|1885229|FG004|Maintenance Phase|Lost to Follow-up|3
908586|NCT00783692|1885230|FG005|Maintenance Phase|Lost to Follow-up|2
908587|NCT00783692|1885231|FG006|Maintenance Phase|Lost to Follow-up|5
908588|NCT00783692|1885225|FG000|Maintenance Phase|Other|0
908589|NCT00783692|1885226|FG001|Maintenance Phase|Other|0
908590|NCT00783692|1885227|FG002|Maintenance Phase|Other|0
908591|NCT00783692|1885228|FG003|Maintenance Phase|Other|1
908592|NCT00783692|1885229|FG004|Maintenance Phase|Other|0
908593|NCT00783692|1885230|FG005|Maintenance Phase|Other|1
908594|NCT00783692|1885231|FG006|Maintenance Phase|Other|1
908595|NCT00783705|1885246|FG000|Overall Study|Adverse Event|2
908596|NCT00783705|1885247|FG001|Overall Study|Adverse Event|0
908597|NCT00783705|1885246|FG000|Overall Study|Withdrawal by Subject|3
908598|NCT00783705|1885247|FG001|Overall Study|Withdrawal by Subject|2
908599|NCT00783705|1885246|FG000|Overall Study|Lost to Follow-up|1
908600|NCT00783705|1885247|FG001|Overall Study|Lost to Follow-up|3
908601|NCT00783718|1885256|FG000|Induction Phase|Adverse Event|4
908602|NCT00783718|1885257|FG001|Induction Phase|Adverse Event|0
908603|NCT00783718|1885258|FG002|Induction Phase|Adverse Event|7
908604|NCT00783718|1885259|FG003|Induction Phase|Adverse Event|0
908605|NCT00783718|1885260|FG004|Induction Phase|Adverse Event|0
908606|NCT00783718|1885261|FG005|Induction Phase|Adverse Event|0
908607|NCT00783718|1885262|FG006|Induction Phase|Adverse Event|0
908608|NCT00783718|1885256|FG000|Induction Phase|Protocol Violation|1
908609|NCT00783718|1885257|FG001|Induction Phase|Protocol Violation|1
1071428|NCT02036502|2125069|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0
1071429|NCT02036502|2125070|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0
1071430|NCT02036502|2125071|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0
1071431|NCT02036502|2125072|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0
1071432|NCT02036502|2125073|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0
1071433|NCT02036502|2125066|FG000|Part 2:Dose Confirmation|Death|0
1071434|NCT02036502|2125067|FG001|Part 2:Dose Confirmation|Death|0
1071435|NCT02036502|2125068|FG002|Part 2:Dose Confirmation|Death|1
1071436|NCT02036502|2125069|FG003|Part 2:Dose Confirmation|Death|0
1071437|NCT02036502|2125070|FG004|Part 2:Dose Confirmation|Death|0
1071438|NCT02036502|2125071|FG005|Part 2:Dose Confirmation|Death|0
1071439|NCT02036502|2125072|FG006|Part 2:Dose Confirmation|Death|0
1071440|NCT02036502|2125073|FG007|Part 2:Dose Confirmation|Death|0
1071441|NCT02036502|2125066|FG000|Part 2:Dose Confirmation|Not treated|0
1071442|NCT02036502|2125067|FG001|Part 2:Dose Confirmation|Not treated|0
1071443|NCT02036502|2125068|FG002|Part 2:Dose Confirmation|Not treated|0
1071444|NCT02036502|2125069|FG003|Part 2:Dose Confirmation|Not treated|1
1071445|NCT02036502|2125070|FG004|Part 2:Dose Confirmation|Not treated|0
1071446|NCT02036502|2125071|FG005|Part 2:Dose Confirmation|Not treated|0
1071447|NCT02036502|2125072|FG006|Part 2:Dose Confirmation|Not treated|0
1071448|NCT02036502|2125073|FG007|Part 2:Dose Confirmation|Not treated|0
1071449|NCT02036502|2125066|FG000|Part 3:Dose Expansion|Adverse Event|0
1071450|NCT02036502|2125067|FG001|Part 3:Dose Expansion|Adverse Event|0
1071451|NCT02036502|2125068|FG002|Part 3:Dose Expansion|Adverse Event|0
1071452|NCT02036502|2125069|FG003|Part 3:Dose Expansion|Adverse Event|0
1071453|NCT02036502|2125070|FG004|Part 3:Dose Expansion|Adverse Event|0
1071454|NCT02036502|2125071|FG005|Part 3:Dose Expansion|Adverse Event|4
1071455|NCT02036502|2125072|FG006|Part 3:Dose Expansion|Adverse Event|0
1071456|NCT02036502|2125073|FG007|Part 3:Dose Expansion|Adverse Event|2
1071457|NCT02036502|2125066|FG000|Part 3:Dose Expansion|Death|0
1071458|NCT02036502|2125067|FG001|Part 3:Dose Expansion|Death|0
1071459|NCT02036502|2125068|FG002|Part 3:Dose Expansion|Death|0
1071460|NCT02036502|2125069|FG003|Part 3:Dose Expansion|Death|0
1071461|NCT02036502|2125070|FG004|Part 3:Dose Expansion|Death|0
1071462|NCT02036502|2125071|FG005|Part 3:Dose Expansion|Death|24
1071463|NCT02036502|2125072|FG006|Part 3:Dose Expansion|Death|0
1071464|NCT02036502|2125073|FG007|Part 3:Dose Expansion|Death|3
1071465|NCT02036502|2125066|FG000|Part 3:Dose Expansion|Lost to Follow-up|0
1071466|NCT02036502|2125067|FG001|Part 3:Dose Expansion|Lost to Follow-up|0
1071467|NCT02036502|2125068|FG002|Part 3:Dose Expansion|Lost to Follow-up|0
1071468|NCT02036502|2125069|FG003|Part 3:Dose Expansion|Lost to Follow-up|0
1071469|NCT02036502|2125070|FG004|Part 3:Dose Expansion|Lost to Follow-up|0
1071470|NCT02036502|2125071|FG005|Part 3:Dose Expansion|Lost to Follow-up|0
1071471|NCT02036502|2125072|FG006|Part 3:Dose Expansion|Lost to Follow-up|0
1071472|NCT02036502|2125073|FG007|Part 3:Dose Expansion|Lost to Follow-up|1
1071473|NCT02036502|2125066|FG000|Part 3:Dose Expansion|Physician Decision|0
1071474|NCT02036502|2125067|FG001|Part 3:Dose Expansion|Physician Decision|0
1071475|NCT02036502|2125068|FG002|Part 3:Dose Expansion|Physician Decision|0
1071476|NCT02036502|2125069|FG003|Part 3:Dose Expansion|Physician Decision|0
1071477|NCT02036502|2125070|FG004|Part 3:Dose Expansion|Physician Decision|0
1071478|NCT02036502|2125071|FG005|Part 3:Dose Expansion|Physician Decision|1
1071479|NCT02036502|2125072|FG006|Part 3:Dose Expansion|Physician Decision|0
1071480|NCT02036502|2125073|FG007|Part 3:Dose Expansion|Physician Decision|0
1071481|NCT02036502|2125066|FG000|Part 3:Dose Expansion|Progressive Disease|0
1071482|NCT02036502|2125067|FG001|Part 3:Dose Expansion|Progressive Disease|0
1071483|NCT02036502|2125068|FG002|Part 3:Dose Expansion|Progressive Disease|0
1071484|NCT02036502|2125069|FG003|Part 3:Dose Expansion|Progressive Disease|0
908610|NCT00783718|1885258|FG002|Induction Phase|Protocol Violation|6
908611|NCT00783718|1885259|FG003|Induction Phase|Protocol Violation|0
1071485|NCT02036502|2125070|FG004|Part 3:Dose Expansion|Progressive Disease|0
1071486|NCT02036502|2125071|FG005|Part 3:Dose Expansion|Progressive Disease|1
1071487|NCT02036502|2125072|FG006|Part 3:Dose Expansion|Progressive Disease|0
1071488|NCT02036502|2125073|FG007|Part 3:Dose Expansion|Progressive Disease|0
1071489|NCT02036502|2125066|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0
1071490|NCT02036502|2125067|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0
1071491|NCT02036502|2125068|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0
1071492|NCT02036502|2125069|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0
1071493|NCT02036502|2125070|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0
1071494|NCT02036502|2125071|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11
1071495|NCT02036502|2125072|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0
1071496|NCT02036502|2125073|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2
1071497|NCT02036502|2125066|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0
1071498|NCT02036502|2125067|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0
1071499|NCT02036502|2125068|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0
1071500|NCT02036502|2125069|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0
1071501|NCT02036502|2125070|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0
1071502|NCT02036502|2125071|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4
908612|NCT00783718|1885260|FG004|Induction Phase|Protocol Violation|0
908613|NCT00783718|1885261|FG005|Induction Phase|Protocol Violation|0
1071503|NCT02036502|2125072|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1
1071504|NCT02036502|2125073|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2
1071505|NCT02036502|2125066|FG000|Part 3:Dose Expansion|Not Treated|0
1071506|NCT02036502|2125067|FG001|Part 3:Dose Expansion|Not Treated|0
1071507|NCT02036502|2125068|FG002|Part 3:Dose Expansion|Not Treated|0
1071508|NCT02036502|2125069|FG003|Part 3:Dose Expansion|Not Treated|0
1071509|NCT02036502|2125070|FG004|Part 3:Dose Expansion|Not Treated|0
1071510|NCT02036502|2125071|FG005|Part 3:Dose Expansion|Not Treated|2
1071511|NCT02036502|2125072|FG006|Part 3:Dose Expansion|Not Treated|0
1071512|NCT02036502|2125073|FG007|Part 3:Dose Expansion|Not Treated|0
1071513|NCT02036515|2125096|FG000|Overall Study|Adverse Event|1
1071514|NCT02036515|2125097|FG001|Overall Study|Adverse Event|1
1071515|NCT02036515|2125098|FG002|Overall Study|Adverse Event|2
1071516|NCT02036515|2125096|FG000|Overall Study|Lost to Follow-up|0
1071517|NCT02036515|2125097|FG001|Overall Study|Lost to Follow-up|2
1071518|NCT02036515|2125098|FG002|Overall Study|Lost to Follow-up|0
1071519|NCT02036515|2125096|FG000|Overall Study|Non-compliance with study drug|0
1071520|NCT02036515|2125097|FG001|Overall Study|Non-compliance with study drug|0
1071521|NCT02036515|2125098|FG002|Overall Study|Non-compliance with study drug|2
1071522|NCT02036515|2125096|FG000|Overall Study|Screen failure|0
1071523|NCT02036515|2125097|FG001|Overall Study|Screen failure|2
1071524|NCT02036515|2125098|FG002|Overall Study|Screen failure|0
1071525|NCT02036515|2125096|FG000|Overall Study|Withdrawal by Subject|4
1071526|NCT02036515|2125097|FG001|Overall Study|Withdrawal by Subject|7
1071527|NCT02036515|2125098|FG002|Overall Study|Withdrawal by Subject|9
1071528|NCT02036515|2125096|FG000|Overall Study|Hyperglycemia|0
1071529|NCT02036515|2125097|FG001|Overall Study|Hyperglycemia|0
1071530|NCT02036515|2125098|FG002|Overall Study|Hyperglycemia|1
1071531|NCT02036580|2125113|FG000|Overall Study|Withdrawal by Subject|0
1071532|NCT02036580|2125114|FG001|Overall Study|Withdrawal by Subject|1
1071533|NCT02036580|2125115|FG002|Overall Study|Withdrawal by Subject|0
1071534|NCT02036580|2125113|FG000|Overall Study|Adverse Event|1
1071535|NCT02036580|2125114|FG001|Overall Study|Adverse Event|0
1071536|NCT02036580|2125115|FG002|Overall Study|Adverse Event|0
1071537|NCT02036645|2125135|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1071538|NCT02036645|2125136|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1071539|NCT02036645|2125137|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1071540|NCT02036645|2125138|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1071541|NCT02036645|2125139|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1071542|NCT02036645|2125140|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1071543|NCT02036645|2125141|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1
1071544|NCT02036645|2125142|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1071545|NCT02036645|2125143|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1071546|NCT02036645|2125144|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1071547|NCT02036645|2125145|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0
908614|NCT00783718|1885262|FG006|Induction Phase|Protocol Violation|0
908615|NCT00783718|1885256|FG000|Induction Phase|Lack of Efficacy|5
908616|NCT00783718|1885257|FG001|Induction Phase|Lack of Efficacy|2
908617|NCT00783718|1885258|FG002|Induction Phase|Lack of Efficacy|14
908618|NCT00783718|1885259|FG003|Induction Phase|Lack of Efficacy|0
908619|NCT00783718|1885260|FG004|Induction Phase|Lack of Efficacy|0
908620|NCT00783718|1885261|FG005|Induction Phase|Lack of Efficacy|0
908621|NCT00783718|1885262|FG006|Induction Phase|Lack of Efficacy|0
908622|NCT00783718|1885256|FG000|Induction Phase|Withdrawal by Subject|3
908623|NCT00783718|1885257|FG001|Induction Phase|Withdrawal by Subject|4
908624|NCT00783718|1885258|FG002|Induction Phase|Withdrawal by Subject|8
908625|NCT00783718|1885259|FG003|Induction Phase|Withdrawal by Subject|0
908626|NCT00783718|1885260|FG004|Induction Phase|Withdrawal by Subject|0
908627|NCT00783718|1885261|FG005|Induction Phase|Withdrawal by Subject|0
908628|NCT00783718|1885262|FG006|Induction Phase|Withdrawal by Subject|0
908629|NCT00783718|1885256|FG000|Induction Phase|Lost to Follow-up|1
908630|NCT00783718|1885257|FG001|Induction Phase|Lost to Follow-up|0
908631|NCT00783718|1885258|FG002|Induction Phase|Lost to Follow-up|1
908632|NCT00783718|1885259|FG003|Induction Phase|Lost to Follow-up|0
908633|NCT00783718|1885260|FG004|Induction Phase|Lost to Follow-up|0
908634|NCT00783718|1885261|FG005|Induction Phase|Lost to Follow-up|0
908635|NCT00783718|1885262|FG006|Induction Phase|Lost to Follow-up|0
908636|NCT00783718|1885256|FG000|Maintenance Phase|Adverse Event|12
908637|NCT00783718|1885257|FG001|Maintenance Phase|Adverse Event|0
908638|NCT00783718|1885258|FG002|Maintenance Phase|Adverse Event|0
908639|NCT00783718|1885259|FG003|Maintenance Phase|Adverse Event|15
908640|NCT00783718|1885260|FG004|Maintenance Phase|Adverse Event|7
908641|NCT00783718|1885261|FG005|Maintenance Phase|Adverse Event|6
908642|NCT00783718|1885262|FG006|Maintenance Phase|Adverse Event|16
908643|NCT00783718|1885256|FG000|Maintenance Phase|Protocol Violation|1
908644|NCT00783718|1885257|FG001|Maintenance Phase|Protocol Violation|0
908645|NCT00783718|1885258|FG002|Maintenance Phase|Protocol Violation|0
908646|NCT00783718|1885259|FG003|Maintenance Phase|Protocol Violation|0
908647|NCT00783718|1885260|FG004|Maintenance Phase|Protocol Violation|0
908648|NCT00783718|1885261|FG005|Maintenance Phase|Protocol Violation|0
908649|NCT00783718|1885262|FG006|Maintenance Phase|Protocol Violation|2
908650|NCT00783718|1885256|FG000|Maintenance Phase|Lack of Efficacy|83
908651|NCT00783718|1885257|FG001|Maintenance Phase|Lack of Efficacy|0
1071548|NCT02036645|2125146|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1071549|NCT02036645|2125135|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1071550|NCT02036645|2125136|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1071551|NCT02036645|2125137|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1071552|NCT02036645|2125138|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
1071553|NCT02036645|2125139|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1071554|NCT02036645|2125140|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1071555|NCT02036645|2125141|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1071556|NCT02036645|2125142|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1071557|NCT02036645|2125143|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1071558|NCT02036645|2125144|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1071559|NCT02036645|2125145|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1071560|NCT02036645|2125146|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1071561|NCT02036775|2125184|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1071562|NCT02036775|2125185|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1071563|NCT02036775|2125186|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1071564|NCT02036775|2125187|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1071565|NCT02036775|2125188|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1071566|NCT02036775|2125189|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
1071567|NCT02036853|2125203|FG000|Overall Study|Adverse Event|0
1071568|NCT02036853|2125204|FG001|Overall Study|Adverse Event|2
1071569|NCT02036853|2125203|FG000|Overall Study|Lack of Efficacy|0
1071570|NCT02036853|2125204|FG001|Overall Study|Lack of Efficacy|2
1071571|NCT02036853|2125203|FG000|Overall Study|Physician Decision|0
1071572|NCT02036853|2125204|FG001|Overall Study|Physician Decision|1
1071573|NCT02036853|2125203|FG000|Overall Study|Withdrawal by Subject|0
1071574|NCT02036853|2125204|FG001|Overall Study|Withdrawal by Subject|1
908652|NCT00783718|1885258|FG002|Maintenance Phase|Lack of Efficacy|0
908653|NCT00783718|1885259|FG003|Maintenance Phase|Lack of Efficacy|61
908654|NCT00783718|1885260|FG004|Maintenance Phase|Lack of Efficacy|31
908655|NCT00783718|1885261|FG005|Maintenance Phase|Lack of Efficacy|33
908656|NCT00783718|1885262|FG006|Maintenance Phase|Lack of Efficacy|155
908657|NCT00783718|1885256|FG000|Maintenance Phase|Withdrawal by Subject|6
908658|NCT00783718|1885257|FG001|Maintenance Phase|Withdrawal by Subject|0
908659|NCT00783718|1885258|FG002|Maintenance Phase|Withdrawal by Subject|0
908660|NCT00783718|1885259|FG003|Maintenance Phase|Withdrawal by Subject|2
908661|NCT00783718|1885260|FG004|Maintenance Phase|Withdrawal by Subject|5
908662|NCT00783718|1885261|FG005|Maintenance Phase|Withdrawal by Subject|2
908663|NCT00783718|1885262|FG006|Maintenance Phase|Withdrawal by Subject|20
908664|NCT00783718|1885256|FG000|Maintenance Phase|Lost to Follow-up|3
908665|NCT00783718|1885257|FG001|Maintenance Phase|Lost to Follow-up|0
908666|NCT00783718|1885258|FG002|Maintenance Phase|Lost to Follow-up|0
908667|NCT00783718|1885259|FG003|Maintenance Phase|Lost to Follow-up|0
908668|NCT00783718|1885260|FG004|Maintenance Phase|Lost to Follow-up|2
908669|NCT00783718|1885261|FG005|Maintenance Phase|Lost to Follow-up|0
908670|NCT00783718|1885262|FG006|Maintenance Phase|Lost to Follow-up|2
908671|NCT00783796|1885272|FG000|Overall Study|Did not receive any stent|4
908672|NCT00783796|1885272|FG000|Overall Study|Received non-XIENCE V stent|1
908673|NCT00783796|1885272|FG000|Overall Study|Received commercial XIENCE V stent|1
908674|NCT00783835|1885278|FG000|Overall Study|Adverse Event|3
908675|NCT00783835|1885278|FG000|Overall Study|Medical Criteria|1
908676|NCT00783835|1885278|FG000|Overall Study|Withdrawal by Subject|2
908677|NCT00783835|1885278|FG000|Overall Study|Lost to Follow-up|1
908678|NCT00783835|1885278|FG000|Overall Study|Participant not Adherent|3
908679|NCT00784134|1885323|FG000|Overall Study|Lost to Follow-up|3
908680|NCT00784134|1885324|FG001|Overall Study|Lost to Follow-up|6
908681|NCT00784147|1885332|FG000|Overall Study|Lost to Follow-up|2
908682|NCT00784147|1885333|FG001|Overall Study|Lost to Follow-up|4
908683|NCT00784147|1885332|FG000|Overall Study|Withdrawal by Subject|1
908684|NCT00784147|1885333|FG001|Overall Study|Withdrawal by Subject|3
908685|NCT00784147|1885332|FG000|Overall Study|Physician Decision|2
908686|NCT00784147|1885333|FG001|Overall Study|Physician Decision|1
908687|NCT00784147|1885332|FG000|Overall Study|Protocol Violation|1
908688|NCT00784147|1885333|FG001|Overall Study|Protocol Violation|1
908689|NCT00784147|1885332|FG000|Overall Study|Death|2
908690|NCT00784147|1885333|FG001|Overall Study|Death|0
908691|NCT00784238|1885360|FG000|Overall Study|Adverse Event|14
908692|NCT00784238|1885360|FG000|Overall Study|Death|2
908693|NCT00784238|1885360|FG000|Overall Study|Lack of Efficacy|33
908694|NCT00784238|1885360|FG000|Overall Study|Lost to Follow-up|29
908695|NCT00784238|1885360|FG000|Overall Study|Pregnancy|1
908696|NCT00784238|1885360|FG000|Overall Study|Withdrawal by Subject|26
908697|NCT00784238|1885360|FG000|Overall Study|Other|14
908698|NCT00784277|1885371|FG000|IR Treatment|Adverse Event|4
908699|NCT00784277|1885372|FG001|IR Treatment|Adverse Event|8
908700|NCT00784277|1885373|FG002|IR Treatment|Adverse Event|19
908701|NCT00784277|1885374|FG003|IR Treatment|Adverse Event|35
908702|NCT00784277|1885375|FG004|IR Treatment|Adverse Event|0
908703|NCT00784277|1885376|FG005|IR Treatment|Adverse Event|0
908704|NCT00784277|1885377|FG006|IR Treatment|Adverse Event|0
908705|NCT00784277|1885371|FG000|IR Treatment|Lack of Efficacy|4
908706|NCT00784277|1885372|FG001|IR Treatment|Lack of Efficacy|4
908707|NCT00784277|1885373|FG002|IR Treatment|Lack of Efficacy|1
908708|NCT00784277|1885374|FG003|IR Treatment|Lack of Efficacy|0
908709|NCT00784277|1885375|FG004|IR Treatment|Lack of Efficacy|0
908710|NCT00784277|1885376|FG005|IR Treatment|Lack of Efficacy|0
908711|NCT00784277|1885377|FG006|IR Treatment|Lack of Efficacy|0
908712|NCT00784277|1885371|FG000|IR Treatment|Lost to Follow-up|1
908713|NCT00784277|1885372|FG001|IR Treatment|Lost to Follow-up|0
908714|NCT00784277|1885373|FG002|IR Treatment|Lost to Follow-up|1
908715|NCT00784277|1885374|FG003|IR Treatment|Lost to Follow-up|0
908716|NCT00784277|1885375|FG004|IR Treatment|Lost to Follow-up|0
908717|NCT00784277|1885376|FG005|IR Treatment|Lost to Follow-up|0
908718|NCT00784277|1885377|FG006|IR Treatment|Lost to Follow-up|0
908719|NCT00784277|1885371|FG000|IR Treatment|Withdrawal by Subject|5
908720|NCT00784277|1885372|FG001|IR Treatment|Withdrawal by Subject|1
908721|NCT00784277|1885373|FG002|IR Treatment|Withdrawal by Subject|4
908722|NCT00784277|1885374|FG003|IR Treatment|Withdrawal by Subject|6
908723|NCT00784277|1885375|FG004|IR Treatment|Withdrawal by Subject|0
908724|NCT00784277|1885376|FG005|IR Treatment|Withdrawal by Subject|0
908725|NCT00784277|1885377|FG006|IR Treatment|Withdrawal by Subject|0
908726|NCT00784277|1885371|FG000|IR Treatment|Resolution Of Pain|0
908727|NCT00784277|1885372|FG001|IR Treatment|Resolution Of Pain|1
908728|NCT00784277|1885373|FG002|IR Treatment|Resolution Of Pain|0
908729|NCT00784277|1885374|FG003|IR Treatment|Resolution Of Pain|0
908730|NCT00784277|1885375|FG004|IR Treatment|Resolution Of Pain|0
908731|NCT00784277|1885376|FG005|IR Treatment|Resolution Of Pain|0
908732|NCT00784277|1885377|FG006|IR Treatment|Resolution Of Pain|0
908733|NCT00784277|1885371|FG000|IR Treatment|Other|2
908734|NCT00784277|1885372|FG001|IR Treatment|Other|3
908735|NCT00784277|1885373|FG002|IR Treatment|Other|3
908736|NCT00784277|1885374|FG003|IR Treatment|Other|2
908737|NCT00784277|1885375|FG004|IR Treatment|Other|0
908738|NCT00784277|1885376|FG005|IR Treatment|Other|0
908739|NCT00784277|1885377|FG006|IR Treatment|Other|0
908740|NCT00784277|1885371|FG000|ER Treatment|Adverse Event|0
908741|NCT00784277|1885372|FG001|ER Treatment|Adverse Event|0
908742|NCT00784277|1885373|FG002|ER Treatment|Adverse Event|0
908743|NCT00784277|1885374|FG003|ER Treatment|Adverse Event|0
908744|NCT00784277|1885375|FG004|ER Treatment|Adverse Event|1
908745|NCT00784277|1885376|FG005|ER Treatment|Adverse Event|7
908746|NCT00784277|1885377|FG006|ER Treatment|Adverse Event|7
908747|NCT00784277|1885371|FG000|ER Treatment|Lack of Efficacy|0
908748|NCT00784277|1885372|FG001|ER Treatment|Lack of Efficacy|0
908749|NCT00784277|1885373|FG002|ER Treatment|Lack of Efficacy|0
908750|NCT00784277|1885374|FG003|ER Treatment|Lack of Efficacy|0
908751|NCT00784277|1885375|FG004|ER Treatment|Lack of Efficacy|3
908752|NCT00784277|1885376|FG005|ER Treatment|Lack of Efficacy|4
908753|NCT00784277|1885377|FG006|ER Treatment|Lack of Efficacy|0
908754|NCT00784277|1885371|FG000|ER Treatment|Lost to Follow-up|0
908755|NCT00784277|1885372|FG001|ER Treatment|Lost to Follow-up|0
908756|NCT00784277|1885373|FG002|ER Treatment|Lost to Follow-up|0
908757|NCT00784277|1885374|FG003|ER Treatment|Lost to Follow-up|0
908758|NCT00784277|1885375|FG004|ER Treatment|Lost to Follow-up|0
908759|NCT00784277|1885376|FG005|ER Treatment|Lost to Follow-up|2
908760|NCT00784277|1885377|FG006|ER Treatment|Lost to Follow-up|0
908761|NCT00784277|1885371|FG000|ER Treatment|Withdrawal by Subject|0
908762|NCT00784277|1885372|FG001|ER Treatment|Withdrawal by Subject|0
908763|NCT00784277|1885373|FG002|ER Treatment|Withdrawal by Subject|0
908764|NCT00784277|1885374|FG003|ER Treatment|Withdrawal by Subject|0
908765|NCT00784277|1885375|FG004|ER Treatment|Withdrawal by Subject|2
908766|NCT00784277|1885376|FG005|ER Treatment|Withdrawal by Subject|5
908767|NCT00784277|1885377|FG006|ER Treatment|Withdrawal by Subject|3
908768|NCT00784277|1885371|FG000|ER Treatment|Study Medication Non-Compliant|0
908769|NCT00784277|1885372|FG001|ER Treatment|Study Medication Non-Compliant|0
908770|NCT00784277|1885373|FG002|ER Treatment|Study Medication Non-Compliant|0
908771|NCT00784277|1885374|FG003|ER Treatment|Study Medication Non-Compliant|0
908772|NCT00784277|1885375|FG004|ER Treatment|Study Medication Non-Compliant|2
908773|NCT00784277|1885376|FG005|ER Treatment|Study Medication Non-Compliant|3
908774|NCT00784277|1885377|FG006|ER Treatment|Study Medication Non-Compliant|3
908775|NCT00784277|1885371|FG000|ER Treatment|Other|0
908776|NCT00784277|1885372|FG001|ER Treatment|Other|0
908777|NCT00784277|1885373|FG002|ER Treatment|Other|0
908778|NCT00784277|1885374|FG003|ER Treatment|Other|0
908779|NCT00784277|1885375|FG004|ER Treatment|Other|1
908780|NCT00784277|1885376|FG005|ER Treatment|Other|3
908781|NCT00784277|1885377|FG006|ER Treatment|Other|2
908782|NCT00784368|1885403|FG000|Overall Study|Physician Decision|0
908783|NCT00784368|1885404|FG001|Overall Study|Physician Decision|0
908784|NCT00784368|1885405|FG002|Overall Study|Physician Decision|6
908785|NCT00784368|1885403|FG000|Overall Study|Lack of Efficacy|2
908786|NCT00784368|1885404|FG001|Overall Study|Lack of Efficacy|0
908787|NCT00784368|1885405|FG002|Overall Study|Lack of Efficacy|1
908788|NCT00784368|1885403|FG000|Overall Study|Adverse Event|6
908789|NCT00784368|1885404|FG001|Overall Study|Adverse Event|9
908790|NCT00784368|1885405|FG002|Overall Study|Adverse Event|2
908791|NCT00784368|1885403|FG000|Overall Study|Diagnosis of fever|0
908792|NCT00784368|1885404|FG001|Overall Study|Diagnosis of fever|0
908793|NCT00784368|1885405|FG002|Overall Study|Diagnosis of fever|1
908794|NCT00784368|1885403|FG000|Overall Study|Worsening of complications|0
908795|NCT00784368|1885404|FG001|Overall Study|Worsening of complications|0
908796|NCT00784368|1885405|FG002|Overall Study|Worsening of complications|1
908797|NCT00784368|1885403|FG000|Overall Study|Worsening of symptoms|0
908798|NCT00784368|1885404|FG001|Overall Study|Worsening of symptoms|1
908799|NCT00784368|1885405|FG002|Overall Study|Worsening of symptoms|0
908800|NCT00784368|1885403|FG000|Overall Study|Withdrawal of informed consent|0
908801|NCT00784368|1885404|FG001|Overall Study|Withdrawal of informed consent|1
908802|NCT00784368|1885405|FG002|Overall Study|Withdrawal of informed consent|0
908803|NCT00784459|1885418|FG000|Overall Study|Adverse Event|0
908804|NCT00784459|1885419|FG001|Overall Study|Adverse Event|2
908805|NCT00784550|1885431|FG000|Overall Study|Adverse Event|12
908806|NCT00784550|1885432|FG001|Overall Study|Adverse Event|10
908807|NCT00784550|1885431|FG000|Overall Study|Lack of Efficacy|0
908808|NCT00784550|1885432|FG001|Overall Study|Lack of Efficacy|1
908809|NCT00784550|1885431|FG000|Overall Study|Protocol Violation|10
908810|NCT00784550|1885432|FG001|Overall Study|Protocol Violation|10
908811|NCT00784550|1885431|FG000|Overall Study|Lost to Follow-up|8
908812|NCT00784550|1885432|FG001|Overall Study|Lost to Follow-up|5
908813|NCT00784550|1885431|FG000|Overall Study|Physician Decision|2
908814|NCT00784550|1885432|FG001|Overall Study|Physician Decision|3
908815|NCT00784550|1885431|FG000|Overall Study|Withdrawal by Subject|4
908816|NCT00784550|1885432|FG001|Overall Study|Withdrawal by Subject|13
908817|NCT00784563|1885441|FG000|Years 1 & 2|Withdrawal by Subject|3
908818|NCT00784563|1885442|FG001|Years 1 & 2|Withdrawal by Subject|2
908819|NCT00784563|1885443|FG002|Years 1 & 2|Withdrawal by Subject|0
908820|NCT00784563|1885441|FG000|Years 1 & 2|Adverse Event|0
908821|NCT00784563|1885442|FG001|Years 1 & 2|Adverse Event|3
908822|NCT00784563|1885443|FG002|Years 1 & 2|Adverse Event|0
908823|NCT00784563|1885441|FG000|Year 3|Withdrawal by Subject|0
908824|NCT00784563|1885442|FG001|Year 3|Withdrawal by Subject|0
908825|NCT00784563|1885443|FG002|Year 3|Withdrawal by Subject|2
908826|NCT00784563|1885441|FG000|Year 3|Adverse Event|0
908827|NCT00784563|1885442|FG001|Year 3|Adverse Event|0
908828|NCT00784563|1885443|FG002|Year 3|Adverse Event|1
908829|NCT00784654|1885462|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44
908830|NCT00784654|1885463|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0
908831|NCT00784654|1885464|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0
908832|NCT00784654|1885462|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
908833|NCT00784654|1885463|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
908834|NCT00784654|1885464|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
908835|NCT00784654|1885462|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
908836|NCT00784654|1885463|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
908837|NCT00784654|1885464|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
908838|NCT00784654|1885462|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
908839|NCT00784654|1885463|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
908840|NCT00784654|1885464|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
908841|NCT00784654|1885462|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7
908842|NCT00784654|1885463|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0
908843|NCT00784654|1885464|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0
908844|NCT00784654|1885462|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
908845|NCT00784654|1885463|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
908846|NCT00784654|1885464|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
908847|NCT00784654|1885462|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
908848|NCT00784654|1885463|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
908849|NCT00784654|1885464|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
908850|NCT00784654|1885462|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1
908851|NCT00784654|1885463|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0
908852|NCT00784654|1885464|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0
908853|NCT00784654|1885462|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
908854|NCT00784654|1885463|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
908855|NCT00784654|1885464|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
908856|NCT00784654|1885462|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
908857|NCT00784654|1885463|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
1071665|NCT02037165|2125277|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0
1071666|NCT02037165|2125278|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0
1071667|NCT02037165|2125279|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0
1071668|NCT02037165|2125280|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0
1071669|NCT02037165|2125281|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1
1071670|NCT02037256|2125322|FG000|Overall Study|Protocol Violation|0
1071671|NCT02037256|2125323|FG001|Overall Study|Protocol Violation|1
1071672|NCT02037256|2125322|FG000|Overall Study|Withdrawn prior to Velcade|0
1071673|NCT02037256|2125323|FG001|Overall Study|Withdrawn prior to Velcade|2
1071674|NCT02037295|2125335|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
1071675|NCT02037295|2125336|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
1071676|NCT02037295|2125337|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
1071677|NCT02037295|2125338|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
1071678|NCT02037477|2125373|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1071679|NCT02037477|2125374|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1071680|NCT02037477|2125375|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1
1071681|NCT02037477|2125376|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1071682|NCT02037568|2125397|FG000|Overall Study|Withdrawal by Subject|17
1071683|NCT02037568|2125398|FG001|Overall Study|Withdrawal by Subject|24
1071684|NCT02037568|2125397|FG000|Overall Study|Lost to Follow-up|16
1071685|NCT02037568|2125398|FG001|Overall Study|Lost to Follow-up|13
1071686|NCT02037568|2125397|FG000|Overall Study|Screen Failure|3
1071687|NCT02037568|2125398|FG001|Overall Study|Screen Failure|1
1071688|NCT02037568|2125397|FG000|Overall Study|Patient did not receive transplant|0
1071689|NCT02037568|2125398|FG001|Overall Study|Patient did not receive transplant|1
1071690|NCT02037984|2125442|FG000|Overall Study|Lack of Efficacy|0
1071691|NCT02037984|2125443|FG001|Overall Study|Lack of Efficacy|0
1071692|NCT02037984|2125444|FG002|Overall Study|Lack of Efficacy|3
1071693|NCT02037984|2125445|FG003|Overall Study|Lack of Efficacy|10
1071694|NCT02037984|2125446|FG004|Overall Study|Lack of Efficacy|2
1071695|NCT02037984|2125447|FG005|Overall Study|Lack of Efficacy|2
1071696|NCT02037984|2125448|FG006|Overall Study|Lack of Efficacy|4
1071697|NCT02037984|2125449|FG007|Overall Study|Lack of Efficacy|3
1071698|NCT02037984|2125442|FG000|Overall Study|Lost to Follow-up|1
1071699|NCT02037984|2125443|FG001|Overall Study|Lost to Follow-up|0
1071700|NCT02037984|2125444|FG002|Overall Study|Lost to Follow-up|3
1071701|NCT02037984|2125445|FG003|Overall Study|Lost to Follow-up|5
1071702|NCT02037984|2125446|FG004|Overall Study|Lost to Follow-up|2
1071703|NCT02037984|2125447|FG005|Overall Study|Lost to Follow-up|2
1071704|NCT02037984|2125448|FG006|Overall Study|Lost to Follow-up|2
1071705|NCT02037984|2125449|FG007|Overall Study|Lost to Follow-up|4
1071706|NCT02037984|2125442|FG000|Overall Study|Physician Decision|0
1071707|NCT02037984|2125443|FG001|Overall Study|Physician Decision|0
1071708|NCT02037984|2125444|FG002|Overall Study|Physician Decision|0
1071709|NCT02037984|2125445|FG003|Overall Study|Physician Decision|0
1071710|NCT02037984|2125446|FG004|Overall Study|Physician Decision|0
1071711|NCT02037984|2125447|FG005|Overall Study|Physician Decision|0
1071712|NCT02037984|2125448|FG006|Overall Study|Physician Decision|1
1071713|NCT02037984|2125449|FG007|Overall Study|Physician Decision|0
1071714|NCT02037984|2125442|FG000|Overall Study|Protocol Violation|0
1071715|NCT02037984|2125443|FG001|Overall Study|Protocol Violation|0
1071716|NCT02037984|2125444|FG002|Overall Study|Protocol Violation|0
1071717|NCT02037984|2125445|FG003|Overall Study|Protocol Violation|0
1071718|NCT02037984|2125446|FG004|Overall Study|Protocol Violation|0
1071719|NCT02037984|2125447|FG005|Overall Study|Protocol Violation|1
1071720|NCT02037984|2125448|FG006|Overall Study|Protocol Violation|2
1071721|NCT02037984|2125449|FG007|Overall Study|Protocol Violation|0
1071722|NCT02037984|2125442|FG000|Overall Study|Technical Problems|0
1071723|NCT02037984|2125443|FG001|Overall Study|Technical Problems|0
1071724|NCT02037984|2125444|FG002|Overall Study|Technical Problems|3
1071725|NCT02037984|2125445|FG003|Overall Study|Technical Problems|3
1071726|NCT02037984|2125446|FG004|Overall Study|Technical Problems|2
1071727|NCT02037984|2125447|FG005|Overall Study|Technical Problems|3
908858|NCT00784654|1885464|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
908859|NCT00784654|1885462|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
908860|NCT00784654|1885463|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
908861|NCT00784654|1885464|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
908862|NCT00784654|1885462|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0
908863|NCT00784654|1885463|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8
908864|NCT00784654|1885464|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35
908865|NCT00784654|1885462|FG000|Randomized Withdrawal Period|Lack of Efficacy|0
908866|NCT00784654|1885463|FG001|Randomized Withdrawal Period|Lack of Efficacy|5
908867|NCT00784654|1885464|FG002|Randomized Withdrawal Period|Lack of Efficacy|18
908868|NCT00784654|1885462|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
908869|NCT00784654|1885463|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1
908870|NCT00784654|1885464|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7
1071728|NCT02037984|2125448|FG006|Overall Study|Technical Problems|4
1071729|NCT02037984|2125449|FG007|Overall Study|Technical Problems|2
1071730|NCT02037984|2125442|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1071731|NCT02037984|2125443|FG001|Overall Study|Withdrawal by Parent/Guardian|0
1071732|NCT02037984|2125444|FG002|Overall Study|Withdrawal by Parent/Guardian|3
1071733|NCT02037984|2125445|FG003|Overall Study|Withdrawal by Parent/Guardian|2
1071734|NCT02037984|2125446|FG004|Overall Study|Withdrawal by Parent/Guardian|5
1071735|NCT02037984|2125447|FG005|Overall Study|Withdrawal by Parent/Guardian|1
1071736|NCT02037984|2125448|FG006|Overall Study|Withdrawal by Parent/Guardian|4
1071737|NCT02037984|2125449|FG007|Overall Study|Withdrawal by Parent/Guardian|2
1071738|NCT02037984|2125442|FG000|Overall Study|Withdrawal by Subject|0
1071739|NCT02037984|2125443|FG001|Overall Study|Withdrawal by Subject|0
1071740|NCT02037984|2125444|FG002|Overall Study|Withdrawal by Subject|0
1071741|NCT02037984|2125445|FG003|Overall Study|Withdrawal by Subject|1
1071742|NCT02037984|2125446|FG004|Overall Study|Withdrawal by Subject|1
1071743|NCT02037984|2125447|FG005|Overall Study|Withdrawal by Subject|3
1071744|NCT02037984|2125448|FG006|Overall Study|Withdrawal by Subject|0
1071745|NCT02037984|2125449|FG007|Overall Study|Withdrawal by Subject|1
1071746|NCT02038010|2125477|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
1071747|NCT02038010|2125478|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
1071748|NCT02038010|2125479|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
1071749|NCT02038010|2125480|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
1071750|NCT02038010|2125477|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
1071751|NCT02038010|2125478|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
1071752|NCT02038010|2125479|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
1071753|NCT02038010|2125480|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
1071754|NCT02038010|2125477|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
1071755|NCT02038010|2125478|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
1071756|NCT02038010|2125479|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
1071757|NCT02038010|2125480|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
1071758|NCT02038010|2125477|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
1071759|NCT02038010|2125478|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
1071760|NCT02038010|2125479|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
1071761|NCT02038010|2125480|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
1071762|NCT02038010|2125477|FG000|Follow Up|Death|4
1071763|NCT02038010|2125478|FG001|Follow Up|Death|3
1071764|NCT02038010|2125479|FG002|Follow Up|Death|0
1071765|NCT02038010|2125480|FG003|Follow Up|Death|0
1071766|NCT02038010|2125477|FG000|Follow Up|Other|3
1071767|NCT02038010|2125478|FG001|Follow Up|Other|0
1071768|NCT02038010|2125479|FG002|Follow Up|Other|0
1071769|NCT02038010|2125480|FG003|Follow Up|Other|0
1071770|NCT02038036|2125496|FG000|Core Study|Adverse Event|7
1071771|NCT02038036|2125497|FG001|Core Study|Adverse Event|7
1071772|NCT02038036|2125496|FG000|Core Study|Death|1
1071773|NCT02038036|2125497|FG001|Core Study|Death|1
1071774|NCT02038036|2125496|FG000|Core Study|Disease progression|2
1071775|NCT02038036|2125497|FG001|Core Study|Disease progression|2
1071776|NCT02038036|2125496|FG000|Core Study|Lost to Follow-up|0
1071777|NCT02038036|2125497|FG001|Core Study|Lost to Follow-up|1
1071778|NCT02038036|2125496|FG000|Core Study|Physician Decision|2
1071779|NCT02038036|2125497|FG001|Core Study|Physician Decision|1
1071780|NCT02038036|2125496|FG000|Core Study|Subject/guardian decision|0
1071781|NCT02038036|2125497|FG001|Core Study|Subject/guardian decision|1
1071782|NCT02038036|2125496|FG000|Core Study|Withdrawal by Subject|3
1071783|NCT02038036|2125497|FG001|Core Study|Withdrawal by Subject|1
1071784|NCT02038036|2125496|FG000|Crossover Period|Withdrawal by Subject|0
1071785|NCT02038036|2125497|FG001|Crossover Period|Withdrawal by Subject|3
1071786|NCT02038036|2125496|FG000|Crossover Period|Adverse Event|0
1071787|NCT02038036|2125497|FG001|Crossover Period|Adverse Event|9
1071788|NCT02038036|2125496|FG000|Crossover Period|Death|0
1071789|NCT02038036|2125497|FG001|Crossover Period|Death|2
1071790|NCT02038036|2125496|FG000|Crossover Period|Disease progression|0
1071791|NCT02038036|2125497|FG001|Crossover Period|Disease progression|3
1071792|NCT02038036|2125496|FG000|Crossover Period|Lost to Follow-up|0
1071793|NCT02038036|2125497|FG001|Crossover Period|Lost to Follow-up|1
1071794|NCT02038036|2125496|FG000|Crossover Period|Physician Decision|0
1071795|NCT02038036|2125497|FG001|Crossover Period|Physician Decision|2
1071796|NCT02038049|2125508|FG000|Overall Study|Lost to Follow-up|1
1071797|NCT02038049|2125509|FG001|Overall Study|Lost to Follow-up|0
1071798|NCT02038075|2125521|FG000|Overall Study|Withdrawal by Subject|3
1071799|NCT02038075|2125522|FG001|Overall Study|Withdrawal by Subject|0
1071800|NCT02038543|2125548|FG000|Overall Study|Screen Failure|0
1071801|NCT02038543|2125549|FG001|Overall Study|Screen Failure|0
1071802|NCT02038543|2125550|FG002|Overall Study|Screen Failure|0
1071803|NCT02038543|2125551|FG003|Overall Study|Screen Failure|1
1071804|NCT02038543|2125548|FG000|Overall Study|Withdrawal by Subject|0
1071805|NCT02038543|2125549|FG001|Overall Study|Withdrawal by Subject|0
1071806|NCT02038543|2125550|FG002|Overall Study|Withdrawal by Subject|0
1071807|NCT02038543|2125551|FG003|Overall Study|Withdrawal by Subject|1
1071808|NCT02038647|2125568|FG000|Overall Study|Progressive Disease|50
1071809|NCT02038647|2125569|FG001|Overall Study|Progressive Disease|59
1071810|NCT02038647|2125568|FG000|Overall Study|Adverse Event|18
1071811|NCT02038647|2125569|FG001|Overall Study|Adverse Event|10
1071812|NCT02038647|2125568|FG000|Overall Study|Symptomatic Deterioration|7
1071813|NCT02038647|2125569|FG001|Overall Study|Symptomatic Deterioration|7
1071814|NCT02038647|2125568|FG000|Overall Study|Withdrawal by Subject|5
1071815|NCT02038647|2125569|FG001|Overall Study|Withdrawal by Subject|2
1071816|NCT02038647|2125568|FG000|Overall Study|Not Reported|0
1071817|NCT02038647|2125569|FG001|Overall Study|Not Reported|1
1071818|NCT02038647|2125568|FG000|Overall Study|Ongoing at Datacut|9
1071819|NCT02038647|2125569|FG001|Overall Study|Ongoing at Datacut|10
1071820|NCT02038764|2125580|FG000|Overall Study|Adverse Event|0
1071821|NCT02038764|2125581|FG001|Overall Study|Adverse Event|0
1071822|NCT02038764|2125582|FG002|Overall Study|Adverse Event|1
1071823|NCT02038764|2125583|FG003|Overall Study|Adverse Event|0
1071824|NCT02038764|2125584|FG004|Overall Study|Adverse Event|0
1071825|NCT02038764|2125580|FG000|Overall Study|Lost to Follow-up|0
1071826|NCT02038764|2125581|FG001|Overall Study|Lost to Follow-up|1
1071827|NCT02038764|2125582|FG002|Overall Study|Lost to Follow-up|0
1071828|NCT02038764|2125583|FG003|Overall Study|Lost to Follow-up|0
1071829|NCT02038764|2125584|FG004|Overall Study|Lost to Follow-up|0
1071830|NCT02038764|2125580|FG000|Overall Study|Withdrawal by Subject|0
1071831|NCT02038764|2125581|FG001|Overall Study|Withdrawal by Subject|0
1071832|NCT02038764|2125582|FG002|Overall Study|Withdrawal by Subject|0
1071833|NCT02038764|2125583|FG003|Overall Study|Withdrawal by Subject|0
1071834|NCT02038764|2125584|FG004|Overall Study|Withdrawal by Subject|1
1071835|NCT02038764|2125580|FG000|Overall Study|Other|1
1071836|NCT02038764|2125581|FG001|Overall Study|Other|0
1071837|NCT02038764|2125582|FG002|Overall Study|Other|1
1071838|NCT02038764|2125583|FG003|Overall Study|Other|0
1071839|NCT02038764|2125584|FG004|Overall Study|Other|0
1071840|NCT02038790|2125600|FG000|Day 0 - First Treatment|Withdrawal by Subject|1
1071841|NCT02038790|2125601|FG001|Day 0 - First Treatment|Withdrawal by Subject|1
1071842|NCT02038829|2125608|FG000|Washout Period 1|Death|0
1071843|NCT02038829|2125609|FG001|Washout Period 1|Death|0
1071844|NCT02038829|2125610|FG002|Washout Period 1|Death|0
1071845|NCT02038829|2125611|FG003|Washout Period 1|Death|0
1071846|NCT02038829|2125612|FG004|Washout Period 1|Death|1
1071847|NCT02038829|2125613|FG005|Washout Period 1|Death|0
1071848|NCT02038829|2125614|FG006|Washout Period 1|Death|0
1071849|NCT02038829|2125615|FG007|Washout Period 1|Death|0
1071850|NCT02038829|2125616|FG008|Washout Period 1|Death|0
1071851|NCT02038829|2125617|FG009|Washout Period 1|Death|0
1071852|NCT02038829|2125618|FG010|Washout Period 1|Death|0
1071853|NCT02038829|2125619|FG011|Washout Period 1|Death|0
1071854|NCT02038829|2125608|FG000|Treatment Period 2|Adverse Event|0
1071855|NCT02038829|2125609|FG001|Treatment Period 2|Adverse Event|0
1071856|NCT02038829|2125610|FG002|Treatment Period 2|Adverse Event|0
1071857|NCT02038829|2125611|FG003|Treatment Period 2|Adverse Event|0
1071858|NCT02038829|2125612|FG004|Treatment Period 2|Adverse Event|0
1071859|NCT02038829|2125613|FG005|Treatment Period 2|Adverse Event|0
908871|NCT00784654|1885462|FG000|Randomized Withdrawal Period|Protocol Violation|0
908872|NCT00784654|1885463|FG001|Randomized Withdrawal Period|Protocol Violation|2
908873|NCT00784654|1885464|FG002|Randomized Withdrawal Period|Protocol Violation|1
908874|NCT00784654|1885462|FG000|Randomized Withdrawal Period|Adverse Event|0
908875|NCT00784654|1885463|FG001|Randomized Withdrawal Period|Adverse Event|1
908876|NCT00784654|1885464|FG002|Randomized Withdrawal Period|Adverse Event|1
908877|NCT00784654|1885462|FG000|Randomized Withdrawal Period|Did not complete a visit|0
908878|NCT00784654|1885463|FG001|Randomized Withdrawal Period|Did not complete a visit|1
908879|NCT00784654|1885464|FG002|Randomized Withdrawal Period|Did not complete a visit|0
908880|NCT00784654|1885462|FG000|Randomized Withdrawal Period|Family reasons|0
908881|NCT00784654|1885463|FG001|Randomized Withdrawal Period|Family reasons|0
908882|NCT00784654|1885464|FG002|Randomized Withdrawal Period|Family reasons|1
908883|NCT00784693|1885477|FG000|Overall Study|Lost to Follow-up|0
908884|NCT00784693|1885478|FG001|Overall Study|Lost to Follow-up|1
908885|NCT00784693|1885477|FG000|Overall Study|Lack of Efficacy|1
908886|NCT00784693|1885478|FG001|Overall Study|Lack of Efficacy|1
908887|NCT00784693|1885477|FG000|Overall Study|Withdrawal by Subject|0
908888|NCT00784693|1885478|FG001|Overall Study|Withdrawal by Subject|4
908889|NCT00784693|1885477|FG000|Overall Study|Randomized but not Treated|1
908890|NCT00784693|1885478|FG001|Overall Study|Randomized but not Treated|0
908891|NCT00784693|1885477|FG000|Overall Study|Other|1
908892|NCT00784693|1885478|FG001|Overall Study|Other|0
908893|NCT00784719|1885491|FG000|Overall Study|Adverse Event|0
908894|NCT00784719|1885492|FG001|Overall Study|Adverse Event|2
908895|NCT00784719|1885493|FG002|Overall Study|Adverse Event|0
908896|NCT00784719|1885494|FG003|Overall Study|Adverse Event|0
908897|NCT00784719|1885495|FG004|Overall Study|Adverse Event|1
908898|NCT00784719|1885496|FG005|Overall Study|Adverse Event|1
908899|NCT00784719|1885497|FG006|Overall Study|Adverse Event|1
908900|NCT00784719|1885491|FG000|Overall Study|Lost to Follow-up|0
908901|NCT00784719|1885492|FG001|Overall Study|Lost to Follow-up|0
908902|NCT00784719|1885493|FG002|Overall Study|Lost to Follow-up|0
908903|NCT00784719|1885494|FG003|Overall Study|Lost to Follow-up|0
908904|NCT00784719|1885495|FG004|Overall Study|Lost to Follow-up|1
908905|NCT00784719|1885496|FG005|Overall Study|Lost to Follow-up|1
1071860|NCT02038829|2125614|FG006|Treatment Period 2|Adverse Event|0
1071861|NCT02038829|2125615|FG007|Treatment Period 2|Adverse Event|0
1071862|NCT02038829|2125616|FG008|Treatment Period 2|Adverse Event|0
1071863|NCT02038829|2125617|FG009|Treatment Period 2|Adverse Event|0
1071864|NCT02038829|2125618|FG010|Treatment Period 2|Adverse Event|1
1071865|NCT02038829|2125619|FG011|Treatment Period 2|Adverse Event|0
1071866|NCT02038829|2125608|FG000|Treatment Period 2|Withdrawal by Subject|1
1071867|NCT02038829|2125609|FG001|Treatment Period 2|Withdrawal by Subject|0
1071868|NCT02038829|2125610|FG002|Treatment Period 2|Withdrawal by Subject|0
1071869|NCT02038829|2125611|FG003|Treatment Period 2|Withdrawal by Subject|0
1071870|NCT02038829|2125612|FG004|Treatment Period 2|Withdrawal by Subject|0
1071871|NCT02038829|2125613|FG005|Treatment Period 2|Withdrawal by Subject|0
1071872|NCT02038829|2125614|FG006|Treatment Period 2|Withdrawal by Subject|0
1071873|NCT02038829|2125615|FG007|Treatment Period 2|Withdrawal by Subject|0
1071874|NCT02038829|2125616|FG008|Treatment Period 2|Withdrawal by Subject|0
1071875|NCT02038829|2125617|FG009|Treatment Period 2|Withdrawal by Subject|0
1071876|NCT02038829|2125618|FG010|Treatment Period 2|Withdrawal by Subject|0
1071877|NCT02038829|2125619|FG011|Treatment Period 2|Withdrawal by Subject|0
1071878|NCT02038829|2125608|FG000|Washout Period 2|Adverse Event|0
1071879|NCT02038829|2125609|FG001|Washout Period 2|Adverse Event|0
1071880|NCT02038829|2125610|FG002|Washout Period 2|Adverse Event|0
908906|NCT00784719|1885497|FG006|Overall Study|Lost to Follow-up|0
908907|NCT00784719|1885491|FG000|Overall Study|Other|2
908908|NCT00784719|1885492|FG001|Overall Study|Other|1
908909|NCT00784719|1885493|FG002|Overall Study|Other|1
908910|NCT00784719|1885494|FG003|Overall Study|Other|0
908911|NCT00784719|1885495|FG004|Overall Study|Other|2
908912|NCT00784719|1885496|FG005|Overall Study|Other|1
908913|NCT00784719|1885497|FG006|Overall Study|Other|3
908914|NCT00784719|1885491|FG000|Overall Study|Withdrawal by Subject|1
908915|NCT00784719|1885492|FG001|Overall Study|Withdrawal by Subject|0
908916|NCT00784719|1885493|FG002|Overall Study|Withdrawal by Subject|0
908917|NCT00784719|1885494|FG003|Overall Study|Withdrawal by Subject|0
908918|NCT00784719|1885495|FG004|Overall Study|Withdrawal by Subject|2
908919|NCT00784719|1885496|FG005|Overall Study|Withdrawal by Subject|0
908920|NCT00784719|1885497|FG006|Overall Study|Withdrawal by Subject|1
908921|NCT00784758|1885515|FG000|Overall Study|Withdrawal by Subject|3
908922|NCT00784758|1885516|FG001|Overall Study|Withdrawal by Subject|0
908923|NCT00784758|1885515|FG000|Overall Study|Adverse Event|1
908924|NCT00784758|1885516|FG001|Overall Study|Adverse Event|0
908925|NCT00784784|1885526|FG000|Overall Study|Withdrawal by Subject|2
908926|NCT00784784|1885527|FG001|Overall Study|Withdrawal by Subject|2
908927|NCT00784810|1885535|FG000|Overall Study|Adverse Event|32
908928|NCT00784810|1885536|FG001|Overall Study|Adverse Event|20
908929|NCT00784810|1885535|FG000|Overall Study|Lack of Efficacy|14
1071881|NCT02038829|2125611|FG003|Washout Period 2|Adverse Event|0
1071882|NCT02038829|2125612|FG004|Washout Period 2|Adverse Event|0
1071883|NCT02038829|2125613|FG005|Washout Period 2|Adverse Event|0
1071884|NCT02038829|2125614|FG006|Washout Period 2|Adverse Event|0
1071885|NCT02038829|2125615|FG007|Washout Period 2|Adverse Event|0
1071886|NCT02038829|2125616|FG008|Washout Period 2|Adverse Event|1
1071887|NCT02038829|2125617|FG009|Washout Period 2|Adverse Event|0
1071888|NCT02038829|2125618|FG010|Washout Period 2|Adverse Event|0
1071889|NCT02038829|2125619|FG011|Washout Period 2|Adverse Event|0
1071890|NCT02038829|2125608|FG000|Washout Period 2|Withdrawal by Subject|0
1071891|NCT02038829|2125609|FG001|Washout Period 2|Withdrawal by Subject|0
1071892|NCT02038829|2125610|FG002|Washout Period 2|Withdrawal by Subject|0
1071893|NCT02038829|2125611|FG003|Washout Period 2|Withdrawal by Subject|0
1071894|NCT02038829|2125612|FG004|Washout Period 2|Withdrawal by Subject|0
1071895|NCT02038829|2125613|FG005|Washout Period 2|Withdrawal by Subject|1
1071896|NCT02038829|2125614|FG006|Washout Period 2|Withdrawal by Subject|0
908930|NCT00784810|1885536|FG001|Overall Study|Lack of Efficacy|11
908931|NCT00784810|1885535|FG000|Overall Study|Withdrawal by Subject|11
908932|NCT00784810|1885536|FG001|Overall Study|Withdrawal by Subject|9
908933|NCT00784810|1885535|FG000|Overall Study|Administrative|5
908934|NCT00784810|1885536|FG001|Overall Study|Administrative|8
908935|NCT00784810|1885535|FG000|Overall Study|Lost to Follow-up|1
908936|NCT00784810|1885536|FG001|Overall Study|Lost to Follow-up|1
908937|NCT00784836|1885542|FG000|Overall Study|Early Study Termination|3
908938|NCT00784875|1885554|FG000|Period A - Baseline|Entry Criteria Not Met|0
908939|NCT00784875|1885555|FG001|Period A - Baseline|Entry Criteria Not Met|0
908940|NCT00784875|1885556|FG002|Period A - Baseline|Entry Criteria Not Met|0
908941|NCT00784875|1885557|FG003|Period A - Baseline|Entry Criteria Not Met|5
908942|NCT00784875|1885554|FG000|Period A - Baseline|Adverse Event|0
908943|NCT00784875|1885555|FG001|Period A - Baseline|Adverse Event|0
908944|NCT00784875|1885556|FG002|Period A - Baseline|Adverse Event|0
908945|NCT00784875|1885557|FG003|Period A - Baseline|Adverse Event|8
908946|NCT00784875|1885554|FG000|Period A - Baseline|Protocol Violation|0
908947|NCT00784875|1885555|FG001|Period A - Baseline|Protocol Violation|0
908948|NCT00784875|1885556|FG002|Period A - Baseline|Protocol Violation|0
908949|NCT00784875|1885557|FG003|Period A - Baseline|Protocol Violation|25
908950|NCT00784875|1885554|FG000|Period A - Baseline|Withdrawal by Subject|0
908951|NCT00784875|1885555|FG001|Period A - Baseline|Withdrawal by Subject|0
908952|NCT00784875|1885556|FG002|Period A - Baseline|Withdrawal by Subject|0
1071897|NCT02038829|2125615|FG007|Washout Period 2|Withdrawal by Subject|0
1071898|NCT02038829|2125616|FG008|Washout Period 2|Withdrawal by Subject|0
1071899|NCT02038829|2125617|FG009|Washout Period 2|Withdrawal by Subject|0
1071900|NCT02038829|2125618|FG010|Washout Period 2|Withdrawal by Subject|0
1071901|NCT02038829|2125619|FG011|Washout Period 2|Withdrawal by Subject|0
1071902|NCT02038829|2125608|FG000|Treatment Period 4|Adverse Event|0
1071903|NCT02038829|2125609|FG001|Treatment Period 4|Adverse Event|1
1071904|NCT02038829|2125610|FG002|Treatment Period 4|Adverse Event|0
1071905|NCT02038829|2125611|FG003|Treatment Period 4|Adverse Event|0
1071906|NCT02038829|2125612|FG004|Treatment Period 4|Adverse Event|0
1071907|NCT02038829|2125613|FG005|Treatment Period 4|Adverse Event|0
1071908|NCT02038829|2125614|FG006|Treatment Period 4|Adverse Event|0
1071909|NCT02038829|2125615|FG007|Treatment Period 4|Adverse Event|0
1071910|NCT02038829|2125616|FG008|Treatment Period 4|Adverse Event|0
1071911|NCT02038829|2125617|FG009|Treatment Period 4|Adverse Event|0
908953|NCT00784875|1885557|FG003|Period A - Baseline|Withdrawal by Subject|27
908954|NCT00784875|1885554|FG000|Period A - Baseline|Physician Decision|0
908955|NCT00784875|1885555|FG001|Period A - Baseline|Physician Decision|0
908956|NCT00784875|1885556|FG002|Period A - Baseline|Physician Decision|0
908957|NCT00784875|1885557|FG003|Period A - Baseline|Physician Decision|2
908958|NCT00784875|1885554|FG000|Period A - Baseline|Sponsor Decision|0
908959|NCT00784875|1885555|FG001|Period A - Baseline|Sponsor Decision|0
908960|NCT00784875|1885556|FG002|Period A - Baseline|Sponsor Decision|0
908961|NCT00784875|1885557|FG003|Period A - Baseline|Sponsor Decision|113
908962|NCT00784875|1885554|FG000|Period A - Baseline|Lost to Follow-up|0
908963|NCT00784875|1885555|FG001|Period A - Baseline|Lost to Follow-up|0
908964|NCT00784875|1885556|FG002|Period A - Baseline|Lost to Follow-up|0
908965|NCT00784875|1885557|FG003|Period A - Baseline|Lost to Follow-up|2
908966|NCT00784875|1885554|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
908967|NCT00784875|1885555|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
908968|NCT00784875|1885556|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
908969|NCT00784875|1885557|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
908970|NCT00784875|1885554|FG000|Period B - Efficacy Endpoint|Adverse Event|0
908971|NCT00784875|1885555|FG001|Period B - Efficacy Endpoint|Adverse Event|3
908972|NCT00784875|1885556|FG002|Period B - Efficacy Endpoint|Adverse Event|2
908973|NCT00784875|1885557|FG003|Period B - Efficacy Endpoint|Adverse Event|1
908974|NCT00784875|1885554|FG000|Period B - Efficacy Endpoint|Protocol Violation|1
908975|NCT00784875|1885555|FG001|Period B - Efficacy Endpoint|Protocol Violation|1
908976|NCT00784875|1885556|FG002|Period B - Efficacy Endpoint|Protocol Violation|2
908977|NCT00784875|1885557|FG003|Period B - Efficacy Endpoint|Protocol Violation|3
908978|NCT00784875|1885554|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0
908979|NCT00784875|1885555|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1
908980|NCT00784875|1885556|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0
908981|NCT00784875|1885557|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0
908982|NCT00784875|1885554|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4
908983|NCT00784875|1885555|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1
908984|NCT00784875|1885556|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1
908985|NCT00784875|1885557|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2
908986|NCT00784875|1885554|FG000|Period B - Efficacy Endpoint|Physician Decision|0
908987|NCT00784875|1885555|FG001|Period B - Efficacy Endpoint|Physician Decision|0
908988|NCT00784875|1885556|FG002|Period B - Efficacy Endpoint|Physician Decision|1
908989|NCT00784875|1885557|FG003|Period B - Efficacy Endpoint|Physician Decision|0
908990|NCT00784875|1885554|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9
908991|NCT00784875|1885555|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6
908992|NCT00784875|1885556|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12
908993|NCT00784875|1885557|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12
908994|NCT00784875|1885554|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0
908995|NCT00784875|1885555|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0
908996|NCT00784875|1885556|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1
908997|NCT00784875|1885557|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0
908998|NCT00784875|1885554|FG000|Period C|Adverse Event|1
908999|NCT00784875|1885555|FG001|Period C|Adverse Event|0
909000|NCT00784875|1885556|FG002|Period C|Adverse Event|4
909001|NCT00784875|1885557|FG003|Period C|Adverse Event|2
909002|NCT00784875|1885554|FG000|Period C|Protocol Violation|0
909003|NCT00784875|1885555|FG001|Period C|Protocol Violation|0
909004|NCT00784875|1885556|FG002|Period C|Protocol Violation|1
909005|NCT00784875|1885557|FG003|Period C|Protocol Violation|2
909006|NCT00784875|1885554|FG000|Period C|Lack of Efficacy|0
909007|NCT00784875|1885555|FG001|Period C|Lack of Efficacy|0
909008|NCT00784875|1885556|FG002|Period C|Lack of Efficacy|1
909009|NCT00784875|1885557|FG003|Period C|Lack of Efficacy|0
909010|NCT00784875|1885554|FG000|Period C|Withdrawal by Subject|1
909011|NCT00784875|1885555|FG001|Period C|Withdrawal by Subject|1
909012|NCT00784875|1885556|FG002|Period C|Withdrawal by Subject|2
909013|NCT00784875|1885557|FG003|Period C|Withdrawal by Subject|0
909014|NCT00784875|1885554|FG000|Period C|Physician Decision|0
909015|NCT00784875|1885555|FG001|Period C|Physician Decision|0
909016|NCT00784875|1885556|FG002|Period C|Physician Decision|1
909017|NCT00784875|1885557|FG003|Period C|Physician Decision|1
909018|NCT00784875|1885554|FG000|Period C|Sponsor Decision|5
1071912|NCT02038829|2125618|FG010|Treatment Period 4|Adverse Event|0
1071913|NCT02038829|2125619|FG011|Treatment Period 4|Adverse Event|0
1071914|NCT02038829|2125608|FG000|Washout Period 4|Adverse Event|0
1071915|NCT02038829|2125609|FG001|Washout Period 4|Adverse Event|0
1071916|NCT02038829|2125610|FG002|Washout Period 4|Adverse Event|0
909019|NCT00784875|1885555|FG001|Period C|Sponsor Decision|5
909020|NCT00784875|1885556|FG002|Period C|Sponsor Decision|4
909021|NCT00784875|1885557|FG003|Period C|Sponsor Decision|2
909022|NCT00784875|1885554|FG000|Period D|Adverse Event|0
909023|NCT00784875|1885555|FG001|Period D|Adverse Event|2
909024|NCT00784875|1885556|FG002|Period D|Adverse Event|2
909025|NCT00784875|1885557|FG003|Period D|Adverse Event|0
909026|NCT00784875|1885554|FG000|Period D|Protocol Violation|1
909027|NCT00784875|1885555|FG001|Period D|Protocol Violation|0
909028|NCT00784875|1885556|FG002|Period D|Protocol Violation|0
909029|NCT00784875|1885557|FG003|Period D|Protocol Violation|0
909030|NCT00784875|1885554|FG000|Period D|Withdrawal by Subject|2
909031|NCT00784875|1885555|FG001|Period D|Withdrawal by Subject|0
909032|NCT00784875|1885556|FG002|Period D|Withdrawal by Subject|2
909033|NCT00784875|1885557|FG003|Period D|Withdrawal by Subject|0
909034|NCT00784875|1885554|FG000|Period D|Physician Decision|0
909035|NCT00784875|1885555|FG001|Period D|Physician Decision|1
909036|NCT00784875|1885556|FG002|Period D|Physician Decision|0
909037|NCT00784875|1885557|FG003|Period D|Physician Decision|0
909038|NCT00784875|1885554|FG000|Period D|Sponsor Decision|1
909039|NCT00784875|1885555|FG001|Period D|Sponsor Decision|1
909040|NCT00784875|1885556|FG002|Period D|Sponsor Decision|1
909041|NCT00784875|1885557|FG003|Period D|Sponsor Decision|0
909042|NCT00784875|1885554|FG000|Period D|Lost to Follow-up|1
909043|NCT00784875|1885555|FG001|Period D|Lost to Follow-up|0
909044|NCT00784875|1885556|FG002|Period D|Lost to Follow-up|1
909045|NCT00784875|1885557|FG003|Period D|Lost to Follow-up|1
909046|NCT00784927|1885580|FG000|Overall Study|Cancel Prior to Initiating Treatment|1
909047|NCT00784927|1885580|FG000|Overall Study|Protocol Violation|1
909048|NCT00784927|1885580|FG000|Overall Study|Ineligible|1
909049|NCT00784979|1885585|FG000|Overall Study|incomplete data|6
909050|NCT00785044|1885589|FG000|Overall Study|Dosed at non-participating sites|152
909051|NCT00785044|1885589|FG000|Overall Study|Death|77
909052|NCT00785044|1885589|FG000|Overall Study|Lost to Follow-up|266
909053|NCT00785044|1885589|FG000|Overall Study|Withdrawal by Subject|1
909054|NCT00785213|1885594|FG000|Quinine Sulfate Alone|Adverse Event|4
909055|NCT00785213|1885594|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1
909056|NCT00785291|1885604|FG000|Overall Study|Never began treatment|8
909057|NCT00785291|1885605|FG001|Overall Study|Never began treatment|4
909058|NCT00785291|1885606|FG002|Overall Study|Never began treatment|4
909059|NCT00785291|1885604|FG000|Overall Study|Adverse Event|39
909060|NCT00785291|1885605|FG001|Overall Study|Adverse Event|70
909061|NCT00785291|1885606|FG002|Overall Study|Adverse Event|56
909062|NCT00785291|1885604|FG000|Overall Study|Death|7
909063|NCT00785291|1885605|FG001|Overall Study|Death|4
909064|NCT00785291|1885606|FG002|Overall Study|Death|3
909065|NCT00785291|1885604|FG000|Overall Study|Withdrawal by Subject|35
909066|NCT00785291|1885605|FG001|Overall Study|Withdrawal by Subject|36
909067|NCT00785291|1885606|FG002|Overall Study|Withdrawal by Subject|17
909068|NCT00785291|1885604|FG000|Overall Study|Alternative Therapy|12
909069|NCT00785291|1885605|FG001|Overall Study|Alternative Therapy|6
909070|NCT00785291|1885606|FG002|Overall Study|Alternative Therapy|7
909071|NCT00785291|1885604|FG000|Overall Study|Complicating illness|6
909072|NCT00785291|1885605|FG001|Overall Study|Complicating illness|4
909073|NCT00785291|1885606|FG002|Overall Study|Complicating illness|4
909074|NCT00785291|1885604|FG000|Overall Study|Other Medical Reasons|29
909075|NCT00785291|1885605|FG001|Overall Study|Other Medical Reasons|25
909076|NCT00785291|1885606|FG002|Overall Study|Other Medical Reasons|15
909077|NCT00785486|1885614|FG000|Midazolam Alone|Withdrawal by Subject|1
909078|NCT00785512|1885637|FG000|Overall Study|Inclusion/Exclusion not meet|0
909079|NCT00785512|1885638|FG001|Overall Study|Inclusion/Exclusion not meet|0
909080|NCT00785512|1885637|FG000|Overall Study|Adverse Event|0
909081|NCT00785512|1885638|FG001|Overall Study|Adverse Event|0
909082|NCT00785512|1885637|FG000|Overall Study|Lack of Efficacy|0
909083|NCT00785512|1885638|FG001|Overall Study|Lack of Efficacy|2
909084|NCT00785512|1885637|FG000|Overall Study|Withdrawal by Subject|0
909085|NCT00785512|1885638|FG001|Overall Study|Withdrawal by Subject|1
909086|NCT00785512|1885637|FG000|Overall Study|Lost to Follow-up|3
909087|NCT00785512|1885638|FG001|Overall Study|Lost to Follow-up|0
909088|NCT00785512|1885637|FG000|Overall Study|Precedure Refused|0
909089|NCT00785512|1885638|FG001|Overall Study|Precedure Refused|0
909090|NCT00785512|1885637|FG000|Overall Study|IVRS Programing Error|0
909091|NCT00785512|1885638|FG001|Overall Study|IVRS Programing Error|0
909092|NCT00785512|1885637|FG000|Overall Study|Physician Decision|0
909093|NCT00785512|1885638|FG001|Overall Study|Physician Decision|0
909094|NCT00785512|1885637|FG000|Overall Study|Lack of compliance|0
909095|NCT00785512|1885638|FG001|Overall Study|Lack of compliance|1
909096|NCT00785538|1885649|FG000|Treatment Period|Adverse Event|1
909097|NCT00785538|1885650|FG001|Treatment Period|Adverse Event|2
909098|NCT00785538|1885651|FG002|Treatment Period|Adverse Event|2
909099|NCT00785538|1885652|FG003|Treatment Period|Adverse Event|0
909100|NCT00785538|1885649|FG000|Treatment Period|Withdrawal by Subject|0
1071917|NCT02038829|2125611|FG003|Washout Period 4|Adverse Event|0
1071918|NCT02038829|2125612|FG004|Washout Period 4|Adverse Event|0
1071919|NCT02038829|2125613|FG005|Washout Period 4|Adverse Event|0
1071920|NCT02038829|2125614|FG006|Washout Period 4|Adverse Event|1
1071921|NCT02038829|2125615|FG007|Washout Period 4|Adverse Event|0
1071922|NCT02038829|2125616|FG008|Washout Period 4|Adverse Event|0
1071923|NCT02038829|2125617|FG009|Washout Period 4|Adverse Event|0
1071924|NCT02038829|2125618|FG010|Washout Period 4|Adverse Event|0
1071925|NCT02038829|2125619|FG011|Washout Period 4|Adverse Event|0
1071926|NCT02038829|2125608|FG000|Treatment Period 6|Adverse Event|0
1071927|NCT02038829|2125609|FG001|Treatment Period 6|Adverse Event|0
1071928|NCT02038829|2125610|FG002|Treatment Period 6|Adverse Event|1
1071929|NCT02038829|2125611|FG003|Treatment Period 6|Adverse Event|0
1071930|NCT02038829|2125612|FG004|Treatment Period 6|Adverse Event|0
1071931|NCT02038829|2125613|FG005|Treatment Period 6|Adverse Event|0
1071932|NCT02038829|2125614|FG006|Treatment Period 6|Adverse Event|0
1071933|NCT02038829|2125615|FG007|Treatment Period 6|Adverse Event|0
1071934|NCT02038829|2125616|FG008|Treatment Period 6|Adverse Event|0
1071935|NCT02038829|2125617|FG009|Treatment Period 6|Adverse Event|0
1071936|NCT02038829|2125618|FG010|Treatment Period 6|Adverse Event|0
1071937|NCT02038829|2125619|FG011|Treatment Period 6|Adverse Event|0
1071938|NCT02038881|2125637|FG000|Overall Study|Withdrawal by Subject|0
1071939|NCT02038881|2125638|FG001|Overall Study|Withdrawal by Subject|0
909101|NCT00785538|1885650|FG001|Treatment Period|Withdrawal by Subject|0
909102|NCT00785538|1885651|FG002|Treatment Period|Withdrawal by Subject|0
909103|NCT00785538|1885652|FG003|Treatment Period|Withdrawal by Subject|1
909104|NCT00785577|1885668|FG000|Study Period 2: Therapy Phase|Adverse Event|5
909105|NCT00785577|1885669|FG001|Study Period 2: Therapy Phase|Adverse Event|7
909106|NCT00785577|1885670|FG002|Study Period 2: Therapy Phase|Adverse Event|14
909107|NCT00785577|1885671|FG003|Study Period 2: Therapy Phase|Adverse Event|10
909108|NCT00785577|1885672|FG004|Study Period 2: Therapy Phase|Adverse Event|17
909109|NCT00785577|1885668|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0
909110|NCT00785577|1885669|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
909111|NCT00785577|1885670|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0
909112|NCT00785577|1885671|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0
909113|NCT00785577|1885672|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1
909114|NCT00785577|1885668|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0
909115|NCT00785577|1885669|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0
909116|NCT00785577|1885670|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0
909117|NCT00785577|1885671|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1
909118|NCT00785577|1885672|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0
909119|NCT00785577|1885668|FG000|Study Period 2: Therapy Phase|Physician Decision|1
909120|NCT00785577|1885669|FG001|Study Period 2: Therapy Phase|Physician Decision|0
909121|NCT00785577|1885670|FG002|Study Period 2: Therapy Phase|Physician Decision|0
909122|NCT00785577|1885671|FG003|Study Period 2: Therapy Phase|Physician Decision|0
909123|NCT00785577|1885672|FG004|Study Period 2: Therapy Phase|Physician Decision|0
909124|NCT00785577|1885668|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
909125|NCT00785577|1885669|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
909126|NCT00785577|1885670|FG002|Study Period 2: Therapy Phase|Protocol Violation|1
909127|NCT00785577|1885671|FG003|Study Period 2: Therapy Phase|Protocol Violation|0
909128|NCT00785577|1885672|FG004|Study Period 2: Therapy Phase|Protocol Violation|1
909129|NCT00785577|1885668|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2
909130|NCT00785577|1885669|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1
909131|NCT00785577|1885670|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1
909132|NCT00785577|1885671|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0
909133|NCT00785577|1885672|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1
909134|NCT00785577|1885668|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
909135|NCT00785577|1885669|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
909136|NCT00785577|1885670|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
909137|NCT00785577|1885671|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
909138|NCT00785577|1885672|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
909139|NCT00785577|1885668|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1
909140|NCT00785577|1885669|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0
909141|NCT00785577|1885670|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1
909142|NCT00785577|1885671|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1
909143|NCT00785577|1885672|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0
909144|NCT00785577|1885668|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0
909145|NCT00785577|1885669|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0
909146|NCT00785577|1885670|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0
909147|NCT00785577|1885671|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1
909148|NCT00785577|1885672|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0
909149|NCT00785577|1885668|FG000|Study Period 3: 1-Week Washout Phase|Death|0
909150|NCT00785577|1885669|FG001|Study Period 3: 1-Week Washout Phase|Death|0
909151|NCT00785577|1885670|FG002|Study Period 3: 1-Week Washout Phase|Death|0
909152|NCT00785577|1885671|FG003|Study Period 3: 1-Week Washout Phase|Death|0
909153|NCT00785577|1885672|FG004|Study Period 3: 1-Week Washout Phase|Death|1
1071940|NCT02038881|2125639|FG002|Overall Study|Withdrawal by Subject|1
1071941|NCT02038881|2125637|FG000|Overall Study|Lost to Follow-up|2
1071942|NCT02038881|2125638|FG001|Overall Study|Lost to Follow-up|0
1071943|NCT02038881|2125639|FG002|Overall Study|Lost to Follow-up|0
1071944|NCT02038881|2125637|FG000|Overall Study|incarcerated|1
1071945|NCT02038881|2125638|FG001|Overall Study|incarcerated|0
1071946|NCT02038881|2125639|FG002|Overall Study|incarcerated|0
1071947|NCT02038907|2125680|FG000|Overall Study|Protocol Violation|0
1071948|NCT02038907|2125681|FG001|Overall Study|Protocol Violation|0
1071949|NCT02038907|2125682|FG002|Overall Study|Protocol Violation|0
1071950|NCT02038907|2125683|FG003|Overall Study|Protocol Violation|0
1071951|NCT02038907|2125684|FG004|Overall Study|Protocol Violation|0
1071952|NCT02038907|2125685|FG005|Overall Study|Protocol Violation|0
1071953|NCT02038907|2125686|FG006|Overall Study|Protocol Violation|0
1071954|NCT02038907|2125687|FG007|Overall Study|Protocol Violation|0
1071955|NCT02038907|2125688|FG008|Overall Study|Protocol Violation|0
1071956|NCT02038907|2125689|FG009|Overall Study|Protocol Violation|0
1071957|NCT02038907|2125690|FG010|Overall Study|Protocol Violation|1
1071958|NCT02038907|2125691|FG011|Overall Study|Protocol Violation|0
1071959|NCT02038907|2125692|FG012|Overall Study|Protocol Violation|0
1071960|NCT02038907|2125693|FG013|Overall Study|Protocol Violation|0
1071961|NCT02038907|2125680|FG000|Overall Study|Withdrawal by Subject|0
1071962|NCT02038907|2125681|FG001|Overall Study|Withdrawal by Subject|0
1071963|NCT02038907|2125682|FG002|Overall Study|Withdrawal by Subject|0
1071964|NCT02038907|2125683|FG003|Overall Study|Withdrawal by Subject|0
1071965|NCT02038907|2125684|FG004|Overall Study|Withdrawal by Subject|0
1071966|NCT02038907|2125685|FG005|Overall Study|Withdrawal by Subject|0
1071967|NCT02038907|2125686|FG006|Overall Study|Withdrawal by Subject|0
1071968|NCT02038907|2125687|FG007|Overall Study|Withdrawal by Subject|0
1071969|NCT02038907|2125688|FG008|Overall Study|Withdrawal by Subject|0
1071970|NCT02038907|2125689|FG009|Overall Study|Withdrawal by Subject|0
1071971|NCT02038907|2125690|FG010|Overall Study|Withdrawal by Subject|1
1071972|NCT02038907|2125691|FG011|Overall Study|Withdrawal by Subject|0
1071973|NCT02038907|2125692|FG012|Overall Study|Withdrawal by Subject|0
1071974|NCT02038907|2125693|FG013|Overall Study|Withdrawal by Subject|0
1071975|NCT02038920|2125727|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
1071976|NCT02038920|2125728|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
1071977|NCT02038920|2125729|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
1071978|NCT02038920|2125730|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
1071979|NCT02038920|2125731|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
1071980|NCT02038920|2125732|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
1071981|NCT02038920|2125727|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
1071982|NCT02038920|2125728|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
1071983|NCT02038920|2125729|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
1071984|NCT02038920|2125730|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
1071985|NCT02038920|2125731|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
1071986|NCT02038920|2125732|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
1071987|NCT02038920|2125727|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
1071988|NCT02038920|2125728|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
1071989|NCT02038920|2125729|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
1071990|NCT02038920|2125730|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
1071991|NCT02038920|2125731|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
1071992|NCT02038920|2125732|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
1071993|NCT02038920|2125727|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
1071994|NCT02038920|2125728|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
1071995|NCT02038920|2125729|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
1071996|NCT02038920|2125730|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
1071997|NCT02038920|2125731|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
1071998|NCT02038920|2125732|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
1071999|NCT02038920|2125727|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
1072000|NCT02038920|2125728|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
1072001|NCT02038920|2125729|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
1072002|NCT02038920|2125730|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
1162045|NCT03381248|2283985|FG000|Overall Study|Lack of Efficacy|1
909154|NCT00785629|1885698|FG000|Overall Study|Adverse Event|2
909155|NCT00785629|1885699|FG001|Overall Study|Adverse Event|1
909156|NCT00785629|1885700|FG002|Overall Study|Adverse Event|1
909157|NCT00785629|1885701|FG003|Overall Study|Adverse Event|5
909158|NCT00785629|1885698|FG000|Overall Study|Protocol Violation|1
909159|NCT00785629|1885699|FG001|Overall Study|Protocol Violation|2
909160|NCT00785629|1885700|FG002|Overall Study|Protocol Violation|4
909161|NCT00785629|1885701|FG003|Overall Study|Protocol Violation|5
909162|NCT00785629|1885698|FG000|Overall Study|administrative decision|5
909163|NCT00785629|1885699|FG001|Overall Study|administrative decision|1
909164|NCT00785629|1885700|FG002|Overall Study|administrative decision|3
909165|NCT00785629|1885701|FG003|Overall Study|administrative decision|4
909166|NCT00785629|1885698|FG000|Overall Study|Withdrawal by Subject|0
909167|NCT00785629|1885699|FG001|Overall Study|Withdrawal by Subject|1
1072003|NCT02038920|2125731|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
1072004|NCT02038920|2125732|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
909168|NCT00785629|1885700|FG002|Overall Study|Withdrawal by Subject|2
909169|NCT00785629|1885701|FG003|Overall Study|Withdrawal by Subject|2
909170|NCT00785707|1885709|FG000|Overall Study|Lost to Follow-up|7
909171|NCT00785785|1885719|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
909172|NCT00785785|1885720|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
909173|NCT00785785|1885719|FG000|Core Phase up to 36 Months|Adverse Event|31
909174|NCT00785785|1885720|FG001|Core Phase up to 36 Months|Adverse Event|21
909175|NCT00785785|1885719|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1
909176|NCT00785785|1885720|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0
909177|NCT00785785|1885719|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2
909178|NCT00785785|1885720|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2
909179|NCT00785785|1885719|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16
909180|NCT00785785|1885720|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17
909181|NCT00785785|1885719|FG000|Core Phase up to 36 Months|Lost to Follow-up|3
909182|NCT00785785|1885720|FG001|Core Phase up to 36 Months|Lost to Follow-up|7
909183|NCT00785785|1885719|FG000|Core Phase up to 36 Months|Administrative problems|3
909184|NCT00785785|1885720|FG001|Core Phase up to 36 Months|Administrative problems|3
909185|NCT00785785|1885719|FG000|Core Phase up to 36 Months|Death|5
909186|NCT00785785|1885720|FG001|Core Phase up to 36 Months|Death|8
909187|NCT00785785|1885719|FG000|Core Phase up to 36 Months|Disease progression|139
909188|NCT00785785|1885720|FG001|Core Phase up to 36 Months|Disease progression|119
909189|NCT00785785|1885719|FG000|Core Phase up to 36 Months|Protocol deviation|5
909190|NCT00785785|1885720|FG001|Core Phase up to 36 Months|Protocol deviation|6
909191|NCT00785785|1885719|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116
909192|NCT00785785|1885720|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133
909193|NCT00785785|1885719|FG000|Optional Extension Phase|Adverse Event|4
909194|NCT00785785|1885720|FG001|Optional Extension Phase|Adverse Event|5
909195|NCT00785785|1885719|FG000|Optional Extension Phase|Withdrawal by Subject|6
909196|NCT00785785|1885720|FG001|Optional Extension Phase|Withdrawal by Subject|6
909197|NCT00785785|1885719|FG000|Optional Extension Phase|Lost to Follow-up|1
909198|NCT00785785|1885720|FG001|Optional Extension Phase|Lost to Follow-up|0
909199|NCT00785785|1885719|FG000|Optional Extension Phase|Administrative problems|2
909200|NCT00785785|1885720|FG001|Optional Extension Phase|Administrative problems|0
909201|NCT00785785|1885719|FG000|Optional Extension Phase|Death|1
909202|NCT00785785|1885720|FG001|Optional Extension Phase|Death|5
909203|NCT00785785|1885719|FG000|Optional Extension Phase|Disease progression|22
909204|NCT00785785|1885720|FG001|Optional Extension Phase|Disease progression|70
909205|NCT00785785|1885719|FG000|Optional Extension Phase|Protocol deviation|0
909206|NCT00785785|1885720|FG001|Optional Extension Phase|Protocol deviation|2
909207|NCT00785785|1885719|FG000|Optional Extension Phase|Study terminated by sponsor|3
909208|NCT00785785|1885720|FG001|Optional Extension Phase|Study terminated by sponsor|37
909209|NCT00785928|1885739|FG000|Treatment Phase|Adverse Event|1
909210|NCT00785928|1885740|FG001|Treatment Phase|Adverse Event|1
909211|NCT00785928|1885741|FG002|Treatment Phase|Adverse Event|2
909212|NCT00785928|1885742|FG003|Treatment Phase|Adverse Event|0
909213|NCT00785928|1885743|FG004|Treatment Phase|Adverse Event|0
909214|NCT00785928|1885744|FG005|Treatment Phase|Adverse Event|0
909215|NCT00785928|1885745|FG006|Treatment Phase|Adverse Event|2
909216|NCT00785928|1885739|FG000|Treatment Phase|Inadequate Response|0
909217|NCT00785928|1885740|FG001|Treatment Phase|Inadequate Response|1
909218|NCT00785928|1885741|FG002|Treatment Phase|Inadequate Response|0
909219|NCT00785928|1885742|FG003|Treatment Phase|Inadequate Response|0
909220|NCT00785928|1885743|FG004|Treatment Phase|Inadequate Response|0
909221|NCT00785928|1885744|FG005|Treatment Phase|Inadequate Response|0
909222|NCT00785928|1885745|FG006|Treatment Phase|Inadequate Response|0
909223|NCT00785928|1885739|FG000|Treatment Phase|Lack of Efficacy|0
909224|NCT00785928|1885740|FG001|Treatment Phase|Lack of Efficacy|1
909225|NCT00785928|1885741|FG002|Treatment Phase|Lack of Efficacy|1
909226|NCT00785928|1885742|FG003|Treatment Phase|Lack of Efficacy|0
909227|NCT00785928|1885743|FG004|Treatment Phase|Lack of Efficacy|0
909228|NCT00785928|1885744|FG005|Treatment Phase|Lack of Efficacy|0
909229|NCT00785928|1885745|FG006|Treatment Phase|Lack of Efficacy|0
909230|NCT00785928|1885739|FG000|Treatment Phase|Physician Decision|0
909231|NCT00785928|1885740|FG001|Treatment Phase|Physician Decision|0
909232|NCT00785928|1885741|FG002|Treatment Phase|Physician Decision|0
909233|NCT00785928|1885742|FG003|Treatment Phase|Physician Decision|0
909234|NCT00785928|1885743|FG004|Treatment Phase|Physician Decision|1
909235|NCT00785928|1885744|FG005|Treatment Phase|Physician Decision|0
909236|NCT00785928|1885745|FG006|Treatment Phase|Physician Decision|0
909237|NCT00785928|1885739|FG000|Treatment Phase|Sponsor Decision|1
909238|NCT00785928|1885740|FG001|Treatment Phase|Sponsor Decision|0
909239|NCT00785928|1885741|FG002|Treatment Phase|Sponsor Decision|0
909240|NCT00785928|1885742|FG003|Treatment Phase|Sponsor Decision|0
909241|NCT00785928|1885743|FG004|Treatment Phase|Sponsor Decision|0
909242|NCT00785928|1885744|FG005|Treatment Phase|Sponsor Decision|0
909243|NCT00785928|1885745|FG006|Treatment Phase|Sponsor Decision|1
909244|NCT00785928|1885739|FG000|Treatment Phase|Withdrawal by Subject|1
1072005|NCT02038920|2125727|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
1072006|NCT02038920|2125728|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
1072007|NCT02038920|2125729|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
1072008|NCT02038920|2125730|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
1072009|NCT02038920|2125731|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
1072010|NCT02038920|2125732|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
909245|NCT00785928|1885740|FG001|Treatment Phase|Withdrawal by Subject|2
909246|NCT00785928|1885741|FG002|Treatment Phase|Withdrawal by Subject|0
909247|NCT00785928|1885742|FG003|Treatment Phase|Withdrawal by Subject|0
909248|NCT00785928|1885743|FG004|Treatment Phase|Withdrawal by Subject|1
909249|NCT00785928|1885744|FG005|Treatment Phase|Withdrawal by Subject|0
909250|NCT00785928|1885745|FG006|Treatment Phase|Withdrawal by Subject|0
909251|NCT00785980|1885783|FG000|7 Day Washout Period|Protocol Violation|3
909252|NCT00786032|1885801|FG000|Overall Study|Death|4
909253|NCT00786032|1885801|FG000|Overall Study|Withdrawal by Subject|14
909254|NCT00786032|1885801|FG000|Overall Study|Did not complete in the timeframe|6
909255|NCT00786188|1885809|FG000|Overall Study|Adverse Event|3
909256|NCT00786188|1885810|FG001|Overall Study|Adverse Event|1
909257|NCT00786188|1885809|FG000|Overall Study|Withdrawal by Subject|2
909258|NCT00786188|1885810|FG001|Overall Study|Withdrawal by Subject|0
909259|NCT00786409|1885818|FG000|Overall Study|Withdrawal by Subject|2
909260|NCT00786409|1885818|FG000|Overall Study|Adverse Event|2
909261|NCT00786409|1885818|FG000|Overall Study|Pregnancy|2
909262|NCT00786409|1885818|FG000|Overall Study|Lost to Follow-up|1
909263|NCT00786422|1885822|FG000|Rivaroxaban Treatment|Death|2
909264|NCT00786422|1885822|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3
909265|NCT00786422|1885822|FG000|Rivaroxaban Treatment|Lack of Efficacy|1
909266|NCT00786422|1885822|FG000|Rivaroxaban Treatment|Physician Decision|1
909267|NCT00786422|1885822|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1
909268|NCT00786422|1885822|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
909269|NCT00786422|1885822|FG000|Rivaroxaban Treatment|Adverse Event|2
909270|NCT00786422|1885822|FG000|Follow-up Period|Death|1
909271|NCT00786422|1885822|FG000|Follow-up Period|End-of-study done up to 4 days early|2
909272|NCT00786474|1885830|FG000|Overall Study|Death|5
909273|NCT00786474|1885831|FG001|Overall Study|Death|4
909274|NCT00786474|1885830|FG000|Overall Study|Withdrawal by Subject|23
909275|NCT00786474|1885831|FG001|Overall Study|Withdrawal by Subject|31
909276|NCT00786474|1885830|FG000|Overall Study|Lost to Follow-up|3
909277|NCT00786474|1885831|FG001|Overall Study|Lost to Follow-up|3
909278|NCT00786474|1885830|FG000|Overall Study|Physician Decision|2
909279|NCT00786474|1885831|FG001|Overall Study|Physician Decision|1
909280|NCT00786474|1885830|FG000|Overall Study|Other|4
909281|NCT00786474|1885831|FG001|Overall Study|Other|4
909282|NCT00786565|1885854|FG000|Enrollment Prior to Surgery|Site Closed|3
909283|NCT00786565|1885854|FG000|Enrollment Prior to Surgery|Protocol Violation|3
909284|NCT00786565|1885854|FG000|Post Surgery|Abnormal macular pucker|1
909285|NCT00786565|1885854|FG000|Post Surgery|Adapt AO implanted posterior side up|1
909286|NCT00786799|1885871|FG000|Overall Study|Lost to Follow-up|1
909287|NCT00786799|1885872|FG001|Overall Study|Lost to Follow-up|1
909288|NCT00786838|1885892|FG000|Overall Study|Physician Decision|4
909289|NCT00786838|1885892|FG000|Overall Study|Death|4
909290|NCT00786838|1885892|FG000|Overall Study|Adverse Event|6
909291|NCT00786838|1885892|FG000|Overall Study|Progressive disease|31
909292|NCT00786838|1885892|FG000|Overall Study|Withdrawal by Subject|4
909293|NCT00786864|1885903|FG000|Overall Study|Lost to Follow-up|0
909294|NCT00786864|1885904|FG001|Overall Study|Lost to Follow-up|1
909295|NCT00786864|1885903|FG000|Overall Study|Sustained serious back injury|1
909296|NCT00786864|1885904|FG001|Overall Study|Sustained serious back injury|0
909297|NCT00787137|1885951|FG000|Overall Study|Study Termination|0
909298|NCT00787137|1885952|FG001|Overall Study|Study Termination|0
909299|NCT00787137|1885953|FG002|Overall Study|Study Termination|1
909300|NCT00787150|1885964|FG000|Overall Study|Adverse Event|4
909301|NCT00787150|1885965|FG001|Overall Study|Adverse Event|4
909302|NCT00787150|1885966|FG002|Overall Study|Adverse Event|4
909303|NCT00787150|1885964|FG000|Overall Study|Physician Decision|1
909304|NCT00787150|1885965|FG001|Overall Study|Physician Decision|2
909305|NCT00787150|1885966|FG002|Overall Study|Physician Decision|1
909306|NCT00787150|1885964|FG000|Overall Study|Withdrawal by Subject|2
909307|NCT00787150|1885965|FG001|Overall Study|Withdrawal by Subject|1
909308|NCT00787150|1885966|FG002|Overall Study|Withdrawal by Subject|0
909309|NCT00787150|1885964|FG000|Overall Study|Dosing incorrect study durg|2
909310|NCT00787150|1885965|FG001|Overall Study|Dosing incorrect study durg|0
909311|NCT00787150|1885966|FG002|Overall Study|Dosing incorrect study durg|0
909312|NCT00787189|1885978|FG000|Overall Study|Lost to Follow-up|2
909313|NCT00787189|1885979|FG001|Overall Study|Lost to Follow-up|2
909314|NCT00787202|1885990|FG000|Overall Study|Adverse Event|3
909315|NCT00787202|1885991|FG001|Overall Study|Adverse Event|2
909316|NCT00787202|1885992|FG002|Overall Study|Adverse Event|0
909317|NCT00787202|1885993|FG003|Overall Study|Adverse Event|0
909318|NCT00787202|1885994|FG004|Overall Study|Adverse Event|2
909319|NCT00787202|1885990|FG000|Overall Study|Lack of Efficacy|5
909320|NCT00787202|1885991|FG001|Overall Study|Lack of Efficacy|6
909321|NCT00787202|1885992|FG002|Overall Study|Lack of Efficacy|5
1072011|NCT02038920|2125727|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
1072012|NCT02038920|2125728|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
1072013|NCT02038920|2125729|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
1072014|NCT02038920|2125730|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
1072015|NCT02038920|2125731|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
1072016|NCT02038920|2125732|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
1072017|NCT02038920|2125727|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
1072018|NCT02038920|2125728|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
1072019|NCT02038920|2125729|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
1072020|NCT02038920|2125730|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
909322|NCT00787202|1885993|FG003|Overall Study|Lack of Efficacy|2
909323|NCT00787202|1885994|FG004|Overall Study|Lack of Efficacy|1
909324|NCT00787202|1885990|FG000|Overall Study|Lost to Follow-up|1
909325|NCT00787202|1885991|FG001|Overall Study|Lost to Follow-up|0
909326|NCT00787202|1885992|FG002|Overall Study|Lost to Follow-up|0
909327|NCT00787202|1885993|FG003|Overall Study|Lost to Follow-up|0
909328|NCT00787202|1885994|FG004|Overall Study|Lost to Follow-up|0
909329|NCT00787202|1885990|FG000|Overall Study|Withdrawal by Subject|2
909330|NCT00787202|1885991|FG001|Overall Study|Withdrawal by Subject|2
909331|NCT00787202|1885992|FG002|Overall Study|Withdrawal by Subject|2
909332|NCT00787202|1885993|FG003|Overall Study|Withdrawal by Subject|0
909333|NCT00787202|1885994|FG004|Overall Study|Withdrawal by Subject|0
909334|NCT00787202|1885990|FG000|Overall Study|Protocol Violation|2
909335|NCT00787202|1885991|FG001|Overall Study|Protocol Violation|1
909336|NCT00787202|1885992|FG002|Overall Study|Protocol Violation|0
909337|NCT00787202|1885993|FG003|Overall Study|Protocol Violation|0
909338|NCT00787202|1885994|FG004|Overall Study|Protocol Violation|1
909339|NCT00787202|1885990|FG000|Overall Study|Randomized, not treated|1
909340|NCT00787202|1885991|FG001|Overall Study|Randomized, not treated|0
909341|NCT00787202|1885992|FG002|Overall Study|Randomized, not treated|0
909342|NCT00787202|1885993|FG003|Overall Study|Randomized, not treated|0
909343|NCT00787202|1885994|FG004|Overall Study|Randomized, not treated|0
909344|NCT00787254|1886025|FG000|Overall Study|Adverse Event|24
909345|NCT00787254|1886026|FG001|Overall Study|Adverse Event|23
909346|NCT00787254|1886025|FG000|Overall Study|Protocol Violation|26
909347|NCT00787254|1886026|FG001|Overall Study|Protocol Violation|23
909348|NCT00787254|1886025|FG000|Overall Study|Withdrawal by Subject|16
909349|NCT00787254|1886026|FG001|Overall Study|Withdrawal by Subject|11
909350|NCT00787254|1886025|FG000|Overall Study|Lack of Efficacy|4
909351|NCT00787254|1886026|FG001|Overall Study|Lack of Efficacy|15
909352|NCT00787254|1886025|FG000|Overall Study|NSAIDs discontinuation|1
909353|NCT00787254|1886026|FG001|Overall Study|NSAIDs discontinuation|2
909354|NCT00787254|1886025|FG000|Overall Study|Institution closed|1
909355|NCT00787254|1886026|FG001|Overall Study|Institution closed|0
909356|NCT00787254|1886025|FG000|Overall Study|Physician Decision|4
909357|NCT00787254|1886026|FG001|Overall Study|Physician Decision|8
909358|NCT00787267|1886032|FG000|Overall Study|Screen failure/Ineligible|10
909359|NCT00787267|1886032|FG000|Overall Study|No Reason Provided|1
909360|NCT00787267|1886032|FG000|Overall Study|Withdrawal by Subject|1
909361|NCT00787319|1886036|FG000|Overall Study|Lost to Follow-up|2
909362|NCT00787319|1886036|FG000|Overall Study|Withdrawal by Subject|15
909363|NCT00787319|1886036|FG000|Overall Study|Adverse Event|3
909364|NCT00787319|1886036|FG000|Overall Study|Objective progression or relapse|30
909365|NCT00787319|1886036|FG000|Overall Study|Lack of Efficacy|1
909366|NCT00787319|1886036|FG000|Overall Study|Budget exhausted/exceeded|1
909367|NCT00787319|1886036|FG000|Overall Study|Unresponsiveness to visit invitation|1
909368|NCT00787319|1886036|FG000|Overall Study|No health insurance reimbursement|2
909369|NCT00787319|1886036|FG000|Overall Study|Stabilized disease findings|3
909370|NCT00787319|1886036|FG000|Overall Study|Inactive disease|5
909371|NCT00787527|1886049|FG000|Overall Study|Toxicity|3
909372|NCT00787566|1886060|FG000|Overall Study|AE related to chemotherapy|0
909373|NCT00787566|1886061|FG001|Overall Study|AE related to chemotherapy|1
909374|NCT00787566|1886062|FG002|Overall Study|AE related to chemotherapy|0
909375|NCT00787605|1886072|FG000|Overall Study|Administrative Problems|3
909376|NCT00787605|1886073|FG001|Overall Study|Administrative Problems|0
909377|NCT00787605|1886072|FG000|Overall Study|Adverse Event|14
909378|NCT00787605|1886073|FG001|Overall Study|Adverse Event|25
909379|NCT00787605|1886072|FG000|Overall Study|Lost to Follow-up|3
909380|NCT00787605|1886073|FG001|Overall Study|Lost to Follow-up|6
909381|NCT00787605|1886072|FG000|Overall Study|Protocol Violation|7
909382|NCT00787605|1886073|FG001|Overall Study|Protocol Violation|3
909383|NCT00787605|1886072|FG000|Overall Study|Withdrawal by Subject|6
909384|NCT00787605|1886073|FG001|Overall Study|Withdrawal by Subject|13
909385|NCT00787605|1886072|FG000|Overall Study|Lack of Efficacy|13
909386|NCT00787605|1886073|FG001|Overall Study|Lack of Efficacy|9
909387|NCT00787644|1886081|FG000|Overall Study|Lost to Follow-up|1
909388|NCT00787644|1886082|FG001|Overall Study|Lost to Follow-up|1
909389|NCT00787644|1886081|FG000|Overall Study|Withdrawal by Subject|1
909390|NCT00787644|1886082|FG001|Overall Study|Withdrawal by Subject|1
909391|NCT00787787|1886099|FG000|Overall Study|Lack of Efficacy|4
909392|NCT00787787|1886099|FG000|Overall Study|Adverse Event|3
1072021|NCT02038920|2125731|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
1072022|NCT02038920|2125732|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
1072023|NCT02038920|2125727|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
1072024|NCT02038920|2125728|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
1072025|NCT02038920|2125729|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
1072026|NCT02038920|2125730|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
1072027|NCT02038920|2125731|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
1072028|NCT02038920|2125732|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
1072029|NCT02038920|2125727|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0
1072030|NCT02038920|2125728|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0
1072031|NCT02038920|2125729|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0
909393|NCT00787800|1886105|FG000|Overall Study|Withdrawal by Subject|3
909394|NCT00787800|1886106|FG001|Overall Study|Withdrawal by Subject|5
909395|NCT00787800|1886105|FG000|Overall Study|Death|0
909396|NCT00787800|1886106|FG001|Overall Study|Death|2
909397|NCT00787839|1886113|FG000|Overall Study|Failure to have the OGTT was most common|404
909398|NCT00787891|1886145|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1
909399|NCT00787891|1886146|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2
909400|NCT00787891|1886145|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
909401|NCT00787891|1886146|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
909402|NCT00787891|1886145|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
909403|NCT00787891|1886146|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
909404|NCT00787891|1886145|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1
909405|NCT00787891|1886146|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0
909406|NCT00787891|1886145|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
909407|NCT00787891|1886146|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
909408|NCT00787891|1886145|FG000|Short-term Double-blind Phase (Part 1)|Other|0
909409|NCT00787891|1886146|FG001|Short-term Double-blind Phase (Part 1)|Other|2
909410|NCT00787891|1886145|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
909411|NCT00787891|1886146|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
909412|NCT00787891|1886145|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
909413|NCT00787891|1886146|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
909414|NCT00787891|1886145|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
909415|NCT00787891|1886146|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
909416|NCT00787891|1886145|FG000|Maintenance Double-blind Phase (Part 2)|Other|5
909417|NCT00787891|1886146|FG001|Maintenance Double-blind Phase (Part 2)|Other|2
909418|NCT00787930|1886163|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
909419|NCT00788073|1886192|FG000|STX209 Then Placebo|Adverse Event|1
909420|NCT00788073|1886193|FG001|STX209 Then Placebo|Adverse Event|0
909421|NCT00788073|1886192|FG000|STX209 Then Placebo|Lost to Follow-up|0
909422|NCT00788073|1886193|FG001|STX209 Then Placebo|Lost to Follow-up|1
909423|NCT00788073|1886192|FG000|STX209 Then Placebo|Withdrawal by Subject|0
909424|NCT00788073|1886193|FG001|STX209 Then Placebo|Withdrawal by Subject|1
909425|NCT00788073|1886192|FG000|STX209 Then Placebo|unable to return due to travel|0
909426|NCT00788073|1886193|FG001|STX209 Then Placebo|unable to return due to travel|1
909427|NCT00788073|1886192|FG000|Placebo Then STX209|Adverse Event|2
909428|NCT00788073|1886193|FG001|Placebo Then STX209|Adverse Event|0
909429|NCT00788073|1886192|FG000|Placebo Then STX209|Protocol Violation|0
909430|NCT00788073|1886193|FG001|Placebo Then STX209|Protocol Violation|1
909431|NCT00788151|1886201|FG000|Overall Study|Other adverse event|0
909432|NCT00788151|1886202|FG001|Overall Study|Other adverse event|2
909433|NCT00788151|1886201|FG000|Overall Study|Protocol Violation|0
909434|NCT00788151|1886202|FG001|Overall Study|Protocol Violation|1
909435|NCT00788151|1886201|FG000|Overall Study|Withdrawal by Subject|13
909436|NCT00788151|1886202|FG001|Overall Study|Withdrawal by Subject|6
909437|NCT00788151|1886201|FG000|Overall Study|Enrolled but not treated|1
909438|NCT00788151|1886202|FG001|Overall Study|Enrolled but not treated|1
909439|NCT00788372|1886215|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18
909440|NCT00788372|1886215|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
909441|NCT00788372|1886215|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
909442|NCT00788372|1886215|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13
909443|NCT00788372|1886215|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9
909444|NCT00788372|1886215|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
909445|NCT00788372|1886215|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
909446|NCT00788593|1886219|FG000|Placebo Run-in Phase|Adverse Event|2
909447|NCT00788593|1886220|FG001|Placebo Run-in Phase|Adverse Event|0
909448|NCT00788593|1886221|FG002|Placebo Run-in Phase|Adverse Event|0
909449|NCT00788593|1886219|FG000|Placebo Run-in Phase|Withdrawal by Subject|2
909450|NCT00788593|1886220|FG001|Placebo Run-in Phase|Withdrawal by Subject|0
909451|NCT00788593|1886221|FG002|Placebo Run-in Phase|Withdrawal by Subject|0
909452|NCT00788593|1886219|FG000|Placebo Run-in Phase|Protocol Violation|2
909453|NCT00788593|1886220|FG001|Placebo Run-in Phase|Protocol Violation|0
909454|NCT00788593|1886221|FG002|Placebo Run-in Phase|Protocol Violation|0
909455|NCT00788593|1886219|FG000|First Intervention Period|Adverse Event|0
909456|NCT00788593|1886220|FG001|First Intervention Period|Adverse Event|1
1072032|NCT02038920|2125730|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0
1072033|NCT02038920|2125731|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0
1072034|NCT02038920|2125732|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1
1072035|NCT02038920|2125727|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
1072036|NCT02038920|2125728|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
1072037|NCT02038920|2125729|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
1072038|NCT02038920|2125730|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
1072039|NCT02038920|2125731|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
1072040|NCT02038920|2125732|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
1072041|NCT02038920|2125727|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
1072042|NCT02038920|2125728|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
1072043|NCT02038920|2125729|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
1072044|NCT02038920|2125730|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
1072045|NCT02038920|2125731|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
1072046|NCT02038920|2125732|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
1072047|NCT02038933|2125751|FG000|Overall Study|Disease progression|104
1072048|NCT02038933|2125751|FG000|Overall Study|Study drug toxicity|6
1072049|NCT02038933|2125751|FG000|Overall Study|Adverse event unrelated to study drug|6
1072050|NCT02038933|2125751|FG000|Overall Study|Participant request to discontinue treatment|2
1072051|NCT02038933|2125751|FG000|Overall Study|Lost to Follow-up|1
1072052|NCT02038933|2125751|FG000|Overall Study|Other reasons|2
1072057|NCT02038959|2125762|FG000|Overall Study|Withdrawal by Subject|6
1072058|NCT02038959|2125763|FG001|Overall Study|Withdrawal by Subject|8
1072059|NCT02039219|2125780|FG000|Treatment|Withdrawal by Subject|1
1072060|NCT02039219|2125781|FG001|Treatment|Withdrawal by Subject|0
1072061|NCT02039219|2125780|FG000|Treatment|Adverse Event|0
1072062|NCT02039219|2125781|FG001|Treatment|Adverse Event|1
1072063|NCT02039219|2125780|FG000|Treatment|Physician Decision|1
1072064|NCT02039219|2125781|FG001|Treatment|Physician Decision|0
1072065|NCT02039219|2125780|FG000|Treatment|Lost to Follow-up|0
1072066|NCT02039219|2125781|FG001|Treatment|Lost to Follow-up|1
1072067|NCT02039219|2125780|FG000|Treatment|Protocol Violation|1
1072068|NCT02039219|2125781|FG001|Treatment|Protocol Violation|0
1072069|NCT02039219|2125780|FG000|Treatment|Death|1
1072070|NCT02039219|2125781|FG001|Treatment|Death|0
1072071|NCT02039219|2125780|FG000|Follow up|Adverse Event|0
1072072|NCT02039219|2125781|FG001|Follow up|Adverse Event|1
1072073|NCT02039375|2125787|FG000|Overall Study|Lost to Follow-up|2
1072074|NCT02039414|2125793|FG000|Overall Study|Delivered|1
1072075|NCT02039414|2125794|FG001|Overall Study|Delivered|1
1072076|NCT02039414|2125793|FG000|Overall Study|Lost to Follow-up|2
1072077|NCT02039414|2125794|FG001|Overall Study|Lost to Follow-up|0
1072078|NCT02039414|2125793|FG000|Overall Study|Protocol Violation|3
1072079|NCT02039414|2125794|FG001|Overall Study|Protocol Violation|1
1072080|NCT02039427|2125804|FG000|Overall Study|Duration of surgery > 3h|1
1072081|NCT02039427|2125805|FG001|Overall Study|Duration of surgery > 3h|1
1072082|NCT02039427|2125806|FG002|Overall Study|Duration of surgery > 3h|0
1072083|NCT02039427|2125807|FG003|Overall Study|Duration of surgery > 3h|0
1072084|NCT02039427|2125804|FG000|Overall Study|Withdrawal on concent|0
1072085|NCT02039427|2125805|FG001|Overall Study|Withdrawal on concent|0
1072086|NCT02039427|2125806|FG002|Overall Study|Withdrawal on concent|0
1072087|NCT02039427|2125807|FG003|Overall Study|Withdrawal on concent|1
1072088|NCT02039427|2125804|FG000|Overall Study|Cancellation of surgery|0
1072089|NCT02039427|2125805|FG001|Overall Study|Cancellation of surgery|0
1072090|NCT02039427|2125806|FG002|Overall Study|Cancellation of surgery|1
1072091|NCT02039427|2125807|FG003|Overall Study|Cancellation of surgery|0
1072092|NCT02039427|2125804|FG000|Overall Study|Loss of follow - up|1
1072093|NCT02039427|2125805|FG001|Overall Study|Loss of follow - up|0
1072094|NCT02039427|2125806|FG002|Overall Study|Loss of follow - up|2
1072095|NCT02039427|2125807|FG003|Overall Study|Loss of follow - up|4
1072096|NCT02039427|2125804|FG000|Overall Study|Steroid Use|1
1072097|NCT02039427|2125805|FG001|Overall Study|Steroid Use|0
1072098|NCT02039427|2125806|FG002|Overall Study|Steroid Use|0
1072099|NCT02039427|2125807|FG003|Overall Study|Steroid Use|0
1072100|NCT02039505|2125824|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
1072101|NCT02039505|2125825|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
1072102|NCT02039505|2125826|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
1072103|NCT02039505|2125827|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
1072104|NCT02039505|2125828|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
1072105|NCT02039505|2125829|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
1072106|NCT02039505|2125830|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
1072107|NCT02039505|2125824|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
1072108|NCT02039505|2125825|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
1072109|NCT02039505|2125826|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
1072110|NCT02039505|2125827|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
1072111|NCT02039505|2125828|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
1072112|NCT02039505|2125829|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
1072113|NCT02039505|2125830|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
1072114|NCT02039505|2125824|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
1072115|NCT02039505|2125825|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1072116|NCT02039505|2125826|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1072117|NCT02039505|2125827|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1072118|NCT02039505|2125828|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1072119|NCT02039505|2125829|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1072120|NCT02039505|2125830|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1072121|NCT02039505|2125824|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
1072122|NCT02039505|2125825|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
1072123|NCT02039505|2125826|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
1072124|NCT02039505|2125827|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
1072125|NCT02039505|2125828|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
1072126|NCT02039505|2125829|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
1072127|NCT02039505|2125830|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
1072128|NCT02039505|2125824|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
1072129|NCT02039505|2125825|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
1072130|NCT02039505|2125826|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
1072131|NCT02039505|2125827|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
1072132|NCT02039505|2125828|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
1072133|NCT02039505|2125829|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
1072134|NCT02039505|2125830|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
1072135|NCT02039505|2125824|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
1072136|NCT02039505|2125825|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
1072137|NCT02039505|2125826|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
1072138|NCT02039505|2125827|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
1072139|NCT02039505|2125828|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
1072140|NCT02039505|2125829|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
1072141|NCT02039505|2125830|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
1072142|NCT02039505|2125824|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1072143|NCT02039505|2125825|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1072144|NCT02039505|2125826|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1072145|NCT02039505|2125827|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
1072146|NCT02039505|2125828|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1072147|NCT02039505|2125829|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1072148|NCT02039505|2125830|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1072149|NCT02039505|2125824|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1072150|NCT02039505|2125825|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1072151|NCT02039505|2125826|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1072152|NCT02039505|2125827|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1072153|NCT02039505|2125828|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1072154|NCT02039505|2125829|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1072155|NCT02039505|2125830|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
1072156|NCT02039505|2125824|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1072157|NCT02039505|2125825|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1072158|NCT02039505|2125826|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1072159|NCT02039505|2125827|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1072160|NCT02039505|2125828|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1072161|NCT02039505|2125829|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1072162|NCT02039505|2125830|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
1072163|NCT02039505|2125824|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1072164|NCT02039505|2125825|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1072165|NCT02039505|2125826|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1072166|NCT02039505|2125827|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1072167|NCT02039505|2125828|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1072168|NCT02039505|2125829|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1072169|NCT02039505|2125830|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
1072170|NCT02039505|2125824|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1072171|NCT02039505|2125825|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1072172|NCT02039505|2125826|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1072173|NCT02039505|2125827|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1072174|NCT02039505|2125828|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1162046|NCT03381248|2283986|FG001|Overall Study|Lack of Efficacy|0
1072175|NCT02039505|2125829|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1072176|NCT02039505|2125830|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
1072177|NCT02039674|2125864|FG000|Overall Study|Adverse Event|0
1072178|NCT02039674|2125865|FG001|Overall Study|Adverse Event|0
1072179|NCT02039674|2125866|FG002|Overall Study|Adverse Event|1
1072180|NCT02039674|2125867|FG003|Overall Study|Adverse Event|1
1072181|NCT02039674|2125868|FG004|Overall Study|Adverse Event|0
1072182|NCT02039674|2125869|FG005|Overall Study|Adverse Event|0
1072183|NCT02039674|2125870|FG006|Overall Study|Adverse Event|0
1072184|NCT02039674|2125871|FG007|Overall Study|Adverse Event|0
1072185|NCT02039674|2125872|FG008|Overall Study|Adverse Event|2
1072186|NCT02039674|2125873|FG009|Overall Study|Adverse Event|0
1072187|NCT02039674|2125874|FG010|Overall Study|Adverse Event|0
1072188|NCT02039674|2125875|FG011|Overall Study|Adverse Event|2
1072189|NCT02039674|2125876|FG012|Overall Study|Adverse Event|2
1072190|NCT02039674|2125877|FG013|Overall Study|Adverse Event|1
1072191|NCT02039674|2125864|FG000|Overall Study|Death|0
1072192|NCT02039674|2125865|FG001|Overall Study|Death|0
1072193|NCT02039674|2125866|FG002|Overall Study|Death|1
1072194|NCT02039674|2125867|FG003|Overall Study|Death|2
1072195|NCT02039674|2125868|FG004|Overall Study|Death|0
1072196|NCT02039674|2125869|FG005|Overall Study|Death|0
1072197|NCT02039674|2125870|FG006|Overall Study|Death|0
1072198|NCT02039674|2125871|FG007|Overall Study|Death|0
1072199|NCT02039674|2125872|FG008|Overall Study|Death|0
1072200|NCT02039674|2125873|FG009|Overall Study|Death|0
1072201|NCT02039674|2125874|FG010|Overall Study|Death|1
1072202|NCT02039674|2125875|FG011|Overall Study|Death|1
1072203|NCT02039674|2125876|FG012|Overall Study|Death|0
1072204|NCT02039674|2125877|FG013|Overall Study|Death|8
1072205|NCT02039674|2125864|FG000|Overall Study|Excluded Medication|1
1072206|NCT02039674|2125865|FG001|Overall Study|Excluded Medication|1
1072207|NCT02039674|2125866|FG002|Overall Study|Excluded Medication|0
1072208|NCT02039674|2125867|FG003|Overall Study|Excluded Medication|1
1072209|NCT02039674|2125868|FG004|Overall Study|Excluded Medication|0
1072210|NCT02039674|2125869|FG005|Overall Study|Excluded Medication|1
1072211|NCT02039674|2125870|FG006|Overall Study|Excluded Medication|0
1072212|NCT02039674|2125871|FG007|Overall Study|Excluded Medication|0
1072213|NCT02039674|2125872|FG008|Overall Study|Excluded Medication|2
1072214|NCT02039674|2125873|FG009|Overall Study|Excluded Medication|2
1072215|NCT02039674|2125874|FG010|Overall Study|Excluded Medication|4
1072216|NCT02039674|2125875|FG011|Overall Study|Excluded Medication|2
1072217|NCT02039674|2125876|FG012|Overall Study|Excluded Medication|4
1072218|NCT02039674|2125877|FG013|Overall Study|Excluded Medication|3
1072219|NCT02039674|2125864|FG000|Overall Study|Lost to Follow-up|0
1072220|NCT02039674|2125865|FG001|Overall Study|Lost to Follow-up|0
1072221|NCT02039674|2125866|FG002|Overall Study|Lost to Follow-up|0
1072222|NCT02039674|2125867|FG003|Overall Study|Lost to Follow-up|0
1072223|NCT02039674|2125868|FG004|Overall Study|Lost to Follow-up|0
1072224|NCT02039674|2125869|FG005|Overall Study|Lost to Follow-up|0
1072225|NCT02039674|2125870|FG006|Overall Study|Lost to Follow-up|0
1072226|NCT02039674|2125871|FG007|Overall Study|Lost to Follow-up|0
1072227|NCT02039674|2125872|FG008|Overall Study|Lost to Follow-up|0
1072228|NCT02039674|2125873|FG009|Overall Study|Lost to Follow-up|0
1072229|NCT02039674|2125874|FG010|Overall Study|Lost to Follow-up|0
1072230|NCT02039674|2125875|FG011|Overall Study|Lost to Follow-up|0
1072231|NCT02039674|2125876|FG012|Overall Study|Lost to Follow-up|1
1072232|NCT02039674|2125877|FG013|Overall Study|Lost to Follow-up|0
1072233|NCT02039674|2125864|FG000|Overall Study|Physician Decision|0
1072234|NCT02039674|2125865|FG001|Overall Study|Physician Decision|0
1072235|NCT02039674|2125866|FG002|Overall Study|Physician Decision|0
1072236|NCT02039674|2125867|FG003|Overall Study|Physician Decision|0
1072237|NCT02039674|2125868|FG004|Overall Study|Physician Decision|0
1072238|NCT02039674|2125869|FG005|Overall Study|Physician Decision|0
1072239|NCT02039674|2125870|FG006|Overall Study|Physician Decision|0
1072240|NCT02039674|2125871|FG007|Overall Study|Physician Decision|0
1072241|NCT02039674|2125872|FG008|Overall Study|Physician Decision|0
1072242|NCT02039674|2125873|FG009|Overall Study|Physician Decision|0
1072243|NCT02039674|2125874|FG010|Overall Study|Physician Decision|0
1072244|NCT02039674|2125875|FG011|Overall Study|Physician Decision|1
1072245|NCT02039674|2125876|FG012|Overall Study|Physician Decision|0
1072246|NCT02039674|2125877|FG013|Overall Study|Physician Decision|0
1072247|NCT02039674|2125864|FG000|Overall Study|Progressive Disease|6
1072248|NCT02039674|2125865|FG001|Overall Study|Progressive Disease|7
1072249|NCT02039674|2125866|FG002|Overall Study|Progressive Disease|6
1072250|NCT02039674|2125867|FG003|Overall Study|Progressive Disease|7
1072251|NCT02039674|2125868|FG004|Overall Study|Progressive Disease|8
1072252|NCT02039674|2125869|FG005|Overall Study|Progressive Disease|10
1072253|NCT02039674|2125870|FG006|Overall Study|Progressive Disease|1
1072254|NCT02039674|2125871|FG007|Overall Study|Progressive Disease|3
1072255|NCT02039674|2125872|FG008|Overall Study|Progressive Disease|7
1072256|NCT02039674|2125873|FG009|Overall Study|Progressive Disease|2
1072257|NCT02039674|2125874|FG010|Overall Study|Progressive Disease|0
1072258|NCT02039674|2125875|FG011|Overall Study|Progressive Disease|17
1072259|NCT02039674|2125876|FG012|Overall Study|Progressive Disease|18
1072260|NCT02039674|2125877|FG013|Overall Study|Progressive Disease|16
1072261|NCT02039674|2125864|FG000|Overall Study|Withdrawal by Subject|0
1072262|NCT02039674|2125865|FG001|Overall Study|Withdrawal by Subject|2
1072263|NCT02039674|2125866|FG002|Overall Study|Withdrawal by Subject|1
1072264|NCT02039674|2125867|FG003|Overall Study|Withdrawal by Subject|0
1072265|NCT02039674|2125868|FG004|Overall Study|Withdrawal by Subject|1
1072266|NCT02039674|2125869|FG005|Overall Study|Withdrawal by Subject|0
1072267|NCT02039674|2125870|FG006|Overall Study|Withdrawal by Subject|0
1072268|NCT02039674|2125871|FG007|Overall Study|Withdrawal by Subject|0
1072269|NCT02039674|2125872|FG008|Overall Study|Withdrawal by Subject|0
1072270|NCT02039674|2125873|FG009|Overall Study|Withdrawal by Subject|2
1072271|NCT02039674|2125874|FG010|Overall Study|Withdrawal by Subject|1
1072272|NCT02039674|2125875|FG011|Overall Study|Withdrawal by Subject|3
1072273|NCT02039674|2125876|FG012|Overall Study|Withdrawal by Subject|5
1072274|NCT02039674|2125877|FG013|Overall Study|Withdrawal by Subject|2
1072275|NCT02039674|2125864|FG000|Overall Study|Ongoing in Study|5
1072276|NCT02039674|2125865|FG001|Overall Study|Ongoing in Study|2
1072277|NCT02039674|2125866|FG002|Overall Study|Ongoing in Study|3
1072278|NCT02039674|2125867|FG003|Overall Study|Ongoing in Study|2
1072279|NCT02039674|2125868|FG004|Overall Study|Ongoing in Study|3
1072280|NCT02039674|2125869|FG005|Overall Study|Ongoing in Study|1
1072281|NCT02039674|2125870|FG006|Overall Study|Ongoing in Study|2
1072282|NCT02039674|2125871|FG007|Overall Study|Ongoing in Study|0
1072283|NCT02039674|2125872|FG008|Overall Study|Ongoing in Study|1
1072284|NCT02039674|2125873|FG009|Overall Study|Ongoing in Study|6
1072285|NCT02039674|2125874|FG010|Overall Study|Ongoing in Study|1
1072286|NCT02039674|2125875|FG011|Overall Study|Ongoing in Study|34
1072287|NCT02039674|2125876|FG012|Overall Study|Ongoing in Study|33
1072288|NCT02039674|2125877|FG013|Overall Study|Ongoing in Study|3
1072289|NCT02039687|2125914|FG000|Overall Study|Adverse Event|0
1072290|NCT02039687|2125915|FG001|Overall Study|Adverse Event|0
1072291|NCT02039687|2125916|FG002|Overall Study|Adverse Event|1
1072292|NCT02039687|2125917|FG003|Overall Study|Adverse Event|0
1072293|NCT02039687|2125914|FG000|Overall Study|Withdrawal by Subject|0
1072294|NCT02039687|2125915|FG001|Overall Study|Withdrawal by Subject|1
1072295|NCT02039687|2125916|FG002|Overall Study|Withdrawal by Subject|0
1072296|NCT02039687|2125917|FG003|Overall Study|Withdrawal by Subject|0
1072297|NCT02039687|2125914|FG000|Overall Study|treatment assignment could not be confir|0
1072298|NCT02039687|2125915|FG001|Overall Study|treatment assignment could not be confir|0
1072299|NCT02039687|2125916|FG002|Overall Study|treatment assignment could not be confir|2
1072300|NCT02039687|2125917|FG003|Overall Study|treatment assignment could not be confir|0
1072301|NCT02039778|2125936|FG000|Overall Study|Death|2
1072302|NCT02039778|2125936|FG000|Overall Study|Withdrawal by Subject|1
1072303|NCT02039778|2125936|FG000|Overall Study|Never started the protocol treatment|1
1072304|NCT02039856|2125950|FG000|Overall Study|Death|5
1072305|NCT02039856|2125951|FG001|Overall Study|Death|3
1072306|NCT02039856|2125950|FG000|Overall Study|Partial survey completion|61
1072307|NCT02039856|2125951|FG001|Overall Study|Partial survey completion|26
1072308|NCT02039856|2125950|FG000|Overall Study|Lost to Follow-up|388
1072309|NCT02039856|2125951|FG001|Overall Study|Lost to Follow-up|206
1072310|NCT02039856|2125950|FG000|Overall Study|Withdrawal by Subject|1573
1072311|NCT02039856|2125951|FG001|Overall Study|Withdrawal by Subject|618
1072312|NCT02039908|2125959|FG000|Phase 1-Summer|Withdrawal by Subject|7
1072313|NCT02039908|2125960|FG001|Phase 1-Summer|Withdrawal by Subject|6
1072314|NCT02039908|2125961|FG002|Phase 1-Summer|Withdrawal by Subject|0
1072315|NCT02039908|2125962|FG003|Phase 1-Summer|Withdrawal by Subject|0
1072316|NCT02039908|2125959|FG000|Phase 1-Summer|Protocol Violation|6
1072317|NCT02039908|2125960|FG001|Phase 1-Summer|Protocol Violation|0
1072318|NCT02039908|2125961|FG002|Phase 1-Summer|Protocol Violation|0
1072319|NCT02039908|2125962|FG003|Phase 1-Summer|Protocol Violation|0
1072320|NCT02039908|2125959|FG000|Phase 2-School Year|Lost to Follow-up|0
1072321|NCT02039908|2125960|FG001|Phase 2-School Year|Lost to Follow-up|0
1072322|NCT02039908|2125961|FG002|Phase 2-School Year|Lost to Follow-up|1
1072323|NCT02039908|2125962|FG003|Phase 2-School Year|Lost to Follow-up|3
1072324|NCT02039908|2125959|FG000|Phase 2-School Year|Protocol Violation|0
1072325|NCT02039908|2125960|FG001|Phase 2-School Year|Protocol Violation|0
1072326|NCT02039908|2125961|FG002|Phase 2-School Year|Protocol Violation|3
1072327|NCT02039908|2125962|FG003|Phase 2-School Year|Protocol Violation|0
1072328|NCT02039908|2125959|FG000|Phase 2-School Year|Withdrawal by Subject|0
1072329|NCT02039908|2125960|FG001|Phase 2-School Year|Withdrawal by Subject|0
1072330|NCT02039908|2125961|FG002|Phase 2-School Year|Withdrawal by Subject|8
1072331|NCT02039908|2125962|FG003|Phase 2-School Year|Withdrawal by Subject|5
1072332|NCT02040090|2126007|FG000|Overall Study|Adverse Event|2
1072333|NCT02040090|2126008|FG001|Overall Study|Adverse Event|0
1072334|NCT02040090|2126007|FG000|Overall Study|Physician Decision|1
1072335|NCT02040090|2126008|FG001|Overall Study|Physician Decision|0
1072336|NCT02040090|2126007|FG000|Overall Study|Withdrawal by Subject|0
1072337|NCT02040090|2126008|FG001|Overall Study|Withdrawal by Subject|1
1072338|NCT02040090|2126007|FG000|Overall Study|Lost to Follow-up|0
1072339|NCT02040090|2126008|FG001|Overall Study|Lost to Follow-up|1
1072340|NCT02040259|2126022|FG000|Overall Study|Death|280
1072341|NCT02040259|2126022|FG000|Overall Study|Lost to Follow-up|76
1072342|NCT02040259|2126022|FG000|Overall Study|Assessment not completed|3
1072343|NCT02040259|2126022|FG000|Overall Study|Withdrawal by Subject|4
1072344|NCT02040428|2126045|FG000|Overall Study|Death|4
1072345|NCT02040428|2126046|FG001|Overall Study|Death|3
1072346|NCT02040428|2126045|FG000|Overall Study|Withdrawal by Subject|1
1072347|NCT02040428|2126046|FG001|Overall Study|Withdrawal by Subject|1
1072348|NCT02040532|2126052|FG000|Overall Study|Lost to Follow-up|1
1072349|NCT02040532|2126052|FG000|Overall Study|Physician Decision|4
1072350|NCT02040532|2126052|FG000|Overall Study|Adverse Event|4
1072351|NCT02040532|2126052|FG000|Overall Study|Withdrawal by Subject|3
1072352|NCT02040766|2126093|FG000|Overall Study|Adverse Event|1
1072353|NCT02040766|2126094|FG001|Overall Study|Adverse Event|1
1072354|NCT02040766|2126095|FG002|Overall Study|Adverse Event|1
1072355|NCT02040766|2126096|FG003|Overall Study|Adverse Event|0
1072356|NCT02040766|2126097|FG004|Overall Study|Adverse Event|2
1072357|NCT02040766|2126093|FG000|Overall Study|Withdrawal by Subject|4
1072358|NCT02040766|2126094|FG001|Overall Study|Withdrawal by Subject|3
1072359|NCT02040766|2126095|FG002|Overall Study|Withdrawal by Subject|2
1072360|NCT02040766|2126096|FG003|Overall Study|Withdrawal by Subject|3
1072361|NCT02040766|2126097|FG004|Overall Study|Withdrawal by Subject|2
1072362|NCT02040766|2126093|FG000|Overall Study|Non-compliance|0
1072363|NCT02040766|2126094|FG001|Overall Study|Non-compliance|1
1072364|NCT02040766|2126095|FG002|Overall Study|Non-compliance|0
1072365|NCT02040766|2126096|FG003|Overall Study|Non-compliance|0
1072366|NCT02040766|2126097|FG004|Overall Study|Non-compliance|0
1072367|NCT02040766|2126093|FG000|Overall Study|Protocol Violation|2
1072368|NCT02040766|2126094|FG001|Overall Study|Protocol Violation|1
1072369|NCT02040766|2126095|FG002|Overall Study|Protocol Violation|2
1072370|NCT02040766|2126096|FG003|Overall Study|Protocol Violation|3
1072371|NCT02040766|2126097|FG004|Overall Study|Protocol Violation|0
1072372|NCT02040766|2126093|FG000|Overall Study|Lost to Follow-up|4
1072373|NCT02040766|2126094|FG001|Overall Study|Lost to Follow-up|1
1072374|NCT02040766|2126095|FG002|Overall Study|Lost to Follow-up|3
1072375|NCT02040766|2126096|FG003|Overall Study|Lost to Follow-up|1
1072376|NCT02040766|2126097|FG004|Overall Study|Lost to Follow-up|4
1072377|NCT02040766|2126093|FG000|Overall Study|Not reported|1
1072378|NCT02040766|2126094|FG001|Overall Study|Not reported|0
1072379|NCT02040766|2126095|FG002|Overall Study|Not reported|0
1072380|NCT02040766|2126096|FG003|Overall Study|Not reported|0
1072381|NCT02040766|2126097|FG004|Overall Study|Not reported|0
1072382|NCT02040766|2126093|FG000|Overall Study|Lack of Efficacy|6
1072383|NCT02040766|2126094|FG001|Overall Study|Lack of Efficacy|3
1072384|NCT02040766|2126095|FG002|Overall Study|Lack of Efficacy|4
1072385|NCT02040766|2126096|FG003|Overall Study|Lack of Efficacy|6
1072386|NCT02040766|2126097|FG004|Overall Study|Lack of Efficacy|5
1072387|NCT02040779|2126113|FG000|Overall Study|Adverse Event|1
1072388|NCT02040779|2126114|FG001|Overall Study|Adverse Event|0
1072389|NCT02040779|2126115|FG002|Overall Study|Adverse Event|0
1072390|NCT02040779|2126113|FG000|Overall Study|Withdrawal by Subject|4
1072391|NCT02040779|2126114|FG001|Overall Study|Withdrawal by Subject|1
1072392|NCT02040779|2126115|FG002|Overall Study|Withdrawal by Subject|3
1072393|NCT02040779|2126113|FG000|Overall Study|Non-compliance|0
1072394|NCT02040779|2126114|FG001|Overall Study|Non-compliance|1
1072395|NCT02040779|2126115|FG002|Overall Study|Non-compliance|0
1072396|NCT02040779|2126113|FG000|Overall Study|Protocol Violation|2
1072397|NCT02040779|2126114|FG001|Overall Study|Protocol Violation|1
1072398|NCT02040779|2126115|FG002|Overall Study|Protocol Violation|0
1072399|NCT02040779|2126113|FG000|Overall Study|Lost to Follow-up|1
1072400|NCT02040779|2126114|FG001|Overall Study|Lost to Follow-up|2
1072401|NCT02040779|2126115|FG002|Overall Study|Lost to Follow-up|1
1072402|NCT02040779|2126113|FG000|Overall Study|Lack of Efficacy|4
1072403|NCT02040779|2126114|FG001|Overall Study|Lack of Efficacy|2
1072404|NCT02040779|2126115|FG002|Overall Study|Lack of Efficacy|0
1072405|NCT02040805|2126146|FG000|Overall Study|Lost to Follow-up|14
1072406|NCT02040805|2126147|FG001|Overall Study|Lost to Follow-up|9
1072407|NCT02040805|2126146|FG000|Overall Study|Withdrawal by Subject|28
1072408|NCT02040805|2126147|FG001|Overall Study|Withdrawal by Subject|41
1072409|NCT02040844|2126156|FG000|Overall Study|Adverse Event|0
1072410|NCT02040844|2126157|FG001|Overall Study|Adverse Event|0
1072411|NCT02040844|2126158|FG002|Overall Study|Adverse Event|1
1072412|NCT02040844|2126156|FG000|Overall Study|Withdrawal by Subject|16
1072413|NCT02040844|2126157|FG001|Overall Study|Withdrawal by Subject|22
1072414|NCT02040844|2126158|FG002|Overall Study|Withdrawal by Subject|25
1072415|NCT02040844|2126156|FG000|Overall Study|Lost to Follow-up|12
1072416|NCT02040844|2126157|FG001|Overall Study|Lost to Follow-up|9
1072417|NCT02040844|2126158|FG002|Overall Study|Lost to Follow-up|13
1072418|NCT02040844|2126156|FG000|Overall Study|Missing|13
1072419|NCT02040844|2126157|FG001|Overall Study|Missing|3
1072420|NCT02040844|2126158|FG002|Overall Study|Missing|2
1072421|NCT02040844|2126156|FG000|Overall Study|Non-specified|8
1072422|NCT02040844|2126157|FG001|Overall Study|Non-specified|2
1072423|NCT02040844|2126158|FG002|Overall Study|Non-specified|5
1072424|NCT02040844|2126156|FG000|Overall Study|Concomitant medication|1
1072425|NCT02040844|2126157|FG001|Overall Study|Concomitant medication|3
1072426|NCT02040844|2126158|FG002|Overall Study|Concomitant medication|1
1072427|NCT02040857|2126166|FG000|Overall Study|Adverse Event|14
1072428|NCT02040857|2126166|FG000|Overall Study|Physician Decision|5
1072429|NCT02040857|2126166|FG000|Overall Study|Withdrawal by Subject|31
1072430|NCT02040857|2126166|FG000|Overall Study|patient non-compliance|3
1072431|NCT02040857|2126166|FG000|Overall Study|Lost to Follow-up|2
1072432|NCT02040857|2126166|FG000|Overall Study|recurrence|4
1072433|NCT02040857|2126166|FG000|Overall Study|ineligible|1
1072434|NCT02040870|2126173|FG000|Overall Study|Completed treatment phase|6
1072435|NCT02040870|2126173|FG000|Overall Study|Adverse Event|7
1072436|NCT02040870|2126173|FG000|Overall Study|Progressive disease|58
1072437|NCT02040870|2126173|FG000|Overall Study|Physician Decision|6
1072438|NCT02040870|2126173|FG000|Overall Study|Subject/guardian decision|10
1072439|NCT02040870|2126173|FG000|Overall Study|Lost to Follow-up|3
1072440|NCT02040870|2126173|FG000|Overall Study|Death|13
1072441|NCT02041091|2126179|FG000|Treatment|Adverse Event|3
1072442|NCT02041091|2126180|FG001|Treatment|Adverse Event|3
1072443|NCT02041091|2126179|FG000|Treatment|Withdrawal by Subject|2
1072444|NCT02041091|2126180|FG001|Treatment|Withdrawal by Subject|4
1072445|NCT02041091|2126179|FG000|Treatment|Physician Decision|1
1072446|NCT02041091|2126180|FG001|Treatment|Physician Decision|0
1072447|NCT02041091|2126179|FG000|Treatment|Sponsor Decision|15
1072448|NCT02041091|2126180|FG001|Treatment|Sponsor Decision|16
1072449|NCT02041091|2126179|FG000|Treatment|Lost to Follow-up|1
1072450|NCT02041091|2126180|FG001|Treatment|Lost to Follow-up|0
1072451|NCT02041091|2126179|FG000|Optional Safety Extension Period|Adverse Event|4
1072452|NCT02041091|2126180|FG001|Optional Safety Extension Period|Adverse Event|2
1072453|NCT02041091|2126179|FG000|Optional Safety Extension Period|Withdrawal by Subject|5
1072454|NCT02041091|2126180|FG001|Optional Safety Extension Period|Withdrawal by Subject|2
1072455|NCT02041091|2126179|FG000|Optional Safety Extension Period|Protocol Violation|2
1072456|NCT02041091|2126180|FG001|Optional Safety Extension Period|Protocol Violation|0
1072457|NCT02041091|2126179|FG000|Optional Safety Extension Period|Physician Decision|2
1072458|NCT02041091|2126180|FG001|Optional Safety Extension Period|Physician Decision|1
1072459|NCT02041091|2126179|FG000|Optional Safety Extension Period|Sponsor Decision|70
1072460|NCT02041091|2126180|FG001|Optional Safety Extension Period|Sponsor Decision|74
1072461|NCT02041091|2126179|FG000|Optional Safety Extension Period|Lost to Follow-up|2
1072462|NCT02041091|2126180|FG001|Optional Safety Extension Period|Lost to Follow-up|3
1072463|NCT02041104|2126194|FG000|Overall Study|Lost to Follow-up|1
1072464|NCT02041104|2126195|FG001|Overall Study|Lost to Follow-up|4
1072465|NCT02041104|2126194|FG000|Overall Study|discomfort during OGTT|0
1072466|NCT02041104|2126195|FG001|Overall Study|discomfort during OGTT|3
1072467|NCT02041286|2126228|FG000|Overall Study|Adverse Event|1
1072468|NCT02041299|2126236|FG000|Overall Study|Adverse Event|9
1072469|NCT02041299|2126237|FG001|Overall Study|Adverse Event|3
1072470|NCT02041299|2126236|FG000|Overall Study|Lost to Follow-up|4
1072471|NCT02041299|2126237|FG001|Overall Study|Lost to Follow-up|1
1072472|NCT02041299|2126236|FG000|Overall Study|Physician Decision|1
1072473|NCT02041299|2126237|FG001|Overall Study|Physician Decision|1
1072474|NCT02041299|2126236|FG000|Overall Study|Withdrawal by Subject|13
1072475|NCT02041299|2126237|FG001|Overall Study|Withdrawal by Subject|7
1072476|NCT02041299|2126236|FG000|Overall Study|Protocol Violation|11
1072477|NCT02041299|2126237|FG001|Overall Study|Protocol Violation|4
1072478|NCT02041299|2126236|FG000|Overall Study|Termination of the study|7
1072479|NCT02041299|2126237|FG001|Overall Study|Termination of the study|3
1072480|NCT02041299|2126236|FG000|Overall Study|Required bone marrow transplant|0
1072481|NCT02041299|2126237|FG001|Overall Study|Required bone marrow transplant|1
1072482|NCT02041299|2126236|FG000|Overall Study|Patient stopped dosing on unknown date|1
1072483|NCT02041299|2126237|FG001|Overall Study|Patient stopped dosing on unknown date|0
1072484|NCT02041429|2126268|FG000|Overall Study|Progressive Disease|2
1072485|NCT02041429|2126269|FG001|Overall Study|Progressive Disease|2
1072486|NCT02041429|2126270|FG002|Overall Study|Progressive Disease|3
1072487|NCT02041429|2126271|FG003|Overall Study|Progressive Disease|2
1072488|NCT02041429|2126268|FG000|Overall Study|Toxicity|0
1072489|NCT02041429|2126269|FG001|Overall Study|Toxicity|1
1072490|NCT02041429|2126270|FG002|Overall Study|Toxicity|4
1072491|NCT02041429|2126271|FG003|Overall Study|Toxicity|2
1072492|NCT02041429|2126268|FG000|Overall Study|Withdrawal by Subject|0
1072493|NCT02041429|2126269|FG001|Overall Study|Withdrawal by Subject|1
1072494|NCT02041429|2126270|FG002|Overall Study|Withdrawal by Subject|0
1072495|NCT02041429|2126271|FG003|Overall Study|Withdrawal by Subject|0
1072496|NCT02041429|2126268|FG000|Overall Study|On Maintenance Therapy|1
1072497|NCT02041429|2126269|FG001|Overall Study|On Maintenance Therapy|0
1072498|NCT02041429|2126270|FG002|Overall Study|On Maintenance Therapy|0
1072499|NCT02041429|2126271|FG003|Overall Study|On Maintenance Therapy|2
1072500|NCT02041494|2126288|FG000|Overall Study|Death|1
1072501|NCT02041494|2126289|FG001|Overall Study|Death|3
1072502|NCT02041494|2126288|FG000|Overall Study|Lost to Follow-up|2
1072503|NCT02041494|2126289|FG001|Overall Study|Lost to Follow-up|6
1072504|NCT02041494|2126288|FG000|Overall Study|study terminated|16
1072505|NCT02041494|2126289|FG001|Overall Study|study terminated|11
1072506|NCT02041520|2126298|FG000|Overall Study|Adverse Event|2
1072507|NCT02041520|2126299|FG001|Overall Study|Adverse Event|1
1072508|NCT02041520|2126298|FG000|Overall Study|Withdrawal by Subject|3
1072509|NCT02041520|2126299|FG001|Overall Study|Withdrawal by Subject|4
1072510|NCT02041520|2126298|FG000|Overall Study|Protocol Violation|1
1072511|NCT02041520|2126299|FG001|Overall Study|Protocol Violation|0
1072512|NCT02041520|2126298|FG000|Overall Study|Lost to Follow-up|0
1072513|NCT02041520|2126299|FG001|Overall Study|Lost to Follow-up|1
1072514|NCT02041520|2126298|FG000|Overall Study|Hypothiroidism identified during follow-|0
1072515|NCT02041520|2126299|FG001|Overall Study|Hypothiroidism identified during follow-|1
1072516|NCT02041533|2126309|FG000|Overall Study|Disease Progression|168
1072517|NCT02041533|2126310|FG001|Overall Study|Disease Progression|142
1072518|NCT02041533|2126309|FG000|Overall Study|Study drug toxicity|27
1072519|NCT02041533|2126310|FG001|Overall Study|Study drug toxicity|30
1072520|NCT02041533|2126309|FG000|Overall Study|Death|1
1072521|NCT02041533|2126310|FG001|Overall Study|Death|0
1072522|NCT02041533|2126309|FG000|Overall Study|Adverse Event unrelated to study drug|20
1072523|NCT02041533|2126310|FG001|Overall Study|Adverse Event unrelated to study drug|21
1072524|NCT02041533|2126309|FG000|Overall Study|Subject request to discontinue treatment|5
1072525|NCT02041533|2126310|FG001|Overall Study|Subject request to discontinue treatment|9
1072526|NCT02041533|2126309|FG000|Overall Study|Withdrawal by Subject|2
1072527|NCT02041533|2126310|FG001|Overall Study|Withdrawal by Subject|1
1072528|NCT02041533|2126309|FG000|Overall Study|Maximum clinical benefit|0
1072529|NCT02041533|2126310|FG001|Overall Study|Maximum clinical benefit|18
1072530|NCT02041533|2126309|FG000|Overall Study|Poor/non-compliance|1
1072531|NCT02041533|2126310|FG001|Overall Study|Poor/non-compliance|0
1072532|NCT02041533|2126309|FG000|Overall Study|Other reasons|0
1072533|NCT02041533|2126310|FG001|Overall Study|Other reasons|1
1072534|NCT02041533|2126309|FG000|Overall Study|Completed max number of chemo cycles|0
1072535|NCT02041533|2126310|FG001|Overall Study|Completed max number of chemo cycles|29
1072536|NCT02041533|2126309|FG000|Overall Study|Randomized, not treated|4
1072537|NCT02041533|2126310|FG001|Overall Study|Randomized, not treated|7
1072538|NCT02041702|2126318|FG000|Overall Study|Lost to Follow-up|1
1072539|NCT02041702|2126319|FG001|Overall Study|Lost to Follow-up|6
1072540|NCT02041702|2126318|FG000|Overall Study|Death|4
1072541|NCT02041702|2126319|FG001|Overall Study|Death|0
1072542|NCT02041702|2126318|FG000|Overall Study|Withdrawal by Subject|4
1072543|NCT02041702|2126319|FG001|Overall Study|Withdrawal by Subject|3
1072544|NCT02041702|2126318|FG000|Overall Study|Patient not confirmed as MRI compatible|1
1072545|NCT02041702|2126319|FG001|Overall Study|Patient not confirmed as MRI compatible|0
1072546|NCT02041702|2126318|FG000|Overall Study|Cardiac Resynchronization Therapy|1
1072547|NCT02041702|2126319|FG001|Overall Study|Cardiac Resynchronization Therapy|0
1072548|NCT02041923|2126327|FG000|Overall Study|Lost to Follow-up|26
1072549|NCT02041923|2126328|FG001|Overall Study|Lost to Follow-up|30
1072550|NCT02041962|2126338|FG000|Overall Study|Lost Aetna Coverage|43
1072551|NCT02041962|2126339|FG001|Overall Study|Lost Aetna Coverage|40
1072552|NCT02041962|2126338|FG000|Overall Study|Death|1
1072553|NCT02041962|2126339|FG001|Overall Study|Death|1
1072554|NCT02041962|2126338|FG000|Overall Study|Lost to Follow-up|37
1072555|NCT02041962|2126339|FG001|Overall Study|Lost to Follow-up|32
1072556|NCT02041962|2126338|FG000|Overall Study|Withdrawal by Subject|0
1072557|NCT02041962|2126339|FG001|Overall Study|Withdrawal by Subject|11
1072558|NCT02042014|2126345|FG000|Overall Study|Adverse Event|1
1072559|NCT02042014|2126345|FG000|Overall Study|Physician Decision|7
1072560|NCT02042183|2126366|FG000|Overall Study|Physician Decision|7
1072561|NCT02042183|2126367|FG001|Overall Study|Physician Decision|2
1072562|NCT02042183|2126366|FG000|Overall Study|Lack of Efficacy|4
1072563|NCT02042183|2126367|FG001|Overall Study|Lack of Efficacy|3
1072564|NCT02042183|2126366|FG000|Overall Study|Non-compliance with Study Drug|2
1072565|NCT02042183|2126367|FG001|Overall Study|Non-compliance with Study Drug|3
1072566|NCT02042183|2126366|FG000|Overall Study|Adverse Event|17
1072567|NCT02042183|2126367|FG001|Overall Study|Adverse Event|6
1072568|NCT02042183|2126366|FG000|Overall Study|Other|3
1072569|NCT02042183|2126367|FG001|Overall Study|Other|3
1072570|NCT02042183|2126366|FG000|Overall Study|Withdrawal by Subject|21
1072571|NCT02042183|2126367|FG001|Overall Study|Withdrawal by Subject|16
1072572|NCT02042183|2126366|FG000|Overall Study|Site Terminated by Sponsor|2
1072573|NCT02042183|2126367|FG001|Overall Study|Site Terminated by Sponsor|1
1072574|NCT02042183|2126366|FG000|Overall Study|Lost to Follow-up|9
1072575|NCT02042183|2126367|FG001|Overall Study|Lost to Follow-up|2
1072576|NCT02042404|2126379|FG000|Overall Study|Death|1
1072577|NCT02042404|2126380|FG001|Overall Study|Death|0
1072578|NCT02042404|2126379|FG000|Overall Study|Unrelated Adverse Event|3
1072579|NCT02042404|2126380|FG001|Overall Study|Unrelated Adverse Event|0
1072580|NCT02042404|2126379|FG000|Overall Study|Inability to meet time requirements|1
1072581|NCT02042404|2126380|FG001|Overall Study|Inability to meet time requirements|0
1072582|NCT02042443|2126389|FG000|Overall Study|Adverse Event|2
1072583|NCT02042443|2126390|FG001|Overall Study|Adverse Event|1
1072584|NCT02042443|2126389|FG000|Overall Study|Withdrawal by Subject|0
1072585|NCT02042443|2126390|FG001|Overall Study|Withdrawal by Subject|1
1072586|NCT02042443|2126389|FG000|Overall Study|Progression|21
1072587|NCT02042443|2126390|FG001|Overall Study|Progression|17
1072588|NCT02042443|2126389|FG000|Overall Study|not protocol specified|1
1072589|NCT02042443|2126390|FG001|Overall Study|not protocol specified|1
1072590|NCT02042443|2126389|FG000|Overall Study|Not eligible/not analyzable|3
1072591|NCT02042443|2126390|FG001|Overall Study|Not eligible/not analyzable|6
1072592|NCT02043015|2126419|FG000|Overall Study|Lost to Follow-up|4
1072593|NCT02043015|2126419|FG000|Overall Study|Withdrawal by Subject|4
1072594|NCT02043015|2126419|FG000|Overall Study|Removed once target enrollment reached|15
1072595|NCT02043015|2126419|FG000|Overall Study|Participant moved away from study city|4
1072596|NCT02043015|2126419|FG000|Overall Study|Incarceration|1
1072597|NCT02043132|2126427|FG000|Overall Study|Lost to Follow-up|1
1072598|NCT02043132|2126428|FG001|Overall Study|Lost to Follow-up|1
1072599|NCT02043132|2126427|FG000|Overall Study|screen failures|4
1072600|NCT02043132|2126428|FG001|Overall Study|screen failures|8
1072601|NCT02043301|2126456|FG000|Overall Study|Discontinued|0
1072602|NCT02043301|2126457|FG001|Overall Study|Discontinued|1
1072603|NCT02043301|2126458|FG002|Overall Study|Discontinued|0
1072604|NCT02043366|2126472|FG000|Overall Study|Lost to Follow-up|2
1072605|NCT02043366|2126473|FG001|Overall Study|Lost to Follow-up|2
1072606|NCT02043366|2126474|FG002|Overall Study|Lost to Follow-up|2
1072607|NCT02043366|2126475|FG003|Overall Study|Lost to Follow-up|2
1072608|NCT02043366|2126476|FG004|Overall Study|Lost to Follow-up|2
1072609|NCT02043366|2126477|FG005|Overall Study|Lost to Follow-up|2
1072610|NCT02043509|2126504|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61
1072611|NCT02043509|2126505|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47
1072612|NCT02043509|2126504|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4
1072613|NCT02043509|2126505|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0
1072614|NCT02043509|2126504|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67
1072615|NCT02043509|2126505|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67
1072616|NCT02043509|2126504|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7
1072617|NCT02043509|2126505|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5
1072618|NCT02043548|2126513|FG000|Overall Study|Lack of Efficacy|1
1072619|NCT02043548|2126514|FG001|Overall Study|Lack of Efficacy|0
1072620|NCT02043548|2126513|FG000|Overall Study|Adverse Event|0
1072621|NCT02043548|2126514|FG001|Overall Study|Adverse Event|1
1072642|NCT02043782|2126552|FG000|Period 1|Adverse Event|0
1072643|NCT02043782|2126553|FG001|Period 1|Adverse Event|0
1072644|NCT02043782|2126554|FG002|Period 1|Adverse Event|1
1072645|NCT02043782|2126555|FG003|Period 1|Adverse Event|0
1072646|NCT02043782|2126556|FG004|Period 1|Adverse Event|0
1072647|NCT02043782|2126557|FG005|Period 1|Adverse Event|0
1072648|NCT02043899|2126574|FG000|Overall Study|Adverse Event|3
1072649|NCT02043899|2126574|FG000|Overall Study|Physician Decision|1
1072650|NCT02043899|2126574|FG000|Overall Study|Withdrawal by Subject|2
1072651|NCT02043899|2126574|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5
1072652|NCT02043899|2126574|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12
1072653|NCT02043899|2126574|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2
1072654|NCT02043899|2126574|FG000|Overall Study|Clinical progression necessitating urgent treatment|1
1072655|NCT02043899|2126574|FG000|Overall Study|Treatment delayed|1
1072656|NCT02043938|2126578|FG000|Overall Study|Withdrawal by Subject|7
1072657|NCT02043938|2126578|FG000|Overall Study|Unable to place EEG sensors on patient|1
1072658|NCT02043938|2126578|FG000|Overall Study|No show by subject|1
1072659|NCT02043938|2126578|FG000|Overall Study|Investigator decision|1
1072660|NCT02044094|2126585|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
1072661|NCT02044094|2126585|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
1072662|NCT02044094|2126585|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
1072663|NCT02044094|2126585|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
1072664|NCT02044094|2126585|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
1072665|NCT02044094|2126585|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
1072666|NCT02044094|2126585|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
1072667|NCT02044094|2126585|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
1072668|NCT02044159|2126602|FG000|Overall Study|Consent declined (deferred consent)|2
1072669|NCT02044159|2126603|FG001|Overall Study|Consent declined (deferred consent)|4
909457|NCT00788593|1886221|FG002|First Intervention Period|Adverse Event|0
909458|NCT00788593|1886219|FG000|Second Intervention Period|Lost to Follow-up|0
909459|NCT00788593|1886220|FG001|Second Intervention Period|Lost to Follow-up|1
909460|NCT00788593|1886221|FG002|Second Intervention Period|Lost to Follow-up|0
909461|NCT00788593|1886219|FG000|Second Intervention Period|Other|0
909462|NCT00788593|1886220|FG001|Second Intervention Period|Other|0
909463|NCT00788593|1886221|FG002|Second Intervention Period|Other|1
909464|NCT00788697|1886231|FG000|Overall Study|No study drug administered|12
909465|NCT00788697|1886231|FG000|Overall Study|Training Patients|74
1072670|NCT02044159|2126602|FG000|Overall Study|No longer eligible, drug not given|1
1072671|NCT02044159|2126603|FG001|Overall Study|No longer eligible, drug not given|0
1072672|NCT02044159|2126602|FG000|Overall Study|Nurse declined to give study drug|1
1072673|NCT02044159|2126603|FG001|Overall Study|Nurse declined to give study drug|0
1072674|NCT02044458|2126661|FG000|Overall Study|Protocol Violation|3
1072675|NCT02044458|2126662|FG001|Overall Study|Protocol Violation|8
1072676|NCT02044510|2126670|FG000|Overall Study|Adverse Event|1
1072677|NCT02044510|2126671|FG001|Overall Study|Adverse Event|2
1072678|NCT02044874|2126709|FG000|Overall Study|Adverse Event|5
1072679|NCT02044874|2126710|FG001|Overall Study|Adverse Event|6
1072680|NCT02044874|2126711|FG002|Overall Study|Adverse Event|6
1072681|NCT02044874|2126709|FG000|Overall Study|Withdrawal by Subject|8
1072682|NCT02044874|2126710|FG001|Overall Study|Withdrawal by Subject|16
1072683|NCT02044874|2126711|FG002|Overall Study|Withdrawal by Subject|23
1072684|NCT02044874|2126709|FG000|Overall Study|Physician Decision|0
1072685|NCT02044874|2126710|FG001|Overall Study|Physician Decision|2
1072686|NCT02044874|2126711|FG002|Overall Study|Physician Decision|1
1072687|NCT02044874|2126709|FG000|Overall Study|Lost to Follow-up|10
1072688|NCT02044874|2126710|FG001|Overall Study|Lost to Follow-up|27
1072689|NCT02044874|2126711|FG002|Overall Study|Lost to Follow-up|21
1072690|NCT02044874|2126709|FG000|Overall Study|Sponsor Decision|0
1072691|NCT02044874|2126710|FG001|Overall Study|Sponsor Decision|1
1072692|NCT02044874|2126711|FG002|Overall Study|Sponsor Decision|1
1072693|NCT02044874|2126709|FG000|Overall Study|Other|7
1072694|NCT02044874|2126710|FG001|Overall Study|Other|3
1072695|NCT02044874|2126711|FG002|Overall Study|Other|8
1072696|NCT02045095|2126730|FG000|Overall Study|Other|0
1072697|NCT02045095|2126731|FG001|Overall Study|Other|0
1072698|NCT02045095|2126732|FG002|Overall Study|Other|1
1072699|NCT02045095|2126733|FG003|Overall Study|Other|0
1072700|NCT02045095|2126734|FG004|Overall Study|Other|0
1072701|NCT02045095|2126735|FG005|Overall Study|Other|2
1072702|NCT02045095|2126736|FG006|Overall Study|Other|0
1072703|NCT02045095|2126730|FG000|Overall Study|Progressive Disease|3
1072704|NCT02045095|2126731|FG001|Overall Study|Progressive Disease|3
1072705|NCT02045095|2126732|FG002|Overall Study|Progressive Disease|2
1072706|NCT02045095|2126733|FG003|Overall Study|Progressive Disease|4
1072707|NCT02045095|2126734|FG004|Overall Study|Progressive Disease|2
1072708|NCT02045095|2126735|FG005|Overall Study|Progressive Disease|4
1072709|NCT02045095|2126736|FG006|Overall Study|Progressive Disease|1
1072710|NCT02045095|2126730|FG000|Overall Study|Withdrawal by Subject|0
1072711|NCT02045095|2126731|FG001|Overall Study|Withdrawal by Subject|0
1072712|NCT02045095|2126732|FG002|Overall Study|Withdrawal by Subject|0
1072713|NCT02045095|2126733|FG003|Overall Study|Withdrawal by Subject|0
1072714|NCT02045095|2126734|FG004|Overall Study|Withdrawal by Subject|3
1072715|NCT02045095|2126735|FG005|Overall Study|Withdrawal by Subject|0
1072716|NCT02045095|2126736|FG006|Overall Study|Withdrawal by Subject|0
1072717|NCT02045095|2126730|FG000|Overall Study|Adverse Event|0
1072718|NCT02045095|2126731|FG001|Overall Study|Adverse Event|1
1072719|NCT02045095|2126732|FG002|Overall Study|Adverse Event|1
1072720|NCT02045095|2126733|FG003|Overall Study|Adverse Event|0
1072721|NCT02045095|2126734|FG004|Overall Study|Adverse Event|0
1072722|NCT02045095|2126735|FG005|Overall Study|Adverse Event|2
1072723|NCT02045095|2126736|FG006|Overall Study|Adverse Event|0
1072724|NCT02045212|2126771|FG000|Overall Study|Adverse Event|0
1072725|NCT02045212|2126772|FG001|Overall Study|Adverse Event|1
1072726|NCT02045212|2126771|FG000|Overall Study|Withdrawal by Subject|1
1072727|NCT02045212|2126772|FG001|Overall Study|Withdrawal by Subject|0
1072728|NCT02045212|2126771|FG000|Overall Study|Finished 13 weeks, chose not to extend|1
1072729|NCT02045212|2126772|FG001|Overall Study|Finished 13 weeks, chose not to extend|0
1072730|NCT02045433|2126812|FG000|Overall Study|Withdrawal by Subject|1
1072731|NCT02045732|2126827|FG000|Overall Study|At the discretion of the investigator|1
1072732|NCT02045732|2126828|FG001|Overall Study|At the discretion of the investigator|1
1072733|NCT02045836|2126849|FG000|Overall Study|Adverse Event|4
1072734|NCT02045836|2126850|FG001|Overall Study|Adverse Event|4
1072735|NCT02045836|2126849|FG000|Overall Study|Withdrawal by Subject|1
1072736|NCT02045836|2126850|FG001|Overall Study|Withdrawal by Subject|1
1072737|NCT02045836|2126849|FG000|Overall Study|Lost to Follow-up|4
1072738|NCT02045836|2126850|FG001|Overall Study|Lost to Follow-up|7
1072739|NCT02045836|2126849|FG000|Overall Study|Migrated from study area|0
1072740|NCT02045836|2126850|FG001|Overall Study|Migrated from study area|2
1072741|NCT02045862|2126860|FG000|Overall Study|Death|0
1072742|NCT02045862|2126861|FG001|Overall Study|Death|0
1072743|NCT02045862|2126862|FG002|Overall Study|Death|1
1072744|NCT02045862|2126860|FG000|Overall Study|Miscellaneous|5
1072745|NCT02045862|2126861|FG001|Overall Study|Miscellaneous|0
1072746|NCT02045862|2126862|FG002|Overall Study|Miscellaneous|8
1072747|NCT02045862|2126860|FG000|Overall Study|Withdrawal by Patient|18
1072748|NCT02045862|2126861|FG001|Overall Study|Withdrawal by Patient|27
1072749|NCT02045862|2126862|FG002|Overall Study|Withdrawal by Patient|57
1072750|NCT02045862|2126860|FG000|Overall Study|Protocol Violation|0
1072751|NCT02045862|2126861|FG001|Overall Study|Protocol Violation|0
1072752|NCT02045862|2126862|FG002|Overall Study|Protocol Violation|6
1072753|NCT02045862|2126860|FG000|Overall Study|Lack of Efficacy|8
1072754|NCT02045862|2126861|FG001|Overall Study|Lack of Efficacy|4
1072755|NCT02045862|2126862|FG002|Overall Study|Lack of Efficacy|13
1072756|NCT02045862|2126860|FG000|Overall Study|Randomized but not Received Study Drug|0
1072757|NCT02045862|2126861|FG001|Overall Study|Randomized but not Received Study Drug|2
1072758|NCT02045862|2126862|FG002|Overall Study|Randomized but not Received Study Drug|8
1072759|NCT02045862|2126860|FG000|Overall Study|Adverse Event|7
1072760|NCT02045862|2126861|FG001|Overall Study|Adverse Event|5
1072761|NCT02045862|2126862|FG002|Overall Study|Adverse Event|27
1072762|NCT02045862|2126860|FG000|Overall Study|Lost to Follow-up|1
1072763|NCT02045862|2126861|FG001|Overall Study|Lost to Follow-up|2
1072764|NCT02045862|2126862|FG002|Overall Study|Lost to Follow-up|6
1072765|NCT02045875|2126872|FG000|Overall Study|Lost to Follow-up|3
1072766|NCT02045875|2126873|FG001|Overall Study|Lost to Follow-up|0
1072767|NCT02045875|2126872|FG000|Overall Study|Withdrawal by Subject|4
1072768|NCT02045875|2126873|FG001|Overall Study|Withdrawal by Subject|3
1072769|NCT02045979|2126882|FG000|Overall Study|Informed Consent Withdrawn|2
1072770|NCT02045979|2126883|FG001|Overall Study|Informed Consent Withdrawn|0
1072771|NCT02045979|2126884|FG002|Overall Study|Informed Consent Withdrawn|1
1072772|NCT02045979|2126882|FG000|Overall Study|not specified above|0
1072773|NCT02045979|2126883|FG001|Overall Study|not specified above|1
1072774|NCT02045979|2126884|FG002|Overall Study|not specified above|0
1072775|NCT02046070|2126908|FG000|Overall Study|Progressive Disease|18
1072776|NCT02046070|2126909|FG001|Overall Study|Progressive Disease|11
1072777|NCT02046070|2126910|FG002|Overall Study|Progressive Disease|40
1072778|NCT02046070|2126908|FG000|Overall Study|Adverse Event|8
1072779|NCT02046070|2126909|FG001|Overall Study|Adverse Event|10
1072780|NCT02046070|2126910|FG002|Overall Study|Adverse Event|17
1072781|NCT02046070|2126908|FG000|Overall Study|Withdrawal by Subject|1
1072782|NCT02046070|2126909|FG001|Overall Study|Withdrawal by Subject|2
1072783|NCT02046070|2126910|FG002|Overall Study|Withdrawal by Subject|6
1072784|NCT02046070|2126908|FG000|Overall Study|Study Terminated by Sponsor|1
1072785|NCT02046070|2126909|FG001|Overall Study|Study Terminated by Sponsor|1
1072786|NCT02046070|2126910|FG002|Overall Study|Study Terminated by Sponsor|1
1072787|NCT02046070|2126908|FG000|Overall Study|Reason not Specified|4
1072788|NCT02046070|2126909|FG001|Overall Study|Reason not Specified|4
1072789|NCT02046070|2126910|FG002|Overall Study|Reason not Specified|6
1072790|NCT02046122|2126918|FG000|Overall Study|Physician Decision|8
1072791|NCT02046122|2126918|FG000|Overall Study|Withdrawal by Subject|1
1072792|NCT02046148|2126933|FG000|Overall Study|Lost to Follow-up|1
1072793|NCT02046148|2126934|FG001|Overall Study|Lost to Follow-up|1
1072794|NCT02046148|2126933|FG000|Overall Study|Withdrawal by Subject|0
1072795|NCT02046148|2126934|FG001|Overall Study|Withdrawal by Subject|2
1072796|NCT02046174|2126940|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1
1072797|NCT02046174|2126941|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0
1072798|NCT02046369|2127069|FG000|Overall Study|Adverse Event|3
1072799|NCT02046369|2127070|FG001|Overall Study|Adverse Event|3
1072800|NCT02046369|2127069|FG000|Overall Study|Lack of Efficacy|3
1072801|NCT02046369|2127070|FG001|Overall Study|Lack of Efficacy|3
1072802|NCT02046369|2127069|FG000|Overall Study|Lost to Follow-up|3
1072803|NCT02046369|2127070|FG001|Overall Study|Lost to Follow-up|3
1072804|NCT02046369|2127069|FG000|Overall Study|Protocol Violation|1
1072805|NCT02046369|2127070|FG001|Overall Study|Protocol Violation|2
1072806|NCT02046369|2127069|FG000|Overall Study|Withdrawal by Subject|3
1072807|NCT02046369|2127070|FG001|Overall Study|Withdrawal by Subject|6
1072808|NCT02046369|2127069|FG000|Overall Study|never received study drug|0
1072809|NCT02046369|2127070|FG001|Overall Study|never received study drug|1
1072810|NCT02046369|2127069|FG000|Overall Study|non compliance|1
1072811|NCT02046369|2127070|FG001|Overall Study|non compliance|0
1072812|NCT02046564|2127096|FG000|Overall Study|Adverse Event|6
1072813|NCT02046564|2127097|FG001|Overall Study|Adverse Event|3
1072814|NCT02046564|2127096|FG000|Overall Study|Physician Decision|0
1072815|NCT02046564|2127097|FG001|Overall Study|Physician Decision|1
1072816|NCT02046564|2127096|FG000|Overall Study|Protocol Violation|3
1072817|NCT02046564|2127097|FG001|Overall Study|Protocol Violation|1
1072818|NCT02046564|2127096|FG000|Overall Study|Withdrawal by Subject|4
1072819|NCT02046564|2127097|FG001|Overall Study|Withdrawal by Subject|10
1072820|NCT02046564|2127096|FG000|Overall Study|Subject met withdrawal criteria|2
1072821|NCT02046564|2127097|FG001|Overall Study|Subject met withdrawal criteria|5
1072822|NCT02046603|2127105|FG000|Overall Study|Other|11
1072823|NCT02046603|2127106|FG001|Overall Study|Other|66
1072824|NCT02046603|2127105|FG000|Overall Study|Protocol Violation|0
1072825|NCT02046603|2127106|FG001|Overall Study|Protocol Violation|1
1072826|NCT02046603|2127105|FG000|Overall Study|Participant/legal guardian decision|1
1072827|NCT02046603|2127106|FG001|Overall Study|Participant/legal guardian decision|3
1072828|NCT02046603|2127105|FG000|Overall Study|Physician Decision|2
1072829|NCT02046603|2127106|FG001|Overall Study|Physician Decision|1
1072830|NCT02046603|2127105|FG000|Overall Study|Lost to Follow-up|1
1072831|NCT02046603|2127106|FG001|Overall Study|Lost to Follow-up|2
1072832|NCT02046603|2127105|FG000|Overall Study|Death|0
1072833|NCT02046603|2127106|FG001|Overall Study|Death|1
1072834|NCT02046603|2127105|FG000|Overall Study|Adverse Event|0
1072835|NCT02046603|2127106|FG001|Overall Study|Adverse Event|1
1072836|NCT02046616|2127113|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
1072837|NCT02046616|2127113|FG000|24-Week Treatment Period|Any Other Adverse Event|13
1072838|NCT02046616|2127113|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1
1072839|NCT02046616|2127113|FG000|24-Week Treatment Period|Physician Decision|3
1072840|NCT02046616|2127113|FG000|24-Week Treatment Period|Other|1
1072841|NCT02046616|2127113|FG000|8-Week FU Period|Lost to Follow-up|1
1072842|NCT02046993|2127162|FG000|Overall Study|Withdrawal by Subject|2
1072843|NCT02046993|2127163|FG001|Overall Study|Withdrawal by Subject|10
1072844|NCT02046993|2127162|FG000|Overall Study|Lost to Follow-up|1
1072845|NCT02046993|2127163|FG001|Overall Study|Lost to Follow-up|1
1072846|NCT02047045|2127184|FG000|Baseline|Withdrawal by Subject|3
1072847|NCT02047045|2127185|FG001|Baseline|Withdrawal by Subject|2
1072848|NCT02047045|2127184|FG000|Treatment Period (8 Weeks )|Adverse Event|3
1072849|NCT02047045|2127185|FG001|Treatment Period (8 Weeks )|Adverse Event|1
1072850|NCT02047045|2127184|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1
1072851|NCT02047045|2127185|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3
1072852|NCT02047045|2127184|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3
1072853|NCT02047045|2127185|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5
1072854|NCT02047045|2127184|FG000|Treatment Period (8 Weeks )|moved far away out of work|3
1072855|NCT02047045|2127185|FG001|Treatment Period (8 Weeks )|moved far away out of work|0
1072856|NCT02047045|2127184|FG000|Treatment Period (8 Weeks )|no reason was given|1
1072857|NCT02047045|2127185|FG001|Treatment Period (8 Weeks )|no reason was given|0
1072858|NCT02047045|2127184|FG000|Treatment Period (8 Weeks )|refused to take drugs|0
1072859|NCT02047045|2127185|FG001|Treatment Period (8 Weeks )|refused to take drugs|5
1072860|NCT02047045|2127184|FG000|Treatment Period (8 Weeks )|for safety considerations|0
1072861|NCT02047045|2127185|FG001|Treatment Period (8 Weeks )|for safety considerations|1
1072862|NCT02047045|2127184|FG000|Follow-up Period (24 Weeks)|Adverse Event|1
1072863|NCT02047045|2127185|FG001|Follow-up Period (24 Weeks)|Adverse Event|1
1072864|NCT02047110|2127195|FG000|DB Treatment Period up to Week 24|Adverse Event|1
1072865|NCT02047110|2127196|FG001|DB Treatment Period up to Week 24|Adverse Event|0
1072866|NCT02047110|2127197|FG002|DB Treatment Period up to Week 24|Adverse Event|0
1072867|NCT02047110|2127198|FG003|DB Treatment Period up to Week 24|Adverse Event|0
1072868|NCT02047110|2127195|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1
1072869|NCT02047110|2127196|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0
1072870|NCT02047110|2127197|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0
1072871|NCT02047110|2127198|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0
1072872|NCT02047110|2127195|FG000|DB Treatment Period up to Week 24|Protocol Violation|1
1072873|NCT02047110|2127196|FG001|DB Treatment Period up to Week 24|Protocol Violation|0
1072874|NCT02047110|2127197|FG002|DB Treatment Period up to Week 24|Protocol Violation|0
1072875|NCT02047110|2127198|FG003|DB Treatment Period up to Week 24|Protocol Violation|0
1072876|NCT02047110|2127195|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1
1072877|NCT02047110|2127196|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0
1072878|NCT02047110|2127197|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0
1072879|NCT02047110|2127198|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1
1072880|NCT02047110|2127195|FG000|DB Treatment Period up to Week 24|Other than specified|1
1072881|NCT02047110|2127196|FG001|DB Treatment Period up to Week 24|Other than specified|2
1072882|NCT02047110|2127197|FG002|DB Treatment Period up to Week 24|Other than specified|3
1072883|NCT02047110|2127198|FG003|DB Treatment Period up to Week 24|Other than specified|1
1072884|NCT02047110|2127195|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
1072885|NCT02047110|2127196|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
1072886|NCT02047110|2127197|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
1072887|NCT02047110|2127198|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
1072888|NCT02047110|2127195|FG000|DB (Week 12 up to Week 24)|Other than specified|0
1072889|NCT02047110|2127196|FG001|DB (Week 12 up to Week 24)|Other than specified|1
1072890|NCT02047110|2127197|FG002|DB (Week 12 up to Week 24)|Other than specified|1
1072891|NCT02047110|2127198|FG003|DB (Week 12 up to Week 24)|Other than specified|0
1072892|NCT02047110|2127195|FG000|Escape Treatment Period|Withdrawal by Subject|1
1072893|NCT02047110|2127196|FG001|Escape Treatment Period|Withdrawal by Subject|2
1072894|NCT02047110|2127197|FG002|Escape Treatment Period|Withdrawal by Subject|1
1072895|NCT02047110|2127198|FG003|Escape Treatment Period|Withdrawal by Subject|1
1072896|NCT02047110|2127195|FG000|Escape Treatment Period|Adverse Event|1
1072897|NCT02047110|2127196|FG001|Escape Treatment Period|Adverse Event|2
1072898|NCT02047110|2127197|FG002|Escape Treatment Period|Adverse Event|2
1072899|NCT02047110|2127198|FG003|Escape Treatment Period|Adverse Event|0
1072900|NCT02047110|2127195|FG000|Escape Treatment Period|Other than specified|1
1072901|NCT02047110|2127196|FG001|Escape Treatment Period|Other than specified|2
1072902|NCT02047110|2127197|FG002|Escape Treatment Period|Other than specified|0
1072903|NCT02047110|2127198|FG003|Escape Treatment Period|Other than specified|1
1072904|NCT02047110|2127195|FG000|OLE Treatment Period|Other than specified|0
1072905|NCT02047110|2127196|FG001|OLE Treatment Period|Other than specified|0
1072906|NCT02047110|2127197|FG002|OLE Treatment Period|Other than specified|1
1072907|NCT02047110|2127198|FG003|OLE Treatment Period|Other than specified|0
1072908|NCT02047227|2127217|FG000|Overall Study|Adverse Event|2
1072909|NCT02047227|2127218|FG001|Overall Study|Adverse Event|4
1072910|NCT02047227|2127217|FG000|Overall Study|Lost to Follow-up|0
1072911|NCT02047227|2127218|FG001|Overall Study|Lost to Follow-up|3
1072912|NCT02047227|2127217|FG000|Overall Study|Protocol Violation|1
1072913|NCT02047227|2127218|FG001|Overall Study|Protocol Violation|0
1072914|NCT02047227|2127217|FG000|Overall Study|Spontaneous pregnancy|1
1072915|NCT02047227|2127218|FG001|Overall Study|Spontaneous pregnancy|0
1072916|NCT02047227|2127217|FG000|Overall Study|Lack of ovarian response to stimulation|35
1072917|NCT02047227|2127218|FG001|Overall Study|Lack of ovarian response to stimulation|32
1072918|NCT02047227|2127217|FG000|Overall Study|No oocytes retrieved|21
1072919|NCT02047227|2127218|FG001|Overall Study|No oocytes retrieved|20
1072920|NCT02047227|2127217|FG000|Overall Study|No fertilization|61
1072921|NCT02047227|2127218|FG001|Overall Study|No fertilization|51
1072922|NCT02047227|2127217|FG000|Overall Study|Intention to freeze all embryos|1
1072923|NCT02047227|2127218|FG001|Overall Study|Intention to freeze all embryos|0
1072924|NCT02047227|2127217|FG000|Overall Study|All embryos discarded|12
1072925|NCT02047227|2127218|FG001|Overall Study|All embryos discarded|11
1072926|NCT02047227|2127217|FG000|Overall Study|Other|10
1072927|NCT02047227|2127218|FG001|Overall Study|Other|9
1072928|NCT02047253|2127224|FG000|Overall Study|Lost to Follow-up|8
1072929|NCT02047318|2127232|FG000|Core Study Period|Did not consent to 52-week follow- up|8
1072930|NCT02047318|2127232|FG000|Core Study Period|Adverse Event|1
1072931|NCT02047318|2127232|FG000|Core Study Period|Withdrawal by caregiver|3
1072932|NCT02047318|2127232|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1
1072933|NCT02047604|2127272|FG000|Overall Study|Withdrawal by Subject|0
1072934|NCT02047604|2127273|FG001|Overall Study|Withdrawal by Subject|0
1072935|NCT02047604|2127274|FG002|Overall Study|Withdrawal by Subject|0
1072936|NCT02047604|2127275|FG003|Overall Study|Withdrawal by Subject|0
1072937|NCT02047604|2127276|FG004|Overall Study|Withdrawal by Subject|1
1072938|NCT02047604|2127277|FG005|Overall Study|Withdrawal by Subject|1
1072939|NCT02047734|2127301|FG000|Overall Study|Adverse Event|18
1072940|NCT02047734|2127302|FG001|Overall Study|Adverse Event|13
1072941|NCT02047734|2127303|FG002|Overall Study|Adverse Event|13
1072942|NCT02047734|2127301|FG000|Overall Study|Lack of Efficacy|4
1072943|NCT02047734|2127302|FG001|Overall Study|Lack of Efficacy|5
1072944|NCT02047734|2127303|FG002|Overall Study|Lack of Efficacy|1
1072945|NCT02047734|2127301|FG000|Overall Study|Protocol Violation|3
1072946|NCT02047734|2127302|FG001|Overall Study|Protocol Violation|1
1072947|NCT02047734|2127303|FG002|Overall Study|Protocol Violation|1
1072948|NCT02047734|2127301|FG000|Overall Study|Lost to Follow-up|1
1072949|NCT02047734|2127302|FG001|Overall Study|Lost to Follow-up|4
1072950|NCT02047734|2127303|FG002|Overall Study|Lost to Follow-up|0
1072951|NCT02047734|2127301|FG000|Overall Study|Death|0
1072952|NCT02047734|2127302|FG001|Overall Study|Death|1
1072953|NCT02047734|2127303|FG002|Overall Study|Death|0
1072954|NCT02047734|2127301|FG000|Overall Study|Withdrawal by Subject|30
1072955|NCT02047734|2127302|FG001|Overall Study|Withdrawal by Subject|31
1072956|NCT02047734|2127303|FG002|Overall Study|Withdrawal by Subject|19
1072957|NCT02047734|2127301|FG000|Overall Study|Physician Decision|7
1072958|NCT02047734|2127302|FG001|Overall Study|Physician Decision|6
1072959|NCT02047734|2127303|FG002|Overall Study|Physician Decision|5
1072960|NCT02047734|2127301|FG000|Overall Study|Miscellaneous|2
1072961|NCT02047734|2127302|FG001|Overall Study|Miscellaneous|4
1072962|NCT02047734|2127303|FG002|Overall Study|Miscellaneous|6
1072963|NCT02047734|2127301|FG000|Overall Study|Did Not Receive Study Drug|2
1072964|NCT02047734|2127302|FG001|Overall Study|Did Not Receive Study Drug|4
1072965|NCT02047734|2127303|FG002|Overall Study|Did Not Receive Study Drug|1
1072966|NCT02047903|2127311|FG000|Overall Study|Adverse Event|14
1072967|NCT02047903|2127311|FG000|Overall Study|Serious adverse event|10
1072968|NCT02047903|2127311|FG000|Overall Study|Withdrawal by Subject|16
1072969|NCT02047903|2127311|FG000|Overall Study|Lost to Follow-up|4
1072970|NCT02047903|2127311|FG000|Overall Study|Reason not listed|6
1072971|NCT02047903|2127311|FG000|Overall Study|Not Treated|9
1072972|NCT02048072|2127340|FG000|Overall Study|Adverse Event|3
1072973|NCT02048072|2127340|FG000|Overall Study|Lost to Follow-up|1
1072974|NCT02048241|2127346|FG000|Overall Study|Withdrawal by Subject|0
1072975|NCT02048241|2127347|FG001|Overall Study|Withdrawal by Subject|1
1072976|NCT02048722|2127362|FG000|2 Cycles of Treatment|Adverse Event|2
1072977|NCT02048722|2127362|FG000|2 Cycles of Treatment|Withdrawal by Subject|4
1072978|NCT02048722|2127362|FG000|2 Cycles of Treatment|Progressive Disease|2
1072979|NCT02048722|2127362|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10
1072980|NCT02048722|2127362|FG000|Follow up for 5 Years|Death|22
1072981|NCT02048722|2127362|FG000|Follow up for 5 Years|Withdrawal by Subject|3
1072982|NCT02048722|2127362|FG000|Follow up for 5 Years|Still in follow up|4
1072983|NCT02048826|2127368|FG000|Overall Study|Withdrawal by Subject|1
1072984|NCT02048826|2127369|FG001|Overall Study|Withdrawal by Subject|0
1072985|NCT02049437|2127422|FG000|Period 1|Adverse Event|1
1072986|NCT02049437|2127423|FG001|Period 1|Adverse Event|1
1072987|NCT02049437|2127422|FG000|Period 1|Adverse Event|1
1072988|NCT02049437|2127423|FG001|Period 1|Adverse Event|0
1072989|NCT02049450|2127429|FG000|Overall Study|Adverse Event|2
1072990|NCT02049450|2127429|FG000|Overall Study|Withdrawal by Subject|1
1072991|NCT02049450|2127429|FG000|Overall Study|Patients/guardian decision|1
1072992|NCT02049814|2127460|FG000|Overall Study|Reason not Specified|4
1072993|NCT02049814|2127461|FG001|Overall Study|Reason not Specified|3
1072994|NCT02049814|2127460|FG000|Overall Study|Pregnancy|1
1072995|NCT02049814|2127461|FG001|Overall Study|Pregnancy|0
1072996|NCT02049814|2127460|FG000|Overall Study|Lost to Follow-up|2
1072997|NCT02049814|2127461|FG001|Overall Study|Lost to Follow-up|3
1072998|NCT02049814|2127460|FG000|Overall Study|Serious Protocol Violation|5
1072999|NCT02049814|2127461|FG001|Overall Study|Serious Protocol Violation|7
1073000|NCT02049814|2127460|FG000|Overall Study|Study Termination|0
1073001|NCT02049814|2127461|FG001|Overall Study|Study Termination|1
1073002|NCT02049814|2127460|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8
1073003|NCT02049814|2127461|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5
1073004|NCT02049814|2127460|FG000|Overall Study|Voluntary withdrawal|9
1073005|NCT02049814|2127461|FG001|Overall Study|Voluntary withdrawal|8
1073006|NCT02049866|2127467|FG000|Overall Study|Withdrawal by Subject|1
1073007|NCT02049944|2127484|FG000|Overall Study|Protocol Violation|2
1073008|NCT02049957|2127497|FG000|Overall Study|Progressive Disease|5
1073009|NCT02049957|2127498|FG001|Overall Study|Progressive Disease|4
1073010|NCT02049957|2127499|FG002|Overall Study|Progressive Disease|2
1073011|NCT02049957|2127500|FG003|Overall Study|Progressive Disease|2
1073012|NCT02049957|2127501|FG004|Overall Study|Progressive Disease|6
1073013|NCT02049957|2127502|FG005|Overall Study|Progressive Disease|35
1073014|NCT02049957|2127503|FG006|Overall Study|Progressive Disease|7
1073015|NCT02049957|2127504|FG007|Overall Study|Progressive Disease|26
1073016|NCT02049957|2127505|FG008|Overall Study|Progressive Disease|6
1073017|NCT02049957|2127497|FG000|Overall Study|Adverse Event|1
1073018|NCT02049957|2127498|FG001|Overall Study|Adverse Event|1
1073019|NCT02049957|2127499|FG002|Overall Study|Adverse Event|1
1073020|NCT02049957|2127500|FG003|Overall Study|Adverse Event|0
1073021|NCT02049957|2127501|FG004|Overall Study|Adverse Event|0
1073022|NCT02049957|2127502|FG005|Overall Study|Adverse Event|5
1073023|NCT02049957|2127503|FG006|Overall Study|Adverse Event|0
1073024|NCT02049957|2127504|FG007|Overall Study|Adverse Event|6
1073025|NCT02049957|2127505|FG008|Overall Study|Adverse Event|1
1073026|NCT02049957|2127497|FG000|Overall Study|Study Terminated by Sponsor|0
1073027|NCT02049957|2127498|FG001|Overall Study|Study Terminated by Sponsor|1
1073028|NCT02049957|2127499|FG002|Overall Study|Study Terminated by Sponsor|0
1073029|NCT02049957|2127500|FG003|Overall Study|Study Terminated by Sponsor|0
1073030|NCT02049957|2127501|FG004|Overall Study|Study Terminated by Sponsor|0
1073031|NCT02049957|2127502|FG005|Overall Study|Study Terminated by Sponsor|0
1073032|NCT02049957|2127503|FG006|Overall Study|Study Terminated by Sponsor|1
1073033|NCT02049957|2127504|FG007|Overall Study|Study Terminated by Sponsor|0
1073034|NCT02049957|2127505|FG008|Overall Study|Study Terminated by Sponsor|0
1073035|NCT02049957|2127497|FG000|Overall Study|Withdrawal by Subject|0
1073036|NCT02049957|2127498|FG001|Overall Study|Withdrawal by Subject|0
1073037|NCT02049957|2127499|FG002|Overall Study|Withdrawal by Subject|0
1073038|NCT02049957|2127500|FG003|Overall Study|Withdrawal by Subject|1
1073039|NCT02049957|2127501|FG004|Overall Study|Withdrawal by Subject|0
1073040|NCT02049957|2127502|FG005|Overall Study|Withdrawal by Subject|2
1073041|NCT02049957|2127503|FG006|Overall Study|Withdrawal by Subject|0
1073042|NCT02049957|2127504|FG007|Overall Study|Withdrawal by Subject|3
1073043|NCT02049957|2127505|FG008|Overall Study|Withdrawal by Subject|1
1073044|NCT02049957|2127497|FG000|Overall Study|Physician Decision|0
1073045|NCT02049957|2127498|FG001|Overall Study|Physician Decision|0
1073046|NCT02049957|2127499|FG002|Overall Study|Physician Decision|0
1073047|NCT02049957|2127500|FG003|Overall Study|Physician Decision|0
1073048|NCT02049957|2127501|FG004|Overall Study|Physician Decision|0
1073049|NCT02049957|2127502|FG005|Overall Study|Physician Decision|1
1073050|NCT02049957|2127503|FG006|Overall Study|Physician Decision|0
1073051|NCT02049957|2127504|FG007|Overall Study|Physician Decision|0
1073052|NCT02049957|2127505|FG008|Overall Study|Physician Decision|0
1073053|NCT02050048|2127527|FG000|Overall Study|Lost to Follow-up|0
1073054|NCT02050048|2127528|FG001|Overall Study|Lost to Follow-up|1
1073055|NCT02050048|2127527|FG000|Overall Study|Death|1
1073056|NCT02050048|2127528|FG001|Overall Study|Death|0
1073057|NCT02050048|2127527|FG000|Overall Study|Ineligible after ERCP|4
1073058|NCT02050048|2127528|FG001|Overall Study|Ineligible after ERCP|1
1073059|NCT02050321|2127543|FG000|Overall Study|Withdrawal by Subject|1
1073060|NCT02050321|2127543|FG000|Overall Study|Adverse Event|1
1073061|NCT02050373|2127559|FG000|Overall Study|Adverse Event|4
1073062|NCT02050373|2127560|FG001|Overall Study|Adverse Event|7
1073063|NCT02050373|2127559|FG000|Overall Study|Death|3
1073064|NCT02050373|2127560|FG001|Overall Study|Death|3
1073065|NCT02051296|2127583|FG000|Overall Study|Lost to Follow-up|1
1073066|NCT02051296|2127584|FG001|Overall Study|Lost to Follow-up|2
1073067|NCT02051296|2127583|FG000|Overall Study|withdraw prior to treatment|7
1073068|NCT02051296|2127584|FG001|Overall Study|withdraw prior to treatment|7
1073069|NCT02051764|2127640|FG000|Overall Study|Study terminated by sponsor|0
1073070|NCT02051764|2127641|FG001|Overall Study|Study terminated by sponsor|7
909466|NCT00788697|1886231|FG000|Overall Study|no truth standard procedure available|5
909467|NCT00788697|1886231|FG000|Overall Study|Technically inadequate truth standard|1
1073071|NCT02052011|2127674|FG000|Overall Study|Lost to Follow-up|3
1073072|NCT02052011|2127675|FG001|Overall Study|Lost to Follow-up|0
1073073|NCT02052011|2127674|FG000|Overall Study|Withdrawal by Subject|1
1073074|NCT02052011|2127675|FG001|Overall Study|Withdrawal by Subject|2
1073075|NCT02052310|2127692|FG000|Overall Study|Death|64
1073076|NCT02052310|2127693|FG001|Overall Study|Death|54
1073077|NCT02052310|2127692|FG000|Overall Study|Withdrawal by Subject|37
1073078|NCT02052310|2127693|FG001|Overall Study|Withdrawal by Subject|49
1073079|NCT02052310|2127692|FG000|Overall Study|Other than specified|32
1073080|NCT02052310|2127693|FG001|Overall Study|Other than specified|29
1073081|NCT02052310|2127692|FG000|Overall Study|Adverse Event|29
1073082|NCT02052310|2127693|FG001|Overall Study|Adverse Event|22
1073083|NCT02052310|2127692|FG000|Overall Study|Kidney Transplant|23
1073084|NCT02052310|2127693|FG001|Overall Study|Kidney Transplant|29
1073085|NCT02052310|2127692|FG000|Overall Study|Physician Decision|14
1073086|NCT02052310|2127693|FG001|Overall Study|Physician Decision|7
1073087|NCT02052310|2127692|FG000|Overall Study|Lack of Efficacy|6
1073088|NCT02052310|2127693|FG001|Overall Study|Lack of Efficacy|1
1073089|NCT02052310|2127692|FG000|Overall Study|Site Terminated by Sponsor|5
1073090|NCT02052310|2127693|FG001|Overall Study|Site Terminated by Sponsor|13
1073091|NCT02052310|2127692|FG000|Overall Study|Lost to Follow-up|4
1073092|NCT02052310|2127693|FG001|Overall Study|Lost to Follow-up|2
1073093|NCT02052310|2127692|FG000|Overall Study|Protocol Violation|1
1073094|NCT02052310|2127693|FG001|Overall Study|Protocol Violation|6
1073095|NCT02052414|2127699|FG000|Overall Study|Adverse Event|12
1073096|NCT02052414|2127699|FG000|Overall Study|Lack of Efficacy|2
1073097|NCT02052414|2127699|FG000|Overall Study|Withdrawal by Subject|3
1073098|NCT02052440|2127706|FG000|Overall Study|Withdrawal by Subject|0
1073099|NCT02052440|2127707|FG001|Overall Study|Withdrawal by Subject|1
1073100|NCT02052466|2127713|FG000|Overall Study|Withdrawal by Subject|1
1073101|NCT02052466|2127713|FG000|Overall Study|Acromial fracture|1
1073102|NCT02052596|2127735|FG000|Active Phase|Adverse Event|3
1073103|NCT02052596|2127736|FG001|Active Phase|Adverse Event|2
1073104|NCT02052596|2127735|FG000|Active Phase|Lost to Follow-up|8
1073105|NCT02052596|2127736|FG001|Active Phase|Lost to Follow-up|11
1073106|NCT02052596|2127735|FG000|Active Phase|Protocol Violation|1
1073107|NCT02052596|2127736|FG001|Active Phase|Protocol Violation|2
1073108|NCT02052596|2127735|FG000|Active Phase|Withdrawal by Subject|3
1073109|NCT02052596|2127736|FG001|Active Phase|Withdrawal by Subject|4
1073110|NCT02052596|2127735|FG000|Active Phase|Enrolled in error|1
1073111|NCT02052596|2127736|FG001|Active Phase|Enrolled in error|0
1073112|NCT02052596|2127735|FG000|Active Phase|Lost due to Crohn's disease|0
1073113|NCT02052596|2127736|FG001|Active Phase|Lost due to Crohn's disease|1
1073114|NCT02052596|2127735|FG000|Safety Phase|Adverse Event|6
1073115|NCT02052596|2127736|FG001|Safety Phase|Adverse Event|3
1073116|NCT02052596|2127735|FG000|Safety Phase|Lost to Follow-up|11
1073117|NCT02052596|2127736|FG001|Safety Phase|Lost to Follow-up|18
1073118|NCT02052596|2127735|FG000|Safety Phase|Protocol Violation|1
1073119|NCT02052596|2127736|FG001|Safety Phase|Protocol Violation|2
1073120|NCT02052596|2127735|FG000|Safety Phase|Withdrawal by Subject|8
1073121|NCT02052596|2127736|FG001|Safety Phase|Withdrawal by Subject|11
1073122|NCT02052596|2127735|FG000|Safety Phase|Enrolled in error|1
1073123|NCT02052596|2127736|FG001|Safety Phase|Enrolled in error|0
1073124|NCT02052596|2127735|FG000|Safety Phase|Lost due to Crohn's disease|0
1073125|NCT02052596|2127736|FG001|Safety Phase|Lost due to Crohn's disease|1
1073126|NCT02052960|2127783|FG000|Overall Study|Adverse Event|19
1073127|NCT02052960|2127784|FG001|Overall Study|Adverse Event|17
1073128|NCT02052960|2127783|FG000|Overall Study|Protocol Violation|4
1073129|NCT02052960|2127784|FG001|Overall Study|Protocol Violation|3
1073130|NCT02052960|2127783|FG000|Overall Study|Withdrawal by Subject|6
1073131|NCT02052960|2127784|FG001|Overall Study|Withdrawal by Subject|11
1073132|NCT02052960|2127783|FG000|Overall Study|Other|25
1073133|NCT02052960|2127784|FG001|Overall Study|Other|15
1073134|NCT02053168|2127797|FG000|Overall Study|Withdrawal by Subject|1
1073135|NCT02053168|2127797|FG000|Overall Study|Physician Decision|1
1073136|NCT02053168|2127797|FG000|Overall Study|Lost to Follow-up|1
1073137|NCT02053493|2127824|FG000|Overall Study|Withdrawal by Subject|1
1073138|NCT02053493|2127825|FG001|Overall Study|Withdrawal by Subject|1
1073139|NCT02053610|2127833|FG000|Overall Study|Adverse Event/Intercurrent Illness|25
1073140|NCT02053610|2127834|FG001|Overall Study|Adverse Event/Intercurrent Illness|43
1073141|NCT02053610|2127833|FG000|Overall Study|Withdrew Consent|2
1073142|NCT02053610|2127834|FG001|Overall Study|Withdrew Consent|9
1073143|NCT02053610|2127833|FG000|Overall Study|Death|5
1073144|NCT02053610|2127834|FG001|Overall Study|Death|5
1073145|NCT02053610|2127833|FG000|Overall Study|Administrative/Other|1
1073146|NCT02053610|2127834|FG001|Overall Study|Administrative/Other|1
1073147|NCT02053610|2127833|FG000|Overall Study|Disease Progression|2
1073148|NCT02053610|2127834|FG001|Overall Study|Disease Progression|3
1073149|NCT02053610|2127833|FG000|Overall Study|Refused treatment/Did not cooperate|1
1073150|NCT02053610|2127834|FG001|Overall Study|Refused treatment/Did not cooperate|3
1073151|NCT02053610|2127833|FG000|Overall Study|Did not Receive Treatment|4
1073152|NCT02053610|2127834|FG001|Overall Study|Did not Receive Treatment|2
1073153|NCT02053610|2127833|FG000|Overall Study|Insufficient Therapeutic Response|1
1073154|NCT02053610|2127834|FG001|Overall Study|Insufficient Therapeutic Response|1
1073155|NCT02053610|2127833|FG000|Overall Study|Violation of Selection Criteria|1
1073156|NCT02053610|2127834|FG001|Overall Study|Violation of Selection Criteria|0
1073157|NCT02053753|2127842|FG000|Overall Study|Withdrawal by Subject|2
1073158|NCT02053753|2127843|FG001|Overall Study|Withdrawal by Subject|4
1073159|NCT02053753|2127842|FG000|Overall Study|Decision by Sponsor|1
1073160|NCT02053753|2127843|FG001|Overall Study|Decision by Sponsor|1
1073161|NCT02053753|2127842|FG000|Overall Study|Lost to Follow-up|4
1073162|NCT02053753|2127843|FG001|Overall Study|Lost to Follow-up|3
1073163|NCT02054130|2127853|FG000|Overall Study|Withdrawal by Subject|4
1073164|NCT02054130|2127854|FG001|Overall Study|Withdrawal by Subject|4
1073165|NCT02054130|2127855|FG002|Overall Study|Withdrawal by Subject|7
1073166|NCT02054130|2127856|FG003|Overall Study|Withdrawal by Subject|10
1073167|NCT02054130|2127853|FG000|Overall Study|Death|0
1073168|NCT02054130|2127854|FG001|Overall Study|Death|1
1073169|NCT02054130|2127855|FG002|Overall Study|Death|0
1073170|NCT02054130|2127856|FG003|Overall Study|Death|0
1073171|NCT02054130|2127853|FG000|Overall Study|Lost to Follow-up|0
1073172|NCT02054130|2127854|FG001|Overall Study|Lost to Follow-up|0
1073173|NCT02054130|2127855|FG002|Overall Study|Lost to Follow-up|1
1073174|NCT02054130|2127856|FG003|Overall Study|Lost to Follow-up|2
1073175|NCT02054130|2127853|FG000|Overall Study|Missed dose|4
1073176|NCT02054130|2127854|FG001|Overall Study|Missed dose|6
1073177|NCT02054130|2127855|FG002|Overall Study|Missed dose|7
1073178|NCT02054130|2127856|FG003|Overall Study|Missed dose|10
1073179|NCT02054325|2127880|FG000|Overall Study|Lost to Follow-up|8
1073180|NCT02054325|2127881|FG001|Overall Study|Lost to Follow-up|5
1073181|NCT02054481|2127900|FG000|Overall Study|Adverse Event|1
1073182|NCT02054481|2127901|FG001|Overall Study|Adverse Event|1
1073183|NCT02054481|2127902|FG002|Overall Study|Adverse Event|0
1073184|NCT02054481|2127903|FG003|Overall Study|Adverse Event|1
1073185|NCT02054481|2127900|FG000|Overall Study|Lost to Follow-up|1
1073186|NCT02054481|2127901|FG001|Overall Study|Lost to Follow-up|0
1073187|NCT02054481|2127902|FG002|Overall Study|Lost to Follow-up|0
1073188|NCT02054481|2127903|FG003|Overall Study|Lost to Follow-up|0
1073189|NCT02054481|2127900|FG000|Overall Study|Other reason|2
1073190|NCT02054481|2127901|FG001|Overall Study|Other reason|1
1073191|NCT02054481|2127902|FG002|Overall Study|Other reason|2
1073192|NCT02054481|2127903|FG003|Overall Study|Other reason|0
1073193|NCT02054520|2127920|FG000|Overall Study|Adverse Event|1
1073194|NCT02054520|2127921|FG001|Overall Study|Adverse Event|4
1073195|NCT02054520|2127922|FG002|Overall Study|Adverse Event|2
1073196|NCT02054520|2127923|FG003|Overall Study|Adverse Event|1
1073197|NCT02054520|2127924|FG004|Overall Study|Adverse Event|1
1073198|NCT02054520|2127925|FG005|Overall Study|Adverse Event|0
1073199|NCT02054520|2127920|FG000|Overall Study|Lack of Efficacy|7
1073200|NCT02054520|2127921|FG001|Overall Study|Lack of Efficacy|0
1073201|NCT02054520|2127922|FG002|Overall Study|Lack of Efficacy|2
1073202|NCT02054520|2127923|FG003|Overall Study|Lack of Efficacy|1
1073203|NCT02054520|2127924|FG004|Overall Study|Lack of Efficacy|3
1073204|NCT02054520|2127925|FG005|Overall Study|Lack of Efficacy|2
1073205|NCT02054520|2127920|FG000|Overall Study|Withdrawal by Subject|1
1073206|NCT02054520|2127921|FG001|Overall Study|Withdrawal by Subject|0
1073207|NCT02054520|2127922|FG002|Overall Study|Withdrawal by Subject|0
1073208|NCT02054520|2127923|FG003|Overall Study|Withdrawal by Subject|2
1073209|NCT02054520|2127924|FG004|Overall Study|Withdrawal by Subject|1
1073210|NCT02054520|2127925|FG005|Overall Study|Withdrawal by Subject|0
1073211|NCT02054520|2127920|FG000|Overall Study|Physician Decision|0
1073212|NCT02054520|2127921|FG001|Overall Study|Physician Decision|1
1073213|NCT02054520|2127922|FG002|Overall Study|Physician Decision|0
1073214|NCT02054520|2127923|FG003|Overall Study|Physician Decision|1
1073215|NCT02054520|2127924|FG004|Overall Study|Physician Decision|0
1073216|NCT02054520|2127925|FG005|Overall Study|Physician Decision|1
1073217|NCT02054520|2127920|FG000|Overall Study|Study terminated by Sponsor|0
1073218|NCT02054520|2127921|FG001|Overall Study|Study terminated by Sponsor|0
1073219|NCT02054520|2127922|FG002|Overall Study|Study terminated by Sponsor|2
1073220|NCT02054520|2127923|FG003|Overall Study|Study terminated by Sponsor|1
1073221|NCT02054520|2127924|FG004|Overall Study|Study terminated by Sponsor|0
1073222|NCT02054520|2127925|FG005|Overall Study|Study terminated by Sponsor|0
1073223|NCT02054702|2127945|FG000|Overall Study|Lost to Follow-up|3
1073224|NCT02054702|2127946|FG001|Overall Study|Lost to Follow-up|5
1073225|NCT02054702|2127945|FG000|Overall Study|Adverse Event|3
1073226|NCT02054702|2127946|FG001|Overall Study|Adverse Event|1
1073227|NCT02054702|2127945|FG000|Overall Study|Met Withdrawal Criteria|4
1073228|NCT02054702|2127946|FG001|Overall Study|Met Withdrawal Criteria|1
1073229|NCT02054702|2127945|FG000|Overall Study|Physician Decision|0
1073230|NCT02054702|2127946|FG001|Overall Study|Physician Decision|1
1073231|NCT02054702|2127945|FG000|Overall Study|Withdrawal by Subject|14
1073232|NCT02054702|2127946|FG001|Overall Study|Withdrawal by Subject|4
1073233|NCT02054715|2127954|FG000|Baseline/Follow-up 1|Refused|1
1073234|NCT02054715|2127955|FG001|Baseline/Follow-up 1|Refused|3
1073235|NCT02054715|2127954|FG000|Baseline/Follow-up 1|Medical|0
1073236|NCT02054715|2127955|FG001|Baseline/Follow-up 1|Medical|1
1073237|NCT02054715|2127954|FG000|Baseline/Follow-up 1|Changed MD/Facility|0
1073238|NCT02054715|2127955|FG001|Baseline/Follow-up 1|Changed MD/Facility|1
1073239|NCT02054715|2127954|FG000|Baseline/Follow-up 1|Disliked Procedure|0
1073240|NCT02054715|2127955|FG001|Baseline/Follow-up 1|Disliked Procedure|1
1073241|NCT02054715|2127954|FG000|Baseline/Follow-up 1|No Reason|0
1073242|NCT02054715|2127955|FG001|Baseline/Follow-up 1|No Reason|1
1073243|NCT02054715|2127954|FG000|Baseline/Follow-up 1|Overwhelmed|2
1073244|NCT02054715|2127955|FG001|Baseline/Follow-up 1|Overwhelmed|0
1073245|NCT02054715|2127954|FG000|Baseline/Follow-up 1|Ineligible|3
1073246|NCT02054715|2127955|FG001|Baseline/Follow-up 1|Ineligible|0
1073247|NCT02054715|2127954|FG000|Baseline/Follow-up 1|Hospitalization|1
1073248|NCT02054715|2127955|FG001|Baseline/Follow-up 1|Hospitalization|0
1073249|NCT02054715|2127954|FG000|Baseline/Follow-up 1|Changed Mind|1
1073250|NCT02054715|2127955|FG001|Baseline/Follow-up 1|Changed Mind|0
1073251|NCT02054715|2127954|FG000|Follow-up 2|Lost to Followup|3
1073252|NCT02054715|2127955|FG001|Follow-up 2|Lost to Followup|1
1073253|NCT02054715|2127954|FG000|Follow-up 2|Refused|3
1073254|NCT02054715|2127955|FG001|Follow-up 2|Refused|2
1073255|NCT02054715|2127954|FG000|Follow-up 2|Followup Not Completed|3
1073256|NCT02054715|2127955|FG001|Follow-up 2|Followup Not Completed|4
1073257|NCT02054715|2127954|FG000|Follow-up 2|Ineligible|4
1073258|NCT02054715|2127955|FG001|Follow-up 2|Ineligible|5
1073259|NCT02054715|2127954|FG000|Follow-up 2|Death|3
1073260|NCT02054715|2127955|FG001|Follow-up 2|Death|3
1073261|NCT02054715|2127954|FG000|Follow-up 2|Hospitalization|0
1073262|NCT02054715|2127955|FG001|Follow-up 2|Hospitalization|2
1073263|NCT02054715|2127954|FG000|Follow-up 2|Changed MD/Facility|0
1073264|NCT02054715|2127955|FG001|Follow-up 2|Changed MD/Facility|1
1073265|NCT02054715|2127954|FG000|Follow-up 2|Changed Mind|0
1073266|NCT02054715|2127955|FG001|Follow-up 2|Changed Mind|1
1073267|NCT02054715|2127954|FG000|Follow-up 2|No Reason|2
1073268|NCT02054715|2127955|FG001|Follow-up 2|No Reason|0
1073269|NCT02054715|2127954|FG000|Follow-up 2|Treatment Change or Delay|1
1073270|NCT02054715|2127955|FG001|Follow-up 2|Treatment Change or Delay|0
1073271|NCT02054897|2127986|FG000|Overall Study|Withdrawal by Subject|2
1073272|NCT02054897|2127987|FG001|Overall Study|Withdrawal by Subject|0
1073273|NCT02054897|2127988|FG002|Overall Study|Withdrawal by Subject|2
1073274|NCT02054897|2127986|FG000|Overall Study|Missing follow-up information|3
1073275|NCT02054897|2127987|FG001|Overall Study|Missing follow-up information|5
1073276|NCT02054897|2127988|FG002|Overall Study|Missing follow-up information|3
1073277|NCT02054897|2127986|FG000|Overall Study|Lost to Follow-up|4
1073278|NCT02054897|2127987|FG001|Overall Study|Lost to Follow-up|2
1073279|NCT02054897|2127988|FG002|Overall Study|Lost to Follow-up|7
1073280|NCT02054897|2127986|FG000|Overall Study|Randomized but not exposed|1
1073281|NCT02054897|2127987|FG001|Overall Study|Randomized but not exposed|0
1073282|NCT02054897|2127988|FG002|Overall Study|Randomized but not exposed|0
1073283|NCT02055118|2128008|FG000|Overall Study|Withdrawal by Subject|0
1073284|NCT02055118|2128009|FG001|Overall Study|Withdrawal by Subject|2
1073285|NCT02055118|2128010|FG002|Overall Study|Withdrawal by Subject|0
1073286|NCT02055157|2128023|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
1073287|NCT02055157|2128024|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1
1073288|NCT02055157|2128025|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
1073289|NCT02055157|2128026|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
1073290|NCT02055157|2128023|FG000|Initial 6 Months|Adverse Event|0
1073291|NCT02055157|2128024|FG001|Initial 6 Months|Adverse Event|0
1073292|NCT02055157|2128025|FG002|Initial 6 Months|Adverse Event|0
1073293|NCT02055157|2128026|FG003|Initial 6 Months|Adverse Event|1
1073294|NCT02055157|2128023|FG000|Initial 6 Months|Consent withdrawn by subject|1
1073295|NCT02055157|2128024|FG001|Initial 6 Months|Consent withdrawn by subject|0
1073296|NCT02055157|2128025|FG002|Initial 6 Months|Consent withdrawn by subject|0
1073297|NCT02055157|2128026|FG003|Initial 6 Months|Consent withdrawn by subject|0
1073298|NCT02055157|2128023|FG000|18-month Extension|Investigator decision|0
1073299|NCT02055157|2128024|FG001|18-month Extension|Investigator decision|1
1073300|NCT02055157|2128025|FG002|18-month Extension|Investigator decision|0
1073301|NCT02055157|2128026|FG003|18-month Extension|Investigator decision|0
1073302|NCT02055157|2128023|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1
1073303|NCT02055157|2128024|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0
1073304|NCT02055157|2128025|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0
1073305|NCT02055157|2128026|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0
1073306|NCT02055352|2128049|FG000|Overall Study|Adverse Event|0
1073307|NCT02055352|2128050|FG001|Overall Study|Adverse Event|1
1073308|NCT02055352|2128049|FG000|Overall Study|Non-eligible|0
1073309|NCT02055352|2128050|FG001|Overall Study|Non-eligible|1
1073310|NCT02055352|2128049|FG000|Overall Study|Poor compliance|1
1073311|NCT02055352|2128050|FG001|Overall Study|Poor compliance|1
1073312|NCT02055352|2128049|FG000|Overall Study|Death|1
1073313|NCT02055352|2128050|FG001|Overall Study|Death|2
1073314|NCT02055352|2128049|FG000|Overall Study|Patient decision|1
1073315|NCT02055352|2128050|FG001|Overall Study|Patient decision|1
1073316|NCT02055352|2128049|FG000|Overall Study|Use of prohibited treatment|0
1073317|NCT02055352|2128050|FG001|Overall Study|Use of prohibited treatment|3
1073318|NCT02055352|2128049|FG000|Overall Study|AE, study drug would be detrimental|1
1073319|NCT02055352|2128050|FG001|Overall Study|AE, study drug would be detrimental|3
1073320|NCT02055352|2128049|FG000|Overall Study|Withdrawal of informed consent|1
1073321|NCT02055352|2128050|FG001|Overall Study|Withdrawal of informed consent|0
1073322|NCT02055352|2128049|FG000|Overall Study|Reason unknown|1
1073323|NCT02055352|2128050|FG001|Overall Study|Reason unknown|5
1073324|NCT02055365|2128056|FG000|Overall Study|Prematurely Withdrawn|1
1073325|NCT02055820|2128173|FG000|Phase I: Dose-Finding|Death|1
1073326|NCT02055820|2128174|FG001|Phase I: Dose-Finding|Death|0
1073327|NCT02055820|2128175|FG002|Phase I: Dose-Finding|Death|1
1073328|NCT02055820|2128176|FG003|Phase I: Dose-Finding|Death|2
1073329|NCT02055820|2128177|FG004|Phase I: Dose-Finding|Death|0
1073330|NCT02055820|2128178|FG005|Phase I: Dose-Finding|Death|1
1073331|NCT02055820|2128179|FG006|Phase I: Dose-Finding|Death|1
1073332|NCT02055820|2128180|FG007|Phase I: Dose-Finding|Death|0
1073333|NCT02055820|2128181|FG008|Phase I: Dose-Finding|Death|0
1073334|NCT02055820|2128182|FG009|Phase I: Dose-Finding|Death|0
1073335|NCT02055820|2128173|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0
1073336|NCT02055820|2128174|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0
1073337|NCT02055820|2128175|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0
1073338|NCT02055820|2128176|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0
1073339|NCT02055820|2128177|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0
1073340|NCT02055820|2128178|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1
1073341|NCT02055820|2128179|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0
1073342|NCT02055820|2128180|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0
1073343|NCT02055820|2128181|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0
1073344|NCT02055820|2128182|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0
1073345|NCT02055820|2128173|FG000|Phase I: Dose-Finding|Lost to Follow-up|0
1073346|NCT02055820|2128174|FG001|Phase I: Dose-Finding|Lost to Follow-up|0
1073347|NCT02055820|2128175|FG002|Phase I: Dose-Finding|Lost to Follow-up|0
1073348|NCT02055820|2128176|FG003|Phase I: Dose-Finding|Lost to Follow-up|1
1073349|NCT02055820|2128177|FG004|Phase I: Dose-Finding|Lost to Follow-up|0
1073350|NCT02055820|2128178|FG005|Phase I: Dose-Finding|Lost to Follow-up|0
1073351|NCT02055820|2128179|FG006|Phase I: Dose-Finding|Lost to Follow-up|1
1073352|NCT02055820|2128180|FG007|Phase I: Dose-Finding|Lost to Follow-up|0
1073353|NCT02055820|2128181|FG008|Phase I: Dose-Finding|Lost to Follow-up|0
1073354|NCT02055820|2128182|FG009|Phase I: Dose-Finding|Lost to Follow-up|0
1073355|NCT02055820|2128173|FG000|Phase II: Expansion|Death|0
1073356|NCT02055820|2128174|FG001|Phase II: Expansion|Death|0
1073357|NCT02055820|2128175|FG002|Phase II: Expansion|Death|0
1073358|NCT02055820|2128176|FG003|Phase II: Expansion|Death|0
1073359|NCT02055820|2128177|FG004|Phase II: Expansion|Death|33
1073360|NCT02055820|2128178|FG005|Phase II: Expansion|Death|0
1073361|NCT02055820|2128179|FG006|Phase II: Expansion|Death|0
1073362|NCT02055820|2128180|FG007|Phase II: Expansion|Death|0
1073363|NCT02055820|2128181|FG008|Phase II: Expansion|Death|0
1073364|NCT02055820|2128182|FG009|Phase II: Expansion|Death|0
1073365|NCT02055820|2128173|FG000|Phase II: Expansion|Lost to Follow-up|0
1073366|NCT02055820|2128174|FG001|Phase II: Expansion|Lost to Follow-up|0
1073367|NCT02055820|2128175|FG002|Phase II: Expansion|Lost to Follow-up|0
1073368|NCT02055820|2128176|FG003|Phase II: Expansion|Lost to Follow-up|0
1073369|NCT02055820|2128177|FG004|Phase II: Expansion|Lost to Follow-up|4
1073370|NCT02055820|2128178|FG005|Phase II: Expansion|Lost to Follow-up|0
1073371|NCT02055820|2128179|FG006|Phase II: Expansion|Lost to Follow-up|0
1073372|NCT02055820|2128180|FG007|Phase II: Expansion|Lost to Follow-up|0
1073373|NCT02055820|2128181|FG008|Phase II: Expansion|Lost to Follow-up|0
1073374|NCT02055820|2128182|FG009|Phase II: Expansion|Lost to Follow-up|0
1073375|NCT02055820|2128173|FG000|Phase II: Expansion|Withdrawal by Subject|0
1073376|NCT02055820|2128174|FG001|Phase II: Expansion|Withdrawal by Subject|0
1073377|NCT02055820|2128175|FG002|Phase II: Expansion|Withdrawal by Subject|0
1073378|NCT02055820|2128176|FG003|Phase II: Expansion|Withdrawal by Subject|0
1073379|NCT02055820|2128177|FG004|Phase II: Expansion|Withdrawal by Subject|12
1073380|NCT02055820|2128178|FG005|Phase II: Expansion|Withdrawal by Subject|0
1073381|NCT02055820|2128179|FG006|Phase II: Expansion|Withdrawal by Subject|0
1073382|NCT02055820|2128180|FG007|Phase II: Expansion|Withdrawal by Subject|0
1073383|NCT02055820|2128181|FG008|Phase II: Expansion|Withdrawal by Subject|0
1073384|NCT02055820|2128182|FG009|Phase II: Expansion|Withdrawal by Subject|0
1073385|NCT02055898|2128226|FG000|First Intervention (5 Days)|Physician Decision|2
1073386|NCT02055898|2128227|FG001|First Intervention (5 Days)|Physician Decision|0
1073387|NCT02055898|2128226|FG000|First Intervention (5 Days)|Withdrawal by Subject|0
1073388|NCT02055898|2128227|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
1073389|NCT02055976|2128242|FG000|Overall Study|Other|0
1073390|NCT02055976|2128243|FG001|Overall Study|Other|0
1073391|NCT02055976|2128244|FG002|Overall Study|Other|1
1073392|NCT02055976|2128245|FG003|Overall Study|Other|0
1073393|NCT02055976|2128246|FG004|Overall Study|Other|0
1073394|NCT02055976|2128247|FG005|Overall Study|Other|0
1073395|NCT02055976|2128248|FG006|Overall Study|Other|0
1073396|NCT02055976|2128249|FG007|Overall Study|Other|0
1073397|NCT02055976|2128250|FG008|Overall Study|Other|0
1073398|NCT02055976|2128242|FG000|Overall Study|Adverse Event|0
1073399|NCT02055976|2128243|FG001|Overall Study|Adverse Event|0
1073400|NCT02055976|2128244|FG002|Overall Study|Adverse Event|0
1073401|NCT02055976|2128245|FG003|Overall Study|Adverse Event|0
1073402|NCT02055976|2128246|FG004|Overall Study|Adverse Event|0
1073403|NCT02055976|2128247|FG005|Overall Study|Adverse Event|1
1073404|NCT02055976|2128248|FG006|Overall Study|Adverse Event|1
1073405|NCT02055976|2128249|FG007|Overall Study|Adverse Event|0
1073406|NCT02055976|2128250|FG008|Overall Study|Adverse Event|0
1073407|NCT02055976|2128242|FG000|Overall Study|Does not meet entrance criteria|0
1073408|NCT02055976|2128243|FG001|Overall Study|Does not meet entrance criteria|0
1073409|NCT02055976|2128244|FG002|Overall Study|Does not meet entrance criteria|0
1073410|NCT02055976|2128245|FG003|Overall Study|Does not meet entrance criteria|0
1073411|NCT02055976|2128246|FG004|Overall Study|Does not meet entrance criteria|0
1073412|NCT02055976|2128247|FG005|Overall Study|Does not meet entrance criteria|0
1073413|NCT02055976|2128248|FG006|Overall Study|Does not meet entrance criteria|1
1073414|NCT02055976|2128249|FG007|Overall Study|Does not meet entrance criteria|0
1073415|NCT02055976|2128250|FG008|Overall Study|Does not meet entrance criteria|0
1073416|NCT02055976|2128242|FG000|Overall Study|Lost to Follow-up|0
1073417|NCT02055976|2128243|FG001|Overall Study|Lost to Follow-up|0
1073418|NCT02055976|2128244|FG002|Overall Study|Lost to Follow-up|0
1073419|NCT02055976|2128245|FG003|Overall Study|Lost to Follow-up|1
1073420|NCT02055976|2128246|FG004|Overall Study|Lost to Follow-up|0
1073421|NCT02055976|2128247|FG005|Overall Study|Lost to Follow-up|0
1073422|NCT02055976|2128248|FG006|Overall Study|Lost to Follow-up|0
1073423|NCT02055976|2128249|FG007|Overall Study|Lost to Follow-up|0
1073424|NCT02055976|2128250|FG008|Overall Study|Lost to Follow-up|0
1073425|NCT02056288|2128288|FG000|In-Hospital Data|Surgery cancelled|1
1073426|NCT02056288|2128289|FG001|In-Hospital Data|Surgery cancelled|0
1073427|NCT02056288|2128288|FG000|In-Hospital Data|Protocol Violation|3
1073428|NCT02056288|2128289|FG001|In-Hospital Data|Protocol Violation|0
1073429|NCT02056288|2128288|FG000|In-Hospital Data|Physician Decision|1
1073430|NCT02056288|2128289|FG001|In-Hospital Data|Physician Decision|0
1073431|NCT02056288|2128288|FG000|48-Hour Post-Discharge Data|Did not return diary|14
1073432|NCT02056288|2128289|FG001|48-Hour Post-Discharge Data|Did not return diary|20
1073433|NCT02056301|2128297|FG000|Overall Study|Protocol Violation|1
1073434|NCT02056301|2128298|FG001|Overall Study|Protocol Violation|2
1073435|NCT02056301|2128297|FG000|Overall Study|Surgical complications req. 2nd surgery|1
1073436|NCT02056301|2128298|FG001|Overall Study|Surgical complications req. 2nd surgery|0
1073437|NCT02056301|2128297|FG000|Overall Study|Withdrawal by Subject|0
1073438|NCT02056301|2128298|FG001|Overall Study|Withdrawal by Subject|1
1073439|NCT02056301|2128297|FG000|Overall Study|Issues with epidural|0
1073440|NCT02056301|2128298|FG001|Overall Study|Issues with epidural|3
1073441|NCT02056340|2128306|FG000|Overall Study|Lost to Follow-up|5
1073442|NCT02056340|2128307|FG001|Overall Study|Lost to Follow-up|5
1073443|NCT02056340|2128306|FG000|Overall Study|Withdrawal by Subject|2
1073444|NCT02056340|2128307|FG001|Overall Study|Withdrawal by Subject|6
1073445|NCT02056392|2128319|FG000|Overall Study|Lost to Follow-up|0
1073446|NCT02056392|2128320|FG001|Overall Study|Lost to Follow-up|1
1073447|NCT02056392|2128321|FG002|Overall Study|Lost to Follow-up|2
1073448|NCT02056392|2128322|FG003|Overall Study|Lost to Follow-up|0
1073449|NCT02056392|2128323|FG004|Overall Study|Lost to Follow-up|0
1073450|NCT02056392|2128324|FG005|Overall Study|Lost to Follow-up|0
1073451|NCT02056392|2128319|FG000|Overall Study|Protocol Violation|1
1073452|NCT02056392|2128320|FG001|Overall Study|Protocol Violation|0
1073453|NCT02056392|2128321|FG002|Overall Study|Protocol Violation|1
1073454|NCT02056392|2128322|FG003|Overall Study|Protocol Violation|0
1073455|NCT02056392|2128323|FG004|Overall Study|Protocol Violation|0
1073456|NCT02056392|2128324|FG005|Overall Study|Protocol Violation|0
1073457|NCT02056392|2128319|FG000|Overall Study|Withdrawal by Subject|1
1073458|NCT02056392|2128320|FG001|Overall Study|Withdrawal by Subject|0
1073459|NCT02056392|2128321|FG002|Overall Study|Withdrawal by Subject|0
1073460|NCT02056392|2128322|FG003|Overall Study|Withdrawal by Subject|0
1073461|NCT02056392|2128323|FG004|Overall Study|Withdrawal by Subject|1
1073462|NCT02056392|2128324|FG005|Overall Study|Withdrawal by Subject|0
1073463|NCT02056626|2128347|FG000|Overall Study|patient did not follow directions|3
1073464|NCT02056626|2128348|FG001|Overall Study|patient did not follow directions|1
1073465|NCT02056626|2128349|FG002|Overall Study|patient did not follow directions|0
1073466|NCT02056626|2128350|FG003|Overall Study|patient did not follow directions|0
1073467|NCT02056652|2128373|FG000|Overall Study|Withdrawal by Subject|1
1073468|NCT02056652|2128374|FG001|Overall Study|Withdrawal by Subject|0
1073469|NCT02056652|2128373|FG000|Overall Study|Lost to Follow-up|0
1073470|NCT02056652|2128374|FG001|Overall Study|Lost to Follow-up|3
1073471|NCT02056834|2128380|FG000|Overall Study|Lost to Follow-up|7
1073472|NCT02057068|2128396|FG000|Overall Study|Withdrawal by Subject|2
1073473|NCT02057068|2128397|FG001|Overall Study|Withdrawal by Subject|2
1073474|NCT02057068|2128396|FG000|Overall Study|Caregiver (CG) Health|0
1073475|NCT02057068|2128397|FG001|Overall Study|Caregiver (CG) Health|2
1073476|NCT02057068|2128396|FG000|Overall Study|Carepartner (CP) Health|4
1073477|NCT02057068|2128397|FG001|Overall Study|Carepartner (CP) Health|2
1073478|NCT02057068|2128396|FG000|Overall Study|Lost to Follow-up|2
1073479|NCT02057068|2128397|FG001|Overall Study|Lost to Follow-up|2
1073480|NCT02057198|2128417|FG000|Overall Study|Death|0
1073481|NCT02057198|2128418|FG001|Overall Study|Death|0
1073482|NCT02057198|2128419|FG002|Overall Study|Death|1
1073483|NCT02057198|2128417|FG000|Overall Study|Discharged early; lost to followup|0
1073484|NCT02057198|2128418|FG001|Overall Study|Discharged early; lost to followup|1
1073485|NCT02057198|2128419|FG002|Overall Study|Discharged early; lost to followup|0
1073486|NCT02057250|2128431|FG000|AID Assessment Phase|Adverse Event|3
1073487|NCT02057250|2128432|FG001|AID Assessment Phase|Adverse Event|2
1073488|NCT02057250|2128433|FG002|AID Assessment Phase|Adverse Event|6
1073489|NCT02057250|2128434|FG003|AID Assessment Phase|Adverse Event|1
1073490|NCT02057250|2128435|FG004|AID Assessment Phase|Adverse Event|0
1073491|NCT02057250|2128431|FG000|AID Assessment Phase|Other than specified above|1
1073492|NCT02057250|2128432|FG001|AID Assessment Phase|Other than specified above|1
1073493|NCT02057250|2128433|FG002|AID Assessment Phase|Other than specified above|1
1073494|NCT02057250|2128434|FG003|AID Assessment Phase|Other than specified above|1
1073495|NCT02057250|2128435|FG004|AID Assessment Phase|Other than specified above|0
1073496|NCT02057250|2128431|FG000|Extension Phase|Adverse Event|0
1073497|NCT02057250|2128432|FG001|Extension Phase|Adverse Event|0
1073498|NCT02057250|2128433|FG002|Extension Phase|Adverse Event|0
1073499|NCT02057250|2128434|FG003|Extension Phase|Adverse Event|0
1073500|NCT02057250|2128435|FG004|Extension Phase|Adverse Event|15
1073501|NCT02057250|2128431|FG000|Extension Phase|Lack of Efficacy|0
1073502|NCT02057250|2128432|FG001|Extension Phase|Lack of Efficacy|0
1073503|NCT02057250|2128433|FG002|Extension Phase|Lack of Efficacy|0
1073504|NCT02057250|2128434|FG003|Extension Phase|Lack of Efficacy|0
1073505|NCT02057250|2128435|FG004|Extension Phase|Lack of Efficacy|10
1073506|NCT02057250|2128431|FG000|Extension Phase|Entered in this period but not treated|0
1073507|NCT02057250|2128432|FG001|Extension Phase|Entered in this period but not treated|0
1073508|NCT02057250|2128433|FG002|Extension Phase|Entered in this period but not treated|0
1073509|NCT02057250|2128434|FG003|Extension Phase|Entered in this period but not treated|0
1073510|NCT02057250|2128435|FG004|Extension Phase|Entered in this period but not treated|4
1073511|NCT02057250|2128431|FG000|Extension Phase|Other than specified above|0
1073512|NCT02057250|2128432|FG001|Extension Phase|Other than specified above|0
1073513|NCT02057250|2128433|FG002|Extension Phase|Other than specified above|0
1073514|NCT02057250|2128434|FG003|Extension Phase|Other than specified above|0
1073515|NCT02057250|2128435|FG004|Extension Phase|Other than specified above|7
1073516|NCT02057393|2128447|FG000|Overall Study|Withdrawal by Subject|1
1073517|NCT02057393|2128447|FG000|Overall Study|Patient did not meet criteria|1
1073518|NCT02057406|2128454|FG000|Overall Study|Physician Decision|0
1073519|NCT02057406|2128455|FG001|Overall Study|Physician Decision|0
1073520|NCT02057406|2128456|FG002|Overall Study|Physician Decision|2
1073521|NCT02057406|2128454|FG000|Overall Study|Withdrawal by Subject|0
1073522|NCT02057406|2128455|FG001|Overall Study|Withdrawal by Subject|2
1073523|NCT02057406|2128456|FG002|Overall Study|Withdrawal by Subject|0
1073524|NCT02057406|2128454|FG000|Overall Study|Lost to Follow-up|0
1073525|NCT02057406|2128455|FG001|Overall Study|Lost to Follow-up|0
1073526|NCT02057406|2128456|FG002|Overall Study|Lost to Follow-up|1
1073527|NCT02057406|2128454|FG000|Overall Study|Death|1
1073528|NCT02057406|2128455|FG001|Overall Study|Death|0
1073529|NCT02057406|2128456|FG002|Overall Study|Death|0
1073530|NCT02057406|2128454|FG000|Overall Study|Protocol Violation|0
1073531|NCT02057406|2128455|FG001|Overall Study|Protocol Violation|1
1073532|NCT02057406|2128456|FG002|Overall Study|Protocol Violation|0
1073533|NCT02057406|2128454|FG000|Overall Study|Patient transportation issues|0
1073534|NCT02057406|2128455|FG001|Overall Study|Patient transportation issues|0
1073535|NCT02057406|2128456|FG002|Overall Study|Patient transportation issues|1
1073536|NCT02057458|2128464|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0
1073537|NCT02057458|2128465|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1
1073538|NCT02057458|2128466|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0
1073539|NCT02057458|2128464|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
1073540|NCT02057458|2128465|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
1073541|NCT02057458|2128466|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
1073542|NCT02057458|2128464|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
1073543|NCT02057458|2128465|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
1073544|NCT02057458|2128466|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
1073545|NCT02057523|2128496|FG000|Overall Study|Withdrawal by Subject|1
1073546|NCT02057523|2128496|FG000|Overall Study|Lack of Efficacy|1
1073547|NCT02057549|2128502|FG000|Overall Study|Lost to Follow-up|1
1073548|NCT02057549|2128503|FG001|Overall Study|Lost to Follow-up|0
1073549|NCT02057549|2128502|FG000|Overall Study|Physician Decision|1
1073550|NCT02057549|2128503|FG001|Overall Study|Physician Decision|0
1073551|NCT02057549|2128502|FG000|Overall Study|Withdrawal by Subject|1
1073552|NCT02057549|2128503|FG001|Overall Study|Withdrawal by Subject|0
1073553|NCT02057575|2128513|FG000|Overall Study|Adverse Event|0
1073554|NCT02057575|2128514|FG001|Overall Study|Adverse Event|2
1073555|NCT02057575|2128515|FG002|Overall Study|Adverse Event|0
1073556|NCT02057575|2128516|FG003|Overall Study|Adverse Event|1
1073557|NCT02057575|2128513|FG000|Overall Study|Withdrawal by Subject|1
1073558|NCT02057575|2128514|FG001|Overall Study|Withdrawal by Subject|0
1073559|NCT02057575|2128515|FG002|Overall Study|Withdrawal by Subject|0
1073560|NCT02057575|2128516|FG003|Overall Study|Withdrawal by Subject|0
1073561|NCT02057575|2128513|FG000|Overall Study|Dissallowed Concurrent Medication|0
1073562|NCT02057575|2128514|FG001|Overall Study|Dissallowed Concurrent Medication|1
1073563|NCT02057575|2128515|FG002|Overall Study|Dissallowed Concurrent Medication|0
1073564|NCT02057575|2128516|FG003|Overall Study|Dissallowed Concurrent Medication|0
1073565|NCT02057575|2128513|FG000|Overall Study|Protocol Violation|0
1073566|NCT02057575|2128514|FG001|Overall Study|Protocol Violation|1
1073567|NCT02057575|2128515|FG002|Overall Study|Protocol Violation|0
1073568|NCT02057575|2128516|FG003|Overall Study|Protocol Violation|0
1073569|NCT02057666|2128538|FG000|Double Blind Treatment Period|Withdrawal by Subject|8
1073570|NCT02057666|2128539|FG001|Double Blind Treatment Period|Withdrawal by Subject|5
1073571|NCT02057666|2128538|FG000|Double Blind Treatment Period|Poor tolerability|7
1073572|NCT02057666|2128539|FG001|Double Blind Treatment Period|Poor tolerability|2
1073573|NCT02057666|2128538|FG000|Double Blind Treatment Period|Symptomatic disease progression|8
1073574|NCT02057666|2128539|FG001|Double Blind Treatment Period|Symptomatic disease progression|3
1073575|NCT02057666|2128538|FG000|Double Blind Treatment Period|Physician Decision|1
1073576|NCT02057666|2128539|FG001|Double Blind Treatment Period|Physician Decision|0
1073577|NCT02057666|2128538|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1
1073578|NCT02057666|2128539|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0
1073579|NCT02057666|2128538|FG000|Double Blind Treatment Period|Subject planning to withdraw|1
1073580|NCT02057666|2128539|FG001|Double Blind Treatment Period|Subject planning to withdraw|0
1073581|NCT02057666|2128538|FG000|Double Blind Treatment Period|Sponsor's request|70
1073582|NCT02057666|2128539|FG001|Double Blind Treatment Period|Sponsor's request|34
1073583|NCT02057666|2128538|FG000|Open-Label Treatment Period|Poor tolerability|0
1073584|NCT02057666|2128539|FG001|Open-Label Treatment Period|Poor tolerability|1
1073585|NCT02057666|2128538|FG000|Open-Label Treatment Period|Symptomatic disease progression|0
1073586|NCT02057666|2128539|FG001|Open-Label Treatment Period|Symptomatic disease progression|1
1073587|NCT02057666|2128538|FG000|Open-Label Treatment Period|Sponsor's request|0
1073588|NCT02057666|2128539|FG001|Open-Label Treatment Period|Sponsor's request|4
1073589|NCT02057692|2128549|FG000|Overall Study|Adverse Event|1
1073590|NCT02057692|2128550|FG001|Overall Study|Adverse Event|0
1073591|NCT02057692|2128551|FG002|Overall Study|Adverse Event|0
1073592|NCT02057692|2128552|FG003|Overall Study|Adverse Event|0
1073593|NCT02057692|2128549|FG000|Overall Study|Lost to Follow-up|0
1073594|NCT02057692|2128550|FG001|Overall Study|Lost to Follow-up|0
1073595|NCT02057692|2128551|FG002|Overall Study|Lost to Follow-up|0
1073596|NCT02057692|2128552|FG003|Overall Study|Lost to Follow-up|1
1073597|NCT02057718|2128570|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0
1073598|NCT02057718|2128571|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2
1073599|NCT02057718|2128570|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1
1073600|NCT02057718|2128571|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0
1073601|NCT02057718|2128570|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0
1073602|NCT02057718|2128571|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1
1073603|NCT02057718|2128570|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0
1073604|NCT02057718|2128571|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3
1073605|NCT02057718|2128570|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
1073606|NCT02057718|2128571|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
1073607|NCT02057718|2128570|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0
1073608|NCT02057718|2128571|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1
1073609|NCT02057718|2128570|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0
1073610|NCT02057718|2128571|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1
1073611|NCT02057718|2128570|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1
1073612|NCT02057718|2128571|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3
1073613|NCT02057718|2128570|FG000|Optional Follow-up Treatment Period|Progressive disease|0
1073614|NCT02057718|2128571|FG001|Optional Follow-up Treatment Period|Progressive disease|1
1073615|NCT02057718|2128570|FG000|Optional Follow-up Treatment Period|Adverse Event|1
1073616|NCT02057718|2128571|FG001|Optional Follow-up Treatment Period|Adverse Event|2
1073617|NCT02057718|2128570|FG000|Optional Follow-up Treatment Period|Liver Transplant|0
1073618|NCT02057718|2128571|FG001|Optional Follow-up Treatment Period|Liver Transplant|2
1073619|NCT02057757|2128579|FG000|Overall Study|Withdrawal by Subject|3
1073620|NCT02057757|2128580|FG001|Overall Study|Withdrawal by Subject|5
1073621|NCT02057757|2128579|FG000|Overall Study|Death|2
1073622|NCT02057757|2128580|FG001|Overall Study|Death|0
1073623|NCT02057757|2128579|FG000|Overall Study|Lost to Follow-up|8
1073624|NCT02057757|2128580|FG001|Overall Study|Lost to Follow-up|3
1073625|NCT02057757|2128579|FG000|Overall Study|Non-compliance|1
1073626|NCT02057757|2128580|FG001|Overall Study|Non-compliance|0
1073627|NCT02057835|2128600|FG000|Overall Study|Withdrawal by Subject|0
1073628|NCT02057835|2128601|FG001|Overall Study|Withdrawal by Subject|2
1073629|NCT02057835|2128602|FG002|Overall Study|Withdrawal by Subject|0
1073630|NCT02057835|2128603|FG003|Overall Study|Withdrawal by Subject|0
1073631|NCT02057835|2128604|FG004|Overall Study|Withdrawal by Subject|0
1073632|NCT02057835|2128605|FG005|Overall Study|Withdrawal by Subject|0
1073633|NCT02057835|2128606|FG006|Overall Study|Withdrawal by Subject|0
1073634|NCT02057835|2128607|FG007|Overall Study|Withdrawal by Subject|0
1073635|NCT02057835|2128608|FG008|Overall Study|Withdrawal by Subject|0
1073636|NCT02057835|2128609|FG009|Overall Study|Withdrawal by Subject|0
1073637|NCT02058069|2128655|FG000|Overall Study|Exclusion due to implant size|5
1073638|NCT02058069|2128655|FG000|Overall Study|Withdrawal by Subject|6
1073639|NCT02058095|2128661|FG000|Overall Study|Adverse Event|1
1073640|NCT02058095|2128662|FG001|Overall Study|Adverse Event|0
1073641|NCT02058108|2128670|FG000|Overall Study|Abnormal Laboratory Values|0
1073642|NCT02058108|2128671|FG001|Overall Study|Abnormal Laboratory Values|1
1073643|NCT02058108|2128670|FG000|Overall Study|Unsatisfactory therapeutic effect|37
1073644|NCT02058108|2128671|FG001|Overall Study|Unsatisfactory therapeutic effect|4
1073645|NCT02058108|2128670|FG000|Overall Study|No longer requires study drug|0
1073646|NCT02058108|2128671|FG001|Overall Study|No longer requires study drug|1
1073647|NCT02058108|2128670|FG000|Overall Study|Withdrawal by Subject|1
1073648|NCT02058108|2128671|FG001|Overall Study|Withdrawal by Subject|0
1073649|NCT02058108|2128670|FG000|Overall Study|Administrative problems|3
1073650|NCT02058108|2128671|FG001|Overall Study|Administrative problems|3
1073651|NCT02058108|2128670|FG000|Overall Study|Protocol Violation|0
1073652|NCT02058108|2128671|FG001|Overall Study|Protocol Violation|1
1073653|NCT02058147|2128682|FG000|Overall Study|Randomized but not treated|0
1073654|NCT02058147|2128683|FG001|Overall Study|Randomized but not treated|0
1073655|NCT02058147|2128684|FG002|Overall Study|Randomized but not treated|1
1073656|NCT02058147|2128682|FG000|Overall Study|Adverse Event|12
1073657|NCT02058147|2128683|FG001|Overall Study|Adverse Event|9
1073658|NCT02058147|2128684|FG002|Overall Study|Adverse Event|21
1073659|NCT02058147|2128682|FG000|Overall Study|Lack of Efficacy|1
1073660|NCT02058147|2128683|FG001|Overall Study|Lack of Efficacy|0
1073661|NCT02058147|2128684|FG002|Overall Study|Lack of Efficacy|3
1073662|NCT02058147|2128682|FG000|Overall Study|Poor compliance to protocol|8
1073663|NCT02058147|2128683|FG001|Overall Study|Poor compliance to protocol|9
1073664|NCT02058147|2128684|FG002|Overall Study|Poor compliance to protocol|4
1073665|NCT02058147|2128682|FG000|Overall Study|Other than specified|8
1073666|NCT02058147|2128683|FG001|Overall Study|Other than specified|9
1073667|NCT02058147|2128684|FG002|Overall Study|Other than specified|0
1073668|NCT02058160|2128694|FG000|Overall Study|Randomized but not treated|2
1073669|NCT02058160|2128695|FG001|Overall Study|Randomized but not treated|4
1073670|NCT02058160|2128694|FG000|Overall Study|Poor compliance to protocol|4
1073671|NCT02058160|2128695|FG001|Overall Study|Poor compliance to protocol|1
1073672|NCT02058160|2128694|FG000|Overall Study|Adverse Event|12
1073673|NCT02058160|2128695|FG001|Overall Study|Adverse Event|3
1073674|NCT02058160|2128694|FG000|Overall Study|Lost to Follow-up|1
1073675|NCT02058160|2128695|FG001|Overall Study|Lost to Follow-up|0
1073676|NCT02058160|2128694|FG000|Overall Study|Other than specified above|12
1073677|NCT02058160|2128695|FG001|Overall Study|Other than specified above|6
1073678|NCT02058290|2128712|FG000|Overall Study|Protocol Violation|2
1073679|NCT02058290|2128713|FG001|Overall Study|Protocol Violation|1
1073680|NCT02058290|2128712|FG000|Overall Study|Physician Decision|1
1073681|NCT02058290|2128713|FG001|Overall Study|Physician Decision|0
1073682|NCT02058290|2128712|FG000|Overall Study|Didn't meet intraoperative criteria|8
1073683|NCT02058290|2128713|FG001|Overall Study|Didn't meet intraoperative criteria|7
1073684|NCT02058290|2128712|FG000|Overall Study|Withdrawal by Subject|0
1073685|NCT02058290|2128713|FG001|Overall Study|Withdrawal by Subject|1
1073686|NCT02058368|2128721|FG000|Overall Study|Adverse Event|15
1073687|NCT02058368|2128722|FG001|Overall Study|Adverse Event|20
1073688|NCT02058368|2128721|FG000|Overall Study|Lack of Efficacy|0
1073689|NCT02058368|2128722|FG001|Overall Study|Lack of Efficacy|1
1073690|NCT02058368|2128721|FG000|Overall Study|Protocol Violation|0
1073691|NCT02058368|2128722|FG001|Overall Study|Protocol Violation|4
1073692|NCT02058368|2128721|FG000|Overall Study|Lost to Follow-up|2
1073693|NCT02058368|2128722|FG001|Overall Study|Lost to Follow-up|0
1073694|NCT02058368|2128721|FG000|Overall Study|Physician Decision|2
1073695|NCT02058368|2128722|FG001|Overall Study|Physician Decision|3
1073696|NCT02058368|2128721|FG000|Overall Study|Withdrawal by Subject|22
1073697|NCT02058368|2128722|FG001|Overall Study|Withdrawal by Subject|26
1073698|NCT02058498|2128728|FG000|Overall Study|Withdrawal by Subject|4
1073699|NCT02058563|2128738|FG000|Overall Study|Lost to Follow-up|26
1073700|NCT02058563|2128739|FG001|Overall Study|Lost to Follow-up|22
1073701|NCT02058563|2128738|FG000|Overall Study|Other (vaccinated later as new subject)|1
1073702|NCT02058563|2128739|FG001|Overall Study|Other (vaccinated later as new subject)|0
1073703|NCT02058563|2128738|FG000|Overall Study|Consent Withdrawal|1
1073704|NCT02058563|2128739|FG001|Overall Study|Consent Withdrawal|1
1073705|NCT02058563|2128738|FG000|Overall Study|Other (patient incarcerated)|0
1073706|NCT02058563|2128739|FG001|Overall Study|Other (patient incarcerated)|1
1073707|NCT02058589|2128747|FG000|Overall Study|Serious Adverse Event|1
1073708|NCT02058589|2128748|FG001|Overall Study|Serious Adverse Event|1
1073709|NCT02058589|2128747|FG000|Overall Study|Non-Serious Adverse Event|1
1073710|NCT02058589|2128748|FG001|Overall Study|Non-Serious Adverse Event|0
1073711|NCT02058589|2128747|FG000|Overall Study|Withdrawal by Subject|0
1073712|NCT02058589|2128748|FG001|Overall Study|Withdrawal by Subject|1
1073713|NCT02058628|2128758|FG000|Overall Study|Adverse Event|1
1073714|NCT02058628|2128759|FG001|Overall Study|Adverse Event|0
1073715|NCT02058628|2128758|FG000|Overall Study|Withdrawal by Subject|2
1073716|NCT02058628|2128759|FG001|Overall Study|Withdrawal by Subject|2
1073717|NCT02058628|2128758|FG000|Overall Study|Lost to Follow-up|2
1073718|NCT02058628|2128759|FG001|Overall Study|Lost to Follow-up|4
1073719|NCT02058628|2128758|FG000|Overall Study|Not in time schedule|0
1073720|NCT02058628|2128759|FG001|Overall Study|Not in time schedule|1
1073721|NCT02058628|2128758|FG000|Overall Study|The visit date was not in timeline|0
1073722|NCT02058628|2128759|FG001|Overall Study|The visit date was not in timeline|1
1073723|NCT02058628|2128758|FG000|Overall Study|A lot of time for study for participant|1
1073724|NCT02058628|2128759|FG001|Overall Study|A lot of time for study for participant|0
1073725|NCT02058628|2128758|FG000|Overall Study|Non compliance|1
1073726|NCT02058628|2128759|FG001|Overall Study|Non compliance|0
1073727|NCT02058836|2128770|FG000|Overall Study|Withdrawal by Subject|1
1073728|NCT02058836|2128771|FG001|Overall Study|Withdrawal by Subject|1
1073729|NCT02058849|2128779|FG000|Overall Study|Hospitalization|1
1073730|NCT02058849|2128780|FG001|Overall Study|Hospitalization|1
1073731|NCT02058849|2128779|FG000|Overall Study|Death|1
1073732|NCT02058849|2128780|FG001|Overall Study|Death|0
1073733|NCT02058849|2128779|FG000|Overall Study|Lost to Follow-up|1
1073734|NCT02058849|2128780|FG001|Overall Study|Lost to Follow-up|0
1073735|NCT02058849|2128779|FG000|Overall Study|Withdrawal by Subject|4
1073736|NCT02058849|2128780|FG001|Overall Study|Withdrawal by Subject|0
1073737|NCT02058940|2128786|FG000|Overall Study|Discharged from Critical Care Unit|1
1073738|NCT02058966|2128790|FG000|Open-Label Methamphetamine|Adverse Event|1
1073739|NCT02058966|2128790|FG000|First Intervention|Withdrawal by Subject|1
1073740|NCT02058992|2128802|FG000|Overall Study|Lost to Follow-up|4
1073741|NCT02058992|2128802|FG000|Overall Study|Protocol Violation|92
1073742|NCT02058992|2128802|FG000|Overall Study|CRF Uncollected|20
1073743|NCT02059005|2128808|FG000|Overall Study|Death|1
1073744|NCT02059005|2128809|FG001|Overall Study|Death|3
1073745|NCT02059005|2128808|FG000|Overall Study|Lost to Follow-up|19
1073746|NCT02059005|2128809|FG001|Overall Study|Lost to Follow-up|19
1073747|NCT02059005|2128808|FG000|Overall Study|Incarceration|0
1073748|NCT02059005|2128809|FG001|Overall Study|Incarceration|1
1073749|NCT02059005|2128808|FG000|Overall Study|Inpatient|0
1073750|NCT02059005|2128809|FG001|Overall Study|Inpatient|1
1073751|NCT02059135|2128833|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
1073752|NCT02059135|2128834|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
1073753|NCT02059135|2128833|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
1073754|NCT02059135|2128834|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
1073755|NCT02059135|2128833|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0
1073756|NCT02059135|2128834|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1
1073757|NCT02059135|2128833|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
1073758|NCT02059135|2128834|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
1073759|NCT02059135|2128833|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
1073760|NCT02059135|2128834|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
1073761|NCT02059135|2128833|FG000|Neonatal Follow-up (Safety Population)|Death|3
1073762|NCT02059135|2128834|FG001|Neonatal Follow-up (Safety Population)|Death|2
1073763|NCT02059135|2128833|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
1073764|NCT02059135|2128834|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
1073765|NCT02059135|2128833|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
1073766|NCT02059135|2128834|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
1073767|NCT02059148|2128842|FG000|Treatment 1|Protocol Violation|0
1073768|NCT02059148|2128843|FG001|Treatment 1|Protocol Violation|0
1073769|NCT02059148|2128844|FG002|Treatment 1|Protocol Violation|0
1073770|NCT02059148|2128845|FG003|Treatment 1|Protocol Violation|0
1073771|NCT02059148|2128846|FG004|Treatment 1|Protocol Violation|0
1073772|NCT02059148|2128847|FG005|Treatment 1|Protocol Violation|1
1073773|NCT02059161|2128860|FG000|Overall Study|Pregnancy|0
1073774|NCT02059161|2128861|FG001|Overall Study|Pregnancy|2
1073775|NCT02059161|2128860|FG000|Overall Study|Adverse Event|2
1073776|NCT02059161|2128861|FG001|Overall Study|Adverse Event|6
1073777|NCT02059161|2128860|FG000|Overall Study|Lost to Follow-up|20
1073778|NCT02059161|2128861|FG001|Overall Study|Lost to Follow-up|12
1073779|NCT02059161|2128860|FG000|Overall Study|Physician Decision|4
1073780|NCT02059161|2128861|FG001|Overall Study|Physician Decision|4
1073781|NCT02059161|2128860|FG000|Overall Study|Protocol Violation|1
1073782|NCT02059161|2128861|FG001|Overall Study|Protocol Violation|1
1073783|NCT02059161|2128860|FG000|Overall Study|Withdrawal by Subject|16
1073784|NCT02059161|2128861|FG001|Overall Study|Withdrawal by Subject|13
1073785|NCT02059161|2128860|FG000|Overall Study|Randomized in error, no study drug|0
1073786|NCT02059161|2128861|FG001|Overall Study|Randomized in error, no study drug|1
1073787|NCT02059161|2128860|FG000|Overall Study|Non-compliance with study drug|6
1073788|NCT02059161|2128861|FG001|Overall Study|Non-compliance with study drug|2
1073789|NCT02059174|2128867|FG000|Period 1|Withdrawal by Subject|0
1073790|NCT02059174|2128868|FG001|Period 1|Withdrawal by Subject|2
1073791|NCT02059174|2128867|FG000|Period 2|Withdrawal by Subject|0
1073792|NCT02059174|2128868|FG001|Period 2|Withdrawal by Subject|2
1073793|NCT02059174|2128867|FG000|Period 2|Protocol Violation|1
1073794|NCT02059174|2128868|FG001|Period 2|Protocol Violation|0
1073795|NCT02059174|2128867|FG000|Period 3|Physician Decision|1
1073796|NCT02059174|2128868|FG001|Period 3|Physician Decision|0
1073797|NCT02059187|2128876|FG000|Overall Study|Adverse Event|0
1073798|NCT02059187|2128877|FG001|Overall Study|Adverse Event|3
1073799|NCT02059187|2128876|FG000|Overall Study|Death|1
1073800|NCT02059187|2128877|FG001|Overall Study|Death|1
1073801|NCT02059187|2128876|FG000|Overall Study|Lost to Follow-up|9
1073802|NCT02059187|2128877|FG001|Overall Study|Lost to Follow-up|8
1073803|NCT02059187|2128876|FG000|Overall Study|Non-compliance with study drug|1
1073804|NCT02059187|2128877|FG001|Overall Study|Non-compliance with study drug|0
1073805|NCT02059187|2128876|FG000|Overall Study|Physician Decision|1
1073806|NCT02059187|2128877|FG001|Overall Study|Physician Decision|2
1073807|NCT02059187|2128876|FG000|Overall Study|Protocol Violation|1
1073808|NCT02059187|2128877|FG001|Overall Study|Protocol Violation|0
1073809|NCT02059187|2128876|FG000|Overall Study|Withdrawal by Subject|12
1073810|NCT02059187|2128877|FG001|Overall Study|Withdrawal by Subject|8
1073811|NCT02059239|2128897|FG000|Overall Study|Progressive Disease after Bendamustine|1
1073812|NCT02059239|2128898|FG001|Overall Study|Progressive Disease after Bendamustine|3
1073813|NCT02059239|2128897|FG000|Overall Study|Physician Decision|1
1073814|NCT02059239|2128898|FG001|Overall Study|Physician Decision|0
1073816|NCT02059278|2128911|FG000|Overall Study|Adverse Event|1
1073817|NCT02059278|2128912|FG001|Overall Study|Adverse Event|1
1073818|NCT02059278|2128911|FG000|Overall Study|Lost to Follow-up|1
1073819|NCT02059278|2128912|FG001|Overall Study|Lost to Follow-up|0
1073820|NCT02059278|2128911|FG000|Overall Study|Withdrawal by Subject|0
1073821|NCT02059278|2128912|FG001|Overall Study|Withdrawal by Subject|3
1073822|NCT02059278|2128911|FG000|Overall Study|Ran out of IP and decided to discontinue|1
1073823|NCT02059278|2128912|FG001|Overall Study|Ran out of IP and decided to discontinue|0
1073824|NCT02059291|2128927|FG000|Epoch 2|Lack of Efficacy|0
1073825|NCT02059291|2128928|FG001|Epoch 2|Lack of Efficacy|0
1073826|NCT02059291|2128929|FG002|Epoch 2|Lack of Efficacy|0
1073827|NCT02059291|2128930|FG003|Epoch 2|Lack of Efficacy|1
1073828|NCT02059291|2128931|FG004|Epoch 2|Lack of Efficacy|0
1073829|NCT02059291|2128932|FG005|Epoch 2|Lack of Efficacy|1
1073830|NCT02059291|2128933|FG006|Epoch 2|Lack of Efficacy|0
1073831|NCT02059291|2128934|FG007|Epoch 2|Lack of Efficacy|0
1073832|NCT02059291|2128935|FG008|Epoch 2|Lack of Efficacy|0
1073833|NCT02059291|2128936|FG009|Epoch 2|Lack of Efficacy|0
1073834|NCT02059291|2128937|FG010|Epoch 2|Lack of Efficacy|0
1073835|NCT02059291|2128938|FG011|Epoch 2|Lack of Efficacy|0
1073836|NCT02059291|2128939|FG012|Epoch 2|Lack of Efficacy|0
1073837|NCT02059291|2128940|FG013|Epoch 2|Lack of Efficacy|0
1073838|NCT02059291|2128941|FG014|Epoch 2|Lack of Efficacy|0
1073839|NCT02059291|2128942|FG015|Epoch 2|Lack of Efficacy|0
1073840|NCT02059291|2128943|FG016|Epoch 2|Lack of Efficacy|0
1073841|NCT02059291|2128944|FG017|Epoch 2|Lack of Efficacy|0
1073842|NCT02059291|2128945|FG018|Epoch 2|Lack of Efficacy|0
1073843|NCT02059291|2128946|FG019|Epoch 2|Lack of Efficacy|0
1073844|NCT02059291|2128947|FG020|Epoch 2|Lack of Efficacy|0
1073845|NCT02059291|2128948|FG021|Epoch 2|Lack of Efficacy|0
1073846|NCT02059291|2128949|FG022|Epoch 2|Lack of Efficacy|0
1073847|NCT02059291|2128950|FG023|Epoch 2|Lack of Efficacy|0
1073848|NCT02059291|2128951|FG024|Epoch 2|Lack of Efficacy|0
1073849|NCT02059291|2128927|FG000|Epoch 2|Adverse Event|0
1073850|NCT02059291|2128928|FG001|Epoch 2|Adverse Event|0
1073851|NCT02059291|2128929|FG002|Epoch 2|Adverse Event|1
1073852|NCT02059291|2128930|FG003|Epoch 2|Adverse Event|1
1073853|NCT02059291|2128931|FG004|Epoch 2|Adverse Event|0
1073854|NCT02059291|2128932|FG005|Epoch 2|Adverse Event|0
1073855|NCT02059291|2128933|FG006|Epoch 2|Adverse Event|0
1073856|NCT02059291|2128934|FG007|Epoch 2|Adverse Event|1
1073857|NCT02059291|2128935|FG008|Epoch 2|Adverse Event|1
1073858|NCT02059291|2128936|FG009|Epoch 2|Adverse Event|0
1073859|NCT02059291|2128937|FG010|Epoch 2|Adverse Event|0
1073860|NCT02059291|2128938|FG011|Epoch 2|Adverse Event|0
1073861|NCT02059291|2128939|FG012|Epoch 2|Adverse Event|0
1073862|NCT02059291|2128940|FG013|Epoch 2|Adverse Event|0
1073863|NCT02059291|2128941|FG014|Epoch 2|Adverse Event|0
1073864|NCT02059291|2128942|FG015|Epoch 2|Adverse Event|0
1073865|NCT02059291|2128943|FG016|Epoch 2|Adverse Event|0
1073866|NCT02059291|2128944|FG017|Epoch 2|Adverse Event|0
1073867|NCT02059291|2128945|FG018|Epoch 2|Adverse Event|0
1073868|NCT02059291|2128946|FG019|Epoch 2|Adverse Event|0
1073869|NCT02059291|2128947|FG020|Epoch 2|Adverse Event|0
1073870|NCT02059291|2128948|FG021|Epoch 2|Adverse Event|0
1073871|NCT02059291|2128949|FG022|Epoch 2|Adverse Event|0
1073872|NCT02059291|2128950|FG023|Epoch 2|Adverse Event|0
1073873|NCT02059291|2128951|FG024|Epoch 2|Adverse Event|0
1073874|NCT02059291|2128927|FG000|Epoch 2|Withdrawal by Subject|0
1073875|NCT02059291|2128928|FG001|Epoch 2|Withdrawal by Subject|1
1073876|NCT02059291|2128929|FG002|Epoch 2|Withdrawal by Subject|0
1073877|NCT02059291|2128930|FG003|Epoch 2|Withdrawal by Subject|0
1073878|NCT02059291|2128931|FG004|Epoch 2|Withdrawal by Subject|0
1073879|NCT02059291|2128932|FG005|Epoch 2|Withdrawal by Subject|1
1073880|NCT02059291|2128933|FG006|Epoch 2|Withdrawal by Subject|0
1073881|NCT02059291|2128934|FG007|Epoch 2|Withdrawal by Subject|0
1073882|NCT02059291|2128935|FG008|Epoch 2|Withdrawal by Subject|1
1073883|NCT02059291|2128936|FG009|Epoch 2|Withdrawal by Subject|0
1073884|NCT02059291|2128937|FG010|Epoch 2|Withdrawal by Subject|0
1073885|NCT02059291|2128938|FG011|Epoch 2|Withdrawal by Subject|0
1073886|NCT02059291|2128939|FG012|Epoch 2|Withdrawal by Subject|0
1073887|NCT02059291|2128940|FG013|Epoch 2|Withdrawal by Subject|0
1073888|NCT02059291|2128941|FG014|Epoch 2|Withdrawal by Subject|0
1073889|NCT02059291|2128942|FG015|Epoch 2|Withdrawal by Subject|0
1073890|NCT02059291|2128943|FG016|Epoch 2|Withdrawal by Subject|0
1073891|NCT02059291|2128944|FG017|Epoch 2|Withdrawal by Subject|0
1073892|NCT02059291|2128945|FG018|Epoch 2|Withdrawal by Subject|0
1073893|NCT02059291|2128946|FG019|Epoch 2|Withdrawal by Subject|0
1073894|NCT02059291|2128947|FG020|Epoch 2|Withdrawal by Subject|0
1073895|NCT02059291|2128948|FG021|Epoch 2|Withdrawal by Subject|0
1073896|NCT02059291|2128949|FG022|Epoch 2|Withdrawal by Subject|0
1073897|NCT02059291|2128950|FG023|Epoch 2|Withdrawal by Subject|0
1073898|NCT02059291|2128951|FG024|Epoch 2|Withdrawal by Subject|0
1073899|NCT02059291|2128927|FG000|Epoch 3|Physician Decision|0
1073900|NCT02059291|2128928|FG001|Epoch 3|Physician Decision|0
1073901|NCT02059291|2128929|FG002|Epoch 3|Physician Decision|0
1073902|NCT02059291|2128930|FG003|Epoch 3|Physician Decision|0
1073903|NCT02059291|2128931|FG004|Epoch 3|Physician Decision|0
1073904|NCT02059291|2128932|FG005|Epoch 3|Physician Decision|0
1073905|NCT02059291|2128933|FG006|Epoch 3|Physician Decision|0
1073906|NCT02059291|2128934|FG007|Epoch 3|Physician Decision|0
1073907|NCT02059291|2128935|FG008|Epoch 3|Physician Decision|0
1073908|NCT02059291|2128936|FG009|Epoch 3|Physician Decision|0
1073909|NCT02059291|2128937|FG010|Epoch 3|Physician Decision|0
1073910|NCT02059291|2128938|FG011|Epoch 3|Physician Decision|0
1073911|NCT02059291|2128939|FG012|Epoch 3|Physician Decision|0
1073912|NCT02059291|2128940|FG013|Epoch 3|Physician Decision|1
1073913|NCT02059291|2128941|FG014|Epoch 3|Physician Decision|0
1073914|NCT02059291|2128942|FG015|Epoch 3|Physician Decision|1
1073915|NCT02059291|2128943|FG016|Epoch 3|Physician Decision|0
1073916|NCT02059291|2128944|FG017|Epoch 3|Physician Decision|0
1073917|NCT02059291|2128945|FG018|Epoch 3|Physician Decision|0
1073918|NCT02059291|2128946|FG019|Epoch 3|Physician Decision|0
1073919|NCT02059291|2128947|FG020|Epoch 3|Physician Decision|0
1073920|NCT02059291|2128948|FG021|Epoch 3|Physician Decision|0
1073921|NCT02059291|2128949|FG022|Epoch 3|Physician Decision|0
1073922|NCT02059291|2128950|FG023|Epoch 3|Physician Decision|0
1073923|NCT02059291|2128951|FG024|Epoch 3|Physician Decision|0
1073924|NCT02059291|2128927|FG000|Epoch 3|Adverse Event|0
1073925|NCT02059291|2128928|FG001|Epoch 3|Adverse Event|0
1073926|NCT02059291|2128929|FG002|Epoch 3|Adverse Event|0
1073927|NCT02059291|2128930|FG003|Epoch 3|Adverse Event|0
1073928|NCT02059291|2128931|FG004|Epoch 3|Adverse Event|0
1073929|NCT02059291|2128932|FG005|Epoch 3|Adverse Event|0
1073930|NCT02059291|2128933|FG006|Epoch 3|Adverse Event|0
1073931|NCT02059291|2128934|FG007|Epoch 3|Adverse Event|0
1073932|NCT02059291|2128935|FG008|Epoch 3|Adverse Event|0
1073933|NCT02059291|2128936|FG009|Epoch 3|Adverse Event|0
1073934|NCT02059291|2128937|FG010|Epoch 3|Adverse Event|0
1073935|NCT02059291|2128938|FG011|Epoch 3|Adverse Event|0
1073936|NCT02059291|2128939|FG012|Epoch 3|Adverse Event|0
1073937|NCT02059291|2128940|FG013|Epoch 3|Adverse Event|0
1073938|NCT02059291|2128941|FG014|Epoch 3|Adverse Event|0
1073939|NCT02059291|2128942|FG015|Epoch 3|Adverse Event|1
1073940|NCT02059291|2128943|FG016|Epoch 3|Adverse Event|0
1073941|NCT02059291|2128944|FG017|Epoch 3|Adverse Event|0
1073942|NCT02059291|2128945|FG018|Epoch 3|Adverse Event|0
1073943|NCT02059291|2128946|FG019|Epoch 3|Adverse Event|0
1073944|NCT02059291|2128947|FG020|Epoch 3|Adverse Event|0
1073945|NCT02059291|2128948|FG021|Epoch 3|Adverse Event|0
1073946|NCT02059291|2128949|FG022|Epoch 3|Adverse Event|0
1073947|NCT02059291|2128950|FG023|Epoch 3|Adverse Event|0
1073948|NCT02059291|2128951|FG024|Epoch 3|Adverse Event|0
1073949|NCT02059291|2128927|FG000|Epoch 3|Lack of Efficacy|0
1073950|NCT02059291|2128928|FG001|Epoch 3|Lack of Efficacy|0
1073951|NCT02059291|2128929|FG002|Epoch 3|Lack of Efficacy|0
1073952|NCT02059291|2128930|FG003|Epoch 3|Lack of Efficacy|0
1073953|NCT02059291|2128931|FG004|Epoch 3|Lack of Efficacy|0
1073954|NCT02059291|2128932|FG005|Epoch 3|Lack of Efficacy|0
1073955|NCT02059291|2128933|FG006|Epoch 3|Lack of Efficacy|0
1073956|NCT02059291|2128934|FG007|Epoch 3|Lack of Efficacy|0
1073957|NCT02059291|2128935|FG008|Epoch 3|Lack of Efficacy|0
1073958|NCT02059291|2128936|FG009|Epoch 3|Lack of Efficacy|0
1073959|NCT02059291|2128937|FG010|Epoch 3|Lack of Efficacy|0
1073960|NCT02059291|2128938|FG011|Epoch 3|Lack of Efficacy|0
1073961|NCT02059291|2128939|FG012|Epoch 3|Lack of Efficacy|0
1073962|NCT02059291|2128940|FG013|Epoch 3|Lack of Efficacy|0
1073963|NCT02059291|2128941|FG014|Epoch 3|Lack of Efficacy|0
1073964|NCT02059291|2128942|FG015|Epoch 3|Lack of Efficacy|3
1073965|NCT02059291|2128943|FG016|Epoch 3|Lack of Efficacy|0
1073966|NCT02059291|2128944|FG017|Epoch 3|Lack of Efficacy|0
1073967|NCT02059291|2128945|FG018|Epoch 3|Lack of Efficacy|0
1073968|NCT02059291|2128946|FG019|Epoch 3|Lack of Efficacy|0
1073969|NCT02059291|2128947|FG020|Epoch 3|Lack of Efficacy|0
1073970|NCT02059291|2128948|FG021|Epoch 3|Lack of Efficacy|0
1073971|NCT02059291|2128949|FG022|Epoch 3|Lack of Efficacy|0
1073972|NCT02059291|2128950|FG023|Epoch 3|Lack of Efficacy|0
1073973|NCT02059291|2128951|FG024|Epoch 3|Lack of Efficacy|0
1073974|NCT02059291|2128927|FG000|Epoch 3|Withdrawal by Subject|0
1073975|NCT02059291|2128928|FG001|Epoch 3|Withdrawal by Subject|0
1073976|NCT02059291|2128929|FG002|Epoch 3|Withdrawal by Subject|0
1073977|NCT02059291|2128930|FG003|Epoch 3|Withdrawal by Subject|0
1073978|NCT02059291|2128931|FG004|Epoch 3|Withdrawal by Subject|0
1073979|NCT02059291|2128932|FG005|Epoch 3|Withdrawal by Subject|0
1073980|NCT02059291|2128933|FG006|Epoch 3|Withdrawal by Subject|0
1073981|NCT02059291|2128934|FG007|Epoch 3|Withdrawal by Subject|0
1073982|NCT02059291|2128935|FG008|Epoch 3|Withdrawal by Subject|0
1073983|NCT02059291|2128936|FG009|Epoch 3|Withdrawal by Subject|0
1073984|NCT02059291|2128937|FG010|Epoch 3|Withdrawal by Subject|0
1073985|NCT02059291|2128938|FG011|Epoch 3|Withdrawal by Subject|0
1073986|NCT02059291|2128939|FG012|Epoch 3|Withdrawal by Subject|0
1073987|NCT02059291|2128940|FG013|Epoch 3|Withdrawal by Subject|0
1073988|NCT02059291|2128941|FG014|Epoch 3|Withdrawal by Subject|0
1073989|NCT02059291|2128942|FG015|Epoch 3|Withdrawal by Subject|1
1073990|NCT02059291|2128943|FG016|Epoch 3|Withdrawal by Subject|0
1073991|NCT02059291|2128944|FG017|Epoch 3|Withdrawal by Subject|0
1073992|NCT02059291|2128945|FG018|Epoch 3|Withdrawal by Subject|0
1073993|NCT02059291|2128946|FG019|Epoch 3|Withdrawal by Subject|0
1073994|NCT02059291|2128947|FG020|Epoch 3|Withdrawal by Subject|0
1073995|NCT02059291|2128948|FG021|Epoch 3|Withdrawal by Subject|0
1073996|NCT02059291|2128949|FG022|Epoch 3|Withdrawal by Subject|0
1073997|NCT02059291|2128950|FG023|Epoch 3|Withdrawal by Subject|0
1073998|NCT02059291|2128951|FG024|Epoch 3|Withdrawal by Subject|0
1073999|NCT02059291|2128927|FG000|Epoch 4|Adverse Event|0
1074000|NCT02059291|2128928|FG001|Epoch 4|Adverse Event|0
1074001|NCT02059291|2128929|FG002|Epoch 4|Adverse Event|0
1074002|NCT02059291|2128930|FG003|Epoch 4|Adverse Event|0
1074003|NCT02059291|2128931|FG004|Epoch 4|Adverse Event|0
1074004|NCT02059291|2128932|FG005|Epoch 4|Adverse Event|0
1074005|NCT02059291|2128933|FG006|Epoch 4|Adverse Event|0
1074006|NCT02059291|2128934|FG007|Epoch 4|Adverse Event|0
1074007|NCT02059291|2128935|FG008|Epoch 4|Adverse Event|0
1074008|NCT02059291|2128936|FG009|Epoch 4|Adverse Event|0
1074009|NCT02059291|2128937|FG010|Epoch 4|Adverse Event|0
1074010|NCT02059291|2128938|FG011|Epoch 4|Adverse Event|0
1074011|NCT02059291|2128939|FG012|Epoch 4|Adverse Event|0
1074012|NCT02059291|2128940|FG013|Epoch 4|Adverse Event|0
1074013|NCT02059291|2128941|FG014|Epoch 4|Adverse Event|0
1074014|NCT02059291|2128942|FG015|Epoch 4|Adverse Event|0
1074015|NCT02059291|2128943|FG016|Epoch 4|Adverse Event|1
1074016|NCT02059291|2128944|FG017|Epoch 4|Adverse Event|0
1074017|NCT02059291|2128945|FG018|Epoch 4|Adverse Event|0
1074018|NCT02059291|2128946|FG019|Epoch 4|Adverse Event|0
1074019|NCT02059291|2128947|FG020|Epoch 4|Adverse Event|0
1074020|NCT02059291|2128948|FG021|Epoch 4|Adverse Event|0
1074021|NCT02059291|2128949|FG022|Epoch 4|Adverse Event|1
1074022|NCT02059291|2128950|FG023|Epoch 4|Adverse Event|0
1074023|NCT02059291|2128951|FG024|Epoch 4|Adverse Event|0
1074024|NCT02059291|2128927|FG000|Epoch 4|Pregnancy|0
1074025|NCT02059291|2128928|FG001|Epoch 4|Pregnancy|0
1074026|NCT02059291|2128929|FG002|Epoch 4|Pregnancy|0
1074027|NCT02059291|2128930|FG003|Epoch 4|Pregnancy|0
1074028|NCT02059291|2128931|FG004|Epoch 4|Pregnancy|0
1074029|NCT02059291|2128932|FG005|Epoch 4|Pregnancy|0
1074030|NCT02059291|2128933|FG006|Epoch 4|Pregnancy|0
1074031|NCT02059291|2128934|FG007|Epoch 4|Pregnancy|0
1074032|NCT02059291|2128935|FG008|Epoch 4|Pregnancy|0
1074033|NCT02059291|2128936|FG009|Epoch 4|Pregnancy|0
1074034|NCT02059291|2128937|FG010|Epoch 4|Pregnancy|0
1074035|NCT02059291|2128938|FG011|Epoch 4|Pregnancy|0
1074036|NCT02059291|2128939|FG012|Epoch 4|Pregnancy|0
1074037|NCT02059291|2128940|FG013|Epoch 4|Pregnancy|0
1074038|NCT02059291|2128941|FG014|Epoch 4|Pregnancy|0
1074039|NCT02059291|2128942|FG015|Epoch 4|Pregnancy|0
1074040|NCT02059291|2128943|FG016|Epoch 4|Pregnancy|1
1074041|NCT02059291|2128944|FG017|Epoch 4|Pregnancy|0
1074042|NCT02059291|2128945|FG018|Epoch 4|Pregnancy|0
1074043|NCT02059291|2128946|FG019|Epoch 4|Pregnancy|0
1074044|NCT02059291|2128947|FG020|Epoch 4|Pregnancy|0
1074045|NCT02059291|2128948|FG021|Epoch 4|Pregnancy|0
1074046|NCT02059291|2128949|FG022|Epoch 4|Pregnancy|0
1074047|NCT02059291|2128950|FG023|Epoch 4|Pregnancy|0
1074048|NCT02059291|2128951|FG024|Epoch 4|Pregnancy|0
1074049|NCT02059291|2128927|FG000|Epoch 4|Withdrawal by Subject|0
1074050|NCT02059291|2128928|FG001|Epoch 4|Withdrawal by Subject|0
1074051|NCT02059291|2128929|FG002|Epoch 4|Withdrawal by Subject|0
1074052|NCT02059291|2128930|FG003|Epoch 4|Withdrawal by Subject|0
1074053|NCT02059291|2128931|FG004|Epoch 4|Withdrawal by Subject|0
1074054|NCT02059291|2128932|FG005|Epoch 4|Withdrawal by Subject|0
1074055|NCT02059291|2128933|FG006|Epoch 4|Withdrawal by Subject|0
1074056|NCT02059291|2128934|FG007|Epoch 4|Withdrawal by Subject|0
1074057|NCT02059291|2128935|FG008|Epoch 4|Withdrawal by Subject|0
1074058|NCT02059291|2128936|FG009|Epoch 4|Withdrawal by Subject|0
1074059|NCT02059291|2128937|FG010|Epoch 4|Withdrawal by Subject|0
1074060|NCT02059291|2128938|FG011|Epoch 4|Withdrawal by Subject|0
1074061|NCT02059291|2128939|FG012|Epoch 4|Withdrawal by Subject|0
1074062|NCT02059291|2128940|FG013|Epoch 4|Withdrawal by Subject|0
1074063|NCT02059291|2128941|FG014|Epoch 4|Withdrawal by Subject|0
1074064|NCT02059291|2128942|FG015|Epoch 4|Withdrawal by Subject|0
1074065|NCT02059291|2128943|FG016|Epoch 4|Withdrawal by Subject|0
1074066|NCT02059291|2128944|FG017|Epoch 4|Withdrawal by Subject|0
1074067|NCT02059291|2128945|FG018|Epoch 4|Withdrawal by Subject|0
1074068|NCT02059291|2128946|FG019|Epoch 4|Withdrawal by Subject|0
1074069|NCT02059291|2128947|FG020|Epoch 4|Withdrawal by Subject|1
1074070|NCT02059291|2128948|FG021|Epoch 4|Withdrawal by Subject|0
1074071|NCT02059291|2128949|FG022|Epoch 4|Withdrawal by Subject|0
1074072|NCT02059291|2128950|FG023|Epoch 4|Withdrawal by Subject|0
1074073|NCT02059291|2128951|FG024|Epoch 4|Withdrawal by Subject|0
1074074|NCT02059291|2128927|FG000|Epoch 4|Lack of Efficacy|0
1074075|NCT02059291|2128928|FG001|Epoch 4|Lack of Efficacy|0
1074076|NCT02059291|2128929|FG002|Epoch 4|Lack of Efficacy|0
1074077|NCT02059291|2128930|FG003|Epoch 4|Lack of Efficacy|0
1074078|NCT02059291|2128931|FG004|Epoch 4|Lack of Efficacy|0
1074079|NCT02059291|2128932|FG005|Epoch 4|Lack of Efficacy|0
1074080|NCT02059291|2128933|FG006|Epoch 4|Lack of Efficacy|0
1074081|NCT02059291|2128934|FG007|Epoch 4|Lack of Efficacy|0
1074082|NCT02059291|2128935|FG008|Epoch 4|Lack of Efficacy|0
1074083|NCT02059291|2128936|FG009|Epoch 4|Lack of Efficacy|0
1074084|NCT02059291|2128937|FG010|Epoch 4|Lack of Efficacy|0
1074085|NCT02059291|2128938|FG011|Epoch 4|Lack of Efficacy|0
1074086|NCT02059291|2128939|FG012|Epoch 4|Lack of Efficacy|0
1074087|NCT02059291|2128940|FG013|Epoch 4|Lack of Efficacy|0
1074088|NCT02059291|2128941|FG014|Epoch 4|Lack of Efficacy|0
1074089|NCT02059291|2128942|FG015|Epoch 4|Lack of Efficacy|0
1074090|NCT02059291|2128943|FG016|Epoch 4|Lack of Efficacy|0
1074091|NCT02059291|2128944|FG017|Epoch 4|Lack of Efficacy|0
1074092|NCT02059291|2128945|FG018|Epoch 4|Lack of Efficacy|0
1074093|NCT02059291|2128946|FG019|Epoch 4|Lack of Efficacy|0
1074094|NCT02059291|2128947|FG020|Epoch 4|Lack of Efficacy|0
1074095|NCT02059291|2128948|FG021|Epoch 4|Lack of Efficacy|0
1074096|NCT02059291|2128949|FG022|Epoch 4|Lack of Efficacy|0
1074097|NCT02059291|2128950|FG023|Epoch 4|Lack of Efficacy|1
1074098|NCT02059291|2128951|FG024|Epoch 4|Lack of Efficacy|0
1074099|NCT02059395|2128981|FG000|Overall Study|Lost to Follow-up|2
1074100|NCT02059395|2128982|FG001|Overall Study|Lost to Follow-up|4
1074101|NCT02059408|2128991|FG000|Overall Study|Did not get tested|0
1074102|NCT02059408|2128992|FG001|Overall Study|Did not get tested|330
1074103|NCT02059408|2128993|FG002|Overall Study|Did not get tested|358
1074104|NCT02059434|2129012|FG000|Washout Between Periods 1 and 2|Physician Decision|0
1074105|NCT02059434|2129013|FG001|Washout Between Periods 1 and 2|Physician Decision|0
1074106|NCT02059434|2129014|FG002|Washout Between Periods 1 and 2|Physician Decision|0
1074107|NCT02059434|2129015|FG003|Washout Between Periods 1 and 2|Physician Decision|0
1074108|NCT02059434|2129016|FG004|Washout Between Periods 1 and 2|Physician Decision|0
1074109|NCT02059434|2129017|FG005|Washout Between Periods 1 and 2|Physician Decision|0
1074110|NCT02059434|2129018|FG006|Washout Between Periods 1 and 2|Physician Decision|0
1074111|NCT02059434|2129019|FG007|Washout Between Periods 1 and 2|Physician Decision|1
1074112|NCT02059434|2129020|FG008|Washout Between Periods 1 and 2|Physician Decision|0
1074113|NCT02059434|2129012|FG000|Washout Between Periods 4 and 5|Adverse Event|0
1074114|NCT02059434|2129013|FG001|Washout Between Periods 4 and 5|Adverse Event|0
1074115|NCT02059434|2129014|FG002|Washout Between Periods 4 and 5|Adverse Event|0
1074116|NCT02059434|2129015|FG003|Washout Between Periods 4 and 5|Adverse Event|0
1074117|NCT02059434|2129016|FG004|Washout Between Periods 4 and 5|Adverse Event|0
1074118|NCT02059434|2129017|FG005|Washout Between Periods 4 and 5|Adverse Event|0
1074119|NCT02059434|2129018|FG006|Washout Between Periods 4 and 5|Adverse Event|0
1074120|NCT02059434|2129019|FG007|Washout Between Periods 4 and 5|Adverse Event|0
1074121|NCT02059434|2129020|FG008|Washout Between Periods 4 and 5|Adverse Event|1
1074122|NCT02059434|2129012|FG000|Washout Between Periods 6 and 7|Physician Decision|0
1074123|NCT02059434|2129013|FG001|Washout Between Periods 6 and 7|Physician Decision|0
1074124|NCT02059434|2129014|FG002|Washout Between Periods 6 and 7|Physician Decision|0
1074125|NCT02059434|2129015|FG003|Washout Between Periods 6 and 7|Physician Decision|0
1074126|NCT02059434|2129016|FG004|Washout Between Periods 6 and 7|Physician Decision|0
1074127|NCT02059434|2129017|FG005|Washout Between Periods 6 and 7|Physician Decision|0
1074128|NCT02059434|2129018|FG006|Washout Between Periods 6 and 7|Physician Decision|0
1074129|NCT02059434|2129019|FG007|Washout Between Periods 6 and 7|Physician Decision|0
1074130|NCT02059434|2129020|FG008|Washout Between Periods 6 and 7|Physician Decision|1
1074131|NCT02059434|2129012|FG000|Washout Between Periods 7 and 8|Adverse Event|0
1074132|NCT02059434|2129013|FG001|Washout Between Periods 7 and 8|Adverse Event|0
1074133|NCT02059434|2129014|FG002|Washout Between Periods 7 and 8|Adverse Event|0
1074134|NCT02059434|2129015|FG003|Washout Between Periods 7 and 8|Adverse Event|0
1074135|NCT02059434|2129016|FG004|Washout Between Periods 7 and 8|Adverse Event|0
1074136|NCT02059434|2129017|FG005|Washout Between Periods 7 and 8|Adverse Event|0
1074137|NCT02059434|2129018|FG006|Washout Between Periods 7 and 8|Adverse Event|0
1074138|NCT02059434|2129019|FG007|Washout Between Periods 7 and 8|Adverse Event|0
1074139|NCT02059434|2129020|FG008|Washout Between Periods 7 and 8|Adverse Event|1
1074140|NCT02059434|2129012|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1074141|NCT02059434|2129013|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1074142|NCT02059434|2129014|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1074143|NCT02059434|2129015|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1074144|NCT02059434|2129016|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1074145|NCT02059434|2129017|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1074146|NCT02059434|2129018|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1074147|NCT02059434|2129019|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1074148|NCT02059434|2129020|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1
1074149|NCT02059980|2129101|FG000|Overall Study|Lost to Follow-up|2
1074150|NCT02059980|2129102|FG001|Overall Study|Lost to Follow-up|1
1074151|NCT02060370|2129131|FG000|Overall Study|Physician Decision|1
1074152|NCT02060383|2129140|FG000|Core Phase|Unsatisfactory therapeutic effect|1
1074153|NCT02060383|2129141|FG001|Core Phase|Unsatisfactory therapeutic effect|5
1074154|NCT02060383|2129142|FG002|Core Phase|Unsatisfactory therapeutic effect|0
1074155|NCT02060383|2129143|FG003|Core Phase|Unsatisfactory therapeutic effect|0
1074156|NCT02060383|2129144|FG004|Core Phase|Unsatisfactory therapeutic effect|0
1074157|NCT02060383|2129140|FG000|Core Phase|Adverse Event|2
1074158|NCT02060383|2129141|FG001|Core Phase|Adverse Event|0
1074159|NCT02060383|2129142|FG002|Core Phase|Adverse Event|0
1074160|NCT02060383|2129143|FG003|Core Phase|Adverse Event|2
1074161|NCT02060383|2129144|FG004|Core Phase|Adverse Event|6
1074162|NCT02060383|2129140|FG000|Core Phase|Administrative problems|0
1074163|NCT02060383|2129141|FG001|Core Phase|Administrative problems|1
1074164|NCT02060383|2129142|FG002|Core Phase|Administrative problems|0
1074165|NCT02060383|2129143|FG003|Core Phase|Administrative problems|0
1074166|NCT02060383|2129144|FG004|Core Phase|Administrative problems|0
1074167|NCT02060383|2129140|FG000|Core Phase|Protocol Violation|0
1074168|NCT02060383|2129141|FG001|Core Phase|Protocol Violation|0
1074169|NCT02060383|2129142|FG002|Core Phase|Protocol Violation|0
1074170|NCT02060383|2129143|FG003|Core Phase|Protocol Violation|1
1074171|NCT02060383|2129144|FG004|Core Phase|Protocol Violation|0
1074172|NCT02060383|2129140|FG000|Core Phase|Withdrawal by Subject|0
1074173|NCT02060383|2129141|FG001|Core Phase|Withdrawal by Subject|0
1074174|NCT02060383|2129142|FG002|Core Phase|Withdrawal by Subject|0
1074175|NCT02060383|2129143|FG003|Core Phase|Withdrawal by Subject|4
1074176|NCT02060383|2129144|FG004|Core Phase|Withdrawal by Subject|2
1074177|NCT02060383|2129140|FG000|Extension Phase|Unsatisfactory therapeutic effect|1
1074178|NCT02060383|2129141|FG001|Extension Phase|Unsatisfactory therapeutic effect|1
1074179|NCT02060383|2129142|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
1074180|NCT02060383|2129143|FG003|Extension Phase|Unsatisfactory therapeutic effect|2
1074181|NCT02060383|2129144|FG004|Extension Phase|Unsatisfactory therapeutic effect|2
1074182|NCT02060383|2129140|FG000|Extension Phase|Adverse Event|1
1074183|NCT02060383|2129141|FG001|Extension Phase|Adverse Event|1
1074184|NCT02060383|2129142|FG002|Extension Phase|Adverse Event|2
1074185|NCT02060383|2129143|FG003|Extension Phase|Adverse Event|0
1074186|NCT02060383|2129144|FG004|Extension Phase|Adverse Event|1
1074187|NCT02060383|2129140|FG000|Extension Phase|Withdrawal by Subject|0
1074188|NCT02060383|2129141|FG001|Extension Phase|Withdrawal by Subject|1
1074189|NCT02060383|2129142|FG002|Extension Phase|Withdrawal by Subject|0
1074190|NCT02060383|2129143|FG003|Extension Phase|Withdrawal by Subject|0
1074191|NCT02060383|2129144|FG004|Extension Phase|Withdrawal by Subject|2
1074192|NCT02060383|2129140|FG000|Extension Phase|Administrative problems|1
1074193|NCT02060383|2129141|FG001|Extension Phase|Administrative problems|0
1074194|NCT02060383|2129142|FG002|Extension Phase|Administrative problems|0
1074195|NCT02060383|2129143|FG003|Extension Phase|Administrative problems|0
1074196|NCT02060383|2129144|FG004|Extension Phase|Administrative problems|0
1074197|NCT02060383|2129140|FG000|Extension Phase|Death|0
1074198|NCT02060383|2129141|FG001|Extension Phase|Death|0
1074199|NCT02060383|2129142|FG002|Extension Phase|Death|1
1074200|NCT02060383|2129143|FG003|Extension Phase|Death|0
1074201|NCT02060383|2129144|FG004|Extension Phase|Death|1
1074202|NCT02060383|2129140|FG000|Extension Phase|Protocol Violation|0
1074203|NCT02060383|2129141|FG001|Extension Phase|Protocol Violation|0
1074204|NCT02060383|2129142|FG002|Extension Phase|Protocol Violation|0
1074205|NCT02060383|2129143|FG003|Extension Phase|Protocol Violation|0
1074206|NCT02060383|2129144|FG004|Extension Phase|Protocol Violation|1
1074207|NCT02060903|2129197|FG000|Overall Study|Lost to Follow-up|4
1074208|NCT02060903|2129198|FG001|Overall Study|Lost to Follow-up|0
1074209|NCT02060903|2129197|FG000|Overall Study|Withdrawal by Subject|0
1074210|NCT02060903|2129198|FG001|Overall Study|Withdrawal by Subject|7
1074211|NCT02061202|2129206|FG000|Overall Study|Lost to Follow-up|1
1074212|NCT02061202|2129207|FG001|Overall Study|Lost to Follow-up|1
1074213|NCT02061280|2129215|FG000|Overall Study|Protocol Violation|12
1074214|NCT02061280|2129216|FG001|Overall Study|Protocol Violation|8
1074215|NCT02061280|2129215|FG000|Overall Study|moved out of state|0
1074216|NCT02061280|2129216|FG001|Overall Study|moved out of state|1
1074217|NCT02061280|2129215|FG000|Overall Study|Withdrawal by Subject|1
1074218|NCT02061280|2129216|FG001|Overall Study|Withdrawal by Subject|2
1074219|NCT02061280|2129215|FG000|Overall Study|Lost to Follow-up|5
1074220|NCT02061280|2129216|FG001|Overall Study|Lost to Follow-up|1
1074221|NCT02061540|2129275|FG000|Overall Study|Adverse Event|2
1074222|NCT02061540|2129275|FG000|Overall Study|Withdrawal by Subject|2
1074223|NCT02061592|2129286|FG000|Period 1|Withdrawal by Subject|1
1074224|NCT02061592|2129287|FG001|Period 1|Withdrawal by Subject|0
1074225|NCT02061592|2129286|FG000|Period 1|Protocol Violation|1
1074226|NCT02061592|2129287|FG001|Period 1|Protocol Violation|0
1074227|NCT02061592|2129286|FG000|Period 2|Lost to Follow-up|0
1074228|NCT02061592|2129287|FG001|Period 2|Lost to Follow-up|1
1074229|NCT02061813|2129326|FG000|Overall Study|Withdrawal by Subject|1
1074230|NCT02061813|2129326|FG000|Overall Study|Protocol Violation|2
1074231|NCT02062151|2129346|FG000|Overall Study|screen failure|1
1074232|NCT02062385|2129371|FG000|Overall Study|Adverse Event|19
1074233|NCT02062385|2129372|FG001|Overall Study|Adverse Event|13
1074234|NCT02062385|2129373|FG002|Overall Study|Adverse Event|1
1074235|NCT02062385|2129374|FG003|Overall Study|Adverse Event|0
1074236|NCT02062385|2129371|FG000|Overall Study|Protocol Violation|1
1074237|NCT02062385|2129372|FG001|Overall Study|Protocol Violation|0
1074238|NCT02062385|2129373|FG002|Overall Study|Protocol Violation|0
1074239|NCT02062385|2129374|FG003|Overall Study|Protocol Violation|0
1074240|NCT02062385|2129371|FG000|Overall Study|Incomplete EPI by database lock|2
1074241|NCT02062385|2129372|FG001|Overall Study|Incomplete EPI by database lock|0
1074242|NCT02062385|2129373|FG002|Overall Study|Incomplete EPI by database lock|0
1074243|NCT02062385|2129374|FG003|Overall Study|Incomplete EPI by database lock|0
1074244|NCT02062385|2129371|FG000|Overall Study|Moved|10
1074245|NCT02062385|2129372|FG001|Overall Study|Moved|11
1074246|NCT02062385|2129373|FG002|Overall Study|Moved|1
1074247|NCT02062385|2129374|FG003|Overall Study|Moved|0
1074248|NCT02062385|2129371|FG000|Overall Study|Withdrawn by parent/guardian|46
1074249|NCT02062385|2129372|FG001|Overall Study|Withdrawn by parent/guardian|41
1074250|NCT02062385|2129373|FG002|Overall Study|Withdrawn by parent/guardian|9
1074251|NCT02062385|2129374|FG003|Overall Study|Withdrawn by parent/guardian|8
1074252|NCT02062385|2129371|FG000|Overall Study|Death|0
1074253|NCT02062385|2129372|FG001|Overall Study|Death|0
1074254|NCT02062385|2129373|FG002|Overall Study|Death|0
1074255|NCT02062385|2129374|FG003|Overall Study|Death|1
1074256|NCT02062385|2129371|FG000|Overall Study|Lost to Follow-up|0
1074257|NCT02062385|2129372|FG001|Overall Study|Lost to Follow-up|0
1074258|NCT02062385|2129373|FG002|Overall Study|Lost to Follow-up|1
1074259|NCT02062385|2129374|FG003|Overall Study|Lost to Follow-up|0
1074260|NCT02062398|2129382|FG000|Overall Study|Implant removal|1
1074261|NCT02062437|2129386|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31
1074262|NCT02062437|2129386|FG000|Overall Study|Patient not available for the 2y visit|18
1074263|NCT02062437|2129386|FG000|Overall Study|Death|2
1074264|NCT02062437|2129386|FG000|Overall Study|Pt. couldn't come due to med. condition|1
1074265|NCT02062450|2129392|FG000|Overall Study|No follow-up visit|124
1074266|NCT02062632|2129460|FG000|Overall Study|No treatment data|1
1074267|NCT02062645|2129464|FG000|Overall Study|Adverse Event|2
1074268|NCT02062645|2129464|FG000|Overall Study|Protocol Violation|8
1074269|NCT02062645|2129464|FG000|Overall Study|Lost to Follow-up|5
1074270|NCT02062658|2129468|FG000|Overall Study|Withdrawal by Subject|1
1074271|NCT02062658|2129468|FG000|Overall Study|Lack of Efficacy|1
1074272|NCT02062879|2129496|FG000|Overall Study|Withdrawal by Subject|4
1074273|NCT02062879|2129497|FG001|Overall Study|Withdrawal by Subject|1
1074274|NCT02063217|2129546|FG000|Overall Study|Withdrawal by Subject|1
1074275|NCT02063217|2129547|FG001|Overall Study|Withdrawal by Subject|0
1074276|NCT02063217|2129548|FG002|Overall Study|Withdrawal by Subject|0
1074277|NCT02063659|2129585|FG000|Double-Blind Treatment Period|Adverse Event|1
1074278|NCT02063659|2129586|FG001|Double-Blind Treatment Period|Adverse Event|2
1074279|NCT02063659|2129587|FG002|Double-Blind Treatment Period|Adverse Event|0
1074280|NCT02063659|2129588|FG003|Double-Blind Treatment Period|Adverse Event|0
1074281|NCT02063659|2129585|FG000|Double-Blind Treatment Period|Physician Decision|1
1074282|NCT02063659|2129586|FG001|Double-Blind Treatment Period|Physician Decision|0
1074283|NCT02063659|2129587|FG002|Double-Blind Treatment Period|Physician Decision|0
1074284|NCT02063659|2129588|FG003|Double-Blind Treatment Period|Physician Decision|0
1074285|NCT02063659|2129585|FG000|Double-Blind Treatment Period|Withdrawal of consent|0
1074286|NCT02063659|2129586|FG001|Double-Blind Treatment Period|Withdrawal of consent|1
1074287|NCT02063659|2129587|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
1074288|NCT02063659|2129588|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
1074289|NCT02063659|2129585|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
1074290|NCT02063659|2129586|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
1074291|NCT02063659|2129587|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
1074292|NCT02063659|2129588|FG003|Open-Label Extension Period (OLE)|Physician Decision|1
1074293|NCT02063659|2129585|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1074294|NCT02063659|2129586|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1074295|NCT02063659|2129587|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1074296|NCT02063659|2129588|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
1074297|NCT02063659|2129585|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1074298|NCT02063659|2129586|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1074299|NCT02063659|2129587|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1074300|NCT02063659|2129588|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1
1074301|NCT02063659|2129585|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
1074302|NCT02063659|2129586|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
1074303|NCT02063659|2129587|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
1074304|NCT02063659|2129588|FG003|Open-Label Extension Period (OLE)|Adverse Event|7
1074305|NCT02063659|2129585|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
1074306|NCT02063659|2129586|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
1074307|NCT02063659|2129587|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
1074308|NCT02063659|2129588|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
1074309|NCT02063672|2129604|FG000|Overall Study|Ongoing Follow-up|27
1074310|NCT02063672|2129605|FG001|Overall Study|Ongoing Follow-up|14
1074311|NCT02063672|2129604|FG000|Overall Study|Death|5
1074312|NCT02063672|2129605|FG001|Overall Study|Death|3
1074313|NCT02063672|2129604|FG000|Overall Study|Lost to Follow-up|1
1074314|NCT02063672|2129605|FG001|Overall Study|Lost to Follow-up|3
1074315|NCT02063672|2129604|FG000|Overall Study|Withdrawal by Subject|2
1074316|NCT02063672|2129605|FG001|Overall Study|Withdrawal by Subject|2
1074317|NCT02063698|2129613|FG000|Overall Study|did not complete booklet for days 2-8|1
1074318|NCT02063698|2129614|FG001|Overall Study|did not complete booklet for days 2-8|2
1074319|NCT02063724|2129620|FG000|Overall Study|Disease progression|1
1074320|NCT02063737|2129626|FG000|Overall Study|Lost to Follow-up|11
1074321|NCT02063737|2129627|FG001|Overall Study|Lost to Follow-up|4
1074322|NCT02063828|2129636|FG000|Overall Study|Withdrawal by Subject|4
1074323|NCT02063828|2129637|FG001|Overall Study|Withdrawal by Subject|6
1074324|NCT02063828|2129638|FG002|Overall Study|Withdrawal by Subject|3
1074325|NCT02063828|2129636|FG000|Overall Study|Death|0
1074326|NCT02063828|2129637|FG001|Overall Study|Death|0
1074327|NCT02063828|2129638|FG002|Overall Study|Death|1
1074328|NCT02063854|2129653|FG000|Overall Study|Pretreatment Event/Adverse Event|13
1074329|NCT02063854|2129654|FG001|Overall Study|Pretreatment Event/Adverse Event|10
1074330|NCT02063854|2129655|FG002|Overall Study|Pretreatment Event/Adverse Event|13
1074331|NCT02063854|2129656|FG003|Overall Study|Pretreatment Event/Adverse Event|8
1074332|NCT02063854|2129657|FG004|Overall Study|Pretreatment Event/Adverse Event|7
1074333|NCT02063854|2129658|FG005|Overall Study|Pretreatment Event/Adverse Event|18
1074334|NCT02063854|2129659|FG006|Overall Study|Pretreatment Event/Adverse Event|4
1074335|NCT02063854|2129653|FG000|Overall Study|Major Protocol Deviation|0
1074336|NCT02063854|2129654|FG001|Overall Study|Major Protocol Deviation|0
1074337|NCT02063854|2129655|FG002|Overall Study|Major Protocol Deviation|3
1074338|NCT02063854|2129656|FG003|Overall Study|Major Protocol Deviation|0
1074339|NCT02063854|2129657|FG004|Overall Study|Major Protocol Deviation|0
1074340|NCT02063854|2129658|FG005|Overall Study|Major Protocol Deviation|0
1074341|NCT02063854|2129659|FG006|Overall Study|Major Protocol Deviation|0
1074342|NCT02063854|2129653|FG000|Overall Study|Voluntary Withdrawal|2
1074343|NCT02063854|2129654|FG001|Overall Study|Voluntary Withdrawal|0
1074344|NCT02063854|2129655|FG002|Overall Study|Voluntary Withdrawal|8
1074345|NCT02063854|2129656|FG003|Overall Study|Voluntary Withdrawal|1
1074346|NCT02063854|2129657|FG004|Overall Study|Voluntary Withdrawal|3
1074347|NCT02063854|2129658|FG005|Overall Study|Voluntary Withdrawal|6
1074348|NCT02063854|2129659|FG006|Overall Study|Voluntary Withdrawal|1
1074349|NCT02063854|2129653|FG000|Overall Study|Surgical Dental Work Performed/Planned|5
1074350|NCT02063854|2129654|FG001|Overall Study|Surgical Dental Work Performed/Planned|2
1074351|NCT02063854|2129655|FG002|Overall Study|Surgical Dental Work Performed/Planned|6
1074352|NCT02063854|2129656|FG003|Overall Study|Surgical Dental Work Performed/Planned|1
1074353|NCT02063854|2129657|FG004|Overall Study|Surgical Dental Work Performed/Planned|1
1074354|NCT02063854|2129658|FG005|Overall Study|Surgical Dental Work Performed/Planned|6
1074355|NCT02063854|2129659|FG006|Overall Study|Surgical Dental Work Performed/Planned|1
1074356|NCT02063854|2129653|FG000|Overall Study|Reason Not Specified|1
1074357|NCT02063854|2129654|FG001|Overall Study|Reason Not Specified|0
1074358|NCT02063854|2129655|FG002|Overall Study|Reason Not Specified|0
1074359|NCT02063854|2129656|FG003|Overall Study|Reason Not Specified|0
1074360|NCT02063854|2129657|FG004|Overall Study|Reason Not Specified|0
1074361|NCT02063854|2129658|FG005|Overall Study|Reason Not Specified|0
1074362|NCT02063854|2129659|FG006|Overall Study|Reason Not Specified|0
1074363|NCT02063854|2129653|FG000|Overall Study|Did Not Receive Study Drug|0
1074364|NCT02063854|2129654|FG001|Overall Study|Did Not Receive Study Drug|0
1074365|NCT02063854|2129655|FG002|Overall Study|Did Not Receive Study Drug|0
1074366|NCT02063854|2129656|FG003|Overall Study|Did Not Receive Study Drug|0
1074367|NCT02063854|2129657|FG004|Overall Study|Did Not Receive Study Drug|0
1074368|NCT02063854|2129658|FG005|Overall Study|Did Not Receive Study Drug|1
1074369|NCT02063854|2129659|FG006|Overall Study|Did Not Receive Study Drug|0
1074370|NCT02063880|2129688|FG000|Overall Study|Death|21
1074371|NCT02063880|2129689|FG001|Overall Study|Death|18
1074372|NCT02063880|2129688|FG000|Overall Study|Lost to Follow-up|7
1074373|NCT02063880|2129689|FG001|Overall Study|Lost to Follow-up|7
1074374|NCT02063880|2129688|FG000|Overall Study|Ineligible|0
1074375|NCT02063880|2129689|FG001|Overall Study|Ineligible|2
1074376|NCT02063984|2129697|FG000|Overall Study|Lost to Follow-up|6
1074377|NCT02063984|2129698|FG001|Overall Study|Lost to Follow-up|5
1074378|NCT02064166|2129710|FG000|Overall Study|Adverse Event|1
1074379|NCT02064166|2129711|FG001|Overall Study|Adverse Event|0
1074380|NCT02064205|2129739|FG000|Overall Study|Withdrawal by Subject|1
1074381|NCT02064231|2129755|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5
1074382|NCT02064231|2129756|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3
1074383|NCT02064231|2129757|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0
1074384|NCT02064231|2129758|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0
1074385|NCT02064231|2129755|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1
1074386|NCT02064231|2129756|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1
1074387|NCT02064231|2129757|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0
1074388|NCT02064231|2129758|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0
1074389|NCT02064231|2129755|FG000|First Test Period (Test A or Test C)|Adverse Event|1
1074390|NCT02064231|2129756|FG001|First Test Period (Test A or Test C)|Adverse Event|0
1074391|NCT02064231|2129757|FG002|First Test Period (Test A or Test C)|Adverse Event|1
1074392|NCT02064231|2129758|FG003|First Test Period (Test A or Test C)|Adverse Event|0
1074393|NCT02064231|2129755|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1
1074394|NCT02064231|2129756|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1
1074395|NCT02064231|2129757|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0
1074396|NCT02064231|2129758|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0
1074397|NCT02064439|2129844|FG000|Overall Study|Adverse Event|51
1074398|NCT02064439|2129845|FG001|Overall Study|Adverse Event|47
1074399|NCT02064439|2129846|FG002|Overall Study|Adverse Event|46
1074400|NCT02064439|2129844|FG000|Overall Study|Death|0
1074401|NCT02064439|2129845|FG001|Overall Study|Death|2
1074402|NCT02064439|2129846|FG002|Overall Study|Death|3
1074403|NCT02064439|2129844|FG000|Overall Study|Withdrawal by Subject|29
1074404|NCT02064439|2129845|FG001|Overall Study|Withdrawal by Subject|18
1074405|NCT02064439|2129846|FG002|Overall Study|Withdrawal by Subject|26
1074406|NCT02064439|2129844|FG000|Overall Study|Protocol Violation|3
1074407|NCT02064439|2129845|FG001|Overall Study|Protocol Violation|5
1074408|NCT02064439|2129846|FG002|Overall Study|Protocol Violation|3
1074409|NCT02064439|2129844|FG000|Overall Study|Lost to Follow-up|1
1074410|NCT02064439|2129845|FG001|Overall Study|Lost to Follow-up|3
1074411|NCT02064439|2129846|FG002|Overall Study|Lost to Follow-up|4
1074412|NCT02064439|2129844|FG000|Overall Study|Non-compliance with study medication|21
1074413|NCT02064439|2129845|FG001|Overall Study|Non-compliance with study medication|19
1074414|NCT02064439|2129846|FG002|Overall Study|Non-compliance with study medication|23
1074415|NCT02064439|2129844|FG000|Overall Study|Physician Decision|0
1074416|NCT02064439|2129845|FG001|Overall Study|Physician Decision|1
1074417|NCT02064439|2129846|FG002|Overall Study|Physician Decision|1
1074418|NCT02064439|2129844|FG000|Overall Study|Logistical difficulties|6
1074419|NCT02064439|2129845|FG001|Overall Study|Logistical difficulties|5
1074420|NCT02064439|2129846|FG002|Overall Study|Logistical difficulties|2
1074421|NCT02064439|2129844|FG000|Overall Study|Efficacy outcome reached|18
1074422|NCT02064439|2129845|FG001|Overall Study|Efficacy outcome reached|16
1074423|NCT02064439|2129846|FG002|Overall Study|Efficacy outcome reached|57
1074424|NCT02064439|2129844|FG000|Overall Study|Safety outcome reached|12
1074425|NCT02064439|2129845|FG001|Overall Study|Safety outcome reached|20
1074426|NCT02064439|2129846|FG002|Overall Study|Safety outcome reached|10
1074427|NCT02064439|2129844|FG000|Overall Study|Other|2
1074428|NCT02064439|2129845|FG001|Overall Study|Other|2
1074429|NCT02064439|2129846|FG002|Overall Study|Other|7
1074430|NCT02064816|2129860|FG000|Overall Study|Adverse Event|3
1074431|NCT02064816|2129861|FG001|Overall Study|Adverse Event|2
1074432|NCT02064816|2129860|FG000|Overall Study|Withdrawal by Subject|2
1074433|NCT02064816|2129861|FG001|Overall Study|Withdrawal by Subject|1
1074434|NCT02064816|2129860|FG000|Overall Study|Lost to Follow-up|2
1074435|NCT02064816|2129861|FG001|Overall Study|Lost to Follow-up|1
1074436|NCT02064816|2129860|FG000|Overall Study|Therapeutic failure|0
1074437|NCT02064816|2129861|FG001|Overall Study|Therapeutic failure|1
1074438|NCT02064816|2129860|FG000|Overall Study|Other|1
1074439|NCT02064816|2129861|FG001|Overall Study|Other|3
1074440|NCT02064868|2129916|FG000|Overall Study|Lost to Follow-up|14
1074441|NCT02064868|2129917|FG001|Overall Study|Lost to Follow-up|8
1074442|NCT02064868|2129916|FG000|Overall Study|Physician Decision|1
1074443|NCT02064868|2129917|FG001|Overall Study|Physician Decision|0
1074444|NCT02064868|2129916|FG000|Overall Study|Withdrawal by Subject|14
1074445|NCT02064868|2129917|FG001|Overall Study|Withdrawal by Subject|3
1074446|NCT02064868|2129916|FG000|Overall Study|Technical Problems or Missing|5
1074447|NCT02064868|2129917|FG001|Overall Study|Technical Problems or Missing|2
1074448|NCT02064894|2129926|FG000|Overall Study|Withdrawal by Subject|43
1074449|NCT02064894|2129927|FG001|Overall Study|Withdrawal by Subject|102
1074450|NCT02064894|2129928|FG002|Overall Study|Withdrawal by Subject|115
1074451|NCT02064920|2129947|FG000|Overall Study|Adverse Event|0
1074452|NCT02064920|2129948|FG001|Overall Study|Adverse Event|4
1074453|NCT02064920|2129947|FG000|Overall Study|Physician Decision|0
1074454|NCT02064920|2129948|FG001|Overall Study|Physician Decision|1
1074455|NCT02064920|2129947|FG000|Overall Study|Technical Problems|0
1074456|NCT02064920|2129948|FG001|Overall Study|Technical Problems|1
1074457|NCT02064920|2129947|FG000|Overall Study|Withdrawal by Subject|1
1074458|NCT02064920|2129948|FG001|Overall Study|Withdrawal by Subject|3
1074459|NCT02065245|2129983|FG000|Infusion 1|Lost to Follow-up|0
1074460|NCT02065245|2129984|FG001|Infusion 1|Lost to Follow-up|0
1074461|NCT02065245|2129985|FG002|Infusion 1|Lost to Follow-up|0
1074462|NCT02065245|2129986|FG003|Infusion 1|Lost to Follow-up|0
1074463|NCT02065245|2129987|FG004|Infusion 1|Lost to Follow-up|0
1074464|NCT02065245|2129988|FG005|Infusion 1|Lost to Follow-up|0
1074465|NCT02065245|2129989|FG006|Infusion 1|Lost to Follow-up|1
1074466|NCT02065245|2129983|FG000|Infusion 1|Death|0
1074467|NCT02065245|2129984|FG001|Infusion 1|Death|0
1074468|NCT02065245|2129985|FG002|Infusion 1|Death|1
1074469|NCT02065245|2129986|FG003|Infusion 1|Death|0
1074470|NCT02065245|2129987|FG004|Infusion 1|Death|1
1074471|NCT02065245|2129988|FG005|Infusion 1|Death|0
1074472|NCT02065245|2129989|FG006|Infusion 1|Death|0
1074473|NCT02065245|2129983|FG000|Infusion 2|Death|0
1074474|NCT02065245|2129984|FG001|Infusion 2|Death|0
1074475|NCT02065245|2129985|FG002|Infusion 2|Death|0
1074476|NCT02065245|2129986|FG003|Infusion 2|Death|0
1074477|NCT02065245|2129987|FG004|Infusion 2|Death|0
1074478|NCT02065245|2129988|FG005|Infusion 2|Death|0
1074479|NCT02065245|2129989|FG006|Infusion 2|Death|1
1074480|NCT02065245|2129983|FG000|Infusion 3|Lost to Follow-up|1
1074481|NCT02065245|2129984|FG001|Infusion 3|Lost to Follow-up|1
1074482|NCT02065245|2129985|FG002|Infusion 3|Lost to Follow-up|0
1074483|NCT02065245|2129986|FG003|Infusion 3|Lost to Follow-up|0
1074484|NCT02065245|2129987|FG004|Infusion 3|Lost to Follow-up|0
1074485|NCT02065245|2129988|FG005|Infusion 3|Lost to Follow-up|0
1074486|NCT02065245|2129989|FG006|Infusion 3|Lost to Follow-up|0
1074487|NCT02065336|2130013|FG000|Extension Phase|Study Terminated by Sponsor|0
1074488|NCT02065336|2130014|FG001|Extension Phase|Study Terminated by Sponsor|0
1074489|NCT02065336|2130015|FG002|Extension Phase|Study Terminated by Sponsor|0
1074490|NCT02065336|2130016|FG003|Extension Phase|Study Terminated by Sponsor|0
1074491|NCT02065336|2130017|FG004|Extension Phase|Study Terminated by Sponsor|0
1074492|NCT02065336|2130018|FG005|Extension Phase|Study Terminated by Sponsor|0
1074493|NCT02065336|2130019|FG006|Extension Phase|Study Terminated by Sponsor|0
1074494|NCT02065336|2130020|FG007|Extension Phase|Study Terminated by Sponsor|0
1074495|NCT02065336|2130021|FG008|Extension Phase|Study Terminated by Sponsor|2
1074496|NCT02065336|2130022|FG009|Extension Phase|Study Terminated by Sponsor|8
1074497|NCT02065518|2130074|FG000|Overall Study|Lost to Follow-up|3
1074498|NCT02065518|2130075|FG001|Overall Study|Lost to Follow-up|4
1074499|NCT02065518|2130076|FG002|Overall Study|Lost to Follow-up|0
1074500|NCT02065518|2130077|FG003|Overall Study|Lost to Follow-up|3
1074501|NCT02065518|2130074|FG000|Overall Study|Withdrawal by Subject|3
1074502|NCT02065518|2130075|FG001|Overall Study|Withdrawal by Subject|4
1074503|NCT02065518|2130076|FG002|Overall Study|Withdrawal by Subject|9
1074504|NCT02065518|2130077|FG003|Overall Study|Withdrawal by Subject|2
1074505|NCT02065557|2130090|FG000|Induction Period|Withdrawal by Subject|2
1074506|NCT02065557|2130091|FG001|Induction Period|Withdrawal by Subject|1
1074507|NCT02065557|2130092|FG002|Induction Period|Withdrawal by Subject|0
1074508|NCT02065557|2130093|FG003|Induction Period|Withdrawal by Subject|0
1074509|NCT02065557|2130094|FG004|Induction Period|Withdrawal by Subject|0
1074510|NCT02065557|2130095|FG005|Induction Period|Withdrawal by Subject|0
1074511|NCT02065557|2130090|FG000|Induction Period|Lack of Efficacy|2
1074512|NCT02065557|2130091|FG001|Induction Period|Lack of Efficacy|1
1074513|NCT02065557|2130092|FG002|Induction Period|Lack of Efficacy|1
1074514|NCT02065557|2130093|FG003|Induction Period|Lack of Efficacy|0
1074515|NCT02065557|2130094|FG004|Induction Period|Lack of Efficacy|0
1074516|NCT02065557|2130095|FG005|Induction Period|Lack of Efficacy|0
1074517|NCT02065557|2130090|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1
1074518|NCT02065557|2130091|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1
1074519|NCT02065557|2130092|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1
1074520|NCT02065557|2130093|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0
1074521|NCT02065557|2130094|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0
1074522|NCT02065557|2130095|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0
1074523|NCT02065557|2130090|FG000|Induction Period|Non-Responder at Week 8|4
1074524|NCT02065557|2130091|FG001|Induction Period|Non-Responder at Week 8|4
1074525|NCT02065557|2130092|FG002|Induction Period|Non-Responder at Week 8|0
1074526|NCT02065557|2130093|FG003|Induction Period|Non-Responder at Week 8|0
1074527|NCT02065557|2130094|FG004|Induction Period|Non-Responder at Week 8|0
1074528|NCT02065557|2130095|FG005|Induction Period|Non-Responder at Week 8|0
1074529|NCT02065557|2130090|FG000|Induction Period|Adverse Event|1
1074530|NCT02065557|2130091|FG001|Induction Period|Adverse Event|1
1074531|NCT02065557|2130092|FG002|Induction Period|Adverse Event|0
1074532|NCT02065557|2130093|FG003|Induction Period|Adverse Event|0
1074533|NCT02065557|2130094|FG004|Induction Period|Adverse Event|0
1074534|NCT02065557|2130095|FG005|Induction Period|Adverse Event|0
1074535|NCT02065557|2130090|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0
1074536|NCT02065557|2130091|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0
1074537|NCT02065557|2130092|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0
1074538|NCT02065557|2130093|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1
1074539|NCT02065557|2130094|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1
1074540|NCT02065557|2130095|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0
1074541|NCT02065557|2130090|FG000|Maintenance Period|Withdrawal by Subject|0
1074542|NCT02065557|2130091|FG001|Maintenance Period|Withdrawal by Subject|0
1074543|NCT02065557|2130092|FG002|Maintenance Period|Withdrawal by Subject|0
1074544|NCT02065557|2130093|FG003|Maintenance Period|Withdrawal by Subject|0
1074545|NCT02065557|2130094|FG004|Maintenance Period|Withdrawal by Subject|2
1074546|NCT02065557|2130095|FG005|Maintenance Period|Withdrawal by Subject|1
1074547|NCT02065557|2130090|FG000|Maintenance Period|Lack of Efficacy|0
1074548|NCT02065557|2130091|FG001|Maintenance Period|Lack of Efficacy|0
1074549|NCT02065557|2130092|FG002|Maintenance Period|Lack of Efficacy|0
1074550|NCT02065557|2130093|FG003|Maintenance Period|Lack of Efficacy|0
1074551|NCT02065557|2130094|FG004|Maintenance Period|Lack of Efficacy|5
1074552|NCT02065557|2130095|FG005|Maintenance Period|Lack of Efficacy|2
1074553|NCT02065557|2130090|FG000|Maintenance Period|Subject Non-Compliance|0
1074554|NCT02065557|2130091|FG001|Maintenance Period|Subject Non-Compliance|0
1074555|NCT02065557|2130092|FG002|Maintenance Period|Subject Non-Compliance|0
1074556|NCT02065557|2130093|FG003|Maintenance Period|Subject Non-Compliance|0
1074557|NCT02065557|2130094|FG004|Maintenance Period|Subject Non-Compliance|0
1074558|NCT02065557|2130095|FG005|Maintenance Period|Subject Non-Compliance|1
1074559|NCT02065570|2130122|FG000|Induction Study|Adverse Event|5
1074560|NCT02065570|2130123|FG001|Induction Study|Adverse Event|12
1074561|NCT02065570|2130124|FG002|Induction Study|Adverse Event|0
1074562|NCT02065570|2130125|FG003|Induction Study|Adverse Event|0
1074563|NCT02065570|2130122|FG000|Induction Study|Withdrawal by Subject|2
1074564|NCT02065570|2130123|FG001|Induction Study|Withdrawal by Subject|3
1074565|NCT02065570|2130124|FG002|Induction Study|Withdrawal by Subject|0
1074566|NCT02065570|2130125|FG003|Induction Study|Withdrawal by Subject|0
1074567|NCT02065570|2130122|FG000|Induction Study|Lost to Follow-up|1
1074568|NCT02065570|2130123|FG001|Induction Study|Lost to Follow-up|1
1074569|NCT02065570|2130124|FG002|Induction Study|Lost to Follow-up|0
1074570|NCT02065570|2130125|FG003|Induction Study|Lost to Follow-up|0
1074571|NCT02065570|2130122|FG000|Induction Study|Other, Not Specified|6
1074572|NCT02065570|2130123|FG001|Induction Study|Other, Not Specified|5
1074573|NCT02065570|2130124|FG002|Induction Study|Other, Not Specified|0
1074574|NCT02065570|2130125|FG003|Induction Study|Other, Not Specified|0
1074575|NCT02065570|2130122|FG000|Maintenance Study|Adverse Event|0
1074576|NCT02065570|2130123|FG001|Maintenance Study|Adverse Event|0
1074577|NCT02065570|2130124|FG002|Maintenance Study|Adverse Event|8
1074578|NCT02065570|2130125|FG003|Maintenance Study|Adverse Event|8
1074579|NCT02065570|2130122|FG000|Maintenance Study|Withdrawal by Subject|0
1074580|NCT02065570|2130123|FG001|Maintenance Study|Withdrawal by Subject|0
1074581|NCT02065570|2130124|FG002|Maintenance Study|Withdrawal by Subject|1
1074582|NCT02065570|2130125|FG003|Maintenance Study|Withdrawal by Subject|4
1074583|NCT02065570|2130122|FG000|Maintenance Study|Lost to Follow-up|0
1074584|NCT02065570|2130123|FG001|Maintenance Study|Lost to Follow-up|0
1074585|NCT02065570|2130124|FG002|Maintenance Study|Lost to Follow-up|2
1074586|NCT02065570|2130125|FG003|Maintenance Study|Lost to Follow-up|2
1074587|NCT02065570|2130122|FG000|Maintenance Study|Other, Not Specified|0
1074588|NCT02065570|2130123|FG001|Maintenance Study|Other, Not Specified|0
1074589|NCT02065570|2130124|FG002|Maintenance Study|Other, Not Specified|11
1074590|NCT02065570|2130125|FG003|Maintenance Study|Other, Not Specified|5
1074591|NCT02065622|2130138|FG000|Induction Study|Adverse Event|13
1074592|NCT02065622|2130139|FG001|Induction Study|Adverse Event|19
1074593|NCT02065622|2130140|FG002|Induction Study|Adverse Event|0
1074594|NCT02065622|2130141|FG003|Induction Study|Adverse Event|0
1074595|NCT02065622|2130142|FG004|Induction Study|Adverse Event|0
1074596|NCT02065622|2130138|FG000|Induction Study|Withdrawal by Subject|3
1074597|NCT02065622|2130139|FG001|Induction Study|Withdrawal by Subject|5
1074598|NCT02065622|2130140|FG002|Induction Study|Withdrawal by Subject|0
1074599|NCT02065622|2130141|FG003|Induction Study|Withdrawal by Subject|0
1074600|NCT02065622|2130142|FG004|Induction Study|Withdrawal by Subject|0
1074601|NCT02065622|2130138|FG000|Induction Study|Lost to Follow-up|1
1074602|NCT02065622|2130139|FG001|Induction Study|Lost to Follow-up|0
1074603|NCT02065622|2130140|FG002|Induction Study|Lost to Follow-up|0
1074604|NCT02065622|2130141|FG003|Induction Study|Lost to Follow-up|0
1074605|NCT02065622|2130142|FG004|Induction Study|Lost to Follow-up|0
1074606|NCT02065622|2130138|FG000|Induction Study|Lack of Efficacy|22
1074607|NCT02065622|2130139|FG001|Induction Study|Lack of Efficacy|27
1074608|NCT02065622|2130140|FG002|Induction Study|Lack of Efficacy|0
1074609|NCT02065622|2130141|FG003|Induction Study|Lack of Efficacy|0
1074610|NCT02065622|2130142|FG004|Induction Study|Lack of Efficacy|0
1074611|NCT02065622|2130138|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4
1074612|NCT02065622|2130139|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5
1074613|NCT02065622|2130140|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0
1074614|NCT02065622|2130141|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0
1074615|NCT02065622|2130142|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0
1074616|NCT02065622|2130138|FG000|Induction Study|Subject Noncompliance|1
1074617|NCT02065622|2130139|FG001|Induction Study|Subject Noncompliance|1
1074618|NCT02065622|2130140|FG002|Induction Study|Subject Noncompliance|0
1074619|NCT02065622|2130141|FG003|Induction Study|Subject Noncompliance|0
1074620|NCT02065622|2130142|FG004|Induction Study|Subject Noncompliance|0
1074621|NCT02065622|2130138|FG000|Induction Study|Other, Not Specified|3
1074622|NCT02065622|2130139|FG001|Induction Study|Other, Not Specified|2
1074623|NCT02065622|2130140|FG002|Induction Study|Other, Not Specified|0
1074624|NCT02065622|2130141|FG003|Induction Study|Other, Not Specified|0
1074625|NCT02065622|2130142|FG004|Induction Study|Other, Not Specified|0
1074626|NCT02065622|2130138|FG000|Maintenance Study|Adverse Event|0
1074627|NCT02065622|2130139|FG001|Maintenance Study|Adverse Event|0
1074628|NCT02065622|2130140|FG002|Maintenance Study|Adverse Event|25
1074629|NCT02065622|2130141|FG003|Maintenance Study|Adverse Event|22
1074630|NCT02065622|2130142|FG004|Maintenance Study|Adverse Event|11
1074631|NCT02065622|2130138|FG000|Maintenance Study|Withdrawal by Subject|0
1074632|NCT02065622|2130139|FG001|Maintenance Study|Withdrawal by Subject|0
1074633|NCT02065622|2130140|FG002|Maintenance Study|Withdrawal by Subject|11
1074634|NCT02065622|2130141|FG003|Maintenance Study|Withdrawal by Subject|5
1074635|NCT02065622|2130142|FG004|Maintenance Study|Withdrawal by Subject|7
1074636|NCT02065622|2130138|FG000|Maintenance Study|Lost to Follow-up|0
1074637|NCT02065622|2130139|FG001|Maintenance Study|Lost to Follow-up|0
1074638|NCT02065622|2130140|FG002|Maintenance Study|Lost to Follow-up|4
1074639|NCT02065622|2130141|FG003|Maintenance Study|Lost to Follow-up|1
1074640|NCT02065622|2130142|FG004|Maintenance Study|Lost to Follow-up|1
1074641|NCT02065622|2130138|FG000|Maintenance Study|Lack of Efficacy|0
1074642|NCT02065622|2130139|FG001|Maintenance Study|Lack of Efficacy|0
1074643|NCT02065622|2130140|FG002|Maintenance Study|Lack of Efficacy|70
1074644|NCT02065622|2130141|FG003|Maintenance Study|Lack of Efficacy|55
1074645|NCT02065622|2130142|FG004|Maintenance Study|Lack of Efficacy|19
1074646|NCT02065622|2130138|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0
1074647|NCT02065622|2130139|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0
1074648|NCT02065622|2130140|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7
1074649|NCT02065622|2130141|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3
1074650|NCT02065622|2130142|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4
1074651|NCT02065622|2130138|FG000|Maintenance Study|Subject Non-Compliance|0
1074652|NCT02065622|2130139|FG001|Maintenance Study|Subject Non-Compliance|0
1074653|NCT02065622|2130140|FG002|Maintenance Study|Subject Non-Compliance|1
1074654|NCT02065622|2130141|FG003|Maintenance Study|Subject Non-Compliance|3
1074655|NCT02065622|2130142|FG004|Maintenance Study|Subject Non-Compliance|2
1074656|NCT02065622|2130138|FG000|Maintenance Study|Other, Not Specified|0
1074657|NCT02065622|2130139|FG001|Maintenance Study|Other, Not Specified|0
1074658|NCT02065622|2130140|FG002|Maintenance Study|Other, Not Specified|6
1074659|NCT02065622|2130141|FG003|Maintenance Study|Other, Not Specified|14
1074660|NCT02065622|2130142|FG004|Maintenance Study|Other, Not Specified|2
1074661|NCT02065622|2130138|FG000|Maintenance Study|Unknown Reason|0
1074662|NCT02065622|2130139|FG001|Maintenance Study|Unknown Reason|0
1074663|NCT02065622|2130140|FG002|Maintenance Study|Unknown Reason|0
1074664|NCT02065622|2130141|FG003|Maintenance Study|Unknown Reason|1
1074665|NCT02065622|2130142|FG004|Maintenance Study|Unknown Reason|0
1074666|NCT02065713|2130168|FG000|Overall Study|Adverse Event|0
1074667|NCT02065713|2130169|FG001|Overall Study|Adverse Event|1
1074668|NCT02065713|2130168|FG000|Overall Study|Unsatisfactory therapeutic effect|1
1074669|NCT02065713|2130169|FG001|Overall Study|Unsatisfactory therapeutic effect|0
1074670|NCT02065791|2130177|FG000|Overall Study|Closed Site|1
1074671|NCT02065791|2130178|FG001|Overall Study|Closed Site|1
1074672|NCT02065791|2130177|FG000|Overall Study|Withdrawal by Subject|11
1074673|NCT02065791|2130178|FG001|Overall Study|Withdrawal by Subject|5
1074674|NCT02065791|2130177|FG000|Overall Study|Lost to Follow-up|13
1074675|NCT02065791|2130178|FG001|Overall Study|Lost to Follow-up|9
1074676|NCT02065895|2130184|FG000|Overall Study|Protocol Violation|1
1074677|NCT02065895|2130185|FG001|Overall Study|Protocol Violation|0
1074678|NCT02065895|2130186|FG002|Overall Study|Protocol Violation|0
1074679|NCT02065895|2130187|FG003|Overall Study|Protocol Violation|1
1074680|NCT02065895|2130188|FG004|Overall Study|Protocol Violation|0
1074681|NCT02065895|2130189|FG005|Overall Study|Protocol Violation|0
1074682|NCT02065895|2130184|FG000|Overall Study|Scheduling conflicts|0
1074683|NCT02065895|2130185|FG001|Overall Study|Scheduling conflicts|1
1074684|NCT02065895|2130186|FG002|Overall Study|Scheduling conflicts|0
1074685|NCT02065895|2130187|FG003|Overall Study|Scheduling conflicts|0
1074686|NCT02065895|2130188|FG004|Overall Study|Scheduling conflicts|0
1074687|NCT02065895|2130189|FG005|Overall Study|Scheduling conflicts|0
1074688|NCT02066051|2130206|FG000|Overall Study|Subject developed active GVHD|1
1074689|NCT02066129|2130212|FG000|Overall Study|Lost to Follow-up|13
1074690|NCT02066129|2130213|FG001|Overall Study|Lost to Follow-up|12
1074691|NCT02066129|2130212|FG000|Overall Study|Withdrawal by Subject|7
1074692|NCT02066129|2130213|FG001|Overall Study|Withdrawal by Subject|10
1074693|NCT02066129|2130212|FG000|Overall Study|Lack of Efficacy|8
1074694|NCT02066129|2130213|FG001|Overall Study|Lack of Efficacy|10
1074695|NCT02066129|2130212|FG000|Overall Study|Physician Decision|1
1074696|NCT02066129|2130213|FG001|Overall Study|Physician Decision|1
1074699|NCT02066233|2130233|FG000|EG Scan II (Day 1)|difficulty intubating subject|6
1074700|NCT02066233|2130234|FG001|EG Scan II (Day 1)|difficulty intubating subject|6
1074701|NCT02066298|2130246|FG000|Overall Study|Lost to Follow-up|3
1074702|NCT02066298|2130247|FG001|Overall Study|Lost to Follow-up|2
1074703|NCT02066298|2130248|FG002|Overall Study|Lost to Follow-up|3
1074704|NCT02066298|2130249|FG003|Overall Study|Lost to Follow-up|2
1074705|NCT02066298|2130250|FG004|Overall Study|Lost to Follow-up|3
1074706|NCT02066298|2130251|FG005|Overall Study|Lost to Follow-up|4
1074707|NCT02066298|2130246|FG000|Overall Study|Withdrawal by Subject|6
1074708|NCT02066298|2130247|FG001|Overall Study|Withdrawal by Subject|6
1074709|NCT02066298|2130248|FG002|Overall Study|Withdrawal by Subject|6
1074710|NCT02066298|2130249|FG003|Overall Study|Withdrawal by Subject|4
1074711|NCT02066298|2130250|FG004|Overall Study|Withdrawal by Subject|5
1074712|NCT02066298|2130251|FG005|Overall Study|Withdrawal by Subject|8
1074713|NCT02066298|2130246|FG000|Overall Study|Physician Decision|0
1074714|NCT02066298|2130247|FG001|Overall Study|Physician Decision|0
1074715|NCT02066298|2130248|FG002|Overall Study|Physician Decision|1
1074716|NCT02066298|2130249|FG003|Overall Study|Physician Decision|0
1074717|NCT02066298|2130250|FG004|Overall Study|Physician Decision|1
1074718|NCT02066298|2130251|FG005|Overall Study|Physician Decision|0
1074719|NCT02066311|2130263|FG000|Overall Study|Adverse Event|4
1074720|NCT02066311|2130263|FG000|Overall Study|Withdrawal by Subject|1
1074721|NCT02066389|2130273|FG000|Overall Study|Adverse Event|1
1074722|NCT02066389|2130274|FG001|Overall Study|Adverse Event|1
1074723|NCT02066389|2130275|FG002|Overall Study|Adverse Event|1
1074724|NCT02066389|2130276|FG003|Overall Study|Adverse Event|1
1074725|NCT02066389|2130277|FG004|Overall Study|Adverse Event|5
1074726|NCT02066389|2130278|FG005|Overall Study|Adverse Event|1
1074727|NCT02066389|2130273|FG000|Overall Study|Withdrawal by Subject|4
1074728|NCT02066389|2130274|FG001|Overall Study|Withdrawal by Subject|0
1074729|NCT02066389|2130275|FG002|Overall Study|Withdrawal by Subject|5
1074730|NCT02066389|2130276|FG003|Overall Study|Withdrawal by Subject|1
1074731|NCT02066389|2130277|FG004|Overall Study|Withdrawal by Subject|1
1074732|NCT02066389|2130278|FG005|Overall Study|Withdrawal by Subject|2
1074733|NCT02066389|2130273|FG000|Overall Study|Lost to Follow-up|0
1074734|NCT02066389|2130274|FG001|Overall Study|Lost to Follow-up|0
1074735|NCT02066389|2130275|FG002|Overall Study|Lost to Follow-up|0
1074736|NCT02066389|2130276|FG003|Overall Study|Lost to Follow-up|1
1074737|NCT02066389|2130277|FG004|Overall Study|Lost to Follow-up|1
1074738|NCT02066389|2130278|FG005|Overall Study|Lost to Follow-up|1
1074739|NCT02066389|2130273|FG000|Overall Study|Randomized in Error|0
1074740|NCT02066389|2130274|FG001|Overall Study|Randomized in Error|0
1074741|NCT02066389|2130275|FG002|Overall Study|Randomized in Error|0
1074742|NCT02066389|2130276|FG003|Overall Study|Randomized in Error|0
1074743|NCT02066389|2130277|FG004|Overall Study|Randomized in Error|0
1074744|NCT02066389|2130278|FG005|Overall Study|Randomized in Error|1
1074745|NCT02066402|2130294|FG000|Overall Study|Adverse Event|1
1074746|NCT02066402|2130295|FG001|Overall Study|Adverse Event|2
1074747|NCT02066402|2130294|FG000|Overall Study|Lost to Follow-up|11
1074748|NCT02066402|2130295|FG001|Overall Study|Lost to Follow-up|8
1074749|NCT02066402|2130294|FG000|Overall Study|Withdrawal by Subject|14
1074750|NCT02066402|2130295|FG001|Overall Study|Withdrawal by Subject|11
1074751|NCT02066402|2130294|FG000|Overall Study|Progressive disease-clinical progression|0
1074752|NCT02066402|2130295|FG001|Overall Study|Progressive disease-clinical progression|1
1074753|NCT02066402|2130294|FG000|Overall Study|Protocol driven decision point|0
1074754|NCT02066402|2130295|FG001|Overall Study|Protocol driven decision point|1
1074755|NCT02066415|2130304|FG000|Overall Study|Decision by Sponsor|5
1074756|NCT02066415|2130305|FG001|Overall Study|Decision by Sponsor|4
1074757|NCT02066415|2130306|FG002|Overall Study|Decision by Sponsor|2
1074758|NCT02066415|2130304|FG000|Overall Study|Withdrawal by Subject|9
1074759|NCT02066415|2130305|FG001|Overall Study|Withdrawal by Subject|1
1074760|NCT02066415|2130306|FG002|Overall Study|Withdrawal by Subject|4
1074761|NCT02066415|2130304|FG000|Overall Study|Lost to Follow-up|7
1074762|NCT02066415|2130305|FG001|Overall Study|Lost to Follow-up|2
1074763|NCT02066415|2130306|FG002|Overall Study|Lost to Follow-up|2
1074764|NCT02066467|2130314|FG000|Overall Study|Did not undergo implant procedure|24
1074765|NCT02066467|2130314|FG000|Overall Study|Attempted to implant withoput success|43
1074766|NCT02066467|2130314|FG000|Overall Study|Consent ineligible|1
1074767|NCT02066467|2130314|FG000|Overall Study|Death|54
1074768|NCT02066467|2130314|FG000|Overall Study|Lost to Follow-up|51
1074769|NCT02066467|2130314|FG000|Overall Study|Adverse Event|20
1074770|NCT02066467|2130314|FG000|Overall Study|Withdrawal by Subject|16
1074771|NCT02066467|2130314|FG000|Overall Study|Physician Decision|2
1074772|NCT02066467|2130314|FG000|Overall Study|Not defined|4
1074773|NCT02066922|2130367|FG000|Overall Study|Adverse Event|1
1074774|NCT02067533|2130413|FG000|Overall Study|Lost to Follow-up|4
1074775|NCT02067533|2130414|FG001|Overall Study|Lost to Follow-up|2
1074776|NCT02067663|2130435|FG000|Overall Study|Lost to Follow-up|13
1074777|NCT02067663|2130436|FG001|Overall Study|Lost to Follow-up|14
1074778|NCT02067676|2130448|FG000|Overall Study|Withdrawal by Subject|1
1074779|NCT02067676|2130449|FG001|Overall Study|Withdrawal by Subject|0
1074780|NCT02067676|2130450|FG002|Overall Study|Withdrawal by Subject|0
1074781|NCT02067676|2130451|FG003|Overall Study|Withdrawal by Subject|0
1074782|NCT02067676|2130452|FG004|Overall Study|Withdrawal by Subject|0
1074783|NCT02067676|2130453|FG005|Overall Study|Withdrawal by Subject|0
1074784|NCT02067728|2130474|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
1074785|NCT02067728|2130475|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
1074786|NCT02067728|2130474|FG000|6 Month Follow up Survey|Lost to Follow-up|48
1074787|NCT02067728|2130475|FG001|6 Month Follow up Survey|Lost to Follow-up|60
1074788|NCT02067728|2130474|FG000|6 Month Measurements|Unable to attend|114
1074789|NCT02067728|2130475|FG001|6 Month Measurements|Unable to attend|97
1074790|NCT02068118|2130520|FG000|18-month Comparative Study Period|Death|90
1074791|NCT02068118|2130521|FG001|18-month Comparative Study Period|Death|97
1074792|NCT02068118|2130520|FG000|18-month Comparative Study Period|Withdrawal by Subject|23
1074793|NCT02068118|2130521|FG001|18-month Comparative Study Period|Withdrawal by Subject|52
1074794|NCT02068118|2130520|FG000|18-month Comparative Study Period|Lost to Follow-up|6
1074795|NCT02068118|2130521|FG001|18-month Comparative Study Period|Lost to Follow-up|7
1074796|NCT02068118|2130520|FG000|18-month Comparative Study Period|Heart transplant|9
1074797|NCT02068118|2130521|FG001|18-month Comparative Study Period|Heart transplant|15
1074798|NCT02068118|2130520|FG000|18-month Comparative Study Period|Inclusion in another protocol|0
1074799|NCT02068118|2130521|FG001|18-month Comparative Study Period|Inclusion in another protocol|2
1074800|NCT02068118|2130520|FG000|18-month Comparative Study Period|Hemiplegia|0
1074801|NCT02068118|2130521|FG001|18-month Comparative Study Period|Hemiplegia|1
1074802|NCT02068118|2130520|FG000|18-month Comparative Study Period|Alzheimer's disease|0
1074803|NCT02068118|2130521|FG001|18-month Comparative Study Period|Alzheimer's disease|1
1074804|NCT02068118|2130520|FG000|18-month Comparative Study Period|Move|0
1074805|NCT02068118|2130521|FG001|18-month Comparative Study Period|Move|1
1074806|NCT02068118|2130520|FG000|18-month Comparative Study Period|Hearing loss|0
1074807|NCT02068118|2130521|FG001|18-month Comparative Study Period|Hearing loss|1
1074808|NCT02068118|2130520|FG000|Extension Period|Death|0
1074809|NCT02068118|2130521|FG001|Extension Period|Death|2
1074810|NCT02068118|2130520|FG000|Extension Period|Withdrawal by Subject|1
1074811|NCT02068118|2130521|FG001|Extension Period|Withdrawal by Subject|0
1074812|NCT02068118|2130520|FG000|Extension Period|Heart transplant|1
1074813|NCT02068118|2130521|FG001|Extension Period|Heart transplant|0
1074814|NCT02068118|2130520|FG000|Extension Period|Wrong device use|0
1074815|NCT02068118|2130521|FG001|Extension Period|Wrong device use|1
1074816|NCT02068222|2130533|FG000|Overall Study|Lost to Follow-up|1
1074817|NCT02068352|2130540|FG000|Overall Study|Lost to Follow-up|0
1074818|NCT02068352|2130541|FG001|Overall Study|Lost to Follow-up|2
1074819|NCT02068352|2130542|FG002|Overall Study|Lost to Follow-up|0
1074820|NCT02068352|2130540|FG000|Overall Study|Adverse Event|4
1074821|NCT02068352|2130541|FG001|Overall Study|Adverse Event|2
1074822|NCT02068352|2130542|FG002|Overall Study|Adverse Event|7
1074823|NCT02068352|2130540|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
1074824|NCT02068352|2130541|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1
1074825|NCT02068352|2130542|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
1074826|NCT02068352|2130540|FG000|Overall Study|Participant Withdrew Consent to Participate|6
1074827|NCT02068352|2130541|FG001|Overall Study|Participant Withdrew Consent to Participate|3
1074828|NCT02068352|2130542|FG002|Overall Study|Participant Withdrew Consent to Participate|1
1074829|NCT02068352|2130540|FG000|Overall Study|Protocol Deviation|0
1074830|NCT02068352|2130541|FG001|Overall Study|Protocol Deviation|0
1074831|NCT02068352|2130542|FG002|Overall Study|Protocol Deviation|1
1074832|NCT02068443|2130553|FG000|Overall Study|Pretreatment Event/Adverse Event|0
1074833|NCT02068443|2130554|FG001|Overall Study|Pretreatment Event/Adverse Event|5
1074834|NCT02068443|2130555|FG002|Overall Study|Pretreatment Event/Adverse Event|2
1074835|NCT02068443|2130553|FG000|Overall Study|Voluntary Withdrawal|4
1074836|NCT02068443|2130554|FG001|Overall Study|Voluntary Withdrawal|0
1074837|NCT02068443|2130555|FG002|Overall Study|Voluntary Withdrawal|1
1074838|NCT02068443|2130553|FG000|Overall Study|Lack of Efficacy|2
1074839|NCT02068443|2130554|FG001|Overall Study|Lack of Efficacy|1
1074840|NCT02068443|2130555|FG002|Overall Study|Lack of Efficacy|0
1074841|NCT02068443|2130553|FG000|Overall Study|Other Reason Not Specified|1
1074842|NCT02068443|2130554|FG001|Overall Study|Other Reason Not Specified|0
1074843|NCT02068443|2130555|FG002|Overall Study|Other Reason Not Specified|0
1074844|NCT02068495|2130563|FG000|Overall Study|Case Report Forms Uncollected|60
1074845|NCT02068495|2130563|FG000|Overall Study|Protocol Deviation|49
1074846|NCT02068508|2130567|FG000|Overall Study|Case report forms uncollected|27
1074847|NCT02068508|2130567|FG000|Overall Study|Patient did not visit the study site|1
1074848|NCT02068508|2130567|FG000|Overall Study|Protocol Violation|4
1074849|NCT02068599|2130574|FG000|Overall Study|Adverse Event|4
1074850|NCT02068599|2130575|FG001|Overall Study|Adverse Event|1
1074851|NCT02068599|2130576|FG002|Overall Study|Adverse Event|1
1074852|NCT02068599|2130574|FG000|Overall Study|Withdrawal by Subject|2
1074853|NCT02068599|2130575|FG001|Overall Study|Withdrawal by Subject|7
1074854|NCT02068599|2130576|FG002|Overall Study|Withdrawal by Subject|5
1074855|NCT02068599|2130574|FG000|Overall Study|Protocol Violation|4
1074856|NCT02068599|2130575|FG001|Overall Study|Protocol Violation|2
1074857|NCT02068599|2130576|FG002|Overall Study|Protocol Violation|3
1074858|NCT02068599|2130574|FG000|Overall Study|Lost to Follow-up|1
1074859|NCT02068599|2130575|FG001|Overall Study|Lost to Follow-up|0
1074860|NCT02068599|2130576|FG002|Overall Study|Lost to Follow-up|0
1074861|NCT02068599|2130574|FG000|Overall Study|Lack of Efficacy|0
1074862|NCT02068599|2130575|FG001|Overall Study|Lack of Efficacy|0
1074863|NCT02068599|2130576|FG002|Overall Study|Lack of Efficacy|3
1074864|NCT02068599|2130574|FG000|Overall Study|Noncompliance|0
1074865|NCT02068599|2130575|FG001|Overall Study|Noncompliance|0
1074866|NCT02068599|2130576|FG002|Overall Study|Noncompliance|1
1074867|NCT02068768|2130643|FG000|Overall Study|Lost to Follow-up|5
1074868|NCT02068768|2130643|FG000|Overall Study|Early Termination by Sponsor|2
1074869|NCT02068885|2130673|FG000|Overall Study|Withdrew|3
1074870|NCT02068885|2130674|FG001|Overall Study|Withdrew|5
1074871|NCT02068885|2130675|FG002|Overall Study|Withdrew|8
1074872|NCT02069015|2130686|FG000|Overall Study|Lost to Follow-up|39
1074873|NCT02069015|2130687|FG001|Overall Study|Lost to Follow-up|32
1074874|NCT02069015|2130686|FG000|Overall Study|Withdrawal by Subject|1
1074875|NCT02069015|2130687|FG001|Overall Study|Withdrawal by Subject|1
1074876|NCT02069093|2130698|FG000|Overall Study|Disease progression|14
1074877|NCT02069093|2130698|FG000|Overall Study|New cancer therapy|1
1074878|NCT02069093|2130698|FG000|Overall Study|Death|1
1074879|NCT02069093|2130698|FG000|Overall Study|Administrative problems|1
1074880|NCT02069093|2130698|FG000|Overall Study|Withdrawal by Subject|2
1074881|NCT02069093|2130698|FG000|Overall Study|Abnormal laboratory values|1
1074882|NCT02069093|2130698|FG000|Overall Study|Adverse Event|10
1074883|NCT02069379|2130736|FG000|Baseline Measurements|Lost to Follow-up|1
1074884|NCT02069379|2130737|FG001|Baseline Measurements|Lost to Follow-up|0
1074885|NCT02069379|2130738|FG002|Baseline Measurements|Lost to Follow-up|0
1074886|NCT02069379|2130739|FG003|Baseline Measurements|Lost to Follow-up|0
1074887|NCT02069379|2130736|FG000|Baseline Measurements|Ineligible based on initial assessments|2
1074888|NCT02069379|2130737|FG001|Baseline Measurements|Ineligible based on initial assessments|0
1074889|NCT02069379|2130738|FG002|Baseline Measurements|Ineligible based on initial assessments|0
1074890|NCT02069379|2130739|FG003|Baseline Measurements|Ineligible based on initial assessments|2
1074891|NCT02069379|2130736|FG000|First Treatment Arm|Lost to Follow-up|0
1074892|NCT02069379|2130737|FG001|First Treatment Arm|Lost to Follow-up|1
1074893|NCT02069379|2130738|FG002|First Treatment Arm|Lost to Follow-up|1
1074894|NCT02069379|2130739|FG003|First Treatment Arm|Lost to Follow-up|0
1074895|NCT02069379|2130736|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0
1074896|NCT02069379|2130737|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
1074897|NCT02069379|2130738|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0
1074898|NCT02069379|2130739|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0
1074899|NCT02069379|2130736|FG000|Washout Period (4 Weeks)|Unrelated event|0
1074900|NCT02069379|2130737|FG001|Washout Period (4 Weeks)|Unrelated event|1
1074901|NCT02069379|2130738|FG002|Washout Period (4 Weeks)|Unrelated event|0
1074902|NCT02069379|2130739|FG003|Washout Period (4 Weeks)|Unrelated event|0
1074903|NCT02069379|2130736|FG000|Second Treatment Arm|Lost to Follow-up|0
1074904|NCT02069379|2130737|FG001|Second Treatment Arm|Lost to Follow-up|0
1074905|NCT02069379|2130738|FG002|Second Treatment Arm|Lost to Follow-up|1
1074906|NCT02069379|2130739|FG003|Second Treatment Arm|Lost to Follow-up|0
1074907|NCT02069392|2130751|FG000|Overall Study|Withdrawal by Subject|4
1074908|NCT02069392|2130752|FG001|Overall Study|Withdrawal by Subject|2
1074909|NCT02070380|2130819|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
1074910|NCT02070380|2130820|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
1074911|NCT02070380|2130821|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
1074912|NCT02070380|2130822|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
1074913|NCT02070380|2130819|FG000|Second Injection|Image sets missing or technically inadeq|0
1074914|NCT02070380|2130820|FG001|Second Injection|Image sets missing or technically inadeq|1
1074915|NCT02070380|2130821|FG002|Second Injection|Image sets missing or technically inadeq|0
1074916|NCT02070380|2130822|FG003|Second Injection|Image sets missing or technically inadeq|0
1074917|NCT02070380|2130819|FG000|Second Injection|Protocol Violation|0
1074918|NCT02070380|2130820|FG001|Second Injection|Protocol Violation|1
1074919|NCT02070380|2130821|FG002|Second Injection|Protocol Violation|1
1074920|NCT02070380|2130822|FG003|Second Injection|Protocol Violation|5
1074921|NCT02070484|2130836|FG000|Overall Study|Withdrawal by Subject|1
1074922|NCT02070484|2130837|FG001|Overall Study|Withdrawal by Subject|0
1074923|NCT02070588|2130846|FG000|Overall Study|Withdrawal by Subject|29
1074924|NCT02070588|2130847|FG001|Overall Study|Withdrawal by Subject|1
1074925|NCT02070588|2130848|FG002|Overall Study|Withdrawal by Subject|0
1074926|NCT02070588|2130846|FG000|Overall Study|Writhdrawal due to early termination|9
1074927|NCT02070588|2130847|FG001|Overall Study|Writhdrawal due to early termination|0
1074928|NCT02070588|2130848|FG002|Overall Study|Writhdrawal due to early termination|0
1074929|NCT02070588|2130846|FG000|Overall Study|Adverse Event|1
1074930|NCT02070588|2130847|FG001|Overall Study|Adverse Event|0
1074931|NCT02070588|2130848|FG002|Overall Study|Adverse Event|0
1074932|NCT02070744|2130879|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0
1074933|NCT02070744|2130880|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0
1074934|NCT02070744|2130881|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0
1074935|NCT02070744|2130882|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1
1074936|NCT02070744|2130883|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0
1074937|NCT02070744|2130879|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1074938|NCT02070744|2130880|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1074939|NCT02070744|2130881|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1074940|NCT02070744|2130882|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1074941|NCT02070744|2130883|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2
1074942|NCT02070744|2130879|FG000|OLE Phase (48 Weeks)|Other|0
1074943|NCT02070744|2130880|FG001|OLE Phase (48 Weeks)|Other|0
1074944|NCT02070744|2130881|FG002|OLE Phase (48 Weeks)|Other|0
1074945|NCT02070744|2130882|FG003|OLE Phase (48 Weeks)|Other|0
1074946|NCT02070744|2130883|FG004|OLE Phase (48 Weeks)|Other|1
1074947|NCT02070757|2130900|FG000|Overall Study|Adverse Event|107
1074948|NCT02070757|2130901|FG001|Overall Study|Adverse Event|99
1074949|NCT02070757|2130900|FG000|Overall Study|Lost to Follow-up|7
1074950|NCT02070757|2130901|FG001|Overall Study|Lost to Follow-up|4
1074951|NCT02070757|2130900|FG000|Overall Study|Protocol Violation|0
1074952|NCT02070757|2130901|FG001|Overall Study|Protocol Violation|4
1074953|NCT02070757|2130900|FG000|Overall Study|Withdrawal by Subject|1
1074954|NCT02070757|2130901|FG001|Overall Study|Withdrawal by Subject|3
1074955|NCT02070757|2130900|FG000|Overall Study|Investigator Decision|0
1074956|NCT02070757|2130901|FG001|Overall Study|Investigator Decision|2
1074957|NCT02070757|2130900|FG000|Overall Study|Discharged from Study Hospital|2
1074958|NCT02070757|2130901|FG001|Overall Study|Discharged from Study Hospital|2
1074959|NCT02070965|2130910|FG000|Overall Study|Lost to Follow-up|0
1074960|NCT02070965|2130911|FG001|Overall Study|Lost to Follow-up|1
1074961|NCT02070965|2130912|FG002|Overall Study|Lost to Follow-up|0
1074962|NCT02070965|2130910|FG000|Overall Study|Withdrawal by Subject|1
1074963|NCT02070965|2130911|FG001|Overall Study|Withdrawal by Subject|1
1074964|NCT02070965|2130912|FG002|Overall Study|Withdrawal by Subject|1
1074965|NCT02070965|2130910|FG000|Overall Study|Subject moved|1
1074966|NCT02070965|2130911|FG001|Overall Study|Subject moved|0
1074967|NCT02070965|2130912|FG002|Overall Study|Subject moved|0
1074968|NCT02070978|2130923|FG000|Overall Study|Adverse Event|6
1074969|NCT02070978|2130924|FG001|Overall Study|Adverse Event|2
1074970|NCT02070978|2130925|FG002|Overall Study|Adverse Event|0
1074971|NCT02070978|2130923|FG000|Overall Study|Lost to Follow-up|1
1074972|NCT02070978|2130924|FG001|Overall Study|Lost to Follow-up|3
1074973|NCT02070978|2130925|FG002|Overall Study|Lost to Follow-up|4
1074974|NCT02070978|2130923|FG000|Overall Study|Withdrawal by Subject|3
1074975|NCT02070978|2130924|FG001|Overall Study|Withdrawal by Subject|5
1074976|NCT02070978|2130925|FG002|Overall Study|Withdrawal by Subject|3
1074977|NCT02070978|2130923|FG000|Overall Study|Protocol Violation|1
1074978|NCT02070978|2130924|FG001|Overall Study|Protocol Violation|0
1074979|NCT02070978|2130925|FG002|Overall Study|Protocol Violation|3
1074980|NCT02070978|2130923|FG000|Overall Study|Lack of Efficacy|0
1074981|NCT02070978|2130924|FG001|Overall Study|Lack of Efficacy|1
1074982|NCT02070978|2130925|FG002|Overall Study|Lack of Efficacy|0
1074983|NCT02070978|2130923|FG000|Overall Study|Death|0
1074984|NCT02070978|2130924|FG001|Overall Study|Death|0
1074985|NCT02070978|2130925|FG002|Overall Study|Death|2
1074986|NCT02070978|2130923|FG000|Overall Study|Un-specified|3
1074987|NCT02070978|2130924|FG001|Overall Study|Un-specified|2
1074988|NCT02070978|2130925|FG002|Overall Study|Un-specified|2
1074989|NCT02070978|2130923|FG000|Overall Study|Terminated by Sponsor|33
1074990|NCT02070978|2130924|FG001|Overall Study|Terminated by Sponsor|40
1074991|NCT02070978|2130925|FG002|Overall Study|Terminated by Sponsor|39
1074992|NCT02070991|2130935|FG000|Overall Study|Death|2
1074993|NCT02070991|2130936|FG001|Overall Study|Death|0
1074994|NCT02070991|2130935|FG000|Overall Study|Withdrawal by Subject|1
1074995|NCT02070991|2130936|FG001|Overall Study|Withdrawal by Subject|0
1074996|NCT02071082|2130944|FG000|Overall Study|Enrolled and Never Treated|1
1074997|NCT02071082|2130945|FG001|Overall Study|Enrolled and Never Treated|1
1074998|NCT02071082|2130944|FG000|Overall Study|Adverse Event|0
1074999|NCT02071082|2130945|FG001|Overall Study|Adverse Event|1
1075000|NCT02071082|2130944|FG000|Overall Study|Withdrew Consent|0
1075001|NCT02071082|2130945|FG001|Overall Study|Withdrew Consent|4
1075002|NCT02071082|2130944|FG000|Overall Study|Lost to Follow-up|1
1075003|NCT02071082|2130945|FG001|Overall Study|Lost to Follow-up|1
1075004|NCT02071225|2130969|FG000|Overall Study|Withdrawal of Consent|2
1075005|NCT02071225|2130969|FG000|Overall Study|Protocol Deviation|1
1075006|NCT02071225|2130969|FG000|Overall Study|Lost to Follow-up|2
1075007|NCT02071225|2130969|FG000|Overall Study|Death|25
1075008|NCT02071290|2130975|FG000|Overall Study|Death|1
1075009|NCT02071290|2130976|FG001|Overall Study|Death|0
1075010|NCT02071290|2130975|FG000|Overall Study|Withdrawal by Subject|0
1075011|NCT02071290|2130976|FG001|Overall Study|Withdrawal by Subject|1
1075012|NCT02071290|2130975|FG000|Overall Study|Protocol Violation|3
1075013|NCT02071290|2130976|FG001|Overall Study|Protocol Violation|5
1075014|NCT02071290|2130975|FG000|Overall Study|Physician Decision|0
1075015|NCT02071290|2130976|FG001|Overall Study|Physician Decision|1
1075016|NCT02071706|2130991|FG000|Overall Study|Adverse Event|1
1075017|NCT02071706|2130991|FG000|Overall Study|Withdrawal by Subject|2
1075018|NCT02071771|2130995|FG000|Period 1: First 10 Days|Unacceptable lens fit|1
1075019|NCT02071771|2130996|FG001|Period 1: First 10 Days|Unacceptable lens fit|0
1075020|NCT02071771|2130995|FG000|Period 1: First 10 Days|Unavailable lens power|1
1075021|NCT02071771|2130996|FG001|Period 1: First 10 Days|Unavailable lens power|0
1075022|NCT02071849|2131034|FG000|6-month Primary Endpoint|Did not receive device|4
1075023|NCT02071849|2131034|FG000|6-month Primary Endpoint|Adverse Event|1
1075024|NCT02071849|2131034|FG000|2-year Extended Follow-up|Adverse Event|1
1075025|NCT02072096|2131053|FG000|Overall Study|Lack of Efficacy|18
1075026|NCT02072096|2131054|FG001|Overall Study|Lack of Efficacy|29
1075027|NCT02072096|2131053|FG000|Overall Study|Protocol Violation|7
1075028|NCT02072096|2131054|FG001|Overall Study|Protocol Violation|7
1075029|NCT02072096|2131053|FG000|Overall Study|Withdrawal by Subject|5
1075030|NCT02072096|2131054|FG001|Overall Study|Withdrawal by Subject|7
1075031|NCT02072096|2131053|FG000|Overall Study|Adverse Event|5
1075032|NCT02072096|2131054|FG001|Overall Study|Adverse Event|2
1075033|NCT02072096|2131053|FG000|Overall Study|No Reason Provided|4
1075034|NCT02072096|2131054|FG001|Overall Study|No Reason Provided|2
1075035|NCT02072096|2131053|FG000|Overall Study|Death|2
1075036|NCT02072096|2131054|FG001|Overall Study|Death|0
1075037|NCT02072096|2131053|FG000|Overall Study|Physician Decision|0
1075038|NCT02072096|2131054|FG001|Overall Study|Physician Decision|1
1075039|NCT02072096|2131053|FG000|Overall Study|Study Terminated by Sponsor|43
1075040|NCT02072096|2131054|FG001|Overall Study|Study Terminated by Sponsor|30
1075041|NCT02072096|2131053|FG000|Overall Study|Lost to Follow-up|1
1075042|NCT02072096|2131054|FG001|Overall Study|Lost to Follow-up|0
1075043|NCT02072174|2131063|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14
1075044|NCT02072174|2131064|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15
1075045|NCT02072174|2131063|FG000|Overall Study|Protocol Violation|16
1075046|NCT02072174|2131064|FG001|Overall Study|Protocol Violation|23
1075047|NCT02072174|2131063|FG000|Overall Study|Physician Decision|0
1075048|NCT02072174|2131064|FG001|Overall Study|Physician Decision|1
1075049|NCT02072174|2131063|FG000|Overall Study|Non-compliance with protocol requirement|2
1075050|NCT02072174|2131064|FG001|Overall Study|Non-compliance with protocol requirement|0
1075051|NCT02072226|2131078|FG000|Overall Study|Lost to Follow-up|11
1075052|NCT02072226|2131079|FG001|Overall Study|Lost to Follow-up|7
1075053|NCT02072226|2131078|FG000|Overall Study|Patient Non-compliance|2
1075054|NCT02072226|2131079|FG001|Overall Study|Patient Non-compliance|3
1075055|NCT02072226|2131078|FG000|Overall Study|Death|1
1075056|NCT02072226|2131079|FG001|Overall Study|Death|0
1075057|NCT02072226|2131078|FG000|Overall Study|Patient Withdrawal of Consent|1
1075058|NCT02072226|2131079|FG001|Overall Study|Patient Withdrawal of Consent|0
1075059|NCT02072434|2131092|FG000|Overall Study|Protocol Violation|10
1075060|NCT02072434|2131093|FG001|Overall Study|Protocol Violation|9
1075061|NCT02072434|2131092|FG000|Overall Study|Physician Decision|5
1075062|NCT02072434|2131093|FG001|Overall Study|Physician Decision|10
1075063|NCT02072434|2131092|FG000|Overall Study|Adverse event, serious fatal|1
1075064|NCT02072434|2131093|FG001|Overall Study|Adverse event, serious fatal|6
1075065|NCT02072434|2131092|FG000|Overall Study|Adverse Event|7
1075066|NCT02072434|2131093|FG001|Overall Study|Adverse Event|6
1075067|NCT02072434|2131092|FG000|Overall Study|Withdrawal by Subject|17
1075068|NCT02072434|2131093|FG001|Overall Study|Withdrawal by Subject|29
1075069|NCT02072434|2131092|FG000|Overall Study|Other|14
1075070|NCT02072434|2131093|FG001|Overall Study|Other|29
1075071|NCT02072434|2131092|FG000|Overall Study|Lost to Follow-up|0
1075072|NCT02072434|2131093|FG001|Overall Study|Lost to Follow-up|1
1075073|NCT02072668|2131099|FG000|Second Intervention|Lost to Follow-up|1
1075074|NCT02072668|2131100|FG001|Second Intervention|Lost to Follow-up|0
1075075|NCT02072824|2131111|FG000|Overall Study|Insufficient clinical response|1
1075076|NCT02072824|2131112|FG001|Overall Study|Insufficient clinical response|0
1075077|NCT02072824|2131113|FG002|Overall Study|Insufficient clinical response|1
1075078|NCT02072824|2131111|FG000|Overall Study|No longer willing to participate|1
1075079|NCT02072824|2131112|FG001|Overall Study|No longer willing to participate|0
1075080|NCT02072824|2131113|FG002|Overall Study|No longer willing to participate|1
1075081|NCT02072824|2131111|FG000|Overall Study|Medication error|0
1075082|NCT02072824|2131112|FG001|Overall Study|Medication error|1
1075083|NCT02072824|2131113|FG002|Overall Study|Medication error|0
1075084|NCT02072824|2131111|FG000|Overall Study|Adverse Event|0
1075085|NCT02072824|2131112|FG001|Overall Study|Adverse Event|0
1075086|NCT02072824|2131113|FG002|Overall Study|Adverse Event|1
1075087|NCT02072941|2131127|FG000|Overall Study|Withdrawal by Subject|29
1075088|NCT02072941|2131128|FG001|Overall Study|Withdrawal by Subject|21
1075089|NCT02072941|2131127|FG000|Overall Study|Lost to Follow-up|4
1075090|NCT02072941|2131128|FG001|Overall Study|Lost to Follow-up|4
1075091|NCT02072941|2131127|FG000|Overall Study|Death|3
1075092|NCT02072941|2131128|FG001|Overall Study|Death|2
1075093|NCT02072941|2131127|FG000|Overall Study|Removed by Study Staff|2
1075094|NCT02072941|2131128|FG001|Overall Study|Removed by Study Staff|2
1075095|NCT02072980|2131134|FG000|Period 2, Second Wear|Adverse Event|0
1075096|NCT02072980|2131135|FG001|Period 2, Second Wear|Adverse Event|1
1075119|NCT02073565|2131215|FG000|Cohort A|Withdrawal by Subject|1
1075120|NCT02073565|2131216|FG001|Cohort A|Withdrawal by Subject|0
1075121|NCT02073565|2131215|FG000|Cohort B|Withdrawal by Subject|1
1075122|NCT02073565|2131216|FG001|Cohort B|Withdrawal by Subject|2
1075123|NCT02073565|2131215|FG000|Cohort C|Withdrawal by Subject|0
1075124|NCT02073565|2131216|FG001|Cohort C|Withdrawal by Subject|2
1075125|NCT02073565|2131215|FG000|Cohort C|Lost to Follow-up|0
1075126|NCT02073565|2131216|FG001|Cohort C|Lost to Follow-up|2
1075127|NCT02073643|2131222|FG000|Overall Study|Lost to Follow-up|24
1075128|NCT02073656|2131226|FG000|Primary Study|Lost to Follow-up|6
1075129|NCT02073656|2131226|FG000|Primary Study|Death|1
1075130|NCT02073656|2131226|FG000|Primary Study|Withdrew Consent|1
1075131|NCT02073682|2131234|FG000|Overall Study|Low Creatinine Clearance|1
1075132|NCT02073682|2131235|FG001|Overall Study|Low Creatinine Clearance|2
1075133|NCT02073682|2131234|FG000|Overall Study|Death|86
1075134|NCT02073682|2131235|FG001|Overall Study|Death|100
1075135|NCT02073682|2131234|FG000|Overall Study|Cancer Cured|10
1075136|NCT02073682|2131235|FG001|Overall Study|Cancer Cured|15
1075137|NCT02073682|2131234|FG000|Overall Study|ID: Patient Noncompliance|1
1075138|NCT02073682|2131235|FG001|Overall Study|ID: Patient Noncompliance|2
1075139|NCT02073682|2131234|FG000|Overall Study|ID: Palliative Treatment Only|10
1075140|NCT02073682|2131235|FG001|Overall Study|ID: Palliative Treatment Only|7
1075141|NCT02073682|2131234|FG000|Overall Study|Prohibited Concomitant Medication Use|0
1075142|NCT02073682|2131235|FG001|Overall Study|Prohibited Concomitant Medication Use|1
1075143|NCT02073682|2131234|FG000|Overall Study|Platelet Count <50,000/mL|1
1075144|NCT02073682|2131235|FG001|Overall Study|Platelet Count <50,000/mL|2
1075145|NCT02073682|2131234|FG000|Overall Study|Surgery/Medical Procedure|3
1075146|NCT02073682|2131235|FG001|Overall Study|Surgery/Medical Procedure|1
1075147|NCT02073682|2131234|FG000|Overall Study|Withdrawal by Subject|6
1075148|NCT02073682|2131235|FG001|Overall Study|Withdrawal by Subject|8
1075149|NCT02073682|2131234|FG000|Overall Study|Start of New Chemotherapy Regimen|6
1075150|NCT02073682|2131235|FG001|Overall Study|Start of New Chemotherapy Regimen|3
1075151|NCT02073682|2131234|FG000|Overall Study|Cancer Progression|53
1075152|NCT02073682|2131235|FG001|Overall Study|Cancer Progression|33
1075153|NCT02073682|2131234|FG000|Overall Study|Protocol Violation|1
1075154|NCT02073682|2131235|FG001|Overall Study|Protocol Violation|0
1075155|NCT02073682|2131234|FG000|Overall Study|Adverse Event|79
1075156|NCT02073682|2131235|FG001|Overall Study|Adverse Event|62
1075157|NCT02073682|2131234|FG000|Overall Study|No reason provided|11
1075158|NCT02073682|2131235|FG001|Overall Study|No reason provided|9
1075159|NCT02073682|2131234|FG000|Overall Study|PD: Inconvenience of Dosing|21
1075160|NCT02073682|2131235|FG001|Overall Study|PD: Inconvenience of Dosing|78
1075161|NCT02073682|2131234|FG000|Overall Study|Lost to Follow-up|1
1075162|NCT02073682|2131235|FG001|Overall Study|Lost to Follow-up|1
1075163|NCT02073682|2131234|FG000|Overall Study|ID: Benefit/Risk Judgment|32
1075164|NCT02073682|2131235|FG001|Overall Study|ID: Benefit/Risk Judgment|46
1075165|NCT02073929|2131252|FG000|Overall Study|Lost to Follow-up|2
1075166|NCT02073929|2131253|FG001|Overall Study|Lost to Follow-up|1
1075167|NCT02073929|2131252|FG000|Overall Study|Adverse Event|2
1075168|NCT02073929|2131253|FG001|Overall Study|Adverse Event|1
1075169|NCT02073929|2131252|FG000|Overall Study|Withdrawal by Subject|0
1075170|NCT02073929|2131253|FG001|Overall Study|Withdrawal by Subject|1
1075171|NCT02074059|2131269|FG000|Overall Study|Death|0
1075172|NCT02074059|2131270|FG001|Overall Study|Death|0
1075173|NCT02074059|2131271|FG002|Overall Study|Death|0
1075174|NCT02074059|2131272|FG003|Overall Study|Death|0
1075175|NCT02074059|2131273|FG004|Overall Study|Death|1
1075176|NCT02074059|2131274|FG005|Overall Study|Death|1
1075177|NCT02074514|2131323|FG000|Overall Study|Lack of Efficacy|3
1075178|NCT02074514|2131324|FG001|Overall Study|Lack of Efficacy|2
1075179|NCT02074514|2131323|FG000|Overall Study|Lost to Follow-up|0
1075180|NCT02074514|2131324|FG001|Overall Study|Lost to Follow-up|1
1075181|NCT02074514|2131323|FG000|Overall Study|Withdrew Consent|0
1075182|NCT02074514|2131324|FG001|Overall Study|Withdrew Consent|1
1075183|NCT02074553|2131336|FG000|Intervention Period 1|Family Emergency|0
1075184|NCT02074553|2131337|FG001|Intervention Period 1|Family Emergency|0
1075185|NCT02074553|2131338|FG002|Intervention Period 1|Family Emergency|0
1075186|NCT02074553|2131339|FG003|Intervention Period 1|Family Emergency|1
1075187|NCT02074553|2131340|FG004|Intervention Period 1|Family Emergency|0
1075188|NCT02074553|2131341|FG005|Intervention Period 1|Family Emergency|0
1075189|NCT02074553|2131342|FG006|Intervention Period 1|Family Emergency|0
1075190|NCT02074553|2131343|FG007|Intervention Period 1|Family Emergency|0
1075191|NCT02074553|2131336|FG000|Washout Period 1|Adverse Event|1
1075192|NCT02074553|2131337|FG001|Washout Period 1|Adverse Event|0
1075193|NCT02074553|2131338|FG002|Washout Period 1|Adverse Event|0
1075194|NCT02074553|2131339|FG003|Washout Period 1|Adverse Event|0
1075195|NCT02074553|2131340|FG004|Washout Period 1|Adverse Event|0
1075196|NCT02074553|2131341|FG005|Washout Period 1|Adverse Event|0
1075197|NCT02074553|2131342|FG006|Washout Period 1|Adverse Event|0
1075198|NCT02074553|2131343|FG007|Washout Period 1|Adverse Event|0
1075199|NCT02074553|2131336|FG000|Washout Period 1|Physician Decision|0
1075200|NCT02074553|2131337|FG001|Washout Period 1|Physician Decision|0
1075201|NCT02074553|2131338|FG002|Washout Period 1|Physician Decision|0
1075202|NCT02074553|2131339|FG003|Washout Period 1|Physician Decision|1
1075203|NCT02074553|2131340|FG004|Washout Period 1|Physician Decision|0
1075204|NCT02074553|2131341|FG005|Washout Period 1|Physician Decision|0
1075205|NCT02074553|2131342|FG006|Washout Period 1|Physician Decision|0
1075206|NCT02074553|2131343|FG007|Washout Period 1|Physician Decision|0
1075207|NCT02074553|2131336|FG000|Washout Period 1|Other|0
1075208|NCT02074553|2131337|FG001|Washout Period 1|Other|0
1075209|NCT02074553|2131338|FG002|Washout Period 1|Other|0
1075210|NCT02074553|2131339|FG003|Washout Period 1|Other|0
1075211|NCT02074553|2131340|FG004|Washout Period 1|Other|0
1075212|NCT02074553|2131341|FG005|Washout Period 1|Other|1
1075213|NCT02074553|2131342|FG006|Washout Period 1|Other|0
1075214|NCT02074553|2131343|FG007|Washout Period 1|Other|0
1075215|NCT02074553|2131336|FG000|Washout Period 2|Adverse Event|0
1075216|NCT02074553|2131337|FG001|Washout Period 2|Adverse Event|0
1075217|NCT02074553|2131338|FG002|Washout Period 2|Adverse Event|0
1075218|NCT02074553|2131339|FG003|Washout Period 2|Adverse Event|0
1075219|NCT02074553|2131340|FG004|Washout Period 2|Adverse Event|0
1075220|NCT02074553|2131341|FG005|Washout Period 2|Adverse Event|0
1075221|NCT02074553|2131342|FG006|Washout Period 2|Adverse Event|1
1075222|NCT02074553|2131343|FG007|Washout Period 2|Adverse Event|0
1075223|NCT02074553|2131336|FG000|Washout Period 2|Physician Decision|0
1075224|NCT02074553|2131337|FG001|Washout Period 2|Physician Decision|0
1075225|NCT02074553|2131338|FG002|Washout Period 2|Physician Decision|0
1075226|NCT02074553|2131339|FG003|Washout Period 2|Physician Decision|0
1075227|NCT02074553|2131340|FG004|Washout Period 2|Physician Decision|0
1075228|NCT02074553|2131341|FG005|Washout Period 2|Physician Decision|1
1075229|NCT02074553|2131342|FG006|Washout Period 2|Physician Decision|0
909468|NCT00788697|1886231|FG000|Overall Study|Indeterminate diagnosis from truth stand|17
909469|NCT00788710|1886246|FG000|Overall Study|Adverse Event|1
909470|NCT00788710|1886247|FG001|Overall Study|Adverse Event|3
909471|NCT00788710|1886248|FG002|Overall Study|Adverse Event|4
909472|NCT00788710|1886246|FG000|Overall Study|Lack of Efficacy|0
1075230|NCT02074553|2131343|FG007|Washout Period 2|Physician Decision|0
1075231|NCT02074553|2131336|FG000|Washout Period 2|Lost to Follow-up|0
1075232|NCT02074553|2131337|FG001|Washout Period 2|Lost to Follow-up|0
1075233|NCT02074553|2131338|FG002|Washout Period 2|Lost to Follow-up|1
1075234|NCT02074553|2131339|FG003|Washout Period 2|Lost to Follow-up|0
1075235|NCT02074553|2131340|FG004|Washout Period 2|Lost to Follow-up|0
1075236|NCT02074553|2131341|FG005|Washout Period 2|Lost to Follow-up|0
1075237|NCT02074553|2131342|FG006|Washout Period 2|Lost to Follow-up|0
1075238|NCT02074553|2131343|FG007|Washout Period 2|Lost to Follow-up|0
1075239|NCT02074553|2131336|FG000|Washout Period 3|Physician Decision|0
1075240|NCT02074553|2131337|FG001|Washout Period 3|Physician Decision|0
1075241|NCT02074553|2131338|FG002|Washout Period 3|Physician Decision|0
1075242|NCT02074553|2131339|FG003|Washout Period 3|Physician Decision|0
1075243|NCT02074553|2131340|FG004|Washout Period 3|Physician Decision|0
1075244|NCT02074553|2131341|FG005|Washout Period 3|Physician Decision|0
1075245|NCT02074553|2131342|FG006|Washout Period 3|Physician Decision|0
1075246|NCT02074553|2131343|FG007|Washout Period 3|Physician Decision|1
1075247|NCT02074982|2131381|FG000|Overall Study|Adverse Event|15
1075248|NCT02074982|2131382|FG001|Overall Study|Adverse Event|7
1075249|NCT02074982|2131381|FG000|Overall Study|Lack of Efficacy|6
1075250|NCT02074982|2131382|FG001|Overall Study|Lack of Efficacy|1
1075251|NCT02074982|2131381|FG000|Overall Study|Lost to Follow-up|9
1075252|NCT02074982|2131382|FG001|Overall Study|Lost to Follow-up|10
1075253|NCT02074982|2131381|FG000|Overall Study|Non-compliance with study treatment|0
1075254|NCT02074982|2131382|FG001|Overall Study|Non-compliance with study treatment|2
1075255|NCT02074982|2131381|FG000|Overall Study|Physician Decision|1
1075256|NCT02074982|2131382|FG001|Overall Study|Physician Decision|1
1075257|NCT02074982|2131381|FG000|Overall Study|Pregnancy|1
1075258|NCT02074982|2131382|FG001|Overall Study|Pregnancy|2
1075259|NCT02074982|2131381|FG000|Overall Study|Protocol deviation|4
1075260|NCT02074982|2131382|FG001|Overall Study|Protocol deviation|3
1075261|NCT02074982|2131381|FG000|Overall Study|Technical problems|0
1075262|NCT02074982|2131382|FG001|Overall Study|Technical problems|2
1075263|NCT02074982|2131381|FG000|Overall Study|Subject/guardian decision|15
1075264|NCT02074982|2131382|FG001|Overall Study|Subject/guardian decision|24
1075265|NCT02074982|2131381|FG000|Overall Study|Death|0
1075266|NCT02074982|2131382|FG001|Overall Study|Death|2
1075267|NCT02075008|2131394|FG000|Overall Study|Technical problems|1
1075268|NCT02075008|2131394|FG000|Overall Study|Pregnancy|1
1075269|NCT02075008|2131394|FG000|Overall Study|Physician Decision|1
1075270|NCT02075008|2131394|FG000|Overall Study|Lost to Follow-up|1
1075271|NCT02075008|2131394|FG000|Overall Study|Lack of Efficacy|1
1075272|NCT02075008|2131394|FG000|Overall Study|Death|1
1075273|NCT02075008|2131394|FG000|Overall Study|Adverse Event|5
1075274|NCT02075008|2131394|FG000|Overall Study|Withdrawal by Subject|6
1075275|NCT02075008|2131394|FG000|Overall Study|Study terminated by Sponsor|159
1075276|NCT02075047|2131400|FG000|Treatment Phase (4 Weeks)|Adverse Event|14
1075277|NCT02075047|2131401|FG001|Treatment Phase (4 Weeks)|Adverse Event|4
1075278|NCT02075047|2131400|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2
1075279|NCT02075047|2131401|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2
1075280|NCT02075047|2131400|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0
1075281|NCT02075047|2131401|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1
1075282|NCT02075047|2131400|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1
1075283|NCT02075047|2131401|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0
1075284|NCT02075047|2131400|FG000|Treatment Phase (4 Weeks)|Screen Failure|1
1075285|NCT02075047|2131401|FG001|Treatment Phase (4 Weeks)|Screen Failure|0
1075286|NCT02075047|2131400|FG000|Treatment Phase (4 Weeks)|Other|1
1075287|NCT02075047|2131401|FG001|Treatment Phase (4 Weeks)|Other|1
1075288|NCT02075047|2131400|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4
1075289|NCT02075047|2131401|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2
1075290|NCT02075047|2131400|FG000|Follow up Phase (5 Weeks)|Adverse Event|14
1075291|NCT02075047|2131401|FG001|Follow up Phase (5 Weeks)|Adverse Event|4
1075292|NCT02075047|2131400|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2
1075293|NCT02075047|2131401|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2
1075294|NCT02075047|2131400|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0
1075295|NCT02075047|2131401|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1
1075296|NCT02075047|2131400|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1
1075297|NCT02075047|2131401|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0
1075298|NCT02075047|2131400|FG000|Follow up Phase (5 Weeks)|Screen Failure|1
1075299|NCT02075047|2131401|FG001|Follow up Phase (5 Weeks)|Screen Failure|0
1075300|NCT02075047|2131400|FG000|Follow up Phase (5 Weeks)|Other|1
1075301|NCT02075047|2131401|FG001|Follow up Phase (5 Weeks)|Other|2
1075302|NCT02075047|2131400|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7
1075303|NCT02075047|2131401|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4
1075304|NCT02075073|2131410|FG000|Overall Study|Withdrawal by Subject|0
1075305|NCT02075073|2131411|FG001|Overall Study|Withdrawal by Subject|1
1075306|NCT02075073|2131412|FG002|Overall Study|Withdrawal by Subject|0
1075307|NCT02075203|2131432|FG000|Overall Study|Withdrawal by Subject|1
1075308|NCT02075203|2131433|FG001|Overall Study|Withdrawal by Subject|0
1075309|NCT02075203|2131434|FG002|Overall Study|Withdrawal by Subject|1
1075310|NCT02075203|2131432|FG000|Overall Study|Adverse Event|1
1075311|NCT02075203|2131433|FG001|Overall Study|Adverse Event|0
1075312|NCT02075203|2131434|FG002|Overall Study|Adverse Event|0
1075313|NCT02075203|2131432|FG000|Overall Study|participant refused to use contraception|1
1075314|NCT02075203|2131433|FG001|Overall Study|participant refused to use contraception|0
1075315|NCT02075203|2131434|FG002|Overall Study|participant refused to use contraception|0
1075316|NCT02075255|2131445|FG000|Overall Study|Study specific withdrawal criteria|0
1075317|NCT02075255|2131446|FG001|Overall Study|Study specific withdrawal criteria|1
1075318|NCT02075255|2131447|FG002|Overall Study|Study specific withdrawal criteria|1
1075319|NCT02075255|2131445|FG000|Overall Study|Withdrawal by Subject|4
1075320|NCT02075255|2131446|FG001|Overall Study|Withdrawal by Subject|1
1075321|NCT02075255|2131447|FG002|Overall Study|Withdrawal by Subject|0
1075322|NCT02075255|2131445|FG000|Overall Study|Lost to Follow-up|0
1075323|NCT02075255|2131446|FG001|Overall Study|Lost to Follow-up|0
1075324|NCT02075255|2131447|FG002|Overall Study|Lost to Follow-up|1
1075325|NCT02075255|2131445|FG000|Overall Study|Adverse Event|0
1075326|NCT02075255|2131446|FG001|Overall Study|Adverse Event|0
1075327|NCT02075255|2131447|FG002|Overall Study|Adverse Event|1
1075328|NCT02075255|2131445|FG000|Overall Study|Death|0
1075329|NCT02075255|2131446|FG001|Overall Study|Death|2
1075330|NCT02075255|2131447|FG002|Overall Study|Death|0
1075331|NCT02075320|2131455|FG000|Overall Study|Withdrawal by Subject|2
1075332|NCT02075463|2131459|FG000|Overall Study|Adverse Event|3
1075333|NCT02075463|2131459|FG000|Overall Study|Par. reached stopping criteria|4
1075334|NCT02075463|2131459|FG000|Overall Study|Withdrawal by Subject|1
1075335|NCT02075476|2131466|FG000|Overall Study|Death|2
1075336|NCT02075476|2131467|FG001|Overall Study|Death|2
1075337|NCT02075476|2131466|FG000|Overall Study|Lost to Follow-up|1
1075338|NCT02075476|2131467|FG001|Overall Study|Lost to Follow-up|3
1075339|NCT02075515|2131476|FG000|Overall Study|Serious Adverse Event|1
1075340|NCT02075515|2131477|FG001|Overall Study|Serious Adverse Event|1
1075341|NCT02075515|2131478|FG002|Overall Study|Serious Adverse Event|1
1075342|NCT02075515|2131476|FG000|Overall Study|Non-Serious Adverse Event|0
1075343|NCT02075515|2131477|FG001|Overall Study|Non-Serious Adverse Event|1
1075344|NCT02075515|2131478|FG002|Overall Study|Non-Serious Adverse Event|0
1075345|NCT02075515|2131476|FG000|Overall Study|Withdrawal by Subject|2
1075346|NCT02075515|2131477|FG001|Overall Study|Withdrawal by Subject|0
1075347|NCT02075515|2131478|FG002|Overall Study|Withdrawal by Subject|1
1075348|NCT02075515|2131476|FG000|Overall Study|Lost to Follow-up|1
1075349|NCT02075515|2131477|FG001|Overall Study|Lost to Follow-up|3
1075350|NCT02075515|2131478|FG002|Overall Study|Lost to Follow-up|6
1075351|NCT02075541|2131489|FG000|Overall Study|Serious Adverse Event|1
1075352|NCT02075541|2131490|FG001|Overall Study|Serious Adverse Event|4
1075353|NCT02075541|2131489|FG000|Overall Study|Protocol Violation|1
1075354|NCT02075541|2131490|FG001|Overall Study|Protocol Violation|0
1075355|NCT02075541|2131489|FG000|Overall Study|Withdrawal by Subject|1
1075356|NCT02075541|2131490|FG001|Overall Study|Withdrawal by Subject|3
1075357|NCT02075541|2131489|FG000|Overall Study|Sponsor study termination|0
1075358|NCT02075541|2131490|FG001|Overall Study|Sponsor study termination|1
1075359|NCT02075541|2131489|FG000|Overall Study|Other- unable to perform study procedure|1
1075360|NCT02075541|2131490|FG001|Overall Study|Other- unable to perform study procedure|0
1075361|NCT02075554|2131496|FG000|Overall Study|Lost to Follow-up|7
1075362|NCT02075554|2131496|FG000|Overall Study|Withdrawal by Subject|5
1075363|NCT02075554|2131496|FG000|Overall Study|Physician Decision|3
1075364|NCT02075606|2131500|FG000|Overall Study|Adverse Event|5
1075365|NCT02075606|2131500|FG000|Overall Study|Withdrawal by Subject|1
1075366|NCT02075606|2131500|FG000|Overall Study|Death|1
1075367|NCT02075606|2131500|FG000|Overall Study|Investigator's decision|1
1075368|NCT02075606|2131500|FG000|Overall Study|Symptom management|1
1075369|NCT02075606|2131500|FG000|Overall Study|Increasing Symptoms|1
1075370|NCT02075632|2131511|FG000|Overall Study|Adverse Event|1
1075371|NCT02075632|2131512|FG001|Overall Study|Adverse Event|1
1075372|NCT02075632|2131511|FG000|Overall Study|Lost to Follow-up|0
1075373|NCT02075632|2131512|FG001|Overall Study|Lost to Follow-up|3
1075374|NCT02075632|2131511|FG000|Overall Study|Withdrawal by Subject|0
1075375|NCT02075632|2131512|FG001|Overall Study|Withdrawal by Subject|1
1075376|NCT02075658|2131520|FG000|Overall Study|Physician Decision|2
1075377|NCT02075658|2131521|FG001|Overall Study|Physician Decision|2
1075404|NCT02076022|2131547|FG000|Overall Study|Withdrawal by Subject|2
1075405|NCT02076022|2131548|FG001|Overall Study|Withdrawal by Subject|0
1075406|NCT02076113|2131589|FG000|Overall Study|Lost to Follow-up|4
1075407|NCT02076113|2131590|FG001|Overall Study|Lost to Follow-up|1
1075408|NCT02076113|2131589|FG000|Overall Study|Withdrawal by Subject|2
1075409|NCT02076113|2131590|FG001|Overall Study|Withdrawal by Subject|3
1075410|NCT02076113|2131589|FG000|Overall Study|Death|1
1075411|NCT02076113|2131590|FG001|Overall Study|Death|3
1075412|NCT02076165|2131609|FG000|Overall Study|Lost to Follow-up|7
1075413|NCT02076165|2131610|FG001|Overall Study|Lost to Follow-up|5
1075414|NCT02076165|2131609|FG000|Overall Study|Refused follow-up assessment|1
1075415|NCT02076165|2131610|FG001|Overall Study|Refused follow-up assessment|1
1075416|NCT02076334|2131644|FG000|Overall Study|Protocol Violation|1
1075417|NCT02076334|2131645|FG001|Overall Study|Protocol Violation|0
1075418|NCT02076334|2131646|FG002|Overall Study|Protocol Violation|0
1075419|NCT02076334|2131647|FG003|Overall Study|Protocol Violation|0
1075420|NCT02076334|2131644|FG000|Overall Study|Lost to Follow-up|0
1075421|NCT02076334|2131645|FG001|Overall Study|Lost to Follow-up|1
1075422|NCT02076334|2131646|FG002|Overall Study|Lost to Follow-up|1
1075423|NCT02076334|2131647|FG003|Overall Study|Lost to Follow-up|0
1075424|NCT02076334|2131644|FG000|Overall Study|muscle soreness|0
1075425|NCT02076334|2131645|FG001|Overall Study|muscle soreness|0
1075426|NCT02076334|2131646|FG002|Overall Study|muscle soreness|0
1075427|NCT02076334|2131647|FG003|Overall Study|muscle soreness|1
1075428|NCT02077140|2131748|FG000|Overall Study|Lost to Follow-up|4
1075429|NCT02077140|2131749|FG001|Overall Study|Lost to Follow-up|1
1075430|NCT02077140|2131750|FG002|Overall Study|Lost to Follow-up|2
1075431|NCT02077140|2131751|FG003|Overall Study|Lost to Follow-up|2
1075432|NCT02077140|2131752|FG004|Overall Study|Lost to Follow-up|3
1075433|NCT02077140|2131748|FG000|Overall Study|Withdrawal by Subject|0
1075434|NCT02077140|2131749|FG001|Overall Study|Withdrawal by Subject|1
1075435|NCT02077140|2131750|FG002|Overall Study|Withdrawal by Subject|0
1075436|NCT02077140|2131751|FG003|Overall Study|Withdrawal by Subject|2
1075437|NCT02077140|2131752|FG004|Overall Study|Withdrawal by Subject|2
1075438|NCT02077374|2131769|FG000|Overall Study|Withdrawal by Subject|0
1075439|NCT02077374|2131770|FG001|Overall Study|Withdrawal by Subject|1
1075440|NCT02077374|2131769|FG000|Overall Study|Protocol Violation|0
1075441|NCT02077374|2131770|FG001|Overall Study|Protocol Violation|1
1075442|NCT02077465|2131781|FG000|Overall Study|Withdrew Consent|0
1075443|NCT02077465|2131782|FG001|Overall Study|Withdrew Consent|1
1075444|NCT02077465|2131781|FG000|Overall Study|Lost to Follow-up|1
1075445|NCT02077465|2131782|FG001|Overall Study|Lost to Follow-up|0
1075446|NCT02078102|2131790|FG000|Overall Study|Adverse Event|1
1075447|NCT02078102|2131791|FG001|Overall Study|Adverse Event|0
1075448|NCT02078102|2131790|FG000|Overall Study|Withdrawal by Subject|1
1075449|NCT02078102|2131791|FG001|Overall Study|Withdrawal by Subject|0
1075450|NCT02078102|2131790|FG000|Overall Study|Physician Decision|0
1075451|NCT02078102|2131791|FG001|Overall Study|Physician Decision|1
1075452|NCT02078219|2131817|FG000|Overall Study|Other|2
1075453|NCT02078219|2131818|FG001|Overall Study|Other|2
1075454|NCT02078219|2131819|FG002|Overall Study|Other|3
1075455|NCT02078219|2131820|FG003|Overall Study|Other|0
1075456|NCT02078219|2131821|FG004|Overall Study|Other|1
1075457|NCT02078219|2131817|FG000|Overall Study|Withdrawal by Subject|0
1075458|NCT02078219|2131818|FG001|Overall Study|Withdrawal by Subject|1
1075459|NCT02078219|2131819|FG002|Overall Study|Withdrawal by Subject|0
1075460|NCT02078219|2131820|FG003|Overall Study|Withdrawal by Subject|1
1075461|NCT02078219|2131821|FG004|Overall Study|Withdrawal by Subject|1
1075462|NCT02078219|2131817|FG000|Overall Study|Protocol Violation|0
1075463|NCT02078219|2131818|FG001|Overall Study|Protocol Violation|0
1075464|NCT02078219|2131819|FG002|Overall Study|Protocol Violation|0
1075465|NCT02078219|2131820|FG003|Overall Study|Protocol Violation|1
1075466|NCT02078219|2131821|FG004|Overall Study|Protocol Violation|0
1075467|NCT02078219|2131817|FG000|Overall Study|Death|0
1075468|NCT02078219|2131818|FG001|Overall Study|Death|0
1075469|NCT02078219|2131819|FG002|Overall Study|Death|0
1075470|NCT02078219|2131820|FG003|Overall Study|Death|1
1075471|NCT02078219|2131821|FG004|Overall Study|Death|0
1075472|NCT02078219|2131817|FG000|Overall Study|Adverse Event|1
1075473|NCT02078219|2131818|FG001|Overall Study|Adverse Event|1
1075474|NCT02078219|2131819|FG002|Overall Study|Adverse Event|3
1075475|NCT02078219|2131820|FG003|Overall Study|Adverse Event|1
1075476|NCT02078219|2131821|FG004|Overall Study|Adverse Event|0
1075477|NCT02078713|2131875|FG000|Overall Study|Lost to Follow-up|49
1075478|NCT02078713|2131876|FG001|Overall Study|Lost to Follow-up|55
1075479|NCT02078713|2131877|FG002|Overall Study|Lost to Follow-up|0
1075480|NCT02078713|2131878|FG003|Overall Study|Lost to Follow-up|0
1075481|NCT02078713|2131875|FG000|Overall Study|Pregnant at baseline|3
1075482|NCT02078713|2131876|FG001|Overall Study|Pregnant at baseline|5
1075483|NCT02078713|2131877|FG002|Overall Study|Pregnant at baseline|0
1075484|NCT02078713|2131878|FG003|Overall Study|Pregnant at baseline|0
1075485|NCT02078713|2131875|FG000|Overall Study|Enrolled twice|0
1075486|NCT02078713|2131876|FG001|Overall Study|Enrolled twice|1
1075487|NCT02078713|2131877|FG002|Overall Study|Enrolled twice|0
1075488|NCT02078713|2131878|FG003|Overall Study|Enrolled twice|0
1075489|NCT02078752|2131909|FG000|Overall Study|Death|0
1075490|NCT02078752|2131910|FG001|Overall Study|Death|3
1075491|NCT02078752|2131911|FG002|Overall Study|Death|0
1075492|NCT02078752|2131912|FG003|Overall Study|Death|0
1075493|NCT02078752|2131913|FG004|Overall Study|Death|0
1075494|NCT02078752|2131914|FG005|Overall Study|Death|1
1075495|NCT02078752|2131915|FG006|Overall Study|Death|0
1075496|NCT02078752|2131916|FG007|Overall Study|Death|1
1075497|NCT02078752|2131917|FG008|Overall Study|Death|0
1075498|NCT02078752|2131918|FG009|Overall Study|Death|4
1075499|NCT02078752|2131909|FG000|Overall Study|Lost to Follow-up|1
1075500|NCT02078752|2131910|FG001|Overall Study|Lost to Follow-up|0
1075501|NCT02078752|2131911|FG002|Overall Study|Lost to Follow-up|0
1075502|NCT02078752|2131912|FG003|Overall Study|Lost to Follow-up|1
1075503|NCT02078752|2131913|FG004|Overall Study|Lost to Follow-up|0
1075504|NCT02078752|2131914|FG005|Overall Study|Lost to Follow-up|0
1075505|NCT02078752|2131915|FG006|Overall Study|Lost to Follow-up|0
1075506|NCT02078752|2131916|FG007|Overall Study|Lost to Follow-up|0
1075507|NCT02078752|2131917|FG008|Overall Study|Lost to Follow-up|0
1075508|NCT02078752|2131918|FG009|Overall Study|Lost to Follow-up|0
1075509|NCT02078752|2131909|FG000|Overall Study|Withdrawal by Subject|1
1075510|NCT02078752|2131910|FG001|Overall Study|Withdrawal by Subject|1
1075511|NCT02078752|2131911|FG002|Overall Study|Withdrawal by Subject|1
1075512|NCT02078752|2131912|FG003|Overall Study|Withdrawal by Subject|1
1075513|NCT02078752|2131913|FG004|Overall Study|Withdrawal by Subject|0
1075514|NCT02078752|2131914|FG005|Overall Study|Withdrawal by Subject|3
1075515|NCT02078752|2131915|FG006|Overall Study|Withdrawal by Subject|2
1075516|NCT02078752|2131916|FG007|Overall Study|Withdrawal by Subject|1
1075517|NCT02078752|2131917|FG008|Overall Study|Withdrawal by Subject|0
1075518|NCT02078752|2131918|FG009|Overall Study|Withdrawal by Subject|1
1075519|NCT02078752|2131909|FG000|Overall Study|Other|0
1075520|NCT02078752|2131910|FG001|Overall Study|Other|3
1075521|NCT02078752|2131911|FG002|Overall Study|Other|0
1075522|NCT02078752|2131912|FG003|Overall Study|Other|0
1075523|NCT02078752|2131913|FG004|Overall Study|Other|1
1075524|NCT02078752|2131914|FG005|Overall Study|Other|0
1075525|NCT02078752|2131915|FG006|Overall Study|Other|0
1075526|NCT02078752|2131916|FG007|Overall Study|Other|1
1075527|NCT02078752|2131917|FG008|Overall Study|Other|0
1075528|NCT02078752|2131918|FG009|Overall Study|Other|0
1075529|NCT02078752|2131909|FG000|Overall Study|Study terminated by sponsor|0
1075530|NCT02078752|2131910|FG001|Overall Study|Study terminated by sponsor|0
1075531|NCT02078752|2131911|FG002|Overall Study|Study terminated by sponsor|0
1075532|NCT02078752|2131912|FG003|Overall Study|Study terminated by sponsor|0
1075533|NCT02078752|2131913|FG004|Overall Study|Study terminated by sponsor|0
1075534|NCT02078752|2131914|FG005|Overall Study|Study terminated by sponsor|0
1075535|NCT02078752|2131915|FG006|Overall Study|Study terminated by sponsor|0
1075536|NCT02078752|2131916|FG007|Overall Study|Study terminated by sponsor|0
1075537|NCT02078752|2131917|FG008|Overall Study|Study terminated by sponsor|0
1075538|NCT02078752|2131918|FG009|Overall Study|Study terminated by sponsor|5
1075539|NCT02078817|2131949|FG000|Overall Study|Withdrawal by Subject|1
1075540|NCT02078960|2131960|FG000|Treatment Period|Other|0
1075541|NCT02078960|2131961|FG001|Treatment Period|Other|0
1075542|NCT02078960|2131962|FG002|Treatment Period|Other|1
1075543|NCT02078960|2131960|FG000|Treatment Period|Lack of Efficacy|0
1075544|NCT02078960|2131961|FG001|Treatment Period|Lack of Efficacy|1
1075545|NCT02078960|2131962|FG002|Treatment Period|Lack of Efficacy|0
1075546|NCT02078960|2131960|FG000|Treatment Period|Disease progression - accelerated phase|0
1075547|NCT02078960|2131961|FG001|Treatment Period|Disease progression - accelerated phase|1
1075548|NCT02078960|2131962|FG002|Treatment Period|Disease progression - accelerated phase|0
1075549|NCT02078960|2131960|FG000|Treatment Period|Disease progression - blast phase|1
1075550|NCT02078960|2131961|FG001|Treatment Period|Disease progression - blast phase|0
1075551|NCT02078960|2131962|FG002|Treatment Period|Disease progression - blast phase|0
1075552|NCT02078960|2131960|FG000|Treatment Period|Withdrawal by Subject|0
1075553|NCT02078960|2131961|FG001|Treatment Period|Withdrawal by Subject|1
1075554|NCT02078960|2131962|FG002|Treatment Period|Withdrawal by Subject|1
1075555|NCT02078960|2131960|FG000|Treatment Period|Adverse Event|1
1075556|NCT02078960|2131961|FG001|Treatment Period|Adverse Event|0
1075557|NCT02078960|2131962|FG002|Treatment Period|Adverse Event|0
1075558|NCT02078960|2131960|FG000|Treatment Period|Death|0
1075559|NCT02078960|2131961|FG001|Treatment Period|Death|0
1075560|NCT02078960|2131962|FG002|Treatment Period|Death|1
1075561|NCT02078960|2131960|FG000|Follow-up Period|Death|2
1075562|NCT02078960|2131961|FG001|Follow-up Period|Death|0
1075563|NCT02078960|2131962|FG002|Follow-up Period|Death|0
1075564|NCT02078960|2131960|FG000|Follow-up Period|Lost to Follow-up|0
1075565|NCT02078960|2131961|FG001|Follow-up Period|Lost to Follow-up|1
1075566|NCT02078960|2131962|FG002|Follow-up Period|Lost to Follow-up|0
1075567|NCT02079038|2131984|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6
1075568|NCT02079038|2131985|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5
1075569|NCT02079038|2131984|FG000|Modified Intent to Treat Population|Death|1
1075570|NCT02079038|2131985|FG001|Modified Intent to Treat Population|Death|0
1075571|NCT02079038|2131984|FG000|Completed 6 Months|Lost to Follow-up|2
1075572|NCT02079038|2131985|FG001|Completed 6 Months|Lost to Follow-up|1
1075573|NCT02079077|2131993|FG000|Overall Study|Lost to Follow-up|5
1075574|NCT02079077|2131994|FG001|Overall Study|Lost to Follow-up|7
1075575|NCT02079077|2131993|FG000|Overall Study|Became STIs Positive|1
1075576|NCT02079077|2131994|FG001|Overall Study|Became STIs Positive|2
1075577|NCT02079246|2132000|FG000|OLEX|Withdrawal before treatment|1
1075578|NCT02079246|2132001|FG001|OLEX|Withdrawal before treatment|0
1075579|NCT02079246|2132000|FG000|OLEX|Death|11
1075580|NCT02079246|2132001|FG001|OLEX|Death|0
1075581|NCT02079246|2132000|FG000|OLEX|Adverse Event|66
1075582|NCT02079246|2132001|FG001|OLEX|Adverse Event|0
1075583|NCT02079246|2132000|FG000|OLEX|Withdrawal by Subject|60
1075584|NCT02079246|2132001|FG001|OLEX|Withdrawal by Subject|0
1075585|NCT02079246|2132000|FG000|OLEX|Lost to Follow-up|6
1075586|NCT02079246|2132001|FG001|OLEX|Lost to Follow-up|0
1075587|NCT02079246|2132000|FG000|OLEX|Protocol Violation|6
1075588|NCT02079246|2132001|FG001|OLEX|Protocol Violation|0
1075589|NCT02079246|2132000|FG000|OLEX|Lack of Efficacy|3
1075590|NCT02079246|2132001|FG001|OLEX|Lack of Efficacy|0
1075591|NCT02079246|2132000|FG000|OLEX|Results of the lead-in studies|58
1075592|NCT02079246|2132001|FG001|OLEX|Results of the lead-in studies|0
1075593|NCT02079246|2132000|FG000|OLEX|Other: Disallowed medication|8
1075594|NCT02079246|2132001|FG001|OLEX|Other: Disallowed medication|0
1075595|NCT02079246|2132000|FG000|OLEX|Other: Insufficient compliance|2
1075596|NCT02079246|2132001|FG001|OLEX|Other: Insufficient compliance|0
1075597|NCT02079246|2132000|FG000|OLEX|Other: Caregiver unavailable|3
1075598|NCT02079246|2132001|FG001|OLEX|Other: Caregiver unavailable|0
1075599|NCT02079246|2132000|FG000|OLEX|Other: Coordinator decision|1
1075600|NCT02079246|2132001|FG001|OLEX|Other: Coordinator decision|0
1075601|NCT02079246|2132000|FG000|OLEX|Other: Worsening of condition|1
1075602|NCT02079246|2132001|FG001|OLEX|Other: Worsening of condition|0
1075603|NCT02079246|2132000|FG000|OLEX|Other: Moved to nursing home|1
1075604|NCT02079246|2132001|FG001|OLEX|Other: Moved to nursing home|0
1075605|NCT02079246|2132000|FG000|OLEX|Other: Withdrawal of caregiver consent|1
1075606|NCT02079246|2132001|FG001|OLEX|Other: Withdrawal of caregiver consent|0
1075607|NCT02079246|2132000|FG000|OLEX-MEM|Adverse Event|0
1075608|NCT02079246|2132001|FG001|OLEX-MEM|Adverse Event|6
1075609|NCT02079246|2132000|FG000|OLEX-MEM|Withdrawal by Subject|0
1075610|NCT02079246|2132001|FG001|OLEX-MEM|Withdrawal by Subject|7
1075611|NCT02079246|2132000|FG000|OLEX-MEM|Protocol Violation|0
1075612|NCT02079246|2132001|FG001|OLEX-MEM|Protocol Violation|2
1075613|NCT02079246|2132000|FG000|OLEX-MEM|Lost to Follow-up|0
1075614|NCT02079246|2132001|FG001|OLEX-MEM|Lost to Follow-up|1
1075615|NCT02079246|2132000|FG000|OLEX-MEM|Other: Moved to nursing home|0
1075616|NCT02079246|2132001|FG001|OLEX-MEM|Other: Moved to nursing home|3
1075617|NCT02079519|2132019|FG000|Overall Study|Disease Progression|9
1075618|NCT02079519|2132019|FG000|Overall Study|Adverse Event|1
1075619|NCT02079532|2132023|FG000|Overall Study|Adverse Event|7
1075620|NCT02079532|2132023|FG000|Overall Study|Additional or changed therapy|2
1075621|NCT02079532|2132023|FG000|Overall Study|Lack of Efficacy|9
1075622|NCT02079532|2132023|FG000|Overall Study|Protocol Violation|3
1075623|NCT02079532|2132023|FG000|Overall Study|Withdrawal by Subject|1
1075624|NCT02079532|2132023|FG000|Overall Study|Administrative problems|1
1075625|NCT02079532|2132023|FG000|Overall Study|Inclusion into ReFIRST|3
1075626|NCT02079532|2132023|FG000|Overall Study|Other|3
1075627|NCT02079610|2132029|FG000|Overall Study|Withdrawal by Subject|1
1075628|NCT02079610|2132030|FG001|Overall Study|Withdrawal by Subject|1
1075629|NCT02079636|2132051|FG000|Overall Study|Death|2
1075630|NCT02079636|2132052|FG001|Overall Study|Death|1
1075631|NCT02079636|2132053|FG002|Overall Study|Death|0
1075632|NCT02079636|2132054|FG003|Overall Study|Death|5
1075633|NCT02079636|2132055|FG004|Overall Study|Death|1
1075634|NCT02079636|2132056|FG005|Overall Study|Death|2
1075635|NCT02079636|2132057|FG006|Overall Study|Death|1
1075636|NCT02079636|2132058|FG007|Overall Study|Death|0
1075637|NCT02079636|2132059|FG008|Overall Study|Death|0
1075638|NCT02079636|2132060|FG009|Overall Study|Death|0
1075639|NCT02079636|2132061|FG010|Overall Study|Death|0
1075640|NCT02079636|2132062|FG011|Overall Study|Death|1
1075641|NCT02079636|2132063|FG012|Overall Study|Death|1
1075642|NCT02079636|2132064|FG013|Overall Study|Death|0
1075643|NCT02079636|2132065|FG014|Overall Study|Death|2
1075644|NCT02079636|2132051|FG000|Overall Study|Adverse Event|1
1075645|NCT02079636|2132052|FG001|Overall Study|Adverse Event|1
1075646|NCT02079636|2132053|FG002|Overall Study|Adverse Event|0
1075647|NCT02079636|2132054|FG003|Overall Study|Adverse Event|1
1075648|NCT02079636|2132055|FG004|Overall Study|Adverse Event|1
1075649|NCT02079636|2132056|FG005|Overall Study|Adverse Event|2
1075650|NCT02079636|2132057|FG006|Overall Study|Adverse Event|0
1075651|NCT02079636|2132058|FG007|Overall Study|Adverse Event|0
1075652|NCT02079636|2132059|FG008|Overall Study|Adverse Event|0
1075653|NCT02079636|2132060|FG009|Overall Study|Adverse Event|0
1075654|NCT02079636|2132061|FG010|Overall Study|Adverse Event|0
1075655|NCT02079636|2132062|FG011|Overall Study|Adverse Event|0
1075656|NCT02079636|2132063|FG012|Overall Study|Adverse Event|0
1075657|NCT02079636|2132064|FG013|Overall Study|Adverse Event|0
1075658|NCT02079636|2132065|FG014|Overall Study|Adverse Event|0
1075659|NCT02079636|2132051|FG000|Overall Study|Progressive disease|0
1075660|NCT02079636|2132052|FG001|Overall Study|Progressive disease|0
1075661|NCT02079636|2132053|FG002|Overall Study|Progressive disease|0
1075662|NCT02079636|2132054|FG003|Overall Study|Progressive disease|2
1075663|NCT02079636|2132055|FG004|Overall Study|Progressive disease|0
1075664|NCT02079636|2132056|FG005|Overall Study|Progressive disease|0
1075665|NCT02079636|2132057|FG006|Overall Study|Progressive disease|0
1075666|NCT02079636|2132058|FG007|Overall Study|Progressive disease|0
1075667|NCT02079636|2132059|FG008|Overall Study|Progressive disease|0
1075668|NCT02079636|2132060|FG009|Overall Study|Progressive disease|0
1075669|NCT02079636|2132061|FG010|Overall Study|Progressive disease|0
1075670|NCT02079636|2132062|FG011|Overall Study|Progressive disease|0
1075671|NCT02079636|2132063|FG012|Overall Study|Progressive disease|1
1075672|NCT02079636|2132064|FG013|Overall Study|Progressive disease|0
1075673|NCT02079636|2132065|FG014|Overall Study|Progressive disease|0
1075674|NCT02079636|2132051|FG000|Overall Study|Withdrawal by Subject|0
1075675|NCT02079636|2132052|FG001|Overall Study|Withdrawal by Subject|0
1075676|NCT02079636|2132053|FG002|Overall Study|Withdrawal by Subject|0
1075677|NCT02079636|2132054|FG003|Overall Study|Withdrawal by Subject|4
1075678|NCT02079636|2132055|FG004|Overall Study|Withdrawal by Subject|0
1075679|NCT02079636|2132056|FG005|Overall Study|Withdrawal by Subject|1
1075680|NCT02079636|2132057|FG006|Overall Study|Withdrawal by Subject|0
1075681|NCT02079636|2132058|FG007|Overall Study|Withdrawal by Subject|0
1075682|NCT02079636|2132059|FG008|Overall Study|Withdrawal by Subject|0
1075683|NCT02079636|2132060|FG009|Overall Study|Withdrawal by Subject|2
1075684|NCT02079636|2132061|FG010|Overall Study|Withdrawal by Subject|1
1075685|NCT02079636|2132062|FG011|Overall Study|Withdrawal by Subject|1
1075686|NCT02079636|2132063|FG012|Overall Study|Withdrawal by Subject|1
1075687|NCT02079636|2132064|FG013|Overall Study|Withdrawal by Subject|0
1075688|NCT02079636|2132065|FG014|Overall Study|Withdrawal by Subject|2
1075689|NCT02079636|2132051|FG000|Overall Study|Physician Decision|0
1075690|NCT02079636|2132052|FG001|Overall Study|Physician Decision|0
1075691|NCT02079636|2132053|FG002|Overall Study|Physician Decision|0
1075692|NCT02079636|2132054|FG003|Overall Study|Physician Decision|0
1075693|NCT02079636|2132055|FG004|Overall Study|Physician Decision|0
1075694|NCT02079636|2132056|FG005|Overall Study|Physician Decision|1
1075695|NCT02079636|2132057|FG006|Overall Study|Physician Decision|0
1075696|NCT02079636|2132058|FG007|Overall Study|Physician Decision|0
1075697|NCT02079636|2132059|FG008|Overall Study|Physician Decision|0
1075698|NCT02079636|2132060|FG009|Overall Study|Physician Decision|1
1075699|NCT02079636|2132061|FG010|Overall Study|Physician Decision|1
1075700|NCT02079636|2132062|FG011|Overall Study|Physician Decision|0
1075701|NCT02079636|2132063|FG012|Overall Study|Physician Decision|0
1075702|NCT02079636|2132064|FG013|Overall Study|Physician Decision|0
1075703|NCT02079636|2132065|FG014|Overall Study|Physician Decision|1
1075704|NCT02079636|2132051|FG000|Overall Study|Lost to Follow-up|0
1075705|NCT02079636|2132052|FG001|Overall Study|Lost to Follow-up|0
1075706|NCT02079636|2132053|FG002|Overall Study|Lost to Follow-up|0
1075707|NCT02079636|2132054|FG003|Overall Study|Lost to Follow-up|0
1075708|NCT02079636|2132055|FG004|Overall Study|Lost to Follow-up|0
1075709|NCT02079636|2132056|FG005|Overall Study|Lost to Follow-up|0
1075710|NCT02079636|2132057|FG006|Overall Study|Lost to Follow-up|0
1075711|NCT02079636|2132058|FG007|Overall Study|Lost to Follow-up|1
1075712|NCT02079636|2132059|FG008|Overall Study|Lost to Follow-up|0
1075713|NCT02079636|2132060|FG009|Overall Study|Lost to Follow-up|0
1075714|NCT02079636|2132061|FG010|Overall Study|Lost to Follow-up|0
1075715|NCT02079636|2132062|FG011|Overall Study|Lost to Follow-up|0
1075716|NCT02079636|2132063|FG012|Overall Study|Lost to Follow-up|0
1075717|NCT02079636|2132064|FG013|Overall Study|Lost to Follow-up|0
1075718|NCT02079636|2132065|FG014|Overall Study|Lost to Follow-up|0
1075719|NCT02079649|2132133|FG000|Overall Study|Lost to Follow-up|0
1075720|NCT02079649|2132134|FG001|Overall Study|Lost to Follow-up|0
1075721|NCT02079649|2132135|FG002|Overall Study|Lost to Follow-up|0
1075722|NCT02079649|2132136|FG003|Overall Study|Lost to Follow-up|1
1075723|NCT02079649|2132133|FG000|Overall Study|Withdrawal by Subject|0
1075724|NCT02079649|2132134|FG001|Overall Study|Withdrawal by Subject|0
1075725|NCT02079649|2132135|FG002|Overall Study|Withdrawal by Subject|0
1075726|NCT02079649|2132136|FG003|Overall Study|Withdrawal by Subject|1
1075727|NCT02079649|2132133|FG000|Overall Study|Randomization error (prior to treatment)|1
1075728|NCT02079649|2132134|FG001|Overall Study|Randomization error (prior to treatment)|0
1075729|NCT02079649|2132135|FG002|Overall Study|Randomization error (prior to treatment)|1
1075730|NCT02079649|2132136|FG003|Overall Study|Randomization error (prior to treatment)|0
1075731|NCT02079805|2132158|FG000|Overall Study|Pretreatment Event/Adverse Event|0
1075732|NCT02079805|2132159|FG001|Overall Study|Pretreatment Event/Adverse Event|1
1075733|NCT02079805|2132158|FG000|Overall Study|Voluntary Withdrawal|0
1075734|NCT02079805|2132159|FG001|Overall Study|Voluntary Withdrawal|1
1075735|NCT02079844|2132168|FG000|Treatment Period 1|Voluntary Withdrawal|0
1075736|NCT02079844|2132169|FG001|Treatment Period 1|Voluntary Withdrawal|0
1075737|NCT02079844|2132170|FG002|Treatment Period 1|Voluntary Withdrawal|2
1075738|NCT02079844|2132168|FG000|Treatment Period 2|Voluntary Withdrawal|0
1075739|NCT02079844|2132169|FG001|Treatment Period 2|Voluntary Withdrawal|1
1075740|NCT02079844|2132170|FG002|Treatment Period 2|Voluntary Withdrawal|0
1075741|NCT02079909|2132184|FG000|Overall Study|Adverse Event|23
1075742|NCT02079909|2132185|FG001|Overall Study|Adverse Event|23
1075743|NCT02079909|2132186|FG002|Overall Study|Adverse Event|7
1075744|NCT02079909|2132184|FG000|Overall Study|Withdrawal by Subject|9
1075745|NCT02079909|2132185|FG001|Overall Study|Withdrawal by Subject|17
1075746|NCT02079909|2132186|FG002|Overall Study|Withdrawal by Subject|4
1075747|NCT02079909|2132184|FG000|Overall Study|Lost to Follow-up|2
1075748|NCT02079909|2132185|FG001|Overall Study|Lost to Follow-up|3
1075749|NCT02079909|2132186|FG002|Overall Study|Lost to Follow-up|1
1075750|NCT02079909|2132184|FG000|Overall Study|Death|2
1075751|NCT02079909|2132185|FG001|Overall Study|Death|2
1075752|NCT02079909|2132186|FG002|Overall Study|Death|0
1075753|NCT02079909|2132184|FG000|Overall Study|Lack of Efficacy|0
1075754|NCT02079909|2132185|FG001|Overall Study|Lack of Efficacy|0
1075755|NCT02079909|2132186|FG002|Overall Study|Lack of Efficacy|1
1075756|NCT02079909|2132184|FG000|Overall Study|Protocol Violation|0
1075757|NCT02079909|2132185|FG001|Overall Study|Protocol Violation|1
1075758|NCT02079909|2132186|FG002|Overall Study|Protocol Violation|1
1075759|NCT02079909|2132184|FG000|Overall Study|Physician Decision|0
1075760|NCT02079909|2132185|FG001|Overall Study|Physician Decision|1
1075761|NCT02079909|2132186|FG002|Overall Study|Physician Decision|1
1075762|NCT02079909|2132184|FG000|Overall Study|Relocation etc.|2
1075763|NCT02079909|2132185|FG001|Overall Study|Relocation etc.|2
1075764|NCT02079909|2132186|FG002|Overall Study|Relocation etc.|3
1075765|NCT02080091|2132204|FG000|Overall Study|Study Terminated|22
1075766|NCT02080091|2132204|FG000|Overall Study|Death|1
1075767|NCT02080091|2132204|FG000|Overall Study|Withdrawal by Subject|1
1075768|NCT02080091|2132204|FG000|Overall Study|Other|1
1075769|NCT02080221|2132212|FG000|Overall Study|Withdrawal by Subject|1
1075770|NCT02080221|2132212|FG000|Overall Study|Clinical Progression of Disease|1
1075771|NCT02080260|2132216|FG000|Overall Study|Death|18
1075772|NCT02080260|2132216|FG000|Overall Study|Withdrawal by Subject|1
1075773|NCT02080364|2132242|FG000|Baseline Period|Protocol Violation|2
1075774|NCT02080364|2132243|FG001|Baseline Period|Protocol Violation|1
1075775|NCT02080364|2132244|FG002|Baseline Period|Protocol Violation|0
1075776|NCT02080364|2132245|FG003|Baseline Period|Protocol Violation|0
1075777|NCT02080364|2132242|FG000|Baseline Period|Other|0
1075778|NCT02080364|2132243|FG001|Baseline Period|Other|1
1075779|NCT02080364|2132244|FG002|Baseline Period|Other|1
1075780|NCT02080364|2132245|FG003|Baseline Period|Other|0
1075781|NCT02080364|2132242|FG000|Treatment Period|Adverse Event|10
1075782|NCT02080364|2132243|FG001|Treatment Period|Adverse Event|15
1075783|NCT02080364|2132244|FG002|Treatment Period|Adverse Event|11
1075784|NCT02080364|2132245|FG003|Treatment Period|Adverse Event|14
1075785|NCT02080364|2132242|FG000|Treatment Period|Lost to Follow-up|2
1075786|NCT02080364|2132243|FG001|Treatment Period|Lost to Follow-up|3
1075787|NCT02080364|2132244|FG002|Treatment Period|Lost to Follow-up|5
1075788|NCT02080364|2132245|FG003|Treatment Period|Lost to Follow-up|0
1075789|NCT02080364|2132242|FG000|Treatment Period|Protocol Violation|5
1075790|NCT02080364|2132243|FG001|Treatment Period|Protocol Violation|3
1075791|NCT02080364|2132244|FG002|Treatment Period|Protocol Violation|5
1075792|NCT02080364|2132245|FG003|Treatment Period|Protocol Violation|1
1075793|NCT02080364|2132242|FG000|Treatment Period|Withdrawal by Subject|16
1075794|NCT02080364|2132243|FG001|Treatment Period|Withdrawal by Subject|16
1075795|NCT02080364|2132244|FG002|Treatment Period|Withdrawal by Subject|15
1075796|NCT02080364|2132245|FG003|Treatment Period|Withdrawal by Subject|10
1075797|NCT02080364|2132242|FG000|Treatment Period|Study Terminated by Sponsor|0
1075798|NCT02080364|2132243|FG001|Treatment Period|Study Terminated by Sponsor|0
1075799|NCT02080364|2132244|FG002|Treatment Period|Study Terminated by Sponsor|180
1075800|NCT02080364|2132245|FG003|Treatment Period|Study Terminated by Sponsor|183
1075801|NCT02080364|2132242|FG000|Treatment Period|Other|14
1075802|NCT02080364|2132243|FG001|Treatment Period|Other|12
1075803|NCT02080364|2132244|FG002|Treatment Period|Other|21
1075804|NCT02080364|2132245|FG003|Treatment Period|Other|16
1075805|NCT02080403|2132257|FG000|Overall Study|Adverse Event|5
1075806|NCT02080403|2132258|FG001|Overall Study|Adverse Event|1
1075807|NCT02080403|2132257|FG000|Overall Study|Death|0
1075808|NCT02080403|2132258|FG001|Overall Study|Death|2
1075809|NCT02080403|2132257|FG000|Overall Study|Lost to Follow-up|2
1075810|NCT02080403|2132258|FG001|Overall Study|Lost to Follow-up|0
1075811|NCT02080403|2132257|FG000|Overall Study|Pregnancy|0
1075812|NCT02080403|2132258|FG001|Overall Study|Pregnancy|1
1075813|NCT02080403|2132257|FG000|Overall Study|Protocol Violation|3
1075814|NCT02080403|2132258|FG001|Overall Study|Protocol Violation|7
1075815|NCT02080403|2132257|FG000|Overall Study|Withdrawal by Subject|5
1075816|NCT02080403|2132258|FG001|Overall Study|Withdrawal by Subject|1
1075817|NCT02080481|2132299|FG000|Overall Study|Never received a block.|1
1075818|NCT02080481|2132300|FG001|Overall Study|Never received a block.|0
1075819|NCT02080832|2132356|FG000|Overall Study|Excluded from analysis by MRI|9
1075820|NCT02080832|2132357|FG001|Overall Study|Excluded from analysis by MRI|10
1075821|NCT02080832|2132358|FG002|Overall Study|Excluded from analysis by MRI|14
1075822|NCT02080832|2132356|FG000|Overall Study|Lost to Follow-up|0
1075823|NCT02080832|2132357|FG001|Overall Study|Lost to Follow-up|2
1075824|NCT02080832|2132358|FG002|Overall Study|Lost to Follow-up|2
1075825|NCT02080871|2132368|FG000|Overall Study|Death|1
1075826|NCT02080871|2132368|FG000|Overall Study|Lost to Follow-up|1
1075827|NCT02081001|2132374|FG000|Overall Study|Adverse Event|0
1075828|NCT02081001|2132375|FG001|Overall Study|Adverse Event|0
1075829|NCT02081001|2132376|FG002|Overall Study|Adverse Event|0
1075830|NCT02081001|2132377|FG003|Overall Study|Adverse Event|0
1075831|NCT02081001|2132378|FG004|Overall Study|Adverse Event|1
1075832|NCT02081001|2132379|FG005|Overall Study|Adverse Event|0
1075833|NCT02081001|2132380|FG006|Overall Study|Adverse Event|0
1075834|NCT02081001|2132381|FG007|Overall Study|Adverse Event|0
1075835|NCT02081001|2132382|FG008|Overall Study|Adverse Event|0
1075836|NCT02081001|2132383|FG009|Overall Study|Adverse Event|0
1075837|NCT02081001|2132384|FG010|Overall Study|Adverse Event|0
1075838|NCT02081001|2132385|FG011|Overall Study|Adverse Event|0
1075839|NCT02081079|2132422|FG000|Overall Study|Lack of Efficacy|3
1075840|NCT02081079|2132423|FG001|Overall Study|Lack of Efficacy|2
1075841|NCT02081079|2132422|FG000|Overall Study|Lost to Follow-up|1
1075842|NCT02081079|2132423|FG001|Overall Study|Lost to Follow-up|0
1075843|NCT02081196|2132433|FG000|Overall Study|Lost to Follow-up|1
1075844|NCT02081417|2132486|FG000|Overall Study|Lost to Follow-up|26
1075845|NCT02081417|2132487|FG001|Overall Study|Lost to Follow-up|23
1075846|NCT02081417|2132486|FG000|Overall Study|Moved Away|1
1075847|NCT02081417|2132487|FG001|Overall Study|Moved Away|2
1075848|NCT02081417|2132486|FG000|Overall Study|Incarcerated|2
1075849|NCT02081417|2132487|FG001|Overall Study|Incarcerated|2
1075850|NCT02081417|2132486|FG000|Overall Study|Death|4
1075851|NCT02081417|2132487|FG001|Overall Study|Death|3
1075852|NCT02081417|2132486|FG000|Overall Study|Withdrawal by Subject|4
1075853|NCT02081417|2132487|FG001|Overall Study|Withdrawal by Subject|0
1075854|NCT02081417|2132486|FG000|Overall Study|Admitted to Residential Treatment|2
1075855|NCT02081417|2132487|FG001|Overall Study|Admitted to Residential Treatment|0
1075856|NCT02081417|2132486|FG000|Overall Study|Did not start treatment|17
1075857|NCT02081417|2132487|FG001|Overall Study|Did not start treatment|21
1075858|NCT02081534|2132518|FG000|Overall Study|Adverse Event|5
1075859|NCT02081534|2132519|FG001|Overall Study|Adverse Event|4
1075860|NCT02081534|2132520|FG002|Overall Study|Adverse Event|3
1075861|NCT02081534|2132521|FG003|Overall Study|Adverse Event|10
1075862|NCT02081534|2132522|FG004|Overall Study|Adverse Event|2
1075863|NCT02081534|2132523|FG005|Overall Study|Adverse Event|8
1075864|NCT02081534|2132524|FG006|Overall Study|Adverse Event|2
1075865|NCT02081534|2132518|FG000|Overall Study|Withdrawal by Subject|0
1075866|NCT02081534|2132519|FG001|Overall Study|Withdrawal by Subject|1
1075867|NCT02081534|2132520|FG002|Overall Study|Withdrawal by Subject|1
1075868|NCT02081534|2132521|FG003|Overall Study|Withdrawal by Subject|1
1075869|NCT02081534|2132522|FG004|Overall Study|Withdrawal by Subject|1
1075870|NCT02081534|2132523|FG005|Overall Study|Withdrawal by Subject|0
1075871|NCT02081534|2132524|FG006|Overall Study|Withdrawal by Subject|1
1075872|NCT02081534|2132518|FG000|Overall Study|Protocol Violation|0
1075873|NCT02081534|2132519|FG001|Overall Study|Protocol Violation|3
1075874|NCT02081534|2132520|FG002|Overall Study|Protocol Violation|0
1075875|NCT02081534|2132521|FG003|Overall Study|Protocol Violation|0
1075876|NCT02081534|2132522|FG004|Overall Study|Protocol Violation|0
1075877|NCT02081534|2132523|FG005|Overall Study|Protocol Violation|0
1075878|NCT02081534|2132524|FG006|Overall Study|Protocol Violation|1
1075879|NCT02081534|2132518|FG000|Overall Study|Lost to Follow-up|0
1075880|NCT02081534|2132519|FG001|Overall Study|Lost to Follow-up|0
1075881|NCT02081534|2132520|FG002|Overall Study|Lost to Follow-up|0
1075882|NCT02081534|2132521|FG003|Overall Study|Lost to Follow-up|2
1075883|NCT02081534|2132522|FG004|Overall Study|Lost to Follow-up|1
1075884|NCT02081534|2132523|FG005|Overall Study|Lost to Follow-up|1
1075885|NCT02081534|2132524|FG006|Overall Study|Lost to Follow-up|0
1075886|NCT02081586|2132548|FG000|Overall Study|Lost to Follow-up|0
1075887|NCT02081586|2132549|FG001|Overall Study|Lost to Follow-up|1
1075888|NCT02081586|2132550|FG002|Overall Study|Lost to Follow-up|0
1075889|NCT02081586|2132551|FG003|Overall Study|Lost to Follow-up|1
1075890|NCT02081586|2132548|FG000|Overall Study|Head injury not related to study|0
1075891|NCT02081586|2132549|FG001|Overall Study|Head injury not related to study|0
1075892|NCT02081586|2132550|FG002|Overall Study|Head injury not related to study|1
1075893|NCT02081586|2132551|FG003|Overall Study|Head injury not related to study|0
1075894|NCT02081599|2132565|FG000|Period 1：Double-blind Period|Adverse Event|3
1075895|NCT02081599|2132566|FG001|Period 1：Double-blind Period|Adverse Event|0
1075896|NCT02081599|2132565|FG000|Period 1：Double-blind Period|Lack of Efficacy|2
1075897|NCT02081599|2132566|FG001|Period 1：Double-blind Period|Lack of Efficacy|1
1075898|NCT02081599|2132565|FG000|Period 1：Double-blind Period|Physician Decision|1
1075899|NCT02081599|2132566|FG001|Period 1：Double-blind Period|Physician Decision|0
1075900|NCT02081599|2132565|FG000|Period 1：Double-blind Period|Protocol Violation|0
1075901|NCT02081599|2132566|FG001|Period 1：Double-blind Period|Protocol Violation|1
1075902|NCT02081599|2132565|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1
1075903|NCT02081599|2132566|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0
1075904|NCT02081599|2132565|FG000|Period 1：Double-blind Period|stopping criteria|1
1075905|NCT02081599|2132566|FG001|Period 1：Double-blind Period|stopping criteria|0
1075906|NCT02081599|2132565|FG000|Period 2：Open-label Period|Adverse Event|1
1075907|NCT02081599|2132566|FG001|Period 2：Open-label Period|Adverse Event|0
1075908|NCT02081599|2132565|FG000|Period 2：Open-label Period|Lack of Efficacy|2
1075909|NCT02081599|2132566|FG001|Period 2：Open-label Period|Lack of Efficacy|4
1075910|NCT02081599|2132565|FG000|Period 2：Open-label Period|Physician Decision|1
1075911|NCT02081599|2132566|FG001|Period 2：Open-label Period|Physician Decision|0
1075912|NCT02081599|2132565|FG000|Period 2：Open-label Period|Withdrawal by Subject|2
1075913|NCT02081599|2132566|FG001|Period 2：Open-label Period|Withdrawal by Subject|0
1075914|NCT02081677|2132591|FG000|Overall Study|Adverse Event|0
1075915|NCT02081677|2132592|FG001|Overall Study|Adverse Event|0
1075916|NCT02081677|2132593|FG002|Overall Study|Adverse Event|1
1075917|NCT02081677|2132594|FG003|Overall Study|Adverse Event|0
1075918|NCT02081677|2132591|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
1075919|NCT02081677|2132592|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
1075920|NCT02081677|2132593|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
1075921|NCT02081677|2132594|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
1075922|NCT02081677|2132591|FG000|Overall Study|Not comfortable with lens care system|1
1075923|NCT02081677|2132592|FG001|Overall Study|Not comfortable with lens care system|0
1075924|NCT02081677|2132593|FG002|Overall Study|Not comfortable with lens care system|0
1075925|NCT02081677|2132594|FG003|Overall Study|Not comfortable with lens care system|0
1075926|NCT02081677|2132591|FG000|Overall Study|Unsatisfactory Lens Fitting|0
1075927|NCT02081677|2132592|FG001|Overall Study|Unsatisfactory Lens Fitting|1
1075928|NCT02081677|2132593|FG002|Overall Study|Unsatisfactory Lens Fitting|0
1075929|NCT02081677|2132594|FG003|Overall Study|Unsatisfactory Lens Fitting|0
1075930|NCT02081690|2132604|FG000|Overall Study|Death|3
1075931|NCT02081690|2132604|FG000|Overall Study|Physician Decision|3
1075932|NCT02081690|2132604|FG000|Overall Study|Withdrawal by Subject|1
1075933|NCT02081846|2132653|FG000|Overall Study|Withdrawal by Subject|1
1075934|NCT02081846|2132654|FG001|Overall Study|Withdrawal by Subject|0
1075935|NCT02081846|2132653|FG000|Overall Study|invalid consent|1
1075936|NCT02081846|2132654|FG001|Overall Study|invalid consent|0
1075937|NCT02081859|2132662|FG000|Overall Study|No fertilization|2
1075938|NCT02081859|2132663|FG001|Overall Study|No fertilization|2
1075939|NCT02081859|2132662|FG000|Overall Study|No sperm|1
1075940|NCT02081859|2132663|FG001|Overall Study|No sperm|0
1075941|NCT02081859|2132662|FG000|Overall Study|Unanticipated freeze all cycle|2
1075942|NCT02081859|2132663|FG001|Overall Study|Unanticipated freeze all cycle|6
1075943|NCT02081859|2132662|FG000|Overall Study|< 4 embryos|27
1075944|NCT02081859|2132663|FG001|Overall Study|< 4 embryos|23
1075945|NCT02081859|2132662|FG000|Overall Study|Other reasons|2
1075946|NCT02081859|2132663|FG001|Overall Study|Other reasons|0
1075947|NCT02082158|2132705|FG000|Overall Study|Withdrawal by Subject|0
1075948|NCT02082158|2132706|FG001|Overall Study|Withdrawal by Subject|0
1075949|NCT02082158|2132707|FG002|Overall Study|Withdrawal by Subject|0
1075950|NCT02082158|2132708|FG003|Overall Study|Withdrawal by Subject|0
1075951|NCT02082158|2132709|FG004|Overall Study|Withdrawal by Subject|1
1075952|NCT02082158|2132710|FG005|Overall Study|Withdrawal by Subject|0
1075953|NCT02082158|2132705|FG000|Overall Study|Failed Fit-testing|8
1075954|NCT02082158|2132706|FG001|Overall Study|Failed Fit-testing|8
1075955|NCT02082158|2132707|FG002|Overall Study|Failed Fit-testing|14
1075956|NCT02082158|2132708|FG003|Overall Study|Failed Fit-testing|4
1075957|NCT02082158|2132709|FG004|Overall Study|Failed Fit-testing|3
1075958|NCT02082158|2132710|FG005|Overall Study|Failed Fit-testing|7
1075959|NCT02082184|2132732|FG000|Overall Study|Adverse Event|1
1075960|NCT02082184|2132733|FG001|Overall Study|Adverse Event|0
1075961|NCT02082184|2132732|FG000|Overall Study|Medical diagnosis|1
1075962|NCT02082184|2132733|FG001|Overall Study|Medical diagnosis|2
1075963|NCT02082184|2132732|FG000|Overall Study|Device associated symptoms|5
1075964|NCT02082184|2132733|FG001|Overall Study|Device associated symptoms|0
1075965|NCT02082184|2132732|FG000|Overall Study|Withdrawal by Subject|3
1075966|NCT02082184|2132733|FG001|Overall Study|Withdrawal by Subject|2
1075967|NCT02082184|2132732|FG000|Overall Study|Protocol Violation|0
1075968|NCT02082184|2132733|FG001|Overall Study|Protocol Violation|6
1075969|NCT02082184|2132732|FG000|Overall Study|Lost to Follow-up|0
1075970|NCT02082184|2132733|FG001|Overall Study|Lost to Follow-up|2
1075971|NCT02082184|2132732|FG000|Overall Study|Subject non-compliance|0
1075972|NCT02082184|2132733|FG001|Overall Study|Subject non-compliance|1
1075973|NCT02082210|2132745|FG000|Overall Study|Death|0
1075974|NCT02082210|2132746|FG001|Overall Study|Death|0
1075975|NCT02082210|2132747|FG002|Overall Study|Death|1
1075976|NCT02082210|2132748|FG003|Overall Study|Death|1
1075977|NCT02082210|2132749|FG004|Overall Study|Death|1
1075978|NCT02082210|2132750|FG005|Overall Study|Death|0
1075979|NCT02082210|2132745|FG000|Overall Study|Withdrawal by Subject|0
1075980|NCT02082210|2132746|FG001|Overall Study|Withdrawal by Subject|0
1075981|NCT02082210|2132747|FG002|Overall Study|Withdrawal by Subject|0
1075982|NCT02082210|2132748|FG003|Overall Study|Withdrawal by Subject|1
1075983|NCT02082210|2132749|FG004|Overall Study|Withdrawal by Subject|2
1075984|NCT02082210|2132750|FG005|Overall Study|Withdrawal by Subject|2
1075985|NCT02082210|2132745|FG000|Overall Study|Clinical Progression|0
1075986|NCT02082210|2132746|FG001|Overall Study|Clinical Progression|0
1075987|NCT02082210|2132747|FG002|Overall Study|Clinical Progression|0
1075988|NCT02082210|2132748|FG003|Overall Study|Clinical Progression|1
1075989|NCT02082210|2132749|FG004|Overall Study|Clinical Progression|0
1075990|NCT02082210|2132750|FG005|Overall Study|Clinical Progression|0
1075991|NCT02082210|2132745|FG000|Overall Study|No Post-Baseline Tumor Assesment|0
1075992|NCT02082210|2132746|FG001|Overall Study|No Post-Baseline Tumor Assesment|0
1075993|NCT02082210|2132747|FG002|Overall Study|No Post-Baseline Tumor Assesment|1
1075994|NCT02082210|2132748|FG003|Overall Study|No Post-Baseline Tumor Assesment|2
1075995|NCT02082210|2132749|FG004|Overall Study|No Post-Baseline Tumor Assesment|0
1075996|NCT02082210|2132750|FG005|Overall Study|No Post-Baseline Tumor Assesment|0
1075997|NCT02082210|2132745|FG000|Overall Study|Physician Decision|0
1075998|NCT02082210|2132746|FG001|Overall Study|Physician Decision|0
1075999|NCT02082210|2132747|FG002|Overall Study|Physician Decision|1
1076000|NCT02082210|2132748|FG003|Overall Study|Physician Decision|1
1076001|NCT02082210|2132749|FG004|Overall Study|Physician Decision|0
1076002|NCT02082210|2132750|FG005|Overall Study|Physician Decision|0
1076003|NCT02082262|2132776|FG000|Overall Study|Withdrawal by Subject|3
1076004|NCT02082262|2132776|FG000|Overall Study|Adverse Event|48
1076005|NCT02082340|2132786|FG000|Overall Study|Lost to Follow-up|1
1076006|NCT02082340|2132787|FG001|Overall Study|Lost to Follow-up|1
1076007|NCT02082483|2132804|FG000|Overall Study|Lost to Follow-up|1
1076008|NCT02082483|2132805|FG001|Overall Study|Lost to Follow-up|1
1076009|NCT02082483|2132804|FG000|Overall Study|Withdrawal by Subject|2
1076010|NCT02082483|2132805|FG001|Overall Study|Withdrawal by Subject|1
1076011|NCT02082483|2132804|FG000|Overall Study|Physician Decision|1
1076012|NCT02082483|2132805|FG001|Overall Study|Physician Decision|1
1076013|NCT02082483|2132804|FG000|Overall Study|Death|2
1076014|NCT02082483|2132805|FG001|Overall Study|Death|3
1076015|NCT02082522|2132814|FG000|Overall Study|Sponsor termination|5
1076016|NCT02082522|2132815|FG001|Overall Study|Sponsor termination|3
1076017|NCT02082522|2132814|FG000|Overall Study|Withdrawal by Subject|2
1076018|NCT02082522|2132815|FG001|Overall Study|Withdrawal by Subject|4
1076019|NCT02082522|2132814|FG000|Overall Study|Death|1
1076020|NCT02082522|2132815|FG001|Overall Study|Death|0
1076021|NCT02082522|2132814|FG000|Overall Study|Lost to Follow-up|1
1076022|NCT02082522|2132815|FG001|Overall Study|Lost to Follow-up|0
1076023|NCT02082522|2132814|FG000|Overall Study|Physician Decision|3
1076024|NCT02082522|2132815|FG001|Overall Study|Physician Decision|1
1076025|NCT02082522|2132814|FG000|Overall Study|Disease progression|2
1076026|NCT02082522|2132815|FG001|Overall Study|Disease progression|2
1076027|NCT02082522|2132814|FG000|Overall Study|Chemotherapy change|1
1076028|NCT02082522|2132815|FG001|Overall Study|Chemotherapy change|3
1076029|NCT02082912|2132858|FG000|Overall Study|Physician Decision|0
1076030|NCT02082912|2132859|FG001|Overall Study|Physician Decision|1
1076031|NCT02082977|2132875|FG000|Part 1 (Up to 3.2 Years)|Death|1
1076032|NCT02082977|2132876|FG001|Part 1 (Up to 3.2 Years)|Death|0
1076033|NCT02082977|2132877|FG002|Part 1 (Up to 3.2 Years)|Death|0
1076034|NCT02082977|2132878|FG003|Part 1 (Up to 3.2 Years)|Death|0
1076035|NCT02082977|2132879|FG004|Part 1 (Up to 3.2 Years)|Death|0
1076036|NCT02082977|2132880|FG005|Part 1 (Up to 3.2 Years)|Death|1
1076037|NCT02082977|2132881|FG006|Part 1 (Up to 3.2 Years)|Death|2
1076038|NCT02082977|2132882|FG007|Part 1 (Up to 3.2 Years)|Death|0
1076039|NCT02082977|2132883|FG008|Part 1 (Up to 3.2 Years)|Death|1
1076040|NCT02082977|2132884|FG009|Part 1 (Up to 3.2 Years)|Death|0
1076041|NCT02082977|2132875|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1076042|NCT02082977|2132876|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1076043|NCT02082977|2132877|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1076044|NCT02082977|2132878|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1076045|NCT02082977|2132879|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1076046|NCT02082977|2132880|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1076047|NCT02082977|2132881|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1076048|NCT02082977|2132882|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
1076049|NCT02082977|2132883|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1076050|NCT02082977|2132884|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1076051|NCT02082977|2132875|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1076052|NCT02082977|2132876|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1076053|NCT02082977|2132877|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1076054|NCT02082977|2132878|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1076055|NCT02082977|2132879|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1076056|NCT02082977|2132880|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
1076057|NCT02082977|2132881|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1076058|NCT02082977|2132882|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1076059|NCT02082977|2132883|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1076060|NCT02082977|2132884|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1076061|NCT02082977|2132875|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0
1076062|NCT02082977|2132876|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0
1076063|NCT02082977|2132877|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0
1076064|NCT02082977|2132878|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0
1076065|NCT02082977|2132879|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1
1076066|NCT02082977|2132880|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1
1076067|NCT02082977|2132881|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4
1076068|NCT02082977|2132882|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1
1076069|NCT02082977|2132883|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2
1076070|NCT02082977|2132884|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0
1076071|NCT02082977|2132875|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1076072|NCT02082977|2132876|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1076073|NCT02082977|2132877|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1076074|NCT02082977|2132878|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1076075|NCT02082977|2132879|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1076076|NCT02082977|2132880|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1076077|NCT02082977|2132881|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1076078|NCT02082977|2132882|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
1076079|NCT02082977|2132883|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1076080|NCT02082977|2132884|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1076081|NCT02083185|2132932|FG000|Overall Study|Lost to Follow-up|0
1076082|NCT02083185|2132933|FG001|Overall Study|Lost to Follow-up|3
1076083|NCT02083185|2132934|FG002|Overall Study|Lost to Follow-up|0
1076084|NCT02083185|2132932|FG000|Overall Study|Withdrawal by Subject|9
1076085|NCT02083185|2132933|FG001|Overall Study|Withdrawal by Subject|15
1076086|NCT02083185|2132934|FG002|Overall Study|Withdrawal by Subject|1
1076087|NCT02083185|2132932|FG000|Overall Study|Death|2
1076088|NCT02083185|2132933|FG001|Overall Study|Death|2
1076089|NCT02083185|2132934|FG002|Overall Study|Death|1
1076090|NCT02083185|2132932|FG000|Overall Study|Reason not Specified|9
1076091|NCT02083185|2132933|FG001|Overall Study|Reason not Specified|6
1076092|NCT02083185|2132934|FG002|Overall Study|Reason not Specified|5
1076093|NCT02083185|2132932|FG000|Overall Study|Study Terminated by Sponsor|0
1076094|NCT02083185|2132933|FG001|Overall Study|Study Terminated by Sponsor|1
1076095|NCT02083185|2132934|FG002|Overall Study|Study Terminated by Sponsor|0
1076096|NCT02083185|2132932|FG000|Overall Study|Did not Receive Study Drug|0
1076097|NCT02083185|2132933|FG001|Overall Study|Did not Receive Study Drug|2
1076098|NCT02083185|2132934|FG002|Overall Study|Did not Receive Study Drug|0
1076103|NCT02083380|2132958|FG000|Overall Study|Lack of Efficacy|68
1076104|NCT02083380|2132959|FG001|Overall Study|Lack of Efficacy|79
1076105|NCT02083380|2132960|FG002|Overall Study|Lack of Efficacy|64
1076106|NCT02083380|2132958|FG000|Overall Study|Withdrawal by Subject|9
1076107|NCT02083380|2132959|FG001|Overall Study|Withdrawal by Subject|3
1076108|NCT02083380|2132960|FG002|Overall Study|Withdrawal by Subject|7
1076109|NCT02083380|2132958|FG000|Overall Study|Physician Decision|1
1076110|NCT02083380|2132959|FG001|Overall Study|Physician Decision|6
1076111|NCT02083380|2132960|FG002|Overall Study|Physician Decision|3
1076112|NCT02083380|2132958|FG000|Overall Study|Adverse Event|0
1076113|NCT02083380|2132959|FG001|Overall Study|Adverse Event|0
1076114|NCT02083380|2132960|FG002|Overall Study|Adverse Event|1
1076115|NCT02083380|2132958|FG000|Overall Study|Lost to Follow-up|5
1076116|NCT02083380|2132959|FG001|Overall Study|Lost to Follow-up|3
1076117|NCT02083380|2132960|FG002|Overall Study|Lost to Follow-up|3
1076118|NCT02083380|2132958|FG000|Overall Study|Other|8
1076119|NCT02083380|2132959|FG001|Overall Study|Other|4
1076120|NCT02083380|2132960|FG002|Overall Study|Other|6
1076121|NCT02083653|2132989|FG000|Overall Study|Randomized but not Treated|0
1076122|NCT02083653|2132990|FG001|Overall Study|Randomized but not Treated|2
1076123|NCT02083653|2132991|FG002|Overall Study|Randomized but not Treated|7
1076124|NCT02083653|2132989|FG000|Overall Study|Adverse Event|12
1076125|NCT02083653|2132990|FG001|Overall Study|Adverse Event|5
1076126|NCT02083653|2132991|FG002|Overall Study|Adverse Event|4
1076127|NCT02083653|2132989|FG000|Overall Study|Lost to Follow-up|1
1076128|NCT02083653|2132990|FG001|Overall Study|Lost to Follow-up|0
1076129|NCT02083653|2132991|FG002|Overall Study|Lost to Follow-up|0
1076130|NCT02083653|2132989|FG000|Overall Study|Death|2
1076131|NCT02083653|2132990|FG001|Overall Study|Death|2
1076132|NCT02083653|2132991|FG002|Overall Study|Death|2
1076133|NCT02083653|2132989|FG000|Overall Study|Progressive Disease|65
1076134|NCT02083653|2132990|FG001|Overall Study|Progressive Disease|73
1076135|NCT02083653|2132991|FG002|Overall Study|Progressive Disease|63
1076136|NCT02083653|2132989|FG000|Overall Study|Withdrawal by Subject|2
1076137|NCT02083653|2132990|FG001|Overall Study|Withdrawal by Subject|1
1076138|NCT02083653|2132991|FG002|Overall Study|Withdrawal by Subject|2
1076139|NCT02083653|2132989|FG000|Overall Study|Other Events|0
1076140|NCT02083653|2132990|FG001|Overall Study|Other Events|2
1076141|NCT02083653|2132991|FG002|Overall Study|Other Events|2
1076142|NCT02083653|2132989|FG000|Overall Study|Reason Missing|0
1076143|NCT02083653|2132990|FG001|Overall Study|Reason Missing|0
1076144|NCT02083653|2132991|FG002|Overall Study|Reason Missing|4
1076145|NCT02083783|2133018|FG000|Overall Study|Withdrawal by Subject|1
1076146|NCT02083783|2133019|FG001|Overall Study|Withdrawal by Subject|0
1076147|NCT02083926|2133049|FG000|Overall Study|Withdrawal by Subject|1
1076148|NCT02083926|2133050|FG001|Overall Study|Withdrawal by Subject|0
1076149|NCT02083965|2133059|FG000|Treatment Period|Other|1
1076150|NCT02083965|2133060|FG001|Treatment Period|Other|0
1076151|NCT02084056|2133070|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1076152|NCT02084056|2133071|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1076153|NCT02084056|2133072|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1076154|NCT02084056|2133073|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1076155|NCT02084056|2133070|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1
1076156|NCT02084056|2133071|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1076157|NCT02084056|2133072|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1076158|NCT02084056|2133073|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1076159|NCT02084082|2133094|FG000|Washout Period 1 (35 Days)|Adverse Event|0
1076160|NCT02084082|2133095|FG001|Washout Period 1 (35 Days)|Adverse Event|0
1076161|NCT02084082|2133096|FG002|Washout Period 1 (35 Days)|Adverse Event|1
1076162|NCT02084082|2133097|FG003|Washout Period 1 (35 Days)|Adverse Event|1
1076163|NCT02084082|2133094|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1076164|NCT02084082|2133095|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1076165|NCT02084082|2133096|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1076166|NCT02084082|2133097|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1
1076167|NCT02084134|2133109|FG000|Overall Study|Protocol Violation|4
1076168|NCT02084134|2133110|FG001|Overall Study|Protocol Violation|2
1076169|NCT02084134|2133109|FG000|Overall Study|Death|0
1076170|NCT02084134|2133110|FG001|Overall Study|Death|1
1076171|NCT02084238|2133120|FG000|Overall Study|Lost to Follow-up|2
1076172|NCT02085135|2133176|FG000|Overall Study|Adverse Event|4
1076173|NCT02085135|2133177|FG001|Overall Study|Adverse Event|7
1076174|NCT02085135|2133176|FG000|Overall Study|Lost to Follow-up|2
1076175|NCT02085135|2133177|FG001|Overall Study|Lost to Follow-up|2
1076176|NCT02085135|2133176|FG000|Overall Study|Withdrawal by Subject|3
1076177|NCT02085135|2133177|FG001|Overall Study|Withdrawal by Subject|0
1076178|NCT02085135|2133176|FG000|Overall Study|Lack of Efficacy|2
1076179|NCT02085135|2133177|FG001|Overall Study|Lack of Efficacy|0
1076180|NCT02085161|2133187|FG000|Overall Study|Not Treated|1
1076181|NCT02085161|2133188|FG001|Overall Study|Not Treated|0
1076182|NCT02085161|2133189|FG002|Overall Study|Not Treated|0
1076183|NCT02085161|2133190|FG003|Overall Study|Not Treated|0
1076184|NCT02085161|2133187|FG000|Overall Study|Adverse Event|8
1076185|NCT02085161|2133188|FG001|Overall Study|Adverse Event|5
1076186|NCT02085161|2133189|FG002|Overall Study|Adverse Event|4
1076187|NCT02085161|2133190|FG003|Overall Study|Adverse Event|5
1076188|NCT02085161|2133187|FG000|Overall Study|Protocol Violation|0
1076189|NCT02085161|2133188|FG001|Overall Study|Protocol Violation|1
1076190|NCT02085161|2133189|FG002|Overall Study|Protocol Violation|0
1076191|NCT02085161|2133190|FG003|Overall Study|Protocol Violation|1
1076192|NCT02085161|2133187|FG000|Overall Study|Withdrawal by Subject|2
1076193|NCT02085161|2133188|FG001|Overall Study|Withdrawal by Subject|4
1076194|NCT02085161|2133189|FG002|Overall Study|Withdrawal by Subject|0
1076195|NCT02085161|2133190|FG003|Overall Study|Withdrawal by Subject|3
1076196|NCT02085161|2133187|FG000|Overall Study|Other Reason|1
1076197|NCT02085161|2133188|FG001|Overall Study|Other Reason|0
1076198|NCT02085161|2133189|FG002|Overall Study|Other Reason|1
1076199|NCT02085161|2133190|FG003|Overall Study|Other Reason|1
1076200|NCT02085252|2133203|FG000|Overall Study|Withdrawal of Consent|1
1076201|NCT02085252|2133204|FG001|Overall Study|Withdrawal of Consent|0
1076202|NCT02085252|2133203|FG000|Overall Study|Adverse Event|0
1076203|NCT02085252|2133204|FG001|Overall Study|Adverse Event|1
1076204|NCT02085252|2133203|FG000|Overall Study|Discontinuation Due to Patient Decision|0
1076205|NCT02085252|2133204|FG001|Overall Study|Discontinuation Due to Patient Decision|1
1076206|NCT02085252|2133203|FG000|Overall Study|Reason Not Specified|0
1076207|NCT02085252|2133204|FG001|Overall Study|Reason Not Specified|1
1076208|NCT02085252|2133203|FG000|Overall Study|Reason Unknown|0
1076209|NCT02085252|2133204|FG001|Overall Study|Reason Unknown|1
1076210|NCT02085460|2133235|FG000|Overall Study|Adverse Event|2
1076211|NCT02085460|2133236|FG001|Overall Study|Adverse Event|2
1076212|NCT02085460|2133237|FG002|Overall Study|Adverse Event|1
1076213|NCT02085460|2133235|FG000|Overall Study|Physician Decision|1
1076214|NCT02085460|2133236|FG001|Overall Study|Physician Decision|1
1076215|NCT02085460|2133237|FG002|Overall Study|Physician Decision|2
1076216|NCT02085460|2133235|FG000|Overall Study|Withdrawal by Subject|11
1076217|NCT02085460|2133236|FG001|Overall Study|Withdrawal by Subject|5
1076218|NCT02085460|2133237|FG002|Overall Study|Withdrawal by Subject|7
1076219|NCT02085785|2133276|FG000|Overall Study|Withdrawal by Subject|2
1076220|NCT02085785|2133277|FG001|Overall Study|Withdrawal by Subject|1
1076221|NCT02085785|2133276|FG000|Overall Study|Lost to Follow-up|0
1076222|NCT02085785|2133277|FG001|Overall Study|Lost to Follow-up|1
1076223|NCT02086110|2133291|FG000|Overall Study|Withdrawal by Subject|1
1076224|NCT02086110|2133292|FG001|Overall Study|Withdrawal by Subject|1
1076225|NCT02086162|2133301|FG000|Overall Study|Withdrawal by Subject|4
1076226|NCT02086162|2133302|FG001|Overall Study|Withdrawal by Subject|4
1076227|NCT02086162|2133301|FG000|Overall Study|moved|1
1076228|NCT02086162|2133302|FG001|Overall Study|moved|1
1076229|NCT02086162|2133301|FG000|Overall Study|Lost to Follow-up|4
1076230|NCT02086162|2133302|FG001|Overall Study|Lost to Follow-up|2
1076231|NCT02086162|2133301|FG000|Overall Study|Death|1
1076232|NCT02086162|2133302|FG001|Overall Study|Death|0
1076234|NCT02086565|2133344|FG000|Overall Study|Lost to Follow-up|9
1076235|NCT02086565|2133345|FG001|Overall Study|Lost to Follow-up|7
1076236|NCT02086565|2133344|FG000|Overall Study|Withdrawal by Subject|2
1076237|NCT02086565|2133345|FG001|Overall Study|Withdrawal by Subject|1
1076238|NCT02086565|2133344|FG000|Overall Study|Death|3
1076239|NCT02086565|2133345|FG001|Overall Study|Death|2
1076240|NCT02086565|2133344|FG000|Overall Study|withdrawn by research team|2
1076241|NCT02086565|2133345|FG001|Overall Study|withdrawn by research team|2
1076242|NCT02086591|2133351|FG000|Overall Study|Adverse Event|1
1076243|NCT02086591|2133351|FG000|Overall Study|Withdrawal by Subject|1
1076244|NCT02086591|2133351|FG000|Overall Study|protocol terminated|3
1076245|NCT02086968|2133389|FG000|Overall Study|Adverse Event|1
1076246|NCT02086968|2133390|FG001|Overall Study|Adverse Event|5
1076247|NCT02086968|2133389|FG000|Overall Study|Lost to Follow-up|2
1076248|NCT02086968|2133390|FG001|Overall Study|Lost to Follow-up|3
1076249|NCT02086968|2133389|FG000|Overall Study|Study drug received outside protocol|0
1076250|NCT02086968|2133390|FG001|Overall Study|Study drug received outside protocol|1
1076251|NCT02086968|2133389|FG000|Overall Study|Physician Decision|4
1076252|NCT02086968|2133390|FG001|Overall Study|Physician Decision|0
1076253|NCT02086968|2133389|FG000|Overall Study|Withdrawal by Subject|1
1076254|NCT02086968|2133390|FG001|Overall Study|Withdrawal by Subject|4
1076255|NCT02087046|2133396|FG000|Overall Study|Adverse Event|4
1076256|NCT02087046|2133396|FG000|Overall Study|Death|1
1076257|NCT02087046|2133396|FG000|Overall Study|Lost to Follow-up|3
1076258|NCT02087046|2133396|FG000|Overall Study|Withdrawal by Subject|2
1076259|NCT02087046|2133396|FG000|Overall Study|Physician Decision|1
1076260|NCT02087059|2133401|FG000|Overall Study|Disease Progression|1
1076261|NCT02087059|2133401|FG000|Overall Study|Adverse Event|5
1076262|NCT02087059|2133401|FG000|Overall Study|Lost to Follow-up|1
1076263|NCT02087085|2133407|FG000|Overall Study|Adverse Event|10
1076264|NCT02087085|2133408|FG001|Overall Study|Adverse Event|14
1076265|NCT02087085|2133407|FG000|Overall Study|Lack of Efficacy|4
1076266|NCT02087085|2133408|FG001|Overall Study|Lack of Efficacy|3
1076267|NCT02087085|2133407|FG000|Overall Study|Lost to Follow-up|6
1076268|NCT02087085|2133408|FG001|Overall Study|Lost to Follow-up|4
1076269|NCT02087085|2133407|FG000|Overall Study|Withdrawal by Subject|9
1076270|NCT02087085|2133408|FG001|Overall Study|Withdrawal by Subject|11
1076271|NCT02087085|2133407|FG000|Overall Study|Protocol Violation|1
1076272|NCT02087085|2133408|FG001|Overall Study|Protocol Violation|0
1076273|NCT02087085|2133407|FG000|Overall Study|Study Terminated by Sponsor|87
1076274|NCT02087085|2133408|FG001|Overall Study|Study Terminated by Sponsor|80
1076275|NCT02087085|2133407|FG000|Overall Study|Other Miscellaneous Reasons|3
1076276|NCT02087085|2133408|FG001|Overall Study|Other Miscellaneous Reasons|4
1076277|NCT02087150|2133417|FG000|Overall Study|Death|0
1076278|NCT02087150|2133418|FG001|Overall Study|Death|1
1076279|NCT02087150|2133419|FG002|Overall Study|Death|0
1076280|NCT02087150|2133417|FG000|Overall Study|Lost to Follow-up|6
1076281|NCT02087150|2133418|FG001|Overall Study|Lost to Follow-up|13
1076282|NCT02087150|2133419|FG002|Overall Study|Lost to Follow-up|7
1076283|NCT02087150|2133417|FG000|Overall Study|Withdrawal by Subject|2
1076284|NCT02087150|2133418|FG001|Overall Study|Withdrawal by Subject|5
1076285|NCT02087150|2133419|FG002|Overall Study|Withdrawal by Subject|3
1076286|NCT02087150|2133417|FG000|Overall Study|Physician Decision|0
1076287|NCT02087150|2133418|FG001|Overall Study|Physician Decision|1
1076288|NCT02087150|2133419|FG002|Overall Study|Physician Decision|0
1076289|NCT02087150|2133417|FG000|Overall Study|Procedure not done|1
1076290|NCT02087150|2133418|FG001|Overall Study|Procedure not done|13
1076291|NCT02087150|2133419|FG002|Overall Study|Procedure not done|0
1076292|NCT02087150|2133417|FG000|Overall Study|F/U not completed w/in study window|0
1076293|NCT02087150|2133418|FG001|Overall Study|F/U not completed w/in study window|0
1076294|NCT02087150|2133419|FG002|Overall Study|F/U not completed w/in study window|1
1076295|NCT02087150|2133417|FG000|Overall Study|Other|1
1076296|NCT02087150|2133418|FG001|Overall Study|Other|0
1076297|NCT02087150|2133419|FG002|Overall Study|Other|0
1076298|NCT02087150|2133417|FG000|Overall Study|Pt moved out of town|0
1076299|NCT02087150|2133418|FG001|Overall Study|Pt moved out of town|1
1076300|NCT02087150|2133419|FG002|Overall Study|Pt moved out of town|0
1076301|NCT02087176|2133432|FG000|Overall Study|Withdrawal by Subject|1
1076302|NCT02087176|2133432|FG000|Overall Study|Death|10
1076303|NCT02087176|2133432|FG000|Overall Study|Censored|19
1076304|NCT02087176|2133432|FG000|Overall Study|Study Terminated by Sponsor|2
1076305|NCT02087241|2133440|FG000|Overall Study|Death|2
1076306|NCT02087241|2133441|FG001|Overall Study|Death|1
1076307|NCT02087241|2133442|FG002|Overall Study|Death|1
1076308|NCT02087241|2133443|FG003|Overall Study|Death|1
1076309|NCT02087241|2133440|FG000|Overall Study|Withdrawal by Subject|1
1076310|NCT02087241|2133441|FG001|Overall Study|Withdrawal by Subject|0
1076311|NCT02087241|2133442|FG002|Overall Study|Withdrawal by Subject|0
1076312|NCT02087241|2133443|FG003|Overall Study|Withdrawal by Subject|1
1076313|NCT02087241|2133440|FG000|Overall Study|Progressive Disease|0
1076314|NCT02087241|2133441|FG001|Overall Study|Progressive Disease|0
1076315|NCT02087241|2133442|FG002|Overall Study|Progressive Disease|0
1076316|NCT02087241|2133443|FG003|Overall Study|Progressive Disease|1
1076317|NCT02087241|2133440|FG000|Overall Study|Study Terminated by Sponsor|0
1076318|NCT02087241|2133441|FG001|Overall Study|Study Terminated by Sponsor|2
1076319|NCT02087241|2133442|FG002|Overall Study|Study Terminated by Sponsor|0
1076320|NCT02087241|2133443|FG003|Overall Study|Study Terminated by Sponsor|4
1076321|NCT02087423|2133472|FG000|Overall Study|Withdrawal by Subject|20
1076322|NCT02087423|2133473|FG001|Overall Study|Withdrawal by Subject|20
1076323|NCT02087423|2133474|FG002|Overall Study|Withdrawal by Subject|3
1076324|NCT02087423|2133472|FG000|Overall Study|Death|68
1076325|NCT02087423|2133473|FG001|Overall Study|Death|207
1076326|NCT02087423|2133474|FG002|Overall Study|Death|40
1076327|NCT02087423|2133472|FG000|Overall Study|Lost to Follow-up|0
1076328|NCT02087423|2133473|FG001|Overall Study|Lost to Follow-up|2
1076329|NCT02087423|2133474|FG002|Overall Study|Lost to Follow-up|0
1076330|NCT02087423|2133472|FG000|Overall Study|Terminated from study at final DCO|23
1076331|NCT02087423|2133473|FG001|Overall Study|Terminated from study at final DCO|36
1076332|NCT02087423|2133474|FG002|Overall Study|Terminated from study at final DCO|25
1076333|NCT02087670|2133511|FG000|Overall Study|Withdrawal by Subject|3
1076334|NCT02087670|2133512|FG001|Overall Study|Withdrawal by Subject|2
1076335|NCT02087774|2133528|FG000|Overall Study|Were absent day of data collection|8
1076336|NCT02087774|2133529|FG001|Overall Study|Were absent day of data collection|20
1076337|NCT02087904|2133539|FG000|Overall Study|Did Not Receive Study Drug|0
1076338|NCT02087904|2133540|FG001|Overall Study|Did Not Receive Study Drug|0
1076339|NCT02087904|2133541|FG002|Overall Study|Did Not Receive Study Drug|2
1076340|NCT02087904|2133542|FG003|Overall Study|Did Not Receive Study Drug|1
1076341|NCT02087904|2133539|FG000|Overall Study|Adverse Event|8
1076342|NCT02087904|2133540|FG001|Overall Study|Adverse Event|4
1076343|NCT02087904|2133541|FG002|Overall Study|Adverse Event|4
1076344|NCT02087904|2133542|FG003|Overall Study|Adverse Event|12
1076345|NCT02087904|2133539|FG000|Overall Study|Lack of Efficacy|3
1076346|NCT02087904|2133540|FG001|Overall Study|Lack of Efficacy|6
1076347|NCT02087904|2133541|FG002|Overall Study|Lack of Efficacy|3
1076348|NCT02087904|2133542|FG003|Overall Study|Lack of Efficacy|2
1076349|NCT02087904|2133539|FG000|Overall Study|Other|6
1076350|NCT02087904|2133540|FG001|Overall Study|Other|2
1076351|NCT02087904|2133541|FG002|Overall Study|Other|4
1076352|NCT02087904|2133542|FG003|Overall Study|Other|4
1076353|NCT02087904|2133539|FG000|Overall Study|Withdrawal by Subject|8
1076354|NCT02087904|2133540|FG001|Overall Study|Withdrawal by Subject|3
1076355|NCT02087904|2133541|FG002|Overall Study|Withdrawal by Subject|7
1076356|NCT02087904|2133542|FG003|Overall Study|Withdrawal by Subject|4
1076357|NCT02087904|2133539|FG000|Overall Study|Lost to Follow-up|0
1076358|NCT02087904|2133540|FG001|Overall Study|Lost to Follow-up|4
1076359|NCT02087904|2133541|FG002|Overall Study|Lost to Follow-up|2
1076360|NCT02087904|2133542|FG003|Overall Study|Lost to Follow-up|2
1076361|NCT02087943|2133555|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1
1076362|NCT02087943|2133556|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2
1076363|NCT02087943|2133557|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6
1076364|NCT02087943|2133558|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0
1076365|NCT02087943|2133559|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0
1076366|NCT02087943|2133555|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
1076367|NCT02087943|2133556|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
1076368|NCT02087943|2133557|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
1076369|NCT02087943|2133558|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
1076370|NCT02087943|2133559|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
1076371|NCT02087943|2133555|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
1076372|NCT02087943|2133556|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
1076373|NCT02087943|2133557|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
1076374|NCT02087943|2133558|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
1076375|NCT02087943|2133559|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
1076376|NCT02087943|2133555|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
1076377|NCT02087943|2133556|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1076378|NCT02087943|2133557|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
1076379|NCT02087943|2133558|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1076380|NCT02087943|2133559|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1076381|NCT02087943|2133555|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1076382|NCT02087943|2133556|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
1076383|NCT02087943|2133557|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1076384|NCT02087943|2133558|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1076385|NCT02087943|2133559|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1076386|NCT02087943|2133555|FG000|Active Treatment Phase Week 12-24|Adverse Event|0
1076387|NCT02087943|2133556|FG001|Active Treatment Phase Week 12-24|Adverse Event|1
1076388|NCT02087943|2133557|FG002|Active Treatment Phase Week 12-24|Adverse Event|2
1076389|NCT02087943|2133558|FG003|Active Treatment Phase Week 12-24|Adverse Event|0
1076390|NCT02087943|2133559|FG004|Active Treatment Phase Week 12-24|Adverse Event|1
1076391|NCT02087943|2133555|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0
909473|NCT00788710|1886247|FG001|Overall Study|Lack of Efficacy|0
909474|NCT00788710|1886248|FG002|Overall Study|Lack of Efficacy|1
909475|NCT00788710|1886246|FG000|Overall Study|Lost to Follow-up|0
1076392|NCT02087943|2133556|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3
1076393|NCT02087943|2133557|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1
1076394|NCT02087943|2133558|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1
1076395|NCT02087943|2133559|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0
1076396|NCT02087943|2133555|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1076397|NCT02087943|2133556|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1076398|NCT02087943|2133557|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
1076399|NCT02087943|2133558|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1076400|NCT02087943|2133559|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1076401|NCT02087943|2133555|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1076402|NCT02087943|2133556|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1076403|NCT02087943|2133557|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1076404|NCT02087943|2133558|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1076405|NCT02087943|2133559|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1
1076406|NCT02087943|2133555|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0
1076407|NCT02087943|2133556|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0
1076408|NCT02087943|2133557|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1
1076409|NCT02087943|2133558|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1
1076410|NCT02087943|2133559|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0
1076411|NCT02088034|2133589|FG000|Overall Study|Lost to Follow-up|1
1076412|NCT02088034|2133590|FG001|Overall Study|Lost to Follow-up|1
1076413|NCT02088034|2133591|FG002|Overall Study|Lost to Follow-up|0
1076414|NCT02088034|2133589|FG000|Overall Study|Pregnancy|2
1076415|NCT02088034|2133590|FG001|Overall Study|Pregnancy|1
1076416|NCT02088034|2133591|FG002|Overall Study|Pregnancy|2
1076417|NCT02088047|2133601|FG000|Overall Study|Withdrawal by Subject|1
1076418|NCT02088047|2133602|FG001|Overall Study|Withdrawal by Subject|0
1076419|NCT02088073|2133613|FG000|Acute Phase|Withdrawal by Subject|5
1076420|NCT02088073|2133614|FG001|Acute Phase|Withdrawal by Subject|0
1076421|NCT02088073|2133615|FG002|Acute Phase|Withdrawal by Subject|0
1076422|NCT02088073|2133616|FG003|Acute Phase|Withdrawal by Subject|0
1076423|NCT02088073|2133617|FG004|Acute Phase|Withdrawal by Subject|0
1076424|NCT02088073|2133613|FG000|Acute Phase|Hyperkalemia|2
1076425|NCT02088073|2133614|FG001|Acute Phase|Hyperkalemia|0
1076426|NCT02088073|2133615|FG002|Acute Phase|Hyperkalemia|0
1076427|NCT02088073|2133616|FG003|Acute Phase|Hyperkalemia|0
1076428|NCT02088073|2133617|FG004|Acute Phase|Hyperkalemia|0
1076429|NCT02088073|2133613|FG000|Maintanance Phase|Withdrawal by Subject|0
1076430|NCT02088073|2133614|FG001|Maintanance Phase|Withdrawal by Subject|2
1076431|NCT02088073|2133615|FG002|Maintanance Phase|Withdrawal by Subject|0
1076432|NCT02088073|2133616|FG003|Maintanance Phase|Withdrawal by Subject|0
1076433|NCT02088073|2133617|FG004|Maintanance Phase|Withdrawal by Subject|0
1076434|NCT02088073|2133613|FG000|Maintanance Phase|Adverse Event|0
1076435|NCT02088073|2133614|FG001|Maintanance Phase|Adverse Event|0
1076436|NCT02088073|2133615|FG002|Maintanance Phase|Adverse Event|3
1076437|NCT02088073|2133616|FG003|Maintanance Phase|Adverse Event|0
1076438|NCT02088073|2133617|FG004|Maintanance Phase|Adverse Event|1
1076439|NCT02088073|2133613|FG000|Maintanance Phase|Physician Decision|0
1076440|NCT02088073|2133614|FG001|Maintanance Phase|Physician Decision|0
1076441|NCT02088073|2133615|FG002|Maintanance Phase|Physician Decision|0
1076442|NCT02088073|2133616|FG003|Maintanance Phase|Physician Decision|0
1076443|NCT02088073|2133617|FG004|Maintanance Phase|Physician Decision|1
1076444|NCT02088073|2133613|FG000|Maintanance Phase|Sponsor's decision|0
1076445|NCT02088073|2133614|FG001|Maintanance Phase|Sponsor's decision|2
1076446|NCT02088073|2133615|FG002|Maintanance Phase|Sponsor's decision|0
1076447|NCT02088073|2133616|FG003|Maintanance Phase|Sponsor's decision|2
1076448|NCT02088073|2133617|FG004|Maintanance Phase|Sponsor's decision|1
1076449|NCT02088073|2133613|FG000|Maintanance Phase|Hypo- or hyperkalemia|0
1076450|NCT02088073|2133614|FG001|Maintanance Phase|Hypo- or hyperkalemia|3
1076451|NCT02088073|2133615|FG002|Maintanance Phase|Hypo- or hyperkalemia|0
1076452|NCT02088073|2133616|FG003|Maintanance Phase|Hypo- or hyperkalemia|3
1076453|NCT02088073|2133617|FG004|Maintanance Phase|Hypo- or hyperkalemia|1
1076454|NCT02088073|2133613|FG000|Maintanance Phase|Miscellaneous|0
1076455|NCT02088073|2133614|FG001|Maintanance Phase|Miscellaneous|2
1076456|NCT02088073|2133615|FG002|Maintanance Phase|Miscellaneous|1
1076457|NCT02088073|2133616|FG003|Maintanance Phase|Miscellaneous|2
1076458|NCT02088073|2133617|FG004|Maintanance Phase|Miscellaneous|1
1076459|NCT02088073|2133613|FG000|Maintanance Phase|Met ECG withdrawal criteria|0
1076460|NCT02088073|2133614|FG001|Maintanance Phase|Met ECG withdrawal criteria|0
1076461|NCT02088073|2133615|FG002|Maintanance Phase|Met ECG withdrawal criteria|1
1076462|NCT02088073|2133616|FG003|Maintanance Phase|Met ECG withdrawal criteria|0
1076463|NCT02088073|2133617|FG004|Maintanance Phase|Met ECG withdrawal criteria|2
1076464|NCT02088073|2133613|FG000|Maintanance Phase|Subject compliance|0
1076465|NCT02088073|2133614|FG001|Maintanance Phase|Subject compliance|1
1076466|NCT02088073|2133615|FG002|Maintanance Phase|Subject compliance|0
1076467|NCT02088073|2133616|FG003|Maintanance Phase|Subject compliance|0
1076468|NCT02088073|2133617|FG004|Maintanance Phase|Subject compliance|0
1076469|NCT02088177|2133630|FG000|Overall Study|Lost to Follow-up|3
1076470|NCT02088541|2133657|FG000|Overall Study|Adverse Event|3
1076471|NCT02088541|2133658|FG001|Overall Study|Adverse Event|0
1076472|NCT02088541|2133659|FG002|Overall Study|Adverse Event|3
1076473|NCT02088541|2133660|FG003|Overall Study|Adverse Event|3
1076474|NCT02088541|2133661|FG004|Overall Study|Adverse Event|0
1076475|NCT02088541|2133657|FG000|Overall Study|Death|51
1076476|NCT02088541|2133658|FG001|Overall Study|Death|21
1076477|NCT02088541|2133659|FG002|Overall Study|Death|85
1076478|NCT02088541|2133660|FG003|Overall Study|Death|28
1076479|NCT02088541|2133661|FG004|Overall Study|Death|38
1076480|NCT02088541|2133657|FG000|Overall Study|Lost to Follow-up|2
1076481|NCT02088541|2133658|FG001|Overall Study|Lost to Follow-up|0
1076482|NCT02088541|2133659|FG002|Overall Study|Lost to Follow-up|1
1076483|NCT02088541|2133660|FG003|Overall Study|Lost to Follow-up|0
1076484|NCT02088541|2133661|FG004|Overall Study|Lost to Follow-up|0
1076485|NCT02088541|2133657|FG000|Overall Study|Physician Decision|2
1076486|NCT02088541|2133658|FG001|Overall Study|Physician Decision|1
1076487|NCT02088541|2133659|FG002|Overall Study|Physician Decision|2
1076488|NCT02088541|2133660|FG003|Overall Study|Physician Decision|0
1076489|NCT02088541|2133661|FG004|Overall Study|Physician Decision|2
1076490|NCT02088541|2133657|FG000|Overall Study|Disease progression|7
1076491|NCT02088541|2133658|FG001|Overall Study|Disease progression|1
1076492|NCT02088541|2133659|FG002|Overall Study|Disease progression|2
1076493|NCT02088541|2133660|FG003|Overall Study|Disease progression|3
1076494|NCT02088541|2133661|FG004|Overall Study|Disease progression|1
1076495|NCT02088541|2133657|FG000|Overall Study|Study terminated by sponsor|1
1076496|NCT02088541|2133658|FG001|Overall Study|Study terminated by sponsor|1
1076497|NCT02088541|2133659|FG002|Overall Study|Study terminated by sponsor|12
1076498|NCT02088541|2133660|FG003|Overall Study|Study terminated by sponsor|2
1076499|NCT02088541|2133661|FG004|Overall Study|Study terminated by sponsor|6
1076500|NCT02088541|2133657|FG000|Overall Study|Withdrawal by Subject|3
1076501|NCT02088541|2133658|FG001|Overall Study|Withdrawal by Subject|2
1076502|NCT02088541|2133659|FG002|Overall Study|Withdrawal by Subject|9
1076503|NCT02088541|2133660|FG003|Overall Study|Withdrawal by Subject|7
1076504|NCT02088541|2133661|FG004|Overall Study|Withdrawal by Subject|10
1076505|NCT02088541|2133657|FG000|Overall Study|Other|2
1076506|NCT02088541|2133658|FG001|Overall Study|Other|1
1076507|NCT02088541|2133659|FG002|Overall Study|Other|3
1076508|NCT02088541|2133660|FG003|Overall Study|Other|1
1076509|NCT02088541|2133661|FG004|Overall Study|Other|1
1076510|NCT02088697|2133673|FG000|Period I|Physician Decision|1
1076511|NCT02088697|2133674|FG001|Period I|Physician Decision|4
1076512|NCT02088697|2133673|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1
1076513|NCT02088697|2133674|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0
1076514|NCT02088905|2133691|FG000|Overall Study|Withdrawal by Subject|5
1076515|NCT02088905|2133692|FG001|Overall Study|Withdrawal by Subject|1
1076516|NCT02089230|2133717|FG000|Overall Study|Death|0
1076517|NCT02089230|2133718|FG001|Overall Study|Death|0
1076518|NCT02089230|2133719|FG002|Overall Study|Death|2
1076519|NCT02089230|2133717|FG000|Overall Study|Seeking Alternative Therapy|0
1076520|NCT02089230|2133718|FG001|Overall Study|Seeking Alternative Therapy|0
1076521|NCT02089230|2133719|FG002|Overall Study|Seeking Alternative Therapy|4
1076522|NCT02089334|2133731|FG000|Overall Study|Withdrawal by Subject|0
1076523|NCT02089334|2133732|FG001|Overall Study|Withdrawal by Subject|0
1076524|NCT02089334|2133733|FG002|Overall Study|Withdrawal by Subject|0
1076525|NCT02089334|2133734|FG003|Overall Study|Withdrawal by Subject|2
1076526|NCT02089334|2133731|FG000|Overall Study|Adverse Event|0
1076527|NCT02089334|2133732|FG001|Overall Study|Adverse Event|0
1076528|NCT02089334|2133733|FG002|Overall Study|Adverse Event|0
1076529|NCT02089334|2133734|FG003|Overall Study|Adverse Event|2
1076530|NCT02089334|2133731|FG000|Overall Study|Progressive disease|0
1076531|NCT02089334|2133732|FG001|Overall Study|Progressive disease|0
1076532|NCT02089334|2133733|FG002|Overall Study|Progressive disease|0
1076533|NCT02089334|2133734|FG003|Overall Study|Progressive disease|2
1076534|NCT02089334|2133731|FG000|Overall Study|Physician Decision|0
1076535|NCT02089334|2133732|FG001|Overall Study|Physician Decision|0
1076536|NCT02089334|2133733|FG002|Overall Study|Physician Decision|1
1076537|NCT02089334|2133734|FG003|Overall Study|Physician Decision|1
1076538|NCT02089347|2133749|FG000|Overall Study|Protocol Violation|1
1076539|NCT02089347|2133750|FG001|Overall Study|Protocol Violation|0
1076540|NCT02089737|2133775|FG000|Overall Study|Survey form not completed|5
1076541|NCT02089737|2133775|FG000|Overall Study|Not treated|1
1076542|NCT02089997|2133780|FG000|Overall Study|Case report forms uncollected|99
1076543|NCT02089997|2133780|FG000|Overall Study|Protocol Violation|147
1076544|NCT02090283|2133801|FG000|Overall Study|Withdrawal by Subject|6
1076545|NCT02090283|2133802|FG001|Overall Study|Withdrawal by Subject|6
1076546|NCT02090283|2133803|FG002|Overall Study|Withdrawal by Subject|6
1076547|NCT02090283|2133801|FG000|Overall Study|Sponsor Terminated Study|6
1076548|NCT02090283|2133802|FG001|Overall Study|Sponsor Terminated Study|6
1076549|NCT02090283|2133803|FG002|Overall Study|Sponsor Terminated Study|1
1076550|NCT02090283|2133801|FG000|Overall Study|Lost to Follow-up|2
1076551|NCT02090283|2133802|FG001|Overall Study|Lost to Follow-up|2
1076552|NCT02090283|2133803|FG002|Overall Study|Lost to Follow-up|3
1076553|NCT02090283|2133801|FG000|Overall Study|Adverse Event|1
1076554|NCT02090283|2133802|FG001|Overall Study|Adverse Event|1
1076555|NCT02090283|2133803|FG002|Overall Study|Adverse Event|0
1076556|NCT02090283|2133801|FG000|Overall Study|Protocol Violation|2
1076557|NCT02090283|2133802|FG001|Overall Study|Protocol Violation|0
1076558|NCT02090283|2133803|FG002|Overall Study|Protocol Violation|0
1076559|NCT02090413|2133847|FG000|Overall Study|Adverse Event|11
1076560|NCT02090413|2133848|FG001|Overall Study|Adverse Event|15
1076561|NCT02090413|2133849|FG002|Overall Study|Adverse Event|20
1076562|NCT02090413|2133847|FG000|Overall Study|Flushing event|2
1076563|NCT02090413|2133848|FG001|Overall Study|Flushing event|0
1076564|NCT02090413|2133849|FG002|Overall Study|Flushing event|1
1076565|NCT02090413|2133847|FG000|Overall Study|Withdrawal by Subject|2
1076566|NCT02090413|2133848|FG001|Overall Study|Withdrawal by Subject|2
1076567|NCT02090413|2133849|FG002|Overall Study|Withdrawal by Subject|2
1076568|NCT02090413|2133847|FG000|Overall Study|Investigator Decision|1
1076569|NCT02090413|2133848|FG001|Overall Study|Investigator Decision|1
1076570|NCT02090413|2133849|FG002|Overall Study|Investigator Decision|0
1076571|NCT02090413|2133847|FG000|Overall Study|Other|2
1076572|NCT02090413|2133848|FG001|Overall Study|Other|1
1076573|NCT02090413|2133849|FG002|Overall Study|Other|0
1076574|NCT02090413|2133847|FG000|Overall Study|Lost to Follow-up|1
1076575|NCT02090413|2133848|FG001|Overall Study|Lost to Follow-up|1
1076576|NCT02090413|2133849|FG002|Overall Study|Lost to Follow-up|0
1076577|NCT02090426|2133860|FG000|Overall Study|Lost to Follow-up|12
1076578|NCT02090426|2133861|FG001|Overall Study|Lost to Follow-up|6
1076579|NCT02090634|2133869|FG000|Overall Study|Lost to Follow-up|0
1076580|NCT02090634|2133870|FG001|Overall Study|Lost to Follow-up|1
1076581|NCT02090634|2133869|FG000|Overall Study|Death|0
1076582|NCT02090634|2133870|FG001|Overall Study|Death|1
1076583|NCT02090634|2133869|FG000|Overall Study|Protocol Violation|3
1076584|NCT02090634|2133870|FG001|Overall Study|Protocol Violation|1
1076585|NCT02090634|2133869|FG000|Overall Study|Adverse Event|2
1076586|NCT02090634|2133870|FG001|Overall Study|Adverse Event|0
1076587|NCT02090725|2133876|FG000|Overall Study|Withdrawal by Subject|1
1076588|NCT02090725|2133876|FG000|Overall Study|participants moved from area|3
1076589|NCT02090764|2133882|FG000|Overall Study|Adverse Event|1
1076590|NCT02090764|2133883|FG001|Overall Study|Adverse Event|3
1076591|NCT02090764|2133882|FG000|Overall Study|Lack of Efficacy|0
1076592|NCT02090764|2133883|FG001|Overall Study|Lack of Efficacy|13
1076593|NCT02090764|2133882|FG000|Overall Study|Withdrawal by Subject|2
1076594|NCT02090764|2133883|FG001|Overall Study|Withdrawal by Subject|1
1076595|NCT02090764|2133882|FG000|Overall Study|Intercurrent illness and other|1
1076596|NCT02090764|2133883|FG001|Overall Study|Intercurrent illness and other|1
1076597|NCT02090764|2133882|FG000|Overall Study|Lost to Follow-up|2
1076598|NCT02090764|2133883|FG001|Overall Study|Lost to Follow-up|2
1076599|NCT02090855|2133893|FG000|Overall Study|no evaluable Standard of Truth results|2
1076600|NCT02090959|2133904|FG000|Overall Study|Withdrawal by Subject|10
1076601|NCT02090959|2133904|FG000|Overall Study|Adverse Event|1
1076602|NCT02090959|2133904|FG000|Overall Study|Investigator decision|2
1076603|NCT02090959|2133904|FG000|Overall Study|Study termination|6
1076604|NCT02090959|2133904|FG000|Overall Study|Enrolled but not treated|1
1076605|NCT02090959|2133904|FG000|Overall Study|Transfer for compassionate use medicine|4
1076606|NCT02090959|2133904|FG000|Overall Study|Move to medical need program|3
1076607|NCT02090959|2133904|FG000|Overall Study|Entered in to other study|34
1076608|NCT02090959|2133904|FG000|Overall Study|Switched to commercial supply|88
1076609|NCT02090959|2133904|FG000|Overall Study|Other than specified|2
1076610|NCT02091089|2133908|FG000|Overall Study|Lost to Follow-up|2
1076611|NCT02091167|2133918|FG000|Overall Study|Lost to Follow-up|0
1076612|NCT02091167|2133919|FG001|Overall Study|Lost to Follow-up|2
1076613|NCT02091206|2133929|FG000|Treatment Period|Adverse Event|0
1076614|NCT02091206|2133930|FG001|Treatment Period|Adverse Event|1
1076615|NCT02091206|2133931|FG002|Treatment Period|Adverse Event|0
1076616|NCT02091206|2133932|FG003|Treatment Period|Adverse Event|0
1076617|NCT02091206|2133929|FG000|Treatment Period|Met withdrawal criteria|0
1076618|NCT02091206|2133930|FG001|Treatment Period|Met withdrawal criteria|0
1076619|NCT02091206|2133931|FG002|Treatment Period|Met withdrawal criteria|1
1076620|NCT02091206|2133932|FG003|Treatment Period|Met withdrawal criteria|0
1076621|NCT02091206|2133929|FG000|Taper Period|Participant refused study drug|1
1076622|NCT02091206|2133930|FG001|Taper Period|Participant refused study drug|0
1076623|NCT02091206|2133931|FG002|Taper Period|Participant refused study drug|0
1076624|NCT02091206|2133932|FG003|Taper Period|Participant refused study drug|1
1076625|NCT02091206|2133929|FG000|Taper Period|Lost to Follow-up|0
1076626|NCT02091206|2133930|FG001|Taper Period|Lost to Follow-up|0
1076627|NCT02091206|2133931|FG002|Taper Period|Lost to Follow-up|0
1076628|NCT02091206|2133932|FG003|Taper Period|Lost to Follow-up|1
1076629|NCT02091284|2133944|FG000|Overall Study|Withdrawal by Subject|2
1076630|NCT02091284|2133945|FG001|Overall Study|Withdrawal by Subject|1
1076631|NCT02091284|2133944|FG000|Overall Study|unreliable data|1
1076632|NCT02091284|2133945|FG001|Overall Study|unreliable data|0
1076633|NCT02091362|2133955|FG000|Period 1|Protocol Violation|1
1076634|NCT02091362|2133956|FG001|Period 1|Protocol Violation|0
1076635|NCT02091362|2133955|FG000|Period 1|Withdrawal by Subject|2
1076636|NCT02091362|2133956|FG001|Period 1|Withdrawal by Subject|3
1076637|NCT02091362|2133955|FG000|Period 1|Lost to Follow-up|0
1076638|NCT02091362|2133956|FG001|Period 1|Lost to Follow-up|1
1076639|NCT02091362|2133955|FG000|Period 1|Adverse Event|2
1076640|NCT02091362|2133956|FG001|Period 1|Adverse Event|0
1076641|NCT02091362|2133955|FG000|Wash-out|Lost to Follow-up|1
1076642|NCT02091362|2133956|FG001|Wash-out|Lost to Follow-up|1
1076643|NCT02091362|2133955|FG000|Wash-out|Withdrawal by Subject|0
1076644|NCT02091362|2133956|FG001|Wash-out|Withdrawal by Subject|2
1076645|NCT02091362|2133955|FG000|Period 2|Adverse Event|1
1076646|NCT02091362|2133956|FG001|Period 2|Adverse Event|0
1076647|NCT02091362|2133955|FG000|Period 2|Lost to Follow-up|0
1076648|NCT02091362|2133956|FG001|Period 2|Lost to Follow-up|1
1076649|NCT02091362|2133955|FG000|Period 2|Withdrawal by Subject|1
1076650|NCT02091362|2133956|FG001|Period 2|Withdrawal by Subject|1
1076651|NCT02091375|2133968|FG000|Overall Study|Adverse Event|8
1076652|NCT02091375|2133969|FG001|Overall Study|Adverse Event|1
1076653|NCT02091375|2133968|FG000|Overall Study|Lost to Follow-up|0
1076654|NCT02091375|2133969|FG001|Overall Study|Lost to Follow-up|1
1076655|NCT02091375|2133968|FG000|Overall Study|Withdrawal by Subject|0
1076656|NCT02091375|2133969|FG001|Overall Study|Withdrawal by Subject|1
1076657|NCT02091375|2133968|FG000|Overall Study|Withdrawn by the investigator|1
1076658|NCT02091375|2133969|FG001|Overall Study|Withdrawn by the investigator|0
1076659|NCT02091414|2133975|FG000|Overall Study|Withdrawal by Subject|2
1076660|NCT02091414|2133975|FG000|Overall Study|Death|2
1076661|NCT02091440|2133979|FG000|Overall Study|Death|2
1076662|NCT02091726|2133996|FG000|Overall Study|Lost to Follow-up|6
1076663|NCT02091739|2134003|FG000|MP: 16 Weeks|Adverse Event|1
1076664|NCT02091739|2134004|FG001|MP: 16 Weeks|Adverse Event|1
1076665|NCT02091739|2134005|FG002|MP: 16 Weeks|Adverse Event|1
1076666|NCT02091739|2134006|FG003|MP: 16 Weeks|Adverse Event|0
1076667|NCT02091739|2134007|FG004|MP: 16 Weeks|Adverse Event|0
1076668|NCT02091739|2134003|FG000|MP: 16 Weeks|Withdrawal by Subject|3
1076669|NCT02091739|2134004|FG001|MP: 16 Weeks|Withdrawal by Subject|4
1076670|NCT02091739|2134005|FG002|MP: 16 Weeks|Withdrawal by Subject|0
1076671|NCT02091739|2134006|FG003|MP: 16 Weeks|Withdrawal by Subject|0
1076672|NCT02091739|2134007|FG004|MP: 16 Weeks|Withdrawal by Subject|0
1076673|NCT02091739|2134003|FG000|MP: 16 Weeks|Lost to Follow-up|0
1076674|NCT02091739|2134004|FG001|MP: 16 Weeks|Lost to Follow-up|0
1076675|NCT02091739|2134005|FG002|MP: 16 Weeks|Lost to Follow-up|1
1076676|NCT02091739|2134006|FG003|MP: 16 Weeks|Lost to Follow-up|0
1076677|NCT02091739|2134007|FG004|MP: 16 Weeks|Lost to Follow-up|0
1076678|NCT02091739|2134003|FG000|EP: 48 Weeks|Other|0
1076679|NCT02091739|2134004|FG001|EP: 48 Weeks|Other|0
1076680|NCT02091739|2134005|FG002|EP: 48 Weeks|Other|0
1076681|NCT02091739|2134006|FG003|EP: 48 Weeks|Other|1
1076682|NCT02091739|2134007|FG004|EP: 48 Weeks|Other|0
1076683|NCT02091739|2134003|FG000|EP: 48 Weeks|Death|0
1076684|NCT02091739|2134004|FG001|EP: 48 Weeks|Death|0
1076685|NCT02091739|2134005|FG002|EP: 48 Weeks|Death|0
1076686|NCT02091739|2134006|FG003|EP: 48 Weeks|Death|3
1076687|NCT02091739|2134007|FG004|EP: 48 Weeks|Death|2
1076688|NCT02091739|2134003|FG000|EP: 48 Weeks|Adverse Event|0
1076689|NCT02091739|2134004|FG001|EP: 48 Weeks|Adverse Event|0
1076690|NCT02091739|2134005|FG002|EP: 48 Weeks|Adverse Event|0
1076691|NCT02091739|2134006|FG003|EP: 48 Weeks|Adverse Event|2
1076692|NCT02091739|2134007|FG004|EP: 48 Weeks|Adverse Event|6
1076693|NCT02091739|2134003|FG000|EP: 48 Weeks|Withdrawal by Subject|0
1076694|NCT02091739|2134004|FG001|EP: 48 Weeks|Withdrawal by Subject|0
1076695|NCT02091739|2134005|FG002|EP: 48 Weeks|Withdrawal by Subject|0
1076696|NCT02091739|2134006|FG003|EP: 48 Weeks|Withdrawal by Subject|2
1076697|NCT02091739|2134007|FG004|EP: 48 Weeks|Withdrawal by Subject|6
1076698|NCT02091869|2134036|FG000|Overall Study|Withdrawal by Subject|0
1076699|NCT02091869|2134037|FG001|Overall Study|Withdrawal by Subject|3
1076700|NCT02091921|2134047|FG000|Overall Study|Adverse Event|3
1076705|NCT02091986|2134061|FG000|Overall Study|7 rand in error 1 patient decision|2
1076706|NCT02091986|2134062|FG001|Overall Study|7 rand in error 1 patient decision|3
1076707|NCT02091986|2134063|FG002|Overall Study|7 rand in error 1 patient decision|3
1076708|NCT02091986|2134061|FG000|Overall Study|Lost to Follow-up|1
1076709|NCT02091986|2134062|FG001|Overall Study|Lost to Follow-up|0
1076710|NCT02091986|2134063|FG002|Overall Study|Lost to Follow-up|0
1076711|NCT02091986|2134061|FG000|Overall Study|Withdrawal by Subject|4
1076712|NCT02091986|2134062|FG001|Overall Study|Withdrawal by Subject|8
1076713|NCT02091986|2134063|FG002|Overall Study|Withdrawal by Subject|3
1076714|NCT02091986|2134061|FG000|Overall Study|Adverse Event|0
1076715|NCT02091986|2134062|FG001|Overall Study|Adverse Event|0
1076716|NCT02091986|2134063|FG002|Overall Study|Adverse Event|2
1076717|NCT02092025|2134071|FG000|Overall Study|Case Report Forms Uncollected|44
1076718|NCT02092025|2134071|FG000|Overall Study|Protocol Deviation|24
1076719|NCT02092116|2134077|FG000|Overall Study|Withdrawal by Subject|0
1076720|NCT02092116|2134078|FG001|Overall Study|Withdrawal by Subject|3
1076721|NCT02092116|2134077|FG000|Overall Study|Adverse Event|0
1076722|NCT02092116|2134078|FG001|Overall Study|Adverse Event|1
1076723|NCT02092220|2134102|FG000|Period 1|Unrelated Illness|0
1076724|NCT02092220|2134103|FG001|Period 1|Unrelated Illness|2
1076725|NCT02092220|2134102|FG000|Period 2|Severe Hypoglycaemia|1
1076726|NCT02092220|2134103|FG001|Period 2|Severe Hypoglycaemia|0
1076727|NCT02092220|2134102|FG000|Period 2|Nausea, Anxiety, Inconvenience|0
1076728|NCT02092220|2134103|FG001|Period 2|Nausea, Anxiety, Inconvenience|1
1076729|NCT02092285|2134111|FG000|Induction Phase|Adverse Event|7
1076730|NCT02092285|2134111|FG000|Induction Phase|Physician Decision|4
1076731|NCT02092285|2134111|FG000|Induction Phase|Pregnancy|1
1076732|NCT02092285|2134111|FG000|Induction Phase|Relapse/Recurrence|7
1076733|NCT02092285|2134111|FG000|Induction Phase|Withdrawal by Subject|2
1076734|NCT02092285|2134111|FG000|Induction Phase|Lack of Efficacy|14
1076735|NCT02092285|2134111|FG000|Maintenance Phase & Follow-up|Adverse Event|22
1076736|NCT02092285|2134111|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1
1076737|NCT02092285|2134111|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2
1076738|NCT02092285|2134111|FG000|Maintenance Phase & Follow-up|Physician Decision|10
1076739|NCT02092285|2134111|FG000|Maintenance Phase & Follow-up|Pregnancy|1
1076740|NCT02092285|2134111|FG000|Maintenance Phase & Follow-up|Protocol Violation|11
1076741|NCT02092285|2134111|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29
1076742|NCT02092285|2134111|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11
1076743|NCT02092285|2134111|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23
1076744|NCT02092324|2134130|FG000|Overall Study|Adverse Event|1
1076745|NCT02092324|2134130|FG000|Overall Study|Lack of Efficacy|6
1076746|NCT02092324|2134130|FG000|Overall Study|Proceed to Transplant|3
1076747|NCT02092324|2134130|FG000|Overall Study|Physician Decision|7
1076748|NCT02092324|2134130|FG000|Overall Study|Misdiagnosis|2
1076749|NCT02092350|2134139|FG000|Overall Study|Adverse Event|0
1076750|NCT02092350|2134140|FG001|Overall Study|Adverse Event|3
1076751|NCT02092350|2134139|FG000|Overall Study|Death|2
1076752|NCT02092350|2134140|FG001|Overall Study|Death|5
1076753|NCT02092350|2134139|FG000|Overall Study|Lost to Follow-up|3
1076754|NCT02092350|2134140|FG001|Overall Study|Lost to Follow-up|1
1076755|NCT02092350|2134139|FG000|Overall Study|Protocol Violation|1
1076756|NCT02092350|2134140|FG001|Overall Study|Protocol Violation|0
1076757|NCT02092350|2134139|FG000|Overall Study|Physician Decision|1
1076758|NCT02092350|2134140|FG001|Overall Study|Physician Decision|1
1076759|NCT02092350|2134139|FG000|Overall Study|Screen Failure|1
1076760|NCT02092350|2134140|FG001|Overall Study|Screen Failure|0
1076761|NCT02092350|2134139|FG000|Overall Study|Withdrawal by Subject|2
1076762|NCT02092350|2134140|FG001|Overall Study|Withdrawal by Subject|2
1076763|NCT02092389|2134148|FG000|Overall Study|Adverse Event|1
1076764|NCT02092389|2134148|FG000|Overall Study|Other|5
1076765|NCT02092467|2134169|FG000|Overall Study|Death|49
1076766|NCT02092467|2134170|FG001|Overall Study|Death|66
1076767|NCT02092467|2134171|FG002|Overall Study|Death|38
1076768|NCT02092467|2134169|FG000|Overall Study|Lost to Follow-up|38
1076769|NCT02092467|2134170|FG001|Overall Study|Lost to Follow-up|35
1076770|NCT02092467|2134171|FG002|Overall Study|Lost to Follow-up|40
1076771|NCT02092467|2134169|FG000|Overall Study|Global Deterioration of Health Status|1
1076772|NCT02092467|2134170|FG001|Overall Study|Global Deterioration of Health Status|0
1076773|NCT02092467|2134171|FG002|Overall Study|Global Deterioration of Health Status|0
1076774|NCT02092467|2134169|FG000|Overall Study|Other|32
1076775|NCT02092467|2134170|FG001|Overall Study|Other|30
1076776|NCT02092467|2134171|FG002|Overall Study|Other|24
1076777|NCT02092467|2134169|FG000|Overall Study|Withdrawal by Subject|282
1076778|NCT02092467|2134170|FG001|Overall Study|Withdrawal by Subject|327
1076779|NCT02092467|2134171|FG002|Overall Study|Withdrawal by Subject|289
1076780|NCT02092467|2134169|FG000|Overall Study|Randomized but not treated|2
1076781|NCT02092467|2134170|FG001|Overall Study|Randomized but not treated|1
1076782|NCT02092467|2134171|FG002|Overall Study|Randomized but not treated|7
1076783|NCT02092662|2134201|FG000|Overall Study|Lost to Follow-up|13
1076784|NCT02092662|2134202|FG001|Overall Study|Lost to Follow-up|0
1076785|NCT02092909|2134226|FG000|Overall Study|Adverse Event|0
1076786|NCT02092909|2134227|FG001|Overall Study|Adverse Event|0
1076787|NCT02092909|2134228|FG002|Overall Study|Adverse Event|4
1076788|NCT02092909|2134229|FG003|Overall Study|Adverse Event|2
1076789|NCT02092909|2134226|FG000|Overall Study|Lack of Efficacy|0
1076790|NCT02092909|2134227|FG001|Overall Study|Lack of Efficacy|2
1076791|NCT02092909|2134228|FG002|Overall Study|Lack of Efficacy|1
1076792|NCT02092909|2134229|FG003|Overall Study|Lack of Efficacy|0
1076793|NCT02092909|2134226|FG000|Overall Study|Withdrawal by Subject|0
1076794|NCT02092909|2134227|FG001|Overall Study|Withdrawal by Subject|0
1076795|NCT02092909|2134228|FG002|Overall Study|Withdrawal by Subject|2
1076796|NCT02092909|2134229|FG003|Overall Study|Withdrawal by Subject|1
1076797|NCT02092909|2134226|FG000|Overall Study|Study terminated by Sponsor|0
1076798|NCT02092909|2134227|FG001|Overall Study|Study terminated by Sponsor|0
1076799|NCT02092909|2134228|FG002|Overall Study|Study terminated by Sponsor|0
1076800|NCT02092909|2134229|FG003|Overall Study|Study terminated by Sponsor|2
1076801|NCT02092909|2134226|FG000|Overall Study|Miscellaneous|1
1076802|NCT02092909|2134227|FG001|Overall Study|Miscellaneous|1
1076803|NCT02092909|2134228|FG002|Overall Study|Miscellaneous|2
1076804|NCT02092909|2134229|FG003|Overall Study|Miscellaneous|1
1076805|NCT02092961|2134242|FG000|Overall Study|Not reported|1
1076806|NCT02092961|2134243|FG001|Overall Study|Not reported|0
1076807|NCT02092961|2134244|FG002|Overall Study|Not reported|1
1076808|NCT02092961|2134242|FG000|Overall Study|Study stopped|13
1076809|NCT02092961|2134243|FG001|Overall Study|Study stopped|9
1076810|NCT02092961|2134244|FG002|Overall Study|Study stopped|12
1076811|NCT02092961|2134242|FG000|Overall Study|Lack of therapeutic response|2
1076812|NCT02092961|2134243|FG001|Overall Study|Lack of therapeutic response|1
1076813|NCT02092961|2134244|FG002|Overall Study|Lack of therapeutic response|3
1076814|NCT02092961|2134242|FG000|Overall Study|Dev. of study specific discont. criteria|3
1076815|NCT02092961|2134243|FG001|Overall Study|Dev. of study specific discont. criteria|0
1076816|NCT02092961|2134244|FG002|Overall Study|Dev. of study specific discont. criteria|0
1076817|NCT02092961|2134242|FG000|Overall Study|Adverse Event|2
1076818|NCT02092961|2134243|FG001|Overall Study|Adverse Event|4
1076819|NCT02092961|2134244|FG002|Overall Study|Adverse Event|0
1076820|NCT02093026|2134265|FG000|Overall Study|Adverse Event|26
1076821|NCT02093026|2134265|FG000|Overall Study|Death|10
1076822|NCT02093026|2134265|FG000|Overall Study|Other|157
1076823|NCT02093221|2134275|FG000|Overall Study|Adverse Event|1
1076824|NCT02093221|2134276|FG001|Overall Study|Adverse Event|0
1076825|NCT02093221|2134277|FG002|Overall Study|Adverse Event|0
1076826|NCT02093221|2134278|FG003|Overall Study|Adverse Event|0
1076827|NCT02093221|2134279|FG004|Overall Study|Adverse Event|0
1076828|NCT02093221|2134275|FG000|Overall Study|Withdrawal by Subject|1
1076829|NCT02093221|2134276|FG001|Overall Study|Withdrawal by Subject|1
1076830|NCT02093221|2134277|FG002|Overall Study|Withdrawal by Subject|4
1076831|NCT02093221|2134278|FG003|Overall Study|Withdrawal by Subject|1
1076832|NCT02093221|2134279|FG004|Overall Study|Withdrawal by Subject|1
1076833|NCT02093221|2134275|FG000|Overall Study|Lost to Follow-up|2
1076834|NCT02093221|2134276|FG001|Overall Study|Lost to Follow-up|0
1076835|NCT02093221|2134277|FG002|Overall Study|Lost to Follow-up|1
1076836|NCT02093221|2134278|FG003|Overall Study|Lost to Follow-up|1
1076837|NCT02093221|2134279|FG004|Overall Study|Lost to Follow-up|0
1076838|NCT02093221|2134275|FG000|Overall Study|Death|0
1076839|NCT02093221|2134276|FG001|Overall Study|Death|1
1076840|NCT02093221|2134277|FG002|Overall Study|Death|0
1076841|NCT02093221|2134278|FG003|Overall Study|Death|0
1076842|NCT02093221|2134279|FG004|Overall Study|Death|0
1076843|NCT02093221|2134275|FG000|Overall Study|Protocol Violation|0
1076844|NCT02093221|2134276|FG001|Overall Study|Protocol Violation|1
1076845|NCT02093221|2134277|FG002|Overall Study|Protocol Violation|0
1076846|NCT02093221|2134278|FG003|Overall Study|Protocol Violation|0
1076847|NCT02093221|2134279|FG004|Overall Study|Protocol Violation|0
1076848|NCT02093221|2134275|FG000|Overall Study|Study termination|6
1076849|NCT02093221|2134276|FG001|Overall Study|Study termination|5
1076850|NCT02093221|2134277|FG002|Overall Study|Study termination|4
1076851|NCT02093221|2134278|FG003|Overall Study|Study termination|6
1076852|NCT02093221|2134279|FG004|Overall Study|Study termination|7
1076853|NCT02093351|2134307|FG000|Part A|Adverse Event|0
1076854|NCT02093351|2134308|FG001|Part A|Adverse Event|1
1076855|NCT02093351|2134309|FG002|Part A|Adverse Event|1
1076856|NCT02093351|2134310|FG003|Part A|Adverse Event|0
1076857|NCT02093351|2134307|FG000|Part A|Condition under investigation worsened|2
1076858|NCT02093351|2134308|FG001|Part A|Condition under investigation worsened|0
1076859|NCT02093351|2134309|FG002|Part A|Condition under investigation worsened|2
1076860|NCT02093351|2134310|FG003|Part A|Condition under investigation worsened|0
1076861|NCT02093351|2134307|FG000|Part A|Death|0
1076862|NCT02093351|2134308|FG001|Part A|Death|1
1076863|NCT02093351|2134309|FG002|Part A|Death|0
1076864|NCT02093351|2134310|FG003|Part A|Death|0
1076865|NCT02093351|2134307|FG000|Part B|Patient decision|0
1076866|NCT02093351|2134308|FG001|Part B|Patient decision|0
1076867|NCT02093351|2134309|FG002|Part B|Patient decision|0
1076868|NCT02093351|2134310|FG003|Part B|Patient decision|3
1076869|NCT02093351|2134307|FG000|Part B|Disease progression|0
1076870|NCT02093351|2134308|FG001|Part B|Disease progression|0
1076871|NCT02093351|2134309|FG002|Part B|Disease progression|0
1076872|NCT02093351|2134310|FG003|Part B|Disease progression|4
1076873|NCT02093351|2134307|FG000|Part B|Complete response|0
1076874|NCT02093351|2134308|FG001|Part B|Complete response|0
1076875|NCT02093351|2134309|FG002|Part B|Complete response|0
1076876|NCT02093351|2134310|FG003|Part B|Complete response|1
1076877|NCT02093351|2134307|FG000|Part B|Adverse event + disease progression|0
1076878|NCT02093351|2134308|FG001|Part B|Adverse event + disease progression|0
1076879|NCT02093351|2134309|FG002|Part B|Adverse event + disease progression|0
1076880|NCT02093351|2134310|FG003|Part B|Adverse event + disease progression|1
1076881|NCT02093351|2134307|FG000|Part B|Lack of therapeutic response|0
1076882|NCT02093351|2134308|FG001|Part B|Lack of therapeutic response|0
1076883|NCT02093351|2134309|FG002|Part B|Lack of therapeutic response|0
1076884|NCT02093351|2134310|FG003|Part B|Lack of therapeutic response|12
1076885|NCT02093351|2134307|FG000|Part B|Condition under investigation worsened|0
1076886|NCT02093351|2134308|FG001|Part B|Condition under investigation worsened|0
1076887|NCT02093351|2134309|FG002|Part B|Condition under investigation worsened|0
1076888|NCT02093351|2134310|FG003|Part B|Condition under investigation worsened|39
1076889|NCT02093351|2134307|FG000|Part B|Adverse Event|0
1076890|NCT02093351|2134308|FG001|Part B|Adverse Event|0
1076891|NCT02093351|2134309|FG002|Part B|Adverse Event|0
1076892|NCT02093351|2134310|FG003|Part B|Adverse Event|2
1076893|NCT02093351|2134307|FG000|Part B|Death|0
1076894|NCT02093351|2134308|FG001|Part B|Death|0
1076895|NCT02093351|2134309|FG002|Part B|Death|0
1076896|NCT02093351|2134310|FG003|Part B|Death|1
1076897|NCT02093390|2134327|FG000|Overall Study|Withdrawal by Subject|0
1076898|NCT02093390|2134328|FG001|Overall Study|Withdrawal by Subject|1
1076899|NCT02093520|2134337|FG000|Overall Study|Not treated|6
1076900|NCT02093520|2134338|FG001|Overall Study|Not treated|22
1076901|NCT02093663|2134344|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
1076902|NCT02093663|2134345|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
1076903|NCT02093663|2134346|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
1076904|NCT02093663|2134347|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
1076905|NCT02093663|2134348|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
1076906|NCT02093663|2134344|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
1076907|NCT02093663|2134345|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
1076908|NCT02093663|2134346|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
1076909|NCT02093663|2134347|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
1076910|NCT02093663|2134348|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
1076911|NCT02093663|2134344|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
1076912|NCT02093663|2134345|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
1076913|NCT02093663|2134346|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
1076914|NCT02093663|2134347|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
1076915|NCT02093663|2134348|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
1076916|NCT02093663|2134344|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0
1076917|NCT02093663|2134345|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0
1076918|NCT02093663|2134346|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1
1076919|NCT02093663|2134347|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0
1076920|NCT02093663|2134348|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0
1076921|NCT02093663|2134344|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
1076922|NCT02093663|2134345|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
1076923|NCT02093663|2134346|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
1076924|NCT02093663|2134347|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
1076925|NCT02093663|2134348|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
1076926|NCT02093663|2134344|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
1076927|NCT02093663|2134345|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
1076928|NCT02093663|2134346|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
1076929|NCT02093663|2134347|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
1076930|NCT02093663|2134348|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
1076931|NCT02093663|2134344|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
1076932|NCT02093663|2134345|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
1076933|NCT02093663|2134346|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
1076934|NCT02093663|2134347|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
1076935|NCT02093663|2134348|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
1076936|NCT02093663|2134344|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
1076937|NCT02093663|2134345|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
1076938|NCT02093663|2134346|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
1076939|NCT02093663|2134347|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
1076940|NCT02093663|2134348|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
1076941|NCT02093663|2134344|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0
1076942|NCT02093663|2134345|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0
1076943|NCT02093663|2134346|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0
1076944|NCT02093663|2134347|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0
1076945|NCT02093663|2134348|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1
1076946|NCT02093897|2134430|FG000|Overall Study|Physician Decision|1
1076947|NCT02093897|2134430|FG000|Overall Study|Planned age group closure - no's reached|17
1076948|NCT02093897|2134430|FG000|Overall Study|Adverse event, non-fatal|1
1076949|NCT02093923|2134446|FG000|Overall Study|Lost to Follow-up|0
1076950|NCT02093923|2134447|FG001|Overall Study|Lost to Follow-up|0
1076951|NCT02093923|2134448|FG002|Overall Study|Lost to Follow-up|0
1076952|NCT02093923|2134449|FG003|Overall Study|Lost to Follow-up|1
1076953|NCT02093923|2134450|FG004|Overall Study|Lost to Follow-up|0
1076954|NCT02093923|2134446|FG000|Overall Study|Screen failure after randomization|0
1076955|NCT02093923|2134447|FG001|Overall Study|Screen failure after randomization|0
1076956|NCT02093923|2134448|FG002|Overall Study|Screen failure after randomization|0
1076957|NCT02093923|2134449|FG003|Overall Study|Screen failure after randomization|1
1076958|NCT02093923|2134450|FG004|Overall Study|Screen failure after randomization|0
1076959|NCT02094300|2134505|FG000|Overall Study|Death|7
1076960|NCT02094300|2134505|FG000|Overall Study|Lost to Follow-up|10
1076961|NCT02094300|2134505|FG000|Overall Study|Still be eligible for follow-up|3
1076962|NCT02094417|2134518|FG000|Overall Study|Adverse Event|0
1076963|NCT02094417|2134519|FG001|Overall Study|Adverse Event|0
1076964|NCT02094417|2134520|FG002|Overall Study|Adverse Event|0
1076965|NCT02094417|2134521|FG003|Overall Study|Adverse Event|1
1076966|NCT02094417|2134518|FG000|Overall Study|Eligibility criteria|0
1076967|NCT02094417|2134519|FG001|Overall Study|Eligibility criteria|1
1076968|NCT02094417|2134520|FG002|Overall Study|Eligibility criteria|0
1076969|NCT02094417|2134521|FG003|Overall Study|Eligibility criteria|0
1076970|NCT02094417|2134518|FG000|Overall Study|No responder|4
1076971|NCT02094417|2134519|FG001|Overall Study|No responder|4
1076972|NCT02094417|2134520|FG002|Overall Study|No responder|4
1076973|NCT02094417|2134521|FG003|Overall Study|No responder|3
1076974|NCT02094417|2134518|FG000|Overall Study|Unable to conduct observations or assess|0
1076975|NCT02094417|2134519|FG001|Overall Study|Unable to conduct observations or assess|1
1076976|NCT02094417|2134520|FG002|Overall Study|Unable to conduct observations or assess|0
1076977|NCT02094417|2134521|FG003|Overall Study|Unable to conduct observations or assess|0
1076978|NCT02094417|2134518|FG000|Overall Study|Withdrawal by Subject|1
1076979|NCT02094417|2134519|FG001|Overall Study|Withdrawal by Subject|2
1076980|NCT02094417|2134520|FG002|Overall Study|Withdrawal by Subject|1
1076981|NCT02094417|2134521|FG003|Overall Study|Withdrawal by Subject|3
1076982|NCT02094573|2134551|FG000|Overall Study|Adverse Event|4
1076983|NCT02094573|2134552|FG001|Overall Study|Adverse Event|14
1076984|NCT02094573|2134551|FG000|Overall Study|Clinical Progressive Disease|9
1076985|NCT02094573|2134552|FG001|Overall Study|Clinical Progressive Disease|13
1076986|NCT02094573|2134551|FG000|Overall Study|Death|11
1076987|NCT02094573|2134552|FG001|Overall Study|Death|3
1076988|NCT02094573|2134551|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63
1076989|NCT02094573|2134552|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50
1076990|NCT02094573|2134551|FG000|Overall Study|Non-compliance with Study Drug|1
1076991|NCT02094573|2134552|FG001|Overall Study|Non-compliance with Study Drug|1
1076992|NCT02094573|2134551|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1
1076993|NCT02094573|2134552|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0
1076994|NCT02094573|2134551|FG000|Overall Study|Physician Decision|4
1076995|NCT02094573|2134552|FG001|Overall Study|Physician Decision|4
1076996|NCT02094573|2134551|FG000|Overall Study|Site Terminated by Sponsor|10
1076997|NCT02094573|2134552|FG001|Overall Study|Site Terminated by Sponsor|17
1076998|NCT02094573|2134551|FG000|Overall Study|Withdrawal by Subject|6
1076999|NCT02094573|2134552|FG001|Overall Study|Withdrawal by Subject|8
1077000|NCT02094573|2134551|FG000|Overall Study|Randomized but not Treated|3
1077001|NCT02094573|2134552|FG001|Overall Study|Randomized but not Treated|0
1077002|NCT02094612|2134589|FG000|Overall Study|Lost to Follow-up|47
1077003|NCT02094612|2134590|FG001|Overall Study|Lost to Follow-up|47
1077004|NCT02094612|2134589|FG000|Overall Study|Never started ADHD medication|32
1077005|NCT02094612|2134590|FG001|Overall Study|Never started ADHD medication|23
1077006|NCT02094677|2134607|FG000|Overall Study|Screening|3
1077007|NCT02094677|2134608|FG001|Overall Study|Screening|1
1077008|NCT02094885|2134656|FG000|Overall Study|Death|1
1077009|NCT02094885|2134657|FG001|Overall Study|Death|5
1077010|NCT02094885|2134656|FG000|Overall Study|Withdrawn due to age|1
1077011|NCT02094885|2134657|FG001|Overall Study|Withdrawn due to age|0
1077012|NCT02094898|2134663|FG000|Overall Study|Clinical Worsening|2
1077013|NCT02094898|2134663|FG000|Overall Study|Adverse Event|2
1077014|NCT02094898|2134663|FG000|Overall Study|Lack of Efficacy|1
1077015|NCT02094937|2134669|FG000|8 Weeks in Period 1|Adverse Event|9
1077016|NCT02094937|2134670|FG001|8 Weeks in Period 1|Adverse Event|0
1077017|NCT02094937|2134671|FG002|8 Weeks in Period 1|Adverse Event|0
1077018|NCT02094937|2134672|FG003|8 Weeks in Period 1|Adverse Event|0
1077019|NCT02094937|2134669|FG000|8 Weeks in Period 1|Lack of Efficacy|3
1077020|NCT02094937|2134670|FG001|8 Weeks in Period 1|Lack of Efficacy|0
1077021|NCT02094937|2134671|FG002|8 Weeks in Period 1|Lack of Efficacy|0
1077022|NCT02094937|2134672|FG003|8 Weeks in Period 1|Lack of Efficacy|0
1077023|NCT02094937|2134669|FG000|8 Weeks in Period 1|Protocol Violation|2
1077024|NCT02094937|2134670|FG001|8 Weeks in Period 1|Protocol Violation|0
1077025|NCT02094937|2134671|FG002|8 Weeks in Period 1|Protocol Violation|0
1077026|NCT02094937|2134672|FG003|8 Weeks in Period 1|Protocol Violation|0
1077027|NCT02094937|2134669|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41
1077028|NCT02094937|2134670|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0
1077029|NCT02094937|2134671|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0
1077030|NCT02094937|2134672|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0
1077031|NCT02094937|2134669|FG000|8 Weeks in Period 1|Physician Decision|1
1077032|NCT02094937|2134670|FG001|8 Weeks in Period 1|Physician Decision|0
1077033|NCT02094937|2134671|FG002|8 Weeks in Period 1|Physician Decision|0
1077034|NCT02094937|2134672|FG003|8 Weeks in Period 1|Physician Decision|0
1077035|NCT02094937|2134669|FG000|8 Weeks in Period 1|Withdrawal by Subject|4
1077036|NCT02094937|2134670|FG001|8 Weeks in Period 1|Withdrawal by Subject|0
1077037|NCT02094937|2134671|FG002|8 Weeks in Period 1|Withdrawal by Subject|0
1077038|NCT02094937|2134672|FG003|8 Weeks in Period 1|Withdrawal by Subject|0
1077039|NCT02094937|2134669|FG000|12 Weeks in Period 2|Adverse Event|0
1077040|NCT02094937|2134670|FG001|12 Weeks in Period 2|Adverse Event|2
1077041|NCT02094937|2134671|FG002|12 Weeks in Period 2|Adverse Event|4
1077042|NCT02094937|2134672|FG003|12 Weeks in Period 2|Adverse Event|1
1077043|NCT02094937|2134669|FG000|12 Weeks in Period 2|Lack of Efficacy|0
1077044|NCT02094937|2134670|FG001|12 Weeks in Period 2|Lack of Efficacy|1
1077045|NCT02094937|2134671|FG002|12 Weeks in Period 2|Lack of Efficacy|0
1077046|NCT02094937|2134672|FG003|12 Weeks in Period 2|Lack of Efficacy|0
1077047|NCT02094937|2134669|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0
1077048|NCT02094937|2134670|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5
1077049|NCT02094937|2134671|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6
1077050|NCT02094937|2134672|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11
1077051|NCT02094937|2134669|FG000|12 Weeks in Period 2|Withdrawal by Subject|0
1077052|NCT02094937|2134670|FG001|12 Weeks in Period 2|Withdrawal by Subject|2
1077053|NCT02094937|2134671|FG002|12 Weeks in Period 2|Withdrawal by Subject|2
1077054|NCT02094937|2134672|FG003|12 Weeks in Period 2|Withdrawal by Subject|0
1077055|NCT02094937|2134669|FG000|12 Weeks in Period 2|Randomized incorrectly|0
1077056|NCT02094937|2134670|FG001|12 Weeks in Period 2|Randomized incorrectly|1
1077057|NCT02094937|2134671|FG002|12 Weeks in Period 2|Randomized incorrectly|0
1077058|NCT02094937|2134672|FG003|12 Weeks in Period 2|Randomized incorrectly|0
1077059|NCT02095106|2134683|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
1077060|NCT02095106|2134684|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
1077061|NCT02095145|2134696|FG000|Overall Study|Withdrawal by Subject|1
1077062|NCT02095145|2134697|FG001|Overall Study|Withdrawal by Subject|0
1077063|NCT02095158|2134705|FG000|Overall Study|Adverse Event|14
1077064|NCT02095158|2134705|FG000|Overall Study|Lack of Efficacy|3
1077065|NCT02095158|2134705|FG000|Overall Study|Pregnancy|1
1077066|NCT02095158|2134705|FG000|Overall Study|Lost to Follow-up|20
1077067|NCT02095158|2134705|FG000|Overall Study|Personal Reasons|35
1077068|NCT02095158|2134705|FG000|Overall Study|Protocol Violation|1
1077069|NCT02095158|2134705|FG000|Overall Study|Other Miscellaneous Reasons|1
1077070|NCT02095197|2134711|FG000|Overall Study|Lost to Follow-up|0
1077071|NCT02095197|2134712|FG001|Overall Study|Lost to Follow-up|3
1077072|NCT02095223|2134720|FG000|Overall Study|Withdrawal by Subject|1
1077073|NCT02095223|2134721|FG001|Overall Study|Withdrawal by Subject|0
1077074|NCT02095535|2134741|FG000|Recruitment|Protocol Violation|2
1077075|NCT02095678|2134756|FG000|Overall Study|Withdrawal by Subject|0
1077076|NCT02095678|2134757|FG001|Overall Study|Withdrawal by Subject|1
1077077|NCT02095678|2134756|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11
1077078|NCT02095678|2134757|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12
1077079|NCT02095678|2134756|FG000|Overall Study|lesion impacted by previous treatment|1
1077080|NCT02095678|2134757|FG001|Overall Study|lesion impacted by previous treatment|1
1077081|NCT02095678|2134756|FG000|Overall Study|No Confirmed Diagnosis|0
1077082|NCT02095678|2134757|FG001|Overall Study|No Confirmed Diagnosis|3
1077083|NCT02095678|2134756|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1
1077084|NCT02095678|2134757|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1
1077085|NCT02095678|2134756|FG000|Overall Study|No Visible Lesion or Pathological Finding|4
1077086|NCT02095678|2134757|FG001|Overall Study|No Visible Lesion or Pathological Finding|0
1077087|NCT02095691|2134766|FG000|Overall Study|Physician Decision|1
1077088|NCT02095873|2134784|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1
1077089|NCT02095873|2134785|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0
1077090|NCT02095873|2134784|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
1077091|NCT02095873|2134785|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
1077092|NCT02095873|2134784|FG000|Second Intervention (8 Weeks)|Protocol Violation|1
1077093|NCT02095873|2134785|FG001|Second Intervention (8 Weeks)|Protocol Violation|0
1077094|NCT02095951|2134795|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9
1077095|NCT02095951|2134796|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6
1077096|NCT02096003|2134808|FG000|Overall Study|Protocol Violation|0
1077097|NCT02096003|2134809|FG001|Overall Study|Protocol Violation|2
1077098|NCT02096003|2134808|FG000|Overall Study|additional surgery|2
1077099|NCT02096003|2134809|FG001|Overall Study|additional surgery|1
1077100|NCT02096263|2134845|FG000|Overall Study|Adverse Event|1
1077101|NCT02096263|2134846|FG001|Overall Study|Adverse Event|0
1077102|NCT02096263|2134847|FG002|Overall Study|Adverse Event|1
1077103|NCT02096263|2134845|FG000|Overall Study|Lost to Follow-up|14
1077104|NCT02096263|2134846|FG001|Overall Study|Lost to Follow-up|18
1077105|NCT02096263|2134847|FG002|Overall Study|Lost to Follow-up|15
1077106|NCT02096263|2134845|FG000|Overall Study|Other|7
1077107|NCT02096263|2134846|FG001|Overall Study|Other|9
1077108|NCT02096263|2134847|FG002|Overall Study|Other|6
1077109|NCT02096263|2134845|FG000|Overall Study|Sponsor study termination|0
1077110|NCT02096263|2134846|FG001|Overall Study|Sponsor study termination|0
1077111|NCT02096263|2134847|FG002|Overall Study|Sponsor study termination|1
1077112|NCT02096263|2134845|FG000|Overall Study|Protocol Violation|7
1077113|NCT02096263|2134846|FG001|Overall Study|Protocol Violation|2
1077114|NCT02096263|2134847|FG002|Overall Study|Protocol Violation|8
1077115|NCT02096263|2134845|FG000|Overall Study|Withdrawal by Subject|5
1077116|NCT02096263|2134846|FG001|Overall Study|Withdrawal by Subject|7
1077117|NCT02096263|2134847|FG002|Overall Study|Withdrawal by Subject|8
1077118|NCT02096471|2134868|FG000|Overall Study|Adverse Event|1
1077119|NCT02096471|2134868|FG000|Overall Study|Lack of Efficacy|7
1077120|NCT02096471|2134868|FG000|Overall Study|Withdrawal by Subject|3
1077121|NCT02096471|2134868|FG000|Overall Study|Non-Compliant|2
1077122|NCT02096588|2134885|FG000|Overall Study|Lack of Efficacy|2
1077123|NCT02096588|2134886|FG001|Overall Study|Lack of Efficacy|0
1077124|NCT02096588|2134885|FG000|Overall Study|Withdrawal by Subject|0
1077125|NCT02096588|2134886|FG001|Overall Study|Withdrawal by Subject|1
1077126|NCT02096705|2134902|FG000|Treatment|Adverse Event|6
1077127|NCT02096705|2134903|FG001|Treatment|Adverse Event|3
1077128|NCT02096705|2134902|FG000|Treatment|Subject request to discontinue treatment|1
1077129|NCT02096705|2134903|FG001|Treatment|Subject request to discontinue treatment|1
1077130|NCT02096705|2134902|FG000|Treatment|Withdrawal by Subject|1
1077131|NCT02096705|2134903|FG001|Treatment|Withdrawal by Subject|0
1077132|NCT02096705|2134902|FG000|Treatment|Other|1
1077133|NCT02096705|2134903|FG001|Treatment|Other|1
1077134|NCT02096705|2134902|FG000|Follow-up|Withdrawal by Subject|1
1077135|NCT02096705|2134903|FG001|Follow-up|Withdrawal by Subject|0
1077136|NCT02096705|2134902|FG000|Follow-up|Adverse Event|2
1077137|NCT02096705|2134903|FG001|Follow-up|Adverse Event|2
1077138|NCT02096705|2134902|FG000|Follow-up|Subjects not reporting status|1
1077139|NCT02096705|2134903|FG001|Follow-up|Subjects not reporting status|2
1077140|NCT02096744|2134935|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
1077141|NCT02096744|2134936|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
1077142|NCT02096744|2134935|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1
1077143|NCT02096744|2134936|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0
1077144|NCT02096744|2134935|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
1077145|NCT02096744|2134936|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
1077146|NCT02096835|2134947|FG000|Overall Study|Withdrawal by Subject|1
1077147|NCT02096835|2134948|FG001|Overall Study|Withdrawal by Subject|0
1077148|NCT02096835|2134949|FG002|Overall Study|Withdrawal by Subject|0
1077149|NCT02096835|2134947|FG000|Overall Study|converted to open procedures|1
1077150|NCT02096835|2134948|FG001|Overall Study|converted to open procedures|0
1077151|NCT02096835|2134949|FG002|Overall Study|converted to open procedures|0
1077152|NCT02096835|2134947|FG000|Overall Study|Lost to Follow-up|1
1077153|NCT02096835|2134948|FG001|Overall Study|Lost to Follow-up|0
1077154|NCT02096835|2134949|FG002|Overall Study|Lost to Follow-up|1
1077155|NCT02096900|2134978|FG000|Overall Study|Did not receive medication|3
1077156|NCT02096900|2134979|FG001|Overall Study|Did not receive medication|1
1077157|NCT02096900|2134978|FG000|Overall Study|Surgery cancelled- medication received|1
1077158|NCT02096900|2134979|FG001|Overall Study|Surgery cancelled- medication received|1
1077159|NCT02096952|2134985|FG000|Overall Study|Adverse Event|1
1077160|NCT02097030|2134991|FG000|First Intervention (3 Days)|Lost to Follow-up|1
1077161|NCT02097030|2134992|FG001|First Intervention (3 Days)|Lost to Follow-up|0
1077162|NCT02097030|2134991|FG000|First Intervention (3 Days)|Visual Acuity|0
1077163|NCT02097030|2134992|FG001|First Intervention (3 Days)|Visual Acuity|1
1077164|NCT02097056|2135002|FG000|Overall Study|Protocol Violation|2
1077165|NCT02097056|2135002|FG000|Overall Study|Withdrawal by Subject|15
1077166|NCT02097056|2135002|FG000|Overall Study|Lost to Follow-up|2
1077167|NCT02097056|2135002|FG000|Overall Study|Adverse Event|37
1077168|NCT02097056|2135002|FG000|Overall Study|Other|2
1077169|NCT02097108|2135006|FG000|Overall Study|Adverse Event|1
1077170|NCT02097108|2135006|FG000|Overall Study|patient was abroad for 6 months|1
1077175|NCT02097238|2135015|FG000|Overall Study|Death|1
1077176|NCT02097238|2135015|FG000|Overall Study|Physician Decision|1
1077177|NCT02097238|2135015|FG000|Overall Study|Progressive Disease|17
1077178|NCT02097277|2135025|FG000|Overall Study|Subject no longer meets study criteria|0
1077179|NCT02097277|2135026|FG001|Overall Study|Subject no longer meets study criteria|1
1077180|NCT02097277|2135027|FG002|Overall Study|Subject no longer meets study criteria|0
1077181|NCT02097277|2135028|FG003|Overall Study|Subject no longer meets study criteria|1
1077182|NCT02097277|2135029|FG004|Overall Study|Subject no longer meets study criteria|0
1077183|NCT02097277|2135025|FG000|Overall Study|Subject request to discontinue treatment|0
1077184|NCT02097277|2135026|FG001|Overall Study|Subject request to discontinue treatment|0
1077185|NCT02097277|2135027|FG002|Overall Study|Subject request to discontinue treatment|0
1077186|NCT02097277|2135028|FG003|Overall Study|Subject request to discontinue treatment|0
1077187|NCT02097277|2135029|FG004|Overall Study|Subject request to discontinue treatment|1
1077188|NCT02097277|2135025|FG000|Overall Study|Lost to Follow-up|0
1077189|NCT02097277|2135026|FG001|Overall Study|Lost to Follow-up|1
1077190|NCT02097277|2135027|FG002|Overall Study|Lost to Follow-up|1
1077191|NCT02097277|2135028|FG003|Overall Study|Lost to Follow-up|0
1077192|NCT02097277|2135029|FG004|Overall Study|Lost to Follow-up|0
1077193|NCT02097277|2135025|FG000|Overall Study|Withdrawal by Subject|2
1077194|NCT02097277|2135026|FG001|Overall Study|Withdrawal by Subject|1
1077195|NCT02097277|2135027|FG002|Overall Study|Withdrawal by Subject|0
1077196|NCT02097277|2135028|FG003|Overall Study|Withdrawal by Subject|1
1077197|NCT02097277|2135029|FG004|Overall Study|Withdrawal by Subject|0
1077198|NCT02097277|2135025|FG000|Overall Study|Adverse Event|0
1077199|NCT02097277|2135026|FG001|Overall Study|Adverse Event|0
1077200|NCT02097277|2135027|FG002|Overall Study|Adverse Event|1
1077201|NCT02097277|2135028|FG003|Overall Study|Adverse Event|2
1077202|NCT02097277|2135029|FG004|Overall Study|Adverse Event|0
1077203|NCT02097290|2135045|FG000|Overall Study|Death|6
1077204|NCT02097290|2135045|FG000|Overall Study|Total Withdrawals|3
1077205|NCT02097290|2135045|FG000|Overall Study|Attempt|8
1077209|NCT02097472|2135065|FG000|Received Vaccination 2|Adverse Event|0
1077210|NCT02097472|2135066|FG001|Received Vaccination 2|Adverse Event|0
1077211|NCT02097472|2135067|FG002|Received Vaccination 2|Adverse Event|0
1077212|NCT02097472|2135068|FG003|Received Vaccination 2|Adverse Event|0
1077213|NCT02097472|2135069|FG004|Received Vaccination 2|Adverse Event|0
1077214|NCT02097472|2135070|FG005|Received Vaccination 2|Adverse Event|0
1077215|NCT02097472|2135071|FG006|Received Vaccination 2|Adverse Event|1
1077216|NCT02097472|2135072|FG007|Received Vaccination 2|Adverse Event|0
1077217|NCT02097719|2135182|FG000|Overall Study|Subject Withdrew Consent|1
1077218|NCT02097719|2135183|FG001|Overall Study|Subject Withdrew Consent|0
1077219|NCT02097719|2135182|FG000|Overall Study|Lost to Follow-up|0
1077220|NCT02097719|2135183|FG001|Overall Study|Lost to Follow-up|1
1077221|NCT02097719|2135182|FG000|Overall Study|Adverse Event|2
1077222|NCT02097719|2135183|FG001|Overall Study|Adverse Event|0
1077223|NCT02097745|2135199|FG000|Overall Study|Adverse Event|25
1077224|NCT02097745|2135199|FG000|Overall Study|Death|16
1077225|NCT02097745|2135199|FG000|Overall Study|Failure to Return|14
1077226|NCT02097745|2135199|FG000|Overall Study|Administrative/Other|27
1077227|NCT02097745|2135199|FG000|Overall Study|Reason Not Specified|96
1077228|NCT02097823|2135208|FG000|Overall Study|Withdrawal by Subject|1
1077229|NCT02097823|2135209|FG001|Overall Study|Withdrawal by Subject|1
1077230|NCT02098109|2135242|FG000|Overall Study|Protocol Violation|3
1077231|NCT02098109|2135243|FG001|Overall Study|Protocol Violation|0
1077232|NCT02098369|2135258|FG000|Overall Study|Withdrawal by Subject|1
1077233|NCT02098369|2135259|FG001|Overall Study|Withdrawal by Subject|5
1077234|NCT02098369|2135260|FG002|Overall Study|Withdrawal by Subject|0
1077235|NCT02098369|2135258|FG000|Overall Study|Lost to Follow-up|5
1077236|NCT02098369|2135259|FG001|Overall Study|Lost to Follow-up|1
1077237|NCT02098369|2135260|FG002|Overall Study|Lost to Follow-up|3
1077238|NCT02098369|2135258|FG000|Overall Study|Death|1
1077239|NCT02098369|2135259|FG001|Overall Study|Death|1
1077240|NCT02098369|2135260|FG002|Overall Study|Death|1
1077241|NCT02098369|2135258|FG000|Overall Study|Other|0
1077242|NCT02098369|2135259|FG001|Overall Study|Other|2
1077243|NCT02098369|2135260|FG002|Overall Study|Other|1
1077244|NCT02098395|2135272|FG000|Overall Study|Protocol Violation|2
1077245|NCT02098395|2135273|FG001|Overall Study|Protocol Violation|2
1077246|NCT02098395|2135274|FG002|Overall Study|Protocol Violation|0
1077247|NCT02098395|2135275|FG003|Overall Study|Protocol Violation|7
1077248|NCT02098395|2135272|FG000|Overall Study|Withdrawal by Subject|10
1077249|NCT02098395|2135273|FG001|Overall Study|Withdrawal by Subject|10
1077250|NCT02098395|2135274|FG002|Overall Study|Withdrawal by Subject|5
1077251|NCT02098395|2135275|FG003|Overall Study|Withdrawal by Subject|13
1077252|NCT02098395|2135272|FG000|Overall Study|Adverse Event|12
1077253|NCT02098395|2135273|FG001|Overall Study|Adverse Event|19
1077254|NCT02098395|2135274|FG002|Overall Study|Adverse Event|34
1077255|NCT02098395|2135275|FG003|Overall Study|Adverse Event|2
1077256|NCT02098395|2135272|FG000|Overall Study|Lost to Follow-up|2
1077257|NCT02098395|2135273|FG001|Overall Study|Lost to Follow-up|1
1077258|NCT02098395|2135274|FG002|Overall Study|Lost to Follow-up|0
1077259|NCT02098395|2135275|FG003|Overall Study|Lost to Follow-up|3
1077260|NCT02098395|2135272|FG000|Overall Study|Unclassified|0
1077261|NCT02098395|2135273|FG001|Overall Study|Unclassified|0
1077262|NCT02098395|2135274|FG002|Overall Study|Unclassified|3
1077263|NCT02098395|2135275|FG003|Overall Study|Unclassified|2
1077264|NCT02098733|2135285|FG000|Overall Study|Data Not Available|5
1077265|NCT02098733|2135285|FG000|Overall Study|Lost to Follow-up|5
1077266|NCT02098746|2135289|FG000|Overall Study|Changes of Investigator|2
1077267|NCT02098746|2135289|FG000|Overall Study|Other Miscellaneous Reasons|1
1077268|NCT02098746|2135289|FG000|Overall Study|Enrolled 15 Days After the First Dose|1
1077269|NCT02098746|2135289|FG000|Overall Study|Data Not Available After Treatment|1
1077270|NCT02099110|2135320|FG000|Overall Study|Protocol Violation|2
1077271|NCT02099110|2135321|FG001|Overall Study|Protocol Violation|1
1077272|NCT02099110|2135322|FG002|Overall Study|Protocol Violation|0
1077273|NCT02099110|2135323|FG003|Overall Study|Protocol Violation|3
1077274|NCT02099110|2135324|FG004|Overall Study|Protocol Violation|1
1077275|NCT02099110|2135320|FG000|Overall Study|Participant moved|1
1077276|NCT02099110|2135321|FG001|Overall Study|Participant moved|1
1077277|NCT02099110|2135322|FG002|Overall Study|Participant moved|1
1077278|NCT02099110|2135323|FG003|Overall Study|Participant moved|0
1077279|NCT02099110|2135324|FG004|Overall Study|Participant moved|2
1077280|NCT02099110|2135320|FG000|Overall Study|Withdrawal by Subject|7
1077281|NCT02099110|2135321|FG001|Overall Study|Withdrawal by Subject|11
1077282|NCT02099110|2135322|FG002|Overall Study|Withdrawal by Subject|13
1077283|NCT02099110|2135323|FG003|Overall Study|Withdrawal by Subject|9
1077284|NCT02099110|2135324|FG004|Overall Study|Withdrawal by Subject|13
1077285|NCT02099110|2135320|FG000|Overall Study|Adverse Event|3
1077286|NCT02099110|2135321|FG001|Overall Study|Adverse Event|5
1077287|NCT02099110|2135322|FG002|Overall Study|Adverse Event|2
1077288|NCT02099110|2135323|FG003|Overall Study|Adverse Event|3
1077289|NCT02099110|2135324|FG004|Overall Study|Adverse Event|2
1077290|NCT02099110|2135320|FG000|Overall Study|Lost to Follow-up|6
1077291|NCT02099110|2135321|FG001|Overall Study|Lost to Follow-up|12
1077292|NCT02099110|2135322|FG002|Overall Study|Lost to Follow-up|11
1077293|NCT02099110|2135323|FG003|Overall Study|Lost to Follow-up|5
1077294|NCT02099110|2135324|FG004|Overall Study|Lost to Follow-up|6
1077295|NCT02099110|2135320|FG000|Overall Study|Death|0
1077296|NCT02099110|2135321|FG001|Overall Study|Death|1
1077297|NCT02099110|2135322|FG002|Overall Study|Death|0
1077298|NCT02099110|2135323|FG003|Overall Study|Death|0
1077299|NCT02099110|2135324|FG004|Overall Study|Death|0
1077300|NCT02099110|2135320|FG000|Overall Study|Screen failure|0
1077301|NCT02099110|2135321|FG001|Overall Study|Screen failure|0
1077302|NCT02099110|2135322|FG002|Overall Study|Screen failure|0
1077303|NCT02099110|2135323|FG003|Overall Study|Screen failure|0
1077304|NCT02099110|2135324|FG004|Overall Study|Screen failure|1
1077305|NCT02099110|2135320|FG000|Overall Study|Non-compliance with study drug|2
1077306|NCT02099110|2135321|FG001|Overall Study|Non-compliance with study drug|0
1077307|NCT02099110|2135322|FG002|Overall Study|Non-compliance with study drug|0
1077308|NCT02099110|2135323|FG003|Overall Study|Non-compliance with study drug|0
1077309|NCT02099110|2135324|FG004|Overall Study|Non-compliance with study drug|1
1077310|NCT02099110|2135320|FG000|Overall Study|Physician Decision|3
1077311|NCT02099110|2135321|FG001|Overall Study|Physician Decision|0
1077312|NCT02099110|2135322|FG002|Overall Study|Physician Decision|1
1077313|NCT02099110|2135323|FG003|Overall Study|Physician Decision|2
1077314|NCT02099110|2135324|FG004|Overall Study|Physician Decision|1
1077315|NCT02099682|2135356|FG000|Overall Study|Data Not Available|51
1077316|NCT02099682|2135356|FG000|Overall Study|Lost to Follow-up|31
1077317|NCT02099682|2135356|FG000|Overall Study|Other|29
1077318|NCT02099708|2135360|FG000|Overall Study|Data Not Available|30
1077319|NCT02099708|2135360|FG000|Overall Study|Lost to Follow-up|141
1077320|NCT02099708|2135360|FG000|Overall Study|Other|29
1077321|NCT02099838|2135410|FG000|Overall Study|Death|1
1077322|NCT02099838|2135411|FG001|Overall Study|Death|0
1077323|NCT02099838|2135410|FG000|Overall Study|Lost to Follow-up|3
1077324|NCT02099838|2135411|FG001|Overall Study|Lost to Follow-up|1
1077325|NCT02099838|2135410|FG000|Overall Study|Withdrawal by Subject|0
1077326|NCT02099838|2135411|FG001|Overall Study|Withdrawal by Subject|1
1077327|NCT02100124|2135437|FG000|Overall Study|Lost to Follow-up|5
1077328|NCT02100124|2135438|FG001|Overall Study|Lost to Follow-up|11
1077329|NCT02100124|2135439|FG002|Overall Study|Lost to Follow-up|3
1077330|NCT02100124|2135437|FG000|Overall Study|Withdrawal by Subject|1
1077331|NCT02100124|2135438|FG001|Overall Study|Withdrawal by Subject|0
1077332|NCT02100124|2135439|FG002|Overall Study|Withdrawal by Subject|0
1077333|NCT02100228|2135453|FG000|Overall Study|Other|19
1077334|NCT02100228|2135454|FG001|Overall Study|Other|19
1077335|NCT02100228|2135453|FG000|Overall Study|Administrative reason|0
1077336|NCT02100228|2135454|FG001|Overall Study|Administrative reason|1
1077337|NCT02100228|2135453|FG000|Overall Study|Inclusion/Exclusion criteria not met|12
1077338|NCT02100228|2135454|FG001|Overall Study|Inclusion/Exclusion criteria not met|16
1077339|NCT02100228|2135453|FG000|Overall Study|Non-compliance|0
1077340|NCT02100228|2135454|FG001|Overall Study|Non-compliance|3
1077341|NCT02100228|2135453|FG000|Overall Study|Lost to Follow-up|0
1077342|NCT02100228|2135454|FG001|Overall Study|Lost to Follow-up|1
1077343|NCT02100228|2135453|FG000|Overall Study|Withdrawal by Subject|27
1077344|NCT02100228|2135454|FG001|Overall Study|Withdrawal by Subject|37
1077345|NCT02100228|2135453|FG000|Overall Study|Adverse Event|16
1077346|NCT02100228|2135454|FG001|Overall Study|Adverse Event|12
1077347|NCT02100228|2135453|FG000|Overall Study|Death|1
1077348|NCT02100228|2135454|FG001|Overall Study|Death|1
1077349|NCT02100319|2135471|FG000|Overall Study|Case Report Forms Uncollected|11
1077350|NCT02100319|2135471|FG000|Overall Study|Protocol Deviation|5
1077351|NCT02100475|2135494|FG000|Overall Study|Unclassified|1
1077352|NCT02100475|2135495|FG001|Overall Study|Unclassified|2
1077353|NCT02100475|2135494|FG000|Overall Study|Withdrawal criteria|1
1077354|NCT02100475|2135495|FG001|Overall Study|Withdrawal criteria|0
1077355|NCT02100514|2135503|FG000|Treatment Period|Adverse Event|0
1077356|NCT02100514|2135504|FG001|Treatment Period|Adverse Event|5
1077357|NCT02100514|2135505|FG002|Treatment Period|Adverse Event|0
1077358|NCT02100514|2135506|FG003|Treatment Period|Adverse Event|0
1077359|NCT02100514|2135507|FG004|Treatment Period|Adverse Event|0
1077360|NCT02100514|2135503|FG000|Treatment Period|Death|2
1077361|NCT02100514|2135504|FG001|Treatment Period|Death|2
1077362|NCT02100514|2135505|FG002|Treatment Period|Death|0
1077363|NCT02100514|2135506|FG003|Treatment Period|Death|0
1077364|NCT02100514|2135507|FG004|Treatment Period|Death|0
1077365|NCT02100514|2135503|FG000|Treatment Period|Lost to Follow-up|5
1077366|NCT02100514|2135504|FG001|Treatment Period|Lost to Follow-up|17
1077367|NCT02100514|2135505|FG002|Treatment Period|Lost to Follow-up|0
1077368|NCT02100514|2135506|FG003|Treatment Period|Lost to Follow-up|0
1077369|NCT02100514|2135507|FG004|Treatment Period|Lost to Follow-up|0
1077370|NCT02100514|2135503|FG000|Treatment Period|Did Not Meet Entrance Criteria|0
1077371|NCT02100514|2135504|FG001|Treatment Period|Did Not Meet Entrance Criteria|1
1077372|NCT02100514|2135505|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
1077373|NCT02100514|2135506|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
1077374|NCT02100514|2135507|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
1077375|NCT02100514|2135503|FG000|Treatment Period|Protocol Violation|1
1077376|NCT02100514|2135504|FG001|Treatment Period|Protocol Violation|1
1077377|NCT02100514|2135505|FG002|Treatment Period|Protocol Violation|0
1077378|NCT02100514|2135506|FG003|Treatment Period|Protocol Violation|0
1077379|NCT02100514|2135507|FG004|Treatment Period|Protocol Violation|0
1077380|NCT02100514|2135503|FG000|Treatment Period|Withdrawal by Subject|12
1077381|NCT02100514|2135504|FG001|Treatment Period|Withdrawal by Subject|37
1077382|NCT02100514|2135505|FG002|Treatment Period|Withdrawal by Subject|0
1077383|NCT02100514|2135506|FG003|Treatment Period|Withdrawal by Subject|0
1077384|NCT02100514|2135507|FG004|Treatment Period|Withdrawal by Subject|0
1077385|NCT02100514|2135503|FG000|Treatment Period|Other|9
1077386|NCT02100514|2135504|FG001|Treatment Period|Other|11
1077387|NCT02100514|2135505|FG002|Treatment Period|Other|0
1077388|NCT02100514|2135506|FG003|Treatment Period|Other|0
1077389|NCT02100514|2135507|FG004|Treatment Period|Other|0
1077390|NCT02100514|2135503|FG000|Extension Period|Withdrew consent|0
1077391|NCT02100514|2135504|FG001|Extension Period|Withdrew consent|0
1077392|NCT02100514|2135505|FG002|Extension Period|Withdrew consent|2
1077393|NCT02100514|2135506|FG003|Extension Period|Withdrew consent|0
1077394|NCT02100514|2135507|FG004|Extension Period|Withdrew consent|0
1077395|NCT02100631|2135533|FG000|Overall Study|Withdrawal by Subject|1
1077396|NCT02100631|2135534|FG001|Overall Study|Withdrawal by Subject|0
1077397|NCT02100631|2135535|FG002|Overall Study|Withdrawal by Subject|0
1077398|NCT02100631|2135533|FG000|Overall Study|Lost to Follow-up|3
1077399|NCT02100631|2135534|FG001|Overall Study|Lost to Follow-up|4
1077400|NCT02100631|2135535|FG002|Overall Study|Lost to Follow-up|0
1077401|NCT02100631|2135533|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3
1077402|NCT02100631|2135534|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
1077403|NCT02100631|2135535|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
1077404|NCT02100644|2135543|FG000|LTG Escalation Phase|Adverse Event|9
1077405|NCT02100644|2135544|FG001|LTG Escalation Phase|Adverse Event|0
1077406|NCT02100644|2135545|FG002|LTG Escalation Phase|Adverse Event|0
1077407|NCT02100644|2135543|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
1077408|NCT02100644|2135544|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
1077409|NCT02100644|2135545|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
1077410|NCT02100644|2135543|FG000|LTG Escalation Phase|Withdrawal by Subject|3
1077411|NCT02100644|2135544|FG001|LTG Escalation Phase|Withdrawal by Subject|0
1077412|NCT02100644|2135545|FG002|LTG Escalation Phase|Withdrawal by Subject|0
1077413|NCT02100657|2135552|FG000|Cohort 1: Dose Level 1|Progressive disease|6
1077414|NCT02100657|2135553|FG001|Cohort 1: Dose Level 1|Progressive disease|0
1077415|NCT02100657|2135554|FG002|Cohort 1: Dose Level 1|Progressive disease|0
1077416|NCT02100657|2135552|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1
1077417|NCT02100657|2135553|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0
1077418|NCT02100657|2135554|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0
1077419|NCT02100657|2135552|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1
1077420|NCT02100657|2135553|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0
1077421|NCT02100657|2135554|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0
1077422|NCT02100657|2135552|FG000|Cohort 2: Dose Level 2|Progressive disease|0
1077423|NCT02100657|2135553|FG001|Cohort 2: Dose Level 2|Progressive disease|2
1077424|NCT02100657|2135554|FG002|Cohort 2: Dose Level 2|Progressive disease|0
1077425|NCT02100657|2135552|FG000|Cohort 2: Dose Level 2|Physician Decision|0
1077426|NCT02100657|2135553|FG001|Cohort 2: Dose Level 2|Physician Decision|1
1077427|NCT02100657|2135554|FG002|Cohort 2: Dose Level 2|Physician Decision|0
1077428|NCT02100657|2135552|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0
1077429|NCT02100657|2135553|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1
1077430|NCT02100657|2135554|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0
1077431|NCT02100657|2135552|FG000|Cohort 3: Dose Level 3|Progressive disease|0
1077432|NCT02100657|2135553|FG001|Cohort 3: Dose Level 3|Progressive disease|0
1077433|NCT02100657|2135554|FG002|Cohort 3: Dose Level 3|Progressive disease|15
1077434|NCT02100657|2135552|FG000|Cohort 3: Dose Level 3|Death|0
1077435|NCT02100657|2135553|FG001|Cohort 3: Dose Level 3|Death|0
1077436|NCT02100657|2135554|FG002|Cohort 3: Dose Level 3|Death|1
1077437|NCT02100657|2135552|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
1077438|NCT02100657|2135553|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
1077439|NCT02100657|2135554|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1
1077440|NCT02100657|2135552|FG000|Cohort 3: Dose Level 3|Physician Decision|0
1077441|NCT02100657|2135553|FG001|Cohort 3: Dose Level 3|Physician Decision|0
1077442|NCT02100657|2135554|FG002|Cohort 3: Dose Level 3|Physician Decision|1
1077443|NCT02100657|2135552|FG000|Cohort 3: Dose Level 3|Never were treated|0
1077444|NCT02100657|2135553|FG001|Cohort 3: Dose Level 3|Never were treated|0
1077445|NCT02100657|2135554|FG002|Cohort 3: Dose Level 3|Never were treated|3
1077446|NCT02100657|2135552|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0
1077447|NCT02100657|2135553|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0
1077448|NCT02100657|2135554|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3
1077449|NCT02100657|2135552|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0
1077450|NCT02100657|2135553|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0
1077451|NCT02100657|2135554|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3
1077452|NCT02100670|2135567|FG000|Overall Study|Adverse Event|10
1077453|NCT02100670|2135568|FG001|Overall Study|Adverse Event|3
1077454|NCT02100670|2135569|FG002|Overall Study|Adverse Event|3
1077455|NCT02100670|2135570|FG003|Overall Study|Adverse Event|0
1077456|NCT02100670|2135567|FG000|Overall Study|Lost to Follow-up|1
1077457|NCT02100670|2135568|FG001|Overall Study|Lost to Follow-up|0
1077458|NCT02100670|2135569|FG002|Overall Study|Lost to Follow-up|0
1077459|NCT02100670|2135570|FG003|Overall Study|Lost to Follow-up|0
1077460|NCT02100670|2135567|FG000|Overall Study|Protocol Violation|0
1077461|NCT02100670|2135568|FG001|Overall Study|Protocol Violation|1
1077462|NCT02100670|2135569|FG002|Overall Study|Protocol Violation|0
1077463|NCT02100670|2135570|FG003|Overall Study|Protocol Violation|1
1077464|NCT02100670|2135567|FG000|Overall Study|Withdrawal of Consent|0
1077465|NCT02100670|2135568|FG001|Overall Study|Withdrawal of Consent|1
1077466|NCT02100670|2135569|FG002|Overall Study|Withdrawal of Consent|1
1077467|NCT02100670|2135570|FG003|Overall Study|Withdrawal of Consent|0
1077468|NCT02100670|2135567|FG000|Overall Study|No swelling no pain|1
1077469|NCT02100670|2135568|FG001|Overall Study|No swelling no pain|0
1077470|NCT02100670|2135569|FG002|Overall Study|No swelling no pain|0
1077471|NCT02100670|2135570|FG003|Overall Study|No swelling no pain|0
1077472|NCT02100670|2135567|FG000|Overall Study|Poor Efficacy|0
1077473|NCT02100670|2135568|FG001|Overall Study|Poor Efficacy|1
1077474|NCT02100670|2135569|FG002|Overall Study|Poor Efficacy|0
1077475|NCT02100670|2135570|FG003|Overall Study|Poor Efficacy|0
1077476|NCT02100670|2135567|FG000|Overall Study|Physician Decision|0
1077477|NCT02100670|2135568|FG001|Overall Study|Physician Decision|1
1077478|NCT02100670|2135569|FG002|Overall Study|Physician Decision|0
1077479|NCT02100670|2135570|FG003|Overall Study|Physician Decision|0
1077480|NCT02100670|2135567|FG000|Overall Study|Withdrawal by Subject|1
1077481|NCT02100670|2135568|FG001|Overall Study|Withdrawal by Subject|0
1077482|NCT02100670|2135569|FG002|Overall Study|Withdrawal by Subject|0
1077483|NCT02100670|2135570|FG003|Overall Study|Withdrawal by Subject|0
1077484|NCT02100696|2135593|FG000|Induction Phase|Adverse Event|0
1077485|NCT02100696|2135594|FG001|Induction Phase|Adverse Event|0
1077486|NCT02100696|2135595|FG002|Induction Phase|Adverse Event|1
1077487|NCT02100696|2135596|FG003|Induction Phase|Adverse Event|0
1077488|NCT02100696|2135597|FG004|Induction Phase|Adverse Event|0
1077489|NCT02100696|2135598|FG005|Induction Phase|Adverse Event|0
1077490|NCT02100696|2135593|FG000|Induction Phase|Lost to Follow-up|1
1077491|NCT02100696|2135594|FG001|Induction Phase|Lost to Follow-up|0
1077492|NCT02100696|2135595|FG002|Induction Phase|Lost to Follow-up|1
1077493|NCT02100696|2135596|FG003|Induction Phase|Lost to Follow-up|0
1077494|NCT02100696|2135597|FG004|Induction Phase|Lost to Follow-up|0
1077495|NCT02100696|2135598|FG005|Induction Phase|Lost to Follow-up|0
1077496|NCT02100696|2135593|FG000|Induction Phase|Protocol Violation|0
1077497|NCT02100696|2135594|FG001|Induction Phase|Protocol Violation|1
1077498|NCT02100696|2135595|FG002|Induction Phase|Protocol Violation|1
1077499|NCT02100696|2135596|FG003|Induction Phase|Protocol Violation|0
1077500|NCT02100696|2135597|FG004|Induction Phase|Protocol Violation|0
1077501|NCT02100696|2135598|FG005|Induction Phase|Protocol Violation|0
1077502|NCT02100696|2135593|FG000|Induction Phase|Withdrawal by Subject|8
1077503|NCT02100696|2135594|FG001|Induction Phase|Withdrawal by Subject|2
1077504|NCT02100696|2135595|FG002|Induction Phase|Withdrawal by Subject|13
1077505|NCT02100696|2135596|FG003|Induction Phase|Withdrawal by Subject|0
1077506|NCT02100696|2135597|FG004|Induction Phase|Withdrawal by Subject|0
1077507|NCT02100696|2135598|FG005|Induction Phase|Withdrawal by Subject|0
1077508|NCT02100696|2135593|FG000|Induction Phase|Physician Decision|1
1077509|NCT02100696|2135594|FG001|Induction Phase|Physician Decision|0
1077510|NCT02100696|2135595|FG002|Induction Phase|Physician Decision|2
1077511|NCT02100696|2135596|FG003|Induction Phase|Physician Decision|0
1077512|NCT02100696|2135597|FG004|Induction Phase|Physician Decision|0
1077513|NCT02100696|2135598|FG005|Induction Phase|Physician Decision|0
1077514|NCT02100696|2135593|FG000|Induction Phase|Multiple Reasons|5
1077515|NCT02100696|2135594|FG001|Induction Phase|Multiple Reasons|2
1077516|NCT02100696|2135595|FG002|Induction Phase|Multiple Reasons|8
1077517|NCT02100696|2135596|FG003|Induction Phase|Multiple Reasons|0
1077518|NCT02100696|2135597|FG004|Induction Phase|Multiple Reasons|0
1077519|NCT02100696|2135598|FG005|Induction Phase|Multiple Reasons|0
1077520|NCT02100696|2135593|FG000|Maintenance Phase|Adverse Event|0
1077521|NCT02100696|2135594|FG001|Maintenance Phase|Adverse Event|0
1077522|NCT02100696|2135595|FG002|Maintenance Phase|Adverse Event|0
1077523|NCT02100696|2135596|FG003|Maintenance Phase|Adverse Event|0
1077524|NCT02100696|2135597|FG004|Maintenance Phase|Adverse Event|0
1077525|NCT02100696|2135598|FG005|Maintenance Phase|Adverse Event|2
1077526|NCT02100696|2135593|FG000|Maintenance Phase|Lost to Follow-up|0
1077527|NCT02100696|2135594|FG001|Maintenance Phase|Lost to Follow-up|0
1077528|NCT02100696|2135595|FG002|Maintenance Phase|Lost to Follow-up|0
1077529|NCT02100696|2135596|FG003|Maintenance Phase|Lost to Follow-up|0
1077530|NCT02100696|2135597|FG004|Maintenance Phase|Lost to Follow-up|1
1077531|NCT02100696|2135598|FG005|Maintenance Phase|Lost to Follow-up|0
1077532|NCT02100696|2135593|FG000|Maintenance Phase|Protocol Violation|0
1077533|NCT02100696|2135594|FG001|Maintenance Phase|Protocol Violation|0
1077534|NCT02100696|2135595|FG002|Maintenance Phase|Protocol Violation|0
1077535|NCT02100696|2135596|FG003|Maintenance Phase|Protocol Violation|0
1077536|NCT02100696|2135597|FG004|Maintenance Phase|Protocol Violation|1
1077537|NCT02100696|2135598|FG005|Maintenance Phase|Protocol Violation|0
1077538|NCT02100696|2135593|FG000|Maintenance Phase|Withdrawal by Subject|0
1077539|NCT02100696|2135594|FG001|Maintenance Phase|Withdrawal by Subject|0
1077540|NCT02100696|2135595|FG002|Maintenance Phase|Withdrawal by Subject|0
1077541|NCT02100696|2135596|FG003|Maintenance Phase|Withdrawal by Subject|1
1077542|NCT02100696|2135597|FG004|Maintenance Phase|Withdrawal by Subject|4
1077543|NCT02100696|2135598|FG005|Maintenance Phase|Withdrawal by Subject|2
1077544|NCT02100696|2135593|FG000|Maintenance Phase|Physician Decision|0
1077545|NCT02100696|2135594|FG001|Maintenance Phase|Physician Decision|0
1077546|NCT02100696|2135595|FG002|Maintenance Phase|Physician Decision|0
1077547|NCT02100696|2135596|FG003|Maintenance Phase|Physician Decision|0
1077548|NCT02100696|2135597|FG004|Maintenance Phase|Physician Decision|1
1077549|NCT02100696|2135598|FG005|Maintenance Phase|Physician Decision|0
1077550|NCT02100696|2135593|FG000|Maintenance Phase|Multiple Reasons|0
1077551|NCT02100696|2135594|FG001|Maintenance Phase|Multiple Reasons|0
1077552|NCT02100696|2135595|FG002|Maintenance Phase|Multiple Reasons|0
1077553|NCT02100696|2135596|FG003|Maintenance Phase|Multiple Reasons|0
1077554|NCT02100696|2135597|FG004|Maintenance Phase|Multiple Reasons|2
1077555|NCT02100696|2135598|FG005|Maintenance Phase|Multiple Reasons|1
1077556|NCT02100813|2135676|FG000|Overall Study|Adverse Event|0
1077557|NCT02100813|2135677|FG001|Overall Study|Adverse Event|0
1077558|NCT02100813|2135678|FG002|Overall Study|Adverse Event|0
1077559|NCT02100813|2135679|FG003|Overall Study|Adverse Event|0
1077560|NCT02100813|2135680|FG004|Overall Study|Adverse Event|0
1077561|NCT02100813|2135681|FG005|Overall Study|Adverse Event|0
1077562|NCT02100813|2135682|FG006|Overall Study|Adverse Event|0
1077563|NCT02100813|2135683|FG007|Overall Study|Adverse Event|1
1077564|NCT02100839|2135710|FG000|Multiple Ascending Dose|Adverse Event|2
1077565|NCT02100839|2135711|FG001|Multiple Ascending Dose|Adverse Event|0
1077566|NCT02100839|2135710|FG000|Multiple Ascending Dose|Withdrawal by Subject|2
1077567|NCT02100839|2135711|FG001|Multiple Ascending Dose|Withdrawal by Subject|0
1077568|NCT02100969|2135721|FG000|Overall Study|Did not pass screening phase|1
1077569|NCT02101021|2135735|FG000|Overall Study|Death|4
1077570|NCT02101021|2135736|FG001|Overall Study|Death|3
1077571|NCT02101021|2135737|FG002|Overall Study|Death|6
1077572|NCT02101021|2135738|FG003|Overall Study|Death|0
1077573|NCT02101021|2135739|FG004|Overall Study|Death|3
1077574|NCT02101021|2135735|FG000|Overall Study|Withdrew Consent from study|1
1077575|NCT02101021|2135736|FG001|Overall Study|Withdrew Consent from study|1
1077576|NCT02101021|2135737|FG002|Overall Study|Withdrew Consent from study|0
1077577|NCT02101021|2135738|FG003|Overall Study|Withdrew Consent from study|2
1077578|NCT02101021|2135739|FG004|Overall Study|Withdrew Consent from study|0
1077579|NCT02101021|2135735|FG000|Overall Study|Lost to Follow-up|1
1077580|NCT02101021|2135736|FG001|Overall Study|Lost to Follow-up|0
1077581|NCT02101021|2135737|FG002|Overall Study|Lost to Follow-up|0
1077582|NCT02101021|2135738|FG003|Overall Study|Lost to Follow-up|0
1077583|NCT02101021|2135739|FG004|Overall Study|Lost to Follow-up|0
1077584|NCT02101021|2135735|FG000|Overall Study|Study Terminated by Sponsor|1
1077585|NCT02101021|2135736|FG001|Overall Study|Study Terminated by Sponsor|0
1077586|NCT02101021|2135737|FG002|Overall Study|Study Terminated by Sponsor|1
1077587|NCT02101021|2135738|FG003|Overall Study|Study Terminated by Sponsor|1
1077588|NCT02101021|2135739|FG004|Overall Study|Study Terminated by Sponsor|1
1077589|NCT02101034|2135756|FG000|Overall Study|Enrolled but did not start treatment|0
1077590|NCT02101034|2135757|FG001|Overall Study|Enrolled but did not start treatment|0
1077591|NCT02101034|2135758|FG002|Overall Study|Enrolled but did not start treatment|1
1077592|NCT02101034|2135759|FG003|Overall Study|Enrolled but did not start treatment|0
1077593|NCT02101034|2135760|FG004|Overall Study|Enrolled but did not start treatment|0
1077594|NCT02101060|2135780|FG000|Overall Study|Adverse Event|1
1077595|NCT02101060|2135781|FG001|Overall Study|Adverse Event|0
1077596|NCT02101060|2135780|FG000|Overall Study|Withdrawal by Subject|1
1077597|NCT02101060|2135781|FG001|Overall Study|Withdrawal by Subject|1
1077598|NCT02101060|2135780|FG000|Overall Study|Lost to Follow-up|3
1077599|NCT02101060|2135781|FG001|Overall Study|Lost to Follow-up|3
1077600|NCT02101112|2135787|FG000|Overall Study|Adverse Event|0
1077601|NCT02101112|2135788|FG001|Overall Study|Adverse Event|0
1077602|NCT02101112|2135789|FG002|Overall Study|Adverse Event|1
1077603|NCT02101112|2135790|FG003|Overall Study|Adverse Event|0
1077604|NCT02101112|2135791|FG004|Overall Study|Adverse Event|0
1077605|NCT02101112|2135792|FG005|Overall Study|Adverse Event|0
1077606|NCT02101112|2135787|FG000|Overall Study|Withdrawal by Subject|0
1077607|NCT02101112|2135788|FG001|Overall Study|Withdrawal by Subject|0
1077608|NCT02101112|2135789|FG002|Overall Study|Withdrawal by Subject|0
1077609|NCT02101112|2135790|FG003|Overall Study|Withdrawal by Subject|0
1077610|NCT02101112|2135791|FG004|Overall Study|Withdrawal by Subject|1
1077611|NCT02101112|2135792|FG005|Overall Study|Withdrawal by Subject|0
1077612|NCT02101281|2135813|FG000|Overall Study|Adverse Event|0
1077613|NCT02101281|2135814|FG001|Overall Study|Adverse Event|1
1077614|NCT02101294|2135826|FG000|Overall Study|Withdrawal by Subject|5
1077615|NCT02101294|2135826|FG000|Overall Study|Lost to Follow-up|6
1077616|NCT02101359|2135835|FG000|Overall Study|Not included|23
1077617|NCT02101359|2135836|FG001|Overall Study|Not included|13
1077618|NCT02101359|2135835|FG000|Overall Study|Withdrawal by Subject|5
1077619|NCT02101359|2135836|FG001|Overall Study|Withdrawal by Subject|4
1077620|NCT02101359|2135835|FG000|Overall Study|Lost to Follow-up|1
1077621|NCT02101359|2135836|FG001|Overall Study|Lost to Follow-up|0
1077622|NCT02101359|2135835|FG000|Overall Study|Protocol Violation|0
1077623|NCT02101359|2135836|FG001|Overall Study|Protocol Violation|2
1077624|NCT02101554|2135884|FG000|Overall Study|Protocol Violation|0
1077625|NCT02101554|2135885|FG001|Overall Study|Protocol Violation|1
1077626|NCT02101554|2135886|FG002|Overall Study|Protocol Violation|0
1077627|NCT02101554|2135884|FG000|Overall Study|Insufficient Clinical Response|0
1077628|NCT02101554|2135885|FG001|Overall Study|Insufficient Clinical Response|2
1077629|NCT02101554|2135886|FG002|Overall Study|Insufficient Clinical Response|0
1077630|NCT02101554|2135884|FG000|Overall Study|Adverse Event|2
1077631|NCT02101554|2135885|FG001|Overall Study|Adverse Event|1
1077632|NCT02101554|2135886|FG002|Overall Study|Adverse Event|1
1077633|NCT02101554|2135884|FG000|Overall Study|Lost to Follow-up|0
1077634|NCT02101554|2135885|FG001|Overall Study|Lost to Follow-up|1
1077635|NCT02101554|2135886|FG002|Overall Study|Lost to Follow-up|0
1077636|NCT02101554|2135884|FG000|Overall Study|Withdrawl by Parents/Guardians|1
1077637|NCT02101554|2135885|FG001|Overall Study|Withdrawl by Parents/Guardians|0
1077638|NCT02101554|2135886|FG002|Overall Study|Withdrawl by Parents/Guardians|0
1077639|NCT02101983|2135912|FG000|Overall Study|Physician Decision|1
1077640|NCT02101983|2135913|FG001|Overall Study|Physician Decision|0
1077641|NCT02102204|2135928|FG000|Overall Study|Withdrawal by Subject|137
1077642|NCT02102204|2135928|FG000|Overall Study|Death|92
1077643|NCT02102204|2135928|FG000|Overall Study|Lost to Follow-up|65
1077644|NCT02102204|2135928|FG000|Overall Study|Sponsor Decision|5
1077645|NCT02102204|2135928|FG000|Overall Study|Ongoing|5
1077646|NCT02102399|2135948|FG000|Overall Study|Withdrawal by Subject|6
1077647|NCT02102399|2135949|FG001|Overall Study|Withdrawal by Subject|4
1077648|NCT02102464|2135962|FG000|Randomized Study|Withdrawal by Subject|0
1077649|NCT02102464|2135963|FG001|Randomized Study|Withdrawal by Subject|1
1077650|NCT02102464|2135964|FG002|Randomized Study|Withdrawal by Subject|0
1077651|NCT02102490|2135973|FG000|Overall Study|Death|6
1077652|NCT02102490|2135973|FG000|Overall Study|Lost to Follow-up|1
1077653|NCT02102724|2135979|FG000|Overall Study|Lost to Follow-up|1
1077654|NCT02102724|2135980|FG001|Overall Study|Lost to Follow-up|0
1077655|NCT02102724|2135979|FG000|Overall Study|surgery for brain aneurysm|1
1077656|NCT02102724|2135980|FG001|Overall Study|surgery for brain aneurysm|1
1077657|NCT02103062|2136021|FG000|Overall Study|Adverse Event|1
1077658|NCT02103062|2136022|FG001|Overall Study|Adverse Event|2
1077659|NCT02103062|2136021|FG000|Overall Study|Progressive Disease|17
1077660|NCT02103062|2136022|FG001|Overall Study|Progressive Disease|20
1077661|NCT02103062|2136021|FG000|Overall Study|Death|0
1077662|NCT02103062|2136022|FG001|Overall Study|Death|1
1077663|NCT02103439|2136091|FG000|Overall Study|Adverse Event|0
1077664|NCT02103439|2136092|FG001|Overall Study|Adverse Event|2
1077665|NCT02103439|2136091|FG000|Overall Study|Withdrawal by Subject|3
1077666|NCT02103439|2136092|FG001|Overall Study|Withdrawal by Subject|1
1077667|NCT02103478|2136109|FG000|Overall Study|Adverse Event|0
1077668|NCT02103478|2136110|FG001|Overall Study|Adverse Event|0
1077669|NCT02103478|2136111|FG002|Overall Study|Adverse Event|1
1077670|NCT02103478|2136112|FG003|Overall Study|Adverse Event|1
1077671|NCT02103478|2136113|FG004|Overall Study|Adverse Event|2
1077672|NCT02103478|2136114|FG005|Overall Study|Adverse Event|1
1077673|NCT02103478|2136115|FG006|Overall Study|Adverse Event|0
1077674|NCT02103478|2136116|FG007|Overall Study|Adverse Event|0
1077675|NCT02103478|2136117|FG008|Overall Study|Adverse Event|0
1077676|NCT02103478|2136109|FG000|Overall Study|Death|2
1077677|NCT02103478|2136110|FG001|Overall Study|Death|2
1077678|NCT02103478|2136111|FG002|Overall Study|Death|1
1077679|NCT02103478|2136112|FG003|Overall Study|Death|1
1077680|NCT02103478|2136113|FG004|Overall Study|Death|5
1077681|NCT02103478|2136114|FG005|Overall Study|Death|15
1077682|NCT02103478|2136115|FG006|Overall Study|Death|14
1077683|NCT02103478|2136116|FG007|Overall Study|Death|10
1077684|NCT02103478|2136117|FG008|Overall Study|Death|11
1077685|NCT02103478|2136109|FG000|Overall Study|Progressive Disease|2
1077686|NCT02103478|2136110|FG001|Overall Study|Progressive Disease|1
1077687|NCT02103478|2136111|FG002|Overall Study|Progressive Disease|2
1077688|NCT02103478|2136112|FG003|Overall Study|Progressive Disease|0
1077689|NCT02103478|2136113|FG004|Overall Study|Progressive Disease|9
1077690|NCT02103478|2136114|FG005|Overall Study|Progressive Disease|1
1077691|NCT02103478|2136115|FG006|Overall Study|Progressive Disease|2
1077692|NCT02103478|2136116|FG007|Overall Study|Progressive Disease|0
1077693|NCT02103478|2136117|FG008|Overall Study|Progressive Disease|1
1077694|NCT02103478|2136109|FG000|Overall Study|Withdrawal by Subject|2
1077695|NCT02103478|2136110|FG001|Overall Study|Withdrawal by Subject|0
1077696|NCT02103478|2136111|FG002|Overall Study|Withdrawal by Subject|0
1077697|NCT02103478|2136112|FG003|Overall Study|Withdrawal by Subject|4
1077698|NCT02103478|2136113|FG004|Overall Study|Withdrawal by Subject|0
1077699|NCT02103478|2136114|FG005|Overall Study|Withdrawal by Subject|0
1077700|NCT02103478|2136115|FG006|Overall Study|Withdrawal by Subject|1
1077701|NCT02103478|2136116|FG007|Overall Study|Withdrawal by Subject|1
1077702|NCT02103478|2136117|FG008|Overall Study|Withdrawal by Subject|0
1077703|NCT02103478|2136109|FG000|Overall Study|Lost to Follow-up|0
1077704|NCT02103478|2136110|FG001|Overall Study|Lost to Follow-up|0
1077705|NCT02103478|2136111|FG002|Overall Study|Lost to Follow-up|0
1077706|NCT02103478|2136112|FG003|Overall Study|Lost to Follow-up|0
1077707|NCT02103478|2136113|FG004|Overall Study|Lost to Follow-up|0
1077708|NCT02103478|2136114|FG005|Overall Study|Lost to Follow-up|0
1077709|NCT02103478|2136115|FG006|Overall Study|Lost to Follow-up|0
1077710|NCT02103478|2136116|FG007|Overall Study|Lost to Follow-up|1
1077711|NCT02103478|2136117|FG008|Overall Study|Lost to Follow-up|0
1077712|NCT02103478|2136109|FG000|Overall Study|Other|1
1077713|NCT02103478|2136110|FG001|Overall Study|Other|3
1077714|NCT02103478|2136111|FG002|Overall Study|Other|2
1077715|NCT02103478|2136112|FG003|Overall Study|Other|0
1077716|NCT02103478|2136113|FG004|Overall Study|Other|3
1077717|NCT02103478|2136114|FG005|Overall Study|Other|8
1077718|NCT02103478|2136115|FG006|Overall Study|Other|8
1077719|NCT02103478|2136116|FG007|Overall Study|Other|4
1077720|NCT02103478|2136117|FG008|Overall Study|Other|2
1077721|NCT02104180|2136169|FG000|Overall Study|Protocol Violation|1
1077722|NCT02104180|2136170|FG001|Overall Study|Protocol Violation|0
1077723|NCT02104505|2136217|FG000|First Intervention (14 Days)|Adverse Event|2
1077724|NCT02104505|2136218|FG001|First Intervention (14 Days)|Adverse Event|0
1077725|NCT02104505|2136217|FG000|First Intervention (14 Days)|Withdrawal by Subject|0
1077726|NCT02104505|2136218|FG001|First Intervention (14 Days)|Withdrawal by Subject|1
1077727|NCT02104505|2136217|FG000|First Intervention (14 Days)|Lost to Follow-up|0
1077728|NCT02104505|2136218|FG001|First Intervention (14 Days)|Lost to Follow-up|1
1077729|NCT02104505|2136217|FG000|First Intervention (14 Days)|exclusionary condition|0
1077730|NCT02104505|2136218|FG001|First Intervention (14 Days)|exclusionary condition|1
1077731|NCT02104505|2136217|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
1077732|NCT02104505|2136218|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
1077733|NCT02104505|2136217|FG000|Second Intervention (14 Days)|Adverse Event|2
1077734|NCT02104505|2136218|FG001|Second Intervention (14 Days)|Adverse Event|0
1077735|NCT02104557|2136225|FG000|Overall Study|Adverse Event|24
1077736|NCT02104557|2136225|FG000|Overall Study|Lost to Follow-up|34
1077737|NCT02104557|2136225|FG000|Overall Study|Violated the usage and dosage|14
1077738|NCT02104557|2136225|FG000|Overall Study|No longer met inclusion/exclusion criteria|1
1077739|NCT02104557|2136225|FG000|Overall Study|Administered Sayana prior to the contract|1
1077740|NCT02104557|2136225|FG000|Overall Study|Other|17
1077741|NCT02104557|2136225|FG000|Overall Study|Change to other contraception methods|5
1077742|NCT02104557|2136225|FG000|Overall Study|Discontinuation due to no pain|1
1077743|NCT02104557|2136225|FG000|Overall Study|Withdrawal consent|2
1077744|NCT02104557|2136225|FG000|Overall Study|Refusal of administration due to unknown reasons|69
1077745|NCT02104557|2136225|FG000|Overall Study|Discontinuation of contraception|9
1077746|NCT02104583|2136234|FG000|Overall Study|New ICD or CRT-D implanted|2
1077747|NCT02104583|2136235|FG001|Overall Study|New ICD or CRT-D implanted|0
1077748|NCT02104583|2136236|FG002|Overall Study|New ICD or CRT-D implanted|1
1077749|NCT02104583|2136237|FG003|Overall Study|New ICD or CRT-D implanted|0
1077750|NCT02104583|2136238|FG004|Overall Study|New ICD or CRT-D implanted|0
1077751|NCT02104583|2136234|FG000|Overall Study|Death|2
1077752|NCT02104583|2136235|FG001|Overall Study|Death|1
1077753|NCT02104583|2136236|FG002|Overall Study|Death|3
1077754|NCT02104583|2136237|FG003|Overall Study|Death|3
1077755|NCT02104583|2136238|FG004|Overall Study|Death|5
1077756|NCT02104583|2136234|FG000|Overall Study|Subject required cardiac ablation|6
1077757|NCT02104583|2136235|FG001|Overall Study|Subject required cardiac ablation|4
1077758|NCT02104583|2136236|FG002|Overall Study|Subject required cardiac ablation|4
1077759|NCT02104583|2136237|FG003|Overall Study|Subject required cardiac ablation|5
1077760|NCT02104583|2136238|FG004|Overall Study|Subject required cardiac ablation|4
1077761|NCT02104583|2136234|FG000|Overall Study|Subject required prohibited medication|0
909476|NCT00788710|1886247|FG001|Overall Study|Lost to Follow-up|1
909477|NCT00788710|1886248|FG002|Overall Study|Lost to Follow-up|0
909478|NCT00788710|1886246|FG000|Overall Study|Physician Decision|2
909479|NCT00788710|1886247|FG001|Overall Study|Physician Decision|1
909480|NCT00788710|1886248|FG002|Overall Study|Physician Decision|0
909481|NCT00788710|1886246|FG000|Overall Study|Protocol Violation|0
909482|NCT00788710|1886247|FG001|Overall Study|Protocol Violation|1
909483|NCT00788710|1886248|FG002|Overall Study|Protocol Violation|1
909484|NCT00788710|1886246|FG000|Overall Study|Withdrawal by Subject|2
909485|NCT00788710|1886247|FG001|Overall Study|Withdrawal by Subject|2
909486|NCT00788710|1886248|FG002|Overall Study|Withdrawal by Subject|0
909487|NCT00788775|1886258|FG000|Overall Study|Progressive Disease|8
909488|NCT00788775|1886259|FG001|Overall Study|Progressive Disease|6
909489|NCT00788775|1886258|FG000|Overall Study|Withdrawal by Subject|0
909490|NCT00788775|1886259|FG001|Overall Study|Withdrawal by Subject|2
909491|NCT00788775|1886258|FG000|Overall Study|Patient Non-Compliance|1
909492|NCT00788775|1886259|FG001|Overall Study|Patient Non-Compliance|0
909493|NCT00788775|1886258|FG000|Overall Study|Patient's measurable disease resected.|1
909494|NCT00788775|1886259|FG001|Overall Study|Patient's measurable disease resected.|0
909495|NCT00788827|1886265|FG000|Overall Study|Lack of Efficacy|2
909496|NCT00788957|1886284|FG000|Part 1|Death|8
909497|NCT00788957|1886285|FG001|Part 1|Death|0
1077762|NCT02104583|2136235|FG001|Overall Study|Subject required prohibited medication|1
1077763|NCT02104583|2136236|FG002|Overall Study|Subject required prohibited medication|1
1077764|NCT02104583|2136237|FG003|Overall Study|Subject required prohibited medication|0
1077765|NCT02104583|2136238|FG004|Overall Study|Subject required prohibited medication|1
1077766|NCT02104583|2136234|FG000|Overall Study|Withdrew Consent|3
1077767|NCT02104583|2136235|FG001|Overall Study|Withdrew Consent|2
1077768|NCT02104583|2136236|FG002|Overall Study|Withdrew Consent|0
1077769|NCT02104583|2136237|FG003|Overall Study|Withdrew Consent|2
1077770|NCT02104583|2136238|FG004|Overall Study|Withdrew Consent|1
1077771|NCT02104583|2136234|FG000|Overall Study|Investigator's Discretion|1
1077772|NCT02104583|2136235|FG001|Overall Study|Investigator's Discretion|0
1077773|NCT02104583|2136236|FG002|Overall Study|Investigator's Discretion|0
1077774|NCT02104583|2136237|FG003|Overall Study|Investigator's Discretion|0
1077775|NCT02104583|2136238|FG004|Overall Study|Investigator's Discretion|0
1077776|NCT02104583|2136234|FG000|Overall Study|Protocol Violation|0
1077777|NCT02104583|2136235|FG001|Overall Study|Protocol Violation|0
1077778|NCT02104583|2136236|FG002|Overall Study|Protocol Violation|1
1077779|NCT02104583|2136237|FG003|Overall Study|Protocol Violation|0
1077780|NCT02104583|2136238|FG004|Overall Study|Protocol Violation|0
1077781|NCT02104583|2136234|FG000|Overall Study|Adverse Event|3
1077782|NCT02104583|2136235|FG001|Overall Study|Adverse Event|3
1077783|NCT02104583|2136236|FG002|Overall Study|Adverse Event|6
1077784|NCT02104583|2136237|FG003|Overall Study|Adverse Event|6
1077785|NCT02104583|2136238|FG004|Overall Study|Adverse Event|1
1077786|NCT02104583|2136234|FG000|Overall Study|Lost to Follow-up|1
1077787|NCT02104583|2136235|FG001|Overall Study|Lost to Follow-up|0
1077788|NCT02104583|2136236|FG002|Overall Study|Lost to Follow-up|0
1077789|NCT02104583|2136237|FG003|Overall Study|Lost to Follow-up|0
1077790|NCT02104583|2136238|FG004|Overall Study|Lost to Follow-up|0
1077791|NCT02104583|2136234|FG000|Overall Study|Randomized but Never Treated|0
1077792|NCT02104583|2136235|FG001|Overall Study|Randomized but Never Treated|0
1077793|NCT02104583|2136236|FG002|Overall Study|Randomized but Never Treated|0
1077794|NCT02104583|2136237|FG003|Overall Study|Randomized but Never Treated|1
1077795|NCT02104583|2136238|FG004|Overall Study|Randomized but Never Treated|0
1077796|NCT02104752|2136277|FG000|Overall Study|Withdrawal by Subject|1
1077797|NCT02104752|2136278|FG001|Overall Study|Withdrawal by Subject|0
1077798|NCT02104752|2136277|FG000|Overall Study|Weight gain; unrelated anxiety|0
1077799|NCT02104752|2136278|FG001|Overall Study|Weight gain; unrelated anxiety|2
1077800|NCT02104765|2136291|FG000|Overall Study|Lost to Follow-up|0
1077801|NCT02104765|2136292|FG001|Overall Study|Lost to Follow-up|0
1077802|NCT02104765|2136293|FG002|Overall Study|Lost to Follow-up|1
1077803|NCT02104765|2136294|FG003|Overall Study|Lost to Follow-up|0
1077804|NCT02104765|2136295|FG004|Overall Study|Lost to Follow-up|0
1077805|NCT02104765|2136296|FG005|Overall Study|Lost to Follow-up|0
1077806|NCT02104765|2136297|FG006|Overall Study|Lost to Follow-up|0
1077807|NCT02104765|2136291|FG000|Overall Study|Withdrawal by Subject|0
1077808|NCT02104765|2136292|FG001|Overall Study|Withdrawal by Subject|0
1077809|NCT02104765|2136293|FG002|Overall Study|Withdrawal by Subject|0
1077810|NCT02104765|2136294|FG003|Overall Study|Withdrawal by Subject|1
1077811|NCT02104765|2136295|FG004|Overall Study|Withdrawal by Subject|1
1077812|NCT02104765|2136296|FG005|Overall Study|Withdrawal by Subject|0
1077813|NCT02104765|2136297|FG006|Overall Study|Withdrawal by Subject|1
1077814|NCT02104804|2136321|FG000|Overall Study|Did not take study medication|0
1077815|NCT02104804|2136322|FG001|Overall Study|Did not take study medication|1
1077816|NCT02104804|2136321|FG000|Overall Study|Study specific discontinuation criteria|6
1077817|NCT02104804|2136322|FG001|Overall Study|Study specific discontinuation criteria|1
1077818|NCT02104804|2136321|FG000|Overall Study|Other listed|2
1077819|NCT02104804|2136322|FG001|Overall Study|Other listed|1
1077820|NCT02104804|2136321|FG000|Overall Study|Protocol Violation|0
1077821|NCT02104804|2136322|FG001|Overall Study|Protocol Violation|1
1077822|NCT02104804|2136321|FG000|Overall Study|Adverse Event|4
1077823|NCT02104804|2136322|FG001|Overall Study|Adverse Event|3
1077824|NCT02104804|2136321|FG000|Overall Study|Withdrawal by Subject|4
1077825|NCT02104804|2136322|FG001|Overall Study|Withdrawal by Subject|12
1077826|NCT02104817|2136330|FG000|Overall Study|Death|363
1077827|NCT02104817|2136331|FG001|Overall Study|Death|330
1077828|NCT02104817|2136330|FG000|Overall Study|Lost to Follow-up|3
1077829|NCT02104817|2136331|FG001|Overall Study|Lost to Follow-up|2
1077830|NCT02104817|2136330|FG000|Overall Study|Protocol Violation|0
1077831|NCT02104817|2136331|FG001|Overall Study|Protocol Violation|1
1077832|NCT02104817|2136330|FG000|Overall Study|Study terminated by sponsor|5854
1077833|NCT02104817|2136331|FG001|Overall Study|Study terminated by sponsor|5901
1077834|NCT02104817|2136330|FG000|Overall Study|Withdrawal by Subject|111
1077835|NCT02104817|2136331|FG001|Overall Study|Withdrawal by Subject|78
1077836|NCT02104817|2136330|FG000|Overall Study|Other reasons|128
1077837|NCT02104817|2136331|FG001|Overall Study|Other reasons|135
1077838|NCT02104895|2136352|FG000|Overall Study|Withdrawal by Subject|0
1077839|NCT02104895|2136353|FG001|Overall Study|Withdrawal by Subject|14
1077840|NCT02104947|2136361|FG000|Overall Study|Withdrawal by Subject|10
1077841|NCT02104947|2136362|FG001|Overall Study|Withdrawal by Subject|3
1077842|NCT02104947|2136361|FG000|Overall Study|Lost to Follow-up|4
1077843|NCT02104947|2136362|FG001|Overall Study|Lost to Follow-up|4
1077844|NCT02104947|2136361|FG000|Overall Study|Protocol Violation|6
1077845|NCT02104947|2136362|FG001|Overall Study|Protocol Violation|8
1077846|NCT02104947|2136361|FG000|Overall Study|Adverse Event|57
1077847|NCT02104947|2136362|FG001|Overall Study|Adverse Event|38
1077848|NCT02104947|2136361|FG000|Overall Study|Other than stated above|2
1077849|NCT02104947|2136362|FG001|Overall Study|Other than stated above|3
1077850|NCT02105012|2136372|FG000|Overall Study|Withdrawal by Subject|11
1077851|NCT02105012|2136372|FG000|Overall Study|Protocol Specified Criteria|9
1077852|NCT02105012|2136372|FG000|Overall Study|Lost to Follow-up|4
1077853|NCT02105012|2136372|FG000|Overall Study|Protocol Violation|4
1077854|NCT02105012|2136372|FG000|Overall Study|Physician Decision|3
1077855|NCT02105012|2136372|FG000|Overall Study|Adverse Event|1
1077856|NCT02105012|2136372|FG000|Overall Study|Lack of Efficacy|1
1077857|NCT02105272|2136399|FG000|Overall Study|Adverse Event|1
1077858|NCT02105272|2136400|FG001|Overall Study|Adverse Event|2
1077859|NCT02105272|2136399|FG000|Overall Study|Physician Decision|0
1077860|NCT02105272|2136400|FG001|Overall Study|Physician Decision|1
1077861|NCT02105272|2136399|FG000|Overall Study|Protocol Violation|2
1077862|NCT02105272|2136400|FG001|Overall Study|Protocol Violation|0
1077863|NCT02105272|2136399|FG000|Overall Study|Withdrawal by Subject|2
1077864|NCT02105272|2136400|FG001|Overall Study|Withdrawal by Subject|0
1077865|NCT02105285|2136409|FG000|Overall Study|Adverse Event|1
1077866|NCT02105285|2136410|FG001|Overall Study|Adverse Event|1
1077867|NCT02105285|2136411|FG002|Overall Study|Adverse Event|0
1077868|NCT02105285|2136409|FG000|Overall Study|Protocol Violation|0
1077869|NCT02105285|2136410|FG001|Overall Study|Protocol Violation|1
1077870|NCT02105285|2136411|FG002|Overall Study|Protocol Violation|0
1077871|NCT02105285|2136409|FG000|Overall Study|Withdrawal by Subject|1
1077872|NCT02105285|2136410|FG001|Overall Study|Withdrawal by Subject|0
1077873|NCT02105285|2136411|FG002|Overall Study|Withdrawal by Subject|0
1077874|NCT02105454|2136442|FG000|Overall Study|Withdrawal by Subject|1
1077875|NCT02105467|2136448|FG000|Period 1|Lost to Follow-up|1
1077876|NCT02105467|2136449|FG001|Period 1|Lost to Follow-up|0
1077877|NCT02105467|2136448|FG000|Period 1|Death|1
1077878|NCT02105467|2136449|FG001|Period 1|Death|0
1077879|NCT02105467|2136448|FG000|Period 2|Lost to Follow-up|1
1077880|NCT02105467|2136449|FG001|Period 2|Lost to Follow-up|0
1077881|NCT02105467|2136448|FG000|Period 2|Death|1
1077882|NCT02105467|2136449|FG001|Period 2|Death|0
1077883|NCT02105467|2136448|FG000|Period 2|Withdrawal by Subject|0
1077884|NCT02105467|2136449|FG001|Period 2|Withdrawal by Subject|2
1077885|NCT02105467|2136448|FG000|Period 3|Lost to Follow-up|0
1077886|NCT02105467|2136449|FG001|Period 3|Lost to Follow-up|1
1077905|NCT02105662|2136475|FG000|Overall Study|Lost to Follow-up|5
1077906|NCT02105662|2136475|FG000|Overall Study|Withdrawal by Subject|1
1077907|NCT02105688|2136481|FG000|Part A: Double-Blind|Adverse Event|1
1077908|NCT02105688|2136482|FG001|Part A: Double-Blind|Adverse Event|0
1077909|NCT02105688|2136481|FG000|Part A: Double-Blind|Death|0
1077910|NCT02105688|2136482|FG001|Part A: Double-Blind|Death|1
1077911|NCT02105688|2136481|FG000|Part A: Double-Blind|Lost to Follow-up|15
1077912|NCT02105688|2136482|FG001|Part A: Double-Blind|Lost to Follow-up|11
1077913|NCT02105688|2136481|FG000|Part A: Double-Blind|Physician Decision|0
1077914|NCT02105688|2136482|FG001|Part A: Double-Blind|Physician Decision|1
1077915|NCT02105688|2136481|FG000|Part A: Double-Blind|Status Unknown|0
1077916|NCT02105688|2136482|FG001|Part A: Double-Blind|Status Unknown|2
1077917|NCT02105688|2136481|FG000|Part A: Double-Blind|Withdrawal by Subject|4
1077918|NCT02105688|2136482|FG001|Part A: Double-Blind|Withdrawal by Subject|2
1077919|NCT02105688|2136481|FG000|Part B: Observational Follow-up|Death|2
1077920|NCT02105688|2136482|FG001|Part B: Observational Follow-up|Death|1
1077921|NCT02105688|2136481|FG000|Part B: Observational Follow-up|Lost to Follow-up|23
1077922|NCT02105688|2136482|FG001|Part B: Observational Follow-up|Lost to Follow-up|15
1077923|NCT02105688|2136481|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9
1077924|NCT02105688|2136482|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3
1077925|NCT02105688|2136481|FG000|Part B: Observational Follow-up|Physician Decision|3
1077926|NCT02105688|2136482|FG001|Part B: Observational Follow-up|Physician Decision|1
1077927|NCT02105701|2136493|FG000|Overall Study|Lost to Follow-up|1
1077928|NCT02105701|2136494|FG001|Overall Study|Lost to Follow-up|0
1077929|NCT02105701|2136495|FG002|Overall Study|Lost to Follow-up|2
1077930|NCT02105701|2136496|FG003|Overall Study|Lost to Follow-up|1
1077931|NCT02105701|2136493|FG000|Overall Study|Protocol Violation|0
1077932|NCT02105701|2136494|FG001|Overall Study|Protocol Violation|0
1077933|NCT02105701|2136495|FG002|Overall Study|Protocol Violation|1
1077934|NCT02105701|2136496|FG003|Overall Study|Protocol Violation|0
1077935|NCT02105701|2136493|FG000|Overall Study|Withdrawal by Subject|2
1077936|NCT02105701|2136494|FG001|Overall Study|Withdrawal by Subject|1
1077937|NCT02105701|2136495|FG002|Overall Study|Withdrawal by Subject|0
1077938|NCT02105701|2136496|FG003|Overall Study|Withdrawal by Subject|1
1077939|NCT02105701|2136493|FG000|Overall Study|Death|1
1077940|NCT02105701|2136494|FG001|Overall Study|Death|0
1077941|NCT02105701|2136495|FG002|Overall Study|Death|0
1077942|NCT02105701|2136496|FG003|Overall Study|Death|0
1077943|NCT02105948|2136521|FG000|Overall Study|Adverse Event|10
1077944|NCT02105948|2136522|FG001|Overall Study|Adverse Event|7
1077945|NCT02105948|2136523|FG002|Overall Study|Adverse Event|11
1077946|NCT02105948|2136524|FG003|Overall Study|Adverse Event|11
1077947|NCT02105948|2136521|FG000|Overall Study|Lack of Efficacy|0
1077948|NCT02105948|2136522|FG001|Overall Study|Lack of Efficacy|1
1077949|NCT02105948|2136523|FG002|Overall Study|Lack of Efficacy|3
1077950|NCT02105948|2136524|FG003|Overall Study|Lack of Efficacy|2
1077951|NCT02105948|2136521|FG000|Overall Study|Lost to Follow-up|0
1077952|NCT02105948|2136522|FG001|Overall Study|Lost to Follow-up|0
1077953|NCT02105948|2136523|FG002|Overall Study|Lost to Follow-up|2
1077954|NCT02105948|2136524|FG003|Overall Study|Lost to Follow-up|1
1077955|NCT02105948|2136521|FG000|Overall Study|Physician Decision|2
1077956|NCT02105948|2136522|FG001|Overall Study|Physician Decision|2
1077957|NCT02105948|2136523|FG002|Overall Study|Physician Decision|2
1077958|NCT02105948|2136524|FG003|Overall Study|Physician Decision|2
1077959|NCT02105948|2136521|FG000|Overall Study|Withdrawal by Subject|15
1077960|NCT02105948|2136522|FG001|Overall Study|Withdrawal by Subject|10
1077961|NCT02105948|2136523|FG002|Overall Study|Withdrawal by Subject|10
1077962|NCT02105948|2136524|FG003|Overall Study|Withdrawal by Subject|11
1077963|NCT02105961|2136538|FG000|Overall Study|Adverse Event|18
1077964|NCT02105961|2136539|FG001|Overall Study|Adverse Event|7
1077965|NCT02105961|2136540|FG002|Overall Study|Adverse Event|13
1077966|NCT02105961|2136538|FG000|Overall Study|Lack of Efficacy|3
1077967|NCT02105961|2136539|FG001|Overall Study|Lack of Efficacy|0
1077968|NCT02105961|2136540|FG002|Overall Study|Lack of Efficacy|3
1077969|NCT02105961|2136538|FG000|Overall Study|Lost to Follow-up|2
1077970|NCT02105961|2136539|FG001|Overall Study|Lost to Follow-up|0
1077971|NCT02105961|2136540|FG002|Overall Study|Lost to Follow-up|1
1077972|NCT02105961|2136538|FG000|Overall Study|Physician Decision|3
1077973|NCT02105961|2136539|FG001|Overall Study|Physician Decision|3
1077974|NCT02105961|2136540|FG002|Overall Study|Physician Decision|2
1077975|NCT02105961|2136538|FG000|Overall Study|Withdrawal by Subject|15
1077976|NCT02105961|2136539|FG001|Overall Study|Withdrawal by Subject|7
1077977|NCT02105961|2136540|FG002|Overall Study|Withdrawal by Subject|11
1077978|NCT02105974|2136551|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158
1077979|NCT02105974|2136552|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0
1077980|NCT02105974|2136553|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0
1077981|NCT02105974|2136551|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
1077982|NCT02105974|2136552|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
1077983|NCT02105974|2136553|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
1077984|NCT02105974|2136551|FG000|2 Week Run-in Period|Adverse Event|6
1077985|NCT02105974|2136552|FG001|2 Week Run-in Period|Adverse Event|0
1077986|NCT02105974|2136553|FG002|2 Week Run-in Period|Adverse Event|0
1077987|NCT02105974|2136551|FG000|2 Week Run-in Period|Study closed/terminated|1
1077988|NCT02105974|2136552|FG001|2 Week Run-in Period|Study closed/terminated|0
1077989|NCT02105974|2136553|FG002|2 Week Run-in Period|Study closed/terminated|0
1077990|NCT02105974|2136551|FG000|2 Week Run-in Period|Lost to Follow-up|2
1077991|NCT02105974|2136552|FG001|2 Week Run-in Period|Lost to Follow-up|0
1077992|NCT02105974|2136553|FG002|2 Week Run-in Period|Lost to Follow-up|0
1077993|NCT02105974|2136551|FG000|2 Week Run-in Period|Withdrew consent|23
1077994|NCT02105974|2136552|FG001|2 Week Run-in Period|Withdrew consent|0
1077995|NCT02105974|2136553|FG002|2 Week Run-in Period|Withdrew consent|0
1077996|NCT02105974|2136551|FG000|2 Week Run-in Period|Investigator discretion|8
1077997|NCT02105974|2136552|FG001|2 Week Run-in Period|Investigator discretion|0
1077998|NCT02105974|2136553|FG002|2 Week Run-in Period|Investigator discretion|0
1077999|NCT02105974|2136551|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
1078000|NCT02105974|2136552|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
1078001|NCT02105974|2136553|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
1078002|NCT02105974|2136551|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
1078003|NCT02105974|2136552|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
1078004|NCT02105974|2136553|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
1078005|NCT02105974|2136551|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
1078006|NCT02105974|2136552|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
1078007|NCT02105974|2136553|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
1078008|NCT02105974|2136551|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
1078009|NCT02105974|2136552|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
1078010|NCT02105974|2136553|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
1078011|NCT02105974|2136551|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
1078012|NCT02105974|2136552|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
1078013|NCT02105974|2136553|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
1078014|NCT02105974|2136551|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
1078015|NCT02105974|2136552|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
1078016|NCT02105974|2136553|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
1078017|NCT02105974|2136551|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
1078018|NCT02105974|2136552|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
1078019|NCT02105974|2136553|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
1078020|NCT02105987|2136561|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10
1078021|NCT02105987|2136562|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0
1078022|NCT02105987|2136563|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0
1078023|NCT02105987|2136564|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0
1078024|NCT02105987|2136565|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0
1078025|NCT02105987|2136566|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0
1078026|NCT02105987|2136561|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15
1078027|NCT02105987|2136562|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17
1078028|NCT02105987|2136563|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0
1078029|NCT02105987|2136564|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0
1078030|NCT02105987|2136565|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0
1078031|NCT02105987|2136566|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0
1078032|NCT02105987|2136561|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
1078033|NCT02105987|2136562|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
1078034|NCT02105987|2136563|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1078035|NCT02105987|2136564|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1078036|NCT02105987|2136565|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1078037|NCT02105987|2136566|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1078038|NCT02105987|2136561|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
1078039|NCT02105987|2136562|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
1078040|NCT02105987|2136563|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1078041|NCT02105987|2136564|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1078042|NCT02105987|2136565|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1078043|NCT02105987|2136566|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1078044|NCT02105987|2136561|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4
1078045|NCT02105987|2136562|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3
1078046|NCT02105987|2136563|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0
1078047|NCT02105987|2136564|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0
1078048|NCT02105987|2136565|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0
1078049|NCT02105987|2136566|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0
1078050|NCT02105987|2136561|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1078051|NCT02105987|2136562|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
1078052|NCT02105987|2136563|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1078053|NCT02105987|2136564|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1078054|NCT02105987|2136565|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1078055|NCT02105987|2136566|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1078056|NCT02105987|2136561|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0
1078057|NCT02105987|2136562|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0
1078058|NCT02105987|2136563|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10
1078059|NCT02105987|2136564|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4
1078060|NCT02105987|2136565|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0
1078061|NCT02105987|2136566|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0
1078062|NCT02105987|2136561|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0
1078063|NCT02105987|2136562|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0
1078064|NCT02105987|2136563|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15
1078065|NCT02105987|2136564|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1
1078066|NCT02105987|2136565|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0
1078067|NCT02105987|2136566|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0
1078068|NCT02105987|2136561|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1078069|NCT02105987|2136562|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1078070|NCT02105987|2136563|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
1078071|NCT02105987|2136564|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
1078072|NCT02105987|2136565|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1078073|NCT02105987|2136566|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1078074|NCT02105987|2136561|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1078075|NCT02105987|2136562|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1078076|NCT02105987|2136563|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
1078077|NCT02105987|2136564|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
1078078|NCT02105987|2136565|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1078079|NCT02105987|2136566|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1078080|NCT02105987|2136561|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0
1078081|NCT02105987|2136562|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0
1078082|NCT02105987|2136563|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5
1078083|NCT02105987|2136564|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0
1078084|NCT02105987|2136565|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0
1078085|NCT02105987|2136566|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0
1078086|NCT02105987|2136561|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1078087|NCT02105987|2136562|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1078088|NCT02105987|2136563|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1078089|NCT02105987|2136564|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
1078090|NCT02105987|2136565|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1078091|NCT02105987|2136566|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1078092|NCT02105987|2136561|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0
1078093|NCT02105987|2136562|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0
1078094|NCT02105987|2136563|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1
1078095|NCT02105987|2136564|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0
1078096|NCT02105987|2136565|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0
1078097|NCT02105987|2136566|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0
1078098|NCT02105987|2136561|FG000|Continuation Phase|Protocol Violation|0
1078099|NCT02105987|2136562|FG001|Continuation Phase|Protocol Violation|0
1078100|NCT02105987|2136563|FG002|Continuation Phase|Protocol Violation|0
1078101|NCT02105987|2136564|FG003|Continuation Phase|Protocol Violation|0
1078102|NCT02105987|2136565|FG004|Continuation Phase|Protocol Violation|1
1078103|NCT02105987|2136566|FG005|Continuation Phase|Protocol Violation|0
1078104|NCT02106156|2136588|FG000|Overall Study|Patient Died|19
1078105|NCT02106156|2136589|FG001|Overall Study|Patient Died|0
1078106|NCT02106156|2136590|FG002|Overall Study|Patient Died|0
1078107|NCT02106156|2136588|FG000|Overall Study|Lack of Tolerability|305
1078108|NCT02106156|2136589|FG001|Overall Study|Lack of Tolerability|3
1078109|NCT02106156|2136590|FG002|Overall Study|Lack of Tolerability|0
1078110|NCT02106156|2136588|FG000|Overall Study|Lack of Virological Response|1044
1078111|NCT02106156|2136589|FG001|Overall Study|Lack of Virological Response|8
1078112|NCT02106156|2136590|FG002|Overall Study|Lack of Virological Response|0
1078113|NCT02106156|2136588|FG000|Overall Study|Concomitant Disease|74
1078114|NCT02106156|2136589|FG001|Overall Study|Concomitant Disease|2
1078115|NCT02106156|2136590|FG002|Overall Study|Concomitant Disease|0
1078116|NCT02106156|2136588|FG000|Overall Study|Lack of Compliance|211
1078117|NCT02106156|2136589|FG001|Overall Study|Lack of Compliance|7
1078118|NCT02106156|2136590|FG002|Overall Study|Lack of Compliance|0
1078119|NCT02106156|2136588|FG000|Overall Study|Patients Request|307
1078120|NCT02106156|2136589|FG001|Overall Study|Patients Request|9
1078121|NCT02106156|2136590|FG002|Overall Study|Patients Request|0
1078122|NCT02106156|2136588|FG000|Overall Study|Lost to Follow-up|451
1078123|NCT02106156|2136589|FG001|Overall Study|Lost to Follow-up|8
1078124|NCT02106156|2136590|FG002|Overall Study|Lost to Follow-up|0
1078125|NCT02106156|2136588|FG000|Overall Study|Unplanned Event|82
1078126|NCT02106156|2136589|FG001|Overall Study|Unplanned Event|2
1078127|NCT02106156|2136590|FG002|Overall Study|Unplanned Event|0
1078128|NCT02106156|2136588|FG000|Overall Study|Change of Laboratory Parameter|10
1078129|NCT02106156|2136589|FG001|Overall Study|Change of Laboratory Parameter|0
1078130|NCT02106156|2136590|FG002|Overall Study|Change of Laboratory Parameter|0
1078131|NCT02106156|2136588|FG000|Overall Study|Hospitalization/Surgical Intervention|6
1078132|NCT02106156|2136589|FG001|Overall Study|Hospitalization/Surgical Intervention|0
1078133|NCT02106156|2136590|FG002|Overall Study|Hospitalization/Surgical Intervention|0
1078134|NCT02106156|2136588|FG000|Overall Study|Relocation/Change of Physician|40
1078135|NCT02106156|2136589|FG001|Overall Study|Relocation/Change of Physician|1
1078136|NCT02106156|2136590|FG002|Overall Study|Relocation/Change of Physician|0
1078137|NCT02106195|2136597|FG000|Overall Study|Adverse Event|2
1078138|NCT02106195|2136597|FG000|Overall Study|Protocol Violation|1
1078139|NCT02106325|2136609|FG000|Phase 1|Lost to Follow-up|2
1078140|NCT02106325|2136610|FG001|Phase 1|Lost to Follow-up|2
1078141|NCT02106325|2136609|FG000|Phase 2|Lost to Follow-up|2
1078142|NCT02106325|2136610|FG001|Phase 2|Lost to Follow-up|3
1078143|NCT02106325|2136609|FG000|Phase 3|Lost to Follow-up|2
1078144|NCT02106325|2136610|FG001|Phase 3|Lost to Follow-up|1
1078145|NCT02106351|2136619|FG000|Treatment Cycle 1|Adverse Event|2
1078146|NCT02106351|2136620|FG001|Treatment Cycle 1|Adverse Event|0
1078147|NCT02106351|2136621|FG002|Treatment Cycle 1|Adverse Event|0
1078148|NCT02106351|2136619|FG000|Treatment Cycle 1|Consent withdrawn|1
1078149|NCT02106351|2136620|FG001|Treatment Cycle 1|Consent withdrawn|0
1078150|NCT02106351|2136621|FG002|Treatment Cycle 1|Consent withdrawn|2
1078151|NCT02106351|2136619|FG000|Treatment Cycle 1|Lost to Follow-up|1
1078152|NCT02106351|2136620|FG001|Treatment Cycle 1|Lost to Follow-up|0
1078153|NCT02106351|2136621|FG002|Treatment Cycle 1|Lost to Follow-up|0
1078154|NCT02106351|2136619|FG000|Treatment Cycle 1|Other|0
1078155|NCT02106351|2136620|FG001|Treatment Cycle 1|Other|3
1078156|NCT02106351|2136621|FG002|Treatment Cycle 1|Other|1
1078157|NCT02106351|2136619|FG000|Treatment Cycle 1|Randomised but not treated|1
1078158|NCT02106351|2136620|FG001|Treatment Cycle 1|Randomised but not treated|0
1078159|NCT02106351|2136621|FG002|Treatment Cycle 1|Randomised but not treated|1
1078160|NCT02106351|2136619|FG000|Treatment Cycle 2|Adverse Event|0
1078161|NCT02106351|2136620|FG001|Treatment Cycle 2|Adverse Event|2
1078162|NCT02106351|2136621|FG002|Treatment Cycle 2|Adverse Event|0
1078163|NCT02106351|2136619|FG000|Treatment Cycle 2|Consent withdrawn|0
1078164|NCT02106351|2136620|FG001|Treatment Cycle 2|Consent withdrawn|1
1078165|NCT02106351|2136621|FG002|Treatment Cycle 2|Consent withdrawn|1
1078166|NCT02106351|2136619|FG000|Treatment Cycle 2|Other|0
1078167|NCT02106351|2136620|FG001|Treatment Cycle 2|Other|2
1078168|NCT02106351|2136621|FG002|Treatment Cycle 2|Other|2
1078169|NCT02106351|2136619|FG000|Treatment Cycle 3|Adverse Event|0
1078170|NCT02106351|2136620|FG001|Treatment Cycle 3|Adverse Event|1
1078171|NCT02106351|2136621|FG002|Treatment Cycle 3|Adverse Event|0
1078172|NCT02106351|2136619|FG000|Treatment Cycle 3|Consent withdrawn|0
1078173|NCT02106351|2136620|FG001|Treatment Cycle 3|Consent withdrawn|0
1078174|NCT02106351|2136621|FG002|Treatment Cycle 3|Consent withdrawn|2
1078175|NCT02106351|2136619|FG000|Treatment Cycle 3|Lost to Follow-up|0
1078176|NCT02106351|2136620|FG001|Treatment Cycle 3|Lost to Follow-up|1
1078177|NCT02106351|2136621|FG002|Treatment Cycle 3|Lost to Follow-up|0
1078178|NCT02106351|2136619|FG000|Treatment Cycle 3|Other|0
1078179|NCT02106351|2136620|FG001|Treatment Cycle 3|Other|2
1078180|NCT02106351|2136621|FG002|Treatment Cycle 3|Other|3
1078181|NCT02106351|2136619|FG000|Treatment Cycle 4|Consent withdrawn|0
1078182|NCT02106351|2136620|FG001|Treatment Cycle 4|Consent withdrawn|0
1078183|NCT02106351|2136621|FG002|Treatment Cycle 4|Consent withdrawn|2
1078184|NCT02106351|2136619|FG000|Treatment Cycle 4|Other|0
1078185|NCT02106351|2136620|FG001|Treatment Cycle 4|Other|1
1078186|NCT02106351|2136621|FG002|Treatment Cycle 4|Other|0
1078187|NCT02106390|2136638|FG000|Overall Study|Withdrawal by Subject|15
1078188|NCT02106390|2136639|FG001|Overall Study|Withdrawal by Subject|16
1078189|NCT02106390|2136640|FG002|Overall Study|Withdrawal by Subject|15
1078190|NCT02106390|2136638|FG000|Overall Study|Lost to Follow-up|25
1078191|NCT02106390|2136639|FG001|Overall Study|Lost to Follow-up|20
1078192|NCT02106390|2136640|FG002|Overall Study|Lost to Follow-up|13
1078193|NCT02106390|2136638|FG000|Overall Study|Other: Administrative Reason|8
1078194|NCT02106390|2136639|FG001|Overall Study|Other: Administrative Reason|5
1078195|NCT02106390|2136640|FG002|Overall Study|Other: Administrative Reason|12
1078196|NCT02106390|2136638|FG000|Overall Study|Other: Unspecified|1
1078197|NCT02106390|2136639|FG001|Overall Study|Other: Unspecified|4
1078198|NCT02106390|2136640|FG002|Overall Study|Other: Unspecified|2
1078199|NCT02106390|2136638|FG000|Overall Study|Adverse Event|0
1078200|NCT02106390|2136639|FG001|Overall Study|Adverse Event|2
1078201|NCT02106390|2136640|FG002|Overall Study|Adverse Event|1
1078202|NCT02106390|2136638|FG000|Overall Study|Protocol Violation|0
1078203|NCT02106390|2136639|FG001|Overall Study|Protocol Violation|1
1078204|NCT02106390|2136640|FG002|Overall Study|Protocol Violation|0
1078205|NCT02106403|2136651|FG000|Follow-Up Visit 3|Other Reason|0
1078206|NCT02106403|2136652|FG001|Follow-Up Visit 3|Other Reason|0
1078207|NCT02106403|2136653|FG002|Follow-Up Visit 3|Other Reason|0
1078208|NCT02106403|2136654|FG003|Follow-Up Visit 3|Other Reason|0
1078209|NCT02106403|2136655|FG004|Follow-Up Visit 3|Other Reason|0
1078210|NCT02106403|2136656|FG005|Follow-Up Visit 3|Other Reason|1
1078211|NCT02106442|2136666|FG000|Overall Study|Case Report Forms Uncollected|7
1078212|NCT02106442|2136666|FG000|Overall Study|Protocol Deviation|30
1078213|NCT02106455|2136670|FG000|Overall Study|Case Report Form Uncollected|6
1078214|NCT02106455|2136670|FG000|Overall Study|Protocol Deviation|2
1078215|NCT02106832|2136704|FG000|Overall Study|Adverse Event|1
1078216|NCT02106832|2136705|FG001|Overall Study|Adverse Event|2
1078217|NCT02106832|2136706|FG002|Overall Study|Adverse Event|3
1078218|NCT02106832|2136707|FG003|Overall Study|Adverse Event|0
1078219|NCT02106832|2136704|FG000|Overall Study|Death|4
1078220|NCT02106832|2136705|FG001|Overall Study|Death|4
1078221|NCT02106832|2136706|FG002|Overall Study|Death|1
1078222|NCT02106832|2136707|FG003|Overall Study|Death|4
1078223|NCT02106832|2136704|FG000|Overall Study|Deterioration of general conditions|0
1078224|NCT02106832|2136705|FG001|Overall Study|Deterioration of general conditions|0
1078225|NCT02106832|2136706|FG002|Overall Study|Deterioration of general conditions|1
1078226|NCT02106832|2136707|FG003|Overall Study|Deterioration of general conditions|0
1078227|NCT02106832|2136704|FG000|Overall Study|Lost to Follow-up|0
1078228|NCT02106832|2136705|FG001|Overall Study|Lost to Follow-up|1
1078229|NCT02106832|2136706|FG002|Overall Study|Lost to Follow-up|1
1078230|NCT02106832|2136707|FG003|Overall Study|Lost to Follow-up|3
1078231|NCT02106832|2136704|FG000|Overall Study|Physician Decision|1
1078232|NCT02106832|2136705|FG001|Overall Study|Physician Decision|0
1078233|NCT02106832|2136706|FG002|Overall Study|Physician Decision|0
1078234|NCT02106832|2136707|FG003|Overall Study|Physician Decision|0
1078235|NCT02106832|2136704|FG000|Overall Study|Protocol Violation|0
1078236|NCT02106832|2136705|FG001|Overall Study|Protocol Violation|0
1078237|NCT02106832|2136706|FG002|Overall Study|Protocol Violation|0
1078238|NCT02106832|2136707|FG003|Overall Study|Protocol Violation|1
1078239|NCT02106832|2136704|FG000|Overall Study|Withdrawal by Subject|17
1078240|NCT02106832|2136705|FG001|Overall Study|Withdrawal by Subject|17
1078241|NCT02106832|2136706|FG002|Overall Study|Withdrawal by Subject|10
1078242|NCT02106832|2136707|FG003|Overall Study|Withdrawal by Subject|7
1078243|NCT02106832|2136704|FG000|Overall Study|Technical problems|0
1078244|NCT02106832|2136705|FG001|Overall Study|Technical problems|1
1078245|NCT02106832|2136706|FG002|Overall Study|Technical problems|0
1078246|NCT02106832|2136707|FG003|Overall Study|Technical problems|0
1078247|NCT02106884|2136721|FG000|Overall Study|Change of diagnosis/exclusion|0
1078248|NCT02106884|2136722|FG001|Overall Study|Change of diagnosis/exclusion|1
1078249|NCT02106910|2136733|FG000|Overall Study|Lost to Follow-up|1
1078250|NCT02106910|2136734|FG001|Overall Study|Lost to Follow-up|1
1078251|NCT02106923|2136744|FG000|Overall Study|Protocol Violation|0
1078252|NCT02106923|2136745|FG001|Overall Study|Protocol Violation|0
1078253|NCT02106923|2136746|FG002|Overall Study|Protocol Violation|0
1078254|NCT02106923|2136747|FG003|Overall Study|Protocol Violation|0
1078255|NCT02106923|2136748|FG004|Overall Study|Protocol Violation|0
1078256|NCT02106923|2136749|FG005|Overall Study|Protocol Violation|1
1078257|NCT02106975|2136776|FG000|Overall Study|Death|25
1078258|NCT02106975|2136777|FG001|Overall Study|Death|39
1078259|NCT02107014|2136783|FG000|Overall Study|Withdrew before drug: moving interstate|1
1078260|NCT02107092|2136787|FG000|Overall Study|Miscellaneous|3
1078261|NCT02107092|2136787|FG000|Overall Study|Subject compliance|3
1078262|NCT02107092|2136787|FG000|Overall Study|Hypo-or hyperkalemia|2
1078263|NCT02107092|2136787|FG000|Overall Study|Met ECG withdrawal criteria|3
1078264|NCT02107092|2136787|FG000|Overall Study|Physician Decision|3
1078265|NCT02107092|2136787|FG000|Overall Study|Lost to Follow-up|2
1078266|NCT02107092|2136787|FG000|Overall Study|Withdrawal by Subject|9
1078267|NCT02107092|2136787|FG000|Overall Study|Adverse Event|7
1078268|NCT02107092|2136787|FG000|Overall Study|Expected progression of CKD|12
1078269|NCT02107131|2136793|FG000|Overall Study|Lost to Follow-up|4
1078270|NCT02107131|2136794|FG001|Overall Study|Lost to Follow-up|4
1078271|NCT02107131|2136793|FG000|Overall Study|Physician Decision|1
1078272|NCT02107131|2136794|FG001|Overall Study|Physician Decision|0
1078273|NCT02107131|2136793|FG000|Overall Study|Withdrawal by Subject|2
1078274|NCT02107131|2136794|FG001|Overall Study|Withdrawal by Subject|0
1078275|NCT02107131|2136793|FG000|Overall Study|mental instability|1
1078276|NCT02107131|2136794|FG001|Overall Study|mental instability|0
1078277|NCT02107131|2136793|FG000|Overall Study|Death|0
1078278|NCT02107131|2136794|FG001|Overall Study|Death|1
1078279|NCT02107131|2136793|FG000|Overall Study|Protocol Violation|0
1078280|NCT02107131|2136794|FG001|Overall Study|Protocol Violation|4
1078281|NCT02107196|2136817|FG000|12-week Treatment Period|Adverse Event|6
1078282|NCT02107196|2136818|FG001|12-week Treatment Period|Adverse Event|3
1078283|NCT02107196|2136817|FG000|12-week Treatment Period|Lack of Efficacy|2
1078284|NCT02107196|2136818|FG001|12-week Treatment Period|Lack of Efficacy|1
1078285|NCT02107196|2136817|FG000|12-week Treatment Period|Lost to Follow-up|3
1078286|NCT02107196|2136818|FG001|12-week Treatment Period|Lost to Follow-up|6
1078287|NCT02107196|2136817|FG000|12-week Treatment Period|Physician Decision|0
1078288|NCT02107196|2136818|FG001|12-week Treatment Period|Physician Decision|1
1078289|NCT02107196|2136817|FG000|12-week Treatment Period|Withdrawal by Subject|15
1078290|NCT02107196|2136818|FG001|12-week Treatment Period|Withdrawal by Subject|12
1078291|NCT02107196|2136817|FG000|12-week Treatment Period|Protocol Violation|7
1078292|NCT02107196|2136818|FG001|12-week Treatment Period|Protocol Violation|8
1078293|NCT02107196|2136817|FG000|12-week Treatment Period|Reason Missing|11
1078294|NCT02107196|2136818|FG001|12-week Treatment Period|Reason Missing|8
1078295|NCT02107196|2136817|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
1078296|NCT02107196|2136818|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
1078297|NCT02107196|2136817|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
1078298|NCT02107196|2136818|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
1078299|NCT02107196|2136817|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
1078300|NCT02107196|2136818|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
1078301|NCT02107196|2136817|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
1078302|NCT02107196|2136818|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
1078303|NCT02107274|2136826|FG000|Treatment vs. Placebo|Adverse Event|3
1078304|NCT02107274|2136827|FG001|Treatment vs. Placebo|Adverse Event|0
1078305|NCT02107274|2136826|FG000|Treatment vs. Placebo|Lost to Follow-up|0
1078306|NCT02107274|2136827|FG001|Treatment vs. Placebo|Lost to Follow-up|2
1078307|NCT02107274|2136826|FG000|Control Phase|Lost to Follow-up|1
1078308|NCT02107274|2136827|FG001|Control Phase|Lost to Follow-up|1
1078309|NCT02107274|2136826|FG000|Control Phase|Death|2
1078310|NCT02107274|2136827|FG001|Control Phase|Death|0
1078311|NCT02107274|2136826|FG000|Control Phase|Adverse Event|0
1078312|NCT02107274|2136827|FG001|Control Phase|Adverse Event|1
1078313|NCT02107313|2136842|FG000|Overall Study|One participant did not do the FED cohor|0
1078314|NCT02107313|2136843|FG001|Overall Study|One participant did not do the FED cohor|1
1078315|NCT02107443|2136860|FG000|Overall Study|Death|42
1078316|NCT02107443|2136861|FG001|Overall Study|Death|30
1078317|NCT02107443|2136860|FG000|Overall Study|Study Protocol Violation|3
1078318|NCT02107443|2136861|FG001|Overall Study|Study Protocol Violation|1
1078319|NCT02107443|2136860|FG000|Overall Study|Registered but Not Eligible|0
1078320|NCT02107443|2136861|FG001|Overall Study|Registered but Not Eligible|1
1078321|NCT02107443|2136860|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28
1078322|NCT02107443|2136861|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28
1078323|NCT02107443|2136860|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1
1078324|NCT02107443|2136861|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2
1078325|NCT02107443|2136860|FG000|Overall Study|Withdrawal: Changed Mind|2
1078326|NCT02107443|2136861|FG001|Overall Study|Withdrawal: Changed Mind|0
1078327|NCT02107443|2136860|FG000|Overall Study|Withdrawal: Changed MD/Facility|1
1078328|NCT02107443|2136861|FG001|Overall Study|Withdrawal: Changed MD/Facility|3
1078329|NCT02107443|2136860|FG000|Overall Study|Withdrawal: Too Many Forms|3
1078330|NCT02107443|2136861|FG001|Overall Study|Withdrawal: Too Many Forms|1
1078331|NCT02107443|2136860|FG000|Overall Study|Withdrawal: Too Time Consuming|3
1078332|NCT02107443|2136861|FG001|Overall Study|Withdrawal: Too Time Consuming|6
1078333|NCT02107443|2136860|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2
1078334|NCT02107443|2136861|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1
1078335|NCT02107443|2136860|FG000|Overall Study|Withdrawal: Other Medical|9
1078336|NCT02107443|2136861|FG001|Overall Study|Withdrawal: Other Medical|5
1078337|NCT02107443|2136860|FG000|Overall Study|Withdrawal: Disease Progression|4
1078338|NCT02107443|2136861|FG001|Overall Study|Withdrawal: Disease Progression|2
1078339|NCT02107443|2136860|FG000|Overall Study|Withdrawal: Personal Issues|0
1078340|NCT02107443|2136861|FG001|Overall Study|Withdrawal: Personal Issues|3
1078341|NCT02107482|2136868|FG000|Overall Study|inconveinence|2
1078342|NCT02107482|2136868|FG000|Overall Study|Lost to Follow-up|1
1078343|NCT02107482|2136868|FG000|Overall Study|Lack of Efficacy|1
1078344|NCT02107703|2136881|FG000|Overall Study|Withdrawal by Subject|36
1078345|NCT02107703|2136882|FG001|Overall Study|Withdrawal by Subject|19
1078346|NCT02107703|2136881|FG000|Overall Study|Lost to Follow-up|6
1078347|NCT02107703|2136882|FG001|Overall Study|Lost to Follow-up|4
1078348|NCT02107703|2136881|FG000|Overall Study|On study treatment/follow up|319
1078349|NCT02107703|2136882|FG001|Overall Study|On study treatment/follow up|152
1078350|NCT02107859|2136891|FG000|Overall Study|Withdrawal by Subject|14
1078351|NCT02107859|2136891|FG000|Overall Study|Adverse Event|3
1078352|NCT02107859|2136891|FG000|Overall Study|Study closure|41
1078353|NCT02107859|2136891|FG000|Overall Study|Other than specified|3
1078354|NCT02107898|2136897|FG000|Overall Study|Adverse Event|4
1078355|NCT02107898|2136898|FG001|Overall Study|Adverse Event|7
1078356|NCT02107898|2136897|FG000|Overall Study|Poor compliance to protocol|0
1078357|NCT02107898|2136898|FG001|Overall Study|Poor compliance to protocol|1
1078358|NCT02107898|2136897|FG000|Overall Study|Participant moved|0
1078359|NCT02107898|2136898|FG001|Overall Study|Participant moved|2
1078360|NCT02107898|2136897|FG000|Overall Study|Consent withdrawn by participant|2
1078361|NCT02107898|2136898|FG001|Overall Study|Consent withdrawn by participant|1
1078362|NCT02107898|2136897|FG000|Overall Study|Randomized but not treated|0
1078363|NCT02107898|2136898|FG001|Overall Study|Randomized but not treated|1
1078364|NCT02108262|2136934|FG000|Overall Study|Non-compliance|0
1078365|NCT02108262|2136935|FG001|Overall Study|Non-compliance|2
1078366|NCT02108262|2136936|FG002|Overall Study|Non-compliance|1
1078367|NCT02108262|2136937|FG003|Overall Study|Non-compliance|1
1078368|NCT02108262|2136934|FG000|Overall Study|Randomized by error/screen failure|0
1078369|NCT02108262|2136935|FG001|Overall Study|Randomized by error/screen failure|0
1078370|NCT02108262|2136936|FG002|Overall Study|Randomized by error/screen failure|1
1078371|NCT02108262|2136937|FG003|Overall Study|Randomized by error/screen failure|0
1078372|NCT02108262|2136934|FG000|Overall Study|Distance to center|0
1078373|NCT02108262|2136935|FG001|Overall Study|Distance to center|1
1078374|NCT02108262|2136936|FG002|Overall Study|Distance to center|1
1078375|NCT02108262|2136937|FG003|Overall Study|Distance to center|0
1078376|NCT02108262|2136934|FG000|Overall Study|Adverse Event|0
1078377|NCT02108262|2136935|FG001|Overall Study|Adverse Event|11
1078378|NCT02108262|2136936|FG002|Overall Study|Adverse Event|6
1078379|NCT02108262|2136937|FG003|Overall Study|Adverse Event|12
1078380|NCT02108262|2136934|FG000|Overall Study|Death|0
1078381|NCT02108262|2136935|FG001|Overall Study|Death|2
1078382|NCT02108262|2136936|FG002|Overall Study|Death|2
1078383|NCT02108262|2136937|FG003|Overall Study|Death|1
1078384|NCT02108262|2136934|FG000|Overall Study|Lost to Follow-up|0
1078385|NCT02108262|2136935|FG001|Overall Study|Lost to Follow-up|0
1078386|NCT02108262|2136936|FG002|Overall Study|Lost to Follow-up|1
1078387|NCT02108262|2136937|FG003|Overall Study|Lost to Follow-up|0
1078388|NCT02108262|2136934|FG000|Overall Study|Physician Decision|0
1078389|NCT02108262|2136935|FG001|Overall Study|Physician Decision|0
1078390|NCT02108262|2136936|FG002|Overall Study|Physician Decision|2
1078391|NCT02108262|2136937|FG003|Overall Study|Physician Decision|0
1078392|NCT02108262|2136934|FG000|Overall Study|Withdrawal by Subject|0
1078393|NCT02108262|2136935|FG001|Overall Study|Withdrawal by Subject|7
1078394|NCT02108262|2136936|FG002|Overall Study|Withdrawal by Subject|3
1078395|NCT02108262|2136937|FG003|Overall Study|Withdrawal by Subject|4
1078396|NCT02108262|2136934|FG000|Overall Study|Due to key hepatic values|0
1078397|NCT02108262|2136935|FG001|Overall Study|Due to key hepatic values|1
1078398|NCT02108262|2136936|FG002|Overall Study|Due to key hepatic values|0
1078399|NCT02108262|2136937|FG003|Overall Study|Due to key hepatic values|0
1078400|NCT02108262|2136934|FG000|Overall Study|Unable to contact patient|0
1078401|NCT02108262|2136935|FG001|Overall Study|Unable to contact patient|3
1078402|NCT02108262|2136936|FG002|Overall Study|Unable to contact patient|1
1078403|NCT02108262|2136937|FG003|Overall Study|Unable to contact patient|2
1078404|NCT02108262|2136934|FG000|Overall Study|Patient unable to come to site/attend visit|0
1078405|NCT02108262|2136935|FG001|Overall Study|Patient unable to come to site/attend visit|6
1078406|NCT02108262|2136936|FG002|Overall Study|Patient unable to come to site/attend visit|11
1078407|NCT02108262|2136937|FG003|Overall Study|Patient unable to come to site/attend visit|6
1078408|NCT02108262|2136934|FG000|Overall Study|Patient did not want another infusion|0
1078409|NCT02108262|2136935|FG001|Overall Study|Patient did not want another infusion|3
1078410|NCT02108262|2136936|FG002|Overall Study|Patient did not want another infusion|3
1078411|NCT02108262|2136937|FG003|Overall Study|Patient did not want another infusion|2
1078412|NCT02108262|2136934|FG000|Overall Study|Vacation|0
1078413|NCT02108262|2136935|FG001|Overall Study|Vacation|1
1078414|NCT02108262|2136936|FG002|Overall Study|Vacation|0
1078415|NCT02108262|2136937|FG003|Overall Study|Vacation|0
1078416|NCT02108262|2136934|FG000|Overall Study|Patient decision|0
1078417|NCT02108262|2136935|FG001|Overall Study|Patient decision|7
1078418|NCT02108262|2136936|FG002|Overall Study|Patient decision|9
1078419|NCT02108262|2136937|FG003|Overall Study|Patient decision|14
1078420|NCT02108262|2136934|FG000|Overall Study|Missed IV due to pharmacy error|0
1078421|NCT02108262|2136935|FG001|Overall Study|Missed IV due to pharmacy error|0
1078422|NCT02108262|2136936|FG002|Overall Study|Missed IV due to pharmacy error|1
1078423|NCT02108262|2136937|FG003|Overall Study|Missed IV due to pharmacy error|0
1078424|NCT02108600|2136974|FG000|Overall Study|Withdrawal by Subject|2
1078425|NCT02108600|2136975|FG001|Overall Study|Withdrawal by Subject|0
1078426|NCT02108600|2136974|FG000|Overall Study|Lost to Follow-up|1
1078427|NCT02108600|2136975|FG001|Overall Study|Lost to Follow-up|1
1078432|NCT02108912|2137002|FG000|Overall Study|Lost to Follow-up|1
1078433|NCT02108912|2137003|FG001|Overall Study|Lost to Follow-up|1
1078434|NCT02108912|2137002|FG000|Overall Study|lack of transportation|1
1078435|NCT02108912|2137003|FG001|Overall Study|lack of transportation|0
1078436|NCT02108912|2137002|FG000|Overall Study|high blood pressure|1
1078437|NCT02108912|2137003|FG001|Overall Study|high blood pressure|0
1078438|NCT02108951|2137009|FG000|Overall Study|Lost to Follow-up|1
1078439|NCT02108951|2137009|FG000|Overall Study|Patient's/guardian's decision|1
1078440|NCT02108951|2137009|FG000|Overall Study|Study Terminated by Sponsor|14
1078481|NCT02109029|2137061|FG000|Part B|Adverse Event|0
1078482|NCT02109029|2137062|FG001|Part B|Adverse Event|0
1078483|NCT02109029|2137063|FG002|Part B|Adverse Event|0
1078484|NCT02109029|2137064|FG003|Part B|Adverse Event|0
1078485|NCT02109029|2137065|FG004|Part B|Adverse Event|1
1078486|NCT02109029|2137066|FG005|Part B|Adverse Event|1
1078487|NCT02109042|2137077|FG000|Overall Study|Sponsor Decision|15
1078488|NCT02109107|2137082|FG000|Overall Study|Lost to Follow-up|2
1078489|NCT02109133|2137088|FG000|Overall Study|Lost to Follow-up|1
1078490|NCT02109133|2137089|FG001|Overall Study|Lost to Follow-up|0
1078491|NCT02109172|2137106|FG000|Overall Study|Withdrawal by Subject|1
1078492|NCT02109172|2137107|FG001|Overall Study|Withdrawal by Subject|0
1078493|NCT02109172|2137108|FG002|Overall Study|Withdrawal by Subject|0
1078494|NCT02109172|2137109|FG003|Overall Study|Withdrawal by Subject|1
1078495|NCT02109172|2137110|FG004|Overall Study|Withdrawal by Subject|0
1078496|NCT02109172|2137111|FG005|Overall Study|Withdrawal by Subject|0
1078497|NCT02109172|2137106|FG000|Overall Study|Adverse Event|0
1078498|NCT02109172|2137107|FG001|Overall Study|Adverse Event|0
1078499|NCT02109172|2137108|FG002|Overall Study|Adverse Event|1
1078500|NCT02109172|2137109|FG003|Overall Study|Adverse Event|0
1078501|NCT02109172|2137110|FG004|Overall Study|Adverse Event|0
1078502|NCT02109172|2137111|FG005|Overall Study|Adverse Event|1
1078503|NCT02109172|2137106|FG000|Overall Study|Death|0
1078504|NCT02109172|2137107|FG001|Overall Study|Death|0
1078505|NCT02109172|2137108|FG002|Overall Study|Death|0
1078506|NCT02109172|2137109|FG003|Overall Study|Death|0
1078507|NCT02109172|2137110|FG004|Overall Study|Death|1
1078508|NCT02109172|2137111|FG005|Overall Study|Death|0
1078509|NCT02109432|2137125|FG000|Overall Study|Withdrawal by Subject|1
1078510|NCT02109445|2137129|FG000|Overall Study|Symptomatic deterioration|2
1078511|NCT02109445|2137129|FG000|Overall Study|Adverse Event|1
1078512|NCT02109484|2137145|FG000|Overall Study|Lost to Follow-up|0
1078513|NCT02109484|2137146|FG001|Overall Study|Lost to Follow-up|0
1078514|NCT02109484|2137147|FG002|Overall Study|Lost to Follow-up|0
1078515|NCT02109484|2137148|FG003|Overall Study|Lost to Follow-up|1
1078516|NCT02109484|2137149|FG004|Overall Study|Lost to Follow-up|1
1078517|NCT02109484|2137150|FG005|Overall Study|Lost to Follow-up|0
1078518|NCT02109484|2137151|FG006|Overall Study|Lost to Follow-up|1
1078519|NCT02109484|2137152|FG007|Overall Study|Lost to Follow-up|0
1078520|NCT02109484|2137145|FG000|Overall Study|Withdrawal by Subject|0
1078521|NCT02109484|2137146|FG001|Overall Study|Withdrawal by Subject|0
1078522|NCT02109484|2137147|FG002|Overall Study|Withdrawal by Subject|0
1078523|NCT02109484|2137148|FG003|Overall Study|Withdrawal by Subject|0
1078524|NCT02109484|2137149|FG004|Overall Study|Withdrawal by Subject|1
1078525|NCT02109484|2137150|FG005|Overall Study|Withdrawal by Subject|1
1078526|NCT02109484|2137151|FG006|Overall Study|Withdrawal by Subject|1
1078527|NCT02109484|2137152|FG007|Overall Study|Withdrawal by Subject|0
1078528|NCT02109484|2137145|FG000|Overall Study|Physician Decision|0
1078529|NCT02109484|2137146|FG001|Overall Study|Physician Decision|0
1078530|NCT02109484|2137147|FG002|Overall Study|Physician Decision|0
1078531|NCT02109484|2137148|FG003|Overall Study|Physician Decision|0
1078532|NCT02109484|2137149|FG004|Overall Study|Physician Decision|2
1078533|NCT02109484|2137150|FG005|Overall Study|Physician Decision|0
1078534|NCT02109484|2137151|FG006|Overall Study|Physician Decision|0
1078535|NCT02109484|2137152|FG007|Overall Study|Physician Decision|0
1078536|NCT02109484|2137145|FG000|Overall Study|Death|0
1078537|NCT02109484|2137146|FG001|Overall Study|Death|0
1078538|NCT02109484|2137147|FG002|Overall Study|Death|0
1078539|NCT02109484|2137148|FG003|Overall Study|Death|0
1078540|NCT02109484|2137149|FG004|Overall Study|Death|0
1078541|NCT02109484|2137150|FG005|Overall Study|Death|0
1078542|NCT02109484|2137151|FG006|Overall Study|Death|0
1078543|NCT02109484|2137152|FG007|Overall Study|Death|2
1078544|NCT02109484|2137145|FG000|Overall Study|Moved away from study area|0
1078545|NCT02109484|2137146|FG001|Overall Study|Moved away from study area|0
1078546|NCT02109484|2137147|FG002|Overall Study|Moved away from study area|0
1078547|NCT02109484|2137148|FG003|Overall Study|Moved away from study area|0
1078548|NCT02109484|2137149|FG004|Overall Study|Moved away from study area|0
1078549|NCT02109484|2137150|FG005|Overall Study|Moved away from study area|0
1078550|NCT02109484|2137151|FG006|Overall Study|Moved away from study area|1
1078551|NCT02109484|2137152|FG007|Overall Study|Moved away from study area|1
1078552|NCT02109562|2137194|FG000|Overall Study|Insufficient clinical response|2
1078553|NCT02109562|2137195|FG001|Overall Study|Insufficient clinical response|0
1078554|NCT02109562|2137196|FG002|Overall Study|Insufficient clinical response|4
1078555|NCT02109562|2137194|FG000|Overall Study|Adverse Event|0
1078556|NCT02109562|2137195|FG001|Overall Study|Adverse Event|2
1078557|NCT02109562|2137196|FG002|Overall Study|Adverse Event|3
1078558|NCT02109562|2137194|FG000|Overall Study|Lost to Follow-up|1
1078559|NCT02109562|2137195|FG001|Overall Study|Lost to Follow-up|0
1078560|NCT02109562|2137196|FG002|Overall Study|Lost to Follow-up|1
1078561|NCT02109562|2137194|FG000|Overall Study|Protocol Violation|0
1078562|NCT02109562|2137195|FG001|Overall Study|Protocol Violation|3
1078563|NCT02109562|2137196|FG002|Overall Study|Protocol Violation|1
1078564|NCT02109562|2137194|FG000|Overall Study|Withdrawal by Subject|20
1078565|NCT02109562|2137195|FG001|Overall Study|Withdrawal by Subject|25
1078566|NCT02109562|2137196|FG002|Overall Study|Withdrawal by Subject|21
1078567|NCT02109562|2137194|FG000|Overall Study|Physician Decision|3
1078568|NCT02109562|2137195|FG001|Overall Study|Physician Decision|4
1078569|NCT02109562|2137196|FG002|Overall Study|Physician Decision|5
1078570|NCT02110225|2137258|FG000|Overall Study|Lost to Follow-up|0
1078571|NCT02110225|2137259|FG001|Overall Study|Lost to Follow-up|1
1078572|NCT02110225|2137260|FG002|Overall Study|Lost to Follow-up|0
1078573|NCT02110238|2137271|FG000|12 Week Pivotal Phase|Adverse Event|3
1078574|NCT02110238|2137272|FG001|12 Week Pivotal Phase|Adverse Event|0
1078575|NCT02110238|2137271|FG000|12 Week Pivotal Phase|Lack of Efficacy|2
1078576|NCT02110238|2137272|FG001|12 Week Pivotal Phase|Lack of Efficacy|3
1078577|NCT02110238|2137271|FG000|12 Week Pivotal Phase|Lost to Follow-up|2
1078578|NCT02110238|2137272|FG001|12 Week Pivotal Phase|Lost to Follow-up|0
1078579|NCT02110238|2137271|FG000|12 Week Pivotal Phase|Physician Decision|0
1078580|NCT02110238|2137272|FG001|12 Week Pivotal Phase|Physician Decision|2
1078581|NCT02110238|2137271|FG000|12 Week Pivotal Phase|Protocol Violation|0
1078582|NCT02110238|2137272|FG001|12 Week Pivotal Phase|Protocol Violation|1
1078583|NCT02110238|2137271|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3
1078584|NCT02110238|2137272|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3
1078585|NCT02110238|2137271|FG000|14 Week Blinded Extension Phase|Adverse Event|1
1078586|NCT02110238|2137272|FG001|14 Week Blinded Extension Phase|Adverse Event|1
1078587|NCT02110238|2137271|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2
1078588|NCT02110238|2137272|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4
1078589|NCT02110238|2137271|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3
1078590|NCT02110238|2137272|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1
1078591|NCT02110238|2137271|FG000|14 Week Blinded Extension Phase|Protocol Violation|2
1078592|NCT02110238|2137272|FG001|14 Week Blinded Extension Phase|Protocol Violation|3
1078593|NCT02110238|2137271|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4
1078594|NCT02110238|2137272|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3
1078595|NCT02110693|2137310|FG000|Overall Study|Withdrawal by Subject|6
1078596|NCT02110693|2137311|FG001|Overall Study|Withdrawal by Subject|7
1078597|NCT02110693|2137310|FG000|Overall Study|skipped assessment|15
1078598|NCT02110693|2137311|FG001|Overall Study|skipped assessment|18
1078599|NCT02110693|2137310|FG000|Overall Study|technical difficulties|6
1078600|NCT02110693|2137311|FG001|Overall Study|technical difficulties|4
1078601|NCT02110693|2137310|FG000|Overall Study|Other|1
1078602|NCT02110693|2137311|FG001|Overall Study|Other|0
1078603|NCT02110706|2137333|FG000|Overall Study|Adverse Event|2
1078604|NCT02110706|2137334|FG001|Overall Study|Adverse Event|3
1078605|NCT02110706|2137333|FG000|Overall Study|Patients who didn't receive 2nd infusion|3
1078606|NCT02110706|2137334|FG001|Overall Study|Patients who didn't receive 2nd infusion|1
1078607|NCT02110732|2137344|FG000|Overall Study|Physician Decision|5
1078608|NCT02110732|2137345|FG001|Overall Study|Physician Decision|2
1078609|NCT02110732|2137344|FG000|Overall Study|Lost to Follow-up|1
1078610|NCT02110732|2137345|FG001|Overall Study|Lost to Follow-up|1
1078611|NCT02110901|2137374|FG000|Overall Study|Death|6
1078612|NCT02110901|2137375|FG001|Overall Study|Death|3
1078613|NCT02110901|2137374|FG000|Overall Study|Lost to Follow-up|12
1078614|NCT02110901|2137375|FG001|Overall Study|Lost to Follow-up|8
1078615|NCT02110901|2137374|FG000|Overall Study|Withdrawal by Subject|7
1078616|NCT02110901|2137375|FG001|Overall Study|Withdrawal by Subject|3
1078617|NCT02110901|2137374|FG000|Overall Study|received a kidney transplant|5
1078618|NCT02110901|2137375|FG001|Overall Study|received a kidney transplant|0
1078619|NCT02111083|2137384|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1
1078620|NCT02111083|2137385|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1
1078621|NCT02111096|2137394|FG000|Overall Study|Adverse Event|4
1078622|NCT02111096|2137395|FG001|Overall Study|Adverse Event|1
1078623|NCT02111096|2137396|FG002|Overall Study|Adverse Event|2
1078624|NCT02111096|2137394|FG000|Overall Study|Non-Compliance with Study Drug|1
1078625|NCT02111096|2137395|FG001|Overall Study|Non-Compliance with Study Drug|1
1078626|NCT02111096|2137396|FG002|Overall Study|Non-Compliance with Study Drug|0
1078627|NCT02111096|2137394|FG000|Overall Study|Lost to Follow Up|1
1078628|NCT02111096|2137395|FG001|Overall Study|Lost to Follow Up|1
1078629|NCT02111096|2137396|FG002|Overall Study|Lost to Follow Up|1
1078630|NCT02111096|2137394|FG000|Overall Study|Physician Decision|0
1078631|NCT02111096|2137395|FG001|Overall Study|Physician Decision|1
1078632|NCT02111096|2137396|FG002|Overall Study|Physician Decision|0
1078633|NCT02111096|2137394|FG000|Overall Study|Protocol Violation|1
1078634|NCT02111096|2137395|FG001|Overall Study|Protocol Violation|0
1078635|NCT02111096|2137396|FG002|Overall Study|Protocol Violation|1
1078636|NCT02111096|2137394|FG000|Overall Study|Terminated by Sponsor|53
1078637|NCT02111096|2137395|FG001|Overall Study|Terminated by Sponsor|35
1078638|NCT02111096|2137396|FG002|Overall Study|Terminated by Sponsor|54
1078639|NCT02111096|2137394|FG000|Overall Study|Withdrawal by Subject|4
1078640|NCT02111096|2137395|FG001|Overall Study|Withdrawal by Subject|2
1078641|NCT02111096|2137396|FG002|Overall Study|Withdrawal by Subject|8
1078642|NCT02111174|2137409|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
1078643|NCT02111174|2137410|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
1078644|NCT02111174|2137409|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2
1078645|NCT02111174|2137410|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2
1078646|NCT02111174|2137409|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
1078647|NCT02111174|2137410|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
1078648|NCT02111174|2137409|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0
1078649|NCT02111174|2137410|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1
1078650|NCT02111213|2137442|FG000|Overall Study|Withdrawal by Subject|3
1078651|NCT02111213|2137443|FG001|Overall Study|Withdrawal by Subject|2
1078652|NCT02111213|2137442|FG000|Overall Study|Lost to Follow-up|3
1078653|NCT02111213|2137443|FG001|Overall Study|Lost to Follow-up|4
1078654|NCT02111369|2137453|FG000|Overall Study|Lost to Follow-up|2
1078655|NCT02111369|2137453|FG000|Overall Study|Withdrawal by Subject|1
1078656|NCT02111564|2137476|FG000|Overall Study|Death|109
1078657|NCT02111564|2137477|FG001|Overall Study|Death|120
1078658|NCT02111564|2137476|FG000|Overall Study|Lost to Follow-up|2
1078659|NCT02111564|2137477|FG001|Overall Study|Lost to Follow-up|3
1078660|NCT02111564|2137476|FG000|Overall Study|Withdrawal by Subject|20
1078661|NCT02111564|2137477|FG001|Overall Study|Withdrawal by Subject|20
1078662|NCT02111577|2137485|FG000|Overall Study|Protocol Violation|2
1078663|NCT02111577|2137486|FG001|Overall Study|Protocol Violation|0
1078664|NCT02111577|2137485|FG000|Overall Study|Unable to tolerate leukapheresis|1
1078665|NCT02111577|2137486|FG001|Overall Study|Unable to tolerate leukapheresis|0
1078666|NCT02111577|2137485|FG000|Overall Study|Failure to produce study treatment|6
1078667|NCT02111577|2137486|FG001|Overall Study|Failure to produce study treatment|0
1078668|NCT02111577|2137485|FG000|Overall Study|Death|518
1078669|NCT02111577|2137486|FG001|Overall Study|Death|254
1078670|NCT02111577|2137485|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1
1078671|NCT02111577|2137486|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0
1078672|NCT02111577|2137485|FG000|Overall Study|Adverse Event|1
1078673|NCT02111577|2137486|FG001|Overall Study|Adverse Event|1
1078674|NCT02111577|2137485|FG000|Overall Study|Withdrawal by Subject|51
1078675|NCT02111577|2137486|FG001|Overall Study|Withdrawal by Subject|23
1078676|NCT02111577|2137485|FG000|Overall Study|Disease progression|0
1078677|NCT02111577|2137486|FG001|Overall Study|Disease progression|1
1078678|NCT02111577|2137485|FG000|Overall Study|Lost to Follow-up|19
1078679|NCT02111577|2137486|FG001|Overall Study|Lost to Follow-up|10
1078680|NCT02111603|2137494|FG000|Overall Study|Withdrawal by Subject|1
1078681|NCT02111785|2137520|FG000|Overall Study|Death|0
1078682|NCT02111785|2137521|FG001|Overall Study|Death|1
1078683|NCT02111785|2137522|FG002|Overall Study|Death|0
1078684|NCT02111785|2137523|FG003|Overall Study|Death|0
1078685|NCT02111811|2137557|FG000|Treatment Phase|Lost to Follow-up|22
1078686|NCT02111811|2137558|FG001|Treatment Phase|Lost to Follow-up|18
1078687|NCT02111811|2137557|FG000|Treatment Phase|Death|2
1078688|NCT02111811|2137558|FG001|Treatment Phase|Death|0
1078689|NCT02111811|2137557|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26
1078690|NCT02111811|2137558|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17
1078691|NCT02111811|2137557|FG000|Follow up Period (Aim 2)|Death|2
1078692|NCT02111811|2137558|FG001|Follow up Period (Aim 2)|Death|0
1078693|NCT02111993|2137577|FG000|Overall Study|Physician Decision|5
1078694|NCT02111993|2137578|FG001|Overall Study|Physician Decision|4
1078695|NCT02112045|2137588|FG000|Overall Study|Withdrawal by Subject|1
1078696|NCT02112045|2137589|FG001|Overall Study|Withdrawal by Subject|0
1078697|NCT02112448|2137606|FG000|Overall Study|lab values precluding use of ketorolac|2
1078698|NCT02112448|2137607|FG001|Overall Study|lab values precluding use of ketorolac|2
1078699|NCT02112448|2137606|FG000|Overall Study|Protocol Violation|1
1078700|NCT02112448|2137607|FG001|Overall Study|Protocol Violation|2
1078701|NCT02112448|2137606|FG000|Overall Study|Physician Decision|4
1078702|NCT02112448|2137607|FG001|Overall Study|Physician Decision|6
1078703|NCT02112448|2137606|FG000|Overall Study|required heparin so could not use ketoro|1
1078704|NCT02112448|2137607|FG001|Overall Study|required heparin so could not use ketoro|0
1078705|NCT02112877|2137639|FG000|Overall Study|Withdrawal by Subject|1
1078706|NCT02112877|2137640|FG001|Overall Study|Withdrawal by Subject|7
1078707|NCT02112877|2137639|FG000|Overall Study|Visit Missed|1
1078708|NCT02112877|2137640|FG001|Overall Study|Visit Missed|6
1078709|NCT02112994|2137648|FG000|Overall Study|Progressive Disease|0
1078710|NCT02112994|2137649|FG001|Overall Study|Progressive Disease|0
1078711|NCT02112994|2137650|FG002|Overall Study|Progressive Disease|1
1078712|NCT02112994|2137648|FG000|Overall Study|Pregnancy|0
1078713|NCT02112994|2137649|FG001|Overall Study|Pregnancy|1
1078714|NCT02112994|2137650|FG002|Overall Study|Pregnancy|1
1078715|NCT02112994|2137648|FG000|Overall Study|Liver Transplant|0
1078716|NCT02112994|2137649|FG001|Overall Study|Liver Transplant|1
1078717|NCT02112994|2137650|FG002|Overall Study|Liver Transplant|0
1078718|NCT02112994|2137648|FG000|Overall Study|Withdrawal by Subject|0
1078719|NCT02112994|2137649|FG001|Overall Study|Withdrawal by Subject|0
1078720|NCT02112994|2137650|FG002|Overall Study|Withdrawal by Subject|1
1078721|NCT02113007|2137662|FG000|Overall Study|Progressive disease|2
1078722|NCT02113124|2137668|FG000|Overall Study|Unable to retrieve blood sample|1
1078723|NCT02113124|2137669|FG001|Overall Study|Unable to retrieve blood sample|1
1078724|NCT02113189|2137678|FG000|Overall Study|Lost to follow up|2
1078725|NCT02113189|2137679|FG001|Overall Study|Lost to follow up|1
1078726|NCT02113189|2137680|FG002|Overall Study|Lost to follow up|3
1078727|NCT02113436|2137713|FG000|Period 1: 8 Weeks|Adverse Event|1
1078728|NCT02113436|2137714|FG001|Period 1: 8 Weeks|Adverse Event|0
1078729|NCT02113436|2137715|FG002|Period 1: 8 Weeks|Adverse Event|0
1078730|NCT02113436|2137716|FG003|Period 1: 8 Weeks|Adverse Event|0
1078731|NCT02113436|2137713|FG000|Period 1: 8 Weeks|Protocol Violation|1
1078732|NCT02113436|2137714|FG001|Period 1: 8 Weeks|Protocol Violation|0
1078733|NCT02113436|2137715|FG002|Period 1: 8 Weeks|Protocol Violation|0
1078734|NCT02113436|2137716|FG003|Period 1: 8 Weeks|Protocol Violation|0
1078735|NCT02113436|2137713|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
1078736|NCT02113436|2137714|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
1078737|NCT02113436|2137715|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
1078738|NCT02113436|2137716|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
1078739|NCT02113436|2137713|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1
1078740|NCT02113436|2137714|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0
1078741|NCT02113436|2137715|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0
1078742|NCT02113436|2137716|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0
1078743|NCT02113436|2137713|FG000|Period 2: 16 Weeks|Adverse Event|0
1078744|NCT02113436|2137714|FG001|Period 2: 16 Weeks|Adverse Event|0
1078745|NCT02113436|2137715|FG002|Period 2: 16 Weeks|Adverse Event|4
1078746|NCT02113436|2137716|FG003|Period 2: 16 Weeks|Adverse Event|5
1078747|NCT02113436|2137713|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
1078748|NCT02113436|2137714|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
1078749|NCT02113436|2137715|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
1078750|NCT02113436|2137716|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
1078751|NCT02113436|2137713|FG000|Period 2: 16 Weeks|Physician Decision|0
1078752|NCT02113436|2137714|FG001|Period 2: 16 Weeks|Physician Decision|0
1078753|NCT02113436|2137715|FG002|Period 2: 16 Weeks|Physician Decision|2
1078754|NCT02113436|2137716|FG003|Period 2: 16 Weeks|Physician Decision|0
1078755|NCT02113436|2137713|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0
1078756|NCT02113436|2137714|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0
1078757|NCT02113436|2137715|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1
1078758|NCT02113436|2137716|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1
1078759|NCT02113449|2137725|FG000|Overall Study|Adverse Event|4
1078760|NCT02113579|2137735|FG000|Overall Study|Adverse Event|1
1078761|NCT02113579|2137736|FG001|Overall Study|Adverse Event|0
1078762|NCT02113579|2137735|FG000|Overall Study|Withdrawal by Subject|3
1078763|NCT02113579|2137736|FG001|Overall Study|Withdrawal by Subject|2
1078764|NCT02113579|2137735|FG000|Overall Study|Lost to Follow-up|6
1078765|NCT02113579|2137736|FG001|Overall Study|Lost to Follow-up|2
1078766|NCT02113956|2137744|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
1078767|NCT02113956|2137745|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
1078768|NCT02113956|2137744|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
1078769|NCT02113956|2137745|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
1078770|NCT02113956|2137744|FG000|3 Month Post-intervention|Lost to Follow-up|4
1078771|NCT02113956|2137745|FG001|3 Month Post-intervention|Lost to Follow-up|2
1078772|NCT02114151|2137751|FG000|Overall Study|Death|1
1078773|NCT02114151|2137751|FG000|Overall Study|Lost to Follow-up|1
1078774|NCT02114151|2137751|FG000|Overall Study|Withdrawal by Subject|5
1078775|NCT02114177|2137766|FG000|Overall Study|Lost to Follow-up|1
1078776|NCT02114177|2137767|FG001|Overall Study|Lost to Follow-up|2
1078777|NCT02114177|2137766|FG000|Overall Study|Withdrawal by Subject|6
1078778|NCT02114177|2137767|FG001|Overall Study|Withdrawal by Subject|1
1078779|NCT02114177|2137766|FG000|Overall Study|Other|2
1078780|NCT02114177|2137767|FG001|Overall Study|Other|1
1078781|NCT02114203|2137776|FG000|Overall Study|Adverse Event|0
1078782|NCT02114203|2137777|FG001|Overall Study|Adverse Event|1
1078783|NCT02114203|2137778|FG002|Overall Study|Adverse Event|0
1078784|NCT02114203|2137776|FG000|Overall Study|Withdrawal by Subject|0
1078785|NCT02114203|2137777|FG001|Overall Study|Withdrawal by Subject|1
1078786|NCT02114203|2137778|FG002|Overall Study|Withdrawal by Subject|0
1078787|NCT02114268|2137808|FG000|Overall Study|Lost to Follow-up|4
1078788|NCT02114268|2137809|FG001|Overall Study|Lost to Follow-up|1
1078789|NCT02114268|2137810|FG002|Overall Study|Lost to Follow-up|1
1078790|NCT02114268|2137811|FG003|Overall Study|Lost to Follow-up|0
1078791|NCT02114268|2137812|FG004|Overall Study|Lost to Follow-up|0
1078792|NCT02114268|2137813|FG005|Overall Study|Lost to Follow-up|2
1078793|NCT02114268|2137808|FG000|Overall Study|Withdrawal by Subject|1
1078794|NCT02114268|2137809|FG001|Overall Study|Withdrawal by Subject|0
1078795|NCT02114268|2137810|FG002|Overall Study|Withdrawal by Subject|0
1078796|NCT02114268|2137811|FG003|Overall Study|Withdrawal by Subject|0
1078797|NCT02114268|2137812|FG004|Overall Study|Withdrawal by Subject|0
1078798|NCT02114268|2137813|FG005|Overall Study|Withdrawal by Subject|1
1078799|NCT02114268|2137808|FG000|Overall Study|Withdrawn by site due to noncompliance|1
1078800|NCT02114268|2137809|FG001|Overall Study|Withdrawn by site due to noncompliance|0
1078801|NCT02114268|2137810|FG002|Overall Study|Withdrawn by site due to noncompliance|0
1078802|NCT02114268|2137811|FG003|Overall Study|Withdrawn by site due to noncompliance|0
1078803|NCT02114268|2137812|FG004|Overall Study|Withdrawn by site due to noncompliance|0
1078804|NCT02114268|2137813|FG005|Overall Study|Withdrawn by site due to noncompliance|0
1078805|NCT02114385|2137845|FG000|Overall Study|Withdrawal by Subject|3
1078806|NCT02114385|2137846|FG001|Overall Study|Withdrawal by Subject|2
1078807|NCT02114385|2137845|FG000|Overall Study|Lost to Follow-up|0
1078808|NCT02114385|2137846|FG001|Overall Study|Lost to Follow-up|6
1078809|NCT02114515|2137854|FG000|Overall Study|Lost to Follow-up|52
1078810|NCT02114515|2137855|FG001|Overall Study|Lost to Follow-up|55
1078811|NCT02114515|2137854|FG000|Overall Study|Death|12
1078812|NCT02114515|2137855|FG001|Overall Study|Death|12
1078813|NCT02114515|2137854|FG000|Overall Study|Withdrawal by Subject|4
1078814|NCT02114515|2137855|FG001|Overall Study|Withdrawal by Subject|22
1078815|NCT02114515|2137854|FG000|Overall Study|Other|65
1078816|NCT02114515|2137855|FG001|Overall Study|Other|61
1078817|NCT02114606|2137861|FG000|Overall Study|Unable to swallow Cytosponge|6
1078818|NCT02114684|2137867|FG000|Overall Study|Death|6
1078819|NCT02114684|2137868|FG001|Overall Study|Death|4
1078820|NCT02114684|2137867|FG000|Overall Study|Lost to Follow-up|1
1078821|NCT02114684|2137868|FG001|Overall Study|Lost to Follow-up|2
1078822|NCT02114684|2137867|FG000|Overall Study|Withdrawal by Subject|1
1078823|NCT02114684|2137868|FG001|Overall Study|Withdrawal by Subject|2
1078824|NCT02114684|2137867|FG000|Overall Study|Relocation|3
1078825|NCT02114684|2137868|FG001|Overall Study|Relocation|1
1078826|NCT02114684|2137867|FG000|Overall Study|Rifampicin resistant on culture|0
1078827|NCT02114684|2137868|FG001|Overall Study|Rifampicin resistant on culture|1
1078828|NCT02114684|2137867|FG000|Overall Study|Patient Incarcerated|1
1078829|NCT02114684|2137868|FG001|Overall Study|Patient Incarcerated|0
1078830|NCT02114879|2137902|FG000|Overall Study|Withdrawal by Subject|9
1078831|NCT02114879|2137903|FG001|Overall Study|Withdrawal by Subject|5
1078832|NCT02114879|2137902|FG000|Overall Study|Death|6
1078833|NCT02114879|2137903|FG001|Overall Study|Death|11
1078834|NCT02114879|2137902|FG000|Overall Study|Lost to Follow-up|4
1078835|NCT02114879|2137903|FG001|Overall Study|Lost to Follow-up|6
1078836|NCT02114879|2137902|FG000|Overall Study|Physician Decision|0
1078837|NCT02114879|2137903|FG001|Overall Study|Physician Decision|2
1078838|NCT02114892|2137911|FG000|Overall Study|Lost to Follow-up|1
1078839|NCT02114892|2137912|FG001|Overall Study|Lost to Follow-up|2
1078840|NCT02114931|2137920|FG000|Overall Study|Withdrawal by Subject|15
1078841|NCT02114931|2137921|FG001|Overall Study|Withdrawal by Subject|18
1078842|NCT02114931|2137920|FG000|Overall Study|Adverse Event|4
1078843|NCT02114931|2137921|FG001|Overall Study|Adverse Event|6
1078844|NCT02114931|2137920|FG000|Overall Study|Lost to Follow-up|3
1078845|NCT02114931|2137921|FG001|Overall Study|Lost to Follow-up|3
1078846|NCT02114931|2137920|FG000|Overall Study|Physician Decision|1
1078847|NCT02114931|2137921|FG001|Overall Study|Physician Decision|2
1078848|NCT02114931|2137920|FG000|Overall Study|Other|2
1078849|NCT02114931|2137921|FG001|Overall Study|Other|1
1078850|NCT02115113|2137936|FG000|Participants in Run-in Period|Death|0
1078851|NCT02115113|2137937|FG001|Participants in Run-in Period|Death|0
1078852|NCT02115113|2137938|FG002|Participants in Run-in Period|Death|1
1078853|NCT02115113|2137936|FG000|Participants in Run-in Period|Administrative problems|0
1078854|NCT02115113|2137937|FG001|Participants in Run-in Period|Administrative problems|0
1078855|NCT02115113|2137938|FG002|Participants in Run-in Period|Administrative problems|1
1078856|NCT02115113|2137936|FG000|Participants in Run-in Period|Lost to Follow-up|0
1078857|NCT02115113|2137937|FG001|Participants in Run-in Period|Lost to Follow-up|0
1078858|NCT02115113|2137938|FG002|Participants in Run-in Period|Lost to Follow-up|5
1078859|NCT02115113|2137936|FG000|Participants in Run-in Period|Withdrawal by Subject|0
1078860|NCT02115113|2137937|FG001|Participants in Run-in Period|Withdrawal by Subject|0
1078861|NCT02115113|2137938|FG002|Participants in Run-in Period|Withdrawal by Subject|3
1078862|NCT02115113|2137936|FG000|Participants Randomized|Lost to Follow-up|1
1078863|NCT02115113|2137937|FG001|Participants Randomized|Lost to Follow-up|0
1078864|NCT02115113|2137938|FG002|Participants Randomized|Lost to Follow-up|0
1078865|NCT02115113|2137936|FG000|Participants Randomized|Death|1
1078866|NCT02115113|2137937|FG001|Participants Randomized|Death|0
1078867|NCT02115113|2137938|FG002|Participants Randomized|Death|0
1078868|NCT02115139|2137947|FG000|Overall Study|Protocol Violation|1
1078869|NCT02115139|2137947|FG000|Overall Study|treatment discontinuation|6
1078870|NCT02115256|2137953|FG000|Overall Study|Withdrawal by Subject|0
1078871|NCT02115256|2137954|FG001|Overall Study|Withdrawal by Subject|1
1078872|NCT02115269|2137960|FG000|Overall Study|Lost to Follow-up|43
1078873|NCT02115269|2137960|FG000|Overall Study|Did not complete patient diary|3
1078874|NCT02115269|2137960|FG000|Overall Study|Moved to another city|7
1078875|NCT02115269|2137960|FG000|Overall Study|Withdrawal by Subject|2
1078876|NCT02115269|2137960|FG000|Overall Study|Didn't take study drug|2
1078877|NCT02115282|2137977|FG000|Overall Study|Disease progression during treatment|216
1078878|NCT02115282|2137978|FG001|Overall Study|Disease progression during treatment|229
1078879|NCT02115282|2137977|FG000|Overall Study|Adverse Event|49
1078880|NCT02115282|2137978|FG001|Overall Study|Adverse Event|23
1078881|NCT02115282|2137977|FG000|Overall Study|Death|1
1078882|NCT02115282|2137978|FG001|Overall Study|Death|3
1078883|NCT02115282|2137977|FG000|Overall Study|Alternative therapy|1
1078884|NCT02115282|2137978|FG001|Overall Study|Alternative therapy|1
1078885|NCT02115282|2137977|FG000|Overall Study|Complicating disease|0
1078886|NCT02115282|2137978|FG001|Overall Study|Complicating disease|3
1078887|NCT02115282|2137977|FG000|Overall Study|Withdrawal by Subject|12
1078888|NCT02115282|2137978|FG001|Overall Study|Withdrawal by Subject|10
1078889|NCT02115282|2137977|FG000|Overall Study|Symptomatic progression/deterioration|7
1078890|NCT02115282|2137978|FG001|Overall Study|Symptomatic progression/deterioration|18
1078891|NCT02115282|2137977|FG000|Overall Study|Non-compliance|5
1078892|NCT02115282|2137978|FG001|Overall Study|Non-compliance|1
1078893|NCT02115282|2137977|FG000|Overall Study|Protocol Violation|2
1078894|NCT02115282|2137978|FG001|Overall Study|Protocol Violation|2
1078895|NCT02115282|2137977|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3
1078896|NCT02115282|2137978|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3
1078897|NCT02115282|2137977|FG000|Overall Study|Not start protocol therapy|9
1078898|NCT02115282|2137978|FG001|Overall Study|Not start protocol therapy|10
1078899|NCT02115308|2137988|FG000|Overall Study|Safety Screening|2
1078900|NCT02115308|2137989|FG001|Overall Study|Safety Screening|2
1078901|NCT02115321|2138001|FG000|Overall Study|Death|1
1078902|NCT02115321|2138002|FG001|Overall Study|Death|0
1078903|NCT02115386|2138038|FG000|Overall Study|Protocol Violation|1
1078904|NCT02115386|2138038|FG000|Overall Study|Administrative - trial was terminated|6
1078905|NCT02115607|2138055|FG000|Overall Study|Withdrawal by Subject|1
1078906|NCT02115815|2138098|FG000|Overall Study|Withdrawal by Subject|2
1078907|NCT02115815|2138099|FG001|Overall Study|Withdrawal by Subject|0
1078908|NCT02115815|2138100|FG002|Overall Study|Withdrawal by Subject|0
1078909|NCT02115815|2138101|FG003|Overall Study|Withdrawal by Subject|0
1078910|NCT02115815|2138102|FG004|Overall Study|Withdrawal by Subject|0
1078911|NCT02115815|2138103|FG005|Overall Study|Withdrawal by Subject|0
1078912|NCT02115815|2138104|FG006|Overall Study|Withdrawal by Subject|0
1078913|NCT02115815|2138098|FG000|Overall Study|Not enough drug to dose participant|0
1078914|NCT02115815|2138099|FG001|Overall Study|Not enough drug to dose participant|0
1078915|NCT02115815|2138100|FG002|Overall Study|Not enough drug to dose participant|0
1078916|NCT02115815|2138101|FG003|Overall Study|Not enough drug to dose participant|0
1078917|NCT02115815|2138102|FG004|Overall Study|Not enough drug to dose participant|0
1078918|NCT02115815|2138103|FG005|Overall Study|Not enough drug to dose participant|1
1078919|NCT02115815|2138104|FG006|Overall Study|Not enough drug to dose participant|0
1078920|NCT02115815|2138098|FG000|Overall Study|Missed appointment, randomized in error|0
1078921|NCT02115815|2138099|FG001|Overall Study|Missed appointment, randomized in error|0
1078922|NCT02115815|2138100|FG002|Overall Study|Missed appointment, randomized in error|0
1078923|NCT02115815|2138101|FG003|Overall Study|Missed appointment, randomized in error|0
1078924|NCT02115815|2138102|FG004|Overall Study|Missed appointment, randomized in error|0
1078925|NCT02115815|2138103|FG005|Overall Study|Missed appointment, randomized in error|1
1078926|NCT02115815|2138104|FG006|Overall Study|Missed appointment, randomized in error|0
1078927|NCT02116205|2138137|FG000|Overall Study|Withdrawal by Subject|2
1078928|NCT02116205|2138138|FG001|Overall Study|Withdrawal by Subject|4
1078929|NCT02116205|2138139|FG002|Overall Study|Withdrawal by Subject|1
1078930|NCT02116205|2138140|FG003|Overall Study|Withdrawal by Subject|3
1078931|NCT02116205|2138137|FG000|Overall Study|Lost to Follow-up|0
1078932|NCT02116205|2138138|FG001|Overall Study|Lost to Follow-up|2
1078933|NCT02116205|2138139|FG002|Overall Study|Lost to Follow-up|1
1078934|NCT02116205|2138140|FG003|Overall Study|Lost to Follow-up|2
1078935|NCT02116205|2138137|FG000|Overall Study|Physician Decision|0
1078936|NCT02116205|2138138|FG001|Overall Study|Physician Decision|1
1078937|NCT02116205|2138139|FG002|Overall Study|Physician Decision|1
1078938|NCT02116205|2138140|FG003|Overall Study|Physician Decision|1
1078939|NCT02116205|2138137|FG000|Overall Study|Exclusion criteria|0
1078940|NCT02116205|2138138|FG001|Overall Study|Exclusion criteria|0
1078941|NCT02116205|2138139|FG002|Overall Study|Exclusion criteria|1
1078942|NCT02116205|2138140|FG003|Overall Study|Exclusion criteria|0
1078943|NCT02116309|2138152|FG000|Overall Study|Lost to Follow-up|0
1078944|NCT02116309|2138153|FG001|Overall Study|Lost to Follow-up|1
1078945|NCT02116361|2138167|FG000|Overall Study|Pregnancy|0
1078946|NCT02116361|2138168|FG001|Overall Study|Pregnancy|0
1078947|NCT02116361|2138169|FG002|Overall Study|Pregnancy|0
1078948|NCT02116361|2138170|FG003|Overall Study|Pregnancy|1
1078949|NCT02116361|2138167|FG000|Overall Study|Protocol Violation|1
1078950|NCT02116361|2138168|FG001|Overall Study|Protocol Violation|0
1078951|NCT02116361|2138169|FG002|Overall Study|Protocol Violation|0
1078952|NCT02116361|2138170|FG003|Overall Study|Protocol Violation|2
1078953|NCT02116361|2138167|FG000|Overall Study|Physician Decision|2
1078954|NCT02116361|2138168|FG001|Overall Study|Physician Decision|3
1078955|NCT02116361|2138169|FG002|Overall Study|Physician Decision|0
1078956|NCT02116361|2138170|FG003|Overall Study|Physician Decision|0
1078957|NCT02116361|2138167|FG000|Overall Study|Adverse Event|1
1078958|NCT02116361|2138168|FG001|Overall Study|Adverse Event|0
1078959|NCT02116361|2138169|FG002|Overall Study|Adverse Event|0
1078960|NCT02116361|2138170|FG003|Overall Study|Adverse Event|3
1078961|NCT02116361|2138167|FG000|Overall Study|Other Reasons|3
1078962|NCT02116361|2138168|FG001|Overall Study|Other Reasons|3
1078963|NCT02116361|2138169|FG002|Overall Study|Other Reasons|3
1078964|NCT02116361|2138170|FG003|Overall Study|Other Reasons|3
1078965|NCT02116361|2138167|FG000|Overall Study|Lack of Efficacy|5
1078966|NCT02116361|2138168|FG001|Overall Study|Lack of Efficacy|7
1078967|NCT02116361|2138169|FG002|Overall Study|Lack of Efficacy|4
1078968|NCT02116361|2138170|FG003|Overall Study|Lack of Efficacy|3
1078969|NCT02116361|2138167|FG000|Overall Study|Lost to Follow-up|4
1078970|NCT02116361|2138168|FG001|Overall Study|Lost to Follow-up|5
1078971|NCT02116361|2138169|FG002|Overall Study|Lost to Follow-up|7
1078972|NCT02116361|2138170|FG003|Overall Study|Lost to Follow-up|5
1078973|NCT02116361|2138167|FG000|Overall Study|Personal Reasons|6
1078974|NCT02116361|2138168|FG001|Overall Study|Personal Reasons|6
1078975|NCT02116361|2138169|FG002|Overall Study|Personal Reasons|4
1078976|NCT02116361|2138170|FG003|Overall Study|Personal Reasons|9
1078977|NCT02116361|2138167|FG000|Overall Study|Investigator Decision - Relapse|9
1078978|NCT02116361|2138168|FG001|Overall Study|Investigator Decision - Relapse|7
1078979|NCT02116361|2138169|FG002|Overall Study|Investigator Decision - Relapse|8
1078980|NCT02116361|2138170|FG003|Overall Study|Investigator Decision - Relapse|5
1078981|NCT02116530|2138182|FG000|Overall Study|Withdrawal by Subject|1
1078982|NCT02116530|2138183|FG001|Overall Study|Withdrawal by Subject|2
1078983|NCT02116530|2138182|FG000|Overall Study|Adverse Event|4
1078984|NCT02116530|2138183|FG001|Overall Study|Adverse Event|0
1078985|NCT02116530|2138182|FG000|Overall Study|Physician Decision|1
1078986|NCT02116530|2138183|FG001|Overall Study|Physician Decision|0
1078987|NCT02116530|2138182|FG000|Overall Study|Lost to Follow-up|1
1078988|NCT02116530|2138183|FG001|Overall Study|Lost to Follow-up|0
1078989|NCT02116530|2138182|FG000|Overall Study|Other Medical Problems|2
1078990|NCT02116530|2138183|FG001|Overall Study|Other Medical Problems|2
1078991|NCT02116582|2138189|FG000|Overall Study|Enrolled but Never Received Study Drug|1
1078992|NCT02116582|2138189|FG000|Overall Study|Adverse Event|22
1078993|NCT02116582|2138189|FG000|Overall Study|Death|9
1078994|NCT02116582|2138189|FG000|Overall Study|Progressive Disease|148
1078995|NCT02116582|2138189|FG000|Overall Study|Protocol Violation|3
1078996|NCT02116582|2138189|FG000|Overall Study|Withdrawal by Subject|8
1078997|NCT02116582|2138189|FG000|Overall Study|Other: Miscellaneous|11
1078998|NCT02116582|2138189|FG000|Overall Study|Lost to Follow-up|1
1078999|NCT02116582|2138189|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12
1079000|NCT02116608|2138196|FG000|Overall Study|Lost to Follow-up|0
1079001|NCT02116608|2138197|FG001|Overall Study|Lost to Follow-up|0
1079002|NCT02116608|2138198|FG002|Overall Study|Lost to Follow-up|1
1079003|NCT02116608|2138196|FG000|Overall Study|Physician Decision|0
1079004|NCT02116608|2138197|FG001|Overall Study|Physician Decision|1
1079005|NCT02116608|2138198|FG002|Overall Study|Physician Decision|0
1079006|NCT02116608|2138196|FG000|Overall Study|Death|0
1079007|NCT02116608|2138197|FG001|Overall Study|Death|1
1079008|NCT02116608|2138198|FG002|Overall Study|Death|0
1079009|NCT02116621|2138208|FG000|Baseline|Withdrawal by Subject|0
1079010|NCT02116621|2138209|FG001|Baseline|Withdrawal by Subject|4
1079011|NCT02116621|2138208|FG000|Three Month Follow-up|Death|1
1079012|NCT02116621|2138209|FG001|Three Month Follow-up|Death|1
1079013|NCT02116621|2138208|FG000|Three Month Follow-up|Withdrawal by Subject|4
1079014|NCT02116621|2138209|FG001|Three Month Follow-up|Withdrawal by Subject|1
1079015|NCT02116621|2138208|FG000|Three Month Follow-up|Lost to Follow-up|0
1079016|NCT02116621|2138209|FG001|Three Month Follow-up|Lost to Follow-up|1
1079017|NCT02116621|2138208|FG000|Three Month Follow-up|Did not complete follow-up survey|14
1079018|NCT02116621|2138209|FG001|Three Month Follow-up|Did not complete follow-up survey|4
1079019|NCT02116621|2138208|FG000|Six Month Follow-up|Withdrawal by Subject|1
1079020|NCT02116621|2138209|FG001|Six Month Follow-up|Withdrawal by Subject|1
1079021|NCT02116621|2138208|FG000|Six Month Follow-up|Lost to Follow-up|2
1079022|NCT02116621|2138209|FG001|Six Month Follow-up|Lost to Follow-up|1
1079023|NCT02116621|2138208|FG000|Six Month Follow-up|Did not complete follow-up survey|1
1079024|NCT02116621|2138209|FG001|Six Month Follow-up|Did not complete follow-up survey|1
1079025|NCT02116621|2138208|FG000|Twelve Month Follow-up|Withdrawal by Subject|1
1079026|NCT02116621|2138209|FG001|Twelve Month Follow-up|Withdrawal by Subject|0
1079027|NCT02116621|2138208|FG000|Twelve Month Follow-up|Lost to Follow-up|0
1079028|NCT02116621|2138209|FG001|Twelve Month Follow-up|Lost to Follow-up|1
1079029|NCT02116621|2138208|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1
1079030|NCT02116621|2138209|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3
1079031|NCT02116621|2138208|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14
1079032|NCT02116621|2138209|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8
1079033|NCT02116660|2138217|FG000|Overall Study|Deteriorating renal function|0
1079034|NCT02116660|2138218|FG001|Overall Study|Deteriorating renal function|1
1079035|NCT02116660|2138217|FG000|Overall Study|Adverse Event|1
1079036|NCT02116660|2138218|FG001|Overall Study|Adverse Event|1
1079037|NCT02116660|2138217|FG000|Overall Study|Withdrawal by Subject|0
1079038|NCT02116660|2138218|FG001|Overall Study|Withdrawal by Subject|2
1079039|NCT02116660|2138217|FG000|Overall Study|Organization reason|1
1079040|NCT02116660|2138218|FG001|Overall Study|Organization reason|0
1079041|NCT02116777|2138233|FG000|Overall Study|Adverse Event|0
1079042|NCT02116777|2138234|FG001|Overall Study|Adverse Event|0
1079043|NCT02116777|2138235|FG002|Overall Study|Adverse Event|0
1079044|NCT02116777|2138236|FG003|Overall Study|Adverse Event|0
1079045|NCT02116777|2138237|FG004|Overall Study|Adverse Event|2
1079046|NCT02116777|2138238|FG005|Overall Study|Adverse Event|2
1079047|NCT02116777|2138239|FG006|Overall Study|Adverse Event|0
1079048|NCT02116777|2138233|FG000|Overall Study|Death|0
1079049|NCT02116777|2138234|FG001|Overall Study|Death|0
1079050|NCT02116777|2138235|FG002|Overall Study|Death|0
1079051|NCT02116777|2138236|FG003|Overall Study|Death|1
1079052|NCT02116777|2138237|FG004|Overall Study|Death|0
1079053|NCT02116777|2138238|FG005|Overall Study|Death|0
1079054|NCT02116777|2138239|FG006|Overall Study|Death|0
1079055|NCT02116777|2138233|FG000|Overall Study|Lack of Efficacy|3
1079056|NCT02116777|2138234|FG001|Overall Study|Lack of Efficacy|3
1079057|NCT02116777|2138235|FG002|Overall Study|Lack of Efficacy|3
1079058|NCT02116777|2138236|FG003|Overall Study|Lack of Efficacy|8
1079059|NCT02116777|2138237|FG004|Overall Study|Lack of Efficacy|4
1079060|NCT02116777|2138238|FG005|Overall Study|Lack of Efficacy|1
1079061|NCT02116777|2138239|FG006|Overall Study|Lack of Efficacy|9
1079062|NCT02116777|2138233|FG000|Overall Study|Physician Decision|0
1079063|NCT02116777|2138234|FG001|Overall Study|Physician Decision|0
1079064|NCT02116777|2138235|FG002|Overall Study|Physician Decision|0
1079065|NCT02116777|2138236|FG003|Overall Study|Physician Decision|2
1079066|NCT02116777|2138237|FG004|Overall Study|Physician Decision|0
1079067|NCT02116777|2138238|FG005|Overall Study|Physician Decision|0
1079068|NCT02116777|2138239|FG006|Overall Study|Physician Decision|0
1079069|NCT02116777|2138233|FG000|Overall Study|Protocol Violation|0
1079070|NCT02116777|2138234|FG001|Overall Study|Protocol Violation|0
1079071|NCT02116777|2138235|FG002|Overall Study|Protocol Violation|0
1079072|NCT02116777|2138236|FG003|Overall Study|Protocol Violation|1
1079073|NCT02116777|2138237|FG004|Overall Study|Protocol Violation|0
1079074|NCT02116777|2138238|FG005|Overall Study|Protocol Violation|0
1079075|NCT02116777|2138239|FG006|Overall Study|Protocol Violation|0
1079076|NCT02116777|2138233|FG000|Overall Study|Withdrawal by Subject|0
1079077|NCT02116777|2138234|FG001|Overall Study|Withdrawal by Subject|0
1079078|NCT02116777|2138235|FG002|Overall Study|Withdrawal by Subject|0
1079079|NCT02116777|2138236|FG003|Overall Study|Withdrawal by Subject|1
1079080|NCT02116777|2138237|FG004|Overall Study|Withdrawal by Subject|0
1079081|NCT02116777|2138238|FG005|Overall Study|Withdrawal by Subject|0
1079082|NCT02116777|2138239|FG006|Overall Study|Withdrawal by Subject|0
1079083|NCT02116803|2138260|FG000|Overall Study|Adverse Event|2
1079084|NCT02116803|2138261|FG001|Overall Study|Adverse Event|1
1079085|NCT02116803|2138260|FG000|Overall Study|Physician Decision|1
1079086|NCT02116803|2138261|FG001|Overall Study|Physician Decision|0
1079087|NCT02116803|2138260|FG000|Overall Study|Progressive disease|4
1079088|NCT02116803|2138261|FG001|Overall Study|Progressive disease|0
1079089|NCT02116803|2138260|FG000|Overall Study|Study terminated by sponsor|2
1079090|NCT02116803|2138261|FG001|Overall Study|Study terminated by sponsor|1
1079091|NCT02116803|2138260|FG000|Overall Study|Death|1
1079092|NCT02116803|2138261|FG001|Overall Study|Death|0
1079093|NCT02116972|2138270|FG000|Overall Study|Adverse Event|4
1079094|NCT02116972|2138271|FG001|Overall Study|Adverse Event|4
1079095|NCT02116972|2138272|FG002|Overall Study|Adverse Event|1
1079096|NCT02116972|2138270|FG000|Overall Study|Withdrawal by Subject|1
1079097|NCT02116972|2138271|FG001|Overall Study|Withdrawal by Subject|1
1079098|NCT02116972|2138272|FG002|Overall Study|Withdrawal by Subject|5
1079099|NCT02116972|2138270|FG000|Overall Study|Protocol Violation|1
1079100|NCT02116972|2138271|FG001|Overall Study|Protocol Violation|0
1079101|NCT02116972|2138272|FG002|Overall Study|Protocol Violation|1
1079102|NCT02116972|2138270|FG000|Overall Study|Lost to Follow-up|4
1079103|NCT02116972|2138271|FG001|Overall Study|Lost to Follow-up|3
1079104|NCT02116972|2138272|FG002|Overall Study|Lost to Follow-up|1
1079105|NCT02116972|2138270|FG000|Overall Study|Lack of Efficacy|6
1079106|NCT02116972|2138271|FG001|Overall Study|Lack of Efficacy|6
1079107|NCT02116972|2138272|FG002|Overall Study|Lack of Efficacy|5
1079108|NCT02116972|2138270|FG000|Overall Study|scheduling conflicts and relocation|3
1079109|NCT02116972|2138271|FG001|Overall Study|scheduling conflicts and relocation|3
1079110|NCT02116972|2138272|FG002|Overall Study|scheduling conflicts and relocation|6
1079111|NCT02117024|2138284|FG000|Overall Study|Progressive Disease|26
1079112|NCT02117024|2138285|FG001|Overall Study|Progressive Disease|9
1079113|NCT02117024|2138284|FG000|Overall Study|Significant Clinical Progression|7
1079114|NCT02117024|2138285|FG001|Overall Study|Significant Clinical Progression|4
1079115|NCT02117024|2138284|FG000|Overall Study|Death|5
1079116|NCT02117024|2138285|FG001|Overall Study|Death|0
1079117|NCT02117024|2138284|FG000|Overall Study|Withdrawal by Subject|3
1079118|NCT02117024|2138285|FG001|Overall Study|Withdrawal by Subject|1
1079119|NCT02117024|2138284|FG000|Overall Study|Protocol Violation|1
1079120|NCT02117024|2138285|FG001|Overall Study|Protocol Violation|0
1079121|NCT02117024|2138284|FG000|Overall Study|Adverse Event|1
1079122|NCT02117024|2138285|FG001|Overall Study|Adverse Event|2
1079123|NCT02117024|2138284|FG000|Overall Study|Randomized in Error|1
1079124|NCT02117024|2138285|FG001|Overall Study|Randomized in Error|0
1079125|NCT02117024|2138284|FG000|Overall Study|Patient returned to primary oncologist|0
1079126|NCT02117024|2138285|FG001|Overall Study|Patient returned to primary oncologist|1
1079127|NCT02117024|2138284|FG000|Overall Study|Patient took treatment break|0
1079128|NCT02117024|2138285|FG001|Overall Study|Patient took treatment break|1
1079129|NCT02117024|2138284|FG000|Overall Study|Physician Decision|0
1079130|NCT02117024|2138285|FG001|Overall Study|Physician Decision|2
1079131|NCT02117349|2138316|FG000|Overall Study|Withdrawal by Subject|1
1079132|NCT02117349|2138317|FG001|Overall Study|Withdrawal by Subject|0
1079133|NCT02117349|2138316|FG000|Overall Study|Lost to Follow-up|1
1079134|NCT02117349|2138317|FG001|Overall Study|Lost to Follow-up|1
1079135|NCT02117349|2138316|FG000|Overall Study|Death|1
1079136|NCT02117349|2138317|FG001|Overall Study|Death|0
1079137|NCT02117414|2138325|FG000|Overall Study|Death|5
1079138|NCT02117414|2138326|FG001|Overall Study|Death|2
1079139|NCT02117414|2138325|FG000|Overall Study|Withdrawal by Subject|10
1079140|NCT02117414|2138326|FG001|Overall Study|Withdrawal by Subject|4
1079141|NCT02117427|2138337|FG000|Overall Study|Permanent need for exogenous EPO Tx|2
1079142|NCT02117427|2138338|FG001|Overall Study|Permanent need for exogenous EPO Tx|0
1079143|NCT02117427|2138339|FG002|Overall Study|Permanent need for exogenous EPO Tx|0
1079144|NCT02117427|2138337|FG000|Overall Study|Permanent need for exogenous ESA Tx|3
1079145|NCT02117427|2138338|FG001|Overall Study|Permanent need for exogenous ESA Tx|1
1079146|NCT02117427|2138339|FG002|Overall Study|Permanent need for exogenous ESA Tx|0
1079147|NCT02117427|2138337|FG000|Overall Study|Physician Decision|0
1079148|NCT02117427|2138338|FG001|Overall Study|Physician Decision|2
1079149|NCT02117427|2138339|FG002|Overall Study|Physician Decision|0
1079150|NCT02117427|2138337|FG000|Overall Study|No longer meets inclusion criteria|0
1079151|NCT02117427|2138338|FG001|Overall Study|No longer meets inclusion criteria|1
1079152|NCT02117427|2138339|FG002|Overall Study|No longer meets inclusion criteria|0
1079153|NCT02117427|2138337|FG000|Overall Study|Death|0
1079154|NCT02117427|2138338|FG001|Overall Study|Death|1
1079155|NCT02117427|2138339|FG002|Overall Study|Death|0
1079156|NCT02117479|2138347|FG000|Overall Study|Death|13
1079157|NCT02117479|2138348|FG001|Overall Study|Death|8
1079158|NCT02117479|2138347|FG000|Overall Study|Adverse Event|8
1079159|NCT02117479|2138348|FG001|Overall Study|Adverse Event|16
1079160|NCT02117479|2138347|FG000|Overall Study|Subject decision|8
1079161|NCT02117479|2138348|FG001|Overall Study|Subject decision|9
1079162|NCT02117479|2138347|FG000|Overall Study|Disease progression|104
1079163|NCT02117479|2138348|FG001|Overall Study|Disease progression|108
1079164|NCT02117479|2138347|FG000|Overall Study|Noncompliance with study treatment|1
1079165|NCT02117479|2138348|FG001|Overall Study|Noncompliance with study treatment|0
1079166|NCT02117479|2138347|FG000|Overall Study|Study terminated by the sponsor|4
1079167|NCT02117479|2138348|FG001|Overall Study|Study terminated by the sponsor|6
1079168|NCT02117479|2138347|FG000|Overall Study|Physician Decision|7
1079169|NCT02117479|2138348|FG001|Overall Study|Physician Decision|2
1079170|NCT02117479|2138347|FG000|Overall Study|Other unspecified|11
1079171|NCT02117479|2138348|FG001|Overall Study|Other unspecified|7
1079172|NCT02117544|2138354|FG000|Period 1|Lost to follow-up (prior to treatment)|2
1079173|NCT02117544|2138355|FG001|Period 1|Lost to follow-up (prior to treatment)|0
1079174|NCT02117570|2138365|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
1079175|NCT02117570|2138366|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
1079176|NCT02117570|2138367|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
1079177|NCT02117570|2138365|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
1079178|NCT02117570|2138366|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
1079179|NCT02117570|2138367|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
1079180|NCT02117570|2138365|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
1079181|NCT02117570|2138366|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
1079182|NCT02117570|2138367|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
1079183|NCT02117570|2138365|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0
1079184|NCT02117570|2138366|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0
1079185|NCT02117570|2138367|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1
1079186|NCT02117570|2138365|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
1079187|NCT02117570|2138366|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
1079188|NCT02117570|2138367|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
1079189|NCT02117570|2138365|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
1079190|NCT02117570|2138366|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
1079191|NCT02117570|2138367|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
1079192|NCT02117570|2138365|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
1079193|NCT02117570|2138366|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
1079194|NCT02117570|2138367|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
1079195|NCT02117648|2138378|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1
1079196|NCT02117648|2138378|FG000|Abemaciclib Alone Period 1|Adverse Event|1
1079197|NCT02117648|2138378|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
1079198|NCT02117648|2138378|FG000|Abemaciclib + Clarithromycin Period 2|Death|1
1079199|NCT02117648|2138378|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
1079200|NCT02117648|2138378|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
1079201|NCT02117648|2138378|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12
1079202|NCT02117648|2138378|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1
1079203|NCT02117648|2138378|FG000|Abemaciclib Safety-Extension Phase|Death|3
1079204|NCT02117648|2138378|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
1079205|NCT02117648|2138378|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2
1079206|NCT02117687|2138388|FG000|Overall Study|Lost to Follow-up|0
1079207|NCT02117687|2138389|FG001|Overall Study|Lost to Follow-up|1
1079208|NCT02117687|2138388|FG000|Overall Study|Adverse Event|0
1079209|NCT02117687|2138389|FG001|Overall Study|Adverse Event|2
1079210|NCT02117687|2138388|FG000|Overall Study|Other Reasons|1
1079211|NCT02117687|2138389|FG001|Overall Study|Other Reasons|1
1079212|NCT02117713|2138395|FG000|Week 48|Adverse Event|4
1079213|NCT02117713|2138395|FG000|Week 48|Withdrawal by caregiver|2
1079214|NCT02117713|2138395|FG000|Week 48|Did not consent to Protocol Amendment 4|2
1079215|NCT02117713|2138395|FG000|Long Term Follow-up Treatment|Adverse Event|3
1079216|NCT02117713|2138395|FG000|Long Term Follow-up Treatment|Progressive Disease|2
1079217|NCT02117713|2138395|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1
1079218|NCT02118012|2138429|FG000|Overall Study|Adverse Event|0
1079219|NCT02118012|2138430|FG001|Overall Study|Adverse Event|1
1079220|NCT02118012|2138429|FG000|Overall Study|Physician Decision|0
1079221|NCT02118012|2138430|FG001|Overall Study|Physician Decision|1
1079222|NCT02118337|2138445|FG000|Overall Study|Other|1
1079223|NCT02118337|2138446|FG001|Overall Study|Other|0
1079224|NCT02118337|2138447|FG002|Overall Study|Other|0
1079225|NCT02118337|2138448|FG003|Overall Study|Other|0
1079226|NCT02118337|2138449|FG004|Overall Study|Other|2
1079227|NCT02118337|2138450|FG005|Overall Study|Other|3
1079228|NCT02118337|2138451|FG006|Overall Study|Other|1
1079229|NCT02118337|2138452|FG007|Overall Study|Other|28
1079230|NCT02118337|2138453|FG008|Overall Study|Other|15
1079231|NCT02118337|2138445|FG000|Overall Study|Lost to Follow-up|0
1079232|NCT02118337|2138446|FG001|Overall Study|Lost to Follow-up|0
1079233|NCT02118337|2138447|FG002|Overall Study|Lost to Follow-up|0
1079234|NCT02118337|2138448|FG003|Overall Study|Lost to Follow-up|0
1079235|NCT02118337|2138449|FG004|Overall Study|Lost to Follow-up|0
1079236|NCT02118337|2138450|FG005|Overall Study|Lost to Follow-up|0
1079237|NCT02118337|2138451|FG006|Overall Study|Lost to Follow-up|0
1079238|NCT02118337|2138452|FG007|Overall Study|Lost to Follow-up|1
1079239|NCT02118337|2138453|FG008|Overall Study|Lost to Follow-up|0
1079240|NCT02118337|2138445|FG000|Overall Study|Withdrawal by Subject|1
1079241|NCT02118337|2138446|FG001|Overall Study|Withdrawal by Subject|3
1079242|NCT02118337|2138447|FG002|Overall Study|Withdrawal by Subject|2
1079243|NCT02118337|2138448|FG003|Overall Study|Withdrawal by Subject|1
1079244|NCT02118337|2138449|FG004|Overall Study|Withdrawal by Subject|2
1079245|NCT02118337|2138450|FG005|Overall Study|Withdrawal by Subject|2
1079246|NCT02118337|2138451|FG006|Overall Study|Withdrawal by Subject|1
1079247|NCT02118337|2138452|FG007|Overall Study|Withdrawal by Subject|4
1079248|NCT02118337|2138453|FG008|Overall Study|Withdrawal by Subject|2
1079249|NCT02118337|2138445|FG000|Overall Study|Death|2
1079250|NCT02118337|2138446|FG001|Overall Study|Death|2
1079251|NCT02118337|2138447|FG002|Overall Study|Death|1
1079252|NCT02118337|2138448|FG003|Overall Study|Death|2
1079253|NCT02118337|2138449|FG004|Overall Study|Death|5
1079254|NCT02118337|2138450|FG005|Overall Study|Death|1
1079255|NCT02118337|2138451|FG006|Overall Study|Death|2
1079256|NCT02118337|2138452|FG007|Overall Study|Death|9
1079257|NCT02118337|2138453|FG008|Overall Study|Death|4
1079258|NCT02118428|2138479|FG000|Overall Study|Physician Decision|0
1079259|NCT02118428|2138480|FG001|Overall Study|Physician Decision|1
1079260|NCT02118428|2138481|FG002|Overall Study|Physician Decision|0
1079261|NCT02118428|2138479|FG000|Overall Study|Withdrawal by Subject|2
1079262|NCT02118428|2138480|FG001|Overall Study|Withdrawal by Subject|2
1079263|NCT02118428|2138481|FG002|Overall Study|Withdrawal by Subject|0
1079264|NCT02118428|2138479|FG000|Overall Study|Death|7
1079265|NCT02118428|2138480|FG001|Overall Study|Death|5
1079266|NCT02118428|2138481|FG002|Overall Study|Death|0
1079267|NCT02118428|2138479|FG000|Overall Study|Lost to Follow-up|3
1079268|NCT02118428|2138480|FG001|Overall Study|Lost to Follow-up|1
1079269|NCT02118428|2138481|FG002|Overall Study|Lost to Follow-up|0
1079270|NCT02118428|2138479|FG000|Overall Study|Screen Failure or Became Inelegible|1
1079271|NCT02118428|2138480|FG001|Overall Study|Screen Failure or Became Inelegible|0
1079272|NCT02118428|2138481|FG002|Overall Study|Screen Failure or Became Inelegible|1
1079273|NCT02118597|2138497|FG000|Overall Study|Sponsor terminated the study|14
1079274|NCT02118597|2138497|FG000|Overall Study|Serious Adverse Event|1
1079275|NCT02118597|2138497|FG000|Overall Study|Investigator's decision|1
1079276|NCT02118714|2138510|FG000|Overall Study|Lost to Follow-up|2
1079277|NCT02118714|2138510|FG000|Overall Study|Protocol Violation|1
1079278|NCT02118766|2138516|FG000|Overall Study|Adverse Event|7
1079279|NCT02118766|2138517|FG001|Overall Study|Adverse Event|2
1079280|NCT02118766|2138516|FG000|Overall Study|Withdrawal by Subject|3
1079281|NCT02118766|2138517|FG001|Overall Study|Withdrawal by Subject|6
1079282|NCT02118766|2138516|FG000|Overall Study|Lost to Follow-up|5
1079283|NCT02118766|2138517|FG001|Overall Study|Lost to Follow-up|4
1079284|NCT02118766|2138516|FG000|Overall Study|Withdrawal by parent/guardian|12
1079285|NCT02118766|2138517|FG001|Overall Study|Withdrawal by parent/guardian|18
1079286|NCT02118766|2138516|FG000|Overall Study|Other|3
1079287|NCT02118766|2138517|FG001|Overall Study|Other|1
1079288|NCT02118792|2138525|FG000|Overall Study|Withdrawal by Subject|6
1079289|NCT02118792|2138526|FG001|Overall Study|Withdrawal by Subject|3
1079290|NCT02118792|2138525|FG000|Overall Study|Lost to Follow-up|4
1079291|NCT02118792|2138526|FG001|Overall Study|Lost to Follow-up|4
1079292|NCT02118792|2138525|FG000|Overall Study|Adverse Event|5
1079293|NCT02118792|2138526|FG001|Overall Study|Adverse Event|4
1079294|NCT02118792|2138525|FG000|Overall Study|Withdrawal by parent/guardian|14
1079295|NCT02118792|2138526|FG001|Overall Study|Withdrawal by parent/guardian|20
1079296|NCT02118792|2138525|FG000|Overall Study|Other|1
1079297|NCT02118792|2138526|FG001|Overall Study|Other|6
1079298|NCT02118792|2138525|FG000|Overall Study|Randomised but not treated|1
1079299|NCT02118792|2138526|FG001|Overall Study|Randomised but not treated|0
1079300|NCT02118896|2138557|FG000|Overall Study|Death|4
1079301|NCT02118896|2138558|FG001|Overall Study|Death|0
1079302|NCT02118896|2138559|FG002|Overall Study|Death|4
1079303|NCT02118896|2138560|FG003|Overall Study|Death|6
1079304|NCT02118896|2138561|FG004|Overall Study|Death|3
1079305|NCT02118896|2138562|FG005|Overall Study|Death|1
1079306|NCT02118896|2138563|FG006|Overall Study|Death|0
1079307|NCT02118896|2138564|FG007|Overall Study|Death|0
1079308|NCT02118896|2138565|FG008|Overall Study|Death|0
1079309|NCT02118896|2138566|FG009|Overall Study|Death|0
1079310|NCT02118896|2138557|FG000|Overall Study|Adverse Event|5
1079311|NCT02118896|2138558|FG001|Overall Study|Adverse Event|4
1079312|NCT02118896|2138559|FG002|Overall Study|Adverse Event|4
1079313|NCT02118896|2138560|FG003|Overall Study|Adverse Event|5
1079314|NCT02118896|2138561|FG004|Overall Study|Adverse Event|5
1079315|NCT02118896|2138562|FG005|Overall Study|Adverse Event|9
1079316|NCT02118896|2138563|FG006|Overall Study|Adverse Event|1
1079317|NCT02118896|2138564|FG007|Overall Study|Adverse Event|1
1079318|NCT02118896|2138565|FG008|Overall Study|Adverse Event|4
1079319|NCT02118896|2138566|FG009|Overall Study|Adverse Event|0
1079320|NCT02118896|2138557|FG000|Overall Study|Consent withdrawn|2
1079321|NCT02118896|2138558|FG001|Overall Study|Consent withdrawn|0
1079322|NCT02118896|2138559|FG002|Overall Study|Consent withdrawn|3
1079323|NCT02118896|2138560|FG003|Overall Study|Consent withdrawn|4
1079324|NCT02118896|2138561|FG004|Overall Study|Consent withdrawn|1
1079325|NCT02118896|2138562|FG005|Overall Study|Consent withdrawn|4
1079326|NCT02118896|2138563|FG006|Overall Study|Consent withdrawn|0
1079327|NCT02118896|2138564|FG007|Overall Study|Consent withdrawn|0
1079328|NCT02118896|2138565|FG008|Overall Study|Consent withdrawn|0
1079329|NCT02118896|2138566|FG009|Overall Study|Consent withdrawn|0
1079330|NCT02118896|2138557|FG000|Overall Study|Non-compliance|2
1079331|NCT02118896|2138558|FG001|Overall Study|Non-compliance|1
1079332|NCT02118896|2138559|FG002|Overall Study|Non-compliance|1
1079333|NCT02118896|2138560|FG003|Overall Study|Non-compliance|5
1079334|NCT02118896|2138561|FG004|Overall Study|Non-compliance|0
1079335|NCT02118896|2138562|FG005|Overall Study|Non-compliance|1
1079336|NCT02118896|2138563|FG006|Overall Study|Non-compliance|0
1079337|NCT02118896|2138564|FG007|Overall Study|Non-compliance|1
1079338|NCT02118896|2138565|FG008|Overall Study|Non-compliance|0
1079339|NCT02118896|2138566|FG009|Overall Study|Non-compliance|0
1079340|NCT02118896|2138557|FG000|Overall Study|Pregnancy|1
1079341|NCT02118896|2138558|FG001|Overall Study|Pregnancy|1
1079342|NCT02118896|2138559|FG002|Overall Study|Pregnancy|0
1079343|NCT02118896|2138560|FG003|Overall Study|Pregnancy|0
1079344|NCT02118896|2138561|FG004|Overall Study|Pregnancy|1
1079345|NCT02118896|2138562|FG005|Overall Study|Pregnancy|3
1079346|NCT02118896|2138563|FG006|Overall Study|Pregnancy|1
1079347|NCT02118896|2138564|FG007|Overall Study|Pregnancy|0
1079348|NCT02118896|2138565|FG008|Overall Study|Pregnancy|0
1079349|NCT02118896|2138566|FG009|Overall Study|Pregnancy|0
1079350|NCT02118896|2138557|FG000|Overall Study|Lost to Follow-up|1
1079351|NCT02118896|2138558|FG001|Overall Study|Lost to Follow-up|2
1079352|NCT02118896|2138559|FG002|Overall Study|Lost to Follow-up|1
1079353|NCT02118896|2138560|FG003|Overall Study|Lost to Follow-up|0
1079354|NCT02118896|2138561|FG004|Overall Study|Lost to Follow-up|2
1079355|NCT02118896|2138562|FG005|Overall Study|Lost to Follow-up|1
1079356|NCT02118896|2138563|FG006|Overall Study|Lost to Follow-up|0
1079357|NCT02118896|2138564|FG007|Overall Study|Lost to Follow-up|0
1079358|NCT02118896|2138565|FG008|Overall Study|Lost to Follow-up|0
1079359|NCT02118896|2138566|FG009|Overall Study|Lost to Follow-up|0
1079360|NCT02118896|2138557|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1
1079361|NCT02118896|2138558|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5
1079362|NCT02118896|2138559|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1
1079363|NCT02118896|2138560|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2
1079364|NCT02118896|2138561|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4
1079365|NCT02118896|2138562|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2
1079366|NCT02118896|2138563|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0
1079367|NCT02118896|2138564|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0
1079368|NCT02118896|2138565|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0
1079369|NCT02118896|2138566|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2
1079370|NCT02118896|2138557|FG000|Overall Study|Prohibited medication|0
1079371|NCT02118896|2138558|FG001|Overall Study|Prohibited medication|0
1079372|NCT02118896|2138559|FG002|Overall Study|Prohibited medication|0
1079373|NCT02118896|2138560|FG003|Overall Study|Prohibited medication|0
1079374|NCT02118896|2138561|FG004|Overall Study|Prohibited medication|1
1079375|NCT02118896|2138562|FG005|Overall Study|Prohibited medication|3
1079376|NCT02118896|2138563|FG006|Overall Study|Prohibited medication|0
1079377|NCT02118896|2138564|FG007|Overall Study|Prohibited medication|0
1079378|NCT02118896|2138565|FG008|Overall Study|Prohibited medication|0
1079379|NCT02118896|2138566|FG009|Overall Study|Prohibited medication|0
1079380|NCT02118896|2138557|FG000|Overall Study|Miscellaneous|1
1079381|NCT02118896|2138558|FG001|Overall Study|Miscellaneous|2
1079382|NCT02118896|2138559|FG002|Overall Study|Miscellaneous|0
1079383|NCT02118896|2138560|FG003|Overall Study|Miscellaneous|2
1079384|NCT02118896|2138561|FG004|Overall Study|Miscellaneous|0
1079385|NCT02118896|2138562|FG005|Overall Study|Miscellaneous|4
1079386|NCT02118896|2138563|FG006|Overall Study|Miscellaneous|0
1079387|NCT02118896|2138564|FG007|Overall Study|Miscellaneous|0
1079388|NCT02118896|2138565|FG008|Overall Study|Miscellaneous|0
1079389|NCT02118896|2138566|FG009|Overall Study|Miscellaneous|0
1079390|NCT02118961|2138591|FG000|Overall Study|Withdrawal by Subject|1
1079391|NCT02118961|2138592|FG001|Overall Study|Withdrawal by Subject|0
1079392|NCT02119026|2138600|FG000|1st-line Treatment|Adverse Event|9
1079393|NCT02119026|2138601|FG001|1st-line Treatment|Adverse Event|14
1079394|NCT02119026|2138600|FG000|1st-line Treatment|Physician Decision|3
1079395|NCT02119026|2138601|FG001|1st-line Treatment|Physician Decision|8
1079396|NCT02119026|2138600|FG000|1st-line Treatment|Withdrawal by Subject|4
1079397|NCT02119026|2138601|FG001|1st-line Treatment|Withdrawal by Subject|10
1079398|NCT02119026|2138600|FG000|1st-line Treatment|Patient condition or compliance|6
1079399|NCT02119026|2138601|FG001|1st-line Treatment|Patient condition or compliance|4
1079400|NCT02119026|2138600|FG000|1st-line Treatment|Surgery of metastases|2
1079401|NCT02119026|2138601|FG001|1st-line Treatment|Surgery of metastases|1
1079402|NCT02119026|2138600|FG000|1st-line Treatment|Death|2
1079403|NCT02119026|2138601|FG001|1st-line Treatment|Death|1
1079404|NCT02119026|2138600|FG000|2nd-line Treatment|Lost to Follow-up|2
1079405|NCT02119026|2138601|FG001|2nd-line Treatment|Lost to Follow-up|0
1079406|NCT02119026|2138600|FG000|2nd-line Treatment|Withdrawal by Subject|3
1079407|NCT02119026|2138601|FG001|2nd-line Treatment|Withdrawal by Subject|1
1079408|NCT02119026|2138600|FG000|2nd-line Treatment|Adverse Event|4
1079409|NCT02119026|2138601|FG001|2nd-line Treatment|Adverse Event|1
1079410|NCT02119104|2138607|FG000|Overall Study|Protocol Violation|16
1079411|NCT02119156|2138614|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
1079412|NCT02119156|2138615|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
1079413|NCT02119156|2138616|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
1079414|NCT02119156|2138614|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
1079415|NCT02119156|2138615|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
1079416|NCT02119156|2138616|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
1079417|NCT02119156|2138614|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
1079418|NCT02119156|2138615|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
1079419|NCT02119156|2138616|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
1079420|NCT02119156|2138614|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
1079421|NCT02119156|2138615|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
1079422|NCT02119156|2138616|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
1079423|NCT02119156|2138614|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
1079424|NCT02119156|2138615|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
1079425|NCT02119156|2138616|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
1079426|NCT02119260|2138638|FG000|Overall Study|Adverse Event|1
1079427|NCT02119260|2138639|FG001|Overall Study|Adverse Event|0
1079428|NCT02119260|2138640|FG002|Overall Study|Adverse Event|0
1079429|NCT02119260|2138641|FG003|Overall Study|Adverse Event|0
1079430|NCT02119260|2138642|FG004|Overall Study|Adverse Event|0
1079431|NCT02119260|2138643|FG005|Overall Study|Adverse Event|0
1079432|NCT02119260|2138644|FG006|Overall Study|Adverse Event|0
1079433|NCT02119260|2138638|FG000|Overall Study|Withdrew consent|0
1079434|NCT02119260|2138639|FG001|Overall Study|Withdrew consent|1
1079435|NCT02119260|2138640|FG002|Overall Study|Withdrew consent|1
1079436|NCT02119260|2138641|FG003|Overall Study|Withdrew consent|0
1079437|NCT02119260|2138642|FG004|Overall Study|Withdrew consent|0
1079438|NCT02119260|2138643|FG005|Overall Study|Withdrew consent|0
1079439|NCT02119260|2138644|FG006|Overall Study|Withdrew consent|0
1079440|NCT02119286|2138672|FG000|Overall Study|Adverse Event|9
1079441|NCT02119286|2138673|FG001|Overall Study|Adverse Event|7
1079442|NCT02119286|2138674|FG002|Overall Study|Adverse Event|2
1079443|NCT02119286|2138672|FG000|Overall Study|Lack of Efficacy|11
1079444|NCT02119286|2138673|FG001|Overall Study|Lack of Efficacy|3
1079445|NCT02119286|2138674|FG002|Overall Study|Lack of Efficacy|4
1079446|NCT02119286|2138672|FG000|Overall Study|Lost to Follow-up|2
1079447|NCT02119286|2138673|FG001|Overall Study|Lost to Follow-up|0
1079448|NCT02119286|2138674|FG002|Overall Study|Lost to Follow-up|1
1079449|NCT02119286|2138672|FG000|Overall Study|Withdrawal by Subject|4
1079450|NCT02119286|2138673|FG001|Overall Study|Withdrawal by Subject|1
1079451|NCT02119286|2138674|FG002|Overall Study|Withdrawal by Subject|0
1079452|NCT02119299|2138682|FG000|Overall Study|Withdrawal by Subject|7
1079453|NCT02119299|2138682|FG000|Overall Study|Lack of Efficacy|1
1079454|NCT02119299|2138682|FG000|Overall Study|Pregnancy|1
1079455|NCT02119325|2138686|FG000|Washout Period 1|Adverse Event|0
1079456|NCT02119325|2138687|FG001|Washout Period 1|Adverse Event|1
1079457|NCT02119650|2138720|FG000|Overall Study|Adverse Event|3
1079458|NCT02119650|2138721|FG001|Overall Study|Adverse Event|4
1079459|NCT02119650|2138720|FG000|Overall Study|Subject decision|2
1079460|NCT02119650|2138721|FG001|Overall Study|Subject decision|3
1079461|NCT02119650|2138720|FG000|Overall Study|Disease progression|11
1079462|NCT02119650|2138721|FG001|Overall Study|Disease progression|14
1079463|NCT02119650|2138720|FG000|Overall Study|Death|5
1079464|NCT02119650|2138721|FG001|Overall Study|Death|1
1079465|NCT02119650|2138720|FG000|Overall Study|Noncompliance with study treatment|1
1079466|NCT02119650|2138721|FG001|Overall Study|Noncompliance with study treatment|1
1079467|NCT02119650|2138720|FG000|Overall Study|Study terminated by the sponsor|1
1079468|NCT02119650|2138721|FG001|Overall Study|Study terminated by the sponsor|0
1079469|NCT02119650|2138720|FG000|Overall Study|Physician Decision|0
1079470|NCT02119650|2138721|FG001|Overall Study|Physician Decision|2
1079471|NCT02119650|2138720|FG000|Overall Study|Multiple reasons for termination|2
1079472|NCT02119650|2138721|FG001|Overall Study|Multiple reasons for termination|1
1079473|NCT02119663|2138729|FG000|Overall Study|Disease progression|26
1079474|NCT02119663|2138730|FG001|Overall Study|Disease progression|27
1079475|NCT02119663|2138729|FG000|Overall Study|Adverse Event|5
1079476|NCT02119663|2138730|FG001|Overall Study|Adverse Event|5
1079477|NCT02119663|2138729|FG000|Overall Study|Death|3
1079478|NCT02119663|2138730|FG001|Overall Study|Death|2
1079479|NCT02119663|2138729|FG000|Overall Study|Physician Decision|1
1079480|NCT02119663|2138730|FG001|Overall Study|Physician Decision|2
1079481|NCT02119663|2138729|FG000|Overall Study|Other unspecified|2
1079482|NCT02119663|2138730|FG001|Overall Study|Other unspecified|0
1079483|NCT02119663|2138729|FG000|Overall Study|Subject decision|0
1079484|NCT02119663|2138730|FG001|Overall Study|Subject decision|1
1079485|NCT02119663|2138729|FG000|Overall Study|Study Terminated by the Sponsor|3
1079486|NCT02119663|2138730|FG001|Overall Study|Study Terminated by the Sponsor|4
1079487|NCT02119676|2138740|FG000|Overall Study|Adverse Event|9
1079488|NCT02119676|2138741|FG001|Overall Study|Adverse Event|17
1079489|NCT02119676|2138742|FG002|Overall Study|Adverse Event|10
1079490|NCT02119676|2138743|FG003|Overall Study|Adverse Event|10
1079491|NCT02119676|2138740|FG000|Overall Study|Disease progression|53
1079492|NCT02119676|2138741|FG001|Overall Study|Disease progression|55
1079493|NCT02119676|2138742|FG002|Overall Study|Disease progression|68
1079494|NCT02119676|2138743|FG003|Overall Study|Disease progression|73
1079495|NCT02119676|2138740|FG000|Overall Study|Patient decision, inc. consent withdrawn|4
1079496|NCT02119676|2138741|FG001|Overall Study|Patient decision, inc. consent withdrawn|5
1079497|NCT02119676|2138742|FG002|Overall Study|Patient decision, inc. consent withdrawn|5
1079498|NCT02119676|2138743|FG003|Overall Study|Patient decision, inc. consent withdrawn|6
1079499|NCT02119676|2138740|FG000|Overall Study|Physician Decision|4
1079500|NCT02119676|2138741|FG001|Overall Study|Physician Decision|2
1079501|NCT02119676|2138742|FG002|Overall Study|Physician Decision|3
1079502|NCT02119676|2138743|FG003|Overall Study|Physician Decision|2
1079503|NCT02119676|2138740|FG000|Overall Study|Death|9
1079504|NCT02119676|2138741|FG001|Overall Study|Death|3
1079505|NCT02119676|2138742|FG002|Overall Study|Death|2
1079506|NCT02119676|2138743|FG003|Overall Study|Death|1
1079507|NCT02119676|2138740|FG000|Overall Study|Noncompliance|0
1079508|NCT02119676|2138741|FG001|Overall Study|Noncompliance|1
1079509|NCT02119676|2138742|FG002|Overall Study|Noncompliance|0
1079510|NCT02119676|2138743|FG003|Overall Study|Noncompliance|0
1079511|NCT02119676|2138740|FG000|Overall Study|Lost to Follow-up|0
1079512|NCT02119676|2138741|FG001|Overall Study|Lost to Follow-up|0
1079513|NCT02119676|2138742|FG002|Overall Study|Lost to Follow-up|1
1079514|NCT02119676|2138743|FG003|Overall Study|Lost to Follow-up|0
1079515|NCT02119676|2138740|FG000|Overall Study|Protocol deviation|0
1079516|NCT02119676|2138741|FG001|Overall Study|Protocol deviation|0
1079517|NCT02119676|2138742|FG002|Overall Study|Protocol deviation|1
1079518|NCT02119676|2138743|FG003|Overall Study|Protocol deviation|0
1079519|NCT02119676|2138740|FG000|Overall Study|Other, unspecified|2
1079520|NCT02119676|2138741|FG001|Overall Study|Other, unspecified|1
1079521|NCT02119676|2138742|FG002|Overall Study|Other, unspecified|3
1079522|NCT02119676|2138743|FG003|Overall Study|Other, unspecified|4
1079523|NCT02119676|2138740|FG000|Overall Study|Did not receive study med|2
1079524|NCT02119676|2138741|FG001|Overall Study|Did not receive study med|2
1079525|NCT02119676|2138742|FG002|Overall Study|Did not receive study med|4
1079526|NCT02119676|2138743|FG003|Overall Study|Did not receive study med|5
1079527|NCT02119819|2138759|FG000|Overall Study|Adverse Event|3
1079528|NCT02119819|2138760|FG001|Overall Study|Adverse Event|1
1079529|NCT02119819|2138761|FG002|Overall Study|Adverse Event|2
1079530|NCT02119819|2138762|FG003|Overall Study|Adverse Event|3
1079531|NCT02119819|2138763|FG004|Overall Study|Adverse Event|0
1079532|NCT02119819|2138764|FG005|Overall Study|Adverse Event|1
1079533|NCT02119819|2138759|FG000|Overall Study|Lack of Efficacy|0
1079534|NCT02119819|2138760|FG001|Overall Study|Lack of Efficacy|0
1079535|NCT02119819|2138761|FG002|Overall Study|Lack of Efficacy|0
1079536|NCT02119819|2138762|FG003|Overall Study|Lack of Efficacy|0
1079537|NCT02119819|2138763|FG004|Overall Study|Lack of Efficacy|0
1079538|NCT02119819|2138764|FG005|Overall Study|Lack of Efficacy|1
1079539|NCT02119819|2138759|FG000|Overall Study|Lost to Follow-up|0
1079540|NCT02119819|2138760|FG001|Overall Study|Lost to Follow-up|0
1079541|NCT02119819|2138761|FG002|Overall Study|Lost to Follow-up|1
1079542|NCT02119819|2138762|FG003|Overall Study|Lost to Follow-up|2
1079543|NCT02119819|2138763|FG004|Overall Study|Lost to Follow-up|1
1079544|NCT02119819|2138764|FG005|Overall Study|Lost to Follow-up|2
1079545|NCT02119819|2138759|FG000|Overall Study|Physician Decision|1
1079546|NCT02119819|2138760|FG001|Overall Study|Physician Decision|1
1079547|NCT02119819|2138761|FG002|Overall Study|Physician Decision|0
1079548|NCT02119819|2138762|FG003|Overall Study|Physician Decision|0
1079549|NCT02119819|2138763|FG004|Overall Study|Physician Decision|0
1079550|NCT02119819|2138764|FG005|Overall Study|Physician Decision|1
1079551|NCT02119819|2138759|FG000|Overall Study|Withdrawal by Subject|5
1079552|NCT02119819|2138760|FG001|Overall Study|Withdrawal by Subject|3
1079553|NCT02119819|2138761|FG002|Overall Study|Withdrawal by Subject|0
1079554|NCT02119819|2138762|FG003|Overall Study|Withdrawal by Subject|0
1079555|NCT02119819|2138763|FG004|Overall Study|Withdrawal by Subject|6
1079556|NCT02119819|2138764|FG005|Overall Study|Withdrawal by Subject|10
1079557|NCT02119819|2138759|FG000|Overall Study|Jury Duty|0
1079558|NCT02119819|2138760|FG001|Overall Study|Jury Duty|0
1079559|NCT02119819|2138761|FG002|Overall Study|Jury Duty|1
1079560|NCT02119819|2138762|FG003|Overall Study|Jury Duty|0
1079561|NCT02119819|2138763|FG004|Overall Study|Jury Duty|0
1079562|NCT02119819|2138764|FG005|Overall Study|Jury Duty|0
1079563|NCT02119819|2138759|FG000|Overall Study|Protocol Violation|0
1079564|NCT02119819|2138760|FG001|Overall Study|Protocol Violation|0
1079565|NCT02119819|2138761|FG002|Overall Study|Protocol Violation|0
1079566|NCT02119819|2138762|FG003|Overall Study|Protocol Violation|1
1079567|NCT02119819|2138763|FG004|Overall Study|Protocol Violation|0
1079568|NCT02119819|2138764|FG005|Overall Study|Protocol Violation|0
1079569|NCT02119819|2138759|FG000|Overall Study|Left the city to get a job|0
1079570|NCT02119819|2138760|FG001|Overall Study|Left the city to get a job|0
1079571|NCT02119819|2138761|FG002|Overall Study|Left the city to get a job|0
1079572|NCT02119819|2138762|FG003|Overall Study|Left the city to get a job|1
1079573|NCT02119819|2138763|FG004|Overall Study|Left the city to get a job|0
1079574|NCT02119819|2138764|FG005|Overall Study|Left the city to get a job|0
1079575|NCT02119936|2138787|FG000|Overall Study|Lost to Follow-up|10
1079576|NCT02120027|2138802|FG000|Overall Study|Adverse Event|4
1079577|NCT02120027|2138803|FG001|Overall Study|Adverse Event|5
1079578|NCT02120027|2138802|FG000|Overall Study|Lack of Efficacy|3
1079579|NCT02120027|2138803|FG001|Overall Study|Lack of Efficacy|5
1079580|NCT02120027|2138802|FG000|Overall Study|Lost to Follow-up|5
1079581|NCT02120027|2138803|FG001|Overall Study|Lost to Follow-up|13
1079582|NCT02120027|2138802|FG000|Overall Study|Other|4
1079583|NCT02120027|2138803|FG001|Overall Study|Other|0
1079584|NCT02120027|2138802|FG000|Overall Study|Physician Decision|4
1079585|NCT02120027|2138803|FG001|Overall Study|Physician Decision|3
1079586|NCT02120027|2138802|FG000|Overall Study|Protocol Violation|18
1079587|NCT02120027|2138803|FG001|Overall Study|Protocol Violation|21
1079588|NCT02120027|2138802|FG000|Overall Study|Study terminated by Sponsor|45
1079589|NCT02120027|2138803|FG001|Overall Study|Study terminated by Sponsor|47
1079590|NCT02120027|2138802|FG000|Overall Study|Withdrawal by Subject|33
1079591|NCT02120027|2138803|FG001|Overall Study|Withdrawal by Subject|25
1079592|NCT02120157|2138809|FG000|Overall Study|Death|8
1079593|NCT02120300|2138832|FG000|Overall Study|Enrolled but Never Treated|2
1079594|NCT02120300|2138833|FG001|Overall Study|Enrolled but Never Treated|0
1079595|NCT02120300|2138834|FG002|Overall Study|Enrolled but Never Treated|0
1079596|NCT02120300|2138835|FG003|Overall Study|Enrolled but Never Treated|0
1079597|NCT02120300|2138832|FG000|Overall Study|Lack of Efficacy|0
1079598|NCT02120300|2138833|FG001|Overall Study|Lack of Efficacy|0
1079599|NCT02120300|2138834|FG002|Overall Study|Lack of Efficacy|0
1079600|NCT02120300|2138835|FG003|Overall Study|Lack of Efficacy|1
1079601|NCT02120300|2138832|FG000|Overall Study|Lost to Follow-up|1
1079602|NCT02120300|2138833|FG001|Overall Study|Lost to Follow-up|0
1079603|NCT02120300|2138834|FG002|Overall Study|Lost to Follow-up|0
1079604|NCT02120300|2138835|FG003|Overall Study|Lost to Follow-up|0
1079605|NCT02120352|2138847|FG000|Induction Period (20 Weeks)|Adverse Event|3
1079606|NCT02120352|2138848|FG001|Induction Period (20 Weeks)|Adverse Event|0
1079607|NCT02120352|2138849|FG002|Induction Period (20 Weeks)|Adverse Event|0
1079608|NCT02120352|2138850|FG003|Induction Period (20 Weeks)|Adverse Event|0
1079609|NCT02120352|2138847|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5
1079610|NCT02120352|2138848|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0
1079611|NCT02120352|2138849|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0
1079612|NCT02120352|2138850|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0
1079613|NCT02120352|2138847|FG000|Induction Period (20 Weeks)|Protocol Violation|2
1079614|NCT02120352|2138848|FG001|Induction Period (20 Weeks)|Protocol Violation|0
1079615|NCT02120352|2138849|FG002|Induction Period (20 Weeks)|Protocol Violation|0
1079616|NCT02120352|2138850|FG003|Induction Period (20 Weeks)|Protocol Violation|0
1079617|NCT02120352|2138847|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3
1079618|NCT02120352|2138848|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
1079619|NCT02120352|2138849|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
1079620|NCT02120352|2138850|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
1079621|NCT02120352|2138847|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2
1079622|NCT02120352|2138848|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0
1079623|NCT02120352|2138849|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0
1079624|NCT02120352|2138850|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0
1079625|NCT02120352|2138847|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5
1079626|NCT02120352|2138848|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0
1079627|NCT02120352|2138849|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0
1079628|NCT02120352|2138850|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0
1079629|NCT02120352|2138847|FG000|Induction Period (20 Weeks)|Physician Decision|1
1079630|NCT02120352|2138848|FG001|Induction Period (20 Weeks)|Physician Decision|0
1079631|NCT02120352|2138849|FG002|Induction Period (20 Weeks)|Physician Decision|0
1079632|NCT02120352|2138850|FG003|Induction Period (20 Weeks)|Physician Decision|0
1079633|NCT02120352|2138847|FG000|Maintenance Period (32 Weeks)|Adverse Event|0
1079634|NCT02120352|2138848|FG001|Maintenance Period (32 Weeks)|Adverse Event|0
1079635|NCT02120352|2138849|FG002|Maintenance Period (32 Weeks)|Adverse Event|6
1079636|NCT02120352|2138850|FG003|Maintenance Period (32 Weeks)|Adverse Event|1
1079637|NCT02120352|2138847|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0
1079638|NCT02120352|2138848|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1
1079639|NCT02120352|2138849|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0
1079640|NCT02120352|2138850|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1
1079641|NCT02120352|2138847|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0
1079642|NCT02120352|2138848|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0
1079643|NCT02120352|2138849|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2
1079644|NCT02120352|2138850|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0
1079645|NCT02120352|2138847|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
1079646|NCT02120352|2138848|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
1079647|NCT02120352|2138849|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
1079648|NCT02120352|2138850|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
1079649|NCT02120352|2138847|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0
1079650|NCT02120352|2138848|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0
1079651|NCT02120352|2138849|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0
1079652|NCT02120352|2138850|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1
1079653|NCT02120352|2138847|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0
1079654|NCT02120352|2138848|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
1079655|NCT02120352|2138849|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1
1079656|NCT02120352|2138850|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
1079657|NCT02120352|2138847|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0
1079658|NCT02120352|2138848|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112
1079659|NCT02120352|2138849|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105
1079660|NCT02120352|2138850|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50
1079661|NCT02120417|2138866|FG000|Overall Study|Death|5
1079662|NCT02120417|2138867|FG001|Overall Study|Death|1
1079663|NCT02120417|2138866|FG000|Overall Study|Adverse Event|3
1079664|NCT02120417|2138867|FG001|Overall Study|Adverse Event|9
1079665|NCT02120417|2138866|FG000|Overall Study|Participant decision|4
1079666|NCT02120417|2138867|FG001|Overall Study|Participant decision|4
1079667|NCT02120417|2138866|FG000|Overall Study|Disease progression|41
1079668|NCT02120417|2138867|FG001|Overall Study|Disease progression|45
1079669|NCT02120417|2138866|FG000|Overall Study|Noncompliance with study treatment|0
1079670|NCT02120417|2138867|FG001|Overall Study|Noncompliance with study treatment|2
1079671|NCT02120417|2138866|FG000|Overall Study|Physician Decision|2
1079672|NCT02120417|2138867|FG001|Overall Study|Physician Decision|3
1079673|NCT02120417|2138866|FG000|Overall Study|Other unspecified|5
1079674|NCT02120417|2138867|FG001|Overall Study|Other unspecified|4
1079675|NCT02120456|2138886|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0
1079676|NCT02120456|2138887|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0
1079677|NCT02120456|2138888|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0
1079678|NCT02120456|2138889|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0
1079679|NCT02120456|2138890|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0
1079680|NCT02120456|2138891|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0
1079681|NCT02120456|2138892|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1
1079682|NCT02120456|2138893|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0
1079683|NCT02120456|2138894|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0
1079684|NCT02120456|2138886|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0
1079685|NCT02120456|2138887|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0
1079686|NCT02120456|2138888|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0
1079687|NCT02120456|2138889|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0
1079688|NCT02120456|2138890|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0
1079689|NCT02120456|2138891|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0
1079690|NCT02120456|2138892|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1
1079691|NCT02120456|2138893|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0
1079692|NCT02120456|2138894|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0
1079693|NCT02120456|2138886|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1079694|NCT02120456|2138887|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1079695|NCT02120456|2138888|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1079696|NCT02120456|2138889|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1079697|NCT02120456|2138890|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1079698|NCT02120456|2138891|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1079699|NCT02120456|2138892|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1079700|NCT02120456|2138893|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1079701|NCT02120456|2138894|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1
1079702|NCT02120625|2138914|FG000|Overall Study|Physician Decision|2
1079703|NCT02120664|2138923|FG000|Overall Study|Withdrawal by Subject|0
1079704|NCT02120664|2138924|FG001|Overall Study|Withdrawal by Subject|0
1079705|NCT02120664|2138925|FG002|Overall Study|Withdrawal by Subject|0
1079706|NCT02120664|2138926|FG003|Overall Study|Withdrawal by Subject|1
1079707|NCT02120664|2138927|FG004|Overall Study|Withdrawal by Subject|0
1079708|NCT02120781|2138951|FG000|Overall Study|Physician Decision|2
1079709|NCT02120781|2138952|FG001|Overall Study|Physician Decision|0
1079710|NCT02120781|2138951|FG000|Overall Study|Completion not documented|2
1079711|NCT02120781|2138952|FG001|Overall Study|Completion not documented|1
1079712|NCT02120794|2138958|FG000|Overall Study|Withdrawal by Subject|43
1079713|NCT02120794|2138958|FG000|Overall Study|Adverse Event|10
1079714|NCT02120794|2138958|FG000|Overall Study|Physician Decision|4
1079715|NCT02120794|2138958|FG000|Overall Study|Due to insurance coverage|1
1079716|NCT02120833|2138964|FG000|Overall Study|Adverse Event|1
1079717|NCT02120833|2138965|FG001|Overall Study|Adverse Event|0
1079718|NCT02120833|2138964|FG000|Overall Study|Withdrawal by Subject|2
1079719|NCT02120833|2138965|FG001|Overall Study|Withdrawal by Subject|0
1079720|NCT02120833|2138964|FG000|Overall Study|Lost to Follow-up|1
1079721|NCT02120833|2138965|FG001|Overall Study|Lost to Follow-up|1
1079722|NCT02120898|2138974|FG000|Overall Study|Withdrawal by Subject|4
1079723|NCT02120898|2138975|FG001|Overall Study|Withdrawal by Subject|2
1079724|NCT02120898|2138976|FG002|Overall Study|Withdrawal by Subject|2
1079725|NCT02120898|2138974|FG000|Overall Study|Non-compliance with study drug|3
1079726|NCT02120898|2138975|FG001|Overall Study|Non-compliance with study drug|0
1079727|NCT02120898|2138976|FG002|Overall Study|Non-compliance with study drug|0
1079728|NCT02120898|2138974|FG000|Overall Study|Adverse Event|1
1079729|NCT02120898|2138975|FG001|Overall Study|Adverse Event|2
1079730|NCT02120898|2138976|FG002|Overall Study|Adverse Event|1
1079731|NCT02120898|2138974|FG000|Overall Study|Protocol Violation|1
1079732|NCT02120898|2138975|FG001|Overall Study|Protocol Violation|2
1079733|NCT02120898|2138976|FG002|Overall Study|Protocol Violation|0
1079734|NCT02120898|2138974|FG000|Overall Study|Lost to Follow-up|0
1079735|NCT02120898|2138975|FG001|Overall Study|Lost to Follow-up|0
1079736|NCT02120898|2138976|FG002|Overall Study|Lost to Follow-up|1
1079737|NCT02120924|2138987|FG000|Overall Study|Lack of Efficacy|1
1079738|NCT02120924|2138988|FG001|Overall Study|Lack of Efficacy|2
1079739|NCT02120924|2138989|FG002|Overall Study|Lack of Efficacy|3
1079740|NCT02120924|2138987|FG000|Overall Study|Adverse Event|0
1079741|NCT02120924|2138988|FG001|Overall Study|Adverse Event|1
1079742|NCT02120924|2138989|FG002|Overall Study|Adverse Event|3
1079743|NCT02120924|2138987|FG000|Overall Study|Withdrawal by Subject|16
1079744|NCT02120924|2138988|FG001|Overall Study|Withdrawal by Subject|20
1079745|NCT02120924|2138989|FG002|Overall Study|Withdrawal by Subject|8
1079746|NCT02120924|2138987|FG000|Overall Study|Lost to Follow-up|14
1079747|NCT02120924|2138988|FG001|Overall Study|Lost to Follow-up|14
1079748|NCT02120924|2138989|FG002|Overall Study|Lost to Follow-up|11
1079749|NCT02120924|2138987|FG000|Overall Study|Pregnancy|2
1079750|NCT02120924|2138988|FG001|Overall Study|Pregnancy|0
1079751|NCT02120924|2138989|FG002|Overall Study|Pregnancy|0
1079752|NCT02120924|2138987|FG000|Overall Study|Protocol Violation|3
1079753|NCT02120924|2138988|FG001|Overall Study|Protocol Violation|7
1079754|NCT02120924|2138989|FG002|Overall Study|Protocol Violation|2
1079755|NCT02120924|2138987|FG000|Overall Study|Physician Decision|0
1079756|NCT02120924|2138988|FG001|Overall Study|Physician Decision|1
1079757|NCT02120924|2138989|FG002|Overall Study|Physician Decision|1
1079758|NCT02120924|2138987|FG000|Overall Study|Death|1
1079759|NCT02120924|2138988|FG001|Overall Study|Death|0
1079760|NCT02120924|2138989|FG002|Overall Study|Death|0
1079761|NCT02120924|2138987|FG000|Overall Study|Compliance with IP|5
1079762|NCT02120924|2138988|FG001|Overall Study|Compliance with IP|1
1079763|NCT02120924|2138989|FG002|Overall Study|Compliance with IP|1
1079764|NCT02120950|2139000|FG000|Overall Study|Adverse Event|5
1079765|NCT02120950|2139001|FG001|Overall Study|Adverse Event|4
1079766|NCT02120950|2139002|FG002|Overall Study|Adverse Event|3
1079767|NCT02120950|2139000|FG000|Overall Study|Death|3
1079768|NCT02120950|2139001|FG001|Overall Study|Death|0
1079769|NCT02120950|2139002|FG002|Overall Study|Death|1
1079770|NCT02120950|2139000|FG000|Overall Study|Withdrawal by Subject|6
1079771|NCT02120950|2139001|FG001|Overall Study|Withdrawal by Subject|3
1079772|NCT02120950|2139002|FG002|Overall Study|Withdrawal by Subject|2
1079773|NCT02120950|2139000|FG000|Overall Study|Protocol Violation|1
1079774|NCT02120950|2139001|FG001|Overall Study|Protocol Violation|1
1079775|NCT02120950|2139002|FG002|Overall Study|Protocol Violation|7
1079776|NCT02120950|2139000|FG000|Overall Study|Other reasons|5
1079777|NCT02120950|2139001|FG001|Overall Study|Other reasons|4
1079778|NCT02120950|2139002|FG002|Overall Study|Other reasons|1
1079779|NCT02120950|2139000|FG000|Overall Study|Lost to Follow-up|0
1079780|NCT02120950|2139001|FG001|Overall Study|Lost to Follow-up|2
1079781|NCT02120950|2139002|FG002|Overall Study|Lost to Follow-up|1
1079782|NCT02121002|2139012|FG000|Overall Study|Physician Decision|2
1079783|NCT02121002|2139013|FG001|Overall Study|Physician Decision|0
1079784|NCT02121002|2139014|FG002|Overall Study|Physician Decision|0
1079785|NCT02121002|2139012|FG000|Overall Study|Withdrawal by Subject|3
1079786|NCT02121002|2139013|FG001|Overall Study|Withdrawal by Subject|1
1079787|NCT02121002|2139014|FG002|Overall Study|Withdrawal by Subject|4
1079788|NCT02121002|2139012|FG000|Overall Study|Protocol Violation|1
1079789|NCT02121002|2139013|FG001|Overall Study|Protocol Violation|2
1079790|NCT02121002|2139014|FG002|Overall Study|Protocol Violation|4
1079791|NCT02121002|2139012|FG000|Overall Study|Concomitant therapy|0
1079792|NCT02121002|2139013|FG001|Overall Study|Concomitant therapy|1
1079793|NCT02121002|2139014|FG002|Overall Study|Concomitant therapy|1
1079794|NCT02121002|2139012|FG000|Overall Study|Others|1
1079795|NCT02121002|2139013|FG001|Overall Study|Others|0
1079796|NCT02121002|2139014|FG002|Overall Study|Others|1
1079797|NCT02121210|2139038|FG000|Overall Study|Adverse Event|5
1079798|NCT02121210|2139039|FG001|Overall Study|Adverse Event|7
1079799|NCT02121210|2139038|FG000|Overall Study|Lack of Efficacy|2
1079800|NCT02121210|2139039|FG001|Overall Study|Lack of Efficacy|0
1079801|NCT02121210|2139038|FG000|Overall Study|Other than specified above|0
1079802|NCT02121210|2139039|FG001|Overall Study|Other than specified above|2
1079803|NCT02121262|2139047|FG000|Overall Study|Adverse Event|6
1079804|NCT02121262|2139048|FG001|Overall Study|Adverse Event|3
1079805|NCT02121262|2139047|FG000|Overall Study|Lack of Efficacy|3
1079806|NCT02121262|2139048|FG001|Overall Study|Lack of Efficacy|0
1079807|NCT02121262|2139047|FG000|Overall Study|Personal Reasons|19
1079808|NCT02121262|2139048|FG001|Overall Study|Personal Reasons|5
1079809|NCT02121262|2139047|FG000|Overall Study|Protocol Violation|1
1079810|NCT02121262|2139048|FG001|Overall Study|Protocol Violation|1
1079811|NCT02121262|2139047|FG000|Overall Study|Participant Dropped-out|0
1079812|NCT02121262|2139048|FG001|Overall Study|Participant Dropped-out|1
1079813|NCT02121262|2139047|FG000|Overall Study|Participant was Deemed Unsuitable|1
1079814|NCT02121262|2139048|FG001|Overall Study|Participant was Deemed Unsuitable|0
1079815|NCT02121262|2139047|FG000|Overall Study|Consent Withdrawn|1
1079816|NCT02121262|2139048|FG001|Overall Study|Consent Withdrawn|0
1079817|NCT02121301|2139057|FG000|Overall Study|Protocol Violation|1
1079818|NCT02121301|2139058|FG001|Overall Study|Protocol Violation|4
1079819|NCT02121301|2139059|FG002|Overall Study|Protocol Violation|1
1079820|NCT02121392|2139069|FG000|Prior to Intervention|Protocol Violation|40
1079821|NCT02121392|2139070|FG001|Prior to Intervention|Protocol Violation|35
1079822|NCT02121392|2139069|FG000|Prior to Intervention|Withdrawal by Subject|8
1079823|NCT02121392|2139070|FG001|Prior to Intervention|Withdrawal by Subject|6
1079824|NCT02121392|2139069|FG000|After Placement of AC Block vs Sham|Protocol Violation|3
1079825|NCT02121392|2139070|FG001|After Placement of AC Block vs Sham|Protocol Violation|2
1079826|NCT02121392|2139069|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0
1079827|NCT02121392|2139070|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1
1079828|NCT02121509|2139095|FG000|Washout Period (35 Days)|Adverse Event|1
1079829|NCT02121509|2139096|FG001|Washout Period (35 Days)|Adverse Event|1
1079830|NCT02121509|2139097|FG002|Washout Period (35 Days)|Adverse Event|0
1079831|NCT02121509|2139098|FG003|Washout Period (35 Days)|Adverse Event|0
1079832|NCT02121509|2139095|FG000|Washout Period (35 Days)|Withdrawal by Subject|0
1079833|NCT02121509|2139096|FG001|Washout Period (35 Days)|Withdrawal by Subject|3
1079834|NCT02121509|2139097|FG002|Washout Period (35 Days)|Withdrawal by Subject|0
1079835|NCT02121509|2139098|FG003|Washout Period (35 Days)|Withdrawal by Subject|0
1079836|NCT02121509|2139095|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1
1079837|NCT02121509|2139096|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0
1079838|NCT02121509|2139097|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0
1079839|NCT02121509|2139098|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0
1079840|NCT02121522|2139108|FG000|Overall Study|Adverse Event|1
1079841|NCT02121535|2139114|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0
1079842|NCT02121535|2139115|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1
1079843|NCT02121535|2139114|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1
1079844|NCT02121535|2139115|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0
1079845|NCT02121756|2139124|FG000|Overall Study|Adverse Event|3
1079846|NCT02121756|2139125|FG001|Overall Study|Adverse Event|0
1079847|NCT02121756|2139124|FG000|Overall Study|Protocol Violation|1
1079848|NCT02121756|2139125|FG001|Overall Study|Protocol Violation|1
1079849|NCT02121756|2139124|FG000|Overall Study|Physician Decision|2
1079850|NCT02121756|2139125|FG001|Overall Study|Physician Decision|1
1079851|NCT02121795|2139136|FG000|Double-Blind Phase|Randomized but Never Treated|1
1079852|NCT02121795|2139137|FG001|Double-Blind Phase|Randomized but Never Treated|4
1079853|NCT02121795|2139136|FG000|Double-Blind Phase|Withdrawal by Subject|19
1079854|NCT02121795|2139137|FG001|Double-Blind Phase|Withdrawal by Subject|16
1079855|NCT02121795|2139136|FG000|Double-Blind Phase|Lost to Follow-up|7
1079856|NCT02121795|2139137|FG001|Double-Blind Phase|Lost to Follow-up|4
1079857|NCT02121795|2139136|FG000|Double-Blind Phase|Physician Decision|2
1079858|NCT02121795|2139137|FG001|Double-Blind Phase|Physician Decision|5
1079859|NCT02121795|2139136|FG000|Double-Blind Phase|Adverse Event|5
1079860|NCT02121795|2139137|FG001|Double-Blind Phase|Adverse Event|0
1079861|NCT02121795|2139136|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
1079862|NCT02121795|2139137|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
1079863|NCT02121795|2139136|FG000|Double-Blind Phase|Protocol Violation|0
1079864|NCT02121795|2139137|FG001|Double-Blind Phase|Protocol Violation|3
1079865|NCT02121795|2139136|FG000|Double-Blind Phase|Death|1
1079866|NCT02121795|2139137|FG001|Double-Blind Phase|Death|1
1079867|NCT02121795|2139136|FG000|Open-Label Phase|Physician Decision|8
1079868|NCT02121795|2139137|FG001|Open-Label Phase|Physician Decision|8
1079869|NCT02121795|2139136|FG000|Open-Label Phase|Withdrawal by Subject|3
1079870|NCT02121795|2139137|FG001|Open-Label Phase|Withdrawal by Subject|2
1079871|NCT02121795|2139136|FG000|Open-Label Phase|Lost to Follow-up|1
1079872|NCT02121795|2139137|FG001|Open-Label Phase|Lost to Follow-up|0
1079873|NCT02121808|2139145|FG000|Overall Study|Technical problem|3
1079874|NCT02121834|2139161|FG000|Overall Study|Protocol Violation|0
1079875|NCT02121834|2139162|FG001|Overall Study|Protocol Violation|1
1079876|NCT02121834|2139163|FG002|Overall Study|Protocol Violation|0
1079877|NCT02121834|2139164|FG003|Overall Study|Protocol Violation|0
1079878|NCT02121834|2139165|FG004|Overall Study|Protocol Violation|0
1079879|NCT02121834|2139166|FG005|Overall Study|Protocol Violation|0
1079880|NCT02121834|2139167|FG006|Overall Study|Protocol Violation|0
1079881|NCT02121834|2139161|FG000|Overall Study|Withdrawal by Subject|0
1079882|NCT02121834|2139162|FG001|Overall Study|Withdrawal by Subject|1
1079883|NCT02121834|2139163|FG002|Overall Study|Withdrawal by Subject|1
1079884|NCT02121834|2139164|FG003|Overall Study|Withdrawal by Subject|0
1079885|NCT02121834|2139165|FG004|Overall Study|Withdrawal by Subject|0
1079886|NCT02121834|2139166|FG005|Overall Study|Withdrawal by Subject|0
1079887|NCT02121834|2139167|FG006|Overall Study|Withdrawal by Subject|0
1079888|NCT02121834|2139161|FG000|Overall Study|Lost to Follow-up|0
1079889|NCT02121834|2139162|FG001|Overall Study|Lost to Follow-up|0
1079890|NCT02121834|2139163|FG002|Overall Study|Lost to Follow-up|1
1079891|NCT02121834|2139164|FG003|Overall Study|Lost to Follow-up|0
1079892|NCT02121834|2139165|FG004|Overall Study|Lost to Follow-up|0
1079893|NCT02121834|2139166|FG005|Overall Study|Lost to Follow-up|0
1079894|NCT02121834|2139167|FG006|Overall Study|Lost to Follow-up|0
1079895|NCT02121847|2139193|FG000|Overall Study|Administrative Reasons|1
1079896|NCT02121847|2139193|FG000|Overall Study|Adverse Event|2
1079897|NCT02122146|2139228|FG000|Part 1: Dose Escalation|Death|0
1079898|NCT02122146|2139229|FG001|Part 1: Dose Escalation|Death|1
1079899|NCT02122146|2139230|FG002|Part 1: Dose Escalation|Death|1
1079900|NCT02122146|2139231|FG003|Part 1: Dose Escalation|Death|0
1079901|NCT02122146|2139232|FG004|Part 1: Dose Escalation|Death|0
1079902|NCT02122146|2139233|FG005|Part 1: Dose Escalation|Death|0
1079903|NCT02122146|2139234|FG006|Part 1: Dose Escalation|Death|0
1079904|NCT02122146|2139235|FG007|Part 1: Dose Escalation|Death|0
1079905|NCT02122146|2139228|FG000|Part 1: Dose Escalation|Lost to Follow-up|0
1079906|NCT02122146|2139229|FG001|Part 1: Dose Escalation|Lost to Follow-up|0
1079907|NCT02122146|2139230|FG002|Part 1: Dose Escalation|Lost to Follow-up|1
1079908|NCT02122146|2139231|FG003|Part 1: Dose Escalation|Lost to Follow-up|0
1079909|NCT02122146|2139232|FG004|Part 1: Dose Escalation|Lost to Follow-up|1
1079910|NCT02122146|2139233|FG005|Part 1: Dose Escalation|Lost to Follow-up|0
1079911|NCT02122146|2139234|FG006|Part 1: Dose Escalation|Lost to Follow-up|0
1079912|NCT02122146|2139235|FG007|Part 1: Dose Escalation|Lost to Follow-up|0
1079913|NCT02122146|2139228|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
1079914|NCT02122146|2139229|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
1079915|NCT02122146|2139230|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
1079916|NCT02122146|2139231|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1
1079917|NCT02122146|2139232|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0
1079918|NCT02122146|2139233|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
1079919|NCT02122146|2139234|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
1079920|NCT02122146|2139235|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0
1079921|NCT02122146|2139228|FG000|Part 1: Dose Escalation|Other|1
1079922|NCT02122146|2139229|FG001|Part 1: Dose Escalation|Other|0
1079923|NCT02122146|2139230|FG002|Part 1: Dose Escalation|Other|0
1079924|NCT02122146|2139231|FG003|Part 1: Dose Escalation|Other|0
1079925|NCT02122146|2139232|FG004|Part 1: Dose Escalation|Other|0
1079926|NCT02122146|2139233|FG005|Part 1: Dose Escalation|Other|1
1079927|NCT02122146|2139234|FG006|Part 1: Dose Escalation|Other|1
1079928|NCT02122146|2139235|FG007|Part 1: Dose Escalation|Other|2
1079929|NCT02122380|2139265|FG000|First Intervention (30 Days)|Adverse Event|1
1079930|NCT02122380|2139266|FG001|First Intervention (30 Days)|Adverse Event|0
1079931|NCT02122380|2139265|FG000|First Intervention (30 Days)|Physician Decision|0
1079932|NCT02122380|2139266|FG001|First Intervention (30 Days)|Physician Decision|1
1079933|NCT02122380|2139265|FG000|Washout (8 Weeks)|Lost to Follow-up|1
1079934|NCT02122380|2139266|FG001|Washout (8 Weeks)|Lost to Follow-up|0
1079935|NCT02122380|2139265|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
1079936|NCT02122380|2139266|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
1079937|NCT02122380|2139265|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
1079938|NCT02122380|2139266|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
1090922|NCT02250651|2158803|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1
1090923|NCT02250651|2158804|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
1090924|NCT02250651|2158805|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
1090925|NCT02250651|2158803|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2
1090926|NCT02250651|2158804|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3
1090927|NCT02250651|2158805|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5
1090928|NCT02250651|2158803|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1
1090929|NCT02250651|2158804|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
1090930|NCT02250651|2158805|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
1090931|NCT02250651|2158803|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
1090932|NCT02250651|2158804|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
1090933|NCT02250651|2158805|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1
1090934|NCT02250651|2158803|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0
1090935|NCT02250651|2158804|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1
1090936|NCT02250651|2158805|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3
1090937|NCT02250651|2158803|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4
1090938|NCT02250651|2158804|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1
1090939|NCT02250651|2158805|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0
1090940|NCT02250651|2158803|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
1090941|NCT02250651|2158804|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
1090942|NCT02250651|2158805|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3
1090943|NCT02250651|2158803|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
1090944|NCT02250651|2158804|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3
1090945|NCT02250651|2158805|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
1090946|NCT02250651|2158803|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
1090947|NCT02250651|2158804|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1
1090948|NCT02250651|2158805|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
1090949|NCT02250651|2158803|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
1090950|NCT02250651|2158804|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1
1090951|NCT02250651|2158805|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
1090952|NCT02250651|2158803|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4
1090953|NCT02250651|2158804|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
1090954|NCT02250651|2158805|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
1090955|NCT02250651|2158803|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
1090956|NCT02250651|2158804|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2
1090957|NCT02250651|2158805|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
1090958|NCT02250651|2158803|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
1090959|NCT02250651|2158804|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0
1090960|NCT02250651|2158805|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
1079939|NCT02122770|2139303|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3
1079940|NCT02122770|2139304|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0
1079941|NCT02122770|2139305|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1
1079942|NCT02122770|2139306|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2
1079943|NCT02122770|2139307|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0
1079944|NCT02122770|2139308|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0
1079945|NCT02122770|2139303|FG000|Part A: Drug-drug Interaction 2|Other|0
1079946|NCT02122770|2139304|FG001|Part A: Drug-drug Interaction 2|Other|0
1079947|NCT02122770|2139305|FG002|Part A: Drug-drug Interaction 2|Other|1
1079948|NCT02122770|2139306|FG003|Part A: Drug-drug Interaction 2|Other|0
1079949|NCT02122770|2139307|FG004|Part A: Drug-drug Interaction 2|Other|0
1079950|NCT02122770|2139308|FG005|Part A: Drug-drug Interaction 2|Other|0
1079951|NCT02122770|2139303|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
1079952|NCT02122770|2139304|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
1079953|NCT02122770|2139305|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
1079954|NCT02122770|2139306|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
1079955|NCT02122770|2139307|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
1079956|NCT02122770|2139308|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
1079957|NCT02122770|2139303|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
1079958|NCT02122770|2139304|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
1079959|NCT02122770|2139305|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
1079960|NCT02122770|2139306|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
1079961|NCT02122770|2139307|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
1079962|NCT02122770|2139308|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
1079963|NCT02122770|2139303|FG000|Part B: Standard of Care|Adverse Event|0
1079964|NCT02122770|2139304|FG001|Part B: Standard of Care|Adverse Event|0
1079965|NCT02122770|2139305|FG002|Part B: Standard of Care|Adverse Event|0
1079966|NCT02122770|2139306|FG003|Part B: Standard of Care|Adverse Event|0
1079967|NCT02122770|2139307|FG004|Part B: Standard of Care|Adverse Event|4
1079968|NCT02122770|2139308|FG005|Part B: Standard of Care|Adverse Event|1
1079969|NCT02122770|2139303|FG000|Part B: Standard of Care|Other|0
1079970|NCT02122770|2139304|FG001|Part B: Standard of Care|Other|0
1079971|NCT02122770|2139305|FG002|Part B: Standard of Care|Other|0
1079972|NCT02122770|2139306|FG003|Part B: Standard of Care|Other|0
1079973|NCT02122770|2139307|FG004|Part B: Standard of Care|Other|0
1079974|NCT02122770|2139308|FG005|Part B: Standard of Care|Other|2
1079975|NCT02122770|2139303|FG000|Part B: Standard of Care|Withdrawal by Subject|0
1079976|NCT02122770|2139304|FG001|Part B: Standard of Care|Withdrawal by Subject|0
1079977|NCT02122770|2139305|FG002|Part B: Standard of Care|Withdrawal by Subject|0
1079978|NCT02122770|2139306|FG003|Part B: Standard of Care|Withdrawal by Subject|0
1079979|NCT02122770|2139307|FG004|Part B: Standard of Care|Withdrawal by Subject|4
1079980|NCT02122770|2139308|FG005|Part B: Standard of Care|Withdrawal by Subject|2
1079981|NCT02122770|2139303|FG000|Part B: Standard of Care|Symptomatic Deterioration|0
1079982|NCT02122770|2139304|FG001|Part B: Standard of Care|Symptomatic Deterioration|0
1079983|NCT02122770|2139305|FG002|Part B: Standard of Care|Symptomatic Deterioration|0
1079984|NCT02122770|2139306|FG003|Part B: Standard of Care|Symptomatic Deterioration|0
1079985|NCT02122770|2139307|FG004|Part B: Standard of Care|Symptomatic Deterioration|5
1079986|NCT02122770|2139308|FG005|Part B: Standard of Care|Symptomatic Deterioration|0
1079987|NCT02122770|2139303|FG000|Part B: Standard of Care|Progressive Disease|0
1079988|NCT02122770|2139304|FG001|Part B: Standard of Care|Progressive Disease|0
1079989|NCT02122770|2139305|FG002|Part B: Standard of Care|Progressive Disease|0
1079990|NCT02122770|2139306|FG003|Part B: Standard of Care|Progressive Disease|0
1079991|NCT02122770|2139307|FG004|Part B: Standard of Care|Progressive Disease|10
1079992|NCT02122770|2139308|FG005|Part B: Standard of Care|Progressive Disease|8
1079993|NCT02122783|2139333|FG000|Overall Study|Adverse Event|0
1079994|NCT02122783|2139334|FG001|Overall Study|Adverse Event|1
1079995|NCT02122887|2139355|FG000|Overall Study|Withdrawal by Subject|20
1079996|NCT02122887|2139356|FG001|Overall Study|Withdrawal by Subject|2
1079997|NCT02123134|2139386|FG000|Overall Study|Withdrawal of consent|3
1079998|NCT02123134|2139387|FG001|Overall Study|Withdrawal of consent|2
1079999|NCT02123134|2139386|FG000|Overall Study|Administrative decision|0
1080000|NCT02123134|2139387|FG001|Overall Study|Administrative decision|1
1080001|NCT02123251|2139395|FG000|Overall Study|Death|1
1080002|NCT02123251|2139396|FG001|Overall Study|Death|1
1080003|NCT02123251|2139395|FG000|Overall Study|Withdrawal by Subject|0
1080004|NCT02123251|2139396|FG001|Overall Study|Withdrawal by Subject|3
1080005|NCT02123251|2139395|FG000|Overall Study|Lost Medicaid eligibility|29
1080006|NCT02123251|2139396|FG001|Overall Study|Lost Medicaid eligibility|22
1080007|NCT02123251|2139395|FG000|Overall Study|Switched Managed Care Organization (MCO)|4
1080008|NCT02123251|2139396|FG001|Overall Study|Switched Managed Care Organization (MCO)|4
1080009|NCT02123446|2139412|FG000|Washout Period (1 Day)|Physician Decision|1
909498|NCT00788957|1886286|FG002|Part 1|Death|0
909499|NCT00788957|1886287|FG003|Part 1|Death|0
909500|NCT00788957|1886288|FG004|Part 1|Death|0
909501|NCT00788957|1886289|FG005|Part 1|Death|0
909502|NCT00788957|1886284|FG000|Part 1|Lost to Follow-up|1
909503|NCT00788957|1886285|FG001|Part 1|Lost to Follow-up|0
909504|NCT00788957|1886286|FG002|Part 1|Lost to Follow-up|0
909505|NCT00788957|1886287|FG003|Part 1|Lost to Follow-up|0
1080010|NCT02123446|2139413|FG001|Washout Period (1 Day)|Physician Decision|0
1080011|NCT02123459|2139419|FG000|Washout Period (1 Day)|Adverse Event|1
1080012|NCT02123459|2139420|FG001|Washout Period (1 Day)|Adverse Event|0
1080013|NCT02123472|2139426|FG000|Period 2 (7 Days)|Withdrawal by Subject|0
1080014|NCT02123472|2139427|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
1080015|NCT02123511|2139444|FG000|Overall Study|Cancelled treatment|1
1080016|NCT02123511|2139445|FG001|Overall Study|Cancelled treatment|0
1080017|NCT02123511|2139444|FG000|Overall Study|Incomplete data|1
1080018|NCT02123511|2139445|FG001|Overall Study|Incomplete data|3
1080019|NCT02123511|2139444|FG000|Overall Study|Ineligible|0
1080020|NCT02123511|2139445|FG001|Overall Study|Ineligible|1
1080021|NCT02123576|2139453|FG000|Overall Study|Adverse Event|1
1080022|NCT02123576|2139454|FG001|Overall Study|Adverse Event|0
1080023|NCT02123797|2139466|FG000|Baseline Intervention|Death|9
1080024|NCT02123797|2139467|FG001|Baseline Intervention|Death|16
1080025|NCT02123797|2139468|FG002|Baseline Intervention|Death|0
1080026|NCT02123797|2139469|FG003|Baseline Intervention|Death|0
1080027|NCT02123797|2139470|FG004|Baseline Intervention|Death|0
1080028|NCT02123797|2139466|FG000|Baseline Intervention|Withdrawal by Subject|2
1080029|NCT02123797|2139467|FG001|Baseline Intervention|Withdrawal by Subject|8
1080030|NCT02123797|2139468|FG002|Baseline Intervention|Withdrawal by Subject|0
1080031|NCT02123797|2139469|FG003|Baseline Intervention|Withdrawal by Subject|0
1080032|NCT02123797|2139470|FG004|Baseline Intervention|Withdrawal by Subject|0
1080033|NCT02123797|2139466|FG000|Baseline Intervention|Relocation|2
1080034|NCT02123797|2139467|FG001|Baseline Intervention|Relocation|0
1080035|NCT02123797|2139468|FG002|Baseline Intervention|Relocation|0
1080036|NCT02123797|2139469|FG003|Baseline Intervention|Relocation|0
1080037|NCT02123797|2139470|FG004|Baseline Intervention|Relocation|0
1080038|NCT02123797|2139466|FG000|Baseline Intervention|Out of window for initial survey|6
1080039|NCT02123797|2139467|FG001|Baseline Intervention|Out of window for initial survey|13
1080040|NCT02123797|2139468|FG002|Baseline Intervention|Out of window for initial survey|0
1080041|NCT02123797|2139469|FG003|Baseline Intervention|Out of window for initial survey|0
1080042|NCT02123797|2139470|FG004|Baseline Intervention|Out of window for initial survey|0
1080043|NCT02123797|2139466|FG000|Baseline Intervention|Lost to Follow-up|0
1080044|NCT02123797|2139467|FG001|Baseline Intervention|Lost to Follow-up|5
1080045|NCT02123797|2139468|FG002|Baseline Intervention|Lost to Follow-up|0
1080046|NCT02123797|2139469|FG003|Baseline Intervention|Lost to Follow-up|0
1080047|NCT02123797|2139470|FG004|Baseline Intervention|Lost to Follow-up|0
1080048|NCT02123797|2139466|FG000|Baseline Intervention|Other Disease|3
1080049|NCT02123797|2139467|FG001|Baseline Intervention|Other Disease|0
1080050|NCT02123797|2139468|FG002|Baseline Intervention|Other Disease|0
1080051|NCT02123797|2139469|FG003|Baseline Intervention|Other Disease|0
1080052|NCT02123797|2139470|FG004|Baseline Intervention|Other Disease|0
1080053|NCT02123797|2139466|FG000|3-month Follow up (Cumulative Counts)|Death|33
1080054|NCT02123797|2139467|FG001|3-month Follow up (Cumulative Counts)|Death|57
1080055|NCT02123797|2139468|FG002|3-month Follow up (Cumulative Counts)|Death|0
1080056|NCT02123797|2139469|FG003|3-month Follow up (Cumulative Counts)|Death|0
1080057|NCT02123797|2139470|FG004|3-month Follow up (Cumulative Counts)|Death|0
1080058|NCT02123797|2139466|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2
1080059|NCT02123797|2139467|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7
1080060|NCT02123797|2139468|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50
1080061|NCT02123797|2139469|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82
1080062|NCT02123797|2139470|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3
1080063|NCT02123797|2139466|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6
1080064|NCT02123797|2139467|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16
1080065|NCT02123797|2139468|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
1080066|NCT02123797|2139469|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
1080067|NCT02123797|2139470|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
1080068|NCT02123797|2139466|FG000|3-month Follow up (Cumulative Counts)|Relocation|0
1080069|NCT02123797|2139467|FG001|3-month Follow up (Cumulative Counts)|Relocation|1
1080070|NCT02123797|2139468|FG002|3-month Follow up (Cumulative Counts)|Relocation|0
1080071|NCT02123797|2139469|FG003|3-month Follow up (Cumulative Counts)|Relocation|0
1080072|NCT02123797|2139470|FG004|3-month Follow up (Cumulative Counts)|Relocation|0
1080073|NCT02123797|2139466|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16
1080074|NCT02123797|2139467|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36
1080075|NCT02123797|2139468|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
1080076|NCT02123797|2139469|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
1080077|NCT02123797|2139470|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
1080078|NCT02123797|2139466|FG000|6-month Follow up (Cumulative Counts)|Death|51
1080079|NCT02123797|2139467|FG001|6-month Follow up (Cumulative Counts)|Death|97
1080080|NCT02123797|2139468|FG002|6-month Follow up (Cumulative Counts)|Death|0
1080081|NCT02123797|2139469|FG003|6-month Follow up (Cumulative Counts)|Death|0
1080082|NCT02123797|2139470|FG004|6-month Follow up (Cumulative Counts)|Death|0
1162047|NCT03381248|2283985|FG000|Overall Study|Adverse Event|2
1080083|NCT02123797|2139466|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
1080084|NCT02123797|2139467|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20
1080085|NCT02123797|2139468|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66
1080086|NCT02123797|2139469|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113
1080087|NCT02123797|2139470|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
1080088|NCT02123797|2139466|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1
1080089|NCT02123797|2139467|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9
1080090|NCT02123797|2139468|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
1080091|NCT02123797|2139469|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
1080092|NCT02123797|2139470|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
1080093|NCT02123797|2139466|FG000|6-month Follow up (Cumulative Counts)|Relocation|0
1080094|NCT02123797|2139467|FG001|6-month Follow up (Cumulative Counts)|Relocation|2
1080095|NCT02123797|2139468|FG002|6-month Follow up (Cumulative Counts)|Relocation|0
1080096|NCT02123797|2139469|FG003|6-month Follow up (Cumulative Counts)|Relocation|0
1080097|NCT02123797|2139470|FG004|6-month Follow up (Cumulative Counts)|Relocation|0
1080098|NCT02123966|2139501|FG000|Overall Study|Intercurrent Illness|1
1080099|NCT02124161|2139545|FG000|Overall Study|Other unspecified|0
1080100|NCT02124161|2139546|FG001|Overall Study|Other unspecified|1
1080101|NCT02124161|2139545|FG000|Overall Study|Death|1
1080102|NCT02124161|2139546|FG001|Overall Study|Death|0
1080103|NCT02124161|2139545|FG000|Overall Study|Protocol Violation|2
1080104|NCT02124161|2139546|FG001|Overall Study|Protocol Violation|1
1080105|NCT02124161|2139545|FG000|Overall Study|Withdrawal by Subject|1
1080106|NCT02124161|2139546|FG001|Overall Study|Withdrawal by Subject|2
1080107|NCT02124161|2139545|FG000|Overall Study|Adverse Event|2
1080108|NCT02124161|2139546|FG001|Overall Study|Adverse Event|0
1080109|NCT02124161|2139545|FG000|Overall Study|Does not meet entrance criteria|2
1080110|NCT02124161|2139546|FG001|Overall Study|Does not meet entrance criteria|3
1080111|NCT02124161|2139545|FG000|Overall Study|No longer meets eligibility criteria|5
1080112|NCT02124161|2139546|FG001|Overall Study|No longer meets eligibility criteria|4
1080113|NCT02124161|2139545|FG000|Overall Study|Lost to Follow-up|3
1080114|NCT02124161|2139546|FG001|Overall Study|Lost to Follow-up|4
1080115|NCT02124265|2139559|FG000|Overall Study|Adverse Event|1
1080116|NCT02124564|2139591|FG000|Treatment Period|Adverse Event|2
1080117|NCT02124564|2139591|FG000|Treatment Period|Lack of Efficacy|3
1080118|NCT02124564|2139591|FG000|Treatment Period|Withdrawal by Subject|2
1080119|NCT02124707|2139601|FG000|Overall Study|Adverse Event|5
1080120|NCT02124707|2139601|FG000|Overall Study|Physician Decision|1
1080121|NCT02124707|2139601|FG000|Overall Study|Death|1
1080122|NCT02124746|2139609|FG000|Overall Study|Adverse Event|2
1080123|NCT02124746|2139610|FG001|Overall Study|Adverse Event|1
1080124|NCT02124746|2139611|FG002|Overall Study|Adverse Event|2
1080125|NCT02124746|2139609|FG000|Overall Study|Death|2
1080126|NCT02124746|2139610|FG001|Overall Study|Death|1
1080127|NCT02124746|2139611|FG002|Overall Study|Death|3
1080128|NCT02124746|2139609|FG000|Overall Study|Lack of Efficacy|3
1080129|NCT02124746|2139610|FG001|Overall Study|Lack of Efficacy|2
1080130|NCT02124746|2139611|FG002|Overall Study|Lack of Efficacy|2
1080131|NCT02124746|2139609|FG000|Overall Study|Physician Decision|6
1080132|NCT02124746|2139610|FG001|Overall Study|Physician Decision|4
1080133|NCT02124746|2139611|FG002|Overall Study|Physician Decision|5
1080134|NCT02124746|2139609|FG000|Overall Study|Non-Compliance with Study Drug|0
1080135|NCT02124746|2139610|FG001|Overall Study|Non-Compliance with Study Drug|1
1080136|NCT02124746|2139611|FG002|Overall Study|Non-Compliance with Study Drug|0
1080137|NCT02124746|2139609|FG000|Overall Study|Withdrawal by Subject|3
1080138|NCT02124746|2139610|FG001|Overall Study|Withdrawal by Subject|3
1080139|NCT02124746|2139611|FG002|Overall Study|Withdrawal by Subject|0
1080140|NCT02124746|2139609|FG000|Overall Study|Study Terminated by Sponsor|0
1080141|NCT02124746|2139610|FG001|Overall Study|Study Terminated by Sponsor|0
1080142|NCT02124746|2139611|FG002|Overall Study|Study Terminated by Sponsor|6
1080143|NCT02124746|2139609|FG000|Overall Study|Disease Progression|3
1080144|NCT02124746|2139610|FG001|Overall Study|Disease Progression|6
1080145|NCT02124746|2139611|FG002|Overall Study|Disease Progression|4
1080146|NCT02124759|2139622|FG000|Overall Study|Withdrawal by Subject|3
1080147|NCT02124759|2139623|FG001|Overall Study|Withdrawal by Subject|1
1080148|NCT02124759|2139624|FG002|Overall Study|Withdrawal by Subject|1
1080149|NCT02124759|2139622|FG000|Overall Study|Screen Fail|2
1080150|NCT02124759|2139623|FG001|Overall Study|Screen Fail|2
1080151|NCT02124759|2139624|FG002|Overall Study|Screen Fail|3
1080152|NCT02124772|2139650|FG000|Overall Study|Lack of Efficacy|2
1080153|NCT02124772|2139651|FG001|Overall Study|Lack of Efficacy|0
1080154|NCT02124772|2139652|FG002|Overall Study|Lack of Efficacy|0
1080155|NCT02124772|2139653|FG003|Overall Study|Lack of Efficacy|1
1080156|NCT02124772|2139654|FG004|Overall Study|Lack of Efficacy|2
1080157|NCT02124772|2139655|FG005|Overall Study|Lack of Efficacy|3
1080158|NCT02124772|2139656|FG006|Overall Study|Lack of Efficacy|0
1080159|NCT02124772|2139657|FG007|Overall Study|Lack of Efficacy|2
1080160|NCT02124772|2139658|FG008|Overall Study|Lack of Efficacy|0
1080161|NCT02124772|2139659|FG009|Overall Study|Lack of Efficacy|1
1080162|NCT02124772|2139660|FG010|Overall Study|Lack of Efficacy|0
1080163|NCT02124772|2139661|FG011|Overall Study|Lack of Efficacy|0
1080164|NCT02124772|2139662|FG012|Overall Study|Lack of Efficacy|1
909506|NCT00788957|1886288|FG004|Part 1|Lost to Follow-up|0
909507|NCT00788957|1886289|FG005|Part 1|Lost to Follow-up|0
909508|NCT00788957|1886284|FG000|Part 2|Withdrawal by Subject|0
909509|NCT00788957|1886285|FG001|Part 2|Withdrawal by Subject|9
909510|NCT00788957|1886286|FG002|Part 2|Withdrawal by Subject|5
1080165|NCT02124772|2139650|FG000|Overall Study|Adverse Event|1
1080166|NCT02124772|2139651|FG001|Overall Study|Adverse Event|4
1080167|NCT02124772|2139652|FG002|Overall Study|Adverse Event|1
1080168|NCT02124772|2139653|FG003|Overall Study|Adverse Event|5
1080169|NCT02124772|2139654|FG004|Overall Study|Adverse Event|2
1080170|NCT02124772|2139655|FG005|Overall Study|Adverse Event|1
1080171|NCT02124772|2139656|FG006|Overall Study|Adverse Event|1
1080172|NCT02124772|2139657|FG007|Overall Study|Adverse Event|5
1080173|NCT02124772|2139658|FG008|Overall Study|Adverse Event|0
1080174|NCT02124772|2139659|FG009|Overall Study|Adverse Event|3
1080175|NCT02124772|2139660|FG010|Overall Study|Adverse Event|1
1080176|NCT02124772|2139661|FG011|Overall Study|Adverse Event|3
1080177|NCT02124772|2139662|FG012|Overall Study|Adverse Event|1
1080178|NCT02124772|2139650|FG000|Overall Study|Withdrawal consent|0
1080179|NCT02124772|2139651|FG001|Overall Study|Withdrawal consent|1
1080180|NCT02124772|2139652|FG002|Overall Study|Withdrawal consent|1
1080181|NCT02124772|2139653|FG003|Overall Study|Withdrawal consent|1
1080182|NCT02124772|2139654|FG004|Overall Study|Withdrawal consent|0
1080183|NCT02124772|2139655|FG005|Overall Study|Withdrawal consent|1
1080184|NCT02124772|2139656|FG006|Overall Study|Withdrawal consent|1
1080185|NCT02124772|2139657|FG007|Overall Study|Withdrawal consent|0
1080186|NCT02124772|2139658|FG008|Overall Study|Withdrawal consent|0
1080187|NCT02124772|2139659|FG009|Overall Study|Withdrawal consent|1
1080188|NCT02124772|2139660|FG010|Overall Study|Withdrawal consent|0
1080189|NCT02124772|2139661|FG011|Overall Study|Withdrawal consent|1
1080190|NCT02124772|2139662|FG012|Overall Study|Withdrawal consent|0
1080191|NCT02124772|2139650|FG000|Overall Study|Investigator discretion|0
1080192|NCT02124772|2139651|FG001|Overall Study|Investigator discretion|2
1080193|NCT02124772|2139652|FG002|Overall Study|Investigator discretion|2
1080194|NCT02124772|2139653|FG003|Overall Study|Investigator discretion|1
1080195|NCT02124772|2139654|FG004|Overall Study|Investigator discretion|1
1080196|NCT02124772|2139655|FG005|Overall Study|Investigator discretion|0
1080197|NCT02124772|2139656|FG006|Overall Study|Investigator discretion|1
1080198|NCT02124772|2139657|FG007|Overall Study|Investigator discretion|0
1080199|NCT02124772|2139658|FG008|Overall Study|Investigator discretion|0
1080200|NCT02124772|2139659|FG009|Overall Study|Investigator discretion|1
1080201|NCT02124772|2139660|FG010|Overall Study|Investigator discretion|0
1080202|NCT02124772|2139661|FG011|Overall Study|Investigator discretion|1
1080203|NCT02124772|2139662|FG012|Overall Study|Investigator discretion|0
1080204|NCT02124772|2139650|FG000|Overall Study|Progressive disease|0
1080205|NCT02124772|2139651|FG001|Overall Study|Progressive disease|0
1080206|NCT02124772|2139652|FG002|Overall Study|Progressive disease|0
1080207|NCT02124772|2139653|FG003|Overall Study|Progressive disease|0
1080208|NCT02124772|2139654|FG004|Overall Study|Progressive disease|0
1080209|NCT02124772|2139655|FG005|Overall Study|Progressive disease|0
1080210|NCT02124772|2139656|FG006|Overall Study|Progressive disease|1
1080211|NCT02124772|2139657|FG007|Overall Study|Progressive disease|1
1080212|NCT02124772|2139658|FG008|Overall Study|Progressive disease|0
1080213|NCT02124772|2139659|FG009|Overall Study|Progressive disease|0
1080214|NCT02124772|2139660|FG010|Overall Study|Progressive disease|0
1080215|NCT02124772|2139661|FG011|Overall Study|Progressive disease|0
1080216|NCT02124772|2139662|FG012|Overall Study|Progressive disease|0
1080217|NCT02124772|2139650|FG000|Overall Study|Other|0
1080218|NCT02124772|2139651|FG001|Overall Study|Other|7
1080219|NCT02124772|2139652|FG002|Overall Study|Other|2
1080220|NCT02124772|2139653|FG003|Overall Study|Other|5
1080221|NCT02124772|2139654|FG004|Overall Study|Other|4
1080222|NCT02124772|2139655|FG005|Overall Study|Other|3
1080223|NCT02124772|2139656|FG006|Overall Study|Other|4
1080224|NCT02124772|2139657|FG007|Overall Study|Other|1
1080225|NCT02124772|2139658|FG008|Overall Study|Other|1
1080226|NCT02124772|2139659|FG009|Overall Study|Other|1
1080227|NCT02124772|2139660|FG010|Overall Study|Other|1
1080228|NCT02124772|2139661|FG011|Overall Study|Other|1
1080229|NCT02124772|2139662|FG012|Overall Study|Other|0
1080230|NCT02124798|2139714|FG000|Overall Study|Adverse Event|3
1080231|NCT02124798|2139714|FG000|Overall Study|Lost to Follow-up|1
1080232|NCT02124811|2139720|FG000|Overall Study|Early termination|2
1080233|NCT02124811|2139721|FG001|Overall Study|Early termination|2
1080234|NCT02124811|2139720|FG000|Overall Study|Withdrawal by Subject|1
1080235|NCT02124811|2139721|FG001|Overall Study|Withdrawal by Subject|0
1080236|NCT02125279|2139742|FG000|Overall Study|Lack of Efficacy|2
1080237|NCT02125279|2139742|FG000|Overall Study|Withdrawal by Subject|6
1080238|NCT02125279|2139742|FG000|Overall Study|Protocol Violation|1
1080239|NCT02125279|2139742|FG000|Overall Study|Lost to Follow-up|4
1080240|NCT02125331|2139764|FG000|Overall Study|Protocol Violation|1
1080241|NCT02125331|2139765|FG001|Overall Study|Protocol Violation|0
1080242|NCT02125331|2139764|FG000|Overall Study|technical problem|2
1080243|NCT02125331|2139765|FG001|Overall Study|technical problem|0
1080244|NCT02125331|2139764|FG000|Overall Study|screen failure|2
909511|NCT00788957|1886287|FG003|Part 2|Withdrawal by Subject|3
1080245|NCT02125331|2139765|FG001|Overall Study|screen failure|0
1080246|NCT02125604|2139771|FG000|Overall Study|Other|4
1080247|NCT02125604|2139771|FG000|Overall Study|Investigator Decision|1
1080248|NCT02125604|2139771|FG000|Overall Study|Lost to Follow-up|2
1080249|NCT02125604|2139771|FG000|Overall Study|Consent Withdrawn|4
1080250|NCT02125604|2139771|FG000|Overall Study|Adverse Event|20
1080251|NCT02125734|2139781|FG000|Period 2|Adverse Event|0
1080252|NCT02125734|2139782|FG001|Period 2|Adverse Event|1
1080253|NCT02125838|2139790|FG000|Overall Study|Lost to Follow-up|4
1080254|NCT02125838|2139791|FG001|Overall Study|Lost to Follow-up|4
1080255|NCT02125877|2139799|FG000|Overall Study|Physician Decision|1
1080256|NCT02125877|2139800|FG001|Overall Study|Physician Decision|0
1080257|NCT02125877|2139799|FG000|Overall Study|Death|0
1080258|NCT02125877|2139800|FG001|Overall Study|Death|1
1080259|NCT02125877|2139799|FG000|Overall Study|Administrative problems|0
1080260|NCT02125877|2139800|FG001|Overall Study|Administrative problems|1
1080261|NCT02125877|2139799|FG000|Overall Study|Participant/guardian decision|0
1080262|NCT02125877|2139800|FG001|Overall Study|Participant/guardian decision|2
1080263|NCT02125877|2139799|FG000|Overall Study|Withdrawal by Subject|2
1080264|NCT02125877|2139800|FG001|Overall Study|Withdrawal by Subject|1
1080265|NCT02125877|2139799|FG000|Overall Study|Protocol deviation|4
1080266|NCT02125877|2139800|FG001|Overall Study|Protocol deviation|1
1080267|NCT02125877|2139799|FG000|Overall Study|Adverse Event|6
1080268|NCT02125877|2139800|FG001|Overall Study|Adverse Event|4
1080269|NCT02126670|2139830|FG000|Overall Study|Withdrawal by Subject|1
1080270|NCT02126670|2139831|FG001|Overall Study|Withdrawal by Subject|0
1080271|NCT02126670|2139832|FG002|Overall Study|Withdrawal by Subject|0
1080272|NCT02126670|2139833|FG003|Overall Study|Withdrawal by Subject|1
1080273|NCT02126826|2139863|FG000|Overall Study|Withdrawal by Subject|0
1080274|NCT02126826|2139864|FG001|Overall Study|Withdrawal by Subject|0
1080275|NCT02126826|2139865|FG002|Overall Study|Withdrawal by Subject|0
1080276|NCT02126826|2139866|FG003|Overall Study|Withdrawal by Subject|1
1080277|NCT02126826|2139867|FG004|Overall Study|Withdrawal by Subject|0
1080278|NCT02126826|2139868|FG005|Overall Study|Withdrawal by Subject|0
1080279|NCT02126826|2139869|FG006|Overall Study|Withdrawal by Subject|0
1080280|NCT02126839|2139892|FG000|Overall Study|Adverse Event|0
1080281|NCT02126839|2139893|FG001|Overall Study|Adverse Event|1
1080282|NCT02126839|2139892|FG000|Overall Study|Withdrawal by Subject|1
1080283|NCT02126839|2139893|FG001|Overall Study|Withdrawal by Subject|0
1080284|NCT02126839|2139892|FG000|Overall Study|Withdrawal by parent/guardian|1
1080285|NCT02126839|2139893|FG001|Overall Study|Withdrawal by parent/guardian|0
1080286|NCT02126839|2139892|FG000|Overall Study|Protocol Violation|2
1080287|NCT02126839|2139893|FG001|Overall Study|Protocol Violation|3
1080288|NCT02126839|2139892|FG000|Overall Study|Sponsor request|0
1080289|NCT02126839|2139893|FG001|Overall Study|Sponsor request|1
1080290|NCT02126839|2139892|FG000|Overall Study|Lost to Follow-up|1
1080291|NCT02126839|2139893|FG001|Overall Study|Lost to Follow-up|4
1080292|NCT02126839|2139892|FG000|Overall Study|Other|5
1080293|NCT02126839|2139893|FG001|Overall Study|Other|5
1080294|NCT02126969|2139901|FG000|Overall Study|Withdrawal by Subject|1
1080295|NCT02126969|2139902|FG001|Overall Study|Withdrawal by Subject|2
1080296|NCT02127125|2139917|FG000|Overall Study|Lost to Follow-up|0
1080297|NCT02127125|2139918|FG001|Overall Study|Lost to Follow-up|0
1080298|NCT02127125|2139919|FG002|Overall Study|Lost to Follow-up|0
1080299|NCT02127125|2139920|FG003|Overall Study|Lost to Follow-up|0
1080300|NCT02127125|2139921|FG004|Overall Study|Lost to Follow-up|2
1080301|NCT02127125|2139922|FG005|Overall Study|Lost to Follow-up|1
1080302|NCT02127125|2139923|FG006|Overall Study|Lost to Follow-up|0
1080303|NCT02127125|2139924|FG007|Overall Study|Lost to Follow-up|0
1080304|NCT02127125|2139925|FG008|Overall Study|Lost to Follow-up|0
1080305|NCT02127125|2139917|FG000|Overall Study|Withdrawal by Subject|0
1080306|NCT02127125|2139918|FG001|Overall Study|Withdrawal by Subject|0
1080307|NCT02127125|2139919|FG002|Overall Study|Withdrawal by Subject|0
1080308|NCT02127125|2139920|FG003|Overall Study|Withdrawal by Subject|1
1080309|NCT02127125|2139921|FG004|Overall Study|Withdrawal by Subject|0
1080310|NCT02127125|2139922|FG005|Overall Study|Withdrawal by Subject|0
1080311|NCT02127125|2139923|FG006|Overall Study|Withdrawal by Subject|0
1080312|NCT02127125|2139924|FG007|Overall Study|Withdrawal by Subject|0
1080313|NCT02127125|2139925|FG008|Overall Study|Withdrawal by Subject|0
1080314|NCT02127125|2139917|FG000|Overall Study|Physician Decision|0
1080315|NCT02127125|2139918|FG001|Overall Study|Physician Decision|0
1080316|NCT02127125|2139919|FG002|Overall Study|Physician Decision|1
1080317|NCT02127125|2139920|FG003|Overall Study|Physician Decision|0
1080318|NCT02127125|2139921|FG004|Overall Study|Physician Decision|1
1080319|NCT02127125|2139922|FG005|Overall Study|Physician Decision|2
1080320|NCT02127125|2139923|FG006|Overall Study|Physician Decision|0
1080321|NCT02127125|2139924|FG007|Overall Study|Physician Decision|0
1080322|NCT02127125|2139925|FG008|Overall Study|Physician Decision|0
1080323|NCT02127281|2139947|FG000|Overall Study|Lost to Follow-up|1
1080324|NCT02127281|2139948|FG001|Overall Study|Lost to Follow-up|0
1080325|NCT02127307|2139954|FG000|Overall Study|Protocol Violation|36
1080326|NCT02127307|2139954|FG000|Overall Study|Lost to Follow-up|2
1080327|NCT02127307|2139954|FG000|Overall Study|Death|101
1080328|NCT02127307|2139954|FG000|Overall Study|Other than specified above|169
1080329|NCT02127372|2139960|FG000|Overall Study|Withdrawal by Subject|1
1080330|NCT02127372|2139961|FG001|Overall Study|Withdrawal by Subject|0
1080331|NCT02127931|2140022|FG000|Overall Study|Glitch in Game|1
1080332|NCT02127970|2140029|FG000|Overall Study|Adverse Event|2
1080333|NCT02127970|2140030|FG001|Overall Study|Adverse Event|1
1080334|NCT02127970|2140029|FG000|Overall Study|Death|1
1080335|NCT02127970|2140030|FG001|Overall Study|Death|1
1080336|NCT02127970|2140029|FG000|Overall Study|Lost to Follow-up|14
1080337|NCT02127970|2140030|FG001|Overall Study|Lost to Follow-up|14
1080338|NCT02127970|2140029|FG000|Overall Study|Reason not Specified|4
1080339|NCT02127970|2140030|FG001|Overall Study|Reason not Specified|7
1080340|NCT02127970|2140029|FG000|Overall Study|Pregnancy|0
1080341|NCT02127970|2140030|FG001|Overall Study|Pregnancy|1
1080342|NCT02127970|2140029|FG000|Overall Study|Subject Withdrew Consent|5
1080343|NCT02127970|2140030|FG001|Overall Study|Subject Withdrew Consent|3
1080344|NCT02128217|2140042|FG000|Overall Study|Lost to Follow-up|0
1080345|NCT02128217|2140043|FG001|Overall Study|Lost to Follow-up|1
1080346|NCT02128269|2140058|FG000|Treatment Period|Adverse Event|1
1080347|NCT02128269|2140058|FG000|Treatment Period|Physician Decision|1
1080348|NCT02128490|2140067|FG000|Overall Study|Pretreatment Event/Adverse Event|1
1080349|NCT02128490|2140068|FG001|Overall Study|Pretreatment Event/Adverse Event|0
1080350|NCT02128490|2140069|FG002|Overall Study|Pretreatment Event/Adverse Event|1
1080351|NCT02128490|2140070|FG003|Overall Study|Pretreatment Event/Adverse Event|1
1080352|NCT02128490|2140071|FG004|Overall Study|Pretreatment Event/Adverse Event|0
1080353|NCT02128490|2140067|FG000|Overall Study|Major Protocol Deviation|1
1080354|NCT02128490|2140068|FG001|Overall Study|Major Protocol Deviation|2
1080355|NCT02128490|2140069|FG002|Overall Study|Major Protocol Deviation|0
1080356|NCT02128490|2140070|FG003|Overall Study|Major Protocol Deviation|2
1080357|NCT02128490|2140071|FG004|Overall Study|Major Protocol Deviation|2
1080358|NCT02128490|2140067|FG000|Overall Study|Lost to Follow-up|0
1080359|NCT02128490|2140068|FG001|Overall Study|Lost to Follow-up|0
1080360|NCT02128490|2140069|FG002|Overall Study|Lost to Follow-up|1
1080361|NCT02128490|2140070|FG003|Overall Study|Lost to Follow-up|1
1080362|NCT02128490|2140071|FG004|Overall Study|Lost to Follow-up|1
1080363|NCT02128490|2140067|FG000|Overall Study|Voluntary Withdrawal|3
1080364|NCT02128490|2140068|FG001|Overall Study|Voluntary Withdrawal|3
1080365|NCT02128490|2140069|FG002|Overall Study|Voluntary Withdrawal|1
1080366|NCT02128490|2140070|FG003|Overall Study|Voluntary Withdrawal|1
1080367|NCT02128490|2140071|FG004|Overall Study|Voluntary Withdrawal|2
1080368|NCT02128490|2140067|FG000|Overall Study|Lack of Efficacy|0
1080369|NCT02128490|2140068|FG001|Overall Study|Lack of Efficacy|1
1080370|NCT02128490|2140069|FG002|Overall Study|Lack of Efficacy|0
1080371|NCT02128490|2140070|FG003|Overall Study|Lack of Efficacy|0
1080372|NCT02128490|2140071|FG004|Overall Study|Lack of Efficacy|0
1080373|NCT02128490|2140067|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0
1080374|NCT02128490|2140068|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0
1080375|NCT02128490|2140069|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0
1080376|NCT02128490|2140070|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0
1080377|NCT02128490|2140071|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1
1080378|NCT02128490|2140067|FG000|Overall Study|Other Miscellaneous Reasons|0
1080379|NCT02128490|2140068|FG001|Overall Study|Other Miscellaneous Reasons|0
1080380|NCT02128490|2140069|FG002|Overall Study|Other Miscellaneous Reasons|2
1080381|NCT02128490|2140070|FG003|Overall Study|Other Miscellaneous Reasons|1
1080382|NCT02128490|2140071|FG004|Overall Study|Other Miscellaneous Reasons|1
1080383|NCT02128542|2140085|FG000|Overall Study|Lost to Follow-up|3
1080384|NCT02128542|2140086|FG001|Overall Study|Lost to Follow-up|0
1080385|NCT02128542|2140085|FG000|Overall Study|Withdrew Consent|1
1080386|NCT02128542|2140086|FG001|Overall Study|Withdrew Consent|0
1080387|NCT02128724|2140098|FG000|Overall Study|Death|1
1080388|NCT02128724|2140099|FG001|Overall Study|Death|0
1080389|NCT02128724|2140100|FG002|Overall Study|Death|0
1080390|NCT02128724|2140101|FG003|Overall Study|Death|0
1080391|NCT02128724|2140098|FG000|Overall Study|Adverse Event|0
1080392|NCT02128724|2140099|FG001|Overall Study|Adverse Event|1
1080393|NCT02128724|2140100|FG002|Overall Study|Adverse Event|0
1080394|NCT02128724|2140101|FG003|Overall Study|Adverse Event|0
1080395|NCT02128724|2140098|FG000|Overall Study|Physician Decision|0
1080396|NCT02128724|2140099|FG001|Overall Study|Physician Decision|0
1080397|NCT02128724|2140100|FG002|Overall Study|Physician Decision|0
1080398|NCT02128724|2140101|FG003|Overall Study|Physician Decision|2
1080399|NCT02128724|2140098|FG000|Overall Study|Withdrawal by Subject|0
1080400|NCT02128724|2140099|FG001|Overall Study|Withdrawal by Subject|0
1080401|NCT02128724|2140100|FG002|Overall Study|Withdrawal by Subject|0
1080402|NCT02128724|2140101|FG003|Overall Study|Withdrawal by Subject|1
1080403|NCT02128763|2140112|FG000|Overall Study|Death|1
1080404|NCT02128763|2140113|FG001|Overall Study|Death|0
1080405|NCT02128763|2140112|FG000|Overall Study|Lost to Follow-up|19
1080406|NCT02128763|2140113|FG001|Overall Study|Lost to Follow-up|16
1080407|NCT02128932|2140152|FG000|Overall Study|Withdrawal by Subject|11
1080408|NCT02128932|2140153|FG001|Overall Study|Withdrawal by Subject|7
1080409|NCT02128932|2140154|FG002|Overall Study|Withdrawal by Subject|8
1080410|NCT02128932|2140152|FG000|Overall Study|Death|2
1080411|NCT02128932|2140153|FG001|Overall Study|Death|0
1080412|NCT02128932|2140154|FG002|Overall Study|Death|2
1080413|NCT02128932|2140152|FG000|Overall Study|Lost to Follow-up|2
1080414|NCT02128932|2140153|FG001|Overall Study|Lost to Follow-up|1
1080415|NCT02128932|2140154|FG002|Overall Study|Lost to Follow-up|1
1080416|NCT02128932|2140152|FG000|Overall Study|No reason for withdrawal|12
1080417|NCT02128932|2140153|FG001|Overall Study|No reason for withdrawal|11
1080418|NCT02128932|2140154|FG002|Overall Study|No reason for withdrawal|7
1080419|NCT02128997|2140164|FG000|Overall Study|Lost to Follow-up|6
1080420|NCT02128997|2140165|FG001|Overall Study|Lost to Follow-up|11
1080421|NCT02129062|2140171|FG000|Overall Study|Death|1
1080422|NCT02129062|2140171|FG000|Overall Study|Disease Progression|2
1080423|NCT02129192|2140188|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0
1080424|NCT02129192|2140189|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1
1080425|NCT02129205|2140208|FG000|Overall Study|Withdrawal by Subject|0
1080426|NCT02129205|2140209|FG001|Overall Study|Withdrawal by Subject|0
1080427|NCT02129205|2140210|FG002|Overall Study|Withdrawal by Subject|0
1080428|NCT02129205|2140211|FG003|Overall Study|Withdrawal by Subject|0
1080429|NCT02129205|2140212|FG004|Overall Study|Withdrawal by Subject|1
1080430|NCT02129205|2140213|FG005|Overall Study|Withdrawal by Subject|1
1080431|NCT02129205|2140214|FG006|Overall Study|Withdrawal by Subject|1
1080432|NCT02129205|2140215|FG007|Overall Study|Withdrawal by Subject|0
1080433|NCT02129205|2140216|FG008|Overall Study|Withdrawal by Subject|1
1080434|NCT02129205|2140217|FG009|Overall Study|Withdrawal by Subject|0
1080435|NCT02129205|2140208|FG000|Overall Study|Other|1
1080436|NCT02129205|2140209|FG001|Overall Study|Other|0
1080437|NCT02129205|2140210|FG002|Overall Study|Other|0
1080438|NCT02129205|2140211|FG003|Overall Study|Other|0
1080439|NCT02129205|2140212|FG004|Overall Study|Other|2
1080440|NCT02129205|2140213|FG005|Overall Study|Other|3
1080441|NCT02129205|2140214|FG006|Overall Study|Other|3
1080442|NCT02129205|2140215|FG007|Overall Study|Other|2
1080443|NCT02129205|2140216|FG008|Overall Study|Other|1
1080444|NCT02129205|2140217|FG009|Overall Study|Other|0
1080445|NCT02129608|2140281|FG000|Overall Study|Lost to Follow-up|0
1080446|NCT02129608|2140282|FG001|Overall Study|Lost to Follow-up|1
1080447|NCT02129608|2140283|FG002|Overall Study|Lost to Follow-up|1
1080448|NCT02129608|2140281|FG000|Overall Study|Withdrawal by Subject|0
1080449|NCT02129608|2140282|FG001|Overall Study|Withdrawal by Subject|0
1080450|NCT02129608|2140283|FG002|Overall Study|Withdrawal by Subject|2
1080451|NCT02129777|2140327|FG000|Double-Blind Period|Adverse Event|0
1080452|NCT02129777|2140328|FG001|Double-Blind Period|Adverse Event|0
1080453|NCT02129777|2140329|FG002|Double-Blind Period|Adverse Event|0
1080454|NCT02129777|2140330|FG003|Double-Blind Period|Adverse Event|0
1080455|NCT02129777|2140331|FG004|Double-Blind Period|Adverse Event|1
1080456|NCT02129777|2140332|FG005|Double-Blind Period|Adverse Event|0
1080457|NCT02129777|2140333|FG006|Double-Blind Period|Adverse Event|0
1080458|NCT02129777|2140327|FG000|Double-Blind Period|Lost to Follow-up|1
1080459|NCT02129777|2140328|FG001|Double-Blind Period|Lost to Follow-up|1
1080460|NCT02129777|2140329|FG002|Double-Blind Period|Lost to Follow-up|1
1080461|NCT02129777|2140330|FG003|Double-Blind Period|Lost to Follow-up|2
1080462|NCT02129777|2140331|FG004|Double-Blind Period|Lost to Follow-up|0
1080463|NCT02129777|2140332|FG005|Double-Blind Period|Lost to Follow-up|0
1080464|NCT02129777|2140333|FG006|Double-Blind Period|Lost to Follow-up|0
1080465|NCT02129777|2140327|FG000|Double-Blind Period|Withdrawal by Subject|2
1080466|NCT02129777|2140328|FG001|Double-Blind Period|Withdrawal by Subject|4
1080467|NCT02129777|2140329|FG002|Double-Blind Period|Withdrawal by Subject|3
1080468|NCT02129777|2140330|FG003|Double-Blind Period|Withdrawal by Subject|2
1080469|NCT02129777|2140331|FG004|Double-Blind Period|Withdrawal by Subject|3
1080470|NCT02129777|2140332|FG005|Double-Blind Period|Withdrawal by Subject|0
1080471|NCT02129777|2140333|FG006|Double-Blind Period|Withdrawal by Subject|0
1080472|NCT02129777|2140327|FG000|Double-Blind Period|Pregnancy|0
1080473|NCT02129777|2140328|FG001|Double-Blind Period|Pregnancy|0
1080474|NCT02129777|2140329|FG002|Double-Blind Period|Pregnancy|0
1080475|NCT02129777|2140330|FG003|Double-Blind Period|Pregnancy|0
1080476|NCT02129777|2140331|FG004|Double-Blind Period|Pregnancy|1
1080477|NCT02129777|2140332|FG005|Double-Blind Period|Pregnancy|0
1080478|NCT02129777|2140333|FG006|Double-Blind Period|Pregnancy|0
1080479|NCT02129777|2140327|FG000|Double-Blind Period|Lack of Efficacy|3
1080480|NCT02129777|2140328|FG001|Double-Blind Period|Lack of Efficacy|1
1080481|NCT02129777|2140329|FG002|Double-Blind Period|Lack of Efficacy|0
1080482|NCT02129777|2140330|FG003|Double-Blind Period|Lack of Efficacy|3
1080483|NCT02129777|2140331|FG004|Double-Blind Period|Lack of Efficacy|2
1080484|NCT02129777|2140332|FG005|Double-Blind Period|Lack of Efficacy|0
1080485|NCT02129777|2140333|FG006|Double-Blind Period|Lack of Efficacy|0
1080486|NCT02129777|2140327|FG000|Double-Blind Period|Other|1
1080487|NCT02129777|2140328|FG001|Double-Blind Period|Other|2
1080488|NCT02129777|2140329|FG002|Double-Blind Period|Other|0
1080489|NCT02129777|2140330|FG003|Double-Blind Period|Other|0
1080490|NCT02129777|2140331|FG004|Double-Blind Period|Other|0
1080491|NCT02129777|2140332|FG005|Double-Blind Period|Other|0
1080492|NCT02129777|2140333|FG006|Double-Blind Period|Other|0
1080493|NCT02129777|2140327|FG000|Open-Label Period|Lack of Efficacy|0
1080494|NCT02129777|2140328|FG001|Open-Label Period|Lack of Efficacy|0
1080495|NCT02129777|2140329|FG002|Open-Label Period|Lack of Efficacy|0
1080496|NCT02129777|2140330|FG003|Open-Label Period|Lack of Efficacy|0
1080497|NCT02129777|2140331|FG004|Open-Label Period|Lack of Efficacy|0
1080498|NCT02129777|2140332|FG005|Open-Label Period|Lack of Efficacy|0
1080499|NCT02129777|2140333|FG006|Open-Label Period|Lack of Efficacy|5
1080500|NCT02129777|2140327|FG000|Open-Label Period|Lost to Follow-up|0
1080501|NCT02129777|2140328|FG001|Open-Label Period|Lost to Follow-up|0
1080502|NCT02129777|2140329|FG002|Open-Label Period|Lost to Follow-up|0
1080503|NCT02129777|2140330|FG003|Open-Label Period|Lost to Follow-up|0
1080504|NCT02129777|2140331|FG004|Open-Label Period|Lost to Follow-up|0
1080505|NCT02129777|2140332|FG005|Open-Label Period|Lost to Follow-up|1
1080506|NCT02129777|2140333|FG006|Open-Label Period|Lost to Follow-up|1
1080507|NCT02129777|2140327|FG000|Open-Label Period|Withdrawal by Subject|0
1080508|NCT02129777|2140328|FG001|Open-Label Period|Withdrawal by Subject|0
1080509|NCT02129777|2140329|FG002|Open-Label Period|Withdrawal by Subject|0
1080510|NCT02129777|2140330|FG003|Open-Label Period|Withdrawal by Subject|0
1080511|NCT02129777|2140331|FG004|Open-Label Period|Withdrawal by Subject|0
1080512|NCT02129777|2140332|FG005|Open-Label Period|Withdrawal by Subject|1
1080513|NCT02129777|2140333|FG006|Open-Label Period|Withdrawal by Subject|3
1080514|NCT02129777|2140327|FG000|Open-Label Period|Study Termination|0
1080515|NCT02129777|2140328|FG001|Open-Label Period|Study Termination|0
1080516|NCT02129777|2140329|FG002|Open-Label Period|Study Termination|0
1080517|NCT02129777|2140330|FG003|Open-Label Period|Study Termination|0
1080518|NCT02129777|2140331|FG004|Open-Label Period|Study Termination|0
1080519|NCT02129777|2140332|FG005|Open-Label Period|Study Termination|10
1080520|NCT02129777|2140333|FG006|Open-Label Period|Study Termination|39
1080521|NCT02129803|2140354|FG000|Overall Study|Protocol Violation|4
1080522|NCT02129803|2140355|FG001|Overall Study|Protocol Violation|0
1080523|NCT02129803|2140354|FG000|Overall Study|Physician Decision|0
1080524|NCT02129803|2140355|FG001|Overall Study|Physician Decision|1
1080525|NCT02129803|2140354|FG000|Overall Study|Difficulty sleeping|1
1080526|NCT02129803|2140355|FG001|Overall Study|Difficulty sleeping|0
1080527|NCT02129803|2140354|FG000|Overall Study|Morning headache|0
1080528|NCT02129803|2140355|FG001|Overall Study|Morning headache|1
1080529|NCT02129803|2140354|FG000|Overall Study|Withdrawal by Subject|1
1080530|NCT02129803|2140355|FG001|Overall Study|Withdrawal by Subject|1
1080531|NCT02130024|2140363|FG000|Overall Study|Adverse Event|10
1080532|NCT02130024|2140364|FG001|Overall Study|Adverse Event|11
1080533|NCT02130024|2140363|FG000|Overall Study|Death|2
1080534|NCT02130024|2140364|FG001|Overall Study|Death|2
1080535|NCT02130024|2140363|FG000|Overall Study|Lost to Follow-up|1
1080536|NCT02130024|2140364|FG001|Overall Study|Lost to Follow-up|1
1080537|NCT02130024|2140363|FG000|Overall Study|Physician Decision|1
1080538|NCT02130024|2140364|FG001|Overall Study|Physician Decision|3
1080539|NCT02130024|2140363|FG000|Overall Study|Protocol Deviation|4
1080540|NCT02130024|2140364|FG001|Overall Study|Protocol Deviation|0
1080541|NCT02130024|2140363|FG000|Overall Study|Site Administration Problems|1
1080542|NCT02130024|2140364|FG001|Overall Study|Site Administration Problems|0
1080543|NCT02130024|2140363|FG000|Overall Study|Subject Withdrew Consent|6
1080544|NCT02130024|2140364|FG001|Overall Study|Subject Withdrew Consent|14
1080545|NCT02130193|2140381|FG000|Part B: 52-week Double-blind Period|Adverse Event|0
1080546|NCT02130193|2140382|FG001|Part B: 52-week Double-blind Period|Adverse Event|5
1080547|NCT02130193|2140383|FG002|Part B: 52-week Double-blind Period|Adverse Event|3
1080548|NCT02130193|2140381|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0
1080549|NCT02130193|2140382|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2
1080550|NCT02130193|2140383|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1
1080551|NCT02130193|2140381|FG000|Part B: 52-week Double-blind Period|Physician Decision|0
1080552|NCT02130193|2140382|FG001|Part B: 52-week Double-blind Period|Physician Decision|0
1080553|NCT02130193|2140383|FG002|Part B: 52-week Double-blind Period|Physician Decision|1
1080554|NCT02130193|2140381|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
1080555|NCT02130193|2140382|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
1080556|NCT02130193|2140383|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
1080557|NCT02130284|2140401|FG000|Overall Study|Withdrawal by Subject|3
1080558|NCT02130284|2140401|FG000|Overall Study|Subject Withdrew Consent|1
1080559|NCT02130284|2140401|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1
1080560|NCT02130284|2140401|FG000|Overall Study|Subject was screened as backup for study|3
1080561|NCT02130284|2140401|FG000|Overall Study|Screen Failure|1
1080562|NCT02130297|2140405|FG000|Overall Study|Lost to Follow-up|4
1080563|NCT02130427|2140409|FG000|Overall Study|Imaging results not interpretable|30
1080564|NCT02130557|2140415|FG000|Overall Study|Withdrawal by Subject|12
1080565|NCT02130557|2140416|FG001|Overall Study|Withdrawal by Subject|12
1080566|NCT02130557|2140415|FG000|Overall Study|Investigator Request|0
1080567|NCT02130557|2140416|FG001|Overall Study|Investigator Request|2
1080568|NCT02130557|2140415|FG000|Overall Study|Deceased|14
1080569|NCT02130557|2140416|FG001|Overall Study|Deceased|14
1080570|NCT02130557|2140415|FG000|Overall Study|Lost to Follow-up|6
1080571|NCT02130557|2140416|FG001|Overall Study|Lost to Follow-up|7
1080572|NCT02130557|2140415|FG000|Overall Study|Other|2
1080573|NCT02130557|2140416|FG001|Overall Study|Other|1
1080574|NCT02130557|2140415|FG000|Overall Study|Missing|2
1080575|NCT02130557|2140416|FG001|Overall Study|Missing|1
1080576|NCT02130570|2140424|FG000|Overall Study|Death|3
1080577|NCT02130570|2140425|FG001|Overall Study|Death|5
1080578|NCT02130570|2140424|FG000|Overall Study|Withdrawal by Subject|6
1080579|NCT02130570|2140425|FG001|Overall Study|Withdrawal by Subject|3
1080580|NCT02130570|2140424|FG000|Overall Study|Part of practice that discontinued study|0
1080581|NCT02130570|2140425|FG001|Overall Study|Part of practice that discontinued study|5
1080582|NCT02130765|2140520|FG000|Overall Study|Did not receive treatment|4
1080583|NCT02130765|2140521|FG001|Overall Study|Did not receive treatment|0
1080584|NCT02130765|2140522|FG002|Overall Study|Did not receive treatment|0
1080585|NCT02130765|2140523|FG003|Overall Study|Did not receive treatment|0
1080586|NCT02130986|2140537|FG000|Overall Study|Withdrawal by Subject|4
1080587|NCT02130986|2140538|FG001|Overall Study|Withdrawal by Subject|4
1080588|NCT02130986|2140537|FG000|Overall Study|Lost to Follow-up|151
1080589|NCT02130986|2140538|FG001|Overall Study|Lost to Follow-up|160
1080590|NCT02131064|2140560|FG000|Overall Study|Death|5
1080591|NCT02131064|2140561|FG001|Overall Study|Death|6
1080592|NCT02131064|2140560|FG000|Overall Study|Lost to Follow-up|4
1080593|NCT02131064|2140561|FG001|Overall Study|Lost to Follow-up|8
1080594|NCT02131064|2140560|FG000|Overall Study|Withdrawal by Subject|14
1080595|NCT02131064|2140561|FG001|Overall Study|Withdrawal by Subject|18
1080596|NCT02131064|2140560|FG000|Overall Study|Other|2
1080597|NCT02131064|2140561|FG001|Overall Study|Other|2
1080598|NCT02131129|2140570|FG000|Overall Study|Withdrawal by Subject|1
1080599|NCT02131129|2140571|FG001|Overall Study|Withdrawal by Subject|0
1080600|NCT02131233|2140579|FG000|Overall Study|Not Treated|2
1080601|NCT02131233|2140580|FG001|Overall Study|Not Treated|3
1080602|NCT02131233|2140579|FG000|Overall Study|Adverse Event|7
1080603|NCT02131233|2140580|FG001|Overall Study|Adverse Event|6
1080604|NCT02131233|2140579|FG000|Overall Study|Death|0
1080605|NCT02131233|2140580|FG001|Overall Study|Death|1
1080606|NCT02131233|2140579|FG000|Overall Study|Lack of Efficacy|6
1080607|NCT02131233|2140580|FG001|Overall Study|Lack of Efficacy|3
1080608|NCT02131233|2140579|FG000|Overall Study|Lost to Follow-up|14
1080609|NCT02131233|2140580|FG001|Overall Study|Lost to Follow-up|13
1080610|NCT02131233|2140579|FG000|Overall Study|Non-Compliance With Study Drug|8
1080611|NCT02131233|2140580|FG001|Overall Study|Non-Compliance With Study Drug|5
1080612|NCT02131233|2140579|FG000|Overall Study|Physician Decision|7
1080613|NCT02131233|2140580|FG001|Overall Study|Physician Decision|0
1080614|NCT02131233|2140579|FG000|Overall Study|Pregnancy|4
1080615|NCT02131233|2140580|FG001|Overall Study|Pregnancy|0
1080616|NCT02131233|2140579|FG000|Overall Study|Withdrawal by Subject|18
1080617|NCT02131233|2140580|FG001|Overall Study|Withdrawal by Subject|11
1080618|NCT02131259|2140586|FG000|Overall Study|Progressive disease|751
1080619|NCT02131259|2140586|FG000|Overall Study|Adverse Event|341
1080620|NCT02131259|2140586|FG000|Overall Study|Lost to Follow-up|7
1080621|NCT02131259|2140586|FG000|Overall Study|Relocation|32
1080622|NCT02131259|2140586|FG000|Overall Study|Other|63
1080623|NCT02131259|2140586|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22
1080624|NCT02131259|2140586|FG000|Overall Study|Progressive disease/relocation|1
1080625|NCT02131259|2140586|FG000|Overall Study|Progressive disease/other|2
1080626|NCT02131259|2140586|FG000|Overall Study|AE/lost to follow-up|1
1080627|NCT02131259|2140586|FG000|Overall Study|AE/other|1
1080628|NCT02131259|2140586|FG000|Overall Study|Progressive disease/AE/other|1
1080629|NCT02131259|2140586|FG000|Overall Study|Missing|3
1080630|NCT02131272|2140592|FG000|Overall Study|Withdrawal by parent|0
1080631|NCT02131272|2140593|FG001|Overall Study|Withdrawal by parent|1
1080632|NCT02131272|2140592|FG000|Overall Study|Withdrawal by Subject|0
1080633|NCT02131272|2140593|FG001|Overall Study|Withdrawal by Subject|1
1080634|NCT02131272|2140592|FG000|Overall Study|Withdrawal Criteria|1
1080635|NCT02131272|2140593|FG001|Overall Study|Withdrawal Criteria|0
1080636|NCT02131311|2140599|FG000|Overall Study|Adverse Event|2
1080637|NCT02131311|2140599|FG000|Overall Study|Protocol Violation|1
1080638|NCT02131311|2140599|FG000|Overall Study|Lost to Follow-up|1
1080639|NCT02131324|2140606|FG000|Overall Study|Withdrawal by Subject|1
1080640|NCT02131324|2140607|FG001|Overall Study|Withdrawal by Subject|2
1080641|NCT02131324|2140606|FG000|Overall Study|Lost to Follow-up|1
1080642|NCT02131324|2140607|FG001|Overall Study|Lost to Follow-up|1
1080643|NCT02131532|2140676|FG000|Overall Study|Withdrawal by Subject|1
1080644|NCT02131532|2140676|FG000|Overall Study|Physician Decision|1
1080645|NCT02131532|2140676|FG000|Overall Study|Other health conditions|2
1080646|NCT02131636|2140683|FG000|Overall Study|Personal Reasons|4
1080647|NCT02131636|2140684|FG001|Overall Study|Personal Reasons|4
1080648|NCT02131636|2140683|FG000|Overall Study|Lost to Follow-up|4
1080649|NCT02131636|2140684|FG001|Overall Study|Lost to Follow-up|0
1080650|NCT02131636|2140683|FG000|Overall Study|Adverse Event|4
1080651|NCT02131636|2140684|FG001|Overall Study|Adverse Event|1
1080652|NCT02131662|2140695|FG000|Overall Study|Protocol Violation|1
1080653|NCT02131662|2140696|FG001|Overall Study|Protocol Violation|0
1080654|NCT02131662|2140697|FG002|Overall Study|Protocol Violation|0
1080655|NCT02131662|2140698|FG003|Overall Study|Protocol Violation|0
1080656|NCT02131662|2140699|FG004|Overall Study|Protocol Violation|0
1080657|NCT02131662|2140695|FG000|Overall Study|Other|2
1080658|NCT02131662|2140696|FG001|Overall Study|Other|4
1080659|NCT02131662|2140697|FG002|Overall Study|Other|3
1080660|NCT02131662|2140698|FG003|Overall Study|Other|3
1080661|NCT02131662|2140699|FG004|Overall Study|Other|4
1080662|NCT02131662|2140695|FG000|Overall Study|Adverse Event|0
1080663|NCT02131662|2140696|FG001|Overall Study|Adverse Event|1
1080664|NCT02131662|2140697|FG002|Overall Study|Adverse Event|1
1080665|NCT02131662|2140698|FG003|Overall Study|Adverse Event|1
1080666|NCT02131662|2140699|FG004|Overall Study|Adverse Event|3
1080667|NCT02131662|2140695|FG000|Overall Study|Pregnancy|0
1080668|NCT02131662|2140696|FG001|Overall Study|Pregnancy|1
1080669|NCT02131662|2140697|FG002|Overall Study|Pregnancy|0
1080670|NCT02131662|2140698|FG003|Overall Study|Pregnancy|1
1080671|NCT02131662|2140699|FG004|Overall Study|Pregnancy|0
1080672|NCT02131662|2140695|FG000|Overall Study|Wish for pregnancy|0
1080673|NCT02131662|2140696|FG001|Overall Study|Wish for pregnancy|0
1080674|NCT02131662|2140697|FG002|Overall Study|Wish for pregnancy|0
1080675|NCT02131662|2140698|FG003|Overall Study|Wish for pregnancy|0
1080676|NCT02131662|2140699|FG004|Overall Study|Wish for pregnancy|1
1080677|NCT02131662|2140695|FG000|Overall Study|Lack of Efficacy|1
1080678|NCT02131662|2140696|FG001|Overall Study|Lack of Efficacy|0
1080679|NCT02131662|2140697|FG002|Overall Study|Lack of Efficacy|0
1080680|NCT02131662|2140698|FG003|Overall Study|Lack of Efficacy|0
1080681|NCT02131662|2140699|FG004|Overall Study|Lack of Efficacy|1
1080682|NCT02131662|2140695|FG000|Overall Study|Withdrawal by Subject|1
1080683|NCT02131662|2140696|FG001|Overall Study|Withdrawal by Subject|5
1080684|NCT02131662|2140697|FG002|Overall Study|Withdrawal by Subject|1
1080685|NCT02131662|2140698|FG003|Overall Study|Withdrawal by Subject|5
1080686|NCT02131662|2140699|FG004|Overall Study|Withdrawal by Subject|6
1080687|NCT02131662|2140695|FG000|Overall Study|Lost to Follow-up|1
1080688|NCT02131662|2140696|FG001|Overall Study|Lost to Follow-up|3
1080689|NCT02131662|2140697|FG002|Overall Study|Lost to Follow-up|0
1080690|NCT02131662|2140698|FG003|Overall Study|Lost to Follow-up|9
1080691|NCT02131662|2140699|FG004|Overall Study|Lost to Follow-up|0
1080692|NCT02131662|2140695|FG000|Overall Study|Not treated|2
1080693|NCT02131662|2140696|FG001|Overall Study|Not treated|0
1080694|NCT02131662|2140697|FG002|Overall Study|Not treated|2
1080695|NCT02131662|2140698|FG003|Overall Study|Not treated|2
1080696|NCT02131662|2140699|FG004|Overall Study|Not treated|3
1080697|NCT02131766|2140715|FG000|Overall Study|Withdrawal by Subject|4
1080698|NCT02132117|2140724|FG000|Overall Study|Adverse Event|6
1080699|NCT02132117|2140725|FG001|Overall Study|Adverse Event|1
1080700|NCT02132117|2140724|FG000|Overall Study|Lost to Follow-up|2
1080701|NCT02132117|2140725|FG001|Overall Study|Lost to Follow-up|2
1080702|NCT02132117|2140724|FG000|Overall Study|Personal Reasons|1
1080703|NCT02132117|2140725|FG001|Overall Study|Personal Reasons|2
1080704|NCT02132117|2140724|FG000|Overall Study|Other Miscellaneous Reasons|2
1080705|NCT02132117|2140725|FG001|Overall Study|Other Miscellaneous Reasons|0
1080706|NCT02132130|2140735|FG000|Overall Study|Lost to Follow-up|0
1080707|NCT02132130|2140736|FG001|Overall Study|Lost to Follow-up|2
1080708|NCT02132130|2140737|FG002|Overall Study|Lost to Follow-up|0
1080709|NCT02132130|2140738|FG003|Overall Study|Lost to Follow-up|0
1080710|NCT02132130|2140735|FG000|Overall Study|Withdrawal by Subject|0
1080711|NCT02132130|2140736|FG001|Overall Study|Withdrawal by Subject|0
1080712|NCT02132130|2140737|FG002|Overall Study|Withdrawal by Subject|0
1080713|NCT02132130|2140738|FG003|Overall Study|Withdrawal by Subject|1
1080714|NCT02132195|2140764|FG000|Initial Assignment|Relapsed|14
1080715|NCT02132195|2140765|FG001|Initial Assignment|Relapsed|0
1080716|NCT02132195|2140766|FG002|Initial Assignment|Relapsed|0
1080717|NCT02132195|2140764|FG000|Rescue Therapy|Relapsed|0
1080718|NCT02132195|2140765|FG001|Rescue Therapy|Relapsed|0
1080719|NCT02132195|2140766|FG002|Rescue Therapy|Relapsed|7
1080720|NCT02132195|2140764|FG000|Rescue Therapy|Physician Decision|0
1080721|NCT02132195|2140765|FG001|Rescue Therapy|Physician Decision|0
1080722|NCT02132195|2140766|FG002|Rescue Therapy|Physician Decision|1
1080723|NCT02132195|2140764|FG000|Rescue Therapy|Withdrawal by Subject|0
1080724|NCT02132195|2140765|FG001|Rescue Therapy|Withdrawal by Subject|0
1080725|NCT02132195|2140766|FG002|Rescue Therapy|Withdrawal by Subject|1
1080726|NCT02132195|2140764|FG000|Rescue Therapy|Adverse Event|0
1080727|NCT02132195|2140765|FG001|Rescue Therapy|Adverse Event|0
1080728|NCT02132195|2140766|FG002|Rescue Therapy|Adverse Event|2
1080729|NCT02132247|2140776|FG000|Overall Study|Protocol Violation|1
1080730|NCT02132247|2140777|FG001|Overall Study|Protocol Violation|0
1080731|NCT02132312|2140785|FG000|Overall Study|Adverse Event|2
1080732|NCT02132312|2140786|FG001|Overall Study|Adverse Event|0
1080733|NCT02132312|2140785|FG000|Overall Study|Physician Decision|1
1080734|NCT02132312|2140786|FG001|Overall Study|Physician Decision|1
1080735|NCT02132312|2140785|FG000|Overall Study|Protocol Violation|0
1080736|NCT02132312|2140786|FG001|Overall Study|Protocol Violation|1
1080737|NCT02132312|2140785|FG000|Overall Study|Withdrawal by Subject|1
1080738|NCT02132312|2140786|FG001|Overall Study|Withdrawal by Subject|0
1080739|NCT02132312|2140785|FG000|Overall Study|Lost to Follow-up|2
1080740|NCT02132312|2140786|FG001|Overall Study|Lost to Follow-up|1
1080742|NCT02132637|2140831|FG000|Study Period 1|Withdrawal by Subject|0
1080743|NCT02132637|2140832|FG001|Study Period 1|Withdrawal by Subject|4
1080744|NCT02132637|2140831|FG000|Study Period 1|Physician Decision|1
1080745|NCT02132637|2140832|FG001|Study Period 1|Physician Decision|0
1080746|NCT02132637|2140831|FG000|Study Period 2 (Crossover)|Adverse Event|0
1080747|NCT02132637|2140832|FG001|Study Period 2 (Crossover)|Adverse Event|1
1080748|NCT02132637|2140831|FG000|Study Period 2 (Crossover)|Physician Decision|2
1080749|NCT02132637|2140832|FG001|Study Period 2 (Crossover)|Physician Decision|0
1080750|NCT02132754|2140891|FG000|Overall Study|Adverse Event|0
1080751|NCT02132754|2140892|FG001|Overall Study|Adverse Event|0
1080752|NCT02132754|2140893|FG002|Overall Study|Adverse Event|0
1080753|NCT02132754|2140894|FG003|Overall Study|Adverse Event|0
1080754|NCT02132754|2140895|FG004|Overall Study|Adverse Event|0
1080755|NCT02132754|2140896|FG005|Overall Study|Adverse Event|0
909512|NCT00788957|1886288|FG004|Part 2|Withdrawal by Subject|0
909513|NCT00788957|1886289|FG005|Part 2|Withdrawal by Subject|0
1080756|NCT02132754|2140897|FG006|Overall Study|Adverse Event|0
1080757|NCT02132754|2140898|FG007|Overall Study|Adverse Event|0
1080758|NCT02132754|2140899|FG008|Overall Study|Adverse Event|0
1080759|NCT02132754|2140900|FG009|Overall Study|Adverse Event|0
1080760|NCT02132754|2140901|FG010|Overall Study|Adverse Event|0
1080761|NCT02132754|2140902|FG011|Overall Study|Adverse Event|0
1080762|NCT02132754|2140903|FG012|Overall Study|Adverse Event|0
1080763|NCT02132754|2140904|FG013|Overall Study|Adverse Event|0
1080764|NCT02132754|2140905|FG014|Overall Study|Adverse Event|0
1080765|NCT02132754|2140906|FG015|Overall Study|Adverse Event|0
1080766|NCT02132754|2140907|FG016|Overall Study|Adverse Event|0
1080767|NCT02132754|2140908|FG017|Overall Study|Adverse Event|1
1080768|NCT02132754|2140909|FG018|Overall Study|Adverse Event|0
1080769|NCT02132754|2140910|FG019|Overall Study|Adverse Event|0
1080770|NCT02132754|2140911|FG020|Overall Study|Adverse Event|0
1080771|NCT02132754|2140912|FG021|Overall Study|Adverse Event|0
1080772|NCT02132754|2140913|FG022|Overall Study|Adverse Event|0
1080773|NCT02132754|2140914|FG023|Overall Study|Adverse Event|0
1080774|NCT02132754|2140915|FG024|Overall Study|Adverse Event|0
1080775|NCT02132754|2140916|FG025|Overall Study|Adverse Event|1
1080776|NCT02132754|2140917|FG026|Overall Study|Adverse Event|1
1080777|NCT02132754|2140918|FG027|Overall Study|Adverse Event|0
1080778|NCT02132754|2140919|FG028|Overall Study|Adverse Event|0
1080779|NCT02132754|2140920|FG029|Overall Study|Adverse Event|0
1080780|NCT02132754|2140921|FG030|Overall Study|Adverse Event|1
1080781|NCT02132754|2140922|FG031|Overall Study|Adverse Event|0
1080782|NCT02132754|2140923|FG032|Overall Study|Adverse Event|1
1080783|NCT02132754|2140924|FG033|Overall Study|Adverse Event|1
1080784|NCT02132754|2140891|FG000|Overall Study|Clinical Progression|0
1080785|NCT02132754|2140892|FG001|Overall Study|Clinical Progression|0
1080786|NCT02132754|2140893|FG002|Overall Study|Clinical Progression|0
1080787|NCT02132754|2140894|FG003|Overall Study|Clinical Progression|0
1080788|NCT02132754|2140895|FG004|Overall Study|Clinical Progression|0
1080789|NCT02132754|2140896|FG005|Overall Study|Clinical Progression|0
1080790|NCT02132754|2140897|FG006|Overall Study|Clinical Progression|0
1080791|NCT02132754|2140898|FG007|Overall Study|Clinical Progression|0
1080792|NCT02132754|2140899|FG008|Overall Study|Clinical Progression|0
1080793|NCT02132754|2140900|FG009|Overall Study|Clinical Progression|1
1080794|NCT02132754|2140901|FG010|Overall Study|Clinical Progression|0
1080795|NCT02132754|2140902|FG011|Overall Study|Clinical Progression|0
1080796|NCT02132754|2140903|FG012|Overall Study|Clinical Progression|0
1080797|NCT02132754|2140904|FG013|Overall Study|Clinical Progression|0
1080798|NCT02132754|2140905|FG014|Overall Study|Clinical Progression|0
1080799|NCT02132754|2140906|FG015|Overall Study|Clinical Progression|0
1080800|NCT02132754|2140907|FG016|Overall Study|Clinical Progression|1
1080801|NCT02132754|2140908|FG017|Overall Study|Clinical Progression|1
1080802|NCT02132754|2140909|FG018|Overall Study|Clinical Progression|0
1080803|NCT02132754|2140910|FG019|Overall Study|Clinical Progression|1
1080804|NCT02132754|2140911|FG020|Overall Study|Clinical Progression|0
1080805|NCT02132754|2140912|FG021|Overall Study|Clinical Progression|0
1080806|NCT02132754|2140913|FG022|Overall Study|Clinical Progression|1
1080807|NCT02132754|2140914|FG023|Overall Study|Clinical Progression|0
1080808|NCT02132754|2140915|FG024|Overall Study|Clinical Progression|1
1080809|NCT02132754|2140916|FG025|Overall Study|Clinical Progression|1
1080810|NCT02132754|2140917|FG026|Overall Study|Clinical Progression|0
1080811|NCT02132754|2140918|FG027|Overall Study|Clinical Progression|1
1080812|NCT02132754|2140919|FG028|Overall Study|Clinical Progression|1
1080813|NCT02132754|2140920|FG029|Overall Study|Clinical Progression|0
1080814|NCT02132754|2140921|FG030|Overall Study|Clinical Progression|1
1080815|NCT02132754|2140922|FG031|Overall Study|Clinical Progression|0
1080816|NCT02132754|2140923|FG032|Overall Study|Clinical Progression|0
1080817|NCT02132754|2140924|FG033|Overall Study|Clinical Progression|2
1080818|NCT02132754|2140891|FG000|Overall Study|Death|0
1080819|NCT02132754|2140892|FG001|Overall Study|Death|0
1080820|NCT02132754|2140893|FG002|Overall Study|Death|0
1080821|NCT02132754|2140894|FG003|Overall Study|Death|0
1080822|NCT02132754|2140895|FG004|Overall Study|Death|0
1080823|NCT02132754|2140896|FG005|Overall Study|Death|0
1080824|NCT02132754|2140897|FG006|Overall Study|Death|0
1080825|NCT02132754|2140898|FG007|Overall Study|Death|0
1080826|NCT02132754|2140899|FG008|Overall Study|Death|0
1080827|NCT02132754|2140900|FG009|Overall Study|Death|0
1080828|NCT02132754|2140901|FG010|Overall Study|Death|0
1080829|NCT02132754|2140902|FG011|Overall Study|Death|0
1080830|NCT02132754|2140903|FG012|Overall Study|Death|0
1080831|NCT02132754|2140904|FG013|Overall Study|Death|0
1080832|NCT02132754|2140905|FG014|Overall Study|Death|0
1080833|NCT02132754|2140906|FG015|Overall Study|Death|1
1080834|NCT02132754|2140907|FG016|Overall Study|Death|0
1080835|NCT02132754|2140908|FG017|Overall Study|Death|0
1080836|NCT02132754|2140909|FG018|Overall Study|Death|0
1080837|NCT02132754|2140910|FG019|Overall Study|Death|1
1080838|NCT02132754|2140911|FG020|Overall Study|Death|0
1080839|NCT02132754|2140912|FG021|Overall Study|Death|1
1080840|NCT02132754|2140913|FG022|Overall Study|Death|0
1080841|NCT02132754|2140914|FG023|Overall Study|Death|0
1080842|NCT02132754|2140915|FG024|Overall Study|Death|0
1080843|NCT02132754|2140916|FG025|Overall Study|Death|0
1080844|NCT02132754|2140917|FG026|Overall Study|Death|1
1080845|NCT02132754|2140918|FG027|Overall Study|Death|0
1080846|NCT02132754|2140919|FG028|Overall Study|Death|0
1080847|NCT02132754|2140920|FG029|Overall Study|Death|0
1080848|NCT02132754|2140921|FG030|Overall Study|Death|0
1080849|NCT02132754|2140922|FG031|Overall Study|Death|0
1080850|NCT02132754|2140923|FG032|Overall Study|Death|0
1080851|NCT02132754|2140924|FG033|Overall Study|Death|2
1080852|NCT02132754|2140891|FG000|Overall Study|Excluded Medication|0
1080853|NCT02132754|2140892|FG001|Overall Study|Excluded Medication|0
1080854|NCT02132754|2140893|FG002|Overall Study|Excluded Medication|0
1080855|NCT02132754|2140894|FG003|Overall Study|Excluded Medication|0
1080856|NCT02132754|2140895|FG004|Overall Study|Excluded Medication|0
1080857|NCT02132754|2140896|FG005|Overall Study|Excluded Medication|0
1080858|NCT02132754|2140897|FG006|Overall Study|Excluded Medication|0
1080859|NCT02132754|2140898|FG007|Overall Study|Excluded Medication|0
1080860|NCT02132754|2140899|FG008|Overall Study|Excluded Medication|0
1080861|NCT02132754|2140900|FG009|Overall Study|Excluded Medication|0
1080862|NCT02132754|2140901|FG010|Overall Study|Excluded Medication|0
1080863|NCT02132754|2140902|FG011|Overall Study|Excluded Medication|0
1080864|NCT02132754|2140903|FG012|Overall Study|Excluded Medication|0
1080865|NCT02132754|2140904|FG013|Overall Study|Excluded Medication|0
1080866|NCT02132754|2140905|FG014|Overall Study|Excluded Medication|0
1080867|NCT02132754|2140906|FG015|Overall Study|Excluded Medication|0
1080868|NCT02132754|2140907|FG016|Overall Study|Excluded Medication|0
1080869|NCT02132754|2140908|FG017|Overall Study|Excluded Medication|0
1080870|NCT02132754|2140909|FG018|Overall Study|Excluded Medication|0
1080871|NCT02132754|2140910|FG019|Overall Study|Excluded Medication|0
1080872|NCT02132754|2140911|FG020|Overall Study|Excluded Medication|1
1080873|NCT02132754|2140912|FG021|Overall Study|Excluded Medication|0
1080874|NCT02132754|2140913|FG022|Overall Study|Excluded Medication|0
1080875|NCT02132754|2140914|FG023|Overall Study|Excluded Medication|0
1080876|NCT02132754|2140915|FG024|Overall Study|Excluded Medication|0
1080877|NCT02132754|2140916|FG025|Overall Study|Excluded Medication|0
1080878|NCT02132754|2140917|FG026|Overall Study|Excluded Medication|0
1080879|NCT02132754|2140918|FG027|Overall Study|Excluded Medication|0
1080880|NCT02132754|2140919|FG028|Overall Study|Excluded Medication|0
1080881|NCT02132754|2140920|FG029|Overall Study|Excluded Medication|0
1080882|NCT02132754|2140921|FG030|Overall Study|Excluded Medication|0
1080883|NCT02132754|2140922|FG031|Overall Study|Excluded Medication|0
1080884|NCT02132754|2140923|FG032|Overall Study|Excluded Medication|0
1080885|NCT02132754|2140924|FG033|Overall Study|Excluded Medication|1
1080886|NCT02132754|2140891|FG000|Overall Study|Physician Decision|0
1080887|NCT02132754|2140892|FG001|Overall Study|Physician Decision|0
1080888|NCT02132754|2140893|FG002|Overall Study|Physician Decision|0
1080889|NCT02132754|2140894|FG003|Overall Study|Physician Decision|0
1080890|NCT02132754|2140895|FG004|Overall Study|Physician Decision|0
1080891|NCT02132754|2140896|FG005|Overall Study|Physician Decision|0
1080892|NCT02132754|2140897|FG006|Overall Study|Physician Decision|0
1080893|NCT02132754|2140898|FG007|Overall Study|Physician Decision|0
1080894|NCT02132754|2140899|FG008|Overall Study|Physician Decision|0
1080895|NCT02132754|2140900|FG009|Overall Study|Physician Decision|1
1080896|NCT02132754|2140901|FG010|Overall Study|Physician Decision|0
1080897|NCT02132754|2140902|FG011|Overall Study|Physician Decision|1
1080898|NCT02132754|2140903|FG012|Overall Study|Physician Decision|1
1080899|NCT02132754|2140904|FG013|Overall Study|Physician Decision|0
1080900|NCT02132754|2140905|FG014|Overall Study|Physician Decision|0
1080901|NCT02132754|2140906|FG015|Overall Study|Physician Decision|1
1080902|NCT02132754|2140907|FG016|Overall Study|Physician Decision|0
1080903|NCT02132754|2140908|FG017|Overall Study|Physician Decision|0
1080904|NCT02132754|2140909|FG018|Overall Study|Physician Decision|0
1080905|NCT02132754|2140910|FG019|Overall Study|Physician Decision|0
1080906|NCT02132754|2140911|FG020|Overall Study|Physician Decision|0
1080907|NCT02132754|2140912|FG021|Overall Study|Physician Decision|0
1080908|NCT02132754|2140913|FG022|Overall Study|Physician Decision|0
1080909|NCT02132754|2140914|FG023|Overall Study|Physician Decision|0
1080910|NCT02132754|2140915|FG024|Overall Study|Physician Decision|1
1080911|NCT02132754|2140916|FG025|Overall Study|Physician Decision|0
1080912|NCT02132754|2140917|FG026|Overall Study|Physician Decision|0
1080913|NCT02132754|2140918|FG027|Overall Study|Physician Decision|0
1080914|NCT02132754|2140919|FG028|Overall Study|Physician Decision|0
1080915|NCT02132754|2140920|FG029|Overall Study|Physician Decision|0
1080916|NCT02132754|2140921|FG030|Overall Study|Physician Decision|0
1080917|NCT02132754|2140922|FG031|Overall Study|Physician Decision|1
1080918|NCT02132754|2140923|FG032|Overall Study|Physician Decision|0
1080919|NCT02132754|2140924|FG033|Overall Study|Physician Decision|3
1080920|NCT02132754|2140891|FG000|Overall Study|Progressive Disease|1
1080921|NCT02132754|2140892|FG001|Overall Study|Progressive Disease|1
1080922|NCT02132754|2140893|FG002|Overall Study|Progressive Disease|1
1080923|NCT02132754|2140894|FG003|Overall Study|Progressive Disease|1
1080924|NCT02132754|2140895|FG004|Overall Study|Progressive Disease|1
1080925|NCT02132754|2140896|FG005|Overall Study|Progressive Disease|1
1080926|NCT02132754|2140897|FG006|Overall Study|Progressive Disease|1
1080927|NCT02132754|2140898|FG007|Overall Study|Progressive Disease|1
1080928|NCT02132754|2140899|FG008|Overall Study|Progressive Disease|1
1080929|NCT02132754|2140900|FG009|Overall Study|Progressive Disease|3
1080930|NCT02132754|2140901|FG010|Overall Study|Progressive Disease|3
1080931|NCT02132754|2140902|FG011|Overall Study|Progressive Disease|2
1080932|NCT02132754|2140903|FG012|Overall Study|Progressive Disease|2
1080933|NCT02132754|2140904|FG013|Overall Study|Progressive Disease|3
1080934|NCT02132754|2140905|FG014|Overall Study|Progressive Disease|2
1080935|NCT02132754|2140906|FG015|Overall Study|Progressive Disease|1
1080936|NCT02132754|2140907|FG016|Overall Study|Progressive Disease|2
1080937|NCT02132754|2140908|FG017|Overall Study|Progressive Disease|1
1080938|NCT02132754|2140909|FG018|Overall Study|Progressive Disease|3
1080939|NCT02132754|2140910|FG019|Overall Study|Progressive Disease|1
1080940|NCT02132754|2140911|FG020|Overall Study|Progressive Disease|1
1080941|NCT02132754|2140912|FG021|Overall Study|Progressive Disease|3
1080942|NCT02132754|2140913|FG022|Overall Study|Progressive Disease|2
1080943|NCT02132754|2140914|FG023|Overall Study|Progressive Disease|3
1080944|NCT02132754|2140915|FG024|Overall Study|Progressive Disease|0
1080945|NCT02132754|2140916|FG025|Overall Study|Progressive Disease|1
1080946|NCT02132754|2140917|FG026|Overall Study|Progressive Disease|2
1080947|NCT02132754|2140918|FG027|Overall Study|Progressive Disease|1
1080948|NCT02132754|2140919|FG028|Overall Study|Progressive Disease|2
1080949|NCT02132754|2140920|FG029|Overall Study|Progressive Disease|3
1080950|NCT02132754|2140921|FG030|Overall Study|Progressive Disease|1
1080951|NCT02132754|2140922|FG031|Overall Study|Progressive Disease|1
1080952|NCT02132754|2140923|FG032|Overall Study|Progressive Disease|3
1080953|NCT02132754|2140924|FG033|Overall Study|Progressive Disease|6
1080954|NCT02132754|2140891|FG000|Overall Study|Screen Failure|0
1080955|NCT02132754|2140892|FG001|Overall Study|Screen Failure|0
1080956|NCT02132754|2140893|FG002|Overall Study|Screen Failure|0
1080957|NCT02132754|2140894|FG003|Overall Study|Screen Failure|0
1080958|NCT02132754|2140895|FG004|Overall Study|Screen Failure|0
1080959|NCT02132754|2140896|FG005|Overall Study|Screen Failure|0
1080960|NCT02132754|2140897|FG006|Overall Study|Screen Failure|0
1080961|NCT02132754|2140898|FG007|Overall Study|Screen Failure|0
1080962|NCT02132754|2140899|FG008|Overall Study|Screen Failure|0
1080963|NCT02132754|2140900|FG009|Overall Study|Screen Failure|0
1080964|NCT02132754|2140901|FG010|Overall Study|Screen Failure|0
1080965|NCT02132754|2140902|FG011|Overall Study|Screen Failure|0
1080966|NCT02132754|2140903|FG012|Overall Study|Screen Failure|0
1080967|NCT02132754|2140904|FG013|Overall Study|Screen Failure|0
1080968|NCT02132754|2140905|FG014|Overall Study|Screen Failure|0
1080969|NCT02132754|2140906|FG015|Overall Study|Screen Failure|0
1080970|NCT02132754|2140907|FG016|Overall Study|Screen Failure|0
1080971|NCT02132754|2140908|FG017|Overall Study|Screen Failure|0
1080972|NCT02132754|2140909|FG018|Overall Study|Screen Failure|0
1080973|NCT02132754|2140910|FG019|Overall Study|Screen Failure|1
1080974|NCT02132754|2140911|FG020|Overall Study|Screen Failure|0
1080975|NCT02132754|2140912|FG021|Overall Study|Screen Failure|1
1080976|NCT02132754|2140913|FG022|Overall Study|Screen Failure|0
1080977|NCT02132754|2140914|FG023|Overall Study|Screen Failure|0
1080978|NCT02132754|2140915|FG024|Overall Study|Screen Failure|0
1080979|NCT02132754|2140916|FG025|Overall Study|Screen Failure|0
1080980|NCT02132754|2140917|FG026|Overall Study|Screen Failure|0
1080981|NCT02132754|2140918|FG027|Overall Study|Screen Failure|0
1080982|NCT02132754|2140919|FG028|Overall Study|Screen Failure|0
1080983|NCT02132754|2140920|FG029|Overall Study|Screen Failure|0
1080984|NCT02132754|2140921|FG030|Overall Study|Screen Failure|0
1080985|NCT02132754|2140922|FG031|Overall Study|Screen Failure|0
1080986|NCT02132754|2140923|FG032|Overall Study|Screen Failure|0
1080987|NCT02132754|2140924|FG033|Overall Study|Screen Failure|0
1080988|NCT02132754|2140891|FG000|Overall Study|Transferred to Extension Study|0
1080989|NCT02132754|2140892|FG001|Overall Study|Transferred to Extension Study|0
1080990|NCT02132754|2140893|FG002|Overall Study|Transferred to Extension Study|0
1080991|NCT02132754|2140894|FG003|Overall Study|Transferred to Extension Study|0
1080992|NCT02132754|2140895|FG004|Overall Study|Transferred to Extension Study|0
1080993|NCT02132754|2140896|FG005|Overall Study|Transferred to Extension Study|0
1080994|NCT02132754|2140897|FG006|Overall Study|Transferred to Extension Study|0
1080995|NCT02132754|2140898|FG007|Overall Study|Transferred to Extension Study|0
1080996|NCT02132754|2140899|FG008|Overall Study|Transferred to Extension Study|0
1080997|NCT02132754|2140900|FG009|Overall Study|Transferred to Extension Study|0
1080998|NCT02132754|2140901|FG010|Overall Study|Transferred to Extension Study|0
1080999|NCT02132754|2140902|FG011|Overall Study|Transferred to Extension Study|0
1081000|NCT02132754|2140903|FG012|Overall Study|Transferred to Extension Study|0
1081001|NCT02132754|2140904|FG013|Overall Study|Transferred to Extension Study|0
1081002|NCT02132754|2140905|FG014|Overall Study|Transferred to Extension Study|0
1081003|NCT02132754|2140906|FG015|Overall Study|Transferred to Extension Study|0
1081004|NCT02132754|2140907|FG016|Overall Study|Transferred to Extension Study|0
1081005|NCT02132754|2140908|FG017|Overall Study|Transferred to Extension Study|0
1081006|NCT02132754|2140909|FG018|Overall Study|Transferred to Extension Study|0
1081007|NCT02132754|2140910|FG019|Overall Study|Transferred to Extension Study|0
1081008|NCT02132754|2140911|FG020|Overall Study|Transferred to Extension Study|0
1081009|NCT02132754|2140912|FG021|Overall Study|Transferred to Extension Study|0
1081010|NCT02132754|2140913|FG022|Overall Study|Transferred to Extension Study|0
1081011|NCT02132754|2140914|FG023|Overall Study|Transferred to Extension Study|0
1081012|NCT02132754|2140915|FG024|Overall Study|Transferred to Extension Study|0
1081013|NCT02132754|2140916|FG025|Overall Study|Transferred to Extension Study|0
1081014|NCT02132754|2140917|FG026|Overall Study|Transferred to Extension Study|0
1081015|NCT02132754|2140918|FG027|Overall Study|Transferred to Extension Study|0
1081016|NCT02132754|2140919|FG028|Overall Study|Transferred to Extension Study|0
1081017|NCT02132754|2140920|FG029|Overall Study|Transferred to Extension Study|0
1081018|NCT02132754|2140921|FG030|Overall Study|Transferred to Extension Study|0
1081019|NCT02132754|2140922|FG031|Overall Study|Transferred to Extension Study|0
1081020|NCT02132754|2140923|FG032|Overall Study|Transferred to Extension Study|0
1081021|NCT02132754|2140924|FG033|Overall Study|Transferred to Extension Study|6
1081022|NCT02132754|2140891|FG000|Overall Study|Withdrawal by Subject|0
1081023|NCT02132754|2140892|FG001|Overall Study|Withdrawal by Subject|0
1081024|NCT02132754|2140893|FG002|Overall Study|Withdrawal by Subject|0
1081025|NCT02132754|2140894|FG003|Overall Study|Withdrawal by Subject|0
1081026|NCT02132754|2140895|FG004|Overall Study|Withdrawal by Subject|0
1081027|NCT02132754|2140896|FG005|Overall Study|Withdrawal by Subject|0
1081028|NCT02132754|2140897|FG006|Overall Study|Withdrawal by Subject|0
1081029|NCT02132754|2140898|FG007|Overall Study|Withdrawal by Subject|0
1081030|NCT02132754|2140899|FG008|Overall Study|Withdrawal by Subject|0
1081031|NCT02132754|2140900|FG009|Overall Study|Withdrawal by Subject|1
1081032|NCT02132754|2140901|FG010|Overall Study|Withdrawal by Subject|0
1081033|NCT02132754|2140902|FG011|Overall Study|Withdrawal by Subject|0
1081034|NCT02132754|2140903|FG012|Overall Study|Withdrawal by Subject|1
1081035|NCT02132754|2140904|FG013|Overall Study|Withdrawal by Subject|0
1081036|NCT02132754|2140905|FG014|Overall Study|Withdrawal by Subject|1
1081037|NCT02132754|2140906|FG015|Overall Study|Withdrawal by Subject|2
1081038|NCT02132754|2140907|FG016|Overall Study|Withdrawal by Subject|1
1081039|NCT02132754|2140908|FG017|Overall Study|Withdrawal by Subject|0
1081040|NCT02132754|2140909|FG018|Overall Study|Withdrawal by Subject|0
1081041|NCT02132754|2140910|FG019|Overall Study|Withdrawal by Subject|0
1081042|NCT02132754|2140911|FG020|Overall Study|Withdrawal by Subject|1
1081043|NCT02132754|2140912|FG021|Overall Study|Withdrawal by Subject|0
1081044|NCT02132754|2140913|FG022|Overall Study|Withdrawal by Subject|0
1081045|NCT02132754|2140914|FG023|Overall Study|Withdrawal by Subject|0
1081046|NCT02132754|2140915|FG024|Overall Study|Withdrawal by Subject|1
1081047|NCT02132754|2140916|FG025|Overall Study|Withdrawal by Subject|0
1081048|NCT02132754|2140917|FG026|Overall Study|Withdrawal by Subject|0
1081049|NCT02132754|2140918|FG027|Overall Study|Withdrawal by Subject|1
1081050|NCT02132754|2140919|FG028|Overall Study|Withdrawal by Subject|0
1081051|NCT02132754|2140920|FG029|Overall Study|Withdrawal by Subject|0
1081052|NCT02132754|2140921|FG030|Overall Study|Withdrawal by Subject|0
1081053|NCT02132754|2140922|FG031|Overall Study|Withdrawal by Subject|1
1081054|NCT02132754|2140923|FG032|Overall Study|Withdrawal by Subject|0
1081055|NCT02132754|2140924|FG033|Overall Study|Withdrawal by Subject|2
1081056|NCT02132767|2141036|FG000|Overall Study|Death|3
1081057|NCT02132767|2141037|FG001|Overall Study|Death|2
1081058|NCT02132767|2141036|FG000|Overall Study|Withdrawal by Subject|10
1081059|NCT02132767|2141037|FG001|Overall Study|Withdrawal by Subject|9
1081060|NCT02132767|2141036|FG000|Overall Study|Lost to Follow-up|4
1081061|NCT02132767|2141037|FG001|Overall Study|Lost to Follow-up|4
1081062|NCT02132949|2141081|FG000|Overall Study|Death|7
1081063|NCT02132949|2141082|FG001|Overall Study|Death|13
1081064|NCT02132949|2141081|FG000|Overall Study|Lost to Follow-up|14
1081065|NCT02132949|2141082|FG001|Overall Study|Lost to Follow-up|4
1081066|NCT02132949|2141081|FG000|Overall Study|Withdrawal by Subject|6
1081067|NCT02132949|2141082|FG001|Overall Study|Withdrawal by Subject|5
1081068|NCT02132949|2141081|FG000|Overall Study|Noncompliance|5
1081069|NCT02132949|2141082|FG001|Overall Study|Noncompliance|1
1081070|NCT02132949|2141081|FG000|Overall Study|Physician Decision|3
1081071|NCT02132949|2141082|FG001|Overall Study|Physician Decision|1
1081072|NCT02132949|2141081|FG000|Overall Study|Disease Progression|3
1081073|NCT02132949|2141082|FG001|Overall Study|Disease Progression|0
1081074|NCT02132949|2141081|FG000|Overall Study|Adverse Event|2
1081075|NCT02132949|2141082|FG001|Overall Study|Adverse Event|1
1081076|NCT02132949|2141081|FG000|Overall Study|Withdrew Prior to Treatment|1
1081077|NCT02132949|2141082|FG001|Overall Study|Withdrew Prior to Treatment|2
1081078|NCT02132949|2141081|FG000|Overall Study|Reason Unspecified|0
1081079|NCT02132949|2141082|FG001|Overall Study|Reason Unspecified|1
1081080|NCT02133001|2141090|FG000|Double Blind (Day 1-25)|Adverse Event|1
1081081|NCT02133001|2141091|FG001|Double Blind (Day 1-25)|Adverse Event|5
1081082|NCT02133001|2141090|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4
1081083|NCT02133001|2141091|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1
1081084|NCT02133001|2141090|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2
1081085|NCT02133001|2141091|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0
1081086|NCT02133001|2141090|FG000|Double Blind (Day 1-25)|Other|2
1081087|NCT02133001|2141091|FG001|Double Blind (Day 1-25)|Other|2
1081088|NCT02133001|2141090|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1
1081089|NCT02133001|2141091|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1
1081090|NCT02133001|2141090|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
1081091|NCT02133001|2141091|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
1081092|NCT02133001|2141090|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
1081093|NCT02133001|2141091|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
1081094|NCT02133001|2141090|FG000|Follow-Up Phase (Day 26-81)|Other|0
1081095|NCT02133001|2141091|FG001|Follow-Up Phase (Day 26-81)|Other|1
1081096|NCT02133131|2141115|FG000|Overall Study|Adverse Event|0
1081097|NCT02133131|2141116|FG001|Overall Study|Adverse Event|0
1081098|NCT02133131|2141117|FG002|Overall Study|Adverse Event|0
1081099|NCT02133131|2141118|FG003|Overall Study|Adverse Event|1
1081100|NCT02133131|2141119|FG004|Overall Study|Adverse Event|0
1081101|NCT02133131|2141120|FG005|Overall Study|Adverse Event|0
1081102|NCT02133131|2141121|FG006|Overall Study|Adverse Event|0
1081103|NCT02133131|2141115|FG000|Overall Study|Lost to Follow-up|1
1081104|NCT02133131|2141116|FG001|Overall Study|Lost to Follow-up|0
1081105|NCT02133131|2141117|FG002|Overall Study|Lost to Follow-up|0
1081106|NCT02133131|2141118|FG003|Overall Study|Lost to Follow-up|1
1081107|NCT02133131|2141119|FG004|Overall Study|Lost to Follow-up|0
1081108|NCT02133131|2141120|FG005|Overall Study|Lost to Follow-up|0
1081109|NCT02133131|2141121|FG006|Overall Study|Lost to Follow-up|0
1081110|NCT02133131|2141115|FG000|Overall Study|Status not recorded|4
1081111|NCT02133131|2141116|FG001|Overall Study|Status not recorded|5
1081112|NCT02133131|2141117|FG002|Overall Study|Status not recorded|1
1081113|NCT02133131|2141118|FG003|Overall Study|Status not recorded|4
1081114|NCT02133131|2141119|FG004|Overall Study|Status not recorded|0
1081115|NCT02133131|2141120|FG005|Overall Study|Status not recorded|0
1081116|NCT02133131|2141121|FG006|Overall Study|Status not recorded|0
1081117|NCT02133131|2141115|FG000|Overall Study|Ongoing in study|0
1081118|NCT02133131|2141116|FG001|Overall Study|Ongoing in study|0
1081119|NCT02133131|2141117|FG002|Overall Study|Ongoing in study|0
1081120|NCT02133131|2141118|FG003|Overall Study|Ongoing in study|0
1081121|NCT02133131|2141119|FG004|Overall Study|Ongoing in study|15
1081122|NCT02133131|2141120|FG005|Overall Study|Ongoing in study|14
1081123|NCT02133131|2141121|FG006|Overall Study|Ongoing in study|11
1081124|NCT02133131|2141115|FG000|Overall Study|Protocol Violation|0
1081125|NCT02133131|2141116|FG001|Overall Study|Protocol Violation|0
1081126|NCT02133131|2141117|FG002|Overall Study|Protocol Violation|0
1081127|NCT02133131|2141118|FG003|Overall Study|Protocol Violation|0
1081128|NCT02133131|2141119|FG004|Overall Study|Protocol Violation|0
1081129|NCT02133131|2141120|FG005|Overall Study|Protocol Violation|0
1081130|NCT02133131|2141121|FG006|Overall Study|Protocol Violation|1
1081131|NCT02133352|2141152|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
1081132|NCT02133508|2141156|FG000|Overall Study|Decision of Investigator or Sponsor|1
1081133|NCT02133508|2141156|FG000|Overall Study|Death|12
1081134|NCT02133508|2141156|FG000|Overall Study|Lost to Follow-up|2
1081135|NCT02133664|2141162|FG000|Overall Study|Lost to Follow-up|2
1081136|NCT02133664|2141163|FG001|Overall Study|Lost to Follow-up|1
1081137|NCT02133664|2141162|FG000|Overall Study|Adverse Event|3
1081138|NCT02133664|2141163|FG001|Overall Study|Adverse Event|6
1081139|NCT02133742|2141169|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2
1081140|NCT02133742|2141169|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31
1081141|NCT02133742|2141169|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13
1081142|NCT02133742|2141169|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5
1081143|NCT02133742|2141169|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1
1081144|NCT02134015|2141190|FG000|Overall Study|Protocol Violation|0
1081145|NCT02134015|2141191|FG001|Overall Study|Protocol Violation|1
1081146|NCT02134015|2141190|FG000|Overall Study|Death|2
1081147|NCT02134015|2141191|FG001|Overall Study|Death|1
1081148|NCT02134015|2141190|FG000|Overall Study|Reason not provided|1
1081149|NCT02134015|2141191|FG001|Overall Study|Reason not provided|2
1081150|NCT02134015|2141190|FG000|Overall Study|Clinical progression|14
1081151|NCT02134015|2141191|FG001|Overall Study|Clinical progression|7
1081152|NCT02134015|2141190|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40
1081153|NCT02134015|2141191|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43
1081154|NCT02134015|2141190|FG000|Overall Study|Study terminated by sponsor|2
1081155|NCT02134015|2141191|FG001|Overall Study|Study terminated by sponsor|3
1081156|NCT02134015|2141190|FG000|Overall Study|Adverse Event|9
1081157|NCT02134015|2141191|FG001|Overall Study|Adverse Event|10
1081158|NCT02134015|2141190|FG000|Overall Study|Withdrawal by Subject|3
1081159|NCT02134015|2141191|FG001|Overall Study|Withdrawal by Subject|7
1081160|NCT02134028|2141205|FG000|Overall Study|Lack of Efficacy|1
1081161|NCT02134028|2141206|FG001|Overall Study|Lack of Efficacy|0
1081162|NCT02134028|2141207|FG002|Overall Study|Lack of Efficacy|3
1081163|NCT02134028|2141208|FG003|Overall Study|Lack of Efficacy|2
1081164|NCT02134028|2141209|FG004|Overall Study|Lack of Efficacy|1
1081165|NCT02134028|2141210|FG005|Overall Study|Lack of Efficacy|2
1081166|NCT02134028|2141211|FG006|Overall Study|Lack of Efficacy|1
1081167|NCT02134028|2141212|FG007|Overall Study|Lack of Efficacy|0
1081168|NCT02134028|2141205|FG000|Overall Study|Poor compliance to protocol|1
1081169|NCT02134028|2141206|FG001|Overall Study|Poor compliance to protocol|1
1081170|NCT02134028|2141207|FG002|Overall Study|Poor compliance to protocol|3
1081171|NCT02134028|2141208|FG003|Overall Study|Poor compliance to protocol|7
1081172|NCT02134028|2141209|FG004|Overall Study|Poor compliance to protocol|1
1081173|NCT02134028|2141210|FG005|Overall Study|Poor compliance to protocol|1
1081174|NCT02134028|2141211|FG006|Overall Study|Poor compliance to protocol|0
1081175|NCT02134028|2141212|FG007|Overall Study|Poor compliance to protocol|0
1081176|NCT02134028|2141205|FG000|Overall Study|Other unspecified|4
1081177|NCT02134028|2141206|FG001|Overall Study|Other unspecified|22
1081178|NCT02134028|2141207|FG002|Overall Study|Other unspecified|33
1081179|NCT02134028|2141208|FG003|Overall Study|Other unspecified|64
1081180|NCT02134028|2141209|FG004|Overall Study|Other unspecified|8
1081181|NCT02134028|2141210|FG005|Overall Study|Other unspecified|6
1081182|NCT02134028|2141211|FG006|Overall Study|Other unspecified|2
1081183|NCT02134028|2141212|FG007|Overall Study|Other unspecified|1
1081184|NCT02134028|2141205|FG000|Overall Study|Adverse Event|3
1081185|NCT02134028|2141206|FG001|Overall Study|Adverse Event|19
1081186|NCT02134028|2141207|FG002|Overall Study|Adverse Event|13
1081187|NCT02134028|2141208|FG003|Overall Study|Adverse Event|32
1081188|NCT02134028|2141209|FG004|Overall Study|Adverse Event|4
1081189|NCT02134028|2141210|FG005|Overall Study|Adverse Event|5
1081190|NCT02134028|2141211|FG006|Overall Study|Adverse Event|1
1081191|NCT02134028|2141212|FG007|Overall Study|Adverse Event|2
1081192|NCT02134353|2141275|FG000|Overall Study|Adverse Event|10
1081193|NCT02134353|2141276|FG001|Overall Study|Adverse Event|6
1081194|NCT02134353|2141275|FG000|Overall Study|Lost to Follow-up|1
1081195|NCT02134353|2141276|FG001|Overall Study|Lost to Follow-up|1
1081196|NCT02134353|2141275|FG000|Overall Study|Lack of Efficacy|2
1081197|NCT02134353|2141276|FG001|Overall Study|Lack of Efficacy|1
1081198|NCT02134353|2141275|FG000|Overall Study|Withdrawal by Subject|12
1081199|NCT02134353|2141276|FG001|Overall Study|Withdrawal by Subject|13
1081200|NCT02134353|2141275|FG000|Overall Study|Death|0
1081201|NCT02134353|2141276|FG001|Overall Study|Death|1
1081202|NCT02134353|2141275|FG000|Overall Study|Pregnancy|0
1081203|NCT02134353|2141276|FG001|Overall Study|Pregnancy|1
1081204|NCT02134353|2141275|FG000|Overall Study|Relocation|1
1081205|NCT02134353|2141276|FG001|Overall Study|Relocation|0
1081206|NCT02134353|2141275|FG000|Overall Study|Other - Patient's Choice|0
1081207|NCT02134353|2141276|FG001|Overall Study|Other - Patient's Choice|1
1081208|NCT02134587|2141286|FG000|Overall Study|Did not completed all meetings|30
1081213|NCT02134977|2141326|FG000|Overall Study|Protocol Deviation|102
1081214|NCT02135107|2141368|FG000|Treatment Period|Withdrawal by Subject|11
1081215|NCT02135107|2141369|FG001|Treatment Period|Withdrawal by Subject|0
1081216|NCT02135107|2141370|FG002|Treatment Period|Withdrawal by Subject|0
1081217|NCT02135107|2141371|FG003|Treatment Period|Withdrawal by Subject|0
1081218|NCT02135107|2141368|FG000|Treatment Period|Adverse Event|5
1081219|NCT02135107|2141369|FG001|Treatment Period|Adverse Event|2
1081220|NCT02135107|2141370|FG002|Treatment Period|Adverse Event|0
909514|NCT00788957|1886284|FG000|Part 2|Death|0
909515|NCT00788957|1886285|FG001|Part 2|Death|32
909516|NCT00788957|1886286|FG002|Part 2|Death|35
909517|NCT00788957|1886287|FG003|Part 2|Death|37
909518|NCT00788957|1886288|FG004|Part 2|Death|0
909519|NCT00788957|1886289|FG005|Part 2|Death|0
909520|NCT00788957|1886284|FG000|Part 2|Lost to Follow-up|0
909521|NCT00788957|1886285|FG001|Part 2|Lost to Follow-up|0
909522|NCT00788957|1886286|FG002|Part 2|Lost to Follow-up|3
909523|NCT00788957|1886287|FG003|Part 2|Lost to Follow-up|0
1081221|NCT02135107|2141371|FG003|Treatment Period|Adverse Event|0
1081222|NCT02135107|2141368|FG000|Treatment Period|Pregnancy|1
1081223|NCT02135107|2141369|FG001|Treatment Period|Pregnancy|0
1081224|NCT02135107|2141370|FG002|Treatment Period|Pregnancy|0
1081225|NCT02135107|2141371|FG003|Treatment Period|Pregnancy|0
1081226|NCT02135107|2141368|FG000|Treatment Period|Other|115
1081227|NCT02135107|2141369|FG001|Treatment Period|Other|24
1081228|NCT02135107|2141370|FG002|Treatment Period|Other|0
1081229|NCT02135107|2141371|FG003|Treatment Period|Other|0
1081230|NCT02135107|2141368|FG000|Maintenance Therapy Period|Adverse Event|0
1081231|NCT02135107|2141369|FG001|Maintenance Therapy Period|Adverse Event|0
1081232|NCT02135107|2141370|FG002|Maintenance Therapy Period|Adverse Event|3
1081233|NCT02135107|2141371|FG003|Maintenance Therapy Period|Adverse Event|7
1081234|NCT02135107|2141368|FG000|Maintenance Therapy Period|Withdrawal by Subject|0
1081235|NCT02135107|2141369|FG001|Maintenance Therapy Period|Withdrawal by Subject|0
1081236|NCT02135107|2141370|FG002|Maintenance Therapy Period|Withdrawal by Subject|5
1081237|NCT02135107|2141371|FG003|Maintenance Therapy Period|Withdrawal by Subject|4
1081238|NCT02135107|2141368|FG000|Maintenance Therapy Period|Pregnancy|0
1081239|NCT02135107|2141369|FG001|Maintenance Therapy Period|Pregnancy|0
1081240|NCT02135107|2141370|FG002|Maintenance Therapy Period|Pregnancy|0
1081241|NCT02135107|2141371|FG003|Maintenance Therapy Period|Pregnancy|1
1081242|NCT02135107|2141368|FG000|Maintenance Therapy Period|Other|0
1081243|NCT02135107|2141369|FG001|Maintenance Therapy Period|Other|0
1081244|NCT02135107|2141370|FG002|Maintenance Therapy Period|Other|7
1081245|NCT02135107|2141371|FG003|Maintenance Therapy Period|Other|8
1081246|NCT02135445|2141404|FG000|Overall Study|Lost to Follow-up|1
1081247|NCT02135445|2141405|FG001|Overall Study|Lost to Follow-up|0
1081248|NCT02135445|2141404|FG000|Overall Study|Withdrawal by Subject|1
1081249|NCT02135445|2141405|FG001|Overall Study|Withdrawal by Subject|0
1081250|NCT02135614|2141413|FG000|Overall Study|Randomized but Not Treated|2
1081251|NCT02135614|2141414|FG001|Overall Study|Randomized but Not Treated|1
1081252|NCT02135614|2141413|FG000|Overall Study|Adverse Event|0
1081253|NCT02135614|2141414|FG001|Overall Study|Adverse Event|1
1081254|NCT02135614|2141413|FG000|Overall Study|Death|1
1081255|NCT02135614|2141414|FG001|Overall Study|Death|0
1081256|NCT02135614|2141413|FG000|Overall Study|Investigator's Discretion|0
909524|NCT00788957|1886288|FG004|Part 2|Lost to Follow-up|0
1081257|NCT02135614|2141414|FG001|Overall Study|Investigator's Discretion|1
1081258|NCT02135614|2141413|FG000|Overall Study|Withdrew Consent|2
1081259|NCT02135614|2141414|FG001|Overall Study|Withdrew Consent|2
1081260|NCT02135614|2141413|FG000|Overall Study|Lost to Follow-up|3
1081261|NCT02135614|2141414|FG001|Overall Study|Lost to Follow-up|0
1081262|NCT02135692|2141431|FG000|Overall Study|Adverse Event|3
1081263|NCT02135692|2141431|FG000|Overall Study|Lack of Efficacy|2
1081264|NCT02135692|2141431|FG000|Overall Study|Protocol Violation|2
1081265|NCT02135692|2141431|FG000|Overall Study|Subject met Liver Stopping Criteria|1
1081266|NCT02135692|2141431|FG000|Overall Study|Product commercially available|159
1081267|NCT02135692|2141431|FG000|Overall Study|Study closed/terminated|153
1081268|NCT02135692|2141431|FG000|Overall Study|Lost to Follow-up|4
1081269|NCT02135692|2141431|FG000|Overall Study|Withdrawal by Subject|15
1081270|NCT02135848|2141437|FG000|Overall Study|Adverse Event|2
1081271|NCT02135848|2141438|FG001|Overall Study|Adverse Event|0
1081272|NCT02135848|2141437|FG000|Overall Study|Withdrawal by Subject|1
1081273|NCT02135848|2141438|FG001|Overall Study|Withdrawal by Subject|1
1081300|NCT02136576|2141549|FG000|Overall Study|Lost to Follow-up|2
1081301|NCT02136576|2141550|FG001|Overall Study|Lost to Follow-up|0
1081302|NCT02136576|2141551|FG002|Overall Study|Lost to Follow-up|0
1081303|NCT02136680|2141561|FG000|Overall Study|No Longer Interested|1
1081304|NCT02136680|2141562|FG001|Overall Study|No Longer Interested|1
1081305|NCT02136680|2141561|FG000|Overall Study|No longer receiving care at clinic|3
1081306|NCT02136680|2141562|FG001|Overall Study|No longer receiving care at clinic|5
1081307|NCT02136680|2141561|FG000|Overall Study|Moved away|5
1081308|NCT02136680|2141562|FG001|Overall Study|Moved away|4
1081309|NCT02136680|2141561|FG000|Overall Study|Unable to schedule|17
1081310|NCT02136680|2141562|FG001|Overall Study|Unable to schedule|16
1081311|NCT02136680|2141561|FG000|Overall Study|Study ended before interview due|6
1081312|NCT02136680|2141562|FG001|Overall Study|Study ended before interview due|3
1081313|NCT02136914|2141574|FG000|Overall Study|Sponsor's Decision to Stop the Study|7
1081314|NCT02136914|2141575|FG001|Overall Study|Sponsor's Decision to Stop the Study|7
1081315|NCT02136914|2141574|FG000|Overall Study|Withdrawal by Subject|3
1081316|NCT02136914|2141575|FG001|Overall Study|Withdrawal by Subject|10
1081317|NCT02136914|2141574|FG000|Overall Study|Subject Unwilling to Proceed|7
1081318|NCT02136914|2141575|FG001|Overall Study|Subject Unwilling to Proceed|2
1081319|NCT02136914|2141574|FG000|Overall Study|Lost to Follow-up|1
1081320|NCT02136914|2141575|FG001|Overall Study|Lost to Follow-up|1
1081321|NCT02136914|2141574|FG000|Overall Study|Did Not Receive Study Drug|2
1081322|NCT02136914|2141575|FG001|Overall Study|Did Not Receive Study Drug|0
1081323|NCT02136914|2141574|FG000|Overall Study|Lack of Efficacy|1
1081324|NCT02136914|2141575|FG001|Overall Study|Lack of Efficacy|0
1081325|NCT02136914|2141574|FG000|Overall Study|Death|0
1081326|NCT02136914|2141575|FG001|Overall Study|Death|1
1081327|NCT02137226|2141583|FG000|Period 1 (Initial Randomization)|Adverse Event|3
1081328|NCT02137226|2141584|FG001|Period 1 (Initial Randomization)|Adverse Event|3
1081329|NCT02137226|2141585|FG002|Period 1 (Initial Randomization)|Adverse Event|0
1081330|NCT02137226|2141586|FG003|Period 1 (Initial Randomization)|Adverse Event|0
1081331|NCT02137226|2141587|FG004|Period 1 (Initial Randomization)|Adverse Event|0
1081332|NCT02137226|2141583|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11
1081333|NCT02137226|2141584|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5
1081334|NCT02137226|2141585|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1081335|NCT02137226|2141586|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1081336|NCT02137226|2141587|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1081337|NCT02137226|2141583|FG000|Period 1 (Initial Randomization)|Physician Decision|1
1081338|NCT02137226|2141584|FG001|Period 1 (Initial Randomization)|Physician Decision|3
1081339|NCT02137226|2141585|FG002|Period 1 (Initial Randomization)|Physician Decision|0
1081340|NCT02137226|2141586|FG003|Period 1 (Initial Randomization)|Physician Decision|0
1081341|NCT02137226|2141587|FG004|Period 1 (Initial Randomization)|Physician Decision|0
1081342|NCT02137226|2141583|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3
1081343|NCT02137226|2141584|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2
1081344|NCT02137226|2141585|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0
1081345|NCT02137226|2141586|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0
1081346|NCT02137226|2141587|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0
1081347|NCT02137226|2141583|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1
1081348|NCT02137226|2141584|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0
1081349|NCT02137226|2141585|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0
1081350|NCT02137226|2141586|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0
1081351|NCT02137226|2141587|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0
1081352|NCT02137226|2141583|FG000|Period 1 (Initial Randomization)|Other Reason|1
1081353|NCT02137226|2141584|FG001|Period 1 (Initial Randomization)|Other Reason|3
1081354|NCT02137226|2141585|FG002|Period 1 (Initial Randomization)|Other Reason|0
1081355|NCT02137226|2141586|FG003|Period 1 (Initial Randomization)|Other Reason|0
1081356|NCT02137226|2141587|FG004|Period 1 (Initial Randomization)|Other Reason|0
1081357|NCT02137226|2141583|FG000|Period 2 (Re - Randomization)|Adverse Event|0
1081358|NCT02137226|2141584|FG001|Period 2 (Re - Randomization)|Adverse Event|0
1081359|NCT02137226|2141585|FG002|Period 2 (Re - Randomization)|Adverse Event|3
1081360|NCT02137226|2141586|FG003|Period 2 (Re - Randomization)|Adverse Event|1
1081361|NCT02137226|2141587|FG004|Period 2 (Re - Randomization)|Adverse Event|4
1081362|NCT02137226|2141583|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0
1081363|NCT02137226|2141584|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0
1081364|NCT02137226|2141585|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8
1081365|NCT02137226|2141586|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5
1081366|NCT02137226|2141587|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4
1081367|NCT02137226|2141583|FG000|Period 2 (Re - Randomization)|Physician Decision|0
1081368|NCT02137226|2141584|FG001|Period 2 (Re - Randomization)|Physician Decision|0
1081369|NCT02137226|2141585|FG002|Period 2 (Re - Randomization)|Physician Decision|0
1081370|NCT02137226|2141586|FG003|Period 2 (Re - Randomization)|Physician Decision|1
1081371|NCT02137226|2141587|FG004|Period 2 (Re - Randomization)|Physician Decision|0
1081372|NCT02137226|2141583|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0
1081373|NCT02137226|2141584|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0
1081374|NCT02137226|2141585|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3
1081375|NCT02137226|2141586|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0
1081376|NCT02137226|2141587|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0
1081377|NCT02137226|2141583|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0
1081378|NCT02137226|2141584|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0
1081379|NCT02137226|2141585|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2
1081380|NCT02137226|2141586|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0
1081381|NCT02137226|2141587|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0
1081382|NCT02137226|2141583|FG000|Period 2 (Re - Randomization)|Other Reason|0
1081383|NCT02137226|2141584|FG001|Period 2 (Re - Randomization)|Other Reason|0
1081384|NCT02137226|2141585|FG002|Period 2 (Re - Randomization)|Other Reason|1
1081385|NCT02137226|2141586|FG003|Period 2 (Re - Randomization)|Other Reason|1
1081386|NCT02137226|2141587|FG004|Period 2 (Re - Randomization)|Other Reason|1
1081387|NCT02137369|2141606|FG000|Overall Study|Withdrawal by Subject|3
1081388|NCT02137369|2141607|FG001|Overall Study|Withdrawal by Subject|2
1081389|NCT02137369|2141606|FG000|Overall Study|Adverse Event|2
1081390|NCT02137369|2141607|FG001|Overall Study|Adverse Event|0
1081391|NCT02137369|2141606|FG000|Overall Study|Lost to Follow-up|1
1081392|NCT02137369|2141607|FG001|Overall Study|Lost to Follow-up|0
1081393|NCT02137369|2141606|FG000|Overall Study|Moved away|2
1081394|NCT02137369|2141607|FG001|Overall Study|Moved away|0
1081395|NCT02137772|2141684|FG000|Overall Study|Adverse Event|6
1081396|NCT02137772|2141685|FG001|Overall Study|Adverse Event|3
1081397|NCT02137772|2141684|FG000|Overall Study|Death|71
1081398|NCT02137772|2141685|FG001|Overall Study|Death|44
1081399|NCT02137772|2141684|FG000|Overall Study|Lost to Follow-up|8
1081400|NCT02137772|2141685|FG001|Overall Study|Lost to Follow-up|4
1081401|NCT02137772|2141684|FG000|Overall Study|Physician Decision|15
1081402|NCT02137772|2141685|FG001|Overall Study|Physician Decision|5
1081403|NCT02137772|2141684|FG000|Overall Study|Withdrawal by Subject|28
1081404|NCT02137772|2141685|FG001|Overall Study|Withdrawal by Subject|17
1081405|NCT02137772|2141684|FG000|Overall Study|Non-compliance with study drug|1
1081406|NCT02137772|2141685|FG001|Overall Study|Non-compliance with study drug|0
1081407|NCT02137772|2141684|FG000|Overall Study|Not treated|3
1081408|NCT02137772|2141685|FG001|Overall Study|Not treated|2
1081409|NCT02137785|2141693|FG000|Overall Study|Lost to Follow-up|1
1081410|NCT02137785|2141694|FG001|Overall Study|Lost to Follow-up|0
1081411|NCT02137785|2141693|FG000|Overall Study|Withdrawal by Subject|1
1081412|NCT02137785|2141694|FG001|Overall Study|Withdrawal by Subject|4
1081413|NCT02137785|2141693|FG000|Overall Study|subject moved out of state|1
1081414|NCT02137785|2141694|FG001|Overall Study|subject moved out of state|0
1081415|NCT02137837|2141703|FG000|Overall Study|Adverse Event|0
1081416|NCT02137837|2141704|FG001|Overall Study|Adverse Event|2
1081417|NCT02137837|2141705|FG002|Overall Study|Adverse Event|1
1081418|NCT02137837|2141703|FG000|Overall Study|Refusal unrelated to adverse event|2
1081419|NCT02137837|2141704|FG001|Overall Study|Refusal unrelated to adverse event|2
1081420|NCT02137837|2141705|FG002|Overall Study|Refusal unrelated to adverse event|1
1081421|NCT02137837|2141703|FG000|Overall Study|Progression/relapse|9
1081422|NCT02137837|2141704|FG001|Overall Study|Progression/relapse|7
1081423|NCT02137837|2141705|FG002|Overall Study|Progression/relapse|7
1081424|NCT02137837|2141703|FG000|Overall Study|Not protocol specified|2
1081425|NCT02137837|2141704|FG001|Overall Study|Not protocol specified|1
1081426|NCT02137837|2141705|FG002|Overall Study|Not protocol specified|3
1081427|NCT02138110|2141770|FG000|Enrolled for Scaffold Implantation|Physician Decision|1
1081428|NCT02138110|2141770|FG000|Overall Scaffold Implantation|Death|3
1081429|NCT02138136|2141774|FG000|Overall Study|Protocol Violation|4
1081430|NCT02138136|2141774|FG000|Overall Study|Physician Decision|7
1081431|NCT02138136|2141774|FG000|Overall Study|Lack of Efficacy|35
1081432|NCT02138136|2141774|FG000|Overall Study|Pregnancy|2
1081433|NCT02138136|2141774|FG000|Overall Study|Adverse Event|18
1081434|NCT02138136|2141774|FG000|Overall Study|Withdrawal by Subject|36
1081435|NCT02138136|2141774|FG000|Overall Study|Lost to Follow-up|32
1081436|NCT02138136|2141774|FG000|Overall Study|Withdrawn by Sponsor|5
1081437|NCT02138214|2141782|FG000|Overall Study|Withdrawal by Subject|0
1081438|NCT02138214|2141783|FG001|Overall Study|Withdrawal by Subject|1
1081439|NCT02138214|2141784|FG002|Overall Study|Withdrawal by Subject|0
1081440|NCT02138214|2141782|FG000|Overall Study|Lost to Follow-up|0
1081441|NCT02138214|2141783|FG001|Overall Study|Lost to Follow-up|2
1081442|NCT02138214|2141784|FG002|Overall Study|Lost to Follow-up|4
1081443|NCT02138214|2141782|FG000|Overall Study|Screen Failure|0
1081444|NCT02138214|2141783|FG001|Overall Study|Screen Failure|1
1081445|NCT02138214|2141784|FG002|Overall Study|Screen Failure|0
1081446|NCT02138253|2141831|FG000|Overall Study|Adverse Event|3
1081447|NCT02138253|2141832|FG001|Overall Study|Adverse Event|3
1081448|NCT02138253|2141831|FG000|Overall Study|Lost to Follow-up|2
1081449|NCT02138253|2141832|FG001|Overall Study|Lost to Follow-up|1
1081450|NCT02138253|2141831|FG000|Overall Study|Physician Decision|2
1081451|NCT02138253|2141832|FG001|Overall Study|Physician Decision|0
1081452|NCT02138253|2141831|FG000|Overall Study|Non compliance|1
1081453|NCT02138253|2141832|FG001|Overall Study|Non compliance|0
1081454|NCT02138253|2141831|FG000|Overall Study|Withdrawal by Subject|1
1081455|NCT02138253|2141832|FG001|Overall Study|Withdrawal by Subject|0
1081456|NCT02138747|2141864|FG000|Treatment Period 1|Adverse Event|10
1081457|NCT02138747|2141865|FG001|Treatment Period 1|Adverse Event|14
1081458|NCT02138747|2141866|FG002|Treatment Period 1|Adverse Event|2
1081459|NCT02138747|2141867|FG003|Treatment Period 1|Adverse Event|1
1081460|NCT02138747|2141864|FG000|Treatment Period 1|Lost to Follow-up|0
1081461|NCT02138747|2141865|FG001|Treatment Period 1|Lost to Follow-up|1
1081462|NCT02138747|2141866|FG002|Treatment Period 1|Lost to Follow-up|1
1081463|NCT02138747|2141867|FG003|Treatment Period 1|Lost to Follow-up|0
1081464|NCT02138747|2141864|FG000|Treatment Period 1|Protocol Violation|0
1081465|NCT02138747|2141865|FG001|Treatment Period 1|Protocol Violation|2
1081466|NCT02138747|2141866|FG002|Treatment Period 1|Protocol Violation|0
1081467|NCT02138747|2141867|FG003|Treatment Period 1|Protocol Violation|0
1081468|NCT02138747|2141864|FG000|Treatment Period 1|Withdrawal by Subject|8
1081469|NCT02138747|2141865|FG001|Treatment Period 1|Withdrawal by Subject|4
1081470|NCT02138747|2141866|FG002|Treatment Period 1|Withdrawal by Subject|1
1081471|NCT02138747|2141867|FG003|Treatment Period 1|Withdrawal by Subject|3
1081472|NCT02138747|2141864|FG000|Treatment Period 1|Other - Miscellaneous|2
1081473|NCT02138747|2141865|FG001|Treatment Period 1|Other - Miscellaneous|4
1081474|NCT02138747|2141866|FG002|Treatment Period 1|Other - Miscellaneous|0
1081475|NCT02138747|2141867|FG003|Treatment Period 1|Other - Miscellaneous|0
1081476|NCT02138747|2141864|FG000|Treatment Period 2|Adverse Event|6
1081477|NCT02138747|2141865|FG001|Treatment Period 2|Adverse Event|3
1081478|NCT02138747|2141866|FG002|Treatment Period 2|Adverse Event|1
1081479|NCT02138747|2141867|FG003|Treatment Period 2|Adverse Event|1
1081480|NCT02138747|2141864|FG000|Treatment Period 2|Lost to Follow-up|2
1081481|NCT02138747|2141865|FG001|Treatment Period 2|Lost to Follow-up|0
1081482|NCT02138747|2141866|FG002|Treatment Period 2|Lost to Follow-up|0
1081483|NCT02138747|2141867|FG003|Treatment Period 2|Lost to Follow-up|0
1081484|NCT02138747|2141864|FG000|Treatment Period 2|Protocol Violation|1
1081485|NCT02138747|2141865|FG001|Treatment Period 2|Protocol Violation|0
1081486|NCT02138747|2141866|FG002|Treatment Period 2|Protocol Violation|0
1081487|NCT02138747|2141867|FG003|Treatment Period 2|Protocol Violation|0
1081488|NCT02138747|2141864|FG000|Treatment Period 2|Withdrawal by Subject|5
1081489|NCT02138747|2141865|FG001|Treatment Period 2|Withdrawal by Subject|4
1081490|NCT02138747|2141866|FG002|Treatment Period 2|Withdrawal by Subject|1
1081491|NCT02138747|2141867|FG003|Treatment Period 2|Withdrawal by Subject|2
1081492|NCT02138747|2141864|FG000|Treatment Period 2|Other - Miscellaneous|3
1081493|NCT02138747|2141865|FG001|Treatment Period 2|Other - Miscellaneous|0
1081494|NCT02138747|2141866|FG002|Treatment Period 2|Other - Miscellaneous|0
1081495|NCT02138747|2141867|FG003|Treatment Period 2|Other - Miscellaneous|0
1081496|NCT02138786|2141880|FG000|Overall Study|Adverse Event|0
1081497|NCT02138786|2141881|FG001|Overall Study|Adverse Event|2
1081498|NCT02138786|2141882|FG002|Overall Study|Adverse Event|1
1081499|NCT02138786|2141880|FG000|Overall Study|Death|1
1081500|NCT02138786|2141881|FG001|Overall Study|Death|7
1081501|NCT02138786|2141882|FG002|Overall Study|Death|2
1081502|NCT02138786|2141880|FG000|Overall Study|Disease Progression|1
1081503|NCT02138786|2141881|FG001|Overall Study|Disease Progression|1
1081504|NCT02138786|2141882|FG002|Overall Study|Disease Progression|3
1081505|NCT02138786|2141880|FG000|Overall Study|Withdrawal by Subject|1
1081506|NCT02138786|2141881|FG001|Overall Study|Withdrawal by Subject|2
1081507|NCT02138786|2141882|FG002|Overall Study|Withdrawal by Subject|0
1081508|NCT02138786|2141880|FG000|Overall Study|Patient's Wish|0
1081509|NCT02138786|2141881|FG001|Overall Study|Patient's Wish|2
1081510|NCT02138786|2141882|FG002|Overall Study|Patient's Wish|0
1081511|NCT02138786|2141880|FG000|Overall Study|Sponsor Terminated Study|0
1081512|NCT02138786|2141881|FG001|Overall Study|Sponsor Terminated Study|1
1081513|NCT02138786|2141882|FG002|Overall Study|Sponsor Terminated Study|1
1081514|NCT02138786|2141880|FG000|Overall Study|Non-Compliance|0
1081515|NCT02138786|2141881|FG001|Overall Study|Non-Compliance|0
1081516|NCT02138786|2141882|FG002|Overall Study|Non-Compliance|1
1081517|NCT02138825|2141890|FG000|Main Study Treatment|Adverse Event|11
1081518|NCT02138825|2141891|FG001|Main Study Treatment|Adverse Event|3
1081519|NCT02138825|2141890|FG000|Main Study Treatment|Death|1
1081520|NCT02138825|2141891|FG001|Main Study Treatment|Death|2
1081521|NCT02138825|2141890|FG000|Main Study Treatment|Protocol Violation|2
1081522|NCT02138825|2141891|FG001|Main Study Treatment|Protocol Violation|2
1081523|NCT02138825|2141890|FG000|Main Study Treatment|Sponsor decision|12
1081524|NCT02138825|2141891|FG001|Main Study Treatment|Sponsor decision|18
1081525|NCT02138825|2141890|FG000|Main Study Treatment|Study terminated by sponsor|10
1081526|NCT02138825|2141891|FG001|Main Study Treatment|Study terminated by sponsor|9
1081527|NCT02138825|2141890|FG000|Main Study Treatment|Withdrawal by Subject|3
1081528|NCT02138825|2141891|FG001|Main Study Treatment|Withdrawal by Subject|1
1081529|NCT02138825|2141890|FG000|Main Study Treatment|Medical decision|1
1081530|NCT02138825|2141891|FG001|Main Study Treatment|Medical decision|0
1081531|NCT02138825|2141890|FG000|Long-term Extension|Study termination by sponsor|32
1081532|NCT02138825|2141891|FG001|Long-term Extension|Study termination by sponsor|38
1081533|NCT02138825|2141890|FG000|Safety Follow-up|Adverse Event|4
1081534|NCT02138825|2141891|FG001|Safety Follow-up|Adverse Event|3
1081535|NCT02138825|2141890|FG000|Safety Follow-up|Death|11
1081536|NCT02138825|2141891|FG001|Safety Follow-up|Death|5
1081537|NCT02138825|2141890|FG000|Safety Follow-up|Withdrawal by Subject|5
1081538|NCT02138825|2141891|FG001|Safety Follow-up|Withdrawal by Subject|3
1081539|NCT02138825|2141890|FG000|Safety Follow-up|clinic worsening|1
1081540|NCT02138825|2141891|FG001|Safety Follow-up|clinic worsening|0
1081541|NCT02138825|2141890|FG000|Safety Follow-up|withdrawal by PI|1
1081542|NCT02138825|2141891|FG001|Safety Follow-up|withdrawal by PI|0
1081543|NCT02138825|2141890|FG000|Safety Follow-up|logistical difficulties|0
1081544|NCT02138825|2141891|FG001|Safety Follow-up|logistical difficulties|1
1081545|NCT02138825|2141890|FG000|Safety Follow-up|progressive disease|0
1081546|NCT02138825|2141891|FG001|Safety Follow-up|progressive disease|2
1081547|NCT02138825|2141890|FG000|Safety Follow-up|too unwell to attend the visit|0
1081548|NCT02138825|2141891|FG001|Safety Follow-up|too unwell to attend the visit|1
1081549|NCT02138825|2141890|FG000|Safety Follow-up|treatment unblinded|0
1081550|NCT02138825|2141891|FG001|Safety Follow-up|treatment unblinded|1
1081551|NCT02138825|2141890|FG000|Safety Follow-up|withdrawn due to lung transplant|0
1081552|NCT02138825|2141891|FG001|Safety Follow-up|withdrawn due to lung transplant|1
1081553|NCT02138838|2141904|FG000|Overall Study|Study Closure|7
1081554|NCT02138838|2141905|FG001|Overall Study|Study Closure|6
1081555|NCT02138838|2141904|FG000|Overall Study|Withdrawal by Subject|1
1081556|NCT02138838|2141905|FG001|Overall Study|Withdrawal by Subject|5
1081557|NCT02138890|2141913|FG000|Overall Study|Adverse Event|1
1081558|NCT02138890|2141914|FG001|Overall Study|Adverse Event|0
1081559|NCT02138916|2141924|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6
1081560|NCT02138916|2141925|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9
1081561|NCT02138916|2141926|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7
1081562|NCT02138916|2141924|FG000|Overall Study|Death|14
1081563|NCT02138916|2141925|FG001|Overall Study|Death|11
1081564|NCT02138916|2141926|FG002|Overall Study|Death|12
1081565|NCT02138916|2141924|FG000|Overall Study|Withdrawal by Subject|27
1081566|NCT02138916|2141925|FG001|Overall Study|Withdrawal by Subject|31
1081567|NCT02138916|2141926|FG002|Overall Study|Withdrawal by Subject|32
1081568|NCT02138916|2141924|FG000|Overall Study|Study specific withdrawal criteria|0
1081569|NCT02138916|2141925|FG001|Overall Study|Study specific withdrawal criteria|0
1081570|NCT02138916|2141926|FG002|Overall Study|Study specific withdrawal criteria|1
1081571|NCT02138916|2141924|FG000|Overall Study|incorrect enrolment|1
1081572|NCT02138916|2141925|FG001|Overall Study|incorrect enrolment|1
1081573|NCT02138916|2141926|FG002|Overall Study|incorrect enrolment|0
1081574|NCT02138916|2141924|FG000|Overall Study|Severe non-compliance|1
1081575|NCT02138916|2141925|FG001|Overall Study|Severe non-compliance|2
1081576|NCT02138916|2141926|FG002|Overall Study|Severe non-compliance|1
1081577|NCT02138916|2141924|FG000|Overall Study|Lost to Follow-up|4
1081578|NCT02138916|2141925|FG001|Overall Study|Lost to Follow-up|2
1081579|NCT02138916|2141926|FG002|Overall Study|Lost to Follow-up|3
1081580|NCT02138916|2141924|FG000|Overall Study|Adverse Event|4
1081581|NCT02138916|2141925|FG001|Overall Study|Adverse Event|4
1081582|NCT02138916|2141926|FG002|Overall Study|Adverse Event|3
1081583|NCT02139046|2141951|FG000|Overall Study|Pretreatment Event/Adverse Event|9
1081584|NCT02139046|2141952|FG001|Overall Study|Pretreatment Event/Adverse Event|9
1081585|NCT02139046|2141953|FG002|Overall Study|Pretreatment Event/Adverse Event|10
1081586|NCT02139046|2141954|FG003|Overall Study|Pretreatment Event/Adverse Event|13
1081587|NCT02139046|2141955|FG004|Overall Study|Pretreatment Event/Adverse Event|7
1081588|NCT02139046|2141951|FG000|Overall Study|Major Protocol Deviation|9
1081589|NCT02139046|2141952|FG001|Overall Study|Major Protocol Deviation|10
1081590|NCT02139046|2141953|FG002|Overall Study|Major Protocol Deviation|16
1081591|NCT02139046|2141954|FG003|Overall Study|Major Protocol Deviation|12
1081592|NCT02139046|2141955|FG004|Overall Study|Major Protocol Deviation|6
1081593|NCT02139046|2141951|FG000|Overall Study|Lost to Follow-up|13
1081594|NCT02139046|2141952|FG001|Overall Study|Lost to Follow-up|16
1081595|NCT02139046|2141953|FG002|Overall Study|Lost to Follow-up|16
1081596|NCT02139046|2141954|FG003|Overall Study|Lost to Follow-up|18
1081597|NCT02139046|2141955|FG004|Overall Study|Lost to Follow-up|13
1081598|NCT02139046|2141951|FG000|Overall Study|Voluntary Withdrawal|20
1081599|NCT02139046|2141952|FG001|Overall Study|Voluntary Withdrawal|8
1081600|NCT02139046|2141953|FG002|Overall Study|Voluntary Withdrawal|10
1081601|NCT02139046|2141954|FG003|Overall Study|Voluntary Withdrawal|15
1081602|NCT02139046|2141955|FG004|Overall Study|Voluntary Withdrawal|16
1081603|NCT02139046|2141951|FG000|Overall Study|Lack of Efficacy|0
1081604|NCT02139046|2141952|FG001|Overall Study|Lack of Efficacy|1
1081605|NCT02139046|2141953|FG002|Overall Study|Lack of Efficacy|2
1081606|NCT02139046|2141954|FG003|Overall Study|Lack of Efficacy|1
1081607|NCT02139046|2141955|FG004|Overall Study|Lack of Efficacy|2
1081608|NCT02139046|2141951|FG000|Overall Study|Withdrawal due to a Gout Flare|1
1081609|NCT02139046|2141952|FG001|Overall Study|Withdrawal due to a Gout Flare|1
1081610|NCT02139046|2141953|FG002|Overall Study|Withdrawal due to a Gout Flare|1
1081611|NCT02139046|2141954|FG003|Overall Study|Withdrawal due to a Gout Flare|0
1081612|NCT02139046|2141955|FG004|Overall Study|Withdrawal due to a Gout Flare|1
1081613|NCT02139046|2141951|FG000|Overall Study|Other Miscellaneous Reasons|10
1081614|NCT02139046|2141952|FG001|Overall Study|Other Miscellaneous Reasons|9
1081615|NCT02139046|2141953|FG002|Overall Study|Other Miscellaneous Reasons|4
1081616|NCT02139046|2141954|FG003|Overall Study|Other Miscellaneous Reasons|9
1081617|NCT02139046|2141955|FG004|Overall Study|Other Miscellaneous Reasons|12
1081618|NCT02139124|2141972|FG000|Overall Study|Adverse Event|2
1081619|NCT02139124|2141973|FG001|Overall Study|Adverse Event|0
1081620|NCT02139124|2141974|FG002|Overall Study|Adverse Event|1
1081621|NCT02139124|2141975|FG003|Overall Study|Adverse Event|2
1081622|NCT02139124|2141976|FG004|Overall Study|Adverse Event|5
1081623|NCT02139124|2141972|FG000|Overall Study|Withdrawal by Subject|2
1081624|NCT02139124|2141973|FG001|Overall Study|Withdrawal by Subject|2
1081625|NCT02139124|2141974|FG002|Overall Study|Withdrawal by Subject|2
1081626|NCT02139124|2141975|FG003|Overall Study|Withdrawal by Subject|2
1081627|NCT02139124|2141976|FG004|Overall Study|Withdrawal by Subject|3
1081628|NCT02139124|2141972|FG000|Overall Study|Protocol Violation|0
1081629|NCT02139124|2141973|FG001|Overall Study|Protocol Violation|0
1081630|NCT02139124|2141974|FG002|Overall Study|Protocol Violation|0
1081631|NCT02139124|2141975|FG003|Overall Study|Protocol Violation|1
1081632|NCT02139124|2141976|FG004|Overall Study|Protocol Violation|1
1081633|NCT02139124|2141972|FG000|Overall Study|non-compliant|1
1081634|NCT02139124|2141973|FG001|Overall Study|non-compliant|0
1081635|NCT02139124|2141974|FG002|Overall Study|non-compliant|0
1081636|NCT02139124|2141975|FG003|Overall Study|non-compliant|2
1081637|NCT02139124|2141976|FG004|Overall Study|non-compliant|0
909525|NCT00788957|1886289|FG005|Part 2|Lost to Follow-up|0
909526|NCT00788957|1886284|FG000|Part 2|On-study at time of data cut-off|0
909527|NCT00788957|1886285|FG001|Part 2|On-study at time of data cut-off|1
909528|NCT00788957|1886286|FG002|Part 2|On-study at time of data cut-off|1
909529|NCT00788957|1886287|FG003|Part 2|On-study at time of data cut-off|1
909530|NCT00788957|1886288|FG004|Part 2|On-study at time of data cut-off|0
909531|NCT00788957|1886289|FG005|Part 2|On-study at time of data cut-off|0
909532|NCT00788957|1886284|FG000|Part 3|Withdrawal by Subject|0
909533|NCT00788957|1886285|FG001|Part 3|Withdrawal by Subject|0
909534|NCT00788957|1886286|FG002|Part 3|Withdrawal by Subject|0
909535|NCT00788957|1886287|FG003|Part 3|Withdrawal by Subject|0
909536|NCT00788957|1886288|FG004|Part 3|Withdrawal by Subject|0
909537|NCT00788957|1886289|FG005|Part 3|Withdrawal by Subject|2
909538|NCT00788957|1886284|FG000|Part 3|Death|0
909539|NCT00788957|1886285|FG001|Part 3|Death|0
909540|NCT00788957|1886286|FG002|Part 3|Death|0
909541|NCT00788957|1886287|FG003|Part 3|Death|0
909542|NCT00788957|1886288|FG004|Part 3|Death|8
909543|NCT00788957|1886289|FG005|Part 3|Death|9
909544|NCT00788957|1886284|FG000|Part 3|On-study at time of data cut-off|0
909545|NCT00788957|1886285|FG001|Part 3|On-study at time of data cut-off|0
909546|NCT00788957|1886286|FG002|Part 3|On-study at time of data cut-off|0
909547|NCT00788957|1886287|FG003|Part 3|On-study at time of data cut-off|0
909548|NCT00788957|1886288|FG004|Part 3|On-study at time of data cut-off|1
909549|NCT00788957|1886289|FG005|Part 3|On-study at time of data cut-off|0
909550|NCT00789035|1886311|FG000|Overall Study|Adverse Event|0
909551|NCT00789035|1886312|FG001|Overall Study|Adverse Event|2
1081638|NCT02139124|2141972|FG000|Overall Study|incarceration|0
1081639|NCT02139124|2141973|FG001|Overall Study|incarceration|0
1081640|NCT02139124|2141974|FG002|Overall Study|incarceration|1
1081641|NCT02139124|2141975|FG003|Overall Study|incarceration|0
1081642|NCT02139124|2141976|FG004|Overall Study|incarceration|0
1081643|NCT02139124|2141972|FG000|Overall Study|subject moved|1
1081644|NCT02139124|2141973|FG001|Overall Study|subject moved|0
1081645|NCT02139124|2141974|FG002|Overall Study|subject moved|0
1081646|NCT02139124|2141975|FG003|Overall Study|subject moved|0
1081647|NCT02139124|2141976|FG004|Overall Study|subject moved|0
1081648|NCT02139124|2141972|FG000|Overall Study|Lost to Follow-up|3
1081649|NCT02139124|2141973|FG001|Overall Study|Lost to Follow-up|2
1081650|NCT02139124|2141974|FG002|Overall Study|Lost to Follow-up|0
1081651|NCT02139124|2141975|FG003|Overall Study|Lost to Follow-up|5
1081652|NCT02139124|2141976|FG004|Overall Study|Lost to Follow-up|4
1081653|NCT02139280|2142018|FG000|Overall Study|No longer eligible|2
1081654|NCT02139280|2142019|FG001|Overall Study|No longer eligible|0
1081655|NCT02139306|2142027|FG000|Overall Study|Withdrawal by Subject|4
1081656|NCT02139306|2142028|FG001|Overall Study|Withdrawal by Subject|6
1081657|NCT02139306|2142027|FG000|Overall Study|Adverse Event|3
1081658|NCT02139306|2142028|FG001|Overall Study|Adverse Event|4
1081659|NCT02139306|2142027|FG000|Overall Study|Physician Decision|0
1081660|NCT02139306|2142028|FG001|Overall Study|Physician Decision|1
1081661|NCT02139306|2142027|FG000|Overall Study|Other Unspecified|2
1081662|NCT02139306|2142028|FG001|Overall Study|Other Unspecified|3
1081663|NCT02139306|2142027|FG000|Overall Study|Protocol Violation|4
1081664|NCT02139306|2142028|FG001|Overall Study|Protocol Violation|0
1081665|NCT02139592|2142048|FG000|Overall Study|Case Report Forms Uncollected|8
1081666|NCT02139644|2142057|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70
1081667|NCT02139644|2142058|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1081668|NCT02139644|2142059|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1081669|NCT02139644|2142060|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1081670|NCT02139644|2142061|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1081671|NCT02139644|2142062|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1081672|NCT02139644|2142057|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
1081673|NCT02139644|2142058|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1081674|NCT02139644|2142059|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1081675|NCT02139644|2142060|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1081676|NCT02139644|2142061|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1081677|NCT02139644|2142062|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1081678|NCT02139644|2142057|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
1081679|NCT02139644|2142058|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1081680|NCT02139644|2142059|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1081681|NCT02139644|2142060|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1081682|NCT02139644|2142061|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1081683|NCT02139644|2142062|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1081684|NCT02139644|2142057|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11
1081685|NCT02139644|2142058|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1081686|NCT02139644|2142059|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1081687|NCT02139644|2142060|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1081688|NCT02139644|2142061|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1081689|NCT02139644|2142062|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1081690|NCT02139644|2142057|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8
1081691|NCT02139644|2142058|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1081692|NCT02139644|2142059|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1081693|NCT02139644|2142060|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1081694|NCT02139644|2142061|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1081695|NCT02139644|2142062|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1081696|NCT02139644|2142057|FG000|Run-In Period (Pre-assignment)|Adverse Event|3
1081697|NCT02139644|2142058|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
1081698|NCT02139644|2142059|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
1081699|NCT02139644|2142060|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
1081700|NCT02139644|2142061|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
1081701|NCT02139644|2142062|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
1081702|NCT02139644|2142057|FG000|Run-In Period (Pre-assignment)|Other|6
1081703|NCT02139644|2142058|FG001|Run-In Period (Pre-assignment)|Other|0
1081704|NCT02139644|2142059|FG002|Run-In Period (Pre-assignment)|Other|0
1081705|NCT02139644|2142060|FG003|Run-In Period (Pre-assignment)|Other|0
1081706|NCT02139644|2142061|FG004|Run-In Period (Pre-assignment)|Other|0
1081707|NCT02139644|2142062|FG005|Run-In Period (Pre-assignment)|Other|0
1081708|NCT02139644|2142057|FG000|Treatment Period|Adverse Event|0
1081709|NCT02139644|2142058|FG001|Treatment Period|Adverse Event|0
1081710|NCT02139644|2142059|FG002|Treatment Period|Adverse Event|3
1081711|NCT02139644|2142060|FG003|Treatment Period|Adverse Event|2
1081712|NCT02139644|2142061|FG004|Treatment Period|Adverse Event|1
1081713|NCT02139644|2142062|FG005|Treatment Period|Adverse Event|6
1081714|NCT02139644|2142057|FG000|Treatment Period|Withdrawal by Subject|0
1081715|NCT02139644|2142058|FG001|Treatment Period|Withdrawal by Subject|0
1081716|NCT02139644|2142059|FG002|Treatment Period|Withdrawal by Subject|2
1081717|NCT02139644|2142060|FG003|Treatment Period|Withdrawal by Subject|2
1081718|NCT02139644|2142061|FG004|Treatment Period|Withdrawal by Subject|3
1081719|NCT02139644|2142062|FG005|Treatment Period|Withdrawal by Subject|2
1081720|NCT02139644|2142057|FG000|Treatment Period|Non-compliance|0
1081721|NCT02139644|2142058|FG001|Treatment Period|Non-compliance|0
1081722|NCT02139644|2142059|FG002|Treatment Period|Non-compliance|0
1081723|NCT02139644|2142060|FG003|Treatment Period|Non-compliance|1
1081724|NCT02139644|2142061|FG004|Treatment Period|Non-compliance|0
1081725|NCT02139644|2142062|FG005|Treatment Period|Non-compliance|0
1081726|NCT02139644|2142057|FG000|Treatment Period|Protocol Violation|0
1081727|NCT02139644|2142058|FG001|Treatment Period|Protocol Violation|0
1081728|NCT02139644|2142059|FG002|Treatment Period|Protocol Violation|0
1081729|NCT02139644|2142060|FG003|Treatment Period|Protocol Violation|1
1081730|NCT02139644|2142061|FG004|Treatment Period|Protocol Violation|1
1081731|NCT02139644|2142062|FG005|Treatment Period|Protocol Violation|1
1081732|NCT02139644|2142057|FG000|Treatment Period|Disease progression|0
1081733|NCT02139644|2142058|FG001|Treatment Period|Disease progression|0
1081734|NCT02139644|2142059|FG002|Treatment Period|Disease progression|0
1081735|NCT02139644|2142060|FG003|Treatment Period|Disease progression|1
1081736|NCT02139644|2142061|FG004|Treatment Period|Disease progression|1
1081737|NCT02139644|2142062|FG005|Treatment Period|Disease progression|2
1081738|NCT02139644|2142057|FG000|Treatment Period|Lost to Follow-up|0
1081739|NCT02139644|2142058|FG001|Treatment Period|Lost to Follow-up|0
1081740|NCT02139644|2142059|FG002|Treatment Period|Lost to Follow-up|1
1081741|NCT02139644|2142060|FG003|Treatment Period|Lost to Follow-up|1
1081742|NCT02139644|2142061|FG004|Treatment Period|Lost to Follow-up|1
1081743|NCT02139644|2142062|FG005|Treatment Period|Lost to Follow-up|1
1081744|NCT02139644|2142057|FG000|Treatment Period|Lack of Efficacy|0
1081745|NCT02139644|2142058|FG001|Treatment Period|Lack of Efficacy|0
1081746|NCT02139644|2142059|FG002|Treatment Period|Lack of Efficacy|1
1081747|NCT02139644|2142060|FG003|Treatment Period|Lack of Efficacy|0
1081748|NCT02139644|2142061|FG004|Treatment Period|Lack of Efficacy|1
1081749|NCT02139644|2142062|FG005|Treatment Period|Lack of Efficacy|4
1081750|NCT02139644|2142057|FG000|Treatment Period|Other|0
1081751|NCT02139644|2142058|FG001|Treatment Period|Other|3
1081752|NCT02139644|2142059|FG002|Treatment Period|Other|1
1081753|NCT02139644|2142060|FG003|Treatment Period|Other|1
1081754|NCT02139644|2142061|FG004|Treatment Period|Other|0
1081755|NCT02139644|2142062|FG005|Treatment Period|Other|1
1081756|NCT02139826|2142083|FG000|Overall Study|Adverse Event|1
1081757|NCT02139943|2142103|FG000|Overall Study|Adverse Event|0
1081758|NCT02139943|2142104|FG001|Overall Study|Adverse Event|1
1081759|NCT02139943|2142105|FG002|Overall Study|Adverse Event|2
1081760|NCT02139943|2142103|FG000|Overall Study|Lost to Follow-up|3
1081761|NCT02139943|2142104|FG001|Overall Study|Lost to Follow-up|2
1081762|NCT02139943|2142105|FG002|Overall Study|Lost to Follow-up|2
1081763|NCT02139943|2142103|FG000|Overall Study|Withdrawal by Subject|4
1081764|NCT02139943|2142104|FG001|Overall Study|Withdrawal by Subject|3
1081765|NCT02139943|2142105|FG002|Overall Study|Withdrawal by Subject|0
1081766|NCT02139943|2142103|FG000|Overall Study|Other|0
1081767|NCT02139943|2142104|FG001|Overall Study|Other|0
1081768|NCT02139943|2142105|FG002|Overall Study|Other|1
1081769|NCT02139943|2142103|FG000|Overall Study|Participant wishes to discontinue|2
1081770|NCT02139943|2142104|FG001|Overall Study|Participant wishes to discontinue|0
1081771|NCT02139943|2142105|FG002|Overall Study|Participant wishes to discontinue|0
1081772|NCT02139943|2142103|FG000|Overall Study|Participant in Poor Compliance|1
1081773|NCT02139943|2142104|FG001|Overall Study|Participant in Poor Compliance|0
1081774|NCT02139943|2142105|FG002|Overall Study|Participant in Poor Compliance|1
1081775|NCT02139943|2142103|FG000|Overall Study|eGFR Withdrawal Criteria|0
1081776|NCT02139943|2142104|FG001|Overall Study|eGFR Withdrawal Criteria|0
1081777|NCT02139943|2142105|FG002|Overall Study|eGFR Withdrawal Criteria|1
1081778|NCT02139982|2142127|FG000|Overall Study|Lack of Efficacy|0
1081779|NCT02139982|2142128|FG001|Overall Study|Lack of Efficacy|1
1081780|NCT02139982|2142129|FG002|Overall Study|Lack of Efficacy|0
1081781|NCT02139982|2142130|FG003|Overall Study|Lack of Efficacy|1
1081782|NCT02139982|2142131|FG004|Overall Study|Lack of Efficacy|0
1081783|NCT02139982|2142132|FG005|Overall Study|Lack of Efficacy|0
1081784|NCT02139982|2142133|FG006|Overall Study|Lack of Efficacy|0
1081785|NCT02139982|2142134|FG007|Overall Study|Lack of Efficacy|0
1081786|NCT02139982|2142135|FG008|Overall Study|Lack of Efficacy|0
1081787|NCT02139982|2142136|FG009|Overall Study|Lack of Efficacy|0
1081788|NCT02140060|2142164|FG000|Overall Study|Adverse Event|0
1081789|NCT02140060|2142165|FG001|Overall Study|Adverse Event|0
1081790|NCT02140060|2142166|FG002|Overall Study|Adverse Event|0
1081791|NCT02140060|2142167|FG003|Overall Study|Adverse Event|1
1081792|NCT02140060|2142168|FG004|Overall Study|Adverse Event|1
1081793|NCT02140060|2142169|FG005|Overall Study|Adverse Event|1
1081794|NCT02140060|2142164|FG000|Overall Study|Lack of Efficacy|0
1081795|NCT02140060|2142165|FG001|Overall Study|Lack of Efficacy|0
1081796|NCT02140060|2142166|FG002|Overall Study|Lack of Efficacy|0
1081797|NCT02140060|2142167|FG003|Overall Study|Lack of Efficacy|1
1081798|NCT02140060|2142168|FG004|Overall Study|Lack of Efficacy|0
1081799|NCT02140060|2142169|FG005|Overall Study|Lack of Efficacy|0
1081800|NCT02140164|2142184|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2
1081801|NCT02140411|2142192|FG000|Overall Study|Adverse Event|1
1081802|NCT02140567|2142196|FG000|Overall Study|Problems with recording equipment|6
1081803|NCT02140645|2142216|FG000|Overall Study|Not linked|5489
1081804|NCT02140645|2142217|FG001|Overall Study|Not linked|61654
1081805|NCT02140645|2142218|FG002|Overall Study|Not linked|4236
1081806|NCT02140645|2142219|FG003|Overall Study|Not linked|13833
1081807|NCT02140645|2142220|FG004|Overall Study|Not linked|3286
1081808|NCT02140645|2142221|FG005|Overall Study|Not linked|70896
1081809|NCT02140762|2142232|FG000|Overall Study|Adverse Event|1
1081810|NCT02140762|2142233|FG001|Overall Study|Adverse Event|1
1081811|NCT02140762|2142232|FG000|Overall Study|Lost to Follow-up|9
1081812|NCT02140762|2142233|FG001|Overall Study|Lost to Follow-up|5
1081813|NCT02140762|2142232|FG000|Overall Study|Protocol Violation|1
1081814|NCT02140762|2142233|FG001|Overall Study|Protocol Violation|1
1081815|NCT02140762|2142232|FG000|Overall Study|Withdrawal by Subject|6
1081816|NCT02140762|2142233|FG001|Overall Study|Withdrawal by Subject|4
1081817|NCT02140762|2142232|FG000|Overall Study|Other|0
1081818|NCT02140762|2142233|FG001|Overall Study|Other|1
1081819|NCT02140775|2142246|FG000|Overall Study|Withdrawal by Subject|30
1081820|NCT02140775|2142247|FG001|Overall Study|Withdrawal by Subject|7
1081821|NCT02140970|2142266|FG000|Overall Study|Lost to Follow-up|1
1081822|NCT02140970|2142267|FG001|Overall Study|Lost to Follow-up|2
1081823|NCT02140970|2142266|FG000|Overall Study|Misplaced consent, subject withdrawn|1
1081824|NCT02140970|2142267|FG001|Overall Study|Misplaced consent, subject withdrawn|0
1081825|NCT02140970|2142266|FG000|Overall Study|Did not meet inclusion criteria|0
1081826|NCT02140970|2142267|FG001|Overall Study|Did not meet inclusion criteria|1
1081827|NCT02141204|2142275|FG000|Overall Study|Lost to Follow-up|2
1081828|NCT02141204|2142276|FG001|Overall Study|Lost to Follow-up|1
1081829|NCT02141204|2142275|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1
1081830|NCT02141204|2142276|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2
1081831|NCT02141204|2142275|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
1081832|NCT02141204|2142276|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5
1081833|NCT02141204|2142275|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9
1081834|NCT02141204|2142276|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7
1081835|NCT02141217|2142284|FG000|Overall Study|Adverse Event|1
1081836|NCT02141217|2142285|FG001|Overall Study|Adverse Event|2
1081837|NCT02141217|2142284|FG000|Overall Study|Protocol Violation|1
1081838|NCT02141217|2142285|FG001|Overall Study|Protocol Violation|4
1081839|NCT02141217|2142284|FG000|Overall Study|Withdrawal by Subject|6
1081840|NCT02141217|2142285|FG001|Overall Study|Withdrawal by Subject|0
1081841|NCT02141217|2142284|FG000|Overall Study|Lost to Follow-up|1
1081842|NCT02141217|2142285|FG001|Overall Study|Lost to Follow-up|1
1081843|NCT02141217|2142284|FG000|Overall Study|Physician Decision|1
1081844|NCT02141217|2142285|FG001|Overall Study|Physician Decision|0
1081845|NCT02141217|2142284|FG000|Overall Study|Surgical Intervention|1
1081846|NCT02141217|2142285|FG001|Overall Study|Surgical Intervention|1
1081847|NCT02141295|2142297|FG000|Overall Study|Adverse Event|1
1081848|NCT02141295|2142298|FG001|Overall Study|Adverse Event|18
1081849|NCT02141295|2142299|FG002|Overall Study|Adverse Event|11
1081850|NCT02141295|2142297|FG000|Overall Study|Physician Decision|2
1081851|NCT02141295|2142298|FG001|Overall Study|Physician Decision|19
1081852|NCT02141295|2142299|FG002|Overall Study|Physician Decision|14
1081853|NCT02141295|2142297|FG000|Overall Study|Study terminated by sponsor|0
1081854|NCT02141295|2142298|FG001|Overall Study|Study terminated by sponsor|6
1081855|NCT02141295|2142299|FG002|Overall Study|Study terminated by sponsor|6
1081856|NCT02141295|2142297|FG000|Overall Study|Non-compliance|0
1081857|NCT02141295|2142298|FG001|Overall Study|Non-compliance|1
1081858|NCT02141295|2142299|FG002|Overall Study|Non-compliance|0
1081859|NCT02141295|2142297|FG000|Overall Study|Progressive disease|3
1081860|NCT02141295|2142298|FG001|Overall Study|Progressive disease|32
1081861|NCT02141295|2142299|FG002|Overall Study|Progressive disease|50
1081862|NCT02141295|2142297|FG000|Overall Study|Reason not specified|0
1081863|NCT02141295|2142298|FG001|Overall Study|Reason not specified|9
1081864|NCT02141295|2142299|FG002|Overall Study|Reason not specified|10
1081865|NCT02141295|2142297|FG000|Overall Study|Withdrawal by Subject|0
1081866|NCT02141295|2142298|FG001|Overall Study|Withdrawal by Subject|9
1081867|NCT02141295|2142299|FG002|Overall Study|Withdrawal by Subject|4
1081868|NCT02141360|2142311|FG000|Overall Study|Withdrawal by Subject|6
1081869|NCT02141360|2142312|FG001|Overall Study|Withdrawal by Subject|0
1081870|NCT02141360|2142313|FG002|Overall Study|Withdrawal by Subject|0
1081871|NCT02141360|2142311|FG000|Overall Study|Study Terminated before Visit|1
1081872|NCT02141360|2142312|FG001|Overall Study|Study Terminated before Visit|0
1081873|NCT02141360|2142313|FG002|Overall Study|Study Terminated before Visit|0
1081874|NCT02141399|2142321|FG000|Overall Study|Adverse Event|158
1081875|NCT02141399|2142321|FG000|Overall Study|Lack of Efficacy|62
1081876|NCT02141399|2142321|FG000|Overall Study|Lost to Follow-up|151
1081877|NCT02141399|2142321|FG000|Overall Study|Non-compliance with study drug|18
1081878|NCT02141399|2142321|FG000|Overall Study|Other|45
1081879|NCT02141399|2142321|FG000|Overall Study|Physician Decision|17
1081880|NCT02141399|2142321|FG000|Overall Study|Pregnancy|3
1081881|NCT02141399|2142321|FG000|Overall Study|Protocol Violation|38
1081882|NCT02141399|2142321|FG000|Overall Study|Withdrawal by Subject|238
1081883|NCT02141399|2142321|FG000|Overall Study|Failure to meet eligibility criteria|14
1081884|NCT02141490|2142348|FG000|Overall Study|Screening failures|4
1081885|NCT02141490|2142349|FG001|Overall Study|Screening failures|0
1081886|NCT02141490|2142350|FG002|Overall Study|Screening failures|0
1081887|NCT02141516|2142363|FG000|Overall Study|Adverse Event|0
1081888|NCT02141516|2142364|FG001|Overall Study|Adverse Event|1
1081889|NCT02141516|2142365|FG002|Overall Study|Adverse Event|0
1081890|NCT02141516|2142363|FG000|Overall Study|Lost to Follow-up|0
1081891|NCT02141516|2142364|FG001|Overall Study|Lost to Follow-up|1
1081892|NCT02141516|2142365|FG002|Overall Study|Lost to Follow-up|0
1081893|NCT02141516|2142363|FG000|Overall Study|Other|0
1081894|NCT02141516|2142364|FG001|Overall Study|Other|3
1081895|NCT02141516|2142365|FG002|Overall Study|Other|0
1081896|NCT02141620|2142399|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1
1081897|NCT02141620|2142400|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0
1081898|NCT02141633|2142408|FG000|Overall Study|Physician Decision|1
1081899|NCT02141633|2142409|FG001|Overall Study|Physician Decision|0
1081900|NCT02141659|2142421|FG000|Overall Study|Major Protocol Deviation|0
1081901|NCT02141659|2142422|FG001|Overall Study|Major Protocol Deviation|1
1081902|NCT02141659|2142423|FG002|Overall Study|Major Protocol Deviation|0
1081903|NCT02141659|2142424|FG003|Overall Study|Major Protocol Deviation|0
1081904|NCT02141659|2142425|FG004|Overall Study|Major Protocol Deviation|0
1081905|NCT02141659|2142426|FG005|Overall Study|Major Protocol Deviation|0
1081906|NCT02141659|2142421|FG000|Overall Study|Lack of Efficacy|0
1081907|NCT02141659|2142422|FG001|Overall Study|Lack of Efficacy|0
1081908|NCT02141659|2142423|FG002|Overall Study|Lack of Efficacy|0
1081909|NCT02141659|2142424|FG003|Overall Study|Lack of Efficacy|0
1081910|NCT02141659|2142425|FG004|Overall Study|Lack of Efficacy|0
1081911|NCT02141659|2142426|FG005|Overall Study|Lack of Efficacy|1
1081912|NCT02141659|2142421|FG000|Overall Study|Pretreatment Event/ Adverse Event|0
1081913|NCT02141659|2142422|FG001|Overall Study|Pretreatment Event/ Adverse Event|0
1081914|NCT02141659|2142423|FG002|Overall Study|Pretreatment Event/ Adverse Event|0
1081915|NCT02141659|2142424|FG003|Overall Study|Pretreatment Event/ Adverse Event|0
1081916|NCT02141659|2142425|FG004|Overall Study|Pretreatment Event/ Adverse Event|2
1081917|NCT02141659|2142426|FG005|Overall Study|Pretreatment Event/ Adverse Event|1
1081918|NCT02141672|2142443|FG000|Overall Study|Adverse Event|0
1081919|NCT02141672|2142444|FG001|Overall Study|Adverse Event|1
1081920|NCT02141672|2142445|FG002|Overall Study|Adverse Event|0
1081921|NCT02141672|2142443|FG000|Overall Study|Death|10
1081922|NCT02141672|2142444|FG001|Overall Study|Death|2
1081923|NCT02141672|2142445|FG002|Overall Study|Death|1
1081924|NCT02141672|2142443|FG000|Overall Study|Lack of Efficacy|0
1081925|NCT02141672|2142444|FG001|Overall Study|Lack of Efficacy|0
1081926|NCT02141672|2142445|FG002|Overall Study|Lack of Efficacy|2
1081927|NCT02141672|2142443|FG000|Overall Study|Lost to Follow-up|1
1081928|NCT02141672|2142444|FG001|Overall Study|Lost to Follow-up|1
1081929|NCT02141672|2142445|FG002|Overall Study|Lost to Follow-up|3
1081930|NCT02141672|2142443|FG000|Overall Study|Physician Decision|1
1081931|NCT02141672|2142444|FG001|Overall Study|Physician Decision|2
1081932|NCT02141672|2142445|FG002|Overall Study|Physician Decision|5
1081933|NCT02141672|2142443|FG000|Overall Study|Protocol Violation|0
1081934|NCT02141672|2142444|FG001|Overall Study|Protocol Violation|0
1081935|NCT02141672|2142445|FG002|Overall Study|Protocol Violation|1
1081936|NCT02141672|2142443|FG000|Overall Study|Withdrawal by Subject|3
1081937|NCT02141672|2142444|FG001|Overall Study|Withdrawal by Subject|2
1081938|NCT02141672|2142445|FG002|Overall Study|Withdrawal by Subject|5
1081939|NCT02141672|2142443|FG000|Overall Study|refused to follow-up|1
1081940|NCT02141672|2142444|FG001|Overall Study|refused to follow-up|0
1081941|NCT02141672|2142445|FG002|Overall Study|refused to follow-up|1
1081942|NCT02141854|2142458|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
1081943|NCT02141854|2142459|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1081944|NCT02141854|2142460|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1081945|NCT02141854|2142461|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1081946|NCT02141854|2142462|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1081947|NCT02141854|2142463|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1081948|NCT02141854|2142458|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76
1081949|NCT02141854|2142459|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1081950|NCT02141854|2142460|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1081951|NCT02141854|2142461|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1081952|NCT02141854|2142462|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1081953|NCT02141854|2142463|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1081954|NCT02141854|2142458|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14
1081955|NCT02141854|2142459|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1081956|NCT02141854|2142460|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1081957|NCT02141854|2142461|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1081958|NCT02141854|2142462|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1081959|NCT02141854|2142463|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1081960|NCT02141854|2142458|FG000|Run-In Period (Pre-assignment)|Other|14
1081961|NCT02141854|2142459|FG001|Run-In Period (Pre-assignment)|Other|0
1081962|NCT02141854|2142460|FG002|Run-In Period (Pre-assignment)|Other|0
1081963|NCT02141854|2142461|FG003|Run-In Period (Pre-assignment)|Other|0
1081964|NCT02141854|2142462|FG004|Run-In Period (Pre-assignment)|Other|0
1081965|NCT02141854|2142463|FG005|Run-In Period (Pre-assignment)|Other|0
1162048|NCT03381248|2283986|FG001|Overall Study|Adverse Event|0
1081966|NCT02141854|2142458|FG000|Run-In Period (Pre-assignment)|Adverse Event|10
1081967|NCT02141854|2142459|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
1081968|NCT02141854|2142460|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
1081969|NCT02141854|2142461|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
1081970|NCT02141854|2142462|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
1081971|NCT02141854|2142463|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
1081972|NCT02141854|2142458|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
1081973|NCT02141854|2142459|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1081974|NCT02141854|2142460|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1081975|NCT02141854|2142461|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1081976|NCT02141854|2142462|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1081977|NCT02141854|2142463|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1081978|NCT02141854|2142458|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
1081979|NCT02141854|2142459|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1081980|NCT02141854|2142460|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1081981|NCT02141854|2142461|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1081982|NCT02141854|2142462|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1081983|NCT02141854|2142463|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1081984|NCT02141854|2142458|FG000|Treatment Period|Protocol Violation|0
1081985|NCT02141854|2142459|FG001|Treatment Period|Protocol Violation|1
1081986|NCT02141854|2142460|FG002|Treatment Period|Protocol Violation|0
1081987|NCT02141854|2142461|FG003|Treatment Period|Protocol Violation|2
1081988|NCT02141854|2142462|FG004|Treatment Period|Protocol Violation|2
1081989|NCT02141854|2142463|FG005|Treatment Period|Protocol Violation|1
1081990|NCT02141854|2142458|FG000|Treatment Period|Noncompliance|0
1081991|NCT02141854|2142459|FG001|Treatment Period|Noncompliance|0
1081992|NCT02141854|2142460|FG002|Treatment Period|Noncompliance|0
1081993|NCT02141854|2142461|FG003|Treatment Period|Noncompliance|1
1081994|NCT02141854|2142462|FG004|Treatment Period|Noncompliance|0
1081995|NCT02141854|2142463|FG005|Treatment Period|Noncompliance|0
1081996|NCT02141854|2142458|FG000|Treatment Period|Lack of Efficacy|0
1081997|NCT02141854|2142459|FG001|Treatment Period|Lack of Efficacy|0
1081998|NCT02141854|2142460|FG002|Treatment Period|Lack of Efficacy|0
1081999|NCT02141854|2142461|FG003|Treatment Period|Lack of Efficacy|1
1082000|NCT02141854|2142462|FG004|Treatment Period|Lack of Efficacy|1
1082001|NCT02141854|2142463|FG005|Treatment Period|Lack of Efficacy|7
1082002|NCT02141854|2142458|FG000|Treatment Period|Pregnancy|0
1082003|NCT02141854|2142459|FG001|Treatment Period|Pregnancy|1
1082004|NCT02141854|2142460|FG002|Treatment Period|Pregnancy|0
1082005|NCT02141854|2142461|FG003|Treatment Period|Pregnancy|0
1082006|NCT02141854|2142462|FG004|Treatment Period|Pregnancy|0
1082007|NCT02141854|2142463|FG005|Treatment Period|Pregnancy|0
1082008|NCT02141854|2142458|FG000|Treatment Period|Other|0
1082009|NCT02141854|2142459|FG001|Treatment Period|Other|1
1082010|NCT02141854|2142460|FG002|Treatment Period|Other|2
1082011|NCT02141854|2142461|FG003|Treatment Period|Other|0
1082012|NCT02141854|2142462|FG004|Treatment Period|Other|1
1082013|NCT02141854|2142463|FG005|Treatment Period|Other|2
1082014|NCT02141854|2142458|FG000|Treatment Period|Adverse Event|0
1082015|NCT02141854|2142459|FG001|Treatment Period|Adverse Event|2
1082016|NCT02141854|2142460|FG002|Treatment Period|Adverse Event|2
1082017|NCT02141854|2142461|FG003|Treatment Period|Adverse Event|0
1082018|NCT02141854|2142462|FG004|Treatment Period|Adverse Event|2
1082019|NCT02141854|2142463|FG005|Treatment Period|Adverse Event|2
1082020|NCT02141854|2142458|FG000|Treatment Period|Withdrawal by Subject|0
1082021|NCT02141854|2142459|FG001|Treatment Period|Withdrawal by Subject|2
1082022|NCT02141854|2142460|FG002|Treatment Period|Withdrawal by Subject|3
1082023|NCT02141854|2142461|FG003|Treatment Period|Withdrawal by Subject|3
1082024|NCT02141854|2142462|FG004|Treatment Period|Withdrawal by Subject|4
1082025|NCT02141854|2142463|FG005|Treatment Period|Withdrawal by Subject|7
1082026|NCT02141854|2142458|FG000|Treatment Period|Disease progression|0
1082027|NCT02141854|2142459|FG001|Treatment Period|Disease progression|2
1082028|NCT02141854|2142460|FG002|Treatment Period|Disease progression|1
1082029|NCT02141854|2142461|FG003|Treatment Period|Disease progression|3
1082030|NCT02141854|2142462|FG004|Treatment Period|Disease progression|0
1082031|NCT02141854|2142463|FG005|Treatment Period|Disease progression|18
1082032|NCT02141854|2142458|FG000|Treatment Period|Lost to Follow-up|0
1082033|NCT02141854|2142459|FG001|Treatment Period|Lost to Follow-up|1
1082034|NCT02141854|2142460|FG002|Treatment Period|Lost to Follow-up|1
1082035|NCT02141854|2142461|FG003|Treatment Period|Lost to Follow-up|1
1082036|NCT02141854|2142462|FG004|Treatment Period|Lost to Follow-up|0
1082037|NCT02141854|2142463|FG005|Treatment Period|Lost to Follow-up|1
1082038|NCT02141984|2142479|FG000|Overall Study|Lack of Efficacy|2
1082039|NCT02141997|2142487|FG000|Overall Study|Adverse Event|0
1082040|NCT02141997|2142488|FG001|Overall Study|Adverse Event|2
1082041|NCT02141997|2142489|FG002|Overall Study|Adverse Event|0
1082042|NCT02141997|2142490|FG003|Overall Study|Adverse Event|1
1082043|NCT02141997|2142487|FG000|Overall Study|Participant noncompliance|1
1082044|NCT02141997|2142488|FG001|Overall Study|Participant noncompliance|0
1082045|NCT02141997|2142489|FG002|Overall Study|Participant noncompliance|0
1082046|NCT02141997|2142490|FG003|Overall Study|Participant noncompliance|0
1082047|NCT02141997|2142487|FG000|Overall Study|Withdrew consent|1
1082048|NCT02141997|2142488|FG001|Overall Study|Withdrew consent|0
1082049|NCT02141997|2142489|FG002|Overall Study|Withdrew consent|3
1082050|NCT02141997|2142490|FG003|Overall Study|Withdrew consent|0
1082051|NCT02141997|2142487|FG000|Overall Study|Other|1
1082052|NCT02141997|2142488|FG001|Overall Study|Other|4
1082053|NCT02141997|2142489|FG002|Overall Study|Other|0
1082054|NCT02141997|2142490|FG003|Overall Study|Other|0
1082055|NCT02142283|2142579|FG000|Overall Study|Death|20
1082056|NCT02142283|2142580|FG001|Overall Study|Death|18
1082057|NCT02142283|2142579|FG000|Overall Study|Withdrawal by Subject|1
1082058|NCT02142283|2142580|FG001|Overall Study|Withdrawal by Subject|3
1082059|NCT02142387|2142601|FG000|Overall Study|<19 years old|49
1082060|NCT02142387|2142602|FG001|Overall Study|<19 years old|326
1082061|NCT02142387|2142601|FG000|Overall Study|non-cardiac etiology|504
1082062|NCT02142387|2142602|FG001|Overall Study|non-cardiac etiology|3431
1082063|NCT02142387|2142601|FG000|Overall Study|CPR not performed|74
1082064|NCT02142387|2142602|FG001|Overall Study|CPR not performed|473
1082065|NCT02142387|2142601|FG000|Overall Study|witnessed by paramedic|139
1082066|NCT02142387|2142602|FG001|Overall Study|witnessed by paramedic|917
1082067|NCT02142387|2142601|FG000|Overall Study|incomplete data|1
1082068|NCT02142387|2142602|FG001|Overall Study|incomplete data|9
1082069|NCT02142387|2142601|FG000|Overall Study|occurred not at home|298
1082070|NCT02142387|2142602|FG001|Overall Study|occurred not at home|2474
1082071|NCT02142504|2142611|FG000|Overall Study|Protocol Violation|2
1082072|NCT02142504|2142612|FG001|Overall Study|Protocol Violation|1
1082073|NCT02142504|2142613|FG002|Overall Study|Protocol Violation|2
1082074|NCT02142504|2142611|FG000|Overall Study|Adverse Event|2
1082075|NCT02142504|2142612|FG001|Overall Study|Adverse Event|3
1082076|NCT02142504|2142613|FG002|Overall Study|Adverse Event|4
1082077|NCT02142504|2142611|FG000|Overall Study|Lost to Follow-up|12
1082078|NCT02142504|2142612|FG001|Overall Study|Lost to Follow-up|19
1082079|NCT02142504|2142613|FG002|Overall Study|Lost to Follow-up|17
1082080|NCT02142504|2142611|FG000|Overall Study|Withdrawal by Subject|7
1082081|NCT02142504|2142612|FG001|Overall Study|Withdrawal by Subject|9
1082082|NCT02142504|2142613|FG002|Overall Study|Withdrawal by Subject|11
1082083|NCT02142504|2142611|FG000|Overall Study|Pregnancy|4
1082084|NCT02142504|2142612|FG001|Overall Study|Pregnancy|4
1082085|NCT02142504|2142613|FG002|Overall Study|Pregnancy|2
1082086|NCT02142504|2142611|FG000|Overall Study|Physician Decision|0
1082087|NCT02142504|2142612|FG001|Overall Study|Physician Decision|1
1082088|NCT02142504|2142613|FG002|Overall Study|Physician Decision|3
1082089|NCT02142504|2142611|FG000|Overall Study|Reason Not Specified|4
1082090|NCT02142504|2142612|FG001|Overall Study|Reason Not Specified|5
1082091|NCT02142504|2142613|FG002|Overall Study|Reason Not Specified|4
1082092|NCT02142712|2142629|FG000|Overall Study|Lost to Follow-up|1
1082093|NCT02142712|2142630|FG001|Overall Study|Lost to Follow-up|1
1082094|NCT02142712|2142631|FG002|Overall Study|Lost to Follow-up|1
1082095|NCT02142712|2142632|FG003|Overall Study|Lost to Follow-up|0
1082096|NCT02142738|2142643|FG000|Overall Study|Adverse Event|9
1082097|NCT02142738|2142644|FG001|Overall Study|Adverse Event|8
1082098|NCT02142738|2142643|FG000|Overall Study|Death|33
1082099|NCT02142738|2142644|FG001|Overall Study|Death|55
1082100|NCT02142738|2142643|FG000|Overall Study|Progressive Disease|0
1082101|NCT02142738|2142644|FG001|Overall Study|Progressive Disease|1
1082102|NCT02142738|2142643|FG000|Overall Study|Withdrawal by Subject|5
1082103|NCT02142738|2142644|FG001|Overall Study|Withdrawal by Subject|5
1082104|NCT02142738|2142643|FG000|Overall Study|Ongoing in Study|107
1082105|NCT02142738|2142644|FG001|Overall Study|Ongoing in Study|82
1082106|NCT02142894|2142650|FG000|Overall Study|Protocol Violation|8
1082107|NCT02143024|2142656|FG000|Overall Study|Lost to Follow-up|1
1082108|NCT02143024|2142657|FG001|Overall Study|Lost to Follow-up|1
1082109|NCT02143024|2142656|FG000|Overall Study|Withdrawal by Subject|1
1082110|NCT02143024|2142657|FG001|Overall Study|Withdrawal by Subject|0
1082120|NCT02143102|2142678|FG000|Overall Study|Lost to Follow-up|11
1082121|NCT02143102|2142679|FG001|Overall Study|Lost to Follow-up|0
1082122|NCT02143141|2142687|FG000|Overall Study|pain scores at 24 hours not collected|1
1082123|NCT02143141|2142688|FG001|Overall Study|pain scores at 24 hours not collected|0
1082124|NCT02143583|2142701|FG000|Overall Study|Withdrawal by Subject|1
1082125|NCT02143583|2142702|FG001|Overall Study|Withdrawal by Subject|0
1082126|NCT02143583|2142703|FG002|Overall Study|Withdrawal by Subject|1
1082127|NCT02143583|2142701|FG000|Overall Study|husband illness|0
1082128|NCT02143583|2142702|FG001|Overall Study|husband illness|0
1082129|NCT02143583|2142703|FG002|Overall Study|husband illness|1
1082130|NCT02143713|2142728|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1
1082131|NCT02143713|2142729|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2
1082132|NCT02143713|2142730|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5
1082133|NCT02143713|2142731|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4
1082134|NCT02143713|2142728|FG000|Treatment Period (6 Months)|Adverse Event|7
1082135|NCT02143713|2142729|FG001|Treatment Period (6 Months)|Adverse Event|8
1082136|NCT02143713|2142730|FG002|Treatment Period (6 Months)|Adverse Event|8
1082137|NCT02143713|2142731|FG003|Treatment Period (6 Months)|Adverse Event|9
1082138|NCT02143713|2142728|FG000|Treatment Period (6 Months)|Lost to Follow-up|3
1082139|NCT02143713|2142729|FG001|Treatment Period (6 Months)|Lost to Follow-up|0
1082140|NCT02143713|2142730|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
1082141|NCT02143713|2142731|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
1082142|NCT02143713|2142728|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
1082143|NCT02143713|2142729|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
1082144|NCT02143713|2142730|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
1082145|NCT02143713|2142731|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
1082146|NCT02143713|2142728|FG000|Treatment Period (6 Months)|Pregnancy|0
1082147|NCT02143713|2142729|FG001|Treatment Period (6 Months)|Pregnancy|2
1082148|NCT02143713|2142730|FG002|Treatment Period (6 Months)|Pregnancy|2
1082149|NCT02143713|2142731|FG003|Treatment Period (6 Months)|Pregnancy|0
1082150|NCT02143713|2142728|FG000|Treatment Period (6 Months)|Non-compliance|1
1082151|NCT02143713|2142729|FG001|Treatment Period (6 Months)|Non-compliance|0
1082152|NCT02143713|2142730|FG002|Treatment Period (6 Months)|Non-compliance|0
1082153|NCT02143713|2142731|FG003|Treatment Period (6 Months)|Non-compliance|3
1082154|NCT02143713|2142728|FG000|Treatment Period (6 Months)|Other|3
1082155|NCT02143713|2142729|FG001|Treatment Period (6 Months)|Other|0
1082156|NCT02143713|2142730|FG002|Treatment Period (6 Months)|Other|3
1082157|NCT02143713|2142731|FG003|Treatment Period (6 Months)|Other|2
1082158|NCT02143713|2142728|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
1082159|NCT02143713|2142729|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
1082160|NCT02143713|2142730|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
1082161|NCT02143713|2142731|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
1082162|NCT02143713|2142728|FG000|Treatment Period (6 Months)|Exclusionary Medication|2
1082163|NCT02143713|2142729|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
1082164|NCT02143713|2142730|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
1082165|NCT02143713|2142731|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
1082166|NCT02143713|2142728|FG000|Treatment Period (6 Months)|Lack of Efficacy|1
1082167|NCT02143713|2142729|FG001|Treatment Period (6 Months)|Lack of Efficacy|0
1082168|NCT02143713|2142730|FG002|Treatment Period (6 Months)|Lack of Efficacy|0
1082169|NCT02143713|2142731|FG003|Treatment Period (6 Months)|Lack of Efficacy|1
1082170|NCT02143713|2142728|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
1082171|NCT02143713|2142729|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
1082172|NCT02143713|2142730|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
1082173|NCT02143713|2142731|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
1082174|NCT02143713|2142728|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0
1082175|NCT02143713|2142729|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0
1082176|NCT02143713|2142730|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1
1082177|NCT02143713|2142731|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0
1082178|NCT02143713|2142728|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
1082179|NCT02143713|2142729|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
1082180|NCT02143713|2142730|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
1082181|NCT02143713|2142731|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
1082182|NCT02143713|2142728|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
1082183|NCT02143713|2142729|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
1082184|NCT02143713|2142730|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
1082185|NCT02143713|2142731|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
1082186|NCT02143713|2142728|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
1082187|NCT02143713|2142729|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
1082188|NCT02143713|2142730|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
1082189|NCT02143713|2142731|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
1082190|NCT02143713|2142728|FG000|Post-treatment Follow-up (12 Months)|Other|3
1082191|NCT02143713|2142729|FG001|Post-treatment Follow-up (12 Months)|Other|4
1082192|NCT02143713|2142730|FG002|Post-treatment Follow-up (12 Months)|Other|7
1082193|NCT02143713|2142731|FG003|Post-treatment Follow-up (12 Months)|Other|7
1082194|NCT02143778|2142742|FG000|Overall Study|Withdrawal by Subject|2
1082195|NCT02143778|2142742|FG000|Overall Study|Device malfunction|1
1082196|NCT02143843|2142747|FG000|Overall Study|Adverse Event|8
1082197|NCT02143843|2142747|FG000|Overall Study|Lack of Efficacy|2
1082198|NCT02143843|2142747|FG000|Overall Study|Withdrawal by Subject|2
1082199|NCT02143947|2142753|FG000|Overall Study|Lost to Follow-up|4
1082200|NCT02143947|2142754|FG001|Overall Study|Lost to Follow-up|2
1082201|NCT02144012|2142768|FG000|Overall Study|Adverse Event|1
1082202|NCT02144012|2142769|FG001|Overall Study|Adverse Event|0
1082203|NCT02144012|2142768|FG000|Overall Study|Death|1
1082204|NCT02144012|2142769|FG001|Overall Study|Death|0
1082205|NCT02144012|2142768|FG000|Overall Study|Withdrawal by Subject|11
1082206|NCT02144012|2142769|FG001|Overall Study|Withdrawal by Subject|3
1082207|NCT02144012|2142768|FG000|Overall Study|Study Terminated by Sponsor|18
1082208|NCT02144012|2142769|FG001|Overall Study|Study Terminated by Sponsor|12
1082209|NCT02144012|2142768|FG000|Overall Study|Other|3
1082210|NCT02144012|2142769|FG001|Overall Study|Other|0
1082211|NCT02144077|2142777|FG000|Overall Study|Withdrawal by Subject|3
1082212|NCT02144077|2142778|FG001|Overall Study|Withdrawal by Subject|3
1082213|NCT02144077|2142777|FG000|Overall Study|Adverse Event|2
1082214|NCT02144077|2142778|FG001|Overall Study|Adverse Event|3
1082215|NCT02144077|2142777|FG000|Overall Study|Lost to Follow-up|2
1082216|NCT02144077|2142778|FG001|Overall Study|Lost to Follow-up|2
1082217|NCT02144077|2142777|FG000|Overall Study|Protocol Violation|1
1082218|NCT02144077|2142778|FG001|Overall Study|Protocol Violation|2
1082219|NCT02144077|2142777|FG000|Overall Study|Death|0
1082220|NCT02144077|2142778|FG001|Overall Study|Death|1
1082221|NCT02144077|2142777|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2
1082222|NCT02144077|2142778|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0
1082223|NCT02144220|2142784|FG000|Overall Study|technology incompatibility|9
1082224|NCT02144220|2142784|FG000|Overall Study|Lack of Efficacy|4
1082225|NCT02144220|2142784|FG000|Overall Study|Physician Decision|3
1082226|NCT02144220|2142784|FG000|Overall Study|Withdrawal by Subject|2
1082227|NCT02144220|2142784|FG000|Overall Study|Protocol Violation|1
909552|NCT00789035|1886313|FG002|Overall Study|Adverse Event|0
909553|NCT00789035|1886314|FG003|Overall Study|Adverse Event|1
909554|NCT00789035|1886315|FG004|Overall Study|Adverse Event|3
909555|NCT00789035|1886311|FG000|Overall Study|Lack of Efficacy|3
1082228|NCT02144285|2142820|FG000|Overall Study|Withdrawal by Subject|0
1082229|NCT02144285|2142821|FG001|Overall Study|Withdrawal by Subject|0
1082230|NCT02144285|2142822|FG002|Overall Study|Withdrawal by Subject|0
1082231|NCT02144285|2142823|FG003|Overall Study|Withdrawal by Subject|0
1082232|NCT02144285|2142824|FG004|Overall Study|Withdrawal by Subject|1
1082233|NCT02144285|2142825|FG005|Overall Study|Withdrawal by Subject|0
1082234|NCT02144285|2142826|FG006|Overall Study|Withdrawal by Subject|0
1082235|NCT02144285|2142827|FG007|Overall Study|Withdrawal by Subject|0
1082236|NCT02144285|2142828|FG008|Overall Study|Withdrawal by Subject|0
1082237|NCT02144285|2142829|FG009|Overall Study|Withdrawal by Subject|0
1082238|NCT02144337|2142867|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
1082239|NCT02144337|2142868|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
1082240|NCT02144337|2142867|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
1082241|NCT02144337|2142868|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
1082242|NCT02144337|2142867|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
1082243|NCT02144337|2142868|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
1082244|NCT02144337|2142867|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
1082245|NCT02144337|2142868|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
1082246|NCT02144337|2142867|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
1082247|NCT02144337|2142868|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
1082248|NCT02144610|2142899|FG000|Overall Study|Physician Decision|1
1082249|NCT02144610|2142900|FG001|Overall Study|Physician Decision|0
1082250|NCT02144610|2142899|FG000|Overall Study|Withdrawal by Subject|1
1082251|NCT02144610|2142900|FG001|Overall Study|Withdrawal by Subject|5
1082252|NCT02144610|2142899|FG000|Overall Study|Death|2
1082253|NCT02144610|2142900|FG001|Overall Study|Death|2
1082254|NCT02144610|2142899|FG000|Overall Study|Study Discontinuation by Sponsor|19
1082255|NCT02144610|2142900|FG001|Overall Study|Study Discontinuation by Sponsor|14
1082256|NCT02144610|2142899|FG000|Overall Study|Other|0
1082257|NCT02144610|2142900|FG001|Overall Study|Other|1
1082258|NCT02144701|2142917|FG000|Overall Study|development of relapse, GVHD or death|9
1082259|NCT02144701|2142918|FG001|Overall Study|development of relapse, GVHD or death|3
1082260|NCT02145026|2142937|FG000|Overall Study|Adverse Event|2
1082261|NCT02145026|2142937|FG000|Overall Study|Death|4
1082262|NCT02145026|2142937|FG000|Overall Study|Withdrawal by Subject|2
1082263|NCT02145026|2142937|FG000|Overall Study|Physician Decision|4
1082264|NCT02145078|2142945|FG000|Overall Study|Death|1
1082265|NCT02145078|2142945|FG000|Overall Study|Reason not given|3
1082266|NCT02145156|2142952|FG000|Overall Study|No match to vaccination records|60
1082267|NCT02145156|2142953|FG001|Overall Study|No match to vaccination records|52
1082268|NCT02145156|2142954|FG002|Overall Study|No match to vaccination records|41
1082269|NCT02145182|2142964|FG000|Overall Study|Adverse Event|4
1082270|NCT02145182|2142965|FG001|Overall Study|Adverse Event|1
1082271|NCT02145182|2142964|FG000|Overall Study|Death|7
1082272|NCT02145182|2142965|FG001|Overall Study|Death|7
1082273|NCT02145182|2142964|FG000|Overall Study|Lost to Follow-up|2
1082274|NCT02145182|2142965|FG001|Overall Study|Lost to Follow-up|2
1082275|NCT02145182|2142964|FG000|Overall Study|Pre-transplant Withdrawal|0
1082276|NCT02145182|2142965|FG001|Overall Study|Pre-transplant Withdrawal|2
1082277|NCT02145182|2142964|FG000|Overall Study|Withdrawal by Subject|5
1082278|NCT02145182|2142965|FG001|Overall Study|Withdrawal by Subject|4
1082279|NCT02145429|2143008|FG000|Overall Study|Death|4
1082280|NCT02145429|2143009|FG001|Overall Study|Death|5
1082281|NCT02145429|2143008|FG000|Overall Study|Lost to Follow-up|4
1082282|NCT02145429|2143009|FG001|Overall Study|Lost to Follow-up|3
1082283|NCT02145429|2143008|FG000|Overall Study|Withdrawal by Subject|8
1082284|NCT02145429|2143009|FG001|Overall Study|Withdrawal by Subject|3
1082285|NCT02145468|2143017|FG000|Overall Study|Withdrawal by Subject|5
1082286|NCT02145468|2143018|FG001|Overall Study|Withdrawal by Subject|8
1082287|NCT02146105|2143050|FG000|Overall Study|Adverse Event|1
1082288|NCT02146105|2143050|FG000|Overall Study|Withdrawal by Subject|5
1082289|NCT02146131|2143056|FG000|Overall Study|Physician Decision|61
1082290|NCT02146131|2143057|FG001|Overall Study|Physician Decision|56
1082291|NCT02146248|2143063|FG000|Overall Study|Withdrawal by Subject|2
1082292|NCT02146274|2143071|FG000|Overall Study|Protocol Violation|73
1082293|NCT02146326|2143082|FG000|Overall Study|Lost to Follow-up|3
1082294|NCT02146326|2143083|FG001|Overall Study|Lost to Follow-up|3
1082295|NCT02146326|2143084|FG002|Overall Study|Lost to Follow-up|11
1082296|NCT02146326|2143085|FG003|Overall Study|Lost to Follow-up|19
1082297|NCT02146326|2143082|FG000|Overall Study|Withdrawal by Subject|2
1082298|NCT02146326|2143083|FG001|Overall Study|Withdrawal by Subject|1
1082299|NCT02146326|2143084|FG002|Overall Study|Withdrawal by Subject|15
1082300|NCT02146326|2143085|FG003|Overall Study|Withdrawal by Subject|11
1082301|NCT02146326|2143082|FG000|Overall Study|Separated from mental health center|23
1082302|NCT02146326|2143083|FG001|Overall Study|Separated from mental health center|33
1082303|NCT02146326|2143084|FG002|Overall Study|Separated from mental health center|0
1082304|NCT02146326|2143085|FG003|Overall Study|Separated from mental health center|0
1082305|NCT02146326|2143082|FG000|Overall Study|Incarcerated|0
1082306|NCT02146326|2143083|FG001|Overall Study|Incarcerated|0
1082307|NCT02146326|2143084|FG002|Overall Study|Incarcerated|3
1082308|NCT02146326|2143085|FG003|Overall Study|Incarcerated|8
1082309|NCT02146326|2143082|FG000|Overall Study|Death|0
1082310|NCT02146326|2143083|FG001|Overall Study|Death|0
1082311|NCT02146326|2143084|FG002|Overall Study|Death|4
1082312|NCT02146326|2143085|FG003|Overall Study|Death|4
1082313|NCT02146326|2143082|FG000|Overall Study|Unable to complete interview|0
1082314|NCT02146326|2143083|FG001|Overall Study|Unable to complete interview|0
1082315|NCT02146326|2143084|FG002|Overall Study|Unable to complete interview|10
1082316|NCT02146326|2143085|FG003|Overall Study|Unable to complete interview|6
1082317|NCT02146352|2143101|FG000|Overall Study|Death|1
1082318|NCT02146352|2143101|FG000|Overall Study|Patient entered hospice care|1
1082319|NCT02146365|2143111|FG000|Overall Study|Lost to Follow-up|2
1082320|NCT02146365|2143112|FG001|Overall Study|Lost to Follow-up|1
1082321|NCT02146365|2143113|FG002|Overall Study|Lost to Follow-up|3
1082322|NCT02146365|2143114|FG003|Overall Study|Lost to Follow-up|3
1082323|NCT02146365|2143115|FG004|Overall Study|Lost to Follow-up|1
1082324|NCT02146365|2143116|FG005|Overall Study|Lost to Follow-up|1
1082325|NCT02146365|2143117|FG006|Overall Study|Lost to Follow-up|0
1082326|NCT02146365|2143118|FG007|Overall Study|Lost to Follow-up|1
1082327|NCT02146365|2143111|FG000|Overall Study|Withdrawal by Subject|1
1082328|NCT02146365|2143112|FG001|Overall Study|Withdrawal by Subject|2
1082329|NCT02146365|2143113|FG002|Overall Study|Withdrawal by Subject|1
1082330|NCT02146365|2143114|FG003|Overall Study|Withdrawal by Subject|5
1082331|NCT02146365|2143115|FG004|Overall Study|Withdrawal by Subject|1
1082332|NCT02146365|2143116|FG005|Overall Study|Withdrawal by Subject|0
1082333|NCT02146365|2143117|FG006|Overall Study|Withdrawal by Subject|0
1082334|NCT02146365|2143118|FG007|Overall Study|Withdrawal by Subject|0
1082335|NCT02146365|2143111|FG000|Overall Study|Unable to Comply with Protocol|0
1082336|NCT02146365|2143112|FG001|Overall Study|Unable to Comply with Protocol|1
1082337|NCT02146365|2143113|FG002|Overall Study|Unable to Comply with Protocol|1
1082338|NCT02146365|2143114|FG003|Overall Study|Unable to Comply with Protocol|0
1082339|NCT02146365|2143115|FG004|Overall Study|Unable to Comply with Protocol|0
1082340|NCT02146365|2143116|FG005|Overall Study|Unable to Comply with Protocol|0
1082341|NCT02146365|2143117|FG006|Overall Study|Unable to Comply with Protocol|0
1082342|NCT02146365|2143118|FG007|Overall Study|Unable to Comply with Protocol|0
1082343|NCT02146365|2143111|FG000|Overall Study|Other|1
1082344|NCT02146365|2143112|FG001|Overall Study|Other|0
1082345|NCT02146365|2143113|FG002|Overall Study|Other|2
1082346|NCT02146365|2143114|FG003|Overall Study|Other|1
1082347|NCT02146365|2143115|FG004|Overall Study|Other|0
1082348|NCT02146365|2143116|FG005|Overall Study|Other|0
1082349|NCT02146365|2143117|FG006|Overall Study|Other|0
1082350|NCT02146365|2143118|FG007|Overall Study|Other|0
1082351|NCT02146430|2143140|FG000|Overall Study|Protocol Violation|5
1082352|NCT02146430|2143141|FG001|Overall Study|Protocol Violation|4
1082353|NCT02146430|2143142|FG002|Overall Study|Protocol Violation|8
1082354|NCT02146430|2143143|FG003|Overall Study|Protocol Violation|6
1082355|NCT02146430|2143140|FG000|Overall Study|Lack of Efficacy|13
1082356|NCT02146430|2143141|FG001|Overall Study|Lack of Efficacy|11
1082357|NCT02146430|2143142|FG002|Overall Study|Lack of Efficacy|8
1082358|NCT02146430|2143143|FG003|Overall Study|Lack of Efficacy|5
1082359|NCT02146430|2143140|FG000|Overall Study|Adverse Event|20
1082360|NCT02146430|2143141|FG001|Overall Study|Adverse Event|40
1082361|NCT02146430|2143142|FG002|Overall Study|Adverse Event|32
1082362|NCT02146430|2143143|FG003|Overall Study|Adverse Event|49
1082363|NCT02146430|2143140|FG000|Overall Study|Reason missing or not reported|2
1082364|NCT02146430|2143141|FG001|Overall Study|Reason missing or not reported|3
1082365|NCT02146430|2143142|FG002|Overall Study|Reason missing or not reported|4
1082366|NCT02146430|2143143|FG003|Overall Study|Reason missing or not reported|5
1082367|NCT02146430|2143140|FG000|Overall Study|Withdrawal by Subject|27
1082368|NCT02146430|2143141|FG001|Overall Study|Withdrawal by Subject|29
1082369|NCT02146430|2143142|FG002|Overall Study|Withdrawal by Subject|30
1082370|NCT02146430|2143143|FG003|Overall Study|Withdrawal by Subject|34
1082371|NCT02146599|2143166|FG000|Overall Study|Failed to meet inclusion criteria|5
1082372|NCT02146833|2143170|FG000|Overall Study|Death|10
1082373|NCT02146833|2143170|FG000|Overall Study|No longer consented to study treatment|1
1082374|NCT02147067|2143176|FG000|Overall Study|Withdrawal by Subject|2
1082375|NCT02147067|2143177|FG001|Overall Study|Withdrawal by Subject|2
1082376|NCT02147093|2143185|FG000|Period 1|Lost to Follow-up|0
1082377|NCT02147093|2143186|FG001|Period 1|Lost to Follow-up|1
1082378|NCT02147093|2143185|FG000|Period 2|Protocol Violation|2
1082379|NCT02147093|2143186|FG001|Period 2|Protocol Violation|0
1082380|NCT02147132|2143192|FG000|Overall Study|Lost to Follow-up|1
1082381|NCT02147132|2143193|FG001|Overall Study|Lost to Follow-up|0
1082382|NCT02147132|2143194|FG002|Overall Study|Lost to Follow-up|0
1082383|NCT02147132|2143195|FG003|Overall Study|Lost to Follow-up|0
1082384|NCT02147158|2143211|FG000|Treatment Course 1|Adverse Event|1
1082385|NCT02147158|2143212|FG001|Treatment Course 1|Adverse Event|4
1082386|NCT02147158|2143213|FG002|Treatment Course 1|Adverse Event|3
1082387|NCT02147158|2143214|FG003|Treatment Course 1|Adverse Event|4
1082388|NCT02147158|2143215|FG004|Treatment Course 1|Adverse Event|1
1082389|NCT02147158|2143216|FG005|Treatment Course 1|Adverse Event|2
1082390|NCT02147158|2143211|FG000|Treatment Course 1|Lost to Follow-up|2
1082391|NCT02147158|2143212|FG001|Treatment Course 1|Lost to Follow-up|4
1082392|NCT02147158|2143213|FG002|Treatment Course 1|Lost to Follow-up|3
1082393|NCT02147158|2143214|FG003|Treatment Course 1|Lost to Follow-up|3
1082394|NCT02147158|2143215|FG004|Treatment Course 1|Lost to Follow-up|2
1082395|NCT02147158|2143216|FG005|Treatment Course 1|Lost to Follow-up|4
1082396|NCT02147158|2143211|FG000|Treatment Course 1|Protocol Violation|0
1082397|NCT02147158|2143212|FG001|Treatment Course 1|Protocol Violation|0
1082398|NCT02147158|2143213|FG002|Treatment Course 1|Protocol Violation|1
1082399|NCT02147158|2143214|FG003|Treatment Course 1|Protocol Violation|1
1082400|NCT02147158|2143215|FG004|Treatment Course 1|Protocol Violation|0
1082401|NCT02147158|2143216|FG005|Treatment Course 1|Protocol Violation|0
1082402|NCT02147158|2143211|FG000|Treatment Course 1|Withdrawal of Consent|1
1082403|NCT02147158|2143212|FG001|Treatment Course 1|Withdrawal of Consent|1
1082404|NCT02147158|2143213|FG002|Treatment Course 1|Withdrawal of Consent|1
1082405|NCT02147158|2143214|FG003|Treatment Course 1|Withdrawal of Consent|5
1082406|NCT02147158|2143215|FG004|Treatment Course 1|Withdrawal of Consent|3
1082407|NCT02147158|2143216|FG005|Treatment Course 1|Withdrawal of Consent|2
1082408|NCT02147158|2143211|FG000|Off-Treatment Interval 1|Adverse Event|1
1082409|NCT02147158|2143212|FG001|Off-Treatment Interval 1|Adverse Event|0
1082410|NCT02147158|2143213|FG002|Off-Treatment Interval 1|Adverse Event|0
1082411|NCT02147158|2143214|FG003|Off-Treatment Interval 1|Adverse Event|1
1082412|NCT02147158|2143215|FG004|Off-Treatment Interval 1|Adverse Event|0
1082413|NCT02147158|2143216|FG005|Off-Treatment Interval 1|Adverse Event|0
1082414|NCT02147158|2143211|FG000|Off-Treatment Interval 1|Lost to Follow-up|2
1082415|NCT02147158|2143212|FG001|Off-Treatment Interval 1|Lost to Follow-up|1
1082416|NCT02147158|2143213|FG002|Off-Treatment Interval 1|Lost to Follow-up|3
1082417|NCT02147158|2143214|FG003|Off-Treatment Interval 1|Lost to Follow-up|2
1082418|NCT02147158|2143215|FG004|Off-Treatment Interval 1|Lost to Follow-up|4
1082419|NCT02147158|2143216|FG005|Off-Treatment Interval 1|Lost to Follow-up|2
1082420|NCT02147158|2143211|FG000|Off-Treatment Interval 1|Protocol Violation|1
1082421|NCT02147158|2143212|FG001|Off-Treatment Interval 1|Protocol Violation|0
1082422|NCT02147158|2143213|FG002|Off-Treatment Interval 1|Protocol Violation|2
1082423|NCT02147158|2143214|FG003|Off-Treatment Interval 1|Protocol Violation|0
1082424|NCT02147158|2143215|FG004|Off-Treatment Interval 1|Protocol Violation|1
1082425|NCT02147158|2143216|FG005|Off-Treatment Interval 1|Protocol Violation|0
1082426|NCT02147158|2143211|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4
1082427|NCT02147158|2143212|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3
1082428|NCT02147158|2143213|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5
1082429|NCT02147158|2143214|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10
1082430|NCT02147158|2143215|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2
1082431|NCT02147158|2143216|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3
1082432|NCT02147158|2143211|FG000|Off-Treatment Interval 1|Lack of Efficacy|0
1082433|NCT02147158|2143212|FG001|Off-Treatment Interval 1|Lack of Efficacy|0
1082434|NCT02147158|2143213|FG002|Off-Treatment Interval 1|Lack of Efficacy|2
1082435|NCT02147158|2143214|FG003|Off-Treatment Interval 1|Lack of Efficacy|0
1082436|NCT02147158|2143215|FG004|Off-Treatment Interval 1|Lack of Efficacy|1
1082437|NCT02147158|2143216|FG005|Off-Treatment Interval 1|Lack of Efficacy|0
1082438|NCT02147158|2143211|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
1082439|NCT02147158|2143212|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
1082440|NCT02147158|2143213|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
1082441|NCT02147158|2143214|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
1082442|NCT02147158|2143215|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
1082443|NCT02147158|2143216|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
1082444|NCT02147158|2143211|FG000|Treatment Course 2|Adverse Event|0
1082445|NCT02147158|2143212|FG001|Treatment Course 2|Adverse Event|4
1082446|NCT02147158|2143213|FG002|Treatment Course 2|Adverse Event|2
1082447|NCT02147158|2143214|FG003|Treatment Course 2|Adverse Event|1
1082448|NCT02147158|2143215|FG004|Treatment Course 2|Adverse Event|0
1082449|NCT02147158|2143216|FG005|Treatment Course 2|Adverse Event|1
1082450|NCT02147158|2143211|FG000|Treatment Course 2|Withdrawal of Consent|0
1082451|NCT02147158|2143212|FG001|Treatment Course 2|Withdrawal of Consent|1
1082452|NCT02147158|2143213|FG002|Treatment Course 2|Withdrawal of Consent|2
1082453|NCT02147158|2143214|FG003|Treatment Course 2|Withdrawal of Consent|3
1082454|NCT02147158|2143215|FG004|Treatment Course 2|Withdrawal of Consent|0
1082455|NCT02147158|2143216|FG005|Treatment Course 2|Withdrawal of Consent|0
1082456|NCT02147158|2143211|FG000|Treatment Course 2|Lost to Follow-up|1
1082457|NCT02147158|2143212|FG001|Treatment Course 2|Lost to Follow-up|0
1082458|NCT02147158|2143213|FG002|Treatment Course 2|Lost to Follow-up|1
1082459|NCT02147158|2143214|FG003|Treatment Course 2|Lost to Follow-up|1
1082460|NCT02147158|2143215|FG004|Treatment Course 2|Lost to Follow-up|0
1082461|NCT02147158|2143216|FG005|Treatment Course 2|Lost to Follow-up|1
1082462|NCT02147158|2143211|FG000|Off-Treatment Interval 2|Lack of Efficacy|0
1082463|NCT02147158|2143212|FG001|Off-Treatment Interval 2|Lack of Efficacy|1
1082464|NCT02147158|2143213|FG002|Off-Treatment Interval 2|Lack of Efficacy|1
1082465|NCT02147158|2143214|FG003|Off-Treatment Interval 2|Lack of Efficacy|0
1082466|NCT02147158|2143215|FG004|Off-Treatment Interval 2|Lack of Efficacy|0
1082467|NCT02147158|2143216|FG005|Off-Treatment Interval 2|Lack of Efficacy|0
1082468|NCT02147158|2143211|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4
1082469|NCT02147158|2143212|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0
1082470|NCT02147158|2143213|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5
1082471|NCT02147158|2143214|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4
1082472|NCT02147158|2143215|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0
1082473|NCT02147158|2143216|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1
1082474|NCT02147158|2143211|FG000|Off-Treatment Interval 2|Lost to Follow-up|0
1082475|NCT02147158|2143212|FG001|Off-Treatment Interval 2|Lost to Follow-up|0
1082476|NCT02147158|2143213|FG002|Off-Treatment Interval 2|Lost to Follow-up|3
1082477|NCT02147158|2143214|FG003|Off-Treatment Interval 2|Lost to Follow-up|2
1082478|NCT02147158|2143215|FG004|Off-Treatment Interval 2|Lost to Follow-up|2
1082479|NCT02147158|2143216|FG005|Off-Treatment Interval 2|Lost to Follow-up|2
1082480|NCT02147158|2143211|FG000|Off-Treatment Interval 2|Protocol Violation|0
1082481|NCT02147158|2143212|FG001|Off-Treatment Interval 2|Protocol Violation|0
1082482|NCT02147158|2143213|FG002|Off-Treatment Interval 2|Protocol Violation|0
1082483|NCT02147158|2143214|FG003|Off-Treatment Interval 2|Protocol Violation|1
1082484|NCT02147158|2143215|FG004|Off-Treatment Interval 2|Protocol Violation|0
1082485|NCT02147158|2143216|FG005|Off-Treatment Interval 2|Protocol Violation|0
1082486|NCT02147158|2143211|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
1082487|NCT02147158|2143212|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
1082488|NCT02147158|2143213|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
1082489|NCT02147158|2143214|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
1082490|NCT02147158|2143215|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
1082491|NCT02147158|2143216|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
1082504|NCT02147197|2143245|FG000|Overall Study|Adverse Event|1
1082505|NCT02147197|2143246|FG001|Overall Study|Adverse Event|0
1082506|NCT02147197|2143247|FG002|Overall Study|Adverse Event|0
1082507|NCT02147197|2143245|FG000|Overall Study|Withdrawal of Consent|4
1082508|NCT02147197|2143246|FG001|Overall Study|Withdrawal of Consent|3
1082509|NCT02147197|2143247|FG002|Overall Study|Withdrawal of Consent|2
1082510|NCT02147197|2143245|FG000|Overall Study|Lost to Follow-up|2
1082511|NCT02147197|2143246|FG001|Overall Study|Lost to Follow-up|3
1082512|NCT02147197|2143247|FG002|Overall Study|Lost to Follow-up|1
1082513|NCT02147197|2143245|FG000|Overall Study|Protocol Violation|1
1082514|NCT02147197|2143246|FG001|Overall Study|Protocol Violation|0
1082515|NCT02147197|2143247|FG002|Overall Study|Protocol Violation|3
1082516|NCT02147197|2143245|FG000|Overall Study|Other Miscellaneous Reasons|1
1082517|NCT02147197|2143246|FG001|Overall Study|Other Miscellaneous Reasons|0
1082518|NCT02147197|2143247|FG002|Overall Study|Other Miscellaneous Reasons|3
1082519|NCT02147288|2143257|FG000|Overall Study|post-operative hematoma|1
1082520|NCT02147288|2143258|FG001|Overall Study|post-operative hematoma|1
1082521|NCT02147288|2143259|FG002|Overall Study|post-operative hematoma|0
1082522|NCT02147288|2143260|FG003|Overall Study|post-operative hematoma|0
1082523|NCT02147288|2143261|FG004|Overall Study|post-operative hematoma|0
1082524|NCT02147288|2143262|FG005|Overall Study|post-operative hematoma|0
1082525|NCT02147288|2143263|FG006|Overall Study|post-operative hematoma|0
1082526|NCT02147288|2143264|FG007|Overall Study|post-operative hematoma|0
1082527|NCT02147288|2143265|FG008|Overall Study|post-operative hematoma|0
1082528|NCT02147288|2143266|FG009|Overall Study|post-operative hematoma|0
1082529|NCT02147288|2143257|FG000|Overall Study|complications from concurrent hernia rep|0
1082530|NCT02147288|2143258|FG001|Overall Study|complications from concurrent hernia rep|1
1082531|NCT02147288|2143259|FG002|Overall Study|complications from concurrent hernia rep|0
1082532|NCT02147288|2143260|FG003|Overall Study|complications from concurrent hernia rep|0
1082533|NCT02147288|2143261|FG004|Overall Study|complications from concurrent hernia rep|0
1082534|NCT02147288|2143262|FG005|Overall Study|complications from concurrent hernia rep|0
1082535|NCT02147288|2143263|FG006|Overall Study|complications from concurrent hernia rep|0
1082536|NCT02147288|2143264|FG007|Overall Study|complications from concurrent hernia rep|0
1082537|NCT02147288|2143265|FG008|Overall Study|complications from concurrent hernia rep|0
1082538|NCT02147288|2143266|FG009|Overall Study|complications from concurrent hernia rep|0
1082539|NCT02147353|2143278|FG000|Overall Study|Lost to Follow-up|2
1082540|NCT02147353|2143279|FG001|Overall Study|Lost to Follow-up|0
1082541|NCT02147353|2143278|FG000|Overall Study|unable to make visits|4
1082542|NCT02147353|2143279|FG001|Overall Study|unable to make visits|0
1082543|NCT02147353|2143278|FG000|Overall Study|medication noncompliance|3
1082544|NCT02147353|2143279|FG001|Overall Study|medication noncompliance|0
1082545|NCT02147561|2143294|FG000|Overall Study|Lost to Follow-up|3
1082546|NCT02147561|2143294|FG000|Overall Study|Subjects who didn't receive BOTOX|1
1082547|NCT02147587|2143300|FG000|Overall Study|Adverse Event|9
1082548|NCT02147587|2143301|FG001|Overall Study|Adverse Event|4
1082549|NCT02147587|2143300|FG000|Overall Study|Lack of Efficacy|2
1082550|NCT02147587|2143301|FG001|Overall Study|Lack of Efficacy|1
1082551|NCT02147626|2143318|FG000|Overall Study|Lost to Follow-up|4
1082552|NCT02147626|2143319|FG001|Overall Study|Lost to Follow-up|4
1082553|NCT02147626|2143318|FG000|Overall Study|Pregnancy|1
1082554|NCT02147626|2143319|FG001|Overall Study|Pregnancy|2
1082555|NCT02147626|2143318|FG000|Overall Study|Withdrawal by Subject|0
1082556|NCT02147626|2143319|FG001|Overall Study|Withdrawal by Subject|1
1082557|NCT02147691|2143327|FG000|Overall Study|Withdrawal by Subject|2
1082558|NCT02147691|2143328|FG001|Overall Study|Withdrawal by Subject|0
1082559|NCT02147691|2143327|FG000|Overall Study|Adverse Event|2
1082560|NCT02147691|2143328|FG001|Overall Study|Adverse Event|0
1082561|NCT02147691|2143327|FG000|Overall Study|Lost to Follow-up|0
1082562|NCT02147691|2143328|FG001|Overall Study|Lost to Follow-up|1
1082563|NCT02148211|2143382|FG000|Overall Study|Lost to Follow-up|352
1082564|NCT02148250|2143386|FG000|Screening|Withdrawal by Subject|5
1082565|NCT02148250|2143387|FG001|Screening|Withdrawal by Subject|0
1082566|NCT02148445|2143405|FG000|Overall Study|Death|1
1082567|NCT02148445|2143406|FG001|Overall Study|Death|3
1082568|NCT02148718|2143431|FG000|Overall Study|Protocol Violation|26
1082569|NCT02148718|2143431|FG000|Overall Study|Discontinued Study Prematurely|5
1082570|NCT02148952|2143460|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
1082571|NCT02148952|2143461|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
1082572|NCT02148952|2143460|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
1082573|NCT02148952|2143461|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
1082574|NCT02148952|2143460|FG000|Follow-Up|Lost to Follow-up|219
1082575|NCT02148952|2143461|FG001|Follow-Up|Lost to Follow-up|231
1082576|NCT02148952|2143460|FG000|Follow-Up|Withdrawal by Subject|46
1082577|NCT02148952|2143461|FG001|Follow-Up|Withdrawal by Subject|48
1082578|NCT02149108|2143477|FG000|Overall Study|Not treated|1
1082579|NCT02149108|2143478|FG001|Overall Study|Not treated|2
1082580|NCT02149108|2143477|FG000|Overall Study|Progressive Disease (PD)|324
1082581|NCT02149108|2143478|FG001|Overall Study|Progressive Disease (PD)|318
1082582|NCT02149108|2143477|FG000|Overall Study|Worsening/adverse event cancer disease|31
1082583|NCT02149108|2143478|FG001|Overall Study|Worsening/adverse event cancer disease|32
1082584|NCT02149108|2143477|FG000|Overall Study|Other Adverse Event (AE)|8
1082585|NCT02149108|2143478|FG001|Overall Study|Other Adverse Event (AE)|18
1082586|NCT02149108|2143477|FG000|Overall Study|Other not defined above|0
1082587|NCT02149108|2143478|FG001|Overall Study|Other not defined above|2
1082588|NCT02149108|2143477|FG000|Overall Study|Refusal to continue trial medication|15
1082589|NCT02149108|2143478|FG001|Overall Study|Refusal to continue trial medication|11
1082590|NCT02149108|2143477|FG000|Overall Study|Lost to Follow-up|1
1082591|NCT02149108|2143478|FG001|Overall Study|Lost to Follow-up|0
1082592|NCT02149199|2143497|FG000|Overall Study|Study specific withdrawal criteria|4
1082593|NCT02149199|2143498|FG001|Overall Study|Study specific withdrawal criteria|21
1082594|NCT02149199|2143499|FG002|Overall Study|Study specific withdrawal criteria|6
1082595|NCT02149199|2143497|FG000|Overall Study|Other|20
1082596|NCT02149199|2143498|FG001|Overall Study|Other|25
1082597|NCT02149199|2143499|FG002|Overall Study|Other|20
1082598|NCT02149199|2143497|FG000|Overall Study|Eligibility criteria not fulfilled|9
1082599|NCT02149199|2143498|FG001|Overall Study|Eligibility criteria not fulfilled|14
1082600|NCT02149199|2143499|FG002|Overall Study|Eligibility criteria not fulfilled|8
1082601|NCT02149199|2143497|FG000|Overall Study|Withdrawal by Subject|75
1082602|NCT02149199|2143498|FG001|Overall Study|Withdrawal by Subject|93
1082603|NCT02149199|2143499|FG002|Overall Study|Withdrawal by Subject|77
1082604|NCT02149199|2143497|FG000|Overall Study|Protocol Violation|16
1082605|NCT02149199|2143498|FG001|Overall Study|Protocol Violation|13
1082606|NCT02149199|2143499|FG002|Overall Study|Protocol Violation|15
1082607|NCT02149199|2143497|FG000|Overall Study|Lost to Follow-up|3
1082608|NCT02149199|2143498|FG001|Overall Study|Lost to Follow-up|12
1082609|NCT02149199|2143499|FG002|Overall Study|Lost to Follow-up|11
1082610|NCT02149199|2143497|FG000|Overall Study|Death|0
1082611|NCT02149199|2143498|FG001|Overall Study|Death|0
1082612|NCT02149199|2143499|FG002|Overall Study|Death|1
1082613|NCT02149199|2143497|FG000|Overall Study|Adverse Event|6
1082614|NCT02149199|2143498|FG001|Overall Study|Adverse Event|15
1082615|NCT02149199|2143499|FG002|Overall Study|Adverse Event|9
1082616|NCT02149264|2143507|FG000|Overall Study|Withdrawal by Subject|9
1082617|NCT02149264|2143507|FG000|Overall Study|Adverse Event|7
1082618|NCT02149264|2143507|FG000|Overall Study|Physician Decision|3
1082619|NCT02149264|2143507|FG000|Overall Study|Protocol Violation|1
1082620|NCT02149420|2143531|FG000|Core Study|Administrative problems|0
1082621|NCT02149420|2143532|FG001|Core Study|Administrative problems|1
1082622|NCT02149420|2143533|FG002|Core Study|Administrative problems|2
1082623|NCT02149420|2143531|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
1082624|NCT02149420|2143532|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
1082625|NCT02149420|2143533|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
1082626|NCT02149810|2143557|FG000|Overall Study|Physician Decision|1
1082627|NCT02149810|2143558|FG001|Overall Study|Physician Decision|2
1082628|NCT02149810|2143557|FG000|Overall Study|Lost to Follow-up|2
1082629|NCT02149810|2143558|FG001|Overall Study|Lost to Follow-up|1
1082630|NCT02149810|2143557|FG000|Overall Study|Withdrawal by Subject|5
1082631|NCT02149810|2143558|FG001|Overall Study|Withdrawal by Subject|1
1082632|NCT02149836|2143564|FG000|Overall Study|Withdrawal by Subject|1
1082633|NCT02149875|2143571|FG000|Overall Study|Lost to Follow-up|3
1082634|NCT02149875|2143572|FG001|Overall Study|Lost to Follow-up|4
1082635|NCT02149875|2143573|FG002|Overall Study|Lost to Follow-up|5
1082636|NCT02149875|2143571|FG000|Overall Study|Withdrawal by Subject|3
1082637|NCT02149875|2143572|FG001|Overall Study|Withdrawal by Subject|2
1082638|NCT02149875|2143573|FG002|Overall Study|Withdrawal by Subject|2
1082639|NCT02149875|2143571|FG000|Overall Study|Physician Decision|1
1082640|NCT02149875|2143572|FG001|Overall Study|Physician Decision|2
1082641|NCT02149875|2143573|FG002|Overall Study|Physician Decision|2
1082642|NCT02150057|2143587|FG000|Overall Study|Lost to Follow-up|6
1082643|NCT02150057|2143588|FG001|Overall Study|Lost to Follow-up|4
1082644|NCT02150213|2143604|FG000|Overall Study|Lost to Follow-up|1
1082645|NCT02150213|2143604|FG000|Overall Study|Withdrawal by Subject|1
1082646|NCT02150343|2143612|FG000|Overall Study|Adverse Event|2
1082647|NCT02150343|2143613|FG001|Overall Study|Adverse Event|0
1082648|NCT02150343|2143614|FG002|Overall Study|Adverse Event|1
1082649|NCT02150343|2143615|FG003|Overall Study|Adverse Event|1
1082650|NCT02150343|2143612|FG000|Overall Study|Withdrawal by Subject|13
1082651|NCT02150343|2143613|FG001|Overall Study|Withdrawal by Subject|10
1082652|NCT02150343|2143614|FG002|Overall Study|Withdrawal by Subject|9
1082653|NCT02150343|2143615|FG003|Overall Study|Withdrawal by Subject|4
1082654|NCT02150343|2143612|FG000|Overall Study|Lost to Follow-up|4
1082655|NCT02150343|2143613|FG001|Overall Study|Lost to Follow-up|4
1082656|NCT02150343|2143614|FG002|Overall Study|Lost to Follow-up|2
1082657|NCT02150343|2143615|FG003|Overall Study|Lost to Follow-up|3
1082658|NCT02150343|2143612|FG000|Overall Study|Other|2
1082659|NCT02150343|2143613|FG001|Overall Study|Other|6
1082660|NCT02150343|2143614|FG002|Overall Study|Other|0
1082661|NCT02150343|2143615|FG003|Overall Study|Other|2
1082662|NCT02150954|2143663|FG000|Overall Study|Protocol Violation|1
1082663|NCT02150954|2143664|FG001|Overall Study|Protocol Violation|0
1082664|NCT02151058|2143673|FG000|Overall Study|Withdrawal by Subject|1
1082665|NCT02151058|2143674|FG001|Overall Study|Withdrawal by Subject|1
1082666|NCT02151058|2143675|FG002|Overall Study|Withdrawal by Subject|3
1082667|NCT02151058|2143673|FG000|Overall Study|Lost to Follow-up|1
1082668|NCT02151058|2143674|FG001|Overall Study|Lost to Follow-up|0
1082669|NCT02151058|2143675|FG002|Overall Study|Lost to Follow-up|2
1082670|NCT02151110|2143691|FG000|Overall Study|Withdrawal by Subject|0
1082671|NCT02151110|2143692|FG001|Overall Study|Withdrawal by Subject|0
1082672|NCT02151110|2143693|FG002|Overall Study|Withdrawal by Subject|0
1082673|NCT02151110|2143694|FG003|Overall Study|Withdrawal by Subject|0
1082674|NCT02151110|2143695|FG004|Overall Study|Withdrawal by Subject|0
1082675|NCT02151110|2143696|FG005|Overall Study|Withdrawal by Subject|0
1082676|NCT02151110|2143697|FG006|Overall Study|Withdrawal by Subject|0
1082677|NCT02151110|2143698|FG007|Overall Study|Withdrawal by Subject|1
1082678|NCT02151110|2143691|FG000|Overall Study|Lost to Follow-up|0
1082679|NCT02151110|2143692|FG001|Overall Study|Lost to Follow-up|0
1082680|NCT02151110|2143693|FG002|Overall Study|Lost to Follow-up|0
1082681|NCT02151110|2143694|FG003|Overall Study|Lost to Follow-up|0
1082682|NCT02151110|2143695|FG004|Overall Study|Lost to Follow-up|0
1082683|NCT02151110|2143696|FG005|Overall Study|Lost to Follow-up|0
1082684|NCT02151110|2143697|FG006|Overall Study|Lost to Follow-up|0
1082685|NCT02151110|2143698|FG007|Overall Study|Lost to Follow-up|2
1082686|NCT02151149|2143725|FG000|Treatment Period|Death|2
1082687|NCT02151149|2143726|FG001|Treatment Period|Death|3
1082688|NCT02151149|2143725|FG000|Treatment Period|Adverse Event|17
1082689|NCT02151149|2143726|FG001|Treatment Period|Adverse Event|14
1082690|NCT02151149|2143725|FG000|Treatment Period|Progressive Disease|25
1082691|NCT02151149|2143726|FG001|Treatment Period|Progressive Disease|24
1082692|NCT02151149|2143725|FG000|Treatment Period|Symptomatic Deterioration|2
1082693|NCT02151149|2143726|FG001|Treatment Period|Symptomatic Deterioration|10
1082694|NCT02151149|2143725|FG000|Treatment Period|Withdrawal by Subject|13
1082695|NCT02151149|2143726|FG001|Treatment Period|Withdrawal by Subject|11
1082696|NCT02151149|2143725|FG000|Treatment Period|Miscellaneous|8
1082697|NCT02151149|2143726|FG001|Treatment Period|Miscellaneous|7
1082698|NCT02151149|2143725|FG000|Treatment Period|Participants randomized but not treated|3
1082699|NCT02151149|2143726|FG001|Treatment Period|Participants randomized but not treated|2
1082700|NCT02151149|2143725|FG000|Follow-Up Period|Lost to Follow-up|2
1082701|NCT02151149|2143726|FG001|Follow-Up Period|Lost to Follow-up|3
1082702|NCT02151149|2143725|FG000|Follow-Up Period|Death|37
1082703|NCT02151149|2143726|FG001|Follow-Up Period|Death|34
1082704|NCT02151266|2143742|FG000|Overall Study|Lost to Follow-up|1
1082705|NCT02151266|2143743|FG001|Overall Study|Lost to Follow-up|4
1082706|NCT02151266|2143744|FG002|Overall Study|Lost to Follow-up|1
1082707|NCT02151266|2143742|FG000|Overall Study|Did NOT receive intervention|3
1082708|NCT02151266|2143743|FG001|Overall Study|Did NOT receive intervention|6
1082709|NCT02151266|2143744|FG002|Overall Study|Did NOT receive intervention|2
1082710|NCT02151266|2143742|FG000|Overall Study|Not able to exercise|4
1082711|NCT02151266|2143743|FG001|Overall Study|Not able to exercise|5
1082712|NCT02151266|2143744|FG002|Overall Study|Not able to exercise|4
1082713|NCT02151461|2143786|FG000|Overall Study|Adverse Event|5
1082714|NCT02151461|2143787|FG001|Overall Study|Adverse Event|1
1082715|NCT02151461|2143788|FG002|Overall Study|Adverse Event|0
1082716|NCT02151461|2143789|FG003|Overall Study|Adverse Event|2
1082717|NCT02151461|2143786|FG000|Overall Study|Lost to Follow-up|0
1082718|NCT02151461|2143787|FG001|Overall Study|Lost to Follow-up|0
1082719|NCT02151461|2143788|FG002|Overall Study|Lost to Follow-up|1
1082720|NCT02151461|2143789|FG003|Overall Study|Lost to Follow-up|1
1082721|NCT02151461|2143786|FG000|Overall Study|Withdrawal by Subject|1
1082722|NCT02151461|2143787|FG001|Overall Study|Withdrawal by Subject|0
1082723|NCT02151461|2143788|FG002|Overall Study|Withdrawal by Subject|1
1082724|NCT02151461|2143789|FG003|Overall Study|Withdrawal by Subject|1
1082725|NCT02151461|2143786|FG000|Overall Study|Treatment discontinuation|0
1082726|NCT02151461|2143787|FG001|Overall Study|Treatment discontinuation|0
1082727|NCT02151461|2143788|FG002|Overall Study|Treatment discontinuation|1
1082728|NCT02151461|2143789|FG003|Overall Study|Treatment discontinuation|0
1082729|NCT02151591|2143829|FG000|Overall Study|Lost to Follow-up|6
1082730|NCT02151591|2143830|FG001|Overall Study|Lost to Follow-up|3
1082731|NCT02151643|2143841|FG000|Overall Study|Adverse Event|2
1082732|NCT02151643|2143842|FG001|Overall Study|Adverse Event|0
1082733|NCT02151643|2143843|FG002|Overall Study|Adverse Event|1
1082734|NCT02151643|2143844|FG003|Overall Study|Adverse Event|4
1082735|NCT02151643|2143845|FG004|Overall Study|Adverse Event|0
1082736|NCT02151643|2143841|FG000|Overall Study|Withdrawal by Subject|0
1082737|NCT02151643|2143842|FG001|Overall Study|Withdrawal by Subject|1
1082738|NCT02151643|2143843|FG002|Overall Study|Withdrawal by Subject|1
1082739|NCT02151643|2143844|FG003|Overall Study|Withdrawal by Subject|1
1082740|NCT02151643|2143845|FG004|Overall Study|Withdrawal by Subject|1
1082741|NCT02151643|2143841|FG000|Overall Study|Hyperphosphataemia|1
1082742|NCT02151643|2143842|FG001|Overall Study|Hyperphosphataemia|0
1082743|NCT02151643|2143843|FG002|Overall Study|Hyperphosphataemia|0
1082744|NCT02151643|2143844|FG003|Overall Study|Hyperphosphataemia|0
1082745|NCT02151643|2143845|FG004|Overall Study|Hyperphosphataemia|1
1082746|NCT02151643|2143841|FG000|Overall Study|High Ferritin levels|3
1082747|NCT02151643|2143842|FG001|Overall Study|High Ferritin levels|3
1082748|NCT02151643|2143843|FG002|Overall Study|High Ferritin levels|2
1082749|NCT02151643|2143844|FG003|Overall Study|High Ferritin levels|2
1082750|NCT02151643|2143845|FG004|Overall Study|High Ferritin levels|1
1082751|NCT02151682|2143859|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
1082752|NCT02151682|2143860|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
1082753|NCT02151682|2143861|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
1082754|NCT02151682|2143862|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
1082755|NCT02151682|2143863|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
1082756|NCT02151682|2143864|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
1082757|NCT02151682|2143859|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
1082758|NCT02151682|2143860|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
1082759|NCT02151682|2143861|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
1082760|NCT02151682|2143862|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
1082761|NCT02151682|2143863|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
1082762|NCT02151682|2143864|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
1082763|NCT02151682|2143859|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
1082764|NCT02151682|2143860|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
1082765|NCT02151682|2143861|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
1082766|NCT02151682|2143862|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
1082767|NCT02151682|2143863|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
1082768|NCT02151682|2143864|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
1082769|NCT02151682|2143859|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
1082770|NCT02151682|2143860|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
1082771|NCT02151682|2143861|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
1082772|NCT02151682|2143862|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
1082773|NCT02151682|2143863|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
1082774|NCT02151682|2143864|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
1082775|NCT02151682|2143859|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1
1082776|NCT02151682|2143860|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0
1082777|NCT02151682|2143861|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0
1082778|NCT02151682|2143862|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0
1082779|NCT02151682|2143863|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0
1082780|NCT02151682|2143864|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0
1082781|NCT02151682|2143859|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0
1082782|NCT02151682|2143860|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0
1082783|NCT02151682|2143861|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3
1082784|NCT02151682|2143862|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0
1082785|NCT02151682|2143863|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0
1082786|NCT02151682|2143864|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0
1082787|NCT02151682|2143859|FG000|Part 2: Tapent. Extension or Observation|Death|0
1082788|NCT02151682|2143860|FG001|Part 2: Tapent. Extension or Observation|Death|0
1082789|NCT02151682|2143861|FG002|Part 2: Tapent. Extension or Observation|Death|0
1082790|NCT02151682|2143862|FG003|Part 2: Tapent. Extension or Observation|Death|2
1082791|NCT02151682|2143863|FG004|Part 2: Tapent. Extension or Observation|Death|0
1082792|NCT02151682|2143864|FG005|Part 2: Tapent. Extension or Observation|Death|0
1082793|NCT02151682|2143859|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
1082794|NCT02151682|2143860|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
1082795|NCT02151682|2143861|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
1082796|NCT02151682|2143862|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
1082797|NCT02151682|2143863|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
1082798|NCT02151682|2143864|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
1082799|NCT02151682|2143859|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
1082800|NCT02151682|2143860|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
1082801|NCT02151682|2143861|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
1082802|NCT02151682|2143862|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
1082803|NCT02151682|2143863|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
1082804|NCT02151682|2143864|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
1082805|NCT02151682|2143859|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0
1082806|NCT02151682|2143860|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0
1082807|NCT02151682|2143861|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1
1082808|NCT02151682|2143862|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0
1082809|NCT02151682|2143863|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0
1082810|NCT02151682|2143864|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0
1082811|NCT02151682|2143859|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0
1082812|NCT02151682|2143860|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0
1082813|NCT02151682|2143861|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13
1082814|NCT02151682|2143862|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0
1082815|NCT02151682|2143863|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0
1082816|NCT02151682|2143864|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0
1082817|NCT02151682|2143859|FG000|Part 2: Tapent. Extension or Observation|Missing|0
1082818|NCT02151682|2143860|FG001|Part 2: Tapent. Extension or Observation|Missing|0
1082819|NCT02151682|2143861|FG002|Part 2: Tapent. Extension or Observation|Missing|0
1082820|NCT02151682|2143862|FG003|Part 2: Tapent. Extension or Observation|Missing|1
1082821|NCT02151682|2143863|FG004|Part 2: Tapent. Extension or Observation|Missing|0
1082822|NCT02151682|2143864|FG005|Part 2: Tapent. Extension or Observation|Missing|0
1082823|NCT02151682|2143859|FG000|Part 2: Tapent. Extension or Observation|Various other|0
1082824|NCT02151682|2143860|FG001|Part 2: Tapent. Extension or Observation|Various other|0
1082825|NCT02151682|2143861|FG002|Part 2: Tapent. Extension or Observation|Various other|6
1082826|NCT02151682|2143862|FG003|Part 2: Tapent. Extension or Observation|Various other|0
1082827|NCT02151682|2143863|FG004|Part 2: Tapent. Extension or Observation|Various other|0
1082828|NCT02151682|2143864|FG005|Part 2: Tapent. Extension or Observation|Various other|0
1082829|NCT02151682|2143859|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
1082830|NCT02151682|2143860|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
1082831|NCT02151682|2143861|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
1082832|NCT02151682|2143862|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
1082833|NCT02151682|2143863|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
1082834|NCT02151682|2143864|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
1082835|NCT02151682|2143859|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
1082836|NCT02151682|2143860|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
1082837|NCT02151682|2143861|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
1082838|NCT02151682|2143862|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
1082839|NCT02151682|2143863|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
1082840|NCT02151682|2143864|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
1082841|NCT02151682|2143859|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0
1082842|NCT02151682|2143860|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0
1082843|NCT02151682|2143861|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0
1082844|NCT02151682|2143862|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0
1082845|NCT02151682|2143863|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0
1082846|NCT02151682|2143864|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1
1082847|NCT02151682|2143859|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0
1082848|NCT02151682|2143860|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0
1082849|NCT02151682|2143861|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0
1082850|NCT02151682|2143862|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0
1082851|NCT02151682|2143863|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0
1082852|NCT02151682|2143864|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3
1082853|NCT02151682|2143859|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0
1082854|NCT02151682|2143860|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0
1082855|NCT02151682|2143861|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0
1082856|NCT02151682|2143862|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0
1082857|NCT02151682|2143863|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0
1082858|NCT02151682|2143864|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2
1082859|NCT02151773|2143882|FG000|Overall Study|Protocol Deviation|64
1082860|NCT02151786|2143886|FG000|Overall Study|Unavailability of Case Report Form|26
1082861|NCT02151786|2143886|FG000|Overall Study|Outside the Contract Period|1
1082862|NCT02151786|2143886|FG000|Overall Study|Randomized, not Treated|1
1082863|NCT02151786|2143886|FG000|Overall Study|Unavailability of Information|8
1082864|NCT02151851|2143892|FG000|Overall Study|Lack of Efficacy|67
1082865|NCT02151851|2143893|FG001|Overall Study|Lack of Efficacy|94
1082866|NCT02151851|2143892|FG000|Overall Study|Protocol Violation|0
1082867|NCT02151851|2143893|FG001|Overall Study|Protocol Violation|1
1082868|NCT02151851|2143892|FG000|Overall Study|Withdrawal by Subject|2
1082869|NCT02151851|2143893|FG001|Overall Study|Withdrawal by Subject|5
1082870|NCT02151851|2143892|FG000|Overall Study|Medical impairment|1
1082871|NCT02151851|2143893|FG001|Overall Study|Medical impairment|0
1082872|NCT02151851|2143892|FG000|Overall Study|Low compliance to study visits|0
1082873|NCT02151851|2143893|FG001|Overall Study|Low compliance to study visits|1
1082874|NCT02151851|2143892|FG000|Overall Study|Subject entered into study in error|0
1082875|NCT02151851|2143893|FG001|Overall Study|Subject entered into study in error|1
1082876|NCT02151851|2143892|FG000|Overall Study|Adverse Event|6
1082877|NCT02151851|2143893|FG001|Overall Study|Adverse Event|28
1082878|NCT02151903|2143912|FG000|Overall Study|Withdrawal by Subject|1
1082879|NCT02151903|2143913|FG001|Overall Study|Withdrawal by Subject|0
1082880|NCT02151903|2143912|FG000|Overall Study|Progressive disease|2
1082881|NCT02151903|2143913|FG001|Overall Study|Progressive disease|1
1082882|NCT02151981|2143921|FG000|Overall Study|Death|184
1082883|NCT02151981|2143922|FG001|Overall Study|Death|88
1082884|NCT02151981|2143921|FG000|Overall Study|Lost to Follow-up|7
1082885|NCT02151981|2143922|FG001|Overall Study|Lost to Follow-up|1
1082886|NCT02151981|2143921|FG000|Overall Study|Withdrawal by Subject|27
1082887|NCT02151981|2143922|FG001|Overall Study|Withdrawal by Subject|21
1082888|NCT02151981|2143921|FG000|Overall Study|Ongoing Study at Data Cut-off|60
1082889|NCT02151981|2143922|FG001|Overall Study|Ongoing Study at Data Cut-off|27
1082890|NCT02151981|2143921|FG000|Overall Study|Eligibility criteria not fulfilled|0
1082891|NCT02151981|2143922|FG001|Overall Study|Eligibility criteria not fulfilled|1
1082892|NCT02151981|2143921|FG000|Overall Study|Patient had no clinical benefit|1
1082893|NCT02151981|2143922|FG001|Overall Study|Patient had no clinical benefit|0
1082894|NCT02151981|2143921|FG000|Overall Study|Unwilling to continue to follow up visit|0
1082895|NCT02151981|2143922|FG001|Overall Study|Unwilling to continue to follow up visit|1
1082896|NCT02151981|2143921|FG000|Overall Study|Study terminated|0
1082897|NCT02151981|2143922|FG001|Overall Study|Study terminated|1
1082898|NCT02152007|2143980|FG000|Overall Study|Withdrawal by Subject|1
1082899|NCT02152137|2143994|FG000|Overall Study|Withdrawal by Subject|1
1082900|NCT02152137|2143994|FG000|Overall Study|Originally assigned to Arm B|3
1082901|NCT02152163|2144000|FG000|Overall Study|Physician Decision|12
1082902|NCT02152163|2144001|FG001|Overall Study|Physician Decision|13
1082903|NCT02152345|2144009|FG000|Overall Study|Case Cancellations|2
1082904|NCT02152345|2144010|FG001|Overall Study|Case Cancellations|4
1082905|NCT02152345|2144009|FG000|Overall Study|Withdrawal by Subject|2
1082906|NCT02152345|2144010|FG001|Overall Study|Withdrawal by Subject|1
1082907|NCT02152371|2144018|FG000|Overall Study|Adverse Event|6
1082908|NCT02152371|2144019|FG001|Overall Study|Adverse Event|2
1082909|NCT02152371|2144018|FG000|Overall Study|Withdrawal by Subject|3
1082910|NCT02152371|2144019|FG001|Overall Study|Withdrawal by Subject|7
1082911|NCT02152371|2144018|FG000|Overall Study|Protocol Violation|2
1082912|NCT02152371|2144019|FG001|Overall Study|Protocol Violation|3
1082913|NCT02152371|2144018|FG000|Overall Study|Lost to Follow-up|1
1082914|NCT02152371|2144019|FG001|Overall Study|Lost to Follow-up|0
1082915|NCT02152371|2144018|FG000|Overall Study|Lack of Efficacy|0
1082916|NCT02152371|2144019|FG001|Overall Study|Lack of Efficacy|1
1082917|NCT02152371|2144018|FG000|Overall Study|Physician Decision|0
1082918|NCT02152371|2144019|FG001|Overall Study|Physician Decision|2
1082919|NCT02152371|2144018|FG000|Overall Study|Reason Not Given|0
1082920|NCT02152371|2144019|FG001|Overall Study|Reason Not Given|1
1082921|NCT02152384|2144025|FG000|Period 1|Withdrawal by Subject|0
1082922|NCT02152384|2144026|FG001|Period 1|Withdrawal by Subject|1
1082923|NCT02152384|2144025|FG000|Period 1|Adverse Event|1
1082924|NCT02152384|2144026|FG001|Period 1|Adverse Event|1
1082925|NCT02152605|2144054|FG000|Overall Study|Adverse Event|6
1082926|NCT02152605|2144055|FG001|Overall Study|Adverse Event|8
1082927|NCT02152605|2144054|FG000|Overall Study|Lack of Efficacy|7
1082928|NCT02152605|2144055|FG001|Overall Study|Lack of Efficacy|4
1082929|NCT02152605|2144054|FG000|Overall Study|Protocol deviation|1
1082930|NCT02152605|2144055|FG001|Overall Study|Protocol deviation|4
1082931|NCT02152605|2144054|FG000|Overall Study|Lost to Follow-up|1
1082932|NCT02152605|2144055|FG001|Overall Study|Lost to Follow-up|0
1082933|NCT02152605|2144054|FG000|Overall Study|Withdrew consent|4
1082934|NCT02152605|2144055|FG001|Overall Study|Withdrew consent|2
1082935|NCT02152631|2144064|FG000|Overall Study|Adverse Event|32
1082936|NCT02152631|2144065|FG001|Overall Study|Adverse Event|4
1082937|NCT02152631|2144064|FG000|Overall Study|Withdrawal by Subject|13
1082938|NCT02152631|2144065|FG001|Overall Study|Withdrawal by Subject|16
1082939|NCT02152631|2144064|FG000|Overall Study|Noncompliance with study drug|1
1082940|NCT02152631|2144065|FG001|Overall Study|Noncompliance with study drug|0
1082941|NCT02152631|2144064|FG000|Overall Study|Physician Decision|1
1082942|NCT02152631|2144065|FG001|Overall Study|Physician Decision|2
1082943|NCT02152631|2144064|FG000|Overall Study|Lost to Follow-up|0
1082944|NCT02152631|2144065|FG001|Overall Study|Lost to Follow-up|1
1082945|NCT02152631|2144064|FG000|Overall Study|On Treatment|19
1082946|NCT02152631|2144065|FG001|Overall Study|On Treatment|3
1082947|NCT02152761|2144088|FG000|Epoch: Treatment Epoch|Technical problems|0
1082948|NCT02152761|2144089|FG001|Epoch: Treatment Epoch|Technical problems|0
1082949|NCT02152761|2144090|FG002|Epoch: Treatment Epoch|Technical problems|0
1082950|NCT02152761|2144091|FG003|Epoch: Treatment Epoch|Technical problems|1
1082951|NCT02152761|2144088|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0
1082952|NCT02152761|2144089|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2
1082953|NCT02152761|2144090|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0
1082954|NCT02152761|2144091|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0
1082955|NCT02152761|2144088|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7
1082956|NCT02152761|2144089|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8
1082957|NCT02152761|2144090|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3
1082958|NCT02152761|2144091|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5
1082959|NCT02152761|2144088|FG000|Epoch: Treatment Epoch|Adverse Event|3
1082960|NCT02152761|2144089|FG001|Epoch: Treatment Epoch|Adverse Event|6
1082961|NCT02152761|2144090|FG002|Epoch: Treatment Epoch|Adverse Event|1
1082962|NCT02152761|2144091|FG003|Epoch: Treatment Epoch|Adverse Event|2
1082963|NCT02152761|2144088|FG000|Epoch: Treatment Epoch|Death|0
1082964|NCT02152761|2144089|FG001|Epoch: Treatment Epoch|Death|3
1082965|NCT02152761|2144090|FG002|Epoch: Treatment Epoch|Death|1
1082966|NCT02152761|2144091|FG003|Epoch: Treatment Epoch|Death|0
1082967|NCT02152761|2144088|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1
1082968|NCT02152761|2144089|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1
1082969|NCT02152761|2144090|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0
1082970|NCT02152761|2144091|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0
1082971|NCT02152761|2144088|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
1082972|NCT02152761|2144089|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3
1082973|NCT02152761|2144090|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0
1082974|NCT02152761|2144091|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
1082975|NCT02152761|2144088|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1
1082976|NCT02152761|2144089|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4
1082977|NCT02152761|2144090|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
1082978|NCT02152761|2144091|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
1082979|NCT02152761|2144088|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1
1082980|NCT02152761|2144089|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
1082981|NCT02152761|2144090|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
1082982|NCT02152761|2144091|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
1082983|NCT02152761|2144088|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1
1082984|NCT02152761|2144089|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0
1082985|NCT02152761|2144090|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0
1082986|NCT02152761|2144091|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1
1082987|NCT02153073|2144116|FG000|Overall Study|Case Report Forms Uncollected|230
1082988|NCT02153073|2144116|FG000|Overall Study|Protocol Deviation|68
1082989|NCT02153086|2144120|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2
1082990|NCT02153086|2144120|FG000|Overall Study|Other|2
1082991|NCT02153112|2144163|FG000|Overall Study|Adverse Event|0
1082992|NCT02153112|2144164|FG001|Overall Study|Adverse Event|0
1082993|NCT02153112|2144165|FG002|Overall Study|Adverse Event|1
1082994|NCT02153112|2144166|FG003|Overall Study|Adverse Event|0
1082995|NCT02153112|2144167|FG004|Overall Study|Adverse Event|0
1082996|NCT02153112|2144168|FG005|Overall Study|Adverse Event|0
1082997|NCT02153112|2144169|FG006|Overall Study|Adverse Event|0
1082998|NCT02153112|2144170|FG007|Overall Study|Adverse Event|0
1082999|NCT02153112|2144171|FG008|Overall Study|Adverse Event|0
1083000|NCT02153112|2144172|FG009|Overall Study|Adverse Event|0
1083001|NCT02153112|2144163|FG000|Overall Study|Lost to Follow-up|1
1083002|NCT02153112|2144164|FG001|Overall Study|Lost to Follow-up|1
1083003|NCT02153112|2144165|FG002|Overall Study|Lost to Follow-up|0
1083004|NCT02153112|2144166|FG003|Overall Study|Lost to Follow-up|0
1083005|NCT02153112|2144167|FG004|Overall Study|Lost to Follow-up|2
1083006|NCT02153112|2144168|FG005|Overall Study|Lost to Follow-up|1
1083007|NCT02153112|2144169|FG006|Overall Study|Lost to Follow-up|1
1083008|NCT02153112|2144170|FG007|Overall Study|Lost to Follow-up|0
1083009|NCT02153112|2144171|FG008|Overall Study|Lost to Follow-up|1
1083010|NCT02153112|2144172|FG009|Overall Study|Lost to Follow-up|1
1083011|NCT02153112|2144163|FG000|Overall Study|Withdrawal by Subject|3
1083012|NCT02153112|2144164|FG001|Overall Study|Withdrawal by Subject|1
1083013|NCT02153112|2144165|FG002|Overall Study|Withdrawal by Subject|2
1083014|NCT02153112|2144166|FG003|Overall Study|Withdrawal by Subject|2
1083015|NCT02153112|2144167|FG004|Overall Study|Withdrawal by Subject|1
1083016|NCT02153112|2144168|FG005|Overall Study|Withdrawal by Subject|1
1083017|NCT02153112|2144169|FG006|Overall Study|Withdrawal by Subject|7
1083018|NCT02153112|2144170|FG007|Overall Study|Withdrawal by Subject|2
1083019|NCT02153112|2144171|FG008|Overall Study|Withdrawal by Subject|13
1083020|NCT02153112|2144172|FG009|Overall Study|Withdrawal by Subject|12
1083021|NCT02153112|2144163|FG000|Overall Study|Reason not Specified|0
1083022|NCT02153112|2144164|FG001|Overall Study|Reason not Specified|0
1083023|NCT02153112|2144165|FG002|Overall Study|Reason not Specified|0
1083024|NCT02153112|2144166|FG003|Overall Study|Reason not Specified|0
1083025|NCT02153112|2144167|FG004|Overall Study|Reason not Specified|0
1083026|NCT02153112|2144168|FG005|Overall Study|Reason not Specified|0
1083027|NCT02153112|2144169|FG006|Overall Study|Reason not Specified|0
1083028|NCT02153112|2144170|FG007|Overall Study|Reason not Specified|0
1083029|NCT02153112|2144171|FG008|Overall Study|Reason not Specified|1
1083030|NCT02153112|2144172|FG009|Overall Study|Reason not Specified|1
1083031|NCT02153346|2144196|FG000|Overall Study|Lost to Follow-up|11
1083032|NCT02153359|2144201|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0
1083033|NCT02153359|2144202|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2
1083034|NCT02153398|2144216|FG000|Overall Study|Withdrawal by Subject|1
1083035|NCT02153398|2144217|FG001|Overall Study|Withdrawal by Subject|0
1083036|NCT02153398|2144218|FG002|Overall Study|Withdrawal by Subject|0
1083037|NCT02153398|2144219|FG003|Overall Study|Withdrawal by Subject|0
1083038|NCT02153398|2144220|FG004|Overall Study|Withdrawal by Subject|0
1083039|NCT02153398|2144216|FG000|Overall Study|Adverse Event|0
1083040|NCT02153398|2144217|FG001|Overall Study|Adverse Event|0
1083041|NCT02153398|2144218|FG002|Overall Study|Adverse Event|1
1083042|NCT02153398|2144219|FG003|Overall Study|Adverse Event|1
1083043|NCT02153398|2144220|FG004|Overall Study|Adverse Event|0
1083044|NCT02153736|2144309|FG000|Overall Study|Lost to Follow-up|1
1083045|NCT02153736|2144310|FG001|Overall Study|Lost to Follow-up|0
1083046|NCT02153736|2144309|FG000|Overall Study|Medical status change made ineligible|1
1083047|NCT02153736|2144310|FG001|Overall Study|Medical status change made ineligible|0
1083048|NCT02153736|2144309|FG000|Overall Study|Death|0
1083049|NCT02153736|2144310|FG001|Overall Study|Death|1
1083050|NCT02153736|2144309|FG000|Overall Study|Withdrawal by Subject|0
1083051|NCT02153736|2144310|FG001|Overall Study|Withdrawal by Subject|1
1083052|NCT02153788|2144318|FG000|Overall Study|Physician Decision|2
1083053|NCT02153788|2144319|FG001|Overall Study|Physician Decision|1
1083054|NCT02153827|2144327|FG000|Overall Study|Lost to Follow-up|3
1083055|NCT02153827|2144328|FG001|Overall Study|Lost to Follow-up|9
1083056|NCT02153905|2144336|FG000|Overall Study|Death|1
1083057|NCT02153905|2144337|FG001|Overall Study|Death|0
1083058|NCT02153918|2144343|FG000|Overall Study|Refused further treatment|1
1083059|NCT02154061|2144387|FG000|Overall Study|Pregnancy|1
1083060|NCT02154061|2144388|FG001|Overall Study|Pregnancy|0
1083061|NCT02154061|2144387|FG000|Overall Study|enrolled but not vaccinated|1
1083062|NCT02154061|2144388|FG001|Overall Study|enrolled but not vaccinated|0
1083063|NCT02154139|2144394|FG000|Overall Study|Injection not administered|2
1083064|NCT02154139|2144394|FG000|Overall Study|Other|2
1083065|NCT02154139|2144394|FG000|Overall Study|Investigator transferred|3
1083066|NCT02154347|2144413|FG000|Double-blind Period|Adverse Event|1
1083067|NCT02154347|2144414|FG001|Double-blind Period|Adverse Event|2
1083068|NCT02154347|2144413|FG000|Double-blind Period|Lack of Efficacy|1
1083069|NCT02154347|2144414|FG001|Double-blind Period|Lack of Efficacy|0
1083070|NCT02154347|2144413|FG000|Double-blind Period|Physician Decision|0
1083071|NCT02154347|2144414|FG001|Double-blind Period|Physician Decision|1
1083072|NCT02154347|2144413|FG000|Double-blind Period|Withdrawal by Subject|1
1083073|NCT02154347|2144414|FG001|Double-blind Period|Withdrawal by Subject|1
1083074|NCT02154347|2144413|FG000|Open-label Period|Adverse Event|3
1083075|NCT02154347|2144414|FG001|Open-label Period|Adverse Event|4
1083076|NCT02154347|2144413|FG000|Open-label Period|Lack of Efficacy|4
1083077|NCT02154347|2144414|FG001|Open-label Period|Lack of Efficacy|19
1083078|NCT02154347|2144413|FG000|Open-label Period|Protocol Violation|0
1083079|NCT02154347|2144414|FG001|Open-label Period|Protocol Violation|1
1083080|NCT02154347|2144413|FG000|Open-label Period|Withdrawal by Subject|0
1083081|NCT02154347|2144414|FG001|Open-label Period|Withdrawal by Subject|1
1083082|NCT02154425|2144430|FG000|Screening Period|Adverse Event|1
1083083|NCT02154581|2144449|FG000|Overall Study|Lost to Follow-up|7
1083084|NCT02154581|2144450|FG001|Overall Study|Lost to Follow-up|8
1083085|NCT02155283|2144513|FG000|Overall Study|Lost to Follow-up|3
1083086|NCT02155283|2144513|FG000|Overall Study|Withdrawal by Subject|1
1083087|NCT02155283|2144513|FG000|Overall Study|Protocol Violation|3
1083088|NCT02155309|2144519|FG000|Overall Study|Protocol Violation|0
1083089|NCT02155309|2144520|FG001|Overall Study|Protocol Violation|0
1083090|NCT02155309|2144521|FG002|Overall Study|Protocol Violation|1
1083091|NCT02155322|2144528|FG000|Overall Study|Adverse Event|1
1083092|NCT02155322|2144528|FG000|Overall Study|Physician Decision|1
1083093|NCT02155322|2144528|FG000|Overall Study|Relapse/Recurrence|8
1083094|NCT02155322|2144528|FG000|Overall Study|Withdrawal by Subject|4
1083095|NCT02155608|2144597|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
1083096|NCT02155608|2144598|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
1083097|NCT02155608|2144597|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
1083098|NCT02155608|2144598|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
1083099|NCT02155647|2144612|FG000|Overall Study|Still on Treatment|26
1083100|NCT02155647|2144613|FG001|Overall Study|Still on Treatment|26
1083101|NCT02155647|2144612|FG000|Overall Study|Off-Treatment, but follow up ongoing|15
1083102|NCT02155647|2144613|FG001|Overall Study|Off-Treatment, but follow up ongoing|26
1083103|NCT02155660|2144623|FG000|Overall Study|Other Reason|8
1083104|NCT02155660|2144624|FG001|Overall Study|Other Reason|6
1083105|NCT02155660|2144625|FG002|Overall Study|Other Reason|10
1083106|NCT02155660|2144626|FG003|Overall Study|Other Reason|10
1083107|NCT02155660|2144623|FG000|Overall Study|Study-specific withdrawal criteria|0
1083108|NCT02155660|2144624|FG001|Overall Study|Study-specific withdrawal criteria|1
1083109|NCT02155660|2144625|FG002|Overall Study|Study-specific withdrawal criteria|1
1083110|NCT02155660|2144626|FG003|Overall Study|Study-specific withdrawal criteria|1
1083111|NCT02155660|2144623|FG000|Overall Study|Severe non-compliance|0
1083112|NCT02155660|2144624|FG001|Overall Study|Severe non-compliance|4
1083113|NCT02155660|2144625|FG002|Overall Study|Severe non-compliance|0
1083114|NCT02155660|2144626|FG003|Overall Study|Severe non-compliance|1
1083115|NCT02155660|2144623|FG000|Overall Study|Adverse Event|2
1083116|NCT02155660|2144624|FG001|Overall Study|Adverse Event|6
1083117|NCT02155660|2144625|FG002|Overall Study|Adverse Event|3
1083118|NCT02155660|2144626|FG003|Overall Study|Adverse Event|1
1083119|NCT02155660|2144623|FG000|Overall Study|Lost to Follow-up|3
1083120|NCT02155660|2144624|FG001|Overall Study|Lost to Follow-up|6
1083121|NCT02155660|2144625|FG002|Overall Study|Lost to Follow-up|5
1083122|NCT02155660|2144626|FG003|Overall Study|Lost to Follow-up|8
1083123|NCT02155660|2144623|FG000|Overall Study|Death|17
1083124|NCT02155660|2144624|FG001|Overall Study|Death|19
1083125|NCT02155660|2144625|FG002|Overall Study|Death|17
1083126|NCT02155660|2144626|FG003|Overall Study|Death|19
1083127|NCT02155660|2144623|FG000|Overall Study|Withdrawal by Subject|28
1083128|NCT02155660|2144624|FG001|Overall Study|Withdrawal by Subject|31
1083129|NCT02155660|2144625|FG002|Overall Study|Withdrawal by Subject|24
909556|NCT00789035|1886312|FG001|Overall Study|Lack of Efficacy|0
909557|NCT00789035|1886313|FG002|Overall Study|Lack of Efficacy|0
909558|NCT00789035|1886314|FG003|Overall Study|Lack of Efficacy|0
909559|NCT00789035|1886315|FG004|Overall Study|Lack of Efficacy|2
909560|NCT00789035|1886311|FG000|Overall Study|Protocol Violation|1
909561|NCT00789035|1886312|FG001|Overall Study|Protocol Violation|0
909562|NCT00789035|1886313|FG002|Overall Study|Protocol Violation|0
909563|NCT00789035|1886314|FG003|Overall Study|Protocol Violation|0
909564|NCT00789035|1886315|FG004|Overall Study|Protocol Violation|0
909565|NCT00789035|1886311|FG000|Overall Study|Withdrawal by Subject|0
909566|NCT00789035|1886312|FG001|Overall Study|Withdrawal by Subject|2
909567|NCT00789035|1886313|FG002|Overall Study|Withdrawal by Subject|0
909568|NCT00789035|1886314|FG003|Overall Study|Withdrawal by Subject|0
909569|NCT00789035|1886315|FG004|Overall Study|Withdrawal by Subject|0
909570|NCT00789035|1886311|FG000|Overall Study|Other reason not defined above|2
909571|NCT00789035|1886312|FG001|Overall Study|Other reason not defined above|3
909572|NCT00789035|1886313|FG002|Overall Study|Other reason not defined above|1
909573|NCT00789035|1886314|FG003|Overall Study|Other reason not defined above|0
909574|NCT00789035|1886315|FG004|Overall Study|Other reason not defined above|1
909575|NCT00789191|1886349|FG000|Overall Study|Adverse Event|2
909576|NCT00789191|1886350|FG001|Overall Study|Adverse Event|4
909577|NCT00789191|1886349|FG000|Overall Study|Lack of Efficacy|0
909578|NCT00789191|1886350|FG001|Overall Study|Lack of Efficacy|5
909579|NCT00789191|1886349|FG000|Overall Study|Protocol Violation|5
909580|NCT00789191|1886350|FG001|Overall Study|Protocol Violation|3
909581|NCT00789191|1886349|FG000|Overall Study|Withdrawal Criteria|2
909582|NCT00789191|1886350|FG001|Overall Study|Withdrawal Criteria|4
909583|NCT00789191|1886349|FG000|Overall Study|Unclassified|5
909584|NCT00789191|1886350|FG001|Overall Study|Unclassified|3
909585|NCT00789321|1886370|FG000|Overall Study|Adverse Event|0
909586|NCT00789321|1886371|FG001|Overall Study|Adverse Event|1
909587|NCT00789360|1886379|FG000|Overall Study|Protocol Violation|3
909588|NCT00789360|1886380|FG001|Overall Study|Protocol Violation|1
909589|NCT00789373|1886387|FG000|Induction|Adverse Event|64
909590|NCT00789373|1886388|FG001|Induction|Adverse Event|0
909591|NCT00789373|1886389|FG002|Induction|Adverse Event|0
1083130|NCT02155660|2144626|FG003|Overall Study|Withdrawal by Subject|21
1083131|NCT02155712|2144638|FG000|Primary Objective|Death|3
1083132|NCT02155712|2144639|FG001|Primary Objective|Death|0
1083133|NCT02155712|2144638|FG000|Primary Objective|Lost to Follow-up|22
1083134|NCT02155712|2144639|FG001|Primary Objective|Lost to Follow-up|0
1083135|NCT02155712|2144638|FG000|Primary Objective|No 2-Year Forms but not Terminated|13
1083136|NCT02155712|2144639|FG001|Primary Objective|No 2-Year Forms but not Terminated|0
1083137|NCT02155712|2144638|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1
1083138|NCT02155712|2144639|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0
1083139|NCT02155712|2144638|FG000|Primary Objective|Withdrawal by Subject|21
1083140|NCT02155712|2144639|FG001|Primary Objective|Withdrawal by Subject|0
1083141|NCT02155738|2144664|FG000|Overall Study|Missing critical information|1
1083142|NCT02155738|2144665|FG001|Overall Study|Missing critical information|0
1083143|NCT02155738|2144666|FG002|Overall Study|Missing critical information|0
1083144|NCT02155738|2144667|FG003|Overall Study|Missing critical information|1
1083145|NCT02155829|2144679|FG000|Overall Study|Adverse Event|1
1083146|NCT02155829|2144680|FG001|Overall Study|Adverse Event|0
1083147|NCT02155829|2144679|FG000|Overall Study|Withdrawal by Subject|3
1083148|NCT02155829|2144680|FG001|Overall Study|Withdrawal by Subject|3
1083149|NCT02155829|2144679|FG000|Overall Study|Protocol Violation|2
1083150|NCT02155829|2144680|FG001|Overall Study|Protocol Violation|0
1083151|NCT02155881|2144689|FG000|Overall Study|Withdrawal by Subject|0
1083152|NCT02155881|2144690|FG001|Overall Study|Withdrawal by Subject|2
1083153|NCT02155881|2144689|FG000|Overall Study|Inappropriately randomized|2
1083154|NCT02155881|2144690|FG001|Overall Study|Inappropriately randomized|2
1083155|NCT02155985|2144699|FG000|Overall Study|Withdrawal by Subject|0
1083156|NCT02155985|2144700|FG001|Overall Study|Withdrawal by Subject|0
1083157|NCT02155985|2144701|FG002|Overall Study|Withdrawal by Subject|1
1083158|NCT02155985|2144699|FG000|Overall Study|Lost to Follow-up|1
1083159|NCT02155985|2144700|FG001|Overall Study|Lost to Follow-up|0
1083160|NCT02155985|2144701|FG002|Overall Study|Lost to Follow-up|0
1083161|NCT02156076|2144713|FG000|Treatment Period|no longer meets study criteria|0
1083162|NCT02156076|2144714|FG001|Treatment Period|no longer meets study criteria|0
1083163|NCT02156076|2144715|FG002|Treatment Period|no longer meets study criteria|1
1083164|NCT02156076|2144716|FG003|Treatment Period|no longer meets study criteria|0
1083165|NCT02156076|2144713|FG000|Treatment Period|Poor/non-compliance|0
1083166|NCT02156076|2144714|FG001|Treatment Period|Poor/non-compliance|1
1083167|NCT02156076|2144715|FG002|Treatment Period|Poor/non-compliance|0
1083168|NCT02156076|2144716|FG003|Treatment Period|Poor/non-compliance|0
1083169|NCT02156076|2144713|FG000|Treatment Period|Lost to Follow-up|0
1083170|NCT02156076|2144714|FG001|Treatment Period|Lost to Follow-up|0
1083171|NCT02156076|2144715|FG002|Treatment Period|Lost to Follow-up|0
1083172|NCT02156076|2144716|FG003|Treatment Period|Lost to Follow-up|1
1083173|NCT02156076|2144713|FG000|Treatment Period|Withdrawal by Subject|0
1083174|NCT02156076|2144714|FG001|Treatment Period|Withdrawal by Subject|0
1083175|NCT02156076|2144715|FG002|Treatment Period|Withdrawal by Subject|1
1083176|NCT02156076|2144716|FG003|Treatment Period|Withdrawal by Subject|0
1083177|NCT02156076|2144713|FG000|Treatment Period|Subject request to discontinue treatment|0
1083178|NCT02156076|2144714|FG001|Treatment Period|Subject request to discontinue treatment|1
1083179|NCT02156076|2144715|FG002|Treatment Period|Subject request to discontinue treatment|0
1083180|NCT02156076|2144716|FG003|Treatment Period|Subject request to discontinue treatment|0
1083181|NCT02156076|2144713|FG000|Treatment Period|Adverse Event|0
1083182|NCT02156076|2144714|FG001|Treatment Period|Adverse Event|0
1083183|NCT02156076|2144715|FG002|Treatment Period|Adverse Event|0
1083184|NCT02156076|2144716|FG003|Treatment Period|Adverse Event|1
1083185|NCT02156076|2144713|FG000|Follow-up Period|Withdrawal by Subject|1
1083186|NCT02156076|2144714|FG001|Follow-up Period|Withdrawal by Subject|0
1083187|NCT02156076|2144715|FG002|Follow-up Period|Withdrawal by Subject|0
1083188|NCT02156076|2144716|FG003|Follow-up Period|Withdrawal by Subject|0
1083189|NCT02156271|2144754|FG000|Overall Study|Physician Decision|4
1083190|NCT02156271|2144755|FG001|Overall Study|Physician Decision|3
1083191|NCT02156466|2144766|FG000|Overall Study|Adverse Event|0
1083192|NCT02156466|2144767|FG001|Overall Study|Adverse Event|0
1083193|NCT02156466|2144768|FG002|Overall Study|Adverse Event|1
1083194|NCT02156466|2144769|FG003|Overall Study|Adverse Event|1
1083195|NCT02156466|2144770|FG004|Overall Study|Adverse Event|0
1083196|NCT02156466|2144766|FG000|Overall Study|Quantiferon Positivity|0
1083197|NCT02156466|2144767|FG001|Overall Study|Quantiferon Positivity|0
1083198|NCT02156466|2144768|FG002|Overall Study|Quantiferon Positivity|0
1083199|NCT02156466|2144769|FG003|Overall Study|Quantiferon Positivity|1
1083200|NCT02156466|2144770|FG004|Overall Study|Quantiferon Positivity|0
1083201|NCT02156492|2144794|FG000|Period 1|No Reason Given|0
1083202|NCT02156492|2144795|FG001|Period 1|No Reason Given|1
1083203|NCT02156492|2144796|FG002|Period 1|No Reason Given|0
1083204|NCT02156492|2144794|FG000|Period 3|Adverse Event|0
1083205|NCT02156492|2144795|FG001|Period 3|Adverse Event|1
1083206|NCT02156492|2144796|FG002|Period 3|Adverse Event|0
1083207|NCT02156804|2144827|FG000|Overall Study|Withdrawal by Subject|1
1083208|NCT02157298|2144863|FG000|Overall Study|Adverse Event|1
1083209|NCT02157298|2144864|FG001|Overall Study|Adverse Event|0
1083210|NCT02157298|2144863|FG000|Overall Study|Subject no longer meets study criteria|1
1083211|NCT02157298|2144864|FG001|Overall Study|Subject no longer meets study criteria|2
1083212|NCT02157298|2144863|FG000|Overall Study|Poor/Non-compliance|1
1083213|NCT02157298|2144864|FG001|Overall Study|Poor/Non-compliance|0
1083214|NCT02157298|2144863|FG000|Overall Study|Withdrawal by Subject|1
1083215|NCT02157298|2144864|FG001|Overall Study|Withdrawal by Subject|0
1083216|NCT02157376|2144872|FG000|Overall Study|Death|10
1083217|NCT02157376|2144873|FG001|Overall Study|Death|4
1083218|NCT02157376|2144872|FG000|Overall Study|Eligibility criteria not fulfilled|0
1083219|NCT02157376|2144873|FG001|Overall Study|Eligibility criteria not fulfilled|1
1083220|NCT02157376|2144872|FG000|Overall Study|Withdrawal by Subject|3
1083221|NCT02157376|2144873|FG001|Overall Study|Withdrawal by Subject|8
1083222|NCT02157376|2144872|FG000|Overall Study|Not treated|8
1083223|NCT02157376|2144873|FG001|Overall Study|Not treated|3
1083224|NCT02157376|2144872|FG000|Overall Study|Investigator's misjudgement|1
1083225|NCT02157376|2144873|FG001|Overall Study|Investigator's misjudgement|2
1083226|NCT02157506|2144884|FG000|Overall Study|Adverse Event|0
1083227|NCT02157506|2144885|FG001|Overall Study|Adverse Event|1
1083228|NCT02157506|2144886|FG002|Overall Study|Adverse Event|0
1083229|NCT02157506|2144887|FG003|Overall Study|Adverse Event|0
1083230|NCT02157506|2144888|FG004|Overall Study|Adverse Event|0
1083231|NCT02157506|2144884|FG000|Overall Study|Lost to Follow-up|0
1083232|NCT02157506|2144885|FG001|Overall Study|Lost to Follow-up|0
1083233|NCT02157506|2144886|FG002|Overall Study|Lost to Follow-up|1
1083234|NCT02157506|2144887|FG003|Overall Study|Lost to Follow-up|0
1083235|NCT02157506|2144888|FG004|Overall Study|Lost to Follow-up|0
1083236|NCT02157519|2144902|FG000|Overall Study|Death|3
1083237|NCT02157519|2144903|FG001|Overall Study|Death|1
1083238|NCT02157519|2144902|FG000|Overall Study|Withdrawal by Subject|7
1083239|NCT02157519|2144903|FG001|Overall Study|Withdrawal by Subject|0
1083240|NCT02157519|2144902|FG000|Overall Study|Lost to Follow-up|1
1083241|NCT02157519|2144903|FG001|Overall Study|Lost to Follow-up|0
1083242|NCT02157779|2144921|FG000|Overall Study|Logistical|9
1083243|NCT02157779|2144922|FG001|Overall Study|Logistical|3
1083244|NCT02157779|2144921|FG000|Overall Study|Stopped attending, reason unknown|11
1083245|NCT02157779|2144922|FG001|Overall Study|Stopped attending, reason unknown|7
1083246|NCT02157779|2144921|FG000|Overall Study|No response to outreach after Baseline|1
1083247|NCT02157779|2144922|FG001|Overall Study|No response to outreach after Baseline|1
1083248|NCT02157779|2144921|FG000|Overall Study|Moved|1
1083249|NCT02157779|2144922|FG001|Overall Study|Moved|0
1083250|NCT02157779|2144921|FG000|Overall Study|Medical|1
1083251|NCT02157779|2144922|FG001|Overall Study|Medical|0
1083252|NCT02157779|2144921|FG000|Overall Study|Legal issue|1
1083253|NCT02157779|2144922|FG001|Overall Study|Legal issue|0
1083259|NCT02157935|2144950|FG000|Overall Study|Withdrawal by Subject|25
1083260|NCT02157935|2144951|FG001|Overall Study|Withdrawal by Subject|39
1083261|NCT02157935|2144950|FG000|Overall Study|Screen failure|1
1083262|NCT02157935|2144951|FG001|Overall Study|Screen failure|2
1083263|NCT02157935|2144950|FG000|Overall Study|Protocol Violation|1
1083264|NCT02157935|2144951|FG001|Overall Study|Protocol Violation|0
1083265|NCT02157935|2144950|FG000|Overall Study|Progressive disease|0
1083266|NCT02157935|2144951|FG001|Overall Study|Progressive disease|2
1083267|NCT02157935|2144950|FG000|Overall Study|Other|5
1083268|NCT02157935|2144951|FG001|Overall Study|Other|12
1083269|NCT02157935|2144950|FG000|Overall Study|Lack of Efficacy|0
1083270|NCT02157935|2144951|FG001|Overall Study|Lack of Efficacy|1
1083271|NCT02157935|2144950|FG000|Overall Study|Death|4
1083272|NCT02157935|2144951|FG001|Overall Study|Death|4
1083273|NCT02157935|2144950|FG000|Overall Study|Adverse Event|3
1083274|NCT02157935|2144951|FG001|Overall Study|Adverse Event|5
1083275|NCT02157948|2144959|FG000|Overall Study|Withdrawal by Subject|4
1083276|NCT02157948|2144960|FG001|Overall Study|Withdrawal by Subject|5
1083277|NCT02157948|2144959|FG000|Overall Study|Lost to Follow-up|3
1083278|NCT02157948|2144960|FG001|Overall Study|Lost to Follow-up|2
1083279|NCT02157948|2144959|FG000|Overall Study|Protocol Specified Criteria|2
1083280|NCT02157948|2144960|FG001|Overall Study|Protocol Specified Criteria|1
1083281|NCT02157948|2144959|FG000|Overall Study|Decision by Sponsor|0
1083282|NCT02157948|2144960|FG001|Overall Study|Decision by Sponsor|1
1083283|NCT02158039|2144966|FG000|Overall Study|Withdrawal by Subject|1
1083284|NCT02158039|2144966|FG000|Overall Study|Screen Failure|9
1083285|NCT02158091|2144973|FG000|Overall Study|DLT|2
1083286|NCT02158091|2144974|FG001|Overall Study|DLT|1
1083287|NCT02158091|2144975|FG002|Overall Study|DLT|0
1083288|NCT02158247|2144985|FG000|Overall Study|Invisible vocal cords|5
1083289|NCT02158364|2145010|FG000|Overall Study|Case report forms uncollected|10
1083290|NCT02158364|2145010|FG000|Overall Study|Protocol Deviation|50
1083291|NCT02158442|2145016|FG000|Overall Study|Withdrawal by Subject|1
1083292|NCT02158442|2145017|FG001|Overall Study|Withdrawal by Subject|0
1083293|NCT02158442|2145016|FG000|Overall Study|Perfusion staff not available|1
1083294|NCT02158442|2145017|FG001|Overall Study|Perfusion staff not available|0
1083295|NCT02158533|2145051|FG000|Stage 1|Adverse Event|6
1083296|NCT02158533|2145052|FG001|Stage 1|Adverse Event|4
1083297|NCT02158533|2145053|FG002|Stage 1|Adverse Event|7
1083298|NCT02158533|2145054|FG003|Stage 1|Adverse Event|0
1083299|NCT02158533|2145055|FG004|Stage 1|Adverse Event|0
1083300|NCT02158533|2145056|FG005|Stage 1|Adverse Event|0
1083301|NCT02158533|2145051|FG000|Stage 1|Withdrawal by Subject|3
1083302|NCT02158533|2145052|FG001|Stage 1|Withdrawal by Subject|2
1083303|NCT02158533|2145053|FG002|Stage 1|Withdrawal by Subject|1
1083304|NCT02158533|2145054|FG003|Stage 1|Withdrawal by Subject|0
1083305|NCT02158533|2145055|FG004|Stage 1|Withdrawal by Subject|0
1083306|NCT02158533|2145056|FG005|Stage 1|Withdrawal by Subject|0
1083307|NCT02158533|2145051|FG000|Stage 1|Lack of Efficacy|1
1083308|NCT02158533|2145052|FG001|Stage 1|Lack of Efficacy|0
1083309|NCT02158533|2145053|FG002|Stage 1|Lack of Efficacy|0
1083310|NCT02158533|2145054|FG003|Stage 1|Lack of Efficacy|0
1083311|NCT02158533|2145055|FG004|Stage 1|Lack of Efficacy|0
1083312|NCT02158533|2145056|FG005|Stage 1|Lack of Efficacy|0
1083313|NCT02158533|2145051|FG000|Stage 1|Lost to Follow-up|3
1083314|NCT02158533|2145052|FG001|Stage 1|Lost to Follow-up|1
1083315|NCT02158533|2145053|FG002|Stage 1|Lost to Follow-up|0
1083316|NCT02158533|2145054|FG003|Stage 1|Lost to Follow-up|0
1083317|NCT02158533|2145055|FG004|Stage 1|Lost to Follow-up|0
1083318|NCT02158533|2145056|FG005|Stage 1|Lost to Follow-up|0
1083319|NCT02158533|2145051|FG000|Stage 1|Failure to Meet Eligibility Criteria|0
1083320|NCT02158533|2145052|FG001|Stage 1|Failure to Meet Eligibility Criteria|1
1083321|NCT02158533|2145053|FG002|Stage 1|Failure to Meet Eligibility Criteria|0
1083322|NCT02158533|2145054|FG003|Stage 1|Failure to Meet Eligibility Criteria|0
1083323|NCT02158533|2145055|FG004|Stage 1|Failure to Meet Eligibility Criteria|0
1083324|NCT02158533|2145056|FG005|Stage 1|Failure to Meet Eligibility Criteria|0
1083325|NCT02158533|2145051|FG000|Stage 1|Non-compliance with study visits|1
1083326|NCT02158533|2145052|FG001|Stage 1|Non-compliance with study visits|0
1083327|NCT02158533|2145053|FG002|Stage 1|Non-compliance with study visits|0
1083328|NCT02158533|2145054|FG003|Stage 1|Non-compliance with study visits|0
1083329|NCT02158533|2145055|FG004|Stage 1|Non-compliance with study visits|0
1083330|NCT02158533|2145056|FG005|Stage 1|Non-compliance with study visits|0
1083331|NCT02158533|2145051|FG000|Stage 2|Adverse Event|0
1083332|NCT02158533|2145052|FG001|Stage 2|Adverse Event|0
1083333|NCT02158533|2145053|FG002|Stage 2|Adverse Event|0
1083334|NCT02158533|2145054|FG003|Stage 2|Adverse Event|0
1083335|NCT02158533|2145055|FG004|Stage 2|Adverse Event|0
1083336|NCT02158533|2145056|FG005|Stage 2|Adverse Event|1
1083337|NCT02158533|2145051|FG000|Stage 2|Lack of Efficacy|0
1083338|NCT02158533|2145052|FG001|Stage 2|Lack of Efficacy|0
1083339|NCT02158533|2145053|FG002|Stage 2|Lack of Efficacy|0
1083340|NCT02158533|2145054|FG003|Stage 2|Lack of Efficacy|0
1083341|NCT02158533|2145055|FG004|Stage 2|Lack of Efficacy|1
1083342|NCT02158533|2145056|FG005|Stage 2|Lack of Efficacy|0
1083343|NCT02158533|2145051|FG000|Stage 2|Lost to Follow-up|0
1083344|NCT02158533|2145052|FG001|Stage 2|Lost to Follow-up|0
1083345|NCT02158533|2145053|FG002|Stage 2|Lost to Follow-up|0
1083346|NCT02158533|2145054|FG003|Stage 2|Lost to Follow-up|1
1083347|NCT02158533|2145055|FG004|Stage 2|Lost to Follow-up|1
1083348|NCT02158533|2145056|FG005|Stage 2|Lost to Follow-up|2
1083349|NCT02158533|2145051|FG000|Stage 2|Withdrawal by Subject|0
1083350|NCT02158533|2145052|FG001|Stage 2|Withdrawal by Subject|0
1083351|NCT02158533|2145053|FG002|Stage 2|Withdrawal by Subject|0
1083352|NCT02158533|2145054|FG003|Stage 2|Withdrawal by Subject|0
1083353|NCT02158533|2145055|FG004|Stage 2|Withdrawal by Subject|1
1083354|NCT02158533|2145056|FG005|Stage 2|Withdrawal by Subject|2
1083355|NCT02158533|2145051|FG000|Stage 2|Physician Decision|0
1083356|NCT02158533|2145052|FG001|Stage 2|Physician Decision|0
1083357|NCT02158533|2145053|FG002|Stage 2|Physician Decision|0
1083358|NCT02158533|2145054|FG003|Stage 2|Physician Decision|0
1083359|NCT02158533|2145055|FG004|Stage 2|Physician Decision|1
1083360|NCT02158533|2145056|FG005|Stage 2|Physician Decision|0
1083361|NCT02158533|2145051|FG000|Stage 2|Pregnancy|0
1083362|NCT02158533|2145052|FG001|Stage 2|Pregnancy|0
1083363|NCT02158533|2145053|FG002|Stage 2|Pregnancy|0
1083364|NCT02158533|2145054|FG003|Stage 2|Pregnancy|1
1083365|NCT02158533|2145055|FG004|Stage 2|Pregnancy|0
1083366|NCT02158533|2145056|FG005|Stage 2|Pregnancy|0
1083367|NCT02158533|2145051|FG000|Stage 2|Psychiatrist decision to try new tx|0
1083368|NCT02158533|2145052|FG001|Stage 2|Psychiatrist decision to try new tx|0
1083369|NCT02158533|2145053|FG002|Stage 2|Psychiatrist decision to try new tx|0
1083370|NCT02158533|2145054|FG003|Stage 2|Psychiatrist decision to try new tx|1
1083371|NCT02158533|2145055|FG004|Stage 2|Psychiatrist decision to try new tx|0
1083372|NCT02158533|2145056|FG005|Stage 2|Psychiatrist decision to try new tx|0
1083373|NCT02158533|2145051|FG000|Stage 2|Non-adherence with study visits|0
1083374|NCT02158533|2145052|FG001|Stage 2|Non-adherence with study visits|0
1083375|NCT02158533|2145053|FG002|Stage 2|Non-adherence with study visits|0
1083376|NCT02158533|2145054|FG003|Stage 2|Non-adherence with study visits|0
1083377|NCT02158533|2145055|FG004|Stage 2|Non-adherence with study visits|0
1083378|NCT02158533|2145056|FG005|Stage 2|Non-adherence with study visits|1
1083379|NCT02158546|2145074|FG000|Overall Study|Physician Decision|0
1083380|NCT02158546|2145075|FG001|Overall Study|Physician Decision|1
1083381|NCT02158546|2145076|FG002|Overall Study|Physician Decision|0
1083382|NCT02158546|2145077|FG003|Overall Study|Physician Decision|0
1083383|NCT02158546|2145074|FG000|Overall Study|Non-compliance|0
1083384|NCT02158546|2145075|FG001|Overall Study|Non-compliance|1
1083385|NCT02158546|2145076|FG002|Overall Study|Non-compliance|0
1083386|NCT02158546|2145077|FG003|Overall Study|Non-compliance|1
1083387|NCT02158546|2145074|FG000|Overall Study|Failure to meet eligibility criteria|0
1083388|NCT02158546|2145075|FG001|Overall Study|Failure to meet eligibility criteria|1
1083389|NCT02158546|2145076|FG002|Overall Study|Failure to meet eligibility criteria|0
1083390|NCT02158546|2145077|FG003|Overall Study|Failure to meet eligibility criteria|0
1083391|NCT02158546|2145074|FG000|Overall Study|Lack of Efficacy|1
1083392|NCT02158546|2145075|FG001|Overall Study|Lack of Efficacy|1
1083393|NCT02158546|2145076|FG002|Overall Study|Lack of Efficacy|0
1083394|NCT02158546|2145077|FG003|Overall Study|Lack of Efficacy|0
1083395|NCT02158546|2145074|FG000|Overall Study|Adverse Event|2
1083396|NCT02158546|2145075|FG001|Overall Study|Adverse Event|2
1083397|NCT02158546|2145076|FG002|Overall Study|Adverse Event|0
1083398|NCT02158546|2145077|FG003|Overall Study|Adverse Event|0
1083399|NCT02158546|2145074|FG000|Overall Study|Withdrawal by Subject|6
1083400|NCT02158546|2145075|FG001|Overall Study|Withdrawal by Subject|2
1083401|NCT02158546|2145076|FG002|Overall Study|Withdrawal by Subject|1
1083402|NCT02158546|2145077|FG003|Overall Study|Withdrawal by Subject|0
1083403|NCT02158546|2145074|FG000|Overall Study|Lost to Follow-up|5
1083404|NCT02158546|2145075|FG001|Overall Study|Lost to Follow-up|4
1083405|NCT02158546|2145076|FG002|Overall Study|Lost to Follow-up|0
1083406|NCT02158546|2145077|FG003|Overall Study|Lost to Follow-up|1
1083407|NCT02158546|2145074|FG000|Overall Study|Site Excluded|5
1083408|NCT02158546|2145075|FG001|Overall Study|Site Excluded|5
1083409|NCT02158546|2145076|FG002|Overall Study|Site Excluded|3
1083410|NCT02158546|2145077|FG003|Overall Study|Site Excluded|4
1083411|NCT02158663|2145093|FG000|Overall Study|Withdrawal by Subject|5
1083412|NCT02158663|2145094|FG001|Overall Study|Withdrawal by Subject|4
1083413|NCT02158728|2145102|FG000|Overall Study|no procedure according to CIP done|3
1083414|NCT02158728|2145102|FG000|Overall Study|no qualified dataset|24
1083415|NCT02158806|2145108|FG000|Overall Study|Death|2
1083416|NCT02158806|2145109|FG001|Overall Study|Death|0
1083417|NCT02158806|2145108|FG000|Overall Study|Withdrawal by Subject|2
1083418|NCT02158806|2145109|FG001|Overall Study|Withdrawal by Subject|0
1083419|NCT02158806|2145108|FG000|Overall Study|Lost to Follow-up|0
1083420|NCT02158806|2145109|FG001|Overall Study|Lost to Follow-up|3
1083421|NCT02158806|2145108|FG000|Overall Study|Moved out of area|0
1083422|NCT02158806|2145109|FG001|Overall Study|Moved out of area|1
1083423|NCT02158806|2145108|FG000|Overall Study|Transferred to palliative care|0
1083424|NCT02158806|2145109|FG001|Overall Study|Transferred to palliative care|1
1083425|NCT02158884|2145115|FG000|Baseline Assessment|Missed performance assessment|3
1083426|NCT02158884|2145115|FG000|Baseline Assessment|Missed SMFA|1
1083427|NCT02158884|2145115|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6
1083428|NCT02158884|2145115|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
1083429|NCT02158884|2145115|FG000|6 Month Assessment|Missed SMFA|20
1083430|NCT02158884|2145115|FG000|12 Month Assessment|Missed SMFA|17
1083431|NCT02158936|2145122|FG000|Overall Study|Study closed/ terminated|57
1083432|NCT02158936|2145123|FG001|Overall Study|Study closed/ terminated|77
1083433|NCT02158936|2145122|FG000|Overall Study|Azacitidine tx discontinued|53
1083434|NCT02158936|2145123|FG001|Overall Study|Azacitidine tx discontinued|46
1083435|NCT02158936|2145122|FG000|Overall Study|Adverse Event|39
1083436|NCT02158936|2145123|FG001|Overall Study|Adverse Event|24
1083437|NCT02158936|2145122|FG000|Overall Study|Withdrawal by Subject|15
1083438|NCT02158936|2145123|FG001|Overall Study|Withdrawal by Subject|16
1083439|NCT02158936|2145122|FG000|Overall Study|Physician Decision|15
1083440|NCT02158936|2145123|FG001|Overall Study|Physician Decision|13
1083441|NCT02158936|2145122|FG000|Overall Study|Lost to Follow-up|0
1083442|NCT02158936|2145123|FG001|Overall Study|Lost to Follow-up|1
1083443|NCT02158949|2145131|FG000|Overall Study|Withdrawal by Subject|1
1083444|NCT02158949|2145132|FG001|Overall Study|Withdrawal by Subject|0
1083445|NCT02158949|2145131|FG000|Overall Study|Lost to Follow-up|5
1083446|NCT02158949|2145132|FG001|Overall Study|Lost to Follow-up|11
1083447|NCT02158975|2145138|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1
1083448|NCT02159053|2145146|FG000|Overall Study|Death|2
1083449|NCT02159053|2145147|FG001|Overall Study|Death|0
1083450|NCT02159053|2145148|FG002|Overall Study|Death|1
1083451|NCT02159053|2145146|FG000|Overall Study|Physician Decision|0
1083452|NCT02159053|2145147|FG001|Overall Study|Physician Decision|1
1083453|NCT02159053|2145148|FG002|Overall Study|Physician Decision|1
1083454|NCT02159053|2145146|FG000|Overall Study|Lack of Efficacy|3
1083455|NCT02159053|2145147|FG001|Overall Study|Lack of Efficacy|4
1083456|NCT02159053|2145148|FG002|Overall Study|Lack of Efficacy|7
1083457|NCT02159053|2145146|FG000|Overall Study|Adverse Event|7
1083458|NCT02159053|2145147|FG001|Overall Study|Adverse Event|6
1083459|NCT02159053|2145148|FG002|Overall Study|Adverse Event|5
1083460|NCT02159053|2145146|FG000|Overall Study|Participants/guardian decision|8
1083461|NCT02159053|2145147|FG001|Overall Study|Participants/guardian decision|10
1083462|NCT02159053|2145148|FG002|Overall Study|Participants/guardian decision|6
1083463|NCT02159183|2145178|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2
1083464|NCT02159183|2145179|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1
1083465|NCT02159183|2145178|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1
1083466|NCT02159183|2145179|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0
1083467|NCT02159183|2145178|FG000|Analysis After the 36 Months Follow-up|Death|0
1083468|NCT02159183|2145179|FG001|Analysis After the 36 Months Follow-up|Death|1
1083469|NCT02159183|2145178|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
1083470|NCT02159183|2145179|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
1083471|NCT02159183|2145178|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
1083472|NCT02159183|2145179|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
1083473|NCT02159352|2145187|FG000|Overall Study|Adverse Event|3
1083474|NCT02159352|2145188|FG001|Overall Study|Adverse Event|1
1083475|NCT02159352|2145187|FG000|Overall Study|Withdrawal by Subject|0
1083476|NCT02159352|2145188|FG001|Overall Study|Withdrawal by Subject|1
1083477|NCT02159365|2145213|FG000|Overall Study|Disease Progression|23
1083478|NCT02159365|2145213|FG000|Overall Study|Other reasons|11
1083479|NCT02159365|2145213|FG000|Overall Study|Administrative reason by Sponsor|9
1083480|NCT02159365|2145213|FG000|Overall Study|Adverse Event unrelated to study drug|9
1083481|NCT02159365|2145213|FG000|Overall Study|Study drug toxicity|7
1083482|NCT02159365|2145213|FG000|Overall Study|Maximum clinical benefit|3
1083483|NCT02159365|2145213|FG000|Overall Study|Subject request to discontinue treatment|3
1083484|NCT02159365|2145213|FG000|Overall Study|Subject withdrew consent|3
1083485|NCT02159365|2145213|FG000|Overall Study|Death|1
1083486|NCT02159365|2145213|FG000|Overall Study|Lost to Follow-up|1
1083487|NCT02159469|2145217|FG000|Overall Study|Missing Completion status|1
1083488|NCT02159469|2145217|FG000|Overall Study|Adverse Event|5
1083489|NCT02159469|2145217|FG000|Overall Study|Non-compliance|2
1083490|NCT02159469|2145217|FG000|Overall Study|Withdrawal by Subject|9
1083491|NCT02159469|2145217|FG000|Overall Study|Lost to Follow-up|1
1083492|NCT02159469|2145217|FG000|Overall Study|Sponsor's request|2
1083493|NCT02159469|2145217|FG000|Overall Study|Met Stopping Criteria|3
1083494|NCT02159469|2145217|FG000|Overall Study|Other|1
1083495|NCT02159469|2145217|FG000|Overall Study|Multiple|29
1083496|NCT02159482|2145222|FG000|Overall Study|Withdrawal by Subject|2
1083497|NCT02159482|2145222|FG000|Overall Study|Physician Decision|3
1083498|NCT02159521|2145226|FG000|Overall Study|Enrolled but not treated|3
1083499|NCT02159521|2145226|FG000|Overall Study|Withdrawal by Subject|7
1083500|NCT02159521|2145226|FG000|Overall Study|Lost to Follow-up|6
1083501|NCT02159521|2145226|FG000|Overall Study|Death|1
1083502|NCT02159521|2145226|FG000|Overall Study|Other than specified|1
1083503|NCT02159729|2145246|FG000|Overall Study|Adverse Event|0
1083504|NCT02159729|2145247|FG001|Overall Study|Adverse Event|1
1083505|NCT02159729|2145246|FG000|Overall Study|Subject's Request|13
1083506|NCT02159729|2145247|FG001|Overall Study|Subject's Request|10
1083507|NCT02159729|2145246|FG000|Overall Study|Lost to Follow-up|24
1083508|NCT02159729|2145247|FG001|Overall Study|Lost to Follow-up|9
1083509|NCT02159729|2145246|FG000|Overall Study|Non compliance|2
1083510|NCT02159729|2145247|FG001|Overall Study|Non compliance|0
1083511|NCT02159729|2145246|FG000|Overall Study|Other Unspecified|3
1083512|NCT02159729|2145247|FG001|Overall Study|Other Unspecified|1
1083513|NCT02159807|2145260|FG000|Overall Study|Adverse Event|0
1083514|NCT02159807|2145261|FG001|Overall Study|Adverse Event|0
1083515|NCT02159807|2145262|FG002|Overall Study|Adverse Event|1
1083516|NCT02159807|2145260|FG000|Overall Study|No CSF|1
1083517|NCT02159807|2145261|FG001|Overall Study|No CSF|1
1083518|NCT02159807|2145262|FG002|Overall Study|No CSF|1
1083519|NCT02159807|2145260|FG000|Overall Study|elevated blood pressure|0
1083520|NCT02159807|2145261|FG001|Overall Study|elevated blood pressure|0
1083521|NCT02159807|2145262|FG002|Overall Study|elevated blood pressure|1
1083522|NCT02159950|2145291|FG000|Overall Study|Adverse Event|0
1083523|NCT02159950|2145292|FG001|Overall Study|Adverse Event|1
1083524|NCT02159950|2145291|FG000|Overall Study|Progression|0
1083525|NCT02159950|2145292|FG001|Overall Study|Progression|1
1083526|NCT02160002|2145311|FG000|Overall Study|Withdrawal by Subject|2
1083527|NCT02160002|2145312|FG001|Overall Study|Withdrawal by Subject|1
1083528|NCT02160041|2145318|FG000|Overall Study|Adverse Event|11
1083529|NCT02160041|2145318|FG000|Overall Study|Death|2
1083530|NCT02160041|2145318|FG000|Overall Study|disease progression|57
1083531|NCT02160041|2145318|FG000|Overall Study|Protocol Violation|1
1083532|NCT02160041|2145318|FG000|Overall Study|non-compliance with study|1
1083533|NCT02160041|2145318|FG000|Overall Study|Physician Decision|3
1083534|NCT02160041|2145318|FG000|Overall Study|Withdrawal by Subject|8
1083535|NCT02160041|2145318|FG000|Overall Study|study terminated by by sponsor|1
1083536|NCT02160145|2145324|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23
1083537|NCT02160145|2145325|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0
1083538|NCT02160145|2145326|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0
1083539|NCT02160145|2145324|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
1083540|NCT02160145|2145325|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
1083541|NCT02160145|2145326|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
1083542|NCT02160145|2145324|FG000|Randomized Double-blind Period|Subject decision|0
1083543|NCT02160145|2145325|FG001|Randomized Double-blind Period|Subject decision|21
1083544|NCT02160145|2145326|FG002|Randomized Double-blind Period|Subject decision|20
1083545|NCT02160145|2145324|FG000|Randomized Double-blind Period|Lost to Follow-up|0
1083546|NCT02160145|2145325|FG001|Randomized Double-blind Period|Lost to Follow-up|1
1083547|NCT02160145|2145326|FG002|Randomized Double-blind Period|Lost to Follow-up|3
1083548|NCT02160145|2145324|FG000|Randomized Double-blind Period|Physician Decision|0
1083549|NCT02160145|2145325|FG001|Randomized Double-blind Period|Physician Decision|7
1083550|NCT02160145|2145326|FG002|Randomized Double-blind Period|Physician Decision|5
1083551|NCT02160314|2145344|FG000|Overall Study|Adverse Event|0
1083552|NCT02160314|2145345|FG001|Overall Study|Adverse Event|6
1083553|NCT02160314|2145344|FG000|Overall Study|Protocol Violation|0
1083554|NCT02160314|2145345|FG001|Overall Study|Protocol Violation|4
1083555|NCT02160314|2145344|FG000|Overall Study|Withdrawal by Subject|1
909592|NCT00789373|1886387|FG000|Induction|Death Due to study disease|24
909593|NCT00789373|1886388|FG001|Induction|Death Due to study disease|0
909594|NCT00789373|1886389|FG002|Induction|Death Due to study disease|0
909595|NCT00789373|1886387|FG000|Induction|Death due to adverse event|19
909596|NCT00789373|1886388|FG001|Induction|Death due to adverse event|0
909597|NCT00789373|1886389|FG002|Induction|Death due to adverse event|0
909598|NCT00789373|1886387|FG000|Induction|Death due to toxicity|11
909599|NCT00789373|1886388|FG001|Induction|Death due to toxicity|0
909600|NCT00789373|1886389|FG002|Induction|Death due to toxicity|0
909601|NCT00789373|1886387|FG000|Induction|Death due to procedure|1
909602|NCT00789373|1886388|FG001|Induction|Death due to procedure|0
909603|NCT00789373|1886389|FG002|Induction|Death due to procedure|0
909604|NCT00789373|1886387|FG000|Induction|Investigator decision|7
909605|NCT00789373|1886388|FG001|Induction|Investigator decision|0
909606|NCT00789373|1886389|FG002|Induction|Investigator decision|0
909607|NCT00789373|1886387|FG000|Induction|Protocol entry criteria not met|9
909608|NCT00789373|1886388|FG001|Induction|Protocol entry criteria not met|0
909609|NCT00789373|1886389|FG002|Induction|Protocol entry criteria not met|0
909610|NCT00789373|1886387|FG000|Induction|Lost to Follow-up|6
909611|NCT00789373|1886388|FG001|Induction|Lost to Follow-up|0
909612|NCT00789373|1886389|FG002|Induction|Lost to Follow-up|0
909613|NCT00789373|1886387|FG000|Induction|Protocol Violation|1
909614|NCT00789373|1886388|FG001|Induction|Protocol Violation|0
909615|NCT00789373|1886389|FG002|Induction|Protocol Violation|0
1083556|NCT02160314|2145345|FG001|Overall Study|Withdrawal by Subject|2
1083557|NCT02160314|2145344|FG000|Overall Study|Lost to Follow-up|0
1083558|NCT02160314|2145345|FG001|Overall Study|Lost to Follow-up|1
1083559|NCT02160626|2145358|FG000|Overall Study|Adverse Event|1
1083560|NCT02160626|2145359|FG001|Overall Study|Adverse Event|0
1083561|NCT02160626|2145360|FG002|Overall Study|Adverse Event|0
1083562|NCT02160626|2145358|FG000|Overall Study|Schedule not conducive to study visits|0
1083563|NCT02160626|2145359|FG001|Overall Study|Schedule not conducive to study visits|0
1083564|NCT02160626|2145360|FG002|Overall Study|Schedule not conducive to study visits|1
1083565|NCT02160626|2145358|FG000|Overall Study|Withdrawal by Subject|0
1083566|NCT02160626|2145359|FG001|Overall Study|Withdrawal by Subject|1
1083567|NCT02160626|2145360|FG002|Overall Study|Withdrawal by Subject|0
1083568|NCT02160782|2145375|FG000|Open-label Period: Maralixibat|Adverse Event|2
1083569|NCT02160782|2145376|FG001|Open-label Period: Maralixibat|Adverse Event|0
1083570|NCT02160782|2145377|FG002|Open-label Period: Maralixibat|Adverse Event|0
1083571|NCT02160782|2145378|FG003|Open-label Period: Maralixibat|Adverse Event|0
1083572|NCT02160782|2145379|FG004|Open-label Period: Maralixibat|Adverse Event|0
909616|NCT00789373|1886387|FG000|Induction|Progressive Disease|220
909617|NCT00789373|1886388|FG001|Induction|Progressive Disease|0
909618|NCT00789373|1886389|FG002|Induction|Progressive Disease|0
909619|NCT00789373|1886387|FG000|Induction|Withdrawal by Subject|37
909620|NCT00789373|1886388|FG001|Induction|Withdrawal by Subject|0
909621|NCT00789373|1886389|FG002|Induction|Withdrawal by Subject|0
909622|NCT00789373|1886387|FG000|Maintenance|Adverse Event|0
909623|NCT00789373|1886388|FG001|Maintenance|Adverse Event|65
909624|NCT00789373|1886389|FG002|Maintenance|Adverse Event|12
909625|NCT00789373|1886387|FG000|Maintenance|Death due to study disease|0
909626|NCT00789373|1886388|FG001|Maintenance|Death due to study disease|3
909627|NCT00789373|1886389|FG002|Maintenance|Death due to study disease|1
909628|NCT00789373|1886387|FG000|Maintenance|Death due to adverse event|0
909629|NCT00789373|1886388|FG001|Maintenance|Death due to adverse event|4
909630|NCT00789373|1886389|FG002|Maintenance|Death due to adverse event|1
909631|NCT00789373|1886387|FG000|Maintenance|Death due to toxicity|0
909632|NCT00789373|1886388|FG001|Maintenance|Death due to toxicity|1
909633|NCT00789373|1886389|FG002|Maintenance|Death due to toxicity|2
909634|NCT00789373|1886387|FG000|Maintenance|Investigator Decision|0
909635|NCT00789373|1886388|FG001|Maintenance|Investigator Decision|4
909636|NCT00789373|1886389|FG002|Maintenance|Investigator Decision|2
909637|NCT00789373|1886387|FG000|Maintenance|Protocol entry criteria not met|0
909638|NCT00789373|1886388|FG001|Maintenance|Protocol entry criteria not met|2
909639|NCT00789373|1886389|FG002|Maintenance|Protocol entry criteria not met|0
909640|NCT00789373|1886387|FG000|Maintenance|Lost to Follow-up|0
909641|NCT00789373|1886388|FG001|Maintenance|Lost to Follow-up|2
909642|NCT00789373|1886389|FG002|Maintenance|Lost to Follow-up|0
909643|NCT00789373|1886387|FG000|Maintenance|Progressive Disease|0
909644|NCT00789373|1886388|FG001|Maintenance|Progressive Disease|253
909645|NCT00789373|1886389|FG002|Maintenance|Progressive Disease|152
909646|NCT00789373|1886387|FG000|Maintenance|Withdrawal by Subject|0
909647|NCT00789373|1886388|FG001|Maintenance|Withdrawal by Subject|21
909648|NCT00789373|1886389|FG002|Maintenance|Withdrawal by Subject|8
909649|NCT00789373|1886387|FG000|Maintenance|Sponsor Decision|0
909650|NCT00789373|1886388|FG001|Maintenance|Sponsor Decision|0
909651|NCT00789373|1886389|FG002|Maintenance|Sponsor Decision|2
909652|NCT00789373|1886387|FG000|Maintenance|Participants On-Going at Data Cut-Off|0
909653|NCT00789373|1886388|FG001|Maintenance|Participants On-Going at Data Cut-Off|4
909654|NCT00789373|1886389|FG002|Maintenance|Participants On-Going at Data Cut-Off|0
1083573|NCT02160782|2145375|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0
1083574|NCT02160782|2145376|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0
1083575|NCT02160782|2145377|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0
1083576|NCT02160782|2145378|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1
1083577|NCT02160782|2145379|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0
1083578|NCT02160782|2145375|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
1083579|NCT02160782|2145376|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
1083580|NCT02160782|2145377|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
1083581|NCT02160782|2145378|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5
1083582|NCT02160782|2145379|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
1083583|NCT02160782|2145375|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
1083584|NCT02160782|2145376|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
1083585|NCT02160782|2145377|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
1083586|NCT02160782|2145378|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
1083587|NCT02160782|2145379|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4
1083588|NCT02160782|2145375|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0
1083589|NCT02160782|2145376|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0
1083590|NCT02160782|2145377|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0
1083591|NCT02160782|2145378|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0
1083592|NCT02160782|2145379|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1
1083593|NCT02160782|2145375|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0
1083594|NCT02160782|2145376|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0
1083595|NCT02160782|2145377|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0
1083596|NCT02160782|2145378|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0
1083597|NCT02160782|2145379|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3
1083598|NCT02160782|2145375|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
1083599|NCT02160782|2145376|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
1083600|NCT02160782|2145377|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
1083601|NCT02160782|2145378|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
909655|NCT00789477|1886418|FG000|Overall Study|Withdrawal by Subject|2
909656|NCT00789477|1886419|FG001|Overall Study|Withdrawal by Subject|1
909657|NCT00789477|1886420|FG002|Overall Study|Withdrawal by Subject|3
909658|NCT00789477|1886421|FG003|Overall Study|Withdrawal by Subject|2
909659|NCT00789477|1886422|FG004|Overall Study|Withdrawal by Subject|3
909660|NCT00789477|1886418|FG000|Overall Study|Protocol Violation|1
909661|NCT00789477|1886419|FG001|Overall Study|Protocol Violation|0
1083602|NCT02160782|2145379|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1
1083603|NCT02160899|2145442|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
1083604|NCT02160899|2145443|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
1083605|NCT02160899|2145444|FG002|Overall Study|Adverse Event or Serious Adverse Event|0
1083606|NCT02160899|2145445|FG003|Overall Study|Adverse Event or Serious Adverse Event|1
1083607|NCT02160899|2145446|FG004|Overall Study|Adverse Event or Serious Adverse Event|2
1083608|NCT02160899|2145447|FG005|Overall Study|Adverse Event or Serious Adverse Event|0
1083609|NCT02160977|2145463|FG000|Six Weeks After Surgery|Lost to Follow-up|1
1083610|NCT02160977|2145464|FG001|Six Weeks After Surgery|Lost to Follow-up|0
1083611|NCT02160977|2145463|FG000|Three Months After Surgery|Lost to Follow-up|0
1083612|NCT02160977|2145464|FG001|Three Months After Surgery|Lost to Follow-up|2
1083613|NCT02160977|2145463|FG000|Six Months After Surgery|Lost to Follow-up|2
1083614|NCT02160977|2145464|FG001|Six Months After Surgery|Lost to Follow-up|1
1083615|NCT02161146|2145493|FG000|Overall Study|Adverse Event|1
1083616|NCT02161146|2145494|FG001|Overall Study|Adverse Event|1
1083617|NCT02161146|2145495|FG002|Overall Study|Adverse Event|0
1083618|NCT02161146|2145496|FG003|Overall Study|Adverse Event|1
1083619|NCT02161146|2145497|FG004|Overall Study|Adverse Event|0
1083620|NCT02161146|2145493|FG000|Overall Study|Lost to Follow-up|0
1083621|NCT02161146|2145494|FG001|Overall Study|Lost to Follow-up|1
1083622|NCT02161146|2145495|FG002|Overall Study|Lost to Follow-up|0
1083623|NCT02161146|2145496|FG003|Overall Study|Lost to Follow-up|0
1083624|NCT02161146|2145497|FG004|Overall Study|Lost to Follow-up|0
1083625|NCT02161146|2145493|FG000|Overall Study|Personal Reasons|0
1083626|NCT02161146|2145494|FG001|Overall Study|Personal Reasons|1
1083627|NCT02161146|2145495|FG002|Overall Study|Personal Reasons|0
1083628|NCT02161146|2145496|FG003|Overall Study|Personal Reasons|2
1083629|NCT02161146|2145497|FG004|Overall Study|Personal Reasons|1
1083630|NCT02161146|2145493|FG000|Overall Study|Other Miscellaneous Reasons|0
1083631|NCT02161146|2145494|FG001|Overall Study|Other Miscellaneous Reasons|1
1083632|NCT02161146|2145495|FG002|Overall Study|Other Miscellaneous Reasons|0
1083633|NCT02161146|2145496|FG003|Overall Study|Other Miscellaneous Reasons|0
1083634|NCT02161146|2145497|FG004|Overall Study|Other Miscellaneous Reasons|0
1083635|NCT02161185|2145507|FG000|Treatment Phase|Administrative/Other|7
1083636|NCT02161406|2145513|FG000|Overall Study|Death|2
1083637|NCT02161406|2145514|FG001|Overall Study|Death|1
1083638|NCT02161406|2145513|FG000|Overall Study|Lost to Follow-up|2
1083639|NCT02161406|2145514|FG001|Overall Study|Lost to Follow-up|1
1083640|NCT02161406|2145513|FG000|Overall Study|Withdrawal by Subject|2
1083641|NCT02161406|2145514|FG001|Overall Study|Withdrawal by Subject|4
1083642|NCT02161406|2145513|FG000|Overall Study|investigator withdrew subject|3
1083643|NCT02161406|2145514|FG001|Overall Study|investigator withdrew subject|1
1083644|NCT02161406|2145513|FG000|Overall Study|Lack of Efficacy|1
1083645|NCT02161406|2145514|FG001|Overall Study|Lack of Efficacy|1
1083646|NCT02161406|2145513|FG000|Overall Study|relocation|0
1083647|NCT02161406|2145514|FG001|Overall Study|relocation|1
1083648|NCT02161458|2145524|FG000|Overall Study|Withdrawal by Subject|0
1083649|NCT02161458|2145525|FG001|Overall Study|Withdrawal by Subject|4
1083650|NCT02161458|2145526|FG002|Overall Study|Withdrawal by Subject|4
1083651|NCT02161458|2145527|FG003|Overall Study|Withdrawal by Subject|0
1083652|NCT02161458|2145524|FG000|Overall Study|Lost to Follow-up|0
1083653|NCT02161458|2145525|FG001|Overall Study|Lost to Follow-up|2
1083654|NCT02161458|2145526|FG002|Overall Study|Lost to Follow-up|1
1083655|NCT02161458|2145527|FG003|Overall Study|Lost to Follow-up|0
1083656|NCT02161549|2145561|FG000|Overall Study|Physician Decision|6
1083657|NCT02161549|2145562|FG001|Overall Study|Physician Decision|2
1083658|NCT02161562|2145570|FG000|Overall Study|Withdrawal by Subject|5
1083659|NCT02161562|2145571|FG001|Overall Study|Withdrawal by Subject|8
1083660|NCT02161562|2145570|FG000|Overall Study|Protocol Violation|9
1083661|NCT02161562|2145571|FG001|Overall Study|Protocol Violation|4
1083662|NCT02161562|2145570|FG000|Overall Study|Pregnancy|1
1083663|NCT02161562|2145571|FG001|Overall Study|Pregnancy|2
1083664|NCT02161562|2145570|FG000|Overall Study|Lost to Follow-up|3
1083665|NCT02161562|2145571|FG001|Overall Study|Lost to Follow-up|1
1083666|NCT02161562|2145570|FG000|Overall Study|Lack of Efficacy|4
1083667|NCT02161562|2145571|FG001|Overall Study|Lack of Efficacy|1
1083668|NCT02161562|2145570|FG000|Overall Study|Adverse Event|1
1083669|NCT02161562|2145571|FG001|Overall Study|Adverse Event|1
1083670|NCT02161562|2145570|FG000|Overall Study|Participant moved back to home country|1
1083671|NCT02161562|2145571|FG001|Overall Study|Participant moved back to home country|0
1083672|NCT02161562|2145570|FG000|Overall Study|Withdrew due to being out of the country|1
1083673|NCT02161562|2145571|FG001|Overall Study|Withdrew due to being out of the country|0
1083674|NCT02161562|2145570|FG000|Overall Study|Participant moved out of province|1
1083675|NCT02161562|2145571|FG001|Overall Study|Participant moved out of province|0
1083676|NCT02161575|2145590|FG000|Overall Study|Protocol Violation|8
1083677|NCT02161575|2145590|FG000|Overall Study|Lack of Efficacy|1
1083678|NCT02161575|2145590|FG000|Overall Study|Adverse Event|2
1083679|NCT02161718|2145605|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2
1083680|NCT02161718|2145606|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0
1083681|NCT02161718|2145607|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0
1083682|NCT02161718|2145605|FG000|Open-Label ALKS 3831 Period|Physician Decision|1
1083683|NCT02161718|2145606|FG001|Open-Label ALKS 3831 Period|Physician Decision|0
1083684|NCT02161718|2145607|FG002|Open-Label ALKS 3831 Period|Physician Decision|0
1083685|NCT02161718|2145605|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1
1083686|NCT02161718|2145606|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
1083687|NCT02161718|2145607|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
1083688|NCT02161718|2145605|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1
1083689|NCT02161718|2145606|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0
1083690|NCT02161718|2145607|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0
1083691|NCT02161718|2145605|FG000|Open-Label ALKS 3831 Period|Adverse Event|3
1083692|NCT02161718|2145606|FG001|Open-Label ALKS 3831 Period|Adverse Event|0
1083693|NCT02161718|2145607|FG002|Open-Label ALKS 3831 Period|Adverse Event|0
1083694|NCT02161718|2145605|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4
1083695|NCT02161718|2145606|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
1083696|NCT02161718|2145607|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
1083697|NCT02161718|2145605|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3
1083698|NCT02161718|2145606|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0
1083699|NCT02161718|2145607|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0
1083700|NCT02161718|2145605|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6
1083701|NCT02161718|2145606|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
1083702|NCT02161718|2145607|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
1083703|NCT02161718|2145605|FG000|Post- Randomization Period|Withdrawal by Subject|0
1083704|NCT02161718|2145606|FG001|Post- Randomization Period|Withdrawal by Subject|23
1083705|NCT02161718|2145607|FG002|Post- Randomization Period|Withdrawal by Subject|18
1083706|NCT02161718|2145605|FG000|Post- Randomization Period|Lost to Follow-up|0
1083707|NCT02161718|2145606|FG001|Post- Randomization Period|Lost to Follow-up|9
1083708|NCT02161718|2145607|FG002|Post- Randomization Period|Lost to Follow-up|15
1083709|NCT02161718|2145605|FG000|Post- Randomization Period|Adverse Event|0
1083710|NCT02161718|2145606|FG001|Post- Randomization Period|Adverse Event|9
1083711|NCT02161718|2145607|FG002|Post- Randomization Period|Adverse Event|10
1083712|NCT02161718|2145605|FG000|Post- Randomization Period|Non- compliance with study drug|0
1083713|NCT02161718|2145606|FG001|Post- Randomization Period|Non- compliance with study drug|8
1083714|NCT02161718|2145607|FG002|Post- Randomization Period|Non- compliance with study drug|2
1083715|NCT02161718|2145605|FG000|Post- Randomization Period|Physician Decision|0
1083716|NCT02161718|2145606|FG001|Post- Randomization Period|Physician Decision|2
1083717|NCT02161718|2145607|FG002|Post- Randomization Period|Physician Decision|4
1083718|NCT02161718|2145605|FG000|Post- Randomization Period|Protocol Violation|0
1083719|NCT02161718|2145606|FG001|Post- Randomization Period|Protocol Violation|2
1083720|NCT02161718|2145607|FG002|Post- Randomization Period|Protocol Violation|3
1083721|NCT02161718|2145605|FG000|Post- Randomization Period|Lack of Efficacy|0
1083722|NCT02161718|2145606|FG001|Post- Randomization Period|Lack of Efficacy|0
1083723|NCT02161718|2145607|FG002|Post- Randomization Period|Lack of Efficacy|1
1083724|NCT02161718|2145605|FG000|Post- Randomization Period|Non-compliance with study procedures|0
1083725|NCT02161718|2145606|FG001|Post- Randomization Period|Non-compliance with study procedures|2
1083726|NCT02161718|2145607|FG002|Post- Randomization Period|Non-compliance with study procedures|4
1083727|NCT02161718|2145605|FG000|Post- Randomization Period|Received prohibitive treatment|0
1083728|NCT02161718|2145606|FG001|Post- Randomization Period|Received prohibitive treatment|1
1083729|NCT02161718|2145607|FG002|Post- Randomization Period|Received prohibitive treatment|2
1083730|NCT02161718|2145605|FG000|Post- Randomization Period|Relocation|0
1083731|NCT02161718|2145606|FG001|Post- Randomization Period|Relocation|3
1083732|NCT02161718|2145607|FG002|Post- Randomization Period|Relocation|0
1083733|NCT02161731|2145614|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
1083734|NCT02161731|2145615|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
1083735|NCT02161731|2145614|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
1083736|NCT02161731|2145615|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
1083737|NCT02161757|2145625|FG000|Randomised Through Start Treatment|Did not receive treatment|3
1083738|NCT02161757|2145626|FG001|Randomised Through Start Treatment|Did not receive treatment|2
1083739|NCT02161757|2145627|FG002|Randomised Through Start Treatment|Did not receive treatment|0
1083740|NCT02161757|2145625|FG000|Treatment Through Study Completion|Adverse Event|1
1083741|NCT02161757|2145626|FG001|Treatment Through Study Completion|Adverse Event|1
1083742|NCT02161757|2145627|FG002|Treatment Through Study Completion|Adverse Event|0
1083743|NCT02161757|2145625|FG000|Treatment Through Study Completion|Protocol Violation|0
1083744|NCT02161757|2145626|FG001|Treatment Through Study Completion|Protocol Violation|1
1083745|NCT02161757|2145627|FG002|Treatment Through Study Completion|Protocol Violation|2
1083746|NCT02161757|2145625|FG000|Treatment Through Study Completion|Withdrawal by Subject|27
1083747|NCT02161757|2145626|FG001|Treatment Through Study Completion|Withdrawal by Subject|19
1083748|NCT02161757|2145627|FG002|Treatment Through Study Completion|Withdrawal by Subject|20
1083749|NCT02161757|2145625|FG000|Treatment Through Study Completion|Lost to Follow-up|7
1083750|NCT02161757|2145626|FG001|Treatment Through Study Completion|Lost to Follow-up|2
1083751|NCT02161757|2145627|FG002|Treatment Through Study Completion|Lost to Follow-up|4
1083752|NCT02161757|2145625|FG000|Treatment Through Study Completion|Other|20
1083753|NCT02161757|2145626|FG001|Treatment Through Study Completion|Other|19
1083754|NCT02161757|2145627|FG002|Treatment Through Study Completion|Other|12
1083755|NCT02161757|2145625|FG000|Treatment Through Study Completion|Death|2
1083756|NCT02161757|2145626|FG001|Treatment Through Study Completion|Death|1
1083757|NCT02161757|2145627|FG002|Treatment Through Study Completion|Death|1
1083758|NCT02162719|2145694|FG000|Overall Study|Death|41
1083759|NCT02162719|2145695|FG001|Overall Study|Death|46
1083760|NCT02162719|2145694|FG000|Overall Study|Lost to Follow-up|1
1083761|NCT02162719|2145695|FG001|Overall Study|Lost to Follow-up|3
1083762|NCT02162719|2145694|FG000|Overall Study|Disease Progression|2
1083763|NCT02162719|2145695|FG001|Overall Study|Disease Progression|1
1083764|NCT02162719|2145694|FG000|Overall Study|Withdrawal by Subject|8
1083765|NCT02162719|2145695|FG001|Overall Study|Withdrawal by Subject|2
1083766|NCT02162719|2145694|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10
1083767|NCT02162719|2145695|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10
1083768|NCT02162758|2145703|FG000|Overall Study|Study termination|0
1083769|NCT02162758|2145704|FG001|Overall Study|Study termination|1
1083770|NCT02162771|2145712|FG000|Core Study Period (Part 2)|Progressive Disease|2
1083771|NCT02162771|2145713|FG001|Core Study Period (Part 2)|Progressive Disease|3
1083772|NCT02162771|2145712|FG000|Core Study Period (Part 2)|Adverse Event|4
1083773|NCT02162771|2145713|FG001|Core Study Period (Part 2)|Adverse Event|1
1083774|NCT02162771|2145712|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1
1083775|NCT02162771|2145713|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2
1083776|NCT02162771|2145712|FG000|Core Study Period (Part 2)|Physician Decision|0
1083777|NCT02162771|2145713|FG001|Core Study Period (Part 2)|Physician Decision|2
1083778|NCT02162771|2145712|FG000|Core Study Period (Part 2)|Death|1
1083779|NCT02162771|2145713|FG001|Core Study Period (Part 2)|Death|0
1083780|NCT02162771|2145712|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11
1083781|NCT02162771|2145713|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13
1083782|NCT02162771|2145712|FG000|Maintenance Study Period (Part 2)|Adverse Event|3
1083783|NCT02162771|2145713|FG001|Maintenance Study Period (Part 2)|Adverse Event|3
1083784|NCT02162771|2145712|FG000|Maintenance Study Period (Part 2)|Death|2
1083785|NCT02162771|2145713|FG001|Maintenance Study Period (Part 2)|Death|1
1083786|NCT02162771|2145712|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
1083787|NCT02162771|2145713|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
1083788|NCT02162771|2145712|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0
1083789|NCT02162771|2145713|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1
1083790|NCT02162771|2145712|FG000|Maintenance Study Period (Part 2)|Stable Disease|0
1083791|NCT02162771|2145713|FG001|Maintenance Study Period (Part 2)|Stable Disease|1
1083792|NCT02162862|2145722|FG000|Overall Study|Lost to Follow-up|0
1083793|NCT02162862|2145723|FG001|Overall Study|Lost to Follow-up|11
1083794|NCT02162862|2145724|FG002|Overall Study|Lost to Follow-up|0
1083795|NCT02162862|2145722|FG000|Overall Study|Subject did not feel the med was needed|0
1083796|NCT02162862|2145723|FG001|Overall Study|Subject did not feel the med was needed|0
1083797|NCT02162862|2145724|FG002|Overall Study|Subject did not feel the med was needed|4
1083798|NCT02163057|2145745|FG000|Overall Study|Participant Refusal to Continue|2
1083799|NCT02163057|2145746|FG001|Overall Study|Participant Refusal to Continue|2
1083800|NCT02163057|2145745|FG000|Overall Study|Participant Significant Noncompliance|0
1083801|NCT02163057|2145746|FG001|Overall Study|Participant Significant Noncompliance|1
1083802|NCT02163057|2145745|FG000|Overall Study|Progression of Disease|1
1083803|NCT02163057|2145746|FG001|Overall Study|Progression of Disease|2
1083804|NCT02163226|2145756|FG000|Overall Study|Death|2
1083805|NCT02163226|2145757|FG001|Overall Study|Death|1
1083806|NCT02163226|2145756|FG000|Overall Study|Withdrawal by Subject|5
1083807|NCT02163226|2145757|FG001|Overall Study|Withdrawal by Subject|2
1083808|NCT02163226|2145756|FG000|Overall Study|Returned home, local radiotherapy|3
1083809|NCT02163226|2145757|FG001|Overall Study|Returned home, local radiotherapy|0
1083810|NCT02163226|2145756|FG000|Overall Study|Repeat imaging showed no disease|2
1083811|NCT02163226|2145757|FG001|Overall Study|Repeat imaging showed no disease|0
1083812|NCT02163226|2145756|FG000|Overall Study|Incomplete radiotherapy|3
1083813|NCT02163226|2145757|FG001|Overall Study|Incomplete radiotherapy|0
1083814|NCT02163226|2145756|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1
1083815|NCT02163226|2145757|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0
1083816|NCT02163226|2145756|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0
1083817|NCT02163226|2145757|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5
1083818|NCT02163226|2145756|FG000|Overall Study|ineligible|0
1083819|NCT02163226|2145757|FG001|Overall Study|ineligible|3
1083820|NCT02163395|2145763|FG000|Overall Study|Withdrawal by Subject|1
1083821|NCT02163395|2145763|FG000|Overall Study|Lost to Follow-up|3
1083822|NCT02163395|2145763|FG000|Overall Study|Adverse Event|1
1083823|NCT02163447|2145793|FG000|Overall Study|Withdrawal by Subject|2
1083824|NCT02163447|2145794|FG001|Overall Study|Withdrawal by Subject|0
1083825|NCT02163447|2145795|FG002|Overall Study|Withdrawal by Subject|1
1083826|NCT02163447|2145793|FG000|Overall Study|Lost to Follow-up|1
1083827|NCT02163447|2145794|FG001|Overall Study|Lost to Follow-up|3
1083828|NCT02163447|2145795|FG002|Overall Study|Lost to Follow-up|0
1083829|NCT02163447|2145793|FG000|Overall Study|Moved out of study area|2
1083830|NCT02163447|2145794|FG001|Overall Study|Moved out of study area|3
1083831|NCT02163447|2145795|FG002|Overall Study|Moved out of study area|2
1083832|NCT02163447|2145793|FG000|Overall Study|Became HIV infected at time of delivery|1
1083833|NCT02163447|2145794|FG001|Overall Study|Became HIV infected at time of delivery|0
1083834|NCT02163447|2145795|FG002|Overall Study|Became HIV infected at time of delivery|0
1083835|NCT02163499|2145822|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1
1083836|NCT02163499|2145822|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
1083837|NCT02163499|2145822|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1
1083838|NCT02163499|2145822|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1
1083839|NCT02163499|2145822|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
1083840|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Adverse Event|51
1083841|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40
1083842|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Hypokalemia|9
1083843|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5
1083844|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
1083845|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81
1083846|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Physician Decision|8
1083847|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31
1083848|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Protocol Violation|2
1083849|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Death|8
1083850|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Subject Compliance|17
1083851|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5
1083852|NCT02163499|2145822|FG000|Extended Dosing Phase: ZS|Various reasons|16
1083853|NCT02163538|2145832|FG000|Overall Study|Protocol Violation|1
1083854|NCT02163538|2145833|FG001|Overall Study|Protocol Violation|0
1083855|NCT02163538|2145832|FG000|Overall Study|Physician Decision|0
1083856|NCT02163538|2145833|FG001|Overall Study|Physician Decision|1
1083857|NCT02163759|2145851|FG000|Overall Study|Withdrawal by Subject|1
1083858|NCT02163759|2145852|FG001|Overall Study|Withdrawal by Subject|5
1083859|NCT02163759|2145853|FG002|Overall Study|Withdrawal by Subject|1
1083860|NCT02163759|2145851|FG000|Overall Study|Adverse Event|0
1083861|NCT02163759|2145852|FG001|Overall Study|Adverse Event|0
1083862|NCT02163759|2145853|FG002|Overall Study|Adverse Event|1
1083863|NCT02163759|2145851|FG000|Overall Study|Death|0
1083864|NCT02163759|2145852|FG001|Overall Study|Death|0
1083865|NCT02163759|2145853|FG002|Overall Study|Death|1
1083866|NCT02163902|2145892|FG000|Overall Study|Subject's Request|3
1083867|NCT02163902|2145893|FG001|Overall Study|Subject's Request|4
1083868|NCT02163902|2145892|FG000|Overall Study|Lost to Follow-up|6
1083869|NCT02163902|2145893|FG001|Overall Study|Lost to Follow-up|7
1083870|NCT02163902|2145892|FG000|Overall Study|Administrative Decision|2
1083871|NCT02163902|2145893|FG001|Overall Study|Administrative Decision|2
1083872|NCT02163915|2145904|FG000|Overall Study|Withdrawal by Subject|2
1083873|NCT02163915|2145905|FG001|Overall Study|Withdrawal by Subject|0
1083874|NCT02163915|2145906|FG002|Overall Study|Withdrawal by Subject|2
1083875|NCT02163915|2145907|FG003|Overall Study|Withdrawal by Subject|2
1083876|NCT02163915|2145908|FG004|Overall Study|Withdrawal by Subject|2
1083877|NCT02163915|2145904|FG000|Overall Study|Study termination|1
1083878|NCT02163915|2145905|FG001|Overall Study|Study termination|0
1083879|NCT02163915|2145906|FG002|Overall Study|Study termination|0
1083880|NCT02163915|2145907|FG003|Overall Study|Study termination|0
1083881|NCT02163915|2145908|FG004|Overall Study|Study termination|2
1083882|NCT02163915|2145904|FG000|Overall Study|Physician Decision|0
1083883|NCT02163915|2145905|FG001|Overall Study|Physician Decision|0
1083884|NCT02163915|2145906|FG002|Overall Study|Physician Decision|0
1083885|NCT02163915|2145907|FG003|Overall Study|Physician Decision|1
1083886|NCT02163915|2145908|FG004|Overall Study|Physician Decision|0
1083887|NCT02163993|2145945|FG000|Treatment Period|Adverse Event|0
1083888|NCT02163993|2145946|FG001|Treatment Period|Adverse Event|1
1083889|NCT02163993|2145947|FG002|Treatment Period|Adverse Event|0
1083890|NCT02163993|2145948|FG003|Treatment Period|Adverse Event|0
1083891|NCT02163993|2145949|FG004|Treatment Period|Adverse Event|1
1083892|NCT02163993|2145945|FG000|Treatment Period|Lost to Follow-up|2
1083893|NCT02163993|2145946|FG001|Treatment Period|Lost to Follow-up|3
1083894|NCT02163993|2145947|FG002|Treatment Period|Lost to Follow-up|1
1083895|NCT02163993|2145948|FG003|Treatment Period|Lost to Follow-up|3
1083896|NCT02163993|2145949|FG004|Treatment Period|Lost to Follow-up|1
1083897|NCT02163993|2145945|FG000|Treatment Period|Physician Decision|1
1083898|NCT02163993|2145946|FG001|Treatment Period|Physician Decision|0
1083899|NCT02163993|2145947|FG002|Treatment Period|Physician Decision|0
1083900|NCT02163993|2145948|FG003|Treatment Period|Physician Decision|0
1083901|NCT02163993|2145949|FG004|Treatment Period|Physician Decision|0
1083902|NCT02163993|2145945|FG000|Treatment Period|Protocol Violation|2
1083903|NCT02163993|2145946|FG001|Treatment Period|Protocol Violation|1
1083904|NCT02163993|2145947|FG002|Treatment Period|Protocol Violation|0
1083905|NCT02163993|2145948|FG003|Treatment Period|Protocol Violation|1
1083906|NCT02163993|2145949|FG004|Treatment Period|Protocol Violation|2
1083907|NCT02163993|2145945|FG000|Treatment Period|Withdrawal by Subject|6
1083908|NCT02163993|2145946|FG001|Treatment Period|Withdrawal by Subject|4
1083909|NCT02163993|2145947|FG002|Treatment Period|Withdrawal by Subject|1
1083910|NCT02163993|2145948|FG003|Treatment Period|Withdrawal by Subject|4
1083911|NCT02163993|2145949|FG004|Treatment Period|Withdrawal by Subject|1
1083912|NCT02163993|2145945|FG000|Treatment Period|Not treated|1
1083913|NCT02163993|2145946|FG001|Treatment Period|Not treated|0
1083914|NCT02163993|2145947|FG002|Treatment Period|Not treated|0
1083915|NCT02163993|2145948|FG003|Treatment Period|Not treated|1
1083916|NCT02163993|2145949|FG004|Treatment Period|Not treated|2
1083917|NCT02163993|2145945|FG000|Post-treatment Period|Adverse Event|0
1083918|NCT02163993|2145946|FG001|Post-treatment Period|Adverse Event|0
1083919|NCT02163993|2145947|FG002|Post-treatment Period|Adverse Event|1
1083920|NCT02163993|2145948|FG003|Post-treatment Period|Adverse Event|0
1083921|NCT02163993|2145949|FG004|Post-treatment Period|Adverse Event|0
1083922|NCT02163993|2145945|FG000|Post-treatment Period|Lost to Follow-up|2
1083923|NCT02163993|2145946|FG001|Post-treatment Period|Lost to Follow-up|2
1083924|NCT02163993|2145947|FG002|Post-treatment Period|Lost to Follow-up|3
1083925|NCT02163993|2145948|FG003|Post-treatment Period|Lost to Follow-up|1
1083926|NCT02163993|2145949|FG004|Post-treatment Period|Lost to Follow-up|0
1083927|NCT02163993|2145945|FG000|Post-treatment Period|Protocol Violation|0
1083928|NCT02163993|2145946|FG001|Post-treatment Period|Protocol Violation|0
1083929|NCT02163993|2145947|FG002|Post-treatment Period|Protocol Violation|0
1083930|NCT02163993|2145948|FG003|Post-treatment Period|Protocol Violation|0
1083931|NCT02163993|2145949|FG004|Post-treatment Period|Protocol Violation|1
1083932|NCT02163993|2145945|FG000|Post-treatment Period|Withdrawal by Subject|2
1083933|NCT02163993|2145946|FG001|Post-treatment Period|Withdrawal by Subject|4
1083934|NCT02163993|2145947|FG002|Post-treatment Period|Withdrawal by Subject|0
1083935|NCT02163993|2145948|FG003|Post-treatment Period|Withdrawal by Subject|1
1083936|NCT02163993|2145949|FG004|Post-treatment Period|Withdrawal by Subject|2
1083937|NCT02164318|2145985|FG000|Overall Study|Withdrawal by Subject|0
1083938|NCT02164318|2145986|FG001|Overall Study|Withdrawal by Subject|1
1083939|NCT02164318|2145987|FG002|Overall Study|Withdrawal by Subject|0
1083940|NCT02164318|2145988|FG003|Overall Study|Withdrawal by Subject|1
1083941|NCT02164383|2146000|FG000|Overall Study|Lost to Follow-up|1
1083942|NCT02164383|2146001|FG001|Overall Study|Lost to Follow-up|0
1083943|NCT02164513|2146036|FG000|Overall Study|Adverse Event|162
1083944|NCT02164513|2146037|FG001|Overall Study|Adverse Event|180
1083945|NCT02164513|2146038|FG002|Overall Study|Adverse Event|111
1083946|NCT02164513|2146036|FG000|Overall Study|Other: Study Closed or terminated|5
1083947|NCT02164513|2146037|FG001|Overall Study|Other: Study Closed or terminated|2
1083948|NCT02164513|2146038|FG002|Overall Study|Other: Study Closed or terminated|4
1083949|NCT02164513|2146036|FG000|Overall Study|Lost to Follow-up|30
1083950|NCT02164513|2146037|FG001|Overall Study|Lost to Follow-up|36
1083951|NCT02164513|2146038|FG002|Overall Study|Lost to Follow-up|22
1083952|NCT02164513|2146036|FG000|Overall Study|Physician Decision|47
1083953|NCT02164513|2146037|FG001|Overall Study|Physician Decision|57
1083954|NCT02164513|2146038|FG002|Overall Study|Physician Decision|28
1083955|NCT02164513|2146036|FG000|Overall Study|Withdrawal by Subject|192
1083956|NCT02164513|2146037|FG001|Overall Study|Withdrawal by Subject|261
1083957|NCT02164513|2146038|FG002|Overall Study|Withdrawal by Subject|130
1083958|NCT02164513|2146036|FG000|Overall Study|Other: Reason not provided by site|1
1083959|NCT02164513|2146037|FG001|Overall Study|Other: Reason not provided by site|0
1083960|NCT02164513|2146038|FG002|Overall Study|Other: Reason not provided by site|0
1083961|NCT02164539|2146053|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
1083962|NCT02164539|2146054|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
1083963|NCT02164539|2146055|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
1083964|NCT02164539|2146056|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
1083965|NCT02164539|2146057|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
1083966|NCT02164539|2146058|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
1083967|NCT02164539|2146059|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
1083968|NCT02164539|2146053|FG000|Treatment Phase B (1 Week)|Adverse Event|0
1083969|NCT02164539|2146054|FG001|Treatment Phase B (1 Week)|Adverse Event|0
1083970|NCT02164539|2146055|FG002|Treatment Phase B (1 Week)|Adverse Event|0
1083971|NCT02164539|2146056|FG003|Treatment Phase B (1 Week)|Adverse Event|0
1083972|NCT02164539|2146057|FG004|Treatment Phase B (1 Week)|Adverse Event|2
1083973|NCT02164539|2146058|FG005|Treatment Phase B (1 Week)|Adverse Event|0
1083974|NCT02164539|2146059|FG006|Treatment Phase B (1 Week)|Adverse Event|0
1083975|NCT02164539|2146053|FG000|Treatment Phase B (1 Week)|Physician Decision|0
1083976|NCT02164539|2146054|FG001|Treatment Phase B (1 Week)|Physician Decision|0
1083977|NCT02164539|2146055|FG002|Treatment Phase B (1 Week)|Physician Decision|0
1083978|NCT02164539|2146056|FG003|Treatment Phase B (1 Week)|Physician Decision|0
1083979|NCT02164539|2146057|FG004|Treatment Phase B (1 Week)|Physician Decision|1
1083980|NCT02164539|2146058|FG005|Treatment Phase B (1 Week)|Physician Decision|0
1083981|NCT02164539|2146059|FG006|Treatment Phase B (1 Week)|Physician Decision|1
1083982|NCT02164539|2146053|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1
1083983|NCT02164539|2146054|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1083984|NCT02164539|2146055|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1083985|NCT02164539|2146056|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1083986|NCT02164539|2146057|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1083987|NCT02164539|2146058|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1083988|NCT02164539|2146059|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1083989|NCT02164539|2146053|FG000|Treatment Phase C (1 Week)|Adverse Event|0
1083990|NCT02164539|2146054|FG001|Treatment Phase C (1 Week)|Adverse Event|0
1083991|NCT02164539|2146055|FG002|Treatment Phase C (1 Week)|Adverse Event|0
1083992|NCT02164539|2146056|FG003|Treatment Phase C (1 Week)|Adverse Event|0
1083993|NCT02164539|2146057|FG004|Treatment Phase C (1 Week)|Adverse Event|0
1083994|NCT02164539|2146058|FG005|Treatment Phase C (1 Week)|Adverse Event|0
1083995|NCT02164539|2146059|FG006|Treatment Phase C (1 Week)|Adverse Event|1
1083996|NCT02164539|2146053|FG000|Treatment Phase C (1 Week)|Physician Decision|0
1083997|NCT02164539|2146054|FG001|Treatment Phase C (1 Week)|Physician Decision|0
1083998|NCT02164539|2146055|FG002|Treatment Phase C (1 Week)|Physician Decision|0
1083999|NCT02164539|2146056|FG003|Treatment Phase C (1 Week)|Physician Decision|0
1084000|NCT02164539|2146057|FG004|Treatment Phase C (1 Week)|Physician Decision|0
1084001|NCT02164539|2146058|FG005|Treatment Phase C (1 Week)|Physician Decision|0
1084002|NCT02164539|2146059|FG006|Treatment Phase C (1 Week)|Physician Decision|1
1084003|NCT02164864|2146082|FG000|Overall Study|Trial disease worsening|7
1084004|NCT02164864|2146083|FG001|Overall Study|Trial disease worsening|5
1084005|NCT02164864|2146084|FG002|Overall Study|Trial disease worsening|1
1084006|NCT02164864|2146082|FG000|Overall Study|Other pre-existing disease worsening|6
1084007|NCT02164864|2146083|FG001|Overall Study|Other pre-existing disease worsening|4
1084008|NCT02164864|2146084|FG002|Overall Study|Other pre-existing disease worsening|9
1084009|NCT02164864|2146082|FG000|Overall Study|Other Adverse Event (AE)|52
1084010|NCT02164864|2146083|FG001|Overall Study|Other Adverse Event (AE)|32
1084011|NCT02164864|2146084|FG002|Overall Study|Other Adverse Event (AE)|49
1084012|NCT02164864|2146082|FG000|Overall Study|Protocol Violation|2
1084013|NCT02164864|2146083|FG001|Overall Study|Protocol Violation|4
909662|NCT00789477|1886420|FG002|Overall Study|Protocol Violation|0
1084014|NCT02164864|2146084|FG002|Overall Study|Protocol Violation|1
1084015|NCT02164864|2146082|FG000|Overall Study|Lost to Follow-up|4
1084016|NCT02164864|2146083|FG001|Overall Study|Lost to Follow-up|3
1084017|NCT02164864|2146084|FG002|Overall Study|Lost to Follow-up|2
1084018|NCT02164864|2146082|FG000|Overall Study|Consent withdrawn, not due to AE|21
1084019|NCT02164864|2146083|FG001|Overall Study|Consent withdrawn, not due to AE|8
1084020|NCT02164864|2146084|FG002|Overall Study|Consent withdrawn, not due to AE|56
1084021|NCT02164864|2146082|FG000|Overall Study|Other than stated|3
1084022|NCT02164864|2146083|FG001|Overall Study|Other than stated|4
1084023|NCT02164864|2146084|FG002|Overall Study|Other than stated|14
1084024|NCT02164916|2146097|FG000|Overall Study|Adverse Event|3
1084025|NCT02164916|2146098|FG001|Overall Study|Adverse Event|8
1084026|NCT02164916|2146097|FG000|Overall Study|Death|1
1084027|NCT02164916|2146098|FG001|Overall Study|Death|1
1084028|NCT02164916|2146097|FG000|Overall Study|Refusal unrelated to adverse event|3
1084029|NCT02164916|2146098|FG001|Overall Study|Refusal unrelated to adverse event|7
1084030|NCT02164916|2146097|FG000|Overall Study|Progression|37
1084031|NCT02164916|2146098|FG001|Overall Study|Progression|26
1084032|NCT02164916|2146097|FG000|Overall Study|Not protocol specified|5
1084033|NCT02164916|2146098|FG001|Overall Study|Not protocol specified|1
1084034|NCT02164916|2146097|FG000|Overall Study|Reason under review|1
1084035|NCT02164916|2146098|FG001|Overall Study|Reason under review|6
1084036|NCT02164916|2146097|FG000|Overall Study|Not eligible|2
1084037|NCT02164916|2146098|FG001|Overall Study|Not eligible|5
1084038|NCT02164929|2146113|FG000|Overall Study|Converted to open procedure|1
1084039|NCT02164929|2146114|FG001|Overall Study|Converted to open procedure|0
1084040|NCT02164929|2146115|FG002|Overall Study|Converted to open procedure|0
1084041|NCT02164929|2146116|FG003|Overall Study|Converted to open procedure|2
1084042|NCT02164929|2146113|FG000|Overall Study|Failed regional block|0
1084043|NCT02164929|2146114|FG001|Overall Study|Failed regional block|0
1084044|NCT02164929|2146115|FG002|Overall Study|Failed regional block|1
1084045|NCT02164929|2146116|FG003|Overall Study|Failed regional block|0
1084046|NCT02164981|2146129|FG000|Started|Withdrawal by Subject|2
1084047|NCT02164981|2146130|FG001|Started|Withdrawal by Subject|1
1084048|NCT02164981|2146131|FG002|Started|Withdrawal by Subject|0
1084049|NCT02164981|2146129|FG000|Started|Protocol Violation|2
1084050|NCT02164981|2146130|FG001|Started|Protocol Violation|0
1084051|NCT02164981|2146131|FG002|Started|Protocol Violation|0
1084052|NCT02164981|2146129|FG000|Started|Adverse Event|1
1084053|NCT02164981|2146130|FG001|Started|Adverse Event|2
1084054|NCT02164981|2146131|FG002|Started|Adverse Event|0
1084055|NCT02164981|2146129|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0
1084056|NCT02164981|2146130|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2
1084057|NCT02164981|2146131|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0
1084058|NCT02164981|2146129|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2
1084059|NCT02164981|2146130|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1
1084060|NCT02164981|2146131|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0
1084061|NCT02164981|2146129|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
1084062|NCT02164981|2146130|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
1084063|NCT02164981|2146131|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
1084064|NCT02165202|2146173|FG000|Oral Phase|Refused further participation|5
1084065|NCT02165202|2146174|FG001|Oral Phase|Refused further participation|1
1084066|NCT02165202|2146173|FG000|Oral Phase|Study product Related Toxicity|1
1084067|NCT02165202|2146174|FG001|Oral Phase|Study product Related Toxicity|0
1084068|NCT02165202|2146173|FG000|Oral Phase|Unable to contact Participant|1
1084069|NCT02165202|2146174|FG001|Oral Phase|Unable to contact Participant|1
1084070|NCT02165202|2146173|FG000|Oral Phase|Clinical reasons|1
1084071|NCT02165202|2146174|FG001|Oral Phase|Clinical reasons|0
1084072|NCT02165202|2146173|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1
1084073|NCT02165202|2146174|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0
1084074|NCT02165202|2146173|FG000|Oral Phase|CMC advised termination|1
1084075|NCT02165202|2146174|FG001|Oral Phase|CMC advised termination|0
1084076|NCT02165202|2146173|FG000|Oral Phase|Relocated, no follow-up planned|1
1084077|NCT02165202|2146174|FG001|Oral Phase|Relocated, no follow-up planned|0
1084078|NCT02165202|2146173|FG000|Oral Phase|Abnormal EKG|0
1084079|NCT02165202|2146174|FG001|Oral Phase|Abnormal EKG|1
1084080|NCT02165202|2146173|FG000|Injection Phase|Abnormal Lab Value|5
1084081|NCT02165202|2146174|FG001|Injection Phase|Abnormal Lab Value|1
1084082|NCT02165202|2146173|FG000|Injection Phase|Reactive HIV or HIV Suspected|0
1084083|NCT02165202|2146174|FG001|Injection Phase|Reactive HIV or HIV Suspected|2
1084084|NCT02165202|2146173|FG000|Injection Phase|Unable to attend within Visit Window|1
1084085|NCT02165202|2146174|FG001|Injection Phase|Unable to attend within Visit Window|0
1084086|NCT02165202|2146173|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0
1084087|NCT02165202|2146174|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1
1084088|NCT02165202|2146173|FG000|Injection Phase|End of Study|2
1084089|NCT02165202|2146174|FG001|Injection Phase|End of Study|1
1084090|NCT02165202|2146173|FG000|Injection Phase|Study Product related Toxicity|1
1084091|NCT02165202|2146174|FG001|Injection Phase|Study Product related Toxicity|0
1084092|NCT02165202|2146173|FG000|Injection Phase|No longer interested|0
1084093|NCT02165202|2146174|FG001|Injection Phase|No longer interested|1
1084094|NCT02165202|2146173|FG000|Injection Phase|Participant unwilling to comply|1
1084095|NCT02165202|2146174|FG001|Injection Phase|Participant unwilling to comply|0
1084096|NCT02165397|2146203|FG000|Overall Study|Death|7
1084097|NCT02165397|2146204|FG001|Overall Study|Death|10
1084098|NCT02165397|2146205|FG002|Overall Study|Death|8
1084099|NCT02165397|2146203|FG000|Overall Study|Lost to Follow-up|1
1084100|NCT02165397|2146204|FG001|Overall Study|Lost to Follow-up|3
1084101|NCT02165397|2146205|FG002|Overall Study|Lost to Follow-up|0
1084102|NCT02165397|2146203|FG000|Overall Study|Withdrawal by Subject|6
1084103|NCT02165397|2146204|FG001|Overall Study|Withdrawal by Subject|6
1084104|NCT02165397|2146205|FG002|Overall Study|Withdrawal by Subject|1
1084105|NCT02165397|2146203|FG000|Overall Study|Other, Not Specified|0
1084106|NCT02165397|2146204|FG001|Overall Study|Other, Not Specified|0
1084107|NCT02165397|2146205|FG002|Overall Study|Other, Not Specified|1
1084108|NCT02165735|2146243|FG000|Overall Study|Lost to Follow-up|12
1084109|NCT02165735|2146244|FG001|Overall Study|Lost to Follow-up|10
1084110|NCT02165735|2146243|FG000|Overall Study|Withdrawal by Subject|3
1084111|NCT02165735|2146244|FG001|Overall Study|Withdrawal by Subject|0
1084112|NCT02165735|2146243|FG000|Overall Study|Participant indicated lack of time|1
1084113|NCT02165735|2146244|FG001|Overall Study|Participant indicated lack of time|3
1084114|NCT02165735|2146243|FG000|Overall Study|Protocol Violation|0
1084115|NCT02165735|2146244|FG001|Overall Study|Protocol Violation|1
1084116|NCT02165826|2146262|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44
1084117|NCT02165826|2146263|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57
1084118|NCT02165826|2146264|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68
1084119|NCT02165826|2146262|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0
1084120|NCT02165826|2146263|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1
1084121|NCT02165826|2146264|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3
1084122|NCT02165826|2146262|FG000|Main Treatment Period|Lost to Follow-up|4
1084123|NCT02165826|2146263|FG001|Main Treatment Period|Lost to Follow-up|2
1084124|NCT02165826|2146264|FG002|Main Treatment Period|Lost to Follow-up|1
1084125|NCT02165826|2146262|FG000|Main Treatment Period|Voluntary Withdrawal|23
1084126|NCT02165826|2146263|FG001|Main Treatment Period|Voluntary Withdrawal|23
1084127|NCT02165826|2146264|FG002|Main Treatment Period|Voluntary Withdrawal|21
1084128|NCT02165826|2146262|FG000|Main Treatment Period|Lack of Efficacy|2
1084129|NCT02165826|2146263|FG001|Main Treatment Period|Lack of Efficacy|0
1084130|NCT02165826|2146264|FG002|Main Treatment Period|Lack of Efficacy|0
1084131|NCT02165826|2146262|FG000|Main Treatment Period|Reason Not Specified|8
1084132|NCT02165826|2146263|FG001|Main Treatment Period|Reason Not Specified|5
1084133|NCT02165826|2146264|FG002|Main Treatment Period|Reason Not Specified|16
1084134|NCT02165826|2146262|FG000|Main Treatment Period|Did Not Receive Study Drug|0
1084135|NCT02165826|2146263|FG001|Main Treatment Period|Did Not Receive Study Drug|2
1084136|NCT02165826|2146264|FG002|Main Treatment Period|Did Not Receive Study Drug|0
1084137|NCT02165826|2146262|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4
1084138|NCT02165826|2146263|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10
1084139|NCT02165826|2146264|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3
1084140|NCT02165826|2146262|FG000|Down-Titration Period|Voluntary Withdrawal|2
1084141|NCT02165826|2146263|FG001|Down-Titration Period|Voluntary Withdrawal|1
1084142|NCT02165826|2146264|FG002|Down-Titration Period|Voluntary Withdrawal|2
1084143|NCT02165826|2146262|FG000|Down-Titration Period|Reason Not Specified|1
1084144|NCT02165826|2146263|FG001|Down-Titration Period|Reason Not Specified|0
1084145|NCT02165826|2146264|FG002|Down-Titration Period|Reason Not Specified|2
1084146|NCT02166047|2146315|FG000|Overall Study|Withdrawal by Participant|0
1084147|NCT02166047|2146316|FG001|Overall Study|Withdrawal by Participant|1
1084148|NCT02166047|2146317|FG002|Overall Study|Withdrawal by Participant|2
1084149|NCT02166047|2146318|FG003|Overall Study|Withdrawal by Participant|0
1084150|NCT02166047|2146319|FG004|Overall Study|Withdrawal by Participant|0
1084151|NCT02166047|2146320|FG005|Overall Study|Withdrawal by Participant|0
1084152|NCT02166047|2146321|FG006|Overall Study|Withdrawal by Participant|1
1084153|NCT02166047|2146322|FG007|Overall Study|Withdrawal by Participant|0
1084154|NCT02166047|2146323|FG008|Overall Study|Withdrawal by Participant|0
1084155|NCT02166047|2146324|FG009|Overall Study|Withdrawal by Participant|0
1084156|NCT02166047|2146325|FG010|Overall Study|Withdrawal by Participant|0
1084157|NCT02166047|2146326|FG011|Overall Study|Withdrawal by Participant|0
1084158|NCT02166047|2146315|FG000|Overall Study|Adverse Event|0
1084159|NCT02166047|2146316|FG001|Overall Study|Adverse Event|0
1084160|NCT02166047|2146317|FG002|Overall Study|Adverse Event|0
1084161|NCT02166047|2146318|FG003|Overall Study|Adverse Event|0
1084162|NCT02166047|2146319|FG004|Overall Study|Adverse Event|1
1084163|NCT02166047|2146320|FG005|Overall Study|Adverse Event|0
1084164|NCT02166047|2146321|FG006|Overall Study|Adverse Event|1
1084165|NCT02166047|2146322|FG007|Overall Study|Adverse Event|0
1084166|NCT02166047|2146323|FG008|Overall Study|Adverse Event|0
1084167|NCT02166047|2146324|FG009|Overall Study|Adverse Event|0
1084168|NCT02166047|2146325|FG010|Overall Study|Adverse Event|2
1084169|NCT02166047|2146326|FG011|Overall Study|Adverse Event|0
1084170|NCT02166333|2146356|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4
1084171|NCT02166333|2146357|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
1084172|NCT02166333|2146358|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
1084173|NCT02166333|2146359|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
1084174|NCT02166333|2146360|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3
1084175|NCT02166333|2146361|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1
1084176|NCT02166333|2146356|FG000|Stage 1|Death|4
1084177|NCT02166333|2146357|FG001|Stage 1|Death|0
1084178|NCT02166333|2146358|FG002|Stage 1|Death|2
1084179|NCT02166333|2146359|FG003|Stage 1|Death|0
1084180|NCT02166333|2146360|FG004|Stage 1|Death|3
1084181|NCT02166333|2146361|FG005|Stage 1|Death|2
1084182|NCT02166333|2146356|FG000|Stage 1|Lost to Follow-up|12
1084183|NCT02166333|2146357|FG001|Stage 1|Lost to Follow-up|0
1084184|NCT02166333|2146358|FG002|Stage 1|Lost to Follow-up|6
1084185|NCT02166333|2146359|FG003|Stage 1|Lost to Follow-up|0
1084186|NCT02166333|2146360|FG004|Stage 1|Lost to Follow-up|3
1084187|NCT02166333|2146361|FG005|Stage 1|Lost to Follow-up|3
1084188|NCT02166333|2146356|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180
1084189|NCT02166333|2146357|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
1084190|NCT02166333|2146358|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63
1084191|NCT02166333|2146359|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
1084192|NCT02166333|2146360|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54
1084193|NCT02166333|2146361|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52
1084194|NCT02166333|2146356|FG000|Stage 2|Death|4
1084195|NCT02166333|2146357|FG001|Stage 2|Death|2
1084196|NCT02166333|2146358|FG002|Stage 2|Death|1
1084197|NCT02166333|2146359|FG003|Stage 2|Death|0
1084198|NCT02166333|2146360|FG004|Stage 2|Death|0
1084199|NCT02166333|2146361|FG005|Stage 2|Death|1
1084200|NCT02166333|2146356|FG000|Stage 2|Lost to Follow-up|23
1084201|NCT02166333|2146357|FG001|Stage 2|Lost to Follow-up|4
1084202|NCT02166333|2146358|FG002|Stage 2|Lost to Follow-up|11
1084203|NCT02166333|2146359|FG003|Stage 2|Lost to Follow-up|9
1084204|NCT02166333|2146360|FG004|Stage 2|Lost to Follow-up|3
1084205|NCT02166333|2146361|FG005|Stage 2|Lost to Follow-up|6
1084206|NCT02166476|2146382|FG000|Overall Study|Withdrawal by Subject|5
1084207|NCT02166476|2146383|FG001|Overall Study|Withdrawal by Subject|7
1084208|NCT02166476|2146382|FG000|Overall Study|Adverse Event|3
1084209|NCT02166476|2146383|FG001|Overall Study|Adverse Event|3
1084210|NCT02166476|2146382|FG000|Overall Study|Lost to Follow-up|5
1084211|NCT02166476|2146383|FG001|Overall Study|Lost to Follow-up|10
1084212|NCT02166476|2146382|FG000|Overall Study|Physician Decision|1
1084213|NCT02166476|2146383|FG001|Overall Study|Physician Decision|0
1084214|NCT02166476|2146382|FG000|Overall Study|Unable to Come for Visit|0
1084215|NCT02166476|2146383|FG001|Overall Study|Unable to Come for Visit|3
1084216|NCT02166606|2146392|FG000|Overall Study|Adverse Event|3
1084217|NCT02166606|2146392|FG000|Overall Study|Death|31
1084218|NCT02166606|2146392|FG000|Overall Study|Protocol Violation|7
1084219|NCT02166606|2146392|FG000|Overall Study|Lost to Follow-up|30
1084220|NCT02166606|2146392|FG000|Overall Study|Withdrawal by Subject|1
1084221|NCT02166606|2146392|FG000|Overall Study|Physician Decision|1
1084222|NCT02166606|2146392|FG000|Overall Study|Device upgrade|1
1084223|NCT02166606|2146392|FG000|Overall Study|Enrolled after End of Enrollment|4
1084224|NCT02166697|2146396|FG000|Overall Study|Protocol Violation|347
1084225|NCT02167035|2146402|FG000|Overall Study|Adverse Event|2
1084226|NCT02167035|2146403|FG001|Overall Study|Adverse Event|2
1084227|NCT02167035|2146402|FG000|Overall Study|Lost to Follow-up|3
1084228|NCT02167035|2146403|FG001|Overall Study|Lost to Follow-up|3
1084229|NCT02167035|2146402|FG000|Overall Study|Randomized to incorrect Study Medication|0
1084230|NCT02167035|2146403|FG001|Overall Study|Randomized to incorrect Study Medication|1
1084231|NCT02167139|2146422|FG000|Randomised, Double-blind|Withdrawal by Subject|11
1084232|NCT02167139|2146423|FG001|Randomised, Double-blind|Withdrawal by Subject|8
1084233|NCT02167139|2146424|FG002|Randomised, Double-blind|Withdrawal by Subject|0
1084234|NCT02167139|2146425|FG003|Randomised, Double-blind|Withdrawal by Subject|0
1084235|NCT02167139|2146422|FG000|Randomised, Double-blind|Adverse Event|2
1084236|NCT02167139|2146423|FG001|Randomised, Double-blind|Adverse Event|9
1084237|NCT02167139|2146424|FG002|Randomised, Double-blind|Adverse Event|0
1084238|NCT02167139|2146425|FG003|Randomised, Double-blind|Adverse Event|0
1084239|NCT02167139|2146422|FG000|Randomised, Double-blind|Lack of Efficacy|1
1084240|NCT02167139|2146423|FG001|Randomised, Double-blind|Lack of Efficacy|2
1084241|NCT02167139|2146424|FG002|Randomised, Double-blind|Lack of Efficacy|0
1084242|NCT02167139|2146425|FG003|Randomised, Double-blind|Lack of Efficacy|0
1084243|NCT02167139|2146422|FG000|Randomised, Double-blind|Other|3
1084244|NCT02167139|2146423|FG001|Randomised, Double-blind|Other|0
1084245|NCT02167139|2146424|FG002|Randomised, Double-blind|Other|0
1084246|NCT02167139|2146425|FG003|Randomised, Double-blind|Other|0
1084247|NCT02167139|2146422|FG000|Transition-extension|Adverse Event|2
1084248|NCT02167139|2146423|FG001|Transition-extension|Adverse Event|0
1084249|NCT02167139|2146424|FG002|Transition-extension|Adverse Event|2
1084250|NCT02167139|2146425|FG003|Transition-extension|Adverse Event|3
1084251|NCT02167139|2146422|FG000|Transition-extension|Withdrawal by Subject|2
1084252|NCT02167139|2146423|FG001|Transition-extension|Withdrawal by Subject|0
1084253|NCT02167139|2146424|FG002|Transition-extension|Withdrawal by Subject|4
1084254|NCT02167139|2146425|FG003|Transition-extension|Withdrawal by Subject|1
1084255|NCT02167139|2146422|FG000|Transition-extension|Lack of Efficacy|0
1084256|NCT02167139|2146423|FG001|Transition-extension|Lack of Efficacy|0
1084257|NCT02167139|2146424|FG002|Transition-extension|Lack of Efficacy|1
1084258|NCT02167139|2146425|FG003|Transition-extension|Lack of Efficacy|1
1084259|NCT02167139|2146422|FG000|Transition-extension|Other|1
1084260|NCT02167139|2146423|FG001|Transition-extension|Other|0
1084261|NCT02167139|2146424|FG002|Transition-extension|Other|1
1084262|NCT02167139|2146425|FG003|Transition-extension|Other|0
1084263|NCT02167139|2146422|FG000|Transition-extension|Lost to Follow-up|1
1084264|NCT02167139|2146423|FG001|Transition-extension|Lost to Follow-up|0
1084265|NCT02167139|2146424|FG002|Transition-extension|Lost to Follow-up|0
1084266|NCT02167139|2146425|FG003|Transition-extension|Lost to Follow-up|0
1084267|NCT02167256|2146455|FG000|Overall Study|Adverse Event|13
1084268|NCT02167256|2146456|FG001|Overall Study|Adverse Event|6
1084269|NCT02167256|2146455|FG000|Overall Study|Withdrawal by Subject|4
1084270|NCT02167256|2146456|FG001|Overall Study|Withdrawal by Subject|4
1084271|NCT02167256|2146455|FG000|Overall Study|non-compliance|3
1084272|NCT02167256|2146456|FG001|Overall Study|non-compliance|0
1084273|NCT02167256|2146455|FG000|Overall Study|Study partner unable to participate|1
1084274|NCT02167256|2146456|FG001|Overall Study|Study partner unable to participate|0
1084275|NCT02167451|2146462|FG000|Overall Study|Withdrawal by Subject|1
1084276|NCT02167594|2146469|FG000|Overall Study|Withdrawal by Subject|2
1084277|NCT02167594|2146470|FG001|Overall Study|Withdrawal by Subject|0
1084278|NCT02167594|2146471|FG002|Overall Study|Withdrawal by Subject|0
1084279|NCT02167594|2146469|FG000|Overall Study|Death|0
1084280|NCT02167594|2146470|FG001|Overall Study|Death|1
1084281|NCT02167594|2146471|FG002|Overall Study|Death|0
1084282|NCT02167893|2146499|FG000|Overall Study|Investigator transferred|85
1084283|NCT02167893|2146499|FG000|Overall Study|Investigator health reasons|10
1084284|NCT02167893|2146499|FG000|Overall Study|Case report forms not collected|68
1084285|NCT02168101|2146521|FG000|Overall Study|Death|2
1084286|NCT02168101|2146522|FG001|Overall Study|Death|2
1084287|NCT02168101|2146523|FG002|Overall Study|Death|1
1084288|NCT02168387|2146561|FG000|Overall Study|Planned exubation|6
1084289|NCT02168387|2146562|FG001|Overall Study|Planned exubation|3
1084290|NCT02168387|2146561|FG000|Overall Study|Death|1
1084291|NCT02168387|2146562|FG001|Overall Study|Death|0
1084292|NCT02168439|2146570|FG000|Overall Study|Protocol Violation|0
1084293|NCT02168439|2146571|FG001|Overall Study|Protocol Violation|2
1084294|NCT02168478|2146577|FG000|Overall Study|Withdrawal by Subject|1
1084295|NCT02168478|2146577|FG000|Overall Study|Did Not Consent to Participation|2
1084296|NCT02168478|2146577|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1
1084297|NCT02168491|2146581|FG000|Overall Study|Withdrawal by Subject|1
1084298|NCT02168777|2146604|FG000|Overall Study|Withdrawal by Subject|1
1084299|NCT02168777|2146605|FG001|Overall Study|Withdrawal by Subject|0
1084300|NCT02168777|2146606|FG002|Overall Study|Withdrawal by Subject|2
1084301|NCT02168777|2146604|FG000|Overall Study|Adverse Event|1
1084302|NCT02168777|2146605|FG001|Overall Study|Adverse Event|0
1084303|NCT02168777|2146606|FG002|Overall Study|Adverse Event|1
1084304|NCT02168777|2146604|FG000|Overall Study|Disease recurrence|0
1084305|NCT02168777|2146605|FG001|Overall Study|Disease recurrence|0
1084306|NCT02168777|2146606|FG002|Overall Study|Disease recurrence|1
1084307|NCT02168777|2146604|FG000|Overall Study|Radiological disease progression|0
1084308|NCT02168777|2146605|FG001|Overall Study|Radiological disease progression|5
1084309|NCT02168777|2146606|FG002|Overall Study|Radiological disease progression|5
1084310|NCT02168777|2146604|FG000|Overall Study|Clinical disease progression|0
1084311|NCT02168777|2146605|FG001|Overall Study|Clinical disease progression|1
1084312|NCT02168777|2146606|FG002|Overall Study|Clinical disease progression|2
1084313|NCT02168777|2146604|FG000|Overall Study|Other reason|0
1084314|NCT02168777|2146605|FG001|Overall Study|Other reason|1
1084315|NCT02168777|2146606|FG002|Overall Study|Other reason|0
1084316|NCT02168803|2146620|FG000|Overall Study|Lost to Follow-up|1
1084317|NCT02168803|2146621|FG001|Overall Study|Lost to Follow-up|0
1084318|NCT02168803|2146622|FG002|Overall Study|Lost to Follow-up|1
1084319|NCT02168803|2146620|FG000|Overall Study|Withdrawal by Subject|1
1084320|NCT02168803|2146621|FG001|Overall Study|Withdrawal by Subject|1
1084321|NCT02168803|2146622|FG002|Overall Study|Withdrawal by Subject|2
1084322|NCT02168803|2146620|FG000|Overall Study|Physician Decision|0
1084323|NCT02168803|2146621|FG001|Overall Study|Physician Decision|1
1084324|NCT02168803|2146622|FG002|Overall Study|Physician Decision|0
1084325|NCT02168803|2146620|FG000|Overall Study|Adverse Event|0
1084326|NCT02168803|2146621|FG001|Overall Study|Adverse Event|1
1084327|NCT02168803|2146622|FG002|Overall Study|Adverse Event|1
1084328|NCT02168803|2146620|FG000|Overall Study|Death|0
1084329|NCT02168803|2146621|FG001|Overall Study|Death|0
1084330|NCT02168803|2146622|FG002|Overall Study|Death|1
1084331|NCT02168803|2146620|FG000|Overall Study|Sponsor Decision|0
1084332|NCT02168803|2146621|FG001|Overall Study|Sponsor Decision|0
1084333|NCT02168803|2146622|FG002|Overall Study|Sponsor Decision|1
1084334|NCT02168816|2146639|FG000|Overall Study|Lost to Follow-up|2
1084335|NCT02168816|2146640|FG001|Overall Study|Lost to Follow-up|2
1084336|NCT02168842|2146648|FG000|Overall Study|Withdrawal by Subject|5
1084337|NCT02168842|2146649|FG001|Overall Study|Withdrawal by Subject|3
1084338|NCT02168842|2146648|FG000|Overall Study|Lost to Follow-up|0
1084339|NCT02168842|2146649|FG001|Overall Study|Lost to Follow-up|2
1084340|NCT02168842|2146648|FG000|Overall Study|Death|2
1084341|NCT02168842|2146649|FG001|Overall Study|Death|1
1084342|NCT02168842|2146648|FG000|Overall Study|Physician Decision|1
1084343|NCT02168842|2146649|FG001|Overall Study|Physician Decision|2
1084344|NCT02168946|2146678|FG000|Overall Study|Adverse Event|8
1084345|NCT02168946|2146679|FG001|Overall Study|Adverse Event|5
1084346|NCT02168946|2146678|FG000|Overall Study|Lost to Follow-up|3
1084347|NCT02168946|2146679|FG001|Overall Study|Lost to Follow-up|0
1084348|NCT02168946|2146678|FG000|Overall Study|Subject unable to come back for visits|1
1084349|NCT02168946|2146679|FG001|Overall Study|Subject unable to come back for visits|0
1084350|NCT02169219|2146699|FG000|Overall Study|Lack of Efficacy|6
1084351|NCT02169271|2146710|FG000|Overall Study|Protocol Violation|1
1084352|NCT02169271|2146711|FG001|Overall Study|Protocol Violation|2
1084353|NCT02169284|2146719|FG000|Overall Study|Physician Decision|0
1084354|NCT02169284|2146720|FG001|Overall Study|Physician Decision|1
1084355|NCT02169336|2146731|FG000|Overall Study|Lack of Efficacy|1
1084356|NCT02169336|2146732|FG001|Overall Study|Lack of Efficacy|1
1084357|NCT02169336|2146733|FG002|Overall Study|Lack of Efficacy|0
1084358|NCT02169336|2146731|FG000|Overall Study|Adverse Event|2
1084359|NCT02169336|2146732|FG001|Overall Study|Adverse Event|3
1084360|NCT02169336|2146733|FG002|Overall Study|Adverse Event|1
1084361|NCT02169336|2146731|FG000|Overall Study|Withdrawal by Subject|1
1084362|NCT02169336|2146732|FG001|Overall Study|Withdrawal by Subject|0
1084363|NCT02169336|2146733|FG002|Overall Study|Withdrawal by Subject|0
1084364|NCT02169336|2146731|FG000|Overall Study|Physician Decision|0
1084365|NCT02169336|2146732|FG001|Overall Study|Physician Decision|0
1084366|NCT02169336|2146733|FG002|Overall Study|Physician Decision|1
1084367|NCT02169336|2146731|FG000|Overall Study|Subject declined to continue dosing|0
1084368|NCT02169336|2146732|FG001|Overall Study|Subject declined to continue dosing|0
1084369|NCT02169336|2146733|FG002|Overall Study|Subject declined to continue dosing|1
1084370|NCT02169414|2146745|FG000|Overall Study|Withdrawal by Subject|1
1084371|NCT02169414|2146746|FG001|Overall Study|Withdrawal by Subject|0
1084372|NCT02169414|2146747|FG002|Overall Study|Withdrawal by Subject|0
1084373|NCT02169414|2146748|FG003|Overall Study|Withdrawal by Subject|0
1084374|NCT02169414|2146745|FG000|Overall Study|Adverse Event|0
1084375|NCT02169414|2146746|FG001|Overall Study|Adverse Event|1
1084376|NCT02169414|2146747|FG002|Overall Study|Adverse Event|0
1084377|NCT02169414|2146748|FG003|Overall Study|Adverse Event|0
1084378|NCT02169505|2146831|FG000|Overall Study|Withdrawal by Subject|1
1084379|NCT02169674|2146837|FG000|Overall Study|Withdrawal by Subject|2
1084380|NCT02169674|2146838|FG001|Overall Study|Withdrawal by Subject|1
1084381|NCT02169674|2146837|FG000|Overall Study|Seroprotected|30
1084382|NCT02169674|2146838|FG001|Overall Study|Seroprotected|76
1084383|NCT02169674|2146837|FG000|Overall Study|Lost to Follow-up|0
1084384|NCT02169674|2146838|FG001|Overall Study|Lost to Follow-up|1
1084385|NCT02169739|2146846|FG000|Overall Study|Lost to Follow-up|0
1084386|NCT02169739|2146847|FG001|Overall Study|Lost to Follow-up|4
1084387|NCT02169791|2146854|FG000|Overall Study|Death|6
1084388|NCT02169791|2146854|FG000|Overall Study|patient withdrew consent|1
1084389|NCT02170025|2146886|FG000|Overall Study|Adverse Event|2
1084390|NCT02170025|2146887|FG001|Overall Study|Adverse Event|0
1084391|NCT02170051|2146895|FG000|Overall Study|Withdrawal by Subject|10
1084392|NCT02170051|2146896|FG001|Overall Study|Withdrawal by Subject|10
1084393|NCT02170051|2146895|FG000|Overall Study|Lost to Follow-up|1
1084394|NCT02170051|2146896|FG001|Overall Study|Lost to Follow-up|3
1084395|NCT02170064|2146905|FG000|Overall Study|Withdrawal by Subject|5
1084396|NCT02170064|2146906|FG001|Overall Study|Withdrawal by Subject|1
1084397|NCT02170064|2146907|FG002|Overall Study|Withdrawal by Subject|1
1084398|NCT02170064|2146905|FG000|Overall Study|Physician Decision|1
1084399|NCT02170064|2146906|FG001|Overall Study|Physician Decision|1
1084400|NCT02170064|2146907|FG002|Overall Study|Physician Decision|0
1084401|NCT02170077|2146918|FG000|Overall Study|Withdrawal by Subject|3
1084402|NCT02170077|2146919|FG001|Overall Study|Withdrawal by Subject|4
1084403|NCT02170077|2146920|FG002|Overall Study|Withdrawal by Subject|2
1084404|NCT02170077|2146918|FG000|Overall Study|Adverse Event|4
1084405|NCT02170077|2146919|FG001|Overall Study|Adverse Event|4
1084406|NCT02170077|2146920|FG002|Overall Study|Adverse Event|4
1084407|NCT02170077|2146918|FG000|Overall Study|Lost to Follow-up|0
1084408|NCT02170077|2146919|FG001|Overall Study|Lost to Follow-up|1
1084409|NCT02170077|2146920|FG002|Overall Study|Lost to Follow-up|0
1084410|NCT02170077|2146918|FG000|Overall Study|Exclusion criteria|2
1084411|NCT02170077|2146919|FG001|Overall Study|Exclusion criteria|2
1084412|NCT02170077|2146920|FG002|Overall Study|Exclusion criteria|5
1084413|NCT02170077|2146918|FG000|Overall Study|Exacerbation of seizures|0
1084414|NCT02170077|2146919|FG001|Overall Study|Exacerbation of seizures|2
1084415|NCT02170077|2146920|FG002|Overall Study|Exacerbation of seizures|1
1084416|NCT02170207|2146928|FG000|Overall Study|Case report forms unavailable|5
1084417|NCT02170389|2146968|FG000|Overall Study|Study terminated prior to start of treat|1
1084418|NCT02170688|2147011|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4
1084419|NCT02170688|2147012|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2
1084420|NCT02170688|2147013|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3
1084421|NCT02170688|2147014|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2
1084422|NCT02170688|2147015|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0
1084423|NCT02170688|2147011|FG000|Overall Study|Full dose not received|0
1084424|NCT02170688|2147012|FG001|Overall Study|Full dose not received|1
1084425|NCT02170688|2147013|FG002|Overall Study|Full dose not received|0
1084426|NCT02170688|2147014|FG003|Overall Study|Full dose not received|0
1084427|NCT02170688|2147015|FG004|Overall Study|Full dose not received|0
1084428|NCT02170688|2147011|FG000|Overall Study|Physician Decision|0
1084429|NCT02170688|2147012|FG001|Overall Study|Physician Decision|0
1084430|NCT02170688|2147013|FG002|Overall Study|Physician Decision|1
1084431|NCT02170688|2147014|FG003|Overall Study|Physician Decision|0
1084432|NCT02170688|2147015|FG004|Overall Study|Physician Decision|0
1084433|NCT02170727|2147029|FG000|Overall Study|Lost to Follow-up|1
1084434|NCT02170727|2147030|FG001|Overall Study|Lost to Follow-up|0
1084435|NCT02170727|2147029|FG000|Overall Study|Withdrawal by Subject|2
1084436|NCT02170727|2147030|FG001|Overall Study|Withdrawal by Subject|0
1084437|NCT02170779|2147041|FG000|Overall Study|Withdrawal by Subject|1
1084438|NCT02170779|2147042|FG001|Overall Study|Withdrawal by Subject|0
1084439|NCT02170779|2147041|FG000|Overall Study|Lost to Follow-up|0
1084440|NCT02170779|2147042|FG001|Overall Study|Lost to Follow-up|1
1084441|NCT02171065|2147079|FG000|Overall Study|Withdrawal by Subject|1
1084442|NCT02171065|2147080|FG001|Overall Study|Withdrawal by Subject|0
1084443|NCT02171065|2147081|FG002|Overall Study|Withdrawal by Subject|0
1084444|NCT02171065|2147079|FG000|Overall Study|Lost to Follow-up|0
1084445|NCT02171065|2147080|FG001|Overall Study|Lost to Follow-up|0
1084446|NCT02171065|2147081|FG002|Overall Study|Lost to Follow-up|1
1084447|NCT02171130|2147091|FG000|Overall Study|Death|1
1084448|NCT02171130|2147091|FG000|Overall Study|Discontinued; Clinical Material Issue|16
1084449|NCT02171130|2147091|FG000|Overall Study|Discontinued; Site Termination|5
1084450|NCT02171130|2147091|FG000|Overall Study|Withdrawal by Subject|3
1084451|NCT02171130|2147091|FG000|Overall Study|Physician Decision|1
1084452|NCT02171130|2147091|FG000|Overall Study|Lost to Follow-up|1
1084453|NCT02171130|2147091|FG000|Overall Study|Met Exclusion Criteria|1
1084454|NCT02171260|2147166|FG000|Overall Study|Death|0
1084455|NCT02171260|2147167|FG001|Overall Study|Death|0
1084456|NCT02171260|2147168|FG002|Overall Study|Death|0
1084457|NCT02171260|2147169|FG003|Overall Study|Death|1
1084458|NCT02171260|2147166|FG000|Overall Study|Physician Decision|1
1084459|NCT02171260|2147167|FG001|Overall Study|Physician Decision|0
1084460|NCT02171260|2147168|FG002|Overall Study|Physician Decision|1
1084461|NCT02171260|2147169|FG003|Overall Study|Physician Decision|0
1084462|NCT02171260|2147166|FG000|Overall Study|Withdrawal by Subject|1
1084463|NCT02171260|2147167|FG001|Overall Study|Withdrawal by Subject|0
1084464|NCT02171260|2147168|FG002|Overall Study|Withdrawal by Subject|0
1084465|NCT02171260|2147169|FG003|Overall Study|Withdrawal by Subject|0
1084466|NCT02171260|2147166|FG000|Overall Study|Evidence of progressive disease|4
1084467|NCT02171260|2147167|FG001|Overall Study|Evidence of progressive disease|6
1084468|NCT02171260|2147168|FG002|Overall Study|Evidence of progressive disease|4
1084469|NCT02171260|2147169|FG003|Overall Study|Evidence of progressive disease|4
1084470|NCT02171429|2147188|FG000|Overall Study|Other|0
1084471|NCT02171429|2147189|FG001|Overall Study|Other|1
1084472|NCT02171429|2147190|FG002|Overall Study|Other|1
1084473|NCT02171429|2147188|FG000|Overall Study|Non-Compliance|0
1084474|NCT02171429|2147189|FG001|Overall Study|Non-Compliance|0
1084475|NCT02171429|2147190|FG002|Overall Study|Non-Compliance|1
1084476|NCT02171429|2147188|FG000|Overall Study|Physician Decision|0
1084477|NCT02171429|2147189|FG001|Overall Study|Physician Decision|0
1084478|NCT02171429|2147190|FG002|Overall Study|Physician Decision|1
1084479|NCT02171429|2147188|FG000|Overall Study|Withdrawal by Subject|1
1084480|NCT02171429|2147189|FG001|Overall Study|Withdrawal by Subject|1
1084481|NCT02171429|2147190|FG002|Overall Study|Withdrawal by Subject|1
1084482|NCT02171429|2147188|FG000|Overall Study|Lost to Follow-up|0
1084483|NCT02171429|2147189|FG001|Overall Study|Lost to Follow-up|1
1084484|NCT02171429|2147190|FG002|Overall Study|Lost to Follow-up|0
1084485|NCT02171429|2147188|FG000|Overall Study|Death|0
1084486|NCT02171429|2147189|FG001|Overall Study|Death|0
1084487|NCT02171429|2147190|FG002|Overall Study|Death|1
1084488|NCT02172040|2147235|FG000|Overall Study|Adverse Event|0
1084489|NCT02172040|2147236|FG001|Overall Study|Adverse Event|2
1084490|NCT02172040|2147237|FG002|Overall Study|Adverse Event|0
1084491|NCT02172040|2147238|FG003|Overall Study|Adverse Event|0
1084492|NCT02172040|2147235|FG000|Overall Study|Protocol Violation|0
1084493|NCT02172040|2147236|FG001|Overall Study|Protocol Violation|1
1084494|NCT02172040|2147237|FG002|Overall Study|Protocol Violation|0
1084495|NCT02172040|2147238|FG003|Overall Study|Protocol Violation|0
1084496|NCT02172040|2147235|FG000|Overall Study|Withdrawal by Subject|0
1084497|NCT02172040|2147236|FG001|Overall Study|Withdrawal by Subject|0
1084498|NCT02172040|2147237|FG002|Overall Study|Withdrawal by Subject|1
1084499|NCT02172040|2147238|FG003|Overall Study|Withdrawal by Subject|0
1084500|NCT02172040|2147235|FG000|Overall Study|Not available for Day 13 & 14 visits|0
1084501|NCT02172040|2147236|FG001|Overall Study|Not available for Day 13 & 14 visits|0
1084502|NCT02172040|2147237|FG002|Overall Study|Not available for Day 13 & 14 visits|1
1084503|NCT02172040|2147238|FG003|Overall Study|Not available for Day 13 & 14 visits|0
1084504|NCT02172040|2147235|FG000|Overall Study|Family emergency abroad|0
1084505|NCT02172040|2147236|FG001|Overall Study|Family emergency abroad|0
1084506|NCT02172040|2147237|FG002|Overall Study|Family emergency abroad|0
1084507|NCT02172040|2147238|FG003|Overall Study|Family emergency abroad|1
1084508|NCT02172625|2147251|FG000|Overall Study|Adverse Event|0
1084509|NCT02172625|2147252|FG001|Overall Study|Adverse Event|1
1084510|NCT02172625|2147251|FG000|Overall Study|Pregnancy|0
1084511|NCT02172625|2147252|FG001|Overall Study|Pregnancy|1
1084512|NCT02172625|2147251|FG000|Overall Study|car accident|0
1084513|NCT02172625|2147252|FG001|Overall Study|car accident|1
1084514|NCT02172664|2147262|FG000|Overall Study|Lost to Follow-up|4
1084515|NCT02172664|2147263|FG001|Overall Study|Lost to Follow-up|4
1084516|NCT02172664|2147262|FG000|Overall Study|Death|1
1084517|NCT02172664|2147263|FG001|Overall Study|Death|1
1084518|NCT02172664|2147262|FG000|Overall Study|Moved out of area|1
1084519|NCT02172664|2147263|FG001|Overall Study|Moved out of area|1
1084520|NCT02172911|2147296|FG000|Overall Study|Serious Adverse Event|0
1084521|NCT02172911|2147297|FG001|Overall Study|Serious Adverse Event|1
1084522|NCT02172911|2147296|FG000|Overall Study|Progression of Disease|0
1084523|NCT02172911|2147297|FG001|Overall Study|Progression of Disease|1
1084524|NCT02172911|2147296|FG000|Overall Study|Loss of insurance coverage|1
1084525|NCT02172911|2147297|FG001|Overall Study|Loss of insurance coverage|0
1084526|NCT02172950|2147305|FG000|Overall Study|Physician Decision|3
1084527|NCT02172950|2147306|FG001|Overall Study|Physician Decision|3
1084528|NCT02172950|2147305|FG000|Overall Study|Lack of Efficacy|1
1084529|NCT02172950|2147306|FG001|Overall Study|Lack of Efficacy|0
1084530|NCT02172950|2147305|FG000|Overall Study|Adverse Event|4
1084531|NCT02172950|2147306|FG001|Overall Study|Adverse Event|1
1084532|NCT02172950|2147305|FG000|Overall Study|Withdrawal by Subject|10
1084533|NCT02172950|2147306|FG001|Overall Study|Withdrawal by Subject|0
1084534|NCT02172950|2147305|FG000|Overall Study|Protocol Violation|1
1084535|NCT02172950|2147306|FG001|Overall Study|Protocol Violation|0
1084536|NCT02172950|2147305|FG000|Overall Study|Lost to Follow-up|1
1084537|NCT02172950|2147306|FG001|Overall Study|Lost to Follow-up|0
1084538|NCT02172950|2147305|FG000|Overall Study|Death|1
1084539|NCT02172950|2147306|FG001|Overall Study|Death|0
1084540|NCT02172950|2147305|FG000|Overall Study|Patient traveling|1
1084541|NCT02172950|2147306|FG001|Overall Study|Patient traveling|0
1084542|NCT02172950|2147305|FG000|Overall Study|Patient went to other country|1
1084543|NCT02172950|2147306|FG001|Overall Study|Patient went to other country|0
1084544|NCT02172950|2147305|FG000|Overall Study|Patient relocated overseas|1
1084545|NCT02172950|2147306|FG001|Overall Study|Patient relocated overseas|1
1084546|NCT02172950|2147305|FG000|Overall Study|Patient moving|1
1084547|NCT02172950|2147306|FG001|Overall Study|Patient moving|0
1084548|NCT02173054|2147316|FG000|Overall Study|lack of compliance|1
1084549|NCT02173054|2147317|FG001|Overall Study|lack of compliance|0
1084550|NCT02173054|2147318|FG002|Overall Study|lack of compliance|0
1084551|NCT02173054|2147316|FG000|Overall Study|Withdrawal by Subject|0
1084552|NCT02173054|2147317|FG001|Overall Study|Withdrawal by Subject|0
1084553|NCT02173054|2147318|FG002|Overall Study|Withdrawal by Subject|1
1084554|NCT02173158|2147326|FG000|Efficacy Phase|Adverse Event|1
1084555|NCT02173379|2147333|FG000|Overall Study|Lost to Follow-up|48
1084556|NCT02173379|2147334|FG001|Overall Study|Lost to Follow-up|34
1084557|NCT02173379|2147333|FG000|Overall Study|Withdrawal by Subject|14
1084558|NCT02173379|2147334|FG001|Overall Study|Withdrawal by Subject|17
1084559|NCT02173379|2147333|FG000|Overall Study|Physician Decision|7
1084560|NCT02173379|2147334|FG001|Overall Study|Physician Decision|4
1084561|NCT02173379|2147333|FG000|Overall Study|Death|22
1084562|NCT02173379|2147334|FG001|Overall Study|Death|22
1084563|NCT02173548|2147427|FG000|Overall Study|Lost to Follow-up|0
1084564|NCT02173548|2147428|FG001|Overall Study|Lost to Follow-up|2
1084565|NCT02173548|2147427|FG000|Overall Study|Withdrawal by Subject|1
1084566|NCT02173548|2147428|FG001|Overall Study|Withdrawal by Subject|0
1084567|NCT02173704|2147436|FG000|Overall Study|Adverse Event|1
1084568|NCT02173704|2147437|FG001|Overall Study|Adverse Event|0
1084569|NCT02173704|2147436|FG000|Overall Study|Lost to Follow-up|1
1084570|NCT02173704|2147437|FG001|Overall Study|Lost to Follow-up|0
1084571|NCT02173704|2147436|FG000|Overall Study|Other|1
1084572|NCT02173704|2147437|FG001|Overall Study|Other|0
1084573|NCT02173704|2147436|FG000|Overall Study|Protocol Violation|1
1084574|NCT02173704|2147437|FG001|Overall Study|Protocol Violation|0
1084575|NCT02173704|2147436|FG000|Overall Study|Withdrawal by Subject|9
1084576|NCT02173704|2147437|FG001|Overall Study|Withdrawal by Subject|4
1084577|NCT02173769|2147443|FG000|Overall Study|Protocol Violation|4
1084578|NCT02174276|2147461|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
1084579|NCT02174276|2147462|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
1084580|NCT02174276|2147463|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
1084581|NCT02174276|2147464|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
1084582|NCT02174276|2147461|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
1084583|NCT02174276|2147462|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
1084584|NCT02174276|2147463|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
1084585|NCT02174276|2147464|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
1084586|NCT02174276|2147461|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
1084587|NCT02174276|2147462|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
1084588|NCT02174276|2147463|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
1084589|NCT02174276|2147464|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
1084590|NCT02174276|2147461|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
1084591|NCT02174276|2147462|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
1084592|NCT02174276|2147463|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
1084593|NCT02174276|2147464|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
1084594|NCT02174276|2147461|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0
1084595|NCT02174276|2147462|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0
1084596|NCT02174276|2147463|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1
1084597|NCT02174276|2147464|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0
1084598|NCT02174276|2147461|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1
1084599|NCT02174276|2147462|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0
1084600|NCT02174276|2147463|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1
1084601|NCT02174276|2147464|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2
1084602|NCT02174523|2147509|FG000|Overall Study|Withdrawal by Subject|1
1084603|NCT02174523|2147510|FG001|Overall Study|Withdrawal by Subject|0
1084604|NCT02174562|2147517|FG000|Overall Study|Withdrawal by Subject|7
1084605|NCT02174562|2147518|FG001|Overall Study|Withdrawal by Subject|2
1084606|NCT02174562|2147517|FG000|Overall Study|Death|2
1084607|NCT02174562|2147518|FG001|Overall Study|Death|0
1084608|NCT02174562|2147517|FG000|Overall Study|Lost to Follow-up|0
1084609|NCT02174562|2147518|FG001|Overall Study|Lost to Follow-up|3
1084610|NCT02174627|2147526|FG000|Overall Study|Missing|0
1084611|NCT02174627|2147527|FG001|Overall Study|Missing|1
1084612|NCT02174627|2147526|FG000|Overall Study|Incorrect enrolment before randomization|0
1084613|NCT02174627|2147527|FG001|Overall Study|Incorrect enrolment before randomization|1
1084614|NCT02174627|2147526|FG000|Overall Study|Participant decision|84
1084615|NCT02174627|2147527|FG001|Overall Study|Participant decision|128
1084616|NCT02174731|2147535|FG000|Overall Study|Participant decision|67
1084617|NCT02174731|2147536|FG001|Overall Study|Participant decision|64
1084618|NCT02174731|2147535|FG000|Overall Study|Incorrect enrolment before randomization|0
1084619|NCT02174731|2147536|FG001|Overall Study|Incorrect enrolment before randomization|1
1084620|NCT02174731|2147535|FG000|Overall Study|Missing|2
1084621|NCT02174731|2147536|FG001|Overall Study|Missing|0
1084622|NCT02174848|2147544|FG000|Overall Study|Adverse Event|2
1084623|NCT02174848|2147545|FG001|Overall Study|Adverse Event|1
1084624|NCT02174848|2147544|FG000|Overall Study|Withdrawal by Subject|3
1084625|NCT02174848|2147545|FG001|Overall Study|Withdrawal by Subject|3
1084626|NCT02174848|2147544|FG000|Overall Study|Lost to Follow-up|0
1084627|NCT02174848|2147545|FG001|Overall Study|Lost to Follow-up|1
1084628|NCT02174848|2147544|FG000|Overall Study|Worsening of disease|1
1084629|NCT02174848|2147545|FG001|Overall Study|Worsening of disease|1
1084630|NCT02174848|2147544|FG000|Overall Study|Unable to comply with study requirements|1
1084631|NCT02174848|2147545|FG001|Overall Study|Unable to comply with study requirements|0
1084632|NCT02174861|2147556|FG000|Overall Study|Decision by sponsor|8
1084633|NCT02174861|2147556|FG000|Overall Study|Withdrawal by Subject|124
1084634|NCT02174861|2147556|FG000|Overall Study|Lost to Follow-up|26
1084635|NCT02175121|2147576|FG000|Overall Study|Lack of Efficacy|1
1084636|NCT02175121|2147577|FG001|Overall Study|Lack of Efficacy|0
1084637|NCT02175121|2147578|FG002|Overall Study|Lack of Efficacy|0
1084638|NCT02175121|2147579|FG003|Overall Study|Lack of Efficacy|0
1084639|NCT02175121|2147580|FG004|Overall Study|Lack of Efficacy|0
1084640|NCT02175121|2147576|FG000|Overall Study|Lost to Follow-up|0
1084641|NCT02175121|2147577|FG001|Overall Study|Lost to Follow-up|1
1084642|NCT02175121|2147578|FG002|Overall Study|Lost to Follow-up|0
1084643|NCT02175121|2147579|FG003|Overall Study|Lost to Follow-up|1
1084644|NCT02175121|2147580|FG004|Overall Study|Lost to Follow-up|0
1084645|NCT02175121|2147576|FG000|Overall Study|Personal emergency|0
1084646|NCT02175121|2147577|FG001|Overall Study|Personal emergency|0
1084647|NCT02175121|2147578|FG002|Overall Study|Personal emergency|0
1084648|NCT02175121|2147579|FG003|Overall Study|Personal emergency|0
1084649|NCT02175121|2147580|FG004|Overall Study|Personal emergency|1
1084650|NCT02175121|2147576|FG000|Overall Study|Schedule conflict|0
1084651|NCT02175121|2147577|FG001|Overall Study|Schedule conflict|0
1084652|NCT02175121|2147578|FG002|Overall Study|Schedule conflict|1
1084653|NCT02175121|2147579|FG003|Overall Study|Schedule conflict|0
1084654|NCT02175121|2147580|FG004|Overall Study|Schedule conflict|0
1084655|NCT02175121|2147576|FG000|Overall Study|Time issues|0
1084656|NCT02175121|2147577|FG001|Overall Study|Time issues|0
1084657|NCT02175121|2147578|FG002|Overall Study|Time issues|1
1084658|NCT02175121|2147579|FG003|Overall Study|Time issues|0
1084659|NCT02175121|2147580|FG004|Overall Study|Time issues|0
1084660|NCT02175199|2147598|FG000|Overall Study|Withdrawal by Subject|1
1084661|NCT02175199|2147599|FG001|Overall Study|Withdrawal by Subject|5
1084662|NCT02175199|2147598|FG000|Overall Study|Randomized in Error|1
1084663|NCT02175199|2147599|FG001|Overall Study|Randomized in Error|0
1084664|NCT02175199|2147598|FG000|Overall Study|Sponsor Decision|1
1084665|NCT02175199|2147599|FG001|Overall Study|Sponsor Decision|0
1084666|NCT02175225|2147617|FG000|Overall Study|Withdrawal by Subject|1
1084667|NCT02175225|2147618|FG001|Overall Study|Withdrawal by Subject|2
1084668|NCT02175225|2147617|FG000|Overall Study|Lost to Follow-up|6
1084669|NCT02175225|2147618|FG001|Overall Study|Lost to Follow-up|7
1084670|NCT02175225|2147617|FG000|Overall Study|Study drug not administered|1
1084671|NCT02175225|2147618|FG001|Overall Study|Study drug not administered|2
1084672|NCT02175277|2147624|FG000|Overall Study|Protocol-specified Criteria|1
1084673|NCT02175368|2147628|FG000|Overall Study|Lost to Follow-up|1
1084674|NCT02175641|2147643|FG000|Overall Study|Death|3
1084675|NCT02175641|2147644|FG001|Overall Study|Death|4
1084676|NCT02175641|2147643|FG000|Overall Study|Lost to Follow-up|4
1084677|NCT02175641|2147644|FG001|Overall Study|Lost to Follow-up|4
1084678|NCT02175641|2147643|FG000|Overall Study|Withdrawal by Subject|7
1084679|NCT02175641|2147644|FG001|Overall Study|Withdrawal by Subject|4
1084680|NCT02175641|2147643|FG000|Overall Study|Discharged from Supportive Housing Agenc|13
1084681|NCT02175641|2147644|FG001|Overall Study|Discharged from Supportive Housing Agenc|15
1084682|NCT02175641|2147643|FG000|Overall Study|Developed Contraindicated Condition|8
1084683|NCT02175641|2147644|FG001|Overall Study|Developed Contraindicated Condition|0
1084684|NCT02175745|2147650|FG000|Overall Study|Not Eligible|1
1084685|NCT02175758|2147660|FG000|Treatment Phase|Lost to Follow-up|0
1084686|NCT02175758|2147661|FG001|Treatment Phase|Lost to Follow-up|1
1084687|NCT02175758|2147662|FG002|Treatment Phase|Lost to Follow-up|0
1084688|NCT02175758|2147663|FG003|Treatment Phase|Lost to Follow-up|0
1084689|NCT02175758|2147664|FG004|Treatment Phase|Lost to Follow-up|0
1084690|NCT02175758|2147665|FG005|Treatment Phase|Lost to Follow-up|0
1084691|NCT02175758|2147660|FG000|Treatment Phase|Adverse Event|0
1084692|NCT02175758|2147661|FG001|Treatment Phase|Adverse Event|0
1084693|NCT02175758|2147662|FG002|Treatment Phase|Adverse Event|0
1084694|NCT02175758|2147663|FG003|Treatment Phase|Adverse Event|0
1084695|NCT02175758|2147664|FG004|Treatment Phase|Adverse Event|1
1084696|NCT02175758|2147665|FG005|Treatment Phase|Adverse Event|0
1084697|NCT02175771|2147713|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23
1084698|NCT02175771|2147714|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1084699|NCT02175771|2147715|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1084700|NCT02175771|2147716|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1084701|NCT02175771|2147717|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1084702|NCT02175771|2147718|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1084703|NCT02175771|2147719|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1084704|NCT02175771|2147720|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1084705|NCT02175771|2147721|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1084706|NCT02175771|2147713|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20
1084707|NCT02175771|2147714|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1084708|NCT02175771|2147715|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1084709|NCT02175771|2147716|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1084710|NCT02175771|2147717|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1084711|NCT02175771|2147718|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1084712|NCT02175771|2147719|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1084713|NCT02175771|2147720|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1084714|NCT02175771|2147721|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1084715|NCT02175771|2147713|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
1084716|NCT02175771|2147714|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1084717|NCT02175771|2147715|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1084718|NCT02175771|2147716|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1084719|NCT02175771|2147717|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1084720|NCT02175771|2147718|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1084721|NCT02175771|2147719|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1084722|NCT02175771|2147720|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1084723|NCT02175771|2147721|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1084724|NCT02175771|2147713|FG000|Run-In Period (Pre-assignment)|Adverse Event|9
1084725|NCT02175771|2147714|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
1084726|NCT02175771|2147715|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
1084727|NCT02175771|2147716|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
1084728|NCT02175771|2147717|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
1084729|NCT02175771|2147718|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
1084730|NCT02175771|2147719|FG006|Run-In Period (Pre-assignment)|Adverse Event|0
1084731|NCT02175771|2147720|FG007|Run-In Period (Pre-assignment)|Adverse Event|0
1084732|NCT02175771|2147721|FG008|Run-In Period (Pre-assignment)|Adverse Event|0
1084733|NCT02175771|2147713|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
1084734|NCT02175771|2147714|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1084735|NCT02175771|2147715|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1084736|NCT02175771|2147716|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1084737|NCT02175771|2147717|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1084738|NCT02175771|2147718|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1084739|NCT02175771|2147719|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1084740|NCT02175771|2147720|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1084741|NCT02175771|2147721|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1084742|NCT02175771|2147713|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
1084743|NCT02175771|2147714|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1084744|NCT02175771|2147715|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1084745|NCT02175771|2147716|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1084746|NCT02175771|2147717|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1084747|NCT02175771|2147718|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1084748|NCT02175771|2147719|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1084749|NCT02175771|2147720|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1084750|NCT02175771|2147721|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1084751|NCT02175771|2147713|FG000|Run-In Period (Pre-assignment)|Other|8
1084752|NCT02175771|2147714|FG001|Run-In Period (Pre-assignment)|Other|0
1084753|NCT02175771|2147715|FG002|Run-In Period (Pre-assignment)|Other|0
1084754|NCT02175771|2147716|FG003|Run-In Period (Pre-assignment)|Other|0
1084755|NCT02175771|2147717|FG004|Run-In Period (Pre-assignment)|Other|0
1084756|NCT02175771|2147718|FG005|Run-In Period (Pre-assignment)|Other|0
1084757|NCT02175771|2147719|FG006|Run-In Period (Pre-assignment)|Other|0
1084758|NCT02175771|2147720|FG007|Run-In Period (Pre-assignment)|Other|0
1084759|NCT02175771|2147721|FG008|Run-In Period (Pre-assignment)|Other|0
1084760|NCT02175771|2147713|FG000|Treatment Period|Adverse Event|0
1084761|NCT02175771|2147714|FG001|Treatment Period|Adverse Event|2
1084762|NCT02175771|2147715|FG002|Treatment Period|Adverse Event|1
1084763|NCT02175771|2147716|FG003|Treatment Period|Adverse Event|1
1084764|NCT02175771|2147717|FG004|Treatment Period|Adverse Event|1
1084765|NCT02175771|2147718|FG005|Treatment Period|Adverse Event|3
1084766|NCT02175771|2147719|FG006|Treatment Period|Adverse Event|2
1084767|NCT02175771|2147720|FG007|Treatment Period|Adverse Event|0
1084768|NCT02175771|2147721|FG008|Treatment Period|Adverse Event|1
1084769|NCT02175771|2147713|FG000|Treatment Period|Withdrawal by Subject|0
1084770|NCT02175771|2147714|FG001|Treatment Period|Withdrawal by Subject|9
1084771|NCT02175771|2147715|FG002|Treatment Period|Withdrawal by Subject|3
1084772|NCT02175771|2147716|FG003|Treatment Period|Withdrawal by Subject|6
1084773|NCT02175771|2147717|FG004|Treatment Period|Withdrawal by Subject|2
1084774|NCT02175771|2147718|FG005|Treatment Period|Withdrawal by Subject|4
1084775|NCT02175771|2147719|FG006|Treatment Period|Withdrawal by Subject|2
1084776|NCT02175771|2147720|FG007|Treatment Period|Withdrawal by Subject|9
1084777|NCT02175771|2147721|FG008|Treatment Period|Withdrawal by Subject|2
1084778|NCT02175771|2147713|FG000|Treatment Period|Noncompliance|0
1084779|NCT02175771|2147714|FG001|Treatment Period|Noncompliance|1
1084780|NCT02175771|2147715|FG002|Treatment Period|Noncompliance|2
1084781|NCT02175771|2147716|FG003|Treatment Period|Noncompliance|0
1084782|NCT02175771|2147717|FG004|Treatment Period|Noncompliance|0
1084783|NCT02175771|2147718|FG005|Treatment Period|Noncompliance|0
1084784|NCT02175771|2147719|FG006|Treatment Period|Noncompliance|0
1084785|NCT02175771|2147720|FG007|Treatment Period|Noncompliance|0
1084786|NCT02175771|2147721|FG008|Treatment Period|Noncompliance|1
1084787|NCT02175771|2147713|FG000|Treatment Period|Protocol Violation|0
1084788|NCT02175771|2147714|FG001|Treatment Period|Protocol Violation|0
1084789|NCT02175771|2147715|FG002|Treatment Period|Protocol Violation|0
1084790|NCT02175771|2147716|FG003|Treatment Period|Protocol Violation|0
1084791|NCT02175771|2147717|FG004|Treatment Period|Protocol Violation|0
1084792|NCT02175771|2147718|FG005|Treatment Period|Protocol Violation|0
1084793|NCT02175771|2147719|FG006|Treatment Period|Protocol Violation|0
1084794|NCT02175771|2147720|FG007|Treatment Period|Protocol Violation|1
1084795|NCT02175771|2147721|FG008|Treatment Period|Protocol Violation|0
1084796|NCT02175771|2147713|FG000|Treatment Period|Disease progression|0
1084797|NCT02175771|2147714|FG001|Treatment Period|Disease progression|0
1084798|NCT02175771|2147715|FG002|Treatment Period|Disease progression|0
1084799|NCT02175771|2147716|FG003|Treatment Period|Disease progression|0
1084800|NCT02175771|2147717|FG004|Treatment Period|Disease progression|0
1084801|NCT02175771|2147718|FG005|Treatment Period|Disease progression|0
1084802|NCT02175771|2147719|FG006|Treatment Period|Disease progression|0
1084803|NCT02175771|2147720|FG007|Treatment Period|Disease progression|2
1084804|NCT02175771|2147721|FG008|Treatment Period|Disease progression|0
1084805|NCT02175771|2147713|FG000|Treatment Period|Lost to Follow-up|0
1084806|NCT02175771|2147714|FG001|Treatment Period|Lost to Follow-up|3
1084807|NCT02175771|2147715|FG002|Treatment Period|Lost to Follow-up|1
1084808|NCT02175771|2147716|FG003|Treatment Period|Lost to Follow-up|3
1084809|NCT02175771|2147717|FG004|Treatment Period|Lost to Follow-up|1
1084810|NCT02175771|2147718|FG005|Treatment Period|Lost to Follow-up|2
1084811|NCT02175771|2147719|FG006|Treatment Period|Lost to Follow-up|1
1084812|NCT02175771|2147720|FG007|Treatment Period|Lost to Follow-up|2
1084813|NCT02175771|2147721|FG008|Treatment Period|Lost to Follow-up|2
1084814|NCT02175771|2147713|FG000|Treatment Period|Lack of Efficacy|0
1084815|NCT02175771|2147714|FG001|Treatment Period|Lack of Efficacy|0
1084816|NCT02175771|2147715|FG002|Treatment Period|Lack of Efficacy|0
1084817|NCT02175771|2147716|FG003|Treatment Period|Lack of Efficacy|0
1084818|NCT02175771|2147717|FG004|Treatment Period|Lack of Efficacy|0
1084819|NCT02175771|2147718|FG005|Treatment Period|Lack of Efficacy|1
1084820|NCT02175771|2147719|FG006|Treatment Period|Lack of Efficacy|0
1084821|NCT02175771|2147720|FG007|Treatment Period|Lack of Efficacy|1
1084822|NCT02175771|2147721|FG008|Treatment Period|Lack of Efficacy|0
1084823|NCT02175771|2147713|FG000|Treatment Period|Other|0
1084824|NCT02175771|2147714|FG001|Treatment Period|Other|1
1084825|NCT02175771|2147715|FG002|Treatment Period|Other|0
1084826|NCT02175771|2147716|FG003|Treatment Period|Other|3
1084827|NCT02175771|2147717|FG004|Treatment Period|Other|1
1084828|NCT02175771|2147718|FG005|Treatment Period|Other|0
1084829|NCT02175771|2147719|FG006|Treatment Period|Other|0
1084830|NCT02175771|2147720|FG007|Treatment Period|Other|2
1084831|NCT02175771|2147721|FG008|Treatment Period|Other|0
1084832|NCT02175966|2147741|FG000|Follow-up Period|Lack of Efficacy|10
1084833|NCT02175966|2147742|FG001|Follow-up Period|Lack of Efficacy|6
1084834|NCT02176018|2147776|FG000|Overall Study|Adverse Event|0
1084835|NCT02176018|2147777|FG001|Overall Study|Adverse Event|2
1084836|NCT02176018|2147776|FG000|Overall Study|Lost to Follow-up|3
1084837|NCT02176018|2147777|FG001|Overall Study|Lost to Follow-up|1
1084838|NCT02176018|2147776|FG000|Overall Study|Protocol Violation|1
1084839|NCT02176018|2147777|FG001|Overall Study|Protocol Violation|1
1084840|NCT02176018|2147776|FG000|Overall Study|Withdrawal by Subject|1
1084841|NCT02176018|2147777|FG001|Overall Study|Withdrawal by Subject|2
1084842|NCT02176226|2147797|FG000|Overall Study|Lost to Follow-up|3
1084843|NCT02176226|2147797|FG000|Overall Study|Withdrew prior to treatment|6
1084844|NCT02176291|2147803|FG000|Overall Study|Death|1
1084845|NCT02176291|2147804|FG001|Overall Study|Death|0
1084846|NCT02176291|2147803|FG000|Overall Study|non compliance with protocol|2
1084847|NCT02176291|2147804|FG001|Overall Study|non compliance with protocol|0
1084848|NCT02176291|2147803|FG000|Overall Study|Withdrawal by Subject|2
1084849|NCT02176291|2147804|FG001|Overall Study|Withdrawal by Subject|0
1084850|NCT02176356|2147814|FG000|Overall Study|Screen Failure|14
1084851|NCT02176356|2147814|FG000|Overall Study|Lost to Follow-up|4
1084852|NCT02176356|2147814|FG000|Overall Study|Personal Reasons|3
1084853|NCT02176356|2147814|FG000|Overall Study|Other Miscellaneous Reasons|2
1084854|NCT02176421|2147836|FG000|Overall Study|Lost to Follow-up|4
1084855|NCT02176421|2147836|FG000|Overall Study|Adverse Event|1
1084856|NCT02176525|2147863|FG000|Overall Study|Adverse Event|0
1084857|NCT02176525|2147864|FG001|Overall Study|Adverse Event|0
1084858|NCT02176525|2147865|FG002|Overall Study|Adverse Event|0
1084859|NCT02176525|2147866|FG003|Overall Study|Adverse Event|1
1084860|NCT02176525|2147867|FG004|Overall Study|Adverse Event|1
1084861|NCT02176525|2147868|FG005|Overall Study|Adverse Event|0
1084862|NCT02176525|2147869|FG006|Overall Study|Adverse Event|1
1084863|NCT02176525|2147870|FG007|Overall Study|Adverse Event|0
1084864|NCT02176525|2147863|FG000|Overall Study|not treated|1
1084865|NCT02176525|2147864|FG001|Overall Study|not treated|0
1084866|NCT02176525|2147865|FG002|Overall Study|not treated|0
1084867|NCT02176525|2147866|FG003|Overall Study|not treated|0
1084868|NCT02176525|2147867|FG004|Overall Study|not treated|0
1084869|NCT02176525|2147868|FG005|Overall Study|not treated|1
1084870|NCT02176525|2147869|FG006|Overall Study|not treated|0
1084871|NCT02176525|2147870|FG007|Overall Study|not treated|0
1084872|NCT02176642|2147898|FG000|Overall Study|Withdrawal by Subject|0
1084873|NCT02176642|2147899|FG001|Overall Study|Withdrawal by Subject|1
1084874|NCT02176655|2147905|FG000|Overall Study|Subjects did not treat|6
1084875|NCT02176928|2147916|FG000|Overall Study|Lost to Follow-up|2
1084876|NCT02176928|2147917|FG001|Overall Study|Lost to Follow-up|4
1084877|NCT02177032|2147927|FG000|Overall Study|ADMINISTRATIVE REASON|2
1084878|NCT02177032|2147928|FG001|Overall Study|ADMINISTRATIVE REASON|0
1084879|NCT02177032|2147929|FG002|Overall Study|ADMINISTRATIVE REASON|1
1084880|NCT02177032|2147930|FG003|Overall Study|ADMINISTRATIVE REASON|0
1084881|NCT02177032|2147927|FG000|Overall Study|Lost to Follow-up|0
1084882|NCT02177032|2147928|FG001|Overall Study|Lost to Follow-up|2
1084883|NCT02177032|2147929|FG002|Overall Study|Lost to Follow-up|0
1084884|NCT02177032|2147930|FG003|Overall Study|Lost to Follow-up|0
1084885|NCT02177032|2147927|FG000|Overall Study|OTHER|2
1084886|NCT02177032|2147928|FG001|Overall Study|OTHER|0
1084887|NCT02177032|2147929|FG002|Overall Study|OTHER|1
1084888|NCT02177032|2147930|FG003|Overall Study|OTHER|0
1084889|NCT02177032|2147927|FG000|Overall Study|Withdrawal by Subject|1
1084890|NCT02177032|2147928|FG001|Overall Study|Withdrawal by Subject|0
1084891|NCT02177032|2147929|FG002|Overall Study|Withdrawal by Subject|1
1084892|NCT02177032|2147930|FG003|Overall Study|Withdrawal by Subject|0
1084893|NCT02177123|2147951|FG000|Overall Study|Lost to Follow-up|6
1084894|NCT02177123|2147951|FG000|Overall Study|Withdrawal by Subject|4
1084895|NCT02177123|2147951|FG000|Overall Study|Adverse Event|4
1084896|NCT02177123|2147951|FG000|Overall Study|Physician Decision|3
1084897|NCT02177123|2147951|FG000|Overall Study|Excluded by Sponsor - other reason|2
1084898|NCT02177123|2147951|FG000|Overall Study|Excluded for medical reasons|2
1084899|NCT02177123|2147951|FG000|Overall Study|Death|1
1084900|NCT02177123|2147951|FG000|Overall Study|Other|1
1084901|NCT02177123|2147951|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1
1084902|NCT02177136|2147961|FG000|DB Phase|Withdrawal by Subject|2
1084903|NCT02177136|2147962|FG001|DB Phase|Withdrawal by Subject|0
1084904|NCT02177136|2147963|FG002|DB Phase|Withdrawal by Subject|0
1084905|NCT02177136|2147964|FG003|DB Phase|Withdrawal by Subject|0
1084906|NCT02177136|2147961|FG000|DB Phase|Discontinued Due to Pruritus|1
1084907|NCT02177136|2147962|FG001|DB Phase|Discontinued Due to Pruritus|3
1084908|NCT02177136|2147963|FG002|DB Phase|Discontinued Due to Pruritus|0
1084909|NCT02177136|2147964|FG003|DB Phase|Discontinued Due to Pruritus|0
1084910|NCT02177136|2147961|FG000|DB Phase|Adverse Event|3
1084911|NCT02177136|2147962|FG001|DB Phase|Adverse Event|2
1084912|NCT02177136|2147963|FG002|DB Phase|Adverse Event|3
1084913|NCT02177136|2147964|FG003|DB Phase|Adverse Event|0
1084914|NCT02177136|2147961|FG000|DB Phase|Protocol Violation|0
1084915|NCT02177136|2147962|FG001|DB Phase|Protocol Violation|0
1084916|NCT02177136|2147963|FG002|DB Phase|Protocol Violation|1
1084917|NCT02177136|2147964|FG003|DB Phase|Protocol Violation|0
1084918|NCT02177136|2147961|FG000|DB Phase|Withdrew Consent Prior to Dosing|1
1084919|NCT02177136|2147962|FG001|DB Phase|Withdrew Consent Prior to Dosing|0
1084920|NCT02177136|2147963|FG002|DB Phase|Withdrew Consent Prior to Dosing|0
1084921|NCT02177136|2147964|FG003|DB Phase|Withdrew Consent Prior to Dosing|0
1084922|NCT02177136|2147961|FG000|LTSE Phase|Withdrawal by Subject|0
1084923|NCT02177136|2147962|FG001|LTSE Phase|Withdrawal by Subject|0
1084924|NCT02177136|2147963|FG002|LTSE Phase|Withdrawal by Subject|0
1084925|NCT02177136|2147964|FG003|LTSE Phase|Withdrawal by Subject|6
1084926|NCT02177136|2147961|FG000|LTSE Phase|Adverse Event|0
1084927|NCT02177136|2147962|FG001|LTSE Phase|Adverse Event|0
1084928|NCT02177136|2147963|FG002|LTSE Phase|Adverse Event|0
1084929|NCT02177136|2147964|FG003|LTSE Phase|Adverse Event|10
1084930|NCT02177136|2147961|FG000|LTSE Phase|Discontinued Due to Pruritus|0
1084931|NCT02177136|2147962|FG001|LTSE Phase|Discontinued Due to Pruritus|0
1084932|NCT02177136|2147963|FG002|LTSE Phase|Discontinued Due to Pruritus|0
1084933|NCT02177136|2147964|FG003|LTSE Phase|Discontinued Due to Pruritus|4
1084934|NCT02177136|2147961|FG000|LTSE Phase|Physician Decision|0
1084935|NCT02177136|2147962|FG001|LTSE Phase|Physician Decision|0
1084936|NCT02177136|2147963|FG002|LTSE Phase|Physician Decision|0
1084937|NCT02177136|2147964|FG003|LTSE Phase|Physician Decision|2
1084938|NCT02177136|2147961|FG000|LTSE Phase|Lost to Follow-up|0
1084939|NCT02177136|2147962|FG001|LTSE Phase|Lost to Follow-up|0
1084940|NCT02177136|2147963|FG002|LTSE Phase|Lost to Follow-up|0
1084941|NCT02177136|2147964|FG003|LTSE Phase|Lost to Follow-up|1
1084942|NCT02177136|2147961|FG000|LTSE Phase|Participant Moved|0
1084943|NCT02177136|2147962|FG001|LTSE Phase|Participant Moved|0
1084944|NCT02177136|2147963|FG002|LTSE Phase|Participant Moved|0
1084945|NCT02177136|2147964|FG003|LTSE Phase|Participant Moved|1
1084946|NCT02177786|2147988|FG000|Overall Study|Withdrew Consent|2
1084947|NCT02177786|2147989|FG001|Overall Study|Withdrew Consent|6
1084948|NCT02177786|2147990|FG002|Overall Study|Withdrew Consent|9
1084949|NCT02177786|2147991|FG003|Overall Study|Withdrew Consent|5
1084950|NCT02177786|2147988|FG000|Overall Study|Progression to End Stage Renal Disease|2
1084951|NCT02177786|2147989|FG001|Overall Study|Progression to End Stage Renal Disease|3
1084952|NCT02177786|2147990|FG002|Overall Study|Progression to End Stage Renal Disease|2
1084953|NCT02177786|2147991|FG003|Overall Study|Progression to End Stage Renal Disease|1
1084954|NCT02177786|2147988|FG000|Overall Study|Adverse Event|1
1084955|NCT02177786|2147989|FG001|Overall Study|Adverse Event|1
1084956|NCT02177786|2147990|FG002|Overall Study|Adverse Event|2
1084957|NCT02177786|2147991|FG003|Overall Study|Adverse Event|3
1084958|NCT02177786|2147988|FG000|Overall Study|Death|1
1084959|NCT02177786|2147989|FG001|Overall Study|Death|1
1084960|NCT02177786|2147990|FG002|Overall Study|Death|1
1084961|NCT02177786|2147991|FG003|Overall Study|Death|1
1084962|NCT02177786|2147988|FG000|Overall Study|Lost to Follow-up|0
1084963|NCT02177786|2147989|FG001|Overall Study|Lost to Follow-up|0
1084964|NCT02177786|2147990|FG002|Overall Study|Lost to Follow-up|2
1084965|NCT02177786|2147991|FG003|Overall Study|Lost to Follow-up|2
1084966|NCT02177786|2147988|FG000|Overall Study|Non-Compliance with Study Drug|0
1084967|NCT02177786|2147989|FG001|Overall Study|Non-Compliance with Study Drug|1
1084968|NCT02177786|2147990|FG002|Overall Study|Non-Compliance with Study Drug|0
1084969|NCT02177786|2147991|FG003|Overall Study|Non-Compliance with Study Drug|1
1084970|NCT02177786|2147988|FG000|Overall Study|Protocol Violation|0
1084971|NCT02177786|2147989|FG001|Overall Study|Protocol Violation|0
1084972|NCT02177786|2147990|FG002|Overall Study|Protocol Violation|2
1084973|NCT02177786|2147991|FG003|Overall Study|Protocol Violation|0
1084974|NCT02177786|2147988|FG000|Overall Study|Progressive Disease|0
1084975|NCT02177786|2147989|FG001|Overall Study|Progressive Disease|1
1084976|NCT02177786|2147990|FG002|Overall Study|Progressive Disease|0
1084977|NCT02177786|2147991|FG003|Overall Study|Progressive Disease|0
1084978|NCT02177786|2147988|FG000|Overall Study|Missing study completion status|0
1084979|NCT02177786|2147989|FG001|Overall Study|Missing study completion status|1
1084980|NCT02177786|2147990|FG002|Overall Study|Missing study completion status|0
1084981|NCT02177786|2147991|FG003|Overall Study|Missing study completion status|0
1084982|NCT02177812|2148010|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1084983|NCT02177812|2148011|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1084984|NCT02177812|2148012|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1084985|NCT02177812|2148013|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1084986|NCT02177812|2148014|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1084987|NCT02177812|2148015|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
1084988|NCT02177812|2148016|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
1084989|NCT02177812|2148017|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
1084990|NCT02177812|2148018|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1084991|NCT02177812|2148010|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0
1084992|NCT02177812|2148011|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0
1084993|NCT02177812|2148012|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0
1084994|NCT02177812|2148013|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0
1084995|NCT02177812|2148014|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0
1084996|NCT02177812|2148015|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1
1084997|NCT02177812|2148016|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1
1084998|NCT02177812|2148017|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0
1084999|NCT02177812|2148018|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0
1085000|NCT02177812|2148010|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0
1085001|NCT02177812|2148011|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0
1085002|NCT02177812|2148012|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0
1085003|NCT02177812|2148013|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1
1085004|NCT02177812|2148014|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1
1085005|NCT02177812|2148015|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1
1085006|NCT02177812|2148016|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6
1085007|NCT02177812|2148017|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1
1085008|NCT02177812|2148018|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0
1085009|NCT02177838|2148047|FG000|Overall Study|Withdrawal by Subject|1
1085010|NCT02177838|2148047|FG000|Overall Study|Physician Decision|1
1085011|NCT02177838|2148047|FG000|Overall Study|Death|1
1085012|NCT02177942|2148053|FG000|Overall Study|Adverse Event|1
1085013|NCT02177942|2148054|FG001|Overall Study|Adverse Event|0
1085014|NCT02177942|2148053|FG000|Overall Study|Lost to Follow-up|1
1085015|NCT02177942|2148054|FG001|Overall Study|Lost to Follow-up|1
1085016|NCT02177942|2148053|FG000|Overall Study|Protocol Violation|4
1085017|NCT02177942|2148054|FG001|Overall Study|Protocol Violation|6
1085018|NCT02177942|2148053|FG000|Overall Study|Withdrawal by Subject|71
1085019|NCT02177942|2148054|FG001|Overall Study|Withdrawal by Subject|81
1085020|NCT02178059|2148064|FG000|Washout|Physician Decision|1
1085021|NCT02178059|2148065|FG001|Washout|Physician Decision|0
1085022|NCT02178358|2148078|FG000|Overall Study|Withdrawal by Subject|0
1085023|NCT02178358|2148079|FG001|Overall Study|Withdrawal by Subject|2
1085024|NCT02178358|2148080|FG002|Overall Study|Withdrawal by Subject|2
1085025|NCT02178358|2148078|FG000|Overall Study|On study treatment at study conclusion|0
1085026|NCT02178358|2148079|FG001|Overall Study|On study treatment at study conclusion|1
1085027|NCT02178358|2148080|FG002|Overall Study|On study treatment at study conclusion|2
1085028|NCT02178475|2148089|FG000|Overall Study|Withdrawal by Subject|7
1085029|NCT02178475|2148089|FG000|Overall Study|Lost to Follow-up|10
1085030|NCT02178475|2148089|FG000|Overall Study|Death|13
1085031|NCT02178475|2148089|FG000|Overall Study|Protocol-specified Criteria|99
1085032|NCT02178553|2148102|FG000|Overall Study|Did not proceed to open thoracotomy|7
1085033|NCT02178553|2148103|FG001|Overall Study|Did not proceed to open thoracotomy|3
1085034|NCT02178553|2148102|FG000|Overall Study|Physician Decision|0
1085035|NCT02178553|2148103|FG001|Overall Study|Physician Decision|4
1085036|NCT02178553|2148102|FG000|Overall Study|Technical problem with injection|1
1085037|NCT02178553|2148103|FG001|Overall Study|Technical problem with injection|3
1085038|NCT02178592|2148111|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0
1085039|NCT02178592|2148112|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2
1085040|NCT02178592|2148111|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
1085041|NCT02178592|2148112|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
1085042|NCT02178592|2148111|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3
1085043|NCT02178592|2148112|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2
1085044|NCT02178592|2148111|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3
1085045|NCT02178592|2148112|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1
1085046|NCT02178592|2148111|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11
1085047|NCT02178592|2148112|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3
1085048|NCT02178592|2148111|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1
1085049|NCT02178592|2148112|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0
1085050|NCT02178592|2148111|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1
1085051|NCT02178592|2148112|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0
1085052|NCT02178592|2148111|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0
1085053|NCT02178592|2148112|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1
1085054|NCT02178592|2148111|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2
1085055|NCT02178592|2148112|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0
1085056|NCT02178592|2148111|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4
1085057|NCT02178592|2148112|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1
1085058|NCT02178592|2148111|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2
1085059|NCT02178592|2148112|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0
1085060|NCT02178592|2148111|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3
1085061|NCT02178592|2148112|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1
1085067|NCT02178722|2148142|FG000|Overall Study|Participant decision|0
1085068|NCT02178722|2148143|FG001|Overall Study|Participant decision|0
1085069|NCT02178722|2148144|FG002|Overall Study|Participant decision|0
1085070|NCT02178722|2148145|FG003|Overall Study|Participant decision|2
1085071|NCT02178722|2148146|FG004|Overall Study|Participant decision|30
1085072|NCT02178722|2148142|FG000|Overall Study|Death|2
1085073|NCT02178722|2148143|FG001|Overall Study|Death|13
1085074|NCT02178722|2148144|FG002|Overall Study|Death|12
1085075|NCT02178722|2148145|FG003|Overall Study|Death|11
1085076|NCT02178722|2148146|FG004|Overall Study|Death|199
1085077|NCT02178722|2148142|FG000|Overall Study|Lost to Follow-up|0
1085078|NCT02178722|2148143|FG001|Overall Study|Lost to Follow-up|0
1085079|NCT02178722|2148144|FG002|Overall Study|Lost to Follow-up|0
1085080|NCT02178722|2148145|FG003|Overall Study|Lost to Follow-up|2
1085081|NCT02178722|2148146|FG004|Overall Study|Lost to Follow-up|11
1085082|NCT02178722|2148142|FG000|Overall Study|Participant trial terminated by sponsor|1
1085083|NCT02178722|2148143|FG001|Overall Study|Participant trial terminated by sponsor|6
1085084|NCT02178722|2148144|FG002|Overall Study|Participant trial terminated by sponsor|2
1085085|NCT02178722|2148145|FG003|Overall Study|Participant trial terminated by sponsor|3
1085086|NCT02178722|2148146|FG004|Overall Study|Participant trial terminated by sponsor|65
1085087|NCT02178722|2148142|FG000|Overall Study|Physician Decision|0
1085088|NCT02178722|2148143|FG001|Overall Study|Physician Decision|0
1085089|NCT02178722|2148144|FG002|Overall Study|Physician Decision|0
1085090|NCT02178722|2148145|FG003|Overall Study|Physician Decision|0
1085091|NCT02178722|2148146|FG004|Overall Study|Physician Decision|2
1085092|NCT02178722|2148142|FG000|Overall Study|Other Unspecified|0
1085093|NCT02178722|2148143|FG001|Overall Study|Other Unspecified|0
1085094|NCT02178722|2148144|FG002|Overall Study|Other Unspecified|0
1085095|NCT02178722|2148145|FG003|Overall Study|Other Unspecified|0
1085096|NCT02178722|2148146|FG004|Overall Study|Other Unspecified|1
1085097|NCT02178722|2148142|FG000|Overall Study|Participants Ongoing in study|1
1085098|NCT02178722|2148143|FG001|Overall Study|Participants Ongoing in study|1
1085099|NCT02178722|2148144|FG002|Overall Study|Participants Ongoing in study|4
1085100|NCT02178722|2148145|FG003|Overall Study|Participants Ongoing in study|2
1085101|NCT02178722|2148146|FG004|Overall Study|Participants Ongoing in study|74
1085102|NCT02178787|2148160|FG000|Overall Study|Lost to Follow-up|1
1085103|NCT02178787|2148161|FG001|Overall Study|Lost to Follow-up|0
1085104|NCT02178787|2148160|FG000|Overall Study|Withdrawal by Subject|0
1085105|NCT02178787|2148161|FG001|Overall Study|Withdrawal by Subject|2
1085106|NCT02178787|2148160|FG000|Overall Study|No TCD window|3
1085107|NCT02178787|2148161|FG001|Overall Study|No TCD window|7
1085108|NCT02178787|2148160|FG000|Overall Study|Physician Decision|1
1085109|NCT02178787|2148161|FG001|Overall Study|Physician Decision|0
1085110|NCT02178956|2148188|FG000|Overall Study|Lost to Follow-up|4
1085111|NCT02178956|2148189|FG001|Overall Study|Lost to Follow-up|4
1085112|NCT02178956|2148188|FG000|Overall Study|Sponsor terminated study|49
1085113|NCT02178956|2148189|FG001|Overall Study|Sponsor terminated study|58
1085114|NCT02178956|2148188|FG000|Overall Study|Withdrawal by Subject|15
1085115|NCT02178956|2148189|FG001|Overall Study|Withdrawal by Subject|11
1085116|NCT02178956|2148188|FG000|Overall Study|Various Reasons|3
1085117|NCT02178956|2148189|FG001|Overall Study|Various Reasons|5
1085118|NCT02178995|2148201|FG000|Double Blind|Adverse Event|0
1085119|NCT02178995|2148202|FG001|Double Blind|Adverse Event|0
1085120|NCT02178995|2148203|FG002|Double Blind|Adverse Event|0
1085121|NCT02178995|2148204|FG003|Double Blind|Adverse Event|0
1085122|NCT02178995|2148205|FG004|Double Blind|Adverse Event|0
1085123|NCT02178995|2148206|FG005|Double Blind|Adverse Event|1
1085124|NCT02178995|2148207|FG006|Double Blind|Adverse Event|0
1085125|NCT02178995|2148208|FG007|Double Blind|Adverse Event|1
1085126|NCT02178995|2148209|FG008|Double Blind|Adverse Event|1
1085127|NCT02178995|2148201|FG000|Double Blind|Lost to Follow-up|0
1085128|NCT02178995|2148202|FG001|Double Blind|Lost to Follow-up|1
1085129|NCT02178995|2148203|FG002|Double Blind|Lost to Follow-up|0
1085130|NCT02178995|2148204|FG003|Double Blind|Lost to Follow-up|0
1085131|NCT02178995|2148205|FG004|Double Blind|Lost to Follow-up|0
1085132|NCT02178995|2148206|FG005|Double Blind|Lost to Follow-up|0
1085133|NCT02178995|2148207|FG006|Double Blind|Lost to Follow-up|0
1085134|NCT02178995|2148208|FG007|Double Blind|Lost to Follow-up|1
1085135|NCT02178995|2148209|FG008|Double Blind|Lost to Follow-up|0
1085136|NCT02178995|2148201|FG000|Open Label|Adverse Event|2
1085137|NCT02178995|2148202|FG001|Open Label|Adverse Event|0
1085138|NCT02178995|2148203|FG002|Open Label|Adverse Event|0
1085139|NCT02178995|2148204|FG003|Open Label|Adverse Event|0
1085140|NCT02178995|2148205|FG004|Open Label|Adverse Event|0
1085141|NCT02178995|2148206|FG005|Open Label|Adverse Event|0
1085142|NCT02178995|2148207|FG006|Open Label|Adverse Event|0
1085143|NCT02178995|2148208|FG007|Open Label|Adverse Event|0
1085144|NCT02178995|2148209|FG008|Open Label|Adverse Event|0
1085145|NCT02179177|2148255|FG000|Overall Study|Lost to Follow-up|1
1085146|NCT02179177|2148256|FG001|Overall Study|Lost to Follow-up|1
1085147|NCT02179177|2148255|FG000|Overall Study|Withdrawal by Subject|1
1085148|NCT02179177|2148256|FG001|Overall Study|Withdrawal by Subject|1
1085149|NCT02179190|2148262|FG000|Enrollment|Exit Prior to Device Attempt|11
1085150|NCT02179190|2148262|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
1085151|NCT02179190|2148262|FG000|Follow-Up Post Barrel VRD Implanted|Death|3
1085152|NCT02179190|2148262|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
1085153|NCT02179190|2148262|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
1085154|NCT02179190|2148262|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
1085155|NCT02179398|2148268|FG000|Overall Study|Lack of obligatory data|3
1085156|NCT02179398|2148269|FG001|Overall Study|Lack of obligatory data|3
1085157|NCT02179398|2148268|FG000|Overall Study|Lost to Follow-up|0
1085158|NCT02179398|2148269|FG001|Overall Study|Lost to Follow-up|1
1085159|NCT02179515|2148300|FG000|Overall Study|switched to alternative treatment|0
1085160|NCT02179515|2148301|FG001|Overall Study|switched to alternative treatment|1
1085161|NCT02179515|2148302|FG002|Overall Study|switched to alternative treatment|1
1085162|NCT02179515|2148300|FG000|Overall Study|Death|0
1085163|NCT02179515|2148301|FG001|Overall Study|Death|1
1085164|NCT02179515|2148302|FG002|Overall Study|Death|1
1085165|NCT02179515|2148300|FG000|Overall Study|refused further treatment|0
1085166|NCT02179515|2148301|FG001|Overall Study|refused further treatment|3
1085167|NCT02179515|2148302|FG002|Overall Study|refused further treatment|4
1085168|NCT02179515|2148300|FG000|Overall Study|Disease progression on study|2
1085169|NCT02179515|2148301|FG001|Overall Study|Disease progression on study|11
1085170|NCT02179515|2148302|FG002|Overall Study|Disease progression on study|8
1085171|NCT02179918|2148358|FG000|Overall Study|Death|0
1085172|NCT02179918|2148359|FG001|Overall Study|Death|0
1085173|NCT02179918|2148360|FG002|Overall Study|Death|0
1085174|NCT02179918|2148361|FG003|Overall Study|Death|1
1085175|NCT02179918|2148362|FG004|Overall Study|Death|0
1085176|NCT02179918|2148358|FG000|Overall Study|Lost to Follow-up|0
1085177|NCT02179918|2148359|FG001|Overall Study|Lost to Follow-up|0
1085178|NCT02179918|2148360|FG002|Overall Study|Lost to Follow-up|1
1085179|NCT02179918|2148361|FG003|Overall Study|Lost to Follow-up|0
1085180|NCT02179918|2148362|FG004|Overall Study|Lost to Follow-up|0
1085181|NCT02179918|2148358|FG000|Overall Study|Progressive Disease|4
1085182|NCT02179918|2148359|FG001|Overall Study|Progressive Disease|1
1085183|NCT02179918|2148360|FG002|Overall Study|Progressive Disease|1
1085184|NCT02179918|2148361|FG003|Overall Study|Progressive Disease|2
1085185|NCT02179918|2148362|FG004|Overall Study|Progressive Disease|6
1085186|NCT02179918|2148358|FG000|Overall Study|Other|0
1085187|NCT02179918|2148359|FG001|Overall Study|Other|1
1085188|NCT02179918|2148360|FG002|Overall Study|Other|0
1085189|NCT02179918|2148361|FG003|Overall Study|Other|0
1085190|NCT02179918|2148362|FG004|Overall Study|Other|1
1085191|NCT02179918|2148358|FG000|Overall Study|Subject refused further follow-up|0
1085192|NCT02179918|2148359|FG001|Overall Study|Subject refused further follow-up|1
1085193|NCT02179918|2148360|FG002|Overall Study|Subject refused further follow-up|0
1085194|NCT02179918|2148361|FG003|Overall Study|Subject refused further follow-up|0
1085195|NCT02179918|2148362|FG004|Overall Study|Subject refused further follow-up|1
1085196|NCT02180061|2148377|FG000|Overall Study|Adverse Event|4
1085197|NCT02180061|2148378|FG001|Overall Study|Adverse Event|2
1085198|NCT02180061|2148377|FG000|Overall Study|Clinical Progression|5
1085199|NCT02180061|2148378|FG001|Overall Study|Clinical Progression|1
1085200|NCT02180061|2148377|FG000|Overall Study|Progressive Disease|15
1085201|NCT02180061|2148378|FG001|Overall Study|Progressive Disease|5
1085202|NCT02180061|2148377|FG000|Overall Study|Physician Decision|1
1085203|NCT02180061|2148378|FG001|Overall Study|Physician Decision|0
1085204|NCT02180165|2148397|FG000|Overall Study|Not Treated|0
1085205|NCT02180165|2148398|FG001|Overall Study|Not Treated|0
1085206|NCT02180165|2148399|FG002|Overall Study|Not Treated|1
1085207|NCT02180165|2148400|FG003|Overall Study|Not Treated|0
1085208|NCT02180165|2148397|FG000|Overall Study|Adverse Event|7
1085209|NCT02180165|2148398|FG001|Overall Study|Adverse Event|0
1085210|NCT02180165|2148399|FG002|Overall Study|Adverse Event|18
1085211|NCT02180165|2148400|FG003|Overall Study|Adverse Event|3
1085212|NCT02180165|2148397|FG000|Overall Study|Lack of Efficacy|0
1085213|NCT02180165|2148398|FG001|Overall Study|Lack of Efficacy|1
1085214|NCT02180165|2148399|FG002|Overall Study|Lack of Efficacy|3
1085215|NCT02180165|2148400|FG003|Overall Study|Lack of Efficacy|2
1085216|NCT02180165|2148397|FG000|Overall Study|Physician Decision|1
1085217|NCT02180165|2148398|FG001|Overall Study|Physician Decision|0
1085218|NCT02180165|2148399|FG002|Overall Study|Physician Decision|5
1085219|NCT02180165|2148400|FG003|Overall Study|Physician Decision|0
1085220|NCT02180165|2148397|FG000|Overall Study|Withdrawal by Subject|3
1085221|NCT02180165|2148398|FG001|Overall Study|Withdrawal by Subject|0
1085222|NCT02180165|2148399|FG002|Overall Study|Withdrawal by Subject|2
1085223|NCT02180165|2148400|FG003|Overall Study|Withdrawal by Subject|1
1085224|NCT02180438|2148436|FG000|Overall Study|Lost to Follow-up|1
1085225|NCT02180659|2148453|FG000|Overall Study|Adverse Event|1
1085226|NCT02180659|2148454|FG001|Overall Study|Adverse Event|0
1085227|NCT02180659|2148453|FG000|Overall Study|Lost to Follow-up|4
1085228|NCT02180659|2148454|FG001|Overall Study|Lost to Follow-up|2
1085229|NCT02180659|2148453|FG000|Overall Study|Subject incarcerated during conduct|1
1085230|NCT02180659|2148454|FG001|Overall Study|Subject incarcerated during conduct|0
1085231|NCT02180659|2148453|FG000|Overall Study|Withdrawal by Subject|0
1085232|NCT02180659|2148454|FG001|Overall Study|Withdrawal by Subject|2
1085233|NCT02180659|2148453|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0
1085234|NCT02180659|2148454|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1
1085235|NCT02180672|2148462|FG000|Overall Study|Lost to Follow-up|5
1085236|NCT02180672|2148463|FG001|Overall Study|Lost to Follow-up|7
1085245|NCT02180867|2148494|FG000|Overall Study|Adverse Event|3
1085246|NCT02180867|2148495|FG001|Overall Study|Adverse Event|4
1085247|NCT02180867|2148496|FG002|Overall Study|Adverse Event|1
1085248|NCT02180867|2148497|FG003|Overall Study|Adverse Event|5
1085249|NCT02180867|2148498|FG004|Overall Study|Adverse Event|0
1085250|NCT02180867|2148499|FG005|Overall Study|Adverse Event|0
1085251|NCT02180867|2148500|FG006|Overall Study|Adverse Event|0
1085252|NCT02180867|2148494|FG000|Overall Study|Death|0
1085253|NCT02180867|2148495|FG001|Overall Study|Death|0
1085254|NCT02180867|2148496|FG002|Overall Study|Death|0
1085255|NCT02180867|2148497|FG003|Overall Study|Death|0
1085256|NCT02180867|2148498|FG004|Overall Study|Death|1
1085257|NCT02180867|2148499|FG005|Overall Study|Death|0
1085258|NCT02180867|2148500|FG006|Overall Study|Death|0
1085259|NCT02180867|2148494|FG000|Overall Study|Lack of Efficacy|0
1085260|NCT02180867|2148495|FG001|Overall Study|Lack of Efficacy|2
1085261|NCT02180867|2148496|FG002|Overall Study|Lack of Efficacy|0
1085262|NCT02180867|2148497|FG003|Overall Study|Lack of Efficacy|1
1085263|NCT02180867|2148498|FG004|Overall Study|Lack of Efficacy|6
1085264|NCT02180867|2148499|FG005|Overall Study|Lack of Efficacy|0
1085265|NCT02180867|2148500|FG006|Overall Study|Lack of Efficacy|1
1085266|NCT02180867|2148494|FG000|Overall Study|Physician Decision|1
1085267|NCT02180867|2148495|FG001|Overall Study|Physician Decision|3
1085268|NCT02180867|2148496|FG002|Overall Study|Physician Decision|1
1085269|NCT02180867|2148497|FG003|Overall Study|Physician Decision|10
1085270|NCT02180867|2148498|FG004|Overall Study|Physician Decision|9
1085271|NCT02180867|2148499|FG005|Overall Study|Physician Decision|3
1085272|NCT02180867|2148500|FG006|Overall Study|Physician Decision|4
1085273|NCT02180867|2148494|FG000|Overall Study|Withdrawal by Subject|0
1085274|NCT02180867|2148495|FG001|Overall Study|Withdrawal by Subject|0
1085275|NCT02180867|2148496|FG002|Overall Study|Withdrawal by Subject|0
1085276|NCT02180867|2148497|FG003|Overall Study|Withdrawal by Subject|1
1085277|NCT02180867|2148498|FG004|Overall Study|Withdrawal by Subject|1
1085278|NCT02180867|2148499|FG005|Overall Study|Withdrawal by Subject|0
1085279|NCT02180867|2148500|FG006|Overall Study|Withdrawal by Subject|0
1085280|NCT02180867|2148494|FG000|Overall Study|Ineligible|1
1085281|NCT02180867|2148495|FG001|Overall Study|Ineligible|2
1085282|NCT02180867|2148496|FG002|Overall Study|Ineligible|0
1085283|NCT02180867|2148497|FG003|Overall Study|Ineligible|3
1085284|NCT02180867|2148498|FG004|Overall Study|Ineligible|5
1085285|NCT02180867|2148499|FG005|Overall Study|Ineligible|0
1085286|NCT02180867|2148500|FG006|Overall Study|Ineligible|0
1085287|NCT02180867|2148494|FG000|Overall Study|Repeat Eligibility Studies|0
1085288|NCT02180867|2148495|FG001|Overall Study|Repeat Eligibility Studies|0
1085289|NCT02180867|2148496|FG002|Overall Study|Repeat Eligibility Studies|0
1085290|NCT02180867|2148497|FG003|Overall Study|Repeat Eligibility Studies|0
1085291|NCT02180867|2148498|FG004|Overall Study|Repeat Eligibility Studies|1
1085292|NCT02180867|2148499|FG005|Overall Study|Repeat Eligibility Studies|0
1085293|NCT02180867|2148500|FG006|Overall Study|Repeat Eligibility Studies|0
1085294|NCT02180867|2148494|FG000|Overall Study|Refusal of further protocol therapy|1
1085295|NCT02180867|2148495|FG001|Overall Study|Refusal of further protocol therapy|0
1085296|NCT02180867|2148496|FG002|Overall Study|Refusal of further protocol therapy|2
1085297|NCT02180867|2148497|FG003|Overall Study|Refusal of further protocol therapy|6
1085298|NCT02180867|2148498|FG004|Overall Study|Refusal of further protocol therapy|4
1085299|NCT02180867|2148499|FG005|Overall Study|Refusal of further protocol therapy|0
1085300|NCT02180867|2148500|FG006|Overall Study|Refusal of further protocol therapy|0
1085301|NCT02181296|2148574|FG000|Overall Study|Lost to Follow-up|7
1085302|NCT02181296|2148575|FG001|Overall Study|Lost to Follow-up|6
1085303|NCT02181413|2148605|FG000|Overall Study|Adverse Event|7
1085304|NCT02181413|2148606|FG001|Overall Study|Adverse Event|24
1085305|NCT02181413|2148605|FG000|Overall Study|Progressive Disease|121
1085306|NCT02181413|2148606|FG001|Overall Study|Progressive Disease|143
1085307|NCT02181413|2148605|FG000|Overall Study|Withdrawal by Subject|5
1085308|NCT02181413|2148606|FG001|Overall Study|Withdrawal by Subject|8
1085309|NCT02181413|2148605|FG000|Overall Study|Reason Not Specified|19
1085310|NCT02181413|2148606|FG001|Overall Study|Reason Not Specified|20
1085311|NCT02181413|2148605|FG000|Overall Study|Ongoing Study Treatment|0
1085312|NCT02181413|2148606|FG001|Overall Study|Ongoing Study Treatment|1
1085313|NCT02181413|2148605|FG000|Overall Study|Lost to Follow-up|0
1085314|NCT02181413|2148606|FG001|Overall Study|Lost to Follow-up|1
1085315|NCT02181504|2148632|FG000|Overall Study|Adverse Event|1
1085316|NCT02181504|2148633|FG001|Overall Study|Adverse Event|1
1085317|NCT02181504|2148634|FG002|Overall Study|Adverse Event|1
1085318|NCT02181556|2148660|FG000|Overall Study|Withdrawal by Subject|1
1085319|NCT02181634|2148664|FG000|Overall Study|Lack of Efficacy|33
1085320|NCT02181634|2148664|FG000|Overall Study|Adverse Event|17
1085321|NCT02181634|2148664|FG000|Overall Study|Physician Decision|8
1085322|NCT02181634|2148664|FG000|Overall Study|Withdrawal by Subject|5
1085323|NCT02181634|2148664|FG000|Overall Study|Death|2
1085324|NCT02181634|2148664|FG000|Overall Study|Treatment delayed greater than 4 weeks|3
1085325|NCT02181634|2148664|FG000|Overall Study|Ineligible|1
1085326|NCT02181634|2148664|FG000|Overall Study|Max number of dose reduction|1
1085327|NCT02181634|2148664|FG000|Overall Study|Symptomatic progression|1
1085328|NCT02181634|2148664|FG000|Overall Study|Patient opted to proceed to surgery|1
1085329|NCT02181673|2148670|FG000|Up to Week 24|Adverse Event|2
1085330|NCT02181673|2148671|FG001|Up to Week 24|Adverse Event|0
1085331|NCT02181673|2148672|FG002|Up to Week 24|Adverse Event|3
1085332|NCT02181673|2148670|FG000|Up to Week 24|Death|1
1085333|NCT02181673|2148671|FG001|Up to Week 24|Death|0
1085334|NCT02181673|2148672|FG002|Up to Week 24|Death|0
1085335|NCT02181673|2148670|FG000|Up to Week 24|Lack of Efficacy|1
1085336|NCT02181673|2148671|FG001|Up to Week 24|Lack of Efficacy|0
1085337|NCT02181673|2148672|FG002|Up to Week 24|Lack of Efficacy|0
1085338|NCT02181673|2148670|FG000|Up to Week 24|Lost to Follow-up|1
1085339|NCT02181673|2148671|FG001|Up to Week 24|Lost to Follow-up|0
1085340|NCT02181673|2148672|FG002|Up to Week 24|Lost to Follow-up|0
1085341|NCT02181673|2148670|FG000|Up to Week 24|Physician Decision|0
1085342|NCT02181673|2148671|FG001|Up to Week 24|Physician Decision|0
1085343|NCT02181673|2148672|FG002|Up to Week 24|Physician Decision|3
1085344|NCT02181673|2148670|FG000|Up to Week 24|Withdrawal by Subject|10
1085345|NCT02181673|2148671|FG001|Up to Week 24|Withdrawal by Subject|0
1085346|NCT02181673|2148672|FG002|Up to Week 24|Withdrawal by Subject|1
1085347|NCT02181673|2148670|FG000|Up to Week 24|Other|2
1085348|NCT02181673|2148671|FG001|Up to Week 24|Other|0
1085349|NCT02181673|2148672|FG002|Up to Week 24|Other|3
1085350|NCT02181673|2148670|FG000|Up to Week 24|Randomized not Treated|0
1085351|NCT02181673|2148671|FG001|Up to Week 24|Randomized not Treated|0
1085352|NCT02181673|2148672|FG002|Up to Week 24|Randomized not Treated|1
1085353|NCT02181673|2148670|FG000|Week 24-Week 60|Adverse Event|0
1085354|NCT02181673|2148671|FG001|Week 24-Week 60|Adverse Event|4
1085355|NCT02181673|2148672|FG002|Week 24-Week 60|Adverse Event|10
1085356|NCT02181673|2148670|FG000|Week 24-Week 60|Other|0
1085357|NCT02181673|2148671|FG001|Week 24-Week 60|Other|2
1085358|NCT02181673|2148672|FG002|Week 24-Week 60|Other|1
1085359|NCT02181673|2148670|FG000|Week 24-Week 60|Withdrawal by Subject|0
1085360|NCT02181673|2148671|FG001|Week 24-Week 60|Withdrawal by Subject|2
1085361|NCT02181673|2148672|FG002|Week 24-Week 60|Withdrawal by Subject|2
1085362|NCT02181673|2148670|FG000|Week 24-Week 60|Pregnancy|0
1085363|NCT02181673|2148671|FG001|Week 24-Week 60|Pregnancy|0
1085364|NCT02181673|2148672|FG002|Week 24-Week 60|Pregnancy|1
1085365|NCT02181673|2148670|FG000|Week 24-Week 60|Lack of Efficacy|0
1085366|NCT02181673|2148671|FG001|Week 24-Week 60|Lack of Efficacy|0
1085367|NCT02181673|2148672|FG002|Week 24-Week 60|Lack of Efficacy|1
1085368|NCT02181673|2148670|FG000|Week 24-Week 60|Lost to Follow-up|0
1085369|NCT02181673|2148671|FG001|Week 24-Week 60|Lost to Follow-up|0
1085370|NCT02181673|2148672|FG002|Week 24-Week 60|Lost to Follow-up|1
1085371|NCT02181673|2148670|FG000|Week 24-Week 60|Physician Decision|0
1085372|NCT02181673|2148671|FG001|Week 24-Week 60|Physician Decision|0
1085373|NCT02181673|2148672|FG002|Week 24-Week 60|Physician Decision|1
1085374|NCT02181738|2148683|FG000|Overall Study|Death|1
1085375|NCT02181738|2148684|FG001|Overall Study|Death|1
1085376|NCT02181738|2148685|FG002|Overall Study|Death|6
1085377|NCT02181738|2148686|FG003|Overall Study|Death|1
1085378|NCT02181738|2148683|FG000|Overall Study|Subject Withdrew Consent|1
1085379|NCT02181738|2148684|FG001|Overall Study|Subject Withdrew Consent|3
1085380|NCT02181738|2148685|FG002|Overall Study|Subject Withdrew Consent|2
1085381|NCT02181738|2148686|FG003|Overall Study|Subject Withdrew Consent|1
1085382|NCT02181738|2148683|FG000|Overall Study|Lost to Follow-up|0
1085383|NCT02181738|2148684|FG001|Overall Study|Lost to Follow-up|4
1085384|NCT02181738|2148685|FG002|Overall Study|Lost to Follow-up|2
1085385|NCT02181738|2148686|FG003|Overall Study|Lost to Follow-up|0
1085386|NCT02181738|2148683|FG000|Overall Study|Patient Return to Home Country|0
1085387|NCT02181738|2148684|FG001|Overall Study|Patient Return to Home Country|1
1085388|NCT02181738|2148685|FG002|Overall Study|Patient Return to Home Country|0
1085389|NCT02181738|2148686|FG003|Overall Study|Patient Return to Home Country|0
1085390|NCT02181803|2148705|FG000|Overall Study|Withdrawal by Subject|0
1085391|NCT02181803|2148706|FG001|Overall Study|Withdrawal by Subject|2
1085392|NCT02181803|2148707|FG002|Overall Study|Withdrawal by Subject|0
1085393|NCT02181803|2148708|FG003|Overall Study|Withdrawal by Subject|0
1085394|NCT02181803|2148709|FG004|Overall Study|Withdrawal by Subject|0
1085395|NCT02181803|2148710|FG005|Overall Study|Withdrawal by Subject|0
1085396|NCT02181803|2148711|FG006|Overall Study|Withdrawal by Subject|0
1085397|NCT02181803|2148712|FG007|Overall Study|Withdrawal by Subject|0
1085398|NCT02181803|2148713|FG008|Overall Study|Withdrawal by Subject|0
1085399|NCT02181803|2148705|FG000|Overall Study|Physician Decision|0
1085400|NCT02181803|2148706|FG001|Overall Study|Physician Decision|0
1085401|NCT02181803|2148707|FG002|Overall Study|Physician Decision|0
1085402|NCT02181803|2148708|FG003|Overall Study|Physician Decision|1
1085403|NCT02181803|2148709|FG004|Overall Study|Physician Decision|0
1085404|NCT02181803|2148710|FG005|Overall Study|Physician Decision|0
1085405|NCT02181803|2148711|FG006|Overall Study|Physician Decision|0
1085406|NCT02181803|2148712|FG007|Overall Study|Physician Decision|1
1085407|NCT02181803|2148713|FG008|Overall Study|Physician Decision|0
1085408|NCT02181803|2148705|FG000|Overall Study|Adverse Event|0
1085409|NCT02181803|2148706|FG001|Overall Study|Adverse Event|2
1085410|NCT02181803|2148707|FG002|Overall Study|Adverse Event|0
1085411|NCT02181803|2148708|FG003|Overall Study|Adverse Event|1
1085412|NCT02181803|2148709|FG004|Overall Study|Adverse Event|0
1085413|NCT02181803|2148710|FG005|Overall Study|Adverse Event|0
1085414|NCT02181803|2148711|FG006|Overall Study|Adverse Event|1
1085415|NCT02181803|2148712|FG007|Overall Study|Adverse Event|0
1085416|NCT02181803|2148713|FG008|Overall Study|Adverse Event|0
1085417|NCT02181816|2148758|FG000|Overall Study|Case Report Forms Uncollected|38
1085418|NCT02181816|2148758|FG000|Overall Study|Protocol Deviation|21
1085419|NCT02181842|2148766|FG000|Overall Study|Case Report Forms Uncollected|2
1085420|NCT02182440|2148783|FG000|Overall Study|Adverse Event|0
1085421|NCT02182440|2148784|FG001|Overall Study|Adverse Event|1
1085422|NCT02182440|2148785|FG002|Overall Study|Adverse Event|0
1085423|NCT02182440|2148786|FG003|Overall Study|Adverse Event|0
1085424|NCT02182440|2148783|FG000|Overall Study|Death|31
1085425|NCT02182440|2148784|FG001|Overall Study|Death|8
1085426|NCT02182440|2148785|FG002|Overall Study|Death|5
1085427|NCT02182440|2148786|FG003|Overall Study|Death|16
1085428|NCT02182440|2148783|FG000|Overall Study|Protocol Violation|0
1085429|NCT02182440|2148784|FG001|Overall Study|Protocol Violation|1
1085430|NCT02182440|2148785|FG002|Overall Study|Protocol Violation|0
1085431|NCT02182440|2148786|FG003|Overall Study|Protocol Violation|0
1085432|NCT02182440|2148783|FG000|Overall Study|Physician Decision|1
1085433|NCT02182440|2148784|FG001|Overall Study|Physician Decision|0
1085434|NCT02182440|2148785|FG002|Overall Study|Physician Decision|0
1085435|NCT02182440|2148786|FG003|Overall Study|Physician Decision|0
1085436|NCT02182440|2148783|FG000|Overall Study|Withdrawal by Subject|1
1085437|NCT02182440|2148784|FG001|Overall Study|Withdrawal by Subject|1
1085438|NCT02182440|2148785|FG002|Overall Study|Withdrawal by Subject|3
1085439|NCT02182440|2148786|FG003|Overall Study|Withdrawal by Subject|4
1085440|NCT02182440|2148783|FG000|Overall Study|different, e.g adm other hospital|12
1085441|NCT02182440|2148784|FG001|Overall Study|different, e.g adm other hospital|3
1085442|NCT02182440|2148785|FG002|Overall Study|different, e.g adm other hospital|3
1085443|NCT02182440|2148786|FG003|Overall Study|different, e.g adm other hospital|10
1085444|NCT02182830|2148813|FG000|Overall Study|Not Treated|1
1085445|NCT02182830|2148814|FG001|Overall Study|Not Treated|1
1085446|NCT02182830|2148813|FG000|Overall Study|Trial stopped, reason missing|3
1085447|NCT02182830|2148814|FG001|Overall Study|Trial stopped, reason missing|3
1085448|NCT02182830|2148813|FG000|Overall Study|Consent withdrawn|8
1085449|NCT02182830|2148814|FG001|Overall Study|Consent withdrawn|8
1085450|NCT02182830|2148813|FG000|Overall Study|Lost to Follow-up|3
1085451|NCT02182830|2148814|FG001|Overall Study|Lost to Follow-up|3
1085452|NCT02182843|2148820|FG000|Overall Study|Withdrawal by Subject|7
1085453|NCT02182843|2148820|FG000|Overall Study|Lost to Follow-up|2
1085454|NCT02182843|2148820|FG000|Overall Study|Adverse Event|1
1085455|NCT02182895|2148826|FG000|Overall Study|Discharged from hospital within 24 hours|2
1085456|NCT02182895|2148827|FG001|Overall Study|Discharged from hospital within 24 hours|4
1085457|NCT02182947|2148833|FG000|Overall Study|Withdrawal by Subject|7
1085458|NCT02182947|2148833|FG000|Overall Study|Lost to Follow-up|3
1085459|NCT02182947|2148833|FG000|Overall Study|Failed screening activities|8
1085460|NCT02182973|2148839|FG000|Overall Study|Withdrawal by Subject|3
1085461|NCT02182973|2148840|FG001|Overall Study|Withdrawal by Subject|0
1085462|NCT02182999|2148849|FG000|Overall Study|Adverse Event|4
1085463|NCT02182999|2148850|FG001|Overall Study|Adverse Event|3
1085464|NCT02182999|2148849|FG000|Overall Study|Physician Decision|1
1085465|NCT02182999|2148850|FG001|Overall Study|Physician Decision|0
1085466|NCT02183519|2148858|FG000|Overall Study|computer error|3
1085467|NCT02183519|2148859|FG001|Overall Study|computer error|0
1085468|NCT02183519|2148858|FG000|Overall Study|Did not respond to cough inducter|0
1085469|NCT02183519|2148859|FG001|Overall Study|Did not respond to cough inducter|3
1085470|NCT02183675|2148871|FG000|Treatment Period 2 (10 Days)|Adverse Event|0
1085471|NCT02183675|2148872|FG001|Treatment Period 2 (10 Days)|Adverse Event|0
1085472|NCT02183675|2148873|FG002|Treatment Period 2 (10 Days)|Adverse Event|0
1085473|NCT02183675|2148874|FG003|Treatment Period 2 (10 Days)|Adverse Event|0
1085474|NCT02183675|2148875|FG004|Treatment Period 2 (10 Days)|Adverse Event|0
1085475|NCT02183675|2148876|FG005|Treatment Period 2 (10 Days)|Adverse Event|2
1085476|NCT02184143|2148897|FG000|Overall Study|Withdrawal by Subject|4
1085477|NCT02184143|2148898|FG001|Overall Study|Withdrawal by Subject|4
1085478|NCT02184143|2148897|FG000|Overall Study|Lost to Follow-up|5
1085479|NCT02184143|2148898|FG001|Overall Study|Lost to Follow-up|3
1085480|NCT02184143|2148897|FG000|Overall Study|Death|1
1085481|NCT02184143|2148898|FG001|Overall Study|Death|0
1085482|NCT02184195|2148919|FG000|Overall Study|Patient decision|3
1085483|NCT02184195|2148920|FG001|Overall Study|Patient decision|1
1085484|NCT02184195|2148919|FG000|Overall Study|Eligibility criteria not fulfilled|0
1085485|NCT02184195|2148920|FG001|Overall Study|Eligibility criteria not fulfilled|1
1085486|NCT02184195|2148919|FG000|Overall Study|Death|40
1085487|NCT02184195|2148920|FG001|Overall Study|Death|29
1085488|NCT02184195|2148919|FG000|Overall Study|Lost to Follow-up|0
1085489|NCT02184195|2148920|FG001|Overall Study|Lost to Follow-up|2
1085490|NCT02184195|2148919|FG000|Overall Study|Other|0
1085491|NCT02184195|2148920|FG001|Overall Study|Other|2
1085492|NCT02184442|2148934|FG000|Overall Study|Death|61
1085493|NCT02184442|2148935|FG001|Overall Study|Death|65
1085494|NCT02184442|2148934|FG000|Overall Study|Withdrawal by Subject|3
1085495|NCT02184442|2148935|FG001|Overall Study|Withdrawal by Subject|11
1085496|NCT02184455|2148941|FG000|Overall Study|Lost to Follow-up|1
1085497|NCT02184572|2148960|FG000|Overall Study|Lost to Follow-up|29
1085498|NCT02184572|2148961|FG001|Overall Study|Lost to Follow-up|21
1085499|NCT02184572|2148960|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1
1085500|NCT02184572|2148961|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0
1085501|NCT02184572|2148960|FG000|Overall Study|Loss Of Kaiser Insurance|1
1085502|NCT02184572|2148961|FG001|Overall Study|Loss Of Kaiser Insurance|0
1085503|NCT02184572|2148960|FG000|Overall Study|2nd blooddraw & diary card incomplete|1
1085504|NCT02184572|2148961|FG001|Overall Study|2nd blooddraw & diary card incomplete|0
1085505|NCT02184572|2148960|FG000|Overall Study|Traveling Outside The Country|1
1085506|NCT02184572|2148961|FG001|Overall Study|Traveling Outside The Country|0
1085507|NCT02184572|2148960|FG000|Overall Study|Withdrawal by Subject|14
1085508|NCT02184572|2148961|FG001|Overall Study|Withdrawal by Subject|9
1085509|NCT02184611|2148971|FG000|Overall Study|Lack of Efficacy|11
1085510|NCT02184611|2148972|FG001|Overall Study|Lack of Efficacy|15
1085511|NCT02184611|2148971|FG000|Overall Study|Withdrawal by Subject|5
1085512|NCT02184611|2148972|FG001|Overall Study|Withdrawal by Subject|6
1085513|NCT02184611|2148971|FG000|Overall Study|Adverse Event|4
1085514|NCT02184611|2148972|FG001|Overall Study|Adverse Event|5
1085515|NCT02184611|2148971|FG000|Overall Study|Protocol Violation|1
1085516|NCT02184611|2148972|FG001|Overall Study|Protocol Violation|1
1085517|NCT02184611|2148971|FG000|Overall Study|Protocol defined stopping criteria|0
1085518|NCT02184611|2148972|FG001|Overall Study|Protocol defined stopping criteria|1
1085519|NCT02184988|2148999|FG000|Overall Study|Pregnancy|2
1085520|NCT02184988|2148999|FG000|Overall Study|Adverse Event|2
1085521|NCT02184988|2148999|FG000|Overall Study|moving away/travelling/unable to complet|6
1085522|NCT02184988|2148999|FG000|Overall Study|work scheduling issues|4
1085523|NCT02184988|2148999|FG000|Overall Study|various other reasons|9
1085524|NCT02184988|2148999|FG000|Overall Study|Lost to Follow-up|32
1085525|NCT02185014|2149003|FG000|Overall Study|Adverse Event|18
1085526|NCT02185014|2149003|FG000|Overall Study|Withdrew Consent|8
1085527|NCT02185014|2149003|FG000|Overall Study|Lost to Follow-up|4
1085528|NCT02185014|2149003|FG000|Overall Study|Lack of Efficacy|14
1085529|NCT02185014|2149003|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5
1085530|NCT02185014|2149003|FG000|Overall Study|Subject Noncompliance|1
1085531|NCT02185014|2149003|FG000|Overall Study|Other|4
1085532|NCT02185040|2149012|FG000|Part 1 Treatment Phase|Miscellaneous|0
1085533|NCT02185040|2149013|FG001|Part 1 Treatment Phase|Miscellaneous|0
1085534|NCT02185040|2149014|FG002|Part 1 Treatment Phase|Miscellaneous|1
1085535|NCT02185040|2149015|FG003|Part 1 Treatment Phase|Miscellaneous|0
1085536|NCT02185040|2149016|FG004|Part 1 Treatment Phase|Miscellaneous|0
1085537|NCT02185040|2149017|FG005|Part 1 Treatment Phase|Miscellaneous|0
1085538|NCT02185040|2149018|FG006|Part 1 Treatment Phase|Miscellaneous|0
1085539|NCT02185040|2149012|FG000|Part 1 Treatment Phase|Adverse Event|1
1085540|NCT02185040|2149013|FG001|Part 1 Treatment Phase|Adverse Event|0
1085541|NCT02185040|2149014|FG002|Part 1 Treatment Phase|Adverse Event|0
1085542|NCT02185040|2149015|FG003|Part 1 Treatment Phase|Adverse Event|2
1085543|NCT02185040|2149016|FG004|Part 1 Treatment Phase|Adverse Event|3
1085544|NCT02185040|2149017|FG005|Part 1 Treatment Phase|Adverse Event|0
1085545|NCT02185040|2149018|FG006|Part 1 Treatment Phase|Adverse Event|0
1085546|NCT02185040|2149012|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0
1085547|NCT02185040|2149013|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1
1085548|NCT02185040|2149014|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0
1085549|NCT02185040|2149015|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0
1085550|NCT02185040|2149016|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0
1085551|NCT02185040|2149017|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0
1085552|NCT02185040|2149018|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0
1085553|NCT02185040|2149012|FG000|Part 1 Treatment Phase|Lost to Follow-up|0
1085554|NCT02185040|2149013|FG001|Part 1 Treatment Phase|Lost to Follow-up|1
1085555|NCT02185040|2149014|FG002|Part 1 Treatment Phase|Lost to Follow-up|0
1085556|NCT02185040|2149015|FG003|Part 1 Treatment Phase|Lost to Follow-up|0
1085557|NCT02185040|2149016|FG004|Part 1 Treatment Phase|Lost to Follow-up|0
1085558|NCT02185040|2149017|FG005|Part 1 Treatment Phase|Lost to Follow-up|0
1085559|NCT02185040|2149018|FG006|Part 1 Treatment Phase|Lost to Follow-up|0
1085560|NCT02185040|2149012|FG000|Active Treatment Extension Phase|Miscellaneous|0
1085561|NCT02185040|2149013|FG001|Active Treatment Extension Phase|Miscellaneous|0
1085562|NCT02185040|2149014|FG002|Active Treatment Extension Phase|Miscellaneous|0
1085563|NCT02185040|2149015|FG003|Active Treatment Extension Phase|Miscellaneous|0
1085564|NCT02185040|2149016|FG004|Active Treatment Extension Phase|Miscellaneous|0
1085565|NCT02185040|2149017|FG005|Active Treatment Extension Phase|Miscellaneous|1
1085566|NCT02185040|2149018|FG006|Active Treatment Extension Phase|Miscellaneous|0
1085567|NCT02185040|2149012|FG000|Active Treatment Extension Phase|Adverse Event|0
1085568|NCT02185040|2149013|FG001|Active Treatment Extension Phase|Adverse Event|0
1085569|NCT02185040|2149014|FG002|Active Treatment Extension Phase|Adverse Event|0
1085570|NCT02185040|2149015|FG003|Active Treatment Extension Phase|Adverse Event|0
1085571|NCT02185040|2149016|FG004|Active Treatment Extension Phase|Adverse Event|0
1085572|NCT02185040|2149017|FG005|Active Treatment Extension Phase|Adverse Event|1
1085573|NCT02185040|2149018|FG006|Active Treatment Extension Phase|Adverse Event|4
1085574|NCT02185040|2149012|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0
1085575|NCT02185040|2149013|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0
1085576|NCT02185040|2149014|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0
1085577|NCT02185040|2149015|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0
1085578|NCT02185040|2149016|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0
1085579|NCT02185040|2149017|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1
1085580|NCT02185040|2149018|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1
1085581|NCT02185040|2149012|FG000|Active Treatment Extension Phase|Lost to Follow-up|0
1085582|NCT02185040|2149013|FG001|Active Treatment Extension Phase|Lost to Follow-up|0
1085583|NCT02185040|2149014|FG002|Active Treatment Extension Phase|Lost to Follow-up|0
1085584|NCT02185040|2149015|FG003|Active Treatment Extension Phase|Lost to Follow-up|0
1085585|NCT02185040|2149016|FG004|Active Treatment Extension Phase|Lost to Follow-up|0
1085586|NCT02185040|2149017|FG005|Active Treatment Extension Phase|Lost to Follow-up|0
1085587|NCT02185040|2149018|FG006|Active Treatment Extension Phase|Lost to Follow-up|2
1085588|NCT02185053|2149038|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1
1085589|NCT02185053|2149039|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
1085590|NCT02185053|2149040|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
1085591|NCT02185053|2149038|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2
1085592|NCT02185053|2149039|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
1085593|NCT02185053|2149040|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
1085594|NCT02185053|2149038|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0
1085595|NCT02185053|2149039|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1
1085596|NCT02185053|2149040|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0
1085597|NCT02185053|2149038|FG000|Donepezil Dose Escalation Phase|Adverse Event|0
1085598|NCT02185053|2149039|FG001|Donepezil Dose Escalation Phase|Adverse Event|1
1085599|NCT02185053|2149040|FG002|Donepezil Dose Escalation Phase|Adverse Event|0
1085600|NCT02185053|2149038|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
1085601|NCT02185053|2149039|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2
1085602|NCT02185053|2149040|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
1085603|NCT02185053|2149038|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
1085604|NCT02185053|2149039|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1
1085605|NCT02185053|2149040|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
1085606|NCT02185053|2149038|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
1085607|NCT02185053|2149039|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
1085608|NCT02185053|2149040|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1
1085609|NCT02185053|2149038|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
1085610|NCT02185053|2149039|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
1085611|NCT02185053|2149040|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2
1085612|NCT02185521|2149086|FG000|Overall Study|Withdrawal by Subject|1
1085613|NCT02185521|2149086|FG000|Overall Study|Protocol Violation|1
1085614|NCT02185534|2149097|FG000|First Period|Withdrawal by Subject|0
1085615|NCT02185534|2149098|FG001|First Period|Withdrawal by Subject|0
1085616|NCT02185534|2149099|FG002|First Period|Withdrawal by Subject|0
1085617|NCT02185534|2149100|FG003|First Period|Withdrawal by Subject|1
1085618|NCT02185534|2149101|FG004|First Period|Withdrawal by Subject|0
1085619|NCT02185534|2149102|FG005|First Period|Withdrawal by Subject|0
1085620|NCT02185534|2149097|FG000|First Washout Period|Withdrawal by Subject|1
1085621|NCT02185534|2149098|FG001|First Washout Period|Withdrawal by Subject|0
1085622|NCT02185534|2149099|FG002|First Washout Period|Withdrawal by Subject|0
1085623|NCT02185534|2149100|FG003|First Washout Period|Withdrawal by Subject|0
1085624|NCT02185534|2149101|FG004|First Washout Period|Withdrawal by Subject|1
1085625|NCT02185534|2149102|FG005|First Washout Period|Withdrawal by Subject|0
1085626|NCT02185534|2149097|FG000|First Washout Period|Protocol Violation|0
1085627|NCT02185534|2149098|FG001|First Washout Period|Protocol Violation|0
1085628|NCT02185534|2149099|FG002|First Washout Period|Protocol Violation|0
1085629|NCT02185534|2149100|FG003|First Washout Period|Protocol Violation|0
1085630|NCT02185534|2149101|FG004|First Washout Period|Protocol Violation|0
1085631|NCT02185534|2149102|FG005|First Washout Period|Protocol Violation|1
1085632|NCT02185794|2149124|FG000|Overall Study|Enrolled but Never Dosed|1
1085633|NCT02185794|2149125|FG001|Overall Study|Enrolled but Never Dosed|6
1085634|NCT02185794|2149126|FG002|Overall Study|Enrolled but Never Dosed|3
1085635|NCT02185794|2149127|FG003|Overall Study|Enrolled but Never Dosed|1
1085636|NCT02185794|2149128|FG004|Overall Study|Enrolled but Never Dosed|1
1085637|NCT02185794|2149129|FG005|Overall Study|Enrolled but Never Dosed|0
1085638|NCT02185794|2149124|FG000|Overall Study|Investigator's Discretion|1
1085639|NCT02185794|2149125|FG001|Overall Study|Investigator's Discretion|0
1085640|NCT02185794|2149126|FG002|Overall Study|Investigator's Discretion|1
1085641|NCT02185794|2149127|FG003|Overall Study|Investigator's Discretion|2
1085642|NCT02185794|2149128|FG004|Overall Study|Investigator's Discretion|2
1085643|NCT02185794|2149129|FG005|Overall Study|Investigator's Discretion|15
1085644|NCT02185794|2149124|FG000|Overall Study|Withdrew Consent|2
1085645|NCT02185794|2149125|FG001|Overall Study|Withdrew Consent|5
1085646|NCT02185794|2149126|FG002|Overall Study|Withdrew Consent|10
1085647|NCT02185794|2149127|FG003|Overall Study|Withdrew Consent|2
1085648|NCT02185794|2149128|FG004|Overall Study|Withdrew Consent|0
1085649|NCT02185794|2149129|FG005|Overall Study|Withdrew Consent|0
1085650|NCT02185794|2149124|FG000|Overall Study|Lost to Follow-up|1
1085651|NCT02185794|2149125|FG001|Overall Study|Lost to Follow-up|2
1085652|NCT02185794|2149126|FG002|Overall Study|Lost to Follow-up|2
1085653|NCT02185794|2149127|FG003|Overall Study|Lost to Follow-up|3
1085654|NCT02185794|2149128|FG004|Overall Study|Lost to Follow-up|0
1085655|NCT02185794|2149129|FG005|Overall Study|Lost to Follow-up|1
1085656|NCT02186015|2149159|FG000|Overall Study|Physician Decision|1
1085657|NCT02186015|2149160|FG001|Overall Study|Physician Decision|0
1085658|NCT02186171|2149169|FG000|Overall Study|Withdrawal by Subject|1
1085659|NCT02186171|2149170|FG001|Overall Study|Withdrawal by Subject|9
1085660|NCT02186171|2149169|FG000|Overall Study|Lost to Follow-up|2
1085661|NCT02186171|2149170|FG001|Overall Study|Lost to Follow-up|2
1085662|NCT02186171|2149169|FG000|Overall Study|Death|1
1085663|NCT02186171|2149170|FG001|Overall Study|Death|2
1085664|NCT02186171|2149169|FG000|Overall Study|Protocol-specified Criteria|0
1085665|NCT02186171|2149170|FG001|Overall Study|Protocol-specified Criteria|2
1085666|NCT02186223|2149187|FG000|Overall Study|Not eligible for device placement|6
1085667|NCT02186223|2149187|FG000|Overall Study|Unable to obtain femoral access|3
1085668|NCT02186223|2149187|FG000|Overall Study|Death|3
1085669|NCT02186223|2149187|FG000|Overall Study|Device in place less than 48 hours|9
1085670|NCT02186301|2149195|FG000|Overall Study|Progressive Disease|7
1085671|NCT02186301|2149196|FG001|Overall Study|Progressive Disease|22
1085672|NCT02186301|2149197|FG002|Overall Study|Progressive Disease|27
1085673|NCT02186301|2149195|FG000|Overall Study|Adverse Event|5
1085674|NCT02186301|2149196|FG001|Overall Study|Adverse Event|5
1085675|NCT02186301|2149197|FG002|Overall Study|Adverse Event|5
1085676|NCT02186301|2149195|FG000|Overall Study|Death|1
1085677|NCT02186301|2149196|FG001|Overall Study|Death|0
1085678|NCT02186301|2149197|FG002|Overall Study|Death|0
1085679|NCT02186301|2149195|FG000|Overall Study|Withdrawal by Subject|5
1085680|NCT02186301|2149196|FG001|Overall Study|Withdrawal by Subject|1
1085681|NCT02186301|2149197|FG002|Overall Study|Withdrawal by Subject|3
1085682|NCT02186301|2149195|FG000|Overall Study|Physician Decision|1
1085683|NCT02186301|2149196|FG001|Overall Study|Physician Decision|0
1085684|NCT02186301|2149197|FG002|Overall Study|Physician Decision|1
1085685|NCT02186301|2149195|FG000|Overall Study|Study Terminated by Sponsor|1
1085686|NCT02186301|2149196|FG001|Overall Study|Study Terminated by Sponsor|0
1085687|NCT02186301|2149197|FG002|Overall Study|Study Terminated by Sponsor|11
1085688|NCT02186301|2149195|FG000|Overall Study|Protocol Deviation|0
1085689|NCT02186301|2149196|FG001|Overall Study|Protocol Deviation|2
1085690|NCT02186301|2149197|FG002|Overall Study|Protocol Deviation|0
1085691|NCT02186301|2149195|FG000|Overall Study|Missing|0
1085692|NCT02186301|2149196|FG001|Overall Study|Missing|0
1085693|NCT02186301|2149197|FG002|Overall Study|Missing|2
1085694|NCT02186301|2149195|FG000|Overall Study|Other|0
1085695|NCT02186301|2149196|FG001|Overall Study|Other|0
1085696|NCT02186301|2149197|FG002|Overall Study|Other|1
1085697|NCT02186561|2149211|FG000|Enrollment|Did Not Meet Inclusion Criteria|46
1085698|NCT02186561|2149211|FG000|Enrollment|Enrollment Cap Reached|5
1085699|NCT02186561|2149211|FG000|Enrollment|Insurance Denial|2
1085700|NCT02186561|2149211|FG000|Enrollment|Withdrawal by Subject|2
1085701|NCT02186561|2149211|FG000|Enrollment|Investigator Withdrew Consent|1
1085702|NCT02186561|2149211|FG000|30-Day Post Index Procedure Visit|Death|1
1085703|NCT02186561|2149211|FG000|1- Year Post Index Procedure Visit|Death|1
1085704|NCT02186561|2149211|FG000|1- Year Post Index Procedure Visit|Missed|1
1085705|NCT02186652|2149227|FG000|Overall Study|Lost to Follow-up|2
1085706|NCT02186652|2149228|FG001|Overall Study|Lost to Follow-up|0
1085707|NCT02186821|2149263|FG000|Overall Study|Adverse Event|9
1085708|NCT02186821|2149263|FG000|Overall Study|Death|2
1085709|NCT02186821|2149263|FG000|Overall Study|Disease progression|32
1085710|NCT02186821|2149263|FG000|Overall Study|Protocol Violation|1
1085711|NCT02186821|2149263|FG000|Overall Study|Physician Decision|1
1085712|NCT02186821|2149263|FG000|Overall Study|Study terminated by sponsor|2
1085725|NCT02186847|2149283|FG000|Overall Study|Protocol Violation|3
1085726|NCT02186847|2149284|FG001|Overall Study|Protocol Violation|0
1085727|NCT02186873|2149292|FG000|Overall Study|Adverse Event|1
1085728|NCT02186873|2149293|FG001|Overall Study|Adverse Event|3
1085729|NCT02186873|2149292|FG000|Overall Study|Lack of Efficacy|0
1085730|NCT02186873|2149293|FG001|Overall Study|Lack of Efficacy|1
1085731|NCT02186873|2149292|FG000|Overall Study|Lost to Follow-up|1
1085732|NCT02186873|2149293|FG001|Overall Study|Lost to Follow-up|2
1085733|NCT02186873|2149292|FG000|Overall Study|Withdrawal by Subject|7
1085734|NCT02186873|2149293|FG001|Overall Study|Withdrawal by Subject|2
1085735|NCT02187029|2149330|FG000|Overall Study|Adverse Event|0
1085736|NCT02187029|2149331|FG001|Overall Study|Adverse Event|1
1085737|NCT02187029|2149332|FG002|Overall Study|Adverse Event|1
1085738|NCT02187029|2149333|FG003|Overall Study|Adverse Event|0
1085739|NCT02187029|2149330|FG000|Overall Study|Study Terminated by Sponsor|0
1085740|NCT02187029|2149331|FG001|Overall Study|Study Terminated by Sponsor|0
1085741|NCT02187029|2149332|FG002|Overall Study|Study Terminated by Sponsor|10
1085742|NCT02187029|2149333|FG003|Overall Study|Study Terminated by Sponsor|3
1085743|NCT02187029|2149330|FG000|Overall Study|Withdrawal by Subject|1
1085744|NCT02187029|2149331|FG001|Overall Study|Withdrawal by Subject|0
1085745|NCT02187029|2149332|FG002|Overall Study|Withdrawal by Subject|0
1085746|NCT02187029|2149333|FG003|Overall Study|Withdrawal by Subject|0
1085747|NCT02187042|2149345|FG000|Overall Study|Death|1
1085748|NCT02187042|2149346|FG001|Overall Study|Death|1
1085749|NCT02187042|2149345|FG000|Overall Study|Toxicity|6
1085750|NCT02187042|2149346|FG001|Overall Study|Toxicity|5
1085751|NCT02187042|2149345|FG000|Overall Study|Participant choice|1
1085752|NCT02187042|2149346|FG001|Overall Study|Participant choice|0
1085753|NCT02187042|2149345|FG000|Overall Study|Doctor choice|1
1085754|NCT02187042|2149346|FG001|Overall Study|Doctor choice|0
1085755|NCT02187042|2149345|FG000|Overall Study|Progressive disease|4
1085756|NCT02187042|2149346|FG001|Overall Study|Progressive disease|8
1085757|NCT02187055|2149356|FG000|Overall Study|Lack of Efficacy|10
1085758|NCT02187055|2149357|FG001|Overall Study|Lack of Efficacy|3
1085759|NCT02187055|2149358|FG002|Overall Study|Lack of Efficacy|7
1085760|NCT02187055|2149356|FG000|Overall Study|Lost to Follow-up|2
1085761|NCT02187055|2149357|FG001|Overall Study|Lost to Follow-up|7
1085762|NCT02187055|2149358|FG002|Overall Study|Lost to Follow-up|3
1085763|NCT02187055|2149356|FG000|Overall Study|No longer meets eligibility criteria|0
1085764|NCT02187055|2149357|FG001|Overall Study|No longer meets eligibility criteria|2
1085765|NCT02187055|2149358|FG002|Overall Study|No longer meets eligibility criteria|0
1085766|NCT02187055|2149356|FG000|Overall Study|No longer willing to participate|6
1085767|NCT02187055|2149357|FG001|Overall Study|No longer willing to participate|8
1085768|NCT02187055|2149358|FG002|Overall Study|No longer willing to participate|10
1085769|NCT02187055|2149356|FG000|Overall Study|Other|5
1085770|NCT02187055|2149357|FG001|Overall Study|Other|6
1085771|NCT02187055|2149358|FG002|Overall Study|Other|3
1085772|NCT02187055|2149356|FG000|Overall Study|Protocol Violation|9
1085773|NCT02187055|2149357|FG001|Overall Study|Protocol Violation|9
1085774|NCT02187055|2149358|FG002|Overall Study|Protocol Violation|4
1085775|NCT02187055|2149356|FG000|Overall Study|Pregnancy|3
1085776|NCT02187055|2149357|FG001|Overall Study|Pregnancy|1
1085777|NCT02187055|2149358|FG002|Overall Study|Pregnancy|0
1085778|NCT02187055|2149356|FG000|Overall Study|Withdrawal by Subject|11
1085779|NCT02187055|2149357|FG001|Overall Study|Withdrawal by Subject|11
1085780|NCT02187055|2149358|FG002|Overall Study|Withdrawal by Subject|11
1085781|NCT02187055|2149356|FG000|Overall Study|Adverse Event|21
1085782|NCT02187055|2149357|FG001|Overall Study|Adverse Event|26
1085783|NCT02187055|2149358|FG002|Overall Study|Adverse Event|36
1085784|NCT02187055|2149356|FG000|Overall Study|Death|2
1085785|NCT02187055|2149357|FG001|Overall Study|Death|0
1085786|NCT02187055|2149358|FG002|Overall Study|Death|0
1085787|NCT02187159|2149370|FG000|Overall Study|Protocol Violation|4
1085788|NCT02187159|2149371|FG001|Overall Study|Protocol Violation|6
1085789|NCT02187159|2149372|FG002|Overall Study|Protocol Violation|3
1085790|NCT02187159|2149373|FG003|Overall Study|Protocol Violation|4
1085791|NCT02187159|2149370|FG000|Overall Study|Lack of Efficacy|10
1085792|NCT02187159|2149371|FG001|Overall Study|Lack of Efficacy|5
1085793|NCT02187159|2149372|FG002|Overall Study|Lack of Efficacy|4
1085794|NCT02187159|2149373|FG003|Overall Study|Lack of Efficacy|7
1085795|NCT02187159|2149370|FG000|Overall Study|Adverse Event|28
1085796|NCT02187159|2149371|FG001|Overall Study|Adverse Event|33
1085797|NCT02187159|2149372|FG002|Overall Study|Adverse Event|42
1085798|NCT02187159|2149373|FG003|Overall Study|Adverse Event|50
1085799|NCT02187159|2149370|FG000|Overall Study|Withdrawal by Subject|24
1085800|NCT02187159|2149371|FG001|Overall Study|Withdrawal by Subject|28
1085801|NCT02187159|2149372|FG002|Overall Study|Withdrawal by Subject|25
1085802|NCT02187159|2149373|FG003|Overall Study|Withdrawal by Subject|26
1085803|NCT02187159|2149370|FG000|Overall Study|Other|3
1085804|NCT02187159|2149371|FG001|Overall Study|Other|7
1085805|NCT02187159|2149372|FG002|Overall Study|Other|3
1085806|NCT02187159|2149373|FG003|Overall Study|Other|9
1085807|NCT02187172|2149385|FG000|Overall Study|Lost to Follow-up|1
1085808|NCT02187172|2149386|FG001|Overall Study|Lost to Follow-up|2
1085809|NCT02187172|2149385|FG000|Overall Study|Lack of Efficacy|1
1085810|NCT02187172|2149386|FG001|Overall Study|Lack of Efficacy|2
1085811|NCT02187172|2149385|FG000|Overall Study|Adverse Event|0
1085812|NCT02187172|2149386|FG001|Overall Study|Adverse Event|1
1085813|NCT02187172|2149385|FG000|Overall Study|Physician Decision|1
1085814|NCT02187172|2149386|FG001|Overall Study|Physician Decision|1
1085815|NCT02187471|2149398|FG000|Overall Study|Protocol Violation|4
1085816|NCT02187471|2149399|FG001|Overall Study|Protocol Violation|5
1085817|NCT02187471|2149400|FG002|Overall Study|Protocol Violation|4
1085818|NCT02187471|2149401|FG003|Overall Study|Protocol Violation|4
1085819|NCT02187471|2149398|FG000|Overall Study|Missing|0
1085820|NCT02187471|2149399|FG001|Overall Study|Missing|0
1085821|NCT02187471|2149400|FG002|Overall Study|Missing|0
1085822|NCT02187471|2149401|FG003|Overall Study|Missing|1
1085823|NCT02187471|2149398|FG000|Overall Study|Lack of Efficacy|18
1085824|NCT02187471|2149399|FG001|Overall Study|Lack of Efficacy|9
1085825|NCT02187471|2149400|FG002|Overall Study|Lack of Efficacy|13
1085826|NCT02187471|2149401|FG003|Overall Study|Lack of Efficacy|11
1085827|NCT02187471|2149398|FG000|Overall Study|Adverse Event|24
1085828|NCT02187471|2149399|FG001|Overall Study|Adverse Event|34
1085829|NCT02187471|2149400|FG002|Overall Study|Adverse Event|44
1085830|NCT02187471|2149401|FG003|Overall Study|Adverse Event|36
1085831|NCT02187471|2149398|FG000|Overall Study|Withdrawal by Subject|23
1085832|NCT02187471|2149399|FG001|Overall Study|Withdrawal by Subject|29
1085833|NCT02187471|2149400|FG002|Overall Study|Withdrawal by Subject|22
1085834|NCT02187471|2149401|FG003|Overall Study|Withdrawal by Subject|24
1085835|NCT02187471|2149398|FG000|Overall Study|Other|7
1085836|NCT02187471|2149399|FG001|Overall Study|Other|5
1085837|NCT02187471|2149400|FG002|Overall Study|Other|3
1085838|NCT02187471|2149401|FG003|Overall Study|Other|4
1085839|NCT02187744|2149414|FG000|Study|Participant refused further follow-up|1
1085840|NCT02187744|2149415|FG001|Study|Participant refused further follow-up|0
1085841|NCT02187744|2149414|FG000|Study|Other|2
1085842|NCT02187744|2149415|FG001|Study|Other|1
1085843|NCT02187744|2149414|FG000|Study|Lost to Follow-up|0
1085844|NCT02187744|2149415|FG001|Study|Lost to Follow-up|2
1085845|NCT02187744|2149414|FG000|Study|Related adverse event, not serious|0
1085846|NCT02187744|2149415|FG001|Study|Related adverse event, not serious|2
1085847|NCT02187744|2149414|FG000|Study|Death|1
1085848|NCT02187744|2149415|FG001|Study|Death|0
1085849|NCT02187744|2149414|FG000|Study|Related adverse event, serious non-fatal|0
1085850|NCT02187744|2149415|FG001|Study|Related adverse event, serious non-fatal|1
1085851|NCT02187744|2149414|FG000|Treatment|Death|1
1085852|NCT02187744|2149415|FG001|Treatment|Death|0
1085853|NCT02187744|2149414|FG000|Treatment|Related adverse event, serious non-fatal|0
1085854|NCT02187744|2149415|FG001|Treatment|Related adverse event, serious non-fatal|1
1085855|NCT02187744|2149414|FG000|Treatment|Related adverse event, not serious|0
1085856|NCT02187744|2149415|FG001|Treatment|Related adverse event, not serious|2
1085857|NCT02187744|2149414|FG000|Treatment|Lost to Follow-up|0
1085858|NCT02187744|2149415|FG001|Treatment|Lost to Follow-up|1
1085859|NCT02187744|2149414|FG000|Treatment|Other|2
1085860|NCT02187744|2149415|FG001|Treatment|Other|0
1085861|NCT02187744|2149414|FG000|Treatment|Participant refused continued treatment|1
1085862|NCT02187744|2149415|FG001|Treatment|Participant refused continued treatment|1
1085863|NCT02187783|2149421|FG000|Overall Study|Adverse Event|8
1085864|NCT02187783|2149421|FG000|Overall Study|Death|3
1085865|NCT02187783|2149421|FG000|Overall Study|Progressive disease|80
1085866|NCT02187783|2149421|FG000|Overall Study|Protocol Violation|3
1085867|NCT02187783|2149421|FG000|Overall Study|Physician Decision|2
1085868|NCT02187783|2149421|FG000|Overall Study|Withdrawal by Subject|9
1085869|NCT02187783|2149421|FG000|Overall Study|Study terminated by sponsor|1
1085870|NCT02187809|2149425|FG000|Overall Study|The study was terminated|3
1085871|NCT02187861|2149433|FG000|Overall Study|Adverse Event|2
1085872|NCT02187861|2149434|FG001|Overall Study|Adverse Event|1
1085873|NCT02187861|2149435|FG002|Overall Study|Adverse Event|2
1085874|NCT02187861|2149436|FG003|Overall Study|Adverse Event|1
1085875|NCT02187861|2149433|FG000|Overall Study|Death|0
1085876|NCT02187861|2149434|FG001|Overall Study|Death|3
1085877|NCT02187861|2149435|FG002|Overall Study|Death|1
1085878|NCT02187861|2149436|FG003|Overall Study|Death|2
1085879|NCT02187861|2149433|FG000|Overall Study|Physician Decision|0
1085880|NCT02187861|2149434|FG001|Overall Study|Physician Decision|1
1085881|NCT02187861|2149435|FG002|Overall Study|Physician Decision|0
1085882|NCT02187861|2149436|FG003|Overall Study|Physician Decision|3
1085883|NCT02187861|2149433|FG000|Overall Study|Progressive Disease|4
1085884|NCT02187861|2149434|FG001|Overall Study|Progressive Disease|42
1085885|NCT02187861|2149435|FG002|Overall Study|Progressive Disease|19
1085886|NCT02187861|2149436|FG003|Overall Study|Progressive Disease|22
1085887|NCT02187861|2149433|FG000|Overall Study|Withdrawal by Subject|0
1085888|NCT02187861|2149434|FG001|Overall Study|Withdrawal by Subject|0
1085889|NCT02187861|2149435|FG002|Overall Study|Withdrawal by Subject|3
1085890|NCT02187861|2149436|FG003|Overall Study|Withdrawal by Subject|3
1085891|NCT02187861|2149433|FG000|Overall Study|Other|0
1085892|NCT02187861|2149434|FG001|Overall Study|Other|1
1085893|NCT02187861|2149435|FG002|Overall Study|Other|7
1085894|NCT02187861|2149436|FG003|Overall Study|Other|1
1085895|NCT02188160|2149457|FG000|Overall Study|Adverse Event|1
1085896|NCT02188160|2149458|FG001|Overall Study|Adverse Event|0
1085897|NCT02188160|2149457|FG000|Overall Study|Use of an excluded medication|0
1085898|NCT02188160|2149458|FG001|Overall Study|Use of an excluded medication|1
1085899|NCT02188303|2149472|FG000|Overall Study|Adverse Event|0
1085900|NCT02188303|2149473|FG001|Overall Study|Adverse Event|0
1085901|NCT02188303|2149474|FG002|Overall Study|Adverse Event|0
1085902|NCT02188303|2149475|FG003|Overall Study|Adverse Event|0
1085903|NCT02188303|2149476|FG004|Overall Study|Adverse Event|0
1085904|NCT02188303|2149477|FG005|Overall Study|Adverse Event|2
1085905|NCT02188303|2149478|FG006|Overall Study|Adverse Event|0
1085906|NCT02188303|2149479|FG007|Overall Study|Adverse Event|2
1085907|NCT02188303|2149472|FG000|Overall Study|Dose Termination Criteria Met|0
1085908|NCT02188303|2149473|FG001|Overall Study|Dose Termination Criteria Met|0
1085909|NCT02188303|2149474|FG002|Overall Study|Dose Termination Criteria Met|0
1085910|NCT02188303|2149475|FG003|Overall Study|Dose Termination Criteria Met|0
1085911|NCT02188303|2149476|FG004|Overall Study|Dose Termination Criteria Met|0
1085912|NCT02188303|2149477|FG005|Overall Study|Dose Termination Criteria Met|0
1085913|NCT02188303|2149478|FG006|Overall Study|Dose Termination Criteria Met|2
1085914|NCT02188303|2149479|FG007|Overall Study|Dose Termination Criteria Met|4
1085915|NCT02188459|2149505|FG000|Overall Study|Lost to Follow-up|3
1085916|NCT02188459|2149506|FG001|Overall Study|Lost to Follow-up|4
1085917|NCT02188459|2149505|FG000|Overall Study|Early Termination|0
1085918|NCT02188459|2149506|FG001|Overall Study|Early Termination|3
1085919|NCT02188485|2149518|FG000|Overall Study|Withdrawal by Subject|2
1085920|NCT02188485|2149519|FG001|Overall Study|Withdrawal by Subject|1
1085921|NCT02188485|2149518|FG000|Overall Study|PI withdrew, lack of capacity|0
1085922|NCT02188485|2149519|FG001|Overall Study|PI withdrew, lack of capacity|2
1085923|NCT02188589|2149534|FG000|Overall Study|Withdrawal by Subject|5
1085924|NCT02188719|2149543|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
1085925|NCT02188719|2149544|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1
1085926|NCT02188719|2149545|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
1085927|NCT02188719|2149546|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
1085928|NCT02188784|2149556|FG000|Overall Study|Death|3
1085929|NCT02188784|2149557|FG001|Overall Study|Death|1
1085930|NCT02188784|2149556|FG000|Overall Study|Lost to Follow-up|1
1085931|NCT02188784|2149557|FG001|Overall Study|Lost to Follow-up|0
1085932|NCT02188784|2149556|FG000|Overall Study|Withdrawal by Subject|3
1085933|NCT02188784|2149557|FG001|Overall Study|Withdrawal by Subject|9
1085934|NCT02188784|2149556|FG000|Overall Study|Physician Decision|2
1085935|NCT02188784|2149557|FG001|Overall Study|Physician Decision|3
1085936|NCT02188849|2149565|FG000|Overall Study|Lost to Follow-up|3
1085937|NCT02188849|2149566|FG001|Overall Study|Lost to Follow-up|8
1085938|NCT02189252|2149600|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1085939|NCT02189252|2149601|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
1085940|NCT02189252|2149602|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1085941|NCT02189252|2149603|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1085942|NCT02189252|2149600|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1085943|NCT02189252|2149601|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1
1085944|NCT02189252|2149602|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1085945|NCT02189252|2149603|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1085946|NCT02189473|2149634|FG000|Overall Study|Death|22
1085947|NCT02189473|2149635|FG001|Overall Study|Death|23
1085948|NCT02189473|2149634|FG000|Overall Study|Lost to Follow-up|1
1085949|NCT02189473|2149635|FG001|Overall Study|Lost to Follow-up|2
1085950|NCT02189759|2149658|FG000|Overall Study|Lost to Follow-up|0
1085951|NCT02189759|2149659|FG001|Overall Study|Lost to Follow-up|0
1085952|NCT02189759|2149660|FG002|Overall Study|Lost to Follow-up|2
1085953|NCT02189759|2149661|FG003|Overall Study|Lost to Follow-up|5
1085954|NCT02189837|2149677|FG000|Overall Study|Withdrawal by Subject|2
1085955|NCT02189837|2149678|FG001|Overall Study|Withdrawal by Subject|1
1085956|NCT02189837|2149679|FG002|Overall Study|Withdrawal by Subject|3
1085957|NCT02189837|2149680|FG003|Overall Study|Withdrawal by Subject|1
1085958|NCT02189837|2149677|FG000|Overall Study|Sponsor Decision|0
1085959|NCT02189837|2149678|FG001|Overall Study|Sponsor Decision|0
1085960|NCT02189837|2149679|FG002|Overall Study|Sponsor Decision|0
1085961|NCT02189837|2149680|FG003|Overall Study|Sponsor Decision|1
1085962|NCT02189863|2149699|FG000|First 2 Weeks|Motion Sickness|4
1085963|NCT02189863|2149700|FG001|First 2 Weeks|Motion Sickness|2
1085964|NCT02189941|2149722|FG000|Overall Study|Non-compliance|0
1085965|NCT02189941|2149723|FG001|Overall Study|Non-compliance|0
1085966|NCT02189941|2149724|FG002|Overall Study|Non-compliance|1
1085967|NCT02190279|2149753|FG000|Overall Study|Withdrawal consent|1
1085968|NCT02190279|2149754|FG001|Overall Study|Withdrawal consent|0
1085969|NCT02190279|2149755|FG002|Overall Study|Withdrawal consent|1
1085970|NCT02190279|2149753|FG000|Overall Study|Lost to Follow-up|2
1085971|NCT02190279|2149754|FG001|Overall Study|Lost to Follow-up|0
1085972|NCT02190279|2149755|FG002|Overall Study|Lost to Follow-up|0
1085973|NCT02190279|2149753|FG000|Overall Study|Refused further treatment|0
1085974|NCT02190279|2149754|FG001|Overall Study|Refused further treatment|0
1085975|NCT02190279|2149755|FG002|Overall Study|Refused further treatment|1
1085976|NCT02190279|2149753|FG000|Overall Study|Screening failure|0
1085977|NCT02190279|2149754|FG001|Overall Study|Screening failure|0
1085978|NCT02190279|2149755|FG002|Overall Study|Screening failure|1
1085979|NCT02190435|2149767|FG000|Overall Study|First 12 patients were lead-ins|12
1085980|NCT02190435|2149768|FG001|Overall Study|First 12 patients were lead-ins|0
1085981|NCT02190435|2149767|FG000|Overall Study|3 consented screen fails|3
1085982|NCT02190435|2149768|FG001|Overall Study|3 consented screen fails|0
1085983|NCT02190591|2149781|FG000|Overall Study|Withdrawal by Subject|1
1085984|NCT02190591|2149782|FG001|Overall Study|Withdrawal by Subject|8
1085985|NCT02190591|2149781|FG000|Overall Study|Protocol Violation|1
1085986|NCT02190591|2149782|FG001|Overall Study|Protocol Violation|0
1085987|NCT02190591|2149781|FG000|Overall Study|did not use peanut ball as instructed|0
1085988|NCT02190591|2149782|FG001|Overall Study|did not use peanut ball as instructed|2
1085989|NCT02190591|2149781|FG000|Overall Study|face presentation so she was ineligible|0
1085990|NCT02190591|2149782|FG001|Overall Study|face presentation so she was ineligible|1
1085991|NCT02190604|2149807|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085992|NCT02190604|2149808|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085993|NCT02190604|2149809|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085994|NCT02190604|2149810|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085995|NCT02190604|2149811|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085996|NCT02190604|2149812|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085997|NCT02190604|2149813|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085998|NCT02190604|2149814|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085999|NCT02190604|2149815|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1086000|NCT02190604|2149816|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1086001|NCT02190604|2149817|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1086002|NCT02190604|2149818|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1086003|NCT02190604|2149819|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1086004|NCT02190604|2149820|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1086005|NCT02190604|2149821|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
1086006|NCT02190604|2149822|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1086007|NCT02190604|2149823|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1086008|NCT02190604|2149824|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1086009|NCT02190604|2149825|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1086010|NCT02190604|2149807|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086011|NCT02190604|2149808|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086012|NCT02190604|2149809|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086013|NCT02190604|2149810|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086014|NCT02190604|2149811|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086015|NCT02190604|2149812|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086016|NCT02190604|2149813|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086017|NCT02190604|2149814|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086018|NCT02190604|2149815|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086019|NCT02190604|2149816|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086020|NCT02190604|2149817|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086021|NCT02190604|2149818|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086022|NCT02190604|2149819|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086023|NCT02190604|2149820|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
1086024|NCT02190604|2149821|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086025|NCT02190604|2149822|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086026|NCT02190604|2149823|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086027|NCT02190604|2149824|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086028|NCT02190604|2149825|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1086032|NCT02191046|2149928|FG000|Overall Study|low compliance|5
1086033|NCT02191046|2149929|FG001|Overall Study|low compliance|1
1086034|NCT02191137|2149935|FG000|Treatment|Death|4
1086035|NCT02191137|2149935|FG000|Treatment|Withdrawal by Subject|3
1086036|NCT02191137|2149935|FG000|Treatment|Adverse Event|2
1086037|NCT02191137|2149935|FG000|Treatment|Other|1
1086038|NCT02191137|2149935|FG000|Follow-up|Lost to Follow-up|2
1086039|NCT02191137|2149935|FG000|Follow-up|Ongoing/unknown|2
1086040|NCT02191137|2149935|FG000|Follow-up|Adverse Event|1
1086041|NCT02191267|2149942|FG000|Overall Study|Withdrawal by Subject|1
1086042|NCT02191267|2149943|FG001|Overall Study|Withdrawal by Subject|0
1086043|NCT02191267|2149944|FG002|Overall Study|Withdrawal by Subject|0
1086044|NCT02191397|2149954|FG000|Overall Study|Adverse Event|28
1086045|NCT02191397|2149955|FG001|Overall Study|Adverse Event|17
1086046|NCT02191397|2149954|FG000|Overall Study|Lack of Efficacy|10
1086047|NCT02191397|2149955|FG001|Overall Study|Lack of Efficacy|5
1086048|NCT02191397|2149954|FG000|Overall Study|Protocol Violation|0
1086049|NCT02191397|2149955|FG001|Overall Study|Protocol Violation|3
1086050|NCT02191397|2149954|FG000|Overall Study|Met protocol-defined stopping criteria|5
1086051|NCT02191397|2149955|FG001|Overall Study|Met protocol-defined stopping criteria|4
1086052|NCT02191397|2149954|FG000|Overall Study|Lost to Follow-up|10
1086053|NCT02191397|2149955|FG001|Overall Study|Lost to Follow-up|11
1086054|NCT02191397|2149954|FG000|Overall Study|Physician Decision|8
1086055|NCT02191397|2149955|FG001|Overall Study|Physician Decision|3
1086056|NCT02191397|2149954|FG000|Overall Study|Withdrawal by Subject|22
1086057|NCT02191397|2149955|FG001|Overall Study|Withdrawal by Subject|27
1086058|NCT02191579|2149963|FG000|Treatment 1|Multiple Reasons Specified|27
1086059|NCT02191579|2149964|FG001|Treatment 1|Multiple Reasons Specified|58
1086060|NCT02191579|2149963|FG000|Treatment 2|Multiple Reasons Specified|0
1086061|NCT02191579|2149964|FG001|Treatment 2|Multiple Reasons Specified|25
1086062|NCT02191605|2149975|FG000|Overall Study|Lost to Follow-up|9
1086063|NCT02191605|2149976|FG001|Overall Study|Lost to Follow-up|4
1086064|NCT02191605|2149977|FG002|Overall Study|Lost to Follow-up|7
1086065|NCT02191605|2149978|FG003|Overall Study|Lost to Follow-up|3
1086066|NCT02191605|2149979|FG004|Overall Study|Lost to Follow-up|4
1086067|NCT02191618|2149991|FG000|Overall Study|Withdrawal by Subject|3
1086068|NCT02191618|2149991|FG000|Overall Study|Missed Visit|4
1086069|NCT02192099|2150011|FG000|Overall Study|Adverse Event|1
1086070|NCT02192099|2150011|FG000|Overall Study|Lost to Follow-up|2
1086071|NCT02192099|2150011|FG000|Overall Study|Physician Decision|1
1086072|NCT02192099|2150011|FG000|Overall Study|Pregnancy|1
1086073|NCT02192099|2150011|FG000|Overall Study|Protocol Violation|8
1086074|NCT02192099|2150011|FG000|Overall Study|Study Terminated by Sponsor|32
1086075|NCT02192099|2150011|FG000|Overall Study|Withdrawal by Subject|11
1086076|NCT02192099|2150011|FG000|Overall Study|Miscellaneous Reasons|5
1086077|NCT02192164|2150015|FG000|Overall Study|Other|8
1086078|NCT02192164|2150015|FG000|Overall Study|Withdrawal by Subject|1
1086079|NCT02192164|2150015|FG000|Overall Study|Physician Decision|4
1086080|NCT02192164|2150015|FG000|Overall Study|Did not meet the exclusion criteria|1
1086081|NCT02192190|2150028|FG000|Overall Study|Adverse Event|1
1086082|NCT02192190|2150029|FG001|Overall Study|Adverse Event|1
1086083|NCT02192190|2150030|FG002|Overall Study|Adverse Event|0
1086084|NCT02192190|2150031|FG003|Overall Study|Adverse Event|0
1086085|NCT02192190|2150032|FG004|Overall Study|Adverse Event|0
1086086|NCT02192190|2150033|FG005|Overall Study|Adverse Event|0
1086087|NCT02192190|2150028|FG000|Overall Study|Lost to Follow-up|3
1086088|NCT02192190|2150029|FG001|Overall Study|Lost to Follow-up|3
1086089|NCT02192190|2150030|FG002|Overall Study|Lost to Follow-up|2
1086090|NCT02192190|2150031|FG003|Overall Study|Lost to Follow-up|1
1086091|NCT02192190|2150032|FG004|Overall Study|Lost to Follow-up|4
1086092|NCT02192190|2150033|FG005|Overall Study|Lost to Follow-up|3
1086093|NCT02192190|2150028|FG000|Overall Study|Physician Decision|2
1086094|NCT02192190|2150029|FG001|Overall Study|Physician Decision|0
1086095|NCT02192190|2150030|FG002|Overall Study|Physician Decision|0
1086096|NCT02192190|2150031|FG003|Overall Study|Physician Decision|0
1086097|NCT02192190|2150032|FG004|Overall Study|Physician Decision|0
1086098|NCT02192190|2150033|FG005|Overall Study|Physician Decision|0
1086099|NCT02192190|2150028|FG000|Overall Study|Terminated by Sponsor|43
1086100|NCT02192190|2150029|FG001|Overall Study|Terminated by Sponsor|23
1086101|NCT02192190|2150030|FG002|Overall Study|Terminated by Sponsor|20
1086102|NCT02192190|2150031|FG003|Overall Study|Terminated by Sponsor|23
1086103|NCT02192190|2150032|FG004|Overall Study|Terminated by Sponsor|21
1086104|NCT02192190|2150033|FG005|Overall Study|Terminated by Sponsor|23
1086105|NCT02192190|2150028|FG000|Overall Study|Withdrawal by Subject|4
1086106|NCT02192190|2150029|FG001|Overall Study|Withdrawal by Subject|1
1086107|NCT02192190|2150030|FG002|Overall Study|Withdrawal by Subject|2
1086108|NCT02192190|2150031|FG003|Overall Study|Withdrawal by Subject|1
1086109|NCT02192190|2150032|FG004|Overall Study|Withdrawal by Subject|5
1086110|NCT02192190|2150033|FG005|Overall Study|Withdrawal by Subject|3
1086111|NCT02192190|2150028|FG000|Overall Study|Could not Keep Visit Schedule|1
1086112|NCT02192190|2150029|FG001|Overall Study|Could not Keep Visit Schedule|0
1086113|NCT02192190|2150030|FG002|Overall Study|Could not Keep Visit Schedule|0
1086114|NCT02192190|2150031|FG003|Overall Study|Could not Keep Visit Schedule|0
1086115|NCT02192190|2150032|FG004|Overall Study|Could not Keep Visit Schedule|0
1086116|NCT02192190|2150033|FG005|Overall Study|Could not Keep Visit Schedule|0
1086117|NCT02192190|2150028|FG000|Overall Study|Positive Drug Screen|0
1086118|NCT02192190|2150029|FG001|Overall Study|Positive Drug Screen|0
1086119|NCT02192190|2150030|FG002|Overall Study|Positive Drug Screen|0
1086120|NCT02192190|2150031|FG003|Overall Study|Positive Drug Screen|1
1086121|NCT02192190|2150032|FG004|Overall Study|Positive Drug Screen|0
1086122|NCT02192190|2150033|FG005|Overall Study|Positive Drug Screen|0
1086123|NCT02192190|2150028|FG000|Overall Study|Inadequate Pain Relief|0
1086124|NCT02192190|2150029|FG001|Overall Study|Inadequate Pain Relief|1
1086125|NCT02192190|2150030|FG002|Overall Study|Inadequate Pain Relief|1
1086126|NCT02192190|2150031|FG003|Overall Study|Inadequate Pain Relief|0
1086127|NCT02192190|2150032|FG004|Overall Study|Inadequate Pain Relief|0
1086128|NCT02192190|2150033|FG005|Overall Study|Inadequate Pain Relief|0
1086129|NCT02192606|2150069|FG000|Overall Study|surgery type was changed|1
1086130|NCT02192606|2150070|FG001|Overall Study|surgery type was changed|1
1086131|NCT02192606|2150069|FG000|Overall Study|Physician Decision|1
1086132|NCT02192606|2150070|FG001|Overall Study|Physician Decision|2
1086133|NCT02192606|2150069|FG000|Overall Study|3D equipment rep unable to join|0
1086134|NCT02192606|2150070|FG001|Overall Study|3D equipment rep unable to join|1
1086135|NCT02192905|2150102|FG000|Overall Study|Lost to Follow-up|1
1086136|NCT02192970|2150109|FG000|Overall Study|Lost to Follow-up|6
1086137|NCT02192970|2150110|FG001|Overall Study|Lost to Follow-up|0
1086138|NCT02193074|2150118|FG000|Overall Study|Withdrawal by Subject|1
1086139|NCT02193074|2150119|FG001|Overall Study|Withdrawal by Subject|2
1086140|NCT02193074|2150118|FG000|Overall Study|Adverse Event|16
1086141|NCT02193074|2150119|FG001|Overall Study|Adverse Event|13
1086142|NCT02193087|2150129|FG000|Overall Study|Adverse Event|2
1086143|NCT02193087|2150130|FG001|Overall Study|Adverse Event|0
1086144|NCT02193087|2150131|FG002|Overall Study|Adverse Event|0
1086145|NCT02193087|2150132|FG003|Overall Study|Adverse Event|11
1086146|NCT02193087|2150129|FG000|Overall Study|Lost to Follow-up|14
1086147|NCT02193087|2150130|FG001|Overall Study|Lost to Follow-up|6
1086148|NCT02193087|2150131|FG002|Overall Study|Lost to Follow-up|4
1086149|NCT02193087|2150132|FG003|Overall Study|Lost to Follow-up|37
1086150|NCT02193087|2150129|FG000|Overall Study|Protocol Violation|2
1086151|NCT02193087|2150130|FG001|Overall Study|Protocol Violation|0
1086152|NCT02193087|2150131|FG002|Overall Study|Protocol Violation|1
1086153|NCT02193087|2150132|FG003|Overall Study|Protocol Violation|2
1086154|NCT02193087|2150129|FG000|Overall Study|Withdrawal by Subject|10
1086155|NCT02193087|2150130|FG001|Overall Study|Withdrawal by Subject|3
1086156|NCT02193087|2150131|FG002|Overall Study|Withdrawal by Subject|1
1086157|NCT02193087|2150132|FG003|Overall Study|Withdrawal by Subject|19
1086158|NCT02193087|2150129|FG000|Overall Study|Other Reason Not Specified|7
1086159|NCT02193087|2150130|FG001|Overall Study|Other Reason Not Specified|2
1086160|NCT02193087|2150131|FG002|Overall Study|Other Reason Not Specified|1
1086161|NCT02193087|2150132|FG003|Overall Study|Other Reason Not Specified|9
1086162|NCT02193087|2150129|FG000|Overall Study|Did Not Receive Any Vaccination|2
1086163|NCT02193087|2150130|FG001|Overall Study|Did Not Receive Any Vaccination|3
1086164|NCT02193087|2150131|FG002|Overall Study|Did Not Receive Any Vaccination|0
1086165|NCT02193087|2150132|FG003|Overall Study|Did Not Receive Any Vaccination|1
1086166|NCT02193165|2150156|FG000|4 Week Product Use|Lost to Follow-up|1
1086167|NCT02193165|2150157|FG001|4 Week Product Use|Lost to Follow-up|1
1086168|NCT02193165|2150158|FG002|4 Week Product Use|Lost to Follow-up|1
1086169|NCT02193165|2150156|FG000|6 Week Product Use|Lost to Follow-up|0
1086170|NCT02193165|2150157|FG001|6 Week Product Use|Lost to Follow-up|1
1086171|NCT02193165|2150158|FG002|6 Week Product Use|Lost to Follow-up|0
1086172|NCT02193178|2150166|FG000|Overall Study|Lost to Follow-up|1
1086173|NCT02193178|2150166|FG000|Overall Study|Dry eyes|1
1086174|NCT02193776|2150201|FG000|Overall Study|Consent withdrawn|1
1086175|NCT02193776|2150202|FG001|Overall Study|Consent withdrawn|0
1086176|NCT02193776|2150203|FG002|Overall Study|Consent withdrawn|0
1086177|NCT02193776|2150204|FG003|Overall Study|Consent withdrawn|0
1086178|NCT02193776|2150201|FG000|Overall Study|Failure to comply with protocol|0
1086179|NCT02193776|2150202|FG001|Overall Study|Failure to comply with protocol|1
1086180|NCT02193776|2150203|FG002|Overall Study|Failure to comply with protocol|0
1086181|NCT02193776|2150204|FG003|Overall Study|Failure to comply with protocol|0
1086182|NCT02193776|2150201|FG000|Overall Study|Investigator/Sponsor decision|1
1086183|NCT02193776|2150202|FG001|Overall Study|Investigator/Sponsor decision|1
1086184|NCT02193776|2150203|FG002|Overall Study|Investigator/Sponsor decision|0
1086185|NCT02193776|2150204|FG003|Overall Study|Investigator/Sponsor decision|0
1086186|NCT02193776|2150201|FG000|Overall Study|Death|1
1086187|NCT02193776|2150202|FG001|Overall Study|Death|0
1086188|NCT02193776|2150203|FG002|Overall Study|Death|0
1086189|NCT02193776|2150204|FG003|Overall Study|Death|0
1086190|NCT02193776|2150201|FG000|Overall Study|Adverse event/Specific toxicity|5
1086191|NCT02193776|2150202|FG001|Overall Study|Adverse event/Specific toxicity|5
1086192|NCT02193776|2150203|FG002|Overall Study|Adverse event/Specific toxicity|2
1086193|NCT02193776|2150204|FG003|Overall Study|Adverse event/Specific toxicity|2
1086194|NCT02193828|2150232|FG000|Overall Study|Withdrawal by Subject|0
1086195|NCT02193828|2150233|FG001|Overall Study|Withdrawal by Subject|0
1086196|NCT02193828|2150234|FG002|Overall Study|Withdrawal by Subject|1
1086197|NCT02193828|2150235|FG003|Overall Study|Withdrawal by Subject|1
1086198|NCT02193880|2150252|FG000|Overall Study|patients did not collect enough HPC|3
1086199|NCT02194062|2150259|FG000|Overall Study|Lost to Follow-up|2
1086200|NCT02194062|2150260|FG001|Overall Study|Lost to Follow-up|2
1086201|NCT02194062|2150261|FG002|Overall Study|Lost to Follow-up|5
1086202|NCT02194465|2150291|FG000|Overall Study|Adverse Event|6
1086203|NCT02194465|2150292|FG001|Overall Study|Adverse Event|1
1086204|NCT02194465|2150293|FG002|Overall Study|Adverse Event|4
1086205|NCT02194465|2150294|FG003|Overall Study|Adverse Event|4
1086206|NCT02194465|2150295|FG004|Overall Study|Adverse Event|4
1086207|NCT02194465|2150296|FG005|Overall Study|Adverse Event|2
1086208|NCT02194465|2150297|FG006|Overall Study|Adverse Event|0
1086209|NCT02194465|2150291|FG000|Overall Study|Lost to Follow-up|0
1086210|NCT02194465|2150292|FG001|Overall Study|Lost to Follow-up|0
1086211|NCT02194465|2150293|FG002|Overall Study|Lost to Follow-up|0
1086212|NCT02194465|2150294|FG003|Overall Study|Lost to Follow-up|1
1086213|NCT02194465|2150295|FG004|Overall Study|Lost to Follow-up|0
1086214|NCT02194465|2150296|FG005|Overall Study|Lost to Follow-up|1
1086215|NCT02194465|2150297|FG006|Overall Study|Lost to Follow-up|0
1086216|NCT02194465|2150291|FG000|Overall Study|Physician Decision|1
1086217|NCT02194465|2150292|FG001|Overall Study|Physician Decision|0
1086218|NCT02194465|2150293|FG002|Overall Study|Physician Decision|0
1086219|NCT02194465|2150294|FG003|Overall Study|Physician Decision|0
1086220|NCT02194465|2150295|FG004|Overall Study|Physician Decision|0
1086221|NCT02194465|2150296|FG005|Overall Study|Physician Decision|0
1086222|NCT02194465|2150297|FG006|Overall Study|Physician Decision|0
1086223|NCT02194465|2150291|FG000|Overall Study|Protocol Violation|1
1086224|NCT02194465|2150292|FG001|Overall Study|Protocol Violation|1
1086225|NCT02194465|2150293|FG002|Overall Study|Protocol Violation|2
1086226|NCT02194465|2150294|FG003|Overall Study|Protocol Violation|1
1086227|NCT02194465|2150295|FG004|Overall Study|Protocol Violation|1
1086228|NCT02194465|2150296|FG005|Overall Study|Protocol Violation|0
1086229|NCT02194465|2150297|FG006|Overall Study|Protocol Violation|0
1086230|NCT02194465|2150291|FG000|Overall Study|Withdrawal by Subject|1
1086231|NCT02194465|2150292|FG001|Overall Study|Withdrawal by Subject|3
1086232|NCT02194465|2150293|FG002|Overall Study|Withdrawal by Subject|1
1086233|NCT02194465|2150294|FG003|Overall Study|Withdrawal by Subject|2
1086234|NCT02194465|2150295|FG004|Overall Study|Withdrawal by Subject|2
1086235|NCT02194465|2150296|FG005|Overall Study|Withdrawal by Subject|1
1086236|NCT02194465|2150297|FG006|Overall Study|Withdrawal by Subject|2
1086237|NCT02194465|2150291|FG000|Overall Study|Discontinued follow-up period|0
1086238|NCT02194465|2150292|FG001|Overall Study|Discontinued follow-up period|2
1086239|NCT02194465|2150293|FG002|Overall Study|Discontinued follow-up period|1
1086240|NCT02194465|2150294|FG003|Overall Study|Discontinued follow-up period|0
1086241|NCT02194465|2150295|FG004|Overall Study|Discontinued follow-up period|2
1086242|NCT02194465|2150296|FG005|Overall Study|Discontinued follow-up period|0
1086243|NCT02194465|2150297|FG006|Overall Study|Discontinued follow-up period|0
1086244|NCT02194621|2150320|FG000|Overall Study|6 withdrew prior to randomization|2
1086245|NCT02194621|2150321|FG001|Overall Study|6 withdrew prior to randomization|2
1086246|NCT02194621|2150322|FG002|Overall Study|6 withdrew prior to randomization|2
1086247|NCT02194621|2150320|FG000|Overall Study|Withdrawal by Subject|4
1086248|NCT02194621|2150321|FG001|Overall Study|Withdrawal by Subject|4
1086249|NCT02194621|2150322|FG002|Overall Study|Withdrawal by Subject|7
1086250|NCT02194699|2150332|FG000|Randomised|Did not receive treatment|1
1086251|NCT02194699|2150333|FG001|Randomised|Did not receive treatment|5
1086252|NCT02194699|2150332|FG000|Randomised|Without potential for 52 weeks of IP|5
1086253|NCT02194699|2150333|FG001|Randomised|Without potential for 52 weeks of IP|5
1086254|NCT02194699|2150332|FG000|Randomised|Duplicate patient|2
1086255|NCT02194699|2150333|FG001|Randomised|Duplicate patient|1
1086256|NCT02194699|2150332|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4
1086257|NCT02194699|2150333|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3
1086258|NCT02194699|2150332|FG000|With Potential to Receive 52 Weeks of IP|Death|1
1086259|NCT02194699|2150333|FG001|With Potential to Receive 52 Weeks of IP|Death|3
1086260|NCT02194699|2150332|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
1086261|NCT02194699|2150333|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
1086262|NCT02194699|2150332|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
1086263|NCT02194699|2150333|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
1086264|NCT02194699|2150332|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
1086265|NCT02194699|2150333|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
1086266|NCT02194699|2150332|FG000|With Potential to Receive 52 Weeks of IP|Other|24
1086267|NCT02194699|2150333|FG001|With Potential to Receive 52 Weeks of IP|Other|16
1086268|NCT02194933|2150349|FG000|Overall Study|Lost to Follow-up|1
1086269|NCT02194933|2150350|FG001|Overall Study|Lost to Follow-up|2
1086270|NCT02194933|2150349|FG000|Overall Study|Participant met withdrawal criteria|1
1086271|NCT02194933|2150350|FG001|Overall Study|Participant met withdrawal criteria|3
1086272|NCT02194933|2150349|FG000|Overall Study|Withdrawal by Subject|0
1086273|NCT02194933|2150350|FG001|Overall Study|Withdrawal by Subject|2
1086274|NCT02194933|2150349|FG000|Overall Study|Lack of Efficacy|1
1086275|NCT02194933|2150350|FG001|Overall Study|Lack of Efficacy|2
1086276|NCT02194985|2150358|FG000|Overall Study|Adverse Event|1
1086277|NCT02194985|2150358|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3
1086278|NCT02194985|2150358|FG000|Overall Study|Physician Decision|4
1086279|NCT02194985|2150358|FG000|Overall Study|Lost to Follow-up|1
1086280|NCT02194985|2150358|FG000|Overall Study|Withdrawal by Subject|2
1086281|NCT02194998|2150366|FG000|On-HCV Treatment|Did not pick up study medication|0
1086282|NCT02194998|2150367|FG001|On-HCV Treatment|Did not pick up study medication|1
1086283|NCT02194998|2150368|FG002|On-HCV Treatment|Did not pick up study medication|0
1086284|NCT02194998|2150369|FG003|On-HCV Treatment|Did not pick up study medication|0
1086285|NCT02194998|2150366|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
1086286|NCT02194998|2150367|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
1086287|NCT02194998|2150368|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
1086288|NCT02194998|2150369|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
1086289|NCT02195011|2150381|FG000|Overall Study|Adverse Event|4
1086290|NCT02195011|2150382|FG001|Overall Study|Adverse Event|0
1086291|NCT02195011|2150381|FG000|Overall Study|Progressive Disease|18
1086292|NCT02195011|2150382|FG001|Overall Study|Progressive Disease|1
1086293|NCT02195011|2150381|FG000|Overall Study|Withdrawal by Subject|3
1086294|NCT02195011|2150382|FG001|Overall Study|Withdrawal by Subject|0
1086295|NCT02195427|2150477|FG000|Overall Study|Did not consent to study extension|13
1086296|NCT02195427|2150478|FG001|Overall Study|Did not consent to study extension|9
1086297|NCT02195427|2150477|FG000|Overall Study|Withdrawal by Subject|4
1086298|NCT02195427|2150478|FG001|Overall Study|Withdrawal by Subject|2
1086299|NCT02195427|2150477|FG000|Overall Study|Lost to Follow-up|0
1086300|NCT02195427|2150478|FG001|Overall Study|Lost to Follow-up|1
1086301|NCT02195427|2150477|FG000|Overall Study|Protocol Violation|7
1086302|NCT02195427|2150478|FG001|Overall Study|Protocol Violation|14
1086303|NCT02195427|2150477|FG000|Overall Study|Conditional re-treatment at W52|2
1086304|NCT02195427|2150478|FG001|Overall Study|Conditional re-treatment at W52|1
1086317|NCT02195518|2150497|FG000|Overall Study|Adverse Event|1
1086318|NCT02195518|2150497|FG000|Overall Study|Protocol Violation|4
1086319|NCT02195518|2150497|FG000|Overall Study|Pregnancy|2
1086320|NCT02195518|2150497|FG000|Overall Study|Withdrawal by Subject|1
1086321|NCT02195518|2150497|FG000|Overall Study|Lost to Follow-up|1
1086322|NCT02195531|2150504|FG000|Overall Study|Withdrawal by Subject|1
1086323|NCT02195531|2150505|FG001|Overall Study|Withdrawal by Subject|1
1086324|NCT02195531|2150506|FG002|Overall Study|Withdrawal by Subject|1
1086325|NCT02195583|2150514|FG000|Overall Study|Lost to Follow-up|1
1086326|NCT02195583|2150514|FG000|Overall Study|Withdrawal by Subject|4
1086327|NCT02195583|2150514|FG000|Overall Study|Adverse Event|2
1086328|NCT02195583|2150514|FG000|Overall Study|Other Reason|2
1086329|NCT02195687|2150540|FG000|Overall Study|Personal Reasons|1
1086330|NCT02195687|2150541|FG001|Overall Study|Personal Reasons|1
1086331|NCT02195687|2150540|FG000|Overall Study|Lost to Follow-up|4
1086332|NCT02195687|2150541|FG001|Overall Study|Lost to Follow-up|1
1086333|NCT02195700|2150549|FG000|Overall Study|Protocol Violation|0
1086334|NCT02195700|2150550|FG001|Overall Study|Protocol Violation|2
1086335|NCT02195700|2150549|FG000|Overall Study|Noncompliance|1
1086336|NCT02195700|2150550|FG001|Overall Study|Noncompliance|0
1086337|NCT02195700|2150549|FG000|Overall Study|Adverse Event|1
1086338|NCT02195700|2150550|FG001|Overall Study|Adverse Event|2
1086339|NCT02195700|2150549|FG000|Overall Study|Withdrawal by Subject|3
1086340|NCT02195700|2150550|FG001|Overall Study|Withdrawal by Subject|2
1086341|NCT02195700|2150549|FG000|Overall Study|Lost to Follow-up|1
1086342|NCT02195700|2150550|FG001|Overall Study|Lost to Follow-up|1
1086343|NCT02195869|2150565|FG000|Overall Study|cGVHD Progression|5
1086344|NCT02195869|2150565|FG000|Overall Study|Malignancy Progression/relapse|2
1086345|NCT02195869|2150565|FG000|Overall Study|Adverse Event|15
1086346|NCT02195869|2150565|FG000|Overall Study|Withdrawal by Subject|7
1086347|NCT02195869|2150565|FG000|Overall Study|Physician Decision|4
1086348|NCT02195869|2150565|FG000|Overall Study|Study Terminated by Sponsor|7
1086349|NCT02195869|2150565|FG000|Overall Study|Noncompliance with study drug|2
1086350|NCT02195986|2150601|FG000|Overall Study|Adverse Event|3
1086351|NCT02195986|2150602|FG001|Overall Study|Adverse Event|0
1086352|NCT02195986|2150603|FG002|Overall Study|Adverse Event|0
1086353|NCT02195986|2150601|FG000|Overall Study|Withdrawal by Subject|0
1086354|NCT02195986|2150602|FG001|Overall Study|Withdrawal by Subject|3
1086355|NCT02195986|2150603|FG002|Overall Study|Withdrawal by Subject|0
1086356|NCT02195986|2150601|FG000|Overall Study|Family Emergency|0
1086357|NCT02195986|2150602|FG001|Overall Study|Family Emergency|0
1086358|NCT02195986|2150603|FG002|Overall Study|Family Emergency|1
1086359|NCT02195986|2150601|FG000|Overall Study|Protocol Violation|0
1086360|NCT02195986|2150602|FG001|Overall Study|Protocol Violation|1
1086361|NCT02195986|2150603|FG002|Overall Study|Protocol Violation|1
1086362|NCT02195986|2150601|FG000|Overall Study|Non-compliance|0
1086363|NCT02195986|2150602|FG001|Overall Study|Non-compliance|1
1086364|NCT02195986|2150603|FG002|Overall Study|Non-compliance|0
1086365|NCT02196038|2150613|FG000|Overall Study|Death|16
1086366|NCT02196038|2150614|FG001|Overall Study|Death|21
1086367|NCT02196038|2150613|FG000|Overall Study|Withdrawal by Subject|0
1086368|NCT02196038|2150614|FG001|Overall Study|Withdrawal by Subject|1
1086369|NCT02196038|2150613|FG000|Overall Study|Lost to Follow-up|1
1086370|NCT02196038|2150614|FG001|Overall Study|Lost to Follow-up|0
1086371|NCT02196077|2150620|FG000|Overall Study|Adverse Event|4
1086372|NCT02196077|2150620|FG000|Overall Study|Lack of Efficacy|1
1086373|NCT02196077|2150620|FG000|Overall Study|Withdrawal by Subject|14
1086374|NCT02196077|2150620|FG000|Overall Study|Physician Decision|1
1086375|NCT02196077|2150620|FG000|Overall Study|Lost to Follow-up|3
1086376|NCT02196077|2150620|FG000|Overall Study|Protocol Violation|24
1086377|NCT02196259|2150644|FG000|Overall Study|Researcher choice|0
1086378|NCT02196259|2150645|FG001|Overall Study|Researcher choice|0
1086379|NCT02196259|2150646|FG002|Overall Study|Researcher choice|1
1086380|NCT02196259|2150644|FG000|Overall Study|Partial data analysis|0
1086381|NCT02196259|2150645|FG001|Overall Study|Partial data analysis|3
1086382|NCT02196259|2150646|FG002|Overall Study|Partial data analysis|0
1086383|NCT02196324|2150655|FG000|Overall Study|Withdrawal by Subject|8
1086384|NCT02196324|2150656|FG001|Overall Study|Withdrawal by Subject|4
1086385|NCT02196324|2150655|FG000|Overall Study|Adverse Event or Serious Adverse Event|6
1086386|NCT02196324|2150656|FG001|Overall Study|Adverse Event or Serious Adverse Event|3
1086387|NCT02196324|2150655|FG000|Overall Study|Occurrence of an Exclusion Criterion|0
1086388|NCT02196324|2150656|FG001|Overall Study|Occurrence of an Exclusion Criterion|1
1086389|NCT02196324|2150655|FG000|Overall Study|Other|1
1086390|NCT02196324|2150656|FG001|Overall Study|Other|0
1086391|NCT02196506|2150664|FG000|Phase A|Participant Met Withdrawal Criteria|34
1086392|NCT02196506|2150665|FG001|Phase A|Participant Met Withdrawal Criteria|0
1086393|NCT02196506|2150666|FG002|Phase A|Participant Met Withdrawal Criteria|0
1086394|NCT02196506|2150667|FG003|Phase A|Participant Met Withdrawal Criteria|0
1086395|NCT02196506|2150664|FG000|Phase A|Withdrawal by Subject|34
1086396|NCT02196506|2150665|FG001|Phase A|Withdrawal by Subject|0
1086397|NCT02196506|2150666|FG002|Phase A|Withdrawal by Subject|0
1086398|NCT02196506|2150667|FG003|Phase A|Withdrawal by Subject|0
1086399|NCT02196506|2150664|FG000|Phase A|Adverse Event|22
1086400|NCT02196506|2150665|FG001|Phase A|Adverse Event|0
1086401|NCT02196506|2150666|FG002|Phase A|Adverse Event|0
1086402|NCT02196506|2150667|FG003|Phase A|Adverse Event|0
1086403|NCT02196506|2150664|FG000|Phase A|Lost to Follow-up|9
1086404|NCT02196506|2150665|FG001|Phase A|Lost to Follow-up|0
1086405|NCT02196506|2150666|FG002|Phase A|Lost to Follow-up|0
1086406|NCT02196506|2150667|FG003|Phase A|Lost to Follow-up|0
1086407|NCT02196506|2150664|FG000|Phase A|Protocol deviation|12
1086408|NCT02196506|2150665|FG001|Phase A|Protocol deviation|0
1086409|NCT02196506|2150666|FG002|Phase A|Protocol deviation|0
1086410|NCT02196506|2150667|FG003|Phase A|Protocol deviation|0
1086411|NCT02196506|2150664|FG000|Phase A|Participant withdrawn by investigator|10
1086412|NCT02196506|2150665|FG001|Phase A|Participant withdrawn by investigator|0
1086413|NCT02196506|2150666|FG002|Phase A|Participant withdrawn by investigator|0
1086414|NCT02196506|2150667|FG003|Phase A|Participant withdrawn by investigator|0
1086415|NCT02196506|2150664|FG000|Phase B|Participant Met Withdrawal Criteria|0
1086416|NCT02196506|2150665|FG001|Phase B|Participant Met Withdrawal Criteria|0
1086417|NCT02196506|2150666|FG002|Phase B|Participant Met Withdrawal Criteria|1
1086418|NCT02196506|2150667|FG003|Phase B|Participant Met Withdrawal Criteria|0
1086419|NCT02196506|2150664|FG000|Phase B|Lack of Efficacy|0
1086420|NCT02196506|2150665|FG001|Phase B|Lack of Efficacy|1
1086421|NCT02196506|2150666|FG002|Phase B|Lack of Efficacy|2
1086422|NCT02196506|2150667|FG003|Phase B|Lack of Efficacy|0
1086423|NCT02196506|2150664|FG000|Phase B|Withdrawal by Participant|0
1086424|NCT02196506|2150665|FG001|Phase B|Withdrawal by Participant|8
1086425|NCT02196506|2150666|FG002|Phase B|Withdrawal by Participant|1
1086426|NCT02196506|2150667|FG003|Phase B|Withdrawal by Participant|0
1086427|NCT02196506|2150664|FG000|Phase B|Adverse Event|0
1086428|NCT02196506|2150665|FG001|Phase B|Adverse Event|4
1086429|NCT02196506|2150666|FG002|Phase B|Adverse Event|1
1086430|NCT02196506|2150667|FG003|Phase B|Adverse Event|0
1086431|NCT02196506|2150664|FG000|Phase B|Lost to Follow-up|0
1086432|NCT02196506|2150665|FG001|Phase B|Lost to Follow-up|2
1086433|NCT02196506|2150666|FG002|Phase B|Lost to Follow-up|1
1086434|NCT02196506|2150667|FG003|Phase B|Lost to Follow-up|0
1086435|NCT02196506|2150664|FG000|Phase A+|Participant Met Withdrawal Criteria|0
1086436|NCT02196506|2150665|FG001|Phase A+|Participant Met Withdrawal Criteria|0
1086437|NCT02196506|2150666|FG002|Phase A+|Participant Met Withdrawal Criteria|0
1086438|NCT02196506|2150667|FG003|Phase A+|Participant Met Withdrawal Criteria|1
1086439|NCT02196506|2150664|FG000|Phase A+|Withdrawal by Participant|0
1086440|NCT02196506|2150665|FG001|Phase A+|Withdrawal by Participant|0
1086441|NCT02196506|2150666|FG002|Phase A+|Withdrawal by Participant|0
1086442|NCT02196506|2150667|FG003|Phase A+|Withdrawal by Participant|5
1086443|NCT02196506|2150664|FG000|Phase A+|Adverse Event|0
1086444|NCT02196506|2150665|FG001|Phase A+|Adverse Event|0
1086445|NCT02196506|2150666|FG002|Phase A+|Adverse Event|0
1086446|NCT02196506|2150667|FG003|Phase A+|Adverse Event|1
1086447|NCT02196506|2150664|FG000|Phase A+|Lost to Follow-up|0
1086448|NCT02196506|2150665|FG001|Phase A+|Lost to Follow-up|0
1086449|NCT02196506|2150666|FG002|Phase A+|Lost to Follow-up|0
1086450|NCT02196506|2150667|FG003|Phase A+|Lost to Follow-up|6
1086451|NCT02196506|2150664|FG000|Phase A+|Participant withdrawn by investigator|0
1086452|NCT02196506|2150665|FG001|Phase A+|Participant withdrawn by investigator|0
1086453|NCT02196506|2150666|FG002|Phase A+|Participant withdrawn by investigator|0
1086454|NCT02196506|2150667|FG003|Phase A+|Participant withdrawn by investigator|1
1086455|NCT02196558|2150676|FG000|Treatment Phase (12 Weeks)|Adverse Event|0
1086456|NCT02196558|2150677|FG001|Treatment Phase (12 Weeks)|Adverse Event|2
1086457|NCT02196558|2150678|FG002|Treatment Phase (12 Weeks)|Adverse Event|0
1086458|NCT02196558|2150676|FG000|Treatment Phase (12 Weeks)|Participant Choice|0
1086459|NCT02196558|2150677|FG001|Treatment Phase (12 Weeks)|Participant Choice|1
1086460|NCT02196558|2150678|FG002|Treatment Phase (12 Weeks)|Participant Choice|1
1086461|NCT02196558|2150676|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0
1086462|NCT02196558|2150677|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0
1086463|NCT02196558|2150678|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1
1086464|NCT02196558|2150676|FG000|Extension Phase (40 Weeks)|Adverse Event|1
1086465|NCT02196558|2150677|FG001|Extension Phase (40 Weeks)|Adverse Event|2
1086466|NCT02196558|2150678|FG002|Extension Phase (40 Weeks)|Adverse Event|0
1086467|NCT02196558|2150676|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
1086468|NCT02196558|2150677|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
1086469|NCT02196558|2150678|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
1086470|NCT02196675|2150689|FG000|Overall Study|Withdrawal by Subject|1
1086471|NCT02196675|2150690|FG001|Overall Study|Withdrawal by Subject|0
1086472|NCT02196675|2150691|FG002|Overall Study|Withdrawal by Subject|0
1086473|NCT02196675|2150689|FG000|Overall Study|Intra-operative surgical exclusion|1
1086474|NCT02196675|2150690|FG001|Overall Study|Intra-operative surgical exclusion|1
1086475|NCT02196675|2150691|FG002|Overall Study|Intra-operative surgical exclusion|0
1086476|NCT02196675|2150689|FG000|Overall Study|Protocol Violation|0
1086477|NCT02196675|2150690|FG001|Overall Study|Protocol Violation|1
1086478|NCT02196675|2150691|FG002|Overall Study|Protocol Violation|0
1086479|NCT02196675|2150689|FG000|Overall Study|Death|0
1086480|NCT02196675|2150690|FG001|Overall Study|Death|0
1086481|NCT02196675|2150691|FG002|Overall Study|Death|1
1086482|NCT02196701|2150710|FG000|Overall Study|Adverse Event|1
1086483|NCT02196701|2150710|FG000|Overall Study|Lost to Follow-up|1
1086484|NCT02196701|2150710|FG000|Overall Study|Non-adherence to Protocol|1
1086485|NCT02196714|2150717|FG000|Overall Study|Protocol Violation|0
1086486|NCT02196714|2150718|FG001|Overall Study|Protocol Violation|0
1086487|NCT02196714|2150719|FG002|Overall Study|Protocol Violation|1
1086488|NCT02196714|2150720|FG003|Overall Study|Protocol Violation|0
1086489|NCT02197130|2150828|FG000|Overall Study|Adverse Event|13
1086490|NCT02197130|2150829|FG001|Overall Study|Adverse Event|4
1086491|NCT02197130|2150830|FG002|Overall Study|Adverse Event|23
1086492|NCT02197130|2150828|FG000|Overall Study|Death|0
1086493|NCT02197130|2150829|FG001|Overall Study|Death|1
1086494|NCT02197130|2150830|FG002|Overall Study|Death|0
1086495|NCT02197130|2150828|FG000|Overall Study|Lost to Follow-up|2
1086496|NCT02197130|2150829|FG001|Overall Study|Lost to Follow-up|0
1086497|NCT02197130|2150830|FG002|Overall Study|Lost to Follow-up|1
1086498|NCT02197130|2150828|FG000|Overall Study|Does not meet entrance criteria|0
1086499|NCT02197130|2150829|FG001|Overall Study|Does not meet entrance criteria|0
1086500|NCT02197130|2150830|FG002|Overall Study|Does not meet entrance criteria|1
1086501|NCT02197130|2150828|FG000|Overall Study|Withdrawal by Subject|0
1086502|NCT02197130|2150829|FG001|Overall Study|Withdrawal by Subject|3
1086503|NCT02197130|2150830|FG002|Overall Study|Withdrawal by Subject|4
1086504|NCT02197130|2150828|FG000|Overall Study|Other|1
1086505|NCT02197130|2150829|FG001|Overall Study|Other|0
1086506|NCT02197130|2150830|FG002|Overall Study|Other|3
1086507|NCT02197234|2150838|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
1086508|NCT02197234|2150838|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
1086509|NCT02197234|2150838|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
1086510|NCT02197234|2150838|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
1086511|NCT02197234|2150838|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
1086512|NCT02197234|2150838|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6
1086513|NCT02197234|2150838|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
1086514|NCT02197247|2150845|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
1086515|NCT02197247|2150845|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
1086516|NCT02197247|2150845|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
1086517|NCT02197247|2150845|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
1086518|NCT02197247|2150845|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
1086519|NCT02197247|2150845|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
1086520|NCT02197247|2150845|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1
1086521|NCT02197247|2150845|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
1086522|NCT02197377|2150866|FG000|Overall Study|Insertion Failure|0
1086523|NCT02197377|2150867|FG001|Overall Study|Insertion Failure|3
1086524|NCT02197416|2150876|FG000|Overall Study|Other reasons|0
1086525|NCT02197416|2150877|FG001|Overall Study|Other reasons|2
1086526|NCT02197416|2150878|FG002|Overall Study|Other reasons|5
1086527|NCT02197416|2150876|FG000|Overall Study|Withdrawal by Subject|0
1086528|NCT02197416|2150877|FG001|Overall Study|Withdrawal by Subject|2
1086529|NCT02197416|2150878|FG002|Overall Study|Withdrawal by Subject|1
1086530|NCT02197416|2150876|FG000|Overall Study|Protocol Violation|1
1086531|NCT02197416|2150877|FG001|Overall Study|Protocol Violation|0
1086532|NCT02197416|2150878|FG002|Overall Study|Protocol Violation|1
1086533|NCT02197416|2150876|FG000|Overall Study|Adverse Event|0
1086534|NCT02197416|2150877|FG001|Overall Study|Adverse Event|0
1086535|NCT02197416|2150878|FG002|Overall Study|Adverse Event|1
1086536|NCT02197520|2150897|FG000|Period 1|Withdrawal by Subject|1
1086537|NCT02197520|2150898|FG001|Period 1|Withdrawal by Subject|0
1086538|NCT02197520|2150897|FG000|Period 2|Adverse Event|0
1086539|NCT02197520|2150898|FG001|Period 2|Adverse Event|2
1086540|NCT02197520|2150897|FG000|Period 2|Withdrawal by Subject|1
1086541|NCT02197520|2150898|FG001|Period 2|Withdrawal by Subject|0
1086542|NCT02197572|2150906|FG000|Overall Study|Progressive Disease|28
1086543|NCT02197572|2150906|FG000|Overall Study|Withdrawal by Subject|9
1086544|NCT02197572|2150906|FG000|Overall Study|Adverse Event|3
1086545|NCT02197572|2150906|FG000|Overall Study|Reason Not Specified|4
1086546|NCT02197806|2150918|FG000|Overall Study|Adverse Event|0
1086547|NCT02197806|2150919|FG001|Overall Study|Adverse Event|1
1086548|NCT02197806|2150920|FG002|Overall Study|Adverse Event|0
1086549|NCT02197806|2150921|FG003|Overall Study|Adverse Event|1
1086550|NCT02197897|2150931|FG000|Overall Study|not eligible|1
1086551|NCT02198040|2150938|FG000|Overall Study|Work reasons|0
1086552|NCT02198040|2150939|FG001|Overall Study|Work reasons|1
1086553|NCT02198040|2150940|FG002|Overall Study|Work reasons|0
1086554|NCT02198040|2150938|FG000|Overall Study|Withdrawal by Subject|0
1086555|NCT02198040|2150939|FG001|Overall Study|Withdrawal by Subject|0
1086556|NCT02198040|2150940|FG002|Overall Study|Withdrawal by Subject|1
1086557|NCT02198235|2150953|FG000|Overall Study|Lost to Follow-up|3
1086558|NCT02198235|2150954|FG001|Overall Study|Lost to Follow-up|2
1086559|NCT02198235|2150955|FG002|Overall Study|Lost to Follow-up|2
1086560|NCT02198651|2150972|FG000|Lead-in Period|Withdrew consent|13
1086561|NCT02198651|2150973|FG001|Lead-in Period|Withdrew consent|0
1086562|NCT02198651|2150974|FG002|Lead-in Period|Withdrew consent|0
1086563|NCT02198651|2150975|FG003|Lead-in Period|Withdrew consent|0
1086564|NCT02198651|2150976|FG004|Lead-in Period|Withdrew consent|0
1086565|NCT02198651|2150972|FG000|Lead-in Period|Adverse Event|2
1086566|NCT02198651|2150973|FG001|Lead-in Period|Adverse Event|0
1086567|NCT02198651|2150974|FG002|Lead-in Period|Adverse Event|0
1086568|NCT02198651|2150975|FG003|Lead-in Period|Adverse Event|0
1086569|NCT02198651|2150976|FG004|Lead-in Period|Adverse Event|0
1086570|NCT02198651|2150972|FG000|Lead-in Period|Other, not specified|22
1086571|NCT02198651|2150973|FG001|Lead-in Period|Other, not specified|0
1086572|NCT02198651|2150974|FG002|Lead-in Period|Other, not specified|0
1086573|NCT02198651|2150975|FG003|Lead-in Period|Other, not specified|0
1086574|NCT02198651|2150976|FG004|Lead-in Period|Other, not specified|0
1086575|NCT02198651|2150972|FG000|Double-blind Period|Withdrew consent|0
1086576|NCT02198651|2150973|FG001|Double-blind Period|Withdrew consent|4
1086577|NCT02198651|2150974|FG002|Double-blind Period|Withdrew consent|0
1086578|NCT02198651|2150975|FG003|Double-blind Period|Withdrew consent|0
1086579|NCT02198651|2150976|FG004|Double-blind Period|Withdrew consent|0
1086580|NCT02198651|2150972|FG000|Double-blind Period|Adverse Event|0
1086581|NCT02198651|2150973|FG001|Double-blind Period|Adverse Event|1
1086582|NCT02198651|2150974|FG002|Double-blind Period|Adverse Event|0
1086583|NCT02198651|2150975|FG003|Double-blind Period|Adverse Event|0
1086584|NCT02198651|2150976|FG004|Double-blind Period|Adverse Event|0
1086585|NCT02198651|2150972|FG000|Double-blind Period|Other, not specified|0
1086586|NCT02198651|2150973|FG001|Double-blind Period|Other, not specified|4
1086587|NCT02198651|2150974|FG002|Double-blind Period|Other, not specified|1
1086588|NCT02198651|2150975|FG003|Double-blind Period|Other, not specified|0
1086589|NCT02198651|2150976|FG004|Double-blind Period|Other, not specified|0
1086590|NCT02198651|2150972|FG000|Open-label Rescue Period|Withdrew consent|0
1086591|NCT02198651|2150973|FG001|Open-label Rescue Period|Withdrew consent|0
1086592|NCT02198651|2150974|FG002|Open-label Rescue Period|Withdrew consent|0
1086593|NCT02198651|2150975|FG003|Open-label Rescue Period|Withdrew consent|2
1086594|NCT02198651|2150976|FG004|Open-label Rescue Period|Withdrew consent|0
1086595|NCT02198651|2150972|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
1086596|NCT02198651|2150973|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
1086597|NCT02198651|2150974|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
1086598|NCT02198651|2150975|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
1086599|NCT02198651|2150976|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
1086600|NCT02198664|2150991|FG000|Overall Study|Adverse Event|2
1086601|NCT02198664|2150992|FG001|Overall Study|Adverse Event|0
1086602|NCT02198664|2150991|FG000|Overall Study|Withdrawal by Subject|11
1086603|NCT02198664|2150992|FG001|Overall Study|Withdrawal by Subject|8
1086604|NCT02198664|2150991|FG000|Overall Study|Failure to tolerate|2
1086605|NCT02198664|2150992|FG001|Overall Study|Failure to tolerate|0
1086606|NCT02198664|2150991|FG000|Overall Study|Not stated|1
1086607|NCT02198664|2150992|FG001|Overall Study|Not stated|0
1086644|NCT02198963|2151009|FG000|Overall Study|Adverse Event|1
1086645|NCT02198963|2151009|FG000|Overall Study|Withdrawal by Subject|6
1086646|NCT02199028|2151020|FG000|Week 1|Adverse Event|1
1086647|NCT02199028|2151021|FG001|Week 1|Adverse Event|0
1086648|NCT02199028|2151020|FG000|Week 3|Adverse Event|1
1086649|NCT02199028|2151021|FG001|Week 3|Adverse Event|0
1086650|NCT02199080|2151033|FG000|Overall Study|Protocol Violation|12
1086651|NCT02199314|2151049|FG000|Overall Study|Withdrawal by Subject|6
1086652|NCT02199314|2151049|FG000|Overall Study|Physician Decision|10
1086653|NCT02199509|2151064|FG000|Overall Study|Suicidal Ideation|0
1086654|NCT02199509|2151065|FG001|Overall Study|Suicidal Ideation|1
1086655|NCT02199509|2151064|FG000|Overall Study|Misunderstood titration schedule|1
1086656|NCT02199509|2151065|FG001|Overall Study|Misunderstood titration schedule|0
1086657|NCT02199691|2151094|FG000|Overall Study|Protocol Violation|3
1086658|NCT02199691|2151095|FG001|Overall Study|Protocol Violation|3
1086659|NCT02199691|2151096|FG002|Overall Study|Protocol Violation|6
1086660|NCT02199691|2151097|FG003|Overall Study|Protocol Violation|7
1086661|NCT02199691|2151094|FG000|Overall Study|Withdrawal by Subject|5
1086662|NCT02199691|2151095|FG001|Overall Study|Withdrawal by Subject|3
1086663|NCT02199691|2151096|FG002|Overall Study|Withdrawal by Subject|12
1086664|NCT02199691|2151097|FG003|Overall Study|Withdrawal by Subject|13
1086665|NCT02199691|2151094|FG000|Overall Study|Lost to Follow-up|2
1086666|NCT02199691|2151095|FG001|Overall Study|Lost to Follow-up|1
1086667|NCT02199691|2151096|FG002|Overall Study|Lost to Follow-up|9
1086668|NCT02199691|2151097|FG003|Overall Study|Lost to Follow-up|10
1086669|NCT02199795|2151127|FG000|Overall Study|no longer met inclusion criteria|1
1086670|NCT02199795|2151128|FG001|Overall Study|no longer met inclusion criteria|0
1086671|NCT02199795|2151127|FG000|Overall Study|withdrew due to shoulder pain|1
1086672|NCT02199795|2151128|FG001|Overall Study|withdrew due to shoulder pain|0
1086673|NCT02200211|2151153|FG000|Overall Study|Lost to Follow-up|7
1086674|NCT02200211|2151154|FG001|Overall Study|Lost to Follow-up|7
1086675|NCT02200211|2151155|FG002|Overall Study|Lost to Follow-up|1
1086676|NCT02200211|2151156|FG003|Overall Study|Lost to Follow-up|2
1086677|NCT02200211|2151153|FG000|Overall Study|Withdrawal by Subject|1
1086678|NCT02200211|2151154|FG001|Overall Study|Withdrawal by Subject|0
1086679|NCT02200211|2151155|FG002|Overall Study|Withdrawal by Subject|0
1086680|NCT02200211|2151156|FG003|Overall Study|Withdrawal by Subject|0
1086681|NCT02200445|2151177|FG000|Overall Study|Lack of Efficacy|1
1086682|NCT02200445|2151178|FG001|Overall Study|Lack of Efficacy|2
1086683|NCT02200445|2151179|FG002|Overall Study|Lack of Efficacy|2
1086684|NCT02200445|2151177|FG000|Overall Study|Adverse Event|0
1086685|NCT02200445|2151178|FG001|Overall Study|Adverse Event|2
1086686|NCT02200445|2151179|FG002|Overall Study|Adverse Event|0
1086687|NCT02200510|2151193|FG000|Overall Study|Death|1
1086688|NCT02200510|2151194|FG001|Overall Study|Death|1
1086689|NCT02200510|2151193|FG000|Overall Study|Protocol Violation|0
1086690|NCT02200510|2151194|FG001|Overall Study|Protocol Violation|1
1086691|NCT02200510|2151193|FG000|Overall Study|Lost to Follow-up|7
1086692|NCT02200510|2151194|FG001|Overall Study|Lost to Follow-up|1
1086693|NCT02200510|2151193|FG000|Overall Study|potential COI - joined study team|1
1086694|NCT02200510|2151194|FG001|Overall Study|potential COI - joined study team|0
1086695|NCT02200614|2151224|FG000|Double Blind Treatment|Adverse Event|86
1086696|NCT02200614|2151225|FG001|Double Blind Treatment|Adverse Event|48
1086697|NCT02200614|2151224|FG000|Double Blind Treatment|Confirmed metastasis|119
1086698|NCT02200614|2151225|FG001|Double Blind Treatment|Confirmed metastasis|140
1086699|NCT02200614|2151224|FG000|Double Blind Treatment|Judgment of the investigator|60
1086700|NCT02200614|2151225|FG001|Double Blind Treatment|Judgment of the investigator|99
1086701|NCT02200614|2151224|FG000|Double Blind Treatment|Metastasis by local reading|1
1086702|NCT02200614|2151225|FG001|Double Blind Treatment|Metastasis by local reading|3
1086703|NCT02200614|2151224|FG000|Double Blind Treatment|Other reason|6
1086704|NCT02200614|2151225|FG001|Double Blind Treatment|Other reason|2
1086705|NCT02200614|2151224|FG000|Double Blind Treatment|Personal reason|77
1086706|NCT02200614|2151225|FG001|Double Blind Treatment|Personal reason|85
1086707|NCT02200614|2151224|FG000|Double Blind Treatment|Protocol deviation|14
1086708|NCT02200614|2151225|FG001|Double Blind Treatment|Protocol deviation|7
1086709|NCT02200614|2151224|FG000|Double Blind Treatment|Not treated|1
1086710|NCT02200614|2151225|FG001|Double Blind Treatment|Not treated|0
1086711|NCT02200614|2151224|FG000|Open Label|Adverse Event|15
1086712|NCT02200614|2151225|FG001|Open Label|Adverse Event|8
1086713|NCT02200614|2151224|FG000|Open Label|Confirmed metastasis|1
1086714|NCT02200614|2151225|FG001|Open Label|Confirmed metastasis|0
1086715|NCT02200614|2151224|FG000|Open Label|Judgment of the investigator|15
1086716|NCT02200614|2151225|FG001|Open Label|Judgment of the investigator|0
1086717|NCT02200614|2151224|FG000|Open Label|Metastasis by local reading|58
1086718|NCT02200614|2151225|FG001|Open Label|Metastasis by local reading|10
1086719|NCT02200614|2151224|FG000|Open Label|Other reason|6
1086720|NCT02200614|2151225|FG001|Open Label|Other reason|1
1086721|NCT02200614|2151224|FG000|Open Label|Personal reason|29
1086722|NCT02200614|2151225|FG001|Open Label|Personal reason|3
1086723|NCT02200614|2151224|FG000|Open Label|Protocol deviation|1
1086724|NCT02200614|2151225|FG001|Open Label|Protocol deviation|1
1086735|NCT02201108|2151285|FG000|Overall Study|Adverse Event|0
1086736|NCT02201108|2151286|FG001|Overall Study|Adverse Event|6
1086737|NCT02201108|2151285|FG000|Overall Study|Lack of Efficacy|2
1086738|NCT02201108|2151286|FG001|Overall Study|Lack of Efficacy|1
1086739|NCT02201108|2151285|FG000|Overall Study|Withdrawal by Subject|2
1086740|NCT02201108|2151286|FG001|Overall Study|Withdrawal by Subject|0
1086741|NCT02201251|2151301|FG000|Overall Study|Adverse Event|1
1086742|NCT02201251|2151302|FG001|Overall Study|Adverse Event|1
1086743|NCT02201251|2151301|FG000|Overall Study|Protocol Violation|1
1086744|NCT02201251|2151302|FG001|Overall Study|Protocol Violation|0
1086745|NCT02201251|2151301|FG000|Overall Study|Noncompliance with Study Drug|0
1086746|NCT02201251|2151302|FG001|Overall Study|Noncompliance with Study Drug|1
1086747|NCT02201251|2151301|FG000|Overall Study|Withdrawal by Subject|2
1086748|NCT02201251|2151302|FG001|Overall Study|Withdrawal by Subject|1
1086749|NCT02201277|2151310|FG000|Overall Study|Death|3
1086750|NCT02201277|2151311|FG001|Overall Study|Death|4
1086751|NCT02201277|2151310|FG000|Overall Study|Lost to Follow-up|2
1086752|NCT02201277|2151311|FG001|Overall Study|Lost to Follow-up|1
1086753|NCT02201277|2151310|FG000|Overall Study|Failed retrieval|1
1086754|NCT02201277|2151311|FG001|Overall Study|Failed retrieval|0
1086755|NCT02201277|2151310|FG000|Overall Study|Physician Decision|1
1086756|NCT02201277|2151311|FG001|Overall Study|Physician Decision|0
1086757|NCT02201290|2151321|FG000|Overall Study|Withdrawal by Subject|2
1086758|NCT02201290|2151321|FG000|Overall Study|Lack of Efficacy|2
1086759|NCT02201290|2151321|FG000|Overall Study|Adverse Event|1
1086760|NCT02201329|2151325|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
1086761|NCT02201329|2151325|FG000|Overall Study|Withdrawal by Subject|2
1086762|NCT02201524|2151351|FG000|Overall Study|Adverse Event|0
1086763|NCT02201524|2151352|FG001|Overall Study|Adverse Event|2
1086764|NCT02201524|2151353|FG002|Overall Study|Adverse Event|1
1086765|NCT02201524|2151354|FG003|Overall Study|Adverse Event|0
1086766|NCT02201524|2151351|FG000|Overall Study|Insufficient clinical response|1
1086767|NCT02201524|2151352|FG001|Overall Study|Insufficient clinical response|0
1086768|NCT02201524|2151353|FG002|Overall Study|Insufficient clinical response|0
1086769|NCT02201524|2151354|FG003|Overall Study|Insufficient clinical response|0
1086770|NCT02201524|2151351|FG000|Overall Study|Lost to Follow-up|0
1086771|NCT02201524|2151352|FG001|Overall Study|Lost to Follow-up|0
1086772|NCT02201524|2151353|FG002|Overall Study|Lost to Follow-up|2
1086773|NCT02201524|2151354|FG003|Overall Study|Lost to Follow-up|0
1086774|NCT02201524|2151351|FG000|Overall Study|No longer meets eligibility criteria|0
1086775|NCT02201524|2151352|FG001|Overall Study|No longer meets eligibility criteria|0
1086776|NCT02201524|2151353|FG002|Overall Study|No longer meets eligibility criteria|0
1086777|NCT02201524|2151354|FG003|Overall Study|No longer meets eligibility criteria|2
1086778|NCT02201524|2151351|FG000|Overall Study|Protocol Violation|0
1086779|NCT02201524|2151352|FG001|Overall Study|Protocol Violation|0
1086780|NCT02201524|2151353|FG002|Overall Study|Protocol Violation|0
1086781|NCT02201524|2151354|FG003|Overall Study|Protocol Violation|1
1086782|NCT02201524|2151351|FG000|Overall Study|Withdrawal by Subject|0
1086783|NCT02201524|2151352|FG001|Overall Study|Withdrawal by Subject|0
1086784|NCT02201524|2151353|FG002|Overall Study|Withdrawal by Subject|1
1086785|NCT02201524|2151354|FG003|Overall Study|Withdrawal by Subject|1
1086786|NCT02201524|2151351|FG000|Overall Study|Other|1
1086787|NCT02201524|2151352|FG001|Overall Study|Other|1
1086788|NCT02201524|2151353|FG002|Overall Study|Other|0
1086789|NCT02201524|2151354|FG003|Overall Study|Other|0
1086790|NCT02201771|2151367|FG000|Overall Study|Death|3
1086791|NCT02201771|2151368|FG001|Overall Study|Death|2
1086792|NCT02201771|2151369|FG002|Overall Study|Death|0
1086793|NCT02201771|2151367|FG000|Overall Study|Protocol Violation|10
1086794|NCT02201771|2151368|FG001|Overall Study|Protocol Violation|8
1086795|NCT02201771|2151369|FG002|Overall Study|Protocol Violation|10
1086796|NCT02201784|2151379|FG000|Overall Study|Failure to achieve adequate block|2
1086797|NCT02201784|2151380|FG001|Overall Study|Failure to achieve adequate block|0
1086798|NCT02201901|2151389|FG000|Overall Study|Randomized but never treated|0
1086799|NCT02201901|2151390|FG001|Overall Study|Randomized but never treated|1
1086800|NCT02201901|2151391|FG002|Overall Study|Randomized but never treated|0
1086801|NCT02201901|2151389|FG000|Overall Study|Lack of Efficacy|7
1086802|NCT02201901|2151390|FG001|Overall Study|Lack of Efficacy|1
1086803|NCT02201901|2151391|FG002|Overall Study|Lack of Efficacy|6
1086804|NCT02201901|2151389|FG000|Overall Study|Death|3
1086805|NCT02201901|2151390|FG001|Overall Study|Death|3
1086806|NCT02201901|2151391|FG002|Overall Study|Death|3
1086807|NCT02201901|2151389|FG000|Overall Study|Lost to Follow-up|2
1086808|NCT02201901|2151390|FG001|Overall Study|Lost to Follow-up|3
1086809|NCT02201901|2151391|FG002|Overall Study|Lost to Follow-up|2
1086810|NCT02201901|2151389|FG000|Overall Study|Withdrew Consent|2
1086811|NCT02201901|2151390|FG001|Overall Study|Withdrew Consent|0
1086812|NCT02201901|2151391|FG002|Overall Study|Withdrew Consent|2
1086813|NCT02201901|2151389|FG000|Overall Study|Adverse Event|1
1086814|NCT02201901|2151390|FG001|Overall Study|Adverse Event|1
1086815|NCT02201901|2151391|FG002|Overall Study|Adverse Event|0
1086816|NCT02201940|2151402|FG000|Overall Study|Randomized/Enrolled but Never Treated|1
1086817|NCT02201940|2151403|FG001|Overall Study|Randomized/Enrolled but Never Treated|0
1086818|NCT02201940|2151402|FG000|Overall Study|Lack of Efficacy|2
1086819|NCT02201940|2151403|FG001|Overall Study|Lack of Efficacy|113
1086820|NCT02201940|2151402|FG000|Overall Study|Lost to Follow-up|5
1086821|NCT02201940|2151403|FG001|Overall Study|Lost to Follow-up|0
1086822|NCT02201940|2151402|FG000|Overall Study|Withdrew Consent|2
1086823|NCT02201940|2151403|FG001|Overall Study|Withdrew Consent|1
1086824|NCT02201940|2151402|FG000|Overall Study|Investigator's Discretion|1
1086825|NCT02201940|2151403|FG001|Overall Study|Investigator's Discretion|1
1086826|NCT02201940|2151402|FG000|Overall Study|Death|1
1086827|NCT02201940|2151403|FG001|Overall Study|Death|0
1086828|NCT02201940|2151402|FG000|Overall Study|Adverse Event|0
1086829|NCT02201940|2151403|FG001|Overall Study|Adverse Event|1
1086830|NCT02201953|2151411|FG000|Overall Study|Randomized but Never Treated|1
1086831|NCT02201953|2151412|FG001|Overall Study|Randomized but Never Treated|5
1086832|NCT02201953|2151411|FG000|Overall Study|Lack of Efficacy|9
1086833|NCT02201953|2151412|FG001|Overall Study|Lack of Efficacy|30
1086834|NCT02201953|2151411|FG000|Overall Study|Lost to Follow-up|8
1086835|NCT02201953|2151412|FG001|Overall Study|Lost to Follow-up|8
1086836|NCT02201953|2151411|FG000|Overall Study|Withdrew Consent|2
1086837|NCT02201953|2151412|FG001|Overall Study|Withdrew Consent|5
1086838|NCT02201953|2151411|FG000|Overall Study|Adverse Event|0
1086839|NCT02201953|2151412|FG001|Overall Study|Adverse Event|5
1086840|NCT02201953|2151411|FG000|Overall Study|Death|0
1086841|NCT02201953|2151412|FG001|Overall Study|Death|3
1086842|NCT02202031|2151420|FG000|Overall Study|Lost to Follow-up|1
1086843|NCT02202031|2151421|FG001|Overall Study|Lost to Follow-up|0
1086844|NCT02202031|2151420|FG000|Overall Study|Too Busy|1
1086845|NCT02202031|2151421|FG001|Overall Study|Too Busy|3
1086846|NCT02202031|2151420|FG000|Overall Study|Illness/Medical Reason|0
1086847|NCT02202031|2151421|FG001|Overall Study|Illness/Medical Reason|2
1086848|NCT02202031|2151420|FG000|Overall Study|Intolerance/Lack of Improvement|3
1086849|NCT02202031|2151421|FG001|Overall Study|Intolerance/Lack of Improvement|0
1086850|NCT02202109|2151429|FG000|Overall Study|Lost to Follow-up|88
1086851|NCT02202109|2151430|FG001|Overall Study|Lost to Follow-up|87
1086852|NCT02202109|2151429|FG000|Overall Study|Withdrawal by Subject|2
1086853|NCT02202109|2151430|FG001|Overall Study|Withdrawal by Subject|0
1086854|NCT02202161|2151448|FG000|Overall Study|Adverse Event|1
1086855|NCT02202161|2151449|FG001|Overall Study|Adverse Event|1
1086856|NCT02202161|2151450|FG002|Overall Study|Adverse Event|0
1086857|NCT02202161|2151451|FG003|Overall Study|Adverse Event|0
1086858|NCT02202161|2151452|FG004|Overall Study|Adverse Event|0
1086859|NCT02202161|2151453|FG005|Overall Study|Adverse Event|1
1086860|NCT02202161|2151454|FG006|Overall Study|Adverse Event|0
1086861|NCT02202161|2151455|FG007|Overall Study|Adverse Event|0
1086862|NCT02202161|2151448|FG000|Overall Study|Did not meet continuation criteria|0
1086863|NCT02202161|2151449|FG001|Overall Study|Did not meet continuation criteria|0
1086864|NCT02202161|2151450|FG002|Overall Study|Did not meet continuation criteria|0
1086865|NCT02202161|2151451|FG003|Overall Study|Did not meet continuation criteria|0
1086866|NCT02202161|2151452|FG004|Overall Study|Did not meet continuation criteria|0
1086867|NCT02202161|2151453|FG005|Overall Study|Did not meet continuation criteria|0
1086868|NCT02202161|2151454|FG006|Overall Study|Did not meet continuation criteria|0
1086869|NCT02202161|2151455|FG007|Overall Study|Did not meet continuation criteria|3
1086870|NCT02202161|2151448|FG000|Overall Study|Physician Decision|0
1086871|NCT02202161|2151449|FG001|Overall Study|Physician Decision|0
1086872|NCT02202161|2151450|FG002|Overall Study|Physician Decision|0
1086873|NCT02202161|2151451|FG003|Overall Study|Physician Decision|0
1086874|NCT02202161|2151452|FG004|Overall Study|Physician Decision|0
1086875|NCT02202161|2151453|FG005|Overall Study|Physician Decision|0
1086876|NCT02202161|2151454|FG006|Overall Study|Physician Decision|0
1086877|NCT02202161|2151455|FG007|Overall Study|Physician Decision|3
1086878|NCT02202161|2151448|FG000|Overall Study|Withdrawal by Subject|0
1086879|NCT02202161|2151449|FG001|Overall Study|Withdrawal by Subject|0
1086880|NCT02202161|2151450|FG002|Overall Study|Withdrawal by Subject|0
1086881|NCT02202161|2151451|FG003|Overall Study|Withdrawal by Subject|0
1086882|NCT02202161|2151452|FG004|Overall Study|Withdrawal by Subject|1
1086883|NCT02202161|2151453|FG005|Overall Study|Withdrawal by Subject|0
1086884|NCT02202161|2151454|FG006|Overall Study|Withdrawal by Subject|0
1086885|NCT02202161|2151455|FG007|Overall Study|Withdrawal by Subject|0
1086886|NCT02202317|2151483|FG000|Overall Study|Lost to Follow-up|1
1086915|NCT02202499|2151507|FG000|Overall Study|Cancer diagnosis|0
1086916|NCT02202499|2151508|FG001|Overall Study|Cancer diagnosis|0
1086917|NCT02202499|2151509|FG002|Overall Study|Cancer diagnosis|1
1086918|NCT02202499|2151507|FG000|Overall Study|Moved from area|0
1086919|NCT02202499|2151508|FG001|Overall Study|Moved from area|0
1086920|NCT02202499|2151509|FG002|Overall Study|Moved from area|1
1086921|NCT02202499|2151507|FG000|Overall Study|Declined before randomization|1
1086922|NCT02202499|2151508|FG001|Overall Study|Declined before randomization|0
1086923|NCT02202499|2151509|FG002|Overall Study|Declined before randomization|0
1086924|NCT02202499|2151507|FG000|Overall Study|Auto accident|1
1086925|NCT02202499|2151508|FG001|Overall Study|Auto accident|0
1086926|NCT02202499|2151509|FG002|Overall Study|Auto accident|0
1086927|NCT02202538|2151522|FG000|Overall Study|Withdrawal by Subject|5
1086928|NCT02202538|2151522|FG000|Overall Study|Did not meet all inclusion criteria|2
1086929|NCT02202538|2151522|FG000|Overall Study|Investigator Decision|1
1086930|NCT02202551|2151530|FG000|Overall Study|Adverse Event|8
1086931|NCT02202551|2151531|FG001|Overall Study|Adverse Event|19
1086932|NCT02202551|2151532|FG002|Overall Study|Adverse Event|5
1086933|NCT02202551|2151533|FG003|Overall Study|Adverse Event|9
1086934|NCT02202551|2151530|FG000|Overall Study|Death|3
1086935|NCT02202551|2151531|FG001|Overall Study|Death|2
1086936|NCT02202551|2151532|FG002|Overall Study|Death|1
1086937|NCT02202551|2151533|FG003|Overall Study|Death|1
1086938|NCT02202551|2151530|FG000|Overall Study|Lost to Follow-up|0
1086939|NCT02202551|2151531|FG001|Overall Study|Lost to Follow-up|1
1086940|NCT02202551|2151532|FG002|Overall Study|Lost to Follow-up|0
1086941|NCT02202551|2151533|FG003|Overall Study|Lost to Follow-up|1
1086942|NCT02202551|2151530|FG000|Overall Study|Needed to take excluded medication|0
1086943|NCT02202551|2151531|FG001|Overall Study|Needed to take excluded medication|2
1086944|NCT02202551|2151532|FG002|Overall Study|Needed to take excluded medication|0
1086945|NCT02202551|2151533|FG003|Overall Study|Needed to take excluded medication|1
1086946|NCT02202551|2151530|FG000|Overall Study|Subject moved away|0
1086947|NCT02202551|2151531|FG001|Overall Study|Subject moved away|1
1086948|NCT02202551|2151532|FG002|Overall Study|Subject moved away|0
1086949|NCT02202551|2151533|FG003|Overall Study|Subject moved away|0
1086950|NCT02202551|2151530|FG000|Overall Study|DBS surgery|3
1086951|NCT02202551|2151531|FG001|Overall Study|DBS surgery|0
1086952|NCT02202551|2151532|FG002|Overall Study|DBS surgery|0
1086953|NCT02202551|2151533|FG003|Overall Study|DBS surgery|0
1086954|NCT02202551|2151530|FG000|Overall Study|Dyskinesia upon taper|1
1086955|NCT02202551|2151531|FG001|Overall Study|Dyskinesia upon taper|0
1086956|NCT02202551|2151532|FG002|Overall Study|Dyskinesia upon taper|0
1086957|NCT02202551|2151533|FG003|Overall Study|Dyskinesia upon taper|0
1086958|NCT02202551|2151530|FG000|Overall Study|Lack of Efficacy|0
1086959|NCT02202551|2151531|FG001|Overall Study|Lack of Efficacy|1
1086960|NCT02202551|2151532|FG002|Overall Study|Lack of Efficacy|0
1086961|NCT02202551|2151533|FG003|Overall Study|Lack of Efficacy|0
1086962|NCT02202551|2151530|FG000|Overall Study|Physician Decision|1
1086963|NCT02202551|2151531|FG001|Overall Study|Physician Decision|0
1086964|NCT02202551|2151532|FG002|Overall Study|Physician Decision|0
1086965|NCT02202551|2151533|FG003|Overall Study|Physician Decision|0
1086966|NCT02202551|2151530|FG000|Overall Study|Site closure|3
1086967|NCT02202551|2151531|FG001|Overall Study|Site closure|0
1086968|NCT02202551|2151532|FG002|Overall Study|Site closure|0
1086969|NCT02202551|2151533|FG003|Overall Study|Site closure|1
1086970|NCT02202551|2151530|FG000|Overall Study|Unable to complete visits per protocol|1
1086971|NCT02202551|2151531|FG001|Overall Study|Unable to complete visits per protocol|0
1086972|NCT02202551|2151532|FG002|Overall Study|Unable to complete visits per protocol|0
1086973|NCT02202551|2151533|FG003|Overall Study|Unable to complete visits per protocol|0
1086974|NCT02202551|2151530|FG000|Overall Study|Worsening Dyskinesia|0
1086975|NCT02202551|2151531|FG001|Overall Study|Worsening Dyskinesia|0
1086976|NCT02202551|2151532|FG002|Overall Study|Worsening Dyskinesia|0
1086977|NCT02202551|2151533|FG003|Overall Study|Worsening Dyskinesia|1
1086978|NCT02202551|2151530|FG000|Overall Study|Protocol Violation|0
1086979|NCT02202551|2151531|FG001|Overall Study|Protocol Violation|1
1086980|NCT02202551|2151532|FG002|Overall Study|Protocol Violation|0
1086981|NCT02202551|2151533|FG003|Overall Study|Protocol Violation|0
1086982|NCT02202551|2151530|FG000|Overall Study|Sponsor's decision|2
1086983|NCT02202551|2151531|FG001|Overall Study|Sponsor's decision|0
1086984|NCT02202551|2151532|FG002|Overall Study|Sponsor's decision|0
1086985|NCT02202551|2151533|FG003|Overall Study|Sponsor's decision|0
1086986|NCT02202551|2151530|FG000|Overall Study|Subject unwilling to proceed|1
1086987|NCT02202551|2151531|FG001|Overall Study|Subject unwilling to proceed|5
1086988|NCT02202551|2151532|FG002|Overall Study|Subject unwilling to proceed|3
1086989|NCT02202551|2151533|FG003|Overall Study|Subject unwilling to proceed|5
1086990|NCT02202551|2151530|FG000|Overall Study|Subject consent withdrawn|0
1086991|NCT02202551|2151531|FG001|Overall Study|Subject consent withdrawn|3
1086992|NCT02202551|2151532|FG002|Overall Study|Subject consent withdrawn|1
1086993|NCT02202551|2151533|FG003|Overall Study|Subject consent withdrawn|2
1086994|NCT02202551|2151530|FG000|Overall Study|eGFR<50mL/min/m2|2
1086995|NCT02202551|2151531|FG001|Overall Study|eGFR<50mL/min/m2|2
1086996|NCT02202551|2151532|FG002|Overall Study|eGFR<50mL/min/m2|0
1086997|NCT02202551|2151533|FG003|Overall Study|eGFR<50mL/min/m2|1
1086998|NCT02202616|2151547|FG000|Overall Study|Screen failed|24
1086999|NCT02202616|2151547|FG000|Overall Study|Adverse Event|32
1087000|NCT02202616|2151547|FG000|Overall Study|Protocol deviation|18
1087001|NCT02202616|2151547|FG000|Overall Study|Patient withdrew consent|12
1087002|NCT02202616|2151547|FG000|Overall Study|Lost to Follow-up|6
1087003|NCT02202616|2151547|FG000|Overall Study|Administrative problems|6
1087004|NCT02202616|2151547|FG000|Overall Study|Abnormal test procedure result|1
1087005|NCT02202616|2151547|FG000|Overall Study|Unsatisfactory therapeutic effect|1
1087006|NCT02202759|2151567|FG000|Overall Study|Study Terminated by Sponsor|3
1087007|NCT02202759|2151568|FG001|Overall Study|Study Terminated by Sponsor|3
1087008|NCT02202759|2151569|FG002|Overall Study|Study Terminated by Sponsor|3
1087009|NCT02202759|2151567|FG000|Overall Study|Withdrawal by Subject|2
1087010|NCT02202759|2151568|FG001|Overall Study|Withdrawal by Subject|1
1087011|NCT02202759|2151569|FG002|Overall Study|Withdrawal by Subject|1
1087012|NCT02202759|2151567|FG000|Overall Study|Reason not Specified|4
1087013|NCT02202759|2151568|FG001|Overall Study|Reason not Specified|11
1087014|NCT02202759|2151569|FG002|Overall Study|Reason not Specified|10
1087015|NCT02202785|2151579|FG000|Overall Study|Study Terminated by Sponsor|1
1087016|NCT02202785|2151580|FG001|Overall Study|Study Terminated by Sponsor|6
1087017|NCT02202785|2151581|FG002|Overall Study|Study Terminated by Sponsor|4
1087018|NCT02202785|2151579|FG000|Overall Study|Withdrawal by Subject|0
1087019|NCT02202785|2151580|FG001|Overall Study|Withdrawal by Subject|1
1087020|NCT02202785|2151581|FG002|Overall Study|Withdrawal by Subject|0
1087021|NCT02202785|2151579|FG000|Overall Study|Lost to Follow-up|0
1087022|NCT02202785|2151580|FG001|Overall Study|Lost to Follow-up|1
1087023|NCT02202785|2151581|FG002|Overall Study|Lost to Follow-up|0
1087024|NCT02202785|2151579|FG000|Overall Study|Reason not Specified|10
1087025|NCT02202785|2151580|FG001|Overall Study|Reason not Specified|7
1087026|NCT02202785|2151581|FG002|Overall Study|Reason not Specified|13
1087027|NCT02202837|2151591|FG000|Overall Study|Enbrel treatment discontinued|36
1087028|NCT02202837|2151592|FG001|Overall Study|Enbrel treatment discontinued|4
1087029|NCT02202837|2151591|FG000|Overall Study|Other|10
1087030|NCT02202837|2151592|FG001|Overall Study|Other|0
1087031|NCT02202837|2151591|FG000|Overall Study|Lost to Follow-up|7
1087032|NCT02202837|2151592|FG001|Overall Study|Lost to Follow-up|1
1087033|NCT02202850|2151600|FG000|Overall Study|Other|2
1087034|NCT02202850|2151601|FG001|Overall Study|Other|2
1087035|NCT02202850|2151600|FG000|Overall Study|Enbrel treatment discontinued|15
1087036|NCT02202850|2151601|FG001|Overall Study|Enbrel treatment discontinued|3
1087037|NCT02202850|2151600|FG000|Overall Study|Lost to Follow-up|7
1087038|NCT02202850|2151601|FG001|Overall Study|Lost to Follow-up|1
1087039|NCT02202980|2151621|FG000|Overall Study|Lack of Efficacy|1
1087040|NCT02202980|2151622|FG001|Overall Study|Lack of Efficacy|0
1087041|NCT02202980|2151623|FG002|Overall Study|Lack of Efficacy|7
1087042|NCT02202980|2151624|FG003|Overall Study|Lack of Efficacy|0
1087043|NCT02202980|2151625|FG004|Overall Study|Lack of Efficacy|3
1087044|NCT02202980|2151626|FG005|Overall Study|Lack of Efficacy|1
1087045|NCT02202980|2151627|FG006|Overall Study|Lack of Efficacy|11
1087046|NCT02202980|2151628|FG007|Overall Study|Lack of Efficacy|2
1087047|NCT02202980|2151629|FG008|Overall Study|Lack of Efficacy|2
1087048|NCT02202980|2151630|FG009|Overall Study|Lack of Efficacy|0
1087049|NCT02202980|2151631|FG010|Overall Study|Lack of Efficacy|0
1087050|NCT02202980|2151632|FG011|Overall Study|Lack of Efficacy|3
1087051|NCT02202980|2151633|FG012|Overall Study|Lack of Efficacy|10
1087052|NCT02202980|2151634|FG013|Overall Study|Lack of Efficacy|0
1087053|NCT02202980|2151621|FG000|Overall Study|Protocol Violation|0
1087054|NCT02202980|2151622|FG001|Overall Study|Protocol Violation|0
1087055|NCT02202980|2151623|FG002|Overall Study|Protocol Violation|0
1087056|NCT02202980|2151624|FG003|Overall Study|Protocol Violation|3
1087057|NCT02202980|2151625|FG004|Overall Study|Protocol Violation|3
1087058|NCT02202980|2151626|FG005|Overall Study|Protocol Violation|0
1087059|NCT02202980|2151627|FG006|Overall Study|Protocol Violation|0
1087060|NCT02202980|2151628|FG007|Overall Study|Protocol Violation|0
1087061|NCT02202980|2151629|FG008|Overall Study|Protocol Violation|0
1087062|NCT02202980|2151630|FG009|Overall Study|Protocol Violation|0
1087063|NCT02202980|2151631|FG010|Overall Study|Protocol Violation|0
1087064|NCT02202980|2151632|FG011|Overall Study|Protocol Violation|0
1087065|NCT02202980|2151633|FG012|Overall Study|Protocol Violation|0
1087066|NCT02202980|2151634|FG013|Overall Study|Protocol Violation|0
1087067|NCT02202980|2151621|FG000|Overall Study|Lost to Follow-up|0
1087068|NCT02202980|2151622|FG001|Overall Study|Lost to Follow-up|1
1087069|NCT02202980|2151623|FG002|Overall Study|Lost to Follow-up|1
1087070|NCT02202980|2151624|FG003|Overall Study|Lost to Follow-up|1
1087071|NCT02202980|2151625|FG004|Overall Study|Lost to Follow-up|0
1087072|NCT02202980|2151626|FG005|Overall Study|Lost to Follow-up|0
1087073|NCT02202980|2151627|FG006|Overall Study|Lost to Follow-up|0
1087074|NCT02202980|2151628|FG007|Overall Study|Lost to Follow-up|1
1087075|NCT02202980|2151629|FG008|Overall Study|Lost to Follow-up|1
1087076|NCT02202980|2151630|FG009|Overall Study|Lost to Follow-up|0
1087077|NCT02202980|2151631|FG010|Overall Study|Lost to Follow-up|0
1087078|NCT02202980|2151632|FG011|Overall Study|Lost to Follow-up|0
1087079|NCT02202980|2151633|FG012|Overall Study|Lost to Follow-up|1
1087080|NCT02202980|2151634|FG013|Overall Study|Lost to Follow-up|0
1087081|NCT02202980|2151621|FG000|Overall Study|Withdrew Consent|0
1087082|NCT02202980|2151622|FG001|Overall Study|Withdrew Consent|1
1087083|NCT02202980|2151623|FG002|Overall Study|Withdrew Consent|2
1087084|NCT02202980|2151624|FG003|Overall Study|Withdrew Consent|0
1087085|NCT02202980|2151625|FG004|Overall Study|Withdrew Consent|0
1087086|NCT02202980|2151626|FG005|Overall Study|Withdrew Consent|0
1087087|NCT02202980|2151627|FG006|Overall Study|Withdrew Consent|0
1087088|NCT02202980|2151628|FG007|Overall Study|Withdrew Consent|0
1087089|NCT02202980|2151629|FG008|Overall Study|Withdrew Consent|1
1087090|NCT02202980|2151630|FG009|Overall Study|Withdrew Consent|0
1087091|NCT02202980|2151631|FG010|Overall Study|Withdrew Consent|0
1087092|NCT02202980|2151632|FG011|Overall Study|Withdrew Consent|0
1087093|NCT02202980|2151633|FG012|Overall Study|Withdrew Consent|0
1087094|NCT02202980|2151634|FG013|Overall Study|Withdrew Consent|0
1087095|NCT02203032|2151673|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
1087096|NCT02203032|2151674|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1087097|NCT02203032|2151675|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1087098|NCT02203032|2151676|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1087099|NCT02203032|2151673|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
1087100|NCT02203032|2151674|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1087101|NCT02203032|2151675|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1087102|NCT02203032|2151676|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1087103|NCT02203032|2151673|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
1087104|NCT02203032|2151674|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1087105|NCT02203032|2151675|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1087106|NCT02203032|2151676|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1087107|NCT02203032|2151673|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
1087108|NCT02203032|2151674|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1087109|NCT02203032|2151675|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1087110|NCT02203032|2151676|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1087111|NCT02203032|2151673|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
1087112|NCT02203032|2151674|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1087113|NCT02203032|2151675|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1087114|NCT02203032|2151676|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1087115|NCT02203032|2151673|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2
1087116|NCT02203032|2151674|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0
1087117|NCT02203032|2151675|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0
1087118|NCT02203032|2151676|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0
1087119|NCT02203032|2151673|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
1087120|NCT02203032|2151674|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1087121|NCT02203032|2151675|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1087122|NCT02203032|2151676|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1087123|NCT02203032|2151673|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
1087124|NCT02203032|2151674|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
1087125|NCT02203032|2151675|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
1087126|NCT02203032|2151676|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
1087127|NCT02203032|2151673|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
1087128|NCT02203032|2151674|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
1087129|NCT02203032|2151675|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
1087130|NCT02203032|2151676|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
1087131|NCT02203032|2151673|FG000|Blinded Phase (Week 16 to Week 44)|Other|0
1087132|NCT02203032|2151674|FG001|Blinded Phase (Week 16 to Week 44)|Other|4
1087133|NCT02203032|2151675|FG002|Blinded Phase (Week 16 to Week 44)|Other|1
1087134|NCT02203032|2151676|FG003|Blinded Phase (Week 16 to Week 44)|Other|15
1087135|NCT02203032|2151673|FG000|Blinded Phase (Week 16 to Week 44)|Death|0
1087136|NCT02203032|2151674|FG001|Blinded Phase (Week 16 to Week 44)|Death|0
1087137|NCT02203032|2151675|FG002|Blinded Phase (Week 16 to Week 44)|Death|0
1087138|NCT02203032|2151676|FG003|Blinded Phase (Week 16 to Week 44)|Death|1
1087139|NCT02203032|2151673|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
1087140|NCT02203032|2151674|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
1087141|NCT02203032|2151675|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
1087142|NCT02203032|2151676|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
1087143|NCT02203071|2151686|FG000|Overall Study|Lost to Follow-up|3
1087144|NCT02203071|2151687|FG001|Overall Study|Lost to Follow-up|1
1087145|NCT02203149|2151698|FG000|Part 1|Adverse Event|0
1087146|NCT02203149|2151699|FG001|Part 1|Adverse Event|1
1087147|NCT02203149|2151700|FG002|Part 1|Adverse Event|0
1087148|NCT02203149|2151701|FG003|Part 1|Adverse Event|0
1087149|NCT02203149|2151702|FG004|Part 1|Adverse Event|0
1087150|NCT02203149|2151698|FG000|Part 2|Death|0
1087151|NCT02203149|2151699|FG001|Part 2|Death|0
1087152|NCT02203149|2151700|FG002|Part 2|Death|1
1087153|NCT02203149|2151701|FG003|Part 2|Death|1
1087154|NCT02203149|2151702|FG004|Part 2|Death|0
1087155|NCT02203149|2151698|FG000|Part 2|Withdrawal by Subject|0
1087156|NCT02203149|2151699|FG001|Part 2|Withdrawal by Subject|0
1087157|NCT02203149|2151700|FG002|Part 2|Withdrawal by Subject|0
1087158|NCT02203149|2151701|FG003|Part 2|Withdrawal by Subject|1
1087159|NCT02203149|2151702|FG004|Part 2|Withdrawal by Subject|0
1087160|NCT02203149|2151698|FG000|Part 2|Adverse Event|0
1087161|NCT02203149|2151699|FG001|Part 2|Adverse Event|0
1087162|NCT02203149|2151700|FG002|Part 2|Adverse Event|0
1087163|NCT02203149|2151701|FG003|Part 2|Adverse Event|1
1087164|NCT02203149|2151702|FG004|Part 2|Adverse Event|1
1087165|NCT02203331|2151734|FG000|Overall Study|Pregnancy|1
1087166|NCT02203331|2151735|FG001|Overall Study|Pregnancy|0
1087167|NCT02203331|2151736|FG002|Overall Study|Pregnancy|0
1087168|NCT02203331|2151737|FG003|Overall Study|Pregnancy|0
1087169|NCT02203331|2151738|FG004|Overall Study|Pregnancy|2
1087170|NCT02203331|2151739|FG005|Overall Study|Pregnancy|0
1087171|NCT02203331|2151734|FG000|Overall Study|Withdrawal by Subject|1
1087172|NCT02203331|2151735|FG001|Overall Study|Withdrawal by Subject|0
1087173|NCT02203331|2151736|FG002|Overall Study|Withdrawal by Subject|1
1087174|NCT02203331|2151737|FG003|Overall Study|Withdrawal by Subject|0
1087175|NCT02203331|2151738|FG004|Overall Study|Withdrawal by Subject|0
1087176|NCT02203331|2151739|FG005|Overall Study|Withdrawal by Subject|3
1087177|NCT02203331|2151734|FG000|Overall Study|Adverse Event|4
1087178|NCT02203331|2151735|FG001|Overall Study|Adverse Event|8
1087179|NCT02203331|2151736|FG002|Overall Study|Adverse Event|3
1087180|NCT02203331|2151737|FG003|Overall Study|Adverse Event|4
1087181|NCT02203331|2151738|FG004|Overall Study|Adverse Event|3
1087182|NCT02203331|2151739|FG005|Overall Study|Adverse Event|3
1087183|NCT02203331|2151734|FG000|Overall Study|Other Reasons|1
1087184|NCT02203331|2151735|FG001|Overall Study|Other Reasons|2
1087185|NCT02203331|2151736|FG002|Overall Study|Other Reasons|0
1087186|NCT02203331|2151737|FG003|Overall Study|Other Reasons|2
1087187|NCT02203331|2151738|FG004|Overall Study|Other Reasons|0
1087188|NCT02203331|2151739|FG005|Overall Study|Other Reasons|0
1087189|NCT02203331|2151734|FG000|Overall Study|Lack of Efficacy|0
1087190|NCT02203331|2151735|FG001|Overall Study|Lack of Efficacy|2
1087191|NCT02203331|2151736|FG002|Overall Study|Lack of Efficacy|1
1087192|NCT02203331|2151737|FG003|Overall Study|Lack of Efficacy|0
1087193|NCT02203331|2151738|FG004|Overall Study|Lack of Efficacy|0
1087194|NCT02203331|2151739|FG005|Overall Study|Lack of Efficacy|1
1087195|NCT02203331|2151734|FG000|Overall Study|Protocol Violation|0
1087196|NCT02203331|2151735|FG001|Overall Study|Protocol Violation|2
1087197|NCT02203331|2151736|FG002|Overall Study|Protocol Violation|0
1087198|NCT02203331|2151737|FG003|Overall Study|Protocol Violation|1
1087199|NCT02203331|2151738|FG004|Overall Study|Protocol Violation|1
1087200|NCT02203331|2151739|FG005|Overall Study|Protocol Violation|0
1087201|NCT02203331|2151734|FG000|Overall Study|Lost to Follow-up|0
1087202|NCT02203331|2151735|FG001|Overall Study|Lost to Follow-up|0
1087203|NCT02203331|2151736|FG002|Overall Study|Lost to Follow-up|0
1087204|NCT02203331|2151737|FG003|Overall Study|Lost to Follow-up|0
1087205|NCT02203331|2151738|FG004|Overall Study|Lost to Follow-up|1
1087206|NCT02203331|2151739|FG005|Overall Study|Lost to Follow-up|0
1087207|NCT02203357|2151756|FG000|Overall Study|Lost to Follow-up|58
1087208|NCT02203357|2151757|FG001|Overall Study|Lost to Follow-up|66
1087209|NCT02203357|2151758|FG002|Overall Study|Lost to Follow-up|70
1087210|NCT02203591|2151785|FG000|Overall Study|Did not meet treatment day baseline|147
1087211|NCT02203591|2151786|FG001|Overall Study|Did not meet treatment day baseline|141
1087212|NCT02203591|2151787|FG002|Overall Study|Did not meet treatment day baseline|150
1087213|NCT02203591|2151788|FG003|Overall Study|Did not meet treatment day baseline|45
1087214|NCT02203591|2151789|FG004|Overall Study|Did not meet treatment day baseline|33
1087215|NCT02203591|2151790|FG005|Overall Study|Did not meet treatment day baseline|35
1087216|NCT02203591|2151791|FG006|Overall Study|Did not meet treatment day baseline|29
1087217|NCT02203591|2151792|FG007|Overall Study|Did not meet treatment day baseline|12
1087218|NCT02203591|2151785|FG000|Overall Study|Discontinued early due to compromised test sites|0
1087219|NCT02203591|2151786|FG001|Overall Study|Discontinued early due to compromised test sites|1
1087220|NCT02203591|2151787|FG002|Overall Study|Discontinued early due to compromised test sites|1
1087221|NCT02203591|2151788|FG003|Overall Study|Discontinued early due to compromised test sites|0
1087222|NCT02203591|2151789|FG004|Overall Study|Discontinued early due to compromised test sites|1
1087223|NCT02203591|2151790|FG005|Overall Study|Discontinued early due to compromised test sites|0
1087224|NCT02203591|2151791|FG006|Overall Study|Discontinued early due to compromised test sites|0
1087225|NCT02203591|2151792|FG007|Overall Study|Discontinued early due to compromised test sites|1
1087226|NCT02203721|2151825|FG000|Overall Study|Lost to Follow-up|1
1087227|NCT02203721|2151826|FG001|Overall Study|Lost to Follow-up|0
1087228|NCT02203721|2151825|FG000|Overall Study|Death|0
1087229|NCT02203721|2151826|FG001|Overall Study|Death|2
1087230|NCT02203721|2151825|FG000|Overall Study|Illness|0
1087231|NCT02203721|2151826|FG001|Overall Study|Illness|1
1087232|NCT02203838|2151864|FG000|Overall Study|Lack of Efficacy|7
1087233|NCT02203838|2151865|FG001|Overall Study|Lack of Efficacy|0
1087234|NCT02203838|2151866|FG002|Overall Study|Lack of Efficacy|1
1087235|NCT02203838|2151867|FG003|Overall Study|Lack of Efficacy|1
1087236|NCT02203838|2151864|FG000|Overall Study|Adverse Event|46
1087237|NCT02203838|2151865|FG001|Overall Study|Adverse Event|6
1087238|NCT02203838|2151866|FG002|Overall Study|Adverse Event|3
1087239|NCT02203838|2151867|FG003|Overall Study|Adverse Event|2
1087240|NCT02203838|2151864|FG000|Overall Study|Lost to Follow-up|39
1087241|NCT02203838|2151865|FG001|Overall Study|Lost to Follow-up|3
1087242|NCT02203838|2151866|FG002|Overall Study|Lost to Follow-up|2
1087243|NCT02203838|2151867|FG003|Overall Study|Lost to Follow-up|1
1087244|NCT02203838|2151864|FG000|Overall Study|Protocol Violation|7
1087245|NCT02203838|2151865|FG001|Overall Study|Protocol Violation|3
1087246|NCT02203838|2151866|FG002|Overall Study|Protocol Violation|0
1087247|NCT02203838|2151867|FG003|Overall Study|Protocol Violation|0
1087248|NCT02203838|2151864|FG000|Overall Study|Withdrawal by Subject|83
1087249|NCT02203838|2151865|FG001|Overall Study|Withdrawal by Subject|10
1087250|NCT02203838|2151866|FG002|Overall Study|Withdrawal by Subject|8
1087251|NCT02203838|2151867|FG003|Overall Study|Withdrawal by Subject|11
1087252|NCT02203838|2151864|FG000|Overall Study|Physician Decision|27
1087253|NCT02203838|2151865|FG001|Overall Study|Physician Decision|0
1087254|NCT02203838|2151866|FG002|Overall Study|Physician Decision|2
1087255|NCT02203838|2151867|FG003|Overall Study|Physician Decision|3
1087256|NCT02203838|2151864|FG000|Overall Study|Other|1
1087257|NCT02203838|2151865|FG001|Overall Study|Other|0
1087258|NCT02203838|2151866|FG002|Overall Study|Other|0
1087259|NCT02203838|2151867|FG003|Overall Study|Other|0
1087260|NCT02203851|2151877|FG000|Overall Study|Lost to Follow-up|4
1087261|NCT02203851|2151877|FG000|Overall Study|Withdrawal by Subject|6
1087262|NCT02203851|2151877|FG000|Overall Study|Other|1
1087263|NCT02203916|2151891|FG000|Overall Study|Pretreatment Event/Adverse Event|1
1087264|NCT02203916|2151892|FG001|Overall Study|Pretreatment Event/Adverse Event|3
1087265|NCT02203916|2151893|FG002|Overall Study|Pretreatment Event/Adverse Event|2
1087266|NCT02203916|2151891|FG000|Overall Study|Major Protocol Deviation|1
1087267|NCT02203916|2151892|FG001|Overall Study|Major Protocol Deviation|1
1087268|NCT02203916|2151893|FG002|Overall Study|Major Protocol Deviation|0
1087269|NCT02203916|2151891|FG000|Overall Study|Lost to Follow-up|0
1087270|NCT02203916|2151892|FG001|Overall Study|Lost to Follow-up|1
1087271|NCT02203916|2151893|FG002|Overall Study|Lost to Follow-up|0
1087272|NCT02203916|2151891|FG000|Overall Study|Voluntary Withdrawal|3
1087273|NCT02203916|2151892|FG001|Overall Study|Voluntary Withdrawal|3
1087274|NCT02203916|2151893|FG002|Overall Study|Voluntary Withdrawal|8
1087275|NCT02203916|2151891|FG000|Overall Study|Lack of Efficacy|3
1087276|NCT02203916|2151892|FG001|Overall Study|Lack of Efficacy|0
1087277|NCT02203916|2151893|FG002|Overall Study|Lack of Efficacy|0
1087278|NCT02203916|2151891|FG000|Overall Study|Reason Not Specified|0
1087279|NCT02203916|2151892|FG001|Overall Study|Reason Not Specified|2
1087280|NCT02203916|2151893|FG002|Overall Study|Reason Not Specified|1
1087281|NCT02204007|2151903|FG000|Overall Study|Surgery Canceled|1
1087282|NCT02204007|2151904|FG001|Overall Study|Surgery Canceled|1
1087283|NCT02204293|2151938|FG000|Core Study Part I|Met one or more exclusion criteria|1
1087284|NCT02204293|2151939|FG001|Core Study Part I|Met one or more exclusion criteria|0
1087285|NCT02204293|2151940|FG002|Core Study Part I|Met one or more exclusion criteria|0
1087286|NCT02204293|2151941|FG003|Core Study Part I|Met one or more exclusion criteria|0
1087287|NCT02204293|2151942|FG004|Core Study Part I|Met one or more exclusion criteria|0
1087288|NCT02204293|2151943|FG005|Core Study Part I|Met one or more exclusion criteria|0
1087289|NCT02204293|2151938|FG000|Core Study Part I|Adverse Event|1
1087290|NCT02204293|2151939|FG001|Core Study Part I|Adverse Event|0
1087291|NCT02204293|2151940|FG002|Core Study Part I|Adverse Event|0
1087292|NCT02204293|2151941|FG003|Core Study Part I|Adverse Event|0
1087293|NCT02204293|2151942|FG004|Core Study Part I|Adverse Event|0
1087294|NCT02204293|2151943|FG005|Core Study Part I|Adverse Event|0
1087295|NCT02204293|2151938|FG000|Core Study Part I|Physician Decision|0
1087296|NCT02204293|2151939|FG001|Core Study Part I|Physician Decision|3
1087297|NCT02204293|2151940|FG002|Core Study Part I|Physician Decision|0
1087298|NCT02204293|2151941|FG003|Core Study Part I|Physician Decision|0
1087299|NCT02204293|2151942|FG004|Core Study Part I|Physician Decision|0
1087300|NCT02204293|2151943|FG005|Core Study Part I|Physician Decision|0
1087301|NCT02204293|2151938|FG000|LTE Phase|Study Suspended|0
1087302|NCT02204293|2151939|FG001|LTE Phase|Study Suspended|0
1087303|NCT02204293|2151940|FG002|LTE Phase|Study Suspended|0
1087304|NCT02204293|2151941|FG003|LTE Phase|Study Suspended|0
1087305|NCT02204293|2151942|FG004|LTE Phase|Study Suspended|0
1087306|NCT02204293|2151943|FG005|LTE Phase|Study Suspended|7
1087307|NCT02204319|2151957|FG000|Overall Study|Pregnancy|1
1087308|NCT02204319|2151957|FG000|Overall Study|Withdrawal by Subject|2
1087309|NCT02204371|2151962|FG000|Overall Study|Adverse Event|1
1087310|NCT02204410|2151966|FG000|Overall Study|Lost to Follow-up|5
1087311|NCT02204410|2151966|FG000|Overall Study|Physician Decision|2
1087312|NCT02204410|2151966|FG000|Overall Study|Protocol Violation|1
1087313|NCT02204410|2151966|FG000|Overall Study|Withdrawal by Subject|3
1087314|NCT02204449|2151972|FG000|Overall Study|Lost to Follow-up|7
1087315|NCT02204449|2151973|FG001|Overall Study|Lost to Follow-up|9
1087316|NCT02204449|2151972|FG000|Overall Study|Death|0
1087317|NCT02204449|2151973|FG001|Overall Study|Death|1
1087318|NCT02204449|2151972|FG000|Overall Study|Withdrawal by Subject|0
1087319|NCT02204449|2151973|FG001|Overall Study|Withdrawal by Subject|1
1087320|NCT02204579|2151983|FG000|Overall Study|Screen failures|2
1087321|NCT02204917|2152009|FG000|Overall Study|Protocol Violation|1
1087322|NCT02204982|2152018|FG000|Overall Study|Patient ineligible-medical monitor|1
1087323|NCT02204982|2152019|FG001|Overall Study|Patient ineligible-medical monitor|0
1087324|NCT02204982|2152018|FG000|Overall Study|Withdrawal by Subject|1
1087325|NCT02204982|2152019|FG001|Overall Study|Withdrawal by Subject|0
1087326|NCT02204982|2152018|FG000|Overall Study|Adverse Event|1
1087327|NCT02204982|2152019|FG001|Overall Study|Adverse Event|0
1087328|NCT02204982|2152018|FG000|Overall Study|Adverse Event and Investigator decision|1
1087329|NCT02204982|2152019|FG001|Overall Study|Adverse Event and Investigator decision|0
1087330|NCT02204982|2152018|FG000|Overall Study|Physician Decision|0
1087331|NCT02204982|2152019|FG001|Overall Study|Physician Decision|2
1087332|NCT02204982|2152018|FG000|Overall Study|Protocol-Specified Disease Progression|0
1087333|NCT02204982|2152019|FG001|Overall Study|Protocol-Specified Disease Progression|4
1087334|NCT02204982|2152018|FG000|Overall Study|Termination of Study bySponsor|0
1087335|NCT02204982|2152019|FG001|Overall Study|Termination of Study bySponsor|1
1087336|NCT02205333|2152053|FG000|Overall Study|Death|5
1087337|NCT02205333|2152054|FG001|Overall Study|Death|6
1087338|NCT02205333|2152055|FG002|Overall Study|Death|2
1087339|NCT02205333|2152056|FG003|Overall Study|Death|6
1087340|NCT02205333|2152057|FG004|Overall Study|Death|5
1087341|NCT02205333|2152058|FG005|Overall Study|Death|3
1087342|NCT02205333|2152059|FG006|Overall Study|Death|3
1087343|NCT02205333|2152060|FG007|Overall Study|Death|2
1087344|NCT02205333|2152061|FG008|Overall Study|Death|0
1087345|NCT02205333|2152053|FG000|Overall Study|Withdrawal by Subject|1
1087346|NCT02205333|2152054|FG001|Overall Study|Withdrawal by Subject|0
1087347|NCT02205333|2152055|FG002|Overall Study|Withdrawal by Subject|0
1087348|NCT02205333|2152056|FG003|Overall Study|Withdrawal by Subject|1
1087349|NCT02205333|2152057|FG004|Overall Study|Withdrawal by Subject|0
1087350|NCT02205333|2152058|FG005|Overall Study|Withdrawal by Subject|0
1087351|NCT02205333|2152059|FG006|Overall Study|Withdrawal by Subject|2
1087352|NCT02205333|2152060|FG007|Overall Study|Withdrawal by Subject|0
1087353|NCT02205333|2152061|FG008|Overall Study|Withdrawal by Subject|0
1087354|NCT02205476|2152083|FG000|Overall Study|Study termination by Sponsor|7
1087355|NCT02205476|2152084|FG001|Overall Study|Study termination by Sponsor|3
1087356|NCT02205814|2152117|FG000|Overall Study|Lost to Follow-up|0
1087357|NCT02205814|2152118|FG001|Overall Study|Lost to Follow-up|0
1087358|NCT02205814|2152119|FG002|Overall Study|Lost to Follow-up|0
1087359|NCT02205814|2152120|FG003|Overall Study|Lost to Follow-up|1
1087360|NCT02205814|2152117|FG000|Overall Study|Lack of Efficacy|1
1087361|NCT02205814|2152118|FG001|Overall Study|Lack of Efficacy|0
1087362|NCT02205814|2152119|FG002|Overall Study|Lack of Efficacy|1
1087363|NCT02205814|2152120|FG003|Overall Study|Lack of Efficacy|1
1087364|NCT02205814|2152117|FG000|Overall Study|Physician Decision|0
1087365|NCT02205814|2152118|FG001|Overall Study|Physician Decision|0
1087366|NCT02205814|2152119|FG002|Overall Study|Physician Decision|1
1087367|NCT02205814|2152120|FG003|Overall Study|Physician Decision|0
1087368|NCT02205814|2152117|FG000|Overall Study|Protocol Violation|1
1087369|NCT02205814|2152118|FG001|Overall Study|Protocol Violation|0
1087370|NCT02205814|2152119|FG002|Overall Study|Protocol Violation|0
1087371|NCT02205814|2152120|FG003|Overall Study|Protocol Violation|1
1087372|NCT02205814|2152117|FG000|Overall Study|Withdrawal by Subject|0
1087373|NCT02205814|2152118|FG001|Overall Study|Withdrawal by Subject|1
1087374|NCT02205814|2152119|FG002|Overall Study|Withdrawal by Subject|2
1087375|NCT02205814|2152120|FG003|Overall Study|Withdrawal by Subject|1
1087376|NCT02205814|2152117|FG000|Overall Study|not compliant with study procedures|0
1087377|NCT02205814|2152118|FG001|Overall Study|not compliant with study procedures|0
1087378|NCT02205814|2152119|FG002|Overall Study|not compliant with study procedures|1
1087379|NCT02205814|2152120|FG003|Overall Study|not compliant with study procedures|0
1087380|NCT02206061|2152150|FG000|Overall Study|Withdrawal by Subject|4
1087381|NCT02206061|2152151|FG001|Overall Study|Withdrawal by Subject|7
1087382|NCT02206061|2152152|FG002|Overall Study|Withdrawal by Subject|1
1087383|NCT02206061|2152150|FG000|Overall Study|Lost to Follow-up|14
1087384|NCT02206061|2152151|FG001|Overall Study|Lost to Follow-up|7
1087385|NCT02206061|2152152|FG002|Overall Study|Lost to Follow-up|20
1087386|NCT02206152|2152160|FG000|Pre-Randomization|Withdrawal by Subject|2
1087387|NCT02206607|2152175|FG000|Open-Label Run-In|Withdrawal by Subject|3
1087388|NCT02206607|2152176|FG001|Open-Label Run-In|Withdrawal by Subject|0
1087389|NCT02206607|2152177|FG002|Open-Label Run-In|Withdrawal by Subject|0
1087390|NCT02206607|2152178|FG003|Open-Label Run-In|Withdrawal by Subject|0
1087391|NCT02206607|2152179|FG004|Open-Label Run-In|Withdrawal by Subject|0
1087392|NCT02206607|2152175|FG000|Second Intervention Period|Insufficient Clinical Response|0
1087393|NCT02206607|2152176|FG001|Second Intervention Period|Insufficient Clinical Response|0
1087394|NCT02206607|2152177|FG002|Second Intervention Period|Insufficient Clinical Response|0
1087395|NCT02206607|2152178|FG003|Second Intervention Period|Insufficient Clinical Response|1
1087396|NCT02206607|2152179|FG004|Second Intervention Period|Insufficient Clinical Response|0
1087397|NCT02206620|2152195|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
1087398|NCT02206620|2152196|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
1087399|NCT02206620|2152195|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
1087400|NCT02206620|2152196|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
1087401|NCT02206685|2152210|FG000|Overall Study|Surgery cancelled/changed|2
1087402|NCT02206685|2152211|FG001|Overall Study|Surgery cancelled/changed|3
1087403|NCT02206685|2152210|FG000|Overall Study|Withdrawal by Subject|1
1087404|NCT02206685|2152211|FG001|Overall Study|Withdrawal by Subject|2
1087405|NCT02206685|2152210|FG000|Overall Study|Protocol Violation|2
1087406|NCT02206685|2152211|FG001|Overall Study|Protocol Violation|2
1087407|NCT02206828|2152226|FG000|Overall Study|Lost to Follow-up|7
1087408|NCT02207088|2152253|FG000|Overall Study|Adverse Event|2
1087409|NCT02207231|2152260|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
1087410|NCT02207231|2152261|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
1087411|NCT02207231|2152262|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
1087412|NCT02207231|2152263|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1087413|NCT02207231|2152260|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
1087414|NCT02207231|2152261|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1087415|NCT02207231|2152262|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
1087416|NCT02207231|2152263|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1087417|NCT02207231|2152260|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1087418|NCT02207231|2152261|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1087419|NCT02207231|2152262|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1087420|NCT02207231|2152263|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1087421|NCT02207231|2152260|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
1087422|NCT02207231|2152261|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1087423|NCT02207231|2152262|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
1087424|NCT02207231|2152263|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1087425|NCT02207231|2152260|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1087426|NCT02207231|2152261|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1087427|NCT02207231|2152262|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
1087428|NCT02207231|2152263|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1087429|NCT02207231|2152260|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
1087430|NCT02207231|2152261|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
1087431|NCT02207231|2152262|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
1087432|NCT02207231|2152263|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
1087433|NCT02207231|2152260|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1
1087434|NCT02207231|2152261|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6
1087435|NCT02207231|2152262|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10
1087436|NCT02207231|2152263|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0
1087437|NCT02207231|2152260|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0
1087438|NCT02207231|2152261|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0
1087439|NCT02207231|2152262|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1
1087440|NCT02207231|2152263|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0
1087441|NCT02207231|2152260|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
1087442|NCT02207231|2152261|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
1087443|NCT02207231|2152262|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
1087444|NCT02207231|2152263|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
1087445|NCT02207231|2152260|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
1087446|NCT02207231|2152261|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
1087447|NCT02207231|2152262|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
1087448|NCT02207231|2152263|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0
1087449|NCT02207231|2152260|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
1087450|NCT02207231|2152261|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
1087451|NCT02207231|2152262|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
1087452|NCT02207231|2152263|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0
1087453|NCT02207231|2152260|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0
1087454|NCT02207231|2152261|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1
1087455|NCT02207231|2152262|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0
1087456|NCT02207231|2152263|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0
1087457|NCT02207231|2152260|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0
1087458|NCT02207231|2152261|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3
1087459|NCT02207231|2152262|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3
1087460|NCT02207231|2152263|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0
1087461|NCT02207231|2152260|FG000|Active Controlled Period: Week 16 - 48|Other|0
1087462|NCT02207231|2152261|FG001|Active Controlled Period: Week 16 - 48|Other|2
1087463|NCT02207231|2152262|FG002|Active Controlled Period: Week 16 - 48|Other|3
1087464|NCT02207231|2152263|FG003|Active Controlled Period: Week 16 - 48|Other|0
1087465|NCT02207231|2152260|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
1087466|NCT02207231|2152261|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
1087467|NCT02207231|2152262|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12
1087468|NCT02207231|2152263|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19
1087469|NCT02207231|2152260|FG000|Open-label Guselkumab: Week 48 - 264|Death|0
1087470|NCT02207231|2152261|FG001|Open-label Guselkumab: Week 48 - 264|Death|0
1087471|NCT02207231|2152262|FG002|Open-label Guselkumab: Week 48 - 264|Death|1
1087472|NCT02207231|2152263|FG003|Open-label Guselkumab: Week 48 - 264|Death|3
1087473|NCT02207231|2152260|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
1087474|NCT02207231|2152261|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
1087475|NCT02207231|2152262|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3
1087476|NCT02207231|2152263|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7
1087477|NCT02207231|2152260|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
1087478|NCT02207231|2152261|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
1087479|NCT02207231|2152262|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2
1087480|NCT02207231|2152263|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4
1087481|NCT02207231|2152260|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
1087482|NCT02207231|2152261|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
1087483|NCT02207231|2152262|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6
1087484|NCT02207231|2152263|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11
1087485|NCT02207231|2152260|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
1087486|NCT02207231|2152261|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
1087487|NCT02207231|2152262|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10
1087488|NCT02207231|2152263|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28
1087489|NCT02207231|2152260|FG000|Open-label Guselkumab: Week 48 - 264|Other|0
1087490|NCT02207231|2152261|FG001|Open-label Guselkumab: Week 48 - 264|Other|0
1087491|NCT02207231|2152262|FG002|Open-label Guselkumab: Week 48 - 264|Other|4
1087492|NCT02207231|2152263|FG003|Open-label Guselkumab: Week 48 - 264|Other|11
1087493|NCT02207244|2152284|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2
1087494|NCT02207244|2152285|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9
1087495|NCT02207244|2152286|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4
1087496|NCT02207244|2152287|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0
1087497|NCT02207244|2152288|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0
1087498|NCT02207244|2152289|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0
1087499|NCT02207244|2152290|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0
1087500|NCT02207244|2152291|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0
1087501|NCT02207244|2152292|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0
1087502|NCT02207244|2152293|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0
942963|NCT01004822|1932610|FG000|Overall Study|Objective progression or relapse|3
942964|NCT01004822|1932611|FG001|Overall Study|Objective progression or relapse|3
942965|NCT01004822|1932612|FG002|Overall Study|Objective progression or relapse|0
942966|NCT01004822|1932613|FG003|Overall Study|Objective progression or relapse|1
942967|NCT01004822|1932614|FG004|Overall Study|Objective progression or relapse|2
942968|NCT01004822|1932615|FG005|Overall Study|Objective progression or relapse|2
942969|NCT01004822|1932616|FG006|Overall Study|Objective progression or relapse|1
942970|NCT01004822|1932617|FG007|Overall Study|Objective progression or relapse|4
942971|NCT01004822|1932610|FG000|Overall Study|Global deterioration of health status|0
942972|NCT01004822|1932611|FG001|Overall Study|Global deterioration of health status|0
909663|NCT00789477|1886421|FG003|Overall Study|Protocol Violation|1
909664|NCT00789477|1886422|FG004|Overall Study|Protocol Violation|0
909665|NCT00789477|1886418|FG000|Overall Study|Adverse Event|3
942973|NCT01004822|1932612|FG002|Overall Study|Global deterioration of health status|0
942974|NCT01004822|1932613|FG003|Overall Study|Global deterioration of health status|1
942975|NCT01004822|1932614|FG004|Overall Study|Global deterioration of health status|0
1087503|NCT02207244|2152294|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0
1087504|NCT02207244|2152284|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4
1087505|NCT02207244|2152285|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
1087506|NCT02207244|2152286|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2
1087507|NCT02207244|2152287|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
1087508|NCT02207244|2152288|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
1087509|NCT02207244|2152289|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
1087510|NCT02207244|2152290|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
1087511|NCT02207244|2152291|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
1087512|NCT02207244|2152292|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
1087513|NCT02207244|2152293|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
1087514|NCT02207244|2152294|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
1087515|NCT02207244|2152284|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1
1087516|NCT02207244|2152285|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3
1087517|NCT02207244|2152286|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2
1087518|NCT02207244|2152287|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
1087519|NCT02207244|2152288|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
1087520|NCT02207244|2152289|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
1087521|NCT02207244|2152290|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
1087522|NCT02207244|2152291|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
1087523|NCT02207244|2152292|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
1087524|NCT02207244|2152293|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
1087525|NCT02207244|2152294|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
1087526|NCT02207244|2152284|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7
1087527|NCT02207244|2152285|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1
1087528|NCT02207244|2152286|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
1087529|NCT02207244|2152287|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
1087530|NCT02207244|2152288|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
1087531|NCT02207244|2152289|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
1087532|NCT02207244|2152290|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
1087533|NCT02207244|2152291|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
1087534|NCT02207244|2152292|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
1087535|NCT02207244|2152293|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
1087536|NCT02207244|2152294|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
1087537|NCT02207244|2152284|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1
1087538|NCT02207244|2152285|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3
1087539|NCT02207244|2152286|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1
1087540|NCT02207244|2152287|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0
1087541|NCT02207244|2152288|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0
1087542|NCT02207244|2152289|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0
1087543|NCT02207244|2152290|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0
1087544|NCT02207244|2152291|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0
1087545|NCT02207244|2152292|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0
1087546|NCT02207244|2152293|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0
1087547|NCT02207244|2152294|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0
1087548|NCT02207244|2152284|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0
1087549|NCT02207244|2152285|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1
1087550|NCT02207244|2152286|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2
1087551|NCT02207244|2152287|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0
1087552|NCT02207244|2152288|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0
1087553|NCT02207244|2152289|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0
1087554|NCT02207244|2152290|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0
1087555|NCT02207244|2152291|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0
1087556|NCT02207244|2152292|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0
1087557|NCT02207244|2152293|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0
1087558|NCT02207244|2152294|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0
1087559|NCT02207244|2152284|FG000|Placebo Controlled Period: Week 0-16|OTHER|0
1087560|NCT02207244|2152285|FG001|Placebo Controlled Period: Week 0-16|OTHER|1
1087561|NCT02207244|2152286|FG002|Placebo Controlled Period: Week 0-16|OTHER|0
1087562|NCT02207244|2152287|FG003|Placebo Controlled Period: Week 0-16|OTHER|0
1087563|NCT02207244|2152288|FG004|Placebo Controlled Period: Week 0-16|OTHER|0
1087564|NCT02207244|2152289|FG005|Placebo Controlled Period: Week 0-16|OTHER|0
1087565|NCT02207244|2152290|FG006|Placebo Controlled Period: Week 0-16|OTHER|0
1087566|NCT02207244|2152291|FG007|Placebo Controlled Period: Week 0-16|OTHER|0
1087567|NCT02207244|2152292|FG008|Placebo Controlled Period: Week 0-16|OTHER|0
1087568|NCT02207244|2152293|FG009|Placebo Controlled Period: Week 0-16|OTHER|0
1087569|NCT02207244|2152294|FG010|Placebo Controlled Period: Week 0-16|OTHER|0
1087570|NCT02207244|2152284|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
1087571|NCT02207244|2152285|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
1087572|NCT02207244|2152286|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
1087573|NCT02207244|2152287|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
1087574|NCT02207244|2152288|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3
1087575|NCT02207244|2152289|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2
1087576|NCT02207244|2152290|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
1087577|NCT02207244|2152291|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
1087578|NCT02207244|2152292|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
1087579|NCT02207244|2152293|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
1087580|NCT02207244|2152294|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
1087581|NCT02207244|2152284|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
1087582|NCT02207244|2152285|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
1087583|NCT02207244|2152286|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
1087584|NCT02207244|2152287|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
1087585|NCT02207244|2152288|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
1087586|NCT02207244|2152289|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2
1087587|NCT02207244|2152290|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
1087588|NCT02207244|2152291|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
1087589|NCT02207244|2152292|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
1087590|NCT02207244|2152293|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
1087591|NCT02207244|2152294|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
1087592|NCT02207244|2152284|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
1087593|NCT02207244|2152285|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
1087594|NCT02207244|2152286|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
1087595|NCT02207244|2152287|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1
1087596|NCT02207244|2152288|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
1087597|NCT02207244|2152289|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
1087598|NCT02207244|2152290|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
1087599|NCT02207244|2152291|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
1087600|NCT02207244|2152292|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
1087601|NCT02207244|2152293|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
1087602|NCT02207244|2152294|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
1087603|NCT02207244|2152284|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
1087604|NCT02207244|2152285|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
1087605|NCT02207244|2152286|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
1087606|NCT02207244|2152287|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
1087607|NCT02207244|2152288|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
1087608|NCT02207244|2152289|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2
1087609|NCT02207244|2152290|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
1087610|NCT02207244|2152291|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
1087611|NCT02207244|2152292|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
1087612|NCT02207244|2152293|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
1087613|NCT02207244|2152294|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
1087614|NCT02207244|2152284|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
1087615|NCT02207244|2152285|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
1087616|NCT02207244|2152286|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
1087617|NCT02207244|2152287|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
1087618|NCT02207244|2152288|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
1087619|NCT02207244|2152289|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
1087620|NCT02207244|2152290|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
1087621|NCT02207244|2152291|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
1087622|NCT02207244|2152292|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
1087623|NCT02207244|2152293|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
1087624|NCT02207244|2152294|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
1087625|NCT02207244|2152284|FG000|Placebo Crossover and ACP: Week 16-28|Other|0
1087626|NCT02207244|2152285|FG001|Placebo Crossover and ACP: Week 16-28|Other|0
1087627|NCT02207244|2152286|FG002|Placebo Crossover and ACP: Week 16-28|Other|0
1087628|NCT02207244|2152287|FG003|Placebo Crossover and ACP: Week 16-28|Other|1
1087629|NCT02207244|2152288|FG004|Placebo Crossover and ACP: Week 16-28|Other|0
1087630|NCT02207244|2152289|FG005|Placebo Crossover and ACP: Week 16-28|Other|0
1087631|NCT02207244|2152290|FG006|Placebo Crossover and ACP: Week 16-28|Other|0
1087632|NCT02207244|2152291|FG007|Placebo Crossover and ACP: Week 16-28|Other|0
1087633|NCT02207244|2152292|FG008|Placebo Crossover and ACP: Week 16-28|Other|0
1087634|NCT02207244|2152293|FG009|Placebo Crossover and ACP: Week 16-28|Other|0
1087635|NCT02207244|2152294|FG010|Placebo Crossover and ACP: Week 16-28|Other|0
1087636|NCT02207244|2152284|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
1087637|NCT02207244|2152285|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
1087638|NCT02207244|2152286|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
1087639|NCT02207244|2152287|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
1087640|NCT02207244|2152288|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
1087641|NCT02207244|2152289|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
1087642|NCT02207244|2152290|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1
1087643|NCT02207244|2152291|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5
1087644|NCT02207244|2152292|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3
1087645|NCT02207244|2152293|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2
1087646|NCT02207244|2152294|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
1087647|NCT02207244|2152284|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
1087648|NCT02207244|2152285|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
1087649|NCT02207244|2152286|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
1087650|NCT02207244|2152287|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
1087651|NCT02207244|2152288|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
1087652|NCT02207244|2152289|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
1087653|NCT02207244|2152290|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
1087654|NCT02207244|2152291|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2
1087655|NCT02207244|2152292|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
1087656|NCT02207244|2152293|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
1087657|NCT02207244|2152294|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
1087658|NCT02207244|2152284|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
1087659|NCT02207244|2152285|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
1087660|NCT02207244|2152286|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
1087661|NCT02207244|2152287|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
1087662|NCT02207244|2152288|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
1087663|NCT02207244|2152289|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
1087664|NCT02207244|2152290|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1
1087665|NCT02207244|2152291|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3
1087666|NCT02207244|2152292|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
1087667|NCT02207244|2152293|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
1087668|NCT02207244|2152294|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
1087669|NCT02207244|2152284|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
1087670|NCT02207244|2152285|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
1087671|NCT02207244|2152286|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
1087672|NCT02207244|2152287|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
1087673|NCT02207244|2152288|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
1087674|NCT02207244|2152289|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
1087675|NCT02207244|2152290|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
1087676|NCT02207244|2152291|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7
1087677|NCT02207244|2152292|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
1087678|NCT02207244|2152293|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
1087679|NCT02207244|2152294|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
1087680|NCT02207244|2152284|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
1087681|NCT02207244|2152285|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
1087682|NCT02207244|2152286|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
1087683|NCT02207244|2152287|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
1087684|NCT02207244|2152288|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
1087685|NCT02207244|2152289|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
1087686|NCT02207244|2152290|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
1087687|NCT02207244|2152291|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7
1087688|NCT02207244|2152292|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
1087689|NCT02207244|2152293|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
1087690|NCT02207244|2152294|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
1087691|NCT02207244|2152284|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
1087692|NCT02207244|2152285|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
1087693|NCT02207244|2152286|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
1087694|NCT02207244|2152287|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
1087695|NCT02207244|2152288|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
942976|NCT01004822|1932615|FG005|Overall Study|Global deterioration of health status|0
942977|NCT01004822|1932616|FG006|Overall Study|Global deterioration of health status|1
942978|NCT01004822|1932617|FG007|Overall Study|Global deterioration of health status|0
942979|NCT01004822|1932610|FG000|Overall Study|No longer willing to continue|0
942980|NCT01004822|1932611|FG001|Overall Study|No longer willing to continue|0
942981|NCT01004822|1932612|FG002|Overall Study|No longer willing to continue|0
942982|NCT01004822|1932613|FG003|Overall Study|No longer willing to continue|1
942983|NCT01004822|1932614|FG004|Overall Study|No longer willing to continue|2
942984|NCT01004822|1932615|FG005|Overall Study|No longer willing to continue|1
942985|NCT01004822|1932616|FG006|Overall Study|No longer willing to continue|1
942986|NCT01004822|1932617|FG007|Overall Study|No longer willing to continue|0
942987|NCT01004822|1932610|FG000|Overall Study|Adverse Event|0
942988|NCT01004822|1932611|FG001|Overall Study|Adverse Event|0
942989|NCT01004822|1932612|FG002|Overall Study|Adverse Event|0
942990|NCT01004822|1932613|FG003|Overall Study|Adverse Event|0
942991|NCT01004822|1932614|FG004|Overall Study|Adverse Event|0
942992|NCT01004822|1932615|FG005|Overall Study|Adverse Event|0
1087696|NCT02207244|2152289|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
1087697|NCT02207244|2152290|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
1087698|NCT02207244|2152291|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
1087699|NCT02207244|2152292|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
1087700|NCT02207244|2152293|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
1087701|NCT02207244|2152294|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
1087702|NCT02207244|2152284|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
1087703|NCT02207244|2152285|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
1087704|NCT02207244|2152286|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
1087705|NCT02207244|2152287|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
1087706|NCT02207244|2152288|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
1087707|NCT02207244|2152289|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
1087708|NCT02207244|2152290|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
1087709|NCT02207244|2152291|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
1087710|NCT02207244|2152292|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1
1087711|NCT02207244|2152293|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
1087712|NCT02207244|2152294|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
1087713|NCT02207244|2152284|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0
1087714|NCT02207244|2152285|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0
1087715|NCT02207244|2152286|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0
1087716|NCT02207244|2152287|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0
1087717|NCT02207244|2152288|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0
1087718|NCT02207244|2152289|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0
1087719|NCT02207244|2152290|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0
1087720|NCT02207244|2152291|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2
1087721|NCT02207244|2152292|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0
1087722|NCT02207244|2152293|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0
1087723|NCT02207244|2152294|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0
909666|NCT00789477|1886419|FG001|Overall Study|Adverse Event|3
909667|NCT00789477|1886420|FG002|Overall Study|Adverse Event|1
909668|NCT00789477|1886421|FG003|Overall Study|Adverse Event|0
909669|NCT00789477|1886422|FG004|Overall Study|Adverse Event|0
1087724|NCT02207244|2152284|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
1087725|NCT02207244|2152285|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
1087726|NCT02207244|2152286|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
1087727|NCT02207244|2152287|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
1087728|NCT02207244|2152288|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
1087729|NCT02207244|2152289|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
1087730|NCT02207244|2152290|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8
1087731|NCT02207244|2152291|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
1087732|NCT02207244|2152292|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
1087733|NCT02207244|2152293|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
1087734|NCT02207244|2152294|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
1087735|NCT02207244|2152284|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
1162049|NCT03381248|2283985|FG000|Overall Study|Protocol Violation|2
942993|NCT01004822|1932616|FG006|Overall Study|Adverse Event|1
942994|NCT01004822|1932617|FG007|Overall Study|Adverse Event|1
942995|NCT01004822|1932610|FG000|Overall Study|Other|0
942996|NCT01004822|1932611|FG001|Overall Study|Other|0
942997|NCT01004822|1932612|FG002|Overall Study|Other|4
942998|NCT01004822|1932613|FG003|Overall Study|Other|1
942999|NCT01004822|1932614|FG004|Overall Study|Other|0
943000|NCT01004822|1932615|FG005|Overall Study|Other|1
943001|NCT01004822|1932616|FG006|Overall Study|Other|0
943002|NCT01004822|1932617|FG007|Overall Study|Other|0
943003|NCT01004848|1932639|FG000|Overall Study|Lost to Follow-up|55
943004|NCT01004848|1932640|FG001|Overall Study|Lost to Follow-up|45
1087736|NCT02207244|2152285|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
1087737|NCT02207244|2152286|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
1087738|NCT02207244|2152287|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
1087739|NCT02207244|2152288|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
1087740|NCT02207244|2152289|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
1087741|NCT02207244|2152290|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
1087742|NCT02207244|2152291|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
1087743|NCT02207244|2152292|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10
1087744|NCT02207244|2152293|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
1087745|NCT02207244|2152294|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30
1087746|NCT02207244|2152284|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
1087747|NCT02207244|2152285|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
1087748|NCT02207244|2152286|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
1087749|NCT02207244|2152287|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
1087750|NCT02207244|2152288|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
1087751|NCT02207244|2152289|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
1087752|NCT02207244|2152290|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
1087753|NCT02207244|2152291|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
1087754|NCT02207244|2152292|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2
1087755|NCT02207244|2152293|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
1087756|NCT02207244|2152294|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3
1087757|NCT02207244|2152284|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
1087758|NCT02207244|2152285|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
1087759|NCT02207244|2152286|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
1087760|NCT02207244|2152287|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
1087761|NCT02207244|2152288|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
1087762|NCT02207244|2152289|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
1087763|NCT02207244|2152290|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
1087764|NCT02207244|2152291|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
1087765|NCT02207244|2152292|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5
1087766|NCT02207244|2152293|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
1087767|NCT02207244|2152294|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26
1087768|NCT02207244|2152284|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0
1087769|NCT02207244|2152285|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0
1087770|NCT02207244|2152286|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0
1087771|NCT02207244|2152287|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0
1087772|NCT02207244|2152288|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0
1087773|NCT02207244|2152289|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0
1087774|NCT02207244|2152290|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0
1087775|NCT02207244|2152291|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0
1087776|NCT02207244|2152292|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12
1087777|NCT02207244|2152293|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0
1087778|NCT02207244|2152294|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21
1087779|NCT02207244|2152284|FG000|Open-label Guselkumab: Week 72-264|Death|0
1087780|NCT02207244|2152285|FG001|Open-label Guselkumab: Week 72-264|Death|0
1087781|NCT02207244|2152286|FG002|Open-label Guselkumab: Week 72-264|Death|0
1087782|NCT02207244|2152287|FG003|Open-label Guselkumab: Week 72-264|Death|0
1087783|NCT02207244|2152288|FG004|Open-label Guselkumab: Week 72-264|Death|0
1087784|NCT02207244|2152289|FG005|Open-label Guselkumab: Week 72-264|Death|0
1087785|NCT02207244|2152290|FG006|Open-label Guselkumab: Week 72-264|Death|0
1087786|NCT02207244|2152291|FG007|Open-label Guselkumab: Week 72-264|Death|0
1087787|NCT02207244|2152292|FG008|Open-label Guselkumab: Week 72-264|Death|1
1087788|NCT02207244|2152293|FG009|Open-label Guselkumab: Week 72-264|Death|0
1087789|NCT02207244|2152294|FG010|Open-label Guselkumab: Week 72-264|Death|1
1087790|NCT02207244|2152284|FG000|Open-label Guselkumab: Week 72-264|Other|0
1087791|NCT02207244|2152285|FG001|Open-label Guselkumab: Week 72-264|Other|0
1087792|NCT02207244|2152286|FG002|Open-label Guselkumab: Week 72-264|Other|0
1087793|NCT02207244|2152287|FG003|Open-label Guselkumab: Week 72-264|Other|0
1087794|NCT02207244|2152288|FG004|Open-label Guselkumab: Week 72-264|Other|0
1087795|NCT02207244|2152289|FG005|Open-label Guselkumab: Week 72-264|Other|0
1087796|NCT02207244|2152290|FG006|Open-label Guselkumab: Week 72-264|Other|0
1087797|NCT02207244|2152291|FG007|Open-label Guselkumab: Week 72-264|Other|0
1087798|NCT02207244|2152292|FG008|Open-label Guselkumab: Week 72-264|Other|8
1087799|NCT02207244|2152293|FG009|Open-label Guselkumab: Week 72-264|Other|0
1087800|NCT02207244|2152294|FG010|Open-label Guselkumab: Week 72-264|Other|19
1087801|NCT02207244|2152284|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0
1087802|NCT02207244|2152285|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0
1087803|NCT02207244|2152286|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0
1087804|NCT02207244|2152287|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0
1087805|NCT02207244|2152288|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0
1087806|NCT02207244|2152289|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0
1087807|NCT02207244|2152290|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0
1087808|NCT02207244|2152291|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0
1087809|NCT02207244|2152292|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0
1087810|NCT02207244|2152293|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0
1087811|NCT02207244|2152294|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2
1087812|NCT02207374|2152335|FG000|Overall Study|Withdrawal by Subject|5
1087813|NCT02207374|2152336|FG001|Overall Study|Withdrawal by Subject|9
1087814|NCT02207374|2152337|FG002|Overall Study|Withdrawal by Subject|4
1087815|NCT02207374|2152335|FG000|Overall Study|Death|1
1087816|NCT02207374|2152336|FG001|Overall Study|Death|0
1087817|NCT02207374|2152337|FG002|Overall Study|Death|1
1087818|NCT02207374|2152335|FG000|Overall Study|Missing follow-up information|0
1087819|NCT02207374|2152336|FG001|Overall Study|Missing follow-up information|1
1087820|NCT02207374|2152337|FG002|Overall Study|Missing follow-up information|1
1087821|NCT02207400|2152347|FG000|Overall Study|Adverse Event|1
1087822|NCT02207400|2152348|FG001|Overall Study|Adverse Event|1
1087823|NCT02207400|2152347|FG000|Overall Study|Lost to Follow-up|6
1087824|NCT02207400|2152348|FG001|Overall Study|Lost to Follow-up|7
1087825|NCT02207400|2152347|FG000|Overall Study|Protocol Violation|1
1087826|NCT02207400|2152348|FG001|Overall Study|Protocol Violation|1
1087827|NCT02207400|2152347|FG000|Overall Study|Withdrawal by Subject|8
1087828|NCT02207400|2152348|FG001|Overall Study|Withdrawal by Subject|4
1087829|NCT02207400|2152347|FG000|Overall Study|Positive Urine Pregnancy Test|0
1087830|NCT02207400|2152348|FG001|Overall Study|Positive Urine Pregnancy Test|1
1087831|NCT02207413|2152363|FG000|Overall Study|Withdrawal by Subject|1
1087832|NCT02207413|2152364|FG001|Overall Study|Withdrawal by Subject|0
1087833|NCT02207413|2152365|FG002|Overall Study|Withdrawal by Subject|0
1087834|NCT02207413|2152366|FG003|Overall Study|Withdrawal by Subject|0
1087835|NCT02207413|2152367|FG004|Overall Study|Withdrawal by Subject|3
1087836|NCT02207413|2152368|FG005|Overall Study|Withdrawal by Subject|7
1087837|NCT02207413|2152363|FG000|Overall Study|Lost to Follow-up|0
1087838|NCT02207413|2152364|FG001|Overall Study|Lost to Follow-up|0
1087839|NCT02207413|2152365|FG002|Overall Study|Lost to Follow-up|0
1087840|NCT02207413|2152366|FG003|Overall Study|Lost to Follow-up|1
1087841|NCT02207413|2152367|FG004|Overall Study|Lost to Follow-up|1
1087842|NCT02207413|2152368|FG005|Overall Study|Lost to Follow-up|5
1087843|NCT02207413|2152363|FG000|Overall Study|Adverse Event|0
1087844|NCT02207413|2152364|FG001|Overall Study|Adverse Event|0
1087845|NCT02207413|2152365|FG002|Overall Study|Adverse Event|0
1087846|NCT02207413|2152366|FG003|Overall Study|Adverse Event|0
1087847|NCT02207413|2152367|FG004|Overall Study|Adverse Event|2
1087848|NCT02207413|2152368|FG005|Overall Study|Adverse Event|1
1087849|NCT02207413|2152363|FG000|Overall Study|Migrated/moved from study area|0
1087850|NCT02207413|2152364|FG001|Overall Study|Migrated/moved from study area|0
1087851|NCT02207413|2152365|FG002|Overall Study|Migrated/moved from study area|0
1087852|NCT02207413|2152366|FG003|Overall Study|Migrated/moved from study area|0
1087853|NCT02207413|2152367|FG004|Overall Study|Migrated/moved from study area|1
1087854|NCT02207413|2152368|FG005|Overall Study|Migrated/moved from study area|0
1087855|NCT02207491|2152399|FG000|Overall Study|Adverse Event|20
1087856|NCT02207491|2152400|FG001|Overall Study|Adverse Event|4
1087857|NCT02207491|2152399|FG000|Overall Study|Withdrawal by Subject|3
1087858|NCT02207491|2152400|FG001|Overall Study|Withdrawal by Subject|2
1087859|NCT02207491|2152399|FG000|Overall Study|Non-compliant|0
1087860|NCT02207491|2152400|FG001|Overall Study|Non-compliant|1
1087861|NCT02207491|2152399|FG000|Overall Study|Lost to Follow-up|0
1087862|NCT02207491|2152400|FG001|Overall Study|Lost to Follow-up|1
1087863|NCT02207491|2152399|FG000|Overall Study|Lack of Efficacy|3
1087864|NCT02207491|2152400|FG001|Overall Study|Lack of Efficacy|0
1087865|NCT02207491|2152399|FG000|Overall Study|Physician Decision|2
1087866|NCT02207491|2152400|FG001|Overall Study|Physician Decision|0
1087867|NCT02207491|2152399|FG000|Overall Study|Protocol Violation|3
1087868|NCT02207491|2152400|FG001|Overall Study|Protocol Violation|5
1087869|NCT02207530|2152406|FG000|Overall Study|Worsening condition under investigation|78
1087870|NCT02207530|2152406|FG000|Overall Study|Patient decision to stop study treatment|5
1087871|NCT02207530|2152406|FG000|Overall Study|Adverse Event|8
1087872|NCT02207556|2152412|FG000|Overall Study|Physician Decision|1
1087873|NCT02207556|2152413|FG001|Overall Study|Physician Decision|0
1087874|NCT02207556|2152412|FG000|Overall Study|Withdrawal by Subject|1
1087875|NCT02207556|2152413|FG001|Overall Study|Withdrawal by Subject|0
1087876|NCT02207556|2152412|FG000|Overall Study|Death|0
1087877|NCT02207556|2152413|FG001|Overall Study|Death|5
1087878|NCT02207569|2152422|FG000|Implant to 1-Month|Death|6
1087879|NCT02207569|2152422|FG000|Implant to 1-Month|Withdrawal by Subject|2
1087880|NCT02207569|2152422|FG000|Implant to 1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1
1087881|NCT02207569|2152422|FG000|1-Month to 6-Month|Death|8
1087882|NCT02207569|2152422|FG000|1-Month to 6-Month|Withdrawal by Subject|2
1087883|NCT02207569|2152422|FG000|12-Month|Death|8
1087884|NCT02207569|2152422|FG000|12-Month|Withdrawal by Subject|1
1087885|NCT02207569|2152422|FG000|6-Month to 12-Month|Death|14
1087886|NCT02207569|2152422|FG000|6-Month to 12-Month|Withdrawal by Subject|2
1087887|NCT02207569|2152422|FG000|12-Month to 24 Month|Death|23
1087888|NCT02207569|2152422|FG000|12-Month to 24 Month|Withdrawal by Subject|3
1087889|NCT02207569|2152422|FG000|24-Month to 36-Month|Death|23
1087890|NCT02207569|2152422|FG000|24-Month to 36-Month|Withdrawal by Subject|4
1087891|NCT02207569|2152422|FG000|36-Month to 48-Month|Death|25
1087892|NCT02207569|2152422|FG000|36-Month to 48-Month|Withdrawal by Subject|2
1087893|NCT02207569|2152422|FG000|36-Month to 48-Month|Lost to Follow-up|4
1087894|NCT02207569|2152422|FG000|48-Month to 60-Month|Death|1
1087895|NCT02207569|2152422|FG000|48-Month to 60-Month|Lost to Follow-up|1
1087896|NCT02207569|2152422|FG000|48-Month to 60-Month|pt 103 years old no longer traveling for MD visits|1
1087897|NCT02207569|2152422|FG000|48-Month to 60-Month|Covid-19 pt not willing to be seen|1
1087898|NCT02207608|2152428|FG000|Overall Study|Adverse Event|1
1087899|NCT02207608|2152429|FG001|Overall Study|Adverse Event|0
1087900|NCT02207621|2152438|FG000|Overall Study|Adverse Event|71
1087901|NCT02207621|2152439|FG001|Overall Study|Adverse Event|15
1087902|NCT02207621|2152440|FG002|Overall Study|Adverse Event|132
1087903|NCT02207621|2152438|FG000|Overall Study|Withdrawal by Subject|9
1087904|NCT02207621|2152439|FG001|Overall Study|Withdrawal by Subject|9
1087905|NCT02207621|2152440|FG002|Overall Study|Withdrawal by Subject|13
1087906|NCT02207621|2152438|FG000|Overall Study|Non-Compliant|3
1087907|NCT02207621|2152439|FG001|Overall Study|Non-Compliant|3
1087908|NCT02207621|2152440|FG002|Overall Study|Non-Compliant|1
1087909|NCT02207621|2152438|FG000|Overall Study|Lost to Follow-up|1
1087910|NCT02207621|2152439|FG001|Overall Study|Lost to Follow-up|0
1087911|NCT02207621|2152440|FG002|Overall Study|Lost to Follow-up|3
1087912|NCT02207621|2152438|FG000|Overall Study|Lack of Efficacy|10
1087913|NCT02207621|2152439|FG001|Overall Study|Lack of Efficacy|2
1087914|NCT02207621|2152440|FG002|Overall Study|Lack of Efficacy|4
1087915|NCT02207621|2152438|FG000|Overall Study|Disallowed Concurrent Medication|2
1087916|NCT02207621|2152439|FG001|Overall Study|Disallowed Concurrent Medication|5
1087917|NCT02207621|2152440|FG002|Overall Study|Disallowed Concurrent Medication|2
1087918|NCT02207621|2152438|FG000|Overall Study|Physician Decision|1
1087919|NCT02207621|2152439|FG001|Overall Study|Physician Decision|2
1087920|NCT02207621|2152440|FG002|Overall Study|Physician Decision|2
1087921|NCT02207621|2152438|FG000|Overall Study|Protocol Violation|4
1087922|NCT02207621|2152439|FG001|Overall Study|Protocol Violation|10
1087923|NCT02207621|2152440|FG002|Overall Study|Protocol Violation|6
1087924|NCT02207621|2152438|FG000|Overall Study|Death|2
1087925|NCT02207621|2152439|FG001|Overall Study|Death|0
1087926|NCT02207621|2152440|FG002|Overall Study|Death|0
1087927|NCT02207621|2152438|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2
1087928|NCT02207621|2152439|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1
1087929|NCT02207621|2152440|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5
1087930|NCT02207634|2152451|FG000|Overall Study|Withdrawal by Subject|21
1087931|NCT02207634|2152452|FG001|Overall Study|Withdrawal by Subject|31
1087932|NCT02207634|2152451|FG000|Overall Study|Lost to Follow-up|1
1087933|NCT02207634|2152452|FG001|Overall Study|Lost to Follow-up|0
1087934|NCT02207725|2152462|FG000|Overall Study|Did Not Receive Treatment|0
1087935|NCT02207725|2152463|FG001|Overall Study|Did Not Receive Treatment|1
1087936|NCT02207725|2152464|FG002|Overall Study|Did Not Receive Treatment|1
1087937|NCT02207725|2152465|FG003|Overall Study|Did Not Receive Treatment|1
1087938|NCT02207816|2152489|FG000|Overall Study|Serious Adverse Event|0
1087939|NCT02207816|2152490|FG001|Overall Study|Serious Adverse Event|5
1087940|NCT02207816|2152491|FG002|Overall Study|Serious Adverse Event|2
1087941|NCT02207816|2152489|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
1087942|NCT02207816|2152490|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1
1087943|NCT02207816|2152491|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2
1087944|NCT02207816|2152489|FG000|Overall Study|Withdrawal by Subject|4
1087945|NCT02207816|2152490|FG001|Overall Study|Withdrawal by Subject|9
1087946|NCT02207816|2152491|FG002|Overall Study|Withdrawal by Subject|7
1087947|NCT02207816|2152489|FG000|Overall Study|Migrated/Moved From Study Area|41
1087948|NCT02207816|2152490|FG001|Overall Study|Migrated/Moved From Study Area|60
1087949|NCT02207816|2152491|FG002|Overall Study|Migrated/Moved From Study Area|51
1087950|NCT02207816|2152489|FG000|Overall Study|Lost to Follow-up|3
1087951|NCT02207816|2152490|FG001|Overall Study|Lost to Follow-up|9
1087952|NCT02207816|2152491|FG002|Overall Study|Lost to Follow-up|1
1087953|NCT02207816|2152489|FG000|Overall Study|Other|1
1087954|NCT02207816|2152490|FG001|Overall Study|Other|2
1087955|NCT02207816|2152491|FG002|Overall Study|Other|4
1087956|NCT02207829|2152504|FG000|Overall Study|Adverse Event|10
1087957|NCT02207829|2152505|FG001|Overall Study|Adverse Event|9
1087958|NCT02207829|2152504|FG000|Overall Study|Lack of Efficacy|7
1087959|NCT02207829|2152505|FG001|Overall Study|Lack of Efficacy|5
1087960|NCT02207829|2152504|FG000|Overall Study|Lost to Follow-up|2
1087961|NCT02207829|2152505|FG001|Overall Study|Lost to Follow-up|2
1087962|NCT02207829|2152504|FG000|Overall Study|Protocol deviation|5
1087963|NCT02207829|2152505|FG001|Overall Study|Protocol deviation|4
1087964|NCT02207829|2152504|FG000|Overall Study|Withdrew consent|18
1087965|NCT02207829|2152505|FG001|Overall Study|Withdrew consent|14
1087966|NCT02207907|2152513|FG000|Overall Study|Lost to Follow-up|3
1087967|NCT02207907|2152514|FG001|Overall Study|Lost to Follow-up|1
1087968|NCT02207907|2152513|FG000|Overall Study|Withdrawal by Subject|5
1087969|NCT02207907|2152514|FG001|Overall Study|Withdrawal by Subject|6
1087970|NCT02207907|2152513|FG000|Overall Study|Did not meet study criteria|3
1087971|NCT02207907|2152514|FG001|Overall Study|Did not meet study criteria|0
1087972|NCT02207907|2152513|FG000|Overall Study|Pregnancy|0
1087973|NCT02207907|2152514|FG001|Overall Study|Pregnancy|1
1087974|NCT02207946|2152523|FG000|Overall Study|Lost to Follow-up|1
1087975|NCT02207946|2152524|FG001|Overall Study|Lost to Follow-up|0
1087976|NCT02207946|2152523|FG000|Overall Study|Adverse Event|0
1087977|NCT02207946|2152524|FG001|Overall Study|Adverse Event|1
1087978|NCT02208050|2152556|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1
1087979|NCT02208050|2152557|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0
1087980|NCT02208063|2152579|FG000|Overall Study|Death|3
1087981|NCT02208063|2152580|FG001|Overall Study|Death|5
1087982|NCT02208063|2152579|FG000|Overall Study|Not Specified in report|3
1087983|NCT02208063|2152580|FG001|Overall Study|Not Specified in report|4
1087984|NCT02208063|2152579|FG000|Overall Study|Withdrawal by Subject|5
1087985|NCT02208063|2152580|FG001|Overall Study|Withdrawal by Subject|2
1087986|NCT02208063|2152579|FG000|Overall Study|Lost to Follow-up|1
1087987|NCT02208063|2152580|FG001|Overall Study|Lost to Follow-up|0
1087988|NCT02208089|2152588|FG000|Overall Study|Withdrawal by Subject|1
1087989|NCT02208089|2152589|FG001|Overall Study|Withdrawal by Subject|0
1087990|NCT02208089|2152588|FG000|Overall Study|Lost to Follow-up|6
1087991|NCT02208089|2152589|FG001|Overall Study|Lost to Follow-up|0
1087992|NCT02208843|2152638|FG000|Overall Study|Clinical symptoms of progression|2
1087993|NCT02208843|2152638|FG000|Overall Study|Progression disease according to RECIST|24
1087994|NCT02208843|2152638|FG000|Overall Study|Adverse Event|12
1087995|NCT02208843|2152638|FG000|Overall Study|Protocol Violation|1
1087996|NCT02208843|2152638|FG000|Overall Study|Withdrawal by Subject|1
1087997|NCT02208843|2152638|FG000|Overall Study|Switched to commercial afatinib|20
1087998|NCT02208999|2152644|FG000|Overall Study|Lost to Follow-up|1
1087999|NCT02209181|2152672|FG000|Overall Study|Adverse Event|1
1088000|NCT02209181|2152673|FG001|Overall Study|Adverse Event|0
1088001|NCT02209181|2152674|FG002|Overall Study|Adverse Event|1
1088002|NCT02209181|2152675|FG003|Overall Study|Adverse Event|0
1088003|NCT02209181|2152672|FG000|Overall Study|Withdrawal by Subject|0
1088004|NCT02209181|2152673|FG001|Overall Study|Withdrawal by Subject|1
1088005|NCT02209181|2152674|FG002|Overall Study|Withdrawal by Subject|0
1088006|NCT02209181|2152675|FG003|Overall Study|Withdrawal by Subject|0
1088007|NCT02209454|2152707|FG000|Second Period|Adverse Event|1
1088008|NCT02209454|2152708|FG001|Second Period|Adverse Event|0
1088009|NCT02209506|2152719|FG000|Overall Study|Withdrawal by Subject|0
1088010|NCT02209506|2152720|FG001|Overall Study|Withdrawal by Subject|0
1088011|NCT02209506|2152721|FG002|Overall Study|Withdrawal by Subject|0
1088012|NCT02209506|2152722|FG003|Overall Study|Withdrawal by Subject|0
1088013|NCT02209506|2152723|FG004|Overall Study|Withdrawal by Subject|1
1088014|NCT02209597|2152758|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
1088015|NCT02209597|2152758|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
1088016|NCT02209597|2152758|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
1088017|NCT02209597|2152758|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
1088018|NCT02209766|2152782|FG000|Overall Study|Withdrawal by Subject|0
1088019|NCT02209766|2152783|FG001|Overall Study|Withdrawal by Subject|0
1088020|NCT02209766|2152784|FG002|Overall Study|Withdrawal by Subject|0
1088021|NCT02209766|2152785|FG003|Overall Study|Withdrawal by Subject|1
1088022|NCT02209766|2152786|FG004|Overall Study|Withdrawal by Subject|0
1088023|NCT02210000|2152807|FG000|Overall Study|Study Terminated|11
1088024|NCT02210000|2152808|FG001|Overall Study|Study Terminated|12
1088025|NCT02210000|2152807|FG000|Overall Study|Withdrawal by Subject|7
1088026|NCT02210000|2152808|FG001|Overall Study|Withdrawal by Subject|1
1088027|NCT02210000|2152807|FG000|Overall Study|Adverse Event|1
1088028|NCT02210000|2152808|FG001|Overall Study|Adverse Event|5
1088029|NCT02210000|2152807|FG000|Overall Study|Lost to Follow-up|0
1088030|NCT02210000|2152808|FG001|Overall Study|Lost to Follow-up|2
1088031|NCT02210000|2152807|FG000|Overall Study|Physician Decision|0
1088032|NCT02210000|2152808|FG001|Overall Study|Physician Decision|1
1088033|NCT02210091|2152828|FG000|Overall Study|Physician Decision|0
1088034|NCT02210091|2152829|FG001|Overall Study|Physician Decision|1
1088035|NCT02210091|2152828|FG000|Overall Study|Withdrawal by Sponsor|0
1088036|NCT02210091|2152829|FG001|Overall Study|Withdrawal by Sponsor|1
1088037|NCT02210208|2152860|FG000|Period A (Graft Site)|Withdrawal by Subject|1
1088038|NCT02210208|2152860|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1
1088039|NCT02210208|2152860|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7
1088040|NCT02210221|2152866|FG000|Overall Study|Lack of Efficacy|7
1088041|NCT02210221|2152866|FG000|Overall Study|Withdrawal by Subject|43
1088042|NCT02210689|2152912|FG000|Overall Study|Withdrawal by Subject|7
1088043|NCT02210689|2152913|FG001|Overall Study|Withdrawal by Subject|4
1088044|NCT02210689|2152914|FG002|Overall Study|Withdrawal by Subject|2
1088045|NCT02210689|2152912|FG000|Overall Study|Adverse Event|0
1088046|NCT02210689|2152913|FG001|Overall Study|Adverse Event|1
1088047|NCT02210689|2152914|FG002|Overall Study|Adverse Event|0
1088048|NCT02210689|2152912|FG000|Overall Study|Protocol Violation|1
1088049|NCT02210689|2152913|FG001|Overall Study|Protocol Violation|0
1088050|NCT02210689|2152914|FG002|Overall Study|Protocol Violation|0
1088051|NCT02210689|2152912|FG000|Overall Study|Lost to Follow-up|11
1088052|NCT02210689|2152913|FG001|Overall Study|Lost to Follow-up|9
1088053|NCT02210689|2152914|FG002|Overall Study|Lost to Follow-up|5
1088054|NCT02210689|2152912|FG000|Overall Study|Pregnancy|0
1088055|NCT02210689|2152913|FG001|Overall Study|Pregnancy|1
1088056|NCT02210689|2152914|FG002|Overall Study|Pregnancy|0
1088057|NCT02210689|2152912|FG000|Overall Study|Lack of Efficacy|0
1088058|NCT02210689|2152913|FG001|Overall Study|Lack of Efficacy|1
1088059|NCT02210689|2152914|FG002|Overall Study|Lack of Efficacy|5
1088060|NCT02210689|2152912|FG000|Overall Study|Prohibited medication|2
1088061|NCT02210689|2152913|FG001|Overall Study|Prohibited medication|8
1088062|NCT02210689|2152914|FG002|Overall Study|Prohibited medication|1
1088063|NCT02210689|2152912|FG000|Overall Study|Negative Nugent score at baseline|6
1088064|NCT02210689|2152913|FG001|Overall Study|Negative Nugent score at baseline|2
1088065|NCT02210689|2152914|FG002|Overall Study|Negative Nugent score at baseline|2
1088066|NCT02210689|2152912|FG000|Overall Study|Other|25
1088067|NCT02210689|2152913|FG001|Overall Study|Other|21
1088068|NCT02210689|2152914|FG002|Overall Study|Other|8
1088069|NCT02210780|2152924|FG000|Overall Study|Adverse Event|0
1088070|NCT02210780|2152925|FG001|Overall Study|Adverse Event|5
1088071|NCT02210780|2152924|FG000|Overall Study|Lost to Follow-up|2
1088072|NCT02210780|2152925|FG001|Overall Study|Lost to Follow-up|1
1088073|NCT02210780|2152924|FG000|Overall Study|Withdrawal by Subject|1
1088074|NCT02210780|2152925|FG001|Overall Study|Withdrawal by Subject|1
1088075|NCT02210780|2152924|FG000|Overall Study|Physician Decision|1
1088076|NCT02210780|2152925|FG001|Overall Study|Physician Decision|0
1088077|NCT02210780|2152924|FG000|Overall Study|Protocol Violation|1
1088078|NCT02210780|2152925|FG001|Overall Study|Protocol Violation|0
1088079|NCT02210780|2152924|FG000|Overall Study|Other than specified above|0
1088080|NCT02210780|2152925|FG001|Overall Study|Other than specified above|1
1088081|NCT02211014|2152933|FG000|Overall Study|Adverse Event|0
1088082|NCT02211014|2152934|FG001|Overall Study|Adverse Event|2
1088083|NCT02211014|2152933|FG000|Overall Study|Physician Decision|1
1088084|NCT02211014|2152934|FG001|Overall Study|Physician Decision|2
1088085|NCT02211014|2152933|FG000|Overall Study|Started another cancer therapy|1
1088086|NCT02211014|2152934|FG001|Overall Study|Started another cancer therapy|0
1088087|NCT02211014|2152933|FG000|Overall Study|Withdrawal by Subject|0
1088088|NCT02211014|2152934|FG001|Overall Study|Withdrawal by Subject|1
1088089|NCT02211014|2152933|FG000|Overall Study|In agreement with patient, no benefit|0
1088090|NCT02211014|2152934|FG001|Overall Study|In agreement with patient, no benefit|1
1088091|NCT02211261|2152967|FG000|Overall Study|Withdrawal by Subject|0
1088092|NCT02211261|2152968|FG001|Overall Study|Withdrawal by Subject|0
1088093|NCT02211261|2152969|FG002|Overall Study|Withdrawal by Subject|1
1088094|NCT02211261|2152970|FG003|Overall Study|Withdrawal by Subject|0
1088095|NCT02211261|2152971|FG004|Overall Study|Withdrawal by Subject|2
1088096|NCT02211261|2152972|FG005|Overall Study|Withdrawal by Subject|0
1088097|NCT02211261|2152973|FG006|Overall Study|Withdrawal by Subject|0
1088098|NCT02211261|2152974|FG007|Overall Study|Withdrawal by Subject|0
1088099|NCT02211261|2152975|FG008|Overall Study|Withdrawal by Subject|0
1088100|NCT02211261|2152976|FG009|Overall Study|Withdrawal by Subject|0
1088101|NCT02211261|2152977|FG010|Overall Study|Withdrawal by Subject|0
1088102|NCT02211261|2152967|FG000|Overall Study|Other|0
1088103|NCT02211261|2152968|FG001|Overall Study|Other|0
1088104|NCT02211261|2152969|FG002|Overall Study|Other|0
1088105|NCT02211261|2152970|FG003|Overall Study|Other|0
1088106|NCT02211261|2152971|FG004|Overall Study|Other|0
1088107|NCT02211261|2152972|FG005|Overall Study|Other|1
1088108|NCT02211261|2152973|FG006|Overall Study|Other|0
1088109|NCT02211261|2152974|FG007|Overall Study|Other|0
1088110|NCT02211261|2152975|FG008|Overall Study|Other|0
1088111|NCT02211261|2152976|FG009|Overall Study|Other|2
1088112|NCT02211261|2152977|FG010|Overall Study|Other|0
1088113|NCT02211261|2152967|FG000|Overall Study|Lost to Follow-up|0
1088114|NCT02211261|2152968|FG001|Overall Study|Lost to Follow-up|0
1088115|NCT02211261|2152969|FG002|Overall Study|Lost to Follow-up|0
1088116|NCT02211261|2152970|FG003|Overall Study|Lost to Follow-up|0
1088117|NCT02211261|2152971|FG004|Overall Study|Lost to Follow-up|0
1088118|NCT02211261|2152972|FG005|Overall Study|Lost to Follow-up|0
1088119|NCT02211261|2152973|FG006|Overall Study|Lost to Follow-up|0
1088120|NCT02211261|2152974|FG007|Overall Study|Lost to Follow-up|1
1088121|NCT02211261|2152975|FG008|Overall Study|Lost to Follow-up|0
1088122|NCT02211261|2152976|FG009|Overall Study|Lost to Follow-up|0
1088123|NCT02211261|2152977|FG010|Overall Study|Lost to Follow-up|0
1088124|NCT02211313|2153012|FG000|Overall Study|Treatment Failure|5
1088125|NCT02211313|2153013|FG001|Overall Study|Treatment Failure|2
1088126|NCT02211313|2153012|FG000|Overall Study|No Follow up Questionnaires|1
1088127|NCT02211313|2153013|FG001|Overall Study|No Follow up Questionnaires|1
1088128|NCT02211638|2153045|FG000|Overall Study|Case Report Forms Uncollected|291
1088129|NCT02211638|2153045|FG000|Overall Study|Protocol Violation|692
1088130|NCT02212197|2153071|FG000|Overall Study|Need for radiotherapy|1
1088131|NCT02212197|2153072|FG001|Overall Study|Need for radiotherapy|0
1088132|NCT02212197|2153073|FG002|Overall Study|Need for radiotherapy|0
1088133|NCT02212301|2153081|FG000|Period 1|Lost to Follow-up|0
1088134|NCT02212301|2153082|FG001|Period 1|Lost to Follow-up|1
1088135|NCT02212379|2153089|FG000|From Baseline to Week 48|Lack of Efficacy|1
1088136|NCT02212379|2153089|FG000|From Baseline to Week 48|Adverse Event|7
1088137|NCT02212379|2153089|FG000|From Baseline to Week 48|Withdrawal by Subject|1
1088138|NCT02212379|2153089|FG000|From Week 48 to Week 96|Lack of Efficacy|1
1088139|NCT02212379|2153089|FG000|From Week 48 to Week 96|Adverse Event|1
1088140|NCT02212379|2153089|FG000|From Week 48 to Week 96|Withdrawal by Subject|2
1088141|NCT02212457|2153102|FG000|Overall Study|Adverse Event|1
1088142|NCT02212457|2153103|FG001|Overall Study|Adverse Event|2
1088143|NCT02212457|2153104|FG002|Overall Study|Adverse Event|2
1088144|NCT02212457|2153105|FG003|Overall Study|Adverse Event|2
1088145|NCT02212457|2153106|FG004|Overall Study|Adverse Event|0
1088146|NCT02212457|2153107|FG005|Overall Study|Adverse Event|1
1088147|NCT02212457|2153102|FG000|Overall Study|Withdrawal by Subject|8
1088148|NCT02212457|2153103|FG001|Overall Study|Withdrawal by Subject|10
1088149|NCT02212457|2153104|FG002|Overall Study|Withdrawal by Subject|8
1088150|NCT02212457|2153105|FG003|Overall Study|Withdrawal by Subject|6
1088151|NCT02212457|2153106|FG004|Overall Study|Withdrawal by Subject|5
1088152|NCT02212457|2153107|FG005|Overall Study|Withdrawal by Subject|4
1088153|NCT02212457|2153102|FG000|Overall Study|Lost to Follow-up|6
1088154|NCT02212457|2153103|FG001|Overall Study|Lost to Follow-up|7
1088155|NCT02212457|2153104|FG002|Overall Study|Lost to Follow-up|4
1088156|NCT02212457|2153105|FG003|Overall Study|Lost to Follow-up|1
1088157|NCT02212457|2153106|FG004|Overall Study|Lost to Follow-up|8
1088158|NCT02212457|2153107|FG005|Overall Study|Lost to Follow-up|4
1088159|NCT02212457|2153102|FG000|Overall Study|Protocol Violation|2
1088160|NCT02212457|2153103|FG001|Overall Study|Protocol Violation|1
1088161|NCT02212457|2153104|FG002|Overall Study|Protocol Violation|0
1088162|NCT02212457|2153105|FG003|Overall Study|Protocol Violation|1
1088163|NCT02212457|2153106|FG004|Overall Study|Protocol Violation|2
1088164|NCT02212457|2153107|FG005|Overall Study|Protocol Violation|3
1088165|NCT02212457|2153102|FG000|Overall Study|Other|2
1088166|NCT02212457|2153103|FG001|Overall Study|Other|1
1088167|NCT02212457|2153104|FG002|Overall Study|Other|2
1088168|NCT02212457|2153105|FG003|Overall Study|Other|1
1088169|NCT02212457|2153106|FG004|Overall Study|Other|0
1088170|NCT02212457|2153107|FG005|Overall Study|Other|1
1088171|NCT02212678|2153132|FG000|Overall Study|Adverse Event|1
1088172|NCT02212730|2153138|FG000|Overall Study|Tumor not of the required cell histology|1
1088173|NCT02212730|2153139|FG001|Overall Study|Tumor not of the required cell histology|0
1088174|NCT02212730|2153138|FG000|Overall Study|Withdrawal by Subject|1
1088175|NCT02212730|2153139|FG001|Overall Study|Withdrawal by Subject|0
1088176|NCT02212730|2153138|FG000|Overall Study|Disease progression prior to RCC surgery|0
1088177|NCT02212730|2153139|FG001|Overall Study|Disease progression prior to RCC surgery|1
1088178|NCT02213042|2153168|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14
1088179|NCT02213042|2153169|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13
1088180|NCT02213042|2153170|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8
1088181|NCT02213042|2153168|FG000|Overall Study|Adverse Event|2
1088182|NCT02213042|2153169|FG001|Overall Study|Adverse Event|1
1088183|NCT02213042|2153170|FG002|Overall Study|Adverse Event|0
1088184|NCT02213042|2153168|FG000|Overall Study|Withdrawal by Subject|0
1088185|NCT02213042|2153169|FG001|Overall Study|Withdrawal by Subject|1
1088186|NCT02213042|2153170|FG002|Overall Study|Withdrawal by Subject|1
1088187|NCT02213042|2153168|FG000|Overall Study|Protocol Violation|1
1088188|NCT02213042|2153169|FG001|Overall Study|Protocol Violation|0
1088189|NCT02213042|2153170|FG002|Overall Study|Protocol Violation|0
1088190|NCT02213042|2153168|FG000|Overall Study|Investigator discretion|0
1088191|NCT02213042|2153169|FG001|Overall Study|Investigator discretion|0
1088192|NCT02213042|2153170|FG002|Overall Study|Investigator discretion|1
1088193|NCT02213055|2153182|FG000|Overall Study|Protocol was not Followed at Enrollment|5
1088194|NCT02213055|2153183|FG001|Overall Study|Protocol was not Followed at Enrollment|0
1088195|NCT02213055|2153182|FG000|Overall Study|Protocol was not Followed during Study|1
1088196|NCT02213055|2153183|FG001|Overall Study|Protocol was not Followed during Study|0
1088197|NCT02213055|2153182|FG000|Overall Study|Documentation Issue at Enrollment|1
1088198|NCT02213055|2153183|FG001|Overall Study|Documentation Issue at Enrollment|0
1088199|NCT02213055|2153182|FG000|Overall Study|Documentation Issue during Study|10
1088200|NCT02213055|2153183|FG001|Overall Study|Documentation Issue during Study|0
1088201|NCT02213055|2153182|FG000|Overall Study|Did not have Live Lice|8
1088202|NCT02213055|2153183|FG001|Overall Study|Did not have Live Lice|0
1088203|NCT02213055|2153182|FG000|Overall Study|Had another Treatment during the Study|3
1088204|NCT02213055|2153183|FG001|Overall Study|Had another Treatment during the Study|0
1088205|NCT02213055|2153182|FG000|Overall Study|Did not meet Inclusion Criteria|6
1088206|NCT02213055|2153183|FG001|Overall Study|Did not meet Inclusion Criteria|0
1088207|NCT02213055|2153182|FG000|Overall Study|Did not Return to School|5
1088208|NCT02213055|2153183|FG001|Overall Study|Did not Return to School|0
1088209|NCT02213094|2153204|FG000|Overall Study|Adverse Event|1
1088210|NCT02213094|2153205|FG001|Overall Study|Adverse Event|0
1088211|NCT02213133|2153214|FG000|Overall Study|Participant discontinued study therapy|2
1088212|NCT02213133|2153215|FG001|Overall Study|Participant discontinued study therapy|0
1088213|NCT02213133|2153216|FG002|Overall Study|Participant discontinued study therapy|0
1088214|NCT02213133|2153214|FG000|Overall Study|Participant withdrew informed consent|2
1088215|NCT02213133|2153215|FG001|Overall Study|Participant withdrew informed consent|1
1088216|NCT02213133|2153216|FG002|Overall Study|Participant withdrew informed consent|2
1088217|NCT02213133|2153214|FG000|Overall Study|Disease progression|11
1088218|NCT02213133|2153215|FG001|Overall Study|Disease progression|2
1088219|NCT02213133|2153216|FG002|Overall Study|Disease progression|0
1088220|NCT02213133|2153214|FG000|Overall Study|Adverse Event (AE)|1
1088221|NCT02213133|2153215|FG001|Overall Study|Adverse Event (AE)|0
1088222|NCT02213133|2153216|FG002|Overall Study|Adverse Event (AE)|0
1088223|NCT02213133|2153214|FG000|Overall Study|Death|16
1088224|NCT02213133|2153215|FG001|Overall Study|Death|2
1088225|NCT02213133|2153216|FG002|Overall Study|Death|1
1088226|NCT02213133|2153214|FG000|Overall Study|Other|5
1088227|NCT02213133|2153215|FG001|Overall Study|Other|0
1088228|NCT02213133|2153216|FG002|Overall Study|Other|0
1088229|NCT02213198|2153227|FG000|Baseline|No show for intake|7
1088230|NCT02213198|2153228|FG001|Baseline|No show for intake|9
1088231|NCT02213198|2153227|FG000|Baseline|Withdrawal by Subject|34
1088232|NCT02213198|2153228|FG001|Baseline|Withdrawal by Subject|11
1088233|NCT02213198|2153227|FG000|Baseline|transferred out of clinic|7
1088234|NCT02213198|2153228|FG001|Baseline|transferred out of clinic|9
1088235|NCT02213198|2153227|FG000|Baseline|Lost to Follow-up|40
1088236|NCT02213198|2153228|FG001|Baseline|Lost to Follow-up|21
1088237|NCT02213198|2153227|FG000|Baseline|incarcerated,violent|0
1088238|NCT02213198|2153228|FG001|Baseline|incarcerated,violent|1
1088239|NCT02213198|2153227|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
1088240|NCT02213198|2153228|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
1088241|NCT02213198|2153227|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
1088242|NCT02213198|2153228|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
1088243|NCT02213198|2153227|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
1088244|NCT02213198|2153228|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
1088245|NCT02213198|2153227|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
1088246|NCT02213198|2153228|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
1088247|NCT02213198|2153227|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
1088248|NCT02213198|2153228|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
1088249|NCT02213198|2153227|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
1088250|NCT02213198|2153228|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
1088251|NCT02213263|2153244|FG000|Overall Study|Insufficient clinical response|4
1088252|NCT02213263|2153245|FG001|Overall Study|Insufficient clinical response|3
1088253|NCT02213263|2153244|FG000|Overall Study|Lost to Follow-up|0
1088254|NCT02213263|2153245|FG001|Overall Study|Lost to Follow-up|1
1088255|NCT02213263|2153244|FG000|Overall Study|No longer willing to participate|3
1088256|NCT02213263|2153245|FG001|Overall Study|No longer willing to participate|4
1088257|NCT02213263|2153244|FG000|Overall Study|Progressive disease|20
1088258|NCT02213263|2153245|FG001|Overall Study|Progressive disease|14
1088259|NCT02213263|2153244|FG000|Overall Study|Protocol Violation|0
1088260|NCT02213263|2153245|FG001|Overall Study|Protocol Violation|1
1088261|NCT02213263|2153244|FG000|Overall Study|Adverse Event|1
1088262|NCT02213263|2153245|FG001|Overall Study|Adverse Event|3
1088263|NCT02213380|2153266|FG000|Underwent Randomization|Withdrawal by Subject|2
1088264|NCT02213380|2153267|FG001|Underwent Randomization|Withdrawal by Subject|0
1088265|NCT02213380|2153266|FG000|Underwent Randomization|Not treated|3
1088266|NCT02213380|2153267|FG001|Underwent Randomization|Not treated|3
1088267|NCT02213380|2153266|FG000|Per-protocol Analysis|Protocol Violation|32
1088268|NCT02213380|2153267|FG001|Per-protocol Analysis|Protocol Violation|36
1088269|NCT02213458|2153275|FG000|Overall Study|No longer meets criteria: caregiver deceased|4
1088270|NCT02213458|2153276|FG001|Overall Study|No longer meets criteria: caregiver deceased|0
1088271|NCT02213458|2153275|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4
1088272|NCT02213458|2153276|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0
1088273|NCT02213458|2153275|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2
1088274|NCT02213458|2153276|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0
1088275|NCT02213458|2153275|FG000|Overall Study|No longer meets criteria: patient moved out of state|10
1088276|NCT02213458|2153276|FG001|Overall Study|No longer meets criteria: patient moved out of state|0
1088277|NCT02213458|2153275|FG000|Overall Study|Refused re-consent|6
1088278|NCT02213458|2153276|FG001|Overall Study|Refused re-consent|0
1088279|NCT02213458|2153275|FG000|Overall Study|Lost to Follow-up|2
1088280|NCT02213458|2153276|FG001|Overall Study|Lost to Follow-up|2
1088281|NCT02213458|2153275|FG000|Overall Study|Withdrawal by Subject|26
1088282|NCT02213458|2153276|FG001|Overall Study|Withdrawal by Subject|8
1088283|NCT02213510|2153284|FG000|Overall Study|Death|0
1088284|NCT02213510|2153285|FG001|Overall Study|Death|1
1088285|NCT02213510|2153284|FG000|Overall Study|Lost to Follow-up|1
1088286|NCT02213510|2153285|FG001|Overall Study|Lost to Follow-up|0
1088287|NCT02213666|2153291|FG000|Overall Study|Withdrawal by Subject|1
1088288|NCT02214121|2153320|FG000|Part A|Patient decision|2
1088289|NCT02214121|2153321|FG001|Part A|Patient decision|0
1088290|NCT02214121|2153322|FG002|Part A|Patient decision|0
1088291|NCT02214121|2153320|FG000|Part A|Dev. of study-specific withdrawal crit.|4
1088292|NCT02214121|2153321|FG001|Part A|Dev. of study-specific withdrawal crit.|0
1088293|NCT02214121|2153322|FG002|Part A|Dev. of study-specific withdrawal crit.|0
1088294|NCT02214121|2153320|FG000|Part A|Other|1
1088295|NCT02214121|2153321|FG001|Part A|Other|0
1088296|NCT02214121|2153322|FG002|Part A|Other|0
1088297|NCT02214121|2153320|FG000|Part B|Patient decision|0
1088298|NCT02214121|2153321|FG001|Part B|Patient decision|1
1088299|NCT02214121|2153322|FG002|Part B|Patient decision|0
1088300|NCT02214121|2153320|FG000|Part B|Dev. of study-specific withdrawal crit.|0
1088301|NCT02214121|2153321|FG001|Part B|Dev. of study-specific withdrawal crit.|2
1088302|NCT02214121|2153322|FG002|Part B|Dev. of study-specific withdrawal crit.|0
1088303|NCT02214121|2153320|FG000|Part B|Lost to Follow-up|0
1088304|NCT02214121|2153321|FG001|Part B|Lost to Follow-up|0
1088305|NCT02214121|2153322|FG002|Part B|Lost to Follow-up|1
1088306|NCT02214186|2153357|FG000|Overall Study|Lost to Follow-up|1
1088307|NCT02214186|2153358|FG001|Overall Study|Lost to Follow-up|1
1088308|NCT02214186|2153357|FG000|Overall Study|Protocol Violation|1
1088309|NCT02214186|2153358|FG001|Overall Study|Protocol Violation|1
1088310|NCT02214225|2153381|FG000|Overall Study|Lost to Follow-up|46
1088311|NCT02214225|2153382|FG001|Overall Study|Lost to Follow-up|18
1088312|NCT02214225|2153383|FG002|Overall Study|Lost to Follow-up|18
1088313|NCT02214225|2153381|FG000|Overall Study|Withdrawal by Subject|2
1088314|NCT02214225|2153382|FG001|Overall Study|Withdrawal by Subject|0
1088315|NCT02214225|2153383|FG002|Overall Study|Withdrawal by Subject|2
1088316|NCT02214225|2153381|FG000|Overall Study|Death|5
1088317|NCT02214225|2153382|FG001|Overall Study|Death|0
1088318|NCT02214225|2153383|FG002|Overall Study|Death|1
1088319|NCT02214225|2153381|FG000|Overall Study|randomized in error, not vaccinated|2
1088320|NCT02214225|2153382|FG001|Overall Study|randomized in error, not vaccinated|1
1088321|NCT02214225|2153383|FG002|Overall Study|randomized in error, not vaccinated|1
1088322|NCT02215252|2153531|FG000|Overall Study|Adverse Event|1
1088323|NCT02215252|2153532|FG001|Overall Study|Adverse Event|5
1088324|NCT02215252|2153533|FG002|Overall Study|Adverse Event|2
1088325|NCT02215252|2153531|FG000|Overall Study|Lost to Follow-up|0
1088326|NCT02215252|2153532|FG001|Overall Study|Lost to Follow-up|0
1088327|NCT02215252|2153533|FG002|Overall Study|Lost to Follow-up|1
1088328|NCT02215252|2153531|FG000|Overall Study|Does not Meet Entrance Criteria|0
1088329|NCT02215252|2153532|FG001|Overall Study|Does not Meet Entrance Criteria|1
1088330|NCT02215252|2153533|FG002|Overall Study|Does not Meet Entrance Criteria|0
1088331|NCT02215252|2153531|FG000|Overall Study|Protocol Violation|0
1088332|NCT02215252|2153532|FG001|Overall Study|Protocol Violation|1
1088333|NCT02215252|2153533|FG002|Overall Study|Protocol Violation|0
1088334|NCT02215252|2153531|FG000|Overall Study|Withdrawal by Subject|1
1088335|NCT02215252|2153532|FG001|Overall Study|Withdrawal by Subject|0
1088336|NCT02215252|2153533|FG002|Overall Study|Withdrawal by Subject|0
1088337|NCT02215252|2153531|FG000|Overall Study|Other|0
1088338|NCT02215252|2153532|FG001|Overall Study|Other|1
1088339|NCT02215252|2153533|FG002|Overall Study|Other|1
1088340|NCT02215616|2153549|FG000|Overall Study|Sponsor requested to stop study drug|0
1088341|NCT02215616|2153550|FG001|Overall Study|Sponsor requested to stop study drug|0
1088342|NCT02215616|2153551|FG002|Overall Study|Sponsor requested to stop study drug|1
1088343|NCT02215616|2153552|FG003|Overall Study|Sponsor requested to stop study drug|4
1088344|NCT02215616|2153549|FG000|Overall Study|Death|1
1088345|NCT02215616|2153550|FG001|Overall Study|Death|0
1088346|NCT02215616|2153551|FG002|Overall Study|Death|0
1088347|NCT02215616|2153552|FG003|Overall Study|Death|0
1088348|NCT02215616|2153549|FG000|Overall Study|Adverse Event|7
1088349|NCT02215616|2153550|FG001|Overall Study|Adverse Event|4
1088350|NCT02215616|2153551|FG002|Overall Study|Adverse Event|9
1088351|NCT02215616|2153552|FG003|Overall Study|Adverse Event|2
1088352|NCT02215616|2153549|FG000|Overall Study|Withdrawal by Subject|1
1088353|NCT02215616|2153550|FG001|Overall Study|Withdrawal by Subject|8
1088354|NCT02215616|2153551|FG002|Overall Study|Withdrawal by Subject|2
1088355|NCT02215616|2153552|FG003|Overall Study|Withdrawal by Subject|5
1088356|NCT02215616|2153549|FG000|Overall Study|Non-compliance|0
1088357|NCT02215616|2153550|FG001|Overall Study|Non-compliance|2
1088358|NCT02215616|2153551|FG002|Overall Study|Non-compliance|1
1088359|NCT02215616|2153552|FG003|Overall Study|Non-compliance|0
1088360|NCT02215616|2153549|FG000|Overall Study|Protocol Violation|0
1088361|NCT02215616|2153550|FG001|Overall Study|Protocol Violation|2
1088362|NCT02215616|2153551|FG002|Overall Study|Protocol Violation|0
1088363|NCT02215616|2153552|FG003|Overall Study|Protocol Violation|0
1088364|NCT02215616|2153549|FG000|Overall Study|Lost to Follow-up|1
1088365|NCT02215616|2153550|FG001|Overall Study|Lost to Follow-up|1
1088366|NCT02215616|2153551|FG002|Overall Study|Lost to Follow-up|0
1088367|NCT02215616|2153552|FG003|Overall Study|Lost to Follow-up|1
1088368|NCT02215616|2153549|FG000|Overall Study|Other than specified|1
1088369|NCT02215616|2153550|FG001|Overall Study|Other than specified|0
1088370|NCT02215616|2153551|FG002|Overall Study|Other than specified|1
1088371|NCT02215616|2153552|FG003|Overall Study|Other than specified|1
1088372|NCT02215954|2153565|FG000|Overall Study|Adverse Event|0
1088373|NCT02215954|2153566|FG001|Overall Study|Adverse Event|0
1088374|NCT02215954|2153567|FG002|Overall Study|Adverse Event|1
1088375|NCT02215954|2153565|FG000|Overall Study|Withdrawal by Subject|0
1088376|NCT02215954|2153566|FG001|Overall Study|Withdrawal by Subject|0
1088377|NCT02215954|2153567|FG002|Overall Study|Withdrawal by Subject|2
1088378|NCT02215954|2153565|FG000|Overall Study|Not exposed|1
1088379|NCT02215954|2153566|FG001|Overall Study|Not exposed|1
1088380|NCT02215954|2153567|FG002|Overall Study|Not exposed|3
1088381|NCT02215967|2153580|FG000|Overall Study|Patient became ineligible for treatment|0
1088382|NCT02215967|2153581|FG001|Overall Study|Patient became ineligible for treatment|0
1088383|NCT02215967|2153582|FG002|Overall Study|Patient became ineligible for treatment|0
1088384|NCT02215967|2153583|FG003|Overall Study|Patient became ineligible for treatment|3
1088385|NCT02215967|2153580|FG000|Overall Study|Patient did not get CAR T-Cells|0
1088386|NCT02215967|2153581|FG001|Overall Study|Patient did not get CAR T-Cells|0
1088387|NCT02215967|2153582|FG002|Overall Study|Patient did not get CAR T-Cells|1
1088388|NCT02215967|2153583|FG003|Overall Study|Patient did not get CAR T-Cells|0
1088389|NCT02216071|2153595|FG000|Overall Study|Withdrawal by Subject|7
1088390|NCT02216071|2153596|FG001|Overall Study|Withdrawal by Subject|2
1088391|NCT02216071|2153595|FG000|Overall Study|Lost to Follow-up|3
1088392|NCT02216071|2153596|FG001|Overall Study|Lost to Follow-up|3
1088393|NCT02216071|2153595|FG000|Overall Study|Protocol Violation|3
1088394|NCT02216071|2153596|FG001|Overall Study|Protocol Violation|5
1088395|NCT02216071|2153595|FG000|Overall Study|Other|2
1088396|NCT02216071|2153596|FG001|Overall Study|Other|2
1088397|NCT02216123|2153613|FG000|Overall Study|Lost to Follow-up|4
1088398|NCT02216123|2153614|FG001|Overall Study|Lost to Follow-up|2
1088399|NCT02216123|2153613|FG000|Overall Study|Withdrawal by Subject|2
1088400|NCT02216123|2153614|FG001|Overall Study|Withdrawal by Subject|0
1088401|NCT02216214|2153639|FG000|Overall Study|Randomized Never Received Study Drug|1
1088402|NCT02216214|2153640|FG001|Overall Study|Randomized Never Received Study Drug|0
1088403|NCT02216214|2153639|FG000|Overall Study|Adverse Event|10
1088404|NCT02216214|2153640|FG001|Overall Study|Adverse Event|8
1088405|NCT02216214|2153639|FG000|Overall Study|Lack of Efficacy|2
1088406|NCT02216214|2153640|FG001|Overall Study|Lack of Efficacy|2
1088407|NCT02216214|2153639|FG000|Overall Study|Lost to Follow-up|3
1088408|NCT02216214|2153640|FG001|Overall Study|Lost to Follow-up|2
1088409|NCT02216214|2153639|FG000|Overall Study|Protocol Violation|4
1088410|NCT02216214|2153640|FG001|Overall Study|Protocol Violation|2
1088411|NCT02216214|2153639|FG000|Overall Study|Withdrawal by Subject|22
1088412|NCT02216214|2153640|FG001|Overall Study|Withdrawal by Subject|20
1088413|NCT02216214|2153639|FG000|Overall Study|Study Terminated By Sponsor|0
1088414|NCT02216214|2153640|FG001|Overall Study|Study Terminated By Sponsor|1
1088415|NCT02216214|2153639|FG000|Overall Study|Miscellaneous|1
1088416|NCT02216214|2153640|FG001|Overall Study|Miscellaneous|1
1088417|NCT02216357|2153648|FG000|Overall Study|Inclusion or exclusion criteria not met|2
1088418|NCT02216357|2153649|FG001|Overall Study|Inclusion or exclusion criteria not met|1
1088419|NCT02216526|2153662|FG000|Overall Study|Adverse Event|1
1088420|NCT02216526|2153663|FG001|Overall Study|Adverse Event|1
1088421|NCT02216526|2153664|FG002|Overall Study|Adverse Event|0
1088422|NCT02216526|2153662|FG000|Overall Study|Death|0
1088423|NCT02216526|2153663|FG001|Overall Study|Death|1
1088424|NCT02216526|2153664|FG002|Overall Study|Death|3
1088425|NCT02216526|2153662|FG000|Overall Study|Protocol Violation|2
1088426|NCT02216526|2153663|FG001|Overall Study|Protocol Violation|0
1088427|NCT02216526|2153664|FG002|Overall Study|Protocol Violation|2
1088428|NCT02216526|2153662|FG000|Overall Study|Hospitalization|2
1088429|NCT02216526|2153663|FG001|Overall Study|Hospitalization|1
1088430|NCT02216526|2153664|FG002|Overall Study|Hospitalization|3
1088431|NCT02216591|2153674|FG000|Overall Study|Lost to Follow-up|0
1088432|NCT02216591|2153675|FG001|Overall Study|Lost to Follow-up|1
1088433|NCT02216773|2153692|FG000|Overall Study|Disease progression|4
1088434|NCT02216773|2153693|FG001|Overall Study|Disease progression|2
1088435|NCT02216773|2153692|FG000|Overall Study|Insufficient FLRV|4
1088436|NCT02216773|2153693|FG001|Overall Study|Insufficient FLRV|0
1088437|NCT02216773|2153692|FG000|Overall Study|Abandoned|4
1088438|NCT02216773|2153693|FG001|Overall Study|Abandoned|3
1088439|NCT02216812|2153701|FG000|Overall Study|Lost to Follow-up|10
1088440|NCT02216812|2153702|FG001|Overall Study|Lost to Follow-up|5
1088441|NCT02217280|2153717|FG000|Overall Study|Withdrawal by Subject|2
1088442|NCT02217280|2153717|FG000|Overall Study|Post-consent sceen fail|2
1088443|NCT02217332|2153722|FG000|Overall Study|Adverse Event|3
1088444|NCT02217332|2153722|FG000|Overall Study|Dose interruption >1 month|1
1088445|NCT02217332|2153722|FG000|Overall Study|Protocol Violation (eligibility)|1
1088446|NCT02217332|2153722|FG000|Overall Study|Withdrawal by Subject|1
1088447|NCT02217332|2153722|FG000|Overall Study|Lost to Follow-up|1
1088448|NCT02217410|2153729|FG000|Overall Study|Graft Loss|0
1088449|NCT02217410|2153730|FG001|Overall Study|Graft Loss|0
1088450|NCT02217410|2153731|FG002|Overall Study|Graft Loss|2
1088451|NCT02217410|2153729|FG000|Overall Study|Withdrawal by Subject|0
1088452|NCT02217410|2153730|FG001|Overall Study|Withdrawal by Subject|0
1088453|NCT02217410|2153731|FG002|Overall Study|Withdrawal by Subject|2
1088454|NCT02217410|2153729|FG000|Overall Study|Lost to Follow-up|0
1088455|NCT02217410|2153730|FG001|Overall Study|Lost to Follow-up|0
1088456|NCT02217410|2153731|FG002|Overall Study|Lost to Follow-up|1
1088457|NCT02217410|2153729|FG000|Overall Study|Lack of Efficacy|0
1088458|NCT02217410|2153730|FG001|Overall Study|Lack of Efficacy|1
1088459|NCT02217410|2153731|FG002|Overall Study|Lack of Efficacy|0
1088460|NCT02217410|2153729|FG000|Overall Study|Physician Decision|1
1088461|NCT02217410|2153730|FG001|Overall Study|Physician Decision|3
1088462|NCT02217410|2153731|FG002|Overall Study|Physician Decision|0
1088463|NCT02217436|2153746|FG000|Overall Study|Protocol Violation|1
1088464|NCT02217436|2153747|FG001|Overall Study|Protocol Violation|1
1088465|NCT02217436|2153746|FG000|Overall Study|Incomplete data|0
1088466|NCT02217436|2153747|FG001|Overall Study|Incomplete data|1
1088467|NCT02217475|2153756|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
1088468|NCT02217475|2153757|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
1088469|NCT02217475|2153758|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
1088470|NCT02217475|2153756|FG000|Treatment Period 1 (Year 1)|Adverse Event|4
1088471|NCT02217475|2153757|FG001|Treatment Period 1 (Year 1)|Adverse Event|5
1088472|NCT02217475|2153758|FG002|Treatment Period 1 (Year 1)|Adverse Event|9
1088473|NCT02217475|2153756|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1
1088474|NCT02217475|2153757|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0
1088475|NCT02217475|2153758|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0
1088476|NCT02217475|2153756|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
1088477|NCT02217475|2153757|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
1088478|NCT02217475|2153758|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
1088479|NCT02217475|2153756|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
1088480|NCT02217475|2153757|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
1088481|NCT02217475|2153758|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
1088482|NCT02217475|2153756|FG000|Discontinued After Period 1|Adverse Event|1
1088483|NCT02217475|2153757|FG001|Discontinued After Period 1|Adverse Event|2
1088484|NCT02217475|2153758|FG002|Discontinued After Period 1|Adverse Event|0
1088485|NCT02217475|2153756|FG000|Discontinued After Period 1|Participant Withdrew Consent|1
1088486|NCT02217475|2153757|FG001|Discontinued After Period 1|Participant Withdrew Consent|1
1088487|NCT02217475|2153758|FG002|Discontinued After Period 1|Participant Withdrew Consent|2
1088488|NCT02217475|2153756|FG000|Discontinued After Period 1|Physician Decision|0
1088489|NCT02217475|2153757|FG001|Discontinued After Period 1|Physician Decision|0
1088490|NCT02217475|2153758|FG002|Discontinued After Period 1|Physician Decision|1
1088491|NCT02217475|2153756|FG000|Treatment Period 2 (Year 2)|Adverse Event|0
1088492|NCT02217475|2153757|FG001|Treatment Period 2 (Year 2)|Adverse Event|1
1088493|NCT02217475|2153758|FG002|Treatment Period 2 (Year 2)|Adverse Event|5
1088494|NCT02217475|2153756|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0
1088495|NCT02217475|2153757|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1
1088496|NCT02217475|2153758|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2
1088497|NCT02217475|2153756|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
1088498|NCT02217475|2153757|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
1088499|NCT02217475|2153758|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
1088500|NCT02217475|2153756|FG000|Treatment Period 2 (Year 2)|Physician Decision|0
1088501|NCT02217475|2153757|FG001|Treatment Period 2 (Year 2)|Physician Decision|0
1088502|NCT02217475|2153758|FG002|Treatment Period 2 (Year 2)|Physician Decision|2
1088503|NCT02217475|2153756|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
1088504|NCT02217475|2153757|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
1088505|NCT02217475|2153758|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
1088506|NCT02217501|2153777|FG000|Overall Study|Death|3
1088507|NCT02217501|2153778|FG001|Overall Study|Death|4
1088508|NCT02217527|2153786|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
1088509|NCT02217527|2153787|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
1088510|NCT02217527|2153786|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
1088511|NCT02217527|2153787|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
1088512|NCT02217566|2153793|FG000|Overall Study|Lost to Follow-up|2
1088513|NCT02217566|2153793|FG000|Overall Study|Death|3
1088514|NCT02217566|2153793|FG000|Overall Study|Early study termination|6
1088515|NCT02217878|2153815|FG000|Overall Study|required morphine due to chest pain|1
1088516|NCT02217878|2153816|FG001|Overall Study|required morphine due to chest pain|2
1088517|NCT02217878|2153815|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1
1088518|NCT02217878|2153816|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0
1088519|NCT02217982|2153847|FG000|Overall Study|Trial discontinued|1
1088520|NCT02217982|2153848|FG001|Overall Study|Trial discontinued|0
1088521|NCT02217982|2153847|FG000|Overall Study|Adverse Event|0
1088522|NCT02217982|2153848|FG001|Overall Study|Adverse Event|1
1088523|NCT02218008|2153857|FG000|Stage 1 (S1)|Adverse Event|6
1088524|NCT02218008|2153858|FG001|Stage 1 (S1)|Adverse Event|5
1088525|NCT02218008|2153859|FG002|Stage 1 (S1)|Adverse Event|11
1088526|NCT02218008|2153860|FG003|Stage 1 (S1)|Adverse Event|0
1088527|NCT02218008|2153861|FG004|Stage 1 (S1)|Adverse Event|0
1088528|NCT02218008|2153862|FG005|Stage 1 (S1)|Adverse Event|0
1088529|NCT02218008|2153857|FG000|Stage 1 (S1)|Withdrawal by Subject|6
1088530|NCT02218008|2153858|FG001|Stage 1 (S1)|Withdrawal by Subject|1
1088531|NCT02218008|2153859|FG002|Stage 1 (S1)|Withdrawal by Subject|1
1088532|NCT02218008|2153860|FG003|Stage 1 (S1)|Withdrawal by Subject|0
1088533|NCT02218008|2153861|FG004|Stage 1 (S1)|Withdrawal by Subject|0
1088534|NCT02218008|2153862|FG005|Stage 1 (S1)|Withdrawal by Subject|0
1088535|NCT02218008|2153857|FG000|Stage 1 (S1)|Lack of Efficacy|3
1088536|NCT02218008|2153858|FG001|Stage 1 (S1)|Lack of Efficacy|0
1088537|NCT02218008|2153859|FG002|Stage 1 (S1)|Lack of Efficacy|0
1088538|NCT02218008|2153860|FG003|Stage 1 (S1)|Lack of Efficacy|0
1088539|NCT02218008|2153861|FG004|Stage 1 (S1)|Lack of Efficacy|0
1088540|NCT02218008|2153862|FG005|Stage 1 (S1)|Lack of Efficacy|0
1088541|NCT02218008|2153857|FG000|Stage 1 (S1)|Lost to Follow-up|3
1088542|NCT02218008|2153858|FG001|Stage 1 (S1)|Lost to Follow-up|0
1088543|NCT02218008|2153859|FG002|Stage 1 (S1)|Lost to Follow-up|1
1088544|NCT02218008|2153860|FG003|Stage 1 (S1)|Lost to Follow-up|0
1088545|NCT02218008|2153861|FG004|Stage 1 (S1)|Lost to Follow-up|0
1088546|NCT02218008|2153862|FG005|Stage 1 (S1)|Lost to Follow-up|0
1088547|NCT02218008|2153857|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2
1088548|NCT02218008|2153858|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1
1088549|NCT02218008|2153859|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0
1088550|NCT02218008|2153860|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0
1088551|NCT02218008|2153861|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0
1088552|NCT02218008|2153862|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0
1088553|NCT02218008|2153857|FG000|Stage 1 (S1)|Non-compliance; drug use|1
1088554|NCT02218008|2153858|FG001|Stage 1 (S1)|Non-compliance; drug use|0
1088555|NCT02218008|2153859|FG002|Stage 1 (S1)|Non-compliance; drug use|0
1088556|NCT02218008|2153860|FG003|Stage 1 (S1)|Non-compliance; drug use|0
1088557|NCT02218008|2153861|FG004|Stage 1 (S1)|Non-compliance; drug use|0
1088558|NCT02218008|2153862|FG005|Stage 1 (S1)|Non-compliance; drug use|0
1088559|NCT02218008|2153857|FG000|Stage 1 (S1)|Pregnancy|0
1088560|NCT02218008|2153858|FG001|Stage 1 (S1)|Pregnancy|0
1088561|NCT02218008|2153859|FG002|Stage 1 (S1)|Pregnancy|1
1088562|NCT02218008|2153860|FG003|Stage 1 (S1)|Pregnancy|0
1088563|NCT02218008|2153861|FG004|Stage 1 (S1)|Pregnancy|0
1088564|NCT02218008|2153862|FG005|Stage 1 (S1)|Pregnancy|0
1088565|NCT02218008|2153857|FG000|Stage 1 (S1)|Protocol Violation|0
1088566|NCT02218008|2153858|FG001|Stage 1 (S1)|Protocol Violation|0
1088567|NCT02218008|2153859|FG002|Stage 1 (S1)|Protocol Violation|1
1088568|NCT02218008|2153860|FG003|Stage 1 (S1)|Protocol Violation|0
1088569|NCT02218008|2153861|FG004|Stage 1 (S1)|Protocol Violation|0
1088570|NCT02218008|2153862|FG005|Stage 1 (S1)|Protocol Violation|0
1088571|NCT02218008|2153857|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
1088572|NCT02218008|2153858|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
1088573|NCT02218008|2153859|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
1088574|NCT02218008|2153860|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
1088575|NCT02218008|2153861|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
1088576|NCT02218008|2153862|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
1088577|NCT02218008|2153857|FG000|Stage 2 (S2)|Adverse Event|0
1088578|NCT02218008|2153858|FG001|Stage 2 (S2)|Adverse Event|0
1088579|NCT02218008|2153859|FG002|Stage 2 (S2)|Adverse Event|0
1088580|NCT02218008|2153860|FG003|Stage 2 (S2)|Adverse Event|2
1088581|NCT02218008|2153861|FG004|Stage 2 (S2)|Adverse Event|3
1088582|NCT02218008|2153862|FG005|Stage 2 (S2)|Adverse Event|3
1088583|NCT02218008|2153857|FG000|Stage 2 (S2)|Withdrawal by Subject|0
1088584|NCT02218008|2153858|FG001|Stage 2 (S2)|Withdrawal by Subject|0
1088585|NCT02218008|2153859|FG002|Stage 2 (S2)|Withdrawal by Subject|0
1088586|NCT02218008|2153860|FG003|Stage 2 (S2)|Withdrawal by Subject|1
1088587|NCT02218008|2153861|FG004|Stage 2 (S2)|Withdrawal by Subject|1
1088588|NCT02218008|2153862|FG005|Stage 2 (S2)|Withdrawal by Subject|0
1088589|NCT02218008|2153857|FG000|Stage 2 (S2)|Lack of Efficacy|0
1088590|NCT02218008|2153858|FG001|Stage 2 (S2)|Lack of Efficacy|0
1088591|NCT02218008|2153859|FG002|Stage 2 (S2)|Lack of Efficacy|0
1088592|NCT02218008|2153860|FG003|Stage 2 (S2)|Lack of Efficacy|0
1088593|NCT02218008|2153861|FG004|Stage 2 (S2)|Lack of Efficacy|0
1088594|NCT02218008|2153862|FG005|Stage 2 (S2)|Lack of Efficacy|2
1088595|NCT02218008|2153857|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
1088596|NCT02218008|2153858|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
1088597|NCT02218008|2153859|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
1088598|NCT02218008|2153860|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
1088599|NCT02218008|2153861|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
1088600|NCT02218008|2153862|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
1088601|NCT02218008|2153857|FG000|Stage 2 (S2)|Lost to Follow-up|0
1088602|NCT02218008|2153858|FG001|Stage 2 (S2)|Lost to Follow-up|0
1088603|NCT02218008|2153859|FG002|Stage 2 (S2)|Lost to Follow-up|0
1088604|NCT02218008|2153860|FG003|Stage 2 (S2)|Lost to Follow-up|0
1088605|NCT02218008|2153861|FG004|Stage 2 (S2)|Lost to Follow-up|0
1088606|NCT02218008|2153862|FG005|Stage 2 (S2)|Lost to Follow-up|1
1088607|NCT02218216|2153913|FG000|Overall Study|Study terminated before completed|6
1088608|NCT02218216|2153914|FG001|Overall Study|Study terminated before completed|0
1088609|NCT02218216|2153915|FG002|Overall Study|Study terminated before completed|0
1088610|NCT02218268|2153927|FG000|24 Hour Washout|Physician Decision|11
1088611|NCT02218268|2153928|FG001|24 Hour Washout|Physician Decision|9
1088612|NCT02218372|2153954|FG000|Overall Study|Adverse Event|1
1088613|NCT02218372|2153955|FG001|Overall Study|Adverse Event|1
1088614|NCT02218372|2153954|FG000|Overall Study|Miscellaneous|2
1088615|NCT02218372|2153955|FG001|Overall Study|Miscellaneous|1
1088616|NCT02218372|2153954|FG000|Overall Study|Randomized but did not receive treatment|2
1088617|NCT02218372|2153955|FG001|Overall Study|Randomized but did not receive treatment|3
1088618|NCT02218372|2153954|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1088619|NCT02218372|2153955|FG001|Overall Study|Withdrawal by Parent/Guardian|1
1088620|NCT02218489|2153986|FG000|Overall Study|Withdrawal by Subject|4
1088621|NCT02218489|2153987|FG001|Overall Study|Withdrawal by Subject|3
1088622|NCT02218489|2153986|FG000|Overall Study|Lost to Follow-up|1
1088623|NCT02218489|2153987|FG001|Overall Study|Lost to Follow-up|0
1088624|NCT02218541|2153996|FG000|Overall Study|Lost to Follow-up|2
1088625|NCT02218541|2153997|FG001|Overall Study|Lost to Follow-up|1
1088626|NCT02218541|2153996|FG000|Overall Study|Implant Failure|4
1088627|NCT02218541|2153997|FG001|Overall Study|Implant Failure|1
1088628|NCT02218736|2154015|FG000|Overall Study|Withdrawal by Subject|10
1088629|NCT02218736|2154016|FG001|Overall Study|Withdrawal by Subject|9
1088630|NCT02218736|2154015|FG000|Overall Study|Protocol Violation|2
1088631|NCT02218736|2154016|FG001|Overall Study|Protocol Violation|0
1088632|NCT02219009|2154024|FG000|Overall Study|Withdrawal by Subject|5
1088633|NCT02219009|2154025|FG001|Overall Study|Withdrawal by Subject|1
1088634|NCT02219009|2154024|FG000|Overall Study|Adverse Event|2
1088635|NCT02219009|2154025|FG001|Overall Study|Adverse Event|4
1088636|NCT02219009|2154024|FG000|Overall Study|Lost to Follow-up|2
1088637|NCT02219009|2154025|FG001|Overall Study|Lost to Follow-up|2
1088638|NCT02219009|2154024|FG000|Overall Study|Protocol deviation|1
1088639|NCT02219009|2154025|FG001|Overall Study|Protocol deviation|0
1088640|NCT02219009|2154024|FG000|Overall Study|Physician Decision|0
1088641|NCT02219009|2154025|FG001|Overall Study|Physician Decision|1
1088642|NCT02219048|2154033|FG000|Overall Study|Adverse Event|2
1088643|NCT02219048|2154034|FG001|Overall Study|Adverse Event|5
1088644|NCT02219048|2154033|FG000|Overall Study|No longer meets eligibility criteria|1
1088645|NCT02219048|2154034|FG001|Overall Study|No longer meets eligibility criteria|0
1088646|NCT02219048|2154033|FG000|Overall Study|Study terminated by sponsor|16
1088647|NCT02219048|2154034|FG001|Overall Study|Study terminated by sponsor|15
1088648|NCT02219048|2154033|FG000|Overall Study|Withdrawal by Subject|2
1088649|NCT02219048|2154034|FG001|Overall Study|Withdrawal by Subject|0
1088650|NCT02219048|2154033|FG000|Overall Study|Other|0
1088651|NCT02219048|2154034|FG001|Overall Study|Other|1
1088652|NCT02219087|2154042|FG000|Overall Study|Randomization envelope pulled out of seq|0
1088653|NCT02219087|2154043|FG001|Overall Study|Randomization envelope pulled out of seq|1
1088654|NCT02219308|2154113|FG000|Overall Study|Withdrawal by Subject|1
1088655|NCT02219308|2154114|FG001|Overall Study|Withdrawal by Subject|2
1088656|NCT02219334|2154131|FG000|Overall Study|Withdrawal by Subject|1
1088657|NCT02219334|2154132|FG001|Overall Study|Withdrawal by Subject|0
1088658|NCT02219334|2154131|FG000|Overall Study|Protocol Violation|7
1088659|NCT02219334|2154132|FG001|Overall Study|Protocol Violation|3
1088660|NCT02219464|2154151|FG000|Overall Study|Withdrawal by Subject|1
1088661|NCT02219464|2154152|FG001|Overall Study|Withdrawal by Subject|0
1088662|NCT02219464|2154151|FG000|Overall Study|case cancelled|1
1088663|NCT02219464|2154152|FG001|Overall Study|case cancelled|0
1088664|NCT02219464|2154151|FG000|Overall Study|catheter malfunction|1
1088665|NCT02219464|2154152|FG001|Overall Study|catheter malfunction|0
1088666|NCT02219477|2154161|FG000|Overall Study|Adverse Event|0
1088667|NCT02219477|2154162|FG001|Overall Study|Adverse Event|1
1088668|NCT02219477|2154163|FG002|Overall Study|Adverse Event|1
1088669|NCT02219477|2154161|FG000|Overall Study|Withdrawal by Subject|0
1088670|NCT02219477|2154162|FG001|Overall Study|Withdrawal by Subject|1
1088671|NCT02219477|2154163|FG002|Overall Study|Withdrawal by Subject|0
1088672|NCT02219685|2154195|FG000|Blinded Treatment Phase|Lost to Follow-up|1
1088673|NCT02219685|2154196|FG001|Blinded Treatment Phase|Lost to Follow-up|0
1088674|NCT02219685|2154195|FG000|Blinded Treatment Phase|Withdrew Consent|1
1088675|NCT02219685|2154196|FG001|Blinded Treatment Phase|Withdrew Consent|0
1088676|NCT02219932|2154215|FG000|Overall Study|Other|5
1088677|NCT02219932|2154216|FG001|Overall Study|Other|11
1088678|NCT02219932|2154215|FG000|Overall Study|Death|1
1088679|NCT02219932|2154216|FG001|Overall Study|Death|1
1088680|NCT02219932|2154215|FG000|Overall Study|Investigator Decision|0
1088681|NCT02219932|2154216|FG001|Overall Study|Investigator Decision|1
1088682|NCT02219932|2154215|FG000|Overall Study|Consent Withdrawn|11
1088683|NCT02219932|2154216|FG001|Overall Study|Consent Withdrawn|7
1088684|NCT02219932|2154215|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10
1088685|NCT02219932|2154216|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2
1088686|NCT02219932|2154215|FG000|Overall Study|Protocol Violation|10
1088687|NCT02219932|2154216|FG001|Overall Study|Protocol Violation|6
1088688|NCT02219932|2154215|FG000|Overall Study|Pregnancy|1
1088689|NCT02219932|2154216|FG001|Overall Study|Pregnancy|0
1088690|NCT02219932|2154215|FG000|Overall Study|Lost to Follow-up|4
1088691|NCT02219932|2154216|FG001|Overall Study|Lost to Follow-up|2
1088692|NCT02219932|2154215|FG000|Overall Study|Adverse Event|23
1088693|NCT02219932|2154216|FG001|Overall Study|Adverse Event|21
1088694|NCT02220205|2154239|FG000|Overall Study|Withdrawal by Subject|1
1088695|NCT02220205|2154240|FG001|Overall Study|Withdrawal by Subject|0
1088696|NCT02220712|2154246|FG000|Overall Study|Adverse Event|1
1088697|NCT02220712|2154246|FG000|Overall Study|Withdrawal by Subject|2
1088698|NCT02220712|2154246|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1
1088699|NCT02220725|2154258|FG000|Overall Study|Lost to Follow-up|0
1088700|NCT02220725|2154259|FG001|Overall Study|Lost to Follow-up|0
1088701|NCT02220725|2154260|FG002|Overall Study|Lost to Follow-up|0
1088702|NCT02220725|2154261|FG003|Overall Study|Lost to Follow-up|1
1088703|NCT02220725|2154258|FG000|Overall Study|Withdrawal by Subject|0
1088704|NCT02220725|2154259|FG001|Overall Study|Withdrawal by Subject|0
1088705|NCT02220725|2154260|FG002|Overall Study|Withdrawal by Subject|0
1088706|NCT02220725|2154261|FG003|Overall Study|Withdrawal by Subject|1
1088707|NCT02220764|2154276|FG000|Overall Study|Lost to Follow-up|3
1088708|NCT02220764|2154277|FG001|Overall Study|Lost to Follow-up|1
1088709|NCT02220764|2154276|FG000|Overall Study|Death|1
1088710|NCT02220764|2154277|FG001|Overall Study|Death|0
1088711|NCT02220855|2154283|FG000|Overall Study|Adverse Event|8
1088712|NCT02220855|2154283|FG000|Overall Study|Disease Progression|5
1088713|NCT02220855|2154283|FG000|Overall Study|Withdrawal by Subject|1
1088726|NCT02220907|2154296|FG000|Overall Study|Adverse Event|7
1088727|NCT02220907|2154296|FG000|Overall Study|Physician Decision|1
1088728|NCT02220907|2154296|FG000|Overall Study|Withdrawal by Subject|2
1088729|NCT02220907|2154296|FG000|Overall Study|Conflict with the stopping criteria|1
1088730|NCT02220920|2154302|FG000|Overall Study|Adverse Event|1
1088731|NCT02220920|2154303|FG001|Overall Study|Adverse Event|0
1088732|NCT02220920|2154302|FG000|Overall Study|Lack of Efficacy|0
1088733|NCT02220920|2154303|FG001|Overall Study|Lack of Efficacy|1
1088734|NCT02220920|2154302|FG000|Overall Study|Withdrawal by Subject|1
1088735|NCT02220920|2154303|FG001|Overall Study|Withdrawal by Subject|0
1088736|NCT02220920|2154302|FG000|Overall Study|Conflict with the stopping criteria|1
1088737|NCT02220920|2154303|FG001|Overall Study|Conflict with the stopping criteria|2
1088738|NCT02220998|2154311|FG000|Overall Study|Randomized but Never Treated|1
1088739|NCT02220998|2154312|FG001|Overall Study|Randomized but Never Treated|2
1088740|NCT02220998|2154311|FG000|Overall Study|Death|2
1088741|NCT02220998|2154312|FG001|Overall Study|Death|0
1088742|NCT02220998|2154311|FG000|Overall Study|Lack of Efficacy|0
1088743|NCT02220998|2154312|FG001|Overall Study|Lack of Efficacy|5
1088744|NCT02220998|2154311|FG000|Overall Study|Lost to Follow-up|4
1088745|NCT02220998|2154312|FG001|Overall Study|Lost to Follow-up|4
1088746|NCT02221284|2154360|FG000|Overall Study|Case Report Forms Uncollected|56
1088747|NCT02221284|2154360|FG000|Overall Study|Protocol Deviation|5
1088748|NCT02221648|2154385|FG000|Overall Study|Withdrawal by Subject|3
1088749|NCT02221648|2154386|FG001|Overall Study|Withdrawal by Subject|3
1088750|NCT02221674|2154399|FG000|Overall Study|Lost to Follow-up|1
1088751|NCT02221674|2154400|FG001|Overall Study|Lost to Follow-up|0
1088752|NCT02221674|2154401|FG002|Overall Study|Lost to Follow-up|0
1088753|NCT02221882|2154433|FG000|Overall Study|Withdrawal by Subject|0
1088754|NCT02221882|2154434|FG001|Overall Study|Withdrawal by Subject|0
1088755|NCT02221882|2154435|FG002|Overall Study|Withdrawal by Subject|4
1088756|NCT02221882|2154436|FG003|Overall Study|Withdrawal by Subject|2
1088757|NCT02221882|2154437|FG004|Overall Study|Withdrawal by Subject|2
1088758|NCT02221882|2154438|FG005|Overall Study|Withdrawal by Subject|2
1088759|NCT02221882|2154433|FG000|Overall Study|Death|0
1088760|NCT02221882|2154434|FG001|Overall Study|Death|1
1088761|NCT02221882|2154435|FG002|Overall Study|Death|0
1088762|NCT02221882|2154436|FG003|Overall Study|Death|0
1088763|NCT02221882|2154437|FG004|Overall Study|Death|0
1088764|NCT02221882|2154438|FG005|Overall Study|Death|0
1088765|NCT02222207|2154482|FG000|Overall Study|Death|1
1088766|NCT02222207|2154482|FG000|Overall Study|Other reasons|2
1088767|NCT02222207|2154482|FG000|Overall Study|Adverse Event|1
1088768|NCT02222246|2154488|FG000|Overall Study|No Emergency Department Visits|27
1088769|NCT02222246|2154489|FG001|Overall Study|No Emergency Department Visits|26
1088770|NCT02222246|2154488|FG000|Overall Study|Physician Decision|0
1088771|NCT02222246|2154489|FG001|Overall Study|Physician Decision|1
1088772|NCT02222493|2154512|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
1088773|NCT02222493|2154513|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
1088774|NCT02222493|2154512|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
1088775|NCT02222493|2154513|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
1088776|NCT02222493|2154512|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
1088777|NCT02222493|2154513|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
1088778|NCT02222493|2154512|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
1088779|NCT02222493|2154513|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
1088780|NCT02222493|2154512|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
1088781|NCT02222493|2154513|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
1088782|NCT02222493|2154512|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
1088783|NCT02222493|2154513|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
1088784|NCT02222493|2154512|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
1088785|NCT02222493|2154513|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
1088786|NCT02222493|2154512|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
1088787|NCT02222493|2154513|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
1088788|NCT02222493|2154512|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
1088789|NCT02222493|2154513|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
1088790|NCT02222493|2154512|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
1088791|NCT02222493|2154513|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
1088792|NCT02222493|2154512|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
1088793|NCT02222493|2154513|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
1088794|NCT02222493|2154512|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
1088795|NCT02222493|2154513|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
1088796|NCT02222493|2154512|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
1088797|NCT02222493|2154513|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
1088798|NCT02222493|2154512|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
1088799|NCT02222493|2154513|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
1088800|NCT02222493|2154512|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
1088801|NCT02222493|2154513|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
1088802|NCT02222493|2154512|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
1088803|NCT02222493|2154513|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
1088804|NCT02222493|2154512|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
1088805|NCT02222493|2154513|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
1088806|NCT02222493|2154512|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
1088807|NCT02222493|2154513|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
1088808|NCT02222493|2154512|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
1088809|NCT02222493|2154513|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
1088810|NCT02222493|2154512|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
1088811|NCT02222493|2154513|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
1088812|NCT02222493|2154512|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
1088813|NCT02222493|2154513|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
1088814|NCT02222493|2154512|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
1088815|NCT02222493|2154513|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
1088816|NCT02222558|2154532|FG000|Period 1: Single Dose|Withdrawal by Subject|4
1088817|NCT02222558|2154533|FG001|Period 1: Single Dose|Withdrawal by Subject|0
1088818|NCT02222558|2154534|FG002|Period 1: Single Dose|Withdrawal by Subject|0
1088819|NCT02222558|2154535|FG003|Period 1: Single Dose|Withdrawal by Subject|0
1088820|NCT02222558|2154536|FG004|Period 1: Single Dose|Withdrawal by Subject|0
1088821|NCT02222558|2154537|FG005|Period 1: Single Dose|Withdrawal by Subject|0
1088822|NCT02222558|2154532|FG000|Period 3|Withdrawal by Subject|0
1088823|NCT02222558|2154533|FG001|Period 3|Withdrawal by Subject|0
1088824|NCT02222558|2154534|FG002|Period 3|Withdrawal by Subject|0
1088825|NCT02222558|2154535|FG003|Period 3|Withdrawal by Subject|0
1088826|NCT02222558|2154536|FG004|Period 3|Withdrawal by Subject|0
1088827|NCT02222558|2154537|FG005|Period 3|Withdrawal by Subject|1
1088828|NCT02222688|2154571|FG000|Overall Study|Withdrawal by Subject|0
1088829|NCT02222688|2154572|FG001|Overall Study|Withdrawal by Subject|0
1088830|NCT02222688|2154573|FG002|Overall Study|Withdrawal by Subject|0
1088831|NCT02222688|2154574|FG003|Overall Study|Withdrawal by Subject|2
1088832|NCT02222688|2154575|FG004|Overall Study|Withdrawal by Subject|1
1088833|NCT02222688|2154576|FG005|Overall Study|Withdrawal by Subject|0
1088834|NCT02222688|2154577|FG006|Overall Study|Withdrawal by Subject|1
1088835|NCT02222688|2154571|FG000|Overall Study|Disease progression|1
1088836|NCT02222688|2154572|FG001|Overall Study|Disease progression|0
1088837|NCT02222688|2154573|FG002|Overall Study|Disease progression|0
1088838|NCT02222688|2154574|FG003|Overall Study|Disease progression|0
1088839|NCT02222688|2154575|FG004|Overall Study|Disease progression|0
1088840|NCT02222688|2154576|FG005|Overall Study|Disease progression|0
1088841|NCT02222688|2154577|FG006|Overall Study|Disease progression|0
1088842|NCT02222714|2154600|FG000|Overall Study|Death|0
1088843|NCT02222714|2154601|FG001|Overall Study|Death|2
1088844|NCT02222714|2154602|FG002|Overall Study|Death|3
1088845|NCT02222714|2154603|FG003|Overall Study|Death|4
1088846|NCT02222714|2154604|FG004|Overall Study|Death|6
1088847|NCT02222714|2154600|FG000|Overall Study|Withdrawal by Subject|0
1088848|NCT02222714|2154601|FG001|Overall Study|Withdrawal by Subject|0
1088849|NCT02222714|2154602|FG002|Overall Study|Withdrawal by Subject|1
1088850|NCT02222714|2154603|FG003|Overall Study|Withdrawal by Subject|0
1088851|NCT02222714|2154604|FG004|Overall Study|Withdrawal by Subject|1
1088852|NCT02222818|2154621|FG000|Period 1|Eligibility criteria not met|0
1088853|NCT02222818|2154622|FG001|Period 1|Eligibility criteria not met|3
1088854|NCT02222896|2154636|FG000|Abdomen|Did not qualify|34
1088855|NCT02222896|2154637|FG001|Abdomen|Did not qualify|10
1088856|NCT02222896|2154638|FG002|Abdomen|Did not qualify|32
1088857|NCT02222896|2154636|FG000|Groin|Did not qualify|43
1088858|NCT02222896|2154637|FG001|Groin|Did not qualify|9
1088859|NCT02222896|2154638|FG002|Groin|Did not qualify|40
1088860|NCT02222922|2154658|FG000|Overall Study|Death|0
1088861|NCT02222922|2154659|FG001|Overall Study|Death|0
1088862|NCT02222922|2154660|FG002|Overall Study|Death|0
1088863|NCT02222922|2154661|FG003|Overall Study|Death|0
1088864|NCT02222922|2154662|FG004|Overall Study|Death|13
1088865|NCT02222922|2154663|FG005|Overall Study|Death|0
1088866|NCT02222922|2154664|FG006|Overall Study|Death|0
1088867|NCT02222922|2154665|FG007|Overall Study|Death|0
1088868|NCT02222922|2154666|FG008|Overall Study|Death|2
1088869|NCT02222922|2154658|FG000|Overall Study|Lost to Follow-up|0
1088870|NCT02222922|2154659|FG001|Overall Study|Lost to Follow-up|0
1088871|NCT02222922|2154660|FG002|Overall Study|Lost to Follow-up|1
1088872|NCT02222922|2154661|FG003|Overall Study|Lost to Follow-up|0
1088873|NCT02222922|2154662|FG004|Overall Study|Lost to Follow-up|9
1088874|NCT02222922|2154663|FG005|Overall Study|Lost to Follow-up|1
1088875|NCT02222922|2154664|FG006|Overall Study|Lost to Follow-up|0
1088876|NCT02222922|2154665|FG007|Overall Study|Lost to Follow-up|0
1088877|NCT02222922|2154666|FG008|Overall Study|Lost to Follow-up|0
1088878|NCT02222922|2154658|FG000|Overall Study|Other|0
1088879|NCT02222922|2154659|FG001|Overall Study|Other|0
1088880|NCT02222922|2154660|FG002|Overall Study|Other|0
1088881|NCT02222922|2154661|FG003|Overall Study|Other|2
1088882|NCT02222922|2154662|FG004|Overall Study|Other|10
1088883|NCT02222922|2154663|FG005|Overall Study|Other|2
1088884|NCT02222922|2154664|FG006|Overall Study|Other|2
1088885|NCT02222922|2154665|FG007|Overall Study|Other|4
1088886|NCT02222922|2154666|FG008|Overall Study|Other|1
1088887|NCT02222922|2154658|FG000|Overall Study|Participant refused further follow-up|1
1088888|NCT02222922|2154659|FG001|Overall Study|Participant refused further follow-up|0
1088889|NCT02222922|2154660|FG002|Overall Study|Participant refused further follow-up|0
1088890|NCT02222922|2154661|FG003|Overall Study|Participant refused further follow-up|1
1088891|NCT02222922|2154662|FG004|Overall Study|Participant refused further follow-up|6
1088892|NCT02222922|2154663|FG005|Overall Study|Participant refused further follow-up|0
1088893|NCT02222922|2154664|FG006|Overall Study|Participant refused further follow-up|0
1088894|NCT02222922|2154665|FG007|Overall Study|Participant refused further follow-up|0
1088895|NCT02222922|2154666|FG008|Overall Study|Participant refused further follow-up|3
1088896|NCT02223364|2154742|FG000|Overall Study|Protocol Violation|3
1088897|NCT02223364|2154743|FG001|Overall Study|Protocol Violation|0
1088898|NCT02223364|2154744|FG002|Overall Study|Protocol Violation|3
1088899|NCT02223364|2154742|FG000|Overall Study|subject expired before surgery|1
1088900|NCT02223364|2154743|FG001|Overall Study|subject expired before surgery|0
1088901|NCT02223364|2154744|FG002|Overall Study|subject expired before surgery|0
1088902|NCT02223364|2154742|FG000|Overall Study|Physician Decision|1
1088903|NCT02223364|2154743|FG001|Overall Study|Physician Decision|0
1088904|NCT02223364|2154744|FG002|Overall Study|Physician Decision|0
1088905|NCT02223390|2154754|FG000|Overall Study|Lost to Follow-up|9
1088906|NCT02223390|2154755|FG001|Overall Study|Lost to Follow-up|4
1088907|NCT02223715|2154839|FG000|Overall Study|Death|31
1088908|NCT02223715|2154839|FG000|Overall Study|Lost to Follow-up|73
1088909|NCT02223754|2154848|FG000|Period 1|Adverse Event|1
1088910|NCT02223754|2154849|FG001|Period 1|Adverse Event|0
1088911|NCT02223754|2154848|FG000|Period 1|Lost to Follow-up|0
1088912|NCT02223754|2154849|FG001|Period 1|Lost to Follow-up|1
1088913|NCT02223754|2154848|FG000|Period 1|Protocol Violation|2
1088914|NCT02223754|2154849|FG001|Period 1|Protocol Violation|4
1088915|NCT02223754|2154848|FG000|Period 1|Withdrawal by Subject|0
1088916|NCT02223754|2154849|FG001|Period 1|Withdrawal by Subject|4
1088917|NCT02223754|2154848|FG000|Period 1|Test Article No Longer Available|1
1088918|NCT02223754|2154849|FG001|Period 1|Test Article No Longer Available|5
1088919|NCT02223754|2154848|FG000|Period 1|Unsatisfactory Visual Response|0
1088920|NCT02223754|2154849|FG001|Period 1|Unsatisfactory Visual Response|1
1088921|NCT02223754|2154848|FG000|Period 2|Adverse Event|0
1088922|NCT02223754|2154849|FG001|Period 2|Adverse Event|1
1088923|NCT02223754|2154848|FG000|Period 2|Protocol Violation|1
1088924|NCT02223754|2154849|FG001|Period 2|Protocol Violation|0
1088925|NCT02223754|2154848|FG000|Period 2|Lens Discomfort|1
1088926|NCT02223754|2154849|FG001|Period 2|Lens Discomfort|1
1088927|NCT02223754|2154848|FG000|Period 2|Lost to Follow-up|1
1088928|NCT02223754|2154849|FG001|Period 2|Lost to Follow-up|0
1088929|NCT02223754|2154848|FG000|Period 2|Test Article No Longer Available|0
1088930|NCT02223754|2154849|FG001|Period 2|Test Article No Longer Available|1
1088931|NCT02223793|2154859|FG000|Overall Study|Lost to Follow-up|10
1088932|NCT02223793|2154860|FG001|Overall Study|Lost to Follow-up|1
1088933|NCT02223793|2154861|FG002|Overall Study|Lost to Follow-up|2
1088934|NCT02223793|2154859|FG000|Overall Study|Withdrawal by Subject|3
1088935|NCT02223793|2154860|FG001|Overall Study|Withdrawal by Subject|2
1088936|NCT02223793|2154861|FG002|Overall Study|Withdrawal by Subject|3
1088937|NCT02223793|2154859|FG000|Overall Study|Moved/studycenter unable to participate|4
1088938|NCT02223793|2154860|FG001|Overall Study|Moved/studycenter unable to participate|6
1088939|NCT02223793|2154861|FG002|Overall Study|Moved/studycenter unable to participate|8
1088940|NCT02223858|2154871|FG000|Overall Study|Death|1
1088941|NCT02223858|2154872|FG001|Overall Study|Death|1
1088942|NCT02223858|2154871|FG000|Overall Study|Lost to Follow-up|6
1088943|NCT02223858|2154872|FG001|Overall Study|Lost to Follow-up|11
1088944|NCT02223858|2154871|FG000|Overall Study|Withdrawal by Subject|8
1088945|NCT02223858|2154872|FG001|Overall Study|Withdrawal by Subject|5
1088946|NCT02223858|2154871|FG000|Overall Study|Refused|9
1088947|NCT02223858|2154872|FG001|Overall Study|Refused|9
1088948|NCT02224053|2154882|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
1088949|NCT02224053|2154882|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
1088950|NCT02224053|2154882|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3
1088951|NCT02224053|2154882|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
1088952|NCT02224053|2154882|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
1088953|NCT02224157|2154890|FG000|Overall Study|Severe non-compliance to protocol|2
1088954|NCT02224157|2154891|FG001|Overall Study|Severe non-compliance to protocol|2
1088955|NCT02224157|2154890|FG000|Overall Study|Other|13
1088956|NCT02224157|2154891|FG001|Overall Study|Other|10
1088957|NCT02224157|2154890|FG000|Overall Study|Subject decision|58
1088958|NCT02224157|2154891|FG001|Overall Study|Subject decision|50
909670|NCT00789477|1886418|FG000|Overall Study|Death|1
909671|NCT00789477|1886419|FG001|Overall Study|Death|1
909672|NCT00789477|1886420|FG002|Overall Study|Death|2
909673|NCT00789477|1886421|FG003|Overall Study|Death|2
909674|NCT00789477|1886422|FG004|Overall Study|Death|0
1088959|NCT02224157|2154890|FG000|Overall Study|Prematurely closed site|4
1088960|NCT02224157|2154891|FG001|Overall Study|Prematurely closed site|2
1088961|NCT02224157|2154890|FG000|Overall Study|Eligibility criteria not fulfilled|4
1088962|NCT02224157|2154891|FG001|Overall Study|Eligibility criteria not fulfilled|8
1088963|NCT02224157|2154890|FG000|Overall Study|Lost to Follow-up|27
1088964|NCT02224157|2154891|FG001|Overall Study|Lost to Follow-up|35
1088965|NCT02224157|2154890|FG000|Overall Study|Death|1
1088966|NCT02224157|2154891|FG001|Overall Study|Death|1
1088967|NCT02224157|2154890|FG000|Overall Study|Adverse Event|1
1088968|NCT02224157|2154891|FG001|Overall Study|Adverse Event|3
1088969|NCT02224274|2154899|FG000|Overall Study|Death|1
1088970|NCT02224274|2154900|FG001|Overall Study|Death|0
1088971|NCT02224560|2154941|FG000|Overall Study|Protocol Deviation|1
1088972|NCT02224560|2154942|FG001|Overall Study|Protocol Deviation|0
1088973|NCT02224560|2154943|FG002|Overall Study|Protocol Deviation|0
1088974|NCT02224560|2154941|FG000|Overall Study|Withdrawal by Subject|2
1088975|NCT02224560|2154942|FG001|Overall Study|Withdrawal by Subject|0
1088976|NCT02224560|2154943|FG002|Overall Study|Withdrawal by Subject|1
1088977|NCT02224560|2154941|FG000|Overall Study|Met Withdrawal Criteria|1
1088978|NCT02224560|2154942|FG001|Overall Study|Met Withdrawal Criteria|0
1088979|NCT02224560|2154943|FG002|Overall Study|Met Withdrawal Criteria|0
1088980|NCT02224560|2154941|FG000|Overall Study|Adverse Event|4
1088981|NCT02224560|2154942|FG001|Overall Study|Adverse Event|1
1088982|NCT02224560|2154943|FG002|Overall Study|Adverse Event|1
1088983|NCT02224560|2154941|FG000|Overall Study|Withdrawn by Investigator|1
1088984|NCT02224560|2154942|FG001|Overall Study|Withdrawn by Investigator|1
1088985|NCT02224560|2154943|FG002|Overall Study|Withdrawn by Investigator|0
1088986|NCT02224625|2154960|FG000|Irritation|Adverse Event|6
1088987|NCT02224625|2154960|FG000|Sensitization|Adverse Event|55
1088988|NCT02224638|2154974|FG000|Overall Study|Adverse Event|1
1088989|NCT02224638|2154975|FG001|Overall Study|Adverse Event|1
1088990|NCT02224664|2154983|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5
1088991|NCT02224664|2154984|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1088992|NCT02224664|2154985|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1088993|NCT02224664|2154986|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1088994|NCT02224664|2154987|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1088995|NCT02224664|2154983|FG000|Dose Escalation Period (21 Days)|Adverse Event|0
1088996|NCT02224664|2154984|FG001|Dose Escalation Period (21 Days)|Adverse Event|0
1088997|NCT02224664|2154985|FG002|Dose Escalation Period (21 Days)|Adverse Event|2
1088998|NCT02224664|2154986|FG003|Dose Escalation Period (21 Days)|Adverse Event|2
1088999|NCT02224664|2154987|FG004|Dose Escalation Period (21 Days)|Adverse Event|7
1089000|NCT02224664|2154983|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1089001|NCT02224664|2154984|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1089002|NCT02224664|2154985|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1089003|NCT02224664|2154986|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
1089004|NCT02224664|2154987|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
1089005|NCT02224690|2155005|FG000|Overall Study|Adverse Event|8
1089006|NCT02224690|2155006|FG001|Overall Study|Adverse Event|1
1089007|NCT02224690|2155005|FG000|Overall Study|Met Withdrawal Criteria|4
1089008|NCT02224690|2155006|FG001|Overall Study|Met Withdrawal Criteria|0
1089009|NCT02224690|2155005|FG000|Overall Study|Use of G-tube|1
1089010|NCT02224690|2155006|FG001|Overall Study|Use of G-tube|0
1089011|NCT02224690|2155005|FG000|Overall Study|Did not meet eligibility criteria|1
1089012|NCT02224690|2155006|FG001|Overall Study|Did not meet eligibility criteria|0
1089013|NCT02224703|2155015|FG000|Overall Study|Adverse Event|0
1089014|NCT02224703|2155016|FG001|Overall Study|Adverse Event|5
1089015|NCT02224703|2155017|FG002|Overall Study|Adverse Event|0
1089016|NCT02224703|2155015|FG000|Overall Study|Withdrawn by investigator|1
1089017|NCT02224703|2155016|FG001|Overall Study|Withdrawn by investigator|0
1089018|NCT02224703|2155017|FG002|Overall Study|Withdrawn by investigator|0
1089019|NCT02224703|2155015|FG000|Overall Study|Advised by medical monitor|1
1089020|NCT02224703|2155016|FG001|Overall Study|Advised by medical monitor|0
1089021|NCT02224703|2155017|FG002|Overall Study|Advised by medical monitor|0
1089022|NCT02224703|2155015|FG000|Overall Study|Withdrawn by parent/guardian|0
1089023|NCT02224703|2155016|FG001|Overall Study|Withdrawn by parent/guardian|1
1089024|NCT02224703|2155017|FG002|Overall Study|Withdrawn by parent/guardian|0
1089025|NCT02224703|2155015|FG000|Overall Study|Lack of Efficacy|1
1089026|NCT02224703|2155016|FG001|Overall Study|Lack of Efficacy|0
1089027|NCT02224703|2155017|FG002|Overall Study|Lack of Efficacy|0
1089028|NCT02224755|2155032|FG000|Randomization to Device Implant|Withdrawn prior to implant|7
1089029|NCT02224755|2155033|FG001|Randomization to Device Implant|Withdrawn prior to implant|1
1089030|NCT02224755|2155032|FG000|Two Year Follow up Post-implant|Death|103
1089031|NCT02224755|2155033|FG001|Two Year Follow up Post-implant|Death|98
1089032|NCT02224755|2155032|FG000|Two Year Follow up Post-implant|Heart transplant|137
1089033|NCT02224755|2155033|FG001|Two Year Follow up Post-implant|Heart transplant|119
1089034|NCT02224755|2155032|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
1089035|NCT02224755|2155033|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
1089036|NCT02224755|2155032|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15
1089037|NCT02224755|2155033|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6
1089038|NCT02224846|2155049|FG000|Period 1 (Month 3)|Adverse Event|2
1089039|NCT02224846|2155050|FG001|Period 1 (Month 3)|Adverse Event|1
1089040|NCT02224846|2155049|FG000|Period 1 (Month 3)|Lost to Follow-up|3
1089041|NCT02224846|2155050|FG001|Period 1 (Month 3)|Lost to Follow-up|8
1089042|NCT02224846|2155049|FG000|Period 1 (Month 3)|Protocol Violation|4
1089043|NCT02224846|2155050|FG001|Period 1 (Month 3)|Protocol Violation|8
1089044|NCT02224846|2155049|FG000|Period 1 (Month 3)|Withdrawal by Subject|8
1089045|NCT02224846|2155050|FG001|Period 1 (Month 3)|Withdrawal by Subject|18
1089046|NCT02224846|2155049|FG000|Period 1 (Month 3)|Sponsor Decision|2
1089047|NCT02224846|2155050|FG001|Period 1 (Month 3)|Sponsor Decision|1
1089048|NCT02224846|2155049|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1
1089049|NCT02224846|2155050|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2
1089050|NCT02224846|2155049|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
1089051|NCT02224846|2155050|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
1089052|NCT02224846|2155049|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0
1089053|NCT02224846|2155050|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3
1089054|NCT02224846|2155049|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
1089055|NCT02224846|2155050|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
1089056|NCT02224846|2155049|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0
1089057|NCT02224846|2155050|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2
1089058|NCT02224846|2155049|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3
1089059|NCT02224846|2155050|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4
1089060|NCT02224846|2155049|FG000|Period 2 (Month 12 to Month 24)|Death|1
1089061|NCT02224846|2155050|FG001|Period 2 (Month 12 to Month 24)|Death|0
1089062|NCT02224846|2155049|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
1089063|NCT02224846|2155050|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
1089064|NCT02224846|2155049|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4
1089065|NCT02224846|2155050|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11
1089066|NCT02224846|2155049|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
1089067|NCT02224846|2155050|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
1089068|NCT02224846|2155049|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0
1089069|NCT02224846|2155050|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2
1089070|NCT02224846|2155049|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
1089071|NCT02224846|2155050|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
1089072|NCT02225223|2155070|FG000|Overall Study|Death|10
1089073|NCT02225223|2155071|FG001|Overall Study|Death|1
1089074|NCT02225223|2155070|FG000|Overall Study|Lost to Follow-up|5
1089075|NCT02225223|2155071|FG001|Overall Study|Lost to Follow-up|0
1089076|NCT02225223|2155070|FG000|Overall Study|Other|1
1089077|NCT02225223|2155071|FG001|Overall Study|Other|2
1089078|NCT02225223|2155070|FG000|Overall Study|Physician Decision|1
943122|NCT01005251|1932724|FG000|Overall Study|Withdrawal by Subject|2
943123|NCT01005251|1932725|FG001|Overall Study|Withdrawal by Subject|5
943124|NCT01005251|1932726|FG002|Overall Study|Withdrawal by Subject|3
943125|NCT01005251|1932727|FG003|Overall Study|Withdrawal by Subject|4
943126|NCT01005251|1932728|FG004|Overall Study|Withdrawal by Subject|9
943127|NCT01005251|1932724|FG000|Overall Study|Eligibility criteria not fulfilled|4
943128|NCT01005251|1932725|FG001|Overall Study|Eligibility criteria not fulfilled|0
943129|NCT01005251|1932726|FG002|Overall Study|Eligibility criteria not fulfilled|4
943130|NCT01005251|1932727|FG003|Overall Study|Eligibility criteria not fulfilled|1
943131|NCT01005251|1932728|FG004|Overall Study|Eligibility criteria not fulfilled|0
943132|NCT01005251|1932724|FG000|Overall Study|Adverse Event|2
943133|NCT01005251|1932725|FG001|Overall Study|Adverse Event|6
943134|NCT01005251|1932726|FG002|Overall Study|Adverse Event|8
1089079|NCT02225223|2155071|FG001|Overall Study|Physician Decision|0
1089080|NCT02225223|2155070|FG000|Overall Study|Withdrawal by Subject|2
1089081|NCT02225223|2155071|FG001|Overall Study|Withdrawal by Subject|2
1089082|NCT02225353|2155080|FG000|Overall Study|Lost to Follow-up|0
1089083|NCT02225353|2155081|FG001|Overall Study|Lost to Follow-up|1
1089084|NCT02225353|2155082|FG002|Overall Study|Lost to Follow-up|3
1089085|NCT02225353|2155080|FG000|Overall Study|Protocol Violation|4
1089086|NCT02225353|2155081|FG001|Overall Study|Protocol Violation|5
1089087|NCT02225353|2155082|FG002|Overall Study|Protocol Violation|12
1089088|NCT02225587|2155095|FG000|Overall Study|Adverse Event|5
1089089|NCT02225587|2155096|FG001|Overall Study|Adverse Event|5
1089090|NCT02225587|2155095|FG000|Overall Study|Lost to Follow-up|5
1089091|NCT02225587|2155096|FG001|Overall Study|Lost to Follow-up|5
1089092|NCT02225587|2155095|FG000|Overall Study|Non-Compliance With Study Drug|1
1089093|NCT02225587|2155096|FG001|Overall Study|Non-Compliance With Study Drug|0
1089094|NCT02225587|2155095|FG000|Overall Study|Physician Decision|2
1089095|NCT02225587|2155096|FG001|Overall Study|Physician Decision|0
1089096|NCT02225587|2155095|FG000|Overall Study|Protocol Violation|1
1089097|NCT02225587|2155096|FG001|Overall Study|Protocol Violation|0
1089098|NCT02225587|2155095|FG000|Overall Study|Participant Moved|1
1089099|NCT02225587|2155096|FG001|Overall Study|Participant Moved|0
1089100|NCT02225587|2155095|FG000|Overall Study|Withdrawal by Subject|13
1089101|NCT02225587|2155096|FG001|Overall Study|Withdrawal by Subject|28
1089102|NCT02225665|2155104|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1
1089103|NCT02225665|2155105|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0
1089104|NCT02225665|2155104|FG000|Overall Study|Subject restarted HAART prior to month 18.|0
1089105|NCT02225665|2155105|FG001|Overall Study|Subject restarted HAART prior to month 18.|1
1089106|NCT02225743|2155111|FG000|Overall Study|Withdrawal by Subject|18
1089107|NCT02226003|2155132|FG000|Overall Study|Lost to Follow-up|2
1089108|NCT02226003|2155133|FG001|Overall Study|Lost to Follow-up|1
1089109|NCT02226003|2155134|FG002|Overall Study|Lost to Follow-up|3
1089110|NCT02226003|2155132|FG000|Overall Study|Withdrawal by Subject|0
1089111|NCT02226003|2155133|FG001|Overall Study|Withdrawal by Subject|0
1089112|NCT02226003|2155134|FG002|Overall Study|Withdrawal by Subject|3
1089113|NCT02226120|2155142|FG000|Overall Study|Adverse Event|60
1089114|NCT02226120|2155142|FG000|Overall Study|Death|172
1089115|NCT02226120|2155142|FG000|Overall Study|Study terminated by sponsor|1
1089116|NCT02226120|2155142|FG000|Overall Study|Technical problems|4
1089117|NCT02226120|2155142|FG000|Overall Study|Lost to Follow-up|13
1089118|NCT02226120|2155142|FG000|Overall Study|Physician Decision|21
1089119|NCT02226120|2155142|FG000|Overall Study|Withdrawal by parent/guardian|36
1089120|NCT02226120|2155142|FG000|Overall Study|Non-compliance with study drug|10
1089121|NCT02226120|2155142|FG000|Overall Study|Protocol deviation|1
1089122|NCT02226120|2155142|FG000|Overall Study|missing treatment disposition pages|2
1089123|NCT02226172|2155155|FG000|Overall Study|Participant refused further follow-up|4
1089124|NCT02226172|2155155|FG000|Overall Study|Other|5
1089125|NCT02226172|2155155|FG000|Overall Study|Death|1
1089126|NCT02226172|2155155|FG000|Overall Study|Study terminated by sponsor|1
1089127|NCT02226172|2155155|FG000|Overall Study|Adverse Event|6
1089128|NCT02226198|2155159|FG000|Lead-in Phase|Protocol Violation|1
1089129|NCT02226198|2155160|FG001|Lead-in Phase|Protocol Violation|0
1089130|NCT02226198|2155161|FG002|Lead-in Phase|Protocol Violation|0
1089131|NCT02226198|2155159|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
1089132|NCT02226198|2155160|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
1089133|NCT02226198|2155161|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
1089134|NCT02226549|2155189|FG000|Overall Study|Randomized but Never Treated|1
1089135|NCT02226549|2155190|FG001|Overall Study|Randomized but Never Treated|0
943135|NCT01005251|1932727|FG003|Overall Study|Adverse Event|5
943136|NCT01005251|1932728|FG004|Overall Study|Adverse Event|4
943137|NCT01005251|1932724|FG000|Overall Study|Protocol Violation|1
943138|NCT01005251|1932725|FG001|Overall Study|Protocol Violation|0
943139|NCT01005251|1932726|FG002|Overall Study|Protocol Violation|0
943140|NCT01005251|1932727|FG003|Overall Study|Protocol Violation|0
909675|NCT00789477|1886418|FG000|Overall Study|Lost to Follow-up|0
909676|NCT00789477|1886419|FG001|Overall Study|Lost to Follow-up|1
909677|NCT00789477|1886420|FG002|Overall Study|Lost to Follow-up|4
909678|NCT00789477|1886421|FG003|Overall Study|Lost to Follow-up|2
909679|NCT00789477|1886422|FG004|Overall Study|Lost to Follow-up|4
943141|NCT01005251|1932728|FG004|Overall Study|Protocol Violation|2
943142|NCT01005251|1932724|FG000|Overall Study|Developed study-specific withdrawal crit|2
943143|NCT01005251|1932725|FG001|Overall Study|Developed study-specific withdrawal crit|0
943144|NCT01005251|1932726|FG002|Overall Study|Developed study-specific withdrawal crit|3
943145|NCT01005251|1932727|FG003|Overall Study|Developed study-specific withdrawal crit|0
943146|NCT01005251|1932728|FG004|Overall Study|Developed study-specific withdrawal crit|1
943147|NCT01005251|1932724|FG000|Overall Study|Lost to Follow-up|1
943148|NCT01005251|1932725|FG001|Overall Study|Lost to Follow-up|4
943149|NCT01005251|1932726|FG002|Overall Study|Lost to Follow-up|2
943150|NCT01005251|1932727|FG003|Overall Study|Lost to Follow-up|0
943151|NCT01005251|1932728|FG004|Overall Study|Lost to Follow-up|0
1089136|NCT02226549|2155189|FG000|Overall Study|Lost to Follow-up|0
1089137|NCT02226549|2155190|FG001|Overall Study|Lost to Follow-up|1
1089138|NCT02226562|2155198|FG000|Overall Study|Lost to Follow-up|0
1089139|NCT02226562|2155199|FG001|Overall Study|Lost to Follow-up|1
1089140|NCT02226653|2155207|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1
1089141|NCT02226653|2155208|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0
1089142|NCT02226653|2155207|FG000|Treatment Period 5 Fed State|Adverse Event|0
1089143|NCT02226653|2155208|FG001|Treatment Period 5 Fed State|Adverse Event|1
1089144|NCT02227108|2155232|FG000|Overall Study|Did not receive treatment|2
1089145|NCT02227108|2155232|FG000|Overall Study|Other|3
1089146|NCT02227108|2155232|FG000|Overall Study|Progressive disease|17
1089147|NCT02227108|2155232|FG000|Overall Study|Initiation of alternative therapy|2
1089148|NCT02227108|2155232|FG000|Overall Study|Investigator discretion|1
1089149|NCT02227108|2155232|FG000|Overall Study|Adverse Event|6
1089150|NCT02227147|2155242|FG000|Controlled Treatment Period|Adverse Event|4
1089151|NCT02227147|2155243|FG001|Controlled Treatment Period|Adverse Event|3
1089152|NCT02227147|2155242|FG000|Controlled Treatment Period|Other|2
1089153|NCT02227147|2155243|FG001|Controlled Treatment Period|Other|0
1089154|NCT02227147|2155242|FG000|Follow-up Period|Other|3
1089155|NCT02227147|2155243|FG001|Follow-up Period|Other|5
1089162|NCT02227238|2155272|FG000|Overall Study|Other: Reached stopping criteria|0
1089163|NCT02227238|2155273|FG001|Overall Study|Other: Reached stopping criteria|1
1089164|NCT02227238|2155272|FG000|Overall Study|Adverse Event|8
1089165|NCT02227238|2155273|FG001|Overall Study|Adverse Event|18
1089166|NCT02227238|2155272|FG000|Overall Study|Lack of Efficacy|10
1089167|NCT02227238|2155273|FG001|Overall Study|Lack of Efficacy|22
1089168|NCT02227238|2155272|FG000|Overall Study|Protocol Violation|7
1089169|NCT02227238|2155273|FG001|Overall Study|Protocol Violation|8
1089170|NCT02227238|2155272|FG000|Overall Study|Withdrawal by Subject|5
1089171|NCT02227238|2155273|FG001|Overall Study|Withdrawal by Subject|4
1089172|NCT02227238|2155272|FG000|Overall Study|Physician Decision|0
1089173|NCT02227238|2155273|FG001|Overall Study|Physician Decision|9
1089174|NCT02227238|2155272|FG000|Overall Study|Lost to Follow-up|7
1089175|NCT02227238|2155273|FG001|Overall Study|Lost to Follow-up|5
1089176|NCT02227368|2155307|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
1089177|NCT02227368|2155308|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
1089178|NCT02227368|2155307|FG000|Overall Study|Lost to Follow-up|1
1089179|NCT02227368|2155308|FG001|Overall Study|Lost to Follow-up|0
1089180|NCT02227368|2155307|FG000|Overall Study|Adverse Event|1
1089181|NCT02227368|2155308|FG001|Overall Study|Adverse Event|0
1089182|NCT02227446|2155316|FG000|Overall Study|not eligible post randomization|18
1089183|NCT02227446|2155317|FG001|Overall Study|not eligible post randomization|29
1089184|NCT02227446|2155316|FG000|Overall Study|Withdrawal by Subject|4
1089185|NCT02227446|2155317|FG001|Overall Study|Withdrawal by Subject|5
1089186|NCT02227784|2155377|FG000|Double-Blind Phase|Adverse Event|3
1089187|NCT02227784|2155378|FG001|Double-Blind Phase|Adverse Event|2
1089188|NCT02227784|2155379|FG002|Double-Blind Phase|Adverse Event|1
1089189|NCT02227784|2155380|FG003|Double-Blind Phase|Adverse Event|3
1089190|NCT02227784|2155381|FG004|Double-Blind Phase|Adverse Event|0
1089191|NCT02227784|2155377|FG000|Double-Blind Phase|Physician Decision|1
1089192|NCT02227784|2155378|FG001|Double-Blind Phase|Physician Decision|0
1089193|NCT02227784|2155379|FG002|Double-Blind Phase|Physician Decision|0
1089194|NCT02227784|2155380|FG003|Double-Blind Phase|Physician Decision|1
1089195|NCT02227784|2155381|FG004|Double-Blind Phase|Physician Decision|0
1089196|NCT02227784|2155377|FG000|Double-Blind Phase|Protocol Violation|0
1089197|NCT02227784|2155378|FG001|Double-Blind Phase|Protocol Violation|0
1089198|NCT02227784|2155379|FG002|Double-Blind Phase|Protocol Violation|1
1089199|NCT02227784|2155380|FG003|Double-Blind Phase|Protocol Violation|1
1089200|NCT02227784|2155381|FG004|Double-Blind Phase|Protocol Violation|0
1089201|NCT02227784|2155377|FG000|Double-Blind Phase|Sponsor Decision|34
1089202|NCT02227784|2155378|FG001|Double-Blind Phase|Sponsor Decision|15
1089203|NCT02227784|2155379|FG002|Double-Blind Phase|Sponsor Decision|14
1089204|NCT02227784|2155380|FG003|Double-Blind Phase|Sponsor Decision|32
1089205|NCT02227784|2155381|FG004|Double-Blind Phase|Sponsor Decision|0
943152|NCT01005251|1932724|FG000|Overall Study|Physician Decision|0
943153|NCT01005251|1932725|FG001|Overall Study|Physician Decision|0
943154|NCT01005251|1932726|FG002|Overall Study|Physician Decision|0
943155|NCT01005251|1932727|FG003|Overall Study|Physician Decision|0
943156|NCT01005251|1932728|FG004|Overall Study|Physician Decision|2
943157|NCT01005251|1932724|FG000|Overall Study|Patient moved|1
943158|NCT01005251|1932725|FG001|Overall Study|Patient moved|0
943159|NCT01005251|1932726|FG002|Overall Study|Patient moved|0
943160|NCT01005251|1932727|FG003|Overall Study|Patient moved|0
943161|NCT01005251|1932728|FG004|Overall Study|Patient moved|0
943162|NCT01005251|1932724|FG000|Overall Study|Wrong drug dispensed|0
943163|NCT01005251|1932725|FG001|Overall Study|Wrong drug dispensed|1
943164|NCT01005251|1932726|FG002|Overall Study|Wrong drug dispensed|0
943165|NCT01005251|1932727|FG003|Overall Study|Wrong drug dispensed|0
1089206|NCT02227784|2155377|FG000|Double-Blind Phase|Withdrawal by Subject|2
1089207|NCT02227784|2155378|FG001|Double-Blind Phase|Withdrawal by Subject|1
1089208|NCT02227784|2155379|FG002|Double-Blind Phase|Withdrawal by Subject|5
1089209|NCT02227784|2155380|FG003|Double-Blind Phase|Withdrawal by Subject|2
1089210|NCT02227784|2155381|FG004|Double-Blind Phase|Withdrawal by Subject|0
1089211|NCT02227784|2155377|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0
1089212|NCT02227784|2155378|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0
1089213|NCT02227784|2155379|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0
1089214|NCT02227784|2155380|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0
1089215|NCT02227784|2155381|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1
1089216|NCT02227784|2155377|FG000|Open-Label Extension Phase (OLE)|Death|0
1089217|NCT02227784|2155378|FG001|Open-Label Extension Phase (OLE)|Death|0
1089218|NCT02227784|2155379|FG002|Open-Label Extension Phase (OLE)|Death|0
1089219|NCT02227784|2155380|FG003|Open-Label Extension Phase (OLE)|Death|0
1089220|NCT02227784|2155381|FG004|Open-Label Extension Phase (OLE)|Death|1
1089221|NCT02227784|2155377|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1089222|NCT02227784|2155378|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1089223|NCT02227784|2155379|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1089224|NCT02227784|2155380|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1089225|NCT02227784|2155381|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243
1089226|NCT02227784|2155377|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1089227|NCT02227784|2155378|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1089228|NCT02227784|2155379|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1089229|NCT02227784|2155380|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1089230|NCT02227784|2155381|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
1089231|NCT02227849|2155409|FG000|Overall Study|Adverse Event|4
1089232|NCT02227849|2155409|FG000|Overall Study|Physician Decision|1
1089233|NCT02227849|2155409|FG000|Overall Study|Withdrawal by Subject|3
1089234|NCT02227862|2155415|FG000|Overall Study|Protocol Violation|7
1089235|NCT02227862|2155416|FG001|Overall Study|Protocol Violation|9
1089236|NCT02227862|2155415|FG000|Overall Study|Other|0
1089237|NCT02227862|2155416|FG001|Overall Study|Other|2
1089238|NCT02227862|2155415|FG000|Overall Study|Adverse Event|4
1089239|NCT02227862|2155416|FG001|Overall Study|Adverse Event|3
1089240|NCT02227862|2155415|FG000|Overall Study|Withdrawal by Subject|7
1089241|NCT02227862|2155416|FG001|Overall Study|Withdrawal by Subject|6
1089242|NCT02227862|2155415|FG000|Overall Study|Lost to Follow-up|1
1089243|NCT02227862|2155416|FG001|Overall Study|Lost to Follow-up|2
1089244|NCT02227875|2155424|FG000|Overall Study|Protocol Violation|10
1089245|NCT02227875|2155425|FG001|Overall Study|Protocol Violation|7
1089246|NCT02227875|2155424|FG000|Overall Study|Other|1
1089247|NCT02227875|2155425|FG001|Overall Study|Other|3
1089248|NCT02227875|2155424|FG000|Overall Study|Physician Decision|1
1089249|NCT02227875|2155425|FG001|Overall Study|Physician Decision|0
1089250|NCT02227875|2155424|FG000|Overall Study|Adverse Event|3
1089251|NCT02227875|2155425|FG001|Overall Study|Adverse Event|0
1089252|NCT02227875|2155424|FG000|Overall Study|Withdrawal by Subject|12
1089253|NCT02227875|2155425|FG001|Overall Study|Withdrawal by Subject|13
1089254|NCT02227875|2155424|FG000|Overall Study|Lost to Follow-up|10
1089255|NCT02227875|2155425|FG001|Overall Study|Lost to Follow-up|10
1089256|NCT02228096|2155433|FG000|Overall Study|Study terminated by Sponsor|24
1089257|NCT02228096|2155433|FG000|Overall Study|Lack of Efficacy|18
1089258|NCT02228096|2155433|FG000|Overall Study|Death|12
1089259|NCT02228096|2155433|FG000|Overall Study|Physician Decision|3
1089260|NCT02228096|2155433|FG000|Overall Study|Subject/guardian decision|2
1089261|NCT02228096|2155433|FG000|Overall Study|New therapy for study indication|1
1089262|NCT02228096|2155433|FG000|Overall Study|Enrolled, not infused|11
1089263|NCT02228395|2155455|FG000|First Intervention Period|No longer willing to participate|1
1089264|NCT02228395|2155456|FG001|First Intervention Period|No longer willing to participate|0
1089265|NCT02228395|2155457|FG002|First Intervention Period|No longer willing to participate|0
1089266|NCT02228395|2155455|FG000|First Intervention Period|Unable to comply with study dates|0
1089267|NCT02228395|2155456|FG001|First Intervention Period|Unable to comply with study dates|1
1089268|NCT02228395|2155457|FG002|First Intervention Period|Unable to comply with study dates|1
1089269|NCT02228460|2155476|FG000|Overall Study|Adverse Event|1
1089270|NCT02228460|2155476|FG000|Overall Study|Lost to Follow-up|1
1089271|NCT02228564|2155490|FG000|Overall Study|Withdrawal by Subject|10
1089272|NCT02228564|2155490|FG000|Overall Study|Death|11
943166|NCT01005251|1932728|FG004|Overall Study|Wrong drug dispensed|0
943167|NCT01005251|1932724|FG000|Overall Study|Randomized in error|0
943168|NCT01005251|1932725|FG001|Overall Study|Randomized in error|0
943169|NCT01005251|1932726|FG002|Overall Study|Randomized in error|1
943170|NCT01005251|1932727|FG003|Overall Study|Randomized in error|1
943171|NCT01005251|1932728|FG004|Overall Study|Randomized in error|0
943172|NCT01005251|1932724|FG000|Overall Study|Lack of Efficacy|0
943173|NCT01005251|1932725|FG001|Overall Study|Lack of Efficacy|0
943174|NCT01005251|1932726|FG002|Overall Study|Lack of Efficacy|1
943175|NCT01005251|1932727|FG003|Overall Study|Lack of Efficacy|1
943176|NCT01005251|1932728|FG004|Overall Study|Lack of Efficacy|0
943177|NCT01005316|1932752|FG000|Overall Study|Adverse Event|0
943178|NCT01005316|1932753|FG001|Overall Study|Adverse Event|0
943179|NCT01005316|1932754|FG002|Overall Study|Adverse Event|0
943180|NCT01005316|1932755|FG003|Overall Study|Adverse Event|1
1089273|NCT02228564|2155490|FG000|Overall Study|Physician Decision|5
1089274|NCT02228564|2155490|FG000|Overall Study|Lost to Follow-up|17
1089275|NCT02228564|2155490|FG000|Overall Study|Other|6
1089276|NCT02228590|2155494|FG000|Overall Study|Withdrawal by Subject|1
1089277|NCT02228720|2155508|FG000|Open Label - Day 30|Lost to Follow-up|1
1089278|NCT02228967|2155523|FG000|Overall Study|Lost to Follow-up|146
1089279|NCT02228967|2155524|FG001|Overall Study|Lost to Follow-up|142
1089280|NCT02228967|2155523|FG000|Overall Study|Withdrawal by Subject|13
1089281|NCT02228967|2155524|FG001|Overall Study|Withdrawal by Subject|18
1089282|NCT02228980|2155534|FG000|Overall Study|Adverse Event|14
1089283|NCT02228980|2155535|FG001|Overall Study|Adverse Event|0
1089284|NCT02228980|2155536|FG002|Overall Study|Adverse Event|0
1089285|NCT02228980|2155537|FG003|Overall Study|Adverse Event|0
1089286|NCT02228980|2155534|FG000|Overall Study|Protocol Violation|7
1089287|NCT02228980|2155535|FG001|Overall Study|Protocol Violation|0
1089288|NCT02228980|2155536|FG002|Overall Study|Protocol Violation|0
1089289|NCT02228980|2155537|FG003|Overall Study|Protocol Violation|0
1089290|NCT02228980|2155534|FG000|Overall Study|Withdrawal by Subject|3
1089291|NCT02228980|2155535|FG001|Overall Study|Withdrawal by Subject|3
1089292|NCT02228980|2155536|FG002|Overall Study|Withdrawal by Subject|2
909680|NCT00789477|1886418|FG000|Overall Study|Lack of Efficacy|2
909681|NCT00789477|1886419|FG001|Overall Study|Lack of Efficacy|0
909682|NCT00789477|1886420|FG002|Overall Study|Lack of Efficacy|0
909683|NCT00789477|1886421|FG003|Overall Study|Lack of Efficacy|0
1089293|NCT02228980|2155537|FG003|Overall Study|Withdrawal by Subject|3
1089294|NCT02229214|2155553|FG000|Overall Study|Adverse Event|2
1089295|NCT02229214|2155554|FG001|Overall Study|Adverse Event|0
1089296|NCT02229214|2155553|FG000|Overall Study|Withdrawal by Subject|4
1089297|NCT02229214|2155554|FG001|Overall Study|Withdrawal by Subject|0
1089298|NCT02229227|2155564|FG000|Overall Study|Adverse Event|14
1089299|NCT02229227|2155565|FG001|Overall Study|Adverse Event|9
1089300|NCT02229227|2155564|FG000|Overall Study|Lack of Efficacy|3
1089301|NCT02229227|2155565|FG001|Overall Study|Lack of Efficacy|3
1089302|NCT02229227|2155564|FG000|Overall Study|Protocol Violation|6
1089303|NCT02229227|2155565|FG001|Overall Study|Protocol Violation|8
1089304|NCT02229227|2155564|FG000|Overall Study|Protocol defined stopping criteria|1
1089305|NCT02229227|2155565|FG001|Overall Study|Protocol defined stopping criteria|3
1089306|NCT02229227|2155564|FG000|Overall Study|Lost to Follow-up|3
1089307|NCT02229227|2155565|FG001|Overall Study|Lost to Follow-up|3
1089308|NCT02229227|2155564|FG000|Overall Study|Study terminated by sponsor|11
1089309|NCT02229227|2155565|FG001|Overall Study|Study terminated by sponsor|11
1089310|NCT02229227|2155564|FG000|Overall Study|Withdrawal by Subject|8
1089311|NCT02229227|2155565|FG001|Overall Study|Withdrawal by Subject|12
1089312|NCT02229227|2155564|FG000|Overall Study|Other|0
1089313|NCT02229227|2155565|FG001|Overall Study|Other|1
1089314|NCT02229227|2155564|FG000|Overall Study|Physician Decision|5
1089315|NCT02229227|2155565|FG001|Overall Study|Physician Decision|12
1089316|NCT02229383|2155578|FG000|Overall Study|Adverse Event|7
1089317|NCT02229383|2155579|FG001|Overall Study|Adverse Event|4
1089318|NCT02229383|2155578|FG000|Overall Study|Death|0
1089319|NCT02229383|2155579|FG001|Overall Study|Death|1
1089320|NCT02229383|2155578|FG000|Overall Study|Lost to Follow-up|5
1089321|NCT02229383|2155579|FG001|Overall Study|Lost to Follow-up|3
1089322|NCT02229383|2155578|FG000|Overall Study|Withdrawal by Subject|4
1089323|NCT02229383|2155579|FG001|Overall Study|Withdrawal by Subject|6
1089324|NCT02229383|2155578|FG000|Overall Study|Did not receive treatment|1
1089325|NCT02229383|2155579|FG001|Overall Study|Did not receive treatment|0
1089326|NCT02229383|2155578|FG000|Overall Study|Other|3
1089327|NCT02229383|2155579|FG001|Overall Study|Other|8
943181|NCT01005316|1932752|FG000|Overall Study|Death|20
943182|NCT01005316|1932753|FG001|Overall Study|Death|5
943183|NCT01005316|1932754|FG002|Overall Study|Death|1
943184|NCT01005316|1932755|FG003|Overall Study|Death|15
943185|NCT01005316|1932752|FG000|Overall Study|Study Termination|5
943186|NCT01005316|1932753|FG001|Overall Study|Study Termination|63
943187|NCT01005316|1932754|FG002|Overall Study|Study Termination|9
943188|NCT01005316|1932755|FG003|Overall Study|Study Termination|85
943189|NCT01005316|1932752|FG000|Overall Study|Lost to Follow-up|1
943190|NCT01005316|1932753|FG001|Overall Study|Lost to Follow-up|3
943191|NCT01005316|1932754|FG002|Overall Study|Lost to Follow-up|0
943192|NCT01005316|1932755|FG003|Overall Study|Lost to Follow-up|2
943193|NCT01005316|1932752|FG000|Overall Study|Physician Decision|6
943194|NCT01005316|1932753|FG001|Overall Study|Physician Decision|0
943195|NCT01005316|1932754|FG002|Overall Study|Physician Decision|0
943196|NCT01005316|1932755|FG003|Overall Study|Physician Decision|0
943197|NCT01005316|1932752|FG000|Overall Study|Sponsor Decision|6
943198|NCT01005316|1932753|FG001|Overall Study|Sponsor Decision|3
943199|NCT01005316|1932754|FG002|Overall Study|Sponsor Decision|0
943200|NCT01005316|1932755|FG003|Overall Study|Sponsor Decision|0
943201|NCT01005316|1932752|FG000|Overall Study|Withdrawal by Subject|1
943202|NCT01005316|1932753|FG001|Overall Study|Withdrawal by Subject|1
943203|NCT01005316|1932754|FG002|Overall Study|Withdrawal by Subject|0
1089328|NCT02229396|2155588|FG000|Overall Study|Adverse Event|6
1089329|NCT02229396|2155589|FG001|Overall Study|Adverse Event|12
1089330|NCT02229396|2155590|FG002|Overall Study|Adverse Event|12
1089331|NCT02229396|2155588|FG000|Overall Study|Death|2
1089332|NCT02229396|2155589|FG001|Overall Study|Death|3
1089333|NCT02229396|2155590|FG002|Overall Study|Death|1
1089334|NCT02229396|2155588|FG000|Overall Study|Lost to Follow-up|14
1089335|NCT02229396|2155589|FG001|Overall Study|Lost to Follow-up|14
1089336|NCT02229396|2155590|FG002|Overall Study|Lost to Follow-up|21
1089337|NCT02229396|2155588|FG000|Overall Study|Protocol Violation|2
1089338|NCT02229396|2155589|FG001|Overall Study|Protocol Violation|1
1089339|NCT02229396|2155590|FG002|Overall Study|Protocol Violation|0
1089340|NCT02229396|2155588|FG000|Overall Study|Patient Incorrectly Randomized|0
1089341|NCT02229396|2155589|FG001|Overall Study|Patient Incorrectly Randomized|0
1089342|NCT02229396|2155590|FG002|Overall Study|Patient Incorrectly Randomized|1
1089343|NCT02229396|2155588|FG000|Overall Study|Other|10
1089344|NCT02229396|2155589|FG001|Overall Study|Other|18
1089345|NCT02229396|2155590|FG002|Overall Study|Other|15
1089346|NCT02229396|2155588|FG000|Overall Study|Withdrawal by Subject|42
1089347|NCT02229396|2155589|FG001|Overall Study|Withdrawal by Subject|28
1089348|NCT02229396|2155590|FG002|Overall Study|Withdrawal by Subject|41
1089349|NCT02229396|2155588|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
1089350|NCT02229396|2155589|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
1089351|NCT02229396|2155590|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
1089352|NCT02229396|2155588|FG000|Overall Study|Withdrew; No Record on Termination Page|2
1089353|NCT02229396|2155589|FG001|Overall Study|Withdrew; No Record on Termination Page|0
1089354|NCT02229396|2155590|FG002|Overall Study|Withdrew; No Record on Termination Page|1
1089355|NCT02229539|2155656|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
1089356|NCT02229539|2155657|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
1089357|NCT02229539|2155658|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
1089358|NCT02229539|2155656|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
1089359|NCT02229539|2155657|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
1089360|NCT02229539|2155658|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
1089361|NCT02229539|2155656|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
943204|NCT01005316|1932755|FG003|Overall Study|Withdrawal by Subject|2
943205|NCT01005316|1932752|FG000|Overall Study|Consented to Another Study|2
943206|NCT01005316|1932753|FG001|Overall Study|Consented to Another Study|0
943207|NCT01005316|1932754|FG002|Overall Study|Consented to Another Study|0
943208|NCT01005316|1932755|FG003|Overall Study|Consented to Another Study|0
943209|NCT01005316|1932752|FG000|Overall Study|Delisted|8
943210|NCT01005316|1932753|FG001|Overall Study|Delisted|0
943211|NCT01005316|1932754|FG002|Overall Study|Delisted|0
943212|NCT01005316|1932755|FG003|Overall Study|Delisted|0
943213|NCT01005316|1932752|FG000|Overall Study|Transferred Care|1
943214|NCT01005316|1932753|FG001|Overall Study|Transferred Care|0
943215|NCT01005316|1932754|FG002|Overall Study|Transferred Care|1
943216|NCT01005316|1932755|FG003|Overall Study|Transferred Care|3
943217|NCT01005316|1932752|FG000|Overall Study|Retransplanted|0
943218|NCT01005316|1932753|FG001|Overall Study|Retransplanted|1
943219|NCT01005316|1932754|FG002|Overall Study|Retransplanted|0
943220|NCT01005316|1932755|FG003|Overall Study|Retransplanted|0
943221|NCT01005329|1932766|FG000|Overall Study|Ineligible or received no protocol trt.|4
943222|NCT01005602|1932811|FG000|Overall Study|Excluded due to unreliable clinical data|1
943223|NCT01005602|1932812|FG001|Overall Study|Excluded due to unreliable clinical data|0
943224|NCT01005680|1932827|FG000|Overall Study|Lost to Follow-up|4
943225|NCT01005680|1932828|FG001|Overall Study|Lost to Follow-up|6
943226|NCT01005680|1932827|FG000|Overall Study|Withdrawal by Subject|1
943227|NCT01005680|1932828|FG001|Overall Study|Withdrawal by Subject|4
943228|NCT01005680|1932827|FG000|Overall Study|Physician Decision|1
943229|NCT01005680|1932828|FG001|Overall Study|Physician Decision|1
943230|NCT01005719|1932844|FG000|Period 1|Adverse Event|0
943231|NCT01005719|1932845|FG001|Period 1|Adverse Event|0
943232|NCT01005719|1932846|FG002|Period 1|Adverse Event|0
943233|NCT01005719|1932847|FG003|Period 1|Adverse Event|1
943234|NCT01005719|1932848|FG004|Period 1|Adverse Event|0
943235|NCT01005719|1932849|FG005|Period 1|Adverse Event|0
943236|NCT01005719|1932844|FG000|Period 1|Delay in completing study procedures|0
943237|NCT01005719|1932845|FG001|Period 1|Delay in completing study procedures|0
943238|NCT01005719|1932846|FG002|Period 1|Delay in completing study procedures|0
943239|NCT01005719|1932847|FG003|Period 1|Delay in completing study procedures|0
943240|NCT01005719|1932848|FG004|Period 1|Delay in completing study procedures|0
943241|NCT01005719|1932849|FG005|Period 1|Delay in completing study procedures|1
943242|NCT01005719|1932844|FG000|Period 2|Adverse Event|0
943243|NCT01005719|1932845|FG001|Period 2|Adverse Event|0
943244|NCT01005719|1932846|FG002|Period 2|Adverse Event|0
943245|NCT01005719|1932847|FG003|Period 2|Adverse Event|0
943246|NCT01005719|1932848|FG004|Period 2|Adverse Event|1
943247|NCT01005719|1932849|FG005|Period 2|Adverse Event|1
943248|NCT01005732|1932858|FG000|Overall Study|Lost to Follow-up|10
943249|NCT01005732|1932858|FG000|Overall Study|Death|1
943250|NCT01005745|1932866|FG000|Overall Study|No TIL growth|1
943251|NCT01005745|1932866|FG000|Overall Study|Disease progressed during TIL growth|3
943252|NCT01005745|1932866|FG000|Overall Study|Death prior to treatment|1
943253|NCT01005745|1932866|FG000|Overall Study|Inappropriate antidiuretic hormone|1
943254|NCT01005875|1932879|FG000|Overall Study|Death|3
943255|NCT01005901|1932896|FG000|Overall Study|Withdrawal by Subject|38
943256|NCT01005901|1932897|FG001|Overall Study|Withdrawal by Subject|14
943257|NCT01005901|1932896|FG000|Overall Study|Adverse Event|30
1089362|NCT02229539|2155657|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
1089363|NCT02229539|2155658|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
1089364|NCT02229539|2155656|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
1089365|NCT02229539|2155657|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
1089366|NCT02229539|2155658|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
1089367|NCT02229539|2155656|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
1089368|NCT02229539|2155657|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
1089369|NCT02229539|2155658|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
1089370|NCT02229539|2155656|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
1089371|NCT02229539|2155657|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
1089372|NCT02229539|2155658|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
1089373|NCT02229539|2155656|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
1089374|NCT02229539|2155657|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
1089375|NCT02229539|2155658|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
1089376|NCT02229539|2155656|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
1089377|NCT02229539|2155657|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
1089378|NCT02229539|2155658|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
1089379|NCT02229539|2155656|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
1089380|NCT02229539|2155657|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
1089381|NCT02229539|2155658|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
1089382|NCT02229552|2155666|FG000|Baseline|Withdrawal by Subject|6
1089383|NCT02229552|2155666|FG000|1-year Follow up|Withdrawal by Subject|7
1089384|NCT02229552|2155666|FG000|1-year Follow up|Lost to Follow-up|18
1089385|NCT02229552|2155666|FG000|2-Year Follow up|Withdrawal by Subject|9
1089386|NCT02229552|2155666|FG000|2-Year Follow up|Lost to Follow-up|17
1089387|NCT02229851|2155673|FG000|Main Phase (Double-blind Phase)|Unclassified|1
1089388|NCT02229851|2155674|FG001|Main Phase (Double-blind Phase)|Unclassified|2
1089389|NCT02229851|2155675|FG002|Main Phase (Double-blind Phase)|Unclassified|0
1089390|NCT02229851|2155676|FG003|Main Phase (Double-blind Phase)|Unclassified|0
1089391|NCT02229851|2155677|FG004|Main Phase (Double-blind Phase)|Unclassified|0
1089392|NCT02229851|2155678|FG005|Main Phase (Double-blind Phase)|Unclassified|0
1089393|NCT02229851|2155679|FG006|Main Phase (Double-blind Phase)|Unclassified|0
1089394|NCT02229851|2155673|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0
1089395|NCT02229851|2155674|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1
1089396|NCT02229851|2155675|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0
1089397|NCT02229851|2155676|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0
1089398|NCT02229851|2155677|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0
1089399|NCT02229851|2155678|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0
1089400|NCT02229851|2155679|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0
1089401|NCT02229851|2155673|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
1089402|NCT02229851|2155674|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12
1089403|NCT02229851|2155675|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
1089404|NCT02229851|2155676|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
1089405|NCT02229851|2155677|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
1089406|NCT02229851|2155678|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
1089407|NCT02229851|2155679|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
1089408|NCT02229851|2155673|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0
1089409|NCT02229851|2155674|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0
1089410|NCT02229851|2155675|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2
1089411|NCT02229851|2155676|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0
1089412|NCT02229851|2155677|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0
1089413|NCT02229851|2155678|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0
1089414|NCT02229851|2155679|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0
1089415|NCT02229851|2155673|FG000|Main Phase (Double-blind Phase)|Death|1
1089416|NCT02229851|2155674|FG001|Main Phase (Double-blind Phase)|Death|1
1089417|NCT02229851|2155675|FG002|Main Phase (Double-blind Phase)|Death|0
1089418|NCT02229851|2155676|FG003|Main Phase (Double-blind Phase)|Death|0
1089419|NCT02229851|2155677|FG004|Main Phase (Double-blind Phase)|Death|0
1089420|NCT02229851|2155678|FG005|Main Phase (Double-blind Phase)|Death|0
1089421|NCT02229851|2155679|FG006|Main Phase (Double-blind Phase)|Death|0
1089422|NCT02229851|2155673|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0
1089423|NCT02229851|2155674|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0
1089424|NCT02229851|2155675|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0
1089425|NCT02229851|2155676|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0
1089426|NCT02229851|2155677|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1
1089427|NCT02229851|2155678|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1
1089428|NCT02229851|2155679|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1
1089429|NCT02229851|2155673|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
1089430|NCT02229851|2155674|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
1089431|NCT02229851|2155675|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
1089432|NCT02229851|2155676|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
1089433|NCT02229851|2155677|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4
1089434|NCT02229851|2155678|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3
1089435|NCT02229851|2155679|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
1089436|NCT02229851|2155673|FG000|Extension Phase (Open-label Phase)|Death|0
1089437|NCT02229851|2155674|FG001|Extension Phase (Open-label Phase)|Death|0
1089438|NCT02229851|2155675|FG002|Extension Phase (Open-label Phase)|Death|0
1089439|NCT02229851|2155676|FG003|Extension Phase (Open-label Phase)|Death|1
1089440|NCT02229851|2155677|FG004|Extension Phase (Open-label Phase)|Death|0
1089441|NCT02229851|2155678|FG005|Extension Phase (Open-label Phase)|Death|1
1089442|NCT02229851|2155679|FG006|Extension Phase (Open-label Phase)|Death|1
1089443|NCT02229864|2155694|FG000|Overall Study|Death|2
1089444|NCT02229864|2155694|FG000|Overall Study|Lost to Follow-up|1
1089445|NCT02230085|2155698|FG000|Overall Study|Physician Decision|1
1089446|NCT02230085|2155698|FG000|Overall Study|Withdrawal by Subject|3
1089447|NCT02230306|2155702|FG000|Overall Study|Did not receive study treatment|1
1089448|NCT02230332|2155708|FG000|Overall Study|Adverse Event|2
1089449|NCT02230332|2155709|FG001|Overall Study|Adverse Event|1
1089450|NCT02230332|2155708|FG000|Overall Study|Lost to Follow-up|1
1089451|NCT02230332|2155709|FG001|Overall Study|Lost to Follow-up|0
1089452|NCT02230332|2155708|FG000|Overall Study|Protocol Violation|1
943258|NCT01005901|1932897|FG001|Overall Study|Adverse Event|16
943259|NCT01005901|1932896|FG000|Overall Study|Administrative problems|21
943260|NCT01005901|1932897|FG001|Overall Study|Administrative problems|13
943261|NCT01005901|1932896|FG000|Overall Study|Unsatisfactory therapeutic effect|5
943262|NCT01005901|1932897|FG001|Overall Study|Unsatisfactory therapeutic effect|5
943263|NCT01005901|1932896|FG000|Overall Study|Protocol Violation|4
943264|NCT01005901|1932897|FG001|Overall Study|Protocol Violation|3
943265|NCT01005901|1932896|FG000|Overall Study|Death|2
943266|NCT01005901|1932897|FG001|Overall Study|Death|3
943267|NCT01005901|1932896|FG000|Overall Study|Lost to Follow-up|1
943268|NCT01005901|1932897|FG001|Overall Study|Lost to Follow-up|2
943269|NCT01005901|1932896|FG000|Overall Study|Patient's inability to use the device|1
943270|NCT01005901|1932897|FG001|Overall Study|Patient's inability to use the device|1
943271|NCT01005901|1932896|FG000|Overall Study|No longer requires study drug|0
943272|NCT01005901|1932897|FG001|Overall Study|No longer requires study drug|1
943273|NCT01005966|1932903|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
943274|NCT01005966|1932904|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
943275|NCT01005966|1932905|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
943276|NCT01005966|1932906|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
943277|NCT01005966|1932907|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
943278|NCT01005966|1932903|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
943279|NCT01005966|1932904|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0
943280|NCT01005966|1932905|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1
943281|NCT01005966|1932906|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0
943282|NCT01005966|1932907|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0
943283|NCT01005966|1932903|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0
943284|NCT01005966|1932904|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0
943285|NCT01005966|1932905|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0
943286|NCT01005966|1932906|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1
943287|NCT01005966|1932907|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0
943288|NCT01005966|1932903|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
943289|NCT01005966|1932904|FG001|Treatment Period 2 (14 Days)|Adverse Event|1
943290|NCT01005966|1932905|FG002|Treatment Period 2 (14 Days)|Adverse Event|1
943291|NCT01005966|1932906|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
943292|NCT01005966|1932907|FG004|Treatment Period 2 (14 Days)|Adverse Event|0
943293|NCT01005966|1932903|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
943294|NCT01005966|1932904|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
943295|NCT01005966|1932905|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
943296|NCT01005966|1932906|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
943297|NCT01005966|1932907|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
943298|NCT01005966|1932903|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
943299|NCT01005966|1932904|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
943300|NCT01005966|1932905|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
943301|NCT01005966|1932906|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
943302|NCT01005966|1932907|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
943303|NCT01005966|1932903|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0
943304|NCT01005966|1932904|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1
943305|NCT01005966|1932905|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0
943306|NCT01005966|1932906|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0
943307|NCT01005966|1932907|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1
943308|NCT01005966|1932903|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0
943309|NCT01005966|1932904|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1
943310|NCT01005966|1932905|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0
943311|NCT01005966|1932906|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0
943312|NCT01005966|1932907|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0
943313|NCT01005966|1932903|FG000|Treatment Period 4 (14 Days)|Other Reason|0
943314|NCT01005966|1932904|FG001|Treatment Period 4 (14 Days)|Other Reason|0
943315|NCT01005966|1932905|FG002|Treatment Period 4 (14 Days)|Other Reason|0
1089453|NCT02230332|2155709|FG001|Overall Study|Protocol Violation|0
1089454|NCT02230384|2155717|FG000|Phase 1|Lost to Follow-up|1
1089455|NCT02230384|2155718|FG001|Phase 1|Lost to Follow-up|0
1089456|NCT02230384|2155717|FG000|Phase 1|Physician Decision|0
1089457|NCT02230384|2155718|FG001|Phase 1|Physician Decision|1
1089458|NCT02230384|2155717|FG000|Phase 2 - Switch|Withdrawal by Subject|0
1089459|NCT02230384|2155718|FG001|Phase 2 - Switch|Withdrawal by Subject|1
1089460|NCT02230384|2155717|FG000|Phase 2 - Switch|Lost to Follow-up|1
1089461|NCT02230384|2155718|FG001|Phase 2 - Switch|Lost to Follow-up|0
1089462|NCT02230384|2155717|FG000|Phase 2 - Switch|Adverse Event|2
1089463|NCT02230384|2155718|FG001|Phase 2 - Switch|Adverse Event|0
1089464|NCT02230527|2155734|FG000|Overall Study|Withdrawal by Subject|1
1089465|NCT02230527|2155735|FG001|Overall Study|Withdrawal by Subject|1
1089466|NCT02230527|2155734|FG000|Overall Study|Death|1
1089467|NCT02230527|2155735|FG001|Overall Study|Death|0
1089468|NCT02230527|2155734|FG000|Overall Study|Lost to Follow-up|2
1089469|NCT02230527|2155735|FG001|Overall Study|Lost to Follow-up|1
1089470|NCT02230527|2155734|FG000|Overall Study|Other|1
1089471|NCT02230527|2155735|FG001|Overall Study|Other|0
1089472|NCT02230670|2155789|FG000|Overall Study|Adverse Event|1
1089473|NCT02230670|2155790|FG001|Overall Study|Adverse Event|2
1089474|NCT02230670|2155789|FG000|Overall Study|Withdrawal by Subject|2
1089475|NCT02230670|2155790|FG001|Overall Study|Withdrawal by Subject|2
1089476|NCT02230670|2155789|FG000|Overall Study|Physician Decision|0
1089477|NCT02230670|2155790|FG001|Overall Study|Physician Decision|1
1089478|NCT02230670|2155789|FG000|Overall Study|Protocol Violation|0
1089479|NCT02230670|2155790|FG001|Overall Study|Protocol Violation|1
1089480|NCT02230670|2155789|FG000|Overall Study|Progression to Child-Pugh C|1
1089481|NCT02230670|2155790|FG001|Overall Study|Progression to Child-Pugh C|2
1089482|NCT02230683|2155796|FG000|Overall Study|Adverse Event|1
1089483|NCT02230904|2155830|FG000|Overall Study|Safety follow up could not take place|0
1089484|NCT02230904|2155831|FG001|Overall Study|Safety follow up could not take place|1
1089485|NCT02230956|2155842|FG000|Overall Study|Adverse Event|1
1089486|NCT02230956|2155843|FG001|Overall Study|Adverse Event|1
1089487|NCT02230956|2155844|FG002|Overall Study|Adverse Event|0
1089488|NCT02230956|2155842|FG000|Overall Study|Lack of Efficacy|1
1089489|NCT02230956|2155843|FG001|Overall Study|Lack of Efficacy|1
1089490|NCT02230956|2155844|FG002|Overall Study|Lack of Efficacy|1
1089491|NCT02230956|2155842|FG000|Overall Study|Lost to Follow-up|1
1089492|NCT02230956|2155843|FG001|Overall Study|Lost to Follow-up|1
1089493|NCT02230956|2155844|FG002|Overall Study|Lost to Follow-up|2
1089494|NCT02230956|2155842|FG000|Overall Study|Personal Reasons|2
1089495|NCT02230956|2155843|FG001|Overall Study|Personal Reasons|1
1089496|NCT02230956|2155844|FG002|Overall Study|Personal Reasons|1
1089497|NCT02230956|2155842|FG000|Overall Study|Protocol Violation|0
1089498|NCT02230956|2155843|FG001|Overall Study|Protocol Violation|1
1089499|NCT02230956|2155844|FG002|Overall Study|Protocol Violation|1
1089500|NCT02230956|2155842|FG000|Overall Study|Other Miscellaneous Reason|0
1089501|NCT02230956|2155843|FG001|Overall Study|Other Miscellaneous Reason|1
1089502|NCT02230956|2155844|FG002|Overall Study|Other Miscellaneous Reason|2
1089503|NCT02231164|2155872|FG000|Overall Study|Adverse Event|1
1089504|NCT02231164|2155873|FG001|Overall Study|Adverse Event|1
1089505|NCT02231164|2155872|FG000|Overall Study|Lack of Efficacy|4
1089506|NCT02231164|2155873|FG001|Overall Study|Lack of Efficacy|3
1089507|NCT02231164|2155872|FG000|Overall Study|Withdrawal by Subject|1
1089508|NCT02231164|2155873|FG001|Overall Study|Withdrawal by Subject|2
1089509|NCT02231580|2155895|FG000|Overall Study|Adverse Event|5
1089510|NCT02231580|2155896|FG001|Overall Study|Adverse Event|0
1089511|NCT02231749|2155906|FG000|Overall Study|Disease progression|229
1089512|NCT02231749|2155907|FG001|Overall Study|Disease progression|297
1089513|NCT02231749|2155906|FG000|Overall Study|Study Drug Toxicity|134
1089514|NCT02231749|2155907|FG001|Overall Study|Study Drug Toxicity|63
1089515|NCT02231749|2155906|FG000|Overall Study|Death|1
1089516|NCT02231749|2155907|FG001|Overall Study|Death|1
1089517|NCT02231749|2155906|FG000|Overall Study|AE unrelated to Study drug|32
1089518|NCT02231749|2155907|FG001|Overall Study|AE unrelated to Study drug|31
1089519|NCT02231749|2155906|FG000|Overall Study|Participant's request to discontinue|10
1089520|NCT02231749|2155907|FG001|Overall Study|Participant's request to discontinue|21
1089521|NCT02231749|2155906|FG000|Overall Study|Participant withdrew Consent|8
1089522|NCT02231749|2155907|FG001|Overall Study|Participant withdrew Consent|15
1089523|NCT02231749|2155906|FG000|Overall Study|Lost to Follow-up|1
1089524|NCT02231749|2155907|FG001|Overall Study|Lost to Follow-up|2
1089525|NCT02231749|2155906|FG000|Overall Study|Maximum Clinical Benefit|5
1089526|NCT02231749|2155907|FG001|Overall Study|Maximum Clinical Benefit|8
1089527|NCT02231749|2155906|FG000|Overall Study|Poor/Non-Compliance|0
1089528|NCT02231749|2155907|FG001|Overall Study|Poor/Non-Compliance|3
1089529|NCT02231749|2155906|FG000|Overall Study|Pregnancy|1
1089530|NCT02231749|2155907|FG001|Overall Study|Pregnancy|0
1089531|NCT02231749|2155906|FG000|Overall Study|other|0
1089532|NCT02231749|2155907|FG001|Overall Study|other|8
1089533|NCT02231749|2155906|FG000|Overall Study|No longer meets Study Criteria|1
943316|NCT01005966|1932906|FG003|Treatment Period 4 (14 Days)|Other Reason|0
943317|NCT01005966|1932907|FG004|Treatment Period 4 (14 Days)|Other Reason|1
943318|NCT01006122|1932924|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
943319|NCT01006122|1932925|FG001|First Double-blind Intervention Period|Lost to Follow-up|2
1089534|NCT02231749|2155907|FG001|Overall Study|No longer meets Study Criteria|0
1089535|NCT02231918|2155933|FG000|Overall Study|Withdrawal by Subject|0
1089536|NCT02231918|2155934|FG001|Overall Study|Withdrawal by Subject|1
1089537|NCT02231918|2155935|FG002|Overall Study|Withdrawal by Subject|0
1089538|NCT02231918|2155933|FG000|Overall Study|Adverse Event|0
1089539|NCT02231918|2155934|FG001|Overall Study|Adverse Event|0
1089540|NCT02231918|2155935|FG002|Overall Study|Adverse Event|1
1089541|NCT02232061|2155953|FG000|Overall Study|Administrative problems|1
1089542|NCT02232061|2155953|FG000|Overall Study|Withdrawal by Subject|1
1089543|NCT02232074|2155959|FG000|Overall Study|Withdrawal by Subject|5
1089544|NCT02232074|2155960|FG001|Overall Study|Withdrawal by Subject|3
1089545|NCT02232074|2155959|FG000|Overall Study|No legal concerns at baseline|36
1089546|NCT02232074|2155960|FG001|Overall Study|No legal concerns at baseline|41
1089547|NCT02232074|2155959|FG000|Overall Study|deemed ineligible|0
1089548|NCT02232074|2155960|FG001|Overall Study|deemed ineligible|1
1089549|NCT02232087|2155972|FG000|Overall Study|Withdrawal by Subject|2
1089550|NCT02232087|2155973|FG001|Overall Study|Withdrawal by Subject|0
1089551|NCT02232087|2155974|FG002|Overall Study|Withdrawal by Subject|0
1089552|NCT02232087|2155975|FG003|Overall Study|Withdrawal by Subject|0
1089553|NCT02232087|2155976|FG004|Overall Study|Withdrawal by Subject|0
1089554|NCT02232087|2155977|FG005|Overall Study|Withdrawal by Subject|1
1089555|NCT02232087|2155972|FG000|Overall Study|poor inhalation technique|0
1089556|NCT02232087|2155973|FG001|Overall Study|poor inhalation technique|1
1089557|NCT02232087|2155974|FG002|Overall Study|poor inhalation technique|0
1089558|NCT02232087|2155975|FG003|Overall Study|poor inhalation technique|0
1089559|NCT02232087|2155976|FG004|Overall Study|poor inhalation technique|0
1089560|NCT02232087|2155977|FG005|Overall Study|poor inhalation technique|2
1089561|NCT02232087|2155972|FG000|Overall Study|protocol stop criteria|0
1089562|NCT02232087|2155973|FG001|Overall Study|protocol stop criteria|1
1089563|NCT02232087|2155974|FG002|Overall Study|protocol stop criteria|0
1089564|NCT02232087|2155975|FG003|Overall Study|protocol stop criteria|1
1089565|NCT02232087|2155976|FG004|Overall Study|protocol stop criteria|0
1089566|NCT02232087|2155977|FG005|Overall Study|protocol stop criteria|0
1089567|NCT02232087|2155972|FG000|Overall Study|Adverse Event|0
1089568|NCT02232087|2155973|FG001|Overall Study|Adverse Event|0
1089569|NCT02232087|2155974|FG002|Overall Study|Adverse Event|0
1089570|NCT02232087|2155975|FG003|Overall Study|Adverse Event|0
1089571|NCT02232087|2155976|FG004|Overall Study|Adverse Event|1
1089572|NCT02232087|2155977|FG005|Overall Study|Adverse Event|0
1089573|NCT02232178|2156010|FG000|Overall Study|Lost to Follow-up|0
1089574|NCT02232178|2156011|FG001|Overall Study|Lost to Follow-up|1
1089575|NCT02232178|2156012|FG002|Overall Study|Lost to Follow-up|0
1089576|NCT02232178|2156010|FG000|Overall Study|ineligibility|0
1089577|NCT02232178|2156011|FG001|Overall Study|ineligibility|0
1089578|NCT02232178|2156012|FG002|Overall Study|ineligibility|1
1089579|NCT02232178|2156010|FG000|Overall Study|surgical complication|1
1089580|NCT02232178|2156011|FG001|Overall Study|surgical complication|0
1089581|NCT02232178|2156012|FG002|Overall Study|surgical complication|0
1089582|NCT02232243|2156023|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
1089583|NCT02232243|2156024|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
1089584|NCT02232243|2156025|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
1089585|NCT02232425|2156049|FG000|Overall Study|Lost to Follow-up|6
1089586|NCT02232425|2156050|FG001|Overall Study|Lost to Follow-up|2
1089587|NCT02232425|2156049|FG000|Overall Study|Adverse Event|2
1089588|NCT02232425|2156050|FG001|Overall Study|Adverse Event|0
1089589|NCT02232425|2156049|FG000|Overall Study|Withdrawal by Subject|5
1089590|NCT02232425|2156050|FG001|Overall Study|Withdrawal by Subject|6
1089591|NCT02232425|2156049|FG000|Overall Study|Lack of Efficacy|1
1089592|NCT02232425|2156050|FG001|Overall Study|Lack of Efficacy|0
1089593|NCT02232698|2156058|FG000|Overall Study|Pregnancy|1
1089594|NCT02232698|2156059|FG001|Overall Study|Pregnancy|1
1089595|NCT02232698|2156058|FG000|Overall Study|Met exclusion criteria|1
1089596|NCT02232698|2156059|FG001|Overall Study|Met exclusion criteria|1
1089597|NCT02232698|2156058|FG000|Overall Study|Had device-associated symptoms|7
1089598|NCT02232698|2156059|FG001|Overall Study|Had device-associated symptoms|0
1089599|NCT02232698|2156058|FG000|Overall Study|Non-compliance with study device|1
1089600|NCT02232698|2156059|FG001|Overall Study|Non-compliance with study device|4
1089601|NCT02232698|2156058|FG000|Overall Study|Allocated to control group|0
1089602|NCT02232698|2156059|FG001|Overall Study|Allocated to control group|3
1089603|NCT02232698|2156058|FG000|Overall Study|Withdrawal by Subject|0
1089604|NCT02232698|2156059|FG001|Overall Study|Withdrawal by Subject|11
1089605|NCT02232802|2156067|FG000|Period 1|Sponsor request|1
1089606|NCT02232802|2156068|FG001|Period 1|Sponsor request|0
1089607|NCT02232802|2156067|FG000|Period 1|Adverse Event|1
1089608|NCT02232802|2156068|FG001|Period 1|Adverse Event|1
1089609|NCT02232893|2156076|FG000|Overall Study|Withdrawal by Subject|4
1089610|NCT02232893|2156077|FG001|Overall Study|Withdrawal by Subject|1
1089611|NCT02232893|2156076|FG000|Overall Study|Adverse Event|0
1089612|NCT02232893|2156077|FG001|Overall Study|Adverse Event|1
1089613|NCT02232893|2156076|FG000|Overall Study|Sponsor request early termination|0
1089614|NCT02232893|2156077|FG001|Overall Study|Sponsor request early termination|1
1089615|NCT02232893|2156076|FG000|Overall Study|Developed exclusion criteria|0
1089616|NCT02232893|2156077|FG001|Overall Study|Developed exclusion criteria|1
1089617|NCT02232893|2156076|FG000|Overall Study|Other|0
1089618|NCT02232893|2156077|FG001|Overall Study|Other|3
1089619|NCT02232984|2156083|FG000|Overall Study|Withdrawal by Subject|5
1089620|NCT02232984|2156083|FG000|Overall Study|Death|1
1089621|NCT02232984|2156083|FG000|Overall Study|Investigator withdrawal|10
1089622|NCT02232984|2156083|FG000|Overall Study|Device implant unsuccessful|53
1089623|NCT02232984|2156083|FG000|Overall Study|not disclosed by site|7
1089624|NCT02232984|2156083|FG000|Overall Study|Protocol Violation|1
1089625|NCT02233309|2156112|FG000|Overall Study|Physician Decision|5
1089626|NCT02233413|2156118|FG000|Overall Study|Lost to Follow-up|7
1089627|NCT02233413|2156119|FG001|Overall Study|Lost to Follow-up|9
1089628|NCT02233413|2156118|FG000|Overall Study|Withdrawal by Subject|4
1089629|NCT02233413|2156119|FG001|Overall Study|Withdrawal by Subject|5
1089630|NCT02233543|2156151|FG000|Period 1|Withdrawal by Subject|1
1089631|NCT02233543|2156152|FG001|Period 1|Withdrawal by Subject|0
1089632|NCT02233543|2156151|FG000|Period 1|Participants required other treatment.|2
1089633|NCT02233543|2156152|FG001|Period 1|Participants required other treatment.|3
1089634|NCT02233543|2156151|FG000|Period 2|Adverse Event|1
1089635|NCT02233543|2156152|FG001|Period 2|Adverse Event|0
1089636|NCT02233543|2156151|FG000|Period 2|Participant required other treatment.|0
1089637|NCT02233543|2156152|FG001|Period 2|Participant required other treatment.|1
1089638|NCT02233543|2156151|FG000|Period 2|COPD exacerbation|1
1089639|NCT02233543|2156152|FG001|Period 2|COPD exacerbation|0
1089640|NCT02233647|2156158|FG000|Overall Study|Adverse Event|1
1089641|NCT02233738|2156164|FG000|Overall Study|Lost to Follow-up|5
1089642|NCT02233738|2156165|FG001|Overall Study|Lost to Follow-up|12
1089643|NCT02233738|2156164|FG000|Overall Study|Death|0
1089644|NCT02233738|2156165|FG001|Overall Study|Death|1
1089645|NCT02233738|2156164|FG000|Overall Study|Withdrawal by Subject|0
1089646|NCT02233738|2156165|FG001|Overall Study|Withdrawal by Subject|1
1089647|NCT02233738|2156164|FG000|Overall Study|Did not return after Baseline|3
1089648|NCT02233738|2156165|FG001|Overall Study|Did not return after Baseline|2
1089649|NCT02233803|2156342|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
1089650|NCT02233803|2156343|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
1089651|NCT02233803|2156342|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0
1089652|NCT02233803|2156343|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1
1089653|NCT02233803|2156342|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2
1089654|NCT02233803|2156343|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2
1089655|NCT02233803|2156342|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
1089656|NCT02233803|2156343|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
1089657|NCT02233803|2156342|FG000|Washout Period (4-Wks)|Lost to Follow-up|0
1089658|NCT02233803|2156343|FG001|Washout Period (4-Wks)|Lost to Follow-up|1
1089659|NCT02233803|2156342|FG000|Washout Period (4-Wks)|Physician Decision|1
1089660|NCT02233803|2156343|FG001|Washout Period (4-Wks)|Physician Decision|0
1089661|NCT02233803|2156342|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1
1089662|NCT02233803|2156343|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1
1089663|NCT02233803|2156342|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
1089664|NCT02233803|2156343|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
1089665|NCT02233803|2156342|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
1089666|NCT02233803|2156343|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
1089667|NCT02233946|2156358|FG000|Baseline|Withdrawal by Subject|2
1089668|NCT02233946|2156359|FG001|Baseline|Withdrawal by Subject|0
1089669|NCT02233946|2156358|FG000|3-months Follow-up|Lost to Follow-up|53
1089670|NCT02233946|2156359|FG001|3-months Follow-up|Lost to Follow-up|29
1089671|NCT02233946|2156358|FG000|6-months Follow-up|Lost to Follow-up|21
1089672|NCT02233946|2156359|FG001|6-months Follow-up|Lost to Follow-up|2
1089673|NCT02233946|2156358|FG000|9-month Follow-up|Lost to Follow-up|20
1089674|NCT02233946|2156359|FG001|9-month Follow-up|Lost to Follow-up|11
1089675|NCT02233946|2156358|FG000|12-month Follow-up|Lost to Follow-up|28
1089676|NCT02233946|2156359|FG001|12-month Follow-up|Lost to Follow-up|11
1089677|NCT02234063|2156391|FG000|Overall Study|Lost to Follow-up|235
1089678|NCT02234063|2156392|FG001|Overall Study|Lost to Follow-up|42
1089679|NCT02234063|2156391|FG000|Overall Study|Withdrawal by Subject|20
1089680|NCT02234063|2156392|FG001|Overall Study|Withdrawal by Subject|1
1089681|NCT02234141|2156424|FG000|Treatment Period (24 Weeks)|Protocol Violation|0
1089682|NCT02234141|2156425|FG001|Treatment Period (24 Weeks)|Protocol Violation|0
1089683|NCT02234141|2156426|FG002|Treatment Period (24 Weeks)|Protocol Violation|0
1089684|NCT02234141|2156427|FG003|Treatment Period (24 Weeks)|Protocol Violation|1
1089685|NCT02234141|2156428|FG004|Treatment Period (24 Weeks)|Protocol Violation|0
1089686|NCT02234141|2156429|FG005|Treatment Period (24 Weeks)|Protocol Violation|0
1089687|NCT02234141|2156430|FG006|Treatment Period (24 Weeks)|Protocol Violation|0
1089688|NCT02234141|2156424|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0
1089689|NCT02234141|2156425|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2
1089690|NCT02234141|2156426|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0
1089691|NCT02234141|2156427|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0
1089692|NCT02234141|2156428|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0
1089693|NCT02234141|2156429|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0
1089694|NCT02234141|2156430|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0
1089695|NCT02234141|2156424|FG000|Treatment Period (24 Weeks)|Death|1
1089696|NCT02234141|2156425|FG001|Treatment Period (24 Weeks)|Death|2
1089697|NCT02234141|2156426|FG002|Treatment Period (24 Weeks)|Death|0
1089698|NCT02234141|2156427|FG003|Treatment Period (24 Weeks)|Death|1
1089699|NCT02234141|2156428|FG004|Treatment Period (24 Weeks)|Death|0
1089700|NCT02234141|2156429|FG005|Treatment Period (24 Weeks)|Death|0
1089701|NCT02234141|2156430|FG006|Treatment Period (24 Weeks)|Death|0
1089702|NCT02234141|2156424|FG000|Treatment Period (24 Weeks)|Adverse Event|3
1089703|NCT02234141|2156425|FG001|Treatment Period (24 Weeks)|Adverse Event|1
1089704|NCT02234141|2156426|FG002|Treatment Period (24 Weeks)|Adverse Event|2
1089705|NCT02234141|2156427|FG003|Treatment Period (24 Weeks)|Adverse Event|3
1089706|NCT02234141|2156428|FG004|Treatment Period (24 Weeks)|Adverse Event|0
1089707|NCT02234141|2156429|FG005|Treatment Period (24 Weeks)|Adverse Event|0
1089708|NCT02234141|2156430|FG006|Treatment Period (24 Weeks)|Adverse Event|0
1089709|NCT02234141|2156424|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0
1089710|NCT02234141|2156425|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1
1089711|NCT02234141|2156426|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0
1089712|NCT02234141|2156427|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0
1089713|NCT02234141|2156428|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0
1089714|NCT02234141|2156429|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0
1089715|NCT02234141|2156430|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0
1089716|NCT02234141|2156424|FG000|Long-Term Treatment Period|Death|0
1089717|NCT02234141|2156425|FG001|Long-Term Treatment Period|Death|0
1089718|NCT02234141|2156426|FG002|Long-Term Treatment Period|Death|0
1089719|NCT02234141|2156427|FG003|Long-Term Treatment Period|Death|0
1089720|NCT02234141|2156428|FG004|Long-Term Treatment Period|Death|0
1089721|NCT02234141|2156429|FG005|Long-Term Treatment Period|Death|1
1089722|NCT02234141|2156430|FG006|Long-Term Treatment Period|Death|0
1089723|NCT02234141|2156424|FG000|Long-Term Treatment Period|Investigator's discretion|1
1089724|NCT02234141|2156425|FG001|Long-Term Treatment Period|Investigator's discretion|3
1089725|NCT02234141|2156426|FG002|Long-Term Treatment Period|Investigator's discretion|2
1089726|NCT02234141|2156427|FG003|Long-Term Treatment Period|Investigator's discretion|0
1089727|NCT02234141|2156428|FG004|Long-Term Treatment Period|Investigator's discretion|0
1089728|NCT02234141|2156429|FG005|Long-Term Treatment Period|Investigator's discretion|0
1089729|NCT02234141|2156430|FG006|Long-Term Treatment Period|Investigator's discretion|1
1089730|NCT02234141|2156424|FG000|Long-Term Treatment Period|Adverse Event|4
1089731|NCT02234141|2156425|FG001|Long-Term Treatment Period|Adverse Event|0
1089732|NCT02234141|2156426|FG002|Long-Term Treatment Period|Adverse Event|5
1089733|NCT02234141|2156427|FG003|Long-Term Treatment Period|Adverse Event|0
1089734|NCT02234141|2156428|FG004|Long-Term Treatment Period|Adverse Event|1
1089735|NCT02234141|2156429|FG005|Long-Term Treatment Period|Adverse Event|1
1089736|NCT02234141|2156430|FG006|Long-Term Treatment Period|Adverse Event|1
1089737|NCT02234141|2156424|FG000|Long-Term Treatment Period|Withdrew Consent|0
1089738|NCT02234141|2156425|FG001|Long-Term Treatment Period|Withdrew Consent|1
1089739|NCT02234141|2156426|FG002|Long-Term Treatment Period|Withdrew Consent|1
1089740|NCT02234141|2156427|FG003|Long-Term Treatment Period|Withdrew Consent|0
1162050|NCT03381248|2283986|FG001|Overall Study|Protocol Violation|1
943320|NCT01006122|1932924|FG000|First Double-blind Intervention Period|Protocol Violation|1
943321|NCT01006122|1932925|FG001|First Double-blind Intervention Period|Protocol Violation|1
943322|NCT01006122|1932924|FG000|First Double-blind Intervention Period|Pregnancy|0
943323|NCT01006122|1932925|FG001|First Double-blind Intervention Period|Pregnancy|1
943324|NCT01006122|1932924|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9
943325|NCT01006122|1932925|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8
943326|NCT01006122|1932924|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1
943327|NCT01006122|1932925|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0
943328|NCT01006122|1932924|FG000|First Double-blind Intervention Period|Lack of Efficacy|2
943329|NCT01006122|1932925|FG001|First Double-blind Intervention Period|Lack of Efficacy|1
943330|NCT01006122|1932924|FG000|First Double-blind Intervention Period|Other|3
943331|NCT01006122|1932925|FG001|First Double-blind Intervention Period|Other|0
909684|NCT00789477|1886422|FG004|Overall Study|Lack of Efficacy|0
909685|NCT00789477|1886418|FG000|Overall Study|Other|2
909686|NCT00789477|1886419|FG001|Overall Study|Other|0
909687|NCT00789477|1886420|FG002|Overall Study|Other|1
909688|NCT00789477|1886421|FG003|Overall Study|Other|3
909689|NCT00789477|1886422|FG004|Overall Study|Other|0
909690|NCT00789529|1886438|FG000|Overall Study|Withdrawal by Subject|0
909691|NCT00789529|1886439|FG001|Overall Study|Withdrawal by Subject|1
909692|NCT00789529|1886438|FG000|Overall Study|Other Reason|1
909693|NCT00789529|1886439|FG001|Overall Study|Other Reason|0
909694|NCT00789555|1886448|FG000|Overall Study|Protocol Amendment|78
909695|NCT00789555|1886449|FG001|Overall Study|Protocol Amendment|76
909696|NCT00789555|1886450|FG002|Overall Study|Protocol Amendment|80
909697|NCT00789555|1886448|FG000|Overall Study|Adverse Event|17
909698|NCT00789555|1886449|FG001|Overall Study|Adverse Event|7
909699|NCT00789555|1886450|FG002|Overall Study|Adverse Event|10
909700|NCT00789555|1886448|FG000|Overall Study|Lost to Follow-up|9
909701|NCT00789555|1886449|FG001|Overall Study|Lost to Follow-up|10
909702|NCT00789555|1886450|FG002|Overall Study|Lost to Follow-up|18
909703|NCT00789555|1886448|FG000|Overall Study|Patient decision unnrelated to adv event|38
909704|NCT00789555|1886449|FG001|Overall Study|Patient decision unnrelated to adv event|29
909705|NCT00789555|1886450|FG002|Overall Study|Patient decision unnrelated to adv event|26
1089741|NCT02234141|2156428|FG004|Long-Term Treatment Period|Withdrew Consent|0
1089742|NCT02234141|2156429|FG005|Long-Term Treatment Period|Withdrew Consent|0
943332|NCT01006122|1932924|FG000|First Double-blind Intervention Period|Adverse Event|0
943333|NCT01006122|1932925|FG001|First Double-blind Intervention Period|Adverse Event|4
943334|NCT01006122|1932924|FG000|Second Double-blind Intervention Period|Adverse Event|1
943335|NCT01006122|1932925|FG001|Second Double-blind Intervention Period|Adverse Event|1
943336|NCT01006122|1932924|FG000|Second Double-blind Intervention Period|Protocol Violation|1
943337|NCT01006122|1932925|FG001|Second Double-blind Intervention Period|Protocol Violation|0
943338|NCT01006122|1932924|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
943339|NCT01006122|1932925|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3
943340|NCT01006122|1932924|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
943341|NCT01006122|1932925|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2
943342|NCT01006122|1932924|FG000|Second Double-blind Intervention Period|Death|0
943343|NCT01006122|1932925|FG001|Second Double-blind Intervention Period|Death|1
943344|NCT01006135|1932931|FG000|Overall Study|Adverse Event|22
943345|NCT01006135|1932931|FG000|Overall Study|Protocol Violation|14
943346|NCT01006135|1932931|FG000|Overall Study|Lost to Follow-up|32
943347|NCT01006135|1932931|FG000|Overall Study|Other|72
943348|NCT01006265|1932952|FG000|Overall Study|Lost to Follow-up|1
943349|NCT01006265|1932953|FG001|Overall Study|Lost to Follow-up|0
943350|NCT01006265|1932954|FG002|Overall Study|Lost to Follow-up|1
943351|NCT01006265|1932955|FG003|Overall Study|Lost to Follow-up|0
943352|NCT01006265|1932952|FG000|Overall Study|Withdrawal by Subject|4
943353|NCT01006265|1932953|FG001|Overall Study|Withdrawal by Subject|7
943354|NCT01006265|1932954|FG002|Overall Study|Withdrawal by Subject|5
943355|NCT01006265|1932955|FG003|Overall Study|Withdrawal by Subject|5
943356|NCT01006265|1932952|FG000|Overall Study|Administrative reason|1
943357|NCT01006265|1932953|FG001|Overall Study|Administrative reason|2
943358|NCT01006265|1932954|FG002|Overall Study|Administrative reason|3
943359|NCT01006265|1932955|FG003|Overall Study|Administrative reason|0
943360|NCT01006291|1932968|FG000|Overall Study|Adverse Event|2
943361|NCT01006291|1932969|FG001|Overall Study|Adverse Event|1
943362|NCT01006291|1932970|FG002|Overall Study|Adverse Event|2
943363|NCT01006291|1932968|FG000|Overall Study|Lack of Efficacy|2
943364|NCT01006291|1932969|FG001|Overall Study|Lack of Efficacy|2
943365|NCT01006291|1932970|FG002|Overall Study|Lack of Efficacy|1
943366|NCT01006291|1932968|FG000|Overall Study|Protocol Violation|3
943367|NCT01006291|1932969|FG001|Overall Study|Protocol Violation|3
943368|NCT01006291|1932970|FG002|Overall Study|Protocol Violation|3
943369|NCT01006291|1932968|FG000|Overall Study|Withdrawal criteria|5
943370|NCT01006291|1932969|FG001|Overall Study|Withdrawal criteria|4
943371|NCT01006291|1932970|FG002|Overall Study|Withdrawal criteria|4
943372|NCT01006291|1932968|FG000|Overall Study|Other|14
943373|NCT01006291|1932969|FG001|Overall Study|Other|14
943374|NCT01006291|1932970|FG002|Overall Study|Other|17
943375|NCT01006356|1932978|FG000|Overall Study|Adverse Event|6
943376|NCT01006356|1932978|FG000|Overall Study|Physician Decision|1
943377|NCT01006356|1932978|FG000|Overall Study|Paticipants did not cooperate|6
943378|NCT01006356|1932978|FG000|Overall Study|Withdrawal by Subject|1
943379|NCT01006356|1932978|FG000|Overall Study|Choice by participants|2
943380|NCT01006356|1932978|FG000|Overall Study|Protocol Violation|3
943381|NCT01006356|1932978|FG000|Overall Study|Other|23
943382|NCT01006590|1933001|FG000|Overall Study|Adverse Event|2
943383|NCT01006590|1933002|FG001|Overall Study|Adverse Event|3
943384|NCT01006590|1933001|FG000|Overall Study|Death|1
943385|NCT01006590|1933002|FG001|Overall Study|Death|1
943386|NCT01006590|1933001|FG000|Overall Study|Lost to Follow-up|1
943387|NCT01006590|1933002|FG001|Overall Study|Lost to Follow-up|1
943388|NCT01006590|1933001|FG000|Overall Study|Protocol Violation|1
943389|NCT01006590|1933002|FG001|Overall Study|Protocol Violation|0
943390|NCT01006590|1933001|FG000|Overall Study|Withdrawal by Subject|4
943391|NCT01006590|1933002|FG001|Overall Study|Withdrawal by Subject|2
943392|NCT01006590|1933001|FG000|Overall Study|Study specific discontinuation criteria|16
943393|NCT01006590|1933002|FG001|Overall Study|Study specific discontinuation criteria|23
943394|NCT01006590|1933001|FG000|Overall Study|Other|3
943395|NCT01006590|1933002|FG001|Overall Study|Other|2
943396|NCT01006603|1933010|FG000|Overall Study|Withdrawal by Subject|17
943397|NCT01006603|1933011|FG001|Overall Study|Withdrawal by Subject|19
943398|NCT01006603|1933010|FG000|Overall Study|Lost to Follow-up|0
943399|NCT01006603|1933011|FG001|Overall Study|Lost to Follow-up|1
943400|NCT01006603|1933010|FG000|Overall Study|Safety reason|1
943401|NCT01006603|1933011|FG001|Overall Study|Safety reason|1
943402|NCT01006603|1933010|FG000|Overall Study|Protocol Violation|1
943403|NCT01006603|1933011|FG001|Overall Study|Protocol Violation|3
943404|NCT01006603|1933010|FG000|Overall Study|Incorrect enrolment|0
943405|NCT01006603|1933011|FG001|Overall Study|Incorrect enrolment|2
943406|NCT01006603|1933010|FG000|Overall Study|Adverse Event|15
943407|NCT01006603|1933011|FG001|Overall Study|Adverse Event|7
943408|NCT01006603|1933010|FG000|Overall Study|Death|1
943409|NCT01006603|1933011|FG001|Overall Study|Death|1
943410|NCT01006603|1933010|FG000|Overall Study|Study specific discontinuation criteria|33
943411|NCT01006603|1933011|FG001|Overall Study|Study specific discontinuation criteria|34
1089743|NCT02234141|2156430|FG006|Long-Term Treatment Period|Withdrew Consent|0
1089744|NCT02234141|2156424|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28
1089745|NCT02234141|2156425|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27
1089746|NCT02234141|2156426|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25
1089747|NCT02234141|2156427|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0
1089748|NCT02234141|2156428|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9
1089749|NCT02234141|2156429|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10
1089750|NCT02234141|2156430|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8
1089751|NCT02234284|2156448|FG000|Overall Study|Death|4
1089752|NCT02234284|2156449|FG001|Overall Study|Death|2
1089753|NCT02234284|2156448|FG000|Overall Study|Withdrawal by Subject|1
1089754|NCT02234284|2156449|FG001|Overall Study|Withdrawal by Subject|0
1089755|NCT02234284|2156448|FG000|Overall Study|Lost to Follow-up|20
1089756|NCT02234284|2156449|FG001|Overall Study|Lost to Follow-up|7
1089757|NCT02234310|2156459|FG000|Overall Study|Physician Decision|1
1089758|NCT02234310|2156459|FG000|Overall Study|Adverse Event|1
1089759|NCT02234310|2156459|FG000|Overall Study|Eligibility Criteria not fulfilled|2
1089760|NCT02234310|2156459|FG000|Overall Study|Withdrawal by Subject|2
1089761|NCT02234323|2156463|FG000|All Enrolled|Not Treated: Completed study in database|2
1089762|NCT02234323|2156463|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2
1089763|NCT02234323|2156463|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1
1089764|NCT02234323|2156463|FG000|All Treated|Death|1
1089765|NCT02234323|2156463|FG000|All Treated|Physician Decision|5
1089766|NCT02234323|2156463|FG000|All Treated|Lack of Efficacy|3
1089767|NCT02234323|2156463|FG000|All Treated|Exceeded lab value limit|2
1089768|NCT02234323|2156463|FG000|All Treated|Other|7
1089769|NCT02234362|2156469|FG000|Overall Study|Not eligible after first screening visit|17
1089770|NCT02234362|2156469|FG000|Overall Study|Lost to Follow-up|6
1089771|NCT02234362|2156469|FG000|Overall Study|Withdrawal by Subject|3
1089772|NCT02234479|2156479|FG000|Overall Study|Withdrawal by Subject|1
1089773|NCT02234479|2156480|FG001|Overall Study|Withdrawal by Subject|3
1089774|NCT02234583|2156521|FG000|Overall Study|Adverse Event|172
1089775|NCT02234583|2156522|FG001|Overall Study|Adverse Event|156
1089776|NCT02234583|2156521|FG000|Overall Study|Withdrawal by Subject|109
1089777|NCT02234583|2156522|FG001|Overall Study|Withdrawal by Subject|157
1089778|NCT02234583|2156521|FG000|Overall Study|Lost to Follow-up|0
1089779|NCT02234583|2156522|FG001|Overall Study|Lost to Follow-up|1
1089780|NCT02234583|2156521|FG000|Overall Study|Lack of Efficacy|58
1089781|NCT02234583|2156522|FG001|Overall Study|Lack of Efficacy|103
1089782|NCT02234583|2156521|FG000|Overall Study|Protocol Violation|35
1089783|NCT02234583|2156522|FG001|Overall Study|Protocol Violation|42
1089784|NCT02234583|2156521|FG000|Overall Study|Other|39
1089785|NCT02234583|2156522|FG001|Overall Study|Other|97
1089786|NCT02234596|2156534|FG000|Overall Study|Participant not treated|2
1089787|NCT02234622|2156540|FG000|Overall Study|Withdrawal by Subject|16
1089788|NCT02234622|2156541|FG001|Overall Study|Withdrawal by Subject|22
1089789|NCT02234622|2156540|FG000|Overall Study|Lost to Follow-up|27
1089790|NCT02234622|2156541|FG001|Overall Study|Lost to Follow-up|14
1089791|NCT02235077|2156629|FG000|Overall Study|Death|5
1089792|NCT02235077|2156630|FG001|Overall Study|Death|7
1089793|NCT02235077|2156629|FG000|Overall Study|Lost to Follow-up|5
1089794|NCT02235077|2156630|FG001|Overall Study|Lost to Follow-up|6
1089795|NCT02235077|2156629|FG000|Overall Study|Withdrawal by Subject|8
1089796|NCT02235077|2156630|FG001|Overall Study|Withdrawal by Subject|5
1089797|NCT02235077|2156629|FG000|Overall Study|Physician Decision|0
1089798|NCT02235077|2156630|FG001|Overall Study|Physician Decision|1
1089799|NCT02235298|2156642|FG000|Overall Study|Lost to Follow-up|6
1089800|NCT02235298|2156643|FG001|Overall Study|Lost to Follow-up|5
1089801|NCT02235298|2156642|FG000|Overall Study|Adverse Event|2
1089802|NCT02235298|2156643|FG001|Overall Study|Adverse Event|2
1089803|NCT02235298|2156642|FG000|Overall Study|Withdrawal by Subject|0
1089804|NCT02235298|2156643|FG001|Overall Study|Withdrawal by Subject|1
1089805|NCT02235311|2156651|FG000|Overall Study|Lost to Follow-up|0
943412|NCT01006603|1933010|FG000|Overall Study|Other|3
943413|NCT01006603|1933011|FG001|Overall Study|Other|7
943414|NCT01006616|1933021|FG000|Period 1 (6 Months)|Adverse Event|10
943415|NCT01006616|1933022|FG001|Period 1 (6 Months)|Adverse Event|31
943416|NCT01006616|1933023|FG002|Period 1 (6 Months)|Adverse Event|37
943417|NCT01006616|1933024|FG003|Period 1 (6 Months)|Adverse Event|9
943418|NCT01006616|1933021|FG000|Period 1 (6 Months)|Lack of Efficacy|3
943419|NCT01006616|1933022|FG001|Period 1 (6 Months)|Lack of Efficacy|4
943420|NCT01006616|1933023|FG002|Period 1 (6 Months)|Lack of Efficacy|0
943421|NCT01006616|1933024|FG003|Period 1 (6 Months)|Lack of Efficacy|4
943422|NCT01006616|1933021|FG000|Period 1 (6 Months)|Lost to Follow-up|0
943423|NCT01006616|1933022|FG001|Period 1 (6 Months)|Lost to Follow-up|0
943424|NCT01006616|1933023|FG002|Period 1 (6 Months)|Lost to Follow-up|1
943425|NCT01006616|1933024|FG003|Period 1 (6 Months)|Lost to Follow-up|0
943426|NCT01006616|1933021|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
943427|NCT01006616|1933022|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
943428|NCT01006616|1933023|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
943429|NCT01006616|1933024|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
943430|NCT01006616|1933021|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
1089806|NCT02235311|2156652|FG001|Overall Study|Lost to Follow-up|1
1089807|NCT02235311|2156651|FG000|Overall Study|Protocol Violation|0
1089808|NCT02235311|2156652|FG001|Overall Study|Protocol Violation|1
1089809|NCT02235454|2156658|FG000|Overall Study|Withdrawal by Subject|2
1089810|NCT02236130|2156703|FG000|Overall Study|Lost to Follow-up|7
1089811|NCT02236130|2156704|FG001|Overall Study|Lost to Follow-up|12
1089812|NCT02236520|2156723|FG000|Overall Study|Physician Decision|0
1089813|NCT02236520|2156724|FG001|Overall Study|Physician Decision|5
1089814|NCT02236520|2156725|FG002|Overall Study|Physician Decision|0
1089815|NCT02236520|2156726|FG003|Overall Study|Physician Decision|0
1089816|NCT02236520|2156723|FG000|Overall Study|Withdrawal by Subject|1
1089817|NCT02236520|2156724|FG001|Overall Study|Withdrawal by Subject|0
1089818|NCT02236520|2156725|FG002|Overall Study|Withdrawal by Subject|0
1089819|NCT02236520|2156726|FG003|Overall Study|Withdrawal by Subject|1
1089820|NCT02236520|2156723|FG000|Overall Study|Pregnancy|1
1089821|NCT02236520|2156724|FG001|Overall Study|Pregnancy|0
1089822|NCT02236520|2156725|FG002|Overall Study|Pregnancy|0
1089823|NCT02236520|2156726|FG003|Overall Study|Pregnancy|0
1089824|NCT02236559|2156738|FG000|Overall Study|Met Exclusion|3
1089825|NCT02236559|2156739|FG001|Overall Study|Met Exclusion|6
1089826|NCT02236559|2156738|FG000|Overall Study|Did not Meet Inclusion|3
1089827|NCT02236559|2156739|FG001|Overall Study|Did not Meet Inclusion|3
1089828|NCT02236559|2156738|FG000|Overall Study|Subject Did Not Consent|4
1089829|NCT02236559|2156739|FG001|Overall Study|Subject Did Not Consent|2
1089830|NCT02236559|2156738|FG000|Overall Study|Physician Decision|1
1089831|NCT02236559|2156739|FG001|Overall Study|Physician Decision|1
1089832|NCT02236559|2156738|FG000|Overall Study|Withdrawal by Subject|1
1089833|NCT02236559|2156739|FG001|Overall Study|Withdrawal by Subject|0
1089834|NCT02236598|2156747|FG000|Overall Study|Adverse Event|0
1089835|NCT02236598|2156748|FG001|Overall Study|Adverse Event|1
943431|NCT01006616|1933022|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
943432|NCT01006616|1933023|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
943433|NCT01006616|1933024|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
943434|NCT01006616|1933021|FG000|Period 1 (6 Months)|Withdrawal by Subject|2
943435|NCT01006616|1933022|FG001|Period 1 (6 Months)|Withdrawal by Subject|2
943436|NCT01006616|1933023|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
943437|NCT01006616|1933024|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
943438|NCT01006616|1933021|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
943439|NCT01006616|1933022|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
943440|NCT01006616|1933023|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
943441|NCT01006616|1933024|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
943442|NCT01006616|1933021|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0
943443|NCT01006616|1933022|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2
943444|NCT01006616|1933023|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2
943445|NCT01006616|1933024|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3
943446|NCT01006616|1933021|FG000|Period 1 (6 Months)|Not Treated|0
943447|NCT01006616|1933022|FG001|Period 1 (6 Months)|Not Treated|0
943448|NCT01006616|1933023|FG002|Period 1 (6 Months)|Not Treated|1
943449|NCT01006616|1933024|FG003|Period 1 (6 Months)|Not Treated|1
943450|NCT01006616|1933021|FG000|Period 2 (18 Months)|Adverse Event|6
943451|NCT01006616|1933022|FG001|Period 2 (18 Months)|Adverse Event|6
943452|NCT01006616|1933023|FG002|Period 2 (18 Months)|Adverse Event|6
943453|NCT01006616|1933024|FG003|Period 2 (18 Months)|Adverse Event|4
943454|NCT01006616|1933021|FG000|Period 2 (18 Months)|Lack of Efficacy|0
943455|NCT01006616|1933022|FG001|Period 2 (18 Months)|Lack of Efficacy|0
943456|NCT01006616|1933023|FG002|Period 2 (18 Months)|Lack of Efficacy|1
943457|NCT01006616|1933024|FG003|Period 2 (18 Months)|Lack of Efficacy|2
943458|NCT01006616|1933021|FG000|Period 2 (18 Months)|Lost to Follow-up|2
943459|NCT01006616|1933022|FG001|Period 2 (18 Months)|Lost to Follow-up|0
943460|NCT01006616|1933023|FG002|Period 2 (18 Months)|Lost to Follow-up|0
943461|NCT01006616|1933024|FG003|Period 2 (18 Months)|Lost to Follow-up|0
943462|NCT01006616|1933021|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
943463|NCT01006616|1933022|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
943464|NCT01006616|1933023|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
943465|NCT01006616|1933024|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
943466|NCT01006616|1933021|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
943467|NCT01006616|1933022|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
943468|NCT01006616|1933023|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
943469|NCT01006616|1933024|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
943470|NCT01006616|1933021|FG000|Period 2 (18 Months)|Withdrawal by Subject|1
943471|NCT01006616|1933022|FG001|Period 2 (18 Months)|Withdrawal by Subject|4
943472|NCT01006616|1933023|FG002|Period 2 (18 Months)|Withdrawal by Subject|0
943473|NCT01006616|1933024|FG003|Period 2 (18 Months)|Withdrawal by Subject|1
943474|NCT01006616|1933021|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0
943475|NCT01006616|1933022|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1
943476|NCT01006616|1933023|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0
943477|NCT01006616|1933024|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1
943478|NCT01006616|1933021|FG000|Period 2 (18 Months)|Study Terminated|63
943479|NCT01006616|1933022|FG001|Period 2 (18 Months)|Study Terminated|46
1089836|NCT02236598|2156747|FG000|Overall Study|Withdrawal by Subject|0
1089837|NCT02236598|2156748|FG001|Overall Study|Withdrawal by Subject|1
1089838|NCT02236611|2156756|FG000|Overall Study|Adverse Event|10
1089839|NCT02236611|2156757|FG001|Overall Study|Adverse Event|16
1089840|NCT02236611|2156756|FG000|Overall Study|Lack of Efficacy|4
1089841|NCT02236611|2156757|FG001|Overall Study|Lack of Efficacy|7
1089842|NCT02236611|2156756|FG000|Overall Study|Lost to Follow-up|0
1089843|NCT02236611|2156757|FG001|Overall Study|Lost to Follow-up|2
1089844|NCT02236611|2156756|FG000|Overall Study|Protocol deviation|3
1089845|NCT02236611|2156757|FG001|Overall Study|Protocol deviation|5
1089846|NCT02236611|2156756|FG000|Overall Study|Withdrew consent|9
943480|NCT01006616|1933023|FG002|Period 2 (18 Months)|Study Terminated|44
943481|NCT01006616|1933024|FG003|Period 2 (18 Months)|Study Terminated|70
943482|NCT01006629|1933034|FG000|Overall Study|Adverse Event|1
943483|NCT01006629|1933034|FG000|Overall Study|Parent refused to continue participation|1
943484|NCT01006629|1933034|FG000|Overall Study|Parent unable to perform site visit|4
943485|NCT01006707|1933047|FG000|Study Session 1|Lost to Follow-up|2
943486|NCT01006707|1933048|FG001|Study Session 1|Lost to Follow-up|0
943487|NCT01006707|1933049|FG002|Study Session 1|Lost to Follow-up|0
943488|NCT01006707|1933047|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3
943489|NCT01006707|1933048|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0
943490|NCT01006707|1933049|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0
943491|NCT01006889|1933057|FG000|Overall Study|Withdrawal by Subject|3
943492|NCT01006980|1933075|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
943493|NCT01006980|1933076|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
943494|NCT01006980|1933075|FG000|Vemurafenib and Dacarbazine|Adverse Event|25
943495|NCT01006980|1933076|FG001|Vemurafenib and Dacarbazine|Adverse Event|5
943496|NCT01006980|1933075|FG000|Vemurafenib and Dacarbazine|Death|13
943497|NCT01006980|1933076|FG001|Vemurafenib and Dacarbazine|Death|12
943498|NCT01006980|1933075|FG000|Vemurafenib and Dacarbazine|Progression|257
943499|NCT01006980|1933076|FG001|Vemurafenib and Dacarbazine|Progression|218
943500|NCT01006980|1933075|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
943501|NCT01006980|1933076|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
943502|NCT01006980|1933075|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9
943503|NCT01006980|1933076|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6
943504|NCT01006980|1933075|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2
943505|NCT01006980|1933076|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3
943506|NCT01006980|1933075|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26
943507|NCT01006980|1933076|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43
943508|NCT01006980|1933075|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
943509|NCT01006980|1933076|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
943510|NCT01006980|1933075|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0
943511|NCT01006980|1933076|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4
943512|NCT01006980|1933075|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0
943513|NCT01006980|1933076|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65
943514|NCT01006980|1933075|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
943515|NCT01006980|1933076|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
943516|NCT01006980|1933075|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
943517|NCT01006980|1933076|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
943518|NCT01007032|1933087|FG000|Overall Study|On Study Treatment at Cut-off Date|0
943519|NCT01007032|1933088|FG001|Overall Study|On Study Treatment at Cut-off Date|1
943520|NCT01007032|1933089|FG002|Overall Study|On Study Treatment at Cut-off Date|1
943521|NCT01007032|1933090|FG003|Overall Study|On Study Treatment at Cut-off Date|0
943522|NCT01007032|1933087|FG000|Overall Study|Withdrawal by Subject|0
943523|NCT01007032|1933088|FG001|Overall Study|Withdrawal by Subject|0
943524|NCT01007032|1933089|FG002|Overall Study|Withdrawal by Subject|0
943525|NCT01007032|1933090|FG003|Overall Study|Withdrawal by Subject|1
943526|NCT01007123|1933129|FG000|Overall Study|Adverse Event|3
943527|NCT01007123|1933130|FG001|Overall Study|Adverse Event|4
943528|NCT01007123|1933131|FG002|Overall Study|Adverse Event|7
943529|NCT01007123|1933132|FG003|Overall Study|Adverse Event|1
943530|NCT01007123|1933129|FG000|Overall Study|Lack of Efficacy|1
943531|NCT01007123|1933130|FG001|Overall Study|Lack of Efficacy|0
943532|NCT01007123|1933131|FG002|Overall Study|Lack of Efficacy|1
943533|NCT01007123|1933132|FG003|Overall Study|Lack of Efficacy|4
943534|NCT01007123|1933129|FG000|Overall Study|Protocol Violation|1
943535|NCT01007123|1933130|FG001|Overall Study|Protocol Violation|1
943536|NCT01007123|1933131|FG002|Overall Study|Protocol Violation|2
943537|NCT01007123|1933132|FG003|Overall Study|Protocol Violation|1
943538|NCT01007123|1933129|FG000|Overall Study|Withdrawal by Subject|1
943539|NCT01007123|1933130|FG001|Overall Study|Withdrawal by Subject|0
943540|NCT01007123|1933131|FG002|Overall Study|Withdrawal by Subject|1
943541|NCT01007123|1933132|FG003|Overall Study|Withdrawal by Subject|0
943542|NCT01007123|1933129|FG000|Overall Study|Lost to Follow-up|0
943543|NCT01007123|1933130|FG001|Overall Study|Lost to Follow-up|1
909706|NCT00789555|1886448|FG000|Overall Study|Treatment failure|11
909707|NCT00789555|1886449|FG001|Overall Study|Treatment failure|8
909708|NCT00789555|1886450|FG002|Overall Study|Treatment failure|12
909709|NCT00789555|1886448|FG000|Overall Study|Protocol Violation|6
1089847|NCT02236611|2156757|FG001|Overall Study|Withdrew consent|4
1089848|NCT02236988|2156771|FG000|Overall Study|Lost to Follow-up|0
1089849|NCT02236988|2156772|FG001|Overall Study|Lost to Follow-up|0
1089850|NCT02236988|2156773|FG002|Overall Study|Lost to Follow-up|0
1089851|NCT02236988|2156774|FG003|Overall Study|Lost to Follow-up|1
1089852|NCT02236988|2156771|FG000|Overall Study|Unable to Comply with Study Visits|0
1089853|NCT02236988|2156772|FG001|Overall Study|Unable to Comply with Study Visits|0
1089854|NCT02236988|2156773|FG002|Overall Study|Unable to Comply with Study Visits|0
1089855|NCT02236988|2156774|FG003|Overall Study|Unable to Comply with Study Visits|2
1089856|NCT02237001|2156825|FG000|Overall Study|Lost to Follow-up|2
1089857|NCT02237001|2156825|FG000|Overall Study|Withdrawal by Subject|1
1089858|NCT02237001|2156825|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3
1089859|NCT02237001|2156825|FG000|Overall Study|Re-operation|4
1089860|NCT02237001|2156825|FG000|Overall Study|Incarceration|1
1089861|NCT02237118|2156846|FG000|Overall Study|Protocol Violation|0
1089862|NCT02237118|2156847|FG001|Overall Study|Protocol Violation|1
1089863|NCT02237118|2156846|FG000|Overall Study|consent withdrawn|1
1089864|NCT02237118|2156847|FG001|Overall Study|consent withdrawn|0
1089865|NCT02237157|2156861|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3
1089866|NCT02237157|2156862|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
1089867|NCT02237157|2156863|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
1089868|NCT02237157|2156864|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
1089869|NCT02237157|2156861|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1
1089870|NCT02237157|2156862|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
1089871|NCT02237157|2156863|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
1089872|NCT02237157|2156864|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
1089873|NCT02237196|2156875|FG000|Overall Study|Adverse Event|0
1089874|NCT02237196|2156876|FG001|Overall Study|Adverse Event|1
1089875|NCT02237196|2156877|FG002|Overall Study|Adverse Event|1
1089876|NCT02237196|2156878|FG003|Overall Study|Adverse Event|0
1089877|NCT02237196|2156875|FG000|Overall Study|Lost to Follow-up|4
1089878|NCT02237196|2156876|FG001|Overall Study|Lost to Follow-up|2
1089879|NCT02237196|2156877|FG002|Overall Study|Lost to Follow-up|4
1089880|NCT02237196|2156878|FG003|Overall Study|Lost to Follow-up|6
1089881|NCT02237196|2156875|FG000|Overall Study|Physician Decision|2
1089882|NCT02237196|2156876|FG001|Overall Study|Physician Decision|0
1089883|NCT02237196|2156877|FG002|Overall Study|Physician Decision|0
1089884|NCT02237196|2156878|FG003|Overall Study|Physician Decision|1
1089885|NCT02237196|2156875|FG000|Overall Study|Pregnancy|0
1089886|NCT02237196|2156876|FG001|Overall Study|Pregnancy|0
1089887|NCT02237196|2156877|FG002|Overall Study|Pregnancy|1
1089888|NCT02237196|2156878|FG003|Overall Study|Pregnancy|1
1089889|NCT02237196|2156875|FG000|Overall Study|Withdrawal by Subject|1
1089890|NCT02237196|2156876|FG001|Overall Study|Withdrawal by Subject|1
1089891|NCT02237196|2156877|FG002|Overall Study|Withdrawal by Subject|4
1089892|NCT02237196|2156878|FG003|Overall Study|Withdrawal by Subject|1
1089893|NCT02237196|2156875|FG000|Overall Study|Site Error|1
1089894|NCT02237196|2156876|FG001|Overall Study|Site Error|2
1089895|NCT02237196|2156877|FG002|Overall Study|Site Error|0
1089896|NCT02237196|2156878|FG003|Overall Study|Site Error|2
1089897|NCT02237911|2156915|FG000|Overall Study|Withdrawal by Subject|4
1089898|NCT02237911|2156916|FG001|Overall Study|Withdrawal by Subject|7
1089899|NCT02237911|2156917|FG002|Overall Study|Withdrawal by Subject|2
1089900|NCT02237911|2156915|FG000|Overall Study|Lost to Follow-up|3
1089901|NCT02237911|2156916|FG001|Overall Study|Lost to Follow-up|1
1089902|NCT02237911|2156917|FG002|Overall Study|Lost to Follow-up|1
1089903|NCT02238067|2156955|FG000|Overall Study|Not completed survey at Month 6|45
1089904|NCT02238080|2156959|FG000|Overall Study|Death|13
1089905|NCT02238080|2156959|FG000|Overall Study|Treatment interrupted|6
1089906|NCT02238080|2156959|FG000|Overall Study|Withdrawal by Subject|2
1089907|NCT02238080|2156959|FG000|Overall Study|Other|4
1089908|NCT02238379|2156965|FG000|Overall Study|Lost to Follow-up|1
1089909|NCT02238379|2156966|FG001|Overall Study|Lost to Follow-up|0
1089910|NCT02238483|2156974|FG000|Overall Study|Withdrawal by Subject|2
1089911|NCT02238483|2156975|FG001|Overall Study|Withdrawal by Subject|7
1089912|NCT02238483|2156974|FG000|Overall Study|Lost to Follow-up|1
1089913|NCT02238483|2156975|FG001|Overall Study|Lost to Follow-up|1
1089914|NCT02238483|2156974|FG000|Overall Study|Protocol Violation|1
1089915|NCT02238483|2156975|FG001|Overall Study|Protocol Violation|2
1089916|NCT02238483|2156974|FG000|Overall Study|Death|1
1089917|NCT02238483|2156975|FG001|Overall Study|Death|0
1089918|NCT02238483|2156974|FG000|Overall Study|Adverse Event|7
1089919|NCT02238483|2156975|FG001|Overall Study|Adverse Event|3
1089920|NCT02238483|2156974|FG000|Overall Study|Withdrawn due to physician decision|1
1089921|NCT02238483|2156975|FG001|Overall Study|Withdrawn due to physician decision|0
1089922|NCT02238483|2156974|FG000|Overall Study|Completion status not recorded|1
1089923|NCT02238483|2156975|FG001|Overall Study|Completion status not recorded|1
1089924|NCT02238483|2156974|FG000|Overall Study|Illness in family member|1
1089925|NCT02238483|2156975|FG001|Overall Study|Illness in family member|0
1089926|NCT02238626|2156985|FG000|Overall Study|Adverse Event|3
1089927|NCT02238626|2156986|FG001|Overall Study|Adverse Event|5
1089928|NCT02238626|2156987|FG002|Overall Study|Adverse Event|0
1089929|NCT02238626|2156988|FG003|Overall Study|Adverse Event|3
1089930|NCT02238626|2156985|FG000|Overall Study|Lost to Follow-up|2
1089931|NCT02238626|2156986|FG001|Overall Study|Lost to Follow-up|4
1089932|NCT02238626|2156987|FG002|Overall Study|Lost to Follow-up|2
1089933|NCT02238626|2156988|FG003|Overall Study|Lost to Follow-up|2
1089934|NCT02238626|2156985|FG000|Overall Study|Withdrawal by Subject|0
1089935|NCT02238626|2156986|FG001|Overall Study|Withdrawal by Subject|3
1089936|NCT02238626|2156987|FG002|Overall Study|Withdrawal by Subject|0
1089937|NCT02238626|2156988|FG003|Overall Study|Withdrawal by Subject|1
1089938|NCT02238626|2156985|FG000|Overall Study|Death|0
1089939|NCT02238626|2156986|FG001|Overall Study|Death|0
1089940|NCT02238626|2156987|FG002|Overall Study|Death|1
1089941|NCT02238626|2156988|FG003|Overall Study|Death|1
1089942|NCT02238626|2156985|FG000|Overall Study|Other|0
1089943|NCT02238626|2156986|FG001|Overall Study|Other|2
1089944|NCT02238626|2156987|FG002|Overall Study|Other|0
1089945|NCT02238626|2156988|FG003|Overall Study|Other|0
1089946|NCT02239094|2157035|FG000|Overall Study|Withdrawal by Subject|1
1089947|NCT02239094|2157035|FG000|Overall Study|Remitted before started|1
1089948|NCT02239120|2157041|FG000|Overall Study|Death|56
1089949|NCT02239120|2157042|FG001|Overall Study|Death|58
1089950|NCT02239120|2157041|FG000|Overall Study|Lost to Follow-up|19
1089951|NCT02239120|2157042|FG001|Overall Study|Lost to Follow-up|14
1089952|NCT02239224|2157052|FG000|Overall Study|Administrative|0
1089953|NCT02239224|2157053|FG001|Overall Study|Administrative|0
1089954|NCT02239224|2157054|FG002|Overall Study|Administrative|3
1089955|NCT02239224|2157055|FG003|Overall Study|Administrative|1
1089956|NCT02239263|2157065|FG000|Overall Study|Protocol Violation|6
1089957|NCT02239328|2157075|FG000|Overall Study|Benign disease noted at time of surgery|6
1089958|NCT02239328|2157075|FG000|Overall Study|Equipment or website malfunction|2
1089959|NCT02239510|2157085|FG000|Overall Study|Lost to Follow-up|2
1089960|NCT02239510|2157086|FG001|Overall Study|Lost to Follow-up|1
1089961|NCT02239536|2157094|FG000|Overall Study|Non-neoplastic polyp|23
1089962|NCT02239536|2157095|FG001|Overall Study|Non-neoplastic polyp|17
1089963|NCT02239601|2157130|FG000|Overall Study|Withdrawal by Subject|3
1089964|NCT02239601|2157131|FG001|Overall Study|Withdrawal by Subject|4
1089965|NCT02239601|2157130|FG000|Overall Study|Protocol Violation|4
1089966|NCT02239601|2157131|FG001|Overall Study|Protocol Violation|2
1089967|NCT02239640|2157142|FG000|Overall Study|Withdrawal by Subject|3
1089968|NCT02239640|2157142|FG000|Overall Study|Lost to Follow-up|72
1089969|NCT02239640|2157142|FG000|Overall Study|Death|142
1089970|NCT02239679|2157155|FG000|Overall Study|Lost to Follow-up|1
1089971|NCT02239679|2157156|FG001|Overall Study|Lost to Follow-up|0
1089972|NCT02239679|2157157|FG002|Overall Study|Lost to Follow-up|0
1089973|NCT02239679|2157155|FG000|Overall Study|Withdrawal by Subject|2
1089974|NCT02239679|2157156|FG001|Overall Study|Withdrawal by Subject|3
1089975|NCT02239679|2157157|FG002|Overall Study|Withdrawal by Subject|1
1089976|NCT02239692|2157167|FG000|Overall Study|Incomplete colonoscopy|1
943544|NCT01007123|1933131|FG002|Overall Study|Lost to Follow-up|0
943545|NCT01007123|1933132|FG003|Overall Study|Lost to Follow-up|0
943546|NCT01007149|1933165|FG000|Overall Study|Administrative problems|0
943547|NCT01007149|1933166|FG001|Overall Study|Administrative problems|1
943548|NCT01007253|1933172|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1
943549|NCT01007253|1933173|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0
943550|NCT01007253|1933174|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0
943551|NCT01007253|1933175|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0
943552|NCT01007396|1933185|FG000|Overall Study|Lost to Follow-up|47
943553|NCT01007435|1933193|FG000|Overall Study|Adverse Event|16
943554|NCT01007435|1933194|FG001|Overall Study|Adverse Event|25
943555|NCT01007435|1933195|FG002|Overall Study|Adverse Event|47
943556|NCT01007435|1933196|FG003|Overall Study|Adverse Event|31
943557|NCT01007435|1933193|FG000|Overall Study|Death|2
943558|NCT01007435|1933194|FG001|Overall Study|Death|4
943559|NCT01007435|1933195|FG002|Overall Study|Death|2
943560|NCT01007435|1933196|FG003|Overall Study|Death|1
943561|NCT01007435|1933193|FG000|Overall Study|Insufficient Therapeutic Response|21
943562|NCT01007435|1933194|FG001|Overall Study|Insufficient Therapeutic Response|7
943563|NCT01007435|1933195|FG002|Overall Study|Insufficient Therapeutic Response|2
943564|NCT01007435|1933196|FG003|Overall Study|Insufficient Therapeutic Response|9
943565|NCT01007435|1933193|FG000|Overall Study|Violation of Selection Criteria at Entry|3
943566|NCT01007435|1933194|FG001|Overall Study|Violation of Selection Criteria at Entry|5
943567|NCT01007435|1933195|FG002|Overall Study|Violation of Selection Criteria at Entry|2
943568|NCT01007435|1933196|FG003|Overall Study|Violation of Selection Criteria at Entry|0
943569|NCT01007435|1933193|FG000|Overall Study|Other Protocol Violation|2
943570|NCT01007435|1933194|FG001|Overall Study|Other Protocol Violation|0
943571|NCT01007435|1933195|FG002|Overall Study|Other Protocol Violation|1
943572|NCT01007435|1933196|FG003|Overall Study|Other Protocol Violation|0
1089977|NCT02239692|2157168|FG001|Overall Study|Incomplete colonoscopy|2
1089978|NCT02239692|2157167|FG000|Overall Study|Adverse Event|0
1089979|NCT02239692|2157168|FG001|Overall Study|Adverse Event|1
1089980|NCT02239692|2157167|FG000|Overall Study|Physician Decision|0
1089981|NCT02239692|2157168|FG001|Overall Study|Physician Decision|1
1089982|NCT02239692|2157167|FG000|Overall Study|Lost to Follow-up|1
1089983|NCT02239692|2157168|FG001|Overall Study|Lost to Follow-up|4
1089984|NCT02239692|2157167|FG000|Overall Study|Withdrawal by Subject|3
1089985|NCT02239692|2157168|FG001|Overall Study|Withdrawal by Subject|5
1089986|NCT02239692|2157167|FG000|Overall Study|Other reason|1
1089987|NCT02239692|2157168|FG001|Overall Study|Other reason|0
1089988|NCT02239939|2157219|FG000|Overall Study|Adverse Event|1
1089989|NCT02239939|2157220|FG001|Overall Study|Adverse Event|0
1089990|NCT02239939|2157219|FG000|Overall Study|Withdrawal by Subject|1
1089991|NCT02239939|2157220|FG001|Overall Study|Withdrawal by Subject|1
1089992|NCT02239939|2157219|FG000|Overall Study|Lost to Follow-up|0
1089993|NCT02239939|2157220|FG001|Overall Study|Lost to Follow-up|1
1089994|NCT02239978|2157230|FG000|Overall Study|Withdrawal by Subject|2
1089995|NCT02239978|2157231|FG001|Overall Study|Withdrawal by Subject|0
1089996|NCT02240108|2157256|FG000|Overall Study|Other than specified|8
1089997|NCT02240108|2157257|FG001|Overall Study|Other than specified|6
1089998|NCT02240108|2157256|FG000|Overall Study|Adverse Event|1
1089999|NCT02240108|2157257|FG001|Overall Study|Adverse Event|9
1090000|NCT02240108|2157256|FG000|Overall Study|Pregnancy|1
1090001|NCT02240108|2157257|FG001|Overall Study|Pregnancy|0
1090002|NCT02240108|2157256|FG000|Overall Study|Withdrawal by Subject|4
1090003|NCT02240108|2157257|FG001|Overall Study|Withdrawal by Subject|9
1090004|NCT02240108|2157256|FG000|Overall Study|StudyTerminated by Sponsor|0
1090005|NCT02240108|2157257|FG001|Overall Study|StudyTerminated by Sponsor|1
1090006|NCT02240121|2157265|FG000|Overall Study|Protocol Violation|1
1090007|NCT02240121|2157266|FG001|Overall Study|Protocol Violation|2
1090008|NCT02240121|2157265|FG000|Overall Study|Physician Decision|0
1090009|NCT02240121|2157266|FG001|Overall Study|Physician Decision|1
1090010|NCT02240121|2157265|FG000|Overall Study|Change in protocol interpretation|1
1090011|NCT02240121|2157266|FG001|Overall Study|Change in protocol interpretation|0
1090012|NCT02240121|2157265|FG000|Overall Study|Lack of Efficacy|2
1090013|NCT02240121|2157266|FG001|Overall Study|Lack of Efficacy|3
1090014|NCT02240121|2157265|FG000|Overall Study|Site closed|1
1090015|NCT02240121|2157266|FG001|Overall Study|Site closed|1
1090016|NCT02240121|2157265|FG000|Overall Study|Pregnancy|1
1090017|NCT02240121|2157266|FG001|Overall Study|Pregnancy|0
1090018|NCT02240121|2157265|FG000|Overall Study|Adverse Event|2
1090019|NCT02240121|2157266|FG001|Overall Study|Adverse Event|4
1090020|NCT02240121|2157265|FG000|Overall Study|Withdrawal by Subject|6
1090021|NCT02240121|2157266|FG001|Overall Study|Withdrawal by Subject|2
1090022|NCT02240121|2157265|FG000|Overall Study|Lost to Follow-up|3
1090023|NCT02240121|2157266|FG001|Overall Study|Lost to Follow-up|4
1090024|NCT02240121|2157265|FG000|Overall Study|Other than specified|1
1090025|NCT02240121|2157266|FG001|Overall Study|Other than specified|3
1090026|NCT02240368|2157286|FG000|Overall Study|Surgery lasted less then 20 minutes|1
1090027|NCT02240368|2157287|FG001|Overall Study|Surgery lasted less then 20 minutes|0
1090028|NCT02240368|2157288|FG002|Overall Study|Surgery lasted less then 20 minutes|0
1090029|NCT02240368|2157286|FG000|Overall Study|Entropy failed to detect more than 50%|0
1090030|NCT02240368|2157287|FG001|Overall Study|Entropy failed to detect more than 50%|0
1090031|NCT02240368|2157288|FG002|Overall Study|Entropy failed to detect more than 50%|1
1090032|NCT02240628|2157307|FG000|Overall Study|Physician Decision|6
1090033|NCT02240628|2157308|FG001|Overall Study|Physician Decision|5
1090034|NCT02240680|2157346|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6
943573|NCT01007435|1933193|FG000|Overall Study|Refused Treatment|13
943574|NCT01007435|1933194|FG001|Overall Study|Refused Treatment|13
943575|NCT01007435|1933195|FG002|Overall Study|Refused Treatment|5
943576|NCT01007435|1933196|FG003|Overall Study|Refused Treatment|8
943577|NCT01007435|1933193|FG000|Overall Study|Failure to Return|5
943578|NCT01007435|1933194|FG001|Overall Study|Failure to Return|4
943579|NCT01007435|1933195|FG002|Overall Study|Failure to Return|3
943580|NCT01007435|1933196|FG003|Overall Study|Failure to Return|6
943581|NCT01007435|1933193|FG000|Overall Study|Reason not Specified|1
943582|NCT01007435|1933194|FG001|Overall Study|Reason not Specified|1
943583|NCT01007435|1933195|FG002|Overall Study|Reason not Specified|2
943584|NCT01007435|1933196|FG003|Overall Study|Reason not Specified|1
943585|NCT01007448|1933208|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1
943586|NCT01007448|1933209|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0
943587|NCT01007448|1933208|FG000|Overall Study|Staph Skin Infection Flare|1
943588|NCT01007448|1933209|FG001|Overall Study|Staph Skin Infection Flare|0
943589|NCT01007448|1933208|FG000|Overall Study|Participant Leaving the Country|1
943590|NCT01007448|1933209|FG001|Overall Study|Participant Leaving the Country|0
943591|NCT01007448|1933208|FG000|Overall Study|Participant Given Prohibited Medication|1
943592|NCT01007448|1933209|FG001|Overall Study|Participant Given Prohibited Medication|0
943593|NCT01007448|1933208|FG000|Overall Study|Progressive Disease|1
943594|NCT01007448|1933209|FG001|Overall Study|Progressive Disease|2
943595|NCT01007448|1933208|FG000|Overall Study|Lack of Efficacy|2
943596|NCT01007448|1933209|FG001|Overall Study|Lack of Efficacy|0
943597|NCT01007448|1933208|FG000|Overall Study|Withdrawal by Subject|2
943598|NCT01007448|1933209|FG001|Overall Study|Withdrawal by Subject|3
943599|NCT01007448|1933208|FG000|Overall Study|Adverse Event|1
943600|NCT01007448|1933209|FG001|Overall Study|Adverse Event|4
943601|NCT01007552|1933219|FG000|Overall Study|Withdrawal by Subject|1
943602|NCT01007812|1933245|FG000|Period 1, One Week|Lost to Follow-up|0
943603|NCT01007812|1933246|FG001|Period 1, One Week|Lost to Follow-up|1
943604|NCT01007812|1933245|FG000|Period 1, One Week|Discomfort|1
943605|NCT01007812|1933246|FG001|Period 1, One Week|Discomfort|0
943606|NCT01007838|1933256|FG000|Overall Study|Withdrawal by Subject|1
1090035|NCT02240680|2157347|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6
1090036|NCT02240680|2157348|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0
1090037|NCT02240680|2157349|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0
1090038|NCT02240680|2157346|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4
1090039|NCT02240680|2157347|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1
1090040|NCT02240680|2157348|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0
1090041|NCT02240680|2157349|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0
1090042|NCT02240680|2157346|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
1090043|NCT02240680|2157347|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1090044|NCT02240680|2157348|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1090045|NCT02240680|2157349|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1090046|NCT02240680|2157346|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
1090047|NCT02240680|2157347|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
1090048|NCT02240680|2157348|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
1090049|NCT02240680|2157349|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
1090050|NCT02240680|2157346|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1
1090051|NCT02240680|2157347|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0
1090052|NCT02240680|2157348|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0
1090053|NCT02240680|2157349|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0
1090054|NCT02240680|2157346|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
1090055|NCT02240680|2157347|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
1090056|NCT02240680|2157348|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
1090057|NCT02240680|2157349|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
1090058|NCT02240680|2157346|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1090059|NCT02240680|2157347|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1090060|NCT02240680|2157348|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
1090061|NCT02240680|2157349|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1090062|NCT02240680|2157346|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1090063|NCT02240680|2157347|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1090064|NCT02240680|2157348|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
1090065|NCT02240680|2157349|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1090066|NCT02240693|2157362|FG000|Overall Study|Adverse Event|0
1090067|NCT02240693|2157363|FG001|Overall Study|Adverse Event|0
1090068|NCT02240693|2157364|FG002|Overall Study|Adverse Event|0
1090069|NCT02240693|2157365|FG003|Overall Study|Adverse Event|0
1090070|NCT02240693|2157366|FG004|Overall Study|Adverse Event|1
1090071|NCT02240693|2157362|FG000|Overall Study|Withdrawal by Subject|0
1090072|NCT02240693|2157363|FG001|Overall Study|Withdrawal by Subject|0
1090073|NCT02240693|2157364|FG002|Overall Study|Withdrawal by Subject|2
1090074|NCT02240693|2157365|FG003|Overall Study|Withdrawal by Subject|1
1090075|NCT02240693|2157366|FG004|Overall Study|Withdrawal by Subject|0
1090076|NCT02240693|2157362|FG000|Overall Study|Other than specified|0
1090077|NCT02240693|2157363|FG001|Overall Study|Other than specified|0
1090078|NCT02240693|2157364|FG002|Overall Study|Other than specified|2
1090079|NCT02240693|2157365|FG003|Overall Study|Other than specified|0
1090080|NCT02240693|2157366|FG004|Overall Study|Other than specified|0
1090081|NCT02240706|2157385|FG000|Overall Study|Lack of Efficacy|2
1090082|NCT02240706|2157386|FG001|Overall Study|Lack of Efficacy|2
1090083|NCT02240706|2157387|FG002|Overall Study|Lack of Efficacy|2
1090084|NCT02240706|2157388|FG003|Overall Study|Lack of Efficacy|2
1090085|NCT02240706|2157389|FG004|Overall Study|Lack of Efficacy|5
1090086|NCT02240706|2157390|FG005|Overall Study|Lack of Efficacy|0
1090087|NCT02240706|2157391|FG006|Overall Study|Lack of Efficacy|0
1090088|NCT02240706|2157385|FG000|Overall Study|Adverse Event|1
1090089|NCT02240706|2157386|FG001|Overall Study|Adverse Event|0
1090090|NCT02240706|2157387|FG002|Overall Study|Adverse Event|1
1090091|NCT02240706|2157388|FG003|Overall Study|Adverse Event|0
1090092|NCT02240706|2157389|FG004|Overall Study|Adverse Event|2
1090093|NCT02240706|2157390|FG005|Overall Study|Adverse Event|0
1090094|NCT02240706|2157391|FG006|Overall Study|Adverse Event|0
1090095|NCT02240706|2157385|FG000|Overall Study|Progressive disease|0
1090096|NCT02240706|2157386|FG001|Overall Study|Progressive disease|0
943607|NCT01007838|1933257|FG001|Overall Study|Withdrawal by Subject|0
943608|NCT01007838|1933258|FG002|Overall Study|Withdrawal by Subject|0
943609|NCT01007838|1933259|FG003|Overall Study|Withdrawal by Subject|0
943610|NCT01007838|1933256|FG000|Overall Study|Physician Decision|1
943611|NCT01007838|1933257|FG001|Overall Study|Physician Decision|0
943612|NCT01007838|1933258|FG002|Overall Study|Physician Decision|0
943613|NCT01007838|1933259|FG003|Overall Study|Physician Decision|0
943614|NCT01007838|1933256|FG000|Overall Study|Started home haemodialysis|1
943615|NCT01007838|1933257|FG001|Overall Study|Started home haemodialysis|0
943616|NCT01007838|1933258|FG002|Overall Study|Started home haemodialysis|0
943617|NCT01007838|1933259|FG003|Overall Study|Started home haemodialysis|0
943618|NCT01007916|1933269|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
943619|NCT01007916|1933270|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
943620|NCT01007916|1933269|FG000|Period 2, 4 Weeks of Wear|Relocation|1
943621|NCT01007916|1933270|FG001|Period 2, 4 Weeks of Wear|Relocation|0
943622|NCT01007942|1933278|FG000|Overall Study|Adverse Event|29
943623|NCT01007942|1933279|FG001|Overall Study|Adverse Event|14
1090097|NCT02240706|2157387|FG002|Overall Study|Progressive disease|0
1090098|NCT02240706|2157388|FG003|Overall Study|Progressive disease|0
1090099|NCT02240706|2157389|FG004|Overall Study|Progressive disease|1
1090100|NCT02240706|2157390|FG005|Overall Study|Progressive disease|0
1090101|NCT02240706|2157391|FG006|Overall Study|Progressive disease|0
1090102|NCT02240706|2157385|FG000|Overall Study|Dose limiting toxicity|0
1090103|NCT02240706|2157386|FG001|Overall Study|Dose limiting toxicity|0
1090104|NCT02240706|2157387|FG002|Overall Study|Dose limiting toxicity|0
1090105|NCT02240706|2157388|FG003|Overall Study|Dose limiting toxicity|0
1090106|NCT02240706|2157389|FG004|Overall Study|Dose limiting toxicity|1
1090107|NCT02240706|2157390|FG005|Overall Study|Dose limiting toxicity|0
1090108|NCT02240706|2157391|FG006|Overall Study|Dose limiting toxicity|0
1090109|NCT02240706|2157385|FG000|Overall Study|Refused to continue taking medication|0
1090110|NCT02240706|2157386|FG001|Overall Study|Refused to continue taking medication|1
1090111|NCT02240706|2157387|FG002|Overall Study|Refused to continue taking medication|3
1162051|NCT03381339|2283994|FG000|Overall Study|Protocol Violation|4
943624|NCT01007942|1933278|FG000|Overall Study|Abnormal test procedure|0
943625|NCT01007942|1933279|FG001|Overall Study|Abnormal test procedure|1
943626|NCT01007942|1933278|FG000|Overall Study|Disease progression|217
943627|NCT01007942|1933279|FG001|Overall Study|Disease progression|242
943628|NCT01007942|1933278|FG000|Overall Study|New cancer therapy|5
943629|NCT01007942|1933279|FG001|Overall Study|New cancer therapy|1
943630|NCT01007942|1933278|FG000|Overall Study|Protocol Violation|1
943631|NCT01007942|1933279|FG001|Overall Study|Protocol Violation|1
943632|NCT01007942|1933278|FG000|Overall Study|Withdrawal by Subject|19
943633|NCT01007942|1933279|FG001|Overall Study|Withdrawal by Subject|14
943634|NCT01007942|1933278|FG000|Overall Study|Lost to Follow-up|1
943635|NCT01007942|1933279|FG001|Overall Study|Lost to Follow-up|0
943636|NCT01007942|1933278|FG000|Overall Study|Administrative problems|2
943637|NCT01007942|1933279|FG001|Overall Study|Administrative problems|0
943638|NCT01007942|1933278|FG000|Overall Study|Death|3
943639|NCT01007942|1933279|FG001|Overall Study|Death|2
943640|NCT01007942|1933278|FG000|Overall Study|Patients untreated|4
943641|NCT01007942|1933279|FG001|Overall Study|Patients untreated|3
943642|NCT01008150|1933320|FG000|Overall Study|did not receive study drug|1
943643|NCT01008150|1933321|FG001|Overall Study|did not receive study drug|1
943644|NCT01008150|1933322|FG002|Overall Study|did not receive study drug|1
943645|NCT01008150|1933323|FG003|Overall Study|did not receive study drug|0
943646|NCT01008410|1933358|FG000|Overall Study|Adverse Event|13
943647|NCT01008410|1933359|FG001|Overall Study|Adverse Event|7
943648|NCT01008410|1933358|FG000|Overall Study|Withdrawal by Subject|6
943649|NCT01008410|1933359|FG001|Overall Study|Withdrawal by Subject|2
943650|NCT01008410|1933358|FG000|Overall Study|Lost to Follow-up|1
943651|NCT01008410|1933359|FG001|Overall Study|Lost to Follow-up|0
943652|NCT01008410|1933358|FG000|Overall Study|Noncompliance|1
943653|NCT01008410|1933359|FG001|Overall Study|Noncompliance|0
943654|NCT01008410|1933358|FG000|Overall Study|Low Cortisol|2
943655|NCT01008410|1933359|FG001|Overall Study|Low Cortisol|0
943656|NCT01008410|1933358|FG000|Overall Study|Lack of Efficacy|2
943657|NCT01008410|1933359|FG001|Overall Study|Lack of Efficacy|6
943658|NCT01008410|1933358|FG000|Overall Study|Met Exclusion Criterion|0
943659|NCT01008410|1933359|FG001|Overall Study|Met Exclusion Criterion|1
943660|NCT01008423|1933367|FG000|Overall Study|Adverse Event|13
943661|NCT01008423|1933368|FG001|Overall Study|Adverse Event|6
943662|NCT01008423|1933367|FG000|Overall Study|Withdrawal by Subject|4
943663|NCT01008423|1933368|FG001|Overall Study|Withdrawal by Subject|7
943664|NCT01008423|1933367|FG000|Overall Study|Lost to Follow-up|0
943665|NCT01008423|1933368|FG001|Overall Study|Lost to Follow-up|2
943666|NCT01008423|1933367|FG000|Overall Study|Low Cortisol|0
943667|NCT01008423|1933368|FG001|Overall Study|Low Cortisol|1
943668|NCT01008423|1933367|FG000|Overall Study|Lack of Efficacy|0
943669|NCT01008423|1933368|FG001|Overall Study|Lack of Efficacy|5
943670|NCT01008423|1933367|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1
943671|NCT01008423|1933368|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0
943672|NCT01008423|1933367|FG000|Overall Study|Personal Conflict|1
943673|NCT01008423|1933368|FG001|Overall Study|Personal Conflict|0
943674|NCT01008423|1933367|FG000|Overall Study|Other|0
943675|NCT01008423|1933368|FG001|Overall Study|Other|1
943676|NCT01008449|1933376|FG000|Overall Study|Lost to Follow-up|29
943677|NCT01008449|1933377|FG001|Overall Study|Lost to Follow-up|19
943678|NCT01008475|1933394|FG000|Overall Study|Ongoing treatment at data cut-off date|0
943679|NCT01008475|1933395|FG001|Overall Study|Ongoing treatment at data cut-off date|0
943680|NCT01008475|1933396|FG002|Overall Study|Ongoing treatment at data cut-off date|0
943681|NCT01008475|1933397|FG003|Overall Study|Ongoing treatment at data cut-off date|0
943682|NCT01008475|1933398|FG004|Overall Study|Ongoing treatment at data cut-off date|5
943683|NCT01008475|1933399|FG005|Overall Study|Ongoing treatment at data cut-off date|6
943684|NCT01008475|1933400|FG006|Overall Study|Ongoing treatment at data cut-off date|4
943685|NCT01008553|1933416|FG000|Period 1 (Titration Period)|Physician Decision|2
943686|NCT01008553|1933417|FG001|Period 1 (Titration Period)|Physician Decision|0
943687|NCT01008553|1933418|FG002|Period 1 (Titration Period)|Physician Decision|0
943688|NCT01008553|1933416|FG000|Period 1 (Titration Period)|Adverse Event|33
943689|NCT01008553|1933417|FG001|Period 1 (Titration Period)|Adverse Event|0
943690|NCT01008553|1933418|FG002|Period 1 (Titration Period)|Adverse Event|0
1090112|NCT02240706|2157388|FG003|Overall Study|Refused to continue taking medication|1
1090113|NCT02240706|2157389|FG004|Overall Study|Refused to continue taking medication|2
1090114|NCT02240706|2157390|FG005|Overall Study|Refused to continue taking medication|0
1090115|NCT02240706|2157391|FG006|Overall Study|Refused to continue taking medication|0
1090116|NCT02240706|2157385|FG000|Overall Study|Insurance billing concerns|0
1090117|NCT02240706|2157386|FG001|Overall Study|Insurance billing concerns|0
1090118|NCT02240706|2157387|FG002|Overall Study|Insurance billing concerns|0
1090119|NCT02240706|2157388|FG003|Overall Study|Insurance billing concerns|1
1090120|NCT02240706|2157389|FG004|Overall Study|Insurance billing concerns|0
1090121|NCT02240706|2157390|FG005|Overall Study|Insurance billing concerns|0
1090122|NCT02240706|2157391|FG006|Overall Study|Insurance billing concerns|0
1090123|NCT02241512|2157422|FG000|Overall Study|Pump malfunction, drug not delivered|1
1090124|NCT02241512|2157423|FG001|Overall Study|Pump malfunction, drug not delivered|0
1090125|NCT02241733|2157449|FG000|Overall Study|Lost to Follow-up|9
1090126|NCT02241733|2157450|FG001|Overall Study|Lost to Follow-up|4
1090127|NCT02241733|2157449|FG000|Overall Study|Physician Decision|6
1090128|NCT02241733|2157450|FG001|Overall Study|Physician Decision|2
1090129|NCT02241733|2157449|FG000|Overall Study|Withdrawal by Subject|0
1090130|NCT02241733|2157450|FG001|Overall Study|Withdrawal by Subject|2
1090131|NCT02241733|2157449|FG000|Overall Study|Death|0
1090132|NCT02241733|2157450|FG001|Overall Study|Death|2
1090133|NCT02241785|2157456|FG000|Overall Study|Sponsor Termination|43
1090134|NCT02241785|2157456|FG000|Overall Study|Withdrawal by Subject|1
1090135|NCT02241785|2157456|FG000|Overall Study|Lost to Follow-up|2
1090136|NCT02241785|2157456|FG000|Overall Study|Adverse Event|1
1090137|NCT02241889|2157460|FG000|Overall Study|device issues|0
1090138|NCT02241889|2157461|FG001|Overall Study|device issues|0
1090139|NCT02241889|2157462|FG002|Overall Study|device issues|1
1090140|NCT02241889|2157463|FG003|Overall Study|device issues|0
1090141|NCT02241889|2157464|FG004|Overall Study|device issues|0
1090142|NCT02241889|2157465|FG005|Overall Study|device issues|0
1090143|NCT02241889|2157460|FG000|Overall Study|Withdrawal by Subject|0
1090144|NCT02241889|2157461|FG001|Overall Study|Withdrawal by Subject|0
1090145|NCT02241889|2157462|FG002|Overall Study|Withdrawal by Subject|0
1090146|NCT02241889|2157463|FG003|Overall Study|Withdrawal by Subject|0
1090147|NCT02241889|2157464|FG004|Overall Study|Withdrawal by Subject|0
1090148|NCT02241889|2157465|FG005|Overall Study|Withdrawal by Subject|1
1090149|NCT02242045|2157494|FG000|Overall Study|Investigator's Discretion|1
1090150|NCT02242045|2157494|FG000|Overall Study|Progressive Disease|2
1090151|NCT02242045|2157494|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1
1090152|NCT02242045|2157494|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2
1090153|NCT02242201|2157501|FG000|Overall Study|preoperative identified neuropathy|2
1090154|NCT02242201|2157502|FG001|Overall Study|preoperative identified neuropathy|0
1090155|NCT02242201|2157503|FG002|Overall Study|preoperative identified neuropathy|0
1090156|NCT02242201|2157501|FG000|Overall Study|planned post-op anticoagulation|1
1090157|NCT02242201|2157502|FG001|Overall Study|planned post-op anticoagulation|0
1090158|NCT02242201|2157503|FG002|Overall Study|planned post-op anticoagulation|0
1090159|NCT02242201|2157501|FG000|Overall Study|changed surgical procedure|1
1090160|NCT02242201|2157502|FG001|Overall Study|changed surgical procedure|0
1090161|NCT02242201|2157503|FG002|Overall Study|changed surgical procedure|0
1090162|NCT02242201|2157501|FG000|Overall Study|postponed surgery|0
1090163|NCT02242201|2157502|FG001|Overall Study|postponed surgery|0
1090164|NCT02242201|2157503|FG002|Overall Study|postponed surgery|1
1090165|NCT02242201|2157501|FG000|Overall Study|preoperative opioid consumption|0
1090166|NCT02242201|2157502|FG001|Overall Study|preoperative opioid consumption|1
1090167|NCT02242201|2157503|FG002|Overall Study|preoperative opioid consumption|0
1090168|NCT02242305|2157513|FG000|Overall Study|Without spasm-like pain during 3 weeks|1
1090169|NCT02242305|2157514|FG001|Overall Study|Without spasm-like pain during 3 weeks|4
1090170|NCT02242305|2157513|FG000|Overall Study|Adverse Event|1
1090171|NCT02242305|2157514|FG001|Overall Study|Adverse Event|0
1090172|NCT02242305|2157513|FG000|Overall Study|Non-compliance dosing regimen or visit|2
1090173|NCT02242305|2157514|FG001|Overall Study|Non-compliance dosing regimen or visit|2
1090174|NCT02242305|2157513|FG000|Overall Study|Subject withdraws inform consent|0
1090175|NCT02242305|2157514|FG001|Overall Study|Subject withdraws inform consent|4
1090176|NCT02242305|2157513|FG000|Overall Study|Lost to Follow-up|2
1090177|NCT02242305|2157514|FG001|Overall Study|Lost to Follow-up|0
1090178|NCT02242487|2157522|FG000|Overall Study|Adverse Event|13
1090179|NCT02242487|2157523|FG001|Overall Study|Adverse Event|15
1090180|NCT02242487|2157522|FG000|Overall Study|Lack of Efficacy|4
1090181|NCT02242487|2157523|FG001|Overall Study|Lack of Efficacy|6
1090182|NCT02242487|2157522|FG000|Overall Study|Protocol Violation|2
1090183|NCT02242487|2157523|FG001|Overall Study|Protocol Violation|0
1090184|NCT02242487|2157522|FG000|Overall Study|Lost to Follow-up|2
1090185|NCT02242487|2157523|FG001|Overall Study|Lost to Follow-up|1
1090186|NCT02242487|2157522|FG000|Overall Study|Other - Miscellaneous|4
1090187|NCT02242487|2157523|FG001|Overall Study|Other - Miscellaneous|6
1090188|NCT02242487|2157522|FG000|Overall Study|Withdrawal by Subject|37
1090189|NCT02242487|2157523|FG001|Overall Study|Withdrawal by Subject|19
1090190|NCT02242643|2157550|FG000|Overall Study|Protocol Violation|1
1090191|NCT02242643|2157551|FG001|Overall Study|Protocol Violation|2
1090192|NCT02242643|2157550|FG000|Overall Study|Withdrawal by Subject|15
1090193|NCT02242643|2157551|FG001|Overall Study|Withdrawal by Subject|10
1090194|NCT02242643|2157550|FG000|Overall Study|Migrated/moved from study area|1
1090195|NCT02242643|2157551|FG001|Overall Study|Migrated/moved from study area|3
1090196|NCT02242643|2157550|FG000|Overall Study|Lost to Follow-up|54
1090197|NCT02242643|2157551|FG001|Overall Study|Lost to Follow-up|61
1090198|NCT02242643|2157550|FG000|Overall Study|Child placed in foster care by family|0
1090199|NCT02242643|2157551|FG001|Overall Study|Child placed in foster care by family|1
1090200|NCT02242643|2157550|FG000|Overall Study|Non-compliance|1
1090201|NCT02242643|2157551|FG001|Overall Study|Non-compliance|0
1090202|NCT02242643|2157550|FG000|Overall Study|Consent withdrawal by parent|1
1090203|NCT02242643|2157551|FG001|Overall Study|Consent withdrawal by parent|0
1090204|NCT02242643|2157550|FG000|Overall Study|Protocol requirements not followed|1
1090205|NCT02242643|2157551|FG001|Overall Study|Protocol requirements not followed|0
1090206|NCT02242643|2157550|FG000|Overall Study|Language barrier|1
1090207|NCT02242643|2157551|FG001|Overall Study|Language barrier|0
1090208|NCT02242643|2157550|FG000|Overall Study|Withdrawal by subject at Visit 2|0
1090209|NCT02242643|2157551|FG001|Overall Study|Withdrawal by subject at Visit 2|1
1090210|NCT02242903|2157566|FG000|Overall Study|Withdrawal by Subject|1
1090211|NCT02242903|2157567|FG001|Overall Study|Withdrawal by Subject|0
1090212|NCT02242903|2157568|FG002|Overall Study|Withdrawal by Subject|0
1090213|NCT02242903|2157569|FG003|Overall Study|Withdrawal by Subject|0
1090214|NCT02242903|2157570|FG004|Overall Study|Withdrawal by Subject|0
1090215|NCT02242903|2157571|FG005|Overall Study|Withdrawal by Subject|0
1090216|NCT02242903|2157572|FG006|Overall Study|Withdrawal by Subject|0
1090217|NCT02242942|2157597|FG000|Overall Study|Death|17
1090218|NCT02242942|2157598|FG001|Overall Study|Death|20
1090219|NCT02242942|2157599|FG002|Overall Study|Death|2
1090220|NCT02242942|2157597|FG000|Overall Study|Physician Decision|1
1090221|NCT02242942|2157598|FG001|Overall Study|Physician Decision|0
1090222|NCT02242942|2157599|FG002|Overall Study|Physician Decision|0
1090223|NCT02242942|2157597|FG000|Overall Study|Withdrawal by Subject|8
1090224|NCT02242942|2157598|FG001|Overall Study|Withdrawal by Subject|10
1090225|NCT02242942|2157599|FG002|Overall Study|Withdrawal by Subject|0
1090226|NCT02242942|2157597|FG000|Overall Study|On-going in Study|190
1090227|NCT02242942|2157598|FG001|Overall Study|On-going in Study|186
1090228|NCT02242942|2157599|FG002|Overall Study|On-going in Study|11
1090229|NCT02242981|2157609|FG000|Overall Study|Withdrawal by Subject|1
1090230|NCT02243046|2157638|FG000|Overall Study|Lost to Follow-up|1
1090231|NCT02243046|2157639|FG001|Overall Study|Lost to Follow-up|1
1090232|NCT02243046|2157640|FG002|Overall Study|Lost to Follow-up|4
1090233|NCT02243176|2157650|FG000|Overall Study|Other reason|1
1090234|NCT02243176|2157651|FG001|Overall Study|Other reason|2
1090235|NCT02243176|2157650|FG000|Overall Study|protocol specified withdrawal critera|1
1090236|NCT02243176|2157651|FG001|Overall Study|protocol specified withdrawal critera|3
1090237|NCT02243176|2157650|FG000|Overall Study|Protocol Violation|2
1090238|NCT02243176|2157651|FG001|Overall Study|Protocol Violation|1
943691|NCT01008553|1933416|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6
943692|NCT01008553|1933417|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
943693|NCT01008553|1933418|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
943694|NCT01008553|1933416|FG000|Period 1 (Titration Period)|Determined to increase dosage|3
943695|NCT01008553|1933417|FG001|Period 1 (Titration Period)|Determined to increase dosage|0
943696|NCT01008553|1933418|FG002|Period 1 (Titration Period)|Determined to increase dosage|0
943697|NCT01008553|1933416|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
943698|NCT01008553|1933417|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
943699|NCT01008553|1933418|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
943700|NCT01008553|1933416|FG000|Period 1 (Titration Period)|Not appropriate for this study|1
943701|NCT01008553|1933417|FG001|Period 1 (Titration Period)|Not appropriate for this study|0
943702|NCT01008553|1933418|FG002|Period 1 (Titration Period)|Not appropriate for this study|0
943703|NCT01008553|1933416|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
943704|NCT01008553|1933417|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
943705|NCT01008553|1933418|FG002|Period 2 (Double-Blind Period)|Physician Decision|2
943706|NCT01008553|1933416|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
943707|NCT01008553|1933417|FG001|Period 2 (Double-Blind Period)|Adverse Event|14
943708|NCT01008553|1933418|FG002|Period 2 (Double-Blind Period)|Adverse Event|4
943709|NCT01008553|1933416|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
943710|NCT01008553|1933417|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
943711|NCT01008553|1933418|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
943712|NCT01008553|1933416|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
943713|NCT01008553|1933417|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
943714|NCT01008553|1933418|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
943715|NCT01008553|1933416|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
943716|NCT01008553|1933417|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
943717|NCT01008553|1933418|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
943718|NCT01008553|1933416|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
943719|NCT01008553|1933417|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
1090239|NCT02243176|2157650|FG000|Overall Study|Withdrawal by Subject|8
1090240|NCT02243176|2157651|FG001|Overall Study|Withdrawal by Subject|7
1090241|NCT02243176|2157650|FG000|Overall Study|Adverse Event|2
1090242|NCT02243176|2157651|FG001|Overall Study|Adverse Event|2
1090243|NCT02243202|2157661|FG000|Overall Study|Adverse Event|5
1090244|NCT02243202|2157662|FG001|Overall Study|Adverse Event|6
1090245|NCT02243202|2157663|FG002|Overall Study|Adverse Event|10
1090246|NCT02243202|2157664|FG003|Overall Study|Adverse Event|4
1090247|NCT02243202|2157661|FG000|Overall Study|Lost to Follow-up|9
1090248|NCT02243202|2157662|FG001|Overall Study|Lost to Follow-up|9
1090249|NCT02243202|2157663|FG002|Overall Study|Lost to Follow-up|14
1090250|NCT02243202|2157664|FG003|Overall Study|Lost to Follow-up|11
943720|NCT01008553|1933418|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
943721|NCT01008553|1933416|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
943722|NCT01008553|1933417|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
943723|NCT01008553|1933418|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
943724|NCT01008553|1933416|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
943725|NCT01008553|1933417|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
943726|NCT01008553|1933418|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
943727|NCT01008618|1933439|FG000|Period 1 (Titration Period)|Physician Decision|2
943728|NCT01008618|1933440|FG001|Period 1 (Titration Period)|Physician Decision|0
943729|NCT01008618|1933441|FG002|Period 1 (Titration Period)|Physician Decision|0
943730|NCT01008618|1933439|FG000|Period 1 (Titration Period)|Adverse Event|33
943731|NCT01008618|1933440|FG001|Period 1 (Titration Period)|Adverse Event|0
943732|NCT01008618|1933441|FG002|Period 1 (Titration Period)|Adverse Event|0
943733|NCT01008618|1933439|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11
943734|NCT01008618|1933440|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
943735|NCT01008618|1933441|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
943736|NCT01008618|1933439|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
943737|NCT01008618|1933440|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
943738|NCT01008618|1933441|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
943739|NCT01008618|1933439|FG000|Period 1 (Titration Period)|Aggravated symptom|2
943740|NCT01008618|1933440|FG001|Period 1 (Titration Period)|Aggravated symptom|0
943741|NCT01008618|1933441|FG002|Period 1 (Titration Period)|Aggravated symptom|0
943742|NCT01008618|1933439|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
943743|NCT01008618|1933440|FG001|Period 2 (Double-Blind Period)|Adverse Event|11
943744|NCT01008618|1933441|FG002|Period 2 (Double-Blind Period)|Adverse Event|2
943745|NCT01008618|1933439|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
943746|NCT01008618|1933440|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
943747|NCT01008618|1933441|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
943748|NCT01008618|1933439|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
943749|NCT01008618|1933440|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
943750|NCT01008618|1933441|FG002|Period 2 (Double-Blind Period)|Physician Decision|0
943751|NCT01008618|1933439|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
943752|NCT01008618|1933440|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
909710|NCT00789555|1886449|FG001|Overall Study|Protocol Violation|9
909711|NCT00789555|1886450|FG002|Overall Study|Protocol Violation|13
909712|NCT00789581|1886460|FG000|AC Therapy|Adverse Event|2
909713|NCT00789581|1886461|FG001|AC Therapy|Adverse Event|3
909714|NCT00789581|1886460|FG000|AC Therapy|Withdrawal by Subject|4
909715|NCT00789581|1886461|FG001|AC Therapy|Withdrawal by Subject|7
909716|NCT00789581|1886460|FG000|AC Therapy|Disease recurrence|3
909717|NCT00789581|1886461|FG001|AC Therapy|Disease recurrence|1
909718|NCT00789581|1886460|FG000|AC Therapy|Intercurrent Illness|1
909719|NCT00789581|1886461|FG001|AC Therapy|Intercurrent Illness|0
909720|NCT00789581|1886460|FG000|AC Therapy|Never Treated|1
909721|NCT00789581|1886461|FG001|AC Therapy|Never Treated|4
909722|NCT00789581|1886460|FG000|AC Therapy|Other|0
909723|NCT00789581|1886461|FG001|AC Therapy|Other|2
909724|NCT00789581|1886460|FG000|Adjuvant Therapy|Never treated|2
909725|NCT00789581|1886461|FG001|Adjuvant Therapy|Never treated|2
909726|NCT00789581|1886460|FG000|Adjuvant Therapy|Adverse Event|20
909727|NCT00789581|1886461|FG001|Adjuvant Therapy|Adverse Event|44
909728|NCT00789581|1886460|FG000|Adjuvant Therapy|Withdrawal by Subject|14
909729|NCT00789581|1886461|FG001|Adjuvant Therapy|Withdrawal by Subject|5
909730|NCT00789581|1886460|FG000|Adjuvant Therapy|Disease recurrence|2
909731|NCT00789581|1886461|FG001|Adjuvant Therapy|Disease recurrence|1
909732|NCT00789581|1886460|FG000|Adjuvant Therapy|Intercurrent Illness|1
909733|NCT00789581|1886461|FG001|Adjuvant Therapy|Intercurrent Illness|3
909734|NCT00789581|1886460|FG000|Adjuvant Therapy|Protocol Violation|1
909735|NCT00789581|1886461|FG001|Adjuvant Therapy|Protocol Violation|1
909736|NCT00789581|1886460|FG000|Adjuvant Therapy|Other|0
909737|NCT00789581|1886461|FG001|Adjuvant Therapy|Other|1
909738|NCT00789698|1886485|FG000|Overall Study|Lack of Efficacy|10
909739|NCT00789698|1886486|FG001|Overall Study|Lack of Efficacy|4
909740|NCT00789698|1886487|FG002|Overall Study|Lack of Efficacy|5
909741|NCT00789698|1886488|FG003|Overall Study|Lack of Efficacy|18
909742|NCT00789698|1886485|FG000|Overall Study|Adverse Event|5
909743|NCT00789698|1886486|FG001|Overall Study|Adverse Event|5
909744|NCT00789698|1886487|FG002|Overall Study|Adverse Event|3
1090251|NCT02243202|2157661|FG000|Overall Study|Protocol Violation|3
1090252|NCT02243202|2157662|FG001|Overall Study|Protocol Violation|1
1090253|NCT02243202|2157663|FG002|Overall Study|Protocol Violation|2
1090254|NCT02243202|2157664|FG003|Overall Study|Protocol Violation|1
1090255|NCT02243202|2157661|FG000|Overall Study|Withdrawal by Subject|7
1090256|NCT02243202|2157662|FG001|Overall Study|Withdrawal by Subject|6
1090257|NCT02243202|2157663|FG002|Overall Study|Withdrawal by Subject|4
943753|NCT01008618|1933441|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
943754|NCT01008618|1933439|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
943755|NCT01008618|1933440|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
943756|NCT01008618|1933441|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
943757|NCT01008618|1933439|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
943758|NCT01008618|1933440|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
943759|NCT01008618|1933441|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
943760|NCT01008618|1933439|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0
943761|NCT01008618|1933440|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0
943762|NCT01008618|1933441|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1
943763|NCT01008696|1933452|FG000|Overall Study|Participant's evasion of hospital visit|5
943764|NCT01008696|1933453|FG001|Overall Study|Participant's evasion of hospital visit|4
943765|NCT01008696|1933452|FG000|Overall Study|Withdrawal by Subject|2
943766|NCT01008696|1933453|FG001|Overall Study|Withdrawal by Subject|4
943767|NCT01008696|1933452|FG000|Overall Study|Physician Decision|5
943768|NCT01008696|1933453|FG001|Overall Study|Physician Decision|1
943769|NCT01008696|1933452|FG000|Overall Study|Adverse Event|1
943770|NCT01008696|1933453|FG001|Overall Study|Adverse Event|0
943771|NCT01008696|1933452|FG000|Overall Study|Participants' non-cooperation|2
943772|NCT01008696|1933453|FG001|Overall Study|Participants' non-cooperation|3
943773|NCT01008696|1933452|FG000|Overall Study|Other|2
909745|NCT00789698|1886488|FG003|Overall Study|Adverse Event|4
909746|NCT00789698|1886485|FG000|Overall Study|Lost to Follow-up|5
909747|NCT00789698|1886486|FG001|Overall Study|Lost to Follow-up|5
909748|NCT00789698|1886487|FG002|Overall Study|Lost to Follow-up|2
909749|NCT00789698|1886488|FG003|Overall Study|Lost to Follow-up|9
909750|NCT00789698|1886485|FG000|Overall Study|Protocol Violation|6
909751|NCT00789698|1886486|FG001|Overall Study|Protocol Violation|1
909752|NCT00789698|1886487|FG002|Overall Study|Protocol Violation|2
909753|NCT00789698|1886488|FG003|Overall Study|Protocol Violation|1
909754|NCT00789698|1886485|FG000|Overall Study|Withdrawal by Subject|14
909755|NCT00789698|1886486|FG001|Overall Study|Withdrawal by Subject|15
909756|NCT00789698|1886487|FG002|Overall Study|Withdrawal by Subject|12
909757|NCT00789698|1886488|FG003|Overall Study|Withdrawal by Subject|19
909758|NCT00789698|1886485|FG000|Overall Study|Administrative|0
909759|NCT00789698|1886486|FG001|Overall Study|Administrative|3
909760|NCT00789698|1886487|FG002|Overall Study|Administrative|3
909761|NCT00789698|1886488|FG003|Overall Study|Administrative|1
909762|NCT00789737|1886508|FG000|Overall Study|Withdrawal by Subject|13
909763|NCT00789737|1886509|FG001|Overall Study|Withdrawal by Subject|22
909764|NCT00789737|1886508|FG000|Overall Study|Lost to Follow-up|10
909765|NCT00789737|1886509|FG001|Overall Study|Lost to Follow-up|14
909766|NCT00789737|1886508|FG000|Overall Study|Adverse Event|8
909767|NCT00789737|1886509|FG001|Overall Study|Adverse Event|8
909768|NCT00789737|1886508|FG000|Overall Study|Protocol Violation|3
909769|NCT00789737|1886509|FG001|Overall Study|Protocol Violation|0
909770|NCT00789737|1886508|FG000|Overall Study|Lack of Efficacy|3
909771|NCT00789737|1886509|FG001|Overall Study|Lack of Efficacy|0
909772|NCT00789737|1886508|FG000|Overall Study|hyperglycemia that met protocol-specifie|0
909773|NCT00789737|1886509|FG001|Overall Study|hyperglycemia that met protocol-specifie|4
909774|NCT00789737|1886508|FG000|Overall Study|Other|11
909775|NCT00789737|1886509|FG001|Overall Study|Other|7
909776|NCT00789815|1886551|FG000|Overall Study|Protocol Violation|6
909777|NCT00789815|1886552|FG001|Overall Study|Protocol Violation|1
909778|NCT00789815|1886551|FG000|Overall Study|Intubation due to massive bleeding|1
909779|NCT00789815|1886552|FG001|Overall Study|Intubation due to massive bleeding|0
909780|NCT00789828|1886560|FG000|Core Period (48 Weeks)|Administrative problems|0
909781|NCT00789828|1886561|FG001|Core Period (48 Weeks)|Administrative problems|1
909782|NCT00789828|1886560|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0
909783|NCT00789828|1886561|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4
909784|NCT00789828|1886560|FG000|Core Period (48 Weeks)|Lost to Follow-up|0
909785|NCT00789828|1886561|FG001|Core Period (48 Weeks)|Lost to Follow-up|1
909786|NCT00789828|1886560|FG000|Open-label Extension Period (4 Years)|Adverse Event|10
909787|NCT00789828|1886561|FG001|Open-label Extension Period (4 Years)|Adverse Event|0
909788|NCT00789828|1886560|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
909789|NCT00789828|1886561|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
909790|NCT00789828|1886560|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3
909791|NCT00789828|1886561|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0
909792|NCT00789828|1886560|FG000|Open-label Extension Period (4 Years)|Administrative problems|7
909793|NCT00789828|1886561|FG001|Open-label Extension Period (4 Years)|Administrative problems|0
909794|NCT00789828|1886560|FG000|Open-label Extension Period (4 Years)|Death|1
1090258|NCT02243202|2157664|FG003|Overall Study|Withdrawal by Subject|4
1090259|NCT02243202|2157661|FG000|Overall Study|Other|1
1090260|NCT02243202|2157662|FG001|Overall Study|Other|3
1090261|NCT02243202|2157663|FG002|Overall Study|Other|1
1090262|NCT02243202|2157664|FG003|Overall Study|Other|2
1090263|NCT02243202|2157661|FG000|Overall Study|Randomized but not received treatment|0
1090264|NCT02243202|2157662|FG001|Overall Study|Randomized but not received treatment|0
1090265|NCT02243202|2157663|FG002|Overall Study|Randomized but not received treatment|0
1090266|NCT02243202|2157664|FG003|Overall Study|Randomized but not received treatment|1
1090267|NCT02243280|2157685|FG000|Treated|Adverse Event|1
1090268|NCT02243280|2157686|FG001|Treated|Adverse Event|0
1090269|NCT02243280|2157687|FG002|Treated|Adverse Event|0
1090270|NCT02243280|2157688|FG003|Treated|Adverse Event|0
1090271|NCT02243280|2157689|FG004|Treated|Adverse Event|0
1090272|NCT02243280|2157690|FG005|Treated|Adverse Event|0
1090273|NCT02243280|2157691|FG006|Treated|Adverse Event|0
1090274|NCT02243280|2157692|FG007|Treated|Adverse Event|0
1090275|NCT02243280|2157693|FG008|Treated|Adverse Event|0
1090276|NCT02243280|2157694|FG009|Treated|Adverse Event|0
1090277|NCT02243280|2157695|FG010|Treated|Adverse Event|1
1090278|NCT02243280|2157685|FG000|Treated|Lost to Follow-up|0
1090279|NCT02243280|2157686|FG001|Treated|Lost to Follow-up|0
1090280|NCT02243280|2157687|FG002|Treated|Lost to Follow-up|0
1090281|NCT02243280|2157688|FG003|Treated|Lost to Follow-up|0
1090282|NCT02243280|2157689|FG004|Treated|Lost to Follow-up|0
1090283|NCT02243280|2157690|FG005|Treated|Lost to Follow-up|0
1090284|NCT02243280|2157691|FG006|Treated|Lost to Follow-up|0
1090285|NCT02243280|2157692|FG007|Treated|Lost to Follow-up|0
1090286|NCT02243280|2157693|FG008|Treated|Lost to Follow-up|1
1090287|NCT02243280|2157694|FG009|Treated|Lost to Follow-up|0
1090288|NCT02243280|2157695|FG010|Treated|Lost to Follow-up|2
943774|NCT01008696|1933453|FG001|Overall Study|Other|3
943775|NCT01008696|1933452|FG000|Overall Study|Other|0
943776|NCT01008696|1933453|FG001|Overall Study|Other|2
943777|NCT01008748|1933469|FG000|Overall Study|Lost to Follow-up|80
943778|NCT01008748|1933469|FG000|Overall Study|Other|1
943779|NCT01008904|1933473|FG000|Overall Study|Lost to Follow-up|1
943780|NCT01008904|1933473|FG000|Overall Study|Adverse Event|2
943781|NCT01008904|1933473|FG000|Overall Study|unexpected unrelated surgery|1
943782|NCT01008943|1933477|FG000|Overall Study|Withdrawal by Subject|1
943783|NCT01008995|1933487|FG000|Controlled Period|Adverse Event|1
943784|NCT01008995|1933488|FG001|Controlled Period|Adverse Event|2
943785|NCT01008995|1933489|FG002|Controlled Period|Adverse Event|0
943786|NCT01008995|1933490|FG003|Controlled Period|Adverse Event|0
943787|NCT01008995|1933487|FG000|Controlled Period|Other|2
943788|NCT01008995|1933488|FG001|Controlled Period|Other|1
943789|NCT01008995|1933489|FG002|Controlled Period|Other|0
943790|NCT01008995|1933490|FG003|Controlled Period|Other|0
943791|NCT01008995|1933487|FG000|After Controlled Period|Adverse Event|0
943792|NCT01008995|1933488|FG001|After Controlled Period|Adverse Event|0
943793|NCT01008995|1933489|FG002|After Controlled Period|Adverse Event|1
943794|NCT01008995|1933490|FG003|After Controlled Period|Adverse Event|1
943795|NCT01008995|1933487|FG000|After Controlled Period|Other|0
943796|NCT01008995|1933488|FG001|After Controlled Period|Other|0
943797|NCT01008995|1933489|FG002|After Controlled Period|Other|1
943798|NCT01008995|1933490|FG003|After Controlled Period|Other|0
943799|NCT01009034|1933498|FG000|Overall Study|Lost to Follow-up|2
943800|NCT01009034|1933498|FG000|Overall Study|Withdrawal by Subject|2
943801|NCT01009047|1933504|FG000|Overall Study|Adverse Event|5
943802|NCT01009047|1933505|FG001|Overall Study|Adverse Event|0
1090289|NCT02243293|2157730|FG000|Overall Study|Adverse Event|1
909795|NCT00789828|1886561|FG001|Open-label Extension Period (4 Years)|Death|0
909796|NCT00789828|1886560|FG000|Open-label Extension Period (4 Years)|Disease progression|1
909797|NCT00789828|1886561|FG001|Open-label Extension Period (4 Years)|Disease progression|0
909798|NCT00789828|1886560|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1
909799|NCT00789828|1886561|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0
909800|NCT00789854|1886573|FG000|Overall Study|Adverse Event|28
909801|NCT00789854|1886574|FG001|Overall Study|Adverse Event|23
909802|NCT00789854|1886575|FG002|Overall Study|Adverse Event|18
909803|NCT00789854|1886573|FG000|Overall Study|Lost to Follow-up|1
909804|NCT00789854|1886574|FG001|Overall Study|Lost to Follow-up|1
909805|NCT00789854|1886575|FG002|Overall Study|Lost to Follow-up|4
909806|NCT00789854|1886573|FG000|Overall Study|Withdrawal by Subject|9
909807|NCT00789854|1886574|FG001|Overall Study|Withdrawal by Subject|6
909808|NCT00789854|1886575|FG002|Overall Study|Withdrawal by Subject|17
909809|NCT00789854|1886573|FG000|Overall Study|Eligibility criteria not fulfilled|2
909810|NCT00789854|1886574|FG001|Overall Study|Eligibility criteria not fulfilled|5
909811|NCT00789854|1886575|FG002|Overall Study|Eligibility criteria not fulfilled|1
909812|NCT00789854|1886573|FG000|Overall Study|Severe non-compliance to the protocol|3
909813|NCT00789854|1886574|FG001|Overall Study|Severe non-compliance to the protocol|0
909814|NCT00789854|1886575|FG002|Overall Study|Severe non-compliance to the protocol|0
1090290|NCT02243293|2157731|FG001|Overall Study|Adverse Event|0
1090291|NCT02243293|2157732|FG002|Overall Study|Adverse Event|0
1090292|NCT02243293|2157733|FG003|Overall Study|Adverse Event|0
1090293|NCT02243293|2157734|FG004|Overall Study|Adverse Event|0
1090294|NCT02243293|2157735|FG005|Overall Study|Adverse Event|0
1090295|NCT02243293|2157736|FG006|Overall Study|Adverse Event|0
1090296|NCT02243293|2157737|FG007|Overall Study|Adverse Event|0
1090297|NCT02243293|2157738|FG008|Overall Study|Adverse Event|0
1090298|NCT02243293|2157739|FG009|Overall Study|Adverse Event|0
1090299|NCT02243293|2157740|FG010|Overall Study|Adverse Event|0
1090300|NCT02243293|2157741|FG011|Overall Study|Adverse Event|0
943803|NCT01009047|1933504|FG000|Overall Study|Lost to Follow-up|0
943804|NCT01009047|1933505|FG001|Overall Study|Lost to Follow-up|2
943805|NCT01009047|1933504|FG000|Overall Study|Lack of Efficacy|4
943806|NCT01009047|1933505|FG001|Overall Study|Lack of Efficacy|11
943807|NCT01009047|1933504|FG000|Overall Study|Withdrawal by consent|16
943808|NCT01009047|1933505|FG001|Overall Study|Withdrawal by consent|11
943809|NCT01009047|1933504|FG000|Overall Study|Other|3
943810|NCT01009047|1933505|FG001|Overall Study|Other|2
943811|NCT01009060|1933513|FG000|Overall Study|Adverse Event|1
943812|NCT01009060|1933514|FG001|Overall Study|Adverse Event|2
943813|NCT01009060|1933513|FG000|Overall Study|Protocol Violation|0
943814|NCT01009060|1933514|FG001|Overall Study|Protocol Violation|1
943815|NCT01009060|1933513|FG000|Overall Study|Lost to Follow-up|1
943816|NCT01009060|1933514|FG001|Overall Study|Lost to Follow-up|0
943817|NCT01009060|1933513|FG000|Overall Study|Physician Decision|1
943818|NCT01009060|1933514|FG001|Overall Study|Physician Decision|1
943819|NCT01009060|1933513|FG000|Overall Study|Withdrawal by Subject|1
943820|NCT01009060|1933514|FG001|Overall Study|Withdrawal by Subject|1
943821|NCT01009086|1933527|FG000|Overall Study|Lack of Efficacy|16
943822|NCT01009086|1933528|FG001|Overall Study|Lack of Efficacy|15
943823|NCT01009086|1933529|FG002|Overall Study|Lack of Efficacy|9
943824|NCT01009086|1933527|FG000|Overall Study|Lost to Follow-up|4
943825|NCT01009086|1933528|FG001|Overall Study|Lost to Follow-up|5
943826|NCT01009086|1933529|FG002|Overall Study|Lost to Follow-up|3
943827|NCT01009086|1933527|FG000|Overall Study|Adverse Event|12
943828|NCT01009086|1933528|FG001|Overall Study|Adverse Event|11
943829|NCT01009086|1933529|FG002|Overall Study|Adverse Event|8
943830|NCT01009086|1933527|FG000|Overall Study|Withdrawal by Subject|9
943831|NCT01009086|1933528|FG001|Overall Study|Withdrawal by Subject|11
943832|NCT01009086|1933529|FG002|Overall Study|Withdrawal by Subject|13
943833|NCT01009086|1933527|FG000|Overall Study|Other|3
943834|NCT01009086|1933528|FG001|Overall Study|Other|5
943835|NCT01009086|1933529|FG002|Overall Study|Other|1
943836|NCT01009099|1933544|FG000|Overall Study|Lost to Follow-up|1
943837|NCT01009099|1933545|FG001|Overall Study|Lost to Follow-up|0
943838|NCT01009099|1933544|FG000|Overall Study|Physician Decision|3
943839|NCT01009099|1933545|FG001|Overall Study|Physician Decision|2
943840|NCT01009099|1933544|FG000|Overall Study|Withdrawal by Subject|1
943841|NCT01009099|1933545|FG001|Overall Study|Withdrawal by Subject|1
943842|NCT01009099|1933544|FG000|Overall Study|Death|0
943843|NCT01009099|1933545|FG001|Overall Study|Death|1
943844|NCT01009203|1933560|FG000|Overall Study|Withdrawal by Subject|1
943845|NCT01009203|1933560|FG000|Overall Study|Adverse Event|5
943846|NCT01009203|1933560|FG000|Overall Study|Treatment-unrelated death|1
943847|NCT01009281|1933564|FG000|Overall Study|Administrative problems|7
943848|NCT01009346|1933585|FG000|Overall Study|Adverse Event|4
943849|NCT01009463|1933594|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
943850|NCT01009463|1933595|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
943851|NCT01009463|1933596|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
943852|NCT01009463|1933597|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
943853|NCT01009463|1933598|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
943854|NCT01009463|1933594|FG000|4-week, Open-label Run-In Period|Adverse Event|10
943855|NCT01009463|1933595|FG001|4-week, Open-label Run-In Period|Adverse Event|0
943856|NCT01009463|1933596|FG002|4-week, Open-label Run-In Period|Adverse Event|0
943857|NCT01009463|1933597|FG003|4-week, Open-label Run-In Period|Adverse Event|0
943858|NCT01009463|1933598|FG004|4-week, Open-label Run-In Period|Adverse Event|0
943859|NCT01009463|1933594|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
943860|NCT01009463|1933595|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
943861|NCT01009463|1933596|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
943862|NCT01009463|1933597|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
943863|NCT01009463|1933598|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
943864|NCT01009463|1933594|FG000|4-week, Open-label Run-In Period|Physician Decision|10
943865|NCT01009463|1933595|FG001|4-week, Open-label Run-In Period|Physician Decision|0
943866|NCT01009463|1933596|FG002|4-week, Open-label Run-In Period|Physician Decision|0
943867|NCT01009463|1933597|FG003|4-week, Open-label Run-In Period|Physician Decision|0
943868|NCT01009463|1933598|FG004|4-week, Open-label Run-In Period|Physician Decision|0
943869|NCT01009463|1933594|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50
943870|NCT01009463|1933595|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
943871|NCT01009463|1933596|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
909815|NCT00789854|1886573|FG000|Overall Study|Safety reasons|0
1090301|NCT02243293|2157742|FG012|Overall Study|Adverse Event|0
1090302|NCT02243293|2157743|FG013|Overall Study|Adverse Event|0
1090303|NCT02243293|2157744|FG014|Overall Study|Adverse Event|0
1090304|NCT02243293|2157745|FG015|Overall Study|Adverse Event|1
1090305|NCT02243293|2157746|FG016|Overall Study|Adverse Event|0
1090306|NCT02243293|2157747|FG017|Overall Study|Adverse Event|0
1090307|NCT02243293|2157748|FG018|Overall Study|Adverse Event|0
1090308|NCT02243293|2157749|FG019|Overall Study|Adverse Event|0
1090309|NCT02243293|2157750|FG020|Overall Study|Adverse Event|1
1090310|NCT02243293|2157751|FG021|Overall Study|Adverse Event|0
1090311|NCT02243293|2157730|FG000|Overall Study|Withdrawal by Subject|1
1090312|NCT02243293|2157731|FG001|Overall Study|Withdrawal by Subject|0
1090313|NCT02243293|2157732|FG002|Overall Study|Withdrawal by Subject|0
1090314|NCT02243293|2157733|FG003|Overall Study|Withdrawal by Subject|0
1090315|NCT02243293|2157734|FG004|Overall Study|Withdrawal by Subject|0
1090316|NCT02243293|2157735|FG005|Overall Study|Withdrawal by Subject|0
1090317|NCT02243293|2157736|FG006|Overall Study|Withdrawal by Subject|0
1090318|NCT02243293|2157737|FG007|Overall Study|Withdrawal by Subject|0
1090319|NCT02243293|2157738|FG008|Overall Study|Withdrawal by Subject|0
1090320|NCT02243293|2157739|FG009|Overall Study|Withdrawal by Subject|1
1090321|NCT02243293|2157740|FG010|Overall Study|Withdrawal by Subject|0
1090322|NCT02243293|2157741|FG011|Overall Study|Withdrawal by Subject|1
1090323|NCT02243293|2157742|FG012|Overall Study|Withdrawal by Subject|0
1090324|NCT02243293|2157743|FG013|Overall Study|Withdrawal by Subject|0
1090325|NCT02243293|2157744|FG014|Overall Study|Withdrawal by Subject|0
1090326|NCT02243293|2157745|FG015|Overall Study|Withdrawal by Subject|0
1090327|NCT02243293|2157746|FG016|Overall Study|Withdrawal by Subject|0
1090328|NCT02243293|2157747|FG017|Overall Study|Withdrawal by Subject|0
1090329|NCT02243293|2157748|FG018|Overall Study|Withdrawal by Subject|0
1090330|NCT02243293|2157749|FG019|Overall Study|Withdrawal by Subject|0
1090331|NCT02243293|2157750|FG020|Overall Study|Withdrawal by Subject|0
1090332|NCT02243293|2157751|FG021|Overall Study|Withdrawal by Subject|1
1090333|NCT02243293|2157730|FG000|Overall Study|Lost to Follow-up|0
1090334|NCT02243293|2157731|FG001|Overall Study|Lost to Follow-up|1
1090335|NCT02243293|2157732|FG002|Overall Study|Lost to Follow-up|1
1090336|NCT02243293|2157733|FG003|Overall Study|Lost to Follow-up|1
1090337|NCT02243293|2157734|FG004|Overall Study|Lost to Follow-up|0
1090338|NCT02243293|2157735|FG005|Overall Study|Lost to Follow-up|0
1090339|NCT02243293|2157736|FG006|Overall Study|Lost to Follow-up|3
1090340|NCT02243293|2157737|FG007|Overall Study|Lost to Follow-up|0
1090341|NCT02243293|2157738|FG008|Overall Study|Lost to Follow-up|0
1090342|NCT02243293|2157739|FG009|Overall Study|Lost to Follow-up|0
1090343|NCT02243293|2157740|FG010|Overall Study|Lost to Follow-up|0
1090344|NCT02243293|2157741|FG011|Overall Study|Lost to Follow-up|2
1090345|NCT02243293|2157742|FG012|Overall Study|Lost to Follow-up|0
1090346|NCT02243293|2157743|FG013|Overall Study|Lost to Follow-up|0
1090347|NCT02243293|2157744|FG014|Overall Study|Lost to Follow-up|0
1090348|NCT02243293|2157745|FG015|Overall Study|Lost to Follow-up|0
1090349|NCT02243293|2157746|FG016|Overall Study|Lost to Follow-up|3
1090350|NCT02243293|2157747|FG017|Overall Study|Lost to Follow-up|1
1090351|NCT02243293|2157748|FG018|Overall Study|Lost to Follow-up|0
1090352|NCT02243293|2157749|FG019|Overall Study|Lost to Follow-up|0
1090353|NCT02243293|2157750|FG020|Overall Study|Lost to Follow-up|1
1090354|NCT02243293|2157751|FG021|Overall Study|Lost to Follow-up|2
1090355|NCT02243293|2157730|FG000|Overall Study|Enrolled into a Re-treatment Study|0
1090356|NCT02243293|2157731|FG001|Overall Study|Enrolled into a Re-treatment Study|0
1090357|NCT02243293|2157732|FG002|Overall Study|Enrolled into a Re-treatment Study|0
1090358|NCT02243293|2157733|FG003|Overall Study|Enrolled into a Re-treatment Study|0
1090359|NCT02243293|2157734|FG004|Overall Study|Enrolled into a Re-treatment Study|0
1090360|NCT02243293|2157735|FG005|Overall Study|Enrolled into a Re-treatment Study|0
1090361|NCT02243293|2157736|FG006|Overall Study|Enrolled into a Re-treatment Study|0
1090362|NCT02243293|2157737|FG007|Overall Study|Enrolled into a Re-treatment Study|0
1090363|NCT02243293|2157738|FG008|Overall Study|Enrolled into a Re-treatment Study|0
1090364|NCT02243293|2157739|FG009|Overall Study|Enrolled into a Re-treatment Study|0
1090365|NCT02243293|2157740|FG010|Overall Study|Enrolled into a Re-treatment Study|0
1090366|NCT02243293|2157741|FG011|Overall Study|Enrolled into a Re-treatment Study|0
1090367|NCT02243293|2157742|FG012|Overall Study|Enrolled into a Re-treatment Study|0
1090368|NCT02243293|2157743|FG013|Overall Study|Enrolled into a Re-treatment Study|0
1090369|NCT02243293|2157744|FG014|Overall Study|Enrolled into a Re-treatment Study|1
1090370|NCT02243293|2157745|FG015|Overall Study|Enrolled into a Re-treatment Study|0
1090371|NCT02243293|2157746|FG016|Overall Study|Enrolled into a Re-treatment Study|0
1090372|NCT02243293|2157747|FG017|Overall Study|Enrolled into a Re-treatment Study|0
1090373|NCT02243293|2157748|FG018|Overall Study|Enrolled into a Re-treatment Study|0
1090374|NCT02243293|2157749|FG019|Overall Study|Enrolled into a Re-treatment Study|0
1090375|NCT02243293|2157750|FG020|Overall Study|Enrolled into a Re-treatment Study|0
1090376|NCT02243293|2157751|FG021|Overall Study|Enrolled into a Re-treatment Study|0
1090377|NCT02243293|2157730|FG000|Overall Study|Randomized but did'nt receive study drug|0
1090378|NCT02243293|2157731|FG001|Overall Study|Randomized but did'nt receive study drug|0
1090379|NCT02243293|2157732|FG002|Overall Study|Randomized but did'nt receive study drug|0
1090380|NCT02243293|2157733|FG003|Overall Study|Randomized but did'nt receive study drug|0
1090381|NCT02243293|2157734|FG004|Overall Study|Randomized but did'nt receive study drug|1
1090382|NCT02243293|2157735|FG005|Overall Study|Randomized but did'nt receive study drug|0
1090383|NCT02243293|2157736|FG006|Overall Study|Randomized but did'nt receive study drug|0
1090384|NCT02243293|2157737|FG007|Overall Study|Randomized but did'nt receive study drug|0
1090385|NCT02243293|2157738|FG008|Overall Study|Randomized but did'nt receive study drug|0
1090386|NCT02243293|2157739|FG009|Overall Study|Randomized but did'nt receive study drug|1
1090387|NCT02243293|2157740|FG010|Overall Study|Randomized but did'nt receive study drug|0
1090388|NCT02243293|2157741|FG011|Overall Study|Randomized but did'nt receive study drug|0
1090389|NCT02243293|2157742|FG012|Overall Study|Randomized but did'nt receive study drug|0
1090390|NCT02243293|2157743|FG013|Overall Study|Randomized but did'nt receive study drug|0
1090391|NCT02243293|2157744|FG014|Overall Study|Randomized but did'nt receive study drug|0
1090392|NCT02243293|2157745|FG015|Overall Study|Randomized but did'nt receive study drug|0
1090393|NCT02243293|2157746|FG016|Overall Study|Randomized but did'nt receive study drug|0
1090394|NCT02243293|2157747|FG017|Overall Study|Randomized but did'nt receive study drug|0
943872|NCT01009463|1933597|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
943873|NCT01009463|1933598|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
943874|NCT01009463|1933594|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
943875|NCT01009463|1933595|FG001|52-week, Double-blind Treatment Period|Adverse Event|22
943876|NCT01009463|1933596|FG002|52-week, Double-blind Treatment Period|Adverse Event|25
943877|NCT01009463|1933597|FG003|52-week, Double-blind Treatment Period|Adverse Event|29
943878|NCT01009463|1933598|FG004|52-week, Double-blind Treatment Period|Adverse Event|31
943879|NCT01009463|1933594|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
943880|NCT01009463|1933595|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
943881|NCT01009463|1933596|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
943882|NCT01009463|1933597|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
943883|NCT01009463|1933598|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
943884|NCT01009463|1933594|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
943885|NCT01009463|1933595|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24
943886|NCT01009463|1933596|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16
943887|NCT01009463|1933597|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11
943888|NCT01009463|1933598|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18
943889|NCT01009463|1933594|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
943890|NCT01009463|1933595|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8
943891|NCT01009463|1933596|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7
943892|NCT01009463|1933597|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8
943893|NCT01009463|1933598|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7
943894|NCT01009463|1933594|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
943895|NCT01009463|1933595|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
943896|NCT01009463|1933596|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
943897|NCT01009463|1933597|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
943898|NCT01009463|1933598|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
943899|NCT01009463|1933594|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
943900|NCT01009463|1933595|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
943901|NCT01009463|1933596|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
943902|NCT01009463|1933597|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
943903|NCT01009463|1933598|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
943904|NCT01009463|1933594|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
943905|NCT01009463|1933595|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11
943906|NCT01009463|1933596|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7
943907|NCT01009463|1933597|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
943908|NCT01009463|1933598|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5
943909|NCT01009463|1933594|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
943910|NCT01009463|1933595|FG001|52-week, Double-blind Treatment Period|Physician Decision|4
943911|NCT01009463|1933596|FG002|52-week, Double-blind Treatment Period|Physician Decision|6
943912|NCT01009463|1933597|FG003|52-week, Double-blind Treatment Period|Physician Decision|6
943913|NCT01009463|1933598|FG004|52-week, Double-blind Treatment Period|Physician Decision|8
943914|NCT01009515|1933609|FG000|Overall Study|Withdrawal by Subject|3
943915|NCT01009554|1933615|FG000|Overall Study|Adverse Event|1
943916|NCT01009554|1933616|FG001|Overall Study|Adverse Event|1
943917|NCT01009554|1933615|FG000|Overall Study|Withdrawal by Subject|1
943918|NCT01009554|1933616|FG001|Overall Study|Withdrawal by Subject|3
943919|NCT01009554|1933615|FG000|Overall Study|Noncompliant with Study Product|0
943920|NCT01009554|1933616|FG001|Overall Study|Noncompliant with Study Product|3
909816|NCT00789854|1886574|FG001|Overall Study|Safety reasons|0
909817|NCT00789854|1886575|FG002|Overall Study|Safety reasons|2
909818|NCT00789854|1886573|FG000|Overall Study|Other|6
909819|NCT00789854|1886574|FG001|Overall Study|Other|0
909820|NCT00789854|1886575|FG002|Overall Study|Other|5
909821|NCT00789880|1886603|FG000|Overall Study|Adverse Event|0
909822|NCT00789880|1886604|FG001|Overall Study|Adverse Event|0
909823|NCT00789880|1886605|FG002|Overall Study|Adverse Event|0
909824|NCT00789880|1886606|FG003|Overall Study|Adverse Event|0
1090395|NCT02243293|2157748|FG018|Overall Study|Randomized but did'nt receive study drug|0
1090396|NCT02243293|2157749|FG019|Overall Study|Randomized but did'nt receive study drug|1
943921|NCT01009580|1933624|FG000|Overall Study|Adverse Event|4
943922|NCT01009580|1933625|FG001|Overall Study|Adverse Event|4
943923|NCT01009580|1933624|FG000|Overall Study|Lack of Efficacy|0
943924|NCT01009580|1933625|FG001|Overall Study|Lack of Efficacy|1
943925|NCT01009580|1933624|FG000|Overall Study|Protocol Violation|2
943926|NCT01009580|1933625|FG001|Overall Study|Protocol Violation|3
943927|NCT01009580|1933624|FG000|Overall Study|Withdrawal Criteria|4
943928|NCT01009580|1933625|FG001|Overall Study|Withdrawal Criteria|6
943929|NCT01009580|1933624|FG000|Overall Study|Unclassified|17
943930|NCT01009580|1933625|FG001|Overall Study|Unclassified|21
943931|NCT01009645|1933644|FG000|Overall Study|Lost to Follow-up|2
943932|NCT01009645|1933645|FG001|Overall Study|Lost to Follow-up|8
943933|NCT01009645|1933646|FG002|Overall Study|Lost to Follow-up|4
943934|NCT01009645|1933647|FG003|Overall Study|Lost to Follow-up|5
943935|NCT01009814|1933673|FG000|Overall Study|No longer met study criteria|1
943936|NCT01009814|1933674|FG001|Overall Study|No longer met study criteria|1
943937|NCT01009814|1933675|FG002|Overall Study|No longer met study criteria|0
943938|NCT01009814|1933676|FG003|Overall Study|No longer met study criteria|0
943939|NCT01009814|1933677|FG004|Overall Study|No longer met study criteria|0
943940|NCT01009840|1933693|FG000|Overall Study|Lost to Follow-up|1
943941|NCT01009840|1933693|FG000|Overall Study|Adverse Event|4
943942|NCT01009840|1933693|FG000|Overall Study|Subject Met Withdrawal Criteria|7
943943|NCT01009840|1933693|FG000|Overall Study|Subject was Withdrawn by Investigator|1
943944|NCT01009840|1933693|FG000|Overall Study|Subject Withdrew Consent to Participate|1
943945|NCT01009983|1933710|FG000|Overall Study|necessary scans not completed|1
943946|NCT01010061|1933729|FG000|Overall Study|Adverse Events or Intercurrent Illness|33
943947|NCT01010061|1933730|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
943948|NCT01010061|1933729|FG000|Overall Study|Disease Progression|2
943949|NCT01010061|1933730|FG001|Overall Study|Disease Progression|8
943950|NCT01010061|1933729|FG000|Overall Study|Withdrew Consent|5
943951|NCT01010061|1933730|FG001|Overall Study|Withdrew Consent|1
943952|NCT01010061|1933729|FG000|Overall Study|Death|3
943953|NCT01010061|1933730|FG001|Overall Study|Death|6
943954|NCT01010061|1933729|FG000|Overall Study|Administrative/Other|0
943955|NCT01010061|1933730|FG001|Overall Study|Administrative/Other|1
943956|NCT01010061|1933729|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2
943957|NCT01010061|1933730|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
943958|NCT01010061|1933729|FG000|Overall Study|Insufficient Therapeutic Response|1
943959|NCT01010061|1933730|FG001|Overall Study|Insufficient Therapeutic Response|5
943960|NCT01010061|1933729|FG000|Overall Study|Violation of Selection Criteria|0
943961|NCT01010061|1933730|FG001|Overall Study|Violation of Selection Criteria|1
943962|NCT01010061|1933729|FG000|Overall Study|Did Not Receive Treatment|2
943963|NCT01010061|1933730|FG001|Overall Study|Did Not Receive Treatment|2
943964|NCT01010126|1933744|FG000|Overall Study|Withdrawal by Subject|1
943965|NCT01010126|1933745|FG001|Overall Study|Withdrawal by Subject|0
943966|NCT01010126|1933746|FG002|Overall Study|Withdrawal by Subject|1
943967|NCT01010126|1933747|FG003|Overall Study|Withdrawal by Subject|0
943968|NCT01010126|1933748|FG004|Overall Study|Withdrawal by Subject|3
943969|NCT01010126|1933749|FG005|Overall Study|Withdrawal by Subject|0
943970|NCT01010204|1933765|FG000|Overall Study|Lost to Follow-up|2
943971|NCT01010204|1933766|FG001|Overall Study|Lost to Follow-up|2
943972|NCT01010204|1933765|FG000|Overall Study|Adverse Event|1
943973|NCT01010204|1933766|FG001|Overall Study|Adverse Event|3
943974|NCT01010204|1933765|FG000|Overall Study|Withdrawal by Subject|2
943975|NCT01010204|1933766|FG001|Overall Study|Withdrawal by Subject|3
943976|NCT01010204|1933765|FG000|Overall Study|psychiatric hospitalization|2
943977|NCT01010204|1933766|FG001|Overall Study|psychiatric hospitalization|1
943978|NCT01010217|1933777|FG000|Overall Study|Lost to Follow-up|4
943979|NCT01010217|1933778|FG001|Overall Study|Lost to Follow-up|5
943980|NCT01010217|1933779|FG002|Overall Study|Lost to Follow-up|1
943981|NCT01010217|1933780|FG003|Overall Study|Lost to Follow-up|0
943982|NCT01010217|1933781|FG004|Overall Study|Lost to Follow-up|0
943983|NCT01010217|1933777|FG000|Overall Study|Withdrawal by Subject|1
943984|NCT01010217|1933778|FG001|Overall Study|Withdrawal by Subject|0
943985|NCT01010217|1933779|FG002|Overall Study|Withdrawal by Subject|0
943986|NCT01010217|1933780|FG003|Overall Study|Withdrawal by Subject|0
943987|NCT01010217|1933781|FG004|Overall Study|Withdrawal by Subject|0
943988|NCT01010217|1933777|FG000|Overall Study|Physician Decision|0
943989|NCT01010217|1933778|FG001|Overall Study|Physician Decision|0
943990|NCT01010217|1933779|FG002|Overall Study|Physician Decision|0
943991|NCT01010217|1933780|FG003|Overall Study|Physician Decision|6
909825|NCT00789880|1886607|FG004|Overall Study|Adverse Event|1
909826|NCT00789880|1886608|FG005|Overall Study|Adverse Event|0
909827|NCT00789880|1886603|FG000|Overall Study|Protocol Violation|0
909828|NCT00789880|1886604|FG001|Overall Study|Protocol Violation|1
909829|NCT00789880|1886605|FG002|Overall Study|Protocol Violation|0
909830|NCT00789880|1886606|FG003|Overall Study|Protocol Violation|1
909831|NCT00789880|1886607|FG004|Overall Study|Protocol Violation|0
909832|NCT00789880|1886608|FG005|Overall Study|Protocol Violation|0
909833|NCT00789880|1886603|FG000|Overall Study|Withdrawal by Subject|1
909834|NCT00789880|1886604|FG001|Overall Study|Withdrawal by Subject|0
943992|NCT01010217|1933781|FG004|Overall Study|Physician Decision|3
943993|NCT01010230|1933795|FG000|Overall Study|Withdrawal by Subject|6
943994|NCT01010230|1933796|FG001|Overall Study|Withdrawal by Subject|5
943995|NCT01010230|1933795|FG000|Overall Study|Lost to Follow-up|4
943996|NCT01010230|1933796|FG001|Overall Study|Lost to Follow-up|2
943997|NCT01010503|1933828|FG000|Overall Study|Adverse Event|1
943998|NCT01010503|1933828|FG000|Overall Study|Death|1
943999|NCT01010633|1933850|FG000|Overall Study|Adverse Event|1
944000|NCT01010633|1933851|FG001|Overall Study|Adverse Event|1
944001|NCT01010633|1933850|FG000|Overall Study|Protocol Violation|1
944002|NCT01010633|1933851|FG001|Overall Study|Protocol Violation|2
944003|NCT01010633|1933850|FG000|Overall Study|Withdrawal by Subject|2
944004|NCT01010633|1933851|FG001|Overall Study|Withdrawal by Subject|1
944005|NCT01010633|1933850|FG000|Overall Study|Investigator decision|0
944006|NCT01010633|1933851|FG001|Overall Study|Investigator decision|1
944007|NCT01010750|1933863|FG000|Second Intervention|Adverse Event|0
944008|NCT01010750|1933864|FG001|Second Intervention|Adverse Event|1
944009|NCT01010750|1933865|FG002|Second Intervention|Adverse Event|0
944010|NCT01010750|1933866|FG003|Second Intervention|Adverse Event|0
944011|NCT01010750|1933867|FG004|Second Intervention|Adverse Event|0
944012|NCT01010750|1933868|FG005|Second Intervention|Adverse Event|0
944013|NCT01010776|1933885|FG000|Main Phase|Withdrawal by Subject|14
944014|NCT01010776|1933885|FG000|Main Phase|Lack of Efficacy|8
944015|NCT01010776|1933885|FG000|Main Phase|Adverse Event|7
944016|NCT01010776|1933885|FG000|Main Phase|Lost to Follow-up|6
944017|NCT01010776|1933885|FG000|Main Phase|Non-compliance to study medication|5
944018|NCT01010776|1933885|FG000|Main Phase|Selection failure|2
944019|NCT01010776|1933885|FG000|Main Phase|Inform consent withdrawal|1
944020|NCT01010776|1933885|FG000|Main Phase|Other|1
944021|NCT01010776|1933885|FG000|Main Phase|Did not received study medication|5
944022|NCT01010776|1933885|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15
944023|NCT01010776|1933885|FG000|Extension Phase|Other|3
944024|NCT01010867|1933904|FG000|Overall Study|< 50% adherence to probiotic|1
944025|NCT01010971|1933944|FG000|Overall Study|Adverse Event|2
944026|NCT01010971|1933945|FG001|Overall Study|Adverse Event|4
944027|NCT01010971|1933946|FG002|Overall Study|Adverse Event|3
944028|NCT01010971|1933944|FG000|Overall Study|Withdrawal by Subject|0
944029|NCT01010971|1933945|FG001|Overall Study|Withdrawal by Subject|2
944030|NCT01010971|1933946|FG002|Overall Study|Withdrawal by Subject|5
944031|NCT01010971|1933944|FG000|Overall Study|Lost to Follow-up|0
944032|NCT01010971|1933945|FG001|Overall Study|Lost to Follow-up|2
944033|NCT01010971|1933946|FG002|Overall Study|Lost to Follow-up|3
944034|NCT01010971|1933944|FG000|Overall Study|Other|1
944035|NCT01010971|1933945|FG001|Overall Study|Other|0
944036|NCT01010971|1933946|FG002|Overall Study|Other|2
944037|NCT01011049|1933963|FG000|Overall Study|Protocol Violation|0
944038|NCT01011049|1933964|FG001|Overall Study|Protocol Violation|0
944039|NCT01011049|1933965|FG002|Overall Study|Protocol Violation|2
944040|NCT01011049|1933966|FG003|Overall Study|Protocol Violation|0
944041|NCT01011049|1933963|FG000|Overall Study|Lost to Follow-up|1
944042|NCT01011049|1933964|FG001|Overall Study|Lost to Follow-up|2
944043|NCT01011049|1933965|FG002|Overall Study|Lost to Follow-up|1
944044|NCT01011049|1933966|FG003|Overall Study|Lost to Follow-up|0
944045|NCT01011049|1933963|FG000|Overall Study|Withdrawal by Subject|0
944046|NCT01011049|1933964|FG001|Overall Study|Withdrawal by Subject|0
944047|NCT01011049|1933965|FG002|Overall Study|Withdrawal by Subject|1
909835|NCT00789880|1886605|FG002|Overall Study|Withdrawal by Subject|0
909836|NCT00789880|1886606|FG003|Overall Study|Withdrawal by Subject|0
909837|NCT00789880|1886607|FG004|Overall Study|Withdrawal by Subject|2
909838|NCT00789880|1886608|FG005|Overall Study|Withdrawal by Subject|0
909839|NCT00789958|1886622|FG000|Overall Study|Adverse Event|3
909840|NCT00789958|1886622|FG000|Overall Study|Withdrawal by Subject|4
909841|NCT00789958|1886622|FG000|Overall Study|Progression|3
909842|NCT00789958|1886622|FG000|Overall Study|not protocol specified|1
909843|NCT00789958|1886622|FG000|Overall Study|Not eligible/not analyzable|26
909844|NCT00790023|1886640|FG000|Overall Study|Adverse Event|2
909845|NCT00790023|1886641|FG001|Overall Study|Adverse Event|1
909846|NCT00790023|1886642|FG002|Overall Study|Adverse Event|4
909847|NCT00790023|1886640|FG000|Overall Study|Protocol Violation|2
909848|NCT00790023|1886641|FG001|Overall Study|Protocol Violation|4
909849|NCT00790023|1886642|FG002|Overall Study|Protocol Violation|2
909850|NCT00790023|1886640|FG000|Overall Study|Withdrawal by Subject|2
909851|NCT00790023|1886641|FG001|Overall Study|Withdrawal by Subject|0
909852|NCT00790023|1886642|FG002|Overall Study|Withdrawal by Subject|6
909853|NCT00790023|1886640|FG000|Overall Study|Lost to Follow-up|0
909854|NCT00790023|1886641|FG001|Overall Study|Lost to Follow-up|0
909855|NCT00790023|1886642|FG002|Overall Study|Lost to Follow-up|1
909856|NCT00790023|1886640|FG000|Overall Study|Other|5
909857|NCT00790023|1886641|FG001|Overall Study|Other|5
909858|NCT00790023|1886642|FG002|Overall Study|Other|8
909859|NCT00790036|1886653|FG000|Overall Study|Abnormal lab values|3
909860|NCT00790036|1886654|FG001|Overall Study|Abnormal lab values|2
909861|NCT00790036|1886653|FG000|Overall Study|Administrative problems|5
909862|NCT00790036|1886654|FG001|Overall Study|Administrative problems|9
944048|NCT01011049|1933966|FG003|Overall Study|Withdrawal by Subject|0
944049|NCT01011153|1933983|FG000|Overall Study|Less than 78 cases completed|8
1090397|NCT02243293|2157750|FG020|Overall Study|Randomized but did'nt receive study drug|0
1090398|NCT02243293|2157751|FG021|Overall Study|Randomized but did'nt receive study drug|0
1090399|NCT02243371|2157800|FG000|Overall Study|Progressive Disease (clinic & radio)|35
1090400|NCT02243371|2157801|FG001|Overall Study|Progressive Disease (clinic & radio)|24
1090401|NCT02243371|2157800|FG000|Overall Study|Death (unrelated)|2
1090402|NCT02243371|2157801|FG001|Overall Study|Death (unrelated)|4
1090403|NCT02243371|2157800|FG000|Overall Study|Adverse Event (unrelated)|0
1090404|NCT02243371|2157801|FG001|Overall Study|Adverse Event (unrelated)|1
1090405|NCT02243371|2157800|FG000|Overall Study|Lack of Clinical Benefit|0
1090406|NCT02243371|2157801|FG001|Overall Study|Lack of Clinical Benefit|1
1090407|NCT02243371|2157800|FG000|Overall Study|Withdrawal by Subject|0
1090408|NCT02243371|2157801|FG001|Overall Study|Withdrawal by Subject|2
1090409|NCT02243605|2157822|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1
1090410|NCT02243605|2157823|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1
1090411|NCT02243605|2157822|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1
1090412|NCT02243605|2157823|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0
1090413|NCT02243605|2157822|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5
1090414|NCT02243605|2157823|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1
944050|NCT01011153|1933984|FG001|Overall Study|Less than 78 cases completed|11
944051|NCT01011153|1933985|FG002|Overall Study|Less than 78 cases completed|9
944052|NCT01011283|1934031|FG000|Overall Study|Adverse Event|4
944053|NCT01011283|1934032|FG001|Overall Study|Adverse Event|2
944054|NCT01011283|1934031|FG000|Overall Study|Progressive Disease|0
944055|NCT01011283|1934032|FG001|Overall Study|Progressive Disease|2
944056|NCT01011283|1934031|FG000|Overall Study|Terminated by Sponsor|5
944057|NCT01011283|1934032|FG001|Overall Study|Terminated by Sponsor|5
944058|NCT01011283|1934031|FG000|Overall Study|Other|2
944059|NCT01011283|1934032|FG001|Overall Study|Other|2
944060|NCT01011309|1934041|FG000|Overall Study|Adverse Event|2
944061|NCT01011309|1934042|FG001|Overall Study|Adverse Event|1
944062|NCT01011309|1934043|FG002|Overall Study|Adverse Event|2
944063|NCT01011309|1934041|FG000|Overall Study|Lack of Efficacy|0
944064|NCT01011309|1934042|FG001|Overall Study|Lack of Efficacy|1
944065|NCT01011309|1934043|FG002|Overall Study|Lack of Efficacy|0
944066|NCT01011309|1934041|FG000|Overall Study|Protocol Violation|0
944067|NCT01011309|1934042|FG001|Overall Study|Protocol Violation|1
944068|NCT01011309|1934043|FG002|Overall Study|Protocol Violation|3
944069|NCT01011335|1934055|FG000|Overall Study|Lost to Follow-up|0
944070|NCT01011335|1934056|FG001|Overall Study|Lost to Follow-up|0
944071|NCT01011335|1934057|FG002|Overall Study|Lost to Follow-up|1
944072|NCT01011335|1934058|FG003|Overall Study|Lost to Follow-up|1
944073|NCT01011335|1934059|FG004|Overall Study|Lost to Follow-up|1
944074|NCT01011335|1934060|FG005|Overall Study|Lost to Follow-up|1
944075|NCT01011335|1934061|FG006|Overall Study|Lost to Follow-up|2
944076|NCT01011335|1934062|FG007|Overall Study|Lost to Follow-up|2
944077|NCT01011335|1934063|FG008|Overall Study|Lost to Follow-up|1
944078|NCT01011335|1934064|FG009|Overall Study|Lost to Follow-up|0
944079|NCT01011335|1934065|FG010|Overall Study|Lost to Follow-up|0
944080|NCT01011335|1934066|FG011|Overall Study|Lost to Follow-up|1
944081|NCT01011335|1934067|FG012|Overall Study|Lost to Follow-up|2
944082|NCT01011335|1934055|FG000|Overall Study|Protocol Violation|0
944083|NCT01011335|1934056|FG001|Overall Study|Protocol Violation|1
944084|NCT01011335|1934057|FG002|Overall Study|Protocol Violation|0
944085|NCT01011335|1934058|FG003|Overall Study|Protocol Violation|0
944086|NCT01011335|1934059|FG004|Overall Study|Protocol Violation|0
944087|NCT01011335|1934060|FG005|Overall Study|Protocol Violation|0
944088|NCT01011335|1934061|FG006|Overall Study|Protocol Violation|0
944089|NCT01011335|1934062|FG007|Overall Study|Protocol Violation|0
944090|NCT01011335|1934063|FG008|Overall Study|Protocol Violation|0
944091|NCT01011335|1934064|FG009|Overall Study|Protocol Violation|0
944092|NCT01011335|1934065|FG010|Overall Study|Protocol Violation|0
944093|NCT01011335|1934066|FG011|Overall Study|Protocol Violation|0
944094|NCT01011335|1934067|FG012|Overall Study|Protocol Violation|0
944095|NCT01011335|1934055|FG000|Overall Study|Moved/deployed or no booster|1
944096|NCT01011335|1934056|FG001|Overall Study|Moved/deployed or no booster|0
944097|NCT01011335|1934057|FG002|Overall Study|Moved/deployed or no booster|0
944098|NCT01011335|1934058|FG003|Overall Study|Moved/deployed or no booster|1
944099|NCT01011335|1934059|FG004|Overall Study|Moved/deployed or no booster|0
944100|NCT01011335|1934060|FG005|Overall Study|Moved/deployed or no booster|0
944101|NCT01011335|1934061|FG006|Overall Study|Moved/deployed or no booster|1
944102|NCT01011335|1934062|FG007|Overall Study|Moved/deployed or no booster|0
944103|NCT01011335|1934063|FG008|Overall Study|Moved/deployed or no booster|1
944104|NCT01011335|1934064|FG009|Overall Study|Moved/deployed or no booster|0
944105|NCT01011335|1934065|FG010|Overall Study|Moved/deployed or no booster|2
944106|NCT01011335|1934066|FG011|Overall Study|Moved/deployed or no booster|0
944107|NCT01011335|1934067|FG012|Overall Study|Moved/deployed or no booster|0
944108|NCT01011335|1934055|FG000|Overall Study|Adverse Event|0
944109|NCT01011335|1934056|FG001|Overall Study|Adverse Event|0
944110|NCT01011335|1934057|FG002|Overall Study|Adverse Event|0
944111|NCT01011335|1934058|FG003|Overall Study|Adverse Event|0
944112|NCT01011335|1934059|FG004|Overall Study|Adverse Event|0
944113|NCT01011335|1934060|FG005|Overall Study|Adverse Event|0
1090415|NCT02243605|2157822|FG000|Stage 2 - Final Analysis Population|Adverse Event|1
1090416|NCT02243605|2157823|FG001|Stage 2 - Final Analysis Population|Adverse Event|1
1090417|NCT02243605|2157822|FG000|Stage 2 - Final Analysis Population|Progression|0
1090418|NCT02243605|2157823|FG001|Stage 2 - Final Analysis Population|Progression|1
1090419|NCT02243696|2157829|FG000|Overall Study|Death|282
1090420|NCT02243696|2157829|FG000|Overall Study|Withdrawal by Subject|79
1090421|NCT02243696|2157829|FG000|Overall Study|Lost to Follow-up|57
1090422|NCT02243696|2157829|FG000|Overall Study|Subject No Longer has Study System|42
1090423|NCT02243696|2157829|FG000|Overall Study|Subject Withdrawn by Investigator|273
1090424|NCT02243696|2157829|FG000|Overall Study|Study Terminated for EP PASSION|961
1090425|NCT02243865|2157835|FG000|Overall Study|Protocol Violation|1
1090426|NCT02243865|2157836|FG001|Overall Study|Protocol Violation|3
1090427|NCT02243865|2157835|FG000|Overall Study|Lost to Follow-up|1
1090428|NCT02243865|2157836|FG001|Overall Study|Lost to Follow-up|1
1090429|NCT02243865|2157835|FG000|Overall Study|Withdrawal by Subject|1
1090430|NCT02243865|2157836|FG001|Overall Study|Withdrawal by Subject|0
1090431|NCT02243865|2157835|FG000|Overall Study|Adverse Event|1
1090432|NCT02243865|2157836|FG001|Overall Study|Adverse Event|1
1090433|NCT02244424|2157855|FG000|Overall Study|Lost to Follow-up|20
1090434|NCT02244424|2157856|FG001|Overall Study|Lost to Follow-up|10
1090435|NCT02244580|2157862|FG000|Overall Study|No cancer tissues available|241
1090436|NCT02244619|2157872|FG000|Overall Study|Did not receive study intervention|8
1090437|NCT02244619|2157873|FG001|Overall Study|Did not receive study intervention|21
1090438|NCT02244957|2157895|FG000|Overall Study|Lack of Efficacy|1
1090439|NCT02244957|2157896|FG001|Overall Study|Lack of Efficacy|0
1090440|NCT02244996|2157906|FG000|Overall Study|Lack of Efficacy|2
1090441|NCT02244996|2157907|FG001|Overall Study|Lack of Efficacy|6
1090442|NCT02245412|2157938|FG000|Treatment Period|Death|1
1090443|NCT02245412|2157939|FG001|Treatment Period|Death|1
1090444|NCT02245412|2157940|FG002|Treatment Period|Death|0
1090445|NCT02245412|2157938|FG000|Treatment Period|Physician Decision|1
1090446|NCT02245412|2157939|FG001|Treatment Period|Physician Decision|1
1090447|NCT02245412|2157940|FG002|Treatment Period|Physician Decision|0
1090448|NCT02245412|2157938|FG000|Treatment Period|Withdrawal by Subject|2
1090449|NCT02245412|2157939|FG001|Treatment Period|Withdrawal by Subject|1
1090450|NCT02245412|2157940|FG002|Treatment Period|Withdrawal by Subject|0
1090451|NCT02245412|2157938|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1
1090452|NCT02245412|2157939|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0
1090453|NCT02245412|2157940|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0
1090454|NCT02245412|2157938|FG000|Follow-Up Period|Death|4
1090455|NCT02245412|2157939|FG001|Follow-Up Period|Death|2
1090456|NCT02245412|2157940|FG002|Follow-Up Period|Death|1
1090457|NCT02245412|2157938|FG000|Follow-Up Period|Physician Decision|1
1090458|NCT02245412|2157939|FG001|Follow-Up Period|Physician Decision|0
1090459|NCT02245412|2157940|FG002|Follow-Up Period|Physician Decision|0
1090460|NCT02245412|2157938|FG000|Follow-Up Period|Other - Terminated by Sponsor|0
1090461|NCT02245412|2157939|FG001|Follow-Up Period|Other - Terminated by Sponsor|0
1090462|NCT02245412|2157940|FG002|Follow-Up Period|Other - Terminated by Sponsor|1
1090463|NCT02245568|2157957|FG000|Overall Study|Study terminated by Sponsor|346
1090464|NCT02245568|2157957|FG000|Overall Study|Adverse Event|144
1090465|NCT02245568|2157957|FG000|Overall Study|Lack of Efficacy|98
1090466|NCT02245568|2157957|FG000|Overall Study|Withdrawal by Caregiver|85
1090467|NCT02245568|2157957|FG000|Overall Study|Withdrawal by Subject|77
1090468|NCT02245568|2157957|FG000|Overall Study|Withdrawal by Legal Representative|31
1090469|NCT02245568|2157957|FG000|Overall Study|Missing (Site closure)|16
1090470|NCT02245568|2157957|FG000|Overall Study|Physician Decision|14
1090471|NCT02245568|2157957|FG000|Overall Study|Non-compliance with study drug|11
1090472|NCT02245568|2157957|FG000|Overall Study|Death|9
1090473|NCT02245568|2157957|FG000|Overall Study|Blue staining|6
1090474|NCT02245568|2157957|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6
1090475|NCT02245568|2157957|FG000|Overall Study|Intolerance/dosing issues/interruption|5
1090476|NCT02245568|2157957|FG000|Overall Study|Lost to Follow-up|5
1090477|NCT02245620|2157963|FG000|Overall Study|Physician Decision|1
1090478|NCT02245620|2157964|FG001|Overall Study|Physician Decision|1
1090479|NCT02245672|2157973|FG000|Overall Study|Adverse Event|4
1090480|NCT02245672|2157974|FG001|Overall Study|Adverse Event|4
1090481|NCT02245672|2157975|FG002|Overall Study|Adverse Event|4
1090482|NCT02245672|2157973|FG000|Overall Study|Lost to Follow-up|3
1090483|NCT02245672|2157974|FG001|Overall Study|Lost to Follow-up|5
1090484|NCT02245672|2157975|FG002|Overall Study|Lost to Follow-up|1
1090485|NCT02245672|2157973|FG000|Overall Study|Withdrawal by Subject|6
1090486|NCT02245672|2157974|FG001|Overall Study|Withdrawal by Subject|3
1090487|NCT02245672|2157975|FG002|Overall Study|Withdrawal by Subject|0
1090488|NCT02245672|2157973|FG000|Overall Study|Randomized in error (not treated)|0
1090489|NCT02245672|2157974|FG001|Overall Study|Randomized in error (not treated)|1
1090490|NCT02245672|2157975|FG002|Overall Study|Randomized in error (not treated)|0
1090491|NCT02245737|2157986|FG000|Overall Study|Adverse Event|23
1090492|NCT02245737|2157987|FG001|Overall Study|Adverse Event|26
1090493|NCT02245737|2157988|FG002|Overall Study|Adverse Event|33
1090494|NCT02245737|2157986|FG000|Overall Study|Condition Worsened|9
1090495|NCT02245737|2157987|FG001|Overall Study|Condition Worsened|10
1090496|NCT02245737|2157988|FG002|Overall Study|Condition Worsened|9
1090497|NCT02245737|2157986|FG000|Overall Study|Death|2
1090498|NCT02245737|2157987|FG001|Overall Study|Death|4
1090499|NCT02245737|2157988|FG002|Overall Study|Death|4
1090500|NCT02245737|2157986|FG000|Overall Study|Eligibility Criteria No Longer Met|2
1090501|NCT02245737|2157987|FG001|Overall Study|Eligibility Criteria No Longer Met|4
1090502|NCT02245737|2157988|FG002|Overall Study|Eligibility Criteria No Longer Met|4
1090503|NCT02245737|2157986|FG000|Overall Study|Initiation of Symptomatic AD medication|2
1090504|NCT02245737|2157987|FG001|Overall Study|Initiation of Symptomatic AD medication|0
1090505|NCT02245737|2157988|FG002|Overall Study|Initiation of Symptomatic AD medication|0
1090506|NCT02245737|2157986|FG000|Overall Study|Lost to Follow-up|2
1090507|NCT02245737|2157987|FG001|Overall Study|Lost to Follow-up|5
1090508|NCT02245737|2157988|FG002|Overall Study|Lost to Follow-up|4
1090509|NCT02245737|2157986|FG000|Overall Study|Other-determined by Investigator|9
1090510|NCT02245737|2157987|FG001|Overall Study|Other-determined by Investigator|10
1090511|NCT02245737|2157988|FG002|Overall Study|Other-determined by Investigator|10
1090512|NCT02245737|2157986|FG000|Overall Study|Physician Decision|6
1090513|NCT02245737|2157987|FG001|Overall Study|Physician Decision|3
1090514|NCT02245737|2157988|FG002|Overall Study|Physician Decision|6
1090515|NCT02245737|2157986|FG000|Overall Study|Protocol Violation|3
1090516|NCT02245737|2157987|FG001|Overall Study|Protocol Violation|2
1090517|NCT02245737|2157988|FG002|Overall Study|Protocol Violation|3
1090518|NCT02245737|2157986|FG000|Overall Study|Withdrawal by Subject|40
1090519|NCT02245737|2157987|FG001|Overall Study|Withdrawal by Subject|41
1090520|NCT02245737|2157988|FG002|Overall Study|Withdrawal by Subject|44
1090521|NCT02245737|2157986|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10
1090522|NCT02245737|2157987|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20
1090523|NCT02245737|2157988|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22
1090524|NCT02245737|2157986|FG000|Overall Study|Sponsor Decision|445
1090525|NCT02245737|2157987|FG001|Overall Study|Sponsor Decision|430
1090526|NCT02245737|2157988|FG002|Overall Study|Sponsor Decision|432
1090527|NCT02246166|2158037|FG000|Overall Study|Protocol Violation|1
1090528|NCT02246166|2158038|FG001|Overall Study|Protocol Violation|0
1090529|NCT02246218|2158046|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1090530|NCT02246218|2158047|FG001|Overall Study|Withdrawal by Parent/Guardian|1
1090531|NCT02246218|2158046|FG000|Overall Study|Stopping Rule: Liver Transplant|2
1090532|NCT02246218|2158047|FG001|Overall Study|Stopping Rule: Liver Transplant|4
1090533|NCT02246218|2158046|FG000|Overall Study|Adverse Event|1
1090534|NCT02246218|2158047|FG001|Overall Study|Adverse Event|1
1090535|NCT02246218|2158046|FG000|Overall Study|Lost to Follow-up|1
1090536|NCT02246218|2158047|FG001|Overall Study|Lost to Follow-up|0
1090537|NCT02246439|2158073|FG000|Overall Study|Adverse Event|3
1090538|NCT02246439|2158074|FG001|Overall Study|Adverse Event|0
1090539|NCT02246439|2158073|FG000|Overall Study|Lost to Follow-up|7
1090540|NCT02246439|2158074|FG001|Overall Study|Lost to Follow-up|5
1090541|NCT02246439|2158073|FG000|Overall Study|Protocol Violation|0
1090542|NCT02246439|2158074|FG001|Overall Study|Protocol Violation|2
1090543|NCT02246439|2158073|FG000|Overall Study|Physician Decision|0
1090544|NCT02246439|2158074|FG001|Overall Study|Physician Decision|1
1090545|NCT02246439|2158073|FG000|Overall Study|Unkonwn|1
1090546|NCT02246439|2158074|FG001|Overall Study|Unkonwn|3
1090547|NCT02246439|2158073|FG000|Overall Study|Withdrawal by Subject|1
1090548|NCT02246439|2158074|FG001|Overall Study|Withdrawal by Subject|0
1090549|NCT02246478|2158084|FG000|Multiple-dose Phase|Protocol Violation|1
1090550|NCT02246478|2158085|FG001|Multiple-dose Phase|Protocol Violation|0
1090551|NCT02246478|2158086|FG002|Multiple-dose Phase|Protocol Violation|0
1090552|NCT02246478|2158087|FG003|Multiple-dose Phase|Protocol Violation|1
1090553|NCT02246582|2158104|FG000|Overall Study|Withdrawal by Subject|3
1090554|NCT02246582|2158105|FG001|Overall Study|Withdrawal by Subject|4
1090555|NCT02246647|2158129|FG000|Overall Study|Withdrawal by Subject|1
1090556|NCT02246647|2158130|FG001|Overall Study|Withdrawal by Subject|1
1090557|NCT02246660|2158153|FG000|Overall Study|Withdrawal by Subject|0
1090558|NCT02246660|2158154|FG001|Overall Study|Withdrawal by Subject|1
1090559|NCT02246660|2158155|FG002|Overall Study|Withdrawal by Subject|0
1090560|NCT02246660|2158153|FG000|Overall Study|Death|0
1090561|NCT02246660|2158154|FG001|Overall Study|Death|0
1090562|NCT02246660|2158155|FG002|Overall Study|Death|1
1090563|NCT02246673|2158168|FG000|Overall Study|Sponsor Decision|1
1090564|NCT02246673|2158169|FG001|Overall Study|Sponsor Decision|0
1090565|NCT02246673|2158170|FG002|Overall Study|Sponsor Decision|0
1090566|NCT02246673|2158171|FG003|Overall Study|Sponsor Decision|0
1090567|NCT02246673|2158172|FG004|Overall Study|Sponsor Decision|0
1090568|NCT02246673|2158168|FG000|Overall Study|Withdrawal by Subject|0
1090569|NCT02246673|2158169|FG001|Overall Study|Withdrawal by Subject|0
1090570|NCT02246673|2158170|FG002|Overall Study|Withdrawal by Subject|0
1090571|NCT02246673|2158171|FG003|Overall Study|Withdrawal by Subject|0
1090572|NCT02246673|2158172|FG004|Overall Study|Withdrawal by Subject|1
1090573|NCT02246673|2158168|FG000|Overall Study|Lost to Follow-up|0
1090574|NCT02246673|2158169|FG001|Overall Study|Lost to Follow-up|0
1090575|NCT02246673|2158170|FG002|Overall Study|Lost to Follow-up|0
1090576|NCT02246673|2158171|FG003|Overall Study|Lost to Follow-up|1
1090577|NCT02246673|2158172|FG004|Overall Study|Lost to Follow-up|0
1090578|NCT02246673|2158168|FG000|Overall Study|Protocol Violation|0
1090579|NCT02246673|2158169|FG001|Overall Study|Protocol Violation|0
1090580|NCT02246673|2158170|FG002|Overall Study|Protocol Violation|0
1090581|NCT02246673|2158171|FG003|Overall Study|Protocol Violation|1
1090582|NCT02246673|2158172|FG004|Overall Study|Protocol Violation|0
1090583|NCT02246764|2158217|FG000|Overall Study|Adverse Event|15
1090584|NCT02246764|2158218|FG001|Overall Study|Adverse Event|29
1090585|NCT02246764|2158219|FG002|Overall Study|Adverse Event|1
1090586|NCT02246764|2158217|FG000|Overall Study|Withdrawal by Subject|0
1090587|NCT02246764|2158218|FG001|Overall Study|Withdrawal by Subject|0
1090588|NCT02246764|2158219|FG002|Overall Study|Withdrawal by Subject|1
1090589|NCT02246764|2158217|FG000|Overall Study|Disallowed Concomitant Medication|1
1090590|NCT02246764|2158218|FG001|Overall Study|Disallowed Concomitant Medication|0
1090591|NCT02246764|2158219|FG002|Overall Study|Disallowed Concomitant Medication|0
1090592|NCT02246764|2158217|FG000|Overall Study|Physician Decision|0
1090593|NCT02246764|2158218|FG001|Overall Study|Physician Decision|2
1090594|NCT02246764|2158219|FG002|Overall Study|Physician Decision|1
1090595|NCT02246764|2158217|FG000|Overall Study|Protocol Violation|2
1090596|NCT02246764|2158218|FG001|Overall Study|Protocol Violation|1
1090597|NCT02246764|2158219|FG002|Overall Study|Protocol Violation|1
1090598|NCT02246777|2158227|FG000|Overall Study|Adverse Event|2
1090599|NCT02246777|2158227|FG000|Overall Study|Change of residence|1
1090600|NCT02246998|2158240|FG000|Overall Study|Adverse Event|0
1090601|NCT02246998|2158241|FG001|Overall Study|Adverse Event|1
1090602|NCT02246998|2158242|FG002|Overall Study|Adverse Event|1
1090603|NCT02246998|2158243|FG003|Overall Study|Adverse Event|0
1090604|NCT02246998|2158240|FG000|Overall Study|Lost to Follow-up|1
1090605|NCT02246998|2158241|FG001|Overall Study|Lost to Follow-up|0
1090606|NCT02246998|2158242|FG002|Overall Study|Lost to Follow-up|0
1090607|NCT02246998|2158243|FG003|Overall Study|Lost to Follow-up|1
1090608|NCT02246998|2158240|FG000|Overall Study|Randomized but Never Dosed|1
1090609|NCT02246998|2158241|FG001|Overall Study|Randomized but Never Dosed|2
1090610|NCT02246998|2158242|FG002|Overall Study|Randomized but Never Dosed|2
1090611|NCT02246998|2158243|FG003|Overall Study|Randomized but Never Dosed|1
1090612|NCT02247011|2158258|FG000|Overall Study|Poor quality of radiological results|125
1090613|NCT02247401|2158312|FG000|Overall Study|Adverse Event|1
1090614|NCT02247401|2158313|FG001|Overall Study|Adverse Event|0
1090615|NCT02247401|2158314|FG002|Overall Study|Adverse Event|0
1090616|NCT02247401|2158312|FG000|Overall Study|Withdrawal by Subject|4
1090617|NCT02247401|2158313|FG001|Overall Study|Withdrawal by Subject|1
1090618|NCT02247401|2158314|FG002|Overall Study|Withdrawal by Subject|1
1090619|NCT02247401|2158312|FG000|Overall Study|Lost to Follow-up|1
1090620|NCT02247401|2158313|FG001|Overall Study|Lost to Follow-up|1
1090621|NCT02247401|2158314|FG002|Overall Study|Lost to Follow-up|1
1090622|NCT02247440|2158323|FG000|Overall Study|Withdrawal by Subject|1
1090623|NCT02247440|2158323|FG000|Overall Study|Lack of Efficacy|3
1090624|NCT02247466|2158329|FG000|Overall Study|Procedure changed to open surgery|0
1090625|NCT02247466|2158330|FG001|Overall Study|Procedure changed to open surgery|3
1090626|NCT02247479|2158339|FG000|Overall Study|Adverse Event|8
1090627|NCT02247479|2158340|FG001|Overall Study|Adverse Event|9
1090628|NCT02247479|2158341|FG002|Overall Study|Adverse Event|8
1090629|NCT02247479|2158339|FG000|Overall Study|Death|5
1090630|NCT02247479|2158340|FG001|Overall Study|Death|4
1090631|NCT02247479|2158341|FG002|Overall Study|Death|6
1090632|NCT02247479|2158339|FG000|Overall Study|Lost to Follow-up|3
1090633|NCT02247479|2158340|FG001|Overall Study|Lost to Follow-up|3
1090634|NCT02247479|2158341|FG002|Overall Study|Lost to Follow-up|1
1090635|NCT02247479|2158339|FG000|Overall Study|Non-compliance|0
1090636|NCT02247479|2158340|FG001|Overall Study|Non-compliance|0
1090637|NCT02247479|2158341|FG002|Overall Study|Non-compliance|1
1090638|NCT02247479|2158339|FG000|Overall Study|Withdrawal by Subject|25
1090639|NCT02247479|2158340|FG001|Overall Study|Withdrawal by Subject|29
1090640|NCT02247479|2158341|FG002|Overall Study|Withdrawal by Subject|24
1090641|NCT02247479|2158339|FG000|Overall Study|Study Terminated by Sponsor|98
1090642|NCT02247479|2158340|FG001|Overall Study|Study Terminated by Sponsor|88
1090643|NCT02247479|2158341|FG002|Overall Study|Study Terminated by Sponsor|94
1090644|NCT02247479|2158339|FG000|Overall Study|Physician Decision|1
1090645|NCT02247479|2158340|FG001|Overall Study|Physician Decision|0
1090646|NCT02247479|2158341|FG002|Overall Study|Physician Decision|2
1090647|NCT02247479|2158339|FG000|Overall Study|Unspecified Reason|2
1090648|NCT02247479|2158340|FG001|Overall Study|Unspecified Reason|5
1090649|NCT02247479|2158341|FG002|Overall Study|Unspecified Reason|2
1090650|NCT02247531|2158352|FG000|Overall Study|Adverse Event|3
1090651|NCT02247531|2158353|FG001|Overall Study|Adverse Event|4
1090652|NCT02247531|2158354|FG002|Overall Study|Adverse Event|9
1090653|NCT02247531|2158352|FG000|Overall Study|Death|8
1090654|NCT02247531|2158353|FG001|Overall Study|Death|9
1090655|NCT02247531|2158354|FG002|Overall Study|Death|5
1090656|NCT02247531|2158352|FG000|Overall Study|Lost to Follow-up|1
1090657|NCT02247531|2158353|FG001|Overall Study|Lost to Follow-up|8
1090658|NCT02247531|2158354|FG002|Overall Study|Lost to Follow-up|3
1090659|NCT02247531|2158352|FG000|Overall Study|Non-compliance|2
1090660|NCT02247531|2158353|FG001|Overall Study|Non-compliance|2
1090661|NCT02247531|2158354|FG002|Overall Study|Non-compliance|0
1090662|NCT02247531|2158352|FG000|Overall Study|Withdrawal by Subject|26
1090663|NCT02247531|2158353|FG001|Overall Study|Withdrawal by Subject|31
1090664|NCT02247531|2158354|FG002|Overall Study|Withdrawal by Subject|25
1090665|NCT02247531|2158352|FG000|Overall Study|Study Terminated by Sponsor|64
1090666|NCT02247531|2158353|FG001|Overall Study|Study Terminated by Sponsor|66
1090667|NCT02247531|2158354|FG002|Overall Study|Study Terminated by Sponsor|62
1090668|NCT02247531|2158352|FG000|Overall Study|Physician Decision|0
1090669|NCT02247531|2158353|FG001|Overall Study|Physician Decision|2
1090670|NCT02247531|2158354|FG002|Overall Study|Physician Decision|2
1090671|NCT02247531|2158352|FG000|Overall Study|Unspecified Reason|2
1090672|NCT02247531|2158353|FG001|Overall Study|Unspecified Reason|3
1090673|NCT02247531|2158354|FG002|Overall Study|Unspecified Reason|4
1090674|NCT02247804|2158384|FG000|Treatment Period 1|Adverse Event|9
1090675|NCT02247804|2158385|FG001|Treatment Period 1|Adverse Event|2
1090676|NCT02247804|2158386|FG002|Treatment Period 1|Adverse Event|0
1090677|NCT02247804|2158384|FG000|Treatment Period 1|Lack of Efficacy|0
1090678|NCT02247804|2158385|FG001|Treatment Period 1|Lack of Efficacy|0
1090679|NCT02247804|2158386|FG002|Treatment Period 1|Lack of Efficacy|2
1090680|NCT02247804|2158384|FG000|Treatment Period 1|Lost to Follow-up|1
1090681|NCT02247804|2158385|FG001|Treatment Period 1|Lost to Follow-up|0
1090682|NCT02247804|2158386|FG002|Treatment Period 1|Lost to Follow-up|2
1090683|NCT02247804|2158384|FG000|Treatment Period 1|Personal Reasons|7
1090684|NCT02247804|2158385|FG001|Treatment Period 1|Personal Reasons|1
1090685|NCT02247804|2158386|FG002|Treatment Period 1|Personal Reasons|2
1090686|NCT02247804|2158384|FG000|Treatment Period 1|Protocol Deviation|0
1090687|NCT02247804|2158385|FG001|Treatment Period 1|Protocol Deviation|0
1090688|NCT02247804|2158386|FG002|Treatment Period 1|Protocol Deviation|1
1090689|NCT02247804|2158384|FG000|Treatment Period 1|Randomized but not Treated|5
1090690|NCT02247804|2158385|FG001|Treatment Period 1|Randomized but not Treated|1
1090691|NCT02247804|2158386|FG002|Treatment Period 1|Randomized but not Treated|1
1090692|NCT02247804|2158384|FG000|Treatment Period 2|Adverse Event|6
1090693|NCT02247804|2158385|FG001|Treatment Period 2|Adverse Event|3
1090694|NCT02247804|2158386|FG002|Treatment Period 2|Adverse Event|3
1090695|NCT02247804|2158384|FG000|Treatment Period 2|Lack of Efficacy|0
1090696|NCT02247804|2158385|FG001|Treatment Period 2|Lack of Efficacy|0
1090697|NCT02247804|2158386|FG002|Treatment Period 2|Lack of Efficacy|1
1090698|NCT02247804|2158384|FG000|Treatment Period 2|Lost to Follow-up|0
1090699|NCT02247804|2158385|FG001|Treatment Period 2|Lost to Follow-up|1
1090700|NCT02247804|2158386|FG002|Treatment Period 2|Lost to Follow-up|1
1090701|NCT02247804|2158384|FG000|Treatment Period 2|Personal Reasons|2
1090702|NCT02247804|2158385|FG001|Treatment Period 2|Personal Reasons|1
1090703|NCT02247804|2158386|FG002|Treatment Period 2|Personal Reasons|1
1090704|NCT02247804|2158384|FG000|Treatment Period 2|Reason not Specified|0
1090705|NCT02247804|2158385|FG001|Treatment Period 2|Reason not Specified|0
1090706|NCT02247804|2158386|FG002|Treatment Period 2|Reason not Specified|2
1090707|NCT02247804|2158384|FG000|Treatment Period 3|Adverse Event|4
1090708|NCT02247804|2158385|FG001|Treatment Period 3|Adverse Event|3
1090709|NCT02247804|2158386|FG002|Treatment Period 3|Adverse Event|3
1090710|NCT02247804|2158384|FG000|Treatment Period 3|Lack of Efficacy|0
1090711|NCT02247804|2158385|FG001|Treatment Period 3|Lack of Efficacy|1
1090712|NCT02247804|2158386|FG002|Treatment Period 3|Lack of Efficacy|0
1090713|NCT02247804|2158384|FG000|Treatment Period 3|Lost to Follow-up|1
1090714|NCT02247804|2158385|FG001|Treatment Period 3|Lost to Follow-up|2
1090715|NCT02247804|2158386|FG002|Treatment Period 3|Lost to Follow-up|2
1090716|NCT02247804|2158384|FG000|Treatment Period 3|Personal Reasons|4
1090717|NCT02247804|2158385|FG001|Treatment Period 3|Personal Reasons|3
1090718|NCT02247804|2158386|FG002|Treatment Period 3|Personal Reasons|2
1090719|NCT02247804|2158384|FG000|Treatment Period 3|Reason not Specified|2
1090720|NCT02247804|2158385|FG001|Treatment Period 3|Reason not Specified|1
1090721|NCT02247804|2158386|FG002|Treatment Period 3|Reason not Specified|3
1090722|NCT02247960|2158396|FG000|Patient Consent and Randomization|Physician Decision|2
1090723|NCT02247960|2158397|FG001|Patient Consent and Randomization|Physician Decision|2
1090724|NCT02247960|2158396|FG000|Patient Consent and Randomization|Withdrawal by Subject|0
1090725|NCT02247960|2158397|FG001|Patient Consent and Randomization|Withdrawal by Subject|4
1090726|NCT02247960|2158396|FG000|Catheter Removed|Lost to Follow-up|7
1090727|NCT02247960|2158397|FG001|Catheter Removed|Lost to Follow-up|10
1090728|NCT02248480|2158427|FG000|Overall Study|Lack of Efficacy|4
1090729|NCT02248480|2158428|FG001|Overall Study|Lack of Efficacy|6
1090730|NCT02248480|2158427|FG000|Overall Study|Adverse Event|11
1090731|NCT02248480|2158428|FG001|Overall Study|Adverse Event|2
1090732|NCT02248480|2158427|FG000|Overall Study|Withdrawal by Subject|2
1090733|NCT02248480|2158428|FG001|Overall Study|Withdrawal by Subject|4
1090734|NCT02248480|2158427|FG000|Overall Study|Entry Criteria Not Met|0
1090735|NCT02248480|2158428|FG001|Overall Study|Entry Criteria Not Met|1
1090736|NCT02248480|2158427|FG000|Overall Study|Other:Physician Decision|0
1090737|NCT02248480|2158428|FG001|Overall Study|Other:Physician Decision|1
1090738|NCT02248649|2158457|FG000|Overall Study|Death|7
1090739|NCT02248649|2158458|FG001|Overall Study|Death|11
1090740|NCT02248649|2158457|FG000|Overall Study|Lost to Follow-up|14
1090741|NCT02248649|2158458|FG001|Overall Study|Lost to Follow-up|10
1090742|NCT02248675|2158479|FG000|Overall Study|Lost to Follow-up|3
1090743|NCT02248675|2158480|FG001|Overall Study|Lost to Follow-up|1
1090744|NCT02248818|2158518|FG000|Screening|Protocol Violation|0
1090745|NCT02248818|2158519|FG001|Screening|Protocol Violation|0
1090746|NCT02248818|2158520|FG002|Screening|Protocol Violation|0
1090747|NCT02248818|2158521|FG003|Screening|Protocol Violation|0
1090748|NCT02248818|2158522|FG004|Screening|Protocol Violation|0
1090749|NCT02248818|2158523|FG005|Screening|Protocol Violation|0
1090750|NCT02248818|2158524|FG006|Screening|Protocol Violation|0
1090751|NCT02248818|2158525|FG007|Screening|Protocol Violation|0
1090752|NCT02248818|2158526|FG008|Screening|Protocol Violation|7
1090753|NCT02248818|2158518|FG000|Screening|Study fully enrolled|0
1090754|NCT02248818|2158519|FG001|Screening|Study fully enrolled|0
1090755|NCT02248818|2158520|FG002|Screening|Study fully enrolled|0
1090756|NCT02248818|2158521|FG003|Screening|Study fully enrolled|0
1090757|NCT02248818|2158522|FG004|Screening|Study fully enrolled|0
1090758|NCT02248818|2158523|FG005|Screening|Study fully enrolled|0
1090759|NCT02248818|2158524|FG006|Screening|Study fully enrolled|0
1090760|NCT02248818|2158525|FG007|Screening|Study fully enrolled|0
1090761|NCT02248818|2158526|FG008|Screening|Study fully enrolled|14
1090762|NCT02248818|2158518|FG000|Screening|Physician Decision|0
1090763|NCT02248818|2158519|FG001|Screening|Physician Decision|0
944114|NCT01011335|1934061|FG006|Overall Study|Adverse Event|0
944115|NCT01011335|1934062|FG007|Overall Study|Adverse Event|0
944116|NCT01011335|1934063|FG008|Overall Study|Adverse Event|0
944117|NCT01011335|1934064|FG009|Overall Study|Adverse Event|0
944118|NCT01011335|1934065|FG010|Overall Study|Adverse Event|4
944119|NCT01011335|1934066|FG011|Overall Study|Adverse Event|0
944120|NCT01011335|1934067|FG012|Overall Study|Adverse Event|1
944121|NCT01011387|1934104|FG000|Overall Study|Withdrawal by Subject|3
944122|NCT01011387|1934104|FG000|Overall Study|Adverse Event|2
944123|NCT01011387|1934104|FG000|Overall Study|Protocol Violation|1
944124|NCT01011439|1934124|FG000|Overall Study|Death|37
944125|NCT01011439|1934124|FG000|Overall Study|Lost to Follow-up|4
944126|NCT01011439|1934124|FG000|Overall Study|Withdrawal by Subject|1
944127|NCT01011439|1934124|FG000|Overall Study|Sponsor's decision|15
944128|NCT01011465|1934137|FG000|Overall Study|Withdrawal by Subject|2
944129|NCT01011465|1934138|FG001|Overall Study|Withdrawal by Subject|1
944130|NCT01011465|1934139|FG002|Overall Study|Withdrawal by Subject|0
944131|NCT01011465|1934140|FG003|Overall Study|Withdrawal by Subject|0
944132|NCT01011465|1934141|FG004|Overall Study|Withdrawal by Subject|1
944133|NCT01011465|1934142|FG005|Overall Study|Withdrawal by Subject|0
944134|NCT01011465|1934143|FG006|Overall Study|Withdrawal by Subject|1
944135|NCT01011465|1934144|FG007|Overall Study|Withdrawal by Subject|0
944136|NCT01011556|1934164|FG000|Overall Study|Adverse Event|1
944137|NCT01011556|1934165|FG001|Overall Study|Adverse Event|3
944138|NCT01011556|1934166|FG002|Overall Study|Adverse Event|2
944139|NCT01011556|1934167|FG003|Overall Study|Adverse Event|1
944140|NCT01011556|1934164|FG000|Overall Study|Lost to Follow-up|1
944141|NCT01011556|1934165|FG001|Overall Study|Lost to Follow-up|0
944142|NCT01011556|1934166|FG002|Overall Study|Lost to Follow-up|0
944143|NCT01011556|1934167|FG003|Overall Study|Lost to Follow-up|0
944144|NCT01011556|1934164|FG000|Overall Study|Physician Decision|1
944145|NCT01011556|1934165|FG001|Overall Study|Physician Decision|0
944146|NCT01011556|1934166|FG002|Overall Study|Physician Decision|0
944147|NCT01011556|1934167|FG003|Overall Study|Physician Decision|1
944148|NCT01011556|1934164|FG000|Overall Study|Protocol Violation|0
944149|NCT01011556|1934165|FG001|Overall Study|Protocol Violation|1
944150|NCT01011556|1934166|FG002|Overall Study|Protocol Violation|0
944151|NCT01011556|1934167|FG003|Overall Study|Protocol Violation|0
944152|NCT01011556|1934164|FG000|Overall Study|Withdrawal by Subject|1
944153|NCT01011556|1934165|FG001|Overall Study|Withdrawal by Subject|2
944154|NCT01011556|1934166|FG002|Overall Study|Withdrawal by Subject|4
944155|NCT01011556|1934167|FG003|Overall Study|Withdrawal by Subject|4
944156|NCT01011556|1934164|FG000|Overall Study|Sponsor decision|0
944157|NCT01011556|1934165|FG001|Overall Study|Sponsor decision|1
944158|NCT01011556|1934166|FG002|Overall Study|Sponsor decision|1
944159|NCT01011556|1934167|FG003|Overall Study|Sponsor decision|2
944160|NCT01011556|1934164|FG000|Overall Study|Inclusion/exclusion criteria not met|2
944161|NCT01011556|1934165|FG001|Overall Study|Inclusion/exclusion criteria not met|1
944162|NCT01011556|1934166|FG002|Overall Study|Inclusion/exclusion criteria not met|3
944163|NCT01011556|1934167|FG003|Overall Study|Inclusion/exclusion criteria not met|5
944164|NCT01011673|1934182|FG000|Randomized|Secondary headache|2
944165|NCT01011673|1934183|FG001|Randomized|Secondary headache|1
944166|NCT01011673|1934182|FG000|24 Hour Follow-up|Lost to Follow-up|3
944167|NCT01011673|1934183|FG001|24 Hour Follow-up|Lost to Follow-up|3
944168|NCT01011738|1934192|FG000|Overall Study|Death|12
944169|NCT01011738|1934193|FG001|Overall Study|Death|3
944170|NCT01011738|1934194|FG002|Overall Study|Death|0
944171|NCT01011738|1934192|FG000|Overall Study|Unknown reasons|312
944172|NCT01011738|1934193|FG001|Overall Study|Unknown reasons|291
944173|NCT01011738|1934194|FG002|Overall Study|Unknown reasons|17
944174|NCT01011868|1934226|FG000|After Week 18 Follow-up|Adverse Event|8
944175|NCT01011868|1934227|FG001|After Week 18 Follow-up|Adverse Event|6
944176|NCT01011868|1934228|FG002|After Week 18 Follow-up|Adverse Event|13
944177|NCT01011868|1934226|FG000|After Week 18 Follow-up|Lack of Efficacy|1
944178|NCT01011868|1934227|FG001|After Week 18 Follow-up|Lack of Efficacy|0
944179|NCT01011868|1934228|FG002|After Week 18 Follow-up|Lack of Efficacy|0
944180|NCT01011868|1934226|FG000|After Week 18 Follow-up|Protocol Violation|1
944181|NCT01011868|1934227|FG001|After Week 18 Follow-up|Protocol Violation|1
944182|NCT01011868|1934228|FG002|After Week 18 Follow-up|Protocol Violation|1
944183|NCT01011868|1934226|FG000|After Week 18 Follow-up|Lost to Follow-up|5
944184|NCT01011868|1934227|FG001|After Week 18 Follow-up|Lost to Follow-up|3
1090764|NCT02248818|2158520|FG002|Screening|Physician Decision|0
944185|NCT01011868|1934228|FG002|After Week 18 Follow-up|Lost to Follow-up|0
944186|NCT01011868|1934226|FG000|After Week 18 Follow-up|Withdrawal by Subject|6
944187|NCT01011868|1934227|FG001|After Week 18 Follow-up|Withdrawal by Subject|3
944188|NCT01011868|1934228|FG002|After Week 18 Follow-up|Withdrawal by Subject|0
944189|NCT01011868|1934226|FG000|After Week 18 Follow-up|Other reason not defined above|2
944190|NCT01011868|1934227|FG001|After Week 18 Follow-up|Other reason not defined above|3
944191|NCT01011868|1934228|FG002|After Week 18 Follow-up|Other reason not defined above|12
944192|NCT01011868|1934226|FG000|After Week 78 Follow-up|Adverse Event|14
944193|NCT01011868|1934227|FG001|After Week 78 Follow-up|Adverse Event|18
944194|NCT01011868|1934228|FG002|After Week 78 Follow-up|Adverse Event|21
944195|NCT01011868|1934226|FG000|After Week 78 Follow-up|Lack of Efficacy|4
944196|NCT01011868|1934227|FG001|After Week 78 Follow-up|Lack of Efficacy|0
944197|NCT01011868|1934228|FG002|After Week 78 Follow-up|Lack of Efficacy|0
944198|NCT01011868|1934226|FG000|After Week 78 Follow-up|Protocol Violation|9
944199|NCT01011868|1934227|FG001|After Week 78 Follow-up|Protocol Violation|1
944200|NCT01011868|1934228|FG002|After Week 78 Follow-up|Protocol Violation|2
944201|NCT01011868|1934226|FG000|After Week 78 Follow-up|Lost to Follow-up|11
944202|NCT01011868|1934227|FG001|After Week 78 Follow-up|Lost to Follow-up|6
944203|NCT01011868|1934228|FG002|After Week 78 Follow-up|Lost to Follow-up|4
944204|NCT01011868|1934226|FG000|After Week 78 Follow-up|Withdrawal by Subject|9
944205|NCT01011868|1934227|FG001|After Week 78 Follow-up|Withdrawal by Subject|8
944206|NCT01011868|1934228|FG002|After Week 78 Follow-up|Withdrawal by Subject|1
944207|NCT01011868|1934226|FG000|After Week 78 Follow-up|Other reason not defined above|5
944208|NCT01011868|1934227|FG001|After Week 78 Follow-up|Other reason not defined above|5
944209|NCT01011868|1934228|FG002|After Week 78 Follow-up|Other reason not defined above|16
944210|NCT01011907|1934242|FG000|Overall Study|Withdrawal by Subject|13
944211|NCT01011907|1934243|FG001|Overall Study|Withdrawal by Subject|11
909863|NCT00790036|1886653|FG000|Overall Study|Adverse Event|113
909864|NCT00790036|1886654|FG001|Overall Study|Adverse Event|44
909865|NCT00790036|1886653|FG000|Overall Study|Death|1
909866|NCT00790036|1886654|FG001|Overall Study|Death|0
909867|NCT00790036|1886653|FG000|Overall Study|Disease progression|24
909868|NCT00790036|1886654|FG001|Overall Study|Disease progression|48
909869|NCT00790036|1886653|FG000|Overall Study|Lost to Follow-up|1
909870|NCT00790036|1886654|FG001|Overall Study|Lost to Follow-up|2
909871|NCT00790036|1886653|FG000|Overall Study|Protocol Violation|10
909872|NCT00790036|1886654|FG001|Overall Study|Protocol Violation|2
909873|NCT00790036|1886653|FG000|Overall Study|Withdrawal by Subject|18
909874|NCT00790036|1886654|FG001|Overall Study|Withdrawal by Subject|7
909875|NCT00790036|1886653|FG000|Overall Study|Subject/guardian decision|20
909876|NCT00790036|1886654|FG001|Overall Study|Subject/guardian decision|7
909877|NCT00790088|1886683|FG000|Overall Study|Protocol Violation|11
909878|NCT00790088|1886683|FG000|Overall Study|Withdrawal by Subject|17
909879|NCT00790088|1886683|FG000|Overall Study|Lost to Follow-up|7
909880|NCT00790088|1886683|FG000|Overall Study|Physician Decision|4
909881|NCT00790205|1886708|FG000|Overall Study|Lost to Follow-up|61
909882|NCT00790205|1886709|FG001|Overall Study|Lost to Follow-up|71
909883|NCT00790205|1886708|FG000|Overall Study|Withdrawal by Subject|299
909884|NCT00790205|1886709|FG001|Overall Study|Withdrawal by Subject|363
909885|NCT00790218|1886715|FG000|Overall Study|Death|1
909886|NCT00790218|1886716|FG001|Overall Study|Death|0
909887|NCT00790218|1886717|FG002|Overall Study|Death|0
909888|NCT00790296|1886740|FG000|Overall Study|Did not meet study eligibility criteria|1
909889|NCT00790296|1886741|FG001|Overall Study|Did not meet study eligibility criteria|1
909890|NCT00790296|1886740|FG000|Overall Study|Adverse Event|0
909891|NCT00790296|1886741|FG001|Overall Study|Adverse Event|1
909892|NCT00790400|1886758|FG000|Double-blind Period (Core Phase)|Protocol Violation|1
909893|NCT00790400|1886759|FG001|Double-blind Period (Core Phase)|Protocol Violation|0
909894|NCT00790400|1886758|FG000|Double-blind Period (Core Phase)|Progressive disease|0
909895|NCT00790400|1886759|FG001|Double-blind Period (Core Phase)|Progressive disease|9
909896|NCT00790400|1886758|FG000|Double-blind Period (Core Phase)|Adverse Event|2
909897|NCT00790400|1886759|FG001|Double-blind Period (Core Phase)|Adverse Event|4
909898|NCT00790400|1886758|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
909899|NCT00790400|1886759|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
909900|NCT00790400|1886758|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1
909901|NCT00790400|1886759|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0
909902|NCT00790400|1886758|FG000|Double-blind Period (Core Phase)|Administrative problems|1
909903|NCT00790400|1886759|FG001|Double-blind Period (Core Phase)|Administrative problems|0
909904|NCT00790400|1886758|FG000|Double-blind Period (Core Phase)|Death|1
909905|NCT00790400|1886759|FG001|Double-blind Period (Core Phase)|Death|0
909906|NCT00790400|1886758|FG000|Everolimus Period (Core or Extension)|Adverse Event|9
909907|NCT00790400|1886759|FG001|Everolimus Period (Core or Extension)|Adverse Event|0
909908|NCT00790400|1886758|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
909909|NCT00790400|1886759|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
909910|NCT00790400|1886758|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
909911|NCT00790400|1886759|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
909912|NCT00790400|1886758|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1
909913|NCT00790400|1886759|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0
944212|NCT01011907|1934242|FG000|Overall Study|Adverse Event|1
944213|NCT01011907|1934243|FG001|Overall Study|Adverse Event|4
944214|NCT01011933|1934249|FG000|Overall Study|Wrong cell type|1
944215|NCT01011933|1934249|FG000|Overall Study|Improper pre-protocol Rx|1
944216|NCT01011933|1934249|FG000|Overall Study|Inadequate pathology|1
944217|NCT01011933|1934249|FG000|Overall Study|Never treated|1
944218|NCT01011946|1934259|FG000|Overall Study|Transferred to another hospital|2
944219|NCT01011946|1934259|FG000|Overall Study|No pathological lab value|1
944220|NCT01012037|1934266|FG000|Overall Study|Adverse Event|0
944221|NCT01012037|1934267|FG001|Overall Study|Adverse Event|8
944222|NCT01012037|1934268|FG002|Overall Study|Adverse Event|3
944223|NCT01012037|1934266|FG000|Overall Study|Protocol Violation|0
944224|NCT01012037|1934267|FG001|Overall Study|Protocol Violation|3
944225|NCT01012037|1934268|FG002|Overall Study|Protocol Violation|5
944226|NCT01012037|1934266|FG000|Overall Study|Withdrawal by Subject|0
944227|NCT01012037|1934267|FG001|Overall Study|Withdrawal by Subject|4
944228|NCT01012037|1934268|FG002|Overall Study|Withdrawal by Subject|1
944229|NCT01012037|1934266|FG000|Overall Study|Other reason (not specified)|1
944230|NCT01012037|1934267|FG001|Overall Study|Other reason (not specified)|1
944231|NCT01012037|1934268|FG002|Overall Study|Other reason (not specified)|1
944232|NCT01012219|1934304|FG000|Period 1|Withdrawal by Subject|1
944233|NCT01012219|1934304|FG000|Period 2|Withdrawal by Subject|1
944234|NCT01012258|1934326|FG000|Overall Study|Death|14
944235|NCT01012258|1934326|FG000|Overall Study|Lost to Follow-up|1
944236|NCT01012258|1934326|FG000|Overall Study|Adverse Event|1
944237|NCT01012258|1934326|FG000|Overall Study|Progressive Disease (PD)|18
944238|NCT01012258|1934326|FG000|Overall Study|Symptomatic Deterioration|1
944239|NCT01012258|1934326|FG000|Overall Study|Another Anti-cancer Drug Received|1
944240|NCT01012258|1934326|FG000|Overall Study|Another Tumor Discovered|1
944241|NCT01012258|1934326|FG000|Overall Study|Ongoing|29
944242|NCT01012323|1934340|FG000|Overall Study|Investigator Judgment|1
944243|NCT01012440|1934377|FG000|Overall Study|Withdrawal by Subject|2
944244|NCT01012609|1934387|FG000|Overall Study|Withdrawal by Subject|1
944245|NCT01012609|1934388|FG001|Overall Study|Withdrawal by Subject|1
944246|NCT01012622|1934395|FG000|Overall Study|Withdrawal by Subject|6
944247|NCT01012622|1934395|FG000|Overall Study|Lost to Follow-up|5
944248|NCT01012622|1934395|FG000|Overall Study|Adverse Event|7
944249|NCT01012622|1934395|FG000|Overall Study|non-compliance with the drug|9
944250|NCT01012622|1934395|FG000|Overall Study|Other|1
944251|NCT01012622|1934395|FG000|Overall Study|screening failure|1
944252|NCT01012622|1934395|FG000|Overall Study|withdrawal of consent by a parent|2
944253|NCT01012713|1934413|FG000|Overall Study|Lack of Efficacy|3
944254|NCT01012739|1934418|FG000|Treatment Period 1|Adverse Event|0
944255|NCT01012739|1934419|FG001|Treatment Period 1|Adverse Event|0
944256|NCT01012739|1934420|FG002|Treatment Period 1|Adverse Event|0
944257|NCT01012739|1934421|FG003|Treatment Period 1|Adverse Event|1
944258|NCT01012739|1934418|FG000|Treatment Period 2|Abnormal test procedure results|0
944259|NCT01012739|1934419|FG001|Treatment Period 2|Abnormal test procedure results|0
944260|NCT01012739|1934420|FG002|Treatment Period 2|Abnormal test procedure results|0
944261|NCT01012739|1934421|FG003|Treatment Period 2|Abnormal test procedure results|1
944262|NCT01012765|1934432|FG000|Treatment Period 1|Adverse Event|1
944263|NCT01012765|1934433|FG001|Treatment Period 1|Adverse Event|0
909914|NCT00790400|1886758|FG000|Everolimus Period (Core or Extension)|Administrative problems|2
909915|NCT00790400|1886759|FG001|Everolimus Period (Core or Extension)|Administrative problems|0
909916|NCT00790400|1886758|FG000|Everolimus Period (Core or Extension)|Death|1
909917|NCT00790400|1886759|FG001|Everolimus Period (Core or Extension)|Death|0
909918|NCT00790400|1886758|FG000|Everolimus Period (Core or Extension)|Disease progression|5
909919|NCT00790400|1886759|FG001|Everolimus Period (Core or Extension)|Disease progression|0
909920|NCT00790400|1886758|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1
909921|NCT00790400|1886759|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0
909922|NCT00790400|1886758|FG000|Everolimus Period (Core or Extension)|New treatment|2
909923|NCT00790400|1886759|FG001|Everolimus Period (Core or Extension)|New treatment|0
909924|NCT00790556|1886768|FG000|Treatment Period 1|Physician Decision|1
909925|NCT00790556|1886769|FG001|Treatment Period 1|Physician Decision|0
909926|NCT00790556|1886768|FG000|Treatment Period 1|Withdrawal by Subject|1
909927|NCT00790556|1886769|FG001|Treatment Period 1|Withdrawal by Subject|0
909928|NCT00790569|1886778|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20
909929|NCT00790569|1886779|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8
909930|NCT00790569|1886780|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20
909931|NCT00790569|1886778|FG000|End of Treatment (6 Month Interview)|Death|0
909932|NCT00790569|1886779|FG001|End of Treatment (6 Month Interview)|Death|2
909933|NCT00790569|1886780|FG002|End of Treatment (6 Month Interview)|Death|1
909934|NCT00790569|1886778|FG000|End of Treatment (6 Month Interview)|Hospitalized|2
909935|NCT00790569|1886779|FG001|End of Treatment (6 Month Interview)|Hospitalized|0
909936|NCT00790569|1886780|FG002|End of Treatment (6 Month Interview)|Hospitalized|0
909937|NCT00790569|1886778|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0
909938|NCT00790569|1886779|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0
909939|NCT00790569|1886780|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2
909940|NCT00790569|1886778|FG000|End of Treatment (6 Month Interview)|Incarcerated|0
944264|NCT01012765|1934434|FG002|Treatment Period 1|Adverse Event|1
944265|NCT01012765|1934435|FG003|Treatment Period 1|Adverse Event|0
944266|NCT01012765|1934436|FG004|Treatment Period 1|Adverse Event|0
944267|NCT01012765|1934437|FG005|Treatment Period 1|Adverse Event|0
944268|NCT01012765|1934432|FG000|Treatment Period 1|Withdrawal by Subject|2
944269|NCT01012765|1934433|FG001|Treatment Period 1|Withdrawal by Subject|0
944270|NCT01012765|1934434|FG002|Treatment Period 1|Withdrawal by Subject|0
944271|NCT01012765|1934435|FG003|Treatment Period 1|Withdrawal by Subject|0
944272|NCT01012765|1934436|FG004|Treatment Period 1|Withdrawal by Subject|0
944273|NCT01012765|1934437|FG005|Treatment Period 1|Withdrawal by Subject|0
944274|NCT01012765|1934432|FG000|Treatment Period 1|Administrative problems|0
944275|NCT01012765|1934433|FG001|Treatment Period 1|Administrative problems|0
944276|NCT01012765|1934434|FG002|Treatment Period 1|Administrative problems|1
944277|NCT01012765|1934435|FG003|Treatment Period 1|Administrative problems|1
944278|NCT01012765|1934436|FG004|Treatment Period 1|Administrative problems|1
944279|NCT01012765|1934437|FG005|Treatment Period 1|Administrative problems|0
944280|NCT01012765|1934432|FG000|Treatment Period 1|Protocol Violation|0
944281|NCT01012765|1934433|FG001|Treatment Period 1|Protocol Violation|0
944282|NCT01012765|1934434|FG002|Treatment Period 1|Protocol Violation|0
944283|NCT01012765|1934435|FG003|Treatment Period 1|Protocol Violation|2
944284|NCT01012765|1934436|FG004|Treatment Period 1|Protocol Violation|1
944285|NCT01012765|1934437|FG005|Treatment Period 1|Protocol Violation|0
944286|NCT01012765|1934432|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0
944287|NCT01012765|1934433|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0
944288|NCT01012765|1934434|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0
944289|NCT01012765|1934435|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0
944290|NCT01012765|1934436|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1
944291|NCT01012765|1934437|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0
944292|NCT01012765|1934432|FG000|Treatment Period 2|Withdrawal by Subject|1
944293|NCT01012765|1934433|FG001|Treatment Period 2|Withdrawal by Subject|0
944294|NCT01012765|1934434|FG002|Treatment Period 2|Withdrawal by Subject|1
944295|NCT01012765|1934435|FG003|Treatment Period 2|Withdrawal by Subject|0
944296|NCT01012765|1934436|FG004|Treatment Period 2|Withdrawal by Subject|1
944297|NCT01012765|1934437|FG005|Treatment Period 2|Withdrawal by Subject|0
944298|NCT01012765|1934432|FG000|Treatment Period 2|Abnormal laboratory value(s)|0
944299|NCT01012765|1934433|FG001|Treatment Period 2|Abnormal laboratory value(s)|0
944300|NCT01012765|1934434|FG002|Treatment Period 2|Abnormal laboratory value(s)|0
944301|NCT01012765|1934435|FG003|Treatment Period 2|Abnormal laboratory value(s)|0
944302|NCT01012765|1934436|FG004|Treatment Period 2|Abnormal laboratory value(s)|0
944303|NCT01012765|1934437|FG005|Treatment Period 2|Abnormal laboratory value(s)|1
944304|NCT01012765|1934432|FG000|Treatment Period 2|Adverse Event|0
944305|NCT01012765|1934433|FG001|Treatment Period 2|Adverse Event|1
944306|NCT01012765|1934434|FG002|Treatment Period 2|Adverse Event|1
944307|NCT01012765|1934435|FG003|Treatment Period 2|Adverse Event|0
944308|NCT01012765|1934436|FG004|Treatment Period 2|Adverse Event|0
944309|NCT01012765|1934437|FG005|Treatment Period 2|Adverse Event|0
944310|NCT01012765|1934432|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0
944311|NCT01012765|1934433|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1
944312|NCT01012765|1934434|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1
944313|NCT01012765|1934435|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0
944314|NCT01012765|1934436|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0
944315|NCT01012765|1934437|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0
944316|NCT01012947|1934459|FG000|Overall Study|Lost to Follow-up|131
944317|NCT01012947|1934460|FG001|Overall Study|Lost to Follow-up|135
944318|NCT01012947|1934461|FG002|Overall Study|Lost to Follow-up|130
944319|NCT01012947|1934462|FG003|Overall Study|Lost to Follow-up|118
944320|NCT01012947|1934463|FG004|Overall Study|Lost to Follow-up|142
944321|NCT01012973|1934477|FG000|Overall Study|Adverse Event|5
944322|NCT01012973|1934478|FG001|Overall Study|Adverse Event|5
944323|NCT01012973|1934477|FG000|Overall Study|Lack of Efficacy|0
944324|NCT01012973|1934478|FG001|Overall Study|Lack of Efficacy|5
944325|NCT01012973|1934477|FG000|Overall Study|Lost to Follow-up|1
944326|NCT01012973|1934478|FG001|Overall Study|Lost to Follow-up|0
944327|NCT01012973|1934477|FG000|Overall Study|(Overseas travel - indefinite period)|1
944328|NCT01012973|1934478|FG001|Overall Study|(Overseas travel - indefinite period)|0
944329|NCT01012973|1934477|FG000|Overall Study|Increase in vis. acuity, never injected|0
944330|NCT01012973|1934478|FG001|Overall Study|Increase in vis. acuity, never injected|1
944331|NCT01012973|1934477|FG000|Overall Study|Protocol Violation|5
944332|NCT01012973|1934478|FG001|Overall Study|Protocol Violation|2
944333|NCT01012973|1934477|FG000|Overall Study|Withdrawal by Subject|4
944334|NCT01012973|1934478|FG001|Overall Study|Withdrawal by Subject|6
944335|NCT01012999|1934488|FG000|Overall Study|Protocol Violation|1
944336|NCT01013207|1934505|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6
944337|NCT01013285|1934511|FG000|Overall Study|Death|48
944338|NCT01013285|1934512|FG001|Overall Study|Death|89
944339|NCT01013350|1934519|FG000|Overall Study|Lost to Follow-up|15
944340|NCT01013350|1934520|FG001|Overall Study|Lost to Follow-up|95
944341|NCT01013350|1934519|FG000|Overall Study|Adverse Event|0
944342|NCT01013350|1934520|FG001|Overall Study|Adverse Event|1
944343|NCT01013350|1934519|FG000|Overall Study|Physician Decision|4
944344|NCT01013350|1934520|FG001|Overall Study|Physician Decision|20
944345|NCT01013350|1934519|FG000|Overall Study|Withdrawal by Subject|15
944346|NCT01013350|1934520|FG001|Overall Study|Withdrawal by Subject|38
944347|NCT01013350|1934519|FG000|Overall Study|Death|3
944348|NCT01013350|1934520|FG001|Overall Study|Death|5
944349|NCT01013350|1934519|FG000|Overall Study|Participant entered interventional study|0
944350|NCT01013350|1934520|FG001|Overall Study|Participant entered interventional study|8
944351|NCT01013350|1934519|FG000|Overall Study|Other|1
944352|NCT01013350|1934520|FG001|Overall Study|Other|25
944353|NCT01013597|1934527|FG000|Overall Study|Withdrawal by Subject|1
944354|NCT01013740|1934533|FG000|Overall Study|Lost to Follow-up|3
944355|NCT01013740|1934534|FG001|Overall Study|Lost to Follow-up|5
944356|NCT01013740|1934533|FG000|Overall Study|Physician Decision|2
944357|NCT01013740|1934534|FG001|Overall Study|Physician Decision|0
944358|NCT01013740|1934533|FG000|Overall Study|Withdrawal by Subject|2
944359|NCT01013740|1934534|FG001|Overall Study|Withdrawal by Subject|10
944360|NCT01013740|1934533|FG000|Overall Study|study close / terminated : done in error|2
944361|NCT01013740|1934534|FG001|Overall Study|study close / terminated : done in error|1
944362|NCT01013740|1934533|FG000|Overall Study|Missing|2
944363|NCT01013740|1934534|FG001|Overall Study|Missing|1
944364|NCT01013740|1934533|FG000|Overall Study|Ongoing: Study records not completed|0
944365|NCT01013740|1934534|FG001|Overall Study|Ongoing: Study records not completed|2
944366|NCT01013753|1934542|FG000|Overall Study|Adverse Event|8
944367|NCT01013753|1934542|FG000|Overall Study|Protocol Violation|3
944368|NCT01013753|1934542|FG000|Overall Study|Lost to Follow-up|1
944369|NCT01013753|1934542|FG000|Overall Study|Withdrawal by Subject|2
944370|NCT01013753|1934542|FG000|Overall Study|Other|2
944371|NCT01013792|1934558|FG000|Overall Study|Study suspended|2
944372|NCT01013792|1934559|FG001|Overall Study|Study suspended|1
909941|NCT00790569|1886779|FG001|End of Treatment (6 Month Interview)|Incarcerated|0
909942|NCT00790569|1886780|FG002|End of Treatment (6 Month Interview)|Incarcerated|3
909943|NCT00790569|1886778|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66
909944|NCT00790569|1886779|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19
944373|NCT01013792|1934558|FG000|Overall Study|Adverse Event|0
944374|NCT01013792|1934559|FG001|Overall Study|Adverse Event|3
944375|NCT01013792|1934558|FG000|Overall Study|Lost to Follow-up|0
944376|NCT01013792|1934559|FG001|Overall Study|Lost to Follow-up|1
944377|NCT01013870|1934580|FG000|Overall Study|Lost to Follow-up|1
944378|NCT01013870|1934581|FG001|Overall Study|Lost to Follow-up|3
944379|NCT01013883|1934589|FG000|Overall Study|Lost to Follow-up|2
944380|NCT01013883|1934590|FG001|Overall Study|Lost to Follow-up|2
944381|NCT01013961|1934598|FG000|Overall Study|Adverse Event|2
944382|NCT01013961|1934599|FG001|Overall Study|Adverse Event|2
944383|NCT01013961|1934598|FG000|Overall Study|Withdrawal by Subject|1
944384|NCT01013961|1934599|FG001|Overall Study|Withdrawal by Subject|0
944385|NCT01013961|1934598|FG000|Overall Study|Physician Decision|0
944386|NCT01013961|1934599|FG001|Overall Study|Physician Decision|1
944387|NCT01014013|1934607|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
944388|NCT01014013|1934608|FG001|Overall Study|Inclusion/Exclusion criteria not met|3
944389|NCT01014013|1934607|FG000|Overall Study|Clinical adverse experience|4
944390|NCT01014013|1934608|FG001|Overall Study|Clinical adverse experience|2
944391|NCT01014013|1934607|FG000|Overall Study|Laboratory adverse experience|1
944392|NCT01014013|1934608|FG001|Overall Study|Laboratory adverse experience|1
944393|NCT01014013|1934607|FG000|Overall Study|Protocol Violation|1
944394|NCT01014013|1934608|FG001|Overall Study|Protocol Violation|3
944395|NCT01014013|1934607|FG000|Overall Study|Withdrawal by Subject|7
944396|NCT01014013|1934608|FG001|Overall Study|Withdrawal by Subject|4
944397|NCT01014013|1934607|FG000|Overall Study|Clinical/microbiologic failure|1
944398|NCT01014013|1934608|FG001|Overall Study|Clinical/microbiologic failure|2
944399|NCT01014013|1934607|FG000|Overall Study|Pathogen culture = no growth|26
944400|NCT01014013|1934608|FG001|Overall Study|Pathogen culture = no growth|34
944401|NCT01014013|1934607|FG000|Overall Study|Negative urine culture|2
944402|NCT01014013|1934608|FG001|Overall Study|Negative urine culture|0
944403|NCT01014013|1934607|FG000|Overall Study|Pathogen resistant|7
944404|NCT01014013|1934608|FG001|Overall Study|Pathogen resistant|4
944405|NCT01014013|1934607|FG000|Overall Study|Physician Decision|0
944406|NCT01014013|1934608|FG001|Overall Study|Physician Decision|1
944407|NCT01014013|1934607|FG000|Overall Study|Another antibiotic therapy required|0
944408|NCT01014013|1934608|FG001|Overall Study|Another antibiotic therapy required|1
944409|NCT01014013|1934607|FG000|Overall Study|Appendectomy|1
944410|NCT01014013|1934608|FG001|Overall Study|Appendectomy|0
909945|NCT00790569|1886780|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50
909946|NCT00790582|1886790|FG000|Overall Study|Death|14
909947|NCT00790582|1886791|FG001|Overall Study|Death|32
909948|NCT00790582|1886790|FG000|Overall Study|Physician Decision|7
909949|NCT00790582|1886791|FG001|Overall Study|Physician Decision|1
909950|NCT00790582|1886790|FG000|Overall Study|Lost to Follow-up|3
909951|NCT00790582|1886791|FG001|Overall Study|Lost to Follow-up|3
909952|NCT00790582|1886790|FG000|Overall Study|Withdrawal by Subject|7
909953|NCT00790582|1886791|FG001|Overall Study|Withdrawal by Subject|51
909954|NCT00790647|1886799|FG000|Overall Study|Adverse Event|1
909955|NCT00790751|1886846|FG000|Overall Study|Protocol non-compliance|16
909956|NCT00790751|1886847|FG001|Overall Study|Protocol non-compliance|16
944411|NCT01014013|1934607|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0
944412|NCT01014013|1934608|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1
944413|NCT01014143|1934653|FG000|Second Intervention|Lost to Follow-up|2
944414|NCT01014143|1934654|FG001|Second Intervention|Lost to Follow-up|0
944415|NCT01014143|1934655|FG002|Second Intervention|Lost to Follow-up|0
944416|NCT01014208|1934674|FG000|Overall Study|Lost to Follow-up|2
944417|NCT01014208|1934675|FG001|Overall Study|Lost to Follow-up|5
944418|NCT01014208|1934674|FG000|Overall Study|Participant Withdrew Consent|12
944419|NCT01014208|1934675|FG001|Overall Study|Participant Withdrew Consent|12
944420|NCT01014208|1934674|FG000|Overall Study|Did Not Receive Study Drug|2
944421|NCT01014208|1934675|FG001|Overall Study|Did Not Receive Study Drug|0
944422|NCT01014208|1934674|FG000|Overall Study|Study Closed/terminated|78
944423|NCT01014208|1934675|FG001|Overall Study|Study Closed/terminated|83
944424|NCT01014442|1934700|FG000|Overall Study|Adverse Event|0
944425|NCT01014442|1934701|FG001|Overall Study|Adverse Event|8
944426|NCT01014442|1934700|FG000|Overall Study|Withdrawal by Subject|4
944427|NCT01014442|1934701|FG001|Overall Study|Withdrawal by Subject|4
944428|NCT01014442|1934700|FG000|Overall Study|Protocol Violation|2
944429|NCT01014442|1934701|FG001|Overall Study|Protocol Violation|5
944430|NCT01014442|1934700|FG000|Overall Study|Lack of Compliance|0
944431|NCT01014442|1934701|FG001|Overall Study|Lack of Compliance|1
944432|NCT01014442|1934700|FG000|Overall Study|Unspecified Reason|1
944433|NCT01014442|1934701|FG001|Overall Study|Unspecified Reason|1
944434|NCT01014533|1934722|FG000|Overall Study|Protocol Violation|3
944435|NCT01014533|1934723|FG001|Overall Study|Protocol Violation|2
944436|NCT01014533|1934722|FG000|Overall Study|Withdrawal by Subject|2
944437|NCT01014533|1934723|FG001|Overall Study|Withdrawal by Subject|0
1090765|NCT02248818|2158521|FG003|Screening|Physician Decision|0
909957|NCT00790751|1886848|FG002|Overall Study|Protocol non-compliance|10
909958|NCT00790751|1886849|FG003|Overall Study|Protocol non-compliance|11
909959|NCT00790751|1886846|FG000|Overall Study|Lost to Follow-up|4
909960|NCT00790751|1886847|FG001|Overall Study|Lost to Follow-up|9
909961|NCT00790751|1886848|FG002|Overall Study|Lost to Follow-up|4
909962|NCT00790751|1886849|FG003|Overall Study|Lost to Follow-up|5
909963|NCT00790751|1886846|FG000|Overall Study|Adverse Event|5
909964|NCT00790751|1886847|FG001|Overall Study|Adverse Event|3
909965|NCT00790751|1886848|FG002|Overall Study|Adverse Event|5
909966|NCT00790751|1886849|FG003|Overall Study|Adverse Event|4
909967|NCT00790751|1886846|FG000|Overall Study|Requirement for restricted medication|0
909968|NCT00790751|1886847|FG001|Overall Study|Requirement for restricted medication|2
909969|NCT00790751|1886848|FG002|Overall Study|Requirement for restricted medication|0
909970|NCT00790751|1886849|FG003|Overall Study|Requirement for restricted medication|0
909971|NCT00790751|1886846|FG000|Overall Study|Death|0
909972|NCT00790751|1886847|FG001|Overall Study|Death|0
909973|NCT00790751|1886848|FG002|Overall Study|Death|1
909974|NCT00790751|1886849|FG003|Overall Study|Death|0
909975|NCT00790751|1886846|FG000|Overall Study|Physician Decision|0
909976|NCT00790751|1886847|FG001|Overall Study|Physician Decision|0
909977|NCT00790751|1886848|FG002|Overall Study|Physician Decision|0
909978|NCT00790751|1886849|FG003|Overall Study|Physician Decision|1
909979|NCT00790790|1886862|FG000|Study Period 2: Therapy Phase|Adverse Event|3
909980|NCT00790790|1886863|FG001|Study Period 2: Therapy Phase|Adverse Event|16
909981|NCT00790790|1886864|FG002|Study Period 2: Therapy Phase|Adverse Event|16
909982|NCT00790790|1886862|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
909983|NCT00790790|1886863|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
909984|NCT00790790|1886864|FG002|Study Period 2: Therapy Phase|Protocol Violation|0
909985|NCT00790790|1886862|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7
909986|NCT00790790|1886863|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0
909987|NCT00790790|1886864|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2
909988|NCT00790790|1886862|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1
909989|NCT00790790|1886863|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
909990|NCT00790790|1886864|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3
909991|NCT00790790|1886862|FG000|Study Period 2: Therapy Phase|Physician Decision|0
909992|NCT00790790|1886863|FG001|Study Period 2: Therapy Phase|Physician Decision|1
909993|NCT00790790|1886864|FG002|Study Period 2: Therapy Phase|Physician Decision|0
909994|NCT00790842|1886884|FG000|Dose Level 1|Adverse Event|1
909995|NCT00790842|1886885|FG001|Dose Level 1|Adverse Event|0
909996|NCT00790842|1886886|FG002|Dose Level 1|Adverse Event|0
909997|NCT00790842|1886887|FG003|Dose Level 1|Adverse Event|2
909998|NCT00790842|1886888|FG004|Dose Level 1|Adverse Event|0
909999|NCT00790842|1886889|FG005|Dose Level 1|Adverse Event|0
910000|NCT00790842|1886890|FG006|Dose Level 1|Adverse Event|0
910001|NCT00790842|1886891|FG007|Dose Level 1|Adverse Event|1
910002|NCT00790842|1886892|FG008|Dose Level 1|Adverse Event|0
910003|NCT00790842|1886893|FG009|Dose Level 1|Adverse Event|0
910004|NCT00790842|1886894|FG010|Dose Level 1|Adverse Event|0
910005|NCT00790842|1886884|FG000|Dose Level 1|Physician Decision|1
910006|NCT00790842|1886885|FG001|Dose Level 1|Physician Decision|0
910007|NCT00790842|1886886|FG002|Dose Level 1|Physician Decision|0
910008|NCT00790842|1886887|FG003|Dose Level 1|Physician Decision|0
910009|NCT00790842|1886888|FG004|Dose Level 1|Physician Decision|0
910010|NCT00790842|1886889|FG005|Dose Level 1|Physician Decision|0
910011|NCT00790842|1886890|FG006|Dose Level 1|Physician Decision|0
944438|NCT01014533|1934722|FG000|Overall Study|unable to come to appointment|0
944439|NCT01014533|1934723|FG001|Overall Study|unable to come to appointment|3
944440|NCT01014585|1934734|FG000|Overall Study|Adverse Event|0
944441|NCT01014585|1934735|FG001|Overall Study|Adverse Event|2
944442|NCT01014585|1934736|FG002|Overall Study|Adverse Event|0
944443|NCT01014585|1934737|FG003|Overall Study|Adverse Event|3
944444|NCT01014585|1934734|FG000|Overall Study|Withdrawal by Subject|2
944445|NCT01014585|1934735|FG001|Overall Study|Withdrawal by Subject|0
944446|NCT01014585|1934736|FG002|Overall Study|Withdrawal by Subject|1
944447|NCT01014585|1934737|FG003|Overall Study|Withdrawal by Subject|3
944448|NCT01014585|1934734|FG000|Overall Study|Lost to Follow-up|0
944449|NCT01014585|1934735|FG001|Overall Study|Lost to Follow-up|0
944450|NCT01014585|1934736|FG002|Overall Study|Lost to Follow-up|0
944451|NCT01014585|1934737|FG003|Overall Study|Lost to Follow-up|2
944452|NCT01014585|1934734|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
944453|NCT01014585|1934735|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
944454|NCT01014585|1934736|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
944455|NCT01014585|1934737|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
944456|NCT01014624|1934749|FG000|Overall Study|Adverse Event|0
944457|NCT01014624|1934750|FG001|Overall Study|Adverse Event|1
944458|NCT01014624|1934749|FG000|Overall Study|Protocol Violation|1
944459|NCT01014624|1934750|FG001|Overall Study|Protocol Violation|0
944460|NCT01014624|1934749|FG000|Overall Study|Withdrawal by Subject|1
944461|NCT01014624|1934750|FG001|Overall Study|Withdrawal by Subject|0
944462|NCT01014689|1934760|FG000|Overall Study|Lack of Efficacy|0
944463|NCT01014689|1934761|FG001|Overall Study|Lack of Efficacy|1
944464|NCT01014689|1934760|FG000|Overall Study|Adverse Event|3
944465|NCT01014689|1934761|FG001|Overall Study|Adverse Event|0
944466|NCT01014689|1934760|FG000|Overall Study|Withdrawal by Subject|5
944467|NCT01014689|1934761|FG001|Overall Study|Withdrawal by Subject|4
944468|NCT01014689|1934760|FG000|Overall Study|Protocol Violation|1
944469|NCT01014689|1934761|FG001|Overall Study|Protocol Violation|1
944470|NCT01014689|1934760|FG000|Overall Study|Lost to Follow-up|3
944471|NCT01014689|1934761|FG001|Overall Study|Lost to Follow-up|7
944472|NCT01014689|1934760|FG000|Overall Study|Pregnancy|1
944473|NCT01014689|1934761|FG001|Overall Study|Pregnancy|0
944474|NCT01014910|1934793|FG000|Overall Study|Withdrawal by Subject|0
944475|NCT01014910|1934794|FG001|Overall Study|Withdrawal by Subject|2
944476|NCT01014975|1934871|FG000|Overall Study|Withdrawal by Subject|1
944477|NCT01014975|1934872|FG001|Overall Study|Withdrawal by Subject|0
944478|NCT01014975|1934873|FG002|Overall Study|Withdrawal by Subject|1
944479|NCT01014975|1934871|FG000|Overall Study|Death|3
944480|NCT01014975|1934872|FG001|Overall Study|Death|3
944481|NCT01014975|1934873|FG002|Overall Study|Death|4
944482|NCT01014975|1934871|FG000|Overall Study|Lost to Follow-up|0
944483|NCT01014975|1934872|FG001|Overall Study|Lost to Follow-up|0
944484|NCT01014975|1934873|FG002|Overall Study|Lost to Follow-up|1
944485|NCT01014988|1934887|FG000|Overall Study|Adverse Event|20
944486|NCT01014988|1934888|FG001|Overall Study|Adverse Event|0
944487|NCT01014988|1934889|FG002|Overall Study|Adverse Event|1
944488|NCT01014988|1934890|FG003|Overall Study|Adverse Event|0
944489|NCT01014988|1934891|FG004|Overall Study|Adverse Event|1
944490|NCT01014988|1934892|FG005|Overall Study|Adverse Event|3
944491|NCT01014988|1934887|FG000|Overall Study|Lost to Follow-up|1
944492|NCT01014988|1934888|FG001|Overall Study|Lost to Follow-up|0
944493|NCT01014988|1934889|FG002|Overall Study|Lost to Follow-up|1
944494|NCT01014988|1934890|FG003|Overall Study|Lost to Follow-up|0
944495|NCT01014988|1934891|FG004|Overall Study|Lost to Follow-up|0
944496|NCT01014988|1934892|FG005|Overall Study|Lost to Follow-up|0
944497|NCT01014988|1934887|FG000|Overall Study|Physician Decision|1
944498|NCT01014988|1934888|FG001|Overall Study|Physician Decision|0
944499|NCT01014988|1934889|FG002|Overall Study|Physician Decision|0
944500|NCT01014988|1934890|FG003|Overall Study|Physician Decision|0
944501|NCT01014988|1934891|FG004|Overall Study|Physician Decision|0
944502|NCT01014988|1934892|FG005|Overall Study|Physician Decision|0
944503|NCT01014988|1934887|FG000|Overall Study|Withdrawal by Subject|1
944504|NCT01014988|1934888|FG001|Overall Study|Withdrawal by Subject|0
944505|NCT01014988|1934889|FG002|Overall Study|Withdrawal by Subject|0
944506|NCT01014988|1934890|FG003|Overall Study|Withdrawal by Subject|0
944507|NCT01014988|1934891|FG004|Overall Study|Withdrawal by Subject|0
944508|NCT01014988|1934892|FG005|Overall Study|Withdrawal by Subject|0
944509|NCT01015118|1934916|FG000|Overall Study|Protocol Violation|5
944510|NCT01015118|1934917|FG001|Overall Study|Protocol Violation|6
944511|NCT01015118|1934916|FG000|Overall Study|Withdrawal by Subject|103
944512|NCT01015118|1934917|FG001|Overall Study|Withdrawal by Subject|27
944513|NCT01015118|1934916|FG000|Overall Study|Other Adverse Event (AE)|141
944514|NCT01015118|1934917|FG001|Overall Study|Other Adverse Event (AE)|33
944515|NCT01015118|1934916|FG000|Overall Study|Worsening or AE of underlying disease|5
944516|NCT01015118|1934917|FG001|Overall Study|Worsening or AE of underlying disease|4
944517|NCT01015118|1934916|FG000|Overall Study|Progressive disease|364
944518|NCT01015118|1934917|FG001|Overall Study|Progressive disease|229
944519|NCT01015118|1934916|FG000|Overall Study|Not treated|9
944520|NCT01015118|1934917|FG001|Overall Study|Not treated|5
944521|NCT01015118|1934916|FG000|Overall Study|Other than stated above|42
910012|NCT00790842|1886891|FG007|Dose Level 1|Physician Decision|1
944522|NCT01015118|1934917|FG001|Overall Study|Other than stated above|23
944523|NCT01015131|1934923|FG000|Overall Study|Physician Decision|1
944524|NCT01015131|1934923|FG000|Overall Study|Protocol Violation|1
944525|NCT01015131|1934923|FG000|Overall Study|Withdrawal by Subject|2
944526|NCT01015131|1934923|FG000|Overall Study|Other Protocol Specified Criteria|4
944527|NCT01015287|1934935|FG000|Overall Study|Death|21
944528|NCT01015287|1934936|FG001|Overall Study|Death|16
944529|NCT01015287|1934935|FG000|Overall Study|Adverse Event|1
944530|NCT01015287|1934936|FG001|Overall Study|Adverse Event|0
944531|NCT01015287|1934935|FG000|Overall Study|Sponsor Decision|3
944532|NCT01015287|1934936|FG001|Overall Study|Sponsor Decision|7
944533|NCT01015287|1934935|FG000|Overall Study|Physician Decision|19
944534|NCT01015287|1934936|FG001|Overall Study|Physician Decision|21
944535|NCT01015287|1934935|FG000|Overall Study|Withdrawal by Subject|14
944536|NCT01015287|1934936|FG001|Overall Study|Withdrawal by Subject|19
944537|NCT01015287|1934935|FG000|Overall Study|Entry Criteria not Met|11
944538|NCT01015287|1934936|FG001|Overall Study|Entry Criteria not Met|14
944539|NCT01015287|1934935|FG000|Overall Study|Lost to Follow-up|2
944540|NCT01015287|1934936|FG001|Overall Study|Lost to Follow-up|1
944541|NCT01015287|1934935|FG000|Overall Study|Protocol Violation|1
944542|NCT01015287|1934936|FG001|Overall Study|Protocol Violation|1
944543|NCT01015560|1934974|FG000|Overall Study|Adverse Event|1
944544|NCT01015560|1934974|FG000|Overall Study|Not protocol specified|1
944545|NCT01015560|1934974|FG000|Overall Study|Withdrawal by Subject|1
944546|NCT01015612|1934987|FG000|Overall Study|Death|113
944547|NCT01015612|1934987|FG000|Overall Study|Withdrawal by Subject|40
944548|NCT01015638|1934993|FG000|Overall Study|Withdrawal by Subject|1
944549|NCT01015638|1934994|FG001|Overall Study|Withdrawal by Subject|0
944550|NCT01015677|1935003|FG000|Overall Study|Adverse Event|0
944551|NCT01015677|1935004|FG001|Overall Study|Adverse Event|1
944552|NCT01015677|1935005|FG002|Overall Study|Adverse Event|0
944553|NCT01015677|1935003|FG000|Overall Study|Lack of Efficacy|0
944554|NCT01015677|1935004|FG001|Overall Study|Lack of Efficacy|1
944555|NCT01015677|1935005|FG002|Overall Study|Lack of Efficacy|0
944556|NCT01015677|1935003|FG000|Overall Study|Protocol Violation|0
944557|NCT01015677|1935004|FG001|Overall Study|Protocol Violation|1
944558|NCT01015677|1935005|FG002|Overall Study|Protocol Violation|0
944559|NCT01015677|1935003|FG000|Overall Study|Withdrawal by Subject|1
944560|NCT01015677|1935004|FG001|Overall Study|Withdrawal by Subject|1
944561|NCT01015677|1935005|FG002|Overall Study|Withdrawal by Subject|0
944562|NCT01015703|1935018|FG000|Overall Study|Withdrawal by Subject|0
944563|NCT01015703|1935019|FG001|Overall Study|Withdrawal by Subject|1
944564|NCT01015703|1935020|FG002|Overall Study|Withdrawal by Subject|0
944565|NCT01015703|1935021|FG003|Overall Study|Withdrawal by Subject|0
944566|NCT01015703|1935022|FG004|Overall Study|Withdrawal by Subject|0
944567|NCT01015703|1935018|FG000|Overall Study|Adverse Event|1
944568|NCT01015703|1935019|FG001|Overall Study|Adverse Event|0
944569|NCT01015703|1935020|FG002|Overall Study|Adverse Event|0
944570|NCT01015703|1935021|FG003|Overall Study|Adverse Event|0
944571|NCT01015703|1935022|FG004|Overall Study|Adverse Event|0
944572|NCT01015703|1935018|FG000|Overall Study|Protocol Violation|1
944573|NCT01015703|1935019|FG001|Overall Study|Protocol Violation|0
944574|NCT01015703|1935020|FG002|Overall Study|Protocol Violation|0
944575|NCT01015703|1935021|FG003|Overall Study|Protocol Violation|0
910013|NCT00790842|1886892|FG008|Dose Level 1|Physician Decision|0
910014|NCT00790842|1886893|FG009|Dose Level 1|Physician Decision|0
910015|NCT00790842|1886894|FG010|Dose Level 1|Physician Decision|0
910016|NCT00790842|1886884|FG000|Dose Level 1|Withdrawal by Subject|1
910017|NCT00790842|1886885|FG001|Dose Level 1|Withdrawal by Subject|0
910018|NCT00790842|1886886|FG002|Dose Level 1|Withdrawal by Subject|0
910019|NCT00790842|1886887|FG003|Dose Level 1|Withdrawal by Subject|0
910020|NCT00790842|1886888|FG004|Dose Level 1|Withdrawal by Subject|0
910021|NCT00790842|1886889|FG005|Dose Level 1|Withdrawal by Subject|0
910022|NCT00790842|1886890|FG006|Dose Level 1|Withdrawal by Subject|0
910023|NCT00790842|1886891|FG007|Dose Level 1|Withdrawal by Subject|0
910024|NCT00790842|1886892|FG008|Dose Level 1|Withdrawal by Subject|0
910025|NCT00790842|1886893|FG009|Dose Level 1|Withdrawal by Subject|0
910026|NCT00790842|1886894|FG010|Dose Level 1|Withdrawal by Subject|0
910027|NCT00790842|1886884|FG000|Dose Level 2|Death|0
910028|NCT00790842|1886885|FG001|Dose Level 2|Death|1
910029|NCT00790842|1886886|FG002|Dose Level 2|Death|0
910030|NCT00790842|1886887|FG003|Dose Level 2|Death|0
910031|NCT00790842|1886888|FG004|Dose Level 2|Death|1
910032|NCT00790842|1886889|FG005|Dose Level 2|Death|0
910033|NCT00790842|1886890|FG006|Dose Level 2|Death|0
910034|NCT00790842|1886891|FG007|Dose Level 2|Death|0
910035|NCT00790842|1886892|FG008|Dose Level 2|Death|0
910036|NCT00790842|1886893|FG009|Dose Level 2|Death|0
910037|NCT00790842|1886894|FG010|Dose Level 2|Death|0
910038|NCT00790842|1886884|FG000|Dose Level 2|Physician Decision|0
910039|NCT00790842|1886885|FG001|Dose Level 2|Physician Decision|1
910040|NCT00790842|1886886|FG002|Dose Level 2|Physician Decision|0
910041|NCT00790842|1886887|FG003|Dose Level 2|Physician Decision|0
910042|NCT00790842|1886888|FG004|Dose Level 2|Physician Decision|0
910043|NCT00790842|1886889|FG005|Dose Level 2|Physician Decision|0
910044|NCT00790842|1886890|FG006|Dose Level 2|Physician Decision|0
910045|NCT00790842|1886891|FG007|Dose Level 2|Physician Decision|0
944576|NCT01015703|1935022|FG004|Overall Study|Protocol Violation|0
944577|NCT01015768|1935034|FG000|Overall Study|Some subject data unuseable|4
944578|NCT01015768|1935035|FG001|Overall Study|Some subject data unuseable|4
944579|NCT01015820|1935067|FG000|Overall Study|Suboptimal measurements|1
944580|NCT01015820|1935068|FG001|Overall Study|Suboptimal measurements|0
944597|NCT01016015|1935088|FG000|Overall Study|Not Treated|3
944598|NCT01016015|1935088|FG000|Overall Study|Withdrawal by Subject|1
944599|NCT01016015|1935088|FG000|Overall Study|Adverse Event|15
944600|NCT01016067|1935094|FG000|Overall Study|Lost to Follow-up|1
944601|NCT01016067|1935095|FG001|Overall Study|Lost to Follow-up|2
944602|NCT01016067|1935094|FG000|Overall Study|Physician Decision|1
944603|NCT01016067|1935095|FG001|Overall Study|Physician Decision|1
944604|NCT01016067|1935094|FG000|Overall Study|Withdrew due to Relocation|0
944605|NCT01016067|1935095|FG001|Overall Study|Withdrew due to Relocation|1
944606|NCT01016132|1935110|FG000|Overall Study|Discomfort|1
944607|NCT01016262|1935117|FG000|Double-blind Phase|Adverse Event|0
944608|NCT01016262|1935118|FG001|Double-blind Phase|Adverse Event|0
944609|NCT01016262|1935119|FG002|Double-blind Phase|Adverse Event|1
944610|NCT01016262|1935120|FG003|Double-blind Phase|Adverse Event|0
944611|NCT01016262|1935121|FG004|Double-blind Phase|Adverse Event|0
944612|NCT01016262|1935122|FG005|Double-blind Phase|Adverse Event|0
944613|NCT01016262|1935117|FG000|Double-blind Phase|Lack of Efficacy|1
944614|NCT01016262|1935118|FG001|Double-blind Phase|Lack of Efficacy|0
944615|NCT01016262|1935119|FG002|Double-blind Phase|Lack of Efficacy|5
944616|NCT01016262|1935120|FG003|Double-blind Phase|Lack of Efficacy|0
944617|NCT01016262|1935121|FG004|Double-blind Phase|Lack of Efficacy|0
944618|NCT01016262|1935122|FG005|Double-blind Phase|Lack of Efficacy|0
944619|NCT01016262|1935117|FG000|Double-blind Phase|Disease Progression|0
944620|NCT01016262|1935118|FG001|Double-blind Phase|Disease Progression|1
944621|NCT01016262|1935119|FG002|Double-blind Phase|Disease Progression|2
944622|NCT01016262|1935120|FG003|Double-blind Phase|Disease Progression|0
944623|NCT01016262|1935121|FG004|Double-blind Phase|Disease Progression|0
944624|NCT01016262|1935122|FG005|Double-blind Phase|Disease Progression|0
944625|NCT01016262|1935117|FG000|Double-blind Phase|Withdrawal of Informed Consent|0
944626|NCT01016262|1935118|FG001|Double-blind Phase|Withdrawal of Informed Consent|0
944627|NCT01016262|1935119|FG002|Double-blind Phase|Withdrawal of Informed Consent|1
944628|NCT01016262|1935120|FG003|Double-blind Phase|Withdrawal of Informed Consent|0
944629|NCT01016262|1935121|FG004|Double-blind Phase|Withdrawal of Informed Consent|0
944630|NCT01016262|1935122|FG005|Double-blind Phase|Withdrawal of Informed Consent|0
944631|NCT01016262|1935117|FG000|Open-Label Phase|Adverse Event|0
944632|NCT01016262|1935118|FG001|Open-Label Phase|Adverse Event|0
944633|NCT01016262|1935119|FG002|Open-Label Phase|Adverse Event|0
944634|NCT01016262|1935120|FG003|Open-Label Phase|Adverse Event|1
944635|NCT01016262|1935121|FG004|Open-Label Phase|Adverse Event|0
944636|NCT01016262|1935122|FG005|Open-Label Phase|Adverse Event|0
944637|NCT01016262|1935117|FG000|Open-Label Phase|Lost to Follow-up|0
944638|NCT01016262|1935118|FG001|Open-Label Phase|Lost to Follow-up|0
944639|NCT01016262|1935119|FG002|Open-Label Phase|Lost to Follow-up|0
944640|NCT01016262|1935120|FG003|Open-Label Phase|Lost to Follow-up|0
944641|NCT01016262|1935121|FG004|Open-Label Phase|Lost to Follow-up|1
944642|NCT01016262|1935122|FG005|Open-Label Phase|Lost to Follow-up|0
944643|NCT01016262|1935117|FG000|Open-Label Phase|Lack of Efficacy|0
944644|NCT01016262|1935118|FG001|Open-Label Phase|Lack of Efficacy|0
944645|NCT01016262|1935119|FG002|Open-Label Phase|Lack of Efficacy|0
944646|NCT01016262|1935120|FG003|Open-Label Phase|Lack of Efficacy|1
944647|NCT01016262|1935121|FG004|Open-Label Phase|Lack of Efficacy|0
944648|NCT01016262|1935122|FG005|Open-Label Phase|Lack of Efficacy|0
944649|NCT01016262|1935117|FG000|Open-Label Phase|Withdrawal of Informed Consent|0
944650|NCT01016262|1935118|FG001|Open-Label Phase|Withdrawal of Informed Consent|0
944651|NCT01016262|1935119|FG002|Open-Label Phase|Withdrawal of Informed Consent|0
944652|NCT01016262|1935120|FG003|Open-Label Phase|Withdrawal of Informed Consent|0
944653|NCT01016262|1935121|FG004|Open-Label Phase|Withdrawal of Informed Consent|1
944654|NCT01016262|1935122|FG005|Open-Label Phase|Withdrawal of Informed Consent|0
944655|NCT01016600|1935191|FG000|Overall Study|Did not start treatment|1
944656|NCT01016600|1935192|FG001|Overall Study|Did not start treatment|0
944657|NCT01016600|1935193|FG002|Overall Study|Did not start treatment|0
944658|NCT01016600|1935194|FG003|Overall Study|Did not start treatment|0
944659|NCT01016912|1935289|FG000|End of Treatment Period|Lack of Efficacy|0
944660|NCT01016912|1935290|FG001|End of Treatment Period|Lack of Efficacy|1
944661|NCT01016912|1935291|FG002|End of Treatment Period|Lack of Efficacy|0
944662|NCT01016912|1935292|FG003|End of Treatment Period|Lack of Efficacy|4
944663|NCT01016912|1935293|FG004|End of Treatment Period|Lack of Efficacy|4
944664|NCT01016912|1935289|FG000|End of Treatment Period|Adverse Event|0
944665|NCT01016912|1935290|FG001|End of Treatment Period|Adverse Event|1
944666|NCT01016912|1935291|FG002|End of Treatment Period|Adverse Event|1
944667|NCT01016912|1935292|FG003|End of Treatment Period|Adverse Event|0
944668|NCT01016912|1935293|FG004|End of Treatment Period|Adverse Event|0
944669|NCT01016912|1935289|FG000|End of Treatment Period|Completed double-blind period only|0
944670|NCT01016912|1935290|FG001|End of Treatment Period|Completed double-blind period only|1
944671|NCT01016912|1935291|FG002|End of Treatment Period|Completed double-blind period only|0
944672|NCT01016912|1935292|FG003|End of Treatment Period|Completed double-blind period only|0
944673|NCT01016912|1935293|FG004|End of Treatment Period|Completed double-blind period only|0
944674|NCT01016912|1935289|FG000|Follow-up Period|Other reason|0
944675|NCT01016912|1935290|FG001|Follow-up Period|Other reason|0
944676|NCT01016912|1935291|FG002|Follow-up Period|Other reason|1
944677|NCT01016912|1935292|FG003|Follow-up Period|Other reason|1
944678|NCT01016912|1935293|FG004|Follow-up Period|Other reason|0
944679|NCT01016964|1935332|FG000|Overall Study|Lost to Follow-up|3
944680|NCT01016964|1935333|FG001|Overall Study|Lost to Follow-up|3
944681|NCT01016977|1935341|FG000|Overall Study|Lost to Follow-up|1
944682|NCT01016977|1935342|FG001|Overall Study|Lost to Follow-up|0
944683|NCT01016977|1935341|FG000|Overall Study|Withdrawal by Subject|2
944684|NCT01016977|1935342|FG001|Overall Study|Withdrawal by Subject|2
944685|NCT01017029|1935359|FG000|Overall Study|Lost to Follow-up|1
944686|NCT01017029|1935360|FG001|Overall Study|Lost to Follow-up|0
944687|NCT01017029|1935359|FG000|Overall Study|Administrative problem|0
944688|NCT01017029|1935360|FG001|Overall Study|Administrative problem|1
944689|NCT01017029|1935359|FG000|Overall Study|Death|3
944690|NCT01017029|1935360|FG001|Overall Study|Death|1
944691|NCT01017120|1935377|FG000|Overall Study|Adverse Event|9
944692|NCT01017120|1935378|FG001|Overall Study|Adverse Event|0
944693|NCT01017120|1935377|FG000|Overall Study|Lost to Follow-up|13
944694|NCT01017120|1935378|FG001|Overall Study|Lost to Follow-up|11
944695|NCT01017120|1935377|FG000|Overall Study|Lack of Efficacy|1
944696|NCT01017120|1935378|FG001|Overall Study|Lack of Efficacy|0
944697|NCT01017120|1935377|FG000|Overall Study|Withdrawal by Subject|39
944698|NCT01017120|1935378|FG001|Overall Study|Withdrawal by Subject|21
944699|NCT01017120|1935377|FG000|Overall Study|Pregnancy|1
944700|NCT01017120|1935378|FG001|Overall Study|Pregnancy|1
944701|NCT01017120|1935377|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
944702|NCT01017120|1935378|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
944703|NCT01017120|1935377|FG000|Overall Study|Relocated Out of Town|0
944704|NCT01017120|1935378|FG001|Overall Study|Relocated Out of Town|2
944705|NCT01017120|1935377|FG000|Overall Study|Protocol Violation|1
944706|NCT01017120|1935378|FG001|Overall Study|Protocol Violation|0
944707|NCT01017120|1935377|FG000|Overall Study|Parent Unable to Provide Transportation|1
944708|NCT01017120|1935378|FG001|Overall Study|Parent Unable to Provide Transportation|0
944709|NCT01017146|1935386|FG000|Overall Study|Adverse Event|11
944710|NCT01017146|1935387|FG001|Overall Study|Adverse Event|1
944711|NCT01017146|1935386|FG000|Overall Study|Lost to Follow-up|14
944712|NCT01017146|1935387|FG001|Overall Study|Lost to Follow-up|14
944713|NCT01017146|1935386|FG000|Overall Study|Noncompliance with Study Product|1
944714|NCT01017146|1935387|FG001|Overall Study|Noncompliance with Study Product|1
944715|NCT01017146|1935386|FG000|Overall Study|Withdrawal by Subject|32
910046|NCT00790842|1886892|FG008|Dose Level 2|Physician Decision|0
910047|NCT00790842|1886893|FG009|Dose Level 2|Physician Decision|0
910048|NCT00790842|1886894|FG010|Dose Level 2|Physician Decision|0
910049|NCT00790842|1886884|FG000|Dose Level 2|Withdrawal by Subject|0
910050|NCT00790842|1886885|FG001|Dose Level 2|Withdrawal by Subject|1
910051|NCT00790842|1886886|FG002|Dose Level 2|Withdrawal by Subject|0
910052|NCT00790842|1886887|FG003|Dose Level 2|Withdrawal by Subject|0
910053|NCT00790842|1886888|FG004|Dose Level 2|Withdrawal by Subject|0
910054|NCT00790842|1886889|FG005|Dose Level 2|Withdrawal by Subject|0
910055|NCT00790842|1886890|FG006|Dose Level 2|Withdrawal by Subject|0
910056|NCT00790842|1886891|FG007|Dose Level 2|Withdrawal by Subject|0
910057|NCT00790842|1886892|FG008|Dose Level 2|Withdrawal by Subject|0
910058|NCT00790842|1886893|FG009|Dose Level 2|Withdrawal by Subject|0
910059|NCT00790842|1886894|FG010|Dose Level 2|Withdrawal by Subject|0
910060|NCT00790842|1886884|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0
910061|NCT00790842|1886885|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0
910062|NCT00790842|1886886|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0
910063|NCT00790842|1886887|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0
910064|NCT00790842|1886888|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0
910065|NCT00790842|1886889|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0
910066|NCT00790842|1886890|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0
910067|NCT00790842|1886891|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0
910068|NCT00790842|1886892|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2
910069|NCT00790842|1886893|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0
944716|NCT01017146|1935387|FG001|Overall Study|Withdrawal by Subject|16
944717|NCT01017146|1935386|FG000|Overall Study|Relocation|0
944718|NCT01017146|1935387|FG001|Overall Study|Relocation|4
944719|NCT01017146|1935386|FG000|Overall Study|Pregnancy|2
944720|NCT01017146|1935387|FG001|Overall Study|Pregnancy|1
944721|NCT01017146|1935386|FG000|Overall Study|Protocol Violation|2
944722|NCT01017146|1935387|FG001|Overall Study|Protocol Violation|0
944723|NCT01017146|1935386|FG000|Overall Study|Took Excluded Medication|2
944724|NCT01017146|1935387|FG001|Overall Study|Took Excluded Medication|0
944725|NCT01017146|1935386|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
944726|NCT01017146|1935387|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
944727|NCT01017146|1935386|FG000|Overall Study|Change in Work Situation|1
944728|NCT01017146|1935387|FG001|Overall Study|Change in Work Situation|0
944729|NCT01017549|1935425|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
944730|NCT01017549|1935425|FG000|One-year Follow-up|Lost to Follow-up|2
944731|NCT01017549|1935425|FG000|One-year Follow-up|Withdrawal by Subject|5
944732|NCT01017549|1935425|FG000|5 Year Follow-up|Lost to Follow-up|9
944733|NCT01017549|1935425|FG000|5 Year Follow-up|Mastectomy|3
944734|NCT01017575|1935434|FG000|Overall Study|Lack of Efficacy|0
944735|NCT01017575|1935435|FG001|Overall Study|Lack of Efficacy|1
944736|NCT01017575|1935436|FG002|Overall Study|Lack of Efficacy|0
944737|NCT01017575|1935437|FG003|Overall Study|Lack of Efficacy|1
944738|NCT01017575|1935438|FG004|Overall Study|Lack of Efficacy|1
944739|NCT01017575|1935434|FG000|Overall Study|Adverse Event|0
944740|NCT01017575|1935435|FG001|Overall Study|Adverse Event|1
944741|NCT01017575|1935436|FG002|Overall Study|Adverse Event|0
944742|NCT01017575|1935437|FG003|Overall Study|Adverse Event|0
944743|NCT01017575|1935438|FG004|Overall Study|Adverse Event|2
944744|NCT01017575|1935434|FG000|Overall Study|Withdrawal by Subject|1
910070|NCT00790842|1886894|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0
910071|NCT00790842|1886884|FG000|Dose Level 3|Adverse Event|0
910072|NCT00790842|1886885|FG001|Dose Level 3|Adverse Event|0
910073|NCT00790842|1886886|FG002|Dose Level 3|Adverse Event|1
910074|NCT00790842|1886887|FG003|Dose Level 3|Adverse Event|0
910075|NCT00790842|1886888|FG004|Dose Level 3|Adverse Event|0
910076|NCT00790842|1886889|FG005|Dose Level 3|Adverse Event|0
910077|NCT00790842|1886890|FG006|Dose Level 3|Adverse Event|0
910078|NCT00790842|1886891|FG007|Dose Level 3|Adverse Event|0
910079|NCT00790842|1886892|FG008|Dose Level 3|Adverse Event|0
910080|NCT00790842|1886893|FG009|Dose Level 3|Adverse Event|0
910081|NCT00790842|1886894|FG010|Dose Level 3|Adverse Event|0
910082|NCT00790842|1886884|FG000|Dose Level 3|Withdrawal by Subject|0
910083|NCT00790842|1886885|FG001|Dose Level 3|Withdrawal by Subject|0
910084|NCT00790842|1886886|FG002|Dose Level 3|Withdrawal by Subject|3
910085|NCT00790842|1886887|FG003|Dose Level 3|Withdrawal by Subject|0
910086|NCT00790842|1886888|FG004|Dose Level 3|Withdrawal by Subject|0
910087|NCT00790842|1886889|FG005|Dose Level 3|Withdrawal by Subject|0
910088|NCT00790842|1886890|FG006|Dose Level 3|Withdrawal by Subject|0
910089|NCT00790842|1886891|FG007|Dose Level 3|Withdrawal by Subject|0
910090|NCT00790842|1886892|FG008|Dose Level 3|Withdrawal by Subject|0
910091|NCT00790842|1886893|FG009|Dose Level 3|Withdrawal by Subject|2
910092|NCT00790842|1886894|FG010|Dose Level 3|Withdrawal by Subject|0
910093|NCT00790842|1886884|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
910094|NCT00790842|1886885|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
910095|NCT00790842|1886886|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
910096|NCT00790842|1886887|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
910097|NCT00790842|1886888|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
910098|NCT00790842|1886889|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
910099|NCT00790842|1886890|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
910100|NCT00790842|1886891|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
910101|NCT00790842|1886892|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
910102|NCT00790842|1886893|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
910103|NCT00790842|1886894|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
910104|NCT00790842|1886884|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0
910105|NCT00790842|1886885|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0
910106|NCT00790842|1886886|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1
910107|NCT00790842|1886887|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0
910108|NCT00790842|1886888|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0
910109|NCT00790842|1886889|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0
910110|NCT00790842|1886890|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0
910111|NCT00790842|1886891|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0
910112|NCT00790842|1886892|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0
910113|NCT00790842|1886893|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0
910114|NCT00790842|1886894|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0
910115|NCT00790842|1886884|FG000|Dose Level 4|Adverse Event|0
910116|NCT00790842|1886885|FG001|Dose Level 4|Adverse Event|0
910117|NCT00790842|1886886|FG002|Dose Level 4|Adverse Event|0
910118|NCT00790842|1886887|FG003|Dose Level 4|Adverse Event|0
910119|NCT00790842|1886888|FG004|Dose Level 4|Adverse Event|0
910120|NCT00790842|1886889|FG005|Dose Level 4|Adverse Event|0
910121|NCT00790842|1886890|FG006|Dose Level 4|Adverse Event|1
944745|NCT01017575|1935435|FG001|Overall Study|Withdrawal by Subject|0
944746|NCT01017575|1935436|FG002|Overall Study|Withdrawal by Subject|0
944747|NCT01017575|1935437|FG003|Overall Study|Withdrawal by Subject|0
944748|NCT01017575|1935438|FG004|Overall Study|Withdrawal by Subject|0
944749|NCT01017601|1935452|FG000|Overall Study|Disease Progression|12
944750|NCT01017601|1935453|FG001|Overall Study|Disease Progression|12
944751|NCT01017601|1935452|FG000|Overall Study|Withdrawal by Subject|0
944752|NCT01017601|1935453|FG001|Overall Study|Withdrawal by Subject|1
944753|NCT01017731|1935463|FG000|Overall Study|Lost to Follow-up|2
944754|NCT01017731|1935463|FG000|Overall Study|Withdrawal by Subject|3
944755|NCT01017731|1935463|FG000|Overall Study|Physician Decision|2
944756|NCT01017731|1935463|FG000|Overall Study|Adverse Event|1
944757|NCT01017874|1935470|FG000|Overall Study|Withdrawal by Subject|23
944758|NCT01017874|1935471|FG001|Overall Study|Withdrawal by Subject|20
944759|NCT01017874|1935470|FG000|Overall Study|Sponsor decision|3
944760|NCT01017874|1935471|FG001|Overall Study|Sponsor decision|1
944761|NCT01017874|1935470|FG000|Overall Study|Lost to Follow-up|3
944762|NCT01017874|1935471|FG001|Overall Study|Lost to Follow-up|2
944763|NCT01017874|1935470|FG000|Overall Study|Physician Decision|1
944764|NCT01017874|1935471|FG001|Overall Study|Physician Decision|3
944765|NCT01017952|1935481|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
944766|NCT01017952|1935482|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
944767|NCT01017952|1935483|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
944768|NCT01017952|1935484|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
944769|NCT01017952|1935485|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
944770|NCT01017952|1935481|FG000|4-week, Open-label Run-In Period|Adverse Event|23
944771|NCT01017952|1935482|FG001|4-week, Open-label Run-In Period|Adverse Event|0
944772|NCT01017952|1935483|FG002|4-week, Open-label Run-In Period|Adverse Event|0
944773|NCT01017952|1935484|FG003|4-week, Open-label Run-In Period|Adverse Event|0
944774|NCT01017952|1935485|FG004|4-week, Open-label Run-In Period|Adverse Event|0
944775|NCT01017952|1935481|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
944776|NCT01017952|1935482|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
944777|NCT01017952|1935483|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
944778|NCT01017952|1935484|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
944779|NCT01017952|1935485|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
944780|NCT01017952|1935481|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
944781|NCT01017952|1935482|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
944782|NCT01017952|1935483|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
944783|NCT01017952|1935484|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
944784|NCT01017952|1935485|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
944785|NCT01017952|1935481|FG000|4-week, Open-label Run-In Period|Physician Decision|10
944786|NCT01017952|1935482|FG001|4-week, Open-label Run-In Period|Physician Decision|0
944787|NCT01017952|1935483|FG002|4-week, Open-label Run-In Period|Physician Decision|0
944788|NCT01017952|1935484|FG003|4-week, Open-label Run-In Period|Physician Decision|0
944789|NCT01017952|1935485|FG004|4-week, Open-label Run-In Period|Physician Decision|0
944790|NCT01017952|1935481|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63
944791|NCT01017952|1935482|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
944792|NCT01017952|1935483|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
944793|NCT01017952|1935484|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
944794|NCT01017952|1935485|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
944795|NCT01017952|1935481|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
944796|NCT01017952|1935482|FG001|52-week, Double-blind Treatment Period|Adverse Event|25
944797|NCT01017952|1935483|FG002|52-week, Double-blind Treatment Period|Adverse Event|32
944798|NCT01017952|1935484|FG003|52-week, Double-blind Treatment Period|Adverse Event|35
944799|NCT01017952|1935485|FG004|52-week, Double-blind Treatment Period|Adverse Event|30
944800|NCT01017952|1935481|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
944801|NCT01017952|1935482|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
944802|NCT01017952|1935483|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
944803|NCT01017952|1935484|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
944804|NCT01017952|1935485|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
944805|NCT01017952|1935481|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
944806|NCT01017952|1935482|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35
944807|NCT01017952|1935483|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14
944808|NCT01017952|1935484|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16
910122|NCT00790842|1886891|FG007|Dose Level 4|Adverse Event|0
910123|NCT00790842|1886892|FG008|Dose Level 4|Adverse Event|0
910124|NCT00790842|1886893|FG009|Dose Level 4|Adverse Event|0
910125|NCT00790842|1886894|FG010|Dose Level 4|Adverse Event|0
910126|NCT00790842|1886884|FG000|Dose Level 4|Physician Decision|0
910127|NCT00790842|1886885|FG001|Dose Level 4|Physician Decision|0
910128|NCT00790842|1886886|FG002|Dose Level 4|Physician Decision|0
910129|NCT00790842|1886887|FG003|Dose Level 4|Physician Decision|0
910130|NCT00790842|1886888|FG004|Dose Level 4|Physician Decision|0
910131|NCT00790842|1886889|FG005|Dose Level 4|Physician Decision|0
910132|NCT00790842|1886890|FG006|Dose Level 4|Physician Decision|1
944809|NCT01017952|1935485|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14
944810|NCT01017952|1935481|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
944811|NCT01017952|1935482|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7
944812|NCT01017952|1935483|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11
944813|NCT01017952|1935484|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9
944814|NCT01017952|1935485|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8
944815|NCT01017952|1935481|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
944816|NCT01017952|1935482|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
944817|NCT01017952|1935483|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
944818|NCT01017952|1935484|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
944819|NCT01017952|1935485|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
944820|NCT01017952|1935481|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
944821|NCT01017952|1935482|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
944822|NCT01017952|1935483|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
944823|NCT01017952|1935484|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
944824|NCT01017952|1935485|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
944825|NCT01017952|1935481|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
944826|NCT01017952|1935482|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6
944827|NCT01017952|1935483|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8
944828|NCT01017952|1935484|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
944829|NCT01017952|1935485|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10
944830|NCT01017952|1935481|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
944831|NCT01017952|1935482|FG001|52-week, Double-blind Treatment Period|Physician Decision|10
944832|NCT01017952|1935483|FG002|52-week, Double-blind Treatment Period|Physician Decision|8
944833|NCT01017952|1935484|FG003|52-week, Double-blind Treatment Period|Physician Decision|9
944834|NCT01017952|1935485|FG004|52-week, Double-blind Treatment Period|Physician Decision|7
944835|NCT01018030|1935498|FG000|Overall Study|Adverse Event|10
944836|NCT01018030|1935499|FG001|Overall Study|Adverse Event|5
944837|NCT01018030|1935500|FG002|Overall Study|Adverse Event|5
944838|NCT01018030|1935498|FG000|Overall Study|Withdrawal by Subject|2
944839|NCT01018030|1935499|FG001|Overall Study|Withdrawal by Subject|2
944840|NCT01018030|1935500|FG002|Overall Study|Withdrawal by Subject|4
944841|NCT01018030|1935498|FG000|Overall Study|Lost to Follow-up|2
944842|NCT01018030|1935499|FG001|Overall Study|Lost to Follow-up|0
944843|NCT01018030|1935500|FG002|Overall Study|Lost to Follow-up|3
944844|NCT01018030|1935498|FG000|Overall Study|Protocol Violation|2
944845|NCT01018030|1935499|FG001|Overall Study|Protocol Violation|1
944846|NCT01018030|1935500|FG002|Overall Study|Protocol Violation|0
944847|NCT01018030|1935498|FG000|Overall Study|Physician Decision|1
944848|NCT01018030|1935499|FG001|Overall Study|Physician Decision|0
944849|NCT01018030|1935500|FG002|Overall Study|Physician Decision|1
944850|NCT01018030|1935498|FG000|Overall Study|Lack of Efficacy|1
944851|NCT01018030|1935499|FG001|Overall Study|Lack of Efficacy|0
944852|NCT01018030|1935500|FG002|Overall Study|Lack of Efficacy|0
944853|NCT01018030|1935498|FG000|Overall Study|Did Not Receive Study Drug|1
944854|NCT01018030|1935499|FG001|Overall Study|Did Not Receive Study Drug|3
944855|NCT01018030|1935500|FG002|Overall Study|Did Not Receive Study Drug|0
944856|NCT01018186|1935563|FG000|2-week Run-in Period|Protocol Violation|1
944857|NCT01018186|1935564|FG001|2-week Run-in Period|Protocol Violation|0
944858|NCT01018186|1935565|FG002|2-week Run-in Period|Protocol Violation|0
944859|NCT01018186|1935566|FG003|2-week Run-in Period|Protocol Violation|0
944860|NCT01018186|1935563|FG000|2-week Run-in Period|Lost to Follow-up|2
944861|NCT01018186|1935564|FG001|2-week Run-in Period|Lost to Follow-up|0
944862|NCT01018186|1935565|FG002|2-week Run-in Period|Lost to Follow-up|0
944863|NCT01018186|1935566|FG003|2-week Run-in Period|Lost to Follow-up|0
944864|NCT01018186|1935563|FG000|2-week Run-in Period|Physician Decision|3
944865|NCT01018186|1935564|FG001|2-week Run-in Period|Physician Decision|0
944866|NCT01018186|1935565|FG002|2-week Run-in Period|Physician Decision|0
944867|NCT01018186|1935566|FG003|2-week Run-in Period|Physician Decision|0
944868|NCT01018186|1935563|FG000|2-week Run-in Period|Withdrawal by Subject|11
910133|NCT00790842|1886891|FG007|Dose Level 4|Physician Decision|0
910134|NCT00790842|1886892|FG008|Dose Level 4|Physician Decision|0
910135|NCT00790842|1886893|FG009|Dose Level 4|Physician Decision|0
910136|NCT00790842|1886894|FG010|Dose Level 4|Physician Decision|1
910137|NCT00790842|1886884|FG000|Dose Level 4|Withdrawal by Subject|0
910138|NCT00790842|1886885|FG001|Dose Level 4|Withdrawal by Subject|0
910139|NCT00790842|1886886|FG002|Dose Level 4|Withdrawal by Subject|0
910140|NCT00790842|1886887|FG003|Dose Level 4|Withdrawal by Subject|0
910141|NCT00790842|1886888|FG004|Dose Level 4|Withdrawal by Subject|0
910142|NCT00790842|1886889|FG005|Dose Level 4|Withdrawal by Subject|0
910143|NCT00790842|1886890|FG006|Dose Level 4|Withdrawal by Subject|0
910144|NCT00790842|1886891|FG007|Dose Level 4|Withdrawal by Subject|0
910145|NCT00790842|1886892|FG008|Dose Level 4|Withdrawal by Subject|0
910146|NCT00790842|1886893|FG009|Dose Level 4|Withdrawal by Subject|0
910147|NCT00790842|1886894|FG010|Dose Level 4|Withdrawal by Subject|1
910148|NCT00790842|1886884|FG000|Expansion Cohort|Adverse Event|0
910149|NCT00790842|1886885|FG001|Expansion Cohort|Adverse Event|0
944869|NCT01018186|1935564|FG001|2-week Run-in Period|Withdrawal by Subject|0
944870|NCT01018186|1935565|FG002|2-week Run-in Period|Withdrawal by Subject|0
944871|NCT01018186|1935566|FG003|2-week Run-in Period|Withdrawal by Subject|0
944872|NCT01018186|1935563|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97
944873|NCT01018186|1935564|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
944874|NCT01018186|1935565|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
944875|NCT01018186|1935566|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
944876|NCT01018186|1935563|FG000|52-week Double-blind Treatment Period|Adverse Event|0
944877|NCT01018186|1935564|FG001|52-week Double-blind Treatment Period|Adverse Event|5
944878|NCT01018186|1935565|FG002|52-week Double-blind Treatment Period|Adverse Event|3
944879|NCT01018186|1935566|FG003|52-week Double-blind Treatment Period|Adverse Event|6
944880|NCT01018186|1935563|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
944881|NCT01018186|1935564|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1
944882|NCT01018186|1935565|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4
910150|NCT00790842|1886886|FG002|Expansion Cohort|Adverse Event|0
910151|NCT00790842|1886887|FG003|Expansion Cohort|Adverse Event|0
910152|NCT00790842|1886888|FG004|Expansion Cohort|Adverse Event|0
910153|NCT00790842|1886889|FG005|Expansion Cohort|Adverse Event|0
910154|NCT00790842|1886890|FG006|Expansion Cohort|Adverse Event|1
910155|NCT00790842|1886891|FG007|Expansion Cohort|Adverse Event|0
910156|NCT00790842|1886892|FG008|Expansion Cohort|Adverse Event|0
910157|NCT00790842|1886893|FG009|Expansion Cohort|Adverse Event|0
910158|NCT00790842|1886894|FG010|Expansion Cohort|Adverse Event|0
910159|NCT00790842|1886884|FG000|Expansion Cohort|Death|0
910160|NCT00790842|1886885|FG001|Expansion Cohort|Death|0
910161|NCT00790842|1886886|FG002|Expansion Cohort|Death|2
910162|NCT00790842|1886887|FG003|Expansion Cohort|Death|0
910163|NCT00790842|1886888|FG004|Expansion Cohort|Death|0
910164|NCT00790842|1886889|FG005|Expansion Cohort|Death|0
910165|NCT00790842|1886890|FG006|Expansion Cohort|Death|0
910166|NCT00790842|1886891|FG007|Expansion Cohort|Death|0
910167|NCT00790842|1886892|FG008|Expansion Cohort|Death|0
910168|NCT00790842|1886893|FG009|Expansion Cohort|Death|0
910169|NCT00790842|1886894|FG010|Expansion Cohort|Death|0
910170|NCT00790842|1886884|FG000|Expansion Cohort|Physician Decision|0
910171|NCT00790842|1886885|FG001|Expansion Cohort|Physician Decision|0
910172|NCT00790842|1886886|FG002|Expansion Cohort|Physician Decision|1
910173|NCT00790842|1886887|FG003|Expansion Cohort|Physician Decision|0
910174|NCT00790842|1886888|FG004|Expansion Cohort|Physician Decision|0
910175|NCT00790842|1886889|FG005|Expansion Cohort|Physician Decision|0
910176|NCT00790842|1886890|FG006|Expansion Cohort|Physician Decision|0
910177|NCT00790842|1886891|FG007|Expansion Cohort|Physician Decision|0
910178|NCT00790842|1886892|FG008|Expansion Cohort|Physician Decision|0
910179|NCT00790842|1886893|FG009|Expansion Cohort|Physician Decision|0
910180|NCT00790842|1886894|FG010|Expansion Cohort|Physician Decision|0
910181|NCT00790842|1886884|FG000|Expansion Cohort|Withdrawal by Subject|0
910182|NCT00790842|1886885|FG001|Expansion Cohort|Withdrawal by Subject|0
910183|NCT00790842|1886886|FG002|Expansion Cohort|Withdrawal by Subject|3
910184|NCT00790842|1886887|FG003|Expansion Cohort|Withdrawal by Subject|0
910185|NCT00790842|1886888|FG004|Expansion Cohort|Withdrawal by Subject|0
910186|NCT00790842|1886889|FG005|Expansion Cohort|Withdrawal by Subject|0
910187|NCT00790842|1886890|FG006|Expansion Cohort|Withdrawal by Subject|0
910188|NCT00790842|1886891|FG007|Expansion Cohort|Withdrawal by Subject|0
910189|NCT00790842|1886892|FG008|Expansion Cohort|Withdrawal by Subject|0
910190|NCT00790842|1886893|FG009|Expansion Cohort|Withdrawal by Subject|0
910191|NCT00790842|1886894|FG010|Expansion Cohort|Withdrawal by Subject|0
910192|NCT00790842|1886884|FG000|Expansion Cohort|Study Closure|0
910193|NCT00790842|1886885|FG001|Expansion Cohort|Study Closure|0
910194|NCT00790842|1886886|FG002|Expansion Cohort|Study Closure|1
910195|NCT00790842|1886887|FG003|Expansion Cohort|Study Closure|0
910196|NCT00790842|1886888|FG004|Expansion Cohort|Study Closure|0
910197|NCT00790842|1886889|FG005|Expansion Cohort|Study Closure|0
910198|NCT00790842|1886890|FG006|Expansion Cohort|Study Closure|0
910199|NCT00790842|1886891|FG007|Expansion Cohort|Study Closure|0
910200|NCT00790842|1886892|FG008|Expansion Cohort|Study Closure|0
910201|NCT00790842|1886893|FG009|Expansion Cohort|Study Closure|0
910202|NCT00790842|1886894|FG010|Expansion Cohort|Study Closure|0
910203|NCT00790868|1886949|FG000|Overall Study|Withdrawal by Subject|4
910204|NCT00790868|1886950|FG001|Overall Study|Withdrawal by Subject|5
910205|NCT00790868|1886949|FG000|Overall Study|Lost to Follow-up|2
910206|NCT00790868|1886950|FG001|Overall Study|Lost to Follow-up|12
910207|NCT00790907|1886961|FG000|Overall Study|Adverse Event|9
910208|NCT00790907|1886962|FG001|Overall Study|Adverse Event|7
910209|NCT00790907|1886963|FG002|Overall Study|Adverse Event|6
910210|NCT00790907|1886961|FG000|Overall Study|Physician Decision|304
910211|NCT00790907|1886962|FG001|Overall Study|Physician Decision|271
910212|NCT00790907|1886963|FG002|Overall Study|Physician Decision|255
910213|NCT00790907|1886961|FG000|Overall Study|Withdrawal by Subject|1
910214|NCT00790907|1886962|FG001|Overall Study|Withdrawal by Subject|7
910215|NCT00790907|1886963|FG002|Overall Study|Withdrawal by Subject|5
910216|NCT00790907|1886961|FG000|Overall Study|Bleeding Event|11
910217|NCT00790907|1886962|FG001|Overall Study|Bleeding Event|16
910218|NCT00790907|1886963|FG002|Overall Study|Bleeding Event|21
944883|NCT01018186|1935566|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1
944884|NCT01018186|1935563|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
944885|NCT01018186|1935564|FG001|52-week Double-blind Treatment Period|Protocol Violation|8
944886|NCT01018186|1935565|FG002|52-week Double-blind Treatment Period|Protocol Violation|8
944887|NCT01018186|1935566|FG003|52-week Double-blind Treatment Period|Protocol Violation|2
944888|NCT01018186|1935563|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
944889|NCT01018186|1935564|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
944890|NCT01018186|1935565|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
944891|NCT01018186|1935566|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
944892|NCT01018186|1935563|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
944893|NCT01018186|1935564|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1
944894|NCT01018186|1935565|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3
944895|NCT01018186|1935566|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4
944896|NCT01018186|1935563|FG000|52-week Double-blind Treatment Period|Physician Decision|0
944897|NCT01018186|1935564|FG001|52-week Double-blind Treatment Period|Physician Decision|1
944898|NCT01018186|1935565|FG002|52-week Double-blind Treatment Period|Physician Decision|0
944899|NCT01018186|1935566|FG003|52-week Double-blind Treatment Period|Physician Decision|3
944900|NCT01018186|1935563|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
944901|NCT01018186|1935564|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10
944902|NCT01018186|1935565|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7
944903|NCT01018186|1935566|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9
944904|NCT01018264|1935580|FG000|Overall Study|Withdrawal by Subject|1
944905|NCT01018264|1935581|FG001|Overall Study|Withdrawal by Subject|0
944906|NCT01018264|1935580|FG000|Overall Study|Lost to Follow-up|0
944907|NCT01018264|1935581|FG001|Overall Study|Lost to Follow-up|1
944908|NCT01018394|1935589|FG000|Overall Study|Withdrawal by Subject|5
944909|NCT01018394|1935590|FG001|Overall Study|Withdrawal by Subject|5
944910|NCT01018394|1935589|FG000|Overall Study|Lost to Follow-up|4
944911|NCT01018394|1935590|FG001|Overall Study|Lost to Follow-up|3
944912|NCT01018511|1935626|FG000|Overall Study|Not fulfilling eligibility criteria|6
944913|NCT01018511|1935627|FG001|Overall Study|Not fulfilling eligibility criteria|7
944914|NCT01018511|1935628|FG002|Overall Study|Not fulfilling eligibility criteria|7
944915|NCT01018511|1935629|FG003|Overall Study|Not fulfilling eligibility criteria|3
944916|NCT01018511|1935626|FG000|Overall Study|Adverse Event|5
944917|NCT01018511|1935627|FG001|Overall Study|Adverse Event|9
944918|NCT01018511|1935628|FG002|Overall Study|Adverse Event|13
944919|NCT01018511|1935629|FG003|Overall Study|Adverse Event|10
944920|NCT01018511|1935626|FG000|Overall Study|Lack of Efficacy|4
944921|NCT01018511|1935627|FG001|Overall Study|Lack of Efficacy|1
944922|NCT01018511|1935628|FG002|Overall Study|Lack of Efficacy|1
944923|NCT01018511|1935629|FG003|Overall Study|Lack of Efficacy|2
944924|NCT01018511|1935626|FG000|Overall Study|Withdrawal by Subject|6
944925|NCT01018511|1935627|FG001|Overall Study|Withdrawal by Subject|5
944926|NCT01018511|1935628|FG002|Overall Study|Withdrawal by Subject|11
944927|NCT01018511|1935629|FG003|Overall Study|Withdrawal by Subject|9
944928|NCT01018511|1935626|FG000|Overall Study|Lost to Follow-up|0
944929|NCT01018511|1935627|FG001|Overall Study|Lost to Follow-up|0
944930|NCT01018511|1935628|FG002|Overall Study|Lost to Follow-up|1
944931|NCT01018511|1935629|FG003|Overall Study|Lost to Follow-up|0
944932|NCT01018511|1935626|FG000|Overall Study|Protocol Violation|5
944933|NCT01018511|1935627|FG001|Overall Study|Protocol Violation|8
944934|NCT01018511|1935628|FG002|Overall Study|Protocol Violation|7
944935|NCT01018511|1935629|FG003|Overall Study|Protocol Violation|9
944936|NCT01018511|1935626|FG000|Overall Study|Miscellaneous|0
944937|NCT01018511|1935627|FG001|Overall Study|Miscellaneous|2
944938|NCT01018511|1935628|FG002|Overall Study|Miscellaneous|0
944939|NCT01018511|1935629|FG003|Overall Study|Miscellaneous|0
944940|NCT01018680|1935647|FG000|Overall Study|Adverse Event|23
944941|NCT01018680|1935648|FG001|Overall Study|Adverse Event|40
944942|NCT01018680|1935647|FG000|Overall Study|Withdrawal by Subject|10
944943|NCT01018680|1935648|FG001|Overall Study|Withdrawal by Subject|10
944944|NCT01018680|1935647|FG000|Overall Study|Protocol Violation|5
944945|NCT01018680|1935648|FG001|Overall Study|Protocol Violation|8
944946|NCT01018680|1935647|FG000|Overall Study|Sponsor Decision|6
944947|NCT01018680|1935648|FG001|Overall Study|Sponsor Decision|7
944948|NCT01018680|1935647|FG000|Overall Study|Lack of Efficacy|8
944949|NCT01018680|1935648|FG001|Overall Study|Lack of Efficacy|2
944950|NCT01018680|1935647|FG000|Overall Study|Lost to Follow-up|5
944951|NCT01018680|1935648|FG001|Overall Study|Lost to Follow-up|3
944952|NCT01018680|1935647|FG000|Overall Study|Entry Criteria Not Met|1
944953|NCT01018680|1935648|FG001|Overall Study|Entry Criteria Not Met|4
944954|NCT01018680|1935647|FG000|Overall Study|Physician Decision|3
944955|NCT01018680|1935648|FG001|Overall Study|Physician Decision|1
944956|NCT01018732|1935657|FG000|Overall Study|Lost to Follow-up|0
944957|NCT01018732|1935658|FG001|Overall Study|Lost to Follow-up|0
944958|NCT01018732|1935659|FG002|Overall Study|Lost to Follow-up|3
944959|NCT01018732|1935657|FG000|Overall Study|Protocol Violation|1
944960|NCT01018732|1935658|FG001|Overall Study|Protocol Violation|1
944961|NCT01018732|1935659|FG002|Overall Study|Protocol Violation|0
944962|NCT01018732|1935657|FG000|Overall Study|Inappropriate Enrollment|0
944963|NCT01018732|1935658|FG001|Overall Study|Inappropriate Enrollment|1
944964|NCT01018732|1935659|FG002|Overall Study|Inappropriate Enrollment|0
944965|NCT01018732|1935657|FG000|Overall Study|Unable to Classify|0
944966|NCT01018732|1935658|FG001|Overall Study|Unable to Classify|0
944967|NCT01018732|1935659|FG002|Overall Study|Unable to Classify|1
944968|NCT01018862|1935670|FG000|Overall Study|Adverse Event|2
944969|NCT01018862|1935671|FG001|Overall Study|Adverse Event|0
944970|NCT01018862|1935672|FG002|Overall Study|Adverse Event|6
944971|NCT01018862|1935670|FG000|Overall Study|Lack of Efficacy|1
944972|NCT01018862|1935671|FG001|Overall Study|Lack of Efficacy|0
944973|NCT01018862|1935672|FG002|Overall Study|Lack of Efficacy|2
944974|NCT01018862|1935670|FG000|Overall Study|Lost to Follow-up|3
944975|NCT01018862|1935671|FG001|Overall Study|Lost to Follow-up|1
944976|NCT01018862|1935672|FG002|Overall Study|Lost to Follow-up|0
944977|NCT01018862|1935670|FG000|Overall Study|Protocol Violation|1
910219|NCT00790907|1886961|FG000|Overall Study|Required Protocol-prohibited Therapy|17
910220|NCT00790907|1886962|FG001|Overall Study|Required Protocol-prohibited Therapy|5
910221|NCT00790907|1886963|FG002|Overall Study|Required Protocol-prohibited Therapy|7
910222|NCT00790907|1886961|FG000|Overall Study|Qualifying Condition Not Present|29
910223|NCT00790907|1886962|FG001|Overall Study|Qualifying Condition Not Present|14
910224|NCT00790907|1886963|FG002|Overall Study|Qualifying Condition Not Present|16
910225|NCT00790907|1886961|FG000|Overall Study|Verbatim Reason on the Case Report Form|74
910226|NCT00790907|1886962|FG001|Overall Study|Verbatim Reason on the Case Report Form|20
910227|NCT00790907|1886963|FG002|Overall Study|Verbatim Reason on the Case Report Form|29
910228|NCT00790907|1886961|FG000|Overall Study|Did Not Receive Study Drug|10
910229|NCT00790907|1886962|FG001|Overall Study|Did Not Receive Study Drug|0
910230|NCT00790907|1886963|FG002|Overall Study|Did Not Receive Study Drug|0
910231|NCT00790933|1886975|FG000|Overall Study|Adverse Event|94
910232|NCT00790933|1886976|FG001|Overall Study|Adverse Event|119
910233|NCT00790933|1886977|FG002|Overall Study|Adverse Event|65
910234|NCT00790933|1886978|FG003|Overall Study|Adverse Event|5
910235|NCT00790933|1886979|FG004|Overall Study|Adverse Event|69
910236|NCT00790933|1886975|FG000|Overall Study|Protocol Violation(s)|8
910237|NCT00790933|1886976|FG001|Overall Study|Protocol Violation(s)|18
910238|NCT00790933|1886977|FG002|Overall Study|Protocol Violation(s)|7
910239|NCT00790933|1886978|FG003|Overall Study|Protocol Violation(s)|0
910240|NCT00790933|1886979|FG004|Overall Study|Protocol Violation(s)|12
910241|NCT00790933|1886975|FG000|Overall Study|Lack of Efficacy|192
910242|NCT00790933|1886976|FG001|Overall Study|Lack of Efficacy|176
910243|NCT00790933|1886977|FG002|Overall Study|Lack of Efficacy|130
910244|NCT00790933|1886978|FG003|Overall Study|Lack of Efficacy|1
910245|NCT00790933|1886979|FG004|Overall Study|Lack of Efficacy|121
910246|NCT00790933|1886975|FG000|Overall Study|Study Terminated by Sponsor|0
910247|NCT00790933|1886976|FG001|Overall Study|Study Terminated by Sponsor|0
910248|NCT00790933|1886977|FG002|Overall Study|Study Terminated by Sponsor|1
910249|NCT00790933|1886978|FG003|Overall Study|Study Terminated by Sponsor|0
910250|NCT00790933|1886979|FG004|Overall Study|Study Terminated by Sponsor|0
910251|NCT00790933|1886975|FG000|Overall Study|Withdrawal by Subject|123
910252|NCT00790933|1886976|FG001|Overall Study|Withdrawal by Subject|120
910253|NCT00790933|1886977|FG002|Overall Study|Withdrawal by Subject|52
910254|NCT00790933|1886978|FG003|Overall Study|Withdrawal by Subject|6
910255|NCT00790933|1886979|FG004|Overall Study|Withdrawal by Subject|50
910256|NCT00790933|1886975|FG000|Overall Study|Lost to Follow-up|13
910257|NCT00790933|1886976|FG001|Overall Study|Lost to Follow-up|31
910258|NCT00790933|1886977|FG002|Overall Study|Lost to Follow-up|10
910259|NCT00790933|1886978|FG003|Overall Study|Lost to Follow-up|1
910260|NCT00790933|1886979|FG004|Overall Study|Lost to Follow-up|15
910261|NCT00790933|1886975|FG000|Overall Study|Reason Not Specified|8
910262|NCT00790933|1886976|FG001|Overall Study|Reason Not Specified|16
910263|NCT00790933|1886977|FG002|Overall Study|Reason Not Specified|4
910264|NCT00790933|1886978|FG003|Overall Study|Reason Not Specified|1
910265|NCT00790933|1886979|FG004|Overall Study|Reason Not Specified|9
910266|NCT00791128|1887017|FG000|Overall Study|Adverse Event|4
910267|NCT00791128|1887017|FG000|Overall Study|Device migration|2
910268|NCT00791128|1887017|FG000|Overall Study|non-compliance by subject|2
910269|NCT00791128|1887017|FG000|Overall Study|abdominal tumor, unrelated to device|1
910270|NCT00791258|1887034|FG000|Overall Study|Adverse Event|87
910271|NCT00791258|1887034|FG000|Overall Study|Lost to Follow-up|18
910272|NCT00791258|1887034|FG000|Overall Study|Protocol Violation|109
910273|NCT00791258|1887034|FG000|Overall Study|Withdrawal by Subject|40
910274|NCT00791258|1887034|FG000|Overall Study|Did not take medication for >3 days|1
910275|NCT00791258|1887034|FG000|Overall Study|subject left area|2
910276|NCT00791258|1887034|FG000|Overall Study|non-compliance|3
910277|NCT00791258|1887034|FG000|Overall Study|Subject incarcerated|1
910278|NCT00791258|1887034|FG000|Overall Study|Subject required restricted medication|1
910279|NCT00791258|1887034|FG000|Overall Study|Lack of Efficacy|1
910280|NCT00791388|1887052|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
910281|NCT00791388|1887053|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
910282|NCT00791388|1887054|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
910283|NCT00791388|1887055|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
910284|NCT00791388|1887056|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
910285|NCT00791388|1887052|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
944978|NCT01018862|1935671|FG001|Overall Study|Protocol Violation|3
944979|NCT01018862|1935672|FG002|Overall Study|Protocol Violation|3
944980|NCT01018862|1935670|FG000|Overall Study|Withdrawal by Subject|1
944981|NCT01018862|1935671|FG001|Overall Study|Withdrawal by Subject|2
944982|NCT01018862|1935672|FG002|Overall Study|Withdrawal by Subject|1
944983|NCT01018862|1935670|FG000|Overall Study|administrative problems|5
944984|NCT01018862|1935671|FG001|Overall Study|administrative problems|4
944985|NCT01018862|1935672|FG002|Overall Study|administrative problems|4
944986|NCT01018953|1935680|FG000|Overall Study|Adverse Event|2
944987|NCT01018953|1935680|FG000|Overall Study|Withdrawal by Subject|1
944988|NCT01018953|1935680|FG000|Overall Study|Study termination by sponsor|5
944989|NCT01018979|1935687|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
944990|NCT01018979|1935688|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
944991|NCT01018979|1935687|FG000|Overall Study|Not received at least one dose|0
944992|NCT01018979|1935688|FG001|Overall Study|Not received at least one dose|1
944993|NCT01018992|1935699|FG000|Overall Study|Adverse Event|8
944994|NCT01018992|1935700|FG001|Overall Study|Adverse Event|3
944995|NCT01018992|1935699|FG000|Overall Study|Withdrawal by Subject|3
910286|NCT00791388|1887053|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
910287|NCT00791388|1887054|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
910288|NCT00791388|1887055|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
910289|NCT00791388|1887056|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
910290|NCT00791388|1887052|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0
910291|NCT00791388|1887053|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0
910292|NCT00791388|1887054|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0
910293|NCT00791388|1887055|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0
910294|NCT00791388|1887056|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4
910295|NCT00791479|1887074|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0
910296|NCT00791479|1887075|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0
910297|NCT00791479|1887076|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0
910298|NCT00791479|1887077|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0
910299|NCT00791479|1887078|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3
910300|NCT00791479|1887079|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0
910301|NCT00791479|1887074|FG000|Overall Study|Adverse Event|0
910302|NCT00791479|1887075|FG001|Overall Study|Adverse Event|1
910303|NCT00791479|1887076|FG002|Overall Study|Adverse Event|0
910304|NCT00791479|1887077|FG003|Overall Study|Adverse Event|2
910305|NCT00791479|1887078|FG004|Overall Study|Adverse Event|0
910306|NCT00791479|1887079|FG005|Overall Study|Adverse Event|1
910307|NCT00791479|1887074|FG000|Overall Study|Lost to Follow-up|0
910308|NCT00791479|1887075|FG001|Overall Study|Lost to Follow-up|1
910309|NCT00791479|1887076|FG002|Overall Study|Lost to Follow-up|0
910310|NCT00791479|1887077|FG003|Overall Study|Lost to Follow-up|0
910311|NCT00791479|1887078|FG004|Overall Study|Lost to Follow-up|0
910312|NCT00791479|1887079|FG005|Overall Study|Lost to Follow-up|1
910313|NCT00791479|1887074|FG000|Overall Study|Protocol Violation|2
910314|NCT00791479|1887075|FG001|Overall Study|Protocol Violation|1
910315|NCT00791479|1887076|FG002|Overall Study|Protocol Violation|0
910316|NCT00791479|1887077|FG003|Overall Study|Protocol Violation|1
910317|NCT00791479|1887078|FG004|Overall Study|Protocol Violation|0
910318|NCT00791479|1887079|FG005|Overall Study|Protocol Violation|0
910319|NCT00791479|1887074|FG000|Overall Study|Withdrawal by Subject|0
910320|NCT00791479|1887075|FG001|Overall Study|Withdrawal by Subject|0
910321|NCT00791479|1887076|FG002|Overall Study|Withdrawal by Subject|0
910322|NCT00791479|1887077|FG003|Overall Study|Withdrawal by Subject|1
910323|NCT00791479|1887078|FG004|Overall Study|Withdrawal by Subject|0
910324|NCT00791479|1887079|FG005|Overall Study|Withdrawal by Subject|1
910325|NCT00791492|1887102|FG000|Overall Study|Withdrawal by Subject|1
910326|NCT00791492|1887103|FG001|Overall Study|Withdrawal by Subject|2
910327|NCT00791492|1887102|FG000|Overall Study|Liver transplantation|5
910328|NCT00791492|1887103|FG001|Overall Study|Liver transplantation|1
910329|NCT00791518|1887109|FG000|Overall Study|Protocol Violation|93
910330|NCT00791557|1887128|FG000|Overall Study|Adverse Event|1
910331|NCT00791648|1887134|FG000|Overall Study|Physician Decision|0
910332|NCT00791648|1887135|FG001|Overall Study|Physician Decision|1
910333|NCT00791648|1887134|FG000|Overall Study|Withdrawal by Subject|0
910334|NCT00791648|1887135|FG001|Overall Study|Withdrawal by Subject|1
910335|NCT00791661|1887144|FG000|7 Day Wash-out|Adverse Event|0
910336|NCT00791661|1887145|FG001|7 Day Wash-out|Adverse Event|0
910337|NCT00791661|1887146|FG002|7 Day Wash-out|Adverse Event|1
910338|NCT00791661|1887144|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
910339|NCT00791661|1887145|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
910340|NCT00791661|1887146|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
910341|NCT00791700|1887174|FG000|Overall Study|Insufficient clinical response|1
910342|NCT00791700|1887175|FG001|Overall Study|Insufficient clinical response|4
910343|NCT00791700|1887176|FG002|Overall Study|Insufficient clinical response|1
910344|NCT00791700|1887177|FG003|Overall Study|Insufficient clinical response|8
910345|NCT00791700|1887174|FG000|Overall Study|No longer willing to participate|1
910346|NCT00791700|1887175|FG001|Overall Study|No longer willing to participate|1
910347|NCT00791700|1887176|FG002|Overall Study|No longer willing to participate|0
944996|NCT01018992|1935700|FG001|Overall Study|Withdrawal by Subject|8
944997|NCT01018992|1935699|FG000|Overall Study|Protocol Violation|0
944998|NCT01018992|1935700|FG001|Overall Study|Protocol Violation|4
910348|NCT00791700|1887177|FG003|Overall Study|No longer willing to participate|8
910349|NCT00791700|1887174|FG000|Overall Study|Non-compliance with study treatment|0
910350|NCT00791700|1887175|FG001|Overall Study|Non-compliance with study treatment|2
910351|NCT00791700|1887176|FG002|Overall Study|Non-compliance with study treatment|0
910352|NCT00791700|1887177|FG003|Overall Study|Non-compliance with study treatment|4
910353|NCT00791700|1887174|FG000|Overall Study|Withdrawn due to pregnancy|0
910354|NCT00791700|1887175|FG001|Overall Study|Withdrawn due to pregnancy|0
910355|NCT00791700|1887176|FG002|Overall Study|Withdrawn due to pregnancy|0
910356|NCT00791700|1887177|FG003|Overall Study|Withdrawn due to pregnancy|1
910357|NCT00791700|1887174|FG000|Overall Study|Other|0
910358|NCT00791700|1887175|FG001|Overall Study|Other|1
910359|NCT00791700|1887176|FG002|Overall Study|Other|0
910360|NCT00791700|1887177|FG003|Overall Study|Other|1
910361|NCT00791700|1887174|FG000|Overall Study|Death|0
910362|NCT00791700|1887175|FG001|Overall Study|Death|0
910363|NCT00791700|1887176|FG002|Overall Study|Death|0
910364|NCT00791700|1887177|FG003|Overall Study|Death|1
910365|NCT00791700|1887174|FG000|Overall Study|Lost to Follow-up|4
910366|NCT00791700|1887175|FG001|Overall Study|Lost to Follow-up|3
910367|NCT00791700|1887176|FG002|Overall Study|Lost to Follow-up|4
910368|NCT00791700|1887177|FG003|Overall Study|Lost to Follow-up|6
910369|NCT00791700|1887174|FG000|Overall Study|Adverse Event|0
910370|NCT00791700|1887175|FG001|Overall Study|Adverse Event|0
910371|NCT00791700|1887176|FG002|Overall Study|Adverse Event|1
910372|NCT00791700|1887177|FG003|Overall Study|Adverse Event|1
910373|NCT00791765|1887200|FG000|Weeks 1 to 12|Adverse Event|0
910374|NCT00791765|1887201|FG001|Weeks 1 to 12|Adverse Event|1
910375|NCT00791765|1887200|FG000|Weeks 1 to 12|Lost to Follow-up|1
910376|NCT00791765|1887201|FG001|Weeks 1 to 12|Lost to Follow-up|0
910377|NCT00791765|1887200|FG000|Weeks 1 to 12|Withdrawal by Subject|3
910378|NCT00791765|1887201|FG001|Weeks 1 to 12|Withdrawal by Subject|0
910379|NCT00791765|1887200|FG000|Weeks 1 to 12|Physician Decision|1
910380|NCT00791765|1887201|FG001|Weeks 1 to 12|Physician Decision|0
910381|NCT00791765|1887200|FG000|Weeks 1 to 12|Disease progression|3
910382|NCT00791765|1887201|FG001|Weeks 1 to 12|Disease progression|0
910383|NCT00791765|1887200|FG000|Weeks 1 to 12|Ineligibility determined|0
910384|NCT00791765|1887201|FG001|Weeks 1 to 12|Ineligibility determined|3
910385|NCT00791765|1887200|FG000|Weeks 13 to 24|Protocol deviation|2
910386|NCT00791765|1887201|FG001|Weeks 13 to 24|Protocol deviation|0
910387|NCT00791765|1887200|FG000|Weeks 13 to 24|Adverse Event|0
910388|NCT00791765|1887201|FG001|Weeks 13 to 24|Adverse Event|3
910389|NCT00791765|1887200|FG000|Weeks 13 to 24|Withdrawal by Subject|2
910390|NCT00791765|1887201|FG001|Weeks 13 to 24|Withdrawal by Subject|1
910391|NCT00791765|1887200|FG000|Weeks 13 to 24|Disease progression|0
910392|NCT00791765|1887201|FG001|Weeks 13 to 24|Disease progression|1
910393|NCT00791765|1887200|FG000|Weeks 13 to 24|Lost to Follow-up|1
910394|NCT00791765|1887201|FG001|Weeks 13 to 24|Lost to Follow-up|2
910395|NCT00791765|1887200|FG000|Weeks 13 to 24|Other|0
910396|NCT00791765|1887201|FG001|Weeks 13 to 24|Other|1
910397|NCT00791778|1887209|FG000|Double-blind Treatment|Adverse Event|49
910398|NCT00791778|1887210|FG001|Double-blind Treatment|Adverse Event|9
910399|NCT00791778|1887209|FG000|Double-blind Treatment|Physician Decision|6
910400|NCT00791778|1887210|FG001|Double-blind Treatment|Physician Decision|26
910401|NCT00791778|1887209|FG000|Double-blind Treatment|Protocol Violation|0
910402|NCT00791778|1887210|FG001|Double-blind Treatment|Protocol Violation|4
910403|NCT00791778|1887209|FG000|Double-blind Treatment|Withdrawal by Subject|20
910404|NCT00791778|1887210|FG001|Double-blind Treatment|Withdrawal by Subject|9
910405|NCT00791778|1887209|FG000|Double-blind Treatment|Non-compliant with study medication|2
910406|NCT00791778|1887210|FG001|Double-blind Treatment|Non-compliant with study medication|0
910407|NCT00791778|1887209|FG000|Follow-up|Withdrawal by Subject|3
910408|NCT00791778|1887210|FG001|Follow-up|Withdrawal by Subject|0
910409|NCT00791778|1887209|FG000|Follow-up|Lost to Follow-up|2
910410|NCT00791778|1887210|FG001|Follow-up|Lost to Follow-up|1
910411|NCT00791921|1887235|FG000|Overall Study|Protocol planed|24
910412|NCT00791921|1887236|FG001|Overall Study|Protocol planed|88
910413|NCT00791921|1887235|FG000|Overall Study|Withdrawal by Subject|1
910414|NCT00791921|1887236|FG001|Overall Study|Withdrawal by Subject|2
910415|NCT00791921|1887235|FG000|Overall Study|Adverse Event|8
910416|NCT00791921|1887236|FG001|Overall Study|Adverse Event|2
910417|NCT00791921|1887235|FG000|Overall Study|Lack of Efficacy|0
910418|NCT00791921|1887236|FG001|Overall Study|Lack of Efficacy|2
910419|NCT00791921|1887235|FG000|Overall Study|Lack of study drug administration|1
910420|NCT00791921|1887236|FG001|Overall Study|Lack of study drug administration|1
910421|NCT00791921|1887235|FG000|Overall Study|Reason other than those above|0
910422|NCT00791921|1887236|FG001|Overall Study|Reason other than those above|1
910423|NCT00791934|1887242|FG000|Overall Study|Withdrawal by Subject|2
910424|NCT00791934|1887242|FG000|Overall Study|Did not consent for extended follow-up|13
910425|NCT00791999|1887259|FG000|Overall Study|Protocol planed withdrawal|14
910426|NCT00791999|1887260|FG001|Overall Study|Protocol planed withdrawal|11
910427|NCT00791999|1887261|FG002|Overall Study|Protocol planed withdrawal|11
910428|NCT00791999|1887262|FG003|Overall Study|Protocol planed withdrawal|45
944999|NCT01018992|1935699|FG000|Overall Study|Lost to Follow-up|5
945000|NCT01018992|1935700|FG001|Overall Study|Lost to Follow-up|1
945001|NCT01019135|1935709|FG000|Overall Study|Did not receive allocated intervention|12
945002|NCT01019135|1935710|FG001|Overall Study|Did not receive allocated intervention|6
945003|NCT01019135|1935711|FG002|Overall Study|Did not receive allocated intervention|25
945004|NCT01019135|1935709|FG000|Overall Study|Did not attend CR|8
945005|NCT01019135|1935710|FG001|Overall Study|Did not attend CR|13
945006|NCT01019135|1935711|FG002|Overall Study|Did not attend CR|6
945007|NCT01019252|1935721|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2
945008|NCT01019252|1935722|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0
945009|NCT01019252|1935721|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
945010|NCT01019252|1935722|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
945011|NCT01019252|1935721|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0
945012|NCT01019252|1935722|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2
945013|NCT01019252|1935721|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
945014|NCT01019252|1935722|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
945015|NCT01019317|1935728|FG000|Overall Study|Not Eligible|4
945016|NCT01019369|1935734|FG000|Overall Study|Lost to Follow-up|10
945017|NCT01019369|1935735|FG001|Overall Study|Lost to Follow-up|6
945018|NCT01019369|1935734|FG000|Overall Study|Withdrawal by Subject|0
945019|NCT01019369|1935735|FG001|Overall Study|Withdrawal by Subject|1
945020|NCT01019486|1935745|FG000|Overall Study|Withdrawal by Subject|1
945021|NCT01019486|1935746|FG001|Overall Study|Withdrawal by Subject|1
945022|NCT01019486|1935747|FG002|Overall Study|Withdrawal by Subject|1
945023|NCT01019694|1935759|FG000|Overall Study|Adverse Event|12
945024|NCT01019694|1935760|FG001|Overall Study|Adverse Event|16
945025|NCT01019694|1935761|FG002|Overall Study|Adverse Event|19
945026|NCT01019694|1935759|FG000|Overall Study|Protocol Violation|2
945027|NCT01019694|1935760|FG001|Overall Study|Protocol Violation|6
945028|NCT01019694|1935761|FG002|Overall Study|Protocol Violation|4
945029|NCT01019694|1935759|FG000|Overall Study|Lost to Follow-up|5
945030|NCT01019694|1935760|FG001|Overall Study|Lost to Follow-up|3
945031|NCT01019694|1935761|FG002|Overall Study|Lost to Follow-up|3
945032|NCT01019694|1935759|FG000|Overall Study|Withdrawal by Subject|4
945033|NCT01019694|1935760|FG001|Overall Study|Withdrawal by Subject|6
945034|NCT01019694|1935761|FG002|Overall Study|Withdrawal by Subject|12
945035|NCT01019694|1935759|FG000|Overall Study|Not treated|0
945036|NCT01019694|1935760|FG001|Overall Study|Not treated|2
945037|NCT01019694|1935761|FG002|Overall Study|Not treated|3
945038|NCT01019694|1935759|FG000|Overall Study|Other reason (not specified)|1
945039|NCT01019694|1935760|FG001|Overall Study|Other reason (not specified)|5
945040|NCT01019694|1935761|FG002|Overall Study|Other reason (not specified)|6
945041|NCT01020019|1935800|FG000|Overall Study|Lost to Follow-up|21
945042|NCT01020019|1935801|FG001|Overall Study|Lost to Follow-up|18
945043|NCT01020019|1935800|FG000|Overall Study|Adverse Event|1
945044|NCT01020019|1935801|FG001|Overall Study|Adverse Event|5
945045|NCT01020019|1935800|FG000|Overall Study|not interested in treatment|4
945046|NCT01020019|1935801|FG001|Overall Study|not interested in treatment|4
945047|NCT01020019|1935800|FG000|Overall Study|moving|0
945048|NCT01020019|1935801|FG001|Overall Study|moving|2
945049|NCT01020123|1935814|FG000|Main Period|Withdrawal by Subject|6
945050|NCT01020123|1935815|FG001|Main Period|Withdrawal by Subject|5
945051|NCT01020123|1935816|FG002|Main Period|Withdrawal by Subject|3
945052|NCT01020123|1935817|FG003|Main Period|Withdrawal by Subject|1
945053|NCT01020123|1935818|FG004|Main Period|Withdrawal by Subject|6
945054|NCT01020123|1935819|FG005|Main Period|Withdrawal by Subject|3
945055|NCT01020123|1935820|FG006|Main Period|Withdrawal by Subject|2
945056|NCT01020123|1935814|FG000|Main Period|Eligibility Criteria not fullfilled|0
945057|NCT01020123|1935815|FG001|Main Period|Eligibility Criteria not fullfilled|1
945058|NCT01020123|1935816|FG002|Main Period|Eligibility Criteria not fullfilled|0
945059|NCT01020123|1935817|FG003|Main Period|Eligibility Criteria not fullfilled|0
945060|NCT01020123|1935818|FG004|Main Period|Eligibility Criteria not fullfilled|1
945061|NCT01020123|1935819|FG005|Main Period|Eligibility Criteria not fullfilled|0
945062|NCT01020123|1935820|FG006|Main Period|Eligibility Criteria not fullfilled|0
945063|NCT01020123|1935814|FG000|Main Period|Adverse Event|5
910429|NCT00791999|1887259|FG000|Overall Study|Withdrawal by Subject|0
910430|NCT00791999|1887260|FG001|Overall Study|Withdrawal by Subject|1
910431|NCT00791999|1887261|FG002|Overall Study|Withdrawal by Subject|0
910432|NCT00791999|1887262|FG003|Overall Study|Withdrawal by Subject|2
910433|NCT00791999|1887259|FG000|Overall Study|Protocol Violation|3
910434|NCT00791999|1887260|FG001|Overall Study|Protocol Violation|0
910435|NCT00791999|1887261|FG002|Overall Study|Protocol Violation|1
910436|NCT00791999|1887262|FG003|Overall Study|Protocol Violation|0
910437|NCT00791999|1887259|FG000|Overall Study|Adverse Event|3
910438|NCT00791999|1887260|FG001|Overall Study|Adverse Event|3
910439|NCT00791999|1887261|FG002|Overall Study|Adverse Event|7
910440|NCT00791999|1887262|FG003|Overall Study|Adverse Event|3
910441|NCT00791999|1887259|FG000|Overall Study|Lack of Efficacy|0
910442|NCT00791999|1887260|FG001|Overall Study|Lack of Efficacy|1
910443|NCT00791999|1887261|FG002|Overall Study|Lack of Efficacy|0
945064|NCT01020123|1935815|FG001|Main Period|Adverse Event|2
945065|NCT01020123|1935816|FG002|Main Period|Adverse Event|2
945066|NCT01020123|1935817|FG003|Main Period|Adverse Event|1
945067|NCT01020123|1935818|FG004|Main Period|Adverse Event|1
945068|NCT01020123|1935819|FG005|Main Period|Adverse Event|2
945069|NCT01020123|1935820|FG006|Main Period|Adverse Event|1
945070|NCT01020123|1935814|FG000|Main Period|Protocol Violation|4
945071|NCT01020123|1935815|FG001|Main Period|Protocol Violation|4
945072|NCT01020123|1935816|FG002|Main Period|Protocol Violation|2
945073|NCT01020123|1935817|FG003|Main Period|Protocol Violation|5
945074|NCT01020123|1935818|FG004|Main Period|Protocol Violation|2
945075|NCT01020123|1935819|FG005|Main Period|Protocol Violation|3
945076|NCT01020123|1935820|FG006|Main Period|Protocol Violation|2
945077|NCT01020123|1935814|FG000|Main Period|Lost to Follow-up|0
945078|NCT01020123|1935815|FG001|Main Period|Lost to Follow-up|2
945079|NCT01020123|1935816|FG002|Main Period|Lost to Follow-up|0
945080|NCT01020123|1935817|FG003|Main Period|Lost to Follow-up|0
945081|NCT01020123|1935818|FG004|Main Period|Lost to Follow-up|0
945082|NCT01020123|1935819|FG005|Main Period|Lost to Follow-up|0
945083|NCT01020123|1935820|FG006|Main Period|Lost to Follow-up|0
945084|NCT01020123|1935814|FG000|Main Period|Unclasified|2
945085|NCT01020123|1935815|FG001|Main Period|Unclasified|0
945086|NCT01020123|1935816|FG002|Main Period|Unclasified|1
945087|NCT01020123|1935817|FG003|Main Period|Unclasified|0
945088|NCT01020123|1935818|FG004|Main Period|Unclasified|1
945089|NCT01020123|1935819|FG005|Main Period|Unclasified|3
945090|NCT01020123|1935820|FG006|Main Period|Unclasified|6
945091|NCT01020123|1935814|FG000|Extention Period|Withdrawal by Subject|2
910444|NCT00791999|1887262|FG003|Overall Study|Lack of Efficacy|2
910445|NCT00791999|1887259|FG000|Overall Study|Reason other than those above|1
910446|NCT00791999|1887260|FG001|Overall Study|Reason other than those above|0
910447|NCT00791999|1887261|FG002|Overall Study|Reason other than those above|1
910448|NCT00791999|1887262|FG003|Overall Study|Reason other than those above|0
910449|NCT00792103|1887276|FG000|Overall Study|Enrolled, not treated|15
910450|NCT00792103|1887276|FG000|Overall Study|Lost to Follow-up|17
910451|NCT00792103|1887276|FG000|Overall Study|Adverse Event|25
910452|NCT00792103|1887276|FG000|Overall Study|Withdrawal by Subject|52
910453|NCT00792103|1887276|FG000|Overall Study|Protocol Violation|10
910454|NCT00792103|1887276|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14
910455|NCT00792116|1887282|FG000|Overall Study|Lost to Follow-up|0
910456|NCT00792116|1887283|FG001|Overall Study|Lost to Follow-up|1
910457|NCT00792116|1887282|FG000|Overall Study|Discontnued intervention|1
910458|NCT00792116|1887283|FG001|Overall Study|Discontnued intervention|0
910462|NCT00792298|1887304|FG000|Treatment Period 1|Adverse Event|0
910463|NCT00792298|1887305|FG001|Treatment Period 1|Adverse Event|1
910464|NCT00792298|1887306|FG002|Treatment Period 1|Adverse Event|0
910465|NCT00792298|1887307|FG003|Treatment Period 1|Adverse Event|1
910466|NCT00792298|1887308|FG004|Treatment Period 1|Adverse Event|0
910467|NCT00792298|1887309|FG005|Treatment Period 1|Adverse Event|1
910468|NCT00792298|1887310|FG006|Treatment Period 1|Adverse Event|1
910469|NCT00792298|1887311|FG007|Treatment Period 1|Adverse Event|0
910470|NCT00792298|1887304|FG000|Treatment Period 1|Lack of Efficacy|0
910471|NCT00792298|1887305|FG001|Treatment Period 1|Lack of Efficacy|0
910472|NCT00792298|1887306|FG002|Treatment Period 1|Lack of Efficacy|1
910473|NCT00792298|1887307|FG003|Treatment Period 1|Lack of Efficacy|0
910474|NCT00792298|1887308|FG004|Treatment Period 1|Lack of Efficacy|0
910475|NCT00792298|1887309|FG005|Treatment Period 1|Lack of Efficacy|0
910476|NCT00792298|1887310|FG006|Treatment Period 1|Lack of Efficacy|0
910477|NCT00792298|1887311|FG007|Treatment Period 1|Lack of Efficacy|0
910478|NCT00792298|1887304|FG000|Treatment Period 1|Withdrawal by Subject|1
910479|NCT00792298|1887305|FG001|Treatment Period 1|Withdrawal by Subject|0
910480|NCT00792298|1887306|FG002|Treatment Period 1|Withdrawal by Subject|1
910481|NCT00792298|1887307|FG003|Treatment Period 1|Withdrawal by Subject|2
910482|NCT00792298|1887308|FG004|Treatment Period 1|Withdrawal by Subject|0
910483|NCT00792298|1887309|FG005|Treatment Period 1|Withdrawal by Subject|2
910484|NCT00792298|1887310|FG006|Treatment Period 1|Withdrawal by Subject|1
910485|NCT00792298|1887311|FG007|Treatment Period 1|Withdrawal by Subject|0
910486|NCT00792298|1887304|FG000|Treatment Period 1|Lost to Follow-up|0
910487|NCT00792298|1887305|FG001|Treatment Period 1|Lost to Follow-up|0
910488|NCT00792298|1887306|FG002|Treatment Period 1|Lost to Follow-up|0
910489|NCT00792298|1887307|FG003|Treatment Period 1|Lost to Follow-up|0
910490|NCT00792298|1887308|FG004|Treatment Period 1|Lost to Follow-up|0
910491|NCT00792298|1887309|FG005|Treatment Period 1|Lost to Follow-up|0
910492|NCT00792298|1887310|FG006|Treatment Period 1|Lost to Follow-up|1
910493|NCT00792298|1887311|FG007|Treatment Period 1|Lost to Follow-up|0
910494|NCT00792298|1887304|FG000|Treatment Period 1|Physician Decision|0
910495|NCT00792298|1887305|FG001|Treatment Period 1|Physician Decision|0
910496|NCT00792298|1887306|FG002|Treatment Period 1|Physician Decision|0
910497|NCT00792298|1887307|FG003|Treatment Period 1|Physician Decision|1
910498|NCT00792298|1887308|FG004|Treatment Period 1|Physician Decision|0
910499|NCT00792298|1887309|FG005|Treatment Period 1|Physician Decision|0
945092|NCT01020123|1935815|FG001|Extention Period|Withdrawal by Subject|1
945093|NCT01020123|1935816|FG002|Extention Period|Withdrawal by Subject|1
945094|NCT01020123|1935817|FG003|Extention Period|Withdrawal by Subject|0
945095|NCT01020123|1935818|FG004|Extention Period|Withdrawal by Subject|0
945096|NCT01020123|1935819|FG005|Extention Period|Withdrawal by Subject|0
945097|NCT01020123|1935820|FG006|Extention Period|Withdrawal by Subject|0
945098|NCT01020123|1935814|FG000|Extention Period|Adverse Event|0
945099|NCT01020123|1935815|FG001|Extention Period|Adverse Event|0
945100|NCT01020123|1935816|FG002|Extention Period|Adverse Event|0
945101|NCT01020123|1935817|FG003|Extention Period|Adverse Event|1
945102|NCT01020123|1935818|FG004|Extention Period|Adverse Event|0
910500|NCT00792298|1887310|FG006|Treatment Period 1|Physician Decision|1
910501|NCT00792298|1887311|FG007|Treatment Period 1|Physician Decision|0
910502|NCT00792298|1887304|FG000|Treatment Period 1|Protocol Violation|0
910503|NCT00792298|1887305|FG001|Treatment Period 1|Protocol Violation|0
910504|NCT00792298|1887306|FG002|Treatment Period 1|Protocol Violation|0
910505|NCT00792298|1887307|FG003|Treatment Period 1|Protocol Violation|0
910506|NCT00792298|1887308|FG004|Treatment Period 1|Protocol Violation|0
910507|NCT00792298|1887309|FG005|Treatment Period 1|Protocol Violation|0
910508|NCT00792298|1887310|FG006|Treatment Period 1|Protocol Violation|0
910509|NCT00792298|1887311|FG007|Treatment Period 1|Protocol Violation|1
910510|NCT00792298|1887304|FG000|Washout|Adverse Event|0
910511|NCT00792298|1887305|FG001|Washout|Adverse Event|0
910512|NCT00792298|1887306|FG002|Washout|Adverse Event|0
910513|NCT00792298|1887307|FG003|Washout|Adverse Event|0
910514|NCT00792298|1887308|FG004|Washout|Adverse Event|0
910515|NCT00792298|1887309|FG005|Washout|Adverse Event|1
910516|NCT00792298|1887310|FG006|Washout|Adverse Event|0
910517|NCT00792298|1887311|FG007|Washout|Adverse Event|0
910518|NCT00792298|1887304|FG000|Washout|Withdrawal by Subject|0
910519|NCT00792298|1887305|FG001|Washout|Withdrawal by Subject|0
910520|NCT00792298|1887306|FG002|Washout|Withdrawal by Subject|1
910521|NCT00792298|1887307|FG003|Washout|Withdrawal by Subject|0
910522|NCT00792298|1887308|FG004|Washout|Withdrawal by Subject|0
910523|NCT00792298|1887309|FG005|Washout|Withdrawal by Subject|1
910524|NCT00792298|1887310|FG006|Washout|Withdrawal by Subject|0
910525|NCT00792298|1887311|FG007|Washout|Withdrawal by Subject|0
910526|NCT00792298|1887304|FG000|Treatment Period 2|Lack of Efficacy|0
910527|NCT00792298|1887305|FG001|Treatment Period 2|Lack of Efficacy|0
910528|NCT00792298|1887306|FG002|Treatment Period 2|Lack of Efficacy|0
910529|NCT00792298|1887307|FG003|Treatment Period 2|Lack of Efficacy|0
910530|NCT00792298|1887308|FG004|Treatment Period 2|Lack of Efficacy|1
910531|NCT00792298|1887309|FG005|Treatment Period 2|Lack of Efficacy|0
910532|NCT00792298|1887310|FG006|Treatment Period 2|Lack of Efficacy|0
910533|NCT00792298|1887311|FG007|Treatment Period 2|Lack of Efficacy|0
910534|NCT00792298|1887304|FG000|Treatment Period 2|Physician Decision|0
910535|NCT00792298|1887305|FG001|Treatment Period 2|Physician Decision|0
910536|NCT00792298|1887306|FG002|Treatment Period 2|Physician Decision|0
910537|NCT00792298|1887307|FG003|Treatment Period 2|Physician Decision|0
910538|NCT00792298|1887308|FG004|Treatment Period 2|Physician Decision|0
910539|NCT00792298|1887309|FG005|Treatment Period 2|Physician Decision|0
910540|NCT00792298|1887310|FG006|Treatment Period 2|Physician Decision|1
910541|NCT00792298|1887311|FG007|Treatment Period 2|Physician Decision|0
910542|NCT00792298|1887304|FG000|Treatment Period 2|Pregnancy|0
910543|NCT00792298|1887305|FG001|Treatment Period 2|Pregnancy|0
910544|NCT00792298|1887306|FG002|Treatment Period 2|Pregnancy|1
910545|NCT00792298|1887307|FG003|Treatment Period 2|Pregnancy|0
910546|NCT00792298|1887308|FG004|Treatment Period 2|Pregnancy|0
910547|NCT00792298|1887309|FG005|Treatment Period 2|Pregnancy|0
910548|NCT00792298|1887310|FG006|Treatment Period 2|Pregnancy|0
910549|NCT00792298|1887311|FG007|Treatment Period 2|Pregnancy|0
910550|NCT00792298|1887304|FG000|Treatment Period 2|Withdrawal by Subject|1
910551|NCT00792298|1887305|FG001|Treatment Period 2|Withdrawal by Subject|1
910552|NCT00792298|1887306|FG002|Treatment Period 2|Withdrawal by Subject|0
910553|NCT00792298|1887307|FG003|Treatment Period 2|Withdrawal by Subject|2
910554|NCT00792298|1887308|FG004|Treatment Period 2|Withdrawal by Subject|1
910555|NCT00792298|1887309|FG005|Treatment Period 2|Withdrawal by Subject|0
910556|NCT00792298|1887310|FG006|Treatment Period 2|Withdrawal by Subject|0
910557|NCT00792298|1887311|FG007|Treatment Period 2|Withdrawal by Subject|2
910558|NCT00792467|1887337|FG000|Overall Study|progression of disease|17
910559|NCT00792467|1887337|FG000|Overall Study|Adverse Event|1
910560|NCT00792467|1887337|FG000|Overall Study|patient request|1
910561|NCT00792467|1887337|FG000|Overall Study|Lost to Follow-up|1
910562|NCT00792467|1887337|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1
910563|NCT00792467|1887337|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1
910564|NCT00792571|1887342|FG000|Overall Study|Death|1
910565|NCT00792571|1887342|FG000|Overall Study|Adverse Event|4
910566|NCT00792571|1887342|FG000|Overall Study|Withdrawal by Subject|1
910567|NCT00792571|1887342|FG000|Overall Study|Other|4
910568|NCT00792623|1887350|FG000|Overall Study|Adverse Event|2
910569|NCT00792623|1887350|FG000|Overall Study|Withdrawal by Subject|5
910570|NCT00792636|1887358|FG000|Overall Study|Protocol Violation|17
910571|NCT00792636|1887359|FG001|Overall Study|Protocol Violation|23
910572|NCT00792636|1887360|FG002|Overall Study|Protocol Violation|20
910573|NCT00792636|1887358|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19
910574|NCT00792636|1887359|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20
910575|NCT00792636|1887360|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20
945103|NCT01020123|1935819|FG005|Extention Period|Adverse Event|0
945104|NCT01020123|1935820|FG006|Extention Period|Adverse Event|0
945105|NCT01020123|1935814|FG000|Extention Period|Protocol Violation|1
945106|NCT01020123|1935815|FG001|Extention Period|Protocol Violation|1
945107|NCT01020123|1935816|FG002|Extention Period|Protocol Violation|1
945108|NCT01020123|1935817|FG003|Extention Period|Protocol Violation|0
945109|NCT01020123|1935818|FG004|Extention Period|Protocol Violation|0
945110|NCT01020123|1935819|FG005|Extention Period|Protocol Violation|0
945111|NCT01020123|1935820|FG006|Extention Period|Protocol Violation|1
945112|NCT01020123|1935814|FG000|Extention Period|Lost to Follow-up|0
945113|NCT01020123|1935815|FG001|Extention Period|Lost to Follow-up|0
945114|NCT01020123|1935816|FG002|Extention Period|Lost to Follow-up|0
945115|NCT01020123|1935817|FG003|Extention Period|Lost to Follow-up|0
945116|NCT01020123|1935818|FG004|Extention Period|Lost to Follow-up|0
945117|NCT01020123|1935819|FG005|Extention Period|Lost to Follow-up|2
945118|NCT01020123|1935820|FG006|Extention Period|Lost to Follow-up|0
945119|NCT01020305|1935837|FG000|Overall Study|Adverse Event|2
945120|NCT01020435|1935843|FG000|Overall Study|Lost to Follow-up|0
910576|NCT00792636|1887358|FG000|Overall Study|Lost to Follow-up|13
910577|NCT00792636|1887359|FG001|Overall Study|Lost to Follow-up|19
910578|NCT00792636|1887360|FG002|Overall Study|Lost to Follow-up|14
910579|NCT00792636|1887358|FG000|Overall Study|Withdrew Consent|10
910580|NCT00792636|1887359|FG001|Overall Study|Withdrew Consent|13
910581|NCT00792636|1887360|FG002|Overall Study|Withdrew Consent|9
910582|NCT00792636|1887358|FG000|Overall Study|Lack of Efficacy|3
910583|NCT00792636|1887359|FG001|Overall Study|Lack of Efficacy|4
910584|NCT00792636|1887360|FG002|Overall Study|Lack of Efficacy|13
910585|NCT00792636|1887358|FG000|Overall Study|Adverse Event|4
910586|NCT00792636|1887359|FG001|Overall Study|Adverse Event|2
910587|NCT00792636|1887360|FG002|Overall Study|Adverse Event|3
910588|NCT00792636|1887358|FG000|Overall Study|Investigator Discretion|2
910589|NCT00792636|1887359|FG001|Overall Study|Investigator Discretion|0
910590|NCT00792636|1887360|FG002|Overall Study|Investigator Discretion|2
910591|NCT00792701|1887385|FG000|Overall Study|Adverse Event|0
910592|NCT00792701|1887386|FG001|Overall Study|Adverse Event|22
910593|NCT00792701|1887385|FG000|Overall Study|Ineligible|1
910594|NCT00792701|1887386|FG001|Overall Study|Ineligible|3
910595|NCT00792701|1887385|FG000|Overall Study|Withdrawal by Subject|1
910596|NCT00792701|1887386|FG001|Overall Study|Withdrawal by Subject|19
910597|NCT00792701|1887385|FG000|Overall Study|Not protocol specified|17
910598|NCT00792701|1887386|FG001|Overall Study|Not protocol specified|0
910599|NCT00792805|1887397|FG000|Overall Study|Adverse Event|12
910600|NCT00792805|1887398|FG001|Overall Study|Adverse Event|10
910601|NCT00792805|1887399|FG002|Overall Study|Adverse Event|10
910602|NCT00792805|1887397|FG000|Overall Study|Subject withdrew consent|5
910603|NCT00792805|1887398|FG001|Overall Study|Subject withdrew consent|6
910604|NCT00792805|1887399|FG002|Overall Study|Subject withdrew consent|5
910605|NCT00792805|1887397|FG000|Overall Study|Administrative problems|2
910606|NCT00792805|1887398|FG001|Overall Study|Administrative problems|0
910607|NCT00792805|1887399|FG002|Overall Study|Administrative problems|4
910608|NCT00792805|1887397|FG000|Overall Study|Abnormal test procedure result(s)|1
910609|NCT00792805|1887398|FG001|Overall Study|Abnormal test procedure result(s)|2
910610|NCT00792805|1887399|FG002|Overall Study|Abnormal test procedure result(s)|0
910611|NCT00792805|1887397|FG000|Overall Study|Unsatisfactory therapeutic effect|1
910612|NCT00792805|1887398|FG001|Overall Study|Unsatisfactory therapeutic effect|6
910613|NCT00792805|1887399|FG002|Overall Study|Unsatisfactory therapeutic effect|6
910614|NCT00792805|1887397|FG000|Overall Study|Lost to Follow-up|1
910615|NCT00792805|1887398|FG001|Overall Study|Lost to Follow-up|1
910616|NCT00792805|1887399|FG002|Overall Study|Lost to Follow-up|6
910617|NCT00792805|1887397|FG000|Overall Study|Abnormal laboratory value(s)|0
910618|NCT00792805|1887398|FG001|Overall Study|Abnormal laboratory value(s)|0
910619|NCT00792805|1887399|FG002|Overall Study|Abnormal laboratory value(s)|1
910620|NCT00792805|1887397|FG000|Overall Study|Protocol deviation|0
910621|NCT00792805|1887398|FG001|Overall Study|Protocol deviation|1
910622|NCT00792805|1887399|FG002|Overall Study|Protocol deviation|1
910623|NCT00792909|1887410|FG000|Overall Study|Withdrawal by Subject|0
910624|NCT00792909|1887411|FG001|Overall Study|Withdrawal by Subject|1
910625|NCT00792909|1887412|FG002|Overall Study|Withdrawal by Subject|0
910626|NCT00792935|1887444|FG000|Overall Study|Adverse Event|2
910627|NCT00792935|1887445|FG001|Overall Study|Adverse Event|1
910628|NCT00792935|1887444|FG000|Overall Study|Lost to Follow-up|0
910629|NCT00792935|1887445|FG001|Overall Study|Lost to Follow-up|1
910630|NCT00792935|1887444|FG000|Overall Study|Protocol Violation|2
910631|NCT00792935|1887445|FG001|Overall Study|Protocol Violation|0
910632|NCT00792935|1887444|FG000|Overall Study|Withdrawal by Subject|0
910633|NCT00792935|1887445|FG001|Overall Study|Withdrawal by Subject|1
910641|NCT00793104|1887458|FG000|Overall Study|Lost to Follow-up|1
945121|NCT01020435|1935844|FG001|Overall Study|Lost to Follow-up|1
945122|NCT01020448|1935851|FG000|Pre-assignment|Adverse Event|6
945123|NCT01020448|1935851|FG000|Pre-assignment|Withdrawal by Subject|5
945124|NCT01020448|1935851|FG000|Pre-assignment|Does Not Meet Entry Criteria|2
945125|NCT01020448|1935851|FG000|Treatment|Adverse Event|11
945126|NCT01020448|1935851|FG000|Treatment|Consent Withdrawn|3
945127|NCT01020448|1935851|FG000|Treatment|Disease Progression|2
945128|NCT01020448|1935851|FG000|Treatment|Lack of Efficacy|8
945129|NCT01020448|1935851|FG000|Treatment|Lost to Follow-up|2
945130|NCT01020474|1935858|FG000|Overall Study|Adverse Event|4
945131|NCT01020474|1935859|FG001|Overall Study|Adverse Event|4
945132|NCT01020474|1935858|FG000|Overall Study|Protocol Violation|0
945133|NCT01020474|1935859|FG001|Overall Study|Protocol Violation|2
945134|NCT01020474|1935858|FG000|Overall Study|Withdrawal by Subject|5
945135|NCT01020474|1935859|FG001|Overall Study|Withdrawal by Subject|7
945136|NCT01020474|1935858|FG000|Overall Study|Other Reasons|1
945137|NCT01020474|1935859|FG001|Overall Study|Other Reasons|1
910642|NCT00793182|1887468|FG000|Overall Study|Adverse Event|0
910643|NCT00793182|1887469|FG001|Overall Study|Adverse Event|1
910644|NCT00793325|1887475|FG000|Overall Study|Protocol Violation|18
910645|NCT00793325|1887475|FG000|Overall Study|Lost to Follow-up|1
910646|NCT00793403|1887498|FG000|Overall Study|Other|73
910647|NCT00793546|1887514|FG000|Overall Study|Death|3
910648|NCT00793546|1887515|FG001|Overall Study|Death|0
910649|NCT00793546|1887514|FG000|Overall Study|Lost to Follow-up|1
910650|NCT00793546|1887515|FG001|Overall Study|Lost to Follow-up|0
910651|NCT00793546|1887514|FG000|Overall Study|Withdrawal by Subject|1
910652|NCT00793546|1887515|FG001|Overall Study|Withdrawal by Subject|1
910653|NCT00793546|1887514|FG000|Overall Study|Study Terminated by Sponsor|8
910654|NCT00793546|1887515|FG001|Overall Study|Study Terminated by Sponsor|27
910655|NCT00793546|1887514|FG000|Overall Study|Other|1
910656|NCT00793546|1887515|FG001|Overall Study|Other|0
910657|NCT00793585|1887529|FG000|Overall Study|Adverse Event|1
910658|NCT00793585|1887530|FG001|Overall Study|Adverse Event|1
910659|NCT00793585|1887529|FG000|Overall Study|Protocol Violation|1
910660|NCT00793585|1887530|FG001|Overall Study|Protocol Violation|2
910661|NCT00793598|1887541|FG000|Overall Study|Patient Request|0
910662|NCT00793598|1887542|FG001|Overall Study|Patient Request|1
910663|NCT00793598|1887543|FG002|Overall Study|Patient Request|0
910664|NCT00793598|1887544|FG003|Overall Study|Patient Request|0
910665|NCT00793598|1887545|FG004|Overall Study|Patient Request|0
910666|NCT00793598|1887546|FG005|Overall Study|Patient Request|0
910667|NCT00793598|1887547|FG006|Overall Study|Patient Request|0
910668|NCT00793598|1887548|FG007|Overall Study|Patient Request|0
910669|NCT00793598|1887541|FG000|Overall Study|Protocol Violation|0
910670|NCT00793598|1887542|FG001|Overall Study|Protocol Violation|0
910671|NCT00793598|1887543|FG002|Overall Study|Protocol Violation|0
910672|NCT00793598|1887544|FG003|Overall Study|Protocol Violation|0
910673|NCT00793598|1887545|FG004|Overall Study|Protocol Violation|0
910674|NCT00793598|1887546|FG005|Overall Study|Protocol Violation|0
910675|NCT00793598|1887547|FG006|Overall Study|Protocol Violation|0
910676|NCT00793598|1887548|FG007|Overall Study|Protocol Violation|1
910677|NCT00793598|1887541|FG000|Overall Study|Subject not dosed|0
910678|NCT00793598|1887542|FG001|Overall Study|Subject not dosed|0
910679|NCT00793598|1887543|FG002|Overall Study|Subject not dosed|0
910680|NCT00793598|1887544|FG003|Overall Study|Subject not dosed|0
910681|NCT00793598|1887545|FG004|Overall Study|Subject not dosed|0
910682|NCT00793598|1887546|FG005|Overall Study|Subject not dosed|1
910683|NCT00793598|1887547|FG006|Overall Study|Subject not dosed|0
910684|NCT00793598|1887548|FG007|Overall Study|Subject not dosed|0
910685|NCT00793624|1887583|FG000|Overall Study|Adverse Event|18
910686|NCT00793624|1887584|FG001|Overall Study|Adverse Event|16
910687|NCT00793624|1887585|FG002|Overall Study|Adverse Event|15
910688|NCT00793624|1887586|FG003|Overall Study|Adverse Event|20
910689|NCT00793624|1887583|FG000|Overall Study|Lost to Follow-up|2
910690|NCT00793624|1887584|FG001|Overall Study|Lost to Follow-up|2
910691|NCT00793624|1887585|FG002|Overall Study|Lost to Follow-up|4
910692|NCT00793624|1887586|FG003|Overall Study|Lost to Follow-up|0
910693|NCT00793624|1887583|FG000|Overall Study|Withdrawal by Subject|20
910694|NCT00793624|1887584|FG001|Overall Study|Withdrawal by Subject|9
910695|NCT00793624|1887585|FG002|Overall Study|Withdrawal by Subject|11
910696|NCT00793624|1887586|FG003|Overall Study|Withdrawal by Subject|14
910697|NCT00793624|1887583|FG000|Overall Study|Lack of Efficacy|9
910698|NCT00793624|1887584|FG001|Overall Study|Lack of Efficacy|2
910699|NCT00793624|1887585|FG002|Overall Study|Lack of Efficacy|1
910700|NCT00793624|1887586|FG003|Overall Study|Lack of Efficacy|3
910701|NCT00793624|1887583|FG000|Overall Study|Non compliance with protocol|2
910702|NCT00793624|1887584|FG001|Overall Study|Non compliance with protocol|3
910703|NCT00793624|1887585|FG002|Overall Study|Non compliance with protocol|2
910704|NCT00793624|1887586|FG003|Overall Study|Non compliance with protocol|3
910705|NCT00793624|1887583|FG000|Overall Study|Other reason not described above|6
910706|NCT00793624|1887584|FG001|Overall Study|Other reason not described above|4
910707|NCT00793624|1887585|FG002|Overall Study|Other reason not described above|6
910708|NCT00793624|1887586|FG003|Overall Study|Other reason not described above|3
910709|NCT00793780|1887617|FG000|Overall Study|Withdrawal by Subject|2
910710|NCT00793780|1887618|FG001|Overall Study|Withdrawal by Subject|1
910711|NCT00793793|1887636|FG000|Overall Study|Adverse Event|0
945138|NCT01020474|1935858|FG000|Overall Study|Insufficient Clinical Response|0
910712|NCT00793793|1887637|FG001|Overall Study|Adverse Event|0
910713|NCT00793793|1887638|FG002|Overall Study|Adverse Event|1
910714|NCT00793793|1887639|FG003|Overall Study|Adverse Event|1
910715|NCT00793793|1887640|FG004|Overall Study|Adverse Event|0
910716|NCT00793793|1887641|FG005|Overall Study|Adverse Event|1
910717|NCT00793793|1887642|FG006|Overall Study|Adverse Event|2
910718|NCT00793793|1887643|FG007|Overall Study|Adverse Event|0
910719|NCT00793793|1887644|FG008|Overall Study|Adverse Event|0
910720|NCT00793793|1887645|FG009|Overall Study|Adverse Event|0
910721|NCT00793793|1887646|FG010|Overall Study|Adverse Event|0
910722|NCT00793793|1887647|FG011|Overall Study|Adverse Event|2
910723|NCT00793793|1887636|FG000|Overall Study|Protocol Violation|0
910724|NCT00793793|1887637|FG001|Overall Study|Protocol Violation|0
910725|NCT00793793|1887638|FG002|Overall Study|Protocol Violation|0
910726|NCT00793793|1887639|FG003|Overall Study|Protocol Violation|1
910727|NCT00793793|1887640|FG004|Overall Study|Protocol Violation|0
910728|NCT00793793|1887641|FG005|Overall Study|Protocol Violation|0
910729|NCT00793793|1887642|FG006|Overall Study|Protocol Violation|0
910730|NCT00793793|1887643|FG007|Overall Study|Protocol Violation|0
910731|NCT00793793|1887644|FG008|Overall Study|Protocol Violation|0
910732|NCT00793793|1887645|FG009|Overall Study|Protocol Violation|0
910733|NCT00793793|1887646|FG010|Overall Study|Protocol Violation|0
910734|NCT00793793|1887647|FG011|Overall Study|Protocol Violation|0
910735|NCT00793793|1887636|FG000|Overall Study|Lost to Follow-up|0
910736|NCT00793793|1887637|FG001|Overall Study|Lost to Follow-up|0
910737|NCT00793793|1887638|FG002|Overall Study|Lost to Follow-up|1
910738|NCT00793793|1887639|FG003|Overall Study|Lost to Follow-up|0
910739|NCT00793793|1887640|FG004|Overall Study|Lost to Follow-up|0
910740|NCT00793793|1887641|FG005|Overall Study|Lost to Follow-up|0
910741|NCT00793793|1887642|FG006|Overall Study|Lost to Follow-up|0
910742|NCT00793793|1887643|FG007|Overall Study|Lost to Follow-up|0
910743|NCT00793793|1887644|FG008|Overall Study|Lost to Follow-up|1
910744|NCT00793793|1887645|FG009|Overall Study|Lost to Follow-up|3
910745|NCT00793793|1887646|FG010|Overall Study|Lost to Follow-up|1
910746|NCT00793793|1887647|FG011|Overall Study|Lost to Follow-up|0
910747|NCT00793793|1887636|FG000|Overall Study|Withdrawal by Subject|0
910748|NCT00793793|1887637|FG001|Overall Study|Withdrawal by Subject|0
910749|NCT00793793|1887638|FG002|Overall Study|Withdrawal by Subject|0
910750|NCT00793793|1887639|FG003|Overall Study|Withdrawal by Subject|0
910751|NCT00793793|1887640|FG004|Overall Study|Withdrawal by Subject|1
910752|NCT00793793|1887641|FG005|Overall Study|Withdrawal by Subject|0
910753|NCT00793793|1887642|FG006|Overall Study|Withdrawal by Subject|0
910754|NCT00793793|1887643|FG007|Overall Study|Withdrawal by Subject|0
910755|NCT00793793|1887644|FG008|Overall Study|Withdrawal by Subject|1
910756|NCT00793793|1887645|FG009|Overall Study|Withdrawal by Subject|0
910757|NCT00793793|1887646|FG010|Overall Study|Withdrawal by Subject|0
910758|NCT00793793|1887647|FG011|Overall Study|Withdrawal by Subject|0
910759|NCT00793793|1887636|FG000|Overall Study|reason not specified|0
910760|NCT00793793|1887637|FG001|Overall Study|reason not specified|1
910761|NCT00793793|1887638|FG002|Overall Study|reason not specified|0
910762|NCT00793793|1887639|FG003|Overall Study|reason not specified|1
910763|NCT00793793|1887640|FG004|Overall Study|reason not specified|1
910764|NCT00793793|1887641|FG005|Overall Study|reason not specified|1
910765|NCT00793793|1887642|FG006|Overall Study|reason not specified|2
910766|NCT00793793|1887643|FG007|Overall Study|reason not specified|0
910767|NCT00793793|1887644|FG008|Overall Study|reason not specified|7
910768|NCT00793793|1887645|FG009|Overall Study|reason not specified|6
910769|NCT00793793|1887646|FG010|Overall Study|reason not specified|2
910770|NCT00793793|1887647|FG011|Overall Study|reason not specified|4
910771|NCT00793819|1887695|FG000|Overall Study|Adverse Event|8
910772|NCT00793819|1887696|FG001|Overall Study|Adverse Event|4
910773|NCT00793819|1887695|FG000|Overall Study|Lack of Efficacy|1
910774|NCT00793819|1887696|FG001|Overall Study|Lack of Efficacy|1
910775|NCT00793819|1887695|FG000|Overall Study|Withdrawal by Subject|4
910776|NCT00793819|1887696|FG001|Overall Study|Withdrawal by Subject|3
910777|NCT00793819|1887695|FG000|Overall Study|Lost to Follow-up|1
910778|NCT00793819|1887696|FG001|Overall Study|Lost to Follow-up|1
910779|NCT00793871|1887702|FG000|Overall Study|Death|50
910780|NCT00793871|1887702|FG000|Overall Study|Lost to Follow-up|3
910781|NCT00793871|1887702|FG000|Overall Study|Study terminated by the Sponsor|7
910782|NCT00793910|1887708|FG000|Overall Study|discarded study pills|0
910783|NCT00793910|1887709|FG001|Overall Study|discarded study pills|1
910784|NCT00793910|1887708|FG000|Overall Study|did not pick up medications|1
910785|NCT00793910|1887709|FG001|Overall Study|did not pick up medications|1
910786|NCT00793910|1887708|FG000|Overall Study|ineligible based on entry criteria|2
910787|NCT00793910|1887709|FG001|Overall Study|ineligible based on entry criteria|3
910788|NCT00793910|1887708|FG000|Overall Study|decided to undergo LASIK instead of PRK|2
910789|NCT00793910|1887709|FG001|Overall Study|decided to undergo LASIK instead of PRK|1
910790|NCT00793910|1887708|FG000|Overall Study|Withdrawal by Subject|0
910791|NCT00793910|1887709|FG001|Overall Study|Withdrawal by Subject|1
910792|NCT00794040|1887717|FG000|Overall Study|Withdrawal by Subject|3
910793|NCT00794040|1887718|FG001|Overall Study|Withdrawal by Subject|4
910794|NCT00794040|1887717|FG000|Overall Study|Physician Decision|0
1090766|NCT02248818|2158522|FG004|Screening|Physician Decision|0
910795|NCT00794040|1887718|FG001|Overall Study|Physician Decision|1
910796|NCT00794118|1887724|FG000|Overall Study|Lost to Follow-up|16
910797|NCT00794118|1887724|FG000|Overall Study|Withdrawal by Subject|9
910798|NCT00794118|1887724|FG000|Overall Study|Changed hospital center|2
910799|NCT00794157|1887740|FG000|Overall Study|Adverse Event|4
910800|NCT00794157|1887741|FG001|Overall Study|Adverse Event|1
910801|NCT00794157|1887742|FG002|Overall Study|Adverse Event|8
910802|NCT00794157|1887740|FG000|Overall Study|Subject withdrew consent|2
910803|NCT00794157|1887741|FG001|Overall Study|Subject withdrew consent|0
910804|NCT00794157|1887742|FG002|Overall Study|Subject withdrew consent|3
910805|NCT00794157|1887740|FG000|Overall Study|Lost to Follow-up|2
910806|NCT00794157|1887741|FG001|Overall Study|Lost to Follow-up|0
910807|NCT00794157|1887742|FG002|Overall Study|Lost to Follow-up|1
910808|NCT00794157|1887740|FG000|Overall Study|Unsatisfactory therapeutic effect|1
910809|NCT00794157|1887741|FG001|Overall Study|Unsatisfactory therapeutic effect|0
910810|NCT00794157|1887742|FG002|Overall Study|Unsatisfactory therapeutic effect|2
910811|NCT00794157|1887740|FG000|Overall Study|Administrative problems|1
910812|NCT00794157|1887741|FG001|Overall Study|Administrative problems|7
910813|NCT00794157|1887742|FG002|Overall Study|Administrative problems|4
910814|NCT00794157|1887740|FG000|Overall Study|Abnormal test procedure result(s)|0
910815|NCT00794157|1887741|FG001|Overall Study|Abnormal test procedure result(s)|1
910816|NCT00794157|1887742|FG002|Overall Study|Abnormal test procedure result(s)|0
910817|NCT00794157|1887740|FG000|Overall Study|Protocol deviation|0
910818|NCT00794157|1887741|FG001|Overall Study|Protocol deviation|1
910819|NCT00794157|1887742|FG002|Overall Study|Protocol deviation|1
910820|NCT00794196|1887761|FG000|Overall Study|Lost to Follow-up|5
910821|NCT00794196|1887762|FG001|Overall Study|Lost to Follow-up|23
910822|NCT00794339|1887781|FG000|Overall Study|Withdrawal by Subject|3
910823|NCT00794339|1887781|FG000|Overall Study|Ineligible|4
910824|NCT00794339|1887781|FG000|Overall Study|Tx prior to ATSM|3
910825|NCT00794339|1887781|FG000|Overall Study|ATSM imaging not complete or inadequate|3
910826|NCT00794339|1887781|FG000|Overall Study|Tx not per protocol|1
910827|NCT00794365|1887802|FG000|Overall Study|Lost to Follow-up|38
910828|NCT00794365|1887802|FG000|Overall Study|Other|17
910829|NCT00794365|1887802|FG000|Overall Study|Poor Compliance|11
910830|NCT00794365|1887802|FG000|Overall Study|Adverse Event|10
910831|NCT00794365|1887802|FG000|Overall Study|Lack of Efficacy|3
910832|NCT00794417|1887810|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0
910833|NCT00794417|1887811|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0
910834|NCT00794417|1887812|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2
910835|NCT00794417|1887813|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0
910836|NCT00794417|1887810|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
910837|NCT00794417|1887811|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
910838|NCT00794417|1887812|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1
910839|NCT00794417|1887813|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0
910840|NCT00794417|1887810|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0
910841|NCT00794417|1887811|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0
910842|NCT00794417|1887812|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0
910843|NCT00794417|1887813|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7
910844|NCT00794417|1887810|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
910845|NCT00794417|1887811|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
910846|NCT00794417|1887812|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
910847|NCT00794417|1887813|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11
910848|NCT00794417|1887810|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
910849|NCT00794417|1887811|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
910850|NCT00794417|1887812|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
910851|NCT00794417|1887813|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4
910852|NCT00794417|1887810|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
910853|NCT00794417|1887811|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
910854|NCT00794417|1887812|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
910855|NCT00794417|1887813|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13
910856|NCT00794573|1887857|FG000|Overall Study|Death|3
910857|NCT00794573|1887858|FG001|Overall Study|Death|0
910858|NCT00794573|1887857|FG000|Overall Study|Withdrawal by Subject|9
910859|NCT00794573|1887858|FG001|Overall Study|Withdrawal by Subject|12
910860|NCT00794573|1887857|FG000|Overall Study|Lost to Follow-up|26
910861|NCT00794573|1887858|FG001|Overall Study|Lost to Follow-up|33
910862|NCT00794664|1887866|FG000|Treatment Period|Withdrawal by Subject|0
910863|NCT00794664|1887867|FG001|Treatment Period|Withdrawal by Subject|2
910864|NCT00794664|1887866|FG000|Treatment Period|Protocol non-compliance|0
910865|NCT00794664|1887867|FG001|Treatment Period|Protocol non-compliance|1
910866|NCT00794664|1887866|FG000|Treatment Period|Other|0
910867|NCT00794664|1887867|FG001|Treatment Period|Other|1
910868|NCT00794664|1887866|FG000|Treatment Period|Adverse Event|1
910869|NCT00794664|1887867|FG001|Treatment Period|Adverse Event|8
910870|NCT00794664|1887866|FG000|Follow-up Period|Other|1
910871|NCT00794664|1887867|FG001|Follow-up Period|Other|2
910872|NCT00794664|1887866|FG000|Follow-up Period|Withdrawal by Subject|0
910873|NCT00794664|1887867|FG001|Follow-up Period|Withdrawal by Subject|2
945139|NCT01020474|1935859|FG001|Overall Study|Insufficient Clinical Response|3
945140|NCT01020487|1935868|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0
945141|NCT01020487|1935869|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2
910874|NCT00794664|1887866|FG000|Follow-up Period|Protocol non-compliance|0
910875|NCT00794664|1887867|FG001|Follow-up Period|Protocol non-compliance|1
910876|NCT00794677|1887875|FG000|First Intervention|Withdrawal by Subject|2
910877|NCT00794677|1887876|FG001|First Intervention|Withdrawal by Subject|0
910878|NCT00794820|1887880|FG000|Overall Study|Adverse Event|11
910879|NCT00794820|1887880|FG000|Overall Study|Secondary Malignancies|2
910880|NCT00794820|1887880|FG000|Overall Study|Resistant Disease|2
910881|NCT00794820|1887880|FG000|Overall Study|Ineligible/Screen Failure|1
910882|NCT00794924|1887886|FG000|Overall Study|Lost to Follow-up|6
910883|NCT00794924|1887887|FG001|Overall Study|Lost to Follow-up|8
910884|NCT00794924|1887886|FG000|Overall Study|Withdrawal by Subject|48
910885|NCT00794924|1887887|FG001|Overall Study|Withdrawal by Subject|60
910886|NCT00794924|1887886|FG000|Overall Study|Adverse Event|6
910887|NCT00794924|1887887|FG001|Overall Study|Adverse Event|2
910888|NCT00794950|1887891|FG000|BCG Induction|Withdrawal by Subject|2
910889|NCT00794950|1887891|FG000|BCG Induction|ineligible|3
910890|NCT00794950|1887891|FG000|BCG Induction|noncompliant w. BCG|1
910891|NCT00794950|1887891|FG000|BCG Induction|Adverse Event|1
910892|NCT00794950|1887891|FG000|Beginning Sunitinib Treatment|cystectomy|5
910893|NCT00794950|1887891|FG000|Beginning Sunitinib Treatment|Physician Decision|5
910894|NCT00794950|1887891|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1
910895|NCT00794950|1887891|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1
910896|NCT00794963|1887898|FG000|Overall Study|Withdrawal by Subject|1
910897|NCT00794963|1887899|FG001|Overall Study|Withdrawal by Subject|4
910898|NCT00795132|1887914|FG000|Overall Study|Death|1
910899|NCT00795132|1887914|FG000|Overall Study|Relapse|2
910900|NCT00795184|1887961|FG000|Overall Study|Tissue sampling incomplete/conclusive|8
910901|NCT00795184|1887962|FG001|Overall Study|Tissue sampling incomplete/conclusive|13
910902|NCT00795509|1888024|FG000|Overall Study|Protocol Violation|31
910903|NCT00795535|1888028|FG000|Overall Study|incomplete data and technical problems|20
910904|NCT00795600|1888034|FG000|Overall Study|Adverse Event|1
910905|NCT00795600|1888035|FG001|Overall Study|Adverse Event|1
910906|NCT00795600|1888034|FG000|Overall Study|Protocol Violation|1
910907|NCT00795600|1888035|FG001|Overall Study|Protocol Violation|2
910908|NCT00795600|1888034|FG000|Overall Study|Withdrawal by Subject|1
910909|NCT00795600|1888035|FG001|Overall Study|Withdrawal by Subject|0
910910|NCT00795600|1888034|FG000|Overall Study|Unclassified|1
910911|NCT00795600|1888035|FG001|Overall Study|Unclassified|1
910912|NCT00795639|1888043|FG000|Overall Study|Death|1
910913|NCT00795639|1888044|FG001|Overall Study|Death|6
910914|NCT00795639|1888043|FG000|Overall Study|Withdrawal by Subject|1
910915|NCT00795639|1888044|FG001|Overall Study|Withdrawal by Subject|3
910916|NCT00795639|1888043|FG000|Overall Study|Pregnancy|1
910917|NCT00795639|1888044|FG001|Overall Study|Pregnancy|0
910918|NCT00795639|1888043|FG000|Overall Study|Adverse Event|5
910919|NCT00795639|1888044|FG001|Overall Study|Adverse Event|2
910920|NCT00795639|1888043|FG000|Overall Study|Other|0
910921|NCT00795639|1888044|FG001|Overall Study|Other|2
910922|NCT00795639|1888043|FG000|Overall Study|Terminated by sponsor|13
910923|NCT00795639|1888044|FG001|Overall Study|Terminated by sponsor|12
910924|NCT00795639|1888043|FG000|Overall Study|Randomized and not treated|0
910925|NCT00795639|1888044|FG001|Overall Study|Randomized and not treated|1
910926|NCT00795704|1888052|FG000|Overall Study|Withdrawal by Subject|3
910927|NCT00795704|1888053|FG001|Overall Study|Withdrawal by Subject|2
910928|NCT00795704|1888052|FG000|Overall Study|Adverse Event|1
910929|NCT00795704|1888053|FG001|Overall Study|Adverse Event|1
910930|NCT00795717|1888061|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
910931|NCT00795717|1888062|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
910932|NCT00795717|1888061|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
910933|NCT00795717|1888062|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
910934|NCT00795717|1888061|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
910935|NCT00795717|1888062|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
910936|NCT00795717|1888061|FG000|Phase II|too busy|0
910937|NCT00795717|1888062|FG001|Phase II|too busy|1
910938|NCT00795821|1888075|FG000|Acute Treatment Phase|Adverse Event|23
910939|NCT00795821|1888076|FG001|Acute Treatment Phase|Adverse Event|4
910940|NCT00795821|1888075|FG000|Acute Treatment Phase|Death|1
910941|NCT00795821|1888076|FG001|Acute Treatment Phase|Death|0
910942|NCT00795821|1888075|FG000|Acute Treatment Phase|Lack of Efficacy|5
910943|NCT00795821|1888076|FG001|Acute Treatment Phase|Lack of Efficacy|2
910944|NCT00795821|1888075|FG000|Acute Treatment Phase|Lost to Follow-up|9
910945|NCT00795821|1888076|FG001|Acute Treatment Phase|Lost to Follow-up|12
910946|NCT00795821|1888075|FG000|Acute Treatment Phase|Physician Decision|1
910947|NCT00795821|1888076|FG001|Acute Treatment Phase|Physician Decision|1
910948|NCT00795821|1888075|FG000|Acute Treatment Phase|Protocol Violation|1
910949|NCT00795821|1888076|FG001|Acute Treatment Phase|Protocol Violation|2
910950|NCT00795821|1888075|FG000|Acute Treatment Phase|Withdrawal by Subject|16
910951|NCT00795821|1888076|FG001|Acute Treatment Phase|Withdrawal by Subject|10
910952|NCT00795821|1888075|FG000|Long-term Extension Phase|Adverse Event|25
945142|NCT01020487|1935870|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1
945143|NCT01020487|1935868|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
945144|NCT01020487|1935869|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
945145|NCT01020487|1935870|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
945146|NCT01020487|1935868|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
945147|NCT01020487|1935869|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
945148|NCT01020487|1935870|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
945149|NCT01020487|1935868|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0
945150|NCT01020487|1935869|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0
945151|NCT01020487|1935870|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1
945152|NCT01020487|1935868|FG000|Part 2 Open-label Period|Adverse Event|0
945153|NCT01020487|1935869|FG001|Part 2 Open-label Period|Adverse Event|4
945154|NCT01020487|1935870|FG002|Part 2 Open-label Period|Adverse Event|1
945155|NCT01020526|1935880|FG000|Overall Study|Withdrawal by Subject|5
945156|NCT01020526|1935880|FG000|Overall Study|Other reasons|3
945157|NCT01020526|1935880|FG000|Overall Study|Insufficient clinical response|3
945158|NCT01020526|1935880|FG000|Overall Study|Lost to Follow-up|1
945159|NCT01020526|1935880|FG000|Overall Study|Adverse Event|2
945160|NCT01020747|1935895|FG000|Overall Study|Withdrawal by Subject|1
945161|NCT01020773|1935902|FG000|Overall Study|Withdrawal by Subject|4
945162|NCT01020773|1935903|FG001|Overall Study|Withdrawal by Subject|3
945163|NCT01020786|1935909|FG000|Induction Period|Entry Criteria Not Met|2
945164|NCT01020786|1935909|FG000|Induction Period|Adverse Event|10
945165|NCT01020786|1935909|FG000|Induction Period|Progressive Disease|31
945166|NCT01020786|1935909|FG000|Induction Period|Investigator Decision|3
945167|NCT01020786|1935909|FG000|Induction Period|Withdrawal by Subject|3
945168|NCT01020786|1935909|FG000|Maintenance Period|Adverse Event|8
945169|NCT01020786|1935909|FG000|Maintenance Period|Progressive Disease|43
945170|NCT01020786|1935909|FG000|Maintenance Period|Withdrawal by Subject|8
945171|NCT01020786|1935909|FG000|Maintenance Period|Sponsor Decision|1
945172|NCT01020799|1935917|FG000|Overall Study|Adverse Event|4
945173|NCT01020799|1935918|FG001|Overall Study|Adverse Event|3
945174|NCT01020799|1935919|FG002|Overall Study|Adverse Event|2
945175|NCT01020799|1935917|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4
945176|NCT01020799|1935918|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3
945177|NCT01020799|1935919|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0
945178|NCT01020799|1935917|FG000|Overall Study|Protocol Violation|3
945179|NCT01020799|1935918|FG001|Overall Study|Protocol Violation|2
945180|NCT01020799|1935919|FG002|Overall Study|Protocol Violation|0
945181|NCT01020799|1935917|FG000|Overall Study|Withdrawal by Subject|2
945182|NCT01020799|1935918|FG001|Overall Study|Withdrawal by Subject|2
945183|NCT01020799|1935919|FG002|Overall Study|Withdrawal by Subject|3
945184|NCT01020799|1935917|FG000|Overall Study|Lost to Follow-up|6
945185|NCT01020799|1935918|FG001|Overall Study|Lost to Follow-up|4
945186|NCT01020799|1935919|FG002|Overall Study|Lost to Follow-up|2
945187|NCT01020812|1935927|FG000|Overall Study|Physician Decision|1
945188|NCT01020812|1935927|FG000|Overall Study|Withdrawal by Subject|1
945189|NCT01020812|1935927|FG000|Overall Study|Protocol Violation|1
945190|NCT01020838|1935931|FG000|Overall Study|Death|90
945191|NCT01020838|1935931|FG000|Overall Study|Adverse Event|1
945192|NCT01020838|1935931|FG000|Overall Study|Withdrawal by Subject|9
945193|NCT01020838|1935931|FG000|Overall Study|Lost to Follow-up|6
945194|NCT01020838|1935931|FG000|Overall Study|Most common: Study ended by sponsor|77
945195|NCT01020877|1935946|FG000|Second Intervention|Withdrawal by Subject|1
945196|NCT01020877|1935947|FG001|Second Intervention|Withdrawal by Subject|0
945197|NCT01020981|1935955|FG000|Overall Study|Did not return mailed survey|74
945198|NCT01020981|1935956|FG001|Overall Study|Did not return mailed survey|58
945199|NCT01020981|1935955|FG000|Overall Study|Survey returned undeliverable|8
945200|NCT01020981|1935956|FG001|Overall Study|Survey returned undeliverable|32
945201|NCT01020981|1935955|FG000|Overall Study|Participant declined to complete survey|2
945202|NCT01020981|1935956|FG001|Overall Study|Participant declined to complete survey|0
945203|NCT01021007|1935966|FG000|Overall Study|Lost to Follow-up|1
945204|NCT01021007|1935967|FG001|Overall Study|Lost to Follow-up|1
945205|NCT01021007|1935966|FG000|Overall Study|Adverse Event|1
945206|NCT01021007|1935967|FG001|Overall Study|Adverse Event|3
945207|NCT01021020|1935973|FG000|Period I|Protocol Violation|1
945208|NCT01021020|1935973|FG000|Period I|Withdrawal by Subject|1
945209|NCT01021020|1935973|FG000|14 Day Washout Period A|Physician Decision|1
945210|NCT01021137|1935993|FG000|Overall Study|Lost to Follow-up|9
945211|NCT01021137|1935994|FG001|Overall Study|Lost to Follow-up|4
945212|NCT01021137|1935995|FG002|Overall Study|Lost to Follow-up|2
945213|NCT01021137|1935996|FG003|Overall Study|Lost to Follow-up|6
945214|NCT01021137|1935993|FG000|Overall Study|Withdrawal by Subject|1
945215|NCT01021137|1935994|FG001|Overall Study|Withdrawal by Subject|0
945216|NCT01021137|1935995|FG002|Overall Study|Withdrawal by Subject|0
945217|NCT01021137|1935996|FG003|Overall Study|Withdrawal by Subject|3
945218|NCT01021215|1936009|FG000|Overall Study|Lost to Follow-up|3
945219|NCT01021215|1936010|FG001|Overall Study|Lost to Follow-up|0
945220|NCT01021293|1936018|FG000|Overall Study|Serious Adverse Event|2
945221|NCT01021293|1936019|FG001|Overall Study|Serious Adverse Event|1
945222|NCT01021293|1936018|FG000|Overall Study|Adverse Event|2
945223|NCT01021293|1936019|FG001|Overall Study|Adverse Event|1
945224|NCT01021293|1936018|FG000|Overall Study|Withdrawal by Subject|1
945225|NCT01021293|1936019|FG001|Overall Study|Withdrawal by Subject|3
945226|NCT01021293|1936018|FG000|Overall Study|Migrated/moved from study area|6
945227|NCT01021293|1936019|FG001|Overall Study|Migrated/moved from study area|18
945228|NCT01021293|1936018|FG000|Overall Study|Lost to Follow-up|1
945229|NCT01021293|1936019|FG001|Overall Study|Lost to Follow-up|1
945230|NCT01021332|1936043|FG000|Overall Study|Not fulfilling incl./excl.criteria|5
945231|NCT01021332|1936043|FG000|Overall Study|Adverse Event|43
945232|NCT01021332|1936043|FG000|Overall Study|Lack of Efficacy|19
945233|NCT01021332|1936043|FG000|Overall Study|Withdrawal of Consent|23
945234|NCT01021332|1936043|FG000|Overall Study|Lost to Follow-up|4
945235|NCT01021332|1936043|FG000|Overall Study|Protocol Violation|9
945236|NCT01021332|1936043|FG000|Overall Study|Miscellaneous|3
945237|NCT01021423|1936051|FG000|Overall Study|Study terminated|4
945238|NCT01021423|1936052|FG001|Overall Study|Study terminated|5
945239|NCT01021553|1936061|FG000|Overall Study|Adverse Event|1
945240|NCT01021553|1936062|FG001|Overall Study|Adverse Event|0
945241|NCT01021553|1936063|FG002|Overall Study|Adverse Event|0
945242|NCT01021553|1936061|FG000|Overall Study|Lack of Efficacy|2
945243|NCT01021553|1936062|FG001|Overall Study|Lack of Efficacy|2
945244|NCT01021553|1936063|FG002|Overall Study|Lack of Efficacy|0
945245|NCT01021553|1936061|FG000|Overall Study|Protocol Violation|0
945246|NCT01021553|1936062|FG001|Overall Study|Protocol Violation|2
945247|NCT01021553|1936063|FG002|Overall Study|Protocol Violation|2
945248|NCT01021553|1936061|FG000|Overall Study|Lost to Follow-up|0
945249|NCT01021553|1936062|FG001|Overall Study|Lost to Follow-up|0
945250|NCT01021553|1936063|FG002|Overall Study|Lost to Follow-up|1
945251|NCT01021553|1936061|FG000|Overall Study|Withdrawal by Subject|1
945252|NCT01021553|1936062|FG001|Overall Study|Withdrawal by Subject|1
945253|NCT01021553|1936063|FG002|Overall Study|Withdrawal by Subject|0
945254|NCT01021683|1936085|FG000|Overall Study|Lack of Efficacy|12
945255|NCT01021683|1936085|FG000|Overall Study|Recovery of neutrophil count|51
945256|NCT01021683|1936085|FG000|Overall Study|Other|8
945257|NCT01021748|1936098|FG000|Overall Study|Adverse Event|2
945258|NCT01021748|1936099|FG001|Overall Study|Adverse Event|1
945259|NCT01021748|1936100|FG002|Overall Study|Adverse Event|2
945260|NCT01021748|1936101|FG003|Overall Study|Adverse Event|0
945261|NCT01021748|1936102|FG004|Overall Study|Adverse Event|2
945262|NCT01021748|1936103|FG005|Overall Study|Adverse Event|0
945263|NCT01021748|1936104|FG006|Overall Study|Adverse Event|1
945264|NCT01021748|1936105|FG007|Overall Study|Adverse Event|0
945265|NCT01021748|1936106|FG008|Overall Study|Adverse Event|7
945266|NCT01021748|1936098|FG000|Overall Study|Physician Decision|1
945267|NCT01021748|1936099|FG001|Overall Study|Physician Decision|0
945268|NCT01021748|1936100|FG002|Overall Study|Physician Decision|1
945269|NCT01021748|1936101|FG003|Overall Study|Physician Decision|1
945270|NCT01021748|1936102|FG004|Overall Study|Physician Decision|0
945271|NCT01021748|1936103|FG005|Overall Study|Physician Decision|0
945272|NCT01021748|1936104|FG006|Overall Study|Physician Decision|1
945273|NCT01021748|1936105|FG007|Overall Study|Physician Decision|1
945274|NCT01021748|1936106|FG008|Overall Study|Physician Decision|2
945275|NCT01021748|1936098|FG000|Overall Study|Progressive Disease|3
945276|NCT01021748|1936099|FG001|Overall Study|Progressive Disease|3
945277|NCT01021748|1936100|FG002|Overall Study|Progressive Disease|4
945278|NCT01021748|1936101|FG003|Overall Study|Progressive Disease|6
945279|NCT01021748|1936102|FG004|Overall Study|Progressive Disease|7
945280|NCT01021748|1936103|FG005|Overall Study|Progressive Disease|3
945281|NCT01021748|1936104|FG006|Overall Study|Progressive Disease|0
945282|NCT01021748|1936105|FG007|Overall Study|Progressive Disease|5
945283|NCT01021748|1936106|FG008|Overall Study|Progressive Disease|6
945284|NCT01021748|1936098|FG000|Overall Study|Withdrawal by Subject|0
945285|NCT01021748|1936099|FG001|Overall Study|Withdrawal by Subject|0
945286|NCT01021748|1936100|FG002|Overall Study|Withdrawal by Subject|0
945287|NCT01021748|1936101|FG003|Overall Study|Withdrawal by Subject|0
945288|NCT01021748|1936102|FG004|Overall Study|Withdrawal by Subject|0
945289|NCT01021748|1936103|FG005|Overall Study|Withdrawal by Subject|0
945290|NCT01021748|1936104|FG006|Overall Study|Withdrawal by Subject|1
945291|NCT01021748|1936105|FG007|Overall Study|Withdrawal by Subject|0
945292|NCT01021748|1936106|FG008|Overall Study|Withdrawal by Subject|1
945293|NCT01021748|1936098|FG000|Overall Study|Not Treated|0
945294|NCT01021748|1936099|FG001|Overall Study|Not Treated|1
945295|NCT01021748|1936100|FG002|Overall Study|Not Treated|0
945296|NCT01021748|1936101|FG003|Overall Study|Not Treated|0
945297|NCT01021748|1936102|FG004|Overall Study|Not Treated|0
945298|NCT01021748|1936103|FG005|Overall Study|Not Treated|0
945299|NCT01021748|1936104|FG006|Overall Study|Not Treated|0
945300|NCT01021748|1936105|FG007|Overall Study|Not Treated|0
945301|NCT01021748|1936106|FG008|Overall Study|Not Treated|0
945302|NCT01021813|1936141|FG000|DB Treatment Phase|Adverse Event|60
945303|NCT01021813|1936142|FG001|DB Treatment Phase|Adverse Event|22
945304|NCT01021813|1936143|FG002|DB Treatment Phase|Adverse Event|0
945305|NCT01021813|1936144|FG003|DB Treatment Phase|Adverse Event|0
945306|NCT01021813|1936145|FG004|DB Treatment Phase|Adverse Event|0
945307|NCT01021813|1936141|FG000|DB Treatment Phase|Lack of Efficacy|44
945308|NCT01021813|1936142|FG001|DB Treatment Phase|Lack of Efficacy|28
945309|NCT01021813|1936143|FG002|DB Treatment Phase|Lack of Efficacy|0
945310|NCT01021813|1936144|FG003|DB Treatment Phase|Lack of Efficacy|0
945311|NCT01021813|1936145|FG004|DB Treatment Phase|Lack of Efficacy|0
945312|NCT01021813|1936141|FG000|DB Treatment Phase|Lost to Follow-up|14
945313|NCT01021813|1936142|FG001|DB Treatment Phase|Lost to Follow-up|12
945314|NCT01021813|1936143|FG002|DB Treatment Phase|Lost to Follow-up|0
945315|NCT01021813|1936144|FG003|DB Treatment Phase|Lost to Follow-up|0
945316|NCT01021813|1936145|FG004|DB Treatment Phase|Lost to Follow-up|0
945317|NCT01021813|1936141|FG000|DB Treatment Phase|Physician Decision|17
945318|NCT01021813|1936142|FG001|DB Treatment Phase|Physician Decision|8
945319|NCT01021813|1936143|FG002|DB Treatment Phase|Physician Decision|0
945320|NCT01021813|1936144|FG003|DB Treatment Phase|Physician Decision|0
945321|NCT01021813|1936145|FG004|DB Treatment Phase|Physician Decision|0
945322|NCT01021813|1936141|FG000|DB Treatment Phase|Pregnancy|1
945323|NCT01021813|1936142|FG001|DB Treatment Phase|Pregnancy|0
945324|NCT01021813|1936143|FG002|DB Treatment Phase|Pregnancy|0
945325|NCT01021813|1936144|FG003|DB Treatment Phase|Pregnancy|0
945326|NCT01021813|1936145|FG004|DB Treatment Phase|Pregnancy|0
945327|NCT01021813|1936141|FG000|DB Treatment Phase|Protocol Violation|4
945328|NCT01021813|1936142|FG001|DB Treatment Phase|Protocol Violation|3
945329|NCT01021813|1936143|FG002|DB Treatment Phase|Protocol Violation|0
945330|NCT01021813|1936144|FG003|DB Treatment Phase|Protocol Violation|0
945331|NCT01021813|1936145|FG004|DB Treatment Phase|Protocol Violation|0
945332|NCT01021813|1936141|FG000|DB Treatment Phase|Withdrawal by Subject|60
945333|NCT01021813|1936142|FG001|DB Treatment Phase|Withdrawal by Subject|24
945334|NCT01021813|1936143|FG002|DB Treatment Phase|Withdrawal by Subject|0
945335|NCT01021813|1936144|FG003|DB Treatment Phase|Withdrawal by Subject|0
945336|NCT01021813|1936145|FG004|DB Treatment Phase|Withdrawal by Subject|0
945337|NCT01021813|1936141|FG000|DB Randomized Discontinuation Phase|Adverse Event|0
945338|NCT01021813|1936142|FG001|DB Randomized Discontinuation Phase|Adverse Event|0
945339|NCT01021813|1936143|FG002|DB Randomized Discontinuation Phase|Adverse Event|0
945340|NCT01021813|1936144|FG003|DB Randomized Discontinuation Phase|Adverse Event|3
945341|NCT01021813|1936145|FG004|DB Randomized Discontinuation Phase|Adverse Event|1
945342|NCT01021813|1936141|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0
945343|NCT01021813|1936142|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0
945344|NCT01021813|1936143|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0
945345|NCT01021813|1936144|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1
945346|NCT01021813|1936145|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0
945347|NCT01021813|1936141|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0
945348|NCT01021813|1936142|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0
945349|NCT01021813|1936143|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0
945350|NCT01021813|1936144|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0
945351|NCT01021813|1936145|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1
945352|NCT01021813|1936141|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0
945353|NCT01021813|1936142|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0
945354|NCT01021813|1936143|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1
945355|NCT01021813|1936144|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0
945356|NCT01021813|1936145|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0
945357|NCT01021813|1936141|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
945358|NCT01021813|1936142|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
945359|NCT01021813|1936143|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
945360|NCT01021813|1936144|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
945361|NCT01021813|1936145|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
945362|NCT01021852|1936170|FG000|Treatment Period 1|Adverse Event|3
945363|NCT01021852|1936171|FG001|Treatment Period 1|Adverse Event|1
945364|NCT01021852|1936172|FG002|Treatment Period 1|Adverse Event|1
945365|NCT01021852|1936173|FG003|Treatment Period 1|Adverse Event|0
945366|NCT01021852|1936174|FG004|Treatment Period 1|Adverse Event|2
945367|NCT01021852|1936175|FG005|Treatment Period 1|Adverse Event|2
945368|NCT01021852|1936176|FG006|Treatment Period 1|Adverse Event|0
945369|NCT01021852|1936177|FG007|Treatment Period 1|Adverse Event|0
945370|NCT01021852|1936170|FG000|Treatment Period 1|Pregnancy|0
945371|NCT01021852|1936171|FG001|Treatment Period 1|Pregnancy|0
945372|NCT01021852|1936172|FG002|Treatment Period 1|Pregnancy|1
945373|NCT01021852|1936173|FG003|Treatment Period 1|Pregnancy|0
945374|NCT01021852|1936174|FG004|Treatment Period 1|Pregnancy|0
945375|NCT01021852|1936175|FG005|Treatment Period 1|Pregnancy|0
945376|NCT01021852|1936176|FG006|Treatment Period 1|Pregnancy|0
945377|NCT01021852|1936177|FG007|Treatment Period 1|Pregnancy|0
945378|NCT01021852|1936170|FG000|Treatment Period 1|Withdrawal by Subject|0
945379|NCT01021852|1936171|FG001|Treatment Period 1|Withdrawal by Subject|0
945380|NCT01021852|1936172|FG002|Treatment Period 1|Withdrawal by Subject|0
945381|NCT01021852|1936173|FG003|Treatment Period 1|Withdrawal by Subject|0
945382|NCT01021852|1936174|FG004|Treatment Period 1|Withdrawal by Subject|1
945383|NCT01021852|1936175|FG005|Treatment Period 1|Withdrawal by Subject|0
945384|NCT01021852|1936176|FG006|Treatment Period 1|Withdrawal by Subject|0
945385|NCT01021852|1936177|FG007|Treatment Period 1|Withdrawal by Subject|1
945386|NCT01021852|1936170|FG000|Treatment Period 1|Not Treated|0
945387|NCT01021852|1936171|FG001|Treatment Period 1|Not Treated|0
945388|NCT01021852|1936172|FG002|Treatment Period 1|Not Treated|0
945389|NCT01021852|1936173|FG003|Treatment Period 1|Not Treated|2
945390|NCT01021852|1936174|FG004|Treatment Period 1|Not Treated|0
945391|NCT01021852|1936175|FG005|Treatment Period 1|Not Treated|0
945392|NCT01021852|1936176|FG006|Treatment Period 1|Not Treated|0
945393|NCT01021852|1936177|FG007|Treatment Period 1|Not Treated|0
945394|NCT01021852|1936170|FG000|Washout Period-Placebo|Adverse Event|0
945395|NCT01021852|1936171|FG001|Washout Period-Placebo|Adverse Event|0
945396|NCT01021852|1936172|FG002|Washout Period-Placebo|Adverse Event|0
945397|NCT01021852|1936173|FG003|Washout Period-Placebo|Adverse Event|1
945398|NCT01021852|1936174|FG004|Washout Period-Placebo|Adverse Event|0
945399|NCT01021852|1936175|FG005|Washout Period-Placebo|Adverse Event|1
945400|NCT01021852|1936176|FG006|Washout Period-Placebo|Adverse Event|0
945401|NCT01021852|1936177|FG007|Washout Period-Placebo|Adverse Event|0
945402|NCT01021852|1936170|FG000|Washout Period-Placebo|Lost to Follow-up|0
945403|NCT01021852|1936171|FG001|Washout Period-Placebo|Lost to Follow-up|0
945404|NCT01021852|1936172|FG002|Washout Period-Placebo|Lost to Follow-up|0
945405|NCT01021852|1936173|FG003|Washout Period-Placebo|Lost to Follow-up|0
945406|NCT01021852|1936174|FG004|Washout Period-Placebo|Lost to Follow-up|1
945407|NCT01021852|1936175|FG005|Washout Period-Placebo|Lost to Follow-up|0
945408|NCT01021852|1936176|FG006|Washout Period-Placebo|Lost to Follow-up|0
945409|NCT01021852|1936177|FG007|Washout Period-Placebo|Lost to Follow-up|0
945410|NCT01021852|1936170|FG000|Washout Period-Placebo|Protocol Violation|0
945411|NCT01021852|1936171|FG001|Washout Period-Placebo|Protocol Violation|0
945412|NCT01021852|1936172|FG002|Washout Period-Placebo|Protocol Violation|0
945413|NCT01021852|1936173|FG003|Washout Period-Placebo|Protocol Violation|0
945414|NCT01021852|1936174|FG004|Washout Period-Placebo|Protocol Violation|0
945415|NCT01021852|1936175|FG005|Washout Period-Placebo|Protocol Violation|0
945416|NCT01021852|1936176|FG006|Washout Period-Placebo|Protocol Violation|1
945417|NCT01021852|1936177|FG007|Washout Period-Placebo|Protocol Violation|0
945418|NCT01021852|1936170|FG000|Washout Period-No Drug|Adverse Event|1
945419|NCT01021852|1936171|FG001|Washout Period-No Drug|Adverse Event|0
945420|NCT01021852|1936172|FG002|Washout Period-No Drug|Adverse Event|0
945421|NCT01021852|1936173|FG003|Washout Period-No Drug|Adverse Event|0
945422|NCT01021852|1936174|FG004|Washout Period-No Drug|Adverse Event|0
945423|NCT01021852|1936175|FG005|Washout Period-No Drug|Adverse Event|1
945424|NCT01021852|1936176|FG006|Washout Period-No Drug|Adverse Event|0
945425|NCT01021852|1936177|FG007|Washout Period-No Drug|Adverse Event|0
945426|NCT01021852|1936170|FG000|Treatment Period 2|Adverse Event|0
945427|NCT01021852|1936171|FG001|Treatment Period 2|Adverse Event|1
945428|NCT01021852|1936172|FG002|Treatment Period 2|Adverse Event|0
945429|NCT01021852|1936173|FG003|Treatment Period 2|Adverse Event|0
945430|NCT01021852|1936174|FG004|Treatment Period 2|Adverse Event|1
945431|NCT01021852|1936175|FG005|Treatment Period 2|Adverse Event|0
945432|NCT01021852|1936176|FG006|Treatment Period 2|Adverse Event|1
945433|NCT01021852|1936177|FG007|Treatment Period 2|Adverse Event|0
945434|NCT01021852|1936170|FG000|Treatment Period 2|Lack of Efficacy|0
945435|NCT01021852|1936171|FG001|Treatment Period 2|Lack of Efficacy|0
945436|NCT01021852|1936172|FG002|Treatment Period 2|Lack of Efficacy|0
945437|NCT01021852|1936173|FG003|Treatment Period 2|Lack of Efficacy|0
945438|NCT01021852|1936174|FG004|Treatment Period 2|Lack of Efficacy|0
945439|NCT01021852|1936175|FG005|Treatment Period 2|Lack of Efficacy|1
945440|NCT01021852|1936176|FG006|Treatment Period 2|Lack of Efficacy|0
945441|NCT01021852|1936177|FG007|Treatment Period 2|Lack of Efficacy|0
945442|NCT01021852|1936170|FG000|Treatment Period 2|Physician Decision|0
945443|NCT01021852|1936171|FG001|Treatment Period 2|Physician Decision|0
945444|NCT01021852|1936172|FG002|Treatment Period 2|Physician Decision|1
945445|NCT01021852|1936173|FG003|Treatment Period 2|Physician Decision|0
945446|NCT01021852|1936174|FG004|Treatment Period 2|Physician Decision|0
945447|NCT01021852|1936175|FG005|Treatment Period 2|Physician Decision|0
945448|NCT01021852|1936176|FG006|Treatment Period 2|Physician Decision|0
945449|NCT01021852|1936177|FG007|Treatment Period 2|Physician Decision|0
945450|NCT01021852|1936170|FG000|Treatment Period 2|Protocol Violation|0
945451|NCT01021852|1936171|FG001|Treatment Period 2|Protocol Violation|0
945452|NCT01021852|1936172|FG002|Treatment Period 2|Protocol Violation|0
945453|NCT01021852|1936173|FG003|Treatment Period 2|Protocol Violation|0
945454|NCT01021852|1936174|FG004|Treatment Period 2|Protocol Violation|1
945455|NCT01021852|1936175|FG005|Treatment Period 2|Protocol Violation|0
945456|NCT01021852|1936176|FG006|Treatment Period 2|Protocol Violation|1
945457|NCT01021852|1936177|FG007|Treatment Period 2|Protocol Violation|0
945458|NCT01021852|1936170|FG000|Treatment Period 2|Withdrawal by Subject|0
945459|NCT01021852|1936171|FG001|Treatment Period 2|Withdrawal by Subject|0
945460|NCT01021852|1936172|FG002|Treatment Period 2|Withdrawal by Subject|0
945461|NCT01021852|1936173|FG003|Treatment Period 2|Withdrawal by Subject|0
945462|NCT01021852|1936174|FG004|Treatment Period 2|Withdrawal by Subject|0
945463|NCT01021852|1936175|FG005|Treatment Period 2|Withdrawal by Subject|0
945464|NCT01021852|1936176|FG006|Treatment Period 2|Withdrawal by Subject|1
945465|NCT01021852|1936177|FG007|Treatment Period 2|Withdrawal by Subject|2
945466|NCT01021878|1936193|FG000|Overall Study|Lost to Follow-up|4
945467|NCT01021878|1936194|FG001|Overall Study|Lost to Follow-up|3
945468|NCT01021878|1936193|FG000|Overall Study|Death|0
945469|NCT01021878|1936194|FG001|Overall Study|Death|1
945470|NCT01021878|1936193|FG000|Overall Study|Adverse Event|6
945471|NCT01021878|1936194|FG001|Overall Study|Adverse Event|5
945472|NCT01021878|1936193|FG000|Overall Study|Transplantation|6
945473|NCT01021878|1936194|FG001|Overall Study|Transplantation|1
945474|NCT01022112|1936235|FG000|Overall Study|Adverse Event|1
945475|NCT01022112|1936236|FG001|Overall Study|Adverse Event|2
945476|NCT01022112|1936237|FG002|Overall Study|Adverse Event|0
945477|NCT01022112|1936238|FG003|Overall Study|Adverse Event|1
945478|NCT01022112|1936239|FG004|Overall Study|Adverse Event|0
945479|NCT01022112|1936235|FG000|Overall Study|Lack of Efficacy|1
945480|NCT01022112|1936236|FG001|Overall Study|Lack of Efficacy|0
945481|NCT01022112|1936237|FG002|Overall Study|Lack of Efficacy|0
945482|NCT01022112|1936238|FG003|Overall Study|Lack of Efficacy|0
945483|NCT01022112|1936239|FG004|Overall Study|Lack of Efficacy|1
945484|NCT01022112|1936235|FG000|Overall Study|Physician Decision|0
945485|NCT01022112|1936236|FG001|Overall Study|Physician Decision|0
945486|NCT01022112|1936237|FG002|Overall Study|Physician Decision|1
945487|NCT01022112|1936238|FG003|Overall Study|Physician Decision|0
945488|NCT01022112|1936239|FG004|Overall Study|Physician Decision|1
945489|NCT01022112|1936235|FG000|Overall Study|Withdrawal by Subject|0
945490|NCT01022112|1936236|FG001|Overall Study|Withdrawal by Subject|1
945491|NCT01022112|1936237|FG002|Overall Study|Withdrawal by Subject|2
945492|NCT01022112|1936238|FG003|Overall Study|Withdrawal by Subject|2
945493|NCT01022112|1936239|FG004|Overall Study|Withdrawal by Subject|1
945494|NCT01022112|1936235|FG000|Overall Study|Fasting plasma glucose level increased|1
945495|NCT01022112|1936236|FG001|Overall Study|Fasting plasma glucose level increased|0
945496|NCT01022112|1936237|FG002|Overall Study|Fasting plasma glucose level increased|0
945497|NCT01022112|1936238|FG003|Overall Study|Fasting plasma glucose level increased|0
945498|NCT01022112|1936239|FG004|Overall Study|Fasting plasma glucose level increased|7
945499|NCT01022203|1936257|FG000|Post Treatment Assessment|Withdrawal by Subject|12
945500|NCT01022203|1936258|FG001|Post Treatment Assessment|Withdrawal by Subject|12
945501|NCT01022203|1936257|FG000|Post Treatment Assessment|Physician Decision|2
945502|NCT01022203|1936258|FG001|Post Treatment Assessment|Physician Decision|0
945503|NCT01022203|1936257|FG000|Post Treatment Assessment|Adverse Event|0
945504|NCT01022203|1936258|FG001|Post Treatment Assessment|Adverse Event|2
945505|NCT01022203|1936257|FG000|Follow-Up Assessment|Lost to Follow-up|2
945506|NCT01022203|1936258|FG001|Follow-Up Assessment|Lost to Follow-up|2
945507|NCT01022424|1936294|FG000|Overall Study|Adverse Event|1
945508|NCT01022424|1936294|FG000|Overall Study|Physician Decision|1
945509|NCT01022424|1936294|FG000|Overall Study|eGFR under the withdrawal criteria|2
945510|NCT01022502|1936302|FG000|Overall Study|Adverse Event|1
945511|NCT01022502|1936302|FG000|Overall Study|employment related reasons|1
945512|NCT01022502|1936302|FG000|Overall Study|Withdrawal by Subject|1
945513|NCT01022580|1936319|FG000|Overall Study|Death|18
945514|NCT01022580|1936320|FG001|Overall Study|Death|22
945515|NCT01022762|1936334|FG000|Overall Study|Adverse Event|3
945516|NCT01022762|1936335|FG001|Overall Study|Adverse Event|1
945517|NCT01022762|1936334|FG000|Overall Study|Lack of Efficacy|0
945518|NCT01022762|1936335|FG001|Overall Study|Lack of Efficacy|1
945519|NCT01022762|1936334|FG000|Overall Study|Protocol Violation|7
945520|NCT01022762|1936335|FG001|Overall Study|Protocol Violation|6
945521|NCT01022762|1936334|FG000|Overall Study|Unclassified|12
945522|NCT01022762|1936335|FG001|Overall Study|Unclassified|20
945523|NCT01022853|1936346|FG000|Overall Study|Progressive disease|2
945524|NCT01022853|1936347|FG001|Overall Study|Progressive disease|3
945525|NCT01022853|1936348|FG002|Overall Study|Progressive disease|11
945526|NCT01022853|1936349|FG003|Overall Study|Progressive disease|7
945527|NCT01022853|1936350|FG004|Overall Study|Progressive disease|1
945528|NCT01022853|1936346|FG000|Overall Study|Dose-limiting toxicity|0
945529|NCT01022853|1936347|FG001|Overall Study|Dose-limiting toxicity|0
945530|NCT01022853|1936348|FG002|Overall Study|Dose-limiting toxicity|0
945531|NCT01022853|1936349|FG003|Overall Study|Dose-limiting toxicity|0
945532|NCT01022853|1936350|FG004|Overall Study|Dose-limiting toxicity|1
945533|NCT01022853|1936346|FG000|Overall Study|Withdrawal by Subject|0
945534|NCT01022853|1936347|FG001|Overall Study|Withdrawal by Subject|1
945535|NCT01022853|1936348|FG002|Overall Study|Withdrawal by Subject|1
945536|NCT01022853|1936349|FG003|Overall Study|Withdrawal by Subject|1
945537|NCT01022853|1936350|FG004|Overall Study|Withdrawal by Subject|0
945538|NCT01022853|1936346|FG000|Overall Study|Other not stated above|1
945539|NCT01022853|1936347|FG001|Overall Study|Other not stated above|0
945540|NCT01022853|1936348|FG002|Overall Study|Other not stated above|1
945541|NCT01022853|1936349|FG003|Overall Study|Other not stated above|0
945542|NCT01022853|1936350|FG004|Overall Study|Other not stated above|0
945543|NCT01022996|1936365|FG000|Overall Study|Adverse Event|14
945544|NCT01022996|1936365|FG000|Overall Study|Withdrawal by Subject|3
945545|NCT01022996|1936365|FG000|Overall Study|Lost to Follow-up|1
945546|NCT01022996|1936365|FG000|Overall Study|Administrative problems|6
945547|NCT01022996|1936365|FG000|Overall Study|Disease Progression|32
945548|NCT01022996|1936365|FG000|Overall Study|Protocol Violation|1
945549|NCT01023022|1936369|FG000|Overall Study|Death|5
945550|NCT01023022|1936369|FG000|Overall Study|Lost to Follow-up|7
945551|NCT01023022|1936369|FG000|Overall Study|due to technical issues|2
945552|NCT01023035|1936376|FG000|Treatment Period|Adverse Event|27
945553|NCT01023035|1936377|FG001|Treatment Period|Adverse Event|32
945554|NCT01023035|1936378|FG002|Treatment Period|Adverse Event|50
945555|NCT01023035|1936376|FG000|Treatment Period|Non-Medical Reasons|19
945556|NCT01023035|1936377|FG001|Treatment Period|Non-Medical Reasons|22
945557|NCT01023035|1936378|FG002|Treatment Period|Non-Medical Reasons|44
945558|NCT01023035|1936376|FG000|Treatment Period|Treatment Failure|26
945559|NCT01023035|1936377|FG001|Treatment Period|Treatment Failure|31
945560|NCT01023035|1936378|FG002|Treatment Period|Treatment Failure|24
945561|NCT01023035|1936376|FG000|Follow-up Period (up to Week 72)|Adverse Event|2
945562|NCT01023035|1936377|FG001|Follow-up Period (up to Week 72)|Adverse Event|0
945563|NCT01023035|1936378|FG002|Follow-up Period (up to Week 72)|Adverse Event|1
945564|NCT01023035|1936376|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26
945565|NCT01023035|1936377|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28
945566|NCT01023035|1936378|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38
945567|NCT01023061|1936388|FG000|Overall Study|Withdrawal prior to treatment|2
945568|NCT01023217|1936424|FG000|Overall Study|Withdrawal by Subject|1
945569|NCT01023217|1936425|FG001|Overall Study|Withdrawal by Subject|0
945570|NCT01023256|1936435|FG000|Overall Study|Protocol Violation|2
945571|NCT01023256|1936436|FG001|Overall Study|Protocol Violation|3
945572|NCT01023256|1936437|FG002|Overall Study|Protocol Violation|0
945573|NCT01023256|1936438|FG003|Overall Study|Protocol Violation|0
945574|NCT01023256|1936435|FG000|Overall Study|Randomized but not treated|1
945575|NCT01023256|1936436|FG001|Overall Study|Randomized but not treated|0
945576|NCT01023256|1936437|FG002|Overall Study|Randomized but not treated|1
945577|NCT01023256|1936438|FG003|Overall Study|Randomized but not treated|0
945578|NCT01023256|1936435|FG000|Overall Study|Other|1
945579|NCT01023256|1936436|FG001|Overall Study|Other|0
945580|NCT01023256|1936437|FG002|Overall Study|Other|0
945581|NCT01023256|1936438|FG003|Overall Study|Other|2
945582|NCT01023256|1936435|FG000|Overall Study|Adverse Event|0
945583|NCT01023256|1936436|FG001|Overall Study|Adverse Event|0
945584|NCT01023256|1936437|FG002|Overall Study|Adverse Event|0
945585|NCT01023256|1936438|FG003|Overall Study|Adverse Event|1
945586|NCT01023256|1936435|FG000|Overall Study|Withdrawal by Subject|0
945587|NCT01023256|1936436|FG001|Overall Study|Withdrawal by Subject|0
945588|NCT01023256|1936437|FG002|Overall Study|Withdrawal by Subject|0
945589|NCT01023256|1936438|FG003|Overall Study|Withdrawal by Subject|2
945590|NCT01023269|1936451|FG000|Overall Study|early termination of the study|2
945591|NCT01023269|1936452|FG001|Overall Study|early termination of the study|0
945592|NCT01023308|1936458|FG000|Overall Study|Abnormal test proceedure results|3
945593|NCT01023308|1936459|FG001|Overall Study|Abnormal test proceedure results|8
945594|NCT01023308|1936458|FG000|Overall Study|Administrative problems|2
945595|NCT01023308|1936459|FG001|Overall Study|Administrative problems|1
945596|NCT01023308|1936458|FG000|Overall Study|Adverse Event|130
945597|NCT01023308|1936459|FG001|Overall Study|Adverse Event|66
945598|NCT01023308|1936458|FG000|Overall Study|Death|21
945599|NCT01023308|1936459|FG001|Overall Study|Death|17
945600|NCT01023308|1936458|FG000|Overall Study|Disease progression|82
945601|NCT01023308|1936459|FG001|Overall Study|Disease progression|153
945602|NCT01023308|1936458|FG000|Overall Study|New Cancer therapy|4
945603|NCT01023308|1936459|FG001|Overall Study|New Cancer therapy|7
945604|NCT01023308|1936458|FG000|Overall Study|Protocol Violation|3
945605|NCT01023308|1936459|FG001|Overall Study|Protocol Violation|4
945606|NCT01023308|1936458|FG000|Overall Study|Untreated|5
945607|NCT01023308|1936459|FG001|Overall Study|Untreated|5
945608|NCT01023308|1936458|FG000|Overall Study|Lost to Follow-up|1
945609|NCT01023308|1936459|FG001|Overall Study|Lost to Follow-up|0
945610|NCT01023308|1936458|FG000|Overall Study|Withdrawal by Subject|34
945611|NCT01023308|1936459|FG001|Overall Study|Withdrawal by Subject|18
945612|NCT01023516|1936476|FG000|Overall Study|Voluntary discontinuation|7
945613|NCT01023516|1936477|FG001|Overall Study|Voluntary discontinuation|5
945614|NCT01023516|1936476|FG000|Overall Study|Adverse Event|9
945615|NCT01023516|1936477|FG001|Overall Study|Adverse Event|6
945616|NCT01023516|1936476|FG000|Overall Study|Safety reason|0
945617|NCT01023516|1936477|FG001|Overall Study|Safety reason|3
945618|NCT01023516|1936476|FG000|Overall Study|Study-specific criteria|4
945619|NCT01023516|1936477|FG001|Overall Study|Study-specific criteria|2
945620|NCT01023516|1936476|FG000|Overall Study|Incorrect enrolment|4
945621|NCT01023516|1936477|FG001|Overall Study|Incorrect enrolment|2
945622|NCT01023581|1936503|FG000|Overall Study|Adverse Event|4
945623|NCT01023581|1936504|FG001|Overall Study|Adverse Event|4
945624|NCT01023581|1936505|FG002|Overall Study|Adverse Event|7
945625|NCT01023581|1936506|FG003|Overall Study|Adverse Event|3
945626|NCT01023581|1936507|FG004|Overall Study|Adverse Event|2
945627|NCT01023581|1936508|FG005|Overall Study|Adverse Event|5
945628|NCT01023581|1936509|FG006|Overall Study|Adverse Event|11
945629|NCT01023581|1936503|FG000|Overall Study|Major protocol deviation|2
945630|NCT01023581|1936504|FG001|Overall Study|Major protocol deviation|0
945631|NCT01023581|1936505|FG002|Overall Study|Major protocol deviation|3
945632|NCT01023581|1936506|FG003|Overall Study|Major protocol deviation|0
945633|NCT01023581|1936507|FG004|Overall Study|Major protocol deviation|0
945634|NCT01023581|1936508|FG005|Overall Study|Major protocol deviation|0
945635|NCT01023581|1936509|FG006|Overall Study|Major protocol deviation|0
945636|NCT01023581|1936503|FG000|Overall Study|Lost to Follow-up|4
945637|NCT01023581|1936504|FG001|Overall Study|Lost to Follow-up|8
945638|NCT01023581|1936505|FG002|Overall Study|Lost to Follow-up|7
945639|NCT01023581|1936506|FG003|Overall Study|Lost to Follow-up|2
945640|NCT01023581|1936507|FG004|Overall Study|Lost to Follow-up|5
945641|NCT01023581|1936508|FG005|Overall Study|Lost to Follow-up|2
945642|NCT01023581|1936509|FG006|Overall Study|Lost to Follow-up|2
945643|NCT01023581|1936503|FG000|Overall Study|Withdrawal by Subject|13
945644|NCT01023581|1936504|FG001|Overall Study|Withdrawal by Subject|8
945645|NCT01023581|1936505|FG002|Overall Study|Withdrawal by Subject|16
945646|NCT01023581|1936506|FG003|Overall Study|Withdrawal by Subject|10
945647|NCT01023581|1936507|FG004|Overall Study|Withdrawal by Subject|6
945648|NCT01023581|1936508|FG005|Overall Study|Withdrawal by Subject|8
945649|NCT01023581|1936509|FG006|Overall Study|Withdrawal by Subject|5
945650|NCT01023581|1936503|FG000|Overall Study|Pregnancy|0
945651|NCT01023581|1936504|FG001|Overall Study|Pregnancy|0
945652|NCT01023581|1936505|FG002|Overall Study|Pregnancy|0
945653|NCT01023581|1936506|FG003|Overall Study|Pregnancy|2
945654|NCT01023581|1936507|FG004|Overall Study|Pregnancy|0
945655|NCT01023581|1936508|FG005|Overall Study|Pregnancy|1
945656|NCT01023581|1936509|FG006|Overall Study|Pregnancy|0
945657|NCT01023581|1936503|FG000|Overall Study|Lack of Efficacy|9
945658|NCT01023581|1936504|FG001|Overall Study|Lack of Efficacy|3
945659|NCT01023581|1936505|FG002|Overall Study|Lack of Efficacy|6
945660|NCT01023581|1936506|FG003|Overall Study|Lack of Efficacy|2
945661|NCT01023581|1936507|FG004|Overall Study|Lack of Efficacy|1
945662|NCT01023581|1936508|FG005|Overall Study|Lack of Efficacy|2
945663|NCT01023581|1936509|FG006|Overall Study|Lack of Efficacy|1
945664|NCT01023581|1936503|FG000|Overall Study|Physician Decision|2
945665|NCT01023581|1936504|FG001|Overall Study|Physician Decision|0
945666|NCT01023581|1936505|FG002|Overall Study|Physician Decision|2
945667|NCT01023581|1936506|FG003|Overall Study|Physician Decision|1
945668|NCT01023581|1936507|FG004|Overall Study|Physician Decision|1
945669|NCT01023581|1936508|FG005|Overall Study|Physician Decision|1
945670|NCT01023581|1936509|FG006|Overall Study|Physician Decision|1
945671|NCT01023581|1936503|FG000|Overall Study|Other|1
945672|NCT01023581|1936504|FG001|Overall Study|Other|0
945673|NCT01023581|1936505|FG002|Overall Study|Other|1
945674|NCT01023581|1936506|FG003|Overall Study|Other|0
945675|NCT01023581|1936507|FG004|Overall Study|Other|1
945676|NCT01023581|1936508|FG005|Overall Study|Other|0
945677|NCT01023581|1936509|FG006|Overall Study|Other|0
945678|NCT01023659|1936528|FG000|Overall Study|Lost to Follow-up|73
945679|NCT01023659|1936529|FG001|Overall Study|Lost to Follow-up|228
945680|NCT01023659|1936530|FG002|Overall Study|Lost to Follow-up|99
945681|NCT01023672|1936539|FG000|Overall Study|Worsening disease|2
945682|NCT01023672|1936539|FG000|Overall Study|Death|1
945683|NCT01023789|1936561|FG000|3 - Year Visit|Death|29
945684|NCT01023789|1936561|FG000|3 - Year Visit|Withdrawal of consent|1
945685|NCT01023789|1936561|FG000|3 - Year Visit|Lost to Follow-up|13
945686|NCT01023815|1936569|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
945687|NCT01023815|1936570|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
945688|NCT01023815|1936571|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
945689|NCT01023815|1936572|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
945690|NCT01023815|1936569|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
945691|NCT01023815|1936570|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
945692|NCT01023815|1936571|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
945693|NCT01023815|1936572|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
945694|NCT01023815|1936569|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
945695|NCT01023815|1936570|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
945696|NCT01023815|1936571|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
945697|NCT01023815|1936572|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
945698|NCT01023815|1936569|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
945699|NCT01023815|1936570|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
945700|NCT01023815|1936571|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
945701|NCT01023815|1936572|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
945702|NCT01023815|1936569|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0
945703|NCT01023815|1936570|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1
945704|NCT01023815|1936571|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0
945705|NCT01023815|1936572|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0
945706|NCT01023958|1936592|FG000|Overall Study|Progressive disease|48
945707|NCT01023958|1936592|FG000|Overall Study|Other adverse event|1
945708|NCT01023958|1936592|FG000|Overall Study|Refused to continue medication|1
945709|NCT01024036|1936607|FG000|Blinded Treatment|Adverse Event|1
945710|NCT01024036|1936608|FG001|Blinded Treatment|Adverse Event|1
945711|NCT01024036|1936607|FG000|Blinded Treatment|Lack of Efficacy|16
945712|NCT01024036|1936608|FG001|Blinded Treatment|Lack of Efficacy|14
945713|NCT01024036|1936607|FG000|Blinded Treatment|Physician Decision|1
945714|NCT01024036|1936608|FG001|Blinded Treatment|Physician Decision|0
945715|NCT01024036|1936607|FG000|Blinded Treatment|Death|0
945716|NCT01024036|1936608|FG001|Blinded Treatment|Death|2
945717|NCT01024036|1936607|FG000|Blinded Treatment|Withdrawal by Subject|4
945718|NCT01024036|1936608|FG001|Blinded Treatment|Withdrawal by Subject|3
945719|NCT01024036|1936607|FG000|Unblinded Treatment|Adverse Event|0
945720|NCT01024036|1936608|FG001|Unblinded Treatment|Adverse Event|1
945721|NCT01024036|1936607|FG000|Unblinded Treatment|Lack of Efficacy|0
945722|NCT01024036|1936608|FG001|Unblinded Treatment|Lack of Efficacy|2
945723|NCT01024036|1936607|FG000|Follow-Up Period|Lost to Follow-up|1
945724|NCT01024036|1936608|FG001|Follow-Up Period|Lost to Follow-up|1
945725|NCT01024036|1936607|FG000|Follow-Up Period|Withdrawal by Subject|0
945726|NCT01024036|1936608|FG001|Follow-Up Period|Withdrawal by Subject|1
945727|NCT01024036|1936607|FG000|Follow-Up Period|Adverse Event|4
945728|NCT01024036|1936608|FG001|Follow-Up Period|Adverse Event|1
945729|NCT01024231|1936624|FG000|Overall Study|Other Reasons|1
945730|NCT01024231|1936625|FG001|Overall Study|Other Reasons|2
945731|NCT01024231|1936626|FG002|Overall Study|Other Reasons|0
945732|NCT01024231|1936627|FG003|Overall Study|Other Reasons|0
945733|NCT01024231|1936628|FG004|Overall Study|Other Reasons|2
945734|NCT01024231|1936629|FG005|Overall Study|Other Reasons|0
945735|NCT01024231|1936630|FG006|Overall Study|Other Reasons|1
945736|NCT01024231|1936624|FG000|Overall Study|Maximum Clinical Benefit|1
945737|NCT01024231|1936625|FG001|Overall Study|Maximum Clinical Benefit|2
945738|NCT01024231|1936626|FG002|Overall Study|Maximum Clinical Benefit|0
945739|NCT01024231|1936627|FG003|Overall Study|Maximum Clinical Benefit|1
945740|NCT01024231|1936628|FG004|Overall Study|Maximum Clinical Benefit|1
945741|NCT01024231|1936629|FG005|Overall Study|Maximum Clinical Benefit|0
945742|NCT01024231|1936630|FG006|Overall Study|Maximum Clinical Benefit|0
945743|NCT01024231|1936624|FG000|Overall Study|Disease Progression|3
945744|NCT01024231|1936625|FG001|Overall Study|Disease Progression|1
945745|NCT01024231|1936626|FG002|Overall Study|Disease Progression|3
945746|NCT01024231|1936627|FG003|Overall Study|Disease Progression|0
945747|NCT01024231|1936628|FG004|Overall Study|Disease Progression|4
945748|NCT01024231|1936629|FG005|Overall Study|Disease Progression|11
945749|NCT01024231|1936630|FG006|Overall Study|Disease Progression|6
945750|NCT01024231|1936624|FG000|Overall Study|AE unrelated to Study Drug|0
945751|NCT01024231|1936625|FG001|Overall Study|AE unrelated to Study Drug|1
945752|NCT01024231|1936626|FG002|Overall Study|AE unrelated to Study Drug|0
945753|NCT01024231|1936627|FG003|Overall Study|AE unrelated to Study Drug|0
945754|NCT01024231|1936628|FG004|Overall Study|AE unrelated to Study Drug|0
945755|NCT01024231|1936629|FG005|Overall Study|AE unrelated to Study Drug|0
945756|NCT01024231|1936630|FG006|Overall Study|AE unrelated to Study Drug|0
945757|NCT01024231|1936624|FG000|Overall Study|No longer meets criteria|0
945758|NCT01024231|1936625|FG001|Overall Study|No longer meets criteria|0
945759|NCT01024231|1936626|FG002|Overall Study|No longer meets criteria|0
945760|NCT01024231|1936627|FG003|Overall Study|No longer meets criteria|0
945761|NCT01024231|1936628|FG004|Overall Study|No longer meets criteria|1
945762|NCT01024231|1936629|FG005|Overall Study|No longer meets criteria|0
945763|NCT01024231|1936630|FG006|Overall Study|No longer meets criteria|1
945764|NCT01024231|1936624|FG000|Overall Study|Study Drug Toxicity|1
945765|NCT01024231|1936625|FG001|Overall Study|Study Drug Toxicity|6
945766|NCT01024231|1936626|FG002|Overall Study|Study Drug Toxicity|6
945767|NCT01024231|1936627|FG003|Overall Study|Study Drug Toxicity|4
945768|NCT01024231|1936628|FG004|Overall Study|Study Drug Toxicity|2
945769|NCT01024231|1936629|FG005|Overall Study|Study Drug Toxicity|0
945770|NCT01024231|1936630|FG006|Overall Study|Study Drug Toxicity|7
945771|NCT01024231|1936624|FG000|Overall Study|Death|6
945772|NCT01024231|1936625|FG001|Overall Study|Death|2
945773|NCT01024231|1936626|FG002|Overall Study|Death|1
945774|NCT01024231|1936627|FG003|Overall Study|Death|0
945775|NCT01024231|1936628|FG004|Overall Study|Death|4
945776|NCT01024231|1936629|FG005|Overall Study|Death|3
945777|NCT01024231|1936630|FG006|Overall Study|Death|5
945778|NCT01024231|1936624|FG000|Overall Study|Lost to Follow-up|0
945779|NCT01024231|1936625|FG001|Overall Study|Lost to Follow-up|0
945780|NCT01024231|1936626|FG002|Overall Study|Lost to Follow-up|0
945781|NCT01024231|1936627|FG003|Overall Study|Lost to Follow-up|0
945782|NCT01024231|1936628|FG004|Overall Study|Lost to Follow-up|0
945783|NCT01024231|1936629|FG005|Overall Study|Lost to Follow-up|0
945784|NCT01024231|1936630|FG006|Overall Study|Lost to Follow-up|1
945785|NCT01024231|1936624|FG000|Overall Study|Withdrew Consent|0
945786|NCT01024231|1936625|FG001|Overall Study|Withdrew Consent|1
945787|NCT01024231|1936626|FG002|Overall Study|Withdrew Consent|0
945788|NCT01024231|1936627|FG003|Overall Study|Withdrew Consent|0
945789|NCT01024231|1936628|FG004|Overall Study|Withdrew Consent|0
945790|NCT01024231|1936629|FG005|Overall Study|Withdrew Consent|0
945791|NCT01024231|1936630|FG006|Overall Study|Withdrew Consent|0
945792|NCT01024231|1936624|FG000|Overall Study|Continuing on Treatment|0
945793|NCT01024231|1936625|FG001|Overall Study|Continuing on Treatment|0
945794|NCT01024231|1936626|FG002|Overall Study|Continuing on Treatment|0
945795|NCT01024231|1936627|FG003|Overall Study|Continuing on Treatment|0
945796|NCT01024231|1936628|FG004|Overall Study|Continuing on Treatment|3
945797|NCT01024231|1936629|FG005|Overall Study|Continuing on Treatment|2
945798|NCT01024231|1936630|FG006|Overall Study|Continuing on Treatment|0
945799|NCT01024244|1936656|FG000|Overall Study|Adverse Event|1
945800|NCT01024244|1936657|FG001|Overall Study|Adverse Event|2
945801|NCT01024244|1936658|FG002|Overall Study|Adverse Event|0
945802|NCT01024244|1936659|FG003|Overall Study|Adverse Event|1
945803|NCT01024244|1936660|FG004|Overall Study|Adverse Event|2
945804|NCT01024244|1936656|FG000|Overall Study|Entry Criteria Not Met|0
945805|NCT01024244|1936657|FG001|Overall Study|Entry Criteria Not Met|1
945806|NCT01024244|1936658|FG002|Overall Study|Entry Criteria Not Met|0
945807|NCT01024244|1936659|FG003|Overall Study|Entry Criteria Not Met|0
945808|NCT01024244|1936660|FG004|Overall Study|Entry Criteria Not Met|0
945809|NCT01024244|1936656|FG000|Overall Study|Lack of Efficacy|1
945810|NCT01024244|1936657|FG001|Overall Study|Lack of Efficacy|0
945811|NCT01024244|1936658|FG002|Overall Study|Lack of Efficacy|0
945812|NCT01024244|1936659|FG003|Overall Study|Lack of Efficacy|0
945813|NCT01024244|1936660|FG004|Overall Study|Lack of Efficacy|0
945814|NCT01024244|1936656|FG000|Overall Study|Protocol Violation|1
945815|NCT01024244|1936657|FG001|Overall Study|Protocol Violation|0
945816|NCT01024244|1936658|FG002|Overall Study|Protocol Violation|0
945817|NCT01024244|1936659|FG003|Overall Study|Protocol Violation|0
945818|NCT01024244|1936660|FG004|Overall Study|Protocol Violation|2
945819|NCT01024244|1936656|FG000|Overall Study|Sponsor Decision|14
945820|NCT01024244|1936657|FG001|Overall Study|Sponsor Decision|7
945821|NCT01024244|1936658|FG002|Overall Study|Sponsor Decision|14
945822|NCT01024244|1936659|FG003|Overall Study|Sponsor Decision|12
945823|NCT01024244|1936660|FG004|Overall Study|Sponsor Decision|10
945824|NCT01024244|1936656|FG000|Overall Study|Withdrawal by Subject|0
945825|NCT01024244|1936657|FG001|Overall Study|Withdrawal by Subject|1
945826|NCT01024244|1936658|FG002|Overall Study|Withdrawal by Subject|0
945827|NCT01024244|1936659|FG003|Overall Study|Withdrawal by Subject|0
945828|NCT01024244|1936660|FG004|Overall Study|Withdrawal by Subject|0
945829|NCT01024309|1936678|FG000|Overall Study|Physician Decision|4
945830|NCT01024309|1936679|FG001|Overall Study|Physician Decision|0
945831|NCT01024309|1936678|FG000|Overall Study|Withdrawal by Subject|4
945832|NCT01024309|1936679|FG001|Overall Study|Withdrawal by Subject|4
945833|NCT01024387|1936694|FG000|Overall Study|Radiographic Progression|29
945834|NCT01024387|1936694|FG000|Overall Study|Symptomatic Progression|10
945835|NCT01024387|1936694|FG000|Overall Study|Physician Decision|5
945836|NCT01024387|1936694|FG000|Overall Study|Withdrawal by Subject|5
945837|NCT01024387|1936694|FG000|Overall Study|Death|2
945838|NCT01024387|1936694|FG000|Overall Study|Prolonged Treatment Delay|1
945839|NCT01024387|1936694|FG000|Overall Study|Adverse Event|3
945840|NCT01024387|1936694|FG000|Overall Study|Other|5
945841|NCT01024465|1936698|FG000|Overall Study|Adverse Event|2
945842|NCT01024465|1936698|FG000|Overall Study|Physician Decision|1
945853|NCT01024751|1936750|FG000|Enrolled Participants|Ineligible at baseline|3
945854|NCT01024751|1936751|FG001|Enrolled Participants|Ineligible at baseline|4
945855|NCT01024751|1936750|FG000|Eligible Participants|Withdrawal by Subject|0
945856|NCT01024751|1936751|FG001|Eligible Participants|Withdrawal by Subject|1
945857|NCT01024751|1936750|FG000|Eligible Participants|Lost to Follow-up|0
945858|NCT01024751|1936751|FG001|Eligible Participants|Lost to Follow-up|1
945859|NCT01024751|1936750|FG000|Eligible Participants|Ineligible|0
945860|NCT01024751|1936751|FG001|Eligible Participants|Ineligible|1
945861|NCT01024855|1936757|FG000|Overall Study|Inclusion/exclusion criteria|1
945862|NCT01024920|1936764|FG000|Overall Study|Progressive disease|47
945863|NCT01024920|1936765|FG001|Overall Study|Progressive disease|25
945864|NCT01024920|1936764|FG000|Overall Study|Adverse Event|8
945865|NCT01024920|1936765|FG001|Overall Study|Adverse Event|4
945866|NCT01024920|1936764|FG000|Overall Study|Lost to Follow-up|0
945867|NCT01024920|1936765|FG001|Overall Study|Lost to Follow-up|1
945868|NCT01024920|1936764|FG000|Overall Study|Patient refusal to continue|4
945869|NCT01024920|1936765|FG001|Overall Study|Patient refusal to continue|0
945870|NCT01024920|1936764|FG000|Overall Study|Other than listed|5
945871|NCT01024920|1936765|FG001|Overall Study|Other than listed|1
945872|NCT01024920|1936764|FG000|Overall Study|Not treated|3
945873|NCT01024920|1936765|FG001|Overall Study|Not treated|0
945874|NCT01024920|1936764|FG000|Overall Study|Protocol Violation|0
945875|NCT01024920|1936765|FG001|Overall Study|Protocol Violation|1
945876|NCT01024946|1936771|FG000|Overall Study|Screen Failure|3
945877|NCT01024946|1936771|FG000|Overall Study|Withdrawal by Subject|1
945878|NCT01024946|1936771|FG000|Overall Study|Adverse Event|1
945879|NCT01024959|1936775|FG000|Overall Study|ineligible|12
945880|NCT01024959|1936775|FG000|Overall Study|results not evaluable|12
945881|NCT01024959|1936775|FG000|Overall Study|missing results required for analysis|17
945882|NCT01025037|1936794|FG000|Overall Study|Adverse Event|3
945883|NCT01025037|1936794|FG000|Overall Study|Lost to Follow-up|7
945884|NCT01025037|1936794|FG000|Overall Study|Withdrawal by Subject|1
945885|NCT01025154|1936802|FG000|Overall Study|Lost to Follow-up|1
945886|NCT01025154|1936802|FG000|Overall Study|Withdrawal by Subject|1
945887|NCT01025193|1936806|FG000|Overall Study|Protocol Violation|1
945888|NCT01025193|1936806|FG000|Overall Study|Adverse Event|3
945889|NCT01025232|1936816|FG000|Overall Study|Study drug no longer available|3
945890|NCT01025232|1936817|FG001|Overall Study|Study drug no longer available|6
945891|NCT01025284|1936826|FG000|Overall Study|Investigator Decision|0
945892|NCT01025284|1936827|FG001|Overall Study|Investigator Decision|1
945893|NCT01025284|1936828|FG002|Overall Study|Investigator Decision|0
945894|NCT01025284|1936826|FG000|Overall Study|Withdrawal by Subject|0
945895|NCT01025284|1936827|FG001|Overall Study|Withdrawal by Subject|1
945896|NCT01025284|1936828|FG002|Overall Study|Withdrawal by Subject|0
945897|NCT01025336|1936843|FG000|Overall Study|Protocol Violation|0
945898|NCT01025336|1936844|FG001|Overall Study|Protocol Violation|0
945899|NCT01025336|1936845|FG002|Overall Study|Protocol Violation|0
945900|NCT01025336|1936846|FG003|Overall Study|Protocol Violation|2
945901|NCT01025336|1936847|FG004|Overall Study|Protocol Violation|0
945902|NCT01025635|1936881|FG000|Overall Study|Withdrawal by Subject|6
945903|NCT01025635|1936882|FG001|Overall Study|Withdrawal by Subject|7
945904|NCT01025635|1936881|FG000|Overall Study|Protocol Violation|4
945905|NCT01025635|1936882|FG001|Overall Study|Protocol Violation|2
945906|NCT01025635|1936881|FG000|Overall Study|Lack of Efficacy|0
945907|NCT01025635|1936882|FG001|Overall Study|Lack of Efficacy|1
945908|NCT01025635|1936881|FG000|Overall Study|Lost to Follow-up|9
945909|NCT01025635|1936882|FG001|Overall Study|Lost to Follow-up|13
945910|NCT01025635|1936881|FG000|Overall Study|Reason not known|4
945911|NCT01025635|1936882|FG001|Overall Study|Reason not known|2
945912|NCT01025752|1936890|FG000|Overall Study|Lost to Follow-up|7
945913|NCT01025752|1936891|FG001|Overall Study|Lost to Follow-up|10
945914|NCT01025752|1936890|FG000|Overall Study|Physician Decision|1
945915|NCT01025752|1936891|FG001|Overall Study|Physician Decision|3
945916|NCT01025817|1936966|FG000|Completed Study Medication|Adverse Event|66
945917|NCT01025817|1936967|FG001|Completed Study Medication|Adverse Event|39
945918|NCT01025817|1936966|FG000|Completed Study Medication|Protocol Deviation|9
945919|NCT01025817|1936967|FG001|Completed Study Medication|Protocol Deviation|8
945920|NCT01025817|1936966|FG000|Completed Study Medication|Withdrawal by Subject|8
945921|NCT01025817|1936967|FG001|Completed Study Medication|Withdrawal by Subject|9
945922|NCT01025817|1936966|FG000|Completed Study Medication|Administrative problems|7
945923|NCT01025817|1936967|FG001|Completed Study Medication|Administrative problems|5
945924|NCT01025817|1936966|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7
945925|NCT01025817|1936967|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0
945926|NCT01025817|1936966|FG000|Completed Study Medication|Abnormal test procedure|4
945927|NCT01025817|1936967|FG001|Completed Study Medication|Abnormal test procedure|0
945928|NCT01025817|1936966|FG000|Completed Study Medication|Graft loss|2
945929|NCT01025817|1936967|FG001|Completed Study Medication|Graft loss|5
945930|NCT01025817|1936966|FG000|Completed Study Medication|Death|2
945931|NCT01025817|1936967|FG001|Completed Study Medication|Death|2
945932|NCT01025817|1936966|FG000|Completed Study Medication|Abnormal lab values|0
945933|NCT01025817|1936967|FG001|Completed Study Medication|Abnormal lab values|2
945934|NCT01025817|1936966|FG000|Completed Study Medication|Subject no longer required study drug|0
945935|NCT01025817|1936967|FG001|Completed Study Medication|Subject no longer required study drug|1
945936|NCT01025817|1936966|FG000|Completed Study Medication|Lost to Follow-up|0
945937|NCT01025817|1936967|FG001|Completed Study Medication|Lost to Follow-up|1
945938|NCT01025817|1936966|FG000|Completed Study|Withdrawal by Subject|8
945939|NCT01025817|1936967|FG001|Completed Study|Withdrawal by Subject|16
945940|NCT01025817|1936966|FG000|Completed Study|Death|6
945941|NCT01025817|1936967|FG001|Completed Study|Death|5
945942|NCT01025817|1936966|FG000|Completed Study|Missing|2
945943|NCT01025817|1936967|FG001|Completed Study|Missing|0
945944|NCT01025817|1936966|FG000|Completed Study|Lost to Follow-up|0
945945|NCT01025817|1936967|FG001|Completed Study|Lost to Follow-up|1
945946|NCT01025843|1936995|FG000|Washout 4|Withdrawal by Subject|0
945947|NCT01025843|1936996|FG001|Washout 4|Withdrawal by Subject|0
945948|NCT01025843|1936997|FG002|Washout 4|Withdrawal by Subject|1
945949|NCT01025843|1936998|FG003|Washout 4|Withdrawal by Subject|1
945950|NCT01025843|1936999|FG004|Washout 4|Withdrawal by Subject|0
945951|NCT01025843|1937000|FG005|Washout 4|Withdrawal by Subject|0
945952|NCT01025843|1937001|FG006|Washout 4|Withdrawal by Subject|0
945953|NCT01025843|1937002|FG007|Washout 4|Withdrawal by Subject|0
945954|NCT01025843|1937003|FG008|Washout 4|Withdrawal by Subject|0
945955|NCT01025843|1937004|FG009|Washout 4|Withdrawal by Subject|0
945956|NCT01026038|1937039|FG000|Overall Study|Lost to Follow-up|1
945957|NCT01026038|1937040|FG001|Overall Study|Lost to Follow-up|1
945958|NCT01026038|1937041|FG002|Overall Study|Lost to Follow-up|0
945959|NCT01026103|1937049|FG000|Overall Study|Physician Decision|1
945960|NCT01026103|1937049|FG000|Overall Study|did not receive study device bc of error|1
945961|NCT01026142|1937055|FG000|Overall Study|Death|136
945962|NCT01026142|1937056|FG001|Overall Study|Death|134
945963|NCT01026142|1937055|FG000|Overall Study|Withdrew consent or lost to follow-up|36
945964|NCT01026142|1937056|FG001|Overall Study|Withdrew consent or lost to follow-up|29
945965|NCT01026194|1937077|FG000|Period 1：Double Blind Period|Adverse Event|2
945966|NCT01026194|1937078|FG001|Period 1：Double Blind Period|Adverse Event|1
945967|NCT01026194|1937077|FG000|Period 1：Double Blind Period|Lack of Efficacy|1
945968|NCT01026194|1937078|FG001|Period 1：Double Blind Period|Lack of Efficacy|0
945969|NCT01026194|1937077|FG000|Period 1：Double Blind Period|Physician Decision|0
945970|NCT01026194|1937078|FG001|Period 1：Double Blind Period|Physician Decision|4
945971|NCT01026194|1937077|FG000|Period 2：Open-label Period|Adverse Event|4
945972|NCT01026194|1937078|FG001|Period 2：Open-label Period|Adverse Event|5
945973|NCT01026194|1937077|FG000|Period 2：Open-label Period|Physician Decision|3
945974|NCT01026194|1937078|FG001|Period 2：Open-label Period|Physician Decision|1
945975|NCT01026194|1937077|FG000|Period 2：Open-label Period|Withdrawal by Subject|0
945976|NCT01026194|1937078|FG001|Period 2：Open-label Period|Withdrawal by Subject|4
946004|NCT01026324|1937106|FG000|Follow up/Survival|Withdrawal by Subject|1
946005|NCT01026324|1937107|FG001|Follow up/Survival|Withdrawal by Subject|0
946006|NCT01026324|1937108|FG002|Follow up/Survival|Withdrawal by Subject|0
946007|NCT01026389|1937119|FG000|Overall Study|Withdrawal by Subject|1
946008|NCT01026389|1937120|FG001|Overall Study|Withdrawal by Subject|3
946009|NCT01026389|1937119|FG000|Overall Study|change of treatment, patient moved|4
946010|NCT01026389|1937120|FG001|Overall Study|change of treatment, patient moved|2
946011|NCT01026454|1937200|FG000|Second Intervention|Pregnancy|1
946012|NCT01026454|1937201|FG001|Second Intervention|Pregnancy|1
946013|NCT01026493|1937215|FG000|Overall Study|Protocol Violation|0
946014|NCT01026493|1937216|FG001|Overall Study|Protocol Violation|1
946015|NCT01026493|1937217|FG002|Overall Study|Protocol Violation|0
946016|NCT01026493|1937218|FG003|Overall Study|Protocol Violation|0
946017|NCT01026493|1937219|FG004|Overall Study|Protocol Violation|2
946018|NCT01026493|1937220|FG005|Overall Study|Protocol Violation|3
946019|NCT01026493|1937221|FG006|Overall Study|Protocol Violation|4
946020|NCT01026493|1937222|FG007|Overall Study|Protocol Violation|1
946021|NCT01026792|1937254|FG000|Overall Study|Protocol Violation|1
946022|NCT01026818|1937265|FG000|Screening Period|Entry Criteria Not Met|105
946023|NCT01026818|1937266|FG001|Screening Period|Entry Criteria Not Met|0
946024|NCT01026818|1937267|FG002|Screening Period|Entry Criteria Not Met|0
946025|NCT01026818|1937268|FG003|Screening Period|Entry Criteria Not Met|0
946026|NCT01026818|1937265|FG000|Screening Period|Withdrawal by Subject|49
946027|NCT01026818|1937266|FG001|Screening Period|Withdrawal by Subject|0
946028|NCT01026818|1937267|FG002|Screening Period|Withdrawal by Subject|0
946029|NCT01026818|1937268|FG003|Screening Period|Withdrawal by Subject|0
946030|NCT01026818|1937265|FG000|Screening Period|Protocol Deviation|3
946031|NCT01026818|1937266|FG001|Screening Period|Protocol Deviation|0
946032|NCT01026818|1937267|FG002|Screening Period|Protocol Deviation|0
946033|NCT01026818|1937268|FG003|Screening Period|Protocol Deviation|0
946034|NCT01026818|1937265|FG000|Screening Period|Adverse Event|2
946035|NCT01026818|1937266|FG001|Screening Period|Adverse Event|0
946036|NCT01026818|1937267|FG002|Screening Period|Adverse Event|0
946037|NCT01026818|1937268|FG003|Screening Period|Adverse Event|0
946038|NCT01026818|1937265|FG000|Screening Period|Physician Decision|1
946039|NCT01026818|1937266|FG001|Screening Period|Physician Decision|0
946040|NCT01026818|1937267|FG002|Screening Period|Physician Decision|0
946041|NCT01026818|1937268|FG003|Screening Period|Physician Decision|0
946042|NCT01026818|1937265|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0
946043|NCT01026818|1937266|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10
946044|NCT01026818|1937267|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6
946045|NCT01026818|1937268|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4
946046|NCT01026818|1937265|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
946047|NCT01026818|1937266|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
946048|NCT01026818|1937267|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
946049|NCT01026818|1937268|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
946050|NCT01026818|1937265|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
946051|NCT01026818|1937266|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
1090767|NCT02248818|2158523|FG005|Screening|Physician Decision|0
946052|NCT01026818|1937267|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
946053|NCT01026818|1937268|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
946054|NCT01026818|1937265|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
946055|NCT01026818|1937266|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
946056|NCT01026818|1937267|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
946057|NCT01026818|1937268|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
946058|NCT01026818|1937265|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
946059|NCT01026818|1937266|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
946060|NCT01026818|1937267|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
946061|NCT01026818|1937268|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
946062|NCT01026818|1937265|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
946063|NCT01026818|1937266|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
946064|NCT01026818|1937267|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
946065|NCT01026818|1937268|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
946066|NCT01026818|1937265|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
946067|NCT01026818|1937266|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
946068|NCT01026818|1937267|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
946069|NCT01026818|1937268|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
946070|NCT01026818|1937265|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
946071|NCT01026818|1937266|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
946072|NCT01026818|1937267|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
946073|NCT01026818|1937268|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
946074|NCT01026818|1937265|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
946075|NCT01026818|1937266|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
946076|NCT01026818|1937267|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
946077|NCT01026818|1937268|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
946078|NCT01026818|1937265|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
946079|NCT01026818|1937266|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
946080|NCT01026818|1937267|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
946081|NCT01026818|1937268|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
946082|NCT01026818|1937265|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
946083|NCT01026818|1937266|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
946084|NCT01026818|1937267|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
946085|NCT01026818|1937268|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
946086|NCT01026818|1937265|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
946087|NCT01026818|1937266|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
946088|NCT01026818|1937267|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
946089|NCT01026818|1937268|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
946090|NCT01026818|1937265|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
946091|NCT01026818|1937266|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
946092|NCT01026818|1937267|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
946093|NCT01026818|1937268|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
946094|NCT01026818|1937265|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0
946095|NCT01026818|1937266|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0
946096|NCT01026818|1937267|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0
946097|NCT01026818|1937268|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1
946098|NCT01026818|1937265|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
946099|NCT01026818|1937266|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
946100|NCT01026818|1937267|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
946101|NCT01026818|1937268|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
946102|NCT01026818|1937265|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
946103|NCT01026818|1937266|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
946104|NCT01026818|1937267|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
946105|NCT01026818|1937268|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
946106|NCT01026818|1937265|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
946107|NCT01026818|1937266|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
946108|NCT01026818|1937267|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
946109|NCT01026818|1937268|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
946110|NCT01026818|1937265|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
946111|NCT01026818|1937266|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
946112|NCT01026818|1937267|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
946113|NCT01026818|1937268|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
946114|NCT01026818|1937265|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
946115|NCT01026818|1937266|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
946116|NCT01026818|1937267|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
946117|NCT01026818|1937268|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
946118|NCT01026831|1937282|FG000|Overall Study|Adverse Event|4
946119|NCT01026831|1937283|FG001|Overall Study|Adverse Event|3
946120|NCT01026831|1937282|FG000|Overall Study|Lost to Follow-up|2
946121|NCT01026831|1937283|FG001|Overall Study|Lost to Follow-up|0
946122|NCT01026831|1937282|FG000|Overall Study|Physician Decision|1
946123|NCT01026831|1937283|FG001|Overall Study|Physician Decision|1
946124|NCT01026831|1937282|FG000|Overall Study|Protocol Violation|0
946125|NCT01026831|1937283|FG001|Overall Study|Protocol Violation|2
946126|NCT01026831|1937282|FG000|Overall Study|Withdrawal by Subject|7
946127|NCT01026831|1937283|FG001|Overall Study|Withdrawal by Subject|5
946128|NCT01026948|1937307|FG000|Overall Study|Physician Decision|8
946129|NCT01026974|1937316|FG000|Overall Study|Withdrawal by Subject|0
946130|NCT01026974|1937317|FG001|Overall Study|Withdrawal by Subject|1
946131|NCT01026974|1937318|FG002|Overall Study|Withdrawal by Subject|7
946132|NCT01026974|1937319|FG003|Overall Study|Withdrawal by Subject|2
946133|NCT01026974|1937316|FG000|Overall Study|Lost to Follow-up|1
946134|NCT01026974|1937317|FG001|Overall Study|Lost to Follow-up|1
946135|NCT01026974|1937318|FG002|Overall Study|Lost to Follow-up|4
946136|NCT01026974|1937319|FG003|Overall Study|Lost to Follow-up|0
946137|NCT01026974|1937316|FG000|Overall Study|Adverse Event|0
946138|NCT01026974|1937317|FG001|Overall Study|Adverse Event|0
946139|NCT01026974|1937318|FG002|Overall Study|Adverse Event|0
946140|NCT01026974|1937319|FG003|Overall Study|Adverse Event|1
946141|NCT01026974|1937316|FG000|Overall Study|Inappropriate enrollment|0
946142|NCT01026974|1937317|FG001|Overall Study|Inappropriate enrollment|0
946143|NCT01026974|1937318|FG002|Overall Study|Inappropriate enrollment|1
946144|NCT01026974|1937319|FG003|Overall Study|Inappropriate enrollment|0
946145|NCT01027273|1937349|FG000|Overall Study|Lost to Follow-up|57
946146|NCT01027273|1937350|FG001|Overall Study|Lost to Follow-up|31
946147|NCT01027273|1937349|FG000|Overall Study|Death|2
946148|NCT01027273|1937350|FG001|Overall Study|Death|2
946149|NCT01027286|1937358|FG000|Overall Study|Unable to Obtain Required Blood Volume|1
946150|NCT01027286|1937359|FG001|Overall Study|Unable to Obtain Required Blood Volume|0
946151|NCT01027286|1937358|FG000|Overall Study|Lost to Follow-up|0
946152|NCT01027286|1937359|FG001|Overall Study|Lost to Follow-up|1
946153|NCT01027351|1937371|FG000|Overall Study|Withdrawal by Subject|1
946154|NCT01027351|1937372|FG001|Overall Study|Withdrawal by Subject|0
946155|NCT01027351|1937373|FG002|Overall Study|Withdrawal by Subject|1
946156|NCT01027351|1937374|FG003|Overall Study|Withdrawal by Subject|0
946157|NCT01027351|1937375|FG004|Overall Study|Withdrawal by Subject|3
946158|NCT01027351|1937376|FG005|Overall Study|Withdrawal by Subject|5
946159|NCT01027351|1937371|FG000|Overall Study|Lost to Follow-up|1
946160|NCT01027351|1937372|FG001|Overall Study|Lost to Follow-up|1
946161|NCT01027351|1937373|FG002|Overall Study|Lost to Follow-up|0
946162|NCT01027351|1937374|FG003|Overall Study|Lost to Follow-up|1
946163|NCT01027351|1937375|FG004|Overall Study|Lost to Follow-up|6
946164|NCT01027351|1937376|FG005|Overall Study|Lost to Follow-up|0
946165|NCT01027351|1937371|FG000|Overall Study|Inappropriate enrollment|0
946166|NCT01027351|1937372|FG001|Overall Study|Inappropriate enrollment|0
946167|NCT01027351|1937373|FG002|Overall Study|Inappropriate enrollment|0
946168|NCT01027351|1937374|FG003|Overall Study|Inappropriate enrollment|0
946169|NCT01027351|1937375|FG004|Overall Study|Inappropriate enrollment|1
946170|NCT01027351|1937376|FG005|Overall Study|Inappropriate enrollment|0
946171|NCT01027351|1937371|FG000|Overall Study|Protocol Violation|1
946172|NCT01027351|1937372|FG001|Overall Study|Protocol Violation|0
946173|NCT01027351|1937373|FG002|Overall Study|Protocol Violation|0
946174|NCT01027351|1937374|FG003|Overall Study|Protocol Violation|1
946175|NCT01027351|1937375|FG004|Overall Study|Protocol Violation|1
946176|NCT01027351|1937376|FG005|Overall Study|Protocol Violation|0
946177|NCT01027364|1937401|FG000|Overall Study|Adverse Event|1
946178|NCT01027364|1937402|FG001|Overall Study|Adverse Event|0
946179|NCT01027364|1937403|FG002|Overall Study|Adverse Event|1
946180|NCT01027364|1937404|FG003|Overall Study|Adverse Event|0
946181|NCT01027364|1937401|FG000|Overall Study|Lost to Follow-up|1
946182|NCT01027364|1937402|FG001|Overall Study|Lost to Follow-up|0
946183|NCT01027364|1937403|FG002|Overall Study|Lost to Follow-up|0
946184|NCT01027364|1937404|FG003|Overall Study|Lost to Follow-up|0
946185|NCT01027364|1937401|FG000|Overall Study|Protocol Violation|1
946186|NCT01027364|1937402|FG001|Overall Study|Protocol Violation|0
946187|NCT01027364|1937403|FG002|Overall Study|Protocol Violation|0
946188|NCT01027364|1937404|FG003|Overall Study|Protocol Violation|1
946189|NCT01027364|1937401|FG000|Overall Study|Withdrawal by Subject|1
946190|NCT01027364|1937402|FG001|Overall Study|Withdrawal by Subject|2
946191|NCT01027364|1937403|FG002|Overall Study|Withdrawal by Subject|0
946192|NCT01027364|1937404|FG003|Overall Study|Withdrawal by Subject|0
946193|NCT01027416|1937432|FG000|Overall Study|Withdrawal by Subject|0
946194|NCT01027416|1937433|FG001|Overall Study|Withdrawal by Subject|1
946195|NCT01027416|1937432|FG000|Overall Study|Physician Decision|1
946196|NCT01027416|1937433|FG001|Overall Study|Physician Decision|4
946197|NCT01027650|1937474|FG000|Overall Study|Personal Reasons|0
946198|NCT01027650|1937475|FG001|Overall Study|Personal Reasons|0
946199|NCT01027650|1937476|FG002|Overall Study|Personal Reasons|0
946200|NCT01027650|1937477|FG003|Overall Study|Personal Reasons|0
946201|NCT01027650|1937478|FG004|Overall Study|Personal Reasons|2
946202|NCT01027650|1937479|FG005|Overall Study|Personal Reasons|1
946203|NCT01027650|1937480|FG006|Overall Study|Personal Reasons|0
946204|NCT01027650|1937481|FG007|Overall Study|Personal Reasons|0
946205|NCT01027650|1937474|FG000|Overall Study|Lost to Follow-up|0
946206|NCT01027650|1937475|FG001|Overall Study|Lost to Follow-up|0
946207|NCT01027650|1937476|FG002|Overall Study|Lost to Follow-up|0
946208|NCT01027650|1937477|FG003|Overall Study|Lost to Follow-up|0
946209|NCT01027650|1937478|FG004|Overall Study|Lost to Follow-up|0
946210|NCT01027650|1937479|FG005|Overall Study|Lost to Follow-up|0
946211|NCT01027650|1937480|FG006|Overall Study|Lost to Follow-up|1
946212|NCT01027650|1937481|FG007|Overall Study|Lost to Follow-up|0
946213|NCT01027650|1937474|FG000|Overall Study|Lack of Efficacy|0
946214|NCT01027650|1937475|FG001|Overall Study|Lack of Efficacy|0
946215|NCT01027650|1937476|FG002|Overall Study|Lack of Efficacy|0
946216|NCT01027650|1937477|FG003|Overall Study|Lack of Efficacy|0
946217|NCT01027650|1937478|FG004|Overall Study|Lack of Efficacy|0
946218|NCT01027650|1937479|FG005|Overall Study|Lack of Efficacy|1
946219|NCT01027650|1937480|FG006|Overall Study|Lack of Efficacy|0
946220|NCT01027650|1937481|FG007|Overall Study|Lack of Efficacy|0
946221|NCT01027702|1937499|FG000|Overall Study|Received subsequent therapy|1
946222|NCT01027702|1937500|FG001|Overall Study|Received subsequent therapy|2
946223|NCT01027702|1937501|FG002|Overall Study|Received subsequent therapy|0
946224|NCT01027702|1937502|FG003|Overall Study|Received subsequent therapy|4
946225|NCT01027702|1937503|FG004|Overall Study|Received subsequent therapy|1
946226|NCT01027702|1937504|FG005|Overall Study|Received subsequent therapy|0
946227|NCT01027702|1937505|FG006|Overall Study|Received subsequent therapy|1
946228|NCT01027702|1937499|FG000|Overall Study|Death|0
946229|NCT01027702|1937500|FG001|Overall Study|Death|0
946230|NCT01027702|1937501|FG002|Overall Study|Death|1
946231|NCT01027702|1937502|FG003|Overall Study|Death|0
946232|NCT01027702|1937503|FG004|Overall Study|Death|0
946233|NCT01027702|1937504|FG005|Overall Study|Death|0
946234|NCT01027702|1937505|FG006|Overall Study|Death|0
946235|NCT01027754|1937518|FG000|Overall Study|withdrew/lost to follow-up after interve|2
946236|NCT01027754|1937519|FG001|Overall Study|withdrew/lost to follow-up after interve|3
946237|NCT01027754|1937518|FG000|Overall Study|Withdrawal by Subject|0
946238|NCT01027754|1937519|FG001|Overall Study|Withdrawal by Subject|5
946239|NCT01027845|1937564|FG000|Primary Vaccination Phase|Serious Adverse Event|2
946240|NCT01027845|1937565|FG001|Primary Vaccination Phase|Serious Adverse Event|0
946241|NCT01027845|1937566|FG002|Primary Vaccination Phase|Serious Adverse Event|0
946242|NCT01027845|1937567|FG003|Primary Vaccination Phase|Serious Adverse Event|0
946243|NCT01027845|1937564|FG000|Primary Vaccination Phase|Adverse Event|1
946244|NCT01027845|1937565|FG001|Primary Vaccination Phase|Adverse Event|0
946245|NCT01027845|1937566|FG002|Primary Vaccination Phase|Adverse Event|0
946246|NCT01027845|1937567|FG003|Primary Vaccination Phase|Adverse Event|0
946247|NCT01027845|1937564|FG000|Primary Vaccination Phase|Protocol Violation|1
946248|NCT01027845|1937565|FG001|Primary Vaccination Phase|Protocol Violation|0
946249|NCT01027845|1937566|FG002|Primary Vaccination Phase|Protocol Violation|0
946250|NCT01027845|1937567|FG003|Primary Vaccination Phase|Protocol Violation|0
946251|NCT01027845|1937564|FG000|Primary Vaccination Phase|Migrated/moved from study area|0
946252|NCT01027845|1937565|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
946253|NCT01027845|1937566|FG002|Primary Vaccination Phase|Migrated/moved from study area|0
946254|NCT01027845|1937567|FG003|Primary Vaccination Phase|Migrated/moved from study area|0
946255|NCT01027845|1937564|FG000|Booster Vaccination Phase|Withdrawal by Subject|1
946256|NCT01027845|1937565|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
946257|NCT01027845|1937566|FG002|Booster Vaccination Phase|Withdrawal by Subject|0
946258|NCT01027845|1937567|FG003|Booster Vaccination Phase|Withdrawal by Subject|0
946259|NCT01027845|1937564|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
946260|NCT01027845|1937565|FG001|Booster Vaccination Phase|Migrated/moved from study area|0
946261|NCT01027845|1937566|FG002|Booster Vaccination Phase|Migrated/moved from study area|0
946262|NCT01027845|1937567|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
946263|NCT01027871|1937579|FG000|Overall Study|Physician Decision|1
946264|NCT01027871|1937580|FG001|Overall Study|Physician Decision|5
946265|NCT01027871|1937581|FG002|Overall Study|Physician Decision|0
946266|NCT01027871|1937579|FG000|Overall Study|Protocol Violation|0
946267|NCT01027871|1937580|FG001|Overall Study|Protocol Violation|2
946268|NCT01027871|1937581|FG002|Overall Study|Protocol Violation|2
946269|NCT01027871|1937579|FG000|Overall Study|Withdrawal by Subject|1
946270|NCT01027871|1937580|FG001|Overall Study|Withdrawal by Subject|2
946271|NCT01027871|1937581|FG002|Overall Study|Withdrawal by Subject|2
946272|NCT01027871|1937579|FG000|Overall Study|Adverse Event|0
946273|NCT01027871|1937580|FG001|Overall Study|Adverse Event|2
946274|NCT01027871|1937581|FG002|Overall Study|Adverse Event|2
946275|NCT01027871|1937579|FG000|Overall Study|Sponsor Decision|0
946276|NCT01027871|1937580|FG001|Overall Study|Sponsor Decision|2
946277|NCT01027871|1937581|FG002|Overall Study|Sponsor Decision|0
946278|NCT01027871|1937579|FG000|Overall Study|Discontinued Prior to Treatment|0
946279|NCT01027871|1937580|FG001|Overall Study|Discontinued Prior to Treatment|0
946280|NCT01027871|1937581|FG002|Overall Study|Discontinued Prior to Treatment|1
946281|NCT01027884|1937596|FG000|Overall Study|Adverse Event|2
946282|NCT01027884|1937597|FG001|Overall Study|Adverse Event|1
946283|NCT01027884|1937596|FG000|Overall Study|Protocol Violation|1
946284|NCT01027884|1937597|FG001|Overall Study|Protocol Violation|0
946285|NCT01027884|1937596|FG000|Overall Study|Non-compliance|1
946286|NCT01027884|1937597|FG001|Overall Study|Non-compliance|1
946287|NCT01027884|1937596|FG000|Overall Study|Withdrawal by Subject|0
946288|NCT01027884|1937597|FG001|Overall Study|Withdrawal by Subject|1
946289|NCT01027884|1937596|FG000|Overall Study|Lost to Follow-up|0
946290|NCT01027884|1937597|FG001|Overall Study|Lost to Follow-up|1
946291|NCT01027884|1937596|FG000|Overall Study|Spinal fixation surgery|0
946292|NCT01027884|1937597|FG001|Overall Study|Spinal fixation surgery|3
910953|NCT00795821|1888076|FG001|Long-term Extension Phase|Adverse Event|32
910954|NCT00795821|1888075|FG000|Long-term Extension Phase|Lack of Efficacy|16
910955|NCT00795821|1888076|FG001|Long-term Extension Phase|Lack of Efficacy|12
910956|NCT00795821|1888075|FG000|Long-term Extension Phase|Lost to Follow-up|20
910957|NCT00795821|1888076|FG001|Long-term Extension Phase|Lost to Follow-up|16
910958|NCT00795821|1888075|FG000|Long-term Extension Phase|Physician Decision|1
910959|NCT00795821|1888076|FG001|Long-term Extension Phase|Physician Decision|2
910960|NCT00795821|1888075|FG000|Long-term Extension Phase|Protocol Violation|3
910961|NCT00795821|1888076|FG001|Long-term Extension Phase|Protocol Violation|5
910962|NCT00795821|1888075|FG000|Long-term Extension Phase|Withdrawal by Subject|25
910963|NCT00795821|1888076|FG001|Long-term Extension Phase|Withdrawal by Subject|25
910964|NCT00795821|1888075|FG000|Taper Phase|Adverse Event|2
946293|NCT01027897|1937605|FG000|Overall Study|Protocol Violation|1
946294|NCT01027897|1937605|FG000|Overall Study|Withdrawal by Subject|1
946295|NCT01027949|1937620|FG000|Overall Study|Death|174
946296|NCT01027949|1937620|FG000|Overall Study|Progressive Disease|163
946297|NCT01027949|1937620|FG000|Overall Study|Adverse Event|172
946298|NCT01027949|1937620|FG000|Overall Study|Withdrawal by Subject|113
946299|NCT01027949|1937620|FG000|Overall Study|Lost to Follow-up|17
946300|NCT01027949|1937620|FG000|Overall Study|Protocol Violation|13
946301|NCT01027949|1937620|FG000|Overall Study|PI Decision|8
946302|NCT01027949|1937620|FG000|Overall Study|Limited Study Drug Effectiveness|7
946303|NCT01027949|1937620|FG000|Overall Study|Non-compliance with Study Procedures|7
946304|NCT01027949|1937620|FG000|Overall Study|Lung Transplant|5
946305|NCT01027949|1937620|FG000|Overall Study|Unable to Tolerate Study Drug|2
946306|NCT01027949|1937620|FG000|Overall Study|Use of Excluded Medication|2
946307|NCT01027949|1937620|FG000|Overall Study|Patient Self-discontinuation|1
946308|NCT01027949|1937620|FG000|Overall Study|Pregnancy|1
946309|NCT01027949|1937620|FG000|Overall Study|Surgery|1
946310|NCT01028014|1937630|FG000|Overall Study|Lost to Follow-up|1
946311|NCT01028014|1937631|FG001|Overall Study|Lost to Follow-up|2
946312|NCT01028014|1937632|FG002|Overall Study|Lost to Follow-up|0
946313|NCT01028014|1937633|FG003|Overall Study|Lost to Follow-up|1
946314|NCT01028014|1937634|FG004|Overall Study|Lost to Follow-up|1
946315|NCT01028014|1937635|FG005|Overall Study|Lost to Follow-up|2
946316|NCT01028027|1937651|FG000|Overall Study|Lost to Follow-up|4
946317|NCT01028027|1937652|FG001|Overall Study|Lost to Follow-up|1
946318|NCT01028027|1937651|FG000|Overall Study|Withdrawal by Subject|5
946319|NCT01028027|1937652|FG001|Overall Study|Withdrawal by Subject|3
946320|NCT01028027|1937651|FG000|Overall Study|Adverse Event|4
946321|NCT01028027|1937652|FG001|Overall Study|Adverse Event|7
946322|NCT01028027|1937651|FG000|Overall Study|Protocol Violation|3
946323|NCT01028027|1937652|FG001|Overall Study|Protocol Violation|1
946324|NCT01028027|1937651|FG000|Overall Study|Lack of Efficacy|0
946325|NCT01028027|1937652|FG001|Overall Study|Lack of Efficacy|1
946326|NCT01028053|1937658|FG000|Overall Study|Screen Failure|113
946327|NCT01028053|1937658|FG000|Overall Study|Patient Request|11
946328|NCT01028053|1937658|FG000|Overall Study|Protocol Violation|1
946329|NCT01028053|1937658|FG000|Overall Study|Physician Decision|2
946330|NCT01028053|1937658|FG000|Overall Study|Technical Problem|1
946331|NCT01028053|1937658|FG000|Overall Study|Terminated by Sponsor|1
946332|NCT01028053|1937658|FG000|Overall Study|Various reasons|4
946333|NCT01028222|1937683|FG000|Overall Study|Protocol deviation|1
946334|NCT01028222|1937684|FG001|Overall Study|Protocol deviation|0
946335|NCT01028222|1937683|FG000|Overall Study|Disease progression|33
946336|NCT01028222|1937684|FG001|Overall Study|Disease progression|9
946337|NCT01028222|1937683|FG000|Overall Study|Administrative problems|1
946338|NCT01028222|1937684|FG001|Overall Study|Administrative problems|1
946339|NCT01028222|1937683|FG000|Overall Study|Lost to Follow-up|0
946340|NCT01028222|1937684|FG001|Overall Study|Lost to Follow-up|1
946341|NCT01028222|1937683|FG000|Overall Study|Withdrawal by Subject|1
946342|NCT01028222|1937684|FG001|Overall Study|Withdrawal by Subject|0
946343|NCT01028222|1937683|FG000|Overall Study|Crossover to nilotinib w/out progression|0
946344|NCT01028222|1937684|FG001|Overall Study|Crossover to nilotinib w/out progression|2
946345|NCT01028222|1937683|FG000|Overall Study|Adverse Event|2
946346|NCT01028222|1937684|FG001|Overall Study|Adverse Event|0
946347|NCT01028352|1937691|FG000|Overall Study|Ineligible due to baseline average pain|5
946348|NCT01028352|1937691|FG000|Overall Study|Withdrawal by Subject|1
946349|NCT01028378|1937695|FG000|Overall Study|Lost to Follow-up|12
946350|NCT01028378|1937695|FG000|Overall Study|Withdrawal by Subject|1
946351|NCT01028378|1937695|FG000|Overall Study|Adminstrative Reasons|4
946352|NCT01028391|1937701|FG000|Overall Study|Adverse Event|4
946353|NCT01028391|1937702|FG001|Overall Study|Adverse Event|0
946354|NCT01028391|1937701|FG000|Overall Study|Lack of Efficacy|0
946355|NCT01028391|1937702|FG001|Overall Study|Lack of Efficacy|2
946356|NCT01028391|1937701|FG000|Overall Study|Lost to Follow-up|3
946357|NCT01028391|1937702|FG001|Overall Study|Lost to Follow-up|4
946358|NCT01028391|1937701|FG000|Overall Study|Physician Decision|0
946359|NCT01028391|1937702|FG001|Overall Study|Physician Decision|1
946360|NCT01028391|1937701|FG000|Overall Study|Withdrawal by Subject|6
946361|NCT01028391|1937702|FG001|Overall Study|Withdrawal by Subject|3
946362|NCT01028391|1937701|FG000|Overall Study|Needed excluded medication|1
946363|NCT01028391|1937702|FG001|Overall Study|Needed excluded medication|1
946364|NCT01028560|1937710|FG000|Overall Study|Lack of Efficacy|3
946365|NCT01028560|1937711|FG001|Overall Study|Lack of Efficacy|6
946366|NCT01028560|1937710|FG000|Overall Study|Withdrawal by Subject|7
946367|NCT01028560|1937711|FG001|Overall Study|Withdrawal by Subject|12
946368|NCT01028651|1937718|FG000|Overall Study|Death|2
946369|NCT01028651|1937718|FG000|Overall Study|Adverse Event|1
946370|NCT01029262|1937759|FG000|Overall Study|Adverse Event|9
946371|NCT01029262|1937760|FG001|Overall Study|Adverse Event|52
946372|NCT01029262|1937759|FG000|Overall Study|Lack of therapeutic effect|57
946373|NCT01029262|1937760|FG001|Overall Study|Lack of therapeutic effect|76
946374|NCT01029262|1937759|FG000|Overall Study|Withdrawal by Subject|10
946375|NCT01029262|1937760|FG001|Overall Study|Withdrawal by Subject|17
946376|NCT01029262|1937759|FG000|Overall Study|Protocol Violation|2
946377|NCT01029262|1937760|FG001|Overall Study|Protocol Violation|3
946378|NCT01029262|1937759|FG000|Overall Study|Miscellaneous|1
946379|NCT01029262|1937760|FG001|Overall Study|Miscellaneous|9
946380|NCT01029262|1937759|FG000|Overall Study|Death|0
946381|NCT01029262|1937760|FG001|Overall Study|Death|3
946382|NCT01029340|1937776|FG000|Part B Treatment Period|Withdrawal by Subject|0
946383|NCT01029340|1937777|FG001|Part B Treatment Period|Withdrawal by Subject|0
946384|NCT01029340|1937778|FG002|Part B Treatment Period|Withdrawal by Subject|1
946385|NCT01029340|1937779|FG003|Part B Treatment Period|Withdrawal by Subject|0
946386|NCT01029340|1937780|FG004|Part B Treatment Period|Withdrawal by Subject|0
946387|NCT01029340|1937781|FG005|Part B Treatment Period|Withdrawal by Subject|0
946388|NCT01029340|1937776|FG000|Part B Treatment Period|Protocol Violation|0
946389|NCT01029340|1937777|FG001|Part B Treatment Period|Protocol Violation|0
946390|NCT01029340|1937778|FG002|Part B Treatment Period|Protocol Violation|1
946391|NCT01029340|1937779|FG003|Part B Treatment Period|Protocol Violation|0
946392|NCT01029340|1937780|FG004|Part B Treatment Period|Protocol Violation|0
946393|NCT01029340|1937781|FG005|Part B Treatment Period|Protocol Violation|0
946394|NCT01029340|1937776|FG000|Extension Period|Adverse Event|0
946395|NCT01029340|1937777|FG001|Extension Period|Adverse Event|0
946396|NCT01029340|1937778|FG002|Extension Period|Adverse Event|0
946397|NCT01029340|1937779|FG003|Extension Period|Adverse Event|0
946398|NCT01029340|1937780|FG004|Extension Period|Adverse Event|0
946399|NCT01029340|1937781|FG005|Extension Period|Adverse Event|1
946400|NCT01029340|1937776|FG000|Extension Period|starting another study|0
946401|NCT01029340|1937777|FG001|Extension Period|starting another study|0
946402|NCT01029340|1937778|FG002|Extension Period|starting another study|0
946403|NCT01029340|1937779|FG003|Extension Period|starting another study|0
946404|NCT01029340|1937780|FG004|Extension Period|starting another study|0
946405|NCT01029340|1937781|FG005|Extension Period|starting another study|8
946406|NCT01029340|1937776|FG000|Extension Period|non-compliance|0
946407|NCT01029340|1937777|FG001|Extension Period|non-compliance|0
946408|NCT01029340|1937778|FG002|Extension Period|non-compliance|0
946409|NCT01029340|1937779|FG003|Extension Period|non-compliance|0
946410|NCT01029340|1937780|FG004|Extension Period|non-compliance|0
946411|NCT01029340|1937781|FG005|Extension Period|non-compliance|1
946412|NCT01029340|1937776|FG000|Extension Period|Withdrawal by Subject|0
946413|NCT01029340|1937777|FG001|Extension Period|Withdrawal by Subject|0
946414|NCT01029340|1937778|FG002|Extension Period|Withdrawal by Subject|0
946415|NCT01029340|1937779|FG003|Extension Period|Withdrawal by Subject|0
946416|NCT01029340|1937780|FG004|Extension Period|Withdrawal by Subject|0
946417|NCT01029340|1937781|FG005|Extension Period|Withdrawal by Subject|1
946418|NCT01029340|1937776|FG000|Extension Period|Physician Decision|0
946419|NCT01029340|1937777|FG001|Extension Period|Physician Decision|0
946420|NCT01029340|1937778|FG002|Extension Period|Physician Decision|0
946421|NCT01029340|1937779|FG003|Extension Period|Physician Decision|0
946422|NCT01029340|1937780|FG004|Extension Period|Physician Decision|0
946423|NCT01029340|1937781|FG005|Extension Period|Physician Decision|1
946424|NCT01029353|1937798|FG000|Overall Study|Lost to Follow-up|4
946425|NCT01029353|1937799|FG001|Overall Study|Lost to Follow-up|5
946426|NCT01029353|1937800|FG002|Overall Study|Lost to Follow-up|5
946427|NCT01029353|1937801|FG003|Overall Study|Lost to Follow-up|4
946428|NCT01029353|1937798|FG000|Overall Study|Consent Withdrawn|2
946429|NCT01029353|1937799|FG001|Overall Study|Consent Withdrawn|0
946430|NCT01029353|1937800|FG002|Overall Study|Consent Withdrawn|0
946431|NCT01029353|1937801|FG003|Overall Study|Consent Withdrawn|0
946432|NCT01029353|1937798|FG000|Overall Study|Primary Outcome Indeterminate|1
946433|NCT01029353|1937799|FG001|Overall Study|Primary Outcome Indeterminate|3
946434|NCT01029353|1937800|FG002|Overall Study|Primary Outcome Indeterminate|2
946435|NCT01029353|1937801|FG003|Overall Study|Primary Outcome Indeterminate|0
946436|NCT01029366|1937813|FG000|Overall Study|Withdrawal by Subject|1
946437|NCT01029366|1937814|FG001|Overall Study|Withdrawal by Subject|0
946438|NCT01029366|1937813|FG000|Overall Study|Death|1
946439|NCT01029366|1937814|FG001|Overall Study|Death|1
946440|NCT01029366|1937813|FG000|Overall Study|disease progression|2
946441|NCT01029366|1937814|FG001|Overall Study|disease progression|0
946442|NCT01029366|1937813|FG000|Overall Study|manufacturing failure|0
946443|NCT01029366|1937814|FG001|Overall Study|manufacturing failure|1
946444|NCT01029392|1937823|FG000|Overall Study|Withdrawal by Subject|18
946445|NCT01029392|1937824|FG001|Overall Study|Withdrawal by Subject|11
946446|NCT01029392|1937823|FG000|Overall Study|Physician Decision|2
946447|NCT01029392|1937824|FG001|Overall Study|Physician Decision|0
946448|NCT01029405|1937836|FG000|Overall Study|Withdrawal by Subject|0
946449|NCT01029405|1937837|FG001|Overall Study|Withdrawal by Subject|1
946450|NCT01029405|1937838|FG002|Overall Study|Withdrawal by Subject|2
946451|NCT01029405|1937839|FG003|Overall Study|Withdrawal by Subject|0
946452|NCT01029405|1937836|FG000|Overall Study|Protocol Violation|0
946453|NCT01029405|1937837|FG001|Overall Study|Protocol Violation|0
946454|NCT01029405|1937838|FG002|Overall Study|Protocol Violation|0
946455|NCT01029405|1937839|FG003|Overall Study|Protocol Violation|1
946456|NCT01029405|1937836|FG000|Overall Study|Adverse Event|0
946457|NCT01029405|1937837|FG001|Overall Study|Adverse Event|0
946458|NCT01029405|1937838|FG002|Overall Study|Adverse Event|1
946459|NCT01029405|1937839|FG003|Overall Study|Adverse Event|1
946460|NCT01029405|1937836|FG000|Overall Study|Lost to Follow-up|2
946461|NCT01029405|1937837|FG001|Overall Study|Lost to Follow-up|1
946462|NCT01029405|1937838|FG002|Overall Study|Lost to Follow-up|1
946463|NCT01029405|1937839|FG003|Overall Study|Lost to Follow-up|2
946464|NCT01029405|1937836|FG000|Overall Study|Other|0
946465|NCT01029405|1937837|FG001|Overall Study|Other|1
910965|NCT00795821|1888076|FG001|Taper Phase|Adverse Event|0
910966|NCT00795821|1888075|FG000|Taper Phase|Lost to Follow-up|1
910967|NCT00795821|1888076|FG001|Taper Phase|Lost to Follow-up|0
946466|NCT01029405|1937838|FG002|Overall Study|Other|0
946467|NCT01029405|1937839|FG003|Overall Study|Other|1
946468|NCT01029535|1937849|FG000|Overall Study|Lost to Follow-up|24
946469|NCT01029535|1937849|FG000|Overall Study|Protocol Violation|2
946470|NCT01029535|1937849|FG000|Overall Study|Participant Withdrew Consent|2
946471|NCT01029535|1937849|FG000|Overall Study|Adverse Event|1
946472|NCT01029535|1937849|FG000|Overall Study|Use of Another Treatment|1
946473|NCT01029535|1937849|FG000|Overall Study|Death|1
946474|NCT01029652|1937860|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
946475|NCT01029652|1937861|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
946476|NCT01029652|1937860|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
946477|NCT01029652|1937861|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
946478|NCT01029652|1937860|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3
946479|NCT01029652|1937861|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1
946480|NCT01029652|1937860|FG000|Core Study (0-12 Weeks)|Administrative problems|2
946481|NCT01029652|1937861|FG001|Core Study (0-12 Weeks)|Administrative problems|1
946482|NCT01029652|1937860|FG000|Core Study (0-12 Weeks)|Death|0
946483|NCT01029652|1937861|FG001|Core Study (0-12 Weeks)|Death|1
946484|NCT01029652|1937860|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
946485|NCT01029652|1937861|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
946486|NCT01029652|1937860|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
946487|NCT01029652|1937861|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
946488|NCT01029652|1937860|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
946489|NCT01029652|1937861|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
946490|NCT01029652|1937860|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
946491|NCT01029652|1937861|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
946492|NCT01029652|1937860|FG000|Extension Study 2 (25-72 Weeks)|Death|1
946493|NCT01029652|1937861|FG001|Extension Study 2 (25-72 Weeks)|Death|1
946494|NCT01029652|1937860|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
946495|NCT01029652|1937861|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
946496|NCT01029652|1937860|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
946497|NCT01029652|1937861|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
946498|NCT01029691|1937888|FG000|Continued APAP to Delivery|Death|0
946499|NCT01029691|1937889|FG001|Continued APAP to Delivery|Death|0
946500|NCT01029691|1937890|FG002|Continued APAP to Delivery|Death|1
946501|NCT01029704|1937908|FG000|Overall Study|Adverse Event|0
946502|NCT01029704|1937909|FG001|Overall Study|Adverse Event|0
946503|NCT01029704|1937910|FG002|Overall Study|Adverse Event|0
946504|NCT01029704|1937911|FG003|Overall Study|Adverse Event|0
946505|NCT01029704|1937912|FG004|Overall Study|Adverse Event|0
946506|NCT01029704|1937913|FG005|Overall Study|Adverse Event|0
946507|NCT01029704|1937914|FG006|Overall Study|Adverse Event|1
946508|NCT01029704|1937915|FG007|Overall Study|Adverse Event|1
946509|NCT01029704|1937916|FG008|Overall Study|Adverse Event|0
946510|NCT01029704|1937908|FG000|Overall Study|Withdrawal by Subject|0
946511|NCT01029704|1937909|FG001|Overall Study|Withdrawal by Subject|0
946512|NCT01029704|1937910|FG002|Overall Study|Withdrawal by Subject|0
946513|NCT01029704|1937911|FG003|Overall Study|Withdrawal by Subject|0
946514|NCT01029704|1937912|FG004|Overall Study|Withdrawal by Subject|2
946515|NCT01029704|1937913|FG005|Overall Study|Withdrawal by Subject|1
946516|NCT01029704|1937914|FG006|Overall Study|Withdrawal by Subject|1
946517|NCT01029704|1937915|FG007|Overall Study|Withdrawal by Subject|1
946518|NCT01029704|1937916|FG008|Overall Study|Withdrawal by Subject|0
946519|NCT01029704|1937908|FG000|Overall Study|Lost to Follow-up|0
946520|NCT01029704|1937909|FG001|Overall Study|Lost to Follow-up|0
946521|NCT01029704|1937910|FG002|Overall Study|Lost to Follow-up|0
946522|NCT01029704|1937911|FG003|Overall Study|Lost to Follow-up|0
946523|NCT01029704|1937912|FG004|Overall Study|Lost to Follow-up|0
946524|NCT01029704|1937913|FG005|Overall Study|Lost to Follow-up|0
946525|NCT01029704|1937914|FG006|Overall Study|Lost to Follow-up|1
946526|NCT01029704|1937915|FG007|Overall Study|Lost to Follow-up|1
946527|NCT01029704|1937916|FG008|Overall Study|Lost to Follow-up|1
946528|NCT01029704|1937908|FG000|Overall Study|Lack of Efficacy|0
946529|NCT01029704|1937909|FG001|Overall Study|Lack of Efficacy|0
946530|NCT01029704|1937910|FG002|Overall Study|Lack of Efficacy|0
946531|NCT01029704|1937911|FG003|Overall Study|Lack of Efficacy|0
946532|NCT01029704|1937912|FG004|Overall Study|Lack of Efficacy|2
946533|NCT01029704|1937913|FG005|Overall Study|Lack of Efficacy|3
946534|NCT01029704|1937914|FG006|Overall Study|Lack of Efficacy|1
946535|NCT01029704|1937915|FG007|Overall Study|Lack of Efficacy|2
946536|NCT01029704|1937916|FG008|Overall Study|Lack of Efficacy|0
946537|NCT01029704|1937908|FG000|Overall Study|Withdrawn due to major protocol violation|0
946538|NCT01029704|1937909|FG001|Overall Study|Withdrawn due to major protocol violation|0
946539|NCT01029704|1937910|FG002|Overall Study|Withdrawn due to major protocol violation|0
946540|NCT01029704|1937911|FG003|Overall Study|Withdrawn due to major protocol violation|0
946541|NCT01029704|1937912|FG004|Overall Study|Withdrawn due to major protocol violation|1
946542|NCT01029704|1937913|FG005|Overall Study|Withdrawn due to major protocol violation|0
946543|NCT01029704|1937914|FG006|Overall Study|Withdrawn due to major protocol violation|0
946544|NCT01029704|1937915|FG007|Overall Study|Withdrawn due to major protocol violation|1
946545|NCT01029704|1937916|FG008|Overall Study|Withdrawn due to major protocol violation|0
946546|NCT01029782|1937942|FG000|Overall Study|Lost to Follow-up|2
946547|NCT01029782|1937943|FG001|Overall Study|Lost to Follow-up|2
946548|NCT01029782|1937942|FG000|Overall Study|Diagnosis changed|1
946549|NCT01029782|1937943|FG001|Overall Study|Diagnosis changed|1
946550|NCT01029782|1937942|FG000|Overall Study|Adverse Event|0
946551|NCT01029782|1937943|FG001|Overall Study|Adverse Event|1
946552|NCT01029782|1937942|FG000|Overall Study|Physician Decision|0
946553|NCT01029782|1937943|FG001|Overall Study|Physician Decision|1
946554|NCT01029782|1937942|FG000|Overall Study|Protocol Violation|0
946555|NCT01029782|1937943|FG001|Overall Study|Protocol Violation|2
946556|NCT01029782|1937942|FG000|Overall Study|Withdrawal by Subject|0
946557|NCT01029782|1937943|FG001|Overall Study|Withdrawal by Subject|1
946558|NCT01029795|1937951|FG000|Overall Study|Entry Criteria Not Met|2
946559|NCT01029795|1937952|FG001|Overall Study|Entry Criteria Not Met|1
946560|NCT01029795|1937951|FG000|Overall Study|Physician Decision|2
946561|NCT01029795|1937952|FG001|Overall Study|Physician Decision|1
946562|NCT01029795|1937951|FG000|Overall Study|Sponsor Decision|11
946563|NCT01029795|1937952|FG001|Overall Study|Sponsor Decision|17
946564|NCT01029795|1937951|FG000|Overall Study|Withdrawal by Subject|1
946565|NCT01029795|1937952|FG001|Overall Study|Withdrawal by Subject|3
946566|NCT01029886|1937960|FG000|Overall Study|Adverse Event|12
946567|NCT01029886|1937961|FG001|Overall Study|Adverse Event|25
910968|NCT00795821|1888075|FG000|Taper Phase|Physician Decision|2
910969|NCT00795821|1888076|FG001|Taper Phase|Physician Decision|0
910970|NCT00795821|1888075|FG000|Taper Phase|Withdrawal by Subject|4
910971|NCT00795821|1888076|FG001|Taper Phase|Withdrawal by Subject|0
910972|NCT00795886|1888092|FG000|Overall Study|Death|10
910973|NCT00795951|1888097|FG000|Overall Study|Lost to Follow-up|1
910974|NCT00795951|1888097|FG000|Overall Study|Withdrawal by Subject|1
946568|NCT01029886|1937960|FG000|Overall Study|Lost to Follow-up|1
946569|NCT01029886|1937961|FG001|Overall Study|Lost to Follow-up|0
946570|NCT01029886|1937960|FG000|Overall Study|Physician Decision|2
946571|NCT01029886|1937961|FG001|Overall Study|Physician Decision|6
946572|NCT01029886|1937960|FG000|Overall Study|Protocol Violation|17
946573|NCT01029886|1937961|FG001|Overall Study|Protocol Violation|5
946574|NCT01029886|1937960|FG000|Overall Study|Withdrawal by Subject|8
946575|NCT01029886|1937961|FG001|Overall Study|Withdrawal by Subject|18
946576|NCT01029886|1937960|FG000|Overall Study|Entry Criteria Not Met|13
946577|NCT01029886|1937961|FG001|Overall Study|Entry Criteria Not Met|5
946578|NCT01029886|1937960|FG000|Overall Study|Sponsor Decision|1
946579|NCT01029886|1937961|FG001|Overall Study|Sponsor Decision|0
946580|NCT01029886|1937960|FG000|Overall Study|Loss Glucose Control|7
946581|NCT01029886|1937961|FG001|Overall Study|Loss Glucose Control|1
946582|NCT01029925|1937980|FG000|Completion of Cycle 1 (28 Days)|Death|2
946583|NCT01029925|1937980|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
946584|NCT01029925|1937980|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
946585|NCT01030133|1937986|FG000|Overall Study|failed to experience pain at level 7/10|2
946586|NCT01030133|1937987|FG001|Overall Study|failed to experience pain at level 7/10|2
946587|NCT01030341|1938005|FG000|Overall Study|Withdrawal by Subject|1
946588|NCT01030341|1938005|FG000|Overall Study|Lost to Follow-up|2
946589|NCT01030458|1938032|FG000|Overall Study|Lost to Follow-up|9
946590|NCT01030458|1938033|FG001|Overall Study|Lost to Follow-up|10
946591|NCT01030458|1938032|FG000|Overall Study|Withdrawal by Subject|2
946592|NCT01030458|1938033|FG001|Overall Study|Withdrawal by Subject|3
946593|NCT01030458|1938032|FG000|Overall Study|Logistical reasons|9
946594|NCT01030458|1938033|FG001|Overall Study|Logistical reasons|5
946595|NCT01030458|1938032|FG000|Overall Study|Moved or changed job|6
946596|NCT01030458|1938033|FG001|Overall Study|Moved or changed job|13
946597|NCT01030458|1938032|FG000|Overall Study|Side effect of medication|1
946598|NCT01030458|1938033|FG001|Overall Study|Side effect of medication|1
946599|NCT01030523|1938041|FG000|Overall Study|Death|1
946600|NCT01030523|1938042|FG001|Overall Study|Death|0
946601|NCT01030523|1938041|FG000|Overall Study|Lost to Follow-up|4
946602|NCT01030523|1938042|FG001|Overall Study|Lost to Follow-up|4
946603|NCT01030523|1938041|FG000|Overall Study|Implant failure|1
946604|NCT01030523|1938042|FG001|Overall Study|Implant failure|0
946605|NCT01030523|1938041|FG000|Overall Study|Withdrawal by Subject|0
946606|NCT01030523|1938042|FG001|Overall Study|Withdrawal by Subject|1
946607|NCT01030536|1938053|FG000|Overall Study|Withdrawal by Subject|0
946608|NCT01030536|1938054|FG001|Overall Study|Withdrawal by Subject|0
946609|NCT01030536|1938055|FG002|Overall Study|Withdrawal by Subject|1
946610|NCT01030536|1938056|FG003|Overall Study|Withdrawal by Subject|0
946611|NCT01030536|1938057|FG004|Overall Study|Withdrawal by Subject|0
946612|NCT01030536|1938053|FG000|Overall Study|undefined|1
946613|NCT01030536|1938054|FG001|Overall Study|undefined|0
946614|NCT01030536|1938055|FG002|Overall Study|undefined|1
946615|NCT01030536|1938056|FG003|Overall Study|undefined|1
946616|NCT01030536|1938057|FG004|Overall Study|undefined|0
946617|NCT01030536|1938053|FG000|Overall Study|Adverse Event|0
946618|NCT01030536|1938054|FG001|Overall Study|Adverse Event|3
946619|NCT01030536|1938055|FG002|Overall Study|Adverse Event|1
946620|NCT01030536|1938056|FG003|Overall Study|Adverse Event|0
946621|NCT01030536|1938057|FG004|Overall Study|Adverse Event|1
946622|NCT01030536|1938053|FG000|Overall Study|Progressive disease|6
946623|NCT01030536|1938054|FG001|Overall Study|Progressive disease|2
946624|NCT01030536|1938055|FG002|Overall Study|Progressive disease|3
946625|NCT01030536|1938056|FG003|Overall Study|Progressive disease|2
946626|NCT01030536|1938057|FG004|Overall Study|Progressive disease|0
946627|NCT01030536|1938053|FG000|Overall Study|Death|0
946628|NCT01030536|1938054|FG001|Overall Study|Death|1
946629|NCT01030536|1938055|FG002|Overall Study|Death|0
946630|NCT01030536|1938056|FG003|Overall Study|Death|0
946631|NCT01030536|1938057|FG004|Overall Study|Death|0
946632|NCT01030666|1938099|FG000|Overall Study|Lost to Follow-up|3
946633|NCT01030666|1938100|FG001|Overall Study|Lost to Follow-up|2
946634|NCT01030718|1938110|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1
946635|NCT01030718|1938111|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1
946636|NCT01030718|1938112|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11
946637|NCT01030718|1938110|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3
946638|NCT01030718|1938111|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5
946639|NCT01030718|1938112|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1
946640|NCT01030718|1938110|FG000|Studies CA180-031 and -036 Combined|Death|0
946641|NCT01030718|1938111|FG001|Studies CA180-031 and -036 Combined|Death|1
946642|NCT01030718|1938112|FG002|Studies CA180-031 and -036 Combined|Death|0
946643|NCT01030718|1938110|FG000|Studies CA180-031 and -036 Combined|other reasons|0
946644|NCT01030718|1938111|FG001|Studies CA180-031 and -036 Combined|other reasons|2
946645|NCT01030718|1938112|FG002|Studies CA180-031 and -036 Combined|other reasons|0
946646|NCT01030718|1938110|FG000|Study CA180-036 Only|insufficient effect|1
946647|NCT01030718|1938111|FG001|Study CA180-036 Only|insufficient effect|1
946648|NCT01030718|1938112|FG002|Study CA180-036 Only|insufficient effect|5
946649|NCT01030718|1938110|FG000|Study CA180-036 Only|Adverse Event|2
946650|NCT01030718|1938111|FG001|Study CA180-036 Only|Adverse Event|3
946651|NCT01030718|1938112|FG002|Study CA180-036 Only|Adverse Event|0
946652|NCT01030718|1938110|FG000|Study CA180-036 Only|Death|0
946653|NCT01030718|1938111|FG001|Study CA180-036 Only|Death|1
946654|NCT01030718|1938112|FG002|Study CA180-036 Only|Death|0
946655|NCT01030718|1938110|FG000|Study CA180-036 Only|Other Reasons|0
946656|NCT01030718|1938111|FG001|Study CA180-036 Only|Other Reasons|2
946657|NCT01030718|1938112|FG002|Study CA180-036 Only|Other Reasons|0
946658|NCT01030822|1938142|FG000|Overall Study|Moved/migrated from study area|6
946659|NCT01030822|1938143|FG001|Overall Study|Moved/migrated from study area|7
946660|NCT01030822|1938144|FG002|Overall Study|Moved/migrated from study area|3
946661|NCT01030822|1938142|FG000|Overall Study|Withdrawal by Subject|16
946662|NCT01030822|1938143|FG001|Overall Study|Withdrawal by Subject|13
946663|NCT01030822|1938144|FG002|Overall Study|Withdrawal by Subject|16
946664|NCT01030822|1938142|FG000|Overall Study|Lost to Follow-up|9
946665|NCT01030822|1938143|FG001|Overall Study|Lost to Follow-up|4
946666|NCT01030822|1938144|FG002|Overall Study|Lost to Follow-up|7
946667|NCT01030874|1938164|FG000|Overall Study|Withdrawal by Subject|1
946668|NCT01030874|1938165|FG001|Overall Study|Withdrawal by Subject|0
946669|NCT01030874|1938164|FG000|Overall Study|Discharged in first 2 weeks|17
946670|NCT01030874|1938165|FG001|Overall Study|Discharged in first 2 weeks|16
946671|NCT01030952|1938173|FG000|Overall Study|Protocol Violation|0
946672|NCT01030952|1938174|FG001|Overall Study|Protocol Violation|1
946673|NCT01030952|1938173|FG000|Overall Study|Informed consent withdrawal|1
946674|NCT01030952|1938174|FG001|Overall Study|Informed consent withdrawal|0
946675|NCT01030952|1938173|FG000|Overall Study|Lost to Follow-up|0
946676|NCT01030952|1938174|FG001|Overall Study|Lost to Follow-up|1
946677|NCT01030952|1938173|FG000|Overall Study|Unexplained|1
946678|NCT01030952|1938174|FG001|Overall Study|Unexplained|1
946679|NCT01030965|1938186|FG000|Overall Study|Lack of Efficacy|3
946680|NCT01030965|1938187|FG001|Overall Study|Lack of Efficacy|2
946681|NCT01030965|1938188|FG002|Overall Study|Lack of Efficacy|0
946682|NCT01030965|1938189|FG003|Overall Study|Lack of Efficacy|3
946683|NCT01030965|1938186|FG000|Overall Study|Protocol Violation|1
946684|NCT01030965|1938187|FG001|Overall Study|Protocol Violation|1
946685|NCT01030965|1938188|FG002|Overall Study|Protocol Violation|1
946686|NCT01030965|1938189|FG003|Overall Study|Protocol Violation|1
946687|NCT01030965|1938186|FG000|Overall Study|Adverse Event|0
946688|NCT01030965|1938187|FG001|Overall Study|Adverse Event|1
946689|NCT01030965|1938188|FG002|Overall Study|Adverse Event|2
946690|NCT01030965|1938189|FG003|Overall Study|Adverse Event|1
946691|NCT01030965|1938186|FG000|Overall Study|Protocol-defined Stopping Criteria|0
946692|NCT01030965|1938187|FG001|Overall Study|Protocol-defined Stopping Criteria|1
946693|NCT01030965|1938188|FG002|Overall Study|Protocol-defined Stopping Criteria|1
946694|NCT01030965|1938189|FG003|Overall Study|Protocol-defined Stopping Criteria|0
946695|NCT01030965|1938186|FG000|Overall Study|Withdrawal by Subject|0
946696|NCT01030965|1938187|FG001|Overall Study|Withdrawal by Subject|1
946697|NCT01030965|1938188|FG002|Overall Study|Withdrawal by Subject|0
946698|NCT01030965|1938189|FG003|Overall Study|Withdrawal by Subject|2
946699|NCT01031004|1938201|FG000|Overall Study|Protocol Violation|0
946700|NCT01031004|1938202|FG001|Overall Study|Protocol Violation|1
946701|NCT01031004|1938201|FG000|Overall Study|Lost to Follow-up|1
946702|NCT01031004|1938202|FG001|Overall Study|Lost to Follow-up|0
946703|NCT01031069|1938216|FG000|Overall Study|Serious Adverse Event|0
946704|NCT01031069|1938217|FG001|Overall Study|Serious Adverse Event|1
946705|NCT01031069|1938218|FG002|Overall Study|Serious Adverse Event|0
946706|NCT01031069|1938219|FG003|Overall Study|Serious Adverse Event|0
946707|NCT01031069|1938216|FG000|Overall Study|Withdrawal by Subject|2
946708|NCT01031069|1938217|FG001|Overall Study|Withdrawal by Subject|3
946709|NCT01031069|1938218|FG002|Overall Study|Withdrawal by Subject|18
946710|NCT01031069|1938219|FG003|Overall Study|Withdrawal by Subject|18
946711|NCT01031069|1938216|FG000|Overall Study|Migrated/moved from study area|1
946712|NCT01031069|1938217|FG001|Overall Study|Migrated/moved from study area|2
946713|NCT01031069|1938218|FG002|Overall Study|Migrated/moved from study area|1
946714|NCT01031069|1938219|FG003|Overall Study|Migrated/moved from study area|1
946715|NCT01031069|1938216|FG000|Overall Study|Lost to Follow-up|9
946716|NCT01031069|1938217|FG001|Overall Study|Lost to Follow-up|5
946717|NCT01031069|1938218|FG002|Overall Study|Lost to Follow-up|21
946718|NCT01031069|1938219|FG003|Overall Study|Lost to Follow-up|15
946719|NCT01031069|1938216|FG000|Overall Study|Other|0
946720|NCT01031069|1938217|FG001|Overall Study|Other|0
946721|NCT01031069|1938218|FG002|Overall Study|Other|1
946722|NCT01031069|1938219|FG003|Overall Study|Other|0
946723|NCT01031381|1938249|FG000|Overall Study|Physician Decision|3
946724|NCT01031381|1938249|FG000|Overall Study|Withdrawal by Subject|6
946725|NCT01031446|1938258|FG000|Overall Study|Disease Progression|38
946726|NCT01031446|1938258|FG000|Overall Study|Adverse Event|9
946727|NCT01031446|1938258|FG000|Overall Study|Physician Decision|4
946728|NCT01031446|1938258|FG000|Overall Study|Withdrawal by Subject|3
946729|NCT01031446|1938258|FG000|Overall Study|Still on treatment|1
946730|NCT01031537|1938277|FG000|Overall Study|medical reasons not related to study|3
946731|NCT01031537|1938277|FG000|Overall Study|Lack of Efficacy|1
946732|NCT01031537|1938277|FG000|Overall Study|retired from NIH, met exclusion criteria|1
946733|NCT01031537|1938277|FG000|Overall Study|moved, met exclusion criteria|10
946734|NCT01031537|1938277|FG000|Overall Study|Withdrawal by Subject|5
946735|NCT01031537|1938277|FG000|Overall Study|PI removal, no longer met eligibility|12
946736|NCT01031680|1938283|FG000|Overall Study|Adverse Event|8
946737|NCT01031680|1938284|FG001|Overall Study|Adverse Event|3
946738|NCT01031680|1938283|FG000|Overall Study|Lost to Follow-up|2
946739|NCT01031680|1938284|FG001|Overall Study|Lost to Follow-up|10
946740|NCT01031680|1938283|FG000|Overall Study|Withdrawal by Subject|12
946741|NCT01031680|1938284|FG001|Overall Study|Withdrawal by Subject|16
946742|NCT01031680|1938283|FG000|Overall Study|Death|2
946743|NCT01031680|1938284|FG001|Overall Study|Death|1
946744|NCT01031680|1938283|FG000|Overall Study|Subject No Longer Meets Study Criteria|26
946745|NCT01031680|1938284|FG001|Overall Study|Subject No Longer Meets Study Criteria|17
946746|NCT01031680|1938283|FG000|Overall Study|Poor/Non-compliance|5
946747|NCT01031680|1938284|FG001|Overall Study|Poor/Non-compliance|6
946748|NCT01031680|1938283|FG000|Overall Study|Safety|1
946749|NCT01031680|1938284|FG001|Overall Study|Safety|0
946750|NCT01031680|1938283|FG000|Overall Study|Incorrect Enrolment|1
946751|NCT01031680|1938284|FG001|Overall Study|Incorrect Enrolment|2
946752|NCT01031680|1938283|FG000|Overall Study|Administrative Reason by Sponsor|0
946753|NCT01031680|1938284|FG001|Overall Study|Administrative Reason by Sponsor|1
946754|NCT01031680|1938283|FG000|Overall Study|Various|0
946755|NCT01031680|1938284|FG001|Overall Study|Various|2
946756|NCT01031706|1938292|FG000|Overall Study|Adverse Event|1
946757|NCT01031706|1938293|FG001|Overall Study|Adverse Event|0
946758|NCT01031706|1938292|FG000|Overall Study|Withdrawal by Subject|1
946759|NCT01031706|1938293|FG001|Overall Study|Withdrawal by Subject|1
946760|NCT01031836|1938311|FG000|Stage I|Adverse Event|1
946761|NCT01031836|1938312|FG001|Stage I|Adverse Event|1
946762|NCT01031836|1938313|FG002|Stage I|Adverse Event|0
946763|NCT01031836|1938314|FG003|Stage I|Adverse Event|0
946764|NCT01031836|1938315|FG004|Stage I|Adverse Event|0
946765|NCT01031836|1938316|FG005|Stage I|Adverse Event|0
946766|NCT01031836|1938311|FG000|Stage I|Other|0
946767|NCT01031836|1938312|FG001|Stage I|Other|1
946768|NCT01031836|1938313|FG002|Stage I|Other|0
946769|NCT01031836|1938314|FG003|Stage I|Other|0
946770|NCT01031836|1938315|FG004|Stage I|Other|0
946771|NCT01031836|1938316|FG005|Stage I|Other|1
946772|NCT01031836|1938311|FG000|Stage II|Adverse Event|0
946773|NCT01031836|1938312|FG001|Stage II|Adverse Event|0
946774|NCT01031836|1938313|FG002|Stage II|Adverse Event|2
946775|NCT01031836|1938314|FG003|Stage II|Adverse Event|2
946776|NCT01031836|1938315|FG004|Stage II|Adverse Event|1
946777|NCT01031836|1938316|FG005|Stage II|Adverse Event|1
946778|NCT01031836|1938311|FG000|Stage II|Other|2
946779|NCT01031836|1938312|FG001|Stage II|Other|0
946780|NCT01031836|1938313|FG002|Stage II|Other|0
946781|NCT01031836|1938314|FG003|Stage II|Other|1
946782|NCT01031836|1938315|FG004|Stage II|Other|1
946783|NCT01031836|1938316|FG005|Stage II|Other|0
946784|NCT01031979|1938346|FG000|Overall Study|Lost to Follow-up|5
946785|NCT01031979|1938347|FG001|Overall Study|Lost to Follow-up|4
946786|NCT01032018|1938355|FG000|Overall Study|Lost to Follow-up|6
946787|NCT01032018|1938356|FG001|Overall Study|Lost to Follow-up|5
946788|NCT01032018|1938355|FG000|Overall Study|Death|0
946789|NCT01032018|1938356|FG001|Overall Study|Death|1
946790|NCT01032044|1938364|FG000|Overall Study|Protocol Violation|14
946791|NCT01032044|1938365|FG001|Overall Study|Protocol Violation|8
946792|NCT01032044|1938364|FG000|Overall Study|Adverse Event|0
946793|NCT01032044|1938365|FG001|Overall Study|Adverse Event|1
946794|NCT01032044|1938364|FG000|Overall Study|Lost to Follow-up|11
946795|NCT01032044|1938365|FG001|Overall Study|Lost to Follow-up|11
946796|NCT01032070|1938373|FG000|Overall Study|Disease progression|13
946797|NCT01032070|1938374|FG001|Overall Study|Disease progression|8
946798|NCT01032070|1938373|FG000|Overall Study|Medical or ethical reasons|0
946799|NCT01032070|1938374|FG001|Overall Study|Medical or ethical reasons|2
946800|NCT01032070|1938373|FG000|Overall Study|Withdrawal by Subject|0
946801|NCT01032070|1938374|FG001|Overall Study|Withdrawal by Subject|2
946802|NCT01032174|1938407|FG000|Overall Study|Adverse Event|0
946803|NCT01032174|1938408|FG001|Overall Study|Adverse Event|1
946804|NCT01032200|1938416|FG000|Overall Study|Death|1
946805|NCT01032200|1938417|FG001|Overall Study|Death|1
946806|NCT01032200|1938416|FG000|Overall Study|Withdrawal by Subject|1
946807|NCT01032200|1938417|FG001|Overall Study|Withdrawal by Subject|3
946808|NCT01032200|1938416|FG000|Overall Study|Toxicity|0
946809|NCT01032200|1938417|FG001|Overall Study|Toxicity|2
946810|NCT01032200|1938416|FG000|Overall Study|Progression|1
946811|NCT01032200|1938417|FG001|Overall Study|Progression|0
946812|NCT01032200|1938416|FG000|Overall Study|Multiple|1
946813|NCT01032200|1938417|FG001|Overall Study|Multiple|1
946814|NCT01032239|1938425|FG000|Overall Study|Lost to Follow-up|3
946815|NCT01032239|1938426|FG001|Overall Study|Lost to Follow-up|2
946816|NCT01032239|1938425|FG000|Overall Study|Withdrawal by Subject|2
946817|NCT01032239|1938426|FG001|Overall Study|Withdrawal by Subject|3
946818|NCT01032239|1938425|FG000|Overall Study|Death|1
946819|NCT01032239|1938426|FG001|Overall Study|Death|0
946820|NCT01032239|1938425|FG000|Overall Study|Protocol Violation|1
946821|NCT01032239|1938426|FG001|Overall Study|Protocol Violation|0
946822|NCT01032291|1938444|FG000|Safety Lead-in|Adverse Event|1
946823|NCT01032291|1938445|FG001|Safety Lead-in|Adverse Event|0
946824|NCT01032291|1938446|FG002|Safety Lead-in|Adverse Event|0
946825|NCT01032291|1938444|FG000|Safety Lead-in|Death|1
946826|NCT01032291|1938445|FG001|Safety Lead-in|Death|0
946827|NCT01032291|1938446|FG002|Safety Lead-in|Death|0
946828|NCT01032291|1938444|FG000|Proof of Concept|Adverse Event|0
946829|NCT01032291|1938445|FG001|Proof of Concept|Adverse Event|5
946830|NCT01032291|1938446|FG002|Proof of Concept|Adverse Event|1
946831|NCT01032291|1938444|FG000|Proof of Concept|Death|0
946832|NCT01032291|1938445|FG001|Proof of Concept|Death|1
946833|NCT01032291|1938446|FG002|Proof of Concept|Death|2
946834|NCT01032291|1938444|FG000|Proof of Concept|Lack of Efficacy|0
946835|NCT01032291|1938445|FG001|Proof of Concept|Lack of Efficacy|1
946836|NCT01032291|1938446|FG002|Proof of Concept|Lack of Efficacy|0
946837|NCT01032291|1938444|FG000|Proof of Concept|Never Received Study Drug|0
946838|NCT01032291|1938445|FG001|Proof of Concept|Never Received Study Drug|1
946839|NCT01032291|1938446|FG002|Proof of Concept|Never Received Study Drug|0
946840|NCT01032382|1938484|FG000|Overall Study|Disease dissemination|1
946841|NCT01032382|1938485|FG001|Overall Study|Disease dissemination|1
946842|NCT01032382|1938484|FG000|Overall Study|Treatment failure|3
946843|NCT01032382|1938485|FG001|Overall Study|Treatment failure|1
946844|NCT01032382|1938484|FG000|Overall Study|Index lesion relapse|1
946845|NCT01032382|1938485|FG001|Overall Study|Index lesion relapse|3
946846|NCT01032629|1938509|FG000|Overall Study|Closed Site|21
946847|NCT01032629|1938510|FG001|Overall Study|Closed Site|18
946848|NCT01032629|1938511|FG002|Overall Study|Closed Site|16
946849|NCT01032629|1938509|FG000|Overall Study|Withdrawal by Subject|50
946850|NCT01032629|1938510|FG001|Overall Study|Withdrawal by Subject|36
946851|NCT01032629|1938511|FG002|Overall Study|Withdrawal by Subject|35
946852|NCT01032629|1938509|FG000|Overall Study|Lost to Follow-up|74
946853|NCT01032629|1938510|FG001|Overall Study|Lost to Follow-up|47
946854|NCT01032629|1938511|FG002|Overall Study|Lost to Follow-up|37
946855|NCT01032837|1938552|FG000|Overall Study|Adverse event/internal illness|0
946856|NCT01032837|1938553|FG001|Overall Study|Adverse event/internal illness|1
946857|NCT01032837|1938554|FG002|Overall Study|Adverse event/internal illness|0
946858|NCT01032837|1938555|FG003|Overall Study|Adverse event/internal illness|1
946859|NCT01032837|1938552|FG000|Overall Study|Withdrew consent|0
946860|NCT01032837|1938553|FG001|Overall Study|Withdrew consent|2
946861|NCT01032837|1938554|FG002|Overall Study|Withdrew consent|0
946862|NCT01032837|1938555|FG003|Overall Study|Withdrew consent|1
946863|NCT01032837|1938552|FG000|Overall Study|Failed to return|0
946864|NCT01032837|1938553|FG001|Overall Study|Failed to return|0
946865|NCT01032837|1938554|FG002|Overall Study|Failed to return|1
946866|NCT01032837|1938555|FG003|Overall Study|Failed to return|0
946867|NCT01032837|1938552|FG000|Overall Study|Refused treatment|0
946868|NCT01032837|1938553|FG001|Overall Study|Refused treatment|0
946869|NCT01032837|1938554|FG002|Overall Study|Refused treatment|0
946870|NCT01032837|1938555|FG003|Overall Study|Refused treatment|1
946871|NCT01032889|1938572|FG000|Overall Study|Adverse Event|2
946872|NCT01032889|1938573|FG001|Overall Study|Adverse Event|2
946873|NCT01032889|1938574|FG002|Overall Study|Adverse Event|0
946874|NCT01032889|1938572|FG000|Overall Study|Withdrawal of Consent|1
946875|NCT01032889|1938573|FG001|Overall Study|Withdrawal of Consent|2
946876|NCT01032889|1938574|FG002|Overall Study|Withdrawal of Consent|1
946877|NCT01032889|1938572|FG000|Overall Study|Patient Request|0
946878|NCT01032889|1938573|FG001|Overall Study|Patient Request|1
946879|NCT01032889|1938574|FG002|Overall Study|Patient Request|0
946880|NCT01032889|1938572|FG000|Overall Study|Lost to Follow-up|1
946881|NCT01032889|1938573|FG001|Overall Study|Lost to Follow-up|1
946882|NCT01032889|1938574|FG002|Overall Study|Lost to Follow-up|0
946883|NCT01032889|1938572|FG000|Overall Study|Lack of Submental Fat|2
946884|NCT01032889|1938573|FG001|Overall Study|Lack of Submental Fat|8
946885|NCT01032889|1938574|FG002|Overall Study|Lack of Submental Fat|1
946886|NCT01032889|1938572|FG000|Overall Study|Miscellaneous Reasons|2
946887|NCT01032889|1938573|FG001|Overall Study|Miscellaneous Reasons|1
946888|NCT01032889|1938574|FG002|Overall Study|Miscellaneous Reasons|1
946889|NCT01032915|1938586|FG000|Overall Study|Adverse Event|2
946890|NCT01032915|1938587|FG001|Overall Study|Adverse Event|2
946891|NCT01032915|1938588|FG002|Overall Study|Adverse Event|1
946892|NCT01032915|1938589|FG003|Overall Study|Adverse Event|1
946893|NCT01032915|1938586|FG000|Overall Study|Abnormal test procedure result|0
946894|NCT01032915|1938587|FG001|Overall Study|Abnormal test procedure result|0
946895|NCT01032915|1938588|FG002|Overall Study|Abnormal test procedure result|1
946896|NCT01032915|1938589|FG003|Overall Study|Abnormal test procedure result|0
946897|NCT01032915|1938586|FG000|Overall Study|Withdrawal by Subject|0
946898|NCT01032915|1938587|FG001|Overall Study|Withdrawal by Subject|3
946899|NCT01032915|1938588|FG002|Overall Study|Withdrawal by Subject|1
946900|NCT01032915|1938589|FG003|Overall Study|Withdrawal by Subject|1
946901|NCT01032915|1938586|FG000|Overall Study|Administrative reasons|5
946902|NCT01032915|1938587|FG001|Overall Study|Administrative reasons|6
946903|NCT01032915|1938588|FG002|Overall Study|Administrative reasons|4
946904|NCT01032915|1938589|FG003|Overall Study|Administrative reasons|4
946905|NCT01032915|1938586|FG000|Overall Study|Protocol Violation|1
946906|NCT01032915|1938587|FG001|Overall Study|Protocol Violation|0
946907|NCT01032915|1938588|FG002|Overall Study|Protocol Violation|0
946908|NCT01032915|1938589|FG003|Overall Study|Protocol Violation|1
946909|NCT01033019|1938631|FG000|Overall Study|Withdrawal by Subject|1
946910|NCT01033019|1938632|FG001|Overall Study|Withdrawal by Subject|0
946911|NCT01033071|1938649|FG000|Overall Study|Adverse Event|28
946912|NCT01033071|1938650|FG001|Overall Study|Adverse Event|51
946913|NCT01033071|1938651|FG002|Overall Study|Adverse Event|26
946914|NCT01033071|1938649|FG000|Overall Study|Protocol Violation|0
946915|NCT01033071|1938650|FG001|Overall Study|Protocol Violation|2
946916|NCT01033071|1938651|FG002|Overall Study|Protocol Violation|1
946917|NCT01033071|1938649|FG000|Overall Study|Lost to Follow-up|4
946918|NCT01033071|1938650|FG001|Overall Study|Lost to Follow-up|5
946919|NCT01033071|1938651|FG002|Overall Study|Lost to Follow-up|5
946920|NCT01033071|1938649|FG000|Overall Study|Withdrawal by Subject|17
946921|NCT01033071|1938650|FG001|Overall Study|Withdrawal by Subject|14
946922|NCT01033071|1938651|FG002|Overall Study|Withdrawal by Subject|11
946923|NCT01033071|1938649|FG000|Overall Study|Lack of Efficacy|0
946924|NCT01033071|1938650|FG001|Overall Study|Lack of Efficacy|1
946925|NCT01033071|1938651|FG002|Overall Study|Lack of Efficacy|1
946926|NCT01033071|1938649|FG000|Overall Study|Other|6
946927|NCT01033071|1938650|FG001|Overall Study|Other|4
946928|NCT01033071|1938651|FG002|Overall Study|Other|3
946929|NCT01033136|1938661|FG000|Follow-Up (3 Month)|Lost to Follow-up|2
946930|NCT01033136|1938662|FG001|Follow-Up (3 Month)|Lost to Follow-up|2
946931|NCT01033240|1938684|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10
946932|NCT01033240|1938685|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8
946933|NCT01033240|1938686|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6
946934|NCT01033240|1938684|FG000|Overall Study|Death|2
946935|NCT01033240|1938685|FG001|Overall Study|Death|0
946936|NCT01033240|1938686|FG002|Overall Study|Death|0
946937|NCT01033240|1938684|FG000|Overall Study|Withdrew Consent|2
946938|NCT01033240|1938685|FG001|Overall Study|Withdrew Consent|9
946939|NCT01033240|1938686|FG002|Overall Study|Withdrew Consent|2
946940|NCT01033240|1938684|FG000|Overall Study|Disease Progression|35
946941|NCT01033240|1938685|FG001|Overall Study|Disease Progression|32
946942|NCT01033240|1938686|FG002|Overall Study|Disease Progression|41
946943|NCT01033240|1938684|FG000|Overall Study|Investigator Discretion|0
946944|NCT01033240|1938685|FG001|Overall Study|Investigator Discretion|0
946945|NCT01033240|1938686|FG002|Overall Study|Investigator Discretion|2
946946|NCT01033240|1938684|FG000|Overall Study|Other|0
946947|NCT01033240|1938685|FG001|Overall Study|Other|1
946948|NCT01033240|1938686|FG002|Overall Study|Other|2
946949|NCT01033448|1938724|FG000|Overall Study|Withdrawal by Subject|4
946950|NCT01033448|1938724|FG000|Overall Study|Positive HCV-RNA at week 48|1
946951|NCT01033448|1938724|FG000|Overall Study|Lost to Follow-up|3
946952|NCT01033448|1938724|FG000|Overall Study|Withdrew due to other reasons|3
946953|NCT01033448|1938724|FG000|Overall Study|Unknown disposition|1
946954|NCT01033487|1938730|FG000|Fourth Intervention Period|Adverse Event|0
946955|NCT01033487|1938731|FG001|Fourth Intervention Period|Adverse Event|0
946956|NCT01033487|1938732|FG002|Fourth Intervention Period|Adverse Event|0
946957|NCT01033487|1938733|FG003|Fourth Intervention Period|Adverse Event|0
946958|NCT01033487|1938734|FG004|Fourth Intervention Period|Adverse Event|0
946959|NCT01033487|1938735|FG005|Fourth Intervention Period|Adverse Event|0
946960|NCT01033487|1938736|FG006|Fourth Intervention Period|Adverse Event|0
946961|NCT01033487|1938737|FG007|Fourth Intervention Period|Adverse Event|0
946962|NCT01033487|1938738|FG008|Fourth Intervention Period|Adverse Event|1
946963|NCT01033487|1938739|FG009|Fourth Intervention Period|Adverse Event|0
946964|NCT01033643|1938762|FG000|Overall Study|Withdrew Consent|0
946965|NCT01033643|1938763|FG001|Overall Study|Withdrew Consent|3
946966|NCT01033643|1938764|FG002|Overall Study|Withdrew Consent|0
946967|NCT01033643|1938765|FG003|Overall Study|Withdrew Consent|0
946968|NCT01033643|1938766|FG004|Overall Study|Withdrew Consent|0
946969|NCT01033643|1938767|FG005|Overall Study|Withdrew Consent|1
946970|NCT01033734|1938781|FG000|Overall Study|Withdrawal by Subject|1
946971|NCT01033747|1938796|FG000|Overall Study|Adverse Event|9
946972|NCT01033747|1938797|FG001|Overall Study|Adverse Event|4
946973|NCT01033747|1938796|FG000|Overall Study|Abnormal Laboratory Value|1
946974|NCT01033747|1938797|FG001|Overall Study|Abnormal Laboratory Value|0
946975|NCT01033747|1938796|FG000|Overall Study|Abnormal test procedure|0
946976|NCT01033747|1938797|FG001|Overall Study|Abnormal test procedure|1
946977|NCT01033747|1938796|FG000|Overall Study|Unsatisfactory therapeutic effect|14
946978|NCT01033747|1938797|FG001|Overall Study|Unsatisfactory therapeutic effect|4
946979|NCT01033747|1938796|FG000|Overall Study|Protocol Violation|1
946980|NCT01033747|1938797|FG001|Overall Study|Protocol Violation|0
946981|NCT01033747|1938796|FG000|Overall Study|Withdrawal by Subject|9
946982|NCT01033747|1938797|FG001|Overall Study|Withdrawal by Subject|6
946983|NCT01033747|1938796|FG000|Overall Study|Stopped at end of prolongation visit 1|1
946984|NCT01033747|1938797|FG001|Overall Study|Stopped at end of prolongation visit 1|0
946985|NCT01033747|1938796|FG000|Overall Study|Stopped at end of Extension 1|2
946986|NCT01033747|1938797|FG001|Overall Study|Stopped at end of Extension 1|0
946987|NCT01033825|1938814|FG000|Overall Study|Withdrawal by Subject|2
946988|NCT01033825|1938815|FG001|Overall Study|Withdrawal by Subject|3
946989|NCT01033825|1938816|FG002|Overall Study|Withdrawal by Subject|2
946990|NCT01033825|1938817|FG003|Overall Study|Withdrawal by Subject|1
946991|NCT01033825|1938818|FG004|Overall Study|Withdrawal by Subject|1
946992|NCT01033825|1938819|FG005|Overall Study|Withdrawal by Subject|0
946993|NCT01033825|1938820|FG006|Overall Study|Withdrawal by Subject|0
946994|NCT01033825|1938814|FG000|Overall Study|Adverse Event|0
946995|NCT01033825|1938815|FG001|Overall Study|Adverse Event|0
946996|NCT01033825|1938816|FG002|Overall Study|Adverse Event|0
946997|NCT01033825|1938817|FG003|Overall Study|Adverse Event|1
946998|NCT01033825|1938818|FG004|Overall Study|Adverse Event|0
946999|NCT01033825|1938819|FG005|Overall Study|Adverse Event|0
947000|NCT01033825|1938820|FG006|Overall Study|Adverse Event|0
947001|NCT01033825|1938814|FG000|Overall Study|Protocol Violation|1
947002|NCT01033825|1938815|FG001|Overall Study|Protocol Violation|0
947003|NCT01033825|1938816|FG002|Overall Study|Protocol Violation|0
947004|NCT01033825|1938817|FG003|Overall Study|Protocol Violation|0
947005|NCT01033825|1938818|FG004|Overall Study|Protocol Violation|0
947006|NCT01033825|1938819|FG005|Overall Study|Protocol Violation|0
947007|NCT01033825|1938820|FG006|Overall Study|Protocol Violation|0
947008|NCT01033825|1938814|FG000|Overall Study|Other|0
947009|NCT01033825|1938815|FG001|Overall Study|Other|0
947010|NCT01033825|1938816|FG002|Overall Study|Other|0
947011|NCT01033825|1938817|FG003|Overall Study|Other|0
947012|NCT01033825|1938818|FG004|Overall Study|Other|1
947013|NCT01033825|1938819|FG005|Overall Study|Other|0
947014|NCT01033825|1938820|FG006|Overall Study|Other|0
947015|NCT01033851|1938840|FG000|Overall Study|Withdrawal by Subject|3
947016|NCT01033851|1938841|FG001|Overall Study|Withdrawal by Subject|7
947017|NCT01033942|1938859|FG000|Overall Study|Withdrawal by Subject|1
947018|NCT01033942|1938860|FG001|Overall Study|Withdrawal by Subject|1
947019|NCT01033942|1938861|FG002|Overall Study|Withdrawal by Subject|1
947020|NCT01033942|1938859|FG000|Overall Study|Lost to Follow-up|1
947021|NCT01033942|1938860|FG001|Overall Study|Lost to Follow-up|0
947022|NCT01033942|1938861|FG002|Overall Study|Lost to Follow-up|0
947023|NCT01033942|1938859|FG000|Overall Study|Enrolled in Extension Study|0
947024|NCT01033942|1938860|FG001|Overall Study|Enrolled in Extension Study|3
947025|NCT01033942|1938861|FG002|Overall Study|Enrolled in Extension Study|0
947026|NCT01034137|1938878|FG000|Overall Study|Adverse Event|9
947027|NCT01034137|1938879|FG001|Overall Study|Adverse Event|10
947028|NCT01034137|1938880|FG002|Overall Study|Adverse Event|8
947029|NCT01034137|1938878|FG000|Overall Study|Withdrawal by Subject|4
947030|NCT01034137|1938879|FG001|Overall Study|Withdrawal by Subject|3
947031|NCT01034137|1938880|FG002|Overall Study|Withdrawal by Subject|3
947032|NCT01034137|1938878|FG000|Overall Study|Lack of Efficacy|9
947033|NCT01034137|1938879|FG001|Overall Study|Lack of Efficacy|4
947034|NCT01034137|1938880|FG002|Overall Study|Lack of Efficacy|13
947035|NCT01034137|1938878|FG000|Overall Study|Protocol Violation|2
947036|NCT01034137|1938879|FG001|Overall Study|Protocol Violation|2
947037|NCT01034137|1938880|FG002|Overall Study|Protocol Violation|1
947038|NCT01034137|1938878|FG000|Overall Study|Refused treatment or did not cooperate|2
947039|NCT01034137|1938879|FG001|Overall Study|Refused treatment or did not cooperate|0
947040|NCT01034137|1938880|FG002|Overall Study|Refused treatment or did not cooperate|1
947041|NCT01034137|1938878|FG000|Overall Study|Administrative or other|2
947042|NCT01034137|1938879|FG001|Overall Study|Administrative or other|3
947043|NCT01034137|1938880|FG002|Overall Study|Administrative or other|4
947044|NCT01034163|1938891|FG000|Overall Study|Treatment completed as per protocol|8
947045|NCT01034163|1938892|FG001|Overall Study|Treatment completed as per protocol|7
947046|NCT01034163|1938891|FG000|Overall Study|Withdrawal by Subject|8
947047|NCT01034163|1938892|FG001|Overall Study|Withdrawal by Subject|2
947048|NCT01034163|1938891|FG000|Overall Study|Protocol deviation|1
947049|NCT01034163|1938892|FG001|Overall Study|Protocol deviation|0
947050|NCT01034163|1938891|FG000|Overall Study|Disease progression|3
947051|NCT01034163|1938892|FG001|Overall Study|Disease progression|4
947052|NCT01034163|1938891|FG000|Overall Study|Adverse Event|6
947053|NCT01034163|1938892|FG001|Overall Study|Adverse Event|0
947054|NCT01034163|1938891|FG000|Overall Study|Administrative problems|0
947055|NCT01034163|1938892|FG001|Overall Study|Administrative problems|1
947056|NCT01034163|1938891|FG000|Overall Study|Abnormal laboratory value|1
947057|NCT01034163|1938892|FG001|Overall Study|Abnormal laboratory value|0
947058|NCT01034176|1938900|FG000|Overall Study|Physician Decision|2
947059|NCT01034176|1938901|FG001|Overall Study|Physician Decision|0
947060|NCT01034176|1938900|FG000|Overall Study|Withdrawal by Subject|0
947061|NCT01034176|1938901|FG001|Overall Study|Withdrawal by Subject|1
947062|NCT01034176|1938900|FG000|Overall Study|Lost to Follow-up|0
947063|NCT01034176|1938901|FG001|Overall Study|Lost to Follow-up|1
947064|NCT01034306|1938909|FG000|Overall Study|Adverse Event|1
947065|NCT01034306|1938910|FG001|Overall Study|Adverse Event|0
947066|NCT01034306|1938909|FG000|Overall Study|Lost to Follow-up|0
947067|NCT01034306|1938910|FG001|Overall Study|Lost to Follow-up|1
947068|NCT01034306|1938909|FG000|Overall Study|Withdrawal by Subject|2
947069|NCT01034306|1938910|FG001|Overall Study|Withdrawal by Subject|2
947070|NCT01034306|1938909|FG000|Overall Study|hospitalized and decided to stop|1
947071|NCT01034306|1938910|FG001|Overall Study|hospitalized and decided to stop|0
947072|NCT01034306|1938909|FG000|Overall Study|Noncomplience|1
947073|NCT01034306|1938910|FG001|Overall Study|Noncomplience|0
947074|NCT01034358|1938916|FG000|Overall Study|Withdrawal by Subject|1
947075|NCT01034358|1938916|FG000|Overall Study|Protocol Violation|1
947076|NCT01034397|1938922|FG000|Overall Study|Lack of compliance|0
947077|NCT01034397|1938923|FG001|Overall Study|Lack of compliance|1
947078|NCT01034397|1938922|FG000|Overall Study|Lack of Efficacy|3
947079|NCT01034397|1938923|FG001|Overall Study|Lack of Efficacy|0
947080|NCT01034397|1938922|FG000|Overall Study|Adverse Event|4
947081|NCT01034397|1938923|FG001|Overall Study|Adverse Event|0
947082|NCT01034397|1938922|FG000|Overall Study|Other|0
947083|NCT01034397|1938923|FG001|Overall Study|Other|1
947084|NCT01034462|1938940|FG000|Overall Study|Adverse Event|7
947085|NCT01034462|1938941|FG001|Overall Study|Adverse Event|17
947086|NCT01034462|1938940|FG000|Overall Study|Lack of Efficacy|4
947087|NCT01034462|1938941|FG001|Overall Study|Lack of Efficacy|4
947088|NCT01034462|1938940|FG000|Overall Study|Protocol Violation|10
947089|NCT01034462|1938941|FG001|Overall Study|Protocol Violation|7
947090|NCT01034462|1938940|FG000|Overall Study|Withdrawal by Subject|9
947091|NCT01034462|1938941|FG001|Overall Study|Withdrawal by Subject|8
947092|NCT01034462|1938940|FG000|Overall Study|Lost to Follow-up|14
947093|NCT01034462|1938941|FG001|Overall Study|Lost to Follow-up|16
947094|NCT01034462|1938940|FG000|Overall Study|Other reasons|1
947095|NCT01034462|1938941|FG001|Overall Study|Other reasons|2
947096|NCT01034540|1938960|FG000|Overall Study|Adverse Event|0
947097|NCT01034540|1938961|FG001|Overall Study|Adverse Event|1
947098|NCT01034631|1939005|FG000|Phase I|Symptomatic Deterioration before Treatme|3
947099|NCT01034631|1939006|FG001|Phase I|Symptomatic Deterioration before Treatme|0
947100|NCT01034631|1939007|FG002|Phase I|Symptomatic Deterioration before Treatme|0
947101|NCT01034631|1939005|FG000|Phase II|Not Evaluable per protocol|0
947102|NCT01034631|1939006|FG001|Phase II|Not Evaluable per protocol|0
947103|NCT01034631|1939007|FG002|Phase II|Not Evaluable per protocol|2
947104|NCT01034631|1939005|FG000|Phase II|Determined Ineligible per protocol|0
947105|NCT01034631|1939006|FG001|Phase II|Determined Ineligible per protocol|1
947106|NCT01034631|1939007|FG002|Phase II|Determined Ineligible per protocol|0
947107|NCT01034657|1939017|FG000|Core Phase|Withdrawal by Subject|1
947108|NCT01034657|1939018|FG001|Core Phase|Withdrawal by Subject|0
947109|NCT01034657|1939019|FG002|Core Phase|Withdrawal by Subject|0
947110|NCT01034657|1939017|FG000|Core Phase|Lack of Efficacy|2
947111|NCT01034657|1939018|FG001|Core Phase|Lack of Efficacy|0
947112|NCT01034657|1939019|FG002|Core Phase|Lack of Efficacy|0
947113|NCT01034657|1939017|FG000|Core Phase|Abnormal laboratory value|1
947114|NCT01034657|1939018|FG001|Core Phase|Abnormal laboratory value|0
947115|NCT01034657|1939019|FG002|Core Phase|Abnormal laboratory value|0
947116|NCT01034657|1939017|FG000|Core Phase|Adverse Event|8
947117|NCT01034657|1939018|FG001|Core Phase|Adverse Event|0
947118|NCT01034657|1939019|FG002|Core Phase|Adverse Event|0
947119|NCT01034657|1939017|FG000|Core Phase|Protocol Violation|2
947120|NCT01034657|1939018|FG001|Core Phase|Protocol Violation|0
947121|NCT01034657|1939019|FG002|Core Phase|Protocol Violation|0
947122|NCT01034657|1939017|FG000|Randomized Phase|Withdrawal by Subject|0
947123|NCT01034657|1939018|FG001|Randomized Phase|Withdrawal by Subject|2
947124|NCT01034657|1939019|FG002|Randomized Phase|Withdrawal by Subject|0
947125|NCT01034657|1939017|FG000|Randomized Phase|Lack of Efficacy|5
947126|NCT01034657|1939018|FG001|Randomized Phase|Lack of Efficacy|1
947127|NCT01034657|1939019|FG002|Randomized Phase|Lack of Efficacy|0
947128|NCT01034657|1939017|FG000|Randomized Phase|Abnormal laboratory value|0
947129|NCT01034657|1939018|FG001|Randomized Phase|Abnormal laboratory value|1
947130|NCT01034657|1939019|FG002|Randomized Phase|Abnormal laboratory value|0
947131|NCT01034657|1939017|FG000|Randomized Phase|Adverse Event|0
947132|NCT01034657|1939018|FG001|Randomized Phase|Adverse Event|2
947133|NCT01034657|1939019|FG002|Randomized Phase|Adverse Event|1
947134|NCT01034709|1939031|FG000|Overall Study|Protocol Violation|9
947135|NCT01034709|1939032|FG001|Overall Study|Protocol Violation|16
947136|NCT01035060|1939049|FG000|Overall Study|Lost to Follow-up|0
947137|NCT01035060|1939050|FG001|Overall Study|Lost to Follow-up|7
947138|NCT01035060|1939049|FG000|Overall Study|Did not quality after 2nd screening|14
947139|NCT01035060|1939050|FG001|Overall Study|Did not quality after 2nd screening|1
947140|NCT01035060|1939049|FG000|Overall Study|Withdrawal by Subject|8
947141|NCT01035060|1939050|FG001|Overall Study|Withdrawal by Subject|6
947142|NCT01035060|1939049|FG000|Overall Study|Physician Decision|2
947143|NCT01035060|1939050|FG001|Overall Study|Physician Decision|0
947144|NCT01035138|1939069|FG000|Overall Study|Adverse Event|4
947145|NCT01035138|1939070|FG001|Overall Study|Adverse Event|0
947146|NCT01035138|1939071|FG002|Overall Study|Adverse Event|2
947147|NCT01035138|1939069|FG000|Overall Study|Caregiver Decision|2
947148|NCT01035138|1939070|FG001|Overall Study|Caregiver Decision|0
947149|NCT01035138|1939071|FG002|Overall Study|Caregiver Decision|1
947150|NCT01035138|1939069|FG000|Overall Study|Withdrawal by Subject|1
947151|NCT01035138|1939070|FG001|Overall Study|Withdrawal by Subject|0
947152|NCT01035138|1939071|FG002|Overall Study|Withdrawal by Subject|0
947153|NCT01035138|1939069|FG000|Overall Study|Physician Decision|0
947154|NCT01035138|1939070|FG001|Overall Study|Physician Decision|0
947155|NCT01035138|1939071|FG002|Overall Study|Physician Decision|1
947156|NCT01035138|1939069|FG000|Overall Study|Sponsor Decision|66
947157|NCT01035138|1939070|FG001|Overall Study|Sponsor Decision|60
947158|NCT01035138|1939071|FG002|Overall Study|Sponsor Decision|42
947159|NCT01035138|1939069|FG000|Overall Study|Lost to Follow-up|0
947160|NCT01035138|1939070|FG001|Overall Study|Lost to Follow-up|0
947161|NCT01035138|1939071|FG002|Overall Study|Lost to Follow-up|1
947162|NCT01035229|1939092|FG000|Overall Study|Adverse Event|61
947163|NCT01035229|1939093|FG001|Overall Study|Adverse Event|14
947164|NCT01035229|1939092|FG000|Overall Study|Withdrawal by Subject|20
947165|NCT01035229|1939093|FG001|Overall Study|Withdrawal by Subject|7
947166|NCT01035229|1939092|FG000|Overall Study|Lost to Follow-up|1
947167|NCT01035229|1939093|FG001|Overall Study|Lost to Follow-up|0
947168|NCT01035229|1939092|FG000|Overall Study|Administrative problems|1
947169|NCT01035229|1939093|FG001|Overall Study|Administrative problems|1
947170|NCT01035229|1939092|FG000|Overall Study|Death|13
947171|NCT01035229|1939093|FG001|Overall Study|Death|5
947172|NCT01035229|1939092|FG000|Overall Study|New cancer therapy|2
947173|NCT01035229|1939093|FG001|Overall Study|New cancer therapy|0
947174|NCT01035229|1939092|FG000|Overall Study|Protocol Violation|0
947175|NCT01035229|1939093|FG001|Overall Study|Protocol Violation|2
947176|NCT01035229|1939092|FG000|Overall Study|Sponsor's decision to end study|3
947177|NCT01035229|1939093|FG001|Overall Study|Sponsor's decision to end study|3
947178|NCT01035229|1939092|FG000|Overall Study|Disease Progression|261
947179|NCT01035229|1939093|FG001|Overall Study|Disease Progression|152
947180|NCT01035255|1939103|FG000|Overall Study|Death|724
947181|NCT01035255|1939104|FG001|Overall Study|Death|844
947182|NCT01035255|1939103|FG000|Overall Study|Lost to Follow-up|2
947183|NCT01035255|1939104|FG001|Overall Study|Lost to Follow-up|5
947184|NCT01035255|1939103|FG000|Overall Study|patient's request|15
947185|NCT01035255|1939104|FG001|Overall Study|patient's request|13
947186|NCT01035463|1939125|FG000|Overall Study|Adverse Event|0
947187|NCT01035463|1939126|FG001|Overall Study|Adverse Event|0
947188|NCT01035463|1939127|FG002|Overall Study|Adverse Event|4
947189|NCT01035463|1939128|FG003|Overall Study|Adverse Event|1
947190|NCT01035463|1939129|FG004|Overall Study|Adverse Event|5
947191|NCT01035463|1939130|FG005|Overall Study|Adverse Event|7
947192|NCT01035463|1939125|FG000|Overall Study|Withdrawal by Subject|0
947193|NCT01035463|1939126|FG001|Overall Study|Withdrawal by Subject|2
947194|NCT01035463|1939127|FG002|Overall Study|Withdrawal by Subject|1
947195|NCT01035463|1939128|FG003|Overall Study|Withdrawal by Subject|0
947196|NCT01035463|1939129|FG004|Overall Study|Withdrawal by Subject|1
947197|NCT01035463|1939130|FG005|Overall Study|Withdrawal by Subject|4
947198|NCT01035463|1939125|FG000|Overall Study|Disease progression|0
947199|NCT01035463|1939126|FG001|Overall Study|Disease progression|0
947200|NCT01035463|1939127|FG002|Overall Study|Disease progression|0
947201|NCT01035463|1939128|FG003|Overall Study|Disease progression|0
947202|NCT01035463|1939129|FG004|Overall Study|Disease progression|0
947203|NCT01035463|1939130|FG005|Overall Study|Disease progression|3
947204|NCT01035463|1939125|FG000|Overall Study|Other Malignancy|0
947205|NCT01035463|1939126|FG001|Overall Study|Other Malignancy|0
947206|NCT01035463|1939127|FG002|Overall Study|Other Malignancy|0
947207|NCT01035463|1939128|FG003|Overall Study|Other Malignancy|0
947208|NCT01035463|1939129|FG004|Overall Study|Other Malignancy|0
947209|NCT01035463|1939130|FG005|Overall Study|Other Malignancy|2
947210|NCT01035463|1939125|FG000|Overall Study|Other|0
947211|NCT01035463|1939126|FG001|Overall Study|Other|0
947212|NCT01035463|1939127|FG002|Overall Study|Other|0
947213|NCT01035463|1939128|FG003|Overall Study|Other|1
947214|NCT01035463|1939129|FG004|Overall Study|Other|0
947215|NCT01035463|1939130|FG005|Overall Study|Other|2
947216|NCT01035606|1939140|FG000|Overall Study|change in health, job demands,family|3
947217|NCT01035606|1939141|FG001|Overall Study|change in health, job demands,family|3
947218|NCT01035606|1939142|FG002|Overall Study|change in health, job demands,family|4
947219|NCT01035905|1939198|FG000|Overall Study|Lack of Efficacy|1
947220|NCT01035905|1939199|FG001|Overall Study|Lack of Efficacy|1
947221|NCT01036022|1939221|FG000|Overall Study|Adverse Event|1
947222|NCT01036022|1939222|FG001|Overall Study|Adverse Event|3
947223|NCT01036022|1939223|FG002|Overall Study|Adverse Event|2
947224|NCT01036022|1939224|FG003|Overall Study|Adverse Event|1
947225|NCT01036022|1939225|FG004|Overall Study|Adverse Event|0
947226|NCT01036022|1939226|FG005|Overall Study|Adverse Event|2
947227|NCT01036022|1939221|FG000|Overall Study|Lack of Efficacy|1
947228|NCT01036022|1939222|FG001|Overall Study|Lack of Efficacy|1
947229|NCT01036022|1939223|FG002|Overall Study|Lack of Efficacy|1
947230|NCT01036022|1939224|FG003|Overall Study|Lack of Efficacy|0
947231|NCT01036022|1939225|FG004|Overall Study|Lack of Efficacy|1
947232|NCT01036022|1939226|FG005|Overall Study|Lack of Efficacy|1
947233|NCT01036022|1939221|FG000|Overall Study|Physician Decision|0
947234|NCT01036022|1939222|FG001|Overall Study|Physician Decision|0
947235|NCT01036022|1939223|FG002|Overall Study|Physician Decision|1
947236|NCT01036022|1939224|FG003|Overall Study|Physician Decision|0
947237|NCT01036022|1939225|FG004|Overall Study|Physician Decision|0
947238|NCT01036022|1939226|FG005|Overall Study|Physician Decision|0
947239|NCT01036022|1939221|FG000|Overall Study|Withdrawal by Subject|0
947240|NCT01036022|1939222|FG001|Overall Study|Withdrawal by Subject|0
947241|NCT01036022|1939223|FG002|Overall Study|Withdrawal by Subject|0
947242|NCT01036022|1939224|FG003|Overall Study|Withdrawal by Subject|1
947243|NCT01036022|1939225|FG004|Overall Study|Withdrawal by Subject|2
947244|NCT01036022|1939226|FG005|Overall Study|Withdrawal by Subject|0
947245|NCT01036165|1939248|FG000|Overall Study|Adverse Event|6
947246|NCT01036165|1939248|FG000|Overall Study|Lost to Follow-up|2
947247|NCT01036165|1939248|FG000|Overall Study|Withdrawal by Subject|3
947248|NCT01036165|1939248|FG000|Overall Study|Device Related Issues|3
947249|NCT01036165|1939248|FG000|Overall Study|Problems finding proper area to inject|1
947250|NCT01036321|1939254|FG000|Overall Study|Ineligible after randomization|0
947251|NCT01036321|1939255|FG001|Overall Study|Ineligible after randomization|1
947252|NCT01036321|1939254|FG000|Overall Study|Withdrawal by Subject|3
947253|NCT01036321|1939255|FG001|Overall Study|Withdrawal by Subject|2
947254|NCT01036321|1939254|FG000|Overall Study|Adverse Event|2
947255|NCT01036321|1939255|FG001|Overall Study|Adverse Event|1
947256|NCT01036438|1939263|FG000|Overall Study|Adverse Event|7
947257|NCT01036438|1939264|FG001|Overall Study|Adverse Event|8
947258|NCT01036438|1939263|FG000|Overall Study|Death|0
947259|NCT01036438|1939264|FG001|Overall Study|Death|1
947260|NCT01036438|1939263|FG000|Overall Study|No effect of study treatment|3
947261|NCT01036438|1939264|FG001|Overall Study|No effect of study treatment|1
947262|NCT01036529|1939281|FG000|Overall Study|Adverse Event|0
947263|NCT01036529|1939282|FG001|Overall Study|Adverse Event|1
947264|NCT01036529|1939281|FG000|Overall Study|Lost to Follow-up|0
947265|NCT01036529|1939282|FG001|Overall Study|Lost to Follow-up|1
947266|NCT01036529|1939281|FG000|Overall Study|Physician Decision|1
947267|NCT01036529|1939282|FG001|Overall Study|Physician Decision|0
947268|NCT01036529|1939281|FG000|Overall Study|Withdrawal by Subject|1
947269|NCT01036529|1939282|FG001|Overall Study|Withdrawal by Subject|1
947270|NCT01036529|1939281|FG000|Overall Study|Sponsor study termination|11
947271|NCT01036529|1939282|FG001|Overall Study|Sponsor study termination|12
947272|NCT01036594|1939288|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1
947273|NCT01036594|1939289|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0
947274|NCT01036594|1939288|FG000|First Treatment Regimen|Withdrawal by Subject|1
947275|NCT01036594|1939289|FG001|First Treatment Regimen|Withdrawal by Subject|0
947276|NCT01036594|1939288|FG000|Week 12 Evaluation|Adverse Event|5
947277|NCT01036594|1939289|FG001|Week 12 Evaluation|Adverse Event|0
947278|NCT01036594|1939288|FG000|Week 12 Evaluation|Physician Decision|1
947279|NCT01036594|1939289|FG001|Week 12 Evaluation|Physician Decision|0
947280|NCT01036594|1939288|FG000|Treatment Regiments Post Week 12|Physician Decision|1
947281|NCT01036594|1939289|FG001|Treatment Regiments Post Week 12|Physician Decision|1
947282|NCT01036594|1939288|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1
947283|NCT01036594|1939289|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
947284|NCT01036594|1939288|FG000|Treatment Regiments Post Week 12|Adverse Event|0
947285|NCT01036594|1939289|FG001|Treatment Regiments Post Week 12|Adverse Event|1
947286|NCT01036594|1939288|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0
947287|NCT01036594|1939289|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1
947288|NCT01036594|1939288|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0
947289|NCT01036594|1939289|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1
947290|NCT01036724|1939297|FG000|Overall Study|Adverse Event|1
947291|NCT01036724|1939298|FG001|Overall Study|Adverse Event|2
947292|NCT01036724|1939297|FG000|Overall Study|Lack of Efficacy|1
947293|NCT01036724|1939298|FG001|Overall Study|Lack of Efficacy|1
947294|NCT01036724|1939297|FG000|Overall Study|Protocol Violation|4
947295|NCT01036724|1939298|FG001|Overall Study|Protocol Violation|5
947296|NCT01036763|1939304|FG000|Overall Study|Adverse Event|25
947297|NCT01036763|1939304|FG000|Overall Study|Lost to Follow-up|28
947298|NCT01036763|1939304|FG000|Overall Study|Other reason (not specified)|40
947299|NCT01037088|1939318|FG000|Overall Study|Withdrawal by Subject|3
947300|NCT01037114|1939327|FG000|Year 20|Others|1
947301|NCT01037127|1939333|FG000|Overall Study|Lost to Follow-up|2
947302|NCT01037127|1939334|FG001|Overall Study|Lost to Follow-up|4
947303|NCT01037127|1939333|FG000|Overall Study|Physician Decision|1
947304|NCT01037127|1939334|FG001|Overall Study|Physician Decision|0
947305|NCT01037127|1939333|FG000|Overall Study|Study Closed Terminated|2
947306|NCT01037127|1939334|FG001|Overall Study|Study Closed Terminated|17
947307|NCT01037218|1939365|FG000|Overall Study|Adverse Event|4
947308|NCT01037218|1939366|FG001|Overall Study|Adverse Event|2
947309|NCT01037218|1939367|FG002|Overall Study|Adverse Event|2
947310|NCT01037218|1939368|FG003|Overall Study|Adverse Event|1
947311|NCT01037218|1939365|FG000|Overall Study|Lack of Efficacy|0
947312|NCT01037218|1939366|FG001|Overall Study|Lack of Efficacy|2
947313|NCT01037218|1939367|FG002|Overall Study|Lack of Efficacy|1
947314|NCT01037218|1939368|FG003|Overall Study|Lack of Efficacy|5
947315|NCT01037218|1939365|FG000|Overall Study|Lost to Follow-up|3
947316|NCT01037218|1939366|FG001|Overall Study|Lost to Follow-up|5
947317|NCT01037218|1939367|FG002|Overall Study|Lost to Follow-up|4
947318|NCT01037218|1939368|FG003|Overall Study|Lost to Follow-up|2
947319|NCT01037218|1939365|FG000|Overall Study|Withdrawal by Subject|6
947320|NCT01037218|1939366|FG001|Overall Study|Withdrawal by Subject|7
947321|NCT01037218|1939367|FG002|Overall Study|Withdrawal by Subject|7
947322|NCT01037218|1939368|FG003|Overall Study|Withdrawal by Subject|4
947323|NCT01037218|1939365|FG000|Overall Study|Partner Withdrew Consent|0
947324|NCT01037218|1939366|FG001|Overall Study|Partner Withdrew Consent|3
947325|NCT01037218|1939367|FG002|Overall Study|Partner Withdrew Consent|2
947326|NCT01037218|1939368|FG003|Overall Study|Partner Withdrew Consent|1
947327|NCT01037218|1939365|FG000|Overall Study|Protocol Violation|0
947328|NCT01037218|1939366|FG001|Overall Study|Protocol Violation|0
947329|NCT01037218|1939367|FG002|Overall Study|Protocol Violation|2
947330|NCT01037218|1939368|FG003|Overall Study|Protocol Violation|2
947331|NCT01037218|1939365|FG000|Overall Study|Various|3
947332|NCT01037218|1939366|FG001|Overall Study|Various|2
947333|NCT01037218|1939367|FG002|Overall Study|Various|3
947334|NCT01037218|1939368|FG003|Overall Study|Various|1
947335|NCT01037244|1939382|FG000|Overall Study|Adverse Event|3
947336|NCT01037244|1939383|FG001|Overall Study|Adverse Event|2
947337|NCT01037244|1939384|FG002|Overall Study|Adverse Event|6
947338|NCT01037244|1939385|FG003|Overall Study|Adverse Event|3
947339|NCT01037244|1939382|FG000|Overall Study|Lack of Efficacy|1
947340|NCT01037244|1939383|FG001|Overall Study|Lack of Efficacy|1
947341|NCT01037244|1939384|FG002|Overall Study|Lack of Efficacy|0
947342|NCT01037244|1939385|FG003|Overall Study|Lack of Efficacy|1
947343|NCT01037244|1939382|FG000|Overall Study|Lost to Follow-up|3
947344|NCT01037244|1939383|FG001|Overall Study|Lost to Follow-up|3
947345|NCT01037244|1939384|FG002|Overall Study|Lost to Follow-up|4
947346|NCT01037244|1939385|FG003|Overall Study|Lost to Follow-up|4
947347|NCT01037244|1939382|FG000|Overall Study|Withdrawal by Subject|1
947348|NCT01037244|1939383|FG001|Overall Study|Withdrawal by Subject|5
947349|NCT01037244|1939384|FG002|Overall Study|Withdrawal by Subject|3
947350|NCT01037244|1939385|FG003|Overall Study|Withdrawal by Subject|5
947351|NCT01037244|1939382|FG000|Overall Study|Partner Withdrew Consent|2
947352|NCT01037244|1939383|FG001|Overall Study|Partner Withdrew Consent|1
947353|NCT01037244|1939384|FG002|Overall Study|Partner Withdrew Consent|0
947354|NCT01037244|1939385|FG003|Overall Study|Partner Withdrew Consent|0
947355|NCT01037244|1939382|FG000|Overall Study|Various|3
947356|NCT01037244|1939383|FG001|Overall Study|Various|2
947357|NCT01037244|1939384|FG002|Overall Study|Various|1
947358|NCT01037244|1939385|FG003|Overall Study|Various|1
947359|NCT01037413|1939432|FG000|Part A: Skin Testing|Adverse Event|1
947360|NCT01037413|1939433|FG001|Part A: Skin Testing|Adverse Event|0
947361|NCT01037413|1939432|FG000|Part A: Skin Testing|Protocol Violation|1
947362|NCT01037413|1939433|FG001|Part A: Skin Testing|Protocol Violation|0
947363|NCT01037413|1939432|FG000|Part B: Scar Revision|Withdrawal by Subject|0
947364|NCT01037413|1939433|FG001|Part B: Scar Revision|Withdrawal by Subject|1
947365|NCT01037413|1939432|FG000|Part B: Scar Revision|Assigned But Not Treated|0
947366|NCT01037413|1939433|FG001|Part B: Scar Revision|Assigned But Not Treated|1
947367|NCT01037985|1939522|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3
947368|NCT01037985|1939523|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0
947369|NCT01037985|1939522|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1
947370|NCT01037985|1939523|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0
947371|NCT01037985|1939522|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0
947372|NCT01037985|1939523|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1
947373|NCT01037985|1939522|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0
947374|NCT01037985|1939523|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4
947375|NCT01038128|1939533|FG000|Overall Study|Lack of Efficacy|1
947376|NCT01038128|1939533|FG000|Overall Study|Lost to Follow-up|1
947377|NCT01038128|1939533|FG000|Overall Study|Withdrawal by Subject|2
947378|NCT01038297|1939542|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1
947379|NCT01038297|1939543|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
947380|NCT01038297|1939544|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
947381|NCT01038323|1939564|FG000|Overall Study|Withdrawal by Subject|3
947382|NCT01038323|1939565|FG001|Overall Study|Withdrawal by Subject|2
947383|NCT01038323|1939566|FG002|Overall Study|Withdrawal by Subject|4
947384|NCT01038427|1939595|FG000|Overall Study|Lost to follow up|1
947385|NCT01038427|1939596|FG001|Overall Study|Lost to follow up|1
947386|NCT01038427|1939597|FG002|Overall Study|Lost to follow up|0
947387|NCT01038427|1939595|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
947388|NCT01038427|1939596|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0
947389|NCT01038427|1939597|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1
947390|NCT01038427|1939595|FG000|Overall Study|Withdrew consent|0
947391|NCT01038427|1939596|FG001|Overall Study|Withdrew consent|0
947392|NCT01038427|1939597|FG002|Overall Study|Withdrew consent|1
947393|NCT01038427|1939595|FG000|Overall Study|Adverse Event|2
947394|NCT01038427|1939596|FG001|Overall Study|Adverse Event|2
947395|NCT01038427|1939597|FG002|Overall Study|Adverse Event|1
947396|NCT01038427|1939595|FG000|Overall Study|Enrolled in error|0
947397|NCT01038427|1939596|FG001|Overall Study|Enrolled in error|1
947398|NCT01038427|1939597|FG002|Overall Study|Enrolled in error|1
947399|NCT01038427|1939595|FG000|Overall Study|Other|0
947400|NCT01038427|1939596|FG001|Overall Study|Other|2
947401|NCT01038427|1939597|FG002|Overall Study|Other|0
947402|NCT01038609|1939623|FG000|Overall Study|Adverse Event|0
947403|NCT01038609|1939624|FG001|Overall Study|Adverse Event|0
947404|NCT01038609|1939625|FG002|Overall Study|Adverse Event|1
947405|NCT01038609|1939626|FG003|Overall Study|Adverse Event|0
947406|NCT01038609|1939627|FG004|Overall Study|Adverse Event|0
947407|NCT01038609|1939623|FG000|Overall Study|Dosing Error|0
947408|NCT01038609|1939624|FG001|Overall Study|Dosing Error|0
947409|NCT01038609|1939625|FG002|Overall Study|Dosing Error|0
947410|NCT01038609|1939626|FG003|Overall Study|Dosing Error|1
947411|NCT01038609|1939627|FG004|Overall Study|Dosing Error|1
947412|NCT01038609|1939623|FG000|Overall Study|Death in the Family|1
947413|NCT01038609|1939624|FG001|Overall Study|Death in the Family|0
947414|NCT01038609|1939625|FG002|Overall Study|Death in the Family|0
947415|NCT01038609|1939626|FG003|Overall Study|Death in the Family|0
947416|NCT01038609|1939627|FG004|Overall Study|Death in the Family|0
947417|NCT01038609|1939623|FG000|Overall Study|Refusal of Blood Draws|0
947418|NCT01038609|1939624|FG001|Overall Study|Refusal of Blood Draws|1
947419|NCT01038609|1939625|FG002|Overall Study|Refusal of Blood Draws|0
947420|NCT01038609|1939626|FG003|Overall Study|Refusal of Blood Draws|0
947421|NCT01038609|1939627|FG004|Overall Study|Refusal of Blood Draws|0
947422|NCT01038635|1939648|FG000|Overall Study|Disease Progression|2
947423|NCT01038635|1939649|FG001|Overall Study|Disease Progression|0
947424|NCT01038635|1939650|FG002|Overall Study|Disease Progression|0
947425|NCT01038635|1939651|FG003|Overall Study|Disease Progression|0
947426|NCT01038635|1939652|FG004|Overall Study|Disease Progression|0
947427|NCT01038635|1939653|FG005|Overall Study|Disease Progression|0
947428|NCT01038635|1939654|FG006|Overall Study|Disease Progression|1
947429|NCT01038635|1939655|FG007|Overall Study|Disease Progression|4
947430|NCT01038635|1939656|FG008|Overall Study|Disease Progression|0
947431|NCT01038635|1939648|FG000|Overall Study|Death|0
947432|NCT01038635|1939649|FG001|Overall Study|Death|0
947433|NCT01038635|1939650|FG002|Overall Study|Death|0
947434|NCT01038635|1939651|FG003|Overall Study|Death|0
947435|NCT01038635|1939652|FG004|Overall Study|Death|1
947436|NCT01038635|1939653|FG005|Overall Study|Death|0
947437|NCT01038635|1939654|FG006|Overall Study|Death|1
947438|NCT01038635|1939655|FG007|Overall Study|Death|1
947439|NCT01038635|1939656|FG008|Overall Study|Death|2
947440|NCT01038687|1939680|FG000|Overall Study|Adverse Event|0
947441|NCT01038687|1939681|FG001|Overall Study|Adverse Event|2
947442|NCT01038687|1939682|FG002|Overall Study|Adverse Event|1
947443|NCT01038713|1939693|FG000|Overall Study|Patient to hospice|1
947444|NCT01038713|1939694|FG001|Overall Study|Patient to hospice|1
947445|NCT01038713|1939695|FG002|Overall Study|Patient to hospice|1
947446|NCT01038713|1939693|FG000|Overall Study|Lost to Follow-up|3
947447|NCT01038713|1939694|FG001|Overall Study|Lost to Follow-up|0
947448|NCT01038713|1939695|FG002|Overall Study|Lost to Follow-up|0
947449|NCT01038713|1939693|FG000|Overall Study|Neuroendocrine Tumor|0
947450|NCT01038713|1939694|FG001|Overall Study|Neuroendocrine Tumor|1
947451|NCT01038713|1939695|FG002|Overall Study|Neuroendocrine Tumor|0
947452|NCT01038713|1939693|FG000|Overall Study|died from PEP|0
947453|NCT01038713|1939694|FG001|Overall Study|died from PEP|1
947454|NCT01038713|1939695|FG002|Overall Study|died from PEP|0
947455|NCT01038713|1939693|FG000|Overall Study|Autoimmune Pancreatitis|1
947456|NCT01038713|1939694|FG001|Overall Study|Autoimmune Pancreatitis|0
947457|NCT01038713|1939695|FG002|Overall Study|Autoimmune Pancreatitis|0
947458|NCT01038778|1939705|FG000|Overall Study|Withdrawal by Subject|0
947459|NCT01038778|1939706|FG001|Overall Study|Withdrawal by Subject|2
947460|NCT01038778|1939707|FG002|Overall Study|Withdrawal by Subject|3
947461|NCT01038856|1939714|FG000|Overall Study|Adverse Event|2
947462|NCT01038869|1939720|FG000|Overall Study|Withdrawal by Subject|1
947463|NCT01038869|1939720|FG000|Overall Study|Lost to Follow-up|6
947464|NCT01038921|1939730|FG000|Overall Study|Withdrawal by Subject|1
947465|NCT01038921|1939731|FG001|Overall Study|Withdrawal by Subject|0
947466|NCT01038921|1939730|FG000|Overall Study|Physician Decision|1
947467|NCT01038921|1939731|FG001|Overall Study|Physician Decision|0
947468|NCT01039376|1939743|FG000|Overall Study|Lost to Follow-up|5
947469|NCT01039376|1939744|FG001|Overall Study|Lost to Follow-up|12
947470|NCT01039376|1939743|FG000|Overall Study|Physician Decision|15
947471|NCT01039376|1939744|FG001|Overall Study|Physician Decision|10
947472|NCT01039376|1939743|FG000|Overall Study|Withdrawal by Subject|20
947473|NCT01039376|1939744|FG001|Overall Study|Withdrawal by Subject|32
947474|NCT01039376|1939743|FG000|Overall Study|Study terminated by Sponsor|90
947475|NCT01039376|1939744|FG001|Overall Study|Study terminated by Sponsor|72
947476|NCT01039428|1939753|FG000|Overall Study|Protocol Violation|1
947477|NCT01039428|1939754|FG001|Overall Study|Protocol Violation|0
947478|NCT01039428|1939753|FG000|Overall Study|Withdrawal by Subject|1
947479|NCT01039428|1939754|FG001|Overall Study|Withdrawal by Subject|0
947480|NCT01039519|1939771|FG000|Treatment|Progressive disease|20
947481|NCT01039519|1939771|FG000|Treatment|Treatment failure|2
947482|NCT01039519|1939771|FG000|Treatment|Adverse Event|3
947483|NCT01039519|1939771|FG000|Treatment|Physician Decision|2
947484|NCT01039519|1939771|FG000|Survival Follow-up|Death|23
947485|NCT01039519|1939771|FG000|Survival Follow-up|Sponsor decision|4
947486|NCT01039584|1939778|FG000|Overall Study|Withdrawal by Subject|4
947487|NCT01039584|1939779|FG001|Overall Study|Withdrawal by Subject|2
947488|NCT01039584|1939780|FG002|Overall Study|Withdrawal by Subject|1
947489|NCT01039584|1939778|FG000|Overall Study|Protocol Violation|10
947490|NCT01039584|1939779|FG001|Overall Study|Protocol Violation|4
947491|NCT01039584|1939780|FG002|Overall Study|Protocol Violation|6
947492|NCT01039584|1939778|FG000|Overall Study|Lost to Follow-up|5
947493|NCT01039584|1939779|FG001|Overall Study|Lost to Follow-up|3
947494|NCT01039584|1939780|FG002|Overall Study|Lost to Follow-up|4
947495|NCT01039584|1939778|FG000|Overall Study|Negative Baseline culture for Candida|59
947496|NCT01039584|1939779|FG001|Overall Study|Negative Baseline culture for Candida|59
947497|NCT01039584|1939780|FG002|Overall Study|Negative Baseline culture for Candida|24
947498|NCT01039584|1939778|FG000|Overall Study|Lack of Efficacy|7
947499|NCT01039584|1939779|FG001|Overall Study|Lack of Efficacy|6
947500|NCT01039584|1939780|FG002|Overall Study|Lack of Efficacy|10
947501|NCT01039584|1939778|FG000|Overall Study|other|1
947502|NCT01039584|1939779|FG001|Overall Study|other|3
947503|NCT01039584|1939780|FG002|Overall Study|other|1
947504|NCT01039584|1939778|FG000|Overall Study|Pap smear with significant pathology|10
947505|NCT01039584|1939779|FG001|Overall Study|Pap smear with significant pathology|10
947506|NCT01039584|1939780|FG002|Overall Study|Pap smear with significant pathology|3
947507|NCT01039584|1939778|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7
947508|NCT01039584|1939779|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10
947509|NCT01039584|1939780|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8
947510|NCT01039675|1939790|FG000|Overall Study|Adverse Event|0
947511|NCT01039675|1939791|FG001|Overall Study|Adverse Event|2
947512|NCT01039675|1939790|FG000|Overall Study|Lack of Efficacy|0
947513|NCT01039675|1939791|FG001|Overall Study|Lack of Efficacy|2
947514|NCT01039675|1939790|FG000|Overall Study|Withdrawal by Subject|0
947515|NCT01039675|1939791|FG001|Overall Study|Withdrawal by Subject|1
947516|NCT01039675|1939790|FG000|Overall Study|Lost to Follow-up|0
947517|NCT01039675|1939791|FG001|Overall Study|Lost to Follow-up|1
947518|NCT01039675|1939790|FG000|Overall Study|Physician Decision|0
947519|NCT01039675|1939791|FG001|Overall Study|Physician Decision|1
947520|NCT01039688|1939800|FG000|Overall Study|Adverse Event|38
947521|NCT01039688|1939801|FG001|Overall Study|Adverse Event|39
947522|NCT01039688|1939802|FG002|Overall Study|Adverse Event|24
947523|NCT01039688|1939800|FG000|Overall Study|Lack of Efficacy|20
947524|NCT01039688|1939801|FG001|Overall Study|Lack of Efficacy|11
947525|NCT01039688|1939802|FG002|Overall Study|Lack of Efficacy|26
947526|NCT01039688|1939800|FG000|Overall Study|Lost to Follow-up|11
947527|NCT01039688|1939801|FG001|Overall Study|Lost to Follow-up|9
947528|NCT01039688|1939802|FG002|Overall Study|Lost to Follow-up|5
947529|NCT01039688|1939800|FG000|Overall Study|Other|13
947530|NCT01039688|1939801|FG001|Overall Study|Other|25
947531|NCT01039688|1939802|FG002|Overall Study|Other|12
947532|NCT01039688|1939800|FG000|Overall Study|Withdrawal by Subject|23
947533|NCT01039688|1939801|FG001|Overall Study|Withdrawal by Subject|27
947534|NCT01039688|1939802|FG002|Overall Study|Withdrawal by Subject|13
947535|NCT01039688|1939800|FG000|Overall Study|Death|2
947536|NCT01039688|1939801|FG001|Overall Study|Death|0
947537|NCT01039688|1939802|FG002|Overall Study|Death|0
947538|NCT01040130|1939826|FG000|Overall Study|Adverse Event|1
947539|NCT01040130|1939827|FG001|Overall Study|Adverse Event|1
947540|NCT01040130|1939828|FG002|Overall Study|Adverse Event|0
947541|NCT01040130|1939829|FG003|Overall Study|Adverse Event|5
947542|NCT01040130|1939830|FG004|Overall Study|Adverse Event|0
947543|NCT01040130|1939831|FG005|Overall Study|Adverse Event|3
947544|NCT01040130|1939826|FG000|Overall Study|Protocol Violation|0
947545|NCT01040130|1939827|FG001|Overall Study|Protocol Violation|0
947546|NCT01040130|1939828|FG002|Overall Study|Protocol Violation|2
947547|NCT01040130|1939829|FG003|Overall Study|Protocol Violation|0
947548|NCT01040130|1939830|FG004|Overall Study|Protocol Violation|0
947549|NCT01040130|1939831|FG005|Overall Study|Protocol Violation|0
947550|NCT01040130|1939826|FG000|Overall Study|Withdrawal by Subject|0
947551|NCT01040130|1939827|FG001|Overall Study|Withdrawal by Subject|2
947552|NCT01040130|1939828|FG002|Overall Study|Withdrawal by Subject|0
947553|NCT01040130|1939829|FG003|Overall Study|Withdrawal by Subject|0
947554|NCT01040130|1939830|FG004|Overall Study|Withdrawal by Subject|0
947555|NCT01040130|1939831|FG005|Overall Study|Withdrawal by Subject|1
947556|NCT01040130|1939826|FG000|Overall Study|Other reasons not listed above|2
947557|NCT01040130|1939827|FG001|Overall Study|Other reasons not listed above|0
947558|NCT01040130|1939828|FG002|Overall Study|Other reasons not listed above|0
947559|NCT01040130|1939829|FG003|Overall Study|Other reasons not listed above|0
947560|NCT01040130|1939830|FG004|Overall Study|Other reasons not listed above|0
947561|NCT01040130|1939831|FG005|Overall Study|Other reasons not listed above|0
947562|NCT01040169|1939843|FG000|Overall Study|Lost to Follow-up|3
947563|NCT01040169|1939844|FG001|Overall Study|Lost to Follow-up|8
947564|NCT01040260|1939870|FG000|Overall Study|Withdrawal by Subject|12
947565|NCT01040260|1939871|FG001|Overall Study|Withdrawal by Subject|6
947566|NCT01040260|1939870|FG000|Overall Study|Lost to Follow-up|3
947567|NCT01040260|1939871|FG001|Overall Study|Lost to Follow-up|5
947568|NCT01040351|1939879|FG000|Overall Study|poor ovarian response|1
947569|NCT01040351|1939880|FG001|Overall Study|poor ovarian response|2
947570|NCT01040403|1939886|FG000|Overall Study|Adverse Event|10
947571|NCT01040403|1939886|FG000|Overall Study|Protocol Violation|2
947572|NCT01040403|1939886|FG000|Overall Study|Lost to Follow-up|1
947573|NCT01040403|1939886|FG000|Overall Study|Not treated|1
947574|NCT01040403|1939886|FG000|Overall Study|Other reason not defined above|6
947575|NCT01040689|1939914|FG000|Overall Study|Adverse Event|0
947576|NCT01040689|1939915|FG001|Overall Study|Adverse Event|0
947577|NCT01040689|1939916|FG002|Overall Study|Adverse Event|2
947578|NCT01040689|1939917|FG003|Overall Study|Adverse Event|4
947579|NCT01040689|1939914|FG000|Overall Study|Lack of Efficacy|0
947580|NCT01040689|1939915|FG001|Overall Study|Lack of Efficacy|0
947581|NCT01040689|1939916|FG002|Overall Study|Lack of Efficacy|1
947582|NCT01040689|1939917|FG003|Overall Study|Lack of Efficacy|0
947583|NCT01040689|1939914|FG000|Overall Study|Lost to Follow-up|1
947584|NCT01040689|1939915|FG001|Overall Study|Lost to Follow-up|0
947585|NCT01040689|1939916|FG002|Overall Study|Lost to Follow-up|0
947586|NCT01040689|1939917|FG003|Overall Study|Lost to Follow-up|0
947587|NCT01040689|1939914|FG000|Overall Study|Withdrawal by Subject|2
947588|NCT01040689|1939915|FG001|Overall Study|Withdrawal by Subject|1
947589|NCT01040689|1939916|FG002|Overall Study|Withdrawal by Subject|1
947590|NCT01040689|1939917|FG003|Overall Study|Withdrawal by Subject|0
947591|NCT01040689|1939914|FG000|Overall Study|Other reasons not listed above|0
947592|NCT01040689|1939915|FG001|Overall Study|Other reasons not listed above|1
947593|NCT01040689|1939916|FG002|Overall Study|Other reasons not listed above|0
947594|NCT01040689|1939917|FG003|Overall Study|Other reasons not listed above|0
947595|NCT01040728|1939932|FG000|Overall Study|Adverse Event|4
947596|NCT01040728|1939933|FG001|Overall Study|Adverse Event|8
947597|NCT01040728|1939934|FG002|Overall Study|Adverse Event|0
947598|NCT01040728|1939935|FG003|Overall Study|Adverse Event|4
947599|NCT01040728|1939932|FG000|Overall Study|Withdrawal by Subject|0
947600|NCT01040728|1939933|FG001|Overall Study|Withdrawal by Subject|1
947601|NCT01040728|1939934|FG002|Overall Study|Withdrawal by Subject|1
947602|NCT01040728|1939935|FG003|Overall Study|Withdrawal by Subject|0
947603|NCT01040728|1939932|FG000|Overall Study|Protocol Violation|0
947604|NCT01040728|1939933|FG001|Overall Study|Protocol Violation|0
947605|NCT01040728|1939934|FG002|Overall Study|Protocol Violation|0
947606|NCT01040728|1939935|FG003|Overall Study|Protocol Violation|1
947607|NCT01040728|1939932|FG000|Overall Study|Lack of Efficacy|0
947608|NCT01040728|1939933|FG001|Overall Study|Lack of Efficacy|1
947609|NCT01040728|1939934|FG002|Overall Study|Lack of Efficacy|0
947610|NCT01040728|1939935|FG003|Overall Study|Lack of Efficacy|1
947611|NCT01040728|1939932|FG000|Overall Study|Other reasons not listed above|0
947612|NCT01040728|1939933|FG001|Overall Study|Other reasons not listed above|1
947613|NCT01040728|1939934|FG002|Overall Study|Other reasons not listed above|0
947614|NCT01040728|1939935|FG003|Overall Study|Other reasons not listed above|0
947615|NCT01040780|1939953|FG000|Overall Study|Protocol Violation|1
947616|NCT01040780|1939954|FG001|Overall Study|Protocol Violation|3
947617|NCT01040793|1939963|FG000|Overall Study|Adverse Event|5
947618|NCT01040793|1939964|FG001|Overall Study|Adverse Event|3
947619|NCT01040793|1939965|FG002|Overall Study|Adverse Event|0
947620|NCT01040793|1939966|FG003|Overall Study|Adverse Event|2
947621|NCT01040793|1939967|FG004|Overall Study|Adverse Event|2
947622|NCT01040793|1939968|FG005|Overall Study|Adverse Event|1
947623|NCT01040793|1939963|FG000|Overall Study|Protocol Violation|1
947624|NCT01040793|1939964|FG001|Overall Study|Protocol Violation|1
947625|NCT01040793|1939965|FG002|Overall Study|Protocol Violation|1
947626|NCT01040793|1939966|FG003|Overall Study|Protocol Violation|0
947627|NCT01040793|1939967|FG004|Overall Study|Protocol Violation|1
947628|NCT01040793|1939968|FG005|Overall Study|Protocol Violation|0
947629|NCT01040793|1939963|FG000|Overall Study|Lost to Follow-up|0
947630|NCT01040793|1939964|FG001|Overall Study|Lost to Follow-up|1
947631|NCT01040793|1939965|FG002|Overall Study|Lost to Follow-up|1
947632|NCT01040793|1939966|FG003|Overall Study|Lost to Follow-up|0
947633|NCT01040793|1939967|FG004|Overall Study|Lost to Follow-up|0
947634|NCT01040793|1939968|FG005|Overall Study|Lost to Follow-up|0
947635|NCT01040793|1939963|FG000|Overall Study|Withdrawal by Subject|0
947636|NCT01040793|1939964|FG001|Overall Study|Withdrawal by Subject|0
947637|NCT01040793|1939965|FG002|Overall Study|Withdrawal by Subject|0
947638|NCT01040793|1939966|FG003|Overall Study|Withdrawal by Subject|2
947639|NCT01040793|1939967|FG004|Overall Study|Withdrawal by Subject|0
947640|NCT01040793|1939968|FG005|Overall Study|Withdrawal by Subject|0
947641|NCT01040793|1939963|FG000|Overall Study|Other reasons not listed above|0
947642|NCT01040793|1939964|FG001|Overall Study|Other reasons not listed above|0
947643|NCT01040793|1939965|FG002|Overall Study|Other reasons not listed above|1
947644|NCT01040793|1939966|FG003|Overall Study|Other reasons not listed above|0
947645|NCT01040793|1939967|FG004|Overall Study|Other reasons not listed above|1
947646|NCT01040793|1939968|FG005|Overall Study|Other reasons not listed above|0
947647|NCT01040832|1939989|FG000|Overall Study|Adverse Event|4
947648|NCT01040832|1939990|FG001|Overall Study|Adverse Event|5
947649|NCT01040832|1939989|FG000|Overall Study|Death|4
947650|NCT01040832|1939990|FG001|Overall Study|Death|6
947651|NCT01040832|1939989|FG000|Overall Study|Withdrawal by Subject|2
947652|NCT01040832|1939990|FG001|Overall Study|Withdrawal by Subject|3
947653|NCT01040832|1939989|FG000|Overall Study|Progressive disease|32
947654|NCT01040832|1939990|FG001|Overall Study|Progressive disease|17
947655|NCT01040832|1939989|FG000|Overall Study|Symptomatic deterioration|2
947656|NCT01040832|1939990|FG001|Overall Study|Symptomatic deterioration|5
947657|NCT01040832|1939989|FG000|Overall Study|Other|2
947658|NCT01040832|1939990|FG001|Overall Study|Other|1
947659|NCT01040845|1939998|FG000|Overall Study|Withdrawal by Subject|1
947660|NCT01040845|1939999|FG001|Overall Study|Withdrawal by Subject|1
947661|NCT01040845|1939998|FG000|Overall Study|Physician Decision|1
947662|NCT01040845|1939999|FG001|Overall Study|Physician Decision|0
947663|NCT01040871|1940021|FG000|Overall Study|Adverse Event|6
947664|NCT01040871|1940022|FG001|Overall Study|Adverse Event|2
947665|NCT01040871|1940021|FG000|Overall Study|Withdrawal by Subject|2
947666|NCT01040871|1940022|FG001|Overall Study|Withdrawal by Subject|0
947667|NCT01040871|1940021|FG000|Overall Study|Death|1
947668|NCT01040871|1940022|FG001|Overall Study|Death|3
947669|NCT01040871|1940021|FG000|Overall Study|Lack of Efficacy|1
947670|NCT01040871|1940022|FG001|Overall Study|Lack of Efficacy|1
947671|NCT01040871|1940021|FG000|Overall Study|drug supply issue|1
947672|NCT01040871|1940022|FG001|Overall Study|drug supply issue|0
947673|NCT01040871|1940021|FG000|Overall Study|Randomized and Not Treated|2
947674|NCT01040871|1940022|FG001|Overall Study|Randomized and Not Treated|1
947675|NCT01041287|1940054|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3
947676|NCT01041287|1940055|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3
947677|NCT01041287|1940054|FG000|Treatment Period 2 (3 Months)|Adverse Event|0
947678|NCT01041287|1940055|FG001|Treatment Period 2 (3 Months)|Adverse Event|2
947679|NCT01041404|1940063|FG000|Overall Study|Adverse Event|45
947680|NCT01041404|1940064|FG001|Overall Study|Adverse Event|35
947681|NCT01041404|1940063|FG000|Overall Study|Lack of Efficacy|200
947682|NCT01041404|1940064|FG001|Overall Study|Lack of Efficacy|210
947683|NCT01041404|1940063|FG000|Overall Study|Violation of Selection Criteria|0
947684|NCT01041404|1940064|FG001|Overall Study|Violation of Selection Criteria|1
947685|NCT01041404|1940063|FG000|Overall Study|Protocol Violation|4
947686|NCT01041404|1940064|FG001|Overall Study|Protocol Violation|0
947687|NCT01041404|1940063|FG000|Overall Study|Withdrawal by Subject|29
947688|NCT01041404|1940064|FG001|Overall Study|Withdrawal by Subject|23
947689|NCT01041404|1940063|FG000|Overall Study|Failure to Return|1
947690|NCT01041404|1940064|FG001|Overall Study|Failure to Return|2
947691|NCT01041404|1940063|FG000|Overall Study|Other|11
947692|NCT01041404|1940064|FG001|Overall Study|Other|23
947693|NCT01041417|1940075|FG000|Overall Study|Adverse Event|5
947694|NCT01041417|1940076|FG001|Overall Study|Adverse Event|2
947695|NCT01041417|1940075|FG000|Overall Study|Lost to Follow-up|1
947696|NCT01041417|1940076|FG001|Overall Study|Lost to Follow-up|1
947697|NCT01041417|1940075|FG000|Overall Study|Death|1
947698|NCT01041417|1940076|FG001|Overall Study|Death|0
947699|NCT01041495|1940086|FG000|Overall Study|Withdrawal by Subject|2
947700|NCT01041495|1940087|FG001|Overall Study|Withdrawal by Subject|5
947701|NCT01041495|1940086|FG000|Overall Study|Adverse Event|2
947702|NCT01041495|1940087|FG001|Overall Study|Adverse Event|1
947703|NCT01041495|1940086|FG000|Overall Study|Lost to Follow-up|0
947704|NCT01041495|1940087|FG001|Overall Study|Lost to Follow-up|1
947705|NCT01041573|1940106|FG000|Overall Study|Withdrawal by Subject|2
947706|NCT01041573|1940107|FG001|Overall Study|Withdrawal by Subject|5
947707|NCT01041573|1940108|FG002|Overall Study|Withdrawal by Subject|2
947708|NCT01041573|1940109|FG003|Overall Study|Withdrawal by Subject|0
947709|NCT01041573|1940106|FG000|Overall Study|Death|1
947710|NCT01041573|1940107|FG001|Overall Study|Death|0
947711|NCT01041573|1940108|FG002|Overall Study|Death|0
947712|NCT01041573|1940109|FG003|Overall Study|Death|0
947713|NCT01041573|1940106|FG000|Overall Study|Lost to Follow-up|0
947714|NCT01041573|1940107|FG001|Overall Study|Lost to Follow-up|1
947715|NCT01041573|1940108|FG002|Overall Study|Lost to Follow-up|2
947716|NCT01041573|1940109|FG003|Overall Study|Lost to Follow-up|1
947717|NCT01041573|1940106|FG000|Overall Study|Adverse Event|0
947718|NCT01041573|1940107|FG001|Overall Study|Adverse Event|2
947719|NCT01041573|1940108|FG002|Overall Study|Adverse Event|0
947720|NCT01041573|1940109|FG003|Overall Study|Adverse Event|0
947721|NCT01041573|1940106|FG000|Overall Study|relocation|1
947722|NCT01041573|1940107|FG001|Overall Study|relocation|4
947723|NCT01041573|1940108|FG002|Overall Study|relocation|3
947724|NCT01041573|1940109|FG003|Overall Study|relocation|1
947725|NCT01041573|1940106|FG000|Overall Study|further blood extraction|0
947726|NCT01041573|1940107|FG001|Overall Study|further blood extraction|1
947727|NCT01041573|1940108|FG002|Overall Study|further blood extraction|0
947728|NCT01041573|1940109|FG003|Overall Study|further blood extraction|0
947729|NCT01041573|1940106|FG000|Overall Study|positive to anti-HCV|1
947730|NCT01041573|1940107|FG001|Overall Study|positive to anti-HCV|0
947731|NCT01041573|1940108|FG002|Overall Study|positive to anti-HCV|0
947732|NCT01041573|1940109|FG003|Overall Study|positive to anti-HCV|0
947733|NCT01041638|1940128|FG000|Overall Study|Adverse Event|4
947734|NCT01041638|1940128|FG000|Overall Study|Death|1
947735|NCT01041638|1940128|FG000|Overall Study|Lack of Efficacy|7
947736|NCT01041638|1940128|FG000|Overall Study|Physician Decision|4
947737|NCT01041638|1940128|FG000|Overall Study|Withdrawal by Subject|11
947738|NCT01041859|1940151|FG000|Open-Label Titration|Adverse Event|69
947739|NCT01041859|1940152|FG001|Open-Label Titration|Adverse Event|0
947740|NCT01041859|1940153|FG002|Open-Label Titration|Adverse Event|0
947741|NCT01041859|1940151|FG000|Open-Label Titration|Lack of Efficacy|3
947742|NCT01041859|1940152|FG001|Open-Label Titration|Lack of Efficacy|0
947743|NCT01041859|1940153|FG002|Open-Label Titration|Lack of Efficacy|0
947744|NCT01041859|1940151|FG000|Open-Label Titration|Lost to Follow-up|1
947745|NCT01041859|1940152|FG001|Open-Label Titration|Lost to Follow-up|0
947746|NCT01041859|1940153|FG002|Open-Label Titration|Lost to Follow-up|0
947747|NCT01041859|1940151|FG000|Open-Label Titration|Physician Decision|1
947748|NCT01041859|1940152|FG001|Open-Label Titration|Physician Decision|0
947749|NCT01041859|1940153|FG002|Open-Label Titration|Physician Decision|0
947750|NCT01041859|1940151|FG000|Open-Label Titration|Protocol Violation|1
947751|NCT01041859|1940152|FG001|Open-Label Titration|Protocol Violation|0
947752|NCT01041859|1940153|FG002|Open-Label Titration|Protocol Violation|0
947753|NCT01041859|1940151|FG000|Open-Label Titration|Other|7
947754|NCT01041859|1940152|FG001|Open-Label Titration|Other|0
947755|NCT01041859|1940153|FG002|Open-Label Titration|Other|0
947756|NCT01041859|1940151|FG000|Open-Label Titration|Noncompliance With Study Drug|8
947757|NCT01041859|1940152|FG001|Open-Label Titration|Noncompliance With Study Drug|0
947758|NCT01041859|1940153|FG002|Open-Label Titration|Noncompliance With Study Drug|0
947759|NCT01041859|1940151|FG000|Open-Label Titration|Withdrawal by Subject|11
947760|NCT01041859|1940152|FG001|Open-Label Titration|Withdrawal by Subject|0
947761|NCT01041859|1940153|FG002|Open-Label Titration|Withdrawal by Subject|0
947762|NCT01041859|1940151|FG000|Double-Blind Maintenance|Adverse Event|0
947763|NCT01041859|1940152|FG001|Double-Blind Maintenance|Adverse Event|23
947764|NCT01041859|1940153|FG002|Double-Blind Maintenance|Adverse Event|13
947765|NCT01041859|1940151|FG000|Double-Blind Maintenance|Lack of Efficacy|0
947766|NCT01041859|1940152|FG001|Double-Blind Maintenance|Lack of Efficacy|3
947767|NCT01041859|1940153|FG002|Double-Blind Maintenance|Lack of Efficacy|11
947768|NCT01041859|1940151|FG000|Double-Blind Maintenance|Lost to Follow-up|0
947769|NCT01041859|1940152|FG001|Double-Blind Maintenance|Lost to Follow-up|1
947770|NCT01041859|1940153|FG002|Double-Blind Maintenance|Lost to Follow-up|0
947771|NCT01041859|1940151|FG000|Double-Blind Maintenance|Physician Decision|0
947772|NCT01041859|1940152|FG001|Double-Blind Maintenance|Physician Decision|2
947773|NCT01041859|1940153|FG002|Double-Blind Maintenance|Physician Decision|1
947774|NCT01041859|1940151|FG000|Double-Blind Maintenance|Protocol Violation|0
947775|NCT01041859|1940152|FG001|Double-Blind Maintenance|Protocol Violation|1
947776|NCT01041859|1940153|FG002|Double-Blind Maintenance|Protocol Violation|3
947777|NCT01041859|1940151|FG000|Double-Blind Maintenance|Other|0
947778|NCT01041859|1940152|FG001|Double-Blind Maintenance|Other|6
947779|NCT01041859|1940153|FG002|Double-Blind Maintenance|Other|2
947780|NCT01041859|1940151|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0
947781|NCT01041859|1940152|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2
947782|NCT01041859|1940153|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6
947783|NCT01041859|1940151|FG000|Double-Blind Maintenance|Withdrawal by Subject|0
947784|NCT01041859|1940152|FG001|Double-Blind Maintenance|Withdrawal by Subject|8
947785|NCT01041859|1940153|FG002|Double-Blind Maintenance|Withdrawal by Subject|9
947786|NCT01041976|1940162|FG000|Overall Study|Withdrawal by Subject|3
947787|NCT01041976|1940163|FG001|Overall Study|Withdrawal by Subject|0
947788|NCT01041976|1940162|FG000|Overall Study|Incarceration|2
947789|NCT01041976|1940163|FG001|Overall Study|Incarceration|0
947790|NCT01041976|1940162|FG000|Overall Study|Death|0
947791|NCT01041976|1940163|FG001|Overall Study|Death|4
947792|NCT01042093|1940173|FG000|Overall Study|Protocol Violation|2
947793|NCT01042093|1940174|FG001|Overall Study|Protocol Violation|2
947794|NCT01042093|1940175|FG002|Overall Study|Protocol Violation|2
947795|NCT01042093|1940176|FG003|Overall Study|Protocol Violation|3
947796|NCT01042093|1940173|FG000|Overall Study|Withdrawal by Subject|0
947797|NCT01042093|1940174|FG001|Overall Study|Withdrawal by Subject|0
947798|NCT01042093|1940175|FG002|Overall Study|Withdrawal by Subject|0
947799|NCT01042093|1940176|FG003|Overall Study|Withdrawal by Subject|1
947800|NCT01042158|1940198|FG000|Overall Study|Physician Decision|1
947801|NCT01042236|1940202|FG000|Treatment Period 1|Adverse Event|0
947802|NCT01042236|1940203|FG001|Treatment Period 1|Adverse Event|1
947803|NCT01042236|1940204|FG002|Treatment Period 1|Adverse Event|0
947804|NCT01042236|1940205|FG003|Treatment Period 1|Adverse Event|0
947805|NCT01042236|1940206|FG004|Treatment Period 1|Adverse Event|1
947806|NCT01042236|1940207|FG005|Treatment Period 1|Adverse Event|0
947807|NCT01042236|1940202|FG000|Treatment Period 3|Adverse Event|0
947808|NCT01042236|1940203|FG001|Treatment Period 3|Adverse Event|0
947809|NCT01042236|1940204|FG002|Treatment Period 3|Adverse Event|0
947810|NCT01042236|1940205|FG003|Treatment Period 3|Adverse Event|1
947811|NCT01042236|1940206|FG004|Treatment Period 3|Adverse Event|0
947812|NCT01042236|1940207|FG005|Treatment Period 3|Adverse Event|0
947813|NCT01042236|1940202|FG000|Treatment Period 3|Protocol Violation|0
947814|NCT01042236|1940203|FG001|Treatment Period 3|Protocol Violation|0
947815|NCT01042236|1940204|FG002|Treatment Period 3|Protocol Violation|0
947816|NCT01042236|1940205|FG003|Treatment Period 3|Protocol Violation|1
947817|NCT01042236|1940206|FG004|Treatment Period 3|Protocol Violation|0
947818|NCT01042236|1940207|FG005|Treatment Period 3|Protocol Violation|0
947819|NCT01042392|1940232|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
947820|NCT01042392|1940233|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
947821|NCT01042392|1940234|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
947822|NCT01042392|1940235|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
947823|NCT01042392|1940232|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
947824|NCT01042392|1940233|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
947825|NCT01042392|1940234|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
947826|NCT01042392|1940235|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
947827|NCT01042392|1940232|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
947828|NCT01042392|1940233|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
947829|NCT01042392|1940234|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
947830|NCT01042392|1940235|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
947831|NCT01042392|1940232|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
947832|NCT01042392|1940233|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
947833|NCT01042392|1940234|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
947834|NCT01042392|1940235|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
947835|NCT01042392|1940232|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
947836|NCT01042392|1940233|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
947837|NCT01042392|1940234|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
947838|NCT01042392|1940235|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
947839|NCT01042392|1940232|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
947840|NCT01042392|1940233|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
947841|NCT01042392|1940234|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
947842|NCT01042392|1940235|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
947843|NCT01042392|1940232|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
947844|NCT01042392|1940233|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
947845|NCT01042392|1940234|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
947846|NCT01042392|1940235|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
947847|NCT01042392|1940232|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
947848|NCT01042392|1940233|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
947849|NCT01042392|1940234|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
947850|NCT01042392|1940235|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
947851|NCT01042392|1940232|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
947852|NCT01042392|1940233|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
947853|NCT01042392|1940234|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
947854|NCT01042392|1940235|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
947855|NCT01042535|1940264|FG000|Overall Study|disease progression prior to treatment|3
947856|NCT01042535|1940264|FG000|Overall Study|disease progression during treatment|3
947857|NCT01042535|1940264|FG000|Overall Study|complications from other disease|2
947858|NCT01042600|1940270|FG000|Overall Study|Ineligible|1
947859|NCT01042600|1940271|FG001|Overall Study|Ineligible|0
947860|NCT01042678|1940290|FG000|Overall Study|Physician Decision|1
947861|NCT01042678|1940291|FG001|Overall Study|Physician Decision|0
947862|NCT01042678|1940292|FG002|Overall Study|Physician Decision|0
947863|NCT01042678|1940293|FG003|Overall Study|Physician Decision|0
947864|NCT01042678|1940294|FG004|Overall Study|Physician Decision|0
947865|NCT01042678|1940295|FG005|Overall Study|Physician Decision|0
947866|NCT01042938|1940309|FG000|Overall Study|Withdrawal by Subject|1
947867|NCT01042938|1940310|FG001|Overall Study|Withdrawal by Subject|1
947868|NCT01042938|1940309|FG000|Overall Study|Protocol Violation|1
947869|NCT01042938|1940310|FG001|Overall Study|Protocol Violation|1
947870|NCT01042938|1940309|FG000|Overall Study|Ineligible: RTOG study conflict|1
947871|NCT01042938|1940310|FG001|Overall Study|Ineligible: RTOG study conflict|0
947872|NCT01042977|1940320|FG000|Overall Study|Adverse Event|4
947873|NCT01042977|1940321|FG001|Overall Study|Adverse Event|12
947874|NCT01042977|1940320|FG000|Overall Study|Death|2
947875|NCT01042977|1940321|FG001|Overall Study|Death|1
947876|NCT01042977|1940320|FG000|Overall Study|Withdrawal by Subject|8
947877|NCT01042977|1940321|FG001|Overall Study|Withdrawal by Subject|16
947878|NCT01042977|1940320|FG000|Overall Study|Lost to Follow-up|0
947879|NCT01042977|1940321|FG001|Overall Study|Lost to Follow-up|2
947880|NCT01042977|1940320|FG000|Overall Study|Poor/non-compliance|3
947881|NCT01042977|1940321|FG001|Overall Study|Poor/non-compliance|4
947882|NCT01042977|1940320|FG000|Overall Study|Subject no longer meets study criteria|15
947883|NCT01042977|1940321|FG001|Overall Study|Subject no longer meets study criteria|13
947884|NCT01042977|1940320|FG000|Overall Study|Incorrect enrollment|6
947885|NCT01042977|1940321|FG001|Overall Study|Incorrect enrollment|4
947886|NCT01042977|1940320|FG000|Overall Study|Safety|0
947887|NCT01042977|1940321|FG001|Overall Study|Safety|2
947888|NCT01042977|1940320|FG000|Overall Study|Administrative reason by sponsor|0
947889|NCT01042977|1940321|FG001|Overall Study|Administrative reason by sponsor|1
947890|NCT01042977|1940320|FG000|Overall Study|Various|3
947891|NCT01042977|1940321|FG001|Overall Study|Various|0
947892|NCT01043185|1940370|FG000|Period 6 - Third Washout Period|Protocol Violation|0
947893|NCT01043185|1940371|FG001|Period 6 - Third Washout Period|Protocol Violation|0
947894|NCT01043185|1940372|FG002|Period 6 - Third Washout Period|Protocol Violation|0
947895|NCT01043185|1940373|FG003|Period 6 - Third Washout Period|Protocol Violation|0
947896|NCT01043185|1940374|FG004|Period 6 - Third Washout Period|Protocol Violation|0
947897|NCT01043185|1940375|FG005|Period 6 - Third Washout Period|Protocol Violation|0
947898|NCT01043185|1940376|FG006|Period 6 - Third Washout Period|Protocol Violation|0
947899|NCT01043185|1940377|FG007|Period 6 - Third Washout Period|Protocol Violation|0
947900|NCT01043185|1940378|FG008|Period 6 - Third Washout Period|Protocol Violation|1
947901|NCT01043185|1940379|FG009|Period 6 - Third Washout Period|Protocol Violation|0
947902|NCT01043705|1940440|FG000|Overall Study|Death|28
947903|NCT01043705|1940441|FG001|Overall Study|Death|60
947904|NCT01043705|1940442|FG002|Overall Study|Death|26
947905|NCT01043705|1940440|FG000|Overall Study|Lost to Follow-up|27
947906|NCT01043705|1940441|FG001|Overall Study|Lost to Follow-up|12
947907|NCT01043705|1940442|FG002|Overall Study|Lost to Follow-up|0
947908|NCT01043705|1940440|FG000|Overall Study|Multiple Reasons|4
947909|NCT01043705|1940441|FG001|Overall Study|Multiple Reasons|7
947910|NCT01043705|1940442|FG002|Overall Study|Multiple Reasons|0
947911|NCT01043705|1940440|FG000|Overall Study|Protocol Violation|2
947912|NCT01043705|1940441|FG001|Overall Study|Protocol Violation|1
947913|NCT01043705|1940442|FG002|Overall Study|Protocol Violation|0
947914|NCT01043705|1940440|FG000|Overall Study|Withdrawal by Subject|8
947915|NCT01043705|1940441|FG001|Overall Study|Withdrawal by Subject|6
947916|NCT01043705|1940442|FG002|Overall Study|Withdrawal by Subject|0
947917|NCT01043705|1940440|FG000|Overall Study|Site Closure|8
947918|NCT01043705|1940441|FG001|Overall Study|Site Closure|0
947919|NCT01043705|1940442|FG002|Overall Study|Site Closure|0
947920|NCT01043705|1940440|FG000|Overall Study|Subsequent Procedure|9
947921|NCT01043705|1940441|FG001|Overall Study|Subsequent Procedure|24
947922|NCT01043705|1940442|FG002|Overall Study|Subsequent Procedure|29
947923|NCT01043705|1940440|FG000|Overall Study|Adverse Event|0
947924|NCT01043705|1940441|FG001|Overall Study|Adverse Event|2
947925|NCT01043705|1940442|FG002|Overall Study|Adverse Event|0
947926|NCT01043705|1940440|FG000|Overall Study|Screen Fail|21
947927|NCT01043705|1940441|FG001|Overall Study|Screen Fail|0
947928|NCT01043705|1940442|FG002|Overall Study|Screen Fail|0
947929|NCT01043705|1940440|FG000|Overall Study|Other|0
947930|NCT01043705|1940441|FG001|Overall Study|Other|19
947931|NCT01043705|1940442|FG002|Overall Study|Other|25
947932|NCT01043874|1940450|FG000|Overall Study|Adverse Event|3
947933|NCT01043874|1940450|FG000|Overall Study|Withdrawal by Subject|1
947934|NCT01043874|1940450|FG000|Overall Study|Lack of Efficacy|1
947935|NCT01043874|1940450|FG000|Overall Study|Administrative Problems|1
947936|NCT01044290|1940522|FG000|Follow-up 1|Death|3
947937|NCT01044290|1940523|FG001|Follow-up 1|Death|3
947938|NCT01044290|1940524|FG002|Follow-up 1|Death|1
947939|NCT01044290|1940522|FG000|Follow-up 1|Withdrawal by Subject|2
947940|NCT01044290|1940523|FG001|Follow-up 1|Withdrawal by Subject|2
947941|NCT01044290|1940524|FG002|Follow-up 1|Withdrawal by Subject|0
947942|NCT01044290|1940522|FG000|Follow-Up 2|Death|0
947943|NCT01044290|1940523|FG001|Follow-Up 2|Death|1
947944|NCT01044290|1940524|FG002|Follow-Up 2|Death|1
947945|NCT01044290|1940522|FG000|Follow-Up 2|Withdrawal by Subject|0
947946|NCT01044290|1940523|FG001|Follow-Up 2|Withdrawal by Subject|1
947947|NCT01044290|1940524|FG002|Follow-Up 2|Withdrawal by Subject|1
947948|NCT01044303|1940542|FG000|Overall Study|Lost to Follow-up|2
947949|NCT01044433|1940549|FG000|Overall Study|Lost to Follow-up|3
947950|NCT01044433|1940549|FG000|Overall Study|Withdrawal by Subject|3
947951|NCT01044459|1940556|FG000|Overall Study|Withdrawal by Subject|21
947952|NCT01044459|1940557|FG001|Overall Study|Withdrawal by Subject|28
947953|NCT01044459|1940556|FG000|Overall Study|Terminated by Sponsor|22
947954|NCT01044459|1940557|FG001|Overall Study|Terminated by Sponsor|21
947955|NCT01044459|1940556|FG000|Overall Study|Adverse Event|22
947956|NCT01044459|1940557|FG001|Overall Study|Adverse Event|20
947957|NCT01044459|1940556|FG000|Overall Study|Lack of Efficacy|23
947958|NCT01044459|1940557|FG001|Overall Study|Lack of Efficacy|12
947959|NCT01044459|1940556|FG000|Overall Study|Protocol Violation|11
947960|NCT01044459|1940557|FG001|Overall Study|Protocol Violation|16
947961|NCT01044459|1940556|FG000|Overall Study|Other Reason|7
947962|NCT01044459|1940557|FG001|Overall Study|Other Reason|14
947963|NCT01044459|1940556|FG000|Overall Study|COPD exacerbation|9
947964|NCT01044459|1940557|FG001|Overall Study|COPD exacerbation|8
947965|NCT01044459|1940556|FG000|Overall Study|Lost to Follow-up|18
947966|NCT01044459|1940557|FG001|Overall Study|Lost to Follow-up|12
947967|NCT01044498|1940565|FG000|Overall Study|Withdrew consent|1
947968|NCT01044498|1940566|FG001|Overall Study|Withdrew consent|1
947969|NCT01044498|1940565|FG000|Overall Study|Adverse Event|1
947970|NCT01044498|1940566|FG001|Overall Study|Adverse Event|1
947971|NCT01044498|1940565|FG000|Overall Study|Other|1
947972|NCT01044498|1940566|FG001|Overall Study|Other|0
947973|NCT01044732|1940650|FG000|Overall Study|Lost to Follow-up|2
947974|NCT01044732|1940651|FG001|Overall Study|Lost to Follow-up|1
947975|NCT01044732|1940650|FG000|Overall Study|Physician Decision|5
947976|NCT01044732|1940651|FG001|Overall Study|Physician Decision|3
947977|NCT01044732|1940650|FG000|Overall Study|Protocol Violation|11
947978|NCT01044732|1940651|FG001|Overall Study|Protocol Violation|12
947979|NCT01044732|1940650|FG000|Overall Study|Withdrawal by Subject|0
947980|NCT01044732|1940651|FG001|Overall Study|Withdrawal by Subject|1
947981|NCT01044732|1940650|FG000|Overall Study|Inadequate bowel preparation|11
947982|NCT01044732|1940651|FG001|Overall Study|Inadequate bowel preparation|17
947983|NCT01044732|1940650|FG000|Overall Study|Inability to reach cecum|5
947984|NCT01044732|1940651|FG001|Overall Study|Inability to reach cecum|2
947985|NCT01044732|1940650|FG000|Overall Study|Technical error or malfunction|15
947986|NCT01044732|1940651|FG001|Overall Study|Technical error or malfunction|14
947987|NCT01044745|1940659|FG000|Overall Study|Ineiligible|2
947988|NCT01045096|1940750|FG000|Overall Study|Withdrawal by Subject|2
947989|NCT01045096|1940751|FG001|Overall Study|Withdrawal by Subject|0
947990|NCT01045096|1940752|FG002|Overall Study|Withdrawal by Subject|0
947991|NCT01045096|1940750|FG000|Overall Study|Other|1
947992|NCT01045096|1940751|FG001|Overall Study|Other|0
947993|NCT01045096|1940752|FG002|Overall Study|Other|0
1090768|NCT02248818|2158524|FG006|Screening|Physician Decision|0
947994|NCT01045161|1940776|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
947995|NCT01045161|1940777|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
947996|NCT01045161|1940778|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
947997|NCT01045161|1940776|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
947998|NCT01045161|1940777|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
947999|NCT01045161|1940778|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
948000|NCT01045161|1940776|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
948001|NCT01045161|1940777|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
948002|NCT01045161|1940778|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
948003|NCT01045161|1940776|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
948004|NCT01045161|1940777|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
948005|NCT01045161|1940778|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
948006|NCT01045161|1940776|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
948007|NCT01045161|1940777|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
948008|NCT01045161|1940778|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
948009|NCT01045161|1940776|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
948010|NCT01045161|1940777|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
948011|NCT01045161|1940778|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
948012|NCT01045161|1940776|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
948013|NCT01045161|1940777|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
948014|NCT01045161|1940778|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
948015|NCT01045161|1940776|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
948016|NCT01045161|1940777|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
948017|NCT01045161|1940778|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
948018|NCT01045161|1940776|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10
948019|NCT01045161|1940777|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10
948020|NCT01045161|1940778|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7
948021|NCT01045161|1940776|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
948022|NCT01045161|1940777|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
948023|NCT01045161|1940778|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
948024|NCT01045161|1940776|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
948025|NCT01045161|1940777|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
948026|NCT01045161|1940778|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
948027|NCT01045161|1940776|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4
948028|NCT01045161|1940777|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2
948029|NCT01045161|1940778|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1
948030|NCT01045161|1940776|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
948031|NCT01045161|1940777|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
948032|NCT01045161|1940778|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
948033|NCT01045161|1940776|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
948034|NCT01045161|1940777|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
948035|NCT01045161|1940778|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
948036|NCT01045421|1940818|FG000|Phase 1|Progressive Disease|0
948037|NCT01045421|1940819|FG001|Phase 1|Progressive Disease|0
948038|NCT01045421|1940820|FG002|Phase 1|Progressive Disease|0
948039|NCT01045421|1940821|FG003|Phase 1|Progressive Disease|0
948040|NCT01045421|1940822|FG004|Phase 1|Progressive Disease|1
948041|NCT01045421|1940823|FG005|Phase 1|Progressive Disease|0
948042|NCT01045421|1940824|FG006|Phase 1|Progressive Disease|0
948043|NCT01045421|1940825|FG007|Phase 1|Progressive Disease|0
948044|NCT01045421|1940826|FG008|Phase 1|Progressive Disease|0
948045|NCT01045421|1940827|FG009|Phase 1|Progressive Disease|0
948046|NCT01045421|1940828|FG010|Phase 1|Progressive Disease|0
948047|NCT01045421|1940818|FG000|Phase 1|Withdrawal by Subject|0
948048|NCT01045421|1940819|FG001|Phase 1|Withdrawal by Subject|0
948049|NCT01045421|1940820|FG002|Phase 1|Withdrawal by Subject|0
948050|NCT01045421|1940821|FG003|Phase 1|Withdrawal by Subject|1
948051|NCT01045421|1940822|FG004|Phase 1|Withdrawal by Subject|0
948052|NCT01045421|1940823|FG005|Phase 1|Withdrawal by Subject|0
948053|NCT01045421|1940824|FG006|Phase 1|Withdrawal by Subject|0
948054|NCT01045421|1940825|FG007|Phase 1|Withdrawal by Subject|0
948055|NCT01045421|1940826|FG008|Phase 1|Withdrawal by Subject|0
948056|NCT01045421|1940827|FG009|Phase 1|Withdrawal by Subject|0
948057|NCT01045421|1940828|FG010|Phase 1|Withdrawal by Subject|0
948058|NCT01045421|1940818|FG000|Phase 2|Progressive Disease|0
948059|NCT01045421|1940819|FG001|Phase 2|Progressive Disease|0
948060|NCT01045421|1940820|FG002|Phase 2|Progressive Disease|0
948061|NCT01045421|1940821|FG003|Phase 2|Progressive Disease|0
948062|NCT01045421|1940822|FG004|Phase 2|Progressive Disease|0
948063|NCT01045421|1940823|FG005|Phase 2|Progressive Disease|0
948064|NCT01045421|1940824|FG006|Phase 2|Progressive Disease|0
948065|NCT01045421|1940825|FG007|Phase 2|Progressive Disease|1
948066|NCT01045421|1940826|FG008|Phase 2|Progressive Disease|1
948067|NCT01045421|1940827|FG009|Phase 2|Progressive Disease|1
948068|NCT01045421|1940828|FG010|Phase 2|Progressive Disease|1
948069|NCT01045421|1940818|FG000|Phase 2|Death|0
948070|NCT01045421|1940819|FG001|Phase 2|Death|0
948071|NCT01045421|1940820|FG002|Phase 2|Death|0
948072|NCT01045421|1940821|FG003|Phase 2|Death|0
948073|NCT01045421|1940822|FG004|Phase 2|Death|0
948074|NCT01045421|1940823|FG005|Phase 2|Death|0
948075|NCT01045421|1940824|FG006|Phase 2|Death|0
948076|NCT01045421|1940825|FG007|Phase 2|Death|1
948077|NCT01045421|1940826|FG008|Phase 2|Death|1
948078|NCT01045421|1940827|FG009|Phase 2|Death|2
948079|NCT01045421|1940828|FG010|Phase 2|Death|0
948080|NCT01045421|1940818|FG000|Phase 2|Other|0
948081|NCT01045421|1940819|FG001|Phase 2|Other|0
948082|NCT01045421|1940820|FG002|Phase 2|Other|0
948083|NCT01045421|1940821|FG003|Phase 2|Other|0
948084|NCT01045421|1940822|FG004|Phase 2|Other|0
948085|NCT01045421|1940823|FG005|Phase 2|Other|0
948086|NCT01045421|1940824|FG006|Phase 2|Other|0
948087|NCT01045421|1940825|FG007|Phase 2|Other|3
948088|NCT01045421|1940826|FG008|Phase 2|Other|0
948089|NCT01045421|1940827|FG009|Phase 2|Other|0
948090|NCT01045421|1940828|FG010|Phase 2|Other|1
948091|NCT01045447|1940851|FG000|Overall Study|Adverse Event|0
948092|NCT01045447|1940852|FG001|Overall Study|Adverse Event|1
948093|NCT01045447|1940851|FG000|Overall Study|Lack of Efficacy|3
948094|NCT01045447|1940852|FG001|Overall Study|Lack of Efficacy|1
948095|NCT01045447|1940851|FG000|Overall Study|Protocol Violation|6
948096|NCT01045447|1940852|FG001|Overall Study|Protocol Violation|3
948097|NCT01045447|1940851|FG000|Overall Study|Withdrawal Criteria|10
948098|NCT01045447|1940852|FG001|Overall Study|Withdrawal Criteria|10
948099|NCT01045447|1940851|FG000|Overall Study|Unclassified|17
948100|NCT01045447|1940852|FG001|Overall Study|Unclassified|13
948101|NCT01045460|1940860|FG000|Overall Study|Physician Decision|3
948102|NCT01045460|1940861|FG001|Overall Study|Physician Decision|2
948103|NCT01045460|1940860|FG000|Overall Study|Lost to Follow-up|0
948104|NCT01045460|1940861|FG001|Overall Study|Lost to Follow-up|1
948105|NCT01045460|1940860|FG000|Overall Study|Lack of Efficacy|3
948106|NCT01045460|1940861|FG001|Overall Study|Lack of Efficacy|0
948107|NCT01045707|1940880|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
948108|NCT01045707|1940881|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
948109|NCT01045707|1940880|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
948110|NCT01045707|1940881|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
948111|NCT01045707|1940880|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
948112|NCT01045707|1940881|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
948113|NCT01045707|1940880|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
948114|NCT01045707|1940881|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
948115|NCT01045707|1940880|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
948116|NCT01045707|1940881|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
948117|NCT01045707|1940880|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
948118|NCT01045707|1940881|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
948119|NCT01045707|1940880|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
948120|NCT01045707|1940881|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
948121|NCT01045707|1940880|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
948122|NCT01045707|1940881|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
948123|NCT01045707|1940880|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
948124|NCT01045707|1940881|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
948125|NCT01045798|1940889|FG000|Overall Study|Changed to Open-Label Caspofungin|1
948126|NCT01045798|1940890|FG001|Overall Study|Changed to Open-Label Caspofungin|0
948127|NCT01045798|1940889|FG000|Overall Study|Invasive Fungal Infection at Baseline|0
948128|NCT01045798|1940890|FG001|Overall Study|Invasive Fungal Infection at Baseline|1
948129|NCT01045798|1940889|FG000|Overall Study|Changed to Other Antifungal Therapy|1
948130|NCT01045798|1940890|FG001|Overall Study|Changed to Other Antifungal Therapy|2
948131|NCT01045798|1940889|FG000|Overall Study|Received Systemic Antifungal Prestudy|0
948132|NCT01045798|1940890|FG001|Overall Study|Received Systemic Antifungal Prestudy|1
948133|NCT01045967|1940898|FG000|Second Intervention|Protocol Violation|0
948134|NCT01045967|1940899|FG001|Second Intervention|Protocol Violation|1
948135|NCT01045993|1940909|FG000|Overall Study|Treated-later found eligibility not met|0
948136|NCT01045993|1940910|FG001|Overall Study|Treated-later found eligibility not met|1
948137|NCT01045993|1940911|FG002|Overall Study|Treated-later found eligibility not met|0
948138|NCT01045993|1940912|FG003|Overall Study|Treated-later found eligibility not met|0
948139|NCT01046084|1940924|FG000|Third Washout of 7 Days|Withdrawal by Subject|2
948140|NCT01046084|1940925|FG001|Third Washout of 7 Days|Withdrawal by Subject|0
948141|NCT01046110|1940933|FG000|Overall Study|Adverse Event|9
948142|NCT01046110|1940934|FG001|Overall Study|Adverse Event|2
948143|NCT01046110|1940933|FG000|Overall Study|Lack of Efficacy|0
948144|NCT01046110|1940934|FG001|Overall Study|Lack of Efficacy|1
948145|NCT01046110|1940933|FG000|Overall Study|Protocol Violation|7
948146|NCT01046110|1940934|FG001|Overall Study|Protocol Violation|12
948147|NCT01046110|1940933|FG000|Overall Study|Withdrawal Criteria|3
948148|NCT01046110|1940934|FG001|Overall Study|Withdrawal Criteria|5
948149|NCT01046110|1940933|FG000|Overall Study|Unclassified|36
948150|NCT01046110|1940934|FG001|Overall Study|Unclassified|35
948151|NCT01046136|1940942|FG000|Overall Study|Withdrawal by Subject|0
948152|NCT01046136|1940943|FG001|Overall Study|Withdrawal by Subject|4
948153|NCT01046136|1940942|FG000|Overall Study|Physician Decision|1
948154|NCT01046136|1940943|FG001|Overall Study|Physician Decision|1
948155|NCT01046136|1940942|FG000|Overall Study|Lost to Follow-up|3
948156|NCT01046136|1940943|FG001|Overall Study|Lost to Follow-up|3
948157|NCT01046253|1940953|FG000|Second Intervention|Adverse Event|0
948158|NCT01046253|1940954|FG001|Second Intervention|Adverse Event|1
948159|NCT01046253|1940953|FG000|Second Intervention|Protocol Violation|0
948160|NCT01046253|1940954|FG001|Second Intervention|Protocol Violation|1
948161|NCT01046396|1940960|FG000|Overall Study|Withdrawal by Subject|5
948162|NCT01046565|1940967|FG000|Overall Study|Adverse Event|2
948163|NCT01046565|1940967|FG000|Overall Study|Withdrawal by Subject|7
948164|NCT01046643|1940978|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0
948165|NCT01046643|1940979|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1
948166|NCT01046643|1940980|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0
948167|NCT01046643|1940981|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0
948168|NCT01046682|1941002|FG000|Overall Study|Adverse Event|2
948169|NCT01046682|1941003|FG001|Overall Study|Adverse Event|0
948170|NCT01046695|1941011|FG000|Overall Study|Subject had a pacemaker|0
948171|NCT01046695|1941012|FG001|Overall Study|Subject had a pacemaker|1
948172|NCT01046695|1941011|FG000|Overall Study|TENS interfered with the cardiac monitor|0
948173|NCT01046695|1941012|FG001|Overall Study|TENS interfered with the cardiac monitor|1
948174|NCT01046877|1941018|FG000|Overall Study|Exited voluntarily before tube extrusion|7
948175|NCT01046877|1941018|FG000|Overall Study|Exited voluntarily after tube extrusion|11
948176|NCT01046903|1941022|FG000|Overall Study|Lost to Follow-up|16
948177|NCT01046903|1941022|FG000|Overall Study|Adverse Event|4
948178|NCT01046903|1941022|FG000|Overall Study|Withdrawal by Subject|3
948179|NCT01046903|1941022|FG000|Overall Study|Other|5
948180|NCT01047007|1941030|FG000|Overall Study|Adverse Event|0
948181|NCT01047007|1941031|FG001|Overall Study|Adverse Event|2
948182|NCT01047007|1941032|FG002|Overall Study|Adverse Event|1
948183|NCT01047007|1941033|FG003|Overall Study|Adverse Event|0
948184|NCT01047007|1941030|FG000|Overall Study|Progressive Disease|2
948185|NCT01047007|1941031|FG001|Overall Study|Progressive Disease|4
948186|NCT01047007|1941032|FG002|Overall Study|Progressive Disease|1
948187|NCT01047007|1941033|FG003|Overall Study|Progressive Disease|0
948188|NCT01047293|1941059|FG000|Overall Study|DLT criteria not fulfilled|1
948189|NCT01047293|1941060|FG001|Overall Study|DLT criteria not fulfilled|1
948190|NCT01047293|1941061|FG002|Overall Study|DLT criteria not fulfilled|0
948191|NCT01047293|1941062|FG003|Overall Study|DLT criteria not fulfilled|0
948192|NCT01047306|1941071|FG000|Overall Study|Withdrawal by Subject|2
948193|NCT01047306|1941072|FG001|Overall Study|Withdrawal by Subject|0
948194|NCT01047306|1941071|FG000|Overall Study|Lost to Follow-up|1
948195|NCT01047306|1941072|FG001|Overall Study|Lost to Follow-up|0
948226|NCT01047332|1941095|FG000|Overall Study|SEMS Obstruction|11
948227|NCT01047332|1941096|FG001|Overall Study|SEMS Obstruction|20
948228|NCT01047332|1941095|FG000|Overall Study|Died Unobstructed|38
948229|NCT01047332|1941096|FG001|Overall Study|Died Unobstructed|41
948230|NCT01047332|1941095|FG000|Overall Study|Lost to Follow-up|8
948231|NCT01047332|1941096|FG001|Overall Study|Lost to Follow-up|3
948232|NCT01047345|1941104|FG000|Base Study|Adverse Event|3
948233|NCT01047345|1941105|FG001|Base Study|Adverse Event|0
948234|NCT01047345|1941106|FG002|Base Study|Adverse Event|0
948235|NCT01047345|1941104|FG000|Base Study|Lost to Follow-up|4
948236|NCT01047345|1941105|FG001|Base Study|Lost to Follow-up|1
948237|NCT01047345|1941106|FG002|Base Study|Lost to Follow-up|0
948238|NCT01047345|1941104|FG000|Base Study|Protocol Violation|3
948239|NCT01047345|1941105|FG001|Base Study|Protocol Violation|1
948240|NCT01047345|1941106|FG002|Base Study|Protocol Violation|0
948241|NCT01047345|1941104|FG000|Base Study|Withdrawal by Subject|12
948242|NCT01047345|1941105|FG001|Base Study|Withdrawal by Subject|4
948243|NCT01047345|1941106|FG002|Base Study|Withdrawal by Subject|0
948244|NCT01047345|1941104|FG000|Extension|Withdrawal by Subject|0
948245|NCT01047345|1941105|FG001|Extension|Withdrawal by Subject|0
948246|NCT01047345|1941106|FG002|Extension|Withdrawal by Subject|1
948247|NCT01047345|1941104|FG000|Extension|Lost to Follow-up|0
948248|NCT01047345|1941105|FG001|Extension|Lost to Follow-up|0
948249|NCT01047345|1941106|FG002|Extension|Lost to Follow-up|5
948250|NCT01047436|1941121|FG000|Overall Study|Protocol Violation|1
948251|NCT01047436|1941122|FG001|Overall Study|Protocol Violation|0
948252|NCT01047553|1941153|FG000|Overall Study|Adverse Event|10
948253|NCT01047553|1941154|FG001|Overall Study|Adverse Event|5
948254|NCT01047553|1941153|FG000|Overall Study|Withdrawal by Subject|4
948255|NCT01047553|1941154|FG001|Overall Study|Withdrawal by Subject|2
948256|NCT01047553|1941153|FG000|Overall Study|Development of Study-Specific Withdrawal|1
948257|NCT01047553|1941154|FG001|Overall Study|Development of Study-Specific Withdrawal|1
948258|NCT01047553|1941153|FG000|Overall Study|Lost to Follow-up|1
948259|NCT01047553|1941154|FG001|Overall Study|Lost to Follow-up|0
948260|NCT01047553|1941153|FG000|Overall Study|Sever Non-Compliance to Protocol|1
948261|NCT01047553|1941154|FG001|Overall Study|Sever Non-Compliance to Protocol|0
948262|NCT01047553|1941153|FG000|Overall Study|PI's decision|0
948263|NCT01047553|1941154|FG001|Overall Study|PI's decision|1
948264|NCT01048099|1941187|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
948265|NCT01048099|1941187|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
948266|NCT01048242|1941195|FG000|Overall Study|See study flow chart|4
948267|NCT01048242|1941196|FG001|Overall Study|See study flow chart|2
948268|NCT01048333|1941202|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
948269|NCT01048333|1941203|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
948270|NCT01048333|1941204|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
948271|NCT01048333|1941205|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
948272|NCT01048333|1941206|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
948273|NCT01048333|1941207|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
948274|NCT01048502|1941229|FG000|Overall Study|Lost to Follow-up|2
948275|NCT01048502|1941230|FG001|Overall Study|Lost to Follow-up|0
948276|NCT01048502|1941231|FG002|Overall Study|Lost to Follow-up|0
948277|NCT01048502|1941232|FG003|Overall Study|Lost to Follow-up|0
948278|NCT01048502|1941229|FG000|Overall Study|Adverse Event|1
948279|NCT01048502|1941230|FG001|Overall Study|Adverse Event|0
948280|NCT01048502|1941231|FG002|Overall Study|Adverse Event|0
948281|NCT01048502|1941232|FG003|Overall Study|Adverse Event|0
948282|NCT01048502|1941229|FG000|Overall Study|Withdrawal by Subject|1
948283|NCT01048502|1941230|FG001|Overall Study|Withdrawal by Subject|4
948284|NCT01048502|1941231|FG002|Overall Study|Withdrawal by Subject|5
948285|NCT01048502|1941232|FG003|Overall Study|Withdrawal by Subject|3
948286|NCT01048502|1941229|FG000|Overall Study|Physician Decision|0
948287|NCT01048502|1941230|FG001|Overall Study|Physician Decision|3
948288|NCT01048502|1941231|FG002|Overall Study|Physician Decision|0
948289|NCT01048502|1941232|FG003|Overall Study|Physician Decision|1
948290|NCT01048541|1941243|FG000|Overall Study|Withdrawal by Subject|1
948291|NCT01048541|1941244|FG001|Overall Study|Withdrawal by Subject|0
948292|NCT01048671|1941292|FG000|Overall Study|Protocol Violation|0
948293|NCT01048671|1941293|FG001|Overall Study|Protocol Violation|1
948294|NCT01048671|1941294|FG002|Overall Study|Protocol Violation|1
948295|NCT01048788|1941309|FG000|Overall Study|Adverse Event|5
948296|NCT01048788|1941310|FG001|Overall Study|Adverse Event|1
948297|NCT01048788|1941311|FG002|Overall Study|Adverse Event|1
948298|NCT01048788|1941309|FG000|Overall Study|Lack of Efficacy|0
948299|NCT01048788|1941310|FG001|Overall Study|Lack of Efficacy|0
948300|NCT01048788|1941311|FG002|Overall Study|Lack of Efficacy|1
948301|NCT01048788|1941309|FG000|Overall Study|Withdrawal by Subject|0
948302|NCT01048788|1941310|FG001|Overall Study|Withdrawal by Subject|1
948303|NCT01048788|1941311|FG002|Overall Study|Withdrawal by Subject|0
948304|NCT01048866|1941321|FG000|Overall Study|Adverse Event|1
948305|NCT01048866|1941322|FG001|Overall Study|Adverse Event|0
948306|NCT01048866|1941321|FG000|Overall Study|Protocol Violation|1
948307|NCT01048866|1941322|FG001|Overall Study|Protocol Violation|0
948308|NCT01048866|1941321|FG000|Overall Study|Physician Decision|1
948309|NCT01048866|1941322|FG001|Overall Study|Physician Decision|0
948310|NCT01048866|1941321|FG000|Overall Study|Withdrawal by Subject|0
948311|NCT01048866|1941322|FG001|Overall Study|Withdrawal by Subject|2
948312|NCT01048866|1941321|FG000|Overall Study|Lost to Follow-up|0
948313|NCT01048866|1941322|FG001|Overall Study|Lost to Follow-up|2
948314|NCT01048866|1941321|FG000|Overall Study|Other|1
948315|NCT01048866|1941322|FG001|Overall Study|Other|1
948316|NCT01048944|1941349|FG000|Overall Study|Protocol Violation|8
948317|NCT01048944|1941350|FG001|Overall Study|Protocol Violation|10
948318|NCT01048944|1941351|FG002|Overall Study|Protocol Violation|10
948319|NCT01048944|1941352|FG003|Overall Study|Protocol Violation|2
948320|NCT01049009|1941364|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
948321|NCT01049009|1941365|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2
948322|NCT01049009|1941364|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
948323|NCT01049009|1941365|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
948324|NCT01049009|1941364|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
948325|NCT01049009|1941365|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
948326|NCT01049009|1941364|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8
948327|NCT01049009|1941365|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7
948328|NCT01049217|1941412|FG000|Overall Study|Adverse Event|2
948329|NCT01049217|1941413|FG001|Overall Study|Adverse Event|1
948330|NCT01049217|1941412|FG000|Overall Study|Lack of Efficacy|1
948331|NCT01049217|1941413|FG001|Overall Study|Lack of Efficacy|1
948332|NCT01049217|1941412|FG000|Overall Study|Lost to Follow-up|3
948333|NCT01049217|1941413|FG001|Overall Study|Lost to Follow-up|8
948334|NCT01049217|1941412|FG000|Overall Study|Withdrawal by Subject|4
948335|NCT01049217|1941413|FG001|Overall Study|Withdrawal by Subject|3
948336|NCT01049217|1941412|FG000|Overall Study|Protocol Violation|1
948337|NCT01049217|1941413|FG001|Overall Study|Protocol Violation|3
948338|NCT01049217|1941412|FG000|Overall Study|Pregnancy|1
948339|NCT01049217|1941413|FG001|Overall Study|Pregnancy|0
948340|NCT01049217|1941412|FG000|Overall Study|Study Terminated by Sponsor|43
948341|NCT01049217|1941413|FG001|Overall Study|Study Terminated by Sponsor|43
948342|NCT01049217|1941412|FG000|Overall Study|Other|1
948343|NCT01049217|1941413|FG001|Overall Study|Other|2
948344|NCT01049217|1941412|FG000|Overall Study|Randomized but not Treated|0
948345|NCT01049217|1941413|FG001|Overall Study|Randomized but not Treated|2
948346|NCT01049308|1941424|FG000|Pill Counts|Withdrawal by Subject|83
948347|NCT01049334|1941433|FG000|Overall Study|Withdrawal by Subject|5
948348|NCT01049334|1941434|FG001|Overall Study|Withdrawal by Subject|3
948349|NCT01049334|1941433|FG000|Overall Study|Adverse Event|2
948350|NCT01049334|1941434|FG001|Overall Study|Adverse Event|3
948351|NCT01049334|1941433|FG000|Overall Study|Physician Decision|2
948352|NCT01049334|1941434|FG001|Overall Study|Physician Decision|0
948353|NCT01049334|1941433|FG000|Overall Study|Protocol Violation|0
948354|NCT01049334|1941434|FG001|Overall Study|Protocol Violation|1
948355|NCT01049360|1941440|FG000|Period 1|Adverse Event|0
948356|NCT01049360|1941441|FG001|Period 1|Adverse Event|1
948357|NCT01049360|1941442|FG002|Period 1|Adverse Event|0
948358|NCT01049360|1941443|FG003|Period 1|Adverse Event|1
948359|NCT01049360|1941444|FG004|Period 1|Adverse Event|0
948360|NCT01049360|1941445|FG005|Period 1|Adverse Event|0
948361|NCT01049360|1941446|FG006|Period 1|Adverse Event|0
948362|NCT01049360|1941447|FG007|Period 1|Adverse Event|1
948363|NCT01049360|1941448|FG008|Period 1|Adverse Event|0
948364|NCT01049360|1941449|FG009|Period 1|Adverse Event|0
948365|NCT01049360|1941450|FG010|Period 1|Adverse Event|0
948366|NCT01049360|1941451|FG011|Period 1|Adverse Event|0
948367|NCT01049360|1941452|FG012|Period 1|Adverse Event|1
948368|NCT01049360|1941453|FG013|Period 1|Adverse Event|1
948369|NCT01049360|1941454|FG014|Period 1|Adverse Event|0
948370|NCT01049360|1941455|FG015|Period 1|Adverse Event|0
948371|NCT01049360|1941456|FG016|Period 1|Adverse Event|1
948372|NCT01049360|1941457|FG017|Period 1|Adverse Event|0
948373|NCT01049360|1941458|FG018|Period 1|Adverse Event|1
948374|NCT01049360|1941459|FG019|Period 1|Adverse Event|0
948375|NCT01049360|1941440|FG000|Period 1|Did not meet inc/exc criteria|0
948376|NCT01049360|1941441|FG001|Period 1|Did not meet inc/exc criteria|0
948377|NCT01049360|1941442|FG002|Period 1|Did not meet inc/exc criteria|0
948378|NCT01049360|1941443|FG003|Period 1|Did not meet inc/exc criteria|0
948379|NCT01049360|1941444|FG004|Period 1|Did not meet inc/exc criteria|0
948380|NCT01049360|1941445|FG005|Period 1|Did not meet inc/exc criteria|0
948381|NCT01049360|1941446|FG006|Period 1|Did not meet inc/exc criteria|0
948382|NCT01049360|1941447|FG007|Period 1|Did not meet inc/exc criteria|1
948383|NCT01049360|1941448|FG008|Period 1|Did not meet inc/exc criteria|1
948384|NCT01049360|1941449|FG009|Period 1|Did not meet inc/exc criteria|0
948385|NCT01049360|1941450|FG010|Period 1|Did not meet inc/exc criteria|0
948386|NCT01049360|1941451|FG011|Period 1|Did not meet inc/exc criteria|0
948387|NCT01049360|1941452|FG012|Period 1|Did not meet inc/exc criteria|0
948388|NCT01049360|1941453|FG013|Period 1|Did not meet inc/exc criteria|0
948389|NCT01049360|1941454|FG014|Period 1|Did not meet inc/exc criteria|0
948390|NCT01049360|1941455|FG015|Period 1|Did not meet inc/exc criteria|0
948391|NCT01049360|1941456|FG016|Period 1|Did not meet inc/exc criteria|0
948392|NCT01049360|1941457|FG017|Period 1|Did not meet inc/exc criteria|0
948393|NCT01049360|1941458|FG018|Period 1|Did not meet inc/exc criteria|0
948394|NCT01049360|1941459|FG019|Period 1|Did not meet inc/exc criteria|0
948395|NCT01049360|1941440|FG000|Period 1|Withdrawal by Subject|0
948396|NCT01049360|1941441|FG001|Period 1|Withdrawal by Subject|0
948397|NCT01049360|1941442|FG002|Period 1|Withdrawal by Subject|0
948398|NCT01049360|1941443|FG003|Period 1|Withdrawal by Subject|0
948399|NCT01049360|1941444|FG004|Period 1|Withdrawal by Subject|0
948400|NCT01049360|1941445|FG005|Period 1|Withdrawal by Subject|0
948401|NCT01049360|1941446|FG006|Period 1|Withdrawal by Subject|0
948402|NCT01049360|1941447|FG007|Period 1|Withdrawal by Subject|0
948403|NCT01049360|1941448|FG008|Period 1|Withdrawal by Subject|1
948404|NCT01049360|1941449|FG009|Period 1|Withdrawal by Subject|0
948405|NCT01049360|1941450|FG010|Period 1|Withdrawal by Subject|1
948406|NCT01049360|1941451|FG011|Period 1|Withdrawal by Subject|0
948407|NCT01049360|1941452|FG012|Period 1|Withdrawal by Subject|1
948408|NCT01049360|1941453|FG013|Period 1|Withdrawal by Subject|0
948409|NCT01049360|1941454|FG014|Period 1|Withdrawal by Subject|0
948410|NCT01049360|1941455|FG015|Period 1|Withdrawal by Subject|0
948411|NCT01049360|1941456|FG016|Period 1|Withdrawal by Subject|0
948412|NCT01049360|1941457|FG017|Period 1|Withdrawal by Subject|0
948413|NCT01049360|1941458|FG018|Period 1|Withdrawal by Subject|0
948414|NCT01049360|1941459|FG019|Period 1|Withdrawal by Subject|0
948415|NCT01049360|1941440|FG000|Period 2|Protocol Violation|0
948416|NCT01049360|1941441|FG001|Period 2|Protocol Violation|0
948417|NCT01049360|1941442|FG002|Period 2|Protocol Violation|0
948418|NCT01049360|1941443|FG003|Period 2|Protocol Violation|1
948419|NCT01049360|1941444|FG004|Period 2|Protocol Violation|0
948420|NCT01049360|1941445|FG005|Period 2|Protocol Violation|0
948421|NCT01049360|1941446|FG006|Period 2|Protocol Violation|0
948422|NCT01049360|1941447|FG007|Period 2|Protocol Violation|0
948423|NCT01049360|1941448|FG008|Period 2|Protocol Violation|0
948424|NCT01049360|1941449|FG009|Period 2|Protocol Violation|0
948425|NCT01049360|1941450|FG010|Period 2|Protocol Violation|0
948426|NCT01049360|1941451|FG011|Period 2|Protocol Violation|0
948427|NCT01049360|1941452|FG012|Period 2|Protocol Violation|0
948428|NCT01049360|1941453|FG013|Period 2|Protocol Violation|0
948429|NCT01049360|1941454|FG014|Period 2|Protocol Violation|1
948430|NCT01049360|1941455|FG015|Period 2|Protocol Violation|1
948431|NCT01049360|1941456|FG016|Period 2|Protocol Violation|0
948432|NCT01049360|1941457|FG017|Period 2|Protocol Violation|0
948433|NCT01049360|1941458|FG018|Period 2|Protocol Violation|0
948434|NCT01049360|1941459|FG019|Period 2|Protocol Violation|0
948435|NCT01049360|1941440|FG000|Period 2|Adverse Event|0
948436|NCT01049360|1941441|FG001|Period 2|Adverse Event|1
948437|NCT01049360|1941442|FG002|Period 2|Adverse Event|0
948438|NCT01049360|1941443|FG003|Period 2|Adverse Event|0
948439|NCT01049360|1941444|FG004|Period 2|Adverse Event|0
948440|NCT01049360|1941445|FG005|Period 2|Adverse Event|0
948441|NCT01049360|1941446|FG006|Period 2|Adverse Event|0
948442|NCT01049360|1941447|FG007|Period 2|Adverse Event|0
948443|NCT01049360|1941448|FG008|Period 2|Adverse Event|1
948444|NCT01049360|1941449|FG009|Period 2|Adverse Event|0
948445|NCT01049360|1941450|FG010|Period 2|Adverse Event|0
948446|NCT01049360|1941451|FG011|Period 2|Adverse Event|0
948447|NCT01049360|1941452|FG012|Period 2|Adverse Event|0
948448|NCT01049360|1941453|FG013|Period 2|Adverse Event|0
948449|NCT01049360|1941454|FG014|Period 2|Adverse Event|0
948450|NCT01049360|1941455|FG015|Period 2|Adverse Event|0
948451|NCT01049360|1941456|FG016|Period 2|Adverse Event|0
948452|NCT01049360|1941457|FG017|Period 2|Adverse Event|0
948453|NCT01049360|1941458|FG018|Period 2|Adverse Event|0
948454|NCT01049360|1941459|FG019|Period 2|Adverse Event|1
948455|NCT01049360|1941440|FG000|Period 2|Withdrawal by Subject|0
948456|NCT01049360|1941441|FG001|Period 2|Withdrawal by Subject|0
948457|NCT01049360|1941442|FG002|Period 2|Withdrawal by Subject|0
948458|NCT01049360|1941443|FG003|Period 2|Withdrawal by Subject|1
948459|NCT01049360|1941444|FG004|Period 2|Withdrawal by Subject|0
948460|NCT01049360|1941445|FG005|Period 2|Withdrawal by Subject|0
948461|NCT01049360|1941446|FG006|Period 2|Withdrawal by Subject|0
948462|NCT01049360|1941447|FG007|Period 2|Withdrawal by Subject|0
948463|NCT01049360|1941448|FG008|Period 2|Withdrawal by Subject|0
948464|NCT01049360|1941449|FG009|Period 2|Withdrawal by Subject|0
948465|NCT01049360|1941450|FG010|Period 2|Withdrawal by Subject|0
948466|NCT01049360|1941451|FG011|Period 2|Withdrawal by Subject|0
948467|NCT01049360|1941452|FG012|Period 2|Withdrawal by Subject|0
948468|NCT01049360|1941453|FG013|Period 2|Withdrawal by Subject|0
948469|NCT01049360|1941454|FG014|Period 2|Withdrawal by Subject|1
948470|NCT01049360|1941455|FG015|Period 2|Withdrawal by Subject|0
948471|NCT01049360|1941456|FG016|Period 2|Withdrawal by Subject|0
948472|NCT01049360|1941457|FG017|Period 2|Withdrawal by Subject|0
948473|NCT01049360|1941458|FG018|Period 2|Withdrawal by Subject|0
948474|NCT01049360|1941459|FG019|Period 2|Withdrawal by Subject|1
948475|NCT01049360|1941440|FG000|Period 2|Lack of Efficacy|0
948476|NCT01049360|1941441|FG001|Period 2|Lack of Efficacy|0
948477|NCT01049360|1941442|FG002|Period 2|Lack of Efficacy|0
948478|NCT01049360|1941443|FG003|Period 2|Lack of Efficacy|0
948479|NCT01049360|1941444|FG004|Period 2|Lack of Efficacy|0
910975|NCT00796003|1888104|FG000|Overall Study|Disease Progression|2
910976|NCT00796003|1888105|FG001|Overall Study|Disease Progression|13
910977|NCT00796003|1888104|FG000|Overall Study|Adverse Event|1
910978|NCT00796003|1888105|FG001|Overall Study|Adverse Event|7
910979|NCT00796003|1888104|FG000|Overall Study|Specified organ function not met|0
910980|NCT00796003|1888105|FG001|Overall Study|Specified organ function not met|1
948480|NCT01049360|1941445|FG005|Period 2|Lack of Efficacy|1
948481|NCT01049360|1941446|FG006|Period 2|Lack of Efficacy|0
948482|NCT01049360|1941447|FG007|Period 2|Lack of Efficacy|0
948483|NCT01049360|1941448|FG008|Period 2|Lack of Efficacy|0
948484|NCT01049360|1941449|FG009|Period 2|Lack of Efficacy|0
948485|NCT01049360|1941450|FG010|Period 2|Lack of Efficacy|0
948486|NCT01049360|1941451|FG011|Period 2|Lack of Efficacy|0
948487|NCT01049360|1941452|FG012|Period 2|Lack of Efficacy|0
948488|NCT01049360|1941453|FG013|Period 2|Lack of Efficacy|0
948489|NCT01049360|1941454|FG014|Period 2|Lack of Efficacy|0
948490|NCT01049360|1941455|FG015|Period 2|Lack of Efficacy|0
948491|NCT01049360|1941456|FG016|Period 2|Lack of Efficacy|0
948492|NCT01049360|1941457|FG017|Period 2|Lack of Efficacy|0
948493|NCT01049360|1941458|FG018|Period 2|Lack of Efficacy|0
948494|NCT01049360|1941459|FG019|Period 2|Lack of Efficacy|0
948495|NCT01049360|1941440|FG000|Period 4|Protocol Violation|0
948496|NCT01049360|1941441|FG001|Period 4|Protocol Violation|0
948497|NCT01049360|1941442|FG002|Period 4|Protocol Violation|0
948498|NCT01049360|1941443|FG003|Period 4|Protocol Violation|0
948499|NCT01049360|1941444|FG004|Period 4|Protocol Violation|0
948500|NCT01049360|1941445|FG005|Period 4|Protocol Violation|0
948501|NCT01049360|1941446|FG006|Period 4|Protocol Violation|0
948502|NCT01049360|1941447|FG007|Period 4|Protocol Violation|0
948503|NCT01049360|1941448|FG008|Period 4|Protocol Violation|0
948504|NCT01049360|1941449|FG009|Period 4|Protocol Violation|0
948505|NCT01049360|1941450|FG010|Period 4|Protocol Violation|0
948506|NCT01049360|1941451|FG011|Period 4|Protocol Violation|0
948507|NCT01049360|1941452|FG012|Period 4|Protocol Violation|0
948508|NCT01049360|1941453|FG013|Period 4|Protocol Violation|0
948509|NCT01049360|1941454|FG014|Period 4|Protocol Violation|0
948510|NCT01049360|1941455|FG015|Period 4|Protocol Violation|0
948511|NCT01049360|1941456|FG016|Period 4|Protocol Violation|0
948512|NCT01049360|1941457|FG017|Period 4|Protocol Violation|1
948513|NCT01049360|1941458|FG018|Period 4|Protocol Violation|0
948514|NCT01049360|1941459|FG019|Period 4|Protocol Violation|0
948515|NCT01049360|1941440|FG000|Period 4|Withdrawal by Subject|0
948516|NCT01049360|1941441|FG001|Period 4|Withdrawal by Subject|0
948517|NCT01049360|1941442|FG002|Period 4|Withdrawal by Subject|0
948518|NCT01049360|1941443|FG003|Period 4|Withdrawal by Subject|1
948519|NCT01049360|1941444|FG004|Period 4|Withdrawal by Subject|0
948520|NCT01049360|1941445|FG005|Period 4|Withdrawal by Subject|0
948521|NCT01049360|1941446|FG006|Period 4|Withdrawal by Subject|0
948522|NCT01049360|1941447|FG007|Period 4|Withdrawal by Subject|0
948523|NCT01049360|1941448|FG008|Period 4|Withdrawal by Subject|0
948524|NCT01049360|1941449|FG009|Period 4|Withdrawal by Subject|0
948525|NCT01049360|1941450|FG010|Period 4|Withdrawal by Subject|0
948526|NCT01049360|1941451|FG011|Period 4|Withdrawal by Subject|0
948527|NCT01049360|1941452|FG012|Period 4|Withdrawal by Subject|0
948528|NCT01049360|1941453|FG013|Period 4|Withdrawal by Subject|0
948529|NCT01049360|1941454|FG014|Period 4|Withdrawal by Subject|0
948530|NCT01049360|1941455|FG015|Period 4|Withdrawal by Subject|0
948531|NCT01049360|1941456|FG016|Period 4|Withdrawal by Subject|0
948532|NCT01049360|1941457|FG017|Period 4|Withdrawal by Subject|0
948533|NCT01049360|1941458|FG018|Period 4|Withdrawal by Subject|0
948534|NCT01049360|1941459|FG019|Period 4|Withdrawal by Subject|0
948535|NCT01049373|1941473|FG000|Overall Study|Protocol Violation|9
948536|NCT01049373|1941474|FG001|Overall Study|Protocol Violation|9
948537|NCT01049373|1941473|FG000|Overall Study|Withdrawal by Subject|8
948538|NCT01049373|1941474|FG001|Overall Study|Withdrawal by Subject|5
948539|NCT01049373|1941473|FG000|Overall Study|Adverse Event|3
948540|NCT01049373|1941474|FG001|Overall Study|Adverse Event|3
948541|NCT01049373|1941473|FG000|Overall Study|Lost to Follow-up|9
948542|NCT01049373|1941474|FG001|Overall Study|Lost to Follow-up|4
948543|NCT01049373|1941473|FG000|Overall Study|no evaluable study values|9
948544|NCT01049373|1941474|FG001|Overall Study|no evaluable study values|21
948545|NCT01049373|1941473|FG000|Overall Study|Other|1
948546|NCT01049373|1941474|FG001|Overall Study|Other|1
948547|NCT01049373|1941473|FG000|Overall Study|Non-cooperation|0
948548|NCT01049373|1941474|FG001|Overall Study|Non-cooperation|1
948549|NCT01049412|1941484|FG000|Period I|Withdrawal by Subject|4
948550|NCT01049412|1941485|FG001|Period I|Withdrawal by Subject|6
948551|NCT01049412|1941484|FG000|Period I|Lost to Follow-up|2
948552|NCT01049412|1941485|FG001|Period I|Lost to Follow-up|2
948553|NCT01049412|1941484|FG000|Period I|Physician Decision|0
948554|NCT01049412|1941485|FG001|Period I|Physician Decision|3
948555|NCT01049412|1941484|FG000|Period I|Protocol Violation|1
948556|NCT01049412|1941485|FG001|Period I|Protocol Violation|2
948557|NCT01049412|1941484|FG000|Period I|Adverse Event|1
948558|NCT01049412|1941485|FG001|Period I|Adverse Event|0
948559|NCT01049412|1941484|FG000|Period II|Withdrawal by Subject|2
948560|NCT01049412|1941485|FG001|Period II|Withdrawal by Subject|3
948561|NCT01049412|1941484|FG000|Period II|Adverse Event|1
948562|NCT01049412|1941485|FG001|Period II|Adverse Event|0
948563|NCT01049412|1941484|FG000|Period II|Lost to Follow-up|1
948564|NCT01049412|1941485|FG001|Period II|Lost to Follow-up|0
948565|NCT01049503|1941499|FG000|Overall Study|Lost to Follow-up|11
948566|NCT01049503|1941500|FG001|Overall Study|Lost to Follow-up|12
948567|NCT01049503|1941501|FG002|Overall Study|Lost to Follow-up|24
948568|NCT01049503|1941502|FG003|Overall Study|Lost to Follow-up|26
948569|NCT01049503|1941503|FG004|Overall Study|Lost to Follow-up|27
948570|NCT01049503|1941504|FG005|Overall Study|Lost to Follow-up|8
948571|NCT01049581|1941529|FG000|Overall Study|Lost to Follow-up|2
948572|NCT01049581|1941530|FG001|Overall Study|Lost to Follow-up|1
948573|NCT01049919|1941554|FG000|Overall Study|Met study endpoint (major amputation, death)|36
948574|NCT01049919|1941555|FG001|Overall Study|Met study endpoint (major amputation, death)|16
948575|NCT01049919|1941554|FG000|Overall Study|Withdrawal by Subject|5
948576|NCT01049919|1941555|FG001|Overall Study|Withdrawal by Subject|0
948577|NCT01049919|1941554|FG000|Overall Study|Lost to Follow-up|6
948578|NCT01049919|1941555|FG001|Overall Study|Lost to Follow-up|1
948579|NCT01049919|1941554|FG000|Overall Study|Physician Decision|2
948580|NCT01049919|1941555|FG001|Overall Study|Physician Decision|0
948581|NCT01049919|1941554|FG000|Overall Study|Received 2nd treatment via compassionate use|1
948582|NCT01049919|1941555|FG001|Overall Study|Received 2nd treatment via compassionate use|0
948583|NCT01049919|1941554|FG000|Overall Study|Early study termination by sponsor.|2
948584|NCT01049919|1941555|FG001|Overall Study|Early study termination by sponsor.|0
948585|NCT01049984|1941584|FG000|Overall Study|Withdrawal by Subject|1
948586|NCT01049984|1941585|FG001|Overall Study|Withdrawal by Subject|5
948587|NCT01049984|1941584|FG000|Overall Study|Protocol Violation|3
948588|NCT01049984|1941585|FG001|Overall Study|Protocol Violation|4
948589|NCT01049984|1941584|FG000|Overall Study|Lost to Follow-up|2
948590|NCT01049984|1941585|FG001|Overall Study|Lost to Follow-up|1
948591|NCT01049984|1941584|FG000|Overall Study|Adverse Event|13
948592|NCT01049984|1941585|FG001|Overall Study|Adverse Event|7
948593|NCT01049984|1941584|FG000|Overall Study|Treatment failure|0
948594|NCT01049984|1941585|FG001|Overall Study|Treatment failure|2
948595|NCT01050062|1941593|FG000|Overall Study|Adverse Event|75
948596|NCT01050062|1941594|FG001|Overall Study|Adverse Event|22
948597|NCT01050062|1941593|FG000|Overall Study|Lost to Follow-up|83
948598|NCT01050062|1941594|FG001|Overall Study|Lost to Follow-up|35
948599|NCT01050062|1941593|FG000|Overall Study|Lack of Efficacy|22
948600|NCT01050062|1941594|FG001|Overall Study|Lack of Efficacy|35
948601|NCT01050062|1941593|FG000|Overall Study|Physician Decision|74
948602|NCT01050062|1941594|FG001|Overall Study|Physician Decision|9
948603|NCT01050062|1941593|FG000|Overall Study|Others|17
948604|NCT01050062|1941594|FG001|Overall Study|Others|11
948605|NCT01050205|1941613|FG000|Overall Study|Lost to Follow-up|7
948606|NCT01050205|1941614|FG001|Overall Study|Lost to Follow-up|1
948607|NCT01050205|1941613|FG000|Overall Study|Withdrawal by Subject|1
948608|NCT01050205|1941614|FG001|Overall Study|Withdrawal by Subject|1
948609|NCT01050205|1941613|FG000|Overall Study|Relocated from area|1
948610|NCT01050205|1941614|FG001|Overall Study|Relocated from area|2
948611|NCT01050205|1941613|FG000|Overall Study|Discontinued Intervention|2
948612|NCT01050205|1941614|FG001|Overall Study|Discontinued Intervention|0
948613|NCT01050257|1941632|FG000|Overall Study|Adverse Event|4
948614|NCT01050257|1941633|FG001|Overall Study|Adverse Event|4
948615|NCT01050257|1941634|FG002|Overall Study|Adverse Event|2
948616|NCT01050257|1941632|FG000|Overall Study|Admin/Other (did not switch to oral)|6
948617|NCT01050257|1941633|FG001|Overall Study|Admin/Other (did not switch to oral)|2
948618|NCT01050257|1941634|FG002|Overall Study|Admin/Other (did not switch to oral)|2
948619|NCT01050257|1941632|FG000|Overall Study|Withdrawal by Subject|0
948620|NCT01050257|1941633|FG001|Overall Study|Withdrawal by Subject|3
948621|NCT01050257|1941634|FG002|Overall Study|Withdrawal by Subject|0
948622|NCT01050257|1941632|FG000|Overall Study|No reason specified|0
948623|NCT01050257|1941633|FG001|Overall Study|No reason specified|0
948624|NCT01050257|1941634|FG002|Overall Study|No reason specified|2
948625|NCT01050257|1941632|FG000|Overall Study|Refused treatment/ Did not Cooperate|1
948626|NCT01050257|1941633|FG001|Overall Study|Refused treatment/ Did not Cooperate|1
948627|NCT01050257|1941634|FG002|Overall Study|Refused treatment/ Did not Cooperate|0
948628|NCT01050257|1941632|FG000|Overall Study|Violation criteria|0
948629|NCT01050257|1941633|FG001|Overall Study|Violation criteria|1
948630|NCT01050257|1941634|FG002|Overall Study|Violation criteria|0
948631|NCT01050257|1941632|FG000|Overall Study|Failure to return|0
948632|NCT01050257|1941633|FG001|Overall Study|Failure to return|2
948633|NCT01050257|1941634|FG002|Overall Study|Failure to return|0
948634|NCT01050257|1941632|FG000|Overall Study|Death|0
948635|NCT01050257|1941633|FG001|Overall Study|Death|0
948636|NCT01050257|1941634|FG002|Overall Study|Death|1
948637|NCT01050530|1941644|FG000|Overall Study|Adverse Event|6
948638|NCT01050530|1941645|FG001|Overall Study|Adverse Event|3
948639|NCT01050530|1941644|FG000|Overall Study|Lack of Efficacy|1
948640|NCT01050530|1941645|FG001|Overall Study|Lack of Efficacy|4
948641|NCT01050530|1941644|FG000|Overall Study|Withdrawal by Subject|0
948642|NCT01050530|1941645|FG001|Overall Study|Withdrawal by Subject|3
948643|NCT01050530|1941644|FG000|Overall Study|Protocol Violation|1
948644|NCT01050530|1941645|FG001|Overall Study|Protocol Violation|0
948645|NCT01050543|1941653|FG000|Overall Study|Withdrawal by Subject|0
948646|NCT01050543|1941654|FG001|Overall Study|Withdrawal by Subject|2
948647|NCT01050543|1941653|FG000|Overall Study|Protocol Violation|0
948648|NCT01050543|1941654|FG001|Overall Study|Protocol Violation|1
948649|NCT01050543|1941653|FG000|Overall Study|Administrative|4
948650|NCT01050543|1941654|FG001|Overall Study|Administrative|1
948651|NCT01050569|1941663|FG000|Overall Study|Lost to Follow-up|20
948652|NCT01050569|1941664|FG001|Overall Study|Lost to Follow-up|14
948653|NCT01050569|1941665|FG002|Overall Study|Lost to Follow-up|16
948654|NCT01050569|1941663|FG000|Overall Study|Withdrawal by Subject|9
948655|NCT01050569|1941664|FG001|Overall Study|Withdrawal by Subject|3
948656|NCT01050569|1941665|FG002|Overall Study|Withdrawal by Subject|11
948657|NCT01050569|1941663|FG000|Overall Study|Lack of Efficacy|5
948658|NCT01050569|1941664|FG001|Overall Study|Lack of Efficacy|4
948659|NCT01050569|1941665|FG002|Overall Study|Lack of Efficacy|3
948660|NCT01050569|1941663|FG000|Overall Study|Adverse Event|1
948661|NCT01050569|1941664|FG001|Overall Study|Adverse Event|0
948662|NCT01050569|1941665|FG002|Overall Study|Adverse Event|0
948663|NCT01050569|1941663|FG000|Overall Study|Physician Decision|3
948664|NCT01050569|1941664|FG001|Overall Study|Physician Decision|3
948665|NCT01050569|1941665|FG002|Overall Study|Physician Decision|3
948666|NCT01050634|1941686|FG000|Overall Study|Enrolled, but Not Treated|56
948667|NCT01050634|1941686|FG000|Overall Study|Death|2
948668|NCT01050634|1941686|FG000|Overall Study|Adverse Event|42
948669|NCT01050634|1941686|FG000|Overall Study|Lost to Follow-up|2
948670|NCT01050634|1941686|FG000|Overall Study|Other|21
948671|NCT01050634|1941686|FG000|Overall Study|Ongoing at Date of Cut-Off|5
948672|NCT01050673|1941710|FG000|Overall Study|Physician Decision|4
948673|NCT01050673|1941711|FG001|Overall Study|Physician Decision|5
948674|NCT01050764|1941717|FG000|Overall Study|Death, before HSCT|1
948675|NCT01050764|1941717|FG000|Overall Study|Donor mobilization failure, death|1
948676|NCT01050764|1941717|FG000|Overall Study|Death after HSCT, before T-cell infusion|1
948677|NCT01050790|1941721|FG000|Overall Study|Adverse Event|1
948678|NCT01050816|1941726|FG000|Overall Study|Lost to Follow-up|2
948679|NCT01050816|1941726|FG000|Overall Study|patient's refusal|2
948680|NCT01050998|1941744|FG000|Overall Study|Adverse Event|1
948681|NCT01050998|1941745|FG001|Overall Study|Adverse Event|0
948682|NCT01050998|1941746|FG002|Overall Study|Adverse Event|1
948683|NCT01050998|1941747|FG003|Overall Study|Adverse Event|0
948684|NCT01050998|1941748|FG004|Overall Study|Adverse Event|2
948685|NCT01050998|1941744|FG000|Overall Study|Withdrawal by Subject|0
948686|NCT01050998|1941745|FG001|Overall Study|Withdrawal by Subject|0
948687|NCT01050998|1941746|FG002|Overall Study|Withdrawal by Subject|0
948688|NCT01050998|1941747|FG003|Overall Study|Withdrawal by Subject|1
948689|NCT01050998|1941748|FG004|Overall Study|Withdrawal by Subject|3
948690|NCT01050998|1941744|FG000|Overall Study|Other|3
948691|NCT01050998|1941745|FG001|Overall Study|Other|2
948692|NCT01050998|1941746|FG002|Overall Study|Other|1
948693|NCT01050998|1941747|FG003|Overall Study|Other|1
948694|NCT01050998|1941748|FG004|Overall Study|Other|5
948695|NCT01050998|1941744|FG000|Overall Study|Data integrity issues|0
948696|NCT01050998|1941745|FG001|Overall Study|Data integrity issues|0
948697|NCT01050998|1941746|FG002|Overall Study|Data integrity issues|1
948698|NCT01050998|1941747|FG003|Overall Study|Data integrity issues|1
948699|NCT01050998|1941748|FG004|Overall Study|Data integrity issues|4
948700|NCT01051063|1941766|FG000|Overall Study|Death|2
948701|NCT01051063|1941767|FG001|Overall Study|Death|2
948702|NCT01051063|1941766|FG000|Overall Study|Withdrawal by Subject|1
948703|NCT01051063|1941767|FG001|Overall Study|Withdrawal by Subject|1
948704|NCT01051063|1941766|FG000|Overall Study|Termination of the study|5
948705|NCT01051063|1941767|FG001|Overall Study|Termination of the study|0
948706|NCT01051063|1941766|FG000|Overall Study|Moved from the study site area|1
948707|NCT01051063|1941767|FG001|Overall Study|Moved from the study site area|0
948708|NCT01051063|1941766|FG000|Overall Study|Other|1
948709|NCT01051063|1941767|FG001|Overall Study|Other|0
948710|NCT01051063|1941766|FG000|Overall Study|Lost to Follow-up|0
948711|NCT01051063|1941767|FG001|Overall Study|Lost to Follow-up|1
948712|NCT01051323|1941780|FG000|Overall Study|Discontinuation of treatment|103
948713|NCT01051323|1941780|FG000|Overall Study|Transplantation|28
948714|NCT01051323|1941780|FG000|Overall Study|Dialysis dependency|22
948715|NCT01051323|1941780|FG000|Overall Study|Withdrawal by Subject|13
948716|NCT01051323|1941780|FG000|Overall Study|Lost to Follow-up|31
948717|NCT01051323|1941780|FG000|Overall Study|Death|129
948718|NCT01051323|1941780|FG000|Overall Study|Hospitalization|28
948719|NCT01051323|1941780|FG000|Overall Study|Other|148
948720|NCT01051323|1941780|FG000|Overall Study|Missing|37
948721|NCT01051349|1941788|FG000|Overall Study|Adverse Event|88
948722|NCT01051349|1941788|FG000|Overall Study|Consent Withdrawn|54
948723|NCT01051349|1941788|FG000|Overall Study|Investigator Decision|6
948724|NCT01051349|1941788|FG000|Overall Study|Lost to Follow-up|6
948725|NCT01051349|1941788|FG000|Overall Study|Subject non-compliance|7
948726|NCT01051349|1941788|FG000|Overall Study|Reason not Specified|12
948727|NCT01051466|1941806|FG000|Overall Study|Adverse Event|1
948728|NCT01051466|1941807|FG001|Overall Study|Adverse Event|0
948729|NCT01051466|1941806|FG000|Overall Study|Lost to Follow-up|1
948730|NCT01051466|1941807|FG001|Overall Study|Lost to Follow-up|1
948731|NCT01051466|1941806|FG000|Overall Study|Withdrawal by Subject|5
948732|NCT01051466|1941807|FG001|Overall Study|Withdrawal by Subject|1
948733|NCT01051466|1941806|FG000|Overall Study|Entry Criteria Not Met|0
948734|NCT01051466|1941807|FG001|Overall Study|Entry Criteria Not Met|3
948735|NCT01051466|1941806|FG000|Overall Study|Physician Decision|1
948736|NCT01051466|1941807|FG001|Overall Study|Physician Decision|0
948737|NCT01051557|1941833|FG000|Overall Study|Physician Decision|1
948738|NCT01051557|1941834|FG001|Overall Study|Physician Decision|0
948739|NCT01051557|1941835|FG002|Overall Study|Physician Decision|0
948740|NCT01051557|1941836|FG003|Overall Study|Physician Decision|0
948741|NCT01051557|1941837|FG004|Overall Study|Physician Decision|0
948742|NCT01051557|1941838|FG005|Overall Study|Physician Decision|0
948743|NCT01051557|1941839|FG006|Overall Study|Physician Decision|0
948744|NCT01051557|1941833|FG000|Overall Study|disease progression|3
948745|NCT01051557|1941834|FG001|Overall Study|disease progression|3
948746|NCT01051557|1941835|FG002|Overall Study|disease progression|5
948747|NCT01051557|1941836|FG003|Overall Study|disease progression|2
948748|NCT01051557|1941837|FG004|Overall Study|disease progression|4
948749|NCT01051557|1941838|FG005|Overall Study|disease progression|3
948750|NCT01051557|1941839|FG006|Overall Study|disease progression|1
948751|NCT01051557|1941833|FG000|Overall Study|Withdrawal by Subject|0
948752|NCT01051557|1941834|FG001|Overall Study|Withdrawal by Subject|0
948753|NCT01051557|1941835|FG002|Overall Study|Withdrawal by Subject|1
948754|NCT01051557|1941836|FG003|Overall Study|Withdrawal by Subject|0
948755|NCT01051557|1941837|FG004|Overall Study|Withdrawal by Subject|2
948756|NCT01051557|1941838|FG005|Overall Study|Withdrawal by Subject|0
948757|NCT01051557|1941839|FG006|Overall Study|Withdrawal by Subject|1
948758|NCT01051557|1941833|FG000|Overall Study|Adverse Event|0
948759|NCT01051557|1941834|FG001|Overall Study|Adverse Event|0
948760|NCT01051557|1941835|FG002|Overall Study|Adverse Event|0
948761|NCT01051557|1941836|FG003|Overall Study|Adverse Event|1
948762|NCT01051557|1941837|FG004|Overall Study|Adverse Event|1
948763|NCT01051557|1941838|FG005|Overall Study|Adverse Event|3
948764|NCT01051557|1941839|FG006|Overall Study|Adverse Event|4
948765|NCT01051661|1941870|FG000|Overall Study|Adverse Event|1
948766|NCT01051661|1941871|FG001|Overall Study|Adverse Event|1
948767|NCT01051661|1941872|FG002|Overall Study|Adverse Event|1
948768|NCT01051661|1941873|FG003|Overall Study|Adverse Event|1
948769|NCT01051661|1941874|FG004|Overall Study|Adverse Event|0
948770|NCT01051661|1941875|FG005|Overall Study|Adverse Event|0
948771|NCT01051661|1941870|FG000|Overall Study|Lost to Follow-up|13
948772|NCT01051661|1941871|FG001|Overall Study|Lost to Follow-up|22
948773|NCT01051661|1941872|FG002|Overall Study|Lost to Follow-up|15
948774|NCT01051661|1941873|FG003|Overall Study|Lost to Follow-up|17
948775|NCT01051661|1941874|FG004|Overall Study|Lost to Follow-up|10
948776|NCT01051661|1941875|FG005|Overall Study|Lost to Follow-up|24
948777|NCT01051661|1941870|FG000|Overall Study|Migrated/moved from study area|1
948778|NCT01051661|1941871|FG001|Overall Study|Migrated/moved from study area|6
948779|NCT01051661|1941872|FG002|Overall Study|Migrated/moved from study area|6
948780|NCT01051661|1941873|FG003|Overall Study|Migrated/moved from study area|8
948781|NCT01051661|1941874|FG004|Overall Study|Migrated/moved from study area|7
948782|NCT01051661|1941875|FG005|Overall Study|Migrated/moved from study area|3
948783|NCT01051661|1941870|FG000|Overall Study|Refused blood sampling|0
948784|NCT01051661|1941871|FG001|Overall Study|Refused blood sampling|0
948785|NCT01051661|1941872|FG002|Overall Study|Refused blood sampling|0
948786|NCT01051661|1941873|FG003|Overall Study|Refused blood sampling|0
948787|NCT01051661|1941874|FG004|Overall Study|Refused blood sampling|0
948788|NCT01051661|1941875|FG005|Overall Study|Refused blood sampling|1
948789|NCT01051661|1941870|FG000|Overall Study|Data not reliable|1
948790|NCT01051661|1941871|FG001|Overall Study|Data not reliable|0
948791|NCT01051661|1941872|FG002|Overall Study|Data not reliable|0
948792|NCT01051661|1941873|FG003|Overall Study|Data not reliable|0
948793|NCT01051661|1941874|FG004|Overall Study|Data not reliable|0
948794|NCT01051661|1941875|FG005|Overall Study|Data not reliable|1
948795|NCT01051661|1941870|FG000|Overall Study|Unable to attend visit(s)|2
948796|NCT01051661|1941871|FG001|Overall Study|Unable to attend visit(s)|4
948797|NCT01051661|1941872|FG002|Overall Study|Unable to attend visit(s)|2
948798|NCT01051661|1941873|FG003|Overall Study|Unable to attend visit(s)|1
948799|NCT01051661|1941874|FG004|Overall Study|Unable to attend visit(s)|3
948800|NCT01051661|1941875|FG005|Overall Study|Unable to attend visit(s)|2
948801|NCT01051661|1941870|FG000|Overall Study|Consent not received from both parents|0
948802|NCT01051661|1941871|FG001|Overall Study|Consent not received from both parents|0
948803|NCT01051661|1941872|FG002|Overall Study|Consent not received from both parents|0
948804|NCT01051661|1941873|FG003|Overall Study|Consent not received from both parents|0
948805|NCT01051661|1941874|FG004|Overall Study|Consent not received from both parents|0
948806|NCT01051661|1941875|FG005|Overall Study|Consent not received from both parents|1
948807|NCT01051661|1941870|FG000|Overall Study|Failure to comply with protocol|0
948808|NCT01051661|1941871|FG001|Overall Study|Failure to comply with protocol|0
948809|NCT01051661|1941872|FG002|Overall Study|Failure to comply with protocol|2
948810|NCT01051661|1941873|FG003|Overall Study|Failure to comply with protocol|0
948811|NCT01051661|1941874|FG004|Overall Study|Failure to comply with protocol|0
948812|NCT01051661|1941875|FG005|Overall Study|Failure to comply with protocol|0
948813|NCT01051661|1941870|FG000|Overall Study|Subject lost legal representation|0
948814|NCT01051661|1941871|FG001|Overall Study|Subject lost legal representation|0
948815|NCT01051661|1941872|FG002|Overall Study|Subject lost legal representation|0
948816|NCT01051661|1941873|FG003|Overall Study|Subject lost legal representation|0
948817|NCT01051661|1941874|FG004|Overall Study|Subject lost legal representation|1
948818|NCT01051661|1941875|FG005|Overall Study|Subject lost legal representation|0
948819|NCT01051661|1941870|FG000|Overall Study|Protocol Violation|0
948820|NCT01051661|1941871|FG001|Overall Study|Protocol Violation|0
948821|NCT01051661|1941872|FG002|Overall Study|Protocol Violation|0
948822|NCT01051661|1941873|FG003|Overall Study|Protocol Violation|1
948823|NCT01051661|1941874|FG004|Overall Study|Protocol Violation|2
948824|NCT01051661|1941875|FG005|Overall Study|Protocol Violation|1
948825|NCT01051661|1941870|FG000|Overall Study|Withdrawal by Subject|16
948826|NCT01051661|1941871|FG001|Overall Study|Withdrawal by Subject|30
948827|NCT01051661|1941872|FG002|Overall Study|Withdrawal by Subject|13
948828|NCT01051661|1941873|FG003|Overall Study|Withdrawal by Subject|28
948829|NCT01051661|1941874|FG004|Overall Study|Withdrawal by Subject|12
948830|NCT01051661|1941875|FG005|Overall Study|Withdrawal by Subject|34
948831|NCT01051739|1941912|FG000|Overall Study|Death|3
948832|NCT01051739|1941913|FG001|Overall Study|Death|3
948833|NCT01051739|1941912|FG000|Overall Study|Withdrawal by Subject|25
948834|NCT01051739|1941913|FG001|Overall Study|Withdrawal by Subject|10
948835|NCT01051791|1941928|FG000|Overall Study|Failed screening|3
948836|NCT01051791|1941928|FG000|Overall Study|Withdrawal by Subject|1
948837|NCT01051817|1941935|FG000|Overall Study|Adverse Event|0
948838|NCT01051817|1941936|FG001|Overall Study|Adverse Event|2
948839|NCT01051817|1941935|FG000|Overall Study|Abnormal Test Proceedure reults|0
948840|NCT01051817|1941936|FG001|Overall Study|Abnormal Test Proceedure reults|1
948841|NCT01051817|1941935|FG000|Overall Study|Withdrawal by Subject|3
948842|NCT01051817|1941936|FG001|Overall Study|Withdrawal by Subject|5
948843|NCT01051817|1941935|FG000|Overall Study|Protocol Violation|0
948844|NCT01051817|1941936|FG001|Overall Study|Protocol Violation|1
948845|NCT01051856|1941944|FG000|Overall Study|Withdrawal by Subject|1
948846|NCT01051856|1941945|FG001|Overall Study|Withdrawal by Subject|0
948847|NCT01051960|1941951|FG000|Overall Study|Adverse Event|1
948848|NCT01051986|1941957|FG000|Overall Study|Death|1
948849|NCT01051986|1941958|FG001|Overall Study|Death|0
948850|NCT01051986|1941957|FG000|Overall Study|Withdrawal by Subject|2
948851|NCT01051986|1941958|FG001|Overall Study|Withdrawal by Subject|1
948852|NCT01051986|1941957|FG000|Overall Study|Protocol Violation|2
948853|NCT01051986|1941958|FG001|Overall Study|Protocol Violation|3
948854|NCT01052012|1941970|FG000|Overall Study|Not treated|2
948855|NCT01052012|1941971|FG001|Overall Study|Not treated|5
948856|NCT01052012|1941972|FG002|Overall Study|Not treated|0
948857|NCT01052012|1941973|FG003|Overall Study|Not treated|0
948858|NCT01052012|1941974|FG004|Overall Study|Not treated|11
948859|NCT01052012|1941975|FG005|Overall Study|Not treated|8
948860|NCT01052012|1941970|FG000|Overall Study|Adverse Event|1
948861|NCT01052012|1941971|FG001|Overall Study|Adverse Event|0
948862|NCT01052012|1941972|FG002|Overall Study|Adverse Event|0
948863|NCT01052012|1941973|FG003|Overall Study|Adverse Event|1
948864|NCT01052012|1941974|FG004|Overall Study|Adverse Event|0
948865|NCT01052012|1941975|FG005|Overall Study|Adverse Event|0
948866|NCT01052012|1941970|FG000|Overall Study|Lost to Follow-up|0
948867|NCT01052012|1941971|FG001|Overall Study|Lost to Follow-up|0
948868|NCT01052012|1941972|FG002|Overall Study|Lost to Follow-up|0
948869|NCT01052012|1941973|FG003|Overall Study|Lost to Follow-up|0
948870|NCT01052012|1941974|FG004|Overall Study|Lost to Follow-up|1
948871|NCT01052012|1941975|FG005|Overall Study|Lost to Follow-up|0
948872|NCT01052012|1941970|FG000|Overall Study|Withdrawal by Subject|1
948873|NCT01052012|1941971|FG001|Overall Study|Withdrawal by Subject|1
948874|NCT01052012|1941972|FG002|Overall Study|Withdrawal by Subject|0
948875|NCT01052012|1941973|FG003|Overall Study|Withdrawal by Subject|0
948876|NCT01052012|1941974|FG004|Overall Study|Withdrawal by Subject|3
948877|NCT01052012|1941975|FG005|Overall Study|Withdrawal by Subject|1
948878|NCT01052012|1941970|FG000|Overall Study|Physician Decision|0
948879|NCT01052012|1941971|FG001|Overall Study|Physician Decision|0
948880|NCT01052012|1941972|FG002|Overall Study|Physician Decision|0
948881|NCT01052012|1941973|FG003|Overall Study|Physician Decision|0
948882|NCT01052012|1941974|FG004|Overall Study|Physician Decision|0
948883|NCT01052012|1941975|FG005|Overall Study|Physician Decision|1
948884|NCT01052012|1941970|FG000|Overall Study|Other|0
948885|NCT01052012|1941971|FG001|Overall Study|Other|0
948886|NCT01052012|1941972|FG002|Overall Study|Other|0
948887|NCT01052012|1941973|FG003|Overall Study|Other|0
948888|NCT01052012|1941974|FG004|Overall Study|Other|1
948889|NCT01052012|1941975|FG005|Overall Study|Other|0
948890|NCT01052038|1941992|FG000|Overall Study|Lost to Follow-up|2
948891|NCT01052038|1941993|FG001|Overall Study|Lost to Follow-up|3
948892|NCT01052038|1941994|FG002|Overall Study|Lost to Follow-up|1
948893|NCT01052038|1941992|FG000|Overall Study|Protocol Violation|2
948894|NCT01052038|1941993|FG001|Overall Study|Protocol Violation|3
948895|NCT01052038|1941994|FG002|Overall Study|Protocol Violation|3
948896|NCT01052077|1942004|FG000|Phase A|Lost to Follow-up|22
948897|NCT01052077|1942005|FG001|Phase A|Lost to Follow-up|0
948898|NCT01052077|1942006|FG002|Phase A|Lost to Follow-up|0
948899|NCT01052077|1942007|FG003|Phase A|Lost to Follow-up|0
948900|NCT01052077|1942004|FG000|Phase A|Adverse Event|32
948901|NCT01052077|1942005|FG001|Phase A|Adverse Event|0
948902|NCT01052077|1942006|FG002|Phase A|Adverse Event|0
948903|NCT01052077|1942007|FG003|Phase A|Adverse Event|0
948904|NCT01052077|1942004|FG000|Phase A|Met Withdrawal Criteria|26
948905|NCT01052077|1942005|FG001|Phase A|Met Withdrawal Criteria|0
948906|NCT01052077|1942006|FG002|Phase A|Met Withdrawal Criteria|0
948907|NCT01052077|1942007|FG003|Phase A|Met Withdrawal Criteria|0
948908|NCT01052077|1942004|FG000|Phase A|Physician Decision|10
948909|NCT01052077|1942005|FG001|Phase A|Physician Decision|0
948910|NCT01052077|1942006|FG002|Phase A|Physician Decision|0
948911|NCT01052077|1942007|FG003|Phase A|Physician Decision|0
948912|NCT01052077|1942004|FG000|Phase A|Withdrawal by Subject|29
948913|NCT01052077|1942005|FG001|Phase A|Withdrawal by Subject|0
948914|NCT01052077|1942006|FG002|Phase A|Withdrawal by Subject|0
948915|NCT01052077|1942007|FG003|Phase A|Withdrawal by Subject|0
948916|NCT01052077|1942004|FG000|Phase A|Protocol Deviation|27
948917|NCT01052077|1942005|FG001|Phase A|Protocol Deviation|0
948918|NCT01052077|1942006|FG002|Phase A|Protocol Deviation|0
948919|NCT01052077|1942007|FG003|Phase A|Protocol Deviation|0
948920|NCT01052077|1942004|FG000|Phase B|Lost to Follow-up|0
948921|NCT01052077|1942005|FG001|Phase B|Lost to Follow-up|2
948922|NCT01052077|1942006|FG002|Phase B|Lost to Follow-up|3
948923|NCT01052077|1942007|FG003|Phase B|Lost to Follow-up|0
948924|NCT01052077|1942004|FG000|Phase B|Adverse Event|0
948925|NCT01052077|1942005|FG001|Phase B|Adverse Event|9
948926|NCT01052077|1942006|FG002|Phase B|Adverse Event|2
948927|NCT01052077|1942007|FG003|Phase B|Adverse Event|0
948928|NCT01052077|1942004|FG000|Phase B|Met Withdrawal Criteria|0
948929|NCT01052077|1942005|FG001|Phase B|Met Withdrawal Criteria|2
948930|NCT01052077|1942006|FG002|Phase B|Met Withdrawal Criteria|1
948931|NCT01052077|1942007|FG003|Phase B|Met Withdrawal Criteria|0
948932|NCT01052077|1942004|FG000|Phase B|Physician Decision|0
948933|NCT01052077|1942005|FG001|Phase B|Physician Decision|1
948934|NCT01052077|1942006|FG002|Phase B|Physician Decision|1
948935|NCT01052077|1942007|FG003|Phase B|Physician Decision|0
948936|NCT01052077|1942004|FG000|Phase B|Withdrawal by Subject|0
948937|NCT01052077|1942005|FG001|Phase B|Withdrawal by Subject|0
948938|NCT01052077|1942006|FG002|Phase B|Withdrawal by Subject|5
948939|NCT01052077|1942007|FG003|Phase B|Withdrawal by Subject|0
948940|NCT01052077|1942004|FG000|Phase B|Protocol Deviation|0
948941|NCT01052077|1942005|FG001|Phase B|Protocol Deviation|3
948942|NCT01052077|1942006|FG002|Phase B|Protocol Deviation|4
948943|NCT01052077|1942007|FG003|Phase B|Protocol Deviation|0
948944|NCT01052077|1942004|FG000|Phase B|Lack of Efficacy|0
948945|NCT01052077|1942005|FG001|Phase B|Lack of Efficacy|1
948946|NCT01052077|1942006|FG002|Phase B|Lack of Efficacy|0
948947|NCT01052077|1942007|FG003|Phase B|Lack of Efficacy|0
948948|NCT01052077|1942004|FG000|Phase A+|Lost to Follow-up|0
948949|NCT01052077|1942005|FG001|Phase A+|Lost to Follow-up|0
948950|NCT01052077|1942006|FG002|Phase A+|Lost to Follow-up|0
948951|NCT01052077|1942007|FG003|Phase A+|Lost to Follow-up|8
948952|NCT01052077|1942004|FG000|Phase A+|Adverse Event|0
948953|NCT01052077|1942005|FG001|Phase A+|Adverse Event|0
948954|NCT01052077|1942006|FG002|Phase A+|Adverse Event|0
948955|NCT01052077|1942007|FG003|Phase A+|Adverse Event|4
948956|NCT01052077|1942004|FG000|Phase A+|Met Withdrawal Criteria|0
948957|NCT01052077|1942005|FG001|Phase A+|Met Withdrawal Criteria|0
948958|NCT01052077|1942006|FG002|Phase A+|Met Withdrawal Criteria|0
948959|NCT01052077|1942007|FG003|Phase A+|Met Withdrawal Criteria|2
948960|NCT01052077|1942004|FG000|Phase A+|Withdrawal by Subject|0
948961|NCT01052077|1942005|FG001|Phase A+|Withdrawal by Subject|0
948962|NCT01052077|1942006|FG002|Phase A+|Withdrawal by Subject|0
948963|NCT01052077|1942007|FG003|Phase A+|Withdrawal by Subject|7
948964|NCT01052103|1942015|FG000|Overall Study|Adverse Event|10
948965|NCT01052103|1942016|FG001|Overall Study|Adverse Event|6
948966|NCT01052103|1942015|FG000|Overall Study|Entry Criteria Not Met|3
948967|NCT01052103|1942016|FG001|Overall Study|Entry Criteria Not Met|1
948968|NCT01052103|1942015|FG000|Overall Study|Lost to Follow-up|3
948969|NCT01052103|1942016|FG001|Overall Study|Lost to Follow-up|5
948970|NCT01052103|1942015|FG000|Overall Study|Protocol Violation|10
948971|NCT01052103|1942016|FG001|Overall Study|Protocol Violation|4
948972|NCT01052103|1942015|FG000|Overall Study|Scheduling conflict|2
948973|NCT01052103|1942016|FG001|Overall Study|Scheduling conflict|1
948974|NCT01052103|1942015|FG000|Overall Study|Sponsor Decision|2
948975|NCT01052103|1942016|FG001|Overall Study|Sponsor Decision|0
948976|NCT01052103|1942015|FG000|Overall Study|Withdrawal by Subject|3
948977|NCT01052103|1942016|FG001|Overall Study|Withdrawal by Subject|6
948978|NCT01052103|1942015|FG000|Overall Study|Perceived Lack of Efficacy|1
948979|NCT01052103|1942016|FG001|Overall Study|Perceived Lack of Efficacy|0
948980|NCT01052116|1942025|FG000|Overall Study|Lost to Follow-up|11
948981|NCT01052116|1942026|FG001|Overall Study|Lost to Follow-up|17
948982|NCT01052116|1942025|FG000|Overall Study|Withdrawal by Subject|3
948983|NCT01052116|1942026|FG001|Overall Study|Withdrawal by Subject|6
948984|NCT01052116|1942025|FG000|Overall Study|Spirometry not performed|0
948985|NCT01052116|1942026|FG001|Overall Study|Spirometry not performed|4
948986|NCT01052272|1942045|FG000|Overall Study|Death|0
948987|NCT01052272|1942046|FG001|Overall Study|Death|0
948988|NCT01052272|1942047|FG002|Overall Study|Death|1
948989|NCT01052272|1942048|FG003|Overall Study|Death|1
948990|NCT01052272|1942045|FG000|Overall Study|Physician Decision|0
948991|NCT01052272|1942046|FG001|Overall Study|Physician Decision|1
948992|NCT01052272|1942047|FG002|Overall Study|Physician Decision|0
948993|NCT01052272|1942048|FG003|Overall Study|Physician Decision|0
948994|NCT01052272|1942045|FG000|Overall Study|patient refuses follow-up|5
948995|NCT01052272|1942046|FG001|Overall Study|patient refuses follow-up|4
948996|NCT01052272|1942047|FG002|Overall Study|patient refuses follow-up|2
948997|NCT01052272|1942048|FG003|Overall Study|patient refuses follow-up|4
948998|NCT01052272|1942045|FG000|Overall Study|Withdrawal by Subject|0
948999|NCT01052272|1942046|FG001|Overall Study|Withdrawal by Subject|2
949000|NCT01052272|1942047|FG002|Overall Study|Withdrawal by Subject|3
949001|NCT01052272|1942048|FG003|Overall Study|Withdrawal by Subject|2
949002|NCT01052272|1942045|FG000|Overall Study|placed in long-term care|0
949003|NCT01052272|1942046|FG001|Overall Study|placed in long-term care|0
949004|NCT01052272|1942047|FG002|Overall Study|placed in long-term care|1
949005|NCT01052272|1942048|FG003|Overall Study|placed in long-term care|0
949006|NCT01052272|1942045|FG000|Overall Study|decline in health|0
949007|NCT01052272|1942046|FG001|Overall Study|decline in health|0
949008|NCT01052272|1942047|FG002|Overall Study|decline in health|1
949009|NCT01052272|1942048|FG003|Overall Study|decline in health|0
949010|NCT01052428|1942060|FG000|Overall Study|Death|1
949011|NCT01052428|1942061|FG001|Overall Study|Death|0
949012|NCT01052428|1942060|FG000|Overall Study|Withdrawal by Subject|0
949013|NCT01052428|1942061|FG001|Overall Study|Withdrawal by Subject|1
949014|NCT01052480|1942069|FG000|Overall Study|Lost to Follow-up|3
949015|NCT01052480|1942070|FG001|Overall Study|Lost to Follow-up|3
949016|NCT01052480|1942069|FG000|Overall Study|Protocol Violation|1
949017|NCT01052480|1942070|FG001|Overall Study|Protocol Violation|0
949018|NCT01052480|1942069|FG000|Overall Study|Withdrawal by Subject|3
949019|NCT01052480|1942070|FG001|Overall Study|Withdrawal by Subject|7
949020|NCT01052480|1942069|FG000|Overall Study|Physician Decision|0
949021|NCT01052480|1942070|FG001|Overall Study|Physician Decision|2
949022|NCT01052480|1942069|FG000|Overall Study|Death|1
949023|NCT01052480|1942070|FG001|Overall Study|Death|5
949024|NCT01052493|1942076|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1
949025|NCT01052493|1942077|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
949026|NCT01052493|1942078|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
949027|NCT01052662|1942115|FG000|Overall Study|Lost to Follow-up|15
949028|NCT01052662|1942116|FG001|Overall Study|Lost to Follow-up|13
949029|NCT01052662|1942117|FG002|Overall Study|Lost to Follow-up|18
949030|NCT01052662|1942115|FG000|Overall Study|Withdrawal by Subject|3
949031|NCT01052662|1942116|FG001|Overall Study|Withdrawal by Subject|2
949032|NCT01052662|1942117|FG002|Overall Study|Withdrawal by Subject|1
949033|NCT01052662|1942115|FG000|Overall Study|Pharmacy issue|1
949034|NCT01052662|1942116|FG001|Overall Study|Pharmacy issue|3
949035|NCT01052662|1942117|FG002|Overall Study|Pharmacy issue|3
949036|NCT01052662|1942115|FG000|Overall Study|Adverse Event|1
949037|NCT01052662|1942116|FG001|Overall Study|Adverse Event|1
949038|NCT01052662|1942117|FG002|Overall Study|Adverse Event|0
949039|NCT01052662|1942115|FG000|Overall Study|Legal Problem|2
949040|NCT01052662|1942116|FG001|Overall Study|Legal Problem|0
949041|NCT01052662|1942117|FG002|Overall Study|Legal Problem|0
949042|NCT01052662|1942115|FG000|Overall Study|Administrative|0
949043|NCT01052662|1942116|FG001|Overall Study|Administrative|3
949044|NCT01052662|1942117|FG002|Overall Study|Administrative|0
949045|NCT01052714|1942136|FG000|Overall Study|Adverse Event|6
949046|NCT01052714|1942137|FG001|Overall Study|Adverse Event|3
949047|NCT01052714|1942138|FG002|Overall Study|Adverse Event|0
949048|NCT01052714|1942136|FG000|Overall Study|Death|1
949049|NCT01052714|1942137|FG001|Overall Study|Death|2
949050|NCT01052714|1942138|FG002|Overall Study|Death|0
949051|NCT01052714|1942136|FG000|Overall Study|Lost to Follow-up|2
949052|NCT01052714|1942137|FG001|Overall Study|Lost to Follow-up|3
949053|NCT01052714|1942138|FG002|Overall Study|Lost to Follow-up|0
949054|NCT01052714|1942136|FG000|Overall Study|Physician Decision|9
949055|NCT01052714|1942137|FG001|Overall Study|Physician Decision|9
949056|NCT01052714|1942138|FG002|Overall Study|Physician Decision|1
949057|NCT01052714|1942136|FG000|Overall Study|Withdrawal by Subject|7
949058|NCT01052714|1942137|FG001|Overall Study|Withdrawal by Subject|12
949059|NCT01052714|1942138|FG002|Overall Study|Withdrawal by Subject|1
949060|NCT01052779|1942146|FG000|Overall Study|Adverse Event|1
949061|NCT01052779|1942147|FG001|Overall Study|Adverse Event|4
949062|NCT01052779|1942146|FG000|Overall Study|Withdrawal by Subject|1
949063|NCT01052779|1942147|FG001|Overall Study|Withdrawal by Subject|2
949064|NCT01052779|1942146|FG000|Overall Study|Other-Protocol Violation|1
949065|NCT01052779|1942147|FG001|Overall Study|Other-Protocol Violation|1
949066|NCT01052779|1942146|FG000|Overall Study|Other-Surgery|0
949067|NCT01052779|1942147|FG001|Overall Study|Other-Surgery|2
949068|NCT01052779|1942146|FG000|Overall Study|Other-Missed Week 5 Visit|2
949069|NCT01052779|1942147|FG001|Overall Study|Other-Missed Week 5 Visit|0
949070|NCT01052844|1942164|FG000|Overall Study|Adverse Event|0
949071|NCT01052844|1942165|FG001|Overall Study|Adverse Event|1
949072|NCT01053247|1942326|FG000|Overall Study|Withdrawal by Subject|9
949073|NCT01053247|1942327|FG001|Overall Study|Withdrawal by Subject|4
949074|NCT01053247|1942328|FG002|Overall Study|Withdrawal by Subject|15
949075|NCT01053247|1942326|FG000|Overall Study|Lack of Efficacy|1
949076|NCT01053247|1942327|FG001|Overall Study|Lack of Efficacy|0
949077|NCT01053247|1942328|FG002|Overall Study|Lack of Efficacy|1
949078|NCT01053247|1942326|FG000|Overall Study|Protocol Violation|2
949079|NCT01053247|1942327|FG001|Overall Study|Protocol Violation|1
949080|NCT01053247|1942328|FG002|Overall Study|Protocol Violation|2
949081|NCT01053247|1942326|FG000|Overall Study|Lost to Follow-up|8
949082|NCT01053247|1942327|FG001|Overall Study|Lost to Follow-up|5
949083|NCT01053247|1942328|FG002|Overall Study|Lost to Follow-up|7
949084|NCT01053247|1942326|FG000|Overall Study|Adverse Event|0
949085|NCT01053247|1942327|FG001|Overall Study|Adverse Event|9
949086|NCT01053247|1942328|FG002|Overall Study|Adverse Event|3
949087|NCT01053429|1942354|FG000|Overall Study|Adverse Event|64
949088|NCT01053429|1942354|FG000|Overall Study|Other|309
949089|NCT01053663|1942379|FG000|Overall Study|Death|2
949090|NCT01053663|1942379|FG000|Overall Study|Lost to Follow-up|1
949091|NCT01053663|1942379|FG000|Overall Study|Poor IV Access|1
949092|NCT01053663|1942379|FG000|Overall Study|Transferred to Another Hospital|1
949093|NCT01053663|1942379|FG000|Overall Study|Negative Influenza Diagnosis|1
949094|NCT01053741|1942391|FG000|2nd Study Intervention|Physician Decision|0
949095|NCT01053741|1942392|FG001|2nd Study Intervention|Physician Decision|1
949096|NCT01053962|1942418|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0
949097|NCT01053962|1942419|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0
949098|NCT01053962|1942420|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0
949099|NCT01053962|1942421|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1
949100|NCT01053962|1942422|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2
949101|NCT01053962|1942418|FG000|Pretreatment Period|Venipuncture Failure|0
949102|NCT01053962|1942419|FG001|Pretreatment Period|Venipuncture Failure|0
949103|NCT01053962|1942420|FG002|Pretreatment Period|Venipuncture Failure|1
949104|NCT01053962|1942421|FG003|Pretreatment Period|Venipuncture Failure|0
949105|NCT01053962|1942422|FG004|Pretreatment Period|Venipuncture Failure|0
949106|NCT01053962|1942418|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0
949107|NCT01053962|1942419|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1
949108|NCT01053962|1942420|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0
949109|NCT01053962|1942421|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0
949110|NCT01053962|1942422|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0
949111|NCT01053962|1942418|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0
949112|NCT01053962|1942419|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0
949113|NCT01053962|1942420|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0
949114|NCT01053962|1942421|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1
949115|NCT01053962|1942422|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0
949116|NCT01053962|1942418|FG000|Treatment Period|Lack of Efficacy|0
949117|NCT01053962|1942419|FG001|Treatment Period|Lack of Efficacy|0
949118|NCT01053962|1942420|FG002|Treatment Period|Lack of Efficacy|0
949119|NCT01053962|1942421|FG003|Treatment Period|Lack of Efficacy|0
949120|NCT01053962|1942422|FG004|Treatment Period|Lack of Efficacy|1
949121|NCT01053962|1942418|FG000|Treatment Period|Adverse Event|0
949122|NCT01053962|1942419|FG001|Treatment Period|Adverse Event|0
949123|NCT01053962|1942420|FG002|Treatment Period|Adverse Event|0
949124|NCT01053962|1942421|FG003|Treatment Period|Adverse Event|0
949125|NCT01053962|1942422|FG004|Treatment Period|Adverse Event|1
949126|NCT01053962|1942418|FG000|Treatment Period|Withdrawal by Subject|0
949127|NCT01053962|1942419|FG001|Treatment Period|Withdrawal by Subject|0
949128|NCT01053962|1942420|FG002|Treatment Period|Withdrawal by Subject|0
949129|NCT01053962|1942421|FG003|Treatment Period|Withdrawal by Subject|0
949130|NCT01053962|1942422|FG004|Treatment Period|Withdrawal by Subject|1
949131|NCT01053962|1942418|FG000|Treatment Period|Noncompliance with protocol|1
949132|NCT01053962|1942419|FG001|Treatment Period|Noncompliance with protocol|0
949133|NCT01053962|1942420|FG002|Treatment Period|Noncompliance with protocol|0
949134|NCT01053962|1942421|FG003|Treatment Period|Noncompliance with protocol|0
949135|NCT01053962|1942422|FG004|Treatment Period|Noncompliance with protocol|0
949136|NCT01053988|1942444|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
949137|NCT01053988|1942445|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
949138|NCT01053988|1942446|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
949139|NCT01053988|1942447|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
949140|NCT01053988|1942448|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
949141|NCT01053988|1942449|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
949142|NCT01053988|1942444|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
949143|NCT01053988|1942445|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
949144|NCT01053988|1942446|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
949145|NCT01053988|1942447|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
949146|NCT01053988|1942448|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
949147|NCT01053988|1942449|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
949148|NCT01053988|1942444|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
949149|NCT01053988|1942445|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
949150|NCT01053988|1942446|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
949151|NCT01053988|1942447|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
949152|NCT01053988|1942448|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
949153|NCT01053988|1942449|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
949154|NCT01053988|1942444|FG000|2-week, Single-blind Run-In Period|Adverse Event|6
949155|NCT01053988|1942445|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
949156|NCT01053988|1942446|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
949157|NCT01053988|1942447|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
949158|NCT01053988|1942448|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
949159|NCT01053988|1942449|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
949160|NCT01053988|1942444|FG000|2-week, Single-blind Run-In Period|Physician Decision|5
949161|NCT01053988|1942445|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
949162|NCT01053988|1942446|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
949163|NCT01053988|1942447|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
949164|NCT01053988|1942448|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
949165|NCT01053988|1942449|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
949166|NCT01053988|1942444|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
949167|NCT01053988|1942445|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
949168|NCT01053988|1942446|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
949169|NCT01053988|1942447|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
949170|NCT01053988|1942448|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
949171|NCT01053988|1942449|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
949172|NCT01053988|1942444|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
949173|NCT01053988|1942445|FG001|24-week, Double-blind Treatment Period|Adverse Event|15
949174|NCT01053988|1942446|FG002|24-week, Double-blind Treatment Period|Adverse Event|23
949175|NCT01053988|1942447|FG003|24-week, Double-blind Treatment Period|Adverse Event|24
949176|NCT01053988|1942448|FG004|24-week, Double-blind Treatment Period|Adverse Event|17
949177|NCT01053988|1942449|FG005|24-week, Double-blind Treatment Period|Adverse Event|14
949178|NCT01053988|1942444|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
949179|NCT01053988|1942445|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
949180|NCT01053988|1942446|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
949181|NCT01053988|1942447|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
949182|NCT01053988|1942448|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
949183|NCT01053988|1942449|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
949184|NCT01053988|1942444|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
949185|NCT01053988|1942445|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
949186|NCT01053988|1942446|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
949187|NCT01053988|1942447|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
949188|NCT01053988|1942448|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
949189|NCT01053988|1942449|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
949190|NCT01053988|1942444|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
949191|NCT01053988|1942445|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3
949192|NCT01053988|1942446|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4
949193|NCT01053988|1942447|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
949194|NCT01053988|1942448|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
949195|NCT01053988|1942449|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4
949196|NCT01053988|1942444|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
949197|NCT01053988|1942445|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
949198|NCT01053988|1942446|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
949199|NCT01053988|1942447|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
949200|NCT01053988|1942448|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
949201|NCT01053988|1942449|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
949202|NCT01053988|1942444|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
949203|NCT01053988|1942445|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4
949204|NCT01053988|1942446|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
949205|NCT01053988|1942447|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2
949206|NCT01053988|1942448|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
949207|NCT01053988|1942449|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3
949208|NCT01053988|1942444|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
949209|NCT01053988|1942445|FG001|24-week, Double-blind Treatment Period|Physician Decision|5
949210|NCT01053988|1942446|FG002|24-week, Double-blind Treatment Period|Physician Decision|2
949211|NCT01053988|1942447|FG003|24-week, Double-blind Treatment Period|Physician Decision|5
949212|NCT01053988|1942448|FG004|24-week, Double-blind Treatment Period|Physician Decision|5
949213|NCT01053988|1942449|FG005|24-week, Double-blind Treatment Period|Physician Decision|4
949214|NCT01053988|1942444|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
949215|NCT01053988|1942445|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
949216|NCT01053988|1942446|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
949217|NCT01053988|1942447|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
949218|NCT01053988|1942448|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
949219|NCT01053988|1942449|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
949220|NCT01054144|1942465|FG000|Overall Study|Death|2
949221|NCT01054170|1942474|FG000|Overall Study|Protocol Violation|1
949222|NCT01054170|1942475|FG001|Overall Study|Protocol Violation|0
949223|NCT01054170|1942474|FG000|Overall Study|Withdrawal by Subject|3
949224|NCT01054170|1942475|FG001|Overall Study|Withdrawal by Subject|2
949225|NCT01054170|1942474|FG000|Overall Study|Adverse Event|0
949226|NCT01054170|1942475|FG001|Overall Study|Adverse Event|4
949227|NCT01054222|1942499|FG000|Overall Study|Lack of Efficacy|1
949228|NCT01054222|1942499|FG000|Overall Study|Lost to Follow-up|4
949229|NCT01054222|1942499|FG000|Overall Study|Withdrawal by Subject|6
949230|NCT01054300|1942505|FG000|Period 1|Adverse Event|1
949231|NCT01054300|1942506|FG001|Period 1|Adverse Event|0
949232|NCT01054300|1942507|FG002|Period 1|Adverse Event|0
949233|NCT01054300|1942508|FG003|Period 1|Adverse Event|0
949234|NCT01054300|1942505|FG000|Period 2|Withdrawal by Subject|0
949235|NCT01054300|1942506|FG001|Period 2|Withdrawal by Subject|0
949236|NCT01054300|1942507|FG002|Period 2|Withdrawal by Subject|1
949237|NCT01054300|1942508|FG003|Period 2|Withdrawal by Subject|0
949238|NCT01054443|1942546|FG000|Overall Study|Withdrawal by Subject|0
949239|NCT01054443|1942547|FG001|Overall Study|Withdrawal by Subject|0
949240|NCT01054443|1942548|FG002|Overall Study|Withdrawal by Subject|0
949241|NCT01054443|1942549|FG003|Overall Study|Withdrawal by Subject|1
949242|NCT01054456|1942562|FG000|Overall Study|Other|1
949243|NCT01054560|1942568|FG000|Overall Study|Death|10
949244|NCT01054560|1942569|FG001|Overall Study|Death|21
949245|NCT01054560|1942568|FG000|Overall Study|Lost to Follow-up|2
949246|NCT01054560|1942569|FG001|Overall Study|Lost to Follow-up|5
949247|NCT01054560|1942568|FG000|Overall Study|Withdrawal by Subject|0
949248|NCT01054560|1942569|FG001|Overall Study|Withdrawal by Subject|2
949249|NCT01054560|1942568|FG000|Overall Study|Physician Decision|1
949250|NCT01054560|1942569|FG001|Overall Study|Physician Decision|0
949251|NCT01054573|1942581|FG000|Overall Study|Adverse Event|1
949252|NCT01054573|1942582|FG001|Overall Study|Adverse Event|0
949253|NCT01054573|1942583|FG002|Overall Study|Adverse Event|1
949254|NCT01054573|1942584|FG003|Overall Study|Adverse Event|1
949255|NCT01054573|1942581|FG000|Overall Study|Lost to Follow-up|0
949256|NCT01054573|1942582|FG001|Overall Study|Lost to Follow-up|2
949257|NCT01054573|1942583|FG002|Overall Study|Lost to Follow-up|0
949258|NCT01054573|1942584|FG003|Overall Study|Lost to Follow-up|0
949259|NCT01054573|1942581|FG000|Overall Study|Withdrawal by Subject|0
949260|NCT01054573|1942582|FG001|Overall Study|Withdrawal by Subject|2
949261|NCT01054573|1942583|FG002|Overall Study|Withdrawal by Subject|2
949262|NCT01054573|1942584|FG003|Overall Study|Withdrawal by Subject|1
949263|NCT01054599|1942632|FG000|Overall Study|Dizziness due to phenytoin toxicity|1
949264|NCT01054599|1942633|FG001|Overall Study|Dizziness due to phenytoin toxicity|0
949265|NCT01054599|1942632|FG000|Overall Study|Protocol Violation|1
949266|NCT01054599|1942633|FG001|Overall Study|Protocol Violation|0
949267|NCT01054599|1942632|FG000|Overall Study|Spells/seizure-like episodes|1
949268|NCT01054599|1942633|FG001|Overall Study|Spells/seizure-like episodes|1
949269|NCT01054599|1942632|FG000|Overall Study|Timing/scheduling difficulties|1
949270|NCT01054599|1942633|FG001|Overall Study|Timing/scheduling difficulties|1
949271|NCT01054599|1942632|FG000|Overall Study|Visual impairment, WTAR <80|0
949272|NCT01054599|1942633|FG001|Overall Study|Visual impairment, WTAR <80|1
949273|NCT01054599|1942632|FG000|Overall Study|Lost to Follow-up|0
949274|NCT01054599|1942633|FG001|Overall Study|Lost to Follow-up|2
949275|NCT01054599|1942632|FG000|Overall Study|Adverse Event|0
949276|NCT01054599|1942633|FG001|Overall Study|Adverse Event|1
949277|NCT01054599|1942632|FG000|Overall Study|Withdrawal by Subject|0
949278|NCT01054599|1942633|FG001|Overall Study|Withdrawal by Subject|1
949279|NCT01054729|1942660|FG000|Overall Study|Randomized but Not Treated|0
949280|NCT01054729|1942661|FG001|Overall Study|Randomized but Not Treated|1
949281|NCT01054729|1942662|FG002|Overall Study|Randomized but Not Treated|0
949282|NCT01054729|1942663|FG003|Overall Study|Randomized but Not Treated|0
949283|NCT01054729|1942660|FG000|Overall Study|Adverse Event|1
949284|NCT01054729|1942661|FG001|Overall Study|Adverse Event|1
949285|NCT01054729|1942662|FG002|Overall Study|Adverse Event|2
949286|NCT01054729|1942663|FG003|Overall Study|Adverse Event|1
949287|NCT01054729|1942660|FG000|Overall Study|Withdrawal by Subject|1
949288|NCT01054729|1942661|FG001|Overall Study|Withdrawal by Subject|0
949289|NCT01054729|1942662|FG002|Overall Study|Withdrawal by Subject|1
949290|NCT01054729|1942663|FG003|Overall Study|Withdrawal by Subject|0
949291|NCT01054729|1942660|FG000|Overall Study|Lost to Follow-up|0
949292|NCT01054729|1942661|FG001|Overall Study|Lost to Follow-up|1
949293|NCT01054729|1942662|FG002|Overall Study|Lost to Follow-up|0
949294|NCT01054729|1942663|FG003|Overall Study|Lost to Follow-up|0
949295|NCT01054729|1942660|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0
949296|NCT01054729|1942661|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1
949297|NCT01054729|1942662|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0
949298|NCT01054729|1942663|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0
949299|NCT01054729|1942660|FG000|Overall Study|Non-responder|1
949300|NCT01054729|1942661|FG001|Overall Study|Non-responder|0
949301|NCT01054729|1942662|FG002|Overall Study|Non-responder|1
949302|NCT01054729|1942663|FG003|Overall Study|Non-responder|1
949303|NCT01054729|1942660|FG000|Overall Study|PEG/RBV Non-responder|1
949304|NCT01054729|1942661|FG001|Overall Study|PEG/RBV Non-responder|0
949305|NCT01054729|1942662|FG002|Overall Study|PEG/RBV Non-responder|1
949306|NCT01054729|1942663|FG003|Overall Study|PEG/RBV Non-responder|0
949307|NCT01054729|1942660|FG000|Overall Study|Personal/Obligations|0
949308|NCT01054729|1942661|FG001|Overall Study|Personal/Obligations|1
949309|NCT01054729|1942662|FG002|Overall Study|Personal/Obligations|0
949310|NCT01054729|1942663|FG003|Overall Study|Personal/Obligations|0
949311|NCT01054729|1942660|FG000|Overall Study|Subject moved|0
949312|NCT01054729|1942661|FG001|Overall Study|Subject moved|0
949313|NCT01054729|1942662|FG002|Overall Study|Subject moved|1
949314|NCT01054729|1942663|FG003|Overall Study|Subject moved|0
949315|NCT01054729|1942660|FG000|Overall Study|Lack of Efficacy|0
949316|NCT01054729|1942661|FG001|Overall Study|Lack of Efficacy|0
949317|NCT01054729|1942662|FG002|Overall Study|Lack of Efficacy|0
949318|NCT01054729|1942663|FG003|Overall Study|Lack of Efficacy|1
949319|NCT01054820|1942686|FG000|Overall Study|Withdrawal by Subject|2
949320|NCT01054846|1942692|FG000|Overall Study|Lost to Follow-up|76
949321|NCT01054846|1942693|FG001|Overall Study|Lost to Follow-up|17
949322|NCT01054885|1942704|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
949323|NCT01054885|1942705|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
949324|NCT01054885|1942706|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
949325|NCT01054885|1942707|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
949326|NCT01054885|1942708|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
949327|NCT01054885|1942709|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
949328|NCT01054885|1942710|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
949329|NCT01054885|1942704|FG000|2-week, Single-blind Run-In Period|Physician Decision|6
949330|NCT01054885|1942705|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
949331|NCT01054885|1942706|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
949332|NCT01054885|1942707|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
949333|NCT01054885|1942708|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
949334|NCT01054885|1942709|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
949335|NCT01054885|1942710|FG006|2-week, Single-blind Run-In Period|Physician Decision|0
949336|NCT01054885|1942704|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
949337|NCT01054885|1942705|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
949338|NCT01054885|1942706|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
949339|NCT01054885|1942707|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
949340|NCT01054885|1942708|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
949341|NCT01054885|1942709|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
949342|NCT01054885|1942710|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
949343|NCT01054885|1942704|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
949344|NCT01054885|1942705|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
949345|NCT01054885|1942706|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
949346|NCT01054885|1942707|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
949347|NCT01054885|1942708|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
949348|NCT01054885|1942709|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
949349|NCT01054885|1942710|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0
949350|NCT01054885|1942704|FG000|2-week, Single-blind Run-In Period|Adverse Event|7
949351|NCT01054885|1942705|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
949352|NCT01054885|1942706|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
949353|NCT01054885|1942707|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
949354|NCT01054885|1942708|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
949355|NCT01054885|1942709|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
949356|NCT01054885|1942710|FG006|2-week, Single-blind Run-In Period|Adverse Event|0
949357|NCT01054885|1942704|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
949358|NCT01054885|1942705|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
949359|NCT01054885|1942706|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
949360|NCT01054885|1942707|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
949361|NCT01054885|1942708|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
949362|NCT01054885|1942709|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
949363|NCT01054885|1942710|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
949364|NCT01054885|1942704|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
949365|NCT01054885|1942705|FG001|24-week, Double-blind Treatment Period|Adverse Event|18
949366|NCT01054885|1942706|FG002|24-week, Double-blind Treatment Period|Adverse Event|12
949367|NCT01054885|1942707|FG003|24-week, Double-blind Treatment Period|Adverse Event|15
949368|NCT01054885|1942708|FG004|24-week, Double-blind Treatment Period|Adverse Event|15
949369|NCT01054885|1942709|FG005|24-week, Double-blind Treatment Period|Adverse Event|17
949370|NCT01054885|1942710|FG006|24-week, Double-blind Treatment Period|Adverse Event|19
949371|NCT01054885|1942704|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
949372|NCT01054885|1942705|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
949373|NCT01054885|1942706|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
949374|NCT01054885|1942707|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
949375|NCT01054885|1942708|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
949376|NCT01054885|1942709|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
949377|NCT01054885|1942710|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
949378|NCT01054885|1942704|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
949379|NCT01054885|1942705|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
949380|NCT01054885|1942706|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
949381|NCT01054885|1942707|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
949382|NCT01054885|1942708|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
949383|NCT01054885|1942709|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
949384|NCT01054885|1942710|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
949385|NCT01054885|1942704|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
949386|NCT01054885|1942705|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7
949387|NCT01054885|1942706|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7
949388|NCT01054885|1942707|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
949389|NCT01054885|1942708|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3
949390|NCT01054885|1942709|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8
949391|NCT01054885|1942710|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4
949392|NCT01054885|1942704|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
949393|NCT01054885|1942705|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
949394|NCT01054885|1942706|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
949395|NCT01054885|1942707|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
949396|NCT01054885|1942708|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
949397|NCT01054885|1942709|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
949398|NCT01054885|1942710|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
949399|NCT01054885|1942704|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
949400|NCT01054885|1942705|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
949401|NCT01054885|1942706|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
949402|NCT01054885|1942707|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
949403|NCT01054885|1942708|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
949404|NCT01054885|1942709|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
949405|NCT01054885|1942710|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
949406|NCT01054885|1942704|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
949407|NCT01054885|1942705|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
949408|NCT01054885|1942706|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2
949409|NCT01054885|1942707|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
949410|NCT01054885|1942708|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0
949411|NCT01054885|1942709|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2
949412|NCT01054885|1942710|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1
949413|NCT01054885|1942704|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
949414|NCT01054885|1942705|FG001|24-week, Double-blind Treatment Period|Physician Decision|4
949415|NCT01054885|1942706|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
949416|NCT01054885|1942707|FG003|24-week, Double-blind Treatment Period|Physician Decision|6
949417|NCT01054885|1942708|FG004|24-week, Double-blind Treatment Period|Physician Decision|3
949418|NCT01054885|1942709|FG005|24-week, Double-blind Treatment Period|Physician Decision|1
949419|NCT01054885|1942710|FG006|24-week, Double-blind Treatment Period|Physician Decision|1
949420|NCT01054885|1942704|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
949421|NCT01054885|1942705|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
949422|NCT01054885|1942706|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
949423|NCT01054885|1942707|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
949424|NCT01054885|1942708|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
949425|NCT01054885|1942709|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
949426|NCT01054885|1942710|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
949427|NCT01054976|1942731|FG000|Overall Study|Adverse Event|16
949428|NCT01054976|1942731|FG000|Overall Study|Uncooperative participations to study|7
949429|NCT01054976|1942731|FG000|Overall Study|Withdrawal by Subject|4
949430|NCT01054976|1942731|FG000|Overall Study|Other|8
949431|NCT01055028|1942737|FG000|Screening|Screen Failure|1
949432|NCT01055028|1942738|FG001|Screening|Screen Failure|1
949433|NCT01055028|1942737|FG000|Treatment Cycles 1 to 3|Adverse Event|0
949434|NCT01055028|1942738|FG001|Treatment Cycles 1 to 3|Adverse Event|1
949435|NCT01055028|1942737|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
949436|NCT01055028|1942738|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
949437|NCT01055028|1942737|FG000|Inter-treatment Period|Did not start Cycle 4|0
949438|NCT01055028|1942738|FG001|Inter-treatment Period|Did not start Cycle 4|3
949439|NCT01055132|1942754|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
949440|NCT01055132|1942755|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
949441|NCT01055132|1942754|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
949442|NCT01055132|1942755|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
949443|NCT01055197|1942780|FG000|Overall Study|Protocol Violation|7
949444|NCT01055197|1942781|FG001|Overall Study|Protocol Violation|2
949445|NCT01055197|1942780|FG000|Overall Study|Withdrawal by Subject|2
949446|NCT01055197|1942781|FG001|Overall Study|Withdrawal by Subject|0
949447|NCT01055262|1942800|FG000|Overall Study|Adverse Event|5
949448|NCT01055262|1942800|FG000|Overall Study|Protocol Violation|3
949449|NCT01055262|1942800|FG000|Overall Study|Uncooperativeness|1
949450|NCT01055314|1942806|FG000|Overall Study|Adverse Event|7
949451|NCT01055314|1942807|FG001|Overall Study|Adverse Event|4
949452|NCT01055314|1942806|FG000|Overall Study|Death|2
949453|NCT01055314|1942807|FG001|Overall Study|Death|1
949454|NCT01055314|1942806|FG000|Overall Study|Lack of Efficacy|11
949455|NCT01055314|1942807|FG001|Overall Study|Lack of Efficacy|19
949456|NCT01055314|1942806|FG000|Overall Study|Physician Decision|10
949457|NCT01055314|1942807|FG001|Overall Study|Physician Decision|5
949458|NCT01055314|1942806|FG000|Overall Study|Withdrawal by Subject|1
949459|NCT01055314|1942807|FG001|Overall Study|Withdrawal by Subject|0
949460|NCT01055314|1942806|FG000|Overall Study|Ineligible|3
949461|NCT01055314|1942807|FG001|Overall Study|Ineligible|5
949462|NCT01055314|1942806|FG000|Overall Study|Refusal of further protocol therapy|10
949463|NCT01055314|1942807|FG001|Overall Study|Refusal of further protocol therapy|4
949464|NCT01055314|1942806|FG000|Overall Study|No treatment|1
949465|NCT01055314|1942807|FG001|Overall Study|No treatment|0
949466|NCT01055457|1942824|FG000|Overall Study|Lost to Follow-up|0
949467|NCT01055457|1942825|FG001|Overall Study|Lost to Follow-up|1
949468|NCT01055457|1942826|FG002|Overall Study|Lost to Follow-up|0
949469|NCT01055457|1942827|FG003|Overall Study|Lost to Follow-up|0
949470|NCT01055457|1942828|FG004|Overall Study|Lost to Follow-up|0
949471|NCT01055457|1942829|FG005|Overall Study|Lost to Follow-up|1
949472|NCT01055457|1942830|FG006|Overall Study|Lost to Follow-up|0
949473|NCT01055457|1942831|FG007|Overall Study|Lost to Follow-up|0
949474|NCT01055457|1942832|FG008|Overall Study|Lost to Follow-up|0
949475|NCT01055457|1942833|FG009|Overall Study|Lost to Follow-up|0
949476|NCT01055457|1942824|FG000|Overall Study|Protocol Violation|0
949477|NCT01055457|1942825|FG001|Overall Study|Protocol Violation|0
949478|NCT01055457|1942826|FG002|Overall Study|Protocol Violation|1
949479|NCT01055457|1942827|FG003|Overall Study|Protocol Violation|1
949480|NCT01055457|1942828|FG004|Overall Study|Protocol Violation|1
949481|NCT01055457|1942829|FG005|Overall Study|Protocol Violation|2
949482|NCT01055457|1942830|FG006|Overall Study|Protocol Violation|1
949483|NCT01055457|1942831|FG007|Overall Study|Protocol Violation|0
949484|NCT01055457|1942832|FG008|Overall Study|Protocol Violation|0
949485|NCT01055457|1942833|FG009|Overall Study|Protocol Violation|1
949486|NCT01055457|1942824|FG000|Overall Study|Subject Disinterest|0
949487|NCT01055457|1942825|FG001|Overall Study|Subject Disinterest|0
949488|NCT01055457|1942826|FG002|Overall Study|Subject Disinterest|0
949489|NCT01055457|1942827|FG003|Overall Study|Subject Disinterest|0
949490|NCT01055457|1942828|FG004|Overall Study|Subject Disinterest|0
949491|NCT01055457|1942829|FG005|Overall Study|Subject Disinterest|0
949492|NCT01055457|1942830|FG006|Overall Study|Subject Disinterest|0
949493|NCT01055457|1942831|FG007|Overall Study|Subject Disinterest|1
949494|NCT01055457|1942832|FG008|Overall Study|Subject Disinterest|0
949495|NCT01055457|1942833|FG009|Overall Study|Subject Disinterest|0
949496|NCT01055457|1942824|FG000|Overall Study|Subject Ineligible|1
949497|NCT01055457|1942825|FG001|Overall Study|Subject Ineligible|0
949498|NCT01055457|1942826|FG002|Overall Study|Subject Ineligible|1
949499|NCT01055457|1942827|FG003|Overall Study|Subject Ineligible|0
949500|NCT01055457|1942828|FG004|Overall Study|Subject Ineligible|1
949501|NCT01055457|1942829|FG005|Overall Study|Subject Ineligible|0
949502|NCT01055457|1942830|FG006|Overall Study|Subject Ineligible|0
949503|NCT01055457|1942831|FG007|Overall Study|Subject Ineligible|0
949504|NCT01055457|1942832|FG008|Overall Study|Subject Ineligible|0
949505|NCT01055457|1942833|FG009|Overall Study|Subject Ineligible|0
949506|NCT01055457|1942824|FG000|Overall Study|Discomfort|0
949507|NCT01055457|1942825|FG001|Overall Study|Discomfort|0
949508|NCT01055457|1942826|FG002|Overall Study|Discomfort|0
949509|NCT01055457|1942827|FG003|Overall Study|Discomfort|0
949510|NCT01055457|1942828|FG004|Overall Study|Discomfort|1
949511|NCT01055457|1942829|FG005|Overall Study|Discomfort|0
949512|NCT01055457|1942830|FG006|Overall Study|Discomfort|0
949513|NCT01055457|1942831|FG007|Overall Study|Discomfort|0
949514|NCT01055457|1942832|FG008|Overall Study|Discomfort|0
949515|NCT01055457|1942833|FG009|Overall Study|Discomfort|0
949516|NCT01055457|1942824|FG000|Overall Study|Pregnancy|0
949517|NCT01055457|1942825|FG001|Overall Study|Pregnancy|0
949518|NCT01055457|1942826|FG002|Overall Study|Pregnancy|0
949519|NCT01055457|1942827|FG003|Overall Study|Pregnancy|1
949520|NCT01055457|1942828|FG004|Overall Study|Pregnancy|0
949521|NCT01055457|1942829|FG005|Overall Study|Pregnancy|0
949522|NCT01055457|1942830|FG006|Overall Study|Pregnancy|0
949523|NCT01055457|1942831|FG007|Overall Study|Pregnancy|0
949524|NCT01055457|1942832|FG008|Overall Study|Pregnancy|0
949525|NCT01055457|1942833|FG009|Overall Study|Pregnancy|0
949526|NCT01055457|1942824|FG000|Overall Study|Adverse Event|0
949527|NCT01055457|1942825|FG001|Overall Study|Adverse Event|0
949528|NCT01055457|1942826|FG002|Overall Study|Adverse Event|0
949529|NCT01055457|1942827|FG003|Overall Study|Adverse Event|1
949530|NCT01055457|1942828|FG004|Overall Study|Adverse Event|0
949531|NCT01055457|1942829|FG005|Overall Study|Adverse Event|0
949532|NCT01055457|1942830|FG006|Overall Study|Adverse Event|0
949533|NCT01055457|1942831|FG007|Overall Study|Adverse Event|0
949534|NCT01055457|1942832|FG008|Overall Study|Adverse Event|0
949535|NCT01055457|1942833|FG009|Overall Study|Adverse Event|0
949536|NCT01055496|1942857|FG000|Overall Study|Withdrawal by Subject|2
949537|NCT01055496|1942858|FG001|Overall Study|Withdrawal by Subject|4
949538|NCT01055496|1942857|FG000|Overall Study|Death|13
949539|NCT01055496|1942858|FG001|Overall Study|Death|23
949540|NCT01055496|1942857|FG000|Overall Study|Lost to Follow-up|0
949541|NCT01055496|1942858|FG001|Overall Study|Lost to Follow-up|2
949542|NCT01055496|1942857|FG000|Overall Study|Other - Unspecified|0
949543|NCT01055496|1942858|FG001|Overall Study|Other - Unspecified|1
949544|NCT01055613|1942887|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
949545|NCT01055613|1942888|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
949546|NCT01055613|1942887|FG000|Overall Study|Unacceptable lens fit|1
949547|NCT01055613|1942888|FG001|Overall Study|Unacceptable lens fit|0
949548|NCT01055613|1942887|FG000|Overall Study|Discomfort|2
949549|NCT01055613|1942888|FG001|Overall Study|Discomfort|1
949550|NCT01055613|1942887|FG000|Overall Study|Lost to Follow-up|1
949551|NCT01055613|1942888|FG001|Overall Study|Lost to Follow-up|1
949552|NCT01055613|1942887|FG000|Overall Study|Protocol Violation|1
949553|NCT01055613|1942888|FG001|Overall Study|Protocol Violation|1
949554|NCT01055613|1942887|FG000|Overall Study|Subject Disinterest|1
949555|NCT01055613|1942888|FG001|Overall Study|Subject Disinterest|1
949556|NCT01055639|1942896|FG000|Overall Study|Adverse Event|0
949557|NCT01055639|1942897|FG001|Overall Study|Adverse Event|1
949558|NCT01055639|1942896|FG000|Overall Study|Lack of Efficacy|0
949559|NCT01055639|1942897|FG001|Overall Study|Lack of Efficacy|1
949560|NCT01055639|1942896|FG000|Overall Study|Lost to Follow-up|8
949561|NCT01055639|1942897|FG001|Overall Study|Lost to Follow-up|11
949562|NCT01055639|1942896|FG000|Overall Study|Protocol Violation|5
949563|NCT01055639|1942897|FG001|Overall Study|Protocol Violation|5
949564|NCT01055639|1942896|FG000|Overall Study|Withdrawal by Subject|8
949565|NCT01055639|1942897|FG001|Overall Study|Withdrawal by Subject|11
949566|NCT01055834|1942941|FG000|Treatment Period I|Adverse Event|1
949567|NCT01055834|1942942|FG001|Treatment Period I|Adverse Event|0
949568|NCT01055886|1942953|FG000|Overall Study|Withdrawal by Subject|4
949569|NCT01055886|1942954|FG001|Overall Study|Withdrawal by Subject|9
949570|NCT01055886|1942953|FG000|Overall Study|Lost to Follow-up|1
949571|NCT01055886|1942954|FG001|Overall Study|Lost to Follow-up|1
949572|NCT01055886|1942953|FG000|Overall Study|Withdrawal by PI|0
949573|NCT01055886|1942954|FG001|Overall Study|Withdrawal by PI|1
949574|NCT01056107|1942973|FG000|Overall Study|Withdrawal by Subject|0
949575|NCT01056107|1942974|FG001|Overall Study|Withdrawal by Subject|1
949576|NCT01056107|1942975|FG002|Overall Study|Withdrawal by Subject|3
949577|NCT01056107|1942976|FG003|Overall Study|Withdrawal by Subject|0
949578|NCT01056263|1942997|FG000|Overall Study|Adverse Event|12
949579|NCT01056263|1942997|FG000|Overall Study|Death|1
949580|NCT01056263|1942997|FG000|Overall Study|Withdrawal by Subject|1
949581|NCT01056263|1942997|FG000|Overall Study|Lack of Efficacy|29
949582|NCT01056263|1942997|FG000|Overall Study|Progressive disease|2
949583|NCT01056263|1942997|FG000|Overall Study|Neoplasm progression|1
949584|NCT01056263|1942997|FG000|Overall Study|Objective progression or relapse|1
949585|NCT01056263|1942997|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
949586|NCT01056276|1943003|FG000|Treatment Period-Cycles 1-8|Toxicity|2
949587|NCT01056276|1943004|FG001|Treatment Period-Cycles 1-8|Toxicity|1
949588|NCT01056276|1943003|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
949589|NCT01056276|1943004|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
949590|NCT01056276|1943003|FG000|Treatment Period-Cycles 1-8|Disease Progression|2
949591|NCT01056276|1943004|FG001|Treatment Period-Cycles 1-8|Disease Progression|2
949592|NCT01056276|1943003|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1
949593|NCT01056276|1943004|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2
949594|NCT01056276|1943003|FG000|Treatment Period-Cycles 1-8|Physician Decision|3
949595|NCT01056276|1943004|FG001|Treatment Period-Cycles 1-8|Physician Decision|0
949596|NCT01056276|1943003|FG000|Treatment Period-Cycles 1-8|Death|3
949597|NCT01056276|1943004|FG001|Treatment Period-Cycles 1-8|Death|1
949598|NCT01056276|1943003|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1
949599|NCT01056276|1943004|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0
949600|NCT01056276|1943003|FG000|Maintenance Therapy|Toxicity|0
949601|NCT01056276|1943004|FG001|Maintenance Therapy|Toxicity|2
949602|NCT01056276|1943003|FG000|Maintenance Therapy|Progressive Disease|0
949603|NCT01056276|1943004|FG001|Maintenance Therapy|Progressive Disease|9
949604|NCT01056276|1943003|FG000|Maintenance Therapy|Physician Decision|0
949605|NCT01056276|1943004|FG001|Maintenance Therapy|Physician Decision|1
949606|NCT01056276|1943003|FG000|Maintenance Therapy|Withdrawal by Subject|0
949607|NCT01056276|1943004|FG001|Maintenance Therapy|Withdrawal by Subject|1
949608|NCT01056276|1943003|FG000|Maintenance Therapy|Intercurrent Illness|0
949609|NCT01056276|1943004|FG001|Maintenance Therapy|Intercurrent Illness|1
949610|NCT01056276|1943003|FG000|Maintenance Therapy|Continuing maintenance therapy|0
949611|NCT01056276|1943004|FG001|Maintenance Therapy|Continuing maintenance therapy|14
949612|NCT01056289|1943015|FG000|Open-label Phase|Adverse Event|29
949613|NCT01056289|1943016|FG001|Open-label Phase|Adverse Event|0
949614|NCT01056289|1943017|FG002|Open-label Phase|Adverse Event|0
949615|NCT01056289|1943018|FG003|Open-label Phase|Adverse Event|0
949616|NCT01056289|1943015|FG000|Open-label Phase|Lost to Follow-up|30
949617|NCT01056289|1943016|FG001|Open-label Phase|Lost to Follow-up|0
949618|NCT01056289|1943017|FG002|Open-label Phase|Lost to Follow-up|0
949619|NCT01056289|1943018|FG003|Open-label Phase|Lost to Follow-up|0
949620|NCT01056289|1943015|FG000|Open-label Phase|Other|9
949621|NCT01056289|1943016|FG001|Open-label Phase|Other|0
949622|NCT01056289|1943017|FG002|Open-label Phase|Other|0
949623|NCT01056289|1943018|FG003|Open-label Phase|Other|0
949624|NCT01056289|1943015|FG000|Open-label Phase|Protocol Violation|6
949625|NCT01056289|1943016|FG001|Open-label Phase|Protocol Violation|0
949626|NCT01056289|1943017|FG002|Open-label Phase|Protocol Violation|0
949627|NCT01056289|1943018|FG003|Open-label Phase|Protocol Violation|0
949628|NCT01056289|1943015|FG000|Open-label Phase|Withdrawal by Subject|26
949629|NCT01056289|1943016|FG001|Open-label Phase|Withdrawal by Subject|0
949630|NCT01056289|1943017|FG002|Open-label Phase|Withdrawal by Subject|0
949631|NCT01056289|1943018|FG003|Open-label Phase|Withdrawal by Subject|0
949632|NCT01056289|1943015|FG000|Open-label Phase|Lack of Efficacy|18
949633|NCT01056289|1943016|FG001|Open-label Phase|Lack of Efficacy|0
949634|NCT01056289|1943017|FG002|Open-label Phase|Lack of Efficacy|0
949635|NCT01056289|1943018|FG003|Open-label Phase|Lack of Efficacy|0
949636|NCT01056289|1943015|FG000|Open-label Phase|Not randomized to Double-blind phase|1
949637|NCT01056289|1943016|FG001|Open-label Phase|Not randomized to Double-blind phase|0
949638|NCT01056289|1943017|FG002|Open-label Phase|Not randomized to Double-blind phase|0
949639|NCT01056289|1943018|FG003|Open-label Phase|Not randomized to Double-blind phase|0
949640|NCT01056289|1943015|FG000|Double-blind Phase|Adverse Event|0
949641|NCT01056289|1943016|FG001|Double-blind Phase|Adverse Event|1
949642|NCT01056289|1943017|FG002|Double-blind Phase|Adverse Event|2
949643|NCT01056289|1943018|FG003|Double-blind Phase|Adverse Event|1
949644|NCT01056289|1943015|FG000|Double-blind Phase|Lost to Follow-up|0
949645|NCT01056289|1943016|FG001|Double-blind Phase|Lost to Follow-up|2
949646|NCT01056289|1943017|FG002|Double-blind Phase|Lost to Follow-up|2
949647|NCT01056289|1943018|FG003|Double-blind Phase|Lost to Follow-up|2
949648|NCT01056289|1943015|FG000|Double-blind Phase|Other|0
949649|NCT01056289|1943016|FG001|Double-blind Phase|Other|0
949650|NCT01056289|1943017|FG002|Double-blind Phase|Other|1
949651|NCT01056289|1943018|FG003|Double-blind Phase|Other|2
949652|NCT01056289|1943015|FG000|Double-blind Phase|Protocol Violation|0
949653|NCT01056289|1943016|FG001|Double-blind Phase|Protocol Violation|0
949654|NCT01056289|1943017|FG002|Double-blind Phase|Protocol Violation|1
949655|NCT01056289|1943018|FG003|Double-blind Phase|Protocol Violation|1
949656|NCT01056289|1943015|FG000|Double-blind Phase|Withdrawal by Subject|0
949657|NCT01056289|1943016|FG001|Double-blind Phase|Withdrawal by Subject|0
949658|NCT01056289|1943017|FG002|Double-blind Phase|Withdrawal by Subject|4
949659|NCT01056289|1943018|FG003|Double-blind Phase|Withdrawal by Subject|2
949660|NCT01056289|1943015|FG000|Double-blind Phase|Discontinuation symptom|0
949661|NCT01056289|1943016|FG001|Double-blind Phase|Discontinuation symptom|1
949662|NCT01056289|1943017|FG002|Double-blind Phase|Discontinuation symptom|2
949663|NCT01056289|1943018|FG003|Double-blind Phase|Discontinuation symptom|2
949664|NCT01056289|1943015|FG000|Double-blind Phase|Physician Decision|0
949665|NCT01056289|1943016|FG001|Double-blind Phase|Physician Decision|0
949666|NCT01056289|1943017|FG002|Double-blind Phase|Physician Decision|1
949667|NCT01056289|1943018|FG003|Double-blind Phase|Physician Decision|0
949668|NCT01056341|1943050|FG000|Overall Study|Treatment Intolerance|0
949669|NCT01056341|1943051|FG001|Overall Study|Treatment Intolerance|2
949670|NCT01056341|1943052|FG002|Overall Study|Treatment Intolerance|0
949671|NCT01056341|1943053|FG003|Overall Study|Treatment Intolerance|2
949672|NCT01056341|1943054|FG004|Overall Study|Treatment Intolerance|0
949673|NCT01056341|1943050|FG000|Overall Study|Lack of Efficacy|32
949674|NCT01056341|1943051|FG001|Overall Study|Lack of Efficacy|30
949675|NCT01056341|1943052|FG002|Overall Study|Lack of Efficacy|7
949676|NCT01056341|1943053|FG003|Overall Study|Lack of Efficacy|25
949677|NCT01056341|1943054|FG004|Overall Study|Lack of Efficacy|9
949678|NCT01056341|1943050|FG000|Overall Study|Other reasons|4
949679|NCT01056341|1943051|FG001|Overall Study|Other reasons|4
949680|NCT01056341|1943052|FG002|Overall Study|Other reasons|8
949681|NCT01056341|1943053|FG003|Overall Study|Other reasons|9
949682|NCT01056341|1943054|FG004|Overall Study|Other reasons|5
949683|NCT01056380|1943074|FG000|Overall Study|Lost to Follow-up|2
949684|NCT01056380|1943075|FG001|Overall Study|Lost to Follow-up|3
949685|NCT01056484|1943085|FG000|Randomized Controlled Trial|Withdrawal by Subject|6
949686|NCT01056484|1943086|FG001|Randomized Controlled Trial|Withdrawal by Subject|1
949687|NCT01056484|1943085|FG000|Randomized Controlled Trial|Physician Decision|1
949688|NCT01056484|1943086|FG001|Randomized Controlled Trial|Physician Decision|0
949689|NCT01056484|1943085|FG000|Follow up - Non-randomized|Withdrawal by Subject|0
949690|NCT01056484|1943086|FG001|Follow up - Non-randomized|Withdrawal by Subject|2
949691|NCT01056510|1943095|FG000|Overall Study|Dropout Before Start of Treatment|1
949692|NCT01056510|1943096|FG001|Overall Study|Dropout Before Start of Treatment|1
949693|NCT01056510|1943095|FG000|Overall Study|Withdrawal by Subject|4
949694|NCT01056510|1943096|FG001|Overall Study|Withdrawal by Subject|2
910981|NCT00796003|1888104|FG000|Overall Study|Physician Decision|0
910982|NCT00796003|1888105|FG001|Overall Study|Physician Decision|4
910983|NCT00796003|1888104|FG000|Overall Study|Withdrawal by Subject|0
910984|NCT00796003|1888105|FG001|Overall Study|Withdrawal by Subject|1
949695|NCT01056510|1943095|FG000|Overall Study|Death|29
949696|NCT01056510|1943096|FG001|Overall Study|Death|34
949697|NCT01056510|1943095|FG000|Overall Study|Noncompliance|1
949698|NCT01056510|1943096|FG001|Overall Study|Noncompliance|3
949699|NCT01056510|1943095|FG000|Overall Study|Physician Decision|4
949700|NCT01056510|1943096|FG001|Overall Study|Physician Decision|5
949701|NCT01056510|1943095|FG000|Overall Study|Lost to Follow-up|5
949702|NCT01056510|1943096|FG001|Overall Study|Lost to Follow-up|6
949703|NCT01056510|1943095|FG000|Overall Study|Other|10
949704|NCT01056510|1943096|FG001|Overall Study|Other|12
949705|NCT01056510|1943095|FG000|Overall Study|Missing|0
949706|NCT01056510|1943096|FG001|Overall Study|Missing|1
949707|NCT01056523|1943102|FG000|Overall Study|Death|1
949708|NCT01056523|1943103|FG001|Overall Study|Death|0
949709|NCT01056523|1943104|FG002|Overall Study|Death|2
949710|NCT01056523|1943105|FG003|Overall Study|Death|3
949711|NCT01056523|1943106|FG004|Overall Study|Death|0
949712|NCT01056523|1943107|FG005|Overall Study|Death|0
949713|NCT01056523|1943108|FG006|Overall Study|Death|1
949714|NCT01056536|1943116|FG000|Overall Study|Lost to Follow-up|202
949715|NCT01056536|1943117|FG001|Overall Study|Lost to Follow-up|116
949716|NCT01056536|1943118|FG002|Overall Study|Lost to Follow-up|248
949717|NCT01056640|1943132|FG000|Overall Study|Withdrawal by Subject|11
949718|NCT01056640|1943133|FG001|Overall Study|Withdrawal by Subject|8
949719|NCT01056640|1943132|FG000|Overall Study|Death|15
949720|NCT01056640|1943133|FG001|Overall Study|Death|4
949721|NCT01056653|1943142|FG000|Overall Study|Lost to Follow-up|0
949722|NCT01056653|1943143|FG001|Overall Study|Lost to Follow-up|0
949723|NCT01056653|1943144|FG002|Overall Study|Lost to Follow-up|2
949724|NCT01056718|1943153|FG000|Overall Study|Withdrawal by Subject|2
949725|NCT01056718|1943153|FG000|Overall Study|Ischemia on baseline stress test|1
949726|NCT01056822|1943160|FG000|Overall Study|Adverse Event|0
949727|NCT01056822|1943161|FG001|Overall Study|Adverse Event|1
949728|NCT01056822|1943160|FG000|Overall Study|Protocol Violation|6
949729|NCT01056822|1943161|FG001|Overall Study|Protocol Violation|5
949730|NCT01056822|1943160|FG000|Overall Study|Withdrawal by Subject|1
949731|NCT01056822|1943161|FG001|Overall Study|Withdrawal by Subject|1
949732|NCT01056822|1943160|FG000|Overall Study|Lost to Follow-up|1
949733|NCT01056822|1943161|FG001|Overall Study|Lost to Follow-up|0
949734|NCT01057251|1943226|FG000|Overall Study|Did not meet InclusionExclusion criteria|4
949735|NCT01057251|1943227|FG001|Overall Study|Did not meet InclusionExclusion criteria|2
949736|NCT01057251|1943226|FG000|Overall Study|Adverse Event|4
949737|NCT01057251|1943227|FG001|Overall Study|Adverse Event|2
949738|NCT01057251|1943226|FG000|Overall Study|Lack of Efficacy|2
949739|NCT01057251|1943227|FG001|Overall Study|Lack of Efficacy|11
949740|NCT01057251|1943226|FG000|Overall Study|Protocol Violation|6
949741|NCT01057251|1943227|FG001|Overall Study|Protocol Violation|2
949742|NCT01057251|1943226|FG000|Overall Study|Withdrawal by Subject|4
949743|NCT01057251|1943227|FG001|Overall Study|Withdrawal by Subject|5
949744|NCT01057251|1943226|FG000|Overall Study|Lost to Follow-up|7
949745|NCT01057251|1943227|FG001|Overall Study|Lost to Follow-up|6
949746|NCT01057251|1943226|FG000|Overall Study|Other Reason|1
949747|NCT01057251|1943227|FG001|Overall Study|Other Reason|1
949748|NCT01057394|1943254|FG000|Overall Study|Not eligible|0
949749|NCT01057394|1943255|FG001|Overall Study|Not eligible|2
949750|NCT01057433|1943259|FG000|Overall Study|Adverse Event|1
949751|NCT01057589|1943263|FG000|Overall Study|Disease Progression|35
949752|NCT01057589|1943263|FG000|Overall Study|Adverse Event|10
949753|NCT01057589|1943263|FG000|Overall Study|Physician Decision|8
949754|NCT01057589|1943263|FG000|Overall Study|Withdrawal by Subject|3
949755|NCT01057589|1943263|FG000|Overall Study|Sponsor Decision|1
949756|NCT01057589|1943263|FG000|Overall Study|Death|8
949757|NCT01057589|1943263|FG000|Overall Study|Lost to Follow-up|1
949758|NCT01057693|1943267|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45
949759|NCT01057693|1943268|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0
949760|NCT01057693|1943269|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0
949761|NCT01057693|1943267|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
949762|NCT01057693|1943268|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
949763|NCT01057693|1943269|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
949764|NCT01057693|1943267|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
949765|NCT01057693|1943268|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
949766|NCT01057693|1943269|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
949767|NCT01057693|1943267|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
949768|NCT01057693|1943268|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
949769|NCT01057693|1943269|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
949770|NCT01057693|1943267|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
949771|NCT01057693|1943268|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
949772|NCT01057693|1943269|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
949773|NCT01057693|1943267|FG000|Single-Blind Phase (Up to Week 6)|Other|2
949774|NCT01057693|1943268|FG001|Single-Blind Phase (Up to Week 6)|Other|0
949775|NCT01057693|1943269|FG002|Single-Blind Phase (Up to Week 6)|Other|0
949776|NCT01057693|1943267|FG000|Between Single-Blind and Double-Blind|Adverse Event|5
949777|NCT01057693|1943268|FG001|Between Single-Blind and Double-Blind|Adverse Event|0
1090769|NCT02248818|2158525|FG007|Screening|Physician Decision|0
949778|NCT01057693|1943269|FG002|Between Single-Blind and Double-Blind|Adverse Event|0
949779|NCT01057693|1943267|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247
949780|NCT01057693|1943268|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0
949781|NCT01057693|1943269|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0
949782|NCT01057693|1943267|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1
949783|NCT01057693|1943268|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0
949784|NCT01057693|1943269|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0
949785|NCT01057693|1943267|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7
949786|NCT01057693|1943268|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0
949787|NCT01057693|1943269|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0
949788|NCT01057693|1943267|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
949789|NCT01057693|1943268|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
949790|NCT01057693|1943269|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
949791|NCT01057693|1943267|FG000|Between Single-Blind and Double-Blind|Other|6
949792|NCT01057693|1943268|FG001|Between Single-Blind and Double-Blind|Other|0
949793|NCT01057693|1943269|FG002|Between Single-Blind and Double-Blind|Other|0
949794|NCT01057693|1943267|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
949795|NCT01057693|1943268|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
949796|NCT01057693|1943269|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
949797|NCT01057693|1943267|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
949798|NCT01057693|1943268|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
949799|NCT01057693|1943269|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
949800|NCT01057693|1943267|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
949801|NCT01057693|1943268|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
949802|NCT01057693|1943269|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
949803|NCT01057693|1943267|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
949804|NCT01057693|1943268|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
949805|NCT01057693|1943269|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
949806|NCT01057693|1943267|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
949807|NCT01057693|1943268|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
949808|NCT01057693|1943269|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
949809|NCT01057693|1943267|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0
949810|NCT01057693|1943268|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1
949811|NCT01057693|1943269|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0
949812|NCT01057693|1943267|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
949813|NCT01057693|1943268|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
949814|NCT01057693|1943269|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
949815|NCT01057810|1943279|FG000|Overall Study|Disease progression|156
949816|NCT01057810|1943280|FG001|Overall Study|Disease progression|197
949817|NCT01057810|1943279|FG000|Overall Study|Study drug toxicity|5
949818|NCT01057810|1943280|FG001|Overall Study|Study drug toxicity|114
949819|NCT01057810|1943279|FG000|Overall Study|Adverse event unrelated to study drug|13
949820|NCT01057810|1943280|FG001|Overall Study|Adverse event unrelated to study drug|29
949821|NCT01057810|1943279|FG000|Overall Study|Withdrawal by Subject|10
949822|NCT01057810|1943280|FG001|Overall Study|Withdrawal by Subject|25
949823|NCT01057810|1943279|FG000|Overall Study|Death|2
949824|NCT01057810|1943280|FG001|Overall Study|Death|12
949825|NCT01057810|1943279|FG000|Overall Study|Maximum clinical benefit|5
949826|NCT01057810|1943280|FG001|Overall Study|Maximum clinical benefit|5
949827|NCT01057810|1943279|FG000|Overall Study|Poor/non-compliance|0
949828|NCT01057810|1943280|FG001|Overall Study|Poor/non-compliance|1
949829|NCT01057810|1943279|FG000|Overall Study|No longer met study criteria|0
949830|NCT01057810|1943280|FG001|Overall Study|No longer met study criteria|1
949831|NCT01057810|1943279|FG000|Overall Study|Other|7
949832|NCT01057810|1943280|FG001|Overall Study|Other|14
949833|NCT01057862|1943288|FG000|Overall Study|Withdrawal by Subject|1
949834|NCT01057862|1943289|FG001|Overall Study|Withdrawal by Subject|2
949835|NCT01058005|1943318|FG000|Overall Study|Adverse Event|0
949836|NCT01058005|1943319|FG001|Overall Study|Adverse Event|2
949837|NCT01058005|1943320|FG002|Overall Study|Adverse Event|1
949838|NCT01058005|1943318|FG000|Overall Study|Physician Decision|2
949839|NCT01058005|1943319|FG001|Overall Study|Physician Decision|2
949840|NCT01058005|1943320|FG002|Overall Study|Physician Decision|0
949841|NCT01058005|1943318|FG000|Overall Study|Withdrawal by Subject|4
949842|NCT01058005|1943319|FG001|Overall Study|Withdrawal by Subject|5
949843|NCT01058005|1943320|FG002|Overall Study|Withdrawal by Subject|11
949844|NCT01058005|1943318|FG000|Overall Study|Withdrawn Due to Study Termination|27
949845|NCT01058005|1943319|FG001|Overall Study|Withdrawn Due to Study Termination|13
949846|NCT01058005|1943320|FG002|Overall Study|Withdrawn Due to Study Termination|7
949847|NCT01058005|1943318|FG000|Overall Study|Reason Missing|5
949848|NCT01058005|1943319|FG001|Overall Study|Reason Missing|3
949849|NCT01058005|1943320|FG002|Overall Study|Reason Missing|1
949850|NCT01058096|1943335|FG000|Double-blind Treatment Phase|Adverse Event|11
949851|NCT01058096|1943336|FG001|Double-blind Treatment Phase|Adverse Event|15
949852|NCT01058096|1943335|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
949853|NCT01058096|1943336|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
949854|NCT01058096|1943335|FG000|Double-blind Treatment Phase|Protocol Violation|2
949855|NCT01058096|1943336|FG001|Double-blind Treatment Phase|Protocol Violation|1
949856|NCT01058096|1943335|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17
949857|NCT01058096|1943336|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26
949858|NCT01058096|1943335|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
949859|NCT01058096|1943336|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
949860|NCT01058096|1943335|FG000|Double-blind Treatment Phase|Other Unspecified|2
949861|NCT01058096|1943336|FG001|Double-blind Treatment Phase|Other Unspecified|0
949862|NCT01058265|1943348|FG000|Overall Study|Lost to Follow-up|11
949863|NCT01058265|1943349|FG001|Overall Study|Lost to Follow-up|12
949864|NCT01058304|1943357|FG000|Overall Study|Withdrawal by Subject|8
949865|NCT01058304|1943358|FG001|Overall Study|Withdrawal by Subject|5
949866|NCT01058304|1943357|FG000|Overall Study|Lost to Follow-up|13
949867|NCT01058304|1943358|FG001|Overall Study|Lost to Follow-up|16
949868|NCT01058304|1943357|FG000|Overall Study|Developed exclusion criterion|6
949869|NCT01058304|1943358|FG001|Overall Study|Developed exclusion criterion|12
949870|NCT01058356|1943364|FG000|Overall Study|Adverse Event|5
949871|NCT01058356|1943364|FG000|Overall Study|Administration of contraindicated drugs|12
949872|NCT01058356|1943364|FG000|Overall Study|Withdrawal by Subject|21
949873|NCT01058356|1943364|FG000|Overall Study|Lost to Follow-up|4
949874|NCT01058395|1943370|FG000|Overall Study|Death|2
949875|NCT01058395|1943371|FG001|Overall Study|Death|1
949876|NCT01058395|1943370|FG000|Overall Study|Lost to Follow-up|1
949877|NCT01058395|1943371|FG001|Overall Study|Lost to Follow-up|0
949878|NCT01058421|1943379|FG000|1 Month Outcomes|Death|10
949879|NCT01058421|1943380|FG001|1 Month Outcomes|Death|6
949880|NCT01058421|1943379|FG000|1 Month Outcomes|Lost to Follow-up|8
949881|NCT01058421|1943380|FG001|1 Month Outcomes|Lost to Follow-up|7
949882|NCT01058421|1943379|FG000|1 Month Outcomes|Remained in Hospital|5
949883|NCT01058421|1943380|FG001|1 Month Outcomes|Remained in Hospital|12
949884|NCT01058421|1943379|FG000|1 Month Outcomes|Remained in Other Facility|16
949885|NCT01058421|1943380|FG001|1 Month Outcomes|Remained in Other Facility|17
949886|NCT01058421|1943379|FG000|3 Month Outcomes|Death|3
949887|NCT01058421|1943380|FG001|3 Month Outcomes|Death|5
949888|NCT01058421|1943379|FG000|3 Month Outcomes|Lost to Follow-up|12
949889|NCT01058421|1943380|FG001|3 Month Outcomes|Lost to Follow-up|11
949890|NCT01058421|1943379|FG000|3 Month Outcomes|Remained in Hospital|0
949891|NCT01058421|1943380|FG001|3 Month Outcomes|Remained in Hospital|2
949892|NCT01058421|1943379|FG000|3 Month Outcomes|Remained in Other Facility|5
949893|NCT01058421|1943380|FG001|3 Month Outcomes|Remained in Other Facility|8
949894|NCT01058421|1943379|FG000|6 Month Outcomes|Death|2
949895|NCT01058421|1943380|FG001|6 Month Outcomes|Death|2
949896|NCT01058421|1943379|FG000|6 Month Outcomes|Lost to Follow-up|16
949897|NCT01058421|1943380|FG001|6 Month Outcomes|Lost to Follow-up|21
949898|NCT01058421|1943379|FG000|6 Month Outcomes|Remained in Other Facility|1
949899|NCT01058421|1943380|FG001|6 Month Outcomes|Remained in Other Facility|3
949900|NCT01058655|1943390|FG000|Overall Study|Withdrawal by Subject|1
949901|NCT01058655|1943391|FG001|Overall Study|Withdrawal by Subject|0
949902|NCT01058655|1943392|FG002|Overall Study|Withdrawal by Subject|3
949903|NCT01058655|1943393|FG003|Overall Study|Withdrawal by Subject|4
949904|NCT01058655|1943390|FG000|Overall Study|Prolonged Treatment Delay|0
949905|NCT01058655|1943391|FG001|Overall Study|Prolonged Treatment Delay|0
949906|NCT01058655|1943392|FG002|Overall Study|Prolonged Treatment Delay|0
949907|NCT01058655|1943393|FG003|Overall Study|Prolonged Treatment Delay|2
949908|NCT01058655|1943390|FG000|Overall Study|Symptomatic Deterioration|0
949909|NCT01058655|1943391|FG001|Overall Study|Symptomatic Deterioration|0
949910|NCT01058655|1943392|FG002|Overall Study|Symptomatic Deterioration|0
949911|NCT01058655|1943393|FG003|Overall Study|Symptomatic Deterioration|1
949912|NCT01058655|1943390|FG000|Overall Study|Clinical Progression (non-RECIST)|1
949913|NCT01058655|1943391|FG001|Overall Study|Clinical Progression (non-RECIST)|0
949914|NCT01058655|1943392|FG002|Overall Study|Clinical Progression (non-RECIST)|0
949915|NCT01058655|1943393|FG003|Overall Study|Clinical Progression (non-RECIST)|7
949916|NCT01058655|1943390|FG000|Overall Study|Death|0
949917|NCT01058655|1943391|FG001|Overall Study|Death|1
949918|NCT01058655|1943392|FG002|Overall Study|Death|1
949919|NCT01058655|1943393|FG003|Overall Study|Death|0
949920|NCT01058655|1943390|FG000|Overall Study|Disease Progression|1
949921|NCT01058655|1943391|FG001|Overall Study|Disease Progression|2
949922|NCT01058655|1943392|FG002|Overall Study|Disease Progression|4
949923|NCT01058655|1943393|FG003|Overall Study|Disease Progression|24
949924|NCT01058655|1943390|FG000|Overall Study|Other|0
949925|NCT01058655|1943391|FG001|Overall Study|Other|0
949926|NCT01058655|1943392|FG002|Overall Study|Other|0
949927|NCT01058655|1943393|FG003|Overall Study|Other|4
949928|NCT01058668|1943407|FG000|Double-blind Treatment Phase|Adverse Event|8
949929|NCT01058668|1943408|FG001|Double-blind Treatment Phase|Adverse Event|15
949930|NCT01058668|1943409|FG002|Double-blind Treatment Phase|Adverse Event|25
949931|NCT01058668|1943407|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
949932|NCT01058668|1943408|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
949933|NCT01058668|1943409|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
949934|NCT01058668|1943407|FG000|Double-blind Treatment Phase|Protocol Violation|1
949935|NCT01058668|1943408|FG001|Double-blind Treatment Phase|Protocol Violation|1
949936|NCT01058668|1943409|FG002|Double-blind Treatment Phase|Protocol Violation|2
949937|NCT01058668|1943407|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14
949938|NCT01058668|1943408|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18
949939|NCT01058668|1943409|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17
949940|NCT01058668|1943407|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
949941|NCT01058668|1943408|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
949942|NCT01058668|1943409|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
949943|NCT01058668|1943407|FG000|Double-blind Treatment Phase|Other Unspecified|1
949944|NCT01058668|1943408|FG001|Double-blind Treatment Phase|Other Unspecified|1
949945|NCT01058668|1943409|FG002|Double-blind Treatment Phase|Other Unspecified|0
949946|NCT01058707|1943424|FG000|Overall Study|Disease Progression|15
949947|NCT01058707|1943425|FG001|Overall Study|Disease Progression|20
949948|NCT01058707|1943426|FG002|Overall Study|Disease Progression|20
949949|NCT01058707|1943427|FG003|Overall Study|Disease Progression|15
949950|NCT01058707|1943428|FG004|Overall Study|Disease Progression|23
949951|NCT01058707|1943429|FG005|Overall Study|Disease Progression|10
949952|NCT01058707|1943430|FG006|Overall Study|Disease Progression|12
949953|NCT01058707|1943424|FG000|Overall Study|Adverse Event|11
949954|NCT01058707|1943425|FG001|Overall Study|Adverse Event|4
949955|NCT01058707|1943426|FG002|Overall Study|Adverse Event|7
949956|NCT01058707|1943427|FG003|Overall Study|Adverse Event|6
949957|NCT01058707|1943428|FG004|Overall Study|Adverse Event|7
949958|NCT01058707|1943429|FG005|Overall Study|Adverse Event|3
949959|NCT01058707|1943430|FG006|Overall Study|Adverse Event|1
949960|NCT01058707|1943424|FG000|Overall Study|Subject Decision|5
949961|NCT01058707|1943425|FG001|Overall Study|Subject Decision|3
949962|NCT01058707|1943426|FG002|Overall Study|Subject Decision|3
949963|NCT01058707|1943427|FG003|Overall Study|Subject Decision|1
949964|NCT01058707|1943428|FG004|Overall Study|Subject Decision|2
949965|NCT01058707|1943429|FG005|Overall Study|Subject Decision|3
949966|NCT01058707|1943430|FG006|Overall Study|Subject Decision|6
949967|NCT01058707|1943424|FG000|Overall Study|Lost to Follow-up|0
949968|NCT01058707|1943425|FG001|Overall Study|Lost to Follow-up|0
949969|NCT01058707|1943426|FG002|Overall Study|Lost to Follow-up|1
949970|NCT01058707|1943427|FG003|Overall Study|Lost to Follow-up|0
949971|NCT01058707|1943428|FG004|Overall Study|Lost to Follow-up|0
949972|NCT01058707|1943429|FG005|Overall Study|Lost to Follow-up|0
949973|NCT01058707|1943430|FG006|Overall Study|Lost to Follow-up|0
949974|NCT01058707|1943424|FG000|Overall Study|Reason Not Specified|0
949975|NCT01058707|1943425|FG001|Overall Study|Reason Not Specified|3
949976|NCT01058707|1943426|FG002|Overall Study|Reason Not Specified|2
949977|NCT01058707|1943427|FG003|Overall Study|Reason Not Specified|0
949978|NCT01058707|1943428|FG004|Overall Study|Reason Not Specified|7
949979|NCT01058707|1943429|FG005|Overall Study|Reason Not Specified|1
949980|NCT01058707|1943430|FG006|Overall Study|Reason Not Specified|7
949981|NCT01058863|1943468|FG000|Overall Study|Lost to Follow-up|1
949982|NCT01058863|1943468|FG000|Overall Study|Withdrawal by Subject|1
949983|NCT01058863|1943468|FG000|Overall Study|Sponsor requested withdrawal|1
949984|NCT01058863|1943468|FG000|Overall Study|Randomized in error|1
949985|NCT01059071|1943494|FG000|Overall Study|Lack of Efficacy|1
949986|NCT01059071|1943495|FG001|Overall Study|Lack of Efficacy|4
949987|NCT01059071|1943496|FG002|Overall Study|Lack of Efficacy|2
949988|NCT01059071|1943497|FG003|Overall Study|Lack of Efficacy|3
949989|NCT01059071|1943494|FG000|Overall Study|Withdrawal by Subject|1
949990|NCT01059071|1943495|FG001|Overall Study|Withdrawal by Subject|0
949991|NCT01059071|1943496|FG002|Overall Study|Withdrawal by Subject|0
949992|NCT01059071|1943497|FG003|Overall Study|Withdrawal by Subject|2
949993|NCT01059071|1943494|FG000|Overall Study|Physician Decision|0
949994|NCT01059071|1943495|FG001|Overall Study|Physician Decision|0
949995|NCT01059071|1943496|FG002|Overall Study|Physician Decision|0
949996|NCT01059071|1943497|FG003|Overall Study|Physician Decision|1
949997|NCT01059175|1943507|FG000|Overall Study|Death|17
949998|NCT01059175|1943508|FG001|Overall Study|Death|17
949999|NCT01059175|1943507|FG000|Overall Study|Adverse Event|4
950000|NCT01059175|1943508|FG001|Overall Study|Adverse Event|2
950001|NCT01059175|1943507|FG000|Overall Study|Lost to Follow-up|0
950002|NCT01059175|1943508|FG001|Overall Study|Lost to Follow-up|1
950003|NCT01059318|1943518|FG000|Core Study (26 Week)|Adverse Event|3
950004|NCT01059318|1943518|FG000|Core Study (26 Week)|Withdrawal by Subject|1
950005|NCT01059318|1943518|FG000|Extension (36 Week)|Adverse Event|3
950006|NCT01059344|1943527|FG000|Overall Study|Adverse Event|12
950007|NCT01059344|1943528|FG001|Overall Study|Adverse Event|30
950008|NCT01059344|1943527|FG000|Overall Study|Withdrawal by Subject|6
950009|NCT01059344|1943528|FG001|Overall Study|Withdrawal by Subject|9
950010|NCT01059344|1943527|FG000|Overall Study|Lost to Follow-up|1
950011|NCT01059344|1943528|FG001|Overall Study|Lost to Follow-up|1
950012|NCT01059344|1943527|FG000|Overall Study|Other|3
950013|NCT01059344|1943528|FG001|Overall Study|Other|6
950014|NCT01059526|1943593|FG000|Overall Study|Patient enrolled but not treated|20
950015|NCT01059526|1943594|FG001|Overall Study|Patient enrolled but not treated|17
950016|NCT01059526|1943593|FG000|Overall Study|Adverse Event|2
950017|NCT01059526|1943594|FG001|Overall Study|Adverse Event|2
950018|NCT01059526|1943593|FG000|Overall Study|Protocol Violation|0
950019|NCT01059526|1943594|FG001|Overall Study|Protocol Violation|1
950020|NCT01059526|1943593|FG000|Overall Study|Withdrawal by Subject|3
950021|NCT01059526|1943594|FG001|Overall Study|Withdrawal by Subject|1
950022|NCT01059526|1943593|FG000|Overall Study|Lost to Follow-up|4
950023|NCT01059526|1943594|FG001|Overall Study|Lost to Follow-up|1
950024|NCT01059526|1943593|FG000|Overall Study|Patient found to be dermatographic|1
950025|NCT01059526|1943594|FG001|Overall Study|Patient found to be dermatographic|0
950026|NCT01059539|1943600|FG000|Overall Study|Adverse Event|66
950027|NCT01059539|1943600|FG000|Overall Study|Insufficient Therapeutic Response|26
950028|NCT01059539|1943600|FG000|Overall Study|Protocol Violation|55
950029|NCT01059539|1943600|FG000|Overall Study|Withdrawal of Consent|80
950030|NCT01059539|1943600|FG000|Overall Study|Lost to Follow-up|42
950031|NCT01059539|1943600|FG000|Overall Study|Reason Not Specified|2
950032|NCT01059565|1943606|FG000|24-Week Randomized Phase|Randomized but not treated|1
950033|NCT01059565|1943607|FG001|24-Week Randomized Phase|Randomized but not treated|0
950034|NCT01059565|1943606|FG000|24-Week Randomized Phase|Adverse Event|5
950035|NCT01059565|1943607|FG001|24-Week Randomized Phase|Adverse Event|0
950036|NCT01059565|1943606|FG000|24-Week Randomized Phase|Withdrawal by Subject|3
950037|NCT01059565|1943607|FG001|24-Week Randomized Phase|Withdrawal by Subject|1
950038|NCT01059565|1943606|FG000|24-Week Randomized Phase|Lost to Follow-up|0
950039|NCT01059565|1943607|FG001|24-Week Randomized Phase|Lost to Follow-up|1
950040|NCT01059565|1943606|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
950041|NCT01059565|1943607|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
950042|NCT01059565|1943606|FG000|24-Week Open-Label Phase|Adverse Event|2
950043|NCT01059565|1943607|FG001|24-Week Open-Label Phase|Adverse Event|0
950044|NCT01059565|1943606|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1
950045|NCT01059565|1943607|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1
950046|NCT01059565|1943606|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1
950047|NCT01059565|1943607|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0
950048|NCT01059565|1943606|FG000|24-Week Open-Label Phase|Subject noncompliance|1
950049|NCT01059565|1943607|FG001|24-Week Open-Label Phase|Subject noncompliance|0
950050|NCT01059565|1943606|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
950051|NCT01059565|1943607|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
950052|NCT01059565|1943606|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0
950053|NCT01059565|1943607|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1
950054|NCT01059617|1943619|FG000|Overall Study|Other|7
950055|NCT01059617|1943620|FG001|Overall Study|Other|1
950056|NCT01059617|1943621|FG002|Overall Study|Other|8
950057|NCT01059617|1943622|FG003|Overall Study|Other|6
950058|NCT01059630|1943642|FG000|Overall Study|Death|100
950059|NCT01059630|1943643|FG001|Overall Study|Death|84
950060|NCT01059630|1943642|FG000|Overall Study|Lost to Follow-up|4
950061|NCT01059630|1943643|FG001|Overall Study|Lost to Follow-up|1
950062|NCT01059630|1943642|FG000|Overall Study|Physician Decision|2
950063|NCT01059630|1943643|FG001|Overall Study|Physician Decision|4
950064|NCT01059630|1943642|FG000|Overall Study|Withdrawal by Subject|21
950065|NCT01059630|1943643|FG001|Overall Study|Withdrawal by Subject|14
950066|NCT01059643|1943649|FG000|Overall Study|Adverse Event|3
950067|NCT01059643|1943649|FG000|Overall Study|Withdrawal by Subject|2
950068|NCT01059643|1943649|FG000|Overall Study|Physician Decision|1
950069|NCT01059773|1943677|FG000|Overall Study|Adverse Event|2
950070|NCT01059773|1943678|FG001|Overall Study|Adverse Event|2
950071|NCT01059773|1943677|FG000|Overall Study|Withdrawal by Subject|1
950072|NCT01059773|1943678|FG001|Overall Study|Withdrawal by Subject|5
950073|NCT01059773|1943677|FG000|Overall Study|Lost to Follow-up|1
950074|NCT01059773|1943678|FG001|Overall Study|Lost to Follow-up|1
910985|NCT00796003|1888104|FG000|Overall Study|Other|0
910986|NCT00796003|1888105|FG001|Overall Study|Other|1
910987|NCT00796003|1888104|FG000|Overall Study|Participants Not treated|0
910988|NCT00796003|1888105|FG001|Overall Study|Participants Not treated|2
910989|NCT00796120|1888116|FG000|Overall Study|Death|3
910990|NCT00796120|1888117|FG001|Overall Study|Death|0
910991|NCT00796120|1888116|FG000|Overall Study|Adverse Event|11
950075|NCT01059773|1943677|FG000|Overall Study|Pregnancy|1
950076|NCT01059773|1943678|FG001|Overall Study|Pregnancy|1
950077|NCT01059773|1943677|FG000|Overall Study|Protocol Violation|6
950078|NCT01059773|1943678|FG001|Overall Study|Protocol Violation|2
950079|NCT01059773|1943677|FG000|Overall Study|Physician Decision|5
950080|NCT01059773|1943678|FG001|Overall Study|Physician Decision|4
950081|NCT01059773|1943677|FG000|Overall Study|Lack of Efficacy|3
910992|NCT00796120|1888117|FG001|Overall Study|Adverse Event|6
950082|NCT01059773|1943678|FG001|Overall Study|Lack of Efficacy|3
950083|NCT01059773|1943677|FG000|Overall Study|Death|0
950084|NCT01059773|1943678|FG001|Overall Study|Death|1
910993|NCT00796120|1888116|FG000|Overall Study|Progressive disease|22
950085|NCT01059773|1943677|FG000|Overall Study|Malignancy including squamous cell skin|0
950086|NCT01059773|1943678|FG001|Overall Study|Malignancy including squamous cell skin|1
950087|NCT01059773|1943677|FG000|Overall Study|Ineligible follow TB screening criteria|0
950088|NCT01059773|1943678|FG001|Overall Study|Ineligible follow TB screening criteria|1
950089|NCT01059773|1943677|FG000|Overall Study|Other|1
950090|NCT01059773|1943678|FG001|Overall Study|Other|3
950091|NCT01059799|1943691|FG000|Overall Study|Adverse Event|2
950092|NCT01059799|1943692|FG001|Overall Study|Adverse Event|3
950093|NCT01059799|1943691|FG000|Overall Study|Lack of Efficacy|1
950094|NCT01059799|1943692|FG001|Overall Study|Lack of Efficacy|0
950095|NCT01059799|1943691|FG000|Overall Study|Protocol Violation|3
950096|NCT01059799|1943692|FG001|Overall Study|Protocol Violation|2
950097|NCT01059799|1943691|FG000|Overall Study|Withdrawal criteria|13
950098|NCT01059799|1943692|FG001|Overall Study|Withdrawal criteria|2
950099|NCT01059799|1943691|FG000|Overall Study|Other|12
950100|NCT01059799|1943692|FG001|Overall Study|Other|3
950101|NCT01059812|1943700|FG000|Overall Study|Adverse Event|9
950102|NCT01059812|1943701|FG001|Overall Study|Adverse Event|5
950103|NCT01059812|1943700|FG000|Overall Study|Lack of Efficacy|2
950104|NCT01059812|1943701|FG001|Overall Study|Lack of Efficacy|2
950105|NCT01059812|1943700|FG000|Overall Study|Protocol Violation|3
950106|NCT01059812|1943701|FG001|Overall Study|Protocol Violation|1
950107|NCT01059812|1943700|FG000|Overall Study|Withdrawal Criteria|9
950108|NCT01059812|1943701|FG001|Overall Study|Withdrawal Criteria|4
950109|NCT01059812|1943700|FG000|Overall Study|Unclassified|14
950110|NCT01059812|1943701|FG001|Overall Study|Unclassified|4
950111|NCT01059825|1943713|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0
950112|NCT01059825|1943714|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0
950113|NCT01059825|1943715|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0
950114|NCT01059825|1943716|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0
950115|NCT01059825|1943717|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0
950116|NCT01059825|1943718|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0
950117|NCT01059825|1943719|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3
950118|NCT01059825|1943713|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0
950119|NCT01059825|1943714|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0
950120|NCT01059825|1943715|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0
950121|NCT01059825|1943716|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0
950122|NCT01059825|1943717|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0
950123|NCT01059825|1943718|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0
950124|NCT01059825|1943719|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14
950125|NCT01059825|1943713|FG000|Enrolled, Run-in Period|Lost to Follow-up|0
950126|NCT01059825|1943714|FG001|Enrolled, Run-in Period|Lost to Follow-up|0
950127|NCT01059825|1943715|FG002|Enrolled, Run-in Period|Lost to Follow-up|0
950128|NCT01059825|1943716|FG003|Enrolled, Run-in Period|Lost to Follow-up|0
950129|NCT01059825|1943717|FG004|Enrolled, Run-in Period|Lost to Follow-up|0
950130|NCT01059825|1943718|FG005|Enrolled, Run-in Period|Lost to Follow-up|0
950131|NCT01059825|1943719|FG006|Enrolled, Run-in Period|Lost to Follow-up|5
950132|NCT01059825|1943713|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0
950133|NCT01059825|1943714|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0
950134|NCT01059825|1943715|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0
950135|NCT01059825|1943716|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0
950136|NCT01059825|1943717|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0
950137|NCT01059825|1943718|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0
950138|NCT01059825|1943719|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13
950139|NCT01059825|1943713|FG000|Enrolled, Run-in Period|Other reason not specified|0
950140|NCT01059825|1943714|FG001|Enrolled, Run-in Period|Other reason not specified|0
950141|NCT01059825|1943715|FG002|Enrolled, Run-in Period|Other reason not specified|0
950142|NCT01059825|1943716|FG003|Enrolled, Run-in Period|Other reason not specified|0
950143|NCT01059825|1943717|FG004|Enrolled, Run-in Period|Other reason not specified|0
950144|NCT01059825|1943718|FG005|Enrolled, Run-in Period|Other reason not specified|0
950145|NCT01059825|1943719|FG006|Enrolled, Run-in Period|Other reason not specified|7
950146|NCT01059825|1943713|FG000|Enrolled, Run-in Period|Protocol Violation|0
950147|NCT01059825|1943714|FG001|Enrolled, Run-in Period|Protocol Violation|0
950148|NCT01059825|1943715|FG002|Enrolled, Run-in Period|Protocol Violation|0
950149|NCT01059825|1943716|FG003|Enrolled, Run-in Period|Protocol Violation|0
950150|NCT01059825|1943717|FG004|Enrolled, Run-in Period|Protocol Violation|0
950151|NCT01059825|1943718|FG005|Enrolled, Run-in Period|Protocol Violation|0
950152|NCT01059825|1943719|FG006|Enrolled, Run-in Period|Protocol Violation|5
950153|NCT01059825|1943713|FG000|Treatment Period|Lost to Follow-up|2
950154|NCT01059825|1943714|FG001|Treatment Period|Lost to Follow-up|1
950155|NCT01059825|1943715|FG002|Treatment Period|Lost to Follow-up|0
950156|NCT01059825|1943716|FG003|Treatment Period|Lost to Follow-up|1
950157|NCT01059825|1943717|FG004|Treatment Period|Lost to Follow-up|2
950158|NCT01059825|1943718|FG005|Treatment Period|Lost to Follow-up|0
950159|NCT01059825|1943719|FG006|Treatment Period|Lost to Follow-up|0
950160|NCT01059825|1943713|FG000|Treatment Period|Withdrawal by Subject|3
950161|NCT01059825|1943714|FG001|Treatment Period|Withdrawal by Subject|0
950162|NCT01059825|1943715|FG002|Treatment Period|Withdrawal by Subject|1
950163|NCT01059825|1943716|FG003|Treatment Period|Withdrawal by Subject|5
950164|NCT01059825|1943717|FG004|Treatment Period|Withdrawal by Subject|4
950165|NCT01059825|1943718|FG005|Treatment Period|Withdrawal by Subject|1
950166|NCT01059825|1943719|FG006|Treatment Period|Withdrawal by Subject|0
950167|NCT01059825|1943713|FG000|Treatment Period|Other reason not specified|1
950168|NCT01059825|1943714|FG001|Treatment Period|Other reason not specified|2
950169|NCT01059825|1943715|FG002|Treatment Period|Other reason not specified|1
950170|NCT01059825|1943716|FG003|Treatment Period|Other reason not specified|2
950171|NCT01059825|1943717|FG004|Treatment Period|Other reason not specified|0
950172|NCT01059825|1943718|FG005|Treatment Period|Other reason not specified|0
950173|NCT01059825|1943719|FG006|Treatment Period|Other reason not specified|0
950174|NCT01059825|1943713|FG000|Treatment Period|Protocol Violation|0
950175|NCT01059825|1943714|FG001|Treatment Period|Protocol Violation|0
950176|NCT01059825|1943715|FG002|Treatment Period|Protocol Violation|1
950177|NCT01059825|1943716|FG003|Treatment Period|Protocol Violation|1
950178|NCT01059825|1943717|FG004|Treatment Period|Protocol Violation|1
950179|NCT01059825|1943718|FG005|Treatment Period|Protocol Violation|1
950180|NCT01059825|1943719|FG006|Treatment Period|Protocol Violation|0
950181|NCT01059825|1943713|FG000|Treatment Period|Adverse event related to study drug|1
950182|NCT01059825|1943714|FG001|Treatment Period|Adverse event related to study drug|0
950183|NCT01059825|1943715|FG002|Treatment Period|Adverse event related to study drug|1
950184|NCT01059825|1943716|FG003|Treatment Period|Adverse event related to study drug|1
950185|NCT01059825|1943717|FG004|Treatment Period|Adverse event related to study drug|0
950186|NCT01059825|1943718|FG005|Treatment Period|Adverse event related to study drug|0
950187|NCT01059825|1943719|FG006|Treatment Period|Adverse event related to study drug|0
950188|NCT01059825|1943713|FG000|Treatment Period|Insufficient clinical response|3
950189|NCT01059825|1943714|FG001|Treatment Period|Insufficient clinical response|0
950190|NCT01059825|1943715|FG002|Treatment Period|Insufficient clinical response|0
950191|NCT01059825|1943716|FG003|Treatment Period|Insufficient clinical response|0
950192|NCT01059825|1943717|FG004|Treatment Period|Insufficient clinical response|0
950193|NCT01059825|1943718|FG005|Treatment Period|Insufficient clinical response|0
950194|NCT01059825|1943719|FG006|Treatment Period|Insufficient clinical response|0
950195|NCT01059825|1943713|FG000|Treatment Period|Adverse event not related to study drug|0
950196|NCT01059825|1943714|FG001|Treatment Period|Adverse event not related to study drug|1
950197|NCT01059825|1943715|FG002|Treatment Period|Adverse event not related to study drug|2
950198|NCT01059825|1943716|FG003|Treatment Period|Adverse event not related to study drug|1
950199|NCT01059825|1943717|FG004|Treatment Period|Adverse event not related to study drug|1
950200|NCT01059825|1943718|FG005|Treatment Period|Adverse event not related to study drug|1
950201|NCT01059825|1943719|FG006|Treatment Period|Adverse event not related to study drug|0
950202|NCT01059864|1943752|FG000|Open-Label Run-In Phase|Adverse Event|7
950203|NCT01059864|1943753|FG001|Open-Label Run-In Phase|Adverse Event|0
950204|NCT01059864|1943754|FG002|Open-Label Run-In Phase|Adverse Event|0
950205|NCT01059864|1943752|FG000|Open-Label Run-In Phase|Lack of Efficacy|1
950206|NCT01059864|1943753|FG001|Open-Label Run-In Phase|Lack of Efficacy|0
950207|NCT01059864|1943754|FG002|Open-Label Run-In Phase|Lack of Efficacy|0
950208|NCT01059864|1943752|FG000|Open-Label Run-In Phase|Lost to Follow-up|2
950209|NCT01059864|1943753|FG001|Open-Label Run-In Phase|Lost to Follow-up|0
950210|NCT01059864|1943754|FG002|Open-Label Run-In Phase|Lost to Follow-up|0
950211|NCT01059864|1943752|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1
950212|NCT01059864|1943753|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0
950213|NCT01059864|1943754|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0
950214|NCT01059864|1943752|FG000|Open-Label Run-In Phase|Protocol Violation|2
950215|NCT01059864|1943753|FG001|Open-Label Run-In Phase|Protocol Violation|0
950216|NCT01059864|1943754|FG002|Open-Label Run-In Phase|Protocol Violation|0
950217|NCT01059864|1943752|FG000|Double-Blind Treatment Phase|Adverse Event|0
950218|NCT01059864|1943753|FG001|Double-Blind Treatment Phase|Adverse Event|3
950219|NCT01059864|1943754|FG002|Double-Blind Treatment Phase|Adverse Event|3
950220|NCT01059903|1943772|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1
950221|NCT01059903|1943773|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1
950222|NCT01060007|1943805|FG000|Overall Study|Withdrawal by Subject|1
950223|NCT01060007|1943805|FG000|Overall Study|Inevaluable for response at surgery|3
950224|NCT01060059|1943819|FG000|Overall Study|Adverse Event|1
950225|NCT01060059|1943820|FG001|Overall Study|Adverse Event|1
950226|NCT01060059|1943819|FG000|Overall Study|Death|2
950227|NCT01060059|1943820|FG001|Overall Study|Death|3
950228|NCT01060059|1943819|FG000|Overall Study|Lost to Follow-up|18
950229|NCT01060059|1943820|FG001|Overall Study|Lost to Follow-up|34
950230|NCT01060059|1943819|FG000|Overall Study|entry criteria not met|4
950231|NCT01060059|1943820|FG001|Overall Study|entry criteria not met|3
950232|NCT01060059|1943819|FG000|Overall Study|Withdrawal by Subject|35
950233|NCT01060059|1943820|FG001|Overall Study|Withdrawal by Subject|23
950234|NCT01060059|1943819|FG000|Overall Study|lack of glycemic control|2
950235|NCT01060059|1943820|FG001|Overall Study|lack of glycemic control|1
950236|NCT01060059|1943819|FG000|Overall Study|lack of compliance|5
950237|NCT01060059|1943820|FG001|Overall Study|lack of compliance|2
950238|NCT01060072|1943830|FG000|Overall Study|Adverse Event|1
950239|NCT01060072|1943831|FG001|Overall Study|Adverse Event|1
950240|NCT01060072|1943830|FG000|Overall Study|Physician Decision|0
950241|NCT01060072|1943831|FG001|Overall Study|Physician Decision|2
950242|NCT01060072|1943830|FG000|Overall Study|Protocol Violation|0
950243|NCT01060072|1943831|FG001|Overall Study|Protocol Violation|1
950244|NCT01060072|1943830|FG000|Overall Study|Acute cholecystitis|1
950245|NCT01060072|1943831|FG001|Overall Study|Acute cholecystitis|0
950246|NCT01060072|1943830|FG000|Overall Study|Excluded Medications|0
950247|NCT01060072|1943831|FG001|Overall Study|Excluded Medications|1
950248|NCT01060111|1943853|FG000|Overall Study|Adverse Event|9
950249|NCT01060111|1943854|FG001|Overall Study|Adverse Event|5
950250|NCT01060111|1943855|FG002|Overall Study|Adverse Event|18
950251|NCT01060111|1943853|FG000|Overall Study|Lack of Efficacy|2
950252|NCT01060111|1943854|FG001|Overall Study|Lack of Efficacy|1
950253|NCT01060111|1943855|FG002|Overall Study|Lack of Efficacy|0
950254|NCT01060111|1943853|FG000|Overall Study|Inappropriate participant|5
950255|NCT01060111|1943854|FG001|Overall Study|Inappropriate participant|4
950256|NCT01060111|1943855|FG002|Overall Study|Inappropriate participant|5
950257|NCT01060111|1943853|FG000|Overall Study|Participants' evasion for hospital visit|0
950258|NCT01060111|1943854|FG001|Overall Study|Participants' evasion for hospital visit|3
950259|NCT01060111|1943855|FG002|Overall Study|Participants' evasion for hospital visit|2
950260|NCT01060111|1943853|FG000|Overall Study|Participants' non-cooperation|8
950261|NCT01060111|1943854|FG001|Overall Study|Participants' non-cooperation|6
950262|NCT01060111|1943855|FG002|Overall Study|Participants' non-cooperation|6
950263|NCT01060111|1943853|FG000|Overall Study|Adverse event and insufficient effect|0
950264|NCT01060111|1943854|FG001|Overall Study|Adverse event and insufficient effect|1
950265|NCT01060111|1943855|FG002|Overall Study|Adverse event and insufficient effect|0
950266|NCT01060111|1943853|FG000|Overall Study|Participants' non-cooperation|1
950267|NCT01060111|1943854|FG001|Overall Study|Participants' non-cooperation|0
950268|NCT01060111|1943855|FG002|Overall Study|Participants' non-cooperation|0
950269|NCT01060111|1943853|FG000|Overall Study|Other|2
950270|NCT01060111|1943854|FG001|Overall Study|Other|3
950271|NCT01060111|1943855|FG002|Overall Study|Other|4
950272|NCT01060124|1943866|FG000|Overall Study|Other|16
950273|NCT01060124|1943866|FG000|Overall Study|Adverse Event|14
950274|NCT01060124|1943866|FG000|Overall Study|Withdrawal by Subject|7
950275|NCT01060150|1943870|FG000|Overall Study|Adverse Event|6
950276|NCT01060150|1943870|FG000|Overall Study|Lost to Follow-up|1
950277|NCT01060150|1943870|FG000|Overall Study|Protocol Violation|6
950278|NCT01060150|1943870|FG000|Overall Study|Withdrawal by Subject|8
950279|NCT01060150|1943870|FG000|Overall Study|Enrolled, but not treated|2
950280|NCT01060384|1943878|FG000|Overall Study|Withdrawal by Subject|0
950281|NCT01060384|1943879|FG001|Overall Study|Withdrawal by Subject|1
950282|NCT01060384|1943880|FG002|Overall Study|Withdrawal by Subject|0
950283|NCT01060384|1943881|FG003|Overall Study|Withdrawal by Subject|0
950284|NCT01060384|1943882|FG004|Overall Study|Withdrawal by Subject|0
950285|NCT01060384|1943878|FG000|Overall Study|Death|0
950286|NCT01060384|1943879|FG001|Overall Study|Death|0
950287|NCT01060384|1943880|FG002|Overall Study|Death|0
950288|NCT01060384|1943881|FG003|Overall Study|Death|0
950289|NCT01060384|1943882|FG004|Overall Study|Death|1
950290|NCT01060384|1943878|FG000|Overall Study|Intercurrent illness|0
950291|NCT01060384|1943879|FG001|Overall Study|Intercurrent illness|0
950292|NCT01060384|1943880|FG002|Overall Study|Intercurrent illness|0
950293|NCT01060384|1943881|FG003|Overall Study|Intercurrent illness|0
950294|NCT01060384|1943882|FG004|Overall Study|Intercurrent illness|1
950295|NCT01060540|1943893|FG000|Overall Study|Withdrawal by Subject|10
950296|NCT01060540|1943894|FG001|Overall Study|Withdrawal by Subject|20
950297|NCT01060540|1943893|FG000|Overall Study|Lost to Follow-up|52
950298|NCT01060540|1943894|FG001|Overall Study|Lost to Follow-up|43
950299|NCT01060540|1943893|FG000|Overall Study|Death|2
950300|NCT01060540|1943894|FG001|Overall Study|Death|1
950301|NCT01060540|1943893|FG000|Overall Study|Physician Decision|0
950302|NCT01060540|1943894|FG001|Overall Study|Physician Decision|1
950303|NCT01060553|1943902|FG000|Overall Study|Lost to Follow-up|3
950304|NCT01060553|1943903|FG001|Overall Study|Lost to Follow-up|5
950305|NCT01060553|1943902|FG000|Overall Study|Withdrawal by Subject|5
950306|NCT01060553|1943903|FG001|Overall Study|Withdrawal by Subject|5
950307|NCT01060553|1943902|FG000|Overall Study|Lack of Efficacy|1
950308|NCT01060553|1943903|FG001|Overall Study|Lack of Efficacy|0
950309|NCT01060670|1943919|FG000|Run In|screen failure|0
950310|NCT01060670|1943920|FG001|Run In|screen failure|238
950311|NCT01061008|1943930|FG000|Overall Study|Badiocephalic fistula failed|3
950312|NCT01061008|1943931|FG001|Overall Study|Badiocephalic fistula failed|2
950313|NCT01061008|1943930|FG000|Overall Study|Death|1
950314|NCT01061008|1943931|FG001|Overall Study|Death|0
950315|NCT01061008|1943930|FG000|Overall Study|Withdrawal by Subject|1
950316|NCT01061008|1943931|FG001|Overall Study|Withdrawal by Subject|3
950317|NCT01061008|1943930|FG000|Overall Study|Unable to exercise following surgery|1
950318|NCT01061008|1943931|FG001|Overall Study|Unable to exercise following surgery|0
950319|NCT01061008|1943930|FG000|Overall Study|Adverse Event|0
950320|NCT01061008|1943931|FG001|Overall Study|Adverse Event|1
950321|NCT01061151|1943945|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
1090770|NCT02248818|2158526|FG008|Screening|Physician Decision|73
950322|NCT01061151|1943946|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
950323|NCT01061151|1943947|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
950324|NCT01061151|1943948|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
950325|NCT01061151|1943945|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6
950326|NCT01061151|1943946|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9
950327|NCT01061151|1943947|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1
950328|NCT01061151|1943948|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2
950329|NCT01061151|1943945|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
950330|NCT01061151|1943946|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
950331|NCT01061151|1943947|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
950332|NCT01061151|1943948|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
950333|NCT01061151|1943945|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
950334|NCT01061151|1943946|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
950335|NCT01061151|1943947|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
950336|NCT01061151|1943948|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
950337|NCT01061151|1943945|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
950338|NCT01061151|1943946|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
950339|NCT01061151|1943947|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
950340|NCT01061151|1943948|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
950341|NCT01061151|1943945|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
950342|NCT01061151|1943946|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
950343|NCT01061151|1943947|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
950344|NCT01061151|1943948|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
950345|NCT01061151|1943945|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
950346|NCT01061151|1943946|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
950347|NCT01061151|1943947|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
950348|NCT01061151|1943948|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
950349|NCT01061151|1943945|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
950350|NCT01061151|1943946|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
950351|NCT01061151|1943947|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
950352|NCT01061151|1943948|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
950353|NCT01061151|1943945|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
950354|NCT01061151|1943946|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
950355|NCT01061151|1943947|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
950356|NCT01061151|1943948|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
950357|NCT01061151|1943945|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3
950358|NCT01061151|1943946|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5
950359|NCT01061151|1943947|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1
950360|NCT01061151|1943948|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1
950361|NCT01061151|1943945|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
950362|NCT01061151|1943946|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
950363|NCT01061151|1943947|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
950364|NCT01061151|1943948|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
950365|NCT01061151|1943945|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
950366|NCT01061151|1943946|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
950367|NCT01061151|1943947|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
950368|NCT01061151|1943948|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
950369|NCT01061151|1943945|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
950370|NCT01061151|1943946|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
950371|NCT01061151|1943947|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
950372|NCT01061151|1943948|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
950373|NCT01061151|1943945|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
950374|NCT01061151|1943946|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
950375|NCT01061151|1943947|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
950376|NCT01061151|1943948|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
950377|NCT01061151|1943945|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
950378|NCT01061151|1943946|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
950379|NCT01061151|1943947|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
950380|NCT01061151|1943948|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
950381|NCT01061177|1943968|FG000|Overall Study|Adverse Event|117
950382|NCT01061177|1943968|FG000|Overall Study|Withdrawal by Subject|27
950383|NCT01061177|1943968|FG000|Overall Study|Disease progression|17
950384|NCT01061177|1943968|FG000|Overall Study|Protocol Violation|11
950385|NCT01061177|1943968|FG000|Overall Study|Lost to Follow-up|9
950386|NCT01061177|1943968|FG000|Overall Study|New cancer therapy|9
950387|NCT01061177|1943968|FG000|Overall Study|Abnormal laboratory values|6
950388|NCT01061177|1943968|FG000|Overall Study|Abnormal test procedure results|4
950389|NCT01061177|1943968|FG000|Overall Study|Administratie problems|4
950390|NCT01061177|1943968|FG000|Overall Study|Death|4
950391|NCT01061333|1943972|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0
950392|NCT01061333|1943973|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1
950393|NCT01061359|1943984|FG000|Overall Study|Death|32
950394|NCT01061359|1943984|FG000|Overall Study|Lost to Follow-up|1072
950395|NCT01061359|1943984|FG000|Overall Study|Relapse|187
950396|NCT01061359|1943984|FG000|Overall Study|Secondary neoplasm|11
950397|NCT01061385|1943990|FG000|Overall Study|Lost to Follow-up|1
950398|NCT01061385|1943991|FG001|Overall Study|Lost to Follow-up|0
950399|NCT01061385|1943990|FG000|Overall Study|subject decision not related to AE|0
950400|NCT01061385|1943991|FG001|Overall Study|subject decision not related to AE|1
950401|NCT01061567|1944011|FG000|Overall Study|Adverse Event|32
950402|NCT01061567|1944011|FG000|Overall Study|Death|2
950403|NCT01061567|1944011|FG000|Overall Study|Lack of Efficacy|3
910994|NCT00796120|1888117|FG001|Overall Study|Progressive disease|13
910995|NCT00796120|1888116|FG000|Overall Study|Participant refusal|3
910996|NCT00796120|1888117|FG001|Overall Study|Participant refusal|4
910997|NCT00796120|1888116|FG000|Overall Study|Other|6
950404|NCT01061567|1944011|FG000|Overall Study|Lost to Follow-up|24
950405|NCT01061567|1944011|FG000|Overall Study|Protocol Violation|1
950406|NCT01061567|1944011|FG000|Overall Study|Withdrawal by Subject|11
950407|NCT01061567|1944011|FG000|Overall Study|Other reason than stated above|3
950408|NCT01061606|1944015|FG000|Overall Study|Adverse Event|1
950409|NCT01061606|1944015|FG000|Overall Study|Death|1
950410|NCT01061606|1944015|FG000|Overall Study|Disease Progression|4
950411|NCT01061606|1944015|FG000|Overall Study|alternative therapy|2
950412|NCT01061671|1944021|FG000|Overall Study|Withdrawal by Subject|16
950413|NCT01061671|1944022|FG001|Overall Study|Withdrawal by Subject|20
950414|NCT01061671|1944021|FG000|Overall Study|Lost to Follow-up|3
950415|NCT01061671|1944022|FG001|Overall Study|Lost to Follow-up|5
950416|NCT01061671|1944021|FG000|Overall Study|Death|28
950417|NCT01061671|1944022|FG001|Overall Study|Death|30
950418|NCT01061710|1944028|FG000|Overall Study|Protocol Violation|14
950419|NCT01061723|1944038|FG000|Overall Study|Adverse Event|0
950420|NCT01061723|1944039|FG001|Overall Study|Adverse Event|2
950421|NCT01061723|1944040|FG002|Overall Study|Adverse Event|5
950422|NCT01061723|1944041|FG003|Overall Study|Adverse Event|5
950423|NCT01061723|1944042|FG004|Overall Study|Adverse Event|2
950424|NCT01061723|1944043|FG005|Overall Study|Adverse Event|6
950425|NCT01061723|1944038|FG000|Overall Study|Lack of Efficacy|2
950426|NCT01061723|1944039|FG001|Overall Study|Lack of Efficacy|3
950427|NCT01061723|1944040|FG002|Overall Study|Lack of Efficacy|4
950428|NCT01061723|1944041|FG003|Overall Study|Lack of Efficacy|2
950429|NCT01061723|1944042|FG004|Overall Study|Lack of Efficacy|1
950430|NCT01061723|1944043|FG005|Overall Study|Lack of Efficacy|1
950431|NCT01061723|1944038|FG000|Overall Study|Randomized but not treated|0
950432|NCT01061723|1944039|FG001|Overall Study|Randomized but not treated|0
950433|NCT01061723|1944040|FG002|Overall Study|Randomized but not treated|0
950434|NCT01061723|1944041|FG003|Overall Study|Randomized but not treated|0
950435|NCT01061723|1944042|FG004|Overall Study|Randomized but not treated|0
950436|NCT01061723|1944043|FG005|Overall Study|Randomized but not treated|1
950437|NCT01061723|1944038|FG000|Overall Study|Other than specified above|2
950438|NCT01061723|1944039|FG001|Overall Study|Other than specified above|1
950439|NCT01061723|1944040|FG002|Overall Study|Other than specified above|1
950440|NCT01061723|1944041|FG003|Overall Study|Other than specified above|1
950441|NCT01061723|1944042|FG004|Overall Study|Other than specified above|0
950442|NCT01061723|1944043|FG005|Overall Study|Other than specified above|1
950443|NCT01061736|1944072|FG000|Overall Study|Dose regimen not selected|0
950444|NCT01061736|1944073|FG001|Overall Study|Dose regimen not selected|0
950445|NCT01061736|1944074|FG002|Overall Study|Dose regimen not selected|0
950446|NCT01061736|1944075|FG003|Overall Study|Dose regimen not selected|0
950447|NCT01061736|1944076|FG004|Overall Study|Dose regimen not selected|0
950448|NCT01061736|1944077|FG005|Overall Study|Dose regimen not selected|0
950449|NCT01061736|1944078|FG006|Overall Study|Dose regimen not selected|79
950450|NCT01061736|1944079|FG007|Overall Study|Dose regimen not selected|0
950451|NCT01061736|1944080|FG008|Overall Study|Dose regimen not selected|0
950452|NCT01061736|1944081|FG009|Overall Study|Dose regimen not selected|0
950453|NCT01061736|1944072|FG000|Overall Study|Adverse Event|13
950454|NCT01061736|1944073|FG001|Overall Study|Adverse Event|1
950455|NCT01061736|1944074|FG002|Overall Study|Adverse Event|3
950456|NCT01061736|1944075|FG003|Overall Study|Adverse Event|2
950457|NCT01061736|1944076|FG004|Overall Study|Adverse Event|4
950458|NCT01061736|1944077|FG005|Overall Study|Adverse Event|1
950459|NCT01061736|1944078|FG006|Overall Study|Adverse Event|4
950460|NCT01061736|1944079|FG007|Overall Study|Adverse Event|63
950461|NCT01061736|1944080|FG008|Overall Study|Adverse Event|67
950462|NCT01061736|1944081|FG009|Overall Study|Adverse Event|34
950463|NCT01061736|1944072|FG000|Overall Study|Lack of Efficacy|0
950464|NCT01061736|1944073|FG001|Overall Study|Lack of Efficacy|2
950465|NCT01061736|1944074|FG002|Overall Study|Lack of Efficacy|1
950466|NCT01061736|1944075|FG003|Overall Study|Lack of Efficacy|1
950467|NCT01061736|1944076|FG004|Overall Study|Lack of Efficacy|1
950468|NCT01061736|1944077|FG005|Overall Study|Lack of Efficacy|2
950469|NCT01061736|1944078|FG006|Overall Study|Lack of Efficacy|1
950470|NCT01061736|1944079|FG007|Overall Study|Lack of Efficacy|9
950471|NCT01061736|1944080|FG008|Overall Study|Lack of Efficacy|9
950472|NCT01061736|1944081|FG009|Overall Study|Lack of Efficacy|10
950473|NCT01061736|1944072|FG000|Overall Study|Poor compliance to protocol|0
950474|NCT01061736|1944073|FG001|Overall Study|Poor compliance to protocol|0
950475|NCT01061736|1944074|FG002|Overall Study|Poor compliance to protocol|0
950476|NCT01061736|1944075|FG003|Overall Study|Poor compliance to protocol|0
950477|NCT01061736|1944076|FG004|Overall Study|Poor compliance to protocol|0
950478|NCT01061736|1944077|FG005|Overall Study|Poor compliance to protocol|0
950479|NCT01061736|1944078|FG006|Overall Study|Poor compliance to protocol|0
950480|NCT01061736|1944079|FG007|Overall Study|Poor compliance to protocol|2
950481|NCT01061736|1944080|FG008|Overall Study|Poor compliance to protocol|5
950482|NCT01061736|1944081|FG009|Overall Study|Poor compliance to protocol|9
950483|NCT01061736|1944072|FG000|Overall Study|Not treated|0
950484|NCT01061736|1944073|FG001|Overall Study|Not treated|0
950485|NCT01061736|1944074|FG002|Overall Study|Not treated|0
950486|NCT01061736|1944075|FG003|Overall Study|Not treated|0
950487|NCT01061736|1944076|FG004|Overall Study|Not treated|1
950488|NCT01061736|1944077|FG005|Overall Study|Not treated|0
950489|NCT01061736|1944078|FG006|Overall Study|Not treated|0
950490|NCT01061736|1944079|FG007|Overall Study|Not treated|2
950491|NCT01061736|1944080|FG008|Overall Study|Not treated|1
950492|NCT01061736|1944081|FG009|Overall Study|Not treated|0
950493|NCT01061736|1944072|FG000|Overall Study|Other than specified above|0
950494|NCT01061736|1944073|FG001|Overall Study|Other than specified above|1
950495|NCT01061736|1944074|FG002|Overall Study|Other than specified above|2
950496|NCT01061736|1944075|FG003|Overall Study|Other than specified above|0
950497|NCT01061736|1944076|FG004|Overall Study|Other than specified above|1
950498|NCT01061736|1944077|FG005|Overall Study|Other than specified above|0
950499|NCT01061736|1944078|FG006|Overall Study|Other than specified above|0
950500|NCT01061736|1944079|FG007|Overall Study|Other than specified above|18
950501|NCT01061736|1944080|FG008|Overall Study|Other than specified above|15
950502|NCT01061736|1944081|FG009|Overall Study|Other than specified above|21
950503|NCT01061775|1944106|FG000|Overall Study|Physician Decision|2
950504|NCT01061775|1944106|FG000|Overall Study|Lost to Follow-up|1
950505|NCT01061866|1944111|FG000|Overall Study|Adverse Event|2
950506|NCT01062061|1944132|FG000|Overall Study|Enrolled more than once|2
950507|NCT01062061|1944132|FG000|Overall Study|Investigated before study start|13
950508|NCT01062061|1944132|FG000|Overall Study|Outside chief indications|10
950509|NCT01062061|1944132|FG000|Overall Study|Failed to meet inclusion criteria|2
950510|NCT01062113|1944147|FG000|Overall Study|Adverse Event|1
950511|NCT01062113|1944148|FG001|Overall Study|Adverse Event|0
950512|NCT01062113|1944149|FG002|Overall Study|Adverse Event|0
950513|NCT01062113|1944147|FG000|Overall Study|Lack of Efficacy|38
950514|NCT01062113|1944148|FG001|Overall Study|Lack of Efficacy|22
950515|NCT01062113|1944149|FG002|Overall Study|Lack of Efficacy|31
950516|NCT01062113|1944147|FG000|Overall Study|Withdrawal by Subject|1
950517|NCT01062113|1944148|FG001|Overall Study|Withdrawal by Subject|0
950518|NCT01062113|1944149|FG002|Overall Study|Withdrawal by Subject|0
950519|NCT01062126|1944157|FG000|Overall Study|Death|209
950520|NCT01062126|1944157|FG000|Overall Study|All Withdrawals|324
950521|NCT01062256|1944172|FG000|Overall Study|Adverse Event|1
950522|NCT01062256|1944173|FG001|Overall Study|Adverse Event|0
950523|NCT01062256|1944174|FG002|Overall Study|Adverse Event|0
950524|NCT01062256|1944172|FG000|Overall Study|Withdrawal by Subject|1
950525|NCT01062256|1944173|FG001|Overall Study|Withdrawal by Subject|1
950526|NCT01062256|1944174|FG002|Overall Study|Withdrawal by Subject|1
950527|NCT01062256|1944172|FG000|Overall Study|Ineligible|1
950528|NCT01062256|1944173|FG001|Overall Study|Ineligible|4
950529|NCT01062256|1944174|FG002|Overall Study|Ineligible|3
950530|NCT01062256|1944172|FG000|Overall Study|Administrative|0
950531|NCT01062256|1944173|FG001|Overall Study|Administrative|2
950532|NCT01062256|1944174|FG002|Overall Study|Administrative|0
950533|NCT01062399|1944204|FG000|Overall Study|Protocol Violation|0
950534|NCT01062399|1944205|FG001|Overall Study|Protocol Violation|1
950535|NCT01062399|1944206|FG002|Overall Study|Protocol Violation|0
950536|NCT01062399|1944207|FG003|Overall Study|Protocol Violation|6
950537|NCT01062399|1944208|FG004|Overall Study|Protocol Violation|4
950540|NCT01062555|1944231|FG000|Phase 1|Death|10
950541|NCT01062555|1944232|FG001|Phase 1|Death|17
950542|NCT01062555|1944233|FG002|Phase 1|Death|0
950543|NCT01062555|1944234|FG003|Phase 1|Death|0
950544|NCT01062555|1944231|FG000|Phase 1|Graft Failure|12
950545|NCT01062555|1944232|FG001|Phase 1|Graft Failure|8
950546|NCT01062555|1944233|FG002|Phase 1|Graft Failure|0
950547|NCT01062555|1944234|FG003|Phase 1|Graft Failure|0
950548|NCT01062555|1944231|FG000|Phase 1|Withdrawal by Subject|1
950549|NCT01062555|1944232|FG001|Phase 1|Withdrawal by Subject|1
950550|NCT01062555|1944233|FG002|Phase 1|Withdrawal by Subject|0
950551|NCT01062555|1944234|FG003|Phase 1|Withdrawal by Subject|0
950552|NCT01062555|1944231|FG000|Phase 2|Death|0
950553|NCT01062555|1944232|FG001|Phase 2|Death|0
950554|NCT01062555|1944233|FG002|Phase 2|Death|8
950555|NCT01062555|1944234|FG003|Phase 2|Death|3
950556|NCT01062555|1944231|FG000|Phase 2|Graft failure|0
950557|NCT01062555|1944232|FG001|Phase 2|Graft failure|0
950558|NCT01062555|1944233|FG002|Phase 2|Graft failure|7
950559|NCT01062555|1944234|FG003|Phase 2|Graft failure|4
950560|NCT01062555|1944231|FG000|Phase 2|Withdrawal by Subject|0
950561|NCT01062555|1944232|FG001|Phase 2|Withdrawal by Subject|0
950562|NCT01062555|1944233|FG002|Phase 2|Withdrawal by Subject|0
950563|NCT01062555|1944234|FG003|Phase 2|Withdrawal by Subject|7
950564|NCT01062555|1944231|FG000|Phase 2|Protocol Violation|0
950565|NCT01062555|1944232|FG001|Phase 2|Protocol Violation|0
950566|NCT01062555|1944233|FG002|Phase 2|Protocol Violation|0
950567|NCT01062555|1944234|FG003|Phase 2|Protocol Violation|3
950568|NCT01062555|1944231|FG000|Phase 2|Physician Decision|0
950569|NCT01062555|1944232|FG001|Phase 2|Physician Decision|0
950570|NCT01062555|1944233|FG002|Phase 2|Physician Decision|0
950571|NCT01062555|1944234|FG003|Phase 2|Physician Decision|17
950572|NCT01062763|1944260|FG000|Overall Study|Adverse Event|3
950573|NCT01062763|1944261|FG001|Overall Study|Adverse Event|4
950574|NCT01062841|1944269|FG000|Overall Study|Indwelling Device Removed|41
950575|NCT01062841|1944270|FG001|Overall Study|Indwelling Device Removed|48
950576|NCT01062841|1944269|FG000|Overall Study|Death|3
950577|NCT01062841|1944270|FG001|Overall Study|Death|5
950578|NCT01062841|1944269|FG000|Overall Study|Withdrawal by Subject|2
950579|NCT01062841|1944270|FG001|Overall Study|Withdrawal by Subject|0
950580|NCT01062841|1944269|FG000|Overall Study|Withdrawal by Study|3
950581|NCT01062841|1944270|FG001|Overall Study|Withdrawal by Study|0
950582|NCT01062971|1944287|FG000|Overall Study|Protocol Violation|1
950583|NCT01062971|1944288|FG001|Overall Study|Protocol Violation|3
950584|NCT01062971|1944287|FG000|Overall Study|Lost to Follow-up|3
950585|NCT01062971|1944288|FG001|Overall Study|Lost to Follow-up|4
950586|NCT01063036|1944294|FG000|Participants Treated With Study Drug|Adverse Event|1
950587|NCT01063036|1944294|FG000|Participants Treated With Study Drug|Protocol Violation|1
950588|NCT01063036|1944294|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2
950589|NCT01063036|1944294|FG000|Participants Treated With Study Drug|Lost to Follow-up|1
950590|NCT01063036|1944294|FG000|Participants Treated With Study Drug|Pregnancy|1
950591|NCT01063036|1944294|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
950592|NCT01063036|1944294|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
950593|NCT01063036|1944294|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
950594|NCT01063062|1944313|FG000|Overall Study|Patient withdrew consent|0
950595|NCT01063062|1944314|FG001|Overall Study|Patient withdrew consent|1
950596|NCT01063062|1944313|FG000|Overall Study|Adverse Event|2
950597|NCT01063062|1944314|FG001|Overall Study|Adverse Event|4
950598|NCT01063062|1944313|FG000|Overall Study|Protocol Violation|5
950599|NCT01063062|1944314|FG001|Overall Study|Protocol Violation|4
950600|NCT01063062|1944313|FG000|Overall Study|Investigator's request|1
950601|NCT01063062|1944314|FG001|Overall Study|Investigator's request|0
950602|NCT01063062|1944313|FG000|Overall Study|Lost to Follow-up|0
950603|NCT01063062|1944314|FG001|Overall Study|Lost to Follow-up|2
950604|NCT01063062|1944313|FG000|Overall Study|Miscellaneous reason|0
950605|NCT01063062|1944314|FG001|Overall Study|Miscellaneous reason|1
950606|NCT01063153|1944336|FG000|Overall Study|Found Ineligible During Screening|2
950607|NCT01063153|1944337|FG001|Overall Study|Found Ineligible During Screening|0
950608|NCT01063153|1944336|FG000|Overall Study|Lost to Follow-up|0
950609|NCT01063153|1944337|FG001|Overall Study|Lost to Follow-up|7
950610|NCT01063153|1944336|FG000|Overall Study|Withdrawal by Subject|0
950611|NCT01063153|1944337|FG001|Overall Study|Withdrawal by Subject|1
950612|NCT01063153|1944336|FG000|Overall Study|Physician Decision|0
950613|NCT01063153|1944337|FG001|Overall Study|Physician Decision|4
950614|NCT01063283|1944349|FG000|Cycle 1|Adverse Event|2
950615|NCT01063283|1944350|FG001|Cycle 1|Adverse Event|0
950616|NCT01063283|1944351|FG002|Cycle 1|Adverse Event|0
950617|NCT01063283|1944349|FG000|Cycle 1|Technical failure in data collection|1
950618|NCT01063283|1944350|FG001|Cycle 1|Technical failure in data collection|0
950619|NCT01063283|1944351|FG002|Cycle 1|Technical failure in data collection|0
950620|NCT01063348|1944359|FG000|Overall Study|Lost to Follow-up|3
950621|NCT01063348|1944360|FG001|Overall Study|Lost to Follow-up|10
950632|NCT01063595|1944375|FG000|Enrolled in Study and Randomized|Reason not Specified|1
950633|NCT01063595|1944376|FG001|Enrolled in Study and Randomized|Reason not Specified|0
950634|NCT01063595|1944375|FG000|Enrolled in Study and Randomized|Adverse Event|0
950635|NCT01063595|1944376|FG001|Enrolled in Study and Randomized|Adverse Event|1
950636|NCT01063595|1944375|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
950637|NCT01063595|1944376|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
950638|NCT01063595|1944375|FG000|First Intervention|Adverse Event|1
950639|NCT01063595|1944376|FG001|First Intervention|Adverse Event|4
950640|NCT01063595|1944375|FG000|First Intervention|Withdrawal by Subject|1
950641|NCT01063595|1944376|FG001|First Intervention|Withdrawal by Subject|0
950642|NCT01063595|1944375|FG000|First Intervention|Reason not Specified|0
950643|NCT01063595|1944376|FG001|First Intervention|Reason not Specified|1
950644|NCT01063764|1944387|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4
950645|NCT01063764|1944387|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
950646|NCT01063764|1944387|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
950647|NCT01063764|1944387|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3
950648|NCT01063764|1944387|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
950649|NCT01063764|1944387|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
950650|NCT01063764|1944387|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
950651|NCT01063855|1944410|FG000|Overall Study|Adverse Event|4
950652|NCT01063855|1944411|FG001|Overall Study|Adverse Event|4
950653|NCT01063855|1944410|FG000|Overall Study|Death|0
950654|NCT01063855|1944411|FG001|Overall Study|Death|1
950655|NCT01063855|1944410|FG000|Overall Study|Lost to Follow-up|8
950656|NCT01063855|1944411|FG001|Overall Study|Lost to Follow-up|4
950657|NCT01063855|1944410|FG000|Overall Study|Pregnancy|1
950658|NCT01063855|1944411|FG001|Overall Study|Pregnancy|0
950659|NCT01063855|1944410|FG000|Overall Study|Lack of Efficacy|0
950660|NCT01063855|1944411|FG001|Overall Study|Lack of Efficacy|1
950661|NCT01063855|1944410|FG000|Overall Study|Withdrawal by Subject|11
950662|NCT01063855|1944411|FG001|Overall Study|Withdrawal by Subject|8
950663|NCT01063855|1944410|FG000|Overall Study|Reason not specified|13
950664|NCT01063855|1944411|FG001|Overall Study|Reason not specified|11
950665|NCT01063868|1944423|FG000|Overall Study|Adverse Event|9
950666|NCT01063868|1944424|FG001|Overall Study|Adverse Event|7
950667|NCT01063868|1944423|FG000|Overall Study|Withdrawal by Subject|3
950668|NCT01063868|1944424|FG001|Overall Study|Withdrawal by Subject|1
950669|NCT01063868|1944423|FG000|Overall Study|Study Terminated By Sponsor|23
950670|NCT01063868|1944424|FG001|Overall Study|Study Terminated By Sponsor|4
950671|NCT01063881|1944433|FG000|Overall Study|Adverse Event|12
950672|NCT01063881|1944434|FG001|Overall Study|Adverse Event|2
950673|NCT01063881|1944435|FG002|Overall Study|Adverse Event|0
950674|NCT01063881|1944433|FG000|Overall Study|Lost to Follow-up|13
950675|NCT01063881|1944434|FG001|Overall Study|Lost to Follow-up|7
950676|NCT01063881|1944435|FG002|Overall Study|Lost to Follow-up|1
950677|NCT01063881|1944433|FG000|Overall Study|Withdrawal by Subject|25
950678|NCT01063881|1944434|FG001|Overall Study|Withdrawal by Subject|1
950679|NCT01063881|1944435|FG002|Overall Study|Withdrawal by Subject|0
950680|NCT01063881|1944433|FG000|Overall Study|Reason for not completed not specified|5
950681|NCT01063881|1944434|FG001|Overall Study|Reason for not completed not specified|1
950682|NCT01063881|1944435|FG002|Overall Study|Reason for not completed not specified|0
950683|NCT01063972|1944475|FG000|Overall Study|Death|12
950684|NCT01063972|1944476|FG001|Overall Study|Death|11
950685|NCT01063972|1944475|FG000|Overall Study|Incarcerated|2
950686|NCT01063972|1944476|FG001|Overall Study|Incarcerated|1
950687|NCT01064167|1944489|FG000|Overall Study|Protocol Violation|14
950688|NCT01064167|1944490|FG001|Overall Study|Protocol Violation|15
950689|NCT01064297|1944509|FG000|Overall Study|Lost to Follow-up|791
950690|NCT01064297|1944510|FG001|Overall Study|Lost to Follow-up|48
950691|NCT01064297|1944511|FG002|Overall Study|Lost to Follow-up|133
950692|NCT01064310|1944528|FG000|Period 1|Adverse Event|7
950693|NCT01064310|1944529|FG001|Period 1|Adverse Event|10
950694|NCT01064310|1944530|FG002|Period 1|Adverse Event|0
950695|NCT01064310|1944528|FG000|Period 1|Physician Decision|1
950696|NCT01064310|1944529|FG001|Period 1|Physician Decision|0
950697|NCT01064310|1944530|FG002|Period 1|Physician Decision|0
950698|NCT01064310|1944528|FG000|Period 1|Withdrawal by Subject|2
950699|NCT01064310|1944529|FG001|Period 1|Withdrawal by Subject|2
950700|NCT01064310|1944530|FG002|Period 1|Withdrawal by Subject|0
950701|NCT01064310|1944528|FG000|Period 1|Lack of Efficacy|3
950702|NCT01064310|1944529|FG001|Period 1|Lack of Efficacy|5
950703|NCT01064310|1944530|FG002|Period 1|Lack of Efficacy|0
950704|NCT01064310|1944528|FG000|Period 1|Entered Open-label Period|1
950705|NCT01064310|1944529|FG001|Period 1|Entered Open-label Period|1
950706|NCT01064310|1944530|FG002|Period 1|Entered Open-label Period|0
950707|NCT01064310|1944528|FG000|Period 2|Adverse Event|2
950708|NCT01064310|1944529|FG001|Period 2|Adverse Event|1
950709|NCT01064310|1944530|FG002|Period 2|Adverse Event|0
950710|NCT01064310|1944528|FG000|Period 2|Physician Decision|0
950711|NCT01064310|1944529|FG001|Period 2|Physician Decision|1
950712|NCT01064310|1944530|FG002|Period 2|Physician Decision|0
950713|NCT01064310|1944528|FG000|Period 2|Entered Open-label Period|1
950714|NCT01064310|1944529|FG001|Period 2|Entered Open-label Period|0
950715|NCT01064310|1944530|FG002|Period 2|Entered Open-label Period|0
950716|NCT01064310|1944528|FG000|Period 2|Lack of Efficacy|1
950717|NCT01064310|1944529|FG001|Period 2|Lack of Efficacy|4
950718|NCT01064310|1944530|FG002|Period 2|Lack of Efficacy|0
950719|NCT01064310|1944528|FG000|Open Label Pazopinib|Withdrawal by Subject|0
950720|NCT01064310|1944529|FG001|Open Label Pazopinib|Withdrawal by Subject|0
950721|NCT01064310|1944530|FG002|Open Label Pazopinib|Withdrawal by Subject|1
950722|NCT01064310|1944528|FG000|Open Label Pazopinib|Adverse Event|0
950723|NCT01064310|1944529|FG001|Open Label Pazopinib|Adverse Event|0
950724|NCT01064310|1944530|FG002|Open Label Pazopinib|Adverse Event|12
950725|NCT01064310|1944528|FG000|Open Label Pazopinib|Lack of Efficacy|0
950726|NCT01064310|1944529|FG001|Open Label Pazopinib|Lack of Efficacy|0
950727|NCT01064310|1944530|FG002|Open Label Pazopinib|Lack of Efficacy|51
950728|NCT01064310|1944528|FG000|Open Label Pazopinib|Physician Decision|0
950729|NCT01064310|1944529|FG001|Open Label Pazopinib|Physician Decision|0
950730|NCT01064310|1944530|FG002|Open Label Pazopinib|Physician Decision|20
950731|NCT01064401|1944554|FG000|Overall Study|Adverse Event|47
950732|NCT01064401|1944555|FG001|Overall Study|Adverse Event|56
950733|NCT01064401|1944554|FG000|Overall Study|Lack of Efficacy|46
950734|NCT01064401|1944555|FG001|Overall Study|Lack of Efficacy|23
950735|NCT01064401|1944554|FG000|Overall Study|Lost to Follow-up|12
950736|NCT01064401|1944555|FG001|Overall Study|Lost to Follow-up|9
950737|NCT01064401|1944554|FG000|Overall Study|Consent Withdrawn|98
950738|NCT01064401|1944555|FG001|Overall Study|Consent Withdrawn|80
950739|NCT01064401|1944554|FG000|Overall Study|Investigator Decision|4
950740|NCT01064401|1944555|FG001|Overall Study|Investigator Decision|6
950741|NCT01064401|1944554|FG000|Overall Study|Death|4
950742|NCT01064401|1944555|FG001|Overall Study|Death|0
950743|NCT01064401|1944554|FG000|Overall Study|Pregnancy|4
950744|NCT01064401|1944555|FG001|Overall Study|Pregnancy|7
950745|NCT01064401|1944554|FG000|Overall Study|Noncompliance|7
950746|NCT01064401|1944555|FG001|Overall Study|Noncompliance|8
950747|NCT01064401|1944554|FG000|Overall Study|Site Closure|4
950748|NCT01064401|1944555|FG001|Overall Study|Site Closure|5
950749|NCT01064401|1944554|FG000|Overall Study|Other|2
950750|NCT01064401|1944555|FG001|Overall Study|Other|1
950751|NCT01064414|1944565|FG000|Core Period: Baseline to Week 26|Adverse Event|4
950752|NCT01064414|1944566|FG001|Core Period: Baseline to Week 26|Adverse Event|4
950753|NCT01064414|1944567|FG002|Core Period: Baseline to Week 26|Adverse Event|2
950754|NCT01064414|1944565|FG000|Core Period: Baseline to Week 26|Death|0
950755|NCT01064414|1944566|FG001|Core Period: Baseline to Week 26|Death|1
950756|NCT01064414|1944567|FG002|Core Period: Baseline to Week 26|Death|0
950757|NCT01064414|1944565|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
950758|NCT01064414|1944566|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
950759|NCT01064414|1944567|FG002|Core Period: Baseline to Week 26|Protocol Violation|1
950760|NCT01064414|1944565|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
950761|NCT01064414|1944566|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2
950762|NCT01064414|1944567|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2
950763|NCT01064414|1944565|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
950764|NCT01064414|1944566|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
950765|NCT01064414|1944567|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
950766|NCT01064414|1944565|FG000|Core Period: Baseline to Week 26|Other|4
950767|NCT01064414|1944566|FG001|Core Period: Baseline to Week 26|Other|7
950768|NCT01064414|1944567|FG002|Core Period: Baseline to Week 26|Other|2
950769|NCT01064414|1944565|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
950770|NCT01064414|1944566|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
950771|NCT01064414|1944567|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2
950772|NCT01064414|1944565|FG000|Extension Period: Week 26 to Week 52|Death|0
950773|NCT01064414|1944566|FG001|Extension Period: Week 26 to Week 52|Death|1
950774|NCT01064414|1944567|FG002|Extension Period: Week 26 to Week 52|Death|0
950775|NCT01064414|1944565|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
950776|NCT01064414|1944566|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
950777|NCT01064414|1944567|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
950778|NCT01064414|1944565|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1
950779|NCT01064414|1944566|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
950780|NCT01064414|1944567|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
950781|NCT01064414|1944565|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
950782|NCT01064414|1944566|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
950783|NCT01064414|1944567|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
950784|NCT01064414|1944565|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
950785|NCT01064414|1944566|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
950786|NCT01064414|1944567|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
950787|NCT01064414|1944565|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
950788|NCT01064414|1944566|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
950789|NCT01064414|1944567|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1
950790|NCT01064414|1944565|FG000|Extension Period: Week 26 to Week 52|Other|5
950791|NCT01064414|1944566|FG001|Extension Period: Week 26 to Week 52|Other|2
950792|NCT01064414|1944567|FG002|Extension Period: Week 26 to Week 52|Other|1
950793|NCT01064531|1944580|FG000|Overall Study|Lost to Follow-up|0
950794|NCT01064531|1944581|FG001|Overall Study|Lost to Follow-up|2
950795|NCT01064531|1944580|FG000|Overall Study|Physician Decision|0
950796|NCT01064531|1944581|FG001|Overall Study|Physician Decision|1
950797|NCT01064531|1944580|FG000|Overall Study|Withdrawal by Subject|2
950798|NCT01064531|1944581|FG001|Overall Study|Withdrawal by Subject|2
950799|NCT01064531|1944580|FG000|Overall Study|Revision due to femoral stem loosening|1
950800|NCT01064531|1944581|FG001|Overall Study|Revision due to femoral stem loosening|0
950801|NCT01064531|1944580|FG000|Overall Study|Revision due to dislocation|0
950802|NCT01064531|1944581|FG001|Overall Study|Revision due to dislocation|1
950803|NCT01064531|1944580|FG000|Overall Study|Death|0
950804|NCT01064531|1944581|FG001|Overall Study|Death|1
950805|NCT01064622|1944590|FG000|Randomized Phase II|Withdrawal by Subject|2
950806|NCT01064622|1944591|FG001|Randomized Phase II|Withdrawal by Subject|2
950807|NCT01064622|1944590|FG000|Randomized Phase II|Protocol Violation|0
950808|NCT01064622|1944591|FG001|Randomized Phase II|Protocol Violation|1
950857|NCT01064687|1944623|FG000|Overall Study|Adverse Event|9
950858|NCT01064687|1944624|FG001|Overall Study|Adverse Event|4
950859|NCT01064687|1944625|FG002|Overall Study|Adverse Event|10
950860|NCT01064687|1944626|FG003|Overall Study|Adverse Event|3
950861|NCT01064687|1944623|FG000|Overall Study|Death|1
950862|NCT01064687|1944624|FG001|Overall Study|Death|1
950863|NCT01064687|1944625|FG002|Overall Study|Death|0
950864|NCT01064687|1944626|FG003|Overall Study|Death|0
950865|NCT01064687|1944623|FG000|Overall Study|Entry Criteria Not Met|3
950866|NCT01064687|1944624|FG001|Overall Study|Entry Criteria Not Met|0
950867|NCT01064687|1944625|FG002|Overall Study|Entry Criteria Not Met|0
950868|NCT01064687|1944626|FG003|Overall Study|Entry Criteria Not Met|0
950869|NCT01064687|1944623|FG000|Overall Study|Lack of Efficacy|1
950870|NCT01064687|1944624|FG001|Overall Study|Lack of Efficacy|0
950871|NCT01064687|1944625|FG002|Overall Study|Lack of Efficacy|2
950872|NCT01064687|1944626|FG003|Overall Study|Lack of Efficacy|3
950873|NCT01064687|1944623|FG000|Overall Study|Lost to Follow-up|7
950874|NCT01064687|1944624|FG001|Overall Study|Lost to Follow-up|10
950875|NCT01064687|1944625|FG002|Overall Study|Lost to Follow-up|13
950876|NCT01064687|1944626|FG003|Overall Study|Lost to Follow-up|5
950877|NCT01064687|1944623|FG000|Overall Study|Physician Decision|2
950878|NCT01064687|1944624|FG001|Overall Study|Physician Decision|2
950879|NCT01064687|1944625|FG002|Overall Study|Physician Decision|0
950880|NCT01064687|1944626|FG003|Overall Study|Physician Decision|0
950881|NCT01064687|1944623|FG000|Overall Study|Protocol Violation|1
950882|NCT01064687|1944624|FG001|Overall Study|Protocol Violation|1
950883|NCT01064687|1944625|FG002|Overall Study|Protocol Violation|0
950884|NCT01064687|1944626|FG003|Overall Study|Protocol Violation|1
950885|NCT01064687|1944623|FG000|Overall Study|Sponsor Decision|0
950886|NCT01064687|1944624|FG001|Overall Study|Sponsor Decision|0
950887|NCT01064687|1944625|FG002|Overall Study|Sponsor Decision|3
950888|NCT01064687|1944626|FG003|Overall Study|Sponsor Decision|0
950889|NCT01064687|1944623|FG000|Overall Study|Withdrawal by Subject|9
950890|NCT01064687|1944624|FG001|Overall Study|Withdrawal by Subject|7
950891|NCT01064687|1944625|FG002|Overall Study|Withdrawal by Subject|12
950892|NCT01064687|1944626|FG003|Overall Study|Withdrawal by Subject|5
950893|NCT01064687|1944623|FG000|Overall Study|Treatment Noncompliance|1
950894|NCT01064687|1944624|FG001|Overall Study|Treatment Noncompliance|1
950895|NCT01064687|1944625|FG002|Overall Study|Treatment Noncompliance|1
950896|NCT01064687|1944626|FG003|Overall Study|Treatment Noncompliance|0
950897|NCT01064739|1944656|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1
950898|NCT01064817|1944668|FG000|Study Completion|Physician Decision|1
950899|NCT01064817|1944669|FG001|Study Completion|Physician Decision|0
950900|NCT01064817|1944668|FG000|Study Completion|Withdrawal by Subject|1
950901|NCT01064817|1944669|FG001|Study Completion|Withdrawal by Subject|0
950902|NCT01064856|1944688|FG000|Double-blind (DB) Period|Adverse Event|1
950903|NCT01064856|1944689|FG001|Double-blind (DB) Period|Adverse Event|0
950904|NCT01064856|1944690|FG002|Double-blind (DB) Period|Adverse Event|0
950905|NCT01064856|1944691|FG003|Double-blind (DB) Period|Adverse Event|0
950906|NCT01064856|1944688|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1
950907|NCT01064856|1944689|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0
950908|NCT01064856|1944690|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0
950909|NCT01064856|1944691|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0
950910|NCT01064856|1944688|FG000|Open-label (OL) Period|Adverse Event|0
950911|NCT01064856|1944689|FG001|Open-label (OL) Period|Adverse Event|0
950912|NCT01064856|1944690|FG002|Open-label (OL) Period|Adverse Event|12
950913|NCT01064856|1944691|FG003|Open-label (OL) Period|Adverse Event|6
950914|NCT01064856|1944688|FG000|Open-label (OL) Period|Consent withdrawn by participant|0
950915|NCT01064856|1944689|FG001|Open-label (OL) Period|Consent withdrawn by participant|0
950916|NCT01064856|1944690|FG002|Open-label (OL) Period|Consent withdrawn by participant|5
950917|NCT01064856|1944691|FG003|Open-label (OL) Period|Consent withdrawn by participant|6
950918|NCT01064856|1944688|FG000|Open-label (OL) Period|Lost to Follow-up|0
950919|NCT01064856|1944689|FG001|Open-label (OL) Period|Lost to Follow-up|0
950920|NCT01064856|1944690|FG002|Open-label (OL) Period|Lost to Follow-up|2
950921|NCT01064856|1944691|FG003|Open-label (OL) Period|Lost to Follow-up|1
950922|NCT01064856|1944688|FG000|Open-label (OL) Period|Other|0
950923|NCT01064856|1944689|FG001|Open-label (OL) Period|Other|0
950924|NCT01064856|1944690|FG002|Open-label (OL) Period|Other|7
950925|NCT01064856|1944691|FG003|Open-label (OL) Period|Other|7
950926|NCT01064947|1944711|FG000|Overall Study|negative culture|41
950927|NCT01065350|1944721|FG000|Overall Study|Received incorrect drug allocation|0
950928|NCT01065350|1944722|FG001|Overall Study|Received incorrect drug allocation|1
950977|NCT01065597|1944787|FG000|Overall Study|Adverse Event|1
950978|NCT01065766|1944798|FG000|Overall Study|Assessed before the contracted date|1
950979|NCT01065766|1944798|FG000|Overall Study|Contraindication to administration|6
950980|NCT01065766|1944798|FG000|Overall Study|Violated dosage/administration|25
950981|NCT01065779|1944802|FG000|Overall Study|Duplicate Investigation|1
950982|NCT01065779|1944802|FG000|Overall Study|Investigation Before Contract Date|37
950983|NCT01065779|1944802|FG000|Overall Study|Non-enrollment Period Administration|10
950984|NCT01065779|1944802|FG000|Overall Study|Not Administered With Study Drug|17
950985|NCT01065779|1944802|FG000|Overall Study|Failed to Follow-up|10
950986|NCT01065779|1944802|FG000|Overall Study|Inclusion Criteria Violation|7
950987|NCT01065844|1944806|FG000|Overall Study|Adverse Event|5
950988|NCT01066000|1944810|FG000|Overall Study|Protocol Violation|4
950989|NCT01066000|1944810|FG000|Overall Study|Death|3
950990|NCT01066000|1944810|FG000|Overall Study|Withdrawal by Subject|1
950991|NCT01066000|1944810|FG000|Overall Study|Adverse Event|1
950992|NCT01066039|1944820|FG000|Overall Study|Adverse Event|6
950993|NCT01066039|1944820|FG000|Overall Study|Withdrawal by Subject|17
950994|NCT01066039|1944820|FG000|Overall Study|Protocol Violation|2
950995|NCT01066039|1944820|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9
950996|NCT01066039|1944820|FG000|Overall Study|Investigator's Request|1
950997|NCT01066039|1944820|FG000|Overall Study|Dropout due to Insulin Administration|1
950998|NCT01066039|1944820|FG000|Overall Study|Additional Antihypertensive Required|4
950999|NCT01066039|1944820|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2
951000|NCT01066039|1944820|FG000|Overall Study|Failure to Control Blood Pressure|1
951001|NCT01066039|1944820|FG000|Overall Study|Drug/Dose Adjustment Required|1
951002|NCT01066052|1944826|FG000|Overall Study|Enrolled But Not Treated|3
951003|NCT01066052|1944827|FG001|Overall Study|Enrolled But Not Treated|0
951004|NCT01066104|1944834|FG000|Overall Study|Adverse Event|1
951005|NCT01066104|1944835|FG001|Overall Study|Adverse Event|1
951006|NCT01066104|1944834|FG000|Overall Study|Protocol Violation|1
951007|NCT01066104|1944835|FG001|Overall Study|Protocol Violation|0
951008|NCT01066143|1944841|FG000|Overall Study|ineligible for the study|8
951009|NCT01066156|1944845|FG000|Overall Study|ineligible|2
951010|NCT01066156|1944845|FG000|Overall Study|Lost to Follow-up|7
951011|NCT01066156|1944845|FG000|Overall Study|Withdrawal by Subject|1
951012|NCT01066546|1944871|FG000|Overall Study|Study terminated by sponsor|5
951013|NCT01066585|1944877|FG000|Overall Study|Protocol Violation|1
951014|NCT01066585|1944878|FG001|Overall Study|Protocol Violation|0
951015|NCT01066585|1944877|FG000|Overall Study|Withdrawal by Subject|0
951016|NCT01066585|1944878|FG001|Overall Study|Withdrawal by Subject|3
951017|NCT01066780|1944897|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1
951018|NCT01066780|1944898|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1
951019|NCT01066793|1944908|FG000|Overall Study|Death|4
951020|NCT01066793|1944909|FG001|Overall Study|Death|1
951021|NCT01066793|1944910|FG002|Overall Study|Death|1
951022|NCT01066793|1944911|FG003|Overall Study|Death|0
951023|NCT01066793|1944912|FG004|Overall Study|Death|0
951024|NCT01066793|1944913|FG005|Overall Study|Death|0
951025|NCT01066793|1944908|FG000|Overall Study|Lack of Efficacy|2
951026|NCT01066793|1944909|FG001|Overall Study|Lack of Efficacy|1
951027|NCT01066793|1944910|FG002|Overall Study|Lack of Efficacy|0
951028|NCT01066793|1944911|FG003|Overall Study|Lack of Efficacy|0
951029|NCT01066793|1944912|FG004|Overall Study|Lack of Efficacy|0
951030|NCT01066793|1944913|FG005|Overall Study|Lack of Efficacy|0
951031|NCT01066793|1944908|FG000|Overall Study|Lost to Follow-up|180
951032|NCT01066793|1944909|FG001|Overall Study|Lost to Follow-up|39
951033|NCT01066793|1944910|FG002|Overall Study|Lost to Follow-up|82
951034|NCT01066793|1944911|FG003|Overall Study|Lost to Follow-up|16
951035|NCT01066793|1944912|FG004|Overall Study|Lost to Follow-up|0
951036|NCT01066793|1944913|FG005|Overall Study|Lost to Follow-up|1
951037|NCT01066793|1944908|FG000|Overall Study|Physician Decision|3
951038|NCT01066793|1944909|FG001|Overall Study|Physician Decision|0
951039|NCT01066793|1944910|FG002|Overall Study|Physician Decision|0
951040|NCT01066793|1944911|FG003|Overall Study|Physician Decision|0
951041|NCT01066793|1944912|FG004|Overall Study|Physician Decision|0
951042|NCT01066793|1944913|FG005|Overall Study|Physician Decision|0
951043|NCT01066793|1944908|FG000|Overall Study|Protocol Violation|3
951044|NCT01066793|1944909|FG001|Overall Study|Protocol Violation|2
951045|NCT01066793|1944910|FG002|Overall Study|Protocol Violation|2
951046|NCT01066793|1944911|FG003|Overall Study|Protocol Violation|0
951047|NCT01066793|1944912|FG004|Overall Study|Protocol Violation|0
951048|NCT01066793|1944913|FG005|Overall Study|Protocol Violation|0
951049|NCT01066793|1944908|FG000|Overall Study|Withdrawal by Subject|7
951050|NCT01066793|1944909|FG001|Overall Study|Withdrawal by Subject|4
951051|NCT01066793|1944910|FG002|Overall Study|Withdrawal by Subject|1
951052|NCT01066793|1944911|FG003|Overall Study|Withdrawal by Subject|0
951053|NCT01066793|1944912|FG004|Overall Study|Withdrawal by Subject|0
951054|NCT01066793|1944913|FG005|Overall Study|Withdrawal by Subject|0
951055|NCT01066793|1944908|FG000|Overall Study|Early Termination|3
951056|NCT01066793|1944909|FG001|Overall Study|Early Termination|0
951057|NCT01066793|1944910|FG002|Overall Study|Early Termination|0
951058|NCT01066793|1944911|FG003|Overall Study|Early Termination|0
951059|NCT01066793|1944912|FG004|Overall Study|Early Termination|0
951060|NCT01066793|1944913|FG005|Overall Study|Early Termination|0
951061|NCT01066793|1944908|FG000|Overall Study|Lab test not done|7
951062|NCT01066793|1944909|FG001|Overall Study|Lab test not done|0
951063|NCT01066793|1944910|FG002|Overall Study|Lab test not done|0
951064|NCT01066793|1944911|FG003|Overall Study|Lab test not done|1
951065|NCT01066793|1944912|FG004|Overall Study|Lab test not done|0
951066|NCT01066793|1944913|FG005|Overall Study|Lab test not done|0
951067|NCT01066793|1944908|FG000|Overall Study|Miscellaneous|4
951068|NCT01066793|1944909|FG001|Overall Study|Miscellaneous|5
951069|NCT01066793|1944910|FG002|Overall Study|Miscellaneous|6
951070|NCT01066793|1944911|FG003|Overall Study|Miscellaneous|0
951071|NCT01066793|1944912|FG004|Overall Study|Miscellaneous|0
951072|NCT01066793|1944913|FG005|Overall Study|Miscellaneous|0
951073|NCT01066793|1944908|FG000|Overall Study|Non-responders|104
951074|NCT01066793|1944909|FG001|Overall Study|Non-responders|5
951075|NCT01066793|1944910|FG002|Overall Study|Non-responders|11
951076|NCT01066793|1944911|FG003|Overall Study|Non-responders|25
951077|NCT01066793|1944912|FG004|Overall Study|Non-responders|0
951078|NCT01066793|1944913|FG005|Overall Study|Non-responders|0
951079|NCT01066793|1944908|FG000|Overall Study|Other|15
951080|NCT01066793|1944909|FG001|Overall Study|Other|5
951081|NCT01066793|1944910|FG002|Overall Study|Other|6
951082|NCT01066793|1944911|FG003|Overall Study|Other|2
951083|NCT01066793|1944912|FG004|Overall Study|Other|0
951084|NCT01066793|1944913|FG005|Overall Study|Other|0
951085|NCT01066793|1944908|FG000|Overall Study|Relapse|20
951086|NCT01066793|1944909|FG001|Overall Study|Relapse|8
951087|NCT01066793|1944910|FG002|Overall Study|Relapse|2
951088|NCT01066793|1944911|FG003|Overall Study|Relapse|3
951089|NCT01066793|1944912|FG004|Overall Study|Relapse|0
951090|NCT01066793|1944913|FG005|Overall Study|Relapse|0
951091|NCT01066793|1944908|FG000|Overall Study|Result Not Available|1
951092|NCT01066793|1944909|FG001|Overall Study|Result Not Available|0
951093|NCT01066793|1944910|FG002|Overall Study|Result Not Available|0
951094|NCT01066793|1944911|FG003|Overall Study|Result Not Available|0
951095|NCT01066793|1944912|FG004|Overall Study|Result Not Available|0
951096|NCT01066793|1944913|FG005|Overall Study|Result Not Available|0
951097|NCT01066793|1944908|FG000|Overall Study|Treatment Interrupted|1
951098|NCT01066793|1944909|FG001|Overall Study|Treatment Interrupted|1
951099|NCT01066793|1944910|FG002|Overall Study|Treatment Interrupted|0
951100|NCT01066793|1944911|FG003|Overall Study|Treatment Interrupted|0
951101|NCT01066793|1944912|FG004|Overall Study|Treatment Interrupted|0
951102|NCT01066793|1944913|FG005|Overall Study|Treatment Interrupted|0
951103|NCT01066793|1944908|FG000|Overall Study|Treatment Never Started|18
951104|NCT01066793|1944909|FG001|Overall Study|Treatment Never Started|5
951105|NCT01066793|1944910|FG002|Overall Study|Treatment Never Started|4
951106|NCT01066793|1944911|FG003|Overall Study|Treatment Never Started|1
951107|NCT01066793|1944912|FG004|Overall Study|Treatment Never Started|0
951108|NCT01066793|1944913|FG005|Overall Study|Treatment Never Started|0
951109|NCT01066793|1944908|FG000|Overall Study|Treatment Stopped|2
951110|NCT01066793|1944909|FG001|Overall Study|Treatment Stopped|1
951111|NCT01066793|1944910|FG002|Overall Study|Treatment Stopped|0
951112|NCT01066793|1944911|FG003|Overall Study|Treatment Stopped|1
951113|NCT01066793|1944912|FG004|Overall Study|Treatment Stopped|0
951114|NCT01066793|1944913|FG005|Overall Study|Treatment Stopped|0
951115|NCT01066819|1944934|FG000|Overall Study|Adverse Event|18
951116|NCT01066819|1944935|FG001|Overall Study|Adverse Event|1
951117|NCT01066819|1944936|FG002|Overall Study|Adverse Event|6
951118|NCT01066819|1944937|FG003|Overall Study|Adverse Event|0
951119|NCT01066819|1944938|FG004|Overall Study|Adverse Event|0
951120|NCT01066819|1944939|FG005|Overall Study|Adverse Event|0
951121|NCT01066819|1944934|FG000|Overall Study|Death|5
951122|NCT01066819|1944935|FG001|Overall Study|Death|0
951123|NCT01066819|1944936|FG002|Overall Study|Death|1
951124|NCT01066819|1944937|FG003|Overall Study|Death|0
951125|NCT01066819|1944938|FG004|Overall Study|Death|0
951126|NCT01066819|1944939|FG005|Overall Study|Death|0
951127|NCT01066819|1944934|FG000|Overall Study|Lack of Efficacy|22
951128|NCT01066819|1944935|FG001|Overall Study|Lack of Efficacy|1
951129|NCT01066819|1944936|FG002|Overall Study|Lack of Efficacy|2
951130|NCT01066819|1944937|FG003|Overall Study|Lack of Efficacy|1
951131|NCT01066819|1944938|FG004|Overall Study|Lack of Efficacy|0
951132|NCT01066819|1944939|FG005|Overall Study|Lack of Efficacy|0
951133|NCT01066819|1944934|FG000|Overall Study|Physician Decision|6
951134|NCT01066819|1944935|FG001|Overall Study|Physician Decision|2
951135|NCT01066819|1944936|FG002|Overall Study|Physician Decision|3
951136|NCT01066819|1944937|FG003|Overall Study|Physician Decision|0
951137|NCT01066819|1944938|FG004|Overall Study|Physician Decision|0
951138|NCT01066819|1944939|FG005|Overall Study|Physician Decision|0
951139|NCT01066819|1944934|FG000|Overall Study|Protocol Violation|12
951140|NCT01066819|1944935|FG001|Overall Study|Protocol Violation|6
951141|NCT01066819|1944936|FG002|Overall Study|Protocol Violation|0
951142|NCT01066819|1944937|FG003|Overall Study|Protocol Violation|0
951143|NCT01066819|1944938|FG004|Overall Study|Protocol Violation|0
951144|NCT01066819|1944939|FG005|Overall Study|Protocol Violation|0
951145|NCT01066819|1944934|FG000|Overall Study|Withdrawal by Subject|29
951146|NCT01066819|1944935|FG001|Overall Study|Withdrawal by Subject|11
951147|NCT01066819|1944936|FG002|Overall Study|Withdrawal by Subject|6
951148|NCT01066819|1944937|FG003|Overall Study|Withdrawal by Subject|0
951149|NCT01066819|1944938|FG004|Overall Study|Withdrawal by Subject|0
951150|NCT01066819|1944939|FG005|Overall Study|Withdrawal by Subject|0
951151|NCT01066819|1944934|FG000|Overall Study|Administrative|6
951152|NCT01066819|1944935|FG001|Overall Study|Administrative|4
951153|NCT01066819|1944936|FG002|Overall Study|Administrative|2
951154|NCT01066819|1944937|FG003|Overall Study|Administrative|0
951155|NCT01066819|1944938|FG004|Overall Study|Administrative|0
951156|NCT01066819|1944939|FG005|Overall Study|Administrative|0
951157|NCT01066819|1944934|FG000|Overall Study|Not met inclusion/exclusion criteria|1
951158|NCT01066819|1944935|FG001|Overall Study|Not met inclusion/exclusion criteria|0
951159|NCT01066819|1944936|FG002|Overall Study|Not met inclusion/exclusion criteria|0
951160|NCT01066819|1944937|FG003|Overall Study|Not met inclusion/exclusion criteria|0
951161|NCT01066819|1944938|FG004|Overall Study|Not met inclusion/exclusion criteria|0
951162|NCT01066819|1944939|FG005|Overall Study|Not met inclusion/exclusion criteria|0
951163|NCT01066819|1944934|FG000|Overall Study|Early termination|2
951164|NCT01066819|1944935|FG001|Overall Study|Early termination|0
951165|NCT01066819|1944936|FG002|Overall Study|Early termination|0
951166|NCT01066819|1944937|FG003|Overall Study|Early termination|0
951167|NCT01066819|1944938|FG004|Overall Study|Early termination|0
951168|NCT01066819|1944939|FG005|Overall Study|Early termination|0
951169|NCT01066819|1944934|FG000|Overall Study|Failed to return|298
951170|NCT01066819|1944935|FG001|Overall Study|Failed to return|107
951171|NCT01066819|1944936|FG002|Overall Study|Failed to return|68
951172|NCT01066819|1944937|FG003|Overall Study|Failed to return|7
951173|NCT01066819|1944938|FG004|Overall Study|Failed to return|2
951174|NCT01066819|1944939|FG005|Overall Study|Failed to return|3
951175|NCT01066819|1944934|FG000|Overall Study|Lab test not done|9
951176|NCT01066819|1944935|FG001|Overall Study|Lab test not done|0
951177|NCT01066819|1944936|FG002|Overall Study|Lab test not done|2
951178|NCT01066819|1944937|FG003|Overall Study|Lab test not done|1
951179|NCT01066819|1944938|FG004|Overall Study|Lab test not done|0
951180|NCT01066819|1944939|FG005|Overall Study|Lab test not done|0
951181|NCT01066819|1944934|FG000|Overall Study|Miscellaneous|28
951182|NCT01066819|1944935|FG001|Overall Study|Miscellaneous|10
951183|NCT01066819|1944936|FG002|Overall Study|Miscellaneous|18
951184|NCT01066819|1944937|FG003|Overall Study|Miscellaneous|1
951185|NCT01066819|1944938|FG004|Overall Study|Miscellaneous|0
951186|NCT01066819|1944939|FG005|Overall Study|Miscellaneous|0
951187|NCT01066819|1944934|FG000|Overall Study|Non responders|123
951188|NCT01066819|1944935|FG001|Overall Study|Non responders|2
951189|NCT01066819|1944936|FG002|Overall Study|Non responders|7
951190|NCT01066819|1944937|FG003|Overall Study|Non responders|2
951191|NCT01066819|1944938|FG004|Overall Study|Non responders|0
951192|NCT01066819|1944939|FG005|Overall Study|Non responders|1
951193|NCT01066819|1944934|FG000|Overall Study|Not categorised|9
951194|NCT01066819|1944935|FG001|Overall Study|Not categorised|2
951195|NCT01066819|1944936|FG002|Overall Study|Not categorised|6
951196|NCT01066819|1944937|FG003|Overall Study|Not categorised|1
951197|NCT01066819|1944938|FG004|Overall Study|Not categorised|0
951198|NCT01066819|1944939|FG005|Overall Study|Not categorised|0
951199|NCT01066819|1944934|FG000|Overall Study|Relapse|16
951200|NCT01066819|1944935|FG001|Overall Study|Relapse|4
951201|NCT01066819|1944936|FG002|Overall Study|Relapse|3
951202|NCT01066819|1944937|FG003|Overall Study|Relapse|0
951203|NCT01066819|1944938|FG004|Overall Study|Relapse|0
951204|NCT01066819|1944939|FG005|Overall Study|Relapse|0
951205|NCT01066819|1944934|FG000|Overall Study|Results not available|1
951206|NCT01066819|1944935|FG001|Overall Study|Results not available|0
951207|NCT01066819|1944936|FG002|Overall Study|Results not available|0
951208|NCT01066819|1944937|FG003|Overall Study|Results not available|0
951209|NCT01066819|1944938|FG004|Overall Study|Results not available|0
951210|NCT01066819|1944939|FG005|Overall Study|Results not available|0
951211|NCT01066819|1944934|FG000|Overall Study|Screen failure|1
951212|NCT01066819|1944935|FG001|Overall Study|Screen failure|0
951213|NCT01066819|1944936|FG002|Overall Study|Screen failure|0
951214|NCT01066819|1944937|FG003|Overall Study|Screen failure|0
951215|NCT01066819|1944938|FG004|Overall Study|Screen failure|0
951216|NCT01066819|1944939|FG005|Overall Study|Screen failure|0
951217|NCT01066819|1944934|FG000|Overall Study|Spontaneous cure|1
951218|NCT01066819|1944935|FG001|Overall Study|Spontaneous cure|0
951219|NCT01066819|1944936|FG002|Overall Study|Spontaneous cure|0
951220|NCT01066819|1944937|FG003|Overall Study|Spontaneous cure|0
951221|NCT01066819|1944938|FG004|Overall Study|Spontaneous cure|0
951222|NCT01066819|1944939|FG005|Overall Study|Spontaneous cure|0
951223|NCT01066819|1944934|FG000|Overall Study|Treatment never started|85
951224|NCT01066819|1944935|FG001|Overall Study|Treatment never started|19
951225|NCT01066819|1944936|FG002|Overall Study|Treatment never started|19
951226|NCT01066819|1944937|FG003|Overall Study|Treatment never started|3
951227|NCT01066819|1944938|FG004|Overall Study|Treatment never started|2
951228|NCT01066819|1944939|FG005|Overall Study|Treatment never started|2
951229|NCT01066819|1944934|FG000|Overall Study|Treatment stopped|12
951230|NCT01066819|1944935|FG001|Overall Study|Treatment stopped|1
951231|NCT01066819|1944936|FG002|Overall Study|Treatment stopped|2
951232|NCT01066819|1944937|FG003|Overall Study|Treatment stopped|1
951233|NCT01066819|1944938|FG004|Overall Study|Treatment stopped|0
951234|NCT01066819|1944939|FG005|Overall Study|Treatment stopped|0
951235|NCT01066819|1944934|FG000|Overall Study|Other|5
951236|NCT01066819|1944935|FG001|Overall Study|Other|1
951237|NCT01066819|1944936|FG002|Overall Study|Other|1
951238|NCT01066819|1944937|FG003|Overall Study|Other|0
951239|NCT01066819|1944938|FG004|Overall Study|Other|0
951240|NCT01066819|1944939|FG005|Overall Study|Other|0
951241|NCT01066871|1944955|FG000|Overall Study|Lost to Follow-up|0
951242|NCT01066871|1944956|FG001|Overall Study|Lost to Follow-up|2
951243|NCT01066871|1944957|FG002|Overall Study|Lost to Follow-up|2
951244|NCT01066871|1944958|FG003|Overall Study|Lost to Follow-up|0
951245|NCT01066871|1944955|FG000|Overall Study|Protocol Violation|1
951246|NCT01066871|1944956|FG001|Overall Study|Protocol Violation|0
951247|NCT01066871|1944957|FG002|Overall Study|Protocol Violation|3
951248|NCT01066871|1944958|FG003|Overall Study|Protocol Violation|2
951249|NCT01066871|1944955|FG000|Overall Study|Lack of Efficacy|0
951250|NCT01066871|1944956|FG001|Overall Study|Lack of Efficacy|0
951251|NCT01066871|1944957|FG002|Overall Study|Lack of Efficacy|0
951252|NCT01066871|1944958|FG003|Overall Study|Lack of Efficacy|1
951253|NCT01066871|1944955|FG000|Overall Study|Withdrawal by Subject|3
951254|NCT01066871|1944956|FG001|Overall Study|Withdrawal by Subject|1
951255|NCT01066871|1944957|FG002|Overall Study|Withdrawal by Subject|0
951256|NCT01066871|1944958|FG003|Overall Study|Withdrawal by Subject|0
951257|NCT01066871|1944955|FG000|Overall Study|Other|0
951258|NCT01066871|1944956|FG001|Overall Study|Other|2
951259|NCT01066871|1944957|FG002|Overall Study|Other|1
951260|NCT01066871|1944958|FG003|Overall Study|Other|2
951261|NCT01066897|1944975|FG000|Overall Study|Withdrawal by Subject|1
951262|NCT01066897|1944976|FG001|Overall Study|Withdrawal by Subject|0
951263|NCT01066897|1944975|FG000|Overall Study|stopped study after developing the flu.|1
951264|NCT01066897|1944976|FG001|Overall Study|stopped study after developing the flu.|0
951265|NCT01066923|1944987|FG000|Overall Study|Withdrawal by Subject|3
951266|NCT01066923|1944988|FG001|Overall Study|Withdrawal by Subject|3
951267|NCT01066923|1944989|FG002|Overall Study|Withdrawal by Subject|8
951268|NCT01066923|1944990|FG003|Overall Study|Withdrawal by Subject|8
951269|NCT01066936|1945000|FG000|Overall Study|Death|2
951270|NCT01066936|1945000|FG000|Overall Study|Device revised/removed|1
951271|NCT01066936|1945000|FG000|Overall Study|Lost to Follow-up|3
951272|NCT01066936|1945000|FG000|Overall Study|Withdrawal by Subject|4
951273|NCT01067105|1945006|FG000|Overall Study|Adverse Event|14
951274|NCT01067105|1945006|FG000|Overall Study|Protocol Violation|48
951275|NCT01067105|1945006|FG000|Overall Study|Withdrawal by Subject|36
951276|NCT01067105|1945006|FG000|Overall Study|Lost to Follow-up|6
951277|NCT01067105|1945006|FG000|Overall Study|Physician Decision|6
951278|NCT01067105|1945006|FG000|Overall Study|Other|31
951279|NCT01067144|1945012|FG000|Treatment|Did not receive allocated intervention|4
951280|NCT01067144|1945013|FG001|Treatment|Did not receive allocated intervention|7
951281|NCT01067144|1945012|FG000|Follow-up|Lost to Follow-up|22
951282|NCT01067144|1945013|FG001|Follow-up|Lost to Follow-up|12
951283|NCT01067144|1945012|FG000|Follow-up|Censored owing to second surgery|19
951284|NCT01067144|1945013|FG001|Follow-up|Censored owing to second surgery|28
951285|NCT01067144|1945012|FG000|Follow-up|Withdrawal by Subject|18
951286|NCT01067144|1945013|FG001|Follow-up|Withdrawal by Subject|14
951287|NCT01067144|1945012|FG000|Follow-up|Surgery cancelled|0
951288|NCT01067144|1945013|FG001|Follow-up|Surgery cancelled|1
951289|NCT01067144|1945012|FG000|Follow-up|Death|0
951290|NCT01067144|1945013|FG001|Follow-up|Death|1
951291|NCT01067326|1945021|FG000|Overall Study|Adverse Event|0
951292|NCT01067326|1945022|FG001|Overall Study|Adverse Event|2
951293|NCT01067326|1945021|FG000|Overall Study|Withdrawal by Subject|1
951294|NCT01067326|1945022|FG001|Overall Study|Withdrawal by Subject|0
951295|NCT01067326|1945021|FG000|Overall Study|Early Study Termination|1
951296|NCT01067326|1945022|FG001|Overall Study|Early Study Termination|1
951297|NCT01067339|1945030|FG000|Overall Study|Withdrawal by Subject|6
951298|NCT01067339|1945031|FG001|Overall Study|Withdrawal by Subject|5
951299|NCT01067352|1945040|FG000|Overall Study|Withdrawal by Subject|1
951300|NCT01067352|1945041|FG001|Overall Study|Withdrawal by Subject|2
951301|NCT01067352|1945042|FG002|Overall Study|Withdrawal by Subject|1
951302|NCT01067352|1945040|FG000|Overall Study|Physician Decision|0
951303|NCT01067352|1945041|FG001|Overall Study|Physician Decision|1
951304|NCT01067352|1945042|FG002|Overall Study|Physician Decision|0
951305|NCT01067469|1945063|FG000|Overall Study|Withdrawal by Subject|0
951306|NCT01067469|1945064|FG001|Overall Study|Withdrawal by Subject|1
951307|NCT01067469|1945063|FG000|Overall Study|Disease Progression|0
951308|NCT01067469|1945064|FG001|Overall Study|Disease Progression|1
951309|NCT01067508|1945072|FG000|Overall Study|Physician Decision|0
951310|NCT01067508|1945073|FG001|Overall Study|Physician Decision|1
951311|NCT01067508|1945072|FG000|Overall Study|Withdrawal by Subject|0
951312|NCT01067508|1945073|FG001|Overall Study|Withdrawal by Subject|1
951349|NCT01067846|1945136|FG000|Overall Study|Lost to Follow-up|17
951350|NCT01067846|1945137|FG001|Overall Study|Lost to Follow-up|19
951351|NCT01067846|1945136|FG000|Overall Study|Withdrawal by Subject|1
951352|NCT01067846|1945137|FG001|Overall Study|Withdrawal by Subject|0
951353|NCT01067846|1945136|FG000|Overall Study|participation in other tx study|1
951354|NCT01067846|1945137|FG001|Overall Study|participation in other tx study|0
951355|NCT01067976|1945143|FG000|Overall Study|Study drug never administered|20
951356|NCT01067976|1945143|FG000|Overall Study|Study prematurely discontinued|2
951357|NCT01068158|1945163|FG000|Overall Study|Withdrawal by Subject|1
951358|NCT01068158|1945164|FG001|Overall Study|Withdrawal by Subject|2
951359|NCT01068158|1945163|FG000|Overall Study|Lost to Follow-up|7
951360|NCT01068158|1945164|FG001|Overall Study|Lost to Follow-up|0
951361|NCT01068158|1945163|FG000|Overall Study|Protocol Violation|0
951362|NCT01068158|1945164|FG001|Overall Study|Protocol Violation|2
951363|NCT01068262|1945174|FG000|Overall Study|Adverse Event|2
951364|NCT01068262|1945175|FG001|Overall Study|Adverse Event|0
951365|NCT01068262|1945176|FG002|Overall Study|Adverse Event|1
951366|NCT01068262|1945177|FG003|Overall Study|Adverse Event|0
951367|NCT01068262|1945174|FG000|Overall Study|Protocol Violation|1
951368|NCT01068262|1945175|FG001|Overall Study|Protocol Violation|0
951369|NCT01068262|1945176|FG002|Overall Study|Protocol Violation|0
951370|NCT01068262|1945177|FG003|Overall Study|Protocol Violation|0
951371|NCT01068262|1945174|FG000|Overall Study|Withdrawal by Subject|0
951372|NCT01068262|1945175|FG001|Overall Study|Withdrawal by Subject|1
951373|NCT01068262|1945176|FG002|Overall Study|Withdrawal by Subject|0
951374|NCT01068262|1945177|FG003|Overall Study|Withdrawal by Subject|0
951375|NCT01068418|1945190|FG000|Overall Study|Physician Decision|12
951376|NCT01068509|1945197|FG000|Overall Study|Death|0
951377|NCT01068509|1945198|FG001|Overall Study|Death|0
951378|NCT01068509|1945199|FG002|Overall Study|Death|1
951379|NCT01068509|1945197|FG000|Overall Study|Disease Progression|5
951380|NCT01068509|1945198|FG001|Overall Study|Disease Progression|20
951381|NCT01068509|1945199|FG002|Overall Study|Disease Progression|18
951382|NCT01068509|1945197|FG000|Overall Study|Lost to Follow-up|1
951383|NCT01068509|1945198|FG001|Overall Study|Lost to Follow-up|0
951384|NCT01068509|1945199|FG002|Overall Study|Lost to Follow-up|0
951385|NCT01068509|1945197|FG000|Overall Study|Withdrew Consent|0
951386|NCT01068509|1945198|FG001|Overall Study|Withdrew Consent|1
951387|NCT01068509|1945199|FG002|Overall Study|Withdrew Consent|2
951388|NCT01068509|1945197|FG000|Overall Study|Reason Not Specified|0
951389|NCT01068509|1945198|FG001|Overall Study|Reason Not Specified|1
951390|NCT01068509|1945199|FG002|Overall Study|Reason Not Specified|0
951391|NCT01068600|1945218|FG000|Overall Study|Withdrawal by Subject|5
951392|NCT01068600|1945219|FG001|Overall Study|Withdrawal by Subject|6
951393|NCT01068600|1945218|FG000|Overall Study|Adverse Event|3
951394|NCT01068600|1945219|FG001|Overall Study|Adverse Event|3
951395|NCT01068600|1945218|FG000|Overall Study|Abnormal laboratory value(s)|1
951396|NCT01068600|1945219|FG001|Overall Study|Abnormal laboratory value(s)|0
951397|NCT01068600|1945218|FG000|Overall Study|Lost to Follow-up|1
951398|NCT01068600|1945219|FG001|Overall Study|Lost to Follow-up|2
951399|NCT01068600|1945218|FG000|Overall Study|Protocol deviation|1
951400|NCT01068600|1945219|FG001|Overall Study|Protocol deviation|1
951401|NCT01068600|1945218|FG000|Overall Study|Unsatisfactory therapeutic effect|0
951402|NCT01068600|1945219|FG001|Overall Study|Unsatisfactory therapeutic effect|4
951403|NCT01068600|1945218|FG000|Overall Study|Administrative problems|0
951404|NCT01068600|1945219|FG001|Overall Study|Administrative problems|1
951405|NCT01068626|1945227|FG000|Overall Study|Adverse Event|3
951406|NCT01068626|1945228|FG001|Overall Study|Adverse Event|0
951407|NCT01068626|1945227|FG000|Overall Study|Withdrawal by Subject|0
951408|NCT01068626|1945228|FG001|Overall Study|Withdrawal by Subject|2
951409|NCT01068652|1945236|FG000|Overall Study|Adverse Event|4
951410|NCT01068652|1945237|FG001|Overall Study|Adverse Event|0
951411|NCT01068652|1945236|FG000|Overall Study|Lack of Efficacy|0
951412|NCT01068652|1945237|FG001|Overall Study|Lack of Efficacy|2
951413|NCT01068652|1945236|FG000|Overall Study|Lost to Follow-up|2
951414|NCT01068652|1945237|FG001|Overall Study|Lost to Follow-up|1
951415|NCT01068652|1945236|FG000|Overall Study|Protocol Violation|3
951416|NCT01068652|1945237|FG001|Overall Study|Protocol Violation|6
951417|NCT01068652|1945236|FG000|Overall Study|Withdrawal criteria|1
951418|NCT01068652|1945237|FG001|Overall Study|Withdrawal criteria|2
951419|NCT01068652|1945236|FG000|Overall Study|Patient was not eligible|1
951420|NCT01068652|1945237|FG001|Overall Study|Patient was not eligible|0
951421|NCT01068652|1945236|FG000|Overall Study|Unclassified|7
951422|NCT01068652|1945237|FG001|Overall Study|Unclassified|4
951423|NCT01068665|1945245|FG000|Overall Study|Adverse Event|5
951424|NCT01068665|1945246|FG001|Overall Study|Adverse Event|4
951425|NCT01068665|1945245|FG000|Overall Study|Lack of Efficacy|0
951426|NCT01068665|1945246|FG001|Overall Study|Lack of Efficacy|2
951427|NCT01068665|1945245|FG000|Overall Study|Protocol Violation|5
951428|NCT01068665|1945246|FG001|Overall Study|Protocol Violation|2
951429|NCT01068665|1945245|FG000|Overall Study|Withdrawal Criteria|3
951430|NCT01068665|1945246|FG001|Overall Study|Withdrawal Criteria|9
951431|NCT01068665|1945245|FG000|Overall Study|Other|17
951432|NCT01068665|1945246|FG001|Overall Study|Other|12
951433|NCT01068678|1945254|FG000|Overall Study|Lack of Efficacy|3
951434|NCT01068678|1945255|FG001|Overall Study|Lack of Efficacy|2
951435|NCT01068678|1945254|FG000|Overall Study|Protocol Violation|5
951436|NCT01068678|1945255|FG001|Overall Study|Protocol Violation|1
951437|NCT01068678|1945254|FG000|Overall Study|Withdrawal criteria|12
951438|NCT01068678|1945255|FG001|Overall Study|Withdrawal criteria|6
951439|NCT01068678|1945254|FG000|Overall Study|Unclassified|18
951440|NCT01068678|1945255|FG001|Overall Study|Unclassified|15
951441|NCT01068717|1945261|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
951442|NCT01068717|1945262|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
951443|NCT01068717|1945263|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
951444|NCT01068717|1945264|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
951445|NCT01068730|1945278|FG000|Period 3|Personal reason|1
951446|NCT01068730|1945279|FG001|Period 3|Personal reason|0
951447|NCT01068730|1945280|FG002|Period 3|Personal reason|0
951448|NCT01068730|1945281|FG003|Period 3|Personal reason|0
951449|NCT01068730|1945278|FG000|Period 4|Family emergency|0
951450|NCT01068730|1945279|FG001|Period 4|Family emergency|1
951451|NCT01068730|1945280|FG002|Period 4|Family emergency|0
951452|NCT01068730|1945281|FG003|Period 4|Family emergency|0
951453|NCT01068743|1945298|FG000|Period 3|Adverse Event|0
951454|NCT01068743|1945299|FG001|Period 3|Adverse Event|1
951455|NCT01068743|1945300|FG002|Period 3|Adverse Event|0
951456|NCT01068743|1945301|FG003|Period 3|Adverse Event|0
951457|NCT01068769|1945314|FG000|Overall Study|Ineligible|1
951458|NCT01068860|1945337|FG000|Overall Study|Withdrawal by Subject|0
951459|NCT01068860|1945338|FG001|Overall Study|Withdrawal by Subject|0
951460|NCT01068860|1945339|FG002|Overall Study|Withdrawal by Subject|0
951461|NCT01068860|1945340|FG003|Overall Study|Withdrawal by Subject|0
951462|NCT01068860|1945341|FG004|Overall Study|Withdrawal by Subject|0
951463|NCT01068860|1945342|FG005|Overall Study|Withdrawal by Subject|2
951464|NCT01068860|1945343|FG006|Overall Study|Withdrawal by Subject|0
951465|NCT01068860|1945344|FG007|Overall Study|Withdrawal by Subject|0
951466|NCT01068860|1945345|FG008|Overall Study|Withdrawal by Subject|0
951467|NCT01068860|1945346|FG009|Overall Study|Withdrawal by Subject|3
951468|NCT01068860|1945337|FG000|Overall Study|Administrative problems; misrandomized|0
951469|NCT01068860|1945338|FG001|Overall Study|Administrative problems; misrandomized|0
951470|NCT01068860|1945339|FG002|Overall Study|Administrative problems; misrandomized|0
951471|NCT01068860|1945340|FG003|Overall Study|Administrative problems; misrandomized|1
951472|NCT01068860|1945341|FG004|Overall Study|Administrative problems; misrandomized|0
951473|NCT01068860|1945342|FG005|Overall Study|Administrative problems; misrandomized|0
951474|NCT01068860|1945343|FG006|Overall Study|Administrative problems; misrandomized|0
951475|NCT01068860|1945344|FG007|Overall Study|Administrative problems; misrandomized|0
951476|NCT01068860|1945345|FG008|Overall Study|Administrative problems; misrandomized|0
951477|NCT01068860|1945346|FG009|Overall Study|Administrative problems; misrandomized|1
951478|NCT01068860|1945337|FG000|Overall Study|Lost to Follow-up|0
951479|NCT01068860|1945338|FG001|Overall Study|Lost to Follow-up|1
951480|NCT01068860|1945339|FG002|Overall Study|Lost to Follow-up|0
951481|NCT01068860|1945340|FG003|Overall Study|Lost to Follow-up|0
951482|NCT01068860|1945341|FG004|Overall Study|Lost to Follow-up|0
951483|NCT01068860|1945342|FG005|Overall Study|Lost to Follow-up|0
951484|NCT01068860|1945343|FG006|Overall Study|Lost to Follow-up|0
951485|NCT01068860|1945344|FG007|Overall Study|Lost to Follow-up|0
951486|NCT01068860|1945345|FG008|Overall Study|Lost to Follow-up|0
951487|NCT01068860|1945346|FG009|Overall Study|Lost to Follow-up|0
951488|NCT01068912|1945375|FG000|Overall Study|Adverse Event|2
951489|NCT01068912|1945376|FG001|Overall Study|Adverse Event|3
951490|NCT01068912|1945377|FG002|Overall Study|Adverse Event|2
951491|NCT01068912|1945375|FG000|Overall Study|Withdrawal by Subject|5
951492|NCT01068912|1945376|FG001|Overall Study|Withdrawal by Subject|6
951493|NCT01068912|1945377|FG002|Overall Study|Withdrawal by Subject|6
951494|NCT01068912|1945375|FG000|Overall Study|Lost to Follow-up|3
951495|NCT01068912|1945376|FG001|Overall Study|Lost to Follow-up|7
951496|NCT01068912|1945377|FG002|Overall Study|Lost to Follow-up|3
951497|NCT01068912|1945375|FG000|Overall Study|Protocol Violation|0
951498|NCT01068912|1945376|FG001|Overall Study|Protocol Violation|2
951499|NCT01068912|1945377|FG002|Overall Study|Protocol Violation|0
951500|NCT01068912|1945375|FG000|Overall Study|aggravation influenza|1
951501|NCT01068912|1945376|FG001|Overall Study|aggravation influenza|1
951502|NCT01068912|1945377|FG002|Overall Study|aggravation influenza|1
951503|NCT01068912|1945375|FG000|Overall Study|other underlying illness|0
951504|NCT01068912|1945376|FG001|Overall Study|other underlying illness|3
951505|NCT01068912|1945377|FG002|Overall Study|other underlying illness|3
951506|NCT01069172|1945409|FG000|Overall Study|Withdrawal by Subject|1
951507|NCT01069172|1945410|FG001|Overall Study|Withdrawal by Subject|0
951508|NCT01069289|1945428|FG000|Overall Study|Withdrawal by Subject|15
951509|NCT01069289|1945429|FG001|Overall Study|Withdrawal by Subject|26
951510|NCT01069289|1945428|FG000|Overall Study|Adverse Event|21
951511|NCT01069289|1945429|FG001|Overall Study|Adverse Event|28
951512|NCT01069289|1945428|FG000|Overall Study|Eligibility criteria not fulfilled|2
951513|NCT01069289|1945429|FG001|Overall Study|Eligibility criteria not fulfilled|0
951514|NCT01069289|1945428|FG000|Overall Study|Severe non-compliance to protocol|3
951515|NCT01069289|1945429|FG001|Overall Study|Severe non-compliance to protocol|2
951516|NCT01069289|1945428|FG000|Overall Study|Due to deteriorating health condition|1
951517|NCT01069289|1945429|FG001|Overall Study|Due to deteriorating health condition|0
951518|NCT01069341|1945456|FG000|Overall Study|Lost to Follow-up|1
951519|NCT01069419|1945468|FG000|Overall Study|Adverse Event|233
951520|NCT01069419|1945468|FG000|Overall Study|Lack of Efficacy|332
951521|NCT01069419|1945468|FG000|Overall Study|Lost to Follow-up|49
951522|NCT01069419|1945468|FG000|Overall Study|Remission of disease|11
951523|NCT01069419|1945468|FG000|Overall Study|Withdrawal by Subject|34
951524|NCT01069419|1945468|FG000|Overall Study|Other Reason|43
951525|NCT01069419|1945468|FG000|Overall Study|Missing termination information|13
951526|NCT01069484|1945474|FG000|Overall Study|Death-in-near-family|1
910998|NCT00796120|1888117|FG001|Overall Study|Other|17
910999|NCT00796120|1888116|FG000|Overall Study|Physician Decision|16
951527|NCT01069484|1945475|FG001|Overall Study|Death-in-near-family|0
951528|NCT01069484|1945474|FG000|Overall Study|No specific reason|8
951529|NCT01069484|1945475|FG001|Overall Study|No specific reason|2
951530|NCT01069484|1945474|FG000|Overall Study|Illness mother or child|3
951531|NCT01069484|1945475|FG001|Overall Study|Illness mother or child|1
951532|NCT01069523|1945493|FG000|Overall Study|Withdrawal by Subject|4
951533|NCT01069523|1945494|FG001|Overall Study|Withdrawal by Subject|7
951534|NCT01069627|1945511|FG000|Overall Study|Disease progression|7
951535|NCT01069627|1945511|FG000|Overall Study|Adverse Event|12
951536|NCT01069627|1945511|FG000|Overall Study|Protocol Violation|1
951537|NCT01069705|1945515|FG000|Overall Study|Adverse Event|1
951538|NCT01069705|1945515|FG000|Overall Study|Withdrawal by Subject|2
951539|NCT01069900|1945521|FG000|Overall Study|Technical problems|0
951540|NCT01069900|1945522|FG001|Overall Study|Technical problems|1
951541|NCT01069900|1945521|FG000|Overall Study|Lost to Follow-up|7
951542|NCT01069900|1945522|FG001|Overall Study|Lost to Follow-up|1
951543|NCT01069900|1945521|FG000|Overall Study|Withdrawal by Subject|6
951544|NCT01069900|1945522|FG001|Overall Study|Withdrawal by Subject|1
951545|NCT01069900|1945521|FG000|Overall Study|Protocol Violation|4
951546|NCT01069900|1945522|FG001|Overall Study|Protocol Violation|1
951547|NCT01069900|1945521|FG000|Overall Study|Insufficient Therapeutic effect|1
951548|NCT01069900|1945522|FG001|Overall Study|Insufficient Therapeutic effect|0
951549|NCT01069939|1945530|FG000|Randomised and Included in the Analyses|Adverse Event|17
951550|NCT01069939|1945531|FG001|Randomised and Included in the Analyses|Adverse Event|22
951551|NCT01069939|1945530|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15
951552|NCT01069939|1945531|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12
951553|NCT01069939|1945530|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1
951554|NCT01069939|1945531|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1
951555|NCT01069939|1945530|FG000|Randomised and Included in the Analyses|Protocol Violation|0
951556|NCT01069939|1945531|FG001|Randomised and Included in the Analyses|Protocol Violation|1
951557|NCT01069939|1945530|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0
951558|NCT01069939|1945531|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1
951559|NCT01069939|1945530|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
951560|NCT01069939|1945531|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
951561|NCT01069939|1945530|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
951562|NCT01069939|1945531|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
951563|NCT01069939|1945530|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
951564|NCT01069939|1945531|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
951565|NCT01069939|1945530|FG000|Randomised and Included in the Analyses|Physician Decision|0
951566|NCT01069939|1945531|FG001|Randomised and Included in the Analyses|Physician Decision|2
951567|NCT01069939|1945530|FG000|Randomised and Included in the Analyses|Removal|1
951568|NCT01069939|1945531|FG001|Randomised and Included in the Analyses|Removal|0
951569|NCT01070043|1945539|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18
951570|NCT01070043|1945540|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0
951571|NCT01070043|1945541|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0
951572|NCT01070043|1945539|FG000|Double-Blind Treatment|Adverse Event|0
951573|NCT01070043|1945540|FG001|Double-Blind Treatment|Adverse Event|0
951574|NCT01070043|1945541|FG002|Double-Blind Treatment|Adverse Event|2
951575|NCT01070303|1945570|FG000|Overall Study|Adverse Event|39
951576|NCT01070303|1945570|FG000|Overall Study|Withdrawal by Subject|20
951577|NCT01070303|1945570|FG000|Overall Study|Lost to Follow-up|9
951578|NCT01070303|1945570|FG000|Overall Study|Protocol Violation|0
951579|NCT01070303|1945570|FG000|Overall Study|Lack of Efficacy|2
951580|NCT01070303|1945570|FG000|Overall Study|Administrative Reason|1
951581|NCT01070303|1945570|FG000|Overall Study|Other|18
951582|NCT01070316|1945580|FG000|Extension Phase|Lack of Efficacy|3
951583|NCT01070316|1945580|FG000|Extension Phase|Withdrawal by Subject|1
951584|NCT01070329|1945586|FG000|Overall Study|Adverse Event|13
951585|NCT01070329|1945587|FG001|Overall Study|Adverse Event|10
951586|NCT01070329|1945586|FG000|Overall Study|Lost to Follow-up|22
951587|NCT01070329|1945587|FG001|Overall Study|Lost to Follow-up|12
951588|NCT01070329|1945586|FG000|Overall Study|Withdrawal by Subject|9
951589|NCT01070329|1945587|FG001|Overall Study|Withdrawal by Subject|11
951590|NCT01070329|1945586|FG000|Overall Study|Protocol Violation|3
951591|NCT01070329|1945587|FG001|Overall Study|Protocol Violation|8
951592|NCT01070329|1945586|FG000|Overall Study|Lack of Efficacy|2
951593|NCT01070329|1945587|FG001|Overall Study|Lack of Efficacy|6
951594|NCT01070329|1945586|FG000|Overall Study|Physician Decision|2
951595|NCT01070329|1945587|FG001|Overall Study|Physician Decision|1
951596|NCT01070329|1945586|FG000|Overall Study|Entry Criteria Not Met|1
951597|NCT01070329|1945587|FG001|Overall Study|Entry Criteria Not Met|0
951598|NCT01070329|1945586|FG000|Overall Study|Sponsor Decision|0
951599|NCT01070329|1945587|FG001|Overall Study|Sponsor Decision|1
951600|NCT01070381|1945593|FG000|Period 2, 1 Week of Wear|Handling|0
951601|NCT01070381|1945594|FG001|Period 2, 1 Week of Wear|Handling|1
951602|NCT01070381|1945593|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1
951603|NCT01070381|1945594|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0
951604|NCT01070394|1945600|FG000|Overall Study|Adverse Event|6
951605|NCT01070394|1945600|FG000|Overall Study|Withdrawal by Subject|1
951606|NCT01070550|1945612|FG000|Overall Study|Adverse Event|43
951607|NCT01070550|1945613|FG001|Overall Study|Adverse Event|1
951608|NCT01070550|1945614|FG002|Overall Study|Adverse Event|3
951609|NCT01070550|1945615|FG003|Overall Study|Adverse Event|0
951610|NCT01070550|1945616|FG004|Overall Study|Adverse Event|0
951611|NCT01070550|1945617|FG005|Overall Study|Adverse Event|0
951612|NCT01070550|1945612|FG000|Overall Study|Death|20
951613|NCT01070550|1945613|FG001|Overall Study|Death|4
951614|NCT01070550|1945614|FG002|Overall Study|Death|3
951615|NCT01070550|1945615|FG003|Overall Study|Death|0
951616|NCT01070550|1945616|FG004|Overall Study|Death|0
951617|NCT01070550|1945617|FG005|Overall Study|Death|0
951618|NCT01070550|1945612|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2
951619|NCT01070550|1945613|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
951620|NCT01070550|1945614|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1
951621|NCT01070550|1945615|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0
951622|NCT01070550|1945616|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0
951623|NCT01070550|1945617|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0
951624|NCT01070550|1945612|FG000|Overall Study|Early termination|3
951625|NCT01070550|1945613|FG001|Overall Study|Early termination|0
951626|NCT01070550|1945614|FG002|Overall Study|Early termination|0
951627|NCT01070550|1945615|FG003|Overall Study|Early termination|0
951628|NCT01070550|1945616|FG004|Overall Study|Early termination|0
951629|NCT01070550|1945617|FG005|Overall Study|Early termination|0
951630|NCT01070550|1945612|FG000|Overall Study|Failed to return|450
951631|NCT01070550|1945613|FG001|Overall Study|Failed to return|33
951632|NCT01070550|1945614|FG002|Overall Study|Failed to return|144
951633|NCT01070550|1945615|FG003|Overall Study|Failed to return|40
951634|NCT01070550|1945616|FG004|Overall Study|Failed to return|1
951635|NCT01070550|1945617|FG005|Overall Study|Failed to return|2
951636|NCT01070550|1945612|FG000|Overall Study|Incomplete treatment|2
951637|NCT01070550|1945613|FG001|Overall Study|Incomplete treatment|0
951638|NCT01070550|1945614|FG002|Overall Study|Incomplete treatment|0
951639|NCT01070550|1945615|FG003|Overall Study|Incomplete treatment|0
951640|NCT01070550|1945616|FG004|Overall Study|Incomplete treatment|0
951641|NCT01070550|1945617|FG005|Overall Study|Incomplete treatment|0
951642|NCT01070550|1945612|FG000|Overall Study|Lab test not done|22
951643|NCT01070550|1945613|FG001|Overall Study|Lab test not done|3
951644|NCT01070550|1945614|FG002|Overall Study|Lab test not done|4
951645|NCT01070550|1945615|FG003|Overall Study|Lab test not done|1
951646|NCT01070550|1945616|FG004|Overall Study|Lab test not done|0
951647|NCT01070550|1945617|FG005|Overall Study|Lab test not done|1
951648|NCT01070550|1945612|FG000|Overall Study|Lack of Efficacy|65
951649|NCT01070550|1945613|FG001|Overall Study|Lack of Efficacy|1
951650|NCT01070550|1945614|FG002|Overall Study|Lack of Efficacy|5
951651|NCT01070550|1945615|FG003|Overall Study|Lack of Efficacy|5
951652|NCT01070550|1945616|FG004|Overall Study|Lack of Efficacy|0
951653|NCT01070550|1945617|FG005|Overall Study|Lack of Efficacy|1
951654|NCT01070550|1945612|FG000|Overall Study|Miscellaneous|12
951655|NCT01070550|1945613|FG001|Overall Study|Miscellaneous|2
951656|NCT01070550|1945614|FG002|Overall Study|Miscellaneous|3
951657|NCT01070550|1945615|FG003|Overall Study|Miscellaneous|1
951658|NCT01070550|1945616|FG004|Overall Study|Miscellaneous|0
951659|NCT01070550|1945617|FG005|Overall Study|Miscellaneous|0
951660|NCT01070550|1945612|FG000|Overall Study|New treatment started|3
951661|NCT01070550|1945613|FG001|Overall Study|New treatment started|1
951662|NCT01070550|1945614|FG002|Overall Study|New treatment started|0
951663|NCT01070550|1945615|FG003|Overall Study|New treatment started|2
951664|NCT01070550|1945616|FG004|Overall Study|New treatment started|0
951665|NCT01070550|1945617|FG005|Overall Study|New treatment started|0
951666|NCT01070550|1945612|FG000|Overall Study|Non-responders|493
951667|NCT01070550|1945613|FG001|Overall Study|Non-responders|4
951668|NCT01070550|1945614|FG002|Overall Study|Non-responders|21
951669|NCT01070550|1945615|FG003|Overall Study|Non-responders|20
951670|NCT01070550|1945616|FG004|Overall Study|Non-responders|0
951671|NCT01070550|1945617|FG005|Overall Study|Non-responders|2
951672|NCT01070550|1945612|FG000|Overall Study|Not categorized|33
951673|NCT01070550|1945613|FG001|Overall Study|Not categorized|2
951674|NCT01070550|1945614|FG002|Overall Study|Not categorized|6
951675|NCT01070550|1945615|FG003|Overall Study|Not categorized|1
951676|NCT01070550|1945616|FG004|Overall Study|Not categorized|0
951677|NCT01070550|1945617|FG005|Overall Study|Not categorized|1
951678|NCT01070550|1945612|FG000|Overall Study|Protocol Violation|15
951679|NCT01070550|1945613|FG001|Overall Study|Protocol Violation|1
951680|NCT01070550|1945614|FG002|Overall Study|Protocol Violation|1
951681|NCT01070550|1945615|FG003|Overall Study|Protocol Violation|1
951682|NCT01070550|1945616|FG004|Overall Study|Protocol Violation|0
951683|NCT01070550|1945617|FG005|Overall Study|Protocol Violation|0
951684|NCT01070550|1945612|FG000|Overall Study|Relapse|44
951685|NCT01070550|1945613|FG001|Overall Study|Relapse|5
951686|NCT01070550|1945614|FG002|Overall Study|Relapse|14
951687|NCT01070550|1945615|FG003|Overall Study|Relapse|4
951688|NCT01070550|1945616|FG004|Overall Study|Relapse|0
951689|NCT01070550|1945617|FG005|Overall Study|Relapse|0
951690|NCT01070550|1945612|FG000|Overall Study|Result not available|3
951691|NCT01070550|1945613|FG001|Overall Study|Result not available|1
951692|NCT01070550|1945614|FG002|Overall Study|Result not available|3
951693|NCT01070550|1945615|FG003|Overall Study|Result not available|0
951694|NCT01070550|1945616|FG004|Overall Study|Result not available|0
951695|NCT01070550|1945617|FG005|Overall Study|Result not available|0
951696|NCT01070550|1945612|FG000|Overall Study|Screen failure|1
951697|NCT01070550|1945613|FG001|Overall Study|Screen failure|0
951698|NCT01070550|1945614|FG002|Overall Study|Screen failure|0
951699|NCT01070550|1945615|FG003|Overall Study|Screen failure|0
951700|NCT01070550|1945616|FG004|Overall Study|Screen failure|0
951701|NCT01070550|1945617|FG005|Overall Study|Screen failure|0
951702|NCT01070550|1945612|FG000|Overall Study|Sponsor decision|1
951703|NCT01070550|1945613|FG001|Overall Study|Sponsor decision|0
951704|NCT01070550|1945614|FG002|Overall Study|Sponsor decision|0
951705|NCT01070550|1945615|FG003|Overall Study|Sponsor decision|0
951706|NCT01070550|1945616|FG004|Overall Study|Sponsor decision|0
951707|NCT01070550|1945617|FG005|Overall Study|Sponsor decision|0
951708|NCT01070550|1945612|FG000|Overall Study|Treatment duration shortened|1
951709|NCT01070550|1945613|FG001|Overall Study|Treatment duration shortened|0
951710|NCT01070550|1945614|FG002|Overall Study|Treatment duration shortened|0
951711|NCT01070550|1945615|FG003|Overall Study|Treatment duration shortened|0
951712|NCT01070550|1945616|FG004|Overall Study|Treatment duration shortened|0
951713|NCT01070550|1945617|FG005|Overall Study|Treatment duration shortened|0
951714|NCT01070550|1945612|FG000|Overall Study|Treatment interrupted|7
951715|NCT01070550|1945613|FG001|Overall Study|Treatment interrupted|0
951716|NCT01070550|1945614|FG002|Overall Study|Treatment interrupted|1
951717|NCT01070550|1945615|FG003|Overall Study|Treatment interrupted|1
951718|NCT01070550|1945616|FG004|Overall Study|Treatment interrupted|0
951719|NCT01070550|1945617|FG005|Overall Study|Treatment interrupted|0
951720|NCT01070550|1945612|FG000|Overall Study|Treatment not started|14
951721|NCT01070550|1945613|FG001|Overall Study|Treatment not started|2
951722|NCT01070550|1945614|FG002|Overall Study|Treatment not started|4
951723|NCT01070550|1945615|FG003|Overall Study|Treatment not started|0
951724|NCT01070550|1945616|FG004|Overall Study|Treatment not started|0
951725|NCT01070550|1945617|FG005|Overall Study|Treatment not started|0
951726|NCT01070550|1945612|FG000|Overall Study|Treatment restarted|0
951727|NCT01070550|1945613|FG001|Overall Study|Treatment restarted|1
951728|NCT01070550|1945614|FG002|Overall Study|Treatment restarted|0
951729|NCT01070550|1945615|FG003|Overall Study|Treatment restarted|0
951730|NCT01070550|1945616|FG004|Overall Study|Treatment restarted|0
951731|NCT01070550|1945617|FG005|Overall Study|Treatment restarted|0
951732|NCT01070550|1945612|FG000|Overall Study|Treatment stopped|3
951733|NCT01070550|1945613|FG001|Overall Study|Treatment stopped|0
951734|NCT01070550|1945614|FG002|Overall Study|Treatment stopped|0
951735|NCT01070550|1945615|FG003|Overall Study|Treatment stopped|0
951736|NCT01070550|1945616|FG004|Overall Study|Treatment stopped|0
951737|NCT01070550|1945617|FG005|Overall Study|Treatment stopped|0
951738|NCT01070550|1945612|FG000|Overall Study|Treatment unavailable|1
951739|NCT01070550|1945613|FG001|Overall Study|Treatment unavailable|0
951740|NCT01070550|1945614|FG002|Overall Study|Treatment unavailable|0
951741|NCT01070550|1945615|FG003|Overall Study|Treatment unavailable|0
951742|NCT01070550|1945616|FG004|Overall Study|Treatment unavailable|0
951743|NCT01070550|1945617|FG005|Overall Study|Treatment unavailable|0
951744|NCT01070550|1945612|FG000|Overall Study|Treatment was stopped early|7
951745|NCT01070550|1945613|FG001|Overall Study|Treatment was stopped early|0
951746|NCT01070550|1945614|FG002|Overall Study|Treatment was stopped early|0
951747|NCT01070550|1945615|FG003|Overall Study|Treatment was stopped early|0
951748|NCT01070550|1945616|FG004|Overall Study|Treatment was stopped early|0
951749|NCT01070550|1945617|FG005|Overall Study|Treatment was stopped early|0
951750|NCT01070550|1945612|FG000|Overall Study|Other|5
951751|NCT01070550|1945613|FG001|Overall Study|Other|0
951752|NCT01070550|1945614|FG002|Overall Study|Other|0
951753|NCT01070550|1945615|FG003|Overall Study|Other|1
951754|NCT01070550|1945616|FG004|Overall Study|Other|0
951755|NCT01070550|1945617|FG005|Overall Study|Other|0
951756|NCT01070550|1945612|FG000|Overall Study|Withdrawal by Subject|35
951757|NCT01070550|1945613|FG001|Overall Study|Withdrawal by Subject|0
951758|NCT01070550|1945614|FG002|Overall Study|Withdrawal by Subject|3
951759|NCT01070550|1945615|FG003|Overall Study|Withdrawal by Subject|0
951760|NCT01070550|1945616|FG004|Overall Study|Withdrawal by Subject|0
951761|NCT01070550|1945617|FG005|Overall Study|Withdrawal by Subject|0
951762|NCT01070771|1945641|FG000|Overall Study|Adverse Event|2
951763|NCT01070771|1945641|FG000|Overall Study|Protocol Violation|1
951764|NCT01070784|1945648|FG000|Overall Study|Withdrawal by Subject|6
951765|NCT01070784|1945649|FG001|Overall Study|Withdrawal by Subject|9
951766|NCT01070784|1945648|FG000|Overall Study|Adverse Event|14
951767|NCT01070784|1945649|FG001|Overall Study|Adverse Event|9
951768|NCT01070888|1945668|FG000|First Intervention (14 Days)|Adverse Event|0
951769|NCT01070888|1945669|FG001|First Intervention (14 Days)|Adverse Event|1
951770|NCT01070888|1945668|FG000|First Intervention (14 Days)|Lost to Follow-up|0
951771|NCT01070888|1945669|FG001|First Intervention (14 Days)|Lost to Follow-up|1
951772|NCT01070888|1945668|FG000|Washout (14 Days)|Physician Decision|1
951773|NCT01070888|1945669|FG001|Washout (14 Days)|Physician Decision|0
951774|NCT01070953|1945675|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612
951775|NCT01070953|1945675|FG000|Participants for Safety Evaluation|Off-label use|283
951776|NCT01070953|1945675|FG000|Participants for Safety Evaluation|Duplicated participants|22
951777|NCT01070953|1945675|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8
951778|NCT01070953|1945675|FG000|Participants for Safety Evaluation|Uncontracted participants|4
951779|NCT01070953|1945675|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1
951780|NCT01070953|1945675|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1
951781|NCT01070953|1945675|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119
951782|NCT01070953|1945675|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
951783|NCT01070953|1945675|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
951784|NCT01070966|1945685|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59
951785|NCT01070966|1945685|FG000|Participants for Safety Evaluation|Off-label use|9
951786|NCT01070966|1945685|FG000|Participants for Safety Evaluation|Duplicate Participants|4
951787|NCT01070966|1945685|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
951788|NCT01070966|1945685|FG000|Participants for Safety Evaluation|TMT given before date of contract|3
1090771|NCT02248818|2158518|FG000|Screening|Withdrawal by Subject|0
951789|NCT01070966|1945685|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
951790|NCT01070966|1945685|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19
951791|NCT01070966|1945685|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
951792|NCT01070979|1945699|FG000|Overall Study|Adverse Event|2
951793|NCT01070979|1945700|FG001|Overall Study|Adverse Event|3
951794|NCT01070979|1945701|FG002|Overall Study|Adverse Event|3
951795|NCT01070979|1945699|FG000|Overall Study|Lost to Follow-up|2
951796|NCT01070979|1945700|FG001|Overall Study|Lost to Follow-up|1
951797|NCT01070979|1945701|FG002|Overall Study|Lost to Follow-up|1
951798|NCT01070979|1945699|FG000|Overall Study|Protocol Violation|0
951799|NCT01070979|1945700|FG001|Overall Study|Protocol Violation|2
951800|NCT01070979|1945701|FG002|Overall Study|Protocol Violation|6
951801|NCT01070979|1945699|FG000|Overall Study|Surgery, moving, personal, abn. labs|4
951802|NCT01070979|1945700|FG001|Overall Study|Surgery, moving, personal, abn. labs|4
951803|NCT01070979|1945701|FG002|Overall Study|Surgery, moving, personal, abn. labs|2
951804|NCT01070979|1945699|FG000|Overall Study|Withdrawal by Subject|3
951805|NCT01070979|1945700|FG001|Overall Study|Withdrawal by Subject|1
951806|NCT01070979|1945701|FG002|Overall Study|Withdrawal by Subject|1
951807|NCT01070979|1945699|FG000|Overall Study|No study drug taken|0
951808|NCT01070979|1945700|FG001|Overall Study|No study drug taken|1
951809|NCT01070979|1945701|FG002|Overall Study|No study drug taken|0
951810|NCT01071070|1945723|FG000|Overall Study|Adverse Event|0
951811|NCT01071070|1945724|FG001|Overall Study|Adverse Event|3
951812|NCT01071070|1945723|FG000|Overall Study|Withdrawal by Subject|1
951813|NCT01071070|1945724|FG001|Overall Study|Withdrawal by Subject|0
951814|NCT01071070|1945723|FG000|Overall Study|Missed 3 consecutive doses of study drug|2
951815|NCT01071070|1945724|FG001|Overall Study|Missed 3 consecutive doses of study drug|0
951816|NCT01071070|1945723|FG000|Overall Study|Hypercalcemia|1
951817|NCT01071070|1945724|FG001|Overall Study|Hypercalcemia|0
951818|NCT01071083|1945735|FG000|Overall Study|Adverse Event|1
951819|NCT01071083|1945736|FG001|Overall Study|Adverse Event|0
951820|NCT01071083|1945737|FG002|Overall Study|Adverse Event|1
951821|NCT01071083|1945738|FG003|Overall Study|Adverse Event|0
951822|NCT01071083|1945739|FG004|Overall Study|Adverse Event|1
951823|NCT01071083|1945735|FG000|Overall Study|Withdrawal by Subject|3
951824|NCT01071083|1945736|FG001|Overall Study|Withdrawal by Subject|0
951825|NCT01071083|1945737|FG002|Overall Study|Withdrawal by Subject|2
951826|NCT01071083|1945738|FG003|Overall Study|Withdrawal by Subject|0
951827|NCT01071083|1945739|FG004|Overall Study|Withdrawal by Subject|3
951828|NCT01071083|1945735|FG000|Overall Study|Physician Decision|1
951829|NCT01071083|1945736|FG001|Overall Study|Physician Decision|0
951830|NCT01071083|1945737|FG002|Overall Study|Physician Decision|0
951831|NCT01071083|1945738|FG003|Overall Study|Physician Decision|1
951832|NCT01071083|1945739|FG004|Overall Study|Physician Decision|1
951833|NCT01071083|1945735|FG000|Overall Study|Early Rescue|1
951834|NCT01071083|1945736|FG001|Overall Study|Early Rescue|0
951835|NCT01071083|1945737|FG002|Overall Study|Early Rescue|0
951836|NCT01071083|1945738|FG003|Overall Study|Early Rescue|0
951837|NCT01071083|1945739|FG004|Overall Study|Early Rescue|1
951838|NCT01071083|1945735|FG000|Overall Study|Subject Moved|0
951839|NCT01071083|1945736|FG001|Overall Study|Subject Moved|1
951840|NCT01071083|1945737|FG002|Overall Study|Subject Moved|0
951841|NCT01071083|1945738|FG003|Overall Study|Subject Moved|0
951842|NCT01071083|1945739|FG004|Overall Study|Subject Moved|0
951843|NCT01071083|1945735|FG000|Overall Study|Images Not Usable (Motion)|0
951844|NCT01071083|1945736|FG001|Overall Study|Images Not Usable (Motion)|1
951845|NCT01071083|1945737|FG002|Overall Study|Images Not Usable (Motion)|0
951846|NCT01071083|1945738|FG003|Overall Study|Images Not Usable (Motion)|0
951847|NCT01071083|1945739|FG004|Overall Study|Images Not Usable (Motion)|0
951848|NCT01071083|1945735|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
951849|NCT01071083|1945736|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
951850|NCT01071083|1945737|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
951851|NCT01071083|1945738|FG003|Overall Study|Did Not Meet Eligibility Criteria|1
951852|NCT01071083|1945739|FG004|Overall Study|Did Not Meet Eligibility Criteria|1
951853|NCT01071083|1945735|FG000|Overall Study|Did Not Want Per Protocol Treatment|0
951854|NCT01071083|1945736|FG001|Overall Study|Did Not Want Per Protocol Treatment|0
951855|NCT01071083|1945737|FG002|Overall Study|Did Not Want Per Protocol Treatment|1
951856|NCT01071083|1945738|FG003|Overall Study|Did Not Want Per Protocol Treatment|0
951857|NCT01071083|1945739|FG004|Overall Study|Did Not Want Per Protocol Treatment|1
951858|NCT01071083|1945735|FG000|Overall Study|Subject Refused to Continue|1
951859|NCT01071083|1945736|FG001|Overall Study|Subject Refused to Continue|0
951860|NCT01071083|1945737|FG002|Overall Study|Subject Refused to Continue|0
951861|NCT01071083|1945738|FG003|Overall Study|Subject Refused to Continue|0
951862|NCT01071083|1945739|FG004|Overall Study|Subject Refused to Continue|0
951863|NCT01071096|1945751|FG000|First Intervention (90 Days)|Lost to Follow-up|1
951864|NCT01071096|1945752|FG001|First Intervention (90 Days)|Lost to Follow-up|0
951865|NCT01071200|1945771|FG000|Overall Study|Lack of ovarian response|1
951866|NCT01071200|1945772|FG001|Overall Study|Lack of ovarian response|1
951867|NCT01071200|1945771|FG000|Overall Study|No fertilization|4
951868|NCT01071200|1945772|FG001|Overall Study|No fertilization|0
951869|NCT01071200|1945771|FG000|Overall Study|No oocytes retrieved|1
951870|NCT01071200|1945772|FG001|Overall Study|No oocytes retrieved|1
951871|NCT01071200|1945771|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1
951872|NCT01071200|1945772|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0
951873|NCT01071200|1945771|FG000|Overall Study|No viable embryos|0
951874|NCT01071200|1945772|FG001|Overall Study|No viable embryos|1
951875|NCT01071252|1945783|FG000|Overall Study|unsatisfactory therapeutic effect|4
951876|NCT01071252|1945784|FG001|Overall Study|unsatisfactory therapeutic effect|6
951877|NCT01071252|1945785|FG002|Overall Study|unsatisfactory therapeutic effect|2
951878|NCT01071252|1945786|FG003|Overall Study|unsatisfactory therapeutic effect|0
951879|NCT01071252|1945787|FG004|Overall Study|unsatisfactory therapeutic effect|6
951880|NCT01071252|1945783|FG000|Overall Study|Withdrawal by Subject|8
951881|NCT01071252|1945784|FG001|Overall Study|Withdrawal by Subject|2
951882|NCT01071252|1945785|FG002|Overall Study|Withdrawal by Subject|1
951883|NCT01071252|1945786|FG003|Overall Study|Withdrawal by Subject|2
951884|NCT01071252|1945787|FG004|Overall Study|Withdrawal by Subject|3
951885|NCT01071252|1945783|FG000|Overall Study|administrative problems|1
951886|NCT01071252|1945784|FG001|Overall Study|administrative problems|1
951887|NCT01071252|1945785|FG002|Overall Study|administrative problems|0
951888|NCT01071252|1945786|FG003|Overall Study|administrative problems|2
951889|NCT01071252|1945787|FG004|Overall Study|administrative problems|1
951890|NCT01071252|1945783|FG000|Overall Study|Lost to Follow-up|1
951891|NCT01071252|1945784|FG001|Overall Study|Lost to Follow-up|0
951892|NCT01071252|1945785|FG002|Overall Study|Lost to Follow-up|1
951893|NCT01071252|1945786|FG003|Overall Study|Lost to Follow-up|2
951894|NCT01071252|1945787|FG004|Overall Study|Lost to Follow-up|0
951895|NCT01071252|1945783|FG000|Overall Study|Adverse Event|1
951896|NCT01071252|1945784|FG001|Overall Study|Adverse Event|1
951897|NCT01071252|1945785|FG002|Overall Study|Adverse Event|0
951898|NCT01071252|1945786|FG003|Overall Study|Adverse Event|1
951899|NCT01071252|1945787|FG004|Overall Study|Adverse Event|0
951900|NCT01071252|1945783|FG000|Overall Study|Death|0
951901|NCT01071252|1945784|FG001|Overall Study|Death|0
951902|NCT01071252|1945785|FG002|Overall Study|Death|0
951903|NCT01071252|1945786|FG003|Overall Study|Death|0
951904|NCT01071252|1945787|FG004|Overall Study|Death|1
951905|NCT01071278|1945799|FG000|Overall Study|Premature Discontinuation|254
951906|NCT01071278|1945799|FG000|Overall Study|Completion Status Unknown|459
951907|NCT01071317|1945807|FG000|Overall Study|Lost to Follow-up|2
951908|NCT01071317|1945808|FG001|Overall Study|Lost to Follow-up|2
951909|NCT01071395|1945825|FG000|Overall Study|Withdrawal by Subject|2
951910|NCT01071395|1945826|FG001|Overall Study|Withdrawal by Subject|1
951911|NCT01071395|1945825|FG000|Overall Study|Adverse Event|3
951912|NCT01071395|1945826|FG001|Overall Study|Adverse Event|1
951913|NCT01071512|1945832|FG000|Overall Study|Adverse Event|1
951914|NCT01071512|1945832|FG000|Overall Study|Development of antibodies to drug|2
951915|NCT01071512|1945832|FG000|Overall Study|positive anti-JC virus antibody test|2
951916|NCT01071798|1945840|FG000|Participants Who Received One Cycle|Lack of Efficacy|18
951917|NCT01071798|1945840|FG000|Participants Who Received One Cycle|Lack of tolerability|14
951918|NCT01071798|1945840|FG000|Participants Who Received One Cycle|Patient requirement|20
951919|NCT01071798|1945840|FG000|Participants Who Received One Cycle|Death|5
951920|NCT01071798|1945840|FG000|Participants Who Received One Cycle|Change of therapy|6
951921|NCT01071798|1945840|FG000|Participants Who Received One Cycle|Severe concomitant disease|2
951922|NCT01071798|1945840|FG000|Subpopulation Who Received Two Cycles|Remission|1
951923|NCT01071798|1945840|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
951924|NCT01071798|1945840|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
951925|NCT01071798|1945840|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7
951926|NCT01071915|1945854|FG000|Overall Study|Adverse Event|3
951927|NCT01071915|1945854|FG000|Overall Study|Physician Decision|2
951928|NCT01071915|1945854|FG000|Overall Study|Withdrawal by Subject|2
951929|NCT01071915|1945854|FG000|Overall Study|Miscellaneous Reasons|2
951930|NCT01071954|1945858|FG000|Overall Study|Noncompliance|4
951931|NCT01071954|1945858|FG000|Overall Study|Adverse Event|1
951932|NCT01071954|1945858|FG000|Overall Study|Withdrawal by Subject|11
951933|NCT01071954|1945858|FG000|Overall Study|Requirement for Alternative Therapy|5
951934|NCT01071954|1945858|FG000|Overall Study|Administrative Decision|5
951935|NCT01071954|1945858|FG000|Overall Study|Protocol Specified Criteria|1
951936|NCT01072149|1945902|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951937|NCT01072149|1945903|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951938|NCT01072149|1945904|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
951939|NCT01072149|1945905|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951940|NCT01072149|1945906|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951941|NCT01072149|1945907|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951942|NCT01072149|1945908|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951943|NCT01072149|1945909|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951944|NCT01072149|1945910|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951945|NCT01072149|1945911|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951946|NCT01072149|1945912|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951947|NCT01072149|1945913|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1090772|NCT02248818|2158519|FG001|Screening|Withdrawal by Subject|0
951948|NCT01072149|1945914|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951949|NCT01072149|1945915|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951950|NCT01072149|1945916|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951951|NCT01072149|1945917|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951952|NCT01072149|1945918|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951953|NCT01072149|1945919|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951954|NCT01072149|1945902|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0
951955|NCT01072149|1945903|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0
951956|NCT01072149|1945904|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0
951957|NCT01072149|1945905|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0
951958|NCT01072149|1945906|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0
951959|NCT01072149|1945907|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0
951960|NCT01072149|1945908|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0
951961|NCT01072149|1945909|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0
951962|NCT01072149|1945910|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0
951963|NCT01072149|1945911|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0
951964|NCT01072149|1945912|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0
951965|NCT01072149|1945913|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0
951966|NCT01072149|1945914|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0
951967|NCT01072149|1945915|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0
951968|NCT01072149|1945916|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0
951969|NCT01072149|1945917|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0
951970|NCT01072149|1945918|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0
951971|NCT01072149|1945919|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1
951972|NCT01072149|1945902|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951973|NCT01072149|1945903|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951974|NCT01072149|1945904|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951975|NCT01072149|1945905|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951976|NCT01072149|1945906|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951977|NCT01072149|1945907|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951978|NCT01072149|1945908|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951979|NCT01072149|1945909|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951980|NCT01072149|1945910|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951981|NCT01072149|1945911|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951982|NCT01072149|1945912|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1
951983|NCT01072149|1945913|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951984|NCT01072149|1945914|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951985|NCT01072149|1945915|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951986|NCT01072149|1945916|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951987|NCT01072149|1945917|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951988|NCT01072149|1945918|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951989|NCT01072149|1945919|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951990|NCT01072149|1945902|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951991|NCT01072149|1945903|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1
951992|NCT01072149|1945904|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951993|NCT01072149|1945905|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951994|NCT01072149|1945906|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951995|NCT01072149|1945907|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951996|NCT01072149|1945908|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951997|NCT01072149|1945909|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951998|NCT01072149|1945910|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951999|NCT01072149|1945911|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
952000|NCT01072149|1945912|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
952001|NCT01072149|1945913|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
952002|NCT01072149|1945914|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0
952003|NCT01072149|1945915|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0
952004|NCT01072149|1945916|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0
952005|NCT01072149|1945917|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0
952006|NCT01072149|1945918|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0
952007|NCT01072149|1945919|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0
952008|NCT01072149|1945902|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952009|NCT01072149|1945903|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952010|NCT01072149|1945904|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
952011|NCT01072149|1945905|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952012|NCT01072149|1945906|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952013|NCT01072149|1945907|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952014|NCT01072149|1945908|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952015|NCT01072149|1945909|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952016|NCT01072149|1945910|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952017|NCT01072149|1945911|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952018|NCT01072149|1945912|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952019|NCT01072149|1945913|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952020|NCT01072149|1945914|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952021|NCT01072149|1945915|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952022|NCT01072149|1945916|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952023|NCT01072149|1945917|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952024|NCT01072149|1945918|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952025|NCT01072149|1945919|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
952026|NCT01072149|1945902|FG000|Treatment Period 2 (28 Days)|Physician Decision|0
952027|NCT01072149|1945903|FG001|Treatment Period 2 (28 Days)|Physician Decision|0
952028|NCT01072149|1945904|FG002|Treatment Period 2 (28 Days)|Physician Decision|0
952029|NCT01072149|1945905|FG003|Treatment Period 2 (28 Days)|Physician Decision|0
952030|NCT01072149|1945906|FG004|Treatment Period 2 (28 Days)|Physician Decision|0
952031|NCT01072149|1945907|FG005|Treatment Period 2 (28 Days)|Physician Decision|0
952032|NCT01072149|1945908|FG006|Treatment Period 2 (28 Days)|Physician Decision|0
952033|NCT01072149|1945909|FG007|Treatment Period 2 (28 Days)|Physician Decision|1
952034|NCT01072149|1945910|FG008|Treatment Period 2 (28 Days)|Physician Decision|0
952035|NCT01072149|1945911|FG009|Treatment Period 2 (28 Days)|Physician Decision|0
952036|NCT01072149|1945912|FG010|Treatment Period 2 (28 Days)|Physician Decision|0
952037|NCT01072149|1945913|FG011|Treatment Period 2 (28 Days)|Physician Decision|0
952038|NCT01072149|1945914|FG012|Treatment Period 2 (28 Days)|Physician Decision|0
952039|NCT01072149|1945915|FG013|Treatment Period 2 (28 Days)|Physician Decision|0
952040|NCT01072149|1945916|FG014|Treatment Period 2 (28 Days)|Physician Decision|0
952041|NCT01072149|1945917|FG015|Treatment Period 2 (28 Days)|Physician Decision|0
952042|NCT01072149|1945918|FG016|Treatment Period 2 (28 Days)|Physician Decision|0
952043|NCT01072149|1945919|FG017|Treatment Period 2 (28 Days)|Physician Decision|0
952044|NCT01072149|1945902|FG000|Washout Period 2 (14 Days)|Physician Decision|1
952045|NCT01072149|1945903|FG001|Washout Period 2 (14 Days)|Physician Decision|0
952046|NCT01072149|1945904|FG002|Washout Period 2 (14 Days)|Physician Decision|0
952047|NCT01072149|1945905|FG003|Washout Period 2 (14 Days)|Physician Decision|0
952048|NCT01072149|1945906|FG004|Washout Period 2 (14 Days)|Physician Decision|0
952049|NCT01072149|1945907|FG005|Washout Period 2 (14 Days)|Physician Decision|0
952050|NCT01072149|1945908|FG006|Washout Period 2 (14 Days)|Physician Decision|0
952051|NCT01072149|1945909|FG007|Washout Period 2 (14 Days)|Physician Decision|0
952052|NCT01072149|1945910|FG008|Washout Period 2 (14 Days)|Physician Decision|0
952053|NCT01072149|1945911|FG009|Washout Period 2 (14 Days)|Physician Decision|0
952054|NCT01072149|1945912|FG010|Washout Period 2 (14 Days)|Physician Decision|0
952055|NCT01072149|1945913|FG011|Washout Period 2 (14 Days)|Physician Decision|0
952056|NCT01072149|1945914|FG012|Washout Period 2 (14 Days)|Physician Decision|0
952057|NCT01072149|1945915|FG013|Washout Period 2 (14 Days)|Physician Decision|0
952058|NCT01072149|1945916|FG014|Washout Period 2 (14 Days)|Physician Decision|0
952059|NCT01072149|1945917|FG015|Washout Period 2 (14 Days)|Physician Decision|0
952060|NCT01072149|1945918|FG016|Washout Period 2 (14 Days)|Physician Decision|0
952061|NCT01072149|1945919|FG017|Washout Period 2 (14 Days)|Physician Decision|0
952062|NCT01072149|1945902|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952063|NCT01072149|1945903|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952064|NCT01072149|1945904|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952065|NCT01072149|1945905|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952066|NCT01072149|1945906|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952067|NCT01072149|1945907|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952068|NCT01072149|1945908|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952069|NCT01072149|1945909|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952070|NCT01072149|1945910|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952071|NCT01072149|1945911|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952072|NCT01072149|1945912|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952073|NCT01072149|1945913|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952074|NCT01072149|1945914|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952075|NCT01072149|1945915|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952076|NCT01072149|1945916|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952077|NCT01072149|1945917|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1
952078|NCT01072149|1945918|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952079|NCT01072149|1945919|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0
952080|NCT01072149|1945902|FG000|Washout Period 2 (14 Days)|Adverse Event|0
952081|NCT01072149|1945903|FG001|Washout Period 2 (14 Days)|Adverse Event|0
952082|NCT01072149|1945904|FG002|Washout Period 2 (14 Days)|Adverse Event|0
952083|NCT01072149|1945905|FG003|Washout Period 2 (14 Days)|Adverse Event|0
952084|NCT01072149|1945906|FG004|Washout Period 2 (14 Days)|Adverse Event|0
952085|NCT01072149|1945907|FG005|Washout Period 2 (14 Days)|Adverse Event|0
952086|NCT01072149|1945908|FG006|Washout Period 2 (14 Days)|Adverse Event|0
952087|NCT01072149|1945909|FG007|Washout Period 2 (14 Days)|Adverse Event|0
952088|NCT01072149|1945910|FG008|Washout Period 2 (14 Days)|Adverse Event|0
952089|NCT01072149|1945911|FG009|Washout Period 2 (14 Days)|Adverse Event|0
952090|NCT01072149|1945912|FG010|Washout Period 2 (14 Days)|Adverse Event|0
952091|NCT01072149|1945913|FG011|Washout Period 2 (14 Days)|Adverse Event|0
952092|NCT01072149|1945914|FG012|Washout Period 2 (14 Days)|Adverse Event|0
952093|NCT01072149|1945915|FG013|Washout Period 2 (14 Days)|Adverse Event|0
952094|NCT01072149|1945916|FG014|Washout Period 2 (14 Days)|Adverse Event|0
952095|NCT01072149|1945917|FG015|Washout Period 2 (14 Days)|Adverse Event|1
952096|NCT01072149|1945918|FG016|Washout Period 2 (14 Days)|Adverse Event|0
952097|NCT01072149|1945919|FG017|Washout Period 2 (14 Days)|Adverse Event|0
952098|NCT01072149|1945902|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0
952099|NCT01072149|1945903|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0
952100|NCT01072149|1945904|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0
952101|NCT01072149|1945905|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0
952102|NCT01072149|1945906|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0
952103|NCT01072149|1945907|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0
952104|NCT01072149|1945908|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0
952105|NCT01072149|1945909|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0
952106|NCT01072149|1945910|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0
952107|NCT01072149|1945911|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0
952108|NCT01072149|1945912|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0
952109|NCT01072149|1945913|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0
952110|NCT01072149|1945914|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1
952111|NCT01072149|1945915|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0
952112|NCT01072149|1945916|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0
952113|NCT01072149|1945917|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0
952114|NCT01072149|1945918|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0
952115|NCT01072149|1945919|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0
952116|NCT01072149|1945902|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952117|NCT01072149|1945903|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952118|NCT01072149|1945904|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
952119|NCT01072149|1945905|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952120|NCT01072149|1945906|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952121|NCT01072149|1945907|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952122|NCT01072149|1945908|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952123|NCT01072149|1945909|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952124|NCT01072149|1945910|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952125|NCT01072149|1945911|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952126|NCT01072149|1945912|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952127|NCT01072149|1945913|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952128|NCT01072149|1945914|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952129|NCT01072149|1945915|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
952130|NCT01072149|1945916|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952131|NCT01072149|1945917|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952132|NCT01072149|1945918|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952133|NCT01072149|1945919|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
952134|NCT01072201|1945996|FG000|Overall Study|Lost to Follow-up|0
952135|NCT01072201|1945997|FG001|Overall Study|Lost to Follow-up|1
952136|NCT01072344|1946018|FG000|Overall Study|Relasped-reached end point|7
952137|NCT01072344|1946019|FG001|Overall Study|Relasped-reached end point|12
952138|NCT01072344|1946018|FG000|Overall Study|Protocol Violation|1
952139|NCT01072344|1946019|FG001|Overall Study|Protocol Violation|2
952140|NCT01072344|1946018|FG000|Overall Study|Lost to Follow-up|3
952141|NCT01072344|1946019|FG001|Overall Study|Lost to Follow-up|4
952142|NCT01072357|1946027|FG000|Overall Study|Lost to Follow-up|0
952143|NCT01072357|1946028|FG001|Overall Study|Lost to Follow-up|1
952144|NCT01072396|1946036|FG000|Period One|Adverse Event|1
952145|NCT01072396|1946037|FG001|Period One|Adverse Event|1
952146|NCT01072396|1946036|FG000|Period One|Protocol Violation|2
952147|NCT01072396|1946037|FG001|Period One|Protocol Violation|1
952148|NCT01072396|1946036|FG000|Period One|Withdrawal by Subject|2
952149|NCT01072396|1946037|FG001|Period One|Withdrawal by Subject|0
952150|NCT01072396|1946036|FG000|Washout Period|Missing termination information|0
952151|NCT01072396|1946037|FG001|Washout Period|Missing termination information|1
952152|NCT01072396|1946036|FG000|Period Two|Adverse Event|0
952153|NCT01072396|1946037|FG001|Period Two|Adverse Event|3
952154|NCT01072396|1946036|FG000|Period Two|Lost to Follow-up|1
952155|NCT01072396|1946037|FG001|Period Two|Lost to Follow-up|0
952156|NCT01072448|1946049|FG000|Overall Study|Adverse Event|9
952157|NCT01072448|1946050|FG001|Overall Study|Adverse Event|10
952158|NCT01072448|1946049|FG000|Overall Study|Subject withdrew consent|4
952159|NCT01072448|1946050|FG001|Overall Study|Subject withdrew consent|9
952160|NCT01072448|1946049|FG000|Overall Study|Protocol deviation|3
952161|NCT01072448|1946050|FG001|Overall Study|Protocol deviation|4
952162|NCT01072448|1946049|FG000|Overall Study|Abnormal test procedure result(s)|1
952163|NCT01072448|1946050|FG001|Overall Study|Abnormal test procedure result(s)|0
952164|NCT01072448|1946049|FG000|Overall Study|Unsatisfactory therapeutic effect|1
952165|NCT01072448|1946050|FG001|Overall Study|Unsatisfactory therapeutic effect|3
952166|NCT01072448|1946049|FG000|Overall Study|Lost to Follow-up|1
952167|NCT01072448|1946050|FG001|Overall Study|Lost to Follow-up|1
952168|NCT01072448|1946049|FG000|Overall Study|Abnormal laboratory value(s)|0
952169|NCT01072448|1946050|FG001|Overall Study|Abnormal laboratory value(s)|1
952170|NCT01072448|1946049|FG000|Overall Study|Death|0
952171|NCT01072448|1946050|FG001|Overall Study|Death|2
952172|NCT01072500|1946058|FG000|Overall Study|Death|2
952173|NCT01072500|1946059|FG001|Overall Study|Death|2
952174|NCT01072500|1946058|FG000|Overall Study|Lost to Follow-up|5
952175|NCT01072500|1946059|FG001|Overall Study|Lost to Follow-up|2
952176|NCT01072500|1946058|FG000|Overall Study|Withdrawal by Subject|17
952177|NCT01072500|1946059|FG001|Overall Study|Withdrawal by Subject|10
952178|NCT01072539|1946067|FG000|Overall Study|Treated prior to the Site Initiation|1
952179|NCT01072539|1946067|FG000|Overall Study|Protocol Violation|2
952180|NCT01072630|1946079|FG000|Overall Study|Adverse Event|11
952181|NCT01072630|1946080|FG001|Overall Study|Adverse Event|19
952182|NCT01072630|1946081|FG002|Overall Study|Adverse Event|2
952183|NCT01072630|1946079|FG000|Overall Study|Lack of Efficacy|10
952184|NCT01072630|1946080|FG001|Overall Study|Lack of Efficacy|10
952185|NCT01072630|1946081|FG002|Overall Study|Lack of Efficacy|1
952186|NCT01072630|1946079|FG000|Overall Study|Withdrawal by Subject|8
952187|NCT01072630|1946080|FG001|Overall Study|Withdrawal by Subject|7
952188|NCT01072630|1946081|FG002|Overall Study|Withdrawal by Subject|2
952189|NCT01072630|1946079|FG000|Overall Study|Protocol Violation|10
952190|NCT01072630|1946080|FG001|Overall Study|Protocol Violation|8
952191|NCT01072630|1946081|FG002|Overall Study|Protocol Violation|4
952192|NCT01072630|1946079|FG000|Overall Study|Lost to Follow-up|11
952193|NCT01072630|1946080|FG001|Overall Study|Lost to Follow-up|11
952194|NCT01072630|1946081|FG002|Overall Study|Lost to Follow-up|1
952195|NCT01072630|1946079|FG000|Overall Study|Noncompliance with study medication|1
952196|NCT01072630|1946080|FG001|Overall Study|Noncompliance with study medication|1
952197|NCT01072630|1946081|FG002|Overall Study|Noncompliance with study medication|1
952198|NCT01072630|1946079|FG000|Overall Study|Noncompliance with study procedures|1
952199|NCT01072630|1946080|FG001|Overall Study|Noncompliance with study procedures|2
952200|NCT01072630|1946081|FG002|Overall Study|Noncompliance with study procedures|1
952201|NCT01072630|1946079|FG000|Overall Study|Other|3
952202|NCT01072630|1946080|FG001|Overall Study|Other|2
952203|NCT01072630|1946081|FG002|Overall Study|Other|1
952204|NCT01072877|1946141|FG000|Overall Study|Lost to Follow-up|1
952205|NCT01072877|1946142|FG001|Overall Study|Lost to Follow-up|1
952206|NCT01072877|1946143|FG002|Overall Study|Lost to Follow-up|0
952207|NCT01072877|1946144|FG003|Overall Study|Lost to Follow-up|2
952208|NCT01072877|1946145|FG004|Overall Study|Lost to Follow-up|0
952209|NCT01072929|1946162|FG000|Overall Study|Adverse Event|8
952210|NCT01072929|1946163|FG001|Overall Study|Adverse Event|11
952211|NCT01072929|1946164|FG002|Overall Study|Adverse Event|2
952212|NCT01072929|1946162|FG000|Overall Study|Lack of Efficacy|7
952213|NCT01072929|1946163|FG001|Overall Study|Lack of Efficacy|4
952214|NCT01072929|1946164|FG002|Overall Study|Lack of Efficacy|0
952215|NCT01072929|1946162|FG000|Overall Study|Withdrawal by Subject|7
952216|NCT01072929|1946163|FG001|Overall Study|Withdrawal by Subject|15
952217|NCT01072929|1946164|FG002|Overall Study|Withdrawal by Subject|3
952218|NCT01072929|1946162|FG000|Overall Study|Protocol Violation|13
952219|NCT01072929|1946163|FG001|Overall Study|Protocol Violation|11
952220|NCT01072929|1946164|FG002|Overall Study|Protocol Violation|2
952221|NCT01072929|1946162|FG000|Overall Study|Lost to Follow-up|8
952222|NCT01072929|1946163|FG001|Overall Study|Lost to Follow-up|4
952223|NCT01072929|1946164|FG002|Overall Study|Lost to Follow-up|1
952224|NCT01072929|1946162|FG000|Overall Study|Noncompliance with study medication|0
952225|NCT01072929|1946163|FG001|Overall Study|Noncompliance with study medication|3
952226|NCT01072929|1946164|FG002|Overall Study|Noncompliance with study medication|0
952227|NCT01072929|1946162|FG000|Overall Study|Noncompliance with study procedures|1
952228|NCT01072929|1946163|FG001|Overall Study|Noncompliance with study procedures|0
952229|NCT01072929|1946164|FG002|Overall Study|Noncompliance with study procedures|1
952230|NCT01072929|1946162|FG000|Overall Study|Other|0
952231|NCT01072929|1946163|FG001|Overall Study|Other|3
952232|NCT01072929|1946164|FG002|Overall Study|Other|0
952233|NCT01073020|1946177|FG000|Overall Study|Withdrawal by Subject|6
952234|NCT01073020|1946178|FG001|Overall Study|Withdrawal by Subject|4
952235|NCT01073020|1946179|FG002|Overall Study|Withdrawal by Subject|1
952236|NCT01073020|1946180|FG003|Overall Study|Withdrawal by Subject|2
952237|NCT01073020|1946177|FG000|Overall Study|Physician Decision|1
952238|NCT01073020|1946178|FG001|Overall Study|Physician Decision|0
952239|NCT01073020|1946179|FG002|Overall Study|Physician Decision|2
952240|NCT01073020|1946180|FG003|Overall Study|Physician Decision|0
952241|NCT01073020|1946177|FG000|Overall Study|Death|0
952242|NCT01073020|1946178|FG001|Overall Study|Death|1
952243|NCT01073020|1946179|FG002|Overall Study|Death|0
952244|NCT01073020|1946180|FG003|Overall Study|Death|0
952245|NCT01073163|1946190|FG000|Overall Study|Adverse Event|1
952246|NCT01073163|1946190|FG000|Overall Study|Disease Progression|1
952247|NCT01073163|1946190|FG000|Overall Study|Early termination|1
952248|NCT01073267|1946198|FG000|Overall Study|Disease Progression|3
952249|NCT01073293|1946204|FG000|Overall Study|Lost to Follow-up|0
952250|NCT01073293|1946205|FG001|Overall Study|Lost to Follow-up|1
952251|NCT01073293|1946204|FG000|Overall Study|Withdrawal by Subject|5
952252|NCT01073293|1946205|FG001|Overall Study|Withdrawal by Subject|10
952253|NCT01073462|1946215|FG000|Overall Study|Death|14
952254|NCT01073462|1946215|FG000|Overall Study|Kidney transplant|10
952255|NCT01073462|1946215|FG000|Overall Study|Low parathyroid hormone levels|8
952256|NCT01073462|1946215|FG000|Overall Study|Serious adverse event|2
952257|NCT01073462|1946215|FG000|Overall Study|Lost to Follow-up|7
952258|NCT01073566|1946221|FG000|Period 2 (6 Weeks)|Adverse Event|1
952259|NCT01073566|1946222|FG001|Period 2 (6 Weeks)|Adverse Event|0
952260|NCT01073605|1946231|FG000|Overall Study|Ongoing at Cutoff Date|1
952261|NCT01073605|1946232|FG001|Overall Study|Ongoing at Cutoff Date|1
952262|NCT01073605|1946233|FG002|Overall Study|Ongoing at Cutoff Date|0
952263|NCT01073605|1946231|FG000|Overall Study|Adverse Event|2
952264|NCT01073605|1946232|FG001|Overall Study|Adverse Event|1
952265|NCT01073605|1946233|FG002|Overall Study|Adverse Event|0
952266|NCT01073605|1946231|FG000|Overall Study|Lost to Follow-up|3
952267|NCT01073605|1946232|FG001|Overall Study|Lost to Follow-up|4
952268|NCT01073605|1946233|FG002|Overall Study|Lost to Follow-up|9
952269|NCT01073605|1946231|FG000|Overall Study|Other|25
952270|NCT01073605|1946232|FG001|Overall Study|Other|21
952271|NCT01073605|1946233|FG002|Overall Study|Other|29
952272|NCT01073605|1946231|FG000|Overall Study|Withdrawal by Subject|31
952273|NCT01073605|1946232|FG001|Overall Study|Withdrawal by Subject|39
952274|NCT01073605|1946233|FG002|Overall Study|Withdrawal by Subject|22
952275|NCT01073605|1946231|FG000|Overall Study|Randomized But Not Treated|0
952276|NCT01073605|1946232|FG001|Overall Study|Randomized But Not Treated|1
952277|NCT01073605|1946233|FG002|Overall Study|Randomized But Not Treated|1
952278|NCT01073618|1946241|FG000|Overall Study|Death|208
952279|NCT01073618|1946241|FG000|Overall Study|Adverse Event|19
952280|NCT01073618|1946241|FG000|Overall Study|Other|80
952281|NCT01073631|1946245|FG000|Overall Study|Death|82
952282|NCT01073631|1946245|FG000|Overall Study|Adverse Event|24
952283|NCT01073631|1946245|FG000|Overall Study|Other|63
952284|NCT01073865|1946260|FG000|Overall Study|Reasons other than below|19
952285|NCT01073865|1946261|FG001|Overall Study|Reasons other than below|31
952286|NCT01073865|1946260|FG000|Overall Study|Lost to Follow-up|1
952287|NCT01073865|1946261|FG001|Overall Study|Lost to Follow-up|1
952288|NCT01073865|1946260|FG000|Overall Study|Death|3
952289|NCT01073865|1946261|FG001|Overall Study|Death|2
952290|NCT01073865|1946260|FG000|Overall Study|Withdrawal by Subject|5
952291|NCT01073865|1946261|FG001|Overall Study|Withdrawal by Subject|5
952292|NCT01073930|1946269|FG000|Overall Study|Withdrawal by Subject|3
952293|NCT01073930|1946270|FG001|Overall Study|Withdrawal by Subject|2
952294|NCT01073930|1946269|FG000|Overall Study|Lost to Follow-up|0
952295|NCT01073930|1946270|FG001|Overall Study|Lost to Follow-up|1
952296|NCT01073930|1946269|FG000|Overall Study|Adverse Event|0
952297|NCT01073930|1946270|FG001|Overall Study|Adverse Event|1
952298|NCT01073930|1946269|FG000|Overall Study|Noncompliance with study drug|0
952299|NCT01073930|1946270|FG001|Overall Study|Noncompliance with study drug|1
952300|NCT01073930|1946269|FG000|Overall Study|Inadequate prep; unable to do procedure|0
952301|NCT01073930|1946270|FG001|Overall Study|Inadequate prep; unable to do procedure|1
952302|NCT01073943|1946278|FG000|Overall Study|Withdrawal by Subject|8
952303|NCT01073943|1946279|FG001|Overall Study|Withdrawal by Subject|2
952304|NCT01073943|1946278|FG000|Overall Study|Protocol Violation|2
952305|NCT01073943|1946279|FG001|Overall Study|Protocol Violation|1
952306|NCT01073943|1946278|FG000|Overall Study|Adverse Event|1
952307|NCT01073943|1946279|FG001|Overall Study|Adverse Event|1
952308|NCT01073943|1946278|FG000|Overall Study|Lost to Follow-up|0
952309|NCT01073943|1946279|FG001|Overall Study|Lost to Follow-up|2
952310|NCT01073943|1946278|FG000|Overall Study|Power outage; colonoscopy not done|1
952311|NCT01073943|1946279|FG001|Overall Study|Power outage; colonoscopy not done|0
952312|NCT01073943|1946278|FG000|Overall Study|Subject forgot|0
952313|NCT01073943|1946279|FG001|Overall Study|Subject forgot|1
952314|NCT01073943|1946278|FG000|Overall Study|Unable to return for follow-up|0
952315|NCT01073943|1946279|FG001|Overall Study|Unable to return for follow-up|1
952316|NCT01073943|1946278|FG000|Overall Study|Could not tolerate prep|1
952317|NCT01073943|1946279|FG001|Overall Study|Could not tolerate prep|0
952318|NCT01074008|1946294|FG000|Overall Study|Adverse Event|0
952319|NCT01074008|1946295|FG001|Overall Study|Adverse Event|1
952320|NCT01074008|1946296|FG002|Overall Study|Adverse Event|0
952321|NCT01074008|1946297|FG003|Overall Study|Adverse Event|0
952322|NCT01074008|1946298|FG004|Overall Study|Adverse Event|0
952323|NCT01074008|1946299|FG005|Overall Study|Adverse Event|0
952324|NCT01074008|1946300|FG006|Overall Study|Adverse Event|0
952325|NCT01074008|1946301|FG007|Overall Study|Adverse Event|0
952326|NCT01074008|1946302|FG008|Overall Study|Adverse Event|0
952327|NCT01074008|1946294|FG000|Overall Study|Withdrawal by Subject|1
952328|NCT01074008|1946295|FG001|Overall Study|Withdrawal by Subject|1
952329|NCT01074008|1946296|FG002|Overall Study|Withdrawal by Subject|1
952330|NCT01074008|1946297|FG003|Overall Study|Withdrawal by Subject|0
952331|NCT01074008|1946298|FG004|Overall Study|Withdrawal by Subject|1
952332|NCT01074008|1946299|FG005|Overall Study|Withdrawal by Subject|0
952333|NCT01074008|1946300|FG006|Overall Study|Withdrawal by Subject|0
952334|NCT01074008|1946301|FG007|Overall Study|Withdrawal by Subject|0
952335|NCT01074008|1946302|FG008|Overall Study|Withdrawal by Subject|0
952336|NCT01074008|1946294|FG000|Overall Study|Lost to Follow-up|0
952337|NCT01074008|1946295|FG001|Overall Study|Lost to Follow-up|1
952338|NCT01074008|1946296|FG002|Overall Study|Lost to Follow-up|1
952339|NCT01074008|1946297|FG003|Overall Study|Lost to Follow-up|1
952340|NCT01074008|1946298|FG004|Overall Study|Lost to Follow-up|1
952341|NCT01074008|1946299|FG005|Overall Study|Lost to Follow-up|0
952342|NCT01074008|1946300|FG006|Overall Study|Lost to Follow-up|1
952343|NCT01074008|1946301|FG007|Overall Study|Lost to Follow-up|0
952344|NCT01074008|1946302|FG008|Overall Study|Lost to Follow-up|4
952345|NCT01074047|1946338|FG000|Treatment Phase|Adverse Event|89
952346|NCT01074047|1946339|FG001|Treatment Phase|Adverse Event|66
952347|NCT01074047|1946338|FG000|Treatment Phase|Disease Progression|16
952348|NCT01074047|1946339|FG001|Treatment Phase|Disease Progression|21
952349|NCT01074047|1946338|FG000|Treatment Phase|Withdrawal by Subject|27
952350|NCT01074047|1946339|FG001|Treatment Phase|Withdrawal by Subject|48
952351|NCT01074047|1946338|FG000|Treatment Phase|Death|53
952352|NCT01074047|1946339|FG001|Treatment Phase|Death|58
952353|NCT01074047|1946338|FG000|Treatment Phase|Lost to Follow-up|0
952354|NCT01074047|1946339|FG001|Treatment Phase|Lost to Follow-up|1
952355|NCT01074047|1946338|FG000|Treatment Phase|Protocol Violation|0
952356|NCT01074047|1946339|FG001|Treatment Phase|Protocol Violation|1
952357|NCT01074047|1946338|FG000|Treatment Phase|Miscellaneous|32
952358|NCT01074047|1946339|FG001|Treatment Phase|Miscellaneous|39
952359|NCT01074047|1946338|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5
952360|NCT01074047|1946339|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8
952361|NCT01074047|1946338|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
952362|NCT01074047|1946339|FG001|Survival Follow-Up Phase|Lost to Follow-up|1
952363|NCT01074047|1946338|FG000|Survival Follow-Up Phase|Death|116
952364|NCT01074047|1946339|FG001|Survival Follow-Up Phase|Death|124
952365|NCT01074047|1946338|FG000|Survival Follow-Up Phase|Alive at study closure|1
952366|NCT01074047|1946339|FG001|Survival Follow-Up Phase|Alive at study closure|3
952367|NCT01074047|1946338|FG000|Extension Phase|Physician Decision|1
952368|NCT01074047|1946339|FG001|Extension Phase|Physician Decision|0
952369|NCT01074047|1946338|FG000|Extension Phase|Adverse Event|5
952370|NCT01074047|1946339|FG001|Extension Phase|Adverse Event|0
952371|NCT01074047|1946338|FG000|Extension Phase|Disease Progression|9
952372|NCT01074047|1946339|FG001|Extension Phase|Disease Progression|0
952373|NCT01074047|1946338|FG000|Extension Phase|Withdrawal by Subject|2
952374|NCT01074047|1946339|FG001|Extension Phase|Withdrawal by Subject|0
952375|NCT01074047|1946338|FG000|Extension Phase|Death|5
952376|NCT01074047|1946339|FG001|Extension Phase|Death|0
952377|NCT01074216|1946390|FG000|Overall Study|Physician Decision|1
952378|NCT01074216|1946390|FG000|Overall Study|Not Treated|12
952379|NCT01074229|1946397|FG000|Overall Study|Lost to Follow-up|1
952380|NCT01074229|1946398|FG001|Overall Study|Lost to Follow-up|0
952381|NCT01074229|1946399|FG002|Overall Study|Lost to Follow-up|0
952382|NCT01074229|1946397|FG000|Overall Study|Change to open surgical procedure|1
952383|NCT01074229|1946398|FG001|Overall Study|Change to open surgical procedure|3
952384|NCT01074229|1946399|FG002|Overall Study|Change to open surgical procedure|4
952385|NCT01074242|1946409|FG000|Overall Study|Case report before date of contract|40
952386|NCT01074242|1946409|FG000|Overall Study|Lost to Follow-up|1
952387|NCT01074242|1946409|FG000|Overall Study|Case report unclear|6
952388|NCT01074242|1946409|FG000|Overall Study|Violation of vaccine dose or dosage|351
952389|NCT01074242|1946409|FG000|Overall Study|Duplicate Case Report Form|5
952390|NCT01074255|1946413|FG000|Overall Study|Did not receive EMEND|2
952391|NCT01074268|1946419|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
952392|NCT01074268|1946420|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
952393|NCT01074268|1946419|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
952394|NCT01074268|1946420|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
952395|NCT01074268|1946419|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
952396|NCT01074268|1946420|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
952397|NCT01074268|1946419|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
952398|NCT01074268|1946420|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
952399|NCT01074268|1946419|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
952400|NCT01074268|1946420|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
952401|NCT01074268|1946419|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
952402|NCT01074268|1946420|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
952403|NCT01074268|1946419|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
952404|NCT01074268|1946420|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
952405|NCT01074268|1946419|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
952406|NCT01074268|1946420|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
952407|NCT01074268|1946419|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
952408|NCT01074268|1946420|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
952409|NCT01074307|1946428|FG000|Overall Study|No primary endpoint evaluation|14
952410|NCT01074307|1946429|FG001|Overall Study|No primary endpoint evaluation|6
952411|NCT01074307|1946428|FG000|Overall Study|Exclusion criterion|0
952412|NCT01074307|1946429|FG001|Overall Study|Exclusion criterion|1
952413|NCT01074307|1946428|FG000|Overall Study|Protocol Violation|8
952414|NCT01074307|1946429|FG001|Overall Study|Protocol Violation|5
952415|NCT01074450|1946437|FG000|First Intervention|Emesis in Dosing Interval|0
952416|NCT01074450|1946438|FG001|First Intervention|Emesis in Dosing Interval|2
952417|NCT01074450|1946437|FG000|Second Intervention|Protocol Violation|1
952418|NCT01074450|1946438|FG001|Second Intervention|Protocol Violation|0
952419|NCT01074450|1946437|FG000|Second Intervention|Physician Decision|0
952420|NCT01074450|1946438|FG001|Second Intervention|Physician Decision|1
952421|NCT01074554|1946455|FG000|Overall Study|Adverse Event|3
952422|NCT01074554|1946456|FG001|Overall Study|Adverse Event|3
952423|NCT01074554|1946455|FG000|Overall Study|Lost to Follow-up|0
952424|NCT01074554|1946456|FG001|Overall Study|Lost to Follow-up|1
952425|NCT01074658|1946462|FG000|Overall Study|No implant attempted|19
952426|NCT01074931|1946466|FG000|Overall Study|Economic reasons|1
952427|NCT01074931|1946466|FG000|Overall Study|Death|5
952428|NCT01074944|1946474|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2
952429|NCT01074944|1946475|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0
952430|NCT01074944|1946476|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0
952431|NCT01074944|1946477|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0
952432|NCT01074944|1946478|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0
952433|NCT01074944|1946474|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
952434|NCT01074944|1946475|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
952435|NCT01074944|1946476|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
952436|NCT01074944|1946477|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
952437|NCT01074944|1946478|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
952438|NCT01074944|1946474|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4
952439|NCT01074944|1946475|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0
952440|NCT01074944|1946476|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0
952441|NCT01074944|1946477|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0
952442|NCT01074944|1946478|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0
952443|NCT01074944|1946474|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
952444|NCT01074944|1946475|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
952445|NCT01074944|1946476|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
952446|NCT01074944|1946477|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
952447|NCT01074944|1946478|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
952448|NCT01074944|1946474|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
952449|NCT01074944|1946475|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
952450|NCT01074944|1946476|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
952451|NCT01074944|1946477|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
952452|NCT01074944|1946478|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
952453|NCT01074944|1946474|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
952454|NCT01074944|1946475|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
952455|NCT01074944|1946476|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
952456|NCT01074944|1946477|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
952457|NCT01074944|1946478|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
952458|NCT01074944|1946474|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
952459|NCT01074944|1946475|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
952460|NCT01074944|1946476|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
952461|NCT01074944|1946477|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
952462|NCT01074944|1946478|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
952463|NCT01074944|1946474|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
952464|NCT01074944|1946475|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
952465|NCT01074944|1946476|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
952466|NCT01074944|1946477|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
952467|NCT01074944|1946478|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
952468|NCT01074944|1946474|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
952469|NCT01074944|1946475|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
952470|NCT01074944|1946476|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
952471|NCT01074944|1946477|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
952472|NCT01074944|1946478|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
952473|NCT01074944|1946474|FG000|Long Term Treatment|Adverse Event|0
952474|NCT01074944|1946475|FG001|Long Term Treatment|Adverse Event|0
952475|NCT01074944|1946476|FG002|Long Term Treatment|Adverse Event|0
952476|NCT01074944|1946477|FG003|Long Term Treatment|Adverse Event|3
952477|NCT01074944|1946478|FG004|Long Term Treatment|Adverse Event|0
952478|NCT01074944|1946474|FG000|Long Term Treatment|Lost to Follow-up|0
952479|NCT01074944|1946475|FG001|Long Term Treatment|Lost to Follow-up|0
952480|NCT01074944|1946476|FG002|Long Term Treatment|Lost to Follow-up|0
952481|NCT01074944|1946477|FG003|Long Term Treatment|Lost to Follow-up|2
952482|NCT01074944|1946478|FG004|Long Term Treatment|Lost to Follow-up|0
952483|NCT01074944|1946474|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0
952484|NCT01074944|1946475|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0
952485|NCT01074944|1946476|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0
952486|NCT01074944|1946477|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18
952487|NCT01074944|1946478|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0
952488|NCT01074944|1946474|FG000|Long Term Treatment|Entered in Period, But Not Treated|0
952489|NCT01074944|1946475|FG001|Long Term Treatment|Entered in Period, But Not Treated|0
952490|NCT01074944|1946476|FG002|Long Term Treatment|Entered in Period, But Not Treated|0
952491|NCT01074944|1946477|FG003|Long Term Treatment|Entered in Period, But Not Treated|1
952492|NCT01074944|1946478|FG004|Long Term Treatment|Entered in Period, But Not Treated|0
952493|NCT01074944|1946474|FG000|Long Term Treatment|Withdrawal by Subject|0
952494|NCT01074944|1946475|FG001|Long Term Treatment|Withdrawal by Subject|0
952495|NCT01074944|1946476|FG002|Long Term Treatment|Withdrawal by Subject|0
952496|NCT01074944|1946477|FG003|Long Term Treatment|Withdrawal by Subject|2
952497|NCT01074944|1946478|FG004|Long Term Treatment|Withdrawal by Subject|0
952498|NCT01074944|1946474|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0
952499|NCT01074944|1946475|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0
952500|NCT01074944|1946476|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0
952501|NCT01074944|1946477|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0
952502|NCT01074944|1946478|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2
952503|NCT01074944|1946474|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
952504|NCT01074944|1946475|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
952505|NCT01074944|1946476|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
952506|NCT01074944|1946477|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
952507|NCT01074944|1946478|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
952508|NCT01075048|1946489|FG000|Overall Study|Death|4
952509|NCT01075048|1946490|FG001|Overall Study|Death|17
952510|NCT01075048|1946491|FG002|Overall Study|Death|12
952511|NCT01075048|1946489|FG000|Overall Study|Start of other or new therapy|4
952512|NCT01075048|1946490|FG001|Overall Study|Start of other or new therapy|36
952513|NCT01075048|1946491|FG002|Overall Study|Start of other or new therapy|46
952514|NCT01075048|1946489|FG000|Overall Study|Withdrawal by Subject|1
952515|NCT01075048|1946490|FG001|Overall Study|Withdrawal by Subject|6
952516|NCT01075048|1946491|FG002|Overall Study|Withdrawal by Subject|3
952517|NCT01075048|1946489|FG000|Overall Study|Lost to Follow-up|0
952518|NCT01075048|1946490|FG001|Overall Study|Lost to Follow-up|1
952519|NCT01075048|1946491|FG002|Overall Study|Lost to Follow-up|1
952520|NCT01075074|1946505|FG000|Overall Study|Surgeon changed to open incisional case|1
952521|NCT01075074|1946506|FG001|Overall Study|Surgeon changed to open incisional case|2
952522|NCT01075074|1946507|FG002|Overall Study|Surgeon changed to open incisional case|2
952523|NCT01075100|1946530|FG000|Overall Study|Adverse Event|15
952524|NCT01075100|1946531|FG001|Overall Study|Adverse Event|18
952525|NCT01075100|1946530|FG000|Overall Study|Patient Request|4
952526|NCT01075100|1946531|FG001|Overall Study|Patient Request|4
952527|NCT01075100|1946530|FG000|Overall Study|Investigator Request|2
952528|NCT01075100|1946531|FG001|Overall Study|Investigator Request|1
952529|NCT01075100|1946530|FG000|Overall Study|Disease Progression|25
952530|NCT01075100|1946531|FG001|Overall Study|Disease Progression|29
952531|NCT01075100|1946530|FG000|Overall Study|Other|3
952532|NCT01075100|1946531|FG001|Overall Study|Other|1
952533|NCT01075152|1946541|FG000|Overall Study|Withdrawal by Subject|1
952534|NCT01075152|1946542|FG001|Overall Study|Withdrawal by Subject|0
952535|NCT01075178|1946552|FG000|Subject Matching|eligible but not matched|130
952536|NCT01075178|1946553|FG001|Subject Matching|eligible but not matched|403
952537|NCT01075178|1946552|FG000|Subject Chart Review|died before chart review period|0
952538|NCT01075178|1946553|FG001|Subject Chart Review|died before chart review period|2
952539|NCT01075178|1946552|FG000|Subject Chart Review|no data collected due to site closure|3
952540|NCT01075178|1946553|FG001|Subject Chart Review|no data collected due to site closure|4
952541|NCT01075178|1946552|FG000|Subject Chart Review|matched partner excluded (reasons above)|6
952542|NCT01075178|1946553|FG001|Subject Chart Review|matched partner excluded (reasons above)|3
952543|NCT01075191|1946559|FG000|Overall Study|Death|1
952544|NCT01075191|1946559|FG000|Overall Study|Intensification|3
952545|NCT01075191|1946559|FG000|Overall Study|Co-morbidities|1
952546|NCT01075191|1946559|FG000|Overall Study|Adverse Event|4
952547|NCT01075191|1946559|FG000|Overall Study|Noncompliance|3
952548|NCT01075191|1946559|FG000|Overall Study|Therapy Break|3
952549|NCT01075191|1946559|FG000|Overall Study|Patient's Wish|2
952550|NCT01075191|1946559|FG000|Overall Study|Unknown Reasons|1
952551|NCT01075217|1946569|FG000|Overall Study|Adverse Event|1
952552|NCT01075217|1946570|FG001|Overall Study|Adverse Event|1
952553|NCT01075217|1946569|FG000|Overall Study|Physician Decision|1
952554|NCT01075217|1946570|FG001|Overall Study|Physician Decision|0
952555|NCT01075243|1946587|FG000|Overall Study|Lost to Follow-up|5
952556|NCT01075243|1946588|FG001|Overall Study|Lost to Follow-up|2
952557|NCT01075243|1946589|FG002|Overall Study|Lost to Follow-up|0
952558|NCT01075243|1946587|FG000|Overall Study|Withdrawal by Subject|1
952559|NCT01075243|1946588|FG001|Overall Study|Withdrawal by Subject|1
952560|NCT01075243|1946589|FG002|Overall Study|Withdrawal by Subject|0
952561|NCT01075256|1946602|FG000|Overall Study|Withdrawal by Subject|1
952562|NCT01075256|1946603|FG001|Overall Study|Withdrawal by Subject|0
952563|NCT01075256|1946604|FG002|Overall Study|Withdrawal by Subject|0
952564|NCT01075282|1946620|FG000|Overall Study|Withdrawal by Subject|11
952565|NCT01075282|1946621|FG001|Overall Study|Withdrawal by Subject|7
952566|NCT01075282|1946622|FG002|Overall Study|Withdrawal by Subject|11
952567|NCT01075282|1946620|FG000|Overall Study|Adverse Event|9
952568|NCT01075282|1946621|FG001|Overall Study|Adverse Event|8
952569|NCT01075282|1946622|FG002|Overall Study|Adverse Event|5
952570|NCT01075282|1946620|FG000|Overall Study|Entry Criteria Not Met|3
952571|NCT01075282|1946621|FG001|Overall Study|Entry Criteria Not Met|2
952572|NCT01075282|1946622|FG002|Overall Study|Entry Criteria Not Met|0
952573|NCT01075282|1946620|FG000|Overall Study|Lost to Follow-up|3
952574|NCT01075282|1946621|FG001|Overall Study|Lost to Follow-up|3
952575|NCT01075282|1946622|FG002|Overall Study|Lost to Follow-up|3
952576|NCT01075282|1946620|FG000|Overall Study|Physician Decision|3
952577|NCT01075282|1946621|FG001|Overall Study|Physician Decision|3
952578|NCT01075282|1946622|FG002|Overall Study|Physician Decision|3
952579|NCT01075282|1946620|FG000|Overall Study|Lack of Efficacy|1
952580|NCT01075282|1946621|FG001|Overall Study|Lack of Efficacy|1
952581|NCT01075282|1946622|FG002|Overall Study|Lack of Efficacy|0
952582|NCT01075282|1946620|FG000|Overall Study|Treatment Non-compliance|1
952583|NCT01075282|1946621|FG001|Overall Study|Treatment Non-compliance|2
952584|NCT01075282|1946622|FG002|Overall Study|Treatment Non-compliance|2
952585|NCT01075282|1946620|FG000|Overall Study|Protocol Violation|0
952586|NCT01075282|1946621|FG001|Overall Study|Protocol Violation|2
952587|NCT01075282|1946622|FG002|Overall Study|Protocol Violation|1
952588|NCT01075282|1946620|FG000|Overall Study|Death|0
952589|NCT01075282|1946621|FG001|Overall Study|Death|1
952590|NCT01075282|1946622|FG002|Overall Study|Death|2
952591|NCT01075321|1946631|FG000|Overall Study|Withdrawal by Subject|0
952592|NCT01075321|1946632|FG001|Overall Study|Withdrawal by Subject|0
952593|NCT01075321|1946633|FG002|Overall Study|Withdrawal by Subject|1
952594|NCT01075321|1946634|FG003|Overall Study|Withdrawal by Subject|1
952595|NCT01075321|1946631|FG000|Overall Study|Protocol Violation|0
952596|NCT01075321|1946632|FG001|Overall Study|Protocol Violation|0
952597|NCT01075321|1946633|FG002|Overall Study|Protocol Violation|1
952598|NCT01075321|1946634|FG003|Overall Study|Protocol Violation|0
952599|NCT01075321|1946631|FG000|Overall Study|Treatment Incomplete due to progression|1
952600|NCT01075321|1946632|FG001|Overall Study|Treatment Incomplete due to progression|0
952601|NCT01075321|1946633|FG002|Overall Study|Treatment Incomplete due to progression|0
952602|NCT01075321|1946634|FG003|Overall Study|Treatment Incomplete due to progression|0
952603|NCT01075321|1946631|FG000|Overall Study|Ineligible (miscalculated lab value)|0
952604|NCT01075321|1946632|FG001|Overall Study|Ineligible (miscalculated lab value)|0
952605|NCT01075321|1946633|FG002|Overall Study|Ineligible (miscalculated lab value)|0
952606|NCT01075321|1946634|FG003|Overall Study|Ineligible (miscalculated lab value)|1
952607|NCT01075412|1946661|FG000|Overall Study|Withdrawal by Subject|0
952608|NCT01075412|1946662|FG001|Overall Study|Withdrawal by Subject|1
952609|NCT01075516|1946669|FG000|Overall Study|Death|5
952610|NCT01075516|1946670|FG001|Overall Study|Death|9
952611|NCT01075516|1946669|FG000|Overall Study|Lost to Follow-up|10
952612|NCT01075516|1946670|FG001|Overall Study|Lost to Follow-up|2
952613|NCT01075516|1946669|FG000|Overall Study|Withdrawal by Subject|3
952614|NCT01075516|1946670|FG001|Overall Study|Withdrawal by Subject|5
952615|NCT01075646|1946680|FG000|Overall Study|Lost to Follow-up|4
952616|NCT01075646|1946681|FG001|Overall Study|Lost to Follow-up|3
952617|NCT01075646|1946682|FG002|Overall Study|Lost to Follow-up|1
952618|NCT01075646|1946683|FG003|Overall Study|Lost to Follow-up|2
952619|NCT01075685|1946695|FG000|Overall Study|Protocol Violation|9
952620|NCT01075685|1946696|FG001|Overall Study|Protocol Violation|1
952621|NCT01075685|1946695|FG000|Overall Study|Withdrawal by Subject|20
952622|NCT01075685|1946696|FG001|Overall Study|Withdrawal by Subject|5
952623|NCT01075685|1946695|FG000|Overall Study|Lost to Follow-up|563
952624|NCT01075685|1946696|FG001|Overall Study|Lost to Follow-up|220
952625|NCT01075763|1946704|FG000|Overall Study|Lost to Follow-up|2
952626|NCT01075763|1946705|FG001|Overall Study|Lost to Follow-up|1
952627|NCT01075763|1946704|FG000|Overall Study|Lack of Efficacy|0
952628|NCT01075763|1946705|FG001|Overall Study|Lack of Efficacy|1
952629|NCT01075763|1946704|FG000|Overall Study|Withdrawal by Subject|2
952630|NCT01075763|1946705|FG001|Overall Study|Withdrawal by Subject|2
952631|NCT01075815|1946713|FG000|Overall Study|Withdrawal before r-hCG administration|6
952632|NCT01075815|1946714|FG001|Overall Study|Withdrawal before r-hCG administration|1
952633|NCT01075815|1946713|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
952634|NCT01075815|1946714|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
952635|NCT01075815|1946713|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3
952636|NCT01075815|1946714|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
952637|NCT01075958|1946720|FG000|Overall Study|Blood sample could not be obtained|44
952638|NCT01075984|1946733|FG000|Treatment Phase|Adverse Event|0
952639|NCT01075984|1946734|FG001|Treatment Phase|Adverse Event|1
952640|NCT01075984|1946735|FG002|Treatment Phase|Adverse Event|3
952641|NCT01075984|1946736|FG003|Treatment Phase|Adverse Event|7
952642|NCT01075984|1946737|FG004|Treatment Phase|Adverse Event|35
952643|NCT01075984|1946733|FG000|Treatment Phase|Protocol Violation|0
952644|NCT01075984|1946734|FG001|Treatment Phase|Protocol Violation|0
952645|NCT01075984|1946735|FG002|Treatment Phase|Protocol Violation|1
952646|NCT01075984|1946736|FG003|Treatment Phase|Protocol Violation|0
952647|NCT01075984|1946737|FG004|Treatment Phase|Protocol Violation|3
952648|NCT01075984|1946733|FG000|Treatment Phase|Withdrawal by Subject|0
952649|NCT01075984|1946734|FG001|Treatment Phase|Withdrawal by Subject|0
952650|NCT01075984|1946735|FG002|Treatment Phase|Withdrawal by Subject|2
952651|NCT01075984|1946736|FG003|Treatment Phase|Withdrawal by Subject|0
952652|NCT01075984|1946737|FG004|Treatment Phase|Withdrawal by Subject|15
952653|NCT01075984|1946733|FG000|Treatment Phase|Treatment Failure|0
952654|NCT01075984|1946734|FG001|Treatment Phase|Treatment Failure|0
952655|NCT01075984|1946735|FG002|Treatment Phase|Treatment Failure|1
952656|NCT01075984|1946736|FG003|Treatment Phase|Treatment Failure|0
952657|NCT01075984|1946737|FG004|Treatment Phase|Treatment Failure|5
952658|NCT01075984|1946733|FG000|Treatment Phase|Progression of disease|0
952659|NCT01075984|1946734|FG001|Treatment Phase|Progression of disease|0
952660|NCT01075984|1946735|FG002|Treatment Phase|Progression of disease|0
952661|NCT01075984|1946736|FG003|Treatment Phase|Progression of disease|0
952662|NCT01075984|1946737|FG004|Treatment Phase|Progression of disease|2
952663|NCT01075984|1946733|FG000|Follow-up Phase|Protocol Violation|0
952664|NCT01075984|1946734|FG001|Follow-up Phase|Protocol Violation|0
952665|NCT01075984|1946735|FG002|Follow-up Phase|Protocol Violation|1
952666|NCT01075984|1946736|FG003|Follow-up Phase|Protocol Violation|0
952667|NCT01075984|1946737|FG004|Follow-up Phase|Protocol Violation|3
952668|NCT01075984|1946733|FG000|Follow-up Phase|Adverse Event|0
952669|NCT01075984|1946734|FG001|Follow-up Phase|Adverse Event|0
952670|NCT01075984|1946735|FG002|Follow-up Phase|Adverse Event|0
952671|NCT01075984|1946736|FG003|Follow-up Phase|Adverse Event|2
952672|NCT01075984|1946737|FG004|Follow-up Phase|Adverse Event|27
952673|NCT01075984|1946733|FG000|Follow-up Phase|Administrative|0
952674|NCT01075984|1946734|FG001|Follow-up Phase|Administrative|0
952675|NCT01075984|1946735|FG002|Follow-up Phase|Administrative|0
952676|NCT01075984|1946736|FG003|Follow-up Phase|Administrative|0
952677|NCT01075984|1946737|FG004|Follow-up Phase|Administrative|1
952678|NCT01075984|1946733|FG000|Follow-up Phase|Withdrawal by Subject|0
952679|NCT01075984|1946734|FG001|Follow-up Phase|Withdrawal by Subject|0
952680|NCT01075984|1946735|FG002|Follow-up Phase|Withdrawal by Subject|0
952681|NCT01075984|1946736|FG003|Follow-up Phase|Withdrawal by Subject|0
952682|NCT01075984|1946737|FG004|Follow-up Phase|Withdrawal by Subject|10
952683|NCT01075984|1946733|FG000|Follow-up Phase|Progression of disease|0
952684|NCT01075984|1946734|FG001|Follow-up Phase|Progression of disease|0
952685|NCT01075984|1946735|FG002|Follow-up Phase|Progression of disease|0
952686|NCT01075984|1946736|FG003|Follow-up Phase|Progression of disease|0
952687|NCT01075984|1946737|FG004|Follow-up Phase|Progression of disease|2
952688|NCT01075984|1946733|FG000|Follow-up Phase|Treatment failure|0
952689|NCT01075984|1946734|FG001|Follow-up Phase|Treatment failure|0
952690|NCT01075984|1946735|FG002|Follow-up Phase|Treatment failure|0
952691|NCT01075984|1946736|FG003|Follow-up Phase|Treatment failure|0
952692|NCT01075984|1946737|FG004|Follow-up Phase|Treatment failure|4
952693|NCT01076010|1946752|FG000|Overall Study|Death|15
952694|NCT01076010|1946753|FG001|Overall Study|Death|1
952695|NCT01076010|1946754|FG002|Overall Study|Death|0
952696|NCT01076010|1946752|FG000|Overall Study|Adverse Event|7
952697|NCT01076010|1946753|FG001|Overall Study|Adverse Event|2
952698|NCT01076010|1946754|FG002|Overall Study|Adverse Event|0
952699|NCT01076010|1946752|FG000|Overall Study|Progressive disease|90
952700|NCT01076010|1946753|FG001|Overall Study|Progressive disease|30
952701|NCT01076010|1946754|FG002|Overall Study|Progressive disease|1
952702|NCT01076010|1946752|FG000|Overall Study|Lack of Efficacy|4
952703|NCT01076010|1946753|FG001|Overall Study|Lack of Efficacy|0
952704|NCT01076010|1946754|FG002|Overall Study|Lack of Efficacy|0
952705|NCT01076010|1946752|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0
952706|NCT01076010|1946753|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1
952707|NCT01076010|1946754|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0
952708|NCT01076010|1946752|FG000|Overall Study|Significant Surgical Procedure|0
952709|NCT01076010|1946753|FG001|Overall Study|Significant Surgical Procedure|1
952710|NCT01076010|1946754|FG002|Overall Study|Significant Surgical Procedure|0
952711|NCT01076010|1946752|FG000|Overall Study|Protocol Violation|0
952712|NCT01076010|1946753|FG001|Overall Study|Protocol Violation|1
952713|NCT01076010|1946754|FG002|Overall Study|Protocol Violation|0
952714|NCT01076010|1946752|FG000|Overall Study|Noncompliance|1
952715|NCT01076010|1946753|FG001|Overall Study|Noncompliance|1
952716|NCT01076010|1946754|FG002|Overall Study|Noncompliance|0
952717|NCT01076010|1946752|FG000|Overall Study|Withdrawal by Subject|3
952718|NCT01076010|1946753|FG001|Overall Study|Withdrawal by Subject|0
952719|NCT01076010|1946754|FG002|Overall Study|Withdrawal by Subject|1
952720|NCT01076010|1946752|FG000|Overall Study|Other|5
952721|NCT01076010|1946753|FG001|Overall Study|Other|2
952722|NCT01076010|1946754|FG002|Overall Study|Other|0
952723|NCT01076036|1946762|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2
952724|NCT01076075|1946783|FG000|Overall Study|Adverse Event|3
952725|NCT01076075|1946784|FG001|Overall Study|Adverse Event|9
952726|NCT01076075|1946783|FG000|Overall Study|Lack of Efficacy|5
952727|NCT01076075|1946784|FG001|Overall Study|Lack of Efficacy|4
952728|NCT01076075|1946783|FG000|Overall Study|Lost to Follow-up|6
952729|NCT01076075|1946784|FG001|Overall Study|Lost to Follow-up|5
952730|NCT01076075|1946783|FG000|Overall Study|other|19
952731|NCT01076075|1946784|FG001|Overall Study|other|9
952732|NCT01076075|1946783|FG000|Overall Study|Protocol Violation|0
952733|NCT01076075|1946784|FG001|Overall Study|Protocol Violation|1
952734|NCT01076075|1946783|FG000|Overall Study|Withdrawal by Subject|8
952735|NCT01076075|1946784|FG001|Overall Study|Withdrawal by Subject|19
952736|NCT01076088|1946799|FG000|Overall Study|Adverse Event|1
952737|NCT01076088|1946800|FG001|Overall Study|Adverse Event|6
952738|NCT01076088|1946801|FG002|Overall Study|Adverse Event|3
952739|NCT01076088|1946802|FG003|Overall Study|Adverse Event|2
952740|NCT01076088|1946803|FG004|Overall Study|Adverse Event|3
952741|NCT01076088|1946804|FG005|Overall Study|Adverse Event|3
952742|NCT01076088|1946799|FG000|Overall Study|Lost to Follow-up|1
952743|NCT01076088|1946800|FG001|Overall Study|Lost to Follow-up|1
952744|NCT01076088|1946801|FG002|Overall Study|Lost to Follow-up|0
952745|NCT01076088|1946802|FG003|Overall Study|Lost to Follow-up|1
952746|NCT01076088|1946803|FG004|Overall Study|Lost to Follow-up|1
952747|NCT01076088|1946804|FG005|Overall Study|Lost to Follow-up|2
952748|NCT01076088|1946799|FG000|Overall Study|Non-compliance with study drug|0
952749|NCT01076088|1946800|FG001|Overall Study|Non-compliance with study drug|0
952750|NCT01076088|1946801|FG002|Overall Study|Non-compliance with study drug|0
952751|NCT01076088|1946802|FG003|Overall Study|Non-compliance with study drug|1
952752|NCT01076088|1946803|FG004|Overall Study|Non-compliance with study drug|0
952753|NCT01076088|1946804|FG005|Overall Study|Non-compliance with study drug|0
952754|NCT01076088|1946799|FG000|Overall Study|Physician Decision|1
952755|NCT01076088|1946800|FG001|Overall Study|Physician Decision|3
952756|NCT01076088|1946801|FG002|Overall Study|Physician Decision|0
952757|NCT01076088|1946802|FG003|Overall Study|Physician Decision|1
952758|NCT01076088|1946803|FG004|Overall Study|Physician Decision|1
952759|NCT01076088|1946804|FG005|Overall Study|Physician Decision|0
952760|NCT01076088|1946799|FG000|Overall Study|Withdrawal by Subject|8
952761|NCT01076088|1946800|FG001|Overall Study|Withdrawal by Subject|8
952762|NCT01076088|1946801|FG002|Overall Study|Withdrawal by Subject|14
952763|NCT01076088|1946802|FG003|Overall Study|Withdrawal by Subject|10
952764|NCT01076088|1946803|FG004|Overall Study|Withdrawal by Subject|11
952765|NCT01076088|1946804|FG005|Overall Study|Withdrawal by Subject|17
952766|NCT01076088|1946799|FG000|Overall Study|Other protocol specified criteria|0
952767|NCT01076088|1946800|FG001|Overall Study|Other protocol specified criteria|0
952768|NCT01076088|1946801|FG002|Overall Study|Other protocol specified criteria|0
952769|NCT01076088|1946802|FG003|Overall Study|Other protocol specified criteria|0
952770|NCT01076088|1946803|FG004|Overall Study|Other protocol specified criteria|0
952771|NCT01076088|1946804|FG005|Overall Study|Other protocol specified criteria|1
952772|NCT01076153|1946819|FG000|Overall Study|Symptoms improved/resolved|10
952773|NCT01076153|1946819|FG000|Overall Study|Adverse Event|1
952774|NCT01076166|1946827|FG000|Overall Study|Adverse Event|3
952775|NCT01076166|1946827|FG000|Overall Study|Symptoms improved/resolved|6
952776|NCT01076179|1946834|FG000|Overall Study|Withdrawal by Subject|1
952777|NCT01076192|1946839|FG000|Overall Study|Other|197
952778|NCT01076205|1946844|FG000|Overall Study|Adverse Drug Reaction|299
952779|NCT01076205|1946844|FG000|Overall Study|Lack of Effectiveness|1423
952780|NCT01076205|1946844|FG000|Overall Study|Other Reason|1075
952781|NCT01076205|1946844|FG000|Overall Study|Unknown Reason|71
952782|NCT01076205|1946844|FG000|Overall Study|Lost to Follow-up|3151
952783|NCT01076335|1946910|FG000|Overall Study|Withdrawal by Subject|3
952784|NCT01076335|1946910|FG000|Overall Study|Withdrawal without treatment|1
952785|NCT01076361|1946918|FG000|Overall Study|22 leads were excluded from analysis|21
952786|NCT01076400|1946922|FG000|Overall Study|Adverse Event|2
952787|NCT01076400|1946923|FG001|Overall Study|Adverse Event|0
952788|NCT01076400|1946924|FG002|Overall Study|Adverse Event|0
952789|NCT01076400|1946922|FG000|Overall Study|Progressive Disease|5
952790|NCT01076400|1946923|FG001|Overall Study|Progressive Disease|0
952791|NCT01076400|1946924|FG002|Overall Study|Progressive Disease|0
952792|NCT01076543|1946947|FG000|Overall Study|Withdrawal by Subject|2
952793|NCT01076543|1946948|FG001|Overall Study|Withdrawal by Subject|0
952794|NCT01076543|1946949|FG002|Overall Study|Withdrawal by Subject|0
952795|NCT01076543|1946950|FG003|Overall Study|Withdrawal by Subject|0
952796|NCT01076543|1946951|FG004|Overall Study|Withdrawal by Subject|0
952797|NCT01076543|1946952|FG005|Overall Study|Withdrawal by Subject|0
952798|NCT01076647|1946969|FG000|Overall Study|Adverse Event|4
952799|NCT01076647|1946970|FG001|Overall Study|Adverse Event|1
952800|NCT01076647|1946969|FG000|Overall Study|Lack of Efficacy|0
952801|NCT01076647|1946970|FG001|Overall Study|Lack of Efficacy|1
952802|NCT01076647|1946969|FG000|Overall Study|Protocol Violation|7
952803|NCT01076647|1946970|FG001|Overall Study|Protocol Violation|9
952804|NCT01076647|1946969|FG000|Overall Study|Withdrawal criteria|2
952805|NCT01076647|1946970|FG001|Overall Study|Withdrawal criteria|2
952806|NCT01076647|1946969|FG000|Overall Study|Unclassified|12
952807|NCT01076647|1946970|FG001|Overall Study|Unclassified|12
952808|NCT01076959|1946993|FG000|Overall Study|Adverse Event|767
952809|NCT01076959|1946993|FG000|Overall Study|Lack of Efficacy|849
952810|NCT01076959|1946993|FG000|Overall Study|Non-compliance|274
952811|NCT01076959|1946993|FG000|Overall Study|Lost to Follow-up|241
952812|NCT01076959|1946993|FG000|Overall Study|Other|119
952813|NCT01077024|1947032|FG000|Overall Study|Lost to Follow-up|20
952814|NCT01077024|1947033|FG001|Overall Study|Lost to Follow-up|14
952815|NCT01077024|1947032|FG000|Overall Study|Withdrawal by Subject|0
952816|NCT01077024|1947033|FG001|Overall Study|Withdrawal by Subject|2
952817|NCT01077024|1947032|FG000|Overall Study|Incarcerated|7
952818|NCT01077024|1947033|FG001|Overall Study|Incarcerated|8
952819|NCT01077024|1947032|FG000|Overall Study|Other|4
952820|NCT01077024|1947033|FG001|Overall Study|Other|4
952821|NCT01077050|1947039|FG000|Overall Study|Subjects signed ICF could not be located|1
952822|NCT01077050|1947039|FG000|Overall Study|Screen failure|8
952823|NCT01077063|1947045|FG000|Overall Study|Adverse Event|3
952824|NCT01077063|1947046|FG001|Overall Study|Adverse Event|0
952825|NCT01077063|1947045|FG000|Overall Study|Death|1
952826|NCT01077063|1947046|FG001|Overall Study|Death|1
952827|NCT01077063|1947045|FG000|Overall Study|Withdrawal by Subject|0
952828|NCT01077063|1947046|FG001|Overall Study|Withdrawal by Subject|2
952829|NCT01077076|1947052|FG000|First Intervention|Withdrawal by Subject|1
952830|NCT01077076|1947053|FG001|First Intervention|Withdrawal by Subject|0
952831|NCT01077076|1947054|FG002|First Intervention|Withdrawal by Subject|0
952832|NCT01077076|1947055|FG003|First Intervention|Withdrawal by Subject|0
952833|NCT01077076|1947056|FG004|First Intervention|Withdrawal by Subject|0
952834|NCT01077076|1947057|FG005|First Intervention|Withdrawal by Subject|0
952835|NCT01077076|1947052|FG000|Third Intervention|Death in the participant's family|0
952836|NCT01077076|1947053|FG001|Third Intervention|Death in the participant's family|0
952837|NCT01077076|1947054|FG002|Third Intervention|Death in the participant's family|0
952838|NCT01077076|1947055|FG003|Third Intervention|Death in the participant's family|0
952839|NCT01077076|1947056|FG004|Third Intervention|Death in the participant's family|0
952840|NCT01077076|1947057|FG005|Third Intervention|Death in the participant's family|1
952841|NCT01077128|1947065|FG000|Overall Study|Adverse Event|8
952842|NCT01077128|1947065|FG000|Overall Study|Lack of Efficacy|1
952843|NCT01077128|1947065|FG000|Overall Study|Disease exacerbation|1
952844|NCT01077128|1947065|FG000|Overall Study|Adverse event and consent withdrawal|1
952845|NCT01077128|1947065|FG000|Overall Study|Adverse event and disease exacerbation|1
952846|NCT01077128|1947065|FG000|Overall Study|Lack of efficacy/disease exacerbation|1
952847|NCT01077128|1947065|FG000|Overall Study|Other|54
952848|NCT01077154|1947121|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524
952849|NCT01077154|1947122|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514
952850|NCT01077154|1947121|FG000|Overall Study|Withdrawal by Subject|369
952851|NCT01077154|1947122|FG001|Overall Study|Withdrawal by Subject|385
952852|NCT01077154|1947121|FG000|Overall Study|Death|215
952853|NCT01077154|1947122|FG001|Overall Study|Death|214
952854|NCT01077154|1947121|FG000|Overall Study|Lost to Follow-up|43
952855|NCT01077154|1947122|FG001|Overall Study|Lost to Follow-up|35
952856|NCT01077154|1947121|FG000|Overall Study|Noncompliance|22
952857|NCT01077154|1947122|FG001|Overall Study|Noncompliance|20
952858|NCT01077154|1947121|FG000|Overall Study|Disease Progression|18
952859|NCT01077154|1947122|FG001|Overall Study|Disease Progression|20
952860|NCT01077154|1947121|FG000|Overall Study|Ineligibility Determined|10
952861|NCT01077154|1947122|FG001|Overall Study|Ineligibility Determined|14
952862|NCT01077154|1947121|FG000|Overall Study|Other|14
952863|NCT01077154|1947122|FG001|Overall Study|Other|11
952864|NCT01077154|1947121|FG000|Overall Study|Adverse Event|9
952865|NCT01077154|1947122|FG001|Overall Study|Adverse Event|9
952866|NCT01077154|1947121|FG000|Overall Study|Administrative Decision|1
952867|NCT01077154|1947122|FG001|Overall Study|Administrative Decision|6
952868|NCT01077154|1947121|FG000|Overall Study|Protocol Deviation|1
952869|NCT01077154|1947122|FG001|Overall Study|Protocol Deviation|0
952870|NCT01077193|1947128|FG000|Overall Study|Lost to Follow-up|1
952871|NCT01077193|1947128|FG000|Overall Study|Withdrawal by Subject|2
952872|NCT01077193|1947128|FG000|Overall Study|Lack of Efficacy|1
952873|NCT01077193|1947128|FG000|Overall Study|Study Terminated by Sponsor|40
952874|NCT01077258|1947132|FG000|Overall Study|Lost to Follow-up|1390
952875|NCT01077258|1947132|FG000|Overall Study|Adverse drug reaction|218
952876|NCT01077258|1947132|FG000|Overall Study|Lack of Efficacy|663
952877|NCT01077258|1947132|FG000|Overall Study|Clinical remission|37
952878|NCT01077258|1947132|FG000|Overall Study|Other reasons|260
952879|NCT01077271|1947149|FG000|Overall Study|Parental desire|8
952880|NCT01077271|1947149|FG000|Overall Study|Screen failure, did not take palivizumab|4
952881|NCT01077271|1947149|FG000|Overall Study|Noncompliance|2
952882|NCT01077271|1947149|FG000|Overall Study|Quota used up (insurance reimb issue)|2
952883|NCT01077271|1947149|FG000|Overall Study|Changed doctors|2
952884|NCT01077271|1947149|FG000|Overall Study|Parents thought too many injections|2
952885|NCT01077271|1947149|FG000|Overall Study|End of RSV season nearly reached|1
952886|NCT01077271|1947149|FG000|Overall Study|Mother unconvinced of the necessity|1
952887|NCT01077284|1947164|FG000|Overall Study|Adverse Event|2
952888|NCT01077284|1947165|FG001|Overall Study|Adverse Event|0
952889|NCT01077284|1947166|FG002|Overall Study|Adverse Event|1
952890|NCT01077284|1947164|FG000|Overall Study|Lost to Follow-up|1
952891|NCT01077284|1947165|FG001|Overall Study|Lost to Follow-up|2
952892|NCT01077284|1947166|FG002|Overall Study|Lost to Follow-up|0
952893|NCT01077284|1947164|FG000|Overall Study|Withdrawal by Subject|2
952894|NCT01077284|1947165|FG001|Overall Study|Withdrawal by Subject|3
952895|NCT01077284|1947166|FG002|Overall Study|Withdrawal by Subject|1
952896|NCT01077284|1947164|FG000|Overall Study|Other|0
952897|NCT01077284|1947165|FG001|Overall Study|Other|0
952898|NCT01077284|1947166|FG002|Overall Study|Other|1
952899|NCT01077323|1947191|FG000|Overall Study|<9 months enroll before drug dispensed|11226
952900|NCT01077323|1947192|FG001|Overall Study|<9 months enroll before drug dispensed|263954
952901|NCT01077323|1947193|FG002|Overall Study|<9 months enroll before drug dispensed|11655523
952902|NCT01077323|1947191|FG000|Overall Study|Dispensing of drug in baseline period|0
952903|NCT01077323|1947192|FG001|Overall Study|Dispensing of drug in baseline period|120229
952904|NCT01077323|1947193|FG002|Overall Study|Dispensing of drug in baseline period|256446
952905|NCT01077323|1947191|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152
952906|NCT01077323|1947192|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080
952907|NCT01077323|1947193|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120
952908|NCT01077362|1947204|FG000|Overall Study|Lack of Efficacy|13
952909|NCT01077362|1947205|FG001|Overall Study|Lack of Efficacy|8
952910|NCT01077362|1947206|FG002|Overall Study|Lack of Efficacy|10
952911|NCT01077362|1947204|FG000|Overall Study|Lost to Follow-up|1
952912|NCT01077362|1947205|FG001|Overall Study|Lost to Follow-up|0
952913|NCT01077362|1947206|FG002|Overall Study|Lost to Follow-up|3
952914|NCT01077362|1947204|FG000|Overall Study|Adverse Event|12
952915|NCT01077362|1947205|FG001|Overall Study|Adverse Event|7
952916|NCT01077362|1947206|FG002|Overall Study|Adverse Event|4
952917|NCT01077362|1947204|FG000|Overall Study|Withdrawal by Subject|5
952918|NCT01077362|1947205|FG001|Overall Study|Withdrawal by Subject|3
952919|NCT01077362|1947206|FG002|Overall Study|Withdrawal by Subject|5
952920|NCT01077362|1947204|FG000|Overall Study|Other|0
952921|NCT01077362|1947205|FG001|Overall Study|Other|1
952922|NCT01077362|1947206|FG002|Overall Study|Other|2
952923|NCT01077375|1947221|FG000|Overall Study|Adverse Event|2
952924|NCT01077375|1947222|FG001|Overall Study|Adverse Event|15
952925|NCT01077375|1947221|FG000|Overall Study|Lack of Efficacy|6
952926|NCT01077375|1947222|FG001|Overall Study|Lack of Efficacy|8
952927|NCT01077375|1947221|FG000|Overall Study|Withdrawal by Subject|0
952928|NCT01077375|1947222|FG001|Overall Study|Withdrawal by Subject|6
952929|NCT01077375|1947221|FG000|Overall Study|Lost to Follow-up|2
952930|NCT01077375|1947222|FG001|Overall Study|Lost to Follow-up|5
952931|NCT01077375|1947221|FG000|Overall Study|Other Reason|0
952932|NCT01077375|1947222|FG001|Overall Study|Other Reason|1
952933|NCT01077518|1947241|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
952934|NCT01077518|1947242|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
952935|NCT01077518|1947243|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
952936|NCT01077518|1947241|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10
952937|NCT01077518|1947242|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11
952938|NCT01077518|1947243|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0
952939|NCT01077518|1947241|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
952940|NCT01077518|1947242|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
952941|NCT01077518|1947243|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
952942|NCT01077518|1947241|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
952943|NCT01077518|1947242|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
952944|NCT01077518|1947243|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
952945|NCT01077518|1947241|FG000|Optional Ofa Phase|Physician Decision|0
952946|NCT01077518|1947242|FG001|Optional Ofa Phase|Physician Decision|0
952947|NCT01077518|1947243|FG002|Optional Ofa Phase|Physician Decision|1
952948|NCT01077518|1947241|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0
952949|NCT01077518|1947242|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0
952950|NCT01077518|1947243|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12
952951|NCT01077518|1947241|FG000|Optional Ofa Phase|Withdrawal by Subject|0
952952|NCT01077518|1947242|FG001|Optional Ofa Phase|Withdrawal by Subject|0
952953|NCT01077518|1947243|FG002|Optional Ofa Phase|Withdrawal by Subject|3
952954|NCT01077544|1947254|FG000|Overall Study|New Cancer Therapy|3
952955|NCT01077544|1947255|FG001|Overall Study|New Cancer Therapy|3
952956|NCT01077544|1947254|FG000|Overall Study|Adverse Event|0
952957|NCT01077544|1947255|FG001|Overall Study|Adverse Event|1
952958|NCT01077544|1947254|FG000|Overall Study|Disease Progression|0
952959|NCT01077544|1947255|FG001|Overall Study|Disease Progression|1
952960|NCT01077622|1947305|FG000|Overall Study|Physician Decision|2
952961|NCT01077622|1947305|FG000|Overall Study|Withdrawal by Subject|1
952962|NCT01077713|1947311|FG000|Overall Study|Withdrawal by Subject|1
952963|NCT01077713|1947312|FG001|Overall Study|Withdrawal by Subject|2
952964|NCT01077713|1947311|FG000|Overall Study|Progressive Disease (PD)|0
952965|NCT01077713|1947312|FG001|Overall Study|Progressive Disease (PD)|1
952966|NCT01077713|1947311|FG000|Overall Study|Death|28
952967|NCT01077713|1947312|FG001|Overall Study|Death|29
952968|NCT01077713|1947311|FG000|Overall Study|Lost to Follow-up|1
952969|NCT01077713|1947312|FG001|Overall Study|Lost to Follow-up|1
952970|NCT01077713|1947311|FG000|Overall Study|Adverse Event|2
952971|NCT01077713|1947312|FG001|Overall Study|Adverse Event|1
952972|NCT01077713|1947311|FG000|Overall Study|Other|4
952973|NCT01077713|1947312|FG001|Overall Study|Other|2
952974|NCT01077739|1947320|FG000|Overall Study|Premature withdrawal|1
952975|NCT01077739|1947321|FG001|Overall Study|Premature withdrawal|3
952976|NCT01077739|1947320|FG000|Overall Study|Withdrawal by Subject|1
952977|NCT01077739|1947321|FG001|Overall Study|Withdrawal by Subject|0
952978|NCT01077739|1947320|FG000|Overall Study|Death|0
952979|NCT01077739|1947321|FG001|Overall Study|Death|3
952980|NCT01077739|1947320|FG000|Overall Study|Unacceptable toxicity|1
952981|NCT01077739|1947321|FG001|Overall Study|Unacceptable toxicity|2
952982|NCT01077739|1947320|FG000|Overall Study|Other|2
952983|NCT01077739|1947321|FG001|Overall Study|Other|2
952984|NCT01077804|1947327|FG000|Overall Study|Unreachable|102
952985|NCT01077804|1947327|FG000|Overall Study|Refused to continue|79
952986|NCT01077804|1947327|FG000|Overall Study|Other|18
952987|NCT01077960|1947406|FG000|Overall Study|Adverse Event|6
952988|NCT01077960|1947406|FG000|Overall Study|Protocol Violation|3
952989|NCT01077960|1947406|FG000|Overall Study|Lost to Follow-up|5
952990|NCT01077960|1947406|FG000|Overall Study|Subject decision|1
952991|NCT01077960|1947406|FG000|Overall Study|Reason unspecified|1
952992|NCT01078090|1947425|FG000|Overall Study|Lost to Follow-up|2363
952993|NCT01078090|1947425|FG000|Overall Study|Adverse drug reaction (ADR)|453
952994|NCT01078090|1947425|FG000|Overall Study|Lack of Efficacy|1193
952995|NCT01078090|1947425|FG000|Overall Study|ADR and lack of efficacy|61
952996|NCT01078090|1947425|FG000|Overall Study|Other|523
952997|NCT01078116|1947443|FG000|Overall Study|Lost to Follow-up|17
952998|NCT01078116|1947443|FG000|Overall Study|Adverse Event|5
952999|NCT01078116|1947443|FG000|Overall Study|Withdrawal by Subject|8
953000|NCT01078116|1947443|FG000|Overall Study|Lack of effectiveness|15
953001|NCT01078116|1947443|FG000|Overall Study|Case report form not completed|3
953002|NCT01078155|1947447|FG000|Overall Study|Adverse Event|7
953003|NCT01078155|1947447|FG000|Overall Study|Lack of Efficacy|16
953004|NCT01078155|1947447|FG000|Overall Study|Participant's Decision|6
953005|NCT01078155|1947447|FG000|Overall Study|Lost to Follow-up|15
953006|NCT01078168|1947453|FG000|Overall Study|Physician Decision|0
953007|NCT01078168|1947454|FG001|Overall Study|Physician Decision|1
953008|NCT01078298|1947513|FG000|Overall Study|Lost to Follow-up|12
953009|NCT01078298|1947514|FG001|Overall Study|Lost to Follow-up|13
953010|NCT01078298|1947513|FG000|Overall Study|Withdrawal by Subject|31
953011|NCT01078298|1947514|FG001|Overall Study|Withdrawal by Subject|33
953012|NCT01078298|1947513|FG000|Overall Study|Protocol Violation|6
953013|NCT01078298|1947514|FG001|Overall Study|Protocol Violation|6
953014|NCT01078298|1947513|FG000|Overall Study|Adverse Event|6
953015|NCT01078298|1947514|FG001|Overall Study|Adverse Event|5
953016|NCT01078298|1947513|FG000|Overall Study|Death|2
953017|NCT01078298|1947514|FG001|Overall Study|Death|0
953018|NCT01078298|1947513|FG000|Overall Study|Did not meet entrance criteria|0
953019|NCT01078298|1947514|FG001|Overall Study|Did not meet entrance criteria|1
953020|NCT01078298|1947513|FG000|Overall Study|Other|24
953021|NCT01078298|1947514|FG001|Overall Study|Other|32
953022|NCT01078389|1947553|FG000|Overall Study|Adverse Event|10
953023|NCT01078389|1947554|FG001|Overall Study|Adverse Event|6
953024|NCT01078389|1947553|FG000|Overall Study|Major Protocol Deviation|2
953025|NCT01078389|1947554|FG001|Overall Study|Major Protocol Deviation|0
953026|NCT01078389|1947553|FG000|Overall Study|Lost to Follow-up|23
953027|NCT01078389|1947554|FG001|Overall Study|Lost to Follow-up|23
953028|NCT01078389|1947553|FG000|Overall Study|Voluntary Withdrawal|20
953029|NCT01078389|1947554|FG001|Overall Study|Voluntary Withdrawal|36
953030|NCT01078389|1947553|FG000|Overall Study|Other|9
953031|NCT01078389|1947554|FG001|Overall Study|Other|2
953032|NCT01078441|1947577|FG000|Overall Study|Withdrawal by Subject|1
953037|NCT01078545|1947590|FG000|Overall Study|Lost to Follow-up|13
953038|NCT01078545|1947590|FG000|Overall Study|Physician Decision|6
953039|NCT01078545|1947590|FG000|Overall Study|Withdrawal by Subject|3
953040|NCT01078545|1947590|FG000|Overall Study|Death|3
953041|NCT01078545|1947590|FG000|Overall Study|Participant moved to another physician|1
953042|NCT01078571|1947607|FG000|Overall Study|Adverse Event|36
953043|NCT01078571|1947607|FG000|Overall Study|Lack of effectiveness|36
953044|NCT01078571|1947607|FG000|Overall Study|Reason not reported|21
953045|NCT01078571|1947607|FG000|Overall Study|Withdrawal by Subject|12
953046|NCT01078571|1947607|FG000|Overall Study|Lost to Follow-up|8
953047|NCT01078571|1947607|FG000|Overall Study|Protocol Violation|2
953048|NCT01078584|1947616|FG000|Overall Study|Final Status Unknown|1073
953049|NCT01078584|1947616|FG000|Overall Study|Lost to Follow-up|670
953050|NCT01078584|1947616|FG000|Overall Study|Non-serious Adverse Event|577
953051|NCT01078584|1947616|FG000|Overall Study|Withdrawal of Consent|244
953052|NCT01078584|1947616|FG000|Overall Study|Physician Withdrew from Study|90
953053|NCT01078584|1947616|FG000|Overall Study|Non-compliance|67
953054|NCT01078584|1947616|FG000|Overall Study|Blood Pressure Controlled|49
953055|NCT01078584|1947616|FG000|Overall Study|Physician Switched Medication|26
953056|NCT01078584|1947616|FG000|Overall Study|Physician Discontinued Patient|12
953057|NCT01078584|1947616|FG000|Overall Study|Lack of Efficacy|98
953058|NCT01078584|1947616|FG000|Overall Study|Protocol Violation|75
953059|NCT01078584|1947616|FG000|Overall Study|Serious Adverse Event|27
953060|NCT01078584|1947616|FG000|Overall Study|Multiple Reasons|2
953061|NCT01078623|1947633|FG000|Treatment Period 1|Adverse Event|1
953062|NCT01078623|1947634|FG001|Treatment Period 1|Adverse Event|1
953063|NCT01078623|1947635|FG002|Treatment Period 1|Adverse Event|1
953064|NCT01078623|1947636|FG003|Treatment Period 1|Adverse Event|0
953065|NCT01078623|1947637|FG004|Treatment Period 1|Adverse Event|0
953066|NCT01078623|1947638|FG005|Treatment Period 1|Adverse Event|0
953067|NCT01078623|1947639|FG006|Treatment Period 1|Adverse Event|1
953068|NCT01078623|1947640|FG007|Treatment Period 1|Adverse Event|0
953069|NCT01078623|1947641|FG008|Treatment Period 1|Adverse Event|1
953070|NCT01078623|1947642|FG009|Treatment Period 1|Adverse Event|1
953071|NCT01078623|1947643|FG010|Treatment Period 1|Adverse Event|0
953072|NCT01078623|1947644|FG011|Treatment Period 1|Adverse Event|0
953073|NCT01078623|1947645|FG012|Treatment Period 1|Adverse Event|0
953074|NCT01078623|1947646|FG013|Treatment Period 1|Adverse Event|0
953075|NCT01078623|1947647|FG014|Treatment Period 1|Adverse Event|0
953076|NCT01078623|1947648|FG015|Treatment Period 1|Adverse Event|0
953077|NCT01078623|1947649|FG016|Treatment Period 1|Adverse Event|0
953078|NCT01078623|1947650|FG017|Treatment Period 1|Adverse Event|0
953079|NCT01078623|1947651|FG018|Treatment Period 1|Adverse Event|0
953080|NCT01078623|1947652|FG019|Treatment Period 1|Adverse Event|0
953081|NCT01078623|1947633|FG000|Treatment Period 1|Withdrawal by Subject|0
953082|NCT01078623|1947634|FG001|Treatment Period 1|Withdrawal by Subject|0
953083|NCT01078623|1947635|FG002|Treatment Period 1|Withdrawal by Subject|0
953084|NCT01078623|1947636|FG003|Treatment Period 1|Withdrawal by Subject|0
953085|NCT01078623|1947637|FG004|Treatment Period 1|Withdrawal by Subject|0
953086|NCT01078623|1947638|FG005|Treatment Period 1|Withdrawal by Subject|0
953087|NCT01078623|1947639|FG006|Treatment Period 1|Withdrawal by Subject|0
953088|NCT01078623|1947640|FG007|Treatment Period 1|Withdrawal by Subject|1
953089|NCT01078623|1947641|FG008|Treatment Period 1|Withdrawal by Subject|0
953090|NCT01078623|1947642|FG009|Treatment Period 1|Withdrawal by Subject|0
953091|NCT01078623|1947643|FG010|Treatment Period 1|Withdrawal by Subject|1
953092|NCT01078623|1947644|FG011|Treatment Period 1|Withdrawal by Subject|0
953093|NCT01078623|1947645|FG012|Treatment Period 1|Withdrawal by Subject|0
953094|NCT01078623|1947646|FG013|Treatment Period 1|Withdrawal by Subject|0
953095|NCT01078623|1947647|FG014|Treatment Period 1|Withdrawal by Subject|0
953096|NCT01078623|1947648|FG015|Treatment Period 1|Withdrawal by Subject|0
953097|NCT01078623|1947649|FG016|Treatment Period 1|Withdrawal by Subject|0
953098|NCT01078623|1947650|FG017|Treatment Period 1|Withdrawal by Subject|0
953099|NCT01078623|1947651|FG018|Treatment Period 1|Withdrawal by Subject|0
953100|NCT01078623|1947652|FG019|Treatment Period 1|Withdrawal by Subject|0
953101|NCT01078623|1947633|FG000|Treatment Period 1|Protocol Violation|0
953102|NCT01078623|1947634|FG001|Treatment Period 1|Protocol Violation|0
953103|NCT01078623|1947635|FG002|Treatment Period 1|Protocol Violation|0
953104|NCT01078623|1947636|FG003|Treatment Period 1|Protocol Violation|0
953105|NCT01078623|1947637|FG004|Treatment Period 1|Protocol Violation|0
953106|NCT01078623|1947638|FG005|Treatment Period 1|Protocol Violation|1
953107|NCT01078623|1947639|FG006|Treatment Period 1|Protocol Violation|0
953108|NCT01078623|1947640|FG007|Treatment Period 1|Protocol Violation|0
953109|NCT01078623|1947641|FG008|Treatment Period 1|Protocol Violation|0
953110|NCT01078623|1947642|FG009|Treatment Period 1|Protocol Violation|0
953111|NCT01078623|1947643|FG010|Treatment Period 1|Protocol Violation|0
953112|NCT01078623|1947644|FG011|Treatment Period 1|Protocol Violation|0
953113|NCT01078623|1947645|FG012|Treatment Period 1|Protocol Violation|0
953114|NCT01078623|1947646|FG013|Treatment Period 1|Protocol Violation|0
953115|NCT01078623|1947647|FG014|Treatment Period 1|Protocol Violation|0
953116|NCT01078623|1947648|FG015|Treatment Period 1|Protocol Violation|0
953117|NCT01078623|1947649|FG016|Treatment Period 1|Protocol Violation|0
953118|NCT01078623|1947650|FG017|Treatment Period 1|Protocol Violation|0
953119|NCT01078623|1947651|FG018|Treatment Period 1|Protocol Violation|0
953120|NCT01078623|1947652|FG019|Treatment Period 1|Protocol Violation|0
953121|NCT01078623|1947633|FG000|Treatment Period 2|Adverse Event|0
953122|NCT01078623|1947634|FG001|Treatment Period 2|Adverse Event|0
953123|NCT01078623|1947635|FG002|Treatment Period 2|Adverse Event|0
953124|NCT01078623|1947636|FG003|Treatment Period 2|Adverse Event|0
953125|NCT01078623|1947637|FG004|Treatment Period 2|Adverse Event|0
953126|NCT01078623|1947638|FG005|Treatment Period 2|Adverse Event|0
953127|NCT01078623|1947639|FG006|Treatment Period 2|Adverse Event|1
953128|NCT01078623|1947640|FG007|Treatment Period 2|Adverse Event|0
953129|NCT01078623|1947641|FG008|Treatment Period 2|Adverse Event|0
953130|NCT01078623|1947642|FG009|Treatment Period 2|Adverse Event|0
953131|NCT01078623|1947643|FG010|Treatment Period 2|Adverse Event|0
953132|NCT01078623|1947644|FG011|Treatment Period 2|Adverse Event|0
953133|NCT01078623|1947645|FG012|Treatment Period 2|Adverse Event|0
953134|NCT01078623|1947646|FG013|Treatment Period 2|Adverse Event|0
953135|NCT01078623|1947647|FG014|Treatment Period 2|Adverse Event|0
953136|NCT01078623|1947648|FG015|Treatment Period 2|Adverse Event|0
953137|NCT01078623|1947649|FG016|Treatment Period 2|Adverse Event|0
953138|NCT01078623|1947650|FG017|Treatment Period 2|Adverse Event|0
953139|NCT01078623|1947651|FG018|Treatment Period 2|Adverse Event|1
953140|NCT01078623|1947652|FG019|Treatment Period 2|Adverse Event|0
953141|NCT01078623|1947633|FG000|Treatment Period 2|Withdrawal by Subject|0
953142|NCT01078623|1947634|FG001|Treatment Period 2|Withdrawal by Subject|0
953143|NCT01078623|1947635|FG002|Treatment Period 2|Withdrawal by Subject|0
953144|NCT01078623|1947636|FG003|Treatment Period 2|Withdrawal by Subject|0
953145|NCT01078623|1947637|FG004|Treatment Period 2|Withdrawal by Subject|0
953146|NCT01078623|1947638|FG005|Treatment Period 2|Withdrawal by Subject|1
953147|NCT01078623|1947639|FG006|Treatment Period 2|Withdrawal by Subject|0
953148|NCT01078623|1947640|FG007|Treatment Period 2|Withdrawal by Subject|0
953149|NCT01078623|1947641|FG008|Treatment Period 2|Withdrawal by Subject|0
953150|NCT01078623|1947642|FG009|Treatment Period 2|Withdrawal by Subject|0
953151|NCT01078623|1947643|FG010|Treatment Period 2|Withdrawal by Subject|0
953152|NCT01078623|1947644|FG011|Treatment Period 2|Withdrawal by Subject|0
953153|NCT01078623|1947645|FG012|Treatment Period 2|Withdrawal by Subject|0
953154|NCT01078623|1947646|FG013|Treatment Period 2|Withdrawal by Subject|0
953155|NCT01078623|1947647|FG014|Treatment Period 2|Withdrawal by Subject|0
953156|NCT01078623|1947648|FG015|Treatment Period 2|Withdrawal by Subject|0
953157|NCT01078623|1947649|FG016|Treatment Period 2|Withdrawal by Subject|0
953158|NCT01078623|1947650|FG017|Treatment Period 2|Withdrawal by Subject|0
953159|NCT01078623|1947651|FG018|Treatment Period 2|Withdrawal by Subject|0
953160|NCT01078623|1947652|FG019|Treatment Period 2|Withdrawal by Subject|0
953161|NCT01078623|1947633|FG000|Treatment Period 3|Adverse Event|0
953162|NCT01078623|1947634|FG001|Treatment Period 3|Adverse Event|0
953163|NCT01078623|1947635|FG002|Treatment Period 3|Adverse Event|0
953164|NCT01078623|1947636|FG003|Treatment Period 3|Adverse Event|0
953165|NCT01078623|1947637|FG004|Treatment Period 3|Adverse Event|1
953166|NCT01078623|1947638|FG005|Treatment Period 3|Adverse Event|0
953167|NCT01078623|1947639|FG006|Treatment Period 3|Adverse Event|0
953168|NCT01078623|1947640|FG007|Treatment Period 3|Adverse Event|0
953169|NCT01078623|1947641|FG008|Treatment Period 3|Adverse Event|0
953170|NCT01078623|1947642|FG009|Treatment Period 3|Adverse Event|0
953171|NCT01078623|1947643|FG010|Treatment Period 3|Adverse Event|0
953172|NCT01078623|1947644|FG011|Treatment Period 3|Adverse Event|0
953173|NCT01078623|1947645|FG012|Treatment Period 3|Adverse Event|0
953174|NCT01078623|1947646|FG013|Treatment Period 3|Adverse Event|1
953175|NCT01078623|1947647|FG014|Treatment Period 3|Adverse Event|0
953176|NCT01078623|1947648|FG015|Treatment Period 3|Adverse Event|0
953177|NCT01078623|1947649|FG016|Treatment Period 3|Adverse Event|0
953178|NCT01078623|1947650|FG017|Treatment Period 3|Adverse Event|0
953179|NCT01078623|1947651|FG018|Treatment Period 3|Adverse Event|0
953180|NCT01078623|1947652|FG019|Treatment Period 3|Adverse Event|0
953181|NCT01078623|1947633|FG000|Treatment Period 4|Adverse Event|0
953182|NCT01078623|1947634|FG001|Treatment Period 4|Adverse Event|0
953183|NCT01078623|1947635|FG002|Treatment Period 4|Adverse Event|1
953184|NCT01078623|1947636|FG003|Treatment Period 4|Adverse Event|0
953185|NCT01078623|1947637|FG004|Treatment Period 4|Adverse Event|0
953186|NCT01078623|1947638|FG005|Treatment Period 4|Adverse Event|0
953187|NCT01078623|1947639|FG006|Treatment Period 4|Adverse Event|0
953188|NCT01078623|1947640|FG007|Treatment Period 4|Adverse Event|0
953189|NCT01078623|1947641|FG008|Treatment Period 4|Adverse Event|0
953190|NCT01078623|1947642|FG009|Treatment Period 4|Adverse Event|0
953191|NCT01078623|1947643|FG010|Treatment Period 4|Adverse Event|0
953192|NCT01078623|1947644|FG011|Treatment Period 4|Adverse Event|0
953193|NCT01078623|1947645|FG012|Treatment Period 4|Adverse Event|0
953194|NCT01078623|1947646|FG013|Treatment Period 4|Adverse Event|0
953195|NCT01078623|1947647|FG014|Treatment Period 4|Adverse Event|0
953196|NCT01078623|1947648|FG015|Treatment Period 4|Adverse Event|0
953197|NCT01078623|1947649|FG016|Treatment Period 4|Adverse Event|0
953198|NCT01078623|1947650|FG017|Treatment Period 4|Adverse Event|0
953199|NCT01078623|1947651|FG018|Treatment Period 4|Adverse Event|0
953200|NCT01078623|1947652|FG019|Treatment Period 4|Adverse Event|0
953201|NCT01078623|1947633|FG000|Treatment Period 4|Withdrawal by Subject|0
953202|NCT01078623|1947634|FG001|Treatment Period 4|Withdrawal by Subject|0
953203|NCT01078623|1947635|FG002|Treatment Period 4|Withdrawal by Subject|0
953204|NCT01078623|1947636|FG003|Treatment Period 4|Withdrawal by Subject|0
953205|NCT01078623|1947637|FG004|Treatment Period 4|Withdrawal by Subject|0
953206|NCT01078623|1947638|FG005|Treatment Period 4|Withdrawal by Subject|0
953207|NCT01078623|1947639|FG006|Treatment Period 4|Withdrawal by Subject|0
953208|NCT01078623|1947640|FG007|Treatment Period 4|Withdrawal by Subject|0
953209|NCT01078623|1947641|FG008|Treatment Period 4|Withdrawal by Subject|0
953210|NCT01078623|1947642|FG009|Treatment Period 4|Withdrawal by Subject|0
953211|NCT01078623|1947643|FG010|Treatment Period 4|Withdrawal by Subject|0
953212|NCT01078623|1947644|FG011|Treatment Period 4|Withdrawal by Subject|0
953213|NCT01078623|1947645|FG012|Treatment Period 4|Withdrawal by Subject|0
953214|NCT01078623|1947646|FG013|Treatment Period 4|Withdrawal by Subject|0
953215|NCT01078623|1947647|FG014|Treatment Period 4|Withdrawal by Subject|0
953216|NCT01078623|1947648|FG015|Treatment Period 4|Withdrawal by Subject|1
953217|NCT01078623|1947649|FG016|Treatment Period 4|Withdrawal by Subject|0
953218|NCT01078623|1947650|FG017|Treatment Period 4|Withdrawal by Subject|0
953219|NCT01078623|1947651|FG018|Treatment Period 4|Withdrawal by Subject|0
953220|NCT01078623|1947652|FG019|Treatment Period 4|Withdrawal by Subject|0
953221|NCT01078662|1947669|FG000|Overall Study|Death|41
953222|NCT01078662|1947670|FG001|Overall Study|Death|103
953223|NCT01078662|1947671|FG002|Overall Study|Death|18
953224|NCT01078662|1947672|FG003|Overall Study|Death|5
953225|NCT01078662|1947673|FG004|Overall Study|Death|8
953226|NCT01078662|1947669|FG000|Overall Study|Patients reached data cut-off|12
953227|NCT01078662|1947670|FG001|Overall Study|Patients reached data cut-off|53
953228|NCT01078662|1947671|FG002|Overall Study|Patients reached data cut-off|2
953229|NCT01078662|1947672|FG003|Overall Study|Patients reached data cut-off|2
953230|NCT01078662|1947673|FG004|Overall Study|Patients reached data cut-off|3
953231|NCT01078662|1947669|FG000|Overall Study|Withdrawal by Subject|4
953232|NCT01078662|1947670|FG001|Overall Study|Withdrawal by Subject|11
953233|NCT01078662|1947671|FG002|Overall Study|Withdrawal by Subject|1
953234|NCT01078662|1947672|FG003|Overall Study|Withdrawal by Subject|0
953235|NCT01078662|1947673|FG004|Overall Study|Withdrawal by Subject|0
953236|NCT01078662|1947669|FG000|Overall Study|Protocol Violation|0
953237|NCT01078662|1947670|FG001|Overall Study|Protocol Violation|1
953238|NCT01078662|1947671|FG002|Overall Study|Protocol Violation|0
953239|NCT01078662|1947672|FG003|Overall Study|Protocol Violation|0
953240|NCT01078662|1947673|FG004|Overall Study|Protocol Violation|0
953241|NCT01078662|1947669|FG000|Overall Study|Lost to Follow-up|1
953242|NCT01078662|1947670|FG001|Overall Study|Lost to Follow-up|0
953243|NCT01078662|1947671|FG002|Overall Study|Lost to Follow-up|0
953244|NCT01078662|1947672|FG003|Overall Study|Lost to Follow-up|0
953245|NCT01078662|1947673|FG004|Overall Study|Lost to Follow-up|0
953246|NCT01078675|1947684|FG000|Overall Study|Withdrawal by Subject|7
953247|NCT01078675|1947685|FG001|Overall Study|Withdrawal by Subject|3
953248|NCT01078675|1947684|FG000|Overall Study|Protocol Violation|56
953249|NCT01078675|1947685|FG001|Overall Study|Protocol Violation|0
953250|NCT01078675|1947684|FG000|Overall Study|Provided in CRF for specific reasons|2
953251|NCT01078675|1947685|FG001|Overall Study|Provided in CRF for specific reasons|3
953252|NCT01078675|1947684|FG000|Overall Study|Adverse Event|3
953253|NCT01078675|1947685|FG001|Overall Study|Adverse Event|0
953254|NCT01078805|1947700|FG000|Overall Study|Clinically significant abnormal lab|5
953255|NCT01078805|1947700|FG000|Overall Study|Death|134
953256|NCT01078805|1947700|FG000|Overall Study|Lost to Follow-up|676
953257|NCT01078805|1947700|FG000|Overall Study|Physician Decision|169
953258|NCT01078805|1947700|FG000|Overall Study|Serious adverse event|26
953259|NCT01078805|1947700|FG000|Overall Study|Sponsor decision|46
953260|NCT01078805|1947700|FG000|Overall Study|Withdrawal by Subject|739
953261|NCT01078805|1947700|FG000|Overall Study|Other|173
953262|NCT01078805|1947700|FG000|Overall Study|Didn't take study drug|82
953263|NCT01078922|1947725|FG000|Overall Study|Adverse Event|1
953264|NCT01078974|1947730|FG000|Overall Study|Adverse Event|3
953265|NCT01079130|1947740|FG000|Overall Study|Adverse Event|1
953266|NCT01079130|1947741|FG001|Overall Study|Adverse Event|1
953267|NCT01079130|1947742|FG002|Overall Study|Adverse Event|0
953268|NCT01079130|1947743|FG003|Overall Study|Adverse Event|1
953269|NCT01079130|1947744|FG004|Overall Study|Adverse Event|5
953270|NCT01079130|1947745|FG005|Overall Study|Adverse Event|1
953271|NCT01079130|1947740|FG000|Overall Study|Administrative problems|1
953272|NCT01079130|1947741|FG001|Overall Study|Administrative problems|3
953273|NCT01079130|1947742|FG002|Overall Study|Administrative problems|0
953274|NCT01079130|1947743|FG003|Overall Study|Administrative problems|0
953275|NCT01079130|1947744|FG004|Overall Study|Administrative problems|0
953276|NCT01079130|1947745|FG005|Overall Study|Administrative problems|1
953277|NCT01079130|1947740|FG000|Overall Study|Withdrawal by Subject|0
953278|NCT01079130|1947741|FG001|Overall Study|Withdrawal by Subject|1
953279|NCT01079130|1947742|FG002|Overall Study|Withdrawal by Subject|0
953280|NCT01079130|1947743|FG003|Overall Study|Withdrawal by Subject|0
953281|NCT01079130|1947744|FG004|Overall Study|Withdrawal by Subject|1
953282|NCT01079130|1947745|FG005|Overall Study|Withdrawal by Subject|3
953283|NCT01079130|1947740|FG000|Overall Study|Protocol deviation|0
953284|NCT01079130|1947741|FG001|Overall Study|Protocol deviation|2
953285|NCT01079130|1947742|FG002|Overall Study|Protocol deviation|1
953286|NCT01079130|1947743|FG003|Overall Study|Protocol deviation|2
953287|NCT01079130|1947744|FG004|Overall Study|Protocol deviation|0
953288|NCT01079130|1947745|FG005|Overall Study|Protocol deviation|0
953289|NCT01079130|1947740|FG000|Overall Study|Abnormal test procedure result(s)|0
953290|NCT01079130|1947741|FG001|Overall Study|Abnormal test procedure result(s)|0
953291|NCT01079130|1947742|FG002|Overall Study|Abnormal test procedure result(s)|0
953292|NCT01079130|1947743|FG003|Overall Study|Abnormal test procedure result(s)|0
953293|NCT01079130|1947744|FG004|Overall Study|Abnormal test procedure result(s)|1
953294|NCT01079130|1947745|FG005|Overall Study|Abnormal test procedure result(s)|0
953295|NCT01079130|1947740|FG000|Overall Study|Unsatisfactory therapeutic effect|0
953296|NCT01079130|1947741|FG001|Overall Study|Unsatisfactory therapeutic effect|0
953297|NCT01079130|1947742|FG002|Overall Study|Unsatisfactory therapeutic effect|0
953298|NCT01079130|1947743|FG003|Overall Study|Unsatisfactory therapeutic effect|2
953299|NCT01079130|1947744|FG004|Overall Study|Unsatisfactory therapeutic effect|0
953300|NCT01079130|1947745|FG005|Overall Study|Unsatisfactory therapeutic effect|0
953301|NCT01079130|1947740|FG000|Overall Study|Lost to Follow-up|0
953302|NCT01079130|1947741|FG001|Overall Study|Lost to Follow-up|0
953303|NCT01079130|1947742|FG002|Overall Study|Lost to Follow-up|0
953304|NCT01079130|1947743|FG003|Overall Study|Lost to Follow-up|0
953305|NCT01079130|1947744|FG004|Overall Study|Lost to Follow-up|1
953306|NCT01079130|1947745|FG005|Overall Study|Lost to Follow-up|0
953307|NCT01079182|1947780|FG000|Overall Study|Lost to Follow-up|1634
953308|NCT01079182|1947780|FG000|Overall Study|Adverse Drug Reaction (ADR)|261
953309|NCT01079182|1947780|FG000|Overall Study|Lack of Efficacy|514
953310|NCT01079182|1947780|FG000|Overall Study|ADR and Lack of Effectiveness|39
953311|NCT01079182|1947780|FG000|Overall Study|Reasons not Evaluated|271
953312|NCT01079195|1947784|FG000|Overall Study|No Documentation of Tarka Therapy|739
953313|NCT01079195|1947784|FG000|Overall Study|No Documentation Available|437
953314|NCT01079195|1947784|FG000|Overall Study|Adverse Event|157
953315|NCT01079195|1947784|FG000|Overall Study|Reason Unknown|39
953316|NCT01079195|1947784|FG000|Overall Study|Withdrawal by Subject|18
953317|NCT01079195|1947784|FG000|Overall Study|Financial Reasons|15
953318|NCT01079195|1947784|FG000|Overall Study|Lack of Effectiveness|12
953319|NCT01079195|1947784|FG000|Overall Study|Physician Decision|4
953320|NCT01079195|1947784|FG000|Overall Study|Improved Status of Participant|4
953321|NCT01079195|1947784|FG000|Overall Study|No Follow-up Documentation Available|4
953322|NCT01079195|1947784|FG000|Overall Study|Non-compliance|2
953323|NCT01079234|1947791|FG000|Main: Week 0 to 26|Adverse Event|5
953324|NCT01079234|1947792|FG001|Main: Week 0 to 26|Adverse Event|4
953325|NCT01079234|1947793|FG002|Main: Week 0 to 26|Adverse Event|1
953326|NCT01079234|1947794|FG003|Main: Week 0 to 26|Adverse Event|0
953327|NCT01079234|1947791|FG000|Main: Week 0 to 26|Lack of Efficacy|2
953328|NCT01079234|1947792|FG001|Main: Week 0 to 26|Lack of Efficacy|1
953329|NCT01079234|1947793|FG002|Main: Week 0 to 26|Lack of Efficacy|1
953330|NCT01079234|1947794|FG003|Main: Week 0 to 26|Lack of Efficacy|0
953331|NCT01079234|1947791|FG000|Main: Week 0 to 26|Protocol Violation|6
953332|NCT01079234|1947792|FG001|Main: Week 0 to 26|Protocol Violation|2
953333|NCT01079234|1947793|FG002|Main: Week 0 to 26|Protocol Violation|4
953334|NCT01079234|1947794|FG003|Main: Week 0 to 26|Protocol Violation|0
953335|NCT01079234|1947791|FG000|Main: Week 0 to 26|Withdrawal criteria|6
953336|NCT01079234|1947792|FG001|Main: Week 0 to 26|Withdrawal criteria|6
953337|NCT01079234|1947793|FG002|Main: Week 0 to 26|Withdrawal criteria|2
953338|NCT01079234|1947794|FG003|Main: Week 0 to 26|Withdrawal criteria|0
953339|NCT01079234|1947791|FG000|Main: Week 0 to 26|Unclassified|7
953340|NCT01079234|1947792|FG001|Main: Week 0 to 26|Unclassified|13
953341|NCT01079234|1947793|FG002|Main: Week 0 to 26|Unclassified|4
953342|NCT01079234|1947794|FG003|Main: Week 0 to 26|Unclassified|0
953343|NCT01079234|1947791|FG000|Extension: Week 27 to 52|Adverse Event|0
953344|NCT01079234|1947792|FG001|Extension: Week 27 to 52|Adverse Event|0
953345|NCT01079234|1947793|FG002|Extension: Week 27 to 52|Adverse Event|1
953346|NCT01079234|1947794|FG003|Extension: Week 27 to 52|Adverse Event|0
953347|NCT01079234|1947791|FG000|Extension: Week 27 to 52|Lack of Efficacy|0
953348|NCT01079234|1947792|FG001|Extension: Week 27 to 52|Lack of Efficacy|0
953349|NCT01079234|1947793|FG002|Extension: Week 27 to 52|Lack of Efficacy|0
953350|NCT01079234|1947794|FG003|Extension: Week 27 to 52|Lack of Efficacy|2
953351|NCT01079234|1947791|FG000|Extension: Week 27 to 52|Protocol Violation|0
953352|NCT01079234|1947792|FG001|Extension: Week 27 to 52|Protocol Violation|0
953353|NCT01079234|1947793|FG002|Extension: Week 27 to 52|Protocol Violation|2
953354|NCT01079234|1947794|FG003|Extension: Week 27 to 52|Protocol Violation|5
953355|NCT01079234|1947791|FG000|Extension: Week 27 to 52|Withdrawal criteria|0
953356|NCT01079234|1947792|FG001|Extension: Week 27 to 52|Withdrawal criteria|0
953357|NCT01079234|1947793|FG002|Extension: Week 27 to 52|Withdrawal criteria|4
953358|NCT01079234|1947794|FG003|Extension: Week 27 to 52|Withdrawal criteria|2
953359|NCT01079234|1947791|FG000|Extension: Week 27 to 52|Unclassified|0
953360|NCT01079234|1947792|FG001|Extension: Week 27 to 52|Unclassified|0
953361|NCT01079234|1947793|FG002|Extension: Week 27 to 52|Unclassified|4
953362|NCT01079234|1947794|FG003|Extension: Week 27 to 52|Unclassified|7
953363|NCT01079663|1947829|FG000|Overall Study|Adverse Event|0
953364|NCT01079663|1947830|FG001|Overall Study|Adverse Event|2
953365|NCT01079663|1947829|FG000|Overall Study|Protocol Violation|0
953366|NCT01079663|1947830|FG001|Overall Study|Protocol Violation|2
953367|NCT01079741|1947841|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
953368|NCT01079741|1947842|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
953369|NCT01079741|1947843|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
953370|NCT01079741|1947844|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
953371|NCT01079741|1947845|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
953372|NCT01079741|1947841|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
953373|NCT01079741|1947842|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
953374|NCT01079741|1947843|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
953375|NCT01079741|1947844|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
953376|NCT01079741|1947845|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
953377|NCT01079806|1947859|FG000|Day 1 to Week 96|Adverse Event|0
953378|NCT01079806|1947860|FG001|Day 1 to Week 96|Adverse Event|3
953379|NCT01079806|1947859|FG000|Day 1 to Week 96|Withdrawal by Subject|3
953380|NCT01079806|1947860|FG001|Day 1 to Week 96|Withdrawal by Subject|2
953381|NCT01079806|1947859|FG000|Day 1 to Week 96|Pregnancy|0
953382|NCT01079806|1947860|FG001|Day 1 to Week 96|Pregnancy|1
953383|NCT01079806|1947859|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2
953384|NCT01079806|1947860|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0
953385|NCT01079806|1947859|FG000|Day 1 to Week 96|Lost to Follow-up|1
953386|NCT01079806|1947860|FG001|Day 1 to Week 96|Lost to Follow-up|0
953387|NCT01079806|1947859|FG000|Day 1 to Week 96|Subject request to stop study treatment|1
953388|NCT01079806|1947860|FG001|Day 1 to Week 96|Subject request to stop study treatment|0
953389|NCT01079806|1947859|FG000|Day 1 to Week 96|Removal by Medical Monitor|0
953390|NCT01079806|1947860|FG001|Day 1 to Week 96|Removal by Medical Monitor|1
953391|NCT01079806|1947859|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
953392|NCT01079806|1947860|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
953393|NCT01079806|1947859|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
953394|NCT01079806|1947860|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
953395|NCT01079806|1947859|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
953396|NCT01079806|1947860|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
953397|NCT01079832|1947868|FG000|Overall Study|Withdrawal by Subject|1
953398|NCT01079936|1947876|FG000|Phase I: MTD|First Remission Status|2
953399|NCT01079936|1947877|FG001|Phase I: MTD|First Remission Status|0
953400|NCT01079936|1947878|FG002|Phase I: MTD|First Remission Status|0
953401|NCT01079936|1947879|FG003|Phase I: MTD|First Remission Status|0
953402|NCT01079936|1947880|FG004|Phase I: MTD|First Remission Status|0
953403|NCT01079936|1947876|FG000|Phase I: MTD|No Stem Cell Transplantation|2
953404|NCT01079936|1947877|FG001|Phase I: MTD|No Stem Cell Transplantation|0
953405|NCT01079936|1947878|FG002|Phase I: MTD|No Stem Cell Transplantation|0
953406|NCT01079936|1947879|FG003|Phase I: MTD|No Stem Cell Transplantation|0
953407|NCT01079936|1947880|FG004|Phase I: MTD|No Stem Cell Transplantation|0
953408|NCT01079936|1947876|FG000|Phase II|Adverse Event|0
953409|NCT01079936|1947877|FG001|Phase II|Adverse Event|0
953410|NCT01079936|1947878|FG002|Phase II|Adverse Event|1
953411|NCT01079936|1947879|FG003|Phase II|Adverse Event|0
953412|NCT01079936|1947880|FG004|Phase II|Adverse Event|0
953413|NCT01079936|1947876|FG000|Phase II|Insurance Issue|0
953414|NCT01079936|1947877|FG001|Phase II|Insurance Issue|0
953415|NCT01079936|1947878|FG002|Phase II|Insurance Issue|0
953416|NCT01079936|1947879|FG003|Phase II|Insurance Issue|0
953417|NCT01079936|1947880|FG004|Phase II|Insurance Issue|1
953418|NCT01079949|1947893|FG000|Overall Study|Withdrawal before r-hCG administration|2
953419|NCT01079949|1947894|FG001|Overall Study|Withdrawal before r-hCG administration|3
953420|NCT01079949|1947893|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
953421|NCT01079949|1947894|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
953422|NCT01079949|1947893|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8
953423|NCT01079949|1947894|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
953424|NCT01079949|1947893|FG000|Overall Study|Randomized but not treated|1
953425|NCT01079949|1947894|FG001|Overall Study|Randomized but not treated|0
953426|NCT01079962|1947902|FG000|Overall Study|Adverse Event|2
953427|NCT01079962|1947903|FG001|Overall Study|Adverse Event|2
953428|NCT01079962|1947902|FG000|Overall Study|Withdrawal by Subject|5
953429|NCT01079962|1947903|FG001|Overall Study|Withdrawal by Subject|7
953430|NCT01079962|1947902|FG000|Overall Study|Protocol Violation|2
953431|NCT01079962|1947903|FG001|Overall Study|Protocol Violation|2
953432|NCT01079962|1947902|FG000|Overall Study|No blood pressure (BP) control|3
953433|NCT01079962|1947903|FG001|Overall Study|No blood pressure (BP) control|0
953434|NCT01079962|1947902|FG000|Overall Study|Inclusion/exclusion criteria|1
953435|NCT01079962|1947903|FG001|Overall Study|Inclusion/exclusion criteria|3
953436|NCT01079962|1947902|FG000|Overall Study|Participant not returning for next visit|1
953437|NCT01079962|1947903|FG001|Overall Study|Participant not returning for next visit|0
953438|NCT01079962|1947902|FG000|Overall Study|Due to arrhythmia/bradycardia|1
953439|NCT01079962|1947903|FG001|Overall Study|Due to arrhythmia/bradycardia|1
953440|NCT01079988|1947914|FG000|Overall Study|Lost to Follow-up|0
953441|NCT01079988|1947915|FG001|Overall Study|Lost to Follow-up|0
953442|NCT01079988|1947916|FG002|Overall Study|Lost to Follow-up|0
953443|NCT01079988|1947917|FG003|Overall Study|Lost to Follow-up|1
953444|NCT01079988|1947918|FG004|Overall Study|Lost to Follow-up|0
953445|NCT01079988|1947914|FG000|Overall Study|Lack of Efficacy|1
953446|NCT01079988|1947915|FG001|Overall Study|Lack of Efficacy|0
953447|NCT01079988|1947916|FG002|Overall Study|Lack of Efficacy|0
953448|NCT01079988|1947917|FG003|Overall Study|Lack of Efficacy|0
953449|NCT01079988|1947918|FG004|Overall Study|Lack of Efficacy|0
953450|NCT01079988|1947914|FG000|Overall Study|Other|0
953451|NCT01079988|1947915|FG001|Overall Study|Other|0
953452|NCT01079988|1947916|FG002|Overall Study|Other|0
953453|NCT01079988|1947917|FG003|Overall Study|Other|2
953454|NCT01079988|1947918|FG004|Overall Study|Other|1
953455|NCT01080131|1947943|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
953456|NCT01080131|1947944|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
953457|NCT01080131|1947943|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6
953458|NCT01080131|1947944|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4
953459|NCT01080131|1947943|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5
953460|NCT01080131|1947944|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3
953461|NCT01080131|1947943|FG000|Core Study (0- 12 Weeks)|Administrative problems|0
953462|NCT01080131|1947944|FG001|Core Study (0- 12 Weeks)|Administrative problems|1
953463|NCT01080131|1947943|FG000|Core Study (0- 12 Weeks)|Death|1
953464|NCT01080131|1947944|FG001|Core Study (0- 12 Weeks)|Death|0
953465|NCT01080131|1947943|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0
953466|NCT01080131|1947944|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2
953467|NCT01080131|1947943|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
953468|NCT01080131|1947944|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
953469|NCT01080131|1947943|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
953470|NCT01080131|1947944|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
953471|NCT01080131|1947943|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
953472|NCT01080131|1947944|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
953473|NCT01080131|1947943|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
953474|NCT01080131|1947944|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
953475|NCT01080131|1947943|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1
953476|NCT01080131|1947944|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2
953477|NCT01080131|1947943|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
953478|NCT01080131|1947944|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
953479|NCT01080131|1947943|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
953480|NCT01080131|1947944|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
953481|NCT01080300|1948018|FG000|Overall Study|Adverse Event|49
953482|NCT01080300|1948019|FG001|Overall Study|Adverse Event|35
953483|NCT01080300|1948018|FG000|Overall Study|Lack of Efficacy|12
953484|NCT01080300|1948019|FG001|Overall Study|Lack of Efficacy|15
953485|NCT01080300|1948018|FG000|Overall Study|Protocol Violation|7
953486|NCT01080300|1948019|FG001|Overall Study|Protocol Violation|13
953487|NCT01080300|1948018|FG000|Overall Study|Lost to Follow-up|10
953488|NCT01080300|1948019|FG001|Overall Study|Lost to Follow-up|6
953489|NCT01080300|1948018|FG000|Overall Study|Death|0
953490|NCT01080300|1948019|FG001|Overall Study|Death|1
953491|NCT01080300|1948018|FG000|Overall Study|Withdrawal by Subject|12
953492|NCT01080300|1948019|FG001|Overall Study|Withdrawal by Subject|28
953493|NCT01080300|1948018|FG000|Overall Study|Reasons not specified|4
953494|NCT01080300|1948019|FG001|Overall Study|Reasons not specified|6
953495|NCT01080326|1948027|FG000|Overall Study|Patient deterioration prior to procedure|3
953496|NCT01080326|1948027|FG000|Overall Study|Surgeon decision|1
953497|NCT01080391|1948033|FG000|Overall Study|Randomized but not treated|7
953498|NCT01080391|1948034|FG001|Overall Study|Randomized but not treated|4
953499|NCT01080625|1948043|FG000|Overall Study|Physician Decision|0
953500|NCT01080625|1948044|FG001|Overall Study|Physician Decision|2
953501|NCT01080625|1948045|FG002|Overall Study|Physician Decision|1
953502|NCT01080716|1948070|FG000|Part 1|Physician Decision|1
953503|NCT01080716|1948071|FG001|Part 1|Physician Decision|0
953504|NCT01080716|1948072|FG002|Part 1|Physician Decision|0
953505|NCT01080716|1948073|FG003|Part 1|Physician Decision|0
953506|NCT01080807|1948106|FG000|Overall Study|Adverse Event|9
953507|NCT01080807|1948107|FG001|Overall Study|Adverse Event|1
953508|NCT01080807|1948106|FG000|Overall Study|Lack of Efficacy|0
953509|NCT01080807|1948107|FG001|Overall Study|Lack of Efficacy|1
953510|NCT01080807|1948106|FG000|Overall Study|Withdrawal by Subject|7
953511|NCT01080807|1948107|FG001|Overall Study|Withdrawal by Subject|2
953512|NCT01080807|1948106|FG000|Overall Study|Protocol Violation|7
953513|NCT01080807|1948107|FG001|Overall Study|Protocol Violation|6
953514|NCT01080807|1948106|FG000|Overall Study|Lost to Follow-up|6
953515|NCT01080807|1948107|FG001|Overall Study|Lost to Follow-up|4
953516|NCT01080807|1948106|FG000|Overall Study|Noncompliance with drug administration|1
953517|NCT01080807|1948107|FG001|Overall Study|Noncompliance with drug administration|1
953518|NCT01080807|1948106|FG000|Overall Study|Noncompliance to study procedures|1
953519|NCT01080807|1948107|FG001|Overall Study|Noncompliance to study procedures|1
953520|NCT01080807|1948106|FG000|Overall Study|Began working day shift|0
953521|NCT01080807|1948107|FG001|Overall Study|Began working day shift|2
953522|NCT01080807|1948106|FG000|Overall Study|Laid off or terminated from job|1
953523|NCT01080807|1948107|FG001|Overall Study|Laid off or terminated from job|2
953524|NCT01080807|1948106|FG000|Overall Study|Stopped working consistent night shifts|0
953525|NCT01080807|1948107|FG001|Overall Study|Stopped working consistent night shifts|1
953526|NCT01080807|1948106|FG000|Overall Study|Work schedule changing|1
953527|NCT01080807|1948107|FG001|Overall Study|Work schedule changing|1
953528|NCT01080807|1948106|FG000|Overall Study|Work schedule and travel|0
953529|NCT01080807|1948107|FG001|Overall Study|Work schedule and travel|1
953530|NCT01080807|1948106|FG000|Overall Study|Switched to first shift|1
953531|NCT01080807|1948107|FG001|Overall Study|Switched to first shift|0
953532|NCT01080807|1948106|FG000|Overall Study|Moved away without notifying center|1
953533|NCT01080807|1948107|FG001|Overall Study|Moved away without notifying center|0
953534|NCT01081132|1948142|FG000|Overall Study|Lack of Efficacy|25
953535|NCT01081132|1948143|FG001|Overall Study|Lack of Efficacy|9
953536|NCT01081132|1948142|FG000|Overall Study|Withdrawal by Subject|13
953537|NCT01081132|1948143|FG001|Overall Study|Withdrawal by Subject|16
953538|NCT01081132|1948142|FG000|Overall Study|Lost to Follow-up|4
953539|NCT01081132|1948143|FG001|Overall Study|Lost to Follow-up|11
953540|NCT01081132|1948142|FG000|Overall Study|Adverse Event|3
953541|NCT01081132|1948143|FG001|Overall Study|Adverse Event|9
953542|NCT01081132|1948142|FG000|Overall Study|Non Compliance|4
953543|NCT01081132|1948143|FG001|Overall Study|Non Compliance|2
953544|NCT01081132|1948142|FG000|Overall Study|Lack Of Compliance|0
953545|NCT01081132|1948143|FG001|Overall Study|Lack Of Compliance|1
953546|NCT01081132|1948142|FG000|Overall Study|Missed Visits|1
953547|NCT01081132|1948143|FG001|Overall Study|Missed Visits|1
953548|NCT01081132|1948142|FG000|Overall Study|Stopped Taking Meds|2
953549|NCT01081132|1948143|FG001|Overall Study|Stopped Taking Meds|0
953550|NCT01081132|1948142|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0
953551|NCT01081132|1948143|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1
953552|NCT01081132|1948142|FG000|Overall Study|Declined Taper Phase|0
953553|NCT01081132|1948143|FG001|Overall Study|Declined Taper Phase|1
953554|NCT01081132|1948142|FG000|Overall Study|Protocol Violation|3
953555|NCT01081132|1948143|FG001|Overall Study|Protocol Violation|1
953556|NCT01081145|1948149|FG000|Open-Label Phase|Lack of Efficacy|56
953557|NCT01081145|1948150|FG001|Open-Label Phase|Lack of Efficacy|0
953558|NCT01081145|1948149|FG000|Open-Label Phase|Response criteria not met|46
953559|NCT01081145|1948150|FG001|Open-Label Phase|Response criteria not met|0
953560|NCT01081145|1948149|FG000|Open-Label Phase|Adverse Event|42
953561|NCT01081145|1948150|FG001|Open-Label Phase|Adverse Event|0
953562|NCT01081145|1948149|FG000|Open-Label Phase|Withdrawal by Subject|41
953563|NCT01081145|1948150|FG001|Open-Label Phase|Withdrawal by Subject|0
953564|NCT01081145|1948149|FG000|Open-Label Phase|Other|12
953565|NCT01081145|1948150|FG001|Open-Label Phase|Other|0
953566|NCT01081145|1948149|FG000|Open-Label Phase|Lost to Follow-up|11
953567|NCT01081145|1948150|FG001|Open-Label Phase|Lost to Follow-up|0
911000|NCT00796120|1888117|FG001|Overall Study|Physician Decision|17
953568|NCT01081145|1948149|FG000|Open-Label Phase|Protocol Violation|4
953569|NCT01081145|1948150|FG001|Open-Label Phase|Protocol Violation|0
953570|NCT01081145|1948149|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
953571|NCT01081145|1948150|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
953572|NCT01081145|1948149|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
953573|NCT01081145|1948150|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
953574|NCT01081145|1948149|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
953575|NCT01081145|1948150|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
953576|NCT01081145|1948149|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
953577|NCT01081145|1948150|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
953578|NCT01081145|1948149|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
953579|NCT01081145|1948150|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
953580|NCT01081145|1948149|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
953581|NCT01081145|1948150|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
953582|NCT01081145|1948149|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4
953583|NCT01081145|1948150|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3
953584|NCT01081249|1948158|FG000|Overall Study|Diagnosed with Bipolar Disorder|0
953585|NCT01081249|1948159|FG001|Overall Study|Diagnosed with Bipolar Disorder|1
953586|NCT01081301|1948182|FG000|Overall Study|Bereaved|3
953587|NCT01081301|1948182|FG000|Overall Study|Too busy|5
953588|NCT01081301|1948182|FG000|Overall Study|Patient too ill|2
953589|NCT01081301|1948182|FG000|Overall Study|Lost to Follow-up|4
953590|NCT01081626|1948205|FG000|Overall Study|Dosing error|1
953591|NCT01081626|1948206|FG001|Overall Study|Dosing error|1
953592|NCT01081626|1948205|FG000|Overall Study|Missing Estradiol|25
953593|NCT01081626|1948206|FG001|Overall Study|Missing Estradiol|28
953594|NCT01081626|1948205|FG000|Overall Study|Low antral follicle count|1
953595|NCT01081626|1948206|FG001|Overall Study|Low antral follicle count|0
953596|NCT01081626|1948205|FG000|Overall Study|Overstimulation|0
953597|NCT01081626|1948206|FG001|Overall Study|Overstimulation|1
953598|NCT01081626|1948205|FG000|Overall Study|Lost to Follow-up|0
953599|NCT01081626|1948206|FG001|Overall Study|Lost to Follow-up|1
953600|NCT01081626|1948205|FG000|Overall Study|Other|33
953601|NCT01081626|1948206|FG001|Overall Study|Other|30
953602|NCT01081665|1948212|FG000|Overall Study|Death|41
953603|NCT01081665|1948212|FG000|Overall Study|Lost to Follow-up|18
953604|NCT01081665|1948212|FG000|Overall Study|Withdrawal by Subject|17
953605|NCT01081665|1948212|FG000|Overall Study|Change of dialysis unit|10
953606|NCT01081665|1948212|FG000|Overall Study|Regulation of iPTH|5
953607|NCT01081665|1948212|FG000|Overall Study|Change in renal replacement therapy|2
953608|NCT01081665|1948212|FG000|Overall Study|Adverse Event|1
953609|NCT01081665|1948212|FG000|Overall Study|Lack of Efficacy|1
953610|NCT01081678|1948220|FG000|Overall Study|Ineligibility Determined|0
953611|NCT01081678|1948221|FG001|Overall Study|Ineligibility Determined|0
953612|NCT01081678|1948222|FG002|Overall Study|Ineligibility Determined|1
953613|NCT01081678|1948223|FG003|Overall Study|Ineligibility Determined|1
953614|NCT01081678|1948220|FG000|Overall Study|Noncompliance|3
953615|NCT01081678|1948221|FG001|Overall Study|Noncompliance|4
953616|NCT01081678|1948222|FG002|Overall Study|Noncompliance|5
953617|NCT01081678|1948223|FG003|Overall Study|Noncompliance|2
953618|NCT01081678|1948220|FG000|Overall Study|Adverse Event|2
953619|NCT01081678|1948221|FG001|Overall Study|Adverse Event|1
953620|NCT01081678|1948222|FG002|Overall Study|Adverse Event|2
953621|NCT01081678|1948223|FG003|Overall Study|Adverse Event|2
953622|NCT01081678|1948220|FG000|Overall Study|Withdrawal by Subject|15
953623|NCT01081678|1948221|FG001|Overall Study|Withdrawal by Subject|7
953624|NCT01081678|1948222|FG002|Overall Study|Withdrawal by Subject|17
953625|NCT01081678|1948223|FG003|Overall Study|Withdrawal by Subject|14
953626|NCT01081678|1948220|FG000|Overall Study|Administrative Decision|1
953627|NCT01081678|1948221|FG001|Overall Study|Administrative Decision|0
953628|NCT01081678|1948222|FG002|Overall Study|Administrative Decision|0
953629|NCT01081678|1948223|FG003|Overall Study|Administrative Decision|1
953630|NCT01081678|1948220|FG000|Overall Study|Lost to Follow-up|4
953631|NCT01081678|1948221|FG001|Overall Study|Lost to Follow-up|1
953632|NCT01081678|1948222|FG002|Overall Study|Lost to Follow-up|4
953633|NCT01081678|1948223|FG003|Overall Study|Lost to Follow-up|3
953634|NCT01081678|1948220|FG000|Overall Study|Death|2
953635|NCT01081678|1948221|FG001|Overall Study|Death|2
953636|NCT01081678|1948222|FG002|Overall Study|Death|2
953637|NCT01081678|1948223|FG003|Overall Study|Death|6
953638|NCT01081678|1948220|FG000|Overall Study|Other|0
953639|NCT01081678|1948221|FG001|Overall Study|Other|1
953640|NCT01081678|1948222|FG002|Overall Study|Other|0
953641|NCT01081678|1948223|FG003|Overall Study|Other|0
953642|NCT01081769|1948235|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10
953643|NCT01081769|1948236|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12
953644|NCT01081769|1948235|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
953645|NCT01081769|1948236|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
953646|NCT01081769|1948235|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
953647|NCT01081769|1948236|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
1090773|NCT02248818|2158520|FG002|Screening|Withdrawal by Subject|0
953648|NCT01081769|1948235|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
953649|NCT01081769|1948236|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
953650|NCT01081769|1948235|FG000|CORE Intent-To-Treat|Adverse Event|14
953651|NCT01081769|1948236|FG001|CORE Intent-To-Treat|Adverse Event|11
953652|NCT01081769|1948235|FG000|CORE Intent-To-Treat|Death|1
953653|NCT01081769|1948236|FG001|CORE Intent-To-Treat|Death|1
953654|NCT01081769|1948235|FG000|CORE Intent-To-Treat|Lack of Efficacy|2
953655|NCT01081769|1948236|FG001|CORE Intent-To-Treat|Lack of Efficacy|6
953656|NCT01081769|1948235|FG000|CORE Intent-To-Treat|Lost to Follow-up|4
953657|NCT01081769|1948236|FG001|CORE Intent-To-Treat|Lost to Follow-up|5
953658|NCT01081769|1948235|FG000|CORE Intent-To-Treat|Pregnancy|1
953659|NCT01081769|1948236|FG001|CORE Intent-To-Treat|Pregnancy|0
953660|NCT01081769|1948235|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52
953661|NCT01081769|1948236|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60
953662|NCT01081769|1948235|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0
953663|NCT01081769|1948236|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5
953664|NCT01081769|1948235|FG000|CORE Intent-To-Treat|Other|0
953665|NCT01081769|1948236|FG001|CORE Intent-To-Treat|Other|1
953666|NCT01081769|1948235|FG000|CORE Intent-To-Treat|Ineligibility|3
953667|NCT01081769|1948236|FG001|CORE Intent-To-Treat|Ineligibility|4
953668|NCT01081769|1948235|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1
953669|NCT01081769|1948236|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2
953670|NCT01081769|1948235|FG000|CORE Intent-To-Treat|Patient Moved|2
953671|NCT01081769|1948236|FG001|CORE Intent-To-Treat|Patient Moved|2
953672|NCT01081795|1948245|FG000|Overall Study|Adverse Event|18
953673|NCT01081795|1948246|FG001|Overall Study|Adverse Event|23
953674|NCT01081795|1948247|FG002|Overall Study|Adverse Event|6
953675|NCT01081795|1948245|FG000|Overall Study|Lack of Efficacy|7
953676|NCT01081795|1948246|FG001|Overall Study|Lack of Efficacy|5
953677|NCT01081795|1948247|FG002|Overall Study|Lack of Efficacy|19
953678|NCT01081795|1948245|FG000|Overall Study|Subject's schedule|1
953679|NCT01081795|1948246|FG001|Overall Study|Subject's schedule|1
953680|NCT01081795|1948247|FG002|Overall Study|Subject's schedule|2
953681|NCT01081795|1948245|FG000|Overall Study|Revocation of informed consent|2
953682|NCT01081795|1948246|FG001|Overall Study|Revocation of informed consent|0
953683|NCT01081795|1948247|FG002|Overall Study|Revocation of informed consent|0
953684|NCT01081795|1948245|FG000|Overall Study|Ineligible for participation|1
953685|NCT01081795|1948246|FG001|Overall Study|Ineligible for participation|0
953686|NCT01081795|1948247|FG002|Overall Study|Ineligible for participation|0
953687|NCT01081795|1948245|FG000|Overall Study|Use of a prohibited concomitant drug|1
953688|NCT01081795|1948246|FG001|Overall Study|Use of a prohibited concomitant drug|1
953689|NCT01081795|1948247|FG002|Overall Study|Use of a prohibited concomitant drug|1
953690|NCT01081795|1948245|FG000|Overall Study|Using drug with restricted days of use|2
953691|NCT01081795|1948246|FG001|Overall Study|Using drug with restricted days of use|3
953692|NCT01081795|1948247|FG002|Overall Study|Using drug with restricted days of use|2
953693|NCT01081795|1948245|FG000|Overall Study|Other|1
953694|NCT01081795|1948246|FG001|Overall Study|Other|2
953695|NCT01081795|1948247|FG002|Overall Study|Other|0
953696|NCT01081834|1948260|FG000|Core Period: Baseline to Week 26|Pregnancy|1
953697|NCT01081834|1948261|FG001|Core Period: Baseline to Week 26|Pregnancy|0
953698|NCT01081834|1948262|FG002|Core Period: Baseline to Week 26|Pregnancy|0
953699|NCT01081834|1948263|FG003|Core Period: Baseline to Week 26|Pregnancy|0
953700|NCT01081834|1948264|FG004|Core Period: Baseline to Week 26|Pregnancy|0
953701|NCT01081834|1948260|FG000|Core Period: Baseline to Week 26|Adverse Event|2
953702|NCT01081834|1948261|FG001|Core Period: Baseline to Week 26|Adverse Event|5
953703|NCT01081834|1948262|FG002|Core Period: Baseline to Week 26|Adverse Event|3
953704|NCT01081834|1948263|FG003|Core Period: Baseline to Week 26|Adverse Event|1
953705|NCT01081834|1948264|FG004|Core Period: Baseline to Week 26|Adverse Event|1
953706|NCT01081834|1948260|FG000|Core Period: Baseline to Week 26|Death|1
953707|NCT01081834|1948261|FG001|Core Period: Baseline to Week 26|Death|0
953708|NCT01081834|1948262|FG002|Core Period: Baseline to Week 26|Death|0
953709|NCT01081834|1948263|FG003|Core Period: Baseline to Week 26|Death|0
953710|NCT01081834|1948264|FG004|Core Period: Baseline to Week 26|Death|0
953711|NCT01081834|1948260|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2
953712|NCT01081834|1948261|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2
953713|NCT01081834|1948262|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5
953714|NCT01081834|1948263|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0
953715|NCT01081834|1948264|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0
953716|NCT01081834|1948260|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
953717|NCT01081834|1948261|FG001|Core Period: Baseline to Week 26|Protocol Violation|4
953718|NCT01081834|1948262|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
953719|NCT01081834|1948263|FG003|Core Period: Baseline to Week 26|Protocol Violation|0
953720|NCT01081834|1948264|FG004|Core Period: Baseline to Week 26|Protocol Violation|2
953721|NCT01081834|1948260|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15
953722|NCT01081834|1948261|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
953723|NCT01081834|1948262|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9
953724|NCT01081834|1948263|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3
953725|NCT01081834|1948264|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1
953726|NCT01081834|1948260|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3
953727|NCT01081834|1948261|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4
953728|NCT01081834|1948262|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2
953729|NCT01081834|1948263|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2
953730|NCT01081834|1948264|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0
953731|NCT01081834|1948260|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
953732|NCT01081834|1948261|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
953733|NCT01081834|1948262|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
953734|NCT01081834|1948263|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
953735|NCT01081834|1948264|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
953736|NCT01081834|1948260|FG000|Core Period: Baseline to Week 26|Other|4
953737|NCT01081834|1948261|FG001|Core Period: Baseline to Week 26|Other|4
953738|NCT01081834|1948262|FG002|Core Period: Baseline to Week 26|Other|3
953739|NCT01081834|1948263|FG003|Core Period: Baseline to Week 26|Other|1
953740|NCT01081834|1948264|FG004|Core Period: Baseline to Week 26|Other|0
953741|NCT01081834|1948260|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
953742|NCT01081834|1948261|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
953743|NCT01081834|1948262|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
953744|NCT01081834|1948263|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
953745|NCT01081834|1948264|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
953746|NCT01081834|1948260|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
953747|NCT01081834|1948261|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0
953748|NCT01081834|1948262|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
953749|NCT01081834|1948263|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0
953750|NCT01081834|1948264|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0
953751|NCT01081834|1948260|FG000|Extension Period: Week 26 to Week 52|Death|1
953752|NCT01081834|1948261|FG001|Extension Period: Week 26 to Week 52|Death|0
953753|NCT01081834|1948262|FG002|Extension Period: Week 26 to Week 52|Death|0
953754|NCT01081834|1948263|FG003|Extension Period: Week 26 to Week 52|Death|0
953755|NCT01081834|1948264|FG004|Extension Period: Week 26 to Week 52|Death|0
953756|NCT01081834|1948260|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
953757|NCT01081834|1948261|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
953758|NCT01081834|1948262|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
953759|NCT01081834|1948263|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
953760|NCT01081834|1948264|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
953761|NCT01081834|1948260|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
953762|NCT01081834|1948261|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
953763|NCT01081834|1948262|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
953764|NCT01081834|1948263|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
953765|NCT01081834|1948264|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0
953766|NCT01081834|1948260|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
953767|NCT01081834|1948261|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
953768|NCT01081834|1948262|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
953769|NCT01081834|1948263|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
953770|NCT01081834|1948264|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
953771|NCT01081834|1948260|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
953772|NCT01081834|1948261|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
953773|NCT01081834|1948262|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
953774|NCT01081834|1948263|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
953775|NCT01081834|1948264|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
953776|NCT01081834|1948260|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
953777|NCT01081834|1948261|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
953778|NCT01081834|1948262|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
953779|NCT01081834|1948263|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
953780|NCT01081834|1948264|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
953781|NCT01081834|1948260|FG000|Extension Period: Week 26 to Week 52|Other|4
953782|NCT01081834|1948261|FG001|Extension Period: Week 26 to Week 52|Other|5
953783|NCT01081834|1948262|FG002|Extension Period: Week 26 to Week 52|Other|4
953784|NCT01081834|1948263|FG003|Extension Period: Week 26 to Week 52|Other|0
953785|NCT01081834|1948264|FG004|Extension Period: Week 26 to Week 52|Other|0
953786|NCT01081834|1948260|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
953787|NCT01081834|1948261|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
953788|NCT01081834|1948262|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
953789|NCT01081834|1948263|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
953790|NCT01081834|1948264|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
1090774|NCT02248818|2158521|FG003|Screening|Withdrawal by Subject|0
953791|NCT01081834|1948260|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
953792|NCT01081834|1948261|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1
953793|NCT01081834|1948262|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
953794|NCT01081834|1948263|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0
953795|NCT01081834|1948264|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0
953796|NCT01081873|1948283|FG000|Overall Study|Death|86
953797|NCT01081873|1948283|FG000|Overall Study|Withdrawal by Subject|10
953798|NCT01081873|1948283|FG000|Overall Study|Lost to Follow-up|142
953799|NCT01081873|1948283|FG000|Overall Study|Progression of prostate cancer|13
953800|NCT01081873|1948283|FG000|Overall Study|Other|47
953801|NCT01081912|1948312|FG000|Conversion/Titration|Adverse Event|47
953802|NCT01081912|1948313|FG001|Conversion/Titration|Adverse Event|0
953803|NCT01081912|1948314|FG002|Conversion/Titration|Adverse Event|0
953804|NCT01081912|1948312|FG000|Conversion/Titration|Lack of Efficacy|17
953805|NCT01081912|1948313|FG001|Conversion/Titration|Lack of Efficacy|0
953806|NCT01081912|1948314|FG002|Conversion/Titration|Lack of Efficacy|0
953807|NCT01081912|1948312|FG000|Conversion/Titration|Lost to Follow-up|5
953808|NCT01081912|1948313|FG001|Conversion/Titration|Lost to Follow-up|0
953809|NCT01081912|1948314|FG002|Conversion/Titration|Lost to Follow-up|0
953810|NCT01081912|1948312|FG000|Conversion/Titration|Physician Decision|2
953811|NCT01081912|1948313|FG001|Conversion/Titration|Physician Decision|0
953812|NCT01081912|1948314|FG002|Conversion/Titration|Physician Decision|0
953813|NCT01081912|1948312|FG000|Conversion/Titration|Protocol Violation|67
953814|NCT01081912|1948313|FG001|Conversion/Titration|Protocol Violation|0
953815|NCT01081912|1948314|FG002|Conversion/Titration|Protocol Violation|0
953816|NCT01081912|1948312|FG000|Conversion/Titration|Withdrawal by Subject|23
953817|NCT01081912|1948313|FG001|Conversion/Titration|Withdrawal by Subject|0
953818|NCT01081912|1948314|FG002|Conversion/Titration|Withdrawal by Subject|0
953819|NCT01081912|1948312|FG000|Conversion/Titration|Non-Compliance|47
953820|NCT01081912|1948313|FG001|Conversion/Titration|Non-Compliance|0
953821|NCT01081912|1948314|FG002|Conversion/Titration|Non-Compliance|0
953822|NCT01081912|1948312|FG000|Maintenance Treatment|Adverse Event|0
953823|NCT01081912|1948313|FG001|Maintenance Treatment|Adverse Event|2
953824|NCT01081912|1948314|FG002|Maintenance Treatment|Adverse Event|12
953825|NCT01081912|1948312|FG000|Maintenance Treatment|Lack of Efficacy|0
953826|NCT01081912|1948313|FG001|Maintenance Treatment|Lack of Efficacy|14
953827|NCT01081912|1948314|FG002|Maintenance Treatment|Lack of Efficacy|64
953828|NCT01081912|1948312|FG000|Maintenance Treatment|Lost to Follow-up|0
953829|NCT01081912|1948313|FG001|Maintenance Treatment|Lost to Follow-up|1
953830|NCT01081912|1948314|FG002|Maintenance Treatment|Lost to Follow-up|0
953831|NCT01081912|1948312|FG000|Maintenance Treatment|Physician Decision|0
953832|NCT01081912|1948313|FG001|Maintenance Treatment|Physician Decision|0
953833|NCT01081912|1948314|FG002|Maintenance Treatment|Physician Decision|1
953834|NCT01081912|1948312|FG000|Maintenance Treatment|Protocol Violation|0
953835|NCT01081912|1948313|FG001|Maintenance Treatment|Protocol Violation|1
953836|NCT01081912|1948314|FG002|Maintenance Treatment|Protocol Violation|2
953837|NCT01081912|1948312|FG000|Maintenance Treatment|Withdrawal by Subject|0
953838|NCT01081912|1948313|FG001|Maintenance Treatment|Withdrawal by Subject|5
953839|NCT01081912|1948314|FG002|Maintenance Treatment|Withdrawal by Subject|5
953840|NCT01081912|1948312|FG000|Maintenance Treatment|Non-Compliance|0
953841|NCT01081912|1948313|FG001|Maintenance Treatment|Non-Compliance|4
953842|NCT01081912|1948314|FG002|Maintenance Treatment|Non-Compliance|7
953843|NCT01081912|1948312|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0
953844|NCT01081912|1948313|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0
953845|NCT01081912|1948314|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1
953846|NCT01081951|1948323|FG000|Overall Study|Death|54
953847|NCT01081951|1948324|FG001|Overall Study|Death|47
953848|NCT01081951|1948323|FG000|Overall Study|Withdrawal by Subject|2
953849|NCT01081951|1948324|FG001|Overall Study|Withdrawal by Subject|6
953850|NCT01081951|1948323|FG000|Overall Study|Allocated treatment but did not take it|0
953851|NCT01081951|1948324|FG001|Overall Study|Allocated treatment but did not take it|1
953852|NCT01081951|1948323|FG000|Overall Study|Lost to Follow-up|0
953853|NCT01081951|1948324|FG001|Overall Study|Lost to Follow-up|1
953854|NCT01082081|1948333|FG000|Overall Study|Lost to Follow-up|0
953855|NCT01082081|1948334|FG001|Overall Study|Lost to Follow-up|0
953856|NCT01082081|1948335|FG002|Overall Study|Lost to Follow-up|1
953857|NCT01082081|1948333|FG000|Overall Study|Withdrawal by Subject|0
953858|NCT01082081|1948334|FG001|Overall Study|Withdrawal by Subject|0
953859|NCT01082081|1948335|FG002|Overall Study|Withdrawal by Subject|1
953860|NCT01082081|1948333|FG000|Overall Study|Other Reason|0
953861|NCT01082081|1948334|FG001|Overall Study|Other Reason|1
953862|NCT01082081|1948335|FG002|Overall Study|Other Reason|0
953863|NCT01082211|1948348|FG000|Overall Study|Protocol Violation|4
953864|NCT01082211|1948348|FG000|Overall Study|No protocol treatment received|3
953865|NCT01082328|1948355|FG000|Overall Study|Adverse Event|1
953866|NCT01082367|1948361|FG000|Double-blind Period|Administrative problems|0
953867|NCT01082367|1948362|FG001|Double-blind Period|Administrative problems|1
953868|NCT01082367|1948361|FG000|Double-blind Period|Lack of Efficacy|5
953869|NCT01082367|1948362|FG001|Double-blind Period|Lack of Efficacy|11
953870|NCT01082367|1948361|FG000|Double-blind Period|Adverse Event|0
953871|NCT01082367|1948362|FG001|Double-blind Period|Adverse Event|1
953872|NCT01082367|1948361|FG000|Follow-up (F-U) Period|Administrative problems|1
953873|NCT01082367|1948362|FG001|Follow-up (F-U) Period|Administrative problems|0
953874|NCT01082367|1948361|FG000|Follow-up (F-U) Period|Abnormal lab values|1
953875|NCT01082367|1948362|FG001|Follow-up (F-U) Period|Abnormal lab values|0
953876|NCT01082367|1948361|FG000|Follow-up (F-U) Period|Adverse Event|0
953877|NCT01082367|1948362|FG001|Follow-up (F-U) Period|Adverse Event|1
953878|NCT01082614|1948391|FG000|Overall Study|Adverse Event|1
953879|NCT01082614|1948392|FG001|Overall Study|Adverse Event|4
953880|NCT01082614|1948391|FG000|Overall Study|Equipment Malfunction|0
953881|NCT01082614|1948392|FG001|Overall Study|Equipment Malfunction|1
953882|NCT01082614|1948391|FG000|Overall Study|Physician Decision|2
953883|NCT01082614|1948392|FG001|Overall Study|Physician Decision|0
953884|NCT01082640|1948401|FG000|Overall Study|Adverse Event|9
953885|NCT01082640|1948402|FG001|Overall Study|Adverse Event|5
953886|NCT01082640|1948403|FG002|Overall Study|Adverse Event|3
953887|NCT01082640|1948401|FG000|Overall Study|Withdrawal by Subject|3
953888|NCT01082640|1948402|FG001|Overall Study|Withdrawal by Subject|3
953889|NCT01082640|1948403|FG002|Overall Study|Withdrawal by Subject|2
953890|NCT01082640|1948401|FG000|Overall Study|Major protocol deviation|3
953891|NCT01082640|1948402|FG001|Overall Study|Major protocol deviation|3
953892|NCT01082640|1948403|FG002|Overall Study|Major protocol deviation|0
953893|NCT01082640|1948401|FG000|Overall Study|Lost to Follow-up|0
953894|NCT01082640|1948402|FG001|Overall Study|Lost to Follow-up|3
953895|NCT01082640|1948403|FG002|Overall Study|Lost to Follow-up|0
953896|NCT01082640|1948401|FG000|Overall Study|Other|2
953897|NCT01082640|1948402|FG001|Overall Study|Other|1
953898|NCT01082640|1948403|FG002|Overall Study|Other|3
953899|NCT01082874|1948418|FG000|Overall Study|Lost to Follow-up|10
953900|NCT01082874|1948419|FG001|Overall Study|Lost to Follow-up|10
953901|NCT01082874|1948420|FG002|Overall Study|Lost to Follow-up|6
953902|NCT01082874|1948421|FG003|Overall Study|Lost to Follow-up|10
953903|NCT01082874|1948418|FG000|Overall Study|Withdrawal by Subject|1
953904|NCT01082874|1948419|FG001|Overall Study|Withdrawal by Subject|2
953905|NCT01082874|1948420|FG002|Overall Study|Withdrawal by Subject|5
953906|NCT01082874|1948421|FG003|Overall Study|Withdrawal by Subject|3
953907|NCT01082965|1948446|FG000|Overall Study|Protocol Violation|0
953908|NCT01082965|1948447|FG001|Overall Study|Protocol Violation|1
953909|NCT01082965|1948446|FG000|Overall Study|Other|1
953910|NCT01082965|1948447|FG001|Overall Study|Other|1
953911|NCT01083121|1948453|FG000|Overall Study|Use of Humira outside the approved label|81
953912|NCT01083160|1948461|FG000|Overall Study|Adverse Event|1
953913|NCT01083173|1948465|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
953914|NCT01083173|1948466|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
953915|NCT01083173|1948465|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1
953916|NCT01083173|1948466|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0
953917|NCT01083173|1948465|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
953918|NCT01083173|1948466|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
953919|NCT01083173|1948465|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
953920|NCT01083173|1948466|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
953921|NCT01083173|1948465|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
953922|NCT01083173|1948466|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
953923|NCT01083173|1948465|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
953924|NCT01083173|1948466|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
953925|NCT01083173|1948465|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0
953926|NCT01083173|1948466|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1
953927|NCT01083173|1948465|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
953928|NCT01083173|1948466|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
953929|NCT01083173|1948465|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
953930|NCT01083173|1948466|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
953931|NCT01083173|1948465|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
953932|NCT01083173|1948466|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
953933|NCT01083173|1948465|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
953934|NCT01083173|1948466|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
953935|NCT01083186|1948475|FG000|Overall Study|Lost to Follow-up|48
953936|NCT01083186|1948475|FG000|Overall Study|Consent Withdrawal|7
953937|NCT01083186|1948475|FG000|Overall Study|Death|3
953938|NCT01083186|1948475|FG000|Overall Study|Adverse Event|3
953939|NCT01083186|1948475|FG000|Overall Study|Lack of Efficacy|2
953940|NCT01083186|1948475|FG000|Overall Study|Hemodialysis Initiation|28
953941|NCT01083186|1948475|FG000|Overall Study|Administrative Reasons|2
953942|NCT01083186|1948475|FG000|Overall Study|Non-compliance to Study Treatment|1
953943|NCT01083316|1948504|FG000|Overall Study|Adverse Event|2
953944|NCT01083316|1948504|FG000|Overall Study|Withdrawal by Subject|1
953945|NCT01083485|1948524|FG000|Overall Study|Adverse Event|0
953946|NCT01083485|1948525|FG001|Overall Study|Adverse Event|1
953947|NCT01083485|1948524|FG000|Overall Study|Protocol Violation|1
953948|NCT01083485|1948525|FG001|Overall Study|Protocol Violation|0
953949|NCT01083485|1948524|FG000|Overall Study|Withdrawal by Subject|5
953950|NCT01083485|1948525|FG001|Overall Study|Withdrawal by Subject|2
953951|NCT01083485|1948524|FG000|Overall Study|Other|1
953952|NCT01083485|1948525|FG001|Overall Study|Other|0
953953|NCT01083576|1948535|FG000|Overall Study|Treatment Failure|6
953954|NCT01083576|1948536|FG001|Overall Study|Treatment Failure|1
953955|NCT01083602|1948543|FG000|Overall Study|Adverse Event|11
953956|NCT01083602|1948543|FG000|Overall Study|New Cancer Therapy|2
953957|NCT01083602|1948543|FG000|Overall Study|Death|1
953958|NCT01083602|1948543|FG000|Overall Study|Withdrawal by Subject|5
953959|NCT01083602|1948543|FG000|Overall Study|Lack of Efficacy|36
953960|NCT01083641|1948556|FG000|Overall Study|Withdrawal by Subject|2
953961|NCT01083680|1948573|FG000|Overall Study|Lost to Follow-up|2758
953962|NCT01083680|1948573|FG000|Overall Study|Withdrawal by Subject|1086
953963|NCT01083693|1948580|FG000|Overall Study|Adverse Event|1
953964|NCT01083693|1948581|FG001|Overall Study|Adverse Event|1
953965|NCT01083693|1948582|FG002|Overall Study|Adverse Event|0
953966|NCT01083693|1948580|FG000|Overall Study|Lost to Follow-up|2
953967|NCT01083693|1948581|FG001|Overall Study|Lost to Follow-up|0
953968|NCT01083693|1948582|FG002|Overall Study|Lost to Follow-up|2
953969|NCT01083693|1948580|FG000|Overall Study|Lack of effectiveness|13
953970|NCT01083693|1948581|FG001|Overall Study|Lack of effectiveness|2
953971|NCT01083693|1948582|FG002|Overall Study|Lack of effectiveness|2
953972|NCT01083693|1948580|FG000|Overall Study|Patient Moved|0
953973|NCT01083693|1948581|FG001|Overall Study|Patient Moved|1
953974|NCT01083693|1948582|FG002|Overall Study|Patient Moved|0
953975|NCT01083693|1948580|FG000|Overall Study|Complete remission|0
953976|NCT01083693|1948581|FG001|Overall Study|Complete remission|1
953977|NCT01083693|1948582|FG002|Overall Study|Complete remission|0
953978|NCT01083693|1948580|FG000|Overall Study|Other medical condition/surgery|1
953979|NCT01083693|1948581|FG001|Overall Study|Other medical condition/surgery|1
953980|NCT01083693|1948582|FG002|Overall Study|Other medical condition/surgery|0
953981|NCT01083693|1948580|FG000|Overall Study|Withdrawal by Subject|3
953982|NCT01083693|1948581|FG001|Overall Study|Withdrawal by Subject|0
953983|NCT01083693|1948582|FG002|Overall Study|Withdrawal by Subject|2
953984|NCT01083693|1948580|FG000|Overall Study|Reason unknown|0
953985|NCT01083693|1948581|FG001|Overall Study|Reason unknown|0
953986|NCT01083693|1948582|FG002|Overall Study|Reason unknown|1
953987|NCT01083771|1948618|FG000|Overall Study|non-compliant|2
953988|NCT01083771|1948618|FG000|Overall Study|Withdrawal by Subject|3
953989|NCT01083810|1948625|FG000|Overall Study|Lost to Follow-up|23
953990|NCT01083810|1948626|FG001|Overall Study|Lost to Follow-up|11
953991|NCT01083810|1948627|FG002|Overall Study|Lost to Follow-up|4
953992|NCT01083810|1948625|FG000|Overall Study|Adverse Event|15
953993|NCT01083810|1948626|FG001|Overall Study|Adverse Event|11
953994|NCT01083810|1948627|FG002|Overall Study|Adverse Event|4
953995|NCT01083810|1948625|FG000|Overall Study|Withdrawal by Subject|7
953996|NCT01083810|1948626|FG001|Overall Study|Withdrawal by Subject|2
953997|NCT01083810|1948627|FG002|Overall Study|Withdrawal by Subject|4
953998|NCT01083810|1948625|FG000|Overall Study|Reason not reported|6
953999|NCT01083810|1948626|FG001|Overall Study|Reason not reported|1
954000|NCT01083810|1948627|FG002|Overall Study|Reason not reported|1
954001|NCT01083810|1948625|FG000|Overall Study|Non-compliance|4
954002|NCT01083810|1948626|FG001|Overall Study|Non-compliance|7
954003|NCT01083810|1948627|FG002|Overall Study|Non-compliance|2
954004|NCT01083810|1948625|FG000|Overall Study|Simplification|4
954005|NCT01083810|1948626|FG001|Overall Study|Simplification|1
954006|NCT01083810|1948627|FG002|Overall Study|Simplification|0
954007|NCT01083810|1948625|FG000|Overall Study|Death|2
954008|NCT01083810|1948626|FG001|Overall Study|Death|2
954009|NCT01083810|1948627|FG002|Overall Study|Death|3
954010|NCT01083810|1948625|FG000|Overall Study|Co-morbidities|1
954011|NCT01083810|1948626|FG001|Overall Study|Co-morbidities|0
954012|NCT01083810|1948627|FG002|Overall Study|Co-morbidities|0
954013|NCT01083810|1948625|FG000|Overall Study|Participation in study|1
954014|NCT01083810|1948626|FG001|Overall Study|Participation in study|0
954015|NCT01083810|1948627|FG002|Overall Study|Participation in study|0
954016|NCT01083810|1948625|FG000|Overall Study|Therapy break|1
954017|NCT01083810|1948626|FG001|Overall Study|Therapy break|2
954018|NCT01083810|1948627|FG002|Overall Study|Therapy break|2
954019|NCT01083810|1948625|FG000|Overall Study|Virologic failure|1
954020|NCT01083810|1948626|FG001|Overall Study|Virologic failure|8
954021|NCT01083810|1948627|FG002|Overall Study|Virologic failure|0
954022|NCT01084005|1948664|FG000|Overall Study|Adverse Event|1
954023|NCT01084005|1948665|FG001|Overall Study|Adverse Event|8
954024|NCT01084005|1948664|FG000|Overall Study|Protocol Violation|3
954025|NCT01084005|1948665|FG001|Overall Study|Protocol Violation|7
954026|NCT01084005|1948664|FG000|Overall Study|Withdrawal by Subject|1
954027|NCT01084005|1948665|FG001|Overall Study|Withdrawal by Subject|1
954028|NCT01084083|1948671|FG000|Overall Study|Adverse Event|5
954029|NCT01084083|1948671|FG000|Overall Study|Death|1
954030|NCT01084083|1948671|FG000|Overall Study|Withdrawal by Subject|2
954031|NCT01084083|1948671|FG000|Overall Study|Complicating disease|1
954032|NCT01084083|1948671|FG000|Overall Study|Other|2
954033|NCT01084083|1948671|FG000|Overall Study|Never started assigned therapy|1
954034|NCT01084135|1948680|FG000|20 Week|Physician Decision|0
954035|NCT01084135|1948681|FG001|20 Week|Physician Decision|1
954036|NCT01084174|1948702|FG000|Overall Study|gastrointestinal symptoms|1
954037|NCT01084174|1948703|FG001|Overall Study|gastrointestinal symptoms|1
954038|NCT01084174|1948702|FG000|Overall Study|Eosinophilic esophagitis|0
954039|NCT01084174|1948703|FG001|Overall Study|Eosinophilic esophagitis|1
954040|NCT01084174|1948702|FG000|Overall Study|Anaphylaxis|0
954041|NCT01084174|1948703|FG001|Overall Study|Anaphylaxis|1
954042|NCT01084174|1948702|FG000|Overall Study|Participant noncompliance|0
954043|NCT01084174|1948703|FG001|Overall Study|Participant noncompliance|1
954044|NCT01084239|1948711|FG000|28-Day Follow-up|Lost to Follow-up|4
954045|NCT01084239|1948712|FG001|28-Day Follow-up|Lost to Follow-up|9
954046|NCT01084252|1948734|FG000|Phase 1 (120 Weeks)|Adverse Event|0
954047|NCT01084252|1948735|FG001|Phase 1 (120 Weeks)|Adverse Event|0
954048|NCT01084252|1948736|FG002|Phase 1 (120 Weeks)|Adverse Event|1
954049|NCT01084252|1948737|FG003|Phase 1 (120 Weeks)|Adverse Event|1
954050|NCT01084252|1948738|FG004|Phase 1 (120 Weeks)|Adverse Event|1
954051|NCT01084252|1948739|FG005|Phase 1 (120 Weeks)|Adverse Event|0
954052|NCT01084252|1948740|FG006|Phase 1 (120 Weeks)|Adverse Event|1
954053|NCT01084252|1948741|FG007|Phase 1 (120 Weeks)|Adverse Event|0
954054|NCT01084252|1948742|FG008|Phase 1 (120 Weeks)|Adverse Event|0
954055|NCT01084252|1948743|FG009|Phase 1 (120 Weeks)|Adverse Event|0
954056|NCT01084252|1948744|FG010|Phase 1 (120 Weeks)|Adverse Event|0
954057|NCT01084252|1948745|FG011|Phase 1 (120 Weeks)|Adverse Event|0
954058|NCT01084252|1948746|FG012|Phase 1 (120 Weeks)|Adverse Event|0
954059|NCT01084252|1948747|FG013|Phase 1 (120 Weeks)|Adverse Event|0
954060|NCT01084252|1948734|FG000|Phase 1 (120 Weeks)|Progressive disease|15
954061|NCT01084252|1948735|FG001|Phase 1 (120 Weeks)|Progressive disease|5
954062|NCT01084252|1948736|FG002|Phase 1 (120 Weeks)|Progressive disease|2
954063|NCT01084252|1948737|FG003|Phase 1 (120 Weeks)|Progressive disease|22
954064|NCT01084252|1948738|FG004|Phase 1 (120 Weeks)|Progressive disease|16
954065|NCT01084252|1948739|FG005|Phase 1 (120 Weeks)|Progressive disease|6
954066|NCT01084252|1948740|FG006|Phase 1 (120 Weeks)|Progressive disease|5
954067|NCT01084252|1948741|FG007|Phase 1 (120 Weeks)|Progressive disease|6
954068|NCT01084252|1948742|FG008|Phase 1 (120 Weeks)|Progressive disease|0
954069|NCT01084252|1948743|FG009|Phase 1 (120 Weeks)|Progressive disease|0
954070|NCT01084252|1948744|FG010|Phase 1 (120 Weeks)|Progressive disease|0
954071|NCT01084252|1948745|FG011|Phase 1 (120 Weeks)|Progressive disease|0
954072|NCT01084252|1948746|FG012|Phase 1 (120 Weeks)|Progressive disease|0
954073|NCT01084252|1948747|FG013|Phase 1 (120 Weeks)|Progressive disease|0
954074|NCT01084252|1948734|FG000|Phase 1 (120 Weeks)|Other than specified above|1
954075|NCT01084252|1948735|FG001|Phase 1 (120 Weeks)|Other than specified above|1
954076|NCT01084252|1948736|FG002|Phase 1 (120 Weeks)|Other than specified above|0
954077|NCT01084252|1948737|FG003|Phase 1 (120 Weeks)|Other than specified above|3
954078|NCT01084252|1948738|FG004|Phase 1 (120 Weeks)|Other than specified above|1
954079|NCT01084252|1948739|FG005|Phase 1 (120 Weeks)|Other than specified above|0
954080|NCT01084252|1948740|FG006|Phase 1 (120 Weeks)|Other than specified above|1
954081|NCT01084252|1948741|FG007|Phase 1 (120 Weeks)|Other than specified above|1
954082|NCT01084252|1948742|FG008|Phase 1 (120 Weeks)|Other than specified above|0
954083|NCT01084252|1948743|FG009|Phase 1 (120 Weeks)|Other than specified above|0
954084|NCT01084252|1948744|FG010|Phase 1 (120 Weeks)|Other than specified above|0
954085|NCT01084252|1948745|FG011|Phase 1 (120 Weeks)|Other than specified above|0
954086|NCT01084252|1948746|FG012|Phase 1 (120 Weeks)|Other than specified above|0
954087|NCT01084252|1948747|FG013|Phase 1 (120 Weeks)|Other than specified above|0
954088|NCT01084252|1948734|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
954089|NCT01084252|1948735|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
954090|NCT01084252|1948736|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
954091|NCT01084252|1948737|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
954092|NCT01084252|1948738|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
954093|NCT01084252|1948739|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
954094|NCT01084252|1948740|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
954095|NCT01084252|1948741|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
954096|NCT01084252|1948742|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
954097|NCT01084252|1948743|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
954098|NCT01084252|1948744|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
954099|NCT01084252|1948745|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
954100|NCT01084252|1948746|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
954101|NCT01084252|1948747|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
954102|NCT01084252|1948734|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
954103|NCT01084252|1948735|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
954104|NCT01084252|1948736|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
954105|NCT01084252|1948737|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
954106|NCT01084252|1948738|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
954107|NCT01084252|1948739|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
954108|NCT01084252|1948740|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
954109|NCT01084252|1948741|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
954110|NCT01084252|1948742|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
954111|NCT01084252|1948743|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
954112|NCT01084252|1948744|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
954113|NCT01084252|1948745|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
954114|NCT01084252|1948746|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
954115|NCT01084252|1948747|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
954116|NCT01084252|1948734|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
954117|NCT01084252|1948735|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
954118|NCT01084252|1948736|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
954119|NCT01084252|1948737|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
954120|NCT01084252|1948738|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
954121|NCT01084252|1948739|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
954122|NCT01084252|1948740|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
954123|NCT01084252|1948741|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
954124|NCT01084252|1948742|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
954125|NCT01084252|1948743|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
954126|NCT01084252|1948744|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
954127|NCT01084252|1948745|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
954128|NCT01084252|1948746|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
954129|NCT01084252|1948747|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
954130|NCT01084252|1948734|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
954131|NCT01084252|1948735|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
954132|NCT01084252|1948736|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
954133|NCT01084252|1948737|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
954134|NCT01084252|1948738|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
954135|NCT01084252|1948739|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
954136|NCT01084252|1948740|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
954137|NCT01084252|1948741|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
954138|NCT01084252|1948742|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
954139|NCT01084252|1948743|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
954140|NCT01084252|1948744|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
954141|NCT01084252|1948745|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
954142|NCT01084252|1948746|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
954143|NCT01084252|1948747|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
954144|NCT01084252|1948734|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954145|NCT01084252|1948735|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954146|NCT01084252|1948736|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954147|NCT01084252|1948737|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954148|NCT01084252|1948738|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954149|NCT01084252|1948739|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954150|NCT01084252|1948740|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954151|NCT01084252|1948741|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954152|NCT01084252|1948742|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954153|NCT01084252|1948743|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954154|NCT01084252|1948744|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954155|NCT01084252|1948745|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
954156|NCT01084252|1948746|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
954157|NCT01084252|1948747|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
954158|NCT01084252|1948734|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954159|NCT01084252|1948735|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954160|NCT01084252|1948736|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954161|NCT01084252|1948737|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954162|NCT01084252|1948738|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954163|NCT01084252|1948739|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954164|NCT01084252|1948740|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954165|NCT01084252|1948741|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954166|NCT01084252|1948742|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954167|NCT01084252|1948743|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954168|NCT01084252|1948744|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954169|NCT01084252|1948745|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
954170|NCT01084252|1948746|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
954171|NCT01084252|1948747|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
954172|NCT01084252|1948734|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954173|NCT01084252|1948735|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954174|NCT01084252|1948736|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954175|NCT01084252|1948737|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954176|NCT01084252|1948738|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954177|NCT01084252|1948739|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954178|NCT01084252|1948740|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954179|NCT01084252|1948741|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954180|NCT01084252|1948742|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954181|NCT01084252|1948743|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954182|NCT01084252|1948744|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954183|NCT01084252|1948745|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954184|NCT01084252|1948746|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
954185|NCT01084252|1948747|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
954186|NCT01084252|1948734|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954187|NCT01084252|1948735|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954188|NCT01084252|1948736|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954189|NCT01084252|1948737|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954190|NCT01084252|1948738|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954191|NCT01084252|1948739|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954192|NCT01084252|1948740|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954193|NCT01084252|1948741|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954194|NCT01084252|1948742|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954195|NCT01084252|1948743|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954196|NCT01084252|1948744|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954197|NCT01084252|1948745|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
954198|NCT01084252|1948746|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
954199|NCT01084252|1948747|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
954200|NCT01084252|1948734|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954201|NCT01084252|1948735|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954202|NCT01084252|1948736|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954203|NCT01084252|1948737|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954204|NCT01084252|1948738|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954205|NCT01084252|1948739|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954206|NCT01084252|1948740|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954207|NCT01084252|1948741|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954208|NCT01084252|1948742|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954209|NCT01084252|1948743|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954210|NCT01084252|1948744|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954211|NCT01084252|1948745|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
954212|NCT01084252|1948746|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
954213|NCT01084252|1948747|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
954214|NCT01084252|1948734|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954215|NCT01084252|1948735|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954216|NCT01084252|1948736|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954217|NCT01084252|1948737|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954218|NCT01084252|1948738|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954219|NCT01084252|1948739|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954220|NCT01084252|1948740|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954221|NCT01084252|1948741|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954222|NCT01084252|1948742|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954223|NCT01084252|1948743|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954224|NCT01084252|1948744|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954225|NCT01084252|1948745|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954226|NCT01084252|1948746|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
954227|NCT01084252|1948747|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
954228|NCT01084538|1948847|FG000|Overall Study|Drug not available|30
954229|NCT01084538|1948847|FG000|Overall Study|Adverse Event|9
954230|NCT01084538|1948847|FG000|Overall Study|Kidney transplant|6
954231|NCT01084538|1948847|FG000|Overall Study|Serious Adverse Event|3
954232|NCT01084538|1948847|FG000|Overall Study|Lack of effectiveness|2
954233|NCT01084538|1948847|FG000|Overall Study|Patient noncompliance|2
954234|NCT01084538|1948847|FG000|Overall Study|Hyperphosphatemia|2
954235|NCT01084538|1948847|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2
954236|NCT01084538|1948847|FG000|Overall Study|Change of residence|2
954237|NCT01084538|1948847|FG000|Overall Study|Over-suppression of parathyroid gland|2
954238|NCT01084538|1948847|FG000|Overall Study|Reason unknown|8
954239|NCT01084551|1948854|FG000|Overall Study|Adverse Event|2
954240|NCT01084551|1948855|FG001|Overall Study|Adverse Event|9
954241|NCT01084551|1948856|FG002|Overall Study|Adverse Event|4
954242|NCT01084551|1948854|FG000|Overall Study|Lack of Efficacy|2
954243|NCT01084551|1948855|FG001|Overall Study|Lack of Efficacy|0
954244|NCT01084551|1948856|FG002|Overall Study|Lack of Efficacy|1
954245|NCT01084551|1948854|FG000|Overall Study|Withdrawal by Subject|2
954246|NCT01084551|1948855|FG001|Overall Study|Withdrawal by Subject|1
954247|NCT01084551|1948856|FG002|Overall Study|Withdrawal by Subject|0
954248|NCT01084551|1948854|FG000|Overall Study|Protocol Violation|2
954249|NCT01084551|1948855|FG001|Overall Study|Protocol Violation|4
954250|NCT01084551|1948856|FG002|Overall Study|Protocol Violation|0
954251|NCT01084551|1948854|FG000|Overall Study|Lost to Follow-up|0
954252|NCT01084551|1948855|FG001|Overall Study|Lost to Follow-up|0
954253|NCT01084551|1948856|FG002|Overall Study|Lost to Follow-up|3
954254|NCT01084551|1948854|FG000|Overall Study|Physician Decision|1
954255|NCT01084551|1948855|FG001|Overall Study|Physician Decision|0
954256|NCT01084551|1948856|FG002|Overall Study|Physician Decision|0
954257|NCT01084603|1948864|FG000|Baseline|Withdrawal by Subject|2
954258|NCT01084603|1948864|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1
954259|NCT01084603|1948864|FG000|Nicorette® Gum|Withdrawal by Subject|1
954260|NCT01084603|1948864|FG000|Oral Nicotine 1|Withdrawal by Subject|1
954261|NCT01084603|1948864|FG000|Washout Period 4|Adverse Event|1
954262|NCT01084655|1948880|FG000|Overall Study|Radiographic disease progression|3
954263|NCT01084655|1948881|FG001|Overall Study|Radiographic disease progression|2
954264|NCT01084655|1948882|FG002|Overall Study|Radiographic disease progression|8
954265|NCT01084655|1948880|FG000|Overall Study|Withdrawal by Subject|1
954266|NCT01084655|1948881|FG001|Overall Study|Withdrawal by Subject|0
954267|NCT01084655|1948882|FG002|Overall Study|Withdrawal by Subject|4
954268|NCT01084655|1948880|FG000|Overall Study|Adverse Event|2
954269|NCT01084655|1948881|FG001|Overall Study|Adverse Event|1
954270|NCT01084655|1948882|FG002|Overall Study|Adverse Event|2
954271|NCT01084655|1948880|FG000|Overall Study|Other|0
954272|NCT01084655|1948881|FG001|Overall Study|Other|3
954273|NCT01084655|1948882|FG002|Overall Study|Other|2
954274|NCT01084655|1948880|FG000|Overall Study|Symptomatic deterioration|0
954275|NCT01084655|1948881|FG001|Overall Study|Symptomatic deterioration|0
954276|NCT01084655|1948882|FG002|Overall Study|Symptomatic deterioration|2
954277|NCT01084655|1948880|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0
954278|NCT01084655|1948881|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0
954279|NCT01084655|1948882|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1
954280|NCT01084668|1948894|FG000|Overall Study|Lack of Efficacy|5
954281|NCT01084668|1948894|FG000|Overall Study|Withdrawal by Subject|2
954282|NCT01084668|1948894|FG000|Overall Study|Pregnancy|1
954283|NCT01084668|1948894|FG000|Overall Study|Non-compliance|1
954284|NCT01084694|1948902|FG000|Overall Study|Withdrawal by Subject|2
954285|NCT01084694|1948903|FG001|Overall Study|Withdrawal by Subject|1
954286|NCT01084694|1948902|FG000|Overall Study|Death|2
954287|NCT01084694|1948903|FG001|Overall Study|Death|12
954288|NCT01084694|1948902|FG000|Overall Study|eligibility not maintained|2
954289|NCT01084694|1948903|FG001|Overall Study|eligibility not maintained|7
954290|NCT01084707|1948917|FG000|Overall Study|Withdrawal by Subject|6
954291|NCT01084772|1948935|FG000|Baseline|Withdrawal by Subject|7
954292|NCT01084772|1948936|FG001|Baseline|Withdrawal by Subject|6
954293|NCT01084772|1948935|FG000|3 Months|Death|1
954294|NCT01084772|1948936|FG001|3 Months|Death|0
954295|NCT01084772|1948935|FG000|3 Months|Study Termination|2
954296|NCT01084772|1948936|FG001|3 Months|Study Termination|2
954297|NCT01084772|1948935|FG000|1 Year|Withdrawal by Subject|0
954298|NCT01084772|1948936|FG001|1 Year|Withdrawal by Subject|1
954299|NCT01084772|1948935|FG000|1 Year|Lost to Follow-up|3
954300|NCT01084772|1948936|FG001|1 Year|Lost to Follow-up|0
954301|NCT01084772|1948935|FG000|1 Year|Study Termination|0
954302|NCT01084772|1948936|FG001|1 Year|Study Termination|7
954303|NCT01084772|1948935|FG000|2 Years|Withdrawal by Subject|1
954304|NCT01084772|1948936|FG001|2 Years|Withdrawal by Subject|0
954305|NCT01084772|1948935|FG000|2 Years|Lost to Follow-up|5
954306|NCT01084772|1948936|FG001|2 Years|Lost to Follow-up|2
954307|NCT01084772|1948935|FG000|2 Years|Study Termination|3
954308|NCT01084772|1948936|FG001|2 Years|Study Termination|2
954309|NCT01085045|1948951|FG000|Part A|Withdrawal by Subject|4
954310|NCT01085045|1948951|FG000|Part A|Adverse Event|6
954311|NCT01085045|1948951|FG000|Part A|Protocol Violation|1
954312|NCT01085045|1948951|FG000|Part A|Protocol Specified Criteria|7
954313|NCT01085045|1948951|FG000|Part B|Withdrawal by Subject|2
954314|NCT01085045|1948951|FG000|Part B|Protocol Specified Criteria|6
954315|NCT01085045|1948951|FG000|Part B|Lost to Follow-up|1
954316|NCT01085045|1948951|FG000|Part B|Adverse Event|6
954317|NCT01085136|1948971|FG000|Part A|Other Adverse event|223
954318|NCT01085136|1948972|FG001|Part A|Other Adverse event|0
954319|NCT01085136|1948973|FG002|Part A|Other Adverse event|0
954320|NCT01085136|1948971|FG000|Part A|Protocol Violation|3
954321|NCT01085136|1948972|FG001|Part A|Protocol Violation|0
954322|NCT01085136|1948973|FG002|Part A|Protocol Violation|0
954323|NCT01085136|1948971|FG000|Part A|Lost to Follow-up|3
954324|NCT01085136|1948972|FG001|Part A|Lost to Follow-up|0
954325|NCT01085136|1948973|FG002|Part A|Lost to Follow-up|0
954326|NCT01085136|1948971|FG000|Part A|Refusal to continue trial medication|64
954327|NCT01085136|1948972|FG001|Part A|Refusal to continue trial medication|0
954328|NCT01085136|1948973|FG002|Part A|Refusal to continue trial medication|0
954329|NCT01085136|1948971|FG000|Part A|Other reason not defined above|30
954330|NCT01085136|1948972|FG001|Part A|Other reason not defined above|0
954331|NCT01085136|1948973|FG002|Part A|Other reason not defined above|0
954332|NCT01085136|1948971|FG000|Part B|Other AE|0
954333|NCT01085136|1948972|FG001|Part B|Other AE|29
954334|NCT01085136|1948973|FG002|Part B|Other AE|8
954335|NCT01085136|1948971|FG000|Part B|Refusal to continue trial medication|0
954336|NCT01085136|1948972|FG001|Part B|Refusal to continue trial medication|12
954337|NCT01085136|1948973|FG002|Part B|Refusal to continue trial medication|7
954338|NCT01085136|1948971|FG000|Part B|Not treated|0
954339|NCT01085136|1948972|FG001|Part B|Not treated|4
954340|NCT01085136|1948973|FG002|Part B|Not treated|8
954341|NCT01085136|1948971|FG000|Part B|Other reason not defined above|0
954342|NCT01085136|1948972|FG001|Part B|Other reason not defined above|6
954343|NCT01085136|1948973|FG002|Part B|Other reason not defined above|3
954344|NCT01085201|1948988|FG000|Overall Study|Scheduling conflict|1
954345|NCT01085201|1948989|FG001|Overall Study|Scheduling conflict|0
954346|NCT01085201|1948990|FG002|Overall Study|Scheduling conflict|1
954347|NCT01085201|1948991|FG003|Overall Study|Scheduling conflict|0
954348|NCT01085201|1948992|FG004|Overall Study|Scheduling conflict|0
954349|NCT01085201|1948988|FG000|Overall Study|Unknown- no study drug|2
954350|NCT01085201|1948989|FG001|Overall Study|Unknown- no study drug|0
954351|NCT01085201|1948990|FG002|Overall Study|Unknown- no study drug|0
954352|NCT01085201|1948991|FG003|Overall Study|Unknown- no study drug|0
954353|NCT01085201|1948992|FG004|Overall Study|Unknown- no study drug|0
954354|NCT01085201|1948988|FG000|Overall Study|Fond ineligible after consent|0
954355|NCT01085201|1948989|FG001|Overall Study|Fond ineligible after consent|1
954356|NCT01085201|1948990|FG002|Overall Study|Fond ineligible after consent|1
954357|NCT01085201|1948991|FG003|Overall Study|Fond ineligible after consent|0
954358|NCT01085201|1948992|FG004|Overall Study|Fond ineligible after consent|0
954359|NCT01085214|1949009|FG000|Overall Study|Alternate treatment required|1
954360|NCT01085357|1949041|FG000|Overall Study|Adverse Event|1
954361|NCT01085357|1949042|FG001|Overall Study|Adverse Event|1
954362|NCT01085357|1949041|FG000|Overall Study|Subject Decision|4
954363|NCT01085357|1949042|FG001|Overall Study|Subject Decision|3
954364|NCT01085357|1949041|FG000|Overall Study|Investigator Decision|1
954365|NCT01085357|1949042|FG001|Overall Study|Investigator Decision|1
954366|NCT01085357|1949041|FG000|Overall Study|Death|11
954367|NCT01085357|1949042|FG001|Overall Study|Death|1
954368|NCT01085357|1949041|FG000|Overall Study|Lost to Follow-up|2
954369|NCT01085357|1949042|FG001|Overall Study|Lost to Follow-up|0
954370|NCT01085591|1949073|FG000|Overall Study|Adverse Event|0
954371|NCT01085591|1949074|FG001|Overall Study|Adverse Event|1
954372|NCT01085591|1949075|FG002|Overall Study|Adverse Event|3
954373|NCT01085591|1949073|FG000|Overall Study|Physician Decision|1
954374|NCT01085591|1949074|FG001|Overall Study|Physician Decision|0
954375|NCT01085591|1949075|FG002|Overall Study|Physician Decision|1
954376|NCT01085591|1949073|FG000|Overall Study|Withdrawal by Subject|0
954377|NCT01085591|1949074|FG001|Overall Study|Withdrawal by Subject|2
954378|NCT01085591|1949075|FG002|Overall Study|Withdrawal by Subject|1
954379|NCT01085591|1949073|FG000|Overall Study|Lost to Follow-up|0
954380|NCT01085591|1949074|FG001|Overall Study|Lost to Follow-up|1
954381|NCT01085591|1949075|FG002|Overall Study|Lost to Follow-up|1
954382|NCT01085591|1949073|FG000|Overall Study|Protocol Violation|1
954383|NCT01085591|1949074|FG001|Overall Study|Protocol Violation|1
954384|NCT01085591|1949075|FG002|Overall Study|Protocol Violation|1
954385|NCT01085591|1949073|FG000|Overall Study|Other|0
954386|NCT01085591|1949074|FG001|Overall Study|Other|1
954387|NCT01085591|1949075|FG002|Overall Study|Other|0
954388|NCT01085591|1949073|FG000|Overall Study|Not Properly Consented|1
954389|NCT01085591|1949074|FG001|Overall Study|Not Properly Consented|0
954390|NCT01085591|1949075|FG002|Overall Study|Not Properly Consented|0
954391|NCT01085630|1949086|FG000|Overall Study|Insufficient data|1
954392|NCT01085630|1949087|FG001|Overall Study|Insufficient data|0
954393|NCT01085630|1949086|FG000|Overall Study|Ineligible|3
954394|NCT01085630|1949087|FG001|Overall Study|Ineligible|0
954395|NCT01085682|1949095|FG000|Overall Study|Withdrawal by Subject|25
954396|NCT01085682|1949096|FG001|Overall Study|Withdrawal by Subject|25
954397|NCT01085734|1949104|FG000|Overall Study|Adverse Event|0
954398|NCT01085734|1949105|FG001|Overall Study|Adverse Event|2
954399|NCT01085734|1949104|FG000|Overall Study|Death|1
954400|NCT01085734|1949105|FG001|Overall Study|Death|0
954401|NCT01085734|1949104|FG000|Overall Study|Lost to Follow-up|0
954402|NCT01085734|1949105|FG001|Overall Study|Lost to Follow-up|1
954403|NCT01085734|1949104|FG000|Overall Study|Withdrawal by Subject|0
954404|NCT01085734|1949105|FG001|Overall Study|Withdrawal by Subject|1
954405|NCT01085812|1949138|FG000|Open-Label Period|Adverse Event|0
954406|NCT01085812|1949139|FG001|Open-Label Period|Adverse Event|80
954407|NCT01085812|1949138|FG000|Open-Label Period|Lack of Efficacy|0
954408|NCT01085812|1949139|FG001|Open-Label Period|Lack of Efficacy|26
954409|NCT01085812|1949138|FG000|Open-Label Period|Protocol Violation|0
954410|NCT01085812|1949139|FG001|Open-Label Period|Protocol Violation|39
954411|NCT01085812|1949138|FG000|Open-Label Period|Withdrawal by Subject|0
954412|NCT01085812|1949139|FG001|Open-Label Period|Withdrawal by Subject|53
954413|NCT01085812|1949138|FG000|Open-Label Period|Lost to Follow-up|0
954414|NCT01085812|1949139|FG001|Open-Label Period|Lost to Follow-up|42
954415|NCT01085812|1949138|FG000|Double-Blind Period|Adverse Event|3
954416|NCT01085812|1949139|FG001|Double-Blind Period|Adverse Event|8
954417|NCT01085812|1949138|FG000|Double-Blind Period|Protocol Violation|2
954418|NCT01085812|1949139|FG001|Double-Blind Period|Protocol Violation|7
954419|NCT01085812|1949138|FG000|Double-Blind Period|Withdrawal by Subject|11
954420|NCT01085812|1949139|FG001|Double-Blind Period|Withdrawal by Subject|24
954421|NCT01085812|1949138|FG000|Double-Blind Period|Lost to Follow-up|5
954422|NCT01085812|1949139|FG001|Double-Blind Period|Lost to Follow-up|17
954423|NCT01085812|1949138|FG000|Double-Blind Period|Other Reasons|0
954424|NCT01085812|1949139|FG001|Double-Blind Period|Other Reasons|2
954425|NCT01085812|1949138|FG000|Double-blind Intent-to-treat Population|Adverse Event|3
954426|NCT01085812|1949139|FG001|Double-blind Intent-to-treat Population|Adverse Event|8
954427|NCT01085812|1949138|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2
954428|NCT01085812|1949139|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7
954429|NCT01085812|1949138|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
954430|NCT01085812|1949139|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
954431|NCT01085812|1949138|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4
954432|NCT01085812|1949139|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17
954433|NCT01085812|1949138|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
954434|NCT01085812|1949139|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
954435|NCT01086033|1949187|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86
954436|NCT01086033|1949187|FG000|Overall Study|Lost to Follow-up|86
954437|NCT01086033|1949187|FG000|Overall Study|Adverse Event|42
954438|NCT01086033|1949187|FG000|Overall Study|Withdrawal by Subject|41
954439|NCT01086033|1949187|FG000|Overall Study|Other|14
954440|NCT01086033|1949187|FG000|Overall Study|Other|13
954441|NCT01086033|1949187|FG000|Overall Study|AE and Withdrew Consent|5
954442|NCT01086033|1949187|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5
954443|NCT01086033|1949187|FG000|Overall Study|Withdrew consent and Other Reason|4
954444|NCT01086033|1949187|FG000|Overall Study|AE and Lack of Efficacy|4
954445|NCT01086033|1949187|FG000|Overall Study|Death|1
954446|NCT01086033|1949187|FG000|Overall Study|AE and Lost to Follow-up|1
954447|NCT01086033|1949187|FG000|Overall Study|AE and Other Reason|1
954448|NCT01086033|1949187|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
954449|NCT01086150|1949197|FG000|Overall Study|Withdrawal by Subject|0
954450|NCT01086150|1949198|FG001|Overall Study|Withdrawal by Subject|4
954451|NCT01086150|1949199|FG002|Overall Study|Withdrawal by Subject|1
954452|NCT01086150|1949197|FG000|Overall Study|Lost to Follow-up|0
954453|NCT01086150|1949198|FG001|Overall Study|Lost to Follow-up|1
954454|NCT01086150|1949199|FG002|Overall Study|Lost to Follow-up|0
954455|NCT01086150|1949197|FG000|Overall Study|Screen Failure|0
954456|NCT01086150|1949198|FG001|Overall Study|Screen Failure|1
954457|NCT01086150|1949199|FG002|Overall Study|Screen Failure|0
954458|NCT01086215|1949211|FG000|Overall Study|Death|14
954459|NCT01086215|1949212|FG001|Overall Study|Death|8
954460|NCT01086215|1949213|FG002|Overall Study|Death|8
954461|NCT01086215|1949214|FG003|Overall Study|Death|1
954462|NCT01086215|1949211|FG000|Overall Study|Lost to Follow-up|22
954463|NCT01086215|1949212|FG001|Overall Study|Lost to Follow-up|39
954464|NCT01086215|1949213|FG002|Overall Study|Lost to Follow-up|18
954465|NCT01086215|1949214|FG003|Overall Study|Lost to Follow-up|2
954466|NCT01086358|1949228|FG000|First Intervention|Lost to Follow-up|9
954467|NCT01086358|1949229|FG001|First Intervention|Lost to Follow-up|4
954468|NCT01086358|1949228|FG000|First Intervention|Withdrawal by Subject|0
954469|NCT01086358|1949229|FG001|First Intervention|Withdrawal by Subject|1
954470|NCT01086358|1949228|FG000|Second Intervention|Lost to Follow-up|4
954471|NCT01086358|1949229|FG001|Second Intervention|Lost to Follow-up|4
954472|NCT01086384|1949237|FG000|2-week Run-in Period|Adverse Event|1
954473|NCT01086384|1949238|FG001|2-week Run-in Period|Adverse Event|0
954474|NCT01086384|1949239|FG002|2-week Run-in Period|Adverse Event|0
954475|NCT01086384|1949237|FG000|2-week Run-in Period|Protocol Violation|1
954476|NCT01086384|1949238|FG001|2-week Run-in Period|Protocol Violation|0
954477|NCT01086384|1949239|FG002|2-week Run-in Period|Protocol Violation|0
954478|NCT01086384|1949237|FG000|2-week Run-in Period|Lost to Follow-up|1
954479|NCT01086384|1949238|FG001|2-week Run-in Period|Lost to Follow-up|0
954480|NCT01086384|1949239|FG002|2-week Run-in Period|Lost to Follow-up|0
954481|NCT01086384|1949237|FG000|2-week Run-in Period|Physician Decision|6
954482|NCT01086384|1949238|FG001|2-week Run-in Period|Physician Decision|0
954483|NCT01086384|1949239|FG002|2-week Run-in Period|Physician Decision|0
954484|NCT01086384|1949237|FG000|2-week Run-in Period|Withdrawal by Subject|19
954485|NCT01086384|1949238|FG001|2-week Run-in Period|Withdrawal by Subject|0
954486|NCT01086384|1949239|FG002|2-week Run-in Period|Withdrawal by Subject|0
954487|NCT01086384|1949237|FG000|2-week Run-in Period|Study Closed/Terminated|42
954488|NCT01086384|1949238|FG001|2-week Run-in Period|Study Closed/Terminated|0
954489|NCT01086384|1949239|FG002|2-week Run-in Period|Study Closed/Terminated|0
954490|NCT01086384|1949237|FG000|2-week Run-in Period|Continuation Criteria Not Met|92
954491|NCT01086384|1949238|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
954492|NCT01086384|1949239|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
954493|NCT01086384|1949237|FG000|2-week Run-in Period|Randomized in Error|1
954494|NCT01086384|1949238|FG001|2-week Run-in Period|Randomized in Error|0
954495|NCT01086384|1949239|FG002|2-week Run-in Period|Randomized in Error|0
954496|NCT01086384|1949237|FG000|Treatment Period|Withdrawal by Subject|0
954497|NCT01086384|1949238|FG001|Treatment Period|Withdrawal by Subject|53
954498|NCT01086384|1949239|FG002|Treatment Period|Withdrawal by Subject|55
954499|NCT01086384|1949237|FG000|Treatment Period|Protocol Violation|0
954500|NCT01086384|1949238|FG001|Treatment Period|Protocol Violation|26
954501|NCT01086384|1949239|FG002|Treatment Period|Protocol Violation|17
911001|NCT00796120|1888116|FG000|Overall Study|Randomized but not treated|0
911002|NCT00796120|1888117|FG001|Overall Study|Randomized but not treated|3
911003|NCT00796224|1888125|FG000|Overall Study|Adverse Event|1
911004|NCT00796224|1888126|FG001|Overall Study|Adverse Event|0
911005|NCT00796224|1888125|FG000|Overall Study|Protocol Violation|0
911006|NCT00796224|1888126|FG001|Overall Study|Protocol Violation|1
911007|NCT00796315|1888144|FG000|Overall Study|Protocol Violation|0
911008|NCT00796315|1888145|FG001|Overall Study|Protocol Violation|1
911009|NCT00796315|1888146|FG002|Overall Study|Protocol Violation|0
911010|NCT00796328|1888157|FG000|Overall Study|experienced hypotension requiring tx|6
911011|NCT00796367|1888164|FG000|Overall Study|Adverse Event|6
911012|NCT00796367|1888165|FG001|Overall Study|Adverse Event|4
911013|NCT00796367|1888166|FG002|Overall Study|Adverse Event|7
911014|NCT00796367|1888164|FG000|Overall Study|Lost to Follow-up|5
911015|NCT00796367|1888165|FG001|Overall Study|Lost to Follow-up|4
954502|NCT01086384|1949237|FG000|Treatment Period|Lack of Efficacy|0
954503|NCT01086384|1949238|FG001|Treatment Period|Lack of Efficacy|22
954504|NCT01086384|1949239|FG002|Treatment Period|Lack of Efficacy|13
954505|NCT01086384|1949237|FG000|Treatment Period|Adverse Event|0
954506|NCT01086384|1949238|FG001|Treatment Period|Adverse Event|19
954507|NCT01086384|1949239|FG002|Treatment Period|Adverse Event|15
954508|NCT01086384|1949237|FG000|Treatment Period|Lost to Follow-up|0
954509|NCT01086384|1949238|FG001|Treatment Period|Lost to Follow-up|11
954510|NCT01086384|1949239|FG002|Treatment Period|Lost to Follow-up|9
954511|NCT01086384|1949237|FG000|Treatment Period|Physician Decision|0
954512|NCT01086384|1949238|FG001|Treatment Period|Physician Decision|9
954513|NCT01086384|1949239|FG002|Treatment Period|Physician Decision|6
954514|NCT01086384|1949237|FG000|Treatment Period|Study Closed/Terminated|0
954515|NCT01086384|1949238|FG001|Treatment Period|Study Closed/Terminated|7
954516|NCT01086384|1949239|FG002|Treatment Period|Study Closed/Terminated|8
954517|NCT01086384|1949237|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0
954518|NCT01086384|1949238|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0
954519|NCT01086384|1949239|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1
954520|NCT01086384|1949237|FG000|Treatment Period|Received Treatment in Error|0
954521|NCT01086384|1949238|FG001|Treatment Period|Received Treatment in Error|1
954522|NCT01086384|1949239|FG002|Treatment Period|Received Treatment in Error|0
954523|NCT01086410|1949249|FG000|Overall Study|Adverse Event|1
954524|NCT01086410|1949250|FG001|Overall Study|Adverse Event|0
954525|NCT01086410|1949251|FG002|Overall Study|Adverse Event|0
954526|NCT01086410|1949252|FG003|Overall Study|Adverse Event|2
954527|NCT01086410|1949249|FG000|Overall Study|Lack of Efficacy|1
954528|NCT01086410|1949250|FG001|Overall Study|Lack of Efficacy|1
954529|NCT01086410|1949251|FG002|Overall Study|Lack of Efficacy|0
954530|NCT01086410|1949252|FG003|Overall Study|Lack of Efficacy|0
954531|NCT01086410|1949249|FG000|Overall Study|Protocol Violation|1
954532|NCT01086410|1949250|FG001|Overall Study|Protocol Violation|1
954533|NCT01086410|1949251|FG002|Overall Study|Protocol Violation|0
954534|NCT01086410|1949252|FG003|Overall Study|Protocol Violation|0
954535|NCT01086410|1949249|FG000|Overall Study|Lost to Follow-up|0
954536|NCT01086410|1949250|FG001|Overall Study|Lost to Follow-up|0
954537|NCT01086410|1949251|FG002|Overall Study|Lost to Follow-up|1
954538|NCT01086410|1949252|FG003|Overall Study|Lost to Follow-up|0
954539|NCT01086423|1949265|FG000|Overall Study|Protocol Violation|0
954540|NCT01086423|1949266|FG001|Overall Study|Protocol Violation|0
954541|NCT01086423|1949267|FG002|Overall Study|Protocol Violation|1
954542|NCT01086423|1949265|FG000|Overall Study|Migrated/moved from study area|2
954543|NCT01086423|1949266|FG001|Overall Study|Migrated/moved from study area|0
954544|NCT01086423|1949267|FG002|Overall Study|Migrated/moved from study area|4
954545|NCT01086423|1949265|FG000|Overall Study|Adverse event, fatal|1
954546|NCT01086423|1949266|FG001|Overall Study|Adverse event, fatal|1
954547|NCT01086423|1949267|FG002|Overall Study|Adverse event, fatal|0
954548|NCT01086423|1949265|FG000|Overall Study|Adverse event, non-fatal|2
954549|NCT01086423|1949266|FG001|Overall Study|Adverse event, non-fatal|1
954550|NCT01086423|1949267|FG002|Overall Study|Adverse event, non-fatal|0
954551|NCT01086423|1949265|FG000|Overall Study|Withdrawal by Subject|5
954552|NCT01086423|1949266|FG001|Overall Study|Withdrawal by Subject|1
954553|NCT01086423|1949267|FG002|Overall Study|Withdrawal by Subject|3
954554|NCT01086423|1949265|FG000|Overall Study|Lost to Follow-up|0
954555|NCT01086423|1949266|FG001|Overall Study|Lost to Follow-up|0
954556|NCT01086423|1949267|FG002|Overall Study|Lost to Follow-up|1
954557|NCT01086540|1949286|FG000|Overall Study|Death|3
954558|NCT01086540|1949287|FG001|Overall Study|Death|1
954559|NCT01086540|1949286|FG000|Overall Study|Physician Decision|2
954560|NCT01086540|1949287|FG001|Overall Study|Physician Decision|1
954561|NCT01086540|1949286|FG000|Overall Study|Addition of new therapy for PAH|1
954562|NCT01086540|1949287|FG001|Overall Study|Addition of new therapy for PAH|0
911016|NCT00796367|1888166|FG002|Overall Study|Lost to Follow-up|21
911017|NCT00796367|1888164|FG000|Overall Study|Withdrawal by Subject|9
911018|NCT00796367|1888165|FG001|Overall Study|Withdrawal by Subject|11
954563|NCT01086969|1949334|FG000|Overall Study|Withdrawal by Subject|1
954564|NCT01086969|1949335|FG001|Overall Study|Withdrawal by Subject|2
954565|NCT01086969|1949336|FG002|Overall Study|Withdrawal by Subject|0
954566|NCT01087489|1949354|FG000|Overall Study|enrolled in another VA study|0
954567|NCT01087489|1949355|FG001|Overall Study|enrolled in another VA study|1
954568|NCT01087489|1949354|FG000|Overall Study|Death|0
954569|NCT01087489|1949355|FG001|Overall Study|Death|1
954570|NCT01087489|1949354|FG000|Overall Study|unable to survey by telephone|0
954571|NCT01087489|1949355|FG001|Overall Study|unable to survey by telephone|1
954572|NCT01087502|1949363|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5
954573|NCT01087502|1949364|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4
954574|NCT01087502|1949363|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1
954575|NCT01087502|1949364|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1
954576|NCT01087502|1949363|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
954577|NCT01087502|1949364|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
954578|NCT01087502|1949363|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
954579|NCT01087502|1949364|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
954580|NCT01087502|1949363|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1
954581|NCT01087502|1949364|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2
954582|NCT01087502|1949363|FG000|Up to Final Analysis (Week 52)|Adverse Event|17
954583|NCT01087502|1949364|FG001|Up to Final Analysis (Week 52)|Adverse Event|10
954584|NCT01087502|1949363|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1
954585|NCT01087502|1949364|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2
954586|NCT01087502|1949363|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4
954587|NCT01087502|1949364|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0
954588|NCT01087502|1949363|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2
954589|NCT01087502|1949364|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0
954590|NCT01087502|1949363|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
954591|NCT01087502|1949364|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
954592|NCT01087502|1949363|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
954593|NCT01087502|1949364|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
954594|NCT01087502|1949363|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5
954595|NCT01087502|1949364|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4
954596|NCT01087528|1949372|FG000|Overall Study|Withdrawal by Subject|1
954597|NCT01087528|1949372|FG000|Overall Study|Incomplete CE procedure|6
954598|NCT01087723|1949389|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0
954599|NCT01087723|1949390|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1
954600|NCT01087723|1949389|FG000|Overall Study|Withdrawal by Subject|10
954601|NCT01087723|1949390|FG001|Overall Study|Withdrawal by Subject|13
954602|NCT01087723|1949389|FG000|Overall Study|Physician Decision|2
954603|NCT01087723|1949390|FG001|Overall Study|Physician Decision|0
954604|NCT01087723|1949389|FG000|Overall Study|Lost to Follow-up|1
954605|NCT01087723|1949390|FG001|Overall Study|Lost to Follow-up|4
954606|NCT01087723|1949389|FG000|Overall Study|Reason Not Specified|1
954607|NCT01087723|1949390|FG001|Overall Study|Reason Not Specified|2
954608|NCT01087736|1949398|FG000|Overall Study|Lost to Follow-up|1
954609|NCT01087736|1949399|FG001|Overall Study|Lost to Follow-up|0
954610|NCT01087736|1949398|FG000|Overall Study|Death|0
954611|NCT01087736|1949399|FG001|Overall Study|Death|1
954612|NCT01087736|1949398|FG000|Overall Study|Withdrawal by Subject|0
954613|NCT01087736|1949399|FG001|Overall Study|Withdrawal by Subject|1
954614|NCT01087762|1949408|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
954615|NCT01087762|1949409|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
954616|NCT01087762|1949410|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
954617|NCT01087762|1949411|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
954618|NCT01087762|1949412|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
954619|NCT01087762|1949408|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6
954620|NCT01087762|1949409|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0
954621|NCT01087762|1949410|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1
954622|NCT01087762|1949411|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0
954623|NCT01087762|1949412|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0
954624|NCT01087762|1949408|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
954625|NCT01087762|1949409|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
954626|NCT01087762|1949410|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
954627|NCT01087762|1949411|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
954628|NCT01087762|1949412|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
954629|NCT01087762|1949408|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
954630|NCT01087762|1949409|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
954631|NCT01087762|1949410|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
954632|NCT01087762|1949411|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
954633|NCT01087762|1949412|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
954634|NCT01087762|1949408|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
954635|NCT01087762|1949409|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
954636|NCT01087762|1949410|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
954637|NCT01087762|1949411|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
954638|NCT01087762|1949412|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
954639|NCT01087762|1949408|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
954640|NCT01087762|1949409|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
954641|NCT01087762|1949410|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
954642|NCT01087762|1949411|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
954643|NCT01087762|1949412|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
954644|NCT01087762|1949408|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0
954645|NCT01087762|1949409|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0
954646|NCT01087762|1949410|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0
954647|NCT01087762|1949411|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1
954648|NCT01087762|1949412|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1
954649|NCT01087762|1949408|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
954650|NCT01087762|1949409|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
954651|NCT01087762|1949410|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
954652|NCT01087762|1949411|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
954653|NCT01087762|1949412|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
954654|NCT01087762|1949408|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
954655|NCT01087762|1949409|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
954656|NCT01087762|1949410|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
954657|NCT01087762|1949411|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
954658|NCT01087762|1949412|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
954659|NCT01087762|1949408|FG000|Open-Label Period (Weeks 48-204)|Other|0
954660|NCT01087762|1949409|FG001|Open-Label Period (Weeks 48-204)|Other|0
954661|NCT01087762|1949410|FG002|Open-Label Period (Weeks 48-204)|Other|0
954662|NCT01087762|1949411|FG003|Open-Label Period (Weeks 48-204)|Other|2
954663|NCT01087762|1949412|FG004|Open-Label Period (Weeks 48-204)|Other|4
954664|NCT01087762|1949408|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
954665|NCT01087762|1949409|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
954666|NCT01087762|1949410|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
954667|NCT01087762|1949411|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
954668|NCT01087762|1949412|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
954669|NCT01087762|1949408|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
954670|NCT01087762|1949409|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
954671|NCT01087762|1949410|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
954672|NCT01087762|1949411|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
954673|NCT01087762|1949412|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
954674|NCT01087762|1949408|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
954675|NCT01087762|1949409|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
954676|NCT01087762|1949410|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
954677|NCT01087762|1949411|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
954678|NCT01087762|1949412|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
954679|NCT01087775|1949422|FG000|Overall Study|failed inclusion criteria|2
954680|NCT01087788|1949430|FG000|24-weeks Double-blind Period|Lack of Efficacy|2
954681|NCT01087788|1949431|FG001|24-weeks Double-blind Period|Lack of Efficacy|0
954682|NCT01087788|1949432|FG002|24-weeks Double-blind Period|Lack of Efficacy|1
954683|NCT01087788|1949430|FG000|24-weeks Double-blind Period|Protocol Violation|0
954684|NCT01087788|1949431|FG001|24-weeks Double-blind Period|Protocol Violation|1
954685|NCT01087788|1949432|FG002|24-weeks Double-blind Period|Protocol Violation|0
954686|NCT01087788|1949430|FG000|24-weeks Double-blind Period|Lost to Follow-up|4
954687|NCT01087788|1949431|FG001|24-weeks Double-blind Period|Lost to Follow-up|1
954688|NCT01087788|1949432|FG002|24-weeks Double-blind Period|Lost to Follow-up|1
954689|NCT01087788|1949430|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7
954690|NCT01087788|1949431|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2
954691|NCT01087788|1949432|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5
954692|NCT01087788|1949430|FG000|24-weeks Double-blind Period|AE, serious fatal|0
954693|NCT01087788|1949431|FG001|24-weeks Double-blind Period|AE, serious fatal|1
954694|NCT01087788|1949432|FG002|24-weeks Double-blind Period|AE, serious fatal|1
954695|NCT01087788|1949430|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0
954696|NCT01087788|1949431|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2
954697|NCT01087788|1949432|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3
954698|NCT01087788|1949430|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2
954699|NCT01087788|1949431|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1
954700|NCT01087788|1949432|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2
954701|NCT01087788|1949430|FG000|24-weeks Double-blind Period|AE, unknown type|0
954702|NCT01087788|1949431|FG001|24-weeks Double-blind Period|AE, unknown type|0
954703|NCT01087788|1949432|FG002|24-weeks Double-blind Period|AE, unknown type|1
954704|NCT01087788|1949430|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1
954705|NCT01087788|1949431|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0
954706|NCT01087788|1949432|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0
954707|NCT01087788|1949430|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
954708|NCT01087788|1949431|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
954709|NCT01087788|1949432|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
954710|NCT01087788|1949430|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0
954711|NCT01087788|1949431|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1
954712|NCT01087788|1949432|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0
954713|NCT01087788|1949430|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
954714|NCT01087788|1949431|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
954715|NCT01087788|1949432|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
954716|NCT01087788|1949430|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0
954717|NCT01087788|1949431|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2
954718|NCT01087788|1949432|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1
954719|NCT01087788|1949430|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1
954720|NCT01087788|1949431|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0
954721|NCT01087788|1949432|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1
954722|NCT01087788|1949430|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1
954723|NCT01087788|1949431|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0
954724|NCT01087788|1949432|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0
954725|NCT01087788|1949430|FG000|24-weeks Dose-blind Period|AE, serious fatal|0
954726|NCT01087788|1949431|FG001|24-weeks Dose-blind Period|AE, serious fatal|1
954727|NCT01087788|1949432|FG002|24-weeks Dose-blind Period|AE, serious fatal|0
954728|NCT01087788|1949430|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2
954729|NCT01087788|1949431|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1
954730|NCT01087788|1949432|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2
954731|NCT01087788|1949430|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
954732|NCT01087788|1949431|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
954733|NCT01087788|1949432|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
954734|NCT01087788|1949430|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
954735|NCT01087788|1949431|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
954736|NCT01087788|1949432|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
954737|NCT01087788|1949430|FG000|24-weeks Dose-blind Period|Patient moved|0
954738|NCT01087788|1949431|FG001|24-weeks Dose-blind Period|Patient moved|0
954739|NCT01087788|1949432|FG002|24-weeks Dose-blind Period|Patient moved|1
954740|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4
954741|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2
954742|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3
954743|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|Protocol Violation|2
954744|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|Protocol Violation|1
954745|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|Protocol Violation|0
954746|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0
954747|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4
954748|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2
954749|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13
954750|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8
954751|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10
954752|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|AE, serious fatal|2
954753|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|AE, serious fatal|0
954754|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|AE, serious fatal|1
954755|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1
954756|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3
954757|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4
954758|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
954759|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
954760|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
954761|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
954762|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
954763|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
954764|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1
954765|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0
954766|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0
954767|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|Sponsor request|1
954768|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|Sponsor request|0
954769|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|Sponsor request|0
954770|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|Principal investigator decision|0
954771|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|Principal investigator decision|1
954772|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|Principal investigator decision|2
954773|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|No participation in study extension|0
954774|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|No participation in study extension|0
954775|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|No participation in study extension|1
954776|NCT01087788|1949430|FG000|Open-Label Period (OL-P)|Personal reasons|0
954777|NCT01087788|1949431|FG001|Open-Label Period (OL-P)|Personal reasons|0
954778|NCT01087788|1949432|FG002|Open-Label Period (OL-P)|Personal reasons|1
954779|NCT01087814|1949452|FG000|First Intervention (5 Days)|Withdrawal by Subject|3
954780|NCT01087814|1949453|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
954781|NCT01087814|1949452|FG000|Second Intervention (5 Days)|Physician Decision|1
954782|NCT01087814|1949453|FG001|Second Intervention (5 Days)|Physician Decision|0
954783|NCT01087905|1949467|FG000|Overall Study|Lost to Follow-up|24
954784|NCT01087905|1949468|FG001|Overall Study|Lost to Follow-up|28
954785|NCT01087905|1949469|FG002|Overall Study|Lost to Follow-up|18
954786|NCT01087905|1949470|FG003|Overall Study|Lost to Follow-up|31
954787|NCT01087905|1949471|FG004|Overall Study|Lost to Follow-up|27
954788|NCT01087905|1949472|FG005|Overall Study|Lost to Follow-up|25
954789|NCT01087905|1949473|FG006|Overall Study|Lost to Follow-up|20
954790|NCT01087905|1949474|FG007|Overall Study|Lost to Follow-up|24
954791|NCT01087905|1949467|FG000|Overall Study|Withdrawal by Subject|5
954792|NCT01087905|1949468|FG001|Overall Study|Withdrawal by Subject|4
954793|NCT01087905|1949469|FG002|Overall Study|Withdrawal by Subject|4
954794|NCT01087905|1949470|FG003|Overall Study|Withdrawal by Subject|5
954795|NCT01087905|1949471|FG004|Overall Study|Withdrawal by Subject|4
954796|NCT01087905|1949472|FG005|Overall Study|Withdrawal by Subject|3
954797|NCT01087905|1949473|FG006|Overall Study|Withdrawal by Subject|3
954798|NCT01087905|1949474|FG007|Overall Study|Withdrawal by Subject|5
954799|NCT01087944|1949512|FG000|Period 1 (Week 1-3)|Adverse Event|1
954800|NCT01087944|1949513|FG001|Period 1 (Week 1-3)|Adverse Event|0
954801|NCT01087944|1949512|FG000|Period 2 (Week 4-6)|Adverse Event|0
954802|NCT01087944|1949513|FG001|Period 2 (Week 4-6)|Adverse Event|2
954803|NCT01087957|1949521|FG000|Overall Study|Death|2
954804|NCT01087957|1949522|FG001|Overall Study|Death|2
954805|NCT01087957|1949521|FG000|Overall Study|Lost to Follow-up|3
954806|NCT01087957|1949522|FG001|Overall Study|Lost to Follow-up|4
954807|NCT01087957|1949521|FG000|Overall Study|Protocol Violation|13
954808|NCT01087957|1949522|FG001|Overall Study|Protocol Violation|25
954809|NCT01087957|1949521|FG000|Overall Study|Withdrawal by Subject|18
954810|NCT01087957|1949522|FG001|Overall Study|Withdrawal by Subject|15
954811|NCT01087957|1949521|FG000|Overall Study|Physician Decision|5
954812|NCT01087957|1949522|FG001|Overall Study|Physician Decision|9
954813|NCT01087970|1949528|FG000|Overall Study|Protocol Violation|2
954814|NCT01088048|1949552|FG000|Overall Study|Adverse Event|7
954815|NCT01088048|1949553|FG001|Overall Study|Adverse Event|9
954816|NCT01088048|1949554|FG002|Overall Study|Adverse Event|7
954817|NCT01088048|1949555|FG003|Overall Study|Adverse Event|5
954818|NCT01088048|1949556|FG004|Overall Study|Adverse Event|6
954819|NCT01088048|1949557|FG005|Overall Study|Adverse Event|3
954820|NCT01088048|1949558|FG006|Overall Study|Adverse Event|3
954821|NCT01088048|1949559|FG007|Overall Study|Adverse Event|0
954822|NCT01088048|1949560|FG008|Overall Study|Adverse Event|2
954823|NCT01088048|1949561|FG009|Overall Study|Adverse Event|2
954824|NCT01088048|1949552|FG000|Overall Study|Withdrew Consent|1
954825|NCT01088048|1949553|FG001|Overall Study|Withdrew Consent|1
954826|NCT01088048|1949554|FG002|Overall Study|Withdrew Consent|1
954827|NCT01088048|1949555|FG003|Overall Study|Withdrew Consent|1
954828|NCT01088048|1949556|FG004|Overall Study|Withdrew Consent|2
954829|NCT01088048|1949557|FG005|Overall Study|Withdrew Consent|1
954830|NCT01088048|1949558|FG006|Overall Study|Withdrew Consent|0
954831|NCT01088048|1949559|FG007|Overall Study|Withdrew Consent|2
954832|NCT01088048|1949560|FG008|Overall Study|Withdrew Consent|2
954833|NCT01088048|1949561|FG009|Overall Study|Withdrew Consent|1
954834|NCT01088048|1949552|FG000|Overall Study|Concomitant Medication Prohibited|1
954835|NCT01088048|1949553|FG001|Overall Study|Concomitant Medication Prohibited|0
954836|NCT01088048|1949554|FG002|Overall Study|Concomitant Medication Prohibited|0
954837|NCT01088048|1949555|FG003|Overall Study|Concomitant Medication Prohibited|0
954838|NCT01088048|1949556|FG004|Overall Study|Concomitant Medication Prohibited|0
954839|NCT01088048|1949557|FG005|Overall Study|Concomitant Medication Prohibited|0
954840|NCT01088048|1949558|FG006|Overall Study|Concomitant Medication Prohibited|0
954841|NCT01088048|1949559|FG007|Overall Study|Concomitant Medication Prohibited|0
954842|NCT01088048|1949560|FG008|Overall Study|Concomitant Medication Prohibited|0
954843|NCT01088048|1949561|FG009|Overall Study|Concomitant Medication Prohibited|0
954844|NCT01088048|1949552|FG000|Overall Study|Investigator Request|2
954845|NCT01088048|1949553|FG001|Overall Study|Investigator Request|2
954846|NCT01088048|1949554|FG002|Overall Study|Investigator Request|0
954847|NCT01088048|1949555|FG003|Overall Study|Investigator Request|0
954848|NCT01088048|1949556|FG004|Overall Study|Investigator Request|3
954849|NCT01088048|1949557|FG005|Overall Study|Investigator Request|1
954850|NCT01088048|1949558|FG006|Overall Study|Investigator Request|1
954851|NCT01088048|1949559|FG007|Overall Study|Investigator Request|0
954852|NCT01088048|1949560|FG008|Overall Study|Investigator Request|0
954853|NCT01088048|1949561|FG009|Overall Study|Investigator Request|0
954854|NCT01088048|1949552|FG000|Overall Study|Patient Non-compliance|0
954855|NCT01088048|1949553|FG001|Overall Study|Patient Non-compliance|1
954856|NCT01088048|1949554|FG002|Overall Study|Patient Non-compliance|0
954857|NCT01088048|1949555|FG003|Overall Study|Patient Non-compliance|0
954858|NCT01088048|1949556|FG004|Overall Study|Patient Non-compliance|0
954859|NCT01088048|1949557|FG005|Overall Study|Patient Non-compliance|0
954860|NCT01088048|1949558|FG006|Overall Study|Patient Non-compliance|0
954861|NCT01088048|1949559|FG007|Overall Study|Patient Non-compliance|0
954862|NCT01088048|1949560|FG008|Overall Study|Patient Non-compliance|0
954863|NCT01088048|1949561|FG009|Overall Study|Patient Non-compliance|0
954864|NCT01088048|1949552|FG000|Overall Study|Disease Progression|7
954865|NCT01088048|1949553|FG001|Overall Study|Disease Progression|4
954866|NCT01088048|1949554|FG002|Overall Study|Disease Progression|3
954867|NCT01088048|1949555|FG003|Overall Study|Disease Progression|5
954868|NCT01088048|1949556|FG004|Overall Study|Disease Progression|3
954869|NCT01088048|1949557|FG005|Overall Study|Disease Progression|3
954870|NCT01088048|1949558|FG006|Overall Study|Disease Progression|2
954871|NCT01088048|1949559|FG007|Overall Study|Disease Progression|1
954872|NCT01088048|1949560|FG008|Overall Study|Disease Progression|0
954873|NCT01088048|1949561|FG009|Overall Study|Disease Progression|0
954874|NCT01088048|1949552|FG000|Overall Study|Death|1
954875|NCT01088048|1949553|FG001|Overall Study|Death|5
954876|NCT01088048|1949554|FG002|Overall Study|Death|3
954877|NCT01088048|1949555|FG003|Overall Study|Death|3
954878|NCT01088048|1949556|FG004|Overall Study|Death|1
954879|NCT01088048|1949557|FG005|Overall Study|Death|3
954880|NCT01088048|1949558|FG006|Overall Study|Death|0
954881|NCT01088048|1949559|FG007|Overall Study|Death|0
954882|NCT01088048|1949560|FG008|Overall Study|Death|3
954883|NCT01088048|1949561|FG009|Overall Study|Death|1
954884|NCT01088048|1949552|FG000|Overall Study|Other|3
954885|NCT01088048|1949553|FG001|Overall Study|Other|5
954886|NCT01088048|1949554|FG002|Overall Study|Other|0
954887|NCT01088048|1949555|FG003|Overall Study|Other|0
954888|NCT01088048|1949556|FG004|Overall Study|Other|2
954889|NCT01088048|1949557|FG005|Overall Study|Other|0
954890|NCT01088048|1949558|FG006|Overall Study|Other|0
954891|NCT01088048|1949559|FG007|Overall Study|Other|2
954892|NCT01088048|1949560|FG008|Overall Study|Other|0
954893|NCT01088048|1949561|FG009|Overall Study|Other|0
954894|NCT01088243|1949596|FG000|Overall Study|Adverse Event|1
954895|NCT01088243|1949597|FG001|Overall Study|Adverse Event|0
954896|NCT01088399|1949610|FG000|Overall Study|Adverse Event|211
954897|NCT01088399|1949611|FG001|Overall Study|Adverse Event|16
954898|NCT01088399|1949612|FG002|Overall Study|Adverse Event|0
954899|NCT01088399|1949610|FG000|Overall Study|Death|204
954900|NCT01088399|1949611|FG001|Overall Study|Death|45
954901|NCT01088399|1949612|FG002|Overall Study|Death|0
954902|NCT01088399|1949610|FG000|Overall Study|Lack of Efficacy|298
954903|NCT01088399|1949611|FG001|Overall Study|Lack of Efficacy|7
954904|NCT01088399|1949612|FG002|Overall Study|Lack of Efficacy|5
954905|NCT01088399|1949610|FG000|Overall Study|Lost to Follow-up|1070
954906|NCT01088399|1949611|FG001|Overall Study|Lost to Follow-up|278
954907|NCT01088399|1949612|FG002|Overall Study|Lost to Follow-up|58
954908|NCT01088399|1949610|FG000|Overall Study|Physician Decision|531
954909|NCT01088399|1949611|FG001|Overall Study|Physician Decision|88
954910|NCT01088399|1949612|FG002|Overall Study|Physician Decision|16
954911|NCT01088399|1949610|FG000|Overall Study|Withdrawal by Subject|544
954912|NCT01088399|1949611|FG001|Overall Study|Withdrawal by Subject|195
954913|NCT01088399|1949612|FG002|Overall Study|Withdrawal by Subject|33
954914|NCT01088399|1949610|FG000|Overall Study|Change to or start of somatropin therapy|234
954915|NCT01088399|1949611|FG001|Overall Study|Change to or start of somatropin therapy|17
954916|NCT01088399|1949612|FG002|Overall Study|Change to or start of somatropin therapy|12
954917|NCT01088399|1949610|FG000|Overall Study|Sponsor decision|1573
954918|NCT01088399|1949611|FG001|Overall Study|Sponsor decision|298
954919|NCT01088399|1949612|FG002|Overall Study|Sponsor decision|7
954920|NCT01088399|1949610|FG000|Overall Study|Protocol Violation|10
954921|NCT01088399|1949611|FG001|Overall Study|Protocol Violation|1
954922|NCT01088399|1949612|FG002|Overall Study|Protocol Violation|0
954923|NCT01088399|1949610|FG000|Overall Study|Enrollment criteria not met|48
954924|NCT01088399|1949611|FG001|Overall Study|Enrollment criteria not met|119
954925|NCT01088399|1949612|FG002|Overall Study|Enrollment criteria not met|70
954926|NCT01088399|1949610|FG000|Overall Study|Study summary visit not completed|2398
954927|NCT01088399|1949611|FG001|Overall Study|Study summary visit not completed|283
954928|NCT01088399|1949612|FG002|Overall Study|Study summary visit not completed|80
954929|NCT01088412|1949623|FG000|Overall Study|Adverse Event|38
954930|NCT01088412|1949624|FG001|Overall Study|Adverse Event|0
954931|NCT01088412|1949625|FG002|Overall Study|Adverse Event|0
954932|NCT01088412|1949623|FG000|Overall Study|Death|42
954933|NCT01088412|1949624|FG001|Overall Study|Death|6
954934|NCT01088412|1949625|FG002|Overall Study|Death|0
954935|NCT01088412|1949623|FG000|Overall Study|Other Reason per Case Report Form|2089
954936|NCT01088412|1949624|FG001|Overall Study|Other Reason per Case Report Form|103
954937|NCT01088412|1949625|FG002|Overall Study|Other Reason per Case Report Form|9
954938|NCT01088412|1949623|FG000|Overall Study|Withdrawal by Subject|1761
954939|NCT01088412|1949624|FG001|Overall Study|Withdrawal by Subject|25
954940|NCT01088412|1949625|FG002|Overall Study|Withdrawal by Subject|1
954941|NCT01088412|1949623|FG000|Overall Study|Received Another GH Product|79
954942|NCT01088412|1949624|FG001|Overall Study|Received Another GH Product|0
954943|NCT01088412|1949625|FG002|Overall Study|Received Another GH Product|0
954944|NCT01088412|1949623|FG000|Overall Study|Participant Moved|601
954945|NCT01088412|1949624|FG001|Overall Study|Participant Moved|21
954946|NCT01088412|1949625|FG002|Overall Study|Participant Moved|2
954947|NCT01088412|1949623|FG000|Overall Study|Physician Decision|1041
954948|NCT01088412|1949624|FG001|Overall Study|Physician Decision|8
954949|NCT01088412|1949625|FG002|Overall Study|Physician Decision|4
954950|NCT01088412|1949623|FG000|Overall Study|Sponsor Decision|4467
954951|NCT01088412|1949624|FG001|Overall Study|Sponsor Decision|79
954952|NCT01088412|1949625|FG002|Overall Study|Sponsor Decision|23
954953|NCT01088412|1949623|FG000|Overall Study|Third Party Required to Change Brand|487
954954|NCT01088412|1949624|FG001|Overall Study|Third Party Required to Change Brand|0
954955|NCT01088412|1949625|FG002|Overall Study|Third Party Required to Change Brand|0
954956|NCT01088412|1949623|FG000|Overall Study|Lost to Follow-up|3052
954957|NCT01088412|1949624|FG001|Overall Study|Lost to Follow-up|130
954958|NCT01088412|1949625|FG002|Overall Study|Lost to Follow-up|11
954959|NCT01088412|1949623|FG000|Overall Study|Study Summary Not Completed|4360
954960|NCT01088412|1949624|FG001|Overall Study|Study Summary Not Completed|64
954961|NCT01088412|1949625|FG002|Overall Study|Study Summary Not Completed|22
954962|NCT01088438|1949638|FG000|Overall Study|Withdrawal by Subject|11
954963|NCT01088438|1949639|FG001|Overall Study|Withdrawal by Subject|6
954964|NCT01088438|1949638|FG000|Overall Study|Lost to Follow-up|18
954965|NCT01088438|1949639|FG001|Overall Study|Lost to Follow-up|30
954966|NCT01088503|1949661|FG000|Overall Study|Withdrawal by Subject|118
954967|NCT01088503|1949662|FG001|Overall Study|Withdrawal by Subject|327
954968|NCT01088503|1949663|FG002|Overall Study|Withdrawal by Subject|10
954969|NCT01088503|1949661|FG000|Overall Study|Death|64
954970|NCT01088503|1949662|FG001|Overall Study|Death|358
954971|NCT01088503|1949663|FG002|Overall Study|Death|7
954972|NCT01088529|1949671|FG000|Overall Study|Did not receive study treatment|0
954973|NCT01088529|1949672|FG001|Overall Study|Did not receive study treatment|1
954974|NCT01088984|1949712|FG000|Phase 1|Death|2
954975|NCT01088984|1949713|FG001|Phase 1|Death|1
954976|NCT01088984|1949712|FG000|Phase 1|Disease Progression|2
954977|NCT01088984|1949713|FG001|Phase 1|Disease Progression|4
954978|NCT01088984|1949712|FG000|Phase 1|Other|1
954979|NCT01088984|1949713|FG001|Phase 1|Other|1
954980|NCT01088984|1949712|FG000|Phase 2|Death|0
954981|NCT01088984|1949713|FG001|Phase 2|Death|5
954982|NCT01088984|1949712|FG000|Phase 2|Withdrawal by Subject|0
954983|NCT01088984|1949713|FG001|Phase 2|Withdrawal by Subject|1
954984|NCT01088984|1949712|FG000|Phase 2|DIsease Progression|0
954985|NCT01088984|1949713|FG001|Phase 2|DIsease Progression|25
954986|NCT01088984|1949712|FG000|Phase 2|Other|0
954987|NCT01088984|1949713|FG001|Phase 2|Other|1
954988|NCT01088997|1949724|FG000|Overall Study|Physician Decision|1
954989|NCT01088997|1949725|FG001|Overall Study|Physician Decision|1
954990|NCT01088997|1949724|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1
954991|NCT01088997|1949725|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1
954992|NCT01088997|1949724|FG000|Overall Study|Excluded prior to receiving drug|1
954993|NCT01088997|1949725|FG001|Overall Study|Excluded prior to receiving drug|1
954994|NCT01089023|1949734|FG000|Overall Study|Lost to Follow-up|3
954995|NCT01089023|1949734|FG000|Overall Study|Adverse Event|1
954996|NCT01089023|1949734|FG000|Overall Study|Withdrawal by Subject|1
954997|NCT01089023|1949734|FG000|Overall Study|Protocol Violation|1
954998|NCT01089023|1949734|FG000|Overall Study|Lack of Efficacy|1
954999|NCT01089127|1949764|FG000|Overall Study|Adverse Event|5
955000|NCT01089127|1949765|FG001|Overall Study|Adverse Event|1
955001|NCT01089127|1949766|FG002|Overall Study|Adverse Event|1
955002|NCT01089127|1949767|FG003|Overall Study|Adverse Event|0
955003|NCT01089127|1949768|FG004|Overall Study|Adverse Event|0
955004|NCT01089127|1949769|FG005|Overall Study|Adverse Event|1
955005|NCT01089127|1949764|FG000|Overall Study|Subject withdrew consent|0
955006|NCT01089127|1949765|FG001|Overall Study|Subject withdrew consent|1
955007|NCT01089127|1949766|FG002|Overall Study|Subject withdrew consent|1
955008|NCT01089127|1949767|FG003|Overall Study|Subject withdrew consent|1
955009|NCT01089127|1949768|FG004|Overall Study|Subject withdrew consent|0
955010|NCT01089127|1949769|FG005|Overall Study|Subject withdrew consent|2
955011|NCT01089127|1949764|FG000|Overall Study|Abnormal test procedure result(s)|2
955012|NCT01089127|1949765|FG001|Overall Study|Abnormal test procedure result(s)|1
955013|NCT01089127|1949766|FG002|Overall Study|Abnormal test procedure result(s)|0
955014|NCT01089127|1949767|FG003|Overall Study|Abnormal test procedure result(s)|0
955015|NCT01089127|1949768|FG004|Overall Study|Abnormal test procedure result(s)|0
955016|NCT01089127|1949769|FG005|Overall Study|Abnormal test procedure result(s)|0
955017|NCT01089127|1949764|FG000|Overall Study|Lost to Follow-up|1
955018|NCT01089127|1949765|FG001|Overall Study|Lost to Follow-up|1
955019|NCT01089127|1949766|FG002|Overall Study|Lost to Follow-up|0
955020|NCT01089127|1949767|FG003|Overall Study|Lost to Follow-up|0
955021|NCT01089127|1949768|FG004|Overall Study|Lost to Follow-up|1
955022|NCT01089127|1949769|FG005|Overall Study|Lost to Follow-up|0
955023|NCT01089127|1949764|FG000|Overall Study|Protocol deviation|0
955024|NCT01089127|1949765|FG001|Overall Study|Protocol deviation|1
955025|NCT01089127|1949766|FG002|Overall Study|Protocol deviation|0
955026|NCT01089127|1949767|FG003|Overall Study|Protocol deviation|0
955027|NCT01089127|1949768|FG004|Overall Study|Protocol deviation|1
955028|NCT01089127|1949769|FG005|Overall Study|Protocol deviation|0
955029|NCT01089361|1949802|FG000|Overall Study|Death|1
955030|NCT01089361|1949803|FG001|Overall Study|Death|0
955031|NCT01089413|1949814|FG000|Overall Study|Lost to Follow-up|1
955032|NCT01089413|1949814|FG000|Overall Study|Progressive Disease|93
955033|NCT01089413|1949814|FG000|Overall Study|Participant Withdrew Consent|1
955034|NCT01089413|1949814|FG000|Overall Study|Unacceptable Toxicity|12
955035|NCT01089413|1949814|FG000|Overall Study|Death|10
955036|NCT01089413|1949814|FG000|Overall Study|Metastasectomy|13
955037|NCT01089413|1949814|FG000|Overall Study|Other|71
955038|NCT01089504|1949826|FG000|Overall Study|Lost to Follow-up|1
955039|NCT01089504|1949827|FG001|Overall Study|Lost to Follow-up|1
955040|NCT01089504|1949826|FG000|Overall Study|Withdrawal by Subject|2
955041|NCT01089504|1949827|FG001|Overall Study|Withdrawal by Subject|0
955042|NCT01089543|1949850|FG000|Overall Study|Withdrawal by Subject|2
955043|NCT01089543|1949851|FG001|Overall Study|Withdrawal by Subject|3
955044|NCT01089543|1949852|FG002|Overall Study|Withdrawal by Subject|3
955045|NCT01089543|1949853|FG003|Overall Study|Withdrawal by Subject|1
955046|NCT01089543|1949850|FG000|Overall Study|Physician Decision|1
955047|NCT01089543|1949851|FG001|Overall Study|Physician Decision|0
955048|NCT01089543|1949852|FG002|Overall Study|Physician Decision|0
955049|NCT01089543|1949853|FG003|Overall Study|Physician Decision|1
955050|NCT01089543|1949850|FG000|Overall Study|Adverse Event|0
955051|NCT01089543|1949851|FG001|Overall Study|Adverse Event|1
955052|NCT01089543|1949852|FG002|Overall Study|Adverse Event|0
955053|NCT01089543|1949853|FG003|Overall Study|Adverse Event|0
955054|NCT01089556|1949865|FG000|Study Period II (Weeks 1-8)|Adverse Event|35
955055|NCT01089556|1949866|FG001|Study Period II (Weeks 1-8)|Adverse Event|39
955056|NCT01089556|1949867|FG002|Study Period II (Weeks 1-8)|Adverse Event|0
955057|NCT01089556|1949868|FG003|Study Period II (Weeks 1-8)|Adverse Event|0
955058|NCT01089556|1949869|FG004|Study Period II (Weeks 1-8)|Adverse Event|0
955059|NCT01089556|1949870|FG005|Study Period II (Weeks 1-8)|Adverse Event|0
955060|NCT01089556|1949865|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
955061|NCT01089556|1949866|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
955062|NCT01089556|1949867|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
955063|NCT01089556|1949868|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
955064|NCT01089556|1949869|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
955065|NCT01089556|1949870|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
955066|NCT01089556|1949865|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1
955067|NCT01089556|1949866|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2
955068|NCT01089556|1949867|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0
955069|NCT01089556|1949868|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0
955070|NCT01089556|1949869|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0
955071|NCT01089556|1949870|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0
955072|NCT01089556|1949865|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0
955073|NCT01089556|1949866|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3
955074|NCT01089556|1949867|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0
955075|NCT01089556|1949868|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0
955076|NCT01089556|1949869|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0
955077|NCT01089556|1949870|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0
955078|NCT01089556|1949865|FG000|Study Period II (Weeks 1-8)|Physician Decision|4
955079|NCT01089556|1949866|FG001|Study Period II (Weeks 1-8)|Physician Decision|0
955080|NCT01089556|1949867|FG002|Study Period II (Weeks 1-8)|Physician Decision|0
955081|NCT01089556|1949868|FG003|Study Period II (Weeks 1-8)|Physician Decision|0
955082|NCT01089556|1949869|FG004|Study Period II (Weeks 1-8)|Physician Decision|0
955083|NCT01089556|1949870|FG005|Study Period II (Weeks 1-8)|Physician Decision|0
955084|NCT01089556|1949865|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4
955085|NCT01089556|1949866|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4
955086|NCT01089556|1949867|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0
955087|NCT01089556|1949868|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0
955088|NCT01089556|1949869|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0
955089|NCT01089556|1949870|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0
955090|NCT01089556|1949865|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
955091|NCT01089556|1949866|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
955092|NCT01089556|1949867|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
955093|NCT01089556|1949868|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
955094|NCT01089556|1949869|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
955095|NCT01089556|1949870|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
955096|NCT01089556|1949865|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3
955097|NCT01089556|1949866|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4
955098|NCT01089556|1949867|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0
955099|NCT01089556|1949868|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0
955100|NCT01089556|1949869|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0
955101|NCT01089556|1949870|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0
955102|NCT01089556|1949865|FG000|Study Period III (Weeks 9-16)|Adverse Event|0
955103|NCT01089556|1949866|FG001|Study Period III (Weeks 9-16)|Adverse Event|0
955104|NCT01089556|1949867|FG002|Study Period III (Weeks 9-16)|Adverse Event|4
955105|NCT01089556|1949868|FG003|Study Period III (Weeks 9-16)|Adverse Event|2
955106|NCT01089556|1949869|FG004|Study Period III (Weeks 9-16)|Adverse Event|4
955107|NCT01089556|1949870|FG005|Study Period III (Weeks 9-16)|Adverse Event|3
955108|NCT01089556|1949865|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
955109|NCT01089556|1949866|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
955110|NCT01089556|1949867|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
955111|NCT01089556|1949868|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
955112|NCT01089556|1949869|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
955113|NCT01089556|1949870|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
955114|NCT01089556|1949865|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0
955115|NCT01089556|1949866|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0
955116|NCT01089556|1949867|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0
955117|NCT01089556|1949868|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2
955118|NCT01089556|1949869|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1
955119|NCT01089556|1949870|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0
955120|NCT01089556|1949865|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0
955121|NCT01089556|1949866|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0
955122|NCT01089556|1949867|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1
955123|NCT01089556|1949868|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0
955124|NCT01089556|1949869|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0
955125|NCT01089556|1949870|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0
955126|NCT01089556|1949865|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0
955127|NCT01089556|1949866|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0
955128|NCT01089556|1949867|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1
955129|NCT01089556|1949868|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1
955130|NCT01089556|1949869|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1
955131|NCT01089556|1949870|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0
955132|NCT01089556|1949865|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0
955133|NCT01089556|1949866|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0
955134|NCT01089556|1949867|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4
955135|NCT01089556|1949868|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3
955136|NCT01089556|1949869|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4
955137|NCT01089556|1949870|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1
955138|NCT01089556|1949865|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
955139|NCT01089556|1949866|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
955140|NCT01089556|1949867|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
955141|NCT01089556|1949868|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
955142|NCT01089556|1949869|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
955143|NCT01089556|1949870|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
955144|NCT01089582|1949895|FG000|Overall Study|Death|2
955145|NCT01089582|1949895|FG000|Overall Study|Adverse Event|15
955146|NCT01089582|1949895|FG000|Overall Study|Lost to Follow-up|8
955147|NCT01089582|1949895|FG000|Overall Study|Other|4
955148|NCT01089582|1949895|FG000|Overall Study|Withdrawal by Subject|1
955149|NCT01089608|1949912|FG000|Overall Study|Adverse Event|0
955150|NCT01089608|1949913|FG001|Overall Study|Adverse Event|4
955151|NCT01089608|1949912|FG000|Overall Study|Lost to Follow-up|0
955152|NCT01089608|1949913|FG001|Overall Study|Lost to Follow-up|2
955153|NCT01089647|1949921|FG000|Overall Study|Lost to Follow-up|2
955154|NCT01089647|1949922|FG001|Overall Study|Lost to Follow-up|2
955155|NCT01089647|1949921|FG000|Overall Study|Withdrawal by Subject|2
955156|NCT01089647|1949922|FG001|Overall Study|Withdrawal by Subject|1
955157|NCT01089647|1949921|FG000|Overall Study|Adverse Event|0
955158|NCT01089647|1949922|FG001|Overall Study|Adverse Event|1
955159|NCT01089725|1949933|FG000|Overall Study|Adverse Event|1
955160|NCT01089725|1949934|FG001|Overall Study|Adverse Event|1
955161|NCT01089725|1949935|FG002|Overall Study|Adverse Event|0
955162|NCT01089725|1949936|FG003|Overall Study|Adverse Event|0
955163|NCT01089725|1949937|FG004|Overall Study|Adverse Event|2
955164|NCT01089725|1949933|FG000|Overall Study|Lack of Efficacy|4
955165|NCT01089725|1949934|FG001|Overall Study|Lack of Efficacy|3
955166|NCT01089725|1949935|FG002|Overall Study|Lack of Efficacy|1
955167|NCT01089725|1949936|FG003|Overall Study|Lack of Efficacy|0
955168|NCT01089725|1949937|FG004|Overall Study|Lack of Efficacy|4
955169|NCT01089725|1949933|FG000|Overall Study|Lost to Follow-up|2
955170|NCT01089725|1949934|FG001|Overall Study|Lost to Follow-up|2
955171|NCT01089725|1949935|FG002|Overall Study|Lost to Follow-up|0
955172|NCT01089725|1949936|FG003|Overall Study|Lost to Follow-up|3
955173|NCT01089725|1949937|FG004|Overall Study|Lost to Follow-up|0
955174|NCT01089725|1949933|FG000|Overall Study|Protocol Violation|0
955175|NCT01089725|1949934|FG001|Overall Study|Protocol Violation|0
955176|NCT01089725|1949935|FG002|Overall Study|Protocol Violation|1
955177|NCT01089725|1949936|FG003|Overall Study|Protocol Violation|1
955178|NCT01089725|1949937|FG004|Overall Study|Protocol Violation|0
955179|NCT01089725|1949933|FG000|Overall Study|Withdrawal by Subject|5
955180|NCT01089725|1949934|FG001|Overall Study|Withdrawal by Subject|5
955181|NCT01089725|1949935|FG002|Overall Study|Withdrawal by Subject|4
955182|NCT01089725|1949936|FG003|Overall Study|Withdrawal by Subject|5
955183|NCT01089725|1949937|FG004|Overall Study|Withdrawal by Subject|4
955184|NCT01089725|1949933|FG000|Overall Study|Study Terminated by Sponsor|51
955185|NCT01089725|1949934|FG001|Overall Study|Study Terminated by Sponsor|56
955186|NCT01089725|1949935|FG002|Overall Study|Study Terminated by Sponsor|53
955187|NCT01089725|1949936|FG003|Overall Study|Study Terminated by Sponsor|68
955188|NCT01089725|1949937|FG004|Overall Study|Study Terminated by Sponsor|68
955189|NCT01089725|1949933|FG000|Overall Study|Randomized, but not treated|0
955190|NCT01089725|1949934|FG001|Overall Study|Randomized, but not treated|1
955191|NCT01089725|1949935|FG002|Overall Study|Randomized, but not treated|2
955192|NCT01089725|1949936|FG003|Overall Study|Randomized, but not treated|1
955193|NCT01089725|1949937|FG004|Overall Study|Randomized, but not treated|2
955194|NCT01089725|1949933|FG000|Overall Study|Other|3
955195|NCT01089725|1949934|FG001|Overall Study|Other|0
955196|NCT01089725|1949935|FG002|Overall Study|Other|0
955197|NCT01089725|1949936|FG003|Overall Study|Other|1
955198|NCT01089725|1949937|FG004|Overall Study|Other|0
955199|NCT01090011|1949962|FG000|Overall Study|Progressive disease|128
955200|NCT01090011|1949962|FG000|Overall Study|Adverse Event|32
955201|NCT01090011|1949962|FG000|Overall Study|Protocol Violation|1
955202|NCT01090011|1949962|FG000|Overall Study|Refusal to start/continue medication|5
955203|NCT01090011|1949962|FG000|Overall Study|Other reason not defined above|5
955204|NCT01090050|1949976|FG000|Overall Study|Lost to Follow-up|0
955205|NCT01090050|1949977|FG001|Overall Study|Lost to Follow-up|1
955206|NCT01090050|1949976|FG000|Overall Study|Lack of Efficacy|1
955207|NCT01090050|1949977|FG001|Overall Study|Lack of Efficacy|5
955208|NCT01090050|1949976|FG000|Overall Study|Physician Decision|0
955209|NCT01090050|1949977|FG001|Overall Study|Physician Decision|1
955210|NCT01090063|1949987|FG000|Screen|Screen Failed|4
955211|NCT01090063|1949987|FG000|Treatment|Withdrawal by Subject|4
955212|NCT01090076|1950003|FG000|Overall Study|Death|1
955213|NCT01090076|1950004|FG001|Overall Study|Death|1
955214|NCT01090076|1950003|FG000|Overall Study|Withdrawal by Subject|0
955215|NCT01090076|1950004|FG001|Overall Study|Withdrawal by Subject|1
955216|NCT01090102|1950014|FG000|First 12 Weeks|Withdrawal by Subject|1
955217|NCT01090102|1950015|FG001|First 12 Weeks|Withdrawal by Subject|1
955218|NCT01090102|1950014|FG000|First 12 Weeks|Adverse Event|2
955219|NCT01090102|1950015|FG001|First 12 Weeks|Adverse Event|0
955220|NCT01090102|1950014|FG000|First 12 Weeks|Death|1
955221|NCT01090102|1950015|FG001|First 12 Weeks|Death|1
955222|NCT01090102|1950014|FG000|Second 12 Weeks|Withdrawal by Subject|0
955223|NCT01090102|1950015|FG001|Second 12 Weeks|Withdrawal by Subject|1
955224|NCT01090310|1950034|FG000|Core Study|Adverse Event|2
955225|NCT01090310|1950035|FG001|Core Study|Adverse Event|2
955226|NCT01090310|1950036|FG002|Core Study|Adverse Event|1
955227|NCT01090310|1950037|FG003|Core Study|Adverse Event|1
955228|NCT01090310|1950034|FG000|Core Study|Subject withdrew consent|0
955229|NCT01090310|1950035|FG001|Core Study|Subject withdrew consent|3
955230|NCT01090310|1950036|FG002|Core Study|Subject withdrew consent|1
955231|NCT01090310|1950037|FG003|Core Study|Subject withdrew consent|1
955232|NCT01090310|1950034|FG000|Core Study|Abnormal test procedure result|0
955233|NCT01090310|1950035|FG001|Core Study|Abnormal test procedure result|0
955234|NCT01090310|1950036|FG002|Core Study|Abnormal test procedure result|1
955235|NCT01090310|1950037|FG003|Core Study|Abnormal test procedure result|0
955236|NCT01090310|1950034|FG000|Core Study|Administrative reasons|5
955237|NCT01090310|1950035|FG001|Core Study|Administrative reasons|6
955238|NCT01090310|1950036|FG002|Core Study|Administrative reasons|4
955239|NCT01090310|1950037|FG003|Core Study|Administrative reasons|4
955240|NCT01090310|1950034|FG000|Core Study|Protocol deviation|1
955241|NCT01090310|1950035|FG001|Core Study|Protocol deviation|0
955242|NCT01090310|1950036|FG002|Core Study|Protocol deviation|0
955243|NCT01090310|1950037|FG003|Core Study|Protocol deviation|1
955244|NCT01090310|1950034|FG000|Extension Study|Aministrative problems|13
955245|NCT01090310|1950035|FG001|Extension Study|Aministrative problems|15
955246|NCT01090310|1950036|FG002|Extension Study|Aministrative problems|14
955247|NCT01090310|1950037|FG003|Extension Study|Aministrative problems|18
955248|NCT01090310|1950034|FG000|Extension Study|Adverse Event|0
955249|NCT01090310|1950035|FG001|Extension Study|Adverse Event|0
955250|NCT01090310|1950036|FG002|Extension Study|Adverse Event|0
955251|NCT01090310|1950037|FG003|Extension Study|Adverse Event|1
955252|NCT01090310|1950034|FG000|Extension Study|Unsatisfactory therapeutic effect|1
955253|NCT01090310|1950035|FG001|Extension Study|Unsatisfactory therapeutic effect|0
955254|NCT01090310|1950036|FG002|Extension Study|Unsatisfactory therapeutic effect|1
955255|NCT01090310|1950037|FG003|Extension Study|Unsatisfactory therapeutic effect|1
955256|NCT01090310|1950034|FG000|Extension Study|Subject withdrew consent|0
955257|NCT01090310|1950035|FG001|Extension Study|Subject withdrew consent|1
955258|NCT01090310|1950036|FG002|Extension Study|Subject withdrew consent|0
955259|NCT01090310|1950037|FG003|Extension Study|Subject withdrew consent|0
955260|NCT01090323|1950049|FG000|Overall Study|Adverse Event|12
955261|NCT01090323|1950050|FG001|Overall Study|Adverse Event|2
955262|NCT01090323|1950049|FG000|Overall Study|Abnormal Lab Values|3
955263|NCT01090323|1950050|FG001|Overall Study|Abnormal Lab Values|1
955264|NCT01090323|1950049|FG000|Overall Study|Abnormal Test Procedure Results|2
955265|NCT01090323|1950050|FG001|Overall Study|Abnormal Test Procedure Results|0
955266|NCT01090323|1950049|FG000|Overall Study|Unsatisfactory therapeutic effect|4
955267|NCT01090323|1950050|FG001|Overall Study|Unsatisfactory therapeutic effect|2
955268|NCT01090323|1950049|FG000|Overall Study|Condition no longer requires drug|5
955269|NCT01090323|1950050|FG001|Overall Study|Condition no longer requires drug|4
955270|NCT01090323|1950049|FG000|Overall Study|Protocol Violation|2
955271|NCT01090323|1950050|FG001|Overall Study|Protocol Violation|1
955272|NCT01090323|1950049|FG000|Overall Study|Withdrew consent|33
955273|NCT01090323|1950050|FG001|Overall Study|Withdrew consent|11
955274|NCT01090323|1950049|FG000|Overall Study|Lost to Follow-up|11
955275|NCT01090323|1950050|FG001|Overall Study|Lost to Follow-up|6
955276|NCT01090323|1950049|FG000|Overall Study|Administrative problems|6
955277|NCT01090323|1950050|FG001|Overall Study|Administrative problems|4
955278|NCT01090323|1950049|FG000|Overall Study|Death|1
955279|NCT01090323|1950050|FG001|Overall Study|Death|2
955280|NCT01090323|1950049|FG000|Overall Study|Stopped end of core|7
955281|NCT01090323|1950050|FG001|Overall Study|Stopped end of core|0
955282|NCT01090323|1950049|FG000|Overall Study|Stopped end of extension 1#|3
955283|NCT01090323|1950050|FG001|Overall Study|Stopped end of extension 1#|1
955284|NCT01090414|1950060|FG000|Study 101-99|Progressive Disease|28
955285|NCT01090414|1950061|FG001|Study 101-99|Progressive Disease|48
955286|NCT01090414|1950062|FG002|Study 101-99|Progressive Disease|10
955287|NCT01090414|1950063|FG003|Study 101-99|Progressive Disease|4
955288|NCT01090414|1950060|FG000|Study 101-99|Adverse Event|10
955289|NCT01090414|1950061|FG001|Study 101-99|Adverse Event|28
955290|NCT01090414|1950062|FG002|Study 101-99|Adverse Event|18
955291|NCT01090414|1950063|FG003|Study 101-99|Adverse Event|0
955292|NCT01090414|1950060|FG000|Study 101-99|Investigator Request|1
955293|NCT01090414|1950061|FG001|Study 101-99|Investigator Request|11
955294|NCT01090414|1950062|FG002|Study 101-99|Investigator Request|4
955295|NCT01090414|1950063|FG003|Study 101-99|Investigator Request|0
955296|NCT01090414|1950060|FG000|Study 101-99|Death|3
955297|NCT01090414|1950061|FG001|Study 101-99|Death|8
955298|NCT01090414|1950062|FG002|Study 101-99|Death|1
955299|NCT01090414|1950063|FG003|Study 101-99|Death|0
955300|NCT01090414|1950060|FG000|Study 101-99|Sponsor Discontinued Study|0
955301|NCT01090414|1950061|FG001|Study 101-99|Sponsor Discontinued Study|7
955302|NCT01090414|1950062|FG002|Study 101-99|Sponsor Discontinued Study|5
955303|NCT01090414|1950063|FG003|Study 101-99|Sponsor Discontinued Study|0
955304|NCT01090414|1950060|FG000|Study 101-99|Other (Unknown Reasons)|3
955305|NCT01090414|1950061|FG001|Study 101-99|Other (Unknown Reasons)|3
955306|NCT01090414|1950062|FG002|Study 101-99|Other (Unknown Reasons)|0
955307|NCT01090414|1950063|FG003|Study 101-99|Other (Unknown Reasons)|0
955308|NCT01090414|1950060|FG000|Study 101-99|Withdrew Consent|0
955309|NCT01090414|1950061|FG001|Study 101-99|Withdrew Consent|2
955310|NCT01090414|1950062|FG002|Study 101-99|Withdrew Consent|3
955311|NCT01090414|1950063|FG003|Study 101-99|Withdrew Consent|1
955312|NCT01090414|1950060|FG000|Study 101-99|Participant Request|3
955313|NCT01090414|1950061|FG001|Study 101-99|Participant Request|1
955314|NCT01090414|1950062|FG002|Study 101-99|Participant Request|0
955315|NCT01090414|1950063|FG003|Study 101-99|Participant Request|0
955316|NCT01090427|1950088|FG000|After Controlled Period|Death|0
955317|NCT01090427|1950089|FG001|After Controlled Period|Death|0
955318|NCT01090427|1950090|FG002|After Controlled Period|Death|0
955319|NCT01090427|1950091|FG003|After Controlled Period|Death|0
955320|NCT01090427|1950092|FG004|After Controlled Period|Death|0
955321|NCT01090427|1950093|FG005|After Controlled Period|Death|1
955322|NCT01090427|1950094|FG006|After Controlled Period|Death|0
955323|NCT01090427|1950088|FG000|After Controlled Period|Lack of Efficacy|0
955324|NCT01090427|1950089|FG001|After Controlled Period|Lack of Efficacy|0
955325|NCT01090427|1950090|FG002|After Controlled Period|Lack of Efficacy|0
955326|NCT01090427|1950091|FG003|After Controlled Period|Lack of Efficacy|0
955327|NCT01090427|1950092|FG004|After Controlled Period|Lack of Efficacy|0
955328|NCT01090427|1950093|FG005|After Controlled Period|Lack of Efficacy|3
955329|NCT01090427|1950094|FG006|After Controlled Period|Lack of Efficacy|2
955330|NCT01090427|1950088|FG000|After Controlled Period|Adverse Event|0
955331|NCT01090427|1950089|FG001|After Controlled Period|Adverse Event|0
955332|NCT01090427|1950090|FG002|After Controlled Period|Adverse Event|0
955333|NCT01090427|1950091|FG003|After Controlled Period|Adverse Event|2
955334|NCT01090427|1950092|FG004|After Controlled Period|Adverse Event|0
955335|NCT01090427|1950093|FG005|After Controlled Period|Adverse Event|1
955336|NCT01090427|1950094|FG006|After Controlled Period|Adverse Event|0
955337|NCT01090453|1950108|FG000|Overall Study|Withdrawal by Subject|1
955338|NCT01090453|1950109|FG001|Overall Study|Withdrawal by Subject|2
955339|NCT01090453|1950108|FG000|Overall Study|Lost to Follow-up|7
955340|NCT01090453|1950109|FG001|Overall Study|Lost to Follow-up|7
955341|NCT01090453|1950108|FG000|Overall Study|Non serious AEs|1
955342|NCT01090453|1950109|FG001|Overall Study|Non serious AEs|0
955343|NCT01090453|1950108|FG000|Overall Study|Protocol Violation|2
955344|NCT01090453|1950109|FG001|Overall Study|Protocol Violation|0
955345|NCT01090453|1950108|FG000|Overall Study|Other|2
955346|NCT01090453|1950109|FG001|Overall Study|Other|4
955347|NCT01090453|1950108|FG000|Overall Study|Eligibility Criteria|0
955348|NCT01090453|1950109|FG001|Overall Study|Eligibility Criteria|1
955349|NCT01090492|1950132|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1
955350|NCT01090492|1950133|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1
955351|NCT01090492|1950134|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1
955352|NCT01090492|1950135|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2
955353|NCT01090492|1950136|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0
955354|NCT01090492|1950137|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0
955355|NCT01090492|1950138|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1
955356|NCT01090492|1950139|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0
955357|NCT01090492|1950132|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
955358|NCT01090492|1950133|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
955359|NCT01090492|1950134|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
955360|NCT01090492|1950135|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
911019|NCT00796367|1888166|FG002|Overall Study|Withdrawal by Subject|12
911020|NCT00796367|1888164|FG000|Overall Study|Lack of Efficacy|2
955361|NCT01090492|1950136|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
955362|NCT01090492|1950137|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
955363|NCT01090492|1950138|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
955364|NCT01090492|1950139|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
955365|NCT01090492|1950132|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0
955366|NCT01090492|1950133|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0
955367|NCT01090492|1950134|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1
955368|NCT01090492|1950135|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0
955369|NCT01090492|1950136|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0
955370|NCT01090492|1950137|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0
955371|NCT01090492|1950138|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0
955372|NCT01090492|1950139|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0
955373|NCT01090492|1950132|FG000|First Intervention Period (4 Weeks)|Other|0
955374|NCT01090492|1950133|FG001|First Intervention Period (4 Weeks)|Other|0
955375|NCT01090492|1950134|FG002|First Intervention Period (4 Weeks)|Other|1
955376|NCT01090492|1950135|FG003|First Intervention Period (4 Weeks)|Other|1
955377|NCT01090492|1950136|FG004|First Intervention Period (4 Weeks)|Other|2
955378|NCT01090492|1950137|FG005|First Intervention Period (4 Weeks)|Other|0
955379|NCT01090492|1950138|FG006|First Intervention Period (4 Weeks)|Other|0
955380|NCT01090492|1950139|FG007|First Intervention Period (4 Weeks)|Other|0
955381|NCT01090492|1950132|FG000|First Intervention Period (4 Weeks)|Pregnancy|0
955382|NCT01090492|1950133|FG001|First Intervention Period (4 Weeks)|Pregnancy|0
955383|NCT01090492|1950134|FG002|First Intervention Period (4 Weeks)|Pregnancy|0
955384|NCT01090492|1950135|FG003|First Intervention Period (4 Weeks)|Pregnancy|0
955385|NCT01090492|1950136|FG004|First Intervention Period (4 Weeks)|Pregnancy|1
955386|NCT01090492|1950137|FG005|First Intervention Period (4 Weeks)|Pregnancy|0
955387|NCT01090492|1950138|FG006|First Intervention Period (4 Weeks)|Pregnancy|0
955388|NCT01090492|1950139|FG007|First Intervention Period (4 Weeks)|Pregnancy|0
955389|NCT01090492|1950132|FG000|First Intervention Period (4 Weeks)|Adverse Event|0
955390|NCT01090492|1950133|FG001|First Intervention Period (4 Weeks)|Adverse Event|2
955391|NCT01090492|1950134|FG002|First Intervention Period (4 Weeks)|Adverse Event|0
955392|NCT01090492|1950135|FG003|First Intervention Period (4 Weeks)|Adverse Event|3
955393|NCT01090492|1950136|FG004|First Intervention Period (4 Weeks)|Adverse Event|1
955394|NCT01090492|1950137|FG005|First Intervention Period (4 Weeks)|Adverse Event|2
955395|NCT01090492|1950138|FG006|First Intervention Period (4 Weeks)|Adverse Event|0
955396|NCT01090492|1950139|FG007|First Intervention Period (4 Weeks)|Adverse Event|5
955397|NCT01090492|1950132|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1
955398|NCT01090492|1950133|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0
955399|NCT01090492|1950134|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0
955400|NCT01090492|1950135|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0
955401|NCT01090492|1950136|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1
955402|NCT01090492|1950137|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0
955403|NCT01090492|1950138|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1
955404|NCT01090492|1950139|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1
955405|NCT01090492|1950132|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0
955406|NCT01090492|1950133|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1
955407|NCT01090492|1950134|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0
955408|NCT01090492|1950135|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0
955409|NCT01090492|1950136|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0
955410|NCT01090492|1950137|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0
955411|NCT01090492|1950138|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0
955412|NCT01090492|1950139|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0
955413|NCT01090492|1950132|FG000|Second Intervention Period (4 Weeks)|Other|0
955414|NCT01090492|1950133|FG001|Second Intervention Period (4 Weeks)|Other|1
955415|NCT01090492|1950134|FG002|Second Intervention Period (4 Weeks)|Other|1
955416|NCT01090492|1950135|FG003|Second Intervention Period (4 Weeks)|Other|0
955417|NCT01090492|1950136|FG004|Second Intervention Period (4 Weeks)|Other|0
955418|NCT01090492|1950137|FG005|Second Intervention Period (4 Weeks)|Other|0
955419|NCT01090492|1950138|FG006|Second Intervention Period (4 Weeks)|Other|0
955420|NCT01090492|1950139|FG007|Second Intervention Period (4 Weeks)|Other|0
955421|NCT01090492|1950132|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0
955422|NCT01090492|1950133|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0
955423|NCT01090492|1950134|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1
955424|NCT01090492|1950135|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0
955425|NCT01090492|1950136|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1
955426|NCT01090492|1950137|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1
955427|NCT01090492|1950138|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7
955428|NCT01090492|1950139|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1
955429|NCT01090492|1950132|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
955430|NCT01090492|1950133|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
955431|NCT01090492|1950134|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
955432|NCT01090492|1950135|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
955433|NCT01090492|1950136|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
955434|NCT01090492|1950137|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
955435|NCT01090492|1950138|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
955436|NCT01090492|1950139|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
955437|NCT01090739|1950158|FG000|Enrollment|Withdrawal by Subject|24
955438|NCT01090739|1950158|FG000|Enrollment|Protocol Violation|14
955439|NCT01090739|1950158|FG000|Enrollment|Lost to Follow-up|5
955440|NCT01090739|1950158|FG000|Enrollment|Physician Decision|5
955441|NCT01090739|1950158|FG000|Enrollment|Sponsor termination of site|4
955442|NCT01090739|1950158|FG000|Enrollment|Study implant limit reached|2
955443|NCT01090739|1950158|FG000|Enrollment|Adverse Event|1
955444|NCT01090739|1950158|FG000|12 Month Follow-up|Withdrawal by Subject|2
955445|NCT01090739|1950158|FG000|12 Month Follow-up|Lost to Follow-up|1
955446|NCT01090739|1950158|FG000|12 Month Follow-up|Physician Decision|1
955447|NCT01090739|1950158|FG000|12 Month Follow-up|Death|1
955448|NCT01090739|1950158|FG000|24 Month Follow-up|Withdrawal by Subject|7
955449|NCT01090739|1950158|FG000|24 Month Follow-up|Lost to Follow-up|1
955450|NCT01090739|1950158|FG000|24 Month Follow-up|Death|1
955451|NCT01090739|1950158|FG000|36 Month Follow-up|Withdrawal by Subject|6
955452|NCT01090739|1950158|FG000|36 Month Follow-up|Visit still pending|17
955453|NCT01090765|1950178|FG000|Overall Study|Patient withdrew consent|0
955454|NCT01090765|1950179|FG001|Overall Study|Patient withdrew consent|0
955455|NCT01090765|1950180|FG002|Overall Study|Patient withdrew consent|0
955456|NCT01090765|1950181|FG003|Overall Study|Patient withdrew consent|0
955457|NCT01090765|1950182|FG004|Overall Study|Patient withdrew consent|1
955458|NCT01090765|1950183|FG005|Overall Study|Patient withdrew consent|1
955459|NCT01090765|1950178|FG000|Overall Study|Developed a DVT, needed anticoagulation|0
955460|NCT01090765|1950179|FG001|Overall Study|Developed a DVT, needed anticoagulation|0
955461|NCT01090765|1950180|FG002|Overall Study|Developed a DVT, needed anticoagulation|0
955462|NCT01090765|1950181|FG003|Overall Study|Developed a DVT, needed anticoagulation|1
955463|NCT01090765|1950182|FG004|Overall Study|Developed a DVT, needed anticoagulation|0
955464|NCT01090765|1950183|FG005|Overall Study|Developed a DVT, needed anticoagulation|0
955465|NCT01090765|1950178|FG000|Overall Study|Vasovagal reaction with first infusion|0
955466|NCT01090765|1950179|FG001|Overall Study|Vasovagal reaction with first infusion|0
955467|NCT01090765|1950180|FG002|Overall Study|Vasovagal reaction with first infusion|0
955468|NCT01090765|1950181|FG003|Overall Study|Vasovagal reaction with first infusion|0
955469|NCT01090765|1950182|FG004|Overall Study|Vasovagal reaction with first infusion|1
955470|NCT01090765|1950183|FG005|Overall Study|Vasovagal reaction with first infusion|0
955471|NCT01090973|1950202|FG000|Overall Study|Disease progression|1
955472|NCT01091103|1950206|FG000|Overall Study|Adverse Event|1
955473|NCT01091103|1950206|FG000|Overall Study|Progressive Disease|3
955474|NCT01091168|1950239|FG000|Overall Study|Progressive disease|250
955475|NCT01091168|1950240|FG001|Overall Study|Progressive disease|234
955476|NCT01091168|1950239|FG000|Overall Study|Adverse Event|21
955477|NCT01091168|1950240|FG001|Overall Study|Adverse Event|24
955478|NCT01091168|1950239|FG000|Overall Study|Lost to Follow-up|0
955479|NCT01091168|1950240|FG001|Overall Study|Lost to Follow-up|1
955480|NCT01091168|1950239|FG000|Overall Study|Physician, patient's decision, other|27
955481|NCT01091168|1950240|FG001|Overall Study|Physician, patient's decision, other|37
955482|NCT01091246|1950249|FG000|Overall Study|Lost to Follow-up|23
955483|NCT01091246|1950250|FG001|Overall Study|Lost to Follow-up|11
955484|NCT01091246|1950251|FG002|Overall Study|Lost to Follow-up|7
955485|NCT01091246|1950249|FG000|Overall Study|Adverse Event|1
955486|NCT01091246|1950250|FG001|Overall Study|Adverse Event|0
955487|NCT01091246|1950251|FG002|Overall Study|Adverse Event|1
955488|NCT01091246|1950249|FG000|Overall Study|Withdrawal by Subject|9
955489|NCT01091246|1950250|FG001|Overall Study|Withdrawal by Subject|5
955490|NCT01091246|1950251|FG002|Overall Study|Withdrawal by Subject|4
955491|NCT01091246|1950249|FG000|Overall Study|Subject not dosed|2
955492|NCT01091246|1950250|FG001|Overall Study|Subject not dosed|0
955493|NCT01091246|1950251|FG002|Overall Study|Subject not dosed|1
955494|NCT01091259|1950261|FG000|Overall Study|Adverse Event|3
955495|NCT01091259|1950261|FG000|Overall Study|Lack of Efficacy|2
955496|NCT01091363|1950267|FG000|Overall Study|Withdrawal by Subject|11
955497|NCT01091363|1950268|FG001|Overall Study|Withdrawal by Subject|15
955498|NCT01091363|1950267|FG000|Overall Study|Lost to Follow-up|2
955499|NCT01091363|1950268|FG001|Overall Study|Lost to Follow-up|2
955500|NCT01091428|1950278|FG000|Phase 1|Progressive Disease|24
955501|NCT01091428|1950279|FG001|Phase 1|Progressive Disease|8
955502|NCT01091428|1950280|FG002|Phase 1|Progressive Disease|0
955503|NCT01091428|1950281|FG003|Phase 1|Progressive Disease|0
955504|NCT01091428|1950278|FG000|Phase 1|Symptomatic Deterioration|3
955505|NCT01091428|1950279|FG001|Phase 1|Symptomatic Deterioration|2
955506|NCT01091428|1950280|FG002|Phase 1|Symptomatic Deterioration|0
955507|NCT01091428|1950281|FG003|Phase 1|Symptomatic Deterioration|0
955508|NCT01091428|1950278|FG000|Phase 1|Adverse Event|2
955509|NCT01091428|1950279|FG001|Phase 1|Adverse Event|0
955510|NCT01091428|1950280|FG002|Phase 1|Adverse Event|0
955511|NCT01091428|1950281|FG003|Phase 1|Adverse Event|0
955512|NCT01091428|1950278|FG000|Phase 1|Withdrawal by Subject|7
955513|NCT01091428|1950279|FG001|Phase 1|Withdrawal by Subject|0
955514|NCT01091428|1950280|FG002|Phase 1|Withdrawal by Subject|0
955515|NCT01091428|1950281|FG003|Phase 1|Withdrawal by Subject|0
955516|NCT01091428|1950278|FG000|Phase 1|Reason not specified|0
955517|NCT01091428|1950279|FG001|Phase 1|Reason not specified|1
955518|NCT01091428|1950280|FG002|Phase 1|Reason not specified|0
955519|NCT01091428|1950281|FG003|Phase 1|Reason not specified|0
955520|NCT01091428|1950278|FG000|Phase 1|Single-Patient IND|2
955521|NCT01091428|1950279|FG001|Phase 1|Single-Patient IND|0
955522|NCT01091428|1950280|FG002|Phase 1|Single-Patient IND|0
955523|NCT01091428|1950281|FG003|Phase 1|Single-Patient IND|0
955524|NCT01091428|1950278|FG000|Phase 2|Progressive Disease|0
955525|NCT01091428|1950279|FG001|Phase 2|Progressive Disease|0
955526|NCT01091428|1950280|FG002|Phase 2|Progressive Disease|44
955527|NCT01091428|1950281|FG003|Phase 2|Progressive Disease|46
955528|NCT01091428|1950278|FG000|Phase 2|Symptomatic Deterioration|0
955529|NCT01091428|1950279|FG001|Phase 2|Symptomatic Deterioration|0
955530|NCT01091428|1950280|FG002|Phase 2|Symptomatic Deterioration|1
955531|NCT01091428|1950281|FG003|Phase 2|Symptomatic Deterioration|6
955532|NCT01091428|1950278|FG000|Phase 2|Adverse Event|0
955533|NCT01091428|1950279|FG001|Phase 2|Adverse Event|0
955534|NCT01091428|1950280|FG002|Phase 2|Adverse Event|12
955535|NCT01091428|1950281|FG003|Phase 2|Adverse Event|5
955536|NCT01091428|1950278|FG000|Phase 2|Withdrawal by Subject|0
955537|NCT01091428|1950279|FG001|Phase 2|Withdrawal by Subject|0
955538|NCT01091428|1950280|FG002|Phase 2|Withdrawal by Subject|9
955539|NCT01091428|1950281|FG003|Phase 2|Withdrawal by Subject|8
955540|NCT01091428|1950278|FG000|Phase 2|Unsatisfactory Therapeutic Response|0
955541|NCT01091428|1950279|FG001|Phase 2|Unsatisfactory Therapeutic Response|0
955542|NCT01091428|1950280|FG002|Phase 2|Unsatisfactory Therapeutic Response|1
955543|NCT01091428|1950281|FG003|Phase 2|Unsatisfactory Therapeutic Response|1
955544|NCT01091428|1950278|FG000|Phase 2|Reason not specified|0
955545|NCT01091428|1950279|FG001|Phase 2|Reason not specified|0
955546|NCT01091428|1950280|FG002|Phase 2|Reason not specified|4
955547|NCT01091428|1950281|FG003|Phase 2|Reason not specified|3
955548|NCT01091428|1950278|FG000|Phase 2|Physician Decision|0
955549|NCT01091428|1950279|FG001|Phase 2|Physician Decision|0
955550|NCT01091428|1950280|FG002|Phase 2|Physician Decision|2
955551|NCT01091428|1950281|FG003|Phase 2|Physician Decision|0
955552|NCT01091454|1950300|FG000|Overall Study|Ineligible|1
955553|NCT01091519|1950306|FG000|Overall Study|Adverse Event|12
955554|NCT01091519|1950307|FG001|Overall Study|Adverse Event|16
955555|NCT01091519|1950306|FG000|Overall Study|Death|1
955556|NCT01091519|1950307|FG001|Overall Study|Death|0
955557|NCT01091519|1950306|FG000|Overall Study|Lack of Efficacy|16
955558|NCT01091519|1950307|FG001|Overall Study|Lack of Efficacy|19
955559|NCT01091519|1950306|FG000|Overall Study|Lost to Follow-up|14
955560|NCT01091519|1950307|FG001|Overall Study|Lost to Follow-up|24
955561|NCT01091519|1950306|FG000|Overall Study|Withdrawal by Subject|2
955562|NCT01091519|1950307|FG001|Overall Study|Withdrawal by Subject|2
955563|NCT01091519|1950306|FG000|Overall Study|Other|6
955564|NCT01091519|1950307|FG001|Overall Study|Other|8
955565|NCT01091519|1950306|FG000|Overall Study|Randomized not treated|4
955566|NCT01091519|1950307|FG001|Overall Study|Randomized not treated|4
955567|NCT01091662|1950315|FG000|Overall Study|Adverse Event|1
955568|NCT01091662|1950316|FG001|Overall Study|Adverse Event|9
955569|NCT01091662|1950315|FG000|Overall Study|Physician Decision|1
955570|NCT01091662|1950316|FG001|Overall Study|Physician Decision|1
955571|NCT01091662|1950315|FG000|Overall Study|Withdrawal by Subject|7
955572|NCT01091662|1950316|FG001|Overall Study|Withdrawal by Subject|6
955573|NCT01091662|1950315|FG000|Overall Study|met exit criteria|7
955574|NCT01091662|1950316|FG001|Overall Study|met exit criteria|13
955575|NCT01091662|1950315|FG000|Overall Study|met exclusion criteria|1
955576|NCT01091662|1950316|FG001|Overall Study|met exclusion criteria|0
955577|NCT01091662|1950315|FG000|Overall Study|Lost to Follow-up|0
955578|NCT01091662|1950316|FG001|Overall Study|Lost to Follow-up|1
955579|NCT01091662|1950315|FG000|Overall Study|Pregnancy|0
955580|NCT01091662|1950316|FG001|Overall Study|Pregnancy|1
955581|NCT01091662|1950315|FG000|Overall Study|Protocol Violation|0
955582|NCT01091662|1950316|FG001|Overall Study|Protocol Violation|2
955583|NCT01091662|1950315|FG000|Overall Study|unable to swallow capsule|0
955584|NCT01091662|1950316|FG001|Overall Study|unable to swallow capsule|1
955585|NCT01091675|1950327|FG000|Overall Study|Adverse Event|7
955586|NCT01091675|1950327|FG000|Overall Study|Lack of Efficacy|27
955587|NCT01091974|1950345|FG000|Overall Study|Did not start intervention|3
955588|NCT01091974|1950346|FG001|Overall Study|Did not start intervention|1
955589|NCT01091974|1950347|FG002|Overall Study|Did not start intervention|3
955590|NCT01091974|1950348|FG003|Overall Study|Did not start intervention|1
955591|NCT01091974|1950345|FG000|Overall Study|resumed sleep medication|0
955592|NCT01091974|1950346|FG001|Overall Study|resumed sleep medication|0
955593|NCT01091974|1950347|FG002|Overall Study|resumed sleep medication|1
955594|NCT01091974|1950348|FG003|Overall Study|resumed sleep medication|2
955595|NCT01091974|1950345|FG000|Overall Study|Withdrawal by Subject|1
955596|NCT01091974|1950346|FG001|Overall Study|Withdrawal by Subject|3
955597|NCT01091974|1950347|FG002|Overall Study|Withdrawal by Subject|2
955598|NCT01091974|1950348|FG003|Overall Study|Withdrawal by Subject|2
955599|NCT01091974|1950345|FG000|Overall Study|side-effects|1
955600|NCT01091974|1950346|FG001|Overall Study|side-effects|1
955601|NCT01091974|1950347|FG002|Overall Study|side-effects|0
955602|NCT01091974|1950348|FG003|Overall Study|side-effects|2
955603|NCT01092182|1950361|FG000|Overall Study|Death|0
955604|NCT01092182|1950362|FG001|Overall Study|Death|5
955605|NCT01092182|1950363|FG002|Overall Study|Death|3
955606|NCT01092182|1950361|FG000|Overall Study|participant safety|1
955607|NCT01092182|1950362|FG001|Overall Study|participant safety|2
955608|NCT01092182|1950363|FG002|Overall Study|participant safety|0
955609|NCT01092182|1950361|FG000|Overall Study|Physician Decision|0
955610|NCT01092182|1950362|FG001|Overall Study|Physician Decision|6
955611|NCT01092182|1950363|FG002|Overall Study|Physician Decision|0
955612|NCT01092182|1950361|FG000|Overall Study|Did not meet criteria|0
955613|NCT01092182|1950362|FG001|Overall Study|Did not meet criteria|0
955614|NCT01092182|1950363|FG002|Overall Study|Did not meet criteria|25
955615|NCT01092182|1950361|FG000|Overall Study|Non-compliance|0
955616|NCT01092182|1950362|FG001|Overall Study|Non-compliance|3
955617|NCT01092182|1950363|FG002|Overall Study|Non-compliance|0
955618|NCT01092182|1950361|FG000|Overall Study|Participant refused follow-up|0
955619|NCT01092182|1950362|FG001|Overall Study|Participant refused follow-up|2
955620|NCT01092182|1950363|FG002|Overall Study|Participant refused follow-up|0
955621|NCT01092416|1950406|FG000|Enrollment|Atherectomy device not inserted|3
955622|NCT01092416|1950406|FG000|30-Day Follow-up|Death|2
955623|NCT01092416|1950406|FG000|30-Day Follow-up|Missed 30-day follow-up|3
955624|NCT01092416|1950406|FG000|30-Day Follow-up|Data collected after close of 30D window|5
955625|NCT01092416|1950406|FG000|12-Month Follow-up|Death|16
955626|NCT01092416|1950406|FG000|12-Month Follow-up|Lost to Follow-up|4
955627|NCT01092416|1950406|FG000|12-Month Follow-up|Withdrawal by Subject|2
955628|NCT01092416|1950406|FG000|12-Month Follow-up|Missed 1-year follow-up|1
955629|NCT01092416|1950406|FG000|12-Month Follow-up|Data collected after close of 1Y window|2
955630|NCT01092507|1950429|FG000|Overall Study|Withdrawal by Subject|2
955631|NCT01092507|1950430|FG001|Overall Study|Withdrawal by Subject|0
955632|NCT01092546|1950436|FG000|Overall Study|Subjects withdrawn prior to dosing|4
955633|NCT01092637|1950446|FG000|Overall Study|Death|47
955634|NCT01092637|1950447|FG001|Overall Study|Death|49
955635|NCT01092663|1950456|FG000|Overall Study|Withdrawal by Subject|3
955636|NCT01092663|1950457|FG001|Overall Study|Withdrawal by Subject|2
955637|NCT01092663|1950456|FG000|Overall Study|Glucose >300mg/dL|1
955638|NCT01092663|1950457|FG001|Overall Study|Glucose >300mg/dL|0
955639|NCT01092663|1950456|FG000|Overall Study|High fasting triglyceride|2
955640|NCT01092663|1950457|FG001|Overall Study|High fasting triglyceride|0
955641|NCT01092663|1950456|FG000|Overall Study|Adverse Event|1
955642|NCT01092663|1950457|FG001|Overall Study|Adverse Event|1
955643|NCT01092663|1950456|FG000|Overall Study|Protocol Violation|0
955644|NCT01092663|1950457|FG001|Overall Study|Protocol Violation|1
955645|NCT01092702|1950477|FG000|Overall Study|Withdrawal by Subject|7
955646|NCT01092702|1950477|FG000|Overall Study|Lost to Follow-up|2
955647|NCT01092728|1950483|FG000|Overall Study|Withdrawal by Subject|2
955648|NCT01092728|1950484|FG001|Overall Study|Withdrawal by Subject|0
955649|NCT01092728|1950483|FG000|Overall Study|Adverse Event|0
955650|NCT01092728|1950484|FG001|Overall Study|Adverse Event|1
955651|NCT01092728|1950483|FG000|Overall Study|Disease Progression|1
955652|NCT01092728|1950484|FG001|Overall Study|Disease Progression|13
955653|NCT01092728|1950483|FG000|Overall Study|Prohibited Concomitant Medications|1
955654|NCT01092728|1950484|FG001|Overall Study|Prohibited Concomitant Medications|0
955655|NCT01092780|1950494|FG000|Washout Period 1|Adverse Event|0
955656|NCT01092780|1950495|FG001|Washout Period 1|Adverse Event|1
955657|NCT01092780|1950496|FG002|Washout Period 1|Adverse Event|0
955658|NCT01092780|1950497|FG003|Washout Period 1|Adverse Event|0
955659|NCT01092780|1950494|FG000|Washout Period 1|Noncompliance with nCPAP|1
955660|NCT01092780|1950495|FG001|Washout Period 1|Noncompliance with nCPAP|0
955661|NCT01092780|1950496|FG002|Washout Period 1|Noncompliance with nCPAP|0
955662|NCT01092780|1950497|FG003|Washout Period 1|Noncompliance with nCPAP|0
955663|NCT01092780|1950494|FG000|Washout Period 2|Adverse Event|0
955664|NCT01092780|1950495|FG001|Washout Period 2|Adverse Event|1
955665|NCT01092780|1950496|FG002|Washout Period 2|Adverse Event|1
955666|NCT01092780|1950497|FG003|Washout Period 2|Adverse Event|0
955667|NCT01092832|1950509|FG000|Overall Study|Other|1
955668|NCT01092832|1950510|FG001|Overall Study|Other|0
955669|NCT01093222|1950561|FG000|Overall Study|Ineligible|6
955670|NCT01093222|1950561|FG000|Overall Study|Adverse Event|7
955671|NCT01093222|1950561|FG000|Overall Study|Progression/relapse|24
955672|NCT01093222|1950561|FG000|Overall Study|Death|2
955673|NCT01093222|1950561|FG000|Overall Study|Not protocol specified|1
955674|NCT01093534|1950600|FG000|Overall Study|Adverse Event|2
955675|NCT01093534|1950601|FG001|Overall Study|Adverse Event|5
955676|NCT01093534|1950602|FG002|Overall Study|Adverse Event|2
955677|NCT01093534|1950600|FG000|Overall Study|Lack of Efficacy|2
955678|NCT01093534|1950601|FG001|Overall Study|Lack of Efficacy|1
955679|NCT01093534|1950602|FG002|Overall Study|Lack of Efficacy|1
955680|NCT01093534|1950600|FG000|Overall Study|Withdrawal by Subject|5
955681|NCT01093534|1950601|FG001|Overall Study|Withdrawal by Subject|7
955682|NCT01093534|1950602|FG002|Overall Study|Withdrawal by Subject|2
955683|NCT01093534|1950600|FG000|Overall Study|Other|1
955684|NCT01093534|1950601|FG001|Overall Study|Other|3
955685|NCT01093534|1950602|FG002|Overall Study|Other|4
955686|NCT01093573|1950614|FG000|Overall Study|Physician Decision|0
955687|NCT01093573|1950615|FG001|Overall Study|Physician Decision|0
955688|NCT01093573|1950616|FG002|Overall Study|Physician Decision|1
955689|NCT01093573|1950614|FG000|Overall Study|Insurance Denied|0
955690|NCT01093573|1950615|FG001|Overall Study|Insurance Denied|0
955691|NCT01093573|1950616|FG002|Overall Study|Insurance Denied|1
955692|NCT01093586|1950627|FG000|Overall Study|Failed to engraft|3
955693|NCT01093599|1950633|FG000|Overall Study|Lost to Follow-up|32
955694|NCT01093599|1950634|FG001|Overall Study|Lost to Follow-up|46
955695|NCT01093625|1950642|FG000|Baseline and Dispensed|Withdrawal by Subject|2
955696|NCT01093625|1950643|FG001|Baseline and Dispensed|Withdrawal by Subject|0
955697|NCT01093625|1950642|FG000|2-Week Visit|Withdrawal by Subject|1
955698|NCT01093625|1950643|FG001|2-Week Visit|Withdrawal by Subject|0
955699|NCT01093625|1950642|FG000|1-Month Visit|Lost to Follow-up|2
955700|NCT01093625|1950643|FG001|1-Month Visit|Lost to Follow-up|0
955701|NCT01093625|1950642|FG000|3-Month Visit|Lost to Follow-up|2
955702|NCT01093625|1950643|FG001|3-Month Visit|Lost to Follow-up|0
955703|NCT01093625|1950642|FG000|6-Month Visit|Withdrawal by Subject|6
955704|NCT01093625|1950643|FG001|6-Month Visit|Withdrawal by Subject|7
955705|NCT01093625|1950642|FG000|6-Month Visit|Lost to Follow-up|2
955706|NCT01093625|1950643|FG001|6-Month Visit|Lost to Follow-up|2
955707|NCT01093625|1950642|FG000|1-Year Visit|Lost to Follow-up|5
955708|NCT01093625|1950643|FG001|1-Year Visit|Lost to Follow-up|3
955709|NCT01093755|1950669|FG000|Overall Study|Withdrawal by Subject|3
955710|NCT01093755|1950670|FG001|Overall Study|Withdrawal by Subject|4
955711|NCT01093885|1950689|FG000|Overall Study|Adverse Event|4
955712|NCT01093885|1950689|FG000|Overall Study|Lost to Follow-up|1
955713|NCT01094119|1950709|FG000|Overall Study|Lack of Efficacy|2
955714|NCT01094119|1950710|FG001|Overall Study|Lack of Efficacy|4
955715|NCT01094171|1950716|FG000|Overall Study|Lost to Follow-up|2
955716|NCT01094171|1950716|FG000|Overall Study|Informed consent withdrawal|4
955717|NCT01094171|1950716|FG000|Overall Study|Migration from the study area|3
955718|NCT01094171|1950716|FG000|Overall Study|Other|1
955719|NCT01094184|1950722|FG000|Overall Study|Death|35
955720|NCT01094184|1950723|FG001|Overall Study|Death|11
955721|NCT01094288|1950737|FG000|Overall Study|Adverse Event|0
955722|NCT01094288|1950738|FG001|Overall Study|Adverse Event|3
955723|NCT01094288|1950739|FG002|Overall Study|Adverse Event|1
955724|NCT01094288|1950740|FG003|Overall Study|Adverse Event|1
955725|NCT01094288|1950741|FG004|Overall Study|Adverse Event|0
955726|NCT01094288|1950742|FG005|Overall Study|Adverse Event|0
955727|NCT01094288|1950743|FG006|Overall Study|Adverse Event|0
955728|NCT01094288|1950744|FG007|Overall Study|Adverse Event|0
955729|NCT01094288|1950737|FG000|Overall Study|Withdrawal by Subject|0
955730|NCT01094288|1950738|FG001|Overall Study|Withdrawal by Subject|1
955731|NCT01094288|1950739|FG002|Overall Study|Withdrawal by Subject|2
955732|NCT01094288|1950740|FG003|Overall Study|Withdrawal by Subject|0
955733|NCT01094288|1950741|FG004|Overall Study|Withdrawal by Subject|0
955734|NCT01094288|1950742|FG005|Overall Study|Withdrawal by Subject|0
955735|NCT01094288|1950743|FG006|Overall Study|Withdrawal by Subject|0
955736|NCT01094288|1950744|FG007|Overall Study|Withdrawal by Subject|2
955737|NCT01094288|1950737|FG000|Overall Study|Initiation of Alternative Therapy|0
955738|NCT01094288|1950738|FG001|Overall Study|Initiation of Alternative Therapy|0
955739|NCT01094288|1950739|FG002|Overall Study|Initiation of Alternative Therapy|1
955740|NCT01094288|1950740|FG003|Overall Study|Initiation of Alternative Therapy|0
955741|NCT01094288|1950741|FG004|Overall Study|Initiation of Alternative Therapy|0
955742|NCT01094288|1950742|FG005|Overall Study|Initiation of Alternative Therapy|0
955743|NCT01094288|1950743|FG006|Overall Study|Initiation of Alternative Therapy|0
955744|NCT01094288|1950744|FG007|Overall Study|Initiation of Alternative Therapy|0
955745|NCT01094288|1950737|FG000|Overall Study|Reason not Specified|2
955746|NCT01094288|1950738|FG001|Overall Study|Reason not Specified|3
955747|NCT01094288|1950739|FG002|Overall Study|Reason not Specified|0
955748|NCT01094288|1950740|FG003|Overall Study|Reason not Specified|1
955749|NCT01094288|1950741|FG004|Overall Study|Reason not Specified|0
955750|NCT01094288|1950742|FG005|Overall Study|Reason not Specified|0
955751|NCT01094288|1950743|FG006|Overall Study|Reason not Specified|0
955752|NCT01094288|1950744|FG007|Overall Study|Reason not Specified|0
955753|NCT01094288|1950737|FG000|Overall Study|Ongoing Participants|0
955754|NCT01094288|1950738|FG001|Overall Study|Ongoing Participants|3
955755|NCT01094288|1950739|FG002|Overall Study|Ongoing Participants|0
955756|NCT01094288|1950740|FG003|Overall Study|Ongoing Participants|0
955757|NCT01094288|1950741|FG004|Overall Study|Ongoing Participants|0
955758|NCT01094288|1950742|FG005|Overall Study|Ongoing Participants|0
955759|NCT01094288|1950743|FG006|Overall Study|Ongoing Participants|0
955760|NCT01094288|1950744|FG007|Overall Study|Ongoing Participants|0
955761|NCT01094301|1950766|FG000|Trial Stage|Withdrawal by Subject|1
955762|NCT01094301|1950766|FG000|Implant Stage|Adverse Event|1
955763|NCT01094301|1950766|FG000|Implant Stage|Protocol Violation|1
955764|NCT01094301|1950766|FG000|Implant Stage|Withdrawal by Subject|2
955765|NCT01094301|1950766|FG000|Implant Stage|No return of pain|4
955766|NCT01094730|1950843|FG000|Period 1 (14 Days)|Lost to Follow-up|0
955767|NCT01094730|1950844|FG001|Period 1 (14 Days)|Lost to Follow-up|1
955768|NCT01094730|1950843|FG000|Period 1 (14 Days)|Withdrawal by Subject|0
955769|NCT01094730|1950844|FG001|Period 1 (14 Days)|Withdrawal by Subject|1
955770|NCT01094730|1950843|FG000|Period 1 (14 Days)|No time for the follow-up visit|1
955771|NCT01094730|1950844|FG001|Period 1 (14 Days)|No time for the follow-up visit|0
955772|NCT01094730|1950843|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1
955773|NCT01094730|1950844|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0
955774|NCT01094730|1950843|FG000|Period 2 (14 Days)|Protocol Violation|2
955775|NCT01094730|1950844|FG001|Period 2 (14 Days)|Protocol Violation|0
955776|NCT01094730|1950843|FG000|Period 2 (14 Days)|No time for the follow-up visit|1
955777|NCT01094730|1950844|FG001|Period 2 (14 Days)|No time for the follow-up visit|0
955778|NCT01094730|1950843|FG000|Period 2 (14 Days)|Adverse Event|0
955779|NCT01094730|1950844|FG001|Period 2 (14 Days)|Adverse Event|1
955780|NCT01094730|1950843|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0
955781|NCT01094730|1950844|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1
955782|NCT01094743|1950851|FG000|Period 1|Unsatisfactory comfort at lens fitting|2
955783|NCT01094782|1950862|FG000|Overall Study|Withdrawal by Subject|5
955784|NCT01094782|1950863|FG001|Overall Study|Withdrawal by Subject|5
955785|NCT01094782|1950864|FG002|Overall Study|Withdrawal by Subject|1
955786|NCT01094782|1950865|FG003|Overall Study|Withdrawal by Subject|5
955787|NCT01094782|1950866|FG004|Overall Study|Withdrawal by Subject|5
955788|NCT01094782|1950867|FG005|Overall Study|Withdrawal by Subject|0
955789|NCT01094782|1950862|FG000|Overall Study|Lost to Follow-up|1
955790|NCT01094782|1950863|FG001|Overall Study|Lost to Follow-up|0
955791|NCT01094782|1950864|FG002|Overall Study|Lost to Follow-up|0
955792|NCT01094782|1950865|FG003|Overall Study|Lost to Follow-up|2
955793|NCT01094782|1950866|FG004|Overall Study|Lost to Follow-up|1
955794|NCT01094782|1950867|FG005|Overall Study|Lost to Follow-up|4
955795|NCT01094782|1950862|FG000|Overall Study|Positive Drug Screen|2
955796|NCT01094782|1950863|FG001|Overall Study|Positive Drug Screen|2
955797|NCT01094782|1950864|FG002|Overall Study|Positive Drug Screen|1
955798|NCT01094782|1950865|FG003|Overall Study|Positive Drug Screen|1
955799|NCT01094782|1950866|FG004|Overall Study|Positive Drug Screen|3
955800|NCT01094782|1950867|FG005|Overall Study|Positive Drug Screen|2
955801|NCT01094782|1950862|FG000|Overall Study|Sensory Deficit at Site of QST|0
955802|NCT01094782|1950863|FG001|Overall Study|Sensory Deficit at Site of QST|1
955803|NCT01094782|1950864|FG002|Overall Study|Sensory Deficit at Site of QST|0
955804|NCT01094782|1950865|FG003|Overall Study|Sensory Deficit at Site of QST|0
955805|NCT01094782|1950866|FG004|Overall Study|Sensory Deficit at Site of QST|0
955806|NCT01094782|1950867|FG005|Overall Study|Sensory Deficit at Site of QST|0
955807|NCT01094782|1950862|FG000|Overall Study|Unable to Complete Questionnaires|0
955808|NCT01094782|1950863|FG001|Overall Study|Unable to Complete Questionnaires|1
955809|NCT01094782|1950864|FG002|Overall Study|Unable to Complete Questionnaires|0
955810|NCT01094782|1950865|FG003|Overall Study|Unable to Complete Questionnaires|0
955811|NCT01094782|1950866|FG004|Overall Study|Unable to Complete Questionnaires|0
955812|NCT01094782|1950867|FG005|Overall Study|Unable to Complete Questionnaires|0
955813|NCT01094782|1950862|FG000|Overall Study|Healthy Subject Had Pain|0
955814|NCT01094782|1950863|FG001|Overall Study|Healthy Subject Had Pain|1
955815|NCT01094782|1950864|FG002|Overall Study|Healthy Subject Had Pain|0
955816|NCT01094782|1950865|FG003|Overall Study|Healthy Subject Had Pain|0
955817|NCT01094782|1950866|FG004|Overall Study|Healthy Subject Had Pain|0
955818|NCT01094782|1950867|FG005|Overall Study|Healthy Subject Had Pain|0
955819|NCT01094782|1950862|FG000|Overall Study|Hypertension|0
955820|NCT01094782|1950863|FG001|Overall Study|Hypertension|0
955821|NCT01094782|1950864|FG002|Overall Study|Hypertension|1
955822|NCT01094782|1950865|FG003|Overall Study|Hypertension|0
955823|NCT01094782|1950866|FG004|Overall Study|Hypertension|0
955824|NCT01094782|1950867|FG005|Overall Study|Hypertension|0
955825|NCT01094782|1950862|FG000|Overall Study|Wrong Pain Condition|0
955826|NCT01094782|1950863|FG001|Overall Study|Wrong Pain Condition|0
955827|NCT01094782|1950864|FG002|Overall Study|Wrong Pain Condition|0
955828|NCT01094782|1950865|FG003|Overall Study|Wrong Pain Condition|2
955829|NCT01094782|1950866|FG004|Overall Study|Wrong Pain Condition|1
955830|NCT01094782|1950867|FG005|Overall Study|Wrong Pain Condition|1
955831|NCT01094782|1950862|FG000|Overall Study|Recent Interventional Injection|0
955832|NCT01094782|1950863|FG001|Overall Study|Recent Interventional Injection|0
955833|NCT01094782|1950864|FG002|Overall Study|Recent Interventional Injection|0
955834|NCT01094782|1950865|FG003|Overall Study|Recent Interventional Injection|0
955835|NCT01094782|1950866|FG004|Overall Study|Recent Interventional Injection|0
955836|NCT01094782|1950867|FG005|Overall Study|Recent Interventional Injection|1
955837|NCT01094782|1950862|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0
955838|NCT01094782|1950863|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0
955839|NCT01094782|1950864|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0
955840|NCT01094782|1950865|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0
955841|NCT01094782|1950866|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1
955842|NCT01094782|1950867|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0
955843|NCT01094782|1950862|FG000|Overall Study|Noncompliance With Study Schedule|0
955844|NCT01094782|1950863|FG001|Overall Study|Noncompliance With Study Schedule|0
955845|NCT01094782|1950864|FG002|Overall Study|Noncompliance With Study Schedule|0
955846|NCT01094782|1950865|FG003|Overall Study|Noncompliance With Study Schedule|1
955847|NCT01094782|1950866|FG004|Overall Study|Noncompliance With Study Schedule|0
955848|NCT01094782|1950867|FG005|Overall Study|Noncompliance With Study Schedule|0
955849|NCT01094808|1950884|FG000|Overall Study|Withdrawal by Subject|1
955850|NCT01094808|1950885|FG001|Overall Study|Withdrawal by Subject|1
955851|NCT01094808|1950886|FG002|Overall Study|Withdrawal by Subject|0
955852|NCT01094886|1950894|FG000|Overall Study|Adverse Event|2
955853|NCT01094886|1950894|FG000|Overall Study|Withdrawal by Subject|5
955854|NCT01095094|1950909|FG000|Overall Study|Withdrawal by Subject|1
955855|NCT01095094|1950909|FG000|Overall Study|Death|1
955856|NCT01095094|1950909|FG000|Overall Study|Physician Decision|1
955857|NCT01095653|1950944|FG000|Overall Study|Lack of Efficacy|3
955858|NCT01095653|1950945|FG001|Overall Study|Lack of Efficacy|0
955859|NCT01095653|1950946|FG002|Overall Study|Lack of Efficacy|0
955860|NCT01095653|1950944|FG000|Overall Study|Adverse Event|1
955861|NCT01095653|1950945|FG001|Overall Study|Adverse Event|4
955862|NCT01095653|1950946|FG002|Overall Study|Adverse Event|4
955863|NCT01095653|1950944|FG000|Overall Study|Lost to Follow-up|1
955864|NCT01095653|1950945|FG001|Overall Study|Lost to Follow-up|0
955865|NCT01095653|1950946|FG002|Overall Study|Lost to Follow-up|4
955866|NCT01095653|1950944|FG000|Overall Study|Withdrawal by Subject|4
955867|NCT01095653|1950945|FG001|Overall Study|Withdrawal by Subject|5
955868|NCT01095653|1950946|FG002|Overall Study|Withdrawal by Subject|3
955869|NCT01095653|1950944|FG000|Overall Study|non-compliance, not met criteria, etc.|10
955870|NCT01095653|1950945|FG001|Overall Study|non-compliance, not met criteria, etc.|6
955871|NCT01095653|1950946|FG002|Overall Study|non-compliance, not met criteria, etc.|5
955872|NCT01095666|1950957|FG000|Overall Study|Lack of Efficacy|0
955873|NCT01095666|1950958|FG001|Overall Study|Lack of Efficacy|0
955874|NCT01095666|1950959|FG002|Overall Study|Lack of Efficacy|1
955875|NCT01095666|1950957|FG000|Overall Study|Adverse Event|2
955876|NCT01095666|1950958|FG001|Overall Study|Adverse Event|1
955877|NCT01095666|1950959|FG002|Overall Study|Adverse Event|3
955878|NCT01095666|1950957|FG000|Overall Study|Lost to Follow-up|2
955879|NCT01095666|1950958|FG001|Overall Study|Lost to Follow-up|2
955880|NCT01095666|1950959|FG002|Overall Study|Lost to Follow-up|0
955881|NCT01095666|1950957|FG000|Overall Study|Withdrawal by Subject|6
955882|NCT01095666|1950958|FG001|Overall Study|Withdrawal by Subject|6
955883|NCT01095666|1950959|FG002|Overall Study|Withdrawal by Subject|1
955884|NCT01095666|1950957|FG000|Overall Study|Non-compliance, not met criteria etc.|7
955885|NCT01095666|1950958|FG001|Overall Study|Non-compliance, not met criteria etc.|2
955886|NCT01095666|1950959|FG002|Overall Study|Non-compliance, not met criteria etc.|2
955887|NCT01095796|1950974|FG000|Overall Study|Randomized but Not Treated|5
955888|NCT01095796|1950975|FG001|Overall Study|Randomized but Not Treated|2
955889|NCT01095796|1950974|FG000|Overall Study|Adverse Event|9
955890|NCT01095796|1950975|FG001|Overall Study|Adverse Event|19
955891|NCT01095796|1950974|FG000|Overall Study|Death|3
955892|NCT01095796|1950975|FG001|Overall Study|Death|2
955893|NCT01095796|1950974|FG000|Overall Study|Pregnancy|2
955894|NCT01095796|1950975|FG001|Overall Study|Pregnancy|0
955895|NCT01095796|1950974|FG000|Overall Study|Lack of Efficacy|5
955896|NCT01095796|1950975|FG001|Overall Study|Lack of Efficacy|3
955897|NCT01095796|1950974|FG000|Overall Study|Investigator's Discretion|7
955898|NCT01095796|1950975|FG001|Overall Study|Investigator's Discretion|2
955899|NCT01095796|1950974|FG000|Overall Study|Withdrew Consent|16
955900|NCT01095796|1950975|FG001|Overall Study|Withdrew Consent|22
955901|NCT01095796|1950974|FG000|Overall Study|Lost to Follow-up|27
955902|NCT01095796|1950975|FG001|Overall Study|Lost to Follow-up|29
955903|NCT01095796|1950974|FG000|Overall Study|Participant Noncompliance|5
955904|NCT01095796|1950975|FG001|Overall Study|Participant Noncompliance|10
955905|NCT01095796|1950974|FG000|Overall Study|Protocol Violation|1
955906|NCT01095796|1950975|FG001|Overall Study|Protocol Violation|0
955907|NCT01095796|1950974|FG000|Overall Study|Participant Transferred to Another Study|215
955908|NCT01095796|1950975|FG001|Overall Study|Participant Transferred to Another Study|200
955909|NCT01095835|1950984|FG000|Overall Study|Adverse Event|8
955910|NCT01095835|1950985|FG001|Overall Study|Adverse Event|6
955911|NCT01095835|1950986|FG002|Overall Study|Adverse Event|6
955912|NCT01095835|1950984|FG000|Overall Study|Lack of Efficacy|0
955913|NCT01095835|1950985|FG001|Overall Study|Lack of Efficacy|1
955914|NCT01095835|1950986|FG002|Overall Study|Lack of Efficacy|0
955915|NCT01095835|1950984|FG000|Overall Study|Physician Decision|0
955916|NCT01095835|1950985|FG001|Overall Study|Physician Decision|0
955917|NCT01095835|1950986|FG002|Overall Study|Physician Decision|1
955918|NCT01095835|1950984|FG000|Overall Study|Withdrawal by Subject|1
955919|NCT01095835|1950985|FG001|Overall Study|Withdrawal by Subject|3
955920|NCT01095835|1950986|FG002|Overall Study|Withdrawal by Subject|0
955921|NCT01095835|1950984|FG000|Overall Study|Non study compliance|0
955922|NCT01095835|1950985|FG001|Overall Study|Non study compliance|0
955923|NCT01095835|1950986|FG002|Overall Study|Non study compliance|1
955924|NCT01095835|1950984|FG000|Overall Study|Protocol Violation|1
955925|NCT01095835|1950985|FG001|Overall Study|Protocol Violation|2
955926|NCT01095835|1950986|FG002|Overall Study|Protocol Violation|0
955927|NCT01095978|1950999|FG000|Overall Study|Did not take Klacid SR|2
955928|NCT01095978|1950999|FG000|Overall Study|Adverse Event|1
955929|NCT01096017|1951005|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1
955930|NCT01096017|1951006|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1
955931|NCT01096056|1951014|FG000|Overall Study|Lost to Follow-up|0
955932|NCT01096056|1951015|FG001|Overall Study|Lost to Follow-up|1
955933|NCT01096160|1951031|FG000|Overall Study|Adverse Event|0
955934|NCT01096160|1951032|FG001|Overall Study|Adverse Event|0
955935|NCT01096160|1951033|FG002|Overall Study|Adverse Event|1
955936|NCT01096160|1951034|FG003|Overall Study|Adverse Event|0
955937|NCT01096160|1951035|FG004|Overall Study|Adverse Event|0
955938|NCT01096160|1951036|FG005|Overall Study|Adverse Event|0
955939|NCT01096160|1951037|FG006|Overall Study|Adverse Event|0
955940|NCT01096160|1951038|FG007|Overall Study|Adverse Event|0
955941|NCT01096160|1951039|FG008|Overall Study|Adverse Event|0
955942|NCT01096160|1951040|FG009|Overall Study|Adverse Event|1
955943|NCT01096160|1951031|FG000|Overall Study|Met stopping criteria per protocol|0
955944|NCT01096160|1951032|FG001|Overall Study|Met stopping criteria per protocol|0
955945|NCT01096160|1951033|FG002|Overall Study|Met stopping criteria per protocol|0
955946|NCT01096160|1951034|FG003|Overall Study|Met stopping criteria per protocol|0
955947|NCT01096160|1951035|FG004|Overall Study|Met stopping criteria per protocol|1
955948|NCT01096160|1951036|FG005|Overall Study|Met stopping criteria per protocol|0
955949|NCT01096160|1951037|FG006|Overall Study|Met stopping criteria per protocol|2
955950|NCT01096160|1951038|FG007|Overall Study|Met stopping criteria per protocol|0
955951|NCT01096160|1951039|FG008|Overall Study|Met stopping criteria per protocol|2
955952|NCT01096160|1951040|FG009|Overall Study|Met stopping criteria per protocol|0
955953|NCT01096186|1951075|FG000|Overall Study|Adverse Event|16
955954|NCT01096186|1951075|FG000|Overall Study|Death|4
955955|NCT01096186|1951075|FG000|Overall Study|Lack of Efficacy|4
955956|NCT01096186|1951075|FG000|Overall Study|Lost to Follow-up|2
955957|NCT01096186|1951075|FG000|Overall Study|Withdrawal by Subject|22
955958|NCT01096186|1951075|FG000|Overall Study|Physician Decision|1
955959|NCT01096186|1951075|FG000|Overall Study|Noncompliance with study drug|1
955960|NCT01096316|1951090|FG000|Overall Study|Lost to Follow-up|15
955961|NCT01096316|1951091|FG001|Overall Study|Lost to Follow-up|9
955962|NCT01096342|1951097|FG000|Overall Study|Protocol Violation|1
955963|NCT01096446|1951103|FG000|Overall Study|Death|1
955964|NCT01096446|1951104|FG001|Overall Study|Death|0
955965|NCT01096446|1951103|FG000|Overall Study|Protocol Violation|2
955966|NCT01096446|1951104|FG001|Overall Study|Protocol Violation|0
955967|NCT01096550|1951111|FG000|Overall Study|discontinued site|10
955968|NCT01096550|1951112|FG001|Overall Study|discontinued site|11
955969|NCT01096550|1951111|FG000|Overall Study|non-regular treatment track at clinic|1
955970|NCT01096550|1951112|FG001|Overall Study|non-regular treatment track at clinic|1
955971|NCT01096550|1951111|FG000|Overall Study|clinic readmission|1
955972|NCT01096550|1951112|FG001|Overall Study|clinic readmission|1
955973|NCT01096550|1951111|FG000|Overall Study|Withdrawal by Subject|0
955974|NCT01096550|1951112|FG001|Overall Study|Withdrawal by Subject|1
955975|NCT01096550|1951111|FG000|Overall Study|non-African American participant|13
955976|NCT01096550|1951112|FG001|Overall Study|non-African American participant|6
955977|NCT01096550|1951111|FG000|Overall Study|Lost to Follow-up|12
955978|NCT01096550|1951112|FG001|Overall Study|Lost to Follow-up|9
955979|NCT01096589|1951122|FG000|Overall Study|Adverse Event|2
955980|NCT01096589|1951123|FG001|Overall Study|Adverse Event|1
955981|NCT01096589|1951124|FG002|Overall Study|Adverse Event|2
955982|NCT01096589|1951125|FG003|Overall Study|Adverse Event|1
955983|NCT01096589|1951122|FG000|Overall Study|Withdrawal by Subject|2
955984|NCT01096589|1951123|FG001|Overall Study|Withdrawal by Subject|1
955985|NCT01096589|1951124|FG002|Overall Study|Withdrawal by Subject|1
955986|NCT01096589|1951125|FG003|Overall Study|Withdrawal by Subject|1
955987|NCT01096589|1951122|FG000|Overall Study|Compliance with protocol|0
955988|NCT01096589|1951123|FG001|Overall Study|Compliance with protocol|0
955989|NCT01096589|1951124|FG002|Overall Study|Compliance with protocol|1
955990|NCT01096589|1951125|FG003|Overall Study|Compliance with protocol|0
955991|NCT01096589|1951122|FG000|Overall Study|found treatment exhausting|0
955992|NCT01096589|1951123|FG001|Overall Study|found treatment exhausting|0
955993|NCT01096589|1951124|FG002|Overall Study|found treatment exhausting|0
955994|NCT01096589|1951125|FG003|Overall Study|found treatment exhausting|1
955995|NCT01096667|1951144|FG000|Overall Study|Lost to Follow-up|1
955996|NCT01096667|1951145|FG001|Overall Study|Lost to Follow-up|1
955997|NCT01096667|1951146|FG002|Overall Study|Lost to Follow-up|1
955998|NCT01096667|1951147|FG003|Overall Study|Lost to Follow-up|0
955999|NCT01096667|1951148|FG004|Overall Study|Lost to Follow-up|0
956000|NCT01096667|1951144|FG000|Overall Study|Withdrawal by Subject|1
956001|NCT01096667|1951145|FG001|Overall Study|Withdrawal by Subject|0
956002|NCT01096667|1951146|FG002|Overall Study|Withdrawal by Subject|0
956003|NCT01096667|1951147|FG003|Overall Study|Withdrawal by Subject|1
956004|NCT01096667|1951148|FG004|Overall Study|Withdrawal by Subject|0
956005|NCT01096667|1951144|FG000|Overall Study|Reason not available|0
956006|NCT01096667|1951145|FG001|Overall Study|Reason not available|1
956007|NCT01096667|1951146|FG002|Overall Study|Reason not available|1
956008|NCT01096667|1951147|FG003|Overall Study|Reason not available|1
956009|NCT01096667|1951148|FG004|Overall Study|Reason not available|0
956010|NCT01096667|1951144|FG000|Overall Study|Protocol Violation|0
956011|NCT01096667|1951145|FG001|Overall Study|Protocol Violation|0
956012|NCT01096667|1951146|FG002|Overall Study|Protocol Violation|0
956013|NCT01096667|1951147|FG003|Overall Study|Protocol Violation|1
956014|NCT01096667|1951148|FG004|Overall Study|Protocol Violation|0
956015|NCT01096667|1951144|FG000|Overall Study|Not treated|1
956016|NCT01096667|1951145|FG001|Overall Study|Not treated|0
956017|NCT01096667|1951146|FG002|Overall Study|Not treated|0
956018|NCT01096667|1951147|FG003|Overall Study|Not treated|0
956019|NCT01096667|1951148|FG004|Overall Study|Not treated|0
956020|NCT01096784|1951193|FG000|Overall Study|Withdrawal by Subject|2
956021|NCT01096784|1951194|FG001|Overall Study|Withdrawal by Subject|1
956022|NCT01096784|1951193|FG000|Overall Study|Adverse Event|11
956023|NCT01096784|1951194|FG001|Overall Study|Adverse Event|9
956024|NCT01096784|1951193|FG000|Overall Study|Protocol Deviation|2
956025|NCT01096784|1951194|FG001|Overall Study|Protocol Deviation|2
956026|NCT01096784|1951193|FG000|Overall Study|Administrative Decision|0
956027|NCT01096784|1951194|FG001|Overall Study|Administrative Decision|1
956028|NCT01096784|1951193|FG000|Overall Study|Other Unspecified|0
956029|NCT01096784|1951194|FG001|Overall Study|Other Unspecified|1
956030|NCT01096849|1951218|FG000|Overall Study|Consent Withdrawn|1
956031|NCT01096849|1951219|FG001|Overall Study|Consent Withdrawn|4
956032|NCT01096849|1951220|FG002|Overall Study|Consent Withdrawn|2
956033|NCT01096849|1951218|FG000|Overall Study|Lack of Efficacy|0
956034|NCT01096849|1951219|FG001|Overall Study|Lack of Efficacy|2
956035|NCT01096849|1951220|FG002|Overall Study|Lack of Efficacy|0
956036|NCT01096849|1951218|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0
956037|NCT01096849|1951219|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1
956038|NCT01096849|1951220|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1
956039|NCT01096849|1951218|FG000|Overall Study|Investigator or Medical Monitor Decision|0
956040|NCT01096849|1951219|FG001|Overall Study|Investigator or Medical Monitor Decision|1
956041|NCT01096849|1951220|FG002|Overall Study|Investigator or Medical Monitor Decision|0
956042|NCT01096849|1951218|FG000|Overall Study|Administrative Reasons|0
956043|NCT01096849|1951219|FG001|Overall Study|Administrative Reasons|1
956044|NCT01096849|1951220|FG002|Overall Study|Administrative Reasons|2
956045|NCT01096849|1951218|FG000|Overall Study|Lost to Follow-up|1
956046|NCT01096849|1951219|FG001|Overall Study|Lost to Follow-up|3
956047|NCT01096849|1951220|FG002|Overall Study|Lost to Follow-up|1
956048|NCT01097005|1951261|FG000|Overall Study|Case Report Form not collected|18
956049|NCT01097005|1951261|FG000|Overall Study|Subjects cannot visit the hospital|1
956050|NCT01097005|1951261|FG000|Overall Study|Poor medication compliance|1
956051|NCT01097005|1951261|FG000|Overall Study|No examination data available|244
956052|NCT01097005|1951261|FG000|Overall Study|Deviation from exclusion criteria|37
956053|NCT01097005|1951261|FG000|Overall Study|Adverse Event|14
956054|NCT01097005|1951261|FG000|Overall Study|Discontinuance by complication|50
956055|NCT01097044|1951269|FG000|Overall Study|Withdrawal by Subject|4
956056|NCT01097044|1951270|FG001|Overall Study|Withdrawal by Subject|4
956057|NCT01097044|1951269|FG000|Overall Study|Lost to Follow-up|1
956058|NCT01097044|1951270|FG001|Overall Study|Lost to Follow-up|0
956059|NCT01097044|1951269|FG000|Overall Study|Withdrawal by Sponsor|0
956060|NCT01097044|1951270|FG001|Overall Study|Withdrawal by Sponsor|1
956061|NCT01097057|1951278|FG000|Overall Study|Physician Decision|3
956062|NCT01097330|1951289|FG000|Overall Study|Study terminated early|7
956063|NCT01097330|1951290|FG001|Overall Study|Study terminated early|5
956064|NCT01097421|1951312|FG000|Overall Study|Adverse Event|8
956065|NCT01097421|1951312|FG000|Overall Study|Protocol Violation|2
956066|NCT01097421|1951312|FG000|Overall Study|Lost to Follow-up|1
956067|NCT01097421|1951312|FG000|Overall Study|Withdrawal by Subject|3
956068|NCT01097577|1951322|FG000|Overall Study|Adverse Event|0
956069|NCT01097577|1951323|FG001|Overall Study|Adverse Event|1
956070|NCT01097616|1951332|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
956071|NCT01097616|1951333|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
956072|NCT01097616|1951334|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
956073|NCT01097616|1951335|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
956074|NCT01097616|1951336|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
956075|NCT01097616|1951337|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
956076|NCT01097616|1951338|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
956077|NCT01097616|1951339|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
956078|NCT01097616|1951332|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
956079|NCT01097616|1951333|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
956080|NCT01097616|1951334|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
956081|NCT01097616|1951335|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
956082|NCT01097616|1951336|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
956083|NCT01097616|1951337|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
956084|NCT01097616|1951338|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
956085|NCT01097616|1951339|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
956086|NCT01097616|1951332|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
956087|NCT01097616|1951333|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
956088|NCT01097616|1951334|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
956089|NCT01097616|1951335|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1090775|NCT02248818|2158522|FG004|Screening|Withdrawal by Subject|0
956090|NCT01097616|1951336|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
956091|NCT01097616|1951337|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
956092|NCT01097616|1951338|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
956093|NCT01097616|1951339|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
956094|NCT01097616|1951332|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
956095|NCT01097616|1951333|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
956096|NCT01097616|1951334|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
956097|NCT01097616|1951335|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
956098|NCT01097616|1951336|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
956099|NCT01097616|1951337|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
956100|NCT01097616|1951338|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
956101|NCT01097616|1951339|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
956102|NCT01097616|1951332|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
956103|NCT01097616|1951333|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
956104|NCT01097616|1951334|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
956105|NCT01097616|1951335|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
956106|NCT01097616|1951336|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
956107|NCT01097616|1951337|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
956108|NCT01097616|1951338|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
956109|NCT01097616|1951339|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
956110|NCT01097616|1951332|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
956111|NCT01097616|1951333|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
956112|NCT01097616|1951334|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
956113|NCT01097616|1951335|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
956114|NCT01097616|1951336|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
956115|NCT01097616|1951337|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
956116|NCT01097616|1951338|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
956117|NCT01097616|1951339|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
956118|NCT01097616|1951332|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
956119|NCT01097616|1951333|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
956120|NCT01097616|1951334|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956121|NCT01097616|1951335|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956122|NCT01097616|1951336|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956123|NCT01097616|1951337|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956124|NCT01097616|1951338|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956125|NCT01097616|1951339|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956126|NCT01097616|1951332|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956127|NCT01097616|1951333|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956128|NCT01097616|1951334|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
956129|NCT01097616|1951335|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956130|NCT01097616|1951336|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956131|NCT01097616|1951337|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956132|NCT01097616|1951338|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956133|NCT01097616|1951339|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956134|NCT01097616|1951332|FG000|Optional DB EXT Phase|Adverse Event|0
956135|NCT01097616|1951333|FG001|Optional DB EXT Phase|Adverse Event|7
956136|NCT01097616|1951334|FG002|Optional DB EXT Phase|Adverse Event|2
956137|NCT01097616|1951335|FG003|Optional DB EXT Phase|Adverse Event|0
956138|NCT01097616|1951336|FG004|Optional DB EXT Phase|Adverse Event|0
956139|NCT01097616|1951337|FG005|Optional DB EXT Phase|Adverse Event|0
956140|NCT01097616|1951338|FG006|Optional DB EXT Phase|Adverse Event|0
956141|NCT01097616|1951339|FG007|Optional DB EXT Phase|Adverse Event|0
956142|NCT01097616|1951332|FG000|Optional DB EXT Phase|Withdrawal by Subject|12
956143|NCT01097616|1951333|FG001|Optional DB EXT Phase|Withdrawal by Subject|6
956144|NCT01097616|1951334|FG002|Optional DB EXT Phase|Withdrawal by Subject|3
956145|NCT01097616|1951335|FG003|Optional DB EXT Phase|Withdrawal by Subject|0
956146|NCT01097616|1951336|FG004|Optional DB EXT Phase|Withdrawal by Subject|0
956147|NCT01097616|1951337|FG005|Optional DB EXT Phase|Withdrawal by Subject|0
956148|NCT01097616|1951338|FG006|Optional DB EXT Phase|Withdrawal by Subject|0
956149|NCT01097616|1951339|FG007|Optional DB EXT Phase|Withdrawal by Subject|0
956150|NCT01097616|1951332|FG000|Optional DB EXT Phase|Protocol Violation|0
956151|NCT01097616|1951333|FG001|Optional DB EXT Phase|Protocol Violation|2
956152|NCT01097616|1951334|FG002|Optional DB EXT Phase|Protocol Violation|3
956153|NCT01097616|1951335|FG003|Optional DB EXT Phase|Protocol Violation|0
956154|NCT01097616|1951336|FG004|Optional DB EXT Phase|Protocol Violation|0
956155|NCT01097616|1951337|FG005|Optional DB EXT Phase|Protocol Violation|0
956156|NCT01097616|1951338|FG006|Optional DB EXT Phase|Protocol Violation|0
956157|NCT01097616|1951339|FG007|Optional DB EXT Phase|Protocol Violation|0
956158|NCT01097616|1951332|FG000|Optional DB EXT Phase|Lost to Follow-up|1
956159|NCT01097616|1951333|FG001|Optional DB EXT Phase|Lost to Follow-up|5
956160|NCT01097616|1951334|FG002|Optional DB EXT Phase|Lost to Follow-up|1
956161|NCT01097616|1951335|FG003|Optional DB EXT Phase|Lost to Follow-up|0
956162|NCT01097616|1951336|FG004|Optional DB EXT Phase|Lost to Follow-up|0
956163|NCT01097616|1951337|FG005|Optional DB EXT Phase|Lost to Follow-up|0
956164|NCT01097616|1951338|FG006|Optional DB EXT Phase|Lost to Follow-up|0
956165|NCT01097616|1951339|FG007|Optional DB EXT Phase|Lost to Follow-up|0
956166|NCT01097616|1951332|FG000|Optional DB EXT Phase|Lack of Efficacy|1
956167|NCT01097616|1951333|FG001|Optional DB EXT Phase|Lack of Efficacy|1
956168|NCT01097616|1951334|FG002|Optional DB EXT Phase|Lack of Efficacy|1
956169|NCT01097616|1951335|FG003|Optional DB EXT Phase|Lack of Efficacy|0
956170|NCT01097616|1951336|FG004|Optional DB EXT Phase|Lack of Efficacy|0
956171|NCT01097616|1951337|FG005|Optional DB EXT Phase|Lack of Efficacy|0
956172|NCT01097616|1951338|FG006|Optional DB EXT Phase|Lack of Efficacy|0
956173|NCT01097616|1951339|FG007|Optional DB EXT Phase|Lack of Efficacy|0
956174|NCT01097616|1951332|FG000|Optional DB EXT Phase|Physician Decision|1
956175|NCT01097616|1951333|FG001|Optional DB EXT Phase|Physician Decision|0
956176|NCT01097616|1951334|FG002|Optional DB EXT Phase|Physician Decision|0
956177|NCT01097616|1951335|FG003|Optional DB EXT Phase|Physician Decision|0
956178|NCT01097616|1951336|FG004|Optional DB EXT Phase|Physician Decision|0
956179|NCT01097616|1951337|FG005|Optional DB EXT Phase|Physician Decision|0
956180|NCT01097616|1951338|FG006|Optional DB EXT Phase|Physician Decision|0
956181|NCT01097616|1951339|FG007|Optional DB EXT Phase|Physician Decision|0
956182|NCT01097616|1951332|FG000|DB RO Phase|Adverse Event|0
956183|NCT01097616|1951333|FG001|DB RO Phase|Adverse Event|0
956184|NCT01097616|1951334|FG002|DB RO Phase|Adverse Event|0
956185|NCT01097616|1951335|FG003|DB RO Phase|Adverse Event|0
956186|NCT01097616|1951336|FG004|DB RO Phase|Adverse Event|0
956187|NCT01097616|1951337|FG005|DB RO Phase|Adverse Event|0
956188|NCT01097616|1951338|FG006|DB RO Phase|Adverse Event|1
956189|NCT01097616|1951339|FG007|DB RO Phase|Adverse Event|0
956190|NCT01097616|1951332|FG000|DB RO Phase|Withdrawal by Subject|0
956191|NCT01097616|1951333|FG001|DB RO Phase|Withdrawal by Subject|0
956192|NCT01097616|1951334|FG002|DB RO Phase|Withdrawal by Subject|0
956193|NCT01097616|1951335|FG003|DB RO Phase|Withdrawal by Subject|0
956194|NCT01097616|1951336|FG004|DB RO Phase|Withdrawal by Subject|0
956195|NCT01097616|1951337|FG005|DB RO Phase|Withdrawal by Subject|1
956196|NCT01097616|1951338|FG006|DB RO Phase|Withdrawal by Subject|0
956197|NCT01097616|1951339|FG007|DB RO Phase|Withdrawal by Subject|0
956198|NCT01097616|1951332|FG000|DB RO Phase|Lost to Follow-up|0
956199|NCT01097616|1951333|FG001|DB RO Phase|Lost to Follow-up|0
956200|NCT01097616|1951334|FG002|DB RO Phase|Lost to Follow-up|0
956201|NCT01097616|1951335|FG003|DB RO Phase|Lost to Follow-up|1
956202|NCT01097616|1951336|FG004|DB RO Phase|Lost to Follow-up|1
956203|NCT01097616|1951337|FG005|DB RO Phase|Lost to Follow-up|0
956204|NCT01097616|1951338|FG006|DB RO Phase|Lost to Follow-up|0
956205|NCT01097616|1951339|FG007|DB RO Phase|Lost to Follow-up|1
956206|NCT01097616|1951332|FG000|DB RO Phase|Not Treated in RO|0
956207|NCT01097616|1951333|FG001|DB RO Phase|Not Treated in RO|0
956208|NCT01097616|1951334|FG002|DB RO Phase|Not Treated in RO|0
956209|NCT01097616|1951335|FG003|DB RO Phase|Not Treated in RO|0
956210|NCT01097616|1951336|FG004|DB RO Phase|Not Treated in RO|0
956211|NCT01097616|1951337|FG005|DB RO Phase|Not Treated in RO|1
956212|NCT01097616|1951338|FG006|DB RO Phase|Not Treated in RO|0
956213|NCT01097616|1951339|FG007|DB RO Phase|Not Treated in RO|0
956214|NCT01097629|1951368|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
956215|NCT01097629|1951369|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
956216|NCT01097629|1951370|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
956217|NCT01097629|1951371|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
956218|NCT01097629|1951372|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
956219|NCT01097629|1951373|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
956220|NCT01097629|1951374|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
956221|NCT01097629|1951375|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
956222|NCT01097629|1951368|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
956223|NCT01097629|1951369|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
956224|NCT01097629|1951370|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
956225|NCT01097629|1951371|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
956226|NCT01097629|1951372|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
956227|NCT01097629|1951373|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
956228|NCT01097629|1951374|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
956229|NCT01097629|1951375|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
956230|NCT01097629|1951368|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
956231|NCT01097629|1951369|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
956232|NCT01097629|1951370|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
956233|NCT01097629|1951371|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
956234|NCT01097629|1951372|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
956235|NCT01097629|1951373|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
956236|NCT01097629|1951374|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
956237|NCT01097629|1951375|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
956238|NCT01097629|1951368|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
956239|NCT01097629|1951369|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
956240|NCT01097629|1951370|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
956241|NCT01097629|1951371|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
956242|NCT01097629|1951372|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
956243|NCT01097629|1951373|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
956244|NCT01097629|1951374|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
956245|NCT01097629|1951375|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
956246|NCT01097629|1951368|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
956247|NCT01097629|1951369|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
956248|NCT01097629|1951370|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
956249|NCT01097629|1951371|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
956250|NCT01097629|1951372|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
956251|NCT01097629|1951373|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
956252|NCT01097629|1951374|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
956253|NCT01097629|1951375|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
956254|NCT01097629|1951368|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
956255|NCT01097629|1951369|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
956256|NCT01097629|1951370|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956257|NCT01097629|1951371|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956258|NCT01097629|1951372|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956259|NCT01097629|1951373|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956260|NCT01097629|1951374|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956261|NCT01097629|1951375|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
956262|NCT01097629|1951368|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
956263|NCT01097629|1951369|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
956264|NCT01097629|1951370|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
956265|NCT01097629|1951371|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956266|NCT01097629|1951372|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956267|NCT01097629|1951373|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956268|NCT01097629|1951374|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956269|NCT01097629|1951375|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
956270|NCT01097629|1951368|FG000|DB RO Phase|Withdrawal by Subject|0
956271|NCT01097629|1951369|FG001|DB RO Phase|Withdrawal by Subject|0
956272|NCT01097629|1951370|FG002|DB RO Phase|Withdrawal by Subject|0
956273|NCT01097629|1951371|FG003|DB RO Phase|Withdrawal by Subject|0
956274|NCT01097629|1951372|FG004|DB RO Phase|Withdrawal by Subject|0
956275|NCT01097629|1951373|FG005|DB RO Phase|Withdrawal by Subject|0
956276|NCT01097629|1951374|FG006|DB RO Phase|Withdrawal by Subject|0
956277|NCT01097629|1951375|FG007|DB RO Phase|Withdrawal by Subject|1
956278|NCT01097629|1951368|FG000|DB RO Phase|Protocol Violation|0
956279|NCT01097629|1951369|FG001|DB RO Phase|Protocol Violation|0
956280|NCT01097629|1951370|FG002|DB RO Phase|Protocol Violation|0
956281|NCT01097629|1951371|FG003|DB RO Phase|Protocol Violation|1
956282|NCT01097629|1951372|FG004|DB RO Phase|Protocol Violation|0
956283|NCT01097629|1951373|FG005|DB RO Phase|Protocol Violation|1
956284|NCT01097629|1951374|FG006|DB RO Phase|Protocol Violation|1
956285|NCT01097629|1951375|FG007|DB RO Phase|Protocol Violation|0
956286|NCT01097629|1951368|FG000|DB RO Phase|Lost to Follow-up|0
956287|NCT01097629|1951369|FG001|DB RO Phase|Lost to Follow-up|0
956288|NCT01097629|1951370|FG002|DB RO Phase|Lost to Follow-up|0
956289|NCT01097629|1951371|FG003|DB RO Phase|Lost to Follow-up|0
956290|NCT01097629|1951372|FG004|DB RO Phase|Lost to Follow-up|0
956291|NCT01097629|1951373|FG005|DB RO Phase|Lost to Follow-up|0
956292|NCT01097629|1951374|FG006|DB RO Phase|Lost to Follow-up|2
956293|NCT01097629|1951375|FG007|DB RO Phase|Lost to Follow-up|0
956294|NCT01097655|1951407|FG000|Overall Study|Withdrawal by Subject|1
956295|NCT01097655|1951407|FG000|Overall Study|Subject Documented Twice|1
956296|NCT01097655|1951407|FG000|Overall Study|Did Not Meet Inclusion Criteria|8
956297|NCT01097668|1951413|FG000|Overall Study|Withdrawal by Subject|1
956298|NCT01097668|1951414|FG001|Overall Study|Withdrawal by Subject|2
956299|NCT01097668|1951413|FG000|Overall Study|Lost to Follow-up|1
956300|NCT01097668|1951414|FG001|Overall Study|Lost to Follow-up|0
956301|NCT01097694|1951426|FG000|Overall Study|Adverse Event|5
956302|NCT01097694|1951427|FG001|Overall Study|Adverse Event|0
956303|NCT01097694|1951426|FG000|Overall Study|Lost to Follow-up|0
956304|NCT01097694|1951427|FG001|Overall Study|Lost to Follow-up|3
956305|NCT01097694|1951426|FG000|Overall Study|Withdrawal by Subject|3
956306|NCT01097694|1951427|FG001|Overall Study|Withdrawal by Subject|1
956307|NCT01097707|1951438|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
956308|NCT01097707|1951439|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
956309|NCT01097707|1951440|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
956310|NCT01097707|1951441|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1
956311|NCT01097707|1951442|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1
956312|NCT01097707|1951438|FG000|Overall Study|Adverse Event|4
956313|NCT01097707|1951439|FG001|Overall Study|Adverse Event|2
956314|NCT01097707|1951440|FG002|Overall Study|Adverse Event|3
956315|NCT01097707|1951441|FG003|Overall Study|Adverse Event|1
956316|NCT01097707|1951442|FG004|Overall Study|Adverse Event|3
956317|NCT01097707|1951438|FG000|Overall Study|Entry Criteria Not Met|2
956318|NCT01097707|1951439|FG001|Overall Study|Entry Criteria Not Met|1
956319|NCT01097707|1951440|FG002|Overall Study|Entry Criteria Not Met|1
956320|NCT01097707|1951441|FG003|Overall Study|Entry Criteria Not Met|0
956321|NCT01097707|1951442|FG004|Overall Study|Entry Criteria Not Met|1
956322|NCT01097707|1951438|FG000|Overall Study|Lack of Efficacy|1
956323|NCT01097707|1951439|FG001|Overall Study|Lack of Efficacy|0
956324|NCT01097707|1951440|FG002|Overall Study|Lack of Efficacy|0
956325|NCT01097707|1951441|FG003|Overall Study|Lack of Efficacy|1
956326|NCT01097707|1951442|FG004|Overall Study|Lack of Efficacy|0
956327|NCT01097707|1951438|FG000|Overall Study|Lost to Follow-up|1
956328|NCT01097707|1951439|FG001|Overall Study|Lost to Follow-up|1
956329|NCT01097707|1951440|FG002|Overall Study|Lost to Follow-up|2
956330|NCT01097707|1951441|FG003|Overall Study|Lost to Follow-up|0
956331|NCT01097707|1951442|FG004|Overall Study|Lost to Follow-up|3
956332|NCT01097707|1951438|FG000|Overall Study|Protocol Violation|2
956333|NCT01097707|1951439|FG001|Overall Study|Protocol Violation|2
956334|NCT01097707|1951440|FG002|Overall Study|Protocol Violation|3
956335|NCT01097707|1951441|FG003|Overall Study|Protocol Violation|2
956336|NCT01097707|1951442|FG004|Overall Study|Protocol Violation|2
956337|NCT01097707|1951438|FG000|Overall Study|Sponsor Decision|31
956338|NCT01097707|1951439|FG001|Overall Study|Sponsor Decision|31
956339|NCT01097707|1951440|FG002|Overall Study|Sponsor Decision|34
956340|NCT01097707|1951441|FG003|Overall Study|Sponsor Decision|35
956341|NCT01097707|1951442|FG004|Overall Study|Sponsor Decision|36
956342|NCT01097707|1951438|FG000|Overall Study|Withdrawal by Subject|3
956343|NCT01097707|1951439|FG001|Overall Study|Withdrawal by Subject|6
956344|NCT01097707|1951440|FG002|Overall Study|Withdrawal by Subject|1
956345|NCT01097707|1951441|FG003|Overall Study|Withdrawal by Subject|4
956346|NCT01097707|1951442|FG004|Overall Study|Withdrawal by Subject|3
956347|NCT01097707|1951438|FG000|Overall Study|Reason unknown|0
956348|NCT01097707|1951439|FG001|Overall Study|Reason unknown|0
956349|NCT01097707|1951440|FG002|Overall Study|Reason unknown|0
956350|NCT01097707|1951441|FG003|Overall Study|Reason unknown|0
956351|NCT01097707|1951442|FG004|Overall Study|Reason unknown|1
956352|NCT01097863|1951467|FG000|Overall Study|Discomfort|1
956353|NCT01097863|1951468|FG001|Overall Study|Discomfort|0
956354|NCT01097863|1951469|FG002|Overall Study|Discomfort|1
956355|NCT01097863|1951467|FG000|Overall Study|Did not return for final visit|0
956356|NCT01097863|1951468|FG001|Overall Study|Did not return for final visit|0
956357|NCT01097863|1951469|FG002|Overall Study|Did not return for final visit|1
956358|NCT01098032|1951516|FG000|Overall Study|Withdrawal by Subject|1
956359|NCT01098032|1951517|FG001|Overall Study|Withdrawal by Subject|1
956360|NCT01098071|1951523|FG000|Overall Study|Surgery (adenoidectomy)|2
956361|NCT01098071|1951523|FG000|Overall Study|Lost to Follow-up|13
956362|NCT01098097|1951527|FG000|Overall Study|Adverse Event|17
956363|NCT01098097|1951527|FG000|Overall Study|Lost to Follow-up|18
956364|NCT01098097|1951527|FG000|Overall Study|Status unknown|16
956365|NCT01098097|1951527|FG000|Overall Study|No reason reported|31
956366|NCT01098110|1951534|FG000|Overall Study|Withdrawal by Subject|14
956367|NCT01098110|1951535|FG001|Overall Study|Withdrawal by Subject|24
956368|NCT01098110|1951536|FG002|Overall Study|Withdrawal by Subject|19
956369|NCT01098110|1951534|FG000|Overall Study|Adverse Event|30
956370|NCT01098110|1951535|FG001|Overall Study|Adverse Event|32
956371|NCT01098110|1951536|FG002|Overall Study|Adverse Event|43
956372|NCT01098110|1951534|FG000|Overall Study|Lack of Efficacy|13
956373|NCT01098110|1951535|FG001|Overall Study|Lack of Efficacy|9
956374|NCT01098110|1951536|FG002|Overall Study|Lack of Efficacy|27
956375|NCT01098110|1951534|FG000|Overall Study|Other|4
956376|NCT01098110|1951535|FG001|Overall Study|Other|7
956377|NCT01098110|1951536|FG002|Overall Study|Other|5
956378|NCT01098110|1951534|FG000|Overall Study|Untreated|1
956379|NCT01098110|1951535|FG001|Overall Study|Untreated|1
956380|NCT01098110|1951536|FG002|Overall Study|Untreated|0
956381|NCT01098162|1951544|FG000|Overall Study|Adverse Event|37
956382|NCT01098162|1951544|FG000|Overall Study|Lack of Efficacy|4
956383|NCT01098162|1951544|FG000|Overall Study|Wish of Patient|7
956384|NCT01098162|1951544|FG000|Overall Study|Lost to Follow-up|9
956385|NCT01098162|1951544|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5
956386|NCT01098162|1951544|FG000|Overall Study|Adverse Event & Lack of Efficacy|6
956387|NCT01098162|1951544|FG000|Overall Study|Adverse Event & Wish of Patient|13
956388|NCT01098162|1951544|FG000|Overall Study|Adverse Event & Lost to Follow-up|2
956389|NCT01098162|1951544|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
956390|NCT01098162|1951544|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1
956391|NCT01098162|1951544|FG000|Overall Study|Other Reason|1
956392|NCT01098162|1951544|FG000|Overall Study|Reason Unknown|26
956393|NCT01098240|1951548|FG000|Open-Label Phase|Study Terminated by Sponsor|27
956394|NCT01098240|1951549|FG001|Open-Label Phase|Study Terminated by Sponsor|0
956395|NCT01098240|1951550|FG002|Open-Label Phase|Study Terminated by Sponsor|0
956396|NCT01098240|1951548|FG000|Open-Label Phase|Protocol Violation|4
956397|NCT01098240|1951549|FG001|Open-Label Phase|Protocol Violation|0
956398|NCT01098240|1951550|FG002|Open-Label Phase|Protocol Violation|0
956399|NCT01098240|1951548|FG000|Open-Label Phase|Lost to Follow-up|13
956400|NCT01098240|1951549|FG001|Open-Label Phase|Lost to Follow-up|0
956401|NCT01098240|1951550|FG002|Open-Label Phase|Lost to Follow-up|0
956402|NCT01098240|1951548|FG000|Open-Label Phase|Other|19
956403|NCT01098240|1951549|FG001|Open-Label Phase|Other|0
956404|NCT01098240|1951550|FG002|Open-Label Phase|Other|0
956405|NCT01098240|1951548|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50
956406|NCT01098240|1951549|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
956407|NCT01098240|1951550|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
956408|NCT01098240|1951548|FG000|Open-Label Phase|Pregnancy|1
956409|NCT01098240|1951549|FG001|Open-Label Phase|Pregnancy|0
956410|NCT01098240|1951550|FG002|Open-Label Phase|Pregnancy|0
956411|NCT01098240|1951548|FG000|Open-Label Phase|Withdrawal by Subject|9
956412|NCT01098240|1951549|FG001|Open-Label Phase|Withdrawal by Subject|0
956413|NCT01098240|1951550|FG002|Open-Label Phase|Withdrawal by Subject|0
956414|NCT01098240|1951548|FG000|Open-Label Phase|Adverse Event|12
956415|NCT01098240|1951549|FG001|Open-Label Phase|Adverse Event|0
956416|NCT01098240|1951550|FG002|Open-Label Phase|Adverse Event|0
956417|NCT01098240|1951548|FG000|Double-Blind Phase|Study Terminated by Sponsor|0
956418|NCT01098240|1951549|FG001|Double-Blind Phase|Study Terminated by Sponsor|5
956419|NCT01098240|1951550|FG002|Double-Blind Phase|Study Terminated by Sponsor|8
956420|NCT01098240|1951548|FG000|Double-Blind Phase|Protocol Violation|0
956421|NCT01098240|1951549|FG001|Double-Blind Phase|Protocol Violation|2
956422|NCT01098240|1951550|FG002|Double-Blind Phase|Protocol Violation|4
956423|NCT01098240|1951548|FG000|Double-Blind Phase|Lost to Follow-up|0
956424|NCT01098240|1951549|FG001|Double-Blind Phase|Lost to Follow-up|2
956425|NCT01098240|1951550|FG002|Double-Blind Phase|Lost to Follow-up|0
956426|NCT01098240|1951548|FG000|Double-Blind Phase|Other|0
956427|NCT01098240|1951549|FG001|Double-Blind Phase|Other|2
956428|NCT01098240|1951550|FG002|Double-Blind Phase|Other|2
956429|NCT01098240|1951548|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0
956430|NCT01098240|1951549|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1
956431|NCT01098240|1951550|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0
956432|NCT01098240|1951548|FG000|Double-Blind Phase|Insufficient Clinical Response|0
956433|NCT01098240|1951549|FG001|Double-Blind Phase|Insufficient Clinical Response|1
956434|NCT01098240|1951550|FG002|Double-Blind Phase|Insufficient Clinical Response|2
956435|NCT01098240|1951548|FG000|Double-Blind Phase|Withdrawal by Subject|0
956436|NCT01098240|1951549|FG001|Double-Blind Phase|Withdrawal by Subject|1
956437|NCT01098240|1951550|FG002|Double-Blind Phase|Withdrawal by Subject|3
956438|NCT01098240|1951548|FG000|Double-Blind Phase|Adverse Event|0
956439|NCT01098240|1951549|FG001|Double-Blind Phase|Adverse Event|3
956440|NCT01098240|1951550|FG002|Double-Blind Phase|Adverse Event|3
956441|NCT01098266|1951568|FG000|Overall Study|Physician Decision|1
956442|NCT01098266|1951569|FG001|Overall Study|Physician Decision|0
956443|NCT01098266|1951568|FG000|Overall Study|Death|3
956444|NCT01098266|1951569|FG001|Overall Study|Death|2
956445|NCT01098266|1951568|FG000|Overall Study|Withdrawal by Subject|3
956446|NCT01098266|1951569|FG001|Overall Study|Withdrawal by Subject|5
956447|NCT01098305|1951577|FG000|Overall Study|Lost to Follow-up|31
956448|NCT01098305|1951578|FG001|Overall Study|Lost to Follow-up|33
956449|NCT01098461|1951605|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
956450|NCT01098461|1951606|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
956451|NCT01098461|1951607|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
956452|NCT01098461|1951608|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
956453|NCT01098461|1951605|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1
956454|NCT01098461|1951606|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2
956455|NCT01098461|1951607|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1
956456|NCT01098461|1951608|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3
956457|NCT01098461|1951605|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
956458|NCT01098461|1951606|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
956459|NCT01098461|1951607|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
956460|NCT01098461|1951608|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
956461|NCT01098461|1951605|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
956462|NCT01098461|1951606|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
956463|NCT01098461|1951607|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
956464|NCT01098461|1951608|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
956465|NCT01098461|1951605|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
956466|NCT01098461|1951606|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
956467|NCT01098461|1951607|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
956468|NCT01098461|1951608|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
956469|NCT01098461|1951605|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
956470|NCT01098461|1951606|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
956471|NCT01098461|1951607|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
956472|NCT01098461|1951608|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
956473|NCT01098461|1951605|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
956474|NCT01098461|1951606|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
956475|NCT01098461|1951607|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
956476|NCT01098461|1951608|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
956477|NCT01098474|1951625|FG000|Active Phase|Other|0
956478|NCT01098474|1951626|FG001|Active Phase|Other|0
956479|NCT01098474|1951627|FG002|Active Phase|Other|3
956480|NCT01098474|1951628|FG003|Active Phase|Other|0
956481|NCT01098474|1951629|FG004|Active Phase|Other|0
956482|NCT01098474|1951630|FG005|Active Phase|Other|0
956483|NCT01098474|1951625|FG000|Active Phase|Withdrawal by Subject|1
956484|NCT01098474|1951626|FG001|Active Phase|Withdrawal by Subject|1
956485|NCT01098474|1951627|FG002|Active Phase|Withdrawal by Subject|2
956486|NCT01098474|1951628|FG003|Active Phase|Withdrawal by Subject|0
956487|NCT01098474|1951629|FG004|Active Phase|Withdrawal by Subject|0
956488|NCT01098474|1951630|FG005|Active Phase|Withdrawal by Subject|0
956489|NCT01098474|1951625|FG000|Active Phase|Lost to Follow-up|1
956490|NCT01098474|1951626|FG001|Active Phase|Lost to Follow-up|0
956491|NCT01098474|1951627|FG002|Active Phase|Lost to Follow-up|0
956492|NCT01098474|1951628|FG003|Active Phase|Lost to Follow-up|0
956493|NCT01098474|1951629|FG004|Active Phase|Lost to Follow-up|0
956494|NCT01098474|1951630|FG005|Active Phase|Lost to Follow-up|0
956495|NCT01098474|1951625|FG000|Follow Up Phase|Travelled out of study area|0
956496|NCT01098474|1951626|FG001|Follow Up Phase|Travelled out of study area|0
956497|NCT01098474|1951627|FG002|Follow Up Phase|Travelled out of study area|0
956498|NCT01098474|1951628|FG003|Follow Up Phase|Travelled out of study area|0
956499|NCT01098474|1951629|FG004|Follow Up Phase|Travelled out of study area|1
956500|NCT01098474|1951630|FG005|Follow Up Phase|Travelled out of study area|0
956501|NCT01098474|1951625|FG000|Follow Up Phase|Other|0
956502|NCT01098474|1951626|FG001|Follow Up Phase|Other|0
956503|NCT01098474|1951627|FG002|Follow Up Phase|Other|0
956504|NCT01098474|1951628|FG003|Follow Up Phase|Other|0
956505|NCT01098474|1951629|FG004|Follow Up Phase|Other|0
956506|NCT01098474|1951630|FG005|Follow Up Phase|Other|4
956507|NCT01098474|1951625|FG000|Follow Up Phase|Withdrawal by Subject|0
956508|NCT01098474|1951626|FG001|Follow Up Phase|Withdrawal by Subject|0
956509|NCT01098474|1951627|FG002|Follow Up Phase|Withdrawal by Subject|0
956510|NCT01098474|1951628|FG003|Follow Up Phase|Withdrawal by Subject|2
956511|NCT01098474|1951629|FG004|Follow Up Phase|Withdrawal by Subject|0
956512|NCT01098474|1951630|FG005|Follow Up Phase|Withdrawal by Subject|1
956513|NCT01098474|1951625|FG000|Follow Up Phase|Lost to Follow-up|0
956514|NCT01098474|1951626|FG001|Follow Up Phase|Lost to Follow-up|0
956515|NCT01098474|1951627|FG002|Follow Up Phase|Lost to Follow-up|0
956516|NCT01098474|1951628|FG003|Follow Up Phase|Lost to Follow-up|0
956517|NCT01098474|1951629|FG004|Follow Up Phase|Lost to Follow-up|1
956518|NCT01098474|1951630|FG005|Follow Up Phase|Lost to Follow-up|0
956519|NCT01098487|1951654|FG000|Overall Study|Adverse Event|22
956520|NCT01098487|1951654|FG000|Overall Study|Lack of Efficacy|11
956521|NCT01098487|1951654|FG000|Overall Study|Withdrawal by Subject|7
956522|NCT01098487|1951654|FG000|Overall Study|Lost to Follow-up|3
956523|NCT01098487|1951654|FG000|Overall Study|Physician Decision|1
956524|NCT01098539|1951664|FG000|Overall Study|Adverse Event|26
956525|NCT01098539|1951665|FG001|Overall Study|Adverse Event|26
956526|NCT01098539|1951664|FG000|Overall Study|Protocol Violation|1
956527|NCT01098539|1951665|FG001|Overall Study|Protocol Violation|4
956528|NCT01098539|1951664|FG000|Overall Study|Noncompliance|3
956529|NCT01098539|1951665|FG001|Overall Study|Noncompliance|5
956530|NCT01098539|1951664|FG000|Overall Study|Lost to Follow-up|4
956531|NCT01098539|1951665|FG001|Overall Study|Lost to Follow-up|4
956532|NCT01098539|1951664|FG000|Overall Study|Withdrawal by Subject|12
956533|NCT01098539|1951665|FG001|Overall Study|Withdrawal by Subject|26
956534|NCT01098539|1951664|FG000|Overall Study|Physician Decision|5
956535|NCT01098539|1951665|FG001|Overall Study|Physician Decision|3
956536|NCT01098812|1951696|FG000|Overall Study|Death|2
956537|NCT01098812|1951697|FG001|Overall Study|Death|0
956538|NCT01098812|1951698|FG002|Overall Study|Death|1
956539|NCT01098812|1951696|FG000|Overall Study|Lost to Follow-up|0
956540|NCT01098812|1951697|FG001|Overall Study|Lost to Follow-up|1
956541|NCT01098812|1951698|FG002|Overall Study|Lost to Follow-up|0
956542|NCT01098851|1951707|FG000|Overall Study|Equipment failure|1
956543|NCT01098851|1951708|FG001|Overall Study|Equipment failure|0
956544|NCT01099215|1951747|FG000|Overall Study|Withdrawal by Subject|1
956545|NCT01099215|1951748|FG001|Overall Study|Withdrawal by Subject|0
956546|NCT01099215|1951747|FG000|Overall Study|Adverse Event|0
956547|NCT01099215|1951748|FG001|Overall Study|Adverse Event|1
956548|NCT01099267|1951754|FG000|MDS-003 Study|Adverse Event|37
956549|NCT01099267|1951754|FG000|MDS-003 Study|Lack of Efficacy|52
956550|NCT01099267|1951754|FG000|MDS-003 Study|Withdrawal by Subject|8
956551|NCT01099267|1951754|FG000|MDS-003 Study|Lost to Follow-up|1
956552|NCT01099267|1951754|FG000|MDS-003 Study|Death|11
956553|NCT01099267|1951754|FG000|MDS-003 Study|Study Closed by Sponsor|2
956554|NCT01099267|1951754|FG000|MDS-003 Study|Disease Progression|7
956555|NCT01099267|1951754|FG000|MDS-003 Study|Investigator Decision|2
956556|NCT01099267|1951754|FG000|MDS-003 Study|Non-Compliance|2
956557|NCT01099267|1951754|FG000|MDS-003 Study|Loss of Response|1
956558|NCT01099267|1951754|FG000|MDS-003 Study|Secondary Malign Disease|1
956559|NCT01099397|1951772|FG000|Overall Study|Lost to Follow-up|4
956560|NCT01099397|1951772|FG000|Overall Study|Protocol Violation|4
956561|NCT01099397|1951772|FG000|Overall Study|Withdrawal by Subject|5
956562|NCT01099579|1951815|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4
956563|NCT01099579|1951816|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1
956564|NCT01099579|1951817|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0
956565|NCT01099579|1951815|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
956566|NCT01099579|1951816|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
956567|NCT01099579|1951817|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
956568|NCT01099579|1951815|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
956569|NCT01099579|1951816|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
956570|NCT01099579|1951817|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
956571|NCT01099579|1951815|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
956572|NCT01099579|1951816|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
956573|NCT01099579|1951817|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
956574|NCT01099579|1951815|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2
956575|NCT01099579|1951816|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2
956576|NCT01099579|1951817|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1
956577|NCT01099579|1951815|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1
956578|NCT01099579|1951816|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1
956579|NCT01099579|1951817|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1
956580|NCT01099579|1951815|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0
956581|NCT01099579|1951816|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0
956582|NCT01099579|1951817|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2
956583|NCT01099579|1951815|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
956584|NCT01099579|1951816|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
956585|NCT01099579|1951817|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
956586|NCT01099579|1951815|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
956587|NCT01099579|1951816|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
956588|NCT01099579|1951817|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
956589|NCT01099579|1951815|FG000|Stage 2 (ATV Capsule)|Adverse Event|0
956590|NCT01099579|1951816|FG001|Stage 2 (ATV Capsule)|Adverse Event|1
956591|NCT01099579|1951817|FG002|Stage 2 (ATV Capsule)|Adverse Event|0
956592|NCT01099709|1951871|FG000|Period 1|Withdrawal by Subject|0
956593|NCT01099709|1951872|FG001|Period 1|Withdrawal by Subject|1
956594|NCT01099709|1951871|FG000|Period 1|Positive cotinine test|0
956595|NCT01099709|1951872|FG001|Period 1|Positive cotinine test|1
956596|NCT01099709|1951871|FG000|Period 1|Adverse Event|1
956597|NCT01099709|1951872|FG001|Period 1|Adverse Event|0
956598|NCT01099917|1951904|FG000|Overall Study|Adverse Event|3
956599|NCT01099917|1951904|FG000|Overall Study|Not Treated|24
956600|NCT01100034|1951925|FG000|Overall Study|Lost to Follow-up|11
956601|NCT01100034|1951925|FG000|Overall Study|Withdrawal of parent/guardian consent|1
956602|NCT01100034|1951925|FG000|Overall Study|Withdrawal by Subject|4
956603|NCT01100034|1951925|FG000|Overall Study|Sponsor decision|21
956604|NCT01100034|1951925|FG000|Overall Study|Participated in another clinical trial|1
956605|NCT01100034|1951925|FG000|Overall Study|Participants moved to another hospital|4
956606|NCT01100034|1951925|FG000|Overall Study|Site closed due to non-responsiveness|1
956607|NCT01100073|1951929|FG000|Overall Study|Lack of Efficacy|4
956608|NCT01100073|1951929|FG000|Overall Study|Insufficient Tolerability|21
956609|NCT01100073|1951929|FG000|Overall Study|Withdrawal by Subject|13
956610|NCT01100073|1951929|FG000|Overall Study|Lost to Follow-up|39
956611|NCT01100073|1951929|FG000|Overall Study|Lack of effect + patient's wish|2
956612|NCT01100073|1951929|FG000|Overall Study|Insufficient tolerability +patients wish|8
956613|NCT01100073|1951929|FG000|Overall Study|Other|8
956614|NCT01100073|1951929|FG000|Overall Study|Missing|5
956615|NCT01100086|1951933|FG000|Period 1|Withdrawal by Subject|1
956616|NCT01100086|1951934|FG001|Period 1|Withdrawal by Subject|0
956617|NCT01100307|1951963|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
956618|NCT01100307|1951964|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
956619|NCT01100307|1951963|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
956620|NCT01100307|1951964|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
956621|NCT01100307|1951963|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5
956622|NCT01100307|1951964|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2
956623|NCT01100307|1951963|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
956624|NCT01100307|1951964|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
956625|NCT01100307|1951963|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
956626|NCT01100307|1951964|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
956627|NCT01100307|1951963|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3
956628|NCT01100307|1951964|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8
956629|NCT01100320|1951972|FG000|Period 1|Withdrawal by Subject|2
956630|NCT01100320|1951973|FG001|Period 1|Withdrawal by Subject|4
956631|NCT01100320|1951972|FG000|Period 1|Positive Drug Screen|1
956632|NCT01100320|1951973|FG001|Period 1|Positive Drug Screen|1
956633|NCT01100320|1951972|FG000|Period 1|Adverse Event|2
956634|NCT01100320|1951973|FG001|Period 1|Adverse Event|2
956635|NCT01100320|1951972|FG000|Period 2|Withdrawal by Subject|1
956636|NCT01100320|1951973|FG001|Period 2|Withdrawal by Subject|1
956637|NCT01100437|1951979|FG000|Titration/Stabilization|Adverse Event|0
956638|NCT01100437|1951980|FG001|Titration/Stabilization|Adverse Event|0
956639|NCT01100437|1951981|FG002|Titration/Stabilization|Adverse Event|4
956640|NCT01100437|1951979|FG000|Titration/Stabilization|Non-compliance|0
956641|NCT01100437|1951980|FG001|Titration/Stabilization|Non-compliance|0
956642|NCT01100437|1951981|FG002|Titration/Stabilization|Non-compliance|1
956643|NCT01100437|1951979|FG000|Titration/Stabilization|Sponsor canceled study|0
956644|NCT01100437|1951980|FG001|Titration/Stabilization|Sponsor canceled study|0
956645|NCT01100437|1951981|FG002|Titration/Stabilization|Sponsor canceled study|1
956646|NCT01100437|1951979|FG000|Maintenance|Withdrawal by Subject|0
956647|NCT01100437|1951980|FG001|Maintenance|Withdrawal by Subject|0
956648|NCT01100437|1951981|FG002|Maintenance|Withdrawal by Subject|1
956649|NCT01100437|1951979|FG000|Maintenance|Sponsor termination of study|0
956650|NCT01100437|1951980|FG001|Maintenance|Sponsor termination of study|0
956651|NCT01100437|1951981|FG002|Maintenance|Sponsor termination of study|1
956652|NCT01100502|1951992|FG000|Overall Study|Withdrawal by Subject|18
956653|NCT01100502|1951993|FG001|Overall Study|Withdrawal by Subject|25
956654|NCT01100502|1951992|FG000|Overall Study|Lost to Follow-up|13
956655|NCT01100502|1951993|FG001|Overall Study|Lost to Follow-up|28
956656|NCT01100502|1951992|FG000|Overall Study|Site request to end participation in study|0
956657|NCT01100502|1951993|FG001|Overall Study|Site request to end participation in study|1
956658|NCT01100502|1951992|FG000|Overall Study|Death|45
956659|NCT01100502|1951993|FG001|Overall Study|Death|40
956660|NCT01100528|1951999|FG000|Overall Study|Death|1
956661|NCT01100528|1951999|FG000|Overall Study|Withdrawal by Subject|2
956662|NCT01100567|1952005|FG000|Overall Study|Withdrawal by Subject|5
956663|NCT01100567|1952006|FG001|Overall Study|Withdrawal by Subject|8
956664|NCT01100567|1952005|FG000|Overall Study|Early Hospital Discharge|6
956665|NCT01100567|1952006|FG001|Overall Study|Early Hospital Discharge|4
956666|NCT01100567|1952005|FG000|Overall Study|Lost to Follow-up|1
956667|NCT01100567|1952006|FG001|Overall Study|Lost to Follow-up|2
956668|NCT01100567|1952005|FG000|Overall Study|Physician Decision|0
956669|NCT01100567|1952006|FG001|Overall Study|Physician Decision|1
956670|NCT01100567|1952005|FG000|Overall Study|Deemed ineligible after consent|0
956671|NCT01100567|1952006|FG001|Overall Study|Deemed ineligible after consent|1
956672|NCT01100853|1952036|FG000|Overall Study|Lost to Follow-up|11
956673|NCT01100853|1952037|FG001|Overall Study|Lost to Follow-up|6
956674|NCT01100853|1952036|FG000|Overall Study|Received <4 study injections|10
956675|NCT01100853|1952037|FG001|Overall Study|Received <4 study injections|13
956676|NCT01100853|1952036|FG000|Overall Study|Withdrawal by Subject|6
956677|NCT01100853|1952037|FG001|Overall Study|Withdrawal by Subject|4
956678|NCT01100944|1952053|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
956679|NCT01100944|1952054|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
956680|NCT01100944|1952055|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
956681|NCT01100944|1952053|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
956682|NCT01100944|1952054|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
956683|NCT01100944|1952055|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
956684|NCT01100944|1952053|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
956685|NCT01100944|1952054|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
956686|NCT01100944|1952055|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
956687|NCT01100944|1952053|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
956688|NCT01100944|1952054|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
956689|NCT01100944|1952055|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
956690|NCT01101022|1952078|FG000|Overall Study|Adverse Event|6
956691|NCT01101022|1952079|FG001|Overall Study|Adverse Event|2
956692|NCT01101022|1952078|FG000|Overall Study|Protocol Violation|4
956693|NCT01101022|1952079|FG001|Overall Study|Protocol Violation|3
956694|NCT01101022|1952078|FG000|Overall Study|Withdrawal by Subject|3
956695|NCT01101022|1952079|FG001|Overall Study|Withdrawal by Subject|8
956696|NCT01101022|1952078|FG000|Overall Study|Lost to Follow-up|1
956697|NCT01101022|1952079|FG001|Overall Study|Lost to Follow-up|4
956698|NCT01101022|1952078|FG000|Overall Study|Lack of Efficacy|0
956699|NCT01101022|1952079|FG001|Overall Study|Lack of Efficacy|7
956700|NCT01101022|1952078|FG000|Overall Study|Sponsor decision|1
956701|NCT01101022|1952079|FG001|Overall Study|Sponsor decision|1
956702|NCT01101022|1952078|FG000|Overall Study|Non-compliance|1
956703|NCT01101022|1952079|FG001|Overall Study|Non-compliance|0
956704|NCT01101022|1952078|FG000|Overall Study|Work schedule|1
956705|NCT01101022|1952079|FG001|Overall Study|Work schedule|1
956706|NCT01101022|1952078|FG000|Overall Study|Vacation|0
956707|NCT01101022|1952079|FG001|Overall Study|Vacation|1
956708|NCT01101035|1952087|FG000|Overall Study|Adverse Event|191
956709|NCT01101035|1952088|FG001|Overall Study|Adverse Event|172
956710|NCT01101035|1952087|FG000|Overall Study|Major Protocol Deviation|52
956711|NCT01101035|1952088|FG001|Overall Study|Major Protocol Deviation|46
956712|NCT01101035|1952087|FG000|Overall Study|Lost to Follow-up|226
956713|NCT01101035|1952088|FG001|Overall Study|Lost to Follow-up|223
956714|NCT01101035|1952087|FG000|Overall Study|Voluntary Withdrawal|595
956715|NCT01101035|1952088|FG001|Overall Study|Voluntary Withdrawal|587
956716|NCT01101035|1952087|FG000|Overall Study|Reason not Specified|333
956717|NCT01101035|1952088|FG001|Overall Study|Reason not Specified|363
956718|NCT01101061|1952100|FG000|Overall Study|Adverse Event|0
956719|NCT01101061|1952101|FG001|Overall Study|Adverse Event|0
956720|NCT01101061|1952102|FG002|Overall Study|Adverse Event|1
956721|NCT01101061|1952103|FG003|Overall Study|Adverse Event|0
956722|NCT01101061|1952104|FG004|Overall Study|Adverse Event|0
956723|NCT01101061|1952105|FG005|Overall Study|Adverse Event|0
956724|NCT01101165|1952128|FG000|Period 1|Adverse Event|1
956725|NCT01101165|1952129|FG001|Period 1|Adverse Event|2
956726|NCT01101165|1952128|FG000|Period 1|Withdrawal by Subject|0
956727|NCT01101165|1952129|FG001|Period 1|Withdrawal by Subject|2
956728|NCT01101165|1952128|FG000|Period 1|Positive Drug Screen|0
956729|NCT01101165|1952129|FG001|Period 1|Positive Drug Screen|1
956730|NCT01101165|1952128|FG000|Period 1|Lost to Follow-up|1
956731|NCT01101165|1952129|FG001|Period 1|Lost to Follow-up|0
956732|NCT01101165|1952128|FG000|Period 2|Withdrawal by Subject|3
956733|NCT01101165|1952129|FG001|Period 2|Withdrawal by Subject|1
956734|NCT01101165|1952128|FG000|Period 2|Adverse Event|1
956735|NCT01101165|1952129|FG001|Period 2|Adverse Event|0
956736|NCT01101178|1952135|FG000|Period 1|Withdrawal by Subject|1
956737|NCT01101178|1952136|FG001|Period 1|Withdrawal by Subject|2
956738|NCT01101178|1952135|FG000|Period 1|Positive drug screen|1
956739|NCT01101178|1952136|FG001|Period 1|Positive drug screen|1
956740|NCT01101178|1952135|FG000|Period 1|Adverse Event|2
956741|NCT01101178|1952136|FG001|Period 1|Adverse Event|1
956742|NCT01101178|1952135|FG000|Period 2|Withdrawal by Subject|0
956743|NCT01101178|1952136|FG001|Period 2|Withdrawal by Subject|1
956744|NCT01101191|1952143|FG000|Period 1|Withdrawal by Subject|1
956745|NCT01101191|1952144|FG001|Period 1|Withdrawal by Subject|0
956746|NCT01101191|1952143|FG000|Period 1|Adverse Event|1
956747|NCT01101191|1952144|FG001|Period 1|Adverse Event|2
956748|NCT01101308|1952151|FG000|Period 1|Adverse Event|2
956749|NCT01101308|1952152|FG001|Period 1|Adverse Event|1
956750|NCT01101308|1952151|FG000|Period 1|Positive for cotinine|1
956751|NCT01101308|1952152|FG001|Period 1|Positive for cotinine|0
956752|NCT01101321|1952159|FG000|Period 1|Withdrawal by Subject|1
956753|NCT01101321|1952160|FG001|Period 1|Withdrawal by Subject|1
956754|NCT01101321|1952159|FG000|Period 1|Adverse Event|3
956755|NCT01101321|1952160|FG001|Period 1|Adverse Event|3
956756|NCT01101334|1952168|FG000|Overall Study|Adverse Event|9
956757|NCT01101334|1952169|FG001|Overall Study|Adverse Event|4
956758|NCT01101334|1952168|FG000|Overall Study|Death|7
956759|NCT01101334|1952169|FG001|Overall Study|Death|1
956760|NCT01101334|1952168|FG000|Overall Study|Withdrawal by Subject|4
956761|NCT01101334|1952169|FG001|Overall Study|Withdrawal by Subject|3
956762|NCT01101334|1952168|FG000|Overall Study|Withdrawal by Sponsor|1
956763|NCT01101334|1952169|FG001|Overall Study|Withdrawal by Sponsor|1
956764|NCT01101334|1952168|FG000|Overall Study|Progressive Disease|22
956765|NCT01101334|1952169|FG001|Overall Study|Progressive Disease|35
956766|NCT01101334|1952168|FG000|Overall Study|Other|2
956767|NCT01101334|1952169|FG001|Overall Study|Other|1
956768|NCT01101477|1952189|FG000|Overall Study|Protocol Violation|5
956769|NCT01101477|1952190|FG001|Overall Study|Protocol Violation|3
956770|NCT01101477|1952191|FG002|Overall Study|Protocol Violation|1
956771|NCT01101542|1952199|FG000|Year 3 Surveillance Period|Lost to Follow-up|7
956772|NCT01101542|1952199|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4
956773|NCT01101542|1952199|FG000|Year 4 Surveillance Period|Other|287
956774|NCT01101542|1952199|FG000|Year 5 Surveillance Period|Lost to Follow-up|140
956775|NCT01101542|1952199|FG000|Year 5 Surveillance Period|Pregnancy|1
956776|NCT01101542|1952199|FG000|Year 6 Surveillance Period|Lost to Follow-up|986
956777|NCT01101542|1952199|FG000|Year 6 Surveillance Period|Pregnancy|1
956778|NCT01101542|1952199|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4
956779|NCT01101841|1952209|FG000|Overall Study|Adverse Event|15
956780|NCT01101841|1952210|FG001|Overall Study|Adverse Event|15
956781|NCT01101841|1952209|FG000|Overall Study|Lost to Follow-up|9
956782|NCT01101841|1952210|FG001|Overall Study|Lost to Follow-up|3
956783|NCT01101841|1952209|FG000|Overall Study|Withdrawal by Subject|21
956784|NCT01101841|1952210|FG001|Overall Study|Withdrawal by Subject|40
956785|NCT01101841|1952209|FG000|Overall Study|Protocol Violation|1
956786|NCT01101841|1952210|FG001|Overall Study|Protocol Violation|1
956787|NCT01101841|1952209|FG000|Overall Study|Physician Decision|0
956788|NCT01101841|1952210|FG001|Overall Study|Physician Decision|2
956789|NCT01101841|1952209|FG000|Overall Study|Lack of Efficacy|0
956790|NCT01101841|1952210|FG001|Overall Study|Lack of Efficacy|2
956791|NCT01101841|1952209|FG000|Overall Study|Other|0
956792|NCT01101841|1952210|FG001|Overall Study|Other|1
956793|NCT01101841|1952209|FG000|Overall Study|Suicidality Tracking Scale|3
956794|NCT01101841|1952210|FG001|Overall Study|Suicidality Tracking Scale|1
956795|NCT01101841|1952209|FG000|Overall Study|Eligibility Criteria|1
956796|NCT01101841|1952210|FG001|Overall Study|Eligibility Criteria|2
956797|NCT01101997|1952247|FG000|Overall Study|Withdrawal by Subject|2
956798|NCT01102231|1952262|FG000|Overall Study|Protocol Violation|3
956799|NCT01102231|1952262|FG000|Overall Study|Lack of Efficacy|2
956800|NCT01102231|1952262|FG000|Overall Study|Death|2
956801|NCT01102231|1952262|FG000|Overall Study|Adverse Event|3
956802|NCT01102231|1952262|FG000|Overall Study|Withdrawal by Subject|1
956803|NCT01102231|1952262|FG000|Overall Study|Did not received the treatment|4
956804|NCT01102257|1952269|FG000|Overall Study|Adverse Event|1
956805|NCT01102257|1952270|FG001|Overall Study|Adverse Event|0
956806|NCT01102257|1952269|FG000|Overall Study|Adverse Event|1
956807|NCT01102257|1952270|FG001|Overall Study|Adverse Event|0
956808|NCT01102374|1952285|FG000|Overall Study|Death|9
956809|NCT01102374|1952286|FG001|Overall Study|Death|13
956810|NCT01102374|1952285|FG000|Overall Study|Lost to Follow-up|7
956811|NCT01102374|1952286|FG001|Overall Study|Lost to Follow-up|6
956812|NCT01102426|1952303|FG000|Overall Study|Randomized but not treated|4
956813|NCT01102426|1952304|FG001|Overall Study|Randomized but not treated|1
956814|NCT01102426|1952303|FG000|Overall Study|Adverse Events (treatment-related)|15
956815|NCT01102426|1952304|FG001|Overall Study|Adverse Events (treatment-related)|8
956816|NCT01102426|1952303|FG000|Overall Study|Physician Decision|9
956817|NCT01102426|1952304|FG001|Overall Study|Physician Decision|6
956818|NCT01102426|1952303|FG000|Overall Study|Progressive Disease|85
956819|NCT01102426|1952304|FG001|Overall Study|Progressive Disease|44
956820|NCT01102426|1952303|FG000|Overall Study|Adverse Events (unrelated to|9
956821|NCT01102426|1952304|FG001|Overall Study|Adverse Events (unrelated to|1
956822|NCT01102426|1952303|FG000|Overall Study|Patient Refusal|24
956823|NCT01102426|1952304|FG001|Overall Study|Patient Refusal|12
956824|NCT01102426|1952303|FG000|Overall Study|Death (due to adverse events|0
956825|NCT01102426|1952304|FG001|Overall Study|Death (due to adverse events|1
956826|NCT01102426|1952303|FG000|Overall Study|Death (non-related to the study|19
956827|NCT01102426|1952304|FG001|Overall Study|Death (non-related to the study|8
956828|NCT01102491|1952312|FG000|Overall Study|Protocol Violation|11
956829|NCT01102491|1952313|FG001|Overall Study|Protocol Violation|12
956830|NCT01102777|1952334|FG000|Overall Study|Death|2
956831|NCT01102777|1952335|FG001|Overall Study|Death|6
956832|NCT01102777|1952334|FG000|Overall Study|Lost to Follow-up|7
956833|NCT01102777|1952335|FG001|Overall Study|Lost to Follow-up|10
956834|NCT01102803|1952344|FG000|Baseline to Post-Treatment|Lost to Follow-up|3
956835|NCT01102803|1952345|FG001|Baseline to Post-Treatment|Lost to Follow-up|0
956836|NCT01102803|1952344|FG000|Post to Follow-Up|Lost to Follow-up|1
956837|NCT01102803|1952345|FG001|Post to Follow-Up|Lost to Follow-up|3
956838|NCT01102972|1952361|FG000|Overall Study|Adverse Event|8
956839|NCT01102972|1952362|FG001|Overall Study|Adverse Event|2
956840|NCT01102972|1952361|FG000|Overall Study|Lack of Efficacy|2
956841|NCT01102972|1952362|FG001|Overall Study|Lack of Efficacy|1
956842|NCT01102972|1952361|FG000|Overall Study|Protocol Violation|1
956843|NCT01102972|1952362|FG001|Overall Study|Protocol Violation|0
956844|NCT01102972|1952361|FG000|Overall Study|Lost to Follow-up|10
956845|NCT01102972|1952362|FG001|Overall Study|Lost to Follow-up|5
956846|NCT01102972|1952361|FG000|Overall Study|Investigator Discretion|2
956847|NCT01102972|1952362|FG001|Overall Study|Investigator Discretion|0
956848|NCT01102972|1952361|FG000|Overall Study|Withdrawal by Subject|6
956849|NCT01102972|1952362|FG001|Overall Study|Withdrawal by Subject|6
956850|NCT01103063|1952370|FG000|Overall Study|Adverse Event|3
956851|NCT01103063|1952371|FG001|Overall Study|Adverse Event|1
956852|NCT01103063|1952370|FG000|Overall Study|Lost to Follow-up|68
956853|NCT01103063|1952371|FG001|Overall Study|Lost to Follow-up|51
956854|NCT01103063|1952370|FG000|Overall Study|Withdrawal by Subject|60
956855|NCT01103063|1952371|FG001|Overall Study|Withdrawal by Subject|15
956856|NCT01103063|1952370|FG000|Overall Study|Other|16
956857|NCT01103063|1952371|FG001|Overall Study|Other|11
956858|NCT01103063|1952370|FG000|Overall Study|Protocol Violation|1
956859|NCT01103063|1952371|FG001|Overall Study|Protocol Violation|0
956860|NCT01103063|1952370|FG000|Overall Study|Study terminated by Sponsor|326
956861|NCT01103063|1952371|FG001|Overall Study|Study terminated by Sponsor|342
956862|NCT01103063|1952370|FG000|Overall Study|Death|3
956863|NCT01103063|1952371|FG001|Overall Study|Death|1
956864|NCT01103141|1952381|FG000|Overall Study|Death|0
956865|NCT01103141|1952382|FG001|Overall Study|Death|1
956866|NCT01103141|1952381|FG000|Overall Study|Lost to Follow-up|2
956867|NCT01103141|1952382|FG001|Overall Study|Lost to Follow-up|1
956868|NCT01103232|1952390|FG000|Overall Study|Withdrawal by Subject|1
956869|NCT01103232|1952391|FG001|Overall Study|Withdrawal by Subject|1
956870|NCT01103232|1952390|FG000|Overall Study|Protocol Violation|0
956871|NCT01103232|1952391|FG001|Overall Study|Protocol Violation|1
956872|NCT01103245|1952401|FG000|Overall Study|Withdrawal by Subject|1
956873|NCT01103245|1952402|FG001|Overall Study|Withdrawal by Subject|0
956874|NCT01103245|1952403|FG002|Overall Study|Withdrawal by Subject|3
956875|NCT01103245|1952404|FG003|Overall Study|Withdrawal by Subject|0
956876|NCT01103245|1952401|FG000|Overall Study|Inadequate IV access|1
956877|NCT01103245|1952402|FG001|Overall Study|Inadequate IV access|0
956878|NCT01103245|1952403|FG002|Overall Study|Inadequate IV access|0
956879|NCT01103245|1952404|FG003|Overall Study|Inadequate IV access|0
956880|NCT01103245|1952401|FG000|Overall Study|Adverse Event|0
956881|NCT01103245|1952402|FG001|Overall Study|Adverse Event|2
956882|NCT01103245|1952403|FG002|Overall Study|Adverse Event|1
956883|NCT01103245|1952404|FG003|Overall Study|Adverse Event|0
956884|NCT01103245|1952401|FG000|Overall Study|Physician Decision|1
956885|NCT01103245|1952402|FG001|Overall Study|Physician Decision|0
956886|NCT01103245|1952403|FG002|Overall Study|Physician Decision|0
956887|NCT01103245|1952404|FG003|Overall Study|Physician Decision|0
956888|NCT01103284|1952426|FG000|Overall Study|Death|2
956889|NCT01103284|1952427|FG001|Overall Study|Death|0
956890|NCT01103284|1952426|FG000|Overall Study|Lost to Follow-up|9
956891|NCT01103284|1952427|FG001|Overall Study|Lost to Follow-up|10
956892|NCT01103284|1952426|FG000|Overall Study|Pregnancy|3
956893|NCT01103284|1952427|FG001|Overall Study|Pregnancy|1
956894|NCT01103284|1952426|FG000|Overall Study|Protocol Violation|12
956895|NCT01103284|1952427|FG001|Overall Study|Protocol Violation|5
956896|NCT01103284|1952426|FG000|Overall Study|Adverse Event|0
956897|NCT01103284|1952427|FG001|Overall Study|Adverse Event|5
956898|NCT01103284|1952426|FG000|Overall Study|Withdrawal by Subject|14
956899|NCT01103284|1952427|FG001|Overall Study|Withdrawal by Subject|18
956900|NCT01103284|1952426|FG000|Overall Study|Dermal Hypersensitivity|0
956901|NCT01103284|1952427|FG001|Overall Study|Dermal Hypersensitivity|1
956902|NCT01103284|1952426|FG000|Overall Study|Termination by the Sponsor|0
956903|NCT01103284|1952427|FG001|Overall Study|Termination by the Sponsor|1
956904|NCT01103284|1952426|FG000|Overall Study|Not described|2
956905|NCT01103284|1952427|FG001|Overall Study|Not described|1
956906|NCT01103284|1952426|FG000|Overall Study|Missing CRF entries for study completion|0
956907|NCT01103284|1952427|FG001|Overall Study|Missing CRF entries for study completion|2
956908|NCT01103323|1952435|FG000|Without/Before Drug Switch|Adverse Event|50
956909|NCT01103323|1952436|FG001|Without/Before Drug Switch|Adverse Event|7
956910|NCT01103323|1952435|FG000|Without/Before Drug Switch|Withdrawal by Subject|17
956911|NCT01103323|1952436|FG001|Without/Before Drug Switch|Withdrawal by Subject|5
956912|NCT01103323|1952435|FG000|Without/Before Drug Switch|Protocol Violation|2
956913|NCT01103323|1952436|FG001|Without/Before Drug Switch|Protocol Violation|0
956914|NCT01103323|1952435|FG000|Without/Before Drug Switch|Physician Decision|2
956915|NCT01103323|1952436|FG001|Without/Before Drug Switch|Physician Decision|0
956916|NCT01103323|1952435|FG000|Without/Before Drug Switch|did not receive study treatment|5
956917|NCT01103323|1952436|FG001|Without/Before Drug Switch|did not receive study treatment|2
956918|NCT01103323|1952435|FG000|Without/Before Drug Switch|Switch to Regorafenib|0
956919|NCT01103323|1952436|FG001|Without/Before Drug Switch|Switch to Regorafenib|4
956920|NCT01103323|1952435|FG000|Switched From Placebo to Regorafenib|Adverse Event|0
956921|NCT01103323|1952436|FG001|Switched From Placebo to Regorafenib|Adverse Event|1
956922|NCT01103362|1952443|FG000|Overall Study|study terminated|596
956923|NCT01103466|1952477|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2
956924|NCT01103466|1952478|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0
956925|NCT01103466|1952479|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0
956926|NCT01103466|1952477|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2
956927|NCT01103466|1952478|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1
956928|NCT01103466|1952479|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0
956929|NCT01103466|1952477|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
956930|NCT01103466|1952478|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
956931|NCT01103466|1952479|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
956932|NCT01103466|1952477|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1
956933|NCT01103466|1952478|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0
956934|NCT01103466|1952479|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0
956935|NCT01103466|1952477|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
956936|NCT01103466|1952478|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
956937|NCT01103466|1952479|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
956938|NCT01103466|1952477|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0
956939|NCT01103466|1952478|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0
956940|NCT01103466|1952479|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1
956941|NCT01103479|1952490|FG000|Overall Study|Up to date with CRC screening|1
956942|NCT01103479|1952491|FG001|Overall Study|Up to date with CRC screening|9
956943|NCT01103479|1952492|FG002|Overall Study|Up to date with CRC screening|12
956944|NCT01103479|1952490|FG000|Overall Study|Family history of CRC|1
956945|NCT01103479|1952491|FG001|Overall Study|Family history of CRC|0
956946|NCT01103479|1952492|FG002|Overall Study|Family history of CRC|2
956947|NCT01103479|1952490|FG000|Overall Study|Active cancer|1
956948|NCT01103479|1952491|FG001|Overall Study|Active cancer|0
956949|NCT01103479|1952492|FG002|Overall Study|Active cancer|0
956950|NCT01103479|1952490|FG000|Overall Study|Saw non-study physician|2
956951|NCT01103479|1952491|FG001|Overall Study|Saw non-study physician|0
956952|NCT01103479|1952492|FG002|Overall Study|Saw non-study physician|0
956953|NCT01103713|1952522|FG000|Overall Study|Lost to Follow-up|2
956954|NCT01103713|1952522|FG000|Overall Study|Withdrawal by Subject|8
956955|NCT01103713|1952522|FG000|Overall Study|Study terminated by sponsor|2
956956|NCT01103713|1952522|FG000|Overall Study|Other|1
956957|NCT01103778|1952529|FG000|Overall Study|Lost to Follow-up|1
956958|NCT01103778|1952529|FG000|Overall Study|Proteinuria improved prior to enrollment|1
956959|NCT01103778|1952529|FG000|Overall Study|Screen failure|1
956960|NCT01103960|1952546|FG000|Overall Study|Adverse Event|2
956961|NCT01103960|1952547|FG001|Overall Study|Adverse Event|1
956962|NCT01103960|1952546|FG000|Overall Study|Withdrawal by Subject|2
956963|NCT01103960|1952547|FG001|Overall Study|Withdrawal by Subject|1
956964|NCT01103960|1952546|FG000|Overall Study|Other|1
956965|NCT01103960|1952547|FG001|Overall Study|Other|0
956966|NCT01104155|1952588|FG000|Overall Study|Adverse Event|15
956967|NCT01104155|1952589|FG001|Overall Study|Adverse Event|8
956968|NCT01104155|1952588|FG000|Overall Study|Participant choice|6
956969|NCT01104155|1952589|FG001|Overall Study|Participant choice|5
956970|NCT01104155|1952588|FG000|Overall Study|Withdrawal of consent|1
956971|NCT01104155|1952589|FG001|Overall Study|Withdrawal of consent|1
956972|NCT01104155|1952588|FG000|Overall Study|Other|3
956973|NCT01104155|1952589|FG001|Overall Study|Other|4
956974|NCT01104246|1952604|FG000|Overall Study|Withdrawal by Subject|1
956975|NCT01104246|1952604|FG000|Overall Study|did not meet inclusion criteria|4
956976|NCT01104311|1952619|FG000|Overall Study|Withdrawal by Subject|6
956977|NCT01104311|1952620|FG001|Overall Study|Withdrawal by Subject|6
956978|NCT01104311|1952619|FG000|Overall Study|Protocol Violation|0
956979|NCT01104311|1952620|FG001|Overall Study|Protocol Violation|1
956980|NCT01104311|1952619|FG000|Overall Study|Physician Decision|2
956981|NCT01104311|1952620|FG001|Overall Study|Physician Decision|2
956982|NCT01104311|1952619|FG000|Overall Study|low compliance|1
956983|NCT01104311|1952620|FG001|Overall Study|low compliance|1
956984|NCT01104311|1952619|FG000|Overall Study|Adverse Event|1
956985|NCT01104311|1952620|FG001|Overall Study|Adverse Event|2
956986|NCT01104376|1952630|FG000|Overall Study|Withdrawal by Subject|15
956987|NCT01104376|1952630|FG000|Overall Study|Consented but excluded after labs|13
956988|NCT01104415|1952643|FG000|Core Phase|Consent withdrawn by subjects|1
956989|NCT01104415|1952644|FG001|Core Phase|Consent withdrawn by subjects|0
956990|NCT01104415|1952643|FG000|Extension Period|Progressive disease|0
956991|NCT01104415|1952644|FG001|Extension Period|Progressive disease|4
956992|NCT01104415|1952643|FG000|Extension Period|Death|0
956993|NCT01104415|1952644|FG001|Extension Period|Death|1
956994|NCT01104415|1952643|FG000|Extension Period|Physician Decision|0
956995|NCT01104415|1952644|FG001|Extension Period|Physician Decision|1
956996|NCT01104415|1952643|FG000|Extension Period|Transition to Study LX1606.302|0
956997|NCT01104415|1952644|FG001|Extension Period|Transition to Study LX1606.302|4
956998|NCT01104415|1952643|FG000|Extension Period|Heart surgery/feeling miserable|0
956999|NCT01104415|1952644|FG001|Extension Period|Heart surgery/feeling miserable|1
957000|NCT01104493|1952653|FG000|Overall Study|Lost to Follow-up|0
957001|NCT01104493|1952654|FG001|Overall Study|Lost to Follow-up|2
957002|NCT01104545|1952663|FG000|Overall Study|Adverse Event|0
957003|NCT01104545|1952664|FG001|Overall Study|Adverse Event|1
957004|NCT01104545|1952665|FG002|Overall Study|Adverse Event|2
957005|NCT01104558|1952710|FG000|Overall Study|Protocol Violation|6
957006|NCT01104558|1952710|FG000|Overall Study|Missing of primary efficacy assessment|10
957007|NCT01104558|1952710|FG000|Overall Study|Missing of genetic analysis results|1
957008|NCT01104584|1952714|FG000|Overall Study|Study drug never administered|21
957009|NCT01104584|1952714|FG000|Overall Study|Study prematurely discontinued|2
957010|NCT01104636|1952736|FG000|Overall Study|Lack of Efficacy|43
957011|NCT01104636|1952736|FG000|Overall Study|Lost to Follow-up|24
957012|NCT01104636|1952736|FG000|Overall Study|Withdrawal by Subject|4
957013|NCT01104636|1952736|FG000|Overall Study|Other|43
957014|NCT01104636|1952736|FG000|Overall Study|Study terminated by sponsor|1
957015|NCT01104636|1952736|FG000|Overall Study|Pregnancy|2
957016|NCT01104636|1952736|FG000|Overall Study|Adverse Event|40
957017|NCT01104636|1952736|FG000|Overall Study|Ongoing|21
957018|NCT01104662|1952748|FG000|Overall Study|Adverse Event|2
957019|NCT01104662|1952749|FG001|Overall Study|Adverse Event|2
957020|NCT01104662|1952750|FG002|Overall Study|Adverse Event|0
957021|NCT01104662|1952751|FG003|Overall Study|Adverse Event|1
957022|NCT01104662|1952752|FG004|Overall Study|Adverse Event|1
957023|NCT01104662|1952753|FG005|Overall Study|Adverse Event|1
957024|NCT01104662|1952754|FG006|Overall Study|Adverse Event|0
957025|NCT01104662|1952755|FG007|Overall Study|Adverse Event|0
957026|NCT01104662|1952748|FG000|Overall Study|Clinical Failure|1
957027|NCT01104662|1952749|FG001|Overall Study|Clinical Failure|0
957028|NCT01104662|1952750|FG002|Overall Study|Clinical Failure|0
957029|NCT01104662|1952751|FG003|Overall Study|Clinical Failure|0
957030|NCT01104662|1952752|FG004|Overall Study|Clinical Failure|0
957031|NCT01104662|1952753|FG005|Overall Study|Clinical Failure|1
957032|NCT01104662|1952754|FG006|Overall Study|Clinical Failure|0
957033|NCT01104662|1952755|FG007|Overall Study|Clinical Failure|0
957034|NCT01104662|1952748|FG000|Overall Study|Participant left investigator's care|1
957035|NCT01104662|1952749|FG001|Overall Study|Participant left investigator's care|1
957036|NCT01104662|1952750|FG002|Overall Study|Participant left investigator's care|0
957037|NCT01104662|1952751|FG003|Overall Study|Participant left investigator's care|0
957038|NCT01104662|1952752|FG004|Overall Study|Participant left investigator's care|0
957039|NCT01104662|1952753|FG005|Overall Study|Participant left investigator's care|0
957040|NCT01104662|1952754|FG006|Overall Study|Participant left investigator's care|0
957041|NCT01104662|1952755|FG007|Overall Study|Participant left investigator's care|0
957042|NCT01104662|1952748|FG000|Overall Study|Reason not specified|3
957043|NCT01104662|1952749|FG001|Overall Study|Reason not specified|3
957044|NCT01104662|1952750|FG002|Overall Study|Reason not specified|0
957045|NCT01104662|1952751|FG003|Overall Study|Reason not specified|0
957046|NCT01104662|1952752|FG004|Overall Study|Reason not specified|0
957047|NCT01104662|1952753|FG005|Overall Study|Reason not specified|1
957048|NCT01104662|1952754|FG006|Overall Study|Reason not specified|0
957049|NCT01104662|1952755|FG007|Overall Study|Reason not specified|0
957050|NCT01104662|1952748|FG000|Overall Study|Randomized but not treated|3
957051|NCT01104662|1952749|FG001|Overall Study|Randomized but not treated|4
957052|NCT01104662|1952750|FG002|Overall Study|Randomized but not treated|1
957053|NCT01104662|1952751|FG003|Overall Study|Randomized but not treated|0
957054|NCT01104662|1952752|FG004|Overall Study|Randomized but not treated|0
957055|NCT01104662|1952753|FG005|Overall Study|Randomized but not treated|1
957056|NCT01104662|1952754|FG006|Overall Study|Randomized but not treated|0
957057|NCT01104662|1952755|FG007|Overall Study|Randomized but not treated|0
957058|NCT01104701|1952778|FG000|Overall Study|Withdrawal by Subject|0
957059|NCT01104701|1952779|FG001|Overall Study|Withdrawal by Subject|1
957060|NCT01104701|1952780|FG002|Overall Study|Withdrawal by Subject|2
957061|NCT01104701|1952781|FG003|Overall Study|Withdrawal by Subject|1
957062|NCT01104701|1952778|FG000|Overall Study|Adverse Event|0
957063|NCT01104701|1952779|FG001|Overall Study|Adverse Event|0
957064|NCT01104701|1952780|FG002|Overall Study|Adverse Event|0
957065|NCT01104701|1952781|FG003|Overall Study|Adverse Event|1
957066|NCT01104701|1952778|FG000|Overall Study|Physician Decision|0
957067|NCT01104701|1952779|FG001|Overall Study|Physician Decision|2
957068|NCT01104701|1952780|FG002|Overall Study|Physician Decision|0
957069|NCT01104701|1952781|FG003|Overall Study|Physician Decision|0
957070|NCT01104766|1952795|FG000|Overall Study|Did not meet inc/exc criteria|1
957071|NCT01104766|1952796|FG001|Overall Study|Did not meet inc/exc criteria|0
957072|NCT01104766|1952797|FG002|Overall Study|Did not meet inc/exc criteria|0
957073|NCT01104766|1952798|FG003|Overall Study|Did not meet inc/exc criteria|0
957074|NCT01104766|1952795|FG000|Overall Study|Adverse Event|17
957075|NCT01104766|1952796|FG001|Overall Study|Adverse Event|15
957076|NCT01104766|1952797|FG002|Overall Study|Adverse Event|20
957077|NCT01104766|1952798|FG003|Overall Study|Adverse Event|14
957078|NCT01104766|1952795|FG000|Overall Study|Lack of Efficacy|20
957079|NCT01104766|1952796|FG001|Overall Study|Lack of Efficacy|15
957080|NCT01104766|1952797|FG002|Overall Study|Lack of Efficacy|14
957081|NCT01104766|1952798|FG003|Overall Study|Lack of Efficacy|8
957082|NCT01104766|1952795|FG000|Overall Study|Protocol Violation|2
957083|NCT01104766|1952796|FG001|Overall Study|Protocol Violation|0
957084|NCT01104766|1952797|FG002|Overall Study|Protocol Violation|0
957085|NCT01104766|1952798|FG003|Overall Study|Protocol Violation|0
957086|NCT01104766|1952795|FG000|Overall Study|Withdrawal by Subject|17
957087|NCT01104766|1952796|FG001|Overall Study|Withdrawal by Subject|19
957088|NCT01104766|1952797|FG002|Overall Study|Withdrawal by Subject|25
957089|NCT01104766|1952798|FG003|Overall Study|Withdrawal by Subject|15
957090|NCT01104766|1952795|FG000|Overall Study|Lost to Follow-up|1
957091|NCT01104766|1952796|FG001|Overall Study|Lost to Follow-up|2
957092|NCT01104766|1952797|FG002|Overall Study|Lost to Follow-up|1
957093|NCT01104766|1952798|FG003|Overall Study|Lost to Follow-up|1
957094|NCT01104779|1952811|FG000|Overall Study|Protocol Violation|1
957095|NCT01104779|1952812|FG001|Overall Study|Protocol Violation|2
957096|NCT01104779|1952813|FG002|Overall Study|Protocol Violation|2
957097|NCT01104779|1952811|FG000|Overall Study|Lack of Efficacy|26
957098|NCT01104779|1952812|FG001|Overall Study|Lack of Efficacy|12
957099|NCT01104779|1952813|FG002|Overall Study|Lack of Efficacy|13
957100|NCT01104779|1952811|FG000|Overall Study|Adverse Event|13
957101|NCT01104779|1952812|FG001|Overall Study|Adverse Event|14
957102|NCT01104779|1952813|FG002|Overall Study|Adverse Event|13
957103|NCT01104779|1952811|FG000|Overall Study|Did not meet inc/exc criteria|1
957104|NCT01104779|1952812|FG001|Overall Study|Did not meet inc/exc criteria|1
957105|NCT01104779|1952813|FG002|Overall Study|Did not meet inc/exc criteria|1
957106|NCT01104779|1952811|FG000|Overall Study|Other reasons|0
957107|NCT01104779|1952812|FG001|Overall Study|Other reasons|1
957108|NCT01104779|1952813|FG002|Overall Study|Other reasons|0
957109|NCT01104779|1952811|FG000|Overall Study|Lost to Follow-up|2
957110|NCT01104779|1952812|FG001|Overall Study|Lost to Follow-up|0
957111|NCT01104779|1952813|FG002|Overall Study|Lost to Follow-up|1
957112|NCT01104779|1952811|FG000|Overall Study|Withdrawal by Subject|16
957113|NCT01104779|1952812|FG001|Overall Study|Withdrawal by Subject|25
957114|NCT01104779|1952813|FG002|Overall Study|Withdrawal by Subject|32
957115|NCT01104792|1952821|FG000|Overall Study|Adverse Event|77
957116|NCT01104792|1952821|FG000|Overall Study|Insufficient Therapeutic Response|22
957117|NCT01104792|1952821|FG000|Overall Study|Protocol Violation|45
957118|NCT01104792|1952821|FG000|Overall Study|Withdrawal of Consent|179
957119|NCT01104792|1952821|FG000|Overall Study|Lost to Follow-up|43
957120|NCT01104792|1952821|FG000|Overall Study|Reasons Not Specified|27
957121|NCT01104792|1952821|FG000|Overall Study|Did Not Meet Eligibility Criteria|133
957122|NCT01104870|1952828|FG000|Overall Study|Adverse Event|1
957123|NCT01104870|1952829|FG001|Overall Study|Adverse Event|1
957124|NCT01104870|1952830|FG002|Overall Study|Adverse Event|0
957125|NCT01104870|1952828|FG000|Overall Study|Death|0
957126|NCT01104870|1952829|FG001|Overall Study|Death|0
957127|NCT01104870|1952830|FG002|Overall Study|Death|1
957128|NCT01104870|1952828|FG000|Overall Study|Withdrawal by Subject|0
957129|NCT01104870|1952829|FG001|Overall Study|Withdrawal by Subject|0
957130|NCT01104870|1952830|FG002|Overall Study|Withdrawal by Subject|1
957131|NCT01105065|1952838|FG000|Overall Study|Adverse Event|5
957132|NCT01105065|1952838|FG000|Overall Study|Technical Problems|1
957133|NCT01105091|1952846|FG000|Overall Study|Death|2
957134|NCT01105091|1952847|FG001|Overall Study|Death|0
957135|NCT01105130|1952867|FG000|Overall Study|Withdrawal by Subject|4
957136|NCT01105130|1952868|FG001|Overall Study|Withdrawal by Subject|6
957137|NCT01105130|1952869|FG002|Overall Study|Withdrawal by Subject|2
957138|NCT01105130|1952867|FG000|Overall Study|Never Started|2
957139|NCT01105130|1952868|FG001|Overall Study|Never Started|2
957140|NCT01105130|1952869|FG002|Overall Study|Never Started|4
957141|NCT01105130|1952867|FG000|Overall Study|Toxicity|1
957142|NCT01105130|1952868|FG001|Overall Study|Toxicity|3
957143|NCT01105130|1952869|FG002|Overall Study|Toxicity|2
957144|NCT01105130|1952867|FG000|Overall Study|Multiple Reasons|3
957145|NCT01105130|1952868|FG001|Overall Study|Multiple Reasons|0
957146|NCT01105130|1952869|FG002|Overall Study|Multiple Reasons|2
957147|NCT01105377|1952906|FG000|Overall Study|Withdrawal by Subject|0
957148|NCT01105377|1952907|FG001|Overall Study|Withdrawal by Subject|1
957149|NCT01105533|1952913|FG000|Overall Study|Death|0
957150|NCT01105533|1952914|FG001|Overall Study|Death|0
957151|NCT01105533|1952915|FG002|Overall Study|Death|0
957152|NCT01105533|1952916|FG003|Overall Study|Death|0
957153|NCT01105533|1952917|FG004|Overall Study|Death|1
957154|NCT01105533|1952918|FG005|Overall Study|Death|0
957155|NCT01105533|1952919|FG006|Overall Study|Death|0
957156|NCT01105533|1952920|FG007|Overall Study|Death|0
957157|NCT01105533|1952921|FG008|Overall Study|Death|0
957158|NCT01105533|1952913|FG000|Overall Study|Lack of Efficacy|1
957159|NCT01105533|1952914|FG001|Overall Study|Lack of Efficacy|1
957160|NCT01105533|1952915|FG002|Overall Study|Lack of Efficacy|3
957161|NCT01105533|1952916|FG003|Overall Study|Lack of Efficacy|3
957162|NCT01105533|1952917|FG004|Overall Study|Lack of Efficacy|4
957163|NCT01105533|1952918|FG005|Overall Study|Lack of Efficacy|5
957164|NCT01105533|1952919|FG006|Overall Study|Lack of Efficacy|3
957165|NCT01105533|1952920|FG007|Overall Study|Lack of Efficacy|2
957166|NCT01105533|1952921|FG008|Overall Study|Lack of Efficacy|9
957167|NCT01105533|1952913|FG000|Overall Study|Adverse Event|0
957168|NCT01105533|1952914|FG001|Overall Study|Adverse Event|0
957169|NCT01105533|1952915|FG002|Overall Study|Adverse Event|0
957170|NCT01105533|1952916|FG003|Overall Study|Adverse Event|0
957171|NCT01105533|1952917|FG004|Overall Study|Adverse Event|1
957172|NCT01105533|1952918|FG005|Overall Study|Adverse Event|2
957173|NCT01105533|1952919|FG006|Overall Study|Adverse Event|2
957174|NCT01105533|1952920|FG007|Overall Study|Adverse Event|0
957175|NCT01105533|1952921|FG008|Overall Study|Adverse Event|1
957176|NCT01105533|1952913|FG000|Overall Study|Other|0
957177|NCT01105533|1952914|FG001|Overall Study|Other|0
957178|NCT01105533|1952915|FG002|Overall Study|Other|0
957179|NCT01105533|1952916|FG003|Overall Study|Other|0
957180|NCT01105533|1952917|FG004|Overall Study|Other|1
957181|NCT01105533|1952918|FG005|Overall Study|Other|0
957182|NCT01105533|1952919|FG006|Overall Study|Other|3
957183|NCT01105533|1952920|FG007|Overall Study|Other|1
957184|NCT01105533|1952921|FG008|Overall Study|Other|2
957185|NCT01105533|1952913|FG000|Overall Study|Physician Decision|0
957186|NCT01105533|1952914|FG001|Overall Study|Physician Decision|0
957187|NCT01105533|1952915|FG002|Overall Study|Physician Decision|0
957188|NCT01105533|1952916|FG003|Overall Study|Physician Decision|0
957189|NCT01105533|1952917|FG004|Overall Study|Physician Decision|0
957190|NCT01105533|1952918|FG005|Overall Study|Physician Decision|0
957191|NCT01105533|1952919|FG006|Overall Study|Physician Decision|0
957192|NCT01105533|1952920|FG007|Overall Study|Physician Decision|1
957193|NCT01105533|1952921|FG008|Overall Study|Physician Decision|0
957194|NCT01105767|1952966|FG000|Overall Study|Lost to Follow-up|1160
957195|NCT01105767|1952967|FG001|Overall Study|Lost to Follow-up|1614
957196|NCT01105767|1952968|FG002|Overall Study|Lost to Follow-up|1184
957197|NCT01105936|1952976|FG000|Period 1|Adverse Event|0
957198|NCT01105936|1952977|FG001|Period 1|Adverse Event|0
957199|NCT01105936|1952978|FG002|Period 1|Adverse Event|0
957200|NCT01105936|1952979|FG003|Period 1|Adverse Event|1
957201|NCT01105936|1952976|FG000|Period 2|Adverse Event|1
957202|NCT01105936|1952977|FG001|Period 2|Adverse Event|0
957203|NCT01105936|1952978|FG002|Period 2|Adverse Event|0
957204|NCT01105936|1952979|FG003|Period 2|Adverse Event|0
957205|NCT01105936|1952976|FG000|Period 3|Protocol Violation|0
957206|NCT01105936|1952977|FG001|Period 3|Protocol Violation|2
957207|NCT01105936|1952978|FG002|Period 3|Protocol Violation|0
957208|NCT01105936|1952979|FG003|Period 3|Protocol Violation|0
957209|NCT01105975|1952998|FG000|Overall Study|Adverse Event|2
957210|NCT01105975|1952999|FG001|Overall Study|Adverse Event|1
957211|NCT01105975|1953000|FG002|Overall Study|Adverse Event|5
957212|NCT01105975|1953001|FG003|Overall Study|Adverse Event|1
957213|NCT01105975|1953002|FG004|Overall Study|Adverse Event|0
957214|NCT01105975|1953003|FG005|Overall Study|Adverse Event|1
957215|NCT01105975|1953004|FG006|Overall Study|Adverse Event|2
957216|NCT01105975|1953005|FG007|Overall Study|Adverse Event|4
957217|NCT01105975|1953006|FG008|Overall Study|Adverse Event|1
957218|NCT01105975|1953007|FG009|Overall Study|Adverse Event|4
957219|NCT01105975|1952998|FG000|Overall Study|Withdrawal by Subject|2
957220|NCT01105975|1952999|FG001|Overall Study|Withdrawal by Subject|2
957221|NCT01105975|1953000|FG002|Overall Study|Withdrawal by Subject|2
957222|NCT01105975|1953001|FG003|Overall Study|Withdrawal by Subject|0
957223|NCT01105975|1953002|FG004|Overall Study|Withdrawal by Subject|4
957224|NCT01105975|1953003|FG005|Overall Study|Withdrawal by Subject|1
957225|NCT01105975|1953004|FG006|Overall Study|Withdrawal by Subject|2
957226|NCT01105975|1953005|FG007|Overall Study|Withdrawal by Subject|1
957227|NCT01105975|1953006|FG008|Overall Study|Withdrawal by Subject|0
957228|NCT01105975|1953007|FG009|Overall Study|Withdrawal by Subject|3
957229|NCT01105975|1952998|FG000|Overall Study|Lost to Follow-up|1
957230|NCT01105975|1952999|FG001|Overall Study|Lost to Follow-up|0
957231|NCT01105975|1953000|FG002|Overall Study|Lost to Follow-up|0
957232|NCT01105975|1953001|FG003|Overall Study|Lost to Follow-up|1
957233|NCT01105975|1953002|FG004|Overall Study|Lost to Follow-up|1
957234|NCT01105975|1953003|FG005|Overall Study|Lost to Follow-up|0
957235|NCT01105975|1953004|FG006|Overall Study|Lost to Follow-up|0
957236|NCT01105975|1953005|FG007|Overall Study|Lost to Follow-up|0
957237|NCT01105975|1953006|FG008|Overall Study|Lost to Follow-up|1
957238|NCT01105975|1953007|FG009|Overall Study|Lost to Follow-up|0
957239|NCT01105975|1952998|FG000|Overall Study|Physician Decision|0
957240|NCT01105975|1952999|FG001|Overall Study|Physician Decision|0
957241|NCT01105975|1953000|FG002|Overall Study|Physician Decision|0
957242|NCT01105975|1953001|FG003|Overall Study|Physician Decision|0
957243|NCT01105975|1953002|FG004|Overall Study|Physician Decision|0
957244|NCT01105975|1953003|FG005|Overall Study|Physician Decision|0
957245|NCT01105975|1953004|FG006|Overall Study|Physician Decision|2
957246|NCT01105975|1953005|FG007|Overall Study|Physician Decision|0
957247|NCT01105975|1953006|FG008|Overall Study|Physician Decision|0
957248|NCT01105975|1953007|FG009|Overall Study|Physician Decision|0
957249|NCT01105975|1952998|FG000|Overall Study|Protocol Violation|0
957250|NCT01105975|1952999|FG001|Overall Study|Protocol Violation|2
957251|NCT01105975|1953000|FG002|Overall Study|Protocol Violation|2
957252|NCT01105975|1953001|FG003|Overall Study|Protocol Violation|0
957253|NCT01105975|1953002|FG004|Overall Study|Protocol Violation|1
957254|NCT01105975|1953003|FG005|Overall Study|Protocol Violation|1
957255|NCT01105975|1953004|FG006|Overall Study|Protocol Violation|1
957256|NCT01105975|1953005|FG007|Overall Study|Protocol Violation|1
957257|NCT01105975|1953006|FG008|Overall Study|Protocol Violation|2
957258|NCT01105975|1953007|FG009|Overall Study|Protocol Violation|2
957259|NCT01105975|1952998|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
957260|NCT01105975|1952999|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
957261|NCT01105975|1953000|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
957262|NCT01105975|1953001|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0
957263|NCT01105975|1953002|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0
957264|NCT01105975|1953003|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2
957265|NCT01105975|1953004|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1
957266|NCT01105975|1953005|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1
957267|NCT01105975|1953006|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2
957268|NCT01105975|1953007|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0
957269|NCT01106014|1953050|FG000|Overall Study|Morbidity or Mortality primary endpoint|155
957270|NCT01106014|1953051|FG001|Overall Study|Morbidity or Mortality primary endpoint|242
957271|NCT01106014|1953050|FG000|Overall Study|Adverse Event|78
957272|NCT01106014|1953051|FG001|Overall Study|Adverse Event|42
957273|NCT01106014|1953050|FG000|Overall Study|Withdrawal by Subject|43
957274|NCT01106014|1953051|FG001|Overall Study|Withdrawal by Subject|37
957275|NCT01106014|1953050|FG000|Overall Study|Administrative reason|7
957276|NCT01106014|1953051|FG001|Overall Study|Administrative reason|6
957277|NCT01106014|1953050|FG000|Overall Study|Lost to Follow-up|2
957278|NCT01106014|1953051|FG001|Overall Study|Lost to Follow-up|3
957279|NCT01106027|1953057|FG000|Overall Study|Lost graft early, discontinued|1
957280|NCT01106092|1953070|FG000|Overall Study|Withdrawal by Subject|0
957281|NCT01106092|1953071|FG001|Overall Study|Withdrawal by Subject|0
957282|NCT01106092|1953072|FG002|Overall Study|Withdrawal by Subject|0
957283|NCT01106092|1953073|FG003|Overall Study|Withdrawal by Subject|1
957284|NCT01106157|1953085|FG000|Overall Study|Withdrawal by Subject|1
957285|NCT01106157|1953086|FG001|Overall Study|Withdrawal by Subject|0
957286|NCT01106248|1953092|FG000|Overall Study|Adverse Event|1
957287|NCT01106248|1953092|FG000|Overall Study|Administrative|2
957288|NCT01106287|1953100|FG000|Overall Study|Adverse Event|1
957289|NCT01106287|1953101|FG001|Overall Study|Adverse Event|0
957290|NCT01106287|1953102|FG002|Overall Study|Adverse Event|0
957291|NCT01106287|1953103|FG003|Overall Study|Adverse Event|0
957292|NCT01106352|1953128|FG000|Overall Study|Subjects untreated|0
957293|NCT01106352|1953129|FG001|Overall Study|Subjects untreated|0
957294|NCT01106352|1953130|FG002|Overall Study|Subjects untreated|0
957295|NCT01106352|1953131|FG003|Overall Study|Subjects untreated|3
957296|NCT01106352|1953132|FG004|Overall Study|Subjects untreated|4
957297|NCT01106352|1953128|FG000|Overall Study|Sponsor Decision|1
957298|NCT01106352|1953129|FG001|Overall Study|Sponsor Decision|0
957299|NCT01106352|1953130|FG002|Overall Study|Sponsor Decision|0
957300|NCT01106352|1953131|FG003|Overall Study|Sponsor Decision|0
957301|NCT01106352|1953132|FG004|Overall Study|Sponsor Decision|0
957302|NCT01106352|1953128|FG000|Overall Study|Too ill to come in for the visit|0
957303|NCT01106352|1953129|FG001|Overall Study|Too ill to come in for the visit|0
957304|NCT01106352|1953130|FG002|Overall Study|Too ill to come in for the visit|1
957305|NCT01106352|1953131|FG003|Overall Study|Too ill to come in for the visit|0
957306|NCT01106352|1953132|FG004|Overall Study|Too ill to come in for the visit|0
957307|NCT01106352|1953128|FG000|Overall Study|Lost to Follow-up|0
957308|NCT01106352|1953129|FG001|Overall Study|Lost to Follow-up|0
957309|NCT01106352|1953130|FG002|Overall Study|Lost to Follow-up|0
957310|NCT01106352|1953131|FG003|Overall Study|Lost to Follow-up|0
957311|NCT01106352|1953132|FG004|Overall Study|Lost to Follow-up|1
957312|NCT01106352|1953128|FG000|Overall Study|Death|0
957313|NCT01106352|1953129|FG001|Overall Study|Death|0
957314|NCT01106352|1953130|FG002|Overall Study|Death|1
957315|NCT01106352|1953131|FG003|Overall Study|Death|3
957316|NCT01106352|1953132|FG004|Overall Study|Death|1
957317|NCT01106352|1953128|FG000|Overall Study|Disease progression|0
957318|NCT01106352|1953129|FG001|Overall Study|Disease progression|0
957319|NCT01106352|1953130|FG002|Overall Study|Disease progression|0
957320|NCT01106352|1953131|FG003|Overall Study|Disease progression|1
957321|NCT01106352|1953132|FG004|Overall Study|Disease progression|0
957322|NCT01106352|1953128|FG000|Overall Study|Withdrawal by Subject|0
957323|NCT01106352|1953129|FG001|Overall Study|Withdrawal by Subject|0
957324|NCT01106352|1953130|FG002|Overall Study|Withdrawal by Subject|0
957325|NCT01106352|1953131|FG003|Overall Study|Withdrawal by Subject|3
957326|NCT01106352|1953132|FG004|Overall Study|Withdrawal by Subject|2
957327|NCT01106352|1953128|FG000|Overall Study|Went on hospice|0
957328|NCT01106352|1953129|FG001|Overall Study|Went on hospice|0
957329|NCT01106352|1953130|FG002|Overall Study|Went on hospice|0
957330|NCT01106352|1953131|FG003|Overall Study|Went on hospice|1
957331|NCT01106352|1953132|FG004|Overall Study|Went on hospice|0
957332|NCT01106352|1953128|FG000|Overall Study|Subject entered hospice|0
957333|NCT01106352|1953129|FG001|Overall Study|Subject entered hospice|0
957334|NCT01106352|1953130|FG002|Overall Study|Subject entered hospice|0
957335|NCT01106352|1953131|FG003|Overall Study|Subject entered hospice|1
957336|NCT01106352|1953132|FG004|Overall Study|Subject entered hospice|0
957337|NCT01106352|1953128|FG000|Overall Study|Home hospice since July 2013|0
957338|NCT01106352|1953129|FG001|Overall Study|Home hospice since July 2013|0
957339|NCT01106352|1953130|FG002|Overall Study|Home hospice since July 2013|0
957340|NCT01106352|1953131|FG003|Overall Study|Home hospice since July 2013|1
957341|NCT01106352|1953132|FG004|Overall Study|Home hospice since July 2013|0
957342|NCT01106404|1953154|FG000|Period I (First 6 Weeks)|Adverse Event|2
957343|NCT01106404|1953155|FG001|Period I (First 6 Weeks)|Adverse Event|0
957344|NCT01106404|1953154|FG000|Period I (First 6 Weeks)|Physician Decision|1
957345|NCT01106404|1953155|FG001|Period I (First 6 Weeks)|Physician Decision|0
957346|NCT01106404|1953154|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0
957347|NCT01106404|1953155|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1
957348|NCT01106404|1953154|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0
957349|NCT01106404|1953155|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1
957350|NCT01106430|1953169|FG000|Overall Study|Adverse Event|8
957351|NCT01106430|1953170|FG001|Overall Study|Adverse Event|10
957352|NCT01106430|1953169|FG000|Overall Study|Lack of Efficacy|2
957353|NCT01106430|1953170|FG001|Overall Study|Lack of Efficacy|13
957354|NCT01106430|1953169|FG000|Overall Study|Lost to Follow-up|5
957355|NCT01106430|1953170|FG001|Overall Study|Lost to Follow-up|1
957356|NCT01106430|1953169|FG000|Overall Study|Early Termination Requested By Sponsor|1
957357|NCT01106430|1953170|FG001|Overall Study|Early Termination Requested By Sponsor|0
957358|NCT01106430|1953169|FG000|Overall Study|Moved Out Of State|0
957359|NCT01106430|1953170|FG001|Overall Study|Moved Out Of State|1
957360|NCT01106430|1953169|FG000|Overall Study|Refused To Take Medication|0
957361|NCT01106430|1953170|FG001|Overall Study|Refused To Take Medication|1
957362|NCT01106430|1953169|FG000|Overall Study|Noncompliance|0
957363|NCT01106430|1953170|FG001|Overall Study|Noncompliance|1
957364|NCT01106430|1953169|FG000|Overall Study|Hard Time Swallowing The Pills|1
957365|NCT01106430|1953170|FG001|Overall Study|Hard Time Swallowing The Pills|0
957366|NCT01106430|1953169|FG000|Overall Study|Previous Use Of Marijuana|1
957367|NCT01106430|1953170|FG001|Overall Study|Previous Use Of Marijuana|0
957368|NCT01106430|1953169|FG000|Overall Study|Protocol Violation|7
957369|NCT01106430|1953170|FG001|Overall Study|Protocol Violation|2
957370|NCT01106430|1953169|FG000|Overall Study|Withdrawal by Subject|8
957371|NCT01106430|1953170|FG001|Overall Study|Withdrawal by Subject|4
957372|NCT01106586|1953187|FG000|Overall Study|Adverse Event|9
957373|NCT01106586|1953188|FG001|Overall Study|Adverse Event|15
957374|NCT01106586|1953187|FG000|Overall Study|Death|1
957375|NCT01106586|1953188|FG001|Overall Study|Death|3
957376|NCT01106586|1953187|FG000|Overall Study|Pregnancy|2
957377|NCT01106586|1953188|FG001|Overall Study|Pregnancy|2
957378|NCT01106586|1953187|FG000|Overall Study|Lack of Efficacy|1
957379|NCT01106586|1953188|FG001|Overall Study|Lack of Efficacy|0
957380|NCT01106586|1953187|FG000|Overall Study|Investigator's Discretion|5
957381|NCT01106586|1953188|FG001|Overall Study|Investigator's Discretion|8
957382|NCT01106586|1953187|FG000|Overall Study|Withdrew Consent|18
957383|NCT01106586|1953188|FG001|Overall Study|Withdrew Consent|30
957384|NCT01106586|1953187|FG000|Overall Study|Lost to Follow-up|24
957385|NCT01106586|1953188|FG001|Overall Study|Lost to Follow-up|20
957386|NCT01106586|1953187|FG000|Overall Study|Participant Noncompliance|12
957387|NCT01106586|1953188|FG001|Overall Study|Participant Noncompliance|10
957388|NCT01106586|1953187|FG000|Overall Study|Protocol Violation|1
957389|NCT01106586|1953188|FG001|Overall Study|Protocol Violation|0
957390|NCT01106586|1953187|FG000|Overall Study|Participant Transferred to Another Study|212
957391|NCT01106586|1953188|FG001|Overall Study|Participant Transferred to Another Study|197
957392|NCT01106625|1953197|FG000|Core Period: Baseline to Week 26|Adverse Event|6
957393|NCT01106625|1953198|FG001|Core Period: Baseline to Week 26|Adverse Event|8
957394|NCT01106625|1953199|FG002|Core Period: Baseline to Week 26|Adverse Event|8
957395|NCT01106625|1953197|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5
957396|NCT01106625|1953198|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0
957397|NCT01106625|1953199|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4
957398|NCT01106625|1953197|FG000|Core Period: Baseline to Week 26|Physician Decision|1
957399|NCT01106625|1953198|FG001|Core Period: Baseline to Week 26|Physician Decision|0
957400|NCT01106625|1953199|FG002|Core Period: Baseline to Week 26|Physician Decision|0
957401|NCT01106625|1953197|FG000|Core Period: Baseline to Week 26|Protocol Violation|2
957402|NCT01106625|1953198|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
957403|NCT01106625|1953199|FG002|Core Period: Baseline to Week 26|Protocol Violation|3
957404|NCT01106625|1953197|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6
957405|NCT01106625|1953198|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9
957406|NCT01106625|1953199|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7
957407|NCT01106625|1953197|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
957408|NCT01106625|1953198|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
957409|NCT01106625|1953199|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
957410|NCT01106625|1953197|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
957411|NCT01106625|1953198|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
957412|NCT01106625|1953199|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
957413|NCT01106625|1953197|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
957414|NCT01106625|1953198|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
957415|NCT01106625|1953199|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
957416|NCT01106625|1953197|FG000|Core Period: Baseline to Week 26|Other|8
957417|NCT01106625|1953198|FG001|Core Period: Baseline to Week 26|Other|7
957418|NCT01106625|1953199|FG002|Core Period: Baseline to Week 26|Other|4
957419|NCT01106625|1953197|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
957420|NCT01106625|1953198|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2
957421|NCT01106625|1953199|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3
957422|NCT01106625|1953197|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
957423|NCT01106625|1953198|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
957424|NCT01106625|1953199|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
957425|NCT01106625|1953197|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
957426|NCT01106625|1953198|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
957427|NCT01106625|1953199|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1
957428|NCT01106625|1953197|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
957429|NCT01106625|1953198|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
957430|NCT01106625|1953199|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
957431|NCT01106625|1953197|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
957432|NCT01106625|1953198|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
957433|NCT01106625|1953199|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
957434|NCT01106625|1953197|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
957435|NCT01106625|1953198|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
957436|NCT01106625|1953199|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
957437|NCT01106625|1953197|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
957438|NCT01106625|1953198|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
957439|NCT01106625|1953199|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
957440|NCT01106625|1953197|FG000|Extension Period: Week 26 to Week 52|Other|5
957441|NCT01106625|1953198|FG001|Extension Period: Week 26 to Week 52|Other|5
957442|NCT01106625|1953199|FG002|Extension Period: Week 26 to Week 52|Other|4
957443|NCT01106651|1953213|FG000|Overall Study|Adverse Event|17
957444|NCT01106651|1953214|FG001|Overall Study|Adverse Event|9
957445|NCT01106651|1953215|FG002|Overall Study|Adverse Event|23
957446|NCT01106651|1953213|FG000|Overall Study|Lost to Follow-up|8
957447|NCT01106651|1953214|FG001|Overall Study|Lost to Follow-up|2
957448|NCT01106651|1953215|FG002|Overall Study|Lost to Follow-up|6
957449|NCT01106651|1953213|FG000|Overall Study|Physician Decision|4
957450|NCT01106651|1953214|FG001|Overall Study|Physician Decision|3
957451|NCT01106651|1953215|FG002|Overall Study|Physician Decision|1
957452|NCT01106651|1953213|FG000|Overall Study|Protocol Violation|1
957453|NCT01106651|1953214|FG001|Overall Study|Protocol Violation|2
957454|NCT01106651|1953215|FG002|Overall Study|Protocol Violation|1
957455|NCT01106651|1953213|FG000|Overall Study|Withdrawal by Subject|14
957456|NCT01106651|1953214|FG001|Overall Study|Withdrawal by Subject|7
957457|NCT01106651|1953215|FG002|Overall Study|Withdrawal by Subject|4
957458|NCT01106651|1953213|FG000|Overall Study|Noncompliance with study drug|1
957459|NCT01106651|1953214|FG001|Overall Study|Noncompliance with study drug|0
957460|NCT01106651|1953215|FG002|Overall Study|Noncompliance with study drug|2
957461|NCT01106651|1953213|FG000|Overall Study|Other|34
957462|NCT01106651|1953214|FG001|Overall Study|Other|31
957463|NCT01106651|1953215|FG002|Overall Study|Other|21
957464|NCT01106651|1953213|FG000|Overall Study|Death|0
957465|NCT01106651|1953214|FG001|Overall Study|Death|3
957466|NCT01106651|1953215|FG002|Overall Study|Death|0
957467|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Adverse Event|7
957468|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Adverse Event|18
957469|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Adverse Event|6
957470|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Adverse Event|8
957471|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Death|0
957472|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Death|0
957473|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Death|1
957474|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Death|0
957475|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1
957476|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0
957477|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0
957478|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0
957479|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3
957480|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
957481|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6
957482|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3
957483|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Physician Decision|2
957484|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Physician Decision|1
957485|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Physician Decision|3
957486|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Physician Decision|1
957487|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
957488|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
957489|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
957490|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Protocol Violation|3
957491|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5
957492|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
957493|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15
957494|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6
957495|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
957496|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
957497|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
957498|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
957499|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
957500|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3
957501|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
957502|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0
957503|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0
957504|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1
957505|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2
957506|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0
957507|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Product quality complaint|0
957508|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Product quality complaint|1
957509|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Product quality complaint|1
957510|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Product quality complaint|0
957511|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Other|8
957512|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Other|14
957513|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Other|8
957514|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Other|23
957515|NCT01106677|1953230|FG000|Core Period: Baseline to Week 26|Pregnancy|0
957516|NCT01106677|1953231|FG001|Core Period: Baseline to Week 26|Pregnancy|1
957517|NCT01106677|1953232|FG002|Core Period: Baseline to Week 26|Pregnancy|0
957518|NCT01106677|1953233|FG003|Core Period: Baseline to Week 26|Pregnancy|0
957519|NCT01106677|1953230|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
957520|NCT01106677|1953231|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
957521|NCT01106677|1953232|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5
957522|NCT01106677|1953233|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9
957523|NCT01106677|1953230|FG000|Extension Period: Week 26 to Week 52|Death|0
957524|NCT01106677|1953231|FG001|Extension Period: Week 26 to Week 52|Death|0
957525|NCT01106677|1953232|FG002|Extension Period: Week 26 to Week 52|Death|0
957526|NCT01106677|1953233|FG003|Extension Period: Week 26 to Week 52|Death|1
957527|NCT01106677|1953230|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
957528|NCT01106677|1953231|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
957529|NCT01106677|1953232|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
957530|NCT01106677|1953233|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
957531|NCT01106677|1953230|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
957532|NCT01106677|1953231|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
957533|NCT01106677|1953232|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
957534|NCT01106677|1953233|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
957535|NCT01106677|1953230|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
957536|NCT01106677|1953231|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3
957537|NCT01106677|1953232|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
957538|NCT01106677|1953233|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3
957539|NCT01106677|1953230|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
957540|NCT01106677|1953231|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0
957541|NCT01106677|1953232|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
957542|NCT01106677|1953233|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
957543|NCT01106677|1953230|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
957544|NCT01106677|1953231|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
957545|NCT01106677|1953232|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
957546|NCT01106677|1953233|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
957547|NCT01106677|1953230|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
957548|NCT01106677|1953231|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
957549|NCT01106677|1953232|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
957550|NCT01106677|1953233|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
957551|NCT01106677|1953230|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
957552|NCT01106677|1953231|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
957553|NCT01106677|1953232|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
957554|NCT01106677|1953233|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
957555|NCT01106677|1953230|FG000|Extension Period: Week 26 to Week 52|Other|6
957556|NCT01106677|1953231|FG001|Extension Period: Week 26 to Week 52|Other|5
957557|NCT01106677|1953232|FG002|Extension Period: Week 26 to Week 52|Other|8
957558|NCT01106677|1953233|FG003|Extension Period: Week 26 to Week 52|Other|5
957559|NCT01106690|1953253|FG000|Core Period: Baseline to Week 26|Adverse Event|6
957560|NCT01106690|1953254|FG001|Core Period: Baseline to Week 26|Adverse Event|1
957561|NCT01106690|1953255|FG002|Core Period: Baseline to Week 26|Adverse Event|4
957562|NCT01106690|1953253|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1
957563|NCT01106690|1953254|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
957564|NCT01106690|1953255|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2
957565|NCT01106690|1953253|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
957566|NCT01106690|1953254|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
957567|NCT01106690|1953255|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
957568|NCT01106690|1953253|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
957569|NCT01106690|1953254|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1
957570|NCT01106690|1953255|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0
957571|NCT01106690|1953253|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
957572|NCT01106690|1953254|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
957573|NCT01106690|1953255|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
957574|NCT01106690|1953253|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
957575|NCT01106690|1953254|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
957576|NCT01106690|1953255|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
957577|NCT01106690|1953253|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
957578|NCT01106690|1953254|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
957579|NCT01106690|1953255|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
957580|NCT01106690|1953253|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
957581|NCT01106690|1953254|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
957582|NCT01106690|1953255|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
957583|NCT01106690|1953253|FG000|Core Period: Baseline to Week 26|Other|10
957584|NCT01106690|1953254|FG001|Core Period: Baseline to Week 26|Other|2
957585|NCT01106690|1953255|FG002|Core Period: Baseline to Week 26|Other|6
957586|NCT01106690|1953253|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
957587|NCT01106690|1953254|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
957588|NCT01106690|1953255|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
957589|NCT01106690|1953253|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
957590|NCT01106690|1953254|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
957591|NCT01106690|1953255|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
957592|NCT01106690|1953253|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
957593|NCT01106690|1953254|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2
957594|NCT01106690|1953255|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
957595|NCT01106690|1953253|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
957596|NCT01106690|1953254|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
957597|NCT01106690|1953255|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
957598|NCT01106690|1953253|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
957599|NCT01106690|1953254|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
957600|NCT01106690|1953255|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
957601|NCT01106690|1953253|FG000|Extension Period: Week 26 to Week 52|Other|8
957602|NCT01106690|1953254|FG001|Extension Period: Week 26 to Week 52|Other|3
957603|NCT01106690|1953255|FG002|Extension Period: Week 26 to Week 52|Other|4
957604|NCT01106690|1953253|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
957605|NCT01106690|1953254|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
957606|NCT01106690|1953255|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
957607|NCT01106846|1953277|FG000|Overall Study|Change in surgical procedure|0
957608|NCT01106846|1953278|FG001|Overall Study|Change in surgical procedure|1
957609|NCT01106898|1953295|FG000|Overall Study|Adverse Event|6
957610|NCT01106911|1953299|FG000|Overall Study|Physician Decision|2
957611|NCT01106911|1953299|FG000|Overall Study|deemed ineligible after screening|3
957612|NCT01106976|1953309|FG000|Overall Study|Lost to Follow-up|8
957613|NCT01107197|1953332|FG000|Overall Study|Death|12
957614|NCT01107197|1953333|FG001|Overall Study|Death|10
957615|NCT01107197|1953332|FG000|Overall Study|Lost to Follow-up|5
957616|NCT01107197|1953333|FG001|Overall Study|Lost to Follow-up|8
957617|NCT01107197|1953332|FG000|Overall Study|Withdrawal by Subject|3
957618|NCT01107197|1953333|FG001|Overall Study|Withdrawal by Subject|5
957619|NCT01107353|1953341|FG000|Overall Study|Positive Drug Screen|1
957620|NCT01107353|1953342|FG001|Overall Study|Positive Drug Screen|0
957621|NCT01107379|1953348|FG000|Overall Study|Withdrawal by Subject|18
957622|NCT01107379|1953348|FG000|Overall Study|Lost to Follow-up|3
957623|NCT01107392|1953354|FG000|Overall Study|Adverse Event|2
957624|NCT01107392|1953355|FG001|Overall Study|Adverse Event|0
957625|NCT01107392|1953354|FG000|Overall Study|Personal Reasons|2
957626|NCT01107392|1953355|FG001|Overall Study|Personal Reasons|3
957627|NCT01107392|1953354|FG000|Overall Study|Administrative decision|1
957628|NCT01107392|1953355|FG001|Overall Study|Administrative decision|0
957629|NCT01107405|1953366|FG000|Overall Study|Adverse Event|1
957630|NCT01107405|1953367|FG001|Overall Study|Adverse Event|1
957631|NCT01107405|1953368|FG002|Overall Study|Adverse Event|0
957632|NCT01107405|1953369|FG003|Overall Study|Adverse Event|0
957633|NCT01107405|1953370|FG004|Overall Study|Adverse Event|2
957634|NCT01107405|1953366|FG000|Overall Study|Withdrawal by Subject|1
957635|NCT01107405|1953367|FG001|Overall Study|Withdrawal by Subject|0
957636|NCT01107405|1953368|FG002|Overall Study|Withdrawal by Subject|1
957637|NCT01107405|1953369|FG003|Overall Study|Withdrawal by Subject|2
957638|NCT01107405|1953370|FG004|Overall Study|Withdrawal by Subject|1
957639|NCT01107405|1953366|FG000|Overall Study|Protocol Violation|0
957640|NCT01107405|1953367|FG001|Overall Study|Protocol Violation|0
957641|NCT01107405|1953368|FG002|Overall Study|Protocol Violation|1
957642|NCT01107405|1953369|FG003|Overall Study|Protocol Violation|1
957643|NCT01107405|1953370|FG004|Overall Study|Protocol Violation|0
957644|NCT01107418|1953386|FG000|Overall Study|Disease Progression|45
957645|NCT01107418|1953386|FG000|Overall Study|Adverse Event|3
957646|NCT01107418|1953386|FG000|Overall Study|Withdrawal by Subject|1
957647|NCT01107418|1953386|FG000|Overall Study|Study Closing|1
957648|NCT01107418|1953386|FG000|Overall Study|Started Other Therapy|1
957649|NCT01107418|1953386|FG000|Overall Study|Entered Extension Study|1
957650|NCT01107444|1953403|FG000|Overall Study|Withdrawal by Subject|8
957651|NCT01107444|1953404|FG001|Overall Study|Withdrawal by Subject|12
957652|NCT01107444|1953403|FG000|Overall Study|Protocol Entry Criteria Not Met|0
957653|NCT01107444|1953404|FG001|Overall Study|Protocol Entry Criteria Not Met|1
957654|NCT01107457|1953418|FG000|Part A|Adverse Event|1
957655|NCT01107457|1953419|FG001|Part A|Adverse Event|2
957656|NCT01107457|1953420|FG002|Part A|Adverse Event|1
957657|NCT01107457|1953421|FG003|Part A|Adverse Event|0
957658|NCT01107457|1953422|FG004|Part A|Adverse Event|0
957659|NCT01107457|1953423|FG005|Part A|Adverse Event|0
957660|NCT01107457|1953418|FG000|Part A|Withdrawal by Subject|3
957661|NCT01107457|1953419|FG001|Part A|Withdrawal by Subject|3
957662|NCT01107457|1953420|FG002|Part A|Withdrawal by Subject|0
957663|NCT01107457|1953421|FG003|Part A|Withdrawal by Subject|3
957664|NCT01107457|1953422|FG004|Part A|Withdrawal by Subject|1
957665|NCT01107457|1953423|FG005|Part A|Withdrawal by Subject|0
957666|NCT01107457|1953418|FG000|Part A|Lost to Follow-up|0
957667|NCT01107457|1953419|FG001|Part A|Lost to Follow-up|1
957668|NCT01107457|1953420|FG002|Part A|Lost to Follow-up|0
957669|NCT01107457|1953421|FG003|Part A|Lost to Follow-up|0
957670|NCT01107457|1953422|FG004|Part A|Lost to Follow-up|0
957671|NCT01107457|1953423|FG005|Part A|Lost to Follow-up|0
957672|NCT01107457|1953418|FG000|Part A|Lack of Efficacy|1
957673|NCT01107457|1953419|FG001|Part A|Lack of Efficacy|0
957674|NCT01107457|1953420|FG002|Part A|Lack of Efficacy|0
957675|NCT01107457|1953421|FG003|Part A|Lack of Efficacy|0
957676|NCT01107457|1953422|FG004|Part A|Lack of Efficacy|0
957677|NCT01107457|1953423|FG005|Part A|Lack of Efficacy|0
957678|NCT01107457|1953418|FG000|Part A|Protocol Violation|0
957679|NCT01107457|1953419|FG001|Part A|Protocol Violation|1
957680|NCT01107457|1953420|FG002|Part A|Protocol Violation|0
957681|NCT01107457|1953421|FG003|Part A|Protocol Violation|0
957682|NCT01107457|1953422|FG004|Part A|Protocol Violation|0
957683|NCT01107457|1953423|FG005|Part A|Protocol Violation|0
957684|NCT01107457|1953418|FG000|Part B and C|Adverse Event|0
957685|NCT01107457|1953419|FG001|Part B and C|Adverse Event|0
957686|NCT01107457|1953420|FG002|Part B and C|Adverse Event|0
957687|NCT01107457|1953421|FG003|Part B and C|Adverse Event|0
957688|NCT01107457|1953422|FG004|Part B and C|Adverse Event|0
957689|NCT01107457|1953423|FG005|Part B and C|Adverse Event|12
957690|NCT01107457|1953418|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0
957691|NCT01107457|1953419|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0
957692|NCT01107457|1953420|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0
957693|NCT01107457|1953421|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0
957694|NCT01107457|1953422|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0
957695|NCT01107457|1953423|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1
957696|NCT01107457|1953418|FG000|Part B and C|Physician Decision|0
957697|NCT01107457|1953419|FG001|Part B and C|Physician Decision|0
957698|NCT01107457|1953420|FG002|Part B and C|Physician Decision|0
957699|NCT01107457|1953421|FG003|Part B and C|Physician Decision|0
957700|NCT01107457|1953422|FG004|Part B and C|Physician Decision|0
957701|NCT01107457|1953423|FG005|Part B and C|Physician Decision|3
957702|NCT01107457|1953418|FG000|Part B and C|Lack of Efficacy|0
957703|NCT01107457|1953419|FG001|Part B and C|Lack of Efficacy|0
957704|NCT01107457|1953420|FG002|Part B and C|Lack of Efficacy|0
957705|NCT01107457|1953421|FG003|Part B and C|Lack of Efficacy|0
957706|NCT01107457|1953422|FG004|Part B and C|Lack of Efficacy|0
957707|NCT01107457|1953423|FG005|Part B and C|Lack of Efficacy|7
957708|NCT01107457|1953418|FG000|Part B and C|Lost to Follow-up|0
957709|NCT01107457|1953419|FG001|Part B and C|Lost to Follow-up|0
957710|NCT01107457|1953420|FG002|Part B and C|Lost to Follow-up|0
957711|NCT01107457|1953421|FG003|Part B and C|Lost to Follow-up|0
957712|NCT01107457|1953422|FG004|Part B and C|Lost to Follow-up|0
957713|NCT01107457|1953423|FG005|Part B and C|Lost to Follow-up|10
957714|NCT01107457|1953418|FG000|Part B and C|Protocol Violation|0
957715|NCT01107457|1953419|FG001|Part B and C|Protocol Violation|0
957716|NCT01107457|1953420|FG002|Part B and C|Protocol Violation|0
957717|NCT01107457|1953421|FG003|Part B and C|Protocol Violation|0
957718|NCT01107457|1953422|FG004|Part B and C|Protocol Violation|0
957719|NCT01107457|1953423|FG005|Part B and C|Protocol Violation|1
957720|NCT01107457|1953418|FG000|Part B and C|Sponsor Decision|0
957721|NCT01107457|1953419|FG001|Part B and C|Sponsor Decision|0
957722|NCT01107457|1953420|FG002|Part B and C|Sponsor Decision|0
957723|NCT01107457|1953421|FG003|Part B and C|Sponsor Decision|0
957724|NCT01107457|1953422|FG004|Part B and C|Sponsor Decision|0
957725|NCT01107457|1953423|FG005|Part B and C|Sponsor Decision|66
957726|NCT01107457|1953418|FG000|Part B and C|Withdrawal by Subject|0
957727|NCT01107457|1953419|FG001|Part B and C|Withdrawal by Subject|0
957728|NCT01107457|1953420|FG002|Part B and C|Withdrawal by Subject|0
957729|NCT01107457|1953421|FG003|Part B and C|Withdrawal by Subject|0
957730|NCT01107457|1953422|FG004|Part B and C|Withdrawal by Subject|0
957731|NCT01107457|1953423|FG005|Part B and C|Withdrawal by Subject|16
957732|NCT01107457|1953418|FG000|Part B and C|Clinical Relapse|0
957733|NCT01107457|1953419|FG001|Part B and C|Clinical Relapse|0
957734|NCT01107457|1953420|FG002|Part B and C|Clinical Relapse|0
957735|NCT01107457|1953421|FG003|Part B and C|Clinical Relapse|0
957736|NCT01107457|1953422|FG004|Part B and C|Clinical Relapse|0
957737|NCT01107457|1953423|FG005|Part B and C|Clinical Relapse|4
957738|NCT01107535|1953441|FG000|Overall Study|Death|5
957739|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Lack of Efficacy|167
957740|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Lack of Efficacy|0
957741|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Lack of Efficacy|0
957742|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Lack of Efficacy|0
957743|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Adverse Event|198
957744|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Adverse Event|0
957745|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Adverse Event|0
957746|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Adverse Event|0
957747|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Death|62
957748|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Death|0
957749|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Death|0
957750|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Death|0
957751|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54
957752|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0
957753|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0
957754|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0
957755|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Complicating disease|13
957756|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Complicating disease|0
957757|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Complicating disease|0
957758|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Complicating disease|0
957759|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Alternative therapy|12
957760|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Alternative therapy|0
957761|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Alternative therapy|0
957762|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Alternative therapy|0
957763|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10
957764|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0
957765|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0
957766|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0
957767|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Non-compliance|4
957768|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Non-compliance|0
957769|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Non-compliance|0
957770|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Non-compliance|0
957771|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Pain|4
957772|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Pain|0
957773|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Pain|0
957774|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Pain|0
957775|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Protocol Violation|1
957776|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Protocol Violation|0
957777|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Protocol Violation|0
957778|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Protocol Violation|0
957779|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Hospice care|1
957780|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Hospice care|0
957781|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Hospice care|0
957782|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Hospice care|0
957783|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Physician Decision|1
957784|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Physician Decision|0
957785|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Physician Decision|0
957786|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Physician Decision|0
957787|NCT01107626|1953449|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50
957788|NCT01107626|1953450|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0
957789|NCT01107626|1953451|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0
957790|NCT01107626|1953452|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0
957791|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0
957792|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217
957793|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217
957794|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170
957795|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Adverse Event|0
957796|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Adverse Event|32
957797|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Adverse Event|29
957798|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Adverse Event|46
957799|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Death|0
957800|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Death|8
957801|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Death|2
957802|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Death|13
957803|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0
957804|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11
957805|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21
957806|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27
957807|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Alternative therapy|0
957808|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Alternative therapy|2
957809|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Alternative therapy|4
957810|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Alternative therapy|5
957811|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Other complicating disease|0
957812|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Other complicating disease|2
957813|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Other complicating disease|5
957814|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Other complicating disease|9
957815|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0
957816|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2
957817|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4
957818|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3
957819|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0
957820|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
957821|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
957822|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3
957823|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
957824|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
957825|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
957826|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
957827|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Financial reason|0
957828|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Financial reason|2
957829|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Financial reason|0
957830|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Financial reason|0
957831|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Physician Decision|0
957832|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Physician Decision|2
957833|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Physician Decision|3
957834|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Physician Decision|3
957835|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Hospice care|0
957836|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Hospice care|1
957837|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Hospice care|2
957838|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Hospice care|0
957839|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Non-compliance|0
957840|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Non-compliance|0
957841|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Non-compliance|0
957842|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Non-compliance|2
957843|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Pain|0
957844|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Pain|0
957845|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Pain|0
957846|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Pain|1
957847|NCT01107626|1953449|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0
957848|NCT01107626|1953450|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4
957849|NCT01107626|1953451|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4
957850|NCT01107626|1953452|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10
957851|NCT01107743|1953480|FG000|Overall Study|Protocol Violation|46
957852|NCT01107886|1953540|FG000|Overall Study|Lost to Follow-up|15
957853|NCT01107886|1953541|FG001|Overall Study|Lost to Follow-up|13
957854|NCT01107886|1953540|FG000|Overall Study|Withdrawal by Subject|180
957855|NCT01107886|1953541|FG001|Overall Study|Withdrawal by Subject|196
957856|NCT01107886|1953540|FG000|Overall Study|Administrative withdrawal of consent|7
957857|NCT01107886|1953541|FG001|Overall Study|Administrative withdrawal of consent|5
957858|NCT01107899|1953550|FG000|Overall Study|Physician Decision|5
957859|NCT01107899|1953551|FG001|Overall Study|Physician Decision|0
957860|NCT01107899|1953552|FG002|Overall Study|Physician Decision|3
957861|NCT01107899|1953550|FG000|Overall Study|Withdrawal by Subject|0
957862|NCT01107899|1953551|FG001|Overall Study|Withdrawal by Subject|0
957863|NCT01107899|1953552|FG002|Overall Study|Withdrawal by Subject|1
957864|NCT01107912|1953567|FG000|Period 1|Adverse Event|0
957865|NCT01107912|1953568|FG001|Period 1|Adverse Event|0
957866|NCT01107912|1953569|FG002|Period 1|Adverse Event|0
957867|NCT01107912|1953570|FG003|Period 1|Adverse Event|0
957868|NCT01107912|1953571|FG004|Period 1|Adverse Event|2
957869|NCT01107912|1953572|FG005|Period 1|Adverse Event|0
957870|NCT01107912|1953567|FG000|Period 1|Physician Decision|0
957871|NCT01107912|1953568|FG001|Period 1|Physician Decision|0
957872|NCT01107912|1953569|FG002|Period 1|Physician Decision|0
957873|NCT01107912|1953570|FG003|Period 1|Physician Decision|0
957874|NCT01107912|1953571|FG004|Period 1|Physician Decision|1
957875|NCT01107912|1953572|FG005|Period 1|Physician Decision|0
957876|NCT01107912|1953567|FG000|Period 1|Withdrawal by Subject|1
957877|NCT01107912|1953568|FG001|Period 1|Withdrawal by Subject|0
957878|NCT01107912|1953569|FG002|Period 1|Withdrawal by Subject|0
957879|NCT01107912|1953570|FG003|Period 1|Withdrawal by Subject|0
957880|NCT01107912|1953571|FG004|Period 1|Withdrawal by Subject|0
957881|NCT01107912|1953572|FG005|Period 1|Withdrawal by Subject|0
957882|NCT01107912|1953567|FG000|Period 2|Physician Decision|0
957883|NCT01107912|1953568|FG001|Period 2|Physician Decision|0
957884|NCT01107912|1953569|FG002|Period 2|Physician Decision|1
957885|NCT01107912|1953570|FG003|Period 2|Physician Decision|0
957886|NCT01107912|1953571|FG004|Period 2|Physician Decision|0
957887|NCT01107912|1953572|FG005|Period 2|Physician Decision|0
957888|NCT01107912|1953567|FG000|Period 3|Adverse Event|0
957889|NCT01107912|1953568|FG001|Period 3|Adverse Event|1
957890|NCT01107912|1953569|FG002|Period 3|Adverse Event|1
957891|NCT01107912|1953570|FG003|Period 3|Adverse Event|0
957892|NCT01107912|1953571|FG004|Period 3|Adverse Event|0
957893|NCT01107912|1953572|FG005|Period 3|Adverse Event|0
957894|NCT01107912|1953567|FG000|Period 3|Withdrawal by Subject|0
957895|NCT01107912|1953568|FG001|Period 3|Withdrawal by Subject|0
957896|NCT01107912|1953569|FG002|Period 3|Withdrawal by Subject|0
957897|NCT01107912|1953570|FG003|Period 3|Withdrawal by Subject|1
957898|NCT01107912|1953571|FG004|Period 3|Withdrawal by Subject|0
957899|NCT01107912|1953572|FG005|Period 3|Withdrawal by Subject|0
957900|NCT01107925|1953591|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
957901|NCT01107925|1953592|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
957902|NCT01107925|1953593|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
957903|NCT01107925|1953594|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
957904|NCT01107925|1953595|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
957905|NCT01107925|1953596|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
957906|NCT01107925|1953591|FG000|Period 2|Withdrawal by Subject|0
957907|NCT01107925|1953592|FG001|Period 2|Withdrawal by Subject|1
957908|NCT01107925|1953593|FG002|Period 2|Withdrawal by Subject|0
957909|NCT01107925|1953594|FG003|Period 2|Withdrawal by Subject|0
957910|NCT01107925|1953595|FG004|Period 2|Withdrawal by Subject|0
957911|NCT01107925|1953596|FG005|Period 2|Withdrawal by Subject|1
957912|NCT01108068|1953648|FG000|Overall Study|5 not started, 1 stop due to side effect|6
957913|NCT01108068|1953649|FG001|Overall Study|5 not started, 1 stop due to side effect|0
957914|NCT01108094|1953677|FG000|Overall Study|Adverse Event|2
957915|NCT01108094|1953678|FG001|Overall Study|Adverse Event|0
957916|NCT01108094|1953679|FG002|Overall Study|Adverse Event|0
957917|NCT01108094|1953680|FG003|Overall Study|Adverse Event|0
957918|NCT01108094|1953677|FG000|Overall Study|Withdrawal by Subject|1
957919|NCT01108094|1953678|FG001|Overall Study|Withdrawal by Subject|0
957920|NCT01108094|1953679|FG002|Overall Study|Withdrawal by Subject|0
957921|NCT01108094|1953680|FG003|Overall Study|Withdrawal by Subject|0
957922|NCT01108185|1953693|FG000|Overall Study|Non-compliance|15
957923|NCT01108185|1953693|FG000|Overall Study|Lost to Follow-up|12
957924|NCT01108237|1953699|FG000|Overall Study|No alignment data|2
957925|NCT01108237|1953700|FG001|Overall Study|No alignment data|17
957926|NCT01108237|1953699|FG000|Overall Study|Did not meet criteria for analysis|7
957927|NCT01108237|1953700|FG001|Overall Study|Did not meet criteria for analysis|0
957928|NCT01108263|1953708|FG000|Overall Study|Adverse Event|0
957929|NCT01108263|1953709|FG001|Overall Study|Adverse Event|1
957930|NCT01108341|1953715|FG000|Overall Study|Death|2
957931|NCT01108341|1953715|FG000|Overall Study|Withdrawal by Subject|1
957932|NCT01108341|1953715|FG000|Overall Study|Lost to Follow-up|1
957933|NCT01108341|1953715|FG000|Overall Study|Other|1
957934|NCT01108458|1953734|FG000|Overall Study|Withdrawal by Subject|1
957935|NCT01108510|1953740|FG000|Overall Study|Randomized but Not Treated|5
957936|NCT01108510|1953741|FG001|Overall Study|Randomized but Not Treated|1
957937|NCT01108510|1953740|FG000|Overall Study|Joined Another Gilead-sponsored Study|186
957938|NCT01108510|1953741|FG001|Overall Study|Joined Another Gilead-sponsored Study|195
957939|NCT01108510|1953740|FG000|Overall Study|Adverse Event|26
957940|NCT01108510|1953741|FG001|Overall Study|Adverse Event|19
957941|NCT01108510|1953740|FG000|Overall Study|Lost to Follow-up|20
957942|NCT01108510|1953741|FG001|Overall Study|Lost to Follow-up|17
957943|NCT01108510|1953740|FG000|Overall Study|Withdrew Consent|21
957944|NCT01108510|1953741|FG001|Overall Study|Withdrew Consent|15
957945|NCT01108510|1953740|FG000|Overall Study|Investigator's Discretion|12
957946|NCT01108510|1953741|FG001|Overall Study|Investigator's Discretion|10
957947|NCT01108510|1953740|FG000|Overall Study|Participant Noncompliance|5
957948|NCT01108510|1953741|FG001|Overall Study|Participant Noncompliance|7
957949|NCT01108510|1953740|FG000|Overall Study|Lack of Efficacy|3
957950|NCT01108510|1953741|FG001|Overall Study|Lack of Efficacy|0
957951|NCT01108510|1953740|FG000|Overall Study|Pregnancy|0
957952|NCT01108510|1953741|FG001|Overall Study|Pregnancy|3
957953|NCT01108510|1953740|FG000|Overall Study|Death|1
957954|NCT01108510|1953741|FG001|Overall Study|Death|1
957955|NCT01108718|1953749|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1
957956|NCT01108718|1953750|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0
957957|NCT01108731|1953757|FG000|Overall Study|Withdrawal by Subject|1
957958|NCT01108731|1953758|FG001|Overall Study|Withdrawal by Subject|1
957959|NCT01108731|1953757|FG000|Overall Study|Adverse Event|3
957960|NCT01108731|1953758|FG001|Overall Study|Adverse Event|3
957961|NCT01108796|1953777|FG000|Overall Study|Adverse Event|0
957962|NCT01108796|1953778|FG001|Overall Study|Adverse Event|1
957963|NCT01108796|1953777|FG000|Overall Study|Lost to Follow-up|7
957964|NCT01108796|1953778|FG001|Overall Study|Lost to Follow-up|6
957965|NCT01108809|1953786|FG000|Overall Study|Adverse Event|3
957966|NCT01108809|1953786|FG000|Overall Study|Lost to Follow-up|1
957967|NCT01109173|1953854|FG000|Overall Study|Adverse Event|15
957968|NCT01109173|1953855|FG001|Overall Study|Adverse Event|17
957969|NCT01109173|1953856|FG002|Overall Study|Adverse Event|9
957970|NCT01109173|1953857|FG003|Overall Study|Adverse Event|6
957971|NCT01109173|1953854|FG000|Overall Study|Lost to Follow-up|0
957972|NCT01109173|1953855|FG001|Overall Study|Lost to Follow-up|1
957973|NCT01109173|1953856|FG002|Overall Study|Lost to Follow-up|0
957974|NCT01109173|1953857|FG003|Overall Study|Lost to Follow-up|0
957975|NCT01109173|1953854|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
957976|NCT01109173|1953855|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
957977|NCT01109173|1953856|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
957978|NCT01109173|1953857|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
957979|NCT01109173|1953854|FG000|Overall Study|Noncompliance|0
957980|NCT01109173|1953855|FG001|Overall Study|Noncompliance|1
957981|NCT01109173|1953856|FG002|Overall Study|Noncompliance|0
957982|NCT01109173|1953857|FG003|Overall Study|Noncompliance|0
957983|NCT01109173|1953854|FG000|Overall Study|Treatment Failure|25
957984|NCT01109173|1953855|FG001|Overall Study|Treatment Failure|32
957985|NCT01109173|1953856|FG002|Overall Study|Treatment Failure|69
957986|NCT01109173|1953857|FG003|Overall Study|Treatment Failure|64
957987|NCT01109173|1953854|FG000|Overall Study|Protocol Violation|4
957988|NCT01109173|1953855|FG001|Overall Study|Protocol Violation|5
957989|NCT01109173|1953856|FG002|Overall Study|Protocol Violation|1
957990|NCT01109173|1953857|FG003|Overall Study|Protocol Violation|2
957991|NCT01109173|1953854|FG000|Overall Study|Patient Did Not Use Study Medication|34
957992|NCT01109173|1953855|FG001|Overall Study|Patient Did Not Use Study Medication|26
957993|NCT01109173|1953856|FG002|Overall Study|Patient Did Not Use Study Medication|11
957994|NCT01109173|1953857|FG003|Overall Study|Patient Did Not Use Study Medication|7
957995|NCT01109173|1953854|FG000|Overall Study|Not Specifiied|5
957996|NCT01109173|1953855|FG001|Overall Study|Not Specifiied|4
957997|NCT01109173|1953856|FG002|Overall Study|Not Specifiied|9
957998|NCT01109173|1953857|FG003|Overall Study|Not Specifiied|14
957999|NCT01109316|1953873|FG000|Study Period 1|Adverse Event|0
958000|NCT01109316|1953874|FG001|Study Period 1|Adverse Event|0
958001|NCT01109316|1953875|FG002|Study Period 1|Adverse Event|1
958002|NCT01109316|1953876|FG003|Study Period 1|Adverse Event|0
958003|NCT01109316|1953877|FG004|Study Period 1|Adverse Event|0
958004|NCT01109316|1953878|FG005|Study Period 1|Adverse Event|0
958005|NCT01109316|1953873|FG000|Study Period 1|Lost to Follow-up|0
958006|NCT01109316|1953874|FG001|Study Period 1|Lost to Follow-up|0
958007|NCT01109316|1953875|FG002|Study Period 1|Lost to Follow-up|1
958008|NCT01109316|1953876|FG003|Study Period 1|Lost to Follow-up|1
958009|NCT01109316|1953877|FG004|Study Period 1|Lost to Follow-up|0
958010|NCT01109316|1953878|FG005|Study Period 1|Lost to Follow-up|0
958011|NCT01109316|1953873|FG000|Study Period 1|Withdrawal by Subject|0
958012|NCT01109316|1953874|FG001|Study Period 1|Withdrawal by Subject|0
958013|NCT01109316|1953875|FG002|Study Period 1|Withdrawal by Subject|1
958014|NCT01109316|1953876|FG003|Study Period 1|Withdrawal by Subject|0
958015|NCT01109316|1953877|FG004|Study Period 1|Withdrawal by Subject|2
958016|NCT01109316|1953878|FG005|Study Period 1|Withdrawal by Subject|0
958017|NCT01109316|1953873|FG000|Study Period 1|Sponsor Decision|0
958018|NCT01109316|1953874|FG001|Study Period 1|Sponsor Decision|0
958019|NCT01109316|1953875|FG002|Study Period 1|Sponsor Decision|0
958020|NCT01109316|1953876|FG003|Study Period 1|Sponsor Decision|0
958021|NCT01109316|1953877|FG004|Study Period 1|Sponsor Decision|0
958022|NCT01109316|1953878|FG005|Study Period 1|Sponsor Decision|2
958023|NCT01109316|1953873|FG000|Study Period 2|Entry Criteria Not Met|0
958024|NCT01109316|1953874|FG001|Study Period 2|Entry Criteria Not Met|1
958025|NCT01109316|1953875|FG002|Study Period 2|Entry Criteria Not Met|0
958026|NCT01109316|1953876|FG003|Study Period 2|Entry Criteria Not Met|0
958027|NCT01109316|1953877|FG004|Study Period 2|Entry Criteria Not Met|0
958028|NCT01109316|1953878|FG005|Study Period 2|Entry Criteria Not Met|0
958029|NCT01109316|1953873|FG000|Study Period 2|Physician Decision|0
958030|NCT01109316|1953874|FG001|Study Period 2|Physician Decision|0
958031|NCT01109316|1953875|FG002|Study Period 2|Physician Decision|0
958032|NCT01109316|1953876|FG003|Study Period 2|Physician Decision|1
958033|NCT01109316|1953877|FG004|Study Period 2|Physician Decision|0
958034|NCT01109316|1953878|FG005|Study Period 2|Physician Decision|0
958035|NCT01109316|1953873|FG000|Study Period 2|Protocol Violation|1
958036|NCT01109316|1953874|FG001|Study Period 2|Protocol Violation|0
958037|NCT01109316|1953875|FG002|Study Period 2|Protocol Violation|0
958038|NCT01109316|1953876|FG003|Study Period 2|Protocol Violation|0
958039|NCT01109316|1953877|FG004|Study Period 2|Protocol Violation|0
958040|NCT01109316|1953878|FG005|Study Period 2|Protocol Violation|0
958041|NCT01109316|1953873|FG000|Study Period 2|Withdrawal by Subject|0
958042|NCT01109316|1953874|FG001|Study Period 2|Withdrawal by Subject|0
958043|NCT01109316|1953875|FG002|Study Period 2|Withdrawal by Subject|1
958044|NCT01109316|1953876|FG003|Study Period 2|Withdrawal by Subject|0
958045|NCT01109316|1953877|FG004|Study Period 2|Withdrawal by Subject|0
958046|NCT01109316|1953878|FG005|Study Period 2|Withdrawal by Subject|1
958047|NCT01109316|1953873|FG000|Study Period 3|Lost to Follow-up|0
958048|NCT01109316|1953874|FG001|Study Period 3|Lost to Follow-up|0
958049|NCT01109316|1953875|FG002|Study Period 3|Lost to Follow-up|0
958050|NCT01109316|1953876|FG003|Study Period 3|Lost to Follow-up|0
958051|NCT01109316|1953877|FG004|Study Period 3|Lost to Follow-up|1
958052|NCT01109316|1953878|FG005|Study Period 3|Lost to Follow-up|0
958053|NCT01109316|1953873|FG000|Study Period 3|Withdrawal by Subject|1
958054|NCT01109316|1953874|FG001|Study Period 3|Withdrawal by Subject|0
958055|NCT01109316|1953875|FG002|Study Period 3|Withdrawal by Subject|0
958056|NCT01109316|1953876|FG003|Study Period 3|Withdrawal by Subject|0
958057|NCT01109316|1953877|FG004|Study Period 3|Withdrawal by Subject|1
958058|NCT01109316|1953878|FG005|Study Period 3|Withdrawal by Subject|0
958059|NCT01109524|1953892|FG000|Overall Study|Disease Progression|29
958060|NCT01109524|1953892|FG000|Overall Study|Study Drug toxicity|6
958061|NCT01109524|1953892|FG000|Overall Study|Adverse Event|4
958062|NCT01109524|1953892|FG000|Overall Study|Withdrawal by Subject|2
958063|NCT01109524|1953892|FG000|Overall Study|Maximum clinical benefit|3
958064|NCT01109524|1953892|FG000|Overall Study|Death|2
958065|NCT01109524|1953892|FG000|Overall Study|No longer meets criteria|2
958066|NCT01109524|1953892|FG000|Overall Study|Participant requested to end treatment|4
958067|NCT01109524|1953892|FG000|Overall Study|Other|5
958068|NCT01109849|1953914|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
958069|NCT01109849|1953915|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
958070|NCT01109849|1953916|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
958071|NCT01109849|1953917|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
958072|NCT01109849|1953918|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
958073|NCT01109849|1953914|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1
958074|NCT01109849|1953915|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0
958075|NCT01109849|1953916|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0
958076|NCT01109849|1953917|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0
958077|NCT01109849|1953918|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0
958078|NCT01109849|1953914|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
958079|NCT01109849|1953915|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
958080|NCT01109849|1953916|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
958081|NCT01109849|1953917|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
958082|NCT01109849|1953918|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
958083|NCT01109849|1953914|FG000|Initial Randomization: ADHD Treatment|move away|2
958084|NCT01109849|1953915|FG001|Initial Randomization: ADHD Treatment|move away|7
958085|NCT01109849|1953916|FG002|Initial Randomization: ADHD Treatment|move away|0
958086|NCT01109849|1953917|FG003|Initial Randomization: ADHD Treatment|move away|0
958087|NCT01109849|1953918|FG004|Initial Randomization: ADHD Treatment|move away|0
958088|NCT01109849|1953914|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
958089|NCT01109849|1953915|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
958090|NCT01109849|1953916|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
958091|NCT01109849|1953917|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
958092|NCT01109849|1953918|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
958093|NCT01109849|1953914|FG000|Adaptive Randomization: Weight Recovery|moved away|0
958094|NCT01109849|1953915|FG001|Adaptive Randomization: Weight Recovery|moved away|0
958095|NCT01109849|1953916|FG002|Adaptive Randomization: Weight Recovery|moved away|0
958096|NCT01109849|1953917|FG003|Adaptive Randomization: Weight Recovery|moved away|2
958097|NCT01109849|1953918|FG004|Adaptive Randomization: Weight Recovery|moved away|0
958098|NCT01109940|1953942|FG000|Overall Study|Administrative problems|2
958099|NCT01109940|1953943|FG001|Overall Study|Administrative problems|0
958100|NCT01109940|1953944|FG002|Overall Study|Administrative problems|0
958101|NCT01109940|1953945|FG003|Overall Study|Administrative problems|0
958102|NCT01109940|1953942|FG000|Overall Study|Serious Adverse Event|2
958103|NCT01109940|1953943|FG001|Overall Study|Serious Adverse Event|1
958104|NCT01109940|1953944|FG002|Overall Study|Serious Adverse Event|0
958105|NCT01109940|1953945|FG003|Overall Study|Serious Adverse Event|0
958106|NCT01109940|1953942|FG000|Overall Study|Lost to Follow-up|1
958107|NCT01109940|1953943|FG001|Overall Study|Lost to Follow-up|0
958108|NCT01109940|1953944|FG002|Overall Study|Lost to Follow-up|0
958109|NCT01109940|1953945|FG003|Overall Study|Lost to Follow-up|0
958110|NCT01109940|1953942|FG000|Overall Study|Patient withdrew consent|1
958111|NCT01109940|1953943|FG001|Overall Study|Patient withdrew consent|1
958112|NCT01109940|1953944|FG002|Overall Study|Patient withdrew consent|0
958113|NCT01109940|1953945|FG003|Overall Study|Patient withdrew consent|0
958114|NCT01109940|1953942|FG000|Overall Study|Unsatisfactory therapeutic effect|2
958115|NCT01109940|1953943|FG001|Overall Study|Unsatisfactory therapeutic effect|0
958116|NCT01109940|1953944|FG002|Overall Study|Unsatisfactory therapeutic effect|1
958117|NCT01109940|1953945|FG003|Overall Study|Unsatisfactory therapeutic effect|0
958118|NCT01109979|1953957|FG000|Overall Study|Physician Decision|2
958119|NCT01109979|1953958|FG001|Overall Study|Physician Decision|0
958120|NCT01109979|1953957|FG000|Overall Study|Withdrawal by Subject|0
958121|NCT01109979|1953958|FG001|Overall Study|Withdrawal by Subject|1
958122|NCT01109992|1953966|FG000|Overall Study|Withdrawal by Subject|0
958123|NCT01109992|1953967|FG001|Overall Study|Withdrawal by Subject|1
958124|NCT01109992|1953966|FG000|Overall Study|Movement during rest scan.|0
958125|NCT01109992|1953967|FG001|Overall Study|Movement during rest scan.|1
958126|NCT01110005|1953978|FG000|Overall Study|ineligible|1
958127|NCT01110005|1953979|FG001|Overall Study|ineligible|2
958128|NCT01110005|1953978|FG000|Overall Study|missing consent|3
958129|NCT01110005|1953979|FG001|Overall Study|missing consent|2
958130|NCT01110005|1953978|FG000|Overall Study|Withdrawal by Subject|0
958131|NCT01110005|1953979|FG001|Overall Study|Withdrawal by Subject|1
958132|NCT01110200|1954002|FG000|Overall Study|Adverse Event|28
958133|NCT01110200|1954003|FG001|Overall Study|Adverse Event|28
958134|NCT01110200|1954002|FG000|Overall Study|Withdrawal by Subject|25
958135|NCT01110200|1954003|FG001|Overall Study|Withdrawal by Subject|32
958136|NCT01110200|1954002|FG000|Overall Study|Lack of Efficacy|16
958137|NCT01110200|1954003|FG001|Overall Study|Lack of Efficacy|25
958138|NCT01110200|1954002|FG000|Overall Study|Protocol Violation|14
958139|NCT01110200|1954003|FG001|Overall Study|Protocol Violation|12
958140|NCT01110200|1954002|FG000|Overall Study|Physician Decision|13
958141|NCT01110200|1954003|FG001|Overall Study|Physician Decision|17
958142|NCT01110200|1954002|FG000|Overall Study|Lost to Follow-up|10
958143|NCT01110200|1954003|FG001|Overall Study|Lost to Follow-up|7
958144|NCT01110239|1954013|FG000|Sham Preconditioning|Withdrawal by Subject|0
958145|NCT01110239|1954014|FG001|Sham Preconditioning|Withdrawal by Subject|0
958146|NCT01110239|1954015|FG002|Sham Preconditioning|Withdrawal by Subject|1
958147|NCT01110239|1954016|FG003|Sham Preconditioning|Withdrawal by Subject|0
958148|NCT01110239|1954013|FG000|7.5 Min Ischemia|Withdrawal by Subject|0
958149|NCT01110239|1954014|FG001|7.5 Min Ischemia|Withdrawal by Subject|0
958150|NCT01110239|1954015|FG002|7.5 Min Ischemia|Withdrawal by Subject|1
958151|NCT01110239|1954016|FG003|7.5 Min Ischemia|Withdrawal by Subject|0
958152|NCT01110330|1954035|FG000|Overall Study|Adverse Event|0
958153|NCT01110330|1954036|FG001|Overall Study|Adverse Event|4
958154|NCT01110330|1954037|FG002|Overall Study|Adverse Event|3
958155|NCT01110330|1954035|FG000|Overall Study|Lack of Efficacy|3
958156|NCT01110330|1954036|FG001|Overall Study|Lack of Efficacy|1
958157|NCT01110330|1954037|FG002|Overall Study|Lack of Efficacy|1
958158|NCT01110330|1954035|FG000|Overall Study|Lost to Follow-up|9
958159|NCT01110330|1954036|FG001|Overall Study|Lost to Follow-up|10
958160|NCT01110330|1954037|FG002|Overall Study|Lost to Follow-up|15
958161|NCT01110330|1954035|FG000|Overall Study|Physician Decision|0
958162|NCT01110330|1954036|FG001|Overall Study|Physician Decision|1
958163|NCT01110330|1954037|FG002|Overall Study|Physician Decision|0
958164|NCT01110330|1954035|FG000|Overall Study|Protocol Violation|2
958165|NCT01110330|1954036|FG001|Overall Study|Protocol Violation|0
958166|NCT01110330|1954037|FG002|Overall Study|Protocol Violation|4
958167|NCT01110330|1954035|FG000|Overall Study|Withdrawal by Subject|0
958168|NCT01110330|1954036|FG001|Overall Study|Withdrawal by Subject|6
958169|NCT01110330|1954037|FG002|Overall Study|Withdrawal by Subject|2
958170|NCT01110330|1954035|FG000|Overall Study|Other|1
958171|NCT01110330|1954036|FG001|Overall Study|Other|1
958172|NCT01110330|1954037|FG002|Overall Study|Other|1
958173|NCT01110382|1954047|FG000|Overall Study|Withdrawal by Subject|0
958174|NCT01110382|1954048|FG001|Overall Study|Withdrawal by Subject|1
958175|NCT01110382|1954047|FG000|Overall Study|Protocol Violation|0
958176|NCT01110382|1954048|FG001|Overall Study|Protocol Violation|1
958177|NCT01110408|1954060|FG000|Overall Study|Protocol Violation|1
958178|NCT01110408|1954061|FG001|Overall Study|Protocol Violation|0
958179|NCT01110707|1954126|FG000|Overall Study|Protocol Violation|0
958180|NCT01110707|1954127|FG001|Overall Study|Protocol Violation|3
958181|NCT01110915|1954146|FG000|Overall Study|Death|2
958182|NCT01110915|1954147|FG001|Overall Study|Death|1
958183|NCT01110915|1954146|FG000|Overall Study|Lost to Follow-up|1
958184|NCT01110915|1954147|FG001|Overall Study|Lost to Follow-up|0
958185|NCT01110915|1954146|FG000|Overall Study|Withdrawal by Subject|7
958186|NCT01110915|1954147|FG001|Overall Study|Withdrawal by Subject|1
958187|NCT01111123|1954182|FG000|Open- Label Phase|Failed to be clear or almost cleared|14
958188|NCT01111123|1954183|FG001|Open- Label Phase|Failed to be clear or almost cleared|0
958189|NCT01111123|1954182|FG000|Maintenance Phase|Lost to Follow-up|0
958190|NCT01111123|1954183|FG001|Maintenance Phase|Lost to Follow-up|2
958191|NCT01111149|1954194|FG000|Overall Study|Protocol Violation|1
958192|NCT01111149|1954195|FG001|Overall Study|Protocol Violation|1
958193|NCT01111149|1954196|FG002|Overall Study|Protocol Violation|2
958194|NCT01111149|1954194|FG000|Overall Study|Withdrawal by Subject|1
958195|NCT01111149|1954195|FG001|Overall Study|Withdrawal by Subject|0
958196|NCT01111149|1954196|FG002|Overall Study|Withdrawal by Subject|2
958197|NCT01111240|1954209|FG000|Overall Study|Adverse Event|190
958198|NCT01111240|1954209|FG000|Overall Study|Lack of Efficacy|545
958199|NCT01111240|1954209|FG000|Overall Study|Lack of Efficacy and Adverse Event|19
958200|NCT01111240|1954209|FG000|Overall Study|Other|312
958201|NCT01111292|1954215|FG000|Treatment|Physician Decision|1
958202|NCT01111292|1954216|FG001|Treatment|Physician Decision|1
958203|NCT01111461|1954265|FG000|Overall Study|Adverse Event|32
958204|NCT01111461|1954265|FG000|Overall Study|Participant choice|11
958205|NCT01111461|1954265|FG000|Overall Study|Lost to Follow-up|1
958206|NCT01111461|1954265|FG000|Overall Study|Withdrawal by Subject|1
958207|NCT01111461|1954265|FG000|Overall Study|Other|6
958208|NCT01111474|1954269|FG000|Overall Study|Lost to Follow-up|12
958209|NCT01111526|1954275|FG000|Overall Study|GVHD Disease Progression|0
958210|NCT01111526|1954276|FG001|Overall Study|GVHD Disease Progression|1
958211|NCT01111526|1954277|FG002|Overall Study|GVHD Disease Progression|2
958212|NCT01111539|1954281|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6
958213|NCT01111539|1954282|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
958214|NCT01111539|1954283|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
958215|NCT01111539|1954284|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
958216|NCT01111539|1954285|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
958217|NCT01111539|1954281|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5
958218|NCT01111539|1954282|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
958219|NCT01111539|1954283|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
958220|NCT01111539|1954284|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
958221|NCT01111539|1954285|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
958222|NCT01111539|1954281|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60
958223|NCT01111539|1954282|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
958224|NCT01111539|1954283|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
958225|NCT01111539|1954284|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
958226|NCT01111539|1954285|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
958227|NCT01111539|1954281|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1
958228|NCT01111539|1954282|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
958229|NCT01111539|1954283|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
958230|NCT01111539|1954284|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
958231|NCT01111539|1954285|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
958232|NCT01111539|1954281|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7
958233|NCT01111539|1954282|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
958234|NCT01111539|1954283|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
958235|NCT01111539|1954284|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
958236|NCT01111539|1954285|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
958237|NCT01111539|1954281|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2
958238|NCT01111539|1954282|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
958239|NCT01111539|1954283|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
958240|NCT01111539|1954284|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
958241|NCT01111539|1954285|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
958242|NCT01111539|1954281|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1
958243|NCT01111539|1954282|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
958244|NCT01111539|1954283|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
958245|NCT01111539|1954284|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
958246|NCT01111539|1954285|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
958247|NCT01111539|1954281|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
958248|NCT01111539|1954282|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
958249|NCT01111539|1954283|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
958250|NCT01111539|1954284|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
958251|NCT01111539|1954285|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
958252|NCT01111539|1954281|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
958253|NCT01111539|1954282|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
958254|NCT01111539|1954283|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
958255|NCT01111539|1954284|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
958256|NCT01111539|1954285|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2
958257|NCT01111539|1954281|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
958258|NCT01111539|1954282|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
958259|NCT01111539|1954283|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
958260|NCT01111539|1954284|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
958261|NCT01111539|1954285|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
958262|NCT01111539|1954281|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
958263|NCT01111539|1954282|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
958264|NCT01111539|1954283|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
958265|NCT01111539|1954284|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
958266|NCT01111539|1954285|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1
958267|NCT01111539|1954281|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
958268|NCT01111539|1954282|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
958269|NCT01111539|1954283|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
958270|NCT01111539|1954284|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1
958271|NCT01111539|1954285|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
958272|NCT01111539|1954281|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
958273|NCT01111539|1954282|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
958274|NCT01111539|1954283|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
958275|NCT01111539|1954284|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2
958276|NCT01111539|1954285|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
958277|NCT01111539|1954281|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
958278|NCT01111539|1954282|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
958279|NCT01111539|1954283|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
958280|NCT01111539|1954284|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
958281|NCT01111539|1954285|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
958282|NCT01111552|1954295|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9
958283|NCT01111552|1954296|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
958284|NCT01111552|1954297|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
958285|NCT01111552|1954298|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
958286|NCT01111552|1954299|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
958287|NCT01111552|1954295|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4
958288|NCT01111552|1954296|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
958289|NCT01111552|1954297|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
958290|NCT01111552|1954298|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
958291|NCT01111552|1954299|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
958292|NCT01111552|1954295|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89
958293|NCT01111552|1954296|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
958294|NCT01111552|1954297|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
958295|NCT01111552|1954298|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
958296|NCT01111552|1954299|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
958297|NCT01111552|1954295|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3
958298|NCT01111552|1954296|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
958299|NCT01111552|1954297|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
958300|NCT01111552|1954298|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
958301|NCT01111552|1954299|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
958302|NCT01111552|1954295|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3
958303|NCT01111552|1954296|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
958304|NCT01111552|1954297|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
958305|NCT01111552|1954298|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
958306|NCT01111552|1954299|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
958307|NCT01111552|1954295|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7
958308|NCT01111552|1954296|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
958309|NCT01111552|1954297|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
958310|NCT01111552|1954298|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
958311|NCT01111552|1954299|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
958312|NCT01111552|1954295|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1
958313|NCT01111552|1954296|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
958314|NCT01111552|1954297|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
958315|NCT01111552|1954298|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
958316|NCT01111552|1954299|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
958317|NCT01111552|1954295|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1
958318|NCT01111552|1954296|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
958319|NCT01111552|1954297|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
958320|NCT01111552|1954298|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
958321|NCT01111552|1954299|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
958322|NCT01111552|1954295|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
958323|NCT01111552|1954296|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
958324|NCT01111552|1954297|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
958325|NCT01111552|1954298|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
958326|NCT01111552|1954299|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
958327|NCT01111552|1954295|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
958328|NCT01111552|1954296|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
958329|NCT01111552|1954297|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
958330|NCT01111552|1954298|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
958331|NCT01111552|1954299|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
958332|NCT01111552|1954295|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
958333|NCT01111552|1954296|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2
958334|NCT01111552|1954297|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
958335|NCT01111552|1954298|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
958336|NCT01111552|1954299|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
958337|NCT01111552|1954295|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
958338|NCT01111552|1954296|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1
958339|NCT01111552|1954297|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
958340|NCT01111552|1954298|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
958341|NCT01111552|1954299|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
958342|NCT01111552|1954295|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
958343|NCT01111552|1954296|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1
958344|NCT01111552|1954297|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
958345|NCT01111552|1954298|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
958346|NCT01111552|1954299|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
958347|NCT01111552|1954295|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
958348|NCT01111552|1954296|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
958349|NCT01111552|1954297|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
958350|NCT01111552|1954298|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
958351|NCT01111552|1954299|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
958352|NCT01111604|1954312|FG000|Overall Study|Lost to Follow-up|0
958353|NCT01111604|1954313|FG001|Overall Study|Lost to Follow-up|0
958354|NCT01111604|1954314|FG002|Overall Study|Lost to Follow-up|1
958355|NCT01111604|1954312|FG000|Overall Study|Withdrew Consent|3
958356|NCT01111604|1954313|FG001|Overall Study|Withdrew Consent|0
958357|NCT01111604|1954314|FG002|Overall Study|Withdrew Consent|2
958358|NCT01111604|1954312|FG000|Overall Study|Withdrawal by Subject|2
958359|NCT01111604|1954313|FG001|Overall Study|Withdrawal by Subject|0
958360|NCT01111604|1954314|FG002|Overall Study|Withdrawal by Subject|0
958361|NCT01111604|1954312|FG000|Overall Study|Death|1
958362|NCT01111604|1954313|FG001|Overall Study|Death|0
958363|NCT01111604|1954314|FG002|Overall Study|Death|0
958364|NCT01111604|1954312|FG000|Overall Study|Met Exclusion Criteria|2
958365|NCT01111604|1954313|FG001|Overall Study|Met Exclusion Criteria|0
958366|NCT01111604|1954314|FG002|Overall Study|Met Exclusion Criteria|0
958367|NCT01111825|1954344|FG000|Overall Study|Withdrawal by Subject|0
958368|NCT01111825|1954345|FG001|Overall Study|Withdrawal by Subject|0
958369|NCT01111825|1954346|FG002|Overall Study|Withdrawal by Subject|1
958370|NCT01111825|1954347|FG003|Overall Study|Withdrawal by Subject|0
958371|NCT01111825|1954344|FG000|Overall Study|Lost to Follow-up|0
958372|NCT01111825|1954345|FG001|Overall Study|Lost to Follow-up|0
958373|NCT01111825|1954346|FG002|Overall Study|Lost to Follow-up|3
958374|NCT01111825|1954347|FG003|Overall Study|Lost to Follow-up|1
958375|NCT01111825|1954344|FG000|Overall Study|Adverse Event|2
958376|NCT01111825|1954345|FG001|Overall Study|Adverse Event|1
958377|NCT01111825|1954346|FG002|Overall Study|Adverse Event|4
958378|NCT01111825|1954347|FG003|Overall Study|Adverse Event|0
958379|NCT01111825|1954344|FG000|Overall Study|Disease Progression|1
958380|NCT01111825|1954345|FG001|Overall Study|Disease Progression|0
958381|NCT01111825|1954346|FG002|Overall Study|Disease Progression|0
958382|NCT01111825|1954347|FG003|Overall Study|Disease Progression|0
958383|NCT01111825|1954344|FG000|Overall Study|Discontinuation by Sponsor|0
958384|NCT01111825|1954345|FG001|Overall Study|Discontinuation by Sponsor|0
958385|NCT01111825|1954346|FG002|Overall Study|Discontinuation by Sponsor|0
958386|NCT01111825|1954347|FG003|Overall Study|Discontinuation by Sponsor|20
958387|NCT01111838|1954357|FG000|Overall Study|Patient Ineligible|2
958388|NCT01111838|1954357|FG000|Overall Study|Not Treated|3
958389|NCT01111838|1954357|FG000|Overall Study|Clinical deterioration|1
958390|NCT01111838|1954357|FG000|Overall Study|Other Complicating Disease|1
958391|NCT01111851|1954363|FG000|Overall Study|All planned PET scans were not obtained.|2
958392|NCT01111851|1954364|FG001|Overall Study|All planned PET scans were not obtained.|0
958393|NCT01112059|1954372|FG000|Overall Study|Withdrawal by Subject|1
958394|NCT01112059|1954373|FG001|Overall Study|Withdrawal by Subject|0
958395|NCT01112267|1954394|FG000|Overall Study|Adverse Event|24
958396|NCT01112267|1954395|FG001|Overall Study|Adverse Event|6
958397|NCT01112267|1954394|FG000|Overall Study|Withdrawal by Subject|3
958398|NCT01112267|1954395|FG001|Overall Study|Withdrawal by Subject|5
958399|NCT01112267|1954394|FG000|Overall Study|Protocol Violation|5
958400|NCT01112267|1954395|FG001|Overall Study|Protocol Violation|3
958401|NCT01112267|1954394|FG000|Overall Study|Participants not compliant|1
958402|NCT01112267|1954395|FG001|Overall Study|Participants not compliant|2
958403|NCT01112267|1954394|FG000|Overall Study|Participants not receive any study drug|1
958404|NCT01112267|1954395|FG001|Overall Study|Participants not receive any study drug|2
958405|NCT01112514|1954414|FG000|Overall Study|Lost to Follow-up|1
958406|NCT01112579|1954420|FG000|Overall Study|Missed Visit|1
958407|NCT01112579|1954421|FG001|Overall Study|Missed Visit|1
958408|NCT01112579|1954420|FG000|Overall Study|Death|0
958409|NCT01112579|1954421|FG001|Overall Study|Death|2
958410|NCT01112917|1954469|FG000|Overall Study|Death|2
958411|NCT01112917|1954470|FG001|Overall Study|Death|11
958412|NCT01112917|1954469|FG000|Overall Study|Lost to Follow-up|1
958413|NCT01112917|1954470|FG001|Overall Study|Lost to Follow-up|1
958414|NCT01112917|1954469|FG000|Overall Study|Withdrawal by Subject|1
958415|NCT01112917|1954470|FG001|Overall Study|Withdrawal by Subject|3
958416|NCT01112917|1954469|FG000|Overall Study|Unable to Convert Filter|3
958417|NCT01112917|1954470|FG001|Overall Study|Unable to Convert Filter|0
958418|NCT01112982|1954474|FG000|Overall Study|Withdrawal by Subject|1
958419|NCT01112982|1954474|FG000|Overall Study|exceeded weight limit to complete MRI|1
958420|NCT01113463|1954498|FG000|Overall Study|Physician Decision|5
958421|NCT01113502|1954507|FG000|Overall Study|Withdrawal by Subject|1
958422|NCT01113502|1954508|FG001|Overall Study|Withdrawal by Subject|0
958423|NCT01113502|1954509|FG002|Overall Study|Withdrawal by Subject|1
958424|NCT01113502|1954510|FG003|Overall Study|Withdrawal by Subject|1
958425|NCT01113502|1954511|FG004|Overall Study|Withdrawal by Subject|0
958426|NCT01113502|1954507|FG000|Overall Study|Adverse Event|0
958427|NCT01113502|1954508|FG001|Overall Study|Adverse Event|0
958428|NCT01113502|1954509|FG002|Overall Study|Adverse Event|3
958429|NCT01113502|1954510|FG003|Overall Study|Adverse Event|2
958430|NCT01113502|1954511|FG004|Overall Study|Adverse Event|0
958431|NCT01113541|1954524|FG000|Overall Study|Withdrawal by Subject|1
958432|NCT01113541|1954524|FG000|Overall Study|Protocol Violation|1
958433|NCT01113541|1954524|FG000|Overall Study|Study Terminated by Sponsor|7
958434|NCT01113541|1954524|FG000|Overall Study|Adverse Event|4
958435|NCT01113580|1954530|FG000|Overall Study|Protocol Violation|1
958436|NCT01113580|1954531|FG001|Overall Study|Protocol Violation|0
958437|NCT01113710|1954546|FG000|Overall Study|Adverse Event|64
958438|NCT01113710|1954546|FG000|Overall Study|Lack of Efficacy|41
958439|NCT01113710|1954546|FG000|Overall Study|No Information Available|40
958440|NCT01113710|1954546|FG000|Overall Study|Withdrawal by Subject|28
958441|NCT01113710|1954546|FG000|Overall Study|Lost to Follow-up|20
958442|NCT01113710|1954546|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
958443|NCT01113710|1954546|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11
958444|NCT01113710|1954546|FG000|Overall Study|Lack of Patient's Compliance|8
958445|NCT01113710|1954546|FG000|Overall Study|Other|7
958446|NCT01113710|1954546|FG000|Overall Study|Adverse Event/Other|5
958447|NCT01113710|1954546|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5
958448|NCT01113710|1954546|FG000|Overall Study|Lack of Efficacy/Other|4
958449|NCT01113710|1954546|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4
958450|NCT01113710|1954546|FG000|Overall Study|Lack of Efficacy/Adverse Event|3
958451|NCT01113710|1954546|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2
958452|NCT01113710|1954546|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
958453|NCT01113710|1954546|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2
958454|NCT01113710|1954546|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1
958455|NCT01113710|1954546|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1
958456|NCT01113710|1954546|FG000|Overall Study|Compliance/Efficacy/AE/Other|1
958457|NCT01113710|1954546|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
958458|NCT01113710|1954546|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
958459|NCT01113710|1954546|FG000|Overall Study|Lack of Patient's Compliance/Other|1
958460|NCT01113710|1954546|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1
958461|NCT01113710|1954546|FG000|Overall Study|Subject Did Not Receive Neupro|3
958462|NCT01113749|1954563|FG000|Overall Study|Lost to Follow-up|1
958463|NCT01113749|1954564|FG001|Overall Study|Lost to Follow-up|2
958464|NCT01113801|1954574|FG000|Overall Study|Adverse Event|4
958465|NCT01113801|1954575|FG001|Overall Study|Adverse Event|0
958466|NCT01113801|1954576|FG002|Overall Study|Adverse Event|2
958467|NCT01113801|1954577|FG003|Overall Study|Adverse Event|6
958468|NCT01113801|1954574|FG000|Overall Study|Death|4
958469|NCT01113801|1954575|FG001|Overall Study|Death|5
958470|NCT01113801|1954576|FG002|Overall Study|Death|3
958471|NCT01113801|1954577|FG003|Overall Study|Death|4
958472|NCT01113801|1954574|FG000|Overall Study|Protocol Violation|0
958473|NCT01113801|1954575|FG001|Overall Study|Protocol Violation|1
958474|NCT01113801|1954576|FG002|Overall Study|Protocol Violation|0
958475|NCT01113801|1954577|FG003|Overall Study|Protocol Violation|0
958476|NCT01113801|1954574|FG000|Overall Study|Withdrawal by Subject|9
958477|NCT01113801|1954575|FG001|Overall Study|Withdrawal by Subject|7
958478|NCT01113801|1954576|FG002|Overall Study|Withdrawal by Subject|7
958479|NCT01113801|1954577|FG003|Overall Study|Withdrawal by Subject|8
958480|NCT01113801|1954574|FG000|Overall Study|Physician Decision|2
958481|NCT01113801|1954575|FG001|Overall Study|Physician Decision|2
958482|NCT01113801|1954576|FG002|Overall Study|Physician Decision|3
958483|NCT01113801|1954577|FG003|Overall Study|Physician Decision|3
958484|NCT01113801|1954574|FG000|Overall Study|Sponsor Decision|15
958485|NCT01113801|1954575|FG001|Overall Study|Sponsor Decision|21
958486|NCT01113801|1954576|FG002|Overall Study|Sponsor Decision|20
958487|NCT01113801|1954577|FG003|Overall Study|Sponsor Decision|15
958488|NCT01113801|1954574|FG000|Overall Study|Clinical Endpoint (ESRD)|7
958489|NCT01113801|1954575|FG001|Overall Study|Clinical Endpoint (ESRD)|4
958490|NCT01113801|1954576|FG002|Overall Study|Clinical Endpoint (ESRD)|2
958491|NCT01113801|1954577|FG003|Overall Study|Clinical Endpoint (ESRD)|5
958492|NCT01113879|1954589|FG000|Period 1: Block 1|Withdrawal by Subject|2
958493|NCT01113879|1954590|FG001|Period 1: Block 1|Withdrawal by Subject|0
958494|NCT01113892|1954600|FG000|Overall Study|Lost to Follow-up|2
958495|NCT01113892|1954601|FG001|Overall Study|Lost to Follow-up|2
958496|NCT01113892|1954600|FG000|Overall Study|Withdrawal by Subject|1
958497|NCT01113892|1954601|FG001|Overall Study|Withdrawal by Subject|1
958498|NCT01113892|1954600|FG000|Overall Study|Death|2
958499|NCT01113892|1954601|FG001|Overall Study|Death|4
958500|NCT01113892|1954600|FG000|Overall Study|Graft no longer evaluable|9
958501|NCT01113892|1954601|FG001|Overall Study|Graft no longer evaluable|9
958502|NCT01113931|1954609|FG000|Overall Study|Adverse Event|2
958503|NCT01113931|1954610|FG001|Overall Study|Adverse Event|2
958504|NCT01113931|1954609|FG000|Overall Study|Physician Decision|0
958505|NCT01113931|1954610|FG001|Overall Study|Physician Decision|2
958506|NCT01113931|1954609|FG000|Overall Study|Lost to Follow-up|12
958507|NCT01113931|1954610|FG001|Overall Study|Lost to Follow-up|9
958508|NCT01113931|1954609|FG000|Overall Study|Various|2
958509|NCT01113931|1954610|FG001|Overall Study|Various|4
958510|NCT01113931|1954609|FG000|Overall Study|Withdrawal by Subject|3
958511|NCT01113931|1954610|FG001|Overall Study|Withdrawal by Subject|0
958512|NCT01114139|1954627|FG000|Overall Study|Adverse Event|3
958513|NCT01114139|1954628|FG001|Overall Study|Adverse Event|2
958514|NCT01114139|1954627|FG000|Overall Study|Lost to Follow-up|15
958515|NCT01114139|1954628|FG001|Overall Study|Lost to Follow-up|3
958516|NCT01114139|1954627|FG000|Overall Study|Withdrawal by Subject|17
958517|NCT01114139|1954628|FG001|Overall Study|Withdrawal by Subject|6
958518|NCT01114139|1954627|FG000|Overall Study|Other-Missed 1 visit|1
958519|NCT01114139|1954628|FG001|Overall Study|Other-Missed 1 visit|0
958520|NCT01114139|1954627|FG000|Overall Study|Other-Protocol Violation|1
958521|NCT01114139|1954628|FG001|Overall Study|Other-Protocol Violation|0
958522|NCT01114139|1954627|FG000|Overall Study|Other-Out of window for study drug dose|1
958523|NCT01114139|1954628|FG001|Overall Study|Other-Out of window for study drug dose|0
958524|NCT01114139|1954627|FG000|Overall Study|Other-Participant falsified records|0
958525|NCT01114139|1954628|FG001|Overall Study|Other-Participant falsified records|1
958526|NCT01114139|1954627|FG000|Overall Study|Other-Participant went on hospice|0
958527|NCT01114139|1954628|FG001|Overall Study|Other-Participant went on hospice|1
958528|NCT01114139|1954627|FG000|Overall Study|Other-Physician changed treatment|1
958529|NCT01114139|1954628|FG001|Overall Study|Other-Physician changed treatment|0
958530|NCT01114139|1954627|FG000|Overall Study|Other-Withdrew prior to receiving dose|1
958531|NCT01114139|1954628|FG001|Overall Study|Other-Withdrew prior to receiving dose|3
958532|NCT01114204|1954636|FG000|Overall Study|Adverse Event|3
958533|NCT01114204|1954637|FG001|Overall Study|Adverse Event|2
958534|NCT01114204|1954636|FG000|Overall Study|Lost to Follow-up|1
958535|NCT01114204|1954637|FG001|Overall Study|Lost to Follow-up|0
958536|NCT01114204|1954636|FG000|Overall Study|Withdrawal by Subject|10
958537|NCT01114204|1954637|FG001|Overall Study|Withdrawal by Subject|6
958538|NCT01114204|1954636|FG000|Overall Study|Death|1
958539|NCT01114204|1954637|FG001|Overall Study|Death|0
958540|NCT01114204|1954636|FG000|Overall Study|Other-Personal reasons|2
958541|NCT01114204|1954637|FG001|Overall Study|Other-Personal reasons|0
958542|NCT01114204|1954636|FG000|Overall Study|Other-Medical monitor request|1
958543|NCT01114204|1954637|FG001|Overall Study|Other-Medical monitor request|0
958544|NCT01114204|1954636|FG000|Overall Study|Other-Participant request|2
958545|NCT01114204|1954637|FG001|Overall Study|Other-Participant request|0
958546|NCT01114204|1954636|FG000|Overall Study|Other-Protocol Violation|1
958547|NCT01114204|1954637|FG001|Overall Study|Other-Protocol Violation|0
958548|NCT01114217|1954645|FG000|Overall Study|Adverse Event|5
958549|NCT01114217|1954646|FG001|Overall Study|Adverse Event|3
958550|NCT01114217|1954645|FG000|Overall Study|Lost to Follow-up|17
958551|NCT01114217|1954646|FG001|Overall Study|Lost to Follow-up|33
958552|NCT01114217|1954645|FG000|Overall Study|Withdrawal by Subject|21
958553|NCT01114217|1954646|FG001|Overall Study|Withdrawal by Subject|28
958554|NCT01114217|1954645|FG000|Overall Study|Other-Clerical Error|3
958555|NCT01114217|1954646|FG001|Overall Study|Other-Clerical Error|0
958556|NCT01114217|1954645|FG000|Overall Study|Other-Early termination|6
958557|NCT01114217|1954646|FG001|Overall Study|Other-Early termination|10
958558|NCT01114217|1954645|FG000|Overall Study|Other-Procedure|1
958559|NCT01114217|1954646|FG001|Overall Study|Other-Procedure|1
958560|NCT01114217|1954645|FG000|Overall Study|Other-Pregnancy|2
958561|NCT01114217|1954646|FG001|Overall Study|Other-Pregnancy|4
958562|NCT01114217|1954645|FG000|Overall Study|Other-Protocol Violation|1
958563|NCT01114217|1954646|FG001|Overall Study|Other-Protocol Violation|3
958564|NCT01114217|1954645|FG000|Overall Study|Other-Lack of Efficacy|1
958565|NCT01114217|1954646|FG001|Overall Study|Other-Lack of Efficacy|0
958566|NCT01114217|1954645|FG000|Overall Study|Other-Non Compliance|2
958567|NCT01114217|1954646|FG001|Overall Study|Other-Non Compliance|0
958568|NCT01114217|1954645|FG000|Overall Study|Other-Physician Decision|1
958569|NCT01114217|1954646|FG001|Overall Study|Other-Physician Decision|1
958570|NCT01114217|1954645|FG000|Overall Study|Other-Sponsor Decision|10
958571|NCT01114217|1954646|FG001|Overall Study|Other-Sponsor Decision|12
958572|NCT01114217|1954645|FG000|Overall Study|Other-Study Termination|0
958573|NCT01114217|1954646|FG001|Overall Study|Other-Study Termination|1
958574|NCT01114217|1954645|FG000|Overall Study|Other-Study Withdrawn|1
958575|NCT01114217|1954646|FG001|Overall Study|Other-Study Withdrawn|1
958576|NCT01114217|1954645|FG000|Overall Study|Other-Site Stopped Communicating|2
958577|NCT01114217|1954646|FG001|Overall Study|Other-Site Stopped Communicating|0
958578|NCT01114217|1954645|FG000|Overall Study|Other-Lost to Follow-up|1
958579|NCT01114217|1954646|FG001|Overall Study|Other-Lost to Follow-up|0
958580|NCT01114217|1954645|FG000|Overall Study|Other-Withdrawal by Subject|1
958581|NCT01114217|1954646|FG001|Overall Study|Other-Withdrawal by Subject|1
958582|NCT01114360|1954660|FG000|Intervention 1 (4 Weeks)|Physician Decision|0
958583|NCT01114360|1954661|FG001|Intervention 1 (4 Weeks)|Physician Decision|1
958584|NCT01114373|1954681|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1
958585|NCT01114373|1954682|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0
958586|NCT01114373|1954681|FG000|Intervention 1 (4 Weeks)|Incarceration|1
958587|NCT01114373|1954682|FG001|Intervention 1 (4 Weeks)|Incarceration|0
958588|NCT01114373|1954681|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
958589|NCT01114373|1954682|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
958590|NCT01114373|1954681|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0
958591|NCT01114373|1954682|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1
958592|NCT01114438|1954692|FG000|Overall Study|Adverse Event|10
958593|NCT01114438|1954692|FG000|Overall Study|concomitant medication|1
958594|NCT01114438|1954692|FG000|Overall Study|Physician Decision|1
958595|NCT01114438|1954692|FG000|Overall Study|Withdrawal by Subject|2
958596|NCT01114516|1954707|FG000|Overall Study|Lost to Follow-up|2
958597|NCT01114516|1954708|FG001|Overall Study|Lost to Follow-up|1
958598|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Adverse Event|87
958599|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Adverse Event|18
958600|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Adverse Event|17
958601|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
958602|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
958603|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
958604|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
958605|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
958606|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
958607|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2
958608|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1
958609|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2
958610|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1
958611|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1
958612|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1
958613|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18
958614|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8
958615|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2
958616|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1
958617|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4
958618|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2
958619|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Administrative problems|2
958620|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Administrative problems|1
958621|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Administrative problems|2
958622|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Death|2
958623|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Death|1
958624|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Death|2
958625|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Graft loss|0
958626|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Graft loss|2
958627|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Graft loss|0
958628|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Protocol Violation|0
958629|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Protocol Violation|5
958630|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Protocol Violation|2
958631|NCT01114529|1954717|FG000|Completed Study Medication at Month 24|Missing|2
958632|NCT01114529|1954718|FG001|Completed Study Medication at Month 24|Missing|0
958633|NCT01114529|1954719|FG002|Completed Study Medication at Month 24|Missing|0
958634|NCT01114529|1954717|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18
958635|NCT01114529|1954718|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6
958636|NCT01114529|1954719|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3
958637|NCT01114529|1954717|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10
958638|NCT01114529|1954718|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5
958639|NCT01114529|1954719|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7
958640|NCT01114529|1954717|FG000|Completed Study Phase at Month 24|Death|8
958641|NCT01114529|1954718|FG001|Completed Study Phase at Month 24|Death|5
958642|NCT01114529|1954719|FG002|Completed Study Phase at Month 24|Death|4
958643|NCT01114529|1954717|FG000|Completed Study Phase at Month 24|Other|2
958644|NCT01114529|1954718|FG001|Completed Study Phase at Month 24|Other|0
958645|NCT01114529|1954719|FG002|Completed Study Phase at Month 24|Other|0
958646|NCT01114529|1954717|FG000|Completed Study Phase at Month 24|Missing|2
958647|NCT01114529|1954718|FG001|Completed Study Phase at Month 24|Missing|0
958648|NCT01114529|1954719|FG002|Completed Study Phase at Month 24|Missing|0
958649|NCT01114646|1954748|FG000|Overall Study|Withdrawal by Subject|3
958650|NCT01114646|1954749|FG001|Overall Study|Withdrawal by Subject|2
958651|NCT01114672|1954757|FG000|Overall Study|Death|0
958652|NCT01114672|1954758|FG001|Overall Study|Death|1
958653|NCT01114672|1954757|FG000|Overall Study|Withdrawal by Subject|2
958654|NCT01114672|1954758|FG001|Overall Study|Withdrawal by Subject|1
958655|NCT01114672|1954757|FG000|Overall Study|Lost to Follow-up|1
958656|NCT01114672|1954758|FG001|Overall Study|Lost to Follow-up|0
958657|NCT01114672|1954757|FG000|Overall Study|transplanted|1
958658|NCT01114672|1954758|FG001|Overall Study|transplanted|0
958659|NCT01114724|1954764|FG000|Overall Study|Death|8
958660|NCT01114724|1954764|FG000|Overall Study|Lost to Follow-up|1
958661|NCT01114724|1954764|FG000|Overall Study|Withdrawal by Subject|1
958662|NCT01114737|1954771|FG000|Randomized Treatment Period|Withdrawal by Subject|1
958663|NCT01114737|1954772|FG001|Randomized Treatment Period|Withdrawal by Subject|0
958664|NCT01114737|1954771|FG000|Randomized Treatment Period|Lost to Follow-up|1
958665|NCT01114737|1954772|FG001|Randomized Treatment Period|Lost to Follow-up|1
958666|NCT01114737|1954771|FG000|Randomized Treatment Period|Pregnancy|1
958667|NCT01114737|1954772|FG001|Randomized Treatment Period|Pregnancy|0
958668|NCT01114737|1954771|FG000|Open-Label Treatment Period|Withdrawal by Subject|1
958669|NCT01114737|1954772|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
958670|NCT01114737|1954771|FG000|Open-Label Treatment Period|Lost to Follow-up|3
958671|NCT01114737|1954772|FG001|Open-Label Treatment Period|Lost to Follow-up|1
958672|NCT01114737|1954771|FG000|Open-Label Treatment Period|Difficult Personal Events|1
958673|NCT01114737|1954772|FG001|Open-Label Treatment Period|Difficult Personal Events|0
958674|NCT01114828|1954791|FG000|Overall Study|Adverse Event|1
958675|NCT01114828|1954792|FG001|Overall Study|Adverse Event|1
958676|NCT01114828|1954791|FG000|Overall Study|Lack of Efficacy|0
958677|NCT01114828|1954792|FG001|Overall Study|Lack of Efficacy|2
958678|NCT01114828|1954791|FG000|Overall Study|Protocol Violation|2
958679|NCT01114828|1954792|FG001|Overall Study|Protocol Violation|0
958680|NCT01114828|1954791|FG000|Overall Study|Withdrawal by Subject|0
958681|NCT01114828|1954792|FG001|Overall Study|Withdrawal by Subject|1
958682|NCT01114880|1954800|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4
958683|NCT01114880|1954801|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0
958684|NCT01114880|1954800|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
958685|NCT01114880|1954801|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
958686|NCT01114880|1954800|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
958687|NCT01114880|1954801|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
958688|NCT01114880|1954800|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
958689|NCT01114880|1954801|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
958690|NCT01114880|1954800|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3
958691|NCT01114880|1954801|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0
958692|NCT01114880|1954800|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
958693|NCT01114880|1954801|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
958694|NCT01115309|1954898|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2
958695|NCT01115309|1954898|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1
958696|NCT01115309|1954898|FG000|Long-term Follow-up|Lost to Follow-up|6
958697|NCT01115491|1954911|FG000|Overall Study|Death|22
958698|NCT01115491|1954911|FG000|Overall Study|Adverse Event|3
958699|NCT01115491|1954911|FG000|Overall Study|Lost to Follow-up|3
958700|NCT01115491|1954911|FG000|Overall Study|Withdrawal by Subject|1
958701|NCT01115491|1954911|FG000|Overall Study|Physician Decision|1
958702|NCT01115569|1954935|FG000|Conversion/Titration Phase|Adverse Event|59
958703|NCT01115569|1954936|FG001|Conversion/Titration Phase|Adverse Event|0
958704|NCT01115569|1954935|FG000|Conversion/Titration Phase|Lost to Follow-up|3
958705|NCT01115569|1954936|FG001|Conversion/Titration Phase|Lost to Follow-up|0
958706|NCT01115569|1954935|FG000|Conversion/Titration Phase|Physician Decision|5
958707|NCT01115569|1954936|FG001|Conversion/Titration Phase|Physician Decision|0
958708|NCT01115569|1954935|FG000|Conversion/Titration Phase|Protocol Violation|68
958709|NCT01115569|1954936|FG001|Conversion/Titration Phase|Protocol Violation|0
958710|NCT01115569|1954935|FG000|Conversion/Titration Phase|Withdrawal by Subject|26
958711|NCT01115569|1954936|FG001|Conversion/Titration Phase|Withdrawal by Subject|0
958712|NCT01115569|1954935|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53
958713|NCT01115569|1954936|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0
958714|NCT01115569|1954935|FG000|Maintenance Phase|Adverse Event|0
958715|NCT01115569|1954936|FG001|Maintenance Phase|Adverse Event|43
958716|NCT01115569|1954935|FG000|Maintenance Phase|Lost to Follow-up|0
958717|NCT01115569|1954936|FG001|Maintenance Phase|Lost to Follow-up|8
958718|NCT01115569|1954935|FG000|Maintenance Phase|Physician Decision|0
958719|NCT01115569|1954936|FG001|Maintenance Phase|Physician Decision|3
958720|NCT01115569|1954935|FG000|Maintenance Phase|Protocol Violation|0
958721|NCT01115569|1954936|FG001|Maintenance Phase|Protocol Violation|9
958722|NCT01115569|1954935|FG000|Maintenance Phase|Withdrawal by Subject|0
958723|NCT01115569|1954936|FG001|Maintenance Phase|Withdrawal by Subject|27
958724|NCT01115569|1954935|FG000|Maintenance Phase|Non-Compliance with Study Drug|0
958725|NCT01115569|1954936|FG001|Maintenance Phase|Non-Compliance with Study Drug|48
958726|NCT01115569|1954935|FG000|Maintenance Phase|Administrative|0
958727|NCT01115569|1954936|FG001|Maintenance Phase|Administrative|1
958728|NCT01115738|1954970|FG000|Overall Study|Death|1
958729|NCT01115738|1954971|FG001|Overall Study|Death|0
958730|NCT01115738|1954972|FG002|Overall Study|Death|0
958731|NCT01115738|1954970|FG000|Overall Study|Lost to Follow-up|0
958732|NCT01115738|1954971|FG001|Overall Study|Lost to Follow-up|0
958733|NCT01115738|1954972|FG002|Overall Study|Lost to Follow-up|1
958734|NCT01115738|1954970|FG000|Overall Study|Physician Decision|18
958735|NCT01115738|1954971|FG001|Overall Study|Physician Decision|15
958736|NCT01115738|1954972|FG002|Overall Study|Physician Decision|17
958737|NCT01115738|1954970|FG000|Overall Study|Withdrawal by Subject|6
958738|NCT01115738|1954971|FG001|Overall Study|Withdrawal by Subject|6
958739|NCT01115738|1954972|FG002|Overall Study|Withdrawal by Subject|9
958740|NCT01115803|1954995|FG000|Overall Study|Withdrawal by Subject|0
958741|NCT01115803|1954996|FG001|Overall Study|Withdrawal by Subject|0
958742|NCT01115803|1954997|FG002|Overall Study|Withdrawal by Subject|0
958743|NCT01115803|1954998|FG003|Overall Study|Withdrawal by Subject|0
958744|NCT01115803|1954999|FG004|Overall Study|Withdrawal by Subject|0
958745|NCT01115803|1955000|FG005|Overall Study|Withdrawal by Subject|0
958746|NCT01115803|1955001|FG006|Overall Study|Withdrawal by Subject|1
958747|NCT01115803|1954995|FG000|Overall Study|Lost to Follow-up|0
958748|NCT01115803|1954996|FG001|Overall Study|Lost to Follow-up|0
958749|NCT01115803|1954997|FG002|Overall Study|Lost to Follow-up|1
958750|NCT01115803|1954998|FG003|Overall Study|Lost to Follow-up|0
958751|NCT01115803|1954999|FG004|Overall Study|Lost to Follow-up|0
958752|NCT01115803|1955000|FG005|Overall Study|Lost to Follow-up|0
958753|NCT01115803|1955001|FG006|Overall Study|Lost to Follow-up|0
958754|NCT01115803|1954995|FG000|Overall Study|Progressive Disease during Cycle1|0
958755|NCT01115803|1954996|FG001|Overall Study|Progressive Disease during Cycle1|0
958756|NCT01115803|1954997|FG002|Overall Study|Progressive Disease during Cycle1|0
958757|NCT01115803|1954998|FG003|Overall Study|Progressive Disease during Cycle1|0
958758|NCT01115803|1954999|FG004|Overall Study|Progressive Disease during Cycle1|0
958759|NCT01115803|1955000|FG005|Overall Study|Progressive Disease during Cycle1|0
958760|NCT01115803|1955001|FG006|Overall Study|Progressive Disease during Cycle1|1
958761|NCT01115855|1955024|FG000|Overall Study|Adverse Event|16
958762|NCT01115855|1955025|FG001|Overall Study|Adverse Event|18
958763|NCT01115855|1955024|FG000|Overall Study|Death|6
958764|NCT01115855|1955025|FG001|Overall Study|Death|5
958765|NCT01115855|1955024|FG000|Overall Study|Lab Abnormality|1
958766|NCT01115855|1955025|FG001|Overall Study|Lab Abnormality|1
958767|NCT01115855|1955024|FG000|Overall Study|Protocol Violation|0
958768|NCT01115855|1955025|FG001|Overall Study|Protocol Violation|1
958769|NCT01115855|1955024|FG000|Overall Study|Withdrawal by Subject|5
958770|NCT01115855|1955025|FG001|Overall Study|Withdrawal by Subject|5
958771|NCT01115855|1955024|FG000|Overall Study|Other|8
958772|NCT01115855|1955025|FG001|Overall Study|Other|6
958773|NCT01115933|1955031|FG000|Overall Study|Did not receive XIENCE PRIME SV|1
958774|NCT01115998|1955090|FG000|Overall Study|Lost to Follow-up|6
958775|NCT01115998|1955091|FG001|Overall Study|Lost to Follow-up|6
958776|NCT01116427|1955166|FG000|Core Phase|Adverse Event|0
958777|NCT01116427|1955167|FG001|Core Phase|Adverse Event|1
958778|NCT01116427|1955166|FG000|Core Phase|Lost to Follow-up|1
958779|NCT01116427|1955167|FG001|Core Phase|Lost to Follow-up|0
958780|NCT01116427|1955166|FG000|Core Phase|Withdrawal by Subject|3
958781|NCT01116427|1955167|FG001|Core Phase|Withdrawal by Subject|0
958782|NCT01116427|1955166|FG000|Core Phase|Worsening Multiple Sclerosis|1
958783|NCT01116427|1955167|FG001|Core Phase|Worsening Multiple Sclerosis|0
958784|NCT01116427|1955166|FG000|Extension Phase|Adverse Event|1
958785|NCT01116427|1955167|FG001|Extension Phase|Adverse Event|1
958786|NCT01116427|1955166|FG000|Extension Phase|Lost to Follow-up|2
958787|NCT01116427|1955167|FG001|Extension Phase|Lost to Follow-up|0
958788|NCT01116427|1955166|FG000|Extension Phase|Withdrawal by Subject|5
958789|NCT01116427|1955167|FG001|Extension Phase|Withdrawal by Subject|1
958790|NCT01116427|1955166|FG000|Extension Phase|Not using appropriate birth control|1
958791|NCT01116427|1955167|FG001|Extension Phase|Not using appropriate birth control|0
958792|NCT01116440|1955179|FG000|Treatment|Withdrawal by Subject|2
958793|NCT01116440|1955180|FG001|Treatment|Withdrawal by Subject|2
958794|NCT01116440|1955179|FG000|Treatment|Lost to Follow-up|1
958795|NCT01116440|1955180|FG001|Treatment|Lost to Follow-up|1
958796|NCT01116440|1955179|FG000|Treatment|Protocol Violation|0
958797|NCT01116440|1955180|FG001|Treatment|Protocol Violation|2
958798|NCT01116440|1955179|FG000|Treatment|Lack of Efficacy|0
958799|NCT01116440|1955180|FG001|Treatment|Lack of Efficacy|1
958800|NCT01116440|1955179|FG000|Treatment|Adverse Event|0
958801|NCT01116440|1955180|FG001|Treatment|Adverse Event|1
958802|NCT01116440|1955179|FG000|Withdrawal|Withdrawal by Subject|0
958803|NCT01116440|1955180|FG001|Withdrawal|Withdrawal by Subject|1
958804|NCT01116440|1955179|FG000|Withdrawal|Lost to Follow-up|0
958805|NCT01116440|1955180|FG001|Withdrawal|Lost to Follow-up|1
958806|NCT01116440|1955179|FG000|Follow-up|Lost to Follow-up|0
958807|NCT01116440|1955180|FG001|Follow-up|Lost to Follow-up|1
958808|NCT01116440|1955179|FG000|Follow-up|Withdrawal by Subject|0
958809|NCT01116440|1955180|FG001|Follow-up|Withdrawal by Subject|1
958810|NCT01116544|1955195|FG000|Overall Study|Protocol Violation|1
958811|NCT01116544|1955196|FG001|Overall Study|Protocol Violation|0
958812|NCT01116544|1955195|FG000|Overall Study|Withdrawal by Subject|1
958813|NCT01116544|1955196|FG001|Overall Study|Withdrawal by Subject|1
958829|NCT01116687|1955260|FG000|Overall Study|Withdrawal by Subject|4
958830|NCT01116739|1955266|FG000|Overall Study|Child had 2 years of HS|110
958831|NCT01116739|1955267|FG001|Overall Study|Child had 2 years of HS|128
958832|NCT01116739|1955266|FG000|Overall Study|Withdrawal by Subject|6
958833|NCT01116739|1955267|FG001|Overall Study|Withdrawal by Subject|0
958834|NCT01116739|1955266|FG000|Overall Study|child too young|2
958835|NCT01116739|1955267|FG001|Overall Study|child too young|6
958836|NCT01116739|1955266|FG000|Overall Study|child not enrolled in head start|10
958837|NCT01116739|1955267|FG001|Overall Study|child not enrolled in head start|2
958838|NCT01116739|1955266|FG000|Overall Study|enrolled caregiver not legal guardian|2
958839|NCT01116739|1955267|FG001|Overall Study|enrolled caregiver not legal guardian|0
958840|NCT01116882|1955275|FG000|30-day|Lost to Follow-up|50
958841|NCT01116882|1955276|FG001|30-day|Lost to Follow-up|21
958842|NCT01116882|1955275|FG000|30-day|Withdrawal by Subject|2
958843|NCT01116882|1955276|FG001|30-day|Withdrawal by Subject|4
958844|NCT01116882|1955275|FG000|30-day|Other Reasons|16
958845|NCT01116882|1955276|FG001|30-day|Other Reasons|6
958846|NCT01116882|1955275|FG000|12-month|Lost to Follow-up|111
958847|NCT01116882|1955276|FG001|12-month|Lost to Follow-up|42
958848|NCT01116882|1955275|FG000|12-month|Other Reasons|151
958849|NCT01116882|1955276|FG001|12-month|Other Reasons|49
958850|NCT01116882|1955275|FG000|12-month|Withdrawal by Subject|5
958851|NCT01116882|1955276|FG001|12-month|Withdrawal by Subject|8
958852|NCT01117012|1955405|FG000|Overall Study|Adverse Event|0
958853|NCT01117012|1955406|FG001|Overall Study|Adverse Event|1
958854|NCT01117012|1955405|FG000|Overall Study|Death|1
958855|NCT01117012|1955406|FG001|Overall Study|Death|1
958856|NCT01117012|1955405|FG000|Overall Study|Withdrawal by Subject|3
958857|NCT01117012|1955406|FG001|Overall Study|Withdrawal by Subject|0
958858|NCT01117012|1955405|FG000|Overall Study|Undefined|4
958859|NCT01117012|1955406|FG001|Overall Study|Undefined|3
958860|NCT01117051|1955414|FG000|Overall Study|Withdrawal by Subject|5
958861|NCT01117051|1955415|FG001|Overall Study|Withdrawal by Subject|3
958862|NCT01117051|1955414|FG000|Overall Study|Adverse Event|4
958863|NCT01117051|1955415|FG001|Overall Study|Adverse Event|3
958864|NCT01117051|1955414|FG000|Overall Study|Lost to Follow-up|0
958865|NCT01117051|1955415|FG001|Overall Study|Lost to Follow-up|1
958866|NCT01117051|1955414|FG000|Overall Study|Did not meet in-/exclusion criteria|0
958867|NCT01117051|1955415|FG001|Overall Study|Did not meet in-/exclusion criteria|1
958868|NCT01117051|1955414|FG000|Overall Study|Sponsor's decision|3
958869|NCT01117051|1955415|FG001|Overall Study|Sponsor's decision|1
958870|NCT01117051|1955414|FG000|Overall Study|Surgical procedure|0
958871|NCT01117051|1955415|FG001|Overall Study|Surgical procedure|1
958872|NCT01117051|1955414|FG000|Overall Study|Randomized by mistake|0
958873|NCT01117051|1955415|FG001|Overall Study|Randomized by mistake|1
958874|NCT01117051|1955414|FG000|Overall Study|Convenience issue|1
958875|NCT01117051|1955415|FG001|Overall Study|Convenience issue|0
958876|NCT01117181|1955435|FG000|Overall Study|Lost to Follow-up|1
958877|NCT01117181|1955436|FG001|Overall Study|Lost to Follow-up|0
958878|NCT01117181|1955435|FG000|Overall Study|Withdrawal by Subject|0
958879|NCT01117181|1955436|FG001|Overall Study|Withdrawal by Subject|2
958880|NCT01117337|1955453|FG000|Overall Study|Lost to Follow-up|4
958881|NCT01117337|1955454|FG001|Overall Study|Lost to Follow-up|0
958882|NCT01117350|1955462|FG000|Comparative Period|Not Treated|5
958883|NCT01117350|1955463|FG001|Comparative Period|Not Treated|8
958884|NCT01117350|1955462|FG000|Comparative Period|Adverse Event|6
958885|NCT01117350|1955463|FG001|Comparative Period|Adverse Event|33
958886|NCT01117350|1955462|FG000|Comparative Period|Lost to Follow-up|11
958887|NCT01117350|1955463|FG001|Comparative Period|Lost to Follow-up|7
958888|NCT01117350|1955462|FG000|Comparative Period|Withdrawal by Subject|9
958889|NCT01117350|1955463|FG001|Comparative Period|Withdrawal by Subject|13
958890|NCT01117350|1955462|FG000|Comparative Period|Protocol Violation|8
958891|NCT01117350|1955463|FG001|Comparative Period|Protocol Violation|12
958892|NCT01117350|1955462|FG000|Comparative Period|Lack of Efficacy|1
958893|NCT01117350|1955463|FG001|Comparative Period|Lack of Efficacy|0
958894|NCT01117350|1955462|FG000|Comparative Period|Physician Decision|0
958895|NCT01117350|1955463|FG001|Comparative Period|Physician Decision|1
958896|NCT01117350|1955462|FG000|Comparative Period|Move to another city/country|2
958897|NCT01117350|1955463|FG001|Comparative Period|Move to another city/country|1
958898|NCT01117350|1955462|FG000|Extension Period|Not included in extension, not treated|0
958899|NCT01117350|1955463|FG001|Extension Period|Not included in extension, not treated|50
958900|NCT01117350|1955462|FG000|Extension Period|Adverse Event|0
958901|NCT01117350|1955463|FG001|Extension Period|Adverse Event|2
958902|NCT01117350|1955462|FG000|Extension Period|Protocol Violation|0
958903|NCT01117350|1955463|FG001|Extension Period|Protocol Violation|2
958904|NCT01117350|1955462|FG000|Extension Period|Lost to Follow-up|0
958905|NCT01117350|1955463|FG001|Extension Period|Lost to Follow-up|2
958906|NCT01117350|1955462|FG000|Extension Period|Withdrawal by Subject|0
958907|NCT01117350|1955463|FG001|Extension Period|Withdrawal by Subject|3
958908|NCT01117350|1955462|FG000|Extension Period|Lack of Efficacy|0
958909|NCT01117350|1955463|FG001|Extension Period|Lack of Efficacy|2
958910|NCT01117350|1955462|FG000|Extension Period|Inclusion criteria not respected|0
958911|NCT01117350|1955463|FG001|Extension Period|Inclusion criteria not respected|1
958912|NCT01117350|1955462|FG000|Extension Period|Prohibited medication|0
958913|NCT01117350|1955463|FG001|Extension Period|Prohibited medication|1
958914|NCT01117428|1955478|FG000|Overall Study|Lack of Efficacy|1
958915|NCT01117428|1955479|FG001|Overall Study|Lack of Efficacy|0
958916|NCT01117428|1955480|FG002|Overall Study|Lack of Efficacy|0
958917|NCT01117428|1955481|FG003|Overall Study|Lack of Efficacy|0
958918|NCT01117428|1955482|FG004|Overall Study|Lack of Efficacy|0
958919|NCT01117428|1955483|FG005|Overall Study|Lack of Efficacy|0
958920|NCT01117428|1955478|FG000|Overall Study|Adverse Event|4
958921|NCT01117428|1955479|FG001|Overall Study|Adverse Event|0
958922|NCT01117428|1955480|FG002|Overall Study|Adverse Event|0
958923|NCT01117428|1955481|FG003|Overall Study|Adverse Event|0
958924|NCT01117428|1955482|FG004|Overall Study|Adverse Event|1
958925|NCT01117428|1955483|FG005|Overall Study|Adverse Event|2
958926|NCT01117428|1955478|FG000|Overall Study|Death|0
958927|NCT01117428|1955479|FG001|Overall Study|Death|1
958928|NCT01117428|1955480|FG002|Overall Study|Death|2
958929|NCT01117428|1955481|FG003|Overall Study|Death|0
958930|NCT01117428|1955482|FG004|Overall Study|Death|0
958931|NCT01117428|1955483|FG005|Overall Study|Death|1
958932|NCT01117428|1955478|FG000|Overall Study|Physician Decision|0
958933|NCT01117428|1955479|FG001|Overall Study|Physician Decision|1
958934|NCT01117428|1955480|FG002|Overall Study|Physician Decision|0
958935|NCT01117428|1955481|FG003|Overall Study|Physician Decision|0
958936|NCT01117428|1955482|FG004|Overall Study|Physician Decision|0
958937|NCT01117428|1955483|FG005|Overall Study|Physician Decision|0
958938|NCT01117428|1955478|FG000|Overall Study|Withdrawal by Subject|0
958939|NCT01117428|1955479|FG001|Overall Study|Withdrawal by Subject|0
958940|NCT01117428|1955480|FG002|Overall Study|Withdrawal by Subject|1
958941|NCT01117428|1955481|FG003|Overall Study|Withdrawal by Subject|0
958942|NCT01117428|1955482|FG004|Overall Study|Withdrawal by Subject|0
958943|NCT01117428|1955483|FG005|Overall Study|Withdrawal by Subject|0
958944|NCT01117428|1955478|FG000|Overall Study|Progressive disease|15
958945|NCT01117428|1955479|FG001|Overall Study|Progressive disease|27
958946|NCT01117428|1955480|FG002|Overall Study|Progressive disease|10
958947|NCT01117428|1955481|FG003|Overall Study|Progressive disease|12
958948|NCT01117428|1955482|FG004|Overall Study|Progressive disease|16
958949|NCT01117428|1955483|FG005|Overall Study|Progressive disease|17
958950|NCT01117454|1955501|FG000|Overall Study|Pregnancy|0
958951|NCT01117454|1955502|FG001|Overall Study|Pregnancy|1
958952|NCT01117480|1955508|FG000|Overall Study|Protocol Violation|8
958953|NCT01117480|1955508|FG000|Overall Study|Did Not Start Adalimumab Therapy|20
958954|NCT01117623|1955520|FG000|Overall Study|Adverse Event|0
958955|NCT01117623|1955521|FG001|Overall Study|Adverse Event|2
958956|NCT01117623|1955522|FG002|Overall Study|Adverse Event|4
958957|NCT01117623|1955523|FG003|Overall Study|Adverse Event|0
958958|NCT01117623|1955524|FG004|Overall Study|Adverse Event|2
958959|NCT01117623|1955525|FG005|Overall Study|Adverse Event|0
958960|NCT01117623|1955526|FG006|Overall Study|Adverse Event|0
958961|NCT01117623|1955527|FG007|Overall Study|Adverse Event|2
958962|NCT01117623|1955520|FG000|Overall Study|Disease progression, recurrence, relapse|3
958963|NCT01117623|1955521|FG001|Overall Study|Disease progression, recurrence, relapse|6
958964|NCT01117623|1955522|FG002|Overall Study|Disease progression, recurrence, relapse|5
958965|NCT01117623|1955523|FG003|Overall Study|Disease progression, recurrence, relapse|6
958966|NCT01117623|1955524|FG004|Overall Study|Disease progression, recurrence, relapse|8
958967|NCT01117623|1955525|FG005|Overall Study|Disease progression, recurrence, relapse|14
958968|NCT01117623|1955526|FG006|Overall Study|Disease progression, recurrence, relapse|5
958969|NCT01117623|1955527|FG007|Overall Study|Disease progression, recurrence, relapse|22
958970|NCT01117623|1955520|FG000|Overall Study|Withdrawal by Subject|0
958971|NCT01117623|1955521|FG001|Overall Study|Withdrawal by Subject|0
958972|NCT01117623|1955522|FG002|Overall Study|Withdrawal by Subject|2
958973|NCT01117623|1955523|FG003|Overall Study|Withdrawal by Subject|0
958974|NCT01117623|1955524|FG004|Overall Study|Withdrawal by Subject|0
958975|NCT01117623|1955525|FG005|Overall Study|Withdrawal by Subject|1
958976|NCT01117623|1955526|FG006|Overall Study|Withdrawal by Subject|1
958977|NCT01117623|1955527|FG007|Overall Study|Withdrawal by Subject|1
958978|NCT01117623|1955520|FG000|Overall Study|Non-compliance with study medication|0
958979|NCT01117623|1955521|FG001|Overall Study|Non-compliance with study medication|0
958980|NCT01117623|1955522|FG002|Overall Study|Non-compliance with study medication|0
958981|NCT01117623|1955523|FG003|Overall Study|Non-compliance with study medication|0
958982|NCT01117623|1955524|FG004|Overall Study|Non-compliance with study medication|0
958983|NCT01117623|1955525|FG005|Overall Study|Non-compliance with study medication|0
958984|NCT01117623|1955526|FG006|Overall Study|Non-compliance with study medication|0
958985|NCT01117623|1955527|FG007|Overall Study|Non-compliance with study medication|1
958986|NCT01117623|1955520|FG000|Overall Study|Invest. text: completed all planned txs|0
958987|NCT01117623|1955521|FG001|Overall Study|Invest. text: completed all planned txs|0
958988|NCT01117623|1955522|FG002|Overall Study|Invest. text: completed all planned txs|0
958989|NCT01117623|1955523|FG003|Overall Study|Invest. text: completed all planned txs|0
958990|NCT01117623|1955524|FG004|Overall Study|Invest. text: completed all planned txs|0
958991|NCT01117623|1955525|FG005|Overall Study|Invest. text: completed all planned txs|1
958992|NCT01117623|1955526|FG006|Overall Study|Invest. text: completed all planned txs|0
958993|NCT01117623|1955527|FG007|Overall Study|Invest. text: completed all planned txs|0
958994|NCT01117766|1955552|FG000|First Intervention|Adverse Event|0
958995|NCT01117766|1955553|FG001|First Intervention|Adverse Event|1
958996|NCT01117766|1955552|FG000|First Intervention|Protocol Violation|1
958997|NCT01117766|1955553|FG001|First Intervention|Protocol Violation|0
958998|NCT01117766|1955552|FG000|Washout Period|Protocol Violation|0
958999|NCT01117766|1955553|FG001|Washout Period|Protocol Violation|2
959000|NCT01117766|1955552|FG000|Second Intervention|Lost to Follow-up|1
959001|NCT01117766|1955553|FG001|Second Intervention|Lost to Follow-up|0
959002|NCT01117766|1955552|FG000|Second Intervention|Other|1
959003|NCT01117766|1955553|FG001|Second Intervention|Other|2
959004|NCT01117766|1955552|FG000|Second Intervention|Adverse Event|0
959005|NCT01117766|1955553|FG001|Second Intervention|Adverse Event|2
959006|NCT01117766|1955552|FG000|Second Intervention|Withdrawal by Subject|0
959007|NCT01117766|1955553|FG001|Second Intervention|Withdrawal by Subject|1
959008|NCT01117792|1955559|FG000|Overall Study|Death|1
959009|NCT01117792|1955559|FG000|Overall Study|Adverse Event|3
959010|NCT01117857|1955563|FG000|Overall Study|Lost to Follow-up|4
959011|NCT01117857|1955563|FG000|Overall Study|Withdrawal by Subject|4
959012|NCT01117857|1955563|FG000|Overall Study|Physician Decision|1
959013|NCT01117870|1955569|FG000|Overall Study|Inability to place needle|1
959014|NCT01117870|1955570|FG001|Overall Study|Inability to place needle|0
959015|NCT01117987|1955591|FG000|Overall Study|Protocol deviation|0
959016|NCT01117987|1955592|FG001|Overall Study|Protocol deviation|1
959017|NCT01117987|1955591|FG000|Overall Study|Subject no longer requires study drug|1
959018|NCT01117987|1955592|FG001|Overall Study|Subject no longer requires study drug|0
959019|NCT01117987|1955591|FG000|Overall Study|Lost to Follow-up|1
959020|NCT01117987|1955592|FG001|Overall Study|Lost to Follow-up|1
959021|NCT01117987|1955591|FG000|Overall Study|Abnormal test procedure result|2
959022|NCT01117987|1955592|FG001|Overall Study|Abnormal test procedure result|0
959023|NCT01117987|1955591|FG000|Overall Study|Lack of Efficacy|3
959024|NCT01117987|1955592|FG001|Overall Study|Lack of Efficacy|4
959025|NCT01117987|1955591|FG000|Overall Study|Death|5
959026|NCT01117987|1955592|FG001|Overall Study|Death|10
959027|NCT01117987|1955591|FG000|Overall Study|Withdrawal by Subject|5
959028|NCT01117987|1955592|FG001|Overall Study|Withdrawal by Subject|10
959029|NCT01117987|1955591|FG000|Overall Study|Adverse Event|19
959030|NCT01117987|1955592|FG001|Overall Study|Adverse Event|26
959031|NCT01117987|1955591|FG000|Overall Study|Administrative problems|25
959032|NCT01117987|1955592|FG001|Overall Study|Administrative problems|22
959033|NCT01118052|1955598|FG000|Overall Study|Never treated|2
959034|NCT01118117|1955619|FG000|Overall Study|Death|8
959035|NCT01118117|1955620|FG001|Overall Study|Death|0
959036|NCT01118117|1955619|FG000|Overall Study|Lost to Follow-up|6
959037|NCT01118117|1955620|FG001|Overall Study|Lost to Follow-up|0
959038|NCT01118117|1955619|FG000|Overall Study|Missed 12 Month Visit|7
959039|NCT01118117|1955620|FG001|Overall Study|Missed 12 Month Visit|0
959040|NCT01118143|1955628|FG000|Overall Study|Withdrawal by Subject|2
959041|NCT01118143|1955629|FG001|Overall Study|Withdrawal by Subject|5
959042|NCT01118299|1955677|FG000|Overall Study|Death|7
959043|NCT01118299|1955678|FG001|Overall Study|Death|5
959044|NCT01118299|1955677|FG000|Overall Study|Withdrawal by Subject|8
959045|NCT01118299|1955678|FG001|Overall Study|Withdrawal by Subject|8
959046|NCT01118299|1955677|FG000|Overall Study|Lost to Follow-up|2
959047|NCT01118299|1955678|FG001|Overall Study|Lost to Follow-up|1
959048|NCT01118299|1955677|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6
959049|NCT01118299|1955678|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15
959050|NCT01118312|1955685|FG000|Overall Study|Lost to Follow-up|33
959051|NCT01118312|1955686|FG001|Overall Study|Lost to Follow-up|32
959052|NCT01118312|1955685|FG000|Overall Study|Withdrawal by Subject|1
959053|NCT01118312|1955686|FG001|Overall Study|Withdrawal by Subject|3
959054|NCT01118325|1955695|FG000|Overall Study|Adverse Event|1
959055|NCT01118325|1955696|FG001|Overall Study|Adverse Event|0
959056|NCT01118325|1955697|FG002|Overall Study|Adverse Event|1
959057|NCT01118351|1955727|FG000|Overall Study|Adverse Event|3
959058|NCT01118351|1955727|FG000|Overall Study|Withdrawal by Subject|1
959059|NCT01118377|1955731|FG000|Overall Study|Did Not Receive Study Medication|1
959060|NCT01118377|1955731|FG000|Overall Study|Death|38
959061|NCT01118377|1955731|FG000|Overall Study|Failure to Return|3
959062|NCT01118455|1955737|FG000|Baseline [Visits 1 & 2]|Adverse Event|1
959063|NCT01118455|1955738|FG001|Baseline [Visits 1 & 2]|Adverse Event|0
959064|NCT01118520|1955755|FG000|Overall Study|AAA repair|9
959065|NCT01118520|1955756|FG001|Overall Study|AAA repair|7
959066|NCT01118520|1955757|FG002|Overall Study|AAA repair|9
959067|NCT01118520|1955755|FG000|Overall Study|Adverse Event|3
959068|NCT01118520|1955756|FG001|Overall Study|Adverse Event|3
959069|NCT01118520|1955757|FG002|Overall Study|Adverse Event|3
959070|NCT01118520|1955755|FG000|Overall Study|Withdrawal by Subject|8
959071|NCT01118520|1955756|FG001|Overall Study|Withdrawal by Subject|13
959072|NCT01118520|1955757|FG002|Overall Study|Withdrawal by Subject|8
959073|NCT01118663|1955771|FG000|Overall Study|Adverse Event|2
959074|NCT01118663|1955772|FG001|Overall Study|Adverse Event|1
959075|NCT01118663|1955771|FG000|Overall Study|Withdrawal by Subject|0
959076|NCT01118663|1955772|FG001|Overall Study|Withdrawal by Subject|1
959077|NCT01118728|1955808|FG000|Overall Study|Adverse Event|17
959078|NCT01118728|1955808|FG000|Overall Study|Lack of Efficacy|27
959079|NCT01118728|1955808|FG000|Overall Study|Sponsor's decision to discontinue study|172
959080|NCT01118728|1955808|FG000|Overall Study|Withdrawal by Subject|3
959081|NCT01118728|1955808|FG000|Overall Study|Lost to Follow-up|4
959082|NCT01118780|1955825|FG000|Overall Study|Adverse Event|15
959083|NCT01118780|1955826|FG001|Overall Study|Adverse Event|15
959084|NCT01118780|1955825|FG000|Overall Study|Death|1
959085|NCT01118780|1955826|FG001|Overall Study|Death|0
959086|NCT01118780|1955825|FG000|Overall Study|Lack of Efficacy|2
959087|NCT01118780|1955826|FG001|Overall Study|Lack of Efficacy|6
959088|NCT01118780|1955825|FG000|Overall Study|Physician Decision|2
959089|NCT01118780|1955826|FG001|Overall Study|Physician Decision|0
959090|NCT01118780|1955825|FG000|Overall Study|Protocol Violation|3
959091|NCT01118780|1955826|FG001|Overall Study|Protocol Violation|6
959092|NCT01118780|1955825|FG000|Overall Study|Withdrawal by Subject|13
959093|NCT01118780|1955826|FG001|Overall Study|Withdrawal by Subject|8
959094|NCT01118949|1955839|FG000|Overall Study|Adverse Event|5
959095|NCT01118949|1955839|FG000|Overall Study|Withdrawal by Subject|4
959096|NCT01118962|1955843|FG000|Overall Study|Adverse Event|2
959097|NCT01118962|1955843|FG000|Overall Study|Lack of Efficacy|1
959098|NCT01118962|1955843|FG000|Overall Study|Protocol Violation|1
959099|NCT01118962|1955843|FG000|Overall Study|Withdrawal by Subject|4
959100|NCT01118962|1955843|FG000|Overall Study|Pregnancy|1
959101|NCT01118962|1955843|FG000|Overall Study|Non-compliance with Medicinal Product|1
959102|NCT01118975|1955849|FG000|Overall Study|Adverse Event|0
959103|NCT01118975|1955850|FG001|Overall Study|Adverse Event|1
959104|NCT01119001|1955868|FG000|Overall Study|Withdrawal by Subject|2
959105|NCT01119105|1955881|FG000|Overall Study|Withdrawal by Subject|1
959106|NCT01119105|1955882|FG001|Overall Study|Withdrawal by Subject|1
959107|NCT01119105|1955883|FG002|Overall Study|Withdrawal by Subject|1
959108|NCT01119105|1955881|FG000|Overall Study|Lost to Follow-up|0
959109|NCT01119105|1955882|FG001|Overall Study|Lost to Follow-up|2
959110|NCT01119105|1955883|FG002|Overall Study|Lost to Follow-up|5
959111|NCT01119105|1955881|FG000|Overall Study|Adverse Event|1
959112|NCT01119105|1955882|FG001|Overall Study|Adverse Event|0
959113|NCT01119105|1955883|FG002|Overall Study|Adverse Event|1
959114|NCT01119105|1955881|FG000|Overall Study|study drug missed on 2 consecutive days|1
959115|NCT01119105|1955882|FG001|Overall Study|study drug missed on 2 consecutive days|2
959116|NCT01119105|1955883|FG002|Overall Study|study drug missed on 2 consecutive days|1
959117|NCT01119105|1955881|FG000|Overall Study|Other|1
959118|NCT01119105|1955882|FG001|Overall Study|Other|1
959119|NCT01119105|1955883|FG002|Overall Study|Other|0
959120|NCT01119118|1955891|FG000|Overall Study|Adverse Event|1
959121|NCT01119131|1955898|FG000|Overall Study|Adverse Event|1
959122|NCT01119131|1955899|FG001|Overall Study|Adverse Event|1
959123|NCT01119131|1955900|FG002|Overall Study|Adverse Event|1
959124|NCT01119131|1955898|FG000|Overall Study|Non-Compliance|1
959125|NCT01119131|1955899|FG001|Overall Study|Non-Compliance|0
959126|NCT01119131|1955900|FG002|Overall Study|Non-Compliance|4
959127|NCT01119131|1955898|FG000|Overall Study|Physician Decision|0
959128|NCT01119131|1955899|FG001|Overall Study|Physician Decision|0
959129|NCT01119131|1955900|FG002|Overall Study|Physician Decision|1
959130|NCT01119248|1955924|FG000|Overall Study|Physician Decision|5
959131|NCT01119287|1955935|FG000|Overall Study|Patient Decision, not related to AE|0
959132|NCT01119287|1955936|FG001|Overall Study|Patient Decision, not related to AE|0
959133|NCT01119287|1955937|FG002|Overall Study|Patient Decision, not related to AE|2
959134|NCT01119287|1955938|FG003|Overall Study|Patient Decision, not related to AE|2
959135|NCT01119287|1955939|FG004|Overall Study|Patient Decision, not related to AE|1
959136|NCT01119287|1955940|FG005|Overall Study|Patient Decision, not related to AE|0
959137|NCT01119443|1955954|FG000|Crossover Period 1 (5 Days)|Adverse Event|0
959138|NCT01119443|1955955|FG001|Crossover Period 1 (5 Days)|Adverse Event|1
959139|NCT01119508|1956004|FG000|Overall Study|Adverse Event|56
959140|NCT01119508|1956004|FG000|Overall Study|Withdrawal by Subject|2
959141|NCT01119508|1956004|FG000|Overall Study|Died before tumor response evaluation|1
959142|NCT01119625|1956010|FG000|Overall Study|Lost to Follow-up|1
959143|NCT01119625|1956011|FG001|Overall Study|Lost to Follow-up|2
959144|NCT01119625|1956010|FG000|Overall Study|Withdrawal by Subject|2
959145|NCT01119625|1956011|FG001|Overall Study|Withdrawal by Subject|1
959146|NCT01119625|1956010|FG000|Overall Study|Other|0
959147|NCT01119625|1956011|FG001|Overall Study|Other|1
959148|NCT01119703|1956019|FG000|Overall Study|Adverse Event|0
959149|NCT01119703|1956020|FG001|Overall Study|Adverse Event|1
959150|NCT01119768|1956039|FG000|Treatment Period|Lack of Efficacy|18
959151|NCT01119768|1956040|FG001|Treatment Period|Lack of Efficacy|25
959152|NCT01119846|1956053|FG000|Overall Study|Adverse Event|1
959153|NCT01119846|1956054|FG001|Overall Study|Adverse Event|0
959154|NCT01119846|1956055|FG002|Overall Study|Adverse Event|6
959155|NCT01119846|1956053|FG000|Overall Study|Physician Decision|1
959156|NCT01119846|1956054|FG001|Overall Study|Physician Decision|0
959157|NCT01119846|1956055|FG002|Overall Study|Physician Decision|0
959158|NCT01119846|1956053|FG000|Overall Study|Protocol Violation|0
959159|NCT01119846|1956054|FG001|Overall Study|Protocol Violation|0
959160|NCT01119846|1956055|FG002|Overall Study|Protocol Violation|1
959161|NCT01119846|1956053|FG000|Overall Study|Withdrawal by Subject|0
959162|NCT01119846|1956054|FG001|Overall Study|Withdrawal by Subject|0
959163|NCT01119846|1956055|FG002|Overall Study|Withdrawal by Subject|4
959164|NCT01119859|1956092|FG000|Overall Study|Adverse Event|9
959165|NCT01119859|1956093|FG001|Overall Study|Adverse Event|10
959166|NCT01119859|1956092|FG000|Overall Study|Death|2
959167|NCT01119859|1956093|FG001|Overall Study|Death|0
959168|NCT01119859|1956092|FG000|Overall Study|Insufficient therapeutic response|7
959169|NCT01119859|1956093|FG001|Overall Study|Insufficient therapeutic response|14
959170|NCT01119859|1956092|FG000|Overall Study|Refused treatment|3
959171|NCT01119859|1956093|FG001|Overall Study|Refused treatment|6
959172|NCT01119859|1956092|FG000|Overall Study|Failure to return|3
959173|NCT01119859|1956093|FG001|Overall Study|Failure to return|0
959174|NCT01119898|1956101|FG000|Overall Study|Adverse Event|4
959175|NCT01119898|1956102|FG001|Overall Study|Adverse Event|5
959176|NCT01119898|1956101|FG000|Overall Study|Withdrawal by Subject|1
959177|NCT01119898|1956102|FG001|Overall Study|Withdrawal by Subject|4
959178|NCT01119898|1956101|FG000|Overall Study|Lack of Efficacy|0
959179|NCT01119898|1956102|FG001|Overall Study|Lack of Efficacy|2
959180|NCT01119898|1956101|FG000|Overall Study|Protocol Violation|1
959181|NCT01119898|1956102|FG001|Overall Study|Protocol Violation|1
959182|NCT01119898|1956101|FG000|Overall Study|Medical procedure|1
959183|NCT01119898|1956102|FG001|Overall Study|Medical procedure|0
959184|NCT01119898|1956101|FG000|Overall Study|Randomized in error did not participate|1
959185|NCT01119898|1956102|FG001|Overall Study|Randomized in error did not participate|0
959186|NCT01119937|1956110|FG000|Overall Study|Adverse Event|11
959187|NCT01119937|1956111|FG001|Overall Study|Adverse Event|5
959188|NCT01119937|1956110|FG000|Overall Study|Protocol deviation|3
959189|NCT01119937|1956111|FG001|Overall Study|Protocol deviation|1
959190|NCT01119937|1956110|FG000|Overall Study|Unsatisfactory therapeutic effect|3
959191|NCT01119937|1956111|FG001|Overall Study|Unsatisfactory therapeutic effect|0
959192|NCT01119937|1956110|FG000|Overall Study|Withdrawal by Subject|2
959193|NCT01119937|1956111|FG001|Overall Study|Withdrawal by Subject|1
959194|NCT01119950|1956117|FG000|Overall Study|Adverse Event|25
959195|NCT01119950|1956117|FG000|Overall Study|Withdrawal by Subject|9
959196|NCT01119950|1956117|FG000|Overall Study|Protocol Violation|5
959197|NCT01119950|1956117|FG000|Overall Study|Lost to Follow-up|4
959198|NCT01119950|1956117|FG000|Overall Study|Administrative|2
959199|NCT01119950|1956117|FG000|Overall Study|Abnormal lab value|1
959200|NCT01119950|1956117|FG000|Overall Study|Death|1
959201|NCT01119963|1956145|FG000|Overall Study|Lost to Follow-up|1
959202|NCT01119963|1956146|FG001|Overall Study|Lost to Follow-up|1
959203|NCT01120028|1956158|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
959204|NCT01120028|1956159|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
959205|NCT01120028|1956160|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
959206|NCT01120028|1956161|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
959207|NCT01120028|1956158|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
959208|NCT01120028|1956159|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
959209|NCT01120028|1956160|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
959210|NCT01120028|1956161|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
959211|NCT01120067|1956174|FG000|Overall Study|Lost to Follow-up|3
959212|NCT01120067|1956175|FG001|Overall Study|Lost to Follow-up|1
959213|NCT01120067|1956174|FG000|Overall Study|fail to engage >3 sessions|2
959214|NCT01120067|1956175|FG001|Overall Study|fail to engage >3 sessions|0
959215|NCT01120093|1956181|FG000|Treatment Period 1|Adverse Event|0
959216|NCT01120093|1956182|FG001|Treatment Period 1|Adverse Event|0
959217|NCT01120093|1956183|FG002|Treatment Period 1|Adverse Event|1
959218|NCT01120093|1956184|FG003|Treatment Period 1|Adverse Event|0
959219|NCT01120093|1956185|FG004|Treatment Period 1|Adverse Event|1
959220|NCT01120093|1956181|FG000|Treatment Period 1|Withdrawal by Subject|0
959221|NCT01120093|1956182|FG001|Treatment Period 1|Withdrawal by Subject|1
959222|NCT01120093|1956183|FG002|Treatment Period 1|Withdrawal by Subject|0
959223|NCT01120093|1956184|FG003|Treatment Period 1|Withdrawal by Subject|0
959224|NCT01120093|1956185|FG004|Treatment Period 1|Withdrawal by Subject|0
959225|NCT01120093|1956181|FG000|Treatment Period 2|Adverse Event|0
959226|NCT01120093|1956182|FG001|Treatment Period 2|Adverse Event|0
959227|NCT01120093|1956183|FG002|Treatment Period 2|Adverse Event|0
959228|NCT01120093|1956184|FG003|Treatment Period 2|Adverse Event|1
959229|NCT01120093|1956185|FG004|Treatment Period 2|Adverse Event|0
959230|NCT01120093|1956181|FG000|Treatment Period 2|Withdrawal by Subject|0
959231|NCT01120093|1956182|FG001|Treatment Period 2|Withdrawal by Subject|0
959232|NCT01120093|1956183|FG002|Treatment Period 2|Withdrawal by Subject|0
959233|NCT01120093|1956184|FG003|Treatment Period 2|Withdrawal by Subject|0
959234|NCT01120093|1956185|FG004|Treatment Period 2|Withdrawal by Subject|1
959235|NCT01120093|1956181|FG000|Treatment Period 3|Lack of Efficacy|0
959236|NCT01120093|1956182|FG001|Treatment Period 3|Lack of Efficacy|0
959237|NCT01120093|1956183|FG002|Treatment Period 3|Lack of Efficacy|0
959238|NCT01120093|1956184|FG003|Treatment Period 3|Lack of Efficacy|1
959239|NCT01120093|1956185|FG004|Treatment Period 3|Lack of Efficacy|0
959240|NCT01120093|1956181|FG000|Treatment Period 3|Adverse Event|0
959241|NCT01120093|1956182|FG001|Treatment Period 3|Adverse Event|0
959242|NCT01120093|1956183|FG002|Treatment Period 3|Adverse Event|0
959243|NCT01120093|1956184|FG003|Treatment Period 3|Adverse Event|0
959244|NCT01120093|1956185|FG004|Treatment Period 3|Adverse Event|1
959245|NCT01120093|1956181|FG000|Treatment Period 3|Withdrawal by Subject|0
959246|NCT01120093|1956182|FG001|Treatment Period 3|Withdrawal by Subject|0
959247|NCT01120093|1956183|FG002|Treatment Period 3|Withdrawal by Subject|1
959248|NCT01120093|1956184|FG003|Treatment Period 3|Withdrawal by Subject|0
959249|NCT01120093|1956185|FG004|Treatment Period 3|Withdrawal by Subject|0
959250|NCT01120093|1956181|FG000|Treatment Period 4|Adverse Event|1
959251|NCT01120093|1956182|FG001|Treatment Period 4|Adverse Event|0
959252|NCT01120093|1956183|FG002|Treatment Period 4|Adverse Event|0
959253|NCT01120093|1956184|FG003|Treatment Period 4|Adverse Event|0
959254|NCT01120093|1956185|FG004|Treatment Period 4|Adverse Event|0
959255|NCT01120093|1956181|FG000|Treatment Period 5|Adverse Event|0
959256|NCT01120093|1956182|FG001|Treatment Period 5|Adverse Event|1
959257|NCT01120093|1956183|FG002|Treatment Period 5|Adverse Event|0
959258|NCT01120093|1956184|FG003|Treatment Period 5|Adverse Event|1
959259|NCT01120093|1956185|FG004|Treatment Period 5|Adverse Event|0
959260|NCT01120184|1956200|FG000|Overall Study|Adverse Event|0
959261|NCT01120184|1956201|FG001|Overall Study|Adverse Event|1
959262|NCT01120184|1956202|FG002|Overall Study|Adverse Event|0
959263|NCT01120184|1956200|FG000|Overall Study|Lost to Follow-up|13
959264|NCT01120184|1956201|FG001|Overall Study|Lost to Follow-up|13
959265|NCT01120184|1956202|FG002|Overall Study|Lost to Follow-up|11
959266|NCT01120184|1956200|FG000|Overall Study|Physician Decision|9
959267|NCT01120184|1956201|FG001|Overall Study|Physician Decision|1
959268|NCT01120184|1956202|FG002|Overall Study|Physician Decision|3
959269|NCT01120184|1956200|FG000|Overall Study|Reason not Specified|8
959270|NCT01120184|1956201|FG001|Overall Study|Reason not Specified|3
959271|NCT01120184|1956202|FG002|Overall Study|Reason not Specified|12
959272|NCT01120184|1956200|FG000|Overall Study|Sponsor Decision to Terminate Study|133
959273|NCT01120184|1956201|FG001|Overall Study|Sponsor Decision to Terminate Study|144
959274|NCT01120184|1956202|FG002|Overall Study|Sponsor Decision to Terminate Study|143
959275|NCT01120184|1956200|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32
959276|NCT01120184|1956201|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29
959277|NCT01120184|1956202|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25
959278|NCT01120184|1956200|FG000|Overall Study|Death|170
959279|NCT01120184|1956201|FG001|Overall Study|Death|176
959280|NCT01120184|1956202|FG002|Overall Study|Death|169
959281|NCT01120210|1956222|FG000|MAIN INFUSION|Adverse Event|1
959282|NCT01120210|1956223|FG001|MAIN INFUSION|Adverse Event|0
959283|NCT01120210|1956222|FG000|MAIN INFUSION|Withdrawal by Subject|0
959284|NCT01120210|1956223|FG001|MAIN INFUSION|Withdrawal by Subject|1
959285|NCT01120275|1956250|FG000|Overall Study|Adverse Event|3
959286|NCT01120275|1956250|FG000|Overall Study|Progression|27
959287|NCT01120275|1956250|FG000|Overall Study|Ineligible|3
959288|NCT01120275|1956250|FG000|Overall Study|Withdrawal by Subject|1
959289|NCT01120275|1956250|FG000|Overall Study|Refusal|1
959290|NCT01120275|1956250|FG000|Overall Study|Not specific|1
959291|NCT01120379|1956255|FG000|One Year Timepoint|Withdrawal by Subject|41
959292|NCT01120379|1956255|FG000|One Year Timepoint|Lost to Follow-up|115
959293|NCT01120379|1956255|FG000|One Year Timepoint|Death|108
959294|NCT01120379|1956255|FG000|One Year Timepoint|Physician Decision|9
959295|NCT01120379|1956255|FG000|One Year Timepoint|Any other reason for early termination|5
959296|NCT01120379|1956255|FG000|Two Year Timepoint|Withdrawal by Subject|11
959297|NCT01120379|1956255|FG000|Two Year Timepoint|Lost to Follow-up|87
959298|NCT01120379|1956255|FG000|Two Year Timepoint|Death|123
959299|NCT01120379|1956255|FG000|Two Year Timepoint|Physician Decision|12
959300|NCT01120379|1956255|FG000|Two Year Timepoint|Any other reason for early termination|4
959301|NCT01120379|1956255|FG000|Three Year Timepoint|Withdrawal by Subject|25
959302|NCT01120379|1956255|FG000|Three Year Timepoint|Lost to Follow-up|43
959303|NCT01120379|1956255|FG000|Three Year Timepoint|Death|120
959304|NCT01120379|1956255|FG000|Three Year Timepoint|Physician Decision|9
959305|NCT01120379|1956255|FG000|Three Year Timepoint|Any other reason for early termination|17
959306|NCT01120379|1956255|FG000|Four Year Timepoint|Withdrawal by Subject|5
959307|NCT01120379|1956255|FG000|Four Year Timepoint|Lost to Follow-up|10
959308|NCT01120379|1956255|FG000|Four Year Timepoint|Death|131
959309|NCT01120379|1956255|FG000|Four Year Timepoint|Physician Decision|5
959310|NCT01120379|1956255|FG000|Four Year Timepoint|Any other reason for early termination|217
959311|NCT01120600|1956272|FG000|Overall Study|Adverse Event|7
959312|NCT01120600|1956273|FG001|Overall Study|Adverse Event|7
959313|NCT01120600|1956272|FG000|Overall Study|Excessive Bone Loss|0
959314|NCT01120600|1956273|FG001|Overall Study|Excessive Bone Loss|4
959315|NCT01120600|1956272|FG000|Overall Study|Lost to Follow-up|1
959316|NCT01120600|1956273|FG001|Overall Study|Lost to Follow-up|3
959317|NCT01120600|1956272|FG000|Overall Study|Physician Decision|1
959318|NCT01120600|1956273|FG001|Overall Study|Physician Decision|3
959319|NCT01120600|1956272|FG000|Overall Study|Protocol Violation|0
959320|NCT01120600|1956273|FG001|Overall Study|Protocol Violation|4
959321|NCT01120600|1956272|FG000|Overall Study|Withdrawal by Subject|10
959322|NCT01120600|1956273|FG001|Overall Study|Withdrawal by Subject|11
959323|NCT01120626|1956281|FG000|Overall Study|Withdrawal by Subject|1
959324|NCT01120626|1956282|FG001|Overall Study|Withdrawal by Subject|0
959325|NCT01120691|1956308|FG000|Overall Study|Adverse Event|59
959326|NCT01120691|1956309|FG001|Overall Study|Adverse Event|67
959327|NCT01120691|1956310|FG002|Overall Study|Adverse Event|47
959328|NCT01120691|1956308|FG000|Overall Study|Subject withdrew consent|33
959329|NCT01120691|1956309|FG001|Overall Study|Subject withdrew consent|50
959330|NCT01120691|1956310|FG002|Overall Study|Subject withdrew consent|44
959331|NCT01120691|1956308|FG000|Overall Study|Death|21
959332|NCT01120691|1956309|FG001|Overall Study|Death|22
959333|NCT01120691|1956310|FG002|Overall Study|Death|24
959334|NCT01120691|1956308|FG000|Overall Study|Unsatisfactory therapeutic effect|18
959335|NCT01120691|1956309|FG001|Overall Study|Unsatisfactory therapeutic effect|32
959336|NCT01120691|1956310|FG002|Overall Study|Unsatisfactory therapeutic effect|38
959337|NCT01120691|1956308|FG000|Overall Study|Administrative problems|15
959338|NCT01120691|1956309|FG001|Overall Study|Administrative problems|8
959339|NCT01120691|1956310|FG002|Overall Study|Administrative problems|9
959340|NCT01120691|1956308|FG000|Overall Study|Protocol deviation|13
959341|NCT01120691|1956309|FG001|Overall Study|Protocol deviation|12
959342|NCT01120691|1956310|FG002|Overall Study|Protocol deviation|12
959343|NCT01120691|1956308|FG000|Overall Study|Lost to Follow-up|5
959344|NCT01120691|1956309|FG001|Overall Study|Lost to Follow-up|6
959345|NCT01120691|1956310|FG002|Overall Study|Lost to Follow-up|4
959346|NCT01120691|1956308|FG000|Overall Study|Abnormal test procedure result(s)|3
959347|NCT01120691|1956309|FG001|Overall Study|Abnormal test procedure result(s)|2
959348|NCT01120691|1956310|FG002|Overall Study|Abnormal test procedure result(s)|1
959349|NCT01120691|1956308|FG000|Overall Study|Patient's inability to use the device|3
959350|NCT01120691|1956309|FG001|Overall Study|Patient's inability to use the device|1
959351|NCT01120691|1956310|FG002|Overall Study|Patient's inability to use the device|0
959352|NCT01120691|1956308|FG000|Overall Study|Abnormal laboratory value(s)|1
959353|NCT01120691|1956309|FG001|Overall Study|Abnormal laboratory value(s)|3
959354|NCT01120691|1956310|FG002|Overall Study|Abnormal laboratory value(s)|4
959355|NCT01120717|1956401|FG000|Overall Study|Withdrawal by Subject|11
959356|NCT01120717|1956402|FG001|Overall Study|Withdrawal by Subject|6
959357|NCT01120717|1956401|FG000|Overall Study|Adverse Event|10
959358|NCT01120717|1956402|FG001|Overall Study|Adverse Event|6
959359|NCT01120717|1956401|FG000|Overall Study|Protocol Deviation|2
959360|NCT01120717|1956402|FG001|Overall Study|Protocol Deviation|5
959361|NCT01120717|1956401|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
959362|NCT01120717|1956402|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
959363|NCT01120717|1956401|FG000|Overall Study|Lost to Follow-up|2
959364|NCT01120717|1956402|FG001|Overall Study|Lost to Follow-up|3
959365|NCT01120717|1956401|FG000|Overall Study|Death|3
959366|NCT01120717|1956402|FG001|Overall Study|Death|1
959367|NCT01120717|1956401|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
959368|NCT01120717|1956402|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
959369|NCT01120756|1956410|FG000|Overall Study|Withdrawal by Subject|1
959370|NCT01120756|1956411|FG001|Overall Study|Withdrawal by Subject|1
959371|NCT01120782|1956417|FG000|Overall Study|Test article shipping error|11
959372|NCT01120899|1956429|FG000|Overall Study|Withdrawal by Subject|3
959373|NCT01121146|1956439|FG000|Overall Study|Death|17
959374|NCT01121146|1956440|FG001|Overall Study|Death|15
959375|NCT01121146|1956439|FG000|Overall Study|Adverse Event|2
959376|NCT01121146|1956440|FG001|Overall Study|Adverse Event|11
959377|NCT01121146|1956439|FG000|Overall Study|Lost to Follow-up|7
959378|NCT01121146|1956440|FG001|Overall Study|Lost to Follow-up|16
959379|NCT01121185|1956459|FG000|Overall Study|Not infused|0
959380|NCT01121185|1956460|FG001|Overall Study|Not infused|1
959381|NCT01121185|1956459|FG000|Overall Study|Not transplanted|1
959382|NCT01121185|1956460|FG001|Overall Study|Not transplanted|0
959383|NCT01121263|1956501|FG000|Overall Study|Death|3
959384|NCT01121263|1956502|FG001|Overall Study|Death|2
959385|NCT01121263|1956501|FG000|Overall Study|Lost to Follow-up|22
959386|NCT01121263|1956502|FG001|Overall Study|Lost to Follow-up|12
959387|NCT01121263|1956501|FG000|Overall Study|Withdrawal by Subject|0
959388|NCT01121263|1956502|FG001|Overall Study|Withdrawal by Subject|1
959389|NCT01121393|1956512|FG000|Overall Study|Progressive disease|201
959390|NCT01121393|1956513|FG001|Overall Study|Progressive disease|20
959391|NCT01121393|1956512|FG000|Overall Study|Other Adverse events|24
959392|NCT01121393|1956513|FG001|Overall Study|Other Adverse events|45
959393|NCT01121393|1956512|FG000|Overall Study|Non-compliant with protocol|0
959394|NCT01121393|1956513|FG001|Overall Study|Non-compliant with protocol|3
959395|NCT01121393|1956512|FG000|Overall Study|Lost to Follow-up|1
959396|NCT01121393|1956513|FG001|Overall Study|Lost to Follow-up|0
959397|NCT01121393|1956512|FG000|Overall Study|Refused cont. medication|7
959398|NCT01121393|1956513|FG001|Overall Study|Refused cont. medication|7
959399|NCT01121393|1956512|FG000|Overall Study|Not treated|3
959400|NCT01121393|1956513|FG001|Overall Study|Not treated|9
959401|NCT01121393|1956512|FG000|Overall Study|Other than listed|6
959402|NCT01121393|1956513|FG001|Overall Study|Other than listed|0
959403|NCT01121406|1956527|FG000|Overall Study|Progressive disease RECIST|44
959404|NCT01121406|1956528|FG001|Overall Study|Progressive disease RECIST|28
959405|NCT01121406|1956527|FG000|Overall Study|Wors. or AE of underlying cancer disease|4
959406|NCT01121406|1956528|FG001|Overall Study|Wors. or AE of underlying cancer disease|6
959407|NCT01121406|1956527|FG000|Overall Study|Other AE|3
959408|NCT01121406|1956528|FG001|Overall Study|Other AE|10
959409|NCT01121406|1956527|FG000|Overall Study|Non-compliant with protocol|0
959410|NCT01121406|1956528|FG001|Overall Study|Non-compliant with protocol|2
959411|NCT01121406|1956527|FG000|Overall Study|Lost to Follow-up|0
959412|NCT01121406|1956528|FG001|Overall Study|Lost to Follow-up|1
959413|NCT01121406|1956527|FG000|Overall Study|Refused continuation of study med.|1
959414|NCT01121406|1956528|FG001|Overall Study|Refused continuation of study med.|2
959415|NCT01121406|1956527|FG000|Overall Study|Reason other than specified above|2
959416|NCT01121406|1956528|FG001|Overall Study|Reason other than specified above|6
959417|NCT01121406|1956527|FG000|Overall Study|Not treated|1
959418|NCT01121406|1956528|FG001|Overall Study|Not treated|0
959419|NCT01121484|1956539|FG000|Overall Study|Adverse Event|12
959420|NCT01121484|1956540|FG001|Overall Study|Adverse Event|5
959421|NCT01121484|1956539|FG000|Overall Study|Lack of Efficacy|3
959422|NCT01121484|1956540|FG001|Overall Study|Lack of Efficacy|11
959423|NCT01121484|1956539|FG000|Overall Study|Lost to Follow-up|5
959424|NCT01121484|1956540|FG001|Overall Study|Lost to Follow-up|9
959425|NCT01121484|1956539|FG000|Overall Study|Physician Decision|0
959426|NCT01121484|1956540|FG001|Overall Study|Physician Decision|3
959427|NCT01121484|1956539|FG000|Overall Study|Protocol Violation|1
959428|NCT01121484|1956540|FG001|Overall Study|Protocol Violation|0
959429|NCT01121484|1956539|FG000|Overall Study|Withdrawal by Subject|8
959430|NCT01121484|1956540|FG001|Overall Study|Withdrawal by Subject|7
959431|NCT01121484|1956539|FG000|Overall Study|Discontinuation of study by sponsor|0
959432|NCT01121484|1956540|FG001|Overall Study|Discontinuation of study by sponsor|1
959433|NCT01121484|1956539|FG000|Overall Study|Other|3
959434|NCT01121484|1956540|FG001|Overall Study|Other|3
959435|NCT01121484|1956539|FG000|Overall Study|Randomized, not treated|1
959436|NCT01121484|1956540|FG001|Overall Study|Randomized, not treated|4
959437|NCT01121536|1956546|FG000|Overall Study|Adverse Event|63
959438|NCT01121536|1956546|FG000|Overall Study|Lack of Efficacy|35
959439|NCT01121536|1956546|FG000|Overall Study|Withdrawal by Subject|65
959440|NCT01121536|1956546|FG000|Overall Study|Protocol Violation|20
959441|NCT01121536|1956546|FG000|Overall Study|Noncompliance with study medication|12
959442|NCT01121536|1956546|FG000|Overall Study|Noncompliance with study procedures|9
959443|NCT01121536|1956546|FG000|Overall Study|Lost to Follow-up|39
959444|NCT01121536|1956546|FG000|Overall Study|Other|118
959445|NCT01121549|1956550|FG000|Overall Study|Adverse Event|10
959446|NCT01121549|1956550|FG000|Overall Study|Lack of Efficacy|11
959447|NCT01121549|1956550|FG000|Overall Study|Lost to Follow-up|12
959448|NCT01121549|1956550|FG000|Overall Study|Did not meet entrance criteria|9
959449|NCT01121549|1956550|FG000|Overall Study|Study terminated by sponsor|197
959450|NCT01121549|1956550|FG000|Overall Study|Pregnancy|1
959451|NCT01121549|1956550|FG000|Overall Study|Protocol Violation|33
959452|NCT01121549|1956550|FG000|Overall Study|Withdrawal by Subject|16
959453|NCT01121549|1956550|FG000|Overall Study|Other|58
959454|NCT01121562|1956554|FG000|Overall Study|Objective progression or relapse|8
959455|NCT01121562|1956554|FG000|Overall Study|Withdrawal by Subject|1
959456|NCT01121562|1956554|FG000|Overall Study|Adverse Event|1
959457|NCT01121562|1956554|FG000|Overall Study|Sponsor Decision|1
959458|NCT01121562|1956554|FG000|Overall Study|Met study discontinuation criteria|1
959459|NCT01121575|1956564|FG000|Overall Study|Participant Refused Further Follow-Up|0
959460|NCT01121575|1956565|FG001|Overall Study|Participant Refused Further Follow-Up|0
959461|NCT01121575|1956566|FG002|Overall Study|Participant Refused Further Follow-Up|0
959462|NCT01121575|1956567|FG003|Overall Study|Participant Refused Further Follow-Up|0
959463|NCT01121575|1956568|FG004|Overall Study|Participant Refused Further Follow-Up|5
959464|NCT01121575|1956569|FG005|Overall Study|Participant Refused Further Follow-Up|1
959465|NCT01121575|1956564|FG000|Overall Study|Unspecified Reasons|8
959466|NCT01121575|1956565|FG001|Overall Study|Unspecified Reasons|6
959467|NCT01121575|1956566|FG002|Overall Study|Unspecified Reasons|7
959468|NCT01121575|1956567|FG003|Overall Study|Unspecified Reasons|5
959469|NCT01121575|1956568|FG004|Overall Study|Unspecified Reasons|13
959470|NCT01121575|1956569|FG005|Overall Study|Unspecified Reasons|10
959471|NCT01121575|1956564|FG000|Overall Study|Death|6
959472|NCT01121575|1956565|FG001|Overall Study|Death|0
959473|NCT01121575|1956566|FG002|Overall Study|Death|0
959474|NCT01121575|1956567|FG003|Overall Study|Death|1
959475|NCT01121575|1956568|FG004|Overall Study|Death|7
959476|NCT01121575|1956569|FG005|Overall Study|Death|1
959477|NCT01121666|1956590|FG000|Overall Study|Protocol Violation|29
959478|NCT01121666|1956591|FG001|Overall Study|Protocol Violation|10
959479|NCT01121757|1956599|FG000|First Drug|Death|1
959480|NCT01121757|1956600|FG001|First Drug|Death|0
959481|NCT01121757|1956599|FG000|First Drug|Disease Progression|0
959482|NCT01121757|1956600|FG001|First Drug|Disease Progression|2
959483|NCT01121757|1956599|FG000|Combination|Physician Decision|0
959484|NCT01121757|1956600|FG001|Combination|Physician Decision|1
959485|NCT01121757|1956599|FG000|Combination|Disease Progression|2
959486|NCT01121757|1956600|FG001|Combination|Disease Progression|0
959487|NCT01121900|1956608|FG000|First Intervention Period|Adverse Event|1
959488|NCT01121900|1956609|FG001|First Intervention Period|Adverse Event|1
959489|NCT01121900|1956608|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
959490|NCT01121900|1956609|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
959491|NCT01121913|1956615|FG000|First Intervention Period|Adverse Event|0
959492|NCT01121913|1956616|FG001|First Intervention Period|Adverse Event|0
959493|NCT01121913|1956617|FG002|First Intervention Period|Adverse Event|1
959494|NCT01121913|1956618|FG003|First Intervention Period|Adverse Event|0
959495|NCT01121913|1956615|FG000|First Washout Period|Withdrawal by Subject|1
959496|NCT01121913|1956616|FG001|First Washout Period|Withdrawal by Subject|0
959497|NCT01121913|1956617|FG002|First Washout Period|Withdrawal by Subject|0
959498|NCT01121913|1956618|FG003|First Washout Period|Withdrawal by Subject|0
959499|NCT01121913|1956615|FG000|Second Intervention Period|Adverse Event|0
959500|NCT01121913|1956616|FG001|Second Intervention Period|Adverse Event|0
959501|NCT01121913|1956617|FG002|Second Intervention Period|Adverse Event|1
959502|NCT01121913|1956618|FG003|Second Intervention Period|Adverse Event|0
959503|NCT01121913|1956615|FG000|Second Washout Period|Withdrawal by Subject|0
959504|NCT01121913|1956616|FG001|Second Washout Period|Withdrawal by Subject|0
959505|NCT01121913|1956617|FG002|Second Washout Period|Withdrawal by Subject|1
959506|NCT01121913|1956618|FG003|Second Washout Period|Withdrawal by Subject|0
959507|NCT01121913|1956615|FG000|Third Washout Period|Adverse Event|1
959508|NCT01121913|1956616|FG001|Third Washout Period|Adverse Event|0
959509|NCT01121913|1956617|FG002|Third Washout Period|Adverse Event|0
959510|NCT01121913|1956618|FG003|Third Washout Period|Adverse Event|0
959511|NCT01121926|1956628|FG000|First Intervention Period|Adverse Event|1
959512|NCT01121926|1956629|FG001|First Intervention Period|Adverse Event|0
959513|NCT01121926|1956628|FG000|Washout Period|Adverse Event|0
959514|NCT01121926|1956629|FG001|Washout Period|Adverse Event|1
959515|NCT01121926|1956628|FG000|Washout Period|Positive pregnancy test|0
959516|NCT01121926|1956629|FG001|Washout Period|Positive pregnancy test|1
959517|NCT01121991|1956642|FG000|Overall Study|Lack of Ovarian Response|2
959518|NCT01121991|1956642|FG000|Overall Study|No Oocytes Retrieved|3
959519|NCT01121991|1956642|FG000|Overall Study|No Fertilization|1
959520|NCT01122173|1956697|FG000|Overall Study|Lost to Follow-up|3
959521|NCT01122173|1956697|FG000|Overall Study|Withdrawal by Subject|3
959522|NCT01122173|1956697|FG000|Overall Study|Left study for other reasons|3
959523|NCT01122264|1956750|FG000|Overall Study|Adverse Event|6
959524|NCT01122264|1956751|FG001|Overall Study|Adverse Event|5
959525|NCT01122264|1956752|FG002|Overall Study|Adverse Event|7
959526|NCT01122264|1956750|FG000|Overall Study|Death|1
959527|NCT01122264|1956751|FG001|Overall Study|Death|0
959528|NCT01122264|1956752|FG002|Overall Study|Death|0
959529|NCT01122264|1956750|FG000|Overall Study|Lost to Follow-up|5
959530|NCT01122264|1956751|FG001|Overall Study|Lost to Follow-up|9
959531|NCT01122264|1956752|FG002|Overall Study|Lost to Follow-up|13
959532|NCT01122264|1956750|FG000|Overall Study|Entry Criteria Not Met|1
959533|NCT01122264|1956751|FG001|Overall Study|Entry Criteria Not Met|0
959534|NCT01122264|1956752|FG002|Overall Study|Entry Criteria Not Met|0
959535|NCT01122264|1956750|FG000|Overall Study|Protocol Violation|7
959536|NCT01122264|1956751|FG001|Overall Study|Protocol Violation|7
959537|NCT01122264|1956752|FG002|Overall Study|Protocol Violation|9
911021|NCT00796367|1888165|FG001|Overall Study|Lack of Efficacy|1
911022|NCT00796367|1888166|FG002|Overall Study|Lack of Efficacy|0
911023|NCT00796367|1888164|FG000|Overall Study|non compliance|3
911024|NCT00796367|1888165|FG001|Overall Study|non compliance|1
911025|NCT00796367|1888166|FG002|Overall Study|non compliance|1
911026|NCT00796367|1888164|FG000|Overall Study|Pregnancy|1
911027|NCT00796367|1888165|FG001|Overall Study|Pregnancy|0
911028|NCT00796367|1888166|FG002|Overall Study|Pregnancy|1
911029|NCT00796367|1888164|FG000|Overall Study|Requirement for restricted medication|2
911030|NCT00796367|1888165|FG001|Overall Study|Requirement for restricted medication|0
911031|NCT00796367|1888166|FG002|Overall Study|Requirement for restricted medication|2
911032|NCT00796367|1888164|FG000|Overall Study|other|2
959538|NCT01122264|1956750|FG000|Overall Study|Withdrawal by Subject|6
959539|NCT01122264|1956751|FG001|Overall Study|Withdrawal by Subject|6
959540|NCT01122264|1956752|FG002|Overall Study|Withdrawal by Subject|16
959541|NCT01122264|1956750|FG000|Overall Study|Physician Decision|3
959542|NCT01122264|1956751|FG001|Overall Study|Physician Decision|1
959543|NCT01122264|1956752|FG002|Overall Study|Physician Decision|1
959544|NCT01122264|1956750|FG000|Overall Study|Lack of Efficacy|3
959545|NCT01122264|1956751|FG001|Overall Study|Lack of Efficacy|1
959546|NCT01122264|1956752|FG002|Overall Study|Lack of Efficacy|1
959547|NCT01122394|1956770|FG000|Overall Study|Withdrawal by Subject|1
959548|NCT01122394|1956771|FG001|Overall Study|Withdrawal by Subject|1
959549|NCT01122394|1956770|FG000|Overall Study|Lost to Follow-up|2
959550|NCT01122394|1956771|FG001|Overall Study|Lost to Follow-up|2
959551|NCT01122394|1956770|FG000|Overall Study|Adverse Event|0
959552|NCT01122394|1956771|FG001|Overall Study|Adverse Event|1
959553|NCT01122576|1956791|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0
959554|NCT01122576|1956792|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1
959555|NCT01122576|1956793|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2
959556|NCT01122576|1956791|FG000|Post-Cataract Surgery|Central Macular Edema|0
959557|NCT01122576|1956792|FG001|Post-Cataract Surgery|Central Macular Edema|0
959558|NCT01122576|1956793|FG002|Post-Cataract Surgery|Central Macular Edema|1
959559|NCT01122576|1956791|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0
959560|NCT01122576|1956792|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0
959561|NCT01122576|1956793|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1
959562|NCT01122680|1956804|FG000|Period 1 (4 Weeks)|Adverse Event|1
959563|NCT01122680|1956805|FG001|Period 1 (4 Weeks)|Adverse Event|0
959564|NCT01122680|1956806|FG002|Period 1 (4 Weeks)|Adverse Event|0
959565|NCT01122680|1956807|FG003|Period 1 (4 Weeks)|Adverse Event|0
959566|NCT01122680|1956804|FG000|Period 1 (4 Weeks)|Protocol Violation|1
959567|NCT01122680|1956805|FG001|Period 1 (4 Weeks)|Protocol Violation|0
959568|NCT01122680|1956806|FG002|Period 1 (4 Weeks)|Protocol Violation|0
959569|NCT01122680|1956807|FG003|Period 1 (4 Weeks)|Protocol Violation|0
959570|NCT01122680|1956804|FG000|Period 1 (4 Weeks)|Other|1
959571|NCT01122680|1956805|FG001|Period 1 (4 Weeks)|Other|1
959572|NCT01122680|1956806|FG002|Period 1 (4 Weeks)|Other|0
959573|NCT01122680|1956807|FG003|Period 1 (4 Weeks)|Other|0
959574|NCT01122680|1956804|FG000|Period 2 (4 Weeks)|Protocol Violation|0
959575|NCT01122680|1956805|FG001|Period 2 (4 Weeks)|Protocol Violation|0
959576|NCT01122680|1956806|FG002|Period 2 (4 Weeks)|Protocol Violation|0
959577|NCT01122680|1956807|FG003|Period 2 (4 Weeks)|Protocol Violation|1
959578|NCT01122680|1956804|FG000|Period 2 (4 Weeks)|Other|1
959579|NCT01122680|1956805|FG001|Period 2 (4 Weeks)|Other|0
959580|NCT01122680|1956806|FG002|Period 2 (4 Weeks)|Other|0
959581|NCT01122680|1956807|FG003|Period 2 (4 Weeks)|Other|0
959582|NCT01122680|1956804|FG000|Period 3 (4 Weeks)|Adverse Event|1
959583|NCT01122680|1956805|FG001|Period 3 (4 Weeks)|Adverse Event|0
959584|NCT01122680|1956806|FG002|Period 3 (4 Weeks)|Adverse Event|0
959585|NCT01122680|1956807|FG003|Period 3 (4 Weeks)|Adverse Event|0
959586|NCT01122680|1956804|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
959587|NCT01122680|1956805|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1
959588|NCT01122680|1956806|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0
959589|NCT01122680|1956807|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
959590|NCT01122862|1956840|FG000|Period 1|Protocol Violation|0
959591|NCT01122862|1956841|FG001|Period 1|Protocol Violation|1
959592|NCT01122862|1956842|FG002|Period 1|Protocol Violation|0
959593|NCT01122862|1956840|FG000|Period 2|Adverse Event|0
959594|NCT01122862|1956841|FG001|Period 2|Adverse Event|0
959595|NCT01122862|1956842|FG002|Period 2|Adverse Event|1
959596|NCT01122927|1956865|FG000|Period 1 - Conversion Phase|Adverse Event|3
959597|NCT01122927|1956866|FG001|Period 1 - Conversion Phase|Adverse Event|0
959598|NCT01122927|1956865|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
959599|NCT01122927|1956866|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
959600|NCT01122927|1956865|FG000|Period 1 - Conversion Phase|Physician Decision|2
959601|NCT01122927|1956866|FG001|Period 1 - Conversion Phase|Physician Decision|0
959602|NCT01122927|1956865|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
959603|NCT01122927|1956866|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
959604|NCT01122927|1956865|FG000|Period 1 - Conversion Phase|Protocol Deviation|1
959605|NCT01122927|1956866|FG001|Period 1 - Conversion Phase|Protocol Deviation|0
959606|NCT01122927|1956865|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
959607|NCT01122927|1956866|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
959608|NCT01122927|1956865|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0
959609|NCT01122927|1956866|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33
959610|NCT01122927|1956865|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
959611|NCT01122927|1956866|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
959612|NCT01122927|1956865|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
959613|NCT01122927|1956866|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
959614|NCT01122927|1956865|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0
959615|NCT01122927|1956866|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12
959616|NCT01122927|1956865|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
959617|NCT01122927|1956866|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
959618|NCT01122927|1956865|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
959619|NCT01122927|1956866|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
959620|NCT01123070|1956880|FG000|Part B Double Blind Period|Protocol Violation|0
959621|NCT01123070|1956881|FG001|Part B Double Blind Period|Protocol Violation|0
959622|NCT01123070|1956882|FG002|Part B Double Blind Period|Protocol Violation|0
959623|NCT01123070|1956883|FG003|Part B Double Blind Period|Protocol Violation|1
959624|NCT01123070|1956880|FG000|Part B Double Blind Period|Adverse Event|0
959625|NCT01123070|1956881|FG001|Part B Double Blind Period|Adverse Event|0
959626|NCT01123070|1956882|FG002|Part B Double Blind Period|Adverse Event|2
959627|NCT01123070|1956883|FG003|Part B Double Blind Period|Adverse Event|0
959628|NCT01123070|1956880|FG000|Part B Double Blind Period|Sponsor's Decision|0
959629|NCT01123070|1956881|FG001|Part B Double Blind Period|Sponsor's Decision|0
959630|NCT01123070|1956882|FG002|Part B Double Blind Period|Sponsor's Decision|2
959631|NCT01123070|1956883|FG003|Part B Double Blind Period|Sponsor's Decision|2
959632|NCT01123083|1956896|FG000|Overall Study|Investigator recommendation|1
959633|NCT01123083|1956897|FG001|Overall Study|Investigator recommendation|1
959634|NCT01123083|1956896|FG000|Overall Study|Administrative reasons|0
959635|NCT01123083|1956897|FG001|Overall Study|Administrative reasons|4
959636|NCT01123083|1956896|FG000|Overall Study|Lost to Follow-up|2
959637|NCT01123083|1956897|FG001|Overall Study|Lost to Follow-up|6
959638|NCT01123083|1956896|FG000|Overall Study|Adverse Event|1
959639|NCT01123083|1956897|FG001|Overall Study|Adverse Event|0
959640|NCT01123083|1956896|FG000|Overall Study|Withdrew for another reason not covered|0
959641|NCT01123083|1956897|FG001|Overall Study|Withdrew for another reason not covered|1
959642|NCT01123083|1956896|FG000|Overall Study|Participant/legal representative request|7
959643|NCT01123083|1956897|FG001|Overall Study|Participant/legal representative request|3
959644|NCT01123148|1956903|FG000|Overall Study|Coughing caused unacceptable EEG quality|1
959645|NCT01123148|1956903|FG000|Overall Study|Didn't meet milestone criteria|1
959646|NCT01123161|1956909|FG000|Overall Study|Lost to Follow-up|1
959647|NCT01123161|1956910|FG001|Overall Study|Lost to Follow-up|0
959648|NCT01123161|1956909|FG000|Overall Study|Withdrawal by Subject|1
959649|NCT01123161|1956910|FG001|Overall Study|Withdrawal by Subject|0
959650|NCT01123200|1956919|FG000|Overall Study|Withdrawal by Subject|1
959651|NCT01123356|1956923|FG000|Overall Study|Adverse Event|2
959652|NCT01123356|1956923|FG000|Overall Study|Lack of Efficacy|4
959653|NCT01123356|1956923|FG000|Overall Study|Withdrawal by Subject|1
959654|NCT01123382|1956930|FG000|Overall Study|Withdrawal by Subject|1
959655|NCT01123382|1956931|FG001|Overall Study|Withdrawal by Subject|4
959656|NCT01123382|1956930|FG000|Overall Study|Lost to Follow-up|1
959657|NCT01123382|1956931|FG001|Overall Study|Lost to Follow-up|2
959658|NCT01123395|1956937|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
959659|NCT01123395|1956938|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
959660|NCT01123642|1956953|FG000|Overall Study|Lost to Follow-up|23
959661|NCT01123642|1956953|FG000|Overall Study|Withdrawal by Subject|9
959662|NCT01123642|1956953|FG000|Overall Study|ineligible at baseline assessment|36
959663|NCT01123655|1956960|FG000|Overall Study|Medication for RA had to be changed|1
959664|NCT01123655|1956961|FG001|Overall Study|Medication for RA had to be changed|0
959665|NCT01123655|1956962|FG002|Overall Study|Medication for RA had to be changed|0
959666|NCT01123655|1956960|FG000|Overall Study|new illness|0
959667|NCT01123655|1956961|FG001|Overall Study|new illness|1
959668|NCT01123655|1956962|FG002|Overall Study|new illness|0
959669|NCT01123655|1956960|FG000|Overall Study|began prohibitive drug|0
959670|NCT01123655|1956961|FG001|Overall Study|began prohibitive drug|0
959671|NCT01123655|1956962|FG002|Overall Study|began prohibitive drug|1
959672|NCT01123889|1956970|FG000|Overall Study|Lost to Follow-up|3
959673|NCT01123889|1956971|FG001|Overall Study|Lost to Follow-up|1
959674|NCT01123941|1956988|FG000|Overall Study|Lost to Follow-up|2
959675|NCT01123941|1956989|FG001|Overall Study|Lost to Follow-up|1
959676|NCT01123980|1956997|FG000|Overall Study|Adverse Event|1
959677|NCT01123980|1956998|FG001|Overall Study|Adverse Event|1
959678|NCT01123980|1956997|FG000|Overall Study|Lack of Efficacy|1
959679|NCT01123980|1956998|FG001|Overall Study|Lack of Efficacy|0
959680|NCT01123980|1956997|FG000|Overall Study|Physician Decision|0
959681|NCT01123980|1956998|FG001|Overall Study|Physician Decision|1
959682|NCT01123980|1956997|FG000|Overall Study|Lost to Follow-up|0
959683|NCT01123980|1956998|FG001|Overall Study|Lost to Follow-up|6
959684|NCT01123980|1956997|FG000|Overall Study|Protocol Violation|6
959685|NCT01123980|1956998|FG001|Overall Study|Protocol Violation|6
959686|NCT01123980|1956997|FG000|Overall Study|Withdrawal by Subject|5
959687|NCT01123980|1956998|FG001|Overall Study|Withdrawal by Subject|3
959688|NCT01123980|1956997|FG000|Overall Study|Unclassified|6
959689|NCT01123980|1956998|FG001|Overall Study|Unclassified|7
959690|NCT01124006|1957007|FG000|Overall Study|Withdrawal by Subject|2
959691|NCT01124006|1957008|FG001|Overall Study|Withdrawal by Subject|2
959692|NCT01124006|1957009|FG002|Overall Study|Withdrawal by Subject|0
959693|NCT01124006|1957007|FG000|Overall Study|Lost to Follow-up|1
959694|NCT01124006|1957008|FG001|Overall Study|Lost to Follow-up|0
959695|NCT01124006|1957009|FG002|Overall Study|Lost to Follow-up|1
959696|NCT01124006|1957007|FG000|Overall Study|Other|0
959697|NCT01124006|1957008|FG001|Overall Study|Other|0
959698|NCT01124006|1957009|FG002|Overall Study|Other|1
959699|NCT01124045|1957019|FG000|Overall Study|Lost to Follow-up|0
959700|NCT01124045|1957020|FG001|Overall Study|Lost to Follow-up|1
959701|NCT01124045|1957019|FG000|Overall Study|Physician Decision|0
959702|NCT01124045|1957020|FG001|Overall Study|Physician Decision|2
959703|NCT01124097|1957030|FG000|Overall Study|Withdrawal by Subject|4
959704|NCT01124097|1957031|FG001|Overall Study|Withdrawal by Subject|3
959705|NCT01124097|1957032|FG002|Overall Study|Withdrawal by Subject|2
959706|NCT01124097|1957033|FG003|Overall Study|Withdrawal by Subject|3
959707|NCT01124097|1957030|FG000|Overall Study|Lack of Efficacy|2
959708|NCT01124097|1957031|FG001|Overall Study|Lack of Efficacy|3
959709|NCT01124097|1957032|FG002|Overall Study|Lack of Efficacy|1
959710|NCT01124097|1957033|FG003|Overall Study|Lack of Efficacy|3
959711|NCT01124097|1957030|FG000|Overall Study|Adverse Event|24
959712|NCT01124097|1957031|FG001|Overall Study|Adverse Event|15
959713|NCT01124097|1957032|FG002|Overall Study|Adverse Event|15
959714|NCT01124097|1957033|FG003|Overall Study|Adverse Event|7
959715|NCT01124097|1957030|FG000|Overall Study|Protocol Violation|2
959716|NCT01124097|1957031|FG001|Overall Study|Protocol Violation|0
959717|NCT01124097|1957032|FG002|Overall Study|Protocol Violation|2
959718|NCT01124097|1957033|FG003|Overall Study|Protocol Violation|1
959719|NCT01124097|1957030|FG000|Overall Study|Physician Decision|2
959720|NCT01124097|1957031|FG001|Overall Study|Physician Decision|1
959721|NCT01124097|1957032|FG002|Overall Study|Physician Decision|0
959722|NCT01124097|1957033|FG003|Overall Study|Physician Decision|0
959723|NCT01124149|1957043|FG000|Acute Phase|Withdrawal by Subject|22
959724|NCT01124149|1957043|FG000|Acute Phase|Adverse Event|21
959725|NCT01124149|1957043|FG000|Acute Phase|Lack of Efficacy|17
959726|NCT01124149|1957043|FG000|Acute Phase|Protocol Violation|14
959727|NCT01124149|1957043|FG000|Acute Phase|Lost to Follow-up|2
959728|NCT01124149|1957043|FG000|Acute Phase|Prolonged antibiotic therapy|1
959729|NCT01124149|1957043|FG000|Acute Phase|Sponsor request|1
959730|NCT01124149|1957043|FG000|Acute Phase|UC symptoms not ameliorated|1
959731|NCT01124149|1957043|FG000|Acute Phase|Non-compliance|1
959732|NCT01124149|1957043|FG000|Acute Phase|Low hemoglobin|1
959733|NCT01124149|1957043|FG000|Acute Phase|Travelling to another country|1
959734|NCT01124149|1957043|FG000|Acute Phase|Sponsor decision|1
959735|NCT01124149|1957043|FG000|Maintenance Phase|Lack of Efficacy|40
959736|NCT01124149|1957043|FG000|Maintenance Phase|Adverse Event|24
959737|NCT01124149|1957043|FG000|Maintenance Phase|Lost to Follow-up|15
959738|NCT01124149|1957043|FG000|Maintenance Phase|Withdrawal by Subject|10
959739|NCT01124149|1957043|FG000|Maintenance Phase|Protocol Violation|5
959740|NCT01124149|1957043|FG000|Maintenance Phase|Coordinator error|1
959741|NCT01124149|1957043|FG000|Maintenance Phase|Non-compliance|1
959742|NCT01124162|1957052|FG000|First Intervention|Adverse Event|2
959743|NCT01124162|1957053|FG001|First Intervention|Adverse Event|0
959744|NCT01124162|1957052|FG000|Washout of 7 Days|Withdrawal by Subject|1
959745|NCT01124162|1957053|FG001|Washout of 7 Days|Withdrawal by Subject|0
959746|NCT01124175|1957061|FG000|Washout of 7 Days|Withdrawal by Subject|0
959747|NCT01124175|1957062|FG001|Washout of 7 Days|Withdrawal by Subject|2
959748|NCT01124292|1957080|FG000|Overall Study|Lost to Follow-up|2
959749|NCT01124292|1957081|FG001|Overall Study|Lost to Follow-up|4
959750|NCT01124292|1957082|FG002|Overall Study|Lost to Follow-up|3
959751|NCT01124292|1957080|FG000|Overall Study|Physician Decision|0
959752|NCT01124292|1957081|FG001|Overall Study|Physician Decision|3
959753|NCT01124292|1957082|FG002|Overall Study|Physician Decision|2
959754|NCT01124292|1957080|FG000|Overall Study|Withdrawal by Subject|0
959755|NCT01124292|1957081|FG001|Overall Study|Withdrawal by Subject|6
959756|NCT01124292|1957082|FG002|Overall Study|Withdrawal by Subject|2
959757|NCT01124292|1957080|FG000|Overall Study|medical issue unrelated to the study|0
959758|NCT01124292|1957081|FG001|Overall Study|medical issue unrelated to the study|0
959759|NCT01124292|1957082|FG002|Overall Study|medical issue unrelated to the study|2
959760|NCT01124292|1957080|FG000|Overall Study|piercing track closed|0
959761|NCT01124292|1957081|FG001|Overall Study|piercing track closed|2
959762|NCT01124292|1957082|FG002|Overall Study|piercing track closed|1
959763|NCT01124422|1957108|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
959764|NCT01124422|1957109|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
959765|NCT01124422|1957110|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
959766|NCT01124422|1957108|FG000|4-Week Open-label Run-in Phase|Adverse Event|7
959767|NCT01124422|1957109|FG001|4-Week Open-label Run-in Phase|Adverse Event|0
959768|NCT01124422|1957110|FG002|4-Week Open-label Run-in Phase|Adverse Event|0
959769|NCT01124422|1957108|FG000|4-Week Open-label Run-in Phase|Physician Decision|4
959770|NCT01124422|1957109|FG001|4-Week Open-label Run-in Phase|Physician Decision|0
959771|NCT01124422|1957110|FG002|4-Week Open-label Run-in Phase|Physician Decision|0
959772|NCT01124422|1957108|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1
959773|NCT01124422|1957109|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0
959774|NCT01124422|1957110|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0
959775|NCT01124422|1957108|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
959776|NCT01124422|1957109|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
959777|NCT01124422|1957110|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
959778|NCT01124422|1957108|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5
959779|NCT01124422|1957109|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0
959780|NCT01124422|1957110|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0
959781|NCT01124422|1957108|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
959782|NCT01124422|1957109|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
959783|NCT01124422|1957110|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
959784|NCT01124422|1957108|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0
959785|NCT01124422|1957109|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6
959786|NCT01124422|1957110|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3
959787|NCT01124422|1957108|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0
959788|NCT01124422|1957109|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5
959789|NCT01124422|1957110|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2
959790|NCT01124422|1957108|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
959791|NCT01124422|1957109|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
959792|NCT01124422|1957110|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
959793|NCT01124448|1957119|FG000|Overall Study|Lost to Follow-up|0
959794|NCT01124448|1957120|FG001|Overall Study|Lost to Follow-up|3
959795|NCT01124448|1957119|FG000|Overall Study|Protocol Violation|2
959796|NCT01124448|1957120|FG001|Overall Study|Protocol Violation|0
959797|NCT01124604|1957128|FG000|Overall Study|Adverse Event|10
959798|NCT01124604|1957129|FG001|Overall Study|Adverse Event|1
959799|NCT01124604|1957128|FG000|Overall Study|Lack of Efficacy|1
959800|NCT01124604|1957129|FG001|Overall Study|Lack of Efficacy|0
959801|NCT01124604|1957128|FG000|Overall Study|Withdrawal by Subject|4
959802|NCT01124604|1957129|FG001|Overall Study|Withdrawal by Subject|0
959803|NCT01124604|1957128|FG000|Overall Study|Disease Progression|0
959804|NCT01124604|1957129|FG001|Overall Study|Disease Progression|1
959805|NCT01124617|1957137|FG000|Overall Study|Adverse Event|5
959806|NCT01124617|1957138|FG001|Overall Study|Adverse Event|2
959807|NCT01124617|1957137|FG000|Overall Study|Lack of Efficacy|2
959808|NCT01124617|1957138|FG001|Overall Study|Lack of Efficacy|1
959809|NCT01124617|1957137|FG000|Overall Study|Protocol Violation|1
959810|NCT01124617|1957138|FG001|Overall Study|Protocol Violation|1
959811|NCT01124617|1957137|FG000|Overall Study|Withdrawal by Subject|9
959812|NCT01124617|1957138|FG001|Overall Study|Withdrawal by Subject|1
959813|NCT01124617|1957137|FG000|Overall Study|Other|2
959814|NCT01124617|1957138|FG001|Overall Study|Other|1
959815|NCT01124643|1957144|FG000|Overall Study|Death|1
959816|NCT01124734|1957148|FG000|Overall Study|Disease progression|13
959817|NCT01124734|1957148|FG000|Overall Study|Adverse Event|1
959818|NCT01124734|1957148|FG000|Overall Study|Withdrawal by Subject|1
959819|NCT01124734|1957148|FG000|Overall Study|Elected for alternative treatment|2
959820|NCT01124838|1957168|FG000|Overall Study|Miscellaneous|4
959821|NCT01124838|1957169|FG001|Overall Study|Miscellaneous|2
959822|NCT01124838|1957168|FG000|Overall Study|Adverse Event|7
959823|NCT01124838|1957169|FG001|Overall Study|Adverse Event|11
959824|NCT01124838|1957168|FG000|Overall Study|Lack of Efficacy|2
959825|NCT01124838|1957169|FG001|Overall Study|Lack of Efficacy|0
959826|NCT01124838|1957168|FG000|Overall Study|Withdrawal by Subject|3
959827|NCT01124838|1957169|FG001|Overall Study|Withdrawal by Subject|2
959828|NCT01124838|1957168|FG000|Overall Study|Lost to Follow-up|2
959829|NCT01124838|1957169|FG001|Overall Study|Lost to Follow-up|0
959830|NCT01124864|1957183|FG000|Overall Study|Follow up phase competed as per protocol|18
959831|NCT01124864|1957184|FG001|Overall Study|Follow up phase competed as per protocol|22
959832|NCT01124864|1957185|FG002|Overall Study|Follow up phase competed as per protocol|24
959833|NCT01124864|1957186|FG003|Overall Study|Follow up phase competed as per protocol|18
959834|NCT01124864|1957187|FG004|Overall Study|Follow up phase competed as per protocol|26
959835|NCT01124864|1957188|FG005|Overall Study|Follow up phase competed as per protocol|2
959836|NCT01124864|1957183|FG000|Overall Study|Death|6
959837|NCT01124864|1957184|FG001|Overall Study|Death|9
959838|NCT01124864|1957185|FG002|Overall Study|Death|6
959839|NCT01124864|1957186|FG003|Overall Study|Death|2
959840|NCT01124864|1957187|FG004|Overall Study|Death|1
959841|NCT01124864|1957188|FG005|Overall Study|Death|0
959842|NCT01124864|1957183|FG000|Overall Study|Withdrawal by Subject|2
959843|NCT01124864|1957184|FG001|Overall Study|Withdrawal by Subject|3
959844|NCT01124864|1957185|FG002|Overall Study|Withdrawal by Subject|4
959845|NCT01124864|1957186|FG003|Overall Study|Withdrawal by Subject|0
959846|NCT01124864|1957187|FG004|Overall Study|Withdrawal by Subject|2
959847|NCT01124864|1957188|FG005|Overall Study|Withdrawal by Subject|1
959848|NCT01124864|1957183|FG000|Overall Study|Lost to Follow-up|1
959849|NCT01124864|1957184|FG001|Overall Study|Lost to Follow-up|1
959850|NCT01124864|1957185|FG002|Overall Study|Lost to Follow-up|0
959851|NCT01124864|1957186|FG003|Overall Study|Lost to Follow-up|1
959852|NCT01124864|1957187|FG004|Overall Study|Lost to Follow-up|0
959853|NCT01124864|1957188|FG005|Overall Study|Lost to Follow-up|0
959854|NCT01124864|1957183|FG000|Overall Study|Protocol Violation|1
959855|NCT01124864|1957184|FG001|Overall Study|Protocol Violation|0
959856|NCT01124864|1957185|FG002|Overall Study|Protocol Violation|0
959857|NCT01124864|1957186|FG003|Overall Study|Protocol Violation|0
959858|NCT01124864|1957187|FG004|Overall Study|Protocol Violation|1
959859|NCT01124864|1957188|FG005|Overall Study|Protocol Violation|0
959860|NCT01124916|1957206|FG000|Overall Study|Lost to Follow-up|3
959861|NCT01124916|1957207|FG001|Overall Study|Lost to Follow-up|2
959862|NCT01125046|1957222|FG000|First 6 Months of Treatment|Death|1
959863|NCT01125046|1957222|FG000|First 6 Months of Treatment|Withdrawal by Subject|2
959864|NCT01125046|1957222|FG000|First 6 Months of Treatment|Non-compliance|1
959865|NCT01125046|1957222|FG000|First 6 Months of Treatment|Surgery|1
959866|NCT01125046|1957222|FG000|First 6 Months of Treatment|Progressive Disease|7
959867|NCT01125046|1957222|FG000|First 6 Months of Treatment|Adverse Event|2
959868|NCT01125046|1957222|FG000|Continued Treatment After 6 Months|Progressive Disease|2
959869|NCT01125046|1957222|FG000|Continued Treatment After 6 Months|Adverse Event|1
959870|NCT01125046|1957222|FG000|Follow-up/Data Cut Off Point|Death|29
959871|NCT01125046|1957222|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4
959872|NCT01125189|1957252|FG000|Treatment Period|Lack of Efficacy|15
959873|NCT01125189|1957253|FG001|Treatment Period|Lack of Efficacy|18
959874|NCT01125189|1957254|FG002|Treatment Period|Lack of Efficacy|25
959875|NCT01125189|1957252|FG000|Treatment Period|Adverse Event|7
959876|NCT01125189|1957253|FG001|Treatment Period|Adverse Event|8
959877|NCT01125189|1957254|FG002|Treatment Period|Adverse Event|8
959878|NCT01125189|1957252|FG000|Treatment Period|Withdrawal by Subject|3
959879|NCT01125189|1957253|FG001|Treatment Period|Withdrawal by Subject|1
959880|NCT01125189|1957254|FG002|Treatment Period|Withdrawal by Subject|1
959881|NCT01125189|1957252|FG000|Treatment Period|Death|1
959882|NCT01125189|1957253|FG001|Treatment Period|Death|0
959883|NCT01125189|1957254|FG002|Treatment Period|Death|0
959884|NCT01125189|1957252|FG000|Treatment Period|Lost to Follow-up|1
959885|NCT01125189|1957253|FG001|Treatment Period|Lost to Follow-up|2
959886|NCT01125189|1957254|FG002|Treatment Period|Lost to Follow-up|1
959887|NCT01125189|1957252|FG000|Treatment Period|Poor compliance/noncompliance|0
959888|NCT01125189|1957253|FG001|Treatment Period|Poor compliance/noncompliance|1
959889|NCT01125189|1957254|FG002|Treatment Period|Poor compliance/noncompliance|0
959890|NCT01125189|1957252|FG000|Treatment Period|Participants requested to discontinue|1
959891|NCT01125189|1957253|FG001|Treatment Period|Participants requested to discontinue|3
959892|NCT01125189|1957254|FG002|Treatment Period|Participants requested to discontinue|4
959893|NCT01125189|1957252|FG000|Treatment Period|Other reasons|1
959894|NCT01125189|1957253|FG001|Treatment Period|Other reasons|1
959895|NCT01125189|1957254|FG002|Treatment Period|Other reasons|0
959896|NCT01125189|1957252|FG000|Treatment Period|Completed 24 week treatment period only|2
959897|NCT01125189|1957253|FG001|Treatment Period|Completed 24 week treatment period only|1
959898|NCT01125189|1957254|FG002|Treatment Period|Completed 24 week treatment period only|2
959899|NCT01125189|1957252|FG000|Follow up Period|Withdrawal by Subject|3
959900|NCT01125189|1957253|FG001|Follow up Period|Withdrawal by Subject|2
959901|NCT01125189|1957254|FG002|Follow up Period|Withdrawal by Subject|5
959902|NCT01125189|1957252|FG000|Follow up Period|Death|1
959903|NCT01125189|1957253|FG001|Follow up Period|Death|0
959904|NCT01125189|1957254|FG002|Follow up Period|Death|0
959905|NCT01125189|1957252|FG000|Follow up Period|Lost to Follow-up|12
959906|NCT01125189|1957253|FG001|Follow up Period|Lost to Follow-up|9
959907|NCT01125189|1957254|FG002|Follow up Period|Lost to Follow-up|6
959908|NCT01125189|1957252|FG000|Follow up Period|Other reasons|4
959909|NCT01125189|1957253|FG001|Follow up Period|Other reasons|4
959910|NCT01125189|1957254|FG002|Follow up Period|Other reasons|5
959911|NCT01125293|1957280|FG000|Overall Study|Disease Progression|1
959912|NCT01125293|1957281|FG001|Overall Study|Disease Progression|3
959913|NCT01125293|1957282|FG002|Overall Study|Disease Progression|4
959914|NCT01125293|1957283|FG003|Overall Study|Disease Progression|3
959915|NCT01125293|1957284|FG004|Overall Study|Disease Progression|5
959916|NCT01125293|1957285|FG005|Overall Study|Disease Progression|12
959917|NCT01125293|1957280|FG000|Overall Study|Adverse Event|1
959918|NCT01125293|1957281|FG001|Overall Study|Adverse Event|0
959919|NCT01125293|1957282|FG002|Overall Study|Adverse Event|0
959920|NCT01125293|1957283|FG003|Overall Study|Adverse Event|0
959921|NCT01125293|1957284|FG004|Overall Study|Adverse Event|2
959922|NCT01125293|1957285|FG005|Overall Study|Adverse Event|8
959923|NCT01125293|1957280|FG000|Overall Study|Symptomatic Deterioration|1
959924|NCT01125293|1957281|FG001|Overall Study|Symptomatic Deterioration|0
959925|NCT01125293|1957282|FG002|Overall Study|Symptomatic Deterioration|0
959926|NCT01125293|1957283|FG003|Overall Study|Symptomatic Deterioration|0
959927|NCT01125293|1957284|FG004|Overall Study|Symptomatic Deterioration|0
959928|NCT01125293|1957285|FG005|Overall Study|Symptomatic Deterioration|0
959929|NCT01125293|1957280|FG000|Overall Study|Death|0
959930|NCT01125293|1957281|FG001|Overall Study|Death|0
959931|NCT01125293|1957282|FG002|Overall Study|Death|0
911033|NCT00796367|1888165|FG001|Overall Study|other|4
911034|NCT00796367|1888166|FG002|Overall Study|other|3
911035|NCT00796419|1888176|FG000|Overall Study|Death|0
911036|NCT00796419|1888177|FG001|Overall Study|Death|1
911037|NCT00796445|1888185|FG000|Overall Study|Protocol Violation|5
911038|NCT00796445|1888186|FG001|Overall Study|Protocol Violation|3
911039|NCT00796445|1888185|FG000|Overall Study|Adverse event, serious fatal|10
911040|NCT00796445|1888186|FG001|Overall Study|Adverse event, serious fatal|5
911041|NCT00796445|1888185|FG000|Overall Study|Adverse event, non-fatal|4
911042|NCT00796445|1888186|FG001|Overall Study|Adverse event, non-fatal|0
911043|NCT00796445|1888185|FG000|Overall Study|Disease progression/recurrence|537
911044|NCT00796445|1888186|FG001|Overall Study|Disease progression/recurrence|268
911045|NCT00796445|1888185|FG000|Overall Study|Other|10
911046|NCT00796445|1888186|FG001|Overall Study|Other|7
911047|NCT00796445|1888185|FG000|Overall Study|Withdrawal by Subject|18
911048|NCT00796445|1888186|FG001|Overall Study|Withdrawal by Subject|9
911049|NCT00796445|1888185|FG000|Overall Study|Invalid Informed Consent Form|1
911050|NCT00796445|1888186|FG001|Overall Study|Invalid Informed Consent Form|0
911051|NCT00796523|1888202|FG000|Overall Study|Lost to Follow-up|9
911052|NCT00796523|1888203|FG001|Overall Study|Lost to Follow-up|7
911053|NCT00796549|1888207|FG000|Overall Study|Adverse Event|11
911054|NCT00796549|1888207|FG000|Overall Study|not entered|149
911055|NCT00796549|1888207|FG000|Overall Study|Other|2
911056|NCT00796549|1888207|FG000|Overall Study|Progressive disease|56
911057|NCT00796562|1888213|FG000|Overall Study|Death|49
911058|NCT00796614|1888221|FG000|Overall Study|Adverse Event|1
959932|NCT01125293|1957283|FG003|Overall Study|Death|0
959933|NCT01125293|1957284|FG004|Overall Study|Death|1
959934|NCT01125293|1957285|FG005|Overall Study|Death|0
959935|NCT01125293|1957280|FG000|Overall Study|Withdrawal by Subject|0
959936|NCT01125293|1957281|FG001|Overall Study|Withdrawal by Subject|0
959937|NCT01125293|1957282|FG002|Overall Study|Withdrawal by Subject|0
959938|NCT01125293|1957283|FG003|Overall Study|Withdrawal by Subject|0
959939|NCT01125293|1957284|FG004|Overall Study|Withdrawal by Subject|2
959940|NCT01125293|1957285|FG005|Overall Study|Withdrawal by Subject|1
959941|NCT01125293|1957280|FG000|Overall Study|Physician Decision|0
959942|NCT01125293|1957281|FG001|Overall Study|Physician Decision|0
959943|NCT01125293|1957282|FG002|Overall Study|Physician Decision|0
959944|NCT01125293|1957283|FG003|Overall Study|Physician Decision|0
959945|NCT01125293|1957284|FG004|Overall Study|Physician Decision|0
959946|NCT01125293|1957285|FG005|Overall Study|Physician Decision|2
959947|NCT01125358|1957306|FG000|Overall Study|Adverse Event|3
959948|NCT01125358|1957307|FG001|Overall Study|Adverse Event|0
959949|NCT01125358|1957308|FG002|Overall Study|Adverse Event|0
959950|NCT01125358|1957309|FG003|Overall Study|Adverse Event|2
959951|NCT01125358|1957306|FG000|Overall Study|Perceived Lack of Efficacy|6
959952|NCT01125358|1957307|FG001|Overall Study|Perceived Lack of Efficacy|3
959953|NCT01125358|1957308|FG002|Overall Study|Perceived Lack of Efficacy|7
959954|NCT01125358|1957309|FG003|Overall Study|Perceived Lack of Efficacy|4
959955|NCT01125358|1957306|FG000|Overall Study|Protocol Violation|1
959956|NCT01125358|1957307|FG001|Overall Study|Protocol Violation|0
959957|NCT01125358|1957308|FG002|Overall Study|Protocol Violation|0
959958|NCT01125358|1957309|FG003|Overall Study|Protocol Violation|0
959959|NCT01125358|1957306|FG000|Overall Study|Sponsor Decision|0
959960|NCT01125358|1957307|FG001|Overall Study|Sponsor Decision|0
959961|NCT01125358|1957308|FG002|Overall Study|Sponsor Decision|1
959962|NCT01125358|1957309|FG003|Overall Study|Sponsor Decision|1
959963|NCT01125358|1957306|FG000|Overall Study|Withdrawal by Subject|2
959964|NCT01125358|1957307|FG001|Overall Study|Withdrawal by Subject|1
959965|NCT01125358|1957308|FG002|Overall Study|Withdrawal by Subject|1
959966|NCT01125358|1957309|FG003|Overall Study|Withdrawal by Subject|1
959967|NCT01125514|1957319|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
959968|NCT01125514|1957319|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
959969|NCT01125514|1957319|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
959970|NCT01125514|1957319|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
959971|NCT01125514|1957319|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
959972|NCT01125514|1957319|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
959973|NCT01125566|1957335|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
959974|NCT01125566|1957336|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
959975|NCT01125566|1957337|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
959976|NCT01125566|1957335|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
959977|NCT01125566|1957336|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
959978|NCT01125566|1957337|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
959979|NCT01125566|1957335|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25
959980|NCT01125566|1957336|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5
959981|NCT01125566|1957337|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0
959982|NCT01125566|1957335|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0
959983|NCT01125566|1957336|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2
959984|NCT01125566|1957337|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0
959985|NCT01125566|1957335|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
959986|NCT01125566|1957336|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
959987|NCT01125566|1957337|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
959988|NCT01125566|1957335|FG000|Patients Before the Switch (26Apr2013)|Not treated|2
959989|NCT01125566|1957336|FG001|Patients Before the Switch (26Apr2013)|Not treated|0
959990|NCT01125566|1957337|FG002|Patients Before the Switch (26Apr2013)|Not treated|0
959991|NCT01125566|1957335|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25
959992|NCT01125566|1957336|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13
959993|NCT01125566|1957337|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0
959994|NCT01125566|1957335|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
959995|NCT01125566|1957336|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
959996|NCT01125566|1957337|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
959997|NCT01125566|1957335|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
959998|NCT01125566|1957336|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
959999|NCT01125566|1957337|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
960000|NCT01125566|1957335|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0
960001|NCT01125566|1957336|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0
960002|NCT01125566|1957337|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7
960003|NCT01125566|1957335|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
960004|NCT01125566|1957336|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
960005|NCT01125566|1957337|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
960006|NCT01125566|1957335|FG000|Patients Who Switched From AV to TV|Other than listed above|0
960007|NCT01125566|1957336|FG001|Patients Who Switched From AV to TV|Other than listed above|0
960008|NCT01125566|1957337|FG002|Patients Who Switched From AV to TV|Other than listed above|4
960009|NCT01125722|1957363|FG000|Overall Study|Withdrawal by Subject|2
960010|NCT01125722|1957364|FG001|Overall Study|Withdrawal by Subject|1
960011|NCT01125722|1957363|FG000|Overall Study|Lost to Follow-up|1
960012|NCT01125722|1957364|FG001|Overall Study|Lost to Follow-up|0
960013|NCT01125748|1957372|FG000|Overall Study|Adverse Event|0
960014|NCT01125748|1957373|FG001|Overall Study|Adverse Event|2
960015|NCT01125748|1957372|FG000|Overall Study|Lost to Follow-up|0
960016|NCT01125748|1957373|FG001|Overall Study|Lost to Follow-up|1
960017|NCT01125748|1957372|FG000|Overall Study|Physician Decision|8
960018|NCT01125748|1957373|FG001|Overall Study|Physician Decision|7
960019|NCT01125748|1957372|FG000|Overall Study|Patient Decision to Withdraw|2
960020|NCT01125748|1957373|FG001|Overall Study|Patient Decision to Withdraw|4
960021|NCT01125800|1957395|FG000|Phase I|Protocol Violation|0
960022|NCT01125800|1957396|FG001|Phase I|Protocol Violation|3
960023|NCT01125800|1957397|FG002|Phase I|Protocol Violation|1
960024|NCT01125800|1957398|FG003|Phase I|Protocol Violation|1
960025|NCT01125800|1957399|FG004|Phase I|Protocol Violation|0
960026|NCT01125800|1957395|FG000|Phase I|Adverse Event|2
960027|NCT01125800|1957396|FG001|Phase I|Adverse Event|2
960028|NCT01125800|1957397|FG002|Phase I|Adverse Event|1
960029|NCT01125800|1957398|FG003|Phase I|Adverse Event|7
960030|NCT01125800|1957399|FG004|Phase I|Adverse Event|0
960031|NCT01125800|1957395|FG000|Phase I|Administrative problems|1
960032|NCT01125800|1957396|FG001|Phase I|Administrative problems|0
960033|NCT01125800|1957397|FG002|Phase I|Administrative problems|0
960034|NCT01125800|1957398|FG003|Phase I|Administrative problems|0
960035|NCT01125800|1957399|FG004|Phase I|Administrative problems|0
960036|NCT01125800|1957395|FG000|Phase I|Withdrawal by Subject|0
960037|NCT01125800|1957396|FG001|Phase I|Withdrawal by Subject|0
960038|NCT01125800|1957397|FG002|Phase I|Withdrawal by Subject|1
960039|NCT01125800|1957398|FG003|Phase I|Withdrawal by Subject|0
960040|NCT01125800|1957399|FG004|Phase I|Withdrawal by Subject|0
960041|NCT01125800|1957395|FG000|Phase I|Disease progression|5
960042|NCT01125800|1957396|FG001|Phase I|Disease progression|4
960043|NCT01125800|1957397|FG002|Phase I|Disease progression|1
960044|NCT01125800|1957398|FG003|Phase I|Disease progression|3
960045|NCT01125800|1957399|FG004|Phase I|Disease progression|0
960046|NCT01125800|1957395|FG000|Phase II|Protocol Violation|0
960047|NCT01125800|1957396|FG001|Phase II|Protocol Violation|0
960048|NCT01125800|1957397|FG002|Phase II|Protocol Violation|0
960049|NCT01125800|1957398|FG003|Phase II|Protocol Violation|0
960050|NCT01125800|1957399|FG004|Phase II|Protocol Violation|1
960051|NCT01125800|1957395|FG000|Phase II|Adverse Event|0
960052|NCT01125800|1957396|FG001|Phase II|Adverse Event|0
960053|NCT01125800|1957397|FG002|Phase II|Adverse Event|0
960054|NCT01125800|1957398|FG003|Phase II|Adverse Event|0
960055|NCT01125800|1957399|FG004|Phase II|Adverse Event|2
960056|NCT01125800|1957395|FG000|Phase II|Disease progression|0
960057|NCT01125800|1957396|FG001|Phase II|Disease progression|0
960058|NCT01125800|1957397|FG002|Phase II|Disease progression|0
960059|NCT01125800|1957398|FG003|Phase II|Disease progression|1
960060|NCT01125800|1957399|FG004|Phase II|Disease progression|8
960061|NCT01125813|1957414|FG000|Overall Study|Death|1
960062|NCT01125813|1957414|FG000|Overall Study|Withdrawal by Subject|1
960063|NCT01125813|1957414|FG000|Overall Study|Screen Failures|4
960064|NCT01125917|1957418|FG000|Overall Study|Adverse Event|43
960065|NCT01125917|1957418|FG000|Overall Study|Lost to Follow-up|23
960066|NCT01125917|1957418|FG000|Overall Study|Withdrawal by Subject|31
960067|NCT01125917|1957418|FG000|Overall Study|Administrative|223
960068|NCT01125917|1957418|FG000|Overall Study|Lack of Efficacy|19
960069|NCT01125930|1957424|FG000|Overall Study|Adverse Event|0
960070|NCT01125930|1957425|FG001|Overall Study|Adverse Event|1
960071|NCT01125930|1957424|FG000|Overall Study|Withdrawal by Subject|1
960072|NCT01125930|1957425|FG001|Overall Study|Withdrawal by Subject|6
960073|NCT01125930|1957424|FG000|Overall Study|Protocol Violation|0
960074|NCT01125930|1957425|FG001|Overall Study|Protocol Violation|1
960075|NCT01125930|1957424|FG000|Overall Study|Lost to Follow-up|0
960076|NCT01125930|1957425|FG001|Overall Study|Lost to Follow-up|2
960077|NCT01126060|1957449|FG000|Overall Study|Protocol Violation|0
960078|NCT01126060|1957450|FG001|Overall Study|Protocol Violation|2
960079|NCT01126268|1957465|FG000|Overall Study|Adverse Event|1
960080|NCT01126359|1957469|FG000|First Intervention (20-minutes)|Physician Decision|0
960081|NCT01126359|1957470|FG001|First Intervention (20-minutes)|Physician Decision|1
960082|NCT01126424|1957486|FG000|Overall Study|Adverse Event|0
960083|NCT01126424|1957487|FG001|Overall Study|Adverse Event|0
960084|NCT01126424|1957488|FG002|Overall Study|Adverse Event|0
960085|NCT01126424|1957489|FG003|Overall Study|Adverse Event|0
960086|NCT01126424|1957490|FG004|Overall Study|Adverse Event|1
960087|NCT01126424|1957491|FG005|Overall Study|Adverse Event|0
960088|NCT01126424|1957486|FG000|Overall Study|Withdrawal by Subject|0
960089|NCT01126424|1957487|FG001|Overall Study|Withdrawal by Subject|0
960090|NCT01126424|1957488|FG002|Overall Study|Withdrawal by Subject|1
960091|NCT01126424|1957489|FG003|Overall Study|Withdrawal by Subject|3
960092|NCT01126424|1957490|FG004|Overall Study|Withdrawal by Subject|1
960093|NCT01126424|1957491|FG005|Overall Study|Withdrawal by Subject|0
960094|NCT01126437|1957502|FG000|Overall Study|Not treated|11
960095|NCT01126437|1957503|FG001|Overall Study|Not treated|18
960096|NCT01126437|1957504|FG002|Overall Study|Not treated|19
960097|NCT01126437|1957502|FG000|Overall Study|Sites with data irregularities/fraud|6
960098|NCT01126437|1957503|FG001|Overall Study|Sites with data irregularities/fraud|6
960099|NCT01126437|1957504|FG002|Overall Study|Sites with data irregularities/fraud|7
960100|NCT01126437|1957502|FG000|Overall Study|Adverse Event|602
960101|NCT01126437|1957503|FG001|Overall Study|Adverse Event|606
960102|NCT01126437|1957504|FG002|Overall Study|Adverse Event|635
960103|NCT01126437|1957502|FG000|Overall Study|Lack of Efficacy|65
960104|NCT01126437|1957503|FG001|Overall Study|Lack of Efficacy|60
960105|NCT01126437|1957504|FG002|Overall Study|Lack of Efficacy|59
960106|NCT01126437|1957502|FG000|Overall Study|Protocol Violation|64
960107|NCT01126437|1957503|FG001|Overall Study|Protocol Violation|66
960108|NCT01126437|1957504|FG002|Overall Study|Protocol Violation|41
960109|NCT01126437|1957502|FG000|Overall Study|Lost to Follow-up|52
960110|NCT01126437|1957503|FG001|Overall Study|Lost to Follow-up|63
960111|NCT01126437|1957504|FG002|Overall Study|Lost to Follow-up|55
960112|NCT01126437|1957502|FG000|Overall Study|Withdrawal by Subject|331
960113|NCT01126437|1957503|FG001|Overall Study|Withdrawal by Subject|335
960114|NCT01126437|1957504|FG002|Overall Study|Withdrawal by Subject|319
960115|NCT01126437|1957502|FG000|Overall Study|Other reason not specified|210
960116|NCT01126437|1957503|FG001|Overall Study|Other reason not specified|176
960117|NCT01126437|1957504|FG002|Overall Study|Other reason not specified|178
960118|NCT01126541|1957515|FG000|Overall Study|Adverse Event|0
960119|NCT01126541|1957516|FG001|Overall Study|Adverse Event|2
960120|NCT01126541|1957517|FG002|Overall Study|Adverse Event|4
960121|NCT01126541|1957515|FG000|Overall Study|Death|0
960122|NCT01126541|1957516|FG001|Overall Study|Death|1
960123|NCT01126541|1957517|FG002|Overall Study|Death|0
960124|NCT01126541|1957515|FG000|Overall Study|Lack of Efficacy|6
960125|NCT01126541|1957516|FG001|Overall Study|Lack of Efficacy|1
960126|NCT01126541|1957517|FG002|Overall Study|Lack of Efficacy|11
960127|NCT01126541|1957515|FG000|Overall Study|Lost to Follow-up|1
960128|NCT01126541|1957516|FG001|Overall Study|Lost to Follow-up|2
960129|NCT01126541|1957517|FG002|Overall Study|Lost to Follow-up|2
960130|NCT01126541|1957515|FG000|Overall Study|Withdrawal by Subject|2
960131|NCT01126541|1957516|FG001|Overall Study|Withdrawal by Subject|5
960132|NCT01126541|1957517|FG002|Overall Study|Withdrawal by Subject|6
960133|NCT01126541|1957515|FG000|Overall Study|Protocol Violation|0
960134|NCT01126541|1957516|FG001|Overall Study|Protocol Violation|0
960135|NCT01126541|1957517|FG002|Overall Study|Protocol Violation|1
960136|NCT01126541|1957515|FG000|Overall Study|Administrative reason or other|1
960137|NCT01126541|1957516|FG001|Overall Study|Administrative reason or other|1
960138|NCT01126541|1957517|FG002|Overall Study|Administrative reason or other|2
960139|NCT01126580|1957530|FG000|Overall Study|Adverse Event|14
960140|NCT01126580|1957531|FG001|Overall Study|Adverse Event|8
960141|NCT01126580|1957532|FG002|Overall Study|Adverse Event|12
960142|NCT01126580|1957530|FG000|Overall Study|Withdrawal by Subject|11
960143|NCT01126580|1957531|FG001|Overall Study|Withdrawal by Subject|19
960144|NCT01126580|1957532|FG002|Overall Study|Withdrawal by Subject|14
960145|NCT01126580|1957530|FG000|Overall Study|Sponsor Decision|5
960146|NCT01126580|1957531|FG001|Overall Study|Sponsor Decision|4
960147|NCT01126580|1957532|FG002|Overall Study|Sponsor Decision|7
960148|NCT01126580|1957530|FG000|Overall Study|Physician Decision|1
960149|NCT01126580|1957531|FG001|Overall Study|Physician Decision|1
960150|NCT01126580|1957532|FG002|Overall Study|Physician Decision|2
960151|NCT01126580|1957530|FG000|Overall Study|Entry Criteria Not Met|1
960152|NCT01126580|1957531|FG001|Overall Study|Entry Criteria Not Met|1
960153|NCT01126580|1957532|FG002|Overall Study|Entry Criteria Not Met|2
960154|NCT01126580|1957530|FG000|Overall Study|Lack of Efficacy|2
960155|NCT01126580|1957531|FG001|Overall Study|Lack of Efficacy|3
960156|NCT01126580|1957532|FG002|Overall Study|Lack of Efficacy|4
960157|NCT01126580|1957530|FG000|Overall Study|Protocol Violation|0
960158|NCT01126580|1957531|FG001|Overall Study|Protocol Violation|1
960159|NCT01126580|1957532|FG002|Overall Study|Protocol Violation|2
960160|NCT01126580|1957530|FG000|Overall Study|Lost to Follow-up|15
960161|NCT01126580|1957531|FG001|Overall Study|Lost to Follow-up|13
960162|NCT01126580|1957532|FG002|Overall Study|Lost to Follow-up|9
960163|NCT01126580|1957530|FG000|Overall Study|Treatment Non-compliance|0
960164|NCT01126580|1957531|FG001|Overall Study|Treatment Non-compliance|2
960165|NCT01126580|1957532|FG002|Overall Study|Treatment Non-compliance|3
960166|NCT01126619|1957554|FG000|Overall Study|Not eligible for the study|2
960167|NCT01126619|1957554|FG000|Overall Study|Investigator decision|4
960168|NCT01126619|1957554|FG000|Overall Study|Serious adverse event|1
960169|NCT01126619|1957554|FG000|Overall Study|Withdrawal by Subject|9
960170|NCT01126619|1957554|FG000|Overall Study|Non-compliance|1
960171|NCT01127061|1957582|FG000|Overall Study|Lost to Follow-up|7
960172|NCT01127061|1957583|FG001|Overall Study|Lost to Follow-up|10
960173|NCT01127061|1957582|FG000|Overall Study|Physician Decision|3
960174|NCT01127061|1957583|FG001|Overall Study|Physician Decision|3
960175|NCT01127139|1957600|FG000|Overall Study|Adverse Event|40
960176|NCT01127139|1957600|FG000|Overall Study|Incompliance|12
960177|NCT01127139|1957600|FG000|Overall Study|Lack of Efficacy|4
960178|NCT01127139|1957600|FG000|Overall Study|Reason not specified|1
960179|NCT01127165|1957609|FG000|Overall Study|Adverse Event|2
960180|NCT01127165|1957610|FG001|Overall Study|Adverse Event|2
960181|NCT01127165|1957609|FG000|Overall Study|Lack of Efficacy|10
960182|NCT01127165|1957610|FG001|Overall Study|Lack of Efficacy|8
960183|NCT01127165|1957609|FG000|Overall Study|Lost to Follow-up|3
960184|NCT01127165|1957610|FG001|Overall Study|Lost to Follow-up|5
960185|NCT01127165|1957609|FG000|Overall Study|Withdrawal by Subject|1
960186|NCT01127165|1957610|FG001|Overall Study|Withdrawal by Subject|3
960187|NCT01127165|1957609|FG000|Overall Study|Protocol Violation|0
960188|NCT01127165|1957610|FG001|Overall Study|Protocol Violation|1
960199|NCT01127373|1957646|FG000|Overall Study|Not Treated|3
960200|NCT01127373|1957646|FG000|Overall Study|Lost to Follow-up|7
960201|NCT01127373|1957646|FG000|Overall Study|Withdrawal by Subject|1
960202|NCT01127373|1957646|FG000|Overall Study|Disease progression|1
960203|NCT01127607|1957682|FG000|Phase II (Between Subjects)|Lost to Follow-up|0
960204|NCT01127607|1957683|FG001|Phase II (Between Subjects)|Lost to Follow-up|2
960205|NCT01127607|1957682|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1
960206|NCT01127607|1957683|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0
960207|NCT01127633|1957708|FG000|Overall Study|Adverse Event|74
960208|NCT01127633|1957709|FG001|Overall Study|Adverse Event|73
960209|NCT01127633|1957708|FG000|Overall Study|Death|40
960210|NCT01127633|1957709|FG001|Overall Study|Death|43
960211|NCT01127633|1957708|FG000|Overall Study|Lost to Follow-up|4
960212|NCT01127633|1957709|FG001|Overall Study|Lost to Follow-up|0
960213|NCT01127633|1957708|FG000|Overall Study|Parent/Caregiver Decision|246
960214|NCT01127633|1957709|FG001|Overall Study|Parent/Caregiver Decision|228
960215|NCT01127633|1957708|FG000|Overall Study|Physician Decision|60
960216|NCT01127633|1957709|FG001|Overall Study|Physician Decision|45
960217|NCT01127633|1957708|FG000|Overall Study|Withdrawal by Subject|57
960218|NCT01127633|1957709|FG001|Overall Study|Withdrawal by Subject|72
960219|NCT01127633|1957708|FG000|Overall Study|Sponsor Decision|163
960220|NCT01127633|1957709|FG001|Overall Study|Sponsor Decision|195
960221|NCT01127633|1957708|FG000|Overall Study|Protocol Violation|8
960222|NCT01127633|1957709|FG001|Overall Study|Protocol Violation|16
960223|NCT01127633|1957708|FG000|Overall Study|Abnormal Lab/ECG Result|0
960224|NCT01127633|1957709|FG001|Overall Study|Abnormal Lab/ECG Result|1
960225|NCT01127633|1957708|FG000|Overall Study|Not treated|1
960226|NCT01127633|1957709|FG001|Overall Study|Not treated|0
960227|NCT01127646|1957717|FG000|Overall Study|Entry Criteria Not Met|1
960228|NCT01127646|1957718|FG001|Overall Study|Entry Criteria Not Met|0
960229|NCT01127646|1957717|FG000|Overall Study|Protocol Violation|0
960230|NCT01127646|1957718|FG001|Overall Study|Protocol Violation|1
960231|NCT01127763|1957760|FG000|Overall Study|Adverse Event|2
960232|NCT01127763|1957760|FG000|Overall Study|Withdrawal by Subject|1
960233|NCT01127763|1957760|FG000|Overall Study|Physician Decision|2
960234|NCT01127893|1957768|FG000|Overall Study|Study Termination by the Sponsor|1
960235|NCT01128153|1957787|FG000|Overall Study|Adverse Event|1
960236|NCT01128153|1957788|FG001|Overall Study|Adverse Event|3
960237|NCT01128153|1957787|FG000|Overall Study|Condition under investigation worsened|8
960238|NCT01128153|1957788|FG001|Overall Study|Condition under investigation worsened|7
960239|NCT01128153|1957787|FG000|Overall Study|Withdrawal by Subject|2
960240|NCT01128153|1957788|FG001|Overall Study|Withdrawal by Subject|3
960241|NCT01128153|1957787|FG000|Overall Study|Incorrect enrolment to study|2
960242|NCT01128153|1957788|FG001|Overall Study|Incorrect enrolment to study|1
960243|NCT01128153|1957787|FG000|Overall Study|Protocol Violation|2
960244|NCT01128153|1957788|FG001|Overall Study|Protocol Violation|0
960245|NCT01128153|1957787|FG000|Overall Study|Developed discontinuation criteria|1
960246|NCT01128153|1957788|FG001|Overall Study|Developed discontinuation criteria|1
960247|NCT01128179|1957796|FG000|Overall Study|Death|1
960248|NCT01128179|1957797|FG001|Overall Study|Death|0
960249|NCT01128179|1957796|FG000|Overall Study|Protocol Violation|1
960250|NCT01128179|1957797|FG001|Overall Study|Protocol Violation|0
960251|NCT01128244|1957818|FG000|Overall Study|Adverse Event|1
960252|NCT01128244|1957818|FG000|Overall Study|Scheduling conflict|2
960253|NCT01128296|1957838|FG000|Overall Study|Physician Decision|0
960254|NCT01128296|1957839|FG001|Overall Study|Physician Decision|0
960255|NCT01128296|1957840|FG002|Overall Study|Physician Decision|0
960256|NCT01128296|1957841|FG003|Overall Study|Physician Decision|0
960257|NCT01128296|1957842|FG004|Overall Study|Physician Decision|0
960258|NCT01128296|1957843|FG005|Overall Study|Physician Decision|3
960259|NCT01128296|1957838|FG000|Overall Study|Withdrawal by Subject|0
960260|NCT01128296|1957839|FG001|Overall Study|Withdrawal by Subject|0
960261|NCT01128296|1957840|FG002|Overall Study|Withdrawal by Subject|0
960262|NCT01128296|1957841|FG003|Overall Study|Withdrawal by Subject|0
960263|NCT01128296|1957842|FG004|Overall Study|Withdrawal by Subject|0
960264|NCT01128296|1957843|FG005|Overall Study|Withdrawal by Subject|2
960265|NCT01128361|1957856|FG000|Overall Study|Lost to Follow-up|0
960266|NCT01128361|1957857|FG001|Overall Study|Lost to Follow-up|1
960267|NCT01128361|1957856|FG000|Overall Study|Withdrawal by Subject|5
911059|NCT00796614|1888222|FG001|Overall Study|Adverse Event|2
911060|NCT00796614|1888223|FG002|Overall Study|Adverse Event|0
911061|NCT00796614|1888224|FG003|Overall Study|Adverse Event|0
911062|NCT00796614|1888221|FG000|Overall Study|Protocol Violation|0
911063|NCT00796614|1888222|FG001|Overall Study|Protocol Violation|0
911064|NCT00796614|1888223|FG002|Overall Study|Protocol Violation|2
911065|NCT00796614|1888224|FG003|Overall Study|Protocol Violation|0
911066|NCT00796614|1888221|FG000|Overall Study|Lost to Follow-up|2
960268|NCT01128361|1957857|FG001|Overall Study|Withdrawal by Subject|2
960269|NCT01128387|1957865|FG000|Overall Study|Physician Decision|0
960270|NCT01128387|1957866|FG001|Overall Study|Physician Decision|1
960271|NCT01128400|1957875|FG000|Overall Study|Lost to Follow-up|1
960272|NCT01128400|1957876|FG001|Overall Study|Lost to Follow-up|0
960273|NCT01128400|1957877|FG002|Overall Study|Lost to Follow-up|1
960274|NCT01128400|1957875|FG000|Overall Study|Screening failure|1
960275|NCT01128400|1957876|FG001|Overall Study|Screening failure|0
960276|NCT01128400|1957877|FG002|Overall Study|Screening failure|0
960277|NCT01128400|1957875|FG000|Overall Study|were not invited to participate on taste|0
960278|NCT01128400|1957876|FG001|Overall Study|were not invited to participate on taste|0
960279|NCT01128400|1957877|FG002|Overall Study|were not invited to participate on taste|15
960280|NCT01128400|1957875|FG000|Overall Study|Excluded due to sinus problems|0
960281|NCT01128400|1957876|FG001|Overall Study|Excluded due to sinus problems|1
960282|NCT01128400|1957877|FG002|Overall Study|Excluded due to sinus problems|0
960283|NCT01128413|1957887|FG000|Overall Study|Withdrawal by Subject|1
960284|NCT01128413|1957888|FG001|Overall Study|Withdrawal by Subject|0
960285|NCT01128413|1957887|FG000|Overall Study|NICOM Monitor Problems|2
960286|NCT01128413|1957888|FG001|Overall Study|NICOM Monitor Problems|1
960287|NCT01128413|1957887|FG000|Overall Study|Pt made DNR|1
960288|NCT01128413|1957888|FG001|Overall Study|Pt made DNR|0
960289|NCT01128543|1957900|FG000|Overall Study|Withdrawal by Subject|3
960290|NCT01128543|1957900|FG000|Overall Study|Protocol Violation|1
960291|NCT01128569|1957904|FG000|Washout Period 1|Adverse Event|0
960292|NCT01128569|1957905|FG001|Washout Period 1|Adverse Event|0
960293|NCT01128569|1957906|FG002|Washout Period 1|Adverse Event|1
960294|NCT01128569|1957907|FG003|Washout Period 1|Adverse Event|0
960295|NCT01128569|1957908|FG004|Washout Period 1|Adverse Event|0
960296|NCT01128569|1957909|FG005|Washout Period 1|Adverse Event|0
960297|NCT01128569|1957904|FG000|Treatment Period 2|Withdrawal by Subject|0
960298|NCT01128569|1957905|FG001|Treatment Period 2|Withdrawal by Subject|1
960299|NCT01128569|1957906|FG002|Treatment Period 2|Withdrawal by Subject|0
960300|NCT01128569|1957907|FG003|Treatment Period 2|Withdrawal by Subject|0
960301|NCT01128569|1957908|FG004|Treatment Period 2|Withdrawal by Subject|0
960302|NCT01128569|1957909|FG005|Treatment Period 2|Withdrawal by Subject|0
960303|NCT01128595|1957917|FG000|Treatment Period 3|Withdrawal by Subject|0
960304|NCT01128595|1957918|FG001|Treatment Period 3|Withdrawal by Subject|1
960305|NCT01128595|1957919|FG002|Treatment Period 3|Withdrawal by Subject|0
960306|NCT01128595|1957920|FG003|Treatment Period 3|Withdrawal by Subject|0
960307|NCT01128621|1957933|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
960308|NCT01128621|1957934|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
960309|NCT01128738|1957958|FG000|First Treatment Phase (TP)|Lost to Follow-up|1
960310|NCT01128738|1957959|FG001|First Treatment Phase (TP)|Lost to Follow-up|0
960311|NCT01128738|1957958|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3
960312|NCT01128738|1957959|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1
960313|NCT01128738|1957958|FG000|Second TP|Lost to Follow-up|0
960314|NCT01128738|1957959|FG001|Second TP|Lost to Follow-up|1
960315|NCT01128738|1957958|FG000|Second TP|Withdrawal by Subject|0
960316|NCT01128738|1957959|FG001|Second TP|Withdrawal by Subject|2
960317|NCT01128842|1957971|FG000|Overall Study|Adverse Event|1
960318|NCT01128842|1957971|FG000|Overall Study|Disease Progression|6
960319|NCT01128894|1957978|FG000|Overall Study|Adverse Event|31
960320|NCT01128894|1957979|FG001|Overall Study|Adverse Event|41
960321|NCT01128894|1957978|FG000|Overall Study|Protocol Violation|2
960322|NCT01128894|1957979|FG001|Overall Study|Protocol Violation|1
960323|NCT01128894|1957978|FG000|Overall Study|Noncompliance|4
960324|NCT01128894|1957979|FG001|Overall Study|Noncompliance|5
960325|NCT01128894|1957978|FG000|Overall Study|Lost to Follow-up|8
960326|NCT01128894|1957979|FG001|Overall Study|Lost to Follow-up|8
960327|NCT01128894|1957978|FG000|Overall Study|Withdrawal by Subject|10
960328|NCT01128894|1957979|FG001|Overall Study|Withdrawal by Subject|12
960329|NCT01128894|1957978|FG000|Overall Study|Physician Decision|2
960330|NCT01128894|1957979|FG001|Overall Study|Physician Decision|1
960331|NCT01128894|1957978|FG000|Overall Study|Conflicting HbA1c Results at Screening|1
960332|NCT01128894|1957979|FG001|Overall Study|Conflicting HbA1c Results at Screening|0
960333|NCT01128946|1957985|FG000|Period I|Protocol Violation|0
960334|NCT01128946|1957986|FG001|Period I|Protocol Violation|1
960335|NCT01128946|1957987|FG002|Period I|Protocol Violation|0
960336|NCT01128946|1957988|FG003|Period I|Protocol Violation|0
960337|NCT01128946|1957985|FG000|Period I|Withdrawal by Subject|0
960338|NCT01128946|1957986|FG001|Period I|Withdrawal by Subject|0
960339|NCT01128946|1957987|FG002|Period I|Withdrawal by Subject|1
960340|NCT01128946|1957988|FG003|Period I|Withdrawal by Subject|1
960341|NCT01128946|1957985|FG000|Period II|Protocol Violation|0
960342|NCT01128946|1957986|FG001|Period II|Protocol Violation|1
960343|NCT01128946|1957987|FG002|Period II|Protocol Violation|0
960344|NCT01128946|1957988|FG003|Period II|Protocol Violation|0
960345|NCT01128946|1957985|FG000|Period II|Withdrawal by Subject|0
960346|NCT01128946|1957986|FG001|Period II|Withdrawal by Subject|0
960347|NCT01128946|1957987|FG002|Period II|Withdrawal by Subject|0
960348|NCT01128946|1957988|FG003|Period II|Withdrawal by Subject|1
960349|NCT01128946|1957985|FG000|Period III|Protocol Violation|1
960350|NCT01128946|1957986|FG001|Period III|Protocol Violation|0
960351|NCT01128946|1957987|FG002|Period III|Protocol Violation|0
960352|NCT01128946|1957988|FG003|Period III|Protocol Violation|0
960353|NCT01128959|1957999|FG000|Lead in Period|Adverse Event|3
960354|NCT01128959|1957999|FG000|Treatment Period|Adverse Event|3
960355|NCT01128959|1957999|FG000|Treatment Period|Withdrawal by Subject|1
960356|NCT01129011|1958029|FG000|Overall Study|Adverse Event|20
960357|NCT01129011|1958030|FG001|Overall Study|Adverse Event|30
960358|NCT01129011|1958029|FG000|Overall Study|Withdrawal by Subject|24
960359|NCT01129011|1958030|FG001|Overall Study|Withdrawal by Subject|8
960360|NCT01129011|1958029|FG000|Overall Study|Lost to Follow-up|6
960361|NCT01129011|1958030|FG001|Overall Study|Lost to Follow-up|7
960362|NCT01129011|1958029|FG000|Overall Study|Duodenal Ulcer|2
960363|NCT01129011|1958030|FG001|Overall Study|Duodenal Ulcer|8
960364|NCT01129011|1958029|FG000|Overall Study|misc|7
960365|NCT01129011|1958030|FG001|Overall Study|misc|4
960366|NCT01129024|1958036|FG000|Overall Study|Physician Decision|5
960367|NCT01129024|1958036|FG000|Overall Study|Study Terminated by Sponsor|8
960368|NCT01129024|1958036|FG000|Overall Study|Withdrawal by Subject|2
960369|NCT01129024|1958036|FG000|Overall Study|Lack of Efficacy|3
960370|NCT01129024|1958036|FG000|Overall Study|Needed a Platelet Transfusion|1
960371|NCT01129102|1958043|FG000|Overall Study|No study drug treatment|2
960372|NCT01129102|1958044|FG001|Overall Study|No study drug treatment|3
960373|NCT01129102|1958045|FG002|Overall Study|No study drug treatment|1
960374|NCT01129102|1958043|FG000|Overall Study|Withdrawal by Subject|2
960375|NCT01129102|1958044|FG001|Overall Study|Withdrawal by Subject|0
960376|NCT01129102|1958045|FG002|Overall Study|Withdrawal by Subject|3
960377|NCT01129102|1958043|FG000|Overall Study|Protocol Violation|0
960378|NCT01129102|1958044|FG001|Overall Study|Protocol Violation|1
960379|NCT01129102|1958045|FG002|Overall Study|Protocol Violation|1
960380|NCT01129102|1958043|FG000|Overall Study|Pregnancy|0
960381|NCT01129102|1958044|FG001|Overall Study|Pregnancy|0
960382|NCT01129102|1958045|FG002|Overall Study|Pregnancy|1
960383|NCT01129102|1958043|FG000|Overall Study|Adverse Event|2
960384|NCT01129102|1958044|FG001|Overall Study|Adverse Event|2
960385|NCT01129102|1958045|FG002|Overall Study|Adverse Event|1
960386|NCT01129102|1958043|FG000|Overall Study|Lost to Follow-up|2
960387|NCT01129102|1958044|FG001|Overall Study|Lost to Follow-up|0
960388|NCT01129102|1958045|FG002|Overall Study|Lost to Follow-up|0
960389|NCT01129115|1958056|FG000|Overall Study|Adverse Event|1
960390|NCT01129115|1958057|FG001|Overall Study|Adverse Event|2
960391|NCT01129115|1958058|FG002|Overall Study|Adverse Event|3
960392|NCT01129115|1958059|FG003|Overall Study|Adverse Event|3
960393|NCT01129115|1958056|FG000|Overall Study|Withdrawal by Subject|1
960394|NCT01129115|1958057|FG001|Overall Study|Withdrawal by Subject|3
960395|NCT01129115|1958058|FG002|Overall Study|Withdrawal by Subject|1
960396|NCT01129115|1958059|FG003|Overall Study|Withdrawal by Subject|4
960397|NCT01129115|1958056|FG000|Overall Study|Protocol Violation|0
960398|NCT01129115|1958057|FG001|Overall Study|Protocol Violation|2
960399|NCT01129115|1958058|FG002|Overall Study|Protocol Violation|2
960400|NCT01129115|1958059|FG003|Overall Study|Protocol Violation|2
960401|NCT01129128|1958072|FG000|Overall Study|Lost to Follow-up|2
960402|NCT01129128|1958073|FG001|Overall Study|Lost to Follow-up|2
960403|NCT01129128|1958074|FG002|Overall Study|Lost to Follow-up|1
960404|NCT01129128|1958072|FG000|Overall Study|Protocol Violation|0
960405|NCT01129128|1958073|FG001|Overall Study|Protocol Violation|1
960406|NCT01129128|1958074|FG002|Overall Study|Protocol Violation|0
960407|NCT01129128|1958072|FG000|Overall Study|Withdrawal by Subject|0
960408|NCT01129128|1958073|FG001|Overall Study|Withdrawal by Subject|1
960409|NCT01129128|1958074|FG002|Overall Study|Withdrawal by Subject|3
960410|NCT01129128|1958072|FG000|Overall Study|Physician Decision|1
960411|NCT01129128|1958073|FG001|Overall Study|Physician Decision|0
960412|NCT01129128|1958074|FG002|Overall Study|Physician Decision|0
960413|NCT01129284|1958113|FG000|Overall Study|Adverse Event|2
960414|NCT01129284|1958114|FG001|Overall Study|Adverse Event|0
960415|NCT01129284|1958115|FG002|Overall Study|Adverse Event|1
960416|NCT01129336|1958125|FG000|Overall Study|Protocol Violation|1
960417|NCT01129336|1958126|FG001|Overall Study|Protocol Violation|0
960418|NCT01129336|1958125|FG000|Overall Study|Disease Progression|1
960419|NCT01129336|1958126|FG001|Overall Study|Disease Progression|4
960420|NCT01129336|1958125|FG000|Overall Study|Lost to Follow-up|1
960421|NCT01129336|1958126|FG001|Overall Study|Lost to Follow-up|0
960422|NCT01129336|1958125|FG000|Overall Study|Withdrawal by Subject|7
960423|NCT01129336|1958126|FG001|Overall Study|Withdrawal by Subject|4
960424|NCT01129336|1958125|FG000|Overall Study|Adverse Event|0
960425|NCT01129336|1958126|FG001|Overall Study|Adverse Event|1
960426|NCT01129336|1958125|FG000|Overall Study|Missing Study Completion Status|2
960427|NCT01129336|1958126|FG001|Overall Study|Missing Study Completion Status|3
960428|NCT01129336|1958125|FG000|Overall Study|Death|0
960429|NCT01129336|1958126|FG001|Overall Study|Death|4
960430|NCT01129557|1958162|FG000|Overall Study|Adverse Event|1
960431|NCT01129557|1958163|FG001|Overall Study|Adverse Event|2
960432|NCT01129557|1958164|FG002|Overall Study|Adverse Event|2
960433|NCT01129557|1958162|FG000|Overall Study|Novartis terminated study early|3
960434|NCT01129557|1958163|FG001|Overall Study|Novartis terminated study early|3
960435|NCT01129557|1958164|FG002|Overall Study|Novartis terminated study early|2
960436|NCT01129583|1958185|FG000|Overall Study|Death|1
960437|NCT01129583|1958186|FG001|Overall Study|Death|0
960438|NCT01129583|1958185|FG000|Overall Study|Lost to Follow-up|1
960439|NCT01129583|1958186|FG001|Overall Study|Lost to Follow-up|1
960440|NCT01129583|1958185|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1
960441|NCT01129583|1958186|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1
960442|NCT01129622|1958196|FG000|Overall Study|Withdrawal by Subject|2
960443|NCT01129882|1958218|FG000|Overall Study|Adverse Event|39
960444|NCT01129882|1958218|FG000|Overall Study|Death|6
960445|NCT01129882|1958218|FG000|Overall Study|Lack of Efficacy|5
960446|NCT01129882|1958218|FG000|Overall Study|Lost to Follow-up|13
960447|NCT01129882|1958218|FG000|Overall Study|Physician Decision|27
960448|NCT01129882|1958218|FG000|Overall Study|Protocol Deviation|3
960449|NCT01129882|1958218|FG000|Overall Study|Withdrawal Criteria Met|19
960450|NCT01129882|1958218|FG000|Overall Study|Trial Termination by Sponsor|6
960451|NCT01129882|1958218|FG000|Overall Study|Withdrawal by Subject|160
960452|NCT01129921|1958224|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
960453|NCT01129921|1958225|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
960454|NCT01129921|1958224|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
960455|NCT01129921|1958225|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
960456|NCT01129921|1958224|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
960457|NCT01129921|1958225|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
960458|NCT01129921|1958224|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
960459|NCT01129921|1958225|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
960460|NCT01129960|1958239|FG000|Overall Study|Withdrawal by Subject|3
960461|NCT01129960|1958240|FG001|Overall Study|Withdrawal by Subject|0
960462|NCT01129960|1958241|FG002|Overall Study|Withdrawal by Subject|3
960463|NCT01129960|1958242|FG003|Overall Study|Withdrawal by Subject|2
960464|NCT01129960|1958239|FG000|Overall Study|Lack of Efficacy|1
960465|NCT01129960|1958240|FG001|Overall Study|Lack of Efficacy|1
960466|NCT01129960|1958241|FG002|Overall Study|Lack of Efficacy|1
960467|NCT01129960|1958242|FG003|Overall Study|Lack of Efficacy|1
960468|NCT01129960|1958239|FG000|Overall Study|Adverse Event|23
960469|NCT01129960|1958240|FG001|Overall Study|Adverse Event|16
960470|NCT01129960|1958241|FG002|Overall Study|Adverse Event|16
960471|NCT01129960|1958242|FG003|Overall Study|Adverse Event|7
960472|NCT01129960|1958239|FG000|Overall Study|Protocol Violation|1
960473|NCT01129960|1958240|FG001|Overall Study|Protocol Violation|2
960474|NCT01129960|1958241|FG002|Overall Study|Protocol Violation|3
960475|NCT01129960|1958242|FG003|Overall Study|Protocol Violation|0
960476|NCT01129960|1958239|FG000|Overall Study|Lost to Follow-up|0
960477|NCT01129960|1958240|FG001|Overall Study|Lost to Follow-up|2
960478|NCT01129960|1958241|FG002|Overall Study|Lost to Follow-up|3
960479|NCT01129960|1958242|FG003|Overall Study|Lost to Follow-up|3
960480|NCT01129960|1958239|FG000|Overall Study|Discontinuation of the study by Sponsor|0
960481|NCT01129960|1958240|FG001|Overall Study|Discontinuation of the study by Sponsor|1
960482|NCT01129960|1958241|FG002|Overall Study|Discontinuation of the study by Sponsor|0
960483|NCT01129960|1958242|FG003|Overall Study|Discontinuation of the study by Sponsor|0
960484|NCT01129960|1958239|FG000|Overall Study|Physician Decision|1
960485|NCT01129960|1958240|FG001|Overall Study|Physician Decision|0
960486|NCT01129960|1958241|FG002|Overall Study|Physician Decision|0
960487|NCT01129960|1958242|FG003|Overall Study|Physician Decision|0
960488|NCT01129960|1958239|FG000|Overall Study|Pregnancy|1
960489|NCT01129960|1958240|FG001|Overall Study|Pregnancy|0
960490|NCT01129960|1958241|FG002|Overall Study|Pregnancy|0
960491|NCT01129960|1958242|FG003|Overall Study|Pregnancy|0
960492|NCT01130051|1958252|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
960493|NCT01130051|1958253|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
960494|NCT01130051|1958252|FG000|Washout Period of 14 Days|Protocol Violation|1
960495|NCT01130051|1958253|FG001|Washout Period of 14 Days|Protocol Violation|1
960496|NCT01130103|1958261|FG000|Randomized Treatment|Adverse Event|1
960497|NCT01130103|1958262|FG001|Randomized Treatment|Adverse Event|1
960498|NCT01130103|1958261|FG000|Randomized Treatment|Lost to Follow-up|1
960499|NCT01130103|1958262|FG001|Randomized Treatment|Lost to Follow-up|0
960500|NCT01130103|1958261|FG000|Randomized Treatment|Protocol Violation|3
960501|NCT01130103|1958262|FG001|Randomized Treatment|Protocol Violation|2
960502|NCT01130103|1958261|FG000|Randomized Treatment|Withdrawal by Subject|1
960503|NCT01130103|1958262|FG001|Randomized Treatment|Withdrawal by Subject|2
960504|NCT01130103|1958261|FG000|Maintenance Treatment|Lack of Efficacy|0
960505|NCT01130103|1958262|FG001|Maintenance Treatment|Lack of Efficacy|1
960506|NCT01130103|1958261|FG000|Maintenance Treatment|Lost to Follow-up|1
960507|NCT01130103|1958262|FG001|Maintenance Treatment|Lost to Follow-up|1
960508|NCT01130103|1958261|FG000|Maintenance Treatment|Withdrawal by Subject|1
960509|NCT01130103|1958262|FG001|Maintenance Treatment|Withdrawal by Subject|0
960510|NCT01130168|1958268|FG000|Period 1|Withdrawal by Subject|0
960511|NCT01130168|1958269|FG001|Period 1|Withdrawal by Subject|1
960512|NCT01130168|1958270|FG002|Period 1|Withdrawal by Subject|0
960513|NCT01130168|1958271|FG003|Period 1|Withdrawal by Subject|1
960514|NCT01130168|1958272|FG004|Period 1|Withdrawal by Subject|0
960515|NCT01130168|1958273|FG005|Period 1|Withdrawal by Subject|0
960516|NCT01130168|1958268|FG000|Period 1|Discontinued For Other Reason|0
960517|NCT01130168|1958269|FG001|Period 1|Discontinued For Other Reason|0
960518|NCT01130168|1958270|FG002|Period 1|Discontinued For Other Reason|1
960519|NCT01130168|1958271|FG003|Period 1|Discontinued For Other Reason|1
960520|NCT01130168|1958272|FG004|Period 1|Discontinued For Other Reason|0
960521|NCT01130168|1958273|FG005|Period 1|Discontinued For Other Reason|0
960522|NCT01130168|1958268|FG000|Period 1|Adverse Event|0
960523|NCT01130168|1958269|FG001|Period 1|Adverse Event|0
960524|NCT01130168|1958270|FG002|Period 1|Adverse Event|0
960525|NCT01130168|1958271|FG003|Period 1|Adverse Event|1
960526|NCT01130168|1958272|FG004|Period 1|Adverse Event|0
960527|NCT01130168|1958273|FG005|Period 1|Adverse Event|0
960528|NCT01130272|1958287|FG000|Overall Study|Adverse Event|2
960529|NCT01130272|1958288|FG001|Overall Study|Adverse Event|5
960530|NCT01130272|1958289|FG002|Overall Study|Adverse Event|6
960531|NCT01130272|1958290|FG003|Overall Study|Adverse Event|22
960532|NCT01130272|1958291|FG004|Overall Study|Adverse Event|7
960533|NCT01130272|1958287|FG000|Overall Study|IVRS-confirmed constipation|0
960534|NCT01130272|1958288|FG001|Overall Study|IVRS-confirmed constipation|1
960535|NCT01130272|1958289|FG002|Overall Study|IVRS-confirmed constipation|1
960536|NCT01130272|1958290|FG003|Overall Study|IVRS-confirmed constipation|2
960537|NCT01130272|1958291|FG004|Overall Study|IVRS-confirmed constipation|0
960538|NCT01130272|1958287|FG000|Overall Study|Rescue medications due to diarrhea|3
960539|NCT01130272|1958288|FG001|Overall Study|Rescue medications due to diarrhea|5
960540|NCT01130272|1958289|FG002|Overall Study|Rescue medications due to diarrhea|8
960541|NCT01130272|1958290|FG003|Overall Study|Rescue medications due to diarrhea|8
960542|NCT01130272|1958291|FG004|Overall Study|Rescue medications due to diarrhea|6
960543|NCT01130272|1958287|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
960544|NCT01130272|1958288|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
960545|NCT01130272|1958289|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
960546|NCT01130272|1958290|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
960547|NCT01130272|1958291|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
960548|NCT01130272|1958287|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
960549|NCT01130272|1958288|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
960550|NCT01130272|1958289|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
960551|NCT01130272|1958290|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
960552|NCT01130272|1958291|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
960553|NCT01130272|1958287|FG000|Overall Study|Protocol Violation|0
960554|NCT01130272|1958288|FG001|Overall Study|Protocol Violation|0
960555|NCT01130272|1958289|FG002|Overall Study|Protocol Violation|3
960556|NCT01130272|1958290|FG003|Overall Study|Protocol Violation|5
960557|NCT01130272|1958291|FG004|Overall Study|Protocol Violation|5
960558|NCT01130272|1958287|FG000|Overall Study|Lost to Follow-up|4
960559|NCT01130272|1958288|FG001|Overall Study|Lost to Follow-up|3
960560|NCT01130272|1958289|FG002|Overall Study|Lost to Follow-up|4
960561|NCT01130272|1958290|FG003|Overall Study|Lost to Follow-up|7
960562|NCT01130272|1958291|FG004|Overall Study|Lost to Follow-up|6
960563|NCT01130272|1958287|FG000|Overall Study|Withdrawal by Subject|4
960564|NCT01130272|1958288|FG001|Overall Study|Withdrawal by Subject|11
960565|NCT01130272|1958289|FG002|Overall Study|Withdrawal by Subject|10
960566|NCT01130272|1958290|FG003|Overall Study|Withdrawal by Subject|9
960567|NCT01130272|1958291|FG004|Overall Study|Withdrawal by Subject|8
960568|NCT01130272|1958287|FG000|Overall Study|Physician Decision|1
960569|NCT01130272|1958288|FG001|Overall Study|Physician Decision|1
960570|NCT01130272|1958289|FG002|Overall Study|Physician Decision|0
960571|NCT01130272|1958290|FG003|Overall Study|Physician Decision|1
960572|NCT01130272|1958291|FG004|Overall Study|Physician Decision|2
960573|NCT01130272|1958287|FG000|Overall Study|Sponsor decision|6
960574|NCT01130272|1958288|FG001|Overall Study|Sponsor decision|15
960575|NCT01130272|1958289|FG002|Overall Study|Sponsor decision|16
960576|NCT01130272|1958290|FG003|Overall Study|Sponsor decision|13
960577|NCT01130272|1958291|FG004|Overall Study|Sponsor decision|16
960578|NCT01130272|1958287|FG000|Overall Study|Study arm discontinued|38
960579|NCT01130272|1958288|FG001|Overall Study|Study arm discontinued|0
960580|NCT01130272|1958289|FG002|Overall Study|Study arm discontinued|0
960581|NCT01130272|1958290|FG003|Overall Study|Study arm discontinued|0
960582|NCT01130272|1958291|FG004|Overall Study|Study arm discontinued|0
960583|NCT01130337|1958303|FG000|Overall Study|Withdrawal by Subject|3
960584|NCT01130337|1958303|FG000|Overall Study|Principal investigator decision|1
960585|NCT01130337|1958303|FG000|Overall Study|Death|1
960586|NCT01130337|1958303|FG000|Overall Study|Disease progression|1
960587|NCT01130337|1958303|FG000|Overall Study|Toxicity, AE/intercurrent disease|7
960588|NCT01130337|1958303|FG000|Overall Study|Surgical resection (R2)|1
960589|NCT01130493|1958307|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1
960590|NCT01130493|1958308|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0
960591|NCT01130493|1958309|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0
960592|NCT01130493|1958307|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3
960593|NCT01130493|1958308|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0
960594|NCT01130493|1958309|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0
960595|NCT01130493|1958307|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
960596|NCT01130493|1958308|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
960597|NCT01130493|1958309|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
960598|NCT01130493|1958307|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
960599|NCT01130493|1958308|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
960600|NCT01130493|1958309|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
960601|NCT01130493|1958307|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1
960602|NCT01130493|1958308|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0
960603|NCT01130493|1958309|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0
960604|NCT01130493|1958307|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
960605|NCT01130493|1958308|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
960606|NCT01130493|1958309|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
960607|NCT01130493|1958307|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
960608|NCT01130493|1958308|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
960609|NCT01130493|1958309|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
960610|NCT01130493|1958307|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
960611|NCT01130493|1958308|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
960612|NCT01130493|1958309|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
960613|NCT01130493|1958307|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0
960614|NCT01130493|1958308|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0
960615|NCT01130493|1958309|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1
960616|NCT01130493|1958307|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
960617|NCT01130493|1958308|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
960618|NCT01130493|1958309|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
960619|NCT01130493|1958307|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
960620|NCT01130493|1958308|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
960621|NCT01130493|1958309|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
960622|NCT01130493|1958307|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0
960623|NCT01130493|1958308|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0
960624|NCT01130493|1958309|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1
960625|NCT01130493|1958307|FG000|Part 2: OLE|Adverse Event|0
960626|NCT01130493|1958308|FG001|Part 2: OLE|Adverse Event|2
960627|NCT01130493|1958309|FG002|Part 2: OLE|Adverse Event|1
960628|NCT01130493|1958307|FG000|Part 2: OLE|Withdrawal by Subject|0
960629|NCT01130493|1958308|FG001|Part 2: OLE|Withdrawal by Subject|1
960630|NCT01130493|1958309|FG002|Part 2: OLE|Withdrawal by Subject|4
960631|NCT01130532|1958323|FG000|Period III (Weeks 0-12)|Adverse Event|3
960632|NCT01130532|1958324|FG001|Period III (Weeks 0-12)|Adverse Event|3
960633|NCT01130532|1958325|FG002|Period III (Weeks 0-12)|Adverse Event|2
960634|NCT01130532|1958326|FG003|Period III (Weeks 0-12)|Adverse Event|0
960635|NCT01130532|1958323|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4
960636|NCT01130532|1958324|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2
960637|NCT01130532|1958325|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4
960638|NCT01130532|1958326|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0
960639|NCT01130532|1958323|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2
960640|NCT01130532|1958324|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0
960641|NCT01130532|1958325|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1
960642|NCT01130532|1958326|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0
960643|NCT01130532|1958323|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2
960644|NCT01130532|1958324|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2
960645|NCT01130532|1958325|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3
960646|NCT01130532|1958326|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0
960647|NCT01130532|1958323|FG000|Period III (Weeks 0-12)|Protocol Violation|0
960648|NCT01130532|1958324|FG001|Period III (Weeks 0-12)|Protocol Violation|0
960649|NCT01130532|1958325|FG002|Period III (Weeks 0-12)|Protocol Violation|1
960650|NCT01130532|1958326|FG003|Period III (Weeks 0-12)|Protocol Violation|0
960651|NCT01130532|1958323|FG000|Period III (Weeks 0-12)|Sponsor Decision|3
960652|NCT01130532|1958324|FG001|Period III (Weeks 0-12)|Sponsor Decision|4
960653|NCT01130532|1958325|FG002|Period III (Weeks 0-12)|Sponsor Decision|2
960654|NCT01130532|1958326|FG003|Period III (Weeks 0-12)|Sponsor Decision|0
960655|NCT01130532|1958323|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7
960656|NCT01130532|1958324|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7
960657|NCT01130532|1958325|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6
960658|NCT01130532|1958326|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0
960659|NCT01130532|1958323|FG000|Period IV (Weeks 13-16)|Adverse Event|0
960660|NCT01130532|1958324|FG001|Period IV (Weeks 13-16)|Adverse Event|0
960661|NCT01130532|1958325|FG002|Period IV (Weeks 13-16)|Adverse Event|0
960662|NCT01130532|1958326|FG003|Period IV (Weeks 13-16)|Adverse Event|1
960663|NCT01130532|1958323|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
960664|NCT01130532|1958324|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
960665|NCT01130532|1958325|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
960666|NCT01130532|1958326|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
960667|NCT01130532|1958323|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0
960668|NCT01130532|1958324|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0
960669|NCT01130532|1958325|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0
960670|NCT01130532|1958326|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5
960671|NCT01130532|1958323|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0
960672|NCT01130532|1958324|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0
960673|NCT01130532|1958325|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0
960674|NCT01130532|1958326|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3
960675|NCT01130597|1958338|FG000|Overall Study|Protocol-specified (High K+)|1
960676|NCT01130597|1958338|FG000|Overall Study|Adverse Event|4
960677|NCT01130597|1958338|FG000|Overall Study|Death|1
960678|NCT01130597|1958338|FG000|Overall Study|Protocol Violation|1
960679|NCT01130831|1958351|FG000|Overall Study|Withdrawal by Subject|7
960680|NCT01130831|1958351|FG000|Overall Study|Death|4
960681|NCT01130831|1958351|FG000|Overall Study|Information was missing|3
960682|NCT01130883|1958383|FG000|Overall Study|Patient Noncompliance|6
960683|NCT01130883|1958383|FG000|Overall Study|Reason Unknown|1
960684|NCT01130883|1958383|FG000|Overall Study|Adverse Event|3
960685|NCT01130974|1958393|FG000|Overall Study|Protocol Violation|10
960686|NCT01130974|1958394|FG001|Overall Study|Protocol Violation|10
960687|NCT01130974|1958393|FG000|Overall Study|Withdrawal by Subject|0
960688|NCT01130974|1958394|FG001|Overall Study|Withdrawal by Subject|1
960689|NCT01130974|1958393|FG000|Overall Study|Ineligibility criteria|5
960690|NCT01130974|1958394|FG001|Overall Study|Ineligibility criteria|2
960691|NCT01131078|1958417|FG000|Overall Study|Adverse Event|22
960692|NCT01131078|1958418|FG001|Overall Study|Adverse Event|12
960693|NCT01131078|1958419|FG002|Overall Study|Adverse Event|17
960694|NCT01131078|1958417|FG000|Overall Study|Progressive Disease|58
960695|NCT01131078|1958418|FG001|Overall Study|Progressive Disease|77
960696|NCT01131078|1958419|FG002|Overall Study|Progressive Disease|71
960697|NCT01131078|1958417|FG000|Overall Study|Protocol Violation|1
960698|NCT01131078|1958418|FG001|Overall Study|Protocol Violation|0
960699|NCT01131078|1958419|FG002|Overall Study|Protocol Violation|0
960700|NCT01131078|1958417|FG000|Overall Study|Lost to Follow-up|1
960701|NCT01131078|1958418|FG001|Overall Study|Lost to Follow-up|1
960702|NCT01131078|1958419|FG002|Overall Study|Lost to Follow-up|1
960703|NCT01131078|1958417|FG000|Overall Study|Withdrawal by Subject|2
960704|NCT01131078|1958418|FG001|Overall Study|Withdrawal by Subject|4
960705|NCT01131078|1958419|FG002|Overall Study|Withdrawal by Subject|3
960706|NCT01131078|1958417|FG000|Overall Study|Non-compliance|3
960707|NCT01131078|1958418|FG001|Overall Study|Non-compliance|0
960708|NCT01131078|1958419|FG002|Overall Study|Non-compliance|0
960709|NCT01131078|1958417|FG000|Overall Study|Physician Decision|10
960710|NCT01131078|1958418|FG001|Overall Study|Physician Decision|6
960711|NCT01131078|1958419|FG002|Overall Study|Physician Decision|8
960712|NCT01131078|1958417|FG000|Overall Study|Death|4
960713|NCT01131078|1958418|FG001|Overall Study|Death|0
960714|NCT01131078|1958419|FG002|Overall Study|Death|2
960715|NCT01131078|1958417|FG000|Overall Study|Other|0
960716|NCT01131078|1958418|FG001|Overall Study|Other|1
960717|NCT01131078|1958419|FG002|Overall Study|Other|0
960718|NCT01131104|1958429|FG000|Overall Study|Withdrawal by Subject|3
960719|NCT01131104|1958429|FG000|Overall Study|Physician Decision|4
960720|NCT01131104|1958429|FG000|Overall Study|Information Not Available|5
960721|NCT01131104|1958429|FG000|Overall Study|No Information on Index Date of Onset|1
960722|NCT01131130|1958433|FG000|Period 1 - Baseline|Pregnancy|1
960723|NCT01131130|1958433|FG000|Period 3- Crossover|+ Slit lamp finding|1
960724|NCT01131182|1958443|FG000|Overall Study|Withdrawal by Subject|1
960725|NCT01131182|1958444|FG001|Overall Study|Withdrawal by Subject|1
960726|NCT01131182|1958443|FG000|Overall Study|Lost to Follow-up|14
960727|NCT01131182|1958444|FG001|Overall Study|Lost to Follow-up|15
960728|NCT01131182|1958443|FG000|Overall Study|Other Reason|1
960729|NCT01131182|1958444|FG001|Overall Study|Other Reason|0
960730|NCT01131260|1958452|FG000|Overall Study|Randomization error|5
960731|NCT01131260|1958453|FG001|Overall Study|Randomization error|1
960732|NCT01131260|1958452|FG000|Overall Study|Declined to continue participation|8
960733|NCT01131260|1958453|FG001|Overall Study|Declined to continue participation|13
960734|NCT01131260|1958452|FG000|Overall Study|Physician Decision|22
960735|NCT01131260|1958453|FG001|Overall Study|Physician Decision|24
960736|NCT01131260|1958452|FG000|Overall Study|Technical problems|7
960737|NCT01131260|1958453|FG001|Overall Study|Technical problems|6
960738|NCT01131260|1958452|FG000|Overall Study|Staff error|2
960739|NCT01131260|1958453|FG001|Overall Study|Staff error|1
960740|NCT01131260|1958452|FG000|Overall Study|Ineligible|0
960741|NCT01131260|1958453|FG001|Overall Study|Ineligible|2
960742|NCT01131299|1958461|FG000|Overall Study|Withdrawal by Subject|4
960743|NCT01131299|1958462|FG001|Overall Study|Withdrawal by Subject|7
960744|NCT01131312|1958470|FG000|Overall Study|Lost to Follow-up|425
960745|NCT01131312|1958471|FG001|Overall Study|Lost to Follow-up|229
960746|NCT01131312|1958472|FG002|Overall Study|Lost to Follow-up|351
960747|NCT01131325|1958480|FG000|Overall Study|Adverse Event|1
960748|NCT01131325|1958480|FG000|Overall Study|The participants discontinued the study as the study got terminated|2
960749|NCT01131494|1958493|FG000|Overall Study|Withdrawal by Subject|2
960750|NCT01131507|1958498|FG000|Overall Study|Adverse Event|1
960751|NCT01131507|1958498|FG000|Overall Study|Lost to Follow-up|1
960752|NCT01131507|1958498|FG000|Overall Study|Withdrawal by Subject|1
960753|NCT01131520|1958504|FG000|Overall Study|Computer problem|1
960754|NCT01131520|1958505|FG001|Overall Study|Computer problem|0
960755|NCT01131520|1958504|FG000|Overall Study|Counselor not available|0
960756|NCT01131520|1958505|FG001|Overall Study|Counselor not available|3
960757|NCT01131520|1958504|FG000|Overall Study|Subject changed history after enrollment|0
960758|NCT01131520|1958505|FG001|Overall Study|Subject changed history after enrollment|1
960759|NCT01131585|1958513|FG000|Overall Study|Adverse Event|0
960760|NCT01131585|1958514|FG001|Overall Study|Adverse Event|2
960761|NCT01131585|1958513|FG000|Overall Study|Abnormal laboratory value|1
960762|NCT01131585|1958514|FG001|Overall Study|Abnormal laboratory value|0
960763|NCT01131585|1958513|FG000|Overall Study|Unsatisfactory therapeutic effect|0
960764|NCT01131585|1958514|FG001|Overall Study|Unsatisfactory therapeutic effect|3
960765|NCT01131585|1958513|FG000|Overall Study|Protocol Violation|2
960766|NCT01131585|1958514|FG001|Overall Study|Protocol Violation|1
960767|NCT01131585|1958513|FG000|Overall Study|Withdrawal by Subject|3
960768|NCT01131585|1958514|FG001|Overall Study|Withdrawal by Subject|3
960769|NCT01131585|1958513|FG000|Overall Study|Lost to Follow-up|0
960770|NCT01131585|1958514|FG001|Overall Study|Lost to Follow-up|1
960771|NCT01131585|1958513|FG000|Overall Study|Administrative problems|1
960772|NCT01131585|1958514|FG001|Overall Study|Administrative problems|1
960773|NCT01131585|1958513|FG000|Overall Study|Study termination|78
960774|NCT01131585|1958514|FG001|Overall Study|Study termination|32
960775|NCT01131676|1958523|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5
960776|NCT01131676|1958524|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3
960777|NCT01131676|1958525|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4
960778|NCT01131676|1958523|FG000|Discontinuation From Treatment|Not treated|4
960779|NCT01131676|1958524|FG001|Discontinuation From Treatment|Not treated|2
960780|NCT01131676|1958525|FG002|Discontinuation From Treatment|Not treated|2
960781|NCT01131676|1958523|FG000|Discontinuation From Treatment|Lack of Efficacy|11
960782|NCT01131676|1958524|FG001|Discontinuation From Treatment|Lack of Efficacy|1
960783|NCT01131676|1958525|FG002|Discontinuation From Treatment|Lack of Efficacy|0
960784|NCT01131676|1958523|FG000|Discontinuation From Treatment|Non compliant with protocol|15
960785|NCT01131676|1958524|FG001|Discontinuation From Treatment|Non compliant with protocol|15
960786|NCT01131676|1958525|FG002|Discontinuation From Treatment|Non compliant with protocol|12
960787|NCT01131676|1958523|FG000|Discontinuation From Treatment|Lost to Follow-up|15
960788|NCT01131676|1958524|FG001|Discontinuation From Treatment|Lost to Follow-up|9
960789|NCT01131676|1958525|FG002|Discontinuation From Treatment|Lost to Follow-up|6
960790|NCT01131676|1958523|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172
960791|NCT01131676|1958524|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118
960792|NCT01131676|1958525|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122
960793|NCT01131676|1958523|FG000|Discontinuation From Treatment|Other than those specified|162
960794|NCT01131676|1958524|FG001|Discontinuation From Treatment|Other than those specified|142
960795|NCT01131676|1958525|FG002|Discontinuation From Treatment|Other than those specified|125
960796|NCT01131676|1958523|FG000|Discontinuation From Treatment|Adverse Event|303
960797|NCT01131676|1958524|FG001|Discontinuation From Treatment|Adverse Event|267
960798|NCT01131676|1958525|FG002|Discontinuation From Treatment|Adverse Event|273
960799|NCT01131676|1958523|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
960800|NCT01131676|1958524|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
960801|NCT01131676|1958525|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
960802|NCT01131676|1958523|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
960803|NCT01131676|1958524|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
960804|NCT01131676|1958525|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
960805|NCT01131676|1958523|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
960806|NCT01131676|1958524|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
960807|NCT01131676|1958525|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
960808|NCT01131676|1958523|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
960809|NCT01131676|1958524|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
960810|NCT01131676|1958525|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
960811|NCT01131676|1958523|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
960812|NCT01131676|1958524|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
960813|NCT01131676|1958525|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
960814|NCT01131676|1958523|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
960815|NCT01131676|1958524|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
960816|NCT01131676|1958525|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
960817|NCT01132118|1958536|FG000|First Intervention (8 Weeks)|Adverse Event|1
960818|NCT01132118|1958537|FG001|First Intervention (8 Weeks)|Adverse Event|0
960819|NCT01132118|1958536|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
960820|NCT01132118|1958537|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3
960821|NCT01132118|1958536|FG000|Second Intervention (8 Weeks)|Adverse Event|0
960822|NCT01132118|1958537|FG001|Second Intervention (8 Weeks)|Adverse Event|1
960823|NCT01132313|1958566|FG000|Overall Study|Lack of Efficacy|1
960824|NCT01132313|1958567|FG001|Overall Study|Lack of Efficacy|0
960825|NCT01132313|1958568|FG002|Overall Study|Lack of Efficacy|0
960826|NCT01132313|1958569|FG003|Overall Study|Lack of Efficacy|0
960827|NCT01132313|1958570|FG004|Overall Study|Lack of Efficacy|0
960828|NCT01132313|1958571|FG005|Overall Study|Lack of Efficacy|0
960829|NCT01132313|1958572|FG006|Overall Study|Lack of Efficacy|0
960830|NCT01132313|1958573|FG007|Overall Study|Lack of Efficacy|3
960831|NCT01132313|1958574|FG008|Overall Study|Lack of Efficacy|14
960832|NCT01132313|1958575|FG009|Overall Study|Lack of Efficacy|16
960833|NCT01132313|1958576|FG010|Overall Study|Lack of Efficacy|0
960834|NCT01132313|1958577|FG011|Overall Study|Lack of Efficacy|0
960835|NCT01132313|1958566|FG000|Overall Study|Not treated|2
960836|NCT01132313|1958567|FG001|Overall Study|Not treated|0
960837|NCT01132313|1958568|FG002|Overall Study|Not treated|0
960838|NCT01132313|1958569|FG003|Overall Study|Not treated|0
960839|NCT01132313|1958570|FG004|Overall Study|Not treated|2
960840|NCT01132313|1958571|FG005|Overall Study|Not treated|1
960841|NCT01132313|1958572|FG006|Overall Study|Not treated|3
960842|NCT01132313|1958573|FG007|Overall Study|Not treated|0
960843|NCT01132313|1958574|FG008|Overall Study|Not treated|0
960844|NCT01132313|1958575|FG009|Overall Study|Not treated|0
960845|NCT01132313|1958576|FG010|Overall Study|Not treated|0
960846|NCT01132313|1958577|FG011|Overall Study|Not treated|0
960847|NCT01132313|1958566|FG000|Overall Study|Adverse Event|0
960848|NCT01132313|1958567|FG001|Overall Study|Adverse Event|0
960849|NCT01132313|1958568|FG002|Overall Study|Adverse Event|4
960850|NCT01132313|1958569|FG003|Overall Study|Adverse Event|10
960851|NCT01132313|1958570|FG004|Overall Study|Adverse Event|19
960852|NCT01132313|1958571|FG005|Overall Study|Adverse Event|6
960853|NCT01132313|1958572|FG006|Overall Study|Adverse Event|5
960854|NCT01132313|1958573|FG007|Overall Study|Adverse Event|3
960855|NCT01132313|1958574|FG008|Overall Study|Adverse Event|7
960856|NCT01132313|1958575|FG009|Overall Study|Adverse Event|2
960857|NCT01132313|1958576|FG010|Overall Study|Adverse Event|0
960858|NCT01132313|1958577|FG011|Overall Study|Adverse Event|0
960859|NCT01132313|1958566|FG000|Overall Study|Protocol Violation|0
960860|NCT01132313|1958567|FG001|Overall Study|Protocol Violation|0
960861|NCT01132313|1958568|FG002|Overall Study|Protocol Violation|0
960862|NCT01132313|1958569|FG003|Overall Study|Protocol Violation|1
960863|NCT01132313|1958570|FG004|Overall Study|Protocol Violation|0
960864|NCT01132313|1958571|FG005|Overall Study|Protocol Violation|0
960865|NCT01132313|1958572|FG006|Overall Study|Protocol Violation|0
960866|NCT01132313|1958573|FG007|Overall Study|Protocol Violation|0
960867|NCT01132313|1958574|FG008|Overall Study|Protocol Violation|0
960868|NCT01132313|1958575|FG009|Overall Study|Protocol Violation|0
960869|NCT01132313|1958576|FG010|Overall Study|Protocol Violation|0
960870|NCT01132313|1958577|FG011|Overall Study|Protocol Violation|0
960871|NCT01132313|1958566|FG000|Overall Study|Lost to Follow-up|0
960872|NCT01132313|1958567|FG001|Overall Study|Lost to Follow-up|0
960873|NCT01132313|1958568|FG002|Overall Study|Lost to Follow-up|1
960874|NCT01132313|1958569|FG003|Overall Study|Lost to Follow-up|0
960875|NCT01132313|1958570|FG004|Overall Study|Lost to Follow-up|0
960876|NCT01132313|1958571|FG005|Overall Study|Lost to Follow-up|0
960877|NCT01132313|1958572|FG006|Overall Study|Lost to Follow-up|0
960878|NCT01132313|1958573|FG007|Overall Study|Lost to Follow-up|1
960879|NCT01132313|1958574|FG008|Overall Study|Lost to Follow-up|0
960880|NCT01132313|1958575|FG009|Overall Study|Lost to Follow-up|0
960881|NCT01132313|1958576|FG010|Overall Study|Lost to Follow-up|0
960882|NCT01132313|1958577|FG011|Overall Study|Lost to Follow-up|0
960883|NCT01132313|1958566|FG000|Overall Study|Withdrawal by Subject|0
960884|NCT01132313|1958567|FG001|Overall Study|Withdrawal by Subject|0
960885|NCT01132313|1958568|FG002|Overall Study|Withdrawal by Subject|3
960886|NCT01132313|1958569|FG003|Overall Study|Withdrawal by Subject|3
960887|NCT01132313|1958570|FG004|Overall Study|Withdrawal by Subject|6
960888|NCT01132313|1958571|FG005|Overall Study|Withdrawal by Subject|0
960889|NCT01132313|1958572|FG006|Overall Study|Withdrawal by Subject|1
960890|NCT01132313|1958573|FG007|Overall Study|Withdrawal by Subject|0
960891|NCT01132313|1958574|FG008|Overall Study|Withdrawal by Subject|0
960892|NCT01132313|1958575|FG009|Overall Study|Withdrawal by Subject|2
960893|NCT01132313|1958576|FG010|Overall Study|Withdrawal by Subject|0
960894|NCT01132313|1958577|FG011|Overall Study|Withdrawal by Subject|0
960895|NCT01132313|1958566|FG000|Overall Study|Lack of antiviral response|0
960896|NCT01132313|1958567|FG001|Overall Study|Lack of antiviral response|0
960897|NCT01132313|1958568|FG002|Overall Study|Lack of antiviral response|12
960898|NCT01132313|1958569|FG003|Overall Study|Lack of antiviral response|18
960899|NCT01132313|1958570|FG004|Overall Study|Lack of antiviral response|18
960900|NCT01132313|1958571|FG005|Overall Study|Lack of antiviral response|18
960901|NCT01132313|1958572|FG006|Overall Study|Lack of antiviral response|21
960902|NCT01132313|1958573|FG007|Overall Study|Lack of antiviral response|0
960903|NCT01132313|1958574|FG008|Overall Study|Lack of antiviral response|0
960904|NCT01132313|1958575|FG009|Overall Study|Lack of antiviral response|0
960905|NCT01132313|1958576|FG010|Overall Study|Lack of antiviral response|1
960906|NCT01132313|1958577|FG011|Overall Study|Lack of antiviral response|0
960907|NCT01132313|1958566|FG000|Overall Study|Other reason not defined above|0
960908|NCT01132313|1958567|FG001|Overall Study|Other reason not defined above|0
960909|NCT01132313|1958568|FG002|Overall Study|Other reason not defined above|0
960910|NCT01132313|1958569|FG003|Overall Study|Other reason not defined above|0
960911|NCT01132313|1958570|FG004|Overall Study|Other reason not defined above|0
960912|NCT01132313|1958571|FG005|Overall Study|Other reason not defined above|0
960913|NCT01132313|1958572|FG006|Overall Study|Other reason not defined above|0
960914|NCT01132313|1958573|FG007|Overall Study|Other reason not defined above|1
960915|NCT01132313|1958574|FG008|Overall Study|Other reason not defined above|0
960916|NCT01132313|1958575|FG009|Overall Study|Other reason not defined above|0
960917|NCT01132313|1958576|FG010|Overall Study|Other reason not defined above|0
960918|NCT01132313|1958577|FG011|Overall Study|Other reason not defined above|0
960919|NCT01132326|1958608|FG000|Overall Study|Lack of Efficacy|25
960920|NCT01132326|1958608|FG000|Overall Study|Adverse Event|37
960921|NCT01132326|1958608|FG000|Overall Study|Protocol Violation|1
960922|NCT01132326|1958608|FG000|Overall Study|Lost to Follow-up|16
960923|NCT01132326|1958608|FG000|Overall Study|Withdrawal by Subject|40
960924|NCT01132326|1958608|FG000|Overall Study|Physician Decision|10
960925|NCT01132326|1958608|FG000|Overall Study|Study Termination|80
911067|NCT00796614|1888222|FG001|Overall Study|Lost to Follow-up|2
911068|NCT00796614|1888223|FG002|Overall Study|Lost to Follow-up|1
960926|NCT01132326|1958608|FG000|Overall Study|Declining Health|1
960927|NCT01132326|1958608|FG000|Overall Study|Pregnancy|1
960928|NCT01132326|1958608|FG000|Overall Study|Caregiver Withdrew Consent|1
960929|NCT01132326|1958608|FG000|Overall Study|Death|5
960930|NCT01132326|1958608|FG000|Overall Study|Subject Unable to Come To Visits|1
960931|NCT01132482|1958619|FG000|Overall Study|Adverse Event|1
960932|NCT01132482|1958620|FG001|Overall Study|Adverse Event|0
960933|NCT01132495|1958630|FG000|Overall Study|Various reasons|40
960934|NCT01132495|1958631|FG001|Overall Study|Various reasons|38
960935|NCT01132495|1958632|FG002|Overall Study|Various reasons|20
960936|NCT01132495|1958633|FG003|Overall Study|Various reasons|12
960937|NCT01132547|1958650|FG000|Overall Study|Withdrawal by Subject|3
960938|NCT01132547|1958651|FG001|Overall Study|Withdrawal by Subject|1
960939|NCT01132547|1958650|FG000|Overall Study|Death|1
960940|NCT01132547|1958651|FG001|Overall Study|Death|0
960941|NCT01132612|1958660|FG000|Overall Study|Death|0
960942|NCT01132612|1958661|FG001|Overall Study|Death|0
960943|NCT01132612|1958662|FG002|Overall Study|Death|1
960944|NCT01132612|1958660|FG000|Overall Study|Protocol deviation|0
960945|NCT01132612|1958661|FG001|Overall Study|Protocol deviation|0
960946|NCT01132612|1958662|FG002|Overall Study|Protocol deviation|3
960947|NCT01132612|1958660|FG000|Overall Study|Lost to Follow-up|2
960948|NCT01132612|1958661|FG001|Overall Study|Lost to Follow-up|2
960949|NCT01132612|1958662|FG002|Overall Study|Lost to Follow-up|7
960950|NCT01132612|1958660|FG000|Overall Study|Adverse Event|5
960951|NCT01132612|1958661|FG001|Overall Study|Adverse Event|2
960952|NCT01132612|1958662|FG002|Overall Study|Adverse Event|15
960953|NCT01132612|1958660|FG000|Overall Study|Withdrawal by Subject|5
960954|NCT01132612|1958661|FG001|Overall Study|Withdrawal by Subject|8
960955|NCT01132612|1958662|FG002|Overall Study|Withdrawal by Subject|19
960956|NCT01132612|1958660|FG000|Overall Study|Administrative problems|5
960957|NCT01132612|1958661|FG001|Overall Study|Administrative problems|1
960958|NCT01132612|1958662|FG002|Overall Study|Administrative problems|52
960959|NCT01132612|1958660|FG000|Overall Study|Lack of Efficacy|23
960960|NCT01132612|1958661|FG001|Overall Study|Lack of Efficacy|22
960961|NCT01132612|1958662|FG002|Overall Study|Lack of Efficacy|73
960962|NCT01132651|1958672|FG000|Overall Study|Lost to Follow-up|1
960963|NCT01132651|1958673|FG001|Overall Study|Lost to Follow-up|1
960964|NCT01132664|1958684|FG000|Phase lb|Adverse Event|0
960965|NCT01132664|1958685|FG001|Phase lb|Adverse Event|1
960966|NCT01132664|1958686|FG002|Phase lb|Adverse Event|0
960967|NCT01132664|1958687|FG003|Phase lb|Adverse Event|0
960968|NCT01132664|1958688|FG004|Phase lb|Adverse Event|0
960969|NCT01132664|1958684|FG000|Phase lb|Withdrawal by Subject|1
960970|NCT01132664|1958685|FG001|Phase lb|Withdrawal by Subject|2
960971|NCT01132664|1958686|FG002|Phase lb|Withdrawal by Subject|0
960972|NCT01132664|1958687|FG003|Phase lb|Withdrawal by Subject|0
960973|NCT01132664|1958688|FG004|Phase lb|Withdrawal by Subject|0
960974|NCT01132664|1958684|FG000|Phase lb|Disease Progression|4
960975|NCT01132664|1958685|FG001|Phase lb|Disease Progression|9
960976|NCT01132664|1958686|FG002|Phase lb|Disease Progression|0
960977|NCT01132664|1958687|FG003|Phase lb|Disease Progression|0
960978|NCT01132664|1958688|FG004|Phase lb|Disease Progression|0
960979|NCT01132664|1958684|FG000|Phase ll|Death|0
960980|NCT01132664|1958685|FG001|Phase ll|Death|0
960981|NCT01132664|1958686|FG002|Phase ll|Death|2
960982|NCT01132664|1958687|FG003|Phase ll|Death|0
960983|NCT01132664|1958688|FG004|Phase ll|Death|0
960984|NCT01132664|1958684|FG000|Phase ll|Adverse Event|0
960985|NCT01132664|1958685|FG001|Phase ll|Adverse Event|0
960986|NCT01132664|1958686|FG002|Phase ll|Adverse Event|10
960987|NCT01132664|1958687|FG003|Phase ll|Adverse Event|0
960988|NCT01132664|1958688|FG004|Phase ll|Adverse Event|0
960989|NCT01132664|1958684|FG000|Phase ll|Withdrawal by Subject|0
960990|NCT01132664|1958685|FG001|Phase ll|Withdrawal by Subject|0
960991|NCT01132664|1958686|FG002|Phase ll|Withdrawal by Subject|3
960992|NCT01132664|1958687|FG003|Phase ll|Withdrawal by Subject|0
960993|NCT01132664|1958688|FG004|Phase ll|Withdrawal by Subject|0
960994|NCT01132664|1958684|FG000|Phase ll|Disease progression|0
960995|NCT01132664|1958685|FG001|Phase ll|Disease progression|0
960996|NCT01132664|1958686|FG002|Phase ll|Disease progression|35
960997|NCT01132664|1958687|FG003|Phase ll|Disease progression|0
960998|NCT01132664|1958688|FG004|Phase ll|Disease progression|0
960999|NCT01132664|1958684|FG000|BM Cohort|Disease progression|0
911069|NCT00796614|1888224|FG003|Overall Study|Lost to Follow-up|0
911070|NCT00796614|1888221|FG000|Overall Study|Withdrawal by Subject|1
911071|NCT00796614|1888222|FG001|Overall Study|Withdrawal by Subject|0
911072|NCT00796614|1888223|FG002|Overall Study|Withdrawal by Subject|0
911073|NCT00796614|1888224|FG003|Overall Study|Withdrawal by Subject|1
911074|NCT00796614|1888221|FG000|Overall Study|Other than stated|1
911075|NCT00796614|1888222|FG001|Overall Study|Other than stated|0
911076|NCT00796614|1888223|FG002|Overall Study|Other than stated|0
911077|NCT00796614|1888224|FG003|Overall Study|Other than stated|0
961000|NCT01132664|1958685|FG001|BM Cohort|Disease progression|0
961001|NCT01132664|1958686|FG002|BM Cohort|Disease progression|0
961002|NCT01132664|1958687|FG003|BM Cohort|Disease progression|3
961003|NCT01132664|1958688|FG004|BM Cohort|Disease progression|4
961004|NCT01132664|1958684|FG000|BM Cohort|Adverse Event|0
961005|NCT01132664|1958685|FG001|BM Cohort|Adverse Event|0
961006|NCT01132664|1958686|FG002|BM Cohort|Adverse Event|0
961007|NCT01132664|1958687|FG003|BM Cohort|Adverse Event|0
961008|NCT01132664|1958688|FG004|BM Cohort|Adverse Event|1
961009|NCT01132664|1958684|FG000|BM Cohort|Withdrawal by Subject|0
961010|NCT01132664|1958685|FG001|BM Cohort|Withdrawal by Subject|0
961011|NCT01132664|1958686|FG002|BM Cohort|Withdrawal by Subject|0
961012|NCT01132664|1958687|FG003|BM Cohort|Withdrawal by Subject|0
961013|NCT01132664|1958688|FG004|BM Cohort|Withdrawal by Subject|1
961014|NCT01132755|1958709|FG000|Overall Study|Procedure not done due to medical reason|23
961015|NCT01132755|1958709|FG000|Overall Study|Protocol Violation|15
961016|NCT01132755|1958709|FG000|Overall Study|Withdrawal by Subject|4
961017|NCT01132807|1958713|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9
961018|NCT01132807|1958714|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
961019|NCT01132807|1958715|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
961020|NCT01132807|1958713|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6
961021|NCT01132807|1958714|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0
961022|NCT01132807|1958715|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0
961023|NCT01132820|1958723|FG000|Overall Study|Ineligible: wrong cell type|1
961024|NCT01132820|1958723|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1
961025|NCT01132820|1958723|FG000|Overall Study|Ineligible:Inadequate pathology|1
961026|NCT01132820|1958723|FG000|Overall Study|Never treated|1
961027|NCT01132820|1958723|FG000|Overall Study|Inadequate data|1
961028|NCT01133067|1958742|FG000|Overall Study|Death|136
961029|NCT01133067|1958742|FG000|Overall Study|Lost to Follow-up|3
961030|NCT01133171|1958755|FG000|Overall Study|Withdrawal by Subject|1
961031|NCT01133171|1958756|FG001|Overall Study|Withdrawal by Subject|2
961032|NCT01133171|1958757|FG002|Overall Study|Withdrawal by Subject|0
961033|NCT01133275|1958765|FG000|Overall Study|Withdrawal by Subject|1
961034|NCT01133275|1958765|FG000|Overall Study|Cerebrovascular accident (CVA)|1
961035|NCT01133379|1958772|FG000|Overall Study|Withdrawal by Subject|0
961036|NCT01133379|1958773|FG001|Overall Study|Withdrawal by Subject|1
961037|NCT01133379|1958774|FG002|Overall Study|Withdrawal by Subject|1
961038|NCT01133379|1958772|FG000|Overall Study|Lost to Follow-up|1
961039|NCT01133379|1958773|FG001|Overall Study|Lost to Follow-up|1
961040|NCT01133379|1958774|FG002|Overall Study|Lost to Follow-up|1
961041|NCT01133392|1958784|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
961042|NCT01133392|1958785|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
961043|NCT01133392|1958784|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0
961044|NCT01133392|1958785|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1
961045|NCT01133405|1958801|FG000|Period 1|Withdrawal by Subject|0
961046|NCT01133405|1958802|FG001|Period 1|Withdrawal by Subject|1
961047|NCT01133405|1958803|FG002|Period 1|Withdrawal by Subject|0
961048|NCT01133405|1958804|FG003|Period 1|Withdrawal by Subject|1
961049|NCT01133405|1958805|FG004|Period 1|Withdrawal by Subject|0
961050|NCT01133405|1958806|FG005|Period 1|Withdrawal by Subject|1
961051|NCT01133405|1958807|FG006|Period 1|Withdrawal by Subject|0
961052|NCT01133405|1958808|FG007|Period 1|Withdrawal by Subject|0
961053|NCT01133405|1958809|FG008|Period 1|Withdrawal by Subject|0
961054|NCT01133405|1958810|FG009|Period 1|Withdrawal by Subject|0
961055|NCT01133405|1958801|FG000|Period 1|Physician Decision|0
961056|NCT01133405|1958802|FG001|Period 1|Physician Decision|0
961057|NCT01133405|1958803|FG002|Period 1|Physician Decision|0
961058|NCT01133405|1958804|FG003|Period 1|Physician Decision|1
961059|NCT01133405|1958805|FG004|Period 1|Physician Decision|0
961060|NCT01133405|1958806|FG005|Period 1|Physician Decision|0
961061|NCT01133405|1958807|FG006|Period 1|Physician Decision|0
961062|NCT01133405|1958808|FG007|Period 1|Physician Decision|0
961063|NCT01133405|1958809|FG008|Period 1|Physician Decision|0
961064|NCT01133405|1958810|FG009|Period 1|Physician Decision|0
961065|NCT01133405|1958801|FG000|Period 1|Discontinued after randomization|1
961066|NCT01133405|1958802|FG001|Period 1|Discontinued after randomization|0
961067|NCT01133405|1958803|FG002|Period 1|Discontinued after randomization|0
961068|NCT01133405|1958804|FG003|Period 1|Discontinued after randomization|0
961069|NCT01133405|1958805|FG004|Period 1|Discontinued after randomization|0
961070|NCT01133405|1958806|FG005|Period 1|Discontinued after randomization|0
961071|NCT01133405|1958807|FG006|Period 1|Discontinued after randomization|1
961072|NCT01133405|1958808|FG007|Period 1|Discontinued after randomization|0
961073|NCT01133405|1958809|FG008|Period 1|Discontinued after randomization|0
961074|NCT01133405|1958810|FG009|Period 1|Discontinued after randomization|0
961075|NCT01133405|1958801|FG000|Period 1|Received drug only in period 2|0
961076|NCT01133405|1958802|FG001|Period 1|Received drug only in period 2|1
961077|NCT01133405|1958803|FG002|Period 1|Received drug only in period 2|0
961078|NCT01133405|1958804|FG003|Period 1|Received drug only in period 2|2
961079|NCT01133405|1958805|FG004|Period 1|Received drug only in period 2|0
961080|NCT01133405|1958806|FG005|Period 1|Received drug only in period 2|1
961081|NCT01133405|1958807|FG006|Period 1|Received drug only in period 2|0
961082|NCT01133405|1958808|FG007|Period 1|Received drug only in period 2|0
961083|NCT01133405|1958809|FG008|Period 1|Received drug only in period 2|0
961084|NCT01133405|1958810|FG009|Period 1|Received drug only in period 2|0
961085|NCT01133405|1958801|FG000|Period 1|Received drug only in period 3|0
961086|NCT01133405|1958802|FG001|Period 1|Received drug only in period 3|1
961087|NCT01133405|1958803|FG002|Period 1|Received drug only in period 3|1
961088|NCT01133405|1958804|FG003|Period 1|Received drug only in period 3|0
961089|NCT01133405|1958805|FG004|Period 1|Received drug only in period 3|0
961090|NCT01133405|1958806|FG005|Period 1|Received drug only in period 3|0
961091|NCT01133405|1958807|FG006|Period 1|Received drug only in period 3|0
961092|NCT01133405|1958808|FG007|Period 1|Received drug only in period 3|0
961093|NCT01133405|1958809|FG008|Period 1|Received drug only in period 3|0
961094|NCT01133405|1958810|FG009|Period 1|Received drug only in period 3|0
961095|NCT01133405|1958801|FG000|Period 2|Adverse Event|0
961096|NCT01133405|1958802|FG001|Period 2|Adverse Event|0
961097|NCT01133405|1958803|FG002|Period 2|Adverse Event|1
961098|NCT01133405|1958804|FG003|Period 2|Adverse Event|0
961099|NCT01133405|1958805|FG004|Period 2|Adverse Event|0
961100|NCT01133405|1958806|FG005|Period 2|Adverse Event|0
961101|NCT01133405|1958807|FG006|Period 2|Adverse Event|0
961102|NCT01133405|1958808|FG007|Period 2|Adverse Event|0
961103|NCT01133405|1958809|FG008|Period 2|Adverse Event|0
961104|NCT01133405|1958810|FG009|Period 2|Adverse Event|0
961105|NCT01133405|1958801|FG000|Period 2|Withdrawal by Subject|0
961106|NCT01133405|1958802|FG001|Period 2|Withdrawal by Subject|0
961107|NCT01133405|1958803|FG002|Period 2|Withdrawal by Subject|0
961108|NCT01133405|1958804|FG003|Period 2|Withdrawal by Subject|1
961109|NCT01133405|1958805|FG004|Period 2|Withdrawal by Subject|0
961110|NCT01133405|1958806|FG005|Period 2|Withdrawal by Subject|1
961111|NCT01133405|1958807|FG006|Period 2|Withdrawal by Subject|0
961112|NCT01133405|1958808|FG007|Period 2|Withdrawal by Subject|0
961113|NCT01133405|1958809|FG008|Period 2|Withdrawal by Subject|0
961114|NCT01133405|1958810|FG009|Period 2|Withdrawal by Subject|0
961115|NCT01133405|1958801|FG000|Period 2|Entry Criteria Not Met|0
961116|NCT01133405|1958802|FG001|Period 2|Entry Criteria Not Met|1
961117|NCT01133405|1958803|FG002|Period 2|Entry Criteria Not Met|0
961118|NCT01133405|1958804|FG003|Period 2|Entry Criteria Not Met|0
961119|NCT01133405|1958805|FG004|Period 2|Entry Criteria Not Met|0
961120|NCT01133405|1958806|FG005|Period 2|Entry Criteria Not Met|0
961121|NCT01133405|1958807|FG006|Period 2|Entry Criteria Not Met|0
961122|NCT01133405|1958808|FG007|Period 2|Entry Criteria Not Met|0
961123|NCT01133405|1958809|FG008|Period 2|Entry Criteria Not Met|0
961124|NCT01133405|1958810|FG009|Period 2|Entry Criteria Not Met|0
961125|NCT01133405|1958801|FG000|Period 2|Physician Decision|0
961126|NCT01133405|1958802|FG001|Period 2|Physician Decision|0
961127|NCT01133405|1958803|FG002|Period 2|Physician Decision|0
961128|NCT01133405|1958804|FG003|Period 2|Physician Decision|0
961129|NCT01133405|1958805|FG004|Period 2|Physician Decision|0
961130|NCT01133405|1958806|FG005|Period 2|Physician Decision|1
961131|NCT01133405|1958807|FG006|Period 2|Physician Decision|0
961132|NCT01133405|1958808|FG007|Period 2|Physician Decision|0
961133|NCT01133405|1958809|FG008|Period 2|Physician Decision|0
961134|NCT01133405|1958810|FG009|Period 2|Physician Decision|0
961135|NCT01133418|1958842|FG000|Overall Study|Lost to Follow-up|5
961136|NCT01133418|1958843|FG001|Overall Study|Lost to Follow-up|6
961137|NCT01133522|1958859|FG000|Overall Study|Withdrawal by Subject|0
961138|NCT01133522|1958860|FG001|Overall Study|Withdrawal by Subject|1
961139|NCT01133522|1958861|FG002|Overall Study|Withdrawal by Subject|0
961140|NCT01133522|1958862|FG003|Overall Study|Withdrawal by Subject|1
961141|NCT01133522|1958863|FG004|Overall Study|Withdrawal by Subject|0
961142|NCT01133522|1958864|FG005|Overall Study|Withdrawal by Subject|0
961143|NCT01133522|1958865|FG006|Overall Study|Withdrawal by Subject|0
961144|NCT01133522|1958866|FG007|Overall Study|Withdrawal by Subject|0
961145|NCT01133522|1958867|FG008|Overall Study|Withdrawal by Subject|0
961146|NCT01133522|1958868|FG009|Overall Study|Withdrawal by Subject|0
961147|NCT01133522|1958859|FG000|Overall Study|Physician Decision|0
961148|NCT01133522|1958860|FG001|Overall Study|Physician Decision|0
961149|NCT01133522|1958861|FG002|Overall Study|Physician Decision|0
961150|NCT01133522|1958862|FG003|Overall Study|Physician Decision|0
961151|NCT01133522|1958863|FG004|Overall Study|Physician Decision|1
961152|NCT01133522|1958864|FG005|Overall Study|Physician Decision|0
961153|NCT01133522|1958865|FG006|Overall Study|Physician Decision|0
961154|NCT01133522|1958866|FG007|Overall Study|Physician Decision|0
961155|NCT01133522|1958867|FG008|Overall Study|Physician Decision|0
961156|NCT01133522|1958868|FG009|Overall Study|Physician Decision|0
961157|NCT01133626|1958900|FG000|Overall Study|Adverse Event|0
961158|NCT01133626|1958901|FG001|Overall Study|Adverse Event|1
961159|NCT01133626|1958902|FG002|Overall Study|Adverse Event|0
961160|NCT01133626|1958900|FG000|Overall Study|Withdrawal by Subject|1
961161|NCT01133626|1958901|FG001|Overall Study|Withdrawal by Subject|2
961162|NCT01133626|1958902|FG002|Overall Study|Withdrawal by Subject|2
961163|NCT01133626|1958900|FG000|Overall Study|Other|0
961164|NCT01133626|1958901|FG001|Overall Study|Other|2
961165|NCT01133626|1958902|FG002|Overall Study|Other|0
961166|NCT01133665|1958910|FG000|Overall Study|Physician Decision|2
961167|NCT01133678|1958916|FG000|Overall Study|Death|1
961168|NCT01133678|1958917|FG001|Overall Study|Death|1
961169|NCT01133704|1958925|FG000|Overall Study|Death|44
961170|NCT01133704|1958926|FG001|Overall Study|Death|26
961171|NCT01133704|1958925|FG000|Overall Study|Patient refused to continue|4
961172|NCT01133704|1958926|FG001|Overall Study|Patient refused to continue|0
961173|NCT01133704|1958925|FG000|Overall Study|Study Closure|1
961174|NCT01133704|1958926|FG001|Overall Study|Study Closure|0
961175|NCT01133756|1958935|FG000|Overall Study|Adverse Event|1
961176|NCT01133756|1958936|FG001|Overall Study|Adverse Event|2
961177|NCT01133756|1958937|FG002|Overall Study|Adverse Event|1
961178|NCT01133756|1958935|FG000|Overall Study|Investigator Decision|1
961179|NCT01133756|1958936|FG001|Overall Study|Investigator Decision|0
961180|NCT01133756|1958937|FG002|Overall Study|Investigator Decision|0
961181|NCT01133756|1958935|FG000|Overall Study|Withdrawal by Subject|0
961182|NCT01133756|1958936|FG001|Overall Study|Withdrawal by Subject|1
961183|NCT01133756|1958937|FG002|Overall Study|Withdrawal by Subject|0
961184|NCT01133756|1958935|FG000|Overall Study|Progression of Disease|0
961185|NCT01133756|1958936|FG001|Overall Study|Progression of Disease|0
961186|NCT01133756|1958937|FG002|Overall Study|Progression of Disease|1
961187|NCT01133821|1958947|FG000|Overall Study|Lost to Follow-up|8
961188|NCT01133821|1958948|FG001|Overall Study|Lost to Follow-up|11
961189|NCT01133821|1958947|FG000|Overall Study|Withdrawal by Subject|8
961190|NCT01133821|1958948|FG001|Overall Study|Withdrawal by Subject|3
961191|NCT01133821|1958947|FG000|Overall Study|preferred other treatment|1
961192|NCT01133821|1958948|FG001|Overall Study|preferred other treatment|1
961193|NCT01133821|1958947|FG000|Overall Study|Protocol Violation|0
961194|NCT01133821|1958948|FG001|Overall Study|Protocol Violation|1
961195|NCT01133821|1958947|FG000|Overall Study|Refused participation|1
961196|NCT01133821|1958948|FG001|Overall Study|Refused participation|3
961197|NCT01133847|1958957|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
961198|NCT01133847|1958958|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
961199|NCT01133847|1958959|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
961200|NCT01133847|1958957|FG000|Follow-Up Phase|Lost to Follow-up|1
961201|NCT01133847|1958958|FG001|Follow-Up Phase|Lost to Follow-up|3
961202|NCT01133847|1958959|FG002|Follow-Up Phase|Lost to Follow-up|7
961203|NCT01133977|1958978|FG000|Overall Study|Adverse Event|0
961204|NCT01133977|1958979|FG001|Overall Study|Adverse Event|0
961205|NCT01133977|1958980|FG002|Overall Study|Adverse Event|1
961206|NCT01133977|1958981|FG003|Overall Study|Adverse Event|0
961207|NCT01133977|1958982|FG004|Overall Study|Adverse Event|0
961208|NCT01133977|1958978|FG000|Overall Study|Death|1
961209|NCT01133977|1958979|FG001|Overall Study|Death|1
961210|NCT01133977|1958980|FG002|Overall Study|Death|1
961211|NCT01133977|1958981|FG003|Overall Study|Death|7
961212|NCT01133977|1958982|FG004|Overall Study|Death|3
961213|NCT01133977|1958978|FG000|Overall Study|Started a New Line of Therapy|2
961214|NCT01133977|1958979|FG001|Overall Study|Started a New Line of Therapy|6
961215|NCT01133977|1958980|FG002|Overall Study|Started a New Line of Therapy|4
961216|NCT01133977|1958981|FG003|Overall Study|Started a New Line of Therapy|25
961217|NCT01133977|1958982|FG004|Overall Study|Started a New Line of Therapy|33
961218|NCT01133977|1958978|FG000|Overall Study|Lost to Follow-up|0
961219|NCT01133977|1958979|FG001|Overall Study|Lost to Follow-up|0
961220|NCT01133977|1958980|FG002|Overall Study|Lost to Follow-up|0
961221|NCT01133977|1958981|FG003|Overall Study|Lost to Follow-up|2
961222|NCT01133977|1958982|FG004|Overall Study|Lost to Follow-up|1
961223|NCT01133977|1958978|FG000|Overall Study|Withdrawal by Subject|0
961224|NCT01133977|1958979|FG001|Overall Study|Withdrawal by Subject|0
961225|NCT01133977|1958980|FG002|Overall Study|Withdrawal by Subject|0
961226|NCT01133977|1958981|FG003|Overall Study|Withdrawal by Subject|5
961227|NCT01133977|1958982|FG004|Overall Study|Withdrawal by Subject|1
961228|NCT01134042|1959033|FG000|Overall Study|Adverse Event|3
961229|NCT01134042|1959034|FG001|Overall Study|Adverse Event|7
961230|NCT01134042|1959035|FG002|Overall Study|Adverse Event|2
961231|NCT01134042|1959033|FG000|Overall Study|Lack of Efficacy|21
961232|NCT01134042|1959034|FG001|Overall Study|Lack of Efficacy|6
961233|NCT01134042|1959035|FG002|Overall Study|Lack of Efficacy|18
961234|NCT01134042|1959033|FG000|Overall Study|Protocol Violation|5
961235|NCT01134042|1959034|FG001|Overall Study|Protocol Violation|3
961236|NCT01134042|1959035|FG002|Overall Study|Protocol Violation|5
961237|NCT01134042|1959033|FG000|Overall Study|Lost to Follow-up|2
961238|NCT01134042|1959034|FG001|Overall Study|Lost to Follow-up|0
961239|NCT01134042|1959035|FG002|Overall Study|Lost to Follow-up|1
961240|NCT01134042|1959033|FG000|Overall Study|Physician Decision|4
961241|NCT01134042|1959034|FG001|Overall Study|Physician Decision|8
961242|NCT01134042|1959035|FG002|Overall Study|Physician Decision|1
961243|NCT01134042|1959033|FG000|Overall Study|Withdrawal by Subject|13
961244|NCT01134042|1959034|FG001|Overall Study|Withdrawal by Subject|4
961245|NCT01134042|1959035|FG002|Overall Study|Withdrawal by Subject|7
961246|NCT01134055|1959051|FG000|Overall Study|Adverse Event|5
961247|NCT01134055|1959052|FG001|Overall Study|Adverse Event|2
961248|NCT01134055|1959053|FG002|Overall Study|Adverse Event|2
961249|NCT01134055|1959054|FG003|Overall Study|Adverse Event|2
961250|NCT01134055|1959055|FG004|Overall Study|Adverse Event|5
961251|NCT01134055|1959056|FG005|Overall Study|Adverse Event|7
961252|NCT01134055|1959057|FG006|Overall Study|Adverse Event|2
961253|NCT01134055|1959051|FG000|Overall Study|Lost to Follow-up|0
961254|NCT01134055|1959052|FG001|Overall Study|Lost to Follow-up|1
961255|NCT01134055|1959053|FG002|Overall Study|Lost to Follow-up|0
961256|NCT01134055|1959054|FG003|Overall Study|Lost to Follow-up|1
961257|NCT01134055|1959055|FG004|Overall Study|Lost to Follow-up|0
961258|NCT01134055|1959056|FG005|Overall Study|Lost to Follow-up|0
961259|NCT01134055|1959057|FG006|Overall Study|Lost to Follow-up|0
961260|NCT01134055|1959051|FG000|Overall Study|Withdrawal by Subject|3
961261|NCT01134055|1959052|FG001|Overall Study|Withdrawal by Subject|3
961262|NCT01134055|1959053|FG002|Overall Study|Withdrawal by Subject|1
961263|NCT01134055|1959054|FG003|Overall Study|Withdrawal by Subject|2
961264|NCT01134055|1959055|FG004|Overall Study|Withdrawal by Subject|0
961265|NCT01134055|1959056|FG005|Overall Study|Withdrawal by Subject|0
961266|NCT01134055|1959057|FG006|Overall Study|Withdrawal by Subject|8
961267|NCT01134055|1959051|FG000|Overall Study|Protocol Violation|0
961268|NCT01134055|1959052|FG001|Overall Study|Protocol Violation|0
961269|NCT01134055|1959053|FG002|Overall Study|Protocol Violation|0
961270|NCT01134055|1959054|FG003|Overall Study|Protocol Violation|1
961271|NCT01134055|1959055|FG004|Overall Study|Protocol Violation|1
961272|NCT01134055|1959056|FG005|Overall Study|Protocol Violation|0
961273|NCT01134055|1959057|FG006|Overall Study|Protocol Violation|0
961274|NCT01134055|1959051|FG000|Overall Study|Physician Decision|0
961275|NCT01134055|1959052|FG001|Overall Study|Physician Decision|0
961276|NCT01134055|1959053|FG002|Overall Study|Physician Decision|0
961277|NCT01134055|1959054|FG003|Overall Study|Physician Decision|0
961278|NCT01134055|1959055|FG004|Overall Study|Physician Decision|0
961279|NCT01134055|1959056|FG005|Overall Study|Physician Decision|0
961280|NCT01134055|1959057|FG006|Overall Study|Physician Decision|1
961281|NCT01134107|1959089|FG000|Period 1-First Treatment Intervention|Adverse Event|1
961282|NCT01134107|1959090|FG001|Period 1-First Treatment Intervention|Adverse Event|0
961283|NCT01134107|1959089|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
961284|NCT01134107|1959090|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
961285|NCT01134107|1959089|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3
961286|NCT01134107|1959090|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4
961287|NCT01134107|1959089|FG000|Period 1-First Treatment Intervention|Physician Decision|1
961288|NCT01134107|1959090|FG001|Period 1-First Treatment Intervention|Physician Decision|0
961289|NCT01134107|1959089|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
961290|NCT01134107|1959090|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
961291|NCT01134107|1959089|FG000|Period 2-Second Treatment Intervention|Physician Decision|1
961292|NCT01134107|1959090|FG001|Period 2-Second Treatment Intervention|Physician Decision|0
961293|NCT01134107|1959089|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1
961294|NCT01134107|1959090|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0
961295|NCT01134263|1959110|FG000|Overall Study|Serious adverse event|2
961296|NCT01134263|1959111|FG001|Overall Study|Serious adverse event|1
961297|NCT01134263|1959112|FG002|Overall Study|Serious adverse event|1
961298|NCT01134263|1959113|FG003|Overall Study|Serious adverse event|1
961299|NCT01134263|1959114|FG004|Overall Study|Serious adverse event|1
961300|NCT01134263|1959110|FG000|Overall Study|Other adverse event|1
961301|NCT01134263|1959111|FG001|Overall Study|Other adverse event|2
961302|NCT01134263|1959112|FG002|Overall Study|Other adverse event|5
961303|NCT01134263|1959113|FG003|Overall Study|Other adverse event|3
961304|NCT01134263|1959114|FG004|Overall Study|Other adverse event|0
961305|NCT01134263|1959110|FG000|Overall Study|Protocol Violation|8
961306|NCT01134263|1959111|FG001|Overall Study|Protocol Violation|7
961307|NCT01134263|1959112|FG002|Overall Study|Protocol Violation|2
961308|NCT01134263|1959113|FG003|Overall Study|Protocol Violation|4
961309|NCT01134263|1959114|FG004|Overall Study|Protocol Violation|2
961310|NCT01134263|1959110|FG000|Overall Study|Lost to Follow-up|4
961311|NCT01134263|1959111|FG001|Overall Study|Lost to Follow-up|3
961312|NCT01134263|1959112|FG002|Overall Study|Lost to Follow-up|5
961313|NCT01134263|1959113|FG003|Overall Study|Lost to Follow-up|3
961314|NCT01134263|1959114|FG004|Overall Study|Lost to Follow-up|1
961315|NCT01134263|1959110|FG000|Overall Study|Withdrawal by Subject|8
961316|NCT01134263|1959111|FG001|Overall Study|Withdrawal by Subject|6
961317|NCT01134263|1959112|FG002|Overall Study|Withdrawal by Subject|16
961318|NCT01134263|1959113|FG003|Overall Study|Withdrawal by Subject|7
961319|NCT01134263|1959114|FG004|Overall Study|Withdrawal by Subject|5
961320|NCT01134263|1959110|FG000|Overall Study|Enrolled, but not treated|1
961321|NCT01134263|1959111|FG001|Overall Study|Enrolled, but not treated|1
961322|NCT01134263|1959112|FG002|Overall Study|Enrolled, but not treated|0
961323|NCT01134263|1959113|FG003|Overall Study|Enrolled, but not treated|1
961324|NCT01134263|1959114|FG004|Overall Study|Enrolled, but not treated|0
961325|NCT01134315|1959146|FG000|Overall Study|Adverse Event|1
961326|NCT01134315|1959147|FG001|Overall Study|Adverse Event|2
961327|NCT01134315|1959146|FG000|Overall Study|Other Reason|8
961328|NCT01134315|1959147|FG001|Overall Study|Other Reason|17
961329|NCT01134393|1959170|FG000|Overall Study|Adverse Event|18
961330|NCT01134393|1959170|FG000|Overall Study|Lack of Efficacy|2
961331|NCT01134393|1959170|FG000|Overall Study|Protocol Violation|12
961332|NCT01134393|1959170|FG000|Overall Study|Lost to Follow-up|3
961333|NCT01134393|1959170|FG000|Overall Study|Withdrawal by Subject|11
961334|NCT01134393|1959170|FG000|Overall Study|Other|6
961335|NCT01134562|1959218|FG000|Overall Study|Adverse Event|0
961336|NCT01134562|1959219|FG001|Overall Study|Adverse Event|1
961337|NCT01134562|1959220|FG002|Overall Study|Adverse Event|0
961338|NCT01134562|1959221|FG003|Overall Study|Adverse Event|0
961339|NCT01134562|1959222|FG004|Overall Study|Adverse Event|0
961340|NCT01134614|1959257|FG000|Overall Study|Still on treatment as of March 2013|21
961341|NCT01134614|1959258|FG001|Overall Study|Still on treatment as of March 2013|13
961342|NCT01134614|1959257|FG000|Overall Study|Progressive disease|60
961343|NCT01134614|1959258|FG001|Overall Study|Progressive disease|54
961344|NCT01134614|1959257|FG000|Overall Study|Adverse Event|26
961345|NCT01134614|1959258|FG001|Overall Study|Adverse Event|39
961346|NCT01134614|1959257|FG000|Overall Study|Death|5
961347|NCT01134614|1959258|FG001|Overall Study|Death|8
961348|NCT01134614|1959257|FG000|Overall Study|Withdrawal by Subject|3
961349|NCT01134614|1959258|FG001|Overall Study|Withdrawal by Subject|2
961350|NCT01134614|1959257|FG000|Overall Study|Alternative therapy|2
961351|NCT01134614|1959258|FG001|Overall Study|Alternative therapy|0
961352|NCT01134614|1959257|FG000|Overall Study|Complicating disease|2
961353|NCT01134614|1959258|FG001|Overall Study|Complicating disease|1
961354|NCT01134614|1959257|FG000|Overall Study|Physician's decision|0
961355|NCT01134614|1959258|FG001|Overall Study|Physician's decision|1
961356|NCT01134614|1959257|FG000|Overall Study|Never started treatment|4
961357|NCT01134614|1959258|FG001|Overall Study|Never started treatment|1
961358|NCT01134614|1959257|FG000|Overall Study|Pt received tx not allowed on study|0
961359|NCT01134614|1959258|FG001|Overall Study|Pt received tx not allowed on study|1
961360|NCT01134614|1959257|FG000|Overall Study|Symptomatic deterioration|0
961361|NCT01134614|1959258|FG001|Overall Study|Symptomatic deterioration|1
961362|NCT01134614|1959257|FG000|Overall Study|Patient in hospice care|0
961363|NCT01134614|1959258|FG001|Overall Study|Patient in hospice care|1
961364|NCT01134627|1959266|FG000|Overall Study|Adverse Event|47
961365|NCT01134627|1959267|FG001|Overall Study|Adverse Event|31
961366|NCT01134627|1959266|FG000|Overall Study|Lost to Follow-up|1
961367|NCT01134627|1959267|FG001|Overall Study|Lost to Follow-up|2
961368|NCT01134627|1959266|FG000|Overall Study|Protocol Violation|3
961369|NCT01134627|1959267|FG001|Overall Study|Protocol Violation|5
961370|NCT01134627|1959266|FG000|Overall Study|Lack of Efficacy|2
961371|NCT01134627|1959267|FG001|Overall Study|Lack of Efficacy|12
961372|NCT01134627|1959266|FG000|Overall Study|Withdrawal by Subject|4
961373|NCT01134627|1959267|FG001|Overall Study|Withdrawal by Subject|3
961374|NCT01134627|1959266|FG000|Overall Study|Planning to become pregnant/pregnancy|1
961375|NCT01134627|1959267|FG001|Overall Study|Planning to become pregnant/pregnancy|0
961376|NCT01134627|1959266|FG000|Overall Study|Other|11
961377|NCT01134627|1959267|FG001|Overall Study|Other|14
961378|NCT01134705|1959275|FG000|Overall Study|Adverse Event|1
961379|NCT01134705|1959276|FG001|Overall Study|Adverse Event|7
961380|NCT01134705|1959275|FG000|Overall Study|Withdrawal by Subject|6
961381|NCT01134705|1959276|FG001|Overall Study|Withdrawal by Subject|6
961382|NCT01134705|1959275|FG000|Overall Study|Pregnancy|1
961383|NCT01134705|1959276|FG001|Overall Study|Pregnancy|0
961384|NCT01134705|1959275|FG000|Overall Study|Lost to Follow-up|5
961385|NCT01134705|1959276|FG001|Overall Study|Lost to Follow-up|2
961386|NCT01134705|1959275|FG000|Overall Study|Protocol Violation|1
961387|NCT01134705|1959276|FG001|Overall Study|Protocol Violation|1
961388|NCT01134705|1959275|FG000|Overall Study|Other|1
961389|NCT01134705|1959276|FG001|Overall Study|Other|6
961390|NCT01134731|1959285|FG000|Overall Study|Adverse Event|3
961391|NCT01134731|1959286|FG001|Overall Study|Adverse Event|2
961392|NCT01134731|1959287|FG002|Overall Study|Adverse Event|1
961393|NCT01134731|1959285|FG000|Overall Study|Physician Decision|2
961394|NCT01134731|1959286|FG001|Overall Study|Physician Decision|2
961395|NCT01134731|1959287|FG002|Overall Study|Physician Decision|2
961396|NCT01134731|1959285|FG000|Overall Study|Lack of Efficacy|0
961397|NCT01134731|1959286|FG001|Overall Study|Lack of Efficacy|0
961398|NCT01134731|1959287|FG002|Overall Study|Lack of Efficacy|1
961399|NCT01134731|1959285|FG000|Overall Study|Withdrawal by Subject|3
961400|NCT01134731|1959286|FG001|Overall Study|Withdrawal by Subject|3
961401|NCT01134731|1959287|FG002|Overall Study|Withdrawal by Subject|1
961402|NCT01134731|1959285|FG000|Overall Study|Lost to Follow-up|5
961403|NCT01134731|1959286|FG001|Overall Study|Lost to Follow-up|4
961404|NCT01134731|1959287|FG002|Overall Study|Lost to Follow-up|3
961405|NCT01134783|1959298|FG000|Overall Study|Pregnancy|16
961406|NCT01134783|1959299|FG001|Overall Study|Pregnancy|8
961407|NCT01134783|1959298|FG000|Overall Study|Withdrawal by Subject|15
961408|NCT01134783|1959299|FG001|Overall Study|Withdrawal by Subject|9
961409|NCT01134783|1959298|FG000|Overall Study|Lost to Follow-up|5
961410|NCT01134783|1959299|FG001|Overall Study|Lost to Follow-up|20
961411|NCT01134939|1959341|FG000|Overall Study|Adverse Event|9
961412|NCT01134939|1959342|FG001|Overall Study|Adverse Event|3
961413|NCT01134939|1959343|FG002|Overall Study|Adverse Event|4
961414|NCT01134939|1959344|FG003|Overall Study|Adverse Event|5
961415|NCT01134939|1959345|FG004|Overall Study|Adverse Event|5
961416|NCT01134939|1959346|FG005|Overall Study|Adverse Event|5
961417|NCT01134939|1959347|FG006|Overall Study|Adverse Event|1
961418|NCT01134939|1959348|FG007|Overall Study|Adverse Event|0
961419|NCT01134939|1959341|FG000|Overall Study|Lack of Efficacy|2
961420|NCT01134939|1959342|FG001|Overall Study|Lack of Efficacy|5
961421|NCT01134939|1959343|FG002|Overall Study|Lack of Efficacy|1
961422|NCT01134939|1959344|FG003|Overall Study|Lack of Efficacy|0
961423|NCT01134939|1959345|FG004|Overall Study|Lack of Efficacy|3
961424|NCT01134939|1959346|FG005|Overall Study|Lack of Efficacy|0
961425|NCT01134939|1959347|FG006|Overall Study|Lack of Efficacy|1
961426|NCT01134939|1959348|FG007|Overall Study|Lack of Efficacy|0
961427|NCT01134939|1959341|FG000|Overall Study|Lost to Follow-up|2
961428|NCT01134939|1959342|FG001|Overall Study|Lost to Follow-up|3
961429|NCT01134939|1959343|FG002|Overall Study|Lost to Follow-up|0
961430|NCT01134939|1959344|FG003|Overall Study|Lost to Follow-up|1
961431|NCT01134939|1959345|FG004|Overall Study|Lost to Follow-up|2
961432|NCT01134939|1959346|FG005|Overall Study|Lost to Follow-up|1
961433|NCT01134939|1959347|FG006|Overall Study|Lost to Follow-up|0
961434|NCT01134939|1959348|FG007|Overall Study|Lost to Follow-up|0
961435|NCT01134939|1959341|FG000|Overall Study|Death|0
961436|NCT01134939|1959342|FG001|Overall Study|Death|1
961437|NCT01134939|1959343|FG002|Overall Study|Death|0
961438|NCT01134939|1959344|FG003|Overall Study|Death|0
961439|NCT01134939|1959345|FG004|Overall Study|Death|0
961440|NCT01134939|1959346|FG005|Overall Study|Death|0
961441|NCT01134939|1959347|FG006|Overall Study|Death|0
961442|NCT01134939|1959348|FG007|Overall Study|Death|0
961443|NCT01134939|1959341|FG000|Overall Study|Termination page not available|4
961444|NCT01134939|1959342|FG001|Overall Study|Termination page not available|6
961445|NCT01134939|1959343|FG002|Overall Study|Termination page not available|5
961446|NCT01134939|1959344|FG003|Overall Study|Termination page not available|8
961447|NCT01134939|1959345|FG004|Overall Study|Termination page not available|0
961448|NCT01134939|1959346|FG005|Overall Study|Termination page not available|3
961449|NCT01134939|1959347|FG006|Overall Study|Termination page not available|7
961450|NCT01134939|1959348|FG007|Overall Study|Termination page not available|0
961451|NCT01135017|1959372|FG000|Overall Study|Adverse Event|3
961452|NCT01135017|1959373|FG001|Overall Study|Adverse Event|8
961453|NCT01135017|1959372|FG000|Overall Study|Other than above|3
961454|NCT01135017|1959373|FG001|Overall Study|Other than above|4
961455|NCT01135134|1959398|FG000|Overall Study|Adverse Event|1
961456|NCT01135134|1959399|FG001|Overall Study|Adverse Event|1
961457|NCT01135134|1959398|FG000|Overall Study|Did not meet protocol eligibility|1
961458|NCT01135134|1959399|FG001|Overall Study|Did not meet protocol eligibility|0
961459|NCT01135394|1959471|FG000|Screening|Lost to Follow-up|2
961460|NCT01135394|1959471|FG000|Screening|Withdrawal by Subject|10
961461|NCT01135394|1959471|FG000|Screening|Screening failure|16
961462|NCT01135394|1959471|FG000|Screening|Physician Decision|5
961463|NCT01135394|1959471|FG000|Baseline Assessment|Withdrawal by Subject|9
961464|NCT01135394|1959471|FG000|Baseline Assessment|Physician Decision|3
961465|NCT01135394|1959471|FG000|Baseline Assessment|Lost to Follow-up|2
961466|NCT01135394|1959471|FG000|Baseline Assessment|Adverse Event|1
961467|NCT01135394|1959471|FG000|Study Treatment|Withdrawal by Subject|1
961468|NCT01135394|1959471|FG000|Study Treatment|Physician Decision|1
961469|NCT01135394|1959471|FG000|Study Treatment|Adverse Event|2
961470|NCT01135498|1959484|FG000|Overall Study|Adverse Event|20
961471|NCT01135498|1959484|FG000|Overall Study|Progressive disease|38
961472|NCT01135498|1959484|FG000|Overall Study|Investigator judgement|25
961473|NCT01135498|1959484|FG000|Overall Study|Withdrawal by Subject|4
961474|NCT01135498|1959484|FG000|Overall Study|Death|1
961475|NCT01135498|1959484|FG000|Overall Study|Ongoing at time of analysis|2
961476|NCT01135511|1959498|FG000|Overall Study|Adverse Event|0
961477|NCT01135511|1959499|FG001|Overall Study|Adverse Event|1
961478|NCT01135511|1959500|FG002|Overall Study|Adverse Event|2
961479|NCT01135511|1959501|FG003|Overall Study|Adverse Event|0
961480|NCT01135511|1959502|FG004|Overall Study|Adverse Event|0
961481|NCT01135511|1959503|FG005|Overall Study|Adverse Event|1
961482|NCT01135511|1959504|FG006|Overall Study|Adverse Event|0
961483|NCT01135511|1959505|FG007|Overall Study|Adverse Event|1
961484|NCT01135511|1959506|FG008|Overall Study|Adverse Event|0
961485|NCT01135511|1959498|FG000|Overall Study|Lack of Efficacy|0
961486|NCT01135511|1959499|FG001|Overall Study|Lack of Efficacy|1
961487|NCT01135511|1959500|FG002|Overall Study|Lack of Efficacy|1
961488|NCT01135511|1959501|FG003|Overall Study|Lack of Efficacy|2
961489|NCT01135511|1959502|FG004|Overall Study|Lack of Efficacy|0
961490|NCT01135511|1959503|FG005|Overall Study|Lack of Efficacy|0
961491|NCT01135511|1959504|FG006|Overall Study|Lack of Efficacy|0
961492|NCT01135511|1959505|FG007|Overall Study|Lack of Efficacy|0
961493|NCT01135511|1959506|FG008|Overall Study|Lack of Efficacy|0
961494|NCT01135511|1959498|FG000|Overall Study|Protocol Violation|0
961495|NCT01135511|1959499|FG001|Overall Study|Protocol Violation|0
961496|NCT01135511|1959500|FG002|Overall Study|Protocol Violation|3
961497|NCT01135511|1959501|FG003|Overall Study|Protocol Violation|0
961498|NCT01135511|1959502|FG004|Overall Study|Protocol Violation|0
961499|NCT01135511|1959503|FG005|Overall Study|Protocol Violation|0
961500|NCT01135511|1959504|FG006|Overall Study|Protocol Violation|0
961501|NCT01135511|1959505|FG007|Overall Study|Protocol Violation|0
961502|NCT01135511|1959506|FG008|Overall Study|Protocol Violation|0
961503|NCT01135511|1959498|FG000|Overall Study|Pregnancy|0
961504|NCT01135511|1959499|FG001|Overall Study|Pregnancy|0
961505|NCT01135511|1959500|FG002|Overall Study|Pregnancy|0
961506|NCT01135511|1959501|FG003|Overall Study|Pregnancy|1
961507|NCT01135511|1959502|FG004|Overall Study|Pregnancy|0
961508|NCT01135511|1959503|FG005|Overall Study|Pregnancy|0
961509|NCT01135511|1959504|FG006|Overall Study|Pregnancy|0
961510|NCT01135511|1959505|FG007|Overall Study|Pregnancy|0
961511|NCT01135511|1959506|FG008|Overall Study|Pregnancy|0
961512|NCT01135511|1959498|FG000|Overall Study|could not visit the clinic|0
961513|NCT01135511|1959499|FG001|Overall Study|could not visit the clinic|1
961514|NCT01135511|1959500|FG002|Overall Study|could not visit the clinic|2
961515|NCT01135511|1959501|FG003|Overall Study|could not visit the clinic|0
961516|NCT01135511|1959502|FG004|Overall Study|could not visit the clinic|0
961517|NCT01135511|1959503|FG005|Overall Study|could not visit the clinic|0
961518|NCT01135511|1959504|FG006|Overall Study|could not visit the clinic|0
961519|NCT01135511|1959505|FG007|Overall Study|could not visit the clinic|0
961520|NCT01135511|1959506|FG008|Overall Study|could not visit the clinic|0
961521|NCT01135511|1959498|FG000|Overall Study|noncompliance with study drug taken|0
961522|NCT01135511|1959499|FG001|Overall Study|noncompliance with study drug taken|0
961523|NCT01135511|1959500|FG002|Overall Study|noncompliance with study drug taken|0
961524|NCT01135511|1959501|FG003|Overall Study|noncompliance with study drug taken|0
961525|NCT01135511|1959502|FG004|Overall Study|noncompliance with study drug taken|1
961526|NCT01135511|1959503|FG005|Overall Study|noncompliance with study drug taken|0
961527|NCT01135511|1959504|FG006|Overall Study|noncompliance with study drug taken|0
961528|NCT01135511|1959505|FG007|Overall Study|noncompliance with study drug taken|0
961529|NCT01135511|1959506|FG008|Overall Study|noncompliance with study drug taken|0
961530|NCT01135511|1959498|FG000|Overall Study|Withdrawal by Subject|0
961531|NCT01135511|1959499|FG001|Overall Study|Withdrawal by Subject|0
961532|NCT01135511|1959500|FG002|Overall Study|Withdrawal by Subject|0
961533|NCT01135511|1959501|FG003|Overall Study|Withdrawal by Subject|0
961534|NCT01135511|1959502|FG004|Overall Study|Withdrawal by Subject|0
961535|NCT01135511|1959503|FG005|Overall Study|Withdrawal by Subject|0
961536|NCT01135511|1959504|FG006|Overall Study|Withdrawal by Subject|1
961537|NCT01135511|1959505|FG007|Overall Study|Withdrawal by Subject|0
961538|NCT01135511|1959506|FG008|Overall Study|Withdrawal by Subject|1
961539|NCT01135524|1959526|FG000|Overall Study|Withdrawal by Subject|14
961540|NCT01135524|1959526|FG000|Overall Study|Adverse Event|20
961541|NCT01135524|1959526|FG000|Overall Study|Lost to Follow-up|3
961542|NCT01135524|1959526|FG000|Overall Study|Administrative|151
961543|NCT01135524|1959526|FG000|Overall Study|Lack of Efficacy|8
961544|NCT01135914|1959537|FG000|Overall Study|Withdrawal by Subject|1
961545|NCT01135914|1959538|FG001|Overall Study|Withdrawal by Subject|3
961546|NCT01135914|1959539|FG002|Overall Study|Withdrawal by Subject|6
961547|NCT01135914|1959537|FG000|Overall Study|Lost to Follow-up|1
961548|NCT01135914|1959538|FG001|Overall Study|Lost to Follow-up|0
961549|NCT01135914|1959539|FG002|Overall Study|Lost to Follow-up|1
961550|NCT01135914|1959537|FG000|Overall Study|Protocol Violation|0
961551|NCT01135914|1959538|FG001|Overall Study|Protocol Violation|0
961552|NCT01135914|1959539|FG002|Overall Study|Protocol Violation|3
961553|NCT01135914|1959537|FG000|Overall Study|Lack of Efficacy|2
961554|NCT01135914|1959538|FG001|Overall Study|Lack of Efficacy|1
961555|NCT01135914|1959539|FG002|Overall Study|Lack of Efficacy|10
961556|NCT01135914|1959537|FG000|Overall Study|Adverse Event|0
961557|NCT01135914|1959538|FG001|Overall Study|Adverse Event|1
961558|NCT01135914|1959539|FG002|Overall Study|Adverse Event|2
961559|NCT01135992|1959547|FG000|Overall Study|Adverse Event|1
961560|NCT01135992|1959547|FG000|Overall Study|Lack of Efficacy|1
961561|NCT01135992|1959547|FG000|Overall Study|Protocol Violation|2
961562|NCT01135992|1959547|FG000|Overall Study|Withdrawal criteria|10
961563|NCT01135992|1959547|FG000|Overall Study|Unclassified|7
961564|NCT01136174|1959555|FG000|Overall Study|Adverse Event|0
961565|NCT01136174|1959556|FG001|Overall Study|Adverse Event|0
961566|NCT01136174|1959557|FG002|Overall Study|Adverse Event|0
961567|NCT01136174|1959558|FG003|Overall Study|Adverse Event|4
961568|NCT01136291|1959584|FG000|Overall Study|Lost to Follow-up|1
961569|NCT01136291|1959585|FG001|Overall Study|Lost to Follow-up|1
961570|NCT01136356|1959591|FG000|First 18-day Withdrawal|Withdrawal by Subject|3
961571|NCT01136356|1959592|FG001|First 18-day Withdrawal|Withdrawal by Subject|0
961572|NCT01136356|1959591|FG000|First 18-day Withdrawal|Physician Decision|1
961573|NCT01136356|1959592|FG001|First 18-day Withdrawal|Physician Decision|0
961574|NCT01136356|1959591|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0
961575|NCT01136356|1959592|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1
961576|NCT01136382|1959599|FG000|Overall Study|Other|8
961577|NCT01136382|1959600|FG001|Overall Study|Other|3
961578|NCT01136382|1959599|FG000|Overall Study|Study-Specific Withdrawal Criteria|48
961579|NCT01136382|1959600|FG001|Overall Study|Study-Specific Withdrawal Criteria|25
961580|NCT01136382|1959599|FG000|Overall Study|Severe Non-Compliance to Protocol|0
961581|NCT01136382|1959600|FG001|Overall Study|Severe Non-Compliance to Protocol|2
961582|NCT01136382|1959599|FG000|Overall Study|Withdrawal by Subject|4
961583|NCT01136382|1959600|FG001|Overall Study|Withdrawal by Subject|1
961584|NCT01136408|1959609|FG000|Overall Study|Adverse Event|4
961585|NCT01136408|1959610|FG001|Overall Study|Adverse Event|8
961586|NCT01136408|1959611|FG002|Overall Study|Adverse Event|4
961587|NCT01136408|1959609|FG000|Overall Study|Protocol Violation|1
961588|NCT01136408|1959610|FG001|Overall Study|Protocol Violation|1
961589|NCT01136408|1959611|FG002|Overall Study|Protocol Violation|1
961590|NCT01136655|1959627|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
961591|NCT01136655|1959627|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
961592|NCT01136655|1959627|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
961593|NCT01136655|1959627|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
961594|NCT01136733|1959647|FG000|Phase 1b|Adverse Event|0
961595|NCT01136733|1959648|FG001|Phase 1b|Adverse Event|3
961596|NCT01136733|1959649|FG002|Phase 1b|Adverse Event|1
961597|NCT01136733|1959650|FG003|Phase 1b|Adverse Event|0
961598|NCT01136733|1959651|FG004|Phase 1b|Adverse Event|0
961599|NCT01136733|1959652|FG005|Phase 1b|Adverse Event|0
961600|NCT01136733|1959653|FG006|Phase 1b|Adverse Event|0
961601|NCT01136733|1959647|FG000|Phase 1b|Participant Choice|0
961602|NCT01136733|1959648|FG001|Phase 1b|Participant Choice|0
961603|NCT01136733|1959649|FG002|Phase 1b|Participant Choice|1
961604|NCT01136733|1959650|FG003|Phase 1b|Participant Choice|0
961605|NCT01136733|1959651|FG004|Phase 1b|Participant Choice|0
961606|NCT01136733|1959652|FG005|Phase 1b|Participant Choice|0
961607|NCT01136733|1959653|FG006|Phase 1b|Participant Choice|0
961608|NCT01136733|1959647|FG000|Phase 1b|Administrative-Withdrew Consent|0
961609|NCT01136733|1959648|FG001|Phase 1b|Administrative-Withdrew Consent|1
961610|NCT01136733|1959649|FG002|Phase 1b|Administrative-Withdrew Consent|0
961611|NCT01136733|1959650|FG003|Phase 1b|Administrative-Withdrew Consent|0
961612|NCT01136733|1959651|FG004|Phase 1b|Administrative-Withdrew Consent|0
961613|NCT01136733|1959652|FG005|Phase 1b|Administrative-Withdrew Consent|0
961614|NCT01136733|1959653|FG006|Phase 1b|Administrative-Withdrew Consent|0
961615|NCT01136733|1959647|FG000|Phase 1b|Clinical Progression|1
961616|NCT01136733|1959648|FG001|Phase 1b|Clinical Progression|1
961617|NCT01136733|1959649|FG002|Phase 1b|Clinical Progression|0
961618|NCT01136733|1959650|FG003|Phase 1b|Clinical Progression|0
961619|NCT01136733|1959651|FG004|Phase 1b|Clinical Progression|0
961620|NCT01136733|1959652|FG005|Phase 1b|Clinical Progression|0
961621|NCT01136733|1959653|FG006|Phase 1b|Clinical Progression|0
961622|NCT01136733|1959647|FG000|Phase 2|Disease Progression|0
961623|NCT01136733|1959648|FG001|Phase 2|Disease Progression|0
961624|NCT01136733|1959649|FG002|Phase 2|Disease Progression|0
961625|NCT01136733|1959650|FG003|Phase 2|Disease Progression|0
961626|NCT01136733|1959651|FG004|Phase 2|Disease Progression|30
961627|NCT01136733|1959652|FG005|Phase 2|Disease Progression|32
961628|NCT01136733|1959653|FG006|Phase 2|Disease Progression|38
961629|NCT01136733|1959647|FG000|Phase 2|Adverse Event|0
961630|NCT01136733|1959648|FG001|Phase 2|Adverse Event|0
961631|NCT01136733|1959649|FG002|Phase 2|Adverse Event|0
961632|NCT01136733|1959650|FG003|Phase 2|Adverse Event|0
961633|NCT01136733|1959651|FG004|Phase 2|Adverse Event|11
961634|NCT01136733|1959652|FG005|Phase 2|Adverse Event|13
961635|NCT01136733|1959653|FG006|Phase 2|Adverse Event|5
961636|NCT01136733|1959647|FG000|Phase 2|Participant Choice|0
961637|NCT01136733|1959648|FG001|Phase 2|Participant Choice|0
961638|NCT01136733|1959649|FG002|Phase 2|Participant Choice|0
961639|NCT01136733|1959650|FG003|Phase 2|Participant Choice|0
961640|NCT01136733|1959651|FG004|Phase 2|Participant Choice|3
961641|NCT01136733|1959652|FG005|Phase 2|Participant Choice|0
961642|NCT01136733|1959653|FG006|Phase 2|Participant Choice|1
961643|NCT01136733|1959647|FG000|Phase 2|Administrative-Withdrew Consent|0
961644|NCT01136733|1959648|FG001|Phase 2|Administrative-Withdrew Consent|0
961645|NCT01136733|1959649|FG002|Phase 2|Administrative-Withdrew Consent|0
961646|NCT01136733|1959650|FG003|Phase 2|Administrative-Withdrew Consent|0
961647|NCT01136733|1959651|FG004|Phase 2|Administrative-Withdrew Consent|1
961648|NCT01136733|1959652|FG005|Phase 2|Administrative-Withdrew Consent|0
961649|NCT01136733|1959653|FG006|Phase 2|Administrative-Withdrew Consent|0
961650|NCT01136733|1959647|FG000|Phase 2|Other|0
961651|NCT01136733|1959648|FG001|Phase 2|Other|0
961652|NCT01136733|1959649|FG002|Phase 2|Other|0
961653|NCT01136733|1959650|FG003|Phase 2|Other|0
961654|NCT01136733|1959651|FG004|Phase 2|Other|6
961655|NCT01136733|1959652|FG005|Phase 2|Other|7
961656|NCT01136733|1959653|FG006|Phase 2|Other|6
961657|NCT01136746|1959685|FG000|Overall Study|Lost to Follow-up|0
961658|NCT01136746|1959686|FG001|Overall Study|Lost to Follow-up|2
961659|NCT01136746|1959685|FG000|Overall Study|Protocol Violation|2
961660|NCT01136746|1959686|FG001|Overall Study|Protocol Violation|1
961661|NCT01136746|1959685|FG000|Overall Study|Death|1
961662|NCT01136746|1959686|FG001|Overall Study|Death|0
961663|NCT01136772|1959694|FG000|Overall Study|Adverse Event|15
961664|NCT01136772|1959695|FG001|Overall Study|Adverse Event|14
961665|NCT01136772|1959694|FG000|Overall Study|Lack of Efficacy|42
961666|NCT01136772|1959695|FG001|Overall Study|Lack of Efficacy|39
961667|NCT01136772|1959694|FG000|Overall Study|Administrative|14
961668|NCT01136772|1959695|FG001|Overall Study|Administrative|12
961669|NCT01136772|1959694|FG000|Overall Study|Withdrawal by Subject|33
961670|NCT01136772|1959695|FG001|Overall Study|Withdrawal by Subject|36
961671|NCT01136772|1959694|FG000|Overall Study|Did not receive injection|10
961672|NCT01136772|1959695|FG001|Overall Study|Did not receive injection|7
961673|NCT01136772|1959694|FG000|Overall Study|Did not follow up after first injection|2
961674|NCT01136772|1959695|FG001|Overall Study|Did not follow up after first injection|2
961675|NCT01136785|1959703|FG000|Overall Study|Protocol Violation|2
961676|NCT01136785|1959704|FG001|Overall Study|Protocol Violation|1
961677|NCT01136876|1959725|FG000|Overall Study|Lost to Follow-up|0
961678|NCT01136876|1959726|FG001|Overall Study|Lost to Follow-up|1
961679|NCT01136876|1959725|FG000|Overall Study|Physician Decision|3
961680|NCT01136876|1959726|FG001|Overall Study|Physician Decision|5
961681|NCT01136876|1959725|FG000|Overall Study|Missing NGAL measurement|2
961682|NCT01136876|1959726|FG001|Overall Study|Missing NGAL measurement|5
961683|NCT01136915|1959736|FG000|Overall Study|Lost to Follow-up|2
961684|NCT01136915|1959737|FG001|Overall Study|Lost to Follow-up|0
961685|NCT01136915|1959736|FG000|Overall Study|Exclusion criterion met|0
961686|NCT01136915|1959737|FG001|Overall Study|Exclusion criterion met|1
961687|NCT01136954|1959747|FG000|Overall Study|Adverse Event|3
961688|NCT01136954|1959748|FG001|Overall Study|Adverse Event|2
961689|NCT01136954|1959747|FG000|Overall Study|Withdrawal by Subject|6
961690|NCT01136954|1959748|FG001|Overall Study|Withdrawal by Subject|2
961691|NCT01136954|1959747|FG000|Overall Study|Lack of Efficacy|14
961692|NCT01136954|1959748|FG001|Overall Study|Lack of Efficacy|13
961693|NCT01136954|1959747|FG000|Overall Study|Physician Decision|0
961694|NCT01136954|1959748|FG001|Overall Study|Physician Decision|1
961695|NCT01136954|1959747|FG000|Overall Study|Other|1
961696|NCT01136954|1959748|FG001|Overall Study|Other|3
961697|NCT01137071|1959798|FG000|Overall Study|Disease Progression|11
961698|NCT01137071|1959798|FG000|Overall Study|Withdrawal by Subject|2
961699|NCT01137071|1959798|FG000|Overall Study|Wrongly Included|1
961700|NCT01137110|1959809|FG000|Overall Study|Protocol Violation|1
961701|NCT01137110|1959810|FG001|Overall Study|Protocol Violation|0
961702|NCT01137292|1959816|FG000|Overall Study|Death|30
961703|NCT01137292|1959816|FG000|Overall Study|Adverse Event|3
961704|NCT01137292|1959816|FG000|Overall Study|Lack of Efficacy|13
961705|NCT01137292|1959816|FG000|Overall Study|Lost to Follow-up|1
961706|NCT01137292|1959816|FG000|Overall Study|Other|7
961707|NCT01137435|1959838|FG000|Overall Study|Lost to Follow-up|24
961708|NCT01137435|1959838|FG000|Overall Study|Off label usage|4
961709|NCT01137474|1959846|FG000|Overall Study|Adverse Event|3
961710|NCT01137474|1959847|FG001|Overall Study|Adverse Event|5
961711|NCT01137474|1959848|FG002|Overall Study|Adverse Event|1
961712|NCT01137474|1959849|FG003|Overall Study|Adverse Event|3
961713|NCT01137474|1959846|FG000|Overall Study|Withdrawal by Subject|7
961714|NCT01137474|1959847|FG001|Overall Study|Withdrawal by Subject|2
911078|NCT00796653|1888247|FG000|Overall Study|Adverse Event|19
911079|NCT00796653|1888248|FG001|Overall Study|Adverse Event|16
961715|NCT01137474|1959848|FG002|Overall Study|Withdrawal by Subject|6
961716|NCT01137474|1959849|FG003|Overall Study|Withdrawal by Subject|9
961717|NCT01137474|1959846|FG000|Overall Study|No longer met study criteria|6
961718|NCT01137474|1959847|FG001|Overall Study|No longer met study criteria|1
961719|NCT01137474|1959848|FG002|Overall Study|No longer met study criteria|0
961720|NCT01137474|1959849|FG003|Overall Study|No longer met study criteria|5
961721|NCT01137474|1959846|FG000|Overall Study|Lost to Follow-up|5
961722|NCT01137474|1959847|FG001|Overall Study|Lost to Follow-up|1
961723|NCT01137474|1959848|FG002|Overall Study|Lost to Follow-up|0
961724|NCT01137474|1959849|FG003|Overall Study|Lost to Follow-up|2
961725|NCT01137474|1959846|FG000|Overall Study|Lack of Efficacy|0
961726|NCT01137474|1959847|FG001|Overall Study|Lack of Efficacy|0
961727|NCT01137474|1959848|FG002|Overall Study|Lack of Efficacy|0
961728|NCT01137474|1959849|FG003|Overall Study|Lack of Efficacy|2
961729|NCT01137474|1959846|FG000|Overall Study|Other|3
961730|NCT01137474|1959847|FG001|Overall Study|Other|1
961731|NCT01137474|1959848|FG002|Overall Study|Other|0
961732|NCT01137474|1959849|FG003|Overall Study|Other|0
961733|NCT01137474|1959846|FG000|Overall Study|Pregnancy|0
961734|NCT01137474|1959847|FG001|Overall Study|Pregnancy|1
961735|NCT01137474|1959848|FG002|Overall Study|Pregnancy|0
961736|NCT01137474|1959849|FG003|Overall Study|Pregnancy|0
961737|NCT01137474|1959846|FG000|Overall Study|Administrative reason by sponsor|0
961738|NCT01137474|1959847|FG001|Overall Study|Administrative reason by sponsor|1
961739|NCT01137474|1959848|FG002|Overall Study|Administrative reason by sponsor|0
961740|NCT01137474|1959849|FG003|Overall Study|Administrative reason by sponsor|0
961741|NCT01137578|1959863|FG000|Overall Study|Participant requested to Discontinue|3
961742|NCT01137578|1959864|FG001|Overall Study|Participant requested to Discontinue|0
961743|NCT01137578|1959865|FG002|Overall Study|Participant requested to Discontinue|0
961744|NCT01137578|1959863|FG000|Overall Study|Withdrawal by Subject|1
961745|NCT01137578|1959864|FG001|Overall Study|Withdrawal by Subject|0
961746|NCT01137578|1959865|FG002|Overall Study|Withdrawal by Subject|0
961747|NCT01137578|1959863|FG000|Overall Study|Other|12
961748|NCT01137578|1959864|FG001|Overall Study|Other|2
961749|NCT01137578|1959865|FG002|Overall Study|Other|6
961750|NCT01137604|1959897|FG000|Overall Study|Adverse Event|1
961751|NCT01137604|1959898|FG001|Overall Study|Adverse Event|6
961752|NCT01137604|1959899|FG002|Overall Study|Adverse Event|9
961753|NCT01137604|1959900|FG003|Overall Study|Adverse Event|9
961754|NCT01137604|1959897|FG000|Overall Study|Withdrawal by Subject|0
961755|NCT01137604|1959898|FG001|Overall Study|Withdrawal by Subject|2
961756|NCT01137604|1959899|FG002|Overall Study|Withdrawal by Subject|2
961757|NCT01137604|1959900|FG003|Overall Study|Withdrawal by Subject|1
961758|NCT01137604|1959897|FG000|Overall Study|Clinical Progression|0
961759|NCT01137604|1959898|FG001|Overall Study|Clinical Progression|2
961760|NCT01137604|1959899|FG002|Overall Study|Clinical Progression|1
961761|NCT01137604|1959900|FG003|Overall Study|Clinical Progression|0
961762|NCT01137604|1959897|FG000|Overall Study|Participant's Decision|1
961763|NCT01137604|1959898|FG001|Overall Study|Participant's Decision|0
961764|NCT01137604|1959899|FG002|Overall Study|Participant's Decision|0
961765|NCT01137604|1959900|FG003|Overall Study|Participant's Decision|0
961766|NCT01137604|1959897|FG000|Overall Study|Clinical Decline|0
961767|NCT01137604|1959898|FG001|Overall Study|Clinical Decline|0
961768|NCT01137604|1959899|FG002|Overall Study|Clinical Decline|1
961769|NCT01137604|1959900|FG003|Overall Study|Clinical Decline|1
961770|NCT01137682|1959913|FG000|Overall Study|Adverse Event-CORE|2
961771|NCT01137682|1959914|FG001|Overall Study|Adverse Event-CORE|4
961772|NCT01137682|1959915|FG002|Overall Study|Adverse Event-CORE|0
961773|NCT01137682|1959913|FG000|Overall Study|Withdrawal by Subject-CORE|2
961774|NCT01137682|1959914|FG001|Overall Study|Withdrawal by Subject-CORE|2
961775|NCT01137682|1959915|FG002|Overall Study|Withdrawal by Subject-CORE|2
961776|NCT01137682|1959913|FG000|Overall Study|Administrative problems-CORE|2
961777|NCT01137682|1959914|FG001|Overall Study|Administrative problems-CORE|1
961778|NCT01137682|1959915|FG002|Overall Study|Administrative problems-CORE|0
961779|NCT01137682|1959913|FG000|Overall Study|Protocol Violation-CORE|0
961780|NCT01137682|1959914|FG001|Overall Study|Protocol Violation-CORE|1
961781|NCT01137682|1959915|FG002|Overall Study|Protocol Violation-CORE|1
961782|NCT01137682|1959913|FG000|Overall Study|Adverse Event-Extension|4
961783|NCT01137682|1959914|FG001|Overall Study|Adverse Event-Extension|8
961784|NCT01137682|1959915|FG002|Overall Study|Adverse Event-Extension|7
961785|NCT01137682|1959913|FG000|Overall Study|Lack of Efficacy-Extension|15
961786|NCT01137682|1959914|FG001|Overall Study|Lack of Efficacy-Extension|9
961787|NCT01137682|1959915|FG002|Overall Study|Lack of Efficacy-Extension|13
961788|NCT01137682|1959913|FG000|Overall Study|Withdrawal by Subject-Extension|6
961789|NCT01137682|1959914|FG001|Overall Study|Withdrawal by Subject-Extension|8
961790|NCT01137682|1959915|FG002|Overall Study|Withdrawal by Subject-Extension|8
961791|NCT01137682|1959913|FG000|Overall Study|Lost to Follow Up-Extension|0
961792|NCT01137682|1959914|FG001|Overall Study|Lost to Follow Up-Extension|1
961793|NCT01137682|1959915|FG002|Overall Study|Lost to Follow Up-Extension|0
961794|NCT01137682|1959913|FG000|Overall Study|Administrative problems-Extension|0
961795|NCT01137682|1959914|FG001|Overall Study|Administrative problems-Extension|2
961796|NCT01137682|1959915|FG002|Overall Study|Administrative problems-Extension|0
961797|NCT01137682|1959913|FG000|Overall Study|Death-Extension|2
961798|NCT01137682|1959914|FG001|Overall Study|Death-Extension|0
961799|NCT01137682|1959915|FG002|Overall Study|Death-Extension|0
961800|NCT01137682|1959913|FG000|Overall Study|Protocol Violation-Extension|2
961801|NCT01137682|1959914|FG001|Overall Study|Protocol Violation-Extension|1
961802|NCT01137682|1959915|FG002|Overall Study|Protocol Violation-Extension|0
961803|NCT01137682|1959913|FG000|Overall Study|Did not enter extension|2
961804|NCT01137682|1959914|FG001|Overall Study|Did not enter extension|3
961805|NCT01137682|1959915|FG002|Overall Study|Did not enter extension|2
961806|NCT01137682|1959913|FG000|Overall Study|Did not receive treatment in extension|0
961807|NCT01137682|1959914|FG001|Overall Study|Did not receive treatment in extension|0
961808|NCT01137682|1959915|FG002|Overall Study|Did not receive treatment in extension|1
911080|NCT00796653|1888249|FG002|Overall Study|Adverse Event|16
911081|NCT00796653|1888250|FG003|Overall Study|Adverse Event|16
911082|NCT00796653|1888247|FG000|Overall Study|Lost to Follow-up|2
911083|NCT00796653|1888248|FG001|Overall Study|Lost to Follow-up|1
911084|NCT00796653|1888249|FG002|Overall Study|Lost to Follow-up|2
911085|NCT00796653|1888250|FG003|Overall Study|Lost to Follow-up|3
911086|NCT00796653|1888247|FG000|Overall Study|Withdrawal by Subject|16
911087|NCT00796653|1888248|FG001|Overall Study|Withdrawal by Subject|8
911088|NCT00796653|1888249|FG002|Overall Study|Withdrawal by Subject|8
911089|NCT00796653|1888250|FG003|Overall Study|Withdrawal by Subject|13
911090|NCT00796653|1888247|FG000|Overall Study|Lack of Efficacy|8
911091|NCT00796653|1888248|FG001|Overall Study|Lack of Efficacy|1
911092|NCT00796653|1888249|FG002|Overall Study|Lack of Efficacy|3
911093|NCT00796653|1888250|FG003|Overall Study|Lack of Efficacy|2
911094|NCT00796653|1888247|FG000|Overall Study|Non compliance with protocol|2
961813|NCT01137786|1959940|FG000|Overall Study|Lost to Follow-up|0
961814|NCT01137786|1959941|FG001|Overall Study|Lost to Follow-up|2
961815|NCT01137786|1959940|FG000|Overall Study|Withdrawal by Subject|1
961816|NCT01137786|1959941|FG001|Overall Study|Withdrawal by Subject|1
961817|NCT01137812|1959951|FG000|Overall Study|Adverse Event|21
961818|NCT01137812|1959952|FG001|Overall Study|Adverse Event|14
961819|NCT01137812|1959951|FG000|Overall Study|Lost to Follow-up|6
961820|NCT01137812|1959952|FG001|Overall Study|Lost to Follow-up|8
961821|NCT01137812|1959951|FG000|Overall Study|Physician Decision|25
961822|NCT01137812|1959952|FG001|Overall Study|Physician Decision|17
961823|NCT01137812|1959951|FG000|Overall Study|Protocol Violation|5
961824|NCT01137812|1959952|FG001|Overall Study|Protocol Violation|4
961825|NCT01137812|1959951|FG000|Overall Study|Withdrawal by Subject|5
961826|NCT01137812|1959952|FG001|Overall Study|Withdrawal by Subject|13
961827|NCT01137812|1959951|FG000|Overall Study|Death|2
961828|NCT01137812|1959952|FG001|Overall Study|Death|0
961829|NCT01137812|1959951|FG000|Overall Study|Patient met glycemic withdrawal criteria|40
961830|NCT01137812|1959952|FG001|Overall Study|Patient met glycemic withdrawal criteria|85
961831|NCT01137812|1959951|FG000|Overall Study|Other|19
961832|NCT01137812|1959952|FG001|Overall Study|Other|27
961833|NCT01138007|1960016|FG000|Overall Study|Adverse Event|4
961834|NCT01138007|1960017|FG001|Overall Study|Adverse Event|12
961835|NCT01138007|1960018|FG002|Overall Study|Adverse Event|9
961836|NCT01138007|1960016|FG000|Overall Study|Lack of Efficacy|2
961837|NCT01138007|1960017|FG001|Overall Study|Lack of Efficacy|0
961838|NCT01138007|1960018|FG002|Overall Study|Lack of Efficacy|6
961839|NCT01138007|1960016|FG000|Overall Study|Protocol Violation|2
961840|NCT01138007|1960017|FG001|Overall Study|Protocol Violation|3
961841|NCT01138007|1960018|FG002|Overall Study|Protocol Violation|2
961842|NCT01138007|1960016|FG000|Overall Study|Protocol-Defined Stopping Criteria|6
961843|NCT01138007|1960017|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
961844|NCT01138007|1960018|FG002|Overall Study|Protocol-Defined Stopping Criteria|8
961845|NCT01138007|1960016|FG000|Overall Study|Lost to Follow-up|3
961846|NCT01138007|1960017|FG001|Overall Study|Lost to Follow-up|3
961847|NCT01138007|1960018|FG002|Overall Study|Lost to Follow-up|5
961848|NCT01138007|1960016|FG000|Overall Study|Physician Decision|0
961849|NCT01138007|1960017|FG001|Overall Study|Physician Decision|5
961850|NCT01138007|1960018|FG002|Overall Study|Physician Decision|3
961851|NCT01138007|1960016|FG000|Overall Study|Withdrawal by Subject|5
961852|NCT01138007|1960017|FG001|Overall Study|Withdrawal by Subject|6
961853|NCT01138007|1960018|FG002|Overall Study|Withdrawal by Subject|15
961854|NCT01138046|1960028|FG000|Overall Study|Withdrawal due to death|6
961855|NCT01138111|1960041|FG000|Overall Study|Withdrawal by Subject|5
961856|NCT01138111|1960041|FG000|Overall Study|Adverse Event|1
961857|NCT01138111|1960041|FG000|Overall Study|Death|1
961858|NCT01138111|1960041|FG000|Overall Study|Lost to Follow-up|2
961859|NCT01138150|1960087|FG000|Overall Study|blood unable to be processed|0
961860|NCT01138150|1960088|FG001|Overall Study|blood unable to be processed|1
961861|NCT01138150|1960087|FG000|Overall Study|Physician Decision|1
961862|NCT01138150|1960088|FG001|Overall Study|Physician Decision|0
961863|NCT01138501|1960123|FG000|Overall Study|Protocol Violation|2
961864|NCT01138501|1960123|FG000|Overall Study|Withdrawal by Subject|3
961865|NCT01138657|1960143|FG000|Overall Study|Adverse Event|3
961866|NCT01138657|1960144|FG001|Overall Study|Adverse Event|10
961867|NCT01138657|1960143|FG000|Overall Study|Lack of Efficacy|2
961868|NCT01138657|1960144|FG001|Overall Study|Lack of Efficacy|1
961869|NCT01138657|1960143|FG000|Overall Study|Lost to Follow-up|0
961870|NCT01138657|1960144|FG001|Overall Study|Lost to Follow-up|3
961871|NCT01138657|1960143|FG000|Overall Study|Miscellaneous Reasons|3
961872|NCT01138657|1960144|FG001|Overall Study|Miscellaneous Reasons|4
961873|NCT01138826|1960161|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1
961874|NCT01138826|1960162|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1
961875|NCT01138826|1960163|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0
961876|NCT01138826|1960164|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0
961877|NCT01138826|1960165|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1
961878|NCT01138826|1960166|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0
961879|NCT01139008|1960201|FG000|Overall Study|Withdrawal by Subject|5
961880|NCT01139008|1960201|FG000|Overall Study|Non-compliant, lost product|1
961881|NCT01139021|1960214|FG000|Overall Study|Adverse Event|0
961882|NCT01139021|1960215|FG001|Overall Study|Adverse Event|0
961883|NCT01139021|1960216|FG002|Overall Study|Adverse Event|0
961884|NCT01139021|1960217|FG003|Overall Study|Adverse Event|0
961885|NCT01139021|1960218|FG004|Overall Study|Adverse Event|1
961886|NCT01139021|1960219|FG005|Overall Study|Adverse Event|0
961887|NCT01139021|1960214|FG000|Overall Study|Lost to Follow-up|0
961888|NCT01139021|1960215|FG001|Overall Study|Lost to Follow-up|0
961889|NCT01139021|1960216|FG002|Overall Study|Lost to Follow-up|0
961890|NCT01139021|1960217|FG003|Overall Study|Lost to Follow-up|0
961891|NCT01139021|1960218|FG004|Overall Study|Lost to Follow-up|2
961892|NCT01139021|1960219|FG005|Overall Study|Lost to Follow-up|0
961893|NCT01139021|1960214|FG000|Overall Study|Protocol Violation|1
961894|NCT01139021|1960215|FG001|Overall Study|Protocol Violation|0
961895|NCT01139021|1960216|FG002|Overall Study|Protocol Violation|0
961896|NCT01139021|1960217|FG003|Overall Study|Protocol Violation|0
961897|NCT01139021|1960218|FG004|Overall Study|Protocol Violation|2
961898|NCT01139021|1960219|FG005|Overall Study|Protocol Violation|0
961899|NCT01139021|1960214|FG000|Overall Study|Withdrawal by Subject|0
961900|NCT01139021|1960215|FG001|Overall Study|Withdrawal by Subject|0
961901|NCT01139021|1960216|FG002|Overall Study|Withdrawal by Subject|0
961902|NCT01139021|1960217|FG003|Overall Study|Withdrawal by Subject|1
961903|NCT01139021|1960218|FG004|Overall Study|Withdrawal by Subject|4
961904|NCT01139021|1960219|FG005|Overall Study|Withdrawal by Subject|0
961905|NCT01139047|1960234|FG000|Overall Study|Withdrawal by Subject|1
961906|NCT01139164|1960244|FG000|Overall Study|Withdrawn prior to study start|0
961907|NCT01139164|1960245|FG001|Overall Study|Withdrawn prior to study start|2
961908|NCT01139164|1960246|FG002|Overall Study|Withdrawn prior to study start|0
961909|NCT01139450|1960277|FG000|Overall Study|Withdrawal by Subject|7
961910|NCT01139450|1960278|FG001|Overall Study|Withdrawal by Subject|10
961911|NCT01139450|1960279|FG002|Overall Study|Withdrawal by Subject|13
961912|NCT01139450|1960277|FG000|Overall Study|Lack of Efficacy|3
961913|NCT01139450|1960278|FG001|Overall Study|Lack of Efficacy|1
961914|NCT01139450|1960279|FG002|Overall Study|Lack of Efficacy|8
961915|NCT01139450|1960277|FG000|Overall Study|Protocol Violation|6
961916|NCT01139450|1960278|FG001|Overall Study|Protocol Violation|5
961917|NCT01139450|1960279|FG002|Overall Study|Protocol Violation|2
961918|NCT01139450|1960277|FG000|Overall Study|Lost to Follow-up|9
961919|NCT01139450|1960278|FG001|Overall Study|Lost to Follow-up|7
961920|NCT01139450|1960279|FG002|Overall Study|Lost to Follow-up|11
961921|NCT01139450|1960277|FG000|Overall Study|Administrative|0
961922|NCT01139450|1960278|FG001|Overall Study|Administrative|0
961923|NCT01139450|1960279|FG002|Overall Study|Administrative|1
961924|NCT01139450|1960277|FG000|Overall Study|Adverse Event|2
961925|NCT01139450|1960278|FG001|Overall Study|Adverse Event|2
961926|NCT01139450|1960279|FG002|Overall Study|Adverse Event|3
961927|NCT01139580|1960302|FG000|Overall Study|Adverse Event|5
961928|NCT01139580|1960303|FG001|Overall Study|Adverse Event|4
961929|NCT01139580|1960302|FG000|Overall Study|Lost to Follow-up|9
961930|NCT01139580|1960303|FG001|Overall Study|Lost to Follow-up|1
961931|NCT01139580|1960302|FG000|Overall Study|Lack of Efficacy|0
961932|NCT01139580|1960303|FG001|Overall Study|Lack of Efficacy|2
961933|NCT01139580|1960302|FG000|Overall Study|Withdrawal by Subject|6
961934|NCT01139580|1960303|FG001|Overall Study|Withdrawal by Subject|9
961935|NCT01139580|1960302|FG000|Overall Study|Used Excluded Medicine After Enrollment|1
961936|NCT01139580|1960303|FG001|Overall Study|Used Excluded Medicine After Enrollment|0
961937|NCT01139580|1960302|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
961938|NCT01139580|1960303|FG001|Overall Study|Did Not Meet Exclusion Criteria|0
961939|NCT01139580|1960302|FG000|Overall Study|Misrandomized|1
961940|NCT01139580|1960303|FG001|Overall Study|Misrandomized|0
961941|NCT01139580|1960302|FG000|Overall Study|Beginning Study Exclusion Treatment|0
961942|NCT01139580|1960303|FG001|Overall Study|Beginning Study Exclusion Treatment|1
961943|NCT01139580|1960302|FG000|Overall Study|Participant Randomization in Error|0
961944|NCT01139580|1960303|FG001|Overall Study|Participant Randomization in Error|1
961945|NCT01139658|1960311|FG000|Overall Study|Adverse Event|10
961946|NCT01139658|1960312|FG001|Overall Study|Adverse Event|27
961947|NCT01139658|1960311|FG000|Overall Study|Lack of Efficacy|15
961948|NCT01139658|1960312|FG001|Overall Study|Lack of Efficacy|7
961949|NCT01139658|1960311|FG000|Overall Study|Withdrawal by Subject|2
961950|NCT01139658|1960312|FG001|Overall Study|Withdrawal by Subject|4
961951|NCT01139658|1960311|FG000|Overall Study|No documentation of treatment|1
961952|NCT01139658|1960312|FG001|Overall Study|No documentation of treatment|0
961953|NCT01139658|1960311|FG000|Overall Study|Other|28
961954|NCT01139658|1960312|FG001|Overall Study|Other|75
961955|NCT01139762|1960320|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
961956|NCT01139762|1960321|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
961957|NCT01139762|1960322|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
961958|NCT01139762|1960320|FG000|Washout and Placebo Lead-In Period|Adverse Event|1
961959|NCT01139762|1960321|FG001|Washout and Placebo Lead-In Period|Adverse Event|0
961960|NCT01139762|1960322|FG002|Washout and Placebo Lead-In Period|Adverse Event|0
961961|NCT01139762|1960320|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
961962|NCT01139762|1960321|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
961963|NCT01139762|1960322|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
961964|NCT01139762|1960320|FG000|Washout and Placebo Lead-In Period|Physician Decision|12
961965|NCT01139762|1960321|FG001|Washout and Placebo Lead-In Period|Physician Decision|0
961966|NCT01139762|1960322|FG002|Washout and Placebo Lead-In Period|Physician Decision|0
961967|NCT01139762|1960320|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10
961968|NCT01139762|1960321|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0
961969|NCT01139762|1960322|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0
961970|NCT01139762|1960320|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10
961971|NCT01139762|1960321|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0
961972|NCT01139762|1960322|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0
961973|NCT01139762|1960320|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0
961974|NCT01139762|1960321|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4
961975|NCT01139762|1960322|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10
961976|NCT01139762|1960320|FG000|Double-Blind Randomized Active Treatment|Death|0
961977|NCT01139762|1960321|FG001|Double-Blind Randomized Active Treatment|Death|1
961978|NCT01139762|1960322|FG002|Double-Blind Randomized Active Treatment|Death|1
961979|NCT01139762|1960320|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
961980|NCT01139762|1960321|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
961981|NCT01139762|1960322|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
961982|NCT01139762|1960320|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0
961983|NCT01139762|1960321|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2
961984|NCT01139762|1960322|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8
961985|NCT01139762|1960320|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
961986|NCT01139762|1960321|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
961987|NCT01139762|1960322|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
961988|NCT01139762|1960320|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0
961989|NCT01139762|1960321|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2
961990|NCT01139762|1960322|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0
961991|NCT01139762|1960320|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0
961992|NCT01139762|1960321|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5
961993|NCT01139762|1960322|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6
961994|NCT01139762|1960320|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
961995|NCT01139762|1960321|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
961996|NCT01139762|1960322|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
961997|NCT01139762|1960320|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
961998|NCT01139762|1960321|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
961999|NCT01139762|1960322|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
962000|NCT01139775|1960332|FG000|Overall Study|Adverse Event|0
962001|NCT01139775|1960333|FG001|Overall Study|Adverse Event|6
962002|NCT01139775|1960334|FG002|Overall Study|Adverse Event|2
962003|NCT01139775|1960332|FG000|Overall Study|Protocol Violation|0
962004|NCT01139775|1960333|FG001|Overall Study|Protocol Violation|5
962005|NCT01139775|1960334|FG002|Overall Study|Protocol Violation|0
962006|NCT01139775|1960332|FG000|Overall Study|Withdrawal by Subject|1
962007|NCT01139775|1960333|FG001|Overall Study|Withdrawal by Subject|0
962008|NCT01139775|1960334|FG002|Overall Study|Withdrawal by Subject|2
962009|NCT01139775|1960332|FG000|Overall Study|Physician Decision|0
962010|NCT01139775|1960333|FG001|Overall Study|Physician Decision|2
962011|NCT01139775|1960334|FG002|Overall Study|Physician Decision|2
962012|NCT01140048|1960364|FG000|Overall Study|Physician Decision|1
962013|NCT01140048|1960364|FG000|Overall Study|Withdrawal by Subject|13
962014|NCT01140048|1960364|FG000|Overall Study|Lost to Follow-up|31
962015|NCT01140061|1960378|FG000|Part I|Adverse Event|1
962016|NCT01140061|1960379|FG001|Part I|Adverse Event|0
962017|NCT01140061|1960380|FG002|Part I|Adverse Event|0
962018|NCT01140061|1960381|FG003|Part I|Adverse Event|0
962019|NCT01140061|1960382|FG004|Part I|Adverse Event|0
962020|NCT01140061|1960383|FG005|Part I|Adverse Event|0
962021|NCT01140061|1960384|FG006|Part I|Adverse Event|0
962022|NCT01140061|1960385|FG007|Part I|Adverse Event|0
962023|NCT01140061|1960386|FG008|Part I|Adverse Event|0
962024|NCT01140061|1960387|FG009|Part I|Adverse Event|0
962025|NCT01140061|1960378|FG000|Extension|Laboratory Adverse Event|0
962026|NCT01140061|1960379|FG001|Extension|Laboratory Adverse Event|0
962027|NCT01140061|1960380|FG002|Extension|Laboratory Adverse Event|0
962028|NCT01140061|1960381|FG003|Extension|Laboratory Adverse Event|0
962029|NCT01140061|1960382|FG004|Extension|Laboratory Adverse Event|0
962030|NCT01140061|1960383|FG005|Extension|Laboratory Adverse Event|0
962031|NCT01140061|1960384|FG006|Extension|Laboratory Adverse Event|0
962032|NCT01140061|1960385|FG007|Extension|Laboratory Adverse Event|0
962033|NCT01140061|1960386|FG008|Extension|Laboratory Adverse Event|0
962034|NCT01140061|1960387|FG009|Extension|Laboratory Adverse Event|1
962035|NCT01140347|1960419|FG000|Overall Study|Lost to Follow-up|5
962036|NCT01140347|1960420|FG001|Overall Study|Lost to Follow-up|6
962037|NCT01140347|1960419|FG000|Overall Study|Withdrawal by Subject|13
962038|NCT01140347|1960420|FG001|Overall Study|Withdrawal by Subject|8
962039|NCT01140477|1960442|FG000|Overall Study|Lost to Follow-up|4
962040|NCT01140477|1960443|FG001|Overall Study|Lost to Follow-up|0
962041|NCT01140477|1960442|FG000|Overall Study|Withdrawal by Subject|1
962042|NCT01140477|1960443|FG001|Overall Study|Withdrawal by Subject|4
962043|NCT01140477|1960442|FG000|Overall Study|Surgical complication preventing implant|2
962044|NCT01140477|1960443|FG001|Overall Study|Surgical complication preventing implant|0
962045|NCT01140477|1960442|FG000|Overall Study|Death|1
962046|NCT01140477|1960443|FG001|Overall Study|Death|1
962047|NCT01140477|1960442|FG000|Overall Study|Subject explanted|0
962048|NCT01140477|1960443|FG001|Overall Study|Subject explanted|1
962049|NCT01140503|1960449|FG000|Overall Study|Withdrawal by Subject|1
962050|NCT01140568|1960453|FG000|Overall Study|disease progression|31
962051|NCT01140568|1960453|FG000|Overall Study|Withdrawal by Subject|1
962052|NCT01140568|1960453|FG000|Overall Study|Screen Fail|4
962053|NCT01140646|1960457|FG000|Overall Study|Adverse Event|4
962054|NCT01140646|1960457|FG000|Overall Study|Refused Further Treatment|5
962062|NCT01140880|1960478|FG000|Overall Study|Death|0
962063|NCT01140880|1960479|FG001|Overall Study|Death|1
962064|NCT01140880|1960478|FG000|Overall Study|Withdrawal by Subject|6
962065|NCT01140880|1960479|FG001|Overall Study|Withdrawal by Subject|3
962066|NCT01140880|1960478|FG000|Overall Study|Lost to Follow-up|8
962067|NCT01140880|1960479|FG001|Overall Study|Lost to Follow-up|10
962068|NCT01140880|1960478|FG000|Overall Study|Protocol Violation|0
962069|NCT01140880|1960479|FG001|Overall Study|Protocol Violation|30
962070|NCT01140906|1960489|FG000|Overall Study|Adverse Event|7
962071|NCT01140906|1960490|FG001|Overall Study|Adverse Event|10
962072|NCT01140906|1960491|FG002|Overall Study|Adverse Event|17
962073|NCT01140906|1960492|FG003|Overall Study|Adverse Event|7
962074|NCT01140906|1960489|FG000|Overall Study|Lack of Efficacy|6
962075|NCT01140906|1960490|FG001|Overall Study|Lack of Efficacy|8
962076|NCT01140906|1960491|FG002|Overall Study|Lack of Efficacy|2
962077|NCT01140906|1960492|FG003|Overall Study|Lack of Efficacy|1
962078|NCT01140906|1960489|FG000|Overall Study|Non-compliance|0
962079|NCT01140906|1960490|FG001|Overall Study|Non-compliance|1
962080|NCT01140906|1960491|FG002|Overall Study|Non-compliance|0
962081|NCT01140906|1960492|FG003|Overall Study|Non-compliance|1
962082|NCT01140906|1960489|FG000|Overall Study|Protocol Violation|5
962083|NCT01140906|1960490|FG001|Overall Study|Protocol Violation|3
962084|NCT01140906|1960491|FG002|Overall Study|Protocol Violation|2
962085|NCT01140906|1960492|FG003|Overall Study|Protocol Violation|1
962086|NCT01140906|1960489|FG000|Overall Study|Withdrawal of consent|6
962087|NCT01140906|1960490|FG001|Overall Study|Withdrawal of consent|6
962088|NCT01140906|1960491|FG002|Overall Study|Withdrawal of consent|2
962089|NCT01140906|1960492|FG003|Overall Study|Withdrawal of consent|2
962090|NCT01140906|1960489|FG000|Overall Study|Lost to Follow-up|1
962091|NCT01140906|1960490|FG001|Overall Study|Lost to Follow-up|1
962092|NCT01140906|1960491|FG002|Overall Study|Lost to Follow-up|0
962093|NCT01140906|1960492|FG003|Overall Study|Lost to Follow-up|2
962094|NCT01140906|1960489|FG000|Overall Study|Administrative or other reason|0
962095|NCT01140906|1960490|FG001|Overall Study|Administrative or other reason|5
962096|NCT01140906|1960491|FG002|Overall Study|Administrative or other reason|3
962097|NCT01140906|1960492|FG003|Overall Study|Administrative or other reason|2
962098|NCT01141205|1960517|FG000|Overall Study|Physician Decision|1
962099|NCT01141205|1960518|FG001|Overall Study|Physician Decision|1
962100|NCT01141205|1960517|FG000|Overall Study|Lost to Follow-up|1
962101|NCT01141205|1960518|FG001|Overall Study|Lost to Follow-up|0
962102|NCT01141205|1960517|FG000|Overall Study|Withdrawal by Subject|1
962103|NCT01141205|1960518|FG001|Overall Study|Withdrawal by Subject|1
962104|NCT01141283|1960528|FG000|Overall Study|Adverse Event|56
962105|NCT01141283|1960528|FG000|Overall Study|Lost to Follow-up|4
962106|NCT01141283|1960528|FG000|Overall Study|Withdrawal by Subject|14
962107|NCT01141283|1960528|FG000|Overall Study|Administrative|4
962108|NCT01141283|1960528|FG000|Overall Study|Lack of Efficacy|10
962109|NCT01141478|1960549|FG000|Overall Study|Withdrawal by Subject|1
962110|NCT01141478|1960550|FG001|Overall Study|Withdrawal by Subject|1
962111|NCT01141660|1960593|FG000|Overall Study|Physician Decision|0
962112|NCT01141660|1960594|FG001|Overall Study|Physician Decision|12
962114|NCT01142089|1960624|FG000|Overall Study|Physician Decision|1
962115|NCT01142089|1960625|FG001|Overall Study|Physician Decision|0
962116|NCT01142089|1960624|FG000|Overall Study|Withdrawal by Subject|1
962117|NCT01142089|1960625|FG001|Overall Study|Withdrawal by Subject|2
962118|NCT01142089|1960624|FG000|Overall Study|Use of prohibited medications|0
962119|NCT01142089|1960625|FG001|Overall Study|Use of prohibited medications|1
962120|NCT01142089|1960624|FG000|Overall Study|Noncompliance with study procedures|2
962121|NCT01142089|1960625|FG001|Overall Study|Noncompliance with study procedures|1
962122|NCT01142089|1960624|FG000|Overall Study|Patient required rescue medication|8
962123|NCT01142089|1960625|FG001|Overall Study|Patient required rescue medication|17
962124|NCT01142115|1960631|FG000|First Intervention|Lack of Efficacy|1
962125|NCT01142115|1960632|FG001|First Intervention|Lack of Efficacy|1
962126|NCT01142115|1960631|FG000|First Intervention|Adverse Event|1
962127|NCT01142115|1960632|FG001|First Intervention|Adverse Event|0
962128|NCT01142193|1960639|FG000|Overall Study|Adverse Event|12
962129|NCT01142193|1960640|FG001|Overall Study|Adverse Event|4
962130|NCT01142193|1960639|FG000|Overall Study|Lack of Efficacy|2
962131|NCT01142193|1960640|FG001|Overall Study|Lack of Efficacy|1
962132|NCT01142193|1960639|FG000|Overall Study|Physician Decision|1
962133|NCT01142193|1960640|FG001|Overall Study|Physician Decision|1
962134|NCT01142193|1960639|FG000|Overall Study|Withdrawal by Subject|4
962135|NCT01142193|1960640|FG001|Overall Study|Withdrawal by Subject|3
962136|NCT01142193|1960639|FG000|Overall Study|Protocol Discontinuation Criterion Met|1
962137|NCT01142193|1960640|FG001|Overall Study|Protocol Discontinuation Criterion Met|0
962138|NCT01142193|1960639|FG000|Overall Study|Other|1
962139|NCT01142193|1960640|FG001|Overall Study|Other|2
962140|NCT01142232|1960651|FG000|Overall Study|Adverse Event|1
962141|NCT01142232|1960652|FG001|Overall Study|Adverse Event|2
962142|NCT01142232|1960653|FG002|Overall Study|Adverse Event|1
962143|NCT01142232|1960654|FG003|Overall Study|Adverse Event|0
962144|NCT01142232|1960655|FG004|Overall Study|Adverse Event|4
962145|NCT01142232|1960651|FG000|Overall Study|Death|0
962146|NCT01142232|1960652|FG001|Overall Study|Death|0
962147|NCT01142232|1960653|FG002|Overall Study|Death|0
962148|NCT01142232|1960654|FG003|Overall Study|Death|0
962149|NCT01142232|1960655|FG004|Overall Study|Death|1
962150|NCT01142232|1960651|FG000|Overall Study|Disease Progression|2
962151|NCT01142232|1960652|FG001|Overall Study|Disease Progression|0
962152|NCT01142232|1960653|FG002|Overall Study|Disease Progression|1
962153|NCT01142232|1960654|FG003|Overall Study|Disease Progression|2
962154|NCT01142232|1960655|FG004|Overall Study|Disease Progression|12
962155|NCT01142232|1960651|FG000|Overall Study|Withdrawal by Subject|0
962156|NCT01142232|1960652|FG001|Overall Study|Withdrawal by Subject|0
962157|NCT01142232|1960653|FG002|Overall Study|Withdrawal by Subject|0
962158|NCT01142232|1960654|FG003|Overall Study|Withdrawal by Subject|1
962159|NCT01142232|1960655|FG004|Overall Study|Withdrawal by Subject|3
962160|NCT01142232|1960651|FG000|Overall Study|Physician Decision|0
962161|NCT01142232|1960652|FG001|Overall Study|Physician Decision|1
962162|NCT01142232|1960653|FG002|Overall Study|Physician Decision|0
962163|NCT01142232|1960654|FG003|Overall Study|Physician Decision|2
962164|NCT01142232|1960655|FG004|Overall Study|Physician Decision|10
962165|NCT01142232|1960651|FG000|Overall Study|Alternative Therapy|0
962166|NCT01142232|1960652|FG001|Overall Study|Alternative Therapy|1
962167|NCT01142232|1960653|FG002|Overall Study|Alternative Therapy|1
962168|NCT01142232|1960654|FG003|Overall Study|Alternative Therapy|0
962169|NCT01142232|1960655|FG004|Overall Study|Alternative Therapy|1
962170|NCT01142232|1960651|FG000|Overall Study|Off Trt for other complicating disease|0
962171|NCT01142232|1960652|FG001|Overall Study|Off Trt for other complicating disease|0
962172|NCT01142232|1960653|FG002|Overall Study|Off Trt for other complicating disease|0
962173|NCT01142232|1960654|FG003|Overall Study|Off Trt for other complicating disease|0
962174|NCT01142232|1960655|FG004|Overall Study|Off Trt for other complicating disease|1
962175|NCT01142232|1960651|FG000|Overall Study|Noncompliance|0
962176|NCT01142232|1960652|FG001|Overall Study|Noncompliance|0
962177|NCT01142232|1960653|FG002|Overall Study|Noncompliance|0
962178|NCT01142232|1960654|FG003|Overall Study|Noncompliance|0
962179|NCT01142232|1960655|FG004|Overall Study|Noncompliance|2
962180|NCT01142336|1960691|FG000|Overall Study|Adverse Event|1
962181|NCT01142336|1960692|FG001|Overall Study|Adverse Event|1
962182|NCT01142336|1960691|FG000|Overall Study|Lost to Follow-up|0
962183|NCT01142336|1960692|FG001|Overall Study|Lost to Follow-up|1
962184|NCT01142388|1960703|FG000|Overall Study|Lack of Efficacy|21
962185|NCT01142388|1960704|FG001|Overall Study|Lack of Efficacy|31
962186|NCT01142388|1960703|FG000|Overall Study|Adverse Event|9
962187|NCT01142388|1960704|FG001|Overall Study|Adverse Event|5
962188|NCT01142388|1960703|FG000|Overall Study|Death|3
962189|NCT01142388|1960704|FG001|Overall Study|Death|2
962190|NCT01142388|1960703|FG000|Overall Study|Withdrawal by Subject|5
962191|NCT01142388|1960704|FG001|Overall Study|Withdrawal by Subject|3
962192|NCT01142388|1960703|FG000|Overall Study|Alternative therapy|1
962193|NCT01142388|1960704|FG001|Overall Study|Alternative therapy|0
962194|NCT01142388|1960703|FG000|Overall Study|Other complications|0
962195|NCT01142388|1960704|FG001|Overall Study|Other complications|2
962196|NCT01142388|1960703|FG000|Overall Study|Other|1
962197|NCT01142388|1960704|FG001|Overall Study|Other|1
962198|NCT01142388|1960703|FG000|Overall Study|Never started therapy|7
962199|NCT01142388|1960704|FG001|Overall Study|Never started therapy|3
962200|NCT01142466|1960712|FG000|Overall Study|Adverse Event|2
962201|NCT01142466|1960713|FG001|Overall Study|Adverse Event|1
962202|NCT01142466|1960712|FG000|Overall Study|Withdrawal by Subject|1
962203|NCT01142466|1960713|FG001|Overall Study|Withdrawal by Subject|1
962204|NCT01142596|1960721|FG000|Overall Study|Withdrawal by Subject|9
962205|NCT01142596|1960722|FG001|Overall Study|Withdrawal by Subject|35
962206|NCT01142596|1960721|FG000|Overall Study|Adverse Event|8
962207|NCT01142596|1960722|FG001|Overall Study|Adverse Event|35
962208|NCT01142596|1960721|FG000|Overall Study|Lack of Efficacy|5
962209|NCT01142596|1960722|FG001|Overall Study|Lack of Efficacy|9
962210|NCT01142596|1960721|FG000|Overall Study|Lost to Follow-up|2
962211|NCT01142596|1960722|FG001|Overall Study|Lost to Follow-up|3
962212|NCT01142596|1960721|FG000|Overall Study|Other reason (not specified)|5
962213|NCT01142596|1960722|FG001|Overall Study|Other reason (not specified)|4
962214|NCT01142661|1960728|FG000|Overall Study|Adverse Event|2
962215|NCT01142661|1960728|FG000|Overall Study|Withdrawal by Subject|1
962216|NCT01142661|1960728|FG000|Overall Study|Physician Decision|1
962217|NCT01142726|1960735|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
962218|NCT01142726|1960736|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
962219|NCT01142726|1960737|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
962220|NCT01142726|1960735|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
962221|NCT01142726|1960736|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
962222|NCT01142726|1960737|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
962223|NCT01142726|1960735|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
962224|NCT01142726|1960736|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
962225|NCT01142726|1960737|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
962226|NCT01142726|1960735|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
962227|NCT01142726|1960736|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
962228|NCT01142726|1960737|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
962229|NCT01142726|1960735|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
962230|NCT01142726|1960736|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
962231|NCT01142726|1960737|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
962232|NCT01142726|1960735|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
962233|NCT01142726|1960736|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
962234|NCT01142726|1960737|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
962235|NCT01142726|1960735|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
962236|NCT01142726|1960736|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
962237|NCT01142726|1960737|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
962238|NCT01142726|1960735|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
962239|NCT01142726|1960736|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
962240|NCT01142726|1960737|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
962241|NCT01142726|1960735|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
962242|NCT01142726|1960736|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
962243|NCT01142726|1960737|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
962244|NCT01142726|1960735|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
962245|NCT01142726|1960736|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
962246|NCT01142726|1960737|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
962247|NCT01142726|1960735|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
962248|NCT01142726|1960736|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
962249|NCT01142726|1960737|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
962250|NCT01142726|1960735|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0
962251|NCT01142726|1960736|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1
962252|NCT01142726|1960737|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1
962253|NCT01142726|1960735|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
962254|NCT01142726|1960736|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
962255|NCT01142726|1960737|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
962256|NCT01142726|1960735|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
962257|NCT01142726|1960736|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
962258|NCT01142726|1960737|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
962259|NCT01142726|1960735|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
962260|NCT01142726|1960736|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
962261|NCT01142726|1960737|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
962262|NCT01142726|1960735|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
962263|NCT01142726|1960736|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
962264|NCT01142726|1960737|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
962265|NCT01142791|1960753|FG000|Overall Study|Alternative Treatment|1
962266|NCT01142791|1960754|FG001|Overall Study|Alternative Treatment|0
962267|NCT01142791|1960753|FG000|Overall Study|Lost to Follow-up|1
962268|NCT01142791|1960754|FG001|Overall Study|Lost to Follow-up|0
962269|NCT01142791|1960753|FG000|Overall Study|Withdrawal by Subject|5
962270|NCT01142791|1960754|FG001|Overall Study|Withdrawal by Subject|0
962271|NCT01142791|1960753|FG000|Overall Study|Received only 1 sonication|0
962272|NCT01142791|1960754|FG001|Overall Study|Received only 1 sonication|6
962273|NCT01142908|1960760|FG000|Overall Study|Lost to Follow-up|19
962274|NCT01142908|1960761|FG001|Overall Study|Lost to Follow-up|13
962275|NCT01142908|1960760|FG000|Overall Study|Death|1
962276|NCT01142908|1960761|FG001|Overall Study|Death|4
962277|NCT01142908|1960760|FG000|Overall Study|Excluded - did not meet criteria|9
962278|NCT01142908|1960761|FG001|Overall Study|Excluded - did not meet criteria|5
962279|NCT01142908|1960760|FG000|Overall Study|Withdrawal by Subject|3
962280|NCT01142908|1960761|FG001|Overall Study|Withdrawal by Subject|0
962281|NCT01143038|1960771|FG000|Overall Study|Withdrawal by Subject|4
962282|NCT01143038|1960771|FG000|Overall Study|Requirement for alternative therapy|5
962283|NCT01143038|1960771|FG000|Overall Study|Adverse Event|3
962284|NCT01143038|1960771|FG000|Overall Study|Lost to Follow-up|2
962285|NCT01143038|1960771|FG000|Overall Study|Protocol Deviation|1
962286|NCT01143038|1960771|FG000|Overall Study|Death|1
962287|NCT01143051|1960781|FG000|3-14 Day Washout|Withdrawal by Subject|0
962288|NCT01143051|1960782|FG001|3-14 Day Washout|Withdrawal by Subject|0
962289|NCT01143051|1960783|FG002|3-14 Day Washout|Withdrawal by Subject|1
962290|NCT01143051|1960784|FG003|3-14 Day Washout|Withdrawal by Subject|0
962291|NCT01143051|1960785|FG004|3-14 Day Washout|Withdrawal by Subject|0
962292|NCT01143051|1960786|FG005|3-14 Day Washout|Withdrawal by Subject|0
962293|NCT01143051|1960781|FG000|3-14 Day Washout|Withdrawal by Subject|0
962294|NCT01143051|1960782|FG001|3-14 Day Washout|Withdrawal by Subject|0
962295|NCT01143051|1960783|FG002|3-14 Day Washout|Withdrawal by Subject|0
962296|NCT01143051|1960784|FG003|3-14 Day Washout|Withdrawal by Subject|0
962297|NCT01143051|1960785|FG004|3-14 Day Washout|Withdrawal by Subject|0
962298|NCT01143051|1960786|FG005|3-14 Day Washout|Withdrawal by Subject|1
962299|NCT01143077|1960799|FG000|Overall Study|Lack of Efficacy|0
962300|NCT01143077|1960800|FG001|Overall Study|Lack of Efficacy|2
962301|NCT01143077|1960801|FG002|Overall Study|Lack of Efficacy|1
962302|NCT01143077|1960799|FG000|Overall Study|Adverse Event|5
962303|NCT01143077|1960800|FG001|Overall Study|Adverse Event|6
962304|NCT01143077|1960801|FG002|Overall Study|Adverse Event|5
962305|NCT01143077|1960799|FG000|Overall Study|Lost to Follow-up|2
962306|NCT01143077|1960800|FG001|Overall Study|Lost to Follow-up|3
962307|NCT01143077|1960801|FG002|Overall Study|Lost to Follow-up|4
962308|NCT01143077|1960799|FG000|Overall Study|Protocol Violation|2
962309|NCT01143077|1960800|FG001|Overall Study|Protocol Violation|0
962310|NCT01143077|1960801|FG002|Overall Study|Protocol Violation|0
962311|NCT01143077|1960799|FG000|Overall Study|Withdrawal by Subject|4
962312|NCT01143077|1960800|FG001|Overall Study|Withdrawal by Subject|3
962313|NCT01143077|1960801|FG002|Overall Study|Withdrawal by Subject|3
962314|NCT01143077|1960799|FG000|Overall Study|Non-compliance with study drug|0
962315|NCT01143077|1960800|FG001|Overall Study|Non-compliance with study drug|1
962316|NCT01143077|1960801|FG002|Overall Study|Non-compliance with study drug|1
962317|NCT01143077|1960799|FG000|Overall Study|Administrative|1
962318|NCT01143077|1960800|FG001|Overall Study|Administrative|0
962319|NCT01143077|1960801|FG002|Overall Study|Administrative|0
962320|NCT01143077|1960799|FG000|Overall Study|Principal Investigator Decision|2
962321|NCT01143077|1960800|FG001|Overall Study|Principal Investigator Decision|0
962322|NCT01143077|1960801|FG002|Overall Study|Principal Investigator Decision|1
962323|NCT01143090|1960809|FG000|Overall Study|Lack of Efficacy|2
962324|NCT01143090|1960809|FG000|Overall Study|Adverse Event|17
962325|NCT01143090|1960809|FG000|Overall Study|Lost to Follow-up|9
962326|NCT01143090|1960809|FG000|Overall Study|Protocol Violation|2
962327|NCT01143090|1960809|FG000|Overall Study|Withdrawal by Subject|18
962328|NCT01143090|1960809|FG000|Overall Study|Non-compliance with study drug|1
962329|NCT01143090|1960809|FG000|Overall Study|Failure to meet eligibility criteria|1
962330|NCT01143090|1960809|FG000|Overall Study|Administrative|1
962331|NCT01143207|1960839|FG000|Overall Study|Lost to Follow-up|2
962332|NCT01143259|1960845|FG000|Overall Study|Withdrawal by Subject|3
962333|NCT01143259|1960846|FG001|Overall Study|Withdrawal by Subject|2
962334|NCT01143259|1960845|FG000|Overall Study|Protocol Violation|13
962335|NCT01143259|1960846|FG001|Overall Study|Protocol Violation|9
962336|NCT01143259|1960845|FG000|Overall Study|Screen Failure|7
962337|NCT01143259|1960846|FG001|Overall Study|Screen Failure|9
962338|NCT01143324|1960861|FG000|Overall Study|Lost to Follow-up|11
962339|NCT01143324|1960861|FG000|Overall Study|Withdrawal by Subject|4
962340|NCT01143324|1960861|FG000|Overall Study|Explant of the device|4
962341|NCT01143337|1960867|FG000|Overall Study|Adverse Event|3
962342|NCT01143337|1960868|FG001|Overall Study|Adverse Event|9
962343|NCT01143337|1960869|FG002|Overall Study|Adverse Event|5
962344|NCT01143337|1960867|FG000|Overall Study|Lack of Efficacy|6
962345|NCT01143337|1960868|FG001|Overall Study|Lack of Efficacy|2
962346|NCT01143337|1960869|FG002|Overall Study|Lack of Efficacy|1
962347|NCT01143337|1960867|FG000|Overall Study|Protocol Violation|1
962348|NCT01143337|1960868|FG001|Overall Study|Protocol Violation|0
962349|NCT01143337|1960869|FG002|Overall Study|Protocol Violation|0
962350|NCT01143337|1960867|FG000|Overall Study|Withdrawal by Subject|0
962351|NCT01143337|1960868|FG001|Overall Study|Withdrawal by Subject|0
962352|NCT01143337|1960869|FG002|Overall Study|Withdrawal by Subject|1
962353|NCT01143337|1960867|FG000|Overall Study|Other reason|0
962354|NCT01143337|1960868|FG001|Overall Study|Other reason|0
962355|NCT01143337|1960869|FG002|Overall Study|Other reason|5
962356|NCT01143389|1960877|FG000|Overall Study|Lost to Follow-up|26
962357|NCT01143389|1960878|FG001|Overall Study|Lost to Follow-up|25
962358|NCT01143402|1960887|FG000|Overall Study|Rapid clinical decline|1
962359|NCT01143402|1960888|FG001|Overall Study|Rapid clinical decline|1
962360|NCT01143402|1960889|FG002|Overall Study|Rapid clinical decline|0
962361|NCT01143402|1960887|FG000|Overall Study|Not Treated|0
962362|NCT01143402|1960888|FG001|Overall Study|Not Treated|0
962363|NCT01143402|1960889|FG002|Overall Study|Not Treated|1
1006593|NCT01468701|2025285|FG000|Overall Study|No end of study case report form|0
1006594|NCT01468701|2025286|FG001|Overall Study|No end of study case report form|0
1006595|NCT01468701|2025287|FG002|Overall Study|No end of study case report form|0
1006596|NCT01468701|2025288|FG003|Overall Study|No end of study case report form|0
1006597|NCT01468701|2025289|FG004|Overall Study|No end of study case report form|0
1006598|NCT01468701|2025290|FG005|Overall Study|No end of study case report form|0
1006599|NCT01468701|2025291|FG006|Overall Study|No end of study case report form|0
1006600|NCT01468701|2025292|FG007|Overall Study|No end of study case report form|0
1006601|NCT01468701|2025293|FG008|Overall Study|No end of study case report form|4
1006602|NCT01468701|2025294|FG009|Overall Study|No end of study case report form|1
1006603|NCT01468701|2025295|FG010|Overall Study|No end of study case report form|2
1006604|NCT01468701|2025296|FG011|Overall Study|No end of study case report form|3
1006605|NCT01468701|2025297|FG012|Overall Study|No end of study case report form|0
1006606|NCT01468701|2025298|FG013|Overall Study|No end of study case report form|1
1006607|NCT01468701|2025299|FG014|Overall Study|No end of study case report form|0
1006608|NCT01468701|2025300|FG015|Overall Study|No end of study case report form|0
1006609|NCT01468701|2025301|FG016|Overall Study|No end of study case report form|0
1006610|NCT01468701|2025285|FG000|Overall Study|Not being followed up|0
1006611|NCT01468701|2025286|FG001|Overall Study|Not being followed up|4963
1006612|NCT01468701|2025287|FG002|Overall Study|Not being followed up|1755
1006613|NCT01468701|2025288|FG003|Overall Study|Not being followed up|703
1006614|NCT01468701|2025289|FG004|Overall Study|Not being followed up|1714
1006615|NCT01468701|2025290|FG005|Overall Study|Not being followed up|126
1006616|NCT01468701|2025291|FG006|Overall Study|Not being followed up|1170
1006617|NCT01468701|2025292|FG007|Overall Study|Not being followed up|4
1006618|NCT01468701|2025293|FG008|Overall Study|Not being followed up|0
1006619|NCT01468701|2025294|FG009|Overall Study|Not being followed up|0
962364|NCT01143714|1960966|FG000|Overall Study|Adverse Event|4
962365|NCT01143714|1960967|FG001|Overall Study|Adverse Event|2
962366|NCT01143714|1960966|FG000|Overall Study|Withdrawal by Subject|1
962367|NCT01143714|1960967|FG001|Overall Study|Withdrawal by Subject|0
962368|NCT01143714|1960966|FG000|Overall Study|Subject non-compliance|0
962369|NCT01143714|1960967|FG001|Overall Study|Subject non-compliance|1
962370|NCT01143714|1960966|FG000|Overall Study|wound closed = deemed healed|1
962371|NCT01143714|1960967|FG001|Overall Study|wound closed = deemed healed|0
962372|NCT01143714|1960966|FG000|Overall Study|wound size increased|1
962373|NCT01143714|1960967|FG001|Overall Study|wound size increased|0
962374|NCT01143896|1961045|FG000|Overall Study|Did not complete Baseline Interview|5
962375|NCT01143896|1961046|FG001|Overall Study|Did not complete Baseline Interview|4
962376|NCT01143896|1961045|FG000|Overall Study|Lost to Follow-up|18
962377|NCT01143896|1961046|FG001|Overall Study|Lost to Follow-up|13
962378|NCT01143896|1961045|FG000|Overall Study|Withdrawal by Subject|13
962379|NCT01143896|1961046|FG001|Overall Study|Withdrawal by Subject|5
962380|NCT01143896|1961045|FG000|Overall Study|Death|6
962381|NCT01143896|1961046|FG001|Overall Study|Death|3
962382|NCT01144052|1961064|FG000|Overall Study|Withdrawal by Subject|1
962383|NCT01144052|1961065|FG001|Overall Study|Withdrawal by Subject|1
962384|NCT01144182|1961092|FG000|Overall Study|Death|5
962385|NCT01144182|1961093|FG001|Overall Study|Death|6
962386|NCT01144182|1961092|FG000|Overall Study|Withdrawal by Subject|3
962387|NCT01144182|1961093|FG001|Overall Study|Withdrawal by Subject|6
962388|NCT01144182|1961092|FG000|Overall Study|Lost to Follow-up|9
962389|NCT01144182|1961093|FG001|Overall Study|Lost to Follow-up|9
962390|NCT01144299|1961119|FG000|Overall Study|Lost to Follow-up|1
962391|NCT01144299|1961120|FG001|Overall Study|Lost to Follow-up|0
962392|NCT01144299|1961119|FG000|Overall Study|Withdrawal by Subject|1
962393|NCT01144299|1961120|FG001|Overall Study|Withdrawal by Subject|0
962394|NCT01144364|1961137|FG000|Induction Phase|Disease progression|14
962395|NCT01144364|1961138|FG001|Induction Phase|Disease progression|0
962396|NCT01144364|1961139|FG002|Induction Phase|Disease progression|0
962397|NCT01144364|1961137|FG000|Induction Phase|Adverse Event|9
962398|NCT01144364|1961138|FG001|Induction Phase|Adverse Event|0
962399|NCT01144364|1961139|FG002|Induction Phase|Adverse Event|0
962400|NCT01144364|1961137|FG000|Induction Phase|Death|1
962401|NCT01144364|1961138|FG001|Induction Phase|Death|0
962402|NCT01144364|1961139|FG002|Induction Phase|Death|0
962403|NCT01144364|1961137|FG000|Induction Phase|Withdrawal by Subject|1
962404|NCT01144364|1961138|FG001|Induction Phase|Withdrawal by Subject|0
962405|NCT01144364|1961139|FG002|Induction Phase|Withdrawal by Subject|0
962406|NCT01144364|1961137|FG000|Induction Phase|Lost to Follow-up|2
962407|NCT01144364|1961138|FG001|Induction Phase|Lost to Follow-up|0
962408|NCT01144364|1961139|FG002|Induction Phase|Lost to Follow-up|0
962409|NCT01144364|1961137|FG000|Induction Phase|Physician Decision|1
962410|NCT01144364|1961138|FG001|Induction Phase|Physician Decision|0
962411|NCT01144364|1961139|FG002|Induction Phase|Physician Decision|0
962412|NCT01144364|1961137|FG000|Induction Phase|Stable disease|2
962413|NCT01144364|1961138|FG001|Induction Phase|Stable disease|0
962414|NCT01144364|1961139|FG002|Induction Phase|Stable disease|0
962415|NCT01144364|1961137|FG000|Induction Phase|Secondary neoplasia|1
962416|NCT01144364|1961138|FG001|Induction Phase|Secondary neoplasia|0
962417|NCT01144364|1961139|FG002|Induction Phase|Secondary neoplasia|0
962418|NCT01144364|1961137|FG000|Induction Phase|Protocol Violation|1
962419|NCT01144364|1961138|FG001|Induction Phase|Protocol Violation|0
962420|NCT01144364|1961139|FG002|Induction Phase|Protocol Violation|0
962421|NCT01144364|1961137|FG000|Follow-Up/Maintenance Phase|Disease progression|0
962422|NCT01144364|1961138|FG001|Follow-Up/Maintenance Phase|Disease progression|23
962423|NCT01144364|1961139|FG002|Follow-Up/Maintenance Phase|Disease progression|29
962424|NCT01144364|1961137|FG000|Follow-Up/Maintenance Phase|Adverse Event|0
962425|NCT01144364|1961138|FG001|Follow-Up/Maintenance Phase|Adverse Event|3
962426|NCT01144364|1961139|FG002|Follow-Up/Maintenance Phase|Adverse Event|1
962427|NCT01144364|1961137|FG000|Follow-Up/Maintenance Phase|Death|0
962428|NCT01144364|1961138|FG001|Follow-Up/Maintenance Phase|Death|2
962429|NCT01144364|1961139|FG002|Follow-Up/Maintenance Phase|Death|0
962430|NCT01144364|1961137|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
962431|NCT01144364|1961138|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
962432|NCT01144364|1961139|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
962433|NCT01144364|1961137|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0
962434|NCT01144364|1961138|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1
962435|NCT01144364|1961139|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4
962436|NCT01144364|1961137|FG000|Follow-Up/Maintenance Phase|Relapse|0
962437|NCT01144364|1961138|FG001|Follow-Up/Maintenance Phase|Relapse|5
962438|NCT01144364|1961139|FG002|Follow-Up/Maintenance Phase|Relapse|5
962439|NCT01144364|1961137|FG000|Follow-Up/Maintenance Phase|Physician Decision|0
962440|NCT01144364|1961138|FG001|Follow-Up/Maintenance Phase|Physician Decision|0
962441|NCT01144364|1961139|FG002|Follow-Up/Maintenance Phase|Physician Decision|1
962442|NCT01144377|1961154|FG000|52 Week Treatment Period|Adverse Event|0
962443|NCT01144377|1961155|FG001|52 Week Treatment Period|Adverse Event|0
962444|NCT01144377|1961156|FG002|52 Week Treatment Period|Adverse Event|3
962445|NCT01144377|1961157|FG003|52 Week Treatment Period|Adverse Event|2
962446|NCT01144377|1961158|FG004|52 Week Treatment Period|Adverse Event|1
962447|NCT01144377|1961154|FG000|52 Week Treatment Period|Entry Criteria Not Met|0
962448|NCT01144377|1961155|FG001|52 Week Treatment Period|Entry Criteria Not Met|0
962449|NCT01144377|1961156|FG002|52 Week Treatment Period|Entry Criteria Not Met|1
962450|NCT01144377|1961157|FG003|52 Week Treatment Period|Entry Criteria Not Met|1
962451|NCT01144377|1961158|FG004|52 Week Treatment Period|Entry Criteria Not Met|0
962452|NCT01144377|1961154|FG000|52 Week Treatment Period|Protocol Violation|0
962453|NCT01144377|1961155|FG001|52 Week Treatment Period|Protocol Violation|0
962454|NCT01144377|1961156|FG002|52 Week Treatment Period|Protocol Violation|0
962455|NCT01144377|1961157|FG003|52 Week Treatment Period|Protocol Violation|0
962456|NCT01144377|1961158|FG004|52 Week Treatment Period|Protocol Violation|1
962457|NCT01144377|1961154|FG000|52 Week Treatment Period|Lost to Follow-up|1
962458|NCT01144377|1961155|FG001|52 Week Treatment Period|Lost to Follow-up|0
962459|NCT01144377|1961156|FG002|52 Week Treatment Period|Lost to Follow-up|0
962460|NCT01144377|1961157|FG003|52 Week Treatment Period|Lost to Follow-up|0
962461|NCT01144377|1961158|FG004|52 Week Treatment Period|Lost to Follow-up|0
962462|NCT01144377|1961154|FG000|52 Week Treatment Period|Withdrawal by Subject|4
962463|NCT01144377|1961155|FG001|52 Week Treatment Period|Withdrawal by Subject|1
962464|NCT01144377|1961156|FG002|52 Week Treatment Period|Withdrawal by Subject|1
962465|NCT01144377|1961157|FG003|52 Week Treatment Period|Withdrawal by Subject|1
962466|NCT01144377|1961158|FG004|52 Week Treatment Period|Withdrawal by Subject|0
962467|NCT01144377|1961154|FG000|52 Week Treatment Period|Sponsor Decision|0
962468|NCT01144377|1961155|FG001|52 Week Treatment Period|Sponsor Decision|0
962469|NCT01144377|1961156|FG002|52 Week Treatment Period|Sponsor Decision|0
962470|NCT01144377|1961157|FG003|52 Week Treatment Period|Sponsor Decision|0
962471|NCT01144377|1961158|FG004|52 Week Treatment Period|Sponsor Decision|1
962472|NCT01144377|1961154|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0
962473|NCT01144377|1961155|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1
962474|NCT01144377|1961156|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0
962475|NCT01144377|1961157|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0
962476|NCT01144377|1961158|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1
962477|NCT01144377|1961154|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
962478|NCT01144377|1961155|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
962479|NCT01144377|1961156|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
962480|NCT01144377|1961157|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
962481|NCT01144377|1961158|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
962482|NCT01144377|1961154|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
962483|NCT01144377|1961155|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
962484|NCT01144377|1961156|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
962485|NCT01144377|1961157|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
962486|NCT01144377|1961158|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
962487|NCT01144403|1961172|FG000|Overall Study|Lost to Follow-up|3
962488|NCT01144403|1961172|FG000|Overall Study|Death|1
962489|NCT01144403|1961172|FG000|Overall Study|Adverse Event|1
962490|NCT01144416|1961179|FG000|Intervention Period|Adverse Event|5
962491|NCT01144416|1961180|FG001|Intervention Period|Adverse Event|6
962492|NCT01144416|1961179|FG000|Intervention Period|Insufficient ovarian response|11
962493|NCT01144416|1961180|FG001|Intervention Period|Insufficient ovarian response|17
962494|NCT01144416|1961179|FG000|Intervention Period|Risk of OHSS|0
962495|NCT01144416|1961180|FG001|Intervention Period|Risk of OHSS|1
962496|NCT01144416|1961179|FG000|Intervention Period|Too high ovarian response|4
962497|NCT01144416|1961180|FG001|Intervention Period|Too high ovarian response|2
962498|NCT01144416|1961179|FG000|Intervention Period|No/too few/bad oocytes|7
962499|NCT01144416|1961180|FG001|Intervention Period|No/too few/bad oocytes|5
962500|NCT01144416|1961179|FG000|Intervention Period|No or abnormal fertilization|25
962501|NCT01144416|1961180|FG001|Intervention Period|No or abnormal fertilization|10
962502|NCT01144416|1961179|FG000|Intervention Period|No/too few/bad quality embryos|3
962503|NCT01144416|1961180|FG001|Intervention Period|No/too few/bad quality embryos|3
962504|NCT01144416|1961179|FG000|Intervention Period|Other|7
962505|NCT01144416|1961180|FG001|Intervention Period|Other|5
962506|NCT01144663|1961257|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2
962507|NCT01144663|1961258|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0
962508|NCT01144663|1961259|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1
962509|NCT01144663|1961260|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0
962510|NCT01144663|1961257|FG000|Primary Vaccination Phase|Adverse Event|1
962511|NCT01144663|1961258|FG001|Primary Vaccination Phase|Adverse Event|0
962512|NCT01144663|1961259|FG002|Primary Vaccination Phase|Adverse Event|0
962513|NCT01144663|1961260|FG003|Primary Vaccination Phase|Adverse Event|1
962514|NCT01144663|1961257|FG000|Primary Vaccination Phase|Protocol Violation|2
962515|NCT01144663|1961258|FG001|Primary Vaccination Phase|Protocol Violation|0
962516|NCT01144663|1961259|FG002|Primary Vaccination Phase|Protocol Violation|1
962517|NCT01144663|1961260|FG003|Primary Vaccination Phase|Protocol Violation|0
962518|NCT01144663|1961257|FG000|Primary Vaccination Phase|Withdrawal by Subject|9
962519|NCT01144663|1961258|FG001|Primary Vaccination Phase|Withdrawal by Subject|5
962520|NCT01144663|1961259|FG002|Primary Vaccination Phase|Withdrawal by Subject|3
962521|NCT01144663|1961260|FG003|Primary Vaccination Phase|Withdrawal by Subject|10
962522|NCT01144663|1961257|FG000|Primary Vaccination Phase|Migrated/moved from study area|4
962523|NCT01144663|1961258|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
962524|NCT01144663|1961259|FG002|Primary Vaccination Phase|Migrated/moved from study area|2
962525|NCT01144663|1961260|FG003|Primary Vaccination Phase|Migrated/moved from study area|3
962526|NCT01144663|1961257|FG000|Primary Vaccination Phase|Lost to Follow-up|2
962527|NCT01144663|1961258|FG001|Primary Vaccination Phase|Lost to Follow-up|0
962528|NCT01144663|1961259|FG002|Primary Vaccination Phase|Lost to Follow-up|1
962529|NCT01144663|1961260|FG003|Primary Vaccination Phase|Lost to Follow-up|2
962530|NCT01144663|1961257|FG000|Primary Vaccination Phase|Other|0
962531|NCT01144663|1961258|FG001|Primary Vaccination Phase|Other|1
962532|NCT01144663|1961259|FG002|Primary Vaccination Phase|Other|0
962533|NCT01144663|1961260|FG003|Primary Vaccination Phase|Other|2
962534|NCT01144663|1961257|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
962535|NCT01144663|1961258|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
962536|NCT01144663|1961259|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
962537|NCT01144663|1961260|FG003|Booster Vaccination Phase|Withdrawal by Subject|1
962538|NCT01144663|1961257|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
962539|NCT01144663|1961258|FG001|Booster Vaccination Phase|Migrated/moved from study area|1
962540|NCT01144663|1961259|FG002|Booster Vaccination Phase|Migrated/moved from study area|1
962541|NCT01144663|1961260|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
962542|NCT01144663|1961257|FG000|Booster Vaccination Phase|Lost to Follow-up|2
962543|NCT01144663|1961258|FG001|Booster Vaccination Phase|Lost to Follow-up|1
962544|NCT01144663|1961259|FG002|Booster Vaccination Phase|Lost to Follow-up|3
962545|NCT01144663|1961260|FG003|Booster Vaccination Phase|Lost to Follow-up|0
962546|NCT01144663|1961257|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
962547|NCT01144663|1961258|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
962548|NCT01144663|1961259|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
962549|NCT01144663|1961260|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
962550|NCT01144663|1961257|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
962551|NCT01144663|1961258|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
962552|NCT01144663|1961259|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
962553|NCT01144663|1961260|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
962554|NCT01144663|1961257|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
962555|NCT01144663|1961258|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
962556|NCT01144663|1961259|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
962557|NCT01144663|1961260|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
962558|NCT01144715|1961272|FG000|Overall Study|Lost to Follow-up|2
962559|NCT01144715|1961273|FG001|Overall Study|Lost to Follow-up|1
962560|NCT01144715|1961272|FG000|Overall Study|Withdrawal by Subject|2
962561|NCT01144715|1961273|FG001|Overall Study|Withdrawal by Subject|1
962562|NCT01144715|1961272|FG000|Overall Study|Adverse Event|0
962563|NCT01144715|1961273|FG001|Overall Study|Adverse Event|1
962564|NCT01145053|1961305|FG000|Overall Study|Adverse Event|22
962565|NCT01145053|1961305|FG000|Overall Study|Lost to Follow-up|28
962566|NCT01145053|1961305|FG000|Overall Study|Withdrawal by Subject|25
962567|NCT01145053|1961305|FG000|Overall Study|Other|18
962568|NCT01145066|1961312|FG000|Overall Study|To resume NSAIDs|2
962569|NCT01145066|1961313|FG001|Overall Study|To resume NSAIDs|2
962570|NCT01145066|1961314|FG002|Overall Study|To resume NSAIDs|1
962571|NCT01145066|1961312|FG000|Overall Study|Non-related surgery|0
962572|NCT01145066|1961313|FG001|Overall Study|Non-related surgery|0
962573|NCT01145066|1961314|FG002|Overall Study|Non-related surgery|1
962574|NCT01145066|1961312|FG000|Overall Study|Withdrawal by Subject|0
962575|NCT01145066|1961313|FG001|Overall Study|Withdrawal by Subject|0
962576|NCT01145066|1961314|FG002|Overall Study|Withdrawal by Subject|2
962577|NCT01145066|1961312|FG000|Overall Study|To start new med|1
962578|NCT01145066|1961313|FG001|Overall Study|To start new med|0
962579|NCT01145066|1961314|FG002|Overall Study|To start new med|0
962580|NCT01145066|1961312|FG000|Overall Study|problems swallowing capsule|1
962581|NCT01145066|1961313|FG001|Overall Study|problems swallowing capsule|0
962582|NCT01145066|1961314|FG002|Overall Study|problems swallowing capsule|0
962583|NCT01145066|1961312|FG000|Overall Study|Abdominal discomfort|0
962584|NCT01145066|1961313|FG001|Overall Study|Abdominal discomfort|1
962585|NCT01145066|1961314|FG002|Overall Study|Abdominal discomfort|0
962586|NCT01145066|1961312|FG000|Overall Study|Low platelet count|0
962587|NCT01145066|1961313|FG001|Overall Study|Low platelet count|1
962588|NCT01145066|1961314|FG002|Overall Study|Low platelet count|0
962589|NCT01145222|1961352|FG000|Overall Study|Procedure not done (no anesthesiologist)|0
962590|NCT01145222|1961353|FG001|Overall Study|Procedure not done (no anesthesiologist)|0
962591|NCT01145222|1961354|FG002|Overall Study|Procedure not done (no anesthesiologist)|1
962592|NCT01145222|1961355|FG003|Overall Study|Procedure not done (no anesthesiologist)|0
962593|NCT01145222|1961352|FG000|Overall Study|Poor bowel preparation|0
962594|NCT01145222|1961353|FG001|Overall Study|Poor bowel preparation|0
962595|NCT01145222|1961354|FG002|Overall Study|Poor bowel preparation|0
962596|NCT01145222|1961355|FG003|Overall Study|Poor bowel preparation|1
962597|NCT01145352|1961365|FG000|Overall Study|Found to have been registered twice|6
1006620|NCT01468701|2025295|FG010|Overall Study|Not being followed up|0
962598|NCT01145352|1961365|FG000|Overall Study|Treated before marketing approval|4
962599|NCT01145352|1961365|FG000|Overall Study|Syringe formulation was used|1
962600|NCT01145417|1961382|FG000|Overall Study|Death|1
962601|NCT01145417|1961383|FG001|Overall Study|Death|0
962602|NCT01145417|1961382|FG000|Overall Study|Lost to Follow-up|2
962603|NCT01145417|1961383|FG001|Overall Study|Lost to Follow-up|1
962604|NCT01145417|1961382|FG000|Overall Study|Withdrawal by Subject|1
962605|NCT01145417|1961383|FG001|Overall Study|Withdrawal by Subject|2
962606|NCT01145417|1961382|FG000|Overall Study|Pregnancy|1
962607|NCT01145417|1961383|FG001|Overall Study|Pregnancy|0
962608|NCT01145417|1961382|FG000|Overall Study|Adverse Event|0
962609|NCT01145417|1961383|FG001|Overall Study|Adverse Event|1
962610|NCT01145417|1961382|FG000|Overall Study|Study terminated by sponsor|35
962611|NCT01145417|1961383|FG001|Overall Study|Study terminated by sponsor|43
962612|NCT01145417|1961382|FG000|Overall Study|Other|1
962613|NCT01145417|1961383|FG001|Overall Study|Other|0
962614|NCT01145482|1961391|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
962615|NCT01145482|1961392|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
962616|NCT01145508|1961400|FG000|Overall Study|Adverse Event|1
962617|NCT01145508|1961401|FG001|Overall Study|Adverse Event|0
962618|NCT01145508|1961400|FG000|Overall Study|Death|1
962619|NCT01145508|1961401|FG001|Overall Study|Death|0
962620|NCT01145508|1961400|FG000|Overall Study|Physician Decision|2
962621|NCT01145508|1961401|FG001|Overall Study|Physician Decision|1
962622|NCT01145508|1961400|FG000|Overall Study|Never started treatment|1
962623|NCT01145508|1961401|FG001|Overall Study|Never started treatment|1
962624|NCT01145560|1961417|FG000|Overall Study|Withdrawal by Subject|2
962625|NCT01145560|1961418|FG001|Overall Study|Withdrawal by Subject|1
962626|NCT01145560|1961419|FG002|Overall Study|Withdrawal by Subject|0
962627|NCT01145560|1961417|FG000|Overall Study|Lost to Follow-up|1
962628|NCT01145560|1961418|FG001|Overall Study|Lost to Follow-up|1
962629|NCT01145560|1961419|FG002|Overall Study|Lost to Follow-up|1
962630|NCT01145560|1961417|FG000|Overall Study|No study drug by 24h after organ failure|1
962631|NCT01145560|1961418|FG001|Overall Study|No study drug by 24h after organ failure|0
962632|NCT01145560|1961419|FG002|Overall Study|No study drug by 24h after organ failure|0
962633|NCT01145560|1961417|FG000|Overall Study|Accidental unblinding of study treatment|0
962634|NCT01145560|1961418|FG001|Overall Study|Accidental unblinding of study treatment|1
962635|NCT01145560|1961419|FG002|Overall Study|Accidental unblinding of study treatment|0
962636|NCT01145560|1961417|FG000|Overall Study|False insurance information|0
962637|NCT01145560|1961418|FG001|Overall Study|False insurance information|1
962638|NCT01145560|1961419|FG002|Overall Study|False insurance information|0
962639|NCT01145560|1961417|FG000|Overall Study|Withdrawal of therapy|0
962640|NCT01145560|1961418|FG001|Overall Study|Withdrawal of therapy|0
962641|NCT01145560|1961419|FG002|Overall Study|Withdrawal of therapy|1
962642|NCT01145625|1961429|FG000|Overall Study|Lost to Follow-up|8
962643|NCT01145625|1961430|FG001|Overall Study|Lost to Follow-up|9
962644|NCT01145625|1961429|FG000|Overall Study|Adverse Event|6
962645|NCT01145625|1961430|FG001|Overall Study|Adverse Event|4
962646|NCT01145625|1961429|FG000|Overall Study|Protocol Violation|3
962647|NCT01145625|1961430|FG001|Overall Study|Protocol Violation|1
962648|NCT01145625|1961429|FG000|Overall Study|Withdrawal by Subject|7
962649|NCT01145625|1961430|FG001|Overall Study|Withdrawal by Subject|16
962650|NCT01145625|1961429|FG000|Overall Study|Pregnancy|0
962651|NCT01145625|1961430|FG001|Overall Study|Pregnancy|1
962652|NCT01145755|1961448|FG000|Overall Study|Adverse Event|2
962653|NCT01145755|1961449|FG001|Overall Study|Adverse Event|4
962654|NCT01145755|1961450|FG002|Overall Study|Adverse Event|2
962655|NCT01145755|1961448|FG000|Overall Study|Withdrawal by Subject|2
962656|NCT01145755|1961449|FG001|Overall Study|Withdrawal by Subject|2
962657|NCT01145755|1961450|FG002|Overall Study|Withdrawal by Subject|2
962658|NCT01145755|1961448|FG000|Overall Study|Lost to Follow-up|2
962659|NCT01145755|1961449|FG001|Overall Study|Lost to Follow-up|3
962660|NCT01145755|1961450|FG002|Overall Study|Lost to Follow-up|1
962661|NCT01145755|1961448|FG000|Overall Study|Protocol Violation|0
962662|NCT01145755|1961449|FG001|Overall Study|Protocol Violation|3
962663|NCT01145755|1961450|FG002|Overall Study|Protocol Violation|1
962664|NCT01145755|1961448|FG000|Overall Study|Study Closure|14
962665|NCT01145755|1961449|FG001|Overall Study|Study Closure|14
962666|NCT01145755|1961450|FG002|Overall Study|Study Closure|17
962667|NCT01145755|1961448|FG000|Overall Study|Lack of Efficacy|0
962668|NCT01145755|1961449|FG001|Overall Study|Lack of Efficacy|1
962669|NCT01145755|1961450|FG002|Overall Study|Lack of Efficacy|0
962670|NCT01145755|1961448|FG000|Overall Study|Patient could not swollow medication|0
962671|NCT01145755|1961449|FG001|Overall Study|Patient could not swollow medication|0
962672|NCT01145755|1961450|FG002|Overall Study|Patient could not swollow medication|1
962673|NCT01145755|1961448|FG000|Overall Study|Withdrawal by Subject|0
962674|NCT01145755|1961449|FG001|Overall Study|Withdrawal by Subject|0
962675|NCT01145755|1961450|FG002|Overall Study|Withdrawal by Subject|1
962676|NCT01145755|1961448|FG000|Overall Study|Positive urine ethanol|0
962677|NCT01145755|1961449|FG001|Overall Study|Positive urine ethanol|1
962678|NCT01145755|1961450|FG002|Overall Study|Positive urine ethanol|0
962679|NCT01145885|1961467|FG000|Overall Study|Progressive Disease|7
962680|NCT01145898|1961479|FG000|3-year Treatment|medication change by treating physician|3
962681|NCT01145898|1961480|FG001|3-year Treatment|medication change by treating physician|16
962682|NCT01146054|1961485|FG000|Overall Study|Did not meet dose constraints for SBRT|5
962683|NCT01146054|1961485|FG000|Overall Study|Rapid tumor progression|2
962684|NCT01146054|1961485|FG000|Overall Study|Other illness precluded treatment|2
962685|NCT01146054|1961485|FG000|Overall Study|Lost to Follow-up|1
962686|NCT01146288|1961496|FG000|First Intervention(1 Day)|Adverse Event|0
962687|NCT01146288|1961497|FG001|First Intervention(1 Day)|Adverse Event|1
962688|NCT01146561|1961567|FG000|Overall Study|Withdrawal by Subject|1
962689|NCT01146561|1961567|FG000|Overall Study|Lost to Follow-up|1
962690|NCT01146613|1961583|FG000|Overall Study|Lost to Follow-up|3
962691|NCT01146613|1961584|FG001|Overall Study|Lost to Follow-up|8
962692|NCT01146613|1961583|FG000|Overall Study|Lack of Efficacy|0
962693|NCT01146613|1961584|FG001|Overall Study|Lack of Efficacy|1
962694|NCT01146613|1961583|FG000|Overall Study|Death|1
962695|NCT01146613|1961584|FG001|Overall Study|Death|0
962696|NCT01146613|1961583|FG000|Overall Study|Physician Decision|1
962697|NCT01146613|1961584|FG001|Overall Study|Physician Decision|0
962698|NCT01146613|1961583|FG000|Overall Study|Withdrawal by Subject|0
962699|NCT01146613|1961584|FG001|Overall Study|Withdrawal by Subject|3
962700|NCT01146613|1961583|FG000|Overall Study|schedule conflict|1
962701|NCT01146613|1961584|FG001|Overall Study|schedule conflict|0
962702|NCT01146613|1961583|FG000|Overall Study|Outpatient detox|1
962703|NCT01146613|1961584|FG001|Overall Study|Outpatient detox|0
962704|NCT01146665|1961592|FG000|Overall Study|Withdrawal by Subject|10
962705|NCT01146665|1961593|FG001|Overall Study|Withdrawal by Subject|16
962706|NCT01146782|1961617|FG000|Screening Cohort|Screen Failure|187
962707|NCT01146782|1961617|FG000|Screening Cohort|Lost to Follow-up|4
962708|NCT01146782|1961617|FG000|Screening Cohort|Physician Decision|1
962709|NCT01146782|1961617|FG000|Screening Cohort|Withdrawal by Subject|29
962710|NCT01146782|1961617|FG000|Safety Cohort|Screen Failure|61
962711|NCT01146782|1961617|FG000|Safety Cohort|Withdrawal by Subject|4
962712|NCT01146782|1961617|FG000|Safety Cohort|Control AHI <5|4
962713|NCT01146782|1961617|FG000|Safety Cohort|TST <4 hrs|14
962714|NCT01146782|1961617|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5
962715|NCT01146782|1961617|FG000|Primary Endpoint Cohort|Physician Decision|1
962716|NCT01146795|1961622|FG000|Overall Study|Withdrawal by Subject|4
962717|NCT01146795|1961622|FG000|Overall Study|Adverse Event|6
962718|NCT01146795|1961622|FG000|Overall Study|Still in treatment at study closure|10
962719|NCT01146860|1961653|FG000|Overall Study|Withdrawal by Subject|0
962720|NCT01146860|1961654|FG001|Overall Study|Withdrawal by Subject|1
962721|NCT01146873|1961662|FG000|Overall Study|Transfer out|0
962722|NCT01146873|1961663|FG001|Overall Study|Transfer out|6
962723|NCT01146912|1961676|FG000|Overall Study|Already received influenza vaccination|817
962724|NCT01146912|1961677|FG001|Overall Study|Already received influenza vaccination|822
962725|NCT01146912|1961678|FG002|Overall Study|Already received influenza vaccination|13
962726|NCT01146912|1961679|FG003|Overall Study|Already received influenza vaccination|15
962727|NCT01146912|1961680|FG004|Overall Study|Already received influenza vaccination|41
962728|NCT01146912|1961681|FG005|Overall Study|Already received influenza vaccination|61
962729|NCT01146912|1961682|FG006|Overall Study|Already received influenza vaccination|56
962730|NCT01146912|1961683|FG007|Overall Study|Already received influenza vaccination|0
962731|NCT01146912|1961676|FG000|Overall Study|< 14 weeks gestational age|0
962732|NCT01146912|1961677|FG001|Overall Study|< 14 weeks gestational age|0
962733|NCT01146912|1961678|FG002|Overall Study|< 14 weeks gestational age|3
962734|NCT01146912|1961679|FG003|Overall Study|< 14 weeks gestational age|2
962735|NCT01146912|1961680|FG004|Overall Study|< 14 weeks gestational age|0
962736|NCT01146912|1961681|FG005|Overall Study|< 14 weeks gestational age|0
962737|NCT01146912|1961682|FG006|Overall Study|< 14 weeks gestational age|0
962738|NCT01146912|1961683|FG007|Overall Study|< 14 weeks gestational age|0
962739|NCT01146912|1961676|FG000|Overall Study|Duplicate patient|0
962740|NCT01146912|1961677|FG001|Overall Study|Duplicate patient|0
962741|NCT01146912|1961678|FG002|Overall Study|Duplicate patient|1
962742|NCT01146912|1961679|FG003|Overall Study|Duplicate patient|0
962743|NCT01146912|1961680|FG004|Overall Study|Duplicate patient|0
962744|NCT01146912|1961681|FG005|Overall Study|Duplicate patient|0
962745|NCT01146912|1961682|FG006|Overall Study|Duplicate patient|0
962746|NCT01146912|1961683|FG007|Overall Study|Duplicate patient|0
962747|NCT01146951|1961704|FG000|Overall Study|Adverse Event|4
962748|NCT01146951|1961705|FG001|Overall Study|Adverse Event|1
962749|NCT01147055|1961711|FG000|First Intervention Period|Lost to Follow-up|1
962750|NCT01147055|1961712|FG001|First Intervention Period|Lost to Follow-up|0
962751|NCT01147068|1961725|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1
962752|NCT01147068|1961726|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0
962753|NCT01147068|1961727|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0
962754|NCT01147068|1961728|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0
962755|NCT01147068|1961729|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0
962756|NCT01147068|1961730|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1
962757|NCT01147068|1961731|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0
962758|NCT01147068|1961725|FG000|Subjects That Received 2nd Dose|Ineligible|0
962759|NCT01147068|1961726|FG001|Subjects That Received 2nd Dose|Ineligible|1
962760|NCT01147068|1961727|FG002|Subjects That Received 2nd Dose|Ineligible|0
962761|NCT01147068|1961728|FG003|Subjects That Received 2nd Dose|Ineligible|0
962762|NCT01147068|1961729|FG004|Subjects That Received 2nd Dose|Ineligible|0
962763|NCT01147068|1961730|FG005|Subjects That Received 2nd Dose|Ineligible|0
962764|NCT01147068|1961731|FG006|Subjects That Received 2nd Dose|Ineligible|0
962765|NCT01147068|1961725|FG000|Subjects That Received 2nd Dose|Did not complete the study|0
962766|NCT01147068|1961726|FG001|Subjects That Received 2nd Dose|Did not complete the study|1
962767|NCT01147068|1961727|FG002|Subjects That Received 2nd Dose|Did not complete the study|0
962768|NCT01147068|1961728|FG003|Subjects That Received 2nd Dose|Did not complete the study|0
962769|NCT01147068|1961729|FG004|Subjects That Received 2nd Dose|Did not complete the study|0
962770|NCT01147068|1961730|FG005|Subjects That Received 2nd Dose|Did not complete the study|1
962771|NCT01147068|1961731|FG006|Subjects That Received 2nd Dose|Did not complete the study|0
962772|NCT01147068|1961725|FG000|Subjects That Received 2nd Dose|Other|0
962773|NCT01147068|1961726|FG001|Subjects That Received 2nd Dose|Other|3
962774|NCT01147068|1961727|FG002|Subjects That Received 2nd Dose|Other|3
962775|NCT01147068|1961728|FG003|Subjects That Received 2nd Dose|Other|0
962776|NCT01147068|1961729|FG004|Subjects That Received 2nd Dose|Other|1
962777|NCT01147068|1961730|FG005|Subjects That Received 2nd Dose|Other|0
962778|NCT01147068|1961731|FG006|Subjects That Received 2nd Dose|Other|0
962779|NCT01147068|1961725|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
962780|NCT01147068|1961726|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
962781|NCT01147068|1961727|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
962782|NCT01147068|1961728|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
962783|NCT01147068|1961729|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
962784|NCT01147068|1961730|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
962785|NCT01147068|1961731|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
962786|NCT01147068|1961725|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
962787|NCT01147068|1961726|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
962788|NCT01147068|1961727|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
962789|NCT01147068|1961728|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
962790|NCT01147068|1961729|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
962791|NCT01147068|1961730|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
962792|NCT01147068|1961731|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
962793|NCT01147068|1961725|FG000|Subjects That Completed Safety Follow-up|Ineligible|0
962794|NCT01147068|1961726|FG001|Subjects That Completed Safety Follow-up|Ineligible|1
962795|NCT01147068|1961727|FG002|Subjects That Completed Safety Follow-up|Ineligible|0
962796|NCT01147068|1961728|FG003|Subjects That Completed Safety Follow-up|Ineligible|0
962797|NCT01147068|1961729|FG004|Subjects That Completed Safety Follow-up|Ineligible|0
962798|NCT01147068|1961730|FG005|Subjects That Completed Safety Follow-up|Ineligible|0
962799|NCT01147068|1961731|FG006|Subjects That Completed Safety Follow-up|Ineligible|0
962800|NCT01147107|1961749|FG000|Overall Study|Lack of Efficacy|5
962801|NCT01147107|1961750|FG001|Overall Study|Lack of Efficacy|0
962802|NCT01147107|1961749|FG000|Overall Study|Withdrawal by Subject|1
962803|NCT01147107|1961750|FG001|Overall Study|Withdrawal by Subject|1
962804|NCT01147172|1961756|FG000|Overall Study|Withdrawal by Subject|2
962805|NCT01147172|1961756|FG000|Overall Study|Lost to Follow-up|2
962806|NCT01147250|1961764|FG000|Overall Study|Lost to Follow-up|14
962807|NCT01147250|1961765|FG001|Overall Study|Lost to Follow-up|11
962808|NCT01147250|1961764|FG000|Overall Study|Withdrawal by Subject|83
962809|NCT01147250|1961765|FG001|Overall Study|Withdrawal by Subject|88
962810|NCT01147250|1961764|FG000|Overall Study|Site termination by sponsor|13
962811|NCT01147250|1961765|FG001|Overall Study|Site termination by sponsor|5
962812|NCT01147250|1961764|FG000|Overall Study|Other than specified|0
962813|NCT01147250|1961765|FG001|Overall Study|Other than specified|1
962814|NCT01147341|1961782|FG000|Double Blind Period|Lack of Efficacy|1
962815|NCT01147341|1961783|FG001|Double Blind Period|Lack of Efficacy|1
962816|NCT01147341|1961782|FG000|Double Blind Period|Withdrawal by Subject|0
962817|NCT01147341|1961783|FG001|Double Blind Period|Withdrawal by Subject|1
962818|NCT01147341|1961782|FG000|Open Label Period|Lack of Efficacy|3
962819|NCT01147341|1961783|FG001|Open Label Period|Lack of Efficacy|0
962820|NCT01147341|1961782|FG000|Open Label Period|Subject moved|1
962821|NCT01147341|1961783|FG001|Open Label Period|Subject moved|0
962822|NCT01147458|1961826|FG000|First Intervention|Study terminated by sponsor|8
962823|NCT01147458|1961827|FG001|First Intervention|Study terminated by sponsor|8
962824|NCT01147458|1961828|FG002|First Intervention|Study terminated by sponsor|7
962825|NCT01147458|1961829|FG003|First Intervention|Study terminated by sponsor|8
962826|NCT01147458|1961826|FG000|First Intervention|Protocol Violation|2
962827|NCT01147458|1961827|FG001|First Intervention|Protocol Violation|3
962828|NCT01147458|1961828|FG002|First Intervention|Protocol Violation|2
962829|NCT01147458|1961829|FG003|First Intervention|Protocol Violation|3
962830|NCT01147458|1961826|FG000|First Intervention|Withdrawal by Subject|3
962831|NCT01147458|1961827|FG001|First Intervention|Withdrawal by Subject|0
962832|NCT01147458|1961828|FG002|First Intervention|Withdrawal by Subject|1
962833|NCT01147458|1961829|FG003|First Intervention|Withdrawal by Subject|0
962834|NCT01147458|1961826|FG000|First Intervention|Adverse Event|0
962835|NCT01147458|1961827|FG001|First Intervention|Adverse Event|3
962836|NCT01147458|1961828|FG002|First Intervention|Adverse Event|2
962837|NCT01147458|1961829|FG003|First Intervention|Adverse Event|3
962838|NCT01147458|1961826|FG000|First Intervention|Other|1
962839|NCT01147458|1961827|FG001|First Intervention|Other|2
962840|NCT01147458|1961828|FG002|First Intervention|Other|0
962841|NCT01147458|1961829|FG003|First Intervention|Other|0
962842|NCT01147458|1961826|FG000|Second Intervention|Study terminated by sponsor|7
962843|NCT01147458|1961827|FG001|Second Intervention|Study terminated by sponsor|5
962844|NCT01147458|1961828|FG002|Second Intervention|Study terminated by sponsor|5
962845|NCT01147458|1961829|FG003|Second Intervention|Study terminated by sponsor|3
962846|NCT01147458|1961826|FG000|Second Intervention|Protocol Violation|0
962847|NCT01147458|1961827|FG001|Second Intervention|Protocol Violation|1
962848|NCT01147458|1961828|FG002|Second Intervention|Protocol Violation|1
962849|NCT01147458|1961829|FG003|Second Intervention|Protocol Violation|0
962850|NCT01147458|1961826|FG000|Second Intervention|Withdrawal by Subject|0
962851|NCT01147458|1961827|FG001|Second Intervention|Withdrawal by Subject|1
962852|NCT01147458|1961828|FG002|Second Intervention|Withdrawal by Subject|0
962853|NCT01147458|1961829|FG003|Second Intervention|Withdrawal by Subject|0
962854|NCT01147458|1961826|FG000|Second Intervention|Adverse Event|2
962855|NCT01147458|1961827|FG001|Second Intervention|Adverse Event|0
962856|NCT01147458|1961828|FG002|Second Intervention|Adverse Event|1
962857|NCT01147458|1961829|FG003|Second Intervention|Adverse Event|1
962858|NCT01147458|1961826|FG000|Second Intervention|Other|0
962859|NCT01147458|1961827|FG001|Second Intervention|Other|0
962860|NCT01147458|1961828|FG002|Second Intervention|Other|1
962861|NCT01147458|1961829|FG003|Second Intervention|Other|0
962862|NCT01147471|1961843|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
962863|NCT01147471|1961844|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
962864|NCT01147471|1961843|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
962865|NCT01147471|1961844|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
962866|NCT01147471|1961843|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
962867|NCT01147471|1961844|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
962868|NCT01147471|1961843|FG000|3 Month Follow Up|Lost to Follow-up|1
962869|NCT01147471|1961844|FG001|3 Month Follow Up|Lost to Follow-up|1
962870|NCT01147471|1961843|FG000|3 Month Follow Up|Physician Decision|0
962871|NCT01147471|1961844|FG001|3 Month Follow Up|Physician Decision|1
962872|NCT01147471|1961843|FG000|6 Month Follow Up|Lost to Follow-up|4
962873|NCT01147471|1961844|FG001|6 Month Follow Up|Lost to Follow-up|2
962874|NCT01147497|1961852|FG000|Overall Study|failed insertion|2
962875|NCT01147497|1961853|FG001|Overall Study|failed insertion|0
962876|NCT01147640|1961883|FG000|Overall Study|Adverse Event|2
962877|NCT01147640|1961884|FG001|Overall Study|Adverse Event|0
962878|NCT01147640|1961883|FG000|Overall Study|Physician Decision|1
962879|NCT01147640|1961884|FG001|Overall Study|Physician Decision|0
962880|NCT01147640|1961883|FG000|Overall Study|Withdrawal by Subject|1
962881|NCT01147640|1961884|FG001|Overall Study|Withdrawal by Subject|0
962882|NCT01147640|1961883|FG000|Overall Study|Lost to Follow-up|0
962883|NCT01147640|1961884|FG001|Overall Study|Lost to Follow-up|1
962884|NCT01147640|1961883|FG000|Overall Study|Didn't meet eligibility criteria|1
962885|NCT01147640|1961884|FG001|Overall Study|Didn't meet eligibility criteria|0
962888|NCT01147744|1961918|FG000|Overall Study|Protocol Violation|1
962889|NCT01147744|1961919|FG001|Overall Study|Protocol Violation|0
962890|NCT01147744|1961920|FG002|Overall Study|Protocol Violation|1
962891|NCT01147744|1961921|FG003|Overall Study|Protocol Violation|0
962892|NCT01147744|1961922|FG004|Overall Study|Protocol Violation|1
962893|NCT01147744|1961923|FG005|Overall Study|Protocol Violation|3
962894|NCT01147744|1961924|FG006|Overall Study|Protocol Violation|1
962895|NCT01147744|1961918|FG000|Overall Study|Physician Decision|0
962896|NCT01147744|1961919|FG001|Overall Study|Physician Decision|1
962897|NCT01147744|1961920|FG002|Overall Study|Physician Decision|1
962898|NCT01147744|1961921|FG003|Overall Study|Physician Decision|0
962899|NCT01147744|1961922|FG004|Overall Study|Physician Decision|0
962900|NCT01147744|1961923|FG005|Overall Study|Physician Decision|0
962901|NCT01147744|1961924|FG006|Overall Study|Physician Decision|1
962902|NCT01147744|1961918|FG000|Overall Study|Lack of Efficacy|11
962903|NCT01147744|1961919|FG001|Overall Study|Lack of Efficacy|11
962904|NCT01147744|1961920|FG002|Overall Study|Lack of Efficacy|9
962905|NCT01147744|1961921|FG003|Overall Study|Lack of Efficacy|11
962906|NCT01147744|1961922|FG004|Overall Study|Lack of Efficacy|13
962907|NCT01147744|1961923|FG005|Overall Study|Lack of Efficacy|8
962908|NCT01147744|1961924|FG006|Overall Study|Lack of Efficacy|7
962909|NCT01147744|1961918|FG000|Overall Study|Adverse Event|1
962910|NCT01147744|1961919|FG001|Overall Study|Adverse Event|2
962911|NCT01147744|1961920|FG002|Overall Study|Adverse Event|3
962912|NCT01147744|1961921|FG003|Overall Study|Adverse Event|0
962913|NCT01147744|1961922|FG004|Overall Study|Adverse Event|2
962914|NCT01147744|1961923|FG005|Overall Study|Adverse Event|1
962915|NCT01147744|1961924|FG006|Overall Study|Adverse Event|2
962916|NCT01147744|1961918|FG000|Overall Study|Withdrawal by Subject|8
962917|NCT01147744|1961919|FG001|Overall Study|Withdrawal by Subject|4
962918|NCT01147744|1961920|FG002|Overall Study|Withdrawal by Subject|2
962919|NCT01147744|1961921|FG003|Overall Study|Withdrawal by Subject|2
962920|NCT01147744|1961922|FG004|Overall Study|Withdrawal by Subject|2
962921|NCT01147744|1961923|FG005|Overall Study|Withdrawal by Subject|5
962922|NCT01147744|1961924|FG006|Overall Study|Withdrawal by Subject|2
962923|NCT01147744|1961918|FG000|Overall Study|Lost to Follow-up|0
962924|NCT01147744|1961919|FG001|Overall Study|Lost to Follow-up|1
962925|NCT01147744|1961920|FG002|Overall Study|Lost to Follow-up|0
962926|NCT01147744|1961921|FG003|Overall Study|Lost to Follow-up|0
962927|NCT01147744|1961922|FG004|Overall Study|Lost to Follow-up|0
962928|NCT01147744|1961923|FG005|Overall Study|Lost to Follow-up|0
962929|NCT01147744|1961924|FG006|Overall Study|Lost to Follow-up|0
962930|NCT01147744|1961918|FG000|Overall Study|Sponsor decision to amend protocol|7
962931|NCT01147744|1961919|FG001|Overall Study|Sponsor decision to amend protocol|4
962932|NCT01147744|1961920|FG002|Overall Study|Sponsor decision to amend protocol|2
962933|NCT01147744|1961921|FG003|Overall Study|Sponsor decision to amend protocol|5
962934|NCT01147744|1961922|FG004|Overall Study|Sponsor decision to amend protocol|7
962935|NCT01147744|1961923|FG005|Overall Study|Sponsor decision to amend protocol|2
962936|NCT01147744|1961924|FG006|Overall Study|Sponsor decision to amend protocol|6
962937|NCT01147744|1961918|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
962938|NCT01147744|1961919|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
962939|NCT01147744|1961920|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0
962940|NCT01147744|1961921|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0
962941|NCT01147744|1961922|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0
962942|NCT01147744|1961923|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1
962943|NCT01147744|1961924|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0
962944|NCT01147809|1961952|FG000|Phase I (168 Days)|Adverse Event|0
962945|NCT01147809|1961953|FG001|Phase I (168 Days)|Adverse Event|0
962946|NCT01147809|1961954|FG002|Phase I (168 Days)|Adverse Event|0
962947|NCT01147809|1961955|FG003|Phase I (168 Days)|Adverse Event|1
962948|NCT01147809|1961956|FG004|Phase I (168 Days)|Adverse Event|0
962949|NCT01147809|1961957|FG005|Phase I (168 Days)|Adverse Event|0
962950|NCT01147809|1961952|FG000|Phase I (168 Days)|Lost to Follow-up|1
962951|NCT01147809|1961953|FG001|Phase I (168 Days)|Lost to Follow-up|0
962952|NCT01147809|1961954|FG002|Phase I (168 Days)|Lost to Follow-up|0
962953|NCT01147809|1961955|FG003|Phase I (168 Days)|Lost to Follow-up|1
962954|NCT01147809|1961956|FG004|Phase I (168 Days)|Lost to Follow-up|0
962955|NCT01147809|1961957|FG005|Phase I (168 Days)|Lost to Follow-up|0
962956|NCT01147809|1961952|FG000|Phase I (168 Days)|Physician Decision|0
962957|NCT01147809|1961953|FG001|Phase I (168 Days)|Physician Decision|1
962958|NCT01147809|1961954|FG002|Phase I (168 Days)|Physician Decision|2
962959|NCT01147809|1961955|FG003|Phase I (168 Days)|Physician Decision|0
962960|NCT01147809|1961956|FG004|Phase I (168 Days)|Physician Decision|0
962961|NCT01147809|1961957|FG005|Phase I (168 Days)|Physician Decision|0
962962|NCT01147809|1961952|FG000|Phase I (168 Days)|Withdrawal by Subject|0
962963|NCT01147809|1961953|FG001|Phase I (168 Days)|Withdrawal by Subject|0
962964|NCT01147809|1961954|FG002|Phase I (168 Days)|Withdrawal by Subject|0
962965|NCT01147809|1961955|FG003|Phase I (168 Days)|Withdrawal by Subject|3
962966|NCT01147809|1961956|FG004|Phase I (168 Days)|Withdrawal by Subject|0
962967|NCT01147809|1961957|FG005|Phase I (168 Days)|Withdrawal by Subject|0
962968|NCT01147809|1961952|FG000|Phase II (168 Days)|Adverse Event|0
962969|NCT01147809|1961953|FG001|Phase II (168 Days)|Adverse Event|0
962970|NCT01147809|1961954|FG002|Phase II (168 Days)|Adverse Event|0
962971|NCT01147809|1961955|FG003|Phase II (168 Days)|Adverse Event|0
962972|NCT01147809|1961956|FG004|Phase II (168 Days)|Adverse Event|3
962973|NCT01147809|1961957|FG005|Phase II (168 Days)|Adverse Event|6
962974|NCT01147809|1961952|FG000|Phase II (168 Days)|Protocol Violation|0
962975|NCT01147809|1961953|FG001|Phase II (168 Days)|Protocol Violation|0
962976|NCT01147809|1961954|FG002|Phase II (168 Days)|Protocol Violation|0
962977|NCT01147809|1961955|FG003|Phase II (168 Days)|Protocol Violation|0
962978|NCT01147809|1961956|FG004|Phase II (168 Days)|Protocol Violation|0
962979|NCT01147809|1961957|FG005|Phase II (168 Days)|Protocol Violation|1
962980|NCT01147809|1961952|FG000|Phase II (168 Days)|Physician Decision|0
962981|NCT01147809|1961953|FG001|Phase II (168 Days)|Physician Decision|0
962982|NCT01147809|1961954|FG002|Phase II (168 Days)|Physician Decision|0
962983|NCT01147809|1961955|FG003|Phase II (168 Days)|Physician Decision|0
962984|NCT01147809|1961956|FG004|Phase II (168 Days)|Physician Decision|5
962985|NCT01147809|1961957|FG005|Phase II (168 Days)|Physician Decision|11
962986|NCT01147809|1961952|FG000|Phase II (168 Days)|Withdrawal by Subject|0
962987|NCT01147809|1961953|FG001|Phase II (168 Days)|Withdrawal by Subject|0
962988|NCT01147809|1961954|FG002|Phase II (168 Days)|Withdrawal by Subject|0
962989|NCT01147809|1961955|FG003|Phase II (168 Days)|Withdrawal by Subject|0
962990|NCT01147809|1961956|FG004|Phase II (168 Days)|Withdrawal by Subject|7
962991|NCT01147809|1961957|FG005|Phase II (168 Days)|Withdrawal by Subject|15
962992|NCT01147809|1961952|FG000|Phase II (168 Days)|Ongoing|0
962993|NCT01147809|1961953|FG001|Phase II (168 Days)|Ongoing|0
962994|NCT01147809|1961954|FG002|Phase II (168 Days)|Ongoing|0
962995|NCT01147809|1961955|FG003|Phase II (168 Days)|Ongoing|0
962996|NCT01147809|1961956|FG004|Phase II (168 Days)|Ongoing|1
962997|NCT01147809|1961957|FG005|Phase II (168 Days)|Ongoing|0
963010|NCT01147848|1961983|FG000|Run-in Period|Screen Failure|623
963011|NCT01147848|1961984|FG001|Run-in Period|Screen Failure|0
963012|NCT01147848|1961985|FG002|Run-in Period|Screen Failure|0
963013|NCT01147848|1961983|FG000|Run-in Period|Run-in Failure|135
963014|NCT01147848|1961984|FG001|Run-in Period|Run-in Failure|0
963015|NCT01147848|1961985|FG002|Run-in Period|Run-in Failure|0
963016|NCT01147848|1961983|FG000|Randomized Phase|Adverse Event|0
963017|NCT01147848|1961984|FG001|Randomized Phase|Adverse Event|6
963018|NCT01147848|1961985|FG002|Randomized Phase|Adverse Event|8
963019|NCT01147848|1961983|FG000|Randomized Phase|Lack of Efficacy|0
963020|NCT01147848|1961984|FG001|Randomized Phase|Lack of Efficacy|20
963021|NCT01147848|1961985|FG002|Randomized Phase|Lack of Efficacy|11
963022|NCT01147848|1961983|FG000|Randomized Phase|Protocol Violation|0
963023|NCT01147848|1961984|FG001|Randomized Phase|Protocol Violation|7
963024|NCT01147848|1961985|FG002|Randomized Phase|Protocol Violation|10
963025|NCT01147848|1961983|FG000|Randomized Phase|Lost to Follow-up|0
963026|NCT01147848|1961984|FG001|Randomized Phase|Lost to Follow-up|5
963027|NCT01147848|1961985|FG002|Randomized Phase|Lost to Follow-up|7
963028|NCT01147848|1961983|FG000|Randomized Phase|Physician Decision|0
963029|NCT01147848|1961984|FG001|Randomized Phase|Physician Decision|0
963030|NCT01147848|1961985|FG002|Randomized Phase|Physician Decision|1
963031|NCT01147848|1961983|FG000|Randomized Phase|Withdrawal by Subject|0
963032|NCT01147848|1961984|FG001|Randomized Phase|Withdrawal by Subject|7
963033|NCT01147848|1961985|FG002|Randomized Phase|Withdrawal by Subject|9
963034|NCT01147874|1961992|FG000|Overall Study|Adverse Event|5
963035|NCT01147874|1961992|FG000|Overall Study|Investigator's Request|1
963036|NCT01147874|1961992|FG000|Overall Study|Lost to Follow-up|25
963037|NCT01147874|1961992|FG000|Overall Study|Other|5
963038|NCT01147874|1961992|FG000|Overall Study|Protocol Violation|5
963039|NCT01147874|1961992|FG000|Overall Study|Sponsor's Decision|2
963040|NCT01147874|1961992|FG000|Overall Study|Withdrawal by Subject|24
963041|NCT01147900|1961999|FG000|At Year 10|Lost to Follow-up|0
963042|NCT01147900|1962000|FG001|At Year 10|Lost to Follow-up|1
963043|NCT01147900|1962001|FG002|At Year 10|Lost to Follow-up|0
963044|NCT01147926|1962011|FG000|Overall Study|Subject Withdrew Consent|9
963045|NCT01147926|1962012|FG001|Overall Study|Subject Withdrew Consent|10
963046|NCT01147926|1962011|FG000|Overall Study|Adverse Event|7
963047|NCT01147926|1962012|FG001|Overall Study|Adverse Event|6
963048|NCT01147926|1962011|FG000|Overall Study|Subject Non-Compliant|5
963049|NCT01147926|1962012|FG001|Overall Study|Subject Non-Compliant|4
963050|NCT01147926|1962011|FG000|Overall Study|Principal investigator left hospital|1
963051|NCT01147926|1962012|FG001|Overall Study|Principal investigator left hospital|3
963052|NCT01147926|1962011|FG000|Overall Study|Selection criteria not met|3
963053|NCT01147926|1962012|FG001|Overall Study|Selection criteria not met|1
963054|NCT01147926|1962011|FG000|Overall Study|Lost to Follow-up|0
963055|NCT01147926|1962012|FG001|Overall Study|Lost to Follow-up|2
963056|NCT01147926|1962011|FG000|Overall Study|Sponsor's Decision|0
963057|NCT01147926|1962012|FG001|Overall Study|Sponsor's Decision|1
963058|NCT01147926|1962011|FG000|Overall Study|Lack of Efficacy|1
963059|NCT01147926|1962012|FG001|Overall Study|Lack of Efficacy|0
963060|NCT01147926|1962011|FG000|Overall Study|Too busy, no time for study|1
963061|NCT01147926|1962012|FG001|Overall Study|Too busy, no time for study|0
963062|NCT01147926|1962011|FG000|Overall Study|Went on holiday|0
963063|NCT01147926|1962012|FG001|Overall Study|Went on holiday|1
963064|NCT01147926|1962011|FG000|Overall Study|Colonoscopy result|0
963065|NCT01147926|1962012|FG001|Overall Study|Colonoscopy result|1
963066|NCT01148017|1962022|FG000|Overall Study|Withdrawal by Subject|31
963067|NCT01148017|1962023|FG001|Overall Study|Withdrawal by Subject|14
963068|NCT01148017|1962024|FG002|Overall Study|Withdrawal by Subject|0
963069|NCT01148017|1962025|FG003|Overall Study|Withdrawal by Subject|0
963070|NCT01148017|1962022|FG000|Overall Study|Lost to Follow-up|23
963071|NCT01148017|1962023|FG001|Overall Study|Lost to Follow-up|10
963072|NCT01148017|1962024|FG002|Overall Study|Lost to Follow-up|0
963073|NCT01148017|1962025|FG003|Overall Study|Lost to Follow-up|0
963074|NCT01148017|1962022|FG000|Overall Study|Inappropriate enrollment|1
963075|NCT01148017|1962023|FG001|Overall Study|Inappropriate enrollment|0
963076|NCT01148017|1962024|FG002|Overall Study|Inappropriate enrollment|0
963077|NCT01148017|1962025|FG003|Overall Study|Inappropriate enrollment|0
963078|NCT01148017|1962022|FG000|Overall Study|Administrative reason|22
963079|NCT01148017|1962023|FG001|Overall Study|Administrative reason|9
963080|NCT01148017|1962024|FG002|Overall Study|Administrative reason|0
911095|NCT00796653|1888248|FG001|Overall Study|Non compliance with protocol|2
911096|NCT00796653|1888249|FG002|Overall Study|Non compliance with protocol|0
911097|NCT00796653|1888250|FG003|Overall Study|Non compliance with protocol|2
911098|NCT00796653|1888247|FG000|Overall Study|Other reason not described above|4
911099|NCT00796653|1888248|FG001|Overall Study|Other reason not described above|9
911100|NCT00796653|1888249|FG002|Overall Study|Other reason not described above|7
911101|NCT00796653|1888250|FG003|Overall Study|Other reason not described above|4
963081|NCT01148017|1962025|FG003|Overall Study|Administrative reason|0
963082|NCT01148017|1962022|FG000|Overall Study|Unable to classify|3
963083|NCT01148017|1962023|FG001|Overall Study|Unable to classify|1
963084|NCT01148017|1962024|FG002|Overall Study|Unable to classify|0
963085|NCT01148017|1962025|FG003|Overall Study|Unable to classify|0
963086|NCT01148225|1962036|FG000|Overall Study|Other|185
963087|NCT01148459|1962050|FG000|Overall Study|Serious Adverse Event|5
963088|NCT01148459|1962051|FG001|Overall Study|Serious Adverse Event|4
963089|NCT01148459|1962050|FG000|Overall Study|Withdrawal by Subject|1
963090|NCT01148459|1962051|FG001|Overall Study|Withdrawal by Subject|0
963091|NCT01148459|1962050|FG000|Overall Study|Migrated/moved from study area|3
963092|NCT01148459|1962051|FG001|Overall Study|Migrated/moved from study area|6
963093|NCT01148459|1962050|FG000|Overall Study|Lost to Follow-up|2
963094|NCT01148459|1962051|FG001|Overall Study|Lost to Follow-up|0
963095|NCT01148459|1962050|FG000|Overall Study|Refusal|1
963096|NCT01148459|1962051|FG001|Overall Study|Refusal|0
963097|NCT01148459|1962050|FG000|Overall Study|Failure to comply with study procedures|0
963098|NCT01148459|1962051|FG001|Overall Study|Failure to comply with study procedures|1
963099|NCT01148511|1962059|FG000|Exposed to Study Drug|Protocol Violation|2
963100|NCT01148511|1962060|FG001|Exposed to Study Drug|Protocol Violation|0
963101|NCT01148511|1962061|FG002|Exposed to Study Drug|Protocol Violation|0
963102|NCT01148511|1962059|FG000|Exposed to Study Drug|Lost to Follow-up|4
963103|NCT01148511|1962060|FG001|Exposed to Study Drug|Lost to Follow-up|0
963104|NCT01148511|1962061|FG002|Exposed to Study Drug|Lost to Follow-up|0
963105|NCT01148511|1962059|FG000|Randomized|Adverse Event|0
963106|NCT01148511|1962060|FG001|Randomized|Adverse Event|1
963107|NCT01148511|1962061|FG002|Randomized|Adverse Event|0
963108|NCT01148511|1962059|FG000|Randomized|Protocol Violation|0
963109|NCT01148511|1962060|FG001|Randomized|Protocol Violation|2
963110|NCT01148511|1962061|FG002|Randomized|Protocol Violation|1
963111|NCT01148511|1962059|FG000|Randomized|Lost to Follow-up|0
963112|NCT01148511|1962060|FG001|Randomized|Lost to Follow-up|1
963113|NCT01148511|1962061|FG002|Randomized|Lost to Follow-up|1
963114|NCT01148511|1962059|FG000|Randomized|Consent withdrawal|0
963115|NCT01148511|1962060|FG001|Randomized|Consent withdrawal|5
963116|NCT01148511|1962061|FG002|Randomized|Consent withdrawal|3
963117|NCT01148511|1962059|FG000|Randomized|Other|0
963118|NCT01148511|1962060|FG001|Randomized|Other|1
963119|NCT01148511|1962061|FG002|Randomized|Other|1
963120|NCT01148537|1962108|FG000|Overall Study|Withdrawal by Subject|1
963121|NCT01148537|1962109|FG001|Overall Study|Withdrawal by Subject|0
963122|NCT01148537|1962110|FG002|Overall Study|Withdrawal by Subject|2
963123|NCT01148537|1962108|FG000|Overall Study|Adverse Event|2
963124|NCT01148537|1962109|FG001|Overall Study|Adverse Event|0
963125|NCT01148537|1962110|FG002|Overall Study|Adverse Event|1
963126|NCT01148693|1962131|FG000|Overall Study|Attempts for cannulation were failed|13
963127|NCT01148693|1962132|FG001|Overall Study|Attempts for cannulation were failed|10
963128|NCT01148771|1962146|FG000|Washout Period|Withdrawal by Subject|0
963129|NCT01148771|1962147|FG001|Washout Period|Withdrawal by Subject|1
963130|NCT01148810|1962159|FG000|Overall Study|Adverse Event|0
963131|NCT01148810|1962160|FG001|Overall Study|Adverse Event|2
963132|NCT01148810|1962159|FG000|Overall Study|Lack of Efficacy|0
963133|NCT01148810|1962160|FG001|Overall Study|Lack of Efficacy|1
963134|NCT01148810|1962159|FG000|Overall Study|Withdrawal by Subject|0
963135|NCT01148810|1962160|FG001|Overall Study|Withdrawal by Subject|2
963136|NCT01148810|1962159|FG000|Overall Study|Protocol Violation|1
963137|NCT01148810|1962160|FG001|Overall Study|Protocol Violation|0
963138|NCT01148862|1962176|FG000|Second Intervention|Withdrawal by Subject|0
963139|NCT01148862|1962177|FG001|Second Intervention|Withdrawal by Subject|2
963140|NCT01148979|1962197|FG000|Overall Study|Lost to Follow-up|0
963141|NCT01148979|1962198|FG001|Overall Study|Lost to Follow-up|1
963142|NCT01149057|1962204|FG000|Overall Study|Lack of Efficacy|16
963143|NCT01149057|1962204|FG000|Overall Study|Adverse Event|13
963144|NCT01149057|1962204|FG000|Overall Study|Withdrawal by Subject|9
963145|NCT01149057|1962204|FG000|Overall Study|Positive Hepatitis B Core Antibody|5
963146|NCT01149057|1962204|FG000|Overall Study|B Cell Depletion|4
963147|NCT01149057|1962204|FG000|Overall Study|Participant Non-Compliance|2
963148|NCT01149057|1962204|FG000|Overall Study|Lost to Follow-up|1
963149|NCT01149057|1962204|FG000|Overall Study|High Parathyroid Hormone Value|1
963150|NCT01149057|1962204|FG000|Overall Study|Other|6
963151|NCT01149096|1962210|FG000|Overall Study|Lost to Follow-up|0
963152|NCT01149096|1962211|FG001|Overall Study|Lost to Follow-up|1
963153|NCT01149148|1962220|FG000|Overall Study|Lost to Follow-up|1
963154|NCT01149148|1962221|FG001|Overall Study|Lost to Follow-up|2
963155|NCT01149148|1962220|FG000|Overall Study|Death|1
963156|NCT01149148|1962221|FG001|Overall Study|Death|0
963157|NCT01149343|1962232|FG000|Overall Study|Withdrawal by Subject|1
963158|NCT01149343|1962233|FG001|Overall Study|Withdrawal by Subject|1
963159|NCT01149343|1962234|FG002|Overall Study|Withdrawal by Subject|1
963160|NCT01149343|1962235|FG003|Overall Study|Withdrawal by Subject|5
963161|NCT01149343|1962232|FG000|Overall Study|Death|10
963162|NCT01149343|1962233|FG001|Overall Study|Death|13
963163|NCT01149343|1962234|FG002|Overall Study|Death|18
963164|NCT01149343|1962235|FG003|Overall Study|Death|18
963165|NCT01149343|1962232|FG000|Overall Study|Lost to Follow-up|1
963166|NCT01149343|1962233|FG001|Overall Study|Lost to Follow-up|0
963167|NCT01149343|1962234|FG002|Overall Study|Lost to Follow-up|0
963168|NCT01149343|1962235|FG003|Overall Study|Lost to Follow-up|1
963169|NCT01149343|1962232|FG000|Overall Study|Other|8
963170|NCT01149343|1962233|FG001|Overall Study|Other|10
963171|NCT01149343|1962234|FG002|Overall Study|Other|2
963172|NCT01149343|1962235|FG003|Overall Study|Other|14
963173|NCT01149343|1962232|FG000|Overall Study|Sponsor study termination|0
963174|NCT01149343|1962233|FG001|Overall Study|Sponsor study termination|0
963175|NCT01149343|1962234|FG002|Overall Study|Sponsor study termination|0
963176|NCT01149343|1962235|FG003|Overall Study|Sponsor study termination|2
963177|NCT01149343|1962232|FG000|Overall Study|Recurrence / Progressive disease|0
963178|NCT01149343|1962233|FG001|Overall Study|Recurrence / Progressive disease|0
963179|NCT01149343|1962234|FG002|Overall Study|Recurrence / Progressive disease|1
963180|NCT01149343|1962235|FG003|Overall Study|Recurrence / Progressive disease|0
963181|NCT01149369|1962251|FG000|Overall Study|Adverse Event|6
963182|NCT01149369|1962252|FG001|Overall Study|Adverse Event|3
963183|NCT01149421|1962261|FG000|Overall Study|Adverse Event|22
963184|NCT01149421|1962262|FG001|Overall Study|Adverse Event|6
963185|NCT01149421|1962263|FG002|Overall Study|Adverse Event|11
963186|NCT01149421|1962261|FG000|Overall Study|Withdrawal by Subject|20
963187|NCT01149421|1962262|FG001|Overall Study|Withdrawal by Subject|12
963188|NCT01149421|1962263|FG002|Overall Study|Withdrawal by Subject|13
963189|NCT01149421|1962261|FG000|Overall Study|Sponsor Decision|0
963190|NCT01149421|1962262|FG001|Overall Study|Sponsor Decision|1
963191|NCT01149421|1962263|FG002|Overall Study|Sponsor Decision|1
963192|NCT01149421|1962261|FG000|Overall Study|Lost to Follow-up|2
963193|NCT01149421|1962262|FG001|Overall Study|Lost to Follow-up|4
963194|NCT01149421|1962263|FG002|Overall Study|Lost to Follow-up|5
963195|NCT01149421|1962261|FG000|Overall Study|Physician Decision|5
963196|NCT01149421|1962262|FG001|Overall Study|Physician Decision|3
963197|NCT01149421|1962263|FG002|Overall Study|Physician Decision|6
963198|NCT01149421|1962261|FG000|Overall Study|Entry Criteria Not Met|1
963199|NCT01149421|1962262|FG001|Overall Study|Entry Criteria Not Met|1
963200|NCT01149421|1962263|FG002|Overall Study|Entry Criteria Not Met|2
963201|NCT01149421|1962261|FG000|Overall Study|Protocol Violation|2
963202|NCT01149421|1962262|FG001|Overall Study|Protocol Violation|2
963203|NCT01149421|1962263|FG002|Overall Study|Protocol Violation|6
963204|NCT01149460|1962283|FG000|Overall Study|Withdrawal by Subject|0
963205|NCT01149460|1962284|FG001|Overall Study|Withdrawal by Subject|2
963206|NCT01149473|1962292|FG000|First Intervention|Adverse Event|1
963207|NCT01149473|1962293|FG001|First Intervention|Adverse Event|1
963208|NCT01149473|1962292|FG000|Washout of 7 Days|Withdrawal by Subject|1
963209|NCT01149473|1962293|FG001|Washout of 7 Days|Withdrawal by Subject|1
963210|NCT01149486|1962301|FG000|First Intervention|Adverse Event|0
963211|NCT01149486|1962302|FG001|First Intervention|Adverse Event|1
963212|NCT01149538|1962314|FG000|Overall Study|Lost to Follow-up|0
963213|NCT01149538|1962315|FG001|Overall Study|Lost to Follow-up|1
963214|NCT01149538|1962314|FG000|Overall Study|Withdrawal by Subject|5
963215|NCT01149538|1962315|FG001|Overall Study|Withdrawal by Subject|3
963216|NCT01149655|1962334|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1
963217|NCT01149655|1962335|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0
963218|NCT01149655|1962336|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0
963219|NCT01149655|1962337|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0
963220|NCT01149655|1962334|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
963221|NCT01149655|1962335|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
963222|NCT01149655|1962336|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
963223|NCT01149655|1962337|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
963224|NCT01149655|1962334|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
963225|NCT01149655|1962335|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
963226|NCT01149655|1962336|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
963227|NCT01149655|1962337|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
963228|NCT01149655|1962334|FG000|Period 1 - Conversion Phase|Physician Decision|2
963229|NCT01149655|1962335|FG001|Period 1 - Conversion Phase|Physician Decision|0
963230|NCT01149655|1962336|FG002|Period 1 - Conversion Phase|Physician Decision|0
963231|NCT01149655|1962337|FG003|Period 1 - Conversion Phase|Physician Decision|0
963232|NCT01149655|1962334|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
963233|NCT01149655|1962335|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
963234|NCT01149655|1962336|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0
963235|NCT01149655|1962337|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0
963236|NCT01149655|1962334|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
963237|NCT01149655|1962335|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
963238|NCT01149655|1962336|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
963239|NCT01149655|1962337|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
963240|NCT01149655|1962334|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
963241|NCT01149655|1962335|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
963242|NCT01149655|1962336|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
963243|NCT01149655|1962337|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
963244|NCT01149655|1962334|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
963245|NCT01149655|1962335|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
963246|NCT01149655|1962336|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
963247|NCT01149655|1962337|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
963248|NCT01149655|1962334|FG000|Period 2-Stabilization Phase|Physician Decision|0
963249|NCT01149655|1962335|FG001|Period 2-Stabilization Phase|Physician Decision|3
963250|NCT01149655|1962336|FG002|Period 2-Stabilization Phase|Physician Decision|0
963251|NCT01149655|1962337|FG003|Period 2-Stabilization Phase|Physician Decision|0
963252|NCT01149655|1962334|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0
963253|NCT01149655|1962335|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5
963254|NCT01149655|1962336|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0
963255|NCT01149655|1962337|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0
963256|NCT01149655|1962334|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
963257|NCT01149655|1962335|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
963258|NCT01149655|1962336|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
963259|NCT01149655|1962337|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
963260|NCT01149655|1962334|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
963261|NCT01149655|1962335|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
963262|NCT01149655|1962336|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
963263|NCT01149655|1962337|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
963264|NCT01149655|1962334|FG000|Period 3-DB Maintenance Phase|Physician Decision|0
963265|NCT01149655|1962335|FG001|Period 3-DB Maintenance Phase|Physician Decision|0
963266|NCT01149655|1962336|FG002|Period 3-DB Maintenance Phase|Physician Decision|1
963267|NCT01149655|1962337|FG003|Period 3-DB Maintenance Phase|Physician Decision|0
963268|NCT01149655|1962334|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
963269|NCT01149655|1962335|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
963270|NCT01149655|1962336|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
963271|NCT01149655|1962337|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
963272|NCT01149655|1962334|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
963273|NCT01149655|1962335|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
963274|NCT01149655|1962336|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
963275|NCT01149655|1962337|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
963276|NCT01149655|1962334|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0
963277|NCT01149655|1962335|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0
963278|NCT01149655|1962336|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19
963279|NCT01149655|1962337|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18
963280|NCT01149681|1962345|FG000|Overall Study|Withdrawal by Subject|7
963281|NCT01149681|1962345|FG000|Overall Study|Progressive disease|1
963282|NCT01149681|1962345|FG000|Overall Study|Physician Decision|2
963283|NCT01149681|1962345|FG000|Overall Study|adverse events nonrelated study drug|2
963284|NCT01149863|1962381|FG000|Overall Study|Missing data or Not receiveing studydrug|3
911102|NCT00796666|1888270|FG000|Overall Study|Death|2
911103|NCT00796666|1888271|FG001|Overall Study|Death|4
911104|NCT00796666|1888270|FG000|Overall Study|Withdrawal by Subject|2
911105|NCT00796666|1888271|FG001|Overall Study|Withdrawal by Subject|0
911106|NCT00796666|1888270|FG000|Overall Study|Adverse Event|7
911107|NCT00796666|1888271|FG001|Overall Study|Adverse Event|5
911108|NCT00796666|1888270|FG000|Overall Study|Protocol Violation|1
911109|NCT00796666|1888271|FG001|Overall Study|Protocol Violation|0
911110|NCT00796666|1888270|FG000|Overall Study|Other|1
911111|NCT00796666|1888271|FG001|Overall Study|Other|0
911112|NCT00796666|1888270|FG000|Overall Study|Terminated by sponsor|53
911113|NCT00796666|1888271|FG001|Overall Study|Terminated by sponsor|55
963285|NCT01150045|1962407|FG000|Overall Study|Protocol Violation|0
963286|NCT01150045|1962408|FG001|Overall Study|Protocol Violation|1
963287|NCT01150045|1962409|FG002|Overall Study|Protocol Violation|0
963288|NCT01150045|1962410|FG003|Overall Study|Protocol Violation|1
963289|NCT01150097|1962421|FG000|Months 24 to 36 Post-transplantation|Death|2
963290|NCT01150097|1962422|FG001|Months 24 to 36 Post-transplantation|Death|0
963291|NCT01150097|1962423|FG002|Months 24 to 36 Post-transplantation|Death|0
963292|NCT01150097|1962421|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5
963293|NCT01150097|1962422|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2
963294|NCT01150097|1962423|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2
963295|NCT01150097|1962421|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
963296|NCT01150097|1962422|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
963297|NCT01150097|1962423|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
963298|NCT01150097|1962421|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
963299|NCT01150097|1962422|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
1006621|NCT01468701|2025296|FG011|Overall Study|Not being followed up|0
963300|NCT01150097|1962423|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
963301|NCT01150097|1962421|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5
963302|NCT01150097|1962422|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4
963303|NCT01150097|1962423|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0
963304|NCT01150097|1962421|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
963305|NCT01150097|1962422|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
963306|NCT01150097|1962423|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
963307|NCT01150097|1962421|FG000|Months 24 to 48 Post-transplantation|Death|2
963308|NCT01150097|1962422|FG001|Months 24 to 48 Post-transplantation|Death|0
963309|NCT01150097|1962423|FG002|Months 24 to 48 Post-transplantation|Death|0
963310|NCT01150123|1962451|FG000|Overall Study|Withdrawal by Subject|1
963311|NCT01150123|1962452|FG001|Overall Study|Withdrawal by Subject|1
963312|NCT01150123|1962453|FG002|Overall Study|Withdrawal by Subject|2
963313|NCT01150123|1962454|FG003|Overall Study|Withdrawal by Subject|1
963314|NCT01150123|1962455|FG004|Overall Study|Withdrawal by Subject|1
963315|NCT01150123|1962456|FG005|Overall Study|Withdrawal by Subject|1
963316|NCT01150123|1962457|FG006|Overall Study|Withdrawal by Subject|0
963317|NCT01150123|1962458|FG007|Overall Study|Withdrawal by Subject|3
963318|NCT01150123|1962459|FG008|Overall Study|Withdrawal by Subject|2
963319|NCT01150123|1962460|FG009|Overall Study|Withdrawal by Subject|0
963320|NCT01150123|1962461|FG010|Overall Study|Withdrawal by Subject|1
963321|NCT01150123|1962462|FG011|Overall Study|Withdrawal by Subject|0
963322|NCT01150123|1962463|FG012|Overall Study|Withdrawal by Subject|1
963323|NCT01150123|1962464|FG013|Overall Study|Withdrawal by Subject|0
963324|NCT01150123|1962465|FG014|Overall Study|Withdrawal by Subject|0
963325|NCT01150123|1962466|FG015|Overall Study|Withdrawal by Subject|1
963326|NCT01150123|1962467|FG016|Overall Study|Withdrawal by Subject|0
963327|NCT01150123|1962468|FG017|Overall Study|Withdrawal by Subject|1
963328|NCT01150123|1962451|FG000|Overall Study|Lost to Follow-up|2
963329|NCT01150123|1962452|FG001|Overall Study|Lost to Follow-up|1
963330|NCT01150123|1962453|FG002|Overall Study|Lost to Follow-up|2
963331|NCT01150123|1962454|FG003|Overall Study|Lost to Follow-up|2
963332|NCT01150123|1962455|FG004|Overall Study|Lost to Follow-up|2
963333|NCT01150123|1962456|FG005|Overall Study|Lost to Follow-up|5
963334|NCT01150123|1962457|FG006|Overall Study|Lost to Follow-up|0
963335|NCT01150123|1962458|FG007|Overall Study|Lost to Follow-up|0
963336|NCT01150123|1962459|FG008|Overall Study|Lost to Follow-up|3
963337|NCT01150123|1962460|FG009|Overall Study|Lost to Follow-up|1
963338|NCT01150123|1962461|FG010|Overall Study|Lost to Follow-up|1
963339|NCT01150123|1962462|FG011|Overall Study|Lost to Follow-up|1
963340|NCT01150123|1962463|FG012|Overall Study|Lost to Follow-up|2
963341|NCT01150123|1962464|FG013|Overall Study|Lost to Follow-up|0
963342|NCT01150123|1962465|FG014|Overall Study|Lost to Follow-up|0
963343|NCT01150123|1962466|FG015|Overall Study|Lost to Follow-up|0
963344|NCT01150123|1962467|FG016|Overall Study|Lost to Follow-up|0
963345|NCT01150123|1962468|FG017|Overall Study|Lost to Follow-up|0
963346|NCT01150357|1962528|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0
963347|NCT01150357|1962529|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1
963348|NCT01150357|1962530|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1
963349|NCT01150357|1962528|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
963350|NCT01150357|1962529|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
963351|NCT01150357|1962530|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
963352|NCT01150357|1962528|FG000|Dose Response Phase (Phase 1)|Adverse Event|0
963353|NCT01150357|1962529|FG001|Dose Response Phase (Phase 1)|Adverse Event|0
963354|NCT01150357|1962530|FG002|Dose Response Phase (Phase 1)|Adverse Event|1
963355|NCT01150357|1962528|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
963356|NCT01150357|1962529|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
963357|NCT01150357|1962530|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
963358|NCT01150357|1962528|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
963359|NCT01150357|1962529|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
963360|NCT01150357|1962530|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
963361|NCT01150357|1962528|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
963362|NCT01150357|1962529|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
963363|NCT01150357|1962530|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
963364|NCT01150357|1962528|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
963365|NCT01150357|1962529|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
963366|NCT01150357|1962530|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
963367|NCT01150474|1962561|FG000|Overall Study|Withdrawal by Subject|5
963368|NCT01150474|1962562|FG001|Overall Study|Withdrawal by Subject|2
963369|NCT01150474|1962561|FG000|Overall Study|Cancer found|1
963370|NCT01150474|1962562|FG001|Overall Study|Cancer found|0
963371|NCT01150474|1962561|FG000|Overall Study|Multiple Studies|0
963372|NCT01150474|1962562|FG001|Overall Study|Multiple Studies|1
963373|NCT01150474|1962561|FG000|Overall Study|Rectotomy|1
963374|NCT01150474|1962562|FG001|Overall Study|Rectotomy|0
963375|NCT01150474|1962561|FG000|Overall Study|Drug did not arrive in time|1
963376|NCT01150474|1962562|FG001|Overall Study|Drug did not arrive in time|0
963377|NCT01150474|1962561|FG000|Overall Study|Drug not administered|1
963378|NCT01150474|1962562|FG001|Overall Study|Drug not administered|0
963379|NCT01150474|1962561|FG000|Overall Study|Surgery Changed|1
963380|NCT01150474|1962562|FG001|Overall Study|Surgery Changed|0
963381|NCT01151020|1962617|FG000|Overall Study|Death|25
963382|NCT01151020|1962617|FG000|Overall Study|Conversion to open repair|1
963383|NCT01151020|1962617|FG000|Overall Study|Lost to Follow-up|4
963384|NCT01151020|1962617|FG000|Overall Study|Withdrawal by Subject|22
963385|NCT01151020|1962617|FG000|Overall Study|Patients did not receive the device|2
963386|NCT01151085|1962634|FG000|Overall Study|Lost to Follow-up|31
963387|NCT01151085|1962634|FG000|Overall Study|Protocol Violation|25
963388|NCT01151098|1962645|FG000|Overall Study|Adverse Event|82
963389|NCT01151098|1962645|FG000|Overall Study|Lost to Follow-up|6
963390|NCT01151098|1962645|FG000|Overall Study|Lack of Efficacy|15
963391|NCT01151098|1962645|FG000|Overall Study|Protocol Violation|1
963392|NCT01151098|1962645|FG000|Overall Study|Miscellaneous|13
963393|NCT01151137|1962651|FG000|Overall Study|Death|15
963394|NCT01151137|1962652|FG001|Overall Study|Death|27
963395|NCT01151137|1962651|FG000|Overall Study|Lost to Follow-up|1
963396|NCT01151137|1962652|FG001|Overall Study|Lost to Follow-up|1
963397|NCT01151215|1962670|FG000|Overall Study|Worsening of condition under study|1
963398|NCT01151215|1962671|FG001|Overall Study|Worsening of condition under study|1
963399|NCT01151215|1962672|FG002|Overall Study|Worsening of condition under study|1
963400|NCT01151215|1962670|FG000|Overall Study|Death|16
963401|NCT01151215|1962671|FG001|Overall Study|Death|20
963402|NCT01151215|1962672|FG002|Overall Study|Death|11
963403|NCT01151215|1962670|FG000|Overall Study|Lost to Follow-up|0
963404|NCT01151215|1962671|FG001|Overall Study|Lost to Follow-up|0
963405|NCT01151215|1962672|FG002|Overall Study|Lost to Follow-up|3
963406|NCT01151215|1962670|FG000|Overall Study|Withdrawal by Subject|3
963407|NCT01151215|1962671|FG001|Overall Study|Withdrawal by Subject|1
963408|NCT01151215|1962672|FG002|Overall Study|Withdrawal by Subject|2
963409|NCT01151215|1962670|FG000|Overall Study|Disease progression|0
963410|NCT01151215|1962671|FG001|Overall Study|Disease progression|1
963411|NCT01151215|1962672|FG002|Overall Study|Disease progression|1
963412|NCT01151215|1962670|FG000|Overall Study|Safety as judged by the investigator|0
963413|NCT01151215|1962671|FG001|Overall Study|Safety as judged by the investigator|0
963414|NCT01151215|1962672|FG002|Overall Study|Safety as judged by the investigator|1
963415|NCT01151280|1962680|FG000|Overall Study|Adverse Event|1
963416|NCT01151280|1962680|FG000|Overall Study|Lack of Efficacy|3
963417|NCT01151345|1962684|FG000|First Intervention Period|Protocol Violation|0
963418|NCT01151345|1962685|FG001|First Intervention Period|Protocol Violation|1
963419|NCT01151410|1962706|FG000|Overall Study|Withdrawal by Subject|3
963420|NCT01151410|1962707|FG001|Overall Study|Withdrawal by Subject|5
963421|NCT01151410|1962706|FG000|Overall Study|Lost to Follow-up|3
963422|NCT01151410|1962707|FG001|Overall Study|Lost to Follow-up|4
963423|NCT01151410|1962706|FG000|Overall Study|Adverse Event|1
963424|NCT01151410|1962707|FG001|Overall Study|Adverse Event|2
963425|NCT01151410|1962706|FG000|Overall Study|Protocol deviation|2
963426|NCT01151410|1962707|FG001|Overall Study|Protocol deviation|1
963427|NCT01151410|1962706|FG000|Overall Study|Administrative problems|1
963428|NCT01151410|1962707|FG001|Overall Study|Administrative problems|1
963429|NCT01151410|1962706|FG000|Overall Study|Unsatisfactory therapeutic effect|1
963430|NCT01151410|1962707|FG001|Overall Study|Unsatisfactory therapeutic effect|1
963431|NCT01151410|1962706|FG000|Overall Study|Abnormal laboratory value(s)|0
963432|NCT01151410|1962707|FG001|Overall Study|Abnormal laboratory value(s)|1
963433|NCT01151423|1962715|FG000|Overall Study|Study terminated by Sponsor|9
963434|NCT01151423|1962716|FG001|Overall Study|Study terminated by Sponsor|10
963435|NCT01151423|1962715|FG000|Overall Study|Protocol Violation|0
963436|NCT01151423|1962716|FG001|Overall Study|Protocol Violation|1
963437|NCT01151423|1962715|FG000|Overall Study|Physician Decision|1
963438|NCT01151423|1962716|FG001|Overall Study|Physician Decision|1
963439|NCT01151423|1962715|FG000|Overall Study|Pregnancy|0
963440|NCT01151423|1962716|FG001|Overall Study|Pregnancy|1
963441|NCT01151423|1962715|FG000|Overall Study|Death|0
963442|NCT01151423|1962716|FG001|Overall Study|Death|1
963443|NCT01151423|1962715|FG000|Overall Study|Adverse Event|3
963444|NCT01151423|1962716|FG001|Overall Study|Adverse Event|0
963445|NCT01151423|1962715|FG000|Overall Study|Withdrawal by Subject|1
963446|NCT01151423|1962716|FG001|Overall Study|Withdrawal by Subject|3
963447|NCT01151423|1962715|FG000|Overall Study|Lost to Follow-up|1
963448|NCT01151423|1962716|FG001|Overall Study|Lost to Follow-up|0
963449|NCT01151423|1962715|FG000|Overall Study|Diagnosed as non-TTP patient|0
963450|NCT01151423|1962716|FG001|Overall Study|Diagnosed as non-TTP patient|1
963451|NCT01151423|1962715|FG000|Overall Study|Participated in other clinical trial|1
963452|NCT01151423|1962716|FG001|Overall Study|Participated in other clinical trial|0
963453|NCT01151540|1962730|FG000|Overall Study|Other|2
963454|NCT01151540|1962730|FG000|Overall Study|Adverse event, non-fatal|4
963455|NCT01151540|1962730|FG000|Overall Study|Withdrawal by Subject|7
963456|NCT01151579|1962736|FG000|Overall Study|Physician Decision|3
963457|NCT01151579|1962737|FG001|Overall Study|Physician Decision|1
963458|NCT01151579|1962736|FG000|Overall Study|Withdrawal by Subject|3
963459|NCT01151579|1962737|FG001|Overall Study|Withdrawal by Subject|2
963460|NCT01151579|1962736|FG000|Overall Study|Not meet inclusion criteria|6
963461|NCT01151579|1962737|FG001|Overall Study|Not meet inclusion criteria|4
963462|NCT01151618|1962743|FG000|Overall Study|Adverse Event|2
963463|NCT01151618|1962743|FG000|Overall Study|Withdrawal by Subject|7
963464|NCT01152021|1962770|FG000|Overall Study|Adverse Event|4
963465|NCT01152021|1962771|FG001|Overall Study|Adverse Event|4
963466|NCT01152021|1962770|FG000|Overall Study|Study drug had expired|1
963467|NCT01152021|1962771|FG001|Overall Study|Study drug had expired|0
963468|NCT01152021|1962770|FG000|Overall Study|Physician Decision|1
963469|NCT01152021|1962771|FG001|Overall Study|Physician Decision|1
963470|NCT01152021|1962770|FG000|Overall Study|No access to study drug in Pharmacy|0
963471|NCT01152021|1962771|FG001|Overall Study|No access to study drug in Pharmacy|1
963472|NCT01152190|1962790|FG000|Overall Study|Adverse Event|2
963473|NCT01152190|1962791|FG001|Overall Study|Adverse Event|4
963474|NCT01152190|1962790|FG000|Overall Study|Death|1
963475|NCT01152190|1962791|FG001|Overall Study|Death|0
963476|NCT01152190|1962790|FG000|Overall Study|Protocol Violation|1
963477|NCT01152190|1962791|FG001|Overall Study|Protocol Violation|1
963478|NCT01152190|1962790|FG000|Overall Study|Withdrawal by Subject|1
963479|NCT01152190|1962791|FG001|Overall Study|Withdrawal by Subject|3
963480|NCT01152385|1962828|FG000|Overall Study|Withdrawal by Subject|3
963481|NCT01152385|1962829|FG001|Overall Study|Withdrawal by Subject|1
963482|NCT01152385|1962830|FG002|Overall Study|Withdrawal by Subject|1
963483|NCT01152385|1962831|FG003|Overall Study|Withdrawal by Subject|1
963484|NCT01152385|1962828|FG000|Overall Study|Protocol Violation|0
963485|NCT01152385|1962829|FG001|Overall Study|Protocol Violation|0
963486|NCT01152385|1962830|FG002|Overall Study|Protocol Violation|0
963487|NCT01152385|1962831|FG003|Overall Study|Protocol Violation|1
963488|NCT01152385|1962828|FG000|Overall Study|Adverse Event|1
963489|NCT01152385|1962829|FG001|Overall Study|Adverse Event|1
963490|NCT01152385|1962830|FG002|Overall Study|Adverse Event|0
963491|NCT01152385|1962831|FG003|Overall Study|Adverse Event|0
963492|NCT01152385|1962828|FG000|Overall Study|Study-specific withdrawal criteria|1
963493|NCT01152385|1962829|FG001|Overall Study|Study-specific withdrawal criteria|1
963494|NCT01152385|1962830|FG002|Overall Study|Study-specific withdrawal criteria|2
963495|NCT01152385|1962831|FG003|Overall Study|Study-specific withdrawal criteria|0
963496|NCT01152385|1962828|FG000|Overall Study|Other|4
963497|NCT01152385|1962829|FG001|Overall Study|Other|3
963498|NCT01152385|1962830|FG002|Overall Study|Other|2
963499|NCT01152385|1962831|FG003|Overall Study|Other|3
963500|NCT01152437|1962848|FG000|Overall Study|Other Adverse Event|8
963501|NCT01152437|1962849|FG001|Overall Study|Other Adverse Event|1
963502|NCT01152437|1962850|FG002|Overall Study|Other Adverse Event|7
963503|NCT01152437|1962848|FG000|Overall Study|Not treated|0
963504|NCT01152437|1962849|FG001|Overall Study|Not treated|1
963505|NCT01152437|1962850|FG002|Overall Study|Not treated|2
963506|NCT01152437|1962848|FG000|Overall Study|Progressive disease|27
963507|NCT01152437|1962849|FG001|Overall Study|Progressive disease|13
963508|NCT01152437|1962850|FG002|Overall Study|Progressive disease|32
963509|NCT01152437|1962848|FG000|Overall Study|Refusal to continue taking trial medicat|1
963510|NCT01152437|1962849|FG001|Overall Study|Refusal to continue taking trial medicat|0
963511|NCT01152437|1962850|FG002|Overall Study|Refusal to continue taking trial medicat|2
963512|NCT01152450|1962860|FG000|Period 1 (4 Weeks)|Adverse Event|0
963513|NCT01152450|1962861|FG001|Period 1 (4 Weeks)|Adverse Event|0
963514|NCT01152450|1962862|FG002|Period 1 (4 Weeks)|Adverse Event|0
963515|NCT01152450|1962863|FG003|Period 1 (4 Weeks)|Adverse Event|0
963516|NCT01152450|1962864|FG004|Period 1 (4 Weeks)|Adverse Event|1
963517|NCT01152450|1962865|FG005|Period 1 (4 Weeks)|Adverse Event|1
963518|NCT01152450|1962860|FG000|Period 1 (4 Weeks)|Protocol Violation|0
963519|NCT01152450|1962861|FG001|Period 1 (4 Weeks)|Protocol Violation|0
963520|NCT01152450|1962862|FG002|Period 1 (4 Weeks)|Protocol Violation|0
963521|NCT01152450|1962863|FG003|Period 1 (4 Weeks)|Protocol Violation|0
963522|NCT01152450|1962864|FG004|Period 1 (4 Weeks)|Protocol Violation|1
963523|NCT01152450|1962865|FG005|Period 1 (4 Weeks)|Protocol Violation|0
963524|NCT01152450|1962860|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0
963525|NCT01152450|1962861|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1
963526|NCT01152450|1962862|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1
963527|NCT01152450|1962863|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
963528|NCT01152450|1962864|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
963529|NCT01152450|1962865|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0
963530|NCT01152554|1962884|FG000|Overall Study|Withdrawal by Subject|73
963531|NCT01152554|1962885|FG001|Overall Study|Withdrawal by Subject|28
963532|NCT01152554|1962884|FG000|Overall Study|Eligiblity criteria not fulfilled|0
963533|NCT01152554|1962885|FG001|Overall Study|Eligiblity criteria not fulfilled|1
963534|NCT01152554|1962884|FG000|Overall Study|Adverse Event|67
963535|NCT01152554|1962885|FG001|Overall Study|Adverse Event|14
963536|NCT01152554|1962884|FG000|Overall Study|Severe non-compliance to protocol|36
963537|NCT01152554|1962885|FG001|Overall Study|Severe non-compliance to protocol|14
963538|NCT01152554|1962884|FG000|Overall Study|Condition under investigation worsened|5
963539|NCT01152554|1962885|FG001|Overall Study|Condition under investigation worsened|2
963540|NCT01152554|1962884|FG000|Overall Study|Lack of Efficacy|20
963541|NCT01152554|1962885|FG001|Overall Study|Lack of Efficacy|3
963542|NCT01152554|1962884|FG000|Overall Study|Study-specific withdrawal criteria|17
963543|NCT01152554|1962885|FG001|Overall Study|Study-specific withdrawal criteria|8
963544|NCT01152554|1962884|FG000|Overall Study|Lost to Follow-up|87
963545|NCT01152554|1962885|FG001|Overall Study|Lost to Follow-up|32
963546|NCT01152554|1962884|FG000|Overall Study|Other|28
963547|NCT01152554|1962885|FG001|Overall Study|Other|8
963548|NCT01152554|1962884|FG000|Overall Study|Death|1
963549|NCT01152554|1962885|FG001|Overall Study|Death|1
963550|NCT01152580|1962893|FG000|Overall Study|Withdrawal by Subject|0
963551|NCT01152580|1962894|FG001|Overall Study|Withdrawal by Subject|1
963552|NCT01152788|1962906|FG000|Overall Study|Withdrawal by Subject|0
963553|NCT01152788|1962907|FG001|Overall Study|Withdrawal by Subject|3
963554|NCT01152788|1962906|FG000|Overall Study|No treatment|0
963555|NCT01152788|1962907|FG001|Overall Study|No treatment|1
963556|NCT01152814|1962913|FG000|Overall Study|Lost to Follow-up|2
963557|NCT01152996|1962917|FG000|Overall Study|Withdrawal by Subject|142
963558|NCT01152996|1962917|FG000|Overall Study|Adverse Event|115
963559|NCT01152996|1962917|FG000|Overall Study|Lost to Follow-up|112
963560|NCT01152996|1962917|FG000|Overall Study|Lack of Efficacy|68
963561|NCT01152996|1962917|FG000|Overall Study|Noncompliance|41
963562|NCT01152996|1962917|FG000|Overall Study|Other|36
963563|NCT01152996|1962917|FG000|Overall Study|Protocol Violation|22
963564|NCT01152996|1962917|FG000|Overall Study|Elevated liver enzymes|1
963565|NCT01153009|1962925|FG000|Overall Study|Adverse Event|4
963566|NCT01153009|1962926|FG001|Overall Study|Adverse Event|14
963567|NCT01153009|1962927|FG002|Overall Study|Adverse Event|14
963568|NCT01153009|1962928|FG003|Overall Study|Adverse Event|10
963569|NCT01153009|1962925|FG000|Overall Study|Lack of Efficacy|9
963570|NCT01153009|1962926|FG001|Overall Study|Lack of Efficacy|0
963571|NCT01153009|1962927|FG002|Overall Study|Lack of Efficacy|2
963572|NCT01153009|1962928|FG003|Overall Study|Lack of Efficacy|1
963573|NCT01153009|1962925|FG000|Overall Study|Noncompliance with Study Medication|1
963574|NCT01153009|1962926|FG001|Overall Study|Noncompliance with Study Medication|3
963575|NCT01153009|1962927|FG002|Overall Study|Noncompliance with Study Medication|4
963576|NCT01153009|1962928|FG003|Overall Study|Noncompliance with Study Medication|1
963577|NCT01153009|1962925|FG000|Overall Study|Protocol Deviations|4
963578|NCT01153009|1962926|FG001|Overall Study|Protocol Deviations|3
963579|NCT01153009|1962927|FG002|Overall Study|Protocol Deviations|3
963580|NCT01153009|1962928|FG003|Overall Study|Protocol Deviations|2
963581|NCT01153009|1962925|FG000|Overall Study|Withdrawal of Consent|5
963582|NCT01153009|1962926|FG001|Overall Study|Withdrawal of Consent|5
963583|NCT01153009|1962927|FG002|Overall Study|Withdrawal of Consent|4
963584|NCT01153009|1962928|FG003|Overall Study|Withdrawal of Consent|6
963585|NCT01153009|1962925|FG000|Overall Study|Lost to Follow-up|8
963586|NCT01153009|1962926|FG001|Overall Study|Lost to Follow-up|8
963587|NCT01153009|1962927|FG002|Overall Study|Lost to Follow-up|11
963588|NCT01153009|1962928|FG003|Overall Study|Lost to Follow-up|15
963589|NCT01153009|1962925|FG000|Overall Study|Other|1
963590|NCT01153009|1962926|FG001|Overall Study|Other|1
963591|NCT01153009|1962927|FG002|Overall Study|Other|3
963592|NCT01153009|1962928|FG003|Overall Study|Other|2
963593|NCT01153269|1962938|FG000|Overall Study|Withdrawal by Subject|1
963594|NCT01153269|1962938|FG000|Overall Study|Antiretroviral therapy break|1
963595|NCT01153321|1962947|FG000|Overall Study|Development of study withdrawal criteria|0
963596|NCT01153321|1962948|FG001|Overall Study|Development of study withdrawal criteria|1
963597|NCT01153321|1962947|FG000|Overall Study|Withdrawal by Subject|0
963598|NCT01153321|1962948|FG001|Overall Study|Withdrawal by Subject|1
963599|NCT01153321|1962947|FG000|Overall Study|Adverse Event|1
963600|NCT01153321|1962948|FG001|Overall Study|Adverse Event|1
963601|NCT01153347|1962958|FG000|Overall Study|Withdrawal by Subject|7
963602|NCT01153347|1962959|FG001|Overall Study|Withdrawal by Subject|7
963603|NCT01153347|1962960|FG002|Overall Study|Withdrawal by Subject|7
963604|NCT01153347|1962961|FG003|Overall Study|Withdrawal by Subject|7
963605|NCT01153347|1962958|FG000|Overall Study|Eligibility criteria not fulfilled|0
963606|NCT01153347|1962959|FG001|Overall Study|Eligibility criteria not fulfilled|1
963607|NCT01153347|1962960|FG002|Overall Study|Eligibility criteria not fulfilled|2
963608|NCT01153347|1962961|FG003|Overall Study|Eligibility criteria not fulfilled|1
963609|NCT01153347|1962958|FG000|Overall Study|Adverse Event|3
963610|NCT01153347|1962959|FG001|Overall Study|Adverse Event|9
963611|NCT01153347|1962960|FG002|Overall Study|Adverse Event|21
963612|NCT01153347|1962961|FG003|Overall Study|Adverse Event|7
963613|NCT01153347|1962958|FG000|Overall Study|Severe non-compliance to protocol|6
963614|NCT01153347|1962959|FG001|Overall Study|Severe non-compliance to protocol|7
963615|NCT01153347|1962960|FG002|Overall Study|Severe non-compliance to protocol|4
963616|NCT01153347|1962961|FG003|Overall Study|Severe non-compliance to protocol|3
963617|NCT01153347|1962958|FG000|Overall Study|Condition under investigation worsened|1
963618|NCT01153347|1962959|FG001|Overall Study|Condition under investigation worsened|1
963619|NCT01153347|1962960|FG002|Overall Study|Condition under investigation worsened|0
963620|NCT01153347|1962961|FG003|Overall Study|Condition under investigation worsened|0
963621|NCT01153347|1962958|FG000|Overall Study|Lack of Efficacy|2
963622|NCT01153347|1962959|FG001|Overall Study|Lack of Efficacy|2
963623|NCT01153347|1962960|FG002|Overall Study|Lack of Efficacy|0
963624|NCT01153347|1962961|FG003|Overall Study|Lack of Efficacy|4
963625|NCT01153347|1962958|FG000|Overall Study|Study-specific withdrawal criteria|4
963626|NCT01153347|1962959|FG001|Overall Study|Study-specific withdrawal criteria|3
963627|NCT01153347|1962960|FG002|Overall Study|Study-specific withdrawal criteria|1
963628|NCT01153347|1962961|FG003|Overall Study|Study-specific withdrawal criteria|2
963629|NCT01153347|1962958|FG000|Overall Study|Lost to Follow-up|4
963630|NCT01153347|1962959|FG001|Overall Study|Lost to Follow-up|9
963631|NCT01153347|1962960|FG002|Overall Study|Lost to Follow-up|11
963632|NCT01153347|1962961|FG003|Overall Study|Lost to Follow-up|8
963633|NCT01153347|1962958|FG000|Overall Study|Other|5
963634|NCT01153347|1962959|FG001|Overall Study|Other|5
963635|NCT01153347|1962960|FG002|Overall Study|Other|4
963636|NCT01153347|1962961|FG003|Overall Study|Other|0
963637|NCT01153347|1962958|FG000|Overall Study|Death|1
963638|NCT01153347|1962959|FG001|Overall Study|Death|0
963639|NCT01153347|1962960|FG002|Overall Study|Death|0
963640|NCT01153347|1962961|FG003|Overall Study|Death|0
963641|NCT01153425|1962973|FG000|Overall Study|Withdrawal by Subject|3
963642|NCT01153425|1962974|FG001|Overall Study|Withdrawal by Subject|3
963643|NCT01153516|1962996|FG000|Overall Study|Both subjects refused surgery|2
963644|NCT01153516|1962997|FG001|Overall Study|Both subjects refused surgery|0
963645|NCT01153633|1963024|FG000|Overall Study|Protocol Violation|1
963646|NCT01153633|1963025|FG001|Overall Study|Protocol Violation|1
963647|NCT01153633|1963024|FG000|Overall Study|Therapeutic failure|3
963648|NCT01153633|1963025|FG001|Overall Study|Therapeutic failure|3
963649|NCT01153698|1963046|FG000|Overall Study|Adverse Event|12
963650|NCT01153698|1963046|FG000|Overall Study|Lost to Follow-up|4
963651|NCT01153698|1963046|FG000|Overall Study|Withdrawal by Subject|2
963652|NCT01153698|1963046|FG000|Overall Study|Switch to other anticoagulants|4
963653|NCT01153698|1963046|FG000|Overall Study|Other|2
963654|NCT01153698|1963046|FG000|Overall Study|Not treated with Pradaxa|5
963655|NCT01153724|1963057|FG000|Treatment Period 1|Withdrawal by Subject|1
963656|NCT01153724|1963057|FG000|Treatment Period 2|Adverse Event|1
963657|NCT01153724|1963057|FG000|Treatment Period 2|Other reason not defined above|1
963658|NCT01153763|1963063|FG000|Overall Study|Study Closed|16
963659|NCT01153763|1963063|FG000|Overall Study|Lost to Follow-up|1
963660|NCT01153763|1963063|FG000|Overall Study|Physician Decision|2
963661|NCT01153763|1963063|FG000|Overall Study|Withdrawal by Subject|2
963662|NCT01153815|1963069|FG000|Overall Study|Adverse Event|3
963663|NCT01153815|1963070|FG001|Overall Study|Adverse Event|1
963664|NCT01153815|1963069|FG000|Overall Study|Withdrawal by Subject|6
963665|NCT01153815|1963070|FG001|Overall Study|Withdrawal by Subject|4
963666|NCT01153841|1963078|FG000|Overall Study|Adverse Event|1
963667|NCT01153841|1963079|FG001|Overall Study|Adverse Event|0
963668|NCT01153841|1963078|FG000|Overall Study|Withdrawal by Subject|1
963669|NCT01153841|1963079|FG001|Overall Study|Withdrawal by Subject|0
963670|NCT01153841|1963078|FG000|Overall Study|Protocol Violation|2
963671|NCT01153841|1963079|FG001|Overall Study|Protocol Violation|0
963672|NCT01153841|1963078|FG000|Overall Study|Lost to Follow-up|2
963673|NCT01153841|1963079|FG001|Overall Study|Lost to Follow-up|0
963674|NCT01153893|1963087|FG000|Overall Study|Adverse Event|1
963675|NCT01153893|1963088|FG001|Overall Study|Adverse Event|0
963676|NCT01153958|1963096|FG000|Overall Study|Study Terminated|36
963677|NCT01153958|1963097|FG001|Overall Study|Study Terminated|32
963678|NCT01153971|1963103|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
963679|NCT01153971|1963103|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
963680|NCT01153971|1963103|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
963681|NCT01153971|1963103|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
963682|NCT01153971|1963103|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1
963683|NCT01153971|1963103|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1
963684|NCT01153971|1963103|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2
963685|NCT01153984|1963107|FG000|Overall Study|Withdrawal by Subject|1
963686|NCT01153984|1963107|FG000|Overall Study|Adverse Event|1
963687|NCT01154010|1963113|FG000|Overall Study|Lost to Follow-up|0
963688|NCT01154010|1963114|FG001|Overall Study|Lost to Follow-up|1
963689|NCT01154036|1963123|FG000|Phase I|Physician Decision|0
963690|NCT01154036|1963124|FG001|Phase I|Physician Decision|1
963691|NCT01154036|1963125|FG002|Phase I|Physician Decision|0
963692|NCT01154036|1963126|FG003|Phase I|Physician Decision|0
963693|NCT01154036|1963127|FG004|Phase I|Physician Decision|0
963694|NCT01154036|1963128|FG005|Phase I|Physician Decision|0
963695|NCT01154036|1963129|FG006|Phase I|Physician Decision|0
963696|NCT01154036|1963130|FG007|Phase I|Physician Decision|0
963697|NCT01154036|1963123|FG000|Phase I|Lost to Follow-up|0
963698|NCT01154036|1963124|FG001|Phase I|Lost to Follow-up|3
963699|NCT01154036|1963125|FG002|Phase I|Lost to Follow-up|6
963700|NCT01154036|1963126|FG003|Phase I|Lost to Follow-up|0
963701|NCT01154036|1963127|FG004|Phase I|Lost to Follow-up|0
963702|NCT01154036|1963128|FG005|Phase I|Lost to Follow-up|0
963703|NCT01154036|1963129|FG006|Phase I|Lost to Follow-up|0
963704|NCT01154036|1963130|FG007|Phase I|Lost to Follow-up|0
963705|NCT01154036|1963123|FG000|Phase I|Protocol Violation|0
963706|NCT01154036|1963124|FG001|Phase I|Protocol Violation|3
963707|NCT01154036|1963125|FG002|Phase I|Protocol Violation|9
963708|NCT01154036|1963126|FG003|Phase I|Protocol Violation|0
963709|NCT01154036|1963127|FG004|Phase I|Protocol Violation|0
963710|NCT01154036|1963128|FG005|Phase I|Protocol Violation|0
963711|NCT01154036|1963129|FG006|Phase I|Protocol Violation|0
963712|NCT01154036|1963130|FG007|Phase I|Protocol Violation|0
963713|NCT01154036|1963123|FG000|Phase I|Withdrawal by Subject|2
963714|NCT01154036|1963124|FG001|Phase I|Withdrawal by Subject|10
963715|NCT01154036|1963125|FG002|Phase I|Withdrawal by Subject|29
963716|NCT01154036|1963126|FG003|Phase I|Withdrawal by Subject|0
963717|NCT01154036|1963127|FG004|Phase I|Withdrawal by Subject|0
963718|NCT01154036|1963128|FG005|Phase I|Withdrawal by Subject|0
963719|NCT01154036|1963129|FG006|Phase I|Withdrawal by Subject|0
963720|NCT01154036|1963130|FG007|Phase I|Withdrawal by Subject|0
963721|NCT01154036|1963123|FG000|Phase I|Adverse Event|1
963722|NCT01154036|1963124|FG001|Phase I|Adverse Event|11
963723|NCT01154036|1963125|FG002|Phase I|Adverse Event|12
963724|NCT01154036|1963126|FG003|Phase I|Adverse Event|0
963725|NCT01154036|1963127|FG004|Phase I|Adverse Event|0
963726|NCT01154036|1963128|FG005|Phase I|Adverse Event|0
963727|NCT01154036|1963129|FG006|Phase I|Adverse Event|0
963728|NCT01154036|1963130|FG007|Phase I|Adverse Event|0
963729|NCT01154036|1963123|FG000|Phase II|Adverse Event|0
963730|NCT01154036|1963124|FG001|Phase II|Adverse Event|0
963731|NCT01154036|1963125|FG002|Phase II|Adverse Event|0
963732|NCT01154036|1963126|FG003|Phase II|Adverse Event|0
963733|NCT01154036|1963127|FG004|Phase II|Adverse Event|1
963734|NCT01154036|1963128|FG005|Phase II|Adverse Event|1
963735|NCT01154036|1963129|FG006|Phase II|Adverse Event|1
963736|NCT01154036|1963130|FG007|Phase II|Adverse Event|1
963737|NCT01154036|1963123|FG000|Phase II|Physician Decision|0
963738|NCT01154036|1963124|FG001|Phase II|Physician Decision|0
963739|NCT01154036|1963125|FG002|Phase II|Physician Decision|0
963740|NCT01154036|1963126|FG003|Phase II|Physician Decision|0
963741|NCT01154036|1963127|FG004|Phase II|Physician Decision|0
963742|NCT01154036|1963128|FG005|Phase II|Physician Decision|0
963743|NCT01154036|1963129|FG006|Phase II|Physician Decision|1
963744|NCT01154036|1963130|FG007|Phase II|Physician Decision|0
963745|NCT01154036|1963123|FG000|Phase II|Lost to Follow-up|0
963746|NCT01154036|1963124|FG001|Phase II|Lost to Follow-up|0
963747|NCT01154036|1963125|FG002|Phase II|Lost to Follow-up|0
963748|NCT01154036|1963126|FG003|Phase II|Lost to Follow-up|1
963749|NCT01154036|1963127|FG004|Phase II|Lost to Follow-up|2
963750|NCT01154036|1963128|FG005|Phase II|Lost to Follow-up|0
963751|NCT01154036|1963129|FG006|Phase II|Lost to Follow-up|2
963752|NCT01154036|1963130|FG007|Phase II|Lost to Follow-up|1
963753|NCT01154036|1963123|FG000|Phase II|Protocol Violation|0
963754|NCT01154036|1963124|FG001|Phase II|Protocol Violation|0
963755|NCT01154036|1963125|FG002|Phase II|Protocol Violation|0
963756|NCT01154036|1963126|FG003|Phase II|Protocol Violation|0
963757|NCT01154036|1963127|FG004|Phase II|Protocol Violation|1
963758|NCT01154036|1963128|FG005|Phase II|Protocol Violation|2
963759|NCT01154036|1963129|FG006|Phase II|Protocol Violation|0
963760|NCT01154036|1963130|FG007|Phase II|Protocol Violation|0
963761|NCT01154036|1963123|FG000|Phase II|Withdrawal by Subject|0
963762|NCT01154036|1963124|FG001|Phase II|Withdrawal by Subject|0
963763|NCT01154036|1963125|FG002|Phase II|Withdrawal by Subject|0
963764|NCT01154036|1963126|FG003|Phase II|Withdrawal by Subject|0
963765|NCT01154036|1963127|FG004|Phase II|Withdrawal by Subject|4
963766|NCT01154036|1963128|FG005|Phase II|Withdrawal by Subject|2
963767|NCT01154036|1963129|FG006|Phase II|Withdrawal by Subject|5
963768|NCT01154036|1963130|FG007|Phase II|Withdrawal by Subject|4
963769|NCT01154088|1963153|FG000|Overall Study|Lost to Follow-up|4
963770|NCT01154088|1963154|FG001|Overall Study|Lost to Follow-up|6
963771|NCT01154088|1963155|FG002|Overall Study|Lost to Follow-up|7
963772|NCT01154101|1963169|FG000|Overall Study|Adverse Event|0
963773|NCT01154101|1963170|FG001|Overall Study|Adverse Event|2
963774|NCT01154101|1963171|FG002|Overall Study|Adverse Event|1
963775|NCT01154101|1963172|FG003|Overall Study|Adverse Event|1
963776|NCT01154101|1963173|FG004|Overall Study|Adverse Event|0
963777|NCT01154101|1963169|FG000|Overall Study|Lost to Follow-up|0
963778|NCT01154101|1963170|FG001|Overall Study|Lost to Follow-up|1
963779|NCT01154101|1963171|FG002|Overall Study|Lost to Follow-up|0
963780|NCT01154101|1963172|FG003|Overall Study|Lost to Follow-up|1
963781|NCT01154101|1963173|FG004|Overall Study|Lost to Follow-up|0
963782|NCT01154101|1963169|FG000|Overall Study|Withdrawal by Subject|0
963783|NCT01154101|1963170|FG001|Overall Study|Withdrawal by Subject|1
963784|NCT01154101|1963171|FG002|Overall Study|Withdrawal by Subject|2
963785|NCT01154101|1963172|FG003|Overall Study|Withdrawal by Subject|0
911114|NCT00796666|1888270|FG000|Overall Study|Randomized and not treated|1
963786|NCT01154101|1963173|FG004|Overall Study|Withdrawal by Subject|1
963787|NCT01154127|1963192|FG000|Period 1 (21 Days)|Adverse Event|3
963788|NCT01154127|1963193|FG001|Period 1 (21 Days)|Adverse Event|4
963789|NCT01154127|1963192|FG000|Period 1 (21 Days)|Withdrawal by Subject|0
963790|NCT01154127|1963193|FG001|Period 1 (21 Days)|Withdrawal by Subject|2
963791|NCT01154127|1963192|FG000|Washout (14 - 28 Days)|Adverse Event|2
963792|NCT01154127|1963193|FG001|Washout (14 - 28 Days)|Adverse Event|0
963793|NCT01154127|1963192|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1
963794|NCT01154127|1963193|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0
963795|NCT01154127|1963192|FG000|Period 2 (21 Days)|Protocol Deviation|0
963796|NCT01154127|1963193|FG001|Period 2 (21 Days)|Protocol Deviation|1
963797|NCT01154140|1963201|FG000|Overall Study|Death|71
963798|NCT01154140|1963202|FG001|Overall Study|Death|81
963799|NCT01154140|1963201|FG000|Overall Study|Lost to Follow-up|4
963800|NCT01154140|1963202|FG001|Overall Study|Lost to Follow-up|5
963801|NCT01154140|1963201|FG000|Overall Study|Withdrawal by Subject|12
963802|NCT01154140|1963202|FG001|Overall Study|Withdrawal by Subject|13
963803|NCT01154140|1963201|FG000|Overall Study|Other|3
963804|NCT01154140|1963202|FG001|Overall Study|Other|1
963805|NCT01154140|1963201|FG000|Overall Study|Randomized but not treated|1
963806|NCT01154140|1963202|FG001|Overall Study|Randomized but not treated|2
963807|NCT01154153|1963210|FG000|Overall Study|Poor compliance to protocol|2
963808|NCT01154153|1963211|FG001|Overall Study|Poor compliance to protocol|0
963809|NCT01154153|1963210|FG000|Overall Study|Unable to use labs|2
963810|NCT01154153|1963211|FG001|Overall Study|Unable to use labs|3
963811|NCT01154153|1963210|FG000|Overall Study|Withdrew consent|1
963812|NCT01154153|1963211|FG001|Overall Study|Withdrew consent|0
963813|NCT01154166|1963219|FG000|Overall Study|Adverse Event|14
963814|NCT01154166|1963220|FG001|Overall Study|Adverse Event|9
963815|NCT01154166|1963219|FG000|Overall Study|Lost to Follow-up|1
963816|NCT01154166|1963220|FG001|Overall Study|Lost to Follow-up|1
963817|NCT01154166|1963219|FG000|Overall Study|Protocol Violation|4
963818|NCT01154166|1963220|FG001|Overall Study|Protocol Violation|1
963819|NCT01154166|1963219|FG000|Overall Study|Withdrawal by Subject|10
963820|NCT01154166|1963220|FG001|Overall Study|Withdrawal by Subject|1
963821|NCT01154166|1963219|FG000|Overall Study|Lack of Efficacy|3
963822|NCT01154166|1963220|FG001|Overall Study|Lack of Efficacy|0
963823|NCT01154166|1963219|FG000|Overall Study|Disease Progression|1
963824|NCT01154166|1963220|FG001|Overall Study|Disease Progression|0
963825|NCT01154166|1963219|FG000|Overall Study|Poor Compliance|1
963826|NCT01154166|1963220|FG001|Overall Study|Poor Compliance|0
963827|NCT01154218|1963240|FG000|Third Intervention Period|Adverse Event|0
963828|NCT01154218|1963241|FG001|Third Intervention Period|Adverse Event|1
963829|NCT01154218|1963242|FG002|Third Intervention Period|Adverse Event|0
963830|NCT01154218|1963243|FG003|Third Intervention Period|Adverse Event|0
963831|NCT01154218|1963240|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
963832|NCT01154218|1963241|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
963833|NCT01154218|1963242|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
963834|NCT01154218|1963243|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
963835|NCT01154218|1963240|FG000|Fourth Intervention Period|Withdrawal by Subject|1
963836|NCT01154218|1963241|FG001|Fourth Intervention Period|Withdrawal by Subject|0
963837|NCT01154218|1963242|FG002|Fourth Intervention Period|Withdrawal by Subject|0
963838|NCT01154218|1963243|FG003|Fourth Intervention Period|Withdrawal by Subject|0
963839|NCT01154231|1963253|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1
963840|NCT01154231|1963253|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1
963841|NCT01154283|1963259|FG000|0-6 Weeks|Withdrawal by Subject|7
963842|NCT01154283|1963260|FG001|0-6 Weeks|Withdrawal by Subject|2
963843|NCT01154283|1963259|FG000|0-6 Weeks|Death|0
963844|NCT01154283|1963260|FG001|0-6 Weeks|Death|1
963845|NCT01154283|1963259|FG000|7-12 Weeks|Death|1
963846|NCT01154283|1963260|FG001|7-12 Weeks|Death|0
963847|NCT01154283|1963259|FG000|7-12 Weeks|Withdrawal by Subject|0
963848|NCT01154283|1963260|FG001|7-12 Weeks|Withdrawal by Subject|1
963849|NCT01154296|1963268|FG000|Randomization and Intervention|Decided to decline|1
963850|NCT01154296|1963269|FG001|Randomization and Intervention|Decided to decline|1
963851|NCT01154296|1963268|FG000|Randomization and Intervention|Declined by staff|1
963852|NCT01154296|1963269|FG001|Randomization and Intervention|Declined by staff|0
963853|NCT01154296|1963268|FG000|Randomization and Intervention|Did not return|1
963854|NCT01154296|1963269|FG001|Randomization and Intervention|Did not return|0
963855|NCT01154296|1963268|FG000|Randomization and Intervention|Left before test|0
963856|NCT01154296|1963269|FG001|Randomization and Intervention|Left before test|1
963857|NCT01154296|1963268|FG000|Randomization and Intervention|Left clinic early|2
963858|NCT01154296|1963269|FG001|Randomization and Intervention|Left clinic early|0
963859|NCT01154296|1963268|FG000|6-month Follow-up|Lost contact|269
963860|NCT01154296|1963269|FG001|6-month Follow-up|Lost contact|275
963861|NCT01154296|1963268|FG000|6-month Follow-up|Incarcerated|37
963862|NCT01154296|1963269|FG001|6-month Follow-up|Incarcerated|32
963863|NCT01154296|1963268|FG000|6-month Follow-up|Withdrew consent|14
963864|NCT01154296|1963269|FG001|6-month Follow-up|Withdrew consent|15
963865|NCT01154296|1963268|FG000|6-month Follow-up|Death|3
963866|NCT01154296|1963269|FG001|6-month Follow-up|Death|2
963867|NCT01154296|1963268|FG000|6-month Follow-up|Declined by Study Coordinator|5
963868|NCT01154296|1963269|FG001|6-month Follow-up|Declined by Study Coordinator|4
963869|NCT01154452|1963296|FG000|Phase Ib|Not Treated|1
963870|NCT01154452|1963297|FG001|Phase Ib|Not Treated|0
963871|NCT01154452|1963298|FG002|Phase Ib|Not Treated|0
963872|NCT01154452|1963299|FG003|Phase Ib|Not Treated|0
963873|NCT01154452|1963296|FG000|Phase Ib|Adverse Event|2
963874|NCT01154452|1963297|FG001|Phase Ib|Adverse Event|1
963875|NCT01154452|1963298|FG002|Phase Ib|Adverse Event|0
963876|NCT01154452|1963299|FG003|Phase Ib|Adverse Event|0
963877|NCT01154452|1963296|FG000|Phase II|Withdrawal by Subject|0
963878|NCT01154452|1963297|FG001|Phase II|Withdrawal by Subject|0
963879|NCT01154452|1963298|FG002|Phase II|Withdrawal by Subject|1
963880|NCT01154452|1963299|FG003|Phase II|Withdrawal by Subject|2
963881|NCT01154452|1963296|FG000|Phase II|Adverse Event|0
963882|NCT01154452|1963297|FG001|Phase II|Adverse Event|0
963883|NCT01154452|1963298|FG002|Phase II|Adverse Event|4
963884|NCT01154452|1963299|FG003|Phase II|Adverse Event|4
963885|NCT01154673|1963331|FG000|Overall Study|Lost to Follow-up|1
963886|NCT01154673|1963332|FG001|Overall Study|Lost to Follow-up|0
963887|NCT01154673|1963331|FG000|Overall Study|moved out of province|1
963888|NCT01154673|1963332|FG001|Overall Study|moved out of province|0
963889|NCT01154816|1963365|FG000|Overall Study|Withdrawal by Subject|1
963890|NCT01154816|1963366|FG001|Overall Study|Withdrawal by Subject|0
963891|NCT01154816|1963367|FG002|Overall Study|Withdrawal by Subject|0
963892|NCT01154816|1963368|FG003|Overall Study|Withdrawal by Subject|1
963893|NCT01154816|1963369|FG004|Overall Study|Withdrawal by Subject|0
963894|NCT01154816|1963370|FG005|Overall Study|Withdrawal by Subject|0
963895|NCT01154816|1963371|FG006|Overall Study|Withdrawal by Subject|0
963896|NCT01154816|1963372|FG007|Overall Study|Withdrawal by Subject|0
963897|NCT01154816|1963373|FG008|Overall Study|Withdrawal by Subject|1
963898|NCT01154816|1963374|FG009|Overall Study|Withdrawal by Subject|3
963899|NCT01154816|1963375|FG010|Overall Study|Withdrawal by Subject|0
963900|NCT01154816|1963376|FG011|Overall Study|Withdrawal by Subject|0
963901|NCT01154816|1963365|FG000|Overall Study|Progressive Disease|13
963902|NCT01154816|1963366|FG001|Overall Study|Progressive Disease|8
963903|NCT01154816|1963367|FG002|Overall Study|Progressive Disease|9
963904|NCT01154816|1963368|FG003|Overall Study|Progressive Disease|9
963905|NCT01154816|1963369|FG004|Overall Study|Progressive Disease|8
963906|NCT01154816|1963370|FG005|Overall Study|Progressive Disease|8
963907|NCT01154816|1963371|FG006|Overall Study|Progressive Disease|5
963908|NCT01154816|1963372|FG007|Overall Study|Progressive Disease|6
963909|NCT01154816|1963373|FG008|Overall Study|Progressive Disease|8
963910|NCT01154816|1963374|FG009|Overall Study|Progressive Disease|6
963911|NCT01154816|1963375|FG010|Overall Study|Progressive Disease|10
963912|NCT01154816|1963376|FG011|Overall Study|Progressive Disease|3
963913|NCT01154816|1963365|FG000|Overall Study|Physician Decision|1
963914|NCT01154816|1963366|FG001|Overall Study|Physician Decision|0
963915|NCT01154816|1963367|FG002|Overall Study|Physician Decision|1
963916|NCT01154816|1963368|FG003|Overall Study|Physician Decision|0
963917|NCT01154816|1963369|FG004|Overall Study|Physician Decision|2
963918|NCT01154816|1963370|FG005|Overall Study|Physician Decision|0
963919|NCT01154816|1963371|FG006|Overall Study|Physician Decision|0
963920|NCT01154816|1963372|FG007|Overall Study|Physician Decision|0
963921|NCT01154816|1963373|FG008|Overall Study|Physician Decision|0
963922|NCT01154816|1963374|FG009|Overall Study|Physician Decision|1
963923|NCT01154816|1963375|FG010|Overall Study|Physician Decision|1
963924|NCT01154816|1963376|FG011|Overall Study|Physician Decision|1
963925|NCT01154816|1963365|FG000|Overall Study|Adverse Event|5
963926|NCT01154816|1963366|FG001|Overall Study|Adverse Event|2
963927|NCT01154816|1963367|FG002|Overall Study|Adverse Event|0
963928|NCT01154816|1963368|FG003|Overall Study|Adverse Event|0
963929|NCT01154816|1963369|FG004|Overall Study|Adverse Event|0
963930|NCT01154816|1963370|FG005|Overall Study|Adverse Event|0
963931|NCT01154816|1963371|FG006|Overall Study|Adverse Event|1
963932|NCT01154816|1963372|FG007|Overall Study|Adverse Event|1
963933|NCT01154816|1963373|FG008|Overall Study|Adverse Event|0
963934|NCT01154816|1963374|FG009|Overall Study|Adverse Event|0
963935|NCT01154816|1963375|FG010|Overall Study|Adverse Event|0
963936|NCT01154816|1963376|FG011|Overall Study|Adverse Event|0
963937|NCT01155011|1963419|FG000|Baseline to 6 Months|Withdrawal by Subject|18
963938|NCT01155011|1963420|FG001|Baseline to 6 Months|Withdrawal by Subject|19
963939|NCT01155011|1963419|FG000|Baseline to 6 Months|investigator decision, moved|4
963940|NCT01155011|1963420|FG001|Baseline to 6 Months|investigator decision, moved|5
963941|NCT01155011|1963419|FG000|Baseline to 6 Months|Death|0
963942|NCT01155011|1963420|FG001|Baseline to 6 Months|Death|1
963943|NCT01155011|1963419|FG000|6 to 12 Months|Withdrawal by Subject|8
963944|NCT01155011|1963420|FG001|6 to 12 Months|Withdrawal by Subject|5
963945|NCT01155011|1963419|FG000|6 to 12 Months|Death|1
963946|NCT01155011|1963420|FG001|6 to 12 Months|Death|5
963947|NCT01155024|1963430|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
963948|NCT01155024|1963431|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
963949|NCT01155024|1963430|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
963950|NCT01155024|1963431|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
963951|NCT01155024|1963430|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
963952|NCT01155024|1963431|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
963953|NCT01155050|1963442|FG000|Overall Study|Lost to Follow-up|15
963954|NCT01155050|1963443|FG001|Overall Study|Lost to Follow-up|20
963955|NCT01155050|1963444|FG002|Overall Study|Lost to Follow-up|19
963956|NCT01155050|1963445|FG003|Overall Study|Lost to Follow-up|22
963957|NCT01155063|1963455|FG000|Overall Study|Adverse Event|1
963958|NCT01155063|1963455|FG000|Overall Study|Withdrawal by Subject|1
963959|NCT01155063|1963455|FG000|Overall Study|Study terminated by sponsor|87
963960|NCT01155141|1963459|FG000|Overall Study|Withdrawal by Subject|1
963961|NCT01155141|1963459|FG000|Overall Study|Screen Failure|1
963962|NCT01155167|1963478|FG000|Overall Study|Insufficient ultrasound data|2
963963|NCT01155167|1963479|FG001|Overall Study|Insufficient ultrasound data|0
963964|NCT01155167|1963478|FG000|Overall Study|Access site changed to femoral artery|1
963965|NCT01155167|1963479|FG001|Overall Study|Access site changed to femoral artery|0
963966|NCT01155219|1963518|FG000|Overall Study|Adverse Event|3
963967|NCT01155219|1963519|FG001|Overall Study|Adverse Event|1
963968|NCT01155219|1963518|FG000|Overall Study|non-medical reason|1
963969|NCT01155219|1963519|FG001|Overall Study|non-medical reason|2
963970|NCT01155284|1963527|FG000|Overall Study|Withdrawal by Subject|4
963971|NCT01155284|1963528|FG001|Overall Study|Withdrawal by Subject|3
963972|NCT01155284|1963527|FG000|Overall Study|Lost to Follow-up|1
963973|NCT01155284|1963528|FG001|Overall Study|Lost to Follow-up|2
963974|NCT01155284|1963527|FG000|Overall Study|Physician Decision|1
963975|NCT01155284|1963528|FG001|Overall Study|Physician Decision|0
963976|NCT01155284|1963527|FG000|Overall Study|Adverse Event|1
963977|NCT01155284|1963528|FG001|Overall Study|Adverse Event|0
963978|NCT01155323|1963536|FG000|First Intervention|exclusion criteria|1
963979|NCT01155323|1963537|FG001|First Intervention|exclusion criteria|1
963980|NCT01155323|1963536|FG000|Second Intervention|Lost to Follow-up|1
963981|NCT01155323|1963537|FG001|Second Intervention|Lost to Follow-up|1
963982|NCT01155466|1963557|FG000|Overall Study|Adverse Event|13
963983|NCT01155466|1963558|FG001|Overall Study|Adverse Event|15
963984|NCT01155466|1963559|FG002|Overall Study|Adverse Event|6
963985|NCT01155466|1963560|FG003|Overall Study|Adverse Event|17
963986|NCT01155466|1963561|FG004|Overall Study|Adverse Event|18
963987|NCT01155466|1963557|FG000|Overall Study|Lost to Follow-up|0
963988|NCT01155466|1963558|FG001|Overall Study|Lost to Follow-up|0
963989|NCT01155466|1963559|FG002|Overall Study|Lost to Follow-up|0
963990|NCT01155466|1963560|FG003|Overall Study|Lost to Follow-up|0
963991|NCT01155466|1963561|FG004|Overall Study|Lost to Follow-up|2
963992|NCT01155466|1963557|FG000|Overall Study|Withdrawal by Subject|7
963993|NCT01155466|1963558|FG001|Overall Study|Withdrawal by Subject|5
963994|NCT01155466|1963559|FG002|Overall Study|Withdrawal by Subject|9
963995|NCT01155466|1963560|FG003|Overall Study|Withdrawal by Subject|4
963996|NCT01155466|1963561|FG004|Overall Study|Withdrawal by Subject|4
963997|NCT01155466|1963557|FG000|Overall Study|Protocol Violation|0
963998|NCT01155466|1963558|FG001|Overall Study|Protocol Violation|0
963999|NCT01155466|1963559|FG002|Overall Study|Protocol Violation|2
964000|NCT01155466|1963560|FG003|Overall Study|Protocol Violation|0
964001|NCT01155466|1963561|FG004|Overall Study|Protocol Violation|1
964002|NCT01155466|1963557|FG000|Overall Study|Administrative|0
964003|NCT01155466|1963558|FG001|Overall Study|Administrative|3
964004|NCT01155466|1963559|FG002|Overall Study|Administrative|0
964005|NCT01155466|1963560|FG003|Overall Study|Administrative|0
964006|NCT01155466|1963561|FG004|Overall Study|Administrative|0
964007|NCT01155466|1963557|FG000|Overall Study|Randomized not treated|2
964008|NCT01155466|1963558|FG001|Overall Study|Randomized not treated|2
964009|NCT01155466|1963559|FG002|Overall Study|Randomized not treated|3
964010|NCT01155466|1963560|FG003|Overall Study|Randomized not treated|0
964011|NCT01155466|1963561|FG004|Overall Study|Randomized not treated|2
964012|NCT01155479|1963578|FG000|Part I|Adverse Event|13
964013|NCT01155479|1963579|FG001|Part I|Adverse Event|8
964014|NCT01155479|1963580|FG002|Part I|Adverse Event|18
964015|NCT01155479|1963581|FG003|Part I|Adverse Event|7
964016|NCT01155479|1963582|FG004|Part I|Adverse Event|6
964017|NCT01155479|1963578|FG000|Part I|Administrative|2
964018|NCT01155479|1963579|FG001|Part I|Administrative|2
964019|NCT01155479|1963580|FG002|Part I|Administrative|2
964020|NCT01155479|1963581|FG003|Part I|Administrative|0
964021|NCT01155479|1963582|FG004|Part I|Administrative|0
964022|NCT01155479|1963578|FG000|Part I|Did Not Meet Protocol Eligibility|3
964023|NCT01155479|1963579|FG001|Part I|Did Not Meet Protocol Eligibility|1
964024|NCT01155479|1963580|FG002|Part I|Did Not Meet Protocol Eligibility|2
964025|NCT01155479|1963581|FG003|Part I|Did Not Meet Protocol Eligibility|1
964026|NCT01155479|1963582|FG004|Part I|Did Not Meet Protocol Eligibility|3
964027|NCT01155479|1963578|FG000|Part I|Withdrawal by Subject|11
964028|NCT01155479|1963579|FG001|Part I|Withdrawal by Subject|13
964029|NCT01155479|1963580|FG002|Part I|Withdrawal by Subject|8
964030|NCT01155479|1963581|FG003|Part I|Withdrawal by Subject|8
964031|NCT01155479|1963582|FG004|Part I|Withdrawal by Subject|9
964032|NCT01155479|1963578|FG000|Part I|Lost to Follow-up|0
964033|NCT01155479|1963579|FG001|Part I|Lost to Follow-up|0
964034|NCT01155479|1963580|FG002|Part I|Lost to Follow-up|1
964035|NCT01155479|1963581|FG003|Part I|Lost to Follow-up|1
964036|NCT01155479|1963582|FG004|Part I|Lost to Follow-up|0
964037|NCT01155479|1963578|FG000|Part I|Treatment Failure|3
964038|NCT01155479|1963579|FG001|Part I|Treatment Failure|0
964039|NCT01155479|1963580|FG002|Part I|Treatment Failure|3
964040|NCT01155479|1963581|FG003|Part I|Treatment Failure|1
964041|NCT01155479|1963582|FG004|Part I|Treatment Failure|2
964042|NCT01155479|1963578|FG000|Part I|Did Not Receive Treatment|4
964043|NCT01155479|1963579|FG001|Part I|Did Not Receive Treatment|2
964044|NCT01155479|1963580|FG002|Part I|Did Not Receive Treatment|2
964045|NCT01155479|1963581|FG003|Part I|Did Not Receive Treatment|6
964046|NCT01155479|1963582|FG004|Part I|Did Not Receive Treatment|1
964047|NCT01155479|1963578|FG000|Part I|Non-Compliance with Protocol|2
964048|NCT01155479|1963579|FG001|Part I|Non-Compliance with Protocol|1
964049|NCT01155479|1963580|FG002|Part I|Non-Compliance with Protocol|3
964050|NCT01155479|1963581|FG003|Part I|Non-Compliance with Protocol|3
964051|NCT01155479|1963582|FG004|Part I|Non-Compliance with Protocol|2
964052|NCT01155479|1963578|FG000|Part II|Adverse Event|7
964053|NCT01155479|1963579|FG001|Part II|Adverse Event|6
964054|NCT01155479|1963580|FG002|Part II|Adverse Event|8
964055|NCT01155479|1963581|FG003|Part II|Adverse Event|3
964056|NCT01155479|1963582|FG004|Part II|Adverse Event|4
964057|NCT01155479|1963578|FG000|Part II|Administrative|43
964058|NCT01155479|1963579|FG001|Part II|Administrative|49
964059|NCT01155479|1963580|FG002|Part II|Administrative|36
964060|NCT01155479|1963581|FG003|Part II|Administrative|38
964061|NCT01155479|1963582|FG004|Part II|Administrative|46
964062|NCT01155479|1963578|FG000|Part II|Withdrawal by Subject|8
964063|NCT01155479|1963579|FG001|Part II|Withdrawal by Subject|4
964064|NCT01155479|1963580|FG002|Part II|Withdrawal by Subject|12
964065|NCT01155479|1963581|FG003|Part II|Withdrawal by Subject|7
964066|NCT01155479|1963582|FG004|Part II|Withdrawal by Subject|3
964067|NCT01155479|1963578|FG000|Part II|Lost to Follow-up|1
964068|NCT01155479|1963579|FG001|Part II|Lost to Follow-up|0
964069|NCT01155479|1963580|FG002|Part II|Lost to Follow-up|0
964070|NCT01155479|1963581|FG003|Part II|Lost to Follow-up|0
964071|NCT01155479|1963582|FG004|Part II|Lost to Follow-up|1
964072|NCT01155479|1963578|FG000|Part II|Treatment Failure|0
964073|NCT01155479|1963579|FG001|Part II|Treatment Failure|1
964074|NCT01155479|1963580|FG002|Part II|Treatment Failure|2
964075|NCT01155479|1963581|FG003|Part II|Treatment Failure|0
964076|NCT01155479|1963582|FG004|Part II|Treatment Failure|1
964077|NCT01155479|1963578|FG000|Part II|Non-Compliance with Protocol|0
964078|NCT01155479|1963579|FG001|Part II|Non-Compliance with Protocol|1
964079|NCT01155479|1963580|FG002|Part II|Non-Compliance with Protocol|0
964080|NCT01155479|1963581|FG003|Part II|Non-Compliance with Protocol|2
964081|NCT01155479|1963582|FG004|Part II|Non-Compliance with Protocol|0
964082|NCT01155531|1963614|FG000|Overall Study|Adverse Event|0
964083|NCT01155531|1963615|FG001|Overall Study|Adverse Event|0
964084|NCT01155531|1963616|FG002|Overall Study|Adverse Event|1
964085|NCT01155531|1963617|FG003|Overall Study|Adverse Event|0
964086|NCT01155531|1963614|FG000|Overall Study|Lost to Follow-up|0
964087|NCT01155531|1963615|FG001|Overall Study|Lost to Follow-up|0
964088|NCT01155531|1963616|FG002|Overall Study|Lost to Follow-up|0
964089|NCT01155531|1963617|FG003|Overall Study|Lost to Follow-up|1
964090|NCT01155531|1963614|FG000|Overall Study|Withdrawal by Subject|1
964091|NCT01155531|1963615|FG001|Overall Study|Withdrawal by Subject|0
964092|NCT01155531|1963616|FG002|Overall Study|Withdrawal by Subject|1
964093|NCT01155531|1963617|FG003|Overall Study|Withdrawal by Subject|0
964094|NCT01155570|1963627|FG000|Overall Study|Adverse Event|39
964095|NCT01155570|1963627|FG000|Overall Study|Lack of Efficacy|46
964096|NCT01155570|1963627|FG000|Overall Study|Participant's Economic Reasons|17
964097|NCT01155570|1963627|FG000|Overall Study|No Hospital Visits|7
964098|NCT01155570|1963627|FG000|Overall Study|Adverse Event + Lack of Efficacy|2
964099|NCT01155570|1963627|FG000|Overall Study|Adverse Event + Other Reasons|7
964100|NCT01155570|1963627|FG000|Overall Study|Participant's Economic Reasons + Other|1
964101|NCT01155570|1963627|FG000|Overall Study|Other Reasons|23
964102|NCT01155583|1963642|FG000|Phase I|Screen failure - did not start treatment|0
964103|NCT01155583|1963643|FG001|Phase I|Screen failure - did not start treatment|0
964104|NCT01155583|1963644|FG002|Phase I|Screen failure - did not start treatment|0
964105|NCT01155583|1963645|FG003|Phase I|Screen failure - did not start treatment|0
964106|NCT01155583|1963646|FG004|Phase I|Screen failure - did not start treatment|1
964107|NCT01155583|1963647|FG005|Phase I|Screen failure - did not start treatment|0
964108|NCT01155583|1963648|FG006|Phase I|Screen failure - did not start treatment|0
964109|NCT01155583|1963649|FG007|Phase I|Screen failure - did not start treatment|2
964110|NCT01155583|1963650|FG008|Phase I|Screen failure - did not start treatment|0
964111|NCT01155583|1963642|FG000|Phase I|Withdrawal by Subject|0
964112|NCT01155583|1963643|FG001|Phase I|Withdrawal by Subject|0
964113|NCT01155583|1963644|FG002|Phase I|Withdrawal by Subject|0
964114|NCT01155583|1963645|FG003|Phase I|Withdrawal by Subject|0
964115|NCT01155583|1963646|FG004|Phase I|Withdrawal by Subject|0
964116|NCT01155583|1963647|FG005|Phase I|Withdrawal by Subject|0
964117|NCT01155583|1963648|FG006|Phase I|Withdrawal by Subject|0
964118|NCT01155583|1963649|FG007|Phase I|Withdrawal by Subject|1
964119|NCT01155583|1963650|FG008|Phase I|Withdrawal by Subject|0
964120|NCT01155661|1963666|FG000|Overall Study|Adverse Event|101
964121|NCT01155661|1963666|FG000|Overall Study|Death|1
964122|NCT01155661|1963666|FG000|Overall Study|Lack of Efficacy|32
964123|NCT01155661|1963666|FG000|Overall Study|Lost to Follow-up|22
964124|NCT01155661|1963666|FG000|Overall Study|Physician Decision|3
964125|NCT01155661|1963666|FG000|Overall Study|Protocol Violation|35
964126|NCT01155661|1963666|FG000|Overall Study|Withdrawal by Subject|73
964127|NCT01155661|1963666|FG000|Overall Study|Sponsor Decision|13
964128|NCT01155726|1963672|FG000|Period 1, 3 Days (Masked)|Inconvenience|1
964129|NCT01155726|1963673|FG001|Period 1, 3 Days (Masked)|Inconvenience|0
964130|NCT01155726|1963674|FG002|Period 1, 3 Days (Masked)|Inconvenience|2
964131|NCT01155726|1963675|FG003|Period 1, 3 Days (Masked)|Inconvenience|0
964132|NCT01155869|1963725|FG000|Overall Study|Lost to Follow-up|3
964133|NCT01155869|1963726|FG001|Overall Study|Lost to Follow-up|1
964134|NCT01156012|1963743|FG000|Overall Study|Adverse Event|3
964135|NCT01156012|1963744|FG001|Overall Study|Adverse Event|1
964136|NCT01156012|1963743|FG000|Overall Study|Lost to Follow-up|1
964137|NCT01156012|1963744|FG001|Overall Study|Lost to Follow-up|0
964138|NCT01156012|1963743|FG000|Overall Study|Withdrawal by Subject|1
964139|NCT01156012|1963744|FG001|Overall Study|Withdrawal by Subject|0
964140|NCT01156012|1963743|FG000|Overall Study|use of commercial drug instead of study|0
964141|NCT01156012|1963744|FG001|Overall Study|use of commercial drug instead of study|1
964142|NCT01156012|1963743|FG000|Overall Study|Non respect of one of inclusion criteria|2
964143|NCT01156012|1963744|FG001|Overall Study|Non respect of one of inclusion criteria|1
964144|NCT01156051|1963752|FG000|Overall Study|Lost to Follow-up|1
964145|NCT01156051|1963753|FG001|Overall Study|Lost to Follow-up|0
964146|NCT01156051|1963752|FG000|Overall Study|patient not compliant with protocol|0
964147|NCT01156051|1963753|FG001|Overall Study|patient not compliant with protocol|1
964148|NCT01156116|1963761|FG000|Overall Study|Withdrawal by Subject|3
964149|NCT01156116|1963762|FG001|Overall Study|Withdrawal by Subject|1
964150|NCT01156116|1963761|FG000|Overall Study|CPAP intolerance|2
964151|NCT01156116|1963762|FG001|Overall Study|CPAP intolerance|0
964152|NCT01156142|1963770|FG000|Overall Study|Withdrawal by Subject|8
964153|NCT01156142|1963771|FG001|Overall Study|Withdrawal by Subject|6
964154|NCT01156142|1963770|FG000|Overall Study|Ineligible|0
964155|NCT01156142|1963771|FG001|Overall Study|Ineligible|1
964156|NCT01156311|1963779|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1
964157|NCT01156311|1963780|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1
964158|NCT01156311|1963781|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0
964159|NCT01156311|1963782|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0
964160|NCT01156311|1963779|FG000|2-Month Monotherapy Period|Physician Decision|0
964161|NCT01156311|1963780|FG001|2-Month Monotherapy Period|Physician Decision|1
964162|NCT01156311|1963781|FG002|2-Month Monotherapy Period|Physician Decision|0
964163|NCT01156311|1963782|FG003|2-Month Monotherapy Period|Physician Decision|0
964164|NCT01156311|1963779|FG000|2-Month Monotherapy Period|Other|1
964165|NCT01156311|1963780|FG001|2-Month Monotherapy Period|Other|0
964166|NCT01156311|1963781|FG002|2-Month Monotherapy Period|Other|0
964167|NCT01156311|1963782|FG003|2-Month Monotherapy Period|Other|0
964168|NCT01156311|1963779|FG000|6-month Add-on Therapy Period|Adverse Event|0
964169|NCT01156311|1963780|FG001|6-month Add-on Therapy Period|Adverse Event|0
964170|NCT01156311|1963781|FG002|6-month Add-on Therapy Period|Adverse Event|7
964171|NCT01156311|1963782|FG003|6-month Add-on Therapy Period|Adverse Event|6
964172|NCT01156311|1963779|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0
964173|NCT01156311|1963780|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0
964174|NCT01156311|1963781|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2
964175|NCT01156311|1963782|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0
964176|NCT01156311|1963779|FG000|6-month Add-on Therapy Period|Disease Activity|0
964177|NCT01156311|1963780|FG001|6-month Add-on Therapy Period|Disease Activity|0
964178|NCT01156311|1963781|FG002|6-month Add-on Therapy Period|Disease Activity|1
964179|NCT01156311|1963782|FG003|6-month Add-on Therapy Period|Disease Activity|2
964180|NCT01156311|1963779|FG000|6-month Add-on Therapy Period|Physician Decision|0
964181|NCT01156311|1963780|FG001|6-month Add-on Therapy Period|Physician Decision|0
964182|NCT01156311|1963781|FG002|6-month Add-on Therapy Period|Physician Decision|1
964183|NCT01156311|1963782|FG003|6-month Add-on Therapy Period|Physician Decision|0
964184|NCT01156311|1963779|FG000|6-month Add-on Therapy Period|Other|0
964185|NCT01156311|1963780|FG001|6-month Add-on Therapy Period|Other|0
964186|NCT01156311|1963781|FG002|6-month Add-on Therapy Period|Other|1
964187|NCT01156311|1963782|FG003|6-month Add-on Therapy Period|Other|2
964188|NCT01156363|1963793|FG000|Overall Study|Adverse Event|6
964189|NCT01156363|1963793|FG000|Overall Study|Insufficient Therapeutic Response|5
964190|NCT01156363|1963793|FG000|Overall Study|Failure to Return|1
964191|NCT01156363|1963793|FG000|Overall Study|Refused Treatment|4
964192|NCT01156363|1963793|FG000|Overall Study|Other|6
964193|NCT01156376|1963807|FG000|Overall Study|Adverse Event|1
964194|NCT01156376|1963808|FG001|Overall Study|Adverse Event|0
964195|NCT01156376|1963809|FG002|Overall Study|Adverse Event|1
964196|NCT01156376|1963807|FG000|Overall Study|Withdrawal by Subject|0
964197|NCT01156376|1963808|FG001|Overall Study|Withdrawal by Subject|0
964198|NCT01156376|1963809|FG002|Overall Study|Withdrawal by Subject|3
964199|NCT01156480|1963819|FG000|Overall Study|change in diagnosis|0
964200|NCT01156480|1963820|FG001|Overall Study|change in diagnosis|1
964201|NCT01156532|1963828|FG000|Overall Study|Family Reasons|1
964202|NCT01156532|1963828|FG000|Overall Study|Lost to Follow-up|1
964203|NCT01156675|1963854|FG000|Overall Study|Death|5
964204|NCT01156675|1963855|FG001|Overall Study|Death|3
964205|NCT01156675|1963856|FG002|Overall Study|Death|0
964206|NCT01156675|1963854|FG000|Overall Study|No data|29
964207|NCT01156675|1963855|FG001|Overall Study|No data|22
964208|NCT01156675|1963856|FG002|Overall Study|No data|2
964209|NCT01156714|1963881|FG000|Overall Study|Withdrawal by Subject|9
964210|NCT01156714|1963882|FG001|Overall Study|Withdrawal by Subject|4
964211|NCT01156714|1963883|FG002|Overall Study|Withdrawal by Subject|3
964212|NCT01156792|1963894|FG000|Overall Study|Adverse Event|1
964213|NCT01156792|1963894|FG000|Overall Study|Lack of Efficacy|36
964214|NCT01156792|1963894|FG000|Overall Study|Protocol Violation|6
964215|NCT01156792|1963894|FG000|Overall Study|Lost to Follow-up|3
964216|NCT01156792|1963894|FG000|Overall Study|Physician Decision|3
964217|NCT01156792|1963894|FG000|Overall Study|Withdrawal by Subject|9
964218|NCT01156792|1963894|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11
964219|NCT01156844|1963922|FG000|Overall Study|Adverse Event|0
964220|NCT01156844|1963923|FG001|Overall Study|Adverse Event|0
964221|NCT01156844|1963924|FG002|Overall Study|Adverse Event|1
964222|NCT01156844|1963925|FG003|Overall Study|Adverse Event|1
964223|NCT01156844|1963922|FG000|Overall Study|Abnormal test procedure result(s)|0
964224|NCT01156844|1963923|FG001|Overall Study|Abnormal test procedure result(s)|1
964225|NCT01156844|1963924|FG002|Overall Study|Abnormal test procedure result(s)|2
964226|NCT01156844|1963925|FG003|Overall Study|Abnormal test procedure result(s)|2
964227|NCT01156844|1963922|FG000|Overall Study|Withdrawal by Subject|0
964228|NCT01156844|1963923|FG001|Overall Study|Withdrawal by Subject|0
964229|NCT01156844|1963924|FG002|Overall Study|Withdrawal by Subject|2
964230|NCT01156844|1963925|FG003|Overall Study|Withdrawal by Subject|2
964231|NCT01156844|1963922|FG000|Overall Study|Lost to Follow-up|0
964232|NCT01156844|1963923|FG001|Overall Study|Lost to Follow-up|0
964233|NCT01156844|1963924|FG002|Overall Study|Lost to Follow-up|1
964234|NCT01156844|1963925|FG003|Overall Study|Lost to Follow-up|0
964235|NCT01156844|1963922|FG000|Overall Study|Administrative problems|0
964236|NCT01156844|1963923|FG001|Overall Study|Administrative problems|1
964237|NCT01156844|1963924|FG002|Overall Study|Administrative problems|0
964238|NCT01156844|1963925|FG003|Overall Study|Administrative problems|1
964239|NCT01156844|1963922|FG000|Overall Study|Protocol deviation|2
964240|NCT01156844|1963923|FG001|Overall Study|Protocol deviation|0
964241|NCT01156844|1963924|FG002|Overall Study|Protocol deviation|0
964242|NCT01156844|1963925|FG003|Overall Study|Protocol deviation|0
964243|NCT01157065|1963949|FG000|Overall Study|Death|0
964244|NCT01157065|1963950|FG001|Overall Study|Death|1
964245|NCT01157078|1963958|FG000|Overall Study|Withdrawal by Subject|12
964246|NCT01157078|1963959|FG001|Overall Study|Withdrawal by Subject|14
964247|NCT01157078|1963958|FG000|Overall Study|Eligibility criteria not fulfilled|2
964248|NCT01157078|1963959|FG001|Overall Study|Eligibility criteria not fulfilled|0
964249|NCT01157078|1963958|FG000|Overall Study|Adverse Event|6
964250|NCT01157078|1963959|FG001|Overall Study|Adverse Event|6
964251|NCT01157078|1963958|FG000|Overall Study|Severe non-compliance to protocol|2
964252|NCT01157078|1963959|FG001|Overall Study|Severe non-compliance to protocol|4
964253|NCT01157078|1963958|FG000|Overall Study|Condition under investigation worsened|0
964254|NCT01157078|1963959|FG001|Overall Study|Condition under investigation worsened|1
964255|NCT01157078|1963958|FG000|Overall Study|Lack of Efficacy|2
964256|NCT01157078|1963959|FG001|Overall Study|Lack of Efficacy|0
964257|NCT01157078|1963958|FG000|Overall Study|Study-specific withdrawal criteria|2
964258|NCT01157078|1963959|FG001|Overall Study|Study-specific withdrawal criteria|2
964259|NCT01157078|1963958|FG000|Overall Study|Lost to Follow-up|7
964260|NCT01157078|1963959|FG001|Overall Study|Lost to Follow-up|5
964261|NCT01157078|1963958|FG000|Overall Study|Other|2
964262|NCT01157078|1963959|FG001|Overall Study|Other|4
964263|NCT01157117|1963968|FG000|Overall Study|Dosing Symptoms|0
964264|NCT01157117|1963969|FG001|Overall Study|Dosing Symptoms|4
964265|NCT01157117|1963970|FG002|Overall Study|Dosing Symptoms|0
964266|NCT01157117|1963968|FG000|Overall Study|Withdrawal by Subject|4
964267|NCT01157117|1963969|FG001|Overall Study|Withdrawal by Subject|1
964268|NCT01157117|1963970|FG002|Overall Study|Withdrawal by Subject|1
964269|NCT01157117|1963968|FG000|Overall Study|Lack of Efficacy|1
964270|NCT01157117|1963969|FG001|Overall Study|Lack of Efficacy|1
964271|NCT01157117|1963970|FG002|Overall Study|Lack of Efficacy|0
964272|NCT01157117|1963968|FG000|Overall Study|Lost to Follow-up|0
964273|NCT01157117|1963969|FG001|Overall Study|Lost to Follow-up|0
964274|NCT01157117|1963970|FG002|Overall Study|Lost to Follow-up|1
964275|NCT01157117|1963968|FG000|Overall Study|Unknown (Pending Final Form Submission)|4
964276|NCT01157117|1963969|FG001|Overall Study|Unknown (Pending Final Form Submission)|5
964277|NCT01157117|1963970|FG002|Overall Study|Unknown (Pending Final Form Submission)|13
964278|NCT01157169|1963980|FG000|First Intervention|Emesis Within 4 hrs of Administration|4
964279|NCT01157169|1963981|FG001|First Intervention|Emesis Within 4 hrs of Administration|2
964280|NCT01157169|1963980|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0
964281|NCT01157169|1963981|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1
964282|NCT01157182|1963989|FG000|Washout of 28 Days|Adverse Event|2
964283|NCT01157182|1963990|FG001|Washout of 28 Days|Adverse Event|0
964284|NCT01157234|1963998|FG000|Overall Study|Withdrawal by Subject|1
964285|NCT01157234|1963999|FG001|Overall Study|Withdrawal by Subject|0
964286|NCT01157351|1964014|FG000|Overall Study|Adverse Event|5
964287|NCT01157351|1964015|FG001|Overall Study|Adverse Event|4
964288|NCT01157351|1964014|FG000|Overall Study|Death|1
964289|NCT01157351|1964015|FG001|Overall Study|Death|0
964290|NCT01157351|1964014|FG000|Overall Study|Lost to Follow-up|53
964291|NCT01157351|1964015|FG001|Overall Study|Lost to Follow-up|55
964292|NCT01157351|1964014|FG000|Overall Study|Withdrawal by Subject|37
964293|NCT01157351|1964015|FG001|Overall Study|Withdrawal by Subject|27
964294|NCT01157351|1964014|FG000|Overall Study|Physician Decision|5
964295|NCT01157351|1964015|FG001|Overall Study|Physician Decision|4
964296|NCT01157351|1964014|FG000|Overall Study|Protocol Violation|0
964297|NCT01157351|1964015|FG001|Overall Study|Protocol Violation|1
964298|NCT01157351|1964014|FG000|Overall Study|Other|32
964299|NCT01157351|1964015|FG001|Overall Study|Other|36
964300|NCT01157351|1964014|FG000|Overall Study|Noncompliance with Study Drug|0
964301|NCT01157351|1964015|FG001|Overall Study|Noncompliance with Study Drug|3
964302|NCT01157351|1964014|FG000|Overall Study|Randomized but not Treated|4
964303|NCT01157351|1964015|FG001|Overall Study|Randomized but not Treated|2
964304|NCT01157364|1964027|FG000|Overall Study|Other Reasons|1
964305|NCT01157364|1964028|FG001|Overall Study|Other Reasons|1
964306|NCT01157364|1964029|FG002|Overall Study|Other Reasons|2
964307|NCT01157364|1964030|FG003|Overall Study|Other Reasons|1
964308|NCT01157364|1964031|FG004|Overall Study|Other Reasons|0
964309|NCT01157364|1964032|FG005|Overall Study|Other Reasons|0
964310|NCT01157364|1964027|FG000|Overall Study|Personal Reasons|0
964311|NCT01157364|1964028|FG001|Overall Study|Personal Reasons|2
964312|NCT01157364|1964029|FG002|Overall Study|Personal Reasons|0
964313|NCT01157364|1964030|FG003|Overall Study|Personal Reasons|0
964314|NCT01157364|1964031|FG004|Overall Study|Personal Reasons|1
964315|NCT01157364|1964032|FG005|Overall Study|Personal Reasons|1
964316|NCT01157364|1964027|FG000|Overall Study|Lost to Follow-up|1
964317|NCT01157364|1964028|FG001|Overall Study|Lost to Follow-up|0
964318|NCT01157364|1964029|FG002|Overall Study|Lost to Follow-up|1
964319|NCT01157364|1964030|FG003|Overall Study|Lost to Follow-up|0
964320|NCT01157364|1964031|FG004|Overall Study|Lost to Follow-up|0
964321|NCT01157364|1964032|FG005|Overall Study|Lost to Follow-up|0
964322|NCT01157364|1964027|FG000|Overall Study|Lack of Efficacy|0
964323|NCT01157364|1964028|FG001|Overall Study|Lack of Efficacy|0
964324|NCT01157364|1964029|FG002|Overall Study|Lack of Efficacy|0
964325|NCT01157364|1964030|FG003|Overall Study|Lack of Efficacy|1
964326|NCT01157364|1964031|FG004|Overall Study|Lack of Efficacy|0
964327|NCT01157364|1964032|FG005|Overall Study|Lack of Efficacy|0
964328|NCT01157364|1964027|FG000|Overall Study|Adverse Event|0
964329|NCT01157364|1964028|FG001|Overall Study|Adverse Event|1
964330|NCT01157364|1964029|FG002|Overall Study|Adverse Event|1
964331|NCT01157364|1964030|FG003|Overall Study|Adverse Event|0
964332|NCT01157364|1964031|FG004|Overall Study|Adverse Event|1
964333|NCT01157364|1964032|FG005|Overall Study|Adverse Event|0
964334|NCT01157377|1964053|FG000|Overall Study|Lost to Follow-up|0
964335|NCT01157377|1964054|FG001|Overall Study|Lost to Follow-up|0
964336|NCT01157377|1964055|FG002|Overall Study|Lost to Follow-up|1
964337|NCT01157377|1964056|FG003|Overall Study|Lost to Follow-up|0
964338|NCT01157377|1964057|FG004|Overall Study|Lost to Follow-up|1
964339|NCT01157377|1964058|FG005|Overall Study|Lost to Follow-up|1
964340|NCT01157377|1964059|FG006|Overall Study|Lost to Follow-up|0
964341|NCT01157377|1964053|FG000|Overall Study|Personal Reasons|2
964342|NCT01157377|1964054|FG001|Overall Study|Personal Reasons|1
964343|NCT01157377|1964055|FG002|Overall Study|Personal Reasons|0
964344|NCT01157377|1964056|FG003|Overall Study|Personal Reasons|1
964345|NCT01157377|1964057|FG004|Overall Study|Personal Reasons|0
964346|NCT01157377|1964058|FG005|Overall Study|Personal Reasons|0
964347|NCT01157377|1964059|FG006|Overall Study|Personal Reasons|0
964348|NCT01157377|1964053|FG000|Overall Study|Protocol Violation|0
964349|NCT01157377|1964054|FG001|Overall Study|Protocol Violation|0
964350|NCT01157377|1964055|FG002|Overall Study|Protocol Violation|0
964351|NCT01157377|1964056|FG003|Overall Study|Protocol Violation|0
964352|NCT01157377|1964057|FG004|Overall Study|Protocol Violation|0
964353|NCT01157377|1964058|FG005|Overall Study|Protocol Violation|1
964354|NCT01157377|1964059|FG006|Overall Study|Protocol Violation|0
964355|NCT01157377|1964053|FG000|Overall Study|Lack of Efficacy|0
964356|NCT01157377|1964054|FG001|Overall Study|Lack of Efficacy|0
964357|NCT01157377|1964055|FG002|Overall Study|Lack of Efficacy|0
964358|NCT01157377|1964056|FG003|Overall Study|Lack of Efficacy|0
964359|NCT01157377|1964057|FG004|Overall Study|Lack of Efficacy|0
964360|NCT01157377|1964058|FG005|Overall Study|Lack of Efficacy|0
964361|NCT01157377|1964059|FG006|Overall Study|Lack of Efficacy|1
964362|NCT01157377|1964053|FG000|Overall Study|Other Miscellaneous Reasons|0
964363|NCT01157377|1964054|FG001|Overall Study|Other Miscellaneous Reasons|2
964364|NCT01157377|1964055|FG002|Overall Study|Other Miscellaneous Reasons|0
964365|NCT01157377|1964056|FG003|Overall Study|Other Miscellaneous Reasons|0
964366|NCT01157377|1964057|FG004|Overall Study|Other Miscellaneous Reasons|1
964367|NCT01157377|1964058|FG005|Overall Study|Other Miscellaneous Reasons|1
964368|NCT01157377|1964059|FG006|Overall Study|Other Miscellaneous Reasons|1
964369|NCT01157676|1964095|FG000|Randomization|Death|1
964370|NCT01157676|1964096|FG001|Randomization|Death|1
964371|NCT01157676|1964095|FG000|Randomization|unresectable|2
964372|NCT01157676|1964096|FG001|Randomization|unresectable|3
964373|NCT01157676|1964095|FG000|Randomization|Withdrawal by Subject|17
964374|NCT01157676|1964096|FG001|Randomization|Withdrawal by Subject|13
964375|NCT01157676|1964095|FG000|Randomization|Physician Decision|1
964376|NCT01157676|1964096|FG001|Randomization|Physician Decision|0
964377|NCT01157676|1964095|FG000|Surgery|underwent open cystectomy|0
964378|NCT01157676|1964096|FG001|Surgery|underwent open cystectomy|4
964379|NCT01157676|1964095|FG000|Surgery|converted to open procedure|0
964380|NCT01157676|1964096|FG001|Surgery|converted to open procedure|5
964381|NCT01157676|1964095|FG000|Surgery|underwent robotic cystectomy|1
964382|NCT01157676|1964096|FG001|Surgery|underwent robotic cystectomy|0
964383|NCT01157845|1964108|FG000|Overall Study|Lost to Follow-up|5
964384|NCT01157845|1964108|FG000|Overall Study|Withdrawal by Subject|12
964385|NCT01157845|1964108|FG000|Overall Study|Physician Decision|3
964386|NCT01157845|1964108|FG000|Overall Study|Protocol Violation|13
964387|NCT01157845|1964108|FG000|Overall Study|Study was ended|1
964388|NCT01157845|1964108|FG000|Overall Study|Device malfunction|1
964389|NCT01157897|1964116|FG000|Overall Study|Lost to Follow-up|2
964390|NCT01157897|1964117|FG001|Overall Study|Lost to Follow-up|0
964391|NCT01157897|1964118|FG002|Overall Study|Lost to Follow-up|0
964392|NCT01157897|1964119|FG003|Overall Study|Lost to Follow-up|1
964393|NCT01157897|1964116|FG000|Overall Study|Relocated|0
964394|NCT01157897|1964117|FG001|Overall Study|Relocated|2
964395|NCT01157897|1964118|FG002|Overall Study|Relocated|0
964396|NCT01157897|1964119|FG003|Overall Study|Relocated|0
964397|NCT01158118|1964131|FG000|Overall Study|Screen failure|1
964398|NCT01158118|1964132|FG001|Overall Study|Screen failure|0
964399|NCT01158118|1964131|FG000|Overall Study|Donor match was a screen failure|0
964400|NCT01158118|1964132|FG001|Overall Study|Donor match was a screen failure|1
964401|NCT01158118|1964131|FG000|Overall Study|Suffered stroke prior to transplant|0
964402|NCT01158118|1964132|FG001|Overall Study|Suffered stroke prior to transplant|1
964403|NCT01158118|1964131|FG000|Overall Study|Death|0
964404|NCT01158118|1964132|FG001|Overall Study|Death|1
964405|NCT01158222|1964142|FG000|Overall Study|Not eligible for intermediate phase|17
964406|NCT01158261|1964146|FG000|Overall Study|Lost to Follow-up|9
964407|NCT01158261|1964146|FG000|Overall Study|Death|7
964408|NCT01158261|1964146|FG000|Overall Study|Withdrawal by Subject|1
964409|NCT01158378|1964152|FG000|Overall Study|Death|4
964410|NCT01158378|1964153|FG001|Overall Study|Death|5
964411|NCT01158378|1964152|FG000|Overall Study|Lost to Follow-up|2
964412|NCT01158378|1964153|FG001|Overall Study|Lost to Follow-up|4
964413|NCT01158378|1964152|FG000|Overall Study|Withdrawal by Subject|4
964414|NCT01158378|1964153|FG001|Overall Study|Withdrawal by Subject|0
964415|NCT01158404|1964168|FG000|Overall Study|Withdrawal by Subject|0
964416|NCT01158404|1964169|FG001|Overall Study|Withdrawal by Subject|1
964417|NCT01158404|1964170|FG002|Overall Study|Withdrawal by Subject|0
964418|NCT01158404|1964171|FG003|Overall Study|Withdrawal by Subject|0
964419|NCT01158404|1964172|FG004|Overall Study|Withdrawal by Subject|3
964420|NCT01158404|1964173|FG005|Overall Study|Withdrawal by Subject|1
964421|NCT01158404|1964174|FG006|Overall Study|Withdrawal by Subject|0
964422|NCT01158404|1964175|FG007|Overall Study|Withdrawal by Subject|1
964423|NCT01158404|1964168|FG000|Overall Study|Physician Decision|0
964424|NCT01158404|1964169|FG001|Overall Study|Physician Decision|0
964425|NCT01158404|1964170|FG002|Overall Study|Physician Decision|0
964426|NCT01158404|1964171|FG003|Overall Study|Physician Decision|0
964427|NCT01158404|1964172|FG004|Overall Study|Physician Decision|0
964428|NCT01158404|1964173|FG005|Overall Study|Physician Decision|0
964429|NCT01158404|1964174|FG006|Overall Study|Physician Decision|0
964430|NCT01158404|1964175|FG007|Overall Study|Physician Decision|1
964431|NCT01158404|1964168|FG000|Overall Study|Progressive Disease|0
964432|NCT01158404|1964169|FG001|Overall Study|Progressive Disease|0
964433|NCT01158404|1964170|FG002|Overall Study|Progressive Disease|0
964434|NCT01158404|1964171|FG003|Overall Study|Progressive Disease|0
964435|NCT01158404|1964172|FG004|Overall Study|Progressive Disease|0
964436|NCT01158404|1964173|FG005|Overall Study|Progressive Disease|0
964437|NCT01158404|1964174|FG006|Overall Study|Progressive Disease|1
964438|NCT01158404|1964175|FG007|Overall Study|Progressive Disease|0
964439|NCT01158534|1964201|FG000|Overall Study|Withdrawal by Subject|1
964440|NCT01158534|1964201|FG000|Overall Study|Death|1
964441|NCT01158534|1964201|FG000|Overall Study|Other|1
964442|NCT01158924|1964260|FG000|Overall Study|Withdrawal by Subject|1
964443|NCT01158924|1964261|FG001|Overall Study|Withdrawal by Subject|2
964444|NCT01158924|1964260|FG000|Overall Study|Lost to Follow-up|0
964445|NCT01158924|1964261|FG001|Overall Study|Lost to Follow-up|1
964446|NCT01158950|1964267|FG000|1st Intervention (1 Day)|Physician Decision|1
964447|NCT01158950|1964268|FG001|1st Intervention (1 Day)|Physician Decision|2
964448|NCT01159171|1964299|FG000|Overall Study|Adverse Event|11
964449|NCT01159171|1964299|FG000|Overall Study|Progression of Disease|28
964450|NCT01159171|1964299|FG000|Overall Study|Protocol Violation|1
964451|NCT01159171|1964299|FG000|Overall Study|Need for Surgery|5
964452|NCT01159171|1964299|FG000|Overall Study|Medical Decision|4
964453|NCT01159171|1964299|FG000|Overall Study|Death|1
964454|NCT01159431|1964319|FG000|Overall Study|Adverse Event|1
964455|NCT01159431|1964320|FG001|Overall Study|Adverse Event|2
964456|NCT01159431|1964319|FG000|Overall Study|non-compliance|1
964457|NCT01159431|1964320|FG001|Overall Study|non-compliance|1
964458|NCT01159431|1964319|FG000|Overall Study|Lack of Efficacy|0
964459|NCT01159431|1964320|FG001|Overall Study|Lack of Efficacy|3
964460|NCT01159574|1964346|FG000|Treatment Phase|non-evaluable/not included in analysis|1
964461|NCT01159574|1964346|FG000|Treatment Phase|Adverse Event|3
964462|NCT01159574|1964346|FG000|Treatment Phase|Death|6
964463|NCT01159574|1964346|FG000|Treatment Phase|Physician Decision|2
964464|NCT01159574|1964346|FG000|Treatment Phase|Withdrawal by Subject|7
911115|NCT00796666|1888271|FG001|Overall Study|Randomized and not treated|0
911116|NCT00796718|1888296|FG000|Overall Study|Adverse Event|2
911117|NCT00796718|1888296|FG000|Overall Study|Exclusion Criteria|1
911118|NCT00796718|1888296|FG000|Overall Study|Lost to Follow-up|5
964465|NCT01159574|1964346|FG000|Treatment Phase|still on treatment|2
964466|NCT01159574|1964346|FG000|Follow Up Phase|Lost to Follow-up|2
964467|NCT01159574|1964346|FG000|Follow Up Phase|still being followed for overall surviva|18
964468|NCT01159600|1964358|FG000|Overall Study|Not treated|0
964469|NCT01159600|1964359|FG001|Overall Study|Not treated|0
964470|NCT01159600|1964360|FG002|Overall Study|Not treated|1
964471|NCT01159600|1964361|FG003|Overall Study|Not treated|0
964472|NCT01159600|1964362|FG004|Overall Study|Not treated|0
964473|NCT01159600|1964363|FG005|Overall Study|Not treated|1
964474|NCT01159600|1964364|FG006|Overall Study|Not treated|2
964475|NCT01159600|1964365|FG007|Overall Study|Not treated|2
964476|NCT01159600|1964358|FG000|Overall Study|Adverse Event|7
964477|NCT01159600|1964359|FG001|Overall Study|Adverse Event|2
964478|NCT01159600|1964360|FG002|Overall Study|Adverse Event|5
964479|NCT01159600|1964361|FG003|Overall Study|Adverse Event|1
964480|NCT01159600|1964362|FG004|Overall Study|Adverse Event|8
964481|NCT01159600|1964363|FG005|Overall Study|Adverse Event|6
964482|NCT01159600|1964364|FG006|Overall Study|Adverse Event|7
964483|NCT01159600|1964365|FG007|Overall Study|Adverse Event|5
964484|NCT01159600|1964358|FG000|Overall Study|Lack of Efficacy|0
964485|NCT01159600|1964359|FG001|Overall Study|Lack of Efficacy|0
964486|NCT01159600|1964360|FG002|Overall Study|Lack of Efficacy|0
964487|NCT01159600|1964361|FG003|Overall Study|Lack of Efficacy|0
964488|NCT01159600|1964362|FG004|Overall Study|Lack of Efficacy|2
964489|NCT01159600|1964363|FG005|Overall Study|Lack of Efficacy|0
964490|NCT01159600|1964364|FG006|Overall Study|Lack of Efficacy|0
964491|NCT01159600|1964365|FG007|Overall Study|Lack of Efficacy|1
964492|NCT01159600|1964358|FG000|Overall Study|Non compliant with protocol|2
964493|NCT01159600|1964359|FG001|Overall Study|Non compliant with protocol|1
964494|NCT01159600|1964360|FG002|Overall Study|Non compliant with protocol|0
964495|NCT01159600|1964361|FG003|Overall Study|Non compliant with protocol|0
964496|NCT01159600|1964362|FG004|Overall Study|Non compliant with protocol|2
964497|NCT01159600|1964363|FG005|Overall Study|Non compliant with protocol|0
964498|NCT01159600|1964364|FG006|Overall Study|Non compliant with protocol|2
964499|NCT01159600|1964365|FG007|Overall Study|Non compliant with protocol|0
964500|NCT01159600|1964358|FG000|Overall Study|Lost to Follow-up|2
964501|NCT01159600|1964359|FG001|Overall Study|Lost to Follow-up|3
964502|NCT01159600|1964360|FG002|Overall Study|Lost to Follow-up|4
964503|NCT01159600|1964361|FG003|Overall Study|Lost to Follow-up|3
964504|NCT01159600|1964362|FG004|Overall Study|Lost to Follow-up|3
964505|NCT01159600|1964363|FG005|Overall Study|Lost to Follow-up|0
964506|NCT01159600|1964364|FG006|Overall Study|Lost to Follow-up|3
964507|NCT01159600|1964365|FG007|Overall Study|Lost to Follow-up|2
964508|NCT01159600|1964358|FG000|Overall Study|Patient refusal to continue,not due toAE|7
964509|NCT01159600|1964359|FG001|Overall Study|Patient refusal to continue,not due toAE|2
964510|NCT01159600|1964360|FG002|Overall Study|Patient refusal to continue,not due toAE|4
964511|NCT01159600|1964361|FG003|Overall Study|Patient refusal to continue,not due toAE|5
964512|NCT01159600|1964362|FG004|Overall Study|Patient refusal to continue,not due toAE|4
964513|NCT01159600|1964363|FG005|Overall Study|Patient refusal to continue,not due toAE|4
964514|NCT01159600|1964364|FG006|Overall Study|Patient refusal to continue,not due toAE|2
964515|NCT01159600|1964365|FG007|Overall Study|Patient refusal to continue,not due toAE|5
964516|NCT01159600|1964358|FG000|Overall Study|Other reason not defined above|3
964517|NCT01159600|1964359|FG001|Overall Study|Other reason not defined above|0
964518|NCT01159600|1964360|FG002|Overall Study|Other reason not defined above|4
964519|NCT01159600|1964361|FG003|Overall Study|Other reason not defined above|2
964520|NCT01159600|1964362|FG004|Overall Study|Other reason not defined above|5
964521|NCT01159600|1964363|FG005|Overall Study|Other reason not defined above|7
964522|NCT01159600|1964364|FG006|Overall Study|Other reason not defined above|3
964523|NCT01159600|1964365|FG007|Overall Study|Other reason not defined above|3
964524|NCT01159665|1964390|FG000|Overall Study|Withdrawal by Subject|0
964525|NCT01159665|1964391|FG001|Overall Study|Withdrawal by Subject|1
964526|NCT01159665|1964392|FG002|Overall Study|Withdrawal by Subject|0
964527|NCT01159665|1964393|FG003|Overall Study|Withdrawal by Subject|0
964528|NCT01159665|1964394|FG004|Overall Study|Withdrawal by Subject|0
964529|NCT01159665|1964395|FG005|Overall Study|Withdrawal by Subject|0
964530|NCT01159691|1964409|FG000|Overall Study|Lost to Follow-up|2
964531|NCT01159691|1964409|FG000|Overall Study|Unknown reasons|1
964532|NCT01159691|1964409|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6
964533|NCT01159691|1964409|FG000|Overall Study|Discontinued Neupro due to other reasons|1
964534|NCT01159691|1964409|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2
964535|NCT01159691|1964409|FG000|Overall Study|Disc. Neupro other & unknown reasons|7
964536|NCT01159691|1964409|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2
964537|NCT01159691|1964409|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1
964538|NCT01159769|1964422|FG000|Overall Study|Adverse Event|1
964539|NCT01159912|1964429|FG000|Overall Study|Adverse Event|2
964540|NCT01159912|1964430|FG001|Overall Study|Adverse Event|2
964541|NCT01159912|1964431|FG002|Overall Study|Adverse Event|3
964542|NCT01159912|1964429|FG000|Overall Study|Lack of Efficacy|23
964543|NCT01159912|1964430|FG001|Overall Study|Lack of Efficacy|15
964544|NCT01159912|1964431|FG002|Overall Study|Lack of Efficacy|14
964545|NCT01159912|1964429|FG000|Overall Study|Protocol Violation|1
964546|NCT01159912|1964430|FG001|Overall Study|Protocol Violation|2
964547|NCT01159912|1964431|FG002|Overall Study|Protocol Violation|3
964548|NCT01159912|1964429|FG000|Overall Study|Lost to Follow-up|4
964549|NCT01159912|1964430|FG001|Overall Study|Lost to Follow-up|0
964550|NCT01159912|1964431|FG002|Overall Study|Lost to Follow-up|0
964551|NCT01159912|1964429|FG000|Overall Study|Physician Decision|0
964552|NCT01159912|1964430|FG001|Overall Study|Physician Decision|0
964553|NCT01159912|1964431|FG002|Overall Study|Physician Decision|3
964554|NCT01159912|1964429|FG000|Overall Study|Withdrawal by Subject|10
964555|NCT01159912|1964430|FG001|Overall Study|Withdrawal by Subject|3
964556|NCT01159912|1964431|FG002|Overall Study|Withdrawal by Subject|3
964557|NCT01159938|1964442|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0
964558|NCT01159938|1964443|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0
964559|NCT01159938|1964444|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1
964560|NCT01159938|1964445|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0
964561|NCT01159938|1964446|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0
964562|NCT01160198|1964470|FG000|Overall Study|Withdrawal by Subject|2
964563|NCT01160198|1964471|FG001|Overall Study|Withdrawal by Subject|1
964564|NCT01160198|1964472|FG002|Overall Study|Withdrawal by Subject|0
964565|NCT01160198|1964470|FG000|Overall Study|Adverse Event|0
964566|NCT01160198|1964471|FG001|Overall Study|Adverse Event|1
964567|NCT01160198|1964472|FG002|Overall Study|Adverse Event|0
964568|NCT01160198|1964470|FG000|Overall Study|Lost to Follow-up|0
964569|NCT01160198|1964471|FG001|Overall Study|Lost to Follow-up|1
964570|NCT01160198|1964472|FG002|Overall Study|Lost to Follow-up|0
964571|NCT01160198|1964470|FG000|Overall Study|Participant lost drug; withdrew consent|0
964572|NCT01160198|1964471|FG001|Overall Study|Participant lost drug; withdrew consent|0
964573|NCT01160198|1964472|FG002|Overall Study|Participant lost drug; withdrew consent|1
964574|NCT01160211|1964483|FG000|Overall Study|ongoing|90
964575|NCT01160211|1964484|FG001|Overall Study|ongoing|75
964576|NCT01160211|1964485|FG002|Overall Study|ongoing|79
964577|NCT01160211|1964483|FG000|Overall Study|Withdrawal by Subject|3
964578|NCT01160211|1964484|FG001|Overall Study|Withdrawal by Subject|5
964579|NCT01160211|1964485|FG002|Overall Study|Withdrawal by Subject|3
964580|NCT01160211|1964483|FG000|Overall Study|Physician Decision|2
964581|NCT01160211|1964484|FG001|Overall Study|Physician Decision|0
964582|NCT01160211|1964485|FG002|Overall Study|Physician Decision|0
964583|NCT01160211|1964483|FG000|Overall Study|Lost to Follow-up|4
964584|NCT01160211|1964484|FG001|Overall Study|Lost to Follow-up|7
964585|NCT01160211|1964485|FG002|Overall Study|Lost to Follow-up|5
964586|NCT01160289|1964512|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8
964587|NCT01160289|1964513|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0
964588|NCT01160289|1964514|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0
964589|NCT01160289|1964515|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0
964590|NCT01160289|1964516|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0
964591|NCT01160289|1964517|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0
964592|NCT01160289|1964512|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
964593|NCT01160289|1964513|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
964594|NCT01160289|1964514|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
964595|NCT01160289|1964515|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
964596|NCT01160289|1964516|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
964597|NCT01160289|1964517|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
964598|NCT01160289|1964512|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
964599|NCT01160289|1964513|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
964600|NCT01160289|1964514|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
964601|NCT01160289|1964515|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
964602|NCT01160289|1964516|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
964603|NCT01160289|1964517|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
964604|NCT01160289|1964512|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
964605|NCT01160289|1964513|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
964606|NCT01160289|1964514|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
964607|NCT01160289|1964515|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
964608|NCT01160289|1964516|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
964609|NCT01160289|1964517|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
964610|NCT01160289|1964512|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26
964611|NCT01160289|1964513|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0
964612|NCT01160289|1964514|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0
964613|NCT01160289|1964515|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0
964614|NCT01160289|1964516|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0
964615|NCT01160289|1964517|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0
964616|NCT01160289|1964512|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1
964617|NCT01160289|1964513|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0
964618|NCT01160289|1964514|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0
964619|NCT01160289|1964515|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0
1006622|NCT01468701|2025297|FG012|Overall Study|Not being followed up|0
964620|NCT01160289|1964516|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0
964621|NCT01160289|1964517|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0
964622|NCT01160289|1964512|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
964623|NCT01160289|1964513|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
964624|NCT01160289|1964514|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
964625|NCT01160289|1964515|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
964626|NCT01160289|1964516|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
964627|NCT01160289|1964517|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
964628|NCT01160289|1964512|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
964629|NCT01160289|1964513|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
964630|NCT01160289|1964514|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
964631|NCT01160289|1964515|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
964632|NCT01160289|1964516|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
964633|NCT01160289|1964517|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
964634|NCT01160289|1964512|FG000|Post-Randomization Period|Adverse Event|0
964635|NCT01160289|1964513|FG001|Post-Randomization Period|Adverse Event|4
964636|NCT01160289|1964514|FG002|Post-Randomization Period|Adverse Event|4
964637|NCT01160289|1964515|FG003|Post-Randomization Period|Adverse Event|2
964638|NCT01160289|1964516|FG004|Post-Randomization Period|Adverse Event|0
964639|NCT01160289|1964517|FG005|Post-Randomization Period|Adverse Event|0
964640|NCT01160289|1964512|FG000|Post-Randomization Period|Death|0
964641|NCT01160289|1964513|FG001|Post-Randomization Period|Death|0
964642|NCT01160289|1964514|FG002|Post-Randomization Period|Death|0
964643|NCT01160289|1964515|FG003|Post-Randomization Period|Death|1
964644|NCT01160289|1964516|FG004|Post-Randomization Period|Death|0
964645|NCT01160289|1964517|FG005|Post-Randomization Period|Death|0
964646|NCT01160289|1964512|FG000|Post-Randomization Period|Lack of Efficacy|0
964647|NCT01160289|1964513|FG001|Post-Randomization Period|Lack of Efficacy|1
964648|NCT01160289|1964514|FG002|Post-Randomization Period|Lack of Efficacy|0
964649|NCT01160289|1964515|FG003|Post-Randomization Period|Lack of Efficacy|3
964650|NCT01160289|1964516|FG004|Post-Randomization Period|Lack of Efficacy|0
964651|NCT01160289|1964517|FG005|Post-Randomization Period|Lack of Efficacy|0
964652|NCT01160289|1964512|FG000|Post-Randomization Period|Lost to Follow-up|0
964653|NCT01160289|1964513|FG001|Post-Randomization Period|Lost to Follow-up|3
964654|NCT01160289|1964514|FG002|Post-Randomization Period|Lost to Follow-up|2
964655|NCT01160289|1964515|FG003|Post-Randomization Period|Lost to Follow-up|5
964656|NCT01160289|1964516|FG004|Post-Randomization Period|Lost to Follow-up|3
964657|NCT01160289|1964517|FG005|Post-Randomization Period|Lost to Follow-up|4
964658|NCT01160289|1964512|FG000|Post-Randomization Period|Physician Decision|0
964659|NCT01160289|1964513|FG001|Post-Randomization Period|Physician Decision|0
964660|NCT01160289|1964514|FG002|Post-Randomization Period|Physician Decision|1
964661|NCT01160289|1964515|FG003|Post-Randomization Period|Physician Decision|0
964662|NCT01160289|1964516|FG004|Post-Randomization Period|Physician Decision|0
964663|NCT01160289|1964517|FG005|Post-Randomization Period|Physician Decision|0
964664|NCT01160289|1964512|FG000|Post-Randomization Period|Protocol Violation|0
964665|NCT01160289|1964513|FG001|Post-Randomization Period|Protocol Violation|4
964666|NCT01160289|1964514|FG002|Post-Randomization Period|Protocol Violation|2
964667|NCT01160289|1964515|FG003|Post-Randomization Period|Protocol Violation|0
964668|NCT01160289|1964516|FG004|Post-Randomization Period|Protocol Violation|1
964669|NCT01160289|1964517|FG005|Post-Randomization Period|Protocol Violation|3
964670|NCT01160289|1964512|FG000|Post-Randomization Period|Withdrawal by Subject|0
964671|NCT01160289|1964513|FG001|Post-Randomization Period|Withdrawal by Subject|5
964672|NCT01160289|1964514|FG002|Post-Randomization Period|Withdrawal by Subject|13
964673|NCT01160289|1964515|FG003|Post-Randomization Period|Withdrawal by Subject|8
964674|NCT01160289|1964516|FG004|Post-Randomization Period|Withdrawal by Subject|5
964675|NCT01160289|1964517|FG005|Post-Randomization Period|Withdrawal by Subject|7
964676|NCT01160289|1964512|FG000|Post-Randomization Period|Entry Criteria Not Met|0
964677|NCT01160289|1964513|FG001|Post-Randomization Period|Entry Criteria Not Met|2
964678|NCT01160289|1964514|FG002|Post-Randomization Period|Entry Criteria Not Met|2
964679|NCT01160289|1964515|FG003|Post-Randomization Period|Entry Criteria Not Met|2
964680|NCT01160289|1964516|FG004|Post-Randomization Period|Entry Criteria Not Met|0
964681|NCT01160289|1964517|FG005|Post-Randomization Period|Entry Criteria Not Met|0
964682|NCT01160289|1964512|FG000|Post-Randomization Period|Sponsor Decision|0
964683|NCT01160289|1964513|FG001|Post-Randomization Period|Sponsor Decision|1
964684|NCT01160289|1964514|FG002|Post-Randomization Period|Sponsor Decision|0
964685|NCT01160289|1964515|FG003|Post-Randomization Period|Sponsor Decision|0
964686|NCT01160289|1964516|FG004|Post-Randomization Period|Sponsor Decision|0
964687|NCT01160289|1964517|FG005|Post-Randomization Period|Sponsor Decision|0
964688|NCT01160354|1964533|FG000|Overall Study|Death|0
964689|NCT01160354|1964534|FG001|Overall Study|Death|1
964690|NCT01160354|1964535|FG002|Overall Study|Death|1
964691|NCT01160484|1964565|FG000|Overall Study|Lack of Efficacy|9
964692|NCT01160484|1964565|FG000|Overall Study|Adverse Event|6
964693|NCT01160484|1964565|FG000|Overall Study|Withdrawal by Subject|2
964694|NCT01160484|1964565|FG000|Overall Study|inclusion/exclusion criteria failure|1
964695|NCT01160614|1964571|FG000|Overall Study|Withdrawal by Subject|0
964696|NCT01160614|1964572|FG001|Overall Study|Withdrawal by Subject|2
964697|NCT01160640|1964598|FG000|Overall Study|Physician Decision|3
964698|NCT01160640|1964599|FG001|Overall Study|Physician Decision|3
964699|NCT01160640|1964598|FG000|Overall Study|Incarceration|1
964700|NCT01160640|1964599|FG001|Overall Study|Incarceration|0
964701|NCT01160640|1964598|FG000|Overall Study|Withdrawal by Subject|0
964702|NCT01160640|1964599|FG001|Overall Study|Withdrawal by Subject|3
964703|NCT01160744|1964611|FG000|Overall Study|Withdrawal by Subject|11
964704|NCT01160744|1964612|FG001|Overall Study|Withdrawal by Subject|5
964705|NCT01160744|1964613|FG002|Overall Study|Withdrawal by Subject|6
964706|NCT01160744|1964614|FG003|Overall Study|Withdrawal by Subject|4
964707|NCT01160744|1964611|FG000|Overall Study|Not meet inclusion/exclusion criteria|0
964708|NCT01160744|1964612|FG001|Overall Study|Not meet inclusion/exclusion criteria|0
964709|NCT01160744|1964613|FG002|Overall Study|Not meet inclusion/exclusion criteria|1
964710|NCT01160744|1964614|FG003|Overall Study|Not meet inclusion/exclusion criteria|0
964711|NCT01160770|1964626|FG000|Overall Study|Adverse Event|10
964712|NCT01160770|1964626|FG000|Overall Study|Protocol Violation|2
964713|NCT01160770|1964626|FG000|Overall Study|Subject/parent/caregiver request|33
964714|NCT01160770|1964626|FG000|Overall Study|Physician Decision|1
964715|NCT01160770|1964626|FG000|Overall Study|Lost to Follow-up|7
964716|NCT01160770|1964626|FG000|Overall Study|Study termination or sponsor request|1
964717|NCT01160770|1964626|FG000|Overall Study|Death|9
964718|NCT01160770|1964626|FG000|Overall Study|Lack of Efficacy|15
964719|NCT01160770|1964626|FG000|Overall Study|Other Reasons|1
964720|NCT01160822|1964637|FG000|Overall Study|Adverse Event|0
964721|NCT01160822|1964638|FG001|Overall Study|Adverse Event|0
964722|NCT01160822|1964639|FG002|Overall Study|Adverse Event|0
964723|NCT01160822|1964640|FG003|Overall Study|Adverse Event|0
964724|NCT01160822|1964641|FG004|Overall Study|Adverse Event|1
964725|NCT01160822|1964642|FG005|Overall Study|Adverse Event|2
964726|NCT01160822|1964643|FG006|Overall Study|Adverse Event|5
964727|NCT01160822|1964637|FG000|Overall Study|Unsatisfactory therapeutic effect|0
964728|NCT01160822|1964638|FG001|Overall Study|Unsatisfactory therapeutic effect|0
964729|NCT01160822|1964639|FG002|Overall Study|Unsatisfactory therapeutic effect|0
964730|NCT01160822|1964640|FG003|Overall Study|Unsatisfactory therapeutic effect|0
964731|NCT01160822|1964641|FG004|Overall Study|Unsatisfactory therapeutic effect|4
964732|NCT01160822|1964642|FG005|Overall Study|Unsatisfactory therapeutic effect|5
964733|NCT01160822|1964643|FG006|Overall Study|Unsatisfactory therapeutic effect|3
964734|NCT01160822|1964637|FG000|Overall Study|Withdrawal by Subject|0
964735|NCT01160822|1964638|FG001|Overall Study|Withdrawal by Subject|0
964736|NCT01160822|1964639|FG002|Overall Study|Withdrawal by Subject|0
964737|NCT01160822|1964640|FG003|Overall Study|Withdrawal by Subject|0
964738|NCT01160822|1964641|FG004|Overall Study|Withdrawal by Subject|0
964739|NCT01160822|1964642|FG005|Overall Study|Withdrawal by Subject|0
964740|NCT01160822|1964643|FG006|Overall Study|Withdrawal by Subject|1
964741|NCT01160822|1964637|FG000|Overall Study|Lost to Follow-up|0
964742|NCT01160822|1964638|FG001|Overall Study|Lost to Follow-up|0
964743|NCT01160822|1964639|FG002|Overall Study|Lost to Follow-up|0
964744|NCT01160822|1964640|FG003|Overall Study|Lost to Follow-up|0
964745|NCT01160822|1964641|FG004|Overall Study|Lost to Follow-up|1
964746|NCT01160822|1964642|FG005|Overall Study|Lost to Follow-up|0
964747|NCT01160822|1964643|FG006|Overall Study|Lost to Follow-up|0
964748|NCT01160822|1964637|FG000|Overall Study|Administrative problems|0
964749|NCT01160822|1964638|FG001|Overall Study|Administrative problems|0
964750|NCT01160822|1964639|FG002|Overall Study|Administrative problems|0
964751|NCT01160822|1964640|FG003|Overall Study|Administrative problems|0
964752|NCT01160822|1964641|FG004|Overall Study|Administrative problems|1
964753|NCT01160822|1964642|FG005|Overall Study|Administrative problems|0
964754|NCT01160822|1964643|FG006|Overall Study|Administrative problems|0
964755|NCT01160822|1964637|FG000|Overall Study|Protocol deviation|0
964756|NCT01160822|1964638|FG001|Overall Study|Protocol deviation|0
964757|NCT01160822|1964639|FG002|Overall Study|Protocol deviation|0
964758|NCT01160822|1964640|FG003|Overall Study|Protocol deviation|0
964759|NCT01160822|1964641|FG004|Overall Study|Protocol deviation|2
964760|NCT01160822|1964642|FG005|Overall Study|Protocol deviation|0
964761|NCT01160822|1964643|FG006|Overall Study|Protocol deviation|0
964762|NCT01161043|1964673|FG000|Overall Study|Withdrawal by Subject|3
964763|NCT01161173|1964698|FG000|Overall Study|Protocol Violation|13
964764|NCT01161173|1964698|FG000|Overall Study|Lost to Follow-up|7
964765|NCT01161173|1964698|FG000|Overall Study|Progressive Disease|82
964766|NCT01161173|1964698|FG000|Overall Study|Withdrawal of Consent|5
964767|NCT01161173|1964698|FG000|Overall Study|Unacceptable Toxicity|21
964768|NCT01161173|1964698|FG000|Overall Study|Death|194
964769|NCT01161173|1964698|FG000|Overall Study|End of Study|2
964770|NCT01161173|1964698|FG000|Overall Study|Reasons Not Specified|23
964771|NCT01161407|1964731|FG000|Overall Study|Protocol Violation|3
964772|NCT01161407|1964732|FG001|Overall Study|Protocol Violation|1
964773|NCT01161446|1964750|FG000|Overall Study|Lost to Follow-up|18
964774|NCT01161446|1964751|FG001|Overall Study|Lost to Follow-up|14
964775|NCT01161446|1964750|FG000|Overall Study|Withdrawal by Subject|0
964776|NCT01161446|1964751|FG001|Overall Study|Withdrawal by Subject|1
964777|NCT01161472|1964757|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
964778|NCT01161472|1964758|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
964779|NCT01161472|1964759|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
964780|NCT01161472|1964760|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
964781|NCT01161498|1964772|FG000|Overall Study|Disease Progression|0
964782|NCT01161498|1964773|FG001|Overall Study|Disease Progression|1
964783|NCT01161524|1964781|FG000|Core Study (23 Weeks)|Adverse Event|3
964784|NCT01161524|1964782|FG001|Core Study (23 Weeks)|Adverse Event|0
964785|NCT01161524|1964783|FG002|Core Study (23 Weeks)|Adverse Event|0
964786|NCT01161524|1964781|FG000|Core Study (23 Weeks)|Other|1
964787|NCT01161524|1964782|FG001|Core Study (23 Weeks)|Other|0
964788|NCT01161524|1964783|FG002|Core Study (23 Weeks)|Other|0
964789|NCT01161524|1964781|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1
964790|NCT01161524|1964782|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1
964791|NCT01161524|1964783|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0
964792|NCT01161524|1964781|FG000|Core Study (23 Weeks)|Lost to Follow-up|1
964793|NCT01161524|1964782|FG001|Core Study (23 Weeks)|Lost to Follow-up|2
964794|NCT01161524|1964783|FG002|Core Study (23 Weeks)|Lost to Follow-up|0
964795|NCT01161524|1964781|FG000|Core Study (23 Weeks)|Subject Choice|3
964796|NCT01161524|1964782|FG001|Core Study (23 Weeks)|Subject Choice|2
964797|NCT01161524|1964783|FG002|Core Study (23 Weeks)|Subject Choice|0
964798|NCT01161524|1964781|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
964799|NCT01161524|1964782|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
964800|NCT01161524|1964783|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
964801|NCT01161524|1964781|FG000|Extension Phase (Approximately 83 Weeks)|Other|0
964802|NCT01161524|1964782|FG001|Extension Phase (Approximately 83 Weeks)|Other|0
964803|NCT01161524|1964783|FG002|Extension Phase (Approximately 83 Weeks)|Other|6
964804|NCT01161524|1964781|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
964805|NCT01161524|1964782|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
964806|NCT01161524|1964783|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
964807|NCT01161524|1964781|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
964808|NCT01161524|1964782|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
964809|NCT01161524|1964783|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
964810|NCT01161524|1964781|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
964811|NCT01161524|1964782|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
964812|NCT01161524|1964783|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
964813|NCT01161537|1964792|FG000|Part B|Withdrawal by Subject|2
964814|NCT01161628|1964810|FG000|Overall Study|Death|6
964815|NCT01161628|1964810|FG000|Overall Study|Lack of Efficacy|2
964816|NCT01162122|1964848|FG000|Overall Study|Withdrawal by Subject|52
964817|NCT01162122|1964849|FG001|Overall Study|Withdrawal by Subject|43
964818|NCT01162122|1964848|FG000|Overall Study|Lost to Follow-up|73
964819|NCT01162122|1964849|FG001|Overall Study|Lost to Follow-up|91
964820|NCT01162122|1964848|FG000|Overall Study|Adverse Event|3
964821|NCT01162122|1964849|FG001|Overall Study|Adverse Event|2
964822|NCT01162122|1964848|FG000|Overall Study|Death|51
964823|NCT01162122|1964849|FG001|Overall Study|Death|46
964824|NCT01162122|1964848|FG000|Overall Study|Protocol Violation|2
964825|NCT01162122|1964849|FG001|Overall Study|Protocol Violation|2
964826|NCT01162122|1964848|FG000|Overall Study|Inappropriate enrollment|5
964827|NCT01162122|1964849|FG001|Overall Study|Inappropriate enrollment|4
964828|NCT01162122|1964848|FG000|Overall Study|Administrative reason|1
964829|NCT01162122|1964849|FG001|Overall Study|Administrative reason|1
964830|NCT01162122|1964848|FG000|Overall Study|Unable to classify|3
964831|NCT01162122|1964849|FG001|Overall Study|Unable to classify|7
964832|NCT01162122|1964848|FG000|Overall Study|Missing primary reason|1
964833|NCT01162122|1964849|FG001|Overall Study|Missing primary reason|0
964834|NCT01162135|1964858|FG000|Overall Study|Withdrawal by Subject|1
964835|NCT01162135|1964858|FG000|Overall Study|Severe back pain|1
964836|NCT01162135|1964858|FG000|Overall Study|Ineligible|1
964837|NCT01162239|1964866|FG000|Treatment Phase|Withdrawal by Subject|1
964838|NCT01162239|1964867|FG001|Treatment Phase|Withdrawal by Subject|3
964839|NCT01162239|1964868|FG002|Treatment Phase|Withdrawal by Subject|2
964840|NCT01162239|1964869|FG003|Treatment Phase|Withdrawal by Subject|3
964841|NCT01162239|1964866|FG000|Treatment Phase|Death|0
964842|NCT01162239|1964867|FG001|Treatment Phase|Death|0
964843|NCT01162239|1964868|FG002|Treatment Phase|Death|0
964844|NCT01162239|1964869|FG003|Treatment Phase|Death|1
964845|NCT01162239|1964866|FG000|Treatment Phase|Lost to Follow-up|5
964846|NCT01162239|1964867|FG001|Treatment Phase|Lost to Follow-up|4
964847|NCT01162239|1964868|FG002|Treatment Phase|Lost to Follow-up|2
964848|NCT01162239|1964869|FG003|Treatment Phase|Lost to Follow-up|1
964849|NCT01162239|1964866|FG000|Extended Follow-up|Lost to Follow-up|8
964850|NCT01162239|1964867|FG001|Extended Follow-up|Lost to Follow-up|13
964851|NCT01162239|1964868|FG002|Extended Follow-up|Lost to Follow-up|8
964852|NCT01162239|1964869|FG003|Extended Follow-up|Lost to Follow-up|6
964853|NCT01162343|1964889|FG000|Overall Study|Left ED prior to psychiatrist assessment|80
964854|NCT01162343|1964889|FG000|Overall Study|Refused psychiatrist assessment|12
964855|NCT01162421|1964895|FG000|Overall Study|Did not receive study drug|2
964856|NCT01162421|1964896|FG001|Overall Study|Did not receive study drug|1
964857|NCT01162421|1964895|FG000|Overall Study|Adverse Event|2
964858|NCT01162421|1964896|FG001|Overall Study|Adverse Event|5
964859|NCT01162421|1964895|FG000|Overall Study|Lost to Follow-up|0
964860|NCT01162421|1964896|FG001|Overall Study|Lost to Follow-up|2
964861|NCT01162421|1964895|FG000|Overall Study|Lack of Efficacy|2
964862|NCT01162421|1964896|FG001|Overall Study|Lack of Efficacy|2
964863|NCT01162421|1964895|FG000|Overall Study|Other|2
964864|NCT01162421|1964896|FG001|Overall Study|Other|3
964865|NCT01162473|1964904|FG000|Overall Study|Adverse Event|2
964866|NCT01162473|1964905|FG001|Overall Study|Adverse Event|1
964867|NCT01162473|1964904|FG000|Overall Study|Withdrawal by Subject|0
964868|NCT01162473|1964905|FG001|Overall Study|Withdrawal by Subject|4
964869|NCT01162486|1964916|FG000|Overall Study|low ANC|1
964870|NCT01162486|1964917|FG001|Overall Study|low ANC|0
964871|NCT01162486|1964918|FG002|Overall Study|low ANC|0
964872|NCT01162486|1964919|FG003|Overall Study|low ANC|0
964873|NCT01162486|1964920|FG004|Overall Study|low ANC|0
964874|NCT01162486|1964916|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1
964875|NCT01162486|1964917|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0
964876|NCT01162486|1964918|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0
964877|NCT01162486|1964919|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0
964878|NCT01162486|1964920|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0
964879|NCT01162486|1964916|FG000|Overall Study|elevated LFTs|0
964880|NCT01162486|1964917|FG001|Overall Study|elevated LFTs|0
964881|NCT01162486|1964918|FG002|Overall Study|elevated LFTs|1
964882|NCT01162486|1964919|FG003|Overall Study|elevated LFTs|0
964883|NCT01162486|1964920|FG004|Overall Study|elevated LFTs|0
964884|NCT01162486|1964916|FG000|Overall Study|Pregnancy|0
964885|NCT01162486|1964917|FG001|Overall Study|Pregnancy|0
964886|NCT01162486|1964918|FG002|Overall Study|Pregnancy|0
964887|NCT01162486|1964919|FG003|Overall Study|Pregnancy|1
964888|NCT01162486|1964920|FG004|Overall Study|Pregnancy|0
964889|NCT01162499|1964936|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0
964890|NCT01162499|1964937|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1
964891|NCT01162863|1964961|FG000|Overall Study|Lack of Efficacy|1
964892|NCT01162863|1964962|FG001|Overall Study|Lack of Efficacy|0
964893|NCT01162863|1964963|FG002|Overall Study|Lack of Efficacy|0
964894|NCT01162863|1964961|FG000|Overall Study|Adverse Event|0
964895|NCT01162863|1964962|FG001|Overall Study|Adverse Event|1
964896|NCT01162863|1964963|FG002|Overall Study|Adverse Event|0
964897|NCT01163032|1964974|FG000|Randomization Phase|Withdrawal by Subject|2
964898|NCT01163032|1964975|FG001|Randomization Phase|Withdrawal by Subject|3
964899|NCT01163032|1964976|FG002|Randomization Phase|Withdrawal by Subject|0
964900|NCT01163032|1964974|FG000|Randomization Phase|Adverse Event|3
964901|NCT01163032|1964975|FG001|Randomization Phase|Adverse Event|3
964902|NCT01163032|1964976|FG002|Randomization Phase|Adverse Event|0
964903|NCT01163032|1964974|FG000|Randomization Phase|Protocol Violation|0
964904|NCT01163032|1964975|FG001|Randomization Phase|Protocol Violation|1
964905|NCT01163032|1964976|FG002|Randomization Phase|Protocol Violation|0
964906|NCT01163032|1964974|FG000|Randomization Phase|Various*|5
964907|NCT01163032|1964975|FG001|Randomization Phase|Various*|4
964908|NCT01163032|1964976|FG002|Randomization Phase|Various*|0
964909|NCT01163032|1964974|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0
964910|NCT01163032|1964975|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1
964911|NCT01163032|1964976|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0
964912|NCT01163032|1964974|FG000|Open Label Extension Phase|Adverse Event|0
964913|NCT01163032|1964975|FG001|Open Label Extension Phase|Adverse Event|0
964914|NCT01163032|1964976|FG002|Open Label Extension Phase|Adverse Event|3
964915|NCT01163032|1964974|FG000|Open Label Extension Phase|Withdrawal by Subject|0
964916|NCT01163032|1964975|FG001|Open Label Extension Phase|Withdrawal by Subject|0
964917|NCT01163032|1964976|FG002|Open Label Extension Phase|Withdrawal by Subject|3
964918|NCT01163032|1964974|FG000|Open Label Extension Phase|Protocol Violation|0
964919|NCT01163032|1964975|FG001|Open Label Extension Phase|Protocol Violation|0
964920|NCT01163032|1964976|FG002|Open Label Extension Phase|Protocol Violation|1
964921|NCT01163032|1964974|FG000|Open Label Extension Phase|Study Termination|0
964922|NCT01163032|1964975|FG001|Open Label Extension Phase|Study Termination|0
964923|NCT01163032|1964976|FG002|Open Label Extension Phase|Study Termination|7
964924|NCT01163032|1964974|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
964925|NCT01163032|1964975|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
964926|NCT01163032|1964976|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
964927|NCT01163149|1965002|FG000|Extension Treatment Period|Withdrawal by Subject|2
964928|NCT01163149|1965003|FG001|Extension Treatment Period|Withdrawal by Subject|0
964929|NCT01163149|1965004|FG002|Extension Treatment Period|Withdrawal by Subject|1
964930|NCT01163149|1965002|FG000|Extension Treatment Period|Adverse Event|0
964931|NCT01163149|1965003|FG001|Extension Treatment Period|Adverse Event|1
964932|NCT01163149|1965004|FG002|Extension Treatment Period|Adverse Event|0
964933|NCT01163149|1965002|FG000|Extension Treatment Period|Noncompliance|0
964934|NCT01163149|1965003|FG001|Extension Treatment Period|Noncompliance|0
964935|NCT01163149|1965004|FG002|Extension Treatment Period|Noncompliance|1
964936|NCT01163253|1965041|FG000|Overall Study|Withdrawn Due to Pregnancy|12
964937|NCT01163253|1965042|FG001|Overall Study|Withdrawn Due to Pregnancy|2
964938|NCT01163253|1965041|FG000|Overall Study|Study Terminated by Sponsor|978
964939|NCT01163253|1965042|FG001|Overall Study|Study Terminated by Sponsor|349
964940|NCT01163253|1965041|FG000|Overall Study|Protocol Violation|43
964941|NCT01163253|1965042|FG001|Overall Study|Protocol Violation|12
964942|NCT01163253|1965041|FG000|Overall Study|Withdrawal by Subject|199
964943|NCT01163253|1965042|FG001|Overall Study|Withdrawal by Subject|50
964944|NCT01163253|1965041|FG000|Overall Study|Medication Error|1
964945|NCT01163253|1965042|FG001|Overall Study|Medication Error|0
964946|NCT01163253|1965041|FG000|Overall Study|Lost to Follow-up|125
964947|NCT01163253|1965042|FG001|Overall Study|Lost to Follow-up|23
964948|NCT01163253|1965041|FG000|Overall Study|Insufficient Clinical Response|423
964949|NCT01163253|1965042|FG001|Overall Study|Insufficient Clinical Response|29
964950|NCT01163253|1965041|FG000|Overall Study|Adverse Event|300
964951|NCT01163253|1965042|FG001|Overall Study|Adverse Event|78
964952|NCT01163253|1965041|FG000|Overall Study|Death|17
964953|NCT01163253|1965042|FG001|Overall Study|Death|5
964954|NCT01163253|1965041|FG000|Overall Study|Ongoing|13
964955|NCT01163253|1965042|FG001|Overall Study|Ongoing|4
964956|NCT01163253|1965041|FG000|Overall Study|Other Unspecified|170
964957|NCT01163253|1965042|FG001|Overall Study|Other Unspecified|34
964958|NCT01163266|1965051|FG000|Overall Study|Pretreatment Event or Adverse Event|2
964959|NCT01163266|1965052|FG001|Overall Study|Pretreatment Event or Adverse Event|9
964960|NCT01163266|1965053|FG002|Overall Study|Pretreatment Event or Adverse Event|7
964961|NCT01163266|1965051|FG000|Overall Study|Lack of Efficacy|1
964962|NCT01163266|1965052|FG001|Overall Study|Lack of Efficacy|3
964963|NCT01163266|1965053|FG002|Overall Study|Lack of Efficacy|1
964964|NCT01163266|1965051|FG000|Overall Study|Noncompliance with Study Drug|0
964965|NCT01163266|1965052|FG001|Overall Study|Noncompliance with Study Drug|2
964966|NCT01163266|1965053|FG002|Overall Study|Noncompliance with Study Drug|0
964967|NCT01163266|1965051|FG000|Overall Study|Protocol Deviations|2
964968|NCT01163266|1965052|FG001|Overall Study|Protocol Deviations|2
911119|NCT00796718|1888296|FG000|Overall Study|Withdrawal by Informed Consent|1
911120|NCT00796757|1888315|FG000|Overall Study|Withdrawal by Subject|14
964969|NCT01163266|1965053|FG002|Overall Study|Protocol Deviations|5
964970|NCT01163266|1965051|FG000|Overall Study|Withdrawal of Consent|5
964971|NCT01163266|1965052|FG001|Overall Study|Withdrawal of Consent|7
964972|NCT01163266|1965053|FG002|Overall Study|Withdrawal of Consent|3
964973|NCT01163266|1965051|FG000|Overall Study|Lost to Follow-up|7
964974|NCT01163266|1965052|FG001|Overall Study|Lost to Follow-up|7
964975|NCT01163266|1965053|FG002|Overall Study|Lost to Follow-up|10
964976|NCT01163266|1965051|FG000|Overall Study|Other|1
964977|NCT01163266|1965052|FG001|Overall Study|Other|1
964978|NCT01163266|1965053|FG002|Overall Study|Other|2
964979|NCT01163279|1965063|FG000|Overall Study|Withdrawal by Subject|2
964980|NCT01163279|1965064|FG001|Overall Study|Withdrawal by Subject|0
964981|NCT01163292|1965073|FG000|Overall Study|Lack of Efficacy|9
964982|NCT01163292|1965074|FG001|Overall Study|Lack of Efficacy|0
964983|NCT01163292|1965073|FG000|Overall Study|Adverse Event|6
964984|NCT01163292|1965074|FG001|Overall Study|Adverse Event|0
964985|NCT01163292|1965073|FG000|Overall Study|Initiation of biological therapy|0
964986|NCT01163292|1965074|FG001|Overall Study|Initiation of biological therapy|15
964987|NCT01163292|1965073|FG000|Overall Study|Sufficient response to adalimumab|8
964988|NCT01163292|1965074|FG001|Overall Study|Sufficient response to adalimumab|0
964989|NCT01163292|1965073|FG000|Overall Study|Refusal to receive adalimumab|7
964990|NCT01163292|1965074|FG001|Overall Study|Refusal to receive adalimumab|0
964991|NCT01163292|1965073|FG000|Overall Study|Economic reasons|6
964992|NCT01163292|1965074|FG001|Overall Study|Economic reasons|0
964993|NCT01163292|1965073|FG000|Overall Study|No further visits|5
964994|NCT01163292|1965074|FG001|Overall Study|No further visits|7
964995|NCT01163318|1965080|FG000|Overall Study|Off-Label Use of Adalimumab|8
964996|NCT01163318|1965080|FG000|Overall Study|Did Not Continue Use of Adalimumab|26
964997|NCT01163318|1965080|FG000|Overall Study|History/comorbidity of malignant tumor|3
964998|NCT01163318|1965080|FG000|Overall Study|Participants Without Case Report Form|7
964999|NCT01163318|1965080|FG000|Overall Study|Multiple Reasons Per Participant|224
965000|NCT01163474|1965089|FG000|Overall Study|Withdrawal by Subject|1
965001|NCT01163474|1965089|FG000|Overall Study|Tech barriers to videoteleconference vis|12
965002|NCT01163474|1965089|FG000|Overall Study|Lost to Follow-up|3
965003|NCT01163617|1965105|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
965004|NCT01163617|1965106|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
965005|NCT01163617|1965107|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
965006|NCT01163617|1965108|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
965007|NCT01163617|1965109|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
965008|NCT01163617|1965110|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
965009|NCT01163617|1965111|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
965010|NCT01163617|1965112|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
965011|NCT01163617|1965105|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
965012|NCT01163617|1965106|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
965013|NCT01163617|1965107|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
965014|NCT01163617|1965108|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
965015|NCT01163617|1965109|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
965016|NCT01163617|1965110|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
965017|NCT01163617|1965111|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
965018|NCT01163617|1965112|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
965019|NCT01163617|1965105|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
965020|NCT01163617|1965106|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
965021|NCT01163617|1965107|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
965022|NCT01163617|1965108|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
965023|NCT01163617|1965109|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
965024|NCT01163617|1965110|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
965025|NCT01163617|1965111|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
965026|NCT01163617|1965112|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
965027|NCT01163721|1965168|FG000|Overall Study|Adverse Event|5
965028|NCT01163721|1965169|FG001|Overall Study|Adverse Event|6
965029|NCT01163721|1965168|FG000|Overall Study|Withdrawal by Subject|3
965030|NCT01163721|1965169|FG001|Overall Study|Withdrawal by Subject|4
965031|NCT01163721|1965168|FG000|Overall Study|Lost to Follow-up|0
965032|NCT01163721|1965169|FG001|Overall Study|Lost to Follow-up|1
965033|NCT01163721|1965168|FG000|Overall Study|Physician Decision|0
965034|NCT01163721|1965169|FG001|Overall Study|Physician Decision|1
965035|NCT01163747|1965177|FG000|Overall Study|Adverse Event|0
965036|NCT01163747|1965178|FG001|Overall Study|Adverse Event|5
965037|NCT01163747|1965177|FG000|Overall Study|Insufficient Therapeutic Response|0
965038|NCT01163747|1965178|FG001|Overall Study|Insufficient Therapeutic Response|1
965039|NCT01163747|1965177|FG000|Overall Study|Protocol Violation|0
965040|NCT01163747|1965178|FG001|Overall Study|Protocol Violation|1
965041|NCT01163747|1965177|FG000|Overall Study|Refused Treatment|6
965042|NCT01163747|1965178|FG001|Overall Study|Refused Treatment|4
965043|NCT01163786|1965195|FG000|Treatment With Bortezomib|Withdrawal by Subject|1
965044|NCT01163786|1965195|FG000|Treatment With Bortezomib|Adverse Event|2
965045|NCT01163786|1965195|FG000|Completed Follow up (Visit 9 and 10)|Other|1
965046|NCT01163851|1965201|FG000|Overall Study|Site Closure|0
965047|NCT01163851|1965202|FG001|Overall Study|Site Closure|1
965048|NCT01163851|1965201|FG000|Overall Study|Enrolled but not treated|1
965049|NCT01163851|1965202|FG001|Overall Study|Enrolled but not treated|0
965050|NCT01163916|1965211|FG000|Overall Study|Withdrawal by Subject|2
965051|NCT01163916|1965212|FG001|Overall Study|Withdrawal by Subject|0
965052|NCT01163916|1965213|FG002|Overall Study|Withdrawal by Subject|2
965053|NCT01163916|1965211|FG000|Overall Study|Adverse Event|2
965054|NCT01163916|1965212|FG001|Overall Study|Adverse Event|0
965055|NCT01163916|1965213|FG002|Overall Study|Adverse Event|1
965056|NCT01163916|1965211|FG000|Overall Study|Lack of Efficacy|2
965057|NCT01163916|1965212|FG001|Overall Study|Lack of Efficacy|0
965058|NCT01163916|1965213|FG002|Overall Study|Lack of Efficacy|1
965059|NCT01163916|1965211|FG000|Overall Study|Other|24
965060|NCT01163916|1965212|FG001|Overall Study|Other|4
965061|NCT01163916|1965213|FG002|Overall Study|Other|16
965062|NCT01164007|1965235|FG000|Overall Study|Adverse Event|5
965063|NCT01164007|1965235|FG000|Overall Study|Progression of Disease|30
965064|NCT01164007|1965235|FG000|Overall Study|Protocol Violation|1
965065|NCT01164007|1965235|FG000|Overall Study|Withdrawal by Subject|1
965066|NCT01164007|1965235|FG000|Overall Study|Medical Decision|3
965083|NCT01164475|1965268|FG000|Overall Study|Lack of Efficacy|1
965084|NCT01164475|1965269|FG001|Overall Study|Lack of Efficacy|0
965085|NCT01164475|1965268|FG000|Overall Study|Other|0
965086|NCT01164475|1965269|FG001|Overall Study|Other|1
965087|NCT01164475|1965268|FG000|Overall Study|Progressive disease|0
965088|NCT01164475|1965269|FG001|Overall Study|Progressive disease|1
965089|NCT01164475|1965268|FG000|Overall Study|Protocol Violation|1
965090|NCT01164475|1965269|FG001|Overall Study|Protocol Violation|0
911121|NCT00796757|1888315|FG000|Overall Study|Death|61
911122|NCT00796757|1888315|FG000|Overall Study|Protocol Violation|1
911123|NCT00796757|1888315|FG000|Overall Study|Participant noncompliance|1
911124|NCT00796757|1888315|FG000|Overall Study|Investigator's decision|2
911125|NCT00796757|1888315|FG000|Overall Study|Other|7
911126|NCT00796822|1888321|FG000|Overall Study|Lost to Follow-up|2
911127|NCT00796822|1888322|FG001|Overall Study|Lost to Follow-up|0
911128|NCT00796822|1888321|FG000|Overall Study|Adverse Event|1
965091|NCT01164501|1965278|FG000|Overall Study|Not treated|2
965092|NCT01164501|1965279|FG001|Overall Study|Not treated|0
965093|NCT01164501|1965280|FG002|Overall Study|Not treated|1
965094|NCT01164501|1965278|FG000|Overall Study|Adverse Event|18
965095|NCT01164501|1965279|FG001|Overall Study|Adverse Event|4
965096|NCT01164501|1965280|FG002|Overall Study|Adverse Event|21
965097|NCT01164501|1965278|FG000|Overall Study|Lack of Efficacy|0
965098|NCT01164501|1965279|FG001|Overall Study|Lack of Efficacy|0
965099|NCT01164501|1965280|FG002|Overall Study|Lack of Efficacy|1
965100|NCT01164501|1965278|FG000|Overall Study|Non compliant with protocol|1
965101|NCT01164501|1965279|FG001|Overall Study|Non compliant with protocol|1
965102|NCT01164501|1965280|FG002|Overall Study|Non compliant with protocol|4
965103|NCT01164501|1965278|FG000|Overall Study|Lost to Follow-up|3
965104|NCT01164501|1965279|FG001|Overall Study|Lost to Follow-up|0
965105|NCT01164501|1965280|FG002|Overall Study|Lost to Follow-up|3
965106|NCT01164501|1965278|FG000|Overall Study|Patient refusal to continue,not due toAE|10
965107|NCT01164501|1965279|FG001|Overall Study|Patient refusal to continue,not due toAE|4
965108|NCT01164501|1965280|FG002|Overall Study|Patient refusal to continue,not due toAE|8
965109|NCT01164501|1965278|FG000|Overall Study|Other reason not defined above|9
965110|NCT01164501|1965279|FG001|Overall Study|Other reason not defined above|1
965111|NCT01164501|1965280|FG002|Overall Study|Other reason not defined above|4
965112|NCT01164579|1965293|FG000|Overall Study|Lack of Efficacy|0
965113|NCT01164579|1965294|FG001|Overall Study|Lack of Efficacy|0
965114|NCT01164579|1965295|FG002|Overall Study|Lack of Efficacy|6
965115|NCT01164579|1965293|FG000|Overall Study|Lost to Follow-up|1
965116|NCT01164579|1965294|FG001|Overall Study|Lost to Follow-up|1
965117|NCT01164579|1965295|FG002|Overall Study|Lost to Follow-up|0
965118|NCT01164579|1965293|FG000|Overall Study|Withdrawal by Subject|2
965119|NCT01164579|1965294|FG001|Overall Study|Withdrawal by Subject|5
965120|NCT01164579|1965295|FG002|Overall Study|Withdrawal by Subject|3
965121|NCT01164579|1965293|FG000|Overall Study|Protocol Violation|0
965122|NCT01164579|1965294|FG001|Overall Study|Protocol Violation|1
965123|NCT01164579|1965295|FG002|Overall Study|Protocol Violation|2
965124|NCT01164579|1965293|FG000|Overall Study|Adverse Event|4
965125|NCT01164579|1965294|FG001|Overall Study|Adverse Event|2
965126|NCT01164579|1965295|FG002|Overall Study|Adverse Event|5
965127|NCT01164579|1965293|FG000|Overall Study|Reason not specified|1
965128|NCT01164579|1965294|FG001|Overall Study|Reason not specified|0
965129|NCT01164579|1965295|FG002|Overall Study|Reason not specified|0
965130|NCT01164722|1965315|FG000|Overall Study|Adverse Event|0
965131|NCT01164722|1965316|FG001|Overall Study|Adverse Event|1
965132|NCT01164722|1965315|FG000|Overall Study|Withdrawal by Subject|3
965133|NCT01164722|1965316|FG001|Overall Study|Withdrawal by Subject|4
965134|NCT01164722|1965315|FG000|Overall Study|Lost to Follow-up|3
965135|NCT01164722|1965316|FG001|Overall Study|Lost to Follow-up|6
965136|NCT01164722|1965315|FG000|Overall Study|met protocol criteria for non-treatment|11
965137|NCT01164722|1965316|FG001|Overall Study|met protocol criteria for non-treatment|1
965138|NCT01164722|1965315|FG000|Overall Study|enrolled on other study, concomitant med|1
965139|NCT01164722|1965316|FG001|Overall Study|enrolled on other study, concomitant med|3
965140|NCT01164865|1965324|FG000|Overall Study|Lost to Follow-up|2
965141|NCT01164865|1965325|FG001|Overall Study|Lost to Follow-up|1
965142|NCT01164891|1965331|FG000|Overall Study|Disease Progression|5
965143|NCT01164891|1965331|FG000|Overall Study|Adverse Event|1
965144|NCT01164956|1965336|FG000|Overall Study|Side Effects|1
965145|NCT01164956|1965337|FG001|Overall Study|Side Effects|0
965146|NCT01164956|1965338|FG002|Overall Study|Side Effects|1
965147|NCT01165021|1965346|FG000|Overall Study|Death|1
965148|NCT01165138|1965361|FG000|Overall Study|Adverse Event|0
965149|NCT01165138|1965362|FG001|Overall Study|Adverse Event|1
965150|NCT01165138|1965363|FG002|Overall Study|Adverse Event|0
965151|NCT01165138|1965364|FG003|Overall Study|Adverse Event|2
965152|NCT01165138|1965361|FG000|Overall Study|Lack of Efficacy|0
965153|NCT01165138|1965362|FG001|Overall Study|Lack of Efficacy|32
965154|NCT01165138|1965363|FG002|Overall Study|Lack of Efficacy|6
965155|NCT01165138|1965364|FG003|Overall Study|Lack of Efficacy|7
965156|NCT01165138|1965361|FG000|Overall Study|Protocol Violation|0
965157|NCT01165138|1965362|FG001|Overall Study|Protocol Violation|7
965158|NCT01165138|1965363|FG002|Overall Study|Protocol Violation|0
965159|NCT01165138|1965364|FG003|Overall Study|Protocol Violation|2
965160|NCT01165138|1965361|FG000|Overall Study|Lost to Follow-up|0
965161|NCT01165138|1965362|FG001|Overall Study|Lost to Follow-up|0
965162|NCT01165138|1965363|FG002|Overall Study|Lost to Follow-up|1
965163|NCT01165138|1965364|FG003|Overall Study|Lost to Follow-up|2
965164|NCT01165138|1965361|FG000|Overall Study|Physician Decision|0
965165|NCT01165138|1965362|FG001|Overall Study|Physician Decision|6
965166|NCT01165138|1965363|FG002|Overall Study|Physician Decision|7
965167|NCT01165138|1965364|FG003|Overall Study|Physician Decision|6
965168|NCT01165138|1965361|FG000|Overall Study|Withdrawal by Subject|0
965169|NCT01165138|1965362|FG001|Overall Study|Withdrawal by Subject|6
965170|NCT01165138|1965363|FG002|Overall Study|Withdrawal by Subject|6
965171|NCT01165138|1965364|FG003|Overall Study|Withdrawal by Subject|3
965172|NCT01165177|1965374|FG000|Overall Study|Serious Adverse Event|227
965173|NCT01165177|1965375|FG001|Overall Study|Serious Adverse Event|235
965174|NCT01165177|1965374|FG000|Overall Study|Withdrawal by Subject|368
965175|NCT01165177|1965375|FG001|Overall Study|Withdrawal by Subject|354
965176|NCT01165177|1965374|FG000|Overall Study|Protocol Violation|19
965177|NCT01165177|1965375|FG001|Overall Study|Protocol Violation|21
965178|NCT01165177|1965374|FG000|Overall Study|Non-serious adverse event|30
965179|NCT01165177|1965375|FG001|Overall Study|Non-serious adverse event|18
965180|NCT01165177|1965374|FG000|Overall Study|Other unspecified reasons|47
965181|NCT01165177|1965375|FG001|Overall Study|Other unspecified reasons|35
965182|NCT01165177|1965374|FG000|Overall Study|Suspected HZ episode|0
965183|NCT01165177|1965375|FG001|Overall Study|Suspected HZ episode|2
965184|NCT01165177|1965374|FG000|Overall Study|Lost to Follow-up|183
965185|NCT01165177|1965375|FG001|Overall Study|Lost to Follow-up|194
965186|NCT01165177|1965374|FG000|Overall Study|Migrated/ moved from study area|48
965187|NCT01165177|1965375|FG001|Overall Study|Migrated/ moved from study area|43
965188|NCT01165203|1965391|FG000|Active Phase|Serious Adverse Event|1
965189|NCT01165203|1965392|FG001|Active Phase|Serious Adverse Event|0
965190|NCT01165203|1965391|FG000|Active Phase|Withdrawal by Subject|2
965191|NCT01165203|1965392|FG001|Active Phase|Withdrawal by Subject|1
965192|NCT01165203|1965391|FG000|Active Phase|Migrated/moved from study area|0
965193|NCT01165203|1965392|FG001|Active Phase|Migrated/moved from study area|1
965194|NCT01165203|1965391|FG000|Active Phase|Lost to Follow-up|2
965195|NCT01165203|1965392|FG001|Active Phase|Lost to Follow-up|0
965196|NCT01165203|1965391|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1
965197|NCT01165203|1965392|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0
965198|NCT01165203|1965391|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2
965199|NCT01165203|1965392|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2
965200|NCT01165203|1965391|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2
965201|NCT01165203|1965392|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1
965202|NCT01165203|1965391|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2
965203|NCT01165203|1965392|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0
965204|NCT01165203|1965391|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0
965205|NCT01165203|1965392|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1
965206|NCT01165216|1965407|FG000|Overall Study|Adverse Event|6
965207|NCT01165216|1965408|FG001|Overall Study|Adverse Event|3
965208|NCT01165216|1965407|FG000|Overall Study|Withdrawal by Subject|1
965209|NCT01165216|1965408|FG001|Overall Study|Withdrawal by Subject|1
965210|NCT01165216|1965407|FG000|Overall Study|Disease progression|1
965211|NCT01165216|1965408|FG001|Overall Study|Disease progression|3
965212|NCT01165229|1965418|FG000|Overall Study|Serious Adverse Event|456
965213|NCT01165229|1965419|FG001|Overall Study|Serious Adverse Event|487
965214|NCT01165229|1965418|FG000|Overall Study|Non-Serious Adverse Event|47
965215|NCT01165229|1965419|FG001|Overall Study|Non-Serious Adverse Event|15
965216|NCT01165229|1965418|FG000|Overall Study|Protocol Violation|6
965217|NCT01165229|1965419|FG001|Overall Study|Protocol Violation|8
965218|NCT01165229|1965418|FG000|Overall Study|Withdrawal by Subject|387
965219|NCT01165229|1965419|FG001|Overall Study|Withdrawal by Subject|396
965220|NCT01165229|1965418|FG000|Overall Study|Migrated/moved from study area|51
965221|NCT01165229|1965419|FG001|Overall Study|Migrated/moved from study area|46
965222|NCT01165229|1965418|FG000|Overall Study|Lost to Follow-up|123
965223|NCT01165229|1965419|FG001|Overall Study|Lost to Follow-up|133
965224|NCT01165229|1965418|FG000|Overall Study|Suspected HZ Episode|2
965225|NCT01165229|1965419|FG001|Overall Study|Suspected HZ Episode|2
965226|NCT01165229|1965418|FG000|Overall Study|No reason from the subject|108
965227|NCT01165229|1965419|FG001|Overall Study|No reason from the subject|102
965228|NCT01165229|1965418|FG000|Overall Study|Unknown completion status|0
965229|NCT01165229|1965419|FG001|Overall Study|Unknown completion status|1
965230|NCT01165242|1965458|FG000|Overall Study|Unreachable Subjects|1
965231|NCT01165242|1965459|FG001|Overall Study|Unreachable Subjects|0
965232|NCT01165242|1965460|FG002|Overall Study|Unreachable Subjects|0
965233|NCT01165242|1965458|FG000|Overall Study|Incarcerated Subjects|0
965234|NCT01165242|1965459|FG001|Overall Study|Incarcerated Subjects|1
965235|NCT01165242|1965460|FG002|Overall Study|Incarcerated Subjects|0
965236|NCT01165242|1965458|FG000|Overall Study|Visit 2 Declined by Subject|0
965237|NCT01165242|1965459|FG001|Overall Study|Visit 2 Declined by Subject|0
965238|NCT01165242|1965460|FG002|Overall Study|Visit 2 Declined by Subject|1
965239|NCT01165242|1965458|FG000|Overall Study|Withdrawal by Subject|0
965240|NCT01165242|1965459|FG001|Overall Study|Withdrawal by Subject|2
965241|NCT01165242|1965460|FG002|Overall Study|Withdrawal by Subject|2
965242|NCT01165242|1965458|FG000|Overall Study|Extended Holiday|0
965243|NCT01165242|1965459|FG001|Overall Study|Extended Holiday|0
965244|NCT01165242|1965460|FG002|Overall Study|Extended Holiday|1
965245|NCT01165242|1965458|FG000|Overall Study|Lost to Follow-up|9
965246|NCT01165242|1965459|FG001|Overall Study|Lost to Follow-up|7
965247|NCT01165242|1965460|FG002|Overall Study|Lost to Follow-up|10
965248|NCT01165281|1965472|FG000|Overall Study|Adverse Event|12
965249|NCT01165281|1965473|FG001|Overall Study|Adverse Event|14
965250|NCT01165281|1965472|FG000|Overall Study|Death|3
965251|NCT01165281|1965473|FG001|Overall Study|Death|4
965252|NCT01165281|1965472|FG000|Overall Study|Lack of Efficacy|4
965253|NCT01165281|1965473|FG001|Overall Study|Lack of Efficacy|1
965254|NCT01165281|1965472|FG000|Overall Study|Lost to Follow-up|0
965255|NCT01165281|1965473|FG001|Overall Study|Lost to Follow-up|1
965256|NCT01165281|1965472|FG000|Overall Study|Physician Decision|8
965257|NCT01165281|1965473|FG001|Overall Study|Physician Decision|1
965258|NCT01165281|1965472|FG000|Overall Study|Protocol Violation|6
965259|NCT01165281|1965473|FG001|Overall Study|Protocol Violation|5
965260|NCT01165281|1965472|FG000|Overall Study|Withdrawal by Subject|8
965261|NCT01165281|1965473|FG001|Overall Study|Withdrawal by Subject|7
965262|NCT01165281|1965472|FG000|Overall Study|Noncompliance with Study Drug|1
965263|NCT01165281|1965473|FG001|Overall Study|Noncompliance with Study Drug|4
965264|NCT01165281|1965472|FG000|Overall Study|Progressive Disease|10
965265|NCT01165281|1965473|FG001|Overall Study|Progressive Disease|14
965266|NCT01165281|1965472|FG000|Overall Study|Other|6
965267|NCT01165281|1965473|FG001|Overall Study|Other|0
965268|NCT01165307|1965481|FG000|Overall Study|Lost to Follow-up|11
965269|NCT01165307|1965482|FG001|Overall Study|Lost to Follow-up|3
965270|NCT01165307|1965481|FG000|Overall Study|Withdrawal by Subject|2
965271|NCT01165307|1965482|FG001|Overall Study|Withdrawal by Subject|0
965272|NCT01165307|1965481|FG000|Overall Study|Subject not available for contact|1
965273|NCT01165307|1965482|FG001|Overall Study|Subject not available for contact|0
965274|NCT01165320|1965490|FG000|Overall Study|Clinical adverse experience|2
965275|NCT01165320|1965491|FG001|Overall Study|Clinical adverse experience|1
965276|NCT01165320|1965492|FG002|Overall Study|Clinical adverse experience|0
965277|NCT01165320|1965490|FG000|Overall Study|Laboratory adverse experience|1
965278|NCT01165320|1965491|FG001|Overall Study|Laboratory adverse experience|0
965279|NCT01165320|1965492|FG002|Overall Study|Laboratory adverse experience|0
965280|NCT01165320|1965490|FG000|Overall Study|Lack of Efficacy|0
965281|NCT01165320|1965491|FG001|Overall Study|Lack of Efficacy|2
965282|NCT01165320|1965492|FG002|Overall Study|Lack of Efficacy|0
965283|NCT01165320|1965490|FG000|Overall Study|Reason unknown|0
965284|NCT01165320|1965491|FG001|Overall Study|Reason unknown|1
965285|NCT01165320|1965492|FG002|Overall Study|Reason unknown|0
965286|NCT01165424|1965498|FG000|Overall Study|Clinical adverse experiences|1
965287|NCT01165424|1965498|FG000|Overall Study|Laboratory adverse experiences|1
965288|NCT01165424|1965498|FG000|Overall Study|Did not meet entry criteria|1
965289|NCT01165424|1965498|FG000|Overall Study|Participant moved (relocated)|1
965290|NCT01165554|1965508|FG000|Overall Study|Withdrawal by Subject|23
965291|NCT01165684|1965517|FG000|Overall Study|Adverse Event|1
965292|NCT01165684|1965518|FG001|Overall Study|Adverse Event|1
965293|NCT01165684|1965517|FG000|Overall Study|Lack of Efficacy|2
965294|NCT01165684|1965518|FG001|Overall Study|Lack of Efficacy|1
965295|NCT01165684|1965517|FG000|Overall Study|Protocol Violation|7
965296|NCT01165684|1965518|FG001|Overall Study|Protocol Violation|15
965297|NCT01165684|1965517|FG000|Overall Study|Withdrawal Criteria|2
965298|NCT01165684|1965518|FG001|Overall Study|Withdrawal Criteria|13
965299|NCT01165684|1965517|FG000|Overall Study|Unclassified|16
965300|NCT01165684|1965518|FG001|Overall Study|Unclassified|22
965301|NCT01165996|1965547|FG000|Overall Study|Death|1
965302|NCT01165996|1965547|FG000|Overall Study|Physician Decision|1
965303|NCT01166282|1965571|FG000|Open-label Period|Adverse Event|0
965304|NCT01166282|1965572|FG001|Open-label Period|Adverse Event|0
965305|NCT01166282|1965573|FG002|Open-label Period|Adverse Event|6
965306|NCT01166282|1965571|FG000|Open-label Period|Withdrawal by Subject|0
965307|NCT01166282|1965572|FG001|Open-label Period|Withdrawal by Subject|0
965308|NCT01166282|1965573|FG002|Open-label Period|Withdrawal by Subject|4
965309|NCT01166282|1965571|FG000|Open-label Period|Lack of Efficacy|0
965310|NCT01166282|1965572|FG001|Open-label Period|Lack of Efficacy|0
965311|NCT01166282|1965573|FG002|Open-label Period|Lack of Efficacy|2
965312|NCT01166282|1965571|FG000|Open-label Period|Remission|0
965313|NCT01166282|1965572|FG001|Open-label Period|Remission|0
965314|NCT01166282|1965573|FG002|Open-label Period|Remission|4
965315|NCT01166282|1965571|FG000|Open-label Period|Irregular Compliance|0
965316|NCT01166282|1965572|FG001|Open-label Period|Irregular Compliance|0
965317|NCT01166282|1965573|FG002|Open-label Period|Irregular Compliance|1
965318|NCT01166373|1965594|FG000|Overall Study|Lost to Follow-up|3
965319|NCT01166373|1965595|FG001|Overall Study|Lost to Follow-up|2
965320|NCT01166373|1965596|FG002|Overall Study|Lost to Follow-up|2
965321|NCT01166373|1965597|FG003|Overall Study|Lost to Follow-up|2
965322|NCT01166373|1965594|FG000|Overall Study|Withdrawal by Subject|1
965323|NCT01166373|1965595|FG001|Overall Study|Withdrawal by Subject|2
965324|NCT01166373|1965596|FG002|Overall Study|Withdrawal by Subject|2
965325|NCT01166373|1965597|FG003|Overall Study|Withdrawal by Subject|3
965326|NCT01166373|1965594|FG000|Overall Study|Physician Decision|1
911129|NCT00796822|1888322|FG001|Overall Study|Adverse Event|0
911130|NCT00796978|1888337|FG000|Overall Study|Cardiac adverse event|5
911131|NCT00796978|1888337|FG000|Overall Study|Adverse Event|4
911132|NCT00796978|1888337|FG000|Overall Study|Withdrawal by Subject|3
911133|NCT00796991|1888344|FG000|Overall Study|Adverse Event|0
911134|NCT00796991|1888345|FG001|Overall Study|Adverse Event|0
911135|NCT00796991|1888346|FG002|Overall Study|Adverse Event|1
911136|NCT00796991|1888344|FG000|Overall Study|Death|2
911137|NCT00796991|1888345|FG001|Overall Study|Death|0
911138|NCT00796991|1888346|FG002|Overall Study|Death|0
911139|NCT00796991|1888344|FG000|Overall Study|Disease Progression|10
965327|NCT01166373|1965595|FG001|Overall Study|Physician Decision|0
965328|NCT01166373|1965596|FG002|Overall Study|Physician Decision|0
965329|NCT01166373|1965597|FG003|Overall Study|Physician Decision|0
965330|NCT01166386|1965611|FG000|Overall Study|Withdrawal by Subject|3
965331|NCT01166386|1965612|FG001|Overall Study|Withdrawal by Subject|5
965332|NCT01166438|1965620|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
965333|NCT01166438|1965621|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
965334|NCT01166438|1965620|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
965335|NCT01166438|1965621|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
965336|NCT01166438|1965620|FG000|Double-blind Phase: 1st 6 Months|Not treated|1
965337|NCT01166438|1965621|FG001|Double-blind Phase: 1st 6 Months|Not treated|1
965338|NCT01166438|1965620|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1
965339|NCT01166438|1965621|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2
965340|NCT01166438|1965620|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4
965341|NCT01166438|1965621|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2
965342|NCT01166438|1965620|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29
965343|NCT01166438|1965621|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52
965344|NCT01166568|1965631|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0
965345|NCT01166568|1965632|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0
965346|NCT01166568|1965633|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1
965347|NCT01166568|1965631|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
965348|NCT01166568|1965632|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
965349|NCT01166568|1965633|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
965350|NCT01166568|1965631|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
965351|NCT01166568|1965632|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
965352|NCT01166568|1965633|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
965353|NCT01166646|1965641|FG000|Overall Study|Protocol Violation|0
965354|NCT01166646|1965642|FG001|Overall Study|Protocol Violation|1
965355|NCT01166646|1965641|FG000|Overall Study|Adverse Event|1
965356|NCT01166646|1965642|FG001|Overall Study|Adverse Event|0
965357|NCT01166659|1965648|FG000|Overall Study|Subject Decision|8
965358|NCT01166659|1965648|FG000|Overall Study|Investigator Decision|2
965359|NCT01166659|1965648|FG000|Overall Study|Death|1
965360|NCT01166659|1965648|FG000|Overall Study|Lost to Follow-up|1
965361|NCT01166659|1965648|FG000|Overall Study|Study Closed at Site|1
965362|NCT01166750|1965655|FG000|Overall Study|Lost to Follow-up|1
965363|NCT01166750|1965656|FG001|Overall Study|Lost to Follow-up|0
965364|NCT01166763|1965662|FG000|Overall Study|Withdrawal by Subject|3
965365|NCT01166945|1965668|FG000|Randomized|diagnosed with Group A strep|4
965366|NCT01166945|1965669|FG001|Randomized|diagnosed with Group A strep|4
965367|NCT01166945|1965668|FG000|Day 10|NonCompliance/Lost to Follow Up|3
965368|NCT01166945|1965669|FG001|Day 10|NonCompliance/Lost to Follow Up|2
965369|NCT01166945|1965668|FG000|Day 15|NonCompliance/Lost to Follow Up|2
965370|NCT01166945|1965669|FG001|Day 15|NonCompliance/Lost to Follow Up|1
965371|NCT01166945|1965668|FG000|Day 30|Lost to Follow-up|4
965372|NCT01166945|1965669|FG001|Day 30|Lost to Follow-up|3
965373|NCT01166958|1965679|FG000|Overall Study|Withdrawal by Subject|1
965374|NCT01166958|1965680|FG001|Overall Study|Withdrawal by Subject|0
965375|NCT01167023|1965739|FG000|Overall Study|Lost to Follow-up|0
965376|NCT01167023|1965740|FG001|Overall Study|Lost to Follow-up|1
965377|NCT01167023|1965741|FG002|Overall Study|Lost to Follow-up|1
965378|NCT01167023|1965739|FG000|Overall Study|Screen Failure|0
965379|NCT01167023|1965740|FG001|Overall Study|Screen Failure|1
965380|NCT01167023|1965741|FG002|Overall Study|Screen Failure|0
965381|NCT01167023|1965739|FG000|Overall Study|Sponsor Decision|0
965382|NCT01167023|1965740|FG001|Overall Study|Sponsor Decision|1
965383|NCT01167023|1965741|FG002|Overall Study|Sponsor Decision|0
965384|NCT01167023|1965739|FG000|Overall Study|Withdrawal by Subject|0
965385|NCT01167023|1965740|FG001|Overall Study|Withdrawal by Subject|0
965386|NCT01167023|1965741|FG002|Overall Study|Withdrawal by Subject|1
965387|NCT01167140|1965747|FG000|Overall Study|Withdrawal by Subject|1
965388|NCT01167153|1965753|FG000|Overall Study|Non-effective therapy|1
965389|NCT01167153|1965754|FG001|Overall Study|Non-effective therapy|4
965390|NCT01167153|1965753|FG000|Overall Study|AE including clinical laboratory AE|2
965391|NCT01167153|1965754|FG001|Overall Study|AE including clinical laboratory AE|8
965392|NCT01167153|1965753|FG000|Overall Study|Hypotension|1
965393|NCT01167153|1965754|FG001|Overall Study|Hypotension|0
965394|NCT01167153|1965753|FG000|Overall Study|Lost to Follow-up|7
965395|NCT01167153|1965754|FG001|Overall Study|Lost to Follow-up|9
965396|NCT01167153|1965753|FG000|Overall Study|Non-compliance to concomitant medication|0
965397|NCT01167153|1965754|FG001|Overall Study|Non-compliance to concomitant medication|2
965398|NCT01167153|1965753|FG000|Overall Study|Investigator initiation withdrawal,Other|1
965399|NCT01167153|1965754|FG001|Overall Study|Investigator initiation withdrawal,Other|1
965400|NCT01167153|1965753|FG000|Overall Study|Withdrawal consent|1
965401|NCT01167153|1965754|FG001|Overall Study|Withdrawal consent|1
965402|NCT01167153|1965753|FG000|Overall Study|Subject initiation withdrawal, Other|5
965403|NCT01167153|1965754|FG001|Overall Study|Subject initiation withdrawal, Other|8
965404|NCT01167179|1965762|FG000|Overall Study|disease recurrence|4
965405|NCT01167179|1965763|FG001|Overall Study|disease recurrence|4
965406|NCT01167179|1965762|FG000|Overall Study|Death|4
965407|NCT01167179|1965763|FG001|Overall Study|Death|10
965408|NCT01167179|1965762|FG000|Overall Study|Withdrawal by Subject|1
965409|NCT01167179|1965763|FG001|Overall Study|Withdrawal by Subject|2
965410|NCT01167179|1965762|FG000|Overall Study|diverse|6
965411|NCT01167179|1965763|FG001|Overall Study|diverse|5
965412|NCT01167192|1965769|FG000|Overall Study|Adverse Event|1
965413|NCT01167192|1965769|FG000|Overall Study|Death|1
965414|NCT01167192|1965769|FG000|Overall Study|Withdrawal by Subject|1
965415|NCT01167192|1965769|FG000|Overall Study|Insurance denial|1
965416|NCT01167257|1965775|FG000|Overall Study|Lost to Follow-up|2
965417|NCT01167257|1965776|FG001|Overall Study|Lost to Follow-up|2
965418|NCT01167257|1965775|FG000|Overall Study|Withdrew consent|1
965419|NCT01167257|1965776|FG001|Overall Study|Withdrew consent|1
965420|NCT01167426|1965786|FG000|Overall Study|Lost to Follow-up|6
965421|NCT01167426|1965786|FG000|Overall Study|Protocol Violation|1
965422|NCT01167426|1965786|FG000|Overall Study|Withdrawal by Subject|2
965423|NCT01167426|1965786|FG000|Overall Study|Sponsor Decision|1
965424|NCT01167582|1965813|FG000|Overall Study|Lost to Follow-up|0
965425|NCT01167582|1965814|FG001|Overall Study|Lost to Follow-up|1
965426|NCT01167634|1965838|FG000|Overall Study|Lost to Follow-up|1
965427|NCT01167634|1965839|FG001|Overall Study|Lost to Follow-up|3
965428|NCT01167634|1965840|FG002|Overall Study|Lost to Follow-up|3
965429|NCT01167634|1965841|FG003|Overall Study|Lost to Follow-up|4
965430|NCT01167634|1965838|FG000|Overall Study|Withdrawal by Subject|1
965431|NCT01167634|1965839|FG001|Overall Study|Withdrawal by Subject|1
965432|NCT01167634|1965840|FG002|Overall Study|Withdrawal by Subject|0
965433|NCT01167634|1965841|FG003|Overall Study|Withdrawal by Subject|0
965434|NCT01167881|1965868|FG000|Overall Study|Adverse Event|47
965435|NCT01167881|1965869|FG001|Overall Study|Adverse Event|51
965436|NCT01167881|1965868|FG000|Overall Study|Lack of Efficacy|4
965437|NCT01167881|1965869|FG001|Overall Study|Lack of Efficacy|7
965438|NCT01167881|1965868|FG000|Overall Study|Non compliant with protocol|9
965439|NCT01167881|1965869|FG001|Overall Study|Non compliant with protocol|18
965440|NCT01167881|1965868|FG000|Overall Study|Lost to Follow-up|19
965441|NCT01167881|1965869|FG001|Overall Study|Lost to Follow-up|20
965442|NCT01167881|1965868|FG000|Overall Study|Patient refusal to cont., not due to AE|45
965443|NCT01167881|1965869|FG001|Overall Study|Patient refusal to cont., not due to AE|40
965444|NCT01167881|1965868|FG000|Overall Study|Not treated|4
965445|NCT01167881|1965869|FG001|Overall Study|Not treated|0
965446|NCT01167881|1965868|FG000|Overall Study|Other not defined above|31
965447|NCT01167881|1965869|FG001|Overall Study|Other not defined above|55
965448|NCT01167907|1965877|FG000|Overall Study|Protocol Violation|1
965449|NCT01167907|1965878|FG001|Overall Study|Protocol Violation|0
965450|NCT01167907|1965877|FG000|Overall Study|saphenous catheter dislodged before comp|1
965451|NCT01167907|1965878|FG001|Overall Study|saphenous catheter dislodged before comp|1
965455|NCT01168232|1965897|FG000|Overall Study|Ineligible-Second primary cancer site|1
965456|NCT01168232|1965897|FG000|Overall Study|Ineligible- Wrong cell type|6
965457|NCT01168232|1965897|FG000|Overall Study|Ineligible-Inadequate pathology|1
965458|NCT01168349|1965901|FG000|Overall Study|Death|157
965459|NCT01168349|1965901|FG000|Overall Study|Lost to Follow-up|34
965460|NCT01168349|1965901|FG000|Overall Study|Withdrawal by Subject|9
965461|NCT01168349|1965901|FG000|Overall Study|Kidney transplantation|3
965462|NCT01168349|1965901|FG000|Overall Study|Other|22
965463|NCT01168349|1965901|FG000|Overall Study|Protocol Violation|76
965464|NCT01168401|1965932|FG000|Overall Study|Lost to Follow-up|1
965465|NCT01168401|1965933|FG001|Overall Study|Lost to Follow-up|1
965466|NCT01168401|1965934|FG002|Overall Study|Lost to Follow-up|2
965467|NCT01168401|1965935|FG003|Overall Study|Lost to Follow-up|1
965468|NCT01168401|1965936|FG004|Overall Study|Lost to Follow-up|0
965469|NCT01168401|1965937|FG005|Overall Study|Lost to Follow-up|0
965470|NCT01168401|1965938|FG006|Overall Study|Lost to Follow-up|0
965471|NCT01168401|1965939|FG007|Overall Study|Lost to Follow-up|0
965472|NCT01168401|1965940|FG008|Overall Study|Lost to Follow-up|0
965473|NCT01168401|1965941|FG009|Overall Study|Lost to Follow-up|0
965474|NCT01168401|1965942|FG010|Overall Study|Lost to Follow-up|0
965475|NCT01168401|1965932|FG000|Overall Study|Withdrawal by Subject|0
965476|NCT01168401|1965933|FG001|Overall Study|Withdrawal by Subject|0
965477|NCT01168401|1965934|FG002|Overall Study|Withdrawal by Subject|0
965478|NCT01168401|1965935|FG003|Overall Study|Withdrawal by Subject|1
965479|NCT01168401|1965936|FG004|Overall Study|Withdrawal by Subject|0
965480|NCT01168401|1965937|FG005|Overall Study|Withdrawal by Subject|0
965481|NCT01168401|1965938|FG006|Overall Study|Withdrawal by Subject|0
965482|NCT01168401|1965939|FG007|Overall Study|Withdrawal by Subject|0
965483|NCT01168401|1965940|FG008|Overall Study|Withdrawal by Subject|0
965484|NCT01168401|1965941|FG009|Overall Study|Withdrawal by Subject|0
965485|NCT01168401|1965942|FG010|Overall Study|Withdrawal by Subject|0
965486|NCT01168427|1965966|FG000|Overall Study|Patient exited prior to implant|1
965487|NCT01168596|1965972|FG000|Overall Study|Withdrawal by Subject|3
965488|NCT01168596|1965973|FG001|Overall Study|Withdrawal by Subject|1
965489|NCT01168856|1966011|FG000|Overall Study|Lost to Follow-up|4
965490|NCT01168856|1966012|FG001|Overall Study|Lost to Follow-up|34
965491|NCT01168856|1966011|FG000|Overall Study|Withdrawal by Subject|6
965492|NCT01168856|1966012|FG001|Overall Study|Withdrawal by Subject|8
965493|NCT01168856|1966011|FG000|Overall Study|Physician Decision|2
965494|NCT01168856|1966012|FG001|Overall Study|Physician Decision|1
965495|NCT01168856|1966011|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0
965496|NCT01168856|1966012|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1
965497|NCT01168856|1966011|FG000|Overall Study|Participant received anti-HCV treatment|1
965498|NCT01168856|1966012|FG001|Overall Study|Participant received anti-HCV treatment|0
965499|NCT01168856|1966011|FG000|Overall Study|Death|0
965500|NCT01168856|1966012|FG001|Overall Study|Death|2
965501|NCT01168856|1966011|FG000|Overall Study|Other|1
965502|NCT01168856|1966012|FG001|Overall Study|Other|291
965503|NCT01168856|1966011|FG000|Overall Study|Protocol Violation|4
965504|NCT01168856|1966012|FG001|Overall Study|Protocol Violation|6
965505|NCT01168973|1966042|FG000|Overall Study|Progressive Disease|341
965506|NCT01168973|1966043|FG001|Overall Study|Progressive Disease|429
965507|NCT01168973|1966042|FG000|Overall Study|Adverse Event|94
965508|NCT01168973|1966043|FG001|Overall Study|Adverse Event|55
965509|NCT01168973|1966042|FG000|Overall Study|Withdrawal by Subject|90
965510|NCT01168973|1966043|FG001|Overall Study|Withdrawal by Subject|53
965511|NCT01168973|1966042|FG000|Overall Study|Death|42
965512|NCT01168973|1966043|FG001|Overall Study|Death|45
965513|NCT01168973|1966042|FG000|Overall Study|Physician Decision|37
965514|NCT01168973|1966043|FG001|Overall Study|Physician Decision|19
965515|NCT01168973|1966042|FG000|Overall Study|Sponsor Decision|2
965516|NCT01168973|1966043|FG001|Overall Study|Sponsor Decision|1
965517|NCT01168973|1966042|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7
965518|NCT01168973|1966043|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9
965519|NCT01168999|1966066|FG000|Overall Study|Lost to Follow-up|2
965520|NCT01168999|1966067|FG001|Overall Study|Lost to Follow-up|1
965521|NCT01168999|1966068|FG002|Overall Study|Lost to Follow-up|0
965522|NCT01168999|1966069|FG003|Overall Study|Lost to Follow-up|0
965523|NCT01169038|1966079|FG000|Overall Study|Death|1
965524|NCT01169038|1966079|FG000|Overall Study|Adverse Event|5
965525|NCT01169038|1966079|FG000|Overall Study|Required antibiotic administration|1
965526|NCT01169103|1966096|FG000|Overall Study|Lost to Follow-up|3
965527|NCT01169103|1966097|FG001|Overall Study|Lost to Follow-up|3
965528|NCT01169103|1966096|FG000|Overall Study|Withdrawal by Subject|3
965529|NCT01169103|1966097|FG001|Overall Study|Withdrawal by Subject|1
965530|NCT01169337|1966130|FG000|Overall Study|Lack of Efficacy|5
965531|NCT01169337|1966131|FG001|Overall Study|Lack of Efficacy|7
965532|NCT01169337|1966132|FG002|Overall Study|Lack of Efficacy|0
965533|NCT01169337|1966130|FG000|Overall Study|Adverse Event|12
965534|NCT01169337|1966131|FG001|Overall Study|Adverse Event|18
965535|NCT01169337|1966132|FG002|Overall Study|Adverse Event|0
965536|NCT01169337|1966130|FG000|Overall Study|Death|2
965537|NCT01169337|1966131|FG001|Overall Study|Death|0
965538|NCT01169337|1966132|FG002|Overall Study|Death|0
965539|NCT01169337|1966130|FG000|Overall Study|Withdrawal by Subject|11
965540|NCT01169337|1966131|FG001|Overall Study|Withdrawal by Subject|11
965541|NCT01169337|1966132|FG002|Overall Study|Withdrawal by Subject|6
965542|NCT01169337|1966130|FG000|Overall Study|Noncompliance|2
965543|NCT01169337|1966131|FG001|Overall Study|Noncompliance|0
965544|NCT01169337|1966132|FG002|Overall Study|Noncompliance|0
965545|NCT01169337|1966130|FG000|Overall Study|Other complicating disease|1
965546|NCT01169337|1966131|FG001|Overall Study|Other complicating disease|1
965547|NCT01169337|1966132|FG002|Overall Study|Other complicating disease|0
965548|NCT01169337|1966130|FG000|Overall Study|Physician Decision|1
965549|NCT01169337|1966131|FG001|Overall Study|Physician Decision|5
965550|NCT01169337|1966132|FG002|Overall Study|Physician Decision|0
965551|NCT01169337|1966130|FG000|Overall Study|Alternative therapy|0
965552|NCT01169337|1966131|FG001|Overall Study|Alternative therapy|2
965553|NCT01169337|1966132|FG002|Overall Study|Alternative therapy|0
965554|NCT01169337|1966130|FG000|Overall Study|Changed hospital|0
965555|NCT01169337|1966131|FG001|Overall Study|Changed hospital|1
965556|NCT01169337|1966132|FG002|Overall Study|Changed hospital|0
965557|NCT01169337|1966130|FG000|Overall Study|Never started treatment|0
965558|NCT01169337|1966131|FG001|Overall Study|Never started treatment|2
965559|NCT01169337|1966132|FG002|Overall Study|Never started treatment|0
965560|NCT01169337|1966130|FG000|Overall Study|Reason not reported|1
965561|NCT01169337|1966131|FG001|Overall Study|Reason not reported|0
965562|NCT01169337|1966132|FG002|Overall Study|Reason not reported|0
965563|NCT01169337|1966130|FG000|Overall Study|Continuing lenalidomide|9
965564|NCT01169337|1966131|FG001|Overall Study|Continuing lenalidomide|43
965565|NCT01169337|1966132|FG002|Overall Study|Continuing lenalidomide|0
965566|NCT01169350|1966140|FG000|Overall Study|Physician Decision|3
965567|NCT01169350|1966140|FG000|Overall Study|Lost to Follow-up|2
965568|NCT01169493|1966159|FG000|Period 1 (6 Months)|Withdrawal by Subject|0
965569|NCT01169493|1966160|FG001|Period 1 (6 Months)|Withdrawal by Subject|1
965570|NCT01169493|1966161|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
965571|NCT01169493|1966162|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
965572|NCT01169493|1966163|FG004|Period 1 (6 Months)|Withdrawal by Subject|0
965573|NCT01169493|1966164|FG005|Period 1 (6 Months)|Withdrawal by Subject|3
965574|NCT01169493|1966159|FG000|Period 3 (6 Months)|Adverse Event|0
965575|NCT01169493|1966160|FG001|Period 3 (6 Months)|Adverse Event|1
965576|NCT01169493|1966161|FG002|Period 3 (6 Months)|Adverse Event|0
965577|NCT01169493|1966162|FG003|Period 3 (6 Months)|Adverse Event|0
965578|NCT01169493|1966163|FG004|Period 3 (6 Months)|Adverse Event|0
965579|NCT01169493|1966164|FG005|Period 3 (6 Months)|Adverse Event|0
965580|NCT01169493|1966159|FG000|Period 3 (6 Months)|Physician Decision|0
965581|NCT01169493|1966160|FG001|Period 3 (6 Months)|Physician Decision|1
965582|NCT01169493|1966161|FG002|Period 3 (6 Months)|Physician Decision|1
965583|NCT01169493|1966162|FG003|Period 3 (6 Months)|Physician Decision|0
965584|NCT01169493|1966163|FG004|Period 3 (6 Months)|Physician Decision|0
965585|NCT01169493|1966164|FG005|Period 3 (6 Months)|Physician Decision|0
965586|NCT01169532|1966184|FG000|Overall Study|Withdrawal by Subject|1
965587|NCT01169558|1966188|FG000|Overall Study|Disease progression|98
965588|NCT01169558|1966188|FG000|Overall Study|Adverse Event|25
965589|NCT01169558|1966188|FG000|Overall Study|Withdrawal of Consent|8
965590|NCT01169558|1966188|FG000|Overall Study|Medical Decision|7
965591|NCT01169558|1966188|FG000|Overall Study|Stable Disease|4
965592|NCT01169558|1966188|FG000|Overall Study|Lost to Follow-up|4
965593|NCT01169558|1966188|FG000|Overall Study|Need for Surgery|4
965594|NCT01169558|1966188|FG000|Overall Study|Non-compliance|2
965595|NCT01169558|1966188|FG000|Overall Study|Protocol Violation|2
965596|NCT01169558|1966188|FG000|Overall Study|Partial response|2
965597|NCT01169636|1966197|FG000|Overall Study|Adverse Event|0
965598|NCT01169636|1966198|FG001|Overall Study|Adverse Event|0
965599|NCT01169636|1966199|FG002|Overall Study|Adverse Event|1
965600|NCT01169636|1966200|FG003|Overall Study|Adverse Event|1
965601|NCT01169636|1966201|FG004|Overall Study|Adverse Event|0
965602|NCT01169636|1966197|FG000|Overall Study|Screen failure|0
965603|NCT01169636|1966198|FG001|Overall Study|Screen failure|0
965604|NCT01169636|1966199|FG002|Overall Study|Screen failure|2
965605|NCT01169636|1966200|FG003|Overall Study|Screen failure|0
965606|NCT01169636|1966201|FG004|Overall Study|Screen failure|0
965607|NCT01169636|1966197|FG000|Overall Study|Withdrawal by Subject|0
965608|NCT01169636|1966198|FG001|Overall Study|Withdrawal by Subject|0
965609|NCT01169636|1966199|FG002|Overall Study|Withdrawal by Subject|0
965610|NCT01169636|1966200|FG003|Overall Study|Withdrawal by Subject|0
965611|NCT01169636|1966201|FG004|Overall Study|Withdrawal by Subject|3
965612|NCT01169649|1966211|FG000|Overall Study|Patient Not Treated|3
965613|NCT01169675|1966220|FG000|Overall Study|Progressive disease|13
965614|NCT01169675|1966221|FG001|Overall Study|Progressive disease|2
965615|NCT01169675|1966222|FG002|Overall Study|Progressive disease|5
965616|NCT01169675|1966223|FG003|Overall Study|Progressive disease|15
965617|NCT01169675|1966224|FG004|Overall Study|Progressive disease|1
965618|NCT01169675|1966220|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1
965619|NCT01169675|1966221|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
965620|NCT01169675|1966222|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
965621|NCT01169675|1966223|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
965622|NCT01169675|1966224|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2
965623|NCT01169675|1966220|FG000|Overall Study|Adverse Event|5
965624|NCT01169675|1966221|FG001|Overall Study|Adverse Event|1
965625|NCT01169675|1966222|FG002|Overall Study|Adverse Event|2
965626|NCT01169675|1966223|FG003|Overall Study|Adverse Event|0
965627|NCT01169675|1966224|FG004|Overall Study|Adverse Event|0
965628|NCT01169675|1966220|FG000|Overall Study|Withdrawal by Subject|1
965629|NCT01169675|1966221|FG001|Overall Study|Withdrawal by Subject|0
965630|NCT01169675|1966222|FG002|Overall Study|Withdrawal by Subject|0
965631|NCT01169675|1966223|FG003|Overall Study|Withdrawal by Subject|1
965632|NCT01169675|1966224|FG004|Overall Study|Withdrawal by Subject|2
965633|NCT01169675|1966220|FG000|Overall Study|Other Reason Not Defined Above|0
965634|NCT01169675|1966221|FG001|Overall Study|Other Reason Not Defined Above|0
965635|NCT01169675|1966222|FG002|Overall Study|Other Reason Not Defined Above|0
965636|NCT01169675|1966223|FG003|Overall Study|Other Reason Not Defined Above|1
965637|NCT01169675|1966224|FG004|Overall Study|Other Reason Not Defined Above|1
965638|NCT01169701|1966238|FG000|Overall Study|Lost to Follow-up|1
965639|NCT01169701|1966239|FG001|Overall Study|Lost to Follow-up|1
965640|NCT01169701|1966238|FG000|Overall Study|Withdrawal by Subject|1
965641|NCT01169701|1966239|FG001|Overall Study|Withdrawal by Subject|3
965642|NCT01169701|1966238|FG000|Overall Study|Adverse Event|1
965643|NCT01169701|1966239|FG001|Overall Study|Adverse Event|2
965644|NCT01169701|1966238|FG000|Overall Study|Exclusion criteria|2
965645|NCT01169701|1966239|FG001|Overall Study|Exclusion criteria|0
965646|NCT01169701|1966238|FG000|Overall Study|Death|0
965647|NCT01169701|1966239|FG001|Overall Study|Death|1
965648|NCT01169701|1966238|FG000|Overall Study|Administrative problems|0
965649|NCT01169701|1966239|FG001|Overall Study|Administrative problems|1
965650|NCT01169701|1966238|FG000|Overall Study|Serious adverse event|0
965651|NCT01169701|1966239|FG001|Overall Study|Serious adverse event|1
965652|NCT01169701|1966238|FG000|Overall Study|Sponsor decision|0
965653|NCT01169701|1966239|FG001|Overall Study|Sponsor decision|1
965654|NCT01169779|1966247|FG000|Overall Study|Adverse Event|3
965655|NCT01169779|1966248|FG001|Overall Study|Adverse Event|11
965656|NCT01169779|1966247|FG000|Overall Study|Lack of Efficacy|1
965657|NCT01169779|1966248|FG001|Overall Study|Lack of Efficacy|0
965658|NCT01169779|1966247|FG000|Overall Study|Protocol Violation|1
965659|NCT01169779|1966248|FG001|Overall Study|Protocol Violation|1
965660|NCT01169779|1966247|FG000|Overall Study|Withdrawal by Subject|3
965661|NCT01169779|1966248|FG001|Overall Study|Withdrawal by Subject|2
965662|NCT01169779|1966247|FG000|Overall Study|Familial and personal reasons|3
965663|NCT01169779|1966248|FG001|Overall Study|Familial and personal reasons|3
965664|NCT01169844|1966256|FG000|Overall Study|Adverse Event|0
965665|NCT01169844|1966257|FG001|Overall Study|Adverse Event|1
965666|NCT01169844|1966256|FG000|Overall Study|Patient withdrew consent|4
965667|NCT01169844|1966257|FG001|Overall Study|Patient withdrew consent|0
965668|NCT01169844|1966256|FG000|Overall Study|Unsatisfactory therapeutic effect|1
965669|NCT01169844|1966257|FG001|Overall Study|Unsatisfactory therapeutic effect|0
965670|NCT01169987|1966263|FG000|Overall Study|Withdrawal by Subject|3
965671|NCT01169987|1966263|FG000|Overall Study|Lost to Follow-up|24
965672|NCT01169987|1966263|FG000|Overall Study|Other|4
965673|NCT01170039|1966275|FG000|Overall Study|Withdrawal by Subject|5
965674|NCT01170039|1966276|FG001|Overall Study|Withdrawal by Subject|3
965675|NCT01170039|1966275|FG000|Overall Study|Lack of funding, drug not available|3
965676|NCT01170039|1966276|FG001|Overall Study|Lack of funding, drug not available|3
965677|NCT01170065|1966285|FG000|Overall Study|Adverse Event|17
965678|NCT01170065|1966286|FG001|Overall Study|Adverse Event|50
965679|NCT01170065|1966287|FG002|Overall Study|Adverse Event|10
965680|NCT01170065|1966285|FG000|Overall Study|Lost to Follow-up|1
965681|NCT01170065|1966286|FG001|Overall Study|Lost to Follow-up|4
965682|NCT01170065|1966287|FG002|Overall Study|Lost to Follow-up|1
965683|NCT01170065|1966285|FG000|Overall Study|Consent withdrawn, not due to AE|2
965684|NCT01170065|1966286|FG001|Overall Study|Consent withdrawn, not due to AE|4
965685|NCT01170065|1966287|FG002|Overall Study|Consent withdrawn, not due to AE|2
965686|NCT01170065|1966285|FG000|Overall Study|Reason other than specified|3
965687|NCT01170065|1966286|FG001|Overall Study|Reason other than specified|8
965688|NCT01170065|1966287|FG002|Overall Study|Reason other than specified|3
965689|NCT01170065|1966285|FG000|Overall Study|Ongoing after planned observation time|5
965690|NCT01170065|1966286|FG001|Overall Study|Ongoing after planned observation time|26
965691|NCT01170065|1966287|FG002|Overall Study|Ongoing after planned observation time|10
965692|NCT01170091|1966295|FG000|Overall Study|Missing efficacy evaluation|3
965693|NCT01170091|1966295|FG000|Overall Study|Treatment duration is less than 4 weeks|21
965694|NCT01170208|1966311|FG000|Overall Study|Withdrawal by Subject|5
965695|NCT01170208|1966312|FG001|Overall Study|Withdrawal by Subject|0
965696|NCT01170208|1966313|FG002|Overall Study|Withdrawal by Subject|1
965697|NCT01170208|1966311|FG000|Overall Study|Protocol Violation|1
965698|NCT01170208|1966312|FG001|Overall Study|Protocol Violation|0
965699|NCT01170208|1966313|FG002|Overall Study|Protocol Violation|1
965700|NCT01170221|1966326|FG000|Overall Study|Lost to Follow-up|22
965701|NCT01170221|1966327|FG001|Overall Study|Lost to Follow-up|21
965702|NCT01170221|1966326|FG000|Overall Study|Withdrawal by Subject|9
965703|NCT01170221|1966327|FG001|Overall Study|Withdrawal by Subject|7
965704|NCT01170221|1966326|FG000|Overall Study|Subject completed only screening and LFU|1
965705|NCT01170221|1966327|FG001|Overall Study|Subject completed only screening and LFU|0
965706|NCT01170221|1966326|FG000|Overall Study|Randomized but not treated|1
965707|NCT01170221|1966327|FG001|Overall Study|Randomized but not treated|0
965708|NCT01170273|1966344|FG000|Overall Study|Lost to Follow-up|6
965709|NCT01170273|1966345|FG001|Overall Study|Lost to Follow-up|8
965710|NCT01170273|1966344|FG000|Overall Study|Protocol Violation|1
965711|NCT01170273|1966345|FG001|Overall Study|Protocol Violation|0
965712|NCT01170273|1966344|FG000|Overall Study|Death|1
965713|NCT01170273|1966345|FG001|Overall Study|Death|0
965714|NCT01170273|1966344|FG000|Overall Study|Adverse Event|0
965715|NCT01170273|1966345|FG001|Overall Study|Adverse Event|1
965716|NCT01170364|1966353|FG000|Overall Study|Protocol Violation|4
965717|NCT01170364|1966354|FG001|Overall Study|Protocol Violation|1
965718|NCT01170598|1966400|FG000|Overall Study|Withdrawal by Subject|1
965719|NCT01170598|1966400|FG000|Overall Study|Death|3
965720|NCT01170598|1966400|FG000|Overall Study|Lost to Follow-up|1
965721|NCT01170598|1966400|FG000|Overall Study|Refused|1
965722|NCT01170663|1966406|FG000|Overall Study|Lost to Follow-up|3
965723|NCT01170663|1966407|FG001|Overall Study|Lost to Follow-up|9
965724|NCT01170663|1966406|FG000|Overall Study|Withdrawal of consent without follow-up|11
965725|NCT01170663|1966407|FG001|Overall Study|Withdrawal of consent without follow-up|11
965726|NCT01170962|1966449|FG000|Treatment Period|Lack of Efficacy|96
965727|NCT01170962|1966450|FG001|Treatment Period|Lack of Efficacy|91
965728|NCT01170962|1966451|FG002|Treatment Period|Lack of Efficacy|7
965729|NCT01170962|1966449|FG000|Treatment Period|Adverse Event|11
965730|NCT01170962|1966450|FG001|Treatment Period|Adverse Event|12
965731|NCT01170962|1966451|FG002|Treatment Period|Adverse Event|3
965732|NCT01170962|1966449|FG000|Treatment Period|Withdrawal by Subject|2
965733|NCT01170962|1966450|FG001|Treatment Period|Withdrawal by Subject|1
965734|NCT01170962|1966451|FG002|Treatment Period|Withdrawal by Subject|0
965735|NCT01170962|1966449|FG000|Treatment Period|Lost to Follow-up|1
965736|NCT01170962|1966450|FG001|Treatment Period|Lost to Follow-up|1
965737|NCT01170962|1966451|FG002|Treatment Period|Lost to Follow-up|1
965738|NCT01170962|1966449|FG000|Treatment Period|Participant no longer meets criteria|0
965739|NCT01170962|1966450|FG001|Treatment Period|Participant no longer meets criteria|1
965740|NCT01170962|1966451|FG002|Treatment Period|Participant no longer meets criteria|0
965741|NCT01170962|1966449|FG000|Treatment Period|Request to discontinue treatment|7
965742|NCT01170962|1966450|FG001|Treatment Period|Request to discontinue treatment|3
965743|NCT01170962|1966451|FG002|Treatment Period|Request to discontinue treatment|1
965744|NCT01170962|1966449|FG000|Treatment Period|Completed 24 Week treatment period only|10
965745|NCT01170962|1966450|FG001|Treatment Period|Completed 24 Week treatment period only|2
965746|NCT01170962|1966451|FG002|Treatment Period|Completed 24 Week treatment period only|0
965747|NCT01170962|1966449|FG000|Follow up Period|Withdrawal by Subject|14
965748|NCT01170962|1966450|FG001|Follow up Period|Withdrawal by Subject|10
965749|NCT01170962|1966451|FG002|Follow up Period|Withdrawal by Subject|2
965750|NCT01170962|1966449|FG000|Follow up Period|Lost to Follow-up|13
965751|NCT01170962|1966450|FG001|Follow up Period|Lost to Follow-up|8
965752|NCT01170962|1966451|FG002|Follow up Period|Lost to Follow-up|1
965753|NCT01170962|1966449|FG000|Follow up Period|Death|2
965754|NCT01170962|1966450|FG001|Follow up Period|Death|2
965755|NCT01170962|1966451|FG002|Follow up Period|Death|0
965756|NCT01170962|1966449|FG000|Follow up Period|Others|10
965757|NCT01170962|1966450|FG001|Follow up Period|Others|7
965758|NCT01170962|1966451|FG002|Follow up Period|Others|3
965759|NCT01171183|1966480|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
965760|NCT01171183|1966481|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
965761|NCT01171183|1966480|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0
965762|NCT01171183|1966481|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1
965763|NCT01171183|1966480|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
965764|NCT01171183|1966481|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
965765|NCT01171183|1966480|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
965766|NCT01171183|1966481|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
965767|NCT01171183|1966480|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
965768|NCT01171183|1966481|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
965769|NCT01171183|1966480|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
965770|NCT01171183|1966481|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
965771|NCT01171521|1966487|FG000|Overall Study|Lost to Follow-up|5
965772|NCT01171521|1966487|FG000|Overall Study|screen failure|1
965773|NCT01171612|1966491|FG000|Overall Study|Lost to Follow-up|51
965774|NCT01171625|1966498|FG000|Overall Study|On-Protocol|67
965775|NCT01171625|1966498|FG000|Overall Study|Death|38
965776|NCT01171625|1966498|FG000|Overall Study|Withdrawal by Subject|31
965777|NCT01171625|1966498|FG000|Overall Study|Explanted|10
965778|NCT01171625|1966498|FG000|Overall Study|Lost to Follow-up|5
965779|NCT01171625|1966498|FG000|Overall Study|Patient received valve-in-valve|3
965780|NCT01171625|1966498|FG000|Overall Study|Other|1
965781|NCT01171625|1966498|FG000|Overall Study|Consented but did not receive device|25
965782|NCT01171677|1966512|FG000|Overall Study|Withdrawal by Subject|0
965783|NCT01171677|1966513|FG001|Overall Study|Withdrawal by Subject|3
965784|NCT01171677|1966512|FG000|Overall Study|Adverse Event|1
965785|NCT01171677|1966513|FG001|Overall Study|Adverse Event|0
965786|NCT01171677|1966512|FG000|Overall Study|completed <70% IntenSati classes|5
965787|NCT01171677|1966513|FG001|Overall Study|completed <70% IntenSati classes|0
965788|NCT01171820|1966539|FG000|Overall Study|Death|3
965789|NCT01171820|1966540|FG001|Overall Study|Death|3
965790|NCT01171820|1966539|FG000|Overall Study|Lost to Follow-up|0
965791|NCT01171820|1966540|FG001|Overall Study|Lost to Follow-up|1
965792|NCT01171820|1966539|FG000|Overall Study|Withdrawal by Subject|2
965793|NCT01171820|1966540|FG001|Overall Study|Withdrawal by Subject|0
965794|NCT01171820|1966539|FG000|Overall Study|Physician Decision|0
965795|NCT01171820|1966540|FG001|Overall Study|Physician Decision|1
965796|NCT01171820|1966539|FG000|Overall Study|1-Year Missed Visit|1
965797|NCT01171820|1966540|FG001|Overall Study|1-Year Missed Visit|1
911140|NCT00796991|1888345|FG001|Overall Study|Disease Progression|9
911141|NCT00796991|1888346|FG002|Overall Study|Disease Progression|7
911142|NCT00796991|1888344|FG000|Overall Study|Study Drug Toxicity|3
911143|NCT00796991|1888345|FG001|Overall Study|Study Drug Toxicity|3
911144|NCT00796991|1888346|FG002|Overall Study|Study Drug Toxicity|5
911145|NCT00796991|1888344|FG000|Overall Study|Withdrawal by Subject|0
911146|NCT00796991|1888345|FG001|Overall Study|Withdrawal by Subject|0
911147|NCT00796991|1888346|FG002|Overall Study|Withdrawal by Subject|1
911148|NCT00797108|1888357|FG000|Overall Study|Adverse Event|1
911149|NCT00797108|1888358|FG001|Overall Study|Adverse Event|0
911150|NCT00797108|1888359|FG002|Overall Study|Adverse Event|3
911151|NCT00797108|1888357|FG000|Overall Study|Did Not Meet Entrance Criteria|0
911152|NCT00797108|1888358|FG001|Overall Study|Did Not Meet Entrance Criteria|1
911153|NCT00797108|1888359|FG002|Overall Study|Did Not Meet Entrance Criteria|0
911154|NCT00797108|1888357|FG000|Overall Study|Global Deterioration of Health Status|0
911155|NCT00797108|1888358|FG001|Overall Study|Global Deterioration of Health Status|1
911156|NCT00797108|1888359|FG002|Overall Study|Global Deterioration of Health Status|0
911157|NCT00797108|1888357|FG000|Overall Study|Lack of Efficacy|1
911158|NCT00797108|1888358|FG001|Overall Study|Lack of Efficacy|0
911159|NCT00797108|1888359|FG002|Overall Study|Lack of Efficacy|1
911160|NCT00797108|1888357|FG000|Overall Study|Other|0
911161|NCT00797108|1888358|FG001|Overall Study|Other|0
965822|NCT01171963|1966577|FG000|Overall Study|Adverse Event|10
965823|NCT01171963|1966578|FG001|Overall Study|Adverse Event|15
965824|NCT01171963|1966577|FG000|Overall Study|Lost to Follow-up|23
965825|NCT01171963|1966578|FG001|Overall Study|Lost to Follow-up|24
965826|NCT01171963|1966577|FG000|Overall Study|Other - diarrhoea|1
965827|NCT01171963|1966578|FG001|Overall Study|Other - diarrhoea|0
965828|NCT01171963|1966577|FG000|Overall Study|Withdrawal by Subject|114
965829|NCT01171963|1966578|FG001|Overall Study|Withdrawal by Subject|129
965830|NCT01171976|1966590|FG000|Overall Study|Protocol Violation|0
965831|NCT01171976|1966591|FG001|Overall Study|Protocol Violation|0
965832|NCT01171976|1966592|FG002|Overall Study|Protocol Violation|1
965833|NCT01171976|1966590|FG000|Overall Study|Death|2
965834|NCT01171976|1966591|FG001|Overall Study|Death|4
965835|NCT01171976|1966592|FG002|Overall Study|Death|1
965836|NCT01171976|1966590|FG000|Overall Study|Lost to Follow-up|4
965837|NCT01171976|1966591|FG001|Overall Study|Lost to Follow-up|0
965838|NCT01171976|1966592|FG002|Overall Study|Lost to Follow-up|2
965839|NCT01171976|1966590|FG000|Overall Study|Withdrawal by Subject|1
965840|NCT01171976|1966591|FG001|Overall Study|Withdrawal by Subject|5
965841|NCT01171976|1966592|FG002|Overall Study|Withdrawal by Subject|6
965842|NCT01171976|1966590|FG000|Overall Study|Abnormal test result|1
965843|NCT01171976|1966591|FG001|Overall Study|Abnormal test result|0
965844|NCT01171976|1966592|FG002|Overall Study|Abnormal test result|0
965845|NCT01171976|1966590|FG000|Overall Study|Adverse Event|6
965846|NCT01171976|1966591|FG001|Overall Study|Adverse Event|2
965847|NCT01171976|1966592|FG002|Overall Study|Adverse Event|5
965848|NCT01171989|1966603|FG000|Overall Study|Lost to Follow-up|0
965849|NCT01171989|1966604|FG001|Overall Study|Lost to Follow-up|0
965850|NCT01171989|1966605|FG002|Overall Study|Lost to Follow-up|1
965851|NCT01172275|1966646|FG000|Overall Study|Lost to Follow-up|1
965852|NCT01172275|1966647|FG001|Overall Study|Lost to Follow-up|0
965853|NCT01172275|1966646|FG000|Overall Study|Protocol Violation|1
965854|NCT01172275|1966647|FG001|Overall Study|Protocol Violation|0
965855|NCT01172288|1966655|FG000|Overall Study|Adverse Event|1
965856|NCT01172288|1966656|FG001|Overall Study|Adverse Event|0
965857|NCT01172288|1966655|FG000|Overall Study|Protocol Violation|0
965858|NCT01172288|1966656|FG001|Overall Study|Protocol Violation|1
965859|NCT01172535|1966690|FG000|Overall Study|Death|3
965860|NCT01172535|1966690|FG000|Overall Study|Withdrawal by Subject|2
965861|NCT01172535|1966690|FG000|Overall Study|Lost to Follow-up|1
965862|NCT01172535|1966690|FG000|Overall Study|Ineligible at study entry|1
965863|NCT01172535|1966690|FG000|Overall Study|Unwilling to adhere to study requirement|1
965864|NCT01172639|1966711|FG000|Overall Study|Death|1
965865|NCT01172639|1966712|FG001|Overall Study|Death|1
965866|NCT01172639|1966713|FG002|Overall Study|Death|0
965867|NCT01172639|1966714|FG003|Overall Study|Death|0
965868|NCT01172639|1966715|FG004|Overall Study|Death|0
965869|NCT01172639|1966711|FG000|Overall Study|Lost to Follow-up|9
965870|NCT01172639|1966712|FG001|Overall Study|Lost to Follow-up|7
965871|NCT01172639|1966713|FG002|Overall Study|Lost to Follow-up|11
965872|NCT01172639|1966714|FG003|Overall Study|Lost to Follow-up|6
965873|NCT01172639|1966715|FG004|Overall Study|Lost to Follow-up|6
965874|NCT01172639|1966711|FG000|Overall Study|Withdrawal by Subject|3
965875|NCT01172639|1966712|FG001|Overall Study|Withdrawal by Subject|3
965876|NCT01172639|1966713|FG002|Overall Study|Withdrawal by Subject|5
965877|NCT01172639|1966714|FG003|Overall Study|Withdrawal by Subject|5
965878|NCT01172639|1966715|FG004|Overall Study|Withdrawal by Subject|0
965879|NCT01172808|1966731|FG000|Overall Study|Adverse Event|8
965880|NCT01172808|1966732|FG001|Overall Study|Adverse Event|4
965881|NCT01172808|1966733|FG002|Overall Study|Adverse Event|8
965882|NCT01172808|1966734|FG003|Overall Study|Adverse Event|3
965883|NCT01172808|1966731|FG000|Overall Study|Lack of Efficacy|1
965884|NCT01172808|1966732|FG001|Overall Study|Lack of Efficacy|0
965885|NCT01172808|1966733|FG002|Overall Study|Lack of Efficacy|0
965886|NCT01172808|1966734|FG003|Overall Study|Lack of Efficacy|0
965887|NCT01172808|1966731|FG000|Overall Study|Protocol Violation|2
965888|NCT01172808|1966732|FG001|Overall Study|Protocol Violation|2
965889|NCT01172808|1966733|FG002|Overall Study|Protocol Violation|2
965890|NCT01172808|1966734|FG003|Overall Study|Protocol Violation|0
965891|NCT01172808|1966731|FG000|Overall Study|Lost to Follow-up|0
965892|NCT01172808|1966732|FG001|Overall Study|Lost to Follow-up|1
965893|NCT01172808|1966733|FG002|Overall Study|Lost to Follow-up|1
965894|NCT01172808|1966734|FG003|Overall Study|Lost to Follow-up|3
965895|NCT01172808|1966731|FG000|Overall Study|Withdrawal by Subject|4
965896|NCT01172808|1966732|FG001|Overall Study|Withdrawal by Subject|1
965897|NCT01172808|1966733|FG002|Overall Study|Withdrawal by Subject|3
965898|NCT01172808|1966734|FG003|Overall Study|Withdrawal by Subject|2
965899|NCT01172808|1966731|FG000|Overall Study|Other|6
965900|NCT01172808|1966732|FG001|Overall Study|Other|5
965901|NCT01172808|1966733|FG002|Overall Study|Other|9
965902|NCT01172808|1966734|FG003|Overall Study|Other|7
965903|NCT01172821|1966748|FG000|Overall Study|Adverse Event|5
965904|NCT01172821|1966749|FG001|Overall Study|Adverse Event|2
965905|NCT01172821|1966750|FG002|Overall Study|Adverse Event|2
965906|NCT01172821|1966751|FG003|Overall Study|Adverse Event|7
965907|NCT01172821|1966748|FG000|Overall Study|Protocol Violation|0
965908|NCT01172821|1966749|FG001|Overall Study|Protocol Violation|2
965909|NCT01172821|1966750|FG002|Overall Study|Protocol Violation|1
965910|NCT01172821|1966751|FG003|Overall Study|Protocol Violation|2
965911|NCT01172821|1966748|FG000|Overall Study|Lost to Follow-up|4
965912|NCT01172821|1966749|FG001|Overall Study|Lost to Follow-up|1
965913|NCT01172821|1966750|FG002|Overall Study|Lost to Follow-up|2
965914|NCT01172821|1966751|FG003|Overall Study|Lost to Follow-up|2
965915|NCT01172821|1966748|FG000|Overall Study|Withdrawal by Subject|2
965916|NCT01172821|1966749|FG001|Overall Study|Withdrawal by Subject|3
965917|NCT01172821|1966750|FG002|Overall Study|Withdrawal by Subject|3
965918|NCT01172821|1966751|FG003|Overall Study|Withdrawal by Subject|3
965919|NCT01172821|1966748|FG000|Overall Study|Other|3
965920|NCT01172821|1966749|FG001|Overall Study|Other|4
965921|NCT01172821|1966750|FG002|Overall Study|Other|5
965922|NCT01172821|1966751|FG003|Overall Study|Other|3
965923|NCT01172847|1966761|FG000|Overall Study|Withdrawal by Subject|3
965924|NCT01172873|1966773|FG000|Overall Study|Withdrawal by Subject|3
965925|NCT01172873|1966774|FG001|Overall Study|Withdrawal by Subject|2
965926|NCT01172938|1966783|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
965927|NCT01172938|1966784|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
965928|NCT01172938|1966785|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
965929|NCT01172938|1966786|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
965930|NCT01172938|1966787|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
965931|NCT01172938|1966788|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
965932|NCT01172938|1966789|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
965933|NCT01172938|1966790|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
965934|NCT01172938|1966791|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
965935|NCT01172938|1966783|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
965936|NCT01172938|1966784|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
965937|NCT01172938|1966785|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
965938|NCT01172938|1966786|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
965939|NCT01172938|1966787|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
965940|NCT01172938|1966788|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
965941|NCT01172938|1966789|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
965942|NCT01172938|1966790|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
965943|NCT01172938|1966791|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
965944|NCT01172938|1966783|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
965945|NCT01172938|1966784|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
965946|NCT01172938|1966785|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
911162|NCT00797108|1888359|FG002|Overall Study|Other|2
911163|NCT00797108|1888357|FG000|Overall Study|Randomized but not Treated|2
911164|NCT00797108|1888358|FG001|Overall Study|Randomized but not Treated|0
911165|NCT00797108|1888359|FG002|Overall Study|Randomized but not Treated|0
911166|NCT00797225|1888375|FG000|Weeks 1 to 12|Adverse Event|0
911167|NCT00797225|1888376|FG001|Weeks 1 to 12|Adverse Event|0
911168|NCT00797225|1888377|FG002|Weeks 1 to 12|Adverse Event|1
911169|NCT00797225|1888378|FG003|Weeks 1 to 12|Adverse Event|0
911170|NCT00797225|1888379|FG004|Weeks 1 to 12|Adverse Event|0
911171|NCT00797225|1888380|FG005|Weeks 1 to 12|Adverse Event|0
911172|NCT00797225|1888381|FG006|Weeks 1 to 12|Adverse Event|0
911173|NCT00797225|1888382|FG007|Weeks 1 to 12|Adverse Event|0
911174|NCT00797225|1888375|FG000|Weeks 1 to 12|Non-compliance|0
911175|NCT00797225|1888376|FG001|Weeks 1 to 12|Non-compliance|1
911176|NCT00797225|1888377|FG002|Weeks 1 to 12|Non-compliance|0
911177|NCT00797225|1888378|FG003|Weeks 1 to 12|Non-compliance|0
911178|NCT00797225|1888379|FG004|Weeks 1 to 12|Non-compliance|0
911179|NCT00797225|1888380|FG005|Weeks 1 to 12|Non-compliance|0
911180|NCT00797225|1888381|FG006|Weeks 1 to 12|Non-compliance|0
911181|NCT00797225|1888382|FG007|Weeks 1 to 12|Non-compliance|0
911182|NCT00797225|1888375|FG000|Weeks 1 to 12|Lack of Efficacy|1
911183|NCT00797225|1888376|FG001|Weeks 1 to 12|Lack of Efficacy|0
911184|NCT00797225|1888377|FG002|Weeks 1 to 12|Lack of Efficacy|0
911185|NCT00797225|1888378|FG003|Weeks 1 to 12|Lack of Efficacy|0
965947|NCT01172938|1966786|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
965948|NCT01172938|1966787|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
965949|NCT01172938|1966788|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
965950|NCT01172938|1966789|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
965951|NCT01172938|1966790|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
965952|NCT01172938|1966791|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
965953|NCT01172938|1966783|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
965954|NCT01172938|1966784|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
965955|NCT01172938|1966785|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
965956|NCT01172938|1966786|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
965957|NCT01172938|1966787|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
965958|NCT01172938|1966788|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
965959|NCT01172938|1966789|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
965960|NCT01172938|1966790|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
965961|NCT01172938|1966791|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
965962|NCT01172938|1966783|FG000|Placebo-controlled Phase (Week 0-24)|Death|0
965963|NCT01172938|1966784|FG001|Placebo-controlled Phase (Week 0-24)|Death|1
965964|NCT01172938|1966785|FG002|Placebo-controlled Phase (Week 0-24)|Death|0
965965|NCT01172938|1966786|FG003|Placebo-controlled Phase (Week 0-24)|Death|0
965966|NCT01172938|1966787|FG004|Placebo-controlled Phase (Week 0-24)|Death|0
965967|NCT01172938|1966788|FG005|Placebo-controlled Phase (Week 0-24)|Death|0
965968|NCT01172938|1966789|FG006|Placebo-controlled Phase (Week 0-24)|Death|0
965969|NCT01172938|1966790|FG007|Placebo-controlled Phase (Week 0-24)|Death|0
965970|NCT01172938|1966791|FG008|Placebo-controlled Phase (Week 0-24)|Death|0
965971|NCT01172938|1966783|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
965972|NCT01172938|1966784|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
965973|NCT01172938|1966785|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
965974|NCT01172938|1966786|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
965975|NCT01172938|1966787|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
965976|NCT01172938|1966788|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
965977|NCT01172938|1966789|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
965978|NCT01172938|1966790|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
965979|NCT01172938|1966791|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
965980|NCT01172938|1966783|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
965981|NCT01172938|1966784|FG001|Placebo-controlled Phase (Week 0-24)|Other|2
965982|NCT01172938|1966785|FG002|Placebo-controlled Phase (Week 0-24)|Other|1
965983|NCT01172938|1966786|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
965984|NCT01172938|1966787|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
965985|NCT01172938|1966788|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
965986|NCT01172938|1966789|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
965987|NCT01172938|1966790|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
965988|NCT01172938|1966791|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
965989|NCT01172938|1966783|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
965990|NCT01172938|1966784|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
965991|NCT01172938|1966785|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
965992|NCT01172938|1966786|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
965993|NCT01172938|1966787|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
965994|NCT01172938|1966788|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
965995|NCT01172938|1966789|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
965996|NCT01172938|1966790|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
965997|NCT01172938|1966791|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
965998|NCT01172938|1966783|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
965999|NCT01172938|1966784|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
911186|NCT00797225|1888379|FG004|Weeks 1 to 12|Lack of Efficacy|0
911187|NCT00797225|1888380|FG005|Weeks 1 to 12|Lack of Efficacy|0
911188|NCT00797225|1888381|FG006|Weeks 1 to 12|Lack of Efficacy|0
911189|NCT00797225|1888382|FG007|Weeks 1 to 12|Lack of Efficacy|0
911190|NCT00797225|1888375|FG000|Weeks 1 to 12|Sponsor Decision|1
911191|NCT00797225|1888376|FG001|Weeks 1 to 12|Sponsor Decision|0
911192|NCT00797225|1888377|FG002|Weeks 1 to 12|Sponsor Decision|0
911193|NCT00797225|1888378|FG003|Weeks 1 to 12|Sponsor Decision|0
911194|NCT00797225|1888379|FG004|Weeks 1 to 12|Sponsor Decision|0
911195|NCT00797225|1888380|FG005|Weeks 1 to 12|Sponsor Decision|0
911196|NCT00797225|1888381|FG006|Weeks 1 to 12|Sponsor Decision|0
911197|NCT00797225|1888382|FG007|Weeks 1 to 12|Sponsor Decision|0
911198|NCT00797225|1888375|FG000|Weeks 13 to 24|Non-compliance|0
911199|NCT00797225|1888376|FG001|Weeks 13 to 24|Non-compliance|2
911200|NCT00797225|1888377|FG002|Weeks 13 to 24|Non-compliance|0
911201|NCT00797225|1888378|FG003|Weeks 13 to 24|Non-compliance|0
911202|NCT00797225|1888379|FG004|Weeks 13 to 24|Non-compliance|0
911203|NCT00797225|1888380|FG005|Weeks 13 to 24|Non-compliance|0
966000|NCT01172938|1966785|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
966001|NCT01172938|1966786|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
966002|NCT01172938|1966787|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
966003|NCT01172938|1966788|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
966004|NCT01172938|1966789|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
966005|NCT01172938|1966790|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
966006|NCT01172938|1966791|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
966007|NCT01172938|1966783|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
966008|NCT01172938|1966784|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
966009|NCT01172938|1966785|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
966010|NCT01172938|1966786|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
966011|NCT01172938|1966787|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
966012|NCT01172938|1966788|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
966013|NCT01172938|1966789|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
966014|NCT01172938|1966790|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
966015|NCT01172938|1966791|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
966016|NCT01172938|1966783|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
966017|NCT01172938|1966784|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
966018|NCT01172938|1966785|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
966019|NCT01172938|1966786|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
966020|NCT01172938|1966787|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
966021|NCT01172938|1966788|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
966022|NCT01172938|1966789|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
966023|NCT01172938|1966790|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
966024|NCT01172938|1966791|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
966025|NCT01172938|1966783|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
966026|NCT01172938|1966784|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
966027|NCT01172938|1966785|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
966028|NCT01172938|1966786|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
966029|NCT01172938|1966787|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
966030|NCT01172938|1966788|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
966031|NCT01172938|1966789|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
966032|NCT01172938|1966790|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
966033|NCT01172938|1966791|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
966034|NCT01172938|1966783|FG000|Active Treatment Phase (Weeks 25-52)|Other|0
966035|NCT01172938|1966784|FG001|Active Treatment Phase (Weeks 25-52)|Other|0
966036|NCT01172938|1966785|FG002|Active Treatment Phase (Weeks 25-52)|Other|0
966037|NCT01172938|1966786|FG003|Active Treatment Phase (Weeks 25-52)|Other|0
966038|NCT01172938|1966787|FG004|Active Treatment Phase (Weeks 25-52)|Other|0
966039|NCT01172938|1966788|FG005|Active Treatment Phase (Weeks 25-52)|Other|1
966040|NCT01172938|1966789|FG006|Active Treatment Phase (Weeks 25-52)|Other|1
966041|NCT01172938|1966790|FG007|Active Treatment Phase (Weeks 25-52)|Other|0
966042|NCT01172938|1966791|FG008|Active Treatment Phase (Weeks 25-52)|Other|0
966043|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
966044|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
966045|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
966046|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
966047|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
966048|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
966049|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
966050|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
966051|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
966052|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
966053|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
966054|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
966055|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
966056|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
966057|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
966058|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
966059|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
966060|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
966061|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
966062|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
966063|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
966064|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
966065|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
966066|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1006623|NCT01468701|2025298|FG013|Overall Study|Not being followed up|0
966067|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
966068|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
966069|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
966070|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
966071|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
966072|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
966073|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
966074|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
966075|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
966076|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
966077|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
966078|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
966079|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0
966080|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0
966081|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1
966082|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0
966083|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0
966084|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0
966085|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0
966086|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0
966087|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0
966088|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
966089|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
966090|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
966091|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
966092|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
966093|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
966094|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
966095|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
966096|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
966097|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
966098|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
966099|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
966100|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
966101|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
966102|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
966103|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
966104|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
966105|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
966106|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0
966107|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1
966108|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0
966109|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0
966110|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0
966111|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0
966112|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0
966113|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0
966114|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0
966115|NCT01172938|1966783|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
966116|NCT01172938|1966784|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
966117|NCT01172938|1966785|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
966118|NCT01172938|1966786|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
966119|NCT01172938|1966787|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
966120|NCT01172938|1966788|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
966121|NCT01172938|1966789|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
966122|NCT01172938|1966790|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
966123|NCT01172938|1966791|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
966124|NCT01172938|1966783|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
966125|NCT01172938|1966784|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
911204|NCT00797225|1888381|FG006|Weeks 13 to 24|Non-compliance|0
911205|NCT00797225|1888382|FG007|Weeks 13 to 24|Non-compliance|0
911206|NCT00797225|1888375|FG000|Weeks 13 to 24|Withdrawal by Subject|0
911207|NCT00797225|1888376|FG001|Weeks 13 to 24|Withdrawal by Subject|1
911208|NCT00797225|1888377|FG002|Weeks 13 to 24|Withdrawal by Subject|1
911209|NCT00797225|1888378|FG003|Weeks 13 to 24|Withdrawal by Subject|0
911210|NCT00797225|1888379|FG004|Weeks 13 to 24|Withdrawal by Subject|0
911211|NCT00797225|1888380|FG005|Weeks 13 to 24|Withdrawal by Subject|0
911212|NCT00797225|1888381|FG006|Weeks 13 to 24|Withdrawal by Subject|0
911213|NCT00797225|1888382|FG007|Weeks 13 to 24|Withdrawal by Subject|0
911214|NCT00797225|1888375|FG000|Weeks 13 to 24|Lost to Follow-up|0
911215|NCT00797225|1888376|FG001|Weeks 13 to 24|Lost to Follow-up|0
911216|NCT00797225|1888377|FG002|Weeks 13 to 24|Lost to Follow-up|1
966126|NCT01172938|1966785|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
966127|NCT01172938|1966786|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
966128|NCT01172938|1966787|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
966129|NCT01172938|1966788|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
966130|NCT01172938|1966789|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
966131|NCT01172938|1966790|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
966132|NCT01172938|1966791|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
966133|NCT01172938|1966783|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
966134|NCT01172938|1966784|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
966135|NCT01172938|1966785|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
966136|NCT01172938|1966786|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
966137|NCT01172938|1966787|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
966138|NCT01172938|1966788|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
966139|NCT01172938|1966789|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
966140|NCT01172938|1966790|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
966141|NCT01172938|1966791|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
966142|NCT01172938|1966783|FG000|Active-Treatment Phase Weeks (104-156)|Death|0
966143|NCT01172938|1966784|FG001|Active-Treatment Phase Weeks (104-156)|Death|0
966144|NCT01172938|1966785|FG002|Active-Treatment Phase Weeks (104-156)|Death|0
966145|NCT01172938|1966786|FG003|Active-Treatment Phase Weeks (104-156)|Death|0
966146|NCT01172938|1966787|FG004|Active-Treatment Phase Weeks (104-156)|Death|0
966147|NCT01172938|1966788|FG005|Active-Treatment Phase Weeks (104-156)|Death|0
966148|NCT01172938|1966789|FG006|Active-Treatment Phase Weeks (104-156)|Death|0
966149|NCT01172938|1966790|FG007|Active-Treatment Phase Weeks (104-156)|Death|1
966150|NCT01172938|1966791|FG008|Active-Treatment Phase Weeks (104-156)|Death|0
966151|NCT01172938|1966783|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
966152|NCT01172938|1966784|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
966153|NCT01172938|1966785|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
966154|NCT01172938|1966786|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
966155|NCT01172938|1966787|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
966156|NCT01172938|1966788|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
966157|NCT01172938|1966789|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
966158|NCT01172938|1966790|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
966159|NCT01172938|1966791|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
966160|NCT01172938|1966783|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
966161|NCT01172938|1966784|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
966162|NCT01172938|1966785|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
966163|NCT01172938|1966786|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
966164|NCT01172938|1966787|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
966165|NCT01172938|1966788|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
966166|NCT01172938|1966789|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
966167|NCT01172938|1966790|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
966168|NCT01172938|1966791|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
966169|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
966170|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
966171|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
966172|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
966173|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
966174|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
966175|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
966176|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
966177|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
966178|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
966179|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
966180|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
966181|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
966182|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
966183|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
966184|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
966185|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
966186|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
966187|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
966188|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
966189|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
966190|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
966191|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
966192|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
966193|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
966194|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
966195|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
966196|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
966197|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
966198|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
966199|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
966200|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
966201|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
966202|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
966203|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
966204|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
966205|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
966206|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
966207|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
966208|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
966209|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
966210|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
966211|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
966212|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
966213|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
966214|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
966215|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
966216|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
966217|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
966218|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
966219|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
966220|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
966221|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
966222|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
966223|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
966224|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
966225|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
966226|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
966227|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
966228|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
966229|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
966230|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
966231|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
966232|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
966233|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
966234|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
966235|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
911217|NCT00797225|1888378|FG003|Weeks 13 to 24|Lost to Follow-up|0
911218|NCT00797225|1888379|FG004|Weeks 13 to 24|Lost to Follow-up|1
911219|NCT00797225|1888380|FG005|Weeks 13 to 24|Lost to Follow-up|0
911220|NCT00797225|1888381|FG006|Weeks 13 to 24|Lost to Follow-up|0
911221|NCT00797225|1888382|FG007|Weeks 13 to 24|Lost to Follow-up|0
911222|NCT00797225|1888375|FG000|Weeks 13 to 24|Adverse Event|0
911223|NCT00797225|1888376|FG001|Weeks 13 to 24|Adverse Event|1
911224|NCT00797225|1888377|FG002|Weeks 13 to 24|Adverse Event|0
911225|NCT00797225|1888378|FG003|Weeks 13 to 24|Adverse Event|0
911226|NCT00797225|1888379|FG004|Weeks 13 to 24|Adverse Event|0
911227|NCT00797225|1888380|FG005|Weeks 13 to 24|Adverse Event|0
911228|NCT00797225|1888381|FG006|Weeks 13 to 24|Adverse Event|1
911229|NCT00797225|1888382|FG007|Weeks 13 to 24|Adverse Event|0
911230|NCT00797225|1888375|FG000|Weeks 13 to 24|Sponsor Decision|0
911231|NCT00797225|1888376|FG001|Weeks 13 to 24|Sponsor Decision|0
911232|NCT00797225|1888377|FG002|Weeks 13 to 24|Sponsor Decision|0
911233|NCT00797225|1888378|FG003|Weeks 13 to 24|Sponsor Decision|0
911234|NCT00797225|1888379|FG004|Weeks 13 to 24|Sponsor Decision|0
911235|NCT00797225|1888380|FG005|Weeks 13 to 24|Sponsor Decision|0
911236|NCT00797225|1888381|FG006|Weeks 13 to 24|Sponsor Decision|1
911237|NCT00797225|1888382|FG007|Weeks 13 to 24|Sponsor Decision|0
911238|NCT00797316|1888410|FG000|Overall Study|Administrative problems|1
911239|NCT00797316|1888411|FG001|Overall Study|Administrative problems|0
911240|NCT00797316|1888410|FG000|Overall Study|Adverse Event|5
911241|NCT00797316|1888411|FG001|Overall Study|Adverse Event|3
911242|NCT00797316|1888410|FG000|Overall Study|Lost to Follow-up|4
911243|NCT00797316|1888411|FG001|Overall Study|Lost to Follow-up|8
911244|NCT00797316|1888410|FG000|Overall Study|Protocol Deviation|1
911245|NCT00797316|1888411|FG001|Overall Study|Protocol Deviation|2
911246|NCT00797316|1888410|FG000|Overall Study|Patient withdrew consent|12
911247|NCT00797316|1888411|FG001|Overall Study|Patient withdrew consent|6
911248|NCT00797316|1888410|FG000|Overall Study|Unsatisfactory therapeutic effect|0
911249|NCT00797316|1888411|FG001|Overall Study|Unsatisfactory therapeutic effect|13
911250|NCT00797511|1888425|FG000|Overall Study|Withdrawal by Subject|1
966236|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
966237|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
966238|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
966239|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
966240|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
966241|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
966242|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
966243|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
966244|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
966245|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
966246|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
966247|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
966248|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
966249|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
966250|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0
966251|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0
966252|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1
966253|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0
966254|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0
966255|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0
966256|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0
966257|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0
966258|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0
966259|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
966260|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
966261|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
966262|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
966263|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
966264|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
966265|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
966266|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
966267|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
966268|NCT01172938|1966783|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
966269|NCT01172938|1966784|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
966270|NCT01172938|1966785|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
966271|NCT01172938|1966786|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
966272|NCT01172938|1966787|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
966273|NCT01172938|1966788|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
966274|NCT01172938|1966789|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
966275|NCT01172938|1966790|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
966276|NCT01172938|1966791|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
966277|NCT01173055|1966833|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2
966278|NCT01173055|1966834|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2
966279|NCT01173055|1966833|FG000|Period 2 - Day 64 to 112|Adverse Event|0
966280|NCT01173055|1966834|FG001|Period 2 - Day 64 to 112|Adverse Event|1
966281|NCT01173120|1966840|FG000|Overall Study|Lack of Efficacy|2
966282|NCT01173120|1966840|FG000|Overall Study|Lost to Follow-up|1
966283|NCT01173120|1966840|FG000|Overall Study|Participant Decision|2
966284|NCT01173120|1966840|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33
966285|NCT01173120|1966840|FG000|Overall Study|Switch-Participant Decision|12
966286|NCT01173120|1966840|FG000|Overall Study|Switch-Difficulty With Device|12
966287|NCT01173471|1966879|FG000|Overall Study|Eligibility criteria not fulfilled|0
966288|NCT01173471|1966880|FG001|Overall Study|Eligibility criteria not fulfilled|0
966289|NCT01173471|1966881|FG002|Overall Study|Eligibility criteria not fulfilled|1
966290|NCT01173471|1966882|FG003|Overall Study|Eligibility criteria not fulfilled|1
966291|NCT01173471|1966879|FG000|Overall Study|Condition under investigation worsened|2
966292|NCT01173471|1966880|FG001|Overall Study|Condition under investigation worsened|0
966293|NCT01173471|1966881|FG002|Overall Study|Condition under investigation worsened|0
966294|NCT01173471|1966882|FG003|Overall Study|Condition under investigation worsened|0
966295|NCT01173471|1966879|FG000|Overall Study|Lost to Follow-up|0
966296|NCT01173471|1966880|FG001|Overall Study|Lost to Follow-up|0
966297|NCT01173471|1966881|FG002|Overall Study|Lost to Follow-up|1
966298|NCT01173471|1966882|FG003|Overall Study|Lost to Follow-up|0
966299|NCT01173471|1966879|FG000|Overall Study|Reason given as Other|0
966300|NCT01173471|1966880|FG001|Overall Study|Reason given as Other|0
966301|NCT01173471|1966881|FG002|Overall Study|Reason given as Other|1
966302|NCT01173471|1966882|FG003|Overall Study|Reason given as Other|0
966303|NCT01173523|1966894|FG000|Overall Study|Clinical Progression|1
966304|NCT01173523|1966895|FG001|Overall Study|Clinical Progression|1
966305|NCT01173523|1966894|FG000|Overall Study|Progressive Disease|10
966306|NCT01173523|1966895|FG001|Overall Study|Progressive Disease|8
966307|NCT01173523|1966894|FG000|Overall Study|Other|2
966308|NCT01173523|1966895|FG001|Overall Study|Other|3
966309|NCT01173601|1966905|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
966310|NCT01173601|1966906|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
966311|NCT01173601|1966907|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
966312|NCT01173601|1966908|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
966313|NCT01173601|1966909|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
966314|NCT01173601|1966905|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
966315|NCT01173601|1966906|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
966316|NCT01173601|1966907|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
966317|NCT01173601|1966908|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
966318|NCT01173601|1966909|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
966319|NCT01173601|1966905|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
966320|NCT01173601|1966906|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
966321|NCT01173601|1966907|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
966322|NCT01173601|1966908|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
966323|NCT01173601|1966909|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
966324|NCT01173601|1966905|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
966325|NCT01173601|1966906|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
966326|NCT01173601|1966907|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
966327|NCT01173601|1966908|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
966328|NCT01173601|1966909|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
966329|NCT01173601|1966905|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
966330|NCT01173601|1966906|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
966331|NCT01173601|1966907|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
966332|NCT01173601|1966908|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
966333|NCT01173601|1966909|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
966334|NCT01173601|1966905|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
966335|NCT01173601|1966906|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
966336|NCT01173601|1966907|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
966337|NCT01173601|1966908|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
966338|NCT01173601|1966909|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
966339|NCT01173601|1966905|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
966340|NCT01173601|1966906|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
966341|NCT01173601|1966907|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
966342|NCT01173601|1966908|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
966343|NCT01173601|1966909|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
966344|NCT01173601|1966905|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
966345|NCT01173601|1966906|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
966346|NCT01173601|1966907|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
966347|NCT01173601|1966908|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
966348|NCT01173601|1966909|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
966349|NCT01173601|1966905|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
966350|NCT01173601|1966906|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
966351|NCT01173601|1966907|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
966352|NCT01173601|1966908|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
966353|NCT01173601|1966909|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
966354|NCT01173601|1966905|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
966355|NCT01173601|1966906|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
966356|NCT01173601|1966907|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
966357|NCT01173601|1966908|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
966358|NCT01173601|1966909|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
966359|NCT01173601|1966905|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
966360|NCT01173601|1966906|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
966361|NCT01173601|1966907|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
966362|NCT01173601|1966908|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
966363|NCT01173601|1966909|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
966364|NCT01173601|1966905|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
966365|NCT01173601|1966906|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
966366|NCT01173601|1966907|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
966367|NCT01173601|1966908|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
966368|NCT01173601|1966909|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
966369|NCT01173601|1966905|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
966370|NCT01173601|1966906|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
966371|NCT01173601|1966907|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
966372|NCT01173601|1966908|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
966373|NCT01173601|1966909|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
966374|NCT01173601|1966905|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
966375|NCT01173601|1966906|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
966376|NCT01173601|1966907|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
966377|NCT01173601|1966908|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
966378|NCT01173601|1966909|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
966379|NCT01173653|1966929|FG000|Overall Study|Pts unwilling to provide follow-up|53
966380|NCT01173653|1966930|FG001|Overall Study|Pts unwilling to provide follow-up|41
966381|NCT01173679|1966936|FG000|Overall Study|Death|1
966382|NCT01173692|1966943|FG000|Overall Study|Adverse Event|1
966383|NCT01173692|1966944|FG001|Overall Study|Adverse Event|2
966384|NCT01173692|1966943|FG000|Overall Study|Withdrawal by Subject|1
966385|NCT01173692|1966944|FG001|Overall Study|Withdrawal by Subject|3
966386|NCT01173718|1966950|FG000|Overall Study|Death|17
966387|NCT01173718|1966950|FG000|Overall Study|Abandonment of study graft|27
966388|NCT01174004|1966973|FG000|Overall Study|Adverse Event|2
966389|NCT01174004|1966974|FG001|Overall Study|Adverse Event|10
966390|NCT01174004|1966973|FG000|Overall Study|Withdrawal by Subject|2
966391|NCT01174004|1966974|FG001|Overall Study|Withdrawal by Subject|3
966392|NCT01174004|1966973|FG000|Overall Study|At Discretion of Sponsor|2
966393|NCT01174004|1966974|FG001|Overall Study|At Discretion of Sponsor|2
966394|NCT01174004|1966973|FG000|Overall Study|Protocol Violation|0
966395|NCT01174004|1966974|FG001|Overall Study|Protocol Violation|1
966396|NCT01174004|1966973|FG000|Overall Study|Physician Decision|1
966397|NCT01174004|1966974|FG001|Overall Study|Physician Decision|0
966398|NCT01174043|1967001|FG000|Overall Study|Disease progression|5
966399|NCT01174043|1967001|FG000|Overall Study|Adverse Event|3
966400|NCT01174043|1967001|FG000|Overall Study|Death|1
966401|NCT01174043|1967001|FG000|Overall Study|Withdrawal by Subject|2
966402|NCT01174160|1967016|FG000|Overall Study|Adverse Event|1
966403|NCT01174160|1967017|FG001|Overall Study|Adverse Event|0
966404|NCT01174160|1967016|FG000|Overall Study|Lost to Follow-up|1
966405|NCT01174160|1967017|FG001|Overall Study|Lost to Follow-up|0
966406|NCT01174160|1967016|FG000|Overall Study|Physician Decision|1
966407|NCT01174160|1967017|FG001|Overall Study|Physician Decision|0
966408|NCT01174160|1967016|FG000|Overall Study|Protocol Violation|4
966409|NCT01174160|1967017|FG001|Overall Study|Protocol Violation|6
966410|NCT01174160|1967016|FG000|Overall Study|Withdrawal by Subject|1
966411|NCT01174160|1967017|FG001|Overall Study|Withdrawal by Subject|0
966412|NCT01174173|1967023|FG000|Overall Study|drug-drug interaction|1
966413|NCT01174186|1967030|FG000|Overall Study|Lost to Follow-up|0
966414|NCT01174186|1967031|FG001|Overall Study|Lost to Follow-up|1
966415|NCT01174186|1967030|FG000|Overall Study|Withdrawal by Subject|0
966416|NCT01174186|1967031|FG001|Overall Study|Withdrawal by Subject|2
966417|NCT01174238|1967037|FG000|Overall Study|Lost to Follow-up|2
966418|NCT01174264|1967047|FG000|Single Dose Pharmacokinetics|Early progressive disease|1
966419|NCT01174264|1967048|FG001|Single Dose Pharmacokinetics|Early progressive disease|0
966420|NCT01174264|1967049|FG002|Single Dose Pharmacokinetics|Early progressive disease|1
966421|NCT01174264|1967047|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0
966422|NCT01174264|1967048|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0
966423|NCT01174264|1967049|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1
966424|NCT01174264|1967047|FG000|Steady-state Pharmacokinetics|Not evaluable|6
966425|NCT01174264|1967048|FG001|Steady-state Pharmacokinetics|Not evaluable|0
966426|NCT01174264|1967049|FG002|Steady-state Pharmacokinetics|Not evaluable|2
966427|NCT01174342|1967057|FG000|Overall Study|Conversion to cesarean section|4
966428|NCT01174446|1967061|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
966429|NCT01174446|1967062|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
966430|NCT01174446|1967063|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
966431|NCT01174446|1967064|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
966432|NCT01174446|1967061|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
966433|NCT01174446|1967062|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
966434|NCT01174446|1967063|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
966435|NCT01174446|1967064|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
966436|NCT01174446|1967061|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
966437|NCT01174446|1967062|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
966438|NCT01174446|1967063|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
966439|NCT01174446|1967064|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
966440|NCT01174446|1967061|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
966441|NCT01174446|1967062|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
966442|NCT01174446|1967063|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
966443|NCT01174446|1967064|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
966444|NCT01174459|1967111|FG000|Overall Study|case report form (CRF) not collected|5
966445|NCT01174550|1967117|FG000|Overall Study|Death|75
966446|NCT01174550|1967118|FG001|Overall Study|Death|74
966447|NCT01174550|1967117|FG000|Overall Study|Lost to Follow-up|652
966448|NCT01174550|1967118|FG001|Overall Study|Lost to Follow-up|510
966449|NCT01174550|1967117|FG000|Overall Study|Withdrawal by Subject|543
966450|NCT01174550|1967118|FG001|Overall Study|Withdrawal by Subject|289
966451|NCT01174784|1967141|FG000|Overall Study|Screen fails|4
966452|NCT01175018|1967162|FG000|Overall Study|Adverse Event|3
966453|NCT01175018|1967163|FG001|Overall Study|Adverse Event|1
966454|NCT01175083|1967185|FG000|Primary Epoch|Withdrawal by Subject|0
966455|NCT01175083|1967186|FG001|Primary Epoch|Withdrawal by Subject|0
966456|NCT01175083|1967187|FG002|Primary Epoch|Withdrawal by Subject|0
966457|NCT01175083|1967188|FG003|Primary Epoch|Withdrawal by Subject|0
966458|NCT01175083|1967189|FG004|Primary Epoch|Withdrawal by Subject|0
966459|NCT01175083|1967190|FG005|Primary Epoch|Withdrawal by Subject|2
966460|NCT01175083|1967185|FG000|Primary Epoch|Lost to Follow-up|0
966461|NCT01175083|1967186|FG001|Primary Epoch|Lost to Follow-up|0
966462|NCT01175083|1967187|FG002|Primary Epoch|Lost to Follow-up|0
966463|NCT01175083|1967188|FG003|Primary Epoch|Lost to Follow-up|0
966464|NCT01175083|1967189|FG004|Primary Epoch|Lost to Follow-up|0
966465|NCT01175083|1967190|FG005|Primary Epoch|Lost to Follow-up|1
966466|NCT01175083|1967185|FG000|Booster Epoch|Death|0
966467|NCT01175083|1967186|FG001|Booster Epoch|Death|0
966468|NCT01175083|1967187|FG002|Booster Epoch|Death|1
966469|NCT01175083|1967188|FG003|Booster Epoch|Death|0
966470|NCT01175083|1967189|FG004|Booster Epoch|Death|0
966471|NCT01175083|1967190|FG005|Booster Epoch|Death|0
966472|NCT01175083|1967185|FG000|Booster Epoch|Withdrawal by Subject|0
966473|NCT01175083|1967186|FG001|Booster Epoch|Withdrawal by Subject|0
966474|NCT01175083|1967187|FG002|Booster Epoch|Withdrawal by Subject|0
966475|NCT01175083|1967188|FG003|Booster Epoch|Withdrawal by Subject|1
966476|NCT01175083|1967189|FG004|Booster Epoch|Withdrawal by Subject|0
966477|NCT01175083|1967190|FG005|Booster Epoch|Withdrawal by Subject|0
966478|NCT01175135|1967212|FG000|Overall Study|Adverse Event|2
966479|NCT01175135|1967213|FG001|Overall Study|Adverse Event|5
966480|NCT01175135|1967214|FG002|Overall Study|Adverse Event|3
966481|NCT01175135|1967215|FG003|Overall Study|Adverse Event|4
966482|NCT01175135|1967212|FG000|Overall Study|Death|1
966483|NCT01175135|1967213|FG001|Overall Study|Death|0
966484|NCT01175135|1967214|FG002|Overall Study|Death|0
966485|NCT01175135|1967215|FG003|Overall Study|Death|0
966486|NCT01175135|1967212|FG000|Overall Study|Lack of Efficacy|4
966487|NCT01175135|1967213|FG001|Overall Study|Lack of Efficacy|5
966488|NCT01175135|1967214|FG002|Overall Study|Lack of Efficacy|0
966489|NCT01175135|1967215|FG003|Overall Study|Lack of Efficacy|5
966490|NCT01175135|1967212|FG000|Overall Study|Lost to Follow-up|1
966491|NCT01175135|1967213|FG001|Overall Study|Lost to Follow-up|2
966492|NCT01175135|1967214|FG002|Overall Study|Lost to Follow-up|0
966493|NCT01175135|1967215|FG003|Overall Study|Lost to Follow-up|0
966494|NCT01175135|1967212|FG000|Overall Study|Protocol Violation|1
966495|NCT01175135|1967213|FG001|Overall Study|Protocol Violation|1
966496|NCT01175135|1967214|FG002|Overall Study|Protocol Violation|0
966497|NCT01175135|1967215|FG003|Overall Study|Protocol Violation|0
966498|NCT01175135|1967212|FG000|Overall Study|Withdrawal by Subject|4
966499|NCT01175135|1967213|FG001|Overall Study|Withdrawal by Subject|8
966500|NCT01175135|1967214|FG002|Overall Study|Withdrawal by Subject|5
966501|NCT01175135|1967215|FG003|Overall Study|Withdrawal by Subject|5
966502|NCT01175135|1967212|FG000|Overall Study|Other|3
966503|NCT01175135|1967213|FG001|Overall Study|Other|1
966504|NCT01175135|1967214|FG002|Overall Study|Other|3
966505|NCT01175135|1967215|FG003|Overall Study|Other|0
966506|NCT01175135|1967212|FG000|Overall Study|Randomized But Not Treated|0
966507|NCT01175135|1967213|FG001|Overall Study|Randomized But Not Treated|0
966508|NCT01175135|1967214|FG002|Overall Study|Randomized But Not Treated|1
966509|NCT01175135|1967215|FG003|Overall Study|Randomized But Not Treated|0
966510|NCT01175213|1967237|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
966511|NCT01175213|1967238|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
966512|NCT01175213|1967237|FG000|IGSC, 10%/rHuPH20|Death|1
966513|NCT01175213|1967238|FG001|IGSC, 10%/rHuPH20|Death|0
966514|NCT01175213|1967237|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1
966515|NCT01175213|1967238|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0
966516|NCT01175213|1967237|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
966517|NCT01175213|1967238|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
966518|NCT01175213|1967237|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3
966519|NCT01175213|1967238|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0
966520|NCT01175213|1967237|FG000|Safety Follow-up|Adverse Event|1
966521|NCT01175213|1967238|FG001|Safety Follow-up|Adverse Event|0
966522|NCT01175356|1967269|FG000|Overall Study|Death|1
966523|NCT01175356|1967269|FG000|Overall Study|Lack of Efficacy|12
966524|NCT01175356|1967269|FG000|Overall Study|Lost to Follow-up|1
966525|NCT01175356|1967269|FG000|Overall Study|Physician Decision|23
966526|NCT01175356|1967269|FG000|Overall Study|Ineligible|1
966527|NCT01175356|1967269|FG000|Overall Study|Treatment Slot Not Available|18
966528|NCT01175356|1967269|FG000|Overall Study|Refusal by patient/parent/guardian|6
966529|NCT01175356|1967269|FG000|Overall Study|Pts MIBG non-avid after enrollment|2
966530|NCT01175356|1967269|FG000|Overall Study|On other COG study w/tumor tx intent|7
966531|NCT01175356|1967269|FG000|Overall Study|Inadequate stem cell for transplant|1
966532|NCT01175356|1967269|FG000|Overall Study|Initiation other tx prior to completion|9
966533|NCT01175382|1967285|FG000|Overall Study|Lost to Follow-up|4
966534|NCT01175382|1967286|FG001|Overall Study|Lost to Follow-up|3
966535|NCT01175382|1967287|FG002|Overall Study|Lost to Follow-up|1
966536|NCT01175382|1967285|FG000|Overall Study|Physician Decision|0
966537|NCT01175382|1967286|FG001|Overall Study|Physician Decision|1
966538|NCT01175382|1967287|FG002|Overall Study|Physician Decision|0
966539|NCT01175382|1967285|FG000|Overall Study|Withdrawal by Subject|0
966540|NCT01175382|1967286|FG001|Overall Study|Withdrawal by Subject|0
966541|NCT01175382|1967287|FG002|Overall Study|Withdrawal by Subject|1
966542|NCT01175382|1967285|FG000|Overall Study|No longer having problem|1
966543|NCT01175382|1967286|FG001|Overall Study|No longer having problem|0
966544|NCT01175382|1967287|FG002|Overall Study|No longer having problem|1
966545|NCT01175382|1967285|FG000|Overall Study|Unable/unwilling to attend visits|3
966546|NCT01175382|1967286|FG001|Overall Study|Unable/unwilling to attend visits|1
966547|NCT01175382|1967287|FG002|Overall Study|Unable/unwilling to attend visits|2
966548|NCT01175382|1967285|FG000|Overall Study|Unwilling to follow protocol|0
966549|NCT01175382|1967286|FG001|Overall Study|Unwilling to follow protocol|1
966550|NCT01175382|1967287|FG002|Overall Study|Unwilling to follow protocol|0
966551|NCT01175382|1967285|FG000|Overall Study|Unable to tolerate study meds|0
966552|NCT01175382|1967286|FG001|Overall Study|Unable to tolerate study meds|1
966553|NCT01175382|1967287|FG002|Overall Study|Unable to tolerate study meds|1
966554|NCT01175473|1967310|FG000|Overall Study|Adverse Event|2
966555|NCT01175473|1967311|FG001|Overall Study|Adverse Event|2
966556|NCT01175590|1967319|FG000|Overall Study|Lost to Follow-up|1
966557|NCT01175590|1967320|FG001|Overall Study|Lost to Follow-up|0
966558|NCT01175590|1967319|FG000|Overall Study|Withdrawal by Subject|0
966559|NCT01175590|1967320|FG001|Overall Study|Withdrawal by Subject|2
966560|NCT01175590|1967319|FG000|Overall Study|Adverse Event|4
966561|NCT01175590|1967320|FG001|Overall Study|Adverse Event|0
966562|NCT01175590|1967319|FG000|Overall Study|Physician Decision|1
966563|NCT01175590|1967320|FG001|Overall Study|Physician Decision|4
966564|NCT01175590|1967319|FG000|Overall Study|Lack of Efficacy|1
966565|NCT01175590|1967320|FG001|Overall Study|Lack of Efficacy|1
966566|NCT01175590|1967319|FG000|Overall Study|Residual Bacterial Conjunctivitis|1
966567|NCT01175590|1967320|FG001|Overall Study|Residual Bacterial Conjunctivitis|0
966568|NCT01175590|1967319|FG000|Overall Study|Treated not as randomized|3
966569|NCT01175590|1967320|FG001|Overall Study|Treated not as randomized|2
966570|NCT01175590|1967319|FG000|Overall Study|Herpes Simplex Dermatitis|1
966571|NCT01175590|1967320|FG001|Overall Study|Herpes Simplex Dermatitis|0
966572|NCT01175590|1967319|FG000|Overall Study|Protocol Violation|0
966573|NCT01175590|1967320|FG001|Overall Study|Protocol Violation|1
966574|NCT01175668|1967329|FG000|Overall Study|Withdrawal by Subject|2
966575|NCT01175668|1967330|FG001|Overall Study|Withdrawal by Subject|0
966576|NCT01175707|1967338|FG000|Overall Study|Adverse Event|4
966577|NCT01175707|1967339|FG001|Overall Study|Adverse Event|6
966578|NCT01175811|1967357|FG000|Overall Study|Adverse Event|1
966579|NCT01175811|1967358|FG001|Overall Study|Adverse Event|1
966580|NCT01175811|1967357|FG000|Overall Study|Entry criteria not met|3
966581|NCT01175811|1967358|FG001|Overall Study|Entry criteria not met|1
966582|NCT01175811|1967357|FG000|Overall Study|Lack of Efficacy|1
966583|NCT01175811|1967358|FG001|Overall Study|Lack of Efficacy|0
966584|NCT01175811|1967357|FG000|Overall Study|Lost to Follow-up|3
966585|NCT01175811|1967358|FG001|Overall Study|Lost to Follow-up|2
966586|NCT01175811|1967357|FG000|Overall Study|Physician Decision|1
966587|NCT01175811|1967358|FG001|Overall Study|Physician Decision|1
966588|NCT01175811|1967357|FG000|Overall Study|Protocol Violation|1
966589|NCT01175811|1967358|FG001|Overall Study|Protocol Violation|2
966590|NCT01175811|1967357|FG000|Overall Study|Withdrawal by Subject|6
966591|NCT01175811|1967358|FG001|Overall Study|Withdrawal by Subject|7
966592|NCT01175824|1967366|FG000|Overall Study|Adverse Event|2
966593|NCT01175824|1967367|FG001|Overall Study|Adverse Event|1
966594|NCT01175824|1967366|FG000|Overall Study|Lack of Efficacy|2
966595|NCT01175824|1967367|FG001|Overall Study|Lack of Efficacy|0
966596|NCT01175824|1967366|FG000|Overall Study|Lost to Follow-up|0
966597|NCT01175824|1967367|FG001|Overall Study|Lost to Follow-up|1
966598|NCT01175824|1967366|FG000|Overall Study|Physician Decision|0
966599|NCT01175824|1967367|FG001|Overall Study|Physician Decision|4
966600|NCT01175824|1967366|FG000|Overall Study|Protocol Violation|2
966601|NCT01175824|1967367|FG001|Overall Study|Protocol Violation|5
966602|NCT01175824|1967366|FG000|Overall Study|Withdrawal by Subject|3
966603|NCT01175824|1967367|FG001|Overall Study|Withdrawal by Subject|7
966604|NCT01175824|1967366|FG000|Overall Study|Sponsor Decision|1
966605|NCT01175824|1967367|FG001|Overall Study|Sponsor Decision|0
966606|NCT01175824|1967366|FG000|Overall Study|Entry Criteria Not Met|6
966607|NCT01175824|1967367|FG001|Overall Study|Entry Criteria Not Met|4
966608|NCT01176032|1967400|FG000|Overall Study|Adverse Event|1
966609|NCT01176032|1967401|FG001|Overall Study|Adverse Event|0
966610|NCT01176032|1967400|FG000|Overall Study|Unsatisfactory therapeutic effect|0
966611|NCT01176032|1967401|FG001|Overall Study|Unsatisfactory therapeutic effect|1
966612|NCT01176032|1967400|FG000|Overall Study|Protocol Violation|1
966613|NCT01176032|1967401|FG001|Overall Study|Protocol Violation|0
966614|NCT01176032|1967400|FG000|Overall Study|Informed consent withdrawn|3
966615|NCT01176032|1967401|FG001|Overall Study|Informed consent withdrawn|0
966616|NCT01176032|1967400|FG000|Overall Study|Other|1
966617|NCT01176032|1967401|FG001|Overall Study|Other|0
966618|NCT01176058|1967414|FG000|Overall Study|Adverse Event|1
966619|NCT01176058|1967415|FG001|Overall Study|Adverse Event|0
966620|NCT01176058|1967414|FG000|Overall Study|Insufficient clinical response|2
966621|NCT01176058|1967415|FG001|Overall Study|Insufficient clinical response|2
966622|NCT01176058|1967414|FG000|Overall Study|Insufficient mycological response|0
966623|NCT01176058|1967415|FG001|Overall Study|Insufficient mycological response|1
966624|NCT01176058|1967414|FG000|Overall Study|Withdrawal by Subject|1
966625|NCT01176058|1967415|FG001|Overall Study|Withdrawal by Subject|0
966626|NCT01176240|1967425|FG000|Study 306A|Lack of Efficacy|2
966627|NCT01176240|1967426|FG001|Study 306A|Lack of Efficacy|1
966628|NCT01176240|1967425|FG000|Study 306A|Protocol Violation|0
966629|NCT01176240|1967426|FG001|Study 306A|Protocol Violation|1
966630|NCT01176240|1967425|FG000|Study 306A|Withdrawal by Subject|0
966631|NCT01176240|1967426|FG001|Study 306A|Withdrawal by Subject|1
966632|NCT01176240|1967425|FG000|Study 306A|Stop due to diverse problems|1
966633|NCT01176240|1967426|FG001|Study 306A|Stop due to diverse problems|0
966634|NCT01176240|1967425|FG000|Study 306B|Lack of Efficacy|5
966635|NCT01176240|1967426|FG001|Study 306B|Lack of Efficacy|3
966636|NCT01176240|1967425|FG000|Study 306B|Adverse Event|10
966637|NCT01176240|1967426|FG001|Study 306B|Adverse Event|5
966638|NCT01176240|1967425|FG000|Study 306B|Protocol Violation|2
966639|NCT01176240|1967426|FG001|Study 306B|Protocol Violation|3
966640|NCT01176240|1967425|FG000|Study 306B|Withdrawal by Subject|4
966641|NCT01176240|1967426|FG001|Study 306B|Withdrawal by Subject|1
966642|NCT01176240|1967425|FG000|Study 306B|Physician Decision|2
966643|NCT01176240|1967426|FG001|Study 306B|Physician Decision|1
966644|NCT01176240|1967425|FG000|Study 306B|Supine Hypertension|1
966645|NCT01176240|1967426|FG001|Study 306B|Supine Hypertension|2
966646|NCT01176240|1967425|FG000|Study 306B|Lost to Follow-up|0
966647|NCT01176240|1967426|FG001|Study 306B|Lost to Follow-up|1
966648|NCT01176240|1967425|FG000|Study 306B|withdrew prior to dosing|2
966649|NCT01176240|1967426|FG001|Study 306B|withdrew prior to dosing|1
966650|NCT01176266|1967432|FG000|Overall Study|Death|6
966651|NCT01176266|1967432|FG000|Overall Study|Withdrawal by Subject|3
966652|NCT01176292|1967442|FG000|Overall Study|Lost to Follow-up|2
966653|NCT01176292|1967443|FG001|Overall Study|Lost to Follow-up|4
966654|NCT01176292|1967442|FG000|Overall Study|Adverse Event|1
966655|NCT01176292|1967443|FG001|Overall Study|Adverse Event|1
966656|NCT01176292|1967442|FG000|Overall Study|Physician Decision|0
966657|NCT01176292|1967443|FG001|Overall Study|Physician Decision|2
966658|NCT01176292|1967442|FG000|Overall Study|Has not scheduled one-year visit yet|2
966659|NCT01176292|1967443|FG001|Overall Study|Has not scheduled one-year visit yet|2
966660|NCT01176565|1967472|FG000|Overall Study|Lost to Follow-up|12
966661|NCT01176565|1967473|FG001|Overall Study|Lost to Follow-up|16
966662|NCT01176565|1967472|FG000|Overall Study|Withdrawal by Subject|7
966663|NCT01176565|1967473|FG001|Overall Study|Withdrawal by Subject|1
966664|NCT01176565|1967472|FG000|Overall Study|Not Analyzed (any other reason)|1
966665|NCT01176565|1967473|FG001|Overall Study|Not Analyzed (any other reason)|2
966666|NCT01176773|1967502|FG000|Overall Study|Screen Failure|2
966667|NCT01176773|1967502|FG000|Overall Study|Withdrew consent|1
966668|NCT01176916|1967512|FG000|Overall Study|Adverse Event|61
966669|NCT01176916|1967512|FG000|Overall Study|Death|1
966670|NCT01176916|1967512|FG000|Overall Study|Lost to Follow-up|15
966671|NCT01176916|1967512|FG000|Overall Study|Objective progression or relapse|17
966672|NCT01176916|1967512|FG000|Overall Study|Protocol Violation|24
966673|NCT01176916|1967512|FG000|Overall Study|Withdrawal by Subject|37
966674|NCT01176916|1967512|FG000|Overall Study|Other|6
966675|NCT01176916|1967512|FG000|Overall Study|Withdrawal prior to Treatment|6
966676|NCT01176968|1967530|FG000|Overall Study|Adverse Event|10
966677|NCT01176968|1967531|FG001|Overall Study|Adverse Event|11
966678|NCT01176968|1967530|FG000|Overall Study|Death|2
966679|NCT01176968|1967531|FG001|Overall Study|Death|3
966680|NCT01176968|1967530|FG000|Overall Study|Lack of Efficacy|0
966681|NCT01176968|1967531|FG001|Overall Study|Lack of Efficacy|1
966682|NCT01176968|1967530|FG000|Overall Study|Lost to Follow-up|16
966683|NCT01176968|1967531|FG001|Overall Study|Lost to Follow-up|14
966684|NCT01176968|1967530|FG000|Overall Study|Withdrawal by Subject|48
966685|NCT01176968|1967531|FG001|Overall Study|Withdrawal by Subject|48
966686|NCT01176968|1967530|FG000|Overall Study|Protocol Violation|2
966687|NCT01176968|1967531|FG001|Overall Study|Protocol Violation|1
966688|NCT01176968|1967530|FG000|Overall Study|Did Not Meet Entrance Criteria|1
966689|NCT01176968|1967531|FG001|Overall Study|Did Not Meet Entrance Criteria|0
966690|NCT01176968|1967530|FG000|Overall Study|Study terminated by sponsor|0
966691|NCT01176968|1967531|FG001|Overall Study|Study terminated by sponsor|1
966692|NCT01176968|1967530|FG000|Overall Study|Reason not defined|5
966693|NCT01176968|1967531|FG001|Overall Study|Reason not defined|3
966694|NCT01177007|1967541|FG000|Overall Study|Lost to Follow-up|2
966695|NCT01177007|1967541|FG000|Overall Study|Death|4
966696|NCT01177007|1967541|FG000|Overall Study|Entered hospice care|5
966697|NCT01177007|1967541|FG000|Overall Study|Required additional Y90 treatment|6
966698|NCT01177007|1967541|FG000|Overall Study|Change in treatment modality|21
966699|NCT01177059|1967547|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
911251|NCT00797563|1888430|FG000|Overall Study|Adverse Event|1
911252|NCT00797667|1888437|FG000|Overall Study|Lack of Efficacy|0
911253|NCT00797667|1888438|FG001|Overall Study|Lack of Efficacy|1
911254|NCT00797667|1888439|FG002|Overall Study|Lack of Efficacy|0
911255|NCT00797667|1888437|FG000|Overall Study|Lost to Follow-up|8
911256|NCT00797667|1888438|FG001|Overall Study|Lost to Follow-up|12
911257|NCT00797667|1888439|FG002|Overall Study|Lost to Follow-up|2
966700|NCT01177059|1967547|FG000|Overall Study|Withdrew consent|2
966701|NCT01177059|1967547|FG000|Overall Study|Lost to Follow-up|18
966702|NCT01177137|1967563|FG000|Overall Study|Withdrawal by Subject|10
966703|NCT01177137|1967564|FG001|Overall Study|Withdrawal by Subject|10
966704|NCT01177137|1967565|FG002|Overall Study|Withdrawal by Subject|2
966705|NCT01177228|1967589|FG000|Overall Study|Positive tuberculosis test|0
966706|NCT01177228|1967590|FG001|Overall Study|Positive tuberculosis test|1
966707|NCT01177228|1967591|FG002|Overall Study|Positive tuberculosis test|0
966708|NCT01177228|1967592|FG003|Overall Study|Positive tuberculosis test|0
966709|NCT01177228|1967589|FG000|Overall Study|Worsening disease activity|1
966710|NCT01177228|1967590|FG001|Overall Study|Worsening disease activity|0
966711|NCT01177228|1967591|FG002|Overall Study|Worsening disease activity|0
966712|NCT01177228|1967592|FG003|Overall Study|Worsening disease activity|0
966713|NCT01177228|1967589|FG000|Overall Study|Withdrawal by Subject|0
966714|NCT01177228|1967590|FG001|Overall Study|Withdrawal by Subject|1
966715|NCT01177228|1967591|FG002|Overall Study|Withdrawal by Subject|0
966716|NCT01177228|1967592|FG003|Overall Study|Withdrawal by Subject|0
966717|NCT01177293|1967607|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0
966718|NCT01177293|1967608|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1
966719|NCT01177384|1967616|FG000|Overall Study|Adverse Event|6
966720|NCT01177384|1967617|FG001|Overall Study|Adverse Event|4
966721|NCT01177384|1967616|FG000|Overall Study|Lack of Efficacy|0
966722|NCT01177384|1967617|FG001|Overall Study|Lack of Efficacy|1
966723|NCT01177384|1967616|FG000|Overall Study|Lost to Follow-up|3
966724|NCT01177384|1967617|FG001|Overall Study|Lost to Follow-up|4
966725|NCT01177384|1967616|FG000|Overall Study|Physician Decision|0
966726|NCT01177384|1967617|FG001|Overall Study|Physician Decision|3
966727|NCT01177384|1967616|FG000|Overall Study|Protocol Violation|0
966728|NCT01177384|1967617|FG001|Overall Study|Protocol Violation|2
966729|NCT01177384|1967616|FG000|Overall Study|Withdrawal by Subject|5
966730|NCT01177384|1967617|FG001|Overall Study|Withdrawal by Subject|12
966731|NCT01177410|1967626|FG000|Overall Study|Adverse Event|0
966732|NCT01177410|1967627|FG001|Overall Study|Adverse Event|2
966733|NCT01177410|1967628|FG002|Overall Study|Adverse Event|2
966734|NCT01177410|1967626|FG000|Overall Study|Withdrawal by Subject|1
966735|NCT01177410|1967627|FG001|Overall Study|Withdrawal by Subject|4
966736|NCT01177410|1967628|FG002|Overall Study|Withdrawal by Subject|3
966737|NCT01177410|1967626|FG000|Overall Study|Lost to Follow-up|0
966738|NCT01177410|1967627|FG001|Overall Study|Lost to Follow-up|1
966739|NCT01177410|1967628|FG002|Overall Study|Lost to Follow-up|0
966740|NCT01177553|1967638|FG000|Overall Study|babies not yet 6 months of age|1
966741|NCT01177553|1967639|FG001|Overall Study|babies not yet 6 months of age|0
966742|NCT01177670|1967645|FG000|Overall Study|Study Terminated|115
966743|NCT01177670|1967645|FG000|Overall Study|Physician Decision|50
966744|NCT01177670|1967645|FG000|Overall Study|Withdrawal by Subject|4
966745|NCT01177722|1967657|FG000|Overall Study|Serious Adverse Event|0
966746|NCT01177722|1967658|FG001|Overall Study|Serious Adverse Event|0
966747|NCT01177722|1967659|FG002|Overall Study|Serious Adverse Event|1
966748|NCT01177722|1967660|FG003|Overall Study|Serious Adverse Event|0
966749|NCT01177722|1967657|FG000|Overall Study|Protocol Violation|0
966750|NCT01177722|1967658|FG001|Overall Study|Protocol Violation|0
966751|NCT01177722|1967659|FG002|Overall Study|Protocol Violation|1
966752|NCT01177722|1967660|FG003|Overall Study|Protocol Violation|0
966753|NCT01177722|1967657|FG000|Overall Study|Lost to Follow-up|3
966754|NCT01177722|1967658|FG001|Overall Study|Lost to Follow-up|4
966755|NCT01177722|1967659|FG002|Overall Study|Lost to Follow-up|3
966756|NCT01177722|1967660|FG003|Overall Study|Lost to Follow-up|1
966757|NCT01177722|1967657|FG000|Overall Study|Withdrawal by Subject|10
966758|NCT01177722|1967658|FG001|Overall Study|Withdrawal by Subject|6
966759|NCT01177722|1967659|FG002|Overall Study|Withdrawal by Subject|4
966760|NCT01177722|1967660|FG003|Overall Study|Withdrawal by Subject|6
966761|NCT01177787|1967675|FG000|Cryolipolysis on Thigh|Protocol Violation|4
966762|NCT01177787|1967675|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9
966763|NCT01177787|1967675|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1
966764|NCT01177800|1967689|FG000|Overall Study|Adverse Event|9
966765|NCT01177800|1967690|FG001|Overall Study|Adverse Event|3
966766|NCT01177800|1967689|FG000|Overall Study|Protocol Violation|0
966767|NCT01177800|1967690|FG001|Overall Study|Protocol Violation|1
966768|NCT01177800|1967689|FG000|Overall Study|Physician Decision|1
966769|NCT01177800|1967690|FG001|Overall Study|Physician Decision|0
966770|NCT01177800|1967689|FG000|Overall Study|Withdrawal of informed consent|0
966771|NCT01177800|1967690|FG001|Overall Study|Withdrawal of informed consent|1
966772|NCT01177813|1967701|FG000|Overall Study|Adverse Event|8
966773|NCT01177813|1967702|FG001|Overall Study|Adverse Event|2
966774|NCT01177813|1967703|FG002|Overall Study|Adverse Event|4
966775|NCT01177813|1967704|FG003|Overall Study|Adverse Event|6
966776|NCT01177813|1967705|FG004|Overall Study|Adverse Event|3
966777|NCT01177813|1967701|FG000|Overall Study|Lack of Efficacy|1
966778|NCT01177813|1967702|FG001|Overall Study|Lack of Efficacy|0
966779|NCT01177813|1967703|FG002|Overall Study|Lack of Efficacy|0
966780|NCT01177813|1967704|FG003|Overall Study|Lack of Efficacy|0
966781|NCT01177813|1967705|FG004|Overall Study|Lack of Efficacy|0
966782|NCT01177813|1967701|FG000|Overall Study|Protocol Violation|3
966783|NCT01177813|1967702|FG001|Overall Study|Protocol Violation|2
966784|NCT01177813|1967703|FG002|Overall Study|Protocol Violation|2
966785|NCT01177813|1967704|FG003|Overall Study|Protocol Violation|0
966786|NCT01177813|1967705|FG004|Overall Study|Protocol Violation|1
966787|NCT01177813|1967701|FG000|Overall Study|Lost to Follow-up|12
966788|NCT01177813|1967702|FG001|Overall Study|Lost to Follow-up|5
966789|NCT01177813|1967703|FG002|Overall Study|Lost to Follow-up|6
966790|NCT01177813|1967704|FG003|Overall Study|Lost to Follow-up|3
966791|NCT01177813|1967705|FG004|Overall Study|Lost to Follow-up|0
966792|NCT01177813|1967701|FG000|Overall Study|Withdrawal by Subject|12
966793|NCT01177813|1967702|FG001|Overall Study|Withdrawal by Subject|7
966794|NCT01177813|1967703|FG002|Overall Study|Withdrawal by Subject|6
966795|NCT01177813|1967704|FG003|Overall Study|Withdrawal by Subject|5
966796|NCT01177813|1967705|FG004|Overall Study|Withdrawal by Subject|3
966797|NCT01177813|1967701|FG000|Overall Study|Other reason not defined above|5
966798|NCT01177813|1967702|FG001|Overall Study|Other reason not defined above|2
966799|NCT01177813|1967703|FG002|Overall Study|Other reason not defined above|2
966800|NCT01177813|1967704|FG003|Overall Study|Other reason not defined above|3
966801|NCT01177813|1967705|FG004|Overall Study|Other reason not defined above|2
966802|NCT01177943|1967719|FG000|First Intervention|Withdrawal by Subject|2
966803|NCT01177943|1967720|FG001|First Intervention|Withdrawal by Subject|0
966804|NCT01177969|1967733|FG000|Overall Study|Protocol Violation|2
966805|NCT01177969|1967734|FG001|Overall Study|Protocol Violation|1
966806|NCT01177969|1967733|FG000|Overall Study|Withdrawal by Subject|1
966807|NCT01177969|1967734|FG001|Overall Study|Withdrawal by Subject|2
966808|NCT01178073|1967743|FG000|Overall Study|Adverse Event|34
966809|NCT01178073|1967744|FG001|Overall Study|Adverse Event|27
966810|NCT01178073|1967745|FG002|Overall Study|Adverse Event|24
966811|NCT01178073|1967743|FG000|Overall Study|Protocol Violation|1
966812|NCT01178073|1967744|FG001|Overall Study|Protocol Violation|1
966813|NCT01178073|1967745|FG002|Overall Study|Protocol Violation|1
966814|NCT01178073|1967743|FG000|Overall Study|Lost to Follow-up|2
966815|NCT01178073|1967744|FG001|Overall Study|Lost to Follow-up|0
966816|NCT01178073|1967745|FG002|Overall Study|Lost to Follow-up|3
966817|NCT01178073|1967743|FG000|Overall Study|Physician Decision|14
966818|NCT01178073|1967744|FG001|Overall Study|Physician Decision|10
966819|NCT01178073|1967745|FG002|Overall Study|Physician Decision|10
966820|NCT01178073|1967743|FG000|Overall Study|Withdrawal by Subject|10
966821|NCT01178073|1967744|FG001|Overall Study|Withdrawal by Subject|6
966822|NCT01178073|1967745|FG002|Overall Study|Withdrawal by Subject|8
966823|NCT01178073|1967743|FG000|Overall Study|Missing Completion Status|1
966824|NCT01178073|1967744|FG001|Overall Study|Missing Completion Status|0
966825|NCT01178073|1967745|FG002|Overall Study|Missing Completion Status|0
966826|NCT01178086|1967756|FG000|Overall Study|Participant refusal|7
966827|NCT01178086|1967756|FG000|Overall Study|Physician Decision|44
966828|NCT01178086|1967756|FG000|Overall Study|Switch to other CLL therapy|113
966829|NCT01178086|1967756|FG000|Overall Study|Death|59
966830|NCT01178086|1967756|FG000|Overall Study|Other unspecified|89
966831|NCT01178086|1967756|FG000|Overall Study|Excluded from EAS|20
966832|NCT01178099|1967766|FG000|Overall Study|Physician Decision|0
966833|NCT01178099|1967767|FG001|Overall Study|Physician Decision|1
966834|NCT01178125|1967777|FG000|Overall Study|Lost to Follow-up|397
966835|NCT01178125|1967777|FG000|Overall Study|Adverse Event|244
966836|NCT01178125|1967777|FG000|Overall Study|Withdrawal by Subject|209
966837|NCT01178125|1967777|FG000|Overall Study|Noncompliance|184
966838|NCT01178125|1967777|FG000|Overall Study|Pregnancy|55
966839|NCT01178125|1967777|FG000|Overall Study|Other Reason|39
966840|NCT01178125|1967777|FG000|Overall Study|Sponsor Decision|28
966841|NCT01178125|1967777|FG000|Overall Study|Protocol Violation|17
966842|NCT01178125|1967777|FG000|Overall Study|Investigator Decision|5
966843|NCT01178138|1967786|FG000|Overall Study|Lost to Follow-up|8
966844|NCT01178138|1967786|FG000|Overall Study|Withdrawal by Subject|7
966845|NCT01178138|1967786|FG000|Overall Study|Physician Decision|8
966846|NCT01178294|1967823|FG000|Overall Study|Adverse Event|4
966847|NCT01178294|1967823|FG000|Overall Study|Lost to Follow-up|2
966848|NCT01178294|1967823|FG000|Overall Study|Lack of Efficacy|1
966849|NCT01178294|1967823|FG000|Overall Study|Death|1
966850|NCT01178294|1967823|FG000|Overall Study|Development of inhibitors to OBI-1|1
966851|NCT01178294|1967823|FG000|Overall Study|Subject status is terminal|1
966852|NCT01178294|1967823|FG000|Overall Study|Completion status could not be verified|1
966853|NCT01178385|1967844|FG000|Overall Study|Withdrawal by Subject|2
966854|NCT01178385|1967845|FG001|Overall Study|Withdrawal by Subject|0
966855|NCT01178411|1967851|FG000|Overall Study|Adverse Event|5
966856|NCT01178411|1967851|FG000|Overall Study|Withdrawal by Subject|4
966857|NCT01178411|1967851|FG000|Overall Study|Protocol Violation|1
966858|NCT01178411|1967851|FG000|Overall Study|Progressive disease per RECIST|32
966859|NCT01178411|1967851|FG000|Overall Study|Progressive disease per clinician|9
966860|NCT01178411|1967851|FG000|Overall Study|Physician Decision|6
966861|NCT01178411|1967851|FG000|Overall Study|Death|1
966862|NCT01178411|1967851|FG000|Overall Study|No reason provided|1
966863|NCT01178411|1967851|FG000|Overall Study|Drug manufacturing ended|1
966864|NCT01178671|1967871|FG000|Overall Study|Adverse Event|4
966865|NCT01178671|1967872|FG001|Overall Study|Adverse Event|6
966866|NCT01178671|1967871|FG000|Overall Study|Protocol Violation|1
966867|NCT01178671|1967872|FG001|Overall Study|Protocol Violation|1
966868|NCT01178671|1967871|FG000|Overall Study|Lack of Efficacy|0
966869|NCT01178671|1967872|FG001|Overall Study|Lack of Efficacy|1
966870|NCT01178671|1967871|FG000|Overall Study|Lost to Follow-up|3
966871|NCT01178671|1967872|FG001|Overall Study|Lost to Follow-up|1
966872|NCT01178671|1967871|FG000|Overall Study|Physician Decision|4
966873|NCT01178671|1967872|FG001|Overall Study|Physician Decision|6
966874|NCT01178762|1967878|FG000|Overall Study|Lost to Follow-up|15
966875|NCT01178853|1967901|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1
966876|NCT01178853|1967902|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2
966877|NCT01178853|1967901|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
966878|NCT01178853|1967902|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
966879|NCT01178853|1967901|FG000|Period 3 (Warfarin Titration)|Adverse Event|1
966880|NCT01178853|1967902|FG001|Period 3 (Warfarin Titration)|Adverse Event|0
966881|NCT01178853|1967901|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0
966882|NCT01178853|1967902|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2
966883|NCT01178853|1967901|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
966884|NCT01178853|1967902|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
966885|NCT01179048|1967914|FG000|Overall Study|Withdrawn - does not allow contact|4
966886|NCT01179048|1967915|FG001|Overall Study|Withdrawn - does not allow contact|8
966887|NCT01179048|1967914|FG000|Overall Study|Lost to Follow-up|8
966888|NCT01179048|1967915|FG001|Overall Study|Lost to Follow-up|9
966889|NCT01179048|1967914|FG000|Overall Study|Alive|127
966890|NCT01179048|1967915|FG001|Overall Study|Alive|142
966891|NCT01179191|1967930|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47
966892|NCT01179191|1967930|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
966893|NCT01179191|1967930|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30
966894|NCT01179191|1967930|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
966895|NCT01179191|1967930|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
966896|NCT01179191|1967930|FG000|Titration Phase (up to 6 Weeks)|Other|62
966897|NCT01179191|1967930|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10
966898|NCT01179191|1967930|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
966899|NCT01179191|1967930|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3
966900|NCT01179191|1967930|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
966901|NCT01179191|1967930|FG000|Maintenance Phase (8 Weeks)|Other|66
966902|NCT01179334|1967947|FG000|Treatment Period|Adverse Event|1
966903|NCT01179334|1967948|FG001|Treatment Period|Adverse Event|0
966904|NCT01179334|1967947|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6
966905|NCT01179334|1967948|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2
966906|NCT01179334|1967947|FG000|Long-term Extension (LTE) Period|Death|3
966907|NCT01179334|1967948|FG001|Long-term Extension (LTE) Period|Death|0
966908|NCT01179334|1967947|FG000|Long-term Extension (LTE) Period|Adverse Event|2
966909|NCT01179334|1967948|FG001|Long-term Extension (LTE) Period|Adverse Event|4
966910|NCT01179347|1967956|FG000|Double-blind Period (12 Weeks)|Adverse Event|2
966911|NCT01179347|1967957|FG001|Double-blind Period (12 Weeks)|Adverse Event|6
966912|NCT01179347|1967956|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2
966913|NCT01179347|1967957|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0
966914|NCT01179347|1967956|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1
966915|NCT01179347|1967957|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2
966916|NCT01179347|1967956|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
966917|NCT01179347|1967957|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
966918|NCT01179347|1967956|FG000|Double-blind Period (12 Weeks)|Other|2
966919|NCT01179347|1967957|FG001|Double-blind Period (12 Weeks)|Other|4
966920|NCT01179347|1967956|FG000|Open-label Period (12 Weeks)|Adverse Event|5
966921|NCT01179347|1967957|FG001|Open-label Period (12 Weeks)|Adverse Event|9
966922|NCT01179347|1967956|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0
966923|NCT01179347|1967957|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2
966924|NCT01179347|1967956|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1
966925|NCT01179347|1967957|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0
966926|NCT01179347|1967956|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1
966927|NCT01179347|1967957|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1
966928|NCT01179347|1967956|FG000|Open-label Period (12 Weeks)|Protocol Violation|1
966929|NCT01179347|1967957|FG001|Open-label Period (12 Weeks)|Protocol Violation|0
966930|NCT01179347|1967956|FG000|Open-label Period (12 Weeks)|Other|7
966931|NCT01179347|1967957|FG001|Open-label Period (12 Weeks)|Other|4
911258|NCT00797667|1888437|FG000|Overall Study|Physician Decision|3
911259|NCT00797667|1888438|FG001|Overall Study|Physician Decision|1
911260|NCT00797667|1888439|FG002|Overall Study|Physician Decision|0
911261|NCT00797667|1888437|FG000|Overall Study|Pregnancy|2
911262|NCT00797667|1888438|FG001|Overall Study|Pregnancy|0
911263|NCT00797667|1888439|FG002|Overall Study|Pregnancy|0
911264|NCT00797667|1888437|FG000|Overall Study|Protocol Violation|2
911265|NCT00797667|1888438|FG001|Overall Study|Protocol Violation|7
911266|NCT00797667|1888439|FG002|Overall Study|Protocol Violation|0
911267|NCT00797667|1888437|FG000|Overall Study|Study Terminated by Sponsor|217
911268|NCT00797667|1888438|FG001|Overall Study|Study Terminated by Sponsor|216
911269|NCT00797667|1888439|FG002|Overall Study|Study Terminated by Sponsor|115
911270|NCT00797667|1888437|FG000|Overall Study|Withdrawal by Subject|9
911271|NCT00797667|1888438|FG001|Overall Study|Withdrawal by Subject|14
966932|NCT01179477|1967965|FG000|Overall Study|Death|542
966933|NCT01179477|1967965|FG000|Overall Study|Unsuccessful implant|80
966934|NCT01179477|1967965|FG000|Overall Study|Non-death withdrawal|438
966935|NCT01179477|1967965|FG000|Overall Study|Did not complete final visit|27
966936|NCT01179516|1967976|FG000|Overall Study|Pretreatment Event or Adverse Event|6
966937|NCT01179516|1967977|FG001|Overall Study|Pretreatment Event or Adverse Event|8
966938|NCT01179516|1967978|FG002|Overall Study|Pretreatment Event or Adverse Event|12
966939|NCT01179516|1967976|FG000|Overall Study|Lack of Efficacy|4
966940|NCT01179516|1967977|FG001|Overall Study|Lack of Efficacy|2
966941|NCT01179516|1967978|FG002|Overall Study|Lack of Efficacy|0
966942|NCT01179516|1967976|FG000|Overall Study|Noncompliance with Study Drug|2
966943|NCT01179516|1967977|FG001|Overall Study|Noncompliance with Study Drug|0
966944|NCT01179516|1967978|FG002|Overall Study|Noncompliance with Study Drug|1
966945|NCT01179516|1967976|FG000|Overall Study|Protocol Deviations|4
966946|NCT01179516|1967977|FG001|Overall Study|Protocol Deviations|3
966947|NCT01179516|1967978|FG002|Overall Study|Protocol Deviations|3
966948|NCT01179516|1967976|FG000|Overall Study|Withdrawal of Consent|2
966949|NCT01179516|1967977|FG001|Overall Study|Withdrawal of Consent|6
966950|NCT01179516|1967978|FG002|Overall Study|Withdrawal of Consent|10
966951|NCT01179516|1967976|FG000|Overall Study|Lost to Follow-up|7
966952|NCT01179516|1967977|FG001|Overall Study|Lost to Follow-up|7
966953|NCT01179516|1967978|FG002|Overall Study|Lost to Follow-up|3
966954|NCT01179516|1967976|FG000|Overall Study|Other|2
966955|NCT01179516|1967977|FG001|Overall Study|Other|0
966956|NCT01179516|1967978|FG002|Overall Study|Other|2
966957|NCT01179672|1968008|FG000|Overall Study|Adverse Event|17
966958|NCT01179672|1968009|FG001|Overall Study|Adverse Event|8
966959|NCT01179672|1968008|FG000|Overall Study|Withdrawal by Subject|10
966960|NCT01179672|1968009|FG001|Overall Study|Withdrawal by Subject|12
966961|NCT01179672|1968008|FG000|Overall Study|Entry Criteria Not Met|0
966962|NCT01179672|1968009|FG001|Overall Study|Entry Criteria Not Met|2
966963|NCT01179672|1968008|FG000|Overall Study|Lost to Follow-up|0
966964|NCT01179672|1968009|FG001|Overall Study|Lost to Follow-up|1
966965|NCT01179672|1968008|FG000|Overall Study|Protocol Violation|2
966966|NCT01179672|1968009|FG001|Overall Study|Protocol Violation|2
966967|NCT01179672|1968008|FG000|Overall Study|Physician Decision|1
966968|NCT01179672|1968009|FG001|Overall Study|Physician Decision|1
966969|NCT01179919|1968019|FG000|Overall Study|Protocol Violation|1
966970|NCT01179919|1968019|FG000|Overall Study|Adverse Event|1
966971|NCT01180049|1968041|FG000|Overall Study|Other|9
966972|NCT01180049|1968042|FG001|Overall Study|Other|7
966973|NCT01180049|1968041|FG000|Overall Study|Lost to Follow-up|8
966974|NCT01180049|1968042|FG001|Overall Study|Lost to Follow-up|6
966975|NCT01180049|1968041|FG000|Overall Study|Death|36
966976|NCT01180049|1968042|FG001|Overall Study|Death|35
966977|NCT01180244|1968071|FG000|Overall Study|Lack of Efficacy|0
966978|NCT01180244|1968072|FG001|Overall Study|Lack of Efficacy|7
966979|NCT01180244|1968071|FG000|Overall Study|Physician Decision|3
966980|NCT01180244|1968072|FG001|Overall Study|Physician Decision|0
966981|NCT01180244|1968071|FG000|Overall Study|Adverse Event|1
966982|NCT01180244|1968072|FG001|Overall Study|Adverse Event|0
966983|NCT01180244|1968071|FG000|Overall Study|Withdrawal by Subject|0
966984|NCT01180244|1968072|FG001|Overall Study|Withdrawal by Subject|1
966985|NCT01180244|1968071|FG000|Overall Study|Protocol Violation|1
966986|NCT01180244|1968072|FG001|Overall Study|Protocol Violation|0
966987|NCT01180244|1968071|FG000|Overall Study|Lost to Follow-up|1
966988|NCT01180244|1968072|FG001|Overall Study|Lost to Follow-up|0
966989|NCT01180296|1968080|FG000|Overall Study|Protocol Violation|1
966990|NCT01180296|1968081|FG001|Overall Study|Protocol Violation|2
966991|NCT01180400|1968091|FG000|Overall Study|Withdrawal by Subject|5
966992|NCT01180400|1968092|FG001|Overall Study|Withdrawal by Subject|6
966993|NCT01180400|1968091|FG000|Overall Study|Eligibility criteria not fulfilled|0
966994|NCT01180400|1968092|FG001|Overall Study|Eligibility criteria not fulfilled|2
966995|NCT01180400|1968091|FG000|Overall Study|Adverse Event|12
966996|NCT01180400|1968092|FG001|Overall Study|Adverse Event|10
966997|NCT01180400|1968091|FG000|Overall Study|Severe non-compliance to protocol|1
966998|NCT01180400|1968092|FG001|Overall Study|Severe non-compliance to protocol|2
966999|NCT01180400|1968091|FG000|Overall Study|Condition under investigation worsened|2
967000|NCT01180400|1968092|FG001|Overall Study|Condition under investigation worsened|1
967001|NCT01180400|1968091|FG000|Overall Study|Lack of Efficacy|2
967002|NCT01180400|1968092|FG001|Overall Study|Lack of Efficacy|0
967003|NCT01180400|1968091|FG000|Overall Study|Study-specific withdrawal criteria|1
967004|NCT01180400|1968092|FG001|Overall Study|Study-specific withdrawal criteria|2
967005|NCT01180400|1968091|FG000|Overall Study|Lost to Follow-up|2
967006|NCT01180400|1968092|FG001|Overall Study|Lost to Follow-up|3
967007|NCT01180400|1968091|FG000|Overall Study|Other|0
967008|NCT01180400|1968092|FG001|Overall Study|Other|1
967009|NCT01180647|1968111|FG000|Overall Study|Lost to Follow-up|5
967010|NCT01180647|1968112|FG001|Overall Study|Lost to Follow-up|6
967011|NCT01180660|1968120|FG000|Overall Study|Changed to open surgery|1
967012|NCT01180660|1968121|FG001|Overall Study|Changed to open surgery|0
967013|NCT01180777|1968127|FG000|Overall Study|Protocol Violation|6
967014|NCT01180777|1968127|FG000|Overall Study|Poor lens fit|4
967015|NCT01180777|1968127|FG000|Overall Study|Lost to Follow-up|1
967016|NCT01180777|1968127|FG000|Overall Study|Adverse Event|1
967017|NCT01180790|1968140|FG000|Overall Study|Adverse Event|1
967018|NCT01180790|1968141|FG001|Overall Study|Adverse Event|1
967019|NCT01180790|1968142|FG002|Overall Study|Adverse Event|2
967020|NCT01180790|1968143|FG003|Overall Study|Adverse Event|0
967021|NCT01180790|1968144|FG004|Overall Study|Adverse Event|1
967022|NCT01180790|1968145|FG005|Overall Study|Adverse Event|3
967023|NCT01180790|1968146|FG006|Overall Study|Adverse Event|0
967024|NCT01180790|1968140|FG000|Overall Study|Withdrawal by Subject|3
967025|NCT01180790|1968141|FG001|Overall Study|Withdrawal by Subject|0
967026|NCT01180790|1968142|FG002|Overall Study|Withdrawal by Subject|5
967027|NCT01180790|1968143|FG003|Overall Study|Withdrawal by Subject|0
967028|NCT01180790|1968144|FG004|Overall Study|Withdrawal by Subject|2
967029|NCT01180790|1968145|FG005|Overall Study|Withdrawal by Subject|1
967030|NCT01180790|1968146|FG006|Overall Study|Withdrawal by Subject|0
967031|NCT01180790|1968140|FG000|Overall Study|Lost to Follow-up|3
967032|NCT01180790|1968141|FG001|Overall Study|Lost to Follow-up|1
967033|NCT01180790|1968142|FG002|Overall Study|Lost to Follow-up|0
967034|NCT01180790|1968143|FG003|Overall Study|Lost to Follow-up|2
967035|NCT01180790|1968144|FG004|Overall Study|Lost to Follow-up|1
967036|NCT01180790|1968145|FG005|Overall Study|Lost to Follow-up|0
967037|NCT01180790|1968146|FG006|Overall Study|Lost to Follow-up|1
967038|NCT01180790|1968140|FG000|Overall Study|Physician Decision|1
967039|NCT01180790|1968141|FG001|Overall Study|Physician Decision|0
911272|NCT00797667|1888439|FG002|Overall Study|Withdrawal by Subject|2
911273|NCT00797667|1888437|FG000|Overall Study|Adverse Event|19
911274|NCT00797667|1888438|FG001|Overall Study|Adverse Event|8
911275|NCT00797667|1888439|FG002|Overall Study|Adverse Event|8
911276|NCT00797732|1888449|FG000|Overall Study|Withdrawal by Subject|3
911277|NCT00797732|1888450|FG001|Overall Study|Withdrawal by Subject|3
911278|NCT00797732|1888451|FG002|Overall Study|Withdrawal by Subject|0
911279|NCT00797732|1888449|FG000|Overall Study|Lost to Follow-up|1
911280|NCT00797732|1888450|FG001|Overall Study|Lost to Follow-up|0
911281|NCT00797732|1888451|FG002|Overall Study|Lost to Follow-up|0
911282|NCT00797732|1888449|FG000|Overall Study|Death|1
911283|NCT00797732|1888450|FG001|Overall Study|Death|0
911284|NCT00797732|1888451|FG002|Overall Study|Death|0
911285|NCT00797732|1888449|FG000|Overall Study|Not meet inclusion criteria|0
911286|NCT00797732|1888450|FG001|Overall Study|Not meet inclusion criteria|0
911287|NCT00797732|1888451|FG002|Overall Study|Not meet inclusion criteria|7
911288|NCT00797732|1888449|FG000|Overall Study|Excluded due to time constraints|0
911289|NCT00797732|1888450|FG001|Overall Study|Excluded due to time constraints|0
911290|NCT00797732|1888451|FG002|Overall Study|Excluded due to time constraints|24
911291|NCT00797732|1888449|FG000|Overall Study|Refused to Participate|0
911292|NCT00797732|1888450|FG001|Overall Study|Refused to Participate|0
911293|NCT00797732|1888451|FG002|Overall Study|Refused to Participate|123
911294|NCT00797823|1888469|FG000|First Period (Initial Randomization)|Physician Decision|1
911295|NCT00797823|1888470|FG001|First Period (Initial Randomization)|Physician Decision|0
911296|NCT00797823|1888471|FG002|First Period (Initial Randomization)|Physician Decision|0
911297|NCT00797862|1888481|FG000|Overall Study|Adverse Event|86
911298|NCT00797862|1888482|FG001|Overall Study|Adverse Event|44
911299|NCT00797862|1888483|FG002|Overall Study|Adverse Event|58
911300|NCT00797862|1888481|FG000|Overall Study|Abnormal Test Procedure Result|0
911301|NCT00797862|1888482|FG001|Overall Study|Abnormal Test Procedure Result|1
911302|NCT00797862|1888483|FG002|Overall Study|Abnormal Test Procedure Result|1
911303|NCT00797862|1888481|FG000|Overall Study|Lack of Efficacy|1
911304|NCT00797862|1888482|FG001|Overall Study|Lack of Efficacy|7
911305|NCT00797862|1888483|FG002|Overall Study|Lack of Efficacy|6
911306|NCT00797862|1888481|FG000|Overall Study|No longer required study medication|1
911307|NCT00797862|1888482|FG001|Overall Study|No longer required study medication|0
911308|NCT00797862|1888483|FG002|Overall Study|No longer required study medication|0
911309|NCT00797862|1888481|FG000|Overall Study|Withdrawal by Subject|14
911310|NCT00797862|1888482|FG001|Overall Study|Withdrawal by Subject|7
911311|NCT00797862|1888483|FG002|Overall Study|Withdrawal by Subject|7
911312|NCT00797862|1888481|FG000|Overall Study|Lost to Follow-up|11
911313|NCT00797862|1888482|FG001|Overall Study|Lost to Follow-up|0
911314|NCT00797862|1888483|FG002|Overall Study|Lost to Follow-up|5
911315|NCT00797862|1888481|FG000|Overall Study|Administrative Problem|4
911316|NCT00797862|1888482|FG001|Overall Study|Administrative Problem|0
911317|NCT00797862|1888483|FG002|Overall Study|Administrative Problem|0
911318|NCT00797862|1888481|FG000|Overall Study|Protocol Violation|4
911319|NCT00797862|1888482|FG001|Overall Study|Protocol Violation|6
911320|NCT00797862|1888483|FG002|Overall Study|Protocol Violation|8
911321|NCT00797862|1888481|FG000|Overall Study|Mis-randomized|3
911322|NCT00797862|1888482|FG001|Overall Study|Mis-randomized|3
911323|NCT00797862|1888483|FG002|Overall Study|Mis-randomized|1
911324|NCT00797966|1888495|FG000|Phase A|Lost to Follow-up|0
911325|NCT00797966|1888496|FG001|Phase A|Lost to Follow-up|0
911326|NCT00797966|1888497|FG002|Phase A|Lost to Follow-up|0
911327|NCT00797966|1888498|FG003|Phase A|Lost to Follow-up|0
911328|NCT00797966|1888499|FG004|Phase A|Lost to Follow-up|33
911329|NCT00797966|1888500|FG005|Phase A|Lost to Follow-up|0
911330|NCT00797966|1888495|FG000|Phase A|Adverse Event|0
911331|NCT00797966|1888496|FG001|Phase A|Adverse Event|0
911332|NCT00797966|1888497|FG002|Phase A|Adverse Event|0
911333|NCT00797966|1888498|FG003|Phase A|Adverse Event|0
967040|NCT01180790|1968142|FG002|Overall Study|Physician Decision|0
967041|NCT01180790|1968143|FG003|Overall Study|Physician Decision|1
967042|NCT01180790|1968144|FG004|Overall Study|Physician Decision|0
967043|NCT01180790|1968145|FG005|Overall Study|Physician Decision|0
967044|NCT01180790|1968146|FG006|Overall Study|Physician Decision|0
967045|NCT01180790|1968140|FG000|Overall Study|Lack of Efficacy|1
967046|NCT01180790|1968141|FG001|Overall Study|Lack of Efficacy|2
967047|NCT01180790|1968142|FG002|Overall Study|Lack of Efficacy|5
967048|NCT01180790|1968143|FG003|Overall Study|Lack of Efficacy|6
967049|NCT01180790|1968144|FG004|Overall Study|Lack of Efficacy|1
967050|NCT01180790|1968145|FG005|Overall Study|Lack of Efficacy|3
967051|NCT01180790|1968146|FG006|Overall Study|Lack of Efficacy|0
967052|NCT01180790|1968140|FG000|Overall Study|compliance|0
967053|NCT01180790|1968141|FG001|Overall Study|compliance|1
967054|NCT01180790|1968142|FG002|Overall Study|compliance|0
967055|NCT01180790|1968143|FG003|Overall Study|compliance|0
967056|NCT01180790|1968144|FG004|Overall Study|compliance|0
967057|NCT01180790|1968145|FG005|Overall Study|compliance|0
967058|NCT01180790|1968146|FG006|Overall Study|compliance|0
967059|NCT01180790|1968140|FG000|Overall Study|Severe coronary atherosclerosis (death)|0
967060|NCT01180790|1968141|FG001|Overall Study|Severe coronary atherosclerosis (death)|0
967061|NCT01180790|1968142|FG002|Overall Study|Severe coronary atherosclerosis (death)|1
967062|NCT01180790|1968143|FG003|Overall Study|Severe coronary atherosclerosis (death)|0
967063|NCT01180790|1968144|FG004|Overall Study|Severe coronary atherosclerosis (death)|0
967064|NCT01180790|1968145|FG005|Overall Study|Severe coronary atherosclerosis (death)|0
967065|NCT01180790|1968146|FG006|Overall Study|Severe coronary atherosclerosis (death)|0
967066|NCT01180985|1968201|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
967067|NCT01180985|1968202|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
967068|NCT01180998|1968212|FG000|Overall Study|Poor Vision|0
967069|NCT01180998|1968213|FG001|Overall Study|Poor Vision|2
967070|NCT01180998|1968214|FG002|Overall Study|Poor Vision|2
967071|NCT01180998|1968212|FG000|Overall Study|Lost to Follow-up|0
967072|NCT01180998|1968213|FG001|Overall Study|Lost to Follow-up|0
967073|NCT01180998|1968214|FG002|Overall Study|Lost to Follow-up|1
967074|NCT01180998|1968212|FG000|Overall Study|Protocol Violation|1
967075|NCT01180998|1968213|FG001|Overall Study|Protocol Violation|2
967076|NCT01180998|1968214|FG002|Overall Study|Protocol Violation|0
967077|NCT01180998|1968212|FG000|Overall Study|Withdrawal by Subject|0
967078|NCT01180998|1968213|FG001|Overall Study|Withdrawal by Subject|0
967079|NCT01180998|1968214|FG002|Overall Study|Withdrawal by Subject|1
967080|NCT01180998|1968212|FG000|Overall Study|Poor comfort|3
967081|NCT01180998|1968213|FG001|Overall Study|Poor comfort|0
967082|NCT01180998|1968214|FG002|Overall Study|Poor comfort|4
967083|NCT01180998|1968212|FG000|Overall Study|Poor lens handling|0
967084|NCT01180998|1968213|FG001|Overall Study|Poor lens handling|0
967085|NCT01180998|1968214|FG002|Overall Study|Poor lens handling|2
967086|NCT01181011|1968223|FG000|Overall Study|Adverse Event|2
967087|NCT01181011|1968223|FG000|Overall Study|Lost to Follow-up|1
967088|NCT01181102|1968252|FG000|Overall Study|Adverse Event|28
967089|NCT01181102|1968253|FG001|Overall Study|Adverse Event|26
967090|NCT01181102|1968252|FG000|Overall Study|Lack of Efficacy|3
967091|NCT01181102|1968253|FG001|Overall Study|Lack of Efficacy|1
967092|NCT01181102|1968252|FG000|Overall Study|Lost to Follow-up|2
967093|NCT01181102|1968253|FG001|Overall Study|Lost to Follow-up|0
967094|NCT01181102|1968252|FG000|Overall Study|Physician Decision|3
967095|NCT01181102|1968253|FG001|Overall Study|Physician Decision|1
911334|NCT00797966|1888499|FG004|Phase A|Adverse Event|46
911335|NCT00797966|1888500|FG005|Phase A|Adverse Event|0
911336|NCT00797966|1888495|FG000|Phase A|Met withdrawal criteria|0
911337|NCT00797966|1888496|FG001|Phase A|Met withdrawal criteria|0
911338|NCT00797966|1888497|FG002|Phase A|Met withdrawal criteria|0
911339|NCT00797966|1888498|FG003|Phase A|Met withdrawal criteria|0
911340|NCT00797966|1888499|FG004|Phase A|Met withdrawal criteria|4
911341|NCT00797966|1888500|FG005|Phase A|Met withdrawal criteria|0
911342|NCT00797966|1888495|FG000|Phase A|Physician Decision|0
911343|NCT00797966|1888496|FG001|Phase A|Physician Decision|0
911344|NCT00797966|1888497|FG002|Phase A|Physician Decision|0
911345|NCT00797966|1888498|FG003|Phase A|Physician Decision|0
911346|NCT00797966|1888499|FG004|Phase A|Physician Decision|13
911347|NCT00797966|1888500|FG005|Phase A|Physician Decision|0
911348|NCT00797966|1888495|FG000|Phase A|Withdrawal by Subject|0
911349|NCT00797966|1888496|FG001|Phase A|Withdrawal by Subject|0
911350|NCT00797966|1888497|FG002|Phase A|Withdrawal by Subject|0
911351|NCT00797966|1888498|FG003|Phase A|Withdrawal by Subject|0
911352|NCT00797966|1888499|FG004|Phase A|Withdrawal by Subject|33
911353|NCT00797966|1888500|FG005|Phase A|Withdrawal by Subject|0
911354|NCT00797966|1888495|FG000|Phase A|Protocol deviation|0
911355|NCT00797966|1888496|FG001|Phase A|Protocol deviation|0
911356|NCT00797966|1888497|FG002|Phase A|Protocol deviation|0
911357|NCT00797966|1888498|FG003|Phase A|Protocol deviation|0
911358|NCT00797966|1888499|FG004|Phase A|Protocol deviation|56
911359|NCT00797966|1888500|FG005|Phase A|Protocol deviation|0
911360|NCT00797966|1888495|FG000|Phase B|Lost to Follow-up|0
911361|NCT00797966|1888496|FG001|Phase B|Lost to Follow-up|1
911362|NCT00797966|1888497|FG002|Phase B|Lost to Follow-up|3
911363|NCT00797966|1888498|FG003|Phase B|Lost to Follow-up|0
911364|NCT00797966|1888499|FG004|Phase B|Lost to Follow-up|0
911365|NCT00797966|1888500|FG005|Phase B|Lost to Follow-up|0
967096|NCT01181102|1968252|FG000|Overall Study|Protocol Violation|5
967097|NCT01181102|1968253|FG001|Overall Study|Protocol Violation|6
967098|NCT01181102|1968252|FG000|Overall Study|Withdrawal by Subject|10
967099|NCT01181102|1968253|FG001|Overall Study|Withdrawal by Subject|12
967100|NCT01181128|1968262|FG000|Overall Study|Withdrawal by Subject|2
967101|NCT01181128|1968263|FG001|Overall Study|Withdrawal by Subject|2
967102|NCT01181128|1968264|FG002|Overall Study|Withdrawal by Subject|0
967103|NCT01181128|1968262|FG000|Overall Study|Death|1
967104|NCT01181128|1968263|FG001|Overall Study|Death|0
967105|NCT01181128|1968264|FG002|Overall Study|Death|0
967106|NCT01181128|1968262|FG000|Overall Study|Physician Decision|2
967107|NCT01181128|1968263|FG001|Overall Study|Physician Decision|0
967108|NCT01181128|1968264|FG002|Overall Study|Physician Decision|0
967109|NCT01181128|1968262|FG000|Overall Study|Adverse Event|0
967110|NCT01181128|1968263|FG001|Overall Study|Adverse Event|2
967111|NCT01181128|1968264|FG002|Overall Study|Adverse Event|0
967112|NCT01181128|1968262|FG000|Overall Study|Other|1
967113|NCT01181128|1968263|FG001|Overall Study|Other|1
967114|NCT01181128|1968264|FG002|Overall Study|Other|1
967115|NCT01181141|1968286|FG000|Overall Study|Adverse Event|2
967116|NCT01181141|1968287|FG001|Overall Study|Adverse Event|1
967117|NCT01181141|1968286|FG000|Overall Study|Lack of Efficacy|1
967118|NCT01181141|1968287|FG001|Overall Study|Lack of Efficacy|0
967119|NCT01181141|1968286|FG000|Overall Study|Lost to Follow-up|1
967120|NCT01181141|1968287|FG001|Overall Study|Lost to Follow-up|1
967121|NCT01181141|1968286|FG000|Overall Study|Physician Decision|2
967122|NCT01181141|1968287|FG001|Overall Study|Physician Decision|0
967123|NCT01181141|1968286|FG000|Overall Study|Protocol Violation|3
967124|NCT01181141|1968287|FG001|Overall Study|Protocol Violation|1
967125|NCT01181141|1968286|FG000|Overall Study|Withdrawal by Subject|3
967126|NCT01181141|1968287|FG001|Overall Study|Withdrawal by Subject|1
967127|NCT01181167|1968295|FG000|Overall Study|Adverse Event|11
967128|NCT01181167|1968296|FG001|Overall Study|Adverse Event|21
967129|NCT01181167|1968295|FG000|Overall Study|Lost to Follow-up|1
967130|NCT01181167|1968296|FG001|Overall Study|Lost to Follow-up|0
967131|NCT01181167|1968295|FG000|Overall Study|Physician Decision|2
967132|NCT01181167|1968296|FG001|Overall Study|Physician Decision|3
967133|NCT01181167|1968295|FG000|Overall Study|Protocol Violation|3
967134|NCT01181167|1968296|FG001|Overall Study|Protocol Violation|0
967135|NCT01181167|1968295|FG000|Overall Study|Withdrawal by Subject|6
967136|NCT01181167|1968296|FG001|Overall Study|Withdrawal by Subject|8
967137|NCT01181271|1968306|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
967138|NCT01181271|1968306|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
967139|NCT01181271|1968306|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2
967140|NCT01181271|1968306|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
967141|NCT01181531|1968376|FG000|Overall Study|Other|17
967142|NCT01181531|1968377|FG001|Overall Study|Other|12
967143|NCT01181531|1968376|FG000|Overall Study|Partial consent by subject withdrawn|0
967144|NCT01181531|1968377|FG001|Overall Study|Partial consent by subject withdrawn|1
967145|NCT01181531|1968376|FG000|Overall Study|Physician Decision|3
967146|NCT01181531|1968377|FG001|Overall Study|Physician Decision|1
967147|NCT01181531|1968376|FG000|Overall Study|Noncompliance|2
967148|NCT01181531|1968377|FG001|Overall Study|Noncompliance|2
967149|NCT01181531|1968376|FG000|Overall Study|Ineligibility determined|1
967150|NCT01181531|1968377|FG001|Overall Study|Ineligibility determined|2
967151|NCT01181531|1968376|FG000|Overall Study|Protocol Specified Criteria|15
967152|NCT01181531|1968377|FG001|Overall Study|Protocol Specified Criteria|8
967153|NCT01181531|1968376|FG000|Overall Study|Pregnancy|0
967154|NCT01181531|1968377|FG001|Overall Study|Pregnancy|1
967155|NCT01181531|1968376|FG000|Overall Study|Withdrawal by Subject|8
967156|NCT01181531|1968377|FG001|Overall Study|Withdrawal by Subject|7
967157|NCT01181531|1968376|FG000|Overall Study|Protocol Violation|6
967158|NCT01181531|1968377|FG001|Overall Study|Protocol Violation|6
967159|NCT01181531|1968376|FG000|Overall Study|Death|9
967160|NCT01181531|1968377|FG001|Overall Study|Death|12
967161|NCT01181531|1968376|FG000|Overall Study|Adverse Event|0
967162|NCT01181531|1968377|FG001|Overall Study|Adverse Event|1
967163|NCT01181609|1968388|FG000|Overall Study|Adverse Event|1
967164|NCT01181609|1968388|FG000|Overall Study|Withdrawal by Subject|1
967165|NCT01181609|1968388|FG000|Overall Study|Lost to Follow-up|1
967166|NCT01181609|1968388|FG000|Overall Study|Death|50
967167|NCT01181726|1968407|FG000|First Intervention|Adverse Event|1
967168|NCT01181726|1968408|FG001|First Intervention|Adverse Event|0
967169|NCT01181778|1968414|FG000|Overall Study|Physician Decision|48
967170|NCT01181895|1968440|FG000|Overall Study|Adverse Event|3
967171|NCT01181895|1968441|FG001|Overall Study|Adverse Event|1
967172|NCT01181895|1968442|FG002|Overall Study|Adverse Event|1
967173|NCT01181895|1968440|FG000|Overall Study|Lack of Efficacy|8
967174|NCT01181895|1968441|FG001|Overall Study|Lack of Efficacy|9
967175|NCT01181895|1968442|FG002|Overall Study|Lack of Efficacy|9
967176|NCT01181895|1968440|FG000|Overall Study|Protocol Violation|2
967177|NCT01181895|1968441|FG001|Overall Study|Protocol Violation|1
967178|NCT01181895|1968442|FG002|Overall Study|Protocol Violation|0
967179|NCT01181895|1968440|FG000|Overall Study|Lost to Follow-up|0
967180|NCT01181895|1968441|FG001|Overall Study|Lost to Follow-up|1
967181|NCT01181895|1968442|FG002|Overall Study|Lost to Follow-up|2
967182|NCT01181895|1968440|FG000|Overall Study|Investigator Discretion|1
967183|NCT01181895|1968441|FG001|Overall Study|Investigator Discretion|2
967184|NCT01181895|1968442|FG002|Overall Study|Investigator Discretion|1
967185|NCT01181895|1968440|FG000|Overall Study|Withdrawal by Subject|3
967186|NCT01181895|1968441|FG001|Overall Study|Withdrawal by Subject|0
967187|NCT01181895|1968442|FG002|Overall Study|Withdrawal by Subject|5
967188|NCT01181986|1968457|FG000|Phase 1|Lost to Follow-up|0
967189|NCT01181986|1968458|FG001|Phase 1|Lost to Follow-up|1
967190|NCT01181986|1968459|FG002|Phase 1|Lost to Follow-up|1
967191|NCT01181986|1968457|FG000|Phase 1|Adverse Event|0
967192|NCT01181986|1968458|FG001|Phase 1|Adverse Event|0
967193|NCT01181986|1968459|FG002|Phase 1|Adverse Event|1
967194|NCT01181986|1968457|FG000|Phase 1|Protocol Violation|1
967195|NCT01181986|1968458|FG001|Phase 1|Protocol Violation|0
967196|NCT01181986|1968459|FG002|Phase 1|Protocol Violation|0
967197|NCT01181986|1968457|FG000|Phase 2|Adverse Event|0
967198|NCT01181986|1968458|FG001|Phase 2|Adverse Event|3
967199|NCT01181986|1968459|FG002|Phase 2|Adverse Event|0
967200|NCT01181986|1968457|FG000|Phase 2|Medical condition|0
967201|NCT01181986|1968458|FG001|Phase 2|Medical condition|1
967202|NCT01181986|1968459|FG002|Phase 2|Medical condition|0
967203|NCT01182181|1968487|FG000|First Intervention|Adverse Event|1
967204|NCT01182181|1968488|FG001|First Intervention|Adverse Event|0
967205|NCT01182181|1968487|FG000|Washout of 21 Days|Withdrawal by Subject|0
967206|NCT01182181|1968488|FG001|Washout of 21 Days|Withdrawal by Subject|1
967207|NCT01182194|1968496|FG000|Washout of 28 Days|Withdrawal by Subject|1
967208|NCT01182194|1968497|FG001|Washout of 28 Days|Withdrawal by Subject|0
967209|NCT01182207|1968505|FG000|First Intervention|Positive Hepatitis Results|0
967210|NCT01182207|1968506|FG001|First Intervention|Positive Hepatitis Results|1
967211|NCT01182207|1968505|FG000|Second Intervention|Emeses within 1 hour of dosing|1
967212|NCT01182207|1968506|FG001|Second Intervention|Emeses within 1 hour of dosing|0
967213|NCT01182285|1968512|FG000|First Intervention Week 1-10|Disease progression|1
967214|NCT01182285|1968513|FG001|First Intervention Week 1-10|Disease progression|0
967215|NCT01182285|1968514|FG002|First Intervention Week 1-10|Disease progression|0
967216|NCT01182285|1968512|FG000|First Intervention Week 1-10|Adverse Event|1
967217|NCT01182285|1968513|FG001|First Intervention Week 1-10|Adverse Event|0
967218|NCT01182285|1968514|FG002|First Intervention Week 1-10|Adverse Event|0
967219|NCT01182285|1968512|FG000|First Intervention Week 1-10|Non-compliance|1
967220|NCT01182285|1968513|FG001|First Intervention Week 1-10|Non-compliance|0
967221|NCT01182285|1968514|FG002|First Intervention Week 1-10|Non-compliance|0
967222|NCT01182285|1968512|FG000|Third Intervention Week 11-52|Disease Progression|0
967223|NCT01182285|1968513|FG001|Third Intervention Week 11-52|Disease Progression|0
967224|NCT01182285|1968514|FG002|Third Intervention Week 11-52|Disease Progression|6
967225|NCT01182285|1968512|FG000|Third Intervention Week 11-52|Other|0
967226|NCT01182285|1968513|FG001|Third Intervention Week 11-52|Other|0
967227|NCT01182285|1968514|FG002|Third Intervention Week 11-52|Other|2
967228|NCT01182298|1968521|FG000|Overall Study|Lack of Efficacy|4
967229|NCT01182298|1968521|FG000|Overall Study|Withdrawal by Subject|2
911366|NCT00797966|1888495|FG000|Phase B|Adverse Event|2
911367|NCT00797966|1888496|FG001|Phase B|Adverse Event|1
911368|NCT00797966|1888497|FG002|Phase B|Adverse Event|3
911369|NCT00797966|1888498|FG003|Phase B|Adverse Event|1
911370|NCT00797966|1888499|FG004|Phase B|Adverse Event|0
911371|NCT00797966|1888500|FG005|Phase B|Adverse Event|0
911372|NCT00797966|1888495|FG000|Phase B|Met Withdrawal Criteria|3
911373|NCT00797966|1888496|FG001|Phase B|Met Withdrawal Criteria|3
911374|NCT00797966|1888497|FG002|Phase B|Met Withdrawal Criteria|6
911375|NCT00797966|1888498|FG003|Phase B|Met Withdrawal Criteria|1
911376|NCT00797966|1888499|FG004|Phase B|Met Withdrawal Criteria|0
911377|NCT00797966|1888500|FG005|Phase B|Met Withdrawal Criteria|0
911378|NCT00797966|1888495|FG000|Phase B|Physician Decision|1
911379|NCT00797966|1888496|FG001|Phase B|Physician Decision|0
911380|NCT00797966|1888497|FG002|Phase B|Physician Decision|3
911381|NCT00797966|1888498|FG003|Phase B|Physician Decision|1
911382|NCT00797966|1888499|FG004|Phase B|Physician Decision|0
911383|NCT00797966|1888500|FG005|Phase B|Physician Decision|0
911384|NCT00797966|1888495|FG000|Phase B|Withdrawal by Subject|1
911385|NCT00797966|1888496|FG001|Phase B|Withdrawal by Subject|4
911386|NCT00797966|1888497|FG002|Phase B|Withdrawal by Subject|3
911387|NCT00797966|1888498|FG003|Phase B|Withdrawal by Subject|3
911388|NCT00797966|1888499|FG004|Phase B|Withdrawal by Subject|0
911389|NCT00797966|1888500|FG005|Phase B|Withdrawal by Subject|0
911390|NCT00797966|1888495|FG000|Phase B|Protocol Deviation|4
911391|NCT00797966|1888496|FG001|Phase B|Protocol Deviation|8
911392|NCT00797966|1888497|FG002|Phase B|Protocol Deviation|2
911393|NCT00797966|1888498|FG003|Phase B|Protocol Deviation|6
911394|NCT00797966|1888499|FG004|Phase B|Protocol Deviation|0
911395|NCT00797966|1888500|FG005|Phase B|Protocol Deviation|0
911396|NCT00797966|1888495|FG000|Phase B|Lack of Efficacy|0
911397|NCT00797966|1888496|FG001|Phase B|Lack of Efficacy|1
911398|NCT00797966|1888497|FG002|Phase B|Lack of Efficacy|1
911399|NCT00797966|1888498|FG003|Phase B|Lack of Efficacy|4
911400|NCT00797966|1888499|FG004|Phase B|Lack of Efficacy|0
911401|NCT00797966|1888500|FG005|Phase B|Lack of Efficacy|0
911402|NCT00797966|1888495|FG000|Phase A+|Lost to Follow-up|0
911403|NCT00797966|1888496|FG001|Phase A+|Lost to Follow-up|0
967230|NCT01182337|1968527|FG000|Overall Study|Withdrawal by Subject|3
967231|NCT01182337|1968528|FG001|Overall Study|Withdrawal by Subject|1
967232|NCT01182337|1968527|FG000|Overall Study|Lost to Follow-up|0
967233|NCT01182337|1968528|FG001|Overall Study|Lost to Follow-up|1
967234|NCT01182350|1968535|FG000|Overall Study|Adverse Event|5
967235|NCT01182350|1968536|FG001|Overall Study|Adverse Event|0
967236|NCT01182350|1968537|FG002|Overall Study|Adverse Event|0
967237|NCT01182350|1968538|FG003|Overall Study|Adverse Event|0
967238|NCT01182350|1968539|FG004|Overall Study|Adverse Event|0
967239|NCT01182350|1968535|FG000|Overall Study|Disease Progression|15
967240|NCT01182350|1968536|FG001|Overall Study|Disease Progression|12
967241|NCT01182350|1968537|FG002|Overall Study|Disease Progression|0
967242|NCT01182350|1968538|FG003|Overall Study|Disease Progression|1
967243|NCT01182350|1968539|FG004|Overall Study|Disease Progression|0
967244|NCT01182350|1968535|FG000|Overall Study|Death|0
967245|NCT01182350|1968536|FG001|Overall Study|Death|1
967246|NCT01182350|1968537|FG002|Overall Study|Death|1
967247|NCT01182350|1968538|FG003|Overall Study|Death|0
967248|NCT01182350|1968539|FG004|Overall Study|Death|0
967249|NCT01182350|1968535|FG000|Overall Study|Withdrawal by Subject|3
967250|NCT01182350|1968536|FG001|Overall Study|Withdrawal by Subject|1
967251|NCT01182350|1968537|FG002|Overall Study|Withdrawal by Subject|0
967252|NCT01182350|1968538|FG003|Overall Study|Withdrawal by Subject|1
967253|NCT01182350|1968539|FG004|Overall Study|Withdrawal by Subject|0
967254|NCT01182350|1968535|FG000|Overall Study|Alternative Therapy|2
967255|NCT01182350|1968536|FG001|Overall Study|Alternative Therapy|0
967256|NCT01182350|1968537|FG002|Overall Study|Alternative Therapy|1
967257|NCT01182350|1968538|FG003|Overall Study|Alternative Therapy|0
967258|NCT01182350|1968539|FG004|Overall Study|Alternative Therapy|0
967259|NCT01182350|1968535|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2
967260|NCT01182350|1968536|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0
967261|NCT01182350|1968537|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1
911404|NCT00797966|1888497|FG002|Phase A+|Lost to Follow-up|0
911405|NCT00797966|1888498|FG003|Phase A+|Lost to Follow-up|0
911406|NCT00797966|1888499|FG004|Phase A+|Lost to Follow-up|0
911407|NCT00797966|1888500|FG005|Phase A+|Lost to Follow-up|9
911408|NCT00797966|1888495|FG000|Phase A+|Met withdrawal criteria|0
911409|NCT00797966|1888496|FG001|Phase A+|Met withdrawal criteria|0
911410|NCT00797966|1888497|FG002|Phase A+|Met withdrawal criteria|0
911411|NCT00797966|1888498|FG003|Phase A+|Met withdrawal criteria|0
911412|NCT00797966|1888499|FG004|Phase A+|Met withdrawal criteria|0
911413|NCT00797966|1888500|FG005|Phase A+|Met withdrawal criteria|5
911414|NCT00797966|1888495|FG000|Phase A+|Withdrawal by Subject|0
911415|NCT00797966|1888496|FG001|Phase A+|Withdrawal by Subject|0
911416|NCT00797966|1888497|FG002|Phase A+|Withdrawal by Subject|0
911417|NCT00797966|1888498|FG003|Phase A+|Withdrawal by Subject|0
911418|NCT00797966|1888499|FG004|Phase A+|Withdrawal by Subject|0
911419|NCT00797966|1888500|FG005|Phase A+|Withdrawal by Subject|6
911420|NCT00797966|1888495|FG000|Phase A+|Adverse Event|0
911421|NCT00797966|1888496|FG001|Phase A+|Adverse Event|0
911422|NCT00797966|1888497|FG002|Phase A+|Adverse Event|0
911423|NCT00797966|1888498|FG003|Phase A+|Adverse Event|0
911424|NCT00797966|1888499|FG004|Phase A+|Adverse Event|0
911425|NCT00797966|1888500|FG005|Phase A+|Adverse Event|4
911426|NCT00797966|1888495|FG000|Phase A+|Protocol deviation|0
911427|NCT00797966|1888496|FG001|Phase A+|Protocol deviation|0
911428|NCT00797966|1888497|FG002|Phase A+|Protocol deviation|0
911429|NCT00797966|1888498|FG003|Phase A+|Protocol deviation|0
911430|NCT00797966|1888499|FG004|Phase A+|Protocol deviation|0
911431|NCT00797966|1888500|FG005|Phase A+|Protocol deviation|4
911432|NCT00798096|1888529|FG000|Overall Study|Ongoing|2
911433|NCT00798135|1888533|FG000|Overall Study|Disease progression, relapse|11
911434|NCT00798135|1888533|FG000|Overall Study|Disease progression, refractory|1
911435|NCT00798135|1888533|FG000|Overall Study|Physician Decision|1
911436|NCT00798161|1888544|FG000|Overall Study|Adverse Event|3
911437|NCT00798161|1888545|FG001|Overall Study|Adverse Event|4
911438|NCT00798161|1888546|FG002|Overall Study|Adverse Event|6
911439|NCT00798161|1888547|FG003|Overall Study|Adverse Event|6
911440|NCT00798161|1888548|FG004|Overall Study|Adverse Event|5
911441|NCT00798161|1888549|FG005|Overall Study|Adverse Event|2
911442|NCT00798161|1888550|FG006|Overall Study|Adverse Event|4
911443|NCT00798161|1888544|FG000|Overall Study|Protocol Violation|2
911444|NCT00798161|1888545|FG001|Overall Study|Protocol Violation|1
911445|NCT00798161|1888546|FG002|Overall Study|Protocol Violation|3
911446|NCT00798161|1888547|FG003|Overall Study|Protocol Violation|3
911447|NCT00798161|1888548|FG004|Overall Study|Protocol Violation|3
911448|NCT00798161|1888549|FG005|Overall Study|Protocol Violation|2
911449|NCT00798161|1888550|FG006|Overall Study|Protocol Violation|0
911450|NCT00798161|1888544|FG000|Overall Study|Lost to Follow-up|1
911451|NCT00798161|1888545|FG001|Overall Study|Lost to Follow-up|3
911452|NCT00798161|1888546|FG002|Overall Study|Lost to Follow-up|4
911453|NCT00798161|1888547|FG003|Overall Study|Lost to Follow-up|3
911454|NCT00798161|1888548|FG004|Overall Study|Lost to Follow-up|4
911455|NCT00798161|1888549|FG005|Overall Study|Lost to Follow-up|0
911456|NCT00798161|1888550|FG006|Overall Study|Lost to Follow-up|0
911457|NCT00798161|1888544|FG000|Overall Study|Withdrawal by Subject|5
911458|NCT00798161|1888545|FG001|Overall Study|Withdrawal by Subject|4
967262|NCT01182350|1968538|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1
967263|NCT01182350|1968539|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0
967264|NCT01182350|1968535|FG000|Overall Study|Unevaluable for Biopsy|0
967265|NCT01182350|1968536|FG001|Overall Study|Unevaluable for Biopsy|0
967266|NCT01182350|1968537|FG002|Overall Study|Unevaluable for Biopsy|0
967267|NCT01182350|1968538|FG003|Overall Study|Unevaluable for Biopsy|0
967268|NCT01182350|1968539|FG004|Overall Study|Unevaluable for Biopsy|3
967269|NCT01182415|1968564|FG000|Overall Study|Lost to Follow-up|1
967270|NCT01182428|1968570|FG000|Overall Study|Physician Decision|1
967271|NCT01182428|1968571|FG001|Overall Study|Physician Decision|0
967272|NCT01182428|1968570|FG000|Overall Study|Lost to Follow-up|9
967273|NCT01182428|1968571|FG001|Overall Study|Lost to Follow-up|1
967274|NCT01182428|1968570|FG000|Overall Study|Withdrawal by Subject|1
967275|NCT01182428|1968571|FG001|Overall Study|Withdrawal by Subject|0
967276|NCT01182441|1968579|FG000|Overall Study|Patient Still in Follow-up|152
967277|NCT01182441|1968580|FG001|Overall Study|Patient Still in Follow-up|72
967278|NCT01182441|1968579|FG000|Overall Study|Death|37
967279|NCT01182441|1968580|FG001|Overall Study|Death|25
967280|NCT01182441|1968579|FG000|Overall Study|Implant Attempt Unsuccessful|13
967281|NCT01182441|1968580|FG001|Overall Study|Implant Attempt Unsuccessful|0
967282|NCT01182441|1968579|FG000|Overall Study|Lost to Follow-up|5
967283|NCT01182441|1968580|FG001|Overall Study|Lost to Follow-up|8
967284|NCT01182441|1968579|FG000|Overall Study|Withdrawal by Subject|6
967285|NCT01182441|1968580|FG001|Overall Study|Withdrawal by Subject|13
967286|NCT01182441|1968579|FG000|Overall Study|Implant Not Attempted|4
967287|NCT01182441|1968580|FG001|Overall Study|Implant Not Attempted|0
967288|NCT01182441|1968579|FG000|Overall Study|Adverse Event|2
967289|NCT01182441|1968580|FG001|Overall Study|Adverse Event|0
967290|NCT01182441|1968579|FG000|Overall Study|Physician Decision|1
967291|NCT01182441|1968580|FG001|Overall Study|Physician Decision|1
967292|NCT01182844|1968622|FG000|Overall Study|Withdrawal by Subject|0
967293|NCT01182844|1968623|FG001|Overall Study|Withdrawal by Subject|2
967294|NCT01183013|1968636|FG000|Overall Study|Adverse Event|6
967295|NCT01183013|1968637|FG001|Overall Study|Adverse Event|8
967296|NCT01183013|1968638|FG002|Overall Study|Adverse Event|5
967297|NCT01183013|1968639|FG003|Overall Study|Adverse Event|5
967298|NCT01183013|1968640|FG004|Overall Study|Adverse Event|10
967299|NCT01183013|1968641|FG005|Overall Study|Adverse Event|10
967300|NCT01183013|1968642|FG006|Overall Study|Adverse Event|6
967301|NCT01183013|1968636|FG000|Overall Study|Lack of Efficacy|3
967302|NCT01183013|1968637|FG001|Overall Study|Lack of Efficacy|2
967303|NCT01183013|1968638|FG002|Overall Study|Lack of Efficacy|1
967304|NCT01183013|1968639|FG003|Overall Study|Lack of Efficacy|2
967305|NCT01183013|1968640|FG004|Overall Study|Lack of Efficacy|1
967306|NCT01183013|1968641|FG005|Overall Study|Lack of Efficacy|2
967307|NCT01183013|1968642|FG006|Overall Study|Lack of Efficacy|0
967308|NCT01183013|1968636|FG000|Overall Study|Protocol Violation|5
967309|NCT01183013|1968637|FG001|Overall Study|Protocol Violation|2
967310|NCT01183013|1968638|FG002|Overall Study|Protocol Violation|4
967311|NCT01183013|1968639|FG003|Overall Study|Protocol Violation|0
967312|NCT01183013|1968640|FG004|Overall Study|Protocol Violation|4
967313|NCT01183013|1968641|FG005|Overall Study|Protocol Violation|3
967314|NCT01183013|1968642|FG006|Overall Study|Protocol Violation|3
967315|NCT01183013|1968636|FG000|Overall Study|Lost to Follow-up|7
967316|NCT01183013|1968637|FG001|Overall Study|Lost to Follow-up|3
967317|NCT01183013|1968638|FG002|Overall Study|Lost to Follow-up|4
967318|NCT01183013|1968639|FG003|Overall Study|Lost to Follow-up|3
967319|NCT01183013|1968640|FG004|Overall Study|Lost to Follow-up|2
967320|NCT01183013|1968641|FG005|Overall Study|Lost to Follow-up|6
967321|NCT01183013|1968642|FG006|Overall Study|Lost to Follow-up|5
967322|NCT01183013|1968636|FG000|Overall Study|Withdrawal by Subject|9
967323|NCT01183013|1968637|FG001|Overall Study|Withdrawal by Subject|13
967324|NCT01183013|1968638|FG002|Overall Study|Withdrawal by Subject|10
967325|NCT01183013|1968639|FG003|Overall Study|Withdrawal by Subject|8
967326|NCT01183013|1968640|FG004|Overall Study|Withdrawal by Subject|7
967327|NCT01183013|1968641|FG005|Overall Study|Withdrawal by Subject|9
967328|NCT01183013|1968642|FG006|Overall Study|Withdrawal by Subject|10
967329|NCT01183013|1968636|FG000|Overall Study|Reasons other than stated above|15
967330|NCT01183013|1968637|FG001|Overall Study|Reasons other than stated above|11
967331|NCT01183013|1968638|FG002|Overall Study|Reasons other than stated above|17
967332|NCT01183013|1968639|FG003|Overall Study|Reasons other than stated above|12
967333|NCT01183013|1968640|FG004|Overall Study|Reasons other than stated above|12
967334|NCT01183013|1968641|FG005|Overall Study|Reasons other than stated above|15
967335|NCT01183013|1968642|FG006|Overall Study|Reasons other than stated above|13
967336|NCT01183065|1968659|FG000|Overall Study|Patient no longer fits eligibility crite|1
967337|NCT01183104|1968665|FG000|Overall Study|Adverse Event|8
967338|NCT01183104|1968666|FG001|Overall Study|Adverse Event|6
967339|NCT01183104|1968665|FG000|Overall Study|Death|0
967340|NCT01183104|1968666|FG001|Overall Study|Death|1
967341|NCT01183104|1968665|FG000|Overall Study|Lost to Follow-up|14
967342|NCT01183104|1968666|FG001|Overall Study|Lost to Follow-up|7
967343|NCT01183104|1968665|FG000|Overall Study|Physician Decision|5
967344|NCT01183104|1968666|FG001|Overall Study|Physician Decision|8
967345|NCT01183104|1968665|FG000|Overall Study|Withdrawal by Subject|6
967346|NCT01183104|1968666|FG001|Overall Study|Withdrawal by Subject|11
967347|NCT01183104|1968665|FG000|Overall Study|Nonparticipation in Extension Study|39
967348|NCT01183104|1968666|FG001|Overall Study|Nonparticipation in Extension Study|50
967349|NCT01183104|1968665|FG000|Overall Study|Did not receive study drug|5
967350|NCT01183104|1968666|FG001|Overall Study|Did not receive study drug|9
967351|NCT01183143|1968672|FG000|Overall Study|Protocol Violation|115
967352|NCT01183143|1968672|FG000|Overall Study|Withdrawal by Subject|19
967353|NCT01183143|1968672|FG000|Overall Study|Subject Questionnaires not returned|5
967354|NCT01183143|1968672|FG000|Overall Study|Subjects enrolled, but not treated|11
967355|NCT01183234|1968706|FG000|First Intervention|Adverse Event|1
967356|NCT01183234|1968707|FG001|First Intervention|Adverse Event|0
967357|NCT01183260|1968715|FG000|Overall Study|Intraop screen failure|2
967358|NCT01183260|1968716|FG001|Overall Study|Intraop screen failure|0
967359|NCT01183260|1968715|FG000|Overall Study|Withdrawal by Subject|1
967360|NCT01183260|1968716|FG001|Overall Study|Withdrawal by Subject|1
967361|NCT01183260|1968715|FG000|Overall Study|Revised within 30 days|0
967362|NCT01183260|1968716|FG001|Overall Study|Revised within 30 days|1
967363|NCT01183260|1968715|FG000|Overall Study|Death|1
967364|NCT01183260|1968716|FG001|Overall Study|Death|0
967365|NCT01183390|1968733|FG000|First Intervention|Adverse Event|0
967366|NCT01183390|1968734|FG001|First Intervention|Adverse Event|1
967367|NCT01183780|1968789|FG000|Overall Study|Withdrawal by Subject|25
967368|NCT01183780|1968790|FG001|Overall Study|Withdrawal by Subject|14
967369|NCT01183780|1968789|FG000|Overall Study|Lost to Follow-up|6
967370|NCT01183780|1968790|FG001|Overall Study|Lost to Follow-up|11
967371|NCT01183858|1968798|FG000|Overall Study|Death not related to Progressive Disease|5
967372|NCT01183858|1968799|FG001|Overall Study|Death not related to Progressive Disease|6
967373|NCT01183858|1968798|FG000|Overall Study|Adverse Event|14
967374|NCT01183858|1968799|FG001|Overall Study|Adverse Event|11
967375|NCT01183858|1968798|FG000|Overall Study|Investigator's Decision|0
967376|NCT01183858|1968799|FG001|Overall Study|Investigator's Decision|3
967377|NCT01183858|1968798|FG000|Overall Study|Insufficient Therapeutic Response|2
967378|NCT01183858|1968799|FG001|Overall Study|Insufficient Therapeutic Response|0
967379|NCT01183858|1968798|FG000|Overall Study|Refused Treatment|1
967380|NCT01183858|1968799|FG001|Overall Study|Refused Treatment|4
967381|NCT01183858|1968798|FG000|Overall Study|Withdrew Consent|4
967382|NCT01183858|1968799|FG001|Overall Study|Withdrew Consent|4
967383|NCT01183858|1968798|FG000|Overall Study|Discontinued Smoking|3
967384|NCT01183858|1968799|FG001|Overall Study|Discontinued Smoking|1
967385|NCT01183858|1968798|FG000|Overall Study|Protocol Violation|1
967386|NCT01183858|1968799|FG001|Overall Study|Protocol Violation|0
967387|NCT01183858|1968798|FG000|Overall Study|Administrative/Other|6
967388|NCT01183858|1968799|FG001|Overall Study|Administrative/Other|6
967389|NCT01183858|1968798|FG000|Overall Study|Progressive Disease|112
967390|NCT01183858|1968799|FG001|Overall Study|Progressive Disease|115
967391|NCT01183858|1968798|FG000|Overall Study|Death related to Progressive Disease|4
967392|NCT01183858|1968799|FG001|Overall Study|Death related to Progressive Disease|5
967393|NCT01183858|1968798|FG000|Overall Study|Lost to Follow-up|1
967394|NCT01183858|1968799|FG001|Overall Study|Lost to Follow-up|1
967395|NCT01183975|1968811|FG000|Overall Study|Lost to Follow-up|73
967396|NCT01184053|1968824|FG000|Overall Study|progression while on treatment|3
967397|NCT01184079|1968831|FG000|Overall Study|Lost to Follow-up|14
967398|NCT01184079|1968832|FG001|Overall Study|Lost to Follow-up|2
967399|NCT01184118|1968840|FG000|Overall Study|Only asthma step 1 - screen fail|1
967400|NCT01184118|1968840|FG000|Overall Study|No physiologic confirmation of asthma|8
967401|NCT01184118|1968840|FG000|Overall Study|FEV1 <60% predicted|2
967402|NCT01184118|1968840|FG000|Overall Study|Exclusionary medical condition|2
967403|NCT01184118|1968840|FG000|Overall Study|Withdrawal by Subject|5
967404|NCT01184326|1968847|FG000|Overall Study|Adverse Event|1
967405|NCT01184326|1968848|FG001|Overall Study|Adverse Event|2
967406|NCT01184326|1968849|FG002|Overall Study|Adverse Event|0
967407|NCT01184326|1968847|FG000|Overall Study|Death|0
967408|NCT01184326|1968848|FG001|Overall Study|Death|0
967409|NCT01184326|1968849|FG002|Overall Study|Death|1
967410|NCT01184326|1968847|FG000|Overall Study|Withdrawal by Subject|0
967411|NCT01184326|1968848|FG001|Overall Study|Withdrawal by Subject|0
967412|NCT01184326|1968849|FG002|Overall Study|Withdrawal by Subject|1
967413|NCT01184326|1968847|FG000|Overall Study|Physician Decision|1
967414|NCT01184326|1968848|FG001|Overall Study|Physician Decision|1
967415|NCT01184326|1968849|FG002|Overall Study|Physician Decision|0
967416|NCT01184326|1968847|FG000|Overall Study|Disease Progression|1
967417|NCT01184326|1968848|FG001|Overall Study|Disease Progression|3
967418|NCT01184326|1968849|FG002|Overall Study|Disease Progression|12
967419|NCT01184508|1968871|FG000|Overall Study|Adverse Event|4
967420|NCT01184508|1968872|FG001|Overall Study|Adverse Event|6
967421|NCT01184508|1968871|FG000|Overall Study|Lack of Efficacy|1
967422|NCT01184508|1968872|FG001|Overall Study|Lack of Efficacy|1
967423|NCT01184508|1968871|FG000|Overall Study|Lost to Follow-up|1
967424|NCT01184508|1968872|FG001|Overall Study|Lost to Follow-up|1
967425|NCT01184508|1968871|FG000|Overall Study|Physician Decision|1
967426|NCT01184508|1968872|FG001|Overall Study|Physician Decision|0
967427|NCT01184508|1968871|FG000|Overall Study|Protocol Violation|3
967428|NCT01184508|1968872|FG001|Overall Study|Protocol Violation|1
967429|NCT01184508|1968871|FG000|Overall Study|Sponsor Decision|5
967430|NCT01184508|1968872|FG001|Overall Study|Sponsor Decision|2
967431|NCT01184508|1968871|FG000|Overall Study|Withdrawal by Subject|1
967432|NCT01184508|1968872|FG001|Overall Study|Withdrawal by Subject|3
967433|NCT01184508|1968871|FG000|Overall Study|Randomized, Not Treated|0
967434|NCT01184508|1968872|FG001|Overall Study|Randomized, Not Treated|1
967435|NCT01184846|1968892|FG000|Overall Study|Adverse Event|2
967436|NCT01184846|1968892|FG000|Overall Study|Insufficient response|1
967437|NCT01184859|1968903|FG000|Period 1: Single Dose|Insufficient urine production|0
967438|NCT01184859|1968904|FG001|Period 1: Single Dose|Insufficient urine production|1
967439|NCT01184859|1968905|FG002|Period 1: Single Dose|Insufficient urine production|0
967440|NCT01184859|1968906|FG003|Period 1: Single Dose|Insufficient urine production|0
967441|NCT01184859|1968907|FG004|Period 1: Single Dose|Insufficient urine production|0
967442|NCT01184859|1968903|FG000|Period 1: Single Dose|Protocol Violation|0
967443|NCT01184859|1968904|FG001|Period 1: Single Dose|Protocol Violation|1
967444|NCT01184859|1968905|FG002|Period 1: Single Dose|Protocol Violation|0
967445|NCT01184859|1968906|FG003|Period 1: Single Dose|Protocol Violation|0
967446|NCT01184859|1968907|FG004|Period 1: Single Dose|Protocol Violation|0
967447|NCT01184859|1968903|FG000|Period 1: Single Dose|Adverse Event|0
967448|NCT01184859|1968904|FG001|Period 1: Single Dose|Adverse Event|0
967449|NCT01184859|1968905|FG002|Period 1: Single Dose|Adverse Event|0
967450|NCT01184859|1968906|FG003|Period 1: Single Dose|Adverse Event|0
967451|NCT01184859|1968907|FG004|Period 1: Single Dose|Adverse Event|1
967452|NCT01184859|1968903|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
967453|NCT01184859|1968904|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
967454|NCT01184859|1968905|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
967455|NCT01184859|1968906|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
967456|NCT01184859|1968907|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
967457|NCT01184859|1968903|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1
967458|NCT01184859|1968904|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0
967459|NCT01184859|1968905|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0
967460|NCT01184859|1968906|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0
967461|NCT01184859|1968907|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0
967462|NCT01184872|1968926|FG000|Overall Study|Adverse Event|3
967463|NCT01184872|1968927|FG001|Overall Study|Adverse Event|4
967464|NCT01184872|1968926|FG000|Overall Study|Unsatisfactory therapeutic effect|3
967465|NCT01184872|1968927|FG001|Overall Study|Unsatisfactory therapeutic effect|2
967466|NCT01184872|1968926|FG000|Overall Study|Withdrawal by Subject|2
967467|NCT01184872|1968927|FG001|Overall Study|Withdrawal by Subject|0
967468|NCT01184872|1968926|FG000|Overall Study|Lost to Follow-up|0
967469|NCT01184872|1968927|FG001|Overall Study|Lost to Follow-up|1
967470|NCT01184872|1968926|FG000|Overall Study|Administrative problems|1
967471|NCT01184872|1968927|FG001|Overall Study|Administrative problems|1
967472|NCT01184872|1968926|FG000|Overall Study|Protocol deviation|1
967473|NCT01184872|1968927|FG001|Overall Study|Protocol deviation|0
967474|NCT01184989|1968942|FG000|Overall Study|Adverse Event|11
967475|NCT01184989|1968942|FG000|Overall Study|Withdrawal by Subject|1
967476|NCT01185080|1968953|FG000|Overall Study|Adverse Event|1
967477|NCT01185080|1968954|FG001|Overall Study|Adverse Event|1
967478|NCT01185080|1968955|FG002|Overall Study|Adverse Event|0
967479|NCT01185080|1968953|FG000|Overall Study|Personal reasons|0
967480|NCT01185080|1968954|FG001|Overall Study|Personal reasons|0
967481|NCT01185080|1968955|FG002|Overall Study|Personal reasons|1
967482|NCT01185171|1968963|FG000|Induction Chemotherapy|Withdrawal by Subject|1
967483|NCT01185171|1968963|FG000|Induction Chemotherapy|Duodenal Ulcer|1
967484|NCT01185171|1968963|FG000|Concurrent Chemo and Radiation Treatment|Death|3
967485|NCT01185171|1968963|FG000|Maintenance|Elevated liver transaminases|3
967486|NCT01185171|1968963|FG000|Maintenance|Rush|2
911459|NCT00798161|1888546|FG002|Overall Study|Withdrawal by Subject|5
911460|NCT00798161|1888547|FG003|Overall Study|Withdrawal by Subject|4
911461|NCT00798161|1888548|FG004|Overall Study|Withdrawal by Subject|2
911462|NCT00798161|1888549|FG005|Overall Study|Withdrawal by Subject|3
911463|NCT00798161|1888550|FG006|Overall Study|Withdrawal by Subject|1
911464|NCT00798161|1888544|FG000|Overall Study|Other reason (incl. lack of efficacy)|7
911465|NCT00798161|1888545|FG001|Overall Study|Other reason (incl. lack of efficacy)|5
911466|NCT00798161|1888546|FG002|Overall Study|Other reason (incl. lack of efficacy)|3
911467|NCT00798161|1888547|FG003|Overall Study|Other reason (incl. lack of efficacy)|5
911468|NCT00798161|1888548|FG004|Overall Study|Other reason (incl. lack of efficacy)|2
911469|NCT00798161|1888549|FG005|Overall Study|Other reason (incl. lack of efficacy)|4
911470|NCT00798161|1888550|FG006|Overall Study|Other reason (incl. lack of efficacy)|5
911471|NCT00798174|1888566|FG000|Overall Study|inability to implant azygos coil|3
911472|NCT00798174|1888567|FG001|Overall Study|inability to implant azygos coil|3
911473|NCT00798174|1888566|FG000|Overall Study|Inability to sedate for DFT testing|1
911474|NCT00798174|1888567|FG001|Overall Study|Inability to sedate for DFT testing|0
911475|NCT00798304|1888574|FG000|Overall Study|Adverse Event|0
911476|NCT00798304|1888575|FG001|Overall Study|Adverse Event|1
911477|NCT00798304|1888576|FG002|Overall Study|Adverse Event|1
911478|NCT00798304|1888574|FG000|Overall Study|Discontinuation by Sponsor|14
911479|NCT00798304|1888575|FG001|Overall Study|Discontinuation by Sponsor|21
911480|NCT00798304|1888576|FG002|Overall Study|Discontinuation by Sponsor|9
967487|NCT01185171|1968963|FG000|Maintenance|Diarrhea|1
967488|NCT01185171|1968963|FG000|Maintenance|Xerostomia|1
967489|NCT01185171|1968963|FG000|Maintenance|Nausea|1
967490|NCT01185171|1968963|FG000|Maintenance|Comorbid Illness|2
967491|NCT01185171|1968963|FG000|Maintenance|Withdrawal by Subject|1
967492|NCT01185171|1968963|FG000|Maintenance|Disease Recurrence|1
967493|NCT01185249|1968967|FG000|Overall Study|Patients discharged or change in status|42
967494|NCT01185288|1968974|FG000|Overall Study|Adverse Event|7
967495|NCT01185288|1968975|FG001|Overall Study|Adverse Event|6
967496|NCT01185288|1968974|FG000|Overall Study|Withdrawal by Subject|6
967497|NCT01185288|1968975|FG001|Overall Study|Withdrawal by Subject|4
967498|NCT01185288|1968974|FG000|Overall Study|Lost to Follow-up|2
967499|NCT01185288|1968975|FG001|Overall Study|Lost to Follow-up|5
967500|NCT01185288|1968974|FG000|Overall Study|Lack of Efficacy|2
967501|NCT01185288|1968975|FG001|Overall Study|Lack of Efficacy|0
967502|NCT01185288|1968974|FG000|Overall Study|Investigator discretion|1
967503|NCT01185288|1968975|FG001|Overall Study|Investigator discretion|0
967504|NCT01185288|1968974|FG000|Overall Study|Did not meet inclusion criteria|1
967505|NCT01185288|1968975|FG001|Overall Study|Did not meet inclusion criteria|0
967506|NCT01185288|1968974|FG000|Overall Study|Noncompliance|0
967507|NCT01185288|1968975|FG001|Overall Study|Noncompliance|1
967508|NCT01185301|1968985|FG000|Overall Study|Adverse Event|3
967509|NCT01185301|1968986|FG001|Overall Study|Adverse Event|0
967510|NCT01185301|1968987|FG002|Overall Study|Adverse Event|2
967511|NCT01185301|1968988|FG003|Overall Study|Adverse Event|3
967512|NCT01185301|1968985|FG000|Overall Study|Withdrawal by Subject|7
967513|NCT01185301|1968986|FG001|Overall Study|Withdrawal by Subject|5
967514|NCT01185301|1968987|FG002|Overall Study|Withdrawal by Subject|2
967515|NCT01185301|1968988|FG003|Overall Study|Withdrawal by Subject|3
967516|NCT01185301|1968985|FG000|Overall Study|Lost to Follow-up|2
967517|NCT01185301|1968986|FG001|Overall Study|Lost to Follow-up|0
967518|NCT01185301|1968987|FG002|Overall Study|Lost to Follow-up|0
967519|NCT01185301|1968988|FG003|Overall Study|Lost to Follow-up|1
967520|NCT01185301|1968985|FG000|Overall Study|Other Reason|3
967521|NCT01185301|1968986|FG001|Overall Study|Other Reason|2
967522|NCT01185301|1968987|FG002|Overall Study|Other Reason|2
967523|NCT01185301|1968988|FG003|Overall Study|Other Reason|2
967524|NCT01185340|1969001|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
967525|NCT01185340|1969002|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
967526|NCT01185340|1969003|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
967527|NCT01185340|1969004|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
967528|NCT01185340|1969001|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
967529|NCT01185340|1969002|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
967530|NCT01185340|1969003|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
967531|NCT01185340|1969004|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
967532|NCT01185340|1969001|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
967533|NCT01185340|1969002|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
967534|NCT01185340|1969003|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
967535|NCT01185340|1969004|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
967536|NCT01185340|1969001|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
967537|NCT01185340|1969002|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
967538|NCT01185340|1969003|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
967539|NCT01185340|1969004|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
967540|NCT01185340|1969001|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
967541|NCT01185340|1969002|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
967542|NCT01185340|1969003|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
967543|NCT01185340|1969004|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
967544|NCT01185340|1969001|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
967545|NCT01185340|1969002|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
967546|NCT01185340|1969003|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
967547|NCT01185340|1969004|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
967548|NCT01185340|1969001|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
967549|NCT01185340|1969002|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
967550|NCT01185340|1969003|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
967551|NCT01185340|1969004|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
967552|NCT01185340|1969001|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
967553|NCT01185340|1969002|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
967554|NCT01185340|1969003|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
967555|NCT01185340|1969004|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
967556|NCT01185340|1969001|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
967557|NCT01185340|1969002|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
967558|NCT01185340|1969003|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
967559|NCT01185340|1969004|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
967560|NCT01185340|1969001|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
967561|NCT01185340|1969002|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
967562|NCT01185340|1969003|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
967563|NCT01185340|1969004|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
967564|NCT01185340|1969001|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
967565|NCT01185340|1969002|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
967566|NCT01185340|1969003|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
967567|NCT01185340|1969004|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
967568|NCT01185340|1969001|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
967569|NCT01185340|1969002|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
967570|NCT01185340|1969003|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
967571|NCT01185340|1969004|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
967572|NCT01185340|1969001|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
967573|NCT01185340|1969002|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
967574|NCT01185340|1969003|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
967575|NCT01185340|1969004|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
967576|NCT01185340|1969001|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
967577|NCT01185340|1969002|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
967578|NCT01185340|1969003|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
967579|NCT01185340|1969004|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
967580|NCT01185353|1969021|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1
967581|NCT01185353|1969022|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1
967582|NCT01185353|1969023|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1
967583|NCT01185353|1969024|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1
967584|NCT01185353|1969025|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5
967585|NCT01185353|1969026|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0
967586|NCT01185353|1969027|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0
967587|NCT01185353|1969028|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0
967588|NCT01185353|1969029|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0
967589|NCT01185353|1969030|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0
967590|NCT01185353|1969021|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
967591|NCT01185353|1969022|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
967592|NCT01185353|1969023|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
967593|NCT01185353|1969024|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
967594|NCT01185353|1969025|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
967595|NCT01185353|1969026|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
967596|NCT01185353|1969027|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
967597|NCT01185353|1969028|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
967598|NCT01185353|1969029|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
967599|NCT01185353|1969030|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
911481|NCT00798317|1888586|FG000|Overall Study|Physician Decision|0
911482|NCT00798317|1888587|FG001|Overall Study|Physician Decision|1
911483|NCT00798317|1888586|FG000|Overall Study|Withdrawal by Subject|5
911484|NCT00798317|1888587|FG001|Overall Study|Withdrawal by Subject|4
911485|NCT00798317|1888586|FG000|Overall Study|Lost to Follow-up|2
911486|NCT00798317|1888587|FG001|Overall Study|Lost to Follow-up|2
911487|NCT00798317|1888586|FG000|Overall Study|Adverse Event|2
911488|NCT00798317|1888587|FG001|Overall Study|Adverse Event|0
911489|NCT00798317|1888586|FG000|Overall Study|Death|1
911490|NCT00798317|1888587|FG001|Overall Study|Death|0
911491|NCT00798369|1888599|FG000|Overall Study|Subject withdrew consent|0
911492|NCT00798369|1888600|FG001|Overall Study|Subject withdrew consent|0
911493|NCT00798369|1888601|FG002|Overall Study|Subject withdrew consent|1
911494|NCT00798369|1888602|FG003|Overall Study|Subject withdrew consent|1
911495|NCT00798369|1888603|FG004|Overall Study|Subject withdrew consent|0
911496|NCT00798369|1888604|FG005|Overall Study|Subject withdrew consent|2
911497|NCT00798369|1888599|FG000|Overall Study|Lost to Follow-up|1
911498|NCT00798369|1888600|FG001|Overall Study|Lost to Follow-up|1
911499|NCT00798369|1888601|FG002|Overall Study|Lost to Follow-up|1
911500|NCT00798369|1888602|FG003|Overall Study|Lost to Follow-up|0
911501|NCT00798369|1888603|FG004|Overall Study|Lost to Follow-up|1
911502|NCT00798369|1888604|FG005|Overall Study|Lost to Follow-up|0
911503|NCT00798369|1888599|FG000|Overall Study|Adminstrative problems|0
911504|NCT00798369|1888600|FG001|Overall Study|Adminstrative problems|0
911505|NCT00798369|1888601|FG002|Overall Study|Adminstrative problems|0
911506|NCT00798369|1888602|FG003|Overall Study|Adminstrative problems|0
911507|NCT00798369|1888603|FG004|Overall Study|Adminstrative problems|0
911508|NCT00798369|1888604|FG005|Overall Study|Adminstrative problems|1
911509|NCT00798434|1888621|FG000|Double-Blind|Adverse Event|22
911510|NCT00798434|1888622|FG001|Double-Blind|Adverse Event|46
911511|NCT00798434|1888621|FG000|Double-Blind|Death|0
911512|NCT00798434|1888622|FG001|Double-Blind|Death|1
911513|NCT00798434|1888621|FG000|Double-Blind|Lost to Follow-up|1
911514|NCT00798434|1888622|FG001|Double-Blind|Lost to Follow-up|0
911515|NCT00798434|1888621|FG000|Double-Blind|Lack of Efficacy|8
911516|NCT00798434|1888622|FG001|Double-Blind|Lack of Efficacy|12
911517|NCT00798434|1888621|FG000|Double-Blind|Withdrawal by Subject|17
911518|NCT00798434|1888622|FG001|Double-Blind|Withdrawal by Subject|14
911519|NCT00798434|1888621|FG000|Double-Blind|Protocol Violation|1
911520|NCT00798434|1888622|FG001|Double-Blind|Protocol Violation|4
911521|NCT00798434|1888621|FG000|Double-Blind|Did Not Meet Entrance Criteria|2
911522|NCT00798434|1888622|FG001|Double-Blind|Did Not Meet Entrance Criteria|1
967600|NCT01185353|1969021|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
967601|NCT01185353|1969022|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
967602|NCT01185353|1969023|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
967603|NCT01185353|1969024|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
967604|NCT01185353|1969025|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
967605|NCT01185353|1969026|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
967606|NCT01185353|1969027|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
967607|NCT01185353|1969028|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
967608|NCT01185353|1969029|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
967609|NCT01185353|1969030|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
967610|NCT01185353|1969021|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0
967611|NCT01185353|1969022|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0
967612|NCT01185353|1969023|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1
967613|NCT01185353|1969024|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0
967614|NCT01185353|1969025|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2
967615|NCT01185353|1969026|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0
967616|NCT01185353|1969027|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0
967617|NCT01185353|1969028|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0
967618|NCT01185353|1969029|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0
967619|NCT01185353|1969030|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0
967620|NCT01185353|1969021|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0
967621|NCT01185353|1969022|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0
911523|NCT00798434|1888621|FG000|Double-Blind|Other|1
911524|NCT00798434|1888622|FG001|Double-Blind|Other|0
911525|NCT00798434|1888621|FG000|Double-Blind|Not Treated|3
911526|NCT00798434|1888622|FG001|Double-Blind|Not Treated|6
911527|NCT00798434|1888621|FG000|Open-Label|Adverse Event|33
911528|NCT00798434|1888622|FG001|Open-Label|Adverse Event|11
911529|NCT00798434|1888621|FG000|Open-Label|Lack of Efficacy|5
911530|NCT00798434|1888622|FG001|Open-Label|Lack of Efficacy|11
911531|NCT00798434|1888621|FG000|Open-Label|Withdrawal by Subject|2
911532|NCT00798434|1888622|FG001|Open-Label|Withdrawal by Subject|7
911533|NCT00798434|1888621|FG000|Open-Label|Protocol Violation|1
911534|NCT00798434|1888622|FG001|Open-Label|Protocol Violation|0
911535|NCT00798434|1888621|FG000|Open-Label|Other|1
911536|NCT00798434|1888622|FG001|Open-Label|Other|2
911537|NCT00798434|1888621|FG000|Open-Label|Not Treated|0
911538|NCT00798434|1888622|FG001|Open-Label|Not Treated|1
911539|NCT00798603|1888646|FG000|Overall Study|Still on treatment as of 11/6/2012|1
911540|NCT00798603|1888646|FG000|Overall Study|Withdrawal by Subject|10
911541|NCT00798603|1888646|FG000|Overall Study|Adverse Event|22
911542|NCT00798603|1888646|FG000|Overall Study|Physician Decision|1
911543|NCT00798603|1888646|FG000|Overall Study|Lack of insurance coverage|1
911544|NCT00798655|1888650|FG000|Overall Study|Did not receive at least one dose of pan|2
911545|NCT00798694|1888656|FG000|Overall Study|Lost to Follow-up|1
911546|NCT00798694|1888657|FG001|Overall Study|Lost to Follow-up|1
911547|NCT00798694|1888656|FG000|Overall Study|Physician Decision|1
911548|NCT00798694|1888657|FG001|Overall Study|Physician Decision|0
911549|NCT00798707|1888672|FG000|Overall Study|Adverse Event|6
911550|NCT00798707|1888673|FG001|Overall Study|Adverse Event|8
911551|NCT00798707|1888674|FG002|Overall Study|Adverse Event|8
911552|NCT00798707|1888672|FG000|Overall Study|Failed to return|2
911553|NCT00798707|1888673|FG001|Overall Study|Failed to return|2
911554|NCT00798707|1888674|FG002|Overall Study|Failed to return|0
911555|NCT00798707|1888672|FG000|Overall Study|Investigator|0
911556|NCT00798707|1888673|FG001|Overall Study|Investigator|1
911557|NCT00798707|1888674|FG002|Overall Study|Investigator|2
911558|NCT00798707|1888672|FG000|Overall Study|Lack of Efficacy|2
911559|NCT00798707|1888673|FG001|Overall Study|Lack of Efficacy|2
911560|NCT00798707|1888674|FG002|Overall Study|Lack of Efficacy|1
911561|NCT00798707|1888672|FG000|Overall Study|Lost to Follow-up|5
911562|NCT00798707|1888673|FG001|Overall Study|Lost to Follow-up|6
911563|NCT00798707|1888674|FG002|Overall Study|Lost to Follow-up|6
911564|NCT00798707|1888672|FG000|Overall Study|Other|0
911565|NCT00798707|1888673|FG001|Overall Study|Other|1
911566|NCT00798707|1888674|FG002|Overall Study|Other|0
911567|NCT00798707|1888672|FG000|Overall Study|Protocol Violation|4
911568|NCT00798707|1888673|FG001|Overall Study|Protocol Violation|0
911569|NCT00798707|1888674|FG002|Overall Study|Protocol Violation|2
911570|NCT00798707|1888672|FG000|Overall Study|Withdrawal by Subject|3
911571|NCT00798707|1888673|FG001|Overall Study|Withdrawal by Subject|8
911572|NCT00798707|1888674|FG002|Overall Study|Withdrawal by Subject|2
911573|NCT00798707|1888672|FG000|Overall Study|Randomized not treated|4
911574|NCT00798707|1888673|FG001|Overall Study|Randomized not treated|5
911575|NCT00798707|1888674|FG002|Overall Study|Randomized not treated|1
911576|NCT00798759|1888688|FG000|Overall Study|Adverse Event|3
911577|NCT00798759|1888689|FG001|Overall Study|Adverse Event|3
911578|NCT00798759|1888688|FG000|Overall Study|Lost to Follow-up|1
911579|NCT00798759|1888689|FG001|Overall Study|Lost to Follow-up|1
911580|NCT00798759|1888688|FG000|Overall Study|Protocol Violation|4
911581|NCT00798759|1888689|FG001|Overall Study|Protocol Violation|8
911582|NCT00798759|1888688|FG000|Overall Study|Other|0
911583|NCT00798759|1888689|FG001|Overall Study|Other|1
967622|NCT01185353|1969023|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0
967623|NCT01185353|1969024|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0
967624|NCT01185353|1969025|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1
967625|NCT01185353|1969026|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0
967626|NCT01185353|1969027|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0
967627|NCT01185353|1969028|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0
967628|NCT01185353|1969029|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0
967629|NCT01185353|1969030|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0
967630|NCT01185353|1969021|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
967631|NCT01185353|1969022|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
967632|NCT01185353|1969023|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
967633|NCT01185353|1969024|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
967634|NCT01185353|1969025|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
967635|NCT01185353|1969026|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
967636|NCT01185353|1969027|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
967637|NCT01185353|1969028|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
967638|NCT01185353|1969029|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
967639|NCT01185353|1969030|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
967640|NCT01185353|1969021|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0
967641|NCT01185353|1969022|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0
967642|NCT01185353|1969023|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1
967643|NCT01185353|1969024|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0
967644|NCT01185353|1969025|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0
967645|NCT01185353|1969026|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1
911584|NCT00798889|1888695|FG000|Overall Study|Adverse Event|53
911585|NCT00798889|1888695|FG000|Overall Study|Protocol Violation|2
911586|NCT00798889|1888695|FG000|Overall Study|Withdrawal by Subject|31
911587|NCT00798889|1888695|FG000|Overall Study|Lost to Follow-up|1
911588|NCT00798889|1888695|FG000|Overall Study|Lack of Efficacy|213
911589|NCT00798889|1888695|FG000|Overall Study|Decision of Sponsor|11
911590|NCT00798889|1888695|FG000|Overall Study|Enrolled, Not treated|3
911591|NCT00798967|1888701|FG000|Overall Study|Adverse Event|2
911592|NCT00798967|1888702|FG001|Overall Study|Adverse Event|3
911593|NCT00798967|1888701|FG000|Overall Study|Withdrawal by Subject|0
911594|NCT00798967|1888702|FG001|Overall Study|Withdrawal by Subject|1
911595|NCT00798967|1888701|FG000|Overall Study|Physician Decision|1
911596|NCT00798967|1888702|FG001|Overall Study|Physician Decision|0
911597|NCT00798967|1888701|FG000|Overall Study|Randomized in error by site|1
911598|NCT00798967|1888702|FG001|Overall Study|Randomized in error by site|0
911599|NCT00799383|1888731|FG000|Overall Study|Protocol Violation|1
911600|NCT00799383|1888732|FG001|Overall Study|Protocol Violation|1
911601|NCT00799383|1888731|FG000|Overall Study|Adverse Event|0
911602|NCT00799383|1888732|FG001|Overall Study|Adverse Event|1
911603|NCT00799383|1888731|FG000|Overall Study|Lost to Follow-up|1
911604|NCT00799383|1888732|FG001|Overall Study|Lost to Follow-up|2
911605|NCT00799383|1888731|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1
911606|NCT00799383|1888732|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1
911607|NCT00799383|1888731|FG000|Overall Study|Withdrawal by Subject|0
911608|NCT00799383|1888732|FG001|Overall Study|Withdrawal by Subject|1
911609|NCT00799396|1888738|FG000|Clopidogrel Treatment|Adverse Event|6
911610|NCT00799396|1888738|FG000|Clopidogrel Treatment|Physician Decision|5
911611|NCT00799396|1888738|FG000|Clopidogrel Treatment|Withdrawal by Subject|2
911612|NCT00799396|1888738|FG000|Clopidogrel Plus Aspirin|Adverse Event|2
911613|NCT00799396|1888738|FG000|Clopidogrel Plus Aspirin|Physician Decision|4
911614|NCT00799409|1888745|FG000|Overall Study|Withdrawal by Subject|1
911615|NCT00799409|1888746|FG001|Overall Study|Withdrawal by Subject|0
911616|NCT00799409|1888747|FG002|Overall Study|Withdrawal by Subject|0
911617|NCT00799409|1888745|FG000|Overall Study|Lost to Follow-up|1
911618|NCT00799409|1888746|FG001|Overall Study|Lost to Follow-up|0
911619|NCT00799409|1888747|FG002|Overall Study|Lost to Follow-up|0
911620|NCT00799409|1888745|FG000|Overall Study|Optimal Dose Not Achieved|2
911621|NCT00799409|1888746|FG001|Overall Study|Optimal Dose Not Achieved|0
911622|NCT00799409|1888747|FG002|Overall Study|Optimal Dose Not Achieved|0
911623|NCT00799409|1888745|FG000|Overall Study|Failure to follow study protocol)|1
911624|NCT00799409|1888746|FG001|Overall Study|Failure to follow study protocol)|0
911625|NCT00799409|1888747|FG002|Overall Study|Failure to follow study protocol)|0
911626|NCT00799409|1888745|FG000|Overall Study|Did not attend lab school day 1|1
911627|NCT00799409|1888746|FG001|Overall Study|Did not attend lab school day 1|0
911628|NCT00799409|1888747|FG002|Overall Study|Did not attend lab school day 1|0
911629|NCT00799409|1888745|FG000|Overall Study|medication compliance|1
911630|NCT00799409|1888746|FG001|Overall Study|medication compliance|0
911631|NCT00799409|1888747|FG002|Overall Study|medication compliance|0
911632|NCT00799422|1888755|FG000|First Week of Wear|Lost to Follow-up|0
911633|NCT00799422|1888756|FG001|First Week of Wear|Lost to Follow-up|0
911634|NCT00799422|1888757|FG002|First Week of Wear|Lost to Follow-up|1
911635|NCT00799422|1888758|FG003|First Week of Wear|Lost to Follow-up|0
911636|NCT00799422|1888759|FG004|First Week of Wear|Lost to Follow-up|0
911637|NCT00799422|1888760|FG005|First Week of Wear|Lost to Follow-up|0
911638|NCT00799422|1888755|FG000|First Week of Wear|Adverse Event|0
911639|NCT00799422|1888756|FG001|First Week of Wear|Adverse Event|0
967646|NCT01185353|1969027|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0
967647|NCT01185353|1969028|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0
967648|NCT01185353|1969029|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0
967649|NCT01185353|1969030|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0
967650|NCT01185353|1969021|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
967651|NCT01185353|1969022|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
967652|NCT01185353|1969023|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
967653|NCT01185353|1969024|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
967654|NCT01185353|1969025|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
967655|NCT01185353|1969026|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
967656|NCT01185353|1969027|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
967657|NCT01185353|1969028|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
967658|NCT01185353|1969029|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
967659|NCT01185353|1969030|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
967660|NCT01185353|1969021|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
967661|NCT01185353|1969022|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
967662|NCT01185353|1969023|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
967663|NCT01185353|1969024|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
967664|NCT01185353|1969025|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
967665|NCT01185353|1969026|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
967666|NCT01185353|1969027|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
967667|NCT01185353|1969028|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
967668|NCT01185353|1969029|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
967669|NCT01185353|1969030|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
967670|NCT01185353|1969021|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
967671|NCT01185353|1969022|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
967672|NCT01185353|1969023|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
967673|NCT01185353|1969024|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
967674|NCT01185353|1969025|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
967675|NCT01185353|1969026|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
911640|NCT00799422|1888757|FG002|First Week of Wear|Adverse Event|0
911641|NCT00799422|1888758|FG003|First Week of Wear|Adverse Event|1
911642|NCT00799422|1888759|FG004|First Week of Wear|Adverse Event|0
911643|NCT00799422|1888760|FG005|First Week of Wear|Adverse Event|0
911644|NCT00799487|1888784|FG000|Dose Adjustment Period|Lost to Follow-up|1
911645|NCT00799487|1888785|FG001|Dose Adjustment Period|Lost to Follow-up|0
911646|NCT00799487|1888786|FG002|Dose Adjustment Period|Lost to Follow-up|0
911647|NCT00799487|1888784|FG000|Dose Adjustment Period|Adverse Event|2
911648|NCT00799487|1888785|FG001|Dose Adjustment Period|Adverse Event|0
911649|NCT00799487|1888786|FG002|Dose Adjustment Period|Adverse Event|0
911650|NCT00799487|1888784|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8
911651|NCT00799487|1888785|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0
911652|NCT00799487|1888786|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0
911653|NCT00799487|1888784|FG000|Dose Adjustment Period|Investigator Discretion|2
911654|NCT00799487|1888785|FG001|Dose Adjustment Period|Investigator Discretion|0
911655|NCT00799487|1888786|FG002|Dose Adjustment Period|Investigator Discretion|0
911656|NCT00799487|1888784|FG000|Dose Adjustment Period|Withdrawal by Subject|3
911657|NCT00799487|1888785|FG001|Dose Adjustment Period|Withdrawal by Subject|0
911658|NCT00799487|1888786|FG002|Dose Adjustment Period|Withdrawal by Subject|0
911659|NCT00799487|1888784|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1
911660|NCT00799487|1888785|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0
911661|NCT00799487|1888786|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0
911662|NCT00799487|1888784|FG000|Dose Adjustment Period|Child too young (exclusion)|1
911663|NCT00799487|1888785|FG001|Dose Adjustment Period|Child too young (exclusion)|0
911664|NCT00799487|1888786|FG002|Dose Adjustment Period|Child too young (exclusion)|0
911665|NCT00799487|1888784|FG000|Dose Adjustment Period|Missed laboratory day 1|1
911666|NCT00799487|1888785|FG001|Dose Adjustment Period|Missed laboratory day 1|0
911667|NCT00799487|1888786|FG002|Dose Adjustment Period|Missed laboratory day 1|0
911668|NCT00799487|1888784|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
911669|NCT00799487|1888785|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
911670|NCT00799487|1888786|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
911671|NCT00799487|1888784|FG000|Double-Blind Assessment Period|Lost to Follow-up|0
911672|NCT00799487|1888785|FG001|Double-Blind Assessment Period|Lost to Follow-up|0
911673|NCT00799487|1888786|FG002|Double-Blind Assessment Period|Lost to Follow-up|1
911674|NCT00799487|1888784|FG000|Double-Blind Assessment Period|Subject was out of the state|0
911675|NCT00799487|1888785|FG001|Double-Blind Assessment Period|Subject was out of the state|0
911676|NCT00799487|1888786|FG002|Double-Blind Assessment Period|Subject was out of the state|1
911677|NCT00799487|1888784|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0
911678|NCT00799487|1888785|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1
911679|NCT00799487|1888786|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0
911680|NCT00799591|1888801|FG000|Overall Study|De-escalation of doses|20
911681|NCT00799591|1888801|FG000|Overall Study|Death|14
911682|NCT00799591|1888801|FG000|Overall Study|Technical failure|12
911683|NCT00799591|1888801|FG000|Overall Study|Resistant germ|11
967676|NCT01185353|1969027|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
967677|NCT01185353|1969028|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
967678|NCT01185353|1969029|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
967679|NCT01185353|1969030|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
967680|NCT01185353|1969021|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
967681|NCT01185353|1969022|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
967682|NCT01185353|1969023|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
967683|NCT01185353|1969024|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
967684|NCT01185353|1969025|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
911684|NCT00799591|1888801|FG000|Overall Study|New infection|4
911685|NCT00799591|1888801|FG000|Overall Study|Resistance germ and technical failure|2
911686|NCT00799591|1888801|FG000|Overall Study|Persistance of fever undetermined origin|1
911687|NCT00799591|1888801|FG000|Overall Study|Antibiotic changed, no apparent reason|1
911688|NCT00799591|1888801|FG000|Overall Study|Infectious origin not probable|1
911689|NCT00799617|1888820|FG000|Main Testosterone Trial|Randomized in error|1
911690|NCT00799617|1888821|FG001|Main Testosterone Trial|Randomized in error|1
911691|NCT00799617|1888820|FG000|Main Testosterone Trial|Lost to Follow-up|18
911692|NCT00799617|1888821|FG001|Main Testosterone Trial|Lost to Follow-up|20
911693|NCT00799617|1888820|FG000|Sexual Funtion Trial|Lost to Follow-up|12
911694|NCT00799617|1888821|FG001|Sexual Funtion Trial|Lost to Follow-up|14
911695|NCT00799617|1888820|FG000|Sexual Funtion Trial|No Baseline Data|4
911696|NCT00799617|1888821|FG001|Sexual Funtion Trial|No Baseline Data|7
911697|NCT00799617|1888820|FG000|Physical Function Trial|Lost to Follow-up|6
911698|NCT00799617|1888821|FG001|Physical Function Trial|Lost to Follow-up|11
911699|NCT00799617|1888820|FG000|Vitality Trial|Lost to Follow-up|7
911700|NCT00799617|1888821|FG001|Vitality Trial|Lost to Follow-up|22
911701|NCT00799617|1888820|FG000|Cardiovascular Trial|Month 12 scan not available|15
911702|NCT00799617|1888821|FG001|Cardiovascular Trial|Month 12 scan not available|15
911703|NCT00799617|1888820|FG000|Cardiovascular Trial|Baseline scan not analyzable|0
911704|NCT00799617|1888821|FG001|Cardiovascular Trial|Baseline scan not analyzable|2
911705|NCT00799617|1888820|FG000|Bone Trial|Month 12 scan not available|6
911706|NCT00799617|1888821|FG001|Bone Trial|Month 12 scan not available|16
911707|NCT00799617|1888820|FG000|Cognitive Function Trial|Lost to Follow-up|0
911708|NCT00799617|1888821|FG001|Cognitive Function Trial|Lost to Follow-up|1
911709|NCT00799617|1888820|FG000|Anemia Trial|Withdrawal by Subject|3
911710|NCT00799617|1888821|FG001|Anemia Trial|Withdrawal by Subject|3
911711|NCT00799708|1888840|FG000|Overall Study|non-compliance|1
911712|NCT00799708|1888841|FG001|Overall Study|non-compliance|0
911713|NCT00799708|1888842|FG002|Overall Study|non-compliance|0
911714|NCT00799825|1888864|FG000|Overall Study|Adverse Event|1
911715|NCT00799825|1888864|FG000|Overall Study|Withdrawal by Subject|6
911716|NCT00799825|1888864|FG000|Overall Study|Lost to Follow-up|38
911717|NCT00799825|1888864|FG000|Overall Study|Pregnancy|3
911718|NCT00799903|1888870|FG000|Overall Study|Investigator Site Closed|25
911719|NCT00799903|1888871|FG001|Overall Study|Investigator Site Closed|23
911720|NCT00799903|1888870|FG000|Overall Study|Withdrawal by Subject|179
911721|NCT00799903|1888871|FG001|Overall Study|Withdrawal by Subject|175
911722|NCT00799903|1888870|FG000|Overall Study|Lost to Follow-up|69
911723|NCT00799903|1888871|FG001|Overall Study|Lost to Follow-up|80
911724|NCT00800176|1888897|FG000|Overall Study|Adverse Event|2
911725|NCT00800176|1888898|FG001|Overall Study|Adverse Event|1
911726|NCT00800176|1888899|FG002|Overall Study|Adverse Event|0
911727|NCT00800176|1888900|FG003|Overall Study|Adverse Event|2
911728|NCT00800176|1888901|FG004|Overall Study|Adverse Event|1
911729|NCT00800176|1888902|FG005|Overall Study|Adverse Event|1
911730|NCT00800176|1888897|FG000|Overall Study|Refused treatment|3
911731|NCT00800176|1888898|FG001|Overall Study|Refused treatment|2
911732|NCT00800176|1888899|FG002|Overall Study|Refused treatment|0
911733|NCT00800176|1888900|FG003|Overall Study|Refused treatment|0
911734|NCT00800176|1888901|FG004|Overall Study|Refused treatment|1
911735|NCT00800176|1888902|FG005|Overall Study|Refused treatment|4
911736|NCT00800176|1888897|FG000|Overall Study|Failure to return|3
911737|NCT00800176|1888898|FG001|Overall Study|Failure to return|3
911738|NCT00800176|1888899|FG002|Overall Study|Failure to return|0
911739|NCT00800176|1888900|FG003|Overall Study|Failure to return|2
911740|NCT00800176|1888901|FG004|Overall Study|Failure to return|0
911741|NCT00800176|1888902|FG005|Overall Study|Failure to return|0
911742|NCT00800176|1888897|FG000|Overall Study|Other|1
911743|NCT00800176|1888898|FG001|Overall Study|Other|0
911744|NCT00800176|1888899|FG002|Overall Study|Other|0
911745|NCT00800176|1888900|FG003|Overall Study|Other|0
911746|NCT00800176|1888901|FG004|Overall Study|Other|2
911747|NCT00800176|1888902|FG005|Overall Study|Other|0
911748|NCT00800202|1888918|FG000|Overall Study|Adverse Event|7
911749|NCT00800202|1888919|FG001|Overall Study|Adverse Event|6
911750|NCT00800202|1888918|FG000|Overall Study|Death|1
911751|NCT00800202|1888919|FG001|Overall Study|Death|0
911752|NCT00800202|1888918|FG000|Overall Study|Other|5
911753|NCT00800202|1888919|FG001|Overall Study|Other|0
911754|NCT00800202|1888918|FG000|Overall Study|Disease Progression|54
911755|NCT00800202|1888919|FG001|Overall Study|Disease Progression|18
911756|NCT00800384|1888940|FG000|Overall Study|Withdrawal by Subject|24
911757|NCT00800384|1888941|FG001|Overall Study|Withdrawal by Subject|17
967685|NCT01185353|1969026|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
967686|NCT01185353|1969027|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
967687|NCT01185353|1969028|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
967688|NCT01185353|1969029|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
967689|NCT01185353|1969030|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
967690|NCT01185353|1969021|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0
967691|NCT01185353|1969022|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0
967692|NCT01185353|1969023|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0
967693|NCT01185353|1969024|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0
967694|NCT01185353|1969025|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0
967695|NCT01185353|1969026|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0
967696|NCT01185353|1969027|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0
967697|NCT01185353|1969028|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8
967698|NCT01185353|1969029|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2
967699|NCT01185353|1969030|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2
911758|NCT00800384|1888940|FG000|Overall Study|Lost to Follow-up|17
911759|NCT00800384|1888941|FG001|Overall Study|Lost to Follow-up|26
911760|NCT00800436|1888955|FG000|Overall Study|Withdrawal by Subject|0
911761|NCT00800436|1888956|FG001|Overall Study|Withdrawal by Subject|0
911762|NCT00800436|1888957|FG002|Overall Study|Withdrawal by Subject|1
911763|NCT00800436|1888958|FG003|Overall Study|Withdrawal by Subject|1
911764|NCT00800436|1888959|FG004|Overall Study|Withdrawal by Subject|0
911765|NCT00800436|1888960|FG005|Overall Study|Withdrawal by Subject|0
911766|NCT00800436|1888961|FG006|Overall Study|Withdrawal by Subject|0
911767|NCT00800540|1888977|FG000|Period One: 6 Weeks|Noncompliance|1
911768|NCT00800540|1888978|FG001|Period One: 6 Weeks|Noncompliance|0
911769|NCT00800540|1888977|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
911770|NCT00800540|1888978|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
911771|NCT00800540|1888977|FG000|Period 2: 6 Weeks|Adverse Event|0
911772|NCT00800540|1888978|FG001|Period 2: 6 Weeks|Adverse Event|1
911773|NCT00800683|1888986|FG000|Overall Study|Adverse Event|11
911774|NCT00800683|1888987|FG001|Overall Study|Adverse Event|8
911775|NCT00800683|1888986|FG000|Overall Study|Lost to Follow-up|3
911776|NCT00800683|1888987|FG001|Overall Study|Lost to Follow-up|1
911777|NCT00800683|1888986|FG000|Overall Study|Withdrawal by Subject|1
911778|NCT00800683|1888987|FG001|Overall Study|Withdrawal by Subject|7
911779|NCT00800683|1888986|FG000|Overall Study|Lack of Efficacy|1
911780|NCT00800683|1888987|FG001|Overall Study|Lack of Efficacy|1
911781|NCT00800683|1888986|FG000|Overall Study|Other|1
911782|NCT00800683|1888987|FG001|Overall Study|Other|2
911783|NCT00800735|1888993|FG000|Overall Study|Administrative/Other|2
911784|NCT00800735|1888993|FG000|Overall Study|Insufficient Therapeutic Response|2
911785|NCT00800735|1888993|FG000|Overall Study|Violation of Selection Criteria at Entry|7
911786|NCT00800735|1888993|FG000|Overall Study|Withdrew Consent|3
911787|NCT00800982|1889012|FG000|Overall Study|Lost to Follow-up|1
911788|NCT00800982|1889013|FG001|Overall Study|Lost to Follow-up|2
911789|NCT00800982|1889012|FG000|Overall Study|Withdrawal by Subject|0
911790|NCT00800982|1889013|FG001|Overall Study|Withdrawal by Subject|1
911791|NCT00800982|1889012|FG000|Overall Study|Patient moved out of state|1
911792|NCT00800982|1889013|FG001|Overall Study|Patient moved out of state|0
911793|NCT00801099|1889019|FG000|Overall Study|Lost to Follow-up|101
911794|NCT00801229|1889042|FG000|Signed Consent|Withdrawal by Subject|2
911795|NCT00801229|1889043|FG001|Signed Consent|Withdrawal by Subject|2
911796|NCT00801229|1889042|FG000|Signed Consent|Found Ineligible|1
911797|NCT00801229|1889043|FG001|Signed Consent|Found Ineligible|1
911798|NCT00801229|1889042|FG000|Received Study Drug/Placebo|Elevated SGOT level|1
911799|NCT00801229|1889043|FG001|Received Study Drug/Placebo|Elevated SGOT level|0
911800|NCT00801229|1889042|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0
911801|NCT00801229|1889043|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1
911802|NCT00801229|1889042|FG000|Received Study Drug/Placebo|Simulator sickness|1
911803|NCT00801229|1889043|FG001|Received Study Drug/Placebo|Simulator sickness|1
911804|NCT00801229|1889042|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1
911805|NCT00801229|1889043|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0
911806|NCT00801229|1889042|FG000|Received Study Drug/Placebo|Lost to Follow-up|0
911807|NCT00801229|1889043|FG001|Received Study Drug/Placebo|Lost to Follow-up|1
911808|NCT00801229|1889042|FG000|Received Study Drug/Placebo|Adverse Event|1
911809|NCT00801229|1889043|FG001|Received Study Drug/Placebo|Adverse Event|1
911810|NCT00801242|1889049|FG000|Overall Study|Adverse Event|10
911811|NCT00801242|1889049|FG000|Overall Study|Withdrawal by Subject|13
911812|NCT00801242|1889049|FG000|Overall Study|Protocol Violation|5
911813|NCT00801242|1889049|FG000|Overall Study|Physician Decision|3
911814|NCT00801242|1889049|FG000|Overall Study|Lost to Follow-up|1
911815|NCT00801242|1889049|FG000|Overall Study|Miscellaneous reasons|20
911816|NCT00801632|1889092|FG000|Overall Study|Re-transplant|1
911817|NCT00801892|1889133|FG000|Main Study Period|Withdrawal by Subject|0
911818|NCT00801892|1889134|FG001|Main Study Period|Withdrawal by Subject|1
911819|NCT00801892|1889133|FG000|Sham Crossover Period|Lost to Follow-up|0
911820|NCT00801892|1889134|FG001|Sham Crossover Period|Lost to Follow-up|2
911821|NCT00801983|1889144|FG000|Period 1|Lost to Follow-up|2
911822|NCT00801983|1889145|FG001|Period 1|Lost to Follow-up|0
967700|NCT01185353|1969021|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
967701|NCT01185353|1969022|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
967702|NCT01185353|1969023|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
967703|NCT01185353|1969024|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
967704|NCT01185353|1969025|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
967705|NCT01185353|1969026|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
967706|NCT01185353|1969027|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
967707|NCT01185353|1969028|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
967708|NCT01185353|1969029|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
967709|NCT01185353|1969030|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
967710|NCT01185353|1969021|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
967711|NCT01185353|1969022|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
967712|NCT01185353|1969023|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
967713|NCT01185353|1969024|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
967714|NCT01185353|1969025|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
967715|NCT01185353|1969026|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
967716|NCT01185353|1969027|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
967717|NCT01185353|1969028|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
967718|NCT01185353|1969029|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
967719|NCT01185353|1969030|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
967720|NCT01185353|1969021|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
967721|NCT01185353|1969022|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
967722|NCT01185353|1969023|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
911823|NCT00801983|1889144|FG000|Period 1|Withdrawal by Subject|2
911824|NCT00801983|1889145|FG001|Period 1|Withdrawal by Subject|8
911825|NCT00801983|1889144|FG000|Period 2|Withdrawal by Subject|2
911826|NCT00801983|1889145|FG001|Period 2|Withdrawal by Subject|1
911827|NCT00802074|1889157|FG000|Overall Study|Adverse Event|1
911828|NCT00802074|1889158|FG001|Overall Study|Adverse Event|1
911829|NCT00802074|1889159|FG002|Overall Study|Adverse Event|1
911830|NCT00802074|1889160|FG003|Overall Study|Adverse Event|0
911831|NCT00802074|1889161|FG004|Overall Study|Adverse Event|0
911832|NCT00802074|1889162|FG005|Overall Study|Adverse Event|0
911833|NCT00802074|1889157|FG000|Overall Study|Withdrawal by Subject|1
911834|NCT00802074|1889158|FG001|Overall Study|Withdrawal by Subject|0
911835|NCT00802074|1889159|FG002|Overall Study|Withdrawal by Subject|0
911836|NCT00802074|1889160|FG003|Overall Study|Withdrawal by Subject|0
911837|NCT00802074|1889161|FG004|Overall Study|Withdrawal by Subject|0
911838|NCT00802074|1889162|FG005|Overall Study|Withdrawal by Subject|0
911839|NCT00802178|1889202|FG000|Overall Study|Lack of Efficacy|36
911840|NCT00802178|1889202|FG000|Overall Study|Insufficient tolerability (IT)|17
911841|NCT00802178|1889202|FG000|Overall Study|Withdrawal by Subject|18
911842|NCT00802178|1889202|FG000|Overall Study|Other|32
911843|NCT00802178|1889202|FG000|Overall Study|Lack of efficacy and patient wish|1
911844|NCT00802178|1889202|FG000|Overall Study|IT and patient wish|8
911845|NCT00802178|1889202|FG000|Overall Study|Patients wish and other reason|1
911846|NCT00802360|1889222|FG000|Overall Study|Stimulation failure|4
911847|NCT00802360|1889223|FG001|Overall Study|Stimulation failure|0
911848|NCT00802360|1889224|FG002|Overall Study|Stimulation failure|3
911849|NCT00802360|1889225|FG003|Overall Study|Stimulation failure|3
911850|NCT00802360|1889222|FG000|Overall Study|Inadequate number of oocytes retrieved|0
911851|NCT00802360|1889223|FG001|Overall Study|Inadequate number of oocytes retrieved|0
911852|NCT00802360|1889224|FG002|Overall Study|Inadequate number of oocytes retrieved|0
911853|NCT00802360|1889225|FG003|Overall Study|Inadequate number of oocytes retrieved|1
911854|NCT00802360|1889222|FG000|Overall Study|Cycle cancelled|0
911855|NCT00802360|1889223|FG001|Overall Study|Cycle cancelled|1
911856|NCT00802360|1889224|FG002|Overall Study|Cycle cancelled|1
911857|NCT00802360|1889225|FG003|Overall Study|Cycle cancelled|1
911858|NCT00802360|1889222|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0
911859|NCT00802360|1889223|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0
911860|NCT00802360|1889224|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0
911861|NCT00802360|1889225|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1
911862|NCT00802360|1889222|FG000|Overall Study|No positive serum pregnancy|17
911863|NCT00802360|1889223|FG001|Overall Study|No positive serum pregnancy|20
911864|NCT00802360|1889224|FG002|Overall Study|No positive serum pregnancy|14
911865|NCT00802360|1889225|FG003|Overall Study|No positive serum pregnancy|10
911866|NCT00802360|1889222|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1
911867|NCT00802360|1889223|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
911868|NCT00802360|1889224|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1
911869|NCT00802360|1889225|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0
911870|NCT00802360|1889222|FG000|Overall Study|Pregnancy loss/miscarriage|0
911871|NCT00802360|1889223|FG001|Overall Study|Pregnancy loss/miscarriage|2
911872|NCT00802360|1889224|FG002|Overall Study|Pregnancy loss/miscarriage|0
911873|NCT00802360|1889225|FG003|Overall Study|Pregnancy loss/miscarriage|3
911874|NCT00802360|1889222|FG000|Overall Study|Other|2
911875|NCT00802360|1889223|FG001|Overall Study|Other|3
911876|NCT00802360|1889224|FG002|Overall Study|Other|6
911877|NCT00802360|1889225|FG003|Overall Study|Other|3
911878|NCT00802438|1889246|FG000|Overall Study|Screen Failure|20
967723|NCT01185353|1969024|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
967724|NCT01185353|1969025|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
967725|NCT01185353|1969026|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
967726|NCT01185353|1969027|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
967727|NCT01185353|1969028|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
967728|NCT01185353|1969029|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
967729|NCT01185353|1969030|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
967730|NCT01185353|1969021|FG000|Part C (Weeks 24 Through 76)|Death|0
967731|NCT01185353|1969022|FG001|Part C (Weeks 24 Through 76)|Death|0
967732|NCT01185353|1969023|FG002|Part C (Weeks 24 Through 76)|Death|0
967733|NCT01185353|1969024|FG003|Part C (Weeks 24 Through 76)|Death|0
967734|NCT01185353|1969025|FG004|Part C (Weeks 24 Through 76)|Death|0
967735|NCT01185353|1969026|FG005|Part C (Weeks 24 Through 76)|Death|0
967736|NCT01185353|1969027|FG006|Part C (Weeks 24 Through 76)|Death|0
967737|NCT01185353|1969028|FG007|Part C (Weeks 24 Through 76)|Death|0
967738|NCT01185353|1969029|FG008|Part C (Weeks 24 Through 76)|Death|0
967739|NCT01185353|1969030|FG009|Part C (Weeks 24 Through 76)|Death|1
967740|NCT01185353|1969021|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
967741|NCT01185353|1969022|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
967742|NCT01185353|1969023|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
967743|NCT01185353|1969024|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
967744|NCT01185353|1969025|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
967745|NCT01185353|1969026|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
967746|NCT01185353|1969027|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
967747|NCT01185353|1969028|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
967748|NCT01185353|1969029|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
967749|NCT01185353|1969030|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
967750|NCT01185353|1969021|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0
967751|NCT01185353|1969022|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0
967752|NCT01185353|1969023|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0
967753|NCT01185353|1969024|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0
967754|NCT01185353|1969025|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0
967755|NCT01185353|1969026|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0
967756|NCT01185353|1969027|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0
967757|NCT01185353|1969028|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0
967758|NCT01185353|1969029|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0
967759|NCT01185353|1969030|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1
967760|NCT01185353|1969021|FG000|Part C (Weeks 24 Through 76)|Reason missing|0
911879|NCT00802438|1889246|FG000|Overall Study|Withdrawal by Subject|7
911880|NCT00802438|1889246|FG000|Overall Study|Physician Decision|1
911881|NCT00802464|1889254|FG000|Month 0 - Month 8|Adverse Event|0
911882|NCT00802464|1889255|FG001|Month 0 - Month 8|Adverse Event|1
911883|NCT00802464|1889256|FG002|Month 0 - Month 8|Adverse Event|1
911884|NCT00802464|1889257|FG003|Month 0 - Month 8|Adverse Event|2
911885|NCT00802464|1889254|FG000|Month 0 - Month 8|Protocol Violation|0
911886|NCT00802464|1889255|FG001|Month 0 - Month 8|Protocol Violation|0
911887|NCT00802464|1889256|FG002|Month 0 - Month 8|Protocol Violation|1
911888|NCT00802464|1889257|FG003|Month 0 - Month 8|Protocol Violation|0
911889|NCT00802464|1889254|FG000|Month 0 - Month 8|Withdrawal by Subject|0
911890|NCT00802464|1889255|FG001|Month 0 - Month 8|Withdrawal by Subject|1
911891|NCT00802464|1889256|FG002|Month 0 - Month 8|Withdrawal by Subject|2
911892|NCT00802464|1889257|FG003|Month 0 - Month 8|Withdrawal by Subject|5
911893|NCT00802464|1889254|FG000|Month 0 - Month 8|Lost to Follow-up|0
911894|NCT00802464|1889255|FG001|Month 0 - Month 8|Lost to Follow-up|1
911895|NCT00802464|1889256|FG002|Month 0 - Month 8|Lost to Follow-up|2
911896|NCT00802464|1889257|FG003|Month 0 - Month 8|Lost to Follow-up|2
911897|NCT00802464|1889254|FG000|Month 0 - Month 8|Other|0
911898|NCT00802464|1889255|FG001|Month 0 - Month 8|Other|0
911899|NCT00802464|1889256|FG002|Month 0 - Month 8|Other|1
911900|NCT00802464|1889257|FG003|Month 0 - Month 8|Other|0
911901|NCT00802464|1889254|FG000|Month 8 - Month 14|Adverse Event|0
911902|NCT00802464|1889255|FG001|Month 8 - Month 14|Adverse Event|1
911903|NCT00802464|1889256|FG002|Month 8 - Month 14|Adverse Event|0
911904|NCT00802464|1889257|FG003|Month 8 - Month 14|Adverse Event|0
911905|NCT00802464|1889254|FG000|Month 8 - Month 14|Withdrawal by Subject|1
911906|NCT00802464|1889255|FG001|Month 8 - Month 14|Withdrawal by Subject|1
911907|NCT00802464|1889256|FG002|Month 8 - Month 14|Withdrawal by Subject|0
911908|NCT00802464|1889257|FG003|Month 8 - Month 14|Withdrawal by Subject|0
911909|NCT00802464|1889254|FG000|Month 8 - Month 14|Lost to Follow-up|0
911910|NCT00802464|1889255|FG001|Month 8 - Month 14|Lost to Follow-up|0
911911|NCT00802464|1889256|FG002|Month 8 - Month 14|Lost to Follow-up|1
911912|NCT00802464|1889257|FG003|Month 8 - Month 14|Lost to Follow-up|0
911913|NCT00802529|1889284|FG000|Overall Study|Lost to Follow-up|0
911914|NCT00802529|1889285|FG001|Overall Study|Lost to Follow-up|1
911915|NCT00802672|1889303|FG000|Overall Study|Lack of fungal pathogen at baseline|56
911916|NCT00802672|1889304|FG001|Overall Study|Lack of fungal pathogen at baseline|43
911917|NCT00802672|1889305|FG002|Overall Study|Lack of fungal pathogen at baseline|25
911918|NCT00802672|1889303|FG000|Overall Study|Adverse Event|1
911919|NCT00802672|1889304|FG001|Overall Study|Adverse Event|1
967761|NCT01185353|1969022|FG001|Part C (Weeks 24 Through 76)|Reason missing|0
967762|NCT01185353|1969023|FG002|Part C (Weeks 24 Through 76)|Reason missing|0
967763|NCT01185353|1969024|FG003|Part C (Weeks 24 Through 76)|Reason missing|0
967764|NCT01185353|1969025|FG004|Part C (Weeks 24 Through 76)|Reason missing|0
967765|NCT01185353|1969026|FG005|Part C (Weeks 24 Through 76)|Reason missing|0
967766|NCT01185353|1969027|FG006|Part C (Weeks 24 Through 76)|Reason missing|0
967767|NCT01185353|1969028|FG007|Part C (Weeks 24 Through 76)|Reason missing|0
967768|NCT01185353|1969029|FG008|Part C (Weeks 24 Through 76)|Reason missing|1
967769|NCT01185353|1969030|FG009|Part C (Weeks 24 Through 76)|Reason missing|0
967770|NCT01185353|1969021|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
967771|NCT01185353|1969022|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
967772|NCT01185353|1969023|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
967773|NCT01185353|1969024|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1006624|NCT01468701|2025299|FG014|Overall Study|Not being followed up|0
911920|NCT00802672|1889305|FG002|Overall Study|Adverse Event|1
911921|NCT00802672|1889303|FG000|Overall Study|Protocol Violation|2
911922|NCT00802672|1889304|FG001|Overall Study|Protocol Violation|1
911923|NCT00802672|1889305|FG002|Overall Study|Protocol Violation|1
911924|NCT00802672|1889303|FG000|Overall Study|Lost to Follow-up|5
911925|NCT00802672|1889304|FG001|Overall Study|Lost to Follow-up|5
911926|NCT00802672|1889305|FG002|Overall Study|Lost to Follow-up|3
911927|NCT00802672|1889303|FG000|Overall Study|Withdrawal by Subject|1
911928|NCT00802672|1889304|FG001|Overall Study|Withdrawal by Subject|1
911929|NCT00802672|1889305|FG002|Overall Study|Withdrawal by Subject|2
911930|NCT00802672|1889303|FG000|Overall Study|other|3
911931|NCT00802672|1889304|FG001|Overall Study|other|1
911932|NCT00802672|1889305|FG002|Overall Study|other|2
911933|NCT00802737|1889325|FG000|Overall Study|Withdrawn due to Disease Progression|9
911934|NCT00802737|1889326|FG001|Overall Study|Withdrawn due to Disease Progression|3
911935|NCT00802737|1889327|FG002|Overall Study|Withdrawn due to Disease Progression|0
911936|NCT00802737|1889325|FG000|Overall Study|Death|6
911937|NCT00802737|1889326|FG001|Overall Study|Death|5
911938|NCT00802737|1889327|FG002|Overall Study|Death|1
911939|NCT00802737|1889325|FG000|Overall Study|Adverse Event|1
911940|NCT00802737|1889326|FG001|Overall Study|Adverse Event|0
911941|NCT00802737|1889327|FG002|Overall Study|Adverse Event|0
911942|NCT00802737|1889325|FG000|Overall Study|Received Prohibited Therapy|1
911943|NCT00802737|1889326|FG001|Overall Study|Received Prohibited Therapy|0
911944|NCT00802737|1889327|FG002|Overall Study|Received Prohibited Therapy|0
911945|NCT00802737|1889325|FG000|Overall Study|Ongoing CLL-Treatment|0
911946|NCT00802737|1889326|FG001|Overall Study|Ongoing CLL-Treatment|1
911947|NCT00802737|1889327|FG002|Overall Study|Ongoing CLL-Treatment|0
911948|NCT00802737|1889325|FG000|Overall Study|Participant too Unwell|0
911949|NCT00802737|1889326|FG001|Overall Study|Participant too Unwell|2
911950|NCT00802737|1889327|FG002|Overall Study|Participant too Unwell|0
911951|NCT00802841|1889338|FG000|Overall Study|Administrative problems|1
911952|NCT00802841|1889339|FG001|Overall Study|Administrative problems|0
911953|NCT00802841|1889338|FG000|Overall Study|Lost to Follow-up|2
911954|NCT00802841|1889339|FG001|Overall Study|Lost to Follow-up|1
911955|NCT00802841|1889338|FG000|Overall Study|Death|1
911956|NCT00802841|1889339|FG001|Overall Study|Death|2
911957|NCT00802841|1889338|FG000|Overall Study|Adverse Event|8
911958|NCT00802841|1889339|FG001|Overall Study|Adverse Event|2
911959|NCT00802841|1889338|FG000|Overall Study|Disease progression|7
911960|NCT00802841|1889339|FG001|Overall Study|Disease progression|3
911961|NCT00802841|1889338|FG000|Overall Study|Withdrawal by Subject|9
911962|NCT00802841|1889339|FG001|Overall Study|Withdrawal by Subject|5
911963|NCT00802841|1889338|FG000|Overall Study|Protocol deviation|2
911964|NCT00802841|1889339|FG001|Overall Study|Protocol deviation|6
911965|NCT00802841|1889338|FG000|Overall Study|Treatment duration completed|66
911966|NCT00802841|1889339|FG001|Overall Study|Treatment duration completed|76
911967|NCT00802867|1889351|FG000|Overall Study|Lost to Follow-up|6
911968|NCT00802867|1889351|FG000|Overall Study|Protocol Violation|6
911969|NCT00802867|1889351|FG000|Overall Study|Withdrawal by Subject|1
911970|NCT00802945|1889375|FG000|Overall Study|Death|27
911971|NCT00802945|1889376|FG001|Overall Study|Death|23
911972|NCT00802945|1889375|FG000|Overall Study|Terminated by sponsor|8
911973|NCT00802945|1889376|FG001|Overall Study|Terminated by sponsor|12
911974|NCT00803023|1889406|FG000|Overall Study|Adverse Event|5
911975|NCT00803023|1889407|FG001|Overall Study|Adverse Event|4
911976|NCT00803023|1889408|FG002|Overall Study|Adverse Event|8
911977|NCT00803023|1889409|FG003|Overall Study|Adverse Event|6
911978|NCT00803023|1889406|FG000|Overall Study|Withdrawal by Subject|0
911979|NCT00803023|1889407|FG001|Overall Study|Withdrawal by Subject|2
911980|NCT00803023|1889408|FG002|Overall Study|Withdrawal by Subject|0
911981|NCT00803023|1889409|FG003|Overall Study|Withdrawal by Subject|0
911982|NCT00803023|1889406|FG000|Overall Study|Lost to Follow-up|0
911983|NCT00803023|1889407|FG001|Overall Study|Lost to Follow-up|1
911984|NCT00803023|1889408|FG002|Overall Study|Lost to Follow-up|2
911985|NCT00803023|1889409|FG003|Overall Study|Lost to Follow-up|1
911986|NCT00803023|1889406|FG000|Overall Study|Lack of Efficacy|0
911987|NCT00803023|1889407|FG001|Overall Study|Lack of Efficacy|1
911988|NCT00803023|1889408|FG002|Overall Study|Lack of Efficacy|1
911989|NCT00803023|1889409|FG003|Overall Study|Lack of Efficacy|1
967774|NCT01185353|1969025|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
967775|NCT01185353|1969026|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
967776|NCT01185353|1969027|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
967777|NCT01185353|1969028|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
967778|NCT01185353|1969029|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
967779|NCT01185353|1969030|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
911990|NCT00803049|1889423|FG000|Overall Study|Adverse Event|21
911991|NCT00803049|1889424|FG001|Overall Study|Adverse Event|33
911992|NCT00803049|1889425|FG002|Overall Study|Adverse Event|13
911993|NCT00803049|1889426|FG003|Overall Study|Adverse Event|27
911994|NCT00803049|1889423|FG000|Overall Study|Lack of Efficacy|10
911995|NCT00803049|1889424|FG001|Overall Study|Lack of Efficacy|19
911996|NCT00803049|1889425|FG002|Overall Study|Lack of Efficacy|6
911997|NCT00803049|1889426|FG003|Overall Study|Lack of Efficacy|13
911998|NCT00803049|1889423|FG000|Overall Study|Lost to Follow-up|0
911999|NCT00803049|1889424|FG001|Overall Study|Lost to Follow-up|2
912000|NCT00803049|1889425|FG002|Overall Study|Lost to Follow-up|0
912001|NCT00803049|1889426|FG003|Overall Study|Lost to Follow-up|3
912002|NCT00803049|1889423|FG000|Overall Study|Death|2
912003|NCT00803049|1889424|FG001|Overall Study|Death|1
912004|NCT00803049|1889425|FG002|Overall Study|Death|0
912005|NCT00803049|1889426|FG003|Overall Study|Death|2
912006|NCT00803049|1889423|FG000|Overall Study|Progressive Disease|6
912007|NCT00803049|1889424|FG001|Overall Study|Progressive Disease|10
912008|NCT00803049|1889425|FG002|Overall Study|Progressive Disease|6
912009|NCT00803049|1889426|FG003|Overall Study|Progressive Disease|6
912010|NCT00803049|1889423|FG000|Overall Study|Withdrawal by Subject|19
912011|NCT00803049|1889424|FG001|Overall Study|Withdrawal by Subject|43
912012|NCT00803049|1889425|FG002|Overall Study|Withdrawal by Subject|16
912013|NCT00803049|1889426|FG003|Overall Study|Withdrawal by Subject|44
912014|NCT00803049|1889423|FG000|Overall Study|Protocol Violation|0
912015|NCT00803049|1889424|FG001|Overall Study|Protocol Violation|1
912016|NCT00803049|1889425|FG002|Overall Study|Protocol Violation|1
912017|NCT00803049|1889426|FG003|Overall Study|Protocol Violation|0
912018|NCT00803049|1889423|FG000|Overall Study|Randomized and Not Treated|0
912019|NCT00803049|1889424|FG001|Overall Study|Randomized and Not Treated|0
912020|NCT00803049|1889425|FG002|Overall Study|Randomized and Not Treated|0
912021|NCT00803049|1889426|FG003|Overall Study|Randomized and Not Treated|2
912022|NCT00803049|1889423|FG000|Overall Study|Other than Specified Above|3
912023|NCT00803049|1889424|FG001|Overall Study|Other than Specified Above|9
912024|NCT00803049|1889425|FG002|Overall Study|Other than Specified Above|2
912025|NCT00803049|1889426|FG003|Overall Study|Other than Specified Above|5
912026|NCT00803101|1889455|FG000|Overall Study|Death / Serious Adverse Event|4
912027|NCT00803101|1889456|FG001|Overall Study|Death / Serious Adverse Event|6
912028|NCT00803101|1889455|FG000|Overall Study|Withdrawal by Subject|6
912029|NCT00803101|1889456|FG001|Overall Study|Withdrawal by Subject|4
912030|NCT00803101|1889455|FG000|Overall Study|Lost to Follow-up|2
912031|NCT00803101|1889456|FG001|Overall Study|Lost to Follow-up|2
912032|NCT00803101|1889455|FG000|Overall Study|Protocol Violation|1
912033|NCT00803101|1889456|FG001|Overall Study|Protocol Violation|7
912034|NCT00803101|1889455|FG000|Overall Study|Surgery finished outside protocol window|1
912035|NCT00803101|1889456|FG001|Overall Study|Surgery finished outside protocol window|1
912036|NCT00803101|1889455|FG000|Overall Study|Patient died outside SAE report period|1
912037|NCT00803101|1889456|FG001|Overall Study|Patient died outside SAE report period|0
912038|NCT00803101|1889455|FG000|Overall Study|Patient did not attend scheduled visit|2
912039|NCT00803101|1889456|FG001|Overall Study|Patient did not attend scheduled visit|1
912040|NCT00803101|1889455|FG000|Overall Study|Patient did not have surgery|1
912041|NCT00803101|1889456|FG001|Overall Study|Patient did not have surgery|1
912042|NCT00803205|1889471|FG000|Overall Study|Adverse Event|7
912043|NCT00803205|1889472|FG001|Overall Study|Adverse Event|2
912044|NCT00803205|1889471|FG000|Overall Study|Lost to Follow-up|1
912045|NCT00803205|1889472|FG001|Overall Study|Lost to Follow-up|0
912046|NCT00803205|1889471|FG000|Overall Study|Withdrawal by Subject|9
912047|NCT00803205|1889472|FG001|Overall Study|Withdrawal by Subject|9
912048|NCT00803205|1889471|FG000|Overall Study|Physician Decision|1
912049|NCT00803205|1889472|FG001|Overall Study|Physician Decision|0
912050|NCT00803205|1889471|FG000|Overall Study|Protocol Violation|1
912051|NCT00803205|1889472|FG001|Overall Study|Protocol Violation|1
912052|NCT00803205|1889471|FG000|Overall Study|Medical Monitor Decision|1
912053|NCT00803205|1889472|FG001|Overall Study|Medical Monitor Decision|0
912054|NCT00803205|1889471|FG000|Overall Study|Acquired a Lung Infection|0
912055|NCT00803205|1889472|FG001|Overall Study|Acquired a Lung Infection|1
912056|NCT00803205|1889471|FG000|Overall Study|Sponsor Decision|0
912057|NCT00803205|1889472|FG001|Overall Study|Sponsor Decision|1
912058|NCT00803244|1889480|FG000|Overall Study|Adverse Event|1
912059|NCT00803244|1889481|FG001|Overall Study|Adverse Event|2
912060|NCT00803244|1889480|FG000|Overall Study|Withdrawal by Subject|2
912061|NCT00803244|1889481|FG001|Overall Study|Withdrawal by Subject|3
912062|NCT00803244|1889480|FG000|Overall Study|Any other reason not above-mentioned|4
912063|NCT00803244|1889481|FG001|Overall Study|Any other reason not above-mentioned|10
912064|NCT00803270|1889489|FG000|Overall Study|Lost to Follow-up|1
912065|NCT00803270|1889490|FG001|Overall Study|Lost to Follow-up|2
912066|NCT00803361|1889498|FG000|Overall Study|Adverse Event|13
967780|NCT01185353|1969021|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
967781|NCT01185353|1969022|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
967782|NCT01185353|1969023|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
967783|NCT01185353|1969024|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
967784|NCT01185353|1969025|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
967785|NCT01185353|1969026|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
967786|NCT01185353|1969027|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
967787|NCT01185353|1969028|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
967788|NCT01185353|1969029|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
967789|NCT01185353|1969030|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
967790|NCT01185353|1969021|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0
967791|NCT01185353|1969022|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0
912067|NCT00803361|1889499|FG001|Overall Study|Adverse Event|3
912068|NCT00803361|1889498|FG000|Overall Study|Lack of Efficacy|4
912069|NCT00803361|1889499|FG001|Overall Study|Lack of Efficacy|13
912070|NCT00803361|1889498|FG000|Overall Study|Lost to Follow-up|1
912071|NCT00803361|1889499|FG001|Overall Study|Lost to Follow-up|2
912072|NCT00803361|1889498|FG000|Overall Study|Physician Decision|1
912073|NCT00803361|1889499|FG001|Overall Study|Physician Decision|0
912074|NCT00803361|1889498|FG000|Overall Study|Protocol Violation|2
912075|NCT00803361|1889499|FG001|Overall Study|Protocol Violation|4
912076|NCT00803361|1889498|FG000|Overall Study|Withdrawal by Subject|5
912077|NCT00803361|1889499|FG001|Overall Study|Withdrawal by Subject|6
912078|NCT00803452|1889530|FG000|Overall Study|Adverse Event|0
912079|NCT00803452|1889531|FG001|Overall Study|Adverse Event|2
912080|NCT00803452|1889530|FG000|Overall Study|Lost to Follow-up|0
912081|NCT00803452|1889531|FG001|Overall Study|Lost to Follow-up|3
912082|NCT00803569|1889553|FG000|Overall Study|Progressive Disease|3
912083|NCT00803569|1889553|FG000|Overall Study|Noncompliance|1
912084|NCT00803595|1889560|FG000|Overall Study|Adverse Event|3
912085|NCT00803595|1889561|FG001|Overall Study|Adverse Event|4
912086|NCT00803595|1889562|FG002|Overall Study|Adverse Event|1
912087|NCT00803595|1889560|FG000|Overall Study|Protocol Violation|7
912088|NCT00803595|1889561|FG001|Overall Study|Protocol Violation|2
912089|NCT00803595|1889562|FG002|Overall Study|Protocol Violation|12
912090|NCT00803595|1889560|FG000|Overall Study|Withdrawal by Subject|5
912091|NCT00803595|1889561|FG001|Overall Study|Withdrawal by Subject|2
912092|NCT00803595|1889562|FG002|Overall Study|Withdrawal by Subject|3
912093|NCT00803634|1889572|FG000|Overall Study|Withdrew Consent|1
912094|NCT00803634|1889573|FG001|Overall Study|Withdrew Consent|0
912095|NCT00803634|1889572|FG000|Overall Study|Lost to Follow-up|2
912096|NCT00803634|1889573|FG001|Overall Study|Lost to Follow-up|3
912097|NCT00803634|1889572|FG000|Overall Study|Death|3
912098|NCT00803634|1889573|FG001|Overall Study|Death|2
912099|NCT00803712|1889605|FG000|Overall Study|Noncompliance|3
912100|NCT00803712|1889606|FG001|Overall Study|Noncompliance|0
912101|NCT00803712|1889605|FG000|Overall Study|Adverse Event|5
912102|NCT00803712|1889606|FG001|Overall Study|Adverse Event|0
912103|NCT00803712|1889605|FG000|Overall Study|Death|8
912104|NCT00803712|1889606|FG001|Overall Study|Death|7
912105|NCT00803712|1889605|FG000|Overall Study|Lost to Follow-up|3
912106|NCT00803712|1889606|FG001|Overall Study|Lost to Follow-up|1
912107|NCT00803712|1889605|FG000|Overall Study|Withdrawal by Subject|2
912108|NCT00803712|1889606|FG001|Overall Study|Withdrawal by Subject|4
912109|NCT00803712|1889605|FG000|Overall Study|"Other in electronic Case Report Form"|0
912110|NCT00803712|1889606|FG001|Overall Study|"Other in electronic Case Report Form"|1
912111|NCT00803712|1889605|FG000|Overall Study|Protocol criteria (other)|0
912112|NCT00803712|1889606|FG001|Overall Study|Protocol criteria (other)|2
912113|NCT00803712|1889605|FG000|Overall Study|Protocol criteria (renal transplant)|12
912114|NCT00803712|1889606|FG001|Overall Study|Protocol criteria (renal transplant)|8
912115|NCT00803712|1889605|FG000|Overall Study|Administrative decision|2
912116|NCT00803712|1889606|FG001|Overall Study|Administrative decision|3
912117|NCT00803712|1889605|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1
912118|NCT00803712|1889606|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1
912119|NCT00803738|1889614|FG000|Overall Study|Adverse Event|3
912120|NCT00803738|1889615|FG001|Overall Study|Adverse Event|5
912121|NCT00803738|1889614|FG000|Overall Study|Lost to Follow-up|4
912122|NCT00803738|1889615|FG001|Overall Study|Lost to Follow-up|4
912123|NCT00803738|1889614|FG000|Overall Study|Protocol Violation|18
912124|NCT00803738|1889615|FG001|Overall Study|Protocol Violation|10
912125|NCT00803738|1889614|FG000|Overall Study|Withdrawal by Subject|1
912126|NCT00803738|1889615|FG001|Overall Study|Withdrawal by Subject|4
912127|NCT00803738|1889614|FG000|Overall Study|Lack of Efficacy|10
912128|NCT00803738|1889615|FG001|Overall Study|Lack of Efficacy|16
912129|NCT00803738|1889614|FG000|Overall Study|Negative Baseline Culture of Candida|56
912130|NCT00803738|1889615|FG001|Overall Study|Negative Baseline Culture of Candida|63
912131|NCT00803738|1889614|FG000|Overall Study|Positive Results for STD or abnormal PAP|2
912132|NCT00803738|1889615|FG001|Overall Study|Positive Results for STD or abnormal PAP|8
912133|NCT00803790|1889636|FG000|Period 1|Adverse Event|0
912134|NCT00803790|1889637|FG001|Period 1|Adverse Event|1
912135|NCT00803790|1889638|FG002|Period 1|Adverse Event|0
912136|NCT00803790|1889639|FG003|Period 1|Adverse Event|0
967792|NCT01185353|1969023|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0
967793|NCT01185353|1969024|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0
967794|NCT01185353|1969025|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0
967795|NCT01185353|1969026|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0
912137|NCT00803790|1889636|FG000|Period 1|Lost to Follow-up|1
912138|NCT00803790|1889637|FG001|Period 1|Lost to Follow-up|2
912139|NCT00803790|1889638|FG002|Period 1|Lost to Follow-up|0
912140|NCT00803790|1889639|FG003|Period 1|Lost to Follow-up|0
912141|NCT00803790|1889636|FG000|Period 1|Withdrawal by Subject|8
912142|NCT00803790|1889637|FG001|Period 1|Withdrawal by Subject|6
912143|NCT00803790|1889638|FG002|Period 1|Withdrawal by Subject|0
912144|NCT00803790|1889639|FG003|Period 1|Withdrawal by Subject|0
912145|NCT00803790|1889636|FG000|Period 1|positive drug screen or personal reasons|0
912146|NCT00803790|1889637|FG001|Period 1|positive drug screen or personal reasons|3
912147|NCT00803790|1889638|FG002|Period 1|positive drug screen or personal reasons|0
912148|NCT00803790|1889639|FG003|Period 1|positive drug screen or personal reasons|4
912149|NCT00803790|1889636|FG000|Period 1|Protocol Violation|0
912150|NCT00803790|1889637|FG001|Period 1|Protocol Violation|0
912151|NCT00803790|1889638|FG002|Period 1|Protocol Violation|1
912152|NCT00803790|1889639|FG003|Period 1|Protocol Violation|0
912153|NCT00803790|1889636|FG000|Period 2|Adverse Event|0
912154|NCT00803790|1889637|FG001|Period 2|Adverse Event|0
912155|NCT00803790|1889638|FG002|Period 2|Adverse Event|1
912156|NCT00803790|1889639|FG003|Period 2|Adverse Event|1
912157|NCT00803790|1889636|FG000|Period 2|Withdrawal by Subject|1
912158|NCT00803790|1889637|FG001|Period 2|Withdrawal by Subject|0
912159|NCT00803790|1889638|FG002|Period 2|Withdrawal by Subject|0
912160|NCT00803790|1889639|FG003|Period 2|Withdrawal by Subject|0
912161|NCT00803790|1889636|FG000|Period 2|Positive Drug Screen or Personal Reasons|1
912162|NCT00803790|1889637|FG001|Period 2|Positive Drug Screen or Personal Reasons|0
912163|NCT00803790|1889638|FG002|Period 2|Positive Drug Screen or Personal Reasons|0
912164|NCT00803790|1889639|FG003|Period 2|Positive Drug Screen or Personal Reasons|0
912165|NCT00804141|1889659|FG000|Overall Study|Adverse Event|157
912166|NCT00804141|1889659|FG000|Overall Study|Death|4
912167|NCT00804141|1889659|FG000|Overall Study|Failed to return|96
912168|NCT00804141|1889659|FG000|Overall Study|Investigator request|8
912169|NCT00804141|1889659|FG000|Overall Study|Protocol Violation|85
912170|NCT00804141|1889659|FG000|Overall Study|Withdrawal by Subject|131
912171|NCT00804141|1889659|FG000|Overall Study|Lack of Efficacy|46
912172|NCT00804141|1889659|FG000|Overall Study|Other than specified|30
912173|NCT00804141|1889659|FG000|Overall Study|Enrolled but not treated|6
912174|NCT00804193|1889666|FG000|Overall Study|Lack of baseline fungus|32
912175|NCT00804193|1889667|FG001|Overall Study|Lack of baseline fungus|31
912176|NCT00804193|1889668|FG002|Overall Study|Lack of baseline fungus|19
912177|NCT00804193|1889666|FG000|Overall Study|Adverse Event|0
912178|NCT00804193|1889667|FG001|Overall Study|Adverse Event|0
912179|NCT00804193|1889668|FG002|Overall Study|Adverse Event|2
912180|NCT00804193|1889666|FG000|Overall Study|Lack of Efficacy|1
912181|NCT00804193|1889667|FG001|Overall Study|Lack of Efficacy|1
912182|NCT00804193|1889668|FG002|Overall Study|Lack of Efficacy|3
912183|NCT00804193|1889666|FG000|Overall Study|Protocol Violation|0
912184|NCT00804193|1889667|FG001|Overall Study|Protocol Violation|8
912185|NCT00804193|1889668|FG002|Overall Study|Protocol Violation|2
912186|NCT00804193|1889666|FG000|Overall Study|Lost to Follow-up|3
912187|NCT00804193|1889667|FG001|Overall Study|Lost to Follow-up|3
912188|NCT00804193|1889668|FG002|Overall Study|Lost to Follow-up|4
912189|NCT00804193|1889666|FG000|Overall Study|Withdrawal by Subject|3
912190|NCT00804193|1889667|FG001|Overall Study|Withdrawal by Subject|1
912191|NCT00804193|1889668|FG002|Overall Study|Withdrawal by Subject|2
912192|NCT00804570|1889678|FG000|Overall Study|Adverse Event|14
912193|NCT00804570|1889679|FG001|Overall Study|Adverse Event|7
912194|NCT00804570|1889678|FG000|Overall Study|Lack of Efficacy|0
912195|NCT00804570|1889679|FG001|Overall Study|Lack of Efficacy|1
912196|NCT00804570|1889678|FG000|Overall Study|Lost to Follow-up|18
912197|NCT00804570|1889679|FG001|Overall Study|Lost to Follow-up|21
912198|NCT00804570|1889678|FG000|Overall Study|Entry criteria not met|5
912199|NCT00804570|1889679|FG001|Overall Study|Entry criteria not met|5
912200|NCT00804570|1889678|FG000|Overall Study|Protocol Violation|12
912201|NCT00804570|1889679|FG001|Overall Study|Protocol Violation|16
912202|NCT00804570|1889678|FG000|Overall Study|Physician Decision|1
912203|NCT00804570|1889679|FG001|Overall Study|Physician Decision|2
912204|NCT00804570|1889678|FG000|Overall Study|Sponsor decision|1
912205|NCT00804570|1889679|FG001|Overall Study|Sponsor decision|4
912206|NCT00804570|1889678|FG000|Overall Study|Withdrawal by Subject|21
912207|NCT00804570|1889679|FG001|Overall Study|Withdrawal by Subject|38
912208|NCT00804687|1889712|FG000|Period 3: Treatment Period|Positive Drug screen|0
912209|NCT00804687|1889713|FG001|Period 3: Treatment Period|Positive Drug screen|0
912210|NCT00804687|1889714|FG002|Period 3: Treatment Period|Positive Drug screen|0
912211|NCT00804687|1889715|FG003|Period 3: Treatment Period|Positive Drug screen|1
912212|NCT00804687|1889716|FG004|Period 3: Treatment Period|Positive Drug screen|0
912213|NCT00804687|1889717|FG005|Period 3: Treatment Period|Positive Drug screen|0
912214|NCT00804687|1889712|FG000|Period 5: Treatment Period|Withdrawal by Subject|0
912215|NCT00804687|1889713|FG001|Period 5: Treatment Period|Withdrawal by Subject|0
912216|NCT00804687|1889714|FG002|Period 5: Treatment Period|Withdrawal by Subject|0
967796|NCT01185353|1969027|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0
967797|NCT01185353|1969028|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1
967798|NCT01185353|1969029|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2
967799|NCT01185353|1969030|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0
967800|NCT01185366|1969071|FG000|First Line Therapy|Insurance Coverage Denied|1
967801|NCT01185366|1969072|FG001|First Line Therapy|Insurance Coverage Denied|1
967802|NCT01185366|1969071|FG000|First Line Therapy|Withdrawal by Subject|1
967803|NCT01185366|1969072|FG001|First Line Therapy|Withdrawal by Subject|0
967804|NCT01185366|1969071|FG000|First Line Therapy|Lack of Metastatic Site|1
967805|NCT01185366|1969072|FG001|First Line Therapy|Lack of Metastatic Site|0
967806|NCT01185366|1969071|FG000|Crossover to Second Line Therapy|Adverse Event|3
912217|NCT00804687|1889715|FG003|Period 5: Treatment Period|Withdrawal by Subject|0
912218|NCT00804687|1889716|FG004|Period 5: Treatment Period|Withdrawal by Subject|1
912219|NCT00804687|1889717|FG005|Period 5: Treatment Period|Withdrawal by Subject|0
912220|NCT00804687|1889712|FG000|Period 5: Treatment Period|Positive drugs of abuse|0
912221|NCT00804687|1889713|FG001|Period 5: Treatment Period|Positive drugs of abuse|0
912222|NCT00804687|1889714|FG002|Period 5: Treatment Period|Positive drugs of abuse|1
912223|NCT00804687|1889715|FG003|Period 5: Treatment Period|Positive drugs of abuse|0
912224|NCT00804687|1889716|FG004|Period 5: Treatment Period|Positive drugs of abuse|0
912225|NCT00804687|1889717|FG005|Period 5: Treatment Period|Positive drugs of abuse|0
912226|NCT00804687|1889712|FG000|Period 5: Treatment Period|Positive drug test|1
912227|NCT00804687|1889713|FG001|Period 5: Treatment Period|Positive drug test|0
912228|NCT00804687|1889714|FG002|Period 5: Treatment Period|Positive drug test|0
912229|NCT00804687|1889715|FG003|Period 5: Treatment Period|Positive drug test|0
912230|NCT00804687|1889716|FG004|Period 5: Treatment Period|Positive drug test|0
912231|NCT00804687|1889717|FG005|Period 5: Treatment Period|Positive drug test|0
912232|NCT00804843|1889733|FG000|Overall Study|Protocol Violation|1
912233|NCT00804843|1889734|FG001|Overall Study|Protocol Violation|0
912234|NCT00804843|1889733|FG000|Overall Study|Adverse Event|8
912235|NCT00804843|1889734|FG001|Overall Study|Adverse Event|5
912236|NCT00804843|1889733|FG000|Overall Study|Withdrawal by Subject|1
912237|NCT00804843|1889734|FG001|Overall Study|Withdrawal by Subject|2
912238|NCT00804908|1889744|FG000|Overall Study|Other|115
912239|NCT00804908|1889745|FG001|Overall Study|Other|116
912240|NCT00804908|1889746|FG002|Overall Study|Other|114
912241|NCT00804986|1889773|FG000|Overall Study|Adverse Event|0
912242|NCT00804986|1889774|FG001|Overall Study|Adverse Event|1
912243|NCT00804986|1889775|FG002|Overall Study|Adverse Event|2
912244|NCT00804986|1889776|FG003|Overall Study|Adverse Event|1
912245|NCT00804986|1889777|FG004|Overall Study|Adverse Event|3
912246|NCT00804986|1889778|FG005|Overall Study|Adverse Event|0
912247|NCT00804986|1889773|FG000|Overall Study|Lack of Efficacy|0
912248|NCT00804986|1889774|FG001|Overall Study|Lack of Efficacy|0
912249|NCT00804986|1889775|FG002|Overall Study|Lack of Efficacy|0
912250|NCT00804986|1889776|FG003|Overall Study|Lack of Efficacy|1
912251|NCT00804986|1889777|FG004|Overall Study|Lack of Efficacy|0
912252|NCT00804986|1889778|FG005|Overall Study|Lack of Efficacy|3
912253|NCT00804986|1889773|FG000|Overall Study|Lost to Follow-up|0
912254|NCT00804986|1889774|FG001|Overall Study|Lost to Follow-up|0
912255|NCT00804986|1889775|FG002|Overall Study|Lost to Follow-up|0
912256|NCT00804986|1889776|FG003|Overall Study|Lost to Follow-up|1
912257|NCT00804986|1889777|FG004|Overall Study|Lost to Follow-up|1
912258|NCT00804986|1889778|FG005|Overall Study|Lost to Follow-up|3
912259|NCT00804986|1889773|FG000|Overall Study|Protocol Violation|0
912260|NCT00804986|1889774|FG001|Overall Study|Protocol Violation|1
912261|NCT00804986|1889775|FG002|Overall Study|Protocol Violation|0
912262|NCT00804986|1889776|FG003|Overall Study|Protocol Violation|1
912263|NCT00804986|1889777|FG004|Overall Study|Protocol Violation|0
912264|NCT00804986|1889778|FG005|Overall Study|Protocol Violation|0
912265|NCT00804986|1889773|FG000|Overall Study|Withdrawal by Subject|0
912266|NCT00804986|1889774|FG001|Overall Study|Withdrawal by Subject|3
912267|NCT00804986|1889775|FG002|Overall Study|Withdrawal by Subject|0
912268|NCT00804986|1889776|FG003|Overall Study|Withdrawal by Subject|3
912269|NCT00804986|1889777|FG004|Overall Study|Withdrawal by Subject|5
912270|NCT00804986|1889778|FG005|Overall Study|Withdrawal by Subject|3
912271|NCT00804986|1889773|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
912272|NCT00804986|1889774|FG001|Overall Study|Inclusion/Exclusion criteria not met|2
912273|NCT00804986|1889775|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
912274|NCT00804986|1889776|FG003|Overall Study|Inclusion/Exclusion criteria not met|1
912275|NCT00804986|1889777|FG004|Overall Study|Inclusion/Exclusion criteria not met|0
912276|NCT00804986|1889778|FG005|Overall Study|Inclusion/Exclusion criteria not met|1
912277|NCT00804986|1889773|FG000|Overall Study|Sponsor Decision|0
912278|NCT00804986|1889774|FG001|Overall Study|Sponsor Decision|1
912279|NCT00804986|1889775|FG002|Overall Study|Sponsor Decision|0
912280|NCT00804986|1889776|FG003|Overall Study|Sponsor Decision|0
912281|NCT00804986|1889777|FG004|Overall Study|Sponsor Decision|0
912282|NCT00804986|1889778|FG005|Overall Study|Sponsor Decision|0
912283|NCT00804986|1889773|FG000|Overall Study|Physician Decision|1
912284|NCT00804986|1889774|FG001|Overall Study|Physician Decision|0
912285|NCT00804986|1889775|FG002|Overall Study|Physician Decision|0
912286|NCT00804986|1889776|FG003|Overall Study|Physician Decision|0
967807|NCT01185366|1969072|FG001|Crossover to Second Line Therapy|Adverse Event|6
967808|NCT01185366|1969071|FG000|Crossover to Second Line Therapy|Physician Decision|5
912287|NCT00804986|1889777|FG004|Overall Study|Physician Decision|0
912288|NCT00804986|1889778|FG005|Overall Study|Physician Decision|0
912289|NCT00805025|1889809|FG000|Overall Study|Screened but not enrolled/treated|42
912290|NCT00805025|1889809|FG000|Overall Study|Adverse Event|4
912291|NCT00805025|1889809|FG000|Overall Study|Withdrawal by Subject|2
912292|NCT00805025|1889809|FG000|Overall Study|Physician Decision|1
912293|NCT00805142|1889824|FG000|Titration Period|Adverse Event|3
912294|NCT00805142|1889825|FG001|Titration Period|Adverse Event|3
912295|NCT00805142|1889824|FG000|Titration Period|Lack of Efficacy|1
912296|NCT00805142|1889825|FG001|Titration Period|Lack of Efficacy|1
912297|NCT00805142|1889824|FG000|Titration Period|Lost to Follow-up|0
912298|NCT00805142|1889825|FG001|Titration Period|Lost to Follow-up|1
912299|NCT00805142|1889824|FG000|Titration Period|Disease Progression|2
912300|NCT00805142|1889825|FG001|Titration Period|Disease Progression|1
912301|NCT00805142|1889824|FG000|Titration Period|Withdrawal of consent|0
912302|NCT00805142|1889825|FG001|Titration Period|Withdrawal of consent|1
912303|NCT00805142|1889824|FG000|Titration Period|Other|0
912304|NCT00805142|1889825|FG001|Titration Period|Other|3
912305|NCT00805142|1889824|FG000|Maintenance Period|Adverse Event|0
912306|NCT00805142|1889825|FG001|Maintenance Period|Adverse Event|1
912307|NCT00805142|1889824|FG000|Maintenance Period|Other|0
912308|NCT00805142|1889825|FG001|Maintenance Period|Other|1
912309|NCT00805194|1889840|FG000|Overall Study|Progressive disease (modified RECIST)|404
912310|NCT00805194|1889841|FG001|Overall Study|Progressive disease (modified RECIST)|435
912311|NCT00805194|1889840|FG000|Overall Study|Worsening or AE of underlying disease|64
912312|NCT00805194|1889841|FG001|Overall Study|Worsening or AE of underlying disease|70
912313|NCT00805194|1889840|FG000|Overall Study|Other AE|84
912314|NCT00805194|1889841|FG001|Overall Study|Other AE|73
912315|NCT00805194|1889840|FG000|Overall Study|Protocol Violation|9
912316|NCT00805194|1889841|FG001|Overall Study|Protocol Violation|9
912317|NCT00805194|1889840|FG000|Overall Study|Lost to Follow-up|5
912318|NCT00805194|1889841|FG001|Overall Study|Lost to Follow-up|5
912319|NCT00805194|1889840|FG000|Overall Study|Withdrawal by Subject|60
912320|NCT00805194|1889841|FG001|Overall Study|Withdrawal by Subject|42
912321|NCT00805194|1889840|FG000|Overall Study|Not treated|3
912322|NCT00805194|1889841|FG001|Overall Study|Not treated|4
912323|NCT00805194|1889840|FG000|Overall Study|Reasons other than stated above|20
912324|NCT00805194|1889841|FG001|Overall Study|Reasons other than stated above|16
912325|NCT00805207|1889861|FG000|Overall Study|Protocol Violation|0
912326|NCT00805207|1889862|FG001|Overall Study|Protocol Violation|0
912327|NCT00805207|1889863|FG002|Overall Study|Protocol Violation|1
912328|NCT00805207|1889864|FG003|Overall Study|Protocol Violation|0
912329|NCT00805207|1889865|FG004|Overall Study|Protocol Violation|0
912330|NCT00805207|1889866|FG005|Overall Study|Protocol Violation|0
912331|NCT00805207|1889867|FG006|Overall Study|Protocol Violation|0
912332|NCT00805207|1889868|FG007|Overall Study|Protocol Violation|0
912333|NCT00805207|1889869|FG008|Overall Study|Protocol Violation|0
912334|NCT00805207|1889861|FG000|Overall Study|Physician Decision|0
912335|NCT00805207|1889862|FG001|Overall Study|Physician Decision|1
912336|NCT00805207|1889863|FG002|Overall Study|Physician Decision|0
912337|NCT00805207|1889864|FG003|Overall Study|Physician Decision|0
912338|NCT00805207|1889865|FG004|Overall Study|Physician Decision|0
912339|NCT00805207|1889866|FG005|Overall Study|Physician Decision|1
912340|NCT00805207|1889867|FG006|Overall Study|Physician Decision|0
912341|NCT00805207|1889868|FG007|Overall Study|Physician Decision|0
912342|NCT00805207|1889869|FG008|Overall Study|Physician Decision|0
912343|NCT00805207|1889861|FG000|Overall Study|Withdrawal by Subject|0
912344|NCT00805207|1889862|FG001|Overall Study|Withdrawal by Subject|1
912345|NCT00805207|1889863|FG002|Overall Study|Withdrawal by Subject|0
912346|NCT00805207|1889864|FG003|Overall Study|Withdrawal by Subject|0
912347|NCT00805207|1889865|FG004|Overall Study|Withdrawal by Subject|1
912348|NCT00805207|1889866|FG005|Overall Study|Withdrawal by Subject|2
912349|NCT00805207|1889867|FG006|Overall Study|Withdrawal by Subject|0
912350|NCT00805207|1889868|FG007|Overall Study|Withdrawal by Subject|0
912351|NCT00805207|1889869|FG008|Overall Study|Withdrawal by Subject|0
912352|NCT00805285|1889893|FG000|Overall Study|Lack of Efficacy|1
912353|NCT00805389|1889902|FG000|Overall Study|Adverse Event|0
912354|NCT00805389|1889903|FG001|Overall Study|Adverse Event|0
912355|NCT00805389|1889904|FG002|Overall Study|Adverse Event|1
912356|NCT00805389|1889905|FG003|Overall Study|Adverse Event|2
912357|NCT00805389|1889906|FG004|Overall Study|Adverse Event|0
912358|NCT00805389|1889902|FG000|Overall Study|Lost to Follow-up|4
912359|NCT00805389|1889903|FG001|Overall Study|Lost to Follow-up|3
912360|NCT00805389|1889904|FG002|Overall Study|Lost to Follow-up|6
912361|NCT00805389|1889905|FG003|Overall Study|Lost to Follow-up|10
912362|NCT00805389|1889906|FG004|Overall Study|Lost to Follow-up|9
912363|NCT00805389|1889902|FG000|Overall Study|Protocol Violation|0
912364|NCT00805389|1889903|FG001|Overall Study|Protocol Violation|0
912365|NCT00805389|1889904|FG002|Overall Study|Protocol Violation|1
912366|NCT00805389|1889905|FG003|Overall Study|Protocol Violation|0
912367|NCT00805389|1889906|FG004|Overall Study|Protocol Violation|0
912368|NCT00805389|1889902|FG000|Overall Study|Withdrawal by Subject|3
912369|NCT00805389|1889903|FG001|Overall Study|Withdrawal by Subject|2
967809|NCT01185366|1969072|FG001|Crossover to Second Line Therapy|Physician Decision|1
967810|NCT01185366|1969071|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1
967811|NCT01185366|1969072|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0
967812|NCT01185366|1969071|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5
967813|NCT01185366|1969072|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3
967814|NCT01185509|1969082|FG000|Overall Study|Progression/Relapse|9
912370|NCT00805389|1889904|FG002|Overall Study|Withdrawal by Subject|4
912371|NCT00805389|1889905|FG003|Overall Study|Withdrawal by Subject|5
912372|NCT00805389|1889906|FG004|Overall Study|Withdrawal by Subject|4
912373|NCT00805441|1889930|FG000|Overall Study|Adverse Event|5
912374|NCT00805441|1889931|FG001|Overall Study|Adverse Event|2
912375|NCT00805441|1889930|FG000|Overall Study|Lack of Efficacy|0
912376|NCT00805441|1889931|FG001|Overall Study|Lack of Efficacy|2
912377|NCT00805441|1889930|FG000|Overall Study|Protocol Violation|4
912378|NCT00805441|1889931|FG001|Overall Study|Protocol Violation|8
912379|NCT00805441|1889930|FG000|Overall Study|Lost to Follow-up|10
912380|NCT00805441|1889931|FG001|Overall Study|Lost to Follow-up|13
912381|NCT00805441|1889930|FG000|Overall Study|Withdrawal by Subject|15
912382|NCT00805441|1889931|FG001|Overall Study|Withdrawal by Subject|9
912383|NCT00805441|1889930|FG000|Overall Study|Physician Decision|0
912384|NCT00805441|1889931|FG001|Overall Study|Physician Decision|1
912385|NCT00805441|1889930|FG000|Overall Study|Acute Alcohol Withdrawal|0
912386|NCT00805441|1889931|FG001|Overall Study|Acute Alcohol Withdrawal|1
912387|NCT00805467|1889941|FG000|Overall Study|Lack of Efficacy|0
912388|NCT00805467|1889942|FG001|Overall Study|Lack of Efficacy|8
912389|NCT00805467|1889943|FG002|Overall Study|Lack of Efficacy|13
912390|NCT00805467|1889944|FG003|Overall Study|Lack of Efficacy|86
912391|NCT00805467|1889941|FG000|Overall Study|Lost to Follow-up|0
912392|NCT00805467|1889942|FG001|Overall Study|Lost to Follow-up|1
912393|NCT00805467|1889943|FG002|Overall Study|Lost to Follow-up|7
912394|NCT00805467|1889944|FG003|Overall Study|Lost to Follow-up|21
912395|NCT00805467|1889941|FG000|Overall Study|Withdrawal by Subject|0
912396|NCT00805467|1889942|FG001|Overall Study|Withdrawal by Subject|6
912397|NCT00805467|1889943|FG002|Overall Study|Withdrawal by Subject|45
912398|NCT00805467|1889944|FG003|Overall Study|Withdrawal by Subject|50
912399|NCT00805467|1889941|FG000|Overall Study|Protocol Violation|0
912400|NCT00805467|1889942|FG001|Overall Study|Protocol Violation|3
912401|NCT00805467|1889943|FG002|Overall Study|Protocol Violation|0
912402|NCT00805467|1889944|FG003|Overall Study|Protocol Violation|5
912403|NCT00805467|1889941|FG000|Overall Study|Adverse Event|0
912404|NCT00805467|1889942|FG001|Overall Study|Adverse Event|13
912405|NCT00805467|1889943|FG002|Overall Study|Adverse Event|26
912406|NCT00805467|1889944|FG003|Overall Study|Adverse Event|57
912407|NCT00805467|1889941|FG000|Overall Study|Death|0
912408|NCT00805467|1889942|FG001|Overall Study|Death|2
912409|NCT00805467|1889943|FG002|Overall Study|Death|7
912410|NCT00805467|1889944|FG003|Overall Study|Death|5
912411|NCT00805467|1889941|FG000|Overall Study|Physician Decision|0
912412|NCT00805467|1889942|FG001|Overall Study|Physician Decision|1
912413|NCT00805467|1889943|FG002|Overall Study|Physician Decision|2
912414|NCT00805467|1889944|FG003|Overall Study|Physician Decision|6
912415|NCT00805467|1889941|FG000|Overall Study|Not reported|0
912416|NCT00805467|1889942|FG001|Overall Study|Not reported|0
912417|NCT00805467|1889943|FG002|Overall Study|Not reported|3
912418|NCT00805467|1889944|FG003|Overall Study|Not reported|7
912419|NCT00805480|1889958|FG000|Overall Study|Withdrawal by Subject|13
912420|NCT00805480|1889959|FG001|Overall Study|Withdrawal by Subject|5
912421|NCT00805480|1889960|FG002|Overall Study|Withdrawal by Subject|11
912422|NCT00805480|1889961|FG003|Overall Study|Withdrawal by Subject|5
912423|NCT00805480|1889958|FG000|Overall Study|Lost to Follow-up|1
912424|NCT00805480|1889959|FG001|Overall Study|Lost to Follow-up|2
912425|NCT00805480|1889960|FG002|Overall Study|Lost to Follow-up|0
912426|NCT00805480|1889961|FG003|Overall Study|Lost to Follow-up|0
912427|NCT00805480|1889958|FG000|Overall Study|Adverse Event|0
912428|NCT00805480|1889959|FG001|Overall Study|Adverse Event|0
912429|NCT00805480|1889960|FG002|Overall Study|Adverse Event|1
912430|NCT00805480|1889961|FG003|Overall Study|Adverse Event|0
912431|NCT00805532|1889989|FG000|Overall Study|invalid data|0
912432|NCT00805532|1889990|FG001|Overall Study|invalid data|1
912433|NCT00805545|1890000|FG000|Overall Study|Protocol Violation|3
912434|NCT00805545|1890001|FG001|Overall Study|Protocol Violation|2
912435|NCT00805545|1890000|FG000|Overall Study|Protocol Violation|3
912436|NCT00805545|1890001|FG001|Overall Study|Protocol Violation|1
912437|NCT00805675|1890010|FG000|Overall Study|Adverse Event|0
912438|NCT00805675|1890011|FG001|Overall Study|Adverse Event|0
912439|NCT00805675|1890012|FG002|Overall Study|Adverse Event|1
912440|NCT00805740|1890022|FG000|Overall Study|Death|7
912441|NCT00805740|1890023|FG001|Overall Study|Death|4
912442|NCT00805740|1890022|FG000|Overall Study|Withdrawal by Subject|1
912443|NCT00805740|1890023|FG001|Overall Study|Withdrawal by Subject|0
912444|NCT00805740|1890022|FG000|Overall Study|Lost to Follow-up|1
912445|NCT00805740|1890023|FG001|Overall Study|Lost to Follow-up|0
912446|NCT00805740|1890022|FG000|Overall Study|Randomized, but not treated|2
912447|NCT00805740|1890023|FG001|Overall Study|Randomized, but not treated|0
912448|NCT00805766|1890029|FG000|Screening Period|Adverse Event|1
912449|NCT00805766|1890029|FG000|Screening Period|Lack of Efficacy|2
967815|NCT01185509|1969083|FG001|Overall Study|Progression/Relapse|15
967816|NCT01185509|1969082|FG000|Overall Study|Physician Decision|2
967817|NCT01185509|1969083|FG001|Overall Study|Physician Decision|2
967818|NCT01185509|1969082|FG000|Overall Study|Withdrawal by Subject|0
967819|NCT01185509|1969083|FG001|Overall Study|Withdrawal by Subject|1
967820|NCT01185509|1969082|FG000|Overall Study|Death|0
967821|NCT01185509|1969083|FG001|Overall Study|Death|1
967822|NCT01185509|1969082|FG000|Overall Study|Intercurrent Illness|0
967823|NCT01185509|1969083|FG001|Overall Study|Intercurrent Illness|1
967824|NCT01185522|1969090|FG000|Overall Study|Lack of Efficacy|28
967825|NCT01185522|1969090|FG000|Overall Study|Lost to Follow-up|19
967826|NCT01185522|1969090|FG000|Overall Study|Withdrawal by Subject|10
967827|NCT01185522|1969090|FG000|Overall Study|Poor tolerance|39
967828|NCT01185522|1969090|FG000|Overall Study|Other reasons|12
967829|NCT01185548|1969095|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
967830|NCT01185561|1969110|FG000|Overall Study|Lost to Follow-up|0
967831|NCT01185561|1969111|FG001|Overall Study|Lost to Follow-up|4
967832|NCT01185561|1969110|FG000|Overall Study|Withdrawal by Subject|2
967833|NCT01185561|1969111|FG001|Overall Study|Withdrawal by Subject|8
967834|NCT01185600|1969119|FG000|Overall Study|Adverse Event|1
967835|NCT01185600|1969120|FG001|Overall Study|Adverse Event|1
967836|NCT01185600|1969119|FG000|Overall Study|Death|0
967837|NCT01185600|1969120|FG001|Overall Study|Death|1
967838|NCT01185600|1969119|FG000|Overall Study|Lost to Follow-up|0
967839|NCT01185600|1969120|FG001|Overall Study|Lost to Follow-up|5
967840|NCT01185600|1969119|FG000|Overall Study|Physician Decision|29
967841|NCT01185600|1969120|FG001|Overall Study|Physician Decision|35
967842|NCT01185600|1969119|FG000|Overall Study|Withdrawal by Subject|1
967843|NCT01185600|1969120|FG001|Overall Study|Withdrawal by Subject|1
967844|NCT01185600|1969119|FG000|Overall Study|Hold by DSMB|1
967845|NCT01185600|1969120|FG001|Overall Study|Hold by DSMB|2
967846|NCT01185639|1969129|FG000|Overall Study|Progressed and didn't receive therapy|2
967847|NCT01185704|1969135|FG000|Overall Study|Randomized but not treated|3
967848|NCT01185704|1969136|FG001|Overall Study|Randomized but not treated|3
967849|NCT01185704|1969135|FG000|Overall Study|Lack of ovarian response|5
967850|NCT01185704|1969136|FG001|Overall Study|Lack of ovarian response|1
967851|NCT01185704|1969135|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5
967852|NCT01185704|1969136|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3
967853|NCT01185704|1969135|FG000|Overall Study|Ectopic pregnancy|0
967854|NCT01185704|1969136|FG001|Overall Study|Ectopic pregnancy|1
967855|NCT01185782|1969144|FG000|Overall Study|Adverse Event|0
967856|NCT01185782|1969145|FG001|Overall Study|Adverse Event|1
967857|NCT01185782|1969144|FG000|Overall Study|Protocol Violation|1
967858|NCT01185782|1969145|FG001|Overall Study|Protocol Violation|0
967859|NCT01185782|1969144|FG000|Overall Study|Poor Response to Treatment|3
967860|NCT01185782|1969145|FG001|Overall Study|Poor Response to Treatment|1
967861|NCT01185782|1969144|FG000|Overall Study|Other|2
967862|NCT01185782|1969145|FG001|Overall Study|Other|5
967863|NCT01185782|1969144|FG000|Overall Study|Randomized but not treated|0
967864|NCT01185782|1969145|FG001|Overall Study|Randomized but not treated|4
967865|NCT01185821|1969156|FG000|Overall Study|Abnormal laboratory value(s)|1
967866|NCT01185821|1969157|FG001|Overall Study|Abnormal laboratory value(s)|2
967867|NCT01185821|1969158|FG002|Overall Study|Abnormal laboratory value(s)|1
967868|NCT01185821|1969159|FG003|Overall Study|Abnormal laboratory value(s)|0
967869|NCT01185821|1969160|FG004|Overall Study|Abnormal laboratory value(s)|0
967870|NCT01185821|1969156|FG000|Overall Study|Protocol Violation|0
967871|NCT01185821|1969157|FG001|Overall Study|Protocol Violation|0
967872|NCT01185821|1969158|FG002|Overall Study|Protocol Violation|0
967873|NCT01185821|1969159|FG003|Overall Study|Protocol Violation|1
967874|NCT01185821|1969160|FG004|Overall Study|Protocol Violation|1
967875|NCT01185821|1969156|FG000|Overall Study|Abnormal test procedure result|0
967876|NCT01185821|1969157|FG001|Overall Study|Abnormal test procedure result|0
967877|NCT01185821|1969158|FG002|Overall Study|Abnormal test procedure result|0
967878|NCT01185821|1969159|FG003|Overall Study|Abnormal test procedure result|0
967879|NCT01185821|1969160|FG004|Overall Study|Abnormal test procedure result|1
967880|NCT01185821|1969156|FG000|Overall Study|Death|0
967881|NCT01185821|1969157|FG001|Overall Study|Death|1
967882|NCT01185821|1969158|FG002|Overall Study|Death|0
967883|NCT01185821|1969159|FG003|Overall Study|Death|0
967884|NCT01185821|1969160|FG004|Overall Study|Death|0
967885|NCT01185821|1969156|FG000|Overall Study|Condition no longer required study drug|0
967886|NCT01185821|1969157|FG001|Overall Study|Condition no longer required study drug|0
967887|NCT01185821|1969158|FG002|Overall Study|Condition no longer required study drug|0
967888|NCT01185821|1969159|FG003|Overall Study|Condition no longer required study drug|0
967889|NCT01185821|1969160|FG004|Overall Study|Condition no longer required study drug|1
967890|NCT01185821|1969156|FG000|Overall Study|Adverse Event|2
967891|NCT01185821|1969157|FG001|Overall Study|Adverse Event|3
967892|NCT01185821|1969158|FG002|Overall Study|Adverse Event|1
967893|NCT01185821|1969159|FG003|Overall Study|Adverse Event|2
967894|NCT01185821|1969160|FG004|Overall Study|Adverse Event|5
967895|NCT01185821|1969156|FG000|Overall Study|Lack of Efficacy|0
967896|NCT01185821|1969157|FG001|Overall Study|Lack of Efficacy|0
967897|NCT01185821|1969158|FG002|Overall Study|Lack of Efficacy|3
967898|NCT01185821|1969159|FG003|Overall Study|Lack of Efficacy|0
967899|NCT01185821|1969160|FG004|Overall Study|Lack of Efficacy|9
967900|NCT01185821|1969156|FG000|Overall Study|Withdrawal by Subject|3
967901|NCT01185821|1969157|FG001|Overall Study|Withdrawal by Subject|2
967902|NCT01185821|1969158|FG002|Overall Study|Withdrawal by Subject|2
967903|NCT01185821|1969159|FG003|Overall Study|Withdrawal by Subject|1
967904|NCT01185821|1969160|FG004|Overall Study|Withdrawal by Subject|3
967905|NCT01185821|1969156|FG000|Overall Study|Lost to Follow-up|1
967906|NCT01185821|1969157|FG001|Overall Study|Lost to Follow-up|1
967907|NCT01185821|1969158|FG002|Overall Study|Lost to Follow-up|2
967908|NCT01185821|1969159|FG003|Overall Study|Lost to Follow-up|1
967909|NCT01185821|1969160|FG004|Overall Study|Lost to Follow-up|2
967910|NCT01185821|1969156|FG000|Overall Study|Administrative problems|0
967911|NCT01185821|1969157|FG001|Overall Study|Administrative problems|0
967912|NCT01185821|1969158|FG002|Overall Study|Administrative problems|1
967913|NCT01185821|1969159|FG003|Overall Study|Administrative problems|1
967914|NCT01185821|1969160|FG004|Overall Study|Administrative problems|2
967915|NCT01185834|1969174|FG000|Overall Study|Lost to Follow-up|2
967916|NCT01185834|1969174|FG000|Overall Study|Discomfort|4
967917|NCT01185834|1969174|FG000|Overall Study|Biomicroscopy|4
967918|NCT01185834|1969174|FG000|Overall Study|Time/Job Conflict|2
967919|NCT01185834|1969174|FG000|Overall Study|Early exit - Site error|2
967920|NCT01185964|1969181|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1
967921|NCT01185964|1969182|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6
967922|NCT01185964|1969183|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2
967923|NCT01185964|1969184|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0
967924|NCT01185964|1969181|FG000|Phase 1b and Phase 2|Other Therapy Started|0
967925|NCT01185964|1969182|FG001|Phase 1b and Phase 2|Other Therapy Started|3
967926|NCT01185964|1969183|FG002|Phase 1b and Phase 2|Other Therapy Started|3
967927|NCT01185964|1969184|FG003|Phase 1b and Phase 2|Other Therapy Started|0
1006625|NCT01468701|2025300|FG015|Overall Study|Not being followed up|0
912450|NCT00805766|1890029|FG000|Screening Period|Pregnancy|1
912451|NCT00805766|1890029|FG000|Screening Period|Responder|2
912452|NCT00805766|1890029|FG000|Increased Dose Period|Adverse Event|4
912453|NCT00805766|1890029|FG000|Increased Dose Period|Lack of Efficacy|7
912454|NCT00805766|1890029|FG000|Increased Dose Period|Pregnancy|1
912455|NCT00805766|1890029|FG000|Increased Dose Period|Withdrawal by Subject|1
912456|NCT00805792|1890037|FG000|Overall Study|Death|3
912457|NCT00805792|1890037|FG000|Overall Study|Lost to Follow-up|2
912458|NCT00805935|1890054|FG000|Overall Study|Stimulation Failure|1
912459|NCT00805935|1890055|FG001|Overall Study|Stimulation Failure|5
912460|NCT00805935|1890056|FG002|Overall Study|Stimulation Failure|2
912461|NCT00805935|1890057|FG003|Overall Study|Stimulation Failure|2
912462|NCT00805935|1890054|FG000|Overall Study|Cycle cancelled|0
912463|NCT00805935|1890055|FG001|Overall Study|Cycle cancelled|0
912464|NCT00805935|1890056|FG002|Overall Study|Cycle cancelled|2
912465|NCT00805935|1890057|FG003|Overall Study|Cycle cancelled|0
912466|NCT00805935|1890054|FG000|Overall Study|Cycle cancellation for risk of OHSS|1
912467|NCT00805935|1890055|FG001|Overall Study|Cycle cancellation for risk of OHSS|0
912468|NCT00805935|1890056|FG002|Overall Study|Cycle cancellation for risk of OHSS|1
912469|NCT00805935|1890057|FG003|Overall Study|Cycle cancellation for risk of OHSS|0
912470|NCT00805935|1890054|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
912471|NCT00805935|1890055|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
912472|NCT00805935|1890056|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
912473|NCT00805935|1890057|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
912474|NCT00805935|1890054|FG000|Overall Study|Lost to Follow-up|1
912475|NCT00805935|1890055|FG001|Overall Study|Lost to Follow-up|0
912476|NCT00805935|1890056|FG002|Overall Study|Lost to Follow-up|0
912477|NCT00805935|1890057|FG003|Overall Study|Lost to Follow-up|0
912478|NCT00805935|1890054|FG000|Overall Study|No positive serum pregnancy|8
912479|NCT00805935|1890055|FG001|Overall Study|No positive serum pregnancy|7
912480|NCT00805935|1890056|FG002|Overall Study|No positive serum pregnancy|6
912481|NCT00805935|1890057|FG003|Overall Study|No positive serum pregnancy|5
912482|NCT00805935|1890054|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0
912483|NCT00805935|1890055|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
912484|NCT00805935|1890056|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0
912485|NCT00805935|1890057|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1
912486|NCT00805935|1890054|FG000|Overall Study|Pregnancy loss/miscarriage|2
912487|NCT00805935|1890055|FG001|Overall Study|Pregnancy loss/miscarriage|0
912488|NCT00805935|1890056|FG002|Overall Study|Pregnancy loss/miscarriage|0
912489|NCT00805935|1890057|FG003|Overall Study|Pregnancy loss/miscarriage|0
912490|NCT00805935|1890054|FG000|Overall Study|Biochemical pregnancy|0
912491|NCT00805935|1890055|FG001|Overall Study|Biochemical pregnancy|1
912492|NCT00805935|1890056|FG002|Overall Study|Biochemical pregnancy|0
912493|NCT00805935|1890057|FG003|Overall Study|Biochemical pregnancy|0
912494|NCT00805935|1890054|FG000|Overall Study|Chemical pregnancy|0
912495|NCT00805935|1890055|FG001|Overall Study|Chemical pregnancy|5
912496|NCT00805935|1890056|FG002|Overall Study|Chemical pregnancy|3
912497|NCT00805935|1890057|FG003|Overall Study|Chemical pregnancy|2
912498|NCT00805935|1890054|FG000|Overall Study|Ectopic pregnancy|0
912499|NCT00805935|1890055|FG001|Overall Study|Ectopic pregnancy|0
912500|NCT00805935|1890056|FG002|Overall Study|Ectopic pregnancy|1
967928|NCT01185964|1969181|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0
967929|NCT01185964|1969182|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0
967930|NCT01185964|1969183|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1
967931|NCT01185964|1969184|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0
967932|NCT01185964|1969181|FG000|Phase 1b and Phase 2|Adverse Event|1
967933|NCT01185964|1969182|FG001|Phase 1b and Phase 2|Adverse Event|0
967934|NCT01185964|1969183|FG002|Phase 1b and Phase 2|Adverse Event|2
967935|NCT01185964|1969184|FG003|Phase 1b and Phase 2|Adverse Event|0
967936|NCT01185964|1969181|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0
967937|NCT01185964|1969182|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1
967938|NCT01185964|1969183|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1
967939|NCT01185964|1969184|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0
967940|NCT01185964|1969181|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
967941|NCT01185964|1969182|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
967942|NCT01185964|1969183|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
967943|NCT01185964|1969184|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
967944|NCT01185964|1969181|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
967945|NCT01185964|1969182|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
967946|NCT01185964|1969183|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
967947|NCT01185964|1969184|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
967948|NCT01185964|1969181|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
967949|NCT01185964|1969182|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
967950|NCT01185964|1969183|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
967951|NCT01185964|1969184|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
967952|NCT01186328|1969209|FG000|Overall Study|Death|1
967953|NCT01186328|1969210|FG001|Overall Study|Death|0
967954|NCT01186328|1969211|FG002|Overall Study|Death|0
967955|NCT01186419|1969222|FG000|Overall Study|Withdrawal by Subject|5
967956|NCT01186419|1969223|FG001|Overall Study|Withdrawal by Subject|3
967957|NCT01186419|1969222|FG000|Overall Study|Adverse Event|1
967958|NCT01186419|1969223|FG001|Overall Study|Adverse Event|2
967959|NCT01186419|1969222|FG000|Overall Study|Physician Decision|0
967960|NCT01186419|1969223|FG001|Overall Study|Physician Decision|3
967961|NCT01186419|1969222|FG000|Overall Study|Other|1
967962|NCT01186419|1969223|FG001|Overall Study|Other|1
967963|NCT01186458|1969228|FG000|Overall Study|Adverse Event|1
967964|NCT01186692|1969241|FG000|Overall Study|Not Catheterized|11
967965|NCT01186692|1969241|FG000|Overall Study|Futher testing contraindicated implant|19
967966|NCT01186692|1969241|FG000|Overall Study|Adverse Event|2
967967|NCT01186744|1969259|FG000|Overall Study|Lack of Efficacy|156
967968|NCT01186744|1969260|FG001|Overall Study|Lack of Efficacy|99
967969|NCT01186744|1969261|FG002|Overall Study|Lack of Efficacy|0
967970|NCT01186744|1969262|FG003|Overall Study|Lack of Efficacy|2
967971|NCT01186744|1969263|FG004|Overall Study|Lack of Efficacy|2
967972|NCT01186744|1969264|FG005|Overall Study|Lack of Efficacy|5
967973|NCT01186744|1969259|FG000|Overall Study|Protocol Violation|1
967974|NCT01186744|1969260|FG001|Overall Study|Protocol Violation|2
967975|NCT01186744|1969261|FG002|Overall Study|Protocol Violation|0
967976|NCT01186744|1969262|FG003|Overall Study|Protocol Violation|1
967977|NCT01186744|1969263|FG004|Overall Study|Protocol Violation|1
967978|NCT01186744|1969264|FG005|Overall Study|Protocol Violation|2
967979|NCT01186744|1969259|FG000|Overall Study|Lost to Follow-up|15
967980|NCT01186744|1969260|FG001|Overall Study|Lost to Follow-up|16
967981|NCT01186744|1969261|FG002|Overall Study|Lost to Follow-up|2
967982|NCT01186744|1969262|FG003|Overall Study|Lost to Follow-up|1
967983|NCT01186744|1969263|FG004|Overall Study|Lost to Follow-up|1
967984|NCT01186744|1969264|FG005|Overall Study|Lost to Follow-up|4
967985|NCT01186744|1969259|FG000|Overall Study|Screen failure|1
967986|NCT01186744|1969260|FG001|Overall Study|Screen failure|1
967987|NCT01186744|1969261|FG002|Overall Study|Screen failure|0
967988|NCT01186744|1969262|FG003|Overall Study|Screen failure|1
967989|NCT01186744|1969263|FG004|Overall Study|Screen failure|0
967990|NCT01186744|1969264|FG005|Overall Study|Screen failure|0
967991|NCT01186744|1969259|FG000|Overall Study|Withdrawal by Subject|14
967992|NCT01186744|1969260|FG001|Overall Study|Withdrawal by Subject|10
967993|NCT01186744|1969261|FG002|Overall Study|Withdrawal by Subject|2
967994|NCT01186744|1969262|FG003|Overall Study|Withdrawal by Subject|5
967995|NCT01186744|1969263|FG004|Overall Study|Withdrawal by Subject|0
967996|NCT01186744|1969264|FG005|Overall Study|Withdrawal by Subject|6
967997|NCT01186744|1969259|FG000|Overall Study|Study terminated by Sponsor|1
967998|NCT01186744|1969260|FG001|Overall Study|Study terminated by Sponsor|0
967999|NCT01186744|1969261|FG002|Overall Study|Study terminated by Sponsor|0
968000|NCT01186744|1969262|FG003|Overall Study|Study terminated by Sponsor|0
968001|NCT01186744|1969263|FG004|Overall Study|Study terminated by Sponsor|0
968002|NCT01186744|1969264|FG005|Overall Study|Study terminated by Sponsor|0
968003|NCT01186744|1969259|FG000|Overall Study|Other|9
968004|NCT01186744|1969260|FG001|Overall Study|Other|10
968005|NCT01186744|1969261|FG002|Overall Study|Other|1
968006|NCT01186744|1969262|FG003|Overall Study|Other|2
968007|NCT01186744|1969263|FG004|Overall Study|Other|1
968008|NCT01186744|1969264|FG005|Overall Study|Other|5
968009|NCT01186744|1969259|FG000|Overall Study|Adverse Event|10
968010|NCT01186744|1969260|FG001|Overall Study|Adverse Event|14
968011|NCT01186744|1969261|FG002|Overall Study|Adverse Event|1
968012|NCT01186744|1969262|FG003|Overall Study|Adverse Event|0
968013|NCT01186744|1969263|FG004|Overall Study|Adverse Event|1
968014|NCT01186744|1969264|FG005|Overall Study|Adverse Event|4
968015|NCT01186744|1969259|FG000|Overall Study|Death|1
968016|NCT01186744|1969260|FG001|Overall Study|Death|0
968017|NCT01186744|1969261|FG002|Overall Study|Death|0
968018|NCT01186744|1969262|FG003|Overall Study|Death|0
968019|NCT01186744|1969263|FG004|Overall Study|Death|0
968020|NCT01186744|1969264|FG005|Overall Study|Death|0
968021|NCT01186770|1969303|FG000|Overall Study|Ineligibility|0
968022|NCT01186770|1969304|FG001|Overall Study|Ineligibility|0
968023|NCT01186770|1969305|FG002|Overall Study|Ineligibility|2
968024|NCT01186770|1969306|FG003|Overall Study|Ineligibility|0
968025|NCT01186770|1969303|FG000|Overall Study|Protocol Violation|7
968026|NCT01186770|1969304|FG001|Overall Study|Protocol Violation|9
968027|NCT01186770|1969305|FG002|Overall Study|Protocol Violation|12
968028|NCT01186770|1969306|FG003|Overall Study|Protocol Violation|14
968029|NCT01186770|1969303|FG000|Overall Study|Adverse Event|2
968030|NCT01186770|1969304|FG001|Overall Study|Adverse Event|9
968031|NCT01186770|1969305|FG002|Overall Study|Adverse Event|7
968032|NCT01186770|1969306|FG003|Overall Study|Adverse Event|9
968033|NCT01186770|1969303|FG000|Overall Study|Withdrawal by Subject|15
968034|NCT01186770|1969304|FG001|Overall Study|Withdrawal by Subject|13
968035|NCT01186770|1969305|FG002|Overall Study|Withdrawal by Subject|11
968036|NCT01186770|1969306|FG003|Overall Study|Withdrawal by Subject|17
968037|NCT01186770|1969303|FG000|Overall Study|Lost to Follow-up|10
968038|NCT01186770|1969304|FG001|Overall Study|Lost to Follow-up|6
968039|NCT01186770|1969305|FG002|Overall Study|Lost to Follow-up|14
968040|NCT01186770|1969306|FG003|Overall Study|Lost to Follow-up|9
968041|NCT01186770|1969303|FG000|Overall Study|Insufficient response to treatment|7
968042|NCT01186770|1969304|FG001|Overall Study|Insufficient response to treatment|8
968043|NCT01186770|1969305|FG002|Overall Study|Insufficient response to treatment|5
968044|NCT01186770|1969306|FG003|Overall Study|Insufficient response to treatment|7
968045|NCT01186770|1969303|FG000|Overall Study|Other than specified|0
968046|NCT01186770|1969304|FG001|Overall Study|Other than specified|1
968047|NCT01186770|1969305|FG002|Overall Study|Other than specified|1
968048|NCT01186770|1969306|FG003|Overall Study|Other than specified|2
968049|NCT01186796|1969318|FG000|Overall Study|Adverse Event|3
968050|NCT01186796|1969319|FG001|Overall Study|Adverse Event|0
968051|NCT01186796|1969318|FG000|Overall Study|Withdrawal by Subject|1
968052|NCT01186796|1969319|FG001|Overall Study|Withdrawal by Subject|1
968053|NCT01186796|1969318|FG000|Overall Study|Protocol Violation|0
968054|NCT01186796|1969319|FG001|Overall Study|Protocol Violation|1
968055|NCT01186809|1969325|FG000|Overall Study|Death|30
968059|NCT01186939|1969335|FG000|Overall Study|Death|7
968060|NCT01186939|1969335|FG000|Overall Study|Withdrawal by Subject|2
968061|NCT01186939|1969335|FG000|Overall Study|No longer receiving clinical benefit|17
968062|NCT01186939|1969335|FG000|Overall Study|Program closed|5
968063|NCT01186939|1969335|FG000|Overall Study|Sponsor decision|4
968064|NCT01186939|1969335|FG000|Overall Study|Started additional treatment|1
968065|NCT01186939|1969335|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
968066|NCT01186939|1969335|FG000|Overall Study|Myocardial infarction|1
968067|NCT01186939|1969335|FG000|Overall Study|Bone marrow transplant|1
968068|NCT01186939|1969335|FG000|Overall Study|Transformation to AML|1
968069|NCT01186978|1969339|FG000|Overall Study|Withdrawal by Subject|1
968070|NCT01187043|1969364|FG000|Overall Study|Adverse Event|0
968071|NCT01187043|1969365|FG001|Overall Study|Adverse Event|0
968072|NCT01187043|1969366|FG002|Overall Study|Adverse Event|0
968073|NCT01187043|1969367|FG003|Overall Study|Adverse Event|0
968074|NCT01187043|1969368|FG004|Overall Study|Adverse Event|1
968075|NCT01187043|1969364|FG000|Overall Study|Unable to make scheduled visits|1
968076|NCT01187043|1969365|FG001|Overall Study|Unable to make scheduled visits|0
968077|NCT01187043|1969366|FG002|Overall Study|Unable to make scheduled visits|4
968078|NCT01187043|1969367|FG003|Overall Study|Unable to make scheduled visits|0
968079|NCT01187043|1969368|FG004|Overall Study|Unable to make scheduled visits|1
968080|NCT01187407|1969415|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
968081|NCT01187407|1969416|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
968082|NCT01187407|1969417|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
968083|NCT01187407|1969418|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
968084|NCT01187407|1969419|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
968085|NCT01187407|1969415|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
968086|NCT01187407|1969416|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
968087|NCT01187407|1969417|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
968088|NCT01187407|1969418|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
968089|NCT01187407|1969419|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
968090|NCT01187407|1969415|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
968091|NCT01187407|1969416|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
968092|NCT01187407|1969417|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
968093|NCT01187407|1969418|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
968094|NCT01187407|1969419|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
968095|NCT01187407|1969415|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
968096|NCT01187407|1969416|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
968097|NCT01187407|1969417|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
968098|NCT01187407|1969418|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
968099|NCT01187407|1969419|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
968100|NCT01187407|1969415|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
968101|NCT01187407|1969416|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
968102|NCT01187407|1969417|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
968103|NCT01187407|1969418|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
968104|NCT01187407|1969419|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
968105|NCT01187407|1969415|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
968106|NCT01187407|1969416|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
968107|NCT01187407|1969417|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
968108|NCT01187407|1969418|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
968109|NCT01187407|1969419|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
968110|NCT01187407|1969415|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
968111|NCT01187407|1969416|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
968112|NCT01187407|1969417|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
968113|NCT01187407|1969418|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
968114|NCT01187407|1969419|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
968115|NCT01187407|1969415|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
968116|NCT01187407|1969416|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
968117|NCT01187407|1969417|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
968118|NCT01187407|1969418|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
968119|NCT01187407|1969419|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
968120|NCT01187407|1969415|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
968121|NCT01187407|1969416|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
968122|NCT01187407|1969417|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
968123|NCT01187407|1969418|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
968124|NCT01187407|1969419|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
968125|NCT01187407|1969415|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
968126|NCT01187407|1969416|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
968127|NCT01187407|1969417|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
968128|NCT01187407|1969418|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
968129|NCT01187407|1969419|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
968130|NCT01187407|1969415|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
968131|NCT01187407|1969416|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
968132|NCT01187407|1969417|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
968133|NCT01187407|1969418|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
968134|NCT01187407|1969419|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
968135|NCT01187407|1969415|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
968136|NCT01187407|1969416|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
968137|NCT01187407|1969417|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
968138|NCT01187407|1969418|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
968139|NCT01187407|1969419|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
968140|NCT01187407|1969415|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
968141|NCT01187407|1969416|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
968142|NCT01187407|1969417|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
968143|NCT01187407|1969418|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
968144|NCT01187407|1969419|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
968145|NCT01187407|1969415|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
968146|NCT01187407|1969416|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
968147|NCT01187407|1969417|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
968148|NCT01187407|1969418|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
968149|NCT01187407|1969419|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
968150|NCT01187433|1969438|FG000|Overall Study|Protocol Violation|6
968151|NCT01187433|1969439|FG001|Overall Study|Protocol Violation|2
968152|NCT01187433|1969438|FG000|Overall Study|Withdrawal by Subject|5
968153|NCT01187433|1969439|FG001|Overall Study|Withdrawal by Subject|2
968154|NCT01187446|1969447|FG000|Overall Study|Patient started non-protocol therapy|0
968155|NCT01187446|1969448|FG001|Overall Study|Patient started non-protocol therapy|1
968156|NCT01187550|1969474|FG000|Overall Study|Protocol Violation|3
968157|NCT01187550|1969475|FG001|Overall Study|Protocol Violation|1
968158|NCT01187550|1969474|FG000|Overall Study|Other|3
968159|NCT01187550|1969475|FG001|Overall Study|Other|0
968160|NCT01187550|1969474|FG000|Overall Study|Randomized but not treated|8
968161|NCT01187550|1969475|FG001|Overall Study|Randomized but not treated|0
968162|NCT01187901|1969494|FG000|Overall Study|Protocol Violation|1
968163|NCT01187901|1969495|FG001|Overall Study|Protocol Violation|0
968164|NCT01187901|1969494|FG000|Overall Study|Lost to Follow-up|1
968165|NCT01187901|1969495|FG001|Overall Study|Lost to Follow-up|2
968166|NCT01187901|1969494|FG000|Overall Study|Unrelated Health Reasons|1
968167|NCT01187901|1969495|FG001|Overall Study|Unrelated Health Reasons|2
968168|NCT01187901|1969494|FG000|Overall Study|Suspected Allergic Reaction|1
968169|NCT01187901|1969495|FG001|Overall Study|Suspected Allergic Reaction|1
968170|NCT01187901|1969494|FG000|Overall Study|Adverse Event|3
968171|NCT01187901|1969495|FG001|Overall Study|Adverse Event|0
968172|NCT01187901|1969494|FG000|Overall Study|No Endpoint due to Early Study Halt|2
968173|NCT01187901|1969495|FG001|Overall Study|No Endpoint due to Early Study Halt|3
968174|NCT01187901|1969494|FG000|Overall Study|Pregnancy|0
968175|NCT01187901|1969495|FG001|Overall Study|Pregnancy|2
968176|NCT01187953|1969507|FG000|Overall Study|Death|11
968177|NCT01187953|1969508|FG001|Overall Study|Death|13
968178|NCT01187953|1969507|FG000|Overall Study|Adverse Event|1
968179|NCT01187953|1969508|FG001|Overall Study|Adverse Event|2
968180|NCT01187953|1969507|FG000|Overall Study|Lost to Follow-up|0
968181|NCT01187953|1969508|FG001|Overall Study|Lost to Follow-up|3
968182|NCT01187953|1969507|FG000|Overall Study|Withdrawal by Subject|3
968183|NCT01187953|1969508|FG001|Overall Study|Withdrawal by Subject|3
968184|NCT01188226|1969518|FG000|Overall Study|Withdrawal by Subject|4
968185|NCT01188343|1969535|FG000|Overall Study|Not vaccinated|0
968186|NCT01188343|1969536|FG001|Overall Study|Not vaccinated|2
968187|NCT01188343|1969537|FG002|Overall Study|Not vaccinated|1
968188|NCT01188343|1969535|FG000|Overall Study|Withdrawal by Subject|1
968189|NCT01188343|1969536|FG001|Overall Study|Withdrawal by Subject|24
968190|NCT01188343|1969537|FG002|Overall Study|Withdrawal by Subject|0
968191|NCT01188538|1969607|FG000|Overall Study|Lost to Follow-up|0
968192|NCT01188538|1969608|FG001|Overall Study|Lost to Follow-up|1
968193|NCT01188551|1969620|FG000|Overall Study|Pharmacy issues|1
968194|NCT01188551|1969621|FG001|Overall Study|Pharmacy issues|0
968195|NCT01188551|1969622|FG002|Overall Study|Pharmacy issues|0
968196|NCT01188551|1969623|FG003|Overall Study|Pharmacy issues|0
968197|NCT01188564|1969635|FG000|Double-blind Phase|randomized not treated|1
968198|NCT01188564|1969636|FG001|Double-blind Phase|randomized not treated|0
968199|NCT01188655|1969655|FG000|Overall Study|Lack of Efficacy|1
968200|NCT01188655|1969655|FG000|Overall Study|Lost to Follow-up|1
968201|NCT01188655|1969655|FG000|Overall Study|Other|11
968202|NCT01188668|1969659|FG000|Period 1: ARIP Alone|Protocol Violation|2
968203|NCT01188668|1969659|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
968204|NCT01188668|1969659|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
968205|NCT01188681|1969670|FG000|Overall Study|bladder cancer|0
968206|NCT01188681|1969671|FG001|Overall Study|bladder cancer|0
968207|NCT01188681|1969672|FG002|Overall Study|bladder cancer|1
968208|NCT01188681|1969673|FG003|Overall Study|bladder cancer|0
968209|NCT01188681|1969670|FG000|Overall Study|Withdrawal by Subject|0
968210|NCT01188681|1969671|FG001|Overall Study|Withdrawal by Subject|0
968211|NCT01188681|1969672|FG002|Overall Study|Withdrawal by Subject|0
968212|NCT01188681|1969673|FG003|Overall Study|Withdrawal by Subject|1
968213|NCT01188772|1969704|FG000|Overall Study|Randomized but Not Treated|0
968214|NCT01188772|1969705|FG001|Overall Study|Randomized but Not Treated|1
968215|NCT01188772|1969706|FG002|Overall Study|Randomized but Not Treated|0
968216|NCT01188772|1969707|FG003|Overall Study|Randomized but Not Treated|0
968217|NCT01188772|1969704|FG000|Overall Study|Adverse Event|0
968218|NCT01188772|1969705|FG001|Overall Study|Adverse Event|1
968219|NCT01188772|1969706|FG002|Overall Study|Adverse Event|2
968220|NCT01188772|1969707|FG003|Overall Study|Adverse Event|0
968221|NCT01188772|1969704|FG000|Overall Study|Lost to Follow-up|4
968222|NCT01188772|1969705|FG001|Overall Study|Lost to Follow-up|1
968223|NCT01188772|1969706|FG002|Overall Study|Lost to Follow-up|1
968224|NCT01188772|1969707|FG003|Overall Study|Lost to Follow-up|1
968225|NCT01188772|1969704|FG000|Overall Study|Non-responder|0
968226|NCT01188772|1969705|FG001|Overall Study|Non-responder|0
968227|NCT01188772|1969706|FG002|Overall Study|Non-responder|3
968228|NCT01188772|1969707|FG003|Overall Study|Non-responder|0
968229|NCT01188772|1969704|FG000|Overall Study|Physician Decision|0
968230|NCT01188772|1969705|FG001|Overall Study|Physician Decision|0
968231|NCT01188772|1969706|FG002|Overall Study|Physician Decision|1
968232|NCT01188772|1969707|FG003|Overall Study|Physician Decision|0
968233|NCT01188772|1969704|FG000|Overall Study|Terminated by Sponsor|0
968234|NCT01188772|1969705|FG001|Overall Study|Terminated by Sponsor|0
968235|NCT01188772|1969706|FG002|Overall Study|Terminated by Sponsor|1
968236|NCT01188772|1969707|FG003|Overall Study|Terminated by Sponsor|0
968237|NCT01188772|1969704|FG000|Overall Study|Treatment Failure|0
968238|NCT01188772|1969705|FG001|Overall Study|Treatment Failure|0
968239|NCT01188772|1969706|FG002|Overall Study|Treatment Failure|1
968240|NCT01188772|1969707|FG003|Overall Study|Treatment Failure|0
968241|NCT01188772|1969704|FG000|Overall Study|Virologic Failure|1
968242|NCT01188772|1969705|FG001|Overall Study|Virologic Failure|0
968243|NCT01188772|1969706|FG002|Overall Study|Virologic Failure|0
968244|NCT01188772|1969707|FG003|Overall Study|Virologic Failure|0
968245|NCT01188772|1969704|FG000|Overall Study|Withdrawal by Subject|0
968246|NCT01188772|1969705|FG001|Overall Study|Withdrawal by Subject|0
968247|NCT01188772|1969706|FG002|Overall Study|Withdrawal by Subject|2
968248|NCT01188772|1969707|FG003|Overall Study|Withdrawal by Subject|0
968249|NCT01188811|1969722|FG000|Overall Study|Withdrawal by Subject|0
968250|NCT01188811|1969723|FG001|Overall Study|Withdrawal by Subject|2
968251|NCT01188811|1969722|FG000|Overall Study|Adverse Event|6
968252|NCT01188811|1969723|FG001|Overall Study|Adverse Event|0
968253|NCT01188967|1969752|FG000|Overall Study|Withdrawal by Subject|1
968254|NCT01188967|1969753|FG001|Overall Study|Withdrawal by Subject|1
968255|NCT01188967|1969752|FG000|Overall Study|Physician Decision|1
968256|NCT01188967|1969753|FG001|Overall Study|Physician Decision|1
968257|NCT01188967|1969752|FG000|Overall Study|Lost to Follow-up|3
968258|NCT01188967|1969753|FG001|Overall Study|Lost to Follow-up|2
968259|NCT01189032|1969764|FG000|Overall Study|Adverse Event|1
968260|NCT01189032|1969765|FG001|Overall Study|Adverse Event|3
968261|NCT01189032|1969766|FG002|Overall Study|Adverse Event|4
968262|NCT01189032|1969764|FG000|Overall Study|Lack of Efficacy|2
968263|NCT01189032|1969765|FG001|Overall Study|Lack of Efficacy|3
968264|NCT01189032|1969766|FG002|Overall Study|Lack of Efficacy|0
968265|NCT01189032|1969764|FG000|Overall Study|Withdrawal by Subject|1
968266|NCT01189032|1969765|FG001|Overall Study|Withdrawal by Subject|0
968267|NCT01189032|1969766|FG002|Overall Study|Withdrawal by Subject|1
968268|NCT01189032|1969764|FG000|Overall Study|Protocol Violation|1
968269|NCT01189032|1969765|FG001|Overall Study|Protocol Violation|1
968270|NCT01189032|1969766|FG002|Overall Study|Protocol Violation|1
968271|NCT01189201|1969801|FG000|Overall Study|Adverse Event|1
968272|NCT01189266|1969831|FG000|Overall Study|Adverse Event|1
968273|NCT01189266|1969832|FG001|Overall Study|Adverse Event|0
968274|NCT01189266|1969833|FG002|Overall Study|Adverse Event|5
968275|NCT01189266|1969831|FG000|Overall Study|Death|0
968276|NCT01189266|1969832|FG001|Overall Study|Death|0
968277|NCT01189266|1969833|FG002|Overall Study|Death|5
968278|NCT01189266|1969831|FG000|Overall Study|Lack of Efficacy|4
968279|NCT01189266|1969832|FG001|Overall Study|Lack of Efficacy|5
968280|NCT01189266|1969833|FG002|Overall Study|Lack of Efficacy|44
968281|NCT01189266|1969831|FG000|Overall Study|Physician Decision|0
968282|NCT01189266|1969832|FG001|Overall Study|Physician Decision|0
968283|NCT01189266|1969833|FG002|Overall Study|Physician Decision|1
968284|NCT01189266|1969831|FG000|Overall Study|Protocol Violation|0
968285|NCT01189266|1969832|FG001|Overall Study|Protocol Violation|1
968286|NCT01189266|1969833|FG002|Overall Study|Protocol Violation|1
968287|NCT01189266|1969831|FG000|Overall Study|Withdrawal by Subject|0
968288|NCT01189266|1969832|FG001|Overall Study|Withdrawal by Subject|0
968289|NCT01189266|1969833|FG002|Overall Study|Withdrawal by Subject|1
968290|NCT01189266|1969831|FG000|Overall Study|Patient refuses further therapy|1
968291|NCT01189266|1969832|FG001|Overall Study|Patient refuses further therapy|0
968292|NCT01189266|1969833|FG002|Overall Study|Patient refuses further therapy|7
968293|NCT01189266|1969831|FG000|Overall Study|No treatment|0
968294|NCT01189266|1969832|FG001|Overall Study|No treatment|0
968295|NCT01189266|1969833|FG002|Overall Study|No treatment|1
968296|NCT01189461|1969889|FG000|Overall Study|Lack of Efficacy|13
968297|NCT01189461|1969889|FG000|Overall Study|Lost to Follow-up|1
968298|NCT01189461|1969889|FG000|Overall Study|Withdrawal by Subject|6
968299|NCT01189461|1969889|FG000|Overall Study|Protocol Violation|1
968300|NCT01189461|1969889|FG000|Overall Study|Adverse Event|2
968301|NCT01189461|1969889|FG000|Overall Study|Did not meet entrance criteria|3
968302|NCT01189461|1969889|FG000|Overall Study|Other|8
968303|NCT01189487|1969893|FG000|Overall Study|Lack of Efficacy|2
968304|NCT01189487|1969893|FG000|Overall Study|Adverse Event|1
968305|NCT01189500|1969897|FG000|Period 1: TAMOX Alone|Adverse Event|1
968306|NCT01189500|1969897|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
968307|NCT01189604|1969911|FG000|Overall Study|Impossible to visit|0
968308|NCT01189604|1969912|FG001|Overall Study|Impossible to visit|0
968309|NCT01189604|1969913|FG002|Overall Study|Impossible to visit|0
968310|NCT01189604|1969914|FG003|Overall Study|Impossible to visit|0
968311|NCT01189604|1969915|FG004|Overall Study|Impossible to visit|0
968312|NCT01189604|1969916|FG005|Overall Study|Impossible to visit|1
968313|NCT01189604|1969917|FG006|Overall Study|Impossible to visit|0
968314|NCT01189604|1969911|FG000|Overall Study|Adverse Event|0
968315|NCT01189604|1969912|FG001|Overall Study|Adverse Event|1
968316|NCT01189604|1969913|FG002|Overall Study|Adverse Event|0
968317|NCT01189604|1969914|FG003|Overall Study|Adverse Event|0
968318|NCT01189604|1969915|FG004|Overall Study|Adverse Event|2
968319|NCT01189604|1969916|FG005|Overall Study|Adverse Event|0
968320|NCT01189604|1969917|FG006|Overall Study|Adverse Event|1
968321|NCT01189604|1969911|FG000|Overall Study|Withdrawal by Subject|1
968322|NCT01189604|1969912|FG001|Overall Study|Withdrawal by Subject|0
968323|NCT01189604|1969913|FG002|Overall Study|Withdrawal by Subject|0
968324|NCT01189604|1969914|FG003|Overall Study|Withdrawal by Subject|0
968325|NCT01189604|1969915|FG004|Overall Study|Withdrawal by Subject|0
968326|NCT01189604|1969916|FG005|Overall Study|Withdrawal by Subject|0
968327|NCT01189604|1969917|FG006|Overall Study|Withdrawal by Subject|0
968328|NCT01189812|1969966|FG000|Overall Study|Withdrawal by Subject|2
968329|NCT01189812|1969967|FG001|Overall Study|Withdrawal by Subject|3
968330|NCT01189812|1969966|FG000|Overall Study|Adverse Event|1
968331|NCT01189812|1969967|FG001|Overall Study|Adverse Event|0
968332|NCT01189812|1969966|FG000|Overall Study|Out of Window|4
968333|NCT01189812|1969967|FG001|Overall Study|Out of Window|3
968334|NCT01189812|1969966|FG000|Overall Study|Moved out of State|1
968335|NCT01189812|1969967|FG001|Overall Study|Moved out of State|2
968336|NCT01189890|1969975|FG000|Overall Study|Adverse Event|3
968337|NCT01189890|1969976|FG001|Overall Study|Adverse Event|4
968338|NCT01189890|1969975|FG000|Overall Study|Lack of Efficacy|7
968339|NCT01189890|1969976|FG001|Overall Study|Lack of Efficacy|2
968340|NCT01189890|1969975|FG000|Overall Study|Lost to Follow-up|1
968341|NCT01189890|1969976|FG001|Overall Study|Lost to Follow-up|7
968342|NCT01189890|1969975|FG000|Overall Study|Protocol Violation|1
968343|NCT01189890|1969976|FG001|Overall Study|Protocol Violation|5
968344|NCT01189890|1969975|FG000|Overall Study|Withdrawal by Subject|15
968345|NCT01189890|1969976|FG001|Overall Study|Withdrawal by Subject|11
968346|NCT01189890|1969975|FG000|Overall Study|Non Compliance|0
968347|NCT01189890|1969976|FG001|Overall Study|Non Compliance|1
968348|NCT01189890|1969975|FG000|Overall Study|Physician Decision|5
968349|NCT01189890|1969976|FG001|Overall Study|Physician Decision|4
968350|NCT01189890|1969975|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5
968351|NCT01189890|1969976|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5
968352|NCT01190007|1969982|FG000|Overall Study|Withdrawal by Subject|4
968353|NCT01190007|1969982|FG000|Overall Study|Adverse Event|8
968354|NCT01190007|1969982|FG000|Overall Study|Difficulty of visit for complications|1
968355|NCT01190007|1969982|FG000|Overall Study|Participant was arrested|1
968356|NCT01190020|1969988|FG000|Overall Study|Adverse Event|2
968357|NCT01190020|1969989|FG001|Overall Study|Adverse Event|0
968358|NCT01190020|1969988|FG000|Overall Study|Lost to Follow-up|2
968359|NCT01190020|1969989|FG001|Overall Study|Lost to Follow-up|0
968360|NCT01190020|1969988|FG000|Overall Study|Withdrawal by Subject|3
968361|NCT01190020|1969989|FG001|Overall Study|Withdrawal by Subject|0
968362|NCT01190098|1970010|FG000|Overall Study|Adverse Event|2
968363|NCT01190098|1970011|FG001|Overall Study|Adverse Event|0
968364|NCT01190098|1970010|FG000|Overall Study|Patient coomorbidity|0
968365|NCT01190098|1970011|FG001|Overall Study|Patient coomorbidity|1
968366|NCT01190098|1970010|FG000|Overall Study|Lack of transportation|1
968367|NCT01190098|1970011|FG001|Overall Study|Lack of transportation|0
968368|NCT01190098|1970010|FG000|Overall Study|Other|0
968369|NCT01190098|1970011|FG001|Overall Study|Other|1
968370|NCT01190124|1970020|FG000|Overall Study|Death|3
968371|NCT01190124|1970021|FG001|Overall Study|Death|0
968372|NCT01190124|1970022|FG002|Overall Study|Death|0
968373|NCT01190124|1970020|FG000|Overall Study|Therapeutic Failure|12
968374|NCT01190124|1970021|FG001|Overall Study|Therapeutic Failure|0
968375|NCT01190124|1970022|FG002|Overall Study|Therapeutic Failure|1
968376|NCT01190124|1970020|FG000|Overall Study|Lost to Follow-up|2
968377|NCT01190124|1970021|FG001|Overall Study|Lost to Follow-up|0
968378|NCT01190124|1970022|FG002|Overall Study|Lost to Follow-up|0
968379|NCT01190150|1970035|FG000|First Treatment|Withdrawal by Subject|1
968380|NCT01190150|1970036|FG001|First Treatment|Withdrawal by Subject|0
968381|NCT01190150|1970035|FG000|Washout|Withdrawal by Subject|0
968382|NCT01190150|1970036|FG001|Washout|Withdrawal by Subject|1
968383|NCT01190150|1970035|FG000|Washout|Difficulty in adherence|0
968384|NCT01190150|1970036|FG001|Washout|Difficulty in adherence|1
968385|NCT01190176|1970042|FG000|Overall Study|Withdrawal by Subject|1
968386|NCT01190176|1970042|FG000|Overall Study|Lost to Follow-up|1
968387|NCT01190189|1970046|FG000|Overall Study|Lost to Follow-up|4
968388|NCT01190189|1970046|FG000|Overall Study|Withdrawal by Subject|1
968389|NCT01190189|1970046|FG000|Overall Study|Migrated/moved from study area|1
968390|NCT01190215|1970101|FG000|Up to Month 6|Lost to Follow-up|2
968391|NCT01190215|1970102|FG001|Up to Month 6|Lost to Follow-up|0
968392|NCT01190228|1970111|FG000|Overall Study|Protocol Violation|4
968393|NCT01190228|1970112|FG001|Overall Study|Protocol Violation|0
968394|NCT01190228|1970113|FG002|Overall Study|Protocol Violation|0
968395|NCT01190228|1970111|FG000|Overall Study|Withdrawal by Subject|1
968396|NCT01190228|1970112|FG001|Overall Study|Withdrawal by Subject|0
968397|NCT01190228|1970113|FG002|Overall Study|Withdrawal by Subject|0
968398|NCT01190254|1970126|FG000|Overall Study|Adverse Event|3
968399|NCT01190254|1970127|FG001|Overall Study|Adverse Event|6
968400|NCT01190254|1970128|FG002|Overall Study|Adverse Event|8
968401|NCT01190254|1970126|FG000|Overall Study|Lack of Efficacy|7
968402|NCT01190254|1970127|FG001|Overall Study|Lack of Efficacy|4
968403|NCT01190254|1970128|FG002|Overall Study|Lack of Efficacy|5
968404|NCT01190254|1970126|FG000|Overall Study|Lost to Follow-up|4
968405|NCT01190254|1970127|FG001|Overall Study|Lost to Follow-up|2
968406|NCT01190254|1970128|FG002|Overall Study|Lost to Follow-up|0
968407|NCT01190254|1970126|FG000|Overall Study|Withdrawal by Subject|4
968408|NCT01190254|1970127|FG001|Overall Study|Withdrawal by Subject|5
968409|NCT01190254|1970128|FG002|Overall Study|Withdrawal by Subject|7
968410|NCT01190254|1970126|FG000|Overall Study|Protocol Violation|2
968411|NCT01190254|1970127|FG001|Overall Study|Protocol Violation|0
968412|NCT01190254|1970128|FG002|Overall Study|Protocol Violation|2
968413|NCT01190254|1970126|FG000|Overall Study|Did not meet protocol eligibility|1
968414|NCT01190254|1970127|FG001|Overall Study|Did not meet protocol eligibility|0
968415|NCT01190254|1970128|FG002|Overall Study|Did not meet protocol eligibility|0
968416|NCT01190267|1970138|FG000|Overall Study|Adverse Event|10
968417|NCT01190267|1970139|FG001|Overall Study|Adverse Event|0
968418|NCT01190267|1970138|FG000|Overall Study|Treatment Failure|8
968419|NCT01190267|1970139|FG001|Overall Study|Treatment Failure|2
968420|NCT01190267|1970138|FG000|Overall Study|Lost to Follow-up|2
968421|NCT01190267|1970139|FG001|Overall Study|Lost to Follow-up|0
968422|NCT01190267|1970138|FG000|Overall Study|Withdrawal by Subject|13
968423|NCT01190267|1970139|FG001|Overall Study|Withdrawal by Subject|1
968424|NCT01190267|1970138|FG000|Overall Study|Protocol Violation|8
968425|NCT01190267|1970139|FG001|Overall Study|Protocol Violation|1
968426|NCT01190410|1970147|FG000|Overall Study|Adverse Event|0
968427|NCT01190410|1970148|FG001|Overall Study|Adverse Event|3
968428|NCT01190410|1970147|FG000|Overall Study|Lack of Efficacy|0
968429|NCT01190410|1970148|FG001|Overall Study|Lack of Efficacy|2
968430|NCT01190410|1970147|FG000|Overall Study|Withdrawal by Subject|0
968431|NCT01190410|1970148|FG001|Overall Study|Withdrawal by Subject|2
968432|NCT01190410|1970147|FG000|Overall Study|Administrative decision|1
968433|NCT01190410|1970148|FG001|Overall Study|Administrative decision|0
968434|NCT01190410|1970147|FG000|Overall Study|PI discretion|0
968435|NCT01190410|1970148|FG001|Overall Study|PI discretion|2
968436|NCT01190436|1970160|FG000|Overall Study|Lost to Follow-up|35
968437|NCT01190436|1970160|FG000|Overall Study|Other|4
968438|NCT01190449|1970167|FG000|Overall Study|Ineligible|0
968439|NCT01190449|1970168|FG001|Overall Study|Ineligible|4
968440|NCT01190475|1970177|FG000|Overall Study|Withdrawal by Subject|0
968441|NCT01190475|1970178|FG001|Overall Study|Withdrawal by Subject|0
968442|NCT01190475|1970179|FG002|Overall Study|Withdrawal by Subject|1
968443|NCT01190514|1970189|FG000|First Intervention (Period 1)|Adverse Event|1
968444|NCT01190514|1970190|FG001|First Intervention (Period 1)|Adverse Event|0
968445|NCT01190514|1970191|FG002|First Intervention (Period 1)|Adverse Event|0
968446|NCT01190514|1970192|FG003|First Intervention (Period 1)|Adverse Event|0
968447|NCT01190514|1970189|FG000|Third Intervention (Period 3)|Adverse Event|1
968448|NCT01190514|1970190|FG001|Third Intervention (Period 3)|Adverse Event|0
968449|NCT01190514|1970191|FG002|Third Intervention (Period 3)|Adverse Event|0
968450|NCT01190514|1970192|FG003|Third Intervention (Period 3)|Adverse Event|0
968451|NCT01190813|1970218|FG000|Overall Study|Lost to Follow-up|1
968452|NCT01190813|1970219|FG001|Overall Study|Lost to Follow-up|2
968453|NCT01190813|1970218|FG000|Overall Study|Withdrawal by Subject|2
968454|NCT01190813|1970219|FG001|Overall Study|Withdrawal by Subject|1
968455|NCT01190813|1970218|FG000|Overall Study|Refused study treatment after randomized|1
968456|NCT01190813|1970219|FG001|Overall Study|Refused study treatment after randomized|0
968457|NCT01190813|1970218|FG000|Overall Study|Adverse Event|0
968458|NCT01190813|1970219|FG001|Overall Study|Adverse Event|1
968459|NCT01190839|1970227|FG000|Overall Study|Adverse Event|32
968460|NCT01190839|1970228|FG001|Overall Study|Adverse Event|41
968461|NCT01190839|1970227|FG000|Overall Study|Protocol Violation|2
968462|NCT01190839|1970228|FG001|Overall Study|Protocol Violation|2
968463|NCT01190839|1970227|FG000|Overall Study|Lost to Follow-up|7
968464|NCT01190839|1970228|FG001|Overall Study|Lost to Follow-up|1
968465|NCT01190839|1970227|FG000|Overall Study|Death|1
968466|NCT01190839|1970228|FG001|Overall Study|Death|0
968467|NCT01190839|1970227|FG000|Overall Study|Trial stopped by Sponsor|71
968468|NCT01190839|1970228|FG001|Overall Study|Trial stopped by Sponsor|68
968469|NCT01190839|1970227|FG000|Overall Study|Undefined|35
968470|NCT01190839|1970228|FG001|Overall Study|Undefined|31
968471|NCT01190839|1970227|FG000|Overall Study|Randomized but not treated|2
968472|NCT01190839|1970228|FG001|Overall Study|Randomized but not treated|4
968473|NCT01190865|1970236|FG000|Overall Study|Withdrawal by Subject|1
968474|NCT01190865|1970236|FG000|Overall Study|Non-compliance|2
968475|NCT01190891|1970259|FG000|Overall Study|Protocol Violation|1
968476|NCT01190891|1970260|FG001|Overall Study|Protocol Violation|0
968477|NCT01190891|1970259|FG000|Overall Study|Withdrawal by Subject|5
968478|NCT01190891|1970260|FG001|Overall Study|Withdrawal by Subject|0
968479|NCT01190930|1970268|FG000|Induction|Adverse Event|17
968480|NCT01190930|1970269|FG001|Induction|Adverse Event|0
968481|NCT01190930|1970270|FG002|Induction|Adverse Event|0
968482|NCT01190930|1970271|FG003|Induction|Adverse Event|0
968483|NCT01190930|1970272|FG004|Induction|Adverse Event|0
968484|NCT01190930|1970273|FG005|Induction|Adverse Event|0
968485|NCT01190930|1970274|FG006|Induction|Adverse Event|0
968486|NCT01190930|1970275|FG007|Induction|Adverse Event|0
968487|NCT01190930|1970276|FG008|Induction|Adverse Event|0
968488|NCT01190930|1970277|FG009|Induction|Adverse Event|0
968489|NCT01190930|1970268|FG000|Induction|Death|34
968490|NCT01190930|1970269|FG001|Induction|Death|0
968491|NCT01190930|1970270|FG002|Induction|Death|0
968492|NCT01190930|1970271|FG003|Induction|Death|0
968493|NCT01190930|1970272|FG004|Induction|Death|0
968494|NCT01190930|1970273|FG005|Induction|Death|0
968495|NCT01190930|1970274|FG006|Induction|Death|0
968496|NCT01190930|1970275|FG007|Induction|Death|0
968497|NCT01190930|1970276|FG008|Induction|Death|0
968498|NCT01190930|1970277|FG009|Induction|Death|0
968499|NCT01190930|1970268|FG000|Induction|Lost to Follow-up|1
968500|NCT01190930|1970269|FG001|Induction|Lost to Follow-up|0
968501|NCT01190930|1970270|FG002|Induction|Lost to Follow-up|0
968502|NCT01190930|1970271|FG003|Induction|Lost to Follow-up|0
968503|NCT01190930|1970272|FG004|Induction|Lost to Follow-up|0
968504|NCT01190930|1970273|FG005|Induction|Lost to Follow-up|0
968505|NCT01190930|1970274|FG006|Induction|Lost to Follow-up|0
968506|NCT01190930|1970275|FG007|Induction|Lost to Follow-up|0
968507|NCT01190930|1970276|FG008|Induction|Lost to Follow-up|0
968508|NCT01190930|1970277|FG009|Induction|Lost to Follow-up|0
968509|NCT01190930|1970268|FG000|Induction|Physician Decision|125
968510|NCT01190930|1970269|FG001|Induction|Physician Decision|3
968511|NCT01190930|1970270|FG002|Induction|Physician Decision|0
968512|NCT01190930|1970271|FG003|Induction|Physician Decision|0
968513|NCT01190930|1970272|FG004|Induction|Physician Decision|0
968514|NCT01190930|1970273|FG005|Induction|Physician Decision|0
968515|NCT01190930|1970274|FG006|Induction|Physician Decision|0
968516|NCT01190930|1970275|FG007|Induction|Physician Decision|0
968517|NCT01190930|1970276|FG008|Induction|Physician Decision|0
968518|NCT01190930|1970277|FG009|Induction|Physician Decision|0
968519|NCT01190930|1970268|FG000|Induction|Withdrawal by Subject|9
968520|NCT01190930|1970269|FG001|Induction|Withdrawal by Subject|0
968521|NCT01190930|1970270|FG002|Induction|Withdrawal by Subject|0
968522|NCT01190930|1970271|FG003|Induction|Withdrawal by Subject|0
968523|NCT01190930|1970272|FG004|Induction|Withdrawal by Subject|0
968524|NCT01190930|1970273|FG005|Induction|Withdrawal by Subject|0
968525|NCT01190930|1970274|FG006|Induction|Withdrawal by Subject|0
968526|NCT01190930|1970275|FG007|Induction|Withdrawal by Subject|0
968527|NCT01190930|1970276|FG008|Induction|Withdrawal by Subject|0
968528|NCT01190930|1970277|FG009|Induction|Withdrawal by Subject|0
968529|NCT01190930|1970268|FG000|Induction|Refusal|235
968530|NCT01190930|1970269|FG001|Induction|Refusal|0
968531|NCT01190930|1970270|FG002|Induction|Refusal|0
968532|NCT01190930|1970271|FG003|Induction|Refusal|0
968533|NCT01190930|1970272|FG004|Induction|Refusal|0
968534|NCT01190930|1970273|FG005|Induction|Refusal|0
968535|NCT01190930|1970274|FG006|Induction|Refusal|0
968536|NCT01190930|1970275|FG007|Induction|Refusal|0
968537|NCT01190930|1970276|FG008|Induction|Refusal|0
968538|NCT01190930|1970277|FG009|Induction|Refusal|0
968539|NCT01190930|1970268|FG000|Induction|Inevaluable|23
968540|NCT01190930|1970269|FG001|Induction|Inevaluable|1
968541|NCT01190930|1970270|FG002|Induction|Inevaluable|0
968542|NCT01190930|1970271|FG003|Induction|Inevaluable|0
968543|NCT01190930|1970272|FG004|Induction|Inevaluable|0
968544|NCT01190930|1970273|FG005|Induction|Inevaluable|0
968545|NCT01190930|1970274|FG006|Induction|Inevaluable|0
968546|NCT01190930|1970275|FG007|Induction|Inevaluable|0
968547|NCT01190930|1970276|FG008|Induction|Inevaluable|0
968548|NCT01190930|1970277|FG009|Induction|Inevaluable|0
968549|NCT01190930|1970268|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61
968550|NCT01190930|1970269|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
968551|NCT01190930|1970270|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
968552|NCT01190930|1970271|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
968553|NCT01190930|1970272|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
968554|NCT01190930|1970273|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
968555|NCT01190930|1970274|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
968556|NCT01190930|1970275|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
968557|NCT01190930|1970276|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
968558|NCT01190930|1970277|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
968559|NCT01190930|1970268|FG000|Induction|High Risk Downs|80
968560|NCT01190930|1970269|FG001|Induction|High Risk Downs|0
968561|NCT01190930|1970270|FG002|Induction|High Risk Downs|0
968562|NCT01190930|1970271|FG003|Induction|High Risk Downs|0
968563|NCT01190930|1970272|FG004|Induction|High Risk Downs|0
968564|NCT01190930|1970273|FG005|Induction|High Risk Downs|0
968565|NCT01190930|1970274|FG006|Induction|High Risk Downs|0
968566|NCT01190930|1970275|FG007|Induction|High Risk Downs|0
968567|NCT01190930|1970276|FG008|Induction|High Risk Downs|0
968568|NCT01190930|1970277|FG009|Induction|High Risk Downs|0
968569|NCT01190930|1970268|FG000|Induction|Enrollment onto another COG Protocol|1
968570|NCT01190930|1970269|FG001|Induction|Enrollment onto another COG Protocol|0
968571|NCT01190930|1970270|FG002|Induction|Enrollment onto another COG Protocol|0
968572|NCT01190930|1970271|FG003|Induction|Enrollment onto another COG Protocol|0
968573|NCT01190930|1970272|FG004|Induction|Enrollment onto another COG Protocol|0
968574|NCT01190930|1970273|FG005|Induction|Enrollment onto another COG Protocol|0
968575|NCT01190930|1970274|FG006|Induction|Enrollment onto another COG Protocol|0
968576|NCT01190930|1970275|FG007|Induction|Enrollment onto another COG Protocol|0
968577|NCT01190930|1970276|FG008|Induction|Enrollment onto another COG Protocol|0
968578|NCT01190930|1970277|FG009|Induction|Enrollment onto another COG Protocol|0
968579|NCT01190930|1970268|FG000|Induction|Average Risk|1847
968580|NCT01190930|1970269|FG001|Induction|Average Risk|0
968581|NCT01190930|1970270|FG002|Induction|Average Risk|0
968582|NCT01190930|1970271|FG003|Induction|Average Risk|0
968583|NCT01190930|1970272|FG004|Induction|Average Risk|0
968584|NCT01190930|1970273|FG005|Induction|Average Risk|0
968585|NCT01190930|1970274|FG006|Induction|Average Risk|0
968586|NCT01190930|1970275|FG007|Induction|Average Risk|0
968587|NCT01190930|1970276|FG008|Induction|Average Risk|0
968588|NCT01190930|1970277|FG009|Induction|Average Risk|0
968589|NCT01190930|1970268|FG000|Induction|High Risk|1227
968590|NCT01190930|1970269|FG001|Induction|High Risk|0
968591|NCT01190930|1970270|FG002|Induction|High Risk|0
968592|NCT01190930|1970271|FG003|Induction|High Risk|0
968593|NCT01190930|1970272|FG004|Induction|High Risk|0
968594|NCT01190930|1970273|FG005|Induction|High Risk|0
968595|NCT01190930|1970274|FG006|Induction|High Risk|0
968596|NCT01190930|1970275|FG007|Induction|High Risk|0
968597|NCT01190930|1970276|FG008|Induction|High Risk|0
968598|NCT01190930|1970277|FG009|Induction|High Risk|0
968599|NCT01190930|1970268|FG000|Induction|Low Risk|443
968600|NCT01190930|1970269|FG001|Induction|Low Risk|0
968601|NCT01190930|1970270|FG002|Induction|Low Risk|0
968602|NCT01190930|1970271|FG003|Induction|Low Risk|0
968603|NCT01190930|1970272|FG004|Induction|Low Risk|0
968604|NCT01190930|1970273|FG005|Induction|Low Risk|0
968605|NCT01190930|1970274|FG006|Induction|Low Risk|0
968606|NCT01190930|1970275|FG007|Induction|Low Risk|0
968607|NCT01190930|1970276|FG008|Induction|Low Risk|0
968608|NCT01190930|1970277|FG009|Induction|Low Risk|0
968609|NCT01190930|1970268|FG000|Induction|Very High Risk|1012
968610|NCT01190930|1970269|FG001|Induction|Very High Risk|0
968611|NCT01190930|1970270|FG002|Induction|Very High Risk|0
968612|NCT01190930|1970271|FG003|Induction|Very High Risk|0
968613|NCT01190930|1970272|FG004|Induction|Very High Risk|0
968614|NCT01190930|1970273|FG005|Induction|Very High Risk|0
968615|NCT01190930|1970274|FG006|Induction|Very High Risk|0
968616|NCT01190930|1970275|FG007|Induction|Very High Risk|0
968617|NCT01190930|1970276|FG008|Induction|Very High Risk|0
968618|NCT01190930|1970277|FG009|Induction|Very High Risk|0
968619|NCT01190930|1970268|FG000|Induction|Philadelphia chromosome-positive|99
968620|NCT01190930|1970269|FG001|Induction|Philadelphia chromosome-positive|0
968621|NCT01190930|1970270|FG002|Induction|Philadelphia chromosome-positive|0
968622|NCT01190930|1970271|FG003|Induction|Philadelphia chromosome-positive|0
968623|NCT01190930|1970272|FG004|Induction|Philadelphia chromosome-positive|0
968624|NCT01190930|1970273|FG005|Induction|Philadelphia chromosome-positive|0
968625|NCT01190930|1970274|FG006|Induction|Philadelphia chromosome-positive|0
968626|NCT01190930|1970275|FG007|Induction|Philadelphia chromosome-positive|0
968627|NCT01190930|1970276|FG008|Induction|Philadelphia chromosome-positive|0
968628|NCT01190930|1970277|FG009|Induction|Philadelphia chromosome-positive|0
968629|NCT01190930|1970268|FG000|Induction|Incomplete Induction data|63
968630|NCT01190930|1970269|FG001|Induction|Incomplete Induction data|0
968631|NCT01190930|1970270|FG002|Induction|Incomplete Induction data|0
968632|NCT01190930|1970271|FG003|Induction|Incomplete Induction data|0
968633|NCT01190930|1970272|FG004|Induction|Incomplete Induction data|0
968634|NCT01190930|1970273|FG005|Induction|Incomplete Induction data|0
968635|NCT01190930|1970274|FG006|Induction|Incomplete Induction data|0
968636|NCT01190930|1970275|FG007|Induction|Incomplete Induction data|0
968637|NCT01190930|1970276|FG008|Induction|Incomplete Induction data|0
968638|NCT01190930|1970277|FG009|Induction|Incomplete Induction data|0
968639|NCT01190930|1970268|FG000|Induction|Progressive disease|0
968640|NCT01190930|1970269|FG001|Induction|Progressive disease|1
968641|NCT01190930|1970270|FG002|Induction|Progressive disease|0
968642|NCT01190930|1970271|FG003|Induction|Progressive disease|0
968643|NCT01190930|1970272|FG004|Induction|Progressive disease|0
968644|NCT01190930|1970273|FG005|Induction|Progressive disease|0
968645|NCT01190930|1970274|FG006|Induction|Progressive disease|0
968646|NCT01190930|1970275|FG007|Induction|Progressive disease|0
968647|NCT01190930|1970276|FG008|Induction|Progressive disease|0
968648|NCT01190930|1970277|FG009|Induction|Progressive disease|0
968649|NCT01190930|1970268|FG000|Induction|No treatment|3
968650|NCT01190930|1970269|FG001|Induction|No treatment|0
968651|NCT01190930|1970270|FG002|Induction|No treatment|0
968652|NCT01190930|1970271|FG003|Induction|No treatment|0
968653|NCT01190930|1970272|FG004|Induction|No treatment|0
968654|NCT01190930|1970273|FG005|Induction|No treatment|0
968655|NCT01190930|1970274|FG006|Induction|No treatment|0
968656|NCT01190930|1970275|FG007|Induction|No treatment|0
968657|NCT01190930|1970276|FG008|Induction|No treatment|0
968658|NCT01190930|1970277|FG009|Induction|No treatment|0
968659|NCT01190930|1970268|FG000|Induction|Ineligible|69
968660|NCT01190930|1970269|FG001|Induction|Ineligible|4
968661|NCT01190930|1970270|FG002|Induction|Ineligible|0
968662|NCT01190930|1970271|FG003|Induction|Ineligible|0
968663|NCT01190930|1970272|FG004|Induction|Ineligible|0
968664|NCT01190930|1970273|FG005|Induction|Ineligible|0
968665|NCT01190930|1970274|FG006|Induction|Ineligible|0
968666|NCT01190930|1970275|FG007|Induction|Ineligible|0
968667|NCT01190930|1970276|FG008|Induction|Ineligible|0
968668|NCT01190930|1970277|FG009|Induction|Ineligible|0
968669|NCT01190930|1970268|FG000|Post Induction Pre-Maintenance|Adverse Event|0
968670|NCT01190930|1970269|FG001|Post Induction Pre-Maintenance|Adverse Event|0
968671|NCT01190930|1970270|FG002|Post Induction Pre-Maintenance|Adverse Event|8
968672|NCT01190930|1970271|FG003|Post Induction Pre-Maintenance|Adverse Event|0
968673|NCT01190930|1970272|FG004|Post Induction Pre-Maintenance|Adverse Event|0
968674|NCT01190930|1970273|FG005|Post Induction Pre-Maintenance|Adverse Event|0
968675|NCT01190930|1970274|FG006|Post Induction Pre-Maintenance|Adverse Event|0
968676|NCT01190930|1970275|FG007|Post Induction Pre-Maintenance|Adverse Event|0
968677|NCT01190930|1970276|FG008|Post Induction Pre-Maintenance|Adverse Event|0
968678|NCT01190930|1970277|FG009|Post Induction Pre-Maintenance|Adverse Event|0
968679|NCT01190930|1970268|FG000|Post Induction Pre-Maintenance|Death|0
968680|NCT01190930|1970269|FG001|Post Induction Pre-Maintenance|Death|0
968681|NCT01190930|1970270|FG002|Post Induction Pre-Maintenance|Death|8
968682|NCT01190930|1970271|FG003|Post Induction Pre-Maintenance|Death|4
968683|NCT01190930|1970272|FG004|Post Induction Pre-Maintenance|Death|0
968684|NCT01190930|1970273|FG005|Post Induction Pre-Maintenance|Death|0
968685|NCT01190930|1970274|FG006|Post Induction Pre-Maintenance|Death|0
968686|NCT01190930|1970275|FG007|Post Induction Pre-Maintenance|Death|0
968687|NCT01190930|1970276|FG008|Post Induction Pre-Maintenance|Death|0
968688|NCT01190930|1970277|FG009|Post Induction Pre-Maintenance|Death|0
968689|NCT01190930|1970268|FG000|Post Induction Pre-Maintenance|Physician Decision|0
968690|NCT01190930|1970269|FG001|Post Induction Pre-Maintenance|Physician Decision|2
968691|NCT01190930|1970270|FG002|Post Induction Pre-Maintenance|Physician Decision|35
968692|NCT01190930|1970271|FG003|Post Induction Pre-Maintenance|Physician Decision|7
968693|NCT01190930|1970272|FG004|Post Induction Pre-Maintenance|Physician Decision|5
968694|NCT01190930|1970273|FG005|Post Induction Pre-Maintenance|Physician Decision|3
968695|NCT01190930|1970274|FG006|Post Induction Pre-Maintenance|Physician Decision|0
968696|NCT01190930|1970275|FG007|Post Induction Pre-Maintenance|Physician Decision|0
968697|NCT01190930|1970276|FG008|Post Induction Pre-Maintenance|Physician Decision|0
968698|NCT01190930|1970277|FG009|Post Induction Pre-Maintenance|Physician Decision|0
968699|NCT01190930|1970268|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0
968700|NCT01190930|1970269|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1
968701|NCT01190930|1970270|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5
968702|NCT01190930|1970271|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2
968703|NCT01190930|1970272|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0
968704|NCT01190930|1970273|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0
968705|NCT01190930|1970274|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0
968706|NCT01190930|1970275|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0
968707|NCT01190930|1970276|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0
968708|NCT01190930|1970277|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0
968709|NCT01190930|1970268|FG000|Post Induction Pre-Maintenance|Refusal|0
968710|NCT01190930|1970269|FG001|Post Induction Pre-Maintenance|Refusal|2
968711|NCT01190930|1970270|FG002|Post Induction Pre-Maintenance|Refusal|694
968712|NCT01190930|1970271|FG003|Post Induction Pre-Maintenance|Refusal|4
968713|NCT01190930|1970272|FG004|Post Induction Pre-Maintenance|Refusal|0
968714|NCT01190930|1970273|FG005|Post Induction Pre-Maintenance|Refusal|3
968715|NCT01190930|1970274|FG006|Post Induction Pre-Maintenance|Refusal|0
968716|NCT01190930|1970275|FG007|Post Induction Pre-Maintenance|Refusal|0
968717|NCT01190930|1970276|FG008|Post Induction Pre-Maintenance|Refusal|0
968718|NCT01190930|1970277|FG009|Post Induction Pre-Maintenance|Refusal|0
968719|NCT01190930|1970268|FG000|Post Induction Pre-Maintenance|Inevaluable|0
968720|NCT01190930|1970269|FG001|Post Induction Pre-Maintenance|Inevaluable|0
968721|NCT01190930|1970270|FG002|Post Induction Pre-Maintenance|Inevaluable|6
968722|NCT01190930|1970271|FG003|Post Induction Pre-Maintenance|Inevaluable|0
968723|NCT01190930|1970272|FG004|Post Induction Pre-Maintenance|Inevaluable|0
968724|NCT01190930|1970273|FG005|Post Induction Pre-Maintenance|Inevaluable|0
968725|NCT01190930|1970274|FG006|Post Induction Pre-Maintenance|Inevaluable|0
968726|NCT01190930|1970275|FG007|Post Induction Pre-Maintenance|Inevaluable|0
968727|NCT01190930|1970276|FG008|Post Induction Pre-Maintenance|Inevaluable|0
968728|NCT01190930|1970277|FG009|Post Induction Pre-Maintenance|Inevaluable|0
968729|NCT01190930|1970268|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
968730|NCT01190930|1970269|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1
968731|NCT01190930|1970270|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
968732|NCT01190930|1970271|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
968733|NCT01190930|1970272|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
968734|NCT01190930|1970273|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
968735|NCT01190930|1970274|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
968736|NCT01190930|1970275|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
968737|NCT01190930|1970276|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
968738|NCT01190930|1970277|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
968739|NCT01190930|1970268|FG000|Post Induction Pre-Maintenance|Progressive disease|0
968740|NCT01190930|1970269|FG001|Post Induction Pre-Maintenance|Progressive disease|0
968741|NCT01190930|1970270|FG002|Post Induction Pre-Maintenance|Progressive disease|1
968742|NCT01190930|1970271|FG003|Post Induction Pre-Maintenance|Progressive disease|0
968743|NCT01190930|1970272|FG004|Post Induction Pre-Maintenance|Progressive disease|0
968744|NCT01190930|1970273|FG005|Post Induction Pre-Maintenance|Progressive disease|0
968745|NCT01190930|1970274|FG006|Post Induction Pre-Maintenance|Progressive disease|0
968746|NCT01190930|1970275|FG007|Post Induction Pre-Maintenance|Progressive disease|0
968747|NCT01190930|1970276|FG008|Post Induction Pre-Maintenance|Progressive disease|0
968748|NCT01190930|1970277|FG009|Post Induction Pre-Maintenance|Progressive disease|0
968749|NCT01190930|1970268|FG000|Post Induction Pre-Maintenance|Relapse|0
968750|NCT01190930|1970269|FG001|Post Induction Pre-Maintenance|Relapse|0
968751|NCT01190930|1970270|FG002|Post Induction Pre-Maintenance|Relapse|1
968752|NCT01190930|1970271|FG003|Post Induction Pre-Maintenance|Relapse|0
968753|NCT01190930|1970272|FG004|Post Induction Pre-Maintenance|Relapse|0
968754|NCT01190930|1970273|FG005|Post Induction Pre-Maintenance|Relapse|0
968755|NCT01190930|1970274|FG006|Post Induction Pre-Maintenance|Relapse|0
968756|NCT01190930|1970275|FG007|Post Induction Pre-Maintenance|Relapse|0
968757|NCT01190930|1970276|FG008|Post Induction Pre-Maintenance|Relapse|0
968758|NCT01190930|1970277|FG009|Post Induction Pre-Maintenance|Relapse|0
968759|NCT01190930|1970268|FG000|Maintenance|Adverse Event|0
968760|NCT01190930|1970269|FG001|Maintenance|Adverse Event|0
968761|NCT01190930|1970270|FG002|Maintenance|Adverse Event|0
968762|NCT01190930|1970271|FG003|Maintenance|Adverse Event|0
968763|NCT01190930|1970272|FG004|Maintenance|Adverse Event|0
968764|NCT01190930|1970273|FG005|Maintenance|Adverse Event|1
968765|NCT01190930|1970274|FG006|Maintenance|Adverse Event|1
968766|NCT01190930|1970275|FG007|Maintenance|Adverse Event|3
968767|NCT01190930|1970276|FG008|Maintenance|Adverse Event|3
968768|NCT01190930|1970277|FG009|Maintenance|Adverse Event|0
968769|NCT01190930|1970268|FG000|Maintenance|Death|0
968770|NCT01190930|1970269|FG001|Maintenance|Death|0
968771|NCT01190930|1970270|FG002|Maintenance|Death|0
968772|NCT01190930|1970271|FG003|Maintenance|Death|1
968773|NCT01190930|1970272|FG004|Maintenance|Death|0
968774|NCT01190930|1970273|FG005|Maintenance|Death|0
968775|NCT01190930|1970274|FG006|Maintenance|Death|2
968776|NCT01190930|1970275|FG007|Maintenance|Death|2
968777|NCT01190930|1970276|FG008|Maintenance|Death|2
968778|NCT01190930|1970277|FG009|Maintenance|Death|2
968779|NCT01190930|1970268|FG000|Maintenance|Lost to Follow-up|0
968780|NCT01190930|1970269|FG001|Maintenance|Lost to Follow-up|0
968781|NCT01190930|1970270|FG002|Maintenance|Lost to Follow-up|0
968782|NCT01190930|1970271|FG003|Maintenance|Lost to Follow-up|0
968783|NCT01190930|1970272|FG004|Maintenance|Lost to Follow-up|0
968784|NCT01190930|1970273|FG005|Maintenance|Lost to Follow-up|0
968785|NCT01190930|1970274|FG006|Maintenance|Lost to Follow-up|1
968786|NCT01190930|1970275|FG007|Maintenance|Lost to Follow-up|1
968787|NCT01190930|1970276|FG008|Maintenance|Lost to Follow-up|1
968788|NCT01190930|1970277|FG009|Maintenance|Lost to Follow-up|0
968789|NCT01190930|1970268|FG000|Maintenance|Physician Decision|0
968790|NCT01190930|1970269|FG001|Maintenance|Physician Decision|1
968791|NCT01190930|1970270|FG002|Maintenance|Physician Decision|0
968792|NCT01190930|1970271|FG003|Maintenance|Physician Decision|5
968793|NCT01190930|1970272|FG004|Maintenance|Physician Decision|9
968794|NCT01190930|1970273|FG005|Maintenance|Physician Decision|4
968795|NCT01190930|1970274|FG006|Maintenance|Physician Decision|8
968796|NCT01190930|1970275|FG007|Maintenance|Physician Decision|8
968797|NCT01190930|1970276|FG008|Maintenance|Physician Decision|10
968798|NCT01190930|1970277|FG009|Maintenance|Physician Decision|17
968799|NCT01190930|1970268|FG000|Maintenance|Withdrawal by Subject|0
968800|NCT01190930|1970269|FG001|Maintenance|Withdrawal by Subject|0
968801|NCT01190930|1970270|FG002|Maintenance|Withdrawal by Subject|0
968802|NCT01190930|1970271|FG003|Maintenance|Withdrawal by Subject|0
968803|NCT01190930|1970272|FG004|Maintenance|Withdrawal by Subject|0
968804|NCT01190930|1970273|FG005|Maintenance|Withdrawal by Subject|0
968805|NCT01190930|1970274|FG006|Maintenance|Withdrawal by Subject|2
968806|NCT01190930|1970275|FG007|Maintenance|Withdrawal by Subject|1
968807|NCT01190930|1970276|FG008|Maintenance|Withdrawal by Subject|4
968808|NCT01190930|1970277|FG009|Maintenance|Withdrawal by Subject|1
968809|NCT01190930|1970268|FG000|Maintenance|Refusal|0
968810|NCT01190930|1970269|FG001|Maintenance|Refusal|1
968811|NCT01190930|1970270|FG002|Maintenance|Refusal|0
968812|NCT01190930|1970271|FG003|Maintenance|Refusal|2
968813|NCT01190930|1970272|FG004|Maintenance|Refusal|0
968814|NCT01190930|1970273|FG005|Maintenance|Refusal|4
968815|NCT01190930|1970274|FG006|Maintenance|Refusal|5
968816|NCT01190930|1970275|FG007|Maintenance|Refusal|17
968817|NCT01190930|1970276|FG008|Maintenance|Refusal|13
968818|NCT01190930|1970277|FG009|Maintenance|Refusal|6
968819|NCT01190930|1970268|FG000|Maintenance|second malignant neoplasm|0
968820|NCT01190930|1970269|FG001|Maintenance|second malignant neoplasm|0
968821|NCT01190930|1970270|FG002|Maintenance|second malignant neoplasm|0
968822|NCT01190930|1970271|FG003|Maintenance|second malignant neoplasm|1
968823|NCT01190930|1970272|FG004|Maintenance|second malignant neoplasm|0
968824|NCT01190930|1970273|FG005|Maintenance|second malignant neoplasm|1
968825|NCT01190930|1970274|FG006|Maintenance|second malignant neoplasm|0
968826|NCT01190930|1970275|FG007|Maintenance|second malignant neoplasm|0
968827|NCT01190930|1970276|FG008|Maintenance|second malignant neoplasm|1
968828|NCT01190930|1970277|FG009|Maintenance|second malignant neoplasm|0
968829|NCT01190930|1970268|FG000|Maintenance|Inevaluable|0
968830|NCT01190930|1970269|FG001|Maintenance|Inevaluable|0
968831|NCT01190930|1970270|FG002|Maintenance|Inevaluable|0
968832|NCT01190930|1970271|FG003|Maintenance|Inevaluable|0
968833|NCT01190930|1970272|FG004|Maintenance|Inevaluable|0
968834|NCT01190930|1970273|FG005|Maintenance|Inevaluable|1
968835|NCT01190930|1970274|FG006|Maintenance|Inevaluable|1
968836|NCT01190930|1970275|FG007|Maintenance|Inevaluable|1
968837|NCT01190930|1970276|FG008|Maintenance|Inevaluable|0
968838|NCT01190930|1970277|FG009|Maintenance|Inevaluable|0
968839|NCT01190930|1970268|FG000|Maintenance|Enrollment onto another COG Protocol|0
968840|NCT01190930|1970269|FG001|Maintenance|Enrollment onto another COG Protocol|0
968841|NCT01190930|1970270|FG002|Maintenance|Enrollment onto another COG Protocol|0
968842|NCT01190930|1970271|FG003|Maintenance|Enrollment onto another COG Protocol|0
968843|NCT01190930|1970272|FG004|Maintenance|Enrollment onto another COG Protocol|0
968844|NCT01190930|1970273|FG005|Maintenance|Enrollment onto another COG Protocol|0
968845|NCT01190930|1970274|FG006|Maintenance|Enrollment onto another COG Protocol|0
968846|NCT01190930|1970275|FG007|Maintenance|Enrollment onto another COG Protocol|0
968847|NCT01190930|1970276|FG008|Maintenance|Enrollment onto another COG Protocol|1
968848|NCT01190930|1970277|FG009|Maintenance|Enrollment onto another COG Protocol|0
968849|NCT01190930|1970268|FG000|Maintenance|Relapse|0
968850|NCT01190930|1970269|FG001|Maintenance|Relapse|0
968851|NCT01190930|1970270|FG002|Maintenance|Relapse|0
968852|NCT01190930|1970271|FG003|Maintenance|Relapse|2
968853|NCT01190930|1970272|FG004|Maintenance|Relapse|0
968854|NCT01190930|1970273|FG005|Maintenance|Relapse|1
968855|NCT01190930|1970274|FG006|Maintenance|Relapse|6
968856|NCT01190930|1970275|FG007|Maintenance|Relapse|13
968857|NCT01190930|1970276|FG008|Maintenance|Relapse|11
968858|NCT01190930|1970277|FG009|Maintenance|Relapse|11
968859|NCT01190930|1970268|FG000|Maintenance|Still on therapy|0
968860|NCT01190930|1970269|FG001|Maintenance|Still on therapy|8
968861|NCT01190930|1970270|FG002|Maintenance|Still on therapy|0
968862|NCT01190930|1970271|FG003|Maintenance|Still on therapy|29
968863|NCT01190930|1970272|FG004|Maintenance|Still on therapy|0
968864|NCT01190930|1970273|FG005|Maintenance|Still on therapy|0
968865|NCT01190930|1970274|FG006|Maintenance|Still on therapy|0
968866|NCT01190930|1970275|FG007|Maintenance|Still on therapy|0
968867|NCT01190930|1970276|FG008|Maintenance|Still on therapy|0
968868|NCT01190930|1970277|FG009|Maintenance|Still on therapy|0
968869|NCT01191008|1970301|FG000|Overall Study|Protocol Violation|7
968870|NCT01191008|1970301|FG000|Overall Study|Lost to Follow-up|8
968871|NCT01191086|1970305|FG000|Overall Study|Adverse Event|20
968872|NCT01191086|1970305|FG000|Overall Study|Lack of Efficacy|10
968873|NCT01191086|1970305|FG000|Overall Study|Lost to Follow-up|4
968874|NCT01191086|1970305|FG000|Overall Study|Physician Decision|2
968875|NCT01191086|1970305|FG000|Overall Study|Withdrawal by Subject|24
968876|NCT01191086|1970305|FG000|Overall Study|Discontinuation criterion met|1
968877|NCT01191086|1970305|FG000|Overall Study|Other|1
968878|NCT01191190|1970309|FG000|Overall Study|Withdrawal by Subject|1
968879|NCT01191268|1970337|FG000|Overall Study|Withdrawal by Subject|19
968880|NCT01191268|1970338|FG001|Overall Study|Withdrawal by Subject|25
968881|NCT01191268|1970339|FG002|Overall Study|Withdrawal by Subject|21
968882|NCT01191268|1970337|FG000|Overall Study|Adverse Event|21
968883|NCT01191268|1970338|FG001|Overall Study|Adverse Event|13
968884|NCT01191268|1970339|FG002|Overall Study|Adverse Event|8
968885|NCT01191268|1970337|FG000|Overall Study|Physician Decision|6
968886|NCT01191268|1970338|FG001|Overall Study|Physician Decision|8
968887|NCT01191268|1970339|FG002|Overall Study|Physician Decision|9
968888|NCT01191268|1970337|FG000|Overall Study|Lost to Follow-up|8
968889|NCT01191268|1970338|FG001|Overall Study|Lost to Follow-up|5
968890|NCT01191268|1970339|FG002|Overall Study|Lost to Follow-up|9
968891|NCT01191268|1970337|FG000|Overall Study|Entry Criteria Not Met|3
968892|NCT01191268|1970338|FG001|Overall Study|Entry Criteria Not Met|1
968893|NCT01191268|1970339|FG002|Overall Study|Entry Criteria Not Met|1
968894|NCT01191268|1970337|FG000|Overall Study|Death|0
968895|NCT01191268|1970338|FG001|Overall Study|Death|1
968896|NCT01191268|1970339|FG002|Overall Study|Death|3
968897|NCT01191268|1970337|FG000|Overall Study|Protocol Violation|1
968898|NCT01191268|1970338|FG001|Overall Study|Protocol Violation|0
968899|NCT01191268|1970339|FG002|Overall Study|Protocol Violation|1
968900|NCT01191268|1970337|FG000|Overall Study|Sponsor Decision|0
968901|NCT01191268|1970338|FG001|Overall Study|Sponsor Decision|2
968902|NCT01191268|1970339|FG002|Overall Study|Sponsor Decision|0
968903|NCT01191762|1970479|FG000|Overall Study|Adverse Event|1
968904|NCT01191762|1970480|FG001|Overall Study|Adverse Event|0
968905|NCT01191788|1970488|FG000|Overall Study|Lost to Follow-up|21
968906|NCT01191788|1970489|FG001|Overall Study|Lost to Follow-up|22
968907|NCT01191801|1970498|FG000|Overall Study|Death|36
968908|NCT01191801|1970499|FG001|Overall Study|Death|12
968909|NCT01191801|1970498|FG000|Overall Study|Lack of Efficacy|176
968910|NCT01191801|1970499|FG001|Overall Study|Lack of Efficacy|258
968911|NCT01191801|1970498|FG000|Overall Study|Adverse Event|9
968912|NCT01191801|1970499|FG001|Overall Study|Adverse Event|8
968913|NCT01191801|1970498|FG000|Overall Study|Protocol Violation|2
968914|NCT01191801|1970499|FG001|Overall Study|Protocol Violation|4
968915|NCT01191801|1970498|FG000|Overall Study|Physician Decision|47
968916|NCT01191801|1970499|FG001|Overall Study|Physician Decision|24
968917|NCT01191801|1970498|FG000|Overall Study|Withdrawal by Subject|1
968918|NCT01191801|1970499|FG001|Overall Study|Withdrawal by Subject|4
968919|NCT01191801|1970498|FG000|Overall Study|Not Provided|45
968920|NCT01191801|1970499|FG001|Overall Study|Not Provided|27
968921|NCT01191840|1970516|FG000|Overall Study|withdrew consent|2
968922|NCT01191840|1970517|FG001|Overall Study|withdrew consent|1
968923|NCT01191840|1970516|FG000|Overall Study|Subject discontinued treatment|1
968924|NCT01191840|1970517|FG001|Overall Study|Subject discontinued treatment|2
968925|NCT01191840|1970516|FG000|Overall Study|Lost to Follow-up|4
968926|NCT01191840|1970517|FG001|Overall Study|Lost to Follow-up|6
968927|NCT01191840|1970516|FG000|Overall Study|Non Staph Infection|4
968928|NCT01191840|1970517|FG001|Overall Study|Non Staph Infection|3
968929|NCT01191840|1970516|FG000|Overall Study|ineligible at enrollment|1
968930|NCT01191840|1970517|FG001|Overall Study|ineligible at enrollment|0
968931|NCT01191840|1970516|FG000|Overall Study|IRB approval lapse|0
968932|NCT01191840|1970517|FG001|Overall Study|IRB approval lapse|2
968933|NCT01191840|1970516|FG000|Overall Study|lab error speciation - non Staph infecti|0
968934|NCT01191840|1970517|FG001|Overall Study|lab error speciation - non Staph infecti|1
968935|NCT01191840|1970516|FG000|Overall Study|Withdrawal by Subject|2
968936|NCT01191840|1970517|FG001|Overall Study|Withdrawal by Subject|0
968937|NCT01191944|1970525|FG000|Overall Study|Adverse Event|11
968938|NCT01191944|1970526|FG001|Overall Study|Adverse Event|12
968939|NCT01191944|1970525|FG000|Overall Study|Protocol Violation|1
968940|NCT01191944|1970526|FG001|Overall Study|Protocol Violation|2
968941|NCT01191944|1970525|FG000|Overall Study|Withdrawal by Subject|4
968942|NCT01191944|1970526|FG001|Overall Study|Withdrawal by Subject|2
968943|NCT01191944|1970525|FG000|Overall Study|Other|1
968944|NCT01191944|1970526|FG001|Overall Study|Other|3
968945|NCT01192022|1970536|FG000|Overall Study|Withdrawal of Consent|3
968946|NCT01192022|1970537|FG001|Overall Study|Withdrawal of Consent|1
968947|NCT01192022|1970538|FG002|Overall Study|Withdrawal of Consent|0
968948|NCT01192022|1970539|FG003|Overall Study|Withdrawal of Consent|0
968949|NCT01192022|1970540|FG004|Overall Study|Withdrawal of Consent|0
968950|NCT01192022|1970536|FG000|Overall Study|Lost to Follow-up|4
968951|NCT01192022|1970537|FG001|Overall Study|Lost to Follow-up|2
968952|NCT01192022|1970538|FG002|Overall Study|Lost to Follow-up|1
968953|NCT01192022|1970539|FG003|Overall Study|Lost to Follow-up|1
968954|NCT01192022|1970540|FG004|Overall Study|Lost to Follow-up|0
968955|NCT01192022|1970536|FG000|Overall Study|Adverse Event|1
968956|NCT01192022|1970537|FG001|Overall Study|Adverse Event|0
968957|NCT01192022|1970538|FG002|Overall Study|Adverse Event|0
968958|NCT01192022|1970539|FG003|Overall Study|Adverse Event|0
968959|NCT01192022|1970540|FG004|Overall Study|Adverse Event|0
968960|NCT01192022|1970536|FG000|Overall Study|Fatal Adverse Event|4
968961|NCT01192022|1970537|FG001|Overall Study|Fatal Adverse Event|6
968962|NCT01192022|1970538|FG002|Overall Study|Fatal Adverse Event|0
968963|NCT01192022|1970539|FG003|Overall Study|Fatal Adverse Event|0
968964|NCT01192022|1970540|FG004|Overall Study|Fatal Adverse Event|1
968965|NCT01192022|1970536|FG000|Overall Study|Physician withdrew-patient hardship|1
968966|NCT01192022|1970537|FG001|Overall Study|Physician withdrew-patient hardship|0
968967|NCT01192022|1970538|FG002|Overall Study|Physician withdrew-patient hardship|0
968968|NCT01192022|1970539|FG003|Overall Study|Physician withdrew-patient hardship|0
968969|NCT01192022|1970540|FG004|Overall Study|Physician withdrew-patient hardship|0
968970|NCT01192022|1970536|FG000|Overall Study|Patient too sick from chemotherapy|0
968971|NCT01192022|1970537|FG001|Overall Study|Patient too sick from chemotherapy|1
968972|NCT01192022|1970538|FG002|Overall Study|Patient too sick from chemotherapy|0
968973|NCT01192022|1970539|FG003|Overall Study|Patient too sick from chemotherapy|0
968974|NCT01192022|1970540|FG004|Overall Study|Patient too sick from chemotherapy|0
968975|NCT01192022|1970536|FG000|Overall Study|Patient needed surgery|0
968976|NCT01192022|1970537|FG001|Overall Study|Patient needed surgery|1
968977|NCT01192022|1970538|FG002|Overall Study|Patient needed surgery|0
968978|NCT01192022|1970539|FG003|Overall Study|Patient needed surgery|0
968979|NCT01192022|1970540|FG004|Overall Study|Patient needed surgery|0
968980|NCT01192022|1970536|FG000|Overall Study|Parents did not allow all follow up|0
968981|NCT01192022|1970537|FG001|Overall Study|Parents did not allow all follow up|0
968982|NCT01192022|1970538|FG002|Overall Study|Parents did not allow all follow up|0
968983|NCT01192022|1970539|FG003|Overall Study|Parents did not allow all follow up|1
968984|NCT01192022|1970540|FG004|Overall Study|Parents did not allow all follow up|0
968985|NCT01192100|1970551|FG000|Overall Study|Withdrawal by Subject|0
968986|NCT01192100|1970552|FG001|Overall Study|Withdrawal by Subject|0
968987|NCT01192100|1970553|FG002|Overall Study|Withdrawal by Subject|0
968988|NCT01192100|1970554|FG003|Overall Study|Withdrawal by Subject|0
968989|NCT01192100|1970555|FG004|Overall Study|Withdrawal by Subject|1
968990|NCT01192100|1970556|FG005|Overall Study|Withdrawal by Subject|0
968991|NCT01192100|1970551|FG000|Overall Study|Protocol Violation|0
968992|NCT01192100|1970552|FG001|Overall Study|Protocol Violation|0
968993|NCT01192100|1970553|FG002|Overall Study|Protocol Violation|0
968994|NCT01192100|1970554|FG003|Overall Study|Protocol Violation|1
968995|NCT01192100|1970555|FG004|Overall Study|Protocol Violation|0
968996|NCT01192100|1970556|FG005|Overall Study|Protocol Violation|0
968997|NCT01192126|1970566|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
968998|NCT01192126|1970567|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
968999|NCT01192126|1970566|FG000|First Intervention (1 Week)|Lost to Follow-up|1
969000|NCT01192126|1970567|FG001|First Intervention (1 Week)|Lost to Follow-up|1
969001|NCT01192152|1970586|FG000|Period 1|left prematurely (while on treatment B)|0
969002|NCT01192152|1970587|FG001|Period 1|left prematurely (while on treatment B)|1
969003|NCT01192152|1970586|FG000|Period 3|family emergency|1
969004|NCT01192152|1970587|FG001|Period 3|family emergency|0
969005|NCT01192178|1970597|FG000|Overall Study|Withdrawal by Subject|6
969006|NCT01192178|1970598|FG001|Overall Study|Withdrawal by Subject|10
969007|NCT01192178|1970597|FG000|Overall Study|Protocol Violation|10
969008|NCT01192178|1970598|FG001|Overall Study|Protocol Violation|3
969009|NCT01192178|1970597|FG000|Overall Study|Physician Decision|2
969010|NCT01192178|1970598|FG001|Overall Study|Physician Decision|4
969011|NCT01192178|1970597|FG000|Overall Study|Lost to Follow-up|3
969012|NCT01192178|1970598|FG001|Overall Study|Lost to Follow-up|3
969013|NCT01192178|1970597|FG000|Overall Study|Adverse Event|2
969014|NCT01192178|1970598|FG001|Overall Study|Adverse Event|1
969015|NCT01192178|1970597|FG000|Overall Study|Lack of Efficacy|1
969016|NCT01192178|1970598|FG001|Overall Study|Lack of Efficacy|2
969017|NCT01192191|1970608|FG000|Overall Study|Adverse Event|7
969018|NCT01192191|1970609|FG001|Overall Study|Adverse Event|12
969019|NCT01192191|1970608|FG000|Overall Study|Participants Reached Stopping Criteria|3
969020|NCT01192191|1970609|FG001|Overall Study|Participants Reached Stopping Criteria|2
969021|NCT01192191|1970608|FG000|Overall Study|Lost to Follow-up|0
969022|NCT01192191|1970609|FG001|Overall Study|Lost to Follow-up|1
969023|NCT01192191|1970608|FG000|Overall Study|Withdrawal by Subject|1
969024|NCT01192191|1970609|FG001|Overall Study|Withdrawal by Subject|6
969025|NCT01192204|1970617|FG000|Overall Study|could not keep recall appointments|1
969026|NCT01192204|1970618|FG001|Overall Study|could not keep recall appointments|0
969027|NCT01192295|1970643|FG000|Overall Study|Adverse Event|3
969028|NCT01192295|1970644|FG001|Overall Study|Adverse Event|7
969029|NCT01192295|1970643|FG000|Overall Study|Withdrawal by Subject|3
969030|NCT01192295|1970644|FG001|Overall Study|Withdrawal by Subject|4
969031|NCT01192295|1970643|FG000|Overall Study|Lost to Follow-up|0
969032|NCT01192295|1970644|FG001|Overall Study|Lost to Follow-up|1
969033|NCT01192295|1970643|FG000|Overall Study|Lack of Efficacy|0
969034|NCT01192295|1970644|FG001|Overall Study|Lack of Efficacy|5
969035|NCT01192295|1970643|FG000|Overall Study|Administrative|4
969036|NCT01192295|1970644|FG001|Overall Study|Administrative|6
969037|NCT01192347|1970652|FG000|Overall Study|Death|3
969038|NCT01192347|1970652|FG000|Overall Study|Lost to Follow-up|3
969039|NCT01192347|1970652|FG000|Overall Study|Withdrawal by Subject|1
969040|NCT01192347|1970652|FG000|Overall Study|Adverse Event|1
969041|NCT01192347|1970652|FG000|Overall Study|Suspected serious adverse drug reaction|1
969042|NCT01192347|1970652|FG000|Overall Study|Patient seen in different hospital|1
969043|NCT01192347|1970652|FG000|Overall Study|Patient not visiting hospital regularly|1
969044|NCT01192347|1970652|FG000|Overall Study|Patient did not show up for visits|1
969045|NCT01192399|1970656|FG000|Overall Study|Lack of Efficacy|2
969046|NCT01192412|1970662|FG000|Overall Study|Lost to Follow-up|2
969047|NCT01192412|1970663|FG001|Overall Study|Lost to Follow-up|1
969048|NCT01192412|1970662|FG000|Overall Study|Withdrawal by Subject|2
969049|NCT01192412|1970663|FG001|Overall Study|Withdrawal by Subject|1
969050|NCT01192516|1970672|FG000|Overall Study|Lost to Follow-up|7
969051|NCT01192516|1970673|FG001|Overall Study|Lost to Follow-up|10
969052|NCT01192516|1970674|FG002|Overall Study|Lost to Follow-up|7
969053|NCT01192516|1970672|FG000|Overall Study|Withdrawal by Subject|4
969054|NCT01192516|1970673|FG001|Overall Study|Withdrawal by Subject|4
969055|NCT01192516|1970674|FG002|Overall Study|Withdrawal by Subject|1
969056|NCT01192516|1970672|FG000|Overall Study|started new treatment|5
969057|NCT01192516|1970673|FG001|Overall Study|started new treatment|1
969058|NCT01192516|1970674|FG002|Overall Study|started new treatment|0
969059|NCT01192516|1970672|FG000|Overall Study|Unable to follow Actiwatch instructions|4
969060|NCT01192516|1970673|FG001|Overall Study|Unable to follow Actiwatch instructions|2
969061|NCT01192516|1970674|FG002|Overall Study|Unable to follow Actiwatch instructions|0
969062|NCT01192776|1970708|FG000|Overall Study|Death|8
969063|NCT01192776|1970709|FG001|Overall Study|Death|15
969064|NCT01192776|1970710|FG002|Overall Study|Death|18
969065|NCT01192776|1970711|FG003|Overall Study|Death|15
969066|NCT01192776|1970708|FG000|Overall Study|Lost to Follow-up|3
969067|NCT01192776|1970709|FG001|Overall Study|Lost to Follow-up|6
969068|NCT01192776|1970710|FG002|Overall Study|Lost to Follow-up|3
969069|NCT01192776|1970711|FG003|Overall Study|Lost to Follow-up|5
969070|NCT01192815|1970723|FG000|Overall Study|Withdrawal by Subject|1
969071|NCT01192815|1970723|FG000|Overall Study|Lack of Efficacy|1
969072|NCT01193101|1970753|FG000|Overall Study|Adverse Event|0
969073|NCT01193101|1970754|FG001|Overall Study|Adverse Event|1
969074|NCT01193101|1970755|FG002|Overall Study|Adverse Event|1
969075|NCT01193101|1970756|FG003|Overall Study|Adverse Event|3
969076|NCT01193101|1970753|FG000|Overall Study|Lack of Efficacy|3
969077|NCT01193101|1970754|FG001|Overall Study|Lack of Efficacy|1
969078|NCT01193101|1970755|FG002|Overall Study|Lack of Efficacy|0
969079|NCT01193101|1970756|FG003|Overall Study|Lack of Efficacy|8
969080|NCT01193101|1970753|FG000|Overall Study|Withdrawal by Subject|2
969081|NCT01193101|1970754|FG001|Overall Study|Withdrawal by Subject|4
969082|NCT01193101|1970755|FG002|Overall Study|Withdrawal by Subject|1
969083|NCT01193101|1970756|FG003|Overall Study|Withdrawal by Subject|1
969084|NCT01193101|1970753|FG000|Overall Study|Administrative problems|0
969085|NCT01193101|1970754|FG001|Overall Study|Administrative problems|0
969086|NCT01193101|1970755|FG002|Overall Study|Administrative problems|1
969087|NCT01193101|1970756|FG003|Overall Study|Administrative problems|0
969088|NCT01193101|1970753|FG000|Overall Study|Abnormal test procedure results|0
969089|NCT01193101|1970754|FG001|Overall Study|Abnormal test procedure results|1
969090|NCT01193101|1970755|FG002|Overall Study|Abnormal test procedure results|0
1006626|NCT01468701|2025301|FG016|Overall Study|Not being followed up|0
969091|NCT01193101|1970756|FG003|Overall Study|Abnormal test procedure results|0
969092|NCT01193127|1970779|FG000|Randomized|Surgery Cancelled|0
969093|NCT01193127|1970780|FG001|Randomized|Surgery Cancelled|0
969094|NCT01193127|1970781|FG002|Randomized|Surgery Cancelled|0
969095|NCT01193127|1970782|FG003|Randomized|Surgery Cancelled|1
969096|NCT01193127|1970779|FG000|Treated|Withdrawal by Subject|0
969097|NCT01193127|1970780|FG001|Treated|Withdrawal by Subject|0
969098|NCT01193127|1970781|FG002|Treated|Withdrawal by Subject|0
969099|NCT01193127|1970782|FG003|Treated|Withdrawal by Subject|1
969100|NCT01193153|1970794|FG000|Open-label Lead in Period|Lost to Follow-up|32
969101|NCT01193153|1970795|FG001|Open-label Lead in Period|Lost to Follow-up|0
969102|NCT01193153|1970794|FG000|Open-label Lead in Period|Pregnancy|1
969103|NCT01193153|1970795|FG001|Open-label Lead in Period|Pregnancy|0
969104|NCT01193153|1970794|FG000|Open-label Lead in Period|Withdrawal by Subject|69
969105|NCT01193153|1970795|FG001|Open-label Lead in Period|Withdrawal by Subject|0
969106|NCT01193153|1970794|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
969107|NCT01193153|1970795|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
969108|NCT01193153|1970794|FG000|Open-label Lead in Period|Other|14
969109|NCT01193153|1970795|FG001|Open-label Lead in Period|Other|0
969110|NCT01193153|1970794|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
969111|NCT01193153|1970795|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
969112|NCT01193153|1970794|FG000|Open-label Lead in Period|Adverse Event|41
969113|NCT01193153|1970795|FG001|Open-label Lead in Period|Adverse Event|0
969114|NCT01193153|1970794|FG000|Open-label Lead in Period|Death|1
969115|NCT01193153|1970795|FG001|Open-label Lead in Period|Death|0
969116|NCT01193153|1970794|FG000|Open-label Lead in Period|Lack of Efficacy|26
969117|NCT01193153|1970795|FG001|Open-label Lead in Period|Lack of Efficacy|0
969118|NCT01193153|1970794|FG000|Open-label Stabilization Period|Adverse Event|9
969119|NCT01193153|1970795|FG001|Open-label Stabilization Period|Adverse Event|0
969120|NCT01193153|1970794|FG000|Open-label Stabilization Period|Death|2
969121|NCT01193153|1970795|FG001|Open-label Stabilization Period|Death|0
969122|NCT01193153|1970794|FG000|Open-label Stabilization Period|Lost to Follow-up|10
969123|NCT01193153|1970795|FG001|Open-label Stabilization Period|Lost to Follow-up|0
969124|NCT01193153|1970794|FG000|Open-label Stabilization Period|Lack of Efficacy|5
969125|NCT01193153|1970795|FG001|Open-label Stabilization Period|Lack of Efficacy|0
969126|NCT01193153|1970794|FG000|Open-label Stabilization Period|Withdrawal by Subject|29
969127|NCT01193153|1970795|FG001|Open-label Stabilization Period|Withdrawal by Subject|0
969128|NCT01193153|1970794|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
969129|NCT01193153|1970795|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
969130|NCT01193153|1970794|FG000|Open-label Stabilization Period|Other|8
969131|NCT01193153|1970795|FG001|Open-label Stabilization Period|Other|0
969132|NCT01193153|1970794|FG000|Double Blind Relapse Prevention Period|Other|2
969133|NCT01193153|1970795|FG001|Double Blind Relapse Prevention Period|Other|3
969134|NCT01193153|1970794|FG000|Double Blind Relapse Prevention Period|Adverse Event|12
969135|NCT01193153|1970795|FG001|Double Blind Relapse Prevention Period|Adverse Event|3
969136|NCT01193153|1970794|FG000|Double Blind Relapse Prevention Period|Death|2
969137|NCT01193153|1970795|FG001|Double Blind Relapse Prevention Period|Death|0
969138|NCT01193153|1970794|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2
969139|NCT01193153|1970795|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9
969140|NCT01193153|1970794|FG000|Double Blind Relapse Prevention Period|Pregnancy|1
969141|NCT01193153|1970795|FG001|Double Blind Relapse Prevention Period|Pregnancy|0
969142|NCT01193153|1970794|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
969143|NCT01193153|1970795|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
969144|NCT01193153|1970794|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25
969145|NCT01193153|1970795|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57
969146|NCT01193153|1970794|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
969147|NCT01193153|1970795|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
969148|NCT01193218|1970809|FG000|0-12 Weeks|Adverse Event|6
969149|NCT01193218|1970810|FG001|0-12 Weeks|Adverse Event|0
969150|NCT01193218|1970811|FG002|0-12 Weeks|Adverse Event|1
969151|NCT01193218|1970812|FG003|0-12 Weeks|Adverse Event|0
969152|NCT01193218|1970813|FG004|0-12 Weeks|Adverse Event|0
969153|NCT01193218|1970814|FG005|0-12 Weeks|Adverse Event|2
969154|NCT01193218|1970815|FG006|0-12 Weeks|Adverse Event|2
969155|NCT01193218|1970816|FG007|0-12 Weeks|Adverse Event|0
969156|NCT01193218|1970809|FG000|0-12 Weeks|Protocol Violation|0
969157|NCT01193218|1970810|FG001|0-12 Weeks|Protocol Violation|0
969158|NCT01193218|1970811|FG002|0-12 Weeks|Protocol Violation|0
969159|NCT01193218|1970812|FG003|0-12 Weeks|Protocol Violation|0
969160|NCT01193218|1970813|FG004|0-12 Weeks|Protocol Violation|1
969161|NCT01193218|1970814|FG005|0-12 Weeks|Protocol Violation|1
969162|NCT01193218|1970815|FG006|0-12 Weeks|Protocol Violation|0
969163|NCT01193218|1970816|FG007|0-12 Weeks|Protocol Violation|0
969164|NCT01193218|1970809|FG000|0-12 Weeks|Withdrawal by Subject|3
969165|NCT01193218|1970810|FG001|0-12 Weeks|Withdrawal by Subject|0
969166|NCT01193218|1970811|FG002|0-12 Weeks|Withdrawal by Subject|2
969167|NCT01193218|1970812|FG003|0-12 Weeks|Withdrawal by Subject|0
969168|NCT01193218|1970813|FG004|0-12 Weeks|Withdrawal by Subject|0
969169|NCT01193218|1970814|FG005|0-12 Weeks|Withdrawal by Subject|0
969170|NCT01193218|1970815|FG006|0-12 Weeks|Withdrawal by Subject|1
969171|NCT01193218|1970816|FG007|0-12 Weeks|Withdrawal by Subject|0
969172|NCT01193218|1970809|FG000|12-52 Weeks|Adverse Event|1
969173|NCT01193218|1970810|FG001|12-52 Weeks|Adverse Event|0
969174|NCT01193218|1970811|FG002|12-52 Weeks|Adverse Event|1
969175|NCT01193218|1970812|FG003|12-52 Weeks|Adverse Event|2
969176|NCT01193218|1970813|FG004|12-52 Weeks|Adverse Event|3
969177|NCT01193218|1970814|FG005|12-52 Weeks|Adverse Event|3
969178|NCT01193218|1970815|FG006|12-52 Weeks|Adverse Event|1
969179|NCT01193218|1970816|FG007|12-52 Weeks|Adverse Event|2
969180|NCT01193218|1970809|FG000|12-52 Weeks|Lack of Efficacy|0
969181|NCT01193218|1970810|FG001|12-52 Weeks|Lack of Efficacy|0
969182|NCT01193218|1970811|FG002|12-52 Weeks|Lack of Efficacy|0
969183|NCT01193218|1970812|FG003|12-52 Weeks|Lack of Efficacy|0
969184|NCT01193218|1970813|FG004|12-52 Weeks|Lack of Efficacy|0
969185|NCT01193218|1970814|FG005|12-52 Weeks|Lack of Efficacy|0
969186|NCT01193218|1970815|FG006|12-52 Weeks|Lack of Efficacy|1
969187|NCT01193218|1970816|FG007|12-52 Weeks|Lack of Efficacy|0
969188|NCT01193218|1970809|FG000|12-52 Weeks|Withdrawal by Subject|3
969189|NCT01193218|1970810|FG001|12-52 Weeks|Withdrawal by Subject|0
969190|NCT01193218|1970811|FG002|12-52 Weeks|Withdrawal by Subject|3
969191|NCT01193218|1970812|FG003|12-52 Weeks|Withdrawal by Subject|0
969192|NCT01193218|1970813|FG004|12-52 Weeks|Withdrawal by Subject|0
969193|NCT01193218|1970814|FG005|12-52 Weeks|Withdrawal by Subject|2
969194|NCT01193218|1970815|FG006|12-52 Weeks|Withdrawal by Subject|1
969195|NCT01193218|1970816|FG007|12-52 Weeks|Withdrawal by Subject|2
969196|NCT01193218|1970809|FG000|12-52 Weeks|Other reason than above|1
969197|NCT01193218|1970810|FG001|12-52 Weeks|Other reason than above|0
969198|NCT01193218|1970811|FG002|12-52 Weeks|Other reason than above|0
969199|NCT01193218|1970812|FG003|12-52 Weeks|Other reason than above|1
969200|NCT01193218|1970813|FG004|12-52 Weeks|Other reason than above|1
969201|NCT01193218|1970814|FG005|12-52 Weeks|Other reason than above|0
969202|NCT01193218|1970815|FG006|12-52 Weeks|Other reason than above|0
969203|NCT01193218|1970816|FG007|12-52 Weeks|Other reason than above|0
969204|NCT01193244|1970834|FG000|Overall Study|Withdrawal by Subject|79
969205|NCT01193244|1970835|FG001|Overall Study|Withdrawal by Subject|97
969206|NCT01193244|1970834|FG000|Overall Study|Other|303
969207|NCT01193244|1970835|FG001|Overall Study|Other|278
969208|NCT01193244|1970834|FG000|Overall Study|Lost to Follow-up|6
969209|NCT01193244|1970835|FG001|Overall Study|Lost to Follow-up|15
969210|NCT01193257|1970843|FG000|Overall Study|Death|202
969211|NCT01193257|1970844|FG001|Overall Study|Death|391
969212|NCT01193257|1970843|FG000|Overall Study|Study termination by sponsor|0
969213|NCT01193257|1970844|FG001|Overall Study|Study termination by sponsor|3
969214|NCT01193257|1970843|FG000|Overall Study|Withdrawal by Subject|26
969215|NCT01193257|1970844|FG001|Overall Study|Withdrawal by Subject|86
969216|NCT01193257|1970843|FG000|Overall Study|Lost to Follow-up|2
969217|NCT01193257|1970844|FG001|Overall Study|Lost to Follow-up|3
969218|NCT01193257|1970843|FG000|Overall Study|Unblinded due to futility|135
969219|NCT01193257|1970844|FG001|Overall Study|Unblinded due to futility|251
969220|NCT01193283|1970850|FG000|Overall Study|Death|1
969221|NCT01193335|1970856|FG000|After Infant Series|Lost to Follow-up|1
969222|NCT01193335|1970857|FG001|After Infant Series|Lost to Follow-up|2
969223|NCT01193335|1970856|FG000|After Infant Series|No Longer Met Eligibility Criteria|0
969224|NCT01193335|1970857|FG001|After Infant Series|No Longer Met Eligibility Criteria|1
969225|NCT01193335|1970856|FG000|1-Year Follow-up|No Longer Willing to Participate|7
969226|NCT01193335|1970857|FG001|1-Year Follow-up|No Longer Willing to Participate|9
969227|NCT01193335|1970856|FG000|1-Year Follow-up|Lost to Follow-up|4
969228|NCT01193335|1970857|FG001|1-Year Follow-up|Lost to Follow-up|0
969229|NCT01193335|1970856|FG000|2-Year Follow-up|No Longer Willing to Participate|5
969230|NCT01193335|1970857|FG001|2-Year Follow-up|No Longer Willing to Participate|6
969231|NCT01193335|1970856|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2
969232|NCT01193335|1970857|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2
969233|NCT01193348|1970879|FG000|Screening Period|Screen Failure|5
969234|NCT01193348|1970879|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
969235|NCT01193348|1970879|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1
969236|NCT01193348|1970879|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
969237|NCT01193348|1970879|FG000|Extension Treatment Period|Physician Decision|1
969238|NCT01193348|1970879|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
969239|NCT01193517|1970891|FG000|Overall Study|Early Progression|1
969240|NCT01193517|1970892|FG001|Overall Study|Early Progression|0
969241|NCT01193517|1970893|FG002|Overall Study|Early Progression|0
969242|NCT01193582|1970906|FG000|Vaccination Series|Withdrawal by Subject|11
969243|NCT01193582|1970907|FG001|Vaccination Series|Withdrawal by Subject|13
969244|NCT01193582|1970908|FG002|Vaccination Series|Withdrawal by Subject|8
969245|NCT01193582|1970909|FG003|Vaccination Series|Withdrawal by Subject|3
969246|NCT01193582|1970906|FG000|12 Month Follow-up|Death|0
969247|NCT01193582|1970907|FG001|12 Month Follow-up|Death|0
969248|NCT01193582|1970908|FG002|12 Month Follow-up|Death|1
969249|NCT01193582|1970909|FG003|12 Month Follow-up|Death|0
969250|NCT01193582|1970906|FG000|12 Month Follow-up|Withdrawal by Subject|6
969251|NCT01193582|1970907|FG001|12 Month Follow-up|Withdrawal by Subject|0
969252|NCT01193582|1970908|FG002|12 Month Follow-up|Withdrawal by Subject|3
969253|NCT01193582|1970909|FG003|12 Month Follow-up|Withdrawal by Subject|11
969254|NCT01193608|1970927|FG000|Overall Study|Other|0
969255|NCT01193608|1970928|FG001|Overall Study|Other|1
969256|NCT01193608|1970929|FG002|Overall Study|Other|0
969257|NCT01193608|1970930|FG003|Overall Study|Other|0
969258|NCT01193608|1970931|FG004|Overall Study|Other|0
969259|NCT01193608|1970932|FG005|Overall Study|Other|0
969260|NCT01193608|1970927|FG000|Overall Study|Withdrawal by Subject|0
969261|NCT01193608|1970928|FG001|Overall Study|Withdrawal by Subject|1
969262|NCT01193608|1970929|FG002|Overall Study|Withdrawal by Subject|2
969263|NCT01193608|1970930|FG003|Overall Study|Withdrawal by Subject|3
969264|NCT01193608|1970931|FG004|Overall Study|Withdrawal by Subject|3
969265|NCT01193608|1970932|FG005|Overall Study|Withdrawal by Subject|0
969266|NCT01193608|1970927|FG000|Overall Study|Lost to Follow-up|0
969267|NCT01193608|1970928|FG001|Overall Study|Lost to Follow-up|0
969268|NCT01193608|1970929|FG002|Overall Study|Lost to Follow-up|0
969269|NCT01193608|1970930|FG003|Overall Study|Lost to Follow-up|0
969270|NCT01193608|1970931|FG004|Overall Study|Lost to Follow-up|1
969271|NCT01193608|1970932|FG005|Overall Study|Lost to Follow-up|2
969272|NCT01193608|1970927|FG000|Overall Study|Adverse Event|0
969273|NCT01193608|1970928|FG001|Overall Study|Adverse Event|0
969274|NCT01193608|1970929|FG002|Overall Study|Adverse Event|0
969275|NCT01193608|1970930|FG003|Overall Study|Adverse Event|0
969276|NCT01193608|1970931|FG004|Overall Study|Adverse Event|1
969277|NCT01193608|1970932|FG005|Overall Study|Adverse Event|0
969278|NCT01193660|1970954|FG000|Overall Study|Withdrawal by Subject|2
969279|NCT01193660|1970955|FG001|Overall Study|Withdrawal by Subject|3
969280|NCT01193660|1970956|FG002|Overall Study|Withdrawal by Subject|1
969281|NCT01193660|1970954|FG000|Overall Study|Death|1
969282|NCT01193660|1970955|FG001|Overall Study|Death|0
969283|NCT01193660|1970956|FG002|Overall Study|Death|0
969284|NCT01193660|1970954|FG000|Overall Study|Physician Decision|1
969285|NCT01193660|1970955|FG001|Overall Study|Physician Decision|0
969286|NCT01193660|1970956|FG002|Overall Study|Physician Decision|1
969287|NCT01193686|1970966|FG000|Overall Study|Withdrawal by Subject|4
969288|NCT01193686|1970967|FG001|Overall Study|Withdrawal by Subject|1
969289|NCT01193686|1970966|FG000|Overall Study|Removed by Investigators; unable to matc|3
969290|NCT01193686|1970967|FG001|Overall Study|Removed by Investigators; unable to matc|0
969331|NCT01193920|1971031|FG000|Overall Study|Withdrawal by Subject|1
969332|NCT01193920|1971032|FG001|Overall Study|Withdrawal by Subject|0
969333|NCT01193920|1971033|FG002|Overall Study|Withdrawal by Subject|5
969334|NCT01193920|1971034|FG003|Overall Study|Withdrawal by Subject|1
969335|NCT01193920|1971035|FG004|Overall Study|Withdrawal by Subject|3
969336|NCT01193920|1971036|FG005|Overall Study|Withdrawal by Subject|1
969337|NCT01193920|1971037|FG006|Overall Study|Withdrawal by Subject|3
969338|NCT01193920|1971038|FG007|Overall Study|Withdrawal by Subject|0
969339|NCT01193920|1971039|FG008|Overall Study|Withdrawal by Subject|1
969340|NCT01193920|1971040|FG009|Overall Study|Withdrawal by Subject|0
969341|NCT01193920|1971031|FG000|Overall Study|Lost to Follow-up|1
969342|NCT01193920|1971032|FG001|Overall Study|Lost to Follow-up|0
969343|NCT01193920|1971033|FG002|Overall Study|Lost to Follow-up|1
969344|NCT01193920|1971034|FG003|Overall Study|Lost to Follow-up|1
969345|NCT01193920|1971035|FG004|Overall Study|Lost to Follow-up|3
969346|NCT01193920|1971036|FG005|Overall Study|Lost to Follow-up|3
969347|NCT01193920|1971037|FG006|Overall Study|Lost to Follow-up|1
969348|NCT01193920|1971038|FG007|Overall Study|Lost to Follow-up|0
969349|NCT01193920|1971039|FG008|Overall Study|Lost to Follow-up|2
969350|NCT01193920|1971040|FG009|Overall Study|Lost to Follow-up|3
969351|NCT01193920|1971031|FG000|Overall Study|Protocol Violation|1
969352|NCT01193920|1971032|FG001|Overall Study|Protocol Violation|0
969353|NCT01193920|1971033|FG002|Overall Study|Protocol Violation|0
969354|NCT01193920|1971034|FG003|Overall Study|Protocol Violation|0
969355|NCT01193920|1971035|FG004|Overall Study|Protocol Violation|0
969356|NCT01193920|1971036|FG005|Overall Study|Protocol Violation|0
969357|NCT01193920|1971037|FG006|Overall Study|Protocol Violation|0
969358|NCT01193920|1971038|FG007|Overall Study|Protocol Violation|0
969359|NCT01193920|1971039|FG008|Overall Study|Protocol Violation|0
969360|NCT01193920|1971040|FG009|Overall Study|Protocol Violation|0
969361|NCT01193920|1971031|FG000|Overall Study|Death|0
969362|NCT01193920|1971032|FG001|Overall Study|Death|0
969363|NCT01193920|1971033|FG002|Overall Study|Death|0
969364|NCT01193920|1971034|FG003|Overall Study|Death|1
969365|NCT01193920|1971035|FG004|Overall Study|Death|0
969366|NCT01193920|1971036|FG005|Overall Study|Death|0
969367|NCT01193920|1971037|FG006|Overall Study|Death|2
969368|NCT01193920|1971038|FG007|Overall Study|Death|3
969369|NCT01193920|1971039|FG008|Overall Study|Death|2
969370|NCT01193920|1971040|FG009|Overall Study|Death|4
969371|NCT01193920|1971031|FG000|Overall Study|Unable to classify|0
969372|NCT01193920|1971032|FG001|Overall Study|Unable to classify|0
969373|NCT01193920|1971033|FG002|Overall Study|Unable to classify|0
969374|NCT01193920|1971034|FG003|Overall Study|Unable to classify|1
969375|NCT01193920|1971035|FG004|Overall Study|Unable to classify|0
969376|NCT01193920|1971036|FG005|Overall Study|Unable to classify|0
969377|NCT01193920|1971037|FG006|Overall Study|Unable to classify|0
969378|NCT01193920|1971038|FG007|Overall Study|Unable to classify|1
969379|NCT01193920|1971039|FG008|Overall Study|Unable to classify|0
969380|NCT01193920|1971040|FG009|Overall Study|Unable to classify|0
969381|NCT01194154|1971074|FG000|Overall Study|Adverse Event|12
969382|NCT01194154|1971075|FG001|Overall Study|Adverse Event|7
969383|NCT01194154|1971074|FG000|Overall Study|Lost to Follow-up|2
969384|NCT01194154|1971075|FG001|Overall Study|Lost to Follow-up|3
969385|NCT01194154|1971074|FG000|Overall Study|Protocol Violation|0
969386|NCT01194154|1971075|FG001|Overall Study|Protocol Violation|1
969387|NCT01194154|1971074|FG000|Overall Study|Withdrawal by Subject|5
969388|NCT01194154|1971075|FG001|Overall Study|Withdrawal by Subject|6
969389|NCT01194154|1971074|FG000|Overall Study|Blood pressure increase|5
969390|NCT01194154|1971075|FG001|Overall Study|Blood pressure increase|3
969391|NCT01194154|1971074|FG000|Overall Study|Hemoglobin decrease|0
969392|NCT01194154|1971075|FG001|Overall Study|Hemoglobin decrease|1
969393|NCT01194154|1971074|FG000|Overall Study|Hemoglobin increase|12
969394|NCT01194154|1971075|FG001|Overall Study|Hemoglobin increase|3
969395|NCT01194154|1971074|FG000|Overall Study|Skipping of CERA treatment at two visits|3
969396|NCT01194154|1971075|FG001|Overall Study|Skipping of CERA treatment at two visits|0
969397|NCT01194154|1971074|FG000|Overall Study|Treatment with prohibited medication|4
969398|NCT01194154|1971075|FG001|Overall Study|Treatment with prohibited medication|5
969399|NCT01194154|1971074|FG000|Overall Study|Other|4
969400|NCT01194154|1971075|FG001|Overall Study|Other|0
969401|NCT01194154|1971074|FG000|Overall Study|Did not receive study medication|2
969402|NCT01194154|1971075|FG001|Overall Study|Did not receive study medication|4
969403|NCT01194219|1971085|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
969404|NCT01194219|1971086|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
969405|NCT01194219|1971087|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
969406|NCT01194219|1971088|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
969407|NCT01194219|1971089|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
969408|NCT01194219|1971090|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
969409|NCT01194219|1971091|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
969410|NCT01194219|1971092|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
969411|NCT01194219|1971093|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
969412|NCT01194219|1971094|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
969413|NCT01194219|1971085|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
969414|NCT01194219|1971086|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
969415|NCT01194219|1971087|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
969416|NCT01194219|1971088|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
969417|NCT01194219|1971089|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
969418|NCT01194219|1971090|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
969419|NCT01194219|1971091|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
969420|NCT01194219|1971092|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
969421|NCT01194219|1971093|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
969422|NCT01194219|1971094|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
969423|NCT01194219|1971085|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
969424|NCT01194219|1971086|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
969425|NCT01194219|1971087|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
969426|NCT01194219|1971088|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
969427|NCT01194219|1971089|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
969428|NCT01194219|1971090|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
969429|NCT01194219|1971091|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
969430|NCT01194219|1971092|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
969431|NCT01194219|1971093|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
969432|NCT01194219|1971094|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
969433|NCT01194219|1971085|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
969434|NCT01194219|1971086|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
969435|NCT01194219|1971087|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
969436|NCT01194219|1971088|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
969437|NCT01194219|1971089|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
969438|NCT01194219|1971090|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
969439|NCT01194219|1971091|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
969440|NCT01194219|1971092|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
969441|NCT01194219|1971093|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
969442|NCT01194219|1971094|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
969443|NCT01194219|1971085|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0
969444|NCT01194219|1971086|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1
969445|NCT01194219|1971087|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0
969446|NCT01194219|1971088|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0
969447|NCT01194219|1971089|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0
969448|NCT01194219|1971090|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0
969449|NCT01194219|1971091|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0
969450|NCT01194219|1971092|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0
969451|NCT01194219|1971093|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0
969452|NCT01194219|1971094|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0
969453|NCT01194219|1971085|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
969454|NCT01194219|1971086|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
969455|NCT01194219|1971087|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
969456|NCT01194219|1971088|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
969457|NCT01194219|1971089|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
969458|NCT01194219|1971090|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
969459|NCT01194219|1971091|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
969460|NCT01194219|1971092|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
969461|NCT01194219|1971093|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
969462|NCT01194219|1971094|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
969463|NCT01194219|1971085|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
969464|NCT01194219|1971086|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
969465|NCT01194219|1971087|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
969466|NCT01194219|1971088|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
969467|NCT01194219|1971089|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
969468|NCT01194219|1971090|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
969469|NCT01194219|1971091|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
969470|NCT01194219|1971092|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
969471|NCT01194219|1971093|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
969472|NCT01194219|1971094|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
969473|NCT01194219|1971085|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
969474|NCT01194219|1971086|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
969475|NCT01194219|1971087|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
969476|NCT01194219|1971088|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
969477|NCT01194219|1971089|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
969478|NCT01194219|1971090|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
969479|NCT01194219|1971091|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
969480|NCT01194219|1971092|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
969481|NCT01194219|1971093|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
969482|NCT01194219|1971094|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
969483|NCT01194219|1971085|FG000|Maintenance Phase Weeks16-32|Adverse Event|0
969484|NCT01194219|1971086|FG001|Maintenance Phase Weeks16-32|Adverse Event|0
969485|NCT01194219|1971087|FG002|Maintenance Phase Weeks16-32|Adverse Event|8
969486|NCT01194219|1971088|FG003|Maintenance Phase Weeks16-32|Adverse Event|9
969487|NCT01194219|1971089|FG004|Maintenance Phase Weeks16-32|Adverse Event|0
969488|NCT01194219|1971090|FG005|Maintenance Phase Weeks16-32|Adverse Event|0
969489|NCT01194219|1971091|FG006|Maintenance Phase Weeks16-32|Adverse Event|0
969490|NCT01194219|1971092|FG007|Maintenance Phase Weeks16-32|Adverse Event|0
969491|NCT01194219|1971093|FG008|Maintenance Phase Weeks16-32|Adverse Event|0
969492|NCT01194219|1971094|FG009|Maintenance Phase Weeks16-32|Adverse Event|0
969493|NCT01194219|1971085|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0
969494|NCT01194219|1971086|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0
969495|NCT01194219|1971087|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37
969496|NCT01194219|1971088|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15
969497|NCT01194219|1971089|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0
969498|NCT01194219|1971090|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0
969499|NCT01194219|1971091|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0
969500|NCT01194219|1971092|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0
969501|NCT01194219|1971093|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0
969502|NCT01194219|1971094|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0
969503|NCT01194219|1971085|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
969504|NCT01194219|1971086|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
969505|NCT01194219|1971087|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
969506|NCT01194219|1971088|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
969507|NCT01194219|1971089|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
969508|NCT01194219|1971090|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
969509|NCT01194219|1971091|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
969510|NCT01194219|1971092|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
969511|NCT01194219|1971093|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
969512|NCT01194219|1971094|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
969513|NCT01194219|1971085|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
969514|NCT01194219|1971086|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
969515|NCT01194219|1971087|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
969516|NCT01194219|1971088|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
969517|NCT01194219|1971089|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
969518|NCT01194219|1971090|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
969519|NCT01194219|1971091|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
969520|NCT01194219|1971092|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
969521|NCT01194219|1971093|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
969522|NCT01194219|1971094|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
969523|NCT01194219|1971085|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0
969524|NCT01194219|1971086|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0
969525|NCT01194219|1971087|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9
969526|NCT01194219|1971088|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0
969527|NCT01194219|1971089|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0
969528|NCT01194219|1971090|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0
969529|NCT01194219|1971091|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0
969530|NCT01194219|1971092|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0
969531|NCT01194219|1971093|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0
969532|NCT01194219|1971094|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0
969533|NCT01194219|1971085|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0
969534|NCT01194219|1971086|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0
969535|NCT01194219|1971087|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0
969536|NCT01194219|1971088|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1
969537|NCT01194219|1971089|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0
969538|NCT01194219|1971090|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0
969539|NCT01194219|1971091|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0
969540|NCT01194219|1971092|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0
969541|NCT01194219|1971093|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0
969542|NCT01194219|1971094|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0
969543|NCT01194219|1971085|FG000|Maintenance Phase Weeks16-32|Other|0
969544|NCT01194219|1971086|FG001|Maintenance Phase Weeks16-32|Other|0
969545|NCT01194219|1971087|FG002|Maintenance Phase Weeks16-32|Other|2
969546|NCT01194219|1971088|FG003|Maintenance Phase Weeks16-32|Other|1
969547|NCT01194219|1971089|FG004|Maintenance Phase Weeks16-32|Other|0
969548|NCT01194219|1971090|FG005|Maintenance Phase Weeks16-32|Other|0
969549|NCT01194219|1971091|FG006|Maintenance Phase Weeks16-32|Other|0
969550|NCT01194219|1971092|FG007|Maintenance Phase Weeks16-32|Other|0
969551|NCT01194219|1971093|FG008|Maintenance Phase Weeks16-32|Other|0
969552|NCT01194219|1971094|FG009|Maintenance Phase Weeks16-32|Other|0
969553|NCT01194219|1971085|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
969554|NCT01194219|1971086|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
969555|NCT01194219|1971087|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
969556|NCT01194219|1971088|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
969557|NCT01194219|1971089|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
969558|NCT01194219|1971090|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
969559|NCT01194219|1971091|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
969560|NCT01194219|1971092|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
969561|NCT01194219|1971093|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
969562|NCT01194219|1971094|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
969563|NCT01194219|1971085|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
969564|NCT01194219|1971086|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
969565|NCT01194219|1971087|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
969566|NCT01194219|1971088|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
969567|NCT01194219|1971089|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
969568|NCT01194219|1971090|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
969569|NCT01194219|1971091|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
969570|NCT01194219|1971092|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
969571|NCT01194219|1971093|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
969572|NCT01194219|1971094|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
969573|NCT01194219|1971085|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
969574|NCT01194219|1971086|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
969575|NCT01194219|1971087|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
969576|NCT01194219|1971088|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
969577|NCT01194219|1971089|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
969578|NCT01194219|1971090|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
969579|NCT01194219|1971091|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
969580|NCT01194219|1971092|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
969581|NCT01194219|1971093|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
969582|NCT01194219|1971094|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
969583|NCT01194219|1971085|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
969584|NCT01194219|1971086|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
969585|NCT01194219|1971087|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
969586|NCT01194219|1971088|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
969587|NCT01194219|1971089|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
969588|NCT01194219|1971090|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
969589|NCT01194219|1971091|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
969590|NCT01194219|1971092|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
969591|NCT01194219|1971093|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
969592|NCT01194219|1971094|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
969593|NCT01194219|1971085|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
969594|NCT01194219|1971086|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
969595|NCT01194219|1971087|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
969596|NCT01194219|1971088|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
969597|NCT01194219|1971089|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
969598|NCT01194219|1971090|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
969599|NCT01194219|1971091|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
969600|NCT01194219|1971092|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
969601|NCT01194219|1971093|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
969602|NCT01194219|1971094|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
969603|NCT01194219|1971085|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
969604|NCT01194219|1971086|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
969605|NCT01194219|1971087|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
969606|NCT01194219|1971088|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
969607|NCT01194219|1971089|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
969608|NCT01194219|1971090|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
969609|NCT01194219|1971091|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
969610|NCT01194219|1971092|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
969611|NCT01194219|1971093|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
969612|NCT01194219|1971094|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
969613|NCT01194219|1971085|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0
969614|NCT01194219|1971086|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0
969615|NCT01194219|1971087|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0
969616|NCT01194219|1971088|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0
969617|NCT01194219|1971089|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0
969618|NCT01194219|1971090|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0
969619|NCT01194219|1971091|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1
969620|NCT01194219|1971092|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0
969621|NCT01194219|1971093|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0
969622|NCT01194219|1971094|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0
969623|NCT01194219|1971085|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0
969624|NCT01194219|1971086|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0
969625|NCT01194219|1971087|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0
969626|NCT01194219|1971088|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0
969627|NCT01194219|1971089|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1006627|NCT01468818|2025314|FG000|Overall Study|Death during treatment|2
969628|NCT01194219|1971090|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0
969629|NCT01194219|1971091|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0
969630|NCT01194219|1971092|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0
969631|NCT01194219|1971093|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25
969632|NCT01194219|1971094|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14
969633|NCT01194219|1971085|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
969634|NCT01194219|1971086|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
969635|NCT01194219|1971087|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
969636|NCT01194219|1971088|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
969637|NCT01194219|1971089|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
969638|NCT01194219|1971090|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
969639|NCT01194219|1971091|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
969640|NCT01194219|1971092|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
969641|NCT01194219|1971093|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
969642|NCT01194219|1971094|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
969643|NCT01194219|1971085|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
969644|NCT01194219|1971086|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
969645|NCT01194219|1971087|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
969646|NCT01194219|1971088|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
969647|NCT01194219|1971089|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
969648|NCT01194219|1971090|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
969649|NCT01194219|1971091|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
969650|NCT01194219|1971092|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
969651|NCT01194219|1971093|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
969652|NCT01194219|1971094|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
969653|NCT01194219|1971085|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
969654|NCT01194219|1971086|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
969655|NCT01194219|1971087|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
969656|NCT01194219|1971088|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
969657|NCT01194219|1971089|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
969658|NCT01194219|1971090|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
969659|NCT01194219|1971091|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
969660|NCT01194219|1971092|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
969661|NCT01194219|1971093|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
969662|NCT01194219|1971094|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
969663|NCT01194219|1971085|FG000|Long-Term Extension Weeks 52 to 260|Death|0
969664|NCT01194219|1971086|FG001|Long-Term Extension Weeks 52 to 260|Death|0
969665|NCT01194219|1971087|FG002|Long-Term Extension Weeks 52 to 260|Death|0
969666|NCT01194219|1971088|FG003|Long-Term Extension Weeks 52 to 260|Death|0
969667|NCT01194219|1971089|FG004|Long-Term Extension Weeks 52 to 260|Death|0
969668|NCT01194219|1971090|FG005|Long-Term Extension Weeks 52 to 260|Death|0
969669|NCT01194219|1971091|FG006|Long-Term Extension Weeks 52 to 260|Death|0
969670|NCT01194219|1971092|FG007|Long-Term Extension Weeks 52 to 260|Death|0
969671|NCT01194219|1971093|FG008|Long-Term Extension Weeks 52 to 260|Death|1
969672|NCT01194219|1971094|FG009|Long-Term Extension Weeks 52 to 260|Death|1
969673|NCT01194219|1971085|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
969674|NCT01194219|1971086|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
969675|NCT01194219|1971087|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
969676|NCT01194219|1971088|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
969677|NCT01194219|1971089|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
969678|NCT01194219|1971090|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
969679|NCT01194219|1971091|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
969680|NCT01194219|1971092|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
969681|NCT01194219|1971093|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
969682|NCT01194219|1971094|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
969683|NCT01194219|1971085|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
969684|NCT01194219|1971086|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
969685|NCT01194219|1971087|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
969686|NCT01194219|1971088|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
969687|NCT01194219|1971089|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
969688|NCT01194219|1971090|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
969689|NCT01194219|1971091|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
969690|NCT01194219|1971092|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
969691|NCT01194219|1971093|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
969692|NCT01194219|1971094|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
969693|NCT01194219|1971085|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
969694|NCT01194219|1971086|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
969695|NCT01194219|1971087|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
969696|NCT01194219|1971088|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
969697|NCT01194219|1971089|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
969698|NCT01194219|1971090|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
969699|NCT01194219|1971091|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
969700|NCT01194219|1971092|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
969701|NCT01194219|1971093|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
969702|NCT01194219|1971094|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
969703|NCT01194245|1971122|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
969704|NCT01194245|1971123|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
969705|NCT01194245|1971124|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
969706|NCT01194245|1971125|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
969707|NCT01194245|1971126|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
969708|NCT01194245|1971122|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3
969709|NCT01194245|1971123|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0
969710|NCT01194245|1971124|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0
969711|NCT01194245|1971125|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0
969712|NCT01194245|1971126|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0
969713|NCT01194245|1971122|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3
969714|NCT01194245|1971123|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0
969715|NCT01194245|1971124|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0
969716|NCT01194245|1971125|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0
969717|NCT01194245|1971126|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0
969718|NCT01194245|1971122|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
969719|NCT01194245|1971123|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
969720|NCT01194245|1971124|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
969721|NCT01194245|1971125|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
969722|NCT01194245|1971126|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
969723|NCT01194245|1971122|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
969724|NCT01194245|1971123|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
969725|NCT01194245|1971124|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
969726|NCT01194245|1971125|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
969727|NCT01194245|1971126|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
969728|NCT01194245|1971122|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
969729|NCT01194245|1971123|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
969730|NCT01194245|1971124|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
969731|NCT01194245|1971125|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
969732|NCT01194245|1971126|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
969733|NCT01194258|1971135|FG000|Titration Period|Withdrawal by Subject|6
969734|NCT01194258|1971136|FG001|Titration Period|Withdrawal by Subject|0
969735|NCT01194258|1971137|FG002|Titration Period|Withdrawal by Subject|0
969736|NCT01194258|1971138|FG003|Titration Period|Withdrawal by Subject|0
969737|NCT01194258|1971139|FG004|Titration Period|Withdrawal by Subject|0
969738|NCT01194258|1971135|FG000|Titration Period|Lost to Follow-up|2
969739|NCT01194258|1971136|FG001|Titration Period|Lost to Follow-up|0
969740|NCT01194258|1971137|FG002|Titration Period|Lost to Follow-up|0
969741|NCT01194258|1971138|FG003|Titration Period|Lost to Follow-up|0
969742|NCT01194258|1971139|FG004|Titration Period|Lost to Follow-up|0
969743|NCT01194258|1971135|FG000|Titration Period|Titration failure|3
969744|NCT01194258|1971136|FG001|Titration Period|Titration failure|0
969745|NCT01194258|1971137|FG002|Titration Period|Titration failure|0
969746|NCT01194258|1971138|FG003|Titration Period|Titration failure|0
969747|NCT01194258|1971139|FG004|Titration Period|Titration failure|0
969748|NCT01194258|1971135|FG000|Period 1 (12 Weeks)|Death|0
969749|NCT01194258|1971136|FG001|Period 1 (12 Weeks)|Death|0
969750|NCT01194258|1971137|FG002|Period 1 (12 Weeks)|Death|0
969751|NCT01194258|1971138|FG003|Period 1 (12 Weeks)|Death|0
969752|NCT01194258|1971139|FG004|Period 1 (12 Weeks)|Death|1
969753|NCT01194258|1971135|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0
969754|NCT01194258|1971136|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0
969755|NCT01194258|1971137|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0
969756|NCT01194258|1971138|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0
969757|NCT01194258|1971139|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2
969758|NCT01194258|1971135|FG000|Period 2 (12 Weeks)|Adverse Event|0
969759|NCT01194258|1971136|FG001|Period 2 (12 Weeks)|Adverse Event|1
969760|NCT01194258|1971137|FG002|Period 2 (12 Weeks)|Adverse Event|0
969761|NCT01194258|1971138|FG003|Period 2 (12 Weeks)|Adverse Event|0
969762|NCT01194258|1971139|FG004|Period 2 (12 Weeks)|Adverse Event|0
969763|NCT01194258|1971135|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0
969764|NCT01194258|1971136|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1
969765|NCT01194258|1971137|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1
969766|NCT01194258|1971138|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0
969767|NCT01194258|1971139|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0
969768|NCT01194271|1971150|FG000|Overall Study|Withdrawal by Subject|1
969769|NCT01194271|1971150|FG000|Overall Study|Ineligible, Screen Failure|1
969770|NCT01194271|1971150|FG000|Overall Study|Death|1
969771|NCT01194414|1971165|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
969772|NCT01194414|1971166|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
969773|NCT01194414|1971167|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
969774|NCT01194414|1971168|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
969775|NCT01194414|1971165|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
969776|NCT01194414|1971166|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
969777|NCT01194414|1971167|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
969778|NCT01194414|1971168|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
969779|NCT01194414|1971165|FG000|24 Weeks Double Blind Period|Protocol Violation|5
969780|NCT01194414|1971166|FG001|24 Weeks Double Blind Period|Protocol Violation|3
969781|NCT01194414|1971167|FG002|24 Weeks Double Blind Period|Protocol Violation|0
969782|NCT01194414|1971168|FG003|24 Weeks Double Blind Period|Protocol Violation|0
969783|NCT01194414|1971165|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
969784|NCT01194414|1971166|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
969785|NCT01194414|1971167|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
969786|NCT01194414|1971168|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
969787|NCT01194414|1971165|FG000|24 Weeks Double Blind Period|Pregnancy|2
969788|NCT01194414|1971166|FG001|24 Weeks Double Blind Period|Pregnancy|2
969789|NCT01194414|1971167|FG002|24 Weeks Double Blind Period|Pregnancy|0
969790|NCT01194414|1971168|FG003|24 Weeks Double Blind Period|Pregnancy|0
969791|NCT01194414|1971165|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2
969792|NCT01194414|1971166|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1
969793|NCT01194414|1971167|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0
969794|NCT01194414|1971168|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0
969795|NCT01194414|1971165|FG000|24 Weeks Double Blind Period|Other|0
969796|NCT01194414|1971166|FG001|24 Weeks Double Blind Period|Other|1
969797|NCT01194414|1971167|FG002|24 Weeks Double Blind Period|Other|0
969798|NCT01194414|1971168|FG003|24 Weeks Double Blind Period|Other|0
969799|NCT01194414|1971165|FG000|24 Weeks Double Blind Period|Adverse Event|28
969800|NCT01194414|1971166|FG001|24 Weeks Double Blind Period|Adverse Event|40
969801|NCT01194414|1971167|FG002|24 Weeks Double Blind Period|Adverse Event|0
969802|NCT01194414|1971168|FG003|24 Weeks Double Blind Period|Adverse Event|0
969803|NCT01194414|1971165|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
969804|NCT01194414|1971166|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
969805|NCT01194414|1971167|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
969806|NCT01194414|1971168|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
969807|NCT01194414|1971165|FG000|24 Weeks Double Blind Period|Death|0
969808|NCT01194414|1971166|FG001|24 Weeks Double Blind Period|Death|1
969809|NCT01194414|1971167|FG002|24 Weeks Double Blind Period|Death|0
969810|NCT01194414|1971168|FG003|24 Weeks Double Blind Period|Death|0
969811|NCT01194414|1971165|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3
969812|NCT01194414|1971166|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5
969813|NCT01194414|1971167|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0
969814|NCT01194414|1971168|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0
969815|NCT01194414|1971165|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
969816|NCT01194414|1971166|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
969817|NCT01194414|1971167|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
969818|NCT01194414|1971168|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
969819|NCT01194414|1971165|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
969820|NCT01194414|1971166|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
969821|NCT01194414|1971167|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
969822|NCT01194414|1971168|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
969823|NCT01194414|1971165|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4
969824|NCT01194414|1971166|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3
969825|NCT01194414|1971167|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2
969826|NCT01194414|1971168|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1
969827|NCT01194414|1971165|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
969828|NCT01194414|1971166|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
969829|NCT01194414|1971167|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
969830|NCT01194414|1971168|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
969831|NCT01194414|1971165|FG000|72 Weeks Open Label Extension|Pregnancy|1
969832|NCT01194414|1971166|FG001|72 Weeks Open Label Extension|Pregnancy|3
969833|NCT01194414|1971167|FG002|72 Weeks Open Label Extension|Pregnancy|1
969834|NCT01194414|1971168|FG003|72 Weeks Open Label Extension|Pregnancy|1
969835|NCT01194414|1971165|FG000|72 Weeks Open Label Extension|Other|2
969836|NCT01194414|1971166|FG001|72 Weeks Open Label Extension|Other|1
969837|NCT01194414|1971167|FG002|72 Weeks Open Label Extension|Other|0
969838|NCT01194414|1971168|FG003|72 Weeks Open Label Extension|Other|0
969839|NCT01194414|1971165|FG000|72 Weeks Open Label Extension|Protocol Violation|0
969840|NCT01194414|1971166|FG001|72 Weeks Open Label Extension|Protocol Violation|0
969841|NCT01194414|1971167|FG002|72 Weeks Open Label Extension|Protocol Violation|0
969842|NCT01194414|1971168|FG003|72 Weeks Open Label Extension|Protocol Violation|1
969843|NCT01194414|1971165|FG000|72 Weeks Open Label Extension|Adverse Event|35
969844|NCT01194414|1971166|FG001|72 Weeks Open Label Extension|Adverse Event|21
969845|NCT01194414|1971167|FG002|72 Weeks Open Label Extension|Adverse Event|2
969846|NCT01194414|1971168|FG003|72 Weeks Open Label Extension|Adverse Event|12
969847|NCT01194414|1971165|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
969848|NCT01194414|1971166|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
969849|NCT01194414|1971167|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
969850|NCT01194414|1971168|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
969851|NCT01194414|1971165|FG000|72 Weeks Open Label Extension|Death|1
969852|NCT01194414|1971166|FG001|72 Weeks Open Label Extension|Death|2
969853|NCT01194414|1971167|FG002|72 Weeks Open Label Extension|Death|0
969854|NCT01194414|1971168|FG003|72 Weeks Open Label Extension|Death|2
969855|NCT01194440|1971180|FG000|Baseline (First Dose)|Reason not specified|4
969856|NCT01194440|1971180|FG000|Baseline (First Dose)|Lack of Efficacy|1
969857|NCT01194440|1971180|FG000|Baseline (First Dose)|Change in therapy|1
969858|NCT01194440|1971180|FG000|Baseline (First Dose)|Adverse Event|1
969859|NCT01194440|1971180|FG000|6-months (2nd Dose)|Change in therapy|4
969860|NCT01194531|1971221|FG000|Overall Study|Withdrawal by Subject|1
969861|NCT01194531|1971222|FG001|Overall Study|Withdrawal by Subject|0
969862|NCT01194531|1971221|FG000|Overall Study|Protocol Violation|4
969863|NCT01194531|1971222|FG001|Overall Study|Protocol Violation|1
969864|NCT01194531|1971221|FG000|Overall Study|Physician Decision|0
969865|NCT01194531|1971222|FG001|Overall Study|Physician Decision|2
969890|NCT01194804|1971242|FG000|Overall Study|Withdrawal by Subject|1
969891|NCT01194830|1971248|FG000|Overall Study|Adverse Event|3
969892|NCT01194830|1971249|FG001|Overall Study|Adverse Event|2
969893|NCT01194830|1971248|FG000|Overall Study|Protocol Violation|5
969894|NCT01194830|1971249|FG001|Overall Study|Protocol Violation|4
969895|NCT01194830|1971248|FG000|Overall Study|Lost to Follow-up|9
969896|NCT01194830|1971249|FG001|Overall Study|Lost to Follow-up|7
969897|NCT01194830|1971248|FG000|Overall Study|Withdrawal by Subject|2
969898|NCT01194830|1971249|FG001|Overall Study|Withdrawal by Subject|1
969899|NCT01194830|1971248|FG000|Overall Study|Lack of Efficacy|1
969900|NCT01194830|1971249|FG001|Overall Study|Lack of Efficacy|1
969901|NCT01194830|1971248|FG000|Overall Study|Non-compliance issues|4
969902|NCT01194830|1971249|FG001|Overall Study|Non-compliance issues|4
969903|NCT01194830|1971248|FG000|Overall Study|Other Reason|12
969904|NCT01194830|1971249|FG001|Overall Study|Other Reason|8
969905|NCT01194869|1971255|FG000|Overall Study|Disease Progression|2
969906|NCT01194869|1971255|FG000|Overall Study|Toxicity|2
912501|NCT00805935|1890057|FG003|Overall Study|Ectopic pregnancy|0
912502|NCT00805935|1890054|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0
912503|NCT00805935|1890055|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1
912504|NCT00805935|1890056|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0
912505|NCT00805935|1890057|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0
969907|NCT01194973|1971259|FG000|Screening Period|Screen Failure|3
969908|NCT01194973|1971259|FG000|26 Week Treatment Period|Adverse Event|1
969909|NCT01194973|1971259|FG000|26 Week Treatment Period|Lack of Efficacy|1
969910|NCT01194973|1971259|FG000|26 Week Treatment Period|Pregnancy|1
969911|NCT01194999|1971263|FG000|Overall Study|Lost to Follow-up|17
969912|NCT01195090|1971279|FG000|Overall Study|Adverse Event|1
969913|NCT01195090|1971280|FG001|Overall Study|Adverse Event|2
969914|NCT01195090|1971279|FG000|Overall Study|Lost to Follow-up|2
969915|NCT01195090|1971280|FG001|Overall Study|Lost to Follow-up|2
969916|NCT01195090|1971279|FG000|Overall Study|Protocol Violation|3
969917|NCT01195090|1971280|FG001|Overall Study|Protocol Violation|4
969918|NCT01195103|1971289|FG000|Overall Study|Withdrawal by Subject|1
969919|NCT01195103|1971290|FG001|Overall Study|Withdrawal by Subject|0
969920|NCT01195103|1971291|FG002|Overall Study|Withdrawal by Subject|0
969921|NCT01195272|1971308|FG000|Overall Study|Adverse Event|1
969922|NCT01195272|1971308|FG000|Overall Study|Lack of Efficacy|3
969923|NCT01195363|1971314|FG000|Overall Study|Lost to Follow-up|7
969924|NCT01195363|1971315|FG001|Overall Study|Lost to Follow-up|4
969925|NCT01195363|1971314|FG000|Overall Study|Adverse Event|3
969926|NCT01195363|1971315|FG001|Overall Study|Adverse Event|1
969927|NCT01195363|1971314|FG000|Overall Study|Lack of Efficacy|0
969928|NCT01195363|1971315|FG001|Overall Study|Lack of Efficacy|4
969929|NCT01195363|1971314|FG000|Overall Study|incarceration|1
969930|NCT01195363|1971315|FG001|Overall Study|incarceration|0
969931|NCT01195415|1971321|FG000|Overall Study|No repeat biopsy due to progression|2
969932|NCT01195545|1971329|FG000|Overall Study|Protocol Violation|4
969933|NCT01195623|1971354|FG000|Overall Study|Lost to Follow-up|35
969934|NCT01195623|1971355|FG001|Overall Study|Lost to Follow-up|37
969935|NCT01195636|1971363|FG000|First Intervention (3 Weeks)|Adverse Event|2
969936|NCT01195636|1971364|FG001|First Intervention (3 Weeks)|Adverse Event|3
969937|NCT01195636|1971363|FG000|First Intervention (3 Weeks)|Protocol Violation|1
969938|NCT01195636|1971364|FG001|First Intervention (3 Weeks)|Protocol Violation|0
969939|NCT01195636|1971363|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
969940|NCT01195636|1971364|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0
969941|NCT01195636|1971363|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
969942|NCT01195636|1971364|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0
969943|NCT01195636|1971363|FG000|Washout Period (2 Weeks)|Adverse Event|1
969944|NCT01195636|1971364|FG001|Washout Period (2 Weeks)|Adverse Event|1
969945|NCT01195636|1971363|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
969946|NCT01195636|1971364|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
969947|NCT01195636|1971363|FG000|Second Intervention (3 Weeks)|Adverse Event|1
969948|NCT01195636|1971364|FG001|Second Intervention (3 Weeks)|Adverse Event|1
969949|NCT01195636|1971363|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0
969950|NCT01195636|1971364|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1
969951|NCT01195662|1971373|FG000|Double Blind Treatment Period|Adverse Event|4
969952|NCT01195662|1971374|FG001|Double Blind Treatment Period|Adverse Event|1
969953|NCT01195662|1971375|FG002|Double Blind Treatment Period|Adverse Event|2
969954|NCT01195662|1971373|FG000|Double Blind Treatment Period|Withdrawal by Subject|6
969955|NCT01195662|1971374|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
969956|NCT01195662|1971375|FG002|Double Blind Treatment Period|Withdrawal by Subject|4
969957|NCT01195662|1971373|FG000|Double Blind Treatment Period|Lost to Follow-up|3
969958|NCT01195662|1971374|FG001|Double Blind Treatment Period|Lost to Follow-up|2
969959|NCT01195662|1971375|FG002|Double Blind Treatment Period|Lost to Follow-up|3
969960|NCT01195662|1971373|FG000|Double Blind Treatment Period|Administrative reason|2
969961|NCT01195662|1971374|FG001|Double Blind Treatment Period|Administrative reason|1
969962|NCT01195662|1971375|FG002|Double Blind Treatment Period|Administrative reason|1
969963|NCT01195662|1971373|FG000|Double Blind Treatment Period|Requested discontinue treatment|1
969964|NCT01195662|1971374|FG001|Double Blind Treatment Period|Requested discontinue treatment|0
969965|NCT01195662|1971375|FG002|Double Blind Treatment Period|Requested discontinue treatment|1
969966|NCT01195662|1971373|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1
969967|NCT01195662|1971374|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5
969968|NCT01195662|1971375|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2
969969|NCT01195662|1971373|FG000|Double Blind Treatment Period|Lack of Efficacy|2
969970|NCT01195662|1971374|FG001|Double Blind Treatment Period|Lack of Efficacy|0
969971|NCT01195662|1971375|FG002|Double Blind Treatment Period|Lack of Efficacy|0
969972|NCT01195662|1971373|FG000|Double Blind Treatment Period|Non-specified|3
969973|NCT01195662|1971374|FG001|Double Blind Treatment Period|Non-specified|0
969974|NCT01195662|1971375|FG002|Double Blind Treatment Period|Non-specified|0
969975|NCT01195662|1971373|FG000|Double Blind Treatment Period|Missing disposition information|0
969976|NCT01195662|1971374|FG001|Double Blind Treatment Period|Missing disposition information|1
969977|NCT01195662|1971375|FG002|Double Blind Treatment Period|Missing disposition information|1
969978|NCT01195662|1971373|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
969979|NCT01195662|1971374|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
969980|NCT01195662|1971375|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
969981|NCT01195662|1971373|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
969982|NCT01195662|1971374|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
969983|NCT01195662|1971375|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
969984|NCT01195675|1971384|FG000|Overall Study|Adverse Event|1
969985|NCT01195675|1971384|FG000|Overall Study|Withdrawal by Subject|2
969986|NCT01195831|1971467|FG000|Overall Study|Lost to Follow-up|2
969987|NCT01195831|1971468|FG001|Overall Study|Lost to Follow-up|4
969988|NCT01195831|1971467|FG000|Overall Study|Withdrawal by Subject|2
969989|NCT01195831|1971468|FG001|Overall Study|Withdrawal by Subject|2
969990|NCT01195831|1971467|FG000|Overall Study|Adverse Event|4
969991|NCT01195831|1971468|FG001|Overall Study|Adverse Event|2
969992|NCT01195831|1971467|FG000|Overall Study|Protocol Violation|0
969993|NCT01195831|1971468|FG001|Overall Study|Protocol Violation|2
969994|NCT01195844|1971474|FG000|Overall Study|Fecal sample not collected|40
969995|NCT01195948|1971504|FG000|Overall Study|Lost to Follow-up|0
969996|NCT01195948|1971505|FG001|Overall Study|Lost to Follow-up|1
969997|NCT01195948|1971506|FG002|Overall Study|Lost to Follow-up|2
969998|NCT01196026|1971523|FG000|Overall Study|Withdrawal by Subject|1
969999|NCT01196026|1971524|FG001|Overall Study|Withdrawal by Subject|4
970000|NCT01196026|1971525|FG002|Overall Study|Withdrawal by Subject|0
970001|NCT01196026|1971526|FG003|Overall Study|Withdrawal by Subject|0
970002|NCT01196026|1971527|FG004|Overall Study|Withdrawal by Subject|0
970003|NCT01196026|1971528|FG005|Overall Study|Withdrawal by Subject|0
970004|NCT01196026|1971523|FG000|Overall Study|Lost to Follow-up|0
970005|NCT01196026|1971524|FG001|Overall Study|Lost to Follow-up|3
970006|NCT01196026|1971525|FG002|Overall Study|Lost to Follow-up|0
970007|NCT01196026|1971526|FG003|Overall Study|Lost to Follow-up|0
970008|NCT01196026|1971527|FG004|Overall Study|Lost to Follow-up|1
970009|NCT01196026|1971528|FG005|Overall Study|Lost to Follow-up|0
970010|NCT01196026|1971523|FG000|Overall Study|Other|0
970011|NCT01196026|1971524|FG001|Overall Study|Other|1
970012|NCT01196026|1971525|FG002|Overall Study|Other|0
970013|NCT01196026|1971526|FG003|Overall Study|Other|0
970014|NCT01196026|1971527|FG004|Overall Study|Other|0
970015|NCT01196026|1971528|FG005|Overall Study|Other|0
970016|NCT01196052|1971544|FG000|Overall Study|Adverse Event|9
970017|NCT01196052|1971544|FG000|Overall Study|Lost to Follow-up|1
970018|NCT01196052|1971544|FG000|Overall Study|Noncompliance to Protocol Requirements|2
970019|NCT01196052|1971544|FG000|Overall Study|Reason not Specified|5
970020|NCT01196052|1971544|FG000|Overall Study|Withdrawal by Subject|6
970021|NCT01196078|1971550|FG000|Overall Study|Withdrawal by Subject|3
970022|NCT01196078|1971551|FG001|Overall Study|Withdrawal by Subject|5
970023|NCT01196078|1971550|FG000|Overall Study|Adverse Event|4
970024|NCT01196078|1971551|FG001|Overall Study|Adverse Event|4
970025|NCT01196078|1971550|FG000|Overall Study|Protocol Violation|2
970026|NCT01196078|1971551|FG001|Overall Study|Protocol Violation|1
970027|NCT01196078|1971550|FG000|Overall Study|Lack of Efficacy|17
970028|NCT01196078|1971551|FG001|Overall Study|Lack of Efficacy|23
970029|NCT01196078|1971550|FG000|Overall Study|Lost to Follow-up|1
970030|NCT01196078|1971551|FG001|Overall Study|Lost to Follow-up|0
970031|NCT01196078|1971550|FG000|Overall Study|Death|6
970032|NCT01196078|1971551|FG001|Overall Study|Death|4
970033|NCT01196091|1971560|FG000|Overall Study|Adverse Event|22
970034|NCT01196091|1971561|FG001|Overall Study|Adverse Event|27
970035|NCT01196091|1971562|FG002|Overall Study|Adverse Event|26
970036|NCT01196091|1971560|FG000|Overall Study|Death|3
970037|NCT01196091|1971561|FG001|Overall Study|Death|2
970038|NCT01196091|1971562|FG002|Overall Study|Death|2
970039|NCT01196091|1971560|FG000|Overall Study|Entry Criteria Not Met|11
970040|NCT01196091|1971561|FG001|Overall Study|Entry Criteria Not Met|11
970041|NCT01196091|1971562|FG002|Overall Study|Entry Criteria Not Met|10
970042|NCT01196091|1971560|FG000|Overall Study|Lack of Efficacy|15
970043|NCT01196091|1971561|FG001|Overall Study|Lack of Efficacy|12
970044|NCT01196091|1971562|FG002|Overall Study|Lack of Efficacy|17
970045|NCT01196091|1971560|FG000|Overall Study|Lost to Follow-up|5
970046|NCT01196091|1971561|FG001|Overall Study|Lost to Follow-up|5
970047|NCT01196091|1971562|FG002|Overall Study|Lost to Follow-up|6
970048|NCT01196091|1971560|FG000|Overall Study|Parent/Caregiver Decision|0
970049|NCT01196091|1971561|FG001|Overall Study|Parent/Caregiver Decision|0
970050|NCT01196091|1971562|FG002|Overall Study|Parent/Caregiver Decision|1
970051|NCT01196091|1971560|FG000|Overall Study|Withdrawal by Subject|16
970052|NCT01196091|1971561|FG001|Overall Study|Withdrawal by Subject|19
970053|NCT01196091|1971562|FG002|Overall Study|Withdrawal by Subject|22
970054|NCT01196091|1971560|FG000|Overall Study|Physician Decision|3
970055|NCT01196091|1971561|FG001|Overall Study|Physician Decision|3
970056|NCT01196091|1971562|FG002|Overall Study|Physician Decision|4
970057|NCT01196091|1971560|FG000|Overall Study|Protocol Violation|1
970058|NCT01196091|1971561|FG001|Overall Study|Protocol Violation|3
970059|NCT01196091|1971562|FG002|Overall Study|Protocol Violation|3
970060|NCT01196091|1971560|FG000|Overall Study|Sponsor Decision|6
970061|NCT01196091|1971561|FG001|Overall Study|Sponsor Decision|5
970062|NCT01196091|1971562|FG002|Overall Study|Sponsor Decision|4
970063|NCT01196091|1971560|FG000|Overall Study|Excluded Site|5
970064|NCT01196091|1971561|FG001|Overall Study|Excluded Site|11
970065|NCT01196091|1971562|FG002|Overall Study|Excluded Site|8
970066|NCT01196091|1971560|FG000|Overall Study|Randomized, No Study Drug Received|1
970067|NCT01196091|1971561|FG001|Overall Study|Randomized, No Study Drug Received|0
970068|NCT01196091|1971562|FG002|Overall Study|Randomized, No Study Drug Received|1
970069|NCT01196104|1971577|FG000|Overall Study|Lost to Follow-up|1
970070|NCT01196104|1971578|FG001|Overall Study|Lost to Follow-up|0
970071|NCT01196104|1971577|FG000|Overall Study|Physician Decision|0
970072|NCT01196104|1971578|FG001|Overall Study|Physician Decision|1
970073|NCT01196104|1971577|FG000|Overall Study|Withdrawal by Subject|3
970074|NCT01196104|1971578|FG001|Overall Study|Withdrawal by Subject|3
970075|NCT01196104|1971577|FG000|Overall Study|Various|0
970076|NCT01196104|1971578|FG001|Overall Study|Various|1
970079|NCT01196416|1971625|FG000|Overall Study|Withdrawal by Subject|2
970080|NCT01196429|1971631|FG000|Overall Study|Ineligible - inadequate pathology|1
970081|NCT01196429|1971632|FG001|Overall Study|Ineligible - inadequate pathology|0
970082|NCT01196429|1971631|FG000|Overall Study|Ineligible - wrong cell type|1
970083|NCT01196429|1971632|FG001|Overall Study|Ineligible - wrong cell type|0
970084|NCT01196429|1971631|FG000|Overall Study|Refused - Never Treated|1
970085|NCT01196429|1971632|FG001|Overall Study|Refused - Never Treated|0
970086|NCT01196741|1971651|FG000|Overall Study|Disease progression|34
970087|NCT01196741|1971652|FG001|Overall Study|Disease progression|14
970088|NCT01196741|1971651|FG000|Overall Study|Adverse Event|10
970089|NCT01196741|1971652|FG001|Overall Study|Adverse Event|6
970090|NCT01196741|1971651|FG000|Overall Study|Serious Adverse Event|3
970091|NCT01196741|1971652|FG001|Overall Study|Serious Adverse Event|1
970092|NCT01196741|1971651|FG000|Overall Study|Dose limiting Adverse Event|2
970093|NCT01196741|1971652|FG001|Overall Study|Dose limiting Adverse Event|1
970094|NCT01196741|1971651|FG000|Overall Study|Withdrawal by Subject|3
970095|NCT01196741|1971652|FG001|Overall Study|Withdrawal by Subject|0
970096|NCT01196741|1971651|FG000|Overall Study|Other reason|3
970097|NCT01196741|1971652|FG001|Overall Study|Other reason|3
970098|NCT01196741|1971651|FG000|Overall Study|Other|3
970099|NCT01196741|1971652|FG001|Overall Study|Other|2
970100|NCT01196741|1971651|FG000|Overall Study|Protocol Violation|2
970101|NCT01196741|1971652|FG001|Overall Study|Protocol Violation|1
970102|NCT01196975|1971723|FG000|Overall Study|Adverse Event|2
970103|NCT01196975|1971724|FG001|Overall Study|Adverse Event|2
970104|NCT01196975|1971725|FG002|Overall Study|Adverse Event|0
970105|NCT01196975|1971726|FG003|Overall Study|Adverse Event|0
970106|NCT01196975|1971727|FG004|Overall Study|Adverse Event|2
970107|NCT01196975|1971723|FG000|Overall Study|Withdrawal by Subject|2
970108|NCT01196975|1971724|FG001|Overall Study|Withdrawal by Subject|1
970109|NCT01196975|1971725|FG002|Overall Study|Withdrawal by Subject|0
970110|NCT01196975|1971726|FG003|Overall Study|Withdrawal by Subject|1
970111|NCT01196975|1971727|FG004|Overall Study|Withdrawal by Subject|0
970112|NCT01196975|1971723|FG000|Overall Study|Lost to Follow-up|11
970113|NCT01196975|1971724|FG001|Overall Study|Lost to Follow-up|6
970114|NCT01196975|1971725|FG002|Overall Study|Lost to Follow-up|5
970115|NCT01196975|1971726|FG003|Overall Study|Lost to Follow-up|5
970116|NCT01196975|1971727|FG004|Overall Study|Lost to Follow-up|11
970117|NCT01196988|1971766|FG000|Overall Study|Adverse Event|1
970118|NCT01196988|1971767|FG001|Overall Study|Adverse Event|2
970119|NCT01196988|1971768|FG002|Overall Study|Adverse Event|0
970120|NCT01196988|1971769|FG003|Overall Study|Adverse Event|0
970121|NCT01196988|1971766|FG000|Overall Study|Withdrawal by Subject|5
970122|NCT01196988|1971767|FG001|Overall Study|Withdrawal by Subject|1
970123|NCT01196988|1971768|FG002|Overall Study|Withdrawal by Subject|4
970124|NCT01196988|1971769|FG003|Overall Study|Withdrawal by Subject|0
970125|NCT01196988|1971766|FG000|Overall Study|Lost to Follow-up|16
970126|NCT01196988|1971767|FG001|Overall Study|Lost to Follow-up|29
970127|NCT01196988|1971768|FG002|Overall Study|Lost to Follow-up|21
970128|NCT01196988|1971769|FG003|Overall Study|Lost to Follow-up|1
970129|NCT01196988|1971766|FG000|Overall Study|Other|2
970130|NCT01196988|1971767|FG001|Overall Study|Other|0
970131|NCT01196988|1971768|FG002|Overall Study|Other|0
970132|NCT01196988|1971769|FG003|Overall Study|Other|0
970133|NCT01197300|1971782|FG000|Overall Study|Lost to Follow-up|0
970134|NCT01197300|1971783|FG001|Overall Study|Lost to Follow-up|1
970135|NCT01197300|1971782|FG000|Overall Study|Protocol Violation|0
970136|NCT01197300|1971783|FG001|Overall Study|Protocol Violation|1
970137|NCT01197378|1971800|FG000|Overall Study|Adverse Event|3
970138|NCT01197378|1971800|FG000|Overall Study|Withdrawal by Subject|1
970139|NCT01197378|1971800|FG000|Overall Study|Physician Decision|1
970140|NCT01197378|1971800|FG000|Overall Study|Other|2
970141|NCT01197417|1971806|FG000|Overall Study|Physician Decision|3
970142|NCT01197417|1971807|FG001|Overall Study|Physician Decision|2
970143|NCT01197417|1971806|FG000|Overall Study|Withdrawal by Subject|2
970144|NCT01197417|1971807|FG001|Overall Study|Withdrawal by Subject|4
970145|NCT01197417|1971806|FG000|Overall Study|Site miscommunication|0
970146|NCT01197417|1971807|FG001|Overall Study|Site miscommunication|1
970147|NCT01197417|1971806|FG000|Overall Study|Subject transferred to intensive care|0
970148|NCT01197417|1971807|FG001|Overall Study|Subject transferred to intensive care|1
970149|NCT01197417|1971806|FG000|Overall Study|Not consented in time to receive drug|0
970150|NCT01197417|1971807|FG001|Overall Study|Not consented in time to receive drug|1
970151|NCT01197417|1971806|FG000|Overall Study|Hypotension|1
970152|NCT01197417|1971807|FG001|Overall Study|Hypotension|2
970153|NCT01197417|1971806|FG000|Overall Study|Found to be ineligible|2
970154|NCT01197417|1971807|FG001|Overall Study|Found to be ineligible|5
970155|NCT01197417|1971806|FG000|Overall Study|No 25-hour magnesium level|0
970156|NCT01197417|1971807|FG001|Overall Study|No 25-hour magnesium level|2
970157|NCT01197508|1971835|FG000|Overall Study|Withdrawal by Subject|8
970158|NCT01197508|1971836|FG001|Overall Study|Withdrawal by Subject|7
970159|NCT01197508|1971837|FG002|Overall Study|Withdrawal by Subject|15
970160|NCT01197508|1971838|FG003|Overall Study|Withdrawal by Subject|4
970161|NCT01197508|1971835|FG000|Overall Study|Eligiblity criteria not fulfilled|0
970162|NCT01197508|1971836|FG001|Overall Study|Eligiblity criteria not fulfilled|0
970163|NCT01197508|1971837|FG002|Overall Study|Eligiblity criteria not fulfilled|2
970164|NCT01197508|1971838|FG003|Overall Study|Eligiblity criteria not fulfilled|0
970165|NCT01197508|1971835|FG000|Overall Study|Adverse Event|10
970166|NCT01197508|1971836|FG001|Overall Study|Adverse Event|13
970167|NCT01197508|1971837|FG002|Overall Study|Adverse Event|23
970168|NCT01197508|1971838|FG003|Overall Study|Adverse Event|3
970169|NCT01197508|1971835|FG000|Overall Study|Severe non-compliance to protocol|0
970170|NCT01197508|1971836|FG001|Overall Study|Severe non-compliance to protocol|3
970171|NCT01197508|1971837|FG002|Overall Study|Severe non-compliance to protocol|1
970172|NCT01197508|1971838|FG003|Overall Study|Severe non-compliance to protocol|3
970173|NCT01197508|1971835|FG000|Overall Study|Condition under investigation worsened|1
970174|NCT01197508|1971836|FG001|Overall Study|Condition under investigation worsened|1
970175|NCT01197508|1971837|FG002|Overall Study|Condition under investigation worsened|1
970176|NCT01197508|1971838|FG003|Overall Study|Condition under investigation worsened|1
970177|NCT01197508|1971835|FG000|Overall Study|Lack of Efficacy|1
970178|NCT01197508|1971836|FG001|Overall Study|Lack of Efficacy|2
970179|NCT01197508|1971837|FG002|Overall Study|Lack of Efficacy|2
970180|NCT01197508|1971838|FG003|Overall Study|Lack of Efficacy|1
970181|NCT01197508|1971835|FG000|Overall Study|Study-specific withdrawal criteria|0
970182|NCT01197508|1971836|FG001|Overall Study|Study-specific withdrawal criteria|0
970183|NCT01197508|1971837|FG002|Overall Study|Study-specific withdrawal criteria|1
970184|NCT01197508|1971838|FG003|Overall Study|Study-specific withdrawal criteria|2
970185|NCT01197508|1971835|FG000|Overall Study|Lost to Follow-up|1
970186|NCT01197508|1971836|FG001|Overall Study|Lost to Follow-up|1
970187|NCT01197508|1971837|FG002|Overall Study|Lost to Follow-up|2
970188|NCT01197508|1971838|FG003|Overall Study|Lost to Follow-up|0
970189|NCT01197508|1971835|FG000|Overall Study|Other|2
970190|NCT01197508|1971836|FG001|Overall Study|Other|3
970191|NCT01197508|1971837|FG002|Overall Study|Other|2
970192|NCT01197508|1971838|FG003|Overall Study|Other|2
970193|NCT01197521|1971851|FG000|Overall Study|Not reported|24
970194|NCT01197521|1971852|FG001|Overall Study|Not reported|25
970195|NCT01197521|1971853|FG002|Overall Study|Not reported|21
970196|NCT01197521|1971851|FG000|Overall Study|Enrolment in long term extension|42
970197|NCT01197521|1971852|FG001|Overall Study|Enrolment in long term extension|36
970198|NCT01197521|1971853|FG002|Overall Study|Enrolment in long term extension|87
970199|NCT01197521|1971851|FG000|Overall Study|Severe non-compliance to protocol|1
970200|NCT01197521|1971852|FG001|Overall Study|Severe non-compliance to protocol|3
970201|NCT01197521|1971853|FG002|Overall Study|Severe non-compliance to protocol|3
970202|NCT01197521|1971851|FG000|Overall Study|Lack of therapeutic response|2
970203|NCT01197521|1971852|FG001|Overall Study|Lack of therapeutic response|3
970204|NCT01197521|1971853|FG002|Overall Study|Lack of therapeutic response|4
970205|NCT01197521|1971851|FG000|Overall Study|Dev. of study specific discont. criteria|6
970206|NCT01197521|1971852|FG001|Overall Study|Dev. of study specific discont. criteria|16
970207|NCT01197521|1971853|FG002|Overall Study|Dev. of study specific discont. criteria|2
970208|NCT01197521|1971851|FG000|Overall Study|Lost to Follow-up|3
970209|NCT01197521|1971852|FG001|Overall Study|Lost to Follow-up|2
912519|NCT00806026|1890089|FG000|Overall Study|Death|0
912520|NCT00806026|1890090|FG001|Overall Study|Death|0
912521|NCT00806026|1890091|FG002|Overall Study|Death|0
912522|NCT00806026|1890092|FG003|Overall Study|Death|1
912523|NCT00806026|1890093|FG004|Overall Study|Death|0
912524|NCT00806026|1890094|FG005|Overall Study|Death|0
912525|NCT00806026|1890089|FG000|Overall Study|Did not meet entrance criteria|4
912526|NCT00806026|1890090|FG001|Overall Study|Did not meet entrance criteria|1
912527|NCT00806026|1890091|FG002|Overall Study|Did not meet entrance criteria|2
912528|NCT00806026|1890092|FG003|Overall Study|Did not meet entrance criteria|1
912529|NCT00806026|1890093|FG004|Overall Study|Did not meet entrance criteria|0
970210|NCT01197521|1971853|FG002|Overall Study|Lost to Follow-up|2
970211|NCT01197521|1971851|FG000|Overall Study|Adverse Event|25
970212|NCT01197521|1971852|FG001|Overall Study|Adverse Event|28
970213|NCT01197521|1971853|FG002|Overall Study|Adverse Event|24
970214|NCT01197534|1971867|FG000|Overall Study|Not reported|16
970215|NCT01197534|1971868|FG001|Overall Study|Not reported|10
970216|NCT01197534|1971869|FG002|Overall Study|Not reported|16
970217|NCT01197534|1971867|FG000|Overall Study|Enrolment in long term extension|57
970218|NCT01197534|1971868|FG001|Overall Study|Enrolment in long term extension|66
970219|NCT01197534|1971869|FG002|Overall Study|Enrolment in long term extension|119
970220|NCT01197534|1971867|FG000|Overall Study|Severe non-compliance to protocol|3
970221|NCT01197534|1971868|FG001|Overall Study|Severe non-compliance to protocol|4
970222|NCT01197534|1971869|FG002|Overall Study|Severe non-compliance to protocol|1
970223|NCT01197534|1971867|FG000|Overall Study|Lack of therapeutic response|9
970224|NCT01197534|1971868|FG001|Overall Study|Lack of therapeutic response|4
970225|NCT01197534|1971869|FG002|Overall Study|Lack of therapeutic response|9
970226|NCT01197534|1971867|FG000|Overall Study|Dev. of study specific discont. criteria|13
970227|NCT01197534|1971868|FG001|Overall Study|Dev. of study specific discont. criteria|6
970228|NCT01197534|1971869|FG002|Overall Study|Dev. of study specific discont. criteria|2
970229|NCT01197534|1971867|FG000|Overall Study|Lost to Follow-up|1
970230|NCT01197534|1971868|FG001|Overall Study|Lost to Follow-up|4
970231|NCT01197534|1971869|FG002|Overall Study|Lost to Follow-up|2
970232|NCT01197534|1971867|FG000|Overall Study|Adverse Event|35
970233|NCT01197534|1971868|FG001|Overall Study|Adverse Event|36
970234|NCT01197534|1971869|FG002|Overall Study|Adverse Event|24
970235|NCT01197560|1971886|FG000|Overall Study|Adverse Event|6
970236|NCT01197560|1971887|FG001|Overall Study|Adverse Event|8
970237|NCT01197560|1971886|FG000|Overall Study|Death|3
970238|NCT01197560|1971887|FG001|Overall Study|Death|5
970239|NCT01197560|1971886|FG000|Overall Study|Withdrawal by Subject|1
970240|NCT01197560|1971887|FG001|Overall Study|Withdrawal by Subject|1
970241|NCT01197560|1971886|FG000|Overall Study|Disease progression|40
970242|NCT01197560|1971887|FG001|Overall Study|Disease progression|35
970243|NCT01197560|1971886|FG000|Overall Study|Miscellaneous|4
970244|NCT01197560|1971887|FG001|Overall Study|Miscellaneous|3
970245|NCT01197560|1971886|FG000|Overall Study|Missing|0
970246|NCT01197560|1971887|FG001|Overall Study|Missing|1
970247|NCT01197755|1971921|FG000|Overall Study|Adverse Event|8
970248|NCT01197755|1971922|FG001|Overall Study|Adverse Event|10
970249|NCT01197755|1971923|FG002|Overall Study|Adverse Event|10
970250|NCT01197755|1971921|FG000|Overall Study|Study-specific discontinuation criteria|2
970251|NCT01197755|1971922|FG001|Overall Study|Study-specific discontinuation criteria|1
970252|NCT01197755|1971923|FG002|Overall Study|Study-specific discontinuation criteria|0
970253|NCT01197755|1971921|FG000|Overall Study|Entered the long-term extension study|18
970254|NCT01197755|1971922|FG001|Overall Study|Entered the long-term extension study|21
970255|NCT01197755|1971923|FG002|Overall Study|Entered the long-term extension study|35
970256|NCT01197755|1971921|FG000|Overall Study|Lack of therapeutic response|0
970257|NCT01197755|1971922|FG001|Overall Study|Lack of therapeutic response|7
970258|NCT01197755|1971923|FG002|Overall Study|Lack of therapeutic response|4
970259|NCT01197755|1971921|FG000|Overall Study|Severe non-compliance to the protocol|2
970260|NCT01197755|1971922|FG001|Overall Study|Severe non-compliance to the protocol|1
970261|NCT01197755|1971923|FG002|Overall Study|Severe non-compliance to the protocol|2
970262|NCT01197755|1971921|FG000|Overall Study|Withdrawal by Subject|1
970263|NCT01197755|1971922|FG001|Overall Study|Withdrawal by Subject|0
970264|NCT01197755|1971923|FG002|Overall Study|Withdrawal by Subject|0
970265|NCT01197755|1971921|FG000|Overall Study|Lost to Follow-up|0
970266|NCT01197755|1971922|FG001|Overall Study|Lost to Follow-up|0
970267|NCT01197755|1971923|FG002|Overall Study|Lost to Follow-up|1
970268|NCT01197755|1971921|FG000|Overall Study|eg, change in circumstances|7
970269|NCT01197755|1971922|FG001|Overall Study|eg, change in circumstances|3
970270|NCT01197755|1971923|FG002|Overall Study|eg, change in circumstances|2
970271|NCT01197794|1971940|FG000|Overall Study|Adverse Event|3
970272|NCT01197794|1971941|FG001|Overall Study|Adverse Event|2
970273|NCT01197794|1971942|FG002|Overall Study|Adverse Event|4
970274|NCT01197794|1971943|FG003|Overall Study|Adverse Event|4
970275|NCT01197794|1971944|FG004|Overall Study|Adverse Event|4
970276|NCT01197794|1971945|FG005|Overall Study|Adverse Event|2
970277|NCT01197794|1971946|FG006|Overall Study|Adverse Event|3
970278|NCT01197794|1971940|FG000|Overall Study|Protocol Violation|0
970279|NCT01197794|1971941|FG001|Overall Study|Protocol Violation|0
970280|NCT01197794|1971942|FG002|Overall Study|Protocol Violation|0
970281|NCT01197794|1971943|FG003|Overall Study|Protocol Violation|0
970282|NCT01197794|1971944|FG004|Overall Study|Protocol Violation|2
970283|NCT01197794|1971945|FG005|Overall Study|Protocol Violation|0
970284|NCT01197794|1971946|FG006|Overall Study|Protocol Violation|1
970285|NCT01197794|1971940|FG000|Overall Study|Development of study withdrawal criteria|3
970286|NCT01197794|1971941|FG001|Overall Study|Development of study withdrawal criteria|0
970287|NCT01197794|1971942|FG002|Overall Study|Development of study withdrawal criteria|0
970288|NCT01197794|1971943|FG003|Overall Study|Development of study withdrawal criteria|1
970289|NCT01197794|1971944|FG004|Overall Study|Development of study withdrawal criteria|0
970290|NCT01197794|1971945|FG005|Overall Study|Development of study withdrawal criteria|0
970291|NCT01197794|1971946|FG006|Overall Study|Development of study withdrawal criteria|1
970292|NCT01197794|1971940|FG000|Overall Study|Eligibility criteria not fulfilled|5
970293|NCT01197794|1971941|FG001|Overall Study|Eligibility criteria not fulfilled|8
970294|NCT01197794|1971942|FG002|Overall Study|Eligibility criteria not fulfilled|2
970295|NCT01197794|1971943|FG003|Overall Study|Eligibility criteria not fulfilled|5
970296|NCT01197794|1971944|FG004|Overall Study|Eligibility criteria not fulfilled|5
970297|NCT01197794|1971945|FG005|Overall Study|Eligibility criteria not fulfilled|9
970298|NCT01197794|1971946|FG006|Overall Study|Eligibility criteria not fulfilled|6
970299|NCT01197794|1971940|FG000|Overall Study|Withdrawal by Subject|3
970300|NCT01197794|1971941|FG001|Overall Study|Withdrawal by Subject|3
970301|NCT01197794|1971942|FG002|Overall Study|Withdrawal by Subject|4
970302|NCT01197794|1971943|FG003|Overall Study|Withdrawal by Subject|1
970303|NCT01197794|1971944|FG004|Overall Study|Withdrawal by Subject|1
970304|NCT01197794|1971945|FG005|Overall Study|Withdrawal by Subject|5
970305|NCT01197794|1971946|FG006|Overall Study|Withdrawal by Subject|6
970306|NCT01197794|1971940|FG000|Overall Study|Lost to Follow-up|1
970307|NCT01197794|1971941|FG001|Overall Study|Lost to Follow-up|1
970308|NCT01197794|1971942|FG002|Overall Study|Lost to Follow-up|0
970309|NCT01197794|1971943|FG003|Overall Study|Lost to Follow-up|1
970310|NCT01197794|1971944|FG004|Overall Study|Lost to Follow-up|0
970311|NCT01197794|1971945|FG005|Overall Study|Lost to Follow-up|1
970312|NCT01197794|1971946|FG006|Overall Study|Lost to Follow-up|0
970313|NCT01197794|1971940|FG000|Overall Study|Other|1
970314|NCT01197794|1971941|FG001|Overall Study|Other|1
970315|NCT01197794|1971942|FG002|Overall Study|Other|3
970316|NCT01197794|1971943|FG003|Overall Study|Other|0
970317|NCT01197794|1971944|FG004|Overall Study|Other|2
970318|NCT01197794|1971945|FG005|Overall Study|Other|2
970319|NCT01197794|1971946|FG006|Overall Study|Other|4
970320|NCT01197911|1971988|FG000|Overall Study|Adverse Event|0
970321|NCT01197911|1971989|FG001|Overall Study|Adverse Event|0
970322|NCT01197911|1971990|FG002|Overall Study|Adverse Event|1
970323|NCT01198002|1972002|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
970324|NCT01198002|1972003|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
970325|NCT01198002|1972004|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
970326|NCT01198002|1972002|FG000|Treatment Period 1 (Weeks 0-52)|Death|2
970327|NCT01198002|1972003|FG001|Treatment Period 1 (Weeks 0-52)|Death|0
970328|NCT01198002|1972004|FG002|Treatment Period 1 (Weeks 0-52)|Death|1
970329|NCT01198002|1972002|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
970330|NCT01198002|1972003|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
970331|NCT01198002|1972004|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
970332|NCT01198002|1972002|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
970333|NCT01198002|1972003|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
970334|NCT01198002|1972004|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
970335|NCT01198002|1972002|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
970336|NCT01198002|1972003|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
970337|NCT01198002|1972004|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
970338|NCT01198002|1972002|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
970339|NCT01198002|1972003|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
970340|NCT01198002|1972004|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
970341|NCT01198002|1972002|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
970342|NCT01198002|1972003|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
970343|NCT01198002|1972004|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
970344|NCT01198002|1972002|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
970345|NCT01198002|1972003|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
970346|NCT01198002|1972004|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
970347|NCT01198002|1972002|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
970348|NCT01198002|1972003|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
970349|NCT01198002|1972004|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
970350|NCT01198002|1972002|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
970351|NCT01198002|1972003|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
970352|NCT01198002|1972004|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
970353|NCT01198002|1972002|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
970354|NCT01198002|1972003|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
970355|NCT01198002|1972004|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
970356|NCT01198002|1972002|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
970357|NCT01198002|1972003|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
970358|NCT01198002|1972004|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
970359|NCT01198002|1972002|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
970360|NCT01198002|1972003|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
970361|NCT01198002|1972004|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
970362|NCT01198002|1972002|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
970363|NCT01198002|1972003|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
970364|NCT01198002|1972004|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
970365|NCT01198002|1972002|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
970366|NCT01198002|1972003|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
970367|NCT01198002|1972004|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
970368|NCT01198028|1972034|FG000|Overall Study|Adverse Event|5
970369|NCT01198028|1972034|FG000|Overall Study|Death|3
970370|NCT01198028|1972034|FG000|Overall Study|Physician Decision|2
970371|NCT01198132|1972040|FG000|Overall Study|Withdrawal by Subject|4
970372|NCT01198132|1972041|FG001|Overall Study|Withdrawal by Subject|5
970373|NCT01198132|1972040|FG000|Overall Study|Physician Decision|5
970374|NCT01198132|1972041|FG001|Overall Study|Physician Decision|4
970375|NCT01198132|1972040|FG000|Overall Study|Other Unspecified|3
970376|NCT01198132|1972041|FG001|Overall Study|Other Unspecified|6
970377|NCT01198132|1972040|FG000|Overall Study|Lack of Efficacy|2
970378|NCT01198132|1972041|FG001|Overall Study|Lack of Efficacy|3
970379|NCT01198132|1972040|FG000|Overall Study|Sign/symptoms of underlying disease|2
970380|NCT01198132|1972041|FG001|Overall Study|Sign/symptoms of underlying disease|1
970381|NCT01198132|1972040|FG000|Overall Study|Abnormal/clinically significant biologic|1
970382|NCT01198132|1972041|FG001|Overall Study|Abnormal/clinically significant biologic|1
970383|NCT01198132|1972040|FG000|Overall Study|Adverse Event|0
970384|NCT01198132|1972041|FG001|Overall Study|Adverse Event|1
970385|NCT01198132|1972040|FG000|Overall Study|Protocol Violation|1
970386|NCT01198132|1972041|FG001|Overall Study|Protocol Violation|0
970387|NCT01198145|1972051|FG000|Overall Study|Withdrawal by Subject|1
970388|NCT01198145|1972052|FG001|Overall Study|Withdrawal by Subject|1
970389|NCT01198275|1972070|FG000|Overall Study|Adverse Event|2
970390|NCT01198275|1972071|FG001|Overall Study|Adverse Event|3
970391|NCT01198275|1972070|FG000|Overall Study|spontaneous return to sinus rhythm|4
970392|NCT01198275|1972071|FG001|Overall Study|spontaneous return to sinus rhythm|2
970393|NCT01198470|1972109|FG000|Overall Study|Adverse Event|2
970394|NCT01198509|1972119|FG000|Overall Study|Withdrawal by Subject|1
970395|NCT01198509|1972120|FG001|Overall Study|Withdrawal by Subject|0
970396|NCT01198509|1972121|FG002|Overall Study|Withdrawal by Subject|0
970397|NCT01198509|1972122|FG003|Overall Study|Withdrawal by Subject|0
970398|NCT01198509|1972123|FG004|Overall Study|Withdrawal by Subject|0
970399|NCT01198509|1972124|FG005|Overall Study|Withdrawal by Subject|0
970400|NCT01198574|1972140|FG000|Overall Study|Resigned from schools|4
970401|NCT01198574|1972141|FG001|Overall Study|Resigned from schools|1
970402|NCT01198574|1972142|FG002|Overall Study|Resigned from schools|1
970403|NCT01198574|1972143|FG003|Overall Study|Resigned from schools|4
970404|NCT01198587|1972157|FG000|Overall Study|Lost to Follow-up|8
970405|NCT01198587|1972158|FG001|Overall Study|Lost to Follow-up|0
970406|NCT01198587|1972159|FG002|Overall Study|Lost to Follow-up|9
970407|NCT01198587|1972160|FG003|Overall Study|Lost to Follow-up|0
970408|NCT01198600|1972175|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
970409|NCT01198600|1972176|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
970410|NCT01198600|1972177|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
970411|NCT01198600|1972178|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
970412|NCT01198600|1972175|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
970413|NCT01198600|1972176|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
970414|NCT01198600|1972177|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
970415|NCT01198600|1972178|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
970416|NCT01198600|1972175|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
970417|NCT01198600|1972176|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
970418|NCT01198600|1972177|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
970419|NCT01198600|1972178|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
970420|NCT01198600|1972175|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
970421|NCT01198600|1972176|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
970422|NCT01198600|1972177|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
970423|NCT01198600|1972178|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
970424|NCT01198600|1972175|FG000|Phase 2: 56 Days of Wear|Inconvenience|0
970425|NCT01198600|1972176|FG001|Phase 2: 56 Days of Wear|Inconvenience|0
970426|NCT01198600|1972177|FG002|Phase 2: 56 Days of Wear|Inconvenience|2
970427|NCT01198600|1972178|FG003|Phase 2: 56 Days of Wear|Inconvenience|0
970428|NCT01198600|1972175|FG000|Phase 2: 56 Days of Wear|Relocation|0
970429|NCT01198600|1972176|FG001|Phase 2: 56 Days of Wear|Relocation|0
970430|NCT01198600|1972177|FG002|Phase 2: 56 Days of Wear|Relocation|2
970431|NCT01198600|1972178|FG003|Phase 2: 56 Days of Wear|Relocation|0
970432|NCT01198600|1972175|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
970433|NCT01198600|1972176|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
970434|NCT01198600|1972177|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
970435|NCT01198600|1972178|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
970436|NCT01198756|1972199|FG000|Overall Study|Adverse Event|0
970437|NCT01198756|1972200|FG001|Overall Study|Adverse Event|0
970438|NCT01198756|1972201|FG002|Overall Study|Adverse Event|0
970439|NCT01198756|1972202|FG003|Overall Study|Adverse Event|1
970440|NCT01198756|1972199|FG000|Overall Study|Protocol Violation|0
970441|NCT01198756|1972200|FG001|Overall Study|Protocol Violation|0
970442|NCT01198756|1972201|FG002|Overall Study|Protocol Violation|0
970443|NCT01198756|1972202|FG003|Overall Study|Protocol Violation|2
970444|NCT01198756|1972199|FG000|Overall Study|Withdrawal by Subject|9
970445|NCT01198756|1972200|FG001|Overall Study|Withdrawal by Subject|4
970446|NCT01198756|1972201|FG002|Overall Study|Withdrawal by Subject|7
970447|NCT01198756|1972202|FG003|Overall Study|Withdrawal by Subject|5
970448|NCT01198756|1972199|FG000|Overall Study|Lost to Follow-up|29
970449|NCT01198756|1972200|FG001|Overall Study|Lost to Follow-up|36
970450|NCT01198756|1972201|FG002|Overall Study|Lost to Follow-up|23
970451|NCT01198756|1972202|FG003|Overall Study|Lost to Follow-up|18
970452|NCT01198795|1972223|FG000|Overall Study|Did not meet InclusionExclusion criteria|30
970453|NCT01198795|1972223|FG000|Overall Study|Withdrawal by Subject|17
970454|NCT01198795|1972223|FG000|Overall Study|Lost to Follow-up|15
970455|NCT01198795|1972223|FG000|Overall Study|Adverse Event|9
970456|NCT01198795|1972223|FG000|Overall Study|Lack of Efficacy|5
970457|NCT01198795|1972223|FG000|Overall Study|Protocol Violation|2
970458|NCT01198795|1972223|FG000|Overall Study|Other Reason|4
970459|NCT01198873|1972229|FG000|Overall Study|Adverse Event|4
970460|NCT01198873|1972230|FG001|Overall Study|Adverse Event|7
970461|NCT01198873|1972229|FG000|Overall Study|Study closure|29
970462|NCT01198873|1972230|FG001|Overall Study|Study closure|23
970463|NCT01198873|1972229|FG000|Overall Study|Other than above|4
970464|NCT01198873|1972230|FG001|Overall Study|Other than above|2
970465|NCT01198977|1972238|FG000|Overall Study|Lost to Follow-up|1
970466|NCT01198977|1972239|FG001|Overall Study|Lost to Follow-up|0
970467|NCT01199016|1972247|FG000|Overall Study|No longer meets eligibility criteria|4
970468|NCT01199016|1972247|FG000|Overall Study|Entrance criteria|5
970469|NCT01199016|1972247|FG000|Overall Study|Protocol Violation|9
970470|NCT01199016|1972247|FG000|Overall Study|Other|13
970471|NCT01199016|1972247|FG000|Overall Study|Withdrawal by Subject|21
970472|NCT01199016|1972247|FG000|Overall Study|Lost to Follow-up|25
970473|NCT01199042|1972251|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
970474|NCT01199042|1972251|FG000|At Home (3 Months)|Lost to Follow-up|1
970475|NCT01199055|1972263|FG000|Overall Study|Death|0
970476|NCT01199055|1972264|FG001|Overall Study|Death|1
970477|NCT01199055|1972265|FG002|Overall Study|Death|0
970478|NCT01199055|1972263|FG000|Overall Study|Physician Decision|0
970479|NCT01199055|1972264|FG001|Overall Study|Physician Decision|1
970480|NCT01199055|1972265|FG002|Overall Study|Physician Decision|1
970481|NCT01199055|1972263|FG000|Overall Study|Progressive disease|2
970482|NCT01199055|1972264|FG001|Overall Study|Progressive disease|1
970483|NCT01199055|1972265|FG002|Overall Study|Progressive disease|2
970484|NCT01199055|1972263|FG000|Overall Study|Withdrawal by Subject|0
970485|NCT01199055|1972264|FG001|Overall Study|Withdrawal by Subject|0
970486|NCT01199055|1972265|FG002|Overall Study|Withdrawal by Subject|1
970487|NCT01199068|1972278|FG000|Overall Study|Unacceptable toxicity|0
970488|NCT01199068|1972279|FG001|Overall Study|Unacceptable toxicity|0
970489|NCT01199068|1972280|FG002|Overall Study|Unacceptable toxicity|2
970490|NCT01199068|1972278|FG000|Overall Study|Progressive disease|3
970491|NCT01199068|1972279|FG001|Overall Study|Progressive disease|3
970492|NCT01199068|1972280|FG002|Overall Study|Progressive disease|6
970493|NCT01199068|1972278|FG000|Overall Study|Withdrawal by Subject|0
970494|NCT01199068|1972279|FG001|Overall Study|Withdrawal by Subject|0
970495|NCT01199068|1972280|FG002|Overall Study|Withdrawal by Subject|1
970496|NCT01199198|1972301|FG000|Overall Study|Adverse Event|3
970497|NCT01199198|1972302|FG001|Overall Study|Adverse Event|0
970498|NCT01199198|1972301|FG000|Overall Study|Lost to Follow-up|1
970499|NCT01199198|1972302|FG001|Overall Study|Lost to Follow-up|5
970500|NCT01199198|1972301|FG000|Overall Study|Withdrawal by Subject|1
970501|NCT01199198|1972302|FG001|Overall Study|Withdrawal by Subject|2
970502|NCT01199198|1972301|FG000|Overall Study|ICU Transfer|1
970503|NCT01199198|1972302|FG001|Overall Study|ICU Transfer|2
970504|NCT01199198|1972301|FG000|Overall Study|Hospice-care transfer|1
970505|NCT01199198|1972302|FG001|Overall Study|Hospice-care transfer|2
970506|NCT01199263|1972321|FG000|Overall Study|Ineligible|0
970507|NCT01199263|1972322|FG001|Overall Study|Ineligible|2
970508|NCT01199263|1972321|FG000|Overall Study|Never Treated|6
970509|NCT01199263|1972322|FG001|Overall Study|Never Treated|0
970510|NCT01199289|1972334|FG000|Overall Study|Ineligibility determined|2
970511|NCT01199289|1972335|FG001|Overall Study|Ineligibility determined|1
970512|NCT01199289|1972336|FG002|Overall Study|Ineligibility determined|0
970513|NCT01199289|1972337|FG003|Overall Study|Ineligibility determined|0
970514|NCT01199289|1972334|FG000|Overall Study|Protocol Violation|1
970515|NCT01199289|1972335|FG001|Overall Study|Protocol Violation|0
970516|NCT01199289|1972336|FG002|Overall Study|Protocol Violation|0
970517|NCT01199289|1972337|FG003|Overall Study|Protocol Violation|1
970518|NCT01199289|1972334|FG000|Overall Study|Noncompliance|1
970519|NCT01199289|1972335|FG001|Overall Study|Noncompliance|0
970520|NCT01199289|1972336|FG002|Overall Study|Noncompliance|2
970521|NCT01199289|1972337|FG003|Overall Study|Noncompliance|0
970522|NCT01199289|1972334|FG000|Overall Study|Adverse Event|0
970523|NCT01199289|1972335|FG001|Overall Study|Adverse Event|3
970524|NCT01199289|1972336|FG002|Overall Study|Adverse Event|1
970525|NCT01199289|1972337|FG003|Overall Study|Adverse Event|4
970526|NCT01199289|1972334|FG000|Overall Study|Full consent withdrawn|2
970527|NCT01199289|1972335|FG001|Overall Study|Full consent withdrawn|2
970528|NCT01199289|1972336|FG002|Overall Study|Full consent withdrawn|2
970529|NCT01199289|1972337|FG003|Overall Study|Full consent withdrawn|3
970530|NCT01199289|1972334|FG000|Overall Study|Administrative decision|0
970531|NCT01199289|1972335|FG001|Overall Study|Administrative decision|0
970532|NCT01199289|1972336|FG002|Overall Study|Administrative decision|0
970533|NCT01199289|1972337|FG003|Overall Study|Administrative decision|1
970534|NCT01199289|1972334|FG000|Overall Study|Lost to Follow-up|0
970535|NCT01199289|1972335|FG001|Overall Study|Lost to Follow-up|0
970536|NCT01199289|1972336|FG002|Overall Study|Lost to Follow-up|0
970537|NCT01199289|1972337|FG003|Overall Study|Lost to Follow-up|1
970538|NCT01199289|1972334|FG000|Overall Study|Protocol-specified criteria|3
970539|NCT01199289|1972335|FG001|Overall Study|Protocol-specified criteria|0
970540|NCT01199289|1972336|FG002|Overall Study|Protocol-specified criteria|0
970541|NCT01199289|1972337|FG003|Overall Study|Protocol-specified criteria|1
970542|NCT01199289|1972334|FG000|Overall Study|Pregnancy|0
970543|NCT01199289|1972335|FG001|Overall Study|Pregnancy|1
970544|NCT01199289|1972336|FG002|Overall Study|Pregnancy|0
970545|NCT01199289|1972337|FG003|Overall Study|Pregnancy|1
970546|NCT01199471|1972359|FG000|Overall Study|Protocol Violation|4
970547|NCT01199471|1972359|FG000|Overall Study|Withdrawal by Subject|1
970548|NCT01199471|1972359|FG000|Overall Study|Physician Decision|1
970549|NCT01199575|1972364|FG000|Overall Study|Withdrawal by Subject|5
970550|NCT01199601|1972371|FG000|Overall Study|Lost to Follow-up|47
970551|NCT01199601|1972372|FG001|Overall Study|Lost to Follow-up|66
970552|NCT01199601|1972371|FG000|Overall Study|Withdrawal by Subject|15
970553|NCT01199601|1972372|FG001|Overall Study|Withdrawal by Subject|3
970554|NCT01199601|1972371|FG000|Overall Study|Insecurity prevented staff interviewing.|7
970555|NCT01199601|1972372|FG001|Overall Study|Insecurity prevented staff interviewing.|9
970556|NCT01199705|1972378|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
970557|NCT01199731|1972396|FG000|Overall Study|Adverse Event|0
970558|NCT01199731|1972397|FG001|Overall Study|Adverse Event|1
970559|NCT01199731|1972398|FG002|Overall Study|Adverse Event|0
970560|NCT01199731|1972396|FG000|Overall Study|Study closed/terminated|7
970561|NCT01199731|1972397|FG001|Overall Study|Study closed/terminated|9
970562|NCT01199731|1972398|FG002|Overall Study|Study closed/terminated|7
970563|NCT01199731|1972396|FG000|Overall Study|Lost to Follow-up|0
970564|NCT01199731|1972397|FG001|Overall Study|Lost to Follow-up|0
970565|NCT01199731|1972398|FG002|Overall Study|Lost to Follow-up|2
970566|NCT01199731|1972396|FG000|Overall Study|Physician Decision|0
970567|NCT01199731|1972397|FG001|Overall Study|Physician Decision|1
970568|NCT01199731|1972398|FG002|Overall Study|Physician Decision|1
970569|NCT01199731|1972396|FG000|Overall Study|Withdrawal by Subject|2
970570|NCT01199731|1972397|FG001|Overall Study|Withdrawal by Subject|0
970571|NCT01199731|1972398|FG002|Overall Study|Withdrawal by Subject|0
970572|NCT01199822|1972413|FG000|Overall Study|Investigator discontinued therapy|0
970573|NCT01199822|1972414|FG001|Overall Study|Investigator discontinued therapy|1
970574|NCT01199822|1972415|FG002|Overall Study|Investigator discontinued therapy|0
970575|NCT01199861|1972442|FG000|Overall Study|Administrative problems|1
970576|NCT01199861|1972443|FG001|Overall Study|Administrative problems|0
970577|NCT01199861|1972442|FG000|Overall Study|Adverse Event|1
970578|NCT01199861|1972443|FG001|Overall Study|Adverse Event|0
970579|NCT01199939|1972458|FG000|Overall Study|Adverse Event|4
970580|NCT01199939|1972458|FG000|Overall Study|Protocol Violation|3
970581|NCT01199939|1972458|FG000|Overall Study|Lost to Follow-up|2
970582|NCT01199939|1972458|FG000|Overall Study|Reached a virologic endpoint|4
970583|NCT01200069|1972504|FG000|Overall Study|Withdrawal by Subject|0
970584|NCT01200069|1972505|FG001|Overall Study|Withdrawal by Subject|1
970585|NCT01200238|1972560|FG000|Overall Study|Adverse Event|2
970586|NCT01200238|1972561|FG001|Overall Study|Adverse Event|1
970587|NCT01200238|1972560|FG000|Overall Study|Progressive Disease|5
970588|NCT01200238|1972561|FG001|Overall Study|Progressive Disease|8
970589|NCT01200238|1972560|FG000|Overall Study|Withdrawal by Subject|0
970590|NCT01200238|1972561|FG001|Overall Study|Withdrawal by Subject|1
970591|NCT01200290|1972567|FG000|Treatment Period|Adverse Event|1
970592|NCT01200290|1972567|FG000|Post-Treatment Follow-Up Period|Death|2
970593|NCT01200329|1972571|FG000|Overall Study|Lack of financial coverage|2
970594|NCT01200329|1972571|FG000|Overall Study|Progressive disease|1
970595|NCT01200342|1972575|FG000|Overall Study|Disease Progression|1
970596|NCT01200355|1972581|FG000|Overall Study|Death|7
970597|NCT01200355|1972582|FG001|Overall Study|Death|2
970598|NCT01200368|1972591|FG000|Infant Series|Adverse Event|2
970599|NCT01200368|1972592|FG001|Infant Series|Adverse Event|2
970600|NCT01200368|1972593|FG002|Infant Series|Adverse Event|3
970601|NCT01200368|1972591|FG000|Infant Series|Withdrawal by Subject|0
970602|NCT01200368|1972592|FG001|Infant Series|Withdrawal by Subject|2
970603|NCT01200368|1972593|FG002|Infant Series|Withdrawal by Subject|2
970604|NCT01200368|1972591|FG000|Infant Series|Did not meet entrance criteria|0
970605|NCT01200368|1972592|FG001|Infant Series|Did not meet entrance criteria|1
970606|NCT01200368|1972593|FG002|Infant Series|Did not meet entrance criteria|0
970607|NCT01200368|1972591|FG000|Infant Series|Randomized, not vaccinated|0
970608|NCT01200368|1972592|FG001|Infant Series|Randomized, not vaccinated|1
970609|NCT01200368|1972593|FG002|Infant Series|Randomized, not vaccinated|1
970610|NCT01200368|1972591|FG000|Infant Series|Other|1
970611|NCT01200368|1972592|FG001|Infant Series|Other|0
970612|NCT01200368|1972593|FG002|Infant Series|Other|0
970613|NCT01200368|1972591|FG000|After Infant Series|Adverse Event|6
970614|NCT01200368|1972592|FG001|After Infant Series|Adverse Event|6
970615|NCT01200368|1972593|FG002|After Infant Series|Adverse Event|3
970616|NCT01200368|1972591|FG000|After Infant Series|Withdrawal by Subject|10
970617|NCT01200368|1972592|FG001|After Infant Series|Withdrawal by Subject|8
970618|NCT01200368|1972593|FG002|After Infant Series|Withdrawal by Subject|4
970619|NCT01200368|1972591|FG000|After Infant Series|Lost to Follow-up|1
970620|NCT01200368|1972592|FG001|After Infant Series|Lost to Follow-up|0
970621|NCT01200368|1972593|FG002|After Infant Series|Lost to Follow-up|0
970622|NCT01200368|1972591|FG000|After Infant Series|Other|1
970623|NCT01200368|1972592|FG001|After Infant Series|Other|2
970624|NCT01200368|1972593|FG002|After Infant Series|Other|2
970625|NCT01200368|1972591|FG000|Toddler Dose|Adverse Event|0
970626|NCT01200368|1972592|FG001|Toddler Dose|Adverse Event|3
970627|NCT01200368|1972593|FG002|Toddler Dose|Adverse Event|1
970628|NCT01200394|1972610|FG000|Overall Study|Adverse Event|0
970629|NCT01200394|1972611|FG001|Overall Study|Adverse Event|14
970630|NCT01200394|1972610|FG000|Overall Study|Death|1
970631|NCT01200394|1972611|FG001|Overall Study|Death|0
970632|NCT01200394|1972610|FG000|Overall Study|Lost to Follow-up|0
970633|NCT01200394|1972611|FG001|Overall Study|Lost to Follow-up|1
970634|NCT01200394|1972610|FG000|Overall Study|Did Not Meet Entrance Criteria|1
970635|NCT01200394|1972611|FG001|Overall Study|Did Not Meet Entrance Criteria|4
970636|NCT01200394|1972610|FG000|Overall Study|Protocol Violation|0
970637|NCT01200394|1972611|FG001|Overall Study|Protocol Violation|3
970638|NCT01200394|1972610|FG000|Overall Study|Withdrawal by Subject|0
970639|NCT01200394|1972611|FG001|Overall Study|Withdrawal by Subject|5
970640|NCT01200394|1972610|FG000|Overall Study|Other|0
970641|NCT01200394|1972611|FG001|Overall Study|Other|1
970642|NCT01200407|1972618|FG000|Overall Study|Lost to Follow-up|56
970643|NCT01200407|1972618|FG000|Overall Study|Adverse Event|3
970644|NCT01200407|1972618|FG000|Overall Study|Withdrawal by Subject|4
970645|NCT01200407|1972618|FG000|Overall Study|Other|19
970646|NCT01200485|1972631|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
970647|NCT01200485|1972632|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
970648|NCT01200485|1972633|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
970649|NCT01200485|1972631|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
970650|NCT01200485|1972632|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
970651|NCT01200485|1972633|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
970652|NCT01200511|1972644|FG000|Overall Study|Lost to Follow-up|3
970653|NCT01200511|1972644|FG000|Overall Study|Withdrawal by Subject|1
970654|NCT01200511|1972644|FG000|Overall Study|Adverse Event|1
970655|NCT01200524|1972653|FG000|Overall Study|Withdrawal by Subject|1
970656|NCT01200524|1972654|FG001|Overall Study|Withdrawal by Subject|1
970657|NCT01200524|1972655|FG002|Overall Study|Withdrawal by Subject|3
970658|NCT01200524|1972653|FG000|Overall Study|Adverse Event|1
970659|NCT01200524|1972654|FG001|Overall Study|Adverse Event|0
970660|NCT01200524|1972655|FG002|Overall Study|Adverse Event|0
970661|NCT01200524|1972653|FG000|Overall Study|Non availability of study nurse|0
970662|NCT01200524|1972654|FG001|Overall Study|Non availability of study nurse|0
970663|NCT01200524|1972655|FG002|Overall Study|Non availability of study nurse|1
970664|NCT01200589|1972665|FG000|Overall Study|Withdrawal by Subject|13
970665|NCT01200589|1972666|FG001|Overall Study|Withdrawal by Subject|11
970666|NCT01200589|1972665|FG000|Overall Study|Physician Decision|2
970667|NCT01200589|1972666|FG001|Overall Study|Physician Decision|2
970668|NCT01200589|1972665|FG000|Overall Study|Lost to Follow-up|5
970669|NCT01200589|1972666|FG001|Overall Study|Lost to Follow-up|4
970670|NCT01200589|1972665|FG000|Overall Study|Study terminated|170
970671|NCT01200589|1972666|FG001|Overall Study|Study terminated|172
970672|NCT01200758|1972674|FG000|Stage I|Death|0
970673|NCT01200758|1972675|FG001|Stage I|Death|1
970674|NCT01200758|1972676|FG002|Stage I|Death|0
970675|NCT01200758|1972677|FG003|Stage I|Death|0
970676|NCT01200758|1972674|FG000|Stage I|Physician Decision|1
970677|NCT01200758|1972675|FG001|Stage I|Physician Decision|1
970678|NCT01200758|1972676|FG002|Stage I|Physician Decision|0
970679|NCT01200758|1972677|FG003|Stage I|Physician Decision|0
970680|NCT01200758|1972674|FG000|Stage I|Lack of Efficacy|2
970681|NCT01200758|1972675|FG001|Stage I|Lack of Efficacy|1
970682|NCT01200758|1972676|FG002|Stage I|Lack of Efficacy|0
970683|NCT01200758|1972677|FG003|Stage I|Lack of Efficacy|0
970684|NCT01200758|1972674|FG000|Stage I|Adverse Event|5
970685|NCT01200758|1972675|FG001|Stage I|Adverse Event|5
970686|NCT01200758|1972676|FG002|Stage I|Adverse Event|0
970687|NCT01200758|1972677|FG003|Stage I|Adverse Event|0
970688|NCT01200758|1972674|FG000|Stage I|Withdrawal by Subject|1
970689|NCT01200758|1972675|FG001|Stage I|Withdrawal by Subject|2
970690|NCT01200758|1972676|FG002|Stage I|Withdrawal by Subject|0
970691|NCT01200758|1972677|FG003|Stage I|Withdrawal by Subject|0
970692|NCT01200758|1972674|FG000|Stage I|Disease Progression|9
970693|NCT01200758|1972675|FG001|Stage I|Disease Progression|7
970694|NCT01200758|1972676|FG002|Stage I|Disease Progression|0
970695|NCT01200758|1972677|FG003|Stage I|Disease Progression|0
970696|NCT01200758|1972674|FG000|Stage 2|Disease Progression|0
970697|NCT01200758|1972675|FG001|Stage 2|Disease Progression|0
970698|NCT01200758|1972676|FG002|Stage 2|Disease Progression|16
970699|NCT01200758|1972677|FG003|Stage 2|Disease Progression|21
970700|NCT01200758|1972674|FG000|Stage 2|Lack of Efficacy|0
970701|NCT01200758|1972675|FG001|Stage 2|Lack of Efficacy|0
970702|NCT01200758|1972676|FG002|Stage 2|Lack of Efficacy|4
970703|NCT01200758|1972677|FG003|Stage 2|Lack of Efficacy|2
970704|NCT01200758|1972674|FG000|Stage 2|Physician Decision|0
970705|NCT01200758|1972675|FG001|Stage 2|Physician Decision|0
970706|NCT01200758|1972676|FG002|Stage 2|Physician Decision|5
970707|NCT01200758|1972677|FG003|Stage 2|Physician Decision|7
970708|NCT01200758|1972674|FG000|Stage 2|Adverse Event|0
970709|NCT01200758|1972675|FG001|Stage 2|Adverse Event|0
970710|NCT01200758|1972676|FG002|Stage 2|Adverse Event|5
970711|NCT01200758|1972677|FG003|Stage 2|Adverse Event|9
970712|NCT01200758|1972674|FG000|Stage 2|Withdrawal by Subject|0
970713|NCT01200758|1972675|FG001|Stage 2|Withdrawal by Subject|0
970714|NCT01200758|1972676|FG002|Stage 2|Withdrawal by Subject|4
970715|NCT01200758|1972677|FG003|Stage 2|Withdrawal by Subject|1
970716|NCT01200758|1972674|FG000|Stage 2|Lost to Follow-up|0
970717|NCT01200758|1972675|FG001|Stage 2|Lost to Follow-up|0
970718|NCT01200758|1972676|FG002|Stage 2|Lost to Follow-up|3
970719|NCT01200758|1972677|FG003|Stage 2|Lost to Follow-up|1
970720|NCT01200758|1972674|FG000|Stage 2|Protocol Violation|0
970721|NCT01200758|1972675|FG001|Stage 2|Protocol Violation|0
970722|NCT01200758|1972676|FG002|Stage 2|Protocol Violation|1
970723|NCT01200758|1972677|FG003|Stage 2|Protocol Violation|4
970724|NCT01200758|1972674|FG000|Stage 2|Death|0
970725|NCT01200758|1972675|FG001|Stage 2|Death|0
970726|NCT01200758|1972676|FG002|Stage 2|Death|3
970727|NCT01200758|1972677|FG003|Stage 2|Death|5
970728|NCT01200797|1972689|FG000|Overall Study|symptomatic deterioration|2
970729|NCT01200797|1972689|FG000|Overall Study|Adverse Event|4
970730|NCT01200797|1972689|FG000|Overall Study|Disease Progression|13
970731|NCT01200810|1972696|FG000|Overall Study|Physician Decision|1
970732|NCT01200810|1972697|FG001|Overall Study|Physician Decision|0
970733|NCT01200810|1972696|FG000|Overall Study|Withdrawal by Subject|1
970734|NCT01200810|1972697|FG001|Overall Study|Withdrawal by Subject|2
970735|NCT01200810|1972696|FG000|Overall Study|Sponsor stopped making study drug|3
970736|NCT01200810|1972697|FG001|Overall Study|Sponsor stopped making study drug|3
970737|NCT01200992|1972723|FG000|Overall Study|Study terminated early|35
970738|NCT01200992|1972724|FG001|Overall Study|Study terminated early|41
970739|NCT01200992|1972723|FG000|Overall Study|Randomized but not treated|2
970740|NCT01200992|1972724|FG001|Overall Study|Randomized but not treated|0
970741|NCT01201265|1972749|FG000|Overall Study|Death|14
970742|NCT01201265|1972749|FG000|Overall Study|Insufficient Therapeutic Response|3
970743|NCT01201265|1972749|FG000|Overall Study|Lost to Follow-up|10
970744|NCT01201265|1972749|FG000|Overall Study|Withdrawal by Subject|7
970745|NCT01201265|1972749|FG000|Overall Study|Disease Progression|4
970746|NCT01201317|1972756|FG000|Overall Study|Withdrawal by Subject|5
970747|NCT01201317|1972757|FG001|Overall Study|Withdrawal by Subject|0
970748|NCT01201317|1972758|FG002|Overall Study|Withdrawal by Subject|3
970749|NCT01201317|1972756|FG000|Overall Study|Adverse Event|2
970750|NCT01201317|1972757|FG001|Overall Study|Adverse Event|2
970751|NCT01201317|1972758|FG002|Overall Study|Adverse Event|2
970752|NCT01201317|1972756|FG000|Overall Study|Screen failure|1
970753|NCT01201317|1972757|FG001|Overall Study|Screen failure|1
970754|NCT01201317|1972758|FG002|Overall Study|Screen failure|0
970755|NCT01201317|1972756|FG000|Overall Study|Protocol Violation|0
970756|NCT01201317|1972757|FG001|Overall Study|Protocol Violation|1
970757|NCT01201317|1972758|FG002|Overall Study|Protocol Violation|1
970758|NCT01201317|1972756|FG000|Overall Study|Death|0
970759|NCT01201317|1972757|FG001|Overall Study|Death|1
970760|NCT01201317|1972758|FG002|Overall Study|Death|0
970761|NCT01201317|1972756|FG000|Overall Study|Study-specific withdrawal criteria|0
970762|NCT01201317|1972757|FG001|Overall Study|Study-specific withdrawal criteria|0
970763|NCT01201317|1972758|FG002|Overall Study|Study-specific withdrawal criteria|1
970764|NCT01201317|1972756|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0
970765|NCT01201317|1972757|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1
970766|NCT01201317|1972758|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0
970767|NCT01201317|1972756|FG000|Overall Study|Decrease in renal function|0
970768|NCT01201317|1972757|FG001|Overall Study|Decrease in renal function|1
970769|NCT01201317|1972758|FG002|Overall Study|Decrease in renal function|0
970770|NCT01201317|1972756|FG000|Overall Study|Lack of Efficacy|1
970771|NCT01201317|1972757|FG001|Overall Study|Lack of Efficacy|0
970772|NCT01201317|1972758|FG002|Overall Study|Lack of Efficacy|0
970773|NCT01201317|1972756|FG000|Overall Study|Safety, possible history of tuberculosis|0
970774|NCT01201317|1972757|FG001|Overall Study|Safety, possible history of tuberculosis|0
970775|NCT01201317|1972758|FG002|Overall Study|Safety, possible history of tuberculosis|1
970776|NCT01201343|1972766|FG000|Overall Study|Adverse Event|6
970777|NCT01201343|1972766|FG000|Overall Study|Withdrawal by Subject|5
970778|NCT01201343|1972766|FG000|Overall Study|Lost to Follow-up|2
970779|NCT01201343|1972766|FG000|Overall Study|Lack of Efficacy|2
970780|NCT01201343|1972766|FG000|Overall Study|Participant wrongly included in trial|1
970781|NCT01201343|1972766|FG000|Overall Study|Randomized, not treated|3
970782|NCT01201356|1972770|FG000|Overall Study|Adverse Event|170
970783|NCT01201356|1972770|FG000|Overall Study|Abnormal laboratory value(s)|51
970784|NCT01201356|1972770|FG000|Overall Study|Abnormal test procedure result(s)|3
970785|NCT01201356|1972770|FG000|Overall Study|Unsatisfactory therapeutic effect|112
970786|NCT01201356|1972770|FG000|Overall Study|Condition no longer requires study drug|12
970787|NCT01201356|1972770|FG000|Overall Study|Withdrawal by Subject|144
970788|NCT01201356|1972770|FG000|Overall Study|Lost to Follow-up|50
970789|NCT01201356|1972770|FG000|Overall Study|administrative problems|74
970790|NCT01201356|1972770|FG000|Overall Study|Death|16
970791|NCT01201356|1972770|FG000|Overall Study|Protocol Violation|12
970792|NCT01201759|1972789|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
970793|NCT01201759|1972790|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
970794|NCT01201759|1972789|FG000|Visit 3 - Washout|Adverse Event|0
970795|NCT01201759|1972790|FG001|Visit 3 - Washout|Adverse Event|3
970796|NCT01201759|1972789|FG000|Visit 3 - Washout|Lost to Follow-up|1
970797|NCT01201759|1972790|FG001|Visit 3 - Washout|Lost to Follow-up|0
970798|NCT01201759|1972789|FG000|Visit 4 Crossover|Lost to Follow-up|0
970799|NCT01201759|1972790|FG001|Visit 4 Crossover|Lost to Follow-up|1
970800|NCT01201785|1972809|FG000|Overall Study|Lost to Follow-up|16
970801|NCT01201798|1972815|FG000|Overall Study|Adverse Event|2
970802|NCT01201798|1972816|FG001|Overall Study|Adverse Event|0
970803|NCT01201798|1972815|FG000|Overall Study|Lost to Follow-up|3
970804|NCT01201798|1972816|FG001|Overall Study|Lost to Follow-up|5
970805|NCT01201798|1972815|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
970806|NCT01201798|1972816|FG001|Overall Study|Decision Unrelated to an Adverse Event|1
970807|NCT01201798|1972815|FG000|Overall Study|Noncompliance|1
970808|NCT01201798|1972816|FG001|Overall Study|Noncompliance|0
970809|NCT01201798|1972815|FG000|Overall Study|Protocol Violation|1
970810|NCT01201798|1972816|FG001|Overall Study|Protocol Violation|1
970811|NCT01201798|1972815|FG000|Overall Study|Treatment Failure|1
970812|NCT01201798|1972816|FG001|Overall Study|Treatment Failure|8
970813|NCT01201811|1972822|FG000|Overall Study|Adverse Event|6
970814|NCT01201811|1972822|FG000|Overall Study|Disease progression|3
970815|NCT01201811|1972822|FG000|Overall Study|Withdrawal by Subject|3
970816|NCT01201811|1972822|FG000|Overall Study|Death|4
970817|NCT01201811|1972822|FG000|Overall Study|Treatment Failure|2
970818|NCT01201811|1972822|FG000|Overall Study|Physician Decision|1
970819|NCT01201850|1972826|FG000|Overall Study|Tumor progression|4
970820|NCT01201915|1972846|FG000|Overall Study|Adverse Event|2
970821|NCT01201915|1972847|FG001|Overall Study|Adverse Event|1
970822|NCT01201915|1972848|FG002|Overall Study|Adverse Event|1
970823|NCT01201915|1972846|FG000|Overall Study|Lost to Follow-up|0
970824|NCT01201915|1972847|FG001|Overall Study|Lost to Follow-up|4
970825|NCT01201915|1972848|FG002|Overall Study|Lost to Follow-up|0
970826|NCT01201915|1972846|FG000|Overall Study|Physician Decision|3
970827|NCT01201915|1972847|FG001|Overall Study|Physician Decision|0
970828|NCT01201915|1972848|FG002|Overall Study|Physician Decision|0
970829|NCT01201915|1972846|FG000|Overall Study|Subject Decision|3
970830|NCT01201915|1972847|FG001|Overall Study|Subject Decision|3
970831|NCT01201915|1972848|FG002|Overall Study|Subject Decision|5
970832|NCT01201915|1972846|FG000|Overall Study|Target Lesion Progression|0
970833|NCT01201915|1972847|FG001|Overall Study|Target Lesion Progression|3
970834|NCT01201915|1972848|FG002|Overall Study|Target Lesion Progression|0
970835|NCT01201967|1972858|FG000|Overall Study|Lost to Follow-up|6
970836|NCT01201967|1972859|FG001|Overall Study|Lost to Follow-up|5
970837|NCT01202175|1972890|FG000|Overall Study|Lost to Follow-up|2
970838|NCT01202175|1972890|FG000|Overall Study|Withdrawal by Subject|1
970839|NCT01202175|1972890|FG000|Overall Study|Adverse Event|2
970840|NCT01202188|1972900|FG000|Overall Study|Protocol deviation|14
970841|NCT01202188|1972901|FG001|Overall Study|Protocol deviation|8
970842|NCT01202188|1972902|FG002|Overall Study|Protocol deviation|12
970843|NCT01202188|1972903|FG003|Overall Study|Protocol deviation|10
970844|NCT01202188|1972904|FG004|Overall Study|Protocol deviation|11
970845|NCT01202188|1972900|FG000|Overall Study|Subject withdrew consent|12
970846|NCT01202188|1972901|FG001|Overall Study|Subject withdrew consent|13
970847|NCT01202188|1972902|FG002|Overall Study|Subject withdrew consent|22
970848|NCT01202188|1972903|FG003|Overall Study|Subject withdrew consent|11
970849|NCT01202188|1972904|FG004|Overall Study|Subject withdrew consent|13
970850|NCT01202188|1972900|FG000|Overall Study|Adverse Event|5
970851|NCT01202188|1972901|FG001|Overall Study|Adverse Event|23
970852|NCT01202188|1972902|FG002|Overall Study|Adverse Event|13
970853|NCT01202188|1972903|FG003|Overall Study|Adverse Event|10
970854|NCT01202188|1972904|FG004|Overall Study|Adverse Event|10
970855|NCT01202188|1972900|FG000|Overall Study|Administrative problems|3
970856|NCT01202188|1972901|FG001|Overall Study|Administrative problems|2
970857|NCT01202188|1972902|FG002|Overall Study|Administrative problems|1
970858|NCT01202188|1972903|FG003|Overall Study|Administrative problems|1
970859|NCT01202188|1972904|FG004|Overall Study|Administrative problems|2
970860|NCT01202188|1972900|FG000|Overall Study|Unsatisfactory therapeutic effect|2
970861|NCT01202188|1972901|FG001|Overall Study|Unsatisfactory therapeutic effect|8
970862|NCT01202188|1972902|FG002|Overall Study|Unsatisfactory therapeutic effect|2
970863|NCT01202188|1972903|FG003|Overall Study|Unsatisfactory therapeutic effect|5
970864|NCT01202188|1972904|FG004|Overall Study|Unsatisfactory therapeutic effect|8
970865|NCT01202188|1972900|FG000|Overall Study|Lost to Follow-up|1
970866|NCT01202188|1972901|FG001|Overall Study|Lost to Follow-up|1
970867|NCT01202188|1972902|FG002|Overall Study|Lost to Follow-up|0
970868|NCT01202188|1972903|FG003|Overall Study|Lost to Follow-up|4
970869|NCT01202188|1972904|FG004|Overall Study|Lost to Follow-up|1
970870|NCT01202188|1972900|FG000|Overall Study|Death|1
970871|NCT01202188|1972901|FG001|Overall Study|Death|1
970872|NCT01202188|1972902|FG002|Overall Study|Death|1
970873|NCT01202188|1972903|FG003|Overall Study|Death|1
970874|NCT01202188|1972904|FG004|Overall Study|Death|0
970875|NCT01202188|1972900|FG000|Overall Study|Abnormal test procedure result (s)|0
970876|NCT01202188|1972901|FG001|Overall Study|Abnormal test procedure result (s)|0
970877|NCT01202188|1972902|FG002|Overall Study|Abnormal test procedure result (s)|2
970878|NCT01202188|1972903|FG003|Overall Study|Abnormal test procedure result (s)|0
970879|NCT01202188|1972904|FG004|Overall Study|Abnormal test procedure result (s)|0
970880|NCT01202227|1972922|FG000|Overall Study|Adverse Event|16
970881|NCT01202227|1972922|FG000|Overall Study|Withdrawal by Subject|2
970882|NCT01202227|1972922|FG000|Overall Study|Lack of Efficacy|1
970883|NCT01202279|1972932|FG000|Overall Study|Adverse Event|8
970884|NCT01202279|1972933|FG001|Overall Study|Adverse Event|6
970885|NCT01202279|1972932|FG000|Overall Study|Withdrawal by Subject|13
970886|NCT01202279|1972933|FG001|Overall Study|Withdrawal by Subject|10
970887|NCT01202279|1972932|FG000|Overall Study|Physician Decision|0
970888|NCT01202279|1972933|FG001|Overall Study|Physician Decision|1
970889|NCT01202279|1972932|FG000|Overall Study|Lost to Follow-up|10
970890|NCT01202279|1972933|FG001|Overall Study|Lost to Follow-up|7
970891|NCT01202279|1972932|FG000|Overall Study|Protocol Violation|1
970892|NCT01202279|1972933|FG001|Overall Study|Protocol Violation|1
970893|NCT01202279|1972932|FG000|Overall Study|study compliance|5
970894|NCT01202279|1972933|FG001|Overall Study|study compliance|2
970895|NCT01202409|1972939|FG000|Overall Study|Adverse Event|1
970896|NCT01202409|1972939|FG000|Overall Study|Ineligible - KRAS mutants|7
970897|NCT01202591|1972957|FG000|Overall Study|Adverse Event|2
970898|NCT01202591|1972958|FG001|Overall Study|Adverse Event|1
970899|NCT01202591|1972959|FG002|Overall Study|Adverse Event|4
970900|NCT01202591|1972960|FG003|Overall Study|Adverse Event|4
970901|NCT01202591|1972961|FG004|Overall Study|Adverse Event|0
970902|NCT01202591|1972962|FG005|Overall Study|Adverse Event|0
970903|NCT01202591|1972957|FG000|Overall Study|Other reason as per investigator|3
970904|NCT01202591|1972958|FG001|Overall Study|Other reason as per investigator|4
970905|NCT01202591|1972959|FG002|Overall Study|Other reason as per investigator|7
970906|NCT01202591|1972960|FG003|Overall Study|Other reason as per investigator|3
970907|NCT01202591|1972961|FG004|Overall Study|Other reason as per investigator|1
970908|NCT01202591|1972962|FG005|Overall Study|Other reason as per investigator|3
970909|NCT01202591|1972957|FG000|Overall Study|Withdrawal by Subject|0
970910|NCT01202591|1972958|FG001|Overall Study|Withdrawal by Subject|0
970911|NCT01202591|1972959|FG002|Overall Study|Withdrawal by Subject|0
970912|NCT01202591|1972960|FG003|Overall Study|Withdrawal by Subject|0
970913|NCT01202591|1972961|FG004|Overall Study|Withdrawal by Subject|2
970914|NCT01202591|1972962|FG005|Overall Study|Withdrawal by Subject|1
970915|NCT01202591|1972957|FG000|Overall Study|Objective Disease Progression|0
970916|NCT01202591|1972958|FG001|Overall Study|Objective Disease Progression|0
970917|NCT01202591|1972959|FG002|Overall Study|Objective Disease Progression|0
970918|NCT01202591|1972960|FG003|Overall Study|Objective Disease Progression|0
970919|NCT01202591|1972961|FG004|Overall Study|Objective Disease Progression|2
970920|NCT01202591|1972962|FG005|Overall Study|Objective Disease Progression|0
970921|NCT01202747|1973013|FG000|Overall Study|Withdrawal by Subject|1
970922|NCT01202760|1973020|FG000|Overall Study|Entry Criteria Not Met|0
970923|NCT01202760|1973021|FG001|Overall Study|Entry Criteria Not Met|3
970924|NCT01202760|1973022|FG002|Overall Study|Entry Criteria Not Met|1
970925|NCT01202760|1973020|FG000|Overall Study|Adverse Event|11
970926|NCT01202760|1973021|FG001|Overall Study|Adverse Event|9
970927|NCT01202760|1973022|FG002|Overall Study|Adverse Event|10
970928|NCT01202760|1973020|FG000|Overall Study|Death|2
970929|NCT01202760|1973021|FG001|Overall Study|Death|1
970930|NCT01202760|1973022|FG002|Overall Study|Death|0
970931|NCT01202760|1973020|FG000|Overall Study|Lack of Efficacy|6
970932|NCT01202760|1973021|FG001|Overall Study|Lack of Efficacy|8
970933|NCT01202760|1973022|FG002|Overall Study|Lack of Efficacy|7
970934|NCT01202760|1973020|FG000|Overall Study|Lost to Follow-up|0
970935|NCT01202760|1973021|FG001|Overall Study|Lost to Follow-up|2
970936|NCT01202760|1973022|FG002|Overall Study|Lost to Follow-up|1
970937|NCT01202760|1973020|FG000|Overall Study|Parent / Caregiver Decision|0
970938|NCT01202760|1973021|FG001|Overall Study|Parent / Caregiver Decision|1
970939|NCT01202760|1973022|FG002|Overall Study|Parent / Caregiver Decision|0
970940|NCT01202760|1973020|FG000|Overall Study|Withdrawal by Subject|17
970941|NCT01202760|1973021|FG001|Overall Study|Withdrawal by Subject|18
970942|NCT01202760|1973022|FG002|Overall Study|Withdrawal by Subject|14
970943|NCT01202760|1973020|FG000|Overall Study|Physician Decision|0
970944|NCT01202760|1973021|FG001|Overall Study|Physician Decision|1
970945|NCT01202760|1973022|FG002|Overall Study|Physician Decision|0
970946|NCT01202760|1973020|FG000|Overall Study|Protocol Violation|7
970947|NCT01202760|1973021|FG001|Overall Study|Protocol Violation|5
970948|NCT01202760|1973022|FG002|Overall Study|Protocol Violation|2
970949|NCT01202760|1973020|FG000|Overall Study|Sponsor Decision|4
970950|NCT01202760|1973021|FG001|Overall Study|Sponsor Decision|4
970951|NCT01202760|1973022|FG002|Overall Study|Sponsor Decision|0
970952|NCT01202773|1973045|FG000|Overall Study|Adverse Event|4
970953|NCT01202773|1973046|FG001|Overall Study|Adverse Event|5
970954|NCT01202773|1973047|FG002|Overall Study|Adverse Event|5
970955|NCT01202773|1973045|FG000|Overall Study|Lack of Efficacy|5
970956|NCT01202773|1973046|FG001|Overall Study|Lack of Efficacy|4
970957|NCT01202773|1973047|FG002|Overall Study|Lack of Efficacy|9
970958|NCT01202773|1973045|FG000|Overall Study|Entry Criteria Not Met|2
970959|NCT01202773|1973046|FG001|Overall Study|Entry Criteria Not Met|0
970960|NCT01202773|1973047|FG002|Overall Study|Entry Criteria Not Met|1
970961|NCT01202773|1973045|FG000|Overall Study|Lost to Follow-up|1
970962|NCT01202773|1973046|FG001|Overall Study|Lost to Follow-up|2
970963|NCT01202773|1973047|FG002|Overall Study|Lost to Follow-up|2
970964|NCT01202773|1973045|FG000|Overall Study|Withdrawal by Subject|13
970965|NCT01202773|1973046|FG001|Overall Study|Withdrawal by Subject|6
970966|NCT01202773|1973047|FG002|Overall Study|Withdrawal by Subject|5
970967|NCT01202773|1973045|FG000|Overall Study|Physician Decision|2
970968|NCT01202773|1973046|FG001|Overall Study|Physician Decision|0
970969|NCT01202773|1973047|FG002|Overall Study|Physician Decision|0
970970|NCT01202773|1973045|FG000|Overall Study|Protocol Violation|11
970971|NCT01202773|1973046|FG001|Overall Study|Protocol Violation|6
970972|NCT01202773|1973047|FG002|Overall Study|Protocol Violation|10
970973|NCT01202773|1973045|FG000|Overall Study|Sponsor Decision|19
970974|NCT01202773|1973046|FG001|Overall Study|Sponsor Decision|20
970975|NCT01202773|1973047|FG002|Overall Study|Sponsor Decision|23
970976|NCT01202877|1973068|FG000|Overall Study|Disease Progression|0
970977|NCT01202877|1973069|FG001|Overall Study|Disease Progression|1
912530|NCT00806026|1890094|FG005|Overall Study|Did not meet entrance criteria|0
912531|NCT00806026|1890089|FG000|Overall Study|Lack of Efficacy|5
912532|NCT00806026|1890090|FG001|Overall Study|Lack of Efficacy|18
912533|NCT00806026|1890091|FG002|Overall Study|Lack of Efficacy|13
912534|NCT00806026|1890092|FG003|Overall Study|Lack of Efficacy|4
912535|NCT00806026|1890093|FG004|Overall Study|Lack of Efficacy|8
912536|NCT00806026|1890094|FG005|Overall Study|Lack of Efficacy|7
912537|NCT00806026|1890089|FG000|Overall Study|Lost to Follow-up|8
912538|NCT00806026|1890090|FG001|Overall Study|Lost to Follow-up|15
912539|NCT00806026|1890091|FG002|Overall Study|Lost to Follow-up|8
912540|NCT00806026|1890092|FG003|Overall Study|Lost to Follow-up|2
912541|NCT00806026|1890093|FG004|Overall Study|Lost to Follow-up|6
912542|NCT00806026|1890094|FG005|Overall Study|Lost to Follow-up|6
912543|NCT00806026|1890089|FG000|Overall Study|Withdrawal by Subject|14
912544|NCT00806026|1890090|FG001|Overall Study|Withdrawal by Subject|17
912545|NCT00806026|1890091|FG002|Overall Study|Withdrawal by Subject|9
912546|NCT00806026|1890092|FG003|Overall Study|Withdrawal by Subject|2
912547|NCT00806026|1890093|FG004|Overall Study|Withdrawal by Subject|5
970978|NCT01202877|1973070|FG002|Overall Study|Disease Progression|2
970979|NCT01202877|1973068|FG000|Overall Study|Adverse Event|0
970980|NCT01202877|1973069|FG001|Overall Study|Adverse Event|0
970981|NCT01202877|1973070|FG002|Overall Study|Adverse Event|2
970982|NCT01202877|1973068|FG000|Overall Study|Withdrawal by Subject|0
970983|NCT01202877|1973069|FG001|Overall Study|Withdrawal by Subject|0
970984|NCT01202877|1973070|FG002|Overall Study|Withdrawal by Subject|1
970985|NCT01202877|1973068|FG000|Overall Study|Death|0
970986|NCT01202877|1973069|FG001|Overall Study|Death|0
970987|NCT01202877|1973070|FG002|Overall Study|Death|1
970988|NCT01202903|1973080|FG000|Overall Study|Administrative Probelms|1
970989|NCT01202903|1973081|FG001|Overall Study|Administrative Probelms|4
970990|NCT01202903|1973080|FG000|Overall Study|Protocol Violation|0
970991|NCT01202903|1973081|FG001|Overall Study|Protocol Violation|1
970992|NCT01202903|1973080|FG000|Overall Study|Death|1
970993|NCT01202903|1973081|FG001|Overall Study|Death|0
970994|NCT01202903|1973080|FG000|Overall Study|Lost to Follow-up|1
970995|NCT01202903|1973081|FG001|Overall Study|Lost to Follow-up|1
970996|NCT01202903|1973080|FG000|Overall Study|Lack of Efficacy|1
970997|NCT01202903|1973081|FG001|Overall Study|Lack of Efficacy|3
970998|NCT01202903|1973080|FG000|Overall Study|Adverse Event|3
970999|NCT01202903|1973081|FG001|Overall Study|Adverse Event|3
971000|NCT01202903|1973080|FG000|Overall Study|Withdrawal by Subject|4
971001|NCT01202903|1973081|FG001|Overall Study|Withdrawal by Subject|4
971002|NCT01202955|1973089|FG000|Period 1: 10 Days|Withdrawal by Subject|0
971003|NCT01202955|1973090|FG001|Period 1: 10 Days|Withdrawal by Subject|2
971004|NCT01203072|1973117|FG000|Overall Study|Adverse Event|5
971005|NCT01203072|1973118|FG001|Overall Study|Adverse Event|3
971006|NCT01203072|1973119|FG002|Overall Study|Adverse Event|2
971007|NCT01203072|1973120|FG003|Overall Study|Adverse Event|4
971008|NCT01203072|1973121|FG004|Overall Study|Adverse Event|2
971009|NCT01203072|1973117|FG000|Overall Study|Lack of Efficacy|1
971010|NCT01203072|1973118|FG001|Overall Study|Lack of Efficacy|0
971011|NCT01203072|1973119|FG002|Overall Study|Lack of Efficacy|0
971012|NCT01203072|1973120|FG003|Overall Study|Lack of Efficacy|0
971013|NCT01203072|1973121|FG004|Overall Study|Lack of Efficacy|0
971014|NCT01203072|1973117|FG000|Overall Study|Lost to Follow-up|0
971015|NCT01203072|1973118|FG001|Overall Study|Lost to Follow-up|1
971016|NCT01203072|1973119|FG002|Overall Study|Lost to Follow-up|0
971017|NCT01203072|1973120|FG003|Overall Study|Lost to Follow-up|0
971018|NCT01203072|1973121|FG004|Overall Study|Lost to Follow-up|0
971019|NCT01203072|1973117|FG000|Overall Study|Protocol Violation|2
971020|NCT01203072|1973118|FG001|Overall Study|Protocol Violation|0
971021|NCT01203072|1973119|FG002|Overall Study|Protocol Violation|0
971022|NCT01203072|1973120|FG003|Overall Study|Protocol Violation|0
971023|NCT01203072|1973121|FG004|Overall Study|Protocol Violation|1
971024|NCT01203072|1973117|FG000|Overall Study|Withdrawal by Subject|2
912548|NCT00806026|1890094|FG005|Overall Study|Withdrawal by Subject|3
912549|NCT00806026|1890089|FG000|Overall Study|Other|3
912550|NCT00806026|1890090|FG001|Overall Study|Other|6
971025|NCT01203072|1973118|FG001|Overall Study|Withdrawal by Subject|2
971026|NCT01203072|1973119|FG002|Overall Study|Withdrawal by Subject|1
971027|NCT01203072|1973120|FG003|Overall Study|Withdrawal by Subject|2
971028|NCT01203072|1973121|FG004|Overall Study|Withdrawal by Subject|3
971029|NCT01203098|1973136|FG000|Overall Study|Adverse Event|3
971030|NCT01203098|1973137|FG001|Overall Study|Adverse Event|1
971031|NCT01203098|1973138|FG002|Overall Study|Adverse Event|7
971032|NCT01203098|1973136|FG000|Overall Study|Lost to Follow-up|0
971033|NCT01203098|1973137|FG001|Overall Study|Lost to Follow-up|0
971034|NCT01203098|1973138|FG002|Overall Study|Lost to Follow-up|1
971035|NCT01203098|1973136|FG000|Overall Study|Physician Decision|2
971036|NCT01203098|1973137|FG001|Overall Study|Physician Decision|2
971037|NCT01203098|1973138|FG002|Overall Study|Physician Decision|0
971038|NCT01203098|1973136|FG000|Overall Study|Withdrawal by Subject|1
971039|NCT01203098|1973137|FG001|Overall Study|Withdrawal by Subject|1
971040|NCT01203098|1973138|FG002|Overall Study|Withdrawal by Subject|3
971041|NCT01203787|1973193|FG000|Overall Study|Death|12
971042|NCT01203787|1973194|FG001|Overall Study|Death|10
971043|NCT01203787|1973193|FG000|Overall Study|Withdrawal by Subject|6
971044|NCT01203787|1973194|FG001|Overall Study|Withdrawal by Subject|2
971045|NCT01203787|1973193|FG000|Overall Study|Lost to Follow-up|2
971046|NCT01203787|1973194|FG001|Overall Study|Lost to Follow-up|0
971047|NCT01203787|1973193|FG000|Overall Study|Adverse Event|11
971048|NCT01203787|1973194|FG001|Overall Study|Adverse Event|15
971049|NCT01203852|1973211|FG000|Metoprolol 8 Weeks|Physician Decision|470
971050|NCT01203852|1973211|FG000|Washout 2 Weeks|Physician Decision|46
971051|NCT01203878|1973221|FG000|Overall Study|Withdrawal by Subject|0
971052|NCT01203878|1973222|FG001|Overall Study|Withdrawal by Subject|0
971053|NCT01203878|1973223|FG002|Overall Study|Withdrawal by Subject|1
971054|NCT01203878|1973221|FG000|Overall Study|Adverse Event|0
971055|NCT01203878|1973222|FG001|Overall Study|Adverse Event|0
971056|NCT01203878|1973223|FG002|Overall Study|Adverse Event|2
971057|NCT01203917|1973230|FG000|Overall Study|Death|29
971058|NCT01203917|1973230|FG000|Overall Study|Lost to Follow-up|2
971059|NCT01203917|1973230|FG000|Overall Study|Withdrawal by Subject|3
971060|NCT01203917|1973230|FG000|Overall Study|Due to objective disease progression|1
971061|NCT01203917|1973230|FG000|Overall Study|Due to EGFR M+I patient|1
971062|NCT01203930|1973236|FG000|Overall Study|Disease Progression|0
971063|NCT01203930|1973237|FG001|Overall Study|Disease Progression|4
971064|NCT01203930|1973236|FG000|Overall Study|Death|3
971065|NCT01203930|1973237|FG001|Overall Study|Death|1
971066|NCT01203930|1973236|FG000|Overall Study|Withdrew Consent|1
971067|NCT01203930|1973237|FG001|Overall Study|Withdrew Consent|10
971068|NCT01203930|1973236|FG000|Overall Study|Investigator Request|0
971069|NCT01203930|1973237|FG001|Overall Study|Investigator Request|8
971070|NCT01203930|1973236|FG000|Overall Study|Study Terminated by Sponsor|0
971071|NCT01203930|1973237|FG001|Overall Study|Study Terminated by Sponsor|12
971072|NCT01203930|1973236|FG000|Overall Study|Poor tolerance of study drug|0
971073|NCT01203930|1973237|FG001|Overall Study|Poor tolerance of study drug|1
971074|NCT01203930|1973236|FG000|Overall Study|Adverse Event|17
971075|NCT01203930|1973237|FG001|Overall Study|Adverse Event|5
971076|NCT01203956|1973245|FG000|Second Two-week Period|Non-compliant: no evaluable results|5
971077|NCT01203956|1973246|FG001|Second Two-week Period|Non-compliant: no evaluable results|6
971078|NCT01204294|1973268|FG000|Overall Study|Adverse Event|2
971079|NCT01204294|1973269|FG001|Overall Study|Adverse Event|6
971080|NCT01204294|1973270|FG002|Overall Study|Adverse Event|0
971081|NCT01204294|1973271|FG003|Overall Study|Adverse Event|7
971082|NCT01204294|1973272|FG004|Overall Study|Adverse Event|1
971083|NCT01204294|1973273|FG005|Overall Study|Adverse Event|4
971084|NCT01204294|1973274|FG006|Overall Study|Adverse Event|0
971085|NCT01204294|1973268|FG000|Overall Study|Protocol Violation|1
971086|NCT01204294|1973269|FG001|Overall Study|Protocol Violation|0
971087|NCT01204294|1973270|FG002|Overall Study|Protocol Violation|2
971088|NCT01204294|1973271|FG003|Overall Study|Protocol Violation|1
971089|NCT01204294|1973272|FG004|Overall Study|Protocol Violation|0
971090|NCT01204294|1973273|FG005|Overall Study|Protocol Violation|0
971091|NCT01204294|1973274|FG006|Overall Study|Protocol Violation|0
971092|NCT01204294|1973268|FG000|Overall Study|Withdrawal by Subject|0
971093|NCT01204294|1973269|FG001|Overall Study|Withdrawal by Subject|2
971094|NCT01204294|1973270|FG002|Overall Study|Withdrawal by Subject|2
971095|NCT01204294|1973271|FG003|Overall Study|Withdrawal by Subject|1
971096|NCT01204294|1973272|FG004|Overall Study|Withdrawal by Subject|1
971097|NCT01204294|1973273|FG005|Overall Study|Withdrawal by Subject|1
971098|NCT01204294|1973274|FG006|Overall Study|Withdrawal by Subject|2
971099|NCT01204294|1973268|FG000|Overall Study|Lack of Efficacy|0
971100|NCT01204294|1973269|FG001|Overall Study|Lack of Efficacy|0
971101|NCT01204294|1973270|FG002|Overall Study|Lack of Efficacy|0
971102|NCT01204294|1973271|FG003|Overall Study|Lack of Efficacy|2
971103|NCT01204294|1973272|FG004|Overall Study|Lack of Efficacy|0
971104|NCT01204294|1973273|FG005|Overall Study|Lack of Efficacy|0
971105|NCT01204294|1973274|FG006|Overall Study|Lack of Efficacy|0
971106|NCT01204294|1973268|FG000|Overall Study|Other (house moving)|0
971107|NCT01204294|1973269|FG001|Overall Study|Other (house moving)|0
971108|NCT01204294|1973270|FG002|Overall Study|Other (house moving)|1
971109|NCT01204294|1973271|FG003|Overall Study|Other (house moving)|0
971110|NCT01204294|1973272|FG004|Overall Study|Other (house moving)|0
971111|NCT01204294|1973273|FG005|Overall Study|Other (house moving)|0
971112|NCT01204294|1973274|FG006|Overall Study|Other (house moving)|0
971113|NCT01204398|1973290|FG000|Overall Study|Adverse Event|1
971114|NCT01204658|1973298|FG000|Primary Phase|Adverse Event|0
971115|NCT01204658|1973299|FG001|Primary Phase|Adverse Event|0
971116|NCT01204658|1973300|FG002|Primary Phase|Adverse Event|1
971117|NCT01204658|1973301|FG003|Primary Phase|Adverse Event|0
971118|NCT01204671|1973319|FG000|Overall Study|Adverse Event|4
971119|NCT01204671|1973320|FG001|Overall Study|Adverse Event|3
971120|NCT01204671|1973321|FG002|Overall Study|Adverse Event|3
971121|NCT01204671|1973322|FG003|Overall Study|Adverse Event|3
971122|NCT01204671|1973323|FG004|Overall Study|Adverse Event|1
971123|NCT01204671|1973319|FG000|Overall Study|Withdrawal by Subject|2
971124|NCT01204671|1973320|FG001|Overall Study|Withdrawal by Subject|3
971125|NCT01204671|1973321|FG002|Overall Study|Withdrawal by Subject|4
971126|NCT01204671|1973322|FG003|Overall Study|Withdrawal by Subject|5
971127|NCT01204671|1973323|FG004|Overall Study|Withdrawal by Subject|3
971128|NCT01204671|1973319|FG000|Overall Study|Lost to Follow-up|7
971129|NCT01204671|1973320|FG001|Overall Study|Lost to Follow-up|8
971130|NCT01204671|1973321|FG002|Overall Study|Lost to Follow-up|6
971131|NCT01204671|1973322|FG003|Overall Study|Lost to Follow-up|4
971132|NCT01204671|1973323|FG004|Overall Study|Lost to Follow-up|0
971133|NCT01204671|1973319|FG000|Overall Study|Unknown Completion Status|1
971134|NCT01204671|1973320|FG001|Overall Study|Unknown Completion Status|1
971135|NCT01204671|1973321|FG002|Overall Study|Unknown Completion Status|0
971136|NCT01204671|1973322|FG003|Overall Study|Unknown Completion Status|0
971137|NCT01204671|1973323|FG004|Overall Study|Unknown Completion Status|0
971138|NCT01204671|1973319|FG000|Overall Study|Physician Decision|0
971139|NCT01204671|1973320|FG001|Overall Study|Physician Decision|0
971140|NCT01204671|1973321|FG002|Overall Study|Physician Decision|0
971141|NCT01204671|1973322|FG003|Overall Study|Physician Decision|1
971142|NCT01204671|1973323|FG004|Overall Study|Physician Decision|0
971143|NCT01204697|1973341|FG000|Overall Study|Death|26
971144|NCT01204697|1973342|FG001|Overall Study|Death|27
971145|NCT01204697|1973341|FG000|Overall Study|Lost to Follow-up|3
971146|NCT01204697|1973342|FG001|Overall Study|Lost to Follow-up|4
971147|NCT01204697|1973341|FG000|Overall Study|Withdrawal by Subject|2
971148|NCT01204697|1973342|FG001|Overall Study|Withdrawal by Subject|4
971149|NCT01204697|1973341|FG000|Overall Study|Randomized, but not treated|0
971150|NCT01204697|1973342|FG001|Overall Study|Randomized, but not treated|1
971151|NCT01204710|1973350|FG000|Randomization Treatment|Lost to Follow-up|1
971152|NCT01204710|1973351|FG001|Randomization Treatment|Lost to Follow-up|0
971153|NCT01204710|1973350|FG000|Randomization Treatment|Withdrawal by Subject|6
971154|NCT01204710|1973351|FG001|Randomization Treatment|Withdrawal by Subject|5
971155|NCT01204710|1973350|FG000|Randomization Treatment|Physician Decision|3
971156|NCT01204710|1973351|FG001|Randomization Treatment|Physician Decision|2
971157|NCT01204710|1973350|FG000|Randomization Treatment|Entry criteria not met|0
971158|NCT01204710|1973351|FG001|Randomization Treatment|Entry criteria not met|1
971159|NCT01204710|1973350|FG000|Randomization Treatment|Adverse Event|4
971160|NCT01204710|1973351|FG001|Randomization Treatment|Adverse Event|2
971161|NCT01204710|1973350|FG000|Randomization Treatment|Sponsor Decision|0
971162|NCT01204710|1973351|FG001|Randomization Treatment|Sponsor Decision|1
971163|NCT01204710|1973350|FG000|Randomization Treatment|Worsening of General condition|0
971164|NCT01204710|1973351|FG001|Randomization Treatment|Worsening of General condition|1
971165|NCT01204710|1973350|FG000|Randomization Treatment|Moved and Followed for Survival|0
971166|NCT01204710|1973351|FG001|Randomization Treatment|Moved and Followed for Survival|1
971167|NCT01204710|1973350|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
971168|NCT01204710|1973351|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
971169|NCT01204710|1973350|FG000|Optional Olaratumab Monotherapy|Physician Decision|0
971170|NCT01204710|1973351|FG001|Optional Olaratumab Monotherapy|Physician Decision|1
971171|NCT01204710|1973350|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
971172|NCT01204710|1973351|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
971173|NCT01204775|1973383|FG000|Overall Study|Poor/non-compliance|0
971174|NCT01204775|1973384|FG001|Overall Study|Poor/non-compliance|1
971175|NCT01204775|1973383|FG000|Overall Study|Withdrawal by Subject|1
971176|NCT01204775|1973384|FG001|Overall Study|Withdrawal by Subject|0
971177|NCT01204918|1973401|FG000|Overall Study|Withdrawal by Subject|4
971178|NCT01204918|1973402|FG001|Overall Study|Withdrawal by Subject|10
971179|NCT01204918|1973403|FG002|Overall Study|Withdrawal by Subject|5
971180|NCT01205035|1973413|FG000|Overall Study|Withdrawal by Subject|1
971181|NCT01205035|1973414|FG001|Overall Study|Withdrawal by Subject|0
971182|NCT01205035|1973413|FG000|Overall Study|Physician Decision|1
971183|NCT01205035|1973414|FG001|Overall Study|Physician Decision|0
971184|NCT01205126|1973422|FG000|Titration Phase|Adverse Event|5
971185|NCT01205126|1973423|FG001|Titration Phase|Adverse Event|3
971186|NCT01205126|1973422|FG000|Titration Phase|Withdrawal by Subject|5
971187|NCT01205126|1973423|FG001|Titration Phase|Withdrawal by Subject|5
971188|NCT01205126|1973422|FG000|Titration Phase|Lost to Follow-up|2
971189|NCT01205126|1973423|FG001|Titration Phase|Lost to Follow-up|2
971190|NCT01205126|1973422|FG000|Titration Phase|No stable titration dose|1
971191|NCT01205126|1973423|FG001|Titration Phase|No stable titration dose|0
971192|NCT01205126|1973422|FG000|Titration Phase|More than maximum dosage required|2
971193|NCT01205126|1973423|FG001|Titration Phase|More than maximum dosage required|3
971194|NCT01205126|1973422|FG000|Titration Phase|Other|8
971195|NCT01205126|1973423|FG001|Titration Phase|Other|6
971196|NCT01205126|1973422|FG000|Between Titration & Maintenance Phase|Other|0
971197|NCT01205126|1973423|FG001|Between Titration & Maintenance Phase|Other|4
971198|NCT01205126|1973422|FG000|Maintenance Phase|Adverse Event|3
971199|NCT01205126|1973423|FG001|Maintenance Phase|Adverse Event|7
971200|NCT01205126|1973422|FG000|Maintenance Phase|Death|4
971201|NCT01205126|1973423|FG001|Maintenance Phase|Death|4
971202|NCT01205126|1973422|FG000|Maintenance Phase|More than the maximum dosage required|5
971203|NCT01205126|1973423|FG001|Maintenance Phase|More than the maximum dosage required|5
971204|NCT01205126|1973422|FG000|Maintenance Phase|Prohibited drugs used|1
971205|NCT01205126|1973423|FG001|Maintenance Phase|Prohibited drugs used|0
971206|NCT01205126|1973422|FG000|Maintenance Phase|Other|11
971207|NCT01205126|1973423|FG001|Maintenance Phase|Other|8
971208|NCT01205126|1973422|FG000|Maintenance Phase|Lost to Follow-up|5
971209|NCT01205126|1973423|FG001|Maintenance Phase|Lost to Follow-up|5
971210|NCT01205126|1973422|FG000|Maintenance Phase|Withdrawal by Subject|8
971211|NCT01205126|1973423|FG001|Maintenance Phase|Withdrawal by Subject|11
971212|NCT01205152|1973429|FG000|Overall Study|Death|1
971213|NCT01205165|1973435|FG000|Overall Study|Lost to Follow-up|2
971214|NCT01205230|1973442|FG000|Overall Study|Adverse Event|4
971215|NCT01205230|1973443|FG001|Overall Study|Adverse Event|0
971216|NCT01205230|1973442|FG000|Overall Study|Physician Decision|1
971217|NCT01205230|1973443|FG001|Overall Study|Physician Decision|0
971218|NCT01205269|1973454|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0
971219|NCT01205269|1973455|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0
971220|NCT01205269|1973456|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0
971221|NCT01205269|1973457|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1
971222|NCT01205269|1973458|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0
971223|NCT01205269|1973459|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0
971224|NCT01205438|1973474|FG000|Overall Study|Adverse Event|19
971225|NCT01205438|1973475|FG001|Overall Study|Adverse Event|17
971226|NCT01205438|1973476|FG002|Overall Study|Adverse Event|24
971227|NCT01205438|1973474|FG000|Overall Study|Death|1
971228|NCT01205438|1973475|FG001|Overall Study|Death|1
971229|NCT01205438|1973476|FG002|Overall Study|Death|3
971230|NCT01205438|1973474|FG000|Overall Study|Entry Criteria Not Met|16
971231|NCT01205438|1973475|FG001|Overall Study|Entry Criteria Not Met|15
971232|NCT01205438|1973476|FG002|Overall Study|Entry Criteria Not Met|13
971233|NCT01205438|1973474|FG000|Overall Study|Lack of Efficacy|14
971234|NCT01205438|1973475|FG001|Overall Study|Lack of Efficacy|11
971235|NCT01205438|1973476|FG002|Overall Study|Lack of Efficacy|14
971236|NCT01205438|1973474|FG000|Overall Study|Lost to Follow-up|6
971237|NCT01205438|1973475|FG001|Overall Study|Lost to Follow-up|7
971238|NCT01205438|1973476|FG002|Overall Study|Lost to Follow-up|8
971239|NCT01205438|1973474|FG000|Overall Study|Withdrawal by Subject|19
971240|NCT01205438|1973475|FG001|Overall Study|Withdrawal by Subject|25
971241|NCT01205438|1973476|FG002|Overall Study|Withdrawal by Subject|19
971242|NCT01205438|1973474|FG000|Overall Study|Physician Decision|0
971243|NCT01205438|1973475|FG001|Overall Study|Physician Decision|3
971244|NCT01205438|1973476|FG002|Overall Study|Physician Decision|2
971245|NCT01205438|1973474|FG000|Overall Study|Protocol Violation|2
971246|NCT01205438|1973475|FG001|Overall Study|Protocol Violation|7
971247|NCT01205438|1973476|FG002|Overall Study|Protocol Violation|4
971248|NCT01205438|1973474|FG000|Overall Study|Sponsor Decision|0
971249|NCT01205438|1973475|FG001|Overall Study|Sponsor Decision|1
971250|NCT01205438|1973476|FG002|Overall Study|Sponsor Decision|1
971251|NCT01205451|1973489|FG000|Overall Study|Lost to Follow-up|1
971252|NCT01205451|1973490|FG001|Overall Study|Lost to Follow-up|1
971253|NCT01205451|1973489|FG000|Overall Study|Withdrawal by Subject|5
971254|NCT01205451|1973490|FG001|Overall Study|Withdrawal by Subject|9
971255|NCT01205529|1973505|FG000|Overall Study|Procedure Cancelled|4
971256|NCT01205529|1973505|FG000|Overall Study|Withdrawal by Subject|2
971257|NCT01205529|1973505|FG000|Overall Study|Physician Decision|4
971258|NCT01205529|1973505|FG000|Overall Study|Unstable post op|15
971259|NCT01205529|1973505|FG000|Overall Study|No longer met criteria|30
971260|NCT01205581|1973520|FG000|Overall Study|Withdrawal by Subject|1
971261|NCT01205581|1973521|FG001|Overall Study|Withdrawal by Subject|0
971262|NCT01205581|1973522|FG002|Overall Study|Withdrawal by Subject|0
971263|NCT01205581|1973523|FG003|Overall Study|Withdrawal by Subject|0
971264|NCT01205581|1973524|FG004|Overall Study|Withdrawal by Subject|0
971265|NCT01205581|1973525|FG005|Overall Study|Withdrawal by Subject|0
971266|NCT01205685|1973560|FG000|Overall Study|Disease Progression|10
971267|NCT01205685|1973560|FG000|Overall Study|Withdrawal by Subject|1
971268|NCT01205776|1973566|FG000|Overall Study|Lost to Follow-up|53
971269|NCT01205776|1973567|FG001|Overall Study|Lost to Follow-up|61
971270|NCT01205776|1973566|FG000|Overall Study|Withdrawal by Subject|11
971271|NCT01205776|1973567|FG001|Overall Study|Withdrawal by Subject|34
971272|NCT01206140|1973591|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1
971273|NCT01206140|1973592|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0
971274|NCT01206166|1973600|FG000|Overall Study|No evaluable data|2
971275|NCT01206166|1973601|FG001|Overall Study|No evaluable data|3
971276|NCT01206322|1973612|FG000|Overall Study|Adverse Event|0
971277|NCT01206322|1973613|FG001|Overall Study|Adverse Event|0
971278|NCT01206322|1973614|FG002|Overall Study|Adverse Event|0
971279|NCT01206322|1973615|FG003|Overall Study|Adverse Event|1
971280|NCT01206517|1973678|FG000|Overall Study|Withdrawal by Subject|0
971281|NCT01206517|1973679|FG001|Overall Study|Withdrawal by Subject|0
971282|NCT01206517|1973680|FG002|Overall Study|Withdrawal by Subject|2
971283|NCT01206517|1973681|FG003|Overall Study|Withdrawal by Subject|0
971284|NCT01206517|1973682|FG004|Overall Study|Withdrawal by Subject|1
971285|NCT01206517|1973683|FG005|Overall Study|Withdrawal by Subject|0
971286|NCT01206582|1973696|FG000|Overall Study|Withdrew prior to study|1
971287|NCT01206582|1973697|FG001|Overall Study|Withdrew prior to study|0
971288|NCT01206582|1973696|FG000|Overall Study|Discontinued intervention before week 8|1
971289|NCT01206582|1973697|FG001|Overall Study|Discontinued intervention before week 8|2
971290|NCT01206764|1973747|FG000|Overall Study|Adverse Event|20
971291|NCT01206764|1973747|FG000|Overall Study|Abnormal laboratory value|2
971292|NCT01206764|1973747|FG000|Overall Study|Abnormal test procedure result|1
971293|NCT01206764|1973747|FG000|Overall Study|Patient withdrew consent|5
971294|NCT01206764|1973747|FG000|Overall Study|Lost to Follow-up|6
971295|NCT01206764|1973747|FG000|Overall Study|Death|11
971296|NCT01206764|1973747|FG000|Overall Study|New cancer therapy|2
971297|NCT01206764|1973747|FG000|Overall Study|Disease progression|88
971298|NCT01206764|1973747|FG000|Overall Study|Protocol deviation|3
971299|NCT01206777|1973751|FG000|Overall Study|Death|1
971300|NCT01206777|1973751|FG000|Overall Study|Adverse Event|1
971301|NCT01206816|1973762|FG000|Overall Study|Protocol Violation|0
971302|NCT01206816|1973763|FG001|Overall Study|Protocol Violation|0
971303|NCT01206816|1973764|FG002|Overall Study|Protocol Violation|1
971304|NCT01206816|1973765|FG003|Overall Study|Protocol Violation|0
971305|NCT01206816|1973766|FG004|Overall Study|Protocol Violation|0
971306|NCT01206816|1973767|FG005|Overall Study|Protocol Violation|0
971307|NCT01206816|1973768|FG006|Overall Study|Protocol Violation|0
971308|NCT01206816|1973762|FG000|Overall Study|Withdrawal by Subject|0
971309|NCT01206816|1973763|FG001|Overall Study|Withdrawal by Subject|0
971310|NCT01206816|1973764|FG002|Overall Study|Withdrawal by Subject|1
971311|NCT01206816|1973765|FG003|Overall Study|Withdrawal by Subject|0
971312|NCT01206816|1973766|FG004|Overall Study|Withdrawal by Subject|0
971313|NCT01206816|1973767|FG005|Overall Study|Withdrawal by Subject|0
971314|NCT01206816|1973768|FG006|Overall Study|Withdrawal by Subject|0
971315|NCT01206816|1973762|FG000|Overall Study|Progressive disease|3
971316|NCT01206816|1973763|FG001|Overall Study|Progressive disease|3
971317|NCT01206816|1973764|FG002|Overall Study|Progressive disease|13
971318|NCT01206816|1973765|FG003|Overall Study|Progressive disease|3
971319|NCT01206816|1973766|FG004|Overall Study|Progressive disease|3
971320|NCT01206816|1973767|FG005|Overall Study|Progressive disease|16
971321|NCT01206816|1973768|FG006|Overall Study|Progressive disease|3
971322|NCT01206816|1973762|FG000|Overall Study|Other AE|0
971323|NCT01206816|1973763|FG001|Overall Study|Other AE|0
971324|NCT01206816|1973764|FG002|Overall Study|Other AE|4
971325|NCT01206816|1973765|FG003|Overall Study|Other AE|0
971326|NCT01206816|1973766|FG004|Overall Study|Other AE|0
971327|NCT01206816|1973767|FG005|Overall Study|Other AE|3
971328|NCT01206816|1973768|FG006|Overall Study|Other AE|2
971329|NCT01206816|1973762|FG000|Overall Study|other than stated above|0
971330|NCT01206816|1973763|FG001|Overall Study|other than stated above|0
971331|NCT01206816|1973764|FG002|Overall Study|other than stated above|1
971332|NCT01206816|1973765|FG003|Overall Study|other than stated above|0
971333|NCT01206816|1973766|FG004|Overall Study|other than stated above|0
971334|NCT01206816|1973767|FG005|Overall Study|other than stated above|0
971335|NCT01206816|1973768|FG006|Overall Study|other than stated above|1
971336|NCT01207219|1973791|FG000|Overall Study|changed diagnosis during study period|5
971337|NCT01207219|1973792|FG001|Overall Study|changed diagnosis during study period|3
971338|NCT01207219|1973793|FG002|Overall Study|changed diagnosis during study period|1
971339|NCT01207219|1973791|FG000|Overall Study|Lost to Follow-up|6
971340|NCT01207219|1973792|FG001|Overall Study|Lost to Follow-up|8
971341|NCT01207219|1973793|FG002|Overall Study|Lost to Follow-up|6
971342|NCT01207388|1973801|FG000|Overall Study|Death|67
971343|NCT01207388|1973801|FG000|Overall Study|Withdrawal by Subject|1
971344|NCT01207414|1973824|FG000|Overall Study|Adverse Event|25
971345|NCT01207414|1973825|FG001|Overall Study|Adverse Event|39
971346|NCT01207414|1973824|FG000|Overall Study|Abnormal test procedure results|0
971347|NCT01207414|1973825|FG001|Overall Study|Abnormal test procedure results|1
971348|NCT01207414|1973824|FG000|Overall Study|Unsatisfactory therapeutic effect|5
971349|NCT01207414|1973825|FG001|Overall Study|Unsatisfactory therapeutic effect|4
971350|NCT01207414|1973824|FG000|Overall Study|Patient withdrew consent|14
971351|NCT01207414|1973825|FG001|Overall Study|Patient withdrew consent|11
971352|NCT01207414|1973824|FG000|Overall Study|Lost to Follow-up|15
971353|NCT01207414|1973825|FG001|Overall Study|Lost to Follow-up|17
971354|NCT01207414|1973824|FG000|Overall Study|Administrative problems|1
971355|NCT01207414|1973825|FG001|Overall Study|Administrative problems|1
971356|NCT01207414|1973824|FG000|Overall Study|Protocol deviation|12
971357|NCT01207414|1973825|FG001|Overall Study|Protocol deviation|9
971358|NCT01207414|1973824|FG000|Overall Study|Randomized in error|1
971359|NCT01207414|1973825|FG001|Overall Study|Randomized in error|0
971360|NCT01207427|1973834|FG000|Double-blind Treatment Period|Adverse Event|0
971361|NCT01207427|1973835|FG001|Double-blind Treatment Period|Adverse Event|1
971362|NCT01207427|1973836|FG002|Double-blind Treatment Period|Adverse Event|0
971363|NCT01207427|1973834|FG000|Double-blind Treatment Period|Lost to Follow-up|0
971364|NCT01207427|1973835|FG001|Double-blind Treatment Period|Lost to Follow-up|0
971365|NCT01207427|1973836|FG002|Double-blind Treatment Period|Lost to Follow-up|1
971366|NCT01207427|1973834|FG000|Double-blind Treatment Period|Protocol Violation|2
971367|NCT01207427|1973835|FG001|Double-blind Treatment Period|Protocol Violation|1
971368|NCT01207427|1973836|FG002|Double-blind Treatment Period|Protocol Violation|1
971369|NCT01207427|1973834|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
971370|NCT01207427|1973835|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
971371|NCT01207427|1973836|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
971372|NCT01207440|1973851|FG000|Overall Study|Adverse Event|46
971373|NCT01207440|1973852|FG001|Overall Study|Adverse Event|11
971374|NCT01207440|1973853|FG002|Overall Study|Adverse Event|7
971375|NCT01207440|1973854|FG003|Overall Study|Adverse Event|2
971376|NCT01207440|1973855|FG004|Overall Study|Adverse Event|6
971377|NCT01207440|1973856|FG005|Overall Study|Adverse Event|6
971378|NCT01207440|1973857|FG006|Overall Study|Adverse Event|2
971379|NCT01207440|1973851|FG000|Overall Study|Death|6
971380|NCT01207440|1973852|FG001|Overall Study|Death|3
971381|NCT01207440|1973853|FG002|Overall Study|Death|2
971382|NCT01207440|1973854|FG003|Overall Study|Death|2
971383|NCT01207440|1973855|FG004|Overall Study|Death|7
971384|NCT01207440|1973856|FG005|Overall Study|Death|5
971385|NCT01207440|1973857|FG006|Overall Study|Death|1
971386|NCT01207440|1973851|FG000|Overall Study|Lack of Efficacy|13
971387|NCT01207440|1973852|FG001|Overall Study|Lack of Efficacy|2
971388|NCT01207440|1973853|FG002|Overall Study|Lack of Efficacy|5
971389|NCT01207440|1973854|FG003|Overall Study|Lack of Efficacy|1
971390|NCT01207440|1973855|FG004|Overall Study|Lack of Efficacy|2
971391|NCT01207440|1973856|FG005|Overall Study|Lack of Efficacy|3
971392|NCT01207440|1973857|FG006|Overall Study|Lack of Efficacy|0
971393|NCT01207440|1973851|FG000|Overall Study|Lost to Follow-up|0
971394|NCT01207440|1973852|FG001|Overall Study|Lost to Follow-up|0
971395|NCT01207440|1973853|FG002|Overall Study|Lost to Follow-up|2
971396|NCT01207440|1973854|FG003|Overall Study|Lost to Follow-up|1
971397|NCT01207440|1973855|FG004|Overall Study|Lost to Follow-up|0
971398|NCT01207440|1973856|FG005|Overall Study|Lost to Follow-up|0
971399|NCT01207440|1973857|FG006|Overall Study|Lost to Follow-up|0
971400|NCT01207440|1973851|FG000|Overall Study|Non-compliance with Study Drug|3
971401|NCT01207440|1973852|FG001|Overall Study|Non-compliance with Study Drug|0
971402|NCT01207440|1973853|FG002|Overall Study|Non-compliance with Study Drug|1
971403|NCT01207440|1973854|FG003|Overall Study|Non-compliance with Study Drug|0
971404|NCT01207440|1973855|FG004|Overall Study|Non-compliance with Study Drug|0
971405|NCT01207440|1973856|FG005|Overall Study|Non-compliance with Study Drug|0
971406|NCT01207440|1973857|FG006|Overall Study|Non-compliance with Study Drug|0
971407|NCT01207440|1973851|FG000|Overall Study|Physician Decision|6
971408|NCT01207440|1973852|FG001|Overall Study|Physician Decision|5
971409|NCT01207440|1973853|FG002|Overall Study|Physician Decision|5
971410|NCT01207440|1973854|FG003|Overall Study|Physician Decision|0
971411|NCT01207440|1973855|FG004|Overall Study|Physician Decision|1
971412|NCT01207440|1973856|FG005|Overall Study|Physician Decision|0
971413|NCT01207440|1973857|FG006|Overall Study|Physician Decision|0
971414|NCT01207440|1973851|FG000|Overall Study|Progressive Disease|19
971415|NCT01207440|1973852|FG001|Overall Study|Progressive Disease|10
971416|NCT01207440|1973853|FG002|Overall Study|Progressive Disease|19
971417|NCT01207440|1973854|FG003|Overall Study|Progressive Disease|7
971418|NCT01207440|1973855|FG004|Overall Study|Progressive Disease|23
971419|NCT01207440|1973856|FG005|Overall Study|Progressive Disease|27
971420|NCT01207440|1973857|FG006|Overall Study|Progressive Disease|0
971421|NCT01207440|1973851|FG000|Overall Study|Protocol Violation|2
971422|NCT01207440|1973852|FG001|Overall Study|Protocol Violation|0
971423|NCT01207440|1973853|FG002|Overall Study|Protocol Violation|0
971424|NCT01207440|1973854|FG003|Overall Study|Protocol Violation|0
971425|NCT01207440|1973855|FG004|Overall Study|Protocol Violation|0
971426|NCT01207440|1973856|FG005|Overall Study|Protocol Violation|0
971427|NCT01207440|1973857|FG006|Overall Study|Protocol Violation|0
971428|NCT01207440|1973851|FG000|Overall Study|Site Terminated by Sponsor|69
971429|NCT01207440|1973852|FG001|Overall Study|Site Terminated by Sponsor|19
971430|NCT01207440|1973853|FG002|Overall Study|Site Terminated by Sponsor|12
971431|NCT01207440|1973854|FG003|Overall Study|Site Terminated by Sponsor|2
971432|NCT01207440|1973855|FG004|Overall Study|Site Terminated by Sponsor|3
971433|NCT01207440|1973856|FG005|Overall Study|Site Terminated by Sponsor|0
971434|NCT01207440|1973857|FG006|Overall Study|Site Terminated by Sponsor|2
971435|NCT01207440|1973851|FG000|Overall Study|Withdrawal by Subject|29
971436|NCT01207440|1973852|FG001|Overall Study|Withdrawal by Subject|4
971437|NCT01207440|1973853|FG002|Overall Study|Withdrawal by Subject|5
971438|NCT01207440|1973854|FG003|Overall Study|Withdrawal by Subject|3
971439|NCT01207440|1973855|FG004|Overall Study|Withdrawal by Subject|2
971440|NCT01207440|1973856|FG005|Overall Study|Withdrawal by Subject|2
971441|NCT01207440|1973857|FG006|Overall Study|Withdrawal by Subject|0
971442|NCT01207440|1973851|FG000|Overall Study|Reason Not Specified|10
971443|NCT01207440|1973852|FG001|Overall Study|Reason Not Specified|10
971444|NCT01207440|1973853|FG002|Overall Study|Reason Not Specified|7
971445|NCT01207440|1973854|FG003|Overall Study|Reason Not Specified|0
971446|NCT01207440|1973855|FG004|Overall Study|Reason Not Specified|4
971447|NCT01207440|1973856|FG005|Overall Study|Reason Not Specified|3
971448|NCT01207440|1973857|FG006|Overall Study|Reason Not Specified|0
971449|NCT01207453|1973881|FG000|First Intervention|Adverse Event|2
971450|NCT01207453|1973882|FG001|First Intervention|Adverse Event|1
971451|NCT01207453|1973881|FG000|Washout|Adverse Event|1
971452|NCT01207453|1973882|FG001|Washout|Adverse Event|0
971453|NCT01207453|1973881|FG000|Washout|Lost to Follow-up|1
971454|NCT01207453|1973882|FG001|Washout|Lost to Follow-up|0
971455|NCT01207453|1973881|FG000|2nd Intervention|Adverse Event|1
971456|NCT01207453|1973882|FG001|2nd Intervention|Adverse Event|2
971457|NCT01207453|1973881|FG000|2nd Intervention|Lost to Follow-up|1
971458|NCT01207453|1973882|FG001|2nd Intervention|Lost to Follow-up|0
971459|NCT01207492|1973898|FG000|Overall Study|Still on study|1
971460|NCT01207492|1973898|FG000|Overall Study|Withdrawal by Subject|9
971461|NCT01207492|1973898|FG000|Overall Study|Physician Decision|1
971462|NCT01207492|1973898|FG000|Overall Study|Progressive disease|3
971463|NCT01207492|1973898|FG000|Overall Study|Toxicity|1
971464|NCT01207583|1973916|FG000|Overall Study|Withdrawal by Subject|0
971465|NCT01207583|1973917|FG001|Overall Study|Withdrawal by Subject|3
971466|NCT01207583|1973918|FG002|Overall Study|Withdrawal by Subject|1
971467|NCT01207583|1973916|FG000|Overall Study|Participant failed to return|1
971468|NCT01207583|1973917|FG001|Overall Study|Participant failed to return|0
971469|NCT01207583|1973918|FG002|Overall Study|Participant failed to return|0
971470|NCT01207583|1973916|FG000|Overall Study|Lost to Follow-up|0
971471|NCT01207583|1973917|FG001|Overall Study|Lost to Follow-up|2
971472|NCT01207583|1973918|FG002|Overall Study|Lost to Follow-up|0
971473|NCT01207596|1973939|FG000|Overall Study|Physician Decision|4
971474|NCT01207596|1973939|FG000|Overall Study|Lack of Efficacy|1
971475|NCT01207596|1973939|FG000|Overall Study|Adverse Event|3
971476|NCT01207596|1973939|FG000|Overall Study|Withdrawal by Subject|1
971477|NCT01207687|1973947|FG000|Overall Study|Adverse Event|1
971478|NCT01207687|1973947|FG000|Overall Study|Withdrawal by Subject|1
971479|NCT01208038|1973992|FG000|Overall Study|Withdrawal by Subject|1
971480|NCT01208051|1974001|FG000|Total Enrollment|Withdrawal by Subject|0
971481|NCT01208051|1974002|FG001|Total Enrollment|Withdrawal by Subject|1
971482|NCT01208051|1974003|FG002|Total Enrollment|Withdrawal by Subject|0
971483|NCT01208051|1974004|FG003|Total Enrollment|Withdrawal by Subject|0
971484|NCT01208051|1974005|FG004|Total Enrollment|Withdrawal by Subject|2
971485|NCT01208051|1974001|FG000|Total Enrollment|Brain metastases|0
971486|NCT01208051|1974002|FG001|Total Enrollment|Brain metastases|0
971487|NCT01208051|1974003|FG002|Total Enrollment|Brain metastases|1
971488|NCT01208051|1974004|FG003|Total Enrollment|Brain metastases|0
971489|NCT01208051|1974005|FG004|Total Enrollment|Brain metastases|0
971490|NCT01208103|1974021|FG000|Overall Study|Adverse Event|1
971491|NCT01208103|1974021|FG000|Overall Study|Withdrawal by Subject|1
971492|NCT01208181|1974029|FG000|Part 1|Withdrawal by Subject|11
971493|NCT01208181|1974030|FG001|Part 1|Withdrawal by Subject|10
971494|NCT01208181|1974031|FG002|Part 1|Withdrawal by Subject|0
971495|NCT01208181|1974032|FG003|Part 1|Withdrawal by Subject|0
971496|NCT01208181|1974033|FG004|Part 1|Withdrawal by Subject|0
971497|NCT01208181|1974029|FG000|Part 1|Technical problem|5
971498|NCT01208181|1974030|FG001|Part 1|Technical problem|0
971499|NCT01208181|1974031|FG002|Part 1|Technical problem|0
971500|NCT01208181|1974032|FG003|Part 1|Technical problem|0
971501|NCT01208181|1974033|FG004|Part 1|Technical problem|0
971502|NCT01208181|1974029|FG000|Part 1|Protocol Violation|10
971503|NCT01208181|1974030|FG001|Part 1|Protocol Violation|5
971504|NCT01208181|1974031|FG002|Part 1|Protocol Violation|0
971505|NCT01208181|1974032|FG003|Part 1|Protocol Violation|0
971506|NCT01208181|1974033|FG004|Part 1|Protocol Violation|0
971507|NCT01208181|1974029|FG000|Part 1|Physician Decision|4
971508|NCT01208181|1974030|FG001|Part 1|Physician Decision|0
971509|NCT01208181|1974031|FG002|Part 1|Physician Decision|0
971510|NCT01208181|1974032|FG003|Part 1|Physician Decision|0
971511|NCT01208181|1974033|FG004|Part 1|Physician Decision|0
971512|NCT01208181|1974029|FG000|Part 1|Non-compliance with study drug|1
971513|NCT01208181|1974030|FG001|Part 1|Non-compliance with study drug|1
971514|NCT01208181|1974031|FG002|Part 1|Non-compliance with study drug|0
971515|NCT01208181|1974032|FG003|Part 1|Non-compliance with study drug|0
971516|NCT01208181|1974033|FG004|Part 1|Non-compliance with study drug|0
971517|NCT01208181|1974029|FG000|Part 1|Lost to Follow-up|5
971518|NCT01208181|1974030|FG001|Part 1|Lost to Follow-up|3
971519|NCT01208181|1974031|FG002|Part 1|Lost to Follow-up|0
971520|NCT01208181|1974032|FG003|Part 1|Lost to Follow-up|0
971521|NCT01208181|1974033|FG004|Part 1|Lost to Follow-up|1
971522|NCT01208181|1974029|FG000|Part 1|Lack of Efficacy|37
971523|NCT01208181|1974030|FG001|Part 1|Lack of Efficacy|12
971524|NCT01208181|1974031|FG002|Part 1|Lack of Efficacy|0
971525|NCT01208181|1974032|FG003|Part 1|Lack of Efficacy|0
971526|NCT01208181|1974033|FG004|Part 1|Lack of Efficacy|17
971527|NCT01208181|1974029|FG000|Part 1|Adverse Event|26
971528|NCT01208181|1974030|FG001|Part 1|Adverse Event|24
971529|NCT01208181|1974031|FG002|Part 1|Adverse Event|0
971530|NCT01208181|1974032|FG003|Part 1|Adverse Event|0
971531|NCT01208181|1974033|FG004|Part 1|Adverse Event|4
971532|NCT01208181|1974029|FG000|Part 2|Adverse Event|0
971533|NCT01208181|1974030|FG001|Part 2|Adverse Event|0
971534|NCT01208181|1974031|FG002|Part 2|Adverse Event|6
971535|NCT01208181|1974032|FG003|Part 2|Adverse Event|7
971536|NCT01208181|1974033|FG004|Part 2|Adverse Event|0
971537|NCT01208181|1974029|FG000|Part 2|Withdrawal by Subject|0
971538|NCT01208181|1974030|FG001|Part 2|Withdrawal by Subject|0
971539|NCT01208181|1974031|FG002|Part 2|Withdrawal by Subject|1
971540|NCT01208181|1974032|FG003|Part 2|Withdrawal by Subject|1
971541|NCT01208181|1974033|FG004|Part 2|Withdrawal by Subject|0
971542|NCT01208181|1974029|FG000|Part 2|Protocol Violation|0
971543|NCT01208181|1974030|FG001|Part 2|Protocol Violation|0
971544|NCT01208181|1974031|FG002|Part 2|Protocol Violation|1
971545|NCT01208181|1974032|FG003|Part 2|Protocol Violation|0
971546|NCT01208181|1974033|FG004|Part 2|Protocol Violation|0
971547|NCT01208181|1974029|FG000|Part 2|Physician Decision|0
971548|NCT01208181|1974030|FG001|Part 2|Physician Decision|0
971549|NCT01208181|1974031|FG002|Part 2|Physician Decision|1
971550|NCT01208181|1974032|FG003|Part 2|Physician Decision|2
971551|NCT01208181|1974033|FG004|Part 2|Physician Decision|0
971552|NCT01208181|1974029|FG000|Part 2|Non-compliance with study drug|0
971553|NCT01208181|1974030|FG001|Part 2|Non-compliance with study drug|0
971554|NCT01208181|1974031|FG002|Part 2|Non-compliance with study drug|1
971555|NCT01208181|1974032|FG003|Part 2|Non-compliance with study drug|1
971556|NCT01208181|1974033|FG004|Part 2|Non-compliance with study drug|0
971557|NCT01208181|1974029|FG000|Part 2|Lost to Follow-up|0
971558|NCT01208181|1974030|FG001|Part 2|Lost to Follow-up|0
971559|NCT01208181|1974031|FG002|Part 2|Lost to Follow-up|1
971560|NCT01208181|1974032|FG003|Part 2|Lost to Follow-up|2
971561|NCT01208181|1974033|FG004|Part 2|Lost to Follow-up|0
971562|NCT01208181|1974029|FG000|Part 2|Lack of Efficacy|0
971563|NCT01208181|1974030|FG001|Part 2|Lack of Efficacy|0
971564|NCT01208181|1974031|FG002|Part 2|Lack of Efficacy|5
971565|NCT01208181|1974032|FG003|Part 2|Lack of Efficacy|7
971566|NCT01208181|1974033|FG004|Part 2|Lack of Efficacy|0
971567|NCT01208207|1974053|FG000|Part I|Adverse Event|19
971568|NCT01208207|1974054|FG001|Part I|Adverse Event|2
971569|NCT01208207|1974055|FG002|Part I|Adverse Event|6
971570|NCT01208207|1974056|FG003|Part I|Adverse Event|0
971571|NCT01208207|1974057|FG004|Part I|Adverse Event|0
971572|NCT01208207|1974058|FG005|Part I|Adverse Event|0
971573|NCT01208207|1974059|FG006|Part I|Adverse Event|0
971574|NCT01208207|1974053|FG000|Part I|Lack of Efficacy|21
971575|NCT01208207|1974054|FG001|Part I|Lack of Efficacy|3
971576|NCT01208207|1974055|FG002|Part I|Lack of Efficacy|2
971577|NCT01208207|1974056|FG003|Part I|Lack of Efficacy|0
971578|NCT01208207|1974057|FG004|Part I|Lack of Efficacy|0
971579|NCT01208207|1974058|FG005|Part I|Lack of Efficacy|0
971580|NCT01208207|1974059|FG006|Part I|Lack of Efficacy|0
971581|NCT01208207|1974053|FG000|Part I|Lost to Follow-up|6
971582|NCT01208207|1974054|FG001|Part I|Lost to Follow-up|1
971583|NCT01208207|1974055|FG002|Part I|Lost to Follow-up|0
971584|NCT01208207|1974056|FG003|Part I|Lost to Follow-up|0
971585|NCT01208207|1974057|FG004|Part I|Lost to Follow-up|0
971586|NCT01208207|1974058|FG005|Part I|Lost to Follow-up|0
971587|NCT01208207|1974059|FG006|Part I|Lost to Follow-up|0
971588|NCT01208207|1974053|FG000|Part I|Non-Compliance With Study Drug|1
971589|NCT01208207|1974054|FG001|Part I|Non-Compliance With Study Drug|0
971590|NCT01208207|1974055|FG002|Part I|Non-Compliance With Study Drug|1
971591|NCT01208207|1974056|FG003|Part I|Non-Compliance With Study Drug|0
971592|NCT01208207|1974057|FG004|Part I|Non-Compliance With Study Drug|0
971593|NCT01208207|1974058|FG005|Part I|Non-Compliance With Study Drug|0
971594|NCT01208207|1974059|FG006|Part I|Non-Compliance With Study Drug|0
971595|NCT01208207|1974053|FG000|Part I|Physician Decision|0
971596|NCT01208207|1974054|FG001|Part I|Physician Decision|1
971597|NCT01208207|1974055|FG002|Part I|Physician Decision|0
971598|NCT01208207|1974056|FG003|Part I|Physician Decision|0
971599|NCT01208207|1974057|FG004|Part I|Physician Decision|0
971600|NCT01208207|1974058|FG005|Part I|Physician Decision|0
971601|NCT01208207|1974059|FG006|Part I|Physician Decision|0
971602|NCT01208207|1974053|FG000|Part I|Progressive Disease|1
971603|NCT01208207|1974054|FG001|Part I|Progressive Disease|0
971604|NCT01208207|1974055|FG002|Part I|Progressive Disease|0
971605|NCT01208207|1974056|FG003|Part I|Progressive Disease|0
971606|NCT01208207|1974057|FG004|Part I|Progressive Disease|0
971607|NCT01208207|1974058|FG005|Part I|Progressive Disease|0
971608|NCT01208207|1974059|FG006|Part I|Progressive Disease|0
971609|NCT01208207|1974053|FG000|Part I|Protocol Violation|8
971610|NCT01208207|1974054|FG001|Part I|Protocol Violation|0
971611|NCT01208207|1974055|FG002|Part I|Protocol Violation|2
971612|NCT01208207|1974056|FG003|Part I|Protocol Violation|0
971613|NCT01208207|1974057|FG004|Part I|Protocol Violation|0
971614|NCT01208207|1974058|FG005|Part I|Protocol Violation|0
971615|NCT01208207|1974059|FG006|Part I|Protocol Violation|0
971616|NCT01208207|1974053|FG000|Part I|Withdrawal by Subject|14
971617|NCT01208207|1974054|FG001|Part I|Withdrawal by Subject|4
971618|NCT01208207|1974055|FG002|Part I|Withdrawal by Subject|4
971619|NCT01208207|1974056|FG003|Part I|Withdrawal by Subject|0
971620|NCT01208207|1974057|FG004|Part I|Withdrawal by Subject|0
971621|NCT01208207|1974058|FG005|Part I|Withdrawal by Subject|0
971622|NCT01208207|1974059|FG006|Part I|Withdrawal by Subject|0
971623|NCT01208207|1974053|FG000|Part II|Withdrawal by Subject|0
971624|NCT01208207|1974054|FG001|Part II|Withdrawal by Subject|0
971625|NCT01208207|1974055|FG002|Part II|Withdrawal by Subject|0
971626|NCT01208207|1974056|FG003|Part II|Withdrawal by Subject|10
971627|NCT01208207|1974057|FG004|Part II|Withdrawal by Subject|9
971628|NCT01208207|1974058|FG005|Part II|Withdrawal by Subject|3
971629|NCT01208207|1974059|FG006|Part II|Withdrawal by Subject|5
971630|NCT01208207|1974053|FG000|Part II|Adverse Event|0
971631|NCT01208207|1974054|FG001|Part II|Adverse Event|0
971632|NCT01208207|1974055|FG002|Part II|Adverse Event|0
971633|NCT01208207|1974056|FG003|Part II|Adverse Event|5
971634|NCT01208207|1974057|FG004|Part II|Adverse Event|9
971635|NCT01208207|1974058|FG005|Part II|Adverse Event|4
971636|NCT01208207|1974059|FG006|Part II|Adverse Event|2
971637|NCT01208207|1974053|FG000|Part II|Lack of Efficacy|0
971638|NCT01208207|1974054|FG001|Part II|Lack of Efficacy|0
971639|NCT01208207|1974055|FG002|Part II|Lack of Efficacy|0
971640|NCT01208207|1974056|FG003|Part II|Lack of Efficacy|6
971641|NCT01208207|1974057|FG004|Part II|Lack of Efficacy|4
971642|NCT01208207|1974058|FG005|Part II|Lack of Efficacy|3
971643|NCT01208207|1974059|FG006|Part II|Lack of Efficacy|3
971644|NCT01208207|1974053|FG000|Part II|Lost to Follow-up|0
971645|NCT01208207|1974054|FG001|Part II|Lost to Follow-up|0
971646|NCT01208207|1974055|FG002|Part II|Lost to Follow-up|0
971647|NCT01208207|1974056|FG003|Part II|Lost to Follow-up|4
971648|NCT01208207|1974057|FG004|Part II|Lost to Follow-up|0
971649|NCT01208207|1974058|FG005|Part II|Lost to Follow-up|2
971650|NCT01208207|1974059|FG006|Part II|Lost to Follow-up|1
971651|NCT01208207|1974053|FG000|Part II|Non-Compliance With Study Drug|0
971652|NCT01208207|1974054|FG001|Part II|Non-Compliance With Study Drug|0
971653|NCT01208207|1974055|FG002|Part II|Non-Compliance With Study Drug|0
971654|NCT01208207|1974056|FG003|Part II|Non-Compliance With Study Drug|4
971655|NCT01208207|1974057|FG004|Part II|Non-Compliance With Study Drug|1
971656|NCT01208207|1974058|FG005|Part II|Non-Compliance With Study Drug|1
971657|NCT01208207|1974059|FG006|Part II|Non-Compliance With Study Drug|0
971658|NCT01208207|1974053|FG000|Part II|Physician Decision|0
971659|NCT01208207|1974054|FG001|Part II|Physician Decision|0
971660|NCT01208207|1974055|FG002|Part II|Physician Decision|0
971661|NCT01208207|1974056|FG003|Part II|Physician Decision|1
971662|NCT01208207|1974057|FG004|Part II|Physician Decision|0
971663|NCT01208207|1974058|FG005|Part II|Physician Decision|2
971664|NCT01208207|1974059|FG006|Part II|Physician Decision|0
971665|NCT01208207|1974053|FG000|Part II|Protocol Violation|0
971666|NCT01208207|1974054|FG001|Part II|Protocol Violation|0
971667|NCT01208207|1974055|FG002|Part II|Protocol Violation|0
971668|NCT01208207|1974056|FG003|Part II|Protocol Violation|1
971669|NCT01208207|1974057|FG004|Part II|Protocol Violation|0
971670|NCT01208207|1974058|FG005|Part II|Protocol Violation|0
971671|NCT01208207|1974059|FG006|Part II|Protocol Violation|0
971672|NCT01208207|1974053|FG000|Part II|Technical Problems|0
971673|NCT01208207|1974054|FG001|Part II|Technical Problems|0
971674|NCT01208207|1974055|FG002|Part II|Technical Problems|0
971675|NCT01208207|1974056|FG003|Part II|Technical Problems|1
971676|NCT01208207|1974057|FG004|Part II|Technical Problems|0
971677|NCT01208207|1974058|FG005|Part II|Technical Problems|1
971678|NCT01208207|1974059|FG006|Part II|Technical Problems|0
971679|NCT01208233|1974096|FG000|Overall Study|Adverse Event|0
971680|NCT01208233|1974097|FG001|Overall Study|Adverse Event|1
971681|NCT01208233|1974098|FG002|Overall Study|Adverse Event|2
971682|NCT01208233|1974099|FG003|Overall Study|Adverse Event|0
971683|NCT01208233|1974100|FG004|Overall Study|Adverse Event|3
971684|NCT01208233|1974101|FG005|Overall Study|Adverse Event|5
971685|NCT01208233|1974096|FG000|Overall Study|Death|0
971686|NCT01208233|1974097|FG001|Overall Study|Death|0
971687|NCT01208233|1974098|FG002|Overall Study|Death|0
971688|NCT01208233|1974099|FG003|Overall Study|Death|0
971689|NCT01208233|1974100|FG004|Overall Study|Death|3
971690|NCT01208233|1974101|FG005|Overall Study|Death|5
971691|NCT01208233|1974096|FG000|Overall Study|Did not meet entrance criteria|2
971692|NCT01208233|1974097|FG001|Overall Study|Did not meet entrance criteria|1
971693|NCT01208233|1974098|FG002|Overall Study|Did not meet entrance criteria|1
971694|NCT01208233|1974099|FG003|Overall Study|Did not meet entrance criteria|0
971695|NCT01208233|1974100|FG004|Overall Study|Did not meet entrance criteria|1
971696|NCT01208233|1974101|FG005|Overall Study|Did not meet entrance criteria|0
971697|NCT01208233|1974096|FG000|Overall Study|Medication error without adverse event|0
971698|NCT01208233|1974097|FG001|Overall Study|Medication error without adverse event|0
971699|NCT01208233|1974098|FG002|Overall Study|Medication error without adverse event|0
971700|NCT01208233|1974099|FG003|Overall Study|Medication error without adverse event|0
971701|NCT01208233|1974100|FG004|Overall Study|Medication error without adverse event|0
971702|NCT01208233|1974101|FG005|Overall Study|Medication error without adverse event|1
971703|NCT01208233|1974096|FG000|Overall Study|Study terminated by sponsor|0
971704|NCT01208233|1974097|FG001|Overall Study|Study terminated by sponsor|0
971705|NCT01208233|1974098|FG002|Overall Study|Study terminated by sponsor|0
971706|NCT01208233|1974099|FG003|Overall Study|Study terminated by sponsor|0
971707|NCT01208233|1974100|FG004|Overall Study|Study terminated by sponsor|10
971708|NCT01208233|1974101|FG005|Overall Study|Study terminated by sponsor|7
971709|NCT01208233|1974096|FG000|Overall Study|Protocol Violation|0
971710|NCT01208233|1974097|FG001|Overall Study|Protocol Violation|0
971711|NCT01208233|1974098|FG002|Overall Study|Protocol Violation|0
971712|NCT01208233|1974099|FG003|Overall Study|Protocol Violation|0
971713|NCT01208233|1974100|FG004|Overall Study|Protocol Violation|3
971714|NCT01208233|1974101|FG005|Overall Study|Protocol Violation|0
971715|NCT01208233|1974096|FG000|Overall Study|Other|2
971716|NCT01208233|1974097|FG001|Overall Study|Other|1
971717|NCT01208233|1974098|FG002|Overall Study|Other|0
971718|NCT01208233|1974099|FG003|Overall Study|Other|0
971719|NCT01208233|1974100|FG004|Overall Study|Other|0
971720|NCT01208233|1974101|FG005|Overall Study|Other|1
971721|NCT01208233|1974096|FG000|Overall Study|Withdrawal by Subject|1
971722|NCT01208233|1974097|FG001|Overall Study|Withdrawal by Subject|0
971723|NCT01208233|1974098|FG002|Overall Study|Withdrawal by Subject|1
971724|NCT01208233|1974099|FG003|Overall Study|Withdrawal by Subject|1
971725|NCT01208233|1974100|FG004|Overall Study|Withdrawal by Subject|4
971726|NCT01208233|1974101|FG005|Overall Study|Withdrawal by Subject|2
971727|NCT01208324|1974125|FG000|Post-randomization of Patch|Withdrawal by Subject|1
971728|NCT01208324|1974126|FG001|Post-randomization of Patch|Withdrawal by Subject|0
971729|NCT01208324|1974127|FG002|Post-randomization of Patch|Withdrawal by Subject|0
971730|NCT01208324|1974128|FG003|Post-randomization of Patch|Withdrawal by Subject|0
971731|NCT01208337|1974138|FG000|Overall Study|Death|3
971732|NCT01208402|1974144|FG000|Overall Study|Withdrawal by Subject|1
971733|NCT01208402|1974145|FG001|Overall Study|Withdrawal by Subject|0
971734|NCT01208415|1974151|FG000|Overall Study|Death|1
971735|NCT01208415|1974151|FG000|Overall Study|Lost to Follow-up|2
971736|NCT01208415|1974151|FG000|Overall Study|Withdrawal by Subject|3
971737|NCT01208415|1974151|FG000|Overall Study|Device not placed|1
971738|NCT01208415|1974151|FG000|Overall Study|Still be eligible for follow-up|33
971739|NCT01208870|1974157|FG000|Overall Study|Lost to Follow-up|2
971740|NCT01208870|1974158|FG001|Overall Study|Lost to Follow-up|8
971741|NCT01208961|1974175|FG000|High-Fat Period III|Protocol Violation|1
971742|NCT01208961|1974176|FG001|High-Fat Period III|Protocol Violation|0
971743|NCT01209078|1974183|FG000|Overall Study|Adverse Event|5
971744|NCT01209078|1974184|FG001|Overall Study|Adverse Event|0
971745|NCT01209078|1974183|FG000|Overall Study|Lost to Follow-up|4
971746|NCT01209078|1974184|FG001|Overall Study|Lost to Follow-up|0
971747|NCT01209078|1974183|FG000|Overall Study|Physician Decision|5
971748|NCT01209078|1974184|FG001|Overall Study|Physician Decision|2
971749|NCT01209078|1974183|FG000|Overall Study|Withdrawal by Subject|2
971750|NCT01209078|1974184|FG001|Overall Study|Withdrawal by Subject|1
971751|NCT01209143|1974194|FG000|Overall Study|Adverse Event|2
971752|NCT01209143|1974195|FG001|Overall Study|Adverse Event|1
971753|NCT01209143|1974194|FG000|Overall Study|Death|0
971754|NCT01209143|1974195|FG001|Overall Study|Death|1
971755|NCT01209143|1974194|FG000|Overall Study|Physician Decision|3
971756|NCT01209143|1974195|FG001|Overall Study|Physician Decision|1
971757|NCT01209143|1974194|FG000|Overall Study|Lost to Follow-up|1
971758|NCT01209143|1974195|FG001|Overall Study|Lost to Follow-up|0
971759|NCT01209143|1974194|FG000|Overall Study|Withdrawal by Subject|2
971760|NCT01209143|1974195|FG001|Overall Study|Withdrawal by Subject|1
971761|NCT01209143|1974194|FG000|Overall Study|Disease progression|11
971762|NCT01209143|1974195|FG001|Overall Study|Disease progression|16
971763|NCT01209286|1974247|FG000|Overall Study|Adverse Event|4
971764|NCT01209286|1974248|FG001|Overall Study|Adverse Event|3
971765|NCT01209286|1974249|FG002|Overall Study|Adverse Event|1
971766|NCT01209286|1974247|FG000|Overall Study|Hematological Relapse After Remission|0
971767|NCT01209286|1974248|FG001|Overall Study|Hematological Relapse After Remission|1
971768|NCT01209286|1974249|FG002|Overall Study|Hematological Relapse After Remission|1
971769|NCT01209286|1974247|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1
971770|NCT01209286|1974248|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3
971771|NCT01209286|1974249|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1
971772|NCT01209286|1974247|FG000|Overall Study|Physician Decision|0
971773|NCT01209286|1974248|FG001|Overall Study|Physician Decision|2
971774|NCT01209286|1974249|FG002|Overall Study|Physician Decision|0
971775|NCT01209286|1974247|FG000|Overall Study|Other|0
971776|NCT01209286|1974248|FG001|Overall Study|Other|1
971777|NCT01209286|1974249|FG002|Overall Study|Other|0
971778|NCT01209325|1974266|FG000|Overall Study|Lost to Follow-up|24
971779|NCT01209325|1974266|FG000|Overall Study|Adverse Event|1
971780|NCT01209325|1974266|FG000|Overall Study|Relocated|3
971781|NCT01209325|1974266|FG000|Overall Study|Refusal after starting therapy|8
971782|NCT01209325|1974266|FG000|Overall Study|Protocol Violation|4
971783|NCT01209325|1974266|FG000|Overall Study|Refusal prior to therapy|1
971784|NCT01209325|1974266|FG000|Overall Study|Incarceration|2
971785|NCT01209598|1974298|FG000|Overall Study|Withdrawal by Subject|1
971786|NCT01209598|1974299|FG001|Overall Study|Withdrawal by Subject|0
971787|NCT01209624|1974306|FG000|Overall Study|Death|2
971788|NCT01209624|1974306|FG000|Overall Study|Adverse Event|13
971789|NCT01209624|1974306|FG000|Overall Study|Lack of Efficacy|17
971790|NCT01209624|1974306|FG000|Overall Study|Lost to Follow-up|290
971791|NCT01209624|1974306|FG000|Overall Study|Other|4
971792|NCT01209689|1974312|FG000|Overall Study|Insufficient Therapeutic Response|7
971793|NCT01209689|1974313|FG001|Overall Study|Insufficient Therapeutic Response|2
971794|NCT01209689|1974312|FG000|Overall Study|Refused Treatment|8
971795|NCT01209689|1974313|FG001|Overall Study|Refused Treatment|3
971796|NCT01209689|1974312|FG000|Overall Study|Adverse Event|4
971797|NCT01209689|1974313|FG001|Overall Study|Adverse Event|0
971798|NCT01209689|1974312|FG000|Overall Study|Violation of Selection Criteria at Entry|1
971799|NCT01209689|1974313|FG001|Overall Study|Violation of Selection Criteria at Entry|0
971800|NCT01209689|1974312|FG000|Overall Study|Failure to Return|3
971801|NCT01209689|1974313|FG001|Overall Study|Failure to Return|0
971802|NCT01209689|1974312|FG000|Overall Study|Sponsor's Decision to Stop the Study|68
971803|NCT01209689|1974313|FG001|Overall Study|Sponsor's Decision to Stop the Study|17
971806|NCT01209780|1974355|FG000|Overall Study|Adverse Event|0
971807|NCT01209780|1974356|FG001|Overall Study|Adverse Event|1
971808|NCT01209780|1974357|FG002|Overall Study|Adverse Event|0
971809|NCT01209780|1974358|FG003|Overall Study|Adverse Event|0
971810|NCT01209780|1974359|FG004|Overall Study|Adverse Event|0
971811|NCT01209780|1974355|FG000|Overall Study|Withdrawal by Subject|9
971812|NCT01209780|1974356|FG001|Overall Study|Withdrawal by Subject|2
971813|NCT01209780|1974357|FG002|Overall Study|Withdrawal by Subject|1
971814|NCT01209780|1974358|FG003|Overall Study|Withdrawal by Subject|1
971815|NCT01209780|1974359|FG004|Overall Study|Withdrawal by Subject|0
971816|NCT01209780|1974355|FG000|Overall Study|Lost to Follow-up|17
971817|NCT01209780|1974356|FG001|Overall Study|Lost to Follow-up|12
971818|NCT01209780|1974357|FG002|Overall Study|Lost to Follow-up|3
971819|NCT01209780|1974358|FG003|Overall Study|Lost to Follow-up|9
971820|NCT01209780|1974359|FG004|Overall Study|Lost to Follow-up|4
971821|NCT01209780|1974355|FG000|Overall Study|Protocol Violation|0
971822|NCT01209780|1974356|FG001|Overall Study|Protocol Violation|1
971823|NCT01209780|1974357|FG002|Overall Study|Protocol Violation|0
971824|NCT01209780|1974358|FG003|Overall Study|Protocol Violation|0
971825|NCT01209780|1974359|FG004|Overall Study|Protocol Violation|0
971826|NCT01209780|1974355|FG000|Overall Study|Inappropriate enrollment|0
971827|NCT01209780|1974356|FG001|Overall Study|Inappropriate enrollment|2
971828|NCT01209780|1974357|FG002|Overall Study|Inappropriate enrollment|0
971829|NCT01209780|1974358|FG003|Overall Study|Inappropriate enrollment|0
971830|NCT01209780|1974359|FG004|Overall Study|Inappropriate enrollment|1
971831|NCT01209832|1974372|FG000|Period 1|Sponsor Decision and was not dosed|1
971832|NCT01209832|1974372|FG000|Period 2|Sponsor Decision|1
971833|NCT01209949|1974383|FG000|Overall Study|Lost to Follow-up|3
971834|NCT01210001|1974390|FG000|Overall Study|Not treated|1
971835|NCT01210001|1974391|FG001|Overall Study|Not treated|0
971836|NCT01210001|1974392|FG002|Overall Study|Not treated|0
971837|NCT01210001|1974390|FG000|Overall Study|Adverse Event|4
971838|NCT01210001|1974391|FG001|Overall Study|Adverse Event|2
971839|NCT01210001|1974392|FG002|Overall Study|Adverse Event|5
971840|NCT01210001|1974390|FG000|Overall Study|Non compliant with protocol|2
971841|NCT01210001|1974391|FG001|Overall Study|Non compliant with protocol|2
971842|NCT01210001|1974392|FG002|Overall Study|Non compliant with protocol|3
971843|NCT01210001|1974390|FG000|Overall Study|Lost to Follow-up|4
971844|NCT01210001|1974391|FG001|Overall Study|Lost to Follow-up|3
971845|NCT01210001|1974392|FG002|Overall Study|Lost to Follow-up|2
971846|NCT01210001|1974390|FG000|Overall Study|Patient refusal to continue,not due toAE|6
971847|NCT01210001|1974391|FG001|Overall Study|Patient refusal to continue,not due toAE|2
971848|NCT01210001|1974392|FG002|Overall Study|Patient refusal to continue,not due toAE|1
971849|NCT01210001|1974390|FG000|Overall Study|Other reason not defined above|2
971850|NCT01210001|1974391|FG001|Overall Study|Other reason not defined above|2
971851|NCT01210001|1974392|FG002|Overall Study|Other reason not defined above|1
971852|NCT01210118|1974411|FG000|Overall Study|Lost to Follow-up|1
971853|NCT01210118|1974412|FG001|Overall Study|Lost to Follow-up|1
971854|NCT01210118|1974411|FG000|Overall Study|Protocol Violation|1
971855|NCT01210118|1974412|FG001|Overall Study|Protocol Violation|1
971856|NCT01210118|1974411|FG000|Overall Study|Spontaneous abortion|1
971857|NCT01210118|1974412|FG001|Overall Study|Spontaneous abortion|3
971858|NCT01210144|1974423|FG000|Overall Study|Lack of ovarian response|1
971859|NCT01210144|1974424|FG001|Overall Study|Lack of ovarian response|0
971860|NCT01210144|1974423|FG000|Overall Study|No fertilization|1
971861|NCT01210144|1974424|FG001|Overall Study|No fertilization|0
971862|NCT01210144|1974423|FG000|Overall Study|No transfer|1
971863|NCT01210144|1974424|FG001|Overall Study|No transfer|0
971864|NCT01210222|1974452|FG000|Overall Study|Ineligible|2
971865|NCT01210222|1974452|FG000|Overall Study|Never treated|1
971866|NCT01210352|1974471|FG000|Overall Study|Adverse Event|0
971867|NCT01210352|1974472|FG001|Overall Study|Adverse Event|0
971868|NCT01210352|1974473|FG002|Overall Study|Adverse Event|0
971869|NCT01210352|1974474|FG003|Overall Study|Adverse Event|0
971870|NCT01210352|1974475|FG004|Overall Study|Adverse Event|0
971871|NCT01210352|1974476|FG005|Overall Study|Adverse Event|0
971872|NCT01210352|1974477|FG006|Overall Study|Adverse Event|0
971873|NCT01210352|1974478|FG007|Overall Study|Adverse Event|2
971874|NCT01210352|1974479|FG008|Overall Study|Adverse Event|1
971875|NCT01210352|1974471|FG000|Overall Study|Lack of Efficacy|0
971876|NCT01210352|1974472|FG001|Overall Study|Lack of Efficacy|0
971877|NCT01210352|1974473|FG002|Overall Study|Lack of Efficacy|0
971878|NCT01210352|1974474|FG003|Overall Study|Lack of Efficacy|0
971879|NCT01210352|1974475|FG004|Overall Study|Lack of Efficacy|0
971880|NCT01210352|1974476|FG005|Overall Study|Lack of Efficacy|0
971881|NCT01210352|1974477|FG006|Overall Study|Lack of Efficacy|1
971882|NCT01210352|1974478|FG007|Overall Study|Lack of Efficacy|0
971883|NCT01210352|1974479|FG008|Overall Study|Lack of Efficacy|0
971884|NCT01210352|1974471|FG000|Overall Study|Physician Decision|0
971885|NCT01210352|1974472|FG001|Overall Study|Physician Decision|0
971886|NCT01210352|1974473|FG002|Overall Study|Physician Decision|0
971887|NCT01210352|1974474|FG003|Overall Study|Physician Decision|0
971888|NCT01210352|1974475|FG004|Overall Study|Physician Decision|0
971889|NCT01210352|1974476|FG005|Overall Study|Physician Decision|0
971890|NCT01210352|1974477|FG006|Overall Study|Physician Decision|0
971891|NCT01210352|1974478|FG007|Overall Study|Physician Decision|1
971892|NCT01210352|1974479|FG008|Overall Study|Physician Decision|2
971893|NCT01210352|1974471|FG000|Overall Study|Withdrawal by Subject|0
971894|NCT01210352|1974472|FG001|Overall Study|Withdrawal by Subject|0
971895|NCT01210352|1974473|FG002|Overall Study|Withdrawal by Subject|1
971896|NCT01210352|1974474|FG003|Overall Study|Withdrawal by Subject|0
971897|NCT01210352|1974475|FG004|Overall Study|Withdrawal by Subject|0
971898|NCT01210352|1974476|FG005|Overall Study|Withdrawal by Subject|0
971899|NCT01210352|1974477|FG006|Overall Study|Withdrawal by Subject|1
971900|NCT01210352|1974478|FG007|Overall Study|Withdrawal by Subject|0
971901|NCT01210352|1974479|FG008|Overall Study|Withdrawal by Subject|1
971902|NCT01210352|1974471|FG000|Overall Study|Patient Discharged Early|0
971903|NCT01210352|1974472|FG001|Overall Study|Patient Discharged Early|0
971904|NCT01210352|1974473|FG002|Overall Study|Patient Discharged Early|1
971905|NCT01210352|1974474|FG003|Overall Study|Patient Discharged Early|0
971906|NCT01210352|1974475|FG004|Overall Study|Patient Discharged Early|0
971907|NCT01210352|1974476|FG005|Overall Study|Patient Discharged Early|0
971908|NCT01210352|1974477|FG006|Overall Study|Patient Discharged Early|0
971909|NCT01210352|1974478|FG007|Overall Study|Patient Discharged Early|0
971910|NCT01210352|1974479|FG008|Overall Study|Patient Discharged Early|0
971911|NCT01210443|1974584|FG000|Overall Study|Study terminated by sponsor|2
971912|NCT01210495|1974592|FG000|Overall Study|Participant Refused Further Follow-Up|1
971913|NCT01210495|1974593|FG001|Overall Study|Participant Refused Further Follow-Up|0
971914|NCT01210495|1974594|FG002|Overall Study|Participant Refused Further Follow-Up|11
971915|NCT01210495|1974595|FG003|Overall Study|Participant Refused Further Follow-Up|2
971916|NCT01210495|1974592|FG000|Overall Study|Death|14
971917|NCT01210495|1974593|FG001|Overall Study|Death|7
971918|NCT01210495|1974594|FG002|Overall Study|Death|112
971919|NCT01210495|1974595|FG003|Overall Study|Death|54
971920|NCT01210495|1974592|FG000|Overall Study|Study Terminated by Sponsor|0
971921|NCT01210495|1974593|FG001|Overall Study|Study Terminated by Sponsor|0
971922|NCT01210495|1974594|FG002|Overall Study|Study Terminated by Sponsor|4
971923|NCT01210495|1974595|FG003|Overall Study|Study Terminated by Sponsor|11
971924|NCT01210495|1974592|FG000|Overall Study|Lost to Follow-up|0
971925|NCT01210495|1974593|FG001|Overall Study|Lost to Follow-up|0
971926|NCT01210495|1974594|FG002|Overall Study|Lost to Follow-up|1
971927|NCT01210495|1974595|FG003|Overall Study|Lost to Follow-up|1
971928|NCT01210495|1974592|FG000|Overall Study|Other unspecified|0
971929|NCT01210495|1974593|FG001|Overall Study|Other unspecified|0
971930|NCT01210495|1974594|FG002|Overall Study|Other unspecified|6
971931|NCT01210495|1974595|FG003|Overall Study|Other unspecified|0
971932|NCT01210651|1974630|FG000|Overall Study|Lost to Follow-up|1
971933|NCT01210651|1974631|FG001|Overall Study|Lost to Follow-up|1
971934|NCT01210651|1974630|FG000|Overall Study|schedule conflicts|1
971935|NCT01210651|1974631|FG001|Overall Study|schedule conflicts|5
971936|NCT01210651|1974630|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0
971937|NCT01210651|1974631|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1
971938|NCT01210651|1974630|FG000|Overall Study|Withdrawal by Subject|1
971939|NCT01210651|1974631|FG001|Overall Study|Withdrawal by Subject|1
971940|NCT01210651|1974630|FG000|Overall Study|Injury outside study|2
971941|NCT01210651|1974631|FG001|Overall Study|Injury outside study|0
971942|NCT01210664|1974641|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
971943|NCT01210664|1974642|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
971944|NCT01210664|1974643|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
971945|NCT01210664|1974644|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
971946|NCT01210664|1974641|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
971947|NCT01210664|1974642|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
971948|NCT01210664|1974643|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
971949|NCT01210664|1974644|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
971950|NCT01210664|1974641|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
971951|NCT01210664|1974642|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
971952|NCT01210664|1974643|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
971953|NCT01210664|1974644|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
971954|NCT01210690|1974654|FG000|Overall Study|Adverse Event|7
971955|NCT01210690|1974654|FG000|Overall Study|Lack of Efficacy|12
971956|NCT01210690|1974654|FG000|Overall Study|Lost to Follow-up|3
971957|NCT01210690|1974654|FG000|Overall Study|Disease Remission|1
971958|NCT01210690|1974654|FG000|Overall Study|Withdrawal by Subject|1
971959|NCT01210690|1974654|FG000|Overall Study|Patient refused to swallow|1
971960|NCT01210690|1974654|FG000|Overall Study|Patient could not take glucose|1
971961|NCT01210807|1974668|FG000|Overall Study|Lost to Follow-up|1
971962|NCT01210807|1974669|FG001|Overall Study|Lost to Follow-up|2
971963|NCT01210807|1974668|FG000|Overall Study|Not implanted bilaterally|2
971964|NCT01210807|1974669|FG001|Overall Study|Not implanted bilaterally|1
971965|NCT01211145|1974699|FG000|Overall Study|Reason not specified|3
971966|NCT01211145|1974700|FG001|Overall Study|Reason not specified|2
971967|NCT01211145|1974701|FG002|Overall Study|Reason not specified|2
971968|NCT01211145|1974702|FG003|Overall Study|Reason not specified|1
971969|NCT01211145|1974699|FG000|Overall Study|Lost to Follow-up|3
971970|NCT01211145|1974700|FG001|Overall Study|Lost to Follow-up|2
971971|NCT01211145|1974701|FG002|Overall Study|Lost to Follow-up|1
971972|NCT01211145|1974702|FG003|Overall Study|Lost to Follow-up|2
971973|NCT01211145|1974699|FG000|Overall Study|Study-specific withdrawal criteria|1
971974|NCT01211145|1974700|FG001|Overall Study|Study-specific withdrawal criteria|0
971975|NCT01211145|1974701|FG002|Overall Study|Study-specific withdrawal criteria|0
971976|NCT01211145|1974702|FG003|Overall Study|Study-specific withdrawal criteria|0
971977|NCT01211145|1974699|FG000|Overall Study|Severe noncompliance to protocol|1
971978|NCT01211145|1974700|FG001|Overall Study|Severe noncompliance to protocol|0
971979|NCT01211145|1974701|FG002|Overall Study|Severe noncompliance to protocol|0
971980|NCT01211145|1974702|FG003|Overall Study|Severe noncompliance to protocol|0
971981|NCT01211145|1974699|FG000|Overall Study|Eligibility criteria not fulfilled|16
971982|NCT01211145|1974700|FG001|Overall Study|Eligibility criteria not fulfilled|12
971983|NCT01211145|1974701|FG002|Overall Study|Eligibility criteria not fulfilled|10
971984|NCT01211145|1974702|FG003|Overall Study|Eligibility criteria not fulfilled|15
971985|NCT01211145|1974699|FG000|Overall Study|Patient decision|2
971986|NCT01211145|1974700|FG001|Overall Study|Patient decision|1
971987|NCT01211145|1974701|FG002|Overall Study|Patient decision|0
971988|NCT01211145|1974702|FG003|Overall Study|Patient decision|2
971989|NCT01211184|1974715|FG000|Overall Study|Withdrawal by Subject|0
971990|NCT01211184|1974716|FG001|Overall Study|Withdrawal by Subject|2
971991|NCT01211184|1974717|FG002|Overall Study|Withdrawal by Subject|1
971992|NCT01211197|1974728|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
971993|NCT01211197|1974729|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
971994|NCT01211197|1974730|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1
971995|NCT01211197|1974731|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
971996|NCT01211197|1974732|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
971997|NCT01211197|1974733|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
971998|NCT01211197|1974728|FG000|Washout Period 2 (7 Days)|Adverse Event|1
971999|NCT01211197|1974729|FG001|Washout Period 2 (7 Days)|Adverse Event|0
972000|NCT01211197|1974730|FG002|Washout Period 2 (7 Days)|Adverse Event|0
972001|NCT01211197|1974731|FG003|Washout Period 2 (7 Days)|Adverse Event|0
972002|NCT01211197|1974732|FG004|Washout Period 2 (7 Days)|Adverse Event|0
972003|NCT01211197|1974733|FG005|Washout Period 2 (7 Days)|Adverse Event|0
972004|NCT01211262|1974743|FG000|Overall Study|Progressive Disease|18
972005|NCT01211262|1974744|FG001|Overall Study|Progressive Disease|9
972006|NCT01211262|1974743|FG000|Overall Study|Adverse Event|4
972007|NCT01211262|1974744|FG001|Overall Study|Adverse Event|0
972008|NCT01211262|1974743|FG000|Overall Study|Withdrawal of Consent|1
972009|NCT01211262|1974744|FG001|Overall Study|Withdrawal of Consent|0
972010|NCT01211262|1974743|FG000|Overall Study|Other|0
972011|NCT01211262|1974744|FG001|Overall Study|Other|1
972012|NCT01211288|1974755|FG000|Overall Study|Lost to Follow-up|1
972013|NCT01211288|1974756|FG001|Overall Study|Lost to Follow-up|1
972014|NCT01211483|1974777|FG000|Phase 1b|Death|6
972015|NCT01211483|1974778|FG001|Phase 1b|Death|0
972016|NCT01211483|1974779|FG002|Phase 1b|Death|0
972017|NCT01211483|1974780|FG003|Phase 1b|Death|0
972018|NCT01211483|1974777|FG000|Phase 1b|Withdrawal by Subject|1
972019|NCT01211483|1974778|FG001|Phase 1b|Withdrawal by Subject|0
972020|NCT01211483|1974779|FG002|Phase 1b|Withdrawal by Subject|0
972021|NCT01211483|1974780|FG003|Phase 1b|Withdrawal by Subject|0
972022|NCT01211483|1974777|FG000|Phase 2|Lost to Follow-up|0
972023|NCT01211483|1974778|FG001|Phase 2|Lost to Follow-up|1
972024|NCT01211483|1974779|FG002|Phase 2|Lost to Follow-up|1
972025|NCT01211483|1974780|FG003|Phase 2|Lost to Follow-up|2
972026|NCT01211483|1974777|FG000|Phase 2|Death|0
972027|NCT01211483|1974778|FG001|Phase 2|Death|64
972028|NCT01211483|1974779|FG002|Phase 2|Death|53
972029|NCT01211483|1974780|FG003|Phase 2|Death|53
972030|NCT01211483|1974777|FG000|Phase 2|Withdrawal by Subject|0
972031|NCT01211483|1974778|FG001|Phase 2|Withdrawal by Subject|1
972032|NCT01211483|1974779|FG002|Phase 2|Withdrawal by Subject|10
972033|NCT01211483|1974780|FG003|Phase 2|Withdrawal by Subject|5
972034|NCT01211483|1974777|FG000|Phase 2|Study terminated by Sponsor|0
972035|NCT01211483|1974778|FG001|Phase 2|Study terminated by Sponsor|6
972036|NCT01211483|1974779|FG002|Phase 2|Study terminated by Sponsor|8
972037|NCT01211483|1974780|FG003|Phase 2|Study terminated by Sponsor|11
972038|NCT01211522|1974797|FG000|Overall Study|Withdrawal by Subject|3
972039|NCT01211522|1974798|FG001|Overall Study|Withdrawal by Subject|7
972040|NCT01211522|1974799|FG002|Overall Study|Withdrawal by Subject|5
972041|NCT01211535|1974809|FG000|Overall Study|Adverse Event|0
972042|NCT01211535|1974810|FG001|Overall Study|Adverse Event|1
972043|NCT01211613|1974830|FG000|Overall Study|Lost to Follow-up|2
972044|NCT01211613|1974831|FG001|Overall Study|Lost to Follow-up|2
972045|NCT01211613|1974832|FG002|Overall Study|Lost to Follow-up|2
972046|NCT01211613|1974830|FG000|Overall Study|Withdrawal by Subject|1
972047|NCT01211613|1974831|FG001|Overall Study|Withdrawal by Subject|0
972048|NCT01211613|1974832|FG002|Overall Study|Withdrawal by Subject|0
972049|NCT01211665|1974842|FG000|Overall Study|Withdrawal by Subject|1
972050|NCT01211665|1974843|FG001|Overall Study|Withdrawal by Subject|0
972051|NCT01211665|1974842|FG000|Overall Study|Death|1
972052|NCT01211665|1974843|FG001|Overall Study|Death|0
972053|NCT01211769|1974862|FG000|Overall Study|Lost to Follow-up|7
972054|NCT01211769|1974863|FG001|Overall Study|Lost to Follow-up|9
972055|NCT01211769|1974864|FG002|Overall Study|Lost to Follow-up|5
972056|NCT01211769|1974865|FG003|Overall Study|Lost to Follow-up|9
972057|NCT01211769|1974862|FG000|Overall Study|Physician Decision|2
972058|NCT01211769|1974863|FG001|Overall Study|Physician Decision|0
972059|NCT01211769|1974864|FG002|Overall Study|Physician Decision|2
972060|NCT01211769|1974865|FG003|Overall Study|Physician Decision|1
972061|NCT01211769|1974862|FG000|Overall Study|Adverse Event|0
972062|NCT01211769|1974863|FG001|Overall Study|Adverse Event|1
972063|NCT01211769|1974864|FG002|Overall Study|Adverse Event|1
972064|NCT01211769|1974865|FG003|Overall Study|Adverse Event|1
972065|NCT01212094|1974892|FG000|Year 1: Baseline Monitoring|Study terminated|7
972066|NCT01212094|1974893|FG001|Year 1: Baseline Monitoring|Study terminated|0
972067|NCT01212094|1974894|FG002|Year 1: Baseline Monitoring|Study terminated|0
972068|NCT01212094|1974892|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7
972069|NCT01212094|1974893|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0
972070|NCT01212094|1974894|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0
972071|NCT01212094|1974892|FG000|Year 1: Baseline Monitoring|Started on DMT|2
972072|NCT01212094|1974893|FG001|Year 1: Baseline Monitoring|Started on DMT|0
972073|NCT01212094|1974894|FG002|Year 1: Baseline Monitoring|Started on DMT|0
972074|NCT01212094|1974892|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0
972075|NCT01212094|1974893|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4
972076|NCT01212094|1974894|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7
972077|NCT01212094|1974892|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
972078|NCT01212094|1974893|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
972079|NCT01212094|1974894|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
972080|NCT01212094|1974892|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0
972081|NCT01212094|1974893|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0
972082|NCT01212094|1974894|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1
972083|NCT01212159|1974968|FG000|Overall Study|Withdrawal by Subject|12
972084|NCT01212159|1974969|FG001|Overall Study|Withdrawal by Subject|12
972085|NCT01212185|1974986|FG000|Overall Study|Protocol Violation|2
972086|NCT01212185|1974987|FG001|Overall Study|Protocol Violation|1
972087|NCT01212588|1975033|FG000|Overall Study|Physician Decision|0
972088|NCT01212588|1975034|FG001|Overall Study|Physician Decision|1
972089|NCT01212588|1975033|FG000|Overall Study|Protocol Violation|1
972090|NCT01212588|1975034|FG001|Overall Study|Protocol Violation|1
972091|NCT01212744|1975044|FG000|Overall Study|Withdrawal by Subject|1
972092|NCT01212757|1975053|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
972093|NCT01212757|1975054|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
972094|NCT01212757|1975055|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
972095|NCT01212757|1975056|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
972096|NCT01212757|1975057|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
972097|NCT01212757|1975058|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
972098|NCT01212757|1975059|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
972099|NCT01212757|1975060|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
972100|NCT01212757|1975061|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
972101|NCT01212757|1975053|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
972102|NCT01212757|1975054|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
972103|NCT01212757|1975055|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
972104|NCT01212757|1975056|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972105|NCT01212757|1975057|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972106|NCT01212757|1975058|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972107|NCT01212757|1975059|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972108|NCT01212757|1975060|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972109|NCT01212757|1975061|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972110|NCT01212757|1975053|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
972111|NCT01212757|1975054|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
972112|NCT01212757|1975055|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
972113|NCT01212757|1975056|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972114|NCT01212757|1975057|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972115|NCT01212757|1975058|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972116|NCT01212757|1975059|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972117|NCT01212757|1975060|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972118|NCT01212757|1975061|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972119|NCT01212757|1975053|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
972120|NCT01212757|1975054|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
972121|NCT01212757|1975055|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
972122|NCT01212757|1975056|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
972123|NCT01212757|1975057|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
972124|NCT01212757|1975058|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
972125|NCT01212757|1975059|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
972126|NCT01212757|1975060|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
972127|NCT01212757|1975061|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
972128|NCT01212757|1975053|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
972129|NCT01212757|1975054|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
912551|NCT00806026|1890091|FG002|Overall Study|Other|8
912552|NCT00806026|1890092|FG003|Overall Study|Other|2
912553|NCT00806026|1890093|FG004|Overall Study|Other|0
912554|NCT00806026|1890094|FG005|Overall Study|Other|4
912555|NCT00806026|1890089|FG000|Overall Study|Protocol Violation|6
912556|NCT00806026|1890090|FG001|Overall Study|Protocol Violation|9
912557|NCT00806026|1890091|FG002|Overall Study|Protocol Violation|9
972130|NCT01212757|1975055|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
972131|NCT01212757|1975056|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972132|NCT01212757|1975057|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972133|NCT01212757|1975058|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972134|NCT01212757|1975059|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972135|NCT01212757|1975060|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972136|NCT01212757|1975061|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972137|NCT01212757|1975053|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972138|NCT01212757|1975054|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
972139|NCT01212757|1975055|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
972140|NCT01212757|1975056|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972141|NCT01212757|1975057|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972142|NCT01212757|1975058|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1006628|NCT01468844|2025320|FG000|Overall Study|Adverse Event|1
912558|NCT00806026|1890092|FG003|Overall Study|Protocol Violation|0
912559|NCT00806026|1890093|FG004|Overall Study|Protocol Violation|2
912560|NCT00806026|1890094|FG005|Overall Study|Protocol Violation|3
912561|NCT00806026|1890089|FG000|Overall Study|Adverse Event|52
912562|NCT00806026|1890090|FG001|Overall Study|Adverse Event|35
912563|NCT00806026|1890091|FG002|Overall Study|Adverse Event|44
912564|NCT00806026|1890092|FG003|Overall Study|Adverse Event|17
912565|NCT00806026|1890093|FG004|Overall Study|Adverse Event|9
912566|NCT00806026|1890094|FG005|Overall Study|Adverse Event|9
912567|NCT00806156|1890117|FG000|Overall Study|Death|35
912568|NCT00806156|1890118|FG001|Overall Study|Death|95
912569|NCT00806156|1890117|FG000|Overall Study|Did not meet eligibility criteria|1
912570|NCT00806156|1890118|FG001|Overall Study|Did not meet eligibility criteria|0
912571|NCT00806156|1890117|FG000|Overall Study|Study terminated by Sponsor|2
912572|NCT00806156|1890118|FG001|Overall Study|Study terminated by Sponsor|40
912573|NCT00806156|1890117|FG000|Overall Study|Consent withdrawn by subject|1
912574|NCT00806156|1890118|FG001|Overall Study|Consent withdrawn by subject|3
912575|NCT00806156|1890117|FG000|Overall Study|Lost to Follow-up|0
912576|NCT00806156|1890118|FG001|Overall Study|Lost to Follow-up|1
912577|NCT00806195|1890140|FG000|Overall Study|Death|6
912578|NCT00806195|1890141|FG001|Overall Study|Death|0
912579|NCT00806195|1890142|FG002|Overall Study|Death|1
912580|NCT00806195|1890143|FG003|Overall Study|Death|0
912581|NCT00806195|1890140|FG000|Overall Study|Adverse Event|25
912582|NCT00806195|1890141|FG001|Overall Study|Adverse Event|5
912583|NCT00806195|1890142|FG002|Overall Study|Adverse Event|11
912584|NCT00806195|1890143|FG003|Overall Study|Adverse Event|2
912585|NCT00806195|1890140|FG000|Overall Study|Withdrawal by Subject|119
912586|NCT00806195|1890141|FG001|Overall Study|Withdrawal by Subject|31
912587|NCT00806195|1890142|FG002|Overall Study|Withdrawal by Subject|76
912588|NCT00806195|1890143|FG003|Overall Study|Withdrawal by Subject|35
912589|NCT00806195|1890140|FG000|Overall Study|Lost to Follow-up|217
912590|NCT00806195|1890141|FG001|Overall Study|Lost to Follow-up|66
912591|NCT00806195|1890142|FG002|Overall Study|Lost to Follow-up|90
912592|NCT00806195|1890143|FG003|Overall Study|Lost to Follow-up|34
912593|NCT00806195|1890140|FG000|Overall Study|Inappropriate Enrollment|0
912594|NCT00806195|1890141|FG001|Overall Study|Inappropriate Enrollment|1
912595|NCT00806195|1890142|FG002|Overall Study|Inappropriate Enrollment|0
912596|NCT00806195|1890143|FG003|Overall Study|Inappropriate Enrollment|0
912597|NCT00806195|1890140|FG000|Overall Study|Administrative Reason|113
912598|NCT00806195|1890141|FG001|Overall Study|Administrative Reason|35
912599|NCT00806195|1890142|FG002|Overall Study|Administrative Reason|66
912600|NCT00806195|1890143|FG003|Overall Study|Administrative Reason|26
912601|NCT00806195|1890140|FG000|Overall Study|Protocol Violation|34
912602|NCT00806195|1890141|FG001|Overall Study|Protocol Violation|24
972143|NCT01212757|1975059|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972144|NCT01212757|1975060|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972145|NCT01212757|1975061|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972146|NCT01212757|1975053|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
972147|NCT01212757|1975054|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
972148|NCT01212757|1975055|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
972149|NCT01212757|1975056|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
972150|NCT01212757|1975057|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
972151|NCT01212757|1975058|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
972152|NCT01212757|1975059|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
972153|NCT01212757|1975060|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
972154|NCT01212757|1975061|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
972155|NCT01212757|1975053|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
972156|NCT01212757|1975054|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
972157|NCT01212757|1975055|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
972158|NCT01212757|1975056|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
972159|NCT01212757|1975057|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
972160|NCT01212757|1975058|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
972161|NCT01212757|1975059|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
972162|NCT01212757|1975060|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
972163|NCT01212757|1975061|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
972164|NCT01212757|1975053|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
972165|NCT01212757|1975054|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
972166|NCT01212757|1975055|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
972167|NCT01212757|1975056|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
972168|NCT01212757|1975057|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
972169|NCT01212757|1975058|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
972170|NCT01212757|1975059|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
972171|NCT01212757|1975060|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
972172|NCT01212757|1975061|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
972173|NCT01212757|1975053|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
972174|NCT01212757|1975054|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
972175|NCT01212757|1975055|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
972176|NCT01212757|1975056|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
972177|NCT01212757|1975057|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
972178|NCT01212757|1975058|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
972179|NCT01212757|1975059|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
972180|NCT01212757|1975060|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
972181|NCT01212757|1975061|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
972182|NCT01212757|1975053|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
972183|NCT01212757|1975054|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
972184|NCT01212757|1975055|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
972185|NCT01212757|1975056|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
972186|NCT01212757|1975057|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
972187|NCT01212757|1975058|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
972188|NCT01212757|1975059|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
972189|NCT01212757|1975060|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
972190|NCT01212757|1975061|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
972191|NCT01212757|1975053|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
972192|NCT01212757|1975054|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
972193|NCT01212757|1975055|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
972194|NCT01212757|1975056|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
972195|NCT01212757|1975057|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
972196|NCT01212757|1975058|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
972197|NCT01212757|1975059|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
972198|NCT01212757|1975060|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
972199|NCT01212757|1975061|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
972200|NCT01212757|1975053|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0
972201|NCT01212757|1975054|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1
972202|NCT01212757|1975055|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1
972203|NCT01212757|1975056|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0
972204|NCT01212757|1975057|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0
972205|NCT01212757|1975058|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0
972206|NCT01212757|1975059|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0
972207|NCT01212757|1975060|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0
972208|NCT01212757|1975061|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0
972209|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0
972210|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0
972211|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0
972212|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0
972213|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0
972214|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0
972215|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0
972216|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0
972217|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1
972218|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0
972219|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1
972220|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1
972221|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0
972222|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0
972223|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0
972224|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0
972225|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2
972226|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2
972227|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
972228|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
972229|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
972230|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
972231|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
972232|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
972233|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
972234|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
972235|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
972236|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
972237|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
972238|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
972239|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
972240|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
972241|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
972242|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
972243|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
972244|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
972245|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
972246|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
972247|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
972248|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
972249|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
972250|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
972251|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
972252|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
972253|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
972254|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0
972255|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4
972256|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1
972257|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0
972258|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0
972259|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0
972260|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0
972261|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2
972262|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0
972263|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
972264|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
972265|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
972266|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
972267|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
972268|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
972269|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
972270|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
972271|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
972272|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
972273|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
972274|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
972275|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
972276|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
972277|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
972278|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
972279|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
972280|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
972281|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
972282|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
1006629|NCT01468844|2025321|FG001|Overall Study|Adverse Event|0
972283|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
972284|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
972285|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
972286|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
972287|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
972288|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
972289|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
972290|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
972291|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
972292|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
972293|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
972294|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
972295|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
972296|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
972297|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
972298|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
972299|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0
972300|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1
972301|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0
972302|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0
972303|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0
972304|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0
972305|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0
972306|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0
972307|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0
972308|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0
972309|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0
972310|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3
972311|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0
972312|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0
972313|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0
972314|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0
972315|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0
972316|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2
972317|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0
972318|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2
972319|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0
972320|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0
972321|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0
972322|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0
972323|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0
972324|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0
972325|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1
972326|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0
972327|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1
972328|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2
972329|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0
972330|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0
972331|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0
972332|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0
972333|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1
972334|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1
972335|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
972336|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
972337|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
972338|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
972339|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
972340|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
972341|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
972342|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
972343|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
972344|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
972345|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
972346|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
972347|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
972348|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
972349|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
972350|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
972351|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
972352|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
972353|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 4)|Death|0
972354|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 4)|Death|0
972355|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 4)|Death|1
972356|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 4)|Death|0
972357|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 4)|Death|0
972358|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 4)|Death|0
972359|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 4)|Death|0
972360|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 4)|Death|0
972361|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 4)|Death|1
972362|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
972363|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
972364|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
972365|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
972366|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
972367|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
972368|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
972369|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
972370|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
972371|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
972372|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
972373|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
972374|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
972375|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
972376|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
972377|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
972378|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
972379|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
972380|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0
972381|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2
972382|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2
972383|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0
972384|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0
972385|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0
972386|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0
972387|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2
972388|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0
972389|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
972390|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
972391|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
972392|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
972393|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
972394|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
972395|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
972396|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
972397|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
972398|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
972399|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
972400|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
972401|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
972402|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
972403|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
972404|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
972405|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
972406|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
972407|NCT01212757|1975053|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0
972408|NCT01212757|1975054|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1
972409|NCT01212757|1975055|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1
972410|NCT01212757|1975056|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0
972411|NCT01212757|1975057|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0
972412|NCT01212757|1975058|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0
972413|NCT01212757|1975059|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0
972414|NCT01212757|1975060|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0
972415|NCT01212757|1975061|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0
972416|NCT01212770|1975082|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
972417|NCT01212770|1975083|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
972418|NCT01212770|1975084|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
972419|NCT01212770|1975085|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
972420|NCT01212770|1975086|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
972421|NCT01212770|1975087|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
972422|NCT01212770|1975088|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
972423|NCT01212770|1975089|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1006630|NCT01468844|2025320|FG000|Overall Study|Withdrawal by Subject|1
972424|NCT01212770|1975090|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
972425|NCT01212770|1975082|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
972426|NCT01212770|1975083|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
972427|NCT01212770|1975084|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
972428|NCT01212770|1975085|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972429|NCT01212770|1975086|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972430|NCT01212770|1975087|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972431|NCT01212770|1975088|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972432|NCT01212770|1975089|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972433|NCT01212770|1975090|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
972434|NCT01212770|1975082|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
972435|NCT01212770|1975083|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
972436|NCT01212770|1975084|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
972437|NCT01212770|1975085|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972438|NCT01212770|1975086|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972439|NCT01212770|1975087|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972440|NCT01212770|1975088|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972441|NCT01212770|1975089|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972442|NCT01212770|1975090|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
972443|NCT01212770|1975082|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
972444|NCT01212770|1975083|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972445|NCT01212770|1975084|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
972446|NCT01212770|1975085|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972447|NCT01212770|1975086|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972448|NCT01212770|1975087|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972449|NCT01212770|1975088|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972450|NCT01212770|1975089|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972451|NCT01212770|1975090|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
972452|NCT01212770|1975082|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972453|NCT01212770|1975083|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972454|NCT01212770|1975084|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
972455|NCT01212770|1975085|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972456|NCT01212770|1975086|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972457|NCT01212770|1975087|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972458|NCT01212770|1975088|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972459|NCT01212770|1975089|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972460|NCT01212770|1975090|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
972461|NCT01212770|1975082|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
972462|NCT01212770|1975083|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
972463|NCT01212770|1975084|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
972464|NCT01212770|1975085|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
972465|NCT01212770|1975086|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
972466|NCT01212770|1975087|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
972467|NCT01212770|1975088|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
972468|NCT01212770|1975089|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
972469|NCT01212770|1975090|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
972470|NCT01212770|1975082|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
972471|NCT01212770|1975083|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
972472|NCT01212770|1975084|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
972473|NCT01212770|1975085|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
972474|NCT01212770|1975086|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
972475|NCT01212770|1975087|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
972476|NCT01212770|1975088|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
972477|NCT01212770|1975089|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
972478|NCT01212770|1975090|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
972479|NCT01212770|1975082|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
972480|NCT01212770|1975083|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
972481|NCT01212770|1975084|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
972482|NCT01212770|1975085|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
972483|NCT01212770|1975086|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
972484|NCT01212770|1975087|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
972485|NCT01212770|1975088|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
972486|NCT01212770|1975089|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
972487|NCT01212770|1975090|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
972488|NCT01212770|1975082|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
972489|NCT01212770|1975083|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
972490|NCT01212770|1975084|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
972491|NCT01212770|1975085|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
972492|NCT01212770|1975086|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
972493|NCT01212770|1975087|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
972494|NCT01212770|1975088|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
972495|NCT01212770|1975089|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
972496|NCT01212770|1975090|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
972497|NCT01212770|1975082|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
972498|NCT01212770|1975083|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
972499|NCT01212770|1975084|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
972500|NCT01212770|1975085|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
972501|NCT01212770|1975086|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
972502|NCT01212770|1975087|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
972503|NCT01212770|1975088|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
972504|NCT01212770|1975089|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
972505|NCT01212770|1975090|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
972506|NCT01212770|1975082|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
972507|NCT01212770|1975083|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
972508|NCT01212770|1975084|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
972509|NCT01212770|1975085|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
972510|NCT01212770|1975086|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
972511|NCT01212770|1975087|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
972512|NCT01212770|1975088|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
972513|NCT01212770|1975089|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
972514|NCT01212770|1975090|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
972515|NCT01212770|1975082|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
972516|NCT01212770|1975083|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
972517|NCT01212770|1975084|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
972518|NCT01212770|1975085|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
972519|NCT01212770|1975086|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
972520|NCT01212770|1975087|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
972521|NCT01212770|1975088|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
972522|NCT01212770|1975089|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
972523|NCT01212770|1975090|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
972524|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
972525|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3
972526|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3
972527|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
972528|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
972529|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
972530|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
972531|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0
972532|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2
972533|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
972534|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
972535|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
972536|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
972537|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
972538|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
972539|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
972540|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
972541|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
972542|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
972543|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
972544|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
972545|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
972546|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
972547|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
972548|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
972549|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
972550|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
972551|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
972552|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
972553|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
972554|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
972555|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
972556|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
972557|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
972558|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
972559|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
972560|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
972561|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
972562|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
972563|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
972564|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
972565|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
972566|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
972567|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
972568|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
972569|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
972570|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2
972571|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1
972572|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
972573|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
972574|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
972575|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
972576|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0
972577|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
972578|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
972579|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2
972580|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
972581|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
972582|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
972583|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
972584|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
972585|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2
972586|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1
972587|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
972588|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
972589|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
972590|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
972591|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
972592|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
972593|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
972594|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
972595|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
972596|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
972597|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
972598|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
972599|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
972600|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
972601|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
972602|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
972603|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
972604|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
972605|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
972606|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
972607|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
972608|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
972609|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
972610|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
972611|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
972612|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
972613|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
972614|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0
972615|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0
972616|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0
972617|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0
972618|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0
972619|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0
972620|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0
972621|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1
972622|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0
972623|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
972624|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2
972625|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1
972626|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
972627|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
972628|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
972629|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
972630|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
972631|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1
972632|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
972633|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1
972634|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1
972635|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
972636|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
972637|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
972638|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
972639|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
972640|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1
972641|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
972642|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
972643|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
972644|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
972645|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
972646|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
972647|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
972648|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
972649|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
972650|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
972651|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
972652|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
972653|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
972654|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
972655|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
972656|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
972657|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
972658|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
972659|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
972660|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
972661|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
972662|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
972663|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
972664|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
972665|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
972666|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
972667|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
972668|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
972669|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
972670|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
972671|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
972672|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
972673|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
972674|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
972675|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
972676|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
972677|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
972678|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1
972679|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
972680|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
972681|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
972682|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
972683|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
972684|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0
972685|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1
972686|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 5)|Missing|0
972687|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 5)|Missing|0
972688|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 5)|Missing|1
972689|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 5)|Missing|0
972690|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 5)|Missing|0
972691|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 5)|Missing|0
972692|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 5)|Missing|0
972693|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 5)|Missing|0
972694|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 5)|Missing|0
972695|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
972696|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
972697|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3
972698|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
972699|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
972700|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
972701|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
972702|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0
972703|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0
972704|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
972705|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0
972706|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2
972707|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
1006631|NCT01468844|2025321|FG001|Overall Study|Withdrawal by Subject|0
972708|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
972709|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
972710|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
972711|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
972712|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
972713|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
972714|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
972715|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
972716|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
972717|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
972718|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
972719|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
972720|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
972721|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
972722|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
972723|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
972724|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
972725|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
972726|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
972727|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
972728|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
972729|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
972730|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
972731|NCT01212770|1975082|FG000|Long-term Safety Phase (Year 5)|Death|0
972732|NCT01212770|1975083|FG001|Long-term Safety Phase (Year 5)|Death|0
972733|NCT01212770|1975084|FG002|Long-term Safety Phase (Year 5)|Death|0
972734|NCT01212770|1975085|FG003|Long-term Safety Phase (Year 5)|Death|0
972735|NCT01212770|1975086|FG004|Long-term Safety Phase (Year 5)|Death|0
972736|NCT01212770|1975087|FG005|Long-term Safety Phase (Year 5)|Death|0
972737|NCT01212770|1975088|FG006|Long-term Safety Phase (Year 5)|Death|0
972738|NCT01212770|1975089|FG007|Long-term Safety Phase (Year 5)|Death|1
972739|NCT01212770|1975090|FG008|Long-term Safety Phase (Year 5)|Death|0
972740|NCT01212991|1975147|FG000|Double-blind|Lost to Follow-up|8
972741|NCT01212991|1975148|FG001|Double-blind|Lost to Follow-up|4
972742|NCT01212991|1975149|FG002|Double-blind|Lost to Follow-up|0
972743|NCT01212991|1975147|FG000|Double-blind|Death|699
972744|NCT01212991|1975148|FG001|Double-blind|Death|550
972745|NCT01212991|1975149|FG002|Double-blind|Death|0
972746|NCT01212991|1975147|FG000|Double-blind|Withdrawal by Subject|16
972747|NCT01212991|1975148|FG001|Double-blind|Withdrawal by Subject|19
972748|NCT01212991|1975149|FG002|Double-blind|Withdrawal by Subject|0
972749|NCT01212991|1975147|FG000|Double-blind|Other|7
972750|NCT01212991|1975148|FG001|Double-blind|Other|0
972751|NCT01212991|1975149|FG002|Double-blind|Other|0
972752|NCT01212991|1975147|FG000|Double-blind|Sponsor decision|142
972753|NCT01212991|1975148|FG001|Double-blind|Sponsor decision|38
972754|NCT01212991|1975149|FG002|Double-blind|Sponsor decision|0
972755|NCT01212991|1975147|FG000|Open-label|Death|0
972756|NCT01212991|1975148|FG001|Open-label|Death|0
972757|NCT01212991|1975149|FG002|Open-label|Death|166
972758|NCT01212991|1975147|FG000|Open-label|Lost to Follow-up|0
972759|NCT01212991|1975148|FG001|Open-label|Lost to Follow-up|0
972760|NCT01212991|1975149|FG002|Open-label|Lost to Follow-up|5
972761|NCT01212991|1975147|FG000|Open-label|Withdrawal by Subject|0
972762|NCT01212991|1975148|FG001|Open-label|Withdrawal by Subject|0
972763|NCT01212991|1975149|FG002|Open-label|Withdrawal by Subject|7
972764|NCT01212991|1975147|FG000|Open-label|Sponsor decision|0
972765|NCT01212991|1975148|FG001|Open-label|Sponsor decision|0
972766|NCT01212991|1975149|FG002|Open-label|Sponsor decision|53
972767|NCT01212991|1975147|FG000|Open-label|Other|0
972768|NCT01212991|1975148|FG001|Open-label|Other|0
972769|NCT01212991|1975149|FG002|Open-label|Other|3
972770|NCT01213082|1975169|FG000|Overall Study|Lost to Follow-up|6
972771|NCT01213082|1975170|FG001|Overall Study|Lost to Follow-up|7
972772|NCT01213082|1975171|FG002|Overall Study|Lost to Follow-up|4
972773|NCT01213082|1975169|FG000|Overall Study|Physician Decision|0
972774|NCT01213082|1975170|FG001|Overall Study|Physician Decision|0
972775|NCT01213082|1975171|FG002|Overall Study|Physician Decision|1
972776|NCT01213173|1975181|FG000|Overall Study|Protocol Violation|2
972777|NCT01213173|1975182|FG001|Overall Study|Protocol Violation|0
972778|NCT01213173|1975181|FG000|Overall Study|Adverse Event|4
972779|NCT01213173|1975182|FG001|Overall Study|Adverse Event|8
972780|NCT01213173|1975181|FG000|Overall Study|Withdrawal by Subject|5
972781|NCT01213173|1975182|FG001|Overall Study|Withdrawal by Subject|5
972782|NCT01213173|1975181|FG000|Overall Study|Incorrect Enrollment|1
972783|NCT01213173|1975182|FG001|Overall Study|Incorrect Enrollment|3
972784|NCT01213251|1975195|FG000|Overall Study|Death|2
972785|NCT01213251|1975196|FG001|Overall Study|Death|1
972786|NCT01213251|1975197|FG002|Overall Study|Death|2
972787|NCT01213251|1975195|FG000|Overall Study|Exit|3
972788|NCT01213251|1975196|FG001|Overall Study|Exit|2
972789|NCT01213251|1975197|FG002|Overall Study|Exit|8
972790|NCT01213251|1975195|FG000|Overall Study|Protocol Violation|1
972791|NCT01213251|1975196|FG001|Overall Study|Protocol Violation|1
972792|NCT01213251|1975197|FG002|Overall Study|Protocol Violation|0
972793|NCT01213251|1975195|FG000|Overall Study|Missed 18-Month Follow-up|0
972794|NCT01213251|1975196|FG001|Overall Study|Missed 18-Month Follow-up|0
972795|NCT01213251|1975197|FG002|Overall Study|Missed 18-Month Follow-up|1
972796|NCT01213264|1975213|FG000|Overall Study|Adverse Event|1
972797|NCT01213264|1975214|FG001|Overall Study|Adverse Event|0
972798|NCT01213264|1975215|FG002|Overall Study|Adverse Event|0
972799|NCT01213264|1975213|FG000|Overall Study|Lost to Follow-up|1
972800|NCT01213264|1975214|FG001|Overall Study|Lost to Follow-up|2
972801|NCT01213264|1975215|FG002|Overall Study|Lost to Follow-up|6
972802|NCT01213472|1975234|FG000|Overall Study|Recurrence/Progressive disease|25
972803|NCT01213472|1975234|FG000|Overall Study|Withdrawal by Subject|1
972804|NCT01213472|1975234|FG000|Overall Study|Physician Decision|1
972805|NCT01213524|1975240|FG000|Baseline|Withdrawal by Subject|5
972806|NCT01213524|1975240|FG000|Baseline|high breath alcohol levels|1
972807|NCT01213524|1975240|FG000|Baseline|Physician Decision|1
972808|NCT01213524|1975240|FG000|Session 2|Withdrawal by Subject|5
972809|NCT01213524|1975240|FG000|Session 3|Withdrawal by Subject|4
972810|NCT01213524|1975240|FG000|Session 4|Physician Decision|1
972811|NCT01213524|1975240|FG000|Session 4|Withdrawal by Subject|2
972812|NCT01213836|1975298|FG000|Period 1, First Intervention|Adverse Event|2
972813|NCT01213836|1975299|FG001|Period 1, First Intervention|Adverse Event|1
972814|NCT01213836|1975298|FG000|Period 1, First Intervention|Protocol Violation|0
972815|NCT01213836|1975299|FG001|Period 1, First Intervention|Protocol Violation|1
972816|NCT01213836|1975298|FG000|Period 1, First Intervention|Withdrawal by Subject|1
972817|NCT01213836|1975299|FG001|Period 1, First Intervention|Withdrawal by Subject|1
972818|NCT01213966|1975321|FG000|Overall Study|Protocol Violation|1
972819|NCT01213966|1975322|FG001|Overall Study|Protocol Violation|0
972820|NCT01213966|1975323|FG002|Overall Study|Protocol Violation|3
972821|NCT01213966|1975324|FG003|Overall Study|Protocol Violation|1
972822|NCT01214044|1975334|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
972823|NCT01214044|1975334|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3
972824|NCT01214044|1975334|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
972825|NCT01214044|1975334|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
972826|NCT01214044|1975334|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
972827|NCT01214044|1975334|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
972828|NCT01214174|1975394|FG000|Overall Study|Withdrawal by Subject|0
972829|NCT01214174|1975395|FG001|Overall Study|Withdrawal by Subject|0
972830|NCT01214174|1975396|FG002|Overall Study|Withdrawal by Subject|1
972831|NCT01214187|1975406|FG000|Overall Study|Adverse Event|6
972832|NCT01214187|1975407|FG001|Overall Study|Adverse Event|2
972833|NCT01214187|1975406|FG000|Overall Study|Death|1
972834|NCT01214187|1975407|FG001|Overall Study|Death|1
972835|NCT01214187|1975406|FG000|Overall Study|Withdrawal by Subject|0
972836|NCT01214187|1975407|FG001|Overall Study|Withdrawal by Subject|3
972837|NCT01214200|1975413|FG000|Overall Study|Did not meet inclusion/exclusion|9
972838|NCT01214200|1975413|FG000|Overall Study|Withdrawal by Subject|2
972839|NCT01214239|1975421|FG000|Overall Study|Adverse Event|3
972840|NCT01214239|1975422|FG001|Overall Study|Adverse Event|4
972841|NCT01214239|1975421|FG000|Overall Study|Protocol Violation|2
972842|NCT01214239|1975422|FG001|Overall Study|Protocol Violation|1
972843|NCT01214239|1975421|FG000|Overall Study|Lost to Follow-up|1
972844|NCT01214239|1975422|FG001|Overall Study|Lost to Follow-up|1
972845|NCT01214239|1975421|FG000|Overall Study|Withdrawal by Subject|4
972846|NCT01214239|1975422|FG001|Overall Study|Withdrawal by Subject|9
972847|NCT01214239|1975421|FG000|Overall Study|Lack of Efficacy|1
972848|NCT01214239|1975422|FG001|Overall Study|Lack of Efficacy|2
972849|NCT01214239|1975421|FG000|Overall Study|patient's private reason|1
972850|NCT01214239|1975422|FG001|Overall Study|patient's private reason|1
972851|NCT01214252|1975428|FG000|Overall Study|Not eligible per protocol|82
972852|NCT01214395|1975457|FG000|Overall Study|All patients had infection|5
972853|NCT01214421|1975466|FG000|Overall Study|Lost to Follow-up|7
972854|NCT01214421|1975467|FG001|Overall Study|Lost to Follow-up|3
972855|NCT01214421|1975468|FG002|Overall Study|Lost to Follow-up|7
972856|NCT01214421|1975469|FG003|Overall Study|Lost to Follow-up|3
972857|NCT01214421|1975466|FG000|Overall Study|Adverse Event|16
972858|NCT01214421|1975467|FG001|Overall Study|Adverse Event|35
972859|NCT01214421|1975468|FG002|Overall Study|Adverse Event|14
972860|NCT01214421|1975469|FG003|Overall Study|Adverse Event|3
972861|NCT01214421|1975466|FG000|Overall Study|Sponsor Discontinued Site|1
972862|NCT01214421|1975467|FG001|Overall Study|Sponsor Discontinued Site|2
972863|NCT01214421|1975468|FG002|Overall Study|Sponsor Discontinued Site|0
972864|NCT01214421|1975469|FG003|Overall Study|Sponsor Discontinued Site|0
972865|NCT01214421|1975466|FG000|Overall Study|Withdrawal Criteria Met|3
972866|NCT01214421|1975467|FG001|Overall Study|Withdrawal Criteria Met|0
972867|NCT01214421|1975468|FG002|Overall Study|Withdrawal Criteria Met|2
972868|NCT01214421|1975469|FG003|Overall Study|Withdrawal Criteria Met|1
972869|NCT01214421|1975466|FG000|Overall Study|Physician Decision|2
972870|NCT01214421|1975467|FG001|Overall Study|Physician Decision|0
972871|NCT01214421|1975468|FG002|Overall Study|Physician Decision|4
972872|NCT01214421|1975469|FG003|Overall Study|Physician Decision|0
972873|NCT01214421|1975466|FG000|Overall Study|Withdrawal by Subject|21
972874|NCT01214421|1975467|FG001|Overall Study|Withdrawal by Subject|18
972875|NCT01214421|1975468|FG002|Overall Study|Withdrawal by Subject|11
972876|NCT01214421|1975469|FG003|Overall Study|Withdrawal by Subject|2
972877|NCT01214434|1975481|FG000|Overall Study|Withdrawal by Subject|1
972878|NCT01214434|1975482|FG001|Overall Study|Withdrawal by Subject|0
972879|NCT01214434|1975481|FG000|Overall Study|Lost to Follow-up|2
972880|NCT01214434|1975482|FG001|Overall Study|Lost to Follow-up|2
972881|NCT01214434|1975481|FG000|Overall Study|Site error|1
972882|NCT01214434|1975482|FG001|Overall Study|Site error|0
972883|NCT01214603|1975491|FG000|Overall Study|Adverse Event|0
972884|NCT01214603|1975492|FG001|Overall Study|Adverse Event|0
972885|NCT01214603|1975493|FG002|Overall Study|Adverse Event|1
972886|NCT01214603|1975491|FG000|Overall Study|Death|1
972887|NCT01214603|1975492|FG001|Overall Study|Death|0
972888|NCT01214603|1975493|FG002|Overall Study|Death|0
972889|NCT01214603|1975491|FG000|Overall Study|Progressive Disease|4
972890|NCT01214603|1975492|FG001|Overall Study|Progressive Disease|1
972891|NCT01214603|1975493|FG002|Overall Study|Progressive Disease|3
972892|NCT01214616|1975506|FG000|Overall Study|Progressive disease|2
972893|NCT01214616|1975507|FG001|Overall Study|Progressive disease|2
972894|NCT01214616|1975508|FG002|Overall Study|Progressive disease|2
972895|NCT01214616|1975509|FG003|Overall Study|Progressive disease|4
972896|NCT01214616|1975506|FG000|Overall Study|Dose limiting toxicity|0
972897|NCT01214616|1975507|FG001|Overall Study|Dose limiting toxicity|2
972898|NCT01214616|1975508|FG002|Overall Study|Dose limiting toxicity|0
972899|NCT01214616|1975509|FG003|Overall Study|Dose limiting toxicity|0
972900|NCT01214616|1975506|FG000|Overall Study|Other adverse events|0
972901|NCT01214616|1975507|FG001|Overall Study|Other adverse events|1
972902|NCT01214616|1975508|FG002|Overall Study|Other adverse events|1
972903|NCT01214616|1975509|FG003|Overall Study|Other adverse events|1
972904|NCT01214616|1975506|FG000|Overall Study|Withdrawal by Subject|1
972905|NCT01214616|1975507|FG001|Overall Study|Withdrawal by Subject|0
972906|NCT01214616|1975508|FG002|Overall Study|Withdrawal by Subject|0
972907|NCT01214616|1975509|FG003|Overall Study|Withdrawal by Subject|1
972908|NCT01214629|1975538|FG000|Overall Study|Progressive Disease|1
972909|NCT01214629|1975539|FG001|Overall Study|Progressive Disease|1
972910|NCT01214629|1975540|FG002|Overall Study|Progressive Disease|0
972911|NCT01214629|1975541|FG003|Overall Study|Progressive Disease|1
972912|NCT01214629|1975542|FG004|Overall Study|Progressive Disease|2
972913|NCT01214629|1975543|FG005|Overall Study|Progressive Disease|3
972914|NCT01214629|1975544|FG006|Overall Study|Progressive Disease|1
972915|NCT01214629|1975545|FG007|Overall Study|Progressive Disease|1
972916|NCT01214629|1975546|FG008|Overall Study|Progressive Disease|1
972917|NCT01214629|1975547|FG009|Overall Study|Progressive Disease|5
972918|NCT01214629|1975548|FG010|Overall Study|Progressive Disease|1
972919|NCT01214629|1975538|FG000|Overall Study|Adverse Event|0
972920|NCT01214629|1975539|FG001|Overall Study|Adverse Event|0
972921|NCT01214629|1975540|FG002|Overall Study|Adverse Event|0
972922|NCT01214629|1975541|FG003|Overall Study|Adverse Event|1
972923|NCT01214629|1975542|FG004|Overall Study|Adverse Event|0
972924|NCT01214629|1975543|FG005|Overall Study|Adverse Event|1
972925|NCT01214629|1975544|FG006|Overall Study|Adverse Event|0
972926|NCT01214629|1975545|FG007|Overall Study|Adverse Event|0
972927|NCT01214629|1975546|FG008|Overall Study|Adverse Event|0
972928|NCT01214629|1975547|FG009|Overall Study|Adverse Event|1
972929|NCT01214629|1975548|FG010|Overall Study|Adverse Event|0
972930|NCT01214629|1975538|FG000|Overall Study|Physician Decision|0
972931|NCT01214629|1975539|FG001|Overall Study|Physician Decision|0
972932|NCT01214629|1975540|FG002|Overall Study|Physician Decision|0
972933|NCT01214629|1975541|FG003|Overall Study|Physician Decision|0
972934|NCT01214629|1975542|FG004|Overall Study|Physician Decision|0
972935|NCT01214629|1975543|FG005|Overall Study|Physician Decision|0
972936|NCT01214629|1975544|FG006|Overall Study|Physician Decision|0
972937|NCT01214629|1975545|FG007|Overall Study|Physician Decision|0
972938|NCT01214629|1975546|FG008|Overall Study|Physician Decision|0
972939|NCT01214629|1975547|FG009|Overall Study|Physician Decision|0
972940|NCT01214629|1975548|FG010|Overall Study|Physician Decision|1
972941|NCT01214629|1975538|FG000|Overall Study|Withdrawal by Subject|0
972942|NCT01214629|1975539|FG001|Overall Study|Withdrawal by Subject|0
972943|NCT01214629|1975540|FG002|Overall Study|Withdrawal by Subject|0
972944|NCT01214629|1975541|FG003|Overall Study|Withdrawal by Subject|0
972945|NCT01214629|1975542|FG004|Overall Study|Withdrawal by Subject|0
972946|NCT01214629|1975543|FG005|Overall Study|Withdrawal by Subject|0
972947|NCT01214629|1975544|FG006|Overall Study|Withdrawal by Subject|0
972948|NCT01214629|1975545|FG007|Overall Study|Withdrawal by Subject|0
972949|NCT01214629|1975546|FG008|Overall Study|Withdrawal by Subject|0
972950|NCT01214629|1975547|FG009|Overall Study|Withdrawal by Subject|1
972951|NCT01214629|1975548|FG010|Overall Study|Withdrawal by Subject|0
972952|NCT01214642|1975598|FG000|Overall Study|Progressive Disease|3
972953|NCT01214642|1975599|FG001|Overall Study|Progressive Disease|2
972954|NCT01214642|1975600|FG002|Overall Study|Progressive Disease|3
972955|NCT01214642|1975601|FG003|Overall Study|Progressive Disease|5
972956|NCT01214642|1975602|FG004|Overall Study|Progressive Disease|5
972957|NCT01214642|1975603|FG005|Overall Study|Progressive Disease|3
972958|NCT01214642|1975604|FG006|Overall Study|Progressive Disease|5
972959|NCT01214642|1975605|FG007|Overall Study|Progressive Disease|3
972960|NCT01214642|1975606|FG008|Overall Study|Progressive Disease|10
972961|NCT01214642|1975607|FG009|Overall Study|Progressive Disease|2
972962|NCT01214642|1975608|FG010|Overall Study|Progressive Disease|1
972963|NCT01214642|1975609|FG011|Overall Study|Progressive Disease|4
972964|NCT01214642|1975598|FG000|Overall Study|Adverse Event|0
972965|NCT01214642|1975599|FG001|Overall Study|Adverse Event|1
972966|NCT01214642|1975600|FG002|Overall Study|Adverse Event|0
972967|NCT01214642|1975601|FG003|Overall Study|Adverse Event|0
972968|NCT01214642|1975602|FG004|Overall Study|Adverse Event|0
972969|NCT01214642|1975603|FG005|Overall Study|Adverse Event|0
972970|NCT01214642|1975604|FG006|Overall Study|Adverse Event|1
972971|NCT01214642|1975605|FG007|Overall Study|Adverse Event|0
972972|NCT01214642|1975606|FG008|Overall Study|Adverse Event|0
972973|NCT01214642|1975607|FG009|Overall Study|Adverse Event|1
972974|NCT01214642|1975608|FG010|Overall Study|Adverse Event|1
972975|NCT01214642|1975609|FG011|Overall Study|Adverse Event|0
972976|NCT01214642|1975598|FG000|Overall Study|Death|0
972977|NCT01214642|1975599|FG001|Overall Study|Death|0
972978|NCT01214642|1975600|FG002|Overall Study|Death|1
972979|NCT01214642|1975601|FG003|Overall Study|Death|0
972980|NCT01214642|1975602|FG004|Overall Study|Death|0
972981|NCT01214642|1975603|FG005|Overall Study|Death|0
972982|NCT01214642|1975604|FG006|Overall Study|Death|0
972983|NCT01214642|1975605|FG007|Overall Study|Death|0
972984|NCT01214642|1975606|FG008|Overall Study|Death|0
972985|NCT01214642|1975607|FG009|Overall Study|Death|0
972986|NCT01214642|1975608|FG010|Overall Study|Death|1
972987|NCT01214642|1975609|FG011|Overall Study|Death|0
972988|NCT01214642|1975598|FG000|Overall Study|Withdrawal by Subject|0
972989|NCT01214642|1975599|FG001|Overall Study|Withdrawal by Subject|0
972990|NCT01214642|1975600|FG002|Overall Study|Withdrawal by Subject|1
972991|NCT01214642|1975601|FG003|Overall Study|Withdrawal by Subject|0
972992|NCT01214642|1975602|FG004|Overall Study|Withdrawal by Subject|0
972993|NCT01214642|1975603|FG005|Overall Study|Withdrawal by Subject|0
972994|NCT01214642|1975604|FG006|Overall Study|Withdrawal by Subject|0
972995|NCT01214642|1975605|FG007|Overall Study|Withdrawal by Subject|0
972996|NCT01214642|1975606|FG008|Overall Study|Withdrawal by Subject|3
972997|NCT01214642|1975607|FG009|Overall Study|Withdrawal by Subject|1
972998|NCT01214642|1975608|FG010|Overall Study|Withdrawal by Subject|1
972999|NCT01214642|1975609|FG011|Overall Study|Withdrawal by Subject|0
973000|NCT01214642|1975598|FG000|Overall Study|Physician Decision|0
973001|NCT01214642|1975599|FG001|Overall Study|Physician Decision|0
973002|NCT01214642|1975600|FG002|Overall Study|Physician Decision|1
973003|NCT01214642|1975601|FG003|Overall Study|Physician Decision|1
973004|NCT01214642|1975602|FG004|Overall Study|Physician Decision|1
973005|NCT01214642|1975603|FG005|Overall Study|Physician Decision|0
973006|NCT01214642|1975604|FG006|Overall Study|Physician Decision|0
973007|NCT01214642|1975605|FG007|Overall Study|Physician Decision|0
973008|NCT01214642|1975606|FG008|Overall Study|Physician Decision|0
973009|NCT01214642|1975607|FG009|Overall Study|Physician Decision|0
973010|NCT01214642|1975608|FG010|Overall Study|Physician Decision|0
973011|NCT01214642|1975609|FG011|Overall Study|Physician Decision|2
973012|NCT01214655|1975655|FG000|Part A|Progressive Disease|7
973013|NCT01214655|1975656|FG001|Part A|Progressive Disease|0
973014|NCT01214655|1975657|FG002|Part A|Progressive Disease|0
973015|NCT01214655|1975655|FG000|Part A|Physician Decision|1
973016|NCT01214655|1975656|FG001|Part A|Physician Decision|0
973017|NCT01214655|1975657|FG002|Part A|Physician Decision|0
973018|NCT01214655|1975655|FG000|Part B|Progressive disease|0
973019|NCT01214655|1975656|FG001|Part B|Progressive disease|10
973020|NCT01214655|1975657|FG002|Part B|Progressive disease|0
973021|NCT01214655|1975655|FG000|Part B|Death|0
973022|NCT01214655|1975656|FG001|Part B|Death|1
973023|NCT01214655|1975657|FG002|Part B|Death|0
973024|NCT01214655|1975655|FG000|Part B|Withdrawal by Subject|0
973025|NCT01214655|1975656|FG001|Part B|Withdrawal by Subject|2
973026|NCT01214655|1975657|FG002|Part B|Withdrawal by Subject|0
973027|NCT01214655|1975655|FG000|Part C|Progressive Disease|0
973028|NCT01214655|1975656|FG001|Part C|Progressive Disease|0
973029|NCT01214655|1975657|FG002|Part C|Progressive Disease|5
973030|NCT01214655|1975655|FG000|Part C|Death|0
973031|NCT01214655|1975656|FG001|Part C|Death|0
973032|NCT01214655|1975657|FG002|Part C|Death|1
973033|NCT01214655|1975655|FG000|Part C|Physician Decision|0
973034|NCT01214655|1975656|FG001|Part C|Physician Decision|0
973035|NCT01214655|1975657|FG002|Part C|Physician Decision|1
973036|NCT01214668|1975709|FG000|Overall Study|Adverse Event|0
973037|NCT01214668|1975710|FG001|Overall Study|Adverse Event|1
973038|NCT01214668|1975711|FG002|Overall Study|Adverse Event|0
973039|NCT01214668|1975712|FG003|Overall Study|Adverse Event|2
973040|NCT01214668|1975713|FG004|Overall Study|Adverse Event|1
973041|NCT01214668|1975714|FG005|Overall Study|Adverse Event|1
973042|NCT01214668|1975709|FG000|Overall Study|Death|0
973043|NCT01214668|1975710|FG001|Overall Study|Death|0
973044|NCT01214668|1975711|FG002|Overall Study|Death|1
973045|NCT01214668|1975712|FG003|Overall Study|Death|0
973046|NCT01214668|1975713|FG004|Overall Study|Death|0
973047|NCT01214668|1975714|FG005|Overall Study|Death|0
973048|NCT01214668|1975709|FG000|Overall Study|Progressive Disease|4
973049|NCT01214668|1975710|FG001|Overall Study|Progressive Disease|2
973050|NCT01214668|1975711|FG002|Overall Study|Progressive Disease|5
973051|NCT01214668|1975712|FG003|Overall Study|Progressive Disease|4
973052|NCT01214668|1975713|FG004|Overall Study|Progressive Disease|4
973053|NCT01214668|1975714|FG005|Overall Study|Progressive Disease|5
973054|NCT01214668|1975709|FG000|Overall Study|Withdrawal by Subject|0
973055|NCT01214668|1975710|FG001|Overall Study|Withdrawal by Subject|0
973056|NCT01214668|1975711|FG002|Overall Study|Withdrawal by Subject|0
973057|NCT01214668|1975712|FG003|Overall Study|Withdrawal by Subject|0
973058|NCT01214668|1975713|FG004|Overall Study|Withdrawal by Subject|1
973059|NCT01214668|1975714|FG005|Overall Study|Withdrawal by Subject|0
973060|NCT01214720|1975731|FG000|Overall Study|Alive and still on treatment|34
973061|NCT01214720|1975732|FG001|Overall Study|Alive and still on treatment|18
973062|NCT01214720|1975731|FG000|Overall Study|Alive and in follow-up|45
973063|NCT01214720|1975732|FG001|Overall Study|Alive and in follow-up|48
973064|NCT01214720|1975731|FG000|Overall Study|Lost to Follow-up|6
973065|NCT01214720|1975732|FG001|Overall Study|Lost to Follow-up|2
973066|NCT01214837|1975754|FG000|Overall Study|Death|0
973067|NCT01214837|1975755|FG001|Overall Study|Death|0
973068|NCT01214837|1975756|FG002|Overall Study|Death|1
973069|NCT01214837|1975754|FG000|Overall Study|Adverse Event|1
973070|NCT01214837|1975755|FG001|Overall Study|Adverse Event|2
973071|NCT01214837|1975756|FG002|Overall Study|Adverse Event|1
973072|NCT01214837|1975754|FG000|Overall Study|Withdrawal by Subject|27
973073|NCT01214837|1975755|FG001|Overall Study|Withdrawal by Subject|36
973074|NCT01214837|1975756|FG002|Overall Study|Withdrawal by Subject|28
973075|NCT01214837|1975754|FG000|Overall Study|Lost to Follow-up|20
973076|NCT01214837|1975755|FG001|Overall Study|Lost to Follow-up|15
973077|NCT01214837|1975756|FG002|Overall Study|Lost to Follow-up|21
973078|NCT01214837|1975754|FG000|Overall Study|Inappropriate Enrolment|0
973079|NCT01214837|1975755|FG001|Overall Study|Inappropriate Enrolment|1
973080|NCT01214837|1975756|FG002|Overall Study|Inappropriate Enrolment|2
973081|NCT01214837|1975754|FG000|Overall Study|Administrative Reason|2
973082|NCT01214837|1975755|FG001|Overall Study|Administrative Reason|6
973083|NCT01214837|1975756|FG002|Overall Study|Administrative Reason|4
973084|NCT01214837|1975754|FG000|Overall Study|Protocol Violation|3
973085|NCT01214837|1975755|FG001|Overall Study|Protocol Violation|1
973086|NCT01214837|1975756|FG002|Overall Study|Protocol Violation|5
973087|NCT01214837|1975754|FG000|Overall Study|Unable to Classify|1
973088|NCT01214837|1975755|FG001|Overall Study|Unable to Classify|3
973089|NCT01214837|1975756|FG002|Overall Study|Unable to Classify|0
973090|NCT01214850|1975768|FG000|Overall Study|Withdrawal by Subject|38
973091|NCT01214850|1975769|FG001|Overall Study|Withdrawal by Subject|31
973092|NCT01214850|1975770|FG002|Overall Study|Withdrawal by Subject|28
973093|NCT01214850|1975768|FG000|Overall Study|Lost to Follow-up|124
973094|NCT01214850|1975769|FG001|Overall Study|Lost to Follow-up|98
973095|NCT01214850|1975770|FG002|Overall Study|Lost to Follow-up|123
973096|NCT01214850|1975768|FG000|Overall Study|Protocol Violation|5
973097|NCT01214850|1975769|FG001|Overall Study|Protocol Violation|5
973098|NCT01214850|1975770|FG002|Overall Study|Protocol Violation|6
973099|NCT01214850|1975768|FG000|Overall Study|Adverse event or death|11
973100|NCT01214850|1975769|FG001|Overall Study|Adverse event or death|8
973101|NCT01214850|1975770|FG002|Overall Study|Adverse event or death|3
973102|NCT01214850|1975768|FG000|Overall Study|Inappropriate enrollment|2
973103|NCT01214850|1975769|FG001|Overall Study|Inappropriate enrollment|1
973104|NCT01214850|1975770|FG002|Overall Study|Inappropriate enrollment|0
973105|NCT01214850|1975768|FG000|Overall Study|Administrative reason|1
973106|NCT01214850|1975769|FG001|Overall Study|Administrative reason|0
973107|NCT01214850|1975770|FG002|Overall Study|Administrative reason|0
973108|NCT01214850|1975768|FG000|Overall Study|Unable to classify|2
973109|NCT01214850|1975769|FG001|Overall Study|Unable to classify|1
973110|NCT01214850|1975770|FG002|Overall Study|Unable to classify|1
973111|NCT01214915|1975781|FG000|Overall Study|Adverse Event|8
973112|NCT01214915|1975781|FG000|Overall Study|Lack of Efficacy|3
973113|NCT01215032|1975794|FG000|Overall Study|Adverse Event|3
973114|NCT01215032|1975794|FG000|Overall Study|Lack of Efficacy|17
973115|NCT01215097|1975802|FG000|Overall Study|Adverse Event|1
973116|NCT01215097|1975803|FG001|Overall Study|Adverse Event|3
973117|NCT01215097|1975802|FG000|Overall Study|Protocol Violation|0
973118|NCT01215097|1975803|FG001|Overall Study|Protocol Violation|2
973119|NCT01215097|1975802|FG000|Overall Study|Lost to Follow-up|2
973120|NCT01215097|1975803|FG001|Overall Study|Lost to Follow-up|0
973121|NCT01215097|1975802|FG000|Overall Study|Withdrawal by Subject|6
973122|NCT01215097|1975803|FG001|Overall Study|Withdrawal by Subject|3
973123|NCT01215097|1975802|FG000|Overall Study|Lack of Efficacy|0
973124|NCT01215097|1975803|FG001|Overall Study|Lack of Efficacy|3
973125|NCT01215097|1975802|FG000|Overall Study|patient's refusal to come|2
973126|NCT01215097|1975803|FG001|Overall Study|patient's refusal to come|2
973127|NCT01215097|1975802|FG000|Overall Study|patient's private reason|1
973128|NCT01215097|1975803|FG001|Overall Study|patient's private reason|1
973129|NCT01215175|1975843|FG000|Overall Study|Lost to Follow-up|0
973130|NCT01215175|1975844|FG001|Overall Study|Lost to Follow-up|1
973131|NCT01215175|1975845|FG002|Overall Study|Lost to Follow-up|0
973132|NCT01215175|1975846|FG003|Overall Study|Lost to Follow-up|1
973133|NCT01215175|1975847|FG004|Overall Study|Lost to Follow-up|0
973134|NCT01215188|1975862|FG000|Overall Study|Lost to Follow-up|22
973135|NCT01215188|1975863|FG001|Overall Study|Lost to Follow-up|22
973136|NCT01215188|1975864|FG002|Overall Study|Lost to Follow-up|16
973137|NCT01215188|1975862|FG000|Overall Study|Adverse Event|1
973138|NCT01215188|1975863|FG001|Overall Study|Adverse Event|1
973139|NCT01215188|1975864|FG002|Overall Study|Adverse Event|3
973140|NCT01215188|1975862|FG000|Overall Study|Physician Decision|2
973141|NCT01215188|1975863|FG001|Overall Study|Physician Decision|1
973142|NCT01215188|1975864|FG002|Overall Study|Physician Decision|0
973143|NCT01215188|1975862|FG000|Overall Study|Lack of Efficacy|0
973144|NCT01215188|1975863|FG001|Overall Study|Lack of Efficacy|0
973145|NCT01215188|1975864|FG002|Overall Study|Lack of Efficacy|1
973146|NCT01215188|1975862|FG000|Overall Study|Protocol Violation|1
973147|NCT01215188|1975863|FG001|Overall Study|Protocol Violation|1
973148|NCT01215188|1975864|FG002|Overall Study|Protocol Violation|1
973149|NCT01215188|1975862|FG000|Overall Study|Withdrawal by Subject|32
973150|NCT01215188|1975863|FG001|Overall Study|Withdrawal by Subject|34
973151|NCT01215188|1975864|FG002|Overall Study|Withdrawal by Subject|31
973152|NCT01215227|1975878|FG000|Overall Study|Adverse Event|11
973153|NCT01215227|1975879|FG001|Overall Study|Adverse Event|11
973154|NCT01215227|1975880|FG002|Overall Study|Adverse Event|4
973155|NCT01215227|1975881|FG003|Overall Study|Adverse Event|8
973156|NCT01215227|1975882|FG004|Overall Study|Adverse Event|7
973157|NCT01215227|1975883|FG005|Overall Study|Adverse Event|6
973158|NCT01215227|1975878|FG000|Overall Study|Treatment Failure|8
973159|NCT01215227|1975879|FG001|Overall Study|Treatment Failure|4
973160|NCT01215227|1975880|FG002|Overall Study|Treatment Failure|1
973161|NCT01215227|1975881|FG003|Overall Study|Treatment Failure|5
973162|NCT01215227|1975882|FG004|Overall Study|Treatment Failure|1
973163|NCT01215227|1975883|FG005|Overall Study|Treatment Failure|1
973164|NCT01215227|1975878|FG000|Overall Study|Lost to Follow-up|1
973165|NCT01215227|1975879|FG001|Overall Study|Lost to Follow-up|4
973166|NCT01215227|1975880|FG002|Overall Study|Lost to Follow-up|1
973167|NCT01215227|1975881|FG003|Overall Study|Lost to Follow-up|1
973168|NCT01215227|1975882|FG004|Overall Study|Lost to Follow-up|1
973169|NCT01215227|1975883|FG005|Overall Study|Lost to Follow-up|2
973170|NCT01215227|1975878|FG000|Overall Study|Subject Withdrew Consent|16
973171|NCT01215227|1975879|FG001|Overall Study|Subject Withdrew Consent|20
973172|NCT01215227|1975880|FG002|Overall Study|Subject Withdrew Consent|7
973173|NCT01215227|1975881|FG003|Overall Study|Subject Withdrew Consent|10
973174|NCT01215227|1975882|FG004|Overall Study|Subject Withdrew Consent|11
973175|NCT01215227|1975883|FG005|Overall Study|Subject Withdrew Consent|8
973176|NCT01215227|1975878|FG000|Overall Study|Non-Compliance With Protocol|2
973177|NCT01215227|1975879|FG001|Overall Study|Non-Compliance With Protocol|6
973178|NCT01215227|1975880|FG002|Overall Study|Non-Compliance With Protocol|1
973179|NCT01215227|1975881|FG003|Overall Study|Non-Compliance With Protocol|0
973180|NCT01215227|1975882|FG004|Overall Study|Non-Compliance With Protocol|0
973181|NCT01215227|1975883|FG005|Overall Study|Non-Compliance With Protocol|0
973182|NCT01215227|1975878|FG000|Overall Study|Administrative|83
973183|NCT01215227|1975879|FG001|Overall Study|Administrative|73
973184|NCT01215227|1975880|FG002|Overall Study|Administrative|42
973185|NCT01215227|1975881|FG003|Overall Study|Administrative|24
973186|NCT01215227|1975882|FG004|Overall Study|Administrative|28
973187|NCT01215227|1975883|FG005|Overall Study|Administrative|40
973188|NCT01215227|1975878|FG000|Overall Study|Missing Status|0
973189|NCT01215227|1975879|FG001|Overall Study|Missing Status|1
973190|NCT01215227|1975880|FG002|Overall Study|Missing Status|0
973191|NCT01215227|1975881|FG003|Overall Study|Missing Status|0
973192|NCT01215227|1975882|FG004|Overall Study|Missing Status|0
973193|NCT01215227|1975883|FG005|Overall Study|Missing Status|0
973194|NCT01215227|1975878|FG000|Overall Study|Randomized but not treated|0
973195|NCT01215227|1975879|FG001|Overall Study|Randomized but not treated|0
973196|NCT01215227|1975880|FG002|Overall Study|Randomized but not treated|1
973197|NCT01215227|1975881|FG003|Overall Study|Randomized but not treated|1
973198|NCT01215227|1975882|FG004|Overall Study|Randomized but not treated|0
973199|NCT01215227|1975883|FG005|Overall Study|Randomized but not treated|1
973200|NCT01215253|1975908|FG000|Overall Study|Withdrawal by Subject|57
973201|NCT01215253|1975909|FG001|Overall Study|Withdrawal by Subject|35
973202|NCT01215253|1975908|FG000|Overall Study|Physician Decision|9
973203|NCT01215253|1975909|FG001|Overall Study|Physician Decision|12
973204|NCT01215253|1975908|FG000|Overall Study|Lost to Follow-up|6
973205|NCT01215253|1975909|FG001|Overall Study|Lost to Follow-up|4
973206|NCT01215253|1975908|FG000|Overall Study|Other|14
973207|NCT01215253|1975909|FG001|Overall Study|Other|12
973208|NCT01215357|1975976|FG000|Overall Study|Withdrawal by Subject|3
973209|NCT01215357|1975976|FG000|Overall Study|Protocol Violation|9
973210|NCT01215422|1975984|FG000|Overall Study|Relocation|1
973211|NCT01215422|1975985|FG001|Overall Study|Relocation|0
973212|NCT01215422|1975986|FG002|Overall Study|Relocation|0
973213|NCT01215422|1975987|FG003|Overall Study|Relocation|0
973214|NCT01215422|1975984|FG000|Overall Study|Failed intubations|0
973215|NCT01215422|1975985|FG001|Overall Study|Failed intubations|0
973216|NCT01215422|1975986|FG002|Overall Study|Failed intubations|3
973217|NCT01215422|1975987|FG003|Overall Study|Failed intubations|8
973218|NCT01215422|1975984|FG000|Overall Study|Did not complete all intubations|7
973219|NCT01215422|1975985|FG001|Overall Study|Did not complete all intubations|0
973220|NCT01215422|1975986|FG002|Overall Study|Did not complete all intubations|0
973221|NCT01215422|1975987|FG003|Overall Study|Did not complete all intubations|0
973222|NCT01215435|1976011|FG000|Overall Study|Adverse Event|1
973223|NCT01215435|1976012|FG001|Overall Study|Adverse Event|0
973224|NCT01215435|1976011|FG000|Overall Study|Protocol Violation|2
973225|NCT01215435|1976012|FG001|Overall Study|Protocol Violation|0
973226|NCT01215435|1976011|FG000|Overall Study|Withdrawal Criteria|8
973227|NCT01215435|1976012|FG001|Overall Study|Withdrawal Criteria|11
973228|NCT01215435|1976011|FG000|Overall Study|Lost to Follow-up|3
973229|NCT01215435|1976012|FG001|Overall Study|Lost to Follow-up|0
973230|NCT01215435|1976011|FG000|Overall Study|Unclassified|5
973231|NCT01215435|1976012|FG001|Overall Study|Unclassified|5
973232|NCT01215513|1976018|FG000|Overall Study|Not completed CS42|9
973233|NCT01215513|1976018|FG000|Overall Study|Not enrolled from CS42 to CS42A|21
973234|NCT01215513|1976018|FG000|Overall Study|Adverse event (CS42A)|2
973235|NCT01215513|1976018|FG000|Overall Study|Physician decision (CS42A)|6
973236|NCT01215513|1976018|FG000|Overall Study|Withdrawal by subject (CS42A)|5
973237|NCT01215513|1976018|FG000|Overall Study|Miscellaneous reasons (CS42A)|2
973238|NCT01215721|1976058|FG000|Overall Study|Adverse Event|2
973239|NCT01215734|1976064|FG000|Overall Study|Death|0
973240|NCT01215734|1976065|FG001|Overall Study|Death|1
973241|NCT01215851|1976090|FG000|Treatment Period|Adverse Event|1
973242|NCT01215851|1976091|FG001|Treatment Period|Adverse Event|1
973243|NCT01215851|1976092|FG002|Treatment Period|Adverse Event|1
973244|NCT01215851|1976093|FG003|Treatment Period|Adverse Event|3
973245|NCT01215851|1976094|FG004|Treatment Period|Adverse Event|0
973246|NCT01215851|1976095|FG005|Treatment Period|Adverse Event|1
973247|NCT01215851|1976090|FG000|Follow up Period|Lost to Follow-up|0
973248|NCT01215851|1976091|FG001|Follow up Period|Lost to Follow-up|0
973249|NCT01215851|1976092|FG002|Follow up Period|Lost to Follow-up|0
973250|NCT01215851|1976093|FG003|Follow up Period|Lost to Follow-up|0
973251|NCT01215851|1976094|FG004|Follow up Period|Lost to Follow-up|0
973252|NCT01215851|1976095|FG005|Follow up Period|Lost to Follow-up|1
973253|NCT01215916|1976119|FG000|Overall Study|Progressive Disease|0
973254|NCT01215916|1976120|FG001|Overall Study|Progressive Disease|2
973255|NCT01215916|1976121|FG002|Overall Study|Progressive Disease|1
973256|NCT01215916|1976122|FG003|Overall Study|Progressive Disease|2
973257|NCT01215916|1976123|FG004|Overall Study|Progressive Disease|5
973258|NCT01215916|1976124|FG005|Overall Study|Progressive Disease|4
973259|NCT01215916|1976125|FG006|Overall Study|Progressive Disease|5
973260|NCT01215916|1976126|FG007|Overall Study|Progressive Disease|3
973261|NCT01215916|1976127|FG008|Overall Study|Progressive Disease|1
973262|NCT01215916|1976119|FG000|Overall Study|Adverse Event|1
973263|NCT01215916|1976120|FG001|Overall Study|Adverse Event|1
973264|NCT01215916|1976121|FG002|Overall Study|Adverse Event|0
973265|NCT01215916|1976122|FG003|Overall Study|Adverse Event|1
973266|NCT01215916|1976123|FG004|Overall Study|Adverse Event|0
973267|NCT01215916|1976124|FG005|Overall Study|Adverse Event|0
973268|NCT01215916|1976125|FG006|Overall Study|Adverse Event|3
973269|NCT01215916|1976126|FG007|Overall Study|Adverse Event|0
973270|NCT01215916|1976127|FG008|Overall Study|Adverse Event|0
973271|NCT01215916|1976119|FG000|Overall Study|Withdrawal by Subject|0
973272|NCT01215916|1976120|FG001|Overall Study|Withdrawal by Subject|1
973273|NCT01215916|1976121|FG002|Overall Study|Withdrawal by Subject|1
973274|NCT01215916|1976122|FG003|Overall Study|Withdrawal by Subject|2
973275|NCT01215916|1976123|FG004|Overall Study|Withdrawal by Subject|0
973276|NCT01215916|1976124|FG005|Overall Study|Withdrawal by Subject|0
973277|NCT01215916|1976125|FG006|Overall Study|Withdrawal by Subject|1
973278|NCT01215916|1976126|FG007|Overall Study|Withdrawal by Subject|0
973279|NCT01215916|1976127|FG008|Overall Study|Withdrawal by Subject|0
973280|NCT01215916|1976119|FG000|Overall Study|Death|0
973281|NCT01215916|1976120|FG001|Overall Study|Death|1
973282|NCT01215916|1976121|FG002|Overall Study|Death|0
973283|NCT01215916|1976122|FG003|Overall Study|Death|0
973284|NCT01215916|1976123|FG004|Overall Study|Death|1
973285|NCT01215916|1976124|FG005|Overall Study|Death|0
973286|NCT01215916|1976125|FG006|Overall Study|Death|0
973287|NCT01215916|1976126|FG007|Overall Study|Death|0
973288|NCT01215916|1976127|FG008|Overall Study|Death|1
973289|NCT01215916|1976119|FG000|Overall Study|Physician Decision|0
973290|NCT01215916|1976120|FG001|Overall Study|Physician Decision|0
973291|NCT01215916|1976121|FG002|Overall Study|Physician Decision|1
973292|NCT01215916|1976122|FG003|Overall Study|Physician Decision|1
973293|NCT01215916|1976123|FG004|Overall Study|Physician Decision|0
973294|NCT01215916|1976124|FG005|Overall Study|Physician Decision|0
973295|NCT01215916|1976125|FG006|Overall Study|Physician Decision|0
973296|NCT01215916|1976126|FG007|Overall Study|Physician Decision|0
973297|NCT01215916|1976127|FG008|Overall Study|Physician Decision|0
973298|NCT01215942|1976162|FG000|Treatment Period|Adverse Event|15
973299|NCT01215942|1976163|FG001|Treatment Period|Adverse Event|26
973300|NCT01215942|1976162|FG000|Treatment Period|Death|2
973301|NCT01215942|1976163|FG001|Treatment Period|Death|4
973302|NCT01215942|1976162|FG000|Treatment Period|Lack of Efficacy|23
973303|NCT01215942|1976163|FG001|Treatment Period|Lack of Efficacy|62
973304|NCT01215942|1976162|FG000|Treatment Period|Lost to Follow-up|3
973305|NCT01215942|1976163|FG001|Treatment Period|Lost to Follow-up|4
973306|NCT01215942|1976162|FG000|Treatment Period|Withdrawal by Subject|17
973307|NCT01215942|1976163|FG001|Treatment Period|Withdrawal by Subject|40
973308|NCT01215942|1976162|FG000|Treatment Period|Physician Decision|5
973309|NCT01215942|1976163|FG001|Treatment Period|Physician Decision|5
973310|NCT01215942|1976162|FG000|Treatment Period|Protocol Violation|0
973311|NCT01215942|1976163|FG001|Treatment Period|Protocol Violation|1
973312|NCT01215942|1976162|FG000|Treatment Period|Sponsor Decision|349
973313|NCT01215942|1976163|FG001|Treatment Period|Sponsor Decision|530
973314|NCT01215942|1976162|FG000|Post-Treatment Follow-Up Period|Death|0
973315|NCT01215942|1976163|FG001|Post-Treatment Follow-Up Period|Death|1
973316|NCT01215942|1976162|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13
973317|NCT01215942|1976163|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13
973318|NCT01215942|1976162|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
973319|NCT01215942|1976163|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
973320|NCT01215942|1976162|FG000|Post-Treatment Follow-Up Period|Physician Decision|1
973321|NCT01215942|1976163|FG001|Post-Treatment Follow-Up Period|Physician Decision|2
973322|NCT01215942|1976162|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28
973323|NCT01215942|1976163|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61
973324|NCT01215955|1976184|FG000|Overall Study|Adverse Event|1
973325|NCT01215955|1976185|FG001|Overall Study|Adverse Event|4
973326|NCT01215955|1976186|FG002|Overall Study|Adverse Event|2
973327|NCT01215955|1976187|FG003|Overall Study|Adverse Event|3
973328|NCT01215955|1976184|FG000|Overall Study|Death|2
973329|NCT01215955|1976185|FG001|Overall Study|Death|0
973330|NCT01215955|1976186|FG002|Overall Study|Death|1
973331|NCT01215955|1976187|FG003|Overall Study|Death|3
973332|NCT01215955|1976184|FG000|Overall Study|Entry Criteria Not Met|1
973333|NCT01215955|1976185|FG001|Overall Study|Entry Criteria Not Met|3
973334|NCT01215955|1976186|FG002|Overall Study|Entry Criteria Not Met|4
973335|NCT01215955|1976187|FG003|Overall Study|Entry Criteria Not Met|7
973336|NCT01215955|1976184|FG000|Overall Study|Lack of Efficacy|1
973337|NCT01215955|1976185|FG001|Overall Study|Lack of Efficacy|2
973338|NCT01215955|1976186|FG002|Overall Study|Lack of Efficacy|1
973339|NCT01215955|1976187|FG003|Overall Study|Lack of Efficacy|0
973340|NCT01215955|1976184|FG000|Overall Study|Lost to Follow-up|4
973341|NCT01215955|1976185|FG001|Overall Study|Lost to Follow-up|4
973342|NCT01215955|1976186|FG002|Overall Study|Lost to Follow-up|8
973343|NCT01215955|1976187|FG003|Overall Study|Lost to Follow-up|9
973344|NCT01215955|1976184|FG000|Overall Study|Physician Decision|4
973345|NCT01215955|1976185|FG001|Overall Study|Physician Decision|10
973346|NCT01215955|1976186|FG002|Overall Study|Physician Decision|8
973347|NCT01215955|1976187|FG003|Overall Study|Physician Decision|11
973348|NCT01215955|1976184|FG000|Overall Study|Protocol Violation|17
973349|NCT01215955|1976185|FG001|Overall Study|Protocol Violation|13
973350|NCT01215955|1976186|FG002|Overall Study|Protocol Violation|8
973351|NCT01215955|1976187|FG003|Overall Study|Protocol Violation|8
973352|NCT01215955|1976184|FG000|Overall Study|Sponsor Decision|1
973353|NCT01215955|1976185|FG001|Overall Study|Sponsor Decision|2
973354|NCT01215955|1976186|FG002|Overall Study|Sponsor Decision|0
973355|NCT01215955|1976187|FG003|Overall Study|Sponsor Decision|1
973356|NCT01215955|1976184|FG000|Overall Study|Withdrawal by Subject|14
973357|NCT01215955|1976185|FG001|Overall Study|Withdrawal by Subject|15
973358|NCT01215955|1976186|FG002|Overall Study|Withdrawal by Subject|13
973359|NCT01215955|1976187|FG003|Overall Study|Withdrawal by Subject|9
973360|NCT01215955|1976184|FG000|Overall Study|Quality Issues|0
973361|NCT01215955|1976185|FG001|Overall Study|Quality Issues|0
973362|NCT01215955|1976186|FG002|Overall Study|Quality Issues|3
973363|NCT01215955|1976187|FG003|Overall Study|Quality Issues|2
973364|NCT01215968|1976202|FG000|Overall Study|Adverse Event|0
973365|NCT01215968|1976203|FG001|Overall Study|Adverse Event|2
973366|NCT01215968|1976202|FG000|Overall Study|Protocol Violation|2
973367|NCT01215968|1976203|FG001|Overall Study|Protocol Violation|4
973368|NCT01215968|1976202|FG000|Overall Study|Not received study drug|0
973369|NCT01215968|1976203|FG001|Overall Study|Not received study drug|1
973370|NCT01215981|1976214|FG000|Overall Study|Physician Decision|0
973371|NCT01215981|1976215|FG001|Overall Study|Physician Decision|1
973372|NCT01215981|1976214|FG000|Overall Study|Protocol Violation|1
973373|NCT01215981|1976215|FG001|Overall Study|Protocol Violation|0
973374|NCT01215981|1976214|FG000|Overall Study|Withdrawal by Subject|1
973375|NCT01215981|1976215|FG001|Overall Study|Withdrawal by Subject|0
973376|NCT01216072|1976223|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40
973377|NCT01216072|1976224|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4
973378|NCT01216072|1976223|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
973379|NCT01216072|1976224|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
973380|NCT01216072|1976223|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
973381|NCT01216072|1976224|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
973382|NCT01216072|1976223|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
973383|NCT01216072|1976224|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
973384|NCT01216072|1976223|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
973385|NCT01216072|1976224|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
973386|NCT01216072|1976223|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
973387|NCT01216072|1976224|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
973388|NCT01216072|1976223|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
973389|NCT01216072|1976224|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
973390|NCT01216072|1976223|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0
973391|NCT01216072|1976224|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10
973392|NCT01216072|1976223|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
973393|NCT01216072|1976224|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
973394|NCT01216072|1976223|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
973395|NCT01216072|1976224|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
973396|NCT01216163|1976236|FG000|Overall Study|Withdrawal by Subject|1
973397|NCT01216163|1976237|FG001|Overall Study|Withdrawal by Subject|1
973398|NCT01216163|1976238|FG002|Overall Study|Withdrawal by Subject|0
973399|NCT01216176|1976249|FG000|Overall Study|Adverse Event|0
973400|NCT01216176|1976250|FG001|Overall Study|Adverse Event|8
973401|NCT01216176|1976251|FG002|Overall Study|Adverse Event|0
973402|NCT01216176|1976249|FG000|Overall Study|Physician Decision|0
973403|NCT01216176|1976250|FG001|Overall Study|Physician Decision|0
973404|NCT01216176|1976251|FG002|Overall Study|Physician Decision|1
973405|NCT01216189|1976262|FG000|Overall Study|Lost to Follow-up|21
973406|NCT01216189|1976263|FG001|Overall Study|Lost to Follow-up|3
973407|NCT01216189|1976262|FG000|Overall Study|Death|4
973408|NCT01216189|1976263|FG001|Overall Study|Death|2
973409|NCT01216202|1976271|FG000|Overall Study|Withdrawal by Subject|8
973410|NCT01216202|1976272|FG001|Overall Study|Withdrawal by Subject|0
973411|NCT01216202|1976271|FG000|Overall Study|Death|0
973412|NCT01216202|1976272|FG001|Overall Study|Death|2
973413|NCT01216202|1976271|FG000|Overall Study|Lost to Follow-up|14
973414|NCT01216202|1976272|FG001|Overall Study|Lost to Follow-up|0
973415|NCT01216319|1976289|FG000|Overall Study|Lost to Follow-up|2
973416|NCT01216319|1976289|FG000|Overall Study|Unanticipated chemo for breast cancer|2
973417|NCT01216332|1976295|FG000|Overall Study|Withdrawal by Subject|4
973418|NCT01216332|1976296|FG001|Overall Study|Withdrawal by Subject|0
973419|NCT01216683|1976325|FG000|Induction|Never started treatment|0
973420|NCT01216683|1976326|FG001|Induction|Never started treatment|6
973421|NCT01216683|1976327|FG002|Induction|Never started treatment|3
973422|NCT01216683|1976325|FG000|Induction|Lack of Efficacy|4
973423|NCT01216683|1976326|FG001|Induction|Lack of Efficacy|3
973424|NCT01216683|1976327|FG002|Induction|Lack of Efficacy|7
973425|NCT01216683|1976325|FG000|Induction|Adverse Event|0
973426|NCT01216683|1976326|FG001|Induction|Adverse Event|5
973427|NCT01216683|1976327|FG002|Induction|Adverse Event|5
973428|NCT01216683|1976325|FG000|Induction|Death|0
973429|NCT01216683|1976326|FG001|Induction|Death|0
973430|NCT01216683|1976327|FG002|Induction|Death|2
973431|NCT01216683|1976325|FG000|Induction|Withdrawal by Subject|0
973432|NCT01216683|1976326|FG001|Induction|Withdrawal by Subject|4
973433|NCT01216683|1976327|FG002|Induction|Withdrawal by Subject|2
973434|NCT01216683|1976325|FG000|Induction|Other disease|0
973435|NCT01216683|1976326|FG001|Induction|Other disease|1
973436|NCT01216683|1976327|FG002|Induction|Other disease|2
973437|NCT01216683|1976325|FG000|Continuation|Lack of Efficacy|3
973438|NCT01216683|1976326|FG001|Continuation|Lack of Efficacy|2
973439|NCT01216683|1976327|FG002|Continuation|Lack of Efficacy|7
973440|NCT01216683|1976325|FG000|Continuation|Adverse Event|5
973441|NCT01216683|1976326|FG001|Continuation|Adverse Event|3
973442|NCT01216683|1976327|FG002|Continuation|Adverse Event|16
973443|NCT01216683|1976325|FG000|Continuation|Death|1
973444|NCT01216683|1976326|FG001|Continuation|Death|0
973445|NCT01216683|1976327|FG002|Continuation|Death|2
973446|NCT01216683|1976325|FG000|Continuation|Withdrawal by Subject|4
973447|NCT01216683|1976326|FG001|Continuation|Withdrawal by Subject|5
973448|NCT01216683|1976327|FG002|Continuation|Withdrawal by Subject|9
973449|NCT01216683|1976325|FG000|Continuation|Other diseases|0
973450|NCT01216683|1976326|FG001|Continuation|Other diseases|2
973451|NCT01216683|1976327|FG002|Continuation|Other diseases|1
973452|NCT01216683|1976325|FG000|Continuation|Physician Decision|1
973453|NCT01216683|1976326|FG001|Continuation|Physician Decision|0
973454|NCT01216683|1976327|FG002|Continuation|Physician Decision|1
973455|NCT01216683|1976325|FG000|Continuation|Non-compliance|1
973456|NCT01216683|1976326|FG001|Continuation|Non-compliance|0
973457|NCT01216683|1976327|FG002|Continuation|Non-compliance|1
973458|NCT01216683|1976325|FG000|Continuation|Insurance change|0
973459|NCT01216683|1976326|FG001|Continuation|Insurance change|1
973460|NCT01216683|1976327|FG002|Continuation|Insurance change|0
973461|NCT01216683|1976325|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0
973462|NCT01216683|1976326|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1
973463|NCT01216683|1976327|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0
973464|NCT01216683|1976325|FG000|Continuation|Not reported|0
973465|NCT01216683|1976326|FG001|Continuation|Not reported|0
973466|NCT01216683|1976327|FG002|Continuation|Not reported|1
973467|NCT01216683|1976325|FG000|Continuation|Never started treatment|0
973468|NCT01216683|1976326|FG001|Continuation|Never started treatment|1
973469|NCT01216683|1976327|FG002|Continuation|Never started treatment|5
973470|NCT01217073|1976381|FG000|Base Period|Adverse Event|1
973471|NCT01217073|1976382|FG001|Base Period|Adverse Event|0
973472|NCT01217073|1976383|FG002|Base Period|Adverse Event|1
973473|NCT01217073|1976384|FG003|Base Period|Adverse Event|0
973474|NCT01217073|1976385|FG004|Base Period|Adverse Event|4
973475|NCT01217073|1976386|FG005|Base Period|Adverse Event|1
973476|NCT01217073|1976387|FG006|Base Period|Adverse Event|0
973477|NCT01217073|1976388|FG007|Base Period|Adverse Event|0
973478|NCT01217073|1976381|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1
973479|NCT01217073|1976382|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0
973480|NCT01217073|1976383|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0
973481|NCT01217073|1976384|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0
973482|NCT01217073|1976385|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0
973483|NCT01217073|1976386|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0
973484|NCT01217073|1976387|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0
973485|NCT01217073|1976388|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0
973486|NCT01217073|1976381|FG000|Base Period|Excluded medication|0
973487|NCT01217073|1976382|FG001|Base Period|Excluded medication|0
973488|NCT01217073|1976383|FG002|Base Period|Excluded medication|0
973489|NCT01217073|1976384|FG003|Base Period|Excluded medication|0
973490|NCT01217073|1976385|FG004|Base Period|Excluded medication|1
973491|NCT01217073|1976386|FG005|Base Period|Excluded medication|0
973492|NCT01217073|1976387|FG006|Base Period|Excluded medication|0
973493|NCT01217073|1976388|FG007|Base Period|Excluded medication|0
973494|NCT01217073|1976381|FG000|Base Period|Lack of Efficacy|0
973495|NCT01217073|1976382|FG001|Base Period|Lack of Efficacy|0
973496|NCT01217073|1976383|FG002|Base Period|Lack of Efficacy|0
973497|NCT01217073|1976384|FG003|Base Period|Lack of Efficacy|0
973498|NCT01217073|1976385|FG004|Base Period|Lack of Efficacy|0
973499|NCT01217073|1976386|FG005|Base Period|Lack of Efficacy|1
973500|NCT01217073|1976387|FG006|Base Period|Lack of Efficacy|0
973501|NCT01217073|1976388|FG007|Base Period|Lack of Efficacy|0
973502|NCT01217073|1976381|FG000|Base Period|Lost to Follow-up|0
973503|NCT01217073|1976382|FG001|Base Period|Lost to Follow-up|0
973504|NCT01217073|1976383|FG002|Base Period|Lost to Follow-up|1
973505|NCT01217073|1976384|FG003|Base Period|Lost to Follow-up|1
973506|NCT01217073|1976385|FG004|Base Period|Lost to Follow-up|3
973507|NCT01217073|1976386|FG005|Base Period|Lost to Follow-up|0
973508|NCT01217073|1976387|FG006|Base Period|Lost to Follow-up|0
973509|NCT01217073|1976388|FG007|Base Period|Lost to Follow-up|0
973510|NCT01217073|1976381|FG000|Base Period|Physician Decision|0
973511|NCT01217073|1976382|FG001|Base Period|Physician Decision|0
973512|NCT01217073|1976383|FG002|Base Period|Physician Decision|0
973513|NCT01217073|1976384|FG003|Base Period|Physician Decision|0
973514|NCT01217073|1976385|FG004|Base Period|Physician Decision|1
973515|NCT01217073|1976386|FG005|Base Period|Physician Decision|0
973516|NCT01217073|1976387|FG006|Base Period|Physician Decision|0
973517|NCT01217073|1976388|FG007|Base Period|Physician Decision|0
973518|NCT01217073|1976381|FG000|Base Period|Protocol Violation|1
973519|NCT01217073|1976382|FG001|Base Period|Protocol Violation|0
973520|NCT01217073|1976383|FG002|Base Period|Protocol Violation|0
973521|NCT01217073|1976384|FG003|Base Period|Protocol Violation|0
973522|NCT01217073|1976385|FG004|Base Period|Protocol Violation|1
973523|NCT01217073|1976386|FG005|Base Period|Protocol Violation|2
973524|NCT01217073|1976387|FG006|Base Period|Protocol Violation|0
973525|NCT01217073|1976388|FG007|Base Period|Protocol Violation|0
973526|NCT01217073|1976381|FG000|Base Period|Withdrawal by Subject|4
973527|NCT01217073|1976382|FG001|Base Period|Withdrawal by Subject|5
973528|NCT01217073|1976383|FG002|Base Period|Withdrawal by Subject|5
973529|NCT01217073|1976384|FG003|Base Period|Withdrawal by Subject|1
973530|NCT01217073|1976385|FG004|Base Period|Withdrawal by Subject|5
973531|NCT01217073|1976386|FG005|Base Period|Withdrawal by Subject|5
973532|NCT01217073|1976387|FG006|Base Period|Withdrawal by Subject|0
973533|NCT01217073|1976388|FG007|Base Period|Withdrawal by Subject|0
973534|NCT01217073|1976381|FG000|Extension Period|Adverse Event|0
973535|NCT01217073|1976382|FG001|Extension Period|Adverse Event|0
973536|NCT01217073|1976383|FG002|Extension Period|Adverse Event|0
973537|NCT01217073|1976384|FG003|Extension Period|Adverse Event|0
973538|NCT01217073|1976385|FG004|Extension Period|Adverse Event|0
973539|NCT01217073|1976386|FG005|Extension Period|Adverse Event|0
973540|NCT01217073|1976387|FG006|Extension Period|Adverse Event|19
973541|NCT01217073|1976388|FG007|Extension Period|Adverse Event|5
973542|NCT01217073|1976381|FG000|Extension Period|ALT/AST|0
973543|NCT01217073|1976382|FG001|Extension Period|ALT/AST|0
973544|NCT01217073|1976383|FG002|Extension Period|ALT/AST|0
973545|NCT01217073|1976384|FG003|Extension Period|ALT/AST|0
973546|NCT01217073|1976385|FG004|Extension Period|ALT/AST|0
973547|NCT01217073|1976386|FG005|Extension Period|ALT/AST|0
973548|NCT01217073|1976387|FG006|Extension Period|ALT/AST|2
973549|NCT01217073|1976388|FG007|Extension Period|ALT/AST|0
973550|NCT01217073|1976381|FG000|Extension Period|Contraindication to study medication|0
973551|NCT01217073|1976382|FG001|Extension Period|Contraindication to study medication|0
973552|NCT01217073|1976383|FG002|Extension Period|Contraindication to study medication|0
973553|NCT01217073|1976384|FG003|Extension Period|Contraindication to study medication|0
973554|NCT01217073|1976385|FG004|Extension Period|Contraindication to study medication|0
973555|NCT01217073|1976386|FG005|Extension Period|Contraindication to study medication|0
973556|NCT01217073|1976387|FG006|Extension Period|Contraindication to study medication|1
973557|NCT01217073|1976388|FG007|Extension Period|Contraindication to study medication|0
973558|NCT01217073|1976381|FG000|Extension Period|Creatinine/eGFR|0
973559|NCT01217073|1976382|FG001|Extension Period|Creatinine/eGFR|0
973560|NCT01217073|1976383|FG002|Extension Period|Creatinine/eGFR|0
973561|NCT01217073|1976384|FG003|Extension Period|Creatinine/eGFR|0
973562|NCT01217073|1976385|FG004|Extension Period|Creatinine/eGFR|0
973563|NCT01217073|1976386|FG005|Extension Period|Creatinine/eGFR|0
973564|NCT01217073|1976387|FG006|Extension Period|Creatinine/eGFR|11
973565|NCT01217073|1976388|FG007|Extension Period|Creatinine/eGFR|1
973566|NCT01217073|1976381|FG000|Extension Period|Death|0
973567|NCT01217073|1976382|FG001|Extension Period|Death|0
973568|NCT01217073|1976383|FG002|Extension Period|Death|0
973569|NCT01217073|1976384|FG003|Extension Period|Death|0
973570|NCT01217073|1976385|FG004|Extension Period|Death|0
973571|NCT01217073|1976386|FG005|Extension Period|Death|0
973572|NCT01217073|1976387|FG006|Extension Period|Death|1
973573|NCT01217073|1976388|FG007|Extension Period|Death|0
973574|NCT01217073|1976381|FG000|Extension Period|Excluded medication|0
973575|NCT01217073|1976382|FG001|Extension Period|Excluded medication|0
973576|NCT01217073|1976383|FG002|Extension Period|Excluded medication|0
973577|NCT01217073|1976384|FG003|Extension Period|Excluded medication|0
973578|NCT01217073|1976385|FG004|Extension Period|Excluded medication|0
973579|NCT01217073|1976386|FG005|Extension Period|Excluded medication|0
973580|NCT01217073|1976387|FG006|Extension Period|Excluded medication|2
973581|NCT01217073|1976388|FG007|Extension Period|Excluded medication|0
973582|NCT01217073|1976381|FG000|Extension Period|Lack of Efficacy|0
973583|NCT01217073|1976382|FG001|Extension Period|Lack of Efficacy|0
973584|NCT01217073|1976383|FG002|Extension Period|Lack of Efficacy|0
973585|NCT01217073|1976384|FG003|Extension Period|Lack of Efficacy|0
973586|NCT01217073|1976385|FG004|Extension Period|Lack of Efficacy|0
973587|NCT01217073|1976386|FG005|Extension Period|Lack of Efficacy|0
973588|NCT01217073|1976387|FG006|Extension Period|Lack of Efficacy|3
973589|NCT01217073|1976388|FG007|Extension Period|Lack of Efficacy|0
973590|NCT01217073|1976381|FG000|Extension Period|Lost to Follow-up|0
973591|NCT01217073|1976382|FG001|Extension Period|Lost to Follow-up|0
973592|NCT01217073|1976383|FG002|Extension Period|Lost to Follow-up|0
973593|NCT01217073|1976384|FG003|Extension Period|Lost to Follow-up|0
973594|NCT01217073|1976385|FG004|Extension Period|Lost to Follow-up|0
973595|NCT01217073|1976386|FG005|Extension Period|Lost to Follow-up|0
973596|NCT01217073|1976387|FG006|Extension Period|Lost to Follow-up|9
973597|NCT01217073|1976388|FG007|Extension Period|Lost to Follow-up|1
973598|NCT01217073|1976381|FG000|Extension Period|Non-compliance with study drug|0
973599|NCT01217073|1976382|FG001|Extension Period|Non-compliance with study drug|0
973600|NCT01217073|1976383|FG002|Extension Period|Non-compliance with study drug|0
973601|NCT01217073|1976384|FG003|Extension Period|Non-compliance with study drug|0
973602|NCT01217073|1976385|FG004|Extension Period|Non-compliance with study drug|0
973603|NCT01217073|1976386|FG005|Extension Period|Non-compliance with study drug|0
973604|NCT01217073|1976387|FG006|Extension Period|Non-compliance with study drug|0
973605|NCT01217073|1976388|FG007|Extension Period|Non-compliance with study drug|1
973606|NCT01217073|1976381|FG000|Extension Period|Physician Decision|0
973607|NCT01217073|1976382|FG001|Extension Period|Physician Decision|0
973608|NCT01217073|1976383|FG002|Extension Period|Physician Decision|0
973609|NCT01217073|1976384|FG003|Extension Period|Physician Decision|0
973610|NCT01217073|1976385|FG004|Extension Period|Physician Decision|0
973611|NCT01217073|1976386|FG005|Extension Period|Physician Decision|0
973612|NCT01217073|1976387|FG006|Extension Period|Physician Decision|4
973613|NCT01217073|1976388|FG007|Extension Period|Physician Decision|1
973614|NCT01217073|1976381|FG000|Extension Period|Protocol Violation|0
973615|NCT01217073|1976382|FG001|Extension Period|Protocol Violation|0
973616|NCT01217073|1976383|FG002|Extension Period|Protocol Violation|0
973617|NCT01217073|1976384|FG003|Extension Period|Protocol Violation|0
973618|NCT01217073|1976385|FG004|Extension Period|Protocol Violation|0
973619|NCT01217073|1976386|FG005|Extension Period|Protocol Violation|0
973620|NCT01217073|1976387|FG006|Extension Period|Protocol Violation|2
973621|NCT01217073|1976388|FG007|Extension Period|Protocol Violation|1
973622|NCT01217073|1976381|FG000|Extension Period|Site discontinued study participation|0
973623|NCT01217073|1976382|FG001|Extension Period|Site discontinued study participation|0
973624|NCT01217073|1976383|FG002|Extension Period|Site discontinued study participation|0
973625|NCT01217073|1976384|FG003|Extension Period|Site discontinued study participation|0
973626|NCT01217073|1976385|FG004|Extension Period|Site discontinued study participation|0
973627|NCT01217073|1976386|FG005|Extension Period|Site discontinued study participation|0
973628|NCT01217073|1976387|FG006|Extension Period|Site discontinued study participation|7
973629|NCT01217073|1976388|FG007|Extension Period|Site discontinued study participation|2
973630|NCT01217073|1976381|FG000|Extension Period|Withdrawal by Subject|0
973631|NCT01217073|1976382|FG001|Extension Period|Withdrawal by Subject|0
973632|NCT01217073|1976383|FG002|Extension Period|Withdrawal by Subject|0
973633|NCT01217073|1976384|FG003|Extension Period|Withdrawal by Subject|0
973634|NCT01217073|1976385|FG004|Extension Period|Withdrawal by Subject|0
973635|NCT01217073|1976386|FG005|Extension Period|Withdrawal by Subject|0
973636|NCT01217073|1976387|FG006|Extension Period|Withdrawal by Subject|30
973637|NCT01217073|1976388|FG007|Extension Period|Withdrawal by Subject|8
973638|NCT01217112|1976417|FG000|Overall Study|Adverse Event|0
973639|NCT01217112|1976418|FG001|Overall Study|Adverse Event|2
973640|NCT01217112|1976419|FG002|Overall Study|Adverse Event|0
973641|NCT01217112|1976420|FG003|Overall Study|Adverse Event|2
973642|NCT01217112|1976421|FG004|Overall Study|Adverse Event|0
973643|NCT01217112|1976417|FG000|Overall Study|Withdrawal by Subject|0
973644|NCT01217112|1976418|FG001|Overall Study|Withdrawal by Subject|0
973645|NCT01217112|1976419|FG002|Overall Study|Withdrawal by Subject|1
973646|NCT01217112|1976420|FG003|Overall Study|Withdrawal by Subject|0
973647|NCT01217112|1976421|FG004|Overall Study|Withdrawal by Subject|0
973648|NCT01217112|1976417|FG000|Overall Study|Physician Decision|0
973649|NCT01217112|1976418|FG001|Overall Study|Physician Decision|0
973650|NCT01217112|1976419|FG002|Overall Study|Physician Decision|0
973651|NCT01217112|1976420|FG003|Overall Study|Physician Decision|0
973652|NCT01217112|1976421|FG004|Overall Study|Physician Decision|1
973653|NCT01217190|1976435|FG000|Second Dosing|Withdrawal by Subject|0
973654|NCT01217190|1976436|FG001|Second Dosing|Withdrawal by Subject|2
973655|NCT01217229|1976445|FG000|Overall Study|Adverse Event|1
973656|NCT01217229|1976445|FG000|Overall Study|Disease progression, deterioration|2
973657|NCT01217229|1976445|FG000|Overall Study|Disease progression, Cheson criteria|14
973658|NCT01217229|1976445|FG000|Overall Study|Protocol Violation|1
973659|NCT01217229|1976445|FG000|Overall Study|Disease progression not confirmed|2
973660|NCT01217307|1976451|FG000|Overall Study|Withdrawal by Subject|0
973661|NCT01217307|1976452|FG001|Overall Study|Withdrawal by Subject|1
973662|NCT01217385|1976458|FG000|Overall Study|Withdrawal by Subject|3
973663|NCT01217385|1976458|FG000|Overall Study|DOSI not performed/not eval|12
973664|NCT01217385|1976458|FG000|Overall Study|Central Path not Available|1
973665|NCT01217385|1976458|FG000|Overall Study|Normal Breast TOI not available|10
973666|NCT01217437|1976481|FG000|Overall Study|Adverse Event|0
973667|NCT01217437|1976482|FG001|Overall Study|Adverse Event|8
973668|NCT01217437|1976481|FG000|Overall Study|Death|5
973669|NCT01217437|1976482|FG001|Overall Study|Death|0
973670|NCT01217437|1976481|FG000|Overall Study|Lack of Efficacy|29
973671|NCT01217437|1976482|FG001|Overall Study|Lack of Efficacy|25
973672|NCT01217437|1976481|FG000|Overall Study|Physician Decision|8
973673|NCT01217437|1976482|FG001|Overall Study|Physician Decision|5
973674|NCT01217437|1976481|FG000|Overall Study|Withdrawal by Subject|0
973675|NCT01217437|1976482|FG001|Overall Study|Withdrawal by Subject|2
973676|NCT01217437|1976481|FG000|Overall Study|Ineligible|1
973677|NCT01217437|1976482|FG001|Overall Study|Ineligible|1
973678|NCT01217463|1976490|FG000|Overall Study|Adverse Event|8
973679|NCT01217463|1976491|FG001|Overall Study|Adverse Event|5
973680|NCT01217463|1976490|FG000|Overall Study|Physician Decision|0
973681|NCT01217463|1976491|FG001|Overall Study|Physician Decision|1
973682|NCT01217463|1976490|FG000|Overall Study|Withdrawal by Subject|3
973683|NCT01217463|1976491|FG001|Overall Study|Withdrawal by Subject|0
973684|NCT01217463|1976490|FG000|Overall Study|Surgery on the Target Limb|0
973685|NCT01217463|1976491|FG001|Overall Study|Surgery on the Target Limb|1
973686|NCT01217463|1976490|FG000|Overall Study|Patient Non-compliant|1
973687|NCT01217463|1976491|FG001|Overall Study|Patient Non-compliant|0
973688|NCT01217463|1976490|FG000|Overall Study|Other|1
973689|NCT01217463|1976491|FG001|Overall Study|Other|1
973690|NCT01217476|1976501|FG000|Overall Study|Adverse Event|6
973691|NCT01217476|1976502|FG001|Overall Study|Adverse Event|1
973692|NCT01217476|1976501|FG000|Overall Study|Physician Decision|0
973693|NCT01217476|1976502|FG001|Overall Study|Physician Decision|1
973694|NCT01217476|1976501|FG000|Overall Study|Withdrawal by Subject|3
973695|NCT01217476|1976502|FG001|Overall Study|Withdrawal by Subject|3
973696|NCT01217476|1976501|FG000|Overall Study|Surgery on the Target Limb|0
973697|NCT01217476|1976502|FG001|Overall Study|Surgery on the Target Limb|2
973698|NCT01217476|1976501|FG000|Overall Study|Protocol Deviation|1
973699|NCT01217476|1976502|FG001|Overall Study|Protocol Deviation|0
973700|NCT01217476|1976501|FG000|Overall Study|Other|2
973701|NCT01217476|1976502|FG001|Overall Study|Other|0
973702|NCT01217606|1976523|FG000|Initial Treatment Phase|Other Reasons|0
973703|NCT01217606|1976524|FG001|Initial Treatment Phase|Other Reasons|2
973704|NCT01217606|1976523|FG000|Initial Treatment Phase|Protocol Violation|3
973705|NCT01217606|1976524|FG001|Initial Treatment Phase|Protocol Violation|2
973706|NCT01217606|1976523|FG000|Initial Treatment Phase|Personal Reasons|0
973707|NCT01217606|1976524|FG001|Initial Treatment Phase|Personal Reasons|2
973708|NCT01217606|1976523|FG000|Initial Treatment Phase|Lack of Efficacy|1
973709|NCT01217606|1976524|FG001|Initial Treatment Phase|Lack of Efficacy|0
973710|NCT01217606|1976523|FG000|Initial Treatment Phase|Adverse Event|10
973711|NCT01217606|1976524|FG001|Initial Treatment Phase|Adverse Event|6
973712|NCT01217606|1976523|FG000|9-Month Masked Extension|Adverse Event|3
973713|NCT01217606|1976524|FG001|9-Month Masked Extension|Adverse Event|6
973714|NCT01217606|1976523|FG000|9-Month Masked Extension|Other Reasons|4
973715|NCT01217606|1976524|FG001|9-Month Masked Extension|Other Reasons|4
973716|NCT01217606|1976523|FG000|9-Month Masked Extension|Personal Reasons|2
973717|NCT01217606|1976524|FG001|9-Month Masked Extension|Personal Reasons|1
973718|NCT01217606|1976523|FG000|9-Month Masked Extension|Lost to Follow-up|1
973719|NCT01217606|1976524|FG001|9-Month Masked Extension|Lost to Follow-up|0
973720|NCT01217606|1976523|FG000|9-Month Masked Extension|Pregnancy|1
973721|NCT01217606|1976524|FG001|9-Month Masked Extension|Pregnancy|0
973722|NCT01217606|1976523|FG000|9-Month Masked Extension|Lack of Efficacy|2
973723|NCT01217606|1976524|FG001|9-Month Masked Extension|Lack of Efficacy|0
973724|NCT01217801|1976547|FG000|Period 1|Protocol Violation|1
973725|NCT01217801|1976548|FG001|Period 1|Protocol Violation|1
973726|NCT01217801|1976547|FG000|Period 1|Withdrawal by Subject|0
973727|NCT01217801|1976548|FG001|Period 1|Withdrawal by Subject|1
973728|NCT01217814|1976557|FG000|Overall Study|Adverse Event|1
973729|NCT01217814|1976558|FG001|Overall Study|Adverse Event|1
973730|NCT01217814|1976559|FG002|Overall Study|Adverse Event|0
973731|NCT01217814|1976557|FG000|Overall Study|Lack of Efficacy|0
973732|NCT01217814|1976558|FG001|Overall Study|Lack of Efficacy|0
973733|NCT01217814|1976559|FG002|Overall Study|Lack of Efficacy|1
973734|NCT01217892|1976591|FG000|Overall Study|Adverse Event|1
973735|NCT01217892|1976592|FG001|Overall Study|Adverse Event|1
973736|NCT01217892|1976593|FG002|Overall Study|Adverse Event|1
973737|NCT01217892|1976594|FG003|Overall Study|Adverse Event|0
973738|NCT01217892|1976591|FG000|Overall Study|Withdrawal by Subject|0
973739|NCT01217892|1976592|FG001|Overall Study|Withdrawal by Subject|2
973740|NCT01217892|1976593|FG002|Overall Study|Withdrawal by Subject|1
973741|NCT01217892|1976594|FG003|Overall Study|Withdrawal by Subject|0
973742|NCT01217892|1976591|FG000|Overall Study|Lab value|1
973743|NCT01217892|1976592|FG001|Overall Study|Lab value|0
973744|NCT01217892|1976593|FG002|Overall Study|Lab value|1
973745|NCT01217892|1976594|FG003|Overall Study|Lab value|0
973746|NCT01217892|1976591|FG000|Overall Study|Subject no longer meets study criteria|5
973747|NCT01217892|1976592|FG001|Overall Study|Subject no longer meets study criteria|2
973748|NCT01217892|1976593|FG002|Overall Study|Subject no longer meets study criteria|4
973749|NCT01217892|1976594|FG003|Overall Study|Subject no longer meets study criteria|8
973750|NCT01217892|1976591|FG000|Overall Study|Incorrect enrollment|0
973751|NCT01217892|1976592|FG001|Overall Study|Incorrect enrollment|1
973752|NCT01217892|1976593|FG002|Overall Study|Incorrect enrollment|1
973753|NCT01217892|1976594|FG003|Overall Study|Incorrect enrollment|0
973754|NCT01217892|1976591|FG000|Overall Study|Poor/Non-Compliance|0
973755|NCT01217892|1976592|FG001|Overall Study|Poor/Non-Compliance|0
973756|NCT01217892|1976593|FG002|Overall Study|Poor/Non-Compliance|1
973757|NCT01217892|1976594|FG003|Overall Study|Poor/Non-Compliance|0
973758|NCT01217944|1976607|FG000|Overall Study|Protocol Violation|1
973759|NCT01217944|1976608|FG001|Overall Study|Protocol Violation|1
973760|NCT01217944|1976609|FG002|Overall Study|Protocol Violation|0
973761|NCT01217944|1976607|FG000|Overall Study|Lost to Follow-up|3
973762|NCT01217944|1976608|FG001|Overall Study|Lost to Follow-up|1
973763|NCT01217944|1976609|FG002|Overall Study|Lost to Follow-up|0
973764|NCT01217944|1976607|FG000|Overall Study|Withdrawal by Subject|1
973765|NCT01217944|1976608|FG001|Overall Study|Withdrawal by Subject|2
973766|NCT01217944|1976609|FG002|Overall Study|Withdrawal by Subject|0
973767|NCT01217944|1976607|FG000|Overall Study|Lack of Efficacy|1
973768|NCT01217944|1976608|FG001|Overall Study|Lack of Efficacy|0
973769|NCT01217944|1976609|FG002|Overall Study|Lack of Efficacy|0
973770|NCT01217957|1976624|FG000|Phase 1|Withdrawal by Patient|1
973771|NCT01217957|1976625|FG001|Phase 1|Withdrawal by Patient|0
973772|NCT01217957|1976626|FG002|Phase 1|Withdrawal by Patient|1
973773|NCT01217957|1976627|FG003|Phase 1|Withdrawal by Patient|1
973774|NCT01217957|1976628|FG004|Phase 1|Withdrawal by Patient|0
973775|NCT01217957|1976624|FG000|Phase 2|Withdrawal by Patient|0
973776|NCT01217957|1976625|FG001|Phase 2|Withdrawal by Patient|0
973777|NCT01217957|1976626|FG002|Phase 2|Withdrawal by Patient|0
973778|NCT01217957|1976627|FG003|Phase 2|Withdrawal by Patient|0
973779|NCT01217957|1976628|FG004|Phase 2|Withdrawal by Patient|1
973780|NCT01218009|1976651|FG000|Overall Study|Protocol Violation|2
973781|NCT01218009|1976652|FG001|Overall Study|Protocol Violation|1
973782|NCT01218009|1976651|FG000|Overall Study|Withdrawal by Subject|3
973783|NCT01218009|1976652|FG001|Overall Study|Withdrawal by Subject|1
973784|NCT01218009|1976651|FG000|Overall Study|Sponsor terminated study|161
973785|NCT01218009|1976652|FG001|Overall Study|Sponsor terminated study|163
973786|NCT01218087|1976665|FG000|Overall Study|Death|2
973787|NCT01218087|1976666|FG001|Overall Study|Death|1
973788|NCT01218087|1976665|FG000|Overall Study|Withdrawal by Subject|5
973789|NCT01218087|1976666|FG001|Overall Study|Withdrawal by Subject|0
973790|NCT01218087|1976665|FG000|Overall Study|Transferred|8
973791|NCT01218087|1976666|FG001|Overall Study|Transferred|5
973792|NCT01218100|1976676|FG000|Overall Study|Did not meet InclusionExclusion criteria|1
973793|NCT01218100|1976677|FG001|Overall Study|Did not meet InclusionExclusion criteria|1
973794|NCT01218100|1976678|FG002|Overall Study|Did not meet InclusionExclusion criteria|1
973795|NCT01218100|1976679|FG003|Overall Study|Did not meet InclusionExclusion criteria|2
973796|NCT01218100|1976676|FG000|Overall Study|Adverse Event|4
973797|NCT01218100|1976677|FG001|Overall Study|Adverse Event|6
973798|NCT01218100|1976678|FG002|Overall Study|Adverse Event|6
973799|NCT01218100|1976679|FG003|Overall Study|Adverse Event|7
973800|NCT01218100|1976676|FG000|Overall Study|Lack of Efficacy|9
973801|NCT01218100|1976677|FG001|Overall Study|Lack of Efficacy|6
973802|NCT01218100|1976678|FG002|Overall Study|Lack of Efficacy|5
973803|NCT01218100|1976679|FG003|Overall Study|Lack of Efficacy|12
973804|NCT01218100|1976676|FG000|Overall Study|Protocol Violation|0
973805|NCT01218100|1976677|FG001|Overall Study|Protocol Violation|0
973806|NCT01218100|1976678|FG002|Overall Study|Protocol Violation|1
973807|NCT01218100|1976679|FG003|Overall Study|Protocol Violation|1
973808|NCT01218100|1976676|FG000|Overall Study|Withdrawal by Subject|5
973809|NCT01218100|1976677|FG001|Overall Study|Withdrawal by Subject|2
973810|NCT01218100|1976678|FG002|Overall Study|Withdrawal by Subject|6
973811|NCT01218100|1976679|FG003|Overall Study|Withdrawal by Subject|7
973812|NCT01218100|1976676|FG000|Overall Study|Lost to Follow-up|3
973813|NCT01218100|1976677|FG001|Overall Study|Lost to Follow-up|8
973814|NCT01218100|1976678|FG002|Overall Study|Lost to Follow-up|2
973815|NCT01218100|1976679|FG003|Overall Study|Lost to Follow-up|1
973816|NCT01218100|1976676|FG000|Overall Study|Other Reason|2
973817|NCT01218100|1976677|FG001|Overall Study|Other Reason|2
973818|NCT01218100|1976678|FG002|Overall Study|Other Reason|6
973819|NCT01218100|1976679|FG003|Overall Study|Other Reason|4
973820|NCT01218113|1976692|FG000|Overall Study|Withdrawal by Subject|1
973821|NCT01218113|1976693|FG001|Overall Study|Withdrawal by Subject|0
973822|NCT01218113|1976694|FG002|Overall Study|Withdrawal by Subject|1
973823|NCT01218113|1976692|FG000|Overall Study|Lost to Follow-up|4
973824|NCT01218113|1976693|FG001|Overall Study|Lost to Follow-up|1
973825|NCT01218113|1976694|FG002|Overall Study|Lost to Follow-up|4
973826|NCT01218113|1976692|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0
973827|NCT01218113|1976693|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0
973828|NCT01218113|1976694|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1
973829|NCT01218126|1976713|FG000|Overall Study|Adverse Event|8
973830|NCT01218126|1976714|FG001|Overall Study|Adverse Event|10
973831|NCT01218126|1976715|FG002|Overall Study|Adverse Event|12
973832|NCT01218126|1976716|FG003|Overall Study|Adverse Event|16
973833|NCT01218126|1976713|FG000|Overall Study|Lack of Efficacy|7
973834|NCT01218126|1976714|FG001|Overall Study|Lack of Efficacy|2
973835|NCT01218126|1976715|FG002|Overall Study|Lack of Efficacy|2
973836|NCT01218126|1976716|FG003|Overall Study|Lack of Efficacy|6
973837|NCT01218126|1976713|FG000|Overall Study|Protocol Violation|5
973838|NCT01218126|1976714|FG001|Overall Study|Protocol Violation|2
973839|NCT01218126|1976715|FG002|Overall Study|Protocol Violation|2
973840|NCT01218126|1976716|FG003|Overall Study|Protocol Violation|3
973841|NCT01218126|1976713|FG000|Overall Study|Protocol-defined stopping criteria|1
973842|NCT01218126|1976714|FG001|Overall Study|Protocol-defined stopping criteria|1
973843|NCT01218126|1976715|FG002|Overall Study|Protocol-defined stopping criteria|0
973844|NCT01218126|1976716|FG003|Overall Study|Protocol-defined stopping criteria|0
973845|NCT01218126|1976713|FG000|Overall Study|Lost to Follow-up|0
973846|NCT01218126|1976714|FG001|Overall Study|Lost to Follow-up|0
973847|NCT01218126|1976715|FG002|Overall Study|Lost to Follow-up|0
973848|NCT01218126|1976716|FG003|Overall Study|Lost to Follow-up|2
973849|NCT01218126|1976713|FG000|Overall Study|Physician Decision|1
973850|NCT01218126|1976714|FG001|Overall Study|Physician Decision|2
973851|NCT01218126|1976715|FG002|Overall Study|Physician Decision|4
973852|NCT01218126|1976716|FG003|Overall Study|Physician Decision|2
973853|NCT01218126|1976713|FG000|Overall Study|Withdrawal by Subject|2
973854|NCT01218126|1976714|FG001|Overall Study|Withdrawal by Subject|5
973855|NCT01218126|1976715|FG002|Overall Study|Withdrawal by Subject|4
973856|NCT01218126|1976716|FG003|Overall Study|Withdrawal by Subject|6
973857|NCT01218204|1976728|FG000|Part B Washout|Adverse Event|0
973858|NCT01218204|1976729|FG001|Part B Washout|Adverse Event|1
973859|NCT01218204|1976730|FG002|Part B Washout|Adverse Event|0
973860|NCT01218204|1976731|FG003|Part B Washout|Adverse Event|0
973861|NCT01218204|1976728|FG000|Part B Washout|Lost to Follow-up|0
973862|NCT01218204|1976729|FG001|Part B Washout|Lost to Follow-up|2
973863|NCT01218204|1976730|FG002|Part B Washout|Lost to Follow-up|0
973864|NCT01218204|1976731|FG003|Part B Washout|Lost to Follow-up|0
973865|NCT01218204|1976728|FG000|Part B Washout|Physician Decision|0
973866|NCT01218204|1976729|FG001|Part B Washout|Physician Decision|14
973867|NCT01218204|1976730|FG002|Part B Washout|Physician Decision|0
973868|NCT01218204|1976731|FG003|Part B Washout|Physician Decision|0
973869|NCT01218204|1976728|FG000|Part B Washout|Withdrawal by Subject|0
973870|NCT01218204|1976729|FG001|Part B Washout|Withdrawal by Subject|14
973871|NCT01218204|1976730|FG002|Part B Washout|Withdrawal by Subject|0
973872|NCT01218204|1976731|FG003|Part B Washout|Withdrawal by Subject|0
973873|NCT01218204|1976728|FG000|Part B Washout|Reached defined stopping criteria|0
973874|NCT01218204|1976729|FG001|Part B Washout|Reached defined stopping criteria|2
973875|NCT01218204|1976730|FG002|Part B Washout|Reached defined stopping criteria|0
973876|NCT01218204|1976731|FG003|Part B Washout|Reached defined stopping criteria|0
973877|NCT01218204|1976728|FG000|Part B Washout|Did not meet continuation criteria|0
973878|NCT01218204|1976729|FG001|Part B Washout|Did not meet continuation criteria|112
973879|NCT01218204|1976730|FG002|Part B Washout|Did not meet continuation criteria|0
973880|NCT01218204|1976731|FG003|Part B Washout|Did not meet continuation criteria|0
973881|NCT01218204|1976728|FG000|Part B Run-in|Adverse Event|0
973882|NCT01218204|1976729|FG001|Part B Run-in|Adverse Event|0
973883|NCT01218204|1976730|FG002|Part B Run-in|Adverse Event|1
973884|NCT01218204|1976731|FG003|Part B Run-in|Adverse Event|0
973885|NCT01218204|1976728|FG000|Part B Run-in|Protocol Violation|0
973886|NCT01218204|1976729|FG001|Part B Run-in|Protocol Violation|0
973887|NCT01218204|1976730|FG002|Part B Run-in|Protocol Violation|2
973888|NCT01218204|1976731|FG003|Part B Run-in|Protocol Violation|0
973889|NCT01218204|1976728|FG000|Part B Run-in|Withdrawal by Subject|0
973890|NCT01218204|1976729|FG001|Part B Run-in|Withdrawal by Subject|0
973891|NCT01218204|1976730|FG002|Part B Run-in|Withdrawal by Subject|3
973892|NCT01218204|1976731|FG003|Part B Run-in|Withdrawal by Subject|0
973893|NCT01218204|1976728|FG000|Part B Pooled Treatment Arm|Adverse Event|0
973894|NCT01218204|1976729|FG001|Part B Pooled Treatment Arm|Adverse Event|0
973895|NCT01218204|1976730|FG002|Part B Pooled Treatment Arm|Adverse Event|0
973896|NCT01218204|1976731|FG003|Part B Pooled Treatment Arm|Adverse Event|2
973897|NCT01218204|1976728|FG000|Part B Pooled Treatment Arm|Protocol Violation|0
973898|NCT01218204|1976729|FG001|Part B Pooled Treatment Arm|Protocol Violation|0
973899|NCT01218204|1976730|FG002|Part B Pooled Treatment Arm|Protocol Violation|0
973900|NCT01218204|1976731|FG003|Part B Pooled Treatment Arm|Protocol Violation|1
973901|NCT01218243|1976780|FG000|Overall Study|Lack of Efficacy|1
973902|NCT01218243|1976781|FG001|Overall Study|Lack of Efficacy|1
973903|NCT01218243|1976780|FG000|Overall Study|Lost to Follow-up|3
973904|NCT01218243|1976781|FG001|Overall Study|Lost to Follow-up|3
973905|NCT01218243|1976780|FG000|Overall Study|Protocol Violation|5
973906|NCT01218243|1976781|FG001|Overall Study|Protocol Violation|10
973907|NCT01218308|1976789|FG000|Overall Study|Adverse Event|1
973908|NCT01218308|1976790|FG001|Overall Study|Adverse Event|2
973909|NCT01218308|1976789|FG000|Overall Study|Protocol Violation|0
973910|NCT01218308|1976790|FG001|Overall Study|Protocol Violation|2
973911|NCT01218308|1976789|FG000|Overall Study|Withdrawal by Subject|61
973912|NCT01218308|1976790|FG001|Overall Study|Withdrawal by Subject|64
973913|NCT01218308|1976789|FG000|Overall Study|Lost to Follow-up|27
973914|NCT01218308|1976790|FG001|Overall Study|Lost to Follow-up|31
973915|NCT01218308|1976789|FG000|Overall Study|Other|14
973916|NCT01218308|1976790|FG001|Overall Study|Other|21
973917|NCT01218438|1976805|FG000|Epoch 1|Physician Decision|2
973918|NCT01218438|1976805|FG000|Epoch 1|Adverse Event|1
973919|NCT01218438|1976805|FG000|Epoch 3|Withdrawal by Subject|3
973920|NCT01218438|1976805|FG000|Epoch 3|Adverse Event|1
973921|NCT01218438|1976805|FG000|Epoch 4|Physician Decision|1
973922|NCT01218438|1976805|FG000|Epoch 4|Withdrawal by Subject|2
973923|NCT01218477|1976883|FG000|Overall Study|Disease progression|2
973924|NCT01218477|1976884|FG001|Overall Study|Disease progression|3
973925|NCT01218477|1976885|FG002|Overall Study|Disease progression|6
973926|NCT01218477|1976886|FG003|Overall Study|Disease progression|2
973927|NCT01218477|1976883|FG000|Overall Study|Study drug toxicity|0
973928|NCT01218477|1976884|FG001|Overall Study|Study drug toxicity|2
973929|NCT01218477|1976885|FG002|Overall Study|Study drug toxicity|5
973930|NCT01218477|1976886|FG003|Overall Study|Study drug toxicity|0
973931|NCT01218477|1976883|FG000|Overall Study|No longer meets study criteria|1
973932|NCT01218477|1976884|FG001|Overall Study|No longer meets study criteria|0
973933|NCT01218477|1976885|FG002|Overall Study|No longer meets study criteria|0
973934|NCT01218477|1976886|FG003|Overall Study|No longer meets study criteria|0
973935|NCT01218477|1976883|FG000|Overall Study|Withdrawal by Subject|0
973936|NCT01218477|1976884|FG001|Overall Study|Withdrawal by Subject|0
973937|NCT01218477|1976885|FG002|Overall Study|Withdrawal by Subject|1
973938|NCT01218477|1976886|FG003|Overall Study|Withdrawal by Subject|0
973939|NCT01218477|1976883|FG000|Overall Study|Prepared for cell transplantation|0
973940|NCT01218477|1976884|FG001|Overall Study|Prepared for cell transplantation|1
973941|NCT01218477|1976885|FG002|Overall Study|Prepared for cell transplantation|1
973942|NCT01218477|1976886|FG003|Overall Study|Prepared for cell transplantation|0
973943|NCT01218477|1976883|FG000|Overall Study|Administrative reason by sponsor|0
973944|NCT01218477|1976884|FG001|Overall Study|Administrative reason by sponsor|0
973945|NCT01218477|1976885|FG002|Overall Study|Administrative reason by sponsor|1
973946|NCT01218477|1976886|FG003|Overall Study|Administrative reason by sponsor|0
973947|NCT01218477|1976883|FG000|Overall Study|Maximum clinical benefit|0
973948|NCT01218477|1976884|FG001|Overall Study|Maximum clinical benefit|2
973949|NCT01218477|1976885|FG002|Overall Study|Maximum clinical benefit|0
973950|NCT01218477|1976886|FG003|Overall Study|Maximum clinical benefit|0
973951|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Death|2
973952|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Death|1
973953|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Death|0
973954|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Death|0
973955|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
973956|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3
973957|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
973958|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
1006632|NCT01468909|2025342|FG000|Overall Study|Never Treated|2
973959|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2
973960|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2
973961|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0
973962|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0
973963|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2
973964|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
973965|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
973966|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
973967|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17
973968|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15
973969|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
973970|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
973971|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
973972|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1
973973|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
973974|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
973975|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
973976|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1
973977|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
973978|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
973979|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
973980|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3
973981|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
973982|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
973983|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Other|3
973984|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Other|4
973985|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Other|0
973986|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Other|0
973987|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
973988|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1
973989|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
973990|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
973991|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2
973992|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3
973993|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
973994|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
973995|NCT01218516|1976902|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
973996|NCT01218516|1976903|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
973997|NCT01218516|1976904|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
973998|NCT01218516|1976905|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
973999|NCT01218594|1976920|FG000|Overall Study|Death|1
974000|NCT01218594|1976920|FG000|Overall Study|Withdrawal by Subject|3
974001|NCT01218594|1976920|FG000|Overall Study|Adverse Event|2
974002|NCT01218594|1976920|FG000|Overall Study|Physician Decision|6
974003|NCT01218646|1976928|FG000|Overall Study|Adverse Event|0
974004|NCT01218646|1976929|FG001|Overall Study|Adverse Event|0
974005|NCT01218646|1976930|FG002|Overall Study|Adverse Event|1
974006|NCT01218646|1976931|FG003|Overall Study|Adverse Event|0
974007|NCT01218646|1976928|FG000|Overall Study|Lost to Follow-up|1
974008|NCT01218646|1976929|FG001|Overall Study|Lost to Follow-up|0
974009|NCT01218646|1976930|FG002|Overall Study|Lost to Follow-up|0
974010|NCT01218646|1976931|FG003|Overall Study|Lost to Follow-up|0
974011|NCT01218646|1976928|FG000|Overall Study|Protocol Violation|0
974012|NCT01218646|1976929|FG001|Overall Study|Protocol Violation|0
974013|NCT01218646|1976930|FG002|Overall Study|Protocol Violation|1
974014|NCT01218646|1976931|FG003|Overall Study|Protocol Violation|1
974015|NCT01218659|1976943|FG000|18-Month Randomized Period|Withdrawal by Subject|2
974016|NCT01218659|1976944|FG001|18-Month Randomized Period|Withdrawal by Subject|3
974017|NCT01218659|1976945|FG002|18-Month Randomized Period|Withdrawal by Subject|0
974018|NCT01218659|1976943|FG000|18-Month Randomized Period|Did not receive study drug|0
974019|NCT01218659|1976944|FG001|18-Month Randomized Period|Did not receive study drug|3
974020|NCT01218659|1976945|FG002|18-Month Randomized Period|Did not receive study drug|0
974021|NCT01218659|1976943|FG000|12-Month OLE|Withdrawal by Subject|0
974022|NCT01218659|1976944|FG001|12-Month OLE|Withdrawal by Subject|0
974023|NCT01218659|1976945|FG002|12-Month OLE|Withdrawal by Subject|2
974024|NCT01218659|1976943|FG000|12-Month OLE|Physician Decision|0
974025|NCT01218659|1976944|FG001|12-Month OLE|Physician Decision|0
974026|NCT01218659|1976945|FG002|12-Month OLE|Physician Decision|1
974027|NCT01218659|1976943|FG000|12-Month OLE|Lost to Follow-up|0
974028|NCT01218659|1976944|FG001|12-Month OLE|Lost to Follow-up|0
974029|NCT01218659|1976945|FG002|12-Month OLE|Lost to Follow-up|1
974030|NCT01218659|1976943|FG000|12-Month OLE|Pregnancy|0
974031|NCT01218659|1976944|FG001|12-Month OLE|Pregnancy|0
974032|NCT01218659|1976945|FG002|12-Month OLE|Pregnancy|1
974033|NCT01218659|1976943|FG000|12-Month OLE|Lack of Efficacy|0
974034|NCT01218659|1976944|FG001|12-Month OLE|Lack of Efficacy|0
974035|NCT01218659|1976945|FG002|12-Month OLE|Lack of Efficacy|1
974036|NCT01218659|1976943|FG000|12-Month OLE|Declined to participate in the OLE|0
974037|NCT01218659|1976944|FG001|12-Month OLE|Declined to participate in the OLE|0
974038|NCT01218659|1976945|FG002|12-Month OLE|Declined to participate in the OLE|4
974039|NCT01218802|1976965|FG000|Overall Study|Lost to Follow-up|5
974040|NCT01218802|1976966|FG001|Overall Study|Lost to Follow-up|6
974041|NCT01218802|1976965|FG000|Overall Study|Withdrawal by Subject|3
974042|NCT01218802|1976966|FG001|Overall Study|Withdrawal by Subject|10
974043|NCT01218802|1976965|FG000|Overall Study|Adverse Event|0
974044|NCT01218802|1976966|FG001|Overall Study|Adverse Event|2
974045|NCT01218802|1976965|FG000|Overall Study|Incarcerated|2
974046|NCT01218802|1976966|FG001|Overall Study|Incarcerated|0
974047|NCT01218867|1976983|FG000|Overall Study|Death during treatment|0
974048|NCT01218867|1976984|FG001|Overall Study|Death during treatment|0
974049|NCT01218867|1976985|FG002|Overall Study|Death during treatment|0
974050|NCT01218867|1976986|FG003|Overall Study|Death during treatment|0
974051|NCT01218867|1976987|FG004|Overall Study|Death during treatment|0
974052|NCT01218867|1976988|FG005|Overall Study|Death during treatment|0
974053|NCT01218867|1976989|FG006|Overall Study|Death during treatment|1
974054|NCT01218867|1976990|FG007|Overall Study|Death during treatment|0
974055|NCT01218867|1976991|FG008|Overall Study|Death during treatment|0
974056|NCT01218867|1976992|FG009|Overall Study|Death during treatment|0
974057|NCT01218867|1976993|FG010|Overall Study|Death during treatment|0
974058|NCT01219933|1977123|FG000|Overall Study|Adverse Event|8
974059|NCT01219933|1977123|FG000|Overall Study|No LDA reached|5
974060|NCT01219933|1977123|FG000|Overall Study|No LDA maintained|7
974061|NCT01219933|1977123|FG000|Overall Study|Lost to Follow-up|3
974062|NCT01219933|1977123|FG000|Overall Study|GC free|1
912603|NCT00806195|1890142|FG002|Overall Study|Protocol Violation|26
912604|NCT00806195|1890143|FG003|Overall Study|Protocol Violation|9
912605|NCT00806260|1890178|FG000|Period 1 (1 Day)|Adverse Event|0
912606|NCT00806260|1890179|FG001|Period 1 (1 Day)|Adverse Event|0
912607|NCT00806260|1890180|FG002|Period 1 (1 Day)|Adverse Event|0
912608|NCT00806260|1890181|FG003|Period 1 (1 Day)|Adverse Event|0
912609|NCT00806260|1890182|FG004|Period 1 (1 Day)|Adverse Event|3
912610|NCT00806260|1890183|FG005|Period 1 (1 Day)|Adverse Event|0
912611|NCT00806260|1890178|FG000|Period 2|Adverse Event|0
912612|NCT00806260|1890179|FG001|Period 2|Adverse Event|0
912613|NCT00806260|1890180|FG002|Period 2|Adverse Event|0
912614|NCT00806260|1890181|FG003|Period 2|Adverse Event|1
912615|NCT00806260|1890182|FG004|Period 2|Adverse Event|0
912616|NCT00806260|1890183|FG005|Period 2|Adverse Event|0
912617|NCT00806260|1890178|FG000|Period 2|Protocol Violation|1
912618|NCT00806260|1890179|FG001|Period 2|Protocol Violation|0
912619|NCT00806260|1890180|FG002|Period 2|Protocol Violation|1
912620|NCT00806260|1890181|FG003|Period 2|Protocol Violation|0
912621|NCT00806260|1890182|FG004|Period 2|Protocol Violation|0
912622|NCT00806260|1890183|FG005|Period 2|Protocol Violation|0
974063|NCT01219933|1977123|FG000|Overall Study|Withdrawal by Subject|5
974064|NCT01219933|1977123|FG000|Overall Study|Protocol Violation|8
974065|NCT01219933|1977123|FG000|Overall Study|Lack of Efficacy|1
974066|NCT01219959|1977130|FG000|Overall Study|Adverse Event|6
974067|NCT01219959|1977131|FG001|Overall Study|Adverse Event|14
974068|NCT01219959|1977130|FG000|Overall Study|Physician Decision|0
974069|NCT01219959|1977131|FG001|Overall Study|Physician Decision|4
974070|NCT01219959|1977130|FG000|Overall Study|Withdrawal by Subject|0
974071|NCT01219959|1977131|FG001|Overall Study|Withdrawal by Subject|2
974072|NCT01219959|1977130|FG000|Overall Study|Renal Transplantation|0
974073|NCT01219959|1977131|FG001|Overall Study|Renal Transplantation|3
974074|NCT01219959|1977130|FG000|Overall Study|Other|1
974075|NCT01219959|1977131|FG001|Overall Study|Other|0
974076|NCT01219985|1977137|FG000|Overall Study|Physician Decision|20
974077|NCT01220024|1977145|FG000|Overall Study|Lost to Follow-up|1
974078|NCT01220024|1977146|FG001|Overall Study|Lost to Follow-up|1
974079|NCT01220128|1977159|FG000|Overall Study|Progressive disease|0
974080|NCT01220128|1977160|FG001|Overall Study|Progressive disease|0
974081|NCT01220128|1977161|FG002|Overall Study|Progressive disease|2
974082|NCT01220128|1977162|FG003|Overall Study|Progressive disease|0
974083|NCT01220128|1977163|FG004|Overall Study|Progressive disease|0
974084|NCT01220128|1977164|FG005|Overall Study|Progressive disease|0
974085|NCT01220128|1977165|FG006|Overall Study|Progressive disease|0
974086|NCT01220128|1977159|FG000|Overall Study|Sponsor study termination|0
974087|NCT01220128|1977160|FG001|Overall Study|Sponsor study termination|1
974088|NCT01220128|1977161|FG002|Overall Study|Sponsor study termination|0
974089|NCT01220128|1977162|FG003|Overall Study|Sponsor study termination|0
974090|NCT01220128|1977163|FG004|Overall Study|Sponsor study termination|0
974091|NCT01220128|1977164|FG005|Overall Study|Sponsor study termination|0
974092|NCT01220128|1977165|FG006|Overall Study|Sponsor study termination|1
974093|NCT01220128|1977159|FG000|Overall Study|Adverse event, serious fatal|2
974094|NCT01220128|1977160|FG001|Overall Study|Adverse event, serious fatal|0
974095|NCT01220128|1977161|FG002|Overall Study|Adverse event, serious fatal|0
974096|NCT01220128|1977162|FG003|Overall Study|Adverse event, serious fatal|0
974097|NCT01220128|1977163|FG004|Overall Study|Adverse event, serious fatal|0
974098|NCT01220128|1977164|FG005|Overall Study|Adverse event, serious fatal|0
974099|NCT01220128|1977165|FG006|Overall Study|Adverse event, serious fatal|1
974100|NCT01220128|1977159|FG000|Overall Study|Adverse event, non-fatal|1
974101|NCT01220128|1977160|FG001|Overall Study|Adverse event, non-fatal|0
974102|NCT01220128|1977161|FG002|Overall Study|Adverse event, non-fatal|0
974103|NCT01220128|1977162|FG003|Overall Study|Adverse event, non-fatal|0
974104|NCT01220128|1977163|FG004|Overall Study|Adverse event, non-fatal|0
974105|NCT01220128|1977164|FG005|Overall Study|Adverse event, non-fatal|0
974106|NCT01220128|1977165|FG006|Overall Study|Adverse event, non-fatal|3
974107|NCT01220128|1977159|FG000|Overall Study|Other|0
974108|NCT01220128|1977160|FG001|Overall Study|Other|0
974109|NCT01220128|1977161|FG002|Overall Study|Other|1
974110|NCT01220128|1977162|FG003|Overall Study|Other|0
974111|NCT01220128|1977163|FG004|Overall Study|Other|0
974112|NCT01220128|1977164|FG005|Overall Study|Other|0
974113|NCT01220128|1977165|FG006|Overall Study|Other|0
974114|NCT01220128|1977159|FG000|Overall Study|Consent withdrawn by subject|1
974115|NCT01220128|1977160|FG001|Overall Study|Consent withdrawn by subject|0
974116|NCT01220128|1977161|FG002|Overall Study|Consent withdrawn by subject|0
974117|NCT01220128|1977162|FG003|Overall Study|Consent withdrawn by subject|0
974118|NCT01220128|1977163|FG004|Overall Study|Consent withdrawn by subject|0
974119|NCT01220128|1977164|FG005|Overall Study|Consent withdrawn by subject|0
974120|NCT01220128|1977165|FG006|Overall Study|Consent withdrawn by subject|0
974121|NCT01220167|1977185|FG000|Period 3|Urine positive for substance abuse|0
974122|NCT01220167|1977186|FG001|Period 3|Urine positive for substance abuse|1
974123|NCT01220167|1977187|FG002|Period 3|Urine positive for substance abuse|0
974124|NCT01220180|1977196|FG000|Overall Study|Lost to Follow-up|76
974125|NCT01220180|1977196|FG000|Overall Study|Other|72
974126|NCT01220180|1977196|FG000|Overall Study|Adverse Event|35
974127|NCT01220180|1977196|FG000|Overall Study|Lack of Efficacy|22
974128|NCT01220180|1977196|FG000|Overall Study|Death|1
974129|NCT01220180|1977196|FG000|Overall Study|Randomized but not treated|1
974130|NCT01220297|1977202|FG000|Overall Study|Death|2
974131|NCT01220297|1977202|FG000|Overall Study|Lost to Follow-up|1
974132|NCT01220401|1977208|FG000|Overall Study|Withdrawal by Subject|2
974133|NCT01220401|1977208|FG000|Overall Study|Protocol Violation|1
974134|NCT01220414|1977214|FG000|Overall Study|Withdrawal by Subject|1
974135|NCT01220414|1977215|FG001|Overall Study|Withdrawal by Subject|0
974136|NCT01220414|1977216|FG002|Overall Study|Withdrawal by Subject|0
974137|NCT01220414|1977217|FG003|Overall Study|Withdrawal by Subject|1
974138|NCT01220557|1977239|FG000|Overall Study|Lost to Follow-up|5
974139|NCT01220557|1977240|FG001|Overall Study|Lost to Follow-up|3
974140|NCT01220557|1977239|FG000|Overall Study|attended less than 6 lessons|1
974141|NCT01220557|1977240|FG001|Overall Study|attended less than 6 lessons|2
974142|NCT01220609|1977246|FG000|Overall Study|Ineligible-Wrong primary cancer site|1
974143|NCT01220609|1977246|FG000|Overall Study|Ineligible- Wrong cell type|1
974144|NCT01220609|1977246|FG000|Overall Study|Ineligible-Never treated|1
974145|NCT01220856|1977285|FG000|Overall Study|graft loss|3
974146|NCT01220856|1977286|FG001|Overall Study|graft loss|3
974147|NCT01220856|1977285|FG000|Overall Study|Lost to Follow-up|1
974148|NCT01220856|1977286|FG001|Overall Study|Lost to Follow-up|0
974149|NCT01220999|1977308|FG000|Overall Study|Progressive disease|0
974150|NCT01220999|1977309|FG001|Overall Study|Progressive disease|0
974151|NCT01220999|1977310|FG002|Overall Study|Progressive disease|1
974152|NCT01220999|1977311|FG003|Overall Study|Progressive disease|0
974153|NCT01220999|1977312|FG004|Overall Study|Progressive disease|0
974154|NCT01221090|1977328|FG000|Overall Study|Non-Compliant or Unable to Contact|15
974155|NCT01221090|1977329|FG001|Overall Study|Non-Compliant or Unable to Contact|12
974156|NCT01221090|1977330|FG002|Overall Study|Non-Compliant or Unable to Contact|15
974157|NCT01221090|1977331|FG003|Overall Study|Non-Compliant or Unable to Contact|20
974158|NCT01221090|1977328|FG000|Overall Study|Withdrawal by Subject|0
974159|NCT01221090|1977329|FG001|Overall Study|Withdrawal by Subject|22
974160|NCT01221090|1977330|FG002|Overall Study|Withdrawal by Subject|27
974161|NCT01221090|1977331|FG003|Overall Study|Withdrawal by Subject|2
974162|NCT01221181|1977341|FG000|Overall Study|Lost to Follow-up|1
974163|NCT01221233|1977369|FG000|Overall Study|Withdrawal by Subject|3
974164|NCT01221233|1977370|FG001|Overall Study|Withdrawal by Subject|1
974165|NCT01221272|1977376|FG000|Period 1|Adverse Event|2
974166|NCT01221272|1977377|FG001|Period 1|Adverse Event|0
974167|NCT01221272|1977376|FG000|Period 1|Consent Withdrawal|0
974168|NCT01221272|1977377|FG001|Period 1|Consent Withdrawal|1
974169|NCT01221272|1977376|FG000|Period 1|Significant Dosing Noncompliance|0
974170|NCT01221272|1977377|FG001|Period 1|Significant Dosing Noncompliance|1
974171|NCT01221272|1977376|FG000|Period 2|Adverse Event|0
974172|NCT01221272|1977377|FG001|Period 2|Adverse Event|2
974173|NCT01221285|1977386|FG000|Overall Study|Withdrawal by Subject|1
974174|NCT01221350|1977405|FG000|Overall Study|Discontinued intervention (GERD)|1
974175|NCT01221350|1977406|FG001|Overall Study|Discontinued intervention (GERD)|0
974176|NCT01221350|1977405|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0
974177|NCT01221350|1977406|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1
974178|NCT01221350|1977405|FG000|Overall Study|Withdrawal by Subject|4
974179|NCT01221350|1977406|FG001|Overall Study|Withdrawal by Subject|2
974180|NCT01221363|1977416|FG000|Overall Study|Pregnancy|1
974181|NCT01221363|1977417|FG001|Overall Study|Pregnancy|0
974182|NCT01221363|1977416|FG000|Overall Study|Withdrawal by Subject|11
974183|NCT01221363|1977417|FG001|Overall Study|Withdrawal by Subject|5
974184|NCT01221597|1977434|FG000|Overall Study|Adverse Event|4
974185|NCT01221597|1977435|FG001|Overall Study|Adverse Event|1
974186|NCT01221597|1977434|FG000|Overall Study|Withdrawal by Subject|20
974187|NCT01221597|1977435|FG001|Overall Study|Withdrawal by Subject|6
974188|NCT01221597|1977434|FG000|Overall Study|Lost to Follow-up|6
974189|NCT01221597|1977435|FG001|Overall Study|Lost to Follow-up|5
974190|NCT01221597|1977434|FG000|Overall Study|Protocol Violation|1
974191|NCT01221597|1977435|FG001|Overall Study|Protocol Violation|0
974192|NCT01221597|1977434|FG000|Overall Study|Other|3
974193|NCT01221597|1977435|FG001|Overall Study|Other|4
974194|NCT01221597|1977434|FG000|Overall Study|Death|2
974195|NCT01221597|1977435|FG001|Overall Study|Death|0
974196|NCT01221623|1977444|FG000|Overall Study|Withdrawal by Subject|19
974197|NCT01221623|1977445|FG001|Overall Study|Withdrawal by Subject|8
974198|NCT01221623|1977444|FG000|Overall Study|Lost to Follow-up|7
974199|NCT01221623|1977445|FG001|Overall Study|Lost to Follow-up|1
974200|NCT01221623|1977444|FG000|Overall Study|Adverse Event|6
974201|NCT01221623|1977445|FG001|Overall Study|Adverse Event|3
974202|NCT01221623|1977444|FG000|Overall Study|Death|1
974203|NCT01221623|1977445|FG001|Overall Study|Death|0
974204|NCT01221623|1977444|FG000|Overall Study|Other|5
974205|NCT01221623|1977445|FG001|Overall Study|Other|2
974206|NCT01221727|1977453|FG000|Overall Study|Physician Decision|2
974207|NCT01221727|1977454|FG001|Overall Study|Physician Decision|0
974208|NCT01221727|1977453|FG000|Overall Study|Withdrawal by Subject|1
974209|NCT01221727|1977454|FG001|Overall Study|Withdrawal by Subject|1
974210|NCT01221753|1977466|FG000|Overall Study|Adverse Event|1
974211|NCT01221948|1977478|FG000|Overall Study|Physician Decision|5
974212|NCT01221948|1977478|FG000|Overall Study|Withdrawal by Subject|2
974213|NCT01221948|1977478|FG000|Overall Study|not disclosed|2
974214|NCT01221948|1977478|FG000|Overall Study|Death|1
974215|NCT01221948|1977478|FG000|Overall Study|Protocol Violation|4
974216|NCT01222078|1977482|FG000|Overall Study|Early termination of the study|1
974217|NCT01222104|1977494|FG000|Overall Study|Lost to Follow-up|37
974218|NCT01222104|1977494|FG000|Overall Study|Death|10
974219|NCT01222247|1977569|FG000|Overall Study|Lost to Follow-up|2
974220|NCT01222247|1977570|FG001|Overall Study|Lost to Follow-up|2
974221|NCT01222403|1977616|FG000|Overall Study|Inappropriate enrollment|0
974222|NCT01222403|1977617|FG001|Overall Study|Inappropriate enrollment|2
974223|NCT01222416|1977625|FG000|Overall Study|ineligible;metastasis|3
974224|NCT01222416|1977626|FG001|Overall Study|ineligible;metastasis|0
974225|NCT01222416|1977625|FG000|Overall Study|Adverse Event|4
974226|NCT01222416|1977626|FG001|Overall Study|Adverse Event|0
974227|NCT01222416|1977625|FG000|Overall Study|Withdrawal by Subject|5
974228|NCT01222416|1977626|FG001|Overall Study|Withdrawal by Subject|0
974229|NCT01222416|1977625|FG000|Overall Study|scheduling|6
974230|NCT01222416|1977626|FG001|Overall Study|scheduling|0
974231|NCT01222416|1977625|FG000|Overall Study|missed view/scan|1
974232|NCT01222416|1977626|FG001|Overall Study|missed view/scan|0
974233|NCT01222416|1977625|FG000|Overall Study|Death|1
974234|NCT01222416|1977626|FG001|Overall Study|Death|0
974235|NCT01222507|1977645|FG000|Overall Study|Physician Decision|1
974236|NCT01222507|1977645|FG000|Overall Study|Withdrawal by Subject|1
974237|NCT01222520|1977651|FG000|Open-label run-in Period|Withdrawal by Subject|0
974238|NCT01222520|1977652|FG001|Open-label run-in Period|Withdrawal by Subject|2
974239|NCT01222520|1977651|FG000|Open-label run-in Period|Blood pressure criteria not met|0
974240|NCT01222520|1977652|FG001|Open-label run-in Period|Blood pressure criteria not met|18
974241|NCT01222520|1977651|FG000|Open-label run-in Period|Number of patients fulfilled|0
974242|NCT01222520|1977652|FG001|Open-label run-in Period|Number of patients fulfilled|3
974243|NCT01222520|1977651|FG000|Double-blind Period|Adverse Event|0
974244|NCT01222520|1977652|FG001|Double-blind Period|Adverse Event|1
974245|NCT01222520|1977651|FG000|Double-blind Period|Lack of Efficacy|0
974246|NCT01222520|1977652|FG001|Double-blind Period|Lack of Efficacy|1
974247|NCT01222520|1977651|FG000|Double-blind Period|Study medication stolen|1
974248|NCT01222520|1977652|FG001|Double-blind Period|Study medication stolen|0
974249|NCT01222533|1977658|FG000|Overall Study|Adverse Event|5
974250|NCT01222533|1977658|FG000|Overall Study|Withdrawal by Subject|5
974251|NCT01222533|1977658|FG000|Overall Study|Other|4
974252|NCT01222715|1977686|FG000|Overall Study|Adverse Event|0
974253|NCT01222715|1977687|FG001|Overall Study|Adverse Event|4
974254|NCT01222715|1977686|FG000|Overall Study|Death|0
974255|NCT01222715|1977687|FG001|Overall Study|Death|1
974256|NCT01222715|1977686|FG000|Overall Study|Lack of Efficacy|22
974257|NCT01222715|1977687|FG001|Overall Study|Lack of Efficacy|14
974258|NCT01222715|1977686|FG000|Overall Study|Physician Decision|12
974259|NCT01222715|1977687|FG001|Overall Study|Physician Decision|2
974260|NCT01222715|1977686|FG000|Overall Study|Refusal of further protocol therapy|0
974261|NCT01222715|1977687|FG001|Overall Study|Refusal of further protocol therapy|4
974262|NCT01222715|1977686|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1
974263|NCT01222715|1977687|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1
974264|NCT01222715|1977686|FG000|Overall Study|Ineligible|0
974265|NCT01222715|1977687|FG001|Overall Study|Ineligible|1
974266|NCT01222715|1977686|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
974267|NCT01222715|1977687|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
974268|NCT01222767|1977693|FG000|Overall Study|Progressive disease|13
974269|NCT01222767|1977693|FG000|Overall Study|Adverse Event|2
974270|NCT01222767|1977693|FG000|Overall Study|Surgical resection|1
974271|NCT01222767|1977693|FG000|Overall Study|Never treated|1
974272|NCT01223027|1977717|FG000|Overall Study|Adverse Event|20
974273|NCT01223027|1977718|FG001|Overall Study|Adverse Event|10
974274|NCT01223027|1977717|FG000|Overall Study|Death|42
974275|NCT01223027|1977718|FG001|Overall Study|Death|42
974276|NCT01223027|1977717|FG000|Overall Study|Lost to Follow-up|2
974277|NCT01223027|1977718|FG001|Overall Study|Lost to Follow-up|1
974278|NCT01223027|1977717|FG000|Overall Study|Physician Decision|4
974279|NCT01223027|1977718|FG001|Overall Study|Physician Decision|8
974280|NCT01223027|1977717|FG000|Overall Study|Progressive Disease|167
974281|NCT01223027|1977718|FG001|Overall Study|Progressive Disease|183
974282|NCT01223027|1977717|FG000|Overall Study|Protocol Violation|2
974283|NCT01223027|1977718|FG001|Overall Study|Protocol Violation|1
974284|NCT01223027|1977717|FG000|Overall Study|Subject/guardian decicion|18
974285|NCT01223027|1977718|FG001|Overall Study|Subject/guardian decicion|16
974286|NCT01223027|1977717|FG000|Overall Study|New therapy for study indication|17
974287|NCT01223027|1977718|FG001|Overall Study|New therapy for study indication|8
974288|NCT01223027|1977717|FG000|Overall Study|Study terminated by sponsor|2
974289|NCT01223027|1977718|FG001|Overall Study|Study terminated by sponsor|8
974290|NCT01223183|1977726|FG000|Imaging Day 1|Physician Decision|0
974291|NCT01223183|1977727|FG001|Imaging Day 1|Physician Decision|1
974292|NCT01223183|1977726|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1
974293|NCT01223183|1977727|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0
974294|NCT01223183|1977726|FG000|Washout Period (5-24 Days)|Physician Decision|1
974295|NCT01223183|1977727|FG001|Washout Period (5-24 Days)|Physician Decision|0
974296|NCT01223196|1977736|FG000|Overall Study|Lost to Follow-up|2
974297|NCT01223196|1977737|FG001|Overall Study|Lost to Follow-up|0
974298|NCT01223196|1977736|FG000|Overall Study|Physician Decision|1
974299|NCT01223196|1977737|FG001|Overall Study|Physician Decision|0
974300|NCT01223196|1977736|FG000|Overall Study|Withdrawal by Subject|1
974301|NCT01223196|1977737|FG001|Overall Study|Withdrawal by Subject|0
974302|NCT01223235|1977745|FG000|Overall Study|Withdrawal by Subject|1
974303|NCT01223365|1977764|FG000|Open-label Titration Period|Enrolled but not treated|1
974304|NCT01223365|1977764|FG000|Open-label Titration Period|Adverse Event|23
974305|NCT01223365|1977764|FG000|Open-label Titration Period|Lack of Efficacy|3
974306|NCT01223365|1977764|FG000|Open-label Titration Period|Withdrawal by Subject|5
974307|NCT01223365|1977764|FG000|Open-label Titration Period|Protocol Violation|1
974308|NCT01223365|1977764|FG000|Open-label Titration Period|Lost to Follow-up|2
974309|NCT01223365|1977764|FG000|Open-label Titration Period|Noncompliance with study drug admin|1
974310|NCT01223365|1977764|FG000|Open-label Titration Period|Noncompliance with study procedures|2
974311|NCT01223365|1977764|FG000|Open-label Titration Period|Starting physical therapy|1
974312|NCT01223365|1977764|FG000|Open-label Treatment Period|Adverse Event|39
974313|NCT01223365|1977764|FG000|Open-label Treatment Period|Lack of Efficacy|2
974314|NCT01223365|1977764|FG000|Open-label Treatment Period|Withdrawal by Subject|19
974315|NCT01223365|1977764|FG000|Open-label Treatment Period|Protocol Violation|15
974316|NCT01223365|1977764|FG000|Open-label Treatment Period|Lost to Follow-up|7
974317|NCT01223365|1977764|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7
974318|NCT01223365|1977764|FG000|Open-label Treatment Period|Noncompliance with study procedures|6
974319|NCT01223365|1977764|FG000|Open-label Treatment Period|Moved out of area|2
974320|NCT01223365|1977764|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1
974321|NCT01223365|1977764|FG000|Open-label Treatment Period|"Out of window"|1
974322|NCT01223365|1977764|FG000|Open-label Treatment Period|Starting physical therapy|1
974323|NCT01223365|1977764|FG000|Open-label Treatment Period|Physician Decision|2
974324|NCT01223404|1977794|FG000|First Intervention (1 Day)|Adverse Event|0
974325|NCT01223404|1977795|FG001|First Intervention (1 Day)|Adverse Event|0
974326|NCT01223404|1977796|FG002|First Intervention (1 Day)|Adverse Event|0
974327|NCT01223404|1977797|FG003|First Intervention (1 Day)|Adverse Event|1
974328|NCT01223404|1977798|FG004|First Intervention (1 Day)|Adverse Event|0
974329|NCT01223404|1977799|FG005|First Intervention (1 Day)|Adverse Event|0
974330|NCT01223404|1977794|FG000|Second Intervention (1 Day)|Adverse Event|1
974331|NCT01223404|1977795|FG001|Second Intervention (1 Day)|Adverse Event|0
974332|NCT01223404|1977796|FG002|Second Intervention (1 Day)|Adverse Event|0
974333|NCT01223404|1977797|FG003|Second Intervention (1 Day)|Adverse Event|0
974334|NCT01223404|1977798|FG004|Second Intervention (1 Day)|Adverse Event|0
974335|NCT01223404|1977799|FG005|Second Intervention (1 Day)|Adverse Event|0
974336|NCT01223404|1977794|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0
974337|NCT01223404|1977795|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0
974338|NCT01223404|1977796|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0
974339|NCT01223404|1977797|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1
974340|NCT01223404|1977798|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0
974341|NCT01223404|1977799|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0
974342|NCT01223937|1977835|FG000|Overall Study|Withdrawal by Subject|3
974343|NCT01223937|1977836|FG001|Overall Study|Withdrawal by Subject|2
974344|NCT01223937|1977835|FG000|Overall Study|Lost to Follow-up|1
974345|NCT01223937|1977836|FG001|Overall Study|Lost to Follow-up|4
974346|NCT01223937|1977835|FG000|Overall Study|Adverse Event|1
974347|NCT01223937|1977836|FG001|Overall Study|Adverse Event|4
974348|NCT01223937|1977835|FG000|Overall Study|Protocol Violation|8
974349|NCT01223937|1977836|FG001|Overall Study|Protocol Violation|7
974350|NCT01223937|1977835|FG000|Overall Study|Other|4
974351|NCT01223937|1977836|FG001|Overall Study|Other|1
974352|NCT01224158|1977867|FG000|Overall Study|Withdrawal by Subject|1
974353|NCT01224158|1977868|FG001|Overall Study|Withdrawal by Subject|0
974354|NCT01224171|1977876|FG000|Overall Study|Adverse Event|8
974355|NCT01224171|1977877|FG001|Overall Study|Adverse Event|4
974356|NCT01224171|1977876|FG000|Overall Study|Protocol Violation|0
974357|NCT01224171|1977877|FG001|Overall Study|Protocol Violation|1
974358|NCT01224171|1977876|FG000|Overall Study|Lack of Efficacy|5
974359|NCT01224171|1977877|FG001|Overall Study|Lack of Efficacy|1
974360|NCT01224171|1977876|FG000|Overall Study|Withdrawal of Consent|2
974361|NCT01224171|1977877|FG001|Overall Study|Withdrawal of Consent|4
974362|NCT01224171|1977876|FG000|Overall Study|Lost to Follow-up|0
974363|NCT01224171|1977877|FG001|Overall Study|Lost to Follow-up|3
974364|NCT01224431|1977899|FG000|Overall Study|not randomized|0
974365|NCT01224431|1977900|FG001|Overall Study|not randomized|4
974366|NCT01224431|1977899|FG000|Overall Study|no video record|0
974367|NCT01224431|1977900|FG001|Overall Study|no video record|1
974368|NCT01224639|1977924|FG000|Overall Study|Withdrawal by Subject|0
974369|NCT01224639|1977925|FG001|Overall Study|Withdrawal by Subject|0
974370|NCT01224639|1977926|FG002|Overall Study|Withdrawal by Subject|0
974371|NCT01224639|1977927|FG003|Overall Study|Withdrawal by Subject|0
974372|NCT01224639|1977928|FG004|Overall Study|Withdrawal by Subject|2
974373|NCT01224639|1977929|FG005|Overall Study|Withdrawal by Subject|0
974374|NCT01224639|1977930|FG006|Overall Study|Withdrawal by Subject|1
974375|NCT01224639|1977931|FG007|Overall Study|Withdrawal by Subject|1
974376|NCT01224639|1977924|FG000|Overall Study|Adverse Event|0
974377|NCT01224639|1977925|FG001|Overall Study|Adverse Event|0
974378|NCT01224639|1977926|FG002|Overall Study|Adverse Event|0
974379|NCT01224639|1977927|FG003|Overall Study|Adverse Event|0
974380|NCT01224639|1977928|FG004|Overall Study|Adverse Event|0
974381|NCT01224639|1977929|FG005|Overall Study|Adverse Event|0
974382|NCT01224639|1977930|FG006|Overall Study|Adverse Event|0
974383|NCT01224639|1977931|FG007|Overall Study|Adverse Event|1
974384|NCT01224782|1977958|FG000|Overall Study|Lost to Follow-up|177
974385|NCT01224782|1977958|FG000|Overall Study|Withdrawal by Subject|16
974386|NCT01224782|1977958|FG000|Overall Study|Death|14
974387|NCT01224782|1977958|FG000|Overall Study|Improvement|13
974388|NCT01224782|1977958|FG000|Overall Study|Adverse Event|12
974389|NCT01224782|1977958|FG000|Overall Study|Adverse Reaction|11
974390|NCT01224782|1977958|FG000|Overall Study|Noncompliance|10
974391|NCT01224782|1977958|FG000|Overall Study|Other|4
974392|NCT01224782|1977958|FG000|Overall Study|Start of Dialysis|3
974393|NCT01224782|1977958|FG000|Overall Study|Change of Treatment|1
974394|NCT01224782|1977958|FG000|Overall Study|Financial Reasons|1
974395|NCT01224782|1977958|FG000|Overall Study|Deterioration|1
974396|NCT01224782|1977958|FG000|Overall Study|Transplantation|1
974397|NCT01224821|1977962|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
974398|NCT01224821|1977962|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38
974399|NCT01224821|1977962|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
974400|NCT01224821|1977962|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
974401|NCT01224821|1977962|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
974402|NCT01224821|1977962|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
974403|NCT01224821|1977962|FG000|Long-Term Follow-Up|Death|2
974404|NCT01224821|1977962|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
974405|NCT01224925|1977968|FG000|Overall Study|Lost to Follow-up|3
974406|NCT01224925|1977969|FG001|Overall Study|Lost to Follow-up|2
974407|NCT01225146|1978010|FG000|Overall Study|Sponsor discontinued making 2mg drug|0
974408|NCT01225146|1978011|FG001|Overall Study|Sponsor discontinued making 2mg drug|2
974409|NCT01225159|1978021|FG000|Overall Study|Change operation|1
974410|NCT01225159|1978022|FG001|Overall Study|Change operation|0
974411|NCT01225172|1978030|FG000|Overall Study|Subject decision to stop|1
974412|NCT01225172|1978031|FG001|Overall Study|Subject decision to stop|0
974413|NCT01225172|1978030|FG000|Overall Study|Subject request to discontinue treatment|3
974414|NCT01225172|1978031|FG001|Overall Study|Subject request to discontinue treatment|1
974415|NCT01225172|1978030|FG000|Overall Study|Subject no longer meets study criteria|1
974416|NCT01225172|1978031|FG001|Overall Study|Subject no longer meets study criteria|0
974417|NCT01225172|1978030|FG000|Overall Study|Withdrawal by Subject|1
974418|NCT01225172|1978031|FG001|Overall Study|Withdrawal by Subject|0
974419|NCT01225211|1978047|FG000|Overall Study|Adverse Event|0
974420|NCT01225211|1978048|FG001|Overall Study|Adverse Event|0
974421|NCT01225211|1978049|FG002|Overall Study|Adverse Event|1
974422|NCT01225211|1978050|FG003|Overall Study|Adverse Event|0
974423|NCT01225211|1978051|FG004|Overall Study|Adverse Event|0
974424|NCT01225211|1978052|FG005|Overall Study|Adverse Event|0
974425|NCT01225211|1978053|FG006|Overall Study|Adverse Event|0
974426|NCT01225211|1978054|FG007|Overall Study|Adverse Event|0
974427|NCT01225211|1978055|FG008|Overall Study|Adverse Event|0
974428|NCT01225211|1978056|FG009|Overall Study|Adverse Event|1
974429|NCT01225211|1978047|FG000|Overall Study|Withdrawal by Subject|0
974430|NCT01225211|1978048|FG001|Overall Study|Withdrawal by Subject|0
974431|NCT01225211|1978049|FG002|Overall Study|Withdrawal by Subject|0
974432|NCT01225211|1978050|FG003|Overall Study|Withdrawal by Subject|0
974433|NCT01225211|1978051|FG004|Overall Study|Withdrawal by Subject|0
974434|NCT01225211|1978052|FG005|Overall Study|Withdrawal by Subject|0
974435|NCT01225211|1978053|FG006|Overall Study|Withdrawal by Subject|1
974436|NCT01225211|1978054|FG007|Overall Study|Withdrawal by Subject|0
974437|NCT01225211|1978055|FG008|Overall Study|Withdrawal by Subject|1
974438|NCT01225211|1978056|FG009|Overall Study|Withdrawal by Subject|3
974439|NCT01225211|1978047|FG000|Overall Study|Other|0
974440|NCT01225211|1978048|FG001|Overall Study|Other|0
974441|NCT01225211|1978049|FG002|Overall Study|Other|0
974442|NCT01225211|1978050|FG003|Overall Study|Other|0
974443|NCT01225211|1978051|FG004|Overall Study|Other|0
974444|NCT01225211|1978052|FG005|Overall Study|Other|0
974445|NCT01225211|1978053|FG006|Overall Study|Other|0
974446|NCT01225211|1978054|FG007|Overall Study|Other|0
974447|NCT01225211|1978055|FG008|Overall Study|Other|0
974448|NCT01225211|1978056|FG009|Overall Study|Other|1
974449|NCT01225549|1978155|FG000|Period 4 - Washout|Disallowed medication|0
974450|NCT01225549|1978156|FG001|Period 4 - Washout|Disallowed medication|1
974451|NCT01225549|1978157|FG002|Period 4 - Washout|Disallowed medication|0
974452|NCT01225549|1978158|FG003|Period 4 - Washout|Disallowed medication|0
974453|NCT01225549|1978159|FG004|Period 4 - Washout|Disallowed medication|0
974454|NCT01225549|1978160|FG005|Period 4 - Washout|Disallowed medication|0
974455|NCT01225549|1978161|FG006|Period 4 - Washout|Disallowed medication|0
974456|NCT01225549|1978162|FG007|Period 4 - Washout|Disallowed medication|0
974457|NCT01225549|1978163|FG008|Period 4 - Washout|Disallowed medication|0
974458|NCT01225549|1978164|FG009|Period 4 - Washout|Disallowed medication|0
974459|NCT01225549|1978155|FG000|Period 6 - Washout|Disallowed medication|0
974460|NCT01225549|1978156|FG001|Period 6 - Washout|Disallowed medication|0
974461|NCT01225549|1978157|FG002|Period 6 - Washout|Disallowed medication|0
974462|NCT01225549|1978158|FG003|Period 6 - Washout|Disallowed medication|1
974463|NCT01225549|1978159|FG004|Period 6 - Washout|Disallowed medication|0
974464|NCT01225549|1978160|FG005|Period 6 - Washout|Disallowed medication|0
974465|NCT01225549|1978161|FG006|Period 6 - Washout|Disallowed medication|0
974466|NCT01225549|1978162|FG007|Period 6 - Washout|Disallowed medication|0
974467|NCT01225549|1978163|FG008|Period 6 - Washout|Disallowed medication|0
974468|NCT01225549|1978164|FG009|Period 6 - Washout|Disallowed medication|0
974469|NCT01225562|1978177|FG000|Overall Study|Withdrawal by Subject|52
974470|NCT01225562|1978178|FG001|Overall Study|Withdrawal by Subject|50
974471|NCT01225562|1978179|FG002|Overall Study|Withdrawal by Subject|52
974472|NCT01225562|1978177|FG000|Overall Study|Lost to Follow-up|3
974473|NCT01225562|1978178|FG001|Overall Study|Lost to Follow-up|6
974474|NCT01225562|1978179|FG002|Overall Study|Lost to Follow-up|1
974475|NCT01225731|1978192|FG000|Part 1|Did not meet eligibility criteria|1
974476|NCT01225731|1978193|FG001|Part 1|Did not meet eligibility criteria|0
974477|NCT01225731|1978194|FG002|Part 1|Did not meet eligibility criteria|0
974478|NCT01225731|1978195|FG003|Part 1|Did not meet eligibility criteria|0
974479|NCT01225731|1978196|FG004|Part 1|Did not meet eligibility criteria|1
974480|NCT01225731|1978197|FG005|Part 1|Did not meet eligibility criteria|0
974481|NCT01225731|1978198|FG006|Part 1|Did not meet eligibility criteria|0
974482|NCT01225731|1978199|FG007|Part 1|Did not meet eligibility criteria|0
974483|NCT01225731|1978200|FG008|Part 1|Did not meet eligibility criteria|0
974484|NCT01225731|1978201|FG009|Part 1|Did not meet eligibility criteria|0
974485|NCT01225731|1978202|FG010|Part 1|Did not meet eligibility criteria|0
974486|NCT01225731|1978203|FG011|Part 1|Did not meet eligibility criteria|0
974487|NCT01225731|1978204|FG012|Part 1|Did not meet eligibility criteria|0
974488|NCT01225731|1978192|FG000|Part 1|Adverse Event|1
974489|NCT01225731|1978193|FG001|Part 1|Adverse Event|2
974490|NCT01225731|1978194|FG002|Part 1|Adverse Event|1
974491|NCT01225731|1978195|FG003|Part 1|Adverse Event|1
974492|NCT01225731|1978196|FG004|Part 1|Adverse Event|1
974493|NCT01225731|1978197|FG005|Part 1|Adverse Event|0
974494|NCT01225731|1978198|FG006|Part 1|Adverse Event|0
974495|NCT01225731|1978199|FG007|Part 1|Adverse Event|0
974496|NCT01225731|1978200|FG008|Part 1|Adverse Event|0
974497|NCT01225731|1978201|FG009|Part 1|Adverse Event|0
974498|NCT01225731|1978202|FG010|Part 1|Adverse Event|0
974499|NCT01225731|1978203|FG011|Part 1|Adverse Event|0
974500|NCT01225731|1978204|FG012|Part 1|Adverse Event|0
974501|NCT01225731|1978192|FG000|Part 1|Withdrawal by Subject|0
974502|NCT01225731|1978193|FG001|Part 1|Withdrawal by Subject|3
974503|NCT01225731|1978194|FG002|Part 1|Withdrawal by Subject|0
974504|NCT01225731|1978195|FG003|Part 1|Withdrawal by Subject|0
974505|NCT01225731|1978196|FG004|Part 1|Withdrawal by Subject|4
974506|NCT01225731|1978197|FG005|Part 1|Withdrawal by Subject|0
974507|NCT01225731|1978198|FG006|Part 1|Withdrawal by Subject|0
974508|NCT01225731|1978199|FG007|Part 1|Withdrawal by Subject|0
974509|NCT01225731|1978200|FG008|Part 1|Withdrawal by Subject|0
974510|NCT01225731|1978201|FG009|Part 1|Withdrawal by Subject|0
974511|NCT01225731|1978202|FG010|Part 1|Withdrawal by Subject|0
974512|NCT01225731|1978203|FG011|Part 1|Withdrawal by Subject|0
974513|NCT01225731|1978204|FG012|Part 1|Withdrawal by Subject|0
974514|NCT01225731|1978192|FG000|Part 1|Protocol Violation|0
974515|NCT01225731|1978193|FG001|Part 1|Protocol Violation|0
974516|NCT01225731|1978194|FG002|Part 1|Protocol Violation|0
974517|NCT01225731|1978195|FG003|Part 1|Protocol Violation|1
974518|NCT01225731|1978196|FG004|Part 1|Protocol Violation|0
974519|NCT01225731|1978197|FG005|Part 1|Protocol Violation|0
974520|NCT01225731|1978198|FG006|Part 1|Protocol Violation|0
974521|NCT01225731|1978199|FG007|Part 1|Protocol Violation|0
974522|NCT01225731|1978200|FG008|Part 1|Protocol Violation|0
974523|NCT01225731|1978201|FG009|Part 1|Protocol Violation|0
974524|NCT01225731|1978202|FG010|Part 1|Protocol Violation|0
974525|NCT01225731|1978203|FG011|Part 1|Protocol Violation|0
974526|NCT01225731|1978204|FG012|Part 1|Protocol Violation|0
974527|NCT01225731|1978192|FG000|Part 2|Protocol Violation|0
974528|NCT01225731|1978193|FG001|Part 2|Protocol Violation|0
974529|NCT01225731|1978194|FG002|Part 2|Protocol Violation|0
974530|NCT01225731|1978195|FG003|Part 2|Protocol Violation|0
974531|NCT01225731|1978196|FG004|Part 2|Protocol Violation|0
974532|NCT01225731|1978197|FG005|Part 2|Protocol Violation|1
974533|NCT01225731|1978198|FG006|Part 2|Protocol Violation|0
974534|NCT01225731|1978199|FG007|Part 2|Protocol Violation|0
974535|NCT01225731|1978200|FG008|Part 2|Protocol Violation|1
974536|NCT01225731|1978201|FG009|Part 2|Protocol Violation|0
974537|NCT01225731|1978202|FG010|Part 2|Protocol Violation|0
974538|NCT01225731|1978203|FG011|Part 2|Protocol Violation|0
974539|NCT01225731|1978204|FG012|Part 2|Protocol Violation|0
974540|NCT01225731|1978192|FG000|Part 2|Adverse Event|0
974541|NCT01225731|1978193|FG001|Part 2|Adverse Event|0
974542|NCT01225731|1978194|FG002|Part 2|Adverse Event|0
974543|NCT01225731|1978195|FG003|Part 2|Adverse Event|0
974544|NCT01225731|1978196|FG004|Part 2|Adverse Event|0
974545|NCT01225731|1978197|FG005|Part 2|Adverse Event|0
974546|NCT01225731|1978198|FG006|Part 2|Adverse Event|4
974547|NCT01225731|1978199|FG007|Part 2|Adverse Event|4
974548|NCT01225731|1978200|FG008|Part 2|Adverse Event|2
974549|NCT01225731|1978201|FG009|Part 2|Adverse Event|0
974550|NCT01225731|1978202|FG010|Part 2|Adverse Event|0
974551|NCT01225731|1978203|FG011|Part 2|Adverse Event|0
974552|NCT01225731|1978204|FG012|Part 2|Adverse Event|0
974553|NCT01225731|1978192|FG000|Part 2|Lack of Efficacy|0
974554|NCT01225731|1978193|FG001|Part 2|Lack of Efficacy|0
974555|NCT01225731|1978194|FG002|Part 2|Lack of Efficacy|0
974556|NCT01225731|1978195|FG003|Part 2|Lack of Efficacy|0
974557|NCT01225731|1978196|FG004|Part 2|Lack of Efficacy|0
974558|NCT01225731|1978197|FG005|Part 2|Lack of Efficacy|1
974559|NCT01225731|1978198|FG006|Part 2|Lack of Efficacy|0
974560|NCT01225731|1978199|FG007|Part 2|Lack of Efficacy|12
974561|NCT01225731|1978200|FG008|Part 2|Lack of Efficacy|3
974562|NCT01225731|1978201|FG009|Part 2|Lack of Efficacy|0
974563|NCT01225731|1978202|FG010|Part 2|Lack of Efficacy|0
974564|NCT01225731|1978203|FG011|Part 2|Lack of Efficacy|0
974565|NCT01225731|1978204|FG012|Part 2|Lack of Efficacy|0
974566|NCT01225731|1978192|FG000|Part 2|Pregnancy|0
974567|NCT01225731|1978193|FG001|Part 2|Pregnancy|0
974568|NCT01225731|1978194|FG002|Part 2|Pregnancy|0
974569|NCT01225731|1978195|FG003|Part 2|Pregnancy|0
974570|NCT01225731|1978196|FG004|Part 2|Pregnancy|0
974571|NCT01225731|1978197|FG005|Part 2|Pregnancy|0
974572|NCT01225731|1978198|FG006|Part 2|Pregnancy|1
974573|NCT01225731|1978199|FG007|Part 2|Pregnancy|0
974574|NCT01225731|1978200|FG008|Part 2|Pregnancy|1
974575|NCT01225731|1978201|FG009|Part 2|Pregnancy|0
974576|NCT01225731|1978202|FG010|Part 2|Pregnancy|0
974577|NCT01225731|1978203|FG011|Part 2|Pregnancy|0
974578|NCT01225731|1978204|FG012|Part 2|Pregnancy|0
974579|NCT01225731|1978192|FG000|Part 2|Lost to Follow-up|0
974580|NCT01225731|1978193|FG001|Part 2|Lost to Follow-up|0
974581|NCT01225731|1978194|FG002|Part 2|Lost to Follow-up|0
974582|NCT01225731|1978195|FG003|Part 2|Lost to Follow-up|0
974583|NCT01225731|1978196|FG004|Part 2|Lost to Follow-up|0
974584|NCT01225731|1978197|FG005|Part 2|Lost to Follow-up|0
974585|NCT01225731|1978198|FG006|Part 2|Lost to Follow-up|0
974586|NCT01225731|1978199|FG007|Part 2|Lost to Follow-up|3
974587|NCT01225731|1978200|FG008|Part 2|Lost to Follow-up|1
974588|NCT01225731|1978201|FG009|Part 2|Lost to Follow-up|0
974589|NCT01225731|1978202|FG010|Part 2|Lost to Follow-up|0
974590|NCT01225731|1978203|FG011|Part 2|Lost to Follow-up|0
974591|NCT01225731|1978204|FG012|Part 2|Lost to Follow-up|0
974592|NCT01225731|1978192|FG000|Part 2|Physician Decision|0
974593|NCT01225731|1978193|FG001|Part 2|Physician Decision|0
974594|NCT01225731|1978194|FG002|Part 2|Physician Decision|0
974595|NCT01225731|1978195|FG003|Part 2|Physician Decision|0
974596|NCT01225731|1978196|FG004|Part 2|Physician Decision|0
974597|NCT01225731|1978197|FG005|Part 2|Physician Decision|0
974598|NCT01225731|1978198|FG006|Part 2|Physician Decision|0
974599|NCT01225731|1978199|FG007|Part 2|Physician Decision|2
974600|NCT01225731|1978200|FG008|Part 2|Physician Decision|2
974601|NCT01225731|1978201|FG009|Part 2|Physician Decision|0
974602|NCT01225731|1978202|FG010|Part 2|Physician Decision|0
974603|NCT01225731|1978203|FG011|Part 2|Physician Decision|0
974604|NCT01225731|1978204|FG012|Part 2|Physician Decision|0
974605|NCT01225731|1978192|FG000|Part 2|Withdrawal by Subject|0
974606|NCT01225731|1978193|FG001|Part 2|Withdrawal by Subject|0
974607|NCT01225731|1978194|FG002|Part 2|Withdrawal by Subject|0
974608|NCT01225731|1978195|FG003|Part 2|Withdrawal by Subject|0
974609|NCT01225731|1978196|FG004|Part 2|Withdrawal by Subject|0
974610|NCT01225731|1978197|FG005|Part 2|Withdrawal by Subject|1
974611|NCT01225731|1978198|FG006|Part 2|Withdrawal by Subject|3
974612|NCT01225731|1978199|FG007|Part 2|Withdrawal by Subject|4
974613|NCT01225731|1978200|FG008|Part 2|Withdrawal by Subject|1
974614|NCT01225731|1978201|FG009|Part 2|Withdrawal by Subject|0
974615|NCT01225731|1978202|FG010|Part 2|Withdrawal by Subject|0
974616|NCT01225731|1978203|FG011|Part 2|Withdrawal by Subject|0
974617|NCT01225731|1978204|FG012|Part 2|Withdrawal by Subject|0
974618|NCT01225731|1978192|FG000|Part 3|Adverse Event|0
974619|NCT01225731|1978193|FG001|Part 3|Adverse Event|0
974620|NCT01225731|1978194|FG002|Part 3|Adverse Event|0
974621|NCT01225731|1978195|FG003|Part 3|Adverse Event|0
974622|NCT01225731|1978196|FG004|Part 3|Adverse Event|0
974623|NCT01225731|1978197|FG005|Part 3|Adverse Event|0
974624|NCT01225731|1978198|FG006|Part 3|Adverse Event|0
974625|NCT01225731|1978199|FG007|Part 3|Adverse Event|0
974626|NCT01225731|1978200|FG008|Part 3|Adverse Event|0
974627|NCT01225731|1978201|FG009|Part 3|Adverse Event|0
974628|NCT01225731|1978202|FG010|Part 3|Adverse Event|1
974629|NCT01225731|1978203|FG011|Part 3|Adverse Event|1
974630|NCT01225731|1978204|FG012|Part 3|Adverse Event|0
974631|NCT01225731|1978192|FG000|Part 3|Lost to Follow-up|0
974632|NCT01225731|1978193|FG001|Part 3|Lost to Follow-up|0
974633|NCT01225731|1978194|FG002|Part 3|Lost to Follow-up|0
974634|NCT01225731|1978195|FG003|Part 3|Lost to Follow-up|0
974635|NCT01225731|1978196|FG004|Part 3|Lost to Follow-up|0
974636|NCT01225731|1978197|FG005|Part 3|Lost to Follow-up|0
974637|NCT01225731|1978198|FG006|Part 3|Lost to Follow-up|0
974638|NCT01225731|1978199|FG007|Part 3|Lost to Follow-up|0
974639|NCT01225731|1978200|FG008|Part 3|Lost to Follow-up|0
974640|NCT01225731|1978201|FG009|Part 3|Lost to Follow-up|0
974641|NCT01225731|1978202|FG010|Part 3|Lost to Follow-up|1
974642|NCT01225731|1978203|FG011|Part 3|Lost to Follow-up|2
974643|NCT01225731|1978204|FG012|Part 3|Lost to Follow-up|1
974644|NCT01225731|1978192|FG000|Part 3|Physician Decision|0
974645|NCT01225731|1978193|FG001|Part 3|Physician Decision|0
974646|NCT01225731|1978194|FG002|Part 3|Physician Decision|0
974647|NCT01225731|1978195|FG003|Part 3|Physician Decision|0
974648|NCT01225731|1978196|FG004|Part 3|Physician Decision|0
974649|NCT01225731|1978197|FG005|Part 3|Physician Decision|0
974650|NCT01225731|1978198|FG006|Part 3|Physician Decision|0
974651|NCT01225731|1978199|FG007|Part 3|Physician Decision|0
974652|NCT01225731|1978200|FG008|Part 3|Physician Decision|0
974653|NCT01225731|1978201|FG009|Part 3|Physician Decision|0
974654|NCT01225731|1978202|FG010|Part 3|Physician Decision|0
974655|NCT01225731|1978203|FG011|Part 3|Physician Decision|1
974656|NCT01225731|1978204|FG012|Part 3|Physician Decision|2
974657|NCT01225731|1978192|FG000|Part 3|Withdrawal by Subject|0
974658|NCT01225731|1978193|FG001|Part 3|Withdrawal by Subject|0
974659|NCT01225731|1978194|FG002|Part 3|Withdrawal by Subject|0
974660|NCT01225731|1978195|FG003|Part 3|Withdrawal by Subject|0
974661|NCT01225731|1978196|FG004|Part 3|Withdrawal by Subject|0
974662|NCT01225731|1978197|FG005|Part 3|Withdrawal by Subject|0
974663|NCT01225731|1978198|FG006|Part 3|Withdrawal by Subject|0
974664|NCT01225731|1978199|FG007|Part 3|Withdrawal by Subject|0
974665|NCT01225731|1978200|FG008|Part 3|Withdrawal by Subject|0
974666|NCT01225731|1978201|FG009|Part 3|Withdrawal by Subject|0
974667|NCT01225731|1978202|FG010|Part 3|Withdrawal by Subject|4
974668|NCT01225731|1978203|FG011|Part 3|Withdrawal by Subject|6
974669|NCT01225731|1978204|FG012|Part 3|Withdrawal by Subject|4
974670|NCT01225822|1978238|FG000|Overall Study|Adverse Event|13
974671|NCT01225822|1978239|FG001|Overall Study|Adverse Event|31
974672|NCT01225822|1978240|FG002|Overall Study|Adverse Event|18
974673|NCT01225822|1978241|FG003|Overall Study|Adverse Event|23
974674|NCT01225822|1978242|FG004|Overall Study|Adverse Event|14
974675|NCT01225822|1978238|FG000|Overall Study|Protocol Violation|6
974676|NCT01225822|1978239|FG001|Overall Study|Protocol Violation|8
974677|NCT01225822|1978240|FG002|Overall Study|Protocol Violation|6
974678|NCT01225822|1978241|FG003|Overall Study|Protocol Violation|7
974679|NCT01225822|1978242|FG004|Overall Study|Protocol Violation|4
974680|NCT01225822|1978238|FG000|Overall Study|Lost to Follow-up|0
974681|NCT01225822|1978239|FG001|Overall Study|Lost to Follow-up|0
974682|NCT01225822|1978240|FG002|Overall Study|Lost to Follow-up|0
974683|NCT01225822|1978241|FG003|Overall Study|Lost to Follow-up|1
974684|NCT01225822|1978242|FG004|Overall Study|Lost to Follow-up|0
974685|NCT01225822|1978238|FG000|Overall Study|Withdrawal by Subject|6
974686|NCT01225822|1978239|FG001|Overall Study|Withdrawal by Subject|7
974687|NCT01225822|1978240|FG002|Overall Study|Withdrawal by Subject|7
974688|NCT01225822|1978241|FG003|Overall Study|Withdrawal by Subject|11
974689|NCT01225822|1978242|FG004|Overall Study|Withdrawal by Subject|6
974690|NCT01225822|1978238|FG000|Overall Study|Other|13
974691|NCT01225822|1978239|FG001|Overall Study|Other|10
974692|NCT01225822|1978240|FG002|Overall Study|Other|7
974693|NCT01225822|1978241|FG003|Overall Study|Other|10
974694|NCT01225822|1978242|FG004|Overall Study|Other|7
974695|NCT01225835|1978259|FG000|Overall Study|Completed protocol|2
974696|NCT01225835|1978260|FG001|Overall Study|Completed protocol|1
974697|NCT01225835|1978259|FG000|Overall Study|Did not meet hCG criterion|2
974698|NCT01225835|1978260|FG001|Overall Study|Did not meet hCG criterion|0
974699|NCT01225835|1978259|FG000|Overall Study|Adverse Event|2
974700|NCT01225835|1978260|FG001|Overall Study|Adverse Event|1
974701|NCT01225835|1978259|FG000|Overall Study|Other|1
974702|NCT01225835|1978260|FG001|Overall Study|Other|1
974703|NCT01225887|1978272|FG000|Overall Study|Ineligible:required test not done|2
974704|NCT01225887|1978272|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1
974705|NCT01225887|1978272|FG000|Overall Study|Ineligible:inadequate pathology|2
974706|NCT01225952|1978288|FG000|Overall Study|Lost to Follow-up|1
974707|NCT01225952|1978289|FG001|Overall Study|Lost to Follow-up|0
974708|NCT01225952|1978290|FG002|Overall Study|Lost to Follow-up|0
974709|NCT01225952|1978288|FG000|Overall Study|Study Eye Explanted|0
974710|NCT01225952|1978289|FG001|Overall Study|Study Eye Explanted|0
974711|NCT01225952|1978290|FG002|Overall Study|Study Eye Explanted|1
974712|NCT01225952|1978288|FG000|Overall Study|Withdrawal by Subject|4
974713|NCT01225952|1978289|FG001|Overall Study|Withdrawal by Subject|4
974714|NCT01225952|1978290|FG002|Overall Study|Withdrawal by Subject|5
974715|NCT01225952|1978288|FG000|Overall Study|Surgical complications|1
974716|NCT01225952|1978289|FG001|Overall Study|Surgical complications|0
974717|NCT01225952|1978290|FG002|Overall Study|Surgical complications|0
974718|NCT01225991|1978298|FG000|Overall Study|Withdrawal by Subject|6
974719|NCT01226043|1978304|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1
974720|NCT01226043|1978305|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2
974721|NCT01226043|1978306|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0
974722|NCT01226043|1978307|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0
974723|NCT01226043|1978304|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0
974724|NCT01226043|1978305|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1
974725|NCT01226043|1978306|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0
974726|NCT01226043|1978307|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0
974727|NCT01226043|1978304|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
974728|NCT01226043|1978305|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
974729|NCT01226043|1978306|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
974730|NCT01226043|1978307|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
974731|NCT01226043|1978304|FG000|4-week Crossover Phase - Period 1|Physician Decision|0
974732|NCT01226043|1978305|FG001|4-week Crossover Phase - Period 1|Physician Decision|6
974733|NCT01226043|1978306|FG002|4-week Crossover Phase - Period 1|Physician Decision|0
974734|NCT01226043|1978307|FG003|4-week Crossover Phase - Period 1|Physician Decision|0
974735|NCT01226043|1978304|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
974736|NCT01226043|1978305|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
974737|NCT01226043|1978306|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
974738|NCT01226043|1978307|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
974739|NCT01226043|1978304|FG000|4-week Crossover Phase - Period 2|Physician Decision|4
974740|NCT01226043|1978305|FG001|4-week Crossover Phase - Period 2|Physician Decision|5
974741|NCT01226043|1978306|FG002|4-week Crossover Phase - Period 2|Physician Decision|0
974742|NCT01226043|1978307|FG003|4-week Crossover Phase - Period 2|Physician Decision|0
974743|NCT01226043|1978304|FG000|6-week Re-randomization Phase|Adverse Event|0
974744|NCT01226043|1978305|FG001|6-week Re-randomization Phase|Adverse Event|0
974745|NCT01226043|1978306|FG002|6-week Re-randomization Phase|Adverse Event|1
974746|NCT01226043|1978307|FG003|6-week Re-randomization Phase|Adverse Event|1
974747|NCT01226043|1978304|FG000|6-week Re-randomization Phase|Protocol Violation|0
974748|NCT01226043|1978305|FG001|6-week Re-randomization Phase|Protocol Violation|0
974749|NCT01226043|1978306|FG002|6-week Re-randomization Phase|Protocol Violation|1
974750|NCT01226043|1978307|FG003|6-week Re-randomization Phase|Protocol Violation|1
974751|NCT01226043|1978304|FG000|6-week Re-randomization Phase|Lost to Follow-up|0
974752|NCT01226043|1978305|FG001|6-week Re-randomization Phase|Lost to Follow-up|0
974753|NCT01226043|1978306|FG002|6-week Re-randomization Phase|Lost to Follow-up|1
974754|NCT01226043|1978307|FG003|6-week Re-randomization Phase|Lost to Follow-up|3
974755|NCT01226043|1978304|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0
974756|NCT01226043|1978305|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0
1006633|NCT01468909|2025343|FG001|Overall Study|Never Treated|2
974757|NCT01226043|1978306|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1
974758|NCT01226043|1978307|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3
974759|NCT01226043|1978304|FG000|6-week Re-randomization Phase|Physician Decision|0
974760|NCT01226043|1978305|FG001|6-week Re-randomization Phase|Physician Decision|0
974761|NCT01226043|1978306|FG002|6-week Re-randomization Phase|Physician Decision|3
974762|NCT01226043|1978307|FG003|6-week Re-randomization Phase|Physician Decision|2
974763|NCT01226043|1978304|FG000|6-week Re-randomization Phase|completed in error|0
974764|NCT01226043|1978305|FG001|6-week Re-randomization Phase|completed in error|0
974765|NCT01226043|1978306|FG002|6-week Re-randomization Phase|completed in error|0
974766|NCT01226043|1978307|FG003|6-week Re-randomization Phase|completed in error|1
974767|NCT01226043|1978304|FG000|30-week Observational Phase|Adverse Event|0
974768|NCT01226043|1978305|FG001|30-week Observational Phase|Adverse Event|0
974769|NCT01226043|1978306|FG002|30-week Observational Phase|Adverse Event|1
974770|NCT01226043|1978307|FG003|30-week Observational Phase|Adverse Event|1
974771|NCT01226043|1978304|FG000|30-week Observational Phase|Protocol Violation|0
974772|NCT01226043|1978305|FG001|30-week Observational Phase|Protocol Violation|0
974773|NCT01226043|1978306|FG002|30-week Observational Phase|Protocol Violation|0
974774|NCT01226043|1978307|FG003|30-week Observational Phase|Protocol Violation|1
974775|NCT01226043|1978304|FG000|30-week Observational Phase|Lost to Follow-up|0
974776|NCT01226043|1978305|FG001|30-week Observational Phase|Lost to Follow-up|0
974777|NCT01226043|1978306|FG002|30-week Observational Phase|Lost to Follow-up|2
974778|NCT01226043|1978307|FG003|30-week Observational Phase|Lost to Follow-up|2
974779|NCT01226043|1978304|FG000|30-week Observational Phase|Withdrawal by Subject|0
974780|NCT01226043|1978305|FG001|30-week Observational Phase|Withdrawal by Subject|0
974781|NCT01226043|1978306|FG002|30-week Observational Phase|Withdrawal by Subject|1
974782|NCT01226043|1978307|FG003|30-week Observational Phase|Withdrawal by Subject|7
974783|NCT01226043|1978304|FG000|30-week Observational Phase|Physician Decision|0
974784|NCT01226043|1978305|FG001|30-week Observational Phase|Physician Decision|0
974785|NCT01226043|1978306|FG002|30-week Observational Phase|Physician Decision|2
974786|NCT01226043|1978307|FG003|30-week Observational Phase|Physician Decision|2
974787|NCT01226095|1978337|FG000|Overall Study|Poor compliance|1
974788|NCT01226121|1978351|FG000|Overall Study|Lost to Follow-up|2
974789|NCT01226121|1978352|FG001|Overall Study|Lost to Follow-up|0
974790|NCT01226121|1978353|FG002|Overall Study|Lost to Follow-up|1
974791|NCT01226459|1978367|FG000|Overall Study|Adverse Event|2
974792|NCT01226459|1978368|FG001|Overall Study|Adverse Event|8
974793|NCT01226459|1978367|FG000|Overall Study|Protocol Violation|4
974794|NCT01226459|1978368|FG001|Overall Study|Protocol Violation|3
974795|NCT01226459|1978367|FG000|Overall Study|Withdrawal by Subject|10
974796|NCT01226459|1978368|FG001|Overall Study|Withdrawal by Subject|13
974797|NCT01226459|1978367|FG000|Overall Study|Lost to Follow-up|4
974798|NCT01226459|1978368|FG001|Overall Study|Lost to Follow-up|8
974799|NCT01226459|1978367|FG000|Overall Study|Pregnancy|1
974800|NCT01226459|1978368|FG001|Overall Study|Pregnancy|0
974801|NCT01226472|1978374|FG000|Overall Study|Progressive Disease|1
974802|NCT01226511|1978417|FG000|Acute Treatment Period|Adverse Event|7
974803|NCT01226511|1978418|FG001|Acute Treatment Period|Adverse Event|6
974804|NCT01226511|1978417|FG000|Acute Treatment Period|Lack of Efficacy|2
974805|NCT01226511|1978418|FG001|Acute Treatment Period|Lack of Efficacy|1
974806|NCT01226511|1978417|FG000|Acute Treatment Period|Lost to Follow-up|3
974807|NCT01226511|1978418|FG001|Acute Treatment Period|Lost to Follow-up|6
974808|NCT01226511|1978417|FG000|Acute Treatment Period|Parent/caregiver decision|5
974809|NCT01226511|1978418|FG001|Acute Treatment Period|Parent/caregiver decision|7
974810|NCT01226511|1978417|FG000|Acute Treatment Period|Protocol Violation|5
974811|NCT01226511|1978418|FG001|Acute Treatment Period|Protocol Violation|5
974812|NCT01226511|1978417|FG000|Acute Treatment Period|Withdrawal by Subject|10
974813|NCT01226511|1978418|FG001|Acute Treatment Period|Withdrawal by Subject|6
974814|NCT01226511|1978417|FG000|Extension Treatment Period|Adverse Event|8
974815|NCT01226511|1978418|FG001|Extension Treatment Period|Adverse Event|8
974816|NCT01226511|1978417|FG000|Extension Treatment Period|Lack of Efficacy|3
974817|NCT01226511|1978418|FG001|Extension Treatment Period|Lack of Efficacy|2
974818|NCT01226511|1978417|FG000|Extension Treatment Period|Lost to Follow-up|4
974819|NCT01226511|1978418|FG001|Extension Treatment Period|Lost to Follow-up|3
974820|NCT01226511|1978417|FG000|Extension Treatment Period|Protocol Violation|2
974821|NCT01226511|1978418|FG001|Extension Treatment Period|Protocol Violation|2
974822|NCT01226511|1978417|FG000|Extension Treatment Period|Withdrawal by Subject|1
974823|NCT01226511|1978418|FG001|Extension Treatment Period|Withdrawal by Subject|3
974824|NCT01226511|1978417|FG000|Extension Treatment Period|Parent/Caregiver Decision|8
974825|NCT01226511|1978418|FG001|Extension Treatment Period|Parent/Caregiver Decision|8
974826|NCT01226511|1978417|FG000|Extension Treatment Period|Sponsor Decision|1
974827|NCT01226511|1978418|FG001|Extension Treatment Period|Sponsor Decision|1
974828|NCT01226511|1978417|FG000|Taper Period|Adverse Event|1
974829|NCT01226511|1978418|FG001|Taper Period|Adverse Event|0
974830|NCT01226511|1978417|FG000|Taper Period|Lost to Follow-up|2
974831|NCT01226511|1978418|FG001|Taper Period|Lost to Follow-up|2
974832|NCT01226511|1978417|FG000|Taper Period|Protocol Violation|1
974833|NCT01226511|1978418|FG001|Taper Period|Protocol Violation|0
974834|NCT01226511|1978417|FG000|Taper Period|Parent/Caregiver Decision|1
974835|NCT01226511|1978418|FG001|Taper Period|Parent/Caregiver Decision|1
974836|NCT01226745|1978478|FG000|Overall Study|Did not complete schedule of assessments|8
974837|NCT01226745|1978479|FG001|Overall Study|Did not complete schedule of assessments|3
974838|NCT01226745|1978480|FG002|Overall Study|Did not complete schedule of assessments|6
974839|NCT01226745|1978481|FG003|Overall Study|Did not complete schedule of assessments|0
974840|NCT01226745|1978482|FG004|Overall Study|Did not complete schedule of assessments|0
974841|NCT01226745|1978483|FG005|Overall Study|Did not complete schedule of assessments|1
974842|NCT01226745|1978478|FG000|Overall Study|Lost to Follow-up|2
974843|NCT01226745|1978479|FG001|Overall Study|Lost to Follow-up|6
974844|NCT01226745|1978480|FG002|Overall Study|Lost to Follow-up|6
974845|NCT01226745|1978481|FG003|Overall Study|Lost to Follow-up|1
974846|NCT01226745|1978482|FG004|Overall Study|Lost to Follow-up|1
974847|NCT01226745|1978483|FG005|Overall Study|Lost to Follow-up|2
974848|NCT01226745|1978478|FG000|Overall Study|Death|1
974849|NCT01226745|1978479|FG001|Overall Study|Death|0
974850|NCT01226745|1978480|FG002|Overall Study|Death|0
974851|NCT01226745|1978481|FG003|Overall Study|Death|0
974852|NCT01226745|1978482|FG004|Overall Study|Death|0
974853|NCT01226745|1978483|FG005|Overall Study|Death|1
974854|NCT01226745|1978478|FG000|Overall Study|Other|6
974855|NCT01226745|1978479|FG001|Overall Study|Other|7
974856|NCT01226745|1978480|FG002|Overall Study|Other|8
974857|NCT01226745|1978481|FG003|Overall Study|Other|4
974858|NCT01226745|1978482|FG004|Overall Study|Other|3
974859|NCT01226745|1978483|FG005|Overall Study|Other|1
974860|NCT01227018|1978521|FG000|Overall Study|Disease progression|9
974861|NCT01227018|1978521|FG000|Overall Study|Toxicity|2
974862|NCT01227018|1978521|FG000|Overall Study|Withdrew after beginning treatment|4
974863|NCT01227044|1978527|FG000|Overall Study|Lost to Follow-up|5
974864|NCT01227044|1978528|FG001|Overall Study|Lost to Follow-up|7
974865|NCT01227044|1978527|FG000|Overall Study|Discontinued Intervention|1
974866|NCT01227044|1978528|FG001|Overall Study|Discontinued Intervention|2
974867|NCT01227252|1978548|FG000|Overall Study|Sponsor Decision|0
974868|NCT01227252|1978549|FG001|Overall Study|Sponsor Decision|1
974869|NCT01227252|1978550|FG002|Overall Study|Sponsor Decision|0
974870|NCT01227252|1978551|FG003|Overall Study|Sponsor Decision|0
974871|NCT01227252|1978548|FG000|Overall Study|Lost to Follow-up|0
974872|NCT01227252|1978549|FG001|Overall Study|Lost to Follow-up|1
974873|NCT01227252|1978550|FG002|Overall Study|Lost to Follow-up|0
974874|NCT01227252|1978551|FG003|Overall Study|Lost to Follow-up|0
974875|NCT01227252|1978548|FG000|Overall Study|Withdrawal by Subject|0
974876|NCT01227252|1978549|FG001|Overall Study|Withdrawal by Subject|1
974877|NCT01227252|1978550|FG002|Overall Study|Withdrawal by Subject|0
974878|NCT01227252|1978551|FG003|Overall Study|Withdrawal by Subject|0
974879|NCT01227265|1978567|FG000|Overall Study|Did Not Receive Treatment|1
974880|NCT01227265|1978568|FG001|Overall Study|Did Not Receive Treatment|2
974881|NCT01227265|1978569|FG002|Overall Study|Did Not Receive Treatment|0
974882|NCT01227265|1978567|FG000|Overall Study|Administrative|1
974883|NCT01227265|1978568|FG001|Overall Study|Administrative|0
974884|NCT01227265|1978569|FG002|Overall Study|Administrative|2
974885|NCT01227265|1978567|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
974886|NCT01227265|1978568|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
974887|NCT01227265|1978569|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
974888|NCT01227265|1978567|FG000|Overall Study|Protocol Violation|2
974889|NCT01227265|1978568|FG001|Overall Study|Protocol Violation|1
974890|NCT01227265|1978569|FG002|Overall Study|Protocol Violation|0
974891|NCT01227265|1978567|FG000|Overall Study|Withdrawal by Subject|7
974892|NCT01227265|1978568|FG001|Overall Study|Withdrawal by Subject|7
974893|NCT01227265|1978569|FG002|Overall Study|Withdrawal by Subject|3
974894|NCT01227265|1978567|FG000|Overall Study|Lost to Follow-up|2
974895|NCT01227265|1978568|FG001|Overall Study|Lost to Follow-up|0
974896|NCT01227265|1978569|FG002|Overall Study|Lost to Follow-up|3
974897|NCT01227265|1978567|FG000|Overall Study|Adverse Event|6
974898|NCT01227265|1978568|FG001|Overall Study|Adverse Event|10
974899|NCT01227265|1978569|FG002|Overall Study|Adverse Event|5
974900|NCT01227278|1978579|FG000|Overall Study|Withdrawal by Subject|4
974901|NCT01227278|1978580|FG001|Overall Study|Withdrawal by Subject|4
974902|NCT01227278|1978579|FG000|Overall Study|Death|0
974903|NCT01227278|1978580|FG001|Overall Study|Death|2
974904|NCT01227278|1978579|FG000|Overall Study|Other|1
974905|NCT01227278|1978580|FG001|Overall Study|Other|2
974906|NCT01227395|1978594|FG000|Overall Study|Protocol Violation|0
974907|NCT01227395|1978595|FG001|Overall Study|Protocol Violation|1
974908|NCT01227421|1978623|FG000|Overall Study|Lost to Follow-up|6
974909|NCT01227421|1978624|FG001|Overall Study|Lost to Follow-up|7
974910|NCT01227421|1978625|FG002|Overall Study|Lost to Follow-up|5
974911|NCT01227421|1978623|FG000|Overall Study|Adverse Event|2
974912|NCT01227421|1978624|FG001|Overall Study|Adverse Event|7
974913|NCT01227421|1978625|FG002|Overall Study|Adverse Event|2
974914|NCT01227421|1978623|FG000|Overall Study|Withdrawal by Subject|1
974915|NCT01227421|1978624|FG001|Overall Study|Withdrawal by Subject|2
974916|NCT01227421|1978625|FG002|Overall Study|Withdrawal by Subject|1
974917|NCT01227421|1978623|FG000|Overall Study|Protocol Violation|1
974918|NCT01227421|1978624|FG001|Overall Study|Protocol Violation|1
974919|NCT01227421|1978625|FG002|Overall Study|Protocol Violation|2
974920|NCT01227421|1978623|FG000|Overall Study|Randomized in error|1
974921|NCT01227421|1978624|FG001|Overall Study|Randomized in error|1
974922|NCT01227421|1978625|FG002|Overall Study|Randomized in error|0
974923|NCT01227512|1978645|FG000|Overall Study|Physician Decision|6
974924|NCT01227512|1978646|FG001|Overall Study|Physician Decision|6
974925|NCT01227512|1978645|FG000|Overall Study|Adverse Event|4
974926|NCT01227512|1978646|FG001|Overall Study|Adverse Event|3
974927|NCT01227512|1978645|FG000|Overall Study|Withdrawal by Subject|3
974928|NCT01227512|1978646|FG001|Overall Study|Withdrawal by Subject|0
974929|NCT01227512|1978645|FG000|Overall Study|Participant met withdrawal criteria|0
974930|NCT01227512|1978646|FG001|Overall Study|Participant met withdrawal criteria|1
974931|NCT01227564|1978661|FG000|Overall Study|No Longer Willing to Participate|4
974932|NCT01227564|1978662|FG001|Overall Study|No Longer Willing to Participate|2
974933|NCT01227564|1978663|FG002|Overall Study|No Longer Willing to Participate|5
974934|NCT01227564|1978661|FG000|Overall Study|Participant moved to another town|0
974935|NCT01227564|1978662|FG001|Overall Study|Participant moved to another town|0
974936|NCT01227564|1978663|FG002|Overall Study|Participant moved to another town|1
974937|NCT01227577|1978673|FG000|Overall Study|Protocol deviation|3
974938|NCT01227577|1978673|FG000|Overall Study|Death|3
974939|NCT01227577|1978673|FG000|Overall Study|Administrative problems|2
974940|NCT01227577|1978673|FG000|Overall Study|Lost to Follow-up|1
974941|NCT01227577|1978673|FG000|Overall Study|Withdrawal by Subject|4
974942|NCT01227577|1978673|FG000|Overall Study|Lack of Efficacy|5
974943|NCT01227577|1978673|FG000|Overall Study|Adverse Event|17
974944|NCT01227629|1978696|FG000|Overall Study|Adverse Event|2
974945|NCT01227629|1978697|FG001|Overall Study|Adverse Event|2
974946|NCT01227629|1978698|FG002|Overall Study|Adverse Event|1
974947|NCT01227629|1978699|FG003|Overall Study|Adverse Event|6
974948|NCT01227629|1978700|FG004|Overall Study|Adverse Event|1
974949|NCT01227629|1978701|FG005|Overall Study|Adverse Event|1
974950|NCT01227629|1978702|FG006|Overall Study|Adverse Event|6
974951|NCT01227629|1978703|FG007|Overall Study|Adverse Event|6
974952|NCT01227629|1978704|FG008|Overall Study|Adverse Event|4
974953|NCT01227629|1978705|FG009|Overall Study|Adverse Event|0
974954|NCT01227629|1978696|FG000|Overall Study|Protocol Violation|0
974955|NCT01227629|1978697|FG001|Overall Study|Protocol Violation|0
974956|NCT01227629|1978698|FG002|Overall Study|Protocol Violation|0
974957|NCT01227629|1978699|FG003|Overall Study|Protocol Violation|1
974958|NCT01227629|1978700|FG004|Overall Study|Protocol Violation|0
974959|NCT01227629|1978701|FG005|Overall Study|Protocol Violation|0
974960|NCT01227629|1978702|FG006|Overall Study|Protocol Violation|0
974961|NCT01227629|1978703|FG007|Overall Study|Protocol Violation|0
974962|NCT01227629|1978704|FG008|Overall Study|Protocol Violation|0
974963|NCT01227629|1978705|FG009|Overall Study|Protocol Violation|0
974964|NCT01227629|1978696|FG000|Overall Study|Lost to Follow-up|0
974965|NCT01227629|1978697|FG001|Overall Study|Lost to Follow-up|0
974966|NCT01227629|1978698|FG002|Overall Study|Lost to Follow-up|0
974967|NCT01227629|1978699|FG003|Overall Study|Lost to Follow-up|0
974968|NCT01227629|1978700|FG004|Overall Study|Lost to Follow-up|1
974969|NCT01227629|1978701|FG005|Overall Study|Lost to Follow-up|0
974970|NCT01227629|1978702|FG006|Overall Study|Lost to Follow-up|0
974971|NCT01227629|1978703|FG007|Overall Study|Lost to Follow-up|0
974972|NCT01227629|1978704|FG008|Overall Study|Lost to Follow-up|0
974973|NCT01227629|1978705|FG009|Overall Study|Lost to Follow-up|0
974974|NCT01227629|1978696|FG000|Overall Study|Withdrawal by Subject|0
974975|NCT01227629|1978697|FG001|Overall Study|Withdrawal by Subject|0
974976|NCT01227629|1978698|FG002|Overall Study|Withdrawal by Subject|0
974977|NCT01227629|1978699|FG003|Overall Study|Withdrawal by Subject|0
974978|NCT01227629|1978700|FG004|Overall Study|Withdrawal by Subject|0
974979|NCT01227629|1978701|FG005|Overall Study|Withdrawal by Subject|0
974980|NCT01227629|1978702|FG006|Overall Study|Withdrawal by Subject|2
974981|NCT01227629|1978703|FG007|Overall Study|Withdrawal by Subject|0
974982|NCT01227629|1978704|FG008|Overall Study|Withdrawal by Subject|0
974983|NCT01227629|1978705|FG009|Overall Study|Withdrawal by Subject|1
974984|NCT01227629|1978696|FG000|Overall Study|Other|0
974985|NCT01227629|1978697|FG001|Overall Study|Other|0
974986|NCT01227629|1978698|FG002|Overall Study|Other|0
974987|NCT01227629|1978699|FG003|Overall Study|Other|1
974988|NCT01227629|1978700|FG004|Overall Study|Other|0
974989|NCT01227629|1978701|FG005|Overall Study|Other|0
974990|NCT01227629|1978702|FG006|Overall Study|Other|0
974991|NCT01227629|1978703|FG007|Overall Study|Other|0
974992|NCT01227629|1978704|FG008|Overall Study|Other|2
974993|NCT01227629|1978705|FG009|Overall Study|Other|1
974994|NCT01227668|1978766|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12
974995|NCT01227668|1978767|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0
974996|NCT01227668|1978766|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
974997|NCT01227668|1978767|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
974998|NCT01227668|1978766|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
974999|NCT01227668|1978767|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
975000|NCT01227668|1978766|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
975001|NCT01227668|1978767|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
975002|NCT01227668|1978766|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
975003|NCT01227668|1978767|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
975004|NCT01227668|1978766|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
975005|NCT01227668|1978767|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
975006|NCT01227668|1978766|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
975007|NCT01227668|1978767|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
975008|NCT01227668|1978766|FG000|Phase 2 (Randomization Phase)|Adverse Event|0
975009|NCT01227668|1978767|FG001|Phase 2 (Randomization Phase)|Adverse Event|1
975010|NCT01227668|1978766|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
975011|NCT01227668|1978767|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
975012|NCT01227668|1978766|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1
975013|NCT01227668|1978767|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0
975014|NCT01227668|1978766|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13
975015|NCT01227668|1978767|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23
975016|NCT01227668|1978766|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
975017|NCT01227668|1978767|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
975018|NCT01227707|1978786|FG000|Overall Study|Adverse Event|10
975019|NCT01227707|1978786|FG000|Overall Study|Progression of disease|3
975020|NCT01227707|1978786|FG000|Overall Study|Withdrawal by Subject|1
975021|NCT01227707|1978786|FG000|Overall Study|Patient non-compliance|3
975022|NCT01227707|1978786|FG000|Overall Study|Medical decision|6
975023|NCT01227707|1978786|FG000|Overall Study|Death|1
975024|NCT01227824|1978803|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
975025|NCT01227824|1978804|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
975026|NCT01227824|1978805|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
975027|NCT01227824|1978803|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
975028|NCT01227824|1978804|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
975029|NCT01227824|1978805|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
975030|NCT01227824|1978803|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
975031|NCT01227824|1978804|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
975032|NCT01227824|1978805|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
975033|NCT01227824|1978803|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
975034|NCT01227824|1978804|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
975035|NCT01227824|1978805|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
975036|NCT01227824|1978803|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
975037|NCT01227824|1978804|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
975038|NCT01227824|1978805|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
975039|NCT01227824|1978803|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
975040|NCT01227824|1978804|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
975041|NCT01227824|1978805|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
975042|NCT01227824|1978803|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
975043|NCT01227824|1978804|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
975044|NCT01227824|1978805|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
975045|NCT01227824|1978803|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
975046|NCT01227824|1978804|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
975047|NCT01227824|1978805|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
975048|NCT01227824|1978803|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0
975049|NCT01227824|1978804|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0
975050|NCT01227824|1978805|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4
975051|NCT01227824|1978803|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
975052|NCT01227824|1978804|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
975053|NCT01227824|1978805|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
975054|NCT01227824|1978803|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0
975055|NCT01227824|1978804|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0
975056|NCT01227824|1978805|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5
975057|NCT01227824|1978803|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
975058|NCT01227824|1978804|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
975059|NCT01227824|1978805|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
975060|NCT01227824|1978803|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
975061|NCT01227824|1978804|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
975062|NCT01227824|1978805|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
975063|NCT01227824|1978803|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
975064|NCT01227824|1978804|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
975065|NCT01227824|1978805|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
975066|NCT01227824|1978803|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0
975067|NCT01227824|1978804|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0
975068|NCT01227824|1978805|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3
975069|NCT01227889|1978814|FG000|Randomized Phase (RP)|Adverse Event|13
975070|NCT01227889|1978815|FG001|Randomized Phase (RP)|Adverse Event|0
975071|NCT01227889|1978814|FG000|Randomized Phase (RP)|Physician Decision|13
975072|NCT01227889|1978815|FG001|Randomized Phase (RP)|Physician Decision|5
975073|NCT01227889|1978814|FG000|Randomized Phase (RP)|Progressive Disease|135
975074|NCT01227889|1978815|FG001|Randomized Phase (RP)|Progressive Disease|52
975075|NCT01227889|1978814|FG000|Randomized Phase (RP)|Study terminated by sponsor|10
975076|NCT01227889|1978815|FG001|Randomized Phase (RP)|Study terminated by sponsor|0
975077|NCT01227889|1978814|FG000|Randomized Phase (RP)|Missing|1
975078|NCT01227889|1978815|FG001|Randomized Phase (RP)|Missing|3
975079|NCT01227889|1978814|FG000|Randomized Phase (RP)|Withdrawal by Subject|15
975080|NCT01227889|1978815|FG001|Randomized Phase (RP)|Withdrawal by Subject|3
975081|NCT01227889|1978814|FG000|Crossover Phase|Adverse Event|0
975082|NCT01227889|1978815|FG001|Crossover Phase|Adverse Event|1
975083|NCT01227889|1978814|FG000|Crossover Phase|Physician Decision|0
975084|NCT01227889|1978815|FG001|Crossover Phase|Physician Decision|3
975085|NCT01227889|1978814|FG000|Crossover Phase|Progressive Disease|0
975086|NCT01227889|1978815|FG001|Crossover Phase|Progressive Disease|31
975087|NCT01227889|1978814|FG000|Crossover Phase|Study Terminated By Sponsor|0
975088|NCT01227889|1978815|FG001|Crossover Phase|Study Terminated By Sponsor|1
975089|NCT01227889|1978814|FG000|Crossover Phase|Withdrawal by Subject|0
975090|NCT01227889|1978815|FG001|Crossover Phase|Withdrawal by Subject|1
975091|NCT01227902|1978833|FG000|Overall Study|Adverse Event|12
975092|NCT01227902|1978834|FG001|Overall Study|Adverse Event|8
975093|NCT01227902|1978835|FG002|Overall Study|Adverse Event|11
975094|NCT01227902|1978836|FG003|Overall Study|Adverse Event|4
975095|NCT01227902|1978833|FG000|Overall Study|Lack of Efficacy|1
975096|NCT01227902|1978834|FG001|Overall Study|Lack of Efficacy|2
975097|NCT01227902|1978835|FG002|Overall Study|Lack of Efficacy|2
975098|NCT01227902|1978836|FG003|Overall Study|Lack of Efficacy|1
975099|NCT01227902|1978833|FG000|Overall Study|Protocol Violation|1
975100|NCT01227902|1978834|FG001|Overall Study|Protocol Violation|0
975101|NCT01227902|1978835|FG002|Overall Study|Protocol Violation|0
975102|NCT01227902|1978836|FG003|Overall Study|Protocol Violation|0
975103|NCT01227902|1978833|FG000|Overall Study|Lost to Follow-up|0
975104|NCT01227902|1978834|FG001|Overall Study|Lost to Follow-up|0
975105|NCT01227902|1978835|FG002|Overall Study|Lost to Follow-up|1
975106|NCT01227902|1978836|FG003|Overall Study|Lost to Follow-up|2
975107|NCT01227902|1978833|FG000|Overall Study|Physician Decision|0
975108|NCT01227902|1978834|FG001|Overall Study|Physician Decision|1
975109|NCT01227902|1978835|FG002|Overall Study|Physician Decision|1
975110|NCT01227902|1978836|FG003|Overall Study|Physician Decision|0
975111|NCT01227902|1978833|FG000|Overall Study|Withdrawal by Subject|4
975112|NCT01227902|1978834|FG001|Overall Study|Withdrawal by Subject|2
975113|NCT01227902|1978835|FG002|Overall Study|Withdrawal by Subject|4
975114|NCT01227902|1978836|FG003|Overall Study|Withdrawal by Subject|3
975115|NCT01227928|1978849|FG000|Overall Study|Lost to Follow-up|4
975116|NCT01227928|1978850|FG001|Overall Study|Lost to Follow-up|2
975117|NCT01227928|1978849|FG000|Overall Study|Withdrawal by Subject|4
975118|NCT01227928|1978850|FG001|Overall Study|Withdrawal by Subject|3
975119|NCT01227928|1978849|FG000|Overall Study|Death|14
975120|NCT01227928|1978850|FG001|Overall Study|Death|12
975121|NCT01227954|1978856|FG000|Overall Study|Protocol Violation|6
975122|NCT01227954|1978856|FG000|Overall Study|No protocol treatment|7
975123|NCT01227967|1978862|FG000|Overall Study|Protocol Violation|3
975124|NCT01227967|1978863|FG001|Overall Study|Protocol Violation|1
975125|NCT01227967|1978862|FG000|Overall Study|Death|0
975126|NCT01227967|1978863|FG001|Overall Study|Death|1
975127|NCT01227967|1978862|FG000|Overall Study|Lost to Follow-up|8
975128|NCT01227967|1978863|FG001|Overall Study|Lost to Follow-up|3
975129|NCT01227967|1978862|FG000|Overall Study|Withdrawal by Subject|4
975130|NCT01227967|1978863|FG001|Overall Study|Withdrawal by Subject|3
975131|NCT01227967|1978862|FG000|Overall Study|Physician Decision|0
975132|NCT01227967|1978863|FG001|Overall Study|Physician Decision|1
975133|NCT01227967|1978862|FG000|Overall Study|Never Started Treatment|0
975134|NCT01227967|1978863|FG001|Overall Study|Never Started Treatment|4
975135|NCT01227967|1978862|FG000|Overall Study|Taking Additional Antiviral Drug|1
975136|NCT01227967|1978863|FG001|Overall Study|Taking Additional Antiviral Drug|0
975137|NCT01228019|1978882|FG000|Overall Study|Dose Violation|70
975138|NCT01228019|1978882|FG000|Overall Study|Duplicate enrollment|1
975139|NCT01228019|1978882|FG000|Overall Study|Missing pre-treatment data|72
975140|NCT01228019|1978882|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152
975141|NCT01228019|1978882|FG000|Overall Study|Violation of Entry Criterion|9
975142|NCT01228071|1978886|FG000|Overall Study|Protocol Violation|1
975143|NCT01228071|1978886|FG000|Overall Study|Withdrawal by Subject|1
975144|NCT01228175|1978908|FG000|Overall Study|Lost to Follow-up|64
975145|NCT01228175|1978909|FG001|Overall Study|Lost to Follow-up|50
975146|NCT01228175|1978908|FG000|Overall Study|Withdrawal by Subject|1
975147|NCT01228175|1978909|FG001|Overall Study|Withdrawal by Subject|2
975148|NCT01228175|1978908|FG000|Overall Study|Physician Decision|1
975149|NCT01228175|1978909|FG001|Overall Study|Physician Decision|1
975150|NCT01228318|1978917|FG000|Overall Study|Clinic no show to receive intervention|1
975151|NCT01228318|1978918|FG001|Overall Study|Clinic no show to receive intervention|0
975152|NCT01228318|1978917|FG000|Overall Study|Unable to contact|2
975153|NCT01228318|1978918|FG001|Overall Study|Unable to contact|5
975154|NCT01228318|1978917|FG000|Overall Study|Moved|0
975155|NCT01228318|1978918|FG001|Overall Study|Moved|2
975156|NCT01228318|1978917|FG000|Overall Study|Incarcerated|1
975157|NCT01228318|1978918|FG001|Overall Study|Incarcerated|0
975158|NCT01228591|1978933|FG000|Baseline|Lack of Efficacy|1
975159|NCT01228591|1978934|FG001|Baseline|Lack of Efficacy|2
975160|NCT01228734|1978946|FG000|Overall Study|Randomized, but not treated|0
975161|NCT01228734|1978947|FG001|Overall Study|Randomized, but not treated|4
975162|NCT01228747|1978955|FG000|Overall Study|Adverse Event|8
975163|NCT01228747|1978956|FG001|Overall Study|Adverse Event|4
975164|NCT01228747|1978955|FG000|Overall Study|Lack of Efficacy|40
975165|NCT01228747|1978956|FG001|Overall Study|Lack of Efficacy|27
975166|NCT01228747|1978955|FG000|Overall Study|Protocol Violation|6
975167|NCT01228747|1978956|FG001|Overall Study|Protocol Violation|5
975168|NCT01228747|1978955|FG000|Overall Study|Lost to Follow-up|4
975169|NCT01228747|1978956|FG001|Overall Study|Lost to Follow-up|3
975170|NCT01228747|1978955|FG000|Overall Study|Withdrawal by Subject|5
975171|NCT01228747|1978956|FG001|Overall Study|Withdrawal by Subject|1
975172|NCT01228747|1978955|FG000|Overall Study|Other Reason|2
975173|NCT01228747|1978956|FG001|Overall Study|Other Reason|5
975174|NCT01229111|1978988|FG000|Overall Study|Death|1
975175|NCT01229150|1978996|FG000|Overall Study|Toxicity|2
975176|NCT01229150|1978997|FG001|Overall Study|Toxicity|2
975177|NCT01229150|1978998|FG002|Overall Study|Toxicity|0
975178|NCT01229150|1978999|FG003|Overall Study|Toxicity|0
975179|NCT01229176|1979021|FG000|Overall Study|Withdrawal by Subject|0
975180|NCT01229176|1979022|FG001|Overall Study|Withdrawal by Subject|0
975181|NCT01229176|1979023|FG002|Overall Study|Withdrawal by Subject|0
975182|NCT01229176|1979024|FG003|Overall Study|Withdrawal by Subject|1
975183|NCT01229176|1979025|FG004|Overall Study|Withdrawal by Subject|1
975184|NCT01229176|1979026|FG005|Overall Study|Withdrawal by Subject|1
975185|NCT01229176|1979027|FG006|Overall Study|Withdrawal by Subject|0
975186|NCT01229176|1979028|FG007|Overall Study|Withdrawal by Subject|1
975187|NCT01229176|1979021|FG000|Overall Study|Lost to Follow-up|0
975188|NCT01229176|1979022|FG001|Overall Study|Lost to Follow-up|3
975189|NCT01229176|1979023|FG002|Overall Study|Lost to Follow-up|0
975190|NCT01229176|1979024|FG003|Overall Study|Lost to Follow-up|0
975191|NCT01229176|1979025|FG004|Overall Study|Lost to Follow-up|1
975192|NCT01229176|1979026|FG005|Overall Study|Lost to Follow-up|1
975193|NCT01229176|1979027|FG006|Overall Study|Lost to Follow-up|0
975194|NCT01229176|1979028|FG007|Overall Study|Lost to Follow-up|2
975195|NCT01229254|1979070|FG000|Overall Study|Not Continuing Into Safety Extension|3
975196|NCT01229254|1979071|FG001|Overall Study|Not Continuing Into Safety Extension|1
975197|NCT01229254|1979072|FG002|Overall Study|Not Continuing Into Safety Extension|1
975198|NCT01229254|1979070|FG000|Overall Study|Adverse Event|4
975199|NCT01229254|1979071|FG001|Overall Study|Adverse Event|5
975200|NCT01229254|1979072|FG002|Overall Study|Adverse Event|3
975201|NCT01229254|1979070|FG000|Overall Study|Lost to Follow-up|3
975202|NCT01229254|1979071|FG001|Overall Study|Lost to Follow-up|0
975203|NCT01229254|1979072|FG002|Overall Study|Lost to Follow-up|1
975204|NCT01229254|1979070|FG000|Overall Study|Physician Decision|0
975205|NCT01229254|1979071|FG001|Overall Study|Physician Decision|3
975206|NCT01229254|1979072|FG002|Overall Study|Physician Decision|0
975207|NCT01229254|1979070|FG000|Overall Study|Protocol Violation|4
975208|NCT01229254|1979071|FG001|Overall Study|Protocol Violation|6
975209|NCT01229254|1979072|FG002|Overall Study|Protocol Violation|5
975210|NCT01229254|1979070|FG000|Overall Study|Withdrawal by Subject|1
975211|NCT01229254|1979071|FG001|Overall Study|Withdrawal by Subject|0
975212|NCT01229254|1979072|FG002|Overall Study|Withdrawal by Subject|1
975213|NCT01229254|1979070|FG000|Overall Study|Non-compliance with Study Drug|0
975214|NCT01229254|1979071|FG001|Overall Study|Non-compliance with Study Drug|1
975215|NCT01229254|1979072|FG002|Overall Study|Non-compliance with Study Drug|1
975216|NCT01229267|1979086|FG000|Overall Study|Adverse Event|4
975217|NCT01229267|1979087|FG001|Overall Study|Adverse Event|6
975218|NCT01229267|1979088|FG002|Overall Study|Adverse Event|3
975219|NCT01229267|1979089|FG003|Overall Study|Adverse Event|2
975220|NCT01229267|1979090|FG004|Overall Study|Adverse Event|10
975221|NCT01229267|1979086|FG000|Overall Study|Death|40
975222|NCT01229267|1979087|FG001|Overall Study|Death|37
975223|NCT01229267|1979088|FG002|Overall Study|Death|35
975224|NCT01229267|1979089|FG003|Overall Study|Death|13
975225|NCT01229267|1979090|FG004|Overall Study|Death|103
975226|NCT01229267|1979086|FG000|Overall Study|Withdrawal by Subject|23
975227|NCT01229267|1979087|FG001|Overall Study|Withdrawal by Subject|22
975228|NCT01229267|1979088|FG002|Overall Study|Withdrawal by Subject|32
975229|NCT01229267|1979089|FG003|Overall Study|Withdrawal by Subject|14
975230|NCT01229267|1979090|FG004|Overall Study|Withdrawal by Subject|59
975231|NCT01229267|1979086|FG000|Overall Study|Protocol Violation|0
975232|NCT01229267|1979087|FG001|Overall Study|Protocol Violation|1
975233|NCT01229267|1979088|FG002|Overall Study|Protocol Violation|0
975234|NCT01229267|1979089|FG003|Overall Study|Protocol Violation|0
975235|NCT01229267|1979090|FG004|Overall Study|Protocol Violation|0
975236|NCT01229267|1979086|FG000|Overall Study|Progressive disease|0
975237|NCT01229267|1979087|FG001|Overall Study|Progressive disease|0
975238|NCT01229267|1979088|FG002|Overall Study|Progressive disease|0
975239|NCT01229267|1979089|FG003|Overall Study|Progressive disease|0
975240|NCT01229267|1979090|FG004|Overall Study|Progressive disease|1
975241|NCT01229267|1979086|FG000|Overall Study|Physician Decision|8
975242|NCT01229267|1979087|FG001|Overall Study|Physician Decision|11
975243|NCT01229267|1979088|FG002|Overall Study|Physician Decision|8
975244|NCT01229267|1979089|FG003|Overall Study|Physician Decision|3
975245|NCT01229267|1979090|FG004|Overall Study|Physician Decision|25
975246|NCT01229267|1979086|FG000|Overall Study|Lost to Follow-up|6
975247|NCT01229267|1979087|FG001|Overall Study|Lost to Follow-up|5
975248|NCT01229267|1979088|FG002|Overall Study|Lost to Follow-up|8
975249|NCT01229267|1979089|FG003|Overall Study|Lost to Follow-up|3
975250|NCT01229267|1979090|FG004|Overall Study|Lost to Follow-up|22
975251|NCT01229371|1979101|FG000|Overall Study|Withdrawal by Subject|0
975252|NCT01229371|1979102|FG001|Overall Study|Withdrawal by Subject|1
975253|NCT01229371|1979103|FG002|Overall Study|Withdrawal by Subject|0
975254|NCT01229371|1979104|FG003|Overall Study|Withdrawal by Subject|0
975255|NCT01229397|1979116|FG000|Overall Study|Withdrawal by Subject|3
975256|NCT01229397|1979117|FG001|Overall Study|Withdrawal by Subject|3
975257|NCT01229397|1979116|FG000|Overall Study|Lost to Follow-up|7
975258|NCT01229397|1979117|FG001|Overall Study|Lost to Follow-up|6
975259|NCT01229397|1979116|FG000|Overall Study|Migrated/moved from study area|1
975260|NCT01229397|1979117|FG001|Overall Study|Migrated/moved from study area|0
975261|NCT01229436|1979140|FG000|Overall Study|Withdrawal by Subject|2
975262|NCT01229436|1979140|FG000|Overall Study|Lost to Follow-up|3
975263|NCT01229449|1979149|FG000|Overall Study|Withdrawal by Subject|0
975264|NCT01229449|1979150|FG001|Overall Study|Withdrawal by Subject|3
975265|NCT01229449|1979151|FG002|Overall Study|Withdrawal by Subject|0
975266|NCT01229449|1979152|FG003|Overall Study|Withdrawal by Subject|1
975267|NCT01229449|1979153|FG004|Overall Study|Withdrawal by Subject|1
975268|NCT01229449|1979149|FG000|Overall Study|Lost to Follow-up|1
975269|NCT01229449|1979150|FG001|Overall Study|Lost to Follow-up|1
975270|NCT01229449|1979151|FG002|Overall Study|Lost to Follow-up|1
975271|NCT01229449|1979152|FG003|Overall Study|Lost to Follow-up|0
975272|NCT01229449|1979153|FG004|Overall Study|Lost to Follow-up|0
975273|NCT01229449|1979149|FG000|Overall Study|Physician Decision|0
975274|NCT01229449|1979150|FG001|Overall Study|Physician Decision|0
975275|NCT01229449|1979151|FG002|Overall Study|Physician Decision|1
975276|NCT01229449|1979152|FG003|Overall Study|Physician Decision|0
975277|NCT01229449|1979153|FG004|Overall Study|Physician Decision|0
975278|NCT01229735|1979202|FG000|Overall Study|Lack of Efficacy|8
975279|NCT01229735|1979203|FG001|Overall Study|Lack of Efficacy|8
975280|NCT01229735|1979202|FG000|Overall Study|Protocol Violation|13
975281|NCT01229735|1979203|FG001|Overall Study|Protocol Violation|8
975282|NCT01229735|1979202|FG000|Overall Study|Lost to Follow-up|0
975283|NCT01229735|1979203|FG001|Overall Study|Lost to Follow-up|2
975284|NCT01229735|1979202|FG000|Overall Study|Withdrawal by Subject|18
975285|NCT01229735|1979203|FG001|Overall Study|Withdrawal by Subject|17
975286|NCT01229735|1979202|FG000|Overall Study|Other Reason|13
912623|NCT00806260|1890178|FG000|Period 2|Need to take concomitant medication|1
912624|NCT00806260|1890179|FG001|Period 2|Need to take concomitant medication|0
912625|NCT00806260|1890180|FG002|Period 2|Need to take concomitant medication|0
912626|NCT00806260|1890181|FG003|Period 2|Need to take concomitant medication|0
912627|NCT00806260|1890182|FG004|Period 2|Need to take concomitant medication|0
912628|NCT00806260|1890183|FG005|Period 2|Need to take concomitant medication|0
912629|NCT00806260|1890178|FG000|Period 2|sponsor request|0
912630|NCT00806260|1890179|FG001|Period 2|sponsor request|0
912631|NCT00806260|1890180|FG002|Period 2|sponsor request|1
912632|NCT00806260|1890181|FG003|Period 2|sponsor request|1
912633|NCT00806260|1890182|FG004|Period 2|sponsor request|0
912634|NCT00806260|1890183|FG005|Period 2|sponsor request|0
912635|NCT00806260|1890178|FG000|Period 3|Protocol Violation|0
912636|NCT00806260|1890179|FG001|Period 3|Protocol Violation|1
912637|NCT00806260|1890180|FG002|Period 3|Protocol Violation|1
912638|NCT00806260|1890181|FG003|Period 3|Protocol Violation|0
975287|NCT01229735|1979203|FG001|Overall Study|Other Reason|10
975288|NCT01229735|1979202|FG000|Overall Study|SAE, non-fatal|0
975289|NCT01229735|1979203|FG001|Overall Study|SAE, non-fatal|4
975290|NCT01229735|1979202|FG000|Overall Study|AE, non-serious non-fatal|13
975291|NCT01229735|1979203|FG001|Overall Study|AE, non-serious non-fatal|17
975292|NCT01229735|1979202|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
975293|NCT01229735|1979203|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
975294|NCT01230060|1979239|FG000|Overall Study|Withdrawal by Subject|1
975295|NCT01230554|1979284|FG000|Overall Study|Lost to Follow-up|2
975296|NCT01230554|1979284|FG000|Overall Study|Inability to maintain visit schedule|1
975297|NCT01230710|1979301|FG000|Overall Study|Disease Progression|41
975298|NCT01230710|1979301|FG000|Overall Study|Lost to Follow-up|3
975299|NCT01230710|1979301|FG000|Overall Study|Death|4
975300|NCT01230710|1979301|FG000|Overall Study|Withdrawal of Consent|1
975301|NCT01230749|1979309|FG000|Overall Study|Adverse Event|0
975302|NCT01230749|1979310|FG001|Overall Study|Adverse Event|0
975303|NCT01230749|1979311|FG002|Overall Study|Adverse Event|0
975304|NCT01230749|1979312|FG003|Overall Study|Adverse Event|1
975305|NCT01230749|1979309|FG000|Overall Study|Physician Decision|0
975306|NCT01230749|1979310|FG001|Overall Study|Physician Decision|0
975307|NCT01230749|1979311|FG002|Overall Study|Physician Decision|1
975308|NCT01230749|1979312|FG003|Overall Study|Physician Decision|0
975309|NCT01230749|1979309|FG000|Overall Study|Withdrawal by Subject|0
975310|NCT01230749|1979310|FG001|Overall Study|Withdrawal by Subject|1
975311|NCT01230749|1979311|FG002|Overall Study|Withdrawal by Subject|0
975312|NCT01230749|1979312|FG003|Overall Study|Withdrawal by Subject|0
975313|NCT01230749|1979309|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0
975314|NCT01230749|1979310|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1
975315|NCT01230749|1979311|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1
975316|NCT01230749|1979312|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1
975317|NCT01230814|1979343|FG000|Overall Study|Lost to Follow-up|11
975318|NCT01230814|1979344|FG001|Overall Study|Lost to Follow-up|3
975319|NCT01230814|1979343|FG000|Overall Study|Discontinued (not due to adverse event)|2
975320|NCT01230814|1979344|FG001|Overall Study|Discontinued (not due to adverse event)|1
975321|NCT01230827|1979354|FG000|Overall Study|Lost to Follow-up|0
975322|NCT01230827|1979355|FG001|Overall Study|Lost to Follow-up|0
975323|NCT01230827|1979356|FG002|Overall Study|Lost to Follow-up|1
975324|NCT01230827|1979357|FG003|Overall Study|Lost to Follow-up|3
975325|NCT01230827|1979354|FG000|Overall Study|Withdrawal by Subject|1
975326|NCT01230827|1979355|FG001|Overall Study|Withdrawal by Subject|0
975327|NCT01230827|1979356|FG002|Overall Study|Withdrawal by Subject|3
975328|NCT01230827|1979357|FG003|Overall Study|Withdrawal by Subject|2
975329|NCT01230827|1979354|FG000|Overall Study|Lack of Efficacy|14
975330|NCT01230827|1979355|FG001|Overall Study|Lack of Efficacy|1
975331|NCT01230827|1979356|FG002|Overall Study|Lack of Efficacy|2
975332|NCT01230827|1979357|FG003|Overall Study|Lack of Efficacy|3
975333|NCT01230827|1979354|FG000|Overall Study|Adverse Event|4
975334|NCT01230827|1979355|FG001|Overall Study|Adverse Event|2
975335|NCT01230827|1979356|FG002|Overall Study|Adverse Event|3
975336|NCT01230827|1979357|FG003|Overall Study|Adverse Event|7
975337|NCT01230827|1979354|FG000|Overall Study|Recovery|0
975338|NCT01230827|1979355|FG001|Overall Study|Recovery|6
975339|NCT01230827|1979356|FG002|Overall Study|Recovery|0
975340|NCT01230827|1979357|FG003|Overall Study|Recovery|0
975341|NCT01230827|1979354|FG000|Overall Study|Study terminated by Sponsor|0
975342|NCT01230827|1979355|FG001|Overall Study|Study terminated by Sponsor|2
975343|NCT01230827|1979356|FG002|Overall Study|Study terminated by Sponsor|56
975344|NCT01230827|1979357|FG003|Overall Study|Study terminated by Sponsor|63
975345|NCT01230892|1979367|FG000|Overall Study|Withdrawal by Subject|1
975346|NCT01230892|1979368|FG001|Overall Study|Withdrawal by Subject|1
975347|NCT01230892|1979367|FG000|Overall Study|Lost to Follow-up|2
975348|NCT01230892|1979368|FG001|Overall Study|Lost to Follow-up|0
975349|NCT01231321|1979394|FG000|Overall Study|Adverse Event|3
975350|NCT01231321|1979394|FG000|Overall Study|Lack of Efficacy|2
975351|NCT01231373|1979417|FG000|Overall Study|Withdrew consent prior to randomization|2
975352|NCT01231373|1979418|FG001|Overall Study|Withdrew consent prior to randomization|1
975353|NCT01231373|1979419|FG002|Overall Study|Withdrew consent prior to randomization|0
975354|NCT01231373|1979420|FG003|Overall Study|Withdrew consent prior to randomization|0
975355|NCT01231373|1979417|FG000|Overall Study|Lost to Follow-up|0
975356|NCT01231373|1979418|FG001|Overall Study|Lost to Follow-up|0
975357|NCT01231373|1979419|FG002|Overall Study|Lost to Follow-up|0
975358|NCT01231373|1979420|FG003|Overall Study|Lost to Follow-up|1
975359|NCT01231373|1979417|FG000|Overall Study|Withdrew Consent|1
975360|NCT01231373|1979418|FG001|Overall Study|Withdrew Consent|0
975361|NCT01231373|1979419|FG002|Overall Study|Withdrew Consent|0
975362|NCT01231373|1979420|FG003|Overall Study|Withdrew Consent|0
975363|NCT01231464|1979452|FG000|Overall Study|Adverse Event|0
975364|NCT01231464|1979453|FG001|Overall Study|Adverse Event|1
975365|NCT01231464|1979452|FG000|Overall Study|Protocol Violation|1
975366|NCT01231464|1979453|FG001|Overall Study|Protocol Violation|2
975367|NCT01231464|1979452|FG000|Overall Study|Lost to Follow-up|1
975368|NCT01231464|1979453|FG001|Overall Study|Lost to Follow-up|2
975369|NCT01231464|1979452|FG000|Overall Study|Withdrawal by Subject|3
975370|NCT01231464|1979453|FG001|Overall Study|Withdrawal by Subject|2
975371|NCT01231503|1979469|FG000|Overall Study|Adverse Event|0
975372|NCT01231503|1979470|FG001|Overall Study|Adverse Event|0
975373|NCT01231503|1979471|FG002|Overall Study|Adverse Event|0
975374|NCT01231503|1979472|FG003|Overall Study|Adverse Event|0
975375|NCT01231503|1979473|FG004|Overall Study|Adverse Event|0
975376|NCT01231503|1979474|FG005|Overall Study|Adverse Event|1
975377|NCT01231503|1979475|FG006|Overall Study|Adverse Event|0
975378|NCT01231503|1979476|FG007|Overall Study|Adverse Event|0
975379|NCT01231503|1979469|FG000|Overall Study|Adverse event, serious fatal|0
975380|NCT01231503|1979470|FG001|Overall Study|Adverse event, serious fatal|0
975381|NCT01231503|1979471|FG002|Overall Study|Adverse event, serious fatal|1
975382|NCT01231503|1979472|FG003|Overall Study|Adverse event, serious fatal|1
975383|NCT01231503|1979473|FG004|Overall Study|Adverse event, serious fatal|0
975384|NCT01231503|1979474|FG005|Overall Study|Adverse event, serious fatal|1
975385|NCT01231503|1979475|FG006|Overall Study|Adverse event, serious fatal|0
975386|NCT01231503|1979476|FG007|Overall Study|Adverse event, serious fatal|0
975387|NCT01231503|1979469|FG000|Overall Study|Withdrawal by Subject|6
975388|NCT01231503|1979470|FG001|Overall Study|Withdrawal by Subject|3
975389|NCT01231503|1979471|FG002|Overall Study|Withdrawal by Subject|3
975390|NCT01231503|1979472|FG003|Overall Study|Withdrawal by Subject|1
975391|NCT01231503|1979473|FG004|Overall Study|Withdrawal by Subject|3
975392|NCT01231503|1979474|FG005|Overall Study|Withdrawal by Subject|5
975393|NCT01231503|1979475|FG006|Overall Study|Withdrawal by Subject|1
975394|NCT01231503|1979476|FG007|Overall Study|Withdrawal by Subject|2
975395|NCT01231503|1979469|FG000|Overall Study|Lost to Follow-up|8
975396|NCT01231503|1979470|FG001|Overall Study|Lost to Follow-up|10
975397|NCT01231503|1979471|FG002|Overall Study|Lost to Follow-up|8
975398|NCT01231503|1979472|FG003|Overall Study|Lost to Follow-up|5
975399|NCT01231503|1979473|FG004|Overall Study|Lost to Follow-up|7
975400|NCT01231503|1979474|FG005|Overall Study|Lost to Follow-up|9
975401|NCT01231503|1979475|FG006|Overall Study|Lost to Follow-up|6
975402|NCT01231503|1979476|FG007|Overall Study|Lost to Follow-up|6
975403|NCT01231503|1979469|FG000|Overall Study|Protocol Violation|0
975404|NCT01231503|1979470|FG001|Overall Study|Protocol Violation|0
975405|NCT01231503|1979471|FG002|Overall Study|Protocol Violation|0
975406|NCT01231503|1979472|FG003|Overall Study|Protocol Violation|1
975407|NCT01231503|1979473|FG004|Overall Study|Protocol Violation|0
975408|NCT01231503|1979474|FG005|Overall Study|Protocol Violation|0
975409|NCT01231503|1979475|FG006|Overall Study|Protocol Violation|0
975410|NCT01231503|1979476|FG007|Overall Study|Protocol Violation|0
975411|NCT01231516|1979506|FG000|48 Week Double-blind Phase|Adverse Event|4
975412|NCT01231516|1979507|FG001|48 Week Double-blind Phase|Adverse Event|11
975413|NCT01231516|1979506|FG000|48 Week Double-blind Phase|Lack of Efficacy|20
975414|NCT01231516|1979507|FG001|48 Week Double-blind Phase|Lack of Efficacy|42
975415|NCT01231516|1979506|FG000|48 Week Double-blind Phase|Protocol Violation|9
975416|NCT01231516|1979507|FG001|48 Week Double-blind Phase|Protocol Violation|6
975417|NCT01231516|1979506|FG000|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
975418|NCT01231516|1979507|FG001|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
975419|NCT01231516|1979506|FG000|48 Week Double-blind Phase|Lost to Follow-up|5
975420|NCT01231516|1979507|FG001|48 Week Double-blind Phase|Lost to Follow-up|10
975421|NCT01231516|1979506|FG000|48 Week Double-blind Phase|Physician Decision|1
975422|NCT01231516|1979507|FG001|48 Week Double-blind Phase|Physician Decision|1
975423|NCT01231516|1979506|FG000|48 Week Double-blind Phase|Withdrawal by Subject|11
975424|NCT01231516|1979507|FG001|48 Week Double-blind Phase|Withdrawal by Subject|5
975425|NCT01231516|1979506|FG000|48 Week Double-blind Phase|Site Closed|3
975426|NCT01231516|1979507|FG001|48 Week Double-blind Phase|Site Closed|1
975427|NCT01231516|1979506|FG000|Open-label Phase|Lack of Efficacy|7
975428|NCT01231516|1979507|FG001|Open-label Phase|Lack of Efficacy|3
975429|NCT01231516|1979506|FG000|Open-label Phase|Protocol Violation|2
975430|NCT01231516|1979507|FG001|Open-label Phase|Protocol Violation|0
975431|NCT01231516|1979506|FG000|Open-label Phase|Lost to Follow-up|3
975432|NCT01231516|1979507|FG001|Open-label Phase|Lost to Follow-up|0
975433|NCT01231516|1979506|FG000|Open-label Phase|Withdrawal by Subject|1
975434|NCT01231516|1979507|FG001|Open-label Phase|Withdrawal by Subject|0
975435|NCT01231516|1979506|FG000|Open-label Phase|Ongoing at the time of analysis|282
975436|NCT01231516|1979507|FG001|Open-label Phase|Ongoing at the time of analysis|23
975437|NCT01231555|1979517|FG000|Overall Study|Study terminated|8
975438|NCT01231555|1979518|FG001|Overall Study|Study terminated|5
975439|NCT01231555|1979519|FG002|Overall Study|Study terminated|8
975440|NCT01231555|1979517|FG000|Overall Study|Withdrawal by Subject|0
975441|NCT01231555|1979518|FG001|Overall Study|Withdrawal by Subject|2
975442|NCT01231555|1979519|FG002|Overall Study|Withdrawal by Subject|0
975443|NCT01231581|1979529|FG000|Overall Study|Lost to Follow-up|2
975444|NCT01231581|1979530|FG001|Overall Study|Lost to Follow-up|2
975445|NCT01231581|1979529|FG000|Overall Study|Withdrawal by Subject|6
975446|NCT01231581|1979530|FG001|Overall Study|Withdrawal by Subject|9
975447|NCT01231581|1979529|FG000|Overall Study|Study Closed/Terminated|6
975448|NCT01231581|1979530|FG001|Overall Study|Study Closed/Terminated|5
975449|NCT01231581|1979529|FG000|Overall Study|Death|65
975450|NCT01231581|1979530|FG001|Overall Study|Death|64
975451|NCT01231581|1979529|FG000|Overall Study|Ongoing|1
975452|NCT01231581|1979530|FG001|Overall Study|Ongoing|0
975453|NCT01231607|1979541|FG000|Overall Study|Adverse Event|0
975454|NCT01231607|1979542|FG001|Overall Study|Adverse Event|8
975455|NCT01231607|1979543|FG002|Overall Study|Adverse Event|4
975456|NCT01231607|1979544|FG003|Overall Study|Adverse Event|4
975457|NCT01231607|1979545|FG004|Overall Study|Adverse Event|5
975458|NCT01231607|1979541|FG000|Overall Study|Lost to Follow-up|13
975459|NCT01231607|1979542|FG001|Overall Study|Lost to Follow-up|11
975460|NCT01231607|1979543|FG002|Overall Study|Lost to Follow-up|10
975461|NCT01231607|1979544|FG003|Overall Study|Lost to Follow-up|10
975462|NCT01231607|1979545|FG004|Overall Study|Lost to Follow-up|4
975463|NCT01231607|1979541|FG000|Overall Study|Physician Decision|4
975464|NCT01231607|1979542|FG001|Overall Study|Physician Decision|4
975465|NCT01231607|1979543|FG002|Overall Study|Physician Decision|3
975466|NCT01231607|1979544|FG003|Overall Study|Physician Decision|5
975467|NCT01231607|1979545|FG004|Overall Study|Physician Decision|4
975468|NCT01231607|1979541|FG000|Overall Study|Protocol Violation|3
975469|NCT01231607|1979542|FG001|Overall Study|Protocol Violation|2
975470|NCT01231607|1979543|FG002|Overall Study|Protocol Violation|0
975471|NCT01231607|1979544|FG003|Overall Study|Protocol Violation|2
975472|NCT01231607|1979545|FG004|Overall Study|Protocol Violation|2
975473|NCT01231607|1979541|FG000|Overall Study|Withdrawal by Subject|9
975474|NCT01231607|1979542|FG001|Overall Study|Withdrawal by Subject|9
975475|NCT01231607|1979543|FG002|Overall Study|Withdrawal by Subject|14
975476|NCT01231607|1979544|FG003|Overall Study|Withdrawal by Subject|17
975477|NCT01231607|1979545|FG004|Overall Study|Withdrawal by Subject|9
975478|NCT01231620|1979563|FG000|Overall Study|Physician Decision|3
975479|NCT01231620|1979564|FG001|Overall Study|Physician Decision|5
975480|NCT01231620|1979565|FG002|Overall Study|Physician Decision|10
975481|NCT01231620|1979563|FG000|Overall Study|Death|12
975482|NCT01231620|1979564|FG001|Overall Study|Death|14
975483|NCT01231620|1979565|FG002|Overall Study|Death|11
975484|NCT01231620|1979563|FG000|Overall Study|Adverse Event|2
975485|NCT01231620|1979564|FG001|Overall Study|Adverse Event|2
975486|NCT01231620|1979565|FG002|Overall Study|Adverse Event|1
975487|NCT01231620|1979563|FG000|Overall Study|Withdrawal by Subject|6
975488|NCT01231620|1979564|FG001|Overall Study|Withdrawal by Subject|6
975489|NCT01231620|1979565|FG002|Overall Study|Withdrawal by Subject|8
975490|NCT01231620|1979563|FG000|Overall Study|Lost to Follow-up|3
975491|NCT01231620|1979564|FG001|Overall Study|Lost to Follow-up|4
975492|NCT01231620|1979565|FG002|Overall Study|Lost to Follow-up|9
975493|NCT01231659|1979593|FG000|Overall Study|Adverse Event|9
975494|NCT01231659|1979593|FG000|Overall Study|Disease Progression|48
975495|NCT01231659|1979593|FG000|Overall Study|Death|2
975496|NCT01231659|1979593|FG000|Overall Study|Patient refused to complete study visit|1
975497|NCT01231659|1979593|FG000|Overall Study|Other protocol defined criteria|12
975498|NCT01231906|1979603|FG000|Overall Study|Lack of Efficacy|75
975499|NCT01231906|1979604|FG001|Overall Study|Lack of Efficacy|68
975500|NCT01231906|1979603|FG000|Overall Study|Lost to Follow-up|1
975501|NCT01231906|1979604|FG001|Overall Study|Lost to Follow-up|0
975502|NCT01231906|1979603|FG000|Overall Study|Physician Decision|34
975503|NCT01231906|1979604|FG001|Overall Study|Physician Decision|24
975504|NCT01231906|1979603|FG000|Overall Study|Withdrawal by Subject|0
975505|NCT01231906|1979604|FG001|Overall Study|Withdrawal by Subject|4
975506|NCT01231906|1979603|FG000|Overall Study|Ineligible|10
975507|NCT01231906|1979604|FG001|Overall Study|Ineligible|3
975508|NCT01231906|1979603|FG000|Overall Study|No treatment|1
975509|NCT01231906|1979604|FG001|Overall Study|No treatment|2
975510|NCT01231984|1979612|FG000|Study Period 1|Withdrawal by Subject|0
975511|NCT01231984|1979613|FG001|Study Period 1|Withdrawal by Subject|0
975512|NCT01231984|1979614|FG002|Study Period 1|Withdrawal by Subject|0
975513|NCT01231984|1979615|FG003|Study Period 1|Withdrawal by Subject|1
975514|NCT01231984|1979612|FG000|Study Period 1|Lost to Follow-up|1
975515|NCT01231984|1979613|FG001|Study Period 1|Lost to Follow-up|1
975516|NCT01231984|1979614|FG002|Study Period 1|Lost to Follow-up|1
975517|NCT01231984|1979615|FG003|Study Period 1|Lost to Follow-up|0
975518|NCT01231984|1979612|FG000|Study Period 1|Did not continue to meet I/E Criteria|2
975519|NCT01231984|1979613|FG001|Study Period 1|Did not continue to meet I/E Criteria|2
975520|NCT01231984|1979614|FG002|Study Period 1|Did not continue to meet I/E Criteria|2
975521|NCT01231984|1979615|FG003|Study Period 1|Did not continue to meet I/E Criteria|2
975522|NCT01231984|1979612|FG000|Study Period 1|Screen Failure|0
975523|NCT01231984|1979613|FG001|Study Period 1|Screen Failure|0
975524|NCT01231984|1979614|FG002|Study Period 1|Screen Failure|0
975525|NCT01231984|1979615|FG003|Study Period 1|Screen Failure|1
975526|NCT01231984|1979612|FG000|Study Period 1|Non-compliance with study requirements|5
975527|NCT01231984|1979613|FG001|Study Period 1|Non-compliance with study requirements|0
975528|NCT01231984|1979614|FG002|Study Period 1|Non-compliance with study requirements|2
975529|NCT01231984|1979615|FG003|Study Period 1|Non-compliance with study requirements|1
975530|NCT01231984|1979612|FG000|Study Period 1|Protocol Violation|3
975531|NCT01231984|1979613|FG001|Study Period 1|Protocol Violation|4
975532|NCT01231984|1979614|FG002|Study Period 1|Protocol Violation|2
975533|NCT01231984|1979615|FG003|Study Period 1|Protocol Violation|3
975534|NCT01231984|1979612|FG000|Study Period 1|Adverse Event|1
975535|NCT01231984|1979613|FG001|Study Period 1|Adverse Event|0
975536|NCT01231984|1979614|FG002|Study Period 1|Adverse Event|0
975537|NCT01231984|1979615|FG003|Study Period 1|Adverse Event|0
975538|NCT01231984|1979612|FG000|Study Period 1|Other|0
975539|NCT01231984|1979613|FG001|Study Period 1|Other|0
975540|NCT01231984|1979614|FG002|Study Period 1|Other|0
975541|NCT01231984|1979615|FG003|Study Period 1|Other|1
975542|NCT01231984|1979612|FG000|Study Period 2|Withdrawal by Subject|1
975543|NCT01231984|1979613|FG001|Study Period 2|Withdrawal by Subject|1
975544|NCT01231984|1979614|FG002|Study Period 2|Withdrawal by Subject|0
975545|NCT01231984|1979615|FG003|Study Period 2|Withdrawal by Subject|0
975546|NCT01231984|1979612|FG000|Study Period 2|Lost to Follow-up|1
975547|NCT01231984|1979613|FG001|Study Period 2|Lost to Follow-up|0
975548|NCT01231984|1979614|FG002|Study Period 2|Lost to Follow-up|0
975549|NCT01231984|1979615|FG003|Study Period 2|Lost to Follow-up|3
975550|NCT01231984|1979612|FG000|Study Period 2|Did not continue to meet I/E Criteria|1
975551|NCT01231984|1979613|FG001|Study Period 2|Did not continue to meet I/E Criteria|1
975552|NCT01231984|1979614|FG002|Study Period 2|Did not continue to meet I/E Criteria|0
975553|NCT01231984|1979615|FG003|Study Period 2|Did not continue to meet I/E Criteria|1
975554|NCT01232127|1979633|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1
975555|NCT01232127|1979634|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0
975556|NCT01232127|1979635|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0
975557|NCT01232283|1979658|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
975558|NCT01232283|1979659|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
975559|NCT01232283|1979660|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
975560|NCT01232283|1979661|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
975561|NCT01232283|1979662|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
975562|NCT01232283|1979663|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
975563|NCT01232283|1979664|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
975564|NCT01232283|1979665|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
975565|NCT01232283|1979666|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
975566|NCT01232283|1979667|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
975567|NCT01232283|1979658|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
975568|NCT01232283|1979659|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
975569|NCT01232283|1979660|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
975570|NCT01232283|1979661|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
975571|NCT01232283|1979662|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
975572|NCT01232283|1979663|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
975573|NCT01232283|1979664|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
975574|NCT01232283|1979665|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
975575|NCT01232283|1979666|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
975576|NCT01232283|1979667|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
975577|NCT01232283|1979658|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
975578|NCT01232283|1979659|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
975579|NCT01232283|1979660|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
975580|NCT01232283|1979661|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
975581|NCT01232283|1979662|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
975582|NCT01232283|1979663|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
975583|NCT01232283|1979664|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
975584|NCT01232283|1979665|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
975585|NCT01232283|1979666|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
975586|NCT01232283|1979667|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
975587|NCT01232283|1979658|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
975588|NCT01232283|1979659|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
975589|NCT01232283|1979660|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
975590|NCT01232283|1979661|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
975591|NCT01232283|1979662|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
975592|NCT01232283|1979663|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
975593|NCT01232283|1979664|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
975594|NCT01232283|1979665|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
975595|NCT01232283|1979666|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
975596|NCT01232283|1979667|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
975597|NCT01232283|1979658|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
975598|NCT01232283|1979659|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
975599|NCT01232283|1979660|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
975600|NCT01232283|1979661|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
975601|NCT01232283|1979662|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
975602|NCT01232283|1979663|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
975603|NCT01232283|1979664|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
975604|NCT01232283|1979665|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
975605|NCT01232283|1979666|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
975606|NCT01232283|1979667|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
975607|NCT01232283|1979658|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
975608|NCT01232283|1979659|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
975609|NCT01232283|1979660|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
975610|NCT01232283|1979661|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
975611|NCT01232283|1979662|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
975612|NCT01232283|1979663|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
975613|NCT01232283|1979664|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
975614|NCT01232283|1979665|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
975615|NCT01232283|1979666|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
975616|NCT01232283|1979667|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
975617|NCT01232283|1979658|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2
975618|NCT01232283|1979659|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1
975619|NCT01232283|1979660|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0
975620|NCT01232283|1979661|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0
975621|NCT01232283|1979662|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0
975622|NCT01232283|1979663|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0
975623|NCT01232283|1979664|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0
975624|NCT01232283|1979665|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0
975625|NCT01232283|1979666|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0
975626|NCT01232283|1979667|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0
975627|NCT01232283|1979658|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0
975628|NCT01232283|1979659|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0
975629|NCT01232283|1979660|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8
975630|NCT01232283|1979661|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2
975631|NCT01232283|1979662|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0
975632|NCT01232283|1979663|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0
975633|NCT01232283|1979664|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0
975634|NCT01232283|1979665|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0
975635|NCT01232283|1979666|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0
975636|NCT01232283|1979667|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0
975637|NCT01232283|1979658|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
975638|NCT01232283|1979659|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
975639|NCT01232283|1979660|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
975640|NCT01232283|1979661|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
975641|NCT01232283|1979662|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
975642|NCT01232283|1979663|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
975643|NCT01232283|1979664|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
975644|NCT01232283|1979665|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
975645|NCT01232283|1979666|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
975646|NCT01232283|1979667|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
975647|NCT01232283|1979658|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
975648|NCT01232283|1979659|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
975649|NCT01232283|1979660|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
975650|NCT01232283|1979661|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
975651|NCT01232283|1979662|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
975652|NCT01232283|1979663|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
975653|NCT01232283|1979664|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
975654|NCT01232283|1979665|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
975655|NCT01232283|1979666|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
975656|NCT01232283|1979667|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
975657|NCT01232283|1979658|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
975658|NCT01232283|1979659|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
975659|NCT01232283|1979660|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
975660|NCT01232283|1979661|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
975661|NCT01232283|1979662|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
975662|NCT01232283|1979663|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
975663|NCT01232283|1979664|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
975664|NCT01232283|1979665|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
975665|NCT01232283|1979666|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
975666|NCT01232283|1979667|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
975667|NCT01232283|1979658|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
975668|NCT01232283|1979659|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
975669|NCT01232283|1979660|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
975670|NCT01232283|1979661|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
975671|NCT01232283|1979662|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
975672|NCT01232283|1979663|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
975673|NCT01232283|1979664|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
975674|NCT01232283|1979665|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
975675|NCT01232283|1979666|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
975676|NCT01232283|1979667|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
975677|NCT01232283|1979658|FG000|Maintenance Phase (Weeks16-32)|Other|0
975678|NCT01232283|1979659|FG001|Maintenance Phase (Weeks16-32)|Other|0
975679|NCT01232283|1979660|FG002|Maintenance Phase (Weeks16-32)|Other|2
975680|NCT01232283|1979661|FG003|Maintenance Phase (Weeks16-32)|Other|0
975681|NCT01232283|1979662|FG004|Maintenance Phase (Weeks16-32)|Other|0
975682|NCT01232283|1979663|FG005|Maintenance Phase (Weeks16-32)|Other|0
975683|NCT01232283|1979664|FG006|Maintenance Phase (Weeks16-32)|Other|0
975684|NCT01232283|1979665|FG007|Maintenance Phase (Weeks16-32)|Other|0
975685|NCT01232283|1979666|FG008|Maintenance Phase (Weeks16-32)|Other|0
975686|NCT01232283|1979667|FG009|Maintenance Phase (Weeks16-32)|Other|0
975687|NCT01232283|1979658|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
975688|NCT01232283|1979659|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
975689|NCT01232283|1979660|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
975690|NCT01232283|1979661|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
975691|NCT01232283|1979662|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
975692|NCT01232283|1979663|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
975693|NCT01232283|1979664|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
975694|NCT01232283|1979665|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
975695|NCT01232283|1979666|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
975696|NCT01232283|1979667|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
975697|NCT01232283|1979658|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
975698|NCT01232283|1979659|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
975699|NCT01232283|1979660|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
975700|NCT01232283|1979661|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
975701|NCT01232283|1979662|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
975702|NCT01232283|1979663|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
975703|NCT01232283|1979664|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
975704|NCT01232283|1979665|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
975705|NCT01232283|1979666|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
975706|NCT01232283|1979667|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
975707|NCT01232283|1979658|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
975708|NCT01232283|1979659|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
975709|NCT01232283|1979660|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
975710|NCT01232283|1979661|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
975711|NCT01232283|1979662|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
975712|NCT01232283|1979663|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
975713|NCT01232283|1979664|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
975714|NCT01232283|1979665|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
975715|NCT01232283|1979666|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
975716|NCT01232283|1979667|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
975717|NCT01232283|1979658|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
975718|NCT01232283|1979659|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
975719|NCT01232283|1979660|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
975720|NCT01232283|1979661|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
975721|NCT01232283|1979662|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
975722|NCT01232283|1979663|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
975723|NCT01232283|1979664|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
975724|NCT01232283|1979665|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
975725|NCT01232283|1979666|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
975726|NCT01232283|1979667|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
975727|NCT01232283|1979658|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
975728|NCT01232283|1979659|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
975729|NCT01232283|1979660|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
975730|NCT01232283|1979661|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
975731|NCT01232283|1979662|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
975732|NCT01232283|1979663|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
975733|NCT01232283|1979664|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
975734|NCT01232283|1979665|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
975735|NCT01232283|1979666|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
975736|NCT01232283|1979667|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
975737|NCT01232283|1979658|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
975738|NCT01232283|1979659|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
975739|NCT01232283|1979660|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
975740|NCT01232283|1979661|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
975741|NCT01232283|1979662|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
975742|NCT01232283|1979663|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
975743|NCT01232283|1979664|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
975744|NCT01232283|1979665|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
975745|NCT01232283|1979666|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
975746|NCT01232283|1979667|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
975747|NCT01232283|1979658|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
975748|NCT01232283|1979659|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
975749|NCT01232283|1979660|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
975750|NCT01232283|1979661|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
975751|NCT01232283|1979662|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
975752|NCT01232283|1979663|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
975753|NCT01232283|1979664|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
975754|NCT01232283|1979665|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
975755|NCT01232283|1979666|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
975756|NCT01232283|1979667|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
975757|NCT01232283|1979658|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
975758|NCT01232283|1979659|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
975759|NCT01232283|1979660|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
975760|NCT01232283|1979661|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
975761|NCT01232283|1979662|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
975762|NCT01232283|1979663|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
975763|NCT01232283|1979664|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
975764|NCT01232283|1979665|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1006634|NCT01468987|2025355|FG000|Overall Study|Adverse Event|12
975765|NCT01232283|1979666|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
975766|NCT01232283|1979667|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
975767|NCT01232283|1979658|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
975768|NCT01232283|1979659|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
975769|NCT01232283|1979660|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
975770|NCT01232283|1979661|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
975771|NCT01232283|1979662|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
975772|NCT01232283|1979663|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
975773|NCT01232283|1979664|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
975774|NCT01232283|1979665|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
975775|NCT01232283|1979666|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
975776|NCT01232283|1979667|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
975777|NCT01232283|1979658|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
975778|NCT01232283|1979659|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
975779|NCT01232283|1979660|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
975780|NCT01232283|1979661|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
975781|NCT01232283|1979662|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
975782|NCT01232283|1979663|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
975783|NCT01232283|1979664|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
975784|NCT01232283|1979665|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
975785|NCT01232283|1979666|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
975786|NCT01232283|1979667|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
975787|NCT01232283|1979658|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
975788|NCT01232283|1979659|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
975789|NCT01232283|1979660|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
975790|NCT01232283|1979661|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
975791|NCT01232283|1979662|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
975792|NCT01232283|1979663|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
975793|NCT01232283|1979664|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
975794|NCT01232283|1979665|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
975795|NCT01232283|1979666|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
975796|NCT01232283|1979667|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
975797|NCT01232283|1979658|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
975798|NCT01232283|1979659|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
975799|NCT01232283|1979660|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
975800|NCT01232283|1979661|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
975801|NCT01232283|1979662|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
975802|NCT01232283|1979663|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
975803|NCT01232283|1979664|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
975804|NCT01232283|1979665|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
975805|NCT01232283|1979666|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
975806|NCT01232283|1979667|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
975807|NCT01232283|1979658|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0
975808|NCT01232283|1979659|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0
975809|NCT01232283|1979660|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0
975810|NCT01232283|1979661|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0
975811|NCT01232283|1979662|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0
975812|NCT01232283|1979663|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0
975813|NCT01232283|1979664|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0
975814|NCT01232283|1979665|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0
975815|NCT01232283|1979666|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1
975816|NCT01232283|1979667|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0
975817|NCT01232283|1979658|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
975818|NCT01232283|1979659|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
975819|NCT01232283|1979660|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
975820|NCT01232283|1979661|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
975821|NCT01232283|1979662|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
975822|NCT01232283|1979663|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
975823|NCT01232283|1979664|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
975824|NCT01232283|1979665|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
975825|NCT01232283|1979666|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
975826|NCT01232283|1979667|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
975827|NCT01232283|1979658|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
975828|NCT01232283|1979659|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
975829|NCT01232283|1979660|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
975830|NCT01232283|1979661|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
975831|NCT01232283|1979662|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
975832|NCT01232283|1979663|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
975833|NCT01232283|1979664|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
975834|NCT01232283|1979665|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
975835|NCT01232283|1979666|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
975836|NCT01232283|1979667|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
975837|NCT01232296|1979691|FG000|Overall Study|Adverse Event|24
975838|NCT01232296|1979692|FG001|Overall Study|Adverse Event|12
975839|NCT01232296|1979691|FG000|Overall Study|Physician Decision|1
975840|NCT01232296|1979692|FG001|Overall Study|Physician Decision|1
975841|NCT01232296|1979691|FG000|Overall Study|Progressive disease|43
975842|NCT01232296|1979692|FG001|Overall Study|Progressive disease|61
975843|NCT01232296|1979691|FG000|Overall Study|Study terminated by sponsor|0
975844|NCT01232296|1979692|FG001|Overall Study|Study terminated by sponsor|1
975845|NCT01232296|1979691|FG000|Overall Study|Technical problems|3
975846|NCT01232296|1979692|FG001|Overall Study|Technical problems|0
975847|NCT01232296|1979691|FG000|Overall Study|Subject/guardian decision|10
975848|NCT01232296|1979692|FG001|Overall Study|Subject/guardian decision|2
975849|NCT01232296|1979691|FG000|Overall Study|Death|1
975850|NCT01232296|1979692|FG001|Overall Study|Death|6
975851|NCT01232452|1979700|FG000|Overall Study|Adverse Event|17
975852|NCT01232452|1979701|FG001|Overall Study|Adverse Event|15
975853|NCT01232452|1979700|FG000|Overall Study|Withdrawal by Subject|11
975854|NCT01232452|1979701|FG001|Overall Study|Withdrawal by Subject|8
975855|NCT01232452|1979700|FG000|Overall Study|Physician Decision|8
975856|NCT01232452|1979701|FG001|Overall Study|Physician Decision|12
975857|NCT01232452|1979700|FG000|Overall Study|Protocol entry criterion not met|0
975858|NCT01232452|1979701|FG001|Overall Study|Protocol entry criterion not met|2
975859|NCT01232452|1979700|FG000|Overall Study|Sponsor Decision|3
975860|NCT01232452|1979701|FG001|Overall Study|Sponsor Decision|1
975861|NCT01232452|1979700|FG000|Overall Study|Protocol Violation|0
975862|NCT01232452|1979701|FG001|Overall Study|Protocol Violation|1
975863|NCT01232491|1979718|FG000|Overall Study|Adverse Event|13
975864|NCT01232491|1979719|FG001|Overall Study|Adverse Event|8
975865|NCT01232491|1979718|FG000|Overall Study|Lack of Efficacy|1
975866|NCT01232491|1979719|FG001|Overall Study|Lack of Efficacy|5
975867|NCT01232491|1979718|FG000|Overall Study|Protocol Violation|13
975868|NCT01232491|1979719|FG001|Overall Study|Protocol Violation|11
975869|NCT01232491|1979718|FG000|Overall Study|Withdrawal Criteria|12
975870|NCT01232491|1979719|FG001|Overall Study|Withdrawal Criteria|21
975871|NCT01232491|1979718|FG000|Overall Study|Other|21
975872|NCT01232491|1979719|FG001|Overall Study|Other|18
975873|NCT01232556|1979748|FG000|Overall Study|Withdrawal by Subject|21
975874|NCT01232556|1979749|FG001|Overall Study|Withdrawal by Subject|17
975875|NCT01232556|1979748|FG000|Overall Study|Death|97
975876|NCT01232556|1979749|FG001|Overall Study|Death|97
975877|NCT01232556|1979748|FG000|Overall Study|Lost to Follow-up|0
975878|NCT01232556|1979749|FG001|Overall Study|Lost to Follow-up|2
975879|NCT01232556|1979748|FG000|Overall Study|Terminated by Sponsor|35
975880|NCT01232556|1979749|FG001|Overall Study|Terminated by Sponsor|51
975881|NCT01232556|1979748|FG000|Overall Study|Other|6
975882|NCT01232556|1979749|FG001|Overall Study|Other|4
975883|NCT01232569|1979757|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
975884|NCT01232569|1979758|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
975885|NCT01232569|1979759|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
975886|NCT01232569|1979760|FG003|Double-blind Treatment Period|Withdrawal by Subject|0
975887|NCT01232569|1979757|FG000|Double-blind Treatment Period|Escape|2
975888|NCT01232569|1979758|FG001|Double-blind Treatment Period|Escape|2
975889|NCT01232569|1979759|FG002|Double-blind Treatment Period|Escape|0
975890|NCT01232569|1979760|FG003|Double-blind Treatment Period|Escape|0
975891|NCT01232569|1979757|FG000|Double-blind Treatment Period|Lost to Follow-up|4
975892|NCT01232569|1979758|FG001|Double-blind Treatment Period|Lost to Follow-up|0
975893|NCT01232569|1979759|FG002|Double-blind Treatment Period|Lost to Follow-up|0
975894|NCT01232569|1979760|FG003|Double-blind Treatment Period|Lost to Follow-up|0
975895|NCT01232569|1979757|FG000|Double-blind Treatment Period|Lack of Efficacy|1
975896|NCT01232569|1979758|FG001|Double-blind Treatment Period|Lack of Efficacy|2
975897|NCT01232569|1979759|FG002|Double-blind Treatment Period|Lack of Efficacy|0
975898|NCT01232569|1979760|FG003|Double-blind Treatment Period|Lack of Efficacy|0
975899|NCT01232569|1979757|FG000|Double-blind Treatment Period|Physician Decision|1
975900|NCT01232569|1979758|FG001|Double-blind Treatment Period|Physician Decision|0
975901|NCT01232569|1979759|FG002|Double-blind Treatment Period|Physician Decision|0
975902|NCT01232569|1979760|FG003|Double-blind Treatment Period|Physician Decision|0
975903|NCT01232569|1979757|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
975904|NCT01232569|1979758|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
975905|NCT01232569|1979759|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
975906|NCT01232569|1979760|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
975907|NCT01232569|1979757|FG000|Double-blind Treatment Period|Death|2
975908|NCT01232569|1979758|FG001|Double-blind Treatment Period|Death|0
975909|NCT01232569|1979759|FG002|Double-blind Treatment Period|Death|0
975910|NCT01232569|1979760|FG003|Double-blind Treatment Period|Death|0
975911|NCT01232738|1979769|FG000|Overall Study|Death|3
975912|NCT01232738|1979769|FG000|Overall Study|Physician Decision|2
975913|NCT01232738|1979769|FG000|Overall Study|Lost to Follow-up|1
975914|NCT01232738|1979769|FG000|Overall Study|Withdrawal by Subject|2
975915|NCT01232738|1979769|FG000|Overall Study|Adverse Event|5
975916|NCT01232790|1979777|FG000|Randomization|Withdrawal by Subject|2
975917|NCT01232790|1979778|FG001|Randomization|Withdrawal by Subject|0
975918|NCT01232790|1979777|FG000|Randomization|Protocol Violation|0
975919|NCT01232790|1979778|FG001|Randomization|Protocol Violation|1
975920|NCT01232790|1979777|FG000|Randomization|Physician Decision|0
975921|NCT01232790|1979778|FG001|Randomization|Physician Decision|1
975922|NCT01232790|1979777|FG000|Initial Assessment|Withdrawal by Subject|0
975923|NCT01232790|1979778|FG001|Initial Assessment|Withdrawal by Subject|1
975924|NCT01232790|1979777|FG000|First Crossover|Withdrawal by Subject|1
975925|NCT01232790|1979778|FG001|First Crossover|Withdrawal by Subject|0
975926|NCT01232790|1979777|FG000|Second Crossover|Withdrawal by Subject|1
975927|NCT01232790|1979778|FG001|Second Crossover|Withdrawal by Subject|2
975928|NCT01232868|1979800|FG000|Overall Study|Lost to Follow-up|2
975929|NCT01232868|1979801|FG001|Overall Study|Lost to Follow-up|4
975930|NCT01232894|1979809|FG000|Overall Study|Lost to Follow-up|0
975931|NCT01232894|1979810|FG001|Overall Study|Lost to Follow-up|1
975932|NCT01232894|1979809|FG000|Overall Study|Death|1
975933|NCT01232894|1979810|FG001|Overall Study|Death|0
975934|NCT01232894|1979809|FG000|Overall Study|Protocol Violation|1
975935|NCT01232894|1979810|FG001|Overall Study|Protocol Violation|1
975936|NCT01232894|1979809|FG000|Overall Study|Withdrawal by Subject|8
975937|NCT01232894|1979810|FG001|Overall Study|Withdrawal by Subject|5
975938|NCT01232894|1979809|FG000|Overall Study|Physician Decision|2
975939|NCT01232894|1979810|FG001|Overall Study|Physician Decision|1
975940|NCT01233050|1979840|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8
975941|NCT01233050|1979841|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6
975942|NCT01233076|1979847|FG000|Period 2, One Week|Lost to Follow-up|1
975943|NCT01233076|1979848|FG001|Period 2, One Week|Lost to Follow-up|0
975944|NCT01233232|1979857|FG000|Overall Study|Voluntary Discontinuation by Subject|1
975945|NCT01233232|1979858|FG001|Overall Study|Voluntary Discontinuation by Subject|0
975946|NCT01233232|1979859|FG002|Overall Study|Voluntary Discontinuation by Subject|0
975947|NCT01233258|1979872|FG000|First Intervention (6 Months)|Withdrawal by Subject|0
975948|NCT01233258|1979873|FG001|First Intervention (6 Months)|Withdrawal by Subject|0
975949|NCT01233258|1979874|FG002|First Intervention (6 Months)|Withdrawal by Subject|0
975950|NCT01233258|1979875|FG003|First Intervention (6 Months)|Withdrawal by Subject|1
975951|NCT01233258|1979876|FG004|First Intervention (6 Months)|Withdrawal by Subject|0
975952|NCT01233258|1979877|FG005|First Intervention (6 Months)|Withdrawal by Subject|1
975953|NCT01233258|1979872|FG000|First Intervention (6 Months)|Protocol Violation|0
975954|NCT01233258|1979873|FG001|First Intervention (6 Months)|Protocol Violation|0
975955|NCT01233258|1979874|FG002|First Intervention (6 Months)|Protocol Violation|1
975956|NCT01233258|1979875|FG003|First Intervention (6 Months)|Protocol Violation|0
975957|NCT01233258|1979876|FG004|First Intervention (6 Months)|Protocol Violation|0
975958|NCT01233258|1979877|FG005|First Intervention (6 Months)|Protocol Violation|0
975959|NCT01233258|1979872|FG000|First Intervention (6 Months)|Non-compliance with study medication|1
975960|NCT01233258|1979873|FG001|First Intervention (6 Months)|Non-compliance with study medication|0
975961|NCT01233258|1979874|FG002|First Intervention (6 Months)|Non-compliance with study medication|0
975962|NCT01233258|1979875|FG003|First Intervention (6 Months)|Non-compliance with study medication|0
975963|NCT01233258|1979876|FG004|First Intervention (6 Months)|Non-compliance with study medication|0
975964|NCT01233258|1979877|FG005|First Intervention (6 Months)|Non-compliance with study medication|0
975965|NCT01233284|1979892|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1
975966|NCT01233284|1979893|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0
975967|NCT01233284|1979894|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0
975968|NCT01233284|1979895|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
975969|NCT01233284|1979896|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
975970|NCT01233284|1979892|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0
975971|NCT01233284|1979893|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1
975972|NCT01233284|1979894|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
975973|NCT01233284|1979895|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
975974|NCT01233284|1979896|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0
975975|NCT01233284|1979892|FG000|Period 1 (4 Weeks)|Other|0
975976|NCT01233284|1979893|FG001|Period 1 (4 Weeks)|Other|0
975977|NCT01233284|1979894|FG002|Period 1 (4 Weeks)|Other|1
975978|NCT01233284|1979895|FG003|Period 1 (4 Weeks)|Other|0
975979|NCT01233284|1979896|FG004|Period 1 (4 Weeks)|Other|0
975980|NCT01233284|1979892|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0
975981|NCT01233284|1979893|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0
975982|NCT01233284|1979894|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1
975983|NCT01233284|1979895|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0
975984|NCT01233284|1979896|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0
975985|NCT01233284|1979892|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
975986|NCT01233284|1979893|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0
975987|NCT01233284|1979894|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1
975988|NCT01233284|1979895|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
975989|NCT01233284|1979896|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0
975990|NCT01233284|1979892|FG000|Period 3 (4 Weeks)|Other|0
975991|NCT01233284|1979893|FG001|Period 3 (4 Weeks)|Other|0
975992|NCT01233284|1979894|FG002|Period 3 (4 Weeks)|Other|0
975993|NCT01233284|1979895|FG003|Period 3 (4 Weeks)|Other|1
975994|NCT01233284|1979896|FG004|Period 3 (4 Weeks)|Other|0
975995|NCT01233284|1979892|FG000|Period 4 (4 Weeks)|Adverse Event|0
975996|NCT01233284|1979893|FG001|Period 4 (4 Weeks)|Adverse Event|1
975997|NCT01233284|1979894|FG002|Period 4 (4 Weeks)|Adverse Event|0
975998|NCT01233284|1979895|FG003|Period 4 (4 Weeks)|Adverse Event|0
975999|NCT01233284|1979896|FG004|Period 4 (4 Weeks)|Adverse Event|0
976000|NCT01233284|1979892|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0
976001|NCT01233284|1979893|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0
976002|NCT01233284|1979894|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0
976003|NCT01233284|1979895|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1
976004|NCT01233284|1979896|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0
976005|NCT01233609|1979913|FG000|Overall Study|Death|1
976006|NCT01233609|1979914|FG001|Overall Study|Death|0
976007|NCT01233609|1979913|FG000|Overall Study|Lost to Follow-up|3
976008|NCT01233609|1979914|FG001|Overall Study|Lost to Follow-up|1
976009|NCT01233609|1979913|FG000|Overall Study|Adverse Event|2
976010|NCT01233609|1979914|FG001|Overall Study|Adverse Event|1
976011|NCT01233609|1979913|FG000|Overall Study|Withdrawal by Subject|3
976012|NCT01233609|1979914|FG001|Overall Study|Withdrawal by Subject|0
976013|NCT01233687|1979928|FG000|Phase II AMG 102 + Erlotinib|Death|1
976014|NCT01233687|1979928|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2
976015|NCT01233687|1979928|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
976016|NCT01233817|1979948|FG000|Overall Study|Lost to Follow-up|1
976017|NCT01233817|1979948|FG000|Overall Study|Withdrawal by Subject|2
976018|NCT01233869|1979956|FG000|Initial Treatment Period (24 Months)|Death|1
976019|NCT01233869|1979957|FG001|Initial Treatment Period (24 Months)|Death|0
976020|NCT01233869|1979958|FG002|Initial Treatment Period (24 Months)|Death|0
976021|NCT01233869|1979959|FG003|Initial Treatment Period (24 Months)|Death|0
976022|NCT01233869|1979956|FG000|Initial Treatment Period (24 Months)|Adverse Event|9
976023|NCT01233869|1979957|FG001|Initial Treatment Period (24 Months)|Adverse Event|17
976024|NCT01233869|1979958|FG002|Initial Treatment Period (24 Months)|Adverse Event|0
976025|NCT01233869|1979959|FG003|Initial Treatment Period (24 Months)|Adverse Event|3
976026|NCT01233869|1979956|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
976027|NCT01233869|1979957|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
976028|NCT01233869|1979958|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
976029|NCT01233869|1979959|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
976030|NCT01233869|1979956|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0
976031|NCT01233869|1979957|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0
976032|NCT01233869|1979958|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0
976033|NCT01233869|1979959|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1
976034|NCT01233869|1979956|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
976035|NCT01233869|1979957|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
976036|NCT01233869|1979958|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
976037|NCT01233869|1979959|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
976038|NCT01233869|1979956|FG000|Extended Treatment Period (46 Months)|Other|3
912639|NCT00806260|1890182|FG004|Period 3|Protocol Violation|0
912640|NCT00806260|1890183|FG005|Period 3|Protocol Violation|0
976039|NCT01233869|1979957|FG001|Extended Treatment Period (46 Months)|Other|0
976040|NCT01233869|1979958|FG002|Extended Treatment Period (46 Months)|Other|0
976041|NCT01233869|1979959|FG003|Extended Treatment Period (46 Months)|Other|3
976042|NCT01233869|1979956|FG000|Extended Treatment Period (46 Months)|Adverse Event|1
976043|NCT01233869|1979957|FG001|Extended Treatment Period (46 Months)|Adverse Event|0
976044|NCT01233869|1979958|FG002|Extended Treatment Period (46 Months)|Adverse Event|0
976045|NCT01233869|1979959|FG003|Extended Treatment Period (46 Months)|Adverse Event|1
976046|NCT01233999|1979978|FG000|Overall Study|Withdrawal by Subject|1
976047|NCT01233999|1979978|FG000|Overall Study|Lost to Follow-up|1
976048|NCT01234337|1979993|FG000|Overall Study|Adverse Event|58
976049|NCT01234337|1979994|FG001|Overall Study|Adverse Event|21
976050|NCT01234337|1979993|FG000|Overall Study|Disease progression/recurrence/relapse|181
976051|NCT01234337|1979994|FG001|Overall Study|Disease progression/recurrence/relapse|223
976052|NCT01234337|1979993|FG000|Overall Study|Investi. decision not protocol driven|5
976053|NCT01234337|1979994|FG001|Overall Study|Investi. decision not protocol driven|6
976054|NCT01234337|1979993|FG000|Overall Study|Non-compliant with study medication|3
976055|NCT01234337|1979994|FG001|Overall Study|Non-compliant with study medication|2
976056|NCT01234337|1979993|FG000|Overall Study|Randomized but not treated|6
976057|NCT01234337|1979994|FG001|Overall Study|Randomized but not treated|4
976058|NCT01234337|1979993|FG000|Overall Study|Lost to Follow-up|0
976059|NCT01234337|1979994|FG001|Overall Study|Lost to Follow-up|1
976060|NCT01234337|1979993|FG000|Overall Study|Protocol Violation|2
976061|NCT01234337|1979994|FG001|Overall Study|Protocol Violation|3
976062|NCT01234337|1979993|FG000|Overall Study|Withdrawal by Subject|11
976063|NCT01234337|1979994|FG001|Overall Study|Withdrawal by Subject|9
976064|NCT01234337|1979993|FG000|Overall Study|Death|0
976065|NCT01234337|1979994|FG001|Overall Study|Death|1
976066|NCT01234337|1979993|FG000|Overall Study|Switch to commercial drug|0
976067|NCT01234337|1979994|FG001|Overall Study|Switch to commercial drug|1
976068|NCT01234350|1980002|FG000|Overall Study|Adverse Event|277
976069|NCT01234350|1980003|FG001|Overall Study|Adverse Event|92
976070|NCT01234350|1980002|FG000|Overall Study|Withdrawal by Subject|61
976071|NCT01234350|1980003|FG001|Overall Study|Withdrawal by Subject|36
976072|NCT01234350|1980002|FG000|Overall Study|Lost to Follow-up|115
976073|NCT01234350|1980003|FG001|Overall Study|Lost to Follow-up|47
976074|NCT01234350|1980002|FG000|Overall Study|Covers a diverse set of reasons|234
976075|NCT01234350|1980003|FG001|Overall Study|Covers a diverse set of reasons|92
976076|NCT01234402|1980014|FG000|Overall Study|Lost to Follow-up|0
976077|NCT01234402|1980015|FG001|Overall Study|Lost to Follow-up|1
976078|NCT01234402|1980016|FG002|Overall Study|Lost to Follow-up|3
976079|NCT01234402|1980014|FG000|Overall Study|Withdrawal by Subject|1
976080|NCT01234402|1980015|FG001|Overall Study|Withdrawal by Subject|3
976081|NCT01234402|1980016|FG002|Overall Study|Withdrawal by Subject|4
976082|NCT01234402|1980014|FG000|Overall Study|Never treated: Death|0
976083|NCT01234402|1980015|FG001|Overall Study|Never treated: Death|0
976084|NCT01234402|1980016|FG002|Overall Study|Never treated: Death|1
976085|NCT01234402|1980014|FG000|Overall Study|Never treated: Withdrawal By Subject|0
976086|NCT01234402|1980015|FG001|Overall Study|Never treated: Withdrawal By Subject|1
976087|NCT01234402|1980016|FG002|Overall Study|Never treated: Withdrawal By Subject|0
976088|NCT01234402|1980014|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0
976089|NCT01234402|1980015|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1
976090|NCT01234402|1980016|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0
976091|NCT01234467|1980026|FG000|Overall Study|Adverse Event|3
976092|NCT01234467|1980026|FG000|Overall Study|Death|2
976093|NCT01234467|1980026|FG000|Overall Study|Withdrawal by Subject|2
976094|NCT01234467|1980026|FG000|Overall Study|Disease Progression|2
976095|NCT01234467|1980026|FG000|Overall Study|Clinical deterioration|1
976096|NCT01234467|1980026|FG000|Overall Study|Physician Decision|1
976097|NCT01234467|1980026|FG000|Overall Study|Other complicating disease (stroke)|1
976098|NCT01234480|1980030|FG000|Overall Study|Pregnancy|88
976099|NCT01234480|1980030|FG000|Overall Study|>36/Normal History|50
976100|NCT01234480|1980030|FG000|Overall Study|Age|3
976101|NCT01234480|1980030|FG000|Overall Study|HPV Vaccine History|28
976102|NCT01234480|1980030|FG000|Overall Study|HPV Vaccine after Enrollment|17
976103|NCT01234480|1980030|FG000|Overall Study|Hysterectomy|2
976104|NCT01234480|1980030|FG000|Overall Study|Hysterectomy post enrollment|1
976105|NCT01234480|1980030|FG000|Overall Study|Inclusion/Exclusion Violation|3
976106|NCT01234480|1980030|FG000|Overall Study|Informed Consent Form Violation|30
976107|NCT01234480|1980030|FG000|Overall Study|Incorrect Visit|3
976108|NCT01234480|1980030|FG000|Overall Study|No Florida Lab License|20
976109|NCT01234480|1980030|FG000|Overall Study|Out of Window|42
976110|NCT01234480|1980030|FG000|Overall Study|Sample Processing/Storage|92
976111|NCT01234480|1980030|FG000|Overall Study|Site Amendment prohibited colposcopy|11
976112|NCT01234480|1980030|FG000|Overall Study|Site/Subject non-compliance|44
976113|NCT01234480|1980030|FG000|Overall Study|Missing Sample|9
976114|NCT01234649|1980039|FG000|Overall Study|Withdrawal by Subject|32
976115|NCT01234649|1980040|FG001|Overall Study|Withdrawal by Subject|26
976116|NCT01234649|1980039|FG000|Overall Study|Pregnancy|6
976117|NCT01234649|1980040|FG001|Overall Study|Pregnancy|6
976118|NCT01234649|1980039|FG000|Overall Study|intolerant to side effects|4
976119|NCT01234649|1980040|FG001|Overall Study|intolerant to side effects|3
976120|NCT01234649|1980039|FG000|Overall Study|Allergic reaction|1
976121|NCT01234649|1980040|FG001|Overall Study|Allergic reaction|0
976122|NCT01234649|1980039|FG000|Overall Study|Lack of Efficacy|0
976123|NCT01234649|1980040|FG001|Overall Study|Lack of Efficacy|3
976124|NCT01234675|1980046|FG000|First Intervention (6 Weeks)|Adverse Event|0
976125|NCT01234675|1980047|FG001|First Intervention (6 Weeks)|Adverse Event|1
976126|NCT01234675|1980046|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1
976127|NCT01234675|1980047|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0
976128|NCT01234883|1980081|FG000|Overall Study|Early treatment release|8
976129|NCT01234883|1980082|FG001|Overall Study|Early treatment release|10
976130|NCT01234883|1980081|FG000|Overall Study|Parent/guardian withdrew consent|1
976131|NCT01234883|1980082|FG001|Overall Study|Parent/guardian withdrew consent|2
976132|NCT01234883|1980081|FG000|Overall Study|Technical difficulties with IV infusion|0
976133|NCT01234883|1980082|FG001|Overall Study|Technical difficulties with IV infusion|1
976134|NCT01234883|1980081|FG000|Overall Study|Inclusion/exclusion failure|1
976135|NCT01234883|1980082|FG001|Overall Study|Inclusion/exclusion failure|0
976136|NCT01235234|1980115|FG000|Overall Study|Adverse Event|2
976137|NCT01235234|1980116|FG001|Overall Study|Adverse Event|2
976138|NCT01235234|1980117|FG002|Overall Study|Adverse Event|1
976139|NCT01235338|1980127|FG000|Overall Study|Adverse Event|3
976140|NCT01235338|1980128|FG001|Overall Study|Adverse Event|2
976141|NCT01235338|1980127|FG000|Overall Study|Protocol Violation|1
976142|NCT01235338|1980128|FG001|Overall Study|Protocol Violation|1
976143|NCT01235338|1980127|FG000|Overall Study|Withdrawal by Subject|5
976144|NCT01235338|1980128|FG001|Overall Study|Withdrawal by Subject|0
976145|NCT01235338|1980127|FG000|Overall Study|Exclusion criteria violations|1
976146|NCT01235338|1980128|FG001|Overall Study|Exclusion criteria violations|1
976147|NCT01235338|1980127|FG000|Overall Study|Positive drug screen|0
976148|NCT01235338|1980128|FG001|Overall Study|Positive drug screen|1
976149|NCT01235338|1980127|FG000|Overall Study|Prohibited meds|1
976150|NCT01235338|1980128|FG001|Overall Study|Prohibited meds|0
976151|NCT01235351|1980138|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
976152|NCT01235351|1980139|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
976153|NCT01235403|1980158|FG000|Overall Study|Adverse Event|14
976154|NCT01235403|1980158|FG000|Overall Study|Lost to Follow-up|2
976155|NCT01235403|1980158|FG000|Overall Study|Withdrawal by Subject|4
976156|NCT01235403|1980158|FG000|Overall Study|Lack of Efficacy|2
976157|NCT01235403|1980158|FG000|Overall Study|Other reasons for premature termination|4
976158|NCT01235442|1980164|FG000|Overall Study|Lost to Follow-up|12
976159|NCT01235442|1980165|FG001|Overall Study|Lost to Follow-up|10
976160|NCT01235442|1980164|FG000|Overall Study|Death|0
976161|NCT01235442|1980165|FG001|Overall Study|Death|2
976162|NCT01235442|1980164|FG000|Overall Study|Pregnancy|1
976163|NCT01235442|1980165|FG001|Overall Study|Pregnancy|1
976164|NCT01235442|1980164|FG000|Overall Study|Ineligibility determined|5
976165|NCT01235442|1980165|FG001|Overall Study|Ineligibility determined|4
976166|NCT01235442|1980164|FG000|Overall Study|Protocol Violation|3
976167|NCT01235442|1980165|FG001|Overall Study|Protocol Violation|3
976168|NCT01235442|1980164|FG000|Overall Study|Adverse Event|4
976169|NCT01235442|1980165|FG001|Overall Study|Adverse Event|6
976170|NCT01235442|1980164|FG000|Overall Study|Withdrawal by Subject|15
976171|NCT01235442|1980165|FG001|Overall Study|Withdrawal by Subject|9
976172|NCT01235442|1980164|FG000|Overall Study|Lack of Efficacy|1
976173|NCT01235442|1980165|FG001|Overall Study|Lack of Efficacy|3
976174|NCT01235442|1980164|FG000|Overall Study|Noncompliance|1
976175|NCT01235442|1980165|FG001|Overall Study|Noncompliance|2
976176|NCT01235442|1980164|FG000|Overall Study|Administrative decision|1
976177|NCT01235442|1980165|FG001|Overall Study|Administrative decision|2
976178|NCT01235442|1980164|FG000|Overall Study|Other unspecified|1
976179|NCT01235442|1980165|FG001|Overall Study|Other unspecified|2
976180|NCT01235507|1980171|FG000|Overall Study|Adverse Event|1
976181|NCT01235507|1980171|FG000|Overall Study|Withdrawal by Subject|1
976182|NCT01235546|1980177|FG000|Overall Study|Staff error, medication not administered|1
976183|NCT01235546|1980178|FG001|Overall Study|Staff error, medication not administered|0
976184|NCT01235546|1980177|FG000|Overall Study|Protocol Violation|1
976185|NCT01235546|1980178|FG001|Overall Study|Protocol Violation|1
976186|NCT01235598|1980195|FG000|Overall Study|Adverse Event|0
976187|NCT01235598|1980196|FG001|Overall Study|Adverse Event|3
976188|NCT01235598|1980195|FG000|Overall Study|Lack of Efficacy|0
976189|NCT01235598|1980196|FG001|Overall Study|Lack of Efficacy|1
976190|NCT01235598|1980195|FG000|Overall Study|Withdrawal by Subject|1
976191|NCT01235598|1980196|FG001|Overall Study|Withdrawal by Subject|0
976192|NCT01235689|1980205|FG000|Overall Study|Adverse Event|12
976193|NCT01235689|1980206|FG001|Overall Study|Adverse Event|16
976194|NCT01235689|1980205|FG000|Overall Study|Lack of Efficacy|12
976195|NCT01235689|1980206|FG001|Overall Study|Lack of Efficacy|5
976196|NCT01235689|1980205|FG000|Overall Study|Withdrawal by Subject|3
976197|NCT01235689|1980206|FG001|Overall Study|Withdrawal by Subject|4
976198|NCT01235689|1980205|FG000|Overall Study|Lost to Follow-up|1
976199|NCT01235689|1980206|FG001|Overall Study|Lost to Follow-up|2
976200|NCT01235689|1980205|FG000|Overall Study|Miscellaneous|1
976201|NCT01235689|1980206|FG001|Overall Study|Miscellaneous|5
976202|NCT01235715|1980214|FG000|Overall Study|Physician Decision|0
976203|NCT01235715|1980215|FG001|Overall Study|Physician Decision|2
976204|NCT01235728|1980222|FG000|Overall Study|Protocol Violation|0
976205|NCT01235728|1980223|FG001|Overall Study|Protocol Violation|0
976206|NCT01235728|1980224|FG002|Overall Study|Protocol Violation|0
976207|NCT01235728|1980225|FG003|Overall Study|Protocol Violation|1
976208|NCT01235728|1980226|FG004|Overall Study|Protocol Violation|0
976209|NCT01235728|1980227|FG005|Overall Study|Protocol Violation|0
976210|NCT01235728|1980228|FG006|Overall Study|Protocol Violation|0
976211|NCT01235728|1980229|FG007|Overall Study|Protocol Violation|0
976212|NCT01235741|1980240|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
976213|NCT01235741|1980241|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
976214|NCT01235741|1980242|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
976215|NCT01235741|1980240|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
976216|NCT01235741|1980241|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
976217|NCT01235741|1980242|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
976218|NCT01235741|1980240|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
976219|NCT01235741|1980241|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
976220|NCT01235741|1980242|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
976221|NCT01235741|1980240|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
976222|NCT01235741|1980241|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
976223|NCT01235741|1980242|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
976224|NCT01235741|1980240|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
976225|NCT01235741|1980241|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
976226|NCT01235741|1980242|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
976227|NCT01235741|1980240|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
976228|NCT01235741|1980241|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
976229|NCT01235741|1980242|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
976230|NCT01235741|1980240|FG000|Randomized to Treatment|Withdrawal by Subject|0
976231|NCT01235741|1980241|FG001|Randomized to Treatment|Withdrawal by Subject|0
976232|NCT01235741|1980242|FG002|Randomized to Treatment|Withdrawal by Subject|1
976233|NCT01235741|1980240|FG000|Randomized to Treatment|Adverse Event|0
976234|NCT01235741|1980241|FG001|Randomized to Treatment|Adverse Event|1
976235|NCT01235741|1980242|FG002|Randomized to Treatment|Adverse Event|1
976236|NCT01235741|1980240|FG000|Randomized to Treatment|Sponsor terminated study|0
976237|NCT01235741|1980241|FG001|Randomized to Treatment|Sponsor terminated study|35
976238|NCT01235741|1980242|FG002|Randomized to Treatment|Sponsor terminated study|34
976239|NCT01235741|1980240|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
976240|NCT01235741|1980241|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
976241|NCT01235741|1980242|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
976242|NCT01235741|1980240|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
976243|NCT01235741|1980241|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
976244|NCT01235741|1980242|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
976245|NCT01235741|1980240|FG000|Follow-Up Post Treatment up to Month 6|Other|0
976246|NCT01235741|1980241|FG001|Follow-Up Post Treatment up to Month 6|Other|1
976247|NCT01235741|1980242|FG002|Follow-Up Post Treatment up to Month 6|Other|0
976248|NCT01235793|1980254|FG000|Overall Study|Death|6
976249|NCT01235949|1980295|FG000|Primary Phase|Migrated/moved from study area|1
976250|NCT01235949|1980296|FG001|Primary Phase|Migrated/moved from study area|1
976251|NCT01235949|1980297|FG002|Primary Phase|Migrated/moved from study area|0
976252|NCT01235949|1980298|FG003|Primary Phase|Migrated/moved from study area|0
976253|NCT01235949|1980299|FG004|Primary Phase|Migrated/moved from study area|1
976254|NCT01235949|1980300|FG005|Primary Phase|Migrated/moved from study area|2
976255|NCT01235949|1980301|FG006|Primary Phase|Migrated/moved from study area|0
976256|NCT01235949|1980302|FG007|Primary Phase|Migrated/moved from study area|0
976257|NCT01235949|1980303|FG008|Primary Phase|Migrated/moved from study area|0
976258|NCT01235949|1980304|FG009|Primary Phase|Migrated/moved from study area|0
976259|NCT01235949|1980305|FG010|Primary Phase|Migrated/moved from study area|0
976260|NCT01235949|1980306|FG011|Primary Phase|Migrated/moved from study area|0
976261|NCT01235949|1980307|FG012|Primary Phase|Migrated/moved from study area|0
976262|NCT01235949|1980308|FG013|Primary Phase|Migrated/moved from study area|0
976263|NCT01235949|1980309|FG014|Primary Phase|Migrated/moved from study area|0
976264|NCT01235949|1980310|FG015|Primary Phase|Migrated/moved from study area|0
976265|NCT01235949|1980311|FG016|Primary Phase|Migrated/moved from study area|0
976266|NCT01235949|1980312|FG017|Primary Phase|Migrated/moved from study area|0
976267|NCT01235949|1980295|FG000|Primary Phase|Adverse Event|0
976268|NCT01235949|1980296|FG001|Primary Phase|Adverse Event|0
976269|NCT01235949|1980297|FG002|Primary Phase|Adverse Event|0
976270|NCT01235949|1980298|FG003|Primary Phase|Adverse Event|1
976271|NCT01235949|1980299|FG004|Primary Phase|Adverse Event|0
976272|NCT01235949|1980300|FG005|Primary Phase|Adverse Event|0
976273|NCT01235949|1980301|FG006|Primary Phase|Adverse Event|0
976274|NCT01235949|1980302|FG007|Primary Phase|Adverse Event|0
976275|NCT01235949|1980303|FG008|Primary Phase|Adverse Event|0
976276|NCT01235949|1980304|FG009|Primary Phase|Adverse Event|0
976277|NCT01235949|1980305|FG010|Primary Phase|Adverse Event|0
976278|NCT01235949|1980306|FG011|Primary Phase|Adverse Event|0
976279|NCT01235949|1980307|FG012|Primary Phase|Adverse Event|0
976280|NCT01235949|1980308|FG013|Primary Phase|Adverse Event|0
976281|NCT01235949|1980309|FG014|Primary Phase|Adverse Event|0
976282|NCT01235949|1980310|FG015|Primary Phase|Adverse Event|0
976283|NCT01235949|1980311|FG016|Primary Phase|Adverse Event|0
976284|NCT01235949|1980312|FG017|Primary Phase|Adverse Event|0
976285|NCT01235949|1980295|FG000|Primary Phase|Withdrawal by Subject|3
976286|NCT01235949|1980296|FG001|Primary Phase|Withdrawal by Subject|2
976287|NCT01235949|1980297|FG002|Primary Phase|Withdrawal by Subject|2
976288|NCT01235949|1980298|FG003|Primary Phase|Withdrawal by Subject|0
976289|NCT01235949|1980299|FG004|Primary Phase|Withdrawal by Subject|0
976290|NCT01235949|1980300|FG005|Primary Phase|Withdrawal by Subject|3
976291|NCT01235949|1980301|FG006|Primary Phase|Withdrawal by Subject|0
976292|NCT01235949|1980302|FG007|Primary Phase|Withdrawal by Subject|0
976293|NCT01235949|1980303|FG008|Primary Phase|Withdrawal by Subject|0
976294|NCT01235949|1980304|FG009|Primary Phase|Withdrawal by Subject|0
976295|NCT01235949|1980305|FG010|Primary Phase|Withdrawal by Subject|0
976296|NCT01235949|1980306|FG011|Primary Phase|Withdrawal by Subject|0
976297|NCT01235949|1980307|FG012|Primary Phase|Withdrawal by Subject|0
976298|NCT01235949|1980308|FG013|Primary Phase|Withdrawal by Subject|0
976299|NCT01235949|1980309|FG014|Primary Phase|Withdrawal by Subject|0
976300|NCT01235949|1980310|FG015|Primary Phase|Withdrawal by Subject|0
976301|NCT01235949|1980311|FG016|Primary Phase|Withdrawal by Subject|0
976302|NCT01235949|1980312|FG017|Primary Phase|Withdrawal by Subject|0
976303|NCT01235949|1980295|FG000|Primary Phase|Lost to Follow-up|0
976304|NCT01235949|1980296|FG001|Primary Phase|Lost to Follow-up|0
976305|NCT01235949|1980297|FG002|Primary Phase|Lost to Follow-up|1
976306|NCT01235949|1980298|FG003|Primary Phase|Lost to Follow-up|1
976307|NCT01235949|1980299|FG004|Primary Phase|Lost to Follow-up|0
976308|NCT01235949|1980300|FG005|Primary Phase|Lost to Follow-up|2
976309|NCT01235949|1980301|FG006|Primary Phase|Lost to Follow-up|0
976310|NCT01235949|1980302|FG007|Primary Phase|Lost to Follow-up|0
976311|NCT01235949|1980303|FG008|Primary Phase|Lost to Follow-up|0
976312|NCT01235949|1980304|FG009|Primary Phase|Lost to Follow-up|0
976313|NCT01235949|1980305|FG010|Primary Phase|Lost to Follow-up|0
976314|NCT01235949|1980306|FG011|Primary Phase|Lost to Follow-up|0
976315|NCT01235949|1980307|FG012|Primary Phase|Lost to Follow-up|0
976316|NCT01235949|1980308|FG013|Primary Phase|Lost to Follow-up|0
976317|NCT01235949|1980309|FG014|Primary Phase|Lost to Follow-up|0
976318|NCT01235949|1980310|FG015|Primary Phase|Lost to Follow-up|0
976319|NCT01235949|1980311|FG016|Primary Phase|Lost to Follow-up|0
976320|NCT01235949|1980312|FG017|Primary Phase|Lost to Follow-up|0
976321|NCT01235949|1980295|FG000|Booster Phase|Migrated/moved from study area|0
976322|NCT01235949|1980296|FG001|Booster Phase|Migrated/moved from study area|0
976323|NCT01235949|1980297|FG002|Booster Phase|Migrated/moved from study area|0
976324|NCT01235949|1980298|FG003|Booster Phase|Migrated/moved from study area|0
976325|NCT01235949|1980299|FG004|Booster Phase|Migrated/moved from study area|0
976326|NCT01235949|1980300|FG005|Booster Phase|Migrated/moved from study area|0
976327|NCT01235949|1980301|FG006|Booster Phase|Migrated/moved from study area|0
976328|NCT01235949|1980302|FG007|Booster Phase|Migrated/moved from study area|0
976329|NCT01235949|1980303|FG008|Booster Phase|Migrated/moved from study area|0
976330|NCT01235949|1980304|FG009|Booster Phase|Migrated/moved from study area|0
976331|NCT01235949|1980305|FG010|Booster Phase|Migrated/moved from study area|0
976332|NCT01235949|1980306|FG011|Booster Phase|Migrated/moved from study area|1
976333|NCT01235949|1980307|FG012|Booster Phase|Migrated/moved from study area|1
976334|NCT01235949|1980308|FG013|Booster Phase|Migrated/moved from study area|0
976335|NCT01235949|1980309|FG014|Booster Phase|Migrated/moved from study area|0
976336|NCT01235949|1980310|FG015|Booster Phase|Migrated/moved from study area|0
976337|NCT01235949|1980311|FG016|Booster Phase|Migrated/moved from study area|0
976338|NCT01235949|1980312|FG017|Booster Phase|Migrated/moved from study area|1
976339|NCT01235949|1980295|FG000|Booster Phase|Adverse Event|0
976340|NCT01235949|1980296|FG001|Booster Phase|Adverse Event|0
976341|NCT01235949|1980297|FG002|Booster Phase|Adverse Event|0
976342|NCT01235949|1980298|FG003|Booster Phase|Adverse Event|0
976343|NCT01235949|1980299|FG004|Booster Phase|Adverse Event|0
976344|NCT01235949|1980300|FG005|Booster Phase|Adverse Event|0
976345|NCT01235949|1980301|FG006|Booster Phase|Adverse Event|0
976346|NCT01235949|1980302|FG007|Booster Phase|Adverse Event|0
976347|NCT01235949|1980303|FG008|Booster Phase|Adverse Event|0
976348|NCT01235949|1980304|FG009|Booster Phase|Adverse Event|0
976349|NCT01235949|1980305|FG010|Booster Phase|Adverse Event|0
976350|NCT01235949|1980306|FG011|Booster Phase|Adverse Event|0
976351|NCT01235949|1980307|FG012|Booster Phase|Adverse Event|0
976352|NCT01235949|1980308|FG013|Booster Phase|Adverse Event|0
976353|NCT01235949|1980309|FG014|Booster Phase|Adverse Event|0
976354|NCT01235949|1980310|FG015|Booster Phase|Adverse Event|1
976355|NCT01235949|1980311|FG016|Booster Phase|Adverse Event|0
976356|NCT01235949|1980312|FG017|Booster Phase|Adverse Event|0
976357|NCT01235949|1980295|FG000|Booster Phase|Withdrawal by Subject|0
976358|NCT01235949|1980296|FG001|Booster Phase|Withdrawal by Subject|0
976359|NCT01235949|1980297|FG002|Booster Phase|Withdrawal by Subject|0
976360|NCT01235949|1980298|FG003|Booster Phase|Withdrawal by Subject|0
976361|NCT01235949|1980299|FG004|Booster Phase|Withdrawal by Subject|0
976362|NCT01235949|1980300|FG005|Booster Phase|Withdrawal by Subject|0
976363|NCT01235949|1980301|FG006|Booster Phase|Withdrawal by Subject|0
976364|NCT01235949|1980302|FG007|Booster Phase|Withdrawal by Subject|1
976365|NCT01235949|1980303|FG008|Booster Phase|Withdrawal by Subject|1
976366|NCT01235949|1980304|FG009|Booster Phase|Withdrawal by Subject|0
976367|NCT01235949|1980305|FG010|Booster Phase|Withdrawal by Subject|1
976368|NCT01235949|1980306|FG011|Booster Phase|Withdrawal by Subject|1
976369|NCT01235949|1980307|FG012|Booster Phase|Withdrawal by Subject|2
976370|NCT01235949|1980308|FG013|Booster Phase|Withdrawal by Subject|0
976371|NCT01235949|1980309|FG014|Booster Phase|Withdrawal by Subject|2
976372|NCT01235949|1980310|FG015|Booster Phase|Withdrawal by Subject|0
976373|NCT01235949|1980311|FG016|Booster Phase|Withdrawal by Subject|0
976374|NCT01235949|1980312|FG017|Booster Phase|Withdrawal by Subject|0
976375|NCT01235949|1980295|FG000|Booster Phase|Lost to Follow-up|0
976376|NCT01235949|1980296|FG001|Booster Phase|Lost to Follow-up|0
976377|NCT01235949|1980297|FG002|Booster Phase|Lost to Follow-up|0
976378|NCT01235949|1980298|FG003|Booster Phase|Lost to Follow-up|0
976379|NCT01235949|1980299|FG004|Booster Phase|Lost to Follow-up|0
976380|NCT01235949|1980300|FG005|Booster Phase|Lost to Follow-up|0
976381|NCT01235949|1980301|FG006|Booster Phase|Lost to Follow-up|0
976382|NCT01235949|1980302|FG007|Booster Phase|Lost to Follow-up|0
976383|NCT01235949|1980303|FG008|Booster Phase|Lost to Follow-up|1
976384|NCT01235949|1980304|FG009|Booster Phase|Lost to Follow-up|1
976385|NCT01235949|1980305|FG010|Booster Phase|Lost to Follow-up|1
976386|NCT01235949|1980306|FG011|Booster Phase|Lost to Follow-up|1
976387|NCT01235949|1980307|FG012|Booster Phase|Lost to Follow-up|0
976388|NCT01235949|1980308|FG013|Booster Phase|Lost to Follow-up|0
976389|NCT01235949|1980309|FG014|Booster Phase|Lost to Follow-up|0
976390|NCT01235949|1980310|FG015|Booster Phase|Lost to Follow-up|0
976391|NCT01235949|1980311|FG016|Booster Phase|Lost to Follow-up|0
976392|NCT01235949|1980312|FG017|Booster Phase|Lost to Follow-up|1
976393|NCT01235975|1980377|FG000|Overall Study|Serious Adverse Event|0
976394|NCT01235975|1980378|FG001|Overall Study|Serious Adverse Event|1
976395|NCT01235975|1980377|FG000|Overall Study|Withdrawal by Subject|8
976396|NCT01235975|1980378|FG001|Overall Study|Withdrawal by Subject|2
976397|NCT01235975|1980377|FG000|Overall Study|Migrated/moved from study area|2
976398|NCT01235975|1980378|FG001|Overall Study|Migrated/moved from study area|1
976399|NCT01235975|1980377|FG000|Overall Study|Lost to Follow-up|7
976400|NCT01235975|1980378|FG001|Overall Study|Lost to Follow-up|3
976401|NCT01236001|1980386|FG000|Overall Study|Adverse Event|5
976402|NCT01236001|1980387|FG001|Overall Study|Adverse Event|14
976403|NCT01236001|1980386|FG000|Overall Study|Lack of Efficacy|6
976404|NCT01236001|1980387|FG001|Overall Study|Lack of Efficacy|6
976405|NCT01236001|1980386|FG000|Overall Study|Lost to Follow-up|6
976406|NCT01236001|1980387|FG001|Overall Study|Lost to Follow-up|1
976407|NCT01236001|1980386|FG000|Overall Study|Incompliance|1
976408|NCT01236001|1980387|FG001|Overall Study|Incompliance|0
976409|NCT01236001|1980386|FG000|Overall Study|Planned Visit After End of Study|0
976410|NCT01236001|1980387|FG001|Overall Study|Planned Visit After End of Study|1
976411|NCT01236118|1980497|FG000|Overall Study|Adverse Event|2
976412|NCT01236118|1980498|FG001|Overall Study|Adverse Event|0
976413|NCT01236118|1980499|FG002|Overall Study|Adverse Event|2
976414|NCT01236118|1980497|FG000|Overall Study|Physician Decision|0
976415|NCT01236118|1980498|FG001|Overall Study|Physician Decision|1
976416|NCT01236118|1980499|FG002|Overall Study|Physician Decision|0
976417|NCT01236118|1980497|FG000|Overall Study|Withdrawal by Subject|0
976418|NCT01236118|1980498|FG001|Overall Study|Withdrawal by Subject|0
976419|NCT01236118|1980499|FG002|Overall Study|Withdrawal by Subject|1
976420|NCT01236339|1980536|FG000|Overall Study|Termination of study by sponsor|11
976421|NCT01236339|1980537|FG001|Overall Study|Termination of study by sponsor|13
976422|NCT01236352|1980555|FG000|Overall Study|Death|0
976423|NCT01236352|1980556|FG001|Overall Study|Death|0
976424|NCT01236352|1980557|FG002|Overall Study|Death|0
976425|NCT01236352|1980558|FG003|Overall Study|Death|0
976426|NCT01236352|1980559|FG004|Overall Study|Death|0
976427|NCT01236352|1980560|FG005|Overall Study|Death|0
976428|NCT01236352|1980561|FG006|Overall Study|Death|0
976429|NCT01236352|1980562|FG007|Overall Study|Death|1
976430|NCT01236352|1980563|FG008|Overall Study|Death|0
976431|NCT01236352|1980564|FG009|Overall Study|Death|0
976432|NCT01236352|1980565|FG010|Overall Study|Death|0
976433|NCT01236352|1980555|FG000|Overall Study|Withdrawal by Subject|0
976434|NCT01236352|1980556|FG001|Overall Study|Withdrawal by Subject|0
976435|NCT01236352|1980557|FG002|Overall Study|Withdrawal by Subject|0
976436|NCT01236352|1980558|FG003|Overall Study|Withdrawal by Subject|0
976437|NCT01236352|1980559|FG004|Overall Study|Withdrawal by Subject|0
976438|NCT01236352|1980560|FG005|Overall Study|Withdrawal by Subject|0
976439|NCT01236352|1980561|FG006|Overall Study|Withdrawal by Subject|0
976440|NCT01236352|1980562|FG007|Overall Study|Withdrawal by Subject|0
976441|NCT01236352|1980563|FG008|Overall Study|Withdrawal by Subject|0
976442|NCT01236352|1980564|FG009|Overall Study|Withdrawal by Subject|2
976443|NCT01236352|1980565|FG010|Overall Study|Withdrawal by Subject|1
976444|NCT01236352|1980555|FG000|Overall Study|Adverse Event|0
976445|NCT01236352|1980556|FG001|Overall Study|Adverse Event|0
976446|NCT01236352|1980557|FG002|Overall Study|Adverse Event|0
976447|NCT01236352|1980558|FG003|Overall Study|Adverse Event|0
976448|NCT01236352|1980559|FG004|Overall Study|Adverse Event|0
976449|NCT01236352|1980560|FG005|Overall Study|Adverse Event|0
976450|NCT01236352|1980561|FG006|Overall Study|Adverse Event|2
976451|NCT01236352|1980562|FG007|Overall Study|Adverse Event|0
976452|NCT01236352|1980563|FG008|Overall Study|Adverse Event|0
976453|NCT01236352|1980564|FG009|Overall Study|Adverse Event|4
976454|NCT01236352|1980565|FG010|Overall Study|Adverse Event|1
976455|NCT01236352|1980555|FG000|Overall Study|Study drug toxicity|0
976456|NCT01236352|1980556|FG001|Overall Study|Study drug toxicity|0
976457|NCT01236352|1980557|FG002|Overall Study|Study drug toxicity|0
976458|NCT01236352|1980558|FG003|Overall Study|Study drug toxicity|0
976459|NCT01236352|1980559|FG004|Overall Study|Study drug toxicity|0
976460|NCT01236352|1980560|FG005|Overall Study|Study drug toxicity|1
976461|NCT01236352|1980561|FG006|Overall Study|Study drug toxicity|1
976462|NCT01236352|1980562|FG007|Overall Study|Study drug toxicity|0
976463|NCT01236352|1980563|FG008|Overall Study|Study drug toxicity|0
976464|NCT01236352|1980564|FG009|Overall Study|Study drug toxicity|2
976465|NCT01236352|1980565|FG010|Overall Study|Study drug toxicity|2
976466|NCT01236352|1980555|FG000|Overall Study|Disease progression|1
976467|NCT01236352|1980556|FG001|Overall Study|Disease progression|2
976468|NCT01236352|1980557|FG002|Overall Study|Disease progression|1
976469|NCT01236352|1980558|FG003|Overall Study|Disease progression|2
976470|NCT01236352|1980559|FG004|Overall Study|Disease progression|2
976471|NCT01236352|1980560|FG005|Overall Study|Disease progression|2
976472|NCT01236352|1980561|FG006|Overall Study|Disease progression|1
976473|NCT01236352|1980562|FG007|Overall Study|Disease progression|3
976474|NCT01236352|1980563|FG008|Overall Study|Disease progression|2
976475|NCT01236352|1980564|FG009|Overall Study|Disease progression|2
976476|NCT01236352|1980565|FG010|Overall Study|Disease progression|2
976477|NCT01236352|1980555|FG000|Overall Study|Poor/Non-compliance|1
976478|NCT01236352|1980556|FG001|Overall Study|Poor/Non-compliance|0
976479|NCT01236352|1980557|FG002|Overall Study|Poor/Non-compliance|0
976480|NCT01236352|1980558|FG003|Overall Study|Poor/Non-compliance|0
976481|NCT01236352|1980559|FG004|Overall Study|Poor/Non-compliance|0
976482|NCT01236352|1980560|FG005|Overall Study|Poor/Non-compliance|0
976483|NCT01236352|1980561|FG006|Overall Study|Poor/Non-compliance|0
976484|NCT01236352|1980562|FG007|Overall Study|Poor/Non-compliance|0
976485|NCT01236352|1980563|FG008|Overall Study|Poor/Non-compliance|0
976486|NCT01236352|1980564|FG009|Overall Study|Poor/Non-compliance|0
976487|NCT01236352|1980565|FG010|Overall Study|Poor/Non-compliance|0
976488|NCT01236352|1980555|FG000|Overall Study|Maximum clinical benefit|1
976489|NCT01236352|1980556|FG001|Overall Study|Maximum clinical benefit|1
976490|NCT01236352|1980557|FG002|Overall Study|Maximum clinical benefit|1
976491|NCT01236352|1980558|FG003|Overall Study|Maximum clinical benefit|0
976492|NCT01236352|1980559|FG004|Overall Study|Maximum clinical benefit|2
976493|NCT01236352|1980560|FG005|Overall Study|Maximum clinical benefit|0
976494|NCT01236352|1980561|FG006|Overall Study|Maximum clinical benefit|3
976495|NCT01236352|1980562|FG007|Overall Study|Maximum clinical benefit|1
976496|NCT01236352|1980563|FG008|Overall Study|Maximum clinical benefit|1
976497|NCT01236352|1980564|FG009|Overall Study|Maximum clinical benefit|4
976498|NCT01236352|1980565|FG010|Overall Study|Maximum clinical benefit|2
976499|NCT01236352|1980555|FG000|Overall Study|Subject request to discontinue treatment|0
976500|NCT01236352|1980556|FG001|Overall Study|Subject request to discontinue treatment|0
976501|NCT01236352|1980557|FG002|Overall Study|Subject request to discontinue treatment|1
976502|NCT01236352|1980558|FG003|Overall Study|Subject request to discontinue treatment|1
976503|NCT01236352|1980559|FG004|Overall Study|Subject request to discontinue treatment|0
976504|NCT01236352|1980560|FG005|Overall Study|Subject request to discontinue treatment|1
976505|NCT01236352|1980561|FG006|Overall Study|Subject request to discontinue treatment|0
976506|NCT01236352|1980562|FG007|Overall Study|Subject request to discontinue treatment|0
976507|NCT01236352|1980563|FG008|Overall Study|Subject request to discontinue treatment|0
976508|NCT01236352|1980564|FG009|Overall Study|Subject request to discontinue treatment|1
976509|NCT01236352|1980565|FG010|Overall Study|Subject request to discontinue treatment|4
976510|NCT01236352|1980555|FG000|Overall Study|Subject to receive drug via EAP|1
976511|NCT01236352|1980556|FG001|Overall Study|Subject to receive drug via EAP|1
976512|NCT01236352|1980557|FG002|Overall Study|Subject to receive drug via EAP|1
976513|NCT01236352|1980558|FG003|Overall Study|Subject to receive drug via EAP|0
976514|NCT01236352|1980559|FG004|Overall Study|Subject to receive drug via EAP|0
976515|NCT01236352|1980560|FG005|Overall Study|Subject to receive drug via EAP|0
976516|NCT01236352|1980561|FG006|Overall Study|Subject to receive drug via EAP|0
976517|NCT01236352|1980562|FG007|Overall Study|Subject to receive drug via EAP|2
976518|NCT01236352|1980563|FG008|Overall Study|Subject to receive drug via EAP|0
976519|NCT01236352|1980564|FG009|Overall Study|Subject to receive drug via EAP|4
976520|NCT01236352|1980565|FG010|Overall Study|Subject to receive drug via EAP|0
976521|NCT01236352|1980555|FG000|Overall Study|Patient moving to allogeneic transplant|0
976522|NCT01236352|1980556|FG001|Overall Study|Patient moving to allogeneic transplant|0
976523|NCT01236352|1980557|FG002|Overall Study|Patient moving to allogeneic transplant|0
976524|NCT01236352|1980558|FG003|Overall Study|Patient moving to allogeneic transplant|0
976525|NCT01236352|1980559|FG004|Overall Study|Patient moving to allogeneic transplant|0
976526|NCT01236352|1980560|FG005|Overall Study|Patient moving to allogeneic transplant|0
976527|NCT01236352|1980561|FG006|Overall Study|Patient moving to allogeneic transplant|1
976528|NCT01236352|1980562|FG007|Overall Study|Patient moving to allogeneic transplant|0
976529|NCT01236352|1980563|FG008|Overall Study|Patient moving to allogeneic transplant|0
976530|NCT01236352|1980564|FG009|Overall Study|Patient moving to allogeneic transplant|0
976531|NCT01236352|1980565|FG010|Overall Study|Patient moving to allogeneic transplant|0
976532|NCT01236352|1980555|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0
976533|NCT01236352|1980556|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0
976534|NCT01236352|1980557|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0
976535|NCT01236352|1980558|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0
976536|NCT01236352|1980559|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0
976537|NCT01236352|1980560|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0
976538|NCT01236352|1980561|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0
976539|NCT01236352|1980562|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0
976540|NCT01236352|1980563|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0
976541|NCT01236352|1980564|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0
976542|NCT01236352|1980565|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1
976543|NCT01236352|1980555|FG000|Overall Study|Lack of response to drug|0
976544|NCT01236352|1980556|FG001|Overall Study|Lack of response to drug|0
976545|NCT01236352|1980557|FG002|Overall Study|Lack of response to drug|0
976546|NCT01236352|1980558|FG003|Overall Study|Lack of response to drug|0
976547|NCT01236352|1980559|FG004|Overall Study|Lack of response to drug|0
976548|NCT01236352|1980560|FG005|Overall Study|Lack of response to drug|0
976549|NCT01236352|1980561|FG006|Overall Study|Lack of response to drug|0
976550|NCT01236352|1980562|FG007|Overall Study|Lack of response to drug|0
976551|NCT01236352|1980563|FG008|Overall Study|Lack of response to drug|0
976552|NCT01236352|1980564|FG009|Overall Study|Lack of response to drug|1
976553|NCT01236352|1980565|FG010|Overall Study|Lack of response to drug|1
976554|NCT01236352|1980555|FG000|Overall Study|Patient transferred to IST|0
976555|NCT01236352|1980556|FG001|Overall Study|Patient transferred to IST|0
976556|NCT01236352|1980557|FG002|Overall Study|Patient transferred to IST|0
976557|NCT01236352|1980558|FG003|Overall Study|Patient transferred to IST|0
976558|NCT01236352|1980559|FG004|Overall Study|Patient transferred to IST|0
976559|NCT01236352|1980560|FG005|Overall Study|Patient transferred to IST|0
976560|NCT01236352|1980561|FG006|Overall Study|Patient transferred to IST|0
976561|NCT01236352|1980562|FG007|Overall Study|Patient transferred to IST|0
976562|NCT01236352|1980563|FG008|Overall Study|Patient transferred to IST|0
976563|NCT01236352|1980564|FG009|Overall Study|Patient transferred to IST|2
976564|NCT01236352|1980565|FG010|Overall Study|Patient transferred to IST|6
976565|NCT01236365|1980591|FG000|Overall Study|Lost to Follow-up|0
976566|NCT01236365|1980592|FG001|Overall Study|Lost to Follow-up|2
976567|NCT01236365|1980591|FG000|Overall Study|Moved Out of State|1
976568|NCT01236365|1980592|FG001|Overall Study|Moved Out of State|0
976569|NCT01236365|1980591|FG000|Overall Study|Dropped at Randomization due to high LFT|1
976570|NCT01236365|1980592|FG001|Overall Study|Dropped at Randomization due to high LFT|0
976571|NCT01236521|1980623|FG000|Overall Study|Withdrawal by Subject|12
976572|NCT01236521|1980624|FG001|Overall Study|Withdrawal by Subject|17
976573|NCT01236521|1980623|FG000|Overall Study|Death|2
976574|NCT01236521|1980624|FG001|Overall Study|Death|1
976575|NCT01236521|1980623|FG000|Overall Study|Lost to Follow-up|7
976576|NCT01236521|1980624|FG001|Overall Study|Lost to Follow-up|7
976577|NCT01236534|1980632|FG000|Overall Study|Adverse Event|3
976578|NCT01236534|1980633|FG001|Overall Study|Adverse Event|0
976579|NCT01236547|1980644|FG000|Overall Study|Protocol Violation|0
976580|NCT01236547|1980645|FG001|Overall Study|Protocol Violation|1
976581|NCT01236547|1980646|FG002|Overall Study|Protocol Violation|1
976582|NCT01236547|1980647|FG003|Overall Study|Protocol Violation|6
976583|NCT01236547|1980648|FG004|Overall Study|Protocol Violation|12
976584|NCT01236560|1980667|FG000|Overall Study|Adverse Event|0
976585|NCT01236560|1980668|FG001|Overall Study|Adverse Event|2
976586|NCT01236560|1980669|FG002|Overall Study|Adverse Event|1
976587|NCT01236560|1980670|FG003|Overall Study|Adverse Event|3
976588|NCT01236560|1980671|FG004|Overall Study|Adverse Event|0
976589|NCT01236560|1980672|FG005|Overall Study|Adverse Event|0
976590|NCT01236560|1980667|FG000|Overall Study|Death|0
976591|NCT01236560|1980668|FG001|Overall Study|Death|1
976592|NCT01236560|1980669|FG002|Overall Study|Death|0
976593|NCT01236560|1980670|FG003|Overall Study|Death|1
976594|NCT01236560|1980671|FG004|Overall Study|Death|0
976595|NCT01236560|1980672|FG005|Overall Study|Death|0
976596|NCT01236560|1980667|FG000|Overall Study|Lost to Follow-up|0
976597|NCT01236560|1980668|FG001|Overall Study|Lost to Follow-up|1
976598|NCT01236560|1980669|FG002|Overall Study|Lost to Follow-up|1
976599|NCT01236560|1980670|FG003|Overall Study|Lost to Follow-up|0
976600|NCT01236560|1980671|FG004|Overall Study|Lost to Follow-up|0
976601|NCT01236560|1980672|FG005|Overall Study|Lost to Follow-up|0
976602|NCT01236560|1980667|FG000|Overall Study|Physician Decision|0
976603|NCT01236560|1980668|FG001|Overall Study|Physician Decision|1
976604|NCT01236560|1980669|FG002|Overall Study|Physician Decision|8
976605|NCT01236560|1980670|FG003|Overall Study|Physician Decision|0
976606|NCT01236560|1980671|FG004|Overall Study|Physician Decision|0
976607|NCT01236560|1980672|FG005|Overall Study|Physician Decision|0
976608|NCT01236560|1980667|FG000|Overall Study|Withdrawal by Subject|0
976609|NCT01236560|1980668|FG001|Overall Study|Withdrawal by Subject|0
976610|NCT01236560|1980669|FG002|Overall Study|Withdrawal by Subject|1
976611|NCT01236560|1980670|FG003|Overall Study|Withdrawal by Subject|2
976612|NCT01236560|1980671|FG004|Overall Study|Withdrawal by Subject|0
976613|NCT01236560|1980672|FG005|Overall Study|Withdrawal by Subject|0
976614|NCT01236560|1980667|FG000|Overall Study|Progressive disease|5
976615|NCT01236560|1980668|FG001|Overall Study|Progressive disease|19
976616|NCT01236560|1980669|FG002|Overall Study|Progressive disease|9
976617|NCT01236560|1980670|FG003|Overall Study|Progressive disease|16
976618|NCT01236560|1980671|FG004|Overall Study|Progressive disease|0
976619|NCT01236560|1980672|FG005|Overall Study|Progressive disease|0
976620|NCT01236573|1980693|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
976621|NCT01236573|1980694|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
976622|NCT01236573|1980695|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
976623|NCT01236573|1980696|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
976624|NCT01236573|1980697|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
976625|NCT01236573|1980698|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
976626|NCT01236573|1980699|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
976627|NCT01236573|1980700|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
976628|NCT01236573|1980701|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
976629|NCT01236573|1980702|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
976630|NCT01236573|1980703|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
976631|NCT01236573|1980693|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
976632|NCT01236573|1980694|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
976633|NCT01236573|1980695|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
976634|NCT01236573|1980696|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
976635|NCT01236573|1980697|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
976636|NCT01236573|1980698|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
976637|NCT01236573|1980699|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
976638|NCT01236573|1980700|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
976639|NCT01236573|1980701|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
976640|NCT01236573|1980702|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
976641|NCT01236573|1980703|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
976642|NCT01236573|1980693|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
976643|NCT01236573|1980694|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
976644|NCT01236573|1980695|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
976645|NCT01236573|1980696|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
976646|NCT01236573|1980697|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
976647|NCT01236573|1980698|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
976648|NCT01236573|1980699|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
976649|NCT01236573|1980700|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
976650|NCT01236573|1980701|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
976651|NCT01236573|1980702|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
976652|NCT01236573|1980703|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
976653|NCT01236755|1980741|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8
976654|NCT01236755|1980741|FG000|Spectacles Wearing Phase|Lost to Follow-up|9
976655|NCT01236755|1980741|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5
976656|NCT01236755|1980741|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
976657|NCT01237054|1980775|FG000|Overall Study|imaging 10C0096|1
976658|NCT01237223|1980806|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
976659|NCT01237223|1980807|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
976660|NCT01237223|1980808|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
976661|NCT01237223|1980809|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
976662|NCT01237223|1980810|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
976663|NCT01237223|1980811|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
976664|NCT01237223|1980806|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
976665|NCT01237223|1980807|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
976666|NCT01237223|1980808|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
976667|NCT01237223|1980809|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
976668|NCT01237223|1980810|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
976669|NCT01237223|1980811|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
976670|NCT01237223|1980806|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
976671|NCT01237223|1980807|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
976672|NCT01237223|1980808|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
976673|NCT01237223|1980809|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
976674|NCT01237223|1980810|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
976675|NCT01237223|1980811|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
976676|NCT01237223|1980806|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
976677|NCT01237223|1980807|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
976678|NCT01237223|1980808|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
976679|NCT01237223|1980809|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
976680|NCT01237223|1980810|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
976681|NCT01237223|1980811|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
976682|NCT01237223|1980806|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
976683|NCT01237223|1980807|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
976684|NCT01237223|1980808|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
976685|NCT01237223|1980809|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
976686|NCT01237223|1980810|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
976687|NCT01237223|1980811|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
976688|NCT01237223|1980806|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
976689|NCT01237223|1980807|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
976690|NCT01237223|1980808|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
976691|NCT01237223|1980809|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
976692|NCT01237223|1980810|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
976693|NCT01237223|1980811|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
976694|NCT01237223|1980806|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
976695|NCT01237223|1980807|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
976696|NCT01237223|1980808|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
976697|NCT01237223|1980809|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
976698|NCT01237223|1980810|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
976699|NCT01237223|1980811|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
976700|NCT01237223|1980806|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
976701|NCT01237223|1980807|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
976702|NCT01237223|1980808|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
976703|NCT01237223|1980809|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
976704|NCT01237223|1980810|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
976705|NCT01237223|1980811|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
976706|NCT01237223|1980806|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
976707|NCT01237223|1980807|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
976708|NCT01237223|1980808|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
976709|NCT01237223|1980809|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
976710|NCT01237223|1980810|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
976711|NCT01237223|1980811|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
976712|NCT01237223|1980806|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
976713|NCT01237223|1980807|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
976714|NCT01237223|1980808|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
976715|NCT01237223|1980809|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
976716|NCT01237223|1980810|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
976717|NCT01237223|1980811|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
976718|NCT01237327|1980840|FG000|Overall Study|Protocol Violation: Core Study|1
976719|NCT01237327|1980841|FG001|Overall Study|Protocol Violation: Core Study|0
976720|NCT01237327|1980840|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3
976721|NCT01237327|1980841|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2
976722|NCT01237327|1980840|FG000|Overall Study|Progression of Disease: Core Study|18
976723|NCT01237327|1980841|FG001|Overall Study|Progression of Disease: Core Study|22
976724|NCT01237327|1980840|FG000|Overall Study|Progression of Disease: Extension Study|15
976725|NCT01237327|1980841|FG001|Overall Study|Progression of Disease: Extension Study|13
976726|NCT01237327|1980840|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1
976727|NCT01237327|1980841|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0
976728|NCT01237327|1980840|FG000|Overall Study|Withdrawal by Subject|1
976729|NCT01237327|1980841|FG001|Overall Study|Withdrawal by Subject|3
976730|NCT01237327|1980840|FG000|Overall Study|Lost to Follow-up|3
976731|NCT01237327|1980841|FG001|Overall Study|Lost to Follow-up|0
976732|NCT01237340|1980847|FG000|Overall Study|Adverse Event|3
976733|NCT01237340|1980847|FG000|Overall Study|Withdrawal by Subject|1
976734|NCT01237340|1980847|FG000|Overall Study|Early termination of the trial|36
976735|NCT01237587|1980860|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5
976736|NCT01237587|1980861|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1
976737|NCT01237587|1980860|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
976738|NCT01237587|1980861|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
976739|NCT01237587|1980860|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
976740|NCT01237587|1980861|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
976741|NCT01237587|1980860|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
976742|NCT01237587|1980861|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
976743|NCT01237587|1980860|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4
976744|NCT01237587|1980861|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3
976745|NCT01237587|1980860|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
976746|NCT01237587|1980861|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
976747|NCT01237587|1980860|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
976748|NCT01237587|1980861|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
976749|NCT01237587|1980860|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5
976750|NCT01237587|1980861|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5
976751|NCT01237587|1980860|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
976752|NCT01237587|1980861|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
976753|NCT01237587|1980860|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
976754|NCT01237587|1980861|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
976755|NCT01237587|1980860|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
976756|NCT01237587|1980861|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
976757|NCT01237587|1980860|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1
976758|NCT01237587|1980861|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0
976759|NCT01237587|1980860|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4
976760|NCT01237587|1980861|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4
976761|NCT01237587|1980860|FG000|Taper Phase|Adverse Event|0
976762|NCT01237587|1980861|FG001|Taper Phase|Adverse Event|2
976763|NCT01237587|1980860|FG000|Taper Phase|Protocol Violation|2
976764|NCT01237587|1980861|FG001|Taper Phase|Protocol Violation|0
976765|NCT01237587|1980860|FG000|Taper Phase|Lack of Efficacy|2
976766|NCT01237587|1980861|FG001|Taper Phase|Lack of Efficacy|5
976767|NCT01237587|1980860|FG000|Taper Phase|Parent/Guardian Decision|0
976768|NCT01237587|1980861|FG001|Taper Phase|Parent/Guardian Decision|2
976769|NCT01237587|1980860|FG000|Taper Phase|Sponsor Decision|1
976770|NCT01237587|1980861|FG001|Taper Phase|Sponsor Decision|0
976771|NCT01237587|1980860|FG000|Taper Phase|Withdrawal by Subject|0
976772|NCT01237587|1980861|FG001|Taper Phase|Withdrawal by Subject|1
976773|NCT01237678|1980877|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
976774|NCT01237678|1980878|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
976775|NCT01237678|1980879|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
976776|NCT01237678|1980877|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
976777|NCT01237678|1980878|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
976778|NCT01237678|1980879|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
976779|NCT01237678|1980877|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
976780|NCT01237678|1980878|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
976781|NCT01237678|1980879|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
976782|NCT01237678|1980877|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
976783|NCT01237678|1980878|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
976784|NCT01237678|1980879|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
976785|NCT01237678|1980877|FG000|Phase II|Adverse Event|0
976786|NCT01237678|1980878|FG001|Phase II|Adverse Event|39
976787|NCT01237678|1980879|FG002|Phase II|Adverse Event|9
976788|NCT01237678|1980877|FG000|Phase II|Death|0
976789|NCT01237678|1980878|FG001|Phase II|Death|0
976790|NCT01237678|1980879|FG002|Phase II|Death|2
976791|NCT01237678|1980877|FG000|Phase II|Lack of Efficacy|0
976792|NCT01237678|1980878|FG001|Phase II|Lack of Efficacy|25
976793|NCT01237678|1980879|FG002|Phase II|Lack of Efficacy|3
976794|NCT01237678|1980877|FG000|Phase II|Withdrawal by Subject|0
976795|NCT01237678|1980878|FG001|Phase II|Withdrawal by Subject|1
976796|NCT01237678|1980879|FG002|Phase II|Withdrawal by Subject|5
976797|NCT01237678|1980877|FG000|Phase II|Completed Cycles 4-6|0
976798|NCT01237678|1980878|FG001|Phase II|Completed Cycles 4-6|11
976799|NCT01237678|1980879|FG002|Phase II|Completed Cycles 4-6|21
976800|NCT01237678|1980877|FG000|Phase II|Sponsor Decision/Study Closed|0
976801|NCT01237678|1980878|FG001|Phase II|Sponsor Decision/Study Closed|18
976802|NCT01237678|1980879|FG002|Phase II|Sponsor Decision/Study Closed|7
976803|NCT01237678|1980877|FG000|Phase II|Randomized but were not treated|0
976804|NCT01237678|1980878|FG001|Phase II|Randomized but were not treated|4
976805|NCT01237678|1980879|FG002|Phase II|Randomized but were not treated|3
976806|NCT01237899|1980914|FG000|Washout Period of at Least 7 Days|Adverse Event|0
976807|NCT01237899|1980915|FG001|Washout Period of at Least 7 Days|Adverse Event|0
976808|NCT01237899|1980916|FG002|Washout Period of at Least 7 Days|Adverse Event|1
976809|NCT01237899|1980917|FG003|Washout Period of at Least 7 Days|Adverse Event|0
976810|NCT01237899|1980918|FG004|Washout Period of at Least 7 Days|Adverse Event|0
976811|NCT01237899|1980919|FG005|Washout Period of at Least 7 Days|Adverse Event|0
976812|NCT01237899|1980920|FG006|Washout Period of at Least 7 Days|Adverse Event|0
976813|NCT01237899|1980921|FG007|Washout Period of at Least 7 Days|Adverse Event|0
976814|NCT01237899|1980922|FG008|Washout Period of at Least 7 Days|Adverse Event|0
976815|NCT01237899|1980923|FG009|Washout Period of at Least 7 Days|Adverse Event|0
976816|NCT01237899|1980924|FG010|Washout Period of at Least 7 Days|Adverse Event|0
976817|NCT01237951|1980942|FG000|Overall Study|Death|1
976818|NCT01238120|1980950|FG000|Overall Study|Withdrawal by Subject|4
976819|NCT01238120|1980951|FG001|Overall Study|Withdrawal by Subject|1
976820|NCT01238120|1980952|FG002|Overall Study|Withdrawal by Subject|2
976821|NCT01238120|1980953|FG003|Overall Study|Withdrawal by Subject|5
976822|NCT01238120|1980950|FG000|Overall Study|Lost to Follow-up|2
976823|NCT01238120|1980951|FG001|Overall Study|Lost to Follow-up|0
976824|NCT01238120|1980952|FG002|Overall Study|Lost to Follow-up|1
976825|NCT01238120|1980953|FG003|Overall Study|Lost to Follow-up|1
976826|NCT01238120|1980950|FG000|Overall Study|Withdrawn due to Medical Problem|2
976827|NCT01238120|1980951|FG001|Overall Study|Withdrawn due to Medical Problem|0
976828|NCT01238120|1980952|FG002|Overall Study|Withdrawn due to Medical Problem|1
976829|NCT01238120|1980953|FG003|Overall Study|Withdrawn due to Medical Problem|0
976830|NCT01238172|1980965|FG000|Overall Study|Ineligible: based on Eligibility Review|2
976831|NCT01238172|1980966|FG001|Overall Study|Ineligible: based on Eligibility Review|5
976832|NCT01238172|1980965|FG000|Overall Study|Ineligible: based on Central Path Review|9
976833|NCT01238172|1980966|FG001|Overall Study|Ineligible: based on Central Path Review|19
976841|NCT01238575|1981006|FG000|Overall Study|Lack of Efficacy|2
976842|NCT01238575|1981007|FG001|Overall Study|Lack of Efficacy|4
976843|NCT01238575|1981006|FG000|Overall Study|Adverse Event|2
976844|NCT01238575|1981007|FG001|Overall Study|Adverse Event|0
976845|NCT01238588|1981013|FG000|Overall Study|Withdrawal by Subject|1
976846|NCT01238588|1981013|FG000|Overall Study|Physician Decision|2
976847|NCT01238822|1981025|FG000|Overall Study|COULD NOT SWALLOW PILLS|3
976848|NCT01238835|1981035|FG000|Overall Study|Death|124
976849|NCT01238835|1981035|FG000|Overall Study|Withdrawal by Subject|9
976850|NCT01238835|1981035|FG000|Overall Study|Lost to Follow-up|1
976851|NCT01238835|1981035|FG000|Overall Study|Site early discontinuation|2
976852|NCT01238848|1981041|FG000|Overall Study|Physician Decision|13
976853|NCT01238848|1981042|FG001|Overall Study|Physician Decision|5
976854|NCT01238861|1981054|FG000|Overall Study|Lost to Follow-up|4
976855|NCT01238861|1981055|FG001|Overall Study|Lost to Follow-up|2
976856|NCT01238861|1981056|FG002|Overall Study|Lost to Follow-up|3
976857|NCT01238861|1981057|FG003|Overall Study|Lost to Follow-up|1
976858|NCT01238861|1981058|FG004|Overall Study|Lost to Follow-up|1
976859|NCT01238861|1981059|FG005|Overall Study|Lost to Follow-up|2
976860|NCT01238861|1981054|FG000|Overall Study|Unplanned surgery|1
976861|NCT01238861|1981055|FG001|Overall Study|Unplanned surgery|0
976862|NCT01238861|1981056|FG002|Overall Study|Unplanned surgery|0
976863|NCT01238861|1981057|FG003|Overall Study|Unplanned surgery|0
976864|NCT01238861|1981058|FG004|Overall Study|Unplanned surgery|0
976865|NCT01238861|1981059|FG005|Overall Study|Unplanned surgery|0
976866|NCT01238861|1981054|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0
976867|NCT01238861|1981055|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0
976868|NCT01238861|1981056|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1
976869|NCT01238861|1981057|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0
976870|NCT01238861|1981058|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1
976871|NCT01238861|1981059|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1
976872|NCT01238861|1981054|FG000|Overall Study|Incorrect enrollment/randomization|0
976873|NCT01238861|1981055|FG001|Overall Study|Incorrect enrollment/randomization|0
976874|NCT01238861|1981056|FG002|Overall Study|Incorrect enrollment/randomization|1
976875|NCT01238861|1981057|FG003|Overall Study|Incorrect enrollment/randomization|0
976876|NCT01238861|1981058|FG004|Overall Study|Incorrect enrollment/randomization|1
976877|NCT01238861|1981059|FG005|Overall Study|Incorrect enrollment/randomization|0
976878|NCT01238861|1981054|FG000|Overall Study|Subject traveled to Argentina by 1 year|0
976879|NCT01238861|1981055|FG001|Overall Study|Subject traveled to Argentina by 1 year|0
976880|NCT01238861|1981056|FG002|Overall Study|Subject traveled to Argentina by 1 year|1
976881|NCT01238861|1981057|FG003|Overall Study|Subject traveled to Argentina by 1 year|0
976882|NCT01238861|1981058|FG004|Overall Study|Subject traveled to Argentina by 1 year|0
976883|NCT01238861|1981059|FG005|Overall Study|Subject traveled to Argentina by 1 year|0
976884|NCT01238861|1981054|FG000|Overall Study|Subject moved out of state/area|0
976885|NCT01238861|1981055|FG001|Overall Study|Subject moved out of state/area|0
976886|NCT01238861|1981056|FG002|Overall Study|Subject moved out of state/area|1
976887|NCT01238861|1981057|FG003|Overall Study|Subject moved out of state/area|1
976888|NCT01238861|1981058|FG004|Overall Study|Subject moved out of state/area|0
976889|NCT01238861|1981059|FG005|Overall Study|Subject moved out of state/area|0
976890|NCT01238861|1981054|FG000|Overall Study|Strongyloides stercoralis antibodies +|0
976891|NCT01238861|1981055|FG001|Overall Study|Strongyloides stercoralis antibodies +|0
976892|NCT01238861|1981056|FG002|Overall Study|Strongyloides stercoralis antibodies +|0
976893|NCT01238861|1981057|FG003|Overall Study|Strongyloides stercoralis antibodies +|1
976894|NCT01238861|1981058|FG004|Overall Study|Strongyloides stercoralis antibodies +|0
976895|NCT01238861|1981059|FG005|Overall Study|Strongyloides stercoralis antibodies +|0
976896|NCT01238861|1981054|FG000|Overall Study|Personal problems|0
976897|NCT01238861|1981055|FG001|Overall Study|Personal problems|0
976898|NCT01238861|1981056|FG002|Overall Study|Personal problems|0
976899|NCT01238861|1981057|FG003|Overall Study|Personal problems|1
976900|NCT01238861|1981058|FG004|Overall Study|Personal problems|0
976901|NCT01238861|1981059|FG005|Overall Study|Personal problems|0
976902|NCT01238861|1981054|FG000|Overall Study|Unable to continue visits|0
976903|NCT01238861|1981055|FG001|Overall Study|Unable to continue visits|0
976904|NCT01238861|1981056|FG002|Overall Study|Unable to continue visits|0
976905|NCT01238861|1981057|FG003|Overall Study|Unable to continue visits|1
976906|NCT01238861|1981058|FG004|Overall Study|Unable to continue visits|0
976907|NCT01238861|1981059|FG005|Overall Study|Unable to continue visits|1
976908|NCT01238861|1981054|FG000|Overall Study|Serious adverse event|0
976909|NCT01238861|1981055|FG001|Overall Study|Serious adverse event|0
976910|NCT01238861|1981056|FG002|Overall Study|Serious adverse event|0
976911|NCT01238861|1981057|FG003|Overall Study|Serious adverse event|0
976912|NCT01238861|1981058|FG004|Overall Study|Serious adverse event|0
976913|NCT01238861|1981059|FG005|Overall Study|Serious adverse event|1
976914|NCT01238861|1981054|FG000|Overall Study|Lack of compliance|0
976915|NCT01238861|1981055|FG001|Overall Study|Lack of compliance|0
976916|NCT01238861|1981056|FG002|Overall Study|Lack of compliance|0
976917|NCT01238861|1981057|FG003|Overall Study|Lack of compliance|0
976918|NCT01238861|1981058|FG004|Overall Study|Lack of compliance|0
976919|NCT01238861|1981059|FG005|Overall Study|Lack of compliance|1
976920|NCT01238861|1981054|FG000|Overall Study|Adverse Event|0
976921|NCT01238861|1981055|FG001|Overall Study|Adverse Event|1
976922|NCT01238861|1981056|FG002|Overall Study|Adverse Event|0
976923|NCT01238861|1981057|FG003|Overall Study|Adverse Event|0
976924|NCT01238861|1981058|FG004|Overall Study|Adverse Event|0
976925|NCT01238861|1981059|FG005|Overall Study|Adverse Event|0
976926|NCT01238861|1981054|FG000|Overall Study|Withdrawal by Subject|6
976927|NCT01238861|1981055|FG001|Overall Study|Withdrawal by Subject|5
976928|NCT01238861|1981056|FG002|Overall Study|Withdrawal by Subject|4
976929|NCT01238861|1981057|FG003|Overall Study|Withdrawal by Subject|8
976930|NCT01238861|1981058|FG004|Overall Study|Withdrawal by Subject|10
976931|NCT01238861|1981059|FG005|Overall Study|Withdrawal by Subject|9
976932|NCT01238900|1981080|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4
976933|NCT01238900|1981080|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1
976934|NCT01238991|1981095|FG000|Overall Study|Adverse Event|1
976935|NCT01238991|1981096|FG001|Overall Study|Adverse Event|0
976936|NCT01238991|1981097|FG002|Overall Study|Adverse Event|3
976937|NCT01238991|1981098|FG003|Overall Study|Adverse Event|1
976938|NCT01238991|1981099|FG004|Overall Study|Adverse Event|1
976939|NCT01238991|1981100|FG005|Overall Study|Adverse Event|0
976940|NCT01238991|1981101|FG006|Overall Study|Adverse Event|1
976941|NCT01238991|1981102|FG007|Overall Study|Adverse Event|1
976942|NCT01238991|1981103|FG008|Overall Study|Adverse Event|0
976943|NCT01238991|1981104|FG009|Overall Study|Adverse Event|0
976944|NCT01238991|1981095|FG000|Overall Study|Death|0
976945|NCT01238991|1981096|FG001|Overall Study|Death|0
976946|NCT01238991|1981097|FG002|Overall Study|Death|0
976947|NCT01238991|1981098|FG003|Overall Study|Death|1
976948|NCT01238991|1981099|FG004|Overall Study|Death|0
976949|NCT01238991|1981100|FG005|Overall Study|Death|0
976950|NCT01238991|1981101|FG006|Overall Study|Death|0
976951|NCT01238991|1981102|FG007|Overall Study|Death|0
976952|NCT01238991|1981103|FG008|Overall Study|Death|0
976953|NCT01238991|1981104|FG009|Overall Study|Death|0
976954|NCT01238991|1981095|FG000|Overall Study|Lack of Efficacy|0
976955|NCT01238991|1981096|FG001|Overall Study|Lack of Efficacy|0
976956|NCT01238991|1981097|FG002|Overall Study|Lack of Efficacy|1
976957|NCT01238991|1981098|FG003|Overall Study|Lack of Efficacy|0
976958|NCT01238991|1981099|FG004|Overall Study|Lack of Efficacy|0
976959|NCT01238991|1981100|FG005|Overall Study|Lack of Efficacy|0
976960|NCT01238991|1981101|FG006|Overall Study|Lack of Efficacy|0
976961|NCT01238991|1981102|FG007|Overall Study|Lack of Efficacy|0
976962|NCT01238991|1981103|FG008|Overall Study|Lack of Efficacy|1
976963|NCT01238991|1981104|FG009|Overall Study|Lack of Efficacy|0
976964|NCT01238991|1981095|FG000|Overall Study|Withdrawal by Subject|0
976965|NCT01238991|1981096|FG001|Overall Study|Withdrawal by Subject|0
976966|NCT01238991|1981097|FG002|Overall Study|Withdrawal by Subject|1
976967|NCT01238991|1981098|FG003|Overall Study|Withdrawal by Subject|0
976968|NCT01238991|1981099|FG004|Overall Study|Withdrawal by Subject|0
976969|NCT01238991|1981100|FG005|Overall Study|Withdrawal by Subject|0
976970|NCT01238991|1981101|FG006|Overall Study|Withdrawal by Subject|0
976971|NCT01238991|1981102|FG007|Overall Study|Withdrawal by Subject|0
976972|NCT01238991|1981103|FG008|Overall Study|Withdrawal by Subject|0
976973|NCT01238991|1981104|FG009|Overall Study|Withdrawal by Subject|0
976974|NCT01238991|1981095|FG000|Overall Study|Study Terminated by Sponsor|0
976975|NCT01238991|1981096|FG001|Overall Study|Study Terminated by Sponsor|0
976976|NCT01238991|1981097|FG002|Overall Study|Study Terminated by Sponsor|0
976977|NCT01238991|1981098|FG003|Overall Study|Study Terminated by Sponsor|0
976978|NCT01238991|1981099|FG004|Overall Study|Study Terminated by Sponsor|1
976979|NCT01238991|1981100|FG005|Overall Study|Study Terminated by Sponsor|0
976980|NCT01238991|1981101|FG006|Overall Study|Study Terminated by Sponsor|7
976981|NCT01238991|1981102|FG007|Overall Study|Study Terminated by Sponsor|4
976982|NCT01238991|1981103|FG008|Overall Study|Study Terminated by Sponsor|2
976983|NCT01238991|1981104|FG009|Overall Study|Study Terminated by Sponsor|2
976984|NCT01238991|1981095|FG000|Overall Study|Caregiver's request|0
976985|NCT01238991|1981096|FG001|Overall Study|Caregiver's request|0
976986|NCT01238991|1981097|FG002|Overall Study|Caregiver's request|0
976987|NCT01238991|1981098|FG003|Overall Study|Caregiver's request|0
976988|NCT01238991|1981099|FG004|Overall Study|Caregiver's request|0
976989|NCT01238991|1981100|FG005|Overall Study|Caregiver's request|0
976990|NCT01238991|1981101|FG006|Overall Study|Caregiver's request|0
976991|NCT01238991|1981102|FG007|Overall Study|Caregiver's request|0
976992|NCT01238991|1981103|FG008|Overall Study|Caregiver's request|1
976993|NCT01238991|1981104|FG009|Overall Study|Caregiver's request|0
976994|NCT01238991|1981095|FG000|Overall Study|Admission to a nursing home|1
976995|NCT01238991|1981096|FG001|Overall Study|Admission to a nursing home|0
976996|NCT01238991|1981097|FG002|Overall Study|Admission to a nursing home|1
976997|NCT01238991|1981098|FG003|Overall Study|Admission to a nursing home|0
976998|NCT01238991|1981099|FG004|Overall Study|Admission to a nursing home|0
976999|NCT01238991|1981100|FG005|Overall Study|Admission to a nursing home|0
977000|NCT01238991|1981101|FG006|Overall Study|Admission to a nursing home|0
977001|NCT01238991|1981102|FG007|Overall Study|Admission to a nursing home|0
977002|NCT01238991|1981103|FG008|Overall Study|Admission to a nursing home|0
977003|NCT01238991|1981104|FG009|Overall Study|Admission to a nursing home|0
977004|NCT01239043|1981131|FG000|Overall Study|Protocol Violation|2
977005|NCT01239043|1981132|FG001|Overall Study|Protocol Violation|1
977006|NCT01239121|1981146|FG000|Overall Study|Withdrawal by Subject|2
977007|NCT01239121|1981147|FG001|Overall Study|Withdrawal by Subject|4
977008|NCT01239121|1981148|FG002|Overall Study|Withdrawal by Subject|0
977009|NCT01239160|1981158|FG000|Overall Study|Lost to Follow-up|3
977010|NCT01239160|1981159|FG001|Overall Study|Lost to Follow-up|5
977011|NCT01239160|1981160|FG002|Overall Study|Lost to Follow-up|0
977012|NCT01239160|1981158|FG000|Overall Study|Withdrawal by Subject|17
977013|NCT01239160|1981159|FG001|Overall Study|Withdrawal by Subject|6
977014|NCT01239160|1981160|FG002|Overall Study|Withdrawal by Subject|2
977015|NCT01239160|1981158|FG000|Overall Study|Physician Decision|5
977016|NCT01239160|1981159|FG001|Overall Study|Physician Decision|7
977017|NCT01239160|1981160|FG002|Overall Study|Physician Decision|2
977018|NCT01239160|1981158|FG000|Overall Study|Early Termination Due to Study Closure|0
977019|NCT01239160|1981159|FG001|Overall Study|Early Termination Due to Study Closure|1
977020|NCT01239160|1981160|FG002|Overall Study|Early Termination Due to Study Closure|6
977021|NCT01239316|1981170|FG000|Overall Study|Progression/Relapse|11
977022|NCT01239316|1981170|FG000|Overall Study|Adverse Event|1
977023|NCT01239342|1981176|FG000|Overall Study|Adverse Event|1
977024|NCT01239342|1981177|FG001|Overall Study|Adverse Event|0
977025|NCT01239342|1981176|FG000|Overall Study|Withdrawal by Subject|1
977026|NCT01239342|1981177|FG001|Overall Study|Withdrawal by Subject|5
977027|NCT01239342|1981176|FG000|Overall Study|Reason Unknown|1
977028|NCT01239342|1981177|FG001|Overall Study|Reason Unknown|1
977029|NCT01239381|1981239|FG000|Overall Study|Protocol Violation|1
977030|NCT01239381|1981239|FG000|Overall Study|Withdrawal by Subject|1
977031|NCT01239394|1981244|FG000|Overall Study|Adverse Event|1
977032|NCT01239472|1981250|FG000|Overall Study|Withdrawal by Subject|5
977033|NCT01239472|1981251|FG001|Overall Study|Withdrawal by Subject|1
977034|NCT01239472|1981250|FG000|Overall Study|Adverse Event|0
977035|NCT01239472|1981251|FG001|Overall Study|Adverse Event|1
977036|NCT01239472|1981250|FG000|Overall Study|Lack of Efficacy|0
977037|NCT01239472|1981251|FG001|Overall Study|Lack of Efficacy|1
977038|NCT01239732|1981276|FG000|Overall Study|Termination of study per protocol|667
977039|NCT01239732|1981276|FG000|Overall Study|Death|226
977040|NCT01239732|1981276|FG000|Overall Study|Withdrawal by Subject|87
977041|NCT01239732|1981276|FG000|Overall Study|Adverse Event|6
977042|NCT01239732|1981276|FG000|Overall Study|Protocol Violation|3
977043|NCT01239732|1981276|FG000|Overall Study|Participant non compliance|5
977044|NCT01239732|1981276|FG000|Overall Study|Study termination by sponsor|2
977045|NCT01239732|1981276|FG000|Overall Study|Investigator's decision|4
977046|NCT01239732|1981276|FG000|Overall Study|Treatment failure|2
977047|NCT01239732|1981276|FG000|Overall Study|Other|19
977048|NCT01239745|1981280|FG000|Overall Study|Study terminated by sponsor|45
977049|NCT01239745|1981280|FG000|Overall Study|Adverse Event|1
977050|NCT01239797|1981286|FG000|Treated Participants|Disease Progression|153
977051|NCT01239797|1981287|FG001|Treated Participants|Disease Progression|161
977052|NCT01239797|1981286|FG000|Treated Participants|Study Drug Toxicity|30
977053|NCT01239797|1981287|FG001|Treated Participants|Study Drug Toxicity|44
977054|NCT01239797|1981286|FG000|Treated Participants|Adverse Event Unrelated to Study Drug|22
977055|NCT01239797|1981287|FG001|Treated Participants|Adverse Event Unrelated to Study Drug|32
977056|NCT01239797|1981286|FG000|Treated Participants|Withdrawal by Subject|27
977057|NCT01239797|1981287|FG001|Treated Participants|Withdrawal by Subject|23
977058|NCT01239797|1981286|FG000|Treated Participants|Non-specified|1
977059|NCT01239797|1981287|FG001|Treated Participants|Non-specified|11
977060|NCT01239797|1981286|FG000|Treated Participants|Death|1
977061|NCT01239797|1981287|FG001|Treated Participants|Death|1
977062|NCT01239797|1981286|FG000|Treated Participants|Subject No Longer Meets Study Criteria|1
1006635|NCT01468987|2025356|FG001|Overall Study|Adverse Event|9
977063|NCT01239797|1981287|FG001|Treated Participants|Subject No Longer Meets Study Criteria|1
977064|NCT01239797|1981286|FG000|Treated Participants|Poor/Non-compliance|0
977065|NCT01239797|1981287|FG001|Treated Participants|Poor/Non-compliance|1
977066|NCT01239992|1981293|FG000|Overall Study|Withdrawal by Subject|2
977067|NCT01240135|1981308|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1
977068|NCT01240135|1981309|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1
977069|NCT01240135|1981308|FG000|Period Two, 14 Days of Wear|Adverse Event|0
977070|NCT01240135|1981309|FG001|Period Two, 14 Days of Wear|Adverse Event|1
977071|NCT01240200|1981317|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
977072|NCT01240200|1981318|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
977073|NCT01240356|1981333|FG000|Overall Study|Withdrawal by Subject|2
977074|NCT01240356|1981334|FG001|Overall Study|Withdrawal by Subject|0
977075|NCT01240356|1981333|FG000|Overall Study|MRI contraindication|1
977076|NCT01240356|1981334|FG001|Overall Study|MRI contraindication|0
977077|NCT01240382|1981345|FG000|Overall Study|Adverse Event|2
977078|NCT01240382|1981346|FG001|Overall Study|Adverse Event|1
977079|NCT01240382|1981345|FG000|Overall Study|Lack of Efficacy|0
977080|NCT01240382|1981346|FG001|Overall Study|Lack of Efficacy|2
977081|NCT01240382|1981345|FG000|Overall Study|Fear of adverse events|0
977082|NCT01240382|1981346|FG001|Overall Study|Fear of adverse events|1
977083|NCT01240551|1981354|FG000|Overall Study|Refused further treatment|3
977084|NCT01240551|1981355|FG001|Overall Study|Refused further treatment|2
977085|NCT01240551|1981354|FG000|Overall Study|Lost to Follow-up|1
977086|NCT01240551|1981355|FG001|Overall Study|Lost to Follow-up|1
977087|NCT01240590|1981366|FG000|Phase I|Refused further treatment|0
977088|NCT01240590|1981367|FG001|Phase I|Refused further treatment|0
977089|NCT01240590|1981368|FG002|Phase I|Refused further treatment|3
977090|NCT01240590|1981369|FG003|Phase I|Refused further treatment|0
977091|NCT01240590|1981370|FG004|Phase I|Refused further treatment|0
977092|NCT01240590|1981366|FG000|Phase II|Refused further treatment|0
977093|NCT01240590|1981367|FG001|Phase II|Refused further treatment|0
977094|NCT01240590|1981368|FG002|Phase II|Refused further treatment|0
977095|NCT01240590|1981369|FG003|Phase II|Refused further treatment|2
977096|NCT01240590|1981370|FG004|Phase II|Refused further treatment|1
977097|NCT01240746|1981399|FG000|Overall Study|Adverse Event|2
977098|NCT01240746|1981400|FG001|Overall Study|Adverse Event|0
977099|NCT01240746|1981401|FG002|Overall Study|Adverse Event|10
977100|NCT01240746|1981399|FG000|Overall Study|Lost to Follow-up|23
977101|NCT01240746|1981400|FG001|Overall Study|Lost to Follow-up|20
977102|NCT01240746|1981401|FG002|Overall Study|Lost to Follow-up|102
977103|NCT01240746|1981399|FG000|Overall Study|Protocol Violation|24
977104|NCT01240746|1981400|FG001|Overall Study|Protocol Violation|15
977105|NCT01240746|1981401|FG002|Overall Study|Protocol Violation|72
977106|NCT01240746|1981399|FG000|Overall Study|Withdrawal by Subject|10
977107|NCT01240746|1981400|FG001|Overall Study|Withdrawal by Subject|13
977108|NCT01240746|1981401|FG002|Overall Study|Withdrawal by Subject|59
977109|NCT01240785|1981411|FG000|Overall Study|Lost to Follow-up|1
977110|NCT01240785|1981412|FG001|Overall Study|Lost to Follow-up|0
977111|NCT01240785|1981411|FG000|Overall Study|Protocol Violation|0
977112|NCT01240785|1981412|FG001|Overall Study|Protocol Violation|3
977113|NCT01240811|1981421|FG000|Overall Study|Physician Decision|0
977114|NCT01240811|1981422|FG001|Overall Study|Physician Decision|1
977115|NCT01240811|1981423|FG002|Overall Study|Physician Decision|0
977116|NCT01240811|1981421|FG000|Overall Study|Withdrawal by Subject|0
977117|NCT01240811|1981422|FG001|Overall Study|Withdrawal by Subject|0
977118|NCT01240811|1981423|FG002|Overall Study|Withdrawal by Subject|1
977119|NCT01240863|1981435|FG000|Open-label Titration Period|Adverse Event|47
977120|NCT01240863|1981436|FG001|Open-label Titration Period|Adverse Event|0
977121|NCT01240863|1981437|FG002|Open-label Titration Period|Adverse Event|0
977122|NCT01240863|1981435|FG000|Open-label Titration Period|Lack of Efficacy|19
977123|NCT01240863|1981436|FG001|Open-label Titration Period|Lack of Efficacy|0
977124|NCT01240863|1981437|FG002|Open-label Titration Period|Lack of Efficacy|0
977125|NCT01240863|1981435|FG000|Open-label Titration Period|Withdrawal by Subject|9
977126|NCT01240863|1981436|FG001|Open-label Titration Period|Withdrawal by Subject|0
977127|NCT01240863|1981437|FG002|Open-label Titration Period|Withdrawal by Subject|0
977128|NCT01240863|1981435|FG000|Open-label Titration Period|Protocol Violation|7
977129|NCT01240863|1981436|FG001|Open-label Titration Period|Protocol Violation|0
977130|NCT01240863|1981437|FG002|Open-label Titration Period|Protocol Violation|0
977131|NCT01240863|1981435|FG000|Open-label Titration Period|Noncompliance to study drug admin|3
977132|NCT01240863|1981436|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
977133|NCT01240863|1981437|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
977134|NCT01240863|1981435|FG000|Open-label Titration Period|Noncompliance to study procedures|3
977135|NCT01240863|1981436|FG001|Open-label Titration Period|Noncompliance to study procedures|0
977136|NCT01240863|1981437|FG002|Open-label Titration Period|Noncompliance to study procedures|0
977137|NCT01240863|1981435|FG000|Open-label Titration Period|Dropped out prior to dosing|2
977138|NCT01240863|1981436|FG001|Open-label Titration Period|Dropped out prior to dosing|0
977139|NCT01240863|1981437|FG002|Open-label Titration Period|Dropped out prior to dosing|0
977140|NCT01240863|1981435|FG000|Open-label Titration Period|Other|7
977141|NCT01240863|1981436|FG001|Open-label Titration Period|Other|0
977142|NCT01240863|1981437|FG002|Open-label Titration Period|Other|0
977143|NCT01240863|1981435|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
977144|NCT01240863|1981436|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
977145|NCT01240863|1981437|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
977146|NCT01240863|1981435|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
977147|NCT01240863|1981436|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
977148|NCT01240863|1981437|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
977149|NCT01240863|1981435|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
977150|NCT01240863|1981436|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
977151|NCT01240863|1981437|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
977152|NCT01240863|1981435|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
977153|NCT01240863|1981436|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
977154|NCT01240863|1981437|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
977155|NCT01240863|1981435|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
977156|NCT01240863|1981436|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
977157|NCT01240863|1981437|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
977158|NCT01240863|1981435|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
977159|NCT01240863|1981436|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
977160|NCT01240863|1981437|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
977161|NCT01240863|1981435|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
977162|NCT01240863|1981436|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
977163|NCT01240863|1981437|FG002|Double-blind Treatment Period (12 Weeks)|Other|5
977164|NCT01240863|1981435|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
977165|NCT01240863|1981436|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
977166|NCT01240863|1981437|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
977167|NCT01240915|1981474|FG000|Overall Study|Adverse Event|0
977168|NCT01240915|1981475|FG001|Overall Study|Adverse Event|0
977169|NCT01240915|1981476|FG002|Overall Study|Adverse Event|0
977170|NCT01240915|1981477|FG003|Overall Study|Adverse Event|1
977171|NCT01240915|1981478|FG004|Overall Study|Adverse Event|0
977172|NCT01240915|1981479|FG005|Overall Study|Adverse Event|2
977173|NCT01240915|1981480|FG006|Overall Study|Adverse Event|0
977174|NCT01240915|1981481|FG007|Overall Study|Adverse Event|0
977175|NCT01240915|1981482|FG008|Overall Study|Adverse Event|1
977176|NCT01240915|1981474|FG000|Overall Study|Lost to Follow-up|0
977177|NCT01240915|1981475|FG001|Overall Study|Lost to Follow-up|0
977178|NCT01240915|1981476|FG002|Overall Study|Lost to Follow-up|0
977179|NCT01240915|1981477|FG003|Overall Study|Lost to Follow-up|0
977180|NCT01240915|1981478|FG004|Overall Study|Lost to Follow-up|1
977181|NCT01240915|1981479|FG005|Overall Study|Lost to Follow-up|1
977182|NCT01240915|1981480|FG006|Overall Study|Lost to Follow-up|0
977183|NCT01240915|1981481|FG007|Overall Study|Lost to Follow-up|1
977184|NCT01240915|1981482|FG008|Overall Study|Lost to Follow-up|1
977185|NCT01240915|1981474|FG000|Overall Study|Withdrawal by Subject|2
977186|NCT01240915|1981475|FG001|Overall Study|Withdrawal by Subject|1
977187|NCT01240915|1981476|FG002|Overall Study|Withdrawal by Subject|0
977188|NCT01240915|1981477|FG003|Overall Study|Withdrawal by Subject|2
977189|NCT01240915|1981478|FG004|Overall Study|Withdrawal by Subject|0
977190|NCT01240915|1981479|FG005|Overall Study|Withdrawal by Subject|4
977191|NCT01240915|1981480|FG006|Overall Study|Withdrawal by Subject|2
977192|NCT01240915|1981481|FG007|Overall Study|Withdrawal by Subject|3
977193|NCT01240915|1981482|FG008|Overall Study|Withdrawal by Subject|3
977194|NCT01240915|1981474|FG000|Overall Study|Other|0
977195|NCT01240915|1981475|FG001|Overall Study|Other|0
977196|NCT01240915|1981476|FG002|Overall Study|Other|0
977197|NCT01240915|1981477|FG003|Overall Study|Other|0
977198|NCT01240915|1981478|FG004|Overall Study|Other|2
977199|NCT01240915|1981479|FG005|Overall Study|Other|0
977200|NCT01240915|1981480|FG006|Overall Study|Other|0
977201|NCT01240915|1981481|FG007|Overall Study|Other|0
977202|NCT01240915|1981482|FG008|Overall Study|Other|0
977203|NCT01240915|1981474|FG000|Overall Study|Insufficient Clinical Response|0
977204|NCT01240915|1981475|FG001|Overall Study|Insufficient Clinical Response|0
977205|NCT01240915|1981476|FG002|Overall Study|Insufficient Clinical Response|0
977206|NCT01240915|1981477|FG003|Overall Study|Insufficient Clinical Response|0
977207|NCT01240915|1981478|FG004|Overall Study|Insufficient Clinical Response|1
977208|NCT01240915|1981479|FG005|Overall Study|Insufficient Clinical Response|3
977209|NCT01240915|1981480|FG006|Overall Study|Insufficient Clinical Response|6
977210|NCT01240915|1981481|FG007|Overall Study|Insufficient Clinical Response|0
977211|NCT01240915|1981482|FG008|Overall Study|Insufficient Clinical Response|3
977212|NCT01241240|1981506|FG000|Overall Study|Adverse Event|5
977213|NCT01241240|1981507|FG001|Overall Study|Adverse Event|4
977214|NCT01241240|1981506|FG000|Overall Study|Lost to Follow-up|2
977215|NCT01241240|1981507|FG001|Overall Study|Lost to Follow-up|4
977216|NCT01241240|1981506|FG000|Overall Study|Personal Reasons|1
977217|NCT01241240|1981507|FG001|Overall Study|Personal Reasons|1
977218|NCT01241292|1981515|FG000|Overall Study|Administrative Reason by Sponsor|1
977219|NCT01241292|1981516|FG001|Overall Study|Administrative Reason by Sponsor|0
977220|NCT01241292|1981515|FG000|Overall Study|Disease Progression|2
977221|NCT01241292|1981516|FG001|Overall Study|Disease Progression|0
977222|NCT01241292|1981515|FG000|Overall Study|Study Drug Toxicity|0
977223|NCT01241292|1981516|FG001|Overall Study|Study Drug Toxicity|1
977224|NCT01241292|1981515|FG000|Overall Study|Participant Discontinued Treatment|0
977225|NCT01241292|1981516|FG001|Overall Study|Participant Discontinued Treatment|2
977226|NCT01241318|1981528|FG000|Overall Study|Woman: false pregnancies|27
977227|NCT01241318|1981529|FG001|Overall Study|Woman: false pregnancies|15
977228|NCT01241318|1981528|FG000|Overall Study|Woman: miscarriage/abortion|46
977229|NCT01241318|1981529|FG001|Overall Study|Woman: miscarriage/abortion|38
977230|NCT01241318|1981528|FG000|Overall Study|Withdrawal by Subject|175
977231|NCT01241318|1981529|FG001|Overall Study|Withdrawal by Subject|46
977232|NCT01241318|1981528|FG000|Overall Study|Lost to Follow-up|740
977233|NCT01241318|1981529|FG001|Overall Study|Lost to Follow-up|455
977234|NCT01241318|1981528|FG000|Overall Study|Death|2
977235|NCT01241318|1981529|FG001|Overall Study|Death|4
977236|NCT01241318|1981528|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60
977237|NCT01241318|1981529|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38
977238|NCT01241318|1981528|FG000|Overall Study|Woman: Stillborn infant|129
977239|NCT01241318|1981529|FG001|Overall Study|Woman: Stillborn infant|146
977240|NCT01241448|1981575|FG000|Overall Study|Adverse Event|1
977241|NCT01241448|1981576|FG001|Overall Study|Adverse Event|0
977242|NCT01241448|1981577|FG002|Overall Study|Adverse Event|2
977243|NCT01241448|1981578|FG003|Overall Study|Adverse Event|2
977244|NCT01241448|1981575|FG000|Overall Study|Lost to Follow-up|2
977245|NCT01241448|1981576|FG001|Overall Study|Lost to Follow-up|1
977246|NCT01241448|1981577|FG002|Overall Study|Lost to Follow-up|1
977247|NCT01241448|1981578|FG003|Overall Study|Lost to Follow-up|1
977248|NCT01241448|1981575|FG000|Overall Study|Physician Decision|0
977249|NCT01241448|1981576|FG001|Overall Study|Physician Decision|2
977250|NCT01241448|1981577|FG002|Overall Study|Physician Decision|0
977251|NCT01241448|1981578|FG003|Overall Study|Physician Decision|0
977252|NCT01241448|1981575|FG000|Overall Study|Protocol Violation|10
977253|NCT01241448|1981576|FG001|Overall Study|Protocol Violation|5
977254|NCT01241448|1981577|FG002|Overall Study|Protocol Violation|3
977255|NCT01241448|1981578|FG003|Overall Study|Protocol Violation|6
977256|NCT01241448|1981575|FG000|Overall Study|Sponsor Decision|17
977257|NCT01241448|1981576|FG001|Overall Study|Sponsor Decision|14
977258|NCT01241448|1981577|FG002|Overall Study|Sponsor Decision|12
977259|NCT01241448|1981578|FG003|Overall Study|Sponsor Decision|6
977260|NCT01241448|1981575|FG000|Overall Study|Withdrawal by Subject|4
977261|NCT01241448|1981576|FG001|Overall Study|Withdrawal by Subject|5
977262|NCT01241448|1981577|FG002|Overall Study|Withdrawal by Subject|3
977263|NCT01241448|1981578|FG003|Overall Study|Withdrawal by Subject|6
977264|NCT01241448|1981575|FG000|Overall Study|Excluded due to data integrity issues|3
977265|NCT01241448|1981576|FG001|Overall Study|Excluded due to data integrity issues|2
977266|NCT01241448|1981577|FG002|Overall Study|Excluded due to data integrity issues|2
977267|NCT01241448|1981578|FG003|Overall Study|Excluded due to data integrity issues|2
977268|NCT01241461|1981591|FG000|Overall Study|Progressive Disease|3
977269|NCT01241461|1981592|FG001|Overall Study|Progressive Disease|6
977270|NCT01241552|1981620|FG000|Overall Study|Lack of Efficacy|1
977271|NCT01241552|1981621|FG001|Overall Study|Lack of Efficacy|0
977272|NCT01241552|1981622|FG002|Overall Study|Lack of Efficacy|0
977273|NCT01241552|1981623|FG003|Overall Study|Lack of Efficacy|0
977274|NCT01241552|1981620|FG000|Overall Study|Death|26
977275|NCT01241552|1981621|FG001|Overall Study|Death|30
977276|NCT01241552|1981622|FG002|Overall Study|Death|20
977277|NCT01241552|1981623|FG003|Overall Study|Death|25
977278|NCT01241552|1981620|FG000|Overall Study|Adverse Event|1
977279|NCT01241552|1981621|FG001|Overall Study|Adverse Event|1
977280|NCT01241552|1981622|FG002|Overall Study|Adverse Event|0
977281|NCT01241552|1981623|FG003|Overall Study|Adverse Event|0
977282|NCT01241552|1981620|FG000|Overall Study|Technical Problems|2
977283|NCT01241552|1981621|FG001|Overall Study|Technical Problems|0
977284|NCT01241552|1981622|FG002|Overall Study|Technical Problems|2
977285|NCT01241552|1981623|FG003|Overall Study|Technical Problems|2
977286|NCT01241552|1981620|FG000|Overall Study|Progressive Disease|0
977287|NCT01241552|1981621|FG001|Overall Study|Progressive Disease|0
977288|NCT01241552|1981622|FG002|Overall Study|Progressive Disease|1
977289|NCT01241552|1981623|FG003|Overall Study|Progressive Disease|2
977290|NCT01241552|1981620|FG000|Overall Study|Protocol Violation|0
977291|NCT01241552|1981621|FG001|Overall Study|Protocol Violation|2
977292|NCT01241552|1981622|FG002|Overall Study|Protocol Violation|6
977293|NCT01241552|1981623|FG003|Overall Study|Protocol Violation|1
977294|NCT01241552|1981620|FG000|Overall Study|Withdrawal by Subject|7
977295|NCT01241552|1981621|FG001|Overall Study|Withdrawal by Subject|15
977296|NCT01241552|1981622|FG002|Overall Study|Withdrawal by Subject|14
977297|NCT01241552|1981623|FG003|Overall Study|Withdrawal by Subject|15
977298|NCT01241552|1981620|FG000|Overall Study|Physician Decision|2
977299|NCT01241552|1981621|FG001|Overall Study|Physician Decision|4
977300|NCT01241552|1981622|FG002|Overall Study|Physician Decision|2
977301|NCT01241552|1981623|FG003|Overall Study|Physician Decision|3
977302|NCT01241552|1981620|FG000|Overall Study|Lost to Follow-up|2
977303|NCT01241552|1981621|FG001|Overall Study|Lost to Follow-up|11
977304|NCT01241552|1981622|FG002|Overall Study|Lost to Follow-up|15
977305|NCT01241552|1981623|FG003|Overall Study|Lost to Follow-up|16
977306|NCT01241591|1981642|FG000|Overall Study|Lack of Efficacy|5
977307|NCT01241591|1981643|FG001|Overall Study|Lack of Efficacy|2
977308|NCT01241591|1981644|FG002|Overall Study|Lack of Efficacy|2
977309|NCT01241591|1981645|FG003|Overall Study|Lack of Efficacy|3
977310|NCT01241591|1981642|FG000|Overall Study|Protocol Violation|5
977311|NCT01241591|1981643|FG001|Overall Study|Protocol Violation|2
977312|NCT01241591|1981644|FG002|Overall Study|Protocol Violation|3
977313|NCT01241591|1981645|FG003|Overall Study|Protocol Violation|0
977314|NCT01241591|1981642|FG000|Overall Study|Lost to Follow-up|1
977315|NCT01241591|1981643|FG001|Overall Study|Lost to Follow-up|2
977316|NCT01241591|1981644|FG002|Overall Study|Lost to Follow-up|2
977317|NCT01241591|1981645|FG003|Overall Study|Lost to Follow-up|2
977318|NCT01241591|1981642|FG000|Overall Study|Screen Failure|3
977319|NCT01241591|1981643|FG001|Overall Study|Screen Failure|2
977320|NCT01241591|1981644|FG002|Overall Study|Screen Failure|1
977321|NCT01241591|1981645|FG003|Overall Study|Screen Failure|0
977322|NCT01241591|1981642|FG000|Overall Study|Withdrawal by Subject|6
977323|NCT01241591|1981643|FG001|Overall Study|Withdrawal by Subject|4
977324|NCT01241591|1981644|FG002|Overall Study|Withdrawal by Subject|2
977325|NCT01241591|1981645|FG003|Overall Study|Withdrawal by Subject|2
977326|NCT01241591|1981642|FG000|Overall Study|Other|0
977327|NCT01241591|1981643|FG001|Overall Study|Other|1
977328|NCT01241591|1981644|FG002|Overall Study|Other|0
977329|NCT01241591|1981645|FG003|Overall Study|Other|1
977330|NCT01241591|1981642|FG000|Overall Study|Adverse Event|3
977331|NCT01241591|1981643|FG001|Overall Study|Adverse Event|11
977332|NCT01241591|1981644|FG002|Overall Study|Adverse Event|12
977333|NCT01241591|1981645|FG003|Overall Study|Adverse Event|4
977334|NCT01241604|1981655|FG000|Screening Period|Screen Failure|3
977335|NCT01241604|1981656|FG001|Screening Period|Screen Failure|0
977336|NCT01241604|1981657|FG002|Screening Period|Screen Failure|0
977337|NCT01241760|1981666|FG000|Overall Study|Adverse Event|1
977338|NCT01241760|1981667|FG001|Overall Study|Adverse Event|0
977339|NCT01241760|1981666|FG000|Overall Study|Lost to Follow-up|18
977340|NCT01241760|1981667|FG001|Overall Study|Lost to Follow-up|22
977341|NCT01241760|1981666|FG000|Overall Study|Withdrawal by Subject|13
977342|NCT01241760|1981667|FG001|Overall Study|Withdrawal by Subject|13
977343|NCT01241760|1981666|FG000|Overall Study|Switch To Commercially Available Medicat|1
977344|NCT01241760|1981667|FG001|Overall Study|Switch To Commercially Available Medicat|4
977345|NCT01241760|1981666|FG000|Overall Study|Other|1
977346|NCT01241760|1981667|FG001|Overall Study|Other|1
977347|NCT01242085|1981695|FG000|Overall Study|Withdrawal by Subject|4
977348|NCT01242085|1981696|FG001|Overall Study|Withdrawal by Subject|2
977349|NCT01242085|1981697|FG002|Overall Study|Withdrawal by Subject|0
977350|NCT01242085|1981695|FG000|Overall Study|medically unable to have surgery|4
977351|NCT01242085|1981696|FG001|Overall Study|medically unable to have surgery|5
977352|NCT01242085|1981697|FG002|Overall Study|medically unable to have surgery|0
977353|NCT01242111|1981703|FG000|Overall Study|Adverse Event|1
977354|NCT01242111|1981703|FG000|Overall Study|Withdrawal by Subject|1
977355|NCT01242111|1981703|FG000|Overall Study|Did not consent to MOR-100 follow-up|1
977356|NCT01242176|1981707|FG000|Washout Period of 7 Days|Adverse Event|0
977357|NCT01242176|1981708|FG001|Washout Period of 7 Days|Adverse Event|2
977358|NCT01242176|1981707|FG000|Washout Period of 7 Days|Non-compliant with protocol|1
977359|NCT01242176|1981708|FG001|Washout Period of 7 Days|Non-compliant with protocol|0
977360|NCT01242371|1981725|FG000|Overall Study|Withdrawal by Subject|2
977361|NCT01242371|1981726|FG001|Overall Study|Withdrawal by Subject|2
977362|NCT01242371|1981725|FG000|Overall Study|Protocol Violation|0
977363|NCT01242371|1981726|FG001|Overall Study|Protocol Violation|3
977364|NCT01242514|1981735|FG000|Overall Study|e.g., project closure|1042
977365|NCT01242514|1981736|FG001|Overall Study|e.g., project closure|305
977366|NCT01242514|1981737|FG002|Overall Study|e.g., project closure|171
977367|NCT01242514|1981735|FG000|Overall Study|Subject decision|33
977368|NCT01242514|1981736|FG001|Overall Study|Subject decision|8
977369|NCT01242514|1981737|FG002|Overall Study|Subject decision|2
977370|NCT01242514|1981735|FG000|Overall Study|Severe non-compliance to protocol|5
977371|NCT01242514|1981736|FG001|Overall Study|Severe non-compliance to protocol|2
977372|NCT01242514|1981737|FG002|Overall Study|Severe non-compliance to protocol|1
977373|NCT01242514|1981735|FG000|Overall Study|Lack of therapeutic response|99
977374|NCT01242514|1981736|FG001|Overall Study|Lack of therapeutic response|16
977375|NCT01242514|1981737|FG002|Overall Study|Lack of therapeutic response|10
977376|NCT01242514|1981735|FG000|Overall Study|Dev. of study specific discont. criteria|21
977377|NCT01242514|1981736|FG001|Overall Study|Dev. of study specific discont. criteria|3
977378|NCT01242514|1981737|FG002|Overall Study|Dev. of study specific discont. criteria|5
977379|NCT01242514|1981735|FG000|Overall Study|Lost to Follow-up|14
977380|NCT01242514|1981736|FG001|Overall Study|Lost to Follow-up|5
977381|NCT01242514|1981737|FG002|Overall Study|Lost to Follow-up|4
977382|NCT01242514|1981735|FG000|Overall Study|Adverse Event|129
977383|NCT01242514|1981736|FG001|Overall Study|Adverse Event|18
977384|NCT01242514|1981737|FG002|Overall Study|Adverse Event|19
977385|NCT01242748|1981777|FG000|Overall Study|Adverse Event|10
977386|NCT01242748|1981778|FG001|Overall Study|Adverse Event|5
977387|NCT01242748|1981777|FG000|Overall Study|Lost to Follow-up|6
977388|NCT01242748|1981778|FG001|Overall Study|Lost to Follow-up|2
977389|NCT01242748|1981777|FG000|Overall Study|Physician Decision|3
977390|NCT01242748|1981778|FG001|Overall Study|Physician Decision|2
977391|NCT01242748|1981777|FG000|Overall Study|Protocol Violation|1
977392|NCT01242748|1981778|FG001|Overall Study|Protocol Violation|0
977393|NCT01242748|1981777|FG000|Overall Study|Withdrawal by Subject|10
977394|NCT01242748|1981778|FG001|Overall Study|Withdrawal by Subject|2
977395|NCT01242748|1981777|FG000|Overall Study|Miscellaneous reasons|8
977396|NCT01242748|1981778|FG001|Overall Study|Miscellaneous reasons|3
977397|NCT01242813|1981784|FG000|Overall Study|Lost to Follow-up|2
977398|NCT01243151|1981797|FG000|Overall Study|Adverse Event|0
977399|NCT01243151|1981798|FG001|Overall Study|Adverse Event|1
977400|NCT01243151|1981799|FG002|Overall Study|Adverse Event|0
977401|NCT01243151|1981800|FG003|Overall Study|Adverse Event|0
977402|NCT01243151|1981801|FG004|Overall Study|Adverse Event|0
977403|NCT01243151|1981797|FG000|Overall Study|Protocol Violation|0
977404|NCT01243151|1981798|FG001|Overall Study|Protocol Violation|0
977405|NCT01243151|1981799|FG002|Overall Study|Protocol Violation|1
977406|NCT01243151|1981800|FG003|Overall Study|Protocol Violation|0
977407|NCT01243151|1981801|FG004|Overall Study|Protocol Violation|0
977408|NCT01243151|1981797|FG000|Overall Study|Other|0
977409|NCT01243151|1981798|FG001|Overall Study|Other|0
977410|NCT01243151|1981799|FG002|Overall Study|Other|0
977411|NCT01243151|1981800|FG003|Overall Study|Other|1
977412|NCT01243151|1981801|FG004|Overall Study|Other|0
977413|NCT01243151|1981797|FG000|Overall Study|Randomized but not treated|0
977414|NCT01243151|1981798|FG001|Overall Study|Randomized but not treated|0
977415|NCT01243151|1981799|FG002|Overall Study|Randomized but not treated|0
977416|NCT01243151|1981800|FG003|Overall Study|Randomized but not treated|1
977417|NCT01243151|1981801|FG004|Overall Study|Randomized but not treated|0
977418|NCT01243177|1981819|FG000|Overall Study|Lack of Efficacy|47
977419|NCT01243177|1981820|FG001|Overall Study|Lack of Efficacy|31
977420|NCT01243177|1981819|FG000|Overall Study|Protocol Violation|11
977421|NCT01243177|1981820|FG001|Overall Study|Protocol Violation|10
977422|NCT01243177|1981819|FG000|Overall Study|Lost to Follow-up|15
977423|NCT01243177|1981820|FG001|Overall Study|Lost to Follow-up|18
977424|NCT01243177|1981819|FG000|Overall Study|Withdrawal by Subject|46
977425|NCT01243177|1981820|FG001|Overall Study|Withdrawal by Subject|38
977426|NCT01243177|1981819|FG000|Overall Study|AE, serious fatal|0
977427|NCT01243177|1981820|FG001|Overall Study|AE, serious fatal|1
977428|NCT01243177|1981819|FG000|Overall Study|SAE, non-fatal|7
977429|NCT01243177|1981820|FG001|Overall Study|SAE, non-fatal|9
977430|NCT01243177|1981819|FG000|Overall Study|AE, non-serious non-fatal|40
977431|NCT01243177|1981820|FG001|Overall Study|AE, non-serious non-fatal|58
977432|NCT01243177|1981819|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1
977433|NCT01243177|1981820|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0
977434|NCT01243177|1981819|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
977435|NCT01243177|1981820|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
977436|NCT01243177|1981819|FG000|Overall Study|Other Reason|11
977437|NCT01243177|1981820|FG001|Overall Study|Other Reason|12
977438|NCT01243242|1981828|FG000|Overall Study|Adverse Event|1
977439|NCT01243242|1981829|FG001|Overall Study|Adverse Event|1
977440|NCT01243242|1981828|FG000|Overall Study|Withdrawal by Subject|1
977441|NCT01243242|1981829|FG001|Overall Study|Withdrawal by Subject|1
977442|NCT01243242|1981828|FG000|Overall Study|Physician Decision|0
977443|NCT01243242|1981829|FG001|Overall Study|Physician Decision|1
977444|NCT01243242|1981828|FG000|Overall Study|sponsor decision|0
977445|NCT01243242|1981829|FG001|Overall Study|sponsor decision|1
977446|NCT01243242|1981828|FG000|Overall Study|non compliance|1
977447|NCT01243242|1981829|FG001|Overall Study|non compliance|0
977448|NCT01243268|1981835|FG000|Overall Study|Lost to Follow-up|4
977449|NCT01243268|1981835|FG000|Overall Study|Protocol Violation|51
977450|NCT01243268|1981835|FG000|Overall Study|Deviation with contract date|7
977451|NCT01243268|1981835|FG000|Overall Study|Duplicate subject|2
977452|NCT01243411|1981856|FG000|Overall Study|Withdrawal by Subject|18
977453|NCT01243411|1981856|FG000|Overall Study|Lost to Follow-up|10
977454|NCT01243411|1981856|FG000|Overall Study|Adverse Event|5
977455|NCT01243411|1981856|FG000|Overall Study|Other|8
977456|NCT01243424|1981862|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
977457|NCT01243424|1981863|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
977458|NCT01243424|1981862|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
977459|NCT01243424|1981863|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
977460|NCT01243424|1981862|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
977461|NCT01243424|1981863|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
977462|NCT01243424|1981862|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
977463|NCT01243424|1981863|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
977464|NCT01243424|1981862|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38
977465|NCT01243424|1981863|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35
977466|NCT01243424|1981862|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
977467|NCT01243424|1981863|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
977468|NCT01243424|1981862|FG000|Discontinuation From Study (Treated Set)|Not treated|5
977469|NCT01243424|1981863|FG001|Discontinuation From Study (Treated Set)|Not treated|4
977470|NCT01243424|1981862|FG000|Discontinuation From Treatment|Not treated|5
977471|NCT01243424|1981863|FG001|Discontinuation From Treatment|Not treated|4
977472|NCT01243424|1981862|FG000|Discontinuation From Treatment|Adverse Event|457
977473|NCT01243424|1981863|FG001|Discontinuation From Treatment|Adverse Event|523
977474|NCT01243424|1981862|FG000|Discontinuation From Treatment|Lack of Efficacy|61
977475|NCT01243424|1981863|FG001|Discontinuation From Treatment|Lack of Efficacy|41
977476|NCT01243424|1981862|FG000|Discontinuation From Treatment|Protocol Violation|46
977477|NCT01243424|1981863|FG001|Discontinuation From Treatment|Protocol Violation|47
977478|NCT01243424|1981862|FG000|Discontinuation From Treatment|Lost to Follow-up|24
977479|NCT01243424|1981863|FG001|Discontinuation From Treatment|Lost to Follow-up|28
977480|NCT01243424|1981862|FG000|Discontinuation From Treatment|Withdrawal by Subject|309
977481|NCT01243424|1981863|FG001|Discontinuation From Treatment|Withdrawal by Subject|328
977482|NCT01243424|1981862|FG000|Discontinuation From Treatment|Other than listed above|230
977483|NCT01243424|1981863|FG001|Discontinuation From Treatment|Other than listed above|211
977484|NCT01243671|1981916|FG000|Overall Study|Adverse Event|3
977485|NCT01243671|1981916|FG000|Overall Study|Anti-adalimumab antibody positive|1
977486|NCT01243671|1981916|FG000|Overall Study|Other|1
977487|NCT01243762|1981927|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0
977488|NCT01243762|1981928|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2
977489|NCT01243762|1981929|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0
977490|NCT01243762|1981930|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0
977491|NCT01243762|1981931|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1
977492|NCT01243762|1981932|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1
977493|NCT01243762|1981933|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0
977494|NCT01243762|1981927|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0
977495|NCT01243762|1981928|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1
977496|NCT01243762|1981929|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0
977497|NCT01243762|1981930|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1
977498|NCT01243762|1981931|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0
977499|NCT01243762|1981932|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0
977500|NCT01243762|1981933|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0
977501|NCT01243762|1981927|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
977502|NCT01243762|1981928|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
977503|NCT01243762|1981929|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
977504|NCT01243762|1981930|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
977505|NCT01243762|1981931|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
977506|NCT01243762|1981932|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
977507|NCT01243762|1981933|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
977508|NCT01243762|1981927|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
977509|NCT01243762|1981928|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
977510|NCT01243762|1981929|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
977511|NCT01243762|1981930|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
977512|NCT01243762|1981931|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
977513|NCT01243762|1981932|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
977514|NCT01243762|1981933|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
977515|NCT01243762|1981927|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
977516|NCT01243762|1981928|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
977517|NCT01243762|1981929|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
977518|NCT01243762|1981930|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
977519|NCT01243762|1981931|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
977520|NCT01243762|1981932|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
977521|NCT01243762|1981933|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
977522|NCT01243762|1981927|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
977523|NCT01243762|1981928|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
977524|NCT01243762|1981929|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
977525|NCT01243762|1981930|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
977526|NCT01243762|1981931|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
977527|NCT01243762|1981932|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
977528|NCT01243762|1981933|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
977529|NCT01243762|1981927|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
977530|NCT01243762|1981928|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
977531|NCT01243762|1981929|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
977532|NCT01243762|1981930|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
977533|NCT01243762|1981931|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
977534|NCT01243762|1981932|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
977535|NCT01243762|1981933|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
977536|NCT01243762|1981927|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
977537|NCT01243762|1981928|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
977538|NCT01243762|1981929|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1006636|NCT01468987|2025355|FG000|Overall Study|Death|4
977539|NCT01243762|1981930|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
977540|NCT01243762|1981931|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
977541|NCT01243762|1981932|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
977542|NCT01243762|1981933|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
977543|NCT01243775|1981952|FG000|Overall Study|Withdrawal by Subject|2
977544|NCT01243944|1981958|FG000|Overall Study|Adverse Event|15
977545|NCT01243944|1981959|FG001|Overall Study|Adverse Event|13
977546|NCT01243944|1981958|FG000|Overall Study|Lost to Follow-up|2
977547|NCT01243944|1981959|FG001|Overall Study|Lost to Follow-up|1
977548|NCT01243944|1981958|FG000|Overall Study|Physician Decision|2
977549|NCT01243944|1981959|FG001|Overall Study|Physician Decision|7
977550|NCT01243944|1981958|FG000|Overall Study|Disease progression|12
977551|NCT01243944|1981959|FG001|Overall Study|Disease progression|11
977552|NCT01243944|1981958|FG000|Overall Study|Protocol deviation|1
977553|NCT01243944|1981959|FG001|Overall Study|Protocol deviation|1
977554|NCT01243944|1981958|FG000|Overall Study|Participant decision|10
977555|NCT01243944|1981959|FG001|Overall Study|Participant decision|15
977556|NCT01243944|1981958|FG000|Overall Study|Death|2
977557|NCT01243944|1981959|FG001|Overall Study|Death|3
977558|NCT01243944|1981958|FG000|Overall Study|Non-compliance with study treatment|1
977559|NCT01243944|1981959|FG001|Overall Study|Non-compliance with study treatment|0
977560|NCT01244035|1981972|FG000|Part 1: Period 1|Adverse Event|0
977561|NCT01244035|1981973|FG001|Part 1: Period 1|Adverse Event|0
977562|NCT01244035|1981974|FG002|Part 1: Period 1|Adverse Event|0
977563|NCT01244035|1981975|FG003|Part 1: Period 1|Adverse Event|0
977564|NCT01244035|1981976|FG004|Part 1: Period 1|Adverse Event|0
977565|NCT01244035|1981977|FG005|Part 1: Period 1|Adverse Event|1
977566|NCT01244035|1981972|FG000|Part 1: Period 1|Withdrawal by Subject|0
977567|NCT01244035|1981973|FG001|Part 1: Period 1|Withdrawal by Subject|2
977568|NCT01244035|1981974|FG002|Part 1: Period 1|Withdrawal by Subject|0
977569|NCT01244035|1981975|FG003|Part 1: Period 1|Withdrawal by Subject|0
977570|NCT01244035|1981976|FG004|Part 1: Period 1|Withdrawal by Subject|0
977571|NCT01244035|1981977|FG005|Part 1: Period 1|Withdrawal by Subject|0
977572|NCT01244035|1981972|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1
977573|NCT01244035|1981973|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0
977574|NCT01244035|1981974|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2
977575|NCT01244035|1981975|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0
977576|NCT01244035|1981976|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1
977577|NCT01244035|1981977|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1
977578|NCT01244035|1981972|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0
977579|NCT01244035|1981973|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0
977580|NCT01244035|1981974|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1
977581|NCT01244035|1981975|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0
977582|NCT01244035|1981976|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0
977583|NCT01244035|1981977|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0
977584|NCT01244035|1981972|FG000|Part 1: Period 3|Adverse Event|0
977585|NCT01244035|1981973|FG001|Part 1: Period 3|Adverse Event|0
977586|NCT01244035|1981974|FG002|Part 1: Period 3|Adverse Event|0
977587|NCT01244035|1981975|FG003|Part 1: Period 3|Adverse Event|0
977588|NCT01244035|1981976|FG004|Part 1: Period 3|Adverse Event|0
977589|NCT01244035|1981977|FG005|Part 1: Period 3|Adverse Event|1
977590|NCT01244035|1981972|FG000|Part 1: Period 3|Withdrawal by Subject|0
977591|NCT01244035|1981973|FG001|Part 1: Period 3|Withdrawal by Subject|0
977592|NCT01244035|1981974|FG002|Part 1: Period 3|Withdrawal by Subject|0
977593|NCT01244035|1981975|FG003|Part 1: Period 3|Withdrawal by Subject|0
977594|NCT01244035|1981976|FG004|Part 1: Period 3|Withdrawal by Subject|1
977595|NCT01244035|1981977|FG005|Part 1: Period 3|Withdrawal by Subject|0
977596|NCT01244035|1981972|FG000|Part 1: Period 3|Protocol Deviation|0
977597|NCT01244035|1981973|FG001|Part 1: Period 3|Protocol Deviation|1
977598|NCT01244035|1981974|FG002|Part 1: Period 3|Protocol Deviation|0
977599|NCT01244035|1981975|FG003|Part 1: Period 3|Protocol Deviation|0
977600|NCT01244035|1981976|FG004|Part 1: Period 3|Protocol Deviation|0
977601|NCT01244035|1981977|FG005|Part 1: Period 3|Protocol Deviation|0
977602|NCT01244061|1981999|FG000|Overall Study|Death|1
977603|NCT01244061|1982000|FG001|Overall Study|Death|0
977604|NCT01244061|1981999|FG000|Overall Study|Did not meet entrance criteria|1
977605|NCT01244061|1982000|FG001|Overall Study|Did not meet entrance criteria|0
977606|NCT01244061|1981999|FG000|Overall Study|Lack of Efficacy|1
977607|NCT01244061|1982000|FG001|Overall Study|Lack of Efficacy|3
977608|NCT01244061|1981999|FG000|Overall Study|Lost to Follow-up|34
977609|NCT01244061|1982000|FG001|Overall Study|Lost to Follow-up|30
977610|NCT01244061|1981999|FG000|Overall Study|Withdrawal by Subject|29
977611|NCT01244061|1982000|FG001|Overall Study|Withdrawal by Subject|46
977612|NCT01244061|1981999|FG000|Overall Study|Other|8
977613|NCT01244061|1982000|FG001|Overall Study|Other|19
977614|NCT01244061|1981999|FG000|Overall Study|Protocol Violation|1
977615|NCT01244061|1982000|FG001|Overall Study|Protocol Violation|1
977616|NCT01244061|1981999|FG000|Overall Study|Adverse Event|5
977617|NCT01244061|1982000|FG001|Overall Study|Adverse Event|2
977618|NCT01244061|1981999|FG000|Overall Study|Randomized but not treated|2
977619|NCT01244061|1982000|FG001|Overall Study|Randomized but not treated|2
977620|NCT01244126|1982009|FG000|Overall Study|Protocol Violation|3
977621|NCT01244126|1982010|FG001|Overall Study|Protocol Violation|3
977622|NCT01244126|1982011|FG002|Overall Study|Protocol Violation|9
977623|NCT01244191|1982021|FG000|Overall Study|Progressive disease|295
977624|NCT01244191|1982022|FG001|Overall Study|Progressive disease|350
977625|NCT01244191|1982021|FG000|Overall Study|Clinical disease progression|54
977626|NCT01244191|1982022|FG001|Overall Study|Clinical disease progression|36
977627|NCT01244191|1982021|FG000|Overall Study|Adverse Event|65
977628|NCT01244191|1982022|FG001|Overall Study|Adverse Event|48
977629|NCT01244191|1982021|FG000|Overall Study|Death|22
977630|NCT01244191|1982022|FG001|Overall Study|Death|29
977631|NCT01244191|1982021|FG000|Overall Study|Lost to Follow-up|0
977632|NCT01244191|1982022|FG001|Overall Study|Lost to Follow-up|2
977633|NCT01244191|1982021|FG000|Overall Study|Protocol Violation|1
977634|NCT01244191|1982022|FG001|Overall Study|Protocol Violation|2
977635|NCT01244191|1982021|FG000|Overall Study|Withdrawal by Subject|31
977636|NCT01244191|1982022|FG001|Overall Study|Withdrawal by Subject|23
977637|NCT01244191|1982021|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12
977638|NCT01244191|1982022|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8
977639|NCT01244425|1982038|FG000|Overall Study|Withdrawal by Subject|2
977640|NCT01244425|1982039|FG001|Overall Study|Withdrawal by Subject|2
977641|NCT01244425|1982038|FG000|Overall Study|Adverse Event|1
977642|NCT01244425|1982039|FG001|Overall Study|Adverse Event|1
977643|NCT01244490|1982072|FG000|Overall Study|Lack of Efficacy|14
977644|NCT01244490|1982073|FG001|Overall Study|Lack of Efficacy|5
977645|NCT01244490|1982074|FG002|Overall Study|Lack of Efficacy|5
977646|NCT01244490|1982072|FG000|Overall Study|Withdrawal by Subject|4
977647|NCT01244490|1982073|FG001|Overall Study|Withdrawal by Subject|4
977648|NCT01244490|1982074|FG002|Overall Study|Withdrawal by Subject|9
977649|NCT01244490|1982072|FG000|Overall Study|Adverse Event|1
977650|NCT01244490|1982073|FG001|Overall Study|Adverse Event|9
977651|NCT01244490|1982074|FG002|Overall Study|Adverse Event|5
977652|NCT01244490|1982072|FG000|Overall Study|Lost to Follow-up|0
977653|NCT01244490|1982073|FG001|Overall Study|Lost to Follow-up|6
977654|NCT01244490|1982074|FG002|Overall Study|Lost to Follow-up|3
977655|NCT01244490|1982072|FG000|Overall Study|Other|0
977656|NCT01244490|1982073|FG001|Overall Study|Other|0
977657|NCT01244490|1982074|FG002|Overall Study|Other|1
977658|NCT01244516|1982089|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
977659|NCT01244516|1982090|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
977660|NCT01244516|1982091|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
977661|NCT01244516|1982089|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
977662|NCT01244516|1982090|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
977663|NCT01244516|1982091|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
977664|NCT01244516|1982089|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
977665|NCT01244516|1982090|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
977666|NCT01244516|1982091|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
977667|NCT01244516|1982089|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2
977668|NCT01244516|1982090|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0
977669|NCT01244516|1982091|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0
977670|NCT01244516|1982089|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
977671|NCT01244516|1982090|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
977672|NCT01244516|1982091|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
977673|NCT01244516|1982089|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
977674|NCT01244516|1982090|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
977675|NCT01244516|1982091|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
977676|NCT01244516|1982089|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
977677|NCT01244516|1982090|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
977678|NCT01244516|1982091|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
977679|NCT01244815|1982132|FG000|Overall Study|Not Treated|0
977680|NCT01244815|1982133|FG001|Overall Study|Not Treated|1
977681|NCT01244815|1982134|FG002|Overall Study|Not Treated|0
977682|NCT01244815|1982135|FG003|Overall Study|Not Treated|0
977683|NCT01244815|1982132|FG000|Overall Study|Adverse Event|4
977684|NCT01244815|1982133|FG001|Overall Study|Adverse Event|7
977685|NCT01244815|1982134|FG002|Overall Study|Adverse Event|5
977686|NCT01244815|1982135|FG003|Overall Study|Adverse Event|5
977687|NCT01244815|1982132|FG000|Overall Study|Treatment Failure|0
977688|NCT01244815|1982133|FG001|Overall Study|Treatment Failure|0
977689|NCT01244815|1982134|FG002|Overall Study|Treatment Failure|0
977690|NCT01244815|1982135|FG003|Overall Study|Treatment Failure|1
977691|NCT01244815|1982132|FG000|Overall Study|Lost to Follow-up|3
977692|NCT01244815|1982133|FG001|Overall Study|Lost to Follow-up|2
977693|NCT01244815|1982134|FG002|Overall Study|Lost to Follow-up|3
977694|NCT01244815|1982135|FG003|Overall Study|Lost to Follow-up|2
977695|NCT01244815|1982132|FG000|Overall Study|Withdrawal by Subject|0
977696|NCT01244815|1982133|FG001|Overall Study|Withdrawal by Subject|2
977697|NCT01244815|1982134|FG002|Overall Study|Withdrawal by Subject|0
977698|NCT01244815|1982135|FG003|Overall Study|Withdrawal by Subject|3
977699|NCT01244815|1982132|FG000|Overall Study|Protocol Violation|7
977700|NCT01244815|1982133|FG001|Overall Study|Protocol Violation|4
977701|NCT01244815|1982134|FG002|Overall Study|Protocol Violation|3
977702|NCT01244815|1982135|FG003|Overall Study|Protocol Violation|1
977703|NCT01244815|1982132|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
977704|NCT01244815|1982133|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
977705|NCT01244815|1982134|FG002|Overall Study|Did Not Meet Protocol Eligibility|0
977706|NCT01244815|1982135|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
977707|NCT01244828|1982145|FG000|Overall Study|Adverse Event|37
977708|NCT01244828|1982145|FG000|Overall Study|Withdrawal by Subject|31
977709|NCT01244828|1982145|FG000|Overall Study|Lack of Efficacy|7
977710|NCT01244828|1982145|FG000|Overall Study|Lost to Follow-up|2
977711|NCT01244828|1982145|FG000|Overall Study|Other reason (not specified)|1
977712|NCT01244893|1982149|FG000|Baseline|Protocol Violation|0
977713|NCT01244893|1982150|FG001|Baseline|Protocol Violation|1
977714|NCT01244893|1982149|FG000|1-Week Follow Up|Lost to Follow-up|1
977715|NCT01244893|1982150|FG001|1-Week Follow Up|Lost to Follow-up|0
977716|NCT01244906|1982161|FG000|Overall Study|Death|2
977717|NCT01244906|1982161|FG000|Overall Study|Progression of disease post treatment|6
977718|NCT01244984|1982168|FG000|Overall Study|Adverse Event|2
977719|NCT01244984|1982169|FG001|Overall Study|Adverse Event|11
977720|NCT01244984|1982170|FG002|Overall Study|Adverse Event|2
977721|NCT01244984|1982168|FG000|Overall Study|Protocol Violation|1
977722|NCT01244984|1982169|FG001|Overall Study|Protocol Violation|0
977723|NCT01244984|1982170|FG002|Overall Study|Protocol Violation|0
977724|NCT01244984|1982168|FG000|Overall Study|Protocol Defined Stopping Criteria|1
977725|NCT01244984|1982169|FG001|Overall Study|Protocol Defined Stopping Criteria|1
977726|NCT01244984|1982170|FG002|Overall Study|Protocol Defined Stopping Criteria|0
977727|NCT01244984|1982168|FG000|Overall Study|Withdrawal by Subject|1
977728|NCT01244984|1982169|FG001|Overall Study|Withdrawal by Subject|2
977729|NCT01244984|1982170|FG002|Overall Study|Withdrawal by Subject|2
977730|NCT01245049|1982181|FG000|Overall Study|Migrated/moved from study area|0
977731|NCT01245049|1982182|FG001|Overall Study|Migrated/moved from study area|1
977732|NCT01245049|1982181|FG000|Overall Study|Withdrawal by Subject|0
977733|NCT01245049|1982182|FG001|Overall Study|Withdrawal by Subject|1
977734|NCT01245049|1982181|FG000|Overall Study|Lost to Follow-up|1
977735|NCT01245049|1982182|FG001|Overall Study|Lost to Follow-up|2
977736|NCT01245062|1982190|FG000|Randomization and Crossover Phase|Lost to Follow-up|4
977737|NCT01245062|1982191|FG001|Randomization and Crossover Phase|Lost to Follow-up|2
977738|NCT01245062|1982192|FG002|Randomization and Crossover Phase|Lost to Follow-up|0
977739|NCT01245062|1982190|FG000|Randomization and Crossover Phase|Physician Decision|2
977740|NCT01245062|1982191|FG001|Randomization and Crossover Phase|Physician Decision|4
977741|NCT01245062|1982192|FG002|Randomization and Crossover Phase|Physician Decision|0
977742|NCT01245062|1982190|FG000|Randomization and Crossover Phase|Withdrew Consent|12
977743|NCT01245062|1982191|FG001|Randomization and Crossover Phase|Withdrew Consent|11
977744|NCT01245062|1982192|FG002|Randomization and Crossover Phase|Withdrew Consent|0
977745|NCT01245062|1982190|FG000|Randomization and Crossover Phase|Study closed/ terminated|23
977746|NCT01245062|1982191|FG001|Randomization and Crossover Phase|Study closed/ terminated|14
977747|NCT01245062|1982192|FG002|Randomization and Crossover Phase|Study closed/ terminated|0
977748|NCT01245062|1982190|FG000|Cross-over Phase|Lost to Follow-up|0
977749|NCT01245062|1982191|FG001|Cross-over Phase|Lost to Follow-up|0
977750|NCT01245062|1982192|FG002|Cross-over Phase|Lost to Follow-up|1
977751|NCT01245062|1982190|FG000|Cross-over Phase|Physician Decision|0
977752|NCT01245062|1982191|FG001|Cross-over Phase|Physician Decision|0
977753|NCT01245062|1982192|FG002|Cross-over Phase|Physician Decision|1
977754|NCT01245062|1982190|FG000|Cross-over Phase|Withdrew Consent|0
977755|NCT01245062|1982191|FG001|Cross-over Phase|Withdrew Consent|0
977756|NCT01245062|1982192|FG002|Cross-over Phase|Withdrew Consent|4
977757|NCT01245062|1982190|FG000|Cross-over Phase|Study closed/ terminated|0
977758|NCT01245062|1982191|FG001|Cross-over Phase|Study closed/ terminated|0
977759|NCT01245062|1982192|FG002|Cross-over Phase|Study closed/ terminated|11
977760|NCT01245101|1982202|FG000|Period 1 (Treatment)|Withdrawal by Subject|2
977761|NCT01245101|1982203|FG001|Period 1 (Treatment)|Withdrawal by Subject|0
977762|NCT01245101|1982202|FG000|Period 2 (Washout)|Withdrawal by Subject|1
977763|NCT01245101|1982203|FG001|Period 2 (Washout)|Withdrawal by Subject|0
977764|NCT01245101|1982202|FG000|Period 3 (Treatment)|Withdrawal by Subject|1
977765|NCT01245101|1982203|FG001|Period 3 (Treatment)|Withdrawal by Subject|0
977766|NCT01245140|1982211|FG000|Overall Study|Adverse Event|1
977767|NCT01245140|1982212|FG001|Overall Study|Adverse Event|3
977768|NCT01245140|1982211|FG000|Overall Study|Lack of Efficacy|2
977769|NCT01245140|1982212|FG001|Overall Study|Lack of Efficacy|4
977770|NCT01245140|1982211|FG000|Overall Study|Protocol Violation|0
977771|NCT01245140|1982212|FG001|Overall Study|Protocol Violation|1
977772|NCT01245140|1982211|FG000|Overall Study|Withdrawal by Subject|0
977773|NCT01245140|1982212|FG001|Overall Study|Withdrawal by Subject|1
977774|NCT01245140|1982211|FG000|Overall Study|Refused Treatment/Did Not Coopera|0
977775|NCT01245140|1982212|FG001|Overall Study|Refused Treatment/Did Not Coopera|1
977776|NCT01245283|1982232|FG000|Overall Study|Lost to Follow-up|14
977777|NCT01245283|1982233|FG001|Overall Study|Lost to Follow-up|11
977778|NCT01245283|1982234|FG002|Overall Study|Lost to Follow-up|11
977779|NCT01245374|1982245|FG000|Overall Study|Protocol Violation|1
977780|NCT01245374|1982245|FG000|Overall Study|Withdrawal by Subject|3
977781|NCT01245387|1982250|FG000|Overall Study|Lost to Follow-up|106
977782|NCT01245387|1982250|FG000|Overall Study|Lack of Efficacy|195
977783|NCT01245387|1982250|FG000|Overall Study|Adverse Event|9
977784|NCT01245387|1982250|FG000|Overall Study|Death|3
977785|NCT01245387|1982250|FG000|Overall Study|Other|131
977786|NCT01245387|1982250|FG000|Overall Study|Missing discontinuation status|369
977787|NCT01245673|1982285|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
977788|NCT01245751|1982307|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2
977789|NCT01245751|1982308|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1
977790|NCT01245751|1982309|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0
977791|NCT01245751|1982310|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0
977792|NCT01245751|1982307|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
977793|NCT01245751|1982308|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
977794|NCT01245751|1982309|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
977795|NCT01245751|1982310|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
977796|NCT01245751|1982307|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
977797|NCT01245751|1982308|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
977798|NCT01245751|1982309|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
977799|NCT01245751|1982310|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
977800|NCT01245764|1982325|FG000|Study Phase A|Other|3
977801|NCT01245764|1982326|FG001|Study Phase A|Other|2
977802|NCT01245764|1982327|FG002|Study Phase A|Other|3
977803|NCT01245764|1982328|FG003|Study Phase A|Other|1
977804|NCT01245764|1982325|FG000|Study Phase A|Protocol Violation|6
977805|NCT01245764|1982326|FG001|Study Phase A|Protocol Violation|3
977806|NCT01245764|1982327|FG002|Study Phase A|Protocol Violation|2
977807|NCT01245764|1982328|FG003|Study Phase A|Protocol Violation|2
977808|NCT01245764|1982325|FG000|Study Phase A|Lost to Follow-up|0
977809|NCT01245764|1982326|FG001|Study Phase A|Lost to Follow-up|0
977810|NCT01245764|1982327|FG002|Study Phase A|Lost to Follow-up|5
977811|NCT01245764|1982328|FG003|Study Phase A|Lost to Follow-up|0
977812|NCT01246206|1982401|FG000|Overall Study|Patient did not receive study regiments.|1
977813|NCT01246466|1982430|FG000|Overall Study|Death|1
977814|NCT01246466|1982430|FG000|Overall Study|Withdrawal by Subject|1
977815|NCT01246583|1982443|FG000|Overall Study|Lost to Follow-up|0
977816|NCT01246583|1982444|FG001|Overall Study|Lost to Follow-up|0
977817|NCT01246583|1982445|FG002|Overall Study|Lost to Follow-up|0
977818|NCT01246583|1982446|FG003|Overall Study|Lost to Follow-up|1
977819|NCT01246583|1982443|FG000|Overall Study|Protocol Violation|0
977820|NCT01246583|1982444|FG001|Overall Study|Protocol Violation|0
977821|NCT01246583|1982445|FG002|Overall Study|Protocol Violation|1
977822|NCT01246583|1982446|FG003|Overall Study|Protocol Violation|0
977823|NCT01246583|1982443|FG000|Overall Study|Withdrawal by Subject|1
977824|NCT01246583|1982444|FG001|Overall Study|Withdrawal by Subject|0
977825|NCT01246583|1982445|FG002|Overall Study|Withdrawal by Subject|0
977826|NCT01246583|1982446|FG003|Overall Study|Withdrawal by Subject|0
977827|NCT01246960|1982481|FG000|Overall Study|Lost to Follow-up|3
977828|NCT01246960|1982482|FG001|Overall Study|Lost to Follow-up|1
977829|NCT01246960|1982481|FG000|Overall Study|Withdrawal (by participant or physician)|3
977830|NCT01246960|1982482|FG001|Overall Study|Withdrawal (by participant or physician)|3
977831|NCT01246973|1982490|FG000|Overall Study|Other|38
977832|NCT01246973|1982491|FG001|Overall Study|Other|25
977833|NCT01246973|1982490|FG000|Overall Study|Adverse Event|16
977834|NCT01246973|1982491|FG001|Overall Study|Adverse Event|9
977835|NCT01246973|1982490|FG000|Overall Study|Withdrawal by Subject|7
977836|NCT01246973|1982491|FG001|Overall Study|Withdrawal by Subject|13
977837|NCT01246986|1982504|FG000|Overall Study|Lost to Follow-up|0
977838|NCT01246986|1982505|FG001|Overall Study|Lost to Follow-up|1
977839|NCT01246986|1982506|FG002|Overall Study|Lost to Follow-up|3
977840|NCT01246986|1982507|FG003|Overall Study|Lost to Follow-up|0
977841|NCT01246986|1982508|FG004|Overall Study|Lost to Follow-up|0
977842|NCT01246986|1982509|FG005|Overall Study|Lost to Follow-up|1
977843|NCT01246986|1982510|FG006|Overall Study|Lost to Follow-up|0
977844|NCT01246986|1982504|FG000|Overall Study|Withdrawal by Subject|3
977845|NCT01246986|1982505|FG001|Overall Study|Withdrawal by Subject|4
977846|NCT01246986|1982506|FG002|Overall Study|Withdrawal by Subject|3
977847|NCT01246986|1982507|FG003|Overall Study|Withdrawal by Subject|0
977848|NCT01246986|1982508|FG004|Overall Study|Withdrawal by Subject|4
977849|NCT01246986|1982509|FG005|Overall Study|Withdrawal by Subject|0
977850|NCT01246986|1982510|FG006|Overall Study|Withdrawal by Subject|0
977851|NCT01246999|1982545|FG000|Overall Study|Lost to Follow-up|0
977852|NCT01246999|1982546|FG001|Overall Study|Lost to Follow-up|1
977853|NCT01246999|1982547|FG002|Overall Study|Lost to Follow-up|0
977854|NCT01246999|1982548|FG003|Overall Study|Lost to Follow-up|0
977855|NCT01246999|1982545|FG000|Overall Study|Withdrawal by Subject|0
977856|NCT01246999|1982546|FG001|Overall Study|Withdrawal by Subject|0
977857|NCT01246999|1982547|FG002|Overall Study|Withdrawal by Subject|0
977858|NCT01246999|1982548|FG003|Overall Study|Withdrawal by Subject|2
977859|NCT01247090|1982573|FG000|Overall Study|Physician Decision|1
977860|NCT01247090|1982574|FG001|Overall Study|Physician Decision|0
977861|NCT01247090|1982575|FG002|Overall Study|Physician Decision|0
977862|NCT01247090|1982573|FG000|Overall Study|Withdrawal by Subject|0
977863|NCT01247090|1982574|FG001|Overall Study|Withdrawal by Subject|1
977864|NCT01247090|1982575|FG002|Overall Study|Withdrawal by Subject|0
977887|NCT01247350|1982630|FG000|Overall Study|Adverse Event|0
977888|NCT01247350|1982631|FG001|Overall Study|Adverse Event|0
977889|NCT01247350|1982632|FG002|Overall Study|Adverse Event|1
977890|NCT01247350|1982633|FG003|Overall Study|Adverse Event|0
977891|NCT01247350|1982634|FG004|Overall Study|Adverse Event|0
977892|NCT01247350|1982630|FG000|Overall Study|Withdrawal by Subject|0
977893|NCT01247350|1982631|FG001|Overall Study|Withdrawal by Subject|0
977894|NCT01247350|1982632|FG002|Overall Study|Withdrawal by Subject|0
977895|NCT01247350|1982633|FG003|Overall Study|Withdrawal by Subject|1
977896|NCT01247350|1982634|FG004|Overall Study|Withdrawal by Subject|0
977897|NCT01247350|1982630|FG000|Overall Study|Entry criteria not met|0
977898|NCT01247350|1982631|FG001|Overall Study|Entry criteria not met|0
977899|NCT01247350|1982632|FG002|Overall Study|Entry criteria not met|0
977900|NCT01247350|1982633|FG003|Overall Study|Entry criteria not met|0
977901|NCT01247350|1982634|FG004|Overall Study|Entry criteria not met|1
977902|NCT01247922|1982702|FG000|Overall Study|Disease progression|4
977903|NCT01248013|1982715|FG000|Overall Study|Withdrawal by Subject|14
977904|NCT01248065|1982721|FG000|Overall Study|Lost to Follow-up|3
977905|NCT01248065|1982722|FG001|Overall Study|Lost to Follow-up|5
977906|NCT01248065|1982721|FG000|Overall Study|Withdrawal by Subject|14
977907|NCT01248065|1982722|FG001|Overall Study|Withdrawal by Subject|11
977908|NCT01248065|1982721|FG000|Overall Study|Adverse Event|3
977909|NCT01248065|1982722|FG001|Overall Study|Adverse Event|0
977910|NCT01248065|1982721|FG000|Overall Study|Third treatment failure event|3
977911|NCT01248065|1982722|FG001|Overall Study|Third treatment failure event|1
977912|NCT01248065|1982721|FG000|Overall Study|Other|3
977913|NCT01248065|1982722|FG001|Overall Study|Other|5
977914|NCT01248364|1982752|FG000|Overall Study|Adverse Event|0
977915|NCT01248364|1982753|FG001|Overall Study|Adverse Event|1
977916|NCT01248364|1982754|FG002|Overall Study|Adverse Event|0
977917|NCT01248364|1982755|FG003|Overall Study|Adverse Event|0
977918|NCT01248455|1982780|FG000|Overall Study|switched to alternate treatment|1
977919|NCT01248468|1982787|FG000|Overall Study|Administrative problem|1
977920|NCT01248468|1982788|FG001|Overall Study|Administrative problem|0
977921|NCT01248468|1982789|FG002|Overall Study|Administrative problem|0
977922|NCT01248468|1982787|FG000|Overall Study|Lost to Follow-up|9
977923|NCT01248468|1982788|FG001|Overall Study|Lost to Follow-up|12
977924|NCT01248468|1982789|FG002|Overall Study|Lost to Follow-up|4
977925|NCT01248468|1982787|FG000|Overall Study|Pregnancy|1
977926|NCT01248468|1982788|FG001|Overall Study|Pregnancy|0
977927|NCT01248468|1982789|FG002|Overall Study|Pregnancy|0
977928|NCT01248468|1982787|FG000|Overall Study|Withdrawal by Subject|4
977929|NCT01248468|1982788|FG001|Overall Study|Withdrawal by Subject|2
977930|NCT01248468|1982789|FG002|Overall Study|Withdrawal by Subject|0
977931|NCT01248715|1982808|FG000|Overall Study|Not influenza positive|501
977932|NCT01248715|1982809|FG001|Overall Study|Not influenza positive|510
977933|NCT01248728|1982817|FG000|Overall Study|Adverse Event|1
977934|NCT01248728|1982818|FG001|Overall Study|Adverse Event|1
977935|NCT01248728|1982817|FG000|Overall Study|Withdrawal by Subject|2
977936|NCT01248728|1982818|FG001|Overall Study|Withdrawal by Subject|1
977937|NCT01248728|1982817|FG000|Overall Study|Lack of Efficacy|1
977938|NCT01248728|1982818|FG001|Overall Study|Lack of Efficacy|0
977939|NCT01248780|1982832|FG000|Overall Study|Lack of Efficacy|2
977940|NCT01248780|1982833|FG001|Overall Study|Lack of Efficacy|0
977941|NCT01248780|1982832|FG000|Overall Study|Lost to Follow-up|0
977942|NCT01248780|1982833|FG001|Overall Study|Lost to Follow-up|1
977943|NCT01248780|1982832|FG000|Overall Study|Death|0
977944|NCT01248780|1982833|FG001|Overall Study|Death|1
977945|NCT01248780|1982832|FG000|Overall Study|Adverse Event|2
977946|NCT01248780|1982833|FG001|Overall Study|Adverse Event|7
977947|NCT01248780|1982832|FG000|Overall Study|Protocol Violation|1
977948|NCT01248780|1982833|FG001|Overall Study|Protocol Violation|1
977949|NCT01248780|1982832|FG000|Overall Study|Withdrawal by Subject|4
977950|NCT01248780|1982833|FG001|Overall Study|Withdrawal by Subject|4
977951|NCT01248780|1982832|FG000|Overall Study|Not treated|0
977952|NCT01248780|1982833|FG001|Overall Study|Not treated|1
977953|NCT01248793|1982841|FG000|Overall Study|Lost to Follow-up|0
977954|NCT01248793|1982842|FG001|Overall Study|Lost to Follow-up|1
977955|NCT01248793|1982841|FG000|Overall Study|Adverse Event|1
977956|NCT01248793|1982842|FG001|Overall Study|Adverse Event|1
977957|NCT01248793|1982841|FG000|Overall Study|Protocol Violation|0
977958|NCT01248793|1982842|FG001|Overall Study|Protocol Violation|1
977959|NCT01248793|1982841|FG000|Overall Study|Withdrawal by Subject|3
977960|NCT01248793|1982842|FG001|Overall Study|Withdrawal by Subject|3
977961|NCT01248884|1982851|FG000|Overall Study|Withdrawal by Subject|1
977962|NCT01248884|1982852|FG001|Overall Study|Withdrawal by Subject|3
977963|NCT01248884|1982853|FG002|Overall Study|Withdrawal by Subject|1
977964|NCT01248884|1982851|FG000|Overall Study|Adverse Event|1
977965|NCT01248884|1982852|FG001|Overall Study|Adverse Event|0
977966|NCT01248884|1982853|FG002|Overall Study|Adverse Event|0
977967|NCT01248936|1982863|FG000|Overall Study|Sponsor Decision|259
977968|NCT01248936|1982863|FG000|Overall Study|Progression of Disease|50
977969|NCT01248936|1982863|FG000|Overall Study|Death|26
977970|NCT01248936|1982863|FG000|Overall Study|Withdrawal of Consent|20
977971|NCT01248936|1982863|FG000|Overall Study|Adverse Event|8
977972|NCT01248936|1982863|FG000|Overall Study|Lost to Follow-up|7
977973|NCT01248936|1982863|FG000|Overall Study|Refused Treatment|1
977974|NCT01248936|1982863|FG000|Overall Study|Other reason|3
977975|NCT01248949|1982873|FG000|Overall Study|Lost to Follow-up|2
977976|NCT01248949|1982874|FG001|Overall Study|Lost to Follow-up|2
977977|NCT01248949|1982875|FG002|Overall Study|Lost to Follow-up|2
977978|NCT01248949|1982876|FG003|Overall Study|Lost to Follow-up|1
977979|NCT01248949|1982877|FG004|Overall Study|Lost to Follow-up|0
977980|NCT01248949|1982873|FG000|Overall Study|Withdrawal by Subject|5
977981|NCT01248949|1982874|FG001|Overall Study|Withdrawal by Subject|3
977982|NCT01248949|1982875|FG002|Overall Study|Withdrawal by Subject|11
977983|NCT01248949|1982876|FG003|Overall Study|Withdrawal by Subject|3
977984|NCT01248949|1982877|FG004|Overall Study|Withdrawal by Subject|1
977985|NCT01248949|1982873|FG000|Overall Study|Death|22
977986|NCT01248949|1982874|FG001|Overall Study|Death|7
977987|NCT01248949|1982875|FG002|Overall Study|Death|21
977988|NCT01248949|1982876|FG003|Overall Study|Death|6
977989|NCT01248949|1982877|FG004|Overall Study|Death|2
977990|NCT01248949|1982873|FG000|Overall Study|Alternative Therapy|1
977991|NCT01248949|1982874|FG001|Overall Study|Alternative Therapy|0
977992|NCT01248949|1982875|FG002|Overall Study|Alternative Therapy|0
977993|NCT01248949|1982876|FG003|Overall Study|Alternative Therapy|0
977994|NCT01248949|1982877|FG004|Overall Study|Alternative Therapy|0
977995|NCT01248949|1982873|FG000|Overall Study|Alternative Therapy.|1
977996|NCT01248949|1982874|FG001|Overall Study|Alternative Therapy.|0
977997|NCT01248949|1982875|FG002|Overall Study|Alternative Therapy.|0
977998|NCT01248949|1982876|FG003|Overall Study|Alternative Therapy.|0
977999|NCT01248949|1982877|FG004|Overall Study|Alternative Therapy.|0
978000|NCT01248949|1982873|FG000|Overall Study|Palliative Radiation To Brain Metastases|1
978001|NCT01248949|1982874|FG001|Overall Study|Palliative Radiation To Brain Metastases|0
978002|NCT01248949|1982875|FG002|Overall Study|Palliative Radiation To Brain Metastases|0
978003|NCT01248949|1982876|FG003|Overall Study|Palliative Radiation To Brain Metastases|0
978004|NCT01248949|1982877|FG004|Overall Study|Palliative Radiation To Brain Metastases|0
978005|NCT01248949|1982873|FG000|Overall Study|Entered Hospice And Refused Follow Up|0
978006|NCT01248949|1982874|FG001|Overall Study|Entered Hospice And Refused Follow Up|0
978007|NCT01248949|1982875|FG002|Overall Study|Entered Hospice And Refused Follow Up|0
978008|NCT01248949|1982876|FG003|Overall Study|Entered Hospice And Refused Follow Up|0
978009|NCT01248949|1982877|FG004|Overall Study|Entered Hospice And Refused Follow Up|1
978010|NCT01248949|1982873|FG000|Overall Study|Participant Went To Hospice|0
978011|NCT01248949|1982874|FG001|Overall Study|Participant Went To Hospice|0
978012|NCT01248949|1982875|FG002|Overall Study|Participant Went To Hospice|1
978013|NCT01248949|1982876|FG003|Overall Study|Participant Went To Hospice|0
978014|NCT01248949|1982877|FG004|Overall Study|Participant Went To Hospice|0
978015|NCT01248949|1982873|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1
978016|NCT01248949|1982874|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0
978017|NCT01248949|1982875|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0
978018|NCT01248949|1982876|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0
978019|NCT01248949|1982877|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0
978020|NCT01248949|1982873|FG000|Overall Study|Pi Decision Due To Declining Status|0
978021|NCT01248949|1982874|FG001|Overall Study|Pi Decision Due To Declining Status|0
978022|NCT01248949|1982875|FG002|Overall Study|Pi Decision Due To Declining Status|1
978023|NCT01248949|1982876|FG003|Overall Study|Pi Decision Due To Declining Status|0
978024|NCT01248949|1982877|FG004|Overall Study|Pi Decision Due To Declining Status|0
978025|NCT01248949|1982873|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0
978026|NCT01248949|1982874|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1
978027|NCT01248949|1982875|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0
978028|NCT01248949|1982876|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0
978029|NCT01248949|1982877|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0
978030|NCT01248949|1982873|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
978031|NCT01248949|1982874|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
978032|NCT01248949|1982875|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
978033|NCT01248949|1982876|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
978034|NCT01248949|1982877|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
978035|NCT01248962|1982891|FG000|Overall Study|Withdrawal by Subject|1
978036|NCT01248962|1982892|FG001|Overall Study|Withdrawal by Subject|1
978037|NCT01248962|1982891|FG000|Overall Study|Adverse Event|2
978038|NCT01248962|1982892|FG001|Overall Study|Adverse Event|1
978039|NCT01248962|1982891|FG000|Overall Study|Complete Response after 4 Cycles|1
978040|NCT01248962|1982892|FG001|Overall Study|Complete Response after 4 Cycles|0
978041|NCT01248962|1982891|FG000|Overall Study|Complete Response after 3 Cycles|0
978042|NCT01248962|1982892|FG001|Overall Study|Complete Response after 3 Cycles|1
978043|NCT01248962|1982891|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12
978044|NCT01248962|1982892|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13
978045|NCT01249092|1982903|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1
978046|NCT01249092|1982903|FG000|Overall Study|Unable to tolerate expected SE -nausea|1
978047|NCT01249118|1982909|FG000|First Washout Period|Physician Decision|0
978048|NCT01249118|1982910|FG001|First Washout Period|Physician Decision|1
978049|NCT01249118|1982911|FG002|First Washout Period|Physician Decision|0
978050|NCT01249131|1982918|FG000|Washout Period of 10 Days|Adverse Event|0
978051|NCT01249131|1982919|FG001|Washout Period of 10 Days|Adverse Event|0
978052|NCT01249131|1982920|FG002|Washout Period of 10 Days|Adverse Event|0
978053|NCT01249131|1982921|FG003|Washout Period of 10 Days|Adverse Event|0
978054|NCT01249131|1982922|FG004|Washout Period of 10 Days|Adverse Event|1
978055|NCT01249131|1982923|FG005|Washout Period of 10 Days|Adverse Event|0
978056|NCT01249261|1982933|FG000|Overall Study|Withdrawal by Subject|1
978057|NCT01249261|1982934|FG001|Overall Study|Withdrawal by Subject|0
978058|NCT01249274|1982942|FG000|Overall Study|Lost to Follow-up|3
978059|NCT01249274|1982943|FG001|Overall Study|Lost to Follow-up|4
978060|NCT01249274|1982942|FG000|Overall Study|Received inpatient substance treatment|1
978061|NCT01249274|1982943|FG001|Overall Study|Received inpatient substance treatment|2
978062|NCT01249365|1982951|FG000|Overall Study|Lost to Follow-up|1
978063|NCT01249404|1982958|FG000|Overall Study|Study treatment not received|0
978064|NCT01249404|1982959|FG001|Overall Study|Study treatment not received|1
978065|NCT01249404|1982960|FG002|Overall Study|Study treatment not received|2
978066|NCT01249404|1982958|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2
978067|NCT01249404|1982959|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0
978068|NCT01249404|1982960|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2
978069|NCT01249404|1982958|FG000|Overall Study|Adverse Event|2
978070|NCT01249404|1982959|FG001|Overall Study|Adverse Event|2
978071|NCT01249404|1982960|FG002|Overall Study|Adverse Event|2
978072|NCT01249404|1982958|FG000|Overall Study|Withdrawal by Subject|2
978073|NCT01249404|1982959|FG001|Overall Study|Withdrawal by Subject|2
978074|NCT01249404|1982960|FG002|Overall Study|Withdrawal by Subject|0
978075|NCT01249404|1982958|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1
978076|NCT01249404|1982959|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2
978077|NCT01249404|1982960|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1
978078|NCT01249404|1982958|FG000|Overall Study|Non compliance to visit schedule|0
978079|NCT01249404|1982959|FG001|Overall Study|Non compliance to visit schedule|1
978080|NCT01249404|1982960|FG002|Overall Study|Non compliance to visit schedule|0
978081|NCT01249417|1982971|FG000|Randomised Population|Study treatment not received|0
978082|NCT01249417|1982972|FG001|Randomised Population|Study treatment not received|0
978083|NCT01249417|1982973|FG002|Randomised Population|Study treatment not received|2
978084|NCT01249417|1982971|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1
978085|NCT01249417|1982972|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1
978086|NCT01249417|1982973|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2
978087|NCT01249417|1982971|FG000|Treatment Phase - ITT Population|Other|0
978088|NCT01249417|1982972|FG001|Treatment Phase - ITT Population|Other|0
978089|NCT01249417|1982973|FG002|Treatment Phase - ITT Population|Other|1
978090|NCT01249417|1982971|FG000|Treatment Phase - ITT Population|Adverse Event|0
978091|NCT01249417|1982972|FG001|Treatment Phase - ITT Population|Adverse Event|0
978092|NCT01249417|1982973|FG002|Treatment Phase - ITT Population|Adverse Event|1
978093|NCT01249417|1982971|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1
978094|NCT01249417|1982972|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3
978095|NCT01249417|1982973|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1
978096|NCT01249417|1982971|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0
978097|NCT01249417|1982972|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1
978098|NCT01249417|1982973|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1
978099|NCT01249651|1982990|FG000|Overall Study|Withdrawal by Subject|4
978100|NCT01249651|1982990|FG000|Overall Study|Adverse Event|1
978101|NCT01249651|1982990|FG000|Overall Study|Protocol Violation|1
978102|NCT01249651|1982990|FG000|Overall Study|Sponsor Decision|1
978103|NCT01249664|1982996|FG000|Overall Study|Withdrawal by Subject|5
978104|NCT01249664|1982997|FG001|Overall Study|Withdrawal by Subject|0
978105|NCT01249664|1982996|FG000|Overall Study|Adverse Event|1
978106|NCT01249664|1982997|FG001|Overall Study|Adverse Event|0
978107|NCT01249833|1983007|FG000|Overall Study|Lost to Follow-up|0
978108|NCT01249833|1983008|FG001|Overall Study|Lost to Follow-up|1
978109|NCT01250002|1983049|FG000|Overall Study|Change to open surgical procedure|4
978110|NCT01250002|1983050|FG001|Overall Study|Change to open surgical procedure|3
978111|NCT01250054|1983056|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1
978112|NCT01250054|1983057|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0
978113|NCT01250119|1983063|FG000|Diagnostic Phase|Failed to Produce a Test Results|69
978114|NCT01250119|1983064|FG001|Diagnostic Phase|Failed to Produce a Test Results|0
978115|NCT01250119|1983063|FG000|Diagnostic Phase|Participants Not Tested|44
978116|NCT01250119|1983064|FG001|Diagnostic Phase|Participants Not Tested|0
978117|NCT01250119|1983063|FG000|Treatment Phase|Progressive Disease|0
978118|NCT01250119|1983064|FG001|Treatment Phase|Progressive Disease|32
978119|NCT01250119|1983063|FG000|Treatment Phase|Death|0
978120|NCT01250119|1983064|FG001|Treatment Phase|Death|2
978121|NCT01250119|1983063|FG000|Treatment Phase|Withdrawal by Subject|0
978122|NCT01250119|1983064|FG001|Treatment Phase|Withdrawal by Subject|1
978123|NCT01250119|1983063|FG000|Treatment Phase|Adverse Event|0
978124|NCT01250119|1983064|FG001|Treatment Phase|Adverse Event|2
978125|NCT01250119|1983063|FG000|Treatment Phase|Unknown reason|0
978126|NCT01250119|1983064|FG001|Treatment Phase|Unknown reason|4
978127|NCT01250145|1983073|FG000|Overall Study|Adverse Event|2
978128|NCT01250145|1983074|FG001|Overall Study|Adverse Event|1
978129|NCT01250145|1983073|FG000|Overall Study|Withdrawal by Subject|0
978130|NCT01250145|1983074|FG001|Overall Study|Withdrawal by Subject|4
978131|NCT01250171|1983097|FG000|Overall Study|Administrative reasons|1
978132|NCT01250171|1983098|FG001|Overall Study|Administrative reasons|0
978133|NCT01250171|1983099|FG002|Overall Study|Administrative reasons|0
978134|NCT01250379|1983135|FG000|Overall Study|Death|141
978135|NCT01250379|1983136|FG001|Overall Study|Death|148
978136|NCT01250379|1983135|FG000|Overall Study|Withdrawal by Subject|32
978137|NCT01250379|1983136|FG001|Overall Study|Withdrawal by Subject|20
978138|NCT01250379|1983135|FG000|Overall Study|Physician Decision|11
978139|NCT01250379|1983136|FG001|Overall Study|Physician Decision|3
978140|NCT01250379|1983135|FG000|Overall Study|Protocol Violation|2
978141|NCT01250379|1983136|FG001|Overall Study|Protocol Violation|8
978142|NCT01250379|1983135|FG000|Overall Study|Lost to Follow-up|9
978143|NCT01250379|1983136|FG001|Overall Study|Lost to Follow-up|6
978144|NCT01250379|1983135|FG000|Overall Study|Adverse Event|5
978145|NCT01250379|1983136|FG001|Overall Study|Adverse Event|4
978146|NCT01250379|1983135|FG000|Overall Study|Other|0
978147|NCT01250379|1983136|FG001|Overall Study|Other|4
978148|NCT01250379|1983135|FG000|Overall Study|Participant noncompliance|2
978149|NCT01250379|1983136|FG001|Overall Study|Participant noncompliance|0
978150|NCT01250418|1983144|FG000|Overall Study|monitor data failure|1
978151|NCT01250418|1983145|FG001|Overall Study|monitor data failure|1
978152|NCT01250509|1983153|FG000|Overall Study|Lost to Follow-up|5
978153|NCT01250509|1983154|FG001|Overall Study|Lost to Follow-up|2
978154|NCT01250756|1983181|FG000|Infant Series|Withdrawal by Subject|4
978155|NCT01250756|1983182|FG001|Infant Series|Withdrawal by Subject|5
978156|NCT01250756|1983181|FG000|Infant Series|Randomized, Not Vaccinated|2
978157|NCT01250756|1983182|FG001|Infant Series|Randomized, Not Vaccinated|2
978158|NCT01250756|1983181|FG000|Infant Series|Other|22
978159|NCT01250756|1983182|FG001|Infant Series|Other|0
978160|NCT01250756|1983181|FG000|After Infant Series|Adverse Event|5
978161|NCT01250756|1983182|FG001|After Infant Series|Adverse Event|2
978162|NCT01250756|1983181|FG000|After Infant Series|Withdrawal by Subject|4
978163|NCT01250756|1983182|FG001|After Infant Series|Withdrawal by Subject|1
978164|NCT01250756|1983181|FG000|After Infant Series|Other|2
978165|NCT01250756|1983182|FG001|After Infant Series|Other|1
978166|NCT01250756|1983181|FG000|Toddler Dose|Adverse Event|0
978167|NCT01250756|1983182|FG001|Toddler Dose|Adverse Event|1
978168|NCT01250756|1983181|FG000|After Toddler Dose|Adverse Event|0
978169|NCT01250756|1983182|FG001|After Toddler Dose|Adverse Event|1
978170|NCT01250769|1983198|FG000|Overall Study|Withdrawal by Subject|0
978171|NCT01250769|1983199|FG001|Overall Study|Withdrawal by Subject|1
978172|NCT01250769|1983200|FG002|Overall Study|Withdrawal by Subject|1
978173|NCT01250769|1983201|FG003|Overall Study|Withdrawal by Subject|0
978174|NCT01250769|1983198|FG000|Overall Study|Adverse Event|0
978175|NCT01250769|1983199|FG001|Overall Study|Adverse Event|0
978176|NCT01250769|1983200|FG002|Overall Study|Adverse Event|1
978177|NCT01250769|1983201|FG003|Overall Study|Adverse Event|0
978178|NCT01250873|1983218|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
978179|NCT01250873|1983218|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
978181|NCT01250925|1983241|FG000|Overall Study|Lost to Follow-up|1
978182|NCT01250925|1983242|FG001|Overall Study|Lost to Follow-up|1
978183|NCT01250925|1983243|FG002|Overall Study|Lost to Follow-up|0
978184|NCT01250925|1983241|FG000|Overall Study|Withdrawal by Subject|2
978185|NCT01250925|1983242|FG001|Overall Study|Withdrawal by Subject|0
978186|NCT01250925|1983243|FG002|Overall Study|Withdrawal by Subject|0
978187|NCT01250925|1983241|FG000|Overall Study|Protocol Violation|2
978188|NCT01250925|1983242|FG001|Overall Study|Protocol Violation|0
978189|NCT01250925|1983243|FG002|Overall Study|Protocol Violation|0
978190|NCT01250925|1983241|FG000|Overall Study|Physician Decision|0
978191|NCT01250925|1983242|FG001|Overall Study|Physician Decision|2
978192|NCT01250925|1983243|FG002|Overall Study|Physician Decision|1
978193|NCT01250925|1983241|FG000|Overall Study|Adverse Event|0
978194|NCT01250925|1983242|FG001|Overall Study|Adverse Event|0
978195|NCT01250925|1983243|FG002|Overall Study|Adverse Event|1
978196|NCT01251146|1983280|FG000|Overall Study|Lost to Follow-up|3
978197|NCT01251146|1983281|FG001|Overall Study|Lost to Follow-up|10
978198|NCT01251276|1983289|FG000|Overall Study|Protocol Violation|1
978199|NCT01251276|1983290|FG001|Overall Study|Protocol Violation|0
978200|NCT01251276|1983289|FG000|Overall Study|Lost to Follow-up|0
978201|NCT01251276|1983290|FG001|Overall Study|Lost to Follow-up|1
978202|NCT01251354|1983325|FG000|Overall Study|Adverse Event|1
978203|NCT01251354|1983325|FG000|Overall Study|Investigator's Decision|1
978204|NCT01251354|1983325|FG000|Overall Study|Disease Progression|4
978205|NCT01251367|1983329|FG000|Overall Study|Protocol Violation|1
978206|NCT01251367|1983329|FG000|Overall Study|Lack of Efficacy|2
978207|NCT01251367|1983329|FG000|Overall Study|Adverse Event|19
978208|NCT01251367|1983329|FG000|Overall Study|Withdrawal by Subject|36
978209|NCT01251367|1983329|FG000|Overall Study|Lost to Follow-up|5
978210|NCT01251367|1983329|FG000|Overall Study|Subject Required Alternative Treatment|7
978211|NCT01251367|1983329|FG000|Overall Study|No Study Drug Available|1
978212|NCT01251367|1983329|FG000|Overall Study|Subject had Personal or Medical Issues|4
978213|NCT01251367|1983329|FG000|Overall Study|End of Study Visit Performed in Error|1
978214|NCT01251380|1983333|FG000|Overall Study|Other (Not otherwise specified)|12
978215|NCT01251380|1983333|FG000|Overall Study|Withdrawal by Subject|6
978216|NCT01251380|1983333|FG000|Overall Study|Lack of Efficacy|1
978217|NCT01251380|1983333|FG000|Overall Study|Adverse Event|1
978218|NCT01251380|1983333|FG000|Overall Study|Lost to Follow-up|2
978219|NCT01251614|1983386|FG000|Overall Study|Adverse Event|1
978220|NCT01251614|1983387|FG001|Overall Study|Adverse Event|0
978221|NCT01251614|1983388|FG002|Overall Study|Adverse Event|1
978222|NCT01251614|1983386|FG000|Overall Study|Lack of Efficacy|1
978223|NCT01251614|1983387|FG001|Overall Study|Lack of Efficacy|9
978224|NCT01251614|1983388|FG002|Overall Study|Lack of Efficacy|4
978225|NCT01251614|1983386|FG000|Overall Study|Clearing of Psoriatic Lesions|1
978226|NCT01251614|1983387|FG001|Overall Study|Clearing of Psoriatic Lesions|0
978227|NCT01251614|1983388|FG002|Overall Study|Clearing of Psoriatic Lesions|0
978228|NCT01251614|1983386|FG000|Overall Study|Pregnancy|0
978229|NCT01251614|1983387|FG001|Overall Study|Pregnancy|0
978230|NCT01251614|1983388|FG002|Overall Study|Pregnancy|2
978231|NCT01251614|1983386|FG000|Overall Study|Loss of Disease Control|0
978232|NCT01251614|1983387|FG001|Overall Study|Loss of Disease Control|1
978233|NCT01251614|1983388|FG002|Overall Study|Loss of Disease Control|0
978234|NCT01251614|1983386|FG000|Overall Study|Withdrawal by Subject|0
978235|NCT01251614|1983387|FG001|Overall Study|Withdrawal by Subject|2
978236|NCT01251614|1983388|FG002|Overall Study|Withdrawal by Subject|1
978237|NCT01251614|1983386|FG000|Overall Study|Lost to Follow-up|0
978238|NCT01251614|1983387|FG001|Overall Study|Lost to Follow-up|1
978239|NCT01251614|1983388|FG002|Overall Study|Lost to Follow-up|0
978240|NCT01251653|1983415|FG000|Overall Study|Progressive Disease|1
978241|NCT01251653|1983416|FG001|Overall Study|Progressive Disease|7
978242|NCT01251653|1983417|FG002|Overall Study|Progressive Disease|16
978243|NCT01251653|1983418|FG003|Overall Study|Progressive Disease|4
978244|NCT01251653|1983419|FG004|Overall Study|Progressive Disease|0
978245|NCT01251653|1983420|FG005|Overall Study|Progressive Disease|17
978246|NCT01251653|1983421|FG006|Overall Study|Progressive Disease|14
978247|NCT01251653|1983422|FG007|Overall Study|Progressive Disease|7
978248|NCT01251653|1983423|FG008|Overall Study|Progressive Disease|5
978249|NCT01251653|1983415|FG000|Overall Study|Dose-limiting toxicity|0
978250|NCT01251653|1983416|FG001|Overall Study|Dose-limiting toxicity|1
978251|NCT01251653|1983417|FG002|Overall Study|Dose-limiting toxicity|1
978252|NCT01251653|1983418|FG003|Overall Study|Dose-limiting toxicity|1
978253|NCT01251653|1983419|FG004|Overall Study|Dose-limiting toxicity|0
978254|NCT01251653|1983420|FG005|Overall Study|Dose-limiting toxicity|0
978255|NCT01251653|1983421|FG006|Overall Study|Dose-limiting toxicity|2
978256|NCT01251653|1983422|FG007|Overall Study|Dose-limiting toxicity|0
978257|NCT01251653|1983423|FG008|Overall Study|Dose-limiting toxicity|0
978258|NCT01251653|1983415|FG000|Overall Study|Adverse Event|1
978259|NCT01251653|1983416|FG001|Overall Study|Adverse Event|0
978260|NCT01251653|1983417|FG002|Overall Study|Adverse Event|2
978261|NCT01251653|1983418|FG003|Overall Study|Adverse Event|1
978262|NCT01251653|1983419|FG004|Overall Study|Adverse Event|1
978263|NCT01251653|1983420|FG005|Overall Study|Adverse Event|0
978264|NCT01251653|1983421|FG006|Overall Study|Adverse Event|2
978265|NCT01251653|1983422|FG007|Overall Study|Adverse Event|2
978266|NCT01251653|1983423|FG008|Overall Study|Adverse Event|1
978267|NCT01251653|1983415|FG000|Overall Study|Withdrawal by Subject|1
978268|NCT01251653|1983416|FG001|Overall Study|Withdrawal by Subject|0
978269|NCT01251653|1983417|FG002|Overall Study|Withdrawal by Subject|1
978270|NCT01251653|1983418|FG003|Overall Study|Withdrawal by Subject|0
978271|NCT01251653|1983419|FG004|Overall Study|Withdrawal by Subject|1
978272|NCT01251653|1983420|FG005|Overall Study|Withdrawal by Subject|1
978273|NCT01251653|1983421|FG006|Overall Study|Withdrawal by Subject|0
978274|NCT01251653|1983422|FG007|Overall Study|Withdrawal by Subject|1
978275|NCT01251653|1983423|FG008|Overall Study|Withdrawal by Subject|0
978276|NCT01251653|1983415|FG000|Overall Study|Other reason not mentioned above|0
978277|NCT01251653|1983416|FG001|Overall Study|Other reason not mentioned above|0
978278|NCT01251653|1983417|FG002|Overall Study|Other reason not mentioned above|0
978279|NCT01251653|1983418|FG003|Overall Study|Other reason not mentioned above|0
978280|NCT01251653|1983419|FG004|Overall Study|Other reason not mentioned above|0
978281|NCT01251653|1983420|FG005|Overall Study|Other reason not mentioned above|0
978282|NCT01251653|1983421|FG006|Overall Study|Other reason not mentioned above|0
978283|NCT01251653|1983422|FG007|Overall Study|Other reason not mentioned above|2
978284|NCT01251653|1983423|FG008|Overall Study|Other reason not mentioned above|0
978285|NCT01251744|1983461|FG000|Overall Study|Lost to Follow-up|1
978286|NCT01251744|1983462|FG001|Overall Study|Lost to Follow-up|0
978287|NCT01251770|1983494|FG000|Overall Study|Protocol Violation|13
978288|NCT01251770|1983495|FG001|Overall Study|Protocol Violation|7
978289|NCT01251861|1983503|FG000|Overall Study|Disease progression|6
978290|NCT01251861|1983504|FG001|Overall Study|Disease progression|6
978291|NCT01251861|1983503|FG000|Overall Study|Adverse Event|2
978292|NCT01251861|1983504|FG001|Overall Study|Adverse Event|17
978293|NCT01251861|1983503|FG000|Overall Study|Withdrawal by Subject|2
978294|NCT01251861|1983504|FG001|Overall Study|Withdrawal by Subject|2
978295|NCT01251861|1983503|FG000|Overall Study|Alternative therapy|1
978296|NCT01251861|1983504|FG001|Overall Study|Alternative therapy|0
978297|NCT01251861|1983503|FG000|Overall Study|Other complicating disease|0
978298|NCT01251861|1983504|FG001|Overall Study|Other complicating disease|1
978299|NCT01251861|1983503|FG000|Overall Study|Physician Decision|1
978300|NCT01251861|1983504|FG001|Overall Study|Physician Decision|0
978301|NCT01251861|1983503|FG000|Overall Study|Continued treatment beyond 18 cycles|1
978302|NCT01251861|1983504|FG001|Overall Study|Continued treatment beyond 18 cycles|0
978303|NCT01251861|1983503|FG000|Overall Study|Other|1
978304|NCT01251861|1983504|FG001|Overall Study|Other|0
978305|NCT01251861|1983503|FG000|Overall Study|Never started therapy|4
978306|NCT01251861|1983504|FG001|Overall Study|Never started therapy|1
978307|NCT01251861|1983503|FG000|Overall Study|Potential interaction of drugs|0
978308|NCT01251861|1983504|FG001|Overall Study|Potential interaction of drugs|1
978309|NCT01251887|1983513|FG000|Overall Study|Scheduling conflict|1
978310|NCT01251887|1983514|FG001|Overall Study|Scheduling conflict|2
978311|NCT01251887|1983515|FG002|Overall Study|Scheduling conflict|2
978312|NCT01251887|1983513|FG000|Overall Study|Physician Decision|0
978313|NCT01251887|1983514|FG001|Overall Study|Physician Decision|1
978314|NCT01251887|1983515|FG002|Overall Study|Physician Decision|0
978315|NCT01251965|1983526|FG000|Overall Study|Participant/physician decision|1
978316|NCT01251965|1983527|FG001|Overall Study|Participant/physician decision|2
978317|NCT01251965|1983528|FG002|Overall Study|Participant/physician decision|0
978318|NCT01251965|1983526|FG000|Overall Study|Death|0
978319|NCT01251965|1983527|FG001|Overall Study|Death|0
978320|NCT01251965|1983528|FG002|Overall Study|Death|11
978321|NCT01252095|1983548|FG000|Overall Study|Disease progression|1
978322|NCT01252095|1983549|FG001|Overall Study|Disease progression|0
978323|NCT01252134|1983555|FG000|Period 1, 8 Hours|Personal Reasons|0
978324|NCT01252134|1983556|FG001|Period 1, 8 Hours|Personal Reasons|1
978325|NCT01252134|1983557|FG002|Period 1, 8 Hours|Personal Reasons|1
978326|NCT01252134|1983558|FG003|Period 1, 8 Hours|Personal Reasons|0
978327|NCT01252134|1983559|FG004|Period 1, 8 Hours|Personal Reasons|0
978328|NCT01252134|1983560|FG005|Period 1, 8 Hours|Personal Reasons|0
978329|NCT01252186|1983575|FG000|Overall Study|Adverse Event|9
978330|NCT01252186|1983576|FG001|Overall Study|Adverse Event|6
978331|NCT01252186|1983577|FG002|Overall Study|Adverse Event|8
978332|NCT01252186|1983575|FG000|Overall Study|Withdrawal by Subject|2
978333|NCT01252186|1983576|FG001|Overall Study|Withdrawal by Subject|5
978334|NCT01252186|1983577|FG002|Overall Study|Withdrawal by Subject|2
978335|NCT01252186|1983575|FG000|Overall Study|Physician Decision|0
978336|NCT01252186|1983576|FG001|Overall Study|Physician Decision|0
978337|NCT01252186|1983577|FG002|Overall Study|Physician Decision|1
978338|NCT01252186|1983575|FG000|Overall Study|Non-compliance|0
978339|NCT01252186|1983576|FG001|Overall Study|Non-compliance|3
978340|NCT01252186|1983577|FG002|Overall Study|Non-compliance|4
978341|NCT01252186|1983575|FG000|Overall Study|Protocol Violation|0
978342|NCT01252186|1983576|FG001|Overall Study|Protocol Violation|0
978343|NCT01252186|1983577|FG002|Overall Study|Protocol Violation|1
978344|NCT01252186|1983575|FG000|Overall Study|Pregnancy|2
978345|NCT01252186|1983576|FG001|Overall Study|Pregnancy|2
978346|NCT01252186|1983577|FG002|Overall Study|Pregnancy|0
978347|NCT01252186|1983575|FG000|Overall Study|Sponsor Request|2
978348|NCT01252186|1983576|FG001|Overall Study|Sponsor Request|1
978349|NCT01252186|1983577|FG002|Overall Study|Sponsor Request|0
978350|NCT01252186|1983575|FG000|Overall Study|Lost to Follow-up|10
978351|NCT01252186|1983576|FG001|Overall Study|Lost to Follow-up|10
978352|NCT01252186|1983577|FG002|Overall Study|Lost to Follow-up|11
978353|NCT01252186|1983575|FG000|Overall Study|Other - Miscellaneous Reasons|5
978354|NCT01252186|1983576|FG001|Overall Study|Other - Miscellaneous Reasons|5
978355|NCT01252186|1983577|FG002|Overall Study|Other - Miscellaneous Reasons|7
978356|NCT01252238|1983588|FG000|Overall Study|Sponsor terminated study|4
978357|NCT01252238|1983589|FG001|Overall Study|Sponsor terminated study|4
978358|NCT01252238|1983590|FG002|Overall Study|Sponsor terminated study|4
978359|NCT01252251|1983601|FG000|Overall Study|Withdrawal by Subject|1
978360|NCT01252290|1983610|FG000|Overall Study|Withdrawal by Subject|1
978361|NCT01252355|1983617|FG000|Overall Study|Adverse Event|9
978362|NCT01252355|1983618|FG001|Overall Study|Adverse Event|17
978363|NCT01252355|1983619|FG002|Overall Study|Adverse Event|22
978364|NCT01252355|1983617|FG000|Overall Study|Lack of Efficacy|6
978365|NCT01252355|1983618|FG001|Overall Study|Lack of Efficacy|4
978366|NCT01252355|1983619|FG002|Overall Study|Lack of Efficacy|2
978367|NCT01252355|1983617|FG000|Overall Study|Lost to Follow-up|0
978368|NCT01252355|1983618|FG001|Overall Study|Lost to Follow-up|0
978369|NCT01252355|1983619|FG002|Overall Study|Lost to Follow-up|1
978370|NCT01252355|1983617|FG000|Overall Study|Poor Compliance to Protocol|1
978371|NCT01252355|1983618|FG001|Overall Study|Poor Compliance to Protocol|1
978372|NCT01252355|1983619|FG002|Overall Study|Poor Compliance to Protocol|1
978373|NCT01252355|1983617|FG000|Overall Study|Progressive Disease|2
978374|NCT01252355|1983618|FG001|Overall Study|Progressive Disease|0
978375|NCT01252355|1983619|FG002|Overall Study|Progressive Disease|0
978376|NCT01252355|1983617|FG000|Overall Study|Sponsor Early Termination of Study|149
978377|NCT01252355|1983618|FG001|Overall Study|Sponsor Early Termination of Study|149
978378|NCT01252355|1983619|FG002|Overall Study|Sponsor Early Termination of Study|146
978379|NCT01252355|1983617|FG000|Overall Study|Randomized but not Treated|2
978380|NCT01252355|1983618|FG001|Overall Study|Randomized but not Treated|0
978381|NCT01252355|1983619|FG002|Overall Study|Randomized but not Treated|0
978382|NCT01252355|1983617|FG000|Overall Study|Other Than Above|8
978383|NCT01252355|1983618|FG001|Overall Study|Other Than Above|7
978384|NCT01252355|1983619|FG002|Overall Study|Other Than Above|7
978385|NCT01252563|1983627|FG000|Overall Study|Contract Deviation|41
978386|NCT01252563|1983627|FG000|Overall Study|Centralized Registration Deviation|30
978387|NCT01252563|1983627|FG000|Overall Study|Lost to Follow-up|161
978388|NCT01252563|1983627|FG000|Overall Study|No visit after first day of treatment|194
978389|NCT01252563|1983627|FG000|Overall Study|No drug administration|6
978390|NCT01252667|1983668|FG000|Overall Study|Transplant aborted post-conditioning|0
978391|NCT01252667|1983669|FG001|Overall Study|Transplant aborted post-conditioning|0
978392|NCT01252667|1983670|FG002|Overall Study|Transplant aborted post-conditioning|0
978393|NCT01252667|1983671|FG003|Overall Study|Transplant aborted post-conditioning|0
978394|NCT01252667|1983672|FG004|Overall Study|Transplant aborted post-conditioning|0
978395|NCT01252667|1983673|FG005|Overall Study|Transplant aborted post-conditioning|1
978396|NCT01252810|1983714|FG000|Overall Study|Withdrawal by Subject|4
978397|NCT01252810|1983715|FG001|Overall Study|Withdrawal by Subject|1
978398|NCT01252810|1983714|FG000|Overall Study|Lost to Follow-up|0
978399|NCT01252810|1983715|FG001|Overall Study|Lost to Follow-up|1
978400|NCT01252810|1983714|FG000|Overall Study|Physician Decision|2
978401|NCT01252810|1983715|FG001|Overall Study|Physician Decision|1
978402|NCT01252810|1983714|FG000|Overall Study|Various reasons|8
978403|NCT01252810|1983715|FG001|Overall Study|Various reasons|0
978404|NCT01252940|1983723|FG000|Main Study Phase|Randomized but not treated|4
978405|NCT01252940|1983724|FG001|Main Study Phase|Randomized but not treated|2
978406|NCT01252940|1983723|FG000|Main Study Phase|Adverse Event|3
978407|NCT01252940|1983724|FG001|Main Study Phase|Adverse Event|1
978408|NCT01252940|1983723|FG000|Main Study Phase|Lack of Efficacy|1
978409|NCT01252940|1983724|FG001|Main Study Phase|Lack of Efficacy|0
978410|NCT01252940|1983723|FG000|Main Study Phase|Lost to Follow-up|6
978411|NCT01252940|1983724|FG001|Main Study Phase|Lost to Follow-up|1
978412|NCT01252940|1983723|FG000|Main Study Phase|Physician Decision|1
978413|NCT01252940|1983724|FG001|Main Study Phase|Physician Decision|0
978414|NCT01252940|1983723|FG000|Main Study Phase|Protocol Violation|4
978415|NCT01252940|1983724|FG001|Main Study Phase|Protocol Violation|2
978416|NCT01252940|1983723|FG000|Main Study Phase|Withdrawal by Subject|6
978417|NCT01252940|1983724|FG001|Main Study Phase|Withdrawal by Subject|5
978418|NCT01252940|1983723|FG000|Main Study Phase|Subject Non-compliance|1
978419|NCT01252940|1983724|FG001|Main Study Phase|Subject Non-compliance|1
978420|NCT01252940|1983723|FG000|Extension Phase|Adverse Event|2
978421|NCT01252940|1983724|FG001|Extension Phase|Adverse Event|1
978422|NCT01252940|1983723|FG000|Extension Phase|Lack of Efficacy|1
978423|NCT01252940|1983724|FG001|Extension Phase|Lack of Efficacy|0
978424|NCT01252940|1983723|FG000|Extension Phase|Lost to Follow-up|5
978425|NCT01252940|1983724|FG001|Extension Phase|Lost to Follow-up|0
978426|NCT01252940|1983723|FG000|Extension Phase|Physician Decision|0
978427|NCT01252940|1983724|FG001|Extension Phase|Physician Decision|1
978428|NCT01252940|1983723|FG000|Extension Phase|Subject Non-compliance|1
978429|NCT01252940|1983724|FG001|Extension Phase|Subject Non-compliance|0
978430|NCT01252940|1983723|FG000|Extension Phase|Withdrawal by Subject|1
978431|NCT01252940|1983724|FG001|Extension Phase|Withdrawal by Subject|1
978432|NCT01252953|1983733|FG000|Overall Study|Withdrawal by Subject|16
978433|NCT01252953|1983734|FG001|Overall Study|Withdrawal by Subject|17
978434|NCT01252953|1983733|FG000|Overall Study|Lost to Follow-up|22
978435|NCT01252953|1983734|FG001|Overall Study|Lost to Follow-up|21
978436|NCT01252966|1983743|FG000|Overall Study|Lost to Follow-up|16
978437|NCT01252966|1983744|FG001|Overall Study|Lost to Follow-up|10
978438|NCT01252966|1983743|FG000|Overall Study|Withdrawal by Subject|7
978439|NCT01252966|1983744|FG001|Overall Study|Withdrawal by Subject|3
978440|NCT01253018|1983754|FG000|Overall Study|Lost to Follow-up|1
978441|NCT01253018|1983755|FG001|Overall Study|Lost to Follow-up|1
978442|NCT01253018|1983754|FG000|Overall Study|Robot Repair Issues|2
978443|NCT01253018|1983755|FG001|Overall Study|Robot Repair Issues|0
978444|NCT01253018|1983754|FG000|Overall Study|Withdrawal by Subject|1
978445|NCT01253018|1983755|FG001|Overall Study|Withdrawal by Subject|1
978446|NCT01253044|1983764|FG000|Overall Study|Lost to Follow-up|38
978447|NCT01253044|1983765|FG001|Overall Study|Lost to Follow-up|29
978448|NCT01253135|1983776|FG000|Original Protocol|Protocol Amendment|15
978449|NCT01253135|1983776|FG000|Amended Protocol|Non-compliance|1
978450|NCT01253174|1983788|FG000|Period 1|Randomized but not treated|0
978451|NCT01253174|1983789|FG001|Period 1|Randomized but not treated|1
978452|NCT01253174|1983790|FG002|Period 1|Randomized but not treated|1
978453|NCT01253174|1983791|FG003|Period 1|Randomized but not treated|0
978454|NCT01253174|1983792|FG004|Period 1|Randomized but not treated|1
978455|NCT01253174|1983793|FG005|Period 1|Randomized but not treated|0
978456|NCT01253174|1983788|FG000|Period 2|Adverse Event|0
978457|NCT01253174|1983789|FG001|Period 2|Adverse Event|0
978458|NCT01253174|1983790|FG002|Period 2|Adverse Event|1
978459|NCT01253174|1983791|FG003|Period 2|Adverse Event|0
978460|NCT01253174|1983792|FG004|Period 2|Adverse Event|0
978461|NCT01253174|1983793|FG005|Period 2|Adverse Event|0
978462|NCT01253174|1983788|FG000|Period 3|Withdrawal by Subject|0
978463|NCT01253174|1983789|FG001|Period 3|Withdrawal by Subject|1
978464|NCT01253174|1983790|FG002|Period 3|Withdrawal by Subject|0
978465|NCT01253174|1983791|FG003|Period 3|Withdrawal by Subject|0
978466|NCT01253174|1983792|FG004|Period 3|Withdrawal by Subject|1
978467|NCT01253174|1983793|FG005|Period 3|Withdrawal by Subject|0
978468|NCT01253174|1983788|FG000|Period 3|Pregnancy|0
978469|NCT01253174|1983789|FG001|Period 3|Pregnancy|0
978470|NCT01253174|1983790|FG002|Period 3|Pregnancy|1
978471|NCT01253174|1983791|FG003|Period 3|Pregnancy|0
978472|NCT01253174|1983792|FG004|Period 3|Pregnancy|0
978473|NCT01253174|1983793|FG005|Period 3|Pregnancy|0
978474|NCT01253187|1983802|FG000|Period 2|Withdrawal by Subject|0
978475|NCT01253187|1983803|FG001|Period 2|Withdrawal by Subject|0
978476|NCT01253187|1983804|FG002|Period 2|Withdrawal by Subject|0
978477|NCT01253187|1983805|FG003|Period 2|Withdrawal by Subject|0
978478|NCT01253187|1983806|FG004|Period 2|Withdrawal by Subject|1
978479|NCT01253187|1983807|FG005|Period 2|Withdrawal by Subject|0
978480|NCT01253187|1983802|FG000|Period 3|Pregnancy|1
978481|NCT01253187|1983803|FG001|Period 3|Pregnancy|0
978482|NCT01253187|1983804|FG002|Period 3|Pregnancy|0
978483|NCT01253187|1983805|FG003|Period 3|Pregnancy|0
978484|NCT01253187|1983806|FG004|Period 3|Pregnancy|0
978485|NCT01253187|1983807|FG005|Period 3|Pregnancy|0
978486|NCT01253187|1983802|FG000|Period 3|difficulty with blood sampling|0
978487|NCT01253187|1983803|FG001|Period 3|difficulty with blood sampling|1
978488|NCT01253187|1983804|FG002|Period 3|difficulty with blood sampling|0
978489|NCT01253187|1983805|FG003|Period 3|difficulty with blood sampling|0
978490|NCT01253187|1983806|FG004|Period 3|difficulty with blood sampling|0
978491|NCT01253187|1983807|FG005|Period 3|difficulty with blood sampling|0
978492|NCT01253187|1983802|FG000|Period 3|non-compliance|0
978493|NCT01253187|1983803|FG001|Period 3|non-compliance|0
978494|NCT01253187|1983804|FG002|Period 3|non-compliance|0
978495|NCT01253187|1983805|FG003|Period 3|non-compliance|0
978496|NCT01253187|1983806|FG004|Period 3|non-compliance|1
978497|NCT01253187|1983807|FG005|Period 3|non-compliance|0
978498|NCT01253200|1983823|FG000|Overall Study|Death|1
978499|NCT01253200|1983824|FG001|Overall Study|Death|0
978500|NCT01253200|1983825|FG002|Overall Study|Death|0
978501|NCT01253200|1983826|FG003|Overall Study|Death|0
978502|NCT01253200|1983827|FG004|Overall Study|Death|0
978503|NCT01253200|1983823|FG000|Overall Study|Lost to Follow-up|1
978504|NCT01253200|1983824|FG001|Overall Study|Lost to Follow-up|1
978505|NCT01253200|1983825|FG002|Overall Study|Lost to Follow-up|0
978506|NCT01253200|1983826|FG003|Overall Study|Lost to Follow-up|0
978507|NCT01253200|1983827|FG004|Overall Study|Lost to Follow-up|0
978508|NCT01253200|1983823|FG000|Overall Study|Withdrawal by Subject|2
978509|NCT01253200|1983824|FG001|Overall Study|Withdrawal by Subject|0
978510|NCT01253200|1983825|FG002|Overall Study|Withdrawal by Subject|0
978511|NCT01253200|1983826|FG003|Overall Study|Withdrawal by Subject|0
978512|NCT01253200|1983827|FG004|Overall Study|Withdrawal by Subject|0
978513|NCT01253200|1983823|FG000|Overall Study|Protocol Violation|1
978514|NCT01253200|1983824|FG001|Overall Study|Protocol Violation|4
978515|NCT01253200|1983825|FG002|Overall Study|Protocol Violation|0
978516|NCT01253200|1983826|FG003|Overall Study|Protocol Violation|0
978517|NCT01253200|1983827|FG004|Overall Study|Protocol Violation|5
978518|NCT01253200|1983823|FG000|Overall Study|intents|10
978519|NCT01253200|1983824|FG001|Overall Study|intents|10
978520|NCT01253200|1983825|FG002|Overall Study|intents|1
978521|NCT01253200|1983826|FG003|Overall Study|intents|3
978522|NCT01253200|1983827|FG004|Overall Study|intents|0
978523|NCT01253200|1983823|FG000|Overall Study|Attempts|6
978524|NCT01253200|1983824|FG001|Overall Study|Attempts|4
978525|NCT01253200|1983825|FG002|Overall Study|Attempts|1
978526|NCT01253200|1983826|FG003|Overall Study|Attempts|2
978527|NCT01253200|1983827|FG004|Overall Study|Attempts|0
978528|NCT01253226|1983841|FG000|Overall Study|Adverse Event|0
978529|NCT01253226|1983842|FG001|Overall Study|Adverse Event|0
978530|NCT01253226|1983843|FG002|Overall Study|Adverse Event|1
978531|NCT01253226|1983844|FG003|Overall Study|Adverse Event|0
978532|NCT01253226|1983845|FG004|Overall Study|Adverse Event|0
978533|NCT01253226|1983841|FG000|Overall Study|Death|0
978534|NCT01253226|1983842|FG001|Overall Study|Death|1
978535|NCT01253226|1983843|FG002|Overall Study|Death|0
978536|NCT01253226|1983844|FG003|Overall Study|Death|0
978537|NCT01253226|1983845|FG004|Overall Study|Death|0
978538|NCT01253226|1983841|FG000|Overall Study|Physician Decision|0
978539|NCT01253226|1983842|FG001|Overall Study|Physician Decision|0
978540|NCT01253226|1983843|FG002|Overall Study|Physician Decision|0
978541|NCT01253226|1983844|FG003|Overall Study|Physician Decision|0
978542|NCT01253226|1983845|FG004|Overall Study|Physician Decision|2
978543|NCT01253226|1983841|FG000|Overall Study|Withdrawal by Subject|0
978544|NCT01253226|1983842|FG001|Overall Study|Withdrawal by Subject|0
978545|NCT01253226|1983843|FG002|Overall Study|Withdrawal by Subject|0
978546|NCT01253226|1983844|FG003|Overall Study|Withdrawal by Subject|1
978547|NCT01253226|1983845|FG004|Overall Study|Withdrawal by Subject|0
978548|NCT01253265|1983862|FG000|Overall Study|Met Predefined Discontinuation Criteria|1
978549|NCT01253265|1983863|FG001|Overall Study|Met Predefined Discontinuation Criteria|0
978550|NCT01253265|1983864|FG002|Overall Study|Met Predefined Discontinuation Criteria|0
978551|NCT01253265|1983865|FG003|Overall Study|Met Predefined Discontinuation Criteria|0
978552|NCT01253265|1983866|FG004|Overall Study|Met Predefined Discontinuation Criteria|0
978553|NCT01253265|1983862|FG000|Overall Study|Withdrawal by Subject|0
978554|NCT01253265|1983863|FG001|Overall Study|Withdrawal by Subject|0
978555|NCT01253265|1983864|FG002|Overall Study|Withdrawal by Subject|0
978556|NCT01253265|1983865|FG003|Overall Study|Withdrawal by Subject|0
978557|NCT01253265|1983866|FG004|Overall Study|Withdrawal by Subject|1
978558|NCT01253291|1983883|FG000|Overall Study|Withdrawal by Subject|1
978559|NCT01253291|1983884|FG001|Overall Study|Withdrawal by Subject|1
978560|NCT01253291|1983885|FG002|Overall Study|Withdrawal by Subject|0
978561|NCT01253291|1983886|FG003|Overall Study|Withdrawal by Subject|0
978562|NCT01253291|1983887|FG004|Overall Study|Withdrawal by Subject|0
978563|NCT01253291|1983883|FG000|Overall Study|Adverse Event|0
978564|NCT01253291|1983884|FG001|Overall Study|Adverse Event|1
978565|NCT01253291|1983885|FG002|Overall Study|Adverse Event|0
978566|NCT01253291|1983886|FG003|Overall Study|Adverse Event|0
978567|NCT01253291|1983887|FG004|Overall Study|Adverse Event|0
978568|NCT01253291|1983883|FG000|Overall Study|Lack of Efficacy|1
978569|NCT01253291|1983884|FG001|Overall Study|Lack of Efficacy|0
978570|NCT01253291|1983885|FG002|Overall Study|Lack of Efficacy|0
978571|NCT01253291|1983886|FG003|Overall Study|Lack of Efficacy|0
978572|NCT01253291|1983887|FG004|Overall Study|Lack of Efficacy|0
978573|NCT01253291|1983883|FG000|Overall Study|Physician Decision|2
978574|NCT01253291|1983884|FG001|Overall Study|Physician Decision|0
978575|NCT01253291|1983885|FG002|Overall Study|Physician Decision|0
978576|NCT01253291|1983886|FG003|Overall Study|Physician Decision|0
978577|NCT01253291|1983887|FG004|Overall Study|Physician Decision|2
978578|NCT01253304|1983904|FG000|Overall Study|Adverse Event|0
978579|NCT01253304|1983905|FG001|Overall Study|Adverse Event|0
978580|NCT01253304|1983906|FG002|Overall Study|Adverse Event|0
978581|NCT01253304|1983907|FG003|Overall Study|Adverse Event|1
978582|NCT01253317|1983917|FG000|Overall Study|Adverse Event|2
978583|NCT01253369|1983950|FG000|Overall Study|Adverse Event|4
978584|NCT01253369|1983950|FG000|Overall Study|Withdrawal by Subject|2
978585|NCT01253369|1983950|FG000|Overall Study|Death|1
978586|NCT01253369|1983950|FG000|Overall Study|Progressive disease|23
978587|NCT01253369|1983950|FG000|Overall Study|Not Evaluable|3
978588|NCT01253408|1983957|FG000|Overall Study|Adverse Event|0
978589|NCT01253408|1983958|FG001|Overall Study|Adverse Event|1
978590|NCT01253408|1983959|FG002|Overall Study|Adverse Event|0
978591|NCT01253421|1983971|FG000|Assessment and Scheduling|Found to be Ineligible|74
978592|NCT01253421|1983972|FG001|Assessment and Scheduling|Found to be Ineligible|0
978593|NCT01253421|1983973|FG002|Assessment and Scheduling|Found to be Ineligible|0
978594|NCT01253421|1983974|FG003|Assessment and Scheduling|Found to be Ineligible|0
978595|NCT01253421|1983975|FG004|Assessment and Scheduling|Found to be Ineligible|0
978596|NCT01253421|1983971|FG000|Assessment and Scheduling|Lost to Follow-up|17
978597|NCT01253421|1983972|FG001|Assessment and Scheduling|Lost to Follow-up|0
978598|NCT01253421|1983973|FG002|Assessment and Scheduling|Lost to Follow-up|0
978599|NCT01253421|1983974|FG003|Assessment and Scheduling|Lost to Follow-up|0
978600|NCT01253421|1983975|FG004|Assessment and Scheduling|Lost to Follow-up|0
978601|NCT01253421|1983971|FG000|Assessment and Scheduling|Withdrawal by Subject|7
978602|NCT01253421|1983972|FG001|Assessment and Scheduling|Withdrawal by Subject|0
978603|NCT01253421|1983973|FG002|Assessment and Scheduling|Withdrawal by Subject|0
978604|NCT01253421|1983974|FG003|Assessment and Scheduling|Withdrawal by Subject|0
978605|NCT01253421|1983975|FG004|Assessment and Scheduling|Withdrawal by Subject|0
978606|NCT01253421|1983971|FG000|Assessment and Scheduling|Physician Decision|1
978607|NCT01253421|1983972|FG001|Assessment and Scheduling|Physician Decision|0
978608|NCT01253421|1983973|FG002|Assessment and Scheduling|Physician Decision|0
978609|NCT01253421|1983974|FG003|Assessment and Scheduling|Physician Decision|0
978610|NCT01253421|1983975|FG004|Assessment and Scheduling|Physician Decision|0
978611|NCT01253421|1983971|FG000|Drug+Scanning Visit|Physician Decision|0
978612|NCT01253421|1983972|FG001|Drug+Scanning Visit|Physician Decision|0
978613|NCT01253421|1983973|FG002|Drug+Scanning Visit|Physician Decision|0
978614|NCT01253421|1983974|FG003|Drug+Scanning Visit|Physician Decision|0
978615|NCT01253421|1983975|FG004|Drug+Scanning Visit|Physician Decision|1
978616|NCT01253447|1983985|FG000|Overall Study|Adverse Event|2
978617|NCT01253564|1983998|FG000|Overall Study|Disease Progression|22
978618|NCT01253564|1983998|FG000|Overall Study|Withdrawal by Subject|1
978619|NCT01253564|1983998|FG000|Overall Study|Serious Adverse Event|1
978620|NCT01253577|1984002|FG000|Overall Study|Lost to Follow-up|3
978621|NCT01253811|1984013|FG000|Overall Study|Withdrawal criteria|1
978622|NCT01254019|1984050|FG000|Overall Study|Adverse Event|0
978623|NCT01254019|1984051|FG001|Overall Study|Adverse Event|2
978624|NCT01254019|1984050|FG000|Overall Study|Protocol Violation|1
978625|NCT01254019|1984051|FG001|Overall Study|Protocol Violation|0
978626|NCT01254019|1984050|FG000|Overall Study|Withdrawal by Subject|0
978627|NCT01254019|1984051|FG001|Overall Study|Withdrawal by Subject|2
978628|NCT01254045|1984060|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
978629|NCT01254045|1984061|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
978630|NCT01254045|1984062|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
978631|NCT01254045|1984063|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
978632|NCT01254045|1984064|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
978633|NCT01254045|1984065|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
978634|NCT01254188|1984075|FG000|Overall Study|Disease Progression|6
978635|NCT01254188|1984075|FG000|Overall Study|Protocol Violation|6
978636|NCT01254188|1984075|FG000|Overall Study|Pregnancy|2
978637|NCT01254188|1984075|FG000|Overall Study|Death|4
978638|NCT01254188|1984075|FG000|Overall Study|Lost to Follow-up|5
978639|NCT01254188|1984075|FG000|Overall Study|Withdrawal by Subject|7
978640|NCT01254188|1984075|FG000|Overall Study|Adverse Event|43
978641|NCT01254188|1984075|FG000|Overall Study|per investigator discretion|20
978642|NCT01254227|1984088|FG000|Overall Study|Withdrawal by Subject|6
978643|NCT01254227|1984088|FG000|Overall Study|Lost to Follow-up|6
978644|NCT01254227|1984088|FG000|Overall Study|Adverse Event|5
978645|NCT01254227|1984088|FG000|Overall Study|Abnormal test procedure result|5
978646|NCT01254227|1984088|FG000|Overall Study|Administrative problems|2
978647|NCT01254227|1984088|FG000|Overall Study|Death|1
978648|NCT01254227|1984088|FG000|Overall Study|Protocol deviation|1
978649|NCT01254292|1984094|FG000|Comparative Phase|Adverse Event|25
978650|NCT01254292|1984095|FG001|Comparative Phase|Adverse Event|25
978651|NCT01254292|1984094|FG000|Comparative Phase|Lost to Follow-up|3
978652|NCT01254292|1984095|FG001|Comparative Phase|Lost to Follow-up|21
978653|NCT01254292|1984094|FG000|Comparative Phase|Pregnancy|2
978654|NCT01254292|1984095|FG001|Comparative Phase|Pregnancy|6
978655|NCT01254292|1984094|FG000|Comparative Phase|Withdrawal by Subject|20
978656|NCT01254292|1984095|FG001|Comparative Phase|Withdrawal by Subject|21
978657|NCT01254292|1984094|FG000|Comparative Phase|Protocol Violation|1
978658|NCT01254292|1984095|FG001|Comparative Phase|Protocol Violation|2
978659|NCT01254292|1984094|FG000|Comparative Phase|Wish for pregnancy|4
978660|NCT01254292|1984095|FG001|Comparative Phase|Wish for pregnancy|6
978661|NCT01254292|1984094|FG000|LCS12 Extension Phase|Wish for pregnancy|14
978662|NCT01254292|1984095|FG001|LCS12 Extension Phase|Wish for pregnancy|0
978663|NCT01254292|1984094|FG000|LCS12 Extension Phase|Adverse Event|9
978664|NCT01254292|1984095|FG001|LCS12 Extension Phase|Adverse Event|0
978665|NCT01254292|1984094|FG000|LCS12 Extension Phase|Withdrawal by Subject|7
978666|NCT01254292|1984095|FG001|LCS12 Extension Phase|Withdrawal by Subject|0
978667|NCT01254292|1984094|FG000|LCS12 Extension Phase|Other unknown|4
978668|NCT01254292|1984095|FG001|LCS12 Extension Phase|Other unknown|0
978669|NCT01254292|1984094|FG000|LCS12 Extension Phase|Pregnancy|2
978670|NCT01254292|1984095|FG001|LCS12 Extension Phase|Pregnancy|0
978671|NCT01254292|1984094|FG000|LCS12 Extension Phase|Lost to Follow-up|1
978672|NCT01254292|1984095|FG001|LCS12 Extension Phase|Lost to Follow-up|0
978673|NCT01254305|1984105|FG000|Overall Study|Adverse Event|6
978674|NCT01254305|1984106|FG001|Overall Study|Adverse Event|3
978675|NCT01254305|1984107|FG002|Overall Study|Adverse Event|2
978676|NCT01254305|1984105|FG000|Overall Study|Lack of Efficacy|1
978677|NCT01254305|1984106|FG001|Overall Study|Lack of Efficacy|0
978678|NCT01254305|1984107|FG002|Overall Study|Lack of Efficacy|1
978679|NCT01254305|1984105|FG000|Overall Study|Protocol Violation|1
978680|NCT01254305|1984106|FG001|Overall Study|Protocol Violation|7
978681|NCT01254305|1984107|FG002|Overall Study|Protocol Violation|3
978682|NCT01254305|1984105|FG000|Overall Study|Withdrawal by Subject|4
978683|NCT01254305|1984106|FG001|Overall Study|Withdrawal by Subject|2
978684|NCT01254305|1984107|FG002|Overall Study|Withdrawal by Subject|4
978685|NCT01254305|1984105|FG000|Overall Study|Lost to Follow-up|10
978686|NCT01254305|1984106|FG001|Overall Study|Lost to Follow-up|6
978687|NCT01254305|1984107|FG002|Overall Study|Lost to Follow-up|5
978688|NCT01254305|1984105|FG000|Overall Study|Other Reasons|0
978689|NCT01254305|1984106|FG001|Overall Study|Other Reasons|0
978690|NCT01254305|1984107|FG002|Overall Study|Other Reasons|2
978691|NCT01254318|1984118|FG000|Overall Study|Lost to Follow-up|5
978692|NCT01254318|1984118|FG000|Overall Study|Death|47
978693|NCT01254331|1984122|FG000|Initial Phase|Adverse Event|3
978694|NCT01254331|1984122|FG000|Initial Phase|Withdrawal by Subject|1
978695|NCT01254331|1984122|FG000|Initial Phase|Pregnancy|1
978696|NCT01254331|1984122|FG000|Extension Phase|Lack of Efficacy|1
978697|NCT01254331|1984122|FG000|Extension Phase|Lost to Follow-up|3
978698|NCT01254344|1984128|FG000|Overall Study|Adverse Event|2
978699|NCT01254344|1984129|FG001|Overall Study|Adverse Event|5
978700|NCT01254344|1984128|FG000|Overall Study|Physician Decision|7
978701|NCT01254344|1984129|FG001|Overall Study|Physician Decision|4
978702|NCT01254344|1984128|FG000|Overall Study|Protocol Violation|1
978703|NCT01254344|1984129|FG001|Overall Study|Protocol Violation|4
978704|NCT01254344|1984128|FG000|Overall Study|Withdrawal by Subject|3
978705|NCT01254344|1984129|FG001|Overall Study|Withdrawal by Subject|6
978706|NCT01254409|1984146|FG000|Overall Study|Adverse Event|0
978707|NCT01254409|1984147|FG001|Overall Study|Adverse Event|1
978708|NCT01254409|1984148|FG002|Overall Study|Adverse Event|0
978709|NCT01254409|1984149|FG003|Overall Study|Adverse Event|0
978710|NCT01254422|1984164|FG000|Overall Study|Protocol Violation|1
978711|NCT01254422|1984165|FG001|Overall Study|Protocol Violation|0
978712|NCT01254422|1984164|FG000|Overall Study|Adverse Event|1
978713|NCT01254422|1984165|FG001|Overall Study|Adverse Event|0
978714|NCT01254422|1984164|FG000|Overall Study|Serious adverse event|0
978715|NCT01254422|1984165|FG001|Overall Study|Serious adverse event|1
978716|NCT01254422|1984164|FG000|Overall Study|Lost to Follow-up|1
978717|NCT01254422|1984165|FG001|Overall Study|Lost to Follow-up|0
978718|NCT01254565|1984185|FG000|Overall Study|Non-compliance to Study Procedures|0
978719|NCT01254565|1984186|FG001|Overall Study|Non-compliance to Study Procedures|0
978720|NCT01254565|1984187|FG002|Overall Study|Non-compliance to Study Procedures|0
978721|NCT01254565|1984188|FG003|Overall Study|Non-compliance to Study Procedures|0
978722|NCT01254565|1984189|FG004|Overall Study|Non-compliance to Study Procedures|1
978723|NCT01254565|1984190|FG005|Overall Study|Non-compliance to Study Procedures|0
978724|NCT01254565|1984185|FG000|Overall Study|Did not Receive Treatment|1
978725|NCT01254565|1984186|FG001|Overall Study|Did not Receive Treatment|1
978726|NCT01254565|1984187|FG002|Overall Study|Did not Receive Treatment|0
978727|NCT01254565|1984188|FG003|Overall Study|Did not Receive Treatment|0
978728|NCT01254565|1984189|FG004|Overall Study|Did not Receive Treatment|3
978729|NCT01254565|1984190|FG005|Overall Study|Did not Receive Treatment|4
978730|NCT01254565|1984185|FG000|Overall Study|Other|0
978731|NCT01254565|1984186|FG001|Overall Study|Other|0
978732|NCT01254565|1984187|FG002|Overall Study|Other|0
978733|NCT01254565|1984188|FG003|Overall Study|Other|1
978734|NCT01254565|1984189|FG004|Overall Study|Other|0
978735|NCT01254565|1984190|FG005|Overall Study|Other|0
978736|NCT01254604|1984206|FG000|Overall Study|Lost to Follow-up|1
978737|NCT01254604|1984207|FG001|Overall Study|Lost to Follow-up|1
978738|NCT01254604|1984206|FG000|Overall Study|Protocol Violation|2
978739|NCT01254604|1984207|FG001|Overall Study|Protocol Violation|2
978740|NCT01254604|1984206|FG000|Overall Study|Withdrawal by Subject|2
978741|NCT01254604|1984207|FG001|Overall Study|Withdrawal by Subject|4
978742|NCT01254604|1984206|FG000|Overall Study|Adverse Event|3
978743|NCT01254604|1984207|FG001|Overall Study|Adverse Event|2
978744|NCT01254630|1984217|FG000|Overall Study|Adverse Event|36
978745|NCT01254630|1984218|FG001|Overall Study|Adverse Event|15
978746|NCT01254630|1984219|FG002|Overall Study|Adverse Event|40
978747|NCT01254630|1984220|FG003|Overall Study|Adverse Event|8
978748|NCT01254630|1984217|FG000|Overall Study|Death|461
978749|NCT01254630|1984218|FG001|Overall Study|Death|151
978750|NCT01254630|1984219|FG002|Overall Study|Death|478
978751|NCT01254630|1984220|FG003|Overall Study|Death|139
978752|NCT01254630|1984217|FG000|Overall Study|Lost to Follow-up|80
978753|NCT01254630|1984218|FG001|Overall Study|Lost to Follow-up|26
978754|NCT01254630|1984219|FG002|Overall Study|Lost to Follow-up|89
978755|NCT01254630|1984220|FG003|Overall Study|Lost to Follow-up|32
978756|NCT01254630|1984217|FG000|Overall Study|Physician Decision|24
978757|NCT01254630|1984218|FG001|Overall Study|Physician Decision|8
978758|NCT01254630|1984219|FG002|Overall Study|Physician Decision|16
978759|NCT01254630|1984220|FG003|Overall Study|Physician Decision|7
978760|NCT01254630|1984217|FG000|Overall Study|Withdrawal by Subject|201
978761|NCT01254630|1984218|FG001|Overall Study|Withdrawal by Subject|94
978762|NCT01254630|1984219|FG002|Overall Study|Withdrawal by Subject|188
978763|NCT01254630|1984220|FG003|Overall Study|Withdrawal by Subject|89
978764|NCT01254630|1984217|FG000|Overall Study|Study terminated by sponsor|0
978765|NCT01254630|1984218|FG001|Overall Study|Study terminated by sponsor|994
978766|NCT01254630|1984219|FG002|Overall Study|Study terminated by sponsor|0
978767|NCT01254630|1984220|FG003|Overall Study|Study terminated by sponsor|1010
978768|NCT01254630|1984217|FG000|Overall Study|Status not recorded|0
978769|NCT01254630|1984218|FG001|Overall Study|Status not recorded|0
978770|NCT01254630|1984219|FG002|Overall Study|Status not recorded|1
978771|NCT01254630|1984220|FG003|Overall Study|Status not recorded|0
978772|NCT01254643|1984228|FG000|Overall Study|Withdrawal by Subject|1
978773|NCT01254656|1984235|FG000|Overall Study|Discontinued due to termination of study|40
978774|NCT01254656|1984236|FG001|Overall Study|Discontinued due to termination of study|39
978775|NCT01254656|1984237|FG002|Overall Study|Discontinued due to termination of study|13
978776|NCT01254656|1984235|FG000|Overall Study|Lack of Efficacy|3
978777|NCT01254656|1984236|FG001|Overall Study|Lack of Efficacy|0
978778|NCT01254656|1984237|FG002|Overall Study|Lack of Efficacy|0
978779|NCT01254656|1984235|FG000|Overall Study|Lost to Follow-up|1
978780|NCT01254656|1984236|FG001|Overall Study|Lost to Follow-up|0
978781|NCT01254656|1984237|FG002|Overall Study|Lost to Follow-up|2
978782|NCT01254656|1984235|FG000|Overall Study|Withdrawal by Subject|2
978783|NCT01254656|1984236|FG001|Overall Study|Withdrawal by Subject|2
978784|NCT01254656|1984237|FG002|Overall Study|Withdrawal by Subject|1
978785|NCT01254656|1984235|FG000|Overall Study|Pregnancy|0
978786|NCT01254656|1984236|FG001|Overall Study|Pregnancy|0
978787|NCT01254656|1984237|FG002|Overall Study|Pregnancy|2
978788|NCT01254656|1984235|FG000|Overall Study|Adverse Event|1
978789|NCT01254656|1984236|FG001|Overall Study|Adverse Event|1
978790|NCT01254656|1984237|FG002|Overall Study|Adverse Event|0
978791|NCT01254656|1984235|FG000|Overall Study|Death|0
978792|NCT01254656|1984236|FG001|Overall Study|Death|1
978793|NCT01254656|1984237|FG002|Overall Study|Death|0
978794|NCT01254669|1984247|FG000|Overall Study|Withdrawal by Subject|0
978795|NCT01254669|1984248|FG001|Overall Study|Withdrawal by Subject|1
978796|NCT01254669|1984247|FG000|Overall Study|time constraint|2
978797|NCT01254669|1984248|FG001|Overall Study|time constraint|2
978798|NCT01254669|1984247|FG000|Overall Study|called to clinic during intervention|1
978799|NCT01254669|1984248|FG001|Overall Study|called to clinic during intervention|1
978800|NCT01254721|1984258|FG000|Overall Study|Lost to Follow-up|0
978801|NCT01254721|1984259|FG001|Overall Study|Lost to Follow-up|4
978802|NCT01254721|1984258|FG000|Overall Study|Lack of Efficacy|4
978803|NCT01254721|1984259|FG001|Overall Study|Lack of Efficacy|2
978804|NCT01254721|1984258|FG000|Overall Study|Death|0
978805|NCT01254721|1984259|FG001|Overall Study|Death|1
978806|NCT01254721|1984258|FG000|Overall Study|technical problum|1
978807|NCT01254721|1984259|FG001|Overall Study|technical problum|0
978808|NCT01254721|1984258|FG000|Overall Study|Adverse Event|2
978809|NCT01254721|1984259|FG001|Overall Study|Adverse Event|3
978810|NCT01254721|1984258|FG000|Overall Study|Withdrawal by Subject|8
978811|NCT01254721|1984259|FG001|Overall Study|Withdrawal by Subject|11
978812|NCT01254721|1984258|FG000|Overall Study|Wrongly randomization|0
978813|NCT01254721|1984259|FG001|Overall Study|Wrongly randomization|1
978814|NCT01254747|1984269|FG000|Overall Study|Unacceptable subjective vision|0
978815|NCT01254747|1984270|FG001|Overall Study|Unacceptable subjective vision|0
978816|NCT01254747|1984271|FG002|Overall Study|Unacceptable subjective vision|0
978817|NCT01254747|1984272|FG003|Overall Study|Unacceptable subjective vision|2
978818|NCT01254747|1984269|FG000|Overall Study|Difficult removal handling|0
978819|NCT01254747|1984270|FG001|Overall Study|Difficult removal handling|0
978820|NCT01254747|1984271|FG002|Overall Study|Difficult removal handling|1
978821|NCT01254747|1984272|FG003|Overall Study|Difficult removal handling|0
978822|NCT01254747|1984269|FG000|Overall Study|Symptoms and problems|0
978823|NCT01254747|1984270|FG001|Overall Study|Symptoms and problems|2
978824|NCT01254747|1984271|FG002|Overall Study|Symptoms and problems|1
978825|NCT01254747|1984272|FG003|Overall Study|Symptoms and problems|0
978826|NCT01254747|1984269|FG000|Overall Study|Lost to Follow-up|0
978827|NCT01254747|1984270|FG001|Overall Study|Lost to Follow-up|0
978828|NCT01254747|1984271|FG002|Overall Study|Lost to Follow-up|1
978829|NCT01254747|1984272|FG003|Overall Study|Lost to Follow-up|0
978830|NCT01254747|1984269|FG000|Overall Study|Biomicroscopy|0
978831|NCT01254747|1984270|FG001|Overall Study|Biomicroscopy|0
978832|NCT01254747|1984271|FG002|Overall Study|Biomicroscopy|1
978833|NCT01254747|1984272|FG003|Overall Study|Biomicroscopy|0
978834|NCT01254747|1984269|FG000|Overall Study|Discomfort|0
978835|NCT01254747|1984270|FG001|Overall Study|Discomfort|4
978836|NCT01254747|1984271|FG002|Overall Study|Discomfort|0
978837|NCT01254747|1984272|FG003|Overall Study|Discomfort|0
978838|NCT01254890|1984314|FG000|Overall Study|Ineligible|0
978839|NCT01254890|1984315|FG001|Overall Study|Ineligible|3
978840|NCT01254890|1984314|FG000|Overall Study|Withdrawal by Subject|1
978841|NCT01254890|1984315|FG001|Overall Study|Withdrawal by Subject|2
978842|NCT01254890|1984314|FG000|Overall Study|Disease Progression|0
978843|NCT01254890|1984315|FG001|Overall Study|Disease Progression|5
978844|NCT01255163|1984326|FG000|Overall Study|Withdrawal by Subject|1
978845|NCT01255163|1984327|FG001|Overall Study|Withdrawal by Subject|0
978846|NCT01255163|1984326|FG000|Overall Study|Lost to Follow-up|2
978847|NCT01255163|1984327|FG001|Overall Study|Lost to Follow-up|0
978848|NCT01255163|1984326|FG000|Overall Study|Adverse Event|0
978849|NCT01255163|1984327|FG001|Overall Study|Adverse Event|2
978850|NCT01255163|1984326|FG000|Overall Study|AstraZeneca stopped support of the study|1
978851|NCT01255163|1984327|FG001|Overall Study|AstraZeneca stopped support of the study|3
978852|NCT01255306|1984337|FG000|Overall Study|Physician Decision|1
978853|NCT01255306|1984338|FG001|Overall Study|Physician Decision|1
978854|NCT01255423|1984349|FG000|Overall Study|Abnormal Laboratory value|3
978855|NCT01255423|1984350|FG001|Overall Study|Abnormal Laboratory value|2
978856|NCT01255423|1984349|FG000|Overall Study|Use of prohibited medications|0
978857|NCT01255423|1984350|FG001|Overall Study|Use of prohibited medications|1
978858|NCT01255436|1984358|FG000|Overall Study|Lost to Follow-up|178
978859|NCT01255436|1984359|FG001|Overall Study|Lost to Follow-up|191
978860|NCT01255436|1984358|FG000|Overall Study|Death, stroke, or MI|4
978861|NCT01255436|1984359|FG001|Overall Study|Death, stroke, or MI|3
978862|NCT01255592|1984372|FG000|Overall Study|Adverse Event|5
978863|NCT01255592|1984373|FG001|Overall Study|Adverse Event|0
978864|NCT01255592|1984372|FG000|Overall Study|Withdrawal by Subject|1
978865|NCT01255592|1984373|FG001|Overall Study|Withdrawal by Subject|0
978866|NCT01255592|1984372|FG000|Overall Study|Other|0
978867|NCT01255592|1984373|FG001|Overall Study|Other|1
978868|NCT01255631|1984382|FG000|Overall Study|poor enrollment, no data analyzed|9
978869|NCT01255631|1984383|FG001|Overall Study|poor enrollment, no data analyzed|6
978870|NCT01255670|1984391|FG000|Overall Study|Adverse Event|10
978871|NCT01255670|1984392|FG001|Overall Study|Adverse Event|10
978872|NCT01255670|1984391|FG000|Overall Study|Lost to Follow-up|16
978873|NCT01255670|1984392|FG001|Overall Study|Lost to Follow-up|10
978874|NCT01255722|1984401|FG000|Overall Study|Adverse Event|0
978875|NCT01255722|1984402|FG001|Overall Study|Adverse Event|1
978876|NCT01255722|1984403|FG002|Overall Study|Adverse Event|1
978877|NCT01255722|1984401|FG000|Overall Study|asymptomatic patient|1
978878|NCT01255722|1984402|FG001|Overall Study|asymptomatic patient|0
978879|NCT01255722|1984403|FG002|Overall Study|asymptomatic patient|0
978880|NCT01255722|1984401|FG000|Overall Study|beta-blocker contraindicated|2
978881|NCT01255722|1984402|FG001|Overall Study|beta-blocker contraindicated|0
978882|NCT01255722|1984403|FG002|Overall Study|beta-blocker contraindicated|0
978883|NCT01255761|1984414|FG000|Overall Study|Adverse Event|29
978884|NCT01255761|1984415|FG001|Overall Study|Adverse Event|43
978885|NCT01255761|1984414|FG000|Overall Study|Lack of Efficacy|86
978886|NCT01255761|1984415|FG001|Overall Study|Lack of Efficacy|74
978887|NCT01255761|1984414|FG000|Overall Study|Protocol Violation|9
978888|NCT01255761|1984415|FG001|Overall Study|Protocol Violation|5
978889|NCT01255761|1984414|FG000|Overall Study|Lost to Follow-up|10
978890|NCT01255761|1984415|FG001|Overall Study|Lost to Follow-up|8
978891|NCT01255761|1984414|FG000|Overall Study|Withdrawal by Subject|11
978892|NCT01255761|1984415|FG001|Overall Study|Withdrawal by Subject|27
978893|NCT01255761|1984414|FG000|Overall Study|Other Reasons|37
978894|NCT01255761|1984415|FG001|Overall Study|Other Reasons|18
978895|NCT01255787|1984425|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6
978896|NCT01255787|1984426|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2
978897|NCT01255787|1984427|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9
978898|NCT01255787|1984428|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9
978899|NCT01255787|1984425|FG000|Overall Study|Major Protocol Deviation|1
978900|NCT01255787|1984426|FG001|Overall Study|Major Protocol Deviation|1
978901|NCT01255787|1984427|FG002|Overall Study|Major Protocol Deviation|0
978902|NCT01255787|1984428|FG003|Overall Study|Major Protocol Deviation|4
978903|NCT01255787|1984425|FG000|Overall Study|Lost to Follow-up|1
978904|NCT01255787|1984426|FG001|Overall Study|Lost to Follow-up|2
978905|NCT01255787|1984427|FG002|Overall Study|Lost to Follow-up|4
978906|NCT01255787|1984428|FG003|Overall Study|Lost to Follow-up|2
978907|NCT01255787|1984425|FG000|Overall Study|Withdrawal of Consent|3
978908|NCT01255787|1984426|FG001|Overall Study|Withdrawal of Consent|9
978909|NCT01255787|1984427|FG002|Overall Study|Withdrawal of Consent|3
978910|NCT01255787|1984428|FG003|Overall Study|Withdrawal of Consent|4
978911|NCT01255787|1984425|FG000|Overall Study|Pregnancy|0
978912|NCT01255787|1984426|FG001|Overall Study|Pregnancy|0
978913|NCT01255787|1984427|FG002|Overall Study|Pregnancy|0
978914|NCT01255787|1984428|FG003|Overall Study|Pregnancy|1
978915|NCT01255787|1984425|FG000|Overall Study|Lack of Efficacy|2
978916|NCT01255787|1984426|FG001|Overall Study|Lack of Efficacy|2
978917|NCT01255787|1984427|FG002|Overall Study|Lack of Efficacy|2
978918|NCT01255787|1984428|FG003|Overall Study|Lack of Efficacy|2
978919|NCT01255787|1984425|FG000|Overall Study|Noncompliance with Study Drug|3
978920|NCT01255787|1984426|FG001|Overall Study|Noncompliance with Study Drug|1
978921|NCT01255787|1984427|FG002|Overall Study|Noncompliance with Study Drug|0
978922|NCT01255787|1984428|FG003|Overall Study|Noncompliance with Study Drug|0
978923|NCT01255904|1984469|FG000|Overall Study|Physician Decision|1
978924|NCT01255904|1984470|FG001|Overall Study|Physician Decision|4
978925|NCT01256008|1984479|FG000|Overall Study|Lost to Follow-up|6
978926|NCT01256008|1984480|FG001|Overall Study|Lost to Follow-up|4
978927|NCT01256008|1984481|FG002|Overall Study|Lost to Follow-up|11
978928|NCT01256008|1984479|FG000|Overall Study|Withdrawal by Subject|2
978929|NCT01256008|1984480|FG001|Overall Study|Withdrawal by Subject|3
978930|NCT01256008|1984481|FG002|Overall Study|Withdrawal by Subject|10
978931|NCT01256060|1984500|FG000|Overall Study|Lost to Follow-up|0
978932|NCT01256060|1984501|FG001|Overall Study|Lost to Follow-up|1
978933|NCT01256060|1984502|FG002|Overall Study|Lost to Follow-up|0
978934|NCT01256060|1984503|FG003|Overall Study|Lost to Follow-up|0
978935|NCT01256177|1984537|FG000|Overall Study|Withdrawal by Subject|23
978936|NCT01256177|1984538|FG001|Overall Study|Withdrawal by Subject|22
978937|NCT01256177|1984537|FG000|Overall Study|Lost to Follow-up|2
978938|NCT01256177|1984538|FG001|Overall Study|Lost to Follow-up|2
978939|NCT01256177|1984537|FG000|Overall Study|Adverse Event|8
978940|NCT01256177|1984538|FG001|Overall Study|Adverse Event|9
978941|NCT01256177|1984537|FG000|Overall Study|Severe Non-Compliance to Protocol|4
978942|NCT01256177|1984538|FG001|Overall Study|Severe Non-Compliance to Protocol|2
978943|NCT01256177|1984537|FG000|Overall Study|Condition under Investigation Worsened|1
978944|NCT01256177|1984538|FG001|Overall Study|Condition under Investigation Worsened|0
978945|NCT01256177|1984537|FG000|Overall Study|Lack of Efficacy|11
978946|NCT01256177|1984538|FG001|Overall Study|Lack of Efficacy|2
978947|NCT01256177|1984537|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1
978948|NCT01256177|1984538|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0
978949|NCT01256190|1984546|FG000|Overall Study|Lost to Follow-up|2
978950|NCT01256190|1984547|FG001|Overall Study|Lost to Follow-up|0
978951|NCT01256294|1984553|FG000|Overall Study|Adverse Event|1
978952|NCT01256294|1984554|FG001|Overall Study|Adverse Event|0
978953|NCT01256294|1984553|FG000|Overall Study|Withdrawal by Subject|1
978954|NCT01256294|1984554|FG001|Overall Study|Withdrawal by Subject|1
978955|NCT01256294|1984553|FG000|Overall Study|Protocol deviation|2
978956|NCT01256294|1984554|FG001|Overall Study|Protocol deviation|1
978957|NCT01256385|1984562|FG000|Overall Study|Physician Decision|1
978958|NCT01256385|1984563|FG001|Overall Study|Physician Decision|1
978959|NCT01256385|1984562|FG000|Overall Study|Withdrawal by Subject|2
978960|NCT01256385|1984563|FG001|Overall Study|Withdrawal by Subject|2
978961|NCT01256398|1984569|FG000|Overall Study|Withdrawal by Subject|1
978962|NCT01256411|1984577|FG000|Extension by Maximum Treatment|Protocol deviation|0
978963|NCT01256411|1984578|FG001|Extension by Maximum Treatment|Protocol deviation|0
978964|NCT01256411|1984579|FG002|Extension by Maximum Treatment|Protocol deviation|1
978965|NCT01256411|1984580|FG003|Extension by Maximum Treatment|Protocol deviation|0
978966|NCT01256411|1984581|FG004|Extension by Maximum Treatment|Protocol deviation|0
978967|NCT01256411|1984582|FG005|Extension by Maximum Treatment|Protocol deviation|0
978968|NCT01256411|1984577|FG000|Extension by Maximum Treatment|Lost to Follow-up|1
978969|NCT01256411|1984578|FG001|Extension by Maximum Treatment|Lost to Follow-up|2
978970|NCT01256411|1984579|FG002|Extension by Maximum Treatment|Lost to Follow-up|0
978971|NCT01256411|1984580|FG003|Extension by Maximum Treatment|Lost to Follow-up|0
978972|NCT01256411|1984581|FG004|Extension by Maximum Treatment|Lost to Follow-up|0
978973|NCT01256411|1984582|FG005|Extension by Maximum Treatment|Lost to Follow-up|0
978974|NCT01256411|1984577|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1
978975|NCT01256411|1984578|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6
978976|NCT01256411|1984579|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1
978977|NCT01256411|1984580|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0
978978|NCT01256411|1984581|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0
978979|NCT01256411|1984582|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0
978980|NCT01256411|1984577|FG000|Extension by Maximum Treatment|Lack of Efficacy|1
978981|NCT01256411|1984578|FG001|Extension by Maximum Treatment|Lack of Efficacy|0
978982|NCT01256411|1984579|FG002|Extension by Maximum Treatment|Lack of Efficacy|1
978983|NCT01256411|1984580|FG003|Extension by Maximum Treatment|Lack of Efficacy|0
978984|NCT01256411|1984581|FG004|Extension by Maximum Treatment|Lack of Efficacy|0
978985|NCT01256411|1984582|FG005|Extension by Maximum Treatment|Lack of Efficacy|0
978986|NCT01256411|1984577|FG000|Extension by Maximum Treatment|Adverse Event|4
978987|NCT01256411|1984578|FG001|Extension by Maximum Treatment|Adverse Event|2
978988|NCT01256411|1984579|FG002|Extension by Maximum Treatment|Adverse Event|1
978989|NCT01256411|1984580|FG003|Extension by Maximum Treatment|Adverse Event|0
978990|NCT01256411|1984581|FG004|Extension by Maximum Treatment|Adverse Event|0
978991|NCT01256411|1984582|FG005|Extension by Maximum Treatment|Adverse Event|0
978992|NCT01256411|1984577|FG000|Extension by Mono or Combination Therapy|Adverse Event|0
978993|NCT01256411|1984578|FG001|Extension by Mono or Combination Therapy|Adverse Event|0
978994|NCT01256411|1984579|FG002|Extension by Mono or Combination Therapy|Adverse Event|0
978995|NCT01256411|1984580|FG003|Extension by Mono or Combination Therapy|Adverse Event|0
978996|NCT01256411|1984581|FG004|Extension by Mono or Combination Therapy|Adverse Event|6
978997|NCT01256411|1984582|FG005|Extension by Mono or Combination Therapy|Adverse Event|1
978998|NCT01256411|1984577|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0
978999|NCT01256411|1984578|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0
1006637|NCT01468987|2025356|FG001|Overall Study|Death|1
979000|NCT01256411|1984579|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0
979001|NCT01256411|1984580|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0
979002|NCT01256411|1984581|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0
979003|NCT01256411|1984582|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1
979004|NCT01256411|1984577|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0
979005|NCT01256411|1984578|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0
979006|NCT01256411|1984579|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0
979007|NCT01256411|1984580|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0
979008|NCT01256411|1984581|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3
979009|NCT01256411|1984582|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0
979010|NCT01256411|1984577|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
979011|NCT01256411|1984578|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
979012|NCT01256411|1984579|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
979013|NCT01256411|1984580|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
979014|NCT01256411|1984581|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
979015|NCT01256411|1984582|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
979016|NCT01256411|1984577|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0
979017|NCT01256411|1984578|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0
979018|NCT01256411|1984579|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0
979019|NCT01256411|1984580|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0
979020|NCT01256411|1984581|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1
979021|NCT01256411|1984582|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1
979022|NCT01256450|1984616|FG000|Open-label Titration|Adverse Event|39
979023|NCT01256450|1984617|FG001|Open-label Titration|Adverse Event|0
979024|NCT01256450|1984618|FG002|Open-label Titration|Adverse Event|0
979025|NCT01256450|1984616|FG000|Open-label Titration|Lost to Follow-up|7
979026|NCT01256450|1984617|FG001|Open-label Titration|Lost to Follow-up|0
979027|NCT01256450|1984618|FG002|Open-label Titration|Lost to Follow-up|0
979028|NCT01256450|1984616|FG000|Open-label Titration|Lack of analgesic effect|30
979029|NCT01256450|1984617|FG001|Open-label Titration|Lack of analgesic effect|0
979030|NCT01256450|1984618|FG002|Open-label Titration|Lack of analgesic effect|0
979031|NCT01256450|1984616|FG000|Open-label Titration|Non-compliance|9
979032|NCT01256450|1984617|FG001|Open-label Titration|Non-compliance|0
979033|NCT01256450|1984618|FG002|Open-label Titration|Non-compliance|0
979034|NCT01256450|1984616|FG000|Open-label Titration|Screen failure|1
979035|NCT01256450|1984617|FG001|Open-label Titration|Screen failure|0
979036|NCT01256450|1984618|FG002|Open-label Titration|Screen failure|0
979037|NCT01256450|1984616|FG000|Open-label Titration|Other|13
979038|NCT01256450|1984617|FG001|Open-label Titration|Other|0
979039|NCT01256450|1984618|FG002|Open-label Titration|Other|0
979040|NCT01256450|1984616|FG000|Double-blind Treatment|Adverse Event|0
979041|NCT01256450|1984617|FG001|Double-blind Treatment|Adverse Event|8
979042|NCT01256450|1984618|FG002|Double-blind Treatment|Adverse Event|6
979043|NCT01256450|1984616|FG000|Double-blind Treatment|Lost to Follow-up|0
979044|NCT01256450|1984617|FG001|Double-blind Treatment|Lost to Follow-up|1
979045|NCT01256450|1984618|FG002|Double-blind Treatment|Lost to Follow-up|7
979046|NCT01256450|1984616|FG000|Double-blind Treatment|Withdrawal by Subject|0
979047|NCT01256450|1984617|FG001|Double-blind Treatment|Withdrawal by Subject|0
979048|NCT01256450|1984618|FG002|Double-blind Treatment|Withdrawal by Subject|1
979049|NCT01256450|1984616|FG000|Double-blind Treatment|Lack of analgesic effect|0
979050|NCT01256450|1984617|FG001|Double-blind Treatment|Lack of analgesic effect|5
979051|NCT01256450|1984618|FG002|Double-blind Treatment|Lack of analgesic effect|6
979052|NCT01256450|1984616|FG000|Double-blind Treatment|Non-compliance|0
979053|NCT01256450|1984617|FG001|Double-blind Treatment|Non-compliance|5
979054|NCT01256450|1984618|FG002|Double-blind Treatment|Non-compliance|4
979055|NCT01256450|1984616|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0
979056|NCT01256450|1984617|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0
979057|NCT01256450|1984618|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1
979058|NCT01256450|1984616|FG000|Double-blind Treatment|Other|0
979059|NCT01256450|1984617|FG001|Double-blind Treatment|Other|9
979060|NCT01256450|1984618|FG002|Double-blind Treatment|Other|12
979061|NCT01256476|1984627|FG000|Overall Study|Adverse Event|2
979062|NCT01256476|1984628|FG001|Overall Study|Adverse Event|1
979063|NCT01256476|1984627|FG000|Overall Study|Withdrawal by Subject|2
979064|NCT01256476|1984628|FG001|Overall Study|Withdrawal by Subject|1
979065|NCT01256476|1984627|FG000|Overall Study|Lost to Follow-up|1
979066|NCT01256476|1984628|FG001|Overall Study|Lost to Follow-up|2
979067|NCT01256476|1984627|FG000|Overall Study|Persistent ALT or AST elevation|1
979068|NCT01256476|1984628|FG001|Overall Study|Persistent ALT or AST elevation|0
979069|NCT01256476|1984627|FG000|Overall Study|Physician Decision|0
979070|NCT01256476|1984628|FG001|Overall Study|Physician Decision|1
979071|NCT01256476|1984627|FG000|Overall Study|Subject non-compliance|0
979072|NCT01256476|1984628|FG001|Overall Study|Subject non-compliance|1
979073|NCT01256476|1984627|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
979074|NCT01256476|1984628|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
979075|NCT01256502|1984634|FG000|Overall Study|Had scaffold removed|4
979076|NCT01256502|1984634|FG000|Overall Study|Personal reasons|5
979077|NCT01256502|1984634|FG000|Overall Study|Protocol deviation|1
979078|NCT01256567|1984643|FG000|Overall Study|Withdrawal by Subject|1
979079|NCT01256593|1984648|FG000|Overall Study|Protocol Violation|26
979080|NCT01256593|1984648|FG000|Overall Study|No Drug Administration Information|2
979081|NCT01256593|1984648|FG000|Overall Study|No Visit After Treatment|186
979082|NCT01256658|1984654|FG000|Period 1|Lost to Follow-up|837
979083|NCT01256658|1984655|FG001|Period 1|Lost to Follow-up|661
979084|NCT01256658|1984654|FG000|Period 1|Withdrawal by Subject|35
979085|NCT01256658|1984655|FG001|Period 1|Withdrawal by Subject|43
979086|NCT01256658|1984654|FG000|Period 1|Death|48
979087|NCT01256658|1984655|FG001|Period 1|Death|44
979088|NCT01256671|1984664|FG000|Overall Study|Adverse Event|29
979089|NCT01256671|1984664|FG000|Overall Study|Lost to Follow-up|16
979090|NCT01256671|1984664|FG000|Overall Study|Withdrawal by Subject|31
979091|NCT01256671|1984664|FG000|Overall Study|Physician Decision|3
979092|NCT01256671|1984664|FG000|Overall Study|Lack of Efficacy|4
979093|NCT01256671|1984664|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12
979094|NCT01256684|1984671|FG000|Overall Study|Adverse Event|1
979095|NCT01256684|1984672|FG001|Overall Study|Adverse Event|4
979096|NCT01256684|1984673|FG002|Overall Study|Adverse Event|2
979097|NCT01256684|1984671|FG000|Overall Study|Withdrawal by Subject|4
979098|NCT01256684|1984672|FG001|Overall Study|Withdrawal by Subject|0
979099|NCT01256684|1984673|FG002|Overall Study|Withdrawal by Subject|2
979100|NCT01256684|1984671|FG000|Overall Study|Physician Decision|0
979101|NCT01256684|1984672|FG001|Overall Study|Physician Decision|1
979102|NCT01256684|1984673|FG002|Overall Study|Physician Decision|0
979103|NCT01256684|1984671|FG000|Overall Study|Lack of Efficacy|0
979104|NCT01256684|1984672|FG001|Overall Study|Lack of Efficacy|1
979105|NCT01256684|1984673|FG002|Overall Study|Lack of Efficacy|1
979106|NCT01256684|1984671|FG000|Overall Study|Entry criteria not met/non-compliance|4
979107|NCT01256684|1984672|FG001|Overall Study|Entry criteria not met/non-compliance|7
979108|NCT01256684|1984673|FG002|Overall Study|Entry criteria not met/non-compliance|6
979109|NCT01256788|1984684|FG000|Overall Study|Lost to Follow-up|5
979110|NCT01256788|1984685|FG001|Overall Study|Lost to Follow-up|8
979111|NCT01256788|1984686|FG002|Overall Study|Lost to Follow-up|3
979112|NCT01256879|1984707|FG000|Overall Study|Withdrawal by Subject|1
979113|NCT01257204|1984762|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0
979114|NCT01257204|1984763|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1
979115|NCT01257204|1984764|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3
979116|NCT01257204|1984762|FG000|Treatment Period (up to Week 24)|Adverse Event|3
979117|NCT01257204|1984763|FG001|Treatment Period (up to Week 24)|Adverse Event|1
979118|NCT01257204|1984764|FG002|Treatment Period (up to Week 24)|Adverse Event|2
979119|NCT01257204|1984762|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1
979120|NCT01257204|1984763|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0
979121|NCT01257204|1984764|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1
979122|NCT01257204|1984762|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0
979123|NCT01257204|1984763|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2
979124|NCT01257204|1984764|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0
979125|NCT01257204|1984762|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
979126|NCT01257204|1984763|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
979127|NCT01257204|1984764|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
979128|NCT01257204|1984762|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1
979129|NCT01257204|1984763|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2
979130|NCT01257204|1984764|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2
979131|NCT01257204|1984762|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
979132|NCT01257204|1984763|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
979133|NCT01257204|1984764|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
979134|NCT01257204|1984762|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1
979135|NCT01257204|1984763|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4
979136|NCT01257204|1984764|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4
979137|NCT01257204|1984762|FG000|Follow-up Period (up to Week 48)|Other|0
979138|NCT01257204|1984763|FG001|Follow-up Period (up to Week 48)|Other|0
979139|NCT01257204|1984764|FG002|Follow-up Period (up to Week 48)|Other|5
979140|NCT01257230|1984800|FG000|Overall Study|Not Treated|0
979141|NCT01257230|1984801|FG001|Overall Study|Not Treated|0
979142|NCT01257230|1984802|FG002|Overall Study|Not Treated|1
979143|NCT01257230|1984800|FG000|Overall Study|Adverse Event|2
979144|NCT01257230|1984801|FG001|Overall Study|Adverse Event|0
979145|NCT01257230|1984802|FG002|Overall Study|Adverse Event|0
979146|NCT01257230|1984800|FG000|Overall Study|Lack of Efficacy|0
979147|NCT01257230|1984801|FG001|Overall Study|Lack of Efficacy|1
979148|NCT01257230|1984802|FG002|Overall Study|Lack of Efficacy|0
979149|NCT01257230|1984800|FG000|Overall Study|Protocol Violation|3
979150|NCT01257230|1984801|FG001|Overall Study|Protocol Violation|0
979151|NCT01257230|1984802|FG002|Overall Study|Protocol Violation|1
979152|NCT01257230|1984800|FG000|Overall Study|Withdrawal by Subject|0
979153|NCT01257230|1984801|FG001|Overall Study|Withdrawal by Subject|4
979154|NCT01257230|1984802|FG002|Overall Study|Withdrawal by Subject|1
979155|NCT01257230|1984800|FG000|Overall Study|Other reason not defined above|1
979156|NCT01257230|1984801|FG001|Overall Study|Other reason not defined above|5
979157|NCT01257230|1984802|FG002|Overall Study|Other reason not defined above|3
979158|NCT01257425|1984833|FG000|Overall Study|Lack of Efficacy|3
979159|NCT01257425|1984834|FG001|Overall Study|Lack of Efficacy|3
979160|NCT01257425|1984833|FG000|Overall Study|Adverse Event|1
979161|NCT01257425|1984834|FG001|Overall Study|Adverse Event|1
979162|NCT01257425|1984833|FG000|Overall Study|Protocol Violation|1
979163|NCT01257425|1984834|FG001|Overall Study|Protocol Violation|1
979164|NCT01257425|1984833|FG000|Overall Study|Withdrawal by Subject|0
979165|NCT01257425|1984834|FG001|Overall Study|Withdrawal by Subject|1
979166|NCT01257425|1984833|FG000|Overall Study|Death|1
979167|NCT01257425|1984834|FG001|Overall Study|Death|0
979168|NCT01257503|1984851|FG000|Overall Study|Lost to Follow-up|7
979169|NCT01257503|1984852|FG001|Overall Study|Lost to Follow-up|10
979170|NCT01257503|1984851|FG000|Overall Study|Over 5 years old at enrollment|0
979171|NCT01257503|1984852|FG001|Overall Study|Over 5 years old at enrollment|1
979172|NCT01257503|1984851|FG000|Overall Study|strep culture positive at enrollment|1
979173|NCT01257503|1984852|FG001|Overall Study|strep culture positive at enrollment|0
979174|NCT01257542|1984860|FG000|Overall Study|Protocol Violation|3
979175|NCT01257542|1984861|FG001|Overall Study|Protocol Violation|5
979176|NCT01257542|1984860|FG000|Overall Study|Withdrawal by Subject|0
979177|NCT01257542|1984861|FG001|Overall Study|Withdrawal by Subject|2
979178|NCT01257568|1984867|FG000|Overall Study|Lost to Follow-up|2
979179|NCT01257568|1984867|FG000|Overall Study|Withdrawal by Subject|6
979180|NCT01257568|1984867|FG000|Overall Study|Terminated|1
979181|NCT01257568|1984867|FG000|Overall Study|Component Revision|24
979182|NCT01257581|1984876|FG000|Overall Study|Early Termination|3
979183|NCT01257581|1984877|FG001|Overall Study|Early Termination|1
979184|NCT01257581|1984878|FG002|Overall Study|Early Termination|2
979185|NCT01257581|1984876|FG000|Overall Study|Death|2
979186|NCT01257581|1984877|FG001|Overall Study|Death|2
979187|NCT01257581|1984878|FG002|Overall Study|Death|4
979188|NCT01257698|1984888|FG000|Overall Study|Protocol Violation|4
979189|NCT01257698|1984889|FG001|Overall Study|Protocol Violation|0
979190|NCT01257737|1984897|FG000|Overall Study|Lost to Follow-up|1
979191|NCT01257737|1984898|FG001|Overall Study|Lost to Follow-up|2
979192|NCT01257737|1984897|FG000|Overall Study|Liver transplant|1
979193|NCT01257737|1984898|FG001|Overall Study|Liver transplant|0
979194|NCT01257737|1984897|FG000|Overall Study|Relocation out of the country|0
979195|NCT01257737|1984898|FG001|Overall Study|Relocation out of the country|1
979196|NCT01257737|1984897|FG000|Overall Study|Withdrew from study|0
979197|NCT01257737|1984898|FG001|Overall Study|Withdrew from study|1
979198|NCT01258075|1984940|FG000|Overall Study|Adverse Event|8
979199|NCT01258075|1984941|FG001|Overall Study|Adverse Event|3
979200|NCT01258075|1984940|FG000|Overall Study|Lost to Follow-up|11
979201|NCT01258075|1984941|FG001|Overall Study|Lost to Follow-up|6
979202|NCT01258075|1984940|FG000|Overall Study|Withdrawal by Subject|10
979203|NCT01258075|1984941|FG001|Overall Study|Withdrawal by Subject|7
979204|NCT01258075|1984940|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1
979205|NCT01258075|1984941|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2
979206|NCT01258075|1984940|FG000|Overall Study|Other|12
979207|NCT01258075|1984941|FG001|Overall Study|Other|5
979208|NCT01258101|1984951|FG000|Overall Study|Adverse Event|5
979209|NCT01258101|1984952|FG001|Overall Study|Adverse Event|6
979210|NCT01258101|1984953|FG002|Overall Study|Adverse Event|0
979211|NCT01258101|1984954|FG003|Overall Study|Adverse Event|0
979212|NCT01258101|1984951|FG000|Overall Study|Extra exclusion criterion amended|2
979213|NCT01258101|1984952|FG001|Overall Study|Extra exclusion criterion amended|1
979214|NCT01258101|1984953|FG002|Overall Study|Extra exclusion criterion amended|1
979215|NCT01258101|1984954|FG003|Overall Study|Extra exclusion criterion amended|1
979216|NCT01258101|1984951|FG000|Overall Study|Informed consent has been withdrawn|2
979217|NCT01258101|1984952|FG001|Overall Study|Informed consent has been withdrawn|2
979218|NCT01258101|1984953|FG002|Overall Study|Informed consent has been withdrawn|1
979219|NCT01258101|1984954|FG003|Overall Study|Informed consent has been withdrawn|1
979220|NCT01258101|1984951|FG000|Overall Study|Patient is not able to attend visits|8
979221|NCT01258101|1984952|FG001|Overall Study|Patient is not able to attend visits|9
979222|NCT01258101|1984953|FG002|Overall Study|Patient is not able to attend visits|7
979223|NCT01258101|1984954|FG003|Overall Study|Patient is not able to attend visits|6
979224|NCT01258101|1984951|FG000|Overall Study|Patient´s compliance|4
979225|NCT01258101|1984952|FG001|Overall Study|Patient´s compliance|3
979226|NCT01258101|1984953|FG002|Overall Study|Patient´s compliance|1
979227|NCT01258101|1984954|FG003|Overall Study|Patient´s compliance|2
979228|NCT01258101|1984951|FG000|Overall Study|Lost to Follow-up|5
979229|NCT01258101|1984952|FG001|Overall Study|Lost to Follow-up|5
979230|NCT01258101|1984953|FG002|Overall Study|Lost to Follow-up|0
979231|NCT01258101|1984954|FG003|Overall Study|Lost to Follow-up|6
979232|NCT01258101|1984951|FG000|Overall Study|PCR positive at week 24|0
979233|NCT01258101|1984952|FG001|Overall Study|PCR positive at week 24|0
979234|NCT01258101|1984953|FG002|Overall Study|PCR positive at week 24|0
979235|NCT01258101|1984954|FG003|Overall Study|PCR positive at week 24|1
979236|NCT01258101|1984951|FG000|Overall Study|Other reason|7
979237|NCT01258101|1984952|FG001|Overall Study|Other reason|8
979238|NCT01258101|1984953|FG002|Overall Study|Other reason|1
979239|NCT01258101|1984954|FG003|Overall Study|Other reason|8
979240|NCT01258348|1984979|FG000|Overall Study|Adverse Event|1
979241|NCT01258348|1984980|FG001|Overall Study|Adverse Event|1
979242|NCT01258348|1984981|FG002|Overall Study|Adverse Event|3
979243|NCT01258348|1984982|FG003|Overall Study|Adverse Event|2
979244|NCT01258348|1984983|FG004|Overall Study|Adverse Event|4
979245|NCT01258348|1984979|FG000|Overall Study|Progressive Disease|0
979246|NCT01258348|1984980|FG001|Overall Study|Progressive Disease|3
979247|NCT01258348|1984981|FG002|Overall Study|Progressive Disease|0
979248|NCT01258348|1984982|FG003|Overall Study|Progressive Disease|2
979249|NCT01258348|1984983|FG004|Overall Study|Progressive Disease|2
979250|NCT01258348|1984979|FG000|Overall Study|Physician Decision|0
979251|NCT01258348|1984980|FG001|Overall Study|Physician Decision|0
979252|NCT01258348|1984981|FG002|Overall Study|Physician Decision|0
979253|NCT01258348|1984982|FG003|Overall Study|Physician Decision|2
979254|NCT01258348|1984983|FG004|Overall Study|Physician Decision|0
979255|NCT01258348|1984979|FG000|Overall Study|Withdrawal by Subject|0
979256|NCT01258348|1984980|FG001|Overall Study|Withdrawal by Subject|1
979257|NCT01258348|1984981|FG002|Overall Study|Withdrawal by Subject|0
979258|NCT01258348|1984982|FG003|Overall Study|Withdrawal by Subject|0
979259|NCT01258348|1984983|FG004|Overall Study|Withdrawal by Subject|0
979260|NCT01258595|1985054|FG000|Overall Study|Lost to Follow-up|1
979261|NCT01258595|1985055|FG001|Overall Study|Lost to Follow-up|0
979262|NCT01258595|1985054|FG000|Overall Study|Withdrawal by Subject|0
979263|NCT01258595|1985055|FG001|Overall Study|Withdrawal by Subject|1
979264|NCT01258608|1985063|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1
979265|NCT01258608|1985064|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0
979266|NCT01258608|1985063|FG000|Overall Study|Clinical progression|1
979267|NCT01258608|1985064|FG001|Overall Study|Clinical progression|0
979268|NCT01258608|1985063|FG000|Overall Study|Sponsor decision|0
979269|NCT01258608|1985064|FG001|Overall Study|Sponsor decision|1
979270|NCT01258608|1985063|FG000|Overall Study|Physician Decision|6
979271|NCT01258608|1985064|FG001|Overall Study|Physician Decision|1
979272|NCT01258608|1985063|FG000|Overall Study|Lost to Follow-up|0
979273|NCT01258608|1985064|FG001|Overall Study|Lost to Follow-up|1
979274|NCT01258608|1985063|FG000|Overall Study|Lack of compliance|1
979275|NCT01258608|1985064|FG001|Overall Study|Lack of compliance|0
979276|NCT01258608|1985063|FG000|Overall Study|Lack of Efficacy|0
979277|NCT01258608|1985064|FG001|Overall Study|Lack of Efficacy|1
979278|NCT01258608|1985063|FG000|Overall Study|Adverse Event|6
979279|NCT01258608|1985064|FG001|Overall Study|Adverse Event|10
979280|NCT01258608|1985063|FG000|Overall Study|Withdrawal by Subject|6
979281|NCT01258608|1985064|FG001|Overall Study|Withdrawal by Subject|5
979282|NCT01258660|1985073|FG000|Overall Study|Adverse Event|2
979283|NCT01258660|1985074|FG001|Overall Study|Adverse Event|4
979284|NCT01258660|1985073|FG000|Overall Study|Withdrawal by Subject|3
979285|NCT01258660|1985074|FG001|Overall Study|Withdrawal by Subject|0
979286|NCT01258660|1985073|FG000|Overall Study|due to relocation|2
979287|NCT01258660|1985074|FG001|Overall Study|due to relocation|0
979288|NCT01258660|1985073|FG000|Overall Study|Protocol Violation|0
979289|NCT01258660|1985074|FG001|Overall Study|Protocol Violation|1
979290|NCT01258660|1985073|FG000|Overall Study|Invalid for primary analysis data set|4
979291|NCT01258660|1985074|FG001|Overall Study|Invalid for primary analysis data set|6
979292|NCT01258738|1985083|FG000|Double-blind Period|Did not meet inclusion criteria|3
979293|NCT01258738|1985084|FG001|Double-blind Period|Did not meet inclusion criteria|3
979294|NCT01258738|1985083|FG000|Double-blind Period|Withdrawal by Subject|2
979295|NCT01258738|1985084|FG001|Double-blind Period|Withdrawal by Subject|2
979296|NCT01258738|1985083|FG000|Double-blind Period|Protocol Violation|1
979297|NCT01258738|1985084|FG001|Double-blind Period|Protocol Violation|1
979298|NCT01258738|1985083|FG000|Double-blind Period|Adverse Event|3
979299|NCT01258738|1985084|FG001|Double-blind Period|Adverse Event|1
979300|NCT01258738|1985083|FG000|Open-label Period|Did not meet inclusion criteria|0
979301|NCT01258738|1985084|FG001|Open-label Period|Did not meet inclusion criteria|1
979302|NCT01258738|1985083|FG000|Open-label Period|Insufficient clinical response|5
979303|NCT01258738|1985084|FG001|Open-label Period|Insufficient clinical response|3
979304|NCT01258738|1985083|FG000|Open-label Period|Lost to Follow-up|0
979305|NCT01258738|1985084|FG001|Open-label Period|Lost to Follow-up|2
979306|NCT01258738|1985083|FG000|Open-label Period|Withdrawal by Subject|5
979307|NCT01258738|1985084|FG001|Open-label Period|Withdrawal by Subject|6
979308|NCT01258738|1985083|FG000|Open-label Period|Protocol Violation|2
979309|NCT01258738|1985084|FG001|Open-label Period|Protocol Violation|2
979310|NCT01258738|1985083|FG000|Open-label Period|Adverse Event|4
979311|NCT01258738|1985084|FG001|Open-label Period|Adverse Event|5
979312|NCT01258738|1985083|FG000|Open-label Period|Other Reasons|0
979313|NCT01258738|1985084|FG001|Open-label Period|Other Reasons|1
979314|NCT01258738|1985083|FG000|Open-label Period|Withdrawn due to pregnancy|1
979315|NCT01258738|1985084|FG001|Open-label Period|Withdrawn due to pregnancy|1
979316|NCT01258803|1985099|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1
979317|NCT01258803|1985100|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1
979318|NCT01258803|1985101|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0
979319|NCT01258803|1985102|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0
979320|NCT01258803|1985103|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0
979321|NCT01258803|1985104|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1
979322|NCT01258803|1985099|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
979323|NCT01258803|1985100|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
979324|NCT01258803|1985101|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
979325|NCT01258803|1985102|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
979326|NCT01258803|1985103|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
979327|NCT01258803|1985104|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
979328|NCT01258803|1985099|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0
979329|NCT01258803|1985100|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0
979330|NCT01258803|1985101|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1
979331|NCT01258803|1985102|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0
979332|NCT01258803|1985103|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0
979333|NCT01258803|1985104|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0
979334|NCT01258998|1985136|FG000|Overall Study|Ineligible|1
979335|NCT01259089|1985155|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0
979336|NCT01259089|1985156|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0
979337|NCT01259089|1985157|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0
979338|NCT01259089|1985158|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0
979339|NCT01259089|1985159|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0
979340|NCT01259089|1985160|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1
979341|NCT01259089|1985155|FG000|Reached First Response at 4 Weeks|Adverse Event|0
979342|NCT01259089|1985156|FG001|Reached First Response at 4 Weeks|Adverse Event|0
979343|NCT01259089|1985157|FG002|Reached First Response at 4 Weeks|Adverse Event|0
979344|NCT01259089|1985158|FG003|Reached First Response at 4 Weeks|Adverse Event|0
979345|NCT01259089|1985159|FG004|Reached First Response at 4 Weeks|Adverse Event|0
979346|NCT01259089|1985160|FG005|Reached First Response at 4 Weeks|Adverse Event|1
979347|NCT01259089|1985155|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
979348|NCT01259089|1985156|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
979349|NCT01259089|1985157|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
979350|NCT01259089|1985158|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
979351|NCT01259089|1985159|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
979352|NCT01259089|1985160|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
979353|NCT01259089|1985155|FG000|Confirmed Response at 8 Weeks|Adverse Event|0
979354|NCT01259089|1985156|FG001|Confirmed Response at 8 Weeks|Adverse Event|0
979355|NCT01259089|1985157|FG002|Confirmed Response at 8 Weeks|Adverse Event|0
979356|NCT01259089|1985158|FG003|Confirmed Response at 8 Weeks|Adverse Event|0
979357|NCT01259089|1985159|FG004|Confirmed Response at 8 Weeks|Adverse Event|1
979358|NCT01259089|1985160|FG005|Confirmed Response at 8 Weeks|Adverse Event|2
979359|NCT01259089|1985155|FG000|Confirmed Response at 8 Weeks|Progressive disease|0
979360|NCT01259089|1985156|FG001|Confirmed Response at 8 Weeks|Progressive disease|0
979361|NCT01259089|1985157|FG002|Confirmed Response at 8 Weeks|Progressive disease|1
979362|NCT01259089|1985158|FG003|Confirmed Response at 8 Weeks|Progressive disease|1
979363|NCT01259089|1985159|FG004|Confirmed Response at 8 Weeks|Progressive disease|3
979364|NCT01259089|1985160|FG005|Confirmed Response at 8 Weeks|Progressive disease|7
979365|NCT01259089|1985155|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
979366|NCT01259089|1985156|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
979367|NCT01259089|1985157|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
979368|NCT01259089|1985158|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
979369|NCT01259089|1985159|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
979370|NCT01259089|1985160|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
979371|NCT01259089|1985155|FG000|Continued Treatment After 8 Weeks|Adverse Event|0
979372|NCT01259089|1985156|FG001|Continued Treatment After 8 Weeks|Adverse Event|0
979373|NCT01259089|1985157|FG002|Continued Treatment After 8 Weeks|Adverse Event|0
979374|NCT01259089|1985158|FG003|Continued Treatment After 8 Weeks|Adverse Event|0
979375|NCT01259089|1985159|FG004|Continued Treatment After 8 Weeks|Adverse Event|2
979376|NCT01259089|1985160|FG005|Continued Treatment After 8 Weeks|Adverse Event|1
979377|NCT01259089|1985155|FG000|Continued Treatment After 8 Weeks|Progressive disease|1
979378|NCT01259089|1985156|FG001|Continued Treatment After 8 Weeks|Progressive disease|1
979379|NCT01259089|1985157|FG002|Continued Treatment After 8 Weeks|Progressive disease|1
979380|NCT01259089|1985158|FG003|Continued Treatment After 8 Weeks|Progressive disease|1
979381|NCT01259089|1985159|FG004|Continued Treatment After 8 Weeks|Progressive disease|0
979382|NCT01259089|1985160|FG005|Continued Treatment After 8 Weeks|Progressive disease|0
979383|NCT01259089|1985155|FG000|Survival Follow up for Two Years|Death|3
979384|NCT01259089|1985156|FG001|Survival Follow up for Two Years|Death|2
979385|NCT01259089|1985157|FG002|Survival Follow up for Two Years|Death|2
979386|NCT01259089|1985158|FG003|Survival Follow up for Two Years|Death|3
979387|NCT01259089|1985159|FG004|Survival Follow up for Two Years|Death|6
979388|NCT01259089|1985160|FG005|Survival Follow up for Two Years|Death|13
979389|NCT01259089|1985155|FG000|Survival Follow up for Two Years|Lost to Follow-up|0
979390|NCT01259089|1985156|FG001|Survival Follow up for Two Years|Lost to Follow-up|0
979391|NCT01259089|1985157|FG002|Survival Follow up for Two Years|Lost to Follow-up|0
979392|NCT01259089|1985158|FG003|Survival Follow up for Two Years|Lost to Follow-up|0
979393|NCT01259089|1985159|FG004|Survival Follow up for Two Years|Lost to Follow-up|0
979394|NCT01259089|1985160|FG005|Survival Follow up for Two Years|Lost to Follow-up|2
979395|NCT01259089|1985155|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0
979396|NCT01259089|1985156|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0
979397|NCT01259089|1985157|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0
979398|NCT01259089|1985158|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0
979399|NCT01259089|1985159|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0
979400|NCT01259089|1985160|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4
979401|NCT01259102|1985179|FG000|Overall Study|Adverse Event|1
979402|NCT01259102|1985180|FG001|Overall Study|Adverse Event|0
979403|NCT01259102|1985181|FG002|Overall Study|Adverse Event|1
979404|NCT01259102|1985182|FG003|Overall Study|Adverse Event|1
979405|NCT01259102|1985183|FG004|Overall Study|Adverse Event|0
979406|NCT01259102|1985179|FG000|Overall Study|Other|0
979407|NCT01259102|1985180|FG001|Overall Study|Other|0
979408|NCT01259102|1985181|FG002|Overall Study|Other|1
979409|NCT01259102|1985182|FG003|Overall Study|Other|1
979410|NCT01259102|1985183|FG004|Overall Study|Other|1
979411|NCT01259115|1985195|FG000|Period 1|Adverse Event|1
979412|NCT01259115|1985196|FG001|Period 1|Adverse Event|0
979413|NCT01259115|1985195|FG000|Period 1|Protocol Violation|2
979414|NCT01259115|1985196|FG001|Period 1|Protocol Violation|0
979415|NCT01259115|1985195|FG000|Period 1|Lost to Follow-up|0
979416|NCT01259115|1985196|FG001|Period 1|Lost to Follow-up|1
979417|NCT01259115|1985195|FG000|Period 2|Adverse Event|1
979418|NCT01259115|1985196|FG001|Period 2|Adverse Event|0
979419|NCT01259245|1985218|FG000|Overall Study|Withdrawal by Subject|27
979420|NCT01259245|1985219|FG001|Overall Study|Withdrawal by Subject|24
979421|NCT01259245|1985218|FG000|Overall Study|Death|1
979422|NCT01259245|1985219|FG001|Overall Study|Death|2
979423|NCT01259297|1985235|FG000|Double Blind Randomized Period|Death|1
979424|NCT01259297|1985236|FG001|Double Blind Randomized Period|Death|1
979425|NCT01259297|1985237|FG002|Double Blind Randomized Period|Death|1
979426|NCT01259297|1985238|FG003|Double Blind Randomized Period|Death|2
979427|NCT01259297|1985239|FG004|Double Blind Randomized Period|Death|1
979428|NCT01259297|1985240|FG005|Double Blind Randomized Period|Death|5
979429|NCT01259297|1985241|FG006|Double Blind Randomized Period|Death|2
979430|NCT01259297|1985242|FG007|Double Blind Randomized Period|Death|1
979431|NCT01259297|1985235|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
979432|NCT01259297|1985236|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
979433|NCT01259297|1985237|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
979434|NCT01259297|1985238|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
979435|NCT01259297|1985239|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
979436|NCT01259297|1985240|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
979437|NCT01259297|1985241|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
979438|NCT01259297|1985242|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
979439|NCT01259297|1985235|FG000|Double Blind Randomized Period|Other reasons|0
979440|NCT01259297|1985236|FG001|Double Blind Randomized Period|Other reasons|1
979441|NCT01259297|1985237|FG002|Double Blind Randomized Period|Other reasons|0
979442|NCT01259297|1985238|FG003|Double Blind Randomized Period|Other reasons|0
979443|NCT01259297|1985239|FG004|Double Blind Randomized Period|Other reasons|1
979444|NCT01259297|1985240|FG005|Double Blind Randomized Period|Other reasons|2
979445|NCT01259297|1985241|FG006|Double Blind Randomized Period|Other reasons|3
979446|NCT01259297|1985242|FG007|Double Blind Randomized Period|Other reasons|1
979447|NCT01259375|1985259|FG000|Overall Study|Adverse Event|1
979448|NCT01259388|1985267|FG000|Overall Study|Adverse Event|3
979449|NCT01259388|1985268|FG001|Overall Study|Adverse Event|0
979450|NCT01259388|1985267|FG000|Overall Study|Withdrawal by Subject|1
979451|NCT01259388|1985268|FG001|Overall Study|Withdrawal by Subject|1
979452|NCT01259388|1985267|FG000|Overall Study|Physician Decision|1
979453|NCT01259388|1985268|FG001|Overall Study|Physician Decision|0
979454|NCT01259401|1985276|FG000|4-month Follow-up|Death|0
979455|NCT01259401|1985277|FG001|4-month Follow-up|Death|1
979456|NCT01259401|1985276|FG000|4-month Follow-up|Lost to Follow-up|0
979457|NCT01259401|1985277|FG001|4-month Follow-up|Lost to Follow-up|1
979458|NCT01259466|1985304|FG000|Overall Study|Withdrawal by Subject|1
979459|NCT01259466|1985305|FG001|Overall Study|Withdrawal by Subject|9
979460|NCT01259492|1985315|FG000|Period 1 (9 Weeks)|Adverse Event|13
979461|NCT01259492|1985316|FG001|Period 1 (9 Weeks)|Adverse Event|18
979462|NCT01259492|1985317|FG002|Period 1 (9 Weeks)|Adverse Event|26
979463|NCT01259492|1985318|FG003|Period 1 (9 Weeks)|Adverse Event|3
979464|NCT01259492|1985315|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2
979465|NCT01259492|1985316|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2
979466|NCT01259492|1985317|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4
979467|NCT01259492|1985318|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11
979468|NCT01259492|1985315|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5
979469|NCT01259492|1985316|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8
979470|NCT01259492|1985317|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6
979471|NCT01259492|1985318|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7
979472|NCT01259492|1985315|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4
979473|NCT01259492|1985316|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6
979474|NCT01259492|1985317|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3
979475|NCT01259492|1985318|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4
979476|NCT01259492|1985315|FG000|Period 1 (9 Weeks)|Administrative Problems|0
979477|NCT01259492|1985316|FG001|Period 1 (9 Weeks)|Administrative Problems|1
979478|NCT01259492|1985317|FG002|Period 1 (9 Weeks)|Administrative Problems|1
979479|NCT01259492|1985318|FG003|Period 1 (9 Weeks)|Administrative Problems|2
979480|NCT01259492|1985315|FG000|Period 1 (9 Weeks)|Protocol Violation|5
979481|NCT01259492|1985316|FG001|Period 1 (9 Weeks)|Protocol Violation|6
979482|NCT01259492|1985317|FG002|Period 1 (9 Weeks)|Protocol Violation|3
979483|NCT01259492|1985318|FG003|Period 1 (9 Weeks)|Protocol Violation|1
979484|NCT01259492|1985315|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3
979485|NCT01259492|1985316|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4
979486|NCT01259492|1985317|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7
979487|NCT01259492|1985318|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8
979488|NCT01259492|1985315|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
979489|NCT01259492|1985316|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
979490|NCT01259492|1985317|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
979491|NCT01259492|1985318|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
979492|NCT01259492|1985315|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
979493|NCT01259492|1985316|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
979494|NCT01259492|1985317|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
979495|NCT01259492|1985318|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
979496|NCT01259492|1985315|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
979497|NCT01259492|1985316|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
979498|NCT01259492|1985317|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
979499|NCT01259492|1985318|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
979500|NCT01259492|1985315|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0
979501|NCT01259492|1985316|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2
979502|NCT01259492|1985317|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1
979503|NCT01259492|1985318|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0
979504|NCT01259492|1985315|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
979505|NCT01259492|1985316|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
979506|NCT01259492|1985317|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
979507|NCT01259492|1985318|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
979508|NCT01259492|1985315|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
979509|NCT01259492|1985316|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
979510|NCT01259492|1985317|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
979511|NCT01259492|1985318|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
979512|NCT01259492|1985315|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
979513|NCT01259492|1985316|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
979514|NCT01259492|1985317|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
979515|NCT01259492|1985318|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
979516|NCT01259492|1985315|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
979517|NCT01259492|1985316|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
979518|NCT01259492|1985317|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
979519|NCT01259492|1985318|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
979520|NCT01259492|1985315|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
979521|NCT01259492|1985316|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
979522|NCT01259492|1985317|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
979523|NCT01259492|1985318|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
979524|NCT01259492|1985315|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
979525|NCT01259492|1985316|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
979526|NCT01259492|1985317|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
979527|NCT01259492|1985318|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
979528|NCT01259492|1985315|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
979529|NCT01259492|1985316|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
979530|NCT01259492|1985317|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
979531|NCT01259492|1985318|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
979532|NCT01259492|1985315|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
979533|NCT01259492|1985316|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
979534|NCT01259492|1985317|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
979535|NCT01259492|1985318|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
979536|NCT01259492|1985315|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
979537|NCT01259492|1985316|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
979538|NCT01259492|1985317|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
979539|NCT01259492|1985318|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
979540|NCT01259713|1985340|FG000|Overall Study|Adverse Event|54
979541|NCT01259713|1985341|FG001|Overall Study|Adverse Event|23
979542|NCT01259713|1985340|FG000|Overall Study|Death Not Related to IFI|8
979543|NCT01259713|1985341|FG001|Overall Study|Death Not Related to IFI|1
979544|NCT01259713|1985340|FG000|Overall Study|Investigators Discretion|14
979545|NCT01259713|1985341|FG001|Overall Study|Investigators Discretion|6
979546|NCT01259713|1985340|FG000|Overall Study|Lack of Efficacy|2
979547|NCT01259713|1985341|FG001|Overall Study|Lack of Efficacy|0
979548|NCT01259713|1985340|FG000|Overall Study|Protocol Violation|5
979549|NCT01259713|1985341|FG001|Overall Study|Protocol Violation|4
979550|NCT01259713|1985340|FG000|Overall Study|Subject Withdrew Consent|12
979551|NCT01259713|1985341|FG001|Overall Study|Subject Withdrew Consent|7
979552|NCT01259726|1985351|FG000|Overall Study|Death|1
979553|NCT01259726|1985352|FG001|Overall Study|Death|0
979554|NCT01259726|1985353|FG002|Overall Study|Death|0
979555|NCT01259726|1985354|FG003|Overall Study|Death|0
979556|NCT01259726|1985351|FG000|Overall Study|Physician Decision|2
979557|NCT01259726|1985352|FG001|Overall Study|Physician Decision|0
979558|NCT01259726|1985353|FG002|Overall Study|Physician Decision|1
979559|NCT01259726|1985354|FG003|Overall Study|Physician Decision|1
979560|NCT01259726|1985351|FG000|Overall Study|Withdrawal by Subject|1
979561|NCT01259726|1985352|FG001|Overall Study|Withdrawal by Subject|3
979562|NCT01259726|1985353|FG002|Overall Study|Withdrawal by Subject|2
979563|NCT01259726|1985354|FG003|Overall Study|Withdrawal by Subject|1
979564|NCT01259726|1985351|FG000|Overall Study|Lost to Follow-up|1
979565|NCT01259726|1985352|FG001|Overall Study|Lost to Follow-up|1
979566|NCT01259726|1985353|FG002|Overall Study|Lost to Follow-up|1
979567|NCT01259726|1985354|FG003|Overall Study|Lost to Follow-up|3
979568|NCT01259856|1985366|FG000|Overall Study|Adverse Event|12
979569|NCT01259856|1985367|FG001|Overall Study|Adverse Event|9
979570|NCT01259856|1985366|FG000|Overall Study|Death|0
979571|NCT01259856|1985367|FG001|Overall Study|Death|1
979572|NCT01259856|1985366|FG000|Overall Study|Lack of Efficacy|3
979573|NCT01259856|1985367|FG001|Overall Study|Lack of Efficacy|1
979574|NCT01259856|1985366|FG000|Overall Study|Lost to Follow-up|1
979575|NCT01259856|1985367|FG001|Overall Study|Lost to Follow-up|1
979576|NCT01259856|1985366|FG000|Overall Study|Physician Decision|2
979577|NCT01259856|1985367|FG001|Overall Study|Physician Decision|1
979578|NCT01259856|1985366|FG000|Overall Study|Withdrawal by Subject|9
979579|NCT01259856|1985367|FG001|Overall Study|Withdrawal by Subject|10
979580|NCT01259856|1985366|FG000|Overall Study|Treatment never started|0
979581|NCT01259856|1985367|FG001|Overall Study|Treatment never started|6
979582|NCT01259856|1985366|FG000|Overall Study|Study closure by sponsor|40
979583|NCT01259856|1985367|FG001|Overall Study|Study closure by sponsor|41
979584|NCT01259856|1985366|FG000|Overall Study|Patient developed other disease|0
979585|NCT01259856|1985367|FG001|Overall Study|Patient developed other disease|1
979586|NCT01259856|1985366|FG000|Overall Study|Transfer to another study|0
979587|NCT01259856|1985367|FG001|Overall Study|Transfer to another study|1
979588|NCT01259856|1985366|FG000|Overall Study|Unknown/missing|2
979589|NCT01259856|1985367|FG001|Overall Study|Unknown/missing|2
979590|NCT01259869|1985373|FG000|Overall Study|Duplicated registration|1
979591|NCT01260142|1985383|FG000|Treatment Period 1|Study on hold|1
979592|NCT01260142|1985384|FG001|Treatment Period 1|Study on hold|1
979593|NCT01260142|1985385|FG002|Treatment Period 1|Study on hold|0
979594|NCT01260142|1985386|FG003|Treatment Period 1|Study on hold|0
979595|NCT01260142|1985387|FG004|Treatment Period 1|Study on hold|1
979596|NCT01260142|1985388|FG005|Treatment Period 1|Study on hold|2
979597|NCT01260142|1985383|FG000|Treatment Period 1|Unexplained elevated sys. BP|0
979598|NCT01260142|1985384|FG001|Treatment Period 1|Unexplained elevated sys. BP|0
979599|NCT01260142|1985385|FG002|Treatment Period 1|Unexplained elevated sys. BP|0
979600|NCT01260142|1985386|FG003|Treatment Period 1|Unexplained elevated sys. BP|0
979601|NCT01260142|1985387|FG004|Treatment Period 1|Unexplained elevated sys. BP|1
979602|NCT01260142|1985388|FG005|Treatment Period 1|Unexplained elevated sys. BP|0
979603|NCT01260142|1985383|FG000|Treatment Period 1|Withdrawal by Subject|0
979604|NCT01260142|1985384|FG001|Treatment Period 1|Withdrawal by Subject|0
979605|NCT01260142|1985385|FG002|Treatment Period 1|Withdrawal by Subject|0
979606|NCT01260142|1985386|FG003|Treatment Period 1|Withdrawal by Subject|0
979607|NCT01260142|1985387|FG004|Treatment Period 1|Withdrawal by Subject|0
979608|NCT01260142|1985388|FG005|Treatment Period 1|Withdrawal by Subject|1
979609|NCT01260181|1985408|FG000|Overall Study|Decision of Investigator|1
979610|NCT01260194|1985412|FG000|Overall Study|Withdrawal of Consent|1
979611|NCT01260311|1985427|FG000|Overall Study|Adverse Event|11
979612|NCT01260311|1985427|FG000|Overall Study|Lack of Efficacy|4
979613|NCT01260311|1985427|FG000|Overall Study|Lost to Follow-up|25
979614|NCT01260311|1985427|FG000|Overall Study|Withdrawal by Subject|6
979615|NCT01260311|1985427|FG000|Overall Study|Financial Constraints|77
979616|NCT01260311|1985427|FG000|Overall Study|Gone to Province|2
979617|NCT01260311|1985427|FG000|Overall Study|Medication Stopped|1
979618|NCT01260311|1985427|FG000|Overall Study|Fesoterodine Started Before Enrollment|1
979619|NCT01260350|1985460|FG000|Overall Study|Lack of Efficacy|0
979620|NCT01260350|1985461|FG001|Overall Study|Lack of Efficacy|0
979621|NCT01260350|1985462|FG002|Overall Study|Lack of Efficacy|0
979622|NCT01260350|1985463|FG003|Overall Study|Lack of Efficacy|0
979623|NCT01260350|1985464|FG004|Overall Study|Lack of Efficacy|0
979624|NCT01260350|1985465|FG005|Overall Study|Lack of Efficacy|0
979625|NCT01260350|1985466|FG006|Overall Study|Lack of Efficacy|0
979626|NCT01260350|1985467|FG007|Overall Study|Lack of Efficacy|0
979627|NCT01260350|1985468|FG008|Overall Study|Lack of Efficacy|0
979628|NCT01260350|1985469|FG009|Overall Study|Lack of Efficacy|0
979629|NCT01260350|1985470|FG010|Overall Study|Lack of Efficacy|0
979630|NCT01260350|1985471|FG011|Overall Study|Lack of Efficacy|0
979631|NCT01260350|1985472|FG012|Overall Study|Lack of Efficacy|0
979632|NCT01260350|1985473|FG013|Overall Study|Lack of Efficacy|0
979633|NCT01260350|1985474|FG014|Overall Study|Lack of Efficacy|0
979634|NCT01260350|1985475|FG015|Overall Study|Lack of Efficacy|0
979635|NCT01260350|1985476|FG016|Overall Study|Lack of Efficacy|0
979636|NCT01260350|1985477|FG017|Overall Study|Lack of Efficacy|1
979637|NCT01260350|1985478|FG018|Overall Study|Lack of Efficacy|0
979638|NCT01260350|1985479|FG019|Overall Study|Lack of Efficacy|0
979639|NCT01260350|1985480|FG020|Overall Study|Lack of Efficacy|3
979640|NCT01260350|1985481|FG021|Overall Study|Lack of Efficacy|0
979641|NCT01260350|1985460|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0
979642|NCT01260350|1985461|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0
979643|NCT01260350|1985462|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0
979644|NCT01260350|1985463|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0
979645|NCT01260350|1985464|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0
979646|NCT01260350|1985465|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0
979647|NCT01260350|1985466|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0
979648|NCT01260350|1985467|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0
979649|NCT01260350|1985468|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1
979650|NCT01260350|1985469|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0
979651|NCT01260350|1985470|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0
979652|NCT01260350|1985471|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0
979653|NCT01260350|1985472|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0
979654|NCT01260350|1985473|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0
979655|NCT01260350|1985474|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0
979656|NCT01260350|1985475|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0
979657|NCT01260350|1985476|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0
979658|NCT01260350|1985477|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0
979659|NCT01260350|1985478|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0
979660|NCT01260350|1985479|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0
979661|NCT01260350|1985480|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0
979662|NCT01260350|1985481|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0
979663|NCT01260467|1985539|FG000|Overall Study|Withdrawal by Subject|2
979664|NCT01260584|1985558|FG000|Period 1|Protocol Violation|0
979665|NCT01260584|1985559|FG001|Period 1|Protocol Violation|0
979666|NCT01260584|1985560|FG002|Period 1|Protocol Violation|1
979667|NCT01260584|1985561|FG003|Period 1|Protocol Violation|1
979668|NCT01260584|1985558|FG000|Period 1|Adverse Event|0
979669|NCT01260584|1985559|FG001|Period 1|Adverse Event|0
979670|NCT01260584|1985560|FG002|Period 1|Adverse Event|1
979671|NCT01260584|1985561|FG003|Period 1|Adverse Event|0
979672|NCT01260584|1985558|FG000|Period 2|Protocol Violation|0
979673|NCT01260584|1985559|FG001|Period 2|Protocol Violation|2
979674|NCT01260584|1985560|FG002|Period 2|Protocol Violation|3
979675|NCT01260584|1985561|FG003|Period 2|Protocol Violation|1
979676|NCT01260584|1985558|FG000|Period 2|Adverse Event|1
979677|NCT01260584|1985559|FG001|Period 2|Adverse Event|0
979678|NCT01260584|1985560|FG002|Period 2|Adverse Event|2
979679|NCT01260584|1985561|FG003|Period 2|Adverse Event|0
979680|NCT01260584|1985558|FG000|Period 2|Withdrawal by Subject|0
979681|NCT01260584|1985559|FG001|Period 2|Withdrawal by Subject|1
979682|NCT01260584|1985560|FG002|Period 2|Withdrawal by Subject|0
979683|NCT01260584|1985561|FG003|Period 2|Withdrawal by Subject|0
979684|NCT01260701|1985605|FG000|Overall Study|Adverse Event|9
979685|NCT01260701|1985605|FG000|Overall Study|Withdrawal by Subject|2
979686|NCT01260701|1985605|FG000|Overall Study|Progression|53
979687|NCT01260701|1985605|FG000|Overall Study|Death|2
979688|NCT01260701|1985605|FG000|Overall Study|Not protocol specified|3
979689|NCT01260701|1985605|FG000|Overall Study|Under review|1
979690|NCT01260701|1985605|FG000|Overall Study|Ineligible|4
979691|NCT01260701|1985605|FG000|Overall Study|Did not begin protocol therapy|1
979692|NCT01260896|1985645|FG000|First Intervention|Withdrawn Due to Emesis|2
979693|NCT01260896|1985646|FG001|First Intervention|Withdrawn Due to Emesis|0
979694|NCT01260922|1985654|FG000|First Intervention|Withdrawal by Subject|0
979695|NCT01260922|1985655|FG001|First Intervention|Withdrawal by Subject|1
979696|NCT01260922|1985654|FG000|Washout of 28 Days|Withdrawal by Subject|4
979697|NCT01260922|1985655|FG001|Washout of 28 Days|Withdrawal by Subject|2
979698|NCT01260922|1985654|FG000|Second Intervention|Emesis|0
979699|NCT01260922|1985655|FG001|Second Intervention|Emesis|2
979700|NCT01260948|1985663|FG000|Washout of 28 Days|Withdrawal by Subject|1
979701|NCT01260948|1985664|FG001|Washout of 28 Days|Withdrawal by Subject|3
979702|NCT01260948|1985663|FG000|Second Intervention|Emesis|0
979703|NCT01260948|1985664|FG001|Second Intervention|Emesis|1
979704|NCT01261000|1985670|FG000|Overall Study|Screen failure|1
979705|NCT01261247|1985679|FG000|Overall Study|Ineligible|2
979706|NCT01261325|1985686|FG000|Overall Study|Lack of Efficacy|1
979707|NCT01261325|1985687|FG001|Overall Study|Lack of Efficacy|1
979708|NCT01261325|1985688|FG002|Overall Study|Lack of Efficacy|0
979709|NCT01261325|1985686|FG000|Overall Study|Withdrawal by Subject|2
979710|NCT01261325|1985687|FG001|Overall Study|Withdrawal by Subject|2
979711|NCT01261325|1985688|FG002|Overall Study|Withdrawal by Subject|4
979712|NCT01261325|1985686|FG000|Overall Study|SAE, non-fatal|1
979713|NCT01261325|1985687|FG001|Overall Study|SAE, non-fatal|5
979714|NCT01261325|1985688|FG002|Overall Study|SAE, non-fatal|1
979715|NCT01261325|1985686|FG000|Overall Study|AE, non-serious non-fatal|9
979716|NCT01261325|1985687|FG001|Overall Study|AE, non-serious non-fatal|15
979717|NCT01261325|1985688|FG002|Overall Study|AE, non-serious non-fatal|13
979718|NCT01261325|1985686|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
979719|NCT01261325|1985687|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
979720|NCT01261325|1985688|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
979721|NCT01261325|1985686|FG000|Overall Study|Non Compliance|2
979722|NCT01261325|1985687|FG001|Overall Study|Non Compliance|0
979723|NCT01261325|1985688|FG002|Overall Study|Non Compliance|0
979724|NCT01261325|1985686|FG000|Overall Study|Patient Randomized by Mistake|0
979725|NCT01261325|1985687|FG001|Overall Study|Patient Randomized by Mistake|1
979726|NCT01261325|1985688|FG002|Overall Study|Patient Randomized by Mistake|0
979727|NCT01261325|1985686|FG000|Overall Study|Erroneously Randomized|1
979728|NCT01261325|1985687|FG001|Overall Study|Erroneously Randomized|0
979729|NCT01261325|1985688|FG002|Overall Study|Erroneously Randomized|0
979730|NCT01261325|1985686|FG000|Overall Study|Screen Failure|1
979731|NCT01261325|1985687|FG001|Overall Study|Screen Failure|0
979732|NCT01261325|1985688|FG002|Overall Study|Screen Failure|0
979733|NCT01261325|1985686|FG000|Overall Study|Randomized in Error|0
979734|NCT01261325|1985687|FG001|Overall Study|Randomized in Error|0
979735|NCT01261325|1985688|FG002|Overall Study|Randomized in Error|1
979736|NCT01261325|1985686|FG000|Overall Study|Protocol Violation|0
979737|NCT01261325|1985687|FG001|Overall Study|Protocol Violation|3
979738|NCT01261325|1985688|FG002|Overall Study|Protocol Violation|1
979739|NCT01261325|1985686|FG000|Overall Study|Lost to Follow-up|0
979740|NCT01261325|1985687|FG001|Overall Study|Lost to Follow-up|1
979741|NCT01261325|1985688|FG002|Overall Study|Lost to Follow-up|3
979742|NCT01261325|1985686|FG000|Overall Study|AE, serious fatal|0
979743|NCT01261325|1985687|FG001|Overall Study|AE, serious fatal|0
979744|NCT01261325|1985688|FG002|Overall Study|AE, serious fatal|2
979745|NCT01261338|1985701|FG000|Overall Study|Withdrawal by Subject|3
979746|NCT01261338|1985702|FG001|Overall Study|Withdrawal by Subject|2
979747|NCT01261390|1985712|FG000|Overall Study|Significant Concurrent Illness|1
979748|NCT01261390|1985713|FG001|Overall Study|Significant Concurrent Illness|0
979749|NCT01261390|1985714|FG002|Overall Study|Significant Concurrent Illness|1
979750|NCT01261390|1985715|FG003|Overall Study|Significant Concurrent Illness|0
979751|NCT01261390|1985712|FG000|Overall Study|Dissatisfaction with Treatment|2
979752|NCT01261390|1985713|FG001|Overall Study|Dissatisfaction with Treatment|1
979753|NCT01261390|1985714|FG002|Overall Study|Dissatisfaction with Treatment|1
979754|NCT01261390|1985715|FG003|Overall Study|Dissatisfaction with Treatment|2
979755|NCT01261390|1985712|FG000|Overall Study|Relocation|0
979756|NCT01261390|1985713|FG001|Overall Study|Relocation|1
979757|NCT01261390|1985714|FG002|Overall Study|Relocation|0
979758|NCT01261390|1985715|FG003|Overall Study|Relocation|0
979759|NCT01261390|1985712|FG000|Overall Study|Loss of Interest in the Study|3
979760|NCT01261390|1985713|FG001|Overall Study|Loss of Interest in the Study|1
979761|NCT01261390|1985714|FG002|Overall Study|Loss of Interest in the Study|0
979762|NCT01261390|1985715|FG003|Overall Study|Loss of Interest in the Study|0
979763|NCT01261390|1985712|FG000|Overall Study|Lost to Follow-up|1
979764|NCT01261390|1985713|FG001|Overall Study|Lost to Follow-up|6
979765|NCT01261390|1985714|FG002|Overall Study|Lost to Follow-up|5
979766|NCT01261390|1985715|FG003|Overall Study|Lost to Follow-up|6
979767|NCT01261611|1985750|FG000|Treatment Cycle 1|Withdrawal by Subject|3
979768|NCT01261611|1985751|FG001|Treatment Cycle 1|Withdrawal by Subject|2
979769|NCT01261611|1985752|FG002|Treatment Cycle 1|Withdrawal by Subject|0
979770|NCT01261611|1985750|FG000|Treatment Cycle 1|Lost to Follow-up|1
979771|NCT01261611|1985751|FG001|Treatment Cycle 1|Lost to Follow-up|0
979772|NCT01261611|1985752|FG002|Treatment Cycle 1|Lost to Follow-up|0
979773|NCT01261611|1985750|FG000|Treatment Cycle 1|Adverse Event|0
979774|NCT01261611|1985751|FG001|Treatment Cycle 1|Adverse Event|1
979775|NCT01261611|1985752|FG002|Treatment Cycle 1|Adverse Event|0
979776|NCT01261611|1985750|FG000|Treatment Cycle 1|Protocol Violation|0
979777|NCT01261611|1985751|FG001|Treatment Cycle 1|Protocol Violation|0
979778|NCT01261611|1985752|FG002|Treatment Cycle 1|Protocol Violation|2
979779|NCT01261611|1985750|FG000|Treatment Cycle 2|Completed study|4
979780|NCT01261611|1985751|FG001|Treatment Cycle 2|Completed study|0
979781|NCT01261611|1985752|FG002|Treatment Cycle 2|Completed study|0
979782|NCT01261611|1985750|FG000|Treatment Cycle 2|Withdrawal by Subject|4
979783|NCT01261611|1985751|FG001|Treatment Cycle 2|Withdrawal by Subject|0
979784|NCT01261611|1985752|FG002|Treatment Cycle 2|Withdrawal by Subject|0
979785|NCT01261611|1985750|FG000|Treatment Cycle 2|Adverse Event|1
979786|NCT01261611|1985751|FG001|Treatment Cycle 2|Adverse Event|0
979787|NCT01261611|1985752|FG002|Treatment Cycle 2|Adverse Event|0
979788|NCT01261611|1985750|FG000|Treatment Cycle 2|Protocol Violation|2
979789|NCT01261611|1985751|FG001|Treatment Cycle 2|Protocol Violation|0
979790|NCT01261611|1985752|FG002|Treatment Cycle 2|Protocol Violation|0
979791|NCT01261611|1985750|FG000|Treatment Cycle 2|Not otherwise specified|2
979792|NCT01261611|1985751|FG001|Treatment Cycle 2|Not otherwise specified|0
979793|NCT01261611|1985752|FG002|Treatment Cycle 2|Not otherwise specified|0
979794|NCT01261611|1985750|FG000|Treatment Cycle 3|Completed study|24
979795|NCT01261611|1985751|FG001|Treatment Cycle 3|Completed study|0
979796|NCT01261611|1985752|FG002|Treatment Cycle 3|Completed study|0
979797|NCT01261611|1985750|FG000|Treatment Cycle 3|Withdrawal by Subject|4
979798|NCT01261611|1985751|FG001|Treatment Cycle 3|Withdrawal by Subject|0
979799|NCT01261611|1985752|FG002|Treatment Cycle 3|Withdrawal by Subject|0
979800|NCT01261611|1985750|FG000|Treatment Cycle 3|Adverse Event|1
979801|NCT01261611|1985751|FG001|Treatment Cycle 3|Adverse Event|0
979802|NCT01261611|1985752|FG002|Treatment Cycle 3|Adverse Event|0
979803|NCT01261611|1985750|FG000|Treatment Cycle 3|Lost to Follow-up|1
979804|NCT01261611|1985751|FG001|Treatment Cycle 3|Lost to Follow-up|0
979805|NCT01261611|1985752|FG002|Treatment Cycle 3|Lost to Follow-up|0
979806|NCT01261611|1985750|FG000|Treatment Cycle 4|Completed study|87
979807|NCT01261611|1985751|FG001|Treatment Cycle 4|Completed study|0
979808|NCT01261611|1985752|FG002|Treatment Cycle 4|Completed study|0
979809|NCT01261611|1985750|FG000|Treatment Cycle 4|Withdrawal by Subject|3
979810|NCT01261611|1985751|FG001|Treatment Cycle 4|Withdrawal by Subject|0
979811|NCT01261611|1985752|FG002|Treatment Cycle 4|Withdrawal by Subject|0
979812|NCT01261611|1985750|FG000|Treatment Cycle 4|Adverse Event|1
979813|NCT01261611|1985751|FG001|Treatment Cycle 4|Adverse Event|0
979814|NCT01261611|1985752|FG002|Treatment Cycle 4|Adverse Event|0
979815|NCT01261611|1985750|FG000|Treatment Cycle 4|Lost to Follow-up|2
979816|NCT01261611|1985751|FG001|Treatment Cycle 4|Lost to Follow-up|0
979817|NCT01261611|1985752|FG002|Treatment Cycle 4|Lost to Follow-up|0
979818|NCT01261611|1985750|FG000|Treatment Cycle 4|Not otherwise specified|3
979819|NCT01261611|1985751|FG001|Treatment Cycle 4|Not otherwise specified|0
979820|NCT01261611|1985752|FG002|Treatment Cycle 4|Not otherwise specified|0
979821|NCT01261611|1985750|FG000|Treatment Cycle 5|Withdrawal by Subject|1
979822|NCT01261611|1985751|FG001|Treatment Cycle 5|Withdrawal by Subject|0
979823|NCT01261611|1985752|FG002|Treatment Cycle 5|Withdrawal by Subject|0
979824|NCT01261611|1985750|FG000|Treatment Cycle 5|Adverse Event|1
979825|NCT01261611|1985751|FG001|Treatment Cycle 5|Adverse Event|0
979826|NCT01261611|1985752|FG002|Treatment Cycle 5|Adverse Event|0
979827|NCT01261611|1985750|FG000|Treatment Cycle 5|Lost to Follow-up|1
979828|NCT01261611|1985751|FG001|Treatment Cycle 5|Lost to Follow-up|0
979829|NCT01261611|1985752|FG002|Treatment Cycle 5|Lost to Follow-up|0
979830|NCT01261624|1985766|FG000|Week 0 to Week 12|Disease Progression|1
979831|NCT01261624|1985767|FG001|Week 0 to Week 12|Disease Progression|1
979832|NCT01261624|1985766|FG000|Week 0 to Week 12|Insufficient Response|0
979833|NCT01261624|1985767|FG001|Week 0 to Week 12|Insufficient Response|2
979834|NCT01261624|1985766|FG000|Week 13 to Week 24|Insufficient Response|0
979835|NCT01261624|1985767|FG001|Week 13 to Week 24|Insufficient Response|1
979836|NCT01261780|1985781|FG000|Overall Study|Withdrawal by Subject|1
979837|NCT01261780|1985782|FG001|Overall Study|Withdrawal by Subject|0
979838|NCT01261780|1985781|FG000|Overall Study|Event not related to subject|1
979839|NCT01261780|1985782|FG001|Overall Study|Event not related to subject|2
979840|NCT01261793|1985791|FG000|Overall Study|Lack of Efficacy|44
979841|NCT01261793|1985792|FG001|Overall Study|Lack of Efficacy|37
979842|NCT01261793|1985793|FG002|Overall Study|Lack of Efficacy|32
979843|NCT01261793|1985791|FG000|Overall Study|Protocol Violation|3
979844|NCT01261793|1985792|FG001|Overall Study|Protocol Violation|5
979845|NCT01261793|1985793|FG002|Overall Study|Protocol Violation|6
979846|NCT01261793|1985791|FG000|Overall Study|Lost to Follow-up|10
979847|NCT01261793|1985792|FG001|Overall Study|Lost to Follow-up|3
979848|NCT01261793|1985793|FG002|Overall Study|Lost to Follow-up|7
979849|NCT01261793|1985791|FG000|Overall Study|Withdrawal by Subject|12
979850|NCT01261793|1985792|FG001|Overall Study|Withdrawal by Subject|14
979851|NCT01261793|1985793|FG002|Overall Study|Withdrawal by Subject|14
979852|NCT01261793|1985791|FG000|Overall Study|Death|3
979853|NCT01261793|1985792|FG001|Overall Study|Death|1
979854|NCT01261793|1985793|FG002|Overall Study|Death|0
979855|NCT01261793|1985791|FG000|Overall Study|Adverse Event|9
979856|NCT01261793|1985792|FG001|Overall Study|Adverse Event|24
979857|NCT01261793|1985793|FG002|Overall Study|Adverse Event|19
979858|NCT01261793|1985791|FG000|Overall Study|Patient non-availability|1
979859|NCT01261793|1985792|FG001|Overall Study|Patient non-availability|1
979860|NCT01261793|1985793|FG002|Overall Study|Patient non-availability|1
979861|NCT01261793|1985791|FG000|Overall Study|Suspected pregnancy|1
979862|NCT01261793|1985792|FG001|Overall Study|Suspected pregnancy|1
979863|NCT01261793|1985793|FG002|Overall Study|Suspected pregnancy|0
979864|NCT01261793|1985791|FG000|Overall Study|Patient non-compliance|1
979865|NCT01261793|1985792|FG001|Overall Study|Patient non-compliance|0
979866|NCT01261793|1985793|FG002|Overall Study|Patient non-compliance|1
979867|NCT01261793|1985791|FG000|Overall Study|Patient pregnant|1
979868|NCT01261793|1985792|FG001|Overall Study|Patient pregnant|0
979869|NCT01261793|1985793|FG002|Overall Study|Patient pregnant|0
979870|NCT01261793|1985791|FG000|Overall Study|Outside the study area|0
979871|NCT01261793|1985792|FG001|Overall Study|Outside the study area|2
979872|NCT01261793|1985793|FG002|Overall Study|Outside the study area|1
979873|NCT01261793|1985791|FG000|Overall Study|Lack of efficacy & patient not available|0
979874|NCT01261793|1985792|FG001|Overall Study|Lack of efficacy & patient not available|1
979875|NCT01261793|1985793|FG002|Overall Study|Lack of efficacy & patient not available|0
979876|NCT01261793|1985791|FG000|Overall Study|Patient withdrew after cardiology visit|0
979877|NCT01261793|1985792|FG001|Overall Study|Patient withdrew after cardiology visit|1
979878|NCT01261793|1985793|FG002|Overall Study|Patient withdrew after cardiology visit|0
979879|NCT01261793|1985791|FG000|Overall Study|Randomization error|0
979880|NCT01261793|1985792|FG001|Overall Study|Randomization error|1
979881|NCT01261793|1985793|FG002|Overall Study|Randomization error|0
979882|NCT01261793|1985791|FG000|Overall Study|Patient unable to start IV line|0
979883|NCT01261793|1985792|FG001|Overall Study|Patient unable to start IV line|0
979884|NCT01261793|1985793|FG002|Overall Study|Patient unable to start IV line|1
979885|NCT01261975|1985810|FG000|Overall Study|Surgical complication|1
979886|NCT01262027|1985817|FG000|Overall Study|Adverse Event|1
979887|NCT01262027|1985817|FG000|Overall Study|Withdrawal by Subject|3
979888|NCT01262027|1985817|FG000|Overall Study|Protocol Violation|1
979889|NCT01262092|1985823|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
979890|NCT01262092|1985824|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
979891|NCT01262092|1985823|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
979892|NCT01262092|1985824|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
979893|NCT01262092|1985823|FG000|Buprenorphine Taper|noncompliance - missed medication|1
979894|NCT01262092|1985824|FG001|Buprenorphine Taper|noncompliance - missed medication|1
979895|NCT01262092|1985823|FG000|Gabapentin Taper|noncompliance - missed medications|1
979896|NCT01262092|1985824|FG001|Gabapentin Taper|noncompliance - missed medications|0
979897|NCT01262287|1985863|FG000|Overall Study|Lost to Follow-up|2
979898|NCT01262287|1985864|FG001|Overall Study|Lost to Follow-up|1
979899|NCT01262352|1985876|FG000|Period 1|Illness after randomization|1
979900|NCT01262352|1985877|FG001|Period 1|Illness after randomization|0
979901|NCT01262352|1985876|FG000|Washout|Adverse Event|1
979902|NCT01262352|1985877|FG001|Washout|Adverse Event|1
979903|NCT01262352|1985876|FG000|Washout|Extended Washout|0
979904|NCT01262352|1985877|FG001|Washout|Extended Washout|1
979905|NCT01262365|1985886|FG000|Overall Study|Lack of Efficacy|35
979906|NCT01262365|1985887|FG001|Overall Study|Lack of Efficacy|30
979907|NCT01262365|1985888|FG002|Overall Study|Lack of Efficacy|47
979908|NCT01262365|1985886|FG000|Overall Study|Protocol Violation|3
979909|NCT01262365|1985887|FG001|Overall Study|Protocol Violation|1
979910|NCT01262365|1985888|FG002|Overall Study|Protocol Violation|1
979911|NCT01262365|1985886|FG000|Overall Study|Lost to Follow-up|3
979912|NCT01262365|1985887|FG001|Overall Study|Lost to Follow-up|7
979913|NCT01262365|1985888|FG002|Overall Study|Lost to Follow-up|6
979914|NCT01262365|1985886|FG000|Overall Study|Withdrawal by Subject|17
979915|NCT01262365|1985887|FG001|Overall Study|Withdrawal by Subject|22
979916|NCT01262365|1985888|FG002|Overall Study|Withdrawal by Subject|22
979917|NCT01262365|1985886|FG000|Overall Study|Death|1
979918|NCT01262365|1985887|FG001|Overall Study|Death|2
979919|NCT01262365|1985888|FG002|Overall Study|Death|1
979920|NCT01262365|1985886|FG000|Overall Study|Adverse Event|26
979921|NCT01262365|1985887|FG001|Overall Study|Adverse Event|16
979922|NCT01262365|1985888|FG002|Overall Study|Adverse Event|11
979923|NCT01262365|1985886|FG000|Overall Study|sponsor decision|1
979924|NCT01262365|1985887|FG001|Overall Study|sponsor decision|1
979925|NCT01262365|1985888|FG002|Overall Study|sponsor decision|0
979926|NCT01262365|1985886|FG000|Overall Study|Randomization error|1
979927|NCT01262365|1985887|FG001|Overall Study|Randomization error|0
979928|NCT01262365|1985888|FG002|Overall Study|Randomization error|2
979929|NCT01262365|1985886|FG000|Overall Study|Non-compliance|1
979930|NCT01262365|1985887|FG001|Overall Study|Non-compliance|0
979931|NCT01262365|1985888|FG002|Overall Study|Non-compliance|2
979932|NCT01262365|1985886|FG000|Overall Study|Suspected pregnancy|1
979933|NCT01262365|1985887|FG001|Overall Study|Suspected pregnancy|0
979934|NCT01262365|1985888|FG002|Overall Study|Suspected pregnancy|0
979935|NCT01262365|1985886|FG000|Overall Study|Patient pregnant|1
979936|NCT01262365|1985887|FG001|Overall Study|Patient pregnant|0
979937|NCT01262365|1985888|FG002|Overall Study|Patient pregnant|1
979938|NCT01262365|1985886|FG000|Overall Study|Toxicity related to study drug|0
979939|NCT01262365|1985887|FG001|Overall Study|Toxicity related to study drug|1
979940|NCT01262365|1985888|FG002|Overall Study|Toxicity related to study drug|0
979941|NCT01262365|1985886|FG000|Overall Study|Cannot tolerate the protocol|0
979942|NCT01262365|1985887|FG001|Overall Study|Cannot tolerate the protocol|1
979943|NCT01262365|1985888|FG002|Overall Study|Cannot tolerate the protocol|0
979944|NCT01262365|1985886|FG000|Overall Study|Patient unavailable|0
979945|NCT01262365|1985887|FG001|Overall Study|Patient unavailable|0
979946|NCT01262365|1985888|FG002|Overall Study|Patient unavailable|1
979947|NCT01262456|1985899|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6
979948|NCT01262456|1985900|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8
979949|NCT01262456|1985901|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9
979950|NCT01262456|1985899|FG000|3-Month Double-Blind Period|Lost to Follow-up|4
979951|NCT01262456|1985900|FG001|3-Month Double-Blind Period|Lost to Follow-up|5
979952|NCT01262456|1985901|FG002|3-Month Double-Blind Period|Lost to Follow-up|3
979953|NCT01262456|1985899|FG000|3-Month Double-Blind Period|Adverse Event|6
979954|NCT01262456|1985900|FG001|3-Month Double-Blind Period|Adverse Event|4
979955|NCT01262456|1985901|FG002|3-Month Double-Blind Period|Adverse Event|8
979956|NCT01262456|1985899|FG000|3-Month Double-Blind Period|Protocol Violation|3
979957|NCT01262456|1985900|FG001|3-Month Double-Blind Period|Protocol Violation|6
979958|NCT01262456|1985901|FG002|3-Month Double-Blind Period|Protocol Violation|6
979959|NCT01262456|1985899|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1
979960|NCT01262456|1985900|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1
979961|NCT01262456|1985901|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1
979962|NCT01262456|1985899|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0
979963|NCT01262456|1985900|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1
979964|NCT01262456|1985901|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0
979965|NCT01262456|1985899|FG000|1-Month Open-Label Extension Period|Adverse Event|2
979966|NCT01262456|1985900|FG001|1-Month Open-Label Extension Period|Adverse Event|0
979967|NCT01262456|1985901|FG002|1-Month Open-Label Extension Period|Adverse Event|2
979968|NCT01262456|1985899|FG000|1-Month Open-Label Extension Period|Protocol Violation|1
979969|NCT01262456|1985900|FG001|1-Month Open-Label Extension Period|Protocol Violation|0
979970|NCT01262456|1985901|FG002|1-Month Open-Label Extension Period|Protocol Violation|2
979971|NCT01262456|1985899|FG000|1-Month Open-Label Extension Period|Other Reason|0
979972|NCT01262456|1985900|FG001|1-Month Open-Label Extension Period|Other Reason|1
979973|NCT01262456|1985901|FG002|1-Month Open-Label Extension Period|Other Reason|0
979974|NCT01262560|1985929|FG000|Overall Study|Protocol Violation|0
979975|NCT01262560|1985930|FG001|Overall Study|Protocol Violation|1
979976|NCT01262560|1985931|FG002|Overall Study|Protocol Violation|2
979977|NCT01262573|1985941|FG000|Overall Study|Withdrawal by Subject|0
979978|NCT01262573|1985942|FG001|Overall Study|Withdrawal by Subject|1
979979|NCT01262638|1985963|FG000|Overall Study|Adverse Event|3
979980|NCT01262638|1985964|FG001|Overall Study|Adverse Event|4
979981|NCT01262638|1985965|FG002|Overall Study|Adverse Event|3
979982|NCT01262638|1985966|FG003|Overall Study|Adverse Event|4
979983|NCT01262638|1985963|FG000|Overall Study|Protocol Violation|1
979984|NCT01262638|1985964|FG001|Overall Study|Protocol Violation|0
979985|NCT01262638|1985965|FG002|Overall Study|Protocol Violation|0
979986|NCT01262638|1985966|FG003|Overall Study|Protocol Violation|1
979987|NCT01262638|1985963|FG000|Overall Study|Withdrawal by Subject|2
979988|NCT01262638|1985964|FG001|Overall Study|Withdrawal by Subject|1
979989|NCT01262638|1985965|FG002|Overall Study|Withdrawal by Subject|0
979990|NCT01262638|1985966|FG003|Overall Study|Withdrawal by Subject|1
979991|NCT01262638|1985963|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
979992|NCT01262638|1985964|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
979993|NCT01262638|1985965|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1
979994|NCT01262638|1985966|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
979995|NCT01262638|1985963|FG000|Overall Study|Lost to Follow-up|1
979996|NCT01262638|1985964|FG001|Overall Study|Lost to Follow-up|1
979997|NCT01262638|1985965|FG002|Overall Study|Lost to Follow-up|1
979998|NCT01262638|1985966|FG003|Overall Study|Lost to Follow-up|1
979999|NCT01262638|1985963|FG000|Overall Study|Participant Went Out of Town|0
980000|NCT01262638|1985964|FG001|Overall Study|Participant Went Out of Town|0
980001|NCT01262638|1985965|FG002|Overall Study|Participant Went Out of Town|1
980002|NCT01262638|1985966|FG003|Overall Study|Participant Went Out of Town|0
980003|NCT01262651|1985981|FG000|Overall Study|Adverse Event|40
980004|NCT01262651|1985982|FG001|Overall Study|Adverse Event|35
980005|NCT01262651|1985981|FG000|Overall Study|Withdrawal by Subject|15
980006|NCT01262651|1985982|FG001|Overall Study|Withdrawal by Subject|11
980007|NCT01262651|1985981|FG000|Overall Study|Withdrawal by Investigator|2
980008|NCT01262651|1985982|FG001|Overall Study|Withdrawal by Investigator|2
980009|NCT01262651|1985981|FG000|Overall Study|Met Withdrawal Criteria|1
980010|NCT01262651|1985982|FG001|Overall Study|Met Withdrawal Criteria|0
980011|NCT01262677|1985991|FG000|Overall Study|Does not meet entrance criteria|0
980012|NCT01262677|1985992|FG001|Overall Study|Does not meet entrance criteria|2
980013|NCT01262677|1985993|FG002|Overall Study|Does not meet entrance criteria|0
980014|NCT01262677|1985991|FG000|Overall Study|Insufficient clinical response|0
980015|NCT01262677|1985992|FG001|Overall Study|Insufficient clinical response|0
980016|NCT01262677|1985993|FG002|Overall Study|Insufficient clinical response|1
980017|NCT01262677|1985991|FG000|Overall Study|Lost to Follow-up|1
980018|NCT01262677|1985992|FG001|Overall Study|Lost to Follow-up|0
980019|NCT01262677|1985993|FG002|Overall Study|Lost to Follow-up|2
980020|NCT01262677|1985991|FG000|Overall Study|No longer willing to participate|3
980021|NCT01262677|1985992|FG001|Overall Study|No longer willing to participate|3
980022|NCT01262677|1985993|FG002|Overall Study|No longer willing to participate|2
980023|NCT01262677|1985991|FG000|Overall Study|Reason not provided|2
980024|NCT01262677|1985992|FG001|Overall Study|Reason not provided|1
980025|NCT01262677|1985993|FG002|Overall Study|Reason not provided|3
980026|NCT01262677|1985991|FG000|Overall Study|Protocol Violation|0
980027|NCT01262677|1985992|FG001|Overall Study|Protocol Violation|1
980028|NCT01262677|1985993|FG002|Overall Study|Protocol Violation|1
980029|NCT01262677|1985991|FG000|Overall Study|Adverse Event (AE) related to study drug|3
980030|NCT01262677|1985992|FG001|Overall Study|Adverse Event (AE) related to study drug|8
980031|NCT01262677|1985993|FG002|Overall Study|Adverse Event (AE) related to study drug|3
980032|NCT01262820|1986005|FG000|Overall Study|Adverse Event|5
980033|NCT01262820|1986005|FG000|Overall Study|Lack of Efficacy|9
980034|NCT01262820|1986005|FG000|Overall Study|Drug held for 21+ days|1
980035|NCT01262872|1986026|FG000|Step 2|Death|0
980036|NCT01262872|1986027|FG001|Step 2|Death|0
980037|NCT01262872|1986028|FG002|Step 2|Death|0
980038|NCT01262872|1986029|FG003|Step 2|Death|1
980039|NCT01262872|1986030|FG004|Step 2|Death|0
980040|NCT01262872|1986031|FG005|Step 2|Death|2
980041|NCT01262872|1986032|FG006|Step 2|Death|2
980042|NCT01262872|1986033|FG007|Step 2|Death|1
980043|NCT01262872|1986026|FG000|Step 2|Protocol Violation|0
980044|NCT01262872|1986027|FG001|Step 2|Protocol Violation|0
980045|NCT01262872|1986028|FG002|Step 2|Protocol Violation|1
980046|NCT01262872|1986029|FG003|Step 2|Protocol Violation|0
980047|NCT01262872|1986030|FG004|Step 2|Protocol Violation|0
980048|NCT01262872|1986031|FG005|Step 2|Protocol Violation|0
980049|NCT01262872|1986032|FG006|Step 2|Protocol Violation|3
980050|NCT01262872|1986033|FG007|Step 2|Protocol Violation|1
980051|NCT01262872|1986026|FG000|Step 2|Withdrawal by Subject|0
980052|NCT01262872|1986027|FG001|Step 2|Withdrawal by Subject|0
980053|NCT01262872|1986028|FG002|Step 2|Withdrawal by Subject|4
980054|NCT01262872|1986029|FG003|Step 2|Withdrawal by Subject|6
980055|NCT01262872|1986030|FG004|Step 2|Withdrawal by Subject|3
980056|NCT01262872|1986031|FG005|Step 2|Withdrawal by Subject|1
980057|NCT01262872|1986032|FG006|Step 2|Withdrawal by Subject|2
980058|NCT01262872|1986033|FG007|Step 2|Withdrawal by Subject|1
980059|NCT01262872|1986026|FG000|Step 2|Migrated/moved from study area|0
980060|NCT01262872|1986027|FG001|Step 2|Migrated/moved from study area|0
980061|NCT01262872|1986028|FG002|Step 2|Migrated/moved from study area|4
980062|NCT01262872|1986029|FG003|Step 2|Migrated/moved from study area|3
980063|NCT01262872|1986030|FG004|Step 2|Migrated/moved from study area|2
980064|NCT01262872|1986031|FG005|Step 2|Migrated/moved from study area|6
980065|NCT01262872|1986032|FG006|Step 2|Migrated/moved from study area|2
980066|NCT01262872|1986033|FG007|Step 2|Migrated/moved from study area|3
980067|NCT01262898|1986071|FG000|Overall Study|Protocol Violation|1
980068|NCT01262898|1986072|FG001|Overall Study|Protocol Violation|1
980069|NCT01262898|1986073|FG002|Overall Study|Protocol Violation|0
980070|NCT01262898|1986074|FG003|Overall Study|Protocol Violation|0
980071|NCT01262898|1986071|FG000|Overall Study|Lost to Follow-up|1
980072|NCT01262898|1986072|FG001|Overall Study|Lost to Follow-up|0
980073|NCT01262898|1986073|FG002|Overall Study|Lost to Follow-up|0
980074|NCT01262898|1986074|FG003|Overall Study|Lost to Follow-up|0
980075|NCT01262898|1986071|FG000|Overall Study|Withdrawal by Subject|1
980076|NCT01262898|1986072|FG001|Overall Study|Withdrawal by Subject|1
980077|NCT01262898|1986073|FG002|Overall Study|Withdrawal by Subject|0
980078|NCT01262898|1986074|FG003|Overall Study|Withdrawal by Subject|0
980079|NCT01262976|1986093|FG000|Up to Month 2|Serious Adverse Event|0
980080|NCT01262976|1986094|FG001|Up to Month 2|Serious Adverse Event|0
980081|NCT01262976|1986095|FG002|Up to Month 2|Serious Adverse Event|1
980082|NCT01262976|1986096|FG003|Up to Month 2|Serious Adverse Event|0
980083|NCT01262976|1986097|FG004|Up to Month 2|Serious Adverse Event|0
980084|NCT01262976|1986098|FG005|Up to Month 2|Serious Adverse Event|0
980085|NCT01262976|1986093|FG000|Up to Month 2|Withdrawal by Subject|1
980086|NCT01262976|1986094|FG001|Up to Month 2|Withdrawal by Subject|0
980087|NCT01262976|1986095|FG002|Up to Month 2|Withdrawal by Subject|0
980088|NCT01262976|1986096|FG003|Up to Month 2|Withdrawal by Subject|0
980089|NCT01262976|1986097|FG004|Up to Month 2|Withdrawal by Subject|0
980090|NCT01262976|1986098|FG005|Up to Month 2|Withdrawal by Subject|0
980091|NCT01262976|1986093|FG000|Up to Month 2|Migrated/moved from study area|0
980092|NCT01262976|1986094|FG001|Up to Month 2|Migrated/moved from study area|1
980093|NCT01262976|1986095|FG002|Up to Month 2|Migrated/moved from study area|0
980094|NCT01262976|1986096|FG003|Up to Month 2|Migrated/moved from study area|0
980095|NCT01262976|1986097|FG004|Up to Month 2|Migrated/moved from study area|1
980096|NCT01262976|1986098|FG005|Up to Month 2|Migrated/moved from study area|1
980097|NCT01262976|1986093|FG000|Up to Month 2|Lost to Follow-up|1
980098|NCT01262976|1986094|FG001|Up to Month 2|Lost to Follow-up|0
980099|NCT01262976|1986095|FG002|Up to Month 2|Lost to Follow-up|0
980100|NCT01262976|1986096|FG003|Up to Month 2|Lost to Follow-up|1
980101|NCT01262976|1986097|FG004|Up to Month 2|Lost to Follow-up|1
980102|NCT01262976|1986098|FG005|Up to Month 2|Lost to Follow-up|1
980103|NCT01262976|1986093|FG000|Up to Month 2|Other|1
980104|NCT01262976|1986094|FG001|Up to Month 2|Other|0
980105|NCT01262976|1986095|FG002|Up to Month 2|Other|0
980106|NCT01262976|1986096|FG003|Up to Month 2|Other|1
980107|NCT01262976|1986097|FG004|Up to Month 2|Other|0
980108|NCT01262976|1986098|FG005|Up to Month 2|Other|2
980109|NCT01262976|1986093|FG000|Up to Month 7|Serious Adverse Event|0
980110|NCT01262976|1986094|FG001|Up to Month 7|Serious Adverse Event|0
980111|NCT01262976|1986095|FG002|Up to Month 7|Serious Adverse Event|2
980112|NCT01262976|1986096|FG003|Up to Month 7|Serious Adverse Event|0
980113|NCT01262976|1986097|FG004|Up to Month 7|Serious Adverse Event|0
980114|NCT01262976|1986098|FG005|Up to Month 7|Serious Adverse Event|0
980115|NCT01262976|1986093|FG000|Up to Month 7|Withdrawal by Subject|1
980116|NCT01262976|1986094|FG001|Up to Month 7|Withdrawal by Subject|0
980117|NCT01262976|1986095|FG002|Up to Month 7|Withdrawal by Subject|0
980118|NCT01262976|1986096|FG003|Up to Month 7|Withdrawal by Subject|0
980119|NCT01262976|1986097|FG004|Up to Month 7|Withdrawal by Subject|0
980120|NCT01262976|1986098|FG005|Up to Month 7|Withdrawal by Subject|0
980121|NCT01262976|1986093|FG000|Up to Month 7|Migrated/moved from study area|0
980122|NCT01262976|1986094|FG001|Up to Month 7|Migrated/moved from study area|0
980123|NCT01262976|1986095|FG002|Up to Month 7|Migrated/moved from study area|1
980124|NCT01262976|1986096|FG003|Up to Month 7|Migrated/moved from study area|3
980125|NCT01262976|1986097|FG004|Up to Month 7|Migrated/moved from study area|1
980126|NCT01262976|1986098|FG005|Up to Month 7|Migrated/moved from study area|1
980127|NCT01262976|1986093|FG000|Up to Month 7|Lost to Follow-up|1
980128|NCT01262976|1986094|FG001|Up to Month 7|Lost to Follow-up|0
980129|NCT01262976|1986095|FG002|Up to Month 7|Lost to Follow-up|1
980130|NCT01262976|1986096|FG003|Up to Month 7|Lost to Follow-up|3
980131|NCT01262976|1986097|FG004|Up to Month 7|Lost to Follow-up|1
980132|NCT01262976|1986098|FG005|Up to Month 7|Lost to Follow-up|3
980133|NCT01262976|1986093|FG000|Up to Month 7|Other|3
980134|NCT01262976|1986094|FG001|Up to Month 7|Other|0
980135|NCT01262976|1986095|FG002|Up to Month 7|Other|2
980136|NCT01262976|1986096|FG003|Up to Month 7|Other|0
980137|NCT01262976|1986097|FG004|Up to Month 7|Other|0
980138|NCT01262976|1986098|FG005|Up to Month 7|Other|0
980139|NCT01262976|1986093|FG000|Up to Year 1|Serious Adverse Event|0
980140|NCT01262976|1986094|FG001|Up to Year 1|Serious Adverse Event|0
980141|NCT01262976|1986095|FG002|Up to Year 1|Serious Adverse Event|2
980142|NCT01262976|1986096|FG003|Up to Year 1|Serious Adverse Event|0
980143|NCT01262976|1986097|FG004|Up to Year 1|Serious Adverse Event|0
980144|NCT01262976|1986098|FG005|Up to Year 1|Serious Adverse Event|0
980145|NCT01262976|1986093|FG000|Up to Year 1|Withdrawal by Subject|1
980146|NCT01262976|1986094|FG001|Up to Year 1|Withdrawal by Subject|0
980147|NCT01262976|1986095|FG002|Up to Year 1|Withdrawal by Subject|0
980148|NCT01262976|1986096|FG003|Up to Year 1|Withdrawal by Subject|0
980149|NCT01262976|1986097|FG004|Up to Year 1|Withdrawal by Subject|0
980150|NCT01262976|1986098|FG005|Up to Year 1|Withdrawal by Subject|0
980151|NCT01262976|1986093|FG000|Up to Year 1|Migrated/moved from study area|1
980152|NCT01262976|1986094|FG001|Up to Year 1|Migrated/moved from study area|0
980153|NCT01262976|1986095|FG002|Up to Year 1|Migrated/moved from study area|0
980154|NCT01262976|1986096|FG003|Up to Year 1|Migrated/moved from study area|3
980155|NCT01262976|1986097|FG004|Up to Year 1|Migrated/moved from study area|3
980156|NCT01262976|1986098|FG005|Up to Year 1|Migrated/moved from study area|2
980157|NCT01262976|1986093|FG000|Up to Year 1|Lost to Follow-up|4
980158|NCT01262976|1986094|FG001|Up to Year 1|Lost to Follow-up|0
980159|NCT01262976|1986095|FG002|Up to Year 1|Lost to Follow-up|0
980160|NCT01262976|1986096|FG003|Up to Year 1|Lost to Follow-up|1
980161|NCT01262976|1986097|FG004|Up to Year 1|Lost to Follow-up|6
980162|NCT01262976|1986098|FG005|Up to Year 1|Lost to Follow-up|5
980163|NCT01262976|1986093|FG000|Up to Year 1|Other|3
980164|NCT01262976|1986094|FG001|Up to Year 1|Other|1
980165|NCT01262976|1986095|FG002|Up to Year 1|Other|0
980166|NCT01262976|1986096|FG003|Up to Year 1|Other|0
980167|NCT01262976|1986097|FG004|Up to Year 1|Other|2
980168|NCT01262976|1986098|FG005|Up to Year 1|Other|1
980169|NCT01262976|1986093|FG000|Up to Year 1|Subjects with unknown completion status|0
980170|NCT01262976|1986094|FG001|Up to Year 1|Subjects with unknown completion status|0
980171|NCT01262976|1986095|FG002|Up to Year 1|Subjects with unknown completion status|1
980172|NCT01262976|1986096|FG003|Up to Year 1|Subjects with unknown completion status|0
980173|NCT01262976|1986097|FG004|Up to Year 1|Subjects with unknown completion status|0
980174|NCT01262976|1986098|FG005|Up to Year 1|Subjects with unknown completion status|1
980175|NCT01262976|1986093|FG000|Up to Year 2|Serious Adverse Event|0
980176|NCT01262976|1986094|FG001|Up to Year 2|Serious Adverse Event|0
980177|NCT01262976|1986095|FG002|Up to Year 2|Serious Adverse Event|2
980178|NCT01262976|1986096|FG003|Up to Year 2|Serious Adverse Event|0
980179|NCT01262976|1986097|FG004|Up to Year 2|Serious Adverse Event|0
980180|NCT01262976|1986098|FG005|Up to Year 2|Serious Adverse Event|0
980181|NCT01262976|1986093|FG000|Up to Year 2|Withdrawal by Subject|1
980182|NCT01262976|1986094|FG001|Up to Year 2|Withdrawal by Subject|0
980183|NCT01262976|1986095|FG002|Up to Year 2|Withdrawal by Subject|0
980184|NCT01262976|1986096|FG003|Up to Year 2|Withdrawal by Subject|0
980185|NCT01262976|1986097|FG004|Up to Year 2|Withdrawal by Subject|0
980186|NCT01262976|1986098|FG005|Up to Year 2|Withdrawal by Subject|0
980187|NCT01262976|1986093|FG000|Up to Year 2|Migrated/moved from study area|0
980188|NCT01262976|1986094|FG001|Up to Year 2|Migrated/moved from study area|0
980189|NCT01262976|1986095|FG002|Up to Year 2|Migrated/moved from study area|0
980190|NCT01262976|1986096|FG003|Up to Year 2|Migrated/moved from study area|2
980191|NCT01262976|1986097|FG004|Up to Year 2|Migrated/moved from study area|1
980192|NCT01262976|1986098|FG005|Up to Year 2|Migrated/moved from study area|2
980193|NCT01262976|1986093|FG000|Up to Year 2|Lost to Follow-up|1
980194|NCT01262976|1986094|FG001|Up to Year 2|Lost to Follow-up|1
980195|NCT01262976|1986095|FG002|Up to Year 2|Lost to Follow-up|2
980196|NCT01262976|1986096|FG003|Up to Year 2|Lost to Follow-up|2
980197|NCT01262976|1986097|FG004|Up to Year 2|Lost to Follow-up|3
980198|NCT01262976|1986098|FG005|Up to Year 2|Lost to Follow-up|3
980199|NCT01262976|1986093|FG000|Up to Year 2|Subjects with unknown completion status|0
980200|NCT01262976|1986094|FG001|Up to Year 2|Subjects with unknown completion status|0
980201|NCT01262976|1986095|FG002|Up to Year 2|Subjects with unknown completion status|1
980202|NCT01262976|1986096|FG003|Up to Year 2|Subjects with unknown completion status|0
980203|NCT01262976|1986097|FG004|Up to Year 2|Subjects with unknown completion status|0
980204|NCT01262976|1986098|FG005|Up to Year 2|Subjects with unknown completion status|0
980205|NCT01262976|1986093|FG000|Up to Year 2|Other|3
980206|NCT01262976|1986094|FG001|Up to Year 2|Other|0
980207|NCT01262976|1986095|FG002|Up to Year 2|Other|0
980208|NCT01262976|1986096|FG003|Up to Year 2|Other|0
980209|NCT01262976|1986097|FG004|Up to Year 2|Other|0
980210|NCT01262976|1986098|FG005|Up to Year 2|Other|0
980211|NCT01262976|1986093|FG000|Up to Year 3|Serious Adverse Event|0
980212|NCT01262976|1986094|FG001|Up to Year 3|Serious Adverse Event|0
980213|NCT01262976|1986095|FG002|Up to Year 3|Serious Adverse Event|2
980214|NCT01262976|1986096|FG003|Up to Year 3|Serious Adverse Event|0
980215|NCT01262976|1986097|FG004|Up to Year 3|Serious Adverse Event|0
980216|NCT01262976|1986098|FG005|Up to Year 3|Serious Adverse Event|0
980217|NCT01262976|1986093|FG000|Up to Year 3|Withdrawal by Subject|1
980218|NCT01262976|1986094|FG001|Up to Year 3|Withdrawal by Subject|0
980219|NCT01262976|1986095|FG002|Up to Year 3|Withdrawal by Subject|0
980220|NCT01262976|1986096|FG003|Up to Year 3|Withdrawal by Subject|0
980221|NCT01262976|1986097|FG004|Up to Year 3|Withdrawal by Subject|0
980222|NCT01262976|1986098|FG005|Up to Year 3|Withdrawal by Subject|0
980223|NCT01262976|1986093|FG000|Up to Year 3|Migrated/moved from study area|0
980224|NCT01262976|1986094|FG001|Up to Year 3|Migrated/moved from study area|0
980225|NCT01262976|1986095|FG002|Up to Year 3|Migrated/moved from study area|0
980226|NCT01262976|1986096|FG003|Up to Year 3|Migrated/moved from study area|2
980227|NCT01262976|1986097|FG004|Up to Year 3|Migrated/moved from study area|1
980228|NCT01262976|1986098|FG005|Up to Year 3|Migrated/moved from study area|1
980229|NCT01262976|1986093|FG000|Up to Year 3|Lost to Follow-up|2
980230|NCT01262976|1986094|FG001|Up to Year 3|Lost to Follow-up|2
980231|NCT01262976|1986095|FG002|Up to Year 3|Lost to Follow-up|4
980232|NCT01262976|1986096|FG003|Up to Year 3|Lost to Follow-up|3
980233|NCT01262976|1986097|FG004|Up to Year 3|Lost to Follow-up|1
980234|NCT01262976|1986098|FG005|Up to Year 3|Lost to Follow-up|3
980235|NCT01262976|1986093|FG000|Up to Year 3|Subjects with unknown completion status|0
980236|NCT01262976|1986094|FG001|Up to Year 3|Subjects with unknown completion status|0
980237|NCT01262976|1986095|FG002|Up to Year 3|Subjects with unknown completion status|1
980238|NCT01262976|1986096|FG003|Up to Year 3|Subjects with unknown completion status|0
980239|NCT01262976|1986097|FG004|Up to Year 3|Subjects with unknown completion status|0
980240|NCT01262976|1986098|FG005|Up to Year 3|Subjects with unknown completion status|0
980241|NCT01262976|1986093|FG000|Up to Year 3|Other|3
980242|NCT01262976|1986094|FG001|Up to Year 3|Other|0
980243|NCT01262976|1986095|FG002|Up to Year 3|Other|0
980244|NCT01262976|1986096|FG003|Up to Year 3|Other|0
980245|NCT01262976|1986097|FG004|Up to Year 3|Other|0
980246|NCT01262976|1986098|FG005|Up to Year 3|Other|0
980247|NCT01262989|1986113|FG000|Period 1|Lost to Follow-up|1
980248|NCT01262989|1986114|FG001|Period 1|Lost to Follow-up|1
980249|NCT01262989|1986113|FG000|Period 1|Intercurrent disease|0
980250|NCT01262989|1986114|FG001|Period 1|Intercurrent disease|1
980251|NCT01262989|1986113|FG000|Period 1|Positive answer for exclusion criteria|0
980252|NCT01262989|1986114|FG001|Period 1|Positive answer for exclusion criteria|1
980253|NCT01262989|1986113|FG000|Period 2|Intercurrent disease|0
980254|NCT01262989|1986114|FG001|Period 2|Intercurrent disease|1
980255|NCT01263015|1986122|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
980256|NCT01263015|1986123|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
980257|NCT01263015|1986122|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
980258|NCT01263015|1986123|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
980259|NCT01263015|1986122|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
980260|NCT01263015|1986123|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
980261|NCT01263015|1986122|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
980262|NCT01263015|1986123|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
980263|NCT01263015|1986122|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
980264|NCT01263015|1986123|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
980265|NCT01263015|1986122|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
980266|NCT01263015|1986123|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
980267|NCT01263015|1986122|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3
980268|NCT01263015|1986123|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10
980269|NCT01263015|1986122|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
980270|NCT01263015|1986123|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
980271|NCT01263015|1986122|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
980272|NCT01263015|1986123|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
980273|NCT01263015|1986122|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
980274|NCT01263015|1986123|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
980275|NCT01263015|1986122|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0
980276|NCT01263015|1986123|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2
980277|NCT01263015|1986122|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
980278|NCT01263015|1986123|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
980279|NCT01263054|1986131|FG000|Overall Study|Death|1
980280|NCT01263054|1986132|FG001|Overall Study|Death|0
980281|NCT01263054|1986131|FG000|Overall Study|Lost to Follow-up|2
980282|NCT01263054|1986132|FG001|Overall Study|Lost to Follow-up|2
980283|NCT01263054|1986131|FG000|Overall Study|Withdrawal by Subject|1
980284|NCT01263054|1986132|FG001|Overall Study|Withdrawal by Subject|3
980285|NCT01263054|1986131|FG000|Overall Study|Qualification Violation|1
980286|NCT01263054|1986132|FG001|Overall Study|Qualification Violation|0
980287|NCT01263054|1986131|FG000|Overall Study|Other|0
980288|NCT01263054|1986132|FG001|Overall Study|Other|1
980289|NCT01263093|1986140|FG000|Washout|Physician Decision|1
980290|NCT01263093|1986141|FG001|Washout|Physician Decision|0
980291|NCT01263093|1986140|FG000|Period 2|Adverse Event|1
980292|NCT01263093|1986141|FG001|Period 2|Adverse Event|0
980293|NCT01263106|1986148|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1
980294|NCT01263106|1986149|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1
980295|NCT01263119|1986158|FG000|Period 1|Protocol Violation|2
980296|NCT01263119|1986158|FG000|Period 2|Adverse Event|2
980297|NCT01263197|1986177|FG000|First Intervention (Period 1)|Adverse Event|0
980298|NCT01263197|1986178|FG001|First Intervention (Period 1)|Adverse Event|0
980299|NCT01263197|1986179|FG002|First Intervention (Period 1)|Adverse Event|0
980300|NCT01263197|1986180|FG003|First Intervention (Period 1)|Adverse Event|0
980301|NCT01263197|1986181|FG004|First Intervention (Period 1)|Adverse Event|0
980302|NCT01263197|1986182|FG005|First Intervention (Period 1)|Adverse Event|1
980303|NCT01263197|1986177|FG000|Washout Period 1|Protocol Violation|0
980304|NCT01263197|1986178|FG001|Washout Period 1|Protocol Violation|0
980305|NCT01263197|1986179|FG002|Washout Period 1|Protocol Violation|0
980306|NCT01263197|1986180|FG003|Washout Period 1|Protocol Violation|0
980307|NCT01263197|1986181|FG004|Washout Period 1|Protocol Violation|1
980308|NCT01263197|1986182|FG005|Washout Period 1|Protocol Violation|0
980309|NCT01263197|1986177|FG000|Washout Period 2|Physician Decision|0
980310|NCT01263197|1986178|FG001|Washout Period 2|Physician Decision|0
980311|NCT01263197|1986179|FG002|Washout Period 2|Physician Decision|0
980312|NCT01263197|1986180|FG003|Washout Period 2|Physician Decision|0
980313|NCT01263197|1986181|FG004|Washout Period 2|Physician Decision|0
980314|NCT01263197|1986182|FG005|Washout Period 2|Physician Decision|1
980315|NCT01263197|1986177|FG000|Washout Period 2|Protocol Violation|0
980316|NCT01263197|1986178|FG001|Washout Period 2|Protocol Violation|0
980317|NCT01263197|1986179|FG002|Washout Period 2|Protocol Violation|0
980318|NCT01263197|1986180|FG003|Washout Period 2|Protocol Violation|1
980319|NCT01263197|1986181|FG004|Washout Period 2|Protocol Violation|0
980320|NCT01263197|1986182|FG005|Washout Period 2|Protocol Violation|0
980321|NCT01263197|1986177|FG000|Third Intervention (Period 3)|Adverse Event|0
980322|NCT01263197|1986178|FG001|Third Intervention (Period 3)|Adverse Event|1
980323|NCT01263197|1986179|FG002|Third Intervention (Period 3)|Adverse Event|0
980324|NCT01263197|1986180|FG003|Third Intervention (Period 3)|Adverse Event|0
980325|NCT01263197|1986181|FG004|Third Intervention (Period 3)|Adverse Event|0
980326|NCT01263197|1986182|FG005|Third Intervention (Period 3)|Adverse Event|0
980327|NCT01263223|1986196|FG000|Period 2|Withdrawal by Subject|0
980328|NCT01263223|1986197|FG001|Period 2|Withdrawal by Subject|1
980329|NCT01263223|1986196|FG000|7-day Follow-up|Withdrawal by Subject|0
980330|NCT01263223|1986197|FG001|7-day Follow-up|Withdrawal by Subject|1
980331|NCT01263223|1986196|FG000|7-day Follow-up|Lost to Follow-up|1
980332|NCT01263223|1986197|FG001|7-day Follow-up|Lost to Follow-up|0
980333|NCT01263444|1986254|FG000|Overall Study|Adverse Event|8
980334|NCT01263444|1986254|FG000|Overall Study|Withdrawal by Subject|1
980335|NCT01263444|1986254|FG000|Overall Study|Protocol Violation|1
980336|NCT01263470|1986264|FG000|Overall Study|Adverse Event|2
980337|NCT01263470|1986265|FG001|Overall Study|Adverse Event|2
980338|NCT01263470|1986266|FG002|Overall Study|Adverse Event|1
980339|NCT01263470|1986267|FG003|Overall Study|Adverse Event|1
980340|NCT01263470|1986268|FG004|Overall Study|Adverse Event|2
980341|NCT01263470|1986269|FG005|Overall Study|Adverse Event|2
980342|NCT01263470|1986264|FG000|Overall Study|Protocol Violation|0
980343|NCT01263470|1986265|FG001|Overall Study|Protocol Violation|1
980344|NCT01263470|1986266|FG002|Overall Study|Protocol Violation|0
980345|NCT01263470|1986267|FG003|Overall Study|Protocol Violation|0
980346|NCT01263470|1986268|FG004|Overall Study|Protocol Violation|0
980347|NCT01263470|1986269|FG005|Overall Study|Protocol Violation|1
980348|NCT01263470|1986264|FG000|Overall Study|Withdrawal by Subject|0
980349|NCT01263470|1986265|FG001|Overall Study|Withdrawal by Subject|1
980350|NCT01263470|1986266|FG002|Overall Study|Withdrawal by Subject|1
980351|NCT01263470|1986267|FG003|Overall Study|Withdrawal by Subject|2
980352|NCT01263470|1986268|FG004|Overall Study|Withdrawal by Subject|0
980353|NCT01263470|1986269|FG005|Overall Study|Withdrawal by Subject|2
980354|NCT01263470|1986264|FG000|Overall Study|Lack of Efficacy|0
980355|NCT01263470|1986265|FG001|Overall Study|Lack of Efficacy|0
980356|NCT01263470|1986266|FG002|Overall Study|Lack of Efficacy|2
980357|NCT01263470|1986267|FG003|Overall Study|Lack of Efficacy|0
980358|NCT01263470|1986268|FG004|Overall Study|Lack of Efficacy|0
980359|NCT01263470|1986269|FG005|Overall Study|Lack of Efficacy|0
980360|NCT01263470|1986264|FG000|Overall Study|Participant Unavailability|0
980361|NCT01263470|1986265|FG001|Overall Study|Participant Unavailability|1
980362|NCT01263470|1986266|FG002|Overall Study|Participant Unavailability|0
980363|NCT01263470|1986267|FG003|Overall Study|Participant Unavailability|0
980364|NCT01263470|1986268|FG004|Overall Study|Participant Unavailability|0
980365|NCT01263470|1986269|FG005|Overall Study|Participant Unavailability|0
980366|NCT01263470|1986264|FG000|Overall Study|Study Drug Non-compliance|0
980367|NCT01263470|1986265|FG001|Overall Study|Study Drug Non-compliance|0
980368|NCT01263470|1986266|FG002|Overall Study|Study Drug Non-compliance|0
980369|NCT01263470|1986267|FG003|Overall Study|Study Drug Non-compliance|0
980370|NCT01263470|1986268|FG004|Overall Study|Study Drug Non-compliance|1
980371|NCT01263470|1986269|FG005|Overall Study|Study Drug Non-compliance|0
980372|NCT01263483|1986286|FG000|Overall Study|Adverse Event|4
980373|NCT01263483|1986287|FG001|Overall Study|Adverse Event|0
980374|NCT01263483|1986288|FG002|Overall Study|Adverse Event|3
980375|NCT01263483|1986286|FG000|Overall Study|Withdrawal by Subject|1
980376|NCT01263483|1986287|FG001|Overall Study|Withdrawal by Subject|0
980377|NCT01263483|1986288|FG002|Overall Study|Withdrawal by Subject|0
980378|NCT01263483|1986286|FG000|Overall Study|Lack of Efficacy|2
980379|NCT01263483|1986287|FG001|Overall Study|Lack of Efficacy|0
980380|NCT01263483|1986288|FG002|Overall Study|Lack of Efficacy|0
980381|NCT01263483|1986286|FG000|Overall Study|Protocol Violation|0
980382|NCT01263483|1986287|FG001|Overall Study|Protocol Violation|1
980383|NCT01263483|1986288|FG002|Overall Study|Protocol Violation|1
980384|NCT01263483|1986286|FG000|Overall Study|Participant Unavailability|0
980385|NCT01263483|1986287|FG001|Overall Study|Participant Unavailability|1
980386|NCT01263483|1986288|FG002|Overall Study|Participant Unavailability|1
980387|NCT01263496|1986301|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1
980388|NCT01263496|1986302|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0
980389|NCT01263496|1986303|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0
980390|NCT01263496|1986304|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0
980391|NCT01263496|1986305|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0
980392|NCT01263496|1986306|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0
980393|NCT01263496|1986307|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0
980394|NCT01263496|1986308|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0
980395|NCT01263496|1986309|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0
980396|NCT01263496|1986301|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
980397|NCT01263496|1986302|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
980398|NCT01263496|1986303|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
980399|NCT01263496|1986304|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
980400|NCT01263496|1986305|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2
980401|NCT01263496|1986306|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
980402|NCT01263496|1986307|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
980403|NCT01263496|1986308|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
980404|NCT01263496|1986309|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0
980405|NCT01263496|1986301|FG000|Entered - Long-Term Extension Study|Adverse Event|0
980406|NCT01263496|1986302|FG001|Entered - Long-Term Extension Study|Adverse Event|5
980407|NCT01263496|1986303|FG002|Entered - Long-Term Extension Study|Adverse Event|6
980408|NCT01263496|1986304|FG003|Entered - Long-Term Extension Study|Adverse Event|3
980409|NCT01263496|1986305|FG004|Entered - Long-Term Extension Study|Adverse Event|1
980410|NCT01263496|1986306|FG005|Entered - Long-Term Extension Study|Adverse Event|0
980411|NCT01263496|1986307|FG006|Entered - Long-Term Extension Study|Adverse Event|0
980412|NCT01263496|1986308|FG007|Entered - Long-Term Extension Study|Adverse Event|0
980413|NCT01263496|1986309|FG008|Entered - Long-Term Extension Study|Adverse Event|1
980414|NCT01263496|1986301|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0
980415|NCT01263496|1986302|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2
980416|NCT01263496|1986303|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
980417|NCT01263496|1986304|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
980418|NCT01263496|1986305|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0
980419|NCT01263496|1986306|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0
980420|NCT01263496|1986307|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0
980421|NCT01263496|1986308|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0
980422|NCT01263496|1986309|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0
980423|NCT01263496|1986301|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
980424|NCT01263496|1986302|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1006638|NCT01468987|2025355|FG000|Overall Study|Lost to Follow-up|10
980425|NCT01263496|1986303|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
980426|NCT01263496|1986304|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2
980427|NCT01263496|1986305|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4
980428|NCT01263496|1986306|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1
980429|NCT01263496|1986307|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1
980430|NCT01263496|1986308|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0
980431|NCT01263496|1986309|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1
980432|NCT01263496|1986301|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8
980433|NCT01263496|1986302|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
980434|NCT01263496|1986303|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4
980435|NCT01263496|1986304|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1
980436|NCT01263496|1986305|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5
980437|NCT01263496|1986306|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0
980438|NCT01263496|1986307|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0
980439|NCT01263496|1986308|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0
980440|NCT01263496|1986309|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1
980441|NCT01263496|1986301|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0
980442|NCT01263496|1986302|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0
980443|NCT01263496|1986303|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
980444|NCT01263496|1986304|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
980445|NCT01263496|1986305|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0
980446|NCT01263496|1986306|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0
980447|NCT01263496|1986307|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0
980448|NCT01263496|1986308|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1
980449|NCT01263496|1986309|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0
980450|NCT01263509|1986323|FG000|Entered - Long-Term Extension Study|Adverse Event|5
980451|NCT01263509|1986324|FG001|Entered - Long-Term Extension Study|Adverse Event|5
980452|NCT01263509|1986325|FG002|Entered - Long-Term Extension Study|Adverse Event|4
980453|NCT01263509|1986326|FG003|Entered - Long-Term Extension Study|Adverse Event|1
980454|NCT01263509|1986323|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1
980455|NCT01263509|1986324|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
980456|NCT01263509|1986325|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1
980457|NCT01263509|1986326|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
980458|NCT01263509|1986323|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
980459|NCT01263509|1986324|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
980460|NCT01263509|1986325|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
980461|NCT01263509|1986326|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
980462|NCT01263509|1986323|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1
980463|NCT01263509|1986324|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1
980464|NCT01263509|1986325|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
980465|NCT01263509|1986326|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
980466|NCT01263509|1986323|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
980467|NCT01263509|1986324|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
980468|NCT01263509|1986325|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
980469|NCT01263509|1986326|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
980470|NCT01263561|1986334|FG000|Overall Study|Death|1
980471|NCT01263561|1986335|FG001|Overall Study|Death|2
980472|NCT01263639|1986343|FG000|Overall Study|Lost to Follow-up|66
980473|NCT01263639|1986344|FG001|Overall Study|Lost to Follow-up|70
980474|NCT01263639|1986343|FG000|Overall Study|Exclusion =Admission greater than 7 days|7
980475|NCT01263639|1986344|FG001|Overall Study|Exclusion =Admission greater than 7 days|9
980476|NCT01263665|1986350|FG000|Overall Study|Withdrew Consent|1
980477|NCT01263665|1986350|FG000|Overall Study|Lost to Follow-up|3
980478|NCT01263665|1986350|FG000|Overall Study|Death|2
980479|NCT01263665|1986350|FG000|Overall Study|Amputation above the ankle|1
980480|NCT01263665|1986350|FG000|Overall Study|Surgical Bypass|2
980481|NCT01263691|1986360|FG000|Overall Study|Lost to Follow-up|1
980482|NCT01263691|1986361|FG001|Overall Study|Lost to Follow-up|0
980483|NCT01263691|1986362|FG002|Overall Study|Lost to Follow-up|1
980484|NCT01263691|1986363|FG003|Overall Study|Lost to Follow-up|1
980485|NCT01263691|1986364|FG004|Overall Study|Lost to Follow-up|0
980486|NCT01263691|1986365|FG005|Overall Study|Lost to Follow-up|0
980487|NCT01263691|1986360|FG000|Overall Study|Withdrawal by Subject|1
980488|NCT01263691|1986361|FG001|Overall Study|Withdrawal by Subject|0
980489|NCT01263691|1986362|FG002|Overall Study|Withdrawal by Subject|0
980490|NCT01263691|1986363|FG003|Overall Study|Withdrawal by Subject|0
980491|NCT01263691|1986364|FG004|Overall Study|Withdrawal by Subject|0
980492|NCT01263691|1986365|FG005|Overall Study|Withdrawal by Subject|0
980493|NCT01263691|1986360|FG000|Overall Study|Adverse Event|1
980494|NCT01263691|1986361|FG001|Overall Study|Adverse Event|0
980495|NCT01263691|1986362|FG002|Overall Study|Adverse Event|0
980496|NCT01263691|1986363|FG003|Overall Study|Adverse Event|0
980497|NCT01263691|1986364|FG004|Overall Study|Adverse Event|0
980498|NCT01263691|1986365|FG005|Overall Study|Adverse Event|0
980499|NCT01263704|1986400|FG000|Overall Study|Progressive disease|18
980500|NCT01263704|1986400|FG000|Overall Study|Adverse Event|3
980501|NCT01263704|1986400|FG000|Overall Study|Death|2
980502|NCT01263704|1986400|FG000|Overall Study|Patient withdrew consent|2
980503|NCT01263704|1986400|FG000|Overall Study|Eligibility criteria not fulfilled|1
980504|NCT01263704|1986400|FG000|Overall Study|Lost to Follow-up|1
980505|NCT01263704|1986400|FG000|Overall Study|Colon metastases|1
980506|NCT01263704|1986400|FG000|Overall Study|Principal Investigator (PI) decision|1
980507|NCT01263782|1986417|FG000|Overall Study|Death|0
980508|NCT01263782|1986418|FG001|Overall Study|Death|0
980509|NCT01263782|1986419|FG002|Overall Study|Death|1
980510|NCT01263782|1986420|FG003|Overall Study|Death|0
980511|NCT01263782|1986417|FG000|Overall Study|Progressive disease|0
980512|NCT01263782|1986418|FG001|Overall Study|Progressive disease|0
980513|NCT01263782|1986419|FG002|Overall Study|Progressive disease|0
980514|NCT01263782|1986420|FG003|Overall Study|Progressive disease|1
980515|NCT01263782|1986417|FG000|Overall Study|Too early|0
980516|NCT01263782|1986418|FG001|Overall Study|Too early|0
980517|NCT01263782|1986419|FG002|Overall Study|Too early|1
980518|NCT01263782|1986420|FG003|Overall Study|Too early|0
980519|NCT01263782|1986417|FG000|Overall Study|Inevaluable|0
980520|NCT01263782|1986418|FG001|Overall Study|Inevaluable|0
980521|NCT01263782|1986419|FG002|Overall Study|Inevaluable|1
980522|NCT01263782|1986420|FG003|Overall Study|Inevaluable|0
980523|NCT01263873|1986432|FG000|Overall Study|One provider unable to complete numbers|1
980524|NCT01263873|1986433|FG001|Overall Study|One provider unable to complete numbers|1
980525|NCT01263925|1986441|FG000|Overall Study|Protocol Violation|1
980526|NCT01263925|1986442|FG001|Overall Study|Protocol Violation|0
980527|NCT01263925|1986441|FG000|Overall Study|Lack of Efficacy|0
980528|NCT01263925|1986442|FG001|Overall Study|Lack of Efficacy|1
980529|NCT01263925|1986441|FG000|Overall Study|Adverse Event|23
980530|NCT01263925|1986442|FG001|Overall Study|Adverse Event|22
980531|NCT01263925|1986441|FG000|Overall Study|Unsatisfactory Compliance of Subject|8
980532|NCT01263925|1986442|FG001|Overall Study|Unsatisfactory Compliance of Subject|5
980533|NCT01263925|1986441|FG000|Overall Study|Withdrawal by Subject|6
980534|NCT01263925|1986442|FG001|Overall Study|Withdrawal by Subject|8
980535|NCT01263925|1986441|FG000|Overall Study|Other|4
980536|NCT01263925|1986442|FG001|Overall Study|Other|4
980537|NCT01263925|1986441|FG000|Overall Study|Lost to Follow-up|3
980538|NCT01263925|1986442|FG001|Overall Study|Lost to Follow-up|1
980539|NCT01263925|1986441|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
980540|NCT01263925|1986442|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
980541|NCT01263925|1986441|FG000|Overall Study|AE/ Unsatisfactory Compliance|2
980542|NCT01263925|1986442|FG001|Overall Study|AE/ Unsatisfactory Compliance|2
980543|NCT01263925|1986441|FG000|Overall Study|AE/ Withdrawal|1
980544|NCT01263925|1986442|FG001|Overall Study|AE/ Withdrawal|4
980545|NCT01263925|1986441|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
980546|NCT01263925|1986442|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
980547|NCT01263925|1986441|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
980548|NCT01263925|1986442|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
980549|NCT01263925|1986441|FG000|Overall Study|Withdrawal/ Not specified|0
980550|NCT01263925|1986442|FG001|Overall Study|Withdrawal/ Not specified|1
980551|NCT01264016|1986453|FG000|Overall Study|Withdrawal by Subject|1
980552|NCT01264016|1986453|FG000|Overall Study|Felt faint at sight of blood|1
980553|NCT01264081|1986458|FG000|Participants Screened|Screening failures|30
980554|NCT01264081|1986458|FG000|Started Treatment|Withdrawal by Subject|1
980555|NCT01264081|1986458|FG000|Started Treatment|Not complete cycle 1 due to death|1
980556|NCT01264380|1986462|FG000|Period C|Disease Progression|0
980557|NCT01264380|1986463|FG001|Period C|Disease Progression|0
980558|NCT01264380|1986464|FG002|Period C|Disease Progression|4
980559|NCT01264380|1986462|FG000|Period C|Death|0
980560|NCT01264380|1986463|FG001|Period C|Death|0
980561|NCT01264380|1986464|FG002|Period C|Death|2
980562|NCT01264380|1986462|FG000|Period C|Follow-up for survival status|0
980563|NCT01264380|1986463|FG001|Period C|Follow-up for survival status|0
980564|NCT01264380|1986464|FG002|Period C|Follow-up for survival status|6
980565|NCT01264380|1986462|FG000|Period C|Withdrawal by Subject|0
980566|NCT01264380|1986463|FG001|Period C|Withdrawal by Subject|0
980567|NCT01264380|1986464|FG002|Period C|Withdrawal by Subject|1
980568|NCT01264380|1986462|FG000|Period C|Adverse Event|0
980569|NCT01264380|1986463|FG001|Period C|Adverse Event|0
980570|NCT01264380|1986464|FG002|Period C|Adverse Event|1
980571|NCT01264419|1986472|FG000|Overall Study|Lost to Follow-up|3
980572|NCT01264718|1986512|FG000|Overall Study|Lost to Follow-up|3
980573|NCT01264718|1986513|FG001|Overall Study|Lost to Follow-up|2
980574|NCT01264718|1986512|FG000|Overall Study|Withdrawal by Subject|9
980575|NCT01264718|1986513|FG001|Overall Study|Withdrawal by Subject|15
980576|NCT01264718|1986512|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37
980577|NCT01264718|1986513|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26
980578|NCT01264770|1986525|FG000|Overall Study|Not reported|0
980579|NCT01264770|1986526|FG001|Overall Study|Not reported|0
980580|NCT01264770|1986527|FG002|Overall Study|Not reported|1
980581|NCT01264770|1986528|FG003|Overall Study|Not reported|0
980582|NCT01264770|1986529|FG004|Overall Study|Not reported|0
980583|NCT01264770|1986530|FG005|Overall Study|Not reported|0
980584|NCT01264770|1986525|FG000|Overall Study|e.g., change in circumstances|8
980585|NCT01264770|1986526|FG001|Overall Study|e.g., change in circumstances|3
980586|NCT01264770|1986527|FG002|Overall Study|e.g., change in circumstances|3
980587|NCT01264770|1986528|FG003|Overall Study|e.g., change in circumstances|3
980588|NCT01264770|1986529|FG004|Overall Study|e.g., change in circumstances|4
980589|NCT01264770|1986530|FG005|Overall Study|e.g., change in circumstances|4
980590|NCT01264770|1986525|FG000|Overall Study|Severe non-compliance to protocol|0
980591|NCT01264770|1986526|FG001|Overall Study|Severe non-compliance to protocol|0
980592|NCT01264770|1986527|FG002|Overall Study|Severe non-compliance to protocol|1
980593|NCT01264770|1986528|FG003|Overall Study|Severe non-compliance to protocol|1
980594|NCT01264770|1986529|FG004|Overall Study|Severe non-compliance to protocol|0
980595|NCT01264770|1986530|FG005|Overall Study|Severe non-compliance to protocol|0
980596|NCT01264770|1986525|FG000|Overall Study|Lack of therapeutic response|1
980597|NCT01264770|1986526|FG001|Overall Study|Lack of therapeutic response|0
980598|NCT01264770|1986527|FG002|Overall Study|Lack of therapeutic response|2
980599|NCT01264770|1986528|FG003|Overall Study|Lack of therapeutic response|1
980600|NCT01264770|1986529|FG004|Overall Study|Lack of therapeutic response|1
980601|NCT01264770|1986530|FG005|Overall Study|Lack of therapeutic response|0
980602|NCT01264770|1986525|FG000|Overall Study|Dev. of study specific discont. criteria|2
980603|NCT01264770|1986526|FG001|Overall Study|Dev. of study specific discont. criteria|0
980604|NCT01264770|1986527|FG002|Overall Study|Dev. of study specific discont. criteria|0
980605|NCT01264770|1986528|FG003|Overall Study|Dev. of study specific discont. criteria|0
980606|NCT01264770|1986529|FG004|Overall Study|Dev. of study specific discont. criteria|1
980607|NCT01264770|1986530|FG005|Overall Study|Dev. of study specific discont. criteria|1
980608|NCT01264770|1986525|FG000|Overall Study|Lost to Follow-up|0
980609|NCT01264770|1986526|FG001|Overall Study|Lost to Follow-up|0
980610|NCT01264770|1986527|FG002|Overall Study|Lost to Follow-up|1
980611|NCT01264770|1986528|FG003|Overall Study|Lost to Follow-up|1
980612|NCT01264770|1986529|FG004|Overall Study|Lost to Follow-up|0
980613|NCT01264770|1986530|FG005|Overall Study|Lost to Follow-up|0
980614|NCT01264770|1986525|FG000|Overall Study|Adverse Event|7
980615|NCT01264770|1986526|FG001|Overall Study|Adverse Event|7
980616|NCT01264770|1986527|FG002|Overall Study|Adverse Event|8
980617|NCT01264770|1986528|FG003|Overall Study|Adverse Event|0
980618|NCT01264770|1986529|FG004|Overall Study|Adverse Event|2
980619|NCT01264770|1986530|FG005|Overall Study|Adverse Event|1
980620|NCT01264887|1986550|FG000|Overall Study|Adverse Event|5
980621|NCT01264887|1986550|FG000|Overall Study|Death|7
980622|NCT01264887|1986550|FG000|Overall Study|Lack of Efficacy|5
980623|NCT01264887|1986550|FG000|Overall Study|Physician Decision|4
980624|NCT01264887|1986550|FG000|Overall Study|Withdrawal by Subject|6
980625|NCT01264887|1986550|FG000|Overall Study|Sponsor Decision Administrative Reasons|2
980626|NCT01264887|1986550|FG000|Overall Study|Other|2
980627|NCT01264939|1986558|FG000|Overall Study|Adverse Event|1
980628|NCT01264939|1986559|FG001|Overall Study|Adverse Event|3
980629|NCT01264939|1986558|FG000|Overall Study|Lost to Follow-up|0
980630|NCT01264939|1986559|FG001|Overall Study|Lost to Follow-up|3
980631|NCT01264939|1986558|FG000|Overall Study|Physician Decision|1
980632|NCT01264939|1986559|FG001|Overall Study|Physician Decision|1
980633|NCT01264939|1986558|FG000|Overall Study|Patient/Guardian Decision|8
980634|NCT01264939|1986559|FG001|Overall Study|Patient/Guardian Decision|10
980635|NCT01264939|1986558|FG000|Overall Study|Disease Progression|8
980636|NCT01264939|1986559|FG001|Overall Study|Disease Progression|11
980637|NCT01265056|1986580|FG000|Initial Study Period|Withdrawal by Subject|1
980638|NCT01265056|1986581|FG001|Initial Study Period|Withdrawal by Subject|1
980639|NCT01265056|1986580|FG000|Initial Study Period|Withdrawal by Subject|1
980640|NCT01265056|1986581|FG001|Initial Study Period|Withdrawal by Subject|1
980641|NCT01265056|1986580|FG000|Follow up|Lost to Follow-up|7
980642|NCT01265056|1986581|FG001|Follow up|Lost to Follow-up|3
980643|NCT01265394|1986587|FG000|Overall Study|Subjects withdrawn|37
980644|NCT01265420|1986592|FG000|Overall Study|Lost to Follow-up|1
980645|NCT01265498|1986632|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31
980646|NCT01265498|1986633|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33
980647|NCT01265511|1986641|FG000|Overall Study|Lack of Efficacy|2
980648|NCT01265511|1986642|FG001|Overall Study|Lack of Efficacy|1
980649|NCT01265511|1986641|FG000|Overall Study|Met stopping rules|0
980650|NCT01265511|1986642|FG001|Overall Study|Met stopping rules|2
980651|NCT01265537|1986659|FG000|Overall Study|Adverse Event|2
980652|NCT01265537|1986660|FG001|Overall Study|Adverse Event|1
980653|NCT01265537|1986659|FG000|Overall Study|Physician Decision|0
980654|NCT01265537|1986660|FG001|Overall Study|Physician Decision|1
980655|NCT01265550|1986670|FG000|Pre Randomization|Withdrawal by Subject|0
980656|NCT01265550|1986671|FG001|Pre Randomization|Withdrawal by Subject|0
980657|NCT01265550|1986672|FG002|Pre Randomization|Withdrawal by Subject|0
980658|NCT01265550|1986673|FG003|Pre Randomization|Withdrawal by Subject|70
980659|NCT01265550|1986670|FG000|Pre Randomization|Technical Exclusions|0
980660|NCT01265550|1986671|FG001|Pre Randomization|Technical Exclusions|0
980661|NCT01265550|1986672|FG002|Pre Randomization|Technical Exclusions|0
980662|NCT01265550|1986673|FG003|Pre Randomization|Technical Exclusions|54
980663|NCT01265550|1986670|FG000|Pre Randomization|GERD, PPI-Responsive|0
980664|NCT01265550|1986671|FG001|Pre Randomization|GERD, PPI-Responsive|0
980665|NCT01265550|1986672|FG002|Pre Randomization|GERD, PPI-Responsive|0
980666|NCT01265550|1986673|FG003|Pre Randomization|GERD, PPI-Responsive|42
980667|NCT01265550|1986670|FG000|Pre Randomization|Non-GERD organic disorders|0
980668|NCT01265550|1986671|FG001|Pre Randomization|Non-GERD organic disorders|0
980669|NCT01265550|1986672|FG002|Pre Randomization|Non-GERD organic disorders|0
980670|NCT01265550|1986673|FG003|Pre Randomization|Non-GERD organic disorders|23
980671|NCT01265550|1986670|FG000|Pre Randomization|Functional heartburn|0
980672|NCT01265550|1986671|FG001|Pre Randomization|Functional heartburn|0
980673|NCT01265550|1986672|FG002|Pre Randomization|Functional heartburn|0
980674|NCT01265550|1986673|FG003|Pre Randomization|Functional heartburn|99
980675|NCT01265563|1986692|FG000|Overall Study|Withdrawal by Subject|0
980676|NCT01265563|1986693|FG001|Overall Study|Withdrawal by Subject|1
980677|NCT01265563|1986694|FG002|Overall Study|Withdrawal by Subject|1
980678|NCT01265563|1986695|FG003|Overall Study|Withdrawal by Subject|0
980679|NCT01265563|1986696|FG004|Overall Study|Withdrawal by Subject|2
980680|NCT01265615|1986717|FG000|Overall Study|Protocol Violation|2
980681|NCT01265615|1986718|FG001|Overall Study|Protocol Violation|2
980682|NCT01265615|1986719|FG002|Overall Study|Protocol Violation|4
980683|NCT01265615|1986720|FG003|Overall Study|Protocol Violation|3
980684|NCT01265719|1986741|FG000|Overall Study|Does not meet entrance criteria|0
980685|NCT01265719|1986742|FG001|Overall Study|Does not meet entrance criteria|3
980686|NCT01265719|1986741|FG000|Overall Study|Other reasons|2
980687|NCT01265719|1986742|FG001|Overall Study|Other reasons|0
980688|NCT01265719|1986741|FG000|Overall Study|Withdrawal by Subject|8
980689|NCT01265719|1986742|FG001|Overall Study|Withdrawal by Subject|3
980690|NCT01265719|1986741|FG000|Overall Study|Lost to Follow-up|2
980691|NCT01265719|1986742|FG001|Overall Study|Lost to Follow-up|7
980692|NCT01265719|1986741|FG000|Overall Study|Adverse Event|2
980693|NCT01265719|1986742|FG001|Overall Study|Adverse Event|0
980715|NCT01265797|1986763|FG000|Run-in Month|Withdrawal by Subject|0
980716|NCT01265797|1986764|FG001|Run-in Month|Withdrawal by Subject|4
980717|NCT01265797|1986763|FG000|Run-in Month|1st seizure during run-in month|0
980718|NCT01265797|1986764|FG001|Run-in Month|1st seizure during run-in month|1
980719|NCT01265797|1986763|FG000|Blinded Month|Lack of Efficacy|5
980720|NCT01265797|1986764|FG001|Blinded Month|Lack of Efficacy|0
980721|NCT01265797|1986763|FG000|Blinded Month|Lost to Follow-up|1
980722|NCT01265797|1986764|FG001|Blinded Month|Lost to Follow-up|0
980723|NCT01265797|1986763|FG000|Blinded Month|Protocol Violation|2
980724|NCT01265797|1986764|FG001|Blinded Month|Protocol Violation|1
980725|NCT01265797|1986763|FG000|Blinded Month|Adverse Event|2
980726|NCT01265797|1986764|FG001|Blinded Month|Adverse Event|0
980727|NCT01265797|1986763|FG000|Blinded Month|Diary data incomplete|0
980728|NCT01265797|1986764|FG001|Blinded Month|Diary data incomplete|1
980729|NCT01265797|1986763|FG000|Open Label Month|Lost to Follow-up|0
980730|NCT01265797|1986764|FG001|Open Label Month|Lost to Follow-up|1
980731|NCT01265823|1986772|FG000|Overall Study|Unsatisfactory Response Efficacy|1
980732|NCT01265823|1986772|FG000|Overall Study|Failure to Return|4
980733|NCT01265823|1986772|FG000|Overall Study|Protocol Violation|1
980734|NCT01265823|1986772|FG000|Overall Study|Participant Request|1
980735|NCT01265875|1986780|FG000|Overall Study|Uncooperative/unreliable|1
980736|NCT01265953|1986787|FG000|Overall Study|Non compliance|5
980737|NCT01265953|1986788|FG001|Overall Study|Non compliance|3
980738|NCT01265992|1986807|FG000|Overall Study|Lost to Follow-up|1
980739|NCT01265992|1986807|FG000|Overall Study|Withdrawal by Subject|1
980740|NCT01265992|1986807|FG000|Overall Study|Adverse Event|1
980741|NCT01265992|1986807|FG000|Overall Study|Administrative reasons|2
980742|NCT01265992|1986807|FG000|Overall Study|Stopped treatment|3
980743|NCT01265992|1986807|FG000|Overall Study|Did not receive treatment|1
980744|NCT01266018|1986811|FG000|Overall Study|Physician Decision|1
980745|NCT01266018|1986812|FG001|Overall Study|Physician Decision|0
980746|NCT01266018|1986811|FG000|Overall Study|Progressive disease|0
980747|NCT01266018|1986812|FG001|Overall Study|Progressive disease|1
980748|NCT01266070|1986842|FG000|Overall Study|Adverse Event|3
980749|NCT01266070|1986842|FG000|Overall Study|Protocol Violation|1
980750|NCT01266122|1986848|FG000|Overall Study|Lost to Follow-up|6
980751|NCT01266122|1986849|FG001|Overall Study|Lost to Follow-up|6
980752|NCT01266148|1986857|FG000|Overall Study|Adverse Event|2
980753|NCT01266148|1986858|FG001|Overall Study|Adverse Event|0
980754|NCT01266148|1986857|FG000|Overall Study|Ongoing rejection|1
980755|NCT01266148|1986858|FG001|Overall Study|Ongoing rejection|0
980756|NCT01266148|1986857|FG000|Overall Study|2 2R rejections|1
980757|NCT01266148|1986858|FG001|Overall Study|2 2R rejections|0
980758|NCT01266148|1986857|FG000|Overall Study|Death|2
980759|NCT01266148|1986858|FG001|Overall Study|Death|3
980760|NCT01266148|1986857|FG000|Overall Study|missing mGFR value + AE|1
980761|NCT01266148|1986858|FG001|Overall Study|missing mGFR value + AE|0
980762|NCT01266161|1986866|FG000|Overall Study|Ineligible|1
980763|NCT01266161|1986867|FG001|Overall Study|Ineligible|0
980764|NCT01266161|1986866|FG000|Overall Study|Lack of Efficacy|0
980765|NCT01266161|1986867|FG001|Overall Study|Lack of Efficacy|1
980766|NCT01266161|1986866|FG000|Overall Study|Vomited within 4 hours of dosing|3
980767|NCT01266161|1986867|FG001|Overall Study|Vomited within 4 hours of dosing|0
980768|NCT01266265|1986875|FG000|Overall Study|Death|95
980769|NCT01266265|1986876|FG001|Overall Study|Death|73
980770|NCT01266265|1986875|FG000|Overall Study|Lost to Follow-up|23
980771|NCT01266265|1986876|FG001|Overall Study|Lost to Follow-up|28
980772|NCT01266265|1986875|FG000|Overall Study|Withdrawal by Subject|13
980773|NCT01266265|1986876|FG001|Overall Study|Withdrawal by Subject|11
980774|NCT01266265|1986875|FG000|Overall Study|Respiratory-related adverse event|2
980775|NCT01266265|1986876|FG001|Overall Study|Respiratory-related adverse event|1
980776|NCT01266265|1986875|FG000|Overall Study|Transferred care to another provider|22
980777|NCT01266265|1986876|FG001|Overall Study|Transferred care to another provider|28
980778|NCT01266265|1986875|FG000|Overall Study|Stopped/changed PAH medication(s)|16
980779|NCT01266265|1986876|FG001|Overall Study|Stopped/changed PAH medication(s)|9
980780|NCT01266265|1986875|FG000|Overall Study|Enrolled in another clinical study|15
980781|NCT01266265|1986876|FG001|Overall Study|Enrolled in another clinical study|26
980782|NCT01266265|1986875|FG000|Overall Study|Non-compliance|8
980783|NCT01266265|1986876|FG001|Overall Study|Non-compliance|5
980784|NCT01266265|1986875|FG000|Overall Study|Lung transplant|6
980785|NCT01266265|1986876|FG001|Overall Study|Lung transplant|5
980786|NCT01266265|1986875|FG000|Overall Study|Site closed early|4
980787|NCT01266265|1986876|FG001|Overall Study|Site closed early|3
980788|NCT01266265|1986875|FG000|Overall Study|Clinical worsening|1
980789|NCT01266265|1986876|FG001|Overall Study|Clinical worsening|1
980790|NCT01266291|1986882|FG000|Overall Study|Adverse Event|1
980791|NCT01266317|1986886|FG000|Overall Study|Withdrawal by Subject|2
980792|NCT01266460|1986894|FG000|Overall Study|Adverse Event|3
980793|NCT01266460|1986894|FG000|Overall Study|Withdrawal by Subject|5
980794|NCT01266460|1986894|FG000|Overall Study|Disease Progression|18
980795|NCT01266460|1986894|FG000|Overall Study|Not otherwise specified|8
980796|NCT01266590|1986898|FG000|Overall Study|Adverse Event|3
980797|NCT01266590|1986898|FG000|Overall Study|Lost to Follow-up|1
980798|NCT01266590|1986898|FG000|Overall Study|Withdrawal by Subject|1
980799|NCT01266590|1986898|FG000|Overall Study|Physician Decision|1
980800|NCT01266603|1986905|FG000|Overall Study|Adverse Event|1
980801|NCT01266603|1986905|FG000|Overall Study|Lack of Efficacy|14
980802|NCT01266603|1986905|FG000|Overall Study|Withdrawal by Subject|1
980803|NCT01266603|1986905|FG000|Overall Study|Failed screening; MAGE-A3 negative|26
980804|NCT01266642|1986911|FG000|Overall Study|Protocol Violation|0
980805|NCT01266642|1986912|FG001|Overall Study|Protocol Violation|1
980806|NCT01266850|1986923|FG000|Overall Study|Lost to Follow-up|19
980807|NCT01266850|1986924|FG001|Overall Study|Lost to Follow-up|19
980808|NCT01266850|1986925|FG002|Overall Study|Lost to Follow-up|13
980809|NCT01266850|1986926|FG003|Overall Study|Lost to Follow-up|13
980810|NCT01266850|1986927|FG004|Overall Study|Lost to Follow-up|12
980811|NCT01266850|1986923|FG000|Overall Study|Withdrawal by Subject|8
980812|NCT01266850|1986924|FG001|Overall Study|Withdrawal by Subject|9
980813|NCT01266850|1986925|FG002|Overall Study|Withdrawal by Subject|6
980814|NCT01266850|1986926|FG003|Overall Study|Withdrawal by Subject|9
980815|NCT01266850|1986927|FG004|Overall Study|Withdrawal by Subject|12
980816|NCT01266850|1986923|FG000|Overall Study|Physician Decision|3
980817|NCT01266850|1986924|FG001|Overall Study|Physician Decision|6
980818|NCT01266850|1986925|FG002|Overall Study|Physician Decision|4
980819|NCT01266850|1986926|FG003|Overall Study|Physician Decision|4
980820|NCT01266850|1986927|FG004|Overall Study|Physician Decision|3
980821|NCT01266850|1986923|FG000|Overall Study|Protocol Violation|0
980822|NCT01266850|1986924|FG001|Overall Study|Protocol Violation|1
980823|NCT01266850|1986925|FG002|Overall Study|Protocol Violation|0
980824|NCT01266850|1986926|FG003|Overall Study|Protocol Violation|1
980825|NCT01266850|1986927|FG004|Overall Study|Protocol Violation|2
980826|NCT01266850|1986923|FG000|Overall Study|Adverse Event|0
980827|NCT01266850|1986924|FG001|Overall Study|Adverse Event|0
980828|NCT01266850|1986925|FG002|Overall Study|Adverse Event|0
980829|NCT01266850|1986926|FG003|Overall Study|Adverse Event|0
980830|NCT01266850|1986927|FG004|Overall Study|Adverse Event|1
980831|NCT01266850|1986923|FG000|Overall Study|Site Closure|0
980832|NCT01266850|1986924|FG001|Overall Study|Site Closure|1
980833|NCT01266850|1986925|FG002|Overall Study|Site Closure|1
980834|NCT01266850|1986926|FG003|Overall Study|Site Closure|1
980835|NCT01266850|1986927|FG004|Overall Study|Site Closure|0
980836|NCT01266876|1986944|FG000|Overall Study|Adverse Event|0
980837|NCT01266876|1986945|FG001|Overall Study|Adverse Event|0
980838|NCT01266876|1986946|FG002|Overall Study|Adverse Event|0
980839|NCT01266876|1986947|FG003|Overall Study|Adverse Event|1
980840|NCT01266876|1986948|FG004|Overall Study|Adverse Event|0
980841|NCT01266902|1986962|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2
980842|NCT01266902|1986963|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3
980843|NCT01266902|1986964|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0
980844|NCT01266902|1986962|FG000|Period 1 (Main Study)|Lost to Follow-up|5
980845|NCT01266902|1986963|FG001|Period 1 (Main Study)|Lost to Follow-up|12
980846|NCT01266902|1986964|FG002|Period 1 (Main Study)|Lost to Follow-up|0
980847|NCT01266902|1986962|FG000|Period 1 (Main Study)|Lack of Efficacy|4
980848|NCT01266902|1986963|FG001|Period 1 (Main Study)|Lack of Efficacy|2
980849|NCT01266902|1986964|FG002|Period 1 (Main Study)|Lack of Efficacy|0
980850|NCT01266902|1986962|FG000|Period 1 (Main Study)|Adverse Event|3
980851|NCT01266902|1986963|FG001|Period 1 (Main Study)|Adverse Event|11
980852|NCT01266902|1986964|FG002|Period 1 (Main Study)|Adverse Event|0
980853|NCT01266902|1986962|FG000|Period 1 (Main Study)|Withdrawal by Subject|2
980854|NCT01266902|1986963|FG001|Period 1 (Main Study)|Withdrawal by Subject|12
980855|NCT01266902|1986964|FG002|Period 1 (Main Study)|Withdrawal by Subject|0
980856|NCT01266902|1986962|FG000|Period 1 (Main Study)|Subject non-compliant|3
980857|NCT01266902|1986963|FG001|Period 1 (Main Study)|Subject non-compliant|7
980858|NCT01266902|1986964|FG002|Period 1 (Main Study)|Subject non-compliant|0
980859|NCT01266902|1986962|FG000|Period 1 (Main Study)|Continued RPV treatment|11
980860|NCT01266902|1986963|FG001|Period 1 (Main Study)|Continued RPV treatment|34
980861|NCT01266902|1986964|FG002|Period 1 (Main Study)|Continued RPV treatment|0
980862|NCT01266902|1986962|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
980863|NCT01266902|1986963|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
980864|NCT01266902|1986964|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1
980865|NCT01266902|1986962|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0
980866|NCT01266902|1986963|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0
980867|NCT01266902|1986964|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1
980868|NCT01266902|1986962|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
980869|NCT01266902|1986963|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
980870|NCT01266902|1986964|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6
980871|NCT01266967|1986974|FG000|Overall Study|Death|69
980872|NCT01266967|1986975|FG001|Overall Study|Death|61
980873|NCT01266967|1986974|FG000|Overall Study|Study Closed/Terminated|15
980874|NCT01266967|1986975|FG001|Overall Study|Study Closed/Terminated|17
980875|NCT01266967|1986974|FG000|Overall Study|Lost to Follow-up|2
980876|NCT01266967|1986975|FG001|Overall Study|Lost to Follow-up|1
980877|NCT01266967|1986974|FG000|Overall Study|Physician Decision|0
980878|NCT01266967|1986975|FG001|Overall Study|Physician Decision|1
980879|NCT01266967|1986974|FG000|Overall Study|Withdrawal by Subject|3
980880|NCT01266967|1986975|FG001|Overall Study|Withdrawal by Subject|3
980881|NCT01266993|1986986|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5
980882|NCT01266993|1986987|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1
980883|NCT01266993|1986986|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0
980884|NCT01266993|1986987|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1
980885|NCT01267175|1987027|FG000|Overall Study|Withdrawal by Subject|1
980886|NCT01267175|1987027|FG000|Overall Study|Lost to Follow-up|1
980887|NCT01267201|1987031|FG000|First Intervention Period|Withdrawal by Subject|1
980888|NCT01267201|1987032|FG001|First Intervention Period|Withdrawal by Subject|0
980889|NCT01267201|1987033|FG002|First Intervention Period|Withdrawal by Subject|0
980890|NCT01267201|1987034|FG003|First Intervention Period|Withdrawal by Subject|0
980891|NCT01267201|1987035|FG004|First Intervention Period|Withdrawal by Subject|0
980892|NCT01267201|1987036|FG005|First Intervention Period|Withdrawal by Subject|0
980893|NCT01267201|1987031|FG000|Second Intervention Period|Withdrawal by Subject|0
980894|NCT01267201|1987032|FG001|Second Intervention Period|Withdrawal by Subject|1
980895|NCT01267201|1987033|FG002|Second Intervention Period|Withdrawal by Subject|0
980896|NCT01267201|1987034|FG003|Second Intervention Period|Withdrawal by Subject|0
980897|NCT01267201|1987035|FG004|Second Intervention Period|Withdrawal by Subject|0
980898|NCT01267201|1987036|FG005|Second Intervention Period|Withdrawal by Subject|0
980899|NCT01267253|1987069|FG000|Overall Study|Ineligible - required test not done|1
980900|NCT01267253|1987069|FG000|Overall Study|Inevaluable-never received study treatme|2
980901|NCT01267266|1987073|FG000|Enrollment Phase|Withdrawal by Subject|2
980902|NCT01267266|1987074|FG001|Enrollment Phase|Withdrawal by Subject|0
980903|NCT01267266|1987073|FG000|Lead-in Phase|Lack of Efficacy|20
980904|NCT01267266|1987074|FG001|Lead-in Phase|Lack of Efficacy|0
980905|NCT01267266|1987073|FG000|Lead-in Phase|Adverse Event|2
980906|NCT01267266|1987074|FG001|Lead-in Phase|Adverse Event|0
980907|NCT01267266|1987073|FG000|Lead-in Phase|Withdrawal by Subject|1
980908|NCT01267266|1987074|FG001|Lead-in Phase|Withdrawal by Subject|0
980909|NCT01267955|1987149|FG000|Stage 1 (6 Months)|Death|3
980910|NCT01267955|1987149|FG000|Stage 2 (6 Months)|Death|5
980911|NCT01267955|1987149|FG000|Stage 2 (6 Months)|Protocol Violation|1
980912|NCT01267994|1987153|FG000|Overall Study|Adverse Event|2
980913|NCT01268046|1987162|FG000|Overall Study|Withdrawal by Subject|1
980914|NCT01268046|1987163|FG001|Overall Study|Withdrawal by Subject|0
980915|NCT01268046|1987164|FG002|Overall Study|Withdrawal by Subject|0
980916|NCT01268046|1987165|FG003|Overall Study|Withdrawal by Subject|1
980917|NCT01268046|1987162|FG000|Overall Study|Lost to Follow-up|0
980918|NCT01268046|1987163|FG001|Overall Study|Lost to Follow-up|0
980919|NCT01268046|1987164|FG002|Overall Study|Lost to Follow-up|1
980920|NCT01268046|1987165|FG003|Overall Study|Lost to Follow-up|0
980921|NCT01268059|1987179|FG000|Overall Study|Lost to Follow-up|0
980922|NCT01268059|1987180|FG001|Overall Study|Lost to Follow-up|1
980923|NCT01268059|1987181|FG002|Overall Study|Lost to Follow-up|0
980924|NCT01268059|1987182|FG003|Overall Study|Lost to Follow-up|0
980925|NCT01268059|1987179|FG000|Overall Study|Withdrawal by Subject|7
980926|NCT01268059|1987180|FG001|Overall Study|Withdrawal by Subject|4
980927|NCT01268059|1987181|FG002|Overall Study|Withdrawal by Subject|0
980928|NCT01268059|1987182|FG003|Overall Study|Withdrawal by Subject|0
980929|NCT01268059|1987179|FG000|Overall Study|Death|20
980930|NCT01268059|1987180|FG001|Overall Study|Death|30
980931|NCT01268059|1987181|FG002|Overall Study|Death|3
980932|NCT01268059|1987182|FG003|Overall Study|Death|5
980933|NCT01268059|1987179|FG000|Overall Study|Progression of disease|1
980934|NCT01268059|1987180|FG001|Overall Study|Progression of disease|0
980935|NCT01268059|1987181|FG002|Overall Study|Progression of disease|0
980936|NCT01268059|1987182|FG003|Overall Study|Progression of disease|0
980937|NCT01268098|1987197|FG000|Overall Study|Adverse Event|1
980938|NCT01268098|1987198|FG001|Overall Study|Adverse Event|0
980939|NCT01268150|1987213|FG000|Treatment Phase|Progression of disease|18
980940|NCT01268150|1987213|FG000|Treatment Phase|Adverse Event|3
980941|NCT01268150|1987213|FG000|Treatment Phase|Withdrawal by Subject|3
980942|NCT01268150|1987213|FG000|Treatment Phase|Other|4
980943|NCT01268150|1987213|FG000|Extension Phase|Adverse Event|3
980944|NCT01268150|1987213|FG000|Extension Phase|Disease progression|18
980945|NCT01268150|1987213|FG000|Extension Phase|Other|6
980946|NCT01268267|1987223|FG000|Overall Study|Protocol Violation|1
980947|NCT01268293|1987228|FG000|Overall Study|Disease progression|7
980948|NCT01268293|1987228|FG000|Overall Study|Adverse Event|1
980949|NCT01268293|1987228|FG000|Overall Study|Subject choice|1
980950|NCT01268306|1987232|FG000|Overall Study|Lost to Follow-up|1
980951|NCT01268488|1987236|FG000|Overall Study|Adverse Event|3
980952|NCT01268488|1987236|FG000|Overall Study|Physician Decision|2
980953|NCT01268501|1987241|FG000|Overall Study|Lost to Follow-up|1
980954|NCT01268501|1987241|FG000|Overall Study|Withdrawal by Subject|3
980955|NCT01268501|1987241|FG000|Overall Study|Unacceptable Subjective Vision|3
980956|NCT01268501|1987241|FG000|Overall Study|Handling Difficulties|2
980957|NCT01268514|1987245|FG000|Overall Study|Adverse Event|20
980958|NCT01268514|1987245|FG000|Overall Study|Death|8
980959|NCT01268514|1987245|FG000|Overall Study|Lost to Follow-up|5
980960|NCT01268514|1987245|FG000|Overall Study|Withdrawal by Subject|3
980961|NCT01268514|1987245|FG000|Overall Study|Withdrawal by Surgeon|5
980962|NCT01268566|1987277|FG000|Overall Study|Lost to Follow-up|1
980963|NCT01268566|1987277|FG000|Overall Study|Withdrawal by Subject|12
980964|NCT01268566|1987277|FG000|Overall Study|Death|30
980965|NCT01268683|1987288|FG000|Overall Study|Lost to Follow-up|1
980966|NCT01268683|1987288|FG000|Overall Study|Death|1
980967|NCT01268891|1987294|FG000|Overall Study|Adverse Event|3
980968|NCT01268891|1987295|FG001|Overall Study|Adverse Event|7
980969|NCT01268891|1987294|FG000|Overall Study|Lack of Efficacy|1
980970|NCT01268891|1987295|FG001|Overall Study|Lack of Efficacy|0
980971|NCT01268891|1987294|FG000|Overall Study|Withdrawal of Consent|3
980972|NCT01268891|1987295|FG001|Overall Study|Withdrawal of Consent|1
980973|NCT01268891|1987294|FG000|Overall Study|Administrative or other reason(s)|1
980974|NCT01268891|1987295|FG001|Overall Study|Administrative or other reason(s)|0
980975|NCT01269125|1987336|FG000|Overall Study|Adverse Event|3
912641|NCT00806260|1890178|FG000|Period 3|Pregnancy|1
912642|NCT00806260|1890179|FG001|Period 3|Pregnancy|0
912643|NCT00806260|1890180|FG002|Period 3|Pregnancy|0
912644|NCT00806260|1890181|FG003|Period 3|Pregnancy|0
980976|NCT01269125|1987337|FG001|Overall Study|Adverse Event|5
980977|NCT01269125|1987338|FG002|Overall Study|Adverse Event|0
980978|NCT01269125|1987336|FG000|Overall Study|Lost to Follow-up|4
980979|NCT01269125|1987337|FG001|Overall Study|Lost to Follow-up|0
980980|NCT01269125|1987338|FG002|Overall Study|Lost to Follow-up|0
980981|NCT01269346|1987346|FG000|Treatment Phase|Disease progression|3
980982|NCT01269346|1987346|FG000|Treatment Phase|Adverse Event|3
980983|NCT01269346|1987346|FG000|Treatment Phase|Withdrawal by Subject|1
980984|NCT01269346|1987346|FG000|Treatment Phase|Other|2
980985|NCT01269346|1987346|FG000|Extension Phase|Adverse Event|6
912645|NCT00806260|1890182|FG004|Period 3|Pregnancy|0
912646|NCT00806260|1890183|FG005|Period 3|Pregnancy|0
912647|NCT00806286|1890198|FG000|Overall Study|Adverse Event|5
912648|NCT00806286|1890199|FG001|Overall Study|Adverse Event|2
912649|NCT00806286|1890200|FG002|Overall Study|Adverse Event|0
912650|NCT00806286|1890198|FG000|Overall Study|Disease progression|31
912651|NCT00806286|1890199|FG001|Overall Study|Disease progression|38
912652|NCT00806286|1890200|FG002|Overall Study|Disease progression|1
912653|NCT00806286|1890198|FG000|Overall Study|Death|1
912654|NCT00806286|1890199|FG001|Overall Study|Death|6
980986|NCT01269346|1987346|FG000|Extension Phase|Withdrawal by Subject|4
980987|NCT01269346|1987346|FG000|Extension Phase|Disease progression|22
980988|NCT01269346|1987346|FG000|Extension Phase|Physician decision or participant choice|9
980989|NCT01269346|1987346|FG000|Extension Phase|Clinical progression|1
980990|NCT01269346|1987346|FG000|Extension Phase|Started a prohibited con med|1
980991|NCT01269385|1987360|FG000|Overall Study|Adverse Event|1
980992|NCT01269385|1987361|FG001|Overall Study|Adverse Event|1
980993|NCT01269385|1987362|FG002|Overall Study|Adverse Event|0
980994|NCT01269385|1987363|FG003|Overall Study|Adverse Event|0
980995|NCT01269918|1987399|FG000|Overall Study|Did not receive study drug|0
980996|NCT01269918|1987400|FG001|Overall Study|Did not receive study drug|3
980997|NCT01270139|1987418|FG000|Overall Study|Adverse Event|8
980998|NCT01270139|1987419|FG001|Overall Study|Adverse Event|17
980999|NCT01270139|1987420|FG002|Overall Study|Adverse Event|18
981000|NCT01270139|1987418|FG000|Overall Study|Lost to Follow-up|10
981001|NCT01270139|1987419|FG001|Overall Study|Lost to Follow-up|9
981002|NCT01270139|1987420|FG002|Overall Study|Lost to Follow-up|2
981003|NCT01270256|1987437|FG000|Overall Study|Withdrawal by Subject|1
981004|NCT01270256|1987438|FG001|Overall Study|Withdrawal by Subject|0
981005|NCT01270321|1987447|FG000|Overall Study|Death|3
981006|NCT01270321|1987448|FG001|Overall Study|Death|1
981007|NCT01270321|1987449|FG002|Overall Study|Death|4
981008|NCT01270321|1987447|FG000|Overall Study|Adverse Event|7
981009|NCT01270321|1987448|FG001|Overall Study|Adverse Event|9
981010|NCT01270321|1987449|FG002|Overall Study|Adverse Event|5
981011|NCT01270464|1987460|FG000|Overall Study|Protocol Violation|4
981012|NCT01270464|1987461|FG001|Overall Study|Protocol Violation|3
981013|NCT01270464|1987462|FG002|Overall Study|Protocol Violation|2
981014|NCT01270464|1987460|FG000|Overall Study|Lack of Efficacy|2
981015|NCT01270464|1987461|FG001|Overall Study|Lack of Efficacy|3
981016|NCT01270464|1987462|FG002|Overall Study|Lack of Efficacy|1
981017|NCT01270464|1987460|FG000|Overall Study|Adverse Event|9
981018|NCT01270464|1987461|FG001|Overall Study|Adverse Event|1
981019|NCT01270464|1987462|FG002|Overall Study|Adverse Event|7
981020|NCT01270464|1987460|FG000|Overall Study|Withdrawal by Subject|2
981021|NCT01270464|1987461|FG001|Overall Study|Withdrawal by Subject|1
981022|NCT01270464|1987462|FG002|Overall Study|Withdrawal by Subject|4
981023|NCT01270464|1987460|FG000|Overall Study|Lost to Follow-up|2
981024|NCT01270464|1987461|FG001|Overall Study|Lost to Follow-up|3
981025|NCT01270464|1987462|FG002|Overall Study|Lost to Follow-up|1
981026|NCT01270464|1987460|FG000|Overall Study|Other|1
981027|NCT01270464|1987461|FG001|Overall Study|Other|1
981028|NCT01270464|1987462|FG002|Overall Study|Other|3
981029|NCT01270503|1987470|FG000|Overall Study|Lost to Follow-up|1
981030|NCT01270620|1987520|FG000|Overall Study|Withdrawal by Subject|1
981031|NCT01270620|1987521|FG001|Overall Study|Withdrawal by Subject|3
981032|NCT01270802|1987586|FG000|Overall Study|Withdrawal by Subject|1
981033|NCT01270802|1987587|FG001|Overall Study|Withdrawal by Subject|0
981034|NCT01270802|1987586|FG000|Overall Study|Adverse Event|1
981035|NCT01270802|1987587|FG001|Overall Study|Adverse Event|0
981036|NCT01270802|1987586|FG000|Overall Study|Lost to Follow-up|0
981037|NCT01270802|1987587|FG001|Overall Study|Lost to Follow-up|1
981038|NCT01270828|1987596|FG000|Pregabalin CR SB|Reason Unspecified|0
981039|NCT01270828|1987597|FG001|Pregabalin CR SB|Reason Unspecified|0
981040|NCT01270828|1987598|FG002|Pregabalin CR SB|Reason Unspecified|8
981041|NCT01270828|1987596|FG000|Pregabalin CR SB|Enrolled but not treated|0
981042|NCT01270828|1987597|FG001|Pregabalin CR SB|Enrolled but not treated|0
981043|NCT01270828|1987598|FG002|Pregabalin CR SB|Enrolled but not treated|5
981044|NCT01270828|1987596|FG000|Pregabalin CR SB|Related adverse event|0
981045|NCT01270828|1987597|FG001|Pregabalin CR SB|Related adverse event|0
981046|NCT01270828|1987598|FG002|Pregabalin CR SB|Related adverse event|46
981047|NCT01270828|1987596|FG000|Pregabalin CR SB|Lack of Efficacy|0
981048|NCT01270828|1987597|FG001|Pregabalin CR SB|Lack of Efficacy|0
981049|NCT01270828|1987598|FG002|Pregabalin CR SB|Lack of Efficacy|32
981050|NCT01270828|1987596|FG000|Pregabalin CR SB|Withdrawal by Subject|0
981051|NCT01270828|1987597|FG001|Pregabalin CR SB|Withdrawal by Subject|0
981052|NCT01270828|1987598|FG002|Pregabalin CR SB|Withdrawal by Subject|29
981053|NCT01270828|1987596|FG000|Pregabalin CR SB|Lost to Follow-up|0
981054|NCT01270828|1987597|FG001|Pregabalin CR SB|Lost to Follow-up|0
981055|NCT01270828|1987598|FG002|Pregabalin CR SB|Lost to Follow-up|10
981056|NCT01270828|1987596|FG000|Pregabalin CR SB|Unrelated AE|0
981057|NCT01270828|1987597|FG001|Pregabalin CR SB|Unrelated AE|0
981058|NCT01270828|1987598|FG002|Pregabalin CR SB|Unrelated AE|8
981059|NCT01270828|1987596|FG000|Pregabalin CR SB|Protocol Violation|0
981060|NCT01270828|1987597|FG001|Pregabalin CR SB|Protocol Violation|0
981061|NCT01270828|1987598|FG002|Pregabalin CR SB|Protocol Violation|8
981062|NCT01270828|1987596|FG000|Double Blind Phase|Death|0
981063|NCT01270828|1987597|FG001|Double Blind Phase|Death|1
981064|NCT01270828|1987598|FG002|Double Blind Phase|Death|0
981065|NCT01270828|1987596|FG000|Double Blind Phase|Protocol Violation|0
981066|NCT01270828|1987597|FG001|Double Blind Phase|Protocol Violation|1
981067|NCT01270828|1987598|FG002|Double Blind Phase|Protocol Violation|0
981068|NCT01270828|1987596|FG000|Double Blind Phase|Protocol and GCP non-compliance|4
981069|NCT01270828|1987597|FG001|Double Blind Phase|Protocol and GCP non-compliance|3
981070|NCT01270828|1987598|FG002|Double Blind Phase|Protocol and GCP non-compliance|0
981071|NCT01270828|1987596|FG000|Double Blind Phase|Reason Unspecified|7
981072|NCT01270828|1987597|FG001|Double Blind Phase|Reason Unspecified|4
981073|NCT01270828|1987598|FG002|Double Blind Phase|Reason Unspecified|0
981074|NCT01270828|1987596|FG000|Double Blind Phase|Withdrawal by Subject|6
981075|NCT01270828|1987597|FG001|Double Blind Phase|Withdrawal by Subject|15
981076|NCT01270828|1987598|FG002|Double Blind Phase|Withdrawal by Subject|0
981077|NCT01270828|1987596|FG000|Double Blind Phase|Lost to Follow-up|1
981078|NCT01270828|1987597|FG001|Double Blind Phase|Lost to Follow-up|2
981079|NCT01270828|1987598|FG002|Double Blind Phase|Lost to Follow-up|0
981080|NCT01270828|1987596|FG000|Double Blind Phase|Lack of Efficacy|2
981081|NCT01270828|1987597|FG001|Double Blind Phase|Lack of Efficacy|11
981082|NCT01270828|1987598|FG002|Double Blind Phase|Lack of Efficacy|0
981083|NCT01270828|1987596|FG000|Double Blind Phase|Adverse event not related to study drug|1
981084|NCT01270828|1987597|FG001|Double Blind Phase|Adverse event not related to study drug|1
981085|NCT01270828|1987598|FG002|Double Blind Phase|Adverse event not related to study drug|0
981086|NCT01270828|1987596|FG000|Double Blind Phase|Adverse event related to study drug|5
981087|NCT01270828|1987597|FG001|Double Blind Phase|Adverse event related to study drug|7
981088|NCT01270828|1987598|FG002|Double Blind Phase|Adverse event related to study drug|0
981089|NCT01270841|1987610|FG000|Overall Study|Adverse Event|0
981090|NCT01270841|1987611|FG001|Overall Study|Adverse Event|1
981091|NCT01270841|1987612|FG002|Overall Study|Adverse Event|0
981092|NCT01270841|1987613|FG003|Overall Study|Adverse Event|3
981093|NCT01270841|1987610|FG000|Overall Study|Withdrawal by Subject|3
981094|NCT01270841|1987611|FG001|Overall Study|Withdrawal by Subject|2
981095|NCT01270841|1987612|FG002|Overall Study|Withdrawal by Subject|3
981096|NCT01270841|1987613|FG003|Overall Study|Withdrawal by Subject|3
981097|NCT01270841|1987610|FG000|Overall Study|Lost to Follow-up|3
981098|NCT01270841|1987611|FG001|Overall Study|Lost to Follow-up|1
981099|NCT01270841|1987612|FG002|Overall Study|Lost to Follow-up|4
981100|NCT01270841|1987613|FG003|Overall Study|Lost to Follow-up|2
981101|NCT01270841|1987610|FG000|Overall Study|Physician Decision|0
981102|NCT01270841|1987611|FG001|Overall Study|Physician Decision|1
981103|NCT01270841|1987612|FG002|Overall Study|Physician Decision|0
981104|NCT01270841|1987613|FG003|Overall Study|Physician Decision|0
981105|NCT01270841|1987610|FG000|Overall Study|Did not qualify|6
981106|NCT01270841|1987611|FG001|Overall Study|Did not qualify|3
981107|NCT01270841|1987612|FG002|Overall Study|Did not qualify|4
981108|NCT01270841|1987613|FG003|Overall Study|Did not qualify|5
981109|NCT01270841|1987610|FG000|Overall Study|Protocol Violation|1
981110|NCT01270841|1987611|FG001|Overall Study|Protocol Violation|5
981111|NCT01270841|1987612|FG002|Overall Study|Protocol Violation|0
981112|NCT01270841|1987613|FG003|Overall Study|Protocol Violation|0
981113|NCT01270841|1987610|FG000|Overall Study|Enrolled in error|0
981114|NCT01270841|1987611|FG001|Overall Study|Enrolled in error|1
981115|NCT01270841|1987612|FG002|Overall Study|Enrolled in error|0
981116|NCT01270841|1987613|FG003|Overall Study|Enrolled in error|0
981117|NCT01270880|1987632|FG000|Overall Study|Never rec'd treatment, but registered.|1
981118|NCT01270958|1987636|FG000|Overall Study|Lost to Follow-up|2
981119|NCT01270958|1987636|FG000|Overall Study|Did not meet inclusion criteria for age|2
981120|NCT01270971|1987642|FG000|Overall Study|Withdrawal by Subject|24
981121|NCT01270971|1987643|FG001|Overall Study|Withdrawal by Subject|11
981122|NCT01270971|1987642|FG000|Overall Study|Lost to Follow-up|18
981123|NCT01270971|1987643|FG001|Overall Study|Lost to Follow-up|5
981124|NCT01270971|1987642|FG000|Overall Study|Adverse Event|1
981125|NCT01270971|1987643|FG001|Overall Study|Adverse Event|2
981126|NCT01270971|1987642|FG000|Overall Study|Non compliance|2
981127|NCT01270971|1987643|FG001|Overall Study|Non compliance|2
981128|NCT01270971|1987642|FG000|Overall Study|Non-specific|7
981129|NCT01270971|1987643|FG001|Overall Study|Non-specific|3
981130|NCT01271010|1987649|FG000|Overall Study|Reason not specified|11
981131|NCT01271010|1987649|FG000|Overall Study|Start of new CLL therapy|1
981132|NCT01271010|1987649|FG000|Overall Study|Protocol Violation|1
981133|NCT01271010|1987649|FG000|Overall Study|Death|2
981134|NCT01271010|1987649|FG000|Overall Study|Progression and relapse of disease|1
981135|NCT01271010|1987649|FG000|Overall Study|Withdrawal by Subject|18
981136|NCT01271010|1987649|FG000|Overall Study|Disease progression|27
981137|NCT01271504|1987693|FG000|Overall Study|Death|7
981138|NCT01271504|1987694|FG001|Overall Study|Death|6
981139|NCT01271504|1987695|FG002|Overall Study|Death|32
981140|NCT01271504|1987696|FG003|Overall Study|Death|32
981141|NCT01271504|1987693|FG000|Overall Study|Lost to Follow-up|0
981142|NCT01271504|1987694|FG001|Overall Study|Lost to Follow-up|1
981143|NCT01271504|1987695|FG002|Overall Study|Lost to Follow-up|3
981144|NCT01271504|1987696|FG003|Overall Study|Lost to Follow-up|1
981145|NCT01271504|1987693|FG000|Overall Study|Protocol Violation|0
981146|NCT01271504|1987694|FG001|Overall Study|Protocol Violation|0
981147|NCT01271504|1987695|FG002|Overall Study|Protocol Violation|0
981148|NCT01271504|1987696|FG003|Overall Study|Protocol Violation|2
981149|NCT01271504|1987693|FG000|Overall Study|Administrative Reasons|0
981150|NCT01271504|1987694|FG001|Overall Study|Administrative Reasons|0
981151|NCT01271504|1987695|FG002|Overall Study|Administrative Reasons|6
981152|NCT01271504|1987696|FG003|Overall Study|Administrative Reasons|5
981153|NCT01271504|1987693|FG000|Overall Study|Withdrawal by Subject|0
981154|NCT01271504|1987694|FG001|Overall Study|Withdrawal by Subject|0
981155|NCT01271504|1987695|FG002|Overall Study|Withdrawal by Subject|1
981156|NCT01271504|1987696|FG003|Overall Study|Withdrawal by Subject|3
981157|NCT01271504|1987693|FG000|Overall Study|Other|0
981158|NCT01271504|1987694|FG001|Overall Study|Other|1
981159|NCT01271504|1987695|FG002|Overall Study|Other|2
981160|NCT01271504|1987696|FG003|Overall Study|Other|0
981161|NCT01271712|1987732|FG000|Double Blind Treatment|Death|2
981162|NCT01271712|1987733|FG001|Double Blind Treatment|Death|0
981163|NCT01271712|1987732|FG000|Double Blind Treatment|Lack of Efficacy|1
981164|NCT01271712|1987733|FG001|Double Blind Treatment|Lack of Efficacy|0
981165|NCT01271712|1987732|FG000|Double Blind Treatment|Adverse Event|9
981166|NCT01271712|1987733|FG001|Double Blind Treatment|Adverse Event|4
981167|NCT01271712|1987732|FG000|Double Blind Treatment|Progressive disease|23
981168|NCT01271712|1987733|FG001|Double Blind Treatment|Progressive disease|3
981169|NCT01271712|1987732|FG000|Double Blind Treatment|Withdrawal by Subject|4
981170|NCT01271712|1987733|FG001|Double Blind Treatment|Withdrawal by Subject|1
981171|NCT01271712|1987732|FG000|Double Blind Treatment|Non compliance with study drug|2
981172|NCT01271712|1987733|FG001|Double Blind Treatment|Non compliance with study drug|0
981173|NCT01271712|1987732|FG000|Double Blind Treatment|receive no study drug|1
981174|NCT01271712|1987733|FG001|Double Blind Treatment|receive no study drug|0
981175|NCT01271712|1987732|FG000|Open Label Treatment|Death|6
981176|NCT01271712|1987733|FG001|Open Label Treatment|Death|5
981177|NCT01271712|1987732|FG000|Open Label Treatment|Withdrawal by Subject|6
981178|NCT01271712|1987733|FG001|Open Label Treatment|Withdrawal by Subject|11
981179|NCT01271712|1987732|FG000|Open Label Treatment|Physician Decision|2
981180|NCT01271712|1987733|FG001|Open Label Treatment|Physician Decision|0
981181|NCT01271712|1987732|FG000|Open Label Treatment|Adverse Event|14
981182|NCT01271712|1987733|FG001|Open Label Treatment|Adverse Event|8
981183|NCT01271712|1987732|FG000|Open Label Treatment|Progressive disease|59
981184|NCT01271712|1987733|FG001|Open Label Treatment|Progressive disease|32
981185|NCT01271712|1987732|FG000|Open Label Treatment|transferred to rollover study|1
981186|NCT01271712|1987733|FG001|Open Label Treatment|transferred to rollover study|0
981187|NCT01271712|1987732|FG000|Open Label Treatment|Non-compliance with study drug|1
981188|NCT01271712|1987733|FG001|Open Label Treatment|Non-compliance with study drug|0
981189|NCT01271712|1987732|FG000|Open Label Treatment|Protocol Violation|0
981190|NCT01271712|1987733|FG001|Open Label Treatment|Protocol Violation|1
981191|NCT01271712|1987732|FG000|Open Label Treatment|Switching to other therapy|2
981192|NCT01271712|1987733|FG001|Open Label Treatment|Switching to other therapy|1
981193|NCT01271712|1987732|FG000|Safety Follow-up|Death|11
981194|NCT01271712|1987733|FG001|Safety Follow-up|Death|7
981195|NCT01271712|1987732|FG000|Safety Follow-up|Withdrawal by Subject|4
981196|NCT01271712|1987733|FG001|Safety Follow-up|Withdrawal by Subject|2
981197|NCT01271712|1987732|FG000|Safety Follow-up|Protocol Violation|1
981198|NCT01271712|1987733|FG001|Safety Follow-up|Protocol Violation|1
981199|NCT01271712|1987732|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
981200|NCT01271712|1987733|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
981201|NCT01271712|1987732|FG000|Safety Follow-up|No follow-up|1
981202|NCT01271712|1987733|FG001|Safety Follow-up|No follow-up|1
981203|NCT01271712|1987732|FG000|Safety Follow-up|Progressive disease|1
981204|NCT01271712|1987733|FG001|Safety Follow-up|Progressive disease|0
981205|NCT01271712|1987732|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
981206|NCT01271712|1987733|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
981207|NCT01271725|1987742|FG000|Part A|Progressive disease according to RECIST|8
981208|NCT01271725|1987743|FG001|Part A|Progressive disease according to RECIST|0
981209|NCT01271725|1987742|FG000|Part A|Clinical signs/symptoms of progression|2
981210|NCT01271725|1987743|FG001|Part A|Clinical signs/symptoms of progression|0
981211|NCT01271725|1987742|FG000|Part A|Other Adverse Event|8
981212|NCT01271725|1987743|FG001|Part A|Other Adverse Event|0
981213|NCT01271725|1987742|FG000|Part A|Lost to Follow-up|1
981214|NCT01271725|1987743|FG001|Part A|Lost to Follow-up|0
981215|NCT01271725|1987742|FG000|Part A|Withdrawal by Subject|12
981216|NCT01271725|1987743|FG001|Part A|Withdrawal by Subject|0
981217|NCT01271725|1987742|FG000|Part A|Other than specified|3
981218|NCT01271725|1987743|FG001|Part A|Other than specified|0
981219|NCT01271725|1987742|FG000|Part A|Protocol Violation|1
981220|NCT01271725|1987743|FG001|Part A|Protocol Violation|0
981221|NCT01271725|1987742|FG000|Part B|Other than specified|0
981222|NCT01271725|1987743|FG001|Part B|Other than specified|2
981223|NCT01271725|1987742|FG000|Part B|Clinical signs/symptoms of progression|0
981224|NCT01271725|1987743|FG001|Part B|Clinical signs/symptoms of progression|2
981225|NCT01271725|1987742|FG000|Part B|Other Adverse Event|0
981226|NCT01271725|1987743|FG001|Part B|Other Adverse Event|1
981227|NCT01271725|1987742|FG000|Part B|Protocol Violation|0
981228|NCT01271725|1987743|FG001|Part B|Protocol Violation|1
981229|NCT01271725|1987742|FG000|Part B|Withdrawal by Subject|0
981230|NCT01271725|1987743|FG001|Part B|Withdrawal by Subject|6
981231|NCT01271803|1987755|FG000|Overall Study|Progressive disease|0
981232|NCT01271803|1987756|FG001|Overall Study|Progressive disease|0
981233|NCT01271803|1987757|FG002|Overall Study|Progressive disease|2
981234|NCT01271803|1987755|FG000|Overall Study|Death|53
981235|NCT01271803|1987756|FG001|Overall Study|Death|34
981236|NCT01271803|1987757|FG002|Overall Study|Death|0
981237|NCT01271803|1987755|FG000|Overall Study|Withdrawal by Subject|1
981238|NCT01271803|1987756|FG001|Overall Study|Withdrawal by Subject|5
981239|NCT01271803|1987757|FG002|Overall Study|Withdrawal by Subject|0
981240|NCT01271803|1987755|FG000|Overall Study|Lost to Follow-up|1
981241|NCT01271803|1987756|FG001|Overall Study|Lost to Follow-up|0
981242|NCT01271803|1987757|FG002|Overall Study|Lost to Follow-up|0
981243|NCT01271933|1987830|FG000|Single-Blind Phase|Lack of Efficacy|37
981244|NCT01271933|1987831|FG001|Single-Blind Phase|Lack of Efficacy|0
981245|NCT01271933|1987832|FG002|Single-Blind Phase|Lack of Efficacy|0
981246|NCT01271933|1987830|FG000|Single-Blind Phase|Lost to Follow-up|10
981247|NCT01271933|1987831|FG001|Single-Blind Phase|Lost to Follow-up|0
981248|NCT01271933|1987832|FG002|Single-Blind Phase|Lost to Follow-up|0
981249|NCT01271933|1987830|FG000|Single-Blind Phase|Withdrawal by Subject|15
981250|NCT01271933|1987831|FG001|Single-Blind Phase|Withdrawal by Subject|0
981251|NCT01271933|1987832|FG002|Single-Blind Phase|Withdrawal by Subject|0
981252|NCT01271933|1987830|FG000|Single-Blind Phase|Protocol Violation|3
981253|NCT01271933|1987831|FG001|Single-Blind Phase|Protocol Violation|0
981254|NCT01271933|1987832|FG002|Single-Blind Phase|Protocol Violation|0
981255|NCT01271933|1987830|FG000|Single-Blind Phase|Adverse Event|52
981256|NCT01271933|1987831|FG001|Single-Blind Phase|Adverse Event|0
981257|NCT01271933|1987832|FG002|Single-Blind Phase|Adverse Event|0
981258|NCT01271933|1987830|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1
981259|NCT01271933|1987831|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0
981260|NCT01271933|1987832|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0
981261|NCT01271933|1987830|FG000|Single-Blind Phase|(Protocol non-compliance)|2
981262|NCT01271933|1987831|FG001|Single-Blind Phase|(Protocol non-compliance)|0
981263|NCT01271933|1987832|FG002|Single-Blind Phase|(Protocol non-compliance)|0
981264|NCT01271933|1987830|FG000|Single-Blind Phase|(Participant request-personal reason)|1
981265|NCT01271933|1987831|FG001|Single-Blind Phase|(Participant request-personal reason)|0
981266|NCT01271933|1987832|FG002|Single-Blind Phase|(Participant request-personal reason)|0
981267|NCT01271933|1987830|FG000|Double-Blind Phase|Randomized but not treated|0
981268|NCT01271933|1987831|FG001|Double-Blind Phase|Randomized but not treated|0
981269|NCT01271933|1987832|FG002|Double-Blind Phase|Randomized but not treated|1
981270|NCT01271933|1987830|FG000|Double-Blind Phase|Lack of Efficacy|0
981271|NCT01271933|1987831|FG001|Double-Blind Phase|Lack of Efficacy|6
981272|NCT01271933|1987832|FG002|Double-Blind Phase|Lack of Efficacy|9
981273|NCT01271933|1987830|FG000|Double-Blind Phase|Lost to Follow-up|0
981274|NCT01271933|1987831|FG001|Double-Blind Phase|Lost to Follow-up|1
981275|NCT01271933|1987832|FG002|Double-Blind Phase|Lost to Follow-up|1
981276|NCT01271933|1987830|FG000|Double-Blind Phase|Withdrawal by Subject|0
981277|NCT01271933|1987831|FG001|Double-Blind Phase|Withdrawal by Subject|6
981278|NCT01271933|1987832|FG002|Double-Blind Phase|Withdrawal by Subject|1
981279|NCT01271933|1987830|FG000|Double-Blind Phase|Adverse Event|0
981280|NCT01271933|1987831|FG001|Double-Blind Phase|Adverse Event|3
981281|NCT01271933|1987832|FG002|Double-Blind Phase|Adverse Event|0
981282|NCT01271933|1987830|FG000|Double-Blind Phase|Participant request-personal reason|0
981283|NCT01271933|1987831|FG001|Double-Blind Phase|Participant request-personal reason|1
981284|NCT01271933|1987832|FG002|Double-Blind Phase|Participant request-personal reason|0
981285|NCT01272011|1987868|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0
981286|NCT01272011|1987869|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2
981287|NCT01272011|1987870|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0
981288|NCT01272180|1987886|FG000|Overall Study|Adverse Event|0
981289|NCT01272180|1987887|FG001|Overall Study|Adverse Event|0
981290|NCT01272180|1987888|FG002|Overall Study|Adverse Event|1
981291|NCT01272180|1987889|FG003|Overall Study|Adverse Event|0
981292|NCT01272180|1987886|FG000|Overall Study|Withdrawal by Subject|2
981293|NCT01272180|1987887|FG001|Overall Study|Withdrawal by Subject|6
981294|NCT01272180|1987888|FG002|Overall Study|Withdrawal by Subject|3
981295|NCT01272180|1987889|FG003|Overall Study|Withdrawal by Subject|2
981296|NCT01272180|1987886|FG000|Overall Study|Lost to Follow-up|15
981297|NCT01272180|1987887|FG001|Overall Study|Lost to Follow-up|14
981298|NCT01272180|1987888|FG002|Overall Study|Lost to Follow-up|8
981299|NCT01272180|1987889|FG003|Overall Study|Lost to Follow-up|10
981300|NCT01272180|1987886|FG000|Overall Study|Inappropriate enrollment|0
981301|NCT01272180|1987887|FG001|Overall Study|Inappropriate enrollment|0
981302|NCT01272180|1987888|FG002|Overall Study|Inappropriate enrollment|1
981303|NCT01272180|1987889|FG003|Overall Study|Inappropriate enrollment|1
981304|NCT01272180|1987886|FG000|Overall Study|Protocol Violation|0
981305|NCT01272180|1987887|FG001|Overall Study|Protocol Violation|1
981306|NCT01272180|1987888|FG002|Overall Study|Protocol Violation|0
981307|NCT01272180|1987889|FG003|Overall Study|Protocol Violation|1
981308|NCT01272193|1987905|FG000|Overall Study|Adverse Event|1
981309|NCT01272193|1987906|FG001|Overall Study|Adverse Event|1
981310|NCT01272193|1987905|FG000|Overall Study|Lack of Efficacy|0
981311|NCT01272193|1987906|FG001|Overall Study|Lack of Efficacy|3
981312|NCT01272193|1987905|FG000|Overall Study|Withdrawal Criteria|1
981313|NCT01272193|1987906|FG001|Overall Study|Withdrawal Criteria|1
981314|NCT01272193|1987905|FG000|Overall Study|Unclassified|8
981315|NCT01272193|1987906|FG001|Overall Study|Unclassified|7
981316|NCT01272219|1987916|FG000|Main Period: Week 0 to Week 56|Adverse Event|86
981317|NCT01272219|1987917|FG001|Main Period: Week 0 to Week 56|Adverse Event|0
981318|NCT01272219|1987918|FG002|Main Period: Week 0 to Week 56|Adverse Event|0
981319|NCT01272219|1987919|FG003|Main Period: Week 0 to Week 56|Adverse Event|16
981320|NCT01272219|1987920|FG004|Main Period: Week 0 to Week 56|Adverse Event|152
981321|NCT01272219|1987921|FG005|Main Period: Week 0 to Week 56|Adverse Event|29
981322|NCT01272219|1987916|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11
981323|NCT01272219|1987917|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0
981324|NCT01272219|1987918|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0
981325|NCT01272219|1987919|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14
981326|NCT01272219|1987920|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12
981327|NCT01272219|1987921|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22
981328|NCT01272219|1987916|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25
981329|NCT01272219|1987917|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0
981330|NCT01272219|1987918|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0
981331|NCT01272219|1987919|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18
981332|NCT01272219|1987920|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40
981333|NCT01272219|1987921|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20
981334|NCT01272219|1987916|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122
981335|NCT01272219|1987917|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0
981336|NCT01272219|1987918|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0
981337|NCT01272219|1987919|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114
981338|NCT01272219|1987920|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172
981339|NCT01272219|1987921|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147
981340|NCT01272219|1987916|FG000|Main Period: Week 0 to Week 56|Unclassified|36
981341|NCT01272219|1987917|FG001|Main Period: Week 0 to Week 56|Unclassified|0
981342|NCT01272219|1987918|FG002|Main Period: Week 0 to Week 56|Unclassified|0
981343|NCT01272219|1987919|FG003|Main Period: Week 0 to Week 56|Unclassified|29
981344|NCT01272219|1987920|FG004|Main Period: Week 0 to Week 56|Unclassified|42
981345|NCT01272219|1987921|FG005|Main Period: Week 0 to Week 56|Unclassified|34
981346|NCT01272219|1987916|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
981347|NCT01272219|1987917|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
981348|NCT01272219|1987918|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
981349|NCT01272219|1987919|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
981350|NCT01272219|1987920|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
981351|NCT01272219|1987921|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
981352|NCT01272219|1987916|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
981353|NCT01272219|1987917|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
981354|NCT01272219|1987918|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
981355|NCT01272219|1987919|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
981356|NCT01272219|1987920|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
981357|NCT01272219|1987921|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
981358|NCT01272219|1987916|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
981359|NCT01272219|1987917|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
981360|NCT01272219|1987918|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
981361|NCT01272219|1987919|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
981362|NCT01272219|1987920|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
981363|NCT01272219|1987921|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
981364|NCT01272219|1987916|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
981365|NCT01272219|1987917|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
981366|NCT01272219|1987918|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
981367|NCT01272219|1987919|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
981368|NCT01272219|1987920|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
981369|NCT01272219|1987921|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
981370|NCT01272219|1987916|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0
981371|NCT01272219|1987917|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1
981372|NCT01272219|1987918|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2
981373|NCT01272219|1987919|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2
981374|NCT01272219|1987920|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0
981375|NCT01272219|1987921|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0
981376|NCT01272219|1987916|FG000|Main + Extension Period: Week 0-172|Adverse Event|0
981377|NCT01272219|1987917|FG001|Main + Extension Period: Week 0-172|Adverse Event|0
981378|NCT01272219|1987918|FG002|Main + Extension Period: Week 0-172|Adverse Event|0
981379|NCT01272219|1987919|FG003|Main + Extension Period: Week 0-172|Adverse Event|0
981380|NCT01272219|1987920|FG004|Main + Extension Period: Week 0-172|Adverse Event|191
981381|NCT01272219|1987921|FG005|Main + Extension Period: Week 0-172|Adverse Event|43
981382|NCT01272219|1987916|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0
981383|NCT01272219|1987917|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0
981384|NCT01272219|1987918|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0
981385|NCT01272219|1987919|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0
981386|NCT01272219|1987920|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29
981387|NCT01272219|1987921|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36
981388|NCT01272219|1987916|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0
981389|NCT01272219|1987917|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0
981390|NCT01272219|1987918|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0
981391|NCT01272219|1987919|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0
981392|NCT01272219|1987920|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76
981393|NCT01272219|1987921|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36
981394|NCT01272219|1987916|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0
981395|NCT01272219|1987917|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0
981396|NCT01272219|1987918|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0
981397|NCT01272219|1987919|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0
981398|NCT01272219|1987920|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364
981399|NCT01272219|1987921|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256
981400|NCT01272219|1987916|FG000|Main + Extension Period: Week 0-172|Missing reason|0
981401|NCT01272219|1987917|FG001|Main + Extension Period: Week 0-172|Missing reason|0
981402|NCT01272219|1987918|FG002|Main + Extension Period: Week 0-172|Missing reason|0
981403|NCT01272219|1987919|FG003|Main + Extension Period: Week 0-172|Missing reason|0
981404|NCT01272219|1987920|FG004|Main + Extension Period: Week 0-172|Missing reason|1
981405|NCT01272219|1987921|FG005|Main + Extension Period: Week 0-172|Missing reason|0
981406|NCT01272219|1987916|FG000|Main + Extension Period: Week 0-172|Unclassified|0
981407|NCT01272219|1987917|FG001|Main + Extension Period: Week 0-172|Unclassified|0
981408|NCT01272219|1987918|FG002|Main + Extension Period: Week 0-172|Unclassified|0
981409|NCT01272219|1987919|FG003|Main + Extension Period: Week 0-172|Unclassified|0
981410|NCT01272219|1987920|FG004|Main + Extension Period: Week 0-172|Unclassified|61
981411|NCT01272219|1987921|FG005|Main + Extension Period: Week 0-172|Unclassified|51
981412|NCT01272232|1987937|FG000|Weeks 0-56|Adverse Event|39
981413|NCT01272232|1987938|FG001|Weeks 0-56|Adverse Event|18
981414|NCT01272232|1987939|FG002|Weeks 0-56|Adverse Event|7
981415|NCT01272232|1987937|FG000|Weeks 0-56|Lack of Efficacy|0
981416|NCT01272232|1987938|FG001|Weeks 0-56|Lack of Efficacy|0
981417|NCT01272232|1987939|FG002|Weeks 0-56|Lack of Efficacy|3
981418|NCT01272232|1987937|FG000|Weeks 0-56|Protocol Violation|12
981419|NCT01272232|1987938|FG001|Weeks 0-56|Protocol Violation|8
981420|NCT01272232|1987939|FG002|Weeks 0-56|Protocol Violation|13
981421|NCT01272232|1987937|FG000|Weeks 0-56|Withdrawal criteria|32
981422|NCT01272232|1987938|FG001|Weeks 0-56|Withdrawal criteria|14
981423|NCT01272232|1987939|FG002|Weeks 0-56|Withdrawal criteria|37
981424|NCT01272232|1987937|FG000|Weeks 0-56|Unclassified|16
981425|NCT01272232|1987938|FG001|Weeks 0-56|Unclassified|7
981426|NCT01272232|1987939|FG002|Weeks 0-56|Unclassified|12
981427|NCT01272232|1987937|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
981428|NCT01272232|1987938|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
981429|NCT01272232|1987939|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
981430|NCT01272232|1987937|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
981431|NCT01272232|1987938|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
981432|NCT01272232|1987939|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
981433|NCT01272232|1987937|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
981434|NCT01272232|1987938|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
981435|NCT01272232|1987939|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
981436|NCT01272232|1987937|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
981437|NCT01272232|1987938|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
981438|NCT01272232|1987939|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
981439|NCT01272232|1987937|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
981440|NCT01272232|1987938|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
981441|NCT01272232|1987939|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
981442|NCT01272635|1987978|FG000|Overall Study|Lost to Follow-up|31
981443|NCT01272635|1987979|FG001|Overall Study|Lost to Follow-up|20
981444|NCT01272635|1987980|FG002|Overall Study|Lost to Follow-up|31
981445|NCT01272635|1987981|FG003|Overall Study|Lost to Follow-up|23
981446|NCT01272661|1987992|FG000|Overall Study|lost to followup/case closed/ no birth|126
981447|NCT01272661|1987993|FG001|Overall Study|lost to followup/case closed/ no birth|209
981448|NCT01272661|1987994|FG002|Overall Study|lost to followup/case closed/ no birth|72
981449|NCT01272804|1988008|FG000|Overall Study|Adverse Event|1
981450|NCT01272804|1988009|FG001|Overall Study|Adverse Event|0
981451|NCT01272804|1988010|FG002|Overall Study|Adverse Event|0
981452|NCT01272804|1988011|FG003|Overall Study|Adverse Event|0
981453|NCT01272804|1988012|FG004|Overall Study|Adverse Event|2
981454|NCT01272804|1988013|FG005|Overall Study|Adverse Event|1
981455|NCT01272869|1988038|FG000|Period 2 (14 Days)|Adverse Event|1
981456|NCT01272869|1988039|FG001|Period 2 (14 Days)|Adverse Event|0
981457|NCT01272908|1988049|FG000|Initial Treatment Period|Adverse Event|1
981458|NCT01272908|1988049|FG000|Initial Treatment Period|Lack of Efficacy|5
981459|NCT01272908|1988049|FG000|Initial Treatment Period|Protocol Violation|1
981460|NCT01272908|1988049|FG000|Initial Treatment Period|Withdrawal by Subject|1
981461|NCT01272908|1988049|FG000|Re-Treatment Period|Adverse Event|2
981462|NCT01272908|1988049|FG000|Re-Treatment Period|Lack of Efficacy|3
981463|NCT01272908|1988049|FG000|Re-Treatment Period|Withdrawal by Subject|1
981464|NCT01272921|1988057|FG000|Overall Study|Protocol Violation|2
981465|NCT01272921|1988058|FG001|Overall Study|Protocol Violation|1
981466|NCT01272934|1988068|FG000|Overall Study|Adverse Event|0
981467|NCT01272934|1988069|FG001|Overall Study|Adverse Event|1
981468|NCT01272934|1988068|FG000|Overall Study|Abnormal Laboratory Value|0
981469|NCT01272934|1988069|FG001|Overall Study|Abnormal Laboratory Value|1
981470|NCT01272947|1988078|FG000|Overall Study|Abnormal Laboratory Value|2
981471|NCT01272947|1988079|FG001|Overall Study|Abnormal Laboratory Value|2
981472|NCT01273038|1988108|FG000|Second Intervention (14 Days)|Adverse Event|0
981473|NCT01273038|1988109|FG001|Second Intervention (14 Days)|Adverse Event|1
981474|NCT01273038|1988108|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
981475|NCT01273038|1988109|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
981476|NCT01273155|1988119|FG000|Overall Study|Off study trmt prior to end of C1/PD|2
981477|NCT01273155|1988120|FG001|Overall Study|Off study trmt prior to end of C1/PD|3
981478|NCT01273155|1988121|FG002|Overall Study|Off study trmt prior to end of C1/PD|8
981479|NCT01273155|1988122|FG003|Overall Study|Off study trmt prior to end of C1/PD|0
981480|NCT01273155|1988123|FG004|Overall Study|Off study trmt prior to end of C1/PD|0
981481|NCT01273155|1988124|FG005|Overall Study|Off study trmt prior to end of C1/PD|2
981482|NCT01273155|1988125|FG006|Overall Study|Off study trmt prior to end of C1/PD|3
981483|NCT01273155|1988119|FG000|Overall Study|Change in liver function/no longer eval.|0
981484|NCT01273155|1988120|FG001|Overall Study|Change in liver function/no longer eval.|1
981485|NCT01273155|1988121|FG002|Overall Study|Change in liver function/no longer eval.|0
981486|NCT01273155|1988122|FG003|Overall Study|Change in liver function/no longer eval.|0
981487|NCT01273155|1988123|FG004|Overall Study|Change in liver function/no longer eval.|1
981488|NCT01273155|1988124|FG005|Overall Study|Change in liver function/no longer eval.|0
981489|NCT01273155|1988125|FG006|Overall Study|Change in liver function/no longer eval.|0
981490|NCT01273155|1988119|FG000|Overall Study|Off study prior to C1/due to toxicity|0
981491|NCT01273155|1988120|FG001|Overall Study|Off study prior to C1/due to toxicity|0
981492|NCT01273155|1988121|FG002|Overall Study|Off study prior to C1/due to toxicity|2
981493|NCT01273155|1988122|FG003|Overall Study|Off study prior to C1/due to toxicity|0
981494|NCT01273155|1988123|FG004|Overall Study|Off study prior to C1/due to toxicity|0
981495|NCT01273155|1988124|FG005|Overall Study|Off study prior to C1/due to toxicity|0
981496|NCT01273155|1988125|FG006|Overall Study|Off study prior to C1/due to toxicity|1
981497|NCT01273155|1988119|FG000|Overall Study|Died during Cycle 1|0
981498|NCT01273155|1988120|FG001|Overall Study|Died during Cycle 1|0
981499|NCT01273155|1988121|FG002|Overall Study|Died during Cycle 1|1
981500|NCT01273155|1988122|FG003|Overall Study|Died during Cycle 1|1
981501|NCT01273155|1988123|FG004|Overall Study|Died during Cycle 1|0
981502|NCT01273155|1988124|FG005|Overall Study|Died during Cycle 1|2
981503|NCT01273155|1988125|FG006|Overall Study|Died during Cycle 1|2
981504|NCT01273155|1988119|FG000|Overall Study|Withdrew during C1/refused further trmt|0
981505|NCT01273155|1988120|FG001|Overall Study|Withdrew during C1/refused further trmt|0
981506|NCT01273155|1988121|FG002|Overall Study|Withdrew during C1/refused further trmt|1
981507|NCT01273155|1988122|FG003|Overall Study|Withdrew during C1/refused further trmt|0
981508|NCT01273155|1988123|FG004|Overall Study|Withdrew during C1/refused further trmt|1
981509|NCT01273155|1988124|FG005|Overall Study|Withdrew during C1/refused further trmt|1
981510|NCT01273155|1988125|FG006|Overall Study|Withdrew during C1/refused further trmt|0
981511|NCT01273181|1988152|FG000|Phase I, Dose 1|Study termination|1
981512|NCT01273181|1988153|FG001|Phase I, Dose 1|Study termination|0
981513|NCT01273181|1988154|FG002|Phase I, Dose 1|Study termination|0
981514|NCT01273181|1988155|FG003|Phase I, Dose 1|Study termination|0
981515|NCT01273181|1988152|FG000|Phase I, Dose 2|Death during treatment|0
981516|NCT01273181|1988153|FG001|Phase I, Dose 2|Death during treatment|1
981517|NCT01273181|1988154|FG002|Phase I, Dose 2|Death during treatment|0
981518|NCT01273181|1988155|FG003|Phase I, Dose 2|Death during treatment|0
981519|NCT01273181|1988152|FG000|Phase 2, Dose 1|Study termination|0
981520|NCT01273181|1988153|FG001|Phase 2, Dose 1|Study termination|0
981521|NCT01273181|1988154|FG002|Phase 2, Dose 1|Study termination|1
981522|NCT01273181|1988155|FG003|Phase 2, Dose 1|Study termination|0
981523|NCT01273181|1988152|FG000|Phase 2, Dose 2|Death during treatment|0
981524|NCT01273181|1988153|FG001|Phase 2, Dose 2|Death during treatment|0
981525|NCT01273181|1988154|FG002|Phase 2, Dose 2|Death during treatment|0
981526|NCT01273181|1988155|FG003|Phase 2, Dose 2|Death during treatment|1
981527|NCT01273519|1988176|FG000|Overall Study|Adverse Event|3
981528|NCT01273519|1988177|FG001|Overall Study|Adverse Event|0
981529|NCT01273519|1988178|FG002|Overall Study|Adverse Event|0
981530|NCT01273519|1988176|FG000|Overall Study|Lost to Follow-up|2
981531|NCT01273519|1988177|FG001|Overall Study|Lost to Follow-up|1
981532|NCT01273519|1988178|FG002|Overall Study|Lost to Follow-up|3
981533|NCT01273519|1988176|FG000|Overall Study|Lack of Efficacy|8
981534|NCT01273519|1988177|FG001|Overall Study|Lack of Efficacy|3
981535|NCT01273519|1988178|FG002|Overall Study|Lack of Efficacy|4
981536|NCT01273519|1988176|FG000|Overall Study|Other|6
981537|NCT01273519|1988177|FG001|Overall Study|Other|1
981538|NCT01273519|1988178|FG002|Overall Study|Other|1
981539|NCT01273597|1988189|FG000|Overall Study|Adverse Event|5
981540|NCT01273597|1988189|FG000|Overall Study|Underwent Kidney Transplantation|2
981541|NCT01273597|1988189|FG000|Overall Study|Reason Not Reported|1
981542|NCT01273623|1988193|FG000|Overall Study|did not meet IVUS criteria|29
981543|NCT01273805|1988213|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10
981544|NCT01273805|1988214|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10
981545|NCT01273818|1988223|FG000|Overall Study|Physician Decision|13
981546|NCT01273818|1988224|FG001|Overall Study|Physician Decision|2
981547|NCT01273818|1988225|FG002|Overall Study|Physician Decision|9
981548|NCT01273883|1988242|FG000|First Intervention|Adverse Event|2
981549|NCT01273883|1988243|FG001|First Intervention|Adverse Event|1
981550|NCT01273883|1988242|FG000|Second Intervention|Lost to Follow-up|1
981551|NCT01273883|1988243|FG001|Second Intervention|Lost to Follow-up|1
981552|NCT01273883|1988242|FG000|Second Intervention|Lack of Efficacy|1
981553|NCT01273883|1988243|FG001|Second Intervention|Lack of Efficacy|0
981554|NCT01274182|1988256|FG000|Overall Study|Unsatisfactory therapeutic effect|6
981555|NCT01274182|1988257|FG001|Overall Study|Unsatisfactory therapeutic effect|3
981556|NCT01274182|1988258|FG002|Overall Study|Unsatisfactory therapeutic effect|4
981557|NCT01274182|1988256|FG000|Overall Study|Adverse Event|4
981558|NCT01274182|1988257|FG001|Overall Study|Adverse Event|5
981559|NCT01274182|1988258|FG002|Overall Study|Adverse Event|3
981560|NCT01274182|1988256|FG000|Overall Study|Withdrawal by Subject|5
981561|NCT01274182|1988257|FG001|Overall Study|Withdrawal by Subject|5
981562|NCT01274182|1988258|FG002|Overall Study|Withdrawal by Subject|3
981563|NCT01274182|1988256|FG000|Overall Study|Lost to Follow-up|2
981564|NCT01274182|1988257|FG001|Overall Study|Lost to Follow-up|3
981565|NCT01274182|1988258|FG002|Overall Study|Lost to Follow-up|1
981566|NCT01274182|1988256|FG000|Overall Study|Protocol Violation|3
981567|NCT01274182|1988257|FG001|Overall Study|Protocol Violation|2
981568|NCT01274182|1988258|FG002|Overall Study|Protocol Violation|0
981569|NCT01274182|1988256|FG000|Overall Study|Death|1
981570|NCT01274182|1988257|FG001|Overall Study|Death|0
981571|NCT01274182|1988258|FG002|Overall Study|Death|1
981572|NCT01274338|1988276|FG000|Overall Study|Lack of Efficacy|72
981573|NCT01274338|1988277|FG001|Overall Study|Lack of Efficacy|108
981574|NCT01274338|1988278|FG002|Overall Study|Lack of Efficacy|116
981575|NCT01274338|1988279|FG003|Overall Study|Lack of Efficacy|0
981576|NCT01274338|1988280|FG004|Overall Study|Lack of Efficacy|0
981577|NCT01274338|1988281|FG005|Overall Study|Lack of Efficacy|0
981578|NCT01274338|1988276|FG000|Overall Study|Adverse Event|272
981579|NCT01274338|1988277|FG001|Overall Study|Adverse Event|105
981580|NCT01274338|1988278|FG002|Overall Study|Adverse Event|180
981581|NCT01274338|1988279|FG003|Overall Study|Adverse Event|1
981582|NCT01274338|1988280|FG004|Overall Study|Adverse Event|0
981583|NCT01274338|1988281|FG005|Overall Study|Adverse Event|0
981584|NCT01274338|1988276|FG000|Overall Study|Death|8
981585|NCT01274338|1988277|FG001|Overall Study|Death|1
981586|NCT01274338|1988278|FG002|Overall Study|Death|0
981587|NCT01274338|1988279|FG003|Overall Study|Death|0
981588|NCT01274338|1988280|FG004|Overall Study|Death|0
981589|NCT01274338|1988281|FG005|Overall Study|Death|0
981590|NCT01274338|1988276|FG000|Overall Study|Withdrawal by Subject|27
981591|NCT01274338|1988277|FG001|Overall Study|Withdrawal by Subject|99
981592|NCT01274338|1988278|FG002|Overall Study|Withdrawal by Subject|17
981593|NCT01274338|1988279|FG003|Overall Study|Withdrawal by Subject|0
981594|NCT01274338|1988280|FG004|Overall Study|Withdrawal by Subject|0
981595|NCT01274338|1988281|FG005|Overall Study|Withdrawal by Subject|0
981596|NCT01274338|1988276|FG000|Overall Study|Did not start treatment|8
981597|NCT01274338|1988277|FG001|Overall Study|Did not start treatment|116
981598|NCT01274338|1988278|FG002|Overall Study|Did not start treatment|7
981599|NCT01274338|1988279|FG003|Overall Study|Did not start treatment|0
981600|NCT01274338|1988280|FG004|Overall Study|Did not start treatment|0
981601|NCT01274338|1988281|FG005|Overall Study|Did not start treatment|0
981602|NCT01274338|1988276|FG000|Overall Study|Alternative therapy|0
981603|NCT01274338|1988277|FG001|Overall Study|Alternative therapy|1
981604|NCT01274338|1988278|FG002|Overall Study|Alternative therapy|0
981605|NCT01274338|1988279|FG003|Overall Study|Alternative therapy|0
981606|NCT01274338|1988280|FG004|Overall Study|Alternative therapy|0
981607|NCT01274338|1988281|FG005|Overall Study|Alternative therapy|0
981608|NCT01274338|1988276|FG000|Overall Study|Other complicating diseases|0
981609|NCT01274338|1988277|FG001|Overall Study|Other complicating diseases|3
981610|NCT01274338|1988278|FG002|Overall Study|Other complicating diseases|1
981611|NCT01274338|1988279|FG003|Overall Study|Other complicating diseases|0
981612|NCT01274338|1988280|FG004|Overall Study|Other complicating diseases|0
981613|NCT01274338|1988281|FG005|Overall Study|Other complicating diseases|0
981614|NCT01274338|1988276|FG000|Overall Study|Treatment arm was suspended due to toxicity|4
981615|NCT01274338|1988277|FG001|Overall Study|Treatment arm was suspended due to toxicity|0
981616|NCT01274338|1988278|FG002|Overall Study|Treatment arm was suspended due to toxicity|0
981617|NCT01274338|1988279|FG003|Overall Study|Treatment arm was suspended due to toxicity|0
981618|NCT01274338|1988280|FG004|Overall Study|Treatment arm was suspended due to toxicity|0
981619|NCT01274338|1988281|FG005|Overall Study|Treatment arm was suspended due to toxicity|0
981620|NCT01274338|1988276|FG000|Overall Study|Pregnancy|0
981621|NCT01274338|1988277|FG001|Overall Study|Pregnancy|0
981622|NCT01274338|1988278|FG002|Overall Study|Pregnancy|1
981623|NCT01274338|1988279|FG003|Overall Study|Pregnancy|0
981624|NCT01274338|1988280|FG004|Overall Study|Pregnancy|0
981625|NCT01274338|1988281|FG005|Overall Study|Pregnancy|0
912655|NCT00806286|1890200|FG002|Overall Study|Death|0
912656|NCT00806286|1890198|FG000|Overall Study|Lost to Follow-up|0
912657|NCT00806286|1890199|FG001|Overall Study|Lost to Follow-up|1
912658|NCT00806286|1890200|FG002|Overall Study|Lost to Follow-up|0
912659|NCT00806286|1890198|FG000|Overall Study|Withdrawal by Subject|8
912660|NCT00806286|1890199|FG001|Overall Study|Withdrawal by Subject|3
981626|NCT01274338|1988276|FG000|Overall Study|Reason not reported|12
981627|NCT01274338|1988277|FG001|Overall Study|Reason not reported|21
981628|NCT01274338|1988278|FG002|Overall Study|Reason not reported|3
981629|NCT01274338|1988279|FG003|Overall Study|Reason not reported|0
981630|NCT01274338|1988280|FG004|Overall Study|Reason not reported|1
981631|NCT01274338|1988281|FG005|Overall Study|Reason not reported|0
981632|NCT01274351|1988294|FG000|Overall Study|Lost to Follow-up|1
981633|NCT01274351|1988294|FG000|Overall Study|patient not compliant with the protocol|1
981634|NCT01274351|1988294|FG000|Overall Study|Pregnancy|1
981635|NCT01274351|1988294|FG000|Overall Study|Death|2
981636|NCT01274351|1988294|FG000|Overall Study|Withdrawal by Subject|3
981637|NCT01274351|1988294|FG000|Overall Study|Adverse Event|8
981638|NCT01274351|1988294|FG000|Overall Study|progression of disease|3
981639|NCT01274351|1988294|FG000|Overall Study|hospitalization|1
981640|NCT01274637|1988327|FG000|Overall Study|Withdrawal by Subject|0
981641|NCT01274637|1988328|FG001|Overall Study|Withdrawal by Subject|1
981642|NCT01274637|1988327|FG000|Overall Study|Lost to Follow-up|0
981643|NCT01274637|1988328|FG001|Overall Study|Lost to Follow-up|1
981644|NCT01274715|1988334|FG000|Overall Study|Lost to Follow-up|1
981645|NCT01274715|1988334|FG000|Overall Study|After consent, met exclusion criteria.|1
981646|NCT01274715|1988334|FG000|Overall Study|After consent, met exclusion criteria.|1
981647|NCT01274715|1988334|FG000|Overall Study|After consent, met exclusion criteria.|1
981648|NCT01275066|1988354|FG000|Overall Study|Withdrawal by Subject|0
981649|NCT01275066|1988355|FG001|Overall Study|Withdrawal by Subject|0
981650|NCT01275066|1988356|FG002|Overall Study|Withdrawal by Subject|1
981651|NCT01275066|1988354|FG000|Overall Study|Not Diagnosed w/ Disease|1
981652|NCT01275066|1988355|FG001|Overall Study|Not Diagnosed w/ Disease|0
981653|NCT01275066|1988356|FG002|Overall Study|Not Diagnosed w/ Disease|0
981654|NCT01275131|1988372|FG000|Period 1|Withdrawal by Subject|1
981655|NCT01275131|1988373|FG001|Period 1|Withdrawal by Subject|0
981656|NCT01275131|1988374|FG002|Period 1|Withdrawal by Subject|3
981657|NCT01275131|1988375|FG003|Period 1|Withdrawal by Subject|2
981658|NCT01275131|1988372|FG000|Period 1|Physician Decision|1
981659|NCT01275131|1988373|FG001|Period 1|Physician Decision|0
981660|NCT01275131|1988374|FG002|Period 1|Physician Decision|0
981661|NCT01275131|1988375|FG003|Period 1|Physician Decision|0
981662|NCT01275131|1988372|FG000|Period 2 (Crossover)|Adverse Event|0
912661|NCT00806286|1890200|FG002|Overall Study|Withdrawal by Subject|1
912662|NCT00806286|1890198|FG000|Overall Study|Physician Decision|2
912663|NCT00806286|1890199|FG001|Overall Study|Physician Decision|2
912664|NCT00806286|1890200|FG002|Overall Study|Physician Decision|0
912665|NCT00806286|1890198|FG000|Overall Study|Due to a variety of reasons|7
912666|NCT00806286|1890199|FG001|Overall Study|Due to a variety of reasons|2
912667|NCT00806286|1890200|FG002|Overall Study|Due to a variety of reasons|1
912668|NCT00806351|1890210|FG000|Overall Study|Death|5
912669|NCT00806351|1890211|FG001|Overall Study|Death|4
912670|NCT00806403|1890219|FG000|Overall Study|Death|4
912671|NCT00806403|1890220|FG001|Overall Study|Death|3
912672|NCT00806416|1890226|FG000|Period 1 - Part I|Adverse Event|0
912673|NCT00806416|1890227|FG001|Period 1 - Part I|Adverse Event|1
912674|NCT00806416|1890228|FG002|Period 1 - Part I|Adverse Event|0
912675|NCT00806416|1890229|FG003|Period 1 - Part I|Adverse Event|0
912676|NCT00806416|1890226|FG000|Period 1 - Part I|Lost to Follow-up|0
912677|NCT00806416|1890227|FG001|Period 1 - Part I|Lost to Follow-up|2
912678|NCT00806416|1890228|FG002|Period 1 - Part I|Lost to Follow-up|0
912679|NCT00806416|1890229|FG003|Period 1 - Part I|Lost to Follow-up|0
912680|NCT00806416|1890226|FG000|Period 1 - Part I|Withdrawal by Subject|3
912681|NCT00806416|1890227|FG001|Period 1 - Part I|Withdrawal by Subject|1
912682|NCT00806416|1890228|FG002|Period 1 - Part I|Withdrawal by Subject|0
912683|NCT00806416|1890229|FG003|Period 1 - Part I|Withdrawal by Subject|0
912684|NCT00806416|1890226|FG000|Period 1 - Part II|Withdrawal by Subject|0
912685|NCT00806416|1890227|FG001|Period 1 - Part II|Withdrawal by Subject|0
912686|NCT00806416|1890228|FG002|Period 1 - Part II|Withdrawal by Subject|0
912687|NCT00806416|1890229|FG003|Period 1 - Part II|Withdrawal by Subject|2
912688|NCT00806442|1890237|FG000|Overall Study|Lost to Follow-up|3
912689|NCT00806442|1890238|FG001|Overall Study|Lost to Follow-up|2
912690|NCT00806442|1890237|FG000|Overall Study|Withdrawal by Subject|1
912691|NCT00806442|1890238|FG001|Overall Study|Withdrawal by Subject|5
912692|NCT00806494|1890246|FG000|Overall Study|Adverse Event|29
912693|NCT00806494|1890246|FG000|Overall Study|Lack of Efficacy|6
981663|NCT01275131|1988373|FG001|Period 2 (Crossover)|Adverse Event|1
981664|NCT01275131|1988374|FG002|Period 2 (Crossover)|Adverse Event|0
981665|NCT01275131|1988375|FG003|Period 2 (Crossover)|Adverse Event|0
981666|NCT01275131|1988372|FG000|Period 2 (Crossover)|Withdrawal by Subject|1
981667|NCT01275131|1988373|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
981668|NCT01275131|1988374|FG002|Period 2 (Crossover)|Withdrawal by Subject|1
981669|NCT01275131|1988375|FG003|Period 2 (Crossover)|Withdrawal by Subject|2
981670|NCT01275144|1988393|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1
981671|NCT01275144|1988394|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0
981672|NCT01275170|1988410|FG000|Part 1: Period 1|Equipment malfunction before study drug|1
981673|NCT01275170|1988411|FG001|Part 1: Period 1|Equipment malfunction before study drug|0
981674|NCT01275170|1988412|FG002|Part 1: Period 1|Equipment malfunction before study drug|0
981675|NCT01275170|1988413|FG003|Part 1: Period 1|Equipment malfunction before study drug|0
981676|NCT01275170|1988414|FG004|Part 1: Period 1|Equipment malfunction before study drug|0
981677|NCT01275170|1988415|FG005|Part 1: Period 1|Equipment malfunction before study drug|0
981678|NCT01275170|1988416|FG006|Part 1: Period 1|Equipment malfunction before study drug|0
981679|NCT01275170|1988417|FG007|Part 1: Period 1|Equipment malfunction before study drug|0
981680|NCT01275196|1988452|FG000|Overall Study|Adverse Event|3
981681|NCT01275196|1988453|FG001|Overall Study|Adverse Event|5
981682|NCT01275196|1988452|FG000|Overall Study|Withdrawal by Subject|4
981683|NCT01275196|1988453|FG001|Overall Study|Withdrawal by Subject|5
981684|NCT01275196|1988452|FG000|Overall Study|Lost to Follow-up|1
981685|NCT01275196|1988453|FG001|Overall Study|Lost to Follow-up|0
981686|NCT01275196|1988452|FG000|Overall Study|Disease Progression|6
981687|NCT01275196|1988453|FG001|Overall Study|Disease Progression|5
981688|NCT01275196|1988452|FG000|Overall Study|Protocol Violation|1
981689|NCT01275196|1988453|FG001|Overall Study|Protocol Violation|0
981690|NCT01275196|1988452|FG000|Overall Study|Suboptimal response/treatment failure|5
981691|NCT01275196|1988453|FG001|Overall Study|Suboptimal response/treatment failure|6
981692|NCT01275222|1988467|FG000|Phase l by Treatment|Adverse Event|1
981693|NCT01275222|1988468|FG001|Phase l by Treatment|Adverse Event|4
981694|NCT01275222|1988469|FG002|Phase l by Treatment|Adverse Event|2
981695|NCT01275222|1988470|FG003|Phase l by Treatment|Adverse Event|3
981696|NCT01275222|1988471|FG004|Phase l by Treatment|Adverse Event|0
981697|NCT01275222|1988472|FG005|Phase l by Treatment|Adverse Event|0
981698|NCT01275222|1988467|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0
981699|NCT01275222|1988468|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0
981700|NCT01275222|1988469|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1
981701|NCT01275222|1988470|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0
981702|NCT01275222|1988471|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0
981703|NCT01275222|1988472|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0
981704|NCT01275222|1988467|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0
981705|NCT01275222|1988468|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0
981706|NCT01275222|1988469|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0
981707|NCT01275222|1988470|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1
981708|NCT01275222|1988471|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0
981709|NCT01275222|1988472|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0
981710|NCT01275222|1988467|FG000|Phase l by Treatment|Disease progression|12
981711|NCT01275222|1988468|FG001|Phase l by Treatment|Disease progression|8
981712|NCT01275222|1988469|FG002|Phase l by Treatment|Disease progression|2
981713|NCT01275222|1988470|FG003|Phase l by Treatment|Disease progression|5
981714|NCT01275222|1988471|FG004|Phase l by Treatment|Disease progression|0
981715|NCT01275222|1988472|FG005|Phase l by Treatment|Disease progression|0
981716|NCT01275222|1988467|FG000|Phase l by Treatment|Withdrawal by Subject|0
981717|NCT01275222|1988468|FG001|Phase l by Treatment|Withdrawal by Subject|0
981718|NCT01275222|1988469|FG002|Phase l by Treatment|Withdrawal by Subject|0
981719|NCT01275222|1988470|FG003|Phase l by Treatment|Withdrawal by Subject|1
981720|NCT01275222|1988471|FG004|Phase l by Treatment|Withdrawal by Subject|0
981721|NCT01275222|1988472|FG005|Phase l by Treatment|Withdrawal by Subject|0
981722|NCT01275222|1988467|FG000|Phase l by Treatment|Death|0
981723|NCT01275222|1988468|FG001|Phase l by Treatment|Death|1
981724|NCT01275222|1988469|FG002|Phase l by Treatment|Death|0
981725|NCT01275222|1988470|FG003|Phase l by Treatment|Death|1
981726|NCT01275222|1988471|FG004|Phase l by Treatment|Death|0
981727|NCT01275222|1988472|FG005|Phase l by Treatment|Death|0
981728|NCT01275222|1988467|FG000|Phase ll by Stratum|Adverse Event|0
981729|NCT01275222|1988468|FG001|Phase ll by Stratum|Adverse Event|0
981730|NCT01275222|1988469|FG002|Phase ll by Stratum|Adverse Event|0
981731|NCT01275222|1988470|FG003|Phase ll by Stratum|Adverse Event|0
981732|NCT01275222|1988471|FG004|Phase ll by Stratum|Adverse Event|2
981733|NCT01275222|1988472|FG005|Phase ll by Stratum|Adverse Event|10
981734|NCT01275222|1988467|FG000|Phase ll by Stratum|Abnormal laboratory values|0
981735|NCT01275222|1988468|FG001|Phase ll by Stratum|Abnormal laboratory values|0
981736|NCT01275222|1988469|FG002|Phase ll by Stratum|Abnormal laboratory values|0
981737|NCT01275222|1988470|FG003|Phase ll by Stratum|Abnormal laboratory values|0
981738|NCT01275222|1988471|FG004|Phase ll by Stratum|Abnormal laboratory values|0
981739|NCT01275222|1988472|FG005|Phase ll by Stratum|Abnormal laboratory values|1
981740|NCT01275222|1988467|FG000|Phase ll by Stratum|Disease progression|0
981741|NCT01275222|1988468|FG001|Phase ll by Stratum|Disease progression|0
981742|NCT01275222|1988469|FG002|Phase ll by Stratum|Disease progression|0
981743|NCT01275222|1988470|FG003|Phase ll by Stratum|Disease progression|0
981744|NCT01275222|1988471|FG004|Phase ll by Stratum|Disease progression|23
981745|NCT01275222|1988472|FG005|Phase ll by Stratum|Disease progression|31
981746|NCT01275222|1988467|FG000|Phase ll by Stratum|Withdrawal by Subject|0
981747|NCT01275222|1988468|FG001|Phase ll by Stratum|Withdrawal by Subject|0
981748|NCT01275222|1988469|FG002|Phase ll by Stratum|Withdrawal by Subject|0
981749|NCT01275222|1988470|FG003|Phase ll by Stratum|Withdrawal by Subject|0
981750|NCT01275222|1988471|FG004|Phase ll by Stratum|Withdrawal by Subject|2
981751|NCT01275222|1988472|FG005|Phase ll by Stratum|Withdrawal by Subject|3
981752|NCT01275222|1988467|FG000|Phase ll by Stratum|Death|0
981753|NCT01275222|1988468|FG001|Phase ll by Stratum|Death|0
981754|NCT01275222|1988469|FG002|Phase ll by Stratum|Death|0
981755|NCT01275222|1988470|FG003|Phase ll by Stratum|Death|0
981756|NCT01275222|1988471|FG004|Phase ll by Stratum|Death|1
981757|NCT01275222|1988472|FG005|Phase ll by Stratum|Death|1
981758|NCT01275339|1988510|FG000|Overall Study|Referred for surgery for AS symptoms|1
981759|NCT01275339|1988511|FG001|Overall Study|Referred for surgery for AS symptoms|0
981760|NCT01275339|1988512|FG002|Overall Study|Referred for surgery for AS symptoms|0
981761|NCT01275339|1988513|FG003|Overall Study|Referred for surgery for AS symptoms|0
981762|NCT01275339|1988510|FG000|Overall Study|Withdrawal by Subject|0
981763|NCT01275339|1988511|FG001|Overall Study|Withdrawal by Subject|0
981764|NCT01275339|1988512|FG002|Overall Study|Withdrawal by Subject|1
981765|NCT01275339|1988513|FG003|Overall Study|Withdrawal by Subject|0
981766|NCT01275430|1988540|FG000|Overall Study|Adverse Event|1
981767|NCT01275430|1988540|FG000|Overall Study|No Contrast Injection|6
981768|NCT01275430|1988540|FG000|Overall Study|Device Malfunction|1
981769|NCT01275430|1988540|FG000|Overall Study|Inability to achieve maximum p-wave|1
981770|NCT01275625|1988549|FG000|Overall Study|Death|1
981771|NCT01275625|1988549|FG000|Overall Study|Lack of Efficacy|2
981772|NCT01275625|1988549|FG000|Overall Study|Lost to Follow-up|1
981773|NCT01275625|1988549|FG000|Overall Study|Withdrawal by Subject|3
981774|NCT01275625|1988549|FG000|Overall Study|Protocol Violation|1
981775|NCT01275625|1988549|FG000|Overall Study|Adverse Event|4
981776|NCT01275625|1988549|FG000|Overall Study|Other|1
981783|NCT01275755|1988568|FG000|Double-blind Treatment Period|Adverse Event|0
981784|NCT01275755|1988569|FG001|Double-blind Treatment Period|Adverse Event|2
981785|NCT01275755|1988568|FG000|Double-blind Treatment Period|Lost to Follow-up|1
981786|NCT01275755|1988569|FG001|Double-blind Treatment Period|Lost to Follow-up|1
981787|NCT01275755|1988568|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
981788|NCT01275755|1988569|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
981789|NCT01275755|1988568|FG000|Run-out Placebo Period|Lost to Follow-up|1
981790|NCT01275755|1988569|FG001|Run-out Placebo Period|Lost to Follow-up|0
981791|NCT01275833|1988577|FG000|Overall Study|Study terminated|1
981792|NCT01275833|1988578|FG001|Overall Study|Study terminated|1
981793|NCT01276041|1988584|FG000|Overall Study|Adverse Event|2
981794|NCT01276041|1988584|FG000|Overall Study|Protocol Violation|1
981795|NCT01276106|1988592|FG000|Overall Study|Adverse Event|3
981796|NCT01276106|1988593|FG001|Overall Study|Adverse Event|3
981797|NCT01276106|1988594|FG002|Overall Study|Adverse Event|11
981798|NCT01276106|1988595|FG003|Overall Study|Adverse Event|3
981799|NCT01276106|1988592|FG000|Overall Study|Withdrawal by Subject|6
981800|NCT01276106|1988593|FG001|Overall Study|Withdrawal by Subject|3
981801|NCT01276106|1988594|FG002|Overall Study|Withdrawal by Subject|1
981802|NCT01276106|1988595|FG003|Overall Study|Withdrawal by Subject|6
981803|NCT01276106|1988592|FG000|Overall Study|Lack of Efficacy|0
981804|NCT01276106|1988593|FG001|Overall Study|Lack of Efficacy|1
981805|NCT01276106|1988594|FG002|Overall Study|Lack of Efficacy|0
981806|NCT01276106|1988595|FG003|Overall Study|Lack of Efficacy|1
981807|NCT01276106|1988592|FG000|Overall Study|Lost to Follow-up|2
981808|NCT01276106|1988593|FG001|Overall Study|Lost to Follow-up|1
981809|NCT01276106|1988594|FG002|Overall Study|Lost to Follow-up|1
981810|NCT01276106|1988595|FG003|Overall Study|Lost to Follow-up|0
981811|NCT01276106|1988592|FG000|Overall Study|Physician Decision|0
981812|NCT01276106|1988593|FG001|Overall Study|Physician Decision|0
981813|NCT01276106|1988594|FG002|Overall Study|Physician Decision|1
981814|NCT01276106|1988595|FG003|Overall Study|Physician Decision|1
981815|NCT01276106|1988592|FG000|Overall Study|Protocol Violation|1
981816|NCT01276106|1988593|FG001|Overall Study|Protocol Violation|1
981817|NCT01276106|1988594|FG002|Overall Study|Protocol Violation|0
981818|NCT01276106|1988595|FG003|Overall Study|Protocol Violation|2
981819|NCT01276106|1988592|FG000|Overall Study|Insufficient therapeutic effects|0
981820|NCT01276106|1988593|FG001|Overall Study|Insufficient therapeutic effects|0
981821|NCT01276106|1988594|FG002|Overall Study|Insufficient therapeutic effects|2
981822|NCT01276106|1988595|FG003|Overall Study|Insufficient therapeutic effects|0
981823|NCT01276223|1988639|FG000|Overall Study|Adverse Event|7
981824|NCT01276223|1988640|FG001|Overall Study|Adverse Event|4
981825|NCT01276223|1988641|FG002|Overall Study|Adverse Event|1
981826|NCT01276223|1988639|FG000|Overall Study|Lost to Follow-up|0
981827|NCT01276223|1988640|FG001|Overall Study|Lost to Follow-up|0
981828|NCT01276223|1988641|FG002|Overall Study|Lost to Follow-up|1
981829|NCT01276223|1988639|FG000|Overall Study|Other|0
981830|NCT01276223|1988640|FG001|Overall Study|Other|0
981831|NCT01276223|1988641|FG002|Overall Study|Other|1
981832|NCT01276223|1988639|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3
981833|NCT01276223|1988640|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0
981834|NCT01276223|1988641|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0
981835|NCT01276223|1988639|FG000|Overall Study|Protocol Violation|1
981836|NCT01276223|1988640|FG001|Overall Study|Protocol Violation|0
981837|NCT01276223|1988641|FG002|Overall Study|Protocol Violation|0
981838|NCT01276236|1988648|FG000|Overall Study|Lack of Efficacy|2
981839|NCT01276236|1988648|FG000|Overall Study|Withdrawal by Subject|4
981840|NCT01276288|1988652|FG000|Overall Study|Adverse Event|1
981841|NCT01276288|1988653|FG001|Overall Study|Adverse Event|1
981842|NCT01276288|1988654|FG002|Overall Study|Adverse Event|0
981843|NCT01276288|1988655|FG003|Overall Study|Adverse Event|0
981844|NCT01276288|1988652|FG000|Overall Study|not treated|1
981845|NCT01276288|1988653|FG001|Overall Study|not treated|0
981846|NCT01276288|1988654|FG002|Overall Study|not treated|0
981847|NCT01276288|1988655|FG003|Overall Study|not treated|0
981848|NCT01276327|1988704|FG000|Overall Study|Adverse Event|1
981849|NCT01276327|1988705|FG001|Overall Study|Adverse Event|3
981850|NCT01276327|1988704|FG000|Overall Study|Withdrawal by Subject|1
981851|NCT01276327|1988705|FG001|Overall Study|Withdrawal by Subject|0
981852|NCT01276353|1988713|FG000|Double-blind|Adverse Event|2
981853|NCT01276353|1988714|FG001|Double-blind|Adverse Event|0
981854|NCT01276353|1988713|FG000|Double-blind|Withdrawal by Subject|1
981855|NCT01276353|1988714|FG001|Double-blind|Withdrawal by Subject|0
981856|NCT01276353|1988713|FG000|Extension|Adverse Event|2
981857|NCT01276353|1988714|FG001|Extension|Adverse Event|5
981858|NCT01276353|1988713|FG000|Extension|Withdrawal by Subject|1
981859|NCT01276353|1988714|FG001|Extension|Withdrawal by Subject|2
981860|NCT01276353|1988713|FG000|Extension|Withdrawal of study drug 4 days in a row|3
981861|NCT01276353|1988714|FG001|Extension|Withdrawal of study drug 4 days in a row|1
981862|NCT01276353|1988713|FG000|Extension|Physician Decision|1
981863|NCT01276353|1988714|FG001|Extension|Physician Decision|0
981864|NCT01276353|1988713|FG000|Extension|Prohibited concomitant medications|0
981865|NCT01276353|1988714|FG001|Extension|Prohibited concomitant medications|1
981866|NCT01276379|1988726|FG000|Overall Study|Screening failure|40
981867|NCT01276457|1988734|FG000|Core Study|Adverse Event|6
981868|NCT01276457|1988735|FG001|Core Study|Adverse Event|3
981869|NCT01276457|1988734|FG000|Core Study|Lost to Follow-up|1
981870|NCT01276457|1988735|FG001|Core Study|Lost to Follow-up|2
981871|NCT01276457|1988734|FG000|Core Study|Administrative problems|1
981872|NCT01276457|1988735|FG001|Core Study|Administrative problems|1
981873|NCT01276457|1988734|FG000|Core Study|Death|2
981874|NCT01276457|1988735|FG001|Core Study|Death|2
981875|NCT01276457|1988734|FG000|Core Study|Lack of Efficacy|3
981876|NCT01276457|1988735|FG001|Core Study|Lack of Efficacy|12
981877|NCT01276457|1988734|FG000|Extension Study|Lost to Follow-up|3
981878|NCT01276457|1988735|FG001|Extension Study|Lost to Follow-up|0
981879|NCT01276457|1988734|FG000|Extension Study|Death|0
981880|NCT01276457|1988735|FG001|Extension Study|Death|1
981881|NCT01276457|1988734|FG000|Extension Study|Lack of Efficacy|3
981882|NCT01276457|1988735|FG001|Extension Study|Lack of Efficacy|1
981883|NCT01276509|1988745|FG000|Overall Study|Adverse Event|9
981884|NCT01276509|1988746|FG001|Overall Study|Adverse Event|8
981885|NCT01276509|1988747|FG002|Overall Study|Adverse Event|4
981886|NCT01276509|1988748|FG003|Overall Study|Adverse Event|3
981887|NCT01276509|1988745|FG000|Overall Study|Lack of Efficacy|2
981888|NCT01276509|1988746|FG001|Overall Study|Lack of Efficacy|1
981889|NCT01276509|1988747|FG002|Overall Study|Lack of Efficacy|1
981890|NCT01276509|1988748|FG003|Overall Study|Lack of Efficacy|2
981891|NCT01276509|1988745|FG000|Overall Study|Pregnancy|1
981892|NCT01276509|1988746|FG001|Overall Study|Pregnancy|0
981893|NCT01276509|1988747|FG002|Overall Study|Pregnancy|0
981894|NCT01276509|1988748|FG003|Overall Study|Pregnancy|0
981895|NCT01276509|1988745|FG000|Overall Study|Withdrawal by Subject|1
981896|NCT01276509|1988746|FG001|Overall Study|Withdrawal by Subject|2
981897|NCT01276509|1988747|FG002|Overall Study|Withdrawal by Subject|0
981898|NCT01276509|1988748|FG003|Overall Study|Withdrawal by Subject|0
981899|NCT01276509|1988745|FG000|Overall Study|Other|0
981900|NCT01276509|1988746|FG001|Overall Study|Other|1
981901|NCT01276509|1988747|FG002|Overall Study|Other|0
981902|NCT01276509|1988748|FG003|Overall Study|Other|0
981903|NCT01276639|1988765|FG000|Week 0 to 16|Death|1
981904|NCT01276639|1988766|FG001|Week 0 to 16|Death|0
981905|NCT01276639|1988767|FG002|Week 0 to 16|Death|0
981906|NCT01276639|1988768|FG003|Week 0 to 16|Death|0
981907|NCT01276639|1988769|FG004|Week 0 to 16|Death|0
981908|NCT01276639|1988765|FG000|Week 0 to 16|Adverse Event|11
981909|NCT01276639|1988766|FG001|Week 0 to 16|Adverse Event|8
981910|NCT01276639|1988767|FG002|Week 0 to 16|Adverse Event|11
981911|NCT01276639|1988768|FG003|Week 0 to 16|Adverse Event|0
981912|NCT01276639|1988769|FG004|Week 0 to 16|Adverse Event|0
981913|NCT01276639|1988765|FG000|Week 0 to 16|Lack of Efficacy|20
981914|NCT01276639|1988766|FG001|Week 0 to 16|Lack of Efficacy|15
981915|NCT01276639|1988767|FG002|Week 0 to 16|Lack of Efficacy|25
981916|NCT01276639|1988768|FG003|Week 0 to 16|Lack of Efficacy|0
981917|NCT01276639|1988769|FG004|Week 0 to 16|Lack of Efficacy|0
981918|NCT01276639|1988765|FG000|Week 0 to 16|Lost to Follow-up|3
981919|NCT01276639|1988766|FG001|Week 0 to 16|Lost to Follow-up|5
981920|NCT01276639|1988767|FG002|Week 0 to 16|Lost to Follow-up|3
981921|NCT01276639|1988768|FG003|Week 0 to 16|Lost to Follow-up|0
981922|NCT01276639|1988769|FG004|Week 0 to 16|Lost to Follow-up|0
981923|NCT01276639|1988765|FG000|Week 0 to 16|Withdrawal by Subject|8
981924|NCT01276639|1988766|FG001|Week 0 to 16|Withdrawal by Subject|5
981925|NCT01276639|1988767|FG002|Week 0 to 16|Withdrawal by Subject|4
981926|NCT01276639|1988768|FG003|Week 0 to 16|Withdrawal by Subject|0
981927|NCT01276639|1988769|FG004|Week 0 to 16|Withdrawal by Subject|0
981928|NCT01276639|1988765|FG000|Week 0 to 16|Other|7
981929|NCT01276639|1988766|FG001|Week 0 to 16|Other|7
981930|NCT01276639|1988767|FG002|Week 0 to 16|Other|2
981931|NCT01276639|1988768|FG003|Week 0 to 16|Other|0
981932|NCT01276639|1988769|FG004|Week 0 to 16|Other|0
981933|NCT01276639|1988765|FG000|Week 0 to 16|Randomized, But Not Treated|0
981934|NCT01276639|1988766|FG001|Week 0 to 16|Randomized, But Not Treated|1
981935|NCT01276639|1988767|FG002|Week 0 to 16|Randomized, But Not Treated|0
981936|NCT01276639|1988768|FG003|Week 0 to 16|Randomized, But Not Treated|0
981937|NCT01276639|1988769|FG004|Week 0 to 16|Randomized, But Not Treated|0
981938|NCT01276639|1988765|FG000|Week 16 to 52|Death|1
981939|NCT01276639|1988766|FG001|Week 16 to 52|Death|0
981940|NCT01276639|1988767|FG002|Week 16 to 52|Death|0
981941|NCT01276639|1988768|FG003|Week 16 to 52|Death|0
981942|NCT01276639|1988769|FG004|Week 16 to 52|Death|0
981943|NCT01276639|1988765|FG000|Week 16 to 52|Adverse Event|10
981944|NCT01276639|1988766|FG001|Week 16 to 52|Adverse Event|13
981945|NCT01276639|1988767|FG002|Week 16 to 52|Adverse Event|0
981946|NCT01276639|1988768|FG003|Week 16 to 52|Adverse Event|1
981947|NCT01276639|1988769|FG004|Week 16 to 52|Adverse Event|3
981948|NCT01276639|1988765|FG000|Week 16 to 52|Lack of Efficacy|99
981949|NCT01276639|1988766|FG001|Week 16 to 52|Lack of Efficacy|71
981950|NCT01276639|1988767|FG002|Week 16 to 52|Lack of Efficacy|0
981951|NCT01276639|1988768|FG003|Week 16 to 52|Lack of Efficacy|14
981952|NCT01276639|1988769|FG004|Week 16 to 52|Lack of Efficacy|13
981953|NCT01276639|1988765|FG000|Week 16 to 52|Lost to Follow-up|3
981954|NCT01276639|1988766|FG001|Week 16 to 52|Lost to Follow-up|1
981955|NCT01276639|1988767|FG002|Week 16 to 52|Lost to Follow-up|0
981956|NCT01276639|1988768|FG003|Week 16 to 52|Lost to Follow-up|0
981957|NCT01276639|1988769|FG004|Week 16 to 52|Lost to Follow-up|1
981958|NCT01276639|1988765|FG000|Week 16 to 52|Withdrawal by Subject|4
981959|NCT01276639|1988766|FG001|Week 16 to 52|Withdrawal by Subject|4
981960|NCT01276639|1988767|FG002|Week 16 to 52|Withdrawal by Subject|0
981961|NCT01276639|1988768|FG003|Week 16 to 52|Withdrawal by Subject|0
981962|NCT01276639|1988769|FG004|Week 16 to 52|Withdrawal by Subject|1
981963|NCT01276639|1988765|FG000|Week 16 to 52|Other|10
981964|NCT01276639|1988766|FG001|Week 16 to 52|Other|12
981965|NCT01276639|1988767|FG002|Week 16 to 52|Other|0
981966|NCT01276639|1988768|FG003|Week 16 to 52|Other|1
981967|NCT01276639|1988769|FG004|Week 16 to 52|Other|3
981968|NCT01276756|1988804|FG000|Overall Study|Lost to Follow-up|2
981969|NCT01276756|1988805|FG001|Overall Study|Lost to Follow-up|0
981970|NCT01276756|1988804|FG000|Overall Study|Adverse Event|3
981971|NCT01276756|1988805|FG001|Overall Study|Adverse Event|2
981972|NCT01276821|1988813|FG000|Overall Study|Protocol Violation|0
981973|NCT01276821|1988814|FG001|Overall Study|Protocol Violation|1
981974|NCT01276847|1988823|FG000|Overall Study|Withdrawal by Subject|1
981975|NCT01276847|1988824|FG001|Overall Study|Withdrawal by Subject|0
981976|NCT01276847|1988825|FG002|Overall Study|Withdrawal by Subject|0
981977|NCT01277042|1988843|FG000|Overall Study|Adverse Event|4
981978|NCT01277042|1988844|FG001|Overall Study|Adverse Event|3
981979|NCT01277042|1988843|FG000|Overall Study|Lost to Follow-up|2
981980|NCT01277042|1988844|FG001|Overall Study|Lost to Follow-up|2
981981|NCT01277042|1988843|FG000|Overall Study|Withdrawal by Subject|2
981982|NCT01277042|1988844|FG001|Overall Study|Withdrawal by Subject|0
981983|NCT01277211|1988883|FG000|Overall Study|Adverse Event|60
981984|NCT01277211|1988884|FG001|Overall Study|Adverse Event|22
981985|NCT01277211|1988883|FG000|Overall Study|Pregnancy|9
981986|NCT01277211|1988884|FG001|Overall Study|Pregnancy|4
981987|NCT01277211|1988883|FG000|Overall Study|Lost to Follow-up|14
981988|NCT01277211|1988884|FG001|Overall Study|Lost to Follow-up|9
981989|NCT01277211|1988883|FG000|Overall Study|Did not wish to continue|17
981990|NCT01277211|1988884|FG001|Overall Study|Did not wish to continue|0
981991|NCT01277211|1988883|FG000|Overall Study|Withdrew Consent|9
981992|NCT01277211|1988884|FG001|Overall Study|Withdrew Consent|9
981993|NCT01277211|1988883|FG000|Overall Study|Non-compliance with protocol|13
981994|NCT01277211|1988884|FG001|Overall Study|Non-compliance with protocol|4
981995|NCT01277211|1988883|FG000|Overall Study|Did not meet protocol eligibility|1
981996|NCT01277211|1988884|FG001|Overall Study|Did not meet protocol eligibility|0
981997|NCT01277211|1988883|FG000|Overall Study|Administrative|3
981998|NCT01277211|1988884|FG001|Overall Study|Administrative|0
981999|NCT01277211|1988883|FG000|Overall Study|Pregnancy wish|0
982000|NCT01277211|1988884|FG001|Overall Study|Pregnancy wish|2
982001|NCT01277211|1988883|FG000|Overall Study|Discontinued prior to treatment|24
982002|NCT01277211|1988884|FG001|Overall Study|Discontinued prior to treatment|13
982003|NCT01277302|1988893|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
982004|NCT01277302|1988894|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
982005|NCT01277302|1988895|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
982006|NCT01277302|1988893|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0
982007|NCT01277302|1988894|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0
982008|NCT01277302|1988895|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2
982009|NCT01277302|1988893|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
982010|NCT01277302|1988894|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
982011|NCT01277302|1988895|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
982012|NCT01277302|1988893|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0
982013|NCT01277302|1988894|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0
982014|NCT01277302|1988895|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1
982015|NCT01277302|1988893|FG000|8-Month Alternate Dose Regimen Period|Death|0
982016|NCT01277302|1988894|FG001|8-Month Alternate Dose Regimen Period|Death|1
982017|NCT01277302|1988895|FG002|8-Month Alternate Dose Regimen Period|Death|0
982018|NCT01277302|1988893|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
982019|NCT01277302|1988894|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
982020|NCT01277302|1988895|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
982021|NCT01277302|1988893|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
982022|NCT01277302|1988894|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
982023|NCT01277302|1988895|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
982024|NCT01277302|1988893|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
982025|NCT01277302|1988894|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
982026|NCT01277302|1988895|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
982027|NCT01277302|1988893|FG000|8-Month Alternate Dose Regimen Period|Relocation|1
982028|NCT01277302|1988894|FG001|8-Month Alternate Dose Regimen Period|Relocation|0
982029|NCT01277302|1988895|FG002|8-Month Alternate Dose Regimen Period|Relocation|1
982030|NCT01277510|1988931|FG000|Double-blind Phase|Non-compliance|0
982031|NCT01277510|1988932|FG001|Double-blind Phase|Non-compliance|1
982032|NCT01277510|1988931|FG000|Double-blind Phase|Adverse Event|1
982033|NCT01277510|1988932|FG001|Double-blind Phase|Adverse Event|0
982034|NCT01277510|1988931|FG000|Double-blind Phase|Withdrawal by Subject|2
982035|NCT01277510|1988932|FG001|Double-blind Phase|Withdrawal by Subject|0
982036|NCT01277510|1988931|FG000|Double-blind Phase|Administrative decision|7
982037|NCT01277510|1988932|FG001|Double-blind Phase|Administrative decision|9
982038|NCT01277510|1988931|FG000|Double-blind Phase|Death|0
982039|NCT01277510|1988932|FG001|Double-blind Phase|Death|1
982040|NCT01277510|1988931|FG000|Double-blind Phase|Protocol-specified criteria|2
982041|NCT01277510|1988932|FG001|Double-blind Phase|Protocol-specified criteria|6
982042|NCT01277510|1988931|FG000|Double-blind Phase|Other|1
982043|NCT01277510|1988932|FG001|Double-blind Phase|Other|1
982044|NCT01277510|1988931|FG000|Open-label Phase|Administrative decision|4
982045|NCT01277510|1988932|FG001|Open-label Phase|Administrative decision|3
982046|NCT01277510|1988931|FG000|Open-label Phase|Protocol-specified criteria|1
982047|NCT01277510|1988932|FG001|Open-label Phase|Protocol-specified criteria|0
982048|NCT01277510|1988931|FG000|Open-label Phase|Never received investigational product|2
982049|NCT01277510|1988932|FG001|Open-label Phase|Never received investigational product|0
982050|NCT01277523|1988943|FG000|Overall Study|Adverse Event|1
982051|NCT01277523|1988944|FG001|Overall Study|Adverse Event|0
982052|NCT01277523|1988945|FG002|Overall Study|Adverse Event|0
982053|NCT01277523|1988943|FG000|Overall Study|Protocol Violation|2
982054|NCT01277523|1988944|FG001|Overall Study|Protocol Violation|0
982055|NCT01277523|1988945|FG002|Overall Study|Protocol Violation|0
982056|NCT01277523|1988943|FG000|Overall Study|Other Reason not Defined|0
982057|NCT01277523|1988944|FG001|Overall Study|Other Reason not Defined|1
982058|NCT01277523|1988945|FG002|Overall Study|Other Reason not Defined|0
982059|NCT01277549|1988955|FG000|Overall Study|Failed to meet eligibility criteria|13
982060|NCT01277549|1988956|FG001|Overall Study|Failed to meet eligibility criteria|9
982061|NCT01277549|1988955|FG000|Overall Study|Withdrawal by Subject|1
982062|NCT01277549|1988956|FG001|Overall Study|Withdrawal by Subject|3
982063|NCT01277549|1988955|FG000|Overall Study|Protocol Violation|10
982064|NCT01277549|1988956|FG001|Overall Study|Protocol Violation|1
982065|NCT01277549|1988955|FG000|Overall Study|Physician Decision|2
982066|NCT01277549|1988956|FG001|Overall Study|Physician Decision|1
982067|NCT01277601|1988969|FG000|Overall Study|Adverse Event|5
982068|NCT01277601|1988970|FG001|Overall Study|Adverse Event|3
982069|NCT01277601|1988971|FG002|Overall Study|Adverse Event|0
982070|NCT01277601|1988972|FG003|Overall Study|Adverse Event|7
982071|NCT01277601|1988969|FG000|Overall Study|Withdrawal by Subject|18
982072|NCT01277601|1988970|FG001|Overall Study|Withdrawal by Subject|21
982073|NCT01277601|1988971|FG002|Overall Study|Withdrawal by Subject|8
982074|NCT01277601|1988972|FG003|Overall Study|Withdrawal by Subject|17
982075|NCT01277601|1988969|FG000|Overall Study|Lost to Follow-up|7
982076|NCT01277601|1988970|FG001|Overall Study|Lost to Follow-up|9
982077|NCT01277601|1988971|FG002|Overall Study|Lost to Follow-up|4
982078|NCT01277601|1988972|FG003|Overall Study|Lost to Follow-up|2
982079|NCT01277601|1988969|FG000|Overall Study|Physician Decision|3
982080|NCT01277601|1988970|FG001|Overall Study|Physician Decision|5
982081|NCT01277601|1988971|FG002|Overall Study|Physician Decision|1
982082|NCT01277601|1988972|FG003|Overall Study|Physician Decision|6
982083|NCT01277601|1988969|FG000|Overall Study|Pregnancy|2
982084|NCT01277601|1988970|FG001|Overall Study|Pregnancy|2
982085|NCT01277601|1988971|FG002|Overall Study|Pregnancy|4
982086|NCT01277601|1988972|FG003|Overall Study|Pregnancy|1
982087|NCT01277601|1988969|FG000|Overall Study|Noncompliance with Study Drug|1
982088|NCT01277601|1988970|FG001|Overall Study|Noncompliance with Study Drug|3
982089|NCT01277601|1988971|FG002|Overall Study|Noncompliance with Study Drug|2
982090|NCT01277601|1988972|FG003|Overall Study|Noncompliance with Study Drug|0
982091|NCT01277601|1988969|FG000|Overall Study|Subject Never Dosed with Study Drug|1
982092|NCT01277601|1988970|FG001|Overall Study|Subject Never Dosed with Study Drug|2
982093|NCT01277601|1988971|FG002|Overall Study|Subject Never Dosed with Study Drug|3
982094|NCT01277601|1988972|FG003|Overall Study|Subject Never Dosed with Study Drug|1
982095|NCT01277601|1988969|FG000|Overall Study|Protocol Violation|0
982096|NCT01277601|1988970|FG001|Overall Study|Protocol Violation|2
982097|NCT01277601|1988971|FG002|Overall Study|Protocol Violation|5
982098|NCT01277601|1988972|FG003|Overall Study|Protocol Violation|0
982099|NCT01277601|1988969|FG000|Overall Study|Subject Terminated from Study by Sponsor|0
982100|NCT01277601|1988970|FG001|Overall Study|Subject Terminated from Study by Sponsor|1
982101|NCT01277601|1988971|FG002|Overall Study|Subject Terminated from Study by Sponsor|0
982102|NCT01277601|1988972|FG003|Overall Study|Subject Terminated from Study by Sponsor|2
982103|NCT01277666|1989002|FG000|Overall Study|Adverse Event|26
982104|NCT01277666|1989003|FG001|Overall Study|Adverse Event|25
982105|NCT01277666|1989004|FG002|Overall Study|Adverse Event|20
982106|NCT01277666|1989002|FG000|Overall Study|Lack of Efficacy|8
982107|NCT01277666|1989003|FG001|Overall Study|Lack of Efficacy|20
982108|NCT01277666|1989004|FG002|Overall Study|Lack of Efficacy|12
982109|NCT01277666|1989002|FG000|Overall Study|Protocol Violation|2
982110|NCT01277666|1989003|FG001|Overall Study|Protocol Violation|3
982111|NCT01277666|1989004|FG002|Overall Study|Protocol Violation|2
982112|NCT01277666|1989002|FG000|Overall Study|Protocol Defined Stopping criteria|1
982113|NCT01277666|1989003|FG001|Overall Study|Protocol Defined Stopping criteria|2
982114|NCT01277666|1989004|FG002|Overall Study|Protocol Defined Stopping criteria|6
982115|NCT01277666|1989002|FG000|Overall Study|Lost to Follow-up|1
982116|NCT01277666|1989003|FG001|Overall Study|Lost to Follow-up|1
982117|NCT01277666|1989004|FG002|Overall Study|Lost to Follow-up|2
982118|NCT01277666|1989002|FG000|Overall Study|Withdrawal by Subject|7
982119|NCT01277666|1989003|FG001|Overall Study|Withdrawal by Subject|8
982120|NCT01277666|1989004|FG002|Overall Study|Withdrawal by Subject|6
982121|NCT01277666|1989002|FG000|Overall Study|Death|0
982122|NCT01277666|1989003|FG001|Overall Study|Death|0
982123|NCT01277666|1989004|FG002|Overall Study|Death|1
982124|NCT01277718|1989012|FG000|Period 2 - Second Intervention|Protocol Violation|0
982125|NCT01277718|1989013|FG001|Period 2 - Second Intervention|Protocol Violation|1
982126|NCT01277718|1989012|FG000|Period 2 - Second Intervention|Physician Decision|0
982127|NCT01277718|1989013|FG001|Period 2 - Second Intervention|Physician Decision|2
982128|NCT01277744|1989021|FG000|Overall Study|Physician Decision|2
982129|NCT01277757|1989025|FG000|Overall Study|Disease Progression|1
982130|NCT01277757|1989025|FG000|Overall Study|Withdrawal by Subject|1
982131|NCT01277822|1989036|FG000|Overall Study|Adverse Event|2
982132|NCT01277822|1989037|FG001|Overall Study|Adverse Event|1
982133|NCT01277822|1989036|FG000|Overall Study|Withdrawal by Subject|6
982134|NCT01277822|1989037|FG001|Overall Study|Withdrawal by Subject|7
982135|NCT01277822|1989036|FG000|Overall Study|Physician Decision|1
982136|NCT01277822|1989037|FG001|Overall Study|Physician Decision|1
982137|NCT01277822|1989036|FG000|Overall Study|Protocol Violation|1
982138|NCT01277822|1989037|FG001|Overall Study|Protocol Violation|0
982139|NCT01277822|1989036|FG000|Overall Study|Lost to Follow-up|2
982140|NCT01277822|1989037|FG001|Overall Study|Lost to Follow-up|1
982141|NCT01277822|1989036|FG000|Overall Study|Contraindicated medication used|2
982142|NCT01277822|1989037|FG001|Overall Study|Contraindicated medication used|1
982143|NCT01277822|1989036|FG000|Overall Study|Participant moved|1
982144|NCT01277822|1989037|FG001|Overall Study|Participant moved|0
982145|NCT01277861|1989045|FG000|Overall Study|Physician Decision|2
982146|NCT01277861|1989046|FG001|Overall Study|Physician Decision|2
982147|NCT01277887|1989056|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1
982148|NCT01277887|1989057|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0
982149|NCT01277887|1989056|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2
982150|NCT01277887|1989057|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0
982151|NCT01277887|1989056|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3
982152|NCT01277887|1989057|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5
982153|NCT01278030|1989065|FG000|Overall Study|Withdrawal by Subject|8
982154|NCT01278030|1989066|FG001|Overall Study|Withdrawal by Subject|4
1006639|NCT01468987|2025356|FG001|Overall Study|Lost to Follow-up|5
1006640|NCT01468987|2025355|FG000|Overall Study|Protocol Violation|8
1006641|NCT01468987|2025356|FG001|Overall Study|Protocol Violation|2
1006642|NCT01468987|2025355|FG000|Overall Study|Withdrawal by Subject|28
1006643|NCT01468987|2025356|FG001|Overall Study|Withdrawal by Subject|28
1006644|NCT01468987|2025355|FG000|Overall Study|Physician Decision|8
1006645|NCT01468987|2025356|FG001|Overall Study|Physician Decision|15
1006646|NCT01468987|2025355|FG000|Overall Study|Sponsor Decision|1
1006647|NCT01468987|2025356|FG001|Overall Study|Sponsor Decision|0
1006648|NCT01469000|2025366|FG000|Overall Study|Withdrawal by Subject|16
1006649|NCT01469000|2025367|FG001|Overall Study|Withdrawal by Subject|3
1006650|NCT01469000|2025366|FG000|Overall Study|Sponsor Decision|4
1006651|NCT01469000|2025367|FG001|Overall Study|Sponsor Decision|1
1006652|NCT01469013|2025378|FG000|Part A (Treatment Period)|Adverse Event|1
1006653|NCT01469013|2025379|FG001|Part A (Treatment Period)|Adverse Event|0
1006654|NCT01469013|2025380|FG002|Part A (Treatment Period)|Adverse Event|0
1006655|NCT01469013|2025381|FG003|Part A (Treatment Period)|Adverse Event|0
1006656|NCT01469013|2025382|FG004|Part A (Treatment Period)|Adverse Event|1
1006657|NCT01469013|2025383|FG005|Part A (Treatment Period)|Adverse Event|0
1006658|NCT01469013|2025384|FG006|Part A (Treatment Period)|Adverse Event|0
1006659|NCT01469013|2025385|FG007|Part A (Treatment Period)|Adverse Event|0
1006660|NCT01469013|2025386|FG008|Part A (Treatment Period)|Adverse Event|0
1006661|NCT01469013|2025387|FG009|Part A (Treatment Period)|Adverse Event|0
1006662|NCT01469013|2025388|FG010|Part A (Treatment Period)|Adverse Event|0
1006663|NCT01469013|2025389|FG011|Part A (Treatment Period)|Adverse Event|0
1006664|NCT01469013|2025390|FG012|Part A (Treatment Period)|Adverse Event|0
1006665|NCT01469013|2025378|FG000|Part A (Treatment Period)|Withdrawal by Subject|0
1006666|NCT01469013|2025379|FG001|Part A (Treatment Period)|Withdrawal by Subject|0
1006667|NCT01469013|2025380|FG002|Part A (Treatment Period)|Withdrawal by Subject|1
1006668|NCT01469013|2025381|FG003|Part A (Treatment Period)|Withdrawal by Subject|0
1006669|NCT01469013|2025382|FG004|Part A (Treatment Period)|Withdrawal by Subject|0
1006670|NCT01469013|2025383|FG005|Part A (Treatment Period)|Withdrawal by Subject|0
1006671|NCT01469013|2025384|FG006|Part A (Treatment Period)|Withdrawal by Subject|0
1006672|NCT01469013|2025385|FG007|Part A (Treatment Period)|Withdrawal by Subject|0
1006673|NCT01469013|2025386|FG008|Part A (Treatment Period)|Withdrawal by Subject|0
1006674|NCT01469013|2025387|FG009|Part A (Treatment Period)|Withdrawal by Subject|0
1006675|NCT01469013|2025388|FG010|Part A (Treatment Period)|Withdrawal by Subject|0
1006676|NCT01469013|2025389|FG011|Part A (Treatment Period)|Withdrawal by Subject|0
1006677|NCT01469013|2025390|FG012|Part A (Treatment Period)|Withdrawal by Subject|0
1006678|NCT01469013|2025378|FG000|Part B (Extension Period)|Adverse Event|0
1006679|NCT01469013|2025379|FG001|Part B (Extension Period)|Adverse Event|0
1006680|NCT01469013|2025380|FG002|Part B (Extension Period)|Adverse Event|0
1006681|NCT01469013|2025381|FG003|Part B (Extension Period)|Adverse Event|0
1006682|NCT01469013|2025382|FG004|Part B (Extension Period)|Adverse Event|0
1006683|NCT01469013|2025383|FG005|Part B (Extension Period)|Adverse Event|2
1006684|NCT01469013|2025384|FG006|Part B (Extension Period)|Adverse Event|5
1006685|NCT01469013|2025385|FG007|Part B (Extension Period)|Adverse Event|5
1006686|NCT01469013|2025386|FG008|Part B (Extension Period)|Adverse Event|3
1006687|NCT01469013|2025387|FG009|Part B (Extension Period)|Adverse Event|3
1006688|NCT01469013|2025388|FG010|Part B (Extension Period)|Adverse Event|1
1006689|NCT01469013|2025389|FG011|Part B (Extension Period)|Adverse Event|6
1006690|NCT01469013|2025390|FG012|Part B (Extension Period)|Adverse Event|3
1006691|NCT01469013|2025378|FG000|Part B (Extension Period)|Withdrawal by Subject|0
1006692|NCT01469013|2025379|FG001|Part B (Extension Period)|Withdrawal by Subject|0
1006693|NCT01469013|2025380|FG002|Part B (Extension Period)|Withdrawal by Subject|0
1006694|NCT01469013|2025381|FG003|Part B (Extension Period)|Withdrawal by Subject|0
1006695|NCT01469013|2025382|FG004|Part B (Extension Period)|Withdrawal by Subject|0
1006696|NCT01469013|2025383|FG005|Part B (Extension Period)|Withdrawal by Subject|0
1006697|NCT01469013|2025384|FG006|Part B (Extension Period)|Withdrawal by Subject|0
1006698|NCT01469013|2025385|FG007|Part B (Extension Period)|Withdrawal by Subject|0
1006699|NCT01469013|2025386|FG008|Part B (Extension Period)|Withdrawal by Subject|1
1006700|NCT01469013|2025387|FG009|Part B (Extension Period)|Withdrawal by Subject|0
1006701|NCT01469013|2025388|FG010|Part B (Extension Period)|Withdrawal by Subject|1
1006702|NCT01469013|2025389|FG011|Part B (Extension Period)|Withdrawal by Subject|0
1006703|NCT01469013|2025390|FG012|Part B (Extension Period)|Withdrawal by Subject|3
1006704|NCT01469052|2025436|FG000|Overall Study|Adverse Event|2
1006705|NCT01469052|2025437|FG001|Overall Study|Adverse Event|3
1006706|NCT01469052|2025438|FG002|Overall Study|Adverse Event|0
1006707|NCT01469052|2025439|FG003|Overall Study|Adverse Event|2
1006708|NCT01469052|2025440|FG004|Overall Study|Adverse Event|0
1006709|NCT01469052|2025441|FG005|Overall Study|Adverse Event|1
1006710|NCT01469052|2025436|FG000|Overall Study|Progressive disease|3
1006711|NCT01469052|2025437|FG001|Overall Study|Progressive disease|0
1006712|NCT01469052|2025438|FG002|Overall Study|Progressive disease|5
1006713|NCT01469052|2025439|FG003|Overall Study|Progressive disease|3
1006714|NCT01469052|2025440|FG004|Overall Study|Progressive disease|7
1006715|NCT01469052|2025441|FG005|Overall Study|Progressive disease|2
1006716|NCT01469052|2025436|FG000|Overall Study|Lack of Efficacy|0
1006717|NCT01469052|2025437|FG001|Overall Study|Lack of Efficacy|0
982155|NCT01278160|1989074|FG000|Overall Study|Adverse Event|1
982156|NCT01278160|1989075|FG001|Overall Study|Adverse Event|1
982157|NCT01278160|1989074|FG000|Overall Study|Lost to Follow-up|0
982158|NCT01278160|1989075|FG001|Overall Study|Lost to Follow-up|1
982159|NCT01278160|1989074|FG000|Overall Study|Withdrawal by Subject|3
982160|NCT01278160|1989075|FG001|Overall Study|Withdrawal by Subject|2
982161|NCT01278160|1989074|FG000|Overall Study|Unclassified|1
982162|NCT01278160|1989075|FG001|Overall Study|Unclassified|2
982163|NCT01278173|1989081|FG000|Overall Study|Lack of Efficacy|13
982164|NCT01278173|1989081|FG000|Overall Study|Adverse Event|8
982165|NCT01278173|1989081|FG000|Overall Study|Administrative or other reason|4
982166|NCT01278173|1989081|FG000|Overall Study|Protocol Violation|1
982167|NCT01278173|1989081|FG000|Overall Study|Withdrawal by Subject|1
982168|NCT01278342|1989092|FG000|Overall Study|Physician Decision|0
982169|NCT01278342|1989093|FG001|Overall Study|Physician Decision|1
982170|NCT01278342|1989094|FG002|Overall Study|Physician Decision|0
982171|NCT01278342|1989092|FG000|Overall Study|Lost to Follow-up|1
982172|NCT01278342|1989093|FG001|Overall Study|Lost to Follow-up|0
982173|NCT01278342|1989094|FG002|Overall Study|Lost to Follow-up|0
982174|NCT01278342|1989092|FG000|Overall Study|Administrative problems|2
982175|NCT01278342|1989093|FG001|Overall Study|Administrative problems|0
982176|NCT01278342|1989094|FG002|Overall Study|Administrative problems|0
982177|NCT01278342|1989092|FG000|Overall Study|Other|1
982178|NCT01278342|1989093|FG001|Overall Study|Other|0
982179|NCT01278342|1989094|FG002|Overall Study|Other|0
982180|NCT01278394|1989102|FG000|Overall Study|Lost to Follow-up|1
982181|NCT01278407|1989109|FG000|Confirmatory Phase|Adverse Event|5
982182|NCT01278407|1989110|FG001|Confirmatory Phase|Adverse Event|10
982183|NCT01278407|1989111|FG002|Confirmatory Phase|Adverse Event|1
982184|NCT01278407|1989112|FG003|Confirmatory Phase|Adverse Event|0
982185|NCT01278407|1989113|FG004|Confirmatory Phase|Adverse Event|0
982186|NCT01278407|1989109|FG000|Confirmatory Phase|Participant's Choice|3
982187|NCT01278407|1989110|FG001|Confirmatory Phase|Participant's Choice|5
982188|NCT01278407|1989111|FG002|Confirmatory Phase|Participant's Choice|3
982189|NCT01278407|1989112|FG003|Confirmatory Phase|Participant's Choice|0
982190|NCT01278407|1989113|FG004|Confirmatory Phase|Participant's Choice|0
982191|NCT01278407|1989109|FG000|Confirmatory Phase|Other|1
982192|NCT01278407|1989110|FG001|Confirmatory Phase|Other|1
982193|NCT01278407|1989111|FG002|Confirmatory Phase|Other|2
982194|NCT01278407|1989112|FG003|Confirmatory Phase|Other|0
982195|NCT01278407|1989113|FG004|Confirmatory Phase|Other|0
982196|NCT01278407|1989109|FG000|Extension Phase|Adverse Event|0
982197|NCT01278407|1989110|FG001|Extension Phase|Adverse Event|0
982198|NCT01278407|1989111|FG002|Extension Phase|Adverse Event|0
982199|NCT01278407|1989112|FG003|Extension Phase|Adverse Event|7
982200|NCT01278407|1989113|FG004|Extension Phase|Adverse Event|16
982201|NCT01278407|1989109|FG000|Extension Phase|Participant's Choice|0
982202|NCT01278407|1989110|FG001|Extension Phase|Participant's Choice|0
982203|NCT01278407|1989111|FG002|Extension Phase|Participant's Choice|0
982204|NCT01278407|1989112|FG003|Extension Phase|Participant's Choice|4
982205|NCT01278407|1989113|FG004|Extension Phase|Participant's Choice|11
982206|NCT01278407|1989109|FG000|Extension Phase|Other|0
982207|NCT01278407|1989110|FG001|Extension Phase|Other|0
982208|NCT01278407|1989111|FG002|Extension Phase|Other|0
982209|NCT01278407|1989112|FG003|Extension Phase|Other|1
982210|NCT01278407|1989113|FG004|Extension Phase|Other|3
982211|NCT01278615|1989127|FG000|Overall Study|Withdrawal by Subject|2
982212|NCT01278745|1989133|FG000|Overall Study|Death|2
982213|NCT01278745|1989134|FG001|Overall Study|Death|5
982214|NCT01278745|1989135|FG002|Overall Study|Death|7
982215|NCT01278745|1989136|FG003|Overall Study|Death|0
982216|NCT01278745|1989133|FG000|Overall Study|Physician Decision|1
982217|NCT01278745|1989134|FG001|Overall Study|Physician Decision|0
982218|NCT01278745|1989135|FG002|Overall Study|Physician Decision|0
982219|NCT01278745|1989136|FG003|Overall Study|Physician Decision|9
982220|NCT01278745|1989133|FG000|Overall Study|Withdrawal by Subject|1
982221|NCT01278745|1989134|FG001|Overall Study|Withdrawal by Subject|1
982222|NCT01278745|1989135|FG002|Overall Study|Withdrawal by Subject|5
982223|NCT01278745|1989136|FG003|Overall Study|Withdrawal by Subject|1
982224|NCT01278745|1989133|FG000|Overall Study|Sponsor Decision|1
982225|NCT01278745|1989134|FG001|Overall Study|Sponsor Decision|0
982226|NCT01278745|1989135|FG002|Overall Study|Sponsor Decision|62
982227|NCT01278745|1989136|FG003|Overall Study|Sponsor Decision|6
982228|NCT01278745|1989133|FG000|Overall Study|Ineligible|0
982229|NCT01278745|1989134|FG001|Overall Study|Ineligible|0
982230|NCT01278745|1989135|FG002|Overall Study|Ineligible|42
982231|NCT01278745|1989136|FG003|Overall Study|Ineligible|61
982232|NCT01278745|1989133|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0
982233|NCT01278745|1989134|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0
982234|NCT01278745|1989135|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5
982235|NCT01278745|1989136|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1
982236|NCT01278797|1989144|FG000|Period 1|Adverse Event|0
982237|NCT01278797|1989145|FG001|Period 1|Adverse Event|1
982238|NCT01278797|1989144|FG000|Period 1|Protocol Violation|1
982239|NCT01278797|1989145|FG001|Period 1|Protocol Violation|0
982240|NCT01278862|1989153|FG000|Overall Study|Lost to Follow-up|1
982241|NCT01278862|1989154|FG001|Overall Study|Lost to Follow-up|1
982242|NCT01279044|1989190|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
982243|NCT01279044|1989191|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
982244|NCT01279044|1989192|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
982245|NCT01279044|1989190|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
982246|NCT01279044|1989191|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
982247|NCT01279044|1989192|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
982248|NCT01279044|1989190|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0
982249|NCT01279044|1989191|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0
982250|NCT01279044|1989192|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1
982251|NCT01279057|1989201|FG000|Overall Study|Adverse Event|1
982252|NCT01279057|1989202|FG001|Overall Study|Adverse Event|0
982253|NCT01279057|1989203|FG002|Overall Study|Adverse Event|1
982254|NCT01279057|1989201|FG000|Overall Study|Insufficient therapeutic response|0
982255|NCT01279057|1989202|FG001|Overall Study|Insufficient therapeutic response|0
982256|NCT01279057|1989203|FG002|Overall Study|Insufficient therapeutic response|1
982257|NCT01279057|1989201|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
982258|NCT01279057|1989202|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1
982259|NCT01279057|1989203|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0
982260|NCT01279057|1989201|FG000|Overall Study|Withdrew consent|2
982261|NCT01279057|1989202|FG001|Overall Study|Withdrew consent|0
982262|NCT01279057|1989203|FG002|Overall Study|Withdrew consent|1
982263|NCT01279057|1989201|FG000|Overall Study|Pregnancy|0
982264|NCT01279057|1989202|FG001|Overall Study|Pregnancy|1
982265|NCT01279057|1989203|FG002|Overall Study|Pregnancy|0
982266|NCT01279057|1989201|FG000|Overall Study|Other|3
982267|NCT01279057|1989202|FG001|Overall Study|Other|3
982268|NCT01279057|1989203|FG002|Overall Study|Other|0
982269|NCT01279070|1989213|FG000|Overall Study|Withdrawal by Subject|2
982270|NCT01279070|1989214|FG001|Overall Study|Withdrawal by Subject|3
982271|NCT01279070|1989213|FG000|Overall Study|Acute exacerbation|3
982272|NCT01279070|1989214|FG001|Overall Study|Acute exacerbation|1
982273|NCT01279200|1989244|FG000|Overall Study|Withdrawal by Subject|1
982274|NCT01279200|1989245|FG001|Overall Study|Withdrawal by Subject|3
982275|NCT01279200|1989244|FG000|Overall Study|Patient withdrawal due to high cost|0
982276|NCT01279200|1989245|FG001|Overall Study|Patient withdrawal due to high cost|1
982277|NCT01279200|1989244|FG000|Overall Study|Inconvenience of ultrasound visit|0
982278|NCT01279200|1989245|FG001|Overall Study|Inconvenience of ultrasound visit|1
982279|NCT01279200|1989244|FG000|Overall Study|ultrasound screening failure|0
982280|NCT01279200|1989245|FG001|Overall Study|ultrasound screening failure|1
982281|NCT01279200|1989244|FG000|Overall Study|Lost to Follow-up|0
982282|NCT01279200|1989245|FG001|Overall Study|Lost to Follow-up|1
982283|NCT01279200|1989244|FG000|Overall Study|Adverse Event|1
982284|NCT01279200|1989245|FG001|Overall Study|Adverse Event|0
982285|NCT01279343|1989270|FG000|Overall Study|Did not receive treatment|2
982286|NCT01279343|1989271|FG001|Overall Study|Did not receive treatment|6
982287|NCT01279447|1989279|FG000|Overall Study|Lost to Follow-up|3
982288|NCT01279447|1989280|FG001|Overall Study|Lost to Follow-up|1
982289|NCT01279486|1989286|FG000|Overall Study|Lost to Follow-up|1
982290|NCT01279681|1989301|FG000|Overall Study|Disease Progression|9
982291|NCT01279681|1989302|FG001|Overall Study|Disease Progression|6
982292|NCT01279681|1989301|FG000|Overall Study|Withdrawal by Subject|3
982293|NCT01279681|1989302|FG001|Overall Study|Withdrawal by Subject|4
982294|NCT01279681|1989301|FG000|Overall Study|Adverse Event|2
982295|NCT01279681|1989302|FG001|Overall Study|Adverse Event|3
982296|NCT01279681|1989301|FG000|Overall Study|Death|0
982297|NCT01279681|1989302|FG001|Overall Study|Death|1
982298|NCT01279681|1989301|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0
982299|NCT01279681|1989302|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1
982300|NCT01279681|1989301|FG000|Overall Study|Physician Decision|1
982301|NCT01279681|1989302|FG001|Overall Study|Physician Decision|0
982302|NCT01279681|1989301|FG000|Overall Study|Other Reason|0
982303|NCT01279681|1989302|FG001|Overall Study|Other Reason|2
982304|NCT01279850|1989308|FG000|Overall Study|Protocol Violation|50
982305|NCT01279850|1989308|FG000|Overall Study|No Drug Administration Information|7
982306|NCT01279850|1989308|FG000|Overall Study|No Visit After Treatment|34
982307|NCT01279954|1989314|FG000|Overall Study|Lack of Efficacy|3
982308|NCT01279954|1989315|FG001|Overall Study|Lack of Efficacy|4
982309|NCT01280266|1989365|FG000|First Intervention (Week 1-4)|Adverse Event|1
982310|NCT01280266|1989366|FG001|First Intervention (Week 1-4)|Adverse Event|0
982311|NCT01280266|1989365|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0
982312|NCT01280266|1989366|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2
982313|NCT01280357|1989376|FG000|Overall Study|Excluded no internal monitoring|14
982314|NCT01280357|1989376|FG000|Overall Study|IInsufficient data/No data supplied|12
982315|NCT01280591|1989408|FG000|Overall Study|Withdrawal by Subject|0
982316|NCT01280591|1989409|FG001|Overall Study|Withdrawal by Subject|0
982317|NCT01280591|1989410|FG002|Overall Study|Withdrawal by Subject|0
982318|NCT01280591|1989411|FG003|Overall Study|Withdrawal by Subject|2
982319|NCT01280591|1989408|FG000|Overall Study|Does not meet exclusion #27 criteria|0
982320|NCT01280591|1989409|FG001|Overall Study|Does not meet exclusion #27 criteria|0
982321|NCT01280591|1989410|FG002|Overall Study|Does not meet exclusion #27 criteria|0
982322|NCT01280591|1989411|FG003|Overall Study|Does not meet exclusion #27 criteria|1
982323|NCT01280617|1989432|FG000|Overall Study|Adverse Event|0
982324|NCT01280617|1989433|FG001|Overall Study|Adverse Event|1
982325|NCT01280656|1989442|FG000|Overall Study|Adverse Event|1
982326|NCT01280656|1989443|FG001|Overall Study|Adverse Event|14
982327|NCT01280656|1989444|FG002|Overall Study|Adverse Event|13
982328|NCT01280656|1989442|FG000|Overall Study|Lack of Efficacy|1
982329|NCT01280656|1989443|FG001|Overall Study|Lack of Efficacy|22
982330|NCT01280656|1989444|FG002|Overall Study|Lack of Efficacy|38
982331|NCT01280656|1989442|FG000|Overall Study|Treatment shortening (RGT)|0
982332|NCT01280656|1989443|FG001|Overall Study|Treatment shortening (RGT)|4
982333|NCT01280656|1989444|FG002|Overall Study|Treatment shortening (RGT)|5
982334|NCT01280656|1989442|FG000|Overall Study|Other|1
982335|NCT01280656|1989443|FG001|Overall Study|Other|7
982336|NCT01280656|1989444|FG002|Overall Study|Other|7
982337|NCT01280721|1989473|FG000|Overall Study|Adverse Event|4
982338|NCT01280721|1989473|FG000|Overall Study|Physician Decision|3
982339|NCT01280721|1989473|FG000|Overall Study|Withdrawal by Subject|6
982340|NCT01280721|1989473|FG000|Overall Study|eGFR under the withdrawal criteria|7
982341|NCT01280721|1989473|FG000|Overall Study|No tolerability for the lowest dose|2
982342|NCT01280812|1989491|FG000|Overall Study|Withdrawal by Subject|2
982343|NCT01280812|1989492|FG001|Overall Study|Withdrawal by Subject|1
982344|NCT01280812|1989493|FG002|Overall Study|Withdrawal by Subject|0
982345|NCT01280812|1989491|FG000|Overall Study|Lost to Follow-up|1
982346|NCT01280812|1989492|FG001|Overall Study|Lost to Follow-up|1
982347|NCT01280812|1989493|FG002|Overall Study|Lost to Follow-up|1
982348|NCT01280903|1989504|FG000|Overall Study|Lost to Follow-up|23
982349|NCT01280903|1989505|FG001|Overall Study|Lost to Follow-up|16
982350|NCT01280955|1989520|FG000|Overall Study|Death|2
982351|NCT01280955|1989520|FG000|Overall Study|Withdrawal by Subject|1
982352|NCT01280968|1989528|FG000|Overall Study|Lost to Follow-up|8
982353|NCT01280968|1989529|FG001|Overall Study|Lost to Follow-up|2
982354|NCT01280968|1989528|FG000|Overall Study|Unable to Follow Experimental Protocol|2
982355|NCT01280968|1989529|FG001|Overall Study|Unable to Follow Experimental Protocol|0
982356|NCT01280968|1989528|FG000|Overall Study|Commuting Problems|2
982357|NCT01280968|1989529|FG001|Overall Study|Commuting Problems|0
982358|NCT01280968|1989528|FG000|Overall Study|Anxiety|2
982359|NCT01280968|1989529|FG001|Overall Study|Anxiety|0
982360|NCT01280968|1989528|FG000|Overall Study|Adverse Event|1
982361|NCT01280968|1989529|FG001|Overall Study|Adverse Event|0
982362|NCT01280968|1989528|FG000|Overall Study|Scheduling Conflicts|1
982363|NCT01280968|1989529|FG001|Overall Study|Scheduling Conflicts|1
982364|NCT01280968|1989528|FG000|Overall Study|Pre-existing Neurological Condition|1
982365|NCT01280968|1989529|FG001|Overall Study|Pre-existing Neurological Condition|0
982366|NCT01280968|1989528|FG000|Overall Study|Unable to Smoke in Supine Position|1
982367|NCT01280968|1989529|FG001|Overall Study|Unable to Smoke in Supine Position|0
982368|NCT01280981|1989536|FG000|Overall Study|Withdrawal by Subject|11
982369|NCT01280981|1989536|FG000|Overall Study|Protocol Violation|2
982370|NCT01280981|1989536|FG000|Overall Study|Lack of Efficacy|13
982371|NCT01280981|1989536|FG000|Overall Study|Lost to Follow-up|3
982372|NCT01280981|1989536|FG000|Overall Study|Adverse Event|6
982373|NCT01280981|1989536|FG000|Overall Study|Irregular or discontinued menses|3
982374|NCT01280981|1989536|FG000|Overall Study|Failed to return|45
982375|NCT01280981|1989536|FG000|Overall Study|Non-compliance with protocol|3
982376|NCT01280981|1989536|FG000|Overall Study|Withdrawal of consent|3
982377|NCT01280981|1989536|FG000|Overall Study|Elective surgery|2
982378|NCT01280981|1989536|FG000|Overall Study|Study site closure|1
982379|NCT01281137|1989551|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0
982380|NCT01281137|1989552|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1
982381|NCT01281137|1989551|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4
982382|NCT01281137|1989552|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9
982383|NCT01281137|1989551|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0
982384|NCT01281137|1989552|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5
982385|NCT01281137|1989551|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1
982386|NCT01281137|1989552|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0
982387|NCT01281137|1989551|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1
982388|NCT01281137|1989552|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2
982389|NCT01281189|1989578|FG000|Overall Study|Adverse Event|7
982390|NCT01281189|1989579|FG001|Overall Study|Adverse Event|9
982391|NCT01281189|1989578|FG000|Overall Study|Lost to Follow-up|6
982392|NCT01281189|1989579|FG001|Overall Study|Lost to Follow-up|4
982393|NCT01281189|1989578|FG000|Overall Study|Withdrawal by Subject|21
982394|NCT01281189|1989579|FG001|Overall Study|Withdrawal by Subject|24
982395|NCT01281189|1989578|FG000|Overall Study|Physician Decision|2
982396|NCT01281189|1989579|FG001|Overall Study|Physician Decision|3
982397|NCT01281189|1989578|FG000|Overall Study|Death|103
982398|NCT01281189|1989579|FG001|Overall Study|Death|91
982399|NCT01281189|1989578|FG000|Overall Study|Other|8
982400|NCT01281189|1989579|FG001|Overall Study|Other|12
982401|NCT01281202|1989587|FG000|Overall Study|Adverse Event|2
982402|NCT01281202|1989588|FG001|Overall Study|Adverse Event|0
982403|NCT01281202|1989587|FG000|Overall Study|Withdrawal by Subject|2
982404|NCT01281202|1989588|FG001|Overall Study|Withdrawal by Subject|2
982405|NCT01281202|1989587|FG000|Overall Study|Protocol Violation|11
982406|NCT01281202|1989588|FG001|Overall Study|Protocol Violation|10
982407|NCT01281202|1989587|FG000|Overall Study|Administrative|2
982408|NCT01281202|1989588|FG001|Overall Study|Administrative|8
982409|NCT01281202|1989587|FG000|Overall Study|Lost to Follow-up|11
982410|NCT01281202|1989588|FG001|Overall Study|Lost to Follow-up|13
982411|NCT01281202|1989587|FG000|Overall Study|Incarceration|0
982412|NCT01281202|1989588|FG001|Overall Study|Incarceration|3
982413|NCT01281306|1989603|FG000|Overall Study|Lack of Efficacy|0
982414|NCT01281306|1989604|FG001|Overall Study|Lack of Efficacy|1
982415|NCT01281306|1989605|FG002|Overall Study|Lack of Efficacy|3
982416|NCT01281306|1989606|FG003|Overall Study|Lack of Efficacy|0
982417|NCT01281306|1989607|FG004|Overall Study|Lack of Efficacy|2
982418|NCT01281306|1989608|FG005|Overall Study|Lack of Efficacy|0
982419|NCT01281306|1989609|FG006|Overall Study|Lack of Efficacy|1
982420|NCT01281306|1989603|FG000|Overall Study|Withdrawal by Subject|1
982421|NCT01281306|1989604|FG001|Overall Study|Withdrawal by Subject|0
982422|NCT01281306|1989605|FG002|Overall Study|Withdrawal by Subject|2
982423|NCT01281306|1989606|FG003|Overall Study|Withdrawal by Subject|4
982424|NCT01281306|1989607|FG004|Overall Study|Withdrawal by Subject|1
982425|NCT01281306|1989608|FG005|Overall Study|Withdrawal by Subject|3
982426|NCT01281306|1989609|FG006|Overall Study|Withdrawal by Subject|1
982427|NCT01281306|1989603|FG000|Overall Study|Protocol deviation|0
982428|NCT01281306|1989604|FG001|Overall Study|Protocol deviation|1
982429|NCT01281306|1989605|FG002|Overall Study|Protocol deviation|1
982430|NCT01281306|1989606|FG003|Overall Study|Protocol deviation|1
982431|NCT01281306|1989607|FG004|Overall Study|Protocol deviation|1
982432|NCT01281306|1989608|FG005|Overall Study|Protocol deviation|0
982433|NCT01281306|1989609|FG006|Overall Study|Protocol deviation|0
982434|NCT01281306|1989603|FG000|Overall Study|Condition no longer requires study drug|1
982435|NCT01281306|1989604|FG001|Overall Study|Condition no longer requires study drug|0
982436|NCT01281306|1989605|FG002|Overall Study|Condition no longer requires study drug|0
982437|NCT01281306|1989606|FG003|Overall Study|Condition no longer requires study drug|0
982438|NCT01281306|1989607|FG004|Overall Study|Condition no longer requires study drug|0
982439|NCT01281306|1989608|FG005|Overall Study|Condition no longer requires study drug|1
982440|NCT01281306|1989609|FG006|Overall Study|Condition no longer requires study drug|1
982441|NCT01281306|1989603|FG000|Overall Study|Lost to Follow-up|1
982442|NCT01281306|1989604|FG001|Overall Study|Lost to Follow-up|0
982443|NCT01281306|1989605|FG002|Overall Study|Lost to Follow-up|0
982444|NCT01281306|1989606|FG003|Overall Study|Lost to Follow-up|2
982445|NCT01281306|1989607|FG004|Overall Study|Lost to Follow-up|0
982446|NCT01281306|1989608|FG005|Overall Study|Lost to Follow-up|0
982447|NCT01281306|1989609|FG006|Overall Study|Lost to Follow-up|1
982448|NCT01281306|1989603|FG000|Overall Study|Death|1
982449|NCT01281306|1989604|FG001|Overall Study|Death|0
982450|NCT01281306|1989605|FG002|Overall Study|Death|0
982451|NCT01281306|1989606|FG003|Overall Study|Death|0
982452|NCT01281306|1989607|FG004|Overall Study|Death|0
982453|NCT01281306|1989608|FG005|Overall Study|Death|0
982454|NCT01281306|1989609|FG006|Overall Study|Death|0
982455|NCT01281306|1989603|FG000|Overall Study|Adverse Event|3
982456|NCT01281306|1989604|FG001|Overall Study|Adverse Event|2
982457|NCT01281306|1989605|FG002|Overall Study|Adverse Event|2
982458|NCT01281306|1989606|FG003|Overall Study|Adverse Event|3
982459|NCT01281306|1989607|FG004|Overall Study|Adverse Event|5
982460|NCT01281306|1989608|FG005|Overall Study|Adverse Event|3
982461|NCT01281306|1989609|FG006|Overall Study|Adverse Event|3
982462|NCT01281306|1989603|FG000|Overall Study|Randomized in error|1
982463|NCT01281306|1989604|FG001|Overall Study|Randomized in error|0
982464|NCT01281306|1989605|FG002|Overall Study|Randomized in error|0
982465|NCT01281306|1989606|FG003|Overall Study|Randomized in error|1
982466|NCT01281306|1989607|FG004|Overall Study|Randomized in error|0
982467|NCT01281306|1989608|FG005|Overall Study|Randomized in error|0
982468|NCT01281306|1989609|FG006|Overall Study|Randomized in error|0
982471|NCT01281839|1989653|FG000|Overall Study|Lost to Follow-up|6
982472|NCT01281839|1989654|FG001|Overall Study|Lost to Follow-up|3
982473|NCT01281839|1989653|FG000|Overall Study|Withdrawal by Subject|4
982474|NCT01281839|1989654|FG001|Overall Study|Withdrawal by Subject|10
982475|NCT01281839|1989653|FG000|Overall Study|Reason not specified|0
982476|NCT01281839|1989654|FG001|Overall Study|Reason not specified|1
982477|NCT01281865|1989662|FG000|Overall Study|Adverse Event|1
982478|NCT01281865|1989663|FG001|Overall Study|Adverse Event|1
982479|NCT01281865|1989662|FG000|Overall Study|Withdrawal by Subject|1
982480|NCT01281865|1989663|FG001|Overall Study|Withdrawal by Subject|0
982481|NCT01281865|1989662|FG000|Overall Study|Lack of Efficacy|1
982482|NCT01281865|1989663|FG001|Overall Study|Lack of Efficacy|0
982483|NCT01281917|1989669|FG000|Overall Study|Withdrawal by Subject|1
982484|NCT01281956|1989673|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1
982485|NCT01281956|1989674|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0
982486|NCT01281969|1989685|FG000|Overall Study|not randomized didn't meet criteria|0
982487|NCT01281969|1989686|FG001|Overall Study|not randomized didn't meet criteria|0
982488|NCT01281969|1989687|FG002|Overall Study|not randomized didn't meet criteria|7
982489|NCT01281969|1989685|FG000|Overall Study|AE during LP prior to IVIG admin|1
982490|NCT01281969|1989686|FG001|Overall Study|AE during LP prior to IVIG admin|0
982491|NCT01281969|1989687|FG002|Overall Study|AE during LP prior to IVIG admin|3
982492|NCT01281969|1989685|FG000|Overall Study|not randomized, child consent not given|0
982493|NCT01281969|1989686|FG001|Overall Study|not randomized, child consent not given|0
982494|NCT01281969|1989687|FG002|Overall Study|not randomized, child consent not given|2
982495|NCT01282164|1989711|FG000|Overall Study|Lack of hypoglycemia during ITT|1
982496|NCT01282164|1989712|FG001|Overall Study|Lack of hypoglycemia during ITT|0
982497|NCT01282203|1989726|FG000|Overall Study|Adverse Event|1
982498|NCT01282229|1989733|FG000|Overall Study|Protocol Violation|2
982499|NCT01282294|1989760|FG000|Overall Study|Lost to Follow-up|14
982500|NCT01282294|1989760|FG000|Overall Study|Screening failure|1
982501|NCT01282294|1989760|FG000|Overall Study|Adverse Event|1
982502|NCT01282294|1989760|FG000|Overall Study|Patient non-compliance|2
982503|NCT01282294|1989760|FG000|Overall Study|Physician Decision|1
982504|NCT01282372|1989764|FG000|Overall Study|Lack of Efficacy / Exacerbation|25
982505|NCT01282372|1989764|FG000|Overall Study|Lost to Follow-up|23
982506|NCT01282372|1989764|FG000|Overall Study|Withdrawal by Subject|11
982507|NCT01282372|1989764|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
982508|NCT01282372|1989764|FG000|Overall Study|Death|1
982509|NCT01282372|1989764|FG000|Overall Study|Presence of AE, Lack of Efficacy|1
982510|NCT01282372|1989764|FG000|Overall Study|Presence of AE, Regression of Symptoms|1
982511|NCT01282372|1989764|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
982512|NCT01282372|1989764|FG000|Overall Study|Adverse Event|12
982513|NCT01282424|1989775|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30
982514|NCT01282424|1989775|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6
982515|NCT01282424|1989775|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7
982516|NCT01282424|1989775|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3
982517|NCT01282424|1989775|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
982518|NCT01282424|1989775|FG000|Long-term Follow-up Period (5 Years)|Death|40
982519|NCT01282424|1989775|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
982520|NCT01282424|1989775|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
982521|NCT01282463|1989782|FG000|Overall Study|Lost to Follow-up|1
982522|NCT01282463|1989783|FG001|Overall Study|Lost to Follow-up|0
982523|NCT01282463|1989784|FG002|Overall Study|Lost to Follow-up|0
982524|NCT01282463|1989782|FG000|Overall Study|Withdrawal by Subject|6
982525|NCT01282463|1989783|FG001|Overall Study|Withdrawal by Subject|2
982526|NCT01282463|1989784|FG002|Overall Study|Withdrawal by Subject|3
982527|NCT01282463|1989782|FG000|Overall Study|"Never Treated Death"|0
982528|NCT01282463|1989783|FG001|Overall Study|"Never Treated Death"|1
982529|NCT01282463|1989784|FG002|Overall Study|"Never Treated Death"|0
982530|NCT01282463|1989782|FG000|Overall Study|"Never Treated PD"|0
982531|NCT01282463|1989783|FG001|Overall Study|"Never Treated PD"|1
982532|NCT01282463|1989784|FG002|Overall Study|"Never Treated PD"|0
982533|NCT01282463|1989782|FG000|Overall Study|Protocol Violation|0
982534|NCT01282463|1989783|FG001|Overall Study|Protocol Violation|0
982535|NCT01282463|1989784|FG002|Overall Study|Protocol Violation|1
982536|NCT01282463|1989782|FG000|Overall Study|Physician Decision|1
982537|NCT01282463|1989783|FG001|Overall Study|Physician Decision|0
982538|NCT01282463|1989784|FG002|Overall Study|Physician Decision|0
982539|NCT01282476|1989800|FG000|Overall Study|Death|11
982540|NCT01282801|1989814|FG000|Second Intervention|Emesis During Critical Breakfast|0
912694|NCT00806494|1890246|FG000|Overall Study|Lost to Follow-up|10
912695|NCT00806494|1890246|FG000|Overall Study|Other|30
912696|NCT00806494|1890246|FG000|Overall Study|Withdrawal by Subject|5
912697|NCT00806546|1890251|FG000|Overall Study|Enrolled, not treated|35
912698|NCT00806546|1890251|FG000|Overall Study|Lost to Follow-up|32
912699|NCT00806546|1890251|FG000|Overall Study|Adverse Event|74
912700|NCT00806546|1890251|FG000|Overall Study|Withdrawal by Subject|75
912701|NCT00806546|1890251|FG000|Overall Study|Protocol Violation|49
912702|NCT00806546|1890251|FG000|Overall Study|Various|42
912703|NCT00806585|1890260|FG000|Overall Study|Study terminated by Sponsor|0
912704|NCT00806585|1890261|FG001|Overall Study|Study terminated by Sponsor|0
912705|NCT00806585|1890262|FG002|Overall Study|Study terminated by Sponsor|1
912706|NCT00806585|1890263|FG003|Overall Study|Study terminated by Sponsor|2
912707|NCT00806585|1890264|FG004|Overall Study|Study terminated by Sponsor|0
912708|NCT00806585|1890260|FG000|Overall Study|Protocol Violation|3
982541|NCT01282801|1989815|FG001|Second Intervention|Emesis During Critical Breakfast|1
982542|NCT01282814|1989823|FG000|First Intervention|Emesis During Dosing Interval|0
982543|NCT01282814|1989824|FG001|First Intervention|Emesis During Dosing Interval|3
982544|NCT01282814|1989823|FG000|Washout of 7 Days|Withdrawal by Subject|2
982545|NCT01282814|1989824|FG001|Washout of 7 Days|Withdrawal by Subject|0
982546|NCT01282866|1989830|FG000|Overall Study|Adverse Event|1
982547|NCT01283009|1989836|FG000|Overall Study|Death|83
982548|NCT01283009|1989837|FG001|Overall Study|Death|78
982549|NCT01283009|1989836|FG000|Overall Study|Study ended early|23
982550|NCT01283009|1989837|FG001|Overall Study|Study ended early|26
982551|NCT01283009|1989836|FG000|Overall Study|Withdrawal by Subject|10
982552|NCT01283009|1989837|FG001|Overall Study|Withdrawal by Subject|8
982553|NCT01283009|1989836|FG000|Overall Study|Physician Decision|1
982554|NCT01283009|1989837|FG001|Overall Study|Physician Decision|1
982555|NCT01283009|1989836|FG000|Overall Study|Lost to Follow-up|1
982556|NCT01283009|1989837|FG001|Overall Study|Lost to Follow-up|0
982557|NCT01283009|1989836|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0
982558|NCT01283009|1989837|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4
982559|NCT01283035|1989848|FG000|Overall Study|Subject later found ineligible|1
982560|NCT01283139|1989856|FG000|Overall Study|Lost to Follow-up|5
982561|NCT01283139|1989857|FG001|Overall Study|Lost to Follow-up|2
982562|NCT01283139|1989858|FG002|Overall Study|Lost to Follow-up|3
982563|NCT01283139|1989859|FG003|Overall Study|Lost to Follow-up|1
982564|NCT01283139|1989856|FG000|Overall Study|Withdrawal by Subject|8
982565|NCT01283139|1989857|FG001|Overall Study|Withdrawal by Subject|8
982566|NCT01283139|1989858|FG002|Overall Study|Withdrawal by Subject|6
982567|NCT01283139|1989859|FG003|Overall Study|Withdrawal by Subject|8
982568|NCT01283139|1989856|FG000|Overall Study|Death|2
982569|NCT01283139|1989857|FG001|Overall Study|Death|0
982570|NCT01283139|1989858|FG002|Overall Study|Death|2
982571|NCT01283139|1989859|FG003|Overall Study|Death|2
982572|NCT01283139|1989856|FG000|Overall Study|Lack of Efficacy|1
982573|NCT01283139|1989857|FG001|Overall Study|Lack of Efficacy|2
982574|NCT01283139|1989858|FG002|Overall Study|Lack of Efficacy|2
982575|NCT01283139|1989859|FG003|Overall Study|Lack of Efficacy|1
982576|NCT01283139|1989856|FG000|Overall Study|Early termination due to AE/SAE|1
982577|NCT01283139|1989857|FG001|Overall Study|Early termination due to AE/SAE|1
982578|NCT01283139|1989858|FG002|Overall Study|Early termination due to AE/SAE|0
982579|NCT01283139|1989859|FG003|Overall Study|Early termination due to AE/SAE|0
982580|NCT01283139|1989856|FG000|Overall Study|Participant's refusal to continue|0
982581|NCT01283139|1989857|FG001|Overall Study|Participant's refusal to continue|3
982582|NCT01283139|1989858|FG002|Overall Study|Participant's refusal to continue|1
982583|NCT01283139|1989859|FG003|Overall Study|Participant's refusal to continue|1
982584|NCT01283139|1989856|FG000|Overall Study|Pregnancy|0
982585|NCT01283139|1989857|FG001|Overall Study|Pregnancy|1
982586|NCT01283139|1989858|FG002|Overall Study|Pregnancy|1
982587|NCT01283139|1989859|FG003|Overall Study|Pregnancy|0
982588|NCT01283139|1989856|FG000|Overall Study|Missed follow-up visit|0
982589|NCT01283139|1989857|FG001|Overall Study|Missed follow-up visit|1
982590|NCT01283139|1989858|FG002|Overall Study|Missed follow-up visit|2
982591|NCT01283139|1989859|FG003|Overall Study|Missed follow-up visit|2
982592|NCT01283139|1989856|FG000|Overall Study|Participant randomized in error|0
982593|NCT01283139|1989857|FG001|Overall Study|Participant randomized in error|0
982594|NCT01283139|1989858|FG002|Overall Study|Participant randomized in error|1
982595|NCT01283139|1989859|FG003|Overall Study|Participant randomized in error|0
982596|NCT01283152|1989871|FG000|Overall Study|Discharged prior to 24 hr assessment|1
982597|NCT01283152|1989872|FG001|Overall Study|Discharged prior to 24 hr assessment|0
982598|NCT01283152|1989871|FG000|Overall Study|Refused HESA|1
982599|NCT01283152|1989872|FG001|Overall Study|Refused HESA|0
982600|NCT01283282|1989878|FG000|First Intervention (6 Weeks)|Physician Decision|0
982601|NCT01283282|1989879|FG001|First Intervention (6 Weeks)|Physician Decision|1
982602|NCT01283282|1989878|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2
982603|NCT01283282|1989879|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3
982604|NCT01283282|1989878|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1
982605|NCT01283282|1989879|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0
982606|NCT01283334|1989897|FG000|Overall Study|Withdrawal by Subject|1
982607|NCT01283334|1989897|FG000|Overall Study|Inability to Swallow Everolimus Pills|1
982608|NCT01283334|1989897|FG000|Overall Study|Adverse Event|4
982609|NCT01283334|1989897|FG000|Overall Study|Physician Decision|1
982610|NCT01283386|1989905|FG000|Overall Study|Death|2
982611|NCT01283386|1989906|FG001|Overall Study|Death|0
982612|NCT01283386|1989905|FG000|Overall Study|Withdrawal by Subject|2
982613|NCT01283386|1989906|FG001|Overall Study|Withdrawal by Subject|1
982614|NCT01283386|1989905|FG000|Overall Study|Relapse of underlying disease|1
982615|NCT01283386|1989906|FG001|Overall Study|Relapse of underlying disease|3
982616|NCT01283386|1989905|FG000|Overall Study|Progression of underlying disease|2
982617|NCT01283386|1989906|FG001|Overall Study|Progression of underlying disease|7
982618|NCT01283386|1989905|FG000|Overall Study|Reason not specified|1
982619|NCT01283386|1989906|FG001|Overall Study|Reason not specified|0
982620|NCT01283386|1989905|FG000|Overall Study|Protocol Violation|0
982621|NCT01283386|1989906|FG001|Overall Study|Protocol Violation|1
982622|NCT01283464|1989914|FG000|Overall Study|Lost to Follow-up|0
982623|NCT01283464|1989915|FG001|Overall Study|Lost to Follow-up|1
982624|NCT01283464|1989914|FG000|Overall Study|Withdrawal by Subject|1
982625|NCT01283464|1989915|FG001|Overall Study|Withdrawal by Subject|0
982626|NCT01283464|1989914|FG000|Overall Study|Physician Decision|1
982627|NCT01283464|1989915|FG001|Overall Study|Physician Decision|0
982628|NCT01283516|1989930|FG000|Overall Study|Adverse Event|0
982629|NCT01283516|1989931|FG001|Overall Study|Adverse Event|0
982630|NCT01283516|1989932|FG002|Overall Study|Adverse Event|0
982631|NCT01283516|1989933|FG003|Overall Study|Adverse Event|0
982632|NCT01283516|1989934|FG004|Overall Study|Adverse Event|0
982633|NCT01283516|1989935|FG005|Overall Study|Adverse Event|0
982634|NCT01283516|1989936|FG006|Overall Study|Adverse Event|2
982635|NCT01283516|1989937|FG007|Overall Study|Adverse Event|0
982636|NCT01283516|1989938|FG008|Overall Study|Adverse Event|28
982637|NCT01283516|1989930|FG000|Overall Study|Death|0
982638|NCT01283516|1989931|FG001|Overall Study|Death|0
982639|NCT01283516|1989932|FG002|Overall Study|Death|0
982640|NCT01283516|1989933|FG003|Overall Study|Death|0
982641|NCT01283516|1989934|FG004|Overall Study|Death|0
982642|NCT01283516|1989935|FG005|Overall Study|Death|1
982643|NCT01283516|1989936|FG006|Overall Study|Death|0
982644|NCT01283516|1989937|FG007|Overall Study|Death|1
982645|NCT01283516|1989938|FG008|Overall Study|Death|12
982646|NCT01283516|1989930|FG000|Overall Study|Disease Progression|2
982647|NCT01283516|1989931|FG001|Overall Study|Disease Progression|2
982648|NCT01283516|1989932|FG002|Overall Study|Disease Progression|3
982649|NCT01283516|1989933|FG003|Overall Study|Disease Progression|3
982650|NCT01283516|1989934|FG004|Overall Study|Disease Progression|13
982651|NCT01283516|1989935|FG005|Overall Study|Disease Progression|8
982652|NCT01283516|1989936|FG006|Overall Study|Disease Progression|6
982653|NCT01283516|1989937|FG007|Overall Study|Disease Progression|3
982654|NCT01283516|1989938|FG008|Overall Study|Disease Progression|139
982655|NCT01283516|1989930|FG000|Overall Study|Withdrawal by Subject|0
982656|NCT01283516|1989931|FG001|Overall Study|Withdrawal by Subject|0
982657|NCT01283516|1989932|FG002|Overall Study|Withdrawal by Subject|0
982658|NCT01283516|1989933|FG003|Overall Study|Withdrawal by Subject|0
982659|NCT01283516|1989934|FG004|Overall Study|Withdrawal by Subject|1
982660|NCT01283516|1989935|FG005|Overall Study|Withdrawal by Subject|0
982661|NCT01283516|1989936|FG006|Overall Study|Withdrawal by Subject|1
982662|NCT01283516|1989937|FG007|Overall Study|Withdrawal by Subject|0
982663|NCT01283516|1989938|FG008|Overall Study|Withdrawal by Subject|36
982664|NCT01283516|1989930|FG000|Overall Study|Administrative problems|0
982665|NCT01283516|1989931|FG001|Overall Study|Administrative problems|0
912709|NCT00806585|1890261|FG001|Overall Study|Protocol Violation|1
912710|NCT00806585|1890262|FG002|Overall Study|Protocol Violation|2
912711|NCT00806585|1890263|FG003|Overall Study|Protocol Violation|0
982666|NCT01283516|1989932|FG002|Overall Study|Administrative problems|0
982667|NCT01283516|1989933|FG003|Overall Study|Administrative problems|0
982668|NCT01283516|1989934|FG004|Overall Study|Administrative problems|0
982669|NCT01283516|1989935|FG005|Overall Study|Administrative problems|1
982670|NCT01283516|1989936|FG006|Overall Study|Administrative problems|1
982671|NCT01283516|1989937|FG007|Overall Study|Administrative problems|1
982672|NCT01283516|1989938|FG008|Overall Study|Administrative problems|39
982673|NCT01283516|1989930|FG000|Overall Study|Lost to Follow-up|0
982674|NCT01283516|1989931|FG001|Overall Study|Lost to Follow-up|0
982675|NCT01283516|1989932|FG002|Overall Study|Lost to Follow-up|0
912712|NCT00806585|1890264|FG004|Overall Study|Protocol Violation|0
912713|NCT00806585|1890260|FG000|Overall Study|Physician Decision|0
912714|NCT00806585|1890261|FG001|Overall Study|Physician Decision|2
912715|NCT00806585|1890262|FG002|Overall Study|Physician Decision|3
912716|NCT00806585|1890263|FG003|Overall Study|Physician Decision|0
912717|NCT00806585|1890264|FG004|Overall Study|Physician Decision|1
912718|NCT00806585|1890260|FG000|Overall Study|Lost to Follow-up|2
912719|NCT00806585|1890261|FG001|Overall Study|Lost to Follow-up|1
912720|NCT00806585|1890262|FG002|Overall Study|Lost to Follow-up|2
912721|NCT00806585|1890263|FG003|Overall Study|Lost to Follow-up|2
912722|NCT00806585|1890264|FG004|Overall Study|Lost to Follow-up|5
912723|NCT00806585|1890260|FG000|Overall Study|Lack of Efficacy|1
912724|NCT00806585|1890261|FG001|Overall Study|Lack of Efficacy|0
912725|NCT00806585|1890262|FG002|Overall Study|Lack of Efficacy|0
912726|NCT00806585|1890263|FG003|Overall Study|Lack of Efficacy|0
912727|NCT00806585|1890264|FG004|Overall Study|Lack of Efficacy|0
912728|NCT00806585|1890260|FG000|Overall Study|Adverse Event|1
912729|NCT00806585|1890261|FG001|Overall Study|Adverse Event|5
912730|NCT00806585|1890262|FG002|Overall Study|Adverse Event|3
912731|NCT00806585|1890263|FG003|Overall Study|Adverse Event|4
912732|NCT00806585|1890264|FG004|Overall Study|Adverse Event|2
912733|NCT00806585|1890260|FG000|Overall Study|Withdrawal by Subject|10
912734|NCT00806585|1890261|FG001|Overall Study|Withdrawal by Subject|8
912735|NCT00806585|1890262|FG002|Overall Study|Withdrawal by Subject|9
912736|NCT00806585|1890263|FG003|Overall Study|Withdrawal by Subject|3
982676|NCT01283516|1989933|FG003|Overall Study|Lost to Follow-up|0
982677|NCT01283516|1989934|FG004|Overall Study|Lost to Follow-up|0
982678|NCT01283516|1989935|FG005|Overall Study|Lost to Follow-up|0
982679|NCT01283516|1989936|FG006|Overall Study|Lost to Follow-up|0
982680|NCT01283516|1989937|FG007|Overall Study|Lost to Follow-up|0
982681|NCT01283516|1989938|FG008|Overall Study|Lost to Follow-up|1
982682|NCT01283542|1989966|FG000|Main Phase|Acute or progressive vision loss|1
982683|NCT01283542|1989966|FG000|Main Phase|Uncontrolled diabetes mellitus|1
982684|NCT01283542|1989966|FG000|Main Phase|abnormal laboratory values|5
982685|NCT01283542|1989966|FG000|Extension Phase|Physician Decision|1
982686|NCT01283542|1989966|FG000|Extension Phase|Adverse Event|1
982687|NCT01283542|1989966|FG000|Extension Phase|Administrative problems|1
982688|NCT01283581|1990002|FG000|Overall Study|Lost to Follow-up|8
982689|NCT01283581|1990003|FG001|Overall Study|Lost to Follow-up|6
982690|NCT01283581|1990004|FG002|Overall Study|Lost to Follow-up|8
982691|NCT01283581|1990002|FG000|Overall Study|Withdrawal by Subject|2
982692|NCT01283581|1990003|FG001|Overall Study|Withdrawal by Subject|5
982693|NCT01283581|1990004|FG002|Overall Study|Withdrawal by Subject|2
982694|NCT01283581|1990002|FG000|Overall Study|Adverse Event|1
982695|NCT01283581|1990003|FG001|Overall Study|Adverse Event|1
982696|NCT01283581|1990004|FG002|Overall Study|Adverse Event|4
982697|NCT01283581|1990002|FG000|Overall Study|Physician Decision|0
982698|NCT01283581|1990003|FG001|Overall Study|Physician Decision|1
982699|NCT01283581|1990004|FG002|Overall Study|Physician Decision|2
982700|NCT01283581|1990002|FG000|Overall Study|Protocol Violation|0
982701|NCT01283581|1990003|FG001|Overall Study|Protocol Violation|1
982702|NCT01283581|1990004|FG002|Overall Study|Protocol Violation|2
982703|NCT01283581|1990002|FG000|Overall Study|Noncompliance|1
982704|NCT01283581|1990003|FG001|Overall Study|Noncompliance|0
982705|NCT01283581|1990004|FG002|Overall Study|Noncompliance|0
982706|NCT01283581|1990002|FG000|Overall Study|Investigator unblinded|0
982707|NCT01283581|1990003|FG001|Overall Study|Investigator unblinded|0
982708|NCT01283581|1990004|FG002|Overall Study|Investigator unblinded|1
982709|NCT01283581|1990002|FG000|Overall Study|"Early termination"|0
982710|NCT01283581|1990003|FG001|Overall Study|"Early termination"|0
982711|NCT01283581|1990004|FG002|Overall Study|"Early termination"|1
982712|NCT01283971|1990017|FG000|Overall Study|Adverse Event|3
982713|NCT01283971|1990018|FG001|Overall Study|Adverse Event|5
982714|NCT01283971|1990017|FG000|Overall Study|Insufficient therapeutic responses|3
982715|NCT01283971|1990018|FG001|Overall Study|Insufficient therapeutic responses|3
982716|NCT01283971|1990017|FG000|Overall Study|Protocol Violation|5
982717|NCT01283971|1990018|FG001|Overall Study|Protocol Violation|1
982718|NCT01283971|1990017|FG000|Overall Study|Refused treatment|3
982719|NCT01283971|1990018|FG001|Overall Study|Refused treatment|1
982720|NCT01283971|1990017|FG000|Overall Study|Failure to return|0
982721|NCT01283971|1990018|FG001|Overall Study|Failure to return|1
982722|NCT01283971|1990017|FG000|Overall Study|Administrative reasons|1
982723|NCT01283971|1990018|FG001|Overall Study|Administrative reasons|1
982724|NCT01284062|1990028|FG000|Overall Study|Adverse Event|4
982725|NCT01284062|1990029|FG001|Overall Study|Adverse Event|5
982726|NCT01284062|1990030|FG002|Overall Study|Adverse Event|0
982727|NCT01284062|1990031|FG003|Overall Study|Adverse Event|5
982728|NCT01284062|1990028|FG000|Overall Study|Lack of Efficacy|3
982729|NCT01284062|1990029|FG001|Overall Study|Lack of Efficacy|2
982730|NCT01284062|1990030|FG002|Overall Study|Lack of Efficacy|2
982731|NCT01284062|1990031|FG003|Overall Study|Lack of Efficacy|1
982732|NCT01284062|1990028|FG000|Overall Study|Medication error without adverse event|0
982733|NCT01284062|1990029|FG001|Overall Study|Medication error without adverse event|0
982734|NCT01284062|1990030|FG002|Overall Study|Medication error without adverse event|1
982735|NCT01284062|1990031|FG003|Overall Study|Medication error without adverse event|0
982736|NCT01284062|1990028|FG000|Overall Study|Protocol Violation|1
982737|NCT01284062|1990029|FG001|Overall Study|Protocol Violation|0
982738|NCT01284062|1990030|FG002|Overall Study|Protocol Violation|0
982739|NCT01284062|1990031|FG003|Overall Study|Protocol Violation|2
982740|NCT01284062|1990028|FG000|Overall Study|Withdrawal by Subject|3
982741|NCT01284062|1990029|FG001|Overall Study|Withdrawal by Subject|1
982742|NCT01284062|1990030|FG002|Overall Study|Withdrawal by Subject|2
982743|NCT01284062|1990031|FG003|Overall Study|Withdrawal by Subject|5
982744|NCT01284062|1990028|FG000|Overall Study|Other|0
982745|NCT01284062|1990029|FG001|Overall Study|Other|0
982746|NCT01284062|1990030|FG002|Overall Study|Other|0
982747|NCT01284062|1990031|FG003|Overall Study|Other|1
982748|NCT01284062|1990028|FG000|Overall Study|Site Closed|0
982749|NCT01284062|1990029|FG001|Overall Study|Site Closed|0
982750|NCT01284062|1990030|FG002|Overall Study|Site Closed|1
982751|NCT01284062|1990031|FG003|Overall Study|Site Closed|0
982752|NCT01284114|1990044|FG000|Overall Study|viral infection|1
982753|NCT01284114|1990044|FG000|Overall Study|From the results of ALLTITUDE study|1
982754|NCT01284114|1990044|FG000|Overall Study|Symptomatic hypotension|1
982755|NCT01284114|1990044|FG000|Overall Study|dizziness|1
982756|NCT01284127|1990049|FG000|Overall Study|Adverse Event|2
982757|NCT01284127|1990049|FG000|Overall Study|Withdrawal by Subject|4
982758|NCT01284127|1990049|FG000|Overall Study|Physician Decision|1
982759|NCT01284140|1990055|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
982760|NCT01284140|1990056|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
982761|NCT01284140|1990055|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
982762|NCT01284140|1990056|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
982763|NCT01284361|1990141|FG000|Overall Study|Withdrawal by Subject|1
982764|NCT01284361|1990141|FG000|Overall Study|Protocol Violation|5
982765|NCT01284361|1990141|FG000|Overall Study|Adverse Event|1
982766|NCT01284361|1990141|FG000|Overall Study|Lost to Follow-up|2
982767|NCT01284621|1990161|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
982768|NCT01284621|1990162|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
982769|NCT01284621|1990163|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
982770|NCT01284621|1990164|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
982771|NCT01284621|1990165|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
982772|NCT01284621|1990166|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
982773|NCT01284634|1990180|FG000|Overall Study|Adverse Event|1
982774|NCT01284634|1990181|FG001|Overall Study|Adverse Event|0
982775|NCT01284634|1990182|FG002|Overall Study|Adverse Event|2
982776|NCT01284634|1990183|FG003|Overall Study|Adverse Event|1
982777|NCT01284959|1990196|FG000|Overall Study|Withdrawal by Subject|1
982778|NCT01284959|1990197|FG001|Overall Study|Withdrawal by Subject|0
982779|NCT01284959|1990198|FG002|Overall Study|Withdrawal by Subject|0
982780|NCT01284959|1990196|FG000|Overall Study|Adverse Event|0
982781|NCT01284959|1990197|FG001|Overall Study|Adverse Event|0
982782|NCT01284959|1990198|FG002|Overall Study|Adverse Event|1
982783|NCT01285310|1990227|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
982784|NCT01285310|1990228|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
982785|NCT01285310|1990229|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
982786|NCT01285310|1990230|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
982787|NCT01285310|1990231|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
982788|NCT01285310|1990227|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
982789|NCT01285310|1990228|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
982790|NCT01285310|1990229|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
982791|NCT01285310|1990230|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
982792|NCT01285310|1990231|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
982793|NCT01285310|1990227|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
982794|NCT01285310|1990228|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
982795|NCT01285310|1990229|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
982796|NCT01285310|1990230|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
982797|NCT01285310|1990231|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
982798|NCT01285310|1990227|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
982799|NCT01285310|1990228|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
982800|NCT01285310|1990229|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
982801|NCT01285310|1990230|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
982802|NCT01285310|1990231|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
982803|NCT01285310|1990227|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
982804|NCT01285310|1990228|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
982805|NCT01285310|1990229|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
982806|NCT01285310|1990230|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
982807|NCT01285310|1990231|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
982808|NCT01285310|1990227|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1
982809|NCT01285310|1990228|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0
982810|NCT01285310|1990229|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1
982811|NCT01285310|1990230|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0
982812|NCT01285310|1990231|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0
982813|NCT01285310|1990227|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0
982814|NCT01285310|1990228|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2
982815|NCT01285310|1990229|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3
982816|NCT01285310|1990230|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0
982817|NCT01285310|1990231|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2
982818|NCT01285310|1990227|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
982819|NCT01285310|1990228|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
982820|NCT01285310|1990229|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
982821|NCT01285310|1990230|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
982822|NCT01285310|1990231|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
982823|NCT01285310|1990227|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
982824|NCT01285310|1990228|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
982825|NCT01285310|1990229|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
982826|NCT01285310|1990230|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
982827|NCT01285310|1990231|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
982828|NCT01285310|1990227|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
982829|NCT01285310|1990228|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
982830|NCT01285310|1990229|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
982831|NCT01285310|1990230|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
1006718|NCT01469052|2025438|FG002|Overall Study|Lack of Efficacy|0
982832|NCT01285310|1990231|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
982833|NCT01285310|1990227|FG000|Active Treatment Phase: Weeks 25-52|Other|0
982834|NCT01285310|1990228|FG001|Active Treatment Phase: Weeks 25-52|Other|1
982835|NCT01285310|1990229|FG002|Active Treatment Phase: Weeks 25-52|Other|0
982836|NCT01285310|1990230|FG003|Active Treatment Phase: Weeks 25-52|Other|0
982837|NCT01285310|1990231|FG004|Active Treatment Phase: Weeks 25-52|Other|0
982838|NCT01285310|1990227|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0
982839|NCT01285310|1990228|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1
982840|NCT01285310|1990229|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1
982841|NCT01285310|1990230|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1
982842|NCT01285310|1990231|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0
982843|NCT01285323|1990271|FG000|Overall Study|Adverse Event|9
982844|NCT01285323|1990272|FG001|Overall Study|Adverse Event|8
982845|NCT01285323|1990271|FG000|Overall Study|Lack of Efficacy|4
982846|NCT01285323|1990272|FG001|Overall Study|Lack of Efficacy|2
982847|NCT01285323|1990271|FG000|Overall Study|Withdrawal by Subject|15
982848|NCT01285323|1990272|FG001|Overall Study|Withdrawal by Subject|11
982849|NCT01285323|1990271|FG000|Overall Study|Protocol Violation|1
982850|NCT01285323|1990272|FG001|Overall Study|Protocol Violation|2
982851|NCT01285323|1990271|FG000|Overall Study|Non-compliance with study procedures|2
982852|NCT01285323|1990272|FG001|Overall Study|Non-compliance with study procedures|3
982853|NCT01285323|1990271|FG000|Overall Study|Lost to Follow-up|1
982854|NCT01285323|1990272|FG001|Overall Study|Lost to Follow-up|1
982855|NCT01285323|1990271|FG000|Overall Study|Other|1
982856|NCT01285323|1990272|FG001|Overall Study|Other|3
982857|NCT01285349|1990281|FG000|Overall Study|Lost to Follow-up|27
982858|NCT01285349|1990282|FG001|Overall Study|Lost to Follow-up|20
982859|NCT01285349|1990283|FG002|Overall Study|Lost to Follow-up|27
982860|NCT01285401|1990294|FG000|Overall Study|Prematurely withdrawn from the study|17
982861|NCT01285401|1990295|FG001|Overall Study|Prematurely withdrawn from the study|29
982862|NCT01285492|1990315|FG000|Overall Study|Adverse Event|11
982863|NCT01285492|1990316|FG001|Overall Study|Adverse Event|0
982864|NCT01285492|1990315|FG000|Overall Study|Protocol Violation|3
982865|NCT01285492|1990316|FG001|Overall Study|Protocol Violation|0
982866|NCT01285492|1990315|FG000|Overall Study|Withdrawal by Subject|2
982867|NCT01285492|1990316|FG001|Overall Study|Withdrawal by Subject|1
982868|NCT01285492|1990315|FG000|Overall Study|Death|1
982869|NCT01285492|1990316|FG001|Overall Study|Death|0
982870|NCT01285518|1990330|FG000|Overall Study|Lost to Follow-up|0
982871|NCT01285518|1990331|FG001|Overall Study|Lost to Follow-up|0
982872|NCT01285518|1990332|FG002|Overall Study|Lost to Follow-up|0
982873|NCT01285518|1990333|FG003|Overall Study|Lost to Follow-up|0
982874|NCT01285518|1990334|FG004|Overall Study|Lost to Follow-up|0
982875|NCT01285518|1990335|FG005|Overall Study|Lost to Follow-up|1
982876|NCT01285518|1990336|FG006|Overall Study|Lost to Follow-up|0
982877|NCT01285518|1990337|FG007|Overall Study|Lost to Follow-up|0
982878|NCT01285609|1990358|FG000|Randomized|Progressive Disease|41
982879|NCT01285609|1990359|FG001|Randomized|Progressive Disease|61
982880|NCT01285609|1990358|FG000|Randomized|Adverse Event Unrelated to Study Drug|18
982881|NCT01285609|1990359|FG001|Randomized|Adverse Event Unrelated to Study Drug|18
982882|NCT01285609|1990358|FG000|Randomized|Study Drug Toxicity|13
982883|NCT01285609|1990359|FG001|Randomized|Study Drug Toxicity|14
982884|NCT01285609|1990358|FG000|Randomized|Death|5
982885|NCT01285609|1990359|FG001|Randomized|Death|7
982886|NCT01285609|1990358|FG000|Randomized|Withdrawal by Subject|8
982887|NCT01285609|1990359|FG001|Randomized|Withdrawal by Subject|11
982888|NCT01285609|1990358|FG000|Randomized|Subject No Longer Met Study Criteria|1
982889|NCT01285609|1990359|FG001|Randomized|Subject No Longer Met Study Criteria|1
982890|NCT01285609|1990358|FG000|Randomized|Undisclosed Reasons|1
982891|NCT01285609|1990359|FG001|Randomized|Undisclosed Reasons|0
982892|NCT01285609|1990358|FG000|Randomized|Randomized but not Treated|4
982893|NCT01285609|1990359|FG001|Randomized|Randomized but not Treated|4
982894|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Progressive Disease|223
982895|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Progressive Disease|305
982896|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87
982897|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14
982898|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
982899|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
982900|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20
982901|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7
982902|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Death|11
982903|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Death|3
982904|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2
982905|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4
982906|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Not Reported|0
982907|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Not Reported|2
982908|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1
982909|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2
982910|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
982911|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
982912|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
982913|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
982914|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Physician and Patient decision|1
982915|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Physician and Patient decision|3
982916|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Participant refused participation|1
982917|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Participant refused participation|0
982918|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1
982919|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0
982920|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Participant hospitalized|1
982921|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Participant hospitalized|0
982922|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Investigator's assessment|1
982923|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Investigator's assessment|0
982924|NCT01285609|1990358|FG000|Treated With Blinded Therapy|PI decision to discontinue|0
982925|NCT01285609|1990359|FG001|Treated With Blinded Therapy|PI decision to discontinue|1
982926|NCT01285609|1990358|FG000|Treated With Blinded Therapy|Worsening of general condition|0
982927|NCT01285609|1990359|FG001|Treated With Blinded Therapy|Worsening of general condition|1
982928|NCT01285908|1990414|FG000|Baseline Measurement|unable to insert catheter|1
982929|NCT01285908|1990415|FG001|Baseline Measurement|unable to insert catheter|0
982930|NCT01285908|1990416|FG002|Baseline Measurement|unable to insert catheter|0
982931|NCT01285908|1990414|FG000|Baseline Measurement|History of stroke, exclusion criteria|1
982932|NCT01285908|1990415|FG001|Baseline Measurement|History of stroke, exclusion criteria|0
982933|NCT01285908|1990416|FG002|Baseline Measurement|History of stroke, exclusion criteria|0
982934|NCT01285908|1990414|FG000|Baseline Measurement|unable to tolerate procedure|1
982935|NCT01285908|1990415|FG001|Baseline Measurement|unable to tolerate procedure|0
982936|NCT01285908|1990416|FG002|Baseline Measurement|unable to tolerate procedure|0
982937|NCT01285960|1990455|FG000|Overall Study|Withdrawal by Subject|2
982938|NCT01285960|1990455|FG000|Overall Study|Lost to Follow-up|2
982939|NCT01285960|1990455|FG000|Overall Study|2 subjects received less 10 sonications|2
982940|NCT01286012|1990461|FG000|Overall Study|Adverse Event|3
982941|NCT01286012|1990462|FG001|Overall Study|Adverse Event|3
982942|NCT01286012|1990461|FG000|Overall Study|Death|2
982943|NCT01286012|1990462|FG001|Overall Study|Death|3
982944|NCT01286012|1990461|FG000|Overall Study|Protocol Violation|1
982945|NCT01286012|1990462|FG001|Overall Study|Protocol Violation|1
982946|NCT01286012|1990461|FG000|Overall Study|Withdrawal by Subject|4
982947|NCT01286012|1990462|FG001|Overall Study|Withdrawal by Subject|4
982948|NCT01286012|1990461|FG000|Overall Study|Physician Decision|2
982949|NCT01286012|1990462|FG001|Overall Study|Physician Decision|0
982950|NCT01286012|1990461|FG000|Overall Study|peritoneal dialysis, randomized in error|1
982951|NCT01286012|1990462|FG001|Overall Study|peritoneal dialysis, randomized in error|3
982952|NCT01286077|1990471|FG000|Overall Study|Adverse Event|2
982953|NCT01286077|1990472|FG001|Overall Study|Adverse Event|0
982954|NCT01286077|1990471|FG000|Overall Study|Death|1
982955|NCT01286077|1990472|FG001|Overall Study|Death|0
982956|NCT01286077|1990471|FG000|Overall Study|Protocol Violation|1
982957|NCT01286077|1990472|FG001|Overall Study|Protocol Violation|1
982958|NCT01286077|1990471|FG000|Overall Study|Withdrawal by Subject|0
982959|NCT01286077|1990472|FG001|Overall Study|Withdrawal by Subject|2
982960|NCT01286077|1990471|FG000|Overall Study|Intercurrent illness|1
982961|NCT01286077|1990472|FG001|Overall Study|Intercurrent illness|0
982962|NCT01286077|1990471|FG000|Overall Study|Non-compliance|1
982963|NCT01286077|1990472|FG001|Overall Study|Non-compliance|0
982964|NCT01286077|1990471|FG000|Overall Study|The subject starts with alternative MMY|0
982965|NCT01286077|1990472|FG001|Overall Study|The subject starts with alternative MMY|3
982966|NCT01286077|1990471|FG000|Overall Study|Patient's decision to stop treatment|3
982967|NCT01286077|1990472|FG001|Overall Study|Patient's decision to stop treatment|0
982968|NCT01286077|1990471|FG000|Overall Study|Progression of disease|0
982969|NCT01286077|1990472|FG001|Overall Study|Progression of disease|1
982970|NCT01286077|1990471|FG000|Overall Study|refill medication not received in time|1
982971|NCT01286077|1990472|FG001|Overall Study|refill medication not received in time|0
982972|NCT01286129|1990480|FG000|Overall Study|Withdrawal by Subject|4
982973|NCT01286129|1990481|FG001|Overall Study|Withdrawal by Subject|1
982974|NCT01286129|1990480|FG000|Overall Study|Could not comply with study requirements|4
982975|NCT01286129|1990481|FG001|Overall Study|Could not comply with study requirements|4
982976|NCT01286168|1990489|FG000|Overall Study|Withdrawal by Subject|1
982977|NCT01286168|1990489|FG000|Overall Study|Surgical Drains Fell Out at Home|2
982978|NCT01286207|1990497|FG000|Overall Study|Adverse Event|27
982979|NCT01286207|1990498|FG001|Overall Study|Adverse Event|41
982980|NCT01286207|1990499|FG002|Overall Study|Adverse Event|8
982981|NCT01286207|1990497|FG000|Overall Study|Lost to Follow-up|49
982982|NCT01286207|1990498|FG001|Overall Study|Lost to Follow-up|43
982983|NCT01286207|1990499|FG002|Overall Study|Lost to Follow-up|20
982984|NCT01286207|1990497|FG000|Overall Study|Withdrawal by Subject|93
982985|NCT01286207|1990498|FG001|Overall Study|Withdrawal by Subject|79
982986|NCT01286207|1990499|FG002|Overall Study|Withdrawal by Subject|41
982987|NCT01286207|1990497|FG000|Overall Study|Lack of Response|92
982988|NCT01286207|1990498|FG001|Overall Study|Lack of Response|38
982989|NCT01286207|1990499|FG002|Overall Study|Lack of Response|8
982990|NCT01286207|1990497|FG000|Overall Study|Other|37
982991|NCT01286207|1990498|FG001|Overall Study|Other|47
982992|NCT01286207|1990499|FG002|Overall Study|Other|13
982993|NCT01286311|1990513|FG000|Overall Study|Physician did not want outreach sent|14
982994|NCT01286311|1990514|FG001|Overall Study|Physician did not want outreach sent|0
982995|NCT01286480|1990581|FG000|Overall Study|Withdrawal by Subject|5
982996|NCT01286480|1990582|FG001|Overall Study|Withdrawal by Subject|3
982997|NCT01286558|1990594|FG000|Overall Study|Adverse Event|1
982998|NCT01286558|1990595|FG001|Overall Study|Adverse Event|1
982999|NCT01286558|1990594|FG000|Overall Study|Withdrawal by Subject|0
983000|NCT01286558|1990595|FG001|Overall Study|Withdrawal by Subject|1
983001|NCT01286740|1990601|FG000|Overall Study|Enrolled but not treated|1
983002|NCT01286740|1990601|FG000|Overall Study|Protocol Violation|1
983003|NCT01286753|1990607|FG000|Overall Study|Adverse Event|7
983004|NCT01286753|1990608|FG001|Overall Study|Adverse Event|6
983005|NCT01286753|1990607|FG000|Overall Study|Progression|11
983006|NCT01286753|1990608|FG001|Overall Study|Progression|13
983007|NCT01286753|1990607|FG000|Overall Study|Refused Treatment|1
983008|NCT01286753|1990608|FG001|Overall Study|Refused Treatment|0
983009|NCT01286753|1990607|FG000|Overall Study|Withdrawal of Consent|0
983010|NCT01286753|1990608|FG001|Overall Study|Withdrawal of Consent|2
983011|NCT01286753|1990607|FG000|Overall Study|Discontinued to Join Extension Study|6
983012|NCT01286753|1990608|FG001|Overall Study|Discontinued to Join Extension Study|4
983013|NCT01286753|1990607|FG000|Overall Study|Participant to Receive Radiotherapy|1
983014|NCT01286753|1990608|FG001|Overall Study|Participant to Receive Radiotherapy|0
983015|NCT01286779|1990615|FG000|Overall Study|Withdrawal by Subject|9
983016|NCT01286779|1990615|FG000|Overall Study|Protocol Violation|5
983017|NCT01286779|1990615|FG000|Overall Study|Physician Decision|2
983018|NCT01286779|1990615|FG000|Overall Study|Participant had scheduled surgery|1
983019|NCT01286779|1990615|FG000|Overall Study|Participant moved to another country|1
983020|NCT01286779|1990615|FG000|Overall Study|Discontinued by sponsor|1
983021|NCT01286987|1990661|FG000|Part 1: Dose Escalation|Clinical Progression|1
983022|NCT01286987|1990662|FG001|Part 1: Dose Escalation|Clinical Progression|1
983023|NCT01286987|1990663|FG002|Part 1: Dose Escalation|Clinical Progression|0
983024|NCT01286987|1990664|FG003|Part 1: Dose Escalation|Clinical Progression|1
983025|NCT01286987|1990665|FG004|Part 1: Dose Escalation|Clinical Progression|1
983026|NCT01286987|1990666|FG005|Part 1: Dose Escalation|Clinical Progression|1
983027|NCT01286987|1990667|FG006|Part 1: Dose Escalation|Clinical Progression|0
983028|NCT01286987|1990668|FG007|Part 1: Dose Escalation|Clinical Progression|2
983029|NCT01286987|1990669|FG008|Part 1: Dose Escalation|Clinical Progression|1
983030|NCT01286987|1990670|FG009|Part 1: Dose Escalation|Clinical Progression|0
983031|NCT01286987|1990671|FG010|Part 1: Dose Escalation|Clinical Progression|0
983032|NCT01286987|1990672|FG011|Part 1: Dose Escalation|Clinical Progression|0
983033|NCT01286987|1990673|FG012|Part 1: Dose Escalation|Clinical Progression|0
983034|NCT01286987|1990674|FG013|Part 1: Dose Escalation|Clinical Progression|0
983035|NCT01286987|1990675|FG014|Part 1: Dose Escalation|Clinical Progression|0
983036|NCT01286987|1990661|FG000|Part 1: Dose Escalation|Progressive Disease|2
983037|NCT01286987|1990662|FG001|Part 1: Dose Escalation|Progressive Disease|2
983038|NCT01286987|1990663|FG002|Part 1: Dose Escalation|Progressive Disease|3
983039|NCT01286987|1990664|FG003|Part 1: Dose Escalation|Progressive Disease|2
983040|NCT01286987|1990665|FG004|Part 1: Dose Escalation|Progressive Disease|1
983041|NCT01286987|1990666|FG005|Part 1: Dose Escalation|Progressive Disease|5
983042|NCT01286987|1990667|FG006|Part 1: Dose Escalation|Progressive Disease|5
983043|NCT01286987|1990668|FG007|Part 1: Dose Escalation|Progressive Disease|3
983044|NCT01286987|1990669|FG008|Part 1: Dose Escalation|Progressive Disease|5
983045|NCT01286987|1990670|FG009|Part 1: Dose Escalation|Progressive Disease|0
983046|NCT01286987|1990671|FG010|Part 1: Dose Escalation|Progressive Disease|0
983047|NCT01286987|1990672|FG011|Part 1: Dose Escalation|Progressive Disease|0
983048|NCT01286987|1990673|FG012|Part 1: Dose Escalation|Progressive Disease|0
983049|NCT01286987|1990674|FG013|Part 1: Dose Escalation|Progressive Disease|0
983050|NCT01286987|1990675|FG014|Part 1: Dose Escalation|Progressive Disease|0
983051|NCT01286987|1990661|FG000|Part 1: Dose Escalation|Physician Decision|0
983052|NCT01286987|1990662|FG001|Part 1: Dose Escalation|Physician Decision|0
983053|NCT01286987|1990663|FG002|Part 1: Dose Escalation|Physician Decision|0
983054|NCT01286987|1990664|FG003|Part 1: Dose Escalation|Physician Decision|0
983055|NCT01286987|1990665|FG004|Part 1: Dose Escalation|Physician Decision|1
983056|NCT01286987|1990666|FG005|Part 1: Dose Escalation|Physician Decision|0
983057|NCT01286987|1990667|FG006|Part 1: Dose Escalation|Physician Decision|0
983058|NCT01286987|1990668|FG007|Part 1: Dose Escalation|Physician Decision|0
983059|NCT01286987|1990669|FG008|Part 1: Dose Escalation|Physician Decision|0
983060|NCT01286987|1990670|FG009|Part 1: Dose Escalation|Physician Decision|0
983061|NCT01286987|1990671|FG010|Part 1: Dose Escalation|Physician Decision|0
983062|NCT01286987|1990672|FG011|Part 1: Dose Escalation|Physician Decision|0
983063|NCT01286987|1990673|FG012|Part 1: Dose Escalation|Physician Decision|0
983064|NCT01286987|1990674|FG013|Part 1: Dose Escalation|Physician Decision|0
983065|NCT01286987|1990675|FG014|Part 1: Dose Escalation|Physician Decision|0
983066|NCT01286987|1990661|FG000|Part 2: Dose Expansion|Death|0
983067|NCT01286987|1990662|FG001|Part 2: Dose Expansion|Death|0
983068|NCT01286987|1990663|FG002|Part 2: Dose Expansion|Death|0
983069|NCT01286987|1990664|FG003|Part 2: Dose Expansion|Death|0
983070|NCT01286987|1990665|FG004|Part 2: Dose Expansion|Death|0
983071|NCT01286987|1990666|FG005|Part 2: Dose Expansion|Death|0
983072|NCT01286987|1990667|FG006|Part 2: Dose Expansion|Death|0
983073|NCT01286987|1990668|FG007|Part 2: Dose Expansion|Death|0
983074|NCT01286987|1990669|FG008|Part 2: Dose Expansion|Death|0
983075|NCT01286987|1990670|FG009|Part 2: Dose Expansion|Death|0
983076|NCT01286987|1990671|FG010|Part 2: Dose Expansion|Death|0
983077|NCT01286987|1990672|FG011|Part 2: Dose Expansion|Death|0
983078|NCT01286987|1990673|FG012|Part 2: Dose Expansion|Death|1
983079|NCT01286987|1990674|FG013|Part 2: Dose Expansion|Death|1
983080|NCT01286987|1990675|FG014|Part 2: Dose Expansion|Death|0
983081|NCT01286987|1990661|FG000|Part 2: Dose Expansion|Physician Decision|0
983082|NCT01286987|1990662|FG001|Part 2: Dose Expansion|Physician Decision|0
983083|NCT01286987|1990663|FG002|Part 2: Dose Expansion|Physician Decision|0
983084|NCT01286987|1990664|FG003|Part 2: Dose Expansion|Physician Decision|0
983085|NCT01286987|1990665|FG004|Part 2: Dose Expansion|Physician Decision|0
983086|NCT01286987|1990666|FG005|Part 2: Dose Expansion|Physician Decision|0
983087|NCT01286987|1990667|FG006|Part 2: Dose Expansion|Physician Decision|0
983088|NCT01286987|1990668|FG007|Part 2: Dose Expansion|Physician Decision|0
983089|NCT01286987|1990669|FG008|Part 2: Dose Expansion|Physician Decision|0
983090|NCT01286987|1990670|FG009|Part 2: Dose Expansion|Physician Decision|0
983091|NCT01286987|1990671|FG010|Part 2: Dose Expansion|Physician Decision|1
983092|NCT01286987|1990672|FG011|Part 2: Dose Expansion|Physician Decision|1
983093|NCT01286987|1990673|FG012|Part 2: Dose Expansion|Physician Decision|0
983094|NCT01286987|1990674|FG013|Part 2: Dose Expansion|Physician Decision|1
983095|NCT01286987|1990675|FG014|Part 2: Dose Expansion|Physician Decision|0
983096|NCT01286987|1990661|FG000|Part 2: Dose Expansion|Other|0
983097|NCT01286987|1990662|FG001|Part 2: Dose Expansion|Other|0
983098|NCT01286987|1990663|FG002|Part 2: Dose Expansion|Other|0
983099|NCT01286987|1990664|FG003|Part 2: Dose Expansion|Other|0
983100|NCT01286987|1990665|FG004|Part 2: Dose Expansion|Other|0
983101|NCT01286987|1990666|FG005|Part 2: Dose Expansion|Other|0
983102|NCT01286987|1990667|FG006|Part 2: Dose Expansion|Other|0
983103|NCT01286987|1990668|FG007|Part 2: Dose Expansion|Other|0
983104|NCT01286987|1990669|FG008|Part 2: Dose Expansion|Other|0
983105|NCT01286987|1990670|FG009|Part 2: Dose Expansion|Other|0
983106|NCT01286987|1990671|FG010|Part 2: Dose Expansion|Other|0
983107|NCT01286987|1990672|FG011|Part 2: Dose Expansion|Other|0
983108|NCT01286987|1990673|FG012|Part 2: Dose Expansion|Other|0
983109|NCT01286987|1990674|FG013|Part 2: Dose Expansion|Other|1
983110|NCT01286987|1990675|FG014|Part 2: Dose Expansion|Other|0
983111|NCT01286987|1990661|FG000|Part 2: Dose Expansion|Progressive Disease|0
983112|NCT01286987|1990662|FG001|Part 2: Dose Expansion|Progressive Disease|0
983113|NCT01286987|1990663|FG002|Part 2: Dose Expansion|Progressive Disease|0
983114|NCT01286987|1990664|FG003|Part 2: Dose Expansion|Progressive Disease|0
983115|NCT01286987|1990665|FG004|Part 2: Dose Expansion|Progressive Disease|0
983116|NCT01286987|1990666|FG005|Part 2: Dose Expansion|Progressive Disease|0
983117|NCT01286987|1990667|FG006|Part 2: Dose Expansion|Progressive Disease|0
983118|NCT01286987|1990668|FG007|Part 2: Dose Expansion|Progressive Disease|0
983119|NCT01286987|1990669|FG008|Part 2: Dose Expansion|Progressive Disease|0
983120|NCT01286987|1990670|FG009|Part 2: Dose Expansion|Progressive Disease|11
983121|NCT01286987|1990671|FG010|Part 2: Dose Expansion|Progressive Disease|6
983122|NCT01286987|1990672|FG011|Part 2: Dose Expansion|Progressive Disease|7
983123|NCT01286987|1990673|FG012|Part 2: Dose Expansion|Progressive Disease|11
983124|NCT01286987|1990674|FG013|Part 2: Dose Expansion|Progressive Disease|19
983125|NCT01286987|1990675|FG014|Part 2: Dose Expansion|Progressive Disease|2
983126|NCT01286987|1990661|FG000|Part 2: Dose Expansion|Clinical Progression|0
983127|NCT01286987|1990662|FG001|Part 2: Dose Expansion|Clinical Progression|0
983128|NCT01286987|1990663|FG002|Part 2: Dose Expansion|Clinical Progression|0
983129|NCT01286987|1990664|FG003|Part 2: Dose Expansion|Clinical Progression|0
983130|NCT01286987|1990665|FG004|Part 2: Dose Expansion|Clinical Progression|0
983131|NCT01286987|1990666|FG005|Part 2: Dose Expansion|Clinical Progression|0
983132|NCT01286987|1990667|FG006|Part 2: Dose Expansion|Clinical Progression|0
983133|NCT01286987|1990668|FG007|Part 2: Dose Expansion|Clinical Progression|0
983134|NCT01286987|1990669|FG008|Part 2: Dose Expansion|Clinical Progression|0
983135|NCT01286987|1990670|FG009|Part 2: Dose Expansion|Clinical Progression|0
983136|NCT01286987|1990671|FG010|Part 2: Dose Expansion|Clinical Progression|2
983137|NCT01286987|1990672|FG011|Part 2: Dose Expansion|Clinical Progression|2
983138|NCT01286987|1990673|FG012|Part 2: Dose Expansion|Clinical Progression|0
983139|NCT01286987|1990674|FG013|Part 2: Dose Expansion|Clinical Progression|2
983140|NCT01286987|1990675|FG014|Part 2: Dose Expansion|Clinical Progression|0
983141|NCT01286987|1990661|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0
983142|NCT01286987|1990662|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0
1006719|NCT01469052|2025439|FG003|Overall Study|Lack of Efficacy|0
983143|NCT01286987|1990663|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0
983144|NCT01286987|1990664|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0
983145|NCT01286987|1990665|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0
983146|NCT01286987|1990666|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0
983147|NCT01286987|1990667|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0
983148|NCT01286987|1990668|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0
983149|NCT01286987|1990669|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0
983150|NCT01286987|1990670|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0
983151|NCT01286987|1990671|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1
983152|NCT01286987|1990672|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0
983153|NCT01286987|1990673|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0
983154|NCT01286987|1990674|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0
983155|NCT01286987|1990675|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0
983156|NCT01287013|1990719|FG000|Overall Study|Non-evaluable|3
983157|NCT01287013|1990720|FG001|Overall Study|Non-evaluable|5
983158|NCT01287013|1990721|FG002|Overall Study|Non-evaluable|21
983159|NCT01287039|1990731|FG000|Overall Study|Noncompliance with study procedures|0
983160|NCT01287039|1990732|FG001|Overall Study|Noncompliance with study procedures|1
983161|NCT01287039|1990731|FG000|Overall Study|Change of location/residence|0
983162|NCT01287039|1990732|FG001|Overall Study|Change of location/residence|3
983163|NCT01287039|1990731|FG000|Overall Study|Elective surgery|0
983164|NCT01287039|1990732|FG001|Overall Study|Elective surgery|1
983165|NCT01287039|1990731|FG000|Overall Study|Protocol Violation|2
983166|NCT01287039|1990732|FG001|Overall Study|Protocol Violation|3
983167|NCT01287039|1990731|FG000|Overall Study|Excluded medication taken|1
983168|NCT01287039|1990732|FG001|Overall Study|Excluded medication taken|0
983169|NCT01287039|1990731|FG000|Overall Study|Noncompliance with study medication|0
983170|NCT01287039|1990732|FG001|Overall Study|Noncompliance with study medication|1
983171|NCT01287039|1990731|FG000|Overall Study|Problem with travel|0
983172|NCT01287039|1990732|FG001|Overall Study|Problem with travel|1
983173|NCT01287039|1990731|FG000|Overall Study|Death|1
983174|NCT01287039|1990732|FG001|Overall Study|Death|0
983175|NCT01287039|1990731|FG000|Overall Study|Change of residence|1
983176|NCT01287039|1990732|FG001|Overall Study|Change of residence|0
983177|NCT01287039|1990731|FG000|Overall Study|Adverse Event|7
983178|NCT01287039|1990732|FG001|Overall Study|Adverse Event|4
983179|NCT01287039|1990731|FG000|Overall Study|Withdrawal by Subject|14
983180|NCT01287039|1990732|FG001|Overall Study|Withdrawal by Subject|11
983181|NCT01287039|1990731|FG000|Overall Study|Lost to Follow-up|3
983182|NCT01287039|1990732|FG001|Overall Study|Lost to Follow-up|2
983183|NCT01287065|1990738|FG000|Treatment Period 1|Adverse Event|0
983184|NCT01287065|1990739|FG001|Treatment Period 1|Adverse Event|0
983185|NCT01287065|1990740|FG002|Treatment Period 1|Adverse Event|0
983186|NCT01287065|1990741|FG003|Treatment Period 1|Adverse Event|0
983187|NCT01287065|1990742|FG004|Treatment Period 1|Adverse Event|1
983188|NCT01287065|1990743|FG005|Treatment Period 1|Adverse Event|0
983189|NCT01287065|1990738|FG000|Treatment Period 1|Withdrawal by Subject|0
983190|NCT01287065|1990739|FG001|Treatment Period 1|Withdrawal by Subject|0
983191|NCT01287065|1990740|FG002|Treatment Period 1|Withdrawal by Subject|0
983192|NCT01287065|1990741|FG003|Treatment Period 1|Withdrawal by Subject|0
983193|NCT01287065|1990742|FG004|Treatment Period 1|Withdrawal by Subject|0
983194|NCT01287065|1990743|FG005|Treatment Period 1|Withdrawal by Subject|1
983195|NCT01287104|1990764|FG000|Overall Study|Patient developed progressive disease|1
983196|NCT01287104|1990765|FG001|Overall Study|Patient developed progressive disease|1
983197|NCT01287104|1990766|FG002|Overall Study|Patient developed progressive disease|3
983198|NCT01287104|1990767|FG003|Overall Study|Patient developed progressive disease|2
983199|NCT01287104|1990764|FG000|Overall Study|Donor anaphylaxis|0
983200|NCT01287104|1990765|FG001|Overall Study|Donor anaphylaxis|1
983201|NCT01287104|1990766|FG002|Overall Study|Donor anaphylaxis|0
983202|NCT01287104|1990767|FG003|Overall Study|Donor anaphylaxis|1
983203|NCT01287104|1990764|FG000|Overall Study|Developed GVHD or complications of BMT|0
983204|NCT01287104|1990765|FG001|Overall Study|Developed GVHD or complications of BMT|1
983205|NCT01287104|1990766|FG002|Overall Study|Developed GVHD or complications of BMT|4
983206|NCT01287104|1990767|FG003|Overall Study|Developed GVHD or complications of BMT|0
983207|NCT01287104|1990764|FG000|Overall Study|Low donor chimerism|0
983208|NCT01287104|1990765|FG001|Overall Study|Low donor chimerism|1
983209|NCT01287104|1990766|FG002|Overall Study|Low donor chimerism|0
983210|NCT01287104|1990767|FG003|Overall Study|Low donor chimerism|0
983211|NCT01287104|1990764|FG000|Overall Study|NK cells did not meet release criteria|0
983212|NCT01287104|1990765|FG001|Overall Study|NK cells did not meet release criteria|1
983213|NCT01287104|1990766|FG002|Overall Study|NK cells did not meet release criteria|0
983214|NCT01287104|1990767|FG003|Overall Study|NK cells did not meet release criteria|0
983215|NCT01287117|1990788|FG000|Overall Study|Adverse Event|2
983216|NCT01287117|1990789|FG001|Overall Study|Adverse Event|1
983217|NCT01287117|1990790|FG002|Overall Study|Adverse Event|1
983218|NCT01287117|1990791|FG003|Overall Study|Adverse Event|1
983219|NCT01287117|1990788|FG000|Overall Study|Lost to Follow-up|1
983220|NCT01287117|1990789|FG001|Overall Study|Lost to Follow-up|1
983221|NCT01287117|1990790|FG002|Overall Study|Lost to Follow-up|0
983222|NCT01287117|1990791|FG003|Overall Study|Lost to Follow-up|0
983223|NCT01287117|1990788|FG000|Overall Study|Physician Decision|0
983224|NCT01287117|1990789|FG001|Overall Study|Physician Decision|1
983225|NCT01287117|1990790|FG002|Overall Study|Physician Decision|1
983226|NCT01287117|1990791|FG003|Overall Study|Physician Decision|1
983227|NCT01287117|1990788|FG000|Overall Study|Patient/Legal Guardian's Decision|2
983228|NCT01287117|1990789|FG001|Overall Study|Patient/Legal Guardian's Decision|6
983229|NCT01287117|1990790|FG002|Overall Study|Patient/Legal Guardian's Decision|8
983230|NCT01287117|1990791|FG003|Overall Study|Patient/Legal Guardian's Decision|5
983231|NCT01287117|1990788|FG000|Overall Study|Disease Progression|10
983232|NCT01287117|1990789|FG001|Overall Study|Disease Progression|5
983233|NCT01287117|1990790|FG002|Overall Study|Disease Progression|6
983234|NCT01287117|1990791|FG003|Overall Study|Disease Progression|5
983235|NCT01287195|1990801|FG000|Overall Study|Withdrawal by Subject|2
983236|NCT01287221|1990818|FG000|Overall Study|Lack of Perceived Benefit|1
983237|NCT01287221|1990819|FG001|Overall Study|Lack of Perceived Benefit|1
983238|NCT01287221|1990818|FG000|Overall Study|Adverse Event|3
983239|NCT01287221|1990819|FG001|Overall Study|Adverse Event|3
983240|NCT01287221|1990818|FG000|Overall Study|Withdrawal by Subject|0
983241|NCT01287221|1990819|FG001|Overall Study|Withdrawal by Subject|1
983242|NCT01287364|1990827|FG000|Overall Study|Adverse Event|0
983243|NCT01287364|1990828|FG001|Overall Study|Adverse Event|3
983244|NCT01287364|1990827|FG000|Overall Study|Protocol Violation|5
983245|NCT01287364|1990828|FG001|Overall Study|Protocol Violation|5
983246|NCT01287364|1990827|FG000|Overall Study|Other Reason|4
983247|NCT01287364|1990828|FG001|Overall Study|Other Reason|2
983248|NCT01287403|1990860|FG000|1st Intervention (1 Day)|Adverse Event|1
983249|NCT01287416|1990876|FG000|Pre-post Training|Withdrawal by Subject|17
983250|NCT01287416|1990877|FG001|Pre-post Training|Withdrawal by Subject|24
983251|NCT01287416|1990876|FG000|Pre-post Training|Lost to Follow-up|5
983252|NCT01287416|1990877|FG001|Pre-post Training|Lost to Follow-up|1
983253|NCT01287416|1990876|FG000|6 Month Follow-up|Lost to Follow-up|3
983254|NCT01287416|1990877|FG001|6 Month Follow-up|Lost to Follow-up|2
983255|NCT01287520|1990892|FG000|Overall Study|Adverse Event|2
983256|NCT01287520|1990893|FG001|Overall Study|Adverse Event|2
983257|NCT01287520|1990894|FG002|Overall Study|Adverse Event|2
983258|NCT01287520|1990895|FG003|Overall Study|Adverse Event|1
983259|NCT01287520|1990896|FG004|Overall Study|Adverse Event|1
983260|NCT01287520|1990897|FG005|Overall Study|Adverse Event|2
983261|NCT01287520|1990898|FG006|Overall Study|Adverse Event|0
983262|NCT01287520|1990899|FG007|Overall Study|Adverse Event|2
983263|NCT01287520|1990900|FG008|Overall Study|Adverse Event|0
983264|NCT01287520|1990892|FG000|Overall Study|Physician Decision|1
983265|NCT01287520|1990893|FG001|Overall Study|Physician Decision|1
983266|NCT01287520|1990894|FG002|Overall Study|Physician Decision|2
983267|NCT01287520|1990895|FG003|Overall Study|Physician Decision|0
983268|NCT01287520|1990896|FG004|Overall Study|Physician Decision|1
983269|NCT01287520|1990897|FG005|Overall Study|Physician Decision|1
983270|NCT01287520|1990898|FG006|Overall Study|Physician Decision|0
983271|NCT01287520|1990899|FG007|Overall Study|Physician Decision|1
983272|NCT01287520|1990900|FG008|Overall Study|Physician Decision|0
983273|NCT01287520|1990892|FG000|Overall Study|Progressive disease|0
983274|NCT01287520|1990893|FG001|Overall Study|Progressive disease|4
983275|NCT01287520|1990894|FG002|Overall Study|Progressive disease|1
983276|NCT01287520|1990895|FG003|Overall Study|Progressive disease|6
983277|NCT01287520|1990896|FG004|Overall Study|Progressive disease|1
983278|NCT01287520|1990897|FG005|Overall Study|Progressive disease|0
983279|NCT01287520|1990898|FG006|Overall Study|Progressive disease|2
983280|NCT01287520|1990899|FG007|Overall Study|Progressive disease|2
983281|NCT01287520|1990900|FG008|Overall Study|Progressive disease|4
983282|NCT01287520|1990892|FG000|Overall Study|Withdrawal by Subject|0
983283|NCT01287520|1990893|FG001|Overall Study|Withdrawal by Subject|0
983284|NCT01287520|1990894|FG002|Overall Study|Withdrawal by Subject|0
983285|NCT01287520|1990895|FG003|Overall Study|Withdrawal by Subject|0
983286|NCT01287520|1990896|FG004|Overall Study|Withdrawal by Subject|0
983287|NCT01287520|1990897|FG005|Overall Study|Withdrawal by Subject|1
983288|NCT01287520|1990898|FG006|Overall Study|Withdrawal by Subject|0
983289|NCT01287520|1990899|FG007|Overall Study|Withdrawal by Subject|0
983290|NCT01287520|1990900|FG008|Overall Study|Withdrawal by Subject|1
983291|NCT01287611|1990951|FG000|Overall Study|Lost to Follow-up|29
983292|NCT01287611|1990952|FG001|Overall Study|Lost to Follow-up|16
983293|NCT01287611|1990951|FG000|Overall Study|Exclusion due to expanded Kerr incision|4
983294|NCT01287611|1990952|FG001|Overall Study|Exclusion due to expanded Kerr incision|3
983295|NCT01287754|1990972|FG000|Overall Study|Death|2
983296|NCT01287754|1990973|FG001|Overall Study|Death|12
983297|NCT01287754|1990972|FG000|Overall Study|Lost to Follow-up|1
983298|NCT01287754|1990973|FG001|Overall Study|Lost to Follow-up|6
983299|NCT01287754|1990972|FG000|Overall Study|Protocol Violation|0
983300|NCT01287754|1990973|FG001|Overall Study|Protocol Violation|3
983301|NCT01287832|1990981|FG000|Overall Study|Adverse Event|1
983302|NCT01287832|1990982|FG001|Overall Study|Adverse Event|0
983303|NCT01287832|1990981|FG000|Overall Study|Death|0
983304|NCT01287832|1990982|FG001|Overall Study|Death|1
983305|NCT01287897|1990992|FG000|Overall Study|Adverse Event|5
983306|NCT01287897|1990993|FG001|Overall Study|Adverse Event|3
983307|NCT01287897|1990994|FG002|Overall Study|Adverse Event|6
983308|NCT01287897|1990995|FG003|Overall Study|Adverse Event|4
983309|NCT01287897|1990992|FG000|Overall Study|Lack of Efficacy|2
983310|NCT01287897|1990993|FG001|Overall Study|Lack of Efficacy|0
983311|NCT01287897|1990994|FG002|Overall Study|Lack of Efficacy|0
983312|NCT01287897|1990995|FG003|Overall Study|Lack of Efficacy|0
983313|NCT01287897|1990992|FG000|Overall Study|Protocol Violation|1
983314|NCT01287897|1990993|FG001|Overall Study|Protocol Violation|1
983315|NCT01287897|1990994|FG002|Overall Study|Protocol Violation|0
983316|NCT01287897|1990995|FG003|Overall Study|Protocol Violation|1
983317|NCT01287897|1990992|FG000|Overall Study|Lost to Follow-up|0
983318|NCT01287897|1990993|FG001|Overall Study|Lost to Follow-up|0
983319|NCT01287897|1990994|FG002|Overall Study|Lost to Follow-up|2
983320|NCT01287897|1990995|FG003|Overall Study|Lost to Follow-up|0
983321|NCT01287897|1990992|FG000|Overall Study|Withdrawal by Subject|1
983322|NCT01287897|1990993|FG001|Overall Study|Withdrawal by Subject|5
983323|NCT01287897|1990994|FG002|Overall Study|Withdrawal by Subject|3
983324|NCT01287897|1990995|FG003|Overall Study|Withdrawal by Subject|2
983325|NCT01287897|1990992|FG000|Overall Study|Not consented properly|0
983326|NCT01287897|1990993|FG001|Overall Study|Not consented properly|1
983327|NCT01287897|1990994|FG002|Overall Study|Not consented properly|0
983328|NCT01287897|1990995|FG003|Overall Study|Not consented properly|0
983329|NCT01287897|1990992|FG000|Overall Study|Not meeting entrance criteria|1
983330|NCT01287897|1990993|FG001|Overall Study|Not meeting entrance criteria|1
983331|NCT01287897|1990994|FG002|Overall Study|Not meeting entrance criteria|0
983332|NCT01287897|1990995|FG003|Overall Study|Not meeting entrance criteria|0
983333|NCT01287897|1990992|FG000|Overall Study|Other|1
983334|NCT01287897|1990993|FG001|Overall Study|Other|0
983335|NCT01287897|1990994|FG002|Overall Study|Other|1
983336|NCT01287897|1990995|FG003|Overall Study|Other|0
983337|NCT01288053|1991013|FG000|Overall Study|Death|1
983338|NCT01288079|1991021|FG000|Overall Study|Withdrawal by Subject|2
983339|NCT01288079|1991022|FG001|Overall Study|Withdrawal by Subject|4
983340|NCT01288079|1991023|FG002|Overall Study|Withdrawal by Subject|1
983341|NCT01288079|1991024|FG003|Overall Study|Withdrawal by Subject|0
983342|NCT01288079|1991021|FG000|Overall Study|Adverse Event|2
983343|NCT01288079|1991022|FG001|Overall Study|Adverse Event|1
983344|NCT01288079|1991023|FG002|Overall Study|Adverse Event|2
983345|NCT01288079|1991024|FG003|Overall Study|Adverse Event|3
983346|NCT01288079|1991021|FG000|Overall Study|Severe Non-Compliance to Protocol|1
983347|NCT01288079|1991022|FG001|Overall Study|Severe Non-Compliance to Protocol|3
983348|NCT01288079|1991023|FG002|Overall Study|Severe Non-Compliance to Protocol|1
983349|NCT01288079|1991024|FG003|Overall Study|Severe Non-Compliance to Protocol|3
983350|NCT01288079|1991021|FG000|Overall Study|Condition under Investigation Worsened|0
983351|NCT01288079|1991022|FG001|Overall Study|Condition under Investigation Worsened|0
983352|NCT01288079|1991023|FG002|Overall Study|Condition under Investigation Worsened|0
983353|NCT01288079|1991024|FG003|Overall Study|Condition under Investigation Worsened|1
983354|NCT01288079|1991021|FG000|Overall Study|Lack of Efficacy|2
983355|NCT01288079|1991022|FG001|Overall Study|Lack of Efficacy|2
983356|NCT01288079|1991023|FG002|Overall Study|Lack of Efficacy|0
983357|NCT01288079|1991024|FG003|Overall Study|Lack of Efficacy|2
983358|NCT01288079|1991021|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
983359|NCT01288079|1991022|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
983360|NCT01288079|1991023|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
983361|NCT01288079|1991024|FG003|Overall Study|Study-Specific Withdrawal Criteria|0
983362|NCT01288079|1991021|FG000|Overall Study|Lost to Follow-up|1
983363|NCT01288079|1991022|FG001|Overall Study|Lost to Follow-up|1
983364|NCT01288079|1991023|FG002|Overall Study|Lost to Follow-up|1
983365|NCT01288079|1991024|FG003|Overall Study|Lost to Follow-up|0
983366|NCT01288079|1991021|FG000|Overall Study|Other or Study Termination|11
983367|NCT01288079|1991022|FG001|Overall Study|Other or Study Termination|15
983368|NCT01288079|1991023|FG002|Overall Study|Other or Study Termination|14
983369|NCT01288079|1991024|FG003|Overall Study|Other or Study Termination|8
983370|NCT01288209|1991036|FG000|Overall Study|Withdrawal by Subject|1
983371|NCT01288209|1991037|FG001|Overall Study|Withdrawal by Subject|3
983372|NCT01288209|1991036|FG000|Overall Study|Other|1
983373|NCT01288209|1991037|FG001|Overall Study|Other|0
983374|NCT01288287|1991043|FG000|Overall Study|Lost to Follow-up|8
983375|NCT01288287|1991043|FG000|Overall Study|Withdrawal by Subject|4
983376|NCT01288287|1991043|FG000|Overall Study|Lack of Efficacy|13
983377|NCT01288287|1991043|FG000|Overall Study|Other Reason|13
983378|NCT01288287|1991043|FG000|Overall Study|Unknown Reason|1
983379|NCT01288287|1991043|FG000|Overall Study|Unknown Status|7
983380|NCT01288430|1991058|FG000|Part 1|Progressive disease|2
983381|NCT01288430|1991059|FG001|Part 1|Progressive disease|1
983382|NCT01288430|1991060|FG002|Part 1|Progressive disease|1
983383|NCT01288430|1991061|FG003|Part 1|Progressive disease|6
983384|NCT01288430|1991062|FG004|Part 1|Progressive disease|2
983385|NCT01288430|1991063|FG005|Part 1|Progressive disease|4
983386|NCT01288430|1991064|FG006|Part 1|Progressive disease|2
983387|NCT01288430|1991065|FG007|Part 1|Progressive disease|0
983388|NCT01288430|1991066|FG008|Part 1|Progressive disease|0
983389|NCT01288430|1991067|FG009|Part 1|Progressive disease|0
983390|NCT01288430|1991058|FG000|Part 1|Clinical disease progression|0
983391|NCT01288430|1991059|FG001|Part 1|Clinical disease progression|0
983392|NCT01288430|1991060|FG002|Part 1|Clinical disease progression|1
983393|NCT01288430|1991061|FG003|Part 1|Clinical disease progression|0
983394|NCT01288430|1991062|FG004|Part 1|Clinical disease progression|0
983395|NCT01288430|1991063|FG005|Part 1|Clinical disease progression|2
983396|NCT01288430|1991064|FG006|Part 1|Clinical disease progression|2
983397|NCT01288430|1991065|FG007|Part 1|Clinical disease progression|0
983398|NCT01288430|1991066|FG008|Part 1|Clinical disease progression|0
983399|NCT01288430|1991067|FG009|Part 1|Clinical disease progression|0
983400|NCT01288430|1991058|FG000|Part 1|Death due to disease progression|0
983401|NCT01288430|1991059|FG001|Part 1|Death due to disease progression|0
983402|NCT01288430|1991060|FG002|Part 1|Death due to disease progression|0
983403|NCT01288430|1991061|FG003|Part 1|Death due to disease progression|0
983404|NCT01288430|1991062|FG004|Part 1|Death due to disease progression|1
983405|NCT01288430|1991063|FG005|Part 1|Death due to disease progression|0
983406|NCT01288430|1991064|FG006|Part 1|Death due to disease progression|0
983407|NCT01288430|1991065|FG007|Part 1|Death due to disease progression|0
983408|NCT01288430|1991066|FG008|Part 1|Death due to disease progression|0
983409|NCT01288430|1991067|FG009|Part 1|Death due to disease progression|0
983410|NCT01288430|1991058|FG000|Part 1|Adverse Event|0
983411|NCT01288430|1991059|FG001|Part 1|Adverse Event|0
983412|NCT01288430|1991060|FG002|Part 1|Adverse Event|3
983413|NCT01288430|1991061|FG003|Part 1|Adverse Event|1
983414|NCT01288430|1991062|FG004|Part 1|Adverse Event|0
983415|NCT01288430|1991063|FG005|Part 1|Adverse Event|0
983416|NCT01288430|1991064|FG006|Part 1|Adverse Event|2
983417|NCT01288430|1991065|FG007|Part 1|Adverse Event|0
983418|NCT01288430|1991066|FG008|Part 1|Adverse Event|0
983419|NCT01288430|1991067|FG009|Part 1|Adverse Event|0
983420|NCT01288430|1991058|FG000|Part 1|Other|0
983421|NCT01288430|1991059|FG001|Part 1|Other|2
983422|NCT01288430|1991060|FG002|Part 1|Other|0
983423|NCT01288430|1991061|FG003|Part 1|Other|0
983424|NCT01288430|1991062|FG004|Part 1|Other|0
983425|NCT01288430|1991063|FG005|Part 1|Other|0
983426|NCT01288430|1991064|FG006|Part 1|Other|1
983427|NCT01288430|1991065|FG007|Part 1|Other|0
983428|NCT01288430|1991066|FG008|Part 1|Other|0
983429|NCT01288430|1991067|FG009|Part 1|Other|0
983430|NCT01288430|1991058|FG000|Part 2|Progressive disease|0
983431|NCT01288430|1991059|FG001|Part 2|Progressive disease|0
983432|NCT01288430|1991060|FG002|Part 2|Progressive disease|0
983433|NCT01288430|1991061|FG003|Part 2|Progressive disease|0
983434|NCT01288430|1991062|FG004|Part 2|Progressive disease|0
983435|NCT01288430|1991063|FG005|Part 2|Progressive disease|0
983436|NCT01288430|1991064|FG006|Part 2|Progressive disease|0
983437|NCT01288430|1991065|FG007|Part 2|Progressive disease|8
983438|NCT01288430|1991066|FG008|Part 2|Progressive disease|7
983439|NCT01288430|1991067|FG009|Part 2|Progressive disease|2
983440|NCT01288430|1991058|FG000|Part 2|Clinical disease progression|0
983441|NCT01288430|1991059|FG001|Part 2|Clinical disease progression|0
983442|NCT01288430|1991060|FG002|Part 2|Clinical disease progression|0
983443|NCT01288430|1991061|FG003|Part 2|Clinical disease progression|0
983444|NCT01288430|1991062|FG004|Part 2|Clinical disease progression|0
983445|NCT01288430|1991063|FG005|Part 2|Clinical disease progression|0
983446|NCT01288430|1991064|FG006|Part 2|Clinical disease progression|0
983447|NCT01288430|1991065|FG007|Part 2|Clinical disease progression|2
983448|NCT01288430|1991066|FG008|Part 2|Clinical disease progression|0
983449|NCT01288430|1991067|FG009|Part 2|Clinical disease progression|0
983450|NCT01288430|1991058|FG000|Part 2|Withdrawal by Subject|0
983451|NCT01288430|1991059|FG001|Part 2|Withdrawal by Subject|0
983452|NCT01288430|1991060|FG002|Part 2|Withdrawal by Subject|0
983453|NCT01288430|1991061|FG003|Part 2|Withdrawal by Subject|0
983454|NCT01288430|1991062|FG004|Part 2|Withdrawal by Subject|0
983455|NCT01288430|1991063|FG005|Part 2|Withdrawal by Subject|0
983456|NCT01288430|1991064|FG006|Part 2|Withdrawal by Subject|0
983457|NCT01288430|1991065|FG007|Part 2|Withdrawal by Subject|1
983458|NCT01288430|1991066|FG008|Part 2|Withdrawal by Subject|4
983459|NCT01288430|1991067|FG009|Part 2|Withdrawal by Subject|0
983460|NCT01288430|1991058|FG000|Part 2|Adverse Event|0
983461|NCT01288430|1991059|FG001|Part 2|Adverse Event|0
983462|NCT01288430|1991060|FG002|Part 2|Adverse Event|0
983463|NCT01288430|1991061|FG003|Part 2|Adverse Event|0
983464|NCT01288430|1991062|FG004|Part 2|Adverse Event|0
983465|NCT01288430|1991063|FG005|Part 2|Adverse Event|0
983466|NCT01288430|1991064|FG006|Part 2|Adverse Event|0
983467|NCT01288430|1991065|FG007|Part 2|Adverse Event|1
983468|NCT01288430|1991066|FG008|Part 2|Adverse Event|1
983469|NCT01288430|1991067|FG009|Part 2|Adverse Event|0
983470|NCT01288430|1991058|FG000|Part 2|Other|0
983471|NCT01288430|1991059|FG001|Part 2|Other|0
983472|NCT01288430|1991060|FG002|Part 2|Other|0
983473|NCT01288430|1991061|FG003|Part 2|Other|0
983474|NCT01288430|1991062|FG004|Part 2|Other|0
983475|NCT01288430|1991063|FG005|Part 2|Other|0
983476|NCT01288430|1991064|FG006|Part 2|Other|0
983477|NCT01288430|1991065|FG007|Part 2|Other|0
983478|NCT01288430|1991066|FG008|Part 2|Other|0
983479|NCT01288430|1991067|FG009|Part 2|Other|1
983480|NCT01288443|1991100|FG000|Overall Study|Adverse Event|0
983481|NCT01288443|1991101|FG001|Overall Study|Adverse Event|0
983482|NCT01288443|1991102|FG002|Overall Study|Adverse Event|1
983483|NCT01288443|1991103|FG003|Overall Study|Adverse Event|1
983484|NCT01288443|1991104|FG004|Overall Study|Adverse Event|3
983485|NCT01288443|1991105|FG005|Overall Study|Adverse Event|1
983486|NCT01288443|1991100|FG000|Overall Study|Poor compliance to protocol|0
983487|NCT01288443|1991101|FG001|Overall Study|Poor compliance to protocol|0
983488|NCT01288443|1991102|FG002|Overall Study|Poor compliance to protocol|0
983489|NCT01288443|1991103|FG003|Overall Study|Poor compliance to protocol|0
983490|NCT01288443|1991104|FG004|Overall Study|Poor compliance to protocol|0
983491|NCT01288443|1991105|FG005|Overall Study|Poor compliance to protocol|1
983492|NCT01288443|1991100|FG000|Overall Study|Participant Moved|0
983493|NCT01288443|1991101|FG001|Overall Study|Participant Moved|0
983494|NCT01288443|1991102|FG002|Overall Study|Participant Moved|0
983495|NCT01288443|1991103|FG003|Overall Study|Participant Moved|1
983496|NCT01288443|1991104|FG004|Overall Study|Participant Moved|2
983497|NCT01288443|1991105|FG005|Overall Study|Participant Moved|1
983498|NCT01288443|1991100|FG000|Overall Study|Consent withdrawn by Participant|0
983499|NCT01288443|1991101|FG001|Overall Study|Consent withdrawn by Participant|0
983500|NCT01288443|1991102|FG002|Overall Study|Consent withdrawn by Participant|0
983501|NCT01288443|1991103|FG003|Overall Study|Consent withdrawn by Participant|0
983502|NCT01288443|1991104|FG004|Overall Study|Consent withdrawn by Participant|0
983503|NCT01288443|1991105|FG005|Overall Study|Consent withdrawn by Participant|1
983504|NCT01288443|1991100|FG000|Overall Study|Lost to Follow-up|0
983505|NCT01288443|1991101|FG001|Overall Study|Lost to Follow-up|1
983506|NCT01288443|1991102|FG002|Overall Study|Lost to Follow-up|0
983507|NCT01288443|1991103|FG003|Overall Study|Lost to Follow-up|0
983508|NCT01288443|1991104|FG004|Overall Study|Lost to Follow-up|0
983509|NCT01288443|1991105|FG005|Overall Study|Lost to Follow-up|0
983510|NCT01288443|1991100|FG000|Overall Study|Study drug auto-injector administration|0
983511|NCT01288443|1991101|FG001|Overall Study|Study drug auto-injector administration|0
983512|NCT01288443|1991102|FG002|Overall Study|Study drug auto-injector administration|0
983513|NCT01288443|1991103|FG003|Overall Study|Study drug auto-injector administration|0
983514|NCT01288443|1991104|FG004|Overall Study|Study drug auto-injector administration|1
983515|NCT01288443|1991105|FG005|Overall Study|Study drug auto-injector administration|1
983516|NCT01288443|1991100|FG000|Overall Study|Other than above|0
983517|NCT01288443|1991101|FG001|Overall Study|Other than above|0
983518|NCT01288443|1991102|FG002|Overall Study|Other than above|0
983519|NCT01288443|1991103|FG003|Overall Study|Other than above|2
983520|NCT01288443|1991104|FG004|Overall Study|Other than above|1
983521|NCT01288443|1991105|FG005|Overall Study|Other than above|0
983522|NCT01288469|1991122|FG000|Overall Study|Adverse Event|4
983523|NCT01288469|1991123|FG001|Overall Study|Adverse Event|1
983524|NCT01288469|1991124|FG002|Overall Study|Adverse Event|1
983525|NCT01288469|1991122|FG000|Overall Study|Poor compliance to protocol|0
983526|NCT01288469|1991123|FG001|Overall Study|Poor compliance to protocol|1
983527|NCT01288469|1991124|FG002|Overall Study|Poor compliance to protocol|0
983528|NCT01288469|1991122|FG000|Overall Study|Participant Moved|1
983529|NCT01288469|1991123|FG001|Overall Study|Participant Moved|0
983530|NCT01288469|1991124|FG002|Overall Study|Participant Moved|0
983531|NCT01288469|1991122|FG000|Overall Study|Consent withdrawn by subject|1
983532|NCT01288469|1991123|FG001|Overall Study|Consent withdrawn by subject|1
983533|NCT01288469|1991124|FG002|Overall Study|Consent withdrawn by subject|1
983534|NCT01288469|1991122|FG000|Overall Study|Exclusion criteria finally met|1
983535|NCT01288469|1991123|FG001|Overall Study|Exclusion criteria finally met|0
983536|NCT01288469|1991124|FG002|Overall Study|Exclusion criteria finally met|0
983537|NCT01288612|1991148|FG000|Overall Study|Unable to contact|11
983538|NCT01288612|1991149|FG001|Overall Study|Unable to contact|16
983539|NCT01288612|1991150|FG002|Overall Study|Unable to contact|20
983540|NCT01288612|1991148|FG000|Overall Study|Declined|78
983541|NCT01288612|1991149|FG001|Overall Study|Declined|63
983542|NCT01288612|1991150|FG002|Overall Study|Declined|62
983543|NCT01288612|1991148|FG000|Overall Study|Unable to intubate|0
983544|NCT01288612|1991149|FG001|Overall Study|Unable to intubate|3
983545|NCT01288612|1991150|FG002|Overall Study|Unable to intubate|0
983546|NCT01288729|1991160|FG000|Overall Study|Withdrawal by Subject|1
983547|NCT01288729|1991161|FG001|Overall Study|Withdrawal by Subject|0
983548|NCT01288911|1991216|FG000|Double-blind Period|Death|11
983549|NCT01288911|1991217|FG001|Double-blind Period|Death|7
983550|NCT01288911|1991216|FG000|Double-blind Period|Lost to Follow-up|0
983551|NCT01288911|1991217|FG001|Double-blind Period|Lost to Follow-up|2
983552|NCT01288911|1991216|FG000|Double-blind Period|Progressive Disease|75
983553|NCT01288911|1991217|FG001|Double-blind Period|Progressive Disease|103
983554|NCT01288911|1991216|FG000|Double-blind Period|Protocol Violation|1
983555|NCT01288911|1991217|FG001|Double-blind Period|Protocol Violation|0
983556|NCT01288911|1991216|FG000|Double-blind Period|Withdrawal by Subject|25
983557|NCT01288911|1991217|FG001|Double-blind Period|Withdrawal by Subject|26
983558|NCT01288911|1991216|FG000|Double-blind Period|Miscellaneous Reason|29
983559|NCT01288911|1991217|FG001|Double-blind Period|Miscellaneous Reason|42
983560|NCT01288911|1991216|FG000|Double-blind Period|Randomized but never received study drug|1
983561|NCT01288911|1991217|FG001|Double-blind Period|Randomized but never received study drug|2
983562|NCT01288911|1991216|FG000|Open-label Period (All Enzalutamide)|Death|0
983563|NCT01288911|1991217|FG001|Open-label Period (All Enzalutamide)|Death|1
983564|NCT01288911|1991216|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
983565|NCT01288911|1991217|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
983566|NCT01288911|1991216|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18
983567|NCT01288911|1991217|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3
983568|NCT01288911|1991216|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
983569|NCT01288911|1991217|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
983570|NCT01288911|1991216|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
983571|NCT01288911|1991217|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
983572|NCT01288911|1991216|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
983573|NCT01288911|1991217|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
983574|NCT01288937|1991228|FG000|Overall Study|Adverse Event|1
983575|NCT01288937|1991229|FG001|Overall Study|Adverse Event|0
983576|NCT01288976|1991238|FG000|Overall Study|Withdrawal by Subject|58
983577|NCT01288976|1991239|FG001|Overall Study|Withdrawal by Subject|12
983578|NCT01288976|1991240|FG002|Overall Study|Withdrawal by Subject|9
983579|NCT01288976|1991238|FG000|Overall Study|Death|98
983580|NCT01288976|1991239|FG001|Overall Study|Death|6
983581|NCT01288976|1991240|FG002|Overall Study|Death|4
983582|NCT01288976|1991238|FG000|Overall Study|Data unavailable|22
983583|NCT01288976|1991239|FG001|Overall Study|Data unavailable|9
983584|NCT01288976|1991240|FG002|Overall Study|Data unavailable|7
983585|NCT01288989|1991251|FG000|Overall Study|Death|0
983586|NCT01288989|1991252|FG001|Overall Study|Death|0
983587|NCT01288989|1991253|FG002|Overall Study|Death|0
983588|NCT01288989|1991254|FG003|Overall Study|Death|1
983589|NCT01288989|1991255|FG004|Overall Study|Death|0
983590|NCT01288989|1991251|FG000|Overall Study|Dose limiting toxicity|1
983591|NCT01288989|1991252|FG001|Overall Study|Dose limiting toxicity|0
983592|NCT01288989|1991253|FG002|Overall Study|Dose limiting toxicity|0
983593|NCT01288989|1991254|FG003|Overall Study|Dose limiting toxicity|0
983594|NCT01288989|1991255|FG004|Overall Study|Dose limiting toxicity|0
983595|NCT01288989|1991251|FG000|Overall Study|Adverse Event|0
983596|NCT01288989|1991252|FG001|Overall Study|Adverse Event|0
983597|NCT01288989|1991253|FG002|Overall Study|Adverse Event|0
983598|NCT01288989|1991254|FG003|Overall Study|Adverse Event|0
983599|NCT01288989|1991255|FG004|Overall Study|Adverse Event|2
983600|NCT01288989|1991251|FG000|Overall Study|Physician Decision|0
983601|NCT01288989|1991252|FG001|Overall Study|Physician Decision|0
983602|NCT01288989|1991253|FG002|Overall Study|Physician Decision|0
983603|NCT01288989|1991254|FG003|Overall Study|Physician Decision|0
983604|NCT01288989|1991255|FG004|Overall Study|Physician Decision|1
983605|NCT01288989|1991251|FG000|Overall Study|Withdrawal by Subject|0
983606|NCT01288989|1991252|FG001|Overall Study|Withdrawal by Subject|0
983607|NCT01288989|1991253|FG002|Overall Study|Withdrawal by Subject|0
983608|NCT01288989|1991254|FG003|Overall Study|Withdrawal by Subject|0
983609|NCT01288989|1991255|FG004|Overall Study|Withdrawal by Subject|3
983610|NCT01289015|1991275|FG000|Overall Study|Protocol Violation|12
983611|NCT01289015|1991276|FG001|Overall Study|Protocol Violation|9
983612|NCT01289015|1991275|FG000|Overall Study|Adverse Event|3
983613|NCT01289015|1991276|FG001|Overall Study|Adverse Event|0
983614|NCT01289015|1991275|FG000|Overall Study|Lost to Follow-up|33
983615|NCT01289015|1991276|FG001|Overall Study|Lost to Follow-up|17
983616|NCT01289015|1991275|FG000|Overall Study|Withdrawal by Subject|17
983617|NCT01289015|1991276|FG001|Overall Study|Withdrawal by Subject|8
983618|NCT01289015|1991275|FG000|Overall Study|Disease progression|1
983619|NCT01289015|1991276|FG001|Overall Study|Disease progression|0
983620|NCT01289015|1991275|FG000|Overall Study|Negative baseline culture and others|33
983621|NCT01289015|1991276|FG001|Overall Study|Negative baseline culture and others|20
983622|NCT01289028|1991282|FG000|Overall Study|Progressive Disease|49
983623|NCT01289028|1991282|FG000|Overall Study|Adverse Event|14
983624|NCT01289028|1991282|FG000|Overall Study|Withdrawal by Subject|6
983625|NCT01289028|1991282|FG000|Overall Study|Death|4
983626|NCT01289028|1991282|FG000|Overall Study|Lack of Efficacy|2
983627|NCT01289028|1991282|FG000|Overall Study|No longer required|2
983628|NCT01289028|1991282|FG000|Overall Study|Lost to Follow-up|2
983629|NCT01289028|1991282|FG000|Overall Study|New Cancer Therapy|2
983630|NCT01289028|1991282|FG000|Overall Study|Abnormal Lab Value|1
983631|NCT01289028|1991282|FG000|Overall Study|Missing reason for discon|1
983632|NCT01289041|1991288|FG000|Overall Study|Adverse Event|24
983633|NCT01289041|1991288|FG000|Overall Study|Physician Decision|1
983634|NCT01289041|1991288|FG000|Overall Study|Progressive Disease|41
983635|NCT01289041|1991288|FG000|Overall Study|Withdrawal by Subject|3
983636|NCT01289041|1991288|FG000|Overall Study|Death|1
983637|NCT01289119|1991314|FG000|Overall Study|Adverse Event|2
983638|NCT01289119|1991315|FG001|Overall Study|Adverse Event|1
983639|NCT01289119|1991316|FG002|Overall Study|Adverse Event|0
983640|NCT01289119|1991317|FG003|Overall Study|Adverse Event|2
983641|NCT01289119|1991318|FG004|Overall Study|Adverse Event|1
983642|NCT01289119|1991319|FG005|Overall Study|Adverse Event|0
983643|NCT01289119|1991314|FG000|Overall Study|Major Protocol Deviation|2
983644|NCT01289119|1991315|FG001|Overall Study|Major Protocol Deviation|1
983645|NCT01289119|1991316|FG002|Overall Study|Major Protocol Deviation|3
983646|NCT01289119|1991317|FG003|Overall Study|Major Protocol Deviation|0
983647|NCT01289119|1991318|FG004|Overall Study|Major Protocol Deviation|2
983648|NCT01289119|1991319|FG005|Overall Study|Major Protocol Deviation|1
983649|NCT01289119|1991314|FG000|Overall Study|Lost to Follow-up|0
983650|NCT01289119|1991315|FG001|Overall Study|Lost to Follow-up|3
983651|NCT01289119|1991316|FG002|Overall Study|Lost to Follow-up|0
983652|NCT01289119|1991317|FG003|Overall Study|Lost to Follow-up|0
983653|NCT01289119|1991318|FG004|Overall Study|Lost to Follow-up|0
983654|NCT01289119|1991319|FG005|Overall Study|Lost to Follow-up|1
983655|NCT01289119|1991314|FG000|Overall Study|Withdrawal by Subject|4
983656|NCT01289119|1991315|FG001|Overall Study|Withdrawal by Subject|2
983657|NCT01289119|1991316|FG002|Overall Study|Withdrawal by Subject|4
983658|NCT01289119|1991317|FG003|Overall Study|Withdrawal by Subject|3
983659|NCT01289119|1991318|FG004|Overall Study|Withdrawal by Subject|1
983660|NCT01289119|1991319|FG005|Overall Study|Withdrawal by Subject|1
983661|NCT01289119|1991314|FG000|Overall Study|Pregnancy|0
983662|NCT01289119|1991315|FG001|Overall Study|Pregnancy|1
983663|NCT01289119|1991316|FG002|Overall Study|Pregnancy|0
983664|NCT01289119|1991317|FG003|Overall Study|Pregnancy|0
983665|NCT01289119|1991318|FG004|Overall Study|Pregnancy|0
983666|NCT01289119|1991319|FG005|Overall Study|Pregnancy|0
983667|NCT01289119|1991314|FG000|Overall Study|Lack of Efficacy|0
983668|NCT01289119|1991315|FG001|Overall Study|Lack of Efficacy|1
983669|NCT01289119|1991316|FG002|Overall Study|Lack of Efficacy|1
983670|NCT01289119|1991317|FG003|Overall Study|Lack of Efficacy|1
983671|NCT01289119|1991318|FG004|Overall Study|Lack of Efficacy|1
983672|NCT01289119|1991319|FG005|Overall Study|Lack of Efficacy|1
983673|NCT01289119|1991314|FG000|Overall Study|Other|1
983674|NCT01289119|1991315|FG001|Overall Study|Other|0
983675|NCT01289119|1991316|FG002|Overall Study|Other|1
983676|NCT01289119|1991317|FG003|Overall Study|Other|0
983677|NCT01289119|1991318|FG004|Overall Study|Other|0
983678|NCT01289119|1991319|FG005|Overall Study|Other|0
983679|NCT01289210|1991333|FG000|Overall Study|Adverse Event|1
983680|NCT01289353|1991358|FG000|Overall Study|Lost to Follow-up|2
983681|NCT01289418|1991378|FG000|Day 8 Survey|email address invalid|283
983682|NCT01289418|1991378|FG000|Day 8 Survey|participants did not complete the survey|1935
983683|NCT01289418|1991378|FG000|Day 29 Survey|email address invalid|283
983684|NCT01289418|1991378|FG000|Day 29 Survey|participants did not complete the survey|2185
983685|NCT01289574|1991446|FG000|Overall Study|Lack of Efficacy|4
983686|NCT01289574|1991447|FG001|Overall Study|Lack of Efficacy|0
983687|NCT01289574|1991448|FG002|Overall Study|Lack of Efficacy|1
983688|NCT01289574|1991446|FG000|Overall Study|Lost to Follow-up|2
983689|NCT01289574|1991447|FG001|Overall Study|Lost to Follow-up|0
983690|NCT01289574|1991448|FG002|Overall Study|Lost to Follow-up|1
983691|NCT01289574|1991446|FG000|Overall Study|Withdrawal by Subject|1
983692|NCT01289574|1991447|FG001|Overall Study|Withdrawal by Subject|1
983693|NCT01289574|1991448|FG002|Overall Study|Withdrawal by Subject|1
983694|NCT01289574|1991446|FG000|Overall Study|Adverse Event|0
983695|NCT01289574|1991447|FG001|Overall Study|Adverse Event|1
983696|NCT01289574|1991448|FG002|Overall Study|Adverse Event|0
983697|NCT01289574|1991446|FG000|Overall Study|Subject wanted alternate treatment|0
983698|NCT01289574|1991447|FG001|Overall Study|Subject wanted alternate treatment|1
983699|NCT01289574|1991448|FG002|Overall Study|Subject wanted alternate treatment|0
983700|NCT01289639|1991460|FG000|Overall Study|Lost to Follow-up|1
983701|NCT01289639|1991461|FG001|Overall Study|Lost to Follow-up|0
983702|NCT01289639|1991462|FG002|Overall Study|Lost to Follow-up|0
983703|NCT01289678|1991479|FG000|Overall Study|Physician Decision|6
983704|NCT01289782|1991485|FG000|Overall Study|Lost to Follow-up|14
983705|NCT01289782|1991486|FG001|Overall Study|Lost to Follow-up|7
983706|NCT01289782|1991485|FG000|Overall Study|Protocol Violation|1
983707|NCT01289782|1991486|FG001|Overall Study|Protocol Violation|1
983708|NCT01289782|1991485|FG000|Overall Study|Withdrawal by Subject|8
983709|NCT01289782|1991486|FG001|Overall Study|Withdrawal by Subject|2
983710|NCT01289782|1991485|FG000|Overall Study|Sponsor's Decision|1
983711|NCT01289782|1991486|FG001|Overall Study|Sponsor's Decision|0
983712|NCT01289782|1991485|FG000|Overall Study|Reason not specified|1
983713|NCT01289782|1991486|FG001|Overall Study|Reason not specified|2
983714|NCT01289821|1991492|FG000|Treatment Period|Withdrawal by Subject|1
983715|NCT01289821|1991492|FG000|Treatment Period|Physician Decision|3
983716|NCT01289821|1991492|FG000|Treatment Period|Adverse Event|4
983717|NCT01289821|1991492|FG000|Treatment Period|Radiological Progression|43
983718|NCT01289821|1991492|FG000|Treatment Period|Clinical Progression|2
983719|NCT01289821|1991492|FG000|Treatment Period|Therapeutic procedure required|1
983720|NCT01289821|1991492|FG000|Safety Follow-up Period|Withdrawal by Subject|1
983721|NCT01289821|1991492|FG000|Safety Follow-up Period|Protocol Violation|3
983722|NCT01289821|1991492|FG000|Safety Follow-up Period|Unspecified reason|1
983723|NCT01289821|1991492|FG000|Survival Follow-up Period|Protocol Violation|1
983724|NCT01289821|1991492|FG000|Survival Follow-up Period|Lost to Follow-up|1
983725|NCT01289821|1991492|FG000|Survival Follow-up Period|Clinical endpoint reached|16
983726|NCT01289847|1991496|FG000|Overall Study|Patient could not comply with visits|1
983727|NCT01289990|1991532|FG000|Overall Study|Death|0
983728|NCT01289990|1991533|FG001|Overall Study|Death|0
983729|NCT01289990|1991534|FG002|Overall Study|Death|0
983730|NCT01289990|1991535|FG003|Overall Study|Death|1
983731|NCT01289990|1991536|FG004|Overall Study|Death|2
983732|NCT01289990|1991537|FG005|Overall Study|Death|1
983733|NCT01289990|1991538|FG006|Overall Study|Death|0
983734|NCT01289990|1991539|FG007|Overall Study|Death|0
983735|NCT01289990|1991540|FG008|Overall Study|Death|0
983736|NCT01289990|1991541|FG009|Overall Study|Death|0
983737|NCT01289990|1991542|FG010|Overall Study|Death|0
983738|NCT01289990|1991543|FG011|Overall Study|Death|1
983739|NCT01289990|1991544|FG012|Overall Study|Death|0
983740|NCT01289990|1991532|FG000|Overall Study|Lost to Follow-up|3
983741|NCT01289990|1991533|FG001|Overall Study|Lost to Follow-up|2
983742|NCT01289990|1991534|FG002|Overall Study|Lost to Follow-up|5
983743|NCT01289990|1991535|FG003|Overall Study|Lost to Follow-up|5
983744|NCT01289990|1991536|FG004|Overall Study|Lost to Follow-up|3
983745|NCT01289990|1991537|FG005|Overall Study|Lost to Follow-up|4
983746|NCT01289990|1991538|FG006|Overall Study|Lost to Follow-up|2
983747|NCT01289990|1991539|FG007|Overall Study|Lost to Follow-up|2
983748|NCT01289990|1991540|FG008|Overall Study|Lost to Follow-up|1
983749|NCT01289990|1991541|FG009|Overall Study|Lost to Follow-up|4
983750|NCT01289990|1991542|FG010|Overall Study|Lost to Follow-up|2
983751|NCT01289990|1991543|FG011|Overall Study|Lost to Follow-up|1
983752|NCT01289990|1991544|FG012|Overall Study|Lost to Follow-up|2
983753|NCT01289990|1991532|FG000|Overall Study|Withdrawal by Subject|15
983754|NCT01289990|1991533|FG001|Overall Study|Withdrawal by Subject|14
983755|NCT01289990|1991534|FG002|Overall Study|Withdrawal by Subject|12
983756|NCT01289990|1991535|FG003|Overall Study|Withdrawal by Subject|13
983757|NCT01289990|1991536|FG004|Overall Study|Withdrawal by Subject|8
983758|NCT01289990|1991537|FG005|Overall Study|Withdrawal by Subject|7
983759|NCT01289990|1991538|FG006|Overall Study|Withdrawal by Subject|13
983760|NCT01289990|1991539|FG007|Overall Study|Withdrawal by Subject|9
983761|NCT01289990|1991540|FG008|Overall Study|Withdrawal by Subject|12
983762|NCT01289990|1991541|FG009|Overall Study|Withdrawal by Subject|13
983763|NCT01289990|1991542|FG010|Overall Study|Withdrawal by Subject|11
983764|NCT01289990|1991543|FG011|Overall Study|Withdrawal by Subject|13
983765|NCT01289990|1991544|FG012|Overall Study|Withdrawal by Subject|16
983766|NCT01289990|1991532|FG000|Overall Study|discontinued in preceding trial|18
983767|NCT01289990|1991533|FG001|Overall Study|discontinued in preceding trial|20
983768|NCT01289990|1991534|FG002|Overall Study|discontinued in preceding trial|41
983769|NCT01289990|1991535|FG003|Overall Study|discontinued in preceding trial|17
983770|NCT01289990|1991536|FG004|Overall Study|discontinued in preceding trial|11
983771|NCT01289990|1991537|FG005|Overall Study|discontinued in preceding trial|12
983772|NCT01289990|1991538|FG006|Overall Study|discontinued in preceding trial|18
983773|NCT01289990|1991539|FG007|Overall Study|discontinued in preceding trial|8
983774|NCT01289990|1991540|FG008|Overall Study|discontinued in preceding trial|17
983775|NCT01289990|1991541|FG009|Overall Study|discontinued in preceding trial|21
983776|NCT01289990|1991542|FG010|Overall Study|discontinued in preceding trial|17
983777|NCT01289990|1991543|FG011|Overall Study|discontinued in preceding trial|17
983778|NCT01289990|1991544|FG012|Overall Study|discontinued in preceding trial|24
983779|NCT01289990|1991532|FG000|Overall Study|did not continue in extension|41
983780|NCT01289990|1991533|FG001|Overall Study|did not continue in extension|45
983781|NCT01289990|1991534|FG002|Overall Study|did not continue in extension|51
983782|NCT01289990|1991535|FG003|Overall Study|did not continue in extension|51
983783|NCT01289990|1991536|FG004|Overall Study|did not continue in extension|48
983784|NCT01289990|1991537|FG005|Overall Study|did not continue in extension|50
983785|NCT01289990|1991538|FG006|Overall Study|did not continue in extension|54
983786|NCT01289990|1991539|FG007|Overall Study|did not continue in extension|36
983787|NCT01289990|1991540|FG008|Overall Study|did not continue in extension|44
983788|NCT01289990|1991541|FG009|Overall Study|did not continue in extension|48
983789|NCT01289990|1991542|FG010|Overall Study|did not continue in extension|45
983790|NCT01289990|1991543|FG011|Overall Study|did not continue in extension|34
983791|NCT01289990|1991544|FG012|Overall Study|did not continue in extension|56
983792|NCT01289990|1991532|FG000|Overall Study|Not treated|0
983793|NCT01289990|1991533|FG001|Overall Study|Not treated|0
983794|NCT01289990|1991534|FG002|Overall Study|Not treated|0
983795|NCT01289990|1991535|FG003|Overall Study|Not treated|0
983796|NCT01289990|1991536|FG004|Overall Study|Not treated|0
983797|NCT01289990|1991537|FG005|Overall Study|Not treated|0
983798|NCT01289990|1991538|FG006|Overall Study|Not treated|1
983799|NCT01289990|1991539|FG007|Overall Study|Not treated|0
983800|NCT01289990|1991540|FG008|Overall Study|Not treated|1
983801|NCT01289990|1991541|FG009|Overall Study|Not treated|0
983802|NCT01289990|1991542|FG010|Overall Study|Not treated|1
983803|NCT01289990|1991543|FG011|Overall Study|Not treated|2
983804|NCT01289990|1991544|FG012|Overall Study|Not treated|0
983805|NCT01290029|1991572|FG000|Overall Study|Other|2
983806|NCT01290068|1991578|FG000|Overall Study|Adverse Event|1
983807|NCT01290068|1991579|FG001|Overall Study|Adverse Event|3
983808|NCT01290068|1991578|FG000|Overall Study|Lost to Follow-up|3
983809|NCT01290068|1991579|FG001|Overall Study|Lost to Follow-up|0
983810|NCT01290068|1991578|FG000|Overall Study|Withdrawal by subject prior to implant|0
983811|NCT01290068|1991579|FG001|Overall Study|Withdrawal by subject prior to implant|2
983812|NCT01290068|1991578|FG000|Overall Study|Other|3
983813|NCT01290068|1991579|FG001|Overall Study|Other|1
983814|NCT01290094|1991585|FG000|Overall Study|Withdrawal by Subject|1
983815|NCT01290094|1991585|FG000|Overall Study|Lost to Follow-up|5
983816|NCT01290224|1991589|FG000|Overall Study|Adverse Event|1
983817|NCT01290224|1991589|FG000|Overall Study|Refused Further Treatment|4
983818|NCT01290263|1991608|FG000|Overall Study|Adverse Event|0
983819|NCT01290263|1991609|FG001|Overall Study|Adverse Event|0
983820|NCT01290263|1991610|FG002|Overall Study|Adverse Event|0
983821|NCT01290263|1991611|FG003|Overall Study|Adverse Event|1
983822|NCT01290263|1991612|FG004|Overall Study|Adverse Event|1
983823|NCT01290263|1991608|FG000|Overall Study|Lack of Efficacy|8
983824|NCT01290263|1991609|FG001|Overall Study|Lack of Efficacy|2
983825|NCT01290263|1991610|FG002|Overall Study|Lack of Efficacy|7
983826|NCT01290263|1991611|FG003|Overall Study|Lack of Efficacy|24
983827|NCT01290263|1991612|FG004|Overall Study|Lack of Efficacy|33
983828|NCT01290263|1991608|FG000|Overall Study|Withdrawal by Subject|3
983829|NCT01290263|1991609|FG001|Overall Study|Withdrawal by Subject|1
983830|NCT01290263|1991610|FG002|Overall Study|Withdrawal by Subject|0
983831|NCT01290263|1991611|FG003|Overall Study|Withdrawal by Subject|1
983832|NCT01290263|1991612|FG004|Overall Study|Withdrawal by Subject|2
983833|NCT01290263|1991608|FG000|Overall Study|Participant Non-Compliance|0
983834|NCT01290263|1991609|FG001|Overall Study|Participant Non-Compliance|0
983835|NCT01290263|1991610|FG002|Overall Study|Participant Non-Compliance|0
983836|NCT01290263|1991611|FG003|Overall Study|Participant Non-Compliance|1
983837|NCT01290263|1991612|FG004|Overall Study|Participant Non-Compliance|1
983838|NCT01290315|1991624|FG000|Overall Study|Adverse Event|0
983839|NCT01290315|1991625|FG001|Overall Study|Adverse Event|0
983840|NCT01290315|1991626|FG002|Overall Study|Adverse Event|0
983841|NCT01290315|1991627|FG003|Overall Study|Adverse Event|3
983842|NCT01290315|1991624|FG000|Overall Study|Selection criteria/compliance|2
983843|NCT01290315|1991625|FG001|Overall Study|Selection criteria/compliance|1
983844|NCT01290315|1991626|FG002|Overall Study|Selection criteria/compliance|0
983845|NCT01290315|1991627|FG003|Overall Study|Selection criteria/compliance|2
983846|NCT01290315|1991624|FG000|Overall Study|Lost to Follow-up|0
983847|NCT01290315|1991625|FG001|Overall Study|Lost to Follow-up|1
983848|NCT01290315|1991626|FG002|Overall Study|Lost to Follow-up|0
983849|NCT01290315|1991627|FG003|Overall Study|Lost to Follow-up|0
983850|NCT01290315|1991624|FG000|Overall Study|Withdrawal by Subject|1
983851|NCT01290315|1991625|FG001|Overall Study|Withdrawal by Subject|1
983852|NCT01290315|1991626|FG002|Overall Study|Withdrawal by Subject|0
983853|NCT01290315|1991627|FG003|Overall Study|Withdrawal by Subject|0
983854|NCT01290341|1991638|FG000|Overall Study|Protocol Violation|7
983855|NCT01290341|1991639|FG001|Overall Study|Protocol Violation|3
983856|NCT01290341|1991638|FG000|Overall Study|Adverse Event|1
983857|NCT01290341|1991639|FG001|Overall Study|Adverse Event|0
983858|NCT01290341|1991638|FG000|Overall Study|Lost to Follow-up|21
983859|NCT01290341|1991639|FG001|Overall Study|Lost to Follow-up|10
983860|NCT01290341|1991638|FG000|Overall Study|Withdrawal by Subject|19
983861|NCT01290341|1991639|FG001|Overall Study|Withdrawal by Subject|5
983862|NCT01290341|1991638|FG000|Overall Study|Negative baseline culture and others|44
983863|NCT01290341|1991639|FG001|Overall Study|Negative baseline culture and others|11
983864|NCT01290523|1991662|FG000|Overall Study|Death|3
983865|NCT01290601|1991675|FG000|Overall Study|Adverse Event|0
983866|NCT01290601|1991676|FG001|Overall Study|Adverse Event|2
983867|NCT01290601|1991677|FG002|Overall Study|Adverse Event|0
983868|NCT01290601|1991678|FG003|Overall Study|Adverse Event|0
983869|NCT01290601|1991675|FG000|Overall Study|Lack of Efficacy|2
983870|NCT01290601|1991676|FG001|Overall Study|Lack of Efficacy|1
983871|NCT01290601|1991677|FG002|Overall Study|Lack of Efficacy|0
983872|NCT01290601|1991678|FG003|Overall Study|Lack of Efficacy|0
983873|NCT01290601|1991675|FG000|Overall Study|Lost to Follow-up|7
983874|NCT01290601|1991676|FG001|Overall Study|Lost to Follow-up|2
983875|NCT01290601|1991677|FG002|Overall Study|Lost to Follow-up|0
983876|NCT01290601|1991678|FG003|Overall Study|Lost to Follow-up|0
983877|NCT01290601|1991675|FG000|Overall Study|Other|1
983878|NCT01290601|1991676|FG001|Overall Study|Other|0
983879|NCT01290601|1991677|FG002|Overall Study|Other|0
983880|NCT01290601|1991678|FG003|Overall Study|Other|0
983881|NCT01290601|1991675|FG000|Overall Study|Protocol Violation|1
983882|NCT01290601|1991676|FG001|Overall Study|Protocol Violation|0
983883|NCT01290601|1991677|FG002|Overall Study|Protocol Violation|0
983884|NCT01290601|1991678|FG003|Overall Study|Protocol Violation|0
983885|NCT01290666|1991715|FG000|Overall Study|Lost to Follow-up|11
983886|NCT01290666|1991715|FG000|Overall Study|Withdrawal by Subject|23
983887|NCT01290666|1991715|FG000|Overall Study|Early Termination of Study|4
983888|NCT01290679|1991721|FG000|Overall Study|Adverse Event|2
983889|NCT01290679|1991722|FG001|Overall Study|Adverse Event|0
983890|NCT01290679|1991721|FG000|Overall Study|Lost to Follow-up|8
983891|NCT01290679|1991722|FG001|Overall Study|Lost to Follow-up|10
983892|NCT01290679|1991721|FG000|Overall Study|Protocol Violation|0
983893|NCT01290679|1991722|FG001|Overall Study|Protocol Violation|1
983894|NCT01290679|1991721|FG000|Overall Study|Withdrawal by Subject|6
983895|NCT01290679|1991722|FG001|Overall Study|Withdrawal by Subject|5
983896|NCT01290679|1991721|FG000|Overall Study|Subject Entered Another Trial|0
983897|NCT01290679|1991722|FG001|Overall Study|Subject Entered Another Trial|5
983898|NCT01290731|1991728|FG000|Overall Study|Withdrawal by Subject|1
983899|NCT01290757|1991734|FG000|Overall Study|Adverse Event|1
983900|NCT01290757|1991735|FG001|Overall Study|Adverse Event|0
983901|NCT01290757|1991734|FG000|Overall Study|Protocol Violation|1
983902|NCT01290757|1991735|FG001|Overall Study|Protocol Violation|1
983903|NCT01290757|1991734|FG000|Overall Study|Other|0
983904|NCT01290757|1991735|FG001|Overall Study|Other|1
983905|NCT01290796|1991741|FG000|Overall Study|Lost to Follow-up|21
983906|NCT01290796|1991741|FG000|Overall Study|Withdrawal by Subject|4
983907|NCT01290796|1991741|FG000|Overall Study|Physician Decision|2
983908|NCT01290796|1991741|FG000|Overall Study|Secondary Surgical Intervention|2
983909|NCT01290796|1991741|FG000|Overall Study|Withdrawal by Sponsor|1
983910|NCT01290887|1991757|FG000|Overall Study|Adverse Event|6
983911|NCT01290887|1991758|FG001|Overall Study|Adverse Event|11
983912|NCT01290887|1991757|FG000|Overall Study|Lack of Efficacy|4
983913|NCT01290887|1991758|FG001|Overall Study|Lack of Efficacy|5
983914|NCT01290887|1991757|FG000|Overall Study|Withdrawal by Subject|26
983915|NCT01290887|1991758|FG001|Overall Study|Withdrawal by Subject|32
983916|NCT01290887|1991757|FG000|Overall Study|Protocol Violation|2
983917|NCT01290887|1991758|FG001|Overall Study|Protocol Violation|1
983918|NCT01290887|1991757|FG000|Overall Study|Lost to Follow-up|4
983919|NCT01290887|1991758|FG001|Overall Study|Lost to Follow-up|4
983920|NCT01290887|1991757|FG000|Overall Study|Non-compliance to study procedures|0
983921|NCT01290887|1991758|FG001|Overall Study|Non-compliance to study procedures|1
983922|NCT01290887|1991757|FG000|Overall Study|Non-compliance to study medications|1
983923|NCT01290887|1991758|FG001|Overall Study|Non-compliance to study medications|0
983924|NCT01290887|1991757|FG000|Overall Study|Sponsor closure of study|420
983925|NCT01290887|1991758|FG001|Overall Study|Sponsor closure of study|476
983926|NCT01290887|1991757|FG000|Overall Study|Other|3
983927|NCT01290887|1991758|FG001|Overall Study|Other|6
983928|NCT01291017|1991784|FG000|Overall Study|Lost to Follow-up|2
983929|NCT01291017|1991784|FG000|Overall Study|Withdrawal by Subject|3
983930|NCT01291173|1991830|FG000|Overall Study|Adverse Event|0
983931|NCT01291173|1991831|FG001|Overall Study|Adverse Event|3
983932|NCT01291173|1991832|FG002|Overall Study|Adverse Event|1
983933|NCT01291173|1991833|FG003|Overall Study|Adverse Event|3
983934|NCT01291173|1991830|FG000|Overall Study|Protocol Violation|7
983935|NCT01291173|1991831|FG001|Overall Study|Protocol Violation|2
983936|NCT01291173|1991832|FG002|Overall Study|Protocol Violation|2
983937|NCT01291173|1991833|FG003|Overall Study|Protocol Violation|5
983938|NCT01291173|1991830|FG000|Overall Study|Withdrawal by Subject|6
983939|NCT01291173|1991831|FG001|Overall Study|Withdrawal by Subject|4
983940|NCT01291173|1991832|FG002|Overall Study|Withdrawal by Subject|4
983941|NCT01291173|1991833|FG003|Overall Study|Withdrawal by Subject|2
983942|NCT01291173|1991830|FG000|Overall Study|Lost to Follow-up|4
983943|NCT01291173|1991831|FG001|Overall Study|Lost to Follow-up|6
983944|NCT01291173|1991832|FG002|Overall Study|Lost to Follow-up|3
983945|NCT01291173|1991833|FG003|Overall Study|Lost to Follow-up|2
983946|NCT01291173|1991830|FG000|Overall Study|Unable to meet visit schedule|0
983947|NCT01291173|1991831|FG001|Overall Study|Unable to meet visit schedule|0
983948|NCT01291173|1991832|FG002|Overall Study|Unable to meet visit schedule|1
983949|NCT01291173|1991833|FG003|Overall Study|Unable to meet visit schedule|0
983950|NCT01291173|1991830|FG000|Overall Study|Lack of compliance|0
983951|NCT01291173|1991831|FG001|Overall Study|Lack of compliance|0
983952|NCT01291173|1991832|FG002|Overall Study|Lack of compliance|0
983953|NCT01291173|1991833|FG003|Overall Study|Lack of compliance|1
983954|NCT01291173|1991830|FG000|Overall Study|Subject was unblinded|0
983955|NCT01291173|1991831|FG001|Overall Study|Subject was unblinded|0
983956|NCT01291173|1991832|FG002|Overall Study|Subject was unblinded|1
983957|NCT01291173|1991833|FG003|Overall Study|Subject was unblinded|0
983958|NCT01291173|1991830|FG000|Overall Study|Excluded therapy|0
983959|NCT01291173|1991831|FG001|Overall Study|Excluded therapy|0
983960|NCT01291173|1991832|FG002|Overall Study|Excluded therapy|1
983961|NCT01291173|1991833|FG003|Overall Study|Excluded therapy|0
983962|NCT01291225|1991845|FG000|Overall Study|Lost to Follow-up|85
983963|NCT01291225|1991846|FG001|Overall Study|Lost to Follow-up|39
983964|NCT01291277|1991862|FG000|Overall Study|Death|2
983965|NCT01291277|1991863|FG001|Overall Study|Death|2
983966|NCT01291277|1991862|FG000|Overall Study|Lost to Follow-up|3
983967|NCT01291277|1991863|FG001|Overall Study|Lost to Follow-up|1
983968|NCT01292057|1991903|FG000|Overall Study|Protocol Violation|1
983969|NCT01292057|1991904|FG001|Overall Study|Protocol Violation|1
983970|NCT01292057|1991903|FG000|Overall Study|Lost to Follow-up|1
983971|NCT01292057|1991904|FG001|Overall Study|Lost to Follow-up|1
983972|NCT01292187|1991923|FG000|Overall Study|Adverse Event|10
983973|NCT01292187|1991924|FG001|Overall Study|Adverse Event|5
983974|NCT01292187|1991923|FG000|Overall Study|Withdrawal by Subject|6
983975|NCT01292187|1991924|FG001|Overall Study|Withdrawal by Subject|5
983976|NCT01292187|1991923|FG000|Overall Study|All other reasons|1
983977|NCT01292187|1991924|FG001|Overall Study|All other reasons|3
983978|NCT01292226|1991931|FG000|Overall Study|Adverse Event|5
983979|NCT01292226|1991931|FG000|Overall Study|Death|1
983980|NCT01292226|1991931|FG000|Overall Study|Graft loss|1
983981|NCT01292226|1991931|FG000|Overall Study|Protocol Violation|3
983982|NCT01292226|1991931|FG000|Overall Study|Withdrawal by Subject|1
983983|NCT01292226|1991931|FG000|Overall Study|Other|2
983984|NCT01292239|1991937|FG000|Overall Study|Other|1
983985|NCT01292239|1991938|FG001|Overall Study|Other|1
983986|NCT01292239|1991937|FG000|Overall Study|Withdrawal by Subject|3
983987|NCT01292239|1991938|FG001|Overall Study|Withdrawal by Subject|6
983988|NCT01292473|1991970|FG000|Overall Study|Adverse Event|1
983989|NCT01292473|1991971|FG001|Overall Study|Adverse Event|0
983990|NCT01292473|1991972|FG002|Overall Study|Adverse Event|1
983991|NCT01292473|1991973|FG003|Overall Study|Adverse Event|1
983992|NCT01292473|1991970|FG000|Overall Study|Lost to Follow-up|1
983993|NCT01292473|1991971|FG001|Overall Study|Lost to Follow-up|1
983994|NCT01292473|1991972|FG002|Overall Study|Lost to Follow-up|2
983995|NCT01292473|1991973|FG003|Overall Study|Lost to Follow-up|2
983996|NCT01292473|1991970|FG000|Overall Study|Withdrawal by Subject|3
983997|NCT01292473|1991971|FG001|Overall Study|Withdrawal by Subject|4
983998|NCT01292473|1991972|FG002|Overall Study|Withdrawal by Subject|3
983999|NCT01292473|1991973|FG003|Overall Study|Withdrawal by Subject|3
984000|NCT01292473|1991970|FG000|Overall Study|Physician Decision|0
984001|NCT01292473|1991971|FG001|Overall Study|Physician Decision|1
984002|NCT01292473|1991972|FG002|Overall Study|Physician Decision|0
984003|NCT01292473|1991973|FG003|Overall Study|Physician Decision|0
984004|NCT01292473|1991970|FG000|Overall Study|Disease Progression|0
984005|NCT01292473|1991971|FG001|Overall Study|Disease Progression|1
984006|NCT01292473|1991972|FG002|Overall Study|Disease Progression|3
984007|NCT01292473|1991973|FG003|Overall Study|Disease Progression|6
984008|NCT01292486|1991987|FG000|Overall Study|Protocol Violation|2
984009|NCT01292486|1991987|FG000|Overall Study|Did not meet screening criteria|2
984010|NCT01292486|1991987|FG000|Overall Study|Adverse Event|1
984011|NCT01292486|1991987|FG000|Overall Study|Physician Decision|1
984012|NCT01292603|1992006|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0
984013|NCT01292603|1992007|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0
984014|NCT01292603|1992008|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0
984015|NCT01292603|1992009|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4
984016|NCT01292603|1992010|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0
984017|NCT01292603|1992011|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0
984018|NCT01292603|1992006|FG000|Part 1: Pilot Dose Selection Period|Death|0
984019|NCT01292603|1992007|FG001|Part 1: Pilot Dose Selection Period|Death|0
984020|NCT01292603|1992008|FG002|Part 1: Pilot Dose Selection Period|Death|0
984021|NCT01292603|1992009|FG003|Part 1: Pilot Dose Selection Period|Death|1
984022|NCT01292603|1992010|FG004|Part 1: Pilot Dose Selection Period|Death|0
984023|NCT01292603|1992011|FG005|Part 1: Pilot Dose Selection Period|Death|0
984024|NCT01292603|1992006|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0
984025|NCT01292603|1992007|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0
984026|NCT01292603|1992008|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0
984027|NCT01292603|1992009|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2
984028|NCT01292603|1992010|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0
984029|NCT01292603|1992011|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0
984030|NCT01292603|1992006|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
984031|NCT01292603|1992007|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
984032|NCT01292603|1992008|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
984033|NCT01292603|1992009|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
984034|NCT01292603|1992010|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
984035|NCT01292603|1992011|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
984036|NCT01292603|1992006|FG000|Part 1: Regular Follow-Up Period|Death|3
984037|NCT01292603|1992007|FG001|Part 1: Regular Follow-Up Period|Death|1
984038|NCT01292603|1992008|FG002|Part 1: Regular Follow-Up Period|Death|3
984039|NCT01292603|1992009|FG003|Part 1: Regular Follow-Up Period|Death|1
984040|NCT01292603|1992010|FG004|Part 1: Regular Follow-Up Period|Death|0
984041|NCT01292603|1992011|FG005|Part 1: Regular Follow-Up Period|Death|0
984042|NCT01292603|1992006|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3
984043|NCT01292603|1992007|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6
984044|NCT01292603|1992008|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3
984045|NCT01292603|1992009|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0
984046|NCT01292603|1992010|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0
984047|NCT01292603|1992011|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0
984048|NCT01292603|1992006|FG000|Part 2: Dose Confirmation Period|Death|0
984049|NCT01292603|1992007|FG001|Part 2: Dose Confirmation Period|Death|0
984050|NCT01292603|1992008|FG002|Part 2: Dose Confirmation Period|Death|0
984051|NCT01292603|1992009|FG003|Part 2: Dose Confirmation Period|Death|0
984052|NCT01292603|1992010|FG004|Part 2: Dose Confirmation Period|Death|1
984053|NCT01292603|1992011|FG005|Part 2: Dose Confirmation Period|Death|0
984054|NCT01292603|1992006|FG000|Part 2: Dose Confirmation Period|Physician Decision|0
984055|NCT01292603|1992007|FG001|Part 2: Dose Confirmation Period|Physician Decision|0
984056|NCT01292603|1992008|FG002|Part 2: Dose Confirmation Period|Physician Decision|0
984057|NCT01292603|1992009|FG003|Part 2: Dose Confirmation Period|Physician Decision|0
984058|NCT01292603|1992010|FG004|Part 2: Dose Confirmation Period|Physician Decision|2
984059|NCT01292603|1992011|FG005|Part 2: Dose Confirmation Period|Physician Decision|0
984060|NCT01292603|1992006|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
984061|NCT01292603|1992007|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
984062|NCT01292603|1992008|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
984063|NCT01292603|1992009|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
984064|NCT01292603|1992010|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
984065|NCT01292603|1992011|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
984066|NCT01292603|1992006|FG000|Part 2: Dose Confirmation Period|Adverse Event|0
984067|NCT01292603|1992007|FG001|Part 2: Dose Confirmation Period|Adverse Event|0
984068|NCT01292603|1992008|FG002|Part 2: Dose Confirmation Period|Adverse Event|0
984069|NCT01292603|1992009|FG003|Part 2: Dose Confirmation Period|Adverse Event|0
984070|NCT01292603|1992010|FG004|Part 2: Dose Confirmation Period|Adverse Event|7
984071|NCT01292603|1992011|FG005|Part 2: Dose Confirmation Period|Adverse Event|9
984072|NCT01292603|1992006|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0
984073|NCT01292603|1992007|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0
984074|NCT01292603|1992008|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0
984075|NCT01292603|1992009|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0
984076|NCT01292603|1992010|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5
984077|NCT01292603|1992011|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3
984078|NCT01292603|1992006|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
984079|NCT01292603|1992007|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
984080|NCT01292603|1992008|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
984081|NCT01292603|1992009|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
984082|NCT01292603|1992010|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
984083|NCT01292603|1992011|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
984084|NCT01292603|1992006|FG000|Part 2: Regular Follow-Up|Death|0
984085|NCT01292603|1992007|FG001|Part 2: Regular Follow-Up|Death|0
984086|NCT01292603|1992008|FG002|Part 2: Regular Follow-Up|Death|0
984087|NCT01292603|1992009|FG003|Part 2: Regular Follow-Up|Death|0
984088|NCT01292603|1992010|FG004|Part 2: Regular Follow-Up|Death|6
984089|NCT01292603|1992011|FG005|Part 2: Regular Follow-Up|Death|3
984090|NCT01292603|1992006|FG000|Part 2: Regular Follow-Up|Disease Progression|0
984091|NCT01292603|1992007|FG001|Part 2: Regular Follow-Up|Disease Progression|0
984092|NCT01292603|1992008|FG002|Part 2: Regular Follow-Up|Disease Progression|0
984093|NCT01292603|1992009|FG003|Part 2: Regular Follow-Up|Disease Progression|0
984094|NCT01292603|1992010|FG004|Part 2: Regular Follow-Up|Disease Progression|5
984095|NCT01292603|1992011|FG005|Part 2: Regular Follow-Up|Disease Progression|5
984096|NCT01292603|1992006|FG000|Part 2: Regular Follow-Up|Noncompliance|0
984097|NCT01292603|1992007|FG001|Part 2: Regular Follow-Up|Noncompliance|0
984098|NCT01292603|1992008|FG002|Part 2: Regular Follow-Up|Noncompliance|0
984099|NCT01292603|1992009|FG003|Part 2: Regular Follow-Up|Noncompliance|0
984100|NCT01292603|1992010|FG004|Part 2: Regular Follow-Up|Noncompliance|1
984101|NCT01292603|1992011|FG005|Part 2: Regular Follow-Up|Noncompliance|0
984102|NCT01292603|1992006|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0
984103|NCT01292603|1992007|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0
984104|NCT01292603|1992008|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0
984105|NCT01292603|1992009|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0
984106|NCT01292603|1992010|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0
984107|NCT01292603|1992011|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1
984108|NCT01292603|1992006|FG000|Part 2: Regular Follow-Up|Protocol Violation|0
984109|NCT01292603|1992007|FG001|Part 2: Regular Follow-Up|Protocol Violation|0
984110|NCT01292603|1992008|FG002|Part 2: Regular Follow-Up|Protocol Violation|0
984111|NCT01292603|1992009|FG003|Part 2: Regular Follow-Up|Protocol Violation|0
984112|NCT01292603|1992010|FG004|Part 2: Regular Follow-Up|Protocol Violation|2
984113|NCT01292603|1992011|FG005|Part 2: Regular Follow-Up|Protocol Violation|0
984114|NCT01292603|1992006|FG000|Part 2: Regular Follow-Up|Physician Decision|0
984115|NCT01292603|1992007|FG001|Part 2: Regular Follow-Up|Physician Decision|0
984116|NCT01292603|1992008|FG002|Part 2: Regular Follow-Up|Physician Decision|0
984117|NCT01292603|1992009|FG003|Part 2: Regular Follow-Up|Physician Decision|0
984118|NCT01292603|1992010|FG004|Part 2: Regular Follow-Up|Physician Decision|2
984119|NCT01292603|1992011|FG005|Part 2: Regular Follow-Up|Physician Decision|0
984120|NCT01292603|1992006|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0
984121|NCT01292603|1992007|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0
984122|NCT01292603|1992008|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0
984123|NCT01292603|1992009|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0
984124|NCT01292603|1992010|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1
984125|NCT01292603|1992011|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1
984126|NCT01292603|1992006|FG000|Part 2: Regular Follow-Up|Adverse Event|0
984127|NCT01292603|1992007|FG001|Part 2: Regular Follow-Up|Adverse Event|0
984128|NCT01292603|1992008|FG002|Part 2: Regular Follow-Up|Adverse Event|0
984129|NCT01292603|1992009|FG003|Part 2: Regular Follow-Up|Adverse Event|0
984130|NCT01292603|1992010|FG004|Part 2: Regular Follow-Up|Adverse Event|2
984131|NCT01292603|1992011|FG005|Part 2: Regular Follow-Up|Adverse Event|2
984132|NCT01292603|1992006|FG000|Overall Survival Status|Death|3
984133|NCT01292603|1992007|FG001|Overall Survival Status|Death|1
984134|NCT01292603|1992008|FG002|Overall Survival Status|Death|3
984135|NCT01292603|1992009|FG003|Overall Survival Status|Death|1
984136|NCT01292603|1992010|FG004|Overall Survival Status|Death|16
984137|NCT01292603|1992011|FG005|Overall Survival Status|Death|10
984138|NCT01292837|1992053|FG000|Overall Study|Adverse Event|1
984139|NCT01292837|1992053|FG000|Overall Study|Further treatment determined|1
984140|NCT01292876|1992057|FG000|Overall Study|Physician Decision|4
984141|NCT01292928|1992063|FG000|Overall Study|Death|8
984142|NCT01292928|1992063|FG000|Overall Study|Withdrawal by Subject|8
984143|NCT01292928|1992063|FG000|Overall Study|Lost to Follow-up|6
984144|NCT01292928|1992063|FG000|Overall Study|Physician Decision|2
984145|NCT01293006|1992073|FG000|Period 2|Lost to Follow-up|1
984146|NCT01293006|1992074|FG001|Period 2|Lost to Follow-up|0
984147|NCT01293006|1992075|FG002|Period 2|Lost to Follow-up|0
984148|NCT01293006|1992076|FG003|Period 2|Lost to Follow-up|0
984149|NCT01293032|1992095|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
984150|NCT01293032|1992096|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
984151|NCT01293032|1992097|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
984152|NCT01293032|1992098|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
984153|NCT01293032|1992095|FG000|Treatment|Adverse Event|0
984154|NCT01293032|1992096|FG001|Treatment|Adverse Event|0
984155|NCT01293032|1992097|FG002|Treatment|Adverse Event|1
984156|NCT01293032|1992098|FG003|Treatment|Adverse Event|1
984157|NCT01293032|1992095|FG000|Treatment|Withdrawal by Subject|2
984158|NCT01293032|1992096|FG001|Treatment|Withdrawal by Subject|4
984159|NCT01293032|1992097|FG002|Treatment|Withdrawal by Subject|0
984160|NCT01293032|1992098|FG003|Treatment|Withdrawal by Subject|0
984161|NCT01293032|1992095|FG000|Treatment|Disease Progression, relapse|0
984162|NCT01293032|1992096|FG001|Treatment|Disease Progression, relapse|1
984163|NCT01293032|1992097|FG002|Treatment|Disease Progression, relapse|0
984164|NCT01293032|1992098|FG003|Treatment|Disease Progression, relapse|0
984165|NCT01293084|1992105|FG000|Overall Study|Physician Decision|3
984166|NCT01293084|1992105|FG000|Overall Study|Withdrawal by Subject|2
984167|NCT01293240|1992111|FG000|Overall Study|Noncompliance|2
984168|NCT01293539|1992125|FG000|Overall Study|Physician Decision|1
984169|NCT01293695|1992135|FG000|Overall Study|Withdrawal by Subject|7
984170|NCT01293695|1992136|FG001|Overall Study|Withdrawal by Subject|1
984171|NCT01293695|1992135|FG000|Overall Study|Lost to Follow-up|8
984172|NCT01293695|1992136|FG001|Overall Study|Lost to Follow-up|6
984173|NCT01293968|1992151|FG000|Overall Study|non-cooperation|3
984174|NCT01293968|1992152|FG001|Overall Study|non-cooperation|3
984175|NCT01294150|1992173|FG000|Overall Study|Physician Decision|2
984176|NCT01294150|1992174|FG001|Overall Study|Physician Decision|2
984177|NCT01294358|1992239|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0
984178|NCT01294358|1992240|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2
984179|NCT01294358|1992241|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0
984180|NCT01294358|1992242|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0
984181|NCT01294358|1992243|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0
984182|NCT01294358|1992239|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0
984183|NCT01294358|1992240|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0
984184|NCT01294358|1992241|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2
984185|NCT01294358|1992242|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0
984186|NCT01294358|1992243|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0
984187|NCT01294358|1992239|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
984188|NCT01294358|1992240|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
984189|NCT01294358|1992241|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
984190|NCT01294358|1992242|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
984191|NCT01294358|1992243|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
984192|NCT01294358|1992239|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
984193|NCT01294358|1992240|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
984194|NCT01294358|1992241|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
984195|NCT01294358|1992242|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
984196|NCT01294358|1992243|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
984197|NCT01294371|1992260|FG000|Overall Study|Adverse Event|1
984198|NCT01294371|1992260|FG000|Overall Study|Withdrawal by Subject|12
984199|NCT01294371|1992260|FG000|Overall Study|Lost to Follow-up|6
984200|NCT01294371|1992260|FG000|Overall Study|Administrative Reason|1
984201|NCT01294371|1992260|FG000|Overall Study|Other|14
984202|NCT01294397|1992280|FG000|Overall Study|Withdrawal by Subject|1
984203|NCT01294397|1992280|FG000|Overall Study|Administrative Decision|1
984204|NCT01294423|1992289|FG000|Overall Study|Adverse Event|1
984205|NCT01294423|1992290|FG001|Overall Study|Adverse Event|2
984206|NCT01294423|1992291|FG002|Overall Study|Adverse Event|3
984207|NCT01294423|1992289|FG000|Overall Study|Withdrawal by Subject|1
984208|NCT01294423|1992290|FG001|Overall Study|Withdrawal by Subject|2
984209|NCT01294423|1992291|FG002|Overall Study|Withdrawal by Subject|2
984210|NCT01294423|1992289|FG000|Overall Study|subject no longer meets study criteria|2
984211|NCT01294423|1992290|FG001|Overall Study|subject no longer meets study criteria|5
984212|NCT01294423|1992291|FG002|Overall Study|subject no longer meets study criteria|2
984213|NCT01294423|1992289|FG000|Overall Study|poor/non-compliance|1
984214|NCT01294423|1992290|FG001|Overall Study|poor/non-compliance|0
984215|NCT01294423|1992291|FG002|Overall Study|poor/non-compliance|1
984216|NCT01294436|1992301|FG000|Overall Study|Adverse Event|10
984217|NCT01294436|1992302|FG001|Overall Study|Adverse Event|17
984218|NCT01294436|1992301|FG000|Overall Study|Withdrawal by Subject|11
984219|NCT01294436|1992302|FG001|Overall Study|Withdrawal by Subject|28
984220|NCT01294436|1992301|FG000|Overall Study|subject no longer meets study criteria|5
984221|NCT01294436|1992302|FG001|Overall Study|subject no longer meets study criteria|20
984222|NCT01294436|1992301|FG000|Overall Study|poor/non-compliance|2
984223|NCT01294436|1992302|FG001|Overall Study|poor/non-compliance|5
984224|NCT01294449|1992310|FG000|Overall Study|Death|11
984225|NCT01294449|1992311|FG001|Overall Study|Death|12
984226|NCT01294449|1992310|FG000|Overall Study|Withdrawal by Subject|1
984227|NCT01294449|1992311|FG001|Overall Study|Withdrawal by Subject|3
984228|NCT01294462|1992319|FG000|Overall Study|Lost to Follow-up|1
984229|NCT01294462|1992320|FG001|Overall Study|Lost to Follow-up|0
984230|NCT01294462|1992319|FG000|Overall Study|Withdrawal by Subject|65
984231|NCT01294462|1992320|FG001|Overall Study|Withdrawal by Subject|63
984232|NCT01294514|1992326|FG000|Overall Study|Excluded due to Arrhythmia|1
984233|NCT01294553|1992334|FG000|Overall Study|Duplicated Participants|1
984234|NCT01294553|1992334|FG000|Overall Study|Protocol Violation|268
984235|NCT01294579|1992339|FG000|Overall Study|Disease progression|12
984236|NCT01294579|1992339|FG000|Overall Study|Adverse Event|11
984237|NCT01294579|1992339|FG000|Overall Study|Study closed/terminated|3
984238|NCT01294579|1992339|FG000|Overall Study|Lost to Follow-up|1
984239|NCT01294579|1992339|FG000|Overall Study|Physician Decision|3
984240|NCT01294579|1992339|FG000|Overall Study|Withdrawal by Subject|5
984241|NCT01294592|1992345|FG000|Overall Study|Adverse Event|28
984242|NCT01294592|1992346|FG001|Overall Study|Adverse Event|13
984243|NCT01294592|1992345|FG000|Overall Study|Lack of Efficacy|7
984244|NCT01294592|1992346|FG001|Overall Study|Lack of Efficacy|5
984245|NCT01294592|1992345|FG000|Overall Study|Protocol Violation|1
984246|NCT01294592|1992346|FG001|Overall Study|Protocol Violation|7
984247|NCT01294592|1992345|FG000|Overall Study|Lost to Follow-up|7
984248|NCT01294592|1992346|FG001|Overall Study|Lost to Follow-up|9
984249|NCT01294592|1992345|FG000|Overall Study|Physician Decision|6
984250|NCT01294592|1992346|FG001|Overall Study|Physician Decision|11
984251|NCT01294592|1992345|FG000|Overall Study|Withdrawal by Subject|28
984252|NCT01294592|1992346|FG001|Overall Study|Withdrawal by Subject|28
984253|NCT01294644|1992358|FG000|Overall Study|Adverse Event|2
984254|NCT01294644|1992359|FG001|Overall Study|Adverse Event|0
984255|NCT01294644|1992360|FG002|Overall Study|Adverse Event|1
984256|NCT01294644|1992358|FG000|Overall Study|Withdrawal by Subject|3
984257|NCT01294644|1992359|FG001|Overall Study|Withdrawal by Subject|7
984258|NCT01294644|1992360|FG002|Overall Study|Withdrawal by Subject|4
984259|NCT01294644|1992358|FG000|Overall Study|Lost to Follow-up|3
984260|NCT01294644|1992359|FG001|Overall Study|Lost to Follow-up|2
984261|NCT01294644|1992360|FG002|Overall Study|Lost to Follow-up|5
984262|NCT01294644|1992358|FG000|Overall Study|Miscellaneous Reason|2
984263|NCT01294644|1992359|FG001|Overall Study|Miscellaneous Reason|1
984264|NCT01294644|1992360|FG002|Overall Study|Miscellaneous Reason|4
984265|NCT01294683|1992370|FG000|Precrossover (Periods I/II)|Adverse Event|49
984266|NCT01294683|1992371|FG001|Precrossover (Periods I/II)|Adverse Event|52
984267|NCT01294683|1992370|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3
984268|NCT01294683|1992371|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6
984269|NCT01294683|1992370|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
984270|NCT01294683|1992371|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
984271|NCT01294683|1992370|FG000|Precrossover (Periods I/II)|Physician Decision|1
984272|NCT01294683|1992371|FG001|Precrossover (Periods I/II)|Physician Decision|0
984273|NCT01294683|1992370|FG000|Precrossover (Periods I/II)|Protocol Violation|5
984274|NCT01294683|1992371|FG001|Precrossover (Periods I/II)|Protocol Violation|5
984275|NCT01294683|1992370|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
984276|NCT01294683|1992371|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
984277|NCT01294683|1992370|FG000|Precrossover (Periods I/II)|Technical Problems|0
984278|NCT01294683|1992371|FG001|Precrossover (Periods I/II)|Technical Problems|1
984279|NCT01294683|1992370|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11
984280|NCT01294683|1992371|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9
984281|NCT01294683|1992370|FG000|Post Crossover (Period III)|Adverse Event|6
984282|NCT01294683|1992371|FG001|Post Crossover (Period III)|Adverse Event|6
984283|NCT01294683|1992370|FG000|Post Crossover (Period III)|Lost to Follow-up|1
984284|NCT01294683|1992371|FG001|Post Crossover (Period III)|Lost to Follow-up|3
984285|NCT01294683|1992370|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23
984286|NCT01294683|1992371|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21
984287|NCT01294683|1992370|FG000|Post Crossover (Period III)|Withdrawal by Subject|3
984288|NCT01294683|1992371|FG001|Post Crossover (Period III)|Withdrawal by Subject|2
984289|NCT01294696|1992385|FG000|Overall Study|Screening failures|7
984290|NCT01294696|1992385|FG000|Overall Study|Protocol Violation|8
984291|NCT01294696|1992385|FG000|Overall Study|Missing BPI Response|7
984292|NCT01294696|1992385|FG000|Overall Study|Site closure|52
984293|NCT01294787|1992411|FG000|Period 1|Adverse Event|0
984294|NCT01294787|1992412|FG001|Period 1|Adverse Event|0
984295|NCT01294787|1992413|FG002|Period 1|Adverse Event|0
984296|NCT01294787|1992414|FG003|Period 1|Adverse Event|0
984297|NCT01294787|1992415|FG004|Period 1|Adverse Event|1
984298|NCT01294787|1992416|FG005|Period 1|Adverse Event|0
984299|NCT01294787|1992411|FG000|Period 1|Withdrawal by Subject|0
984300|NCT01294787|1992412|FG001|Period 1|Withdrawal by Subject|0
984301|NCT01294787|1992413|FG002|Period 1|Withdrawal by Subject|0
984302|NCT01294787|1992414|FG003|Period 1|Withdrawal by Subject|1
984303|NCT01294787|1992415|FG004|Period 1|Withdrawal by Subject|1
984304|NCT01294787|1992416|FG005|Period 1|Withdrawal by Subject|1
984305|NCT01294787|1992411|FG000|Period 1|Administrative problem|0
984306|NCT01294787|1992412|FG001|Period 1|Administrative problem|0
984307|NCT01294787|1992413|FG002|Period 1|Administrative problem|1
984308|NCT01294787|1992414|FG003|Period 1|Administrative problem|0
984309|NCT01294787|1992415|FG004|Period 1|Administrative problem|0
984310|NCT01294787|1992416|FG005|Period 1|Administrative problem|1
984311|NCT01294787|1992411|FG000|Period 2|Adverse Event|0
984312|NCT01294787|1992412|FG001|Period 2|Adverse Event|3
984313|NCT01294787|1992413|FG002|Period 2|Adverse Event|0
984314|NCT01294787|1992414|FG003|Period 2|Adverse Event|1
984315|NCT01294787|1992415|FG004|Period 2|Adverse Event|0
984316|NCT01294787|1992416|FG005|Period 2|Adverse Event|0
984317|NCT01294787|1992411|FG000|Period 2|No longer needs study drug|0
984318|NCT01294787|1992412|FG001|Period 2|No longer needs study drug|0
984319|NCT01294787|1992413|FG002|Period 2|No longer needs study drug|0
984320|NCT01294787|1992414|FG003|Period 2|No longer needs study drug|1
984321|NCT01294787|1992415|FG004|Period 2|No longer needs study drug|0
984322|NCT01294787|1992416|FG005|Period 2|No longer needs study drug|0
984323|NCT01294787|1992411|FG000|Period 3|Adverse Event|0
984324|NCT01294787|1992412|FG001|Period 3|Adverse Event|0
984325|NCT01294787|1992413|FG002|Period 3|Adverse Event|0
984326|NCT01294787|1992414|FG003|Period 3|Adverse Event|0
984327|NCT01294787|1992415|FG004|Period 3|Adverse Event|1
984328|NCT01294787|1992416|FG005|Period 3|Adverse Event|0
984329|NCT01294800|1992431|FG000|Overall Study|Adverse Event|7
984330|NCT01294800|1992432|FG001|Overall Study|Adverse Event|6
984331|NCT01294800|1992433|FG002|Overall Study|Adverse Event|12
984332|NCT01294800|1992434|FG003|Overall Study|Adverse Event|5
984333|NCT01294800|1992431|FG000|Overall Study|Subject Withdrew Consent|2
984334|NCT01294800|1992432|FG001|Overall Study|Subject Withdrew Consent|2
984335|NCT01294800|1992433|FG002|Overall Study|Subject Withdrew Consent|2
984336|NCT01294800|1992434|FG003|Overall Study|Subject Withdrew Consent|11
984337|NCT01294800|1992431|FG000|Overall Study|Lost to Follow-up|0
984338|NCT01294800|1992432|FG001|Overall Study|Lost to Follow-up|0
984339|NCT01294800|1992433|FG002|Overall Study|Lost to Follow-up|1
984340|NCT01294800|1992434|FG003|Overall Study|Lost to Follow-up|0
984341|NCT01294800|1992431|FG000|Overall Study|Non-compliance With Protocol|0
984342|NCT01294800|1992432|FG001|Overall Study|Non-compliance With Protocol|1
984343|NCT01294800|1992433|FG002|Overall Study|Non-compliance With Protocol|1
984344|NCT01294800|1992434|FG003|Overall Study|Non-compliance With Protocol|0
984345|NCT01294800|1992431|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
984346|NCT01294800|1992432|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
984347|NCT01294800|1992433|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
984348|NCT01294800|1992434|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
984349|NCT01294917|1992444|FG000|Overall Study|Relocation|5
984350|NCT01294917|1992444|FG000|Overall Study|Inconvenience|1
984351|NCT01295034|1992452|FG000|Overall Study|Lost to Follow-up|5
984352|NCT01295034|1992453|FG001|Overall Study|Lost to Follow-up|5
984353|NCT01295281|1992480|FG000|First Intervention (7 Days)|Death|0
984354|NCT01295281|1992481|FG001|First Intervention (7 Days)|Death|1
984355|NCT01295320|1992487|FG000|Overall Study|Adverse Event|2
984356|NCT01295320|1992487|FG000|Overall Study|Lost to Follow-up|4
984357|NCT01295320|1992487|FG000|Overall Study|Withdrawal by Subject|2
984358|NCT01295320|1992487|FG000|Overall Study|Subject was bedridden|1
984359|NCT01295320|1992487|FG000|Overall Study|Unable to travel|1
984360|NCT01295580|1992497|FG000|Overall Study|Protocol Violation|4
984361|NCT01295580|1992498|FG001|Overall Study|Protocol Violation|2
984362|NCT01295580|1992497|FG000|Overall Study|Withdrawal by Subject|1
984363|NCT01295580|1992498|FG001|Overall Study|Withdrawal by Subject|4
984364|NCT01295580|1992497|FG000|Overall Study|Adverse Event|2
984365|NCT01295580|1992498|FG001|Overall Study|Adverse Event|1
984366|NCT01295580|1992497|FG000|Overall Study|Lost to Follow-up|1
984367|NCT01295580|1992498|FG001|Overall Study|Lost to Follow-up|0
984368|NCT01295580|1992497|FG000|Overall Study|Lack of Efficacy|1
984369|NCT01295580|1992498|FG001|Overall Study|Lack of Efficacy|0
984370|NCT01295580|1992497|FG000|Overall Study|Other: inconvenience|1
984371|NCT01295580|1992498|FG001|Overall Study|Other: inconvenience|0
984372|NCT01295580|1992497|FG000|Overall Study|Other: family objection|0
984373|NCT01295580|1992498|FG001|Overall Study|Other: family objection|1
984374|NCT01295671|1992507|FG000|Overall Study|Lost to Follow-up|4
984375|NCT01295671|1992508|FG001|Overall Study|Lost to Follow-up|6
984376|NCT01295671|1992509|FG002|Overall Study|Lost to Follow-up|3
984377|NCT01295671|1992507|FG000|Overall Study|Withdrawal by Subject|3
984378|NCT01295671|1992508|FG001|Overall Study|Withdrawal by Subject|1
984379|NCT01295671|1992509|FG002|Overall Study|Withdrawal by Subject|0
984380|NCT01295814|1992528|FG000|Overall Study|Lack of Efficacy|0
984381|NCT01295814|1992529|FG001|Overall Study|Lack of Efficacy|2
984382|NCT01295814|1992528|FG000|Overall Study|Withdrawal by Subject|2
984383|NCT01295814|1992529|FG001|Overall Study|Withdrawal by Subject|0
984384|NCT01295827|1992547|FG000|Overall Study|Adverse Event|1
984385|NCT01295827|1992548|FG001|Overall Study|Adverse Event|2
984386|NCT01295827|1992549|FG002|Overall Study|Adverse Event|2
984387|NCT01295827|1992550|FG003|Overall Study|Adverse Event|1
984388|NCT01295827|1992551|FG004|Overall Study|Adverse Event|1
984389|NCT01295827|1992552|FG005|Overall Study|Adverse Event|4
984390|NCT01295827|1992553|FG006|Overall Study|Adverse Event|15
984391|NCT01295827|1992554|FG007|Overall Study|Adverse Event|49
984392|NCT01295827|1992555|FG008|Overall Study|Adverse Event|22
984393|NCT01295827|1992556|FG009|Overall Study|Adverse Event|7
984394|NCT01295827|1992557|FG010|Overall Study|Adverse Event|50
984395|NCT01295827|1992558|FG011|Overall Study|Adverse Event|21
984396|NCT01295827|1992559|FG012|Overall Study|Adverse Event|0
984397|NCT01295827|1992560|FG013|Overall Study|Adverse Event|0
984398|NCT01295827|1992561|FG014|Overall Study|Adverse Event|0
984399|NCT01295827|1992547|FG000|Overall Study|Lost to Follow-up|0
984400|NCT01295827|1992548|FG001|Overall Study|Lost to Follow-up|0
984401|NCT01295827|1992549|FG002|Overall Study|Lost to Follow-up|3
984402|NCT01295827|1992550|FG003|Overall Study|Lost to Follow-up|0
984403|NCT01295827|1992551|FG004|Overall Study|Lost to Follow-up|1
984404|NCT01295827|1992552|FG005|Overall Study|Lost to Follow-up|0
984405|NCT01295827|1992553|FG006|Overall Study|Lost to Follow-up|4
984406|NCT01295827|1992554|FG007|Overall Study|Lost to Follow-up|8
984407|NCT01295827|1992555|FG008|Overall Study|Lost to Follow-up|7
984408|NCT01295827|1992556|FG009|Overall Study|Lost to Follow-up|4
984409|NCT01295827|1992557|FG010|Overall Study|Lost to Follow-up|7
984410|NCT01295827|1992558|FG011|Overall Study|Lost to Follow-up|3
984411|NCT01295827|1992559|FG012|Overall Study|Lost to Follow-up|0
984412|NCT01295827|1992560|FG013|Overall Study|Lost to Follow-up|0
984413|NCT01295827|1992561|FG014|Overall Study|Lost to Follow-up|0
984414|NCT01295827|1992547|FG000|Overall Study|Not Reported|0
984415|NCT01295827|1992548|FG001|Overall Study|Not Reported|0
984416|NCT01295827|1992549|FG002|Overall Study|Not Reported|0
984417|NCT01295827|1992550|FG003|Overall Study|Not Reported|1
984418|NCT01295827|1992551|FG004|Overall Study|Not Reported|0
984419|NCT01295827|1992552|FG005|Overall Study|Not Reported|0
984420|NCT01295827|1992553|FG006|Overall Study|Not Reported|24
984421|NCT01295827|1992554|FG007|Overall Study|Not Reported|58
984422|NCT01295827|1992555|FG008|Overall Study|Not Reported|41
984423|NCT01295827|1992556|FG009|Overall Study|Not Reported|2
984424|NCT01295827|1992557|FG010|Overall Study|Not Reported|23
984425|NCT01295827|1992558|FG011|Overall Study|Not Reported|13
984426|NCT01295827|1992559|FG012|Overall Study|Not Reported|0
984427|NCT01295827|1992560|FG013|Overall Study|Not Reported|0
984428|NCT01295827|1992561|FG014|Overall Study|Not Reported|0
984429|NCT01295827|1992547|FG000|Overall Study|Progressive Disease|2
984430|NCT01295827|1992548|FG001|Overall Study|Progressive Disease|1
984431|NCT01295827|1992549|FG002|Overall Study|Progressive Disease|5
984432|NCT01295827|1992550|FG003|Overall Study|Progressive Disease|2
984433|NCT01295827|1992551|FG004|Overall Study|Progressive Disease|0
984434|NCT01295827|1992552|FG005|Overall Study|Progressive Disease|1
984435|NCT01295827|1992553|FG006|Overall Study|Progressive Disease|87
984436|NCT01295827|1992554|FG007|Overall Study|Progressive Disease|144
984437|NCT01295827|1992555|FG008|Overall Study|Progressive Disease|85
984438|NCT01295827|1992556|FG009|Overall Study|Progressive Disease|40
984439|NCT01295827|1992557|FG010|Overall Study|Progressive Disease|175
984440|NCT01295827|1992558|FG011|Overall Study|Progressive Disease|136
984441|NCT01295827|1992559|FG012|Overall Study|Progressive Disease|0
984442|NCT01295827|1992560|FG013|Overall Study|Progressive Disease|0
984443|NCT01295827|1992561|FG014|Overall Study|Progressive Disease|0
984444|NCT01295827|1992547|FG000|Overall Study|Screen Failure|0
984445|NCT01295827|1992548|FG001|Overall Study|Screen Failure|0
984446|NCT01295827|1992549|FG002|Overall Study|Screen Failure|0
984447|NCT01295827|1992550|FG003|Overall Study|Screen Failure|0
984448|NCT01295827|1992551|FG004|Overall Study|Screen Failure|0
984449|NCT01295827|1992552|FG005|Overall Study|Screen Failure|0
984450|NCT01295827|1992553|FG006|Overall Study|Screen Failure|2
984451|NCT01295827|1992554|FG007|Overall Study|Screen Failure|2
984452|NCT01295827|1992555|FG008|Overall Study|Screen Failure|2
984453|NCT01295827|1992556|FG009|Overall Study|Screen Failure|0
984454|NCT01295827|1992557|FG010|Overall Study|Screen Failure|1
984455|NCT01295827|1992558|FG011|Overall Study|Screen Failure|0
984456|NCT01295827|1992559|FG012|Overall Study|Screen Failure|0
984457|NCT01295827|1992560|FG013|Overall Study|Screen Failure|0
984458|NCT01295827|1992561|FG014|Overall Study|Screen Failure|0
984459|NCT01295827|1992547|FG000|Overall Study|Withdrawal by Subject|1
984460|NCT01295827|1992548|FG001|Overall Study|Withdrawal by Subject|0
984461|NCT01295827|1992549|FG002|Overall Study|Withdrawal by Subject|2
984462|NCT01295827|1992550|FG003|Overall Study|Withdrawal by Subject|0
984463|NCT01295827|1992551|FG004|Overall Study|Withdrawal by Subject|0
984464|NCT01295827|1992552|FG005|Overall Study|Withdrawal by Subject|1
912737|NCT00806585|1890264|FG004|Overall Study|Withdrawal by Subject|11
912738|NCT00806585|1890260|FG000|Overall Study|Completion status unknown|15
984465|NCT01295827|1992553|FG006|Overall Study|Withdrawal by Subject|13
984466|NCT01295827|1992554|FG007|Overall Study|Withdrawal by Subject|35
984467|NCT01295827|1992555|FG008|Overall Study|Withdrawal by Subject|11
984468|NCT01295827|1992556|FG009|Overall Study|Withdrawal by Subject|2
984469|NCT01295827|1992557|FG010|Overall Study|Withdrawal by Subject|18
984470|NCT01295827|1992558|FG011|Overall Study|Withdrawal by Subject|13
984471|NCT01295827|1992559|FG012|Overall Study|Withdrawal by Subject|0
984472|NCT01295827|1992560|FG013|Overall Study|Withdrawal by Subject|0
984473|NCT01295827|1992561|FG014|Overall Study|Withdrawal by Subject|0
984474|NCT01295827|1992547|FG000|Overall Study|Other|0
984475|NCT01295827|1992548|FG001|Overall Study|Other|0
984476|NCT01295827|1992549|FG002|Overall Study|Other|0
984477|NCT01295827|1992550|FG003|Overall Study|Other|0
984478|NCT01295827|1992551|FG004|Overall Study|Other|0
984479|NCT01295827|1992552|FG005|Overall Study|Other|0
984480|NCT01295827|1992553|FG006|Overall Study|Other|1
984481|NCT01295827|1992554|FG007|Overall Study|Other|1
984482|NCT01295827|1992555|FG008|Overall Study|Other|1
984483|NCT01295827|1992556|FG009|Overall Study|Other|0
984484|NCT01295827|1992557|FG010|Overall Study|Other|2
984485|NCT01295827|1992558|FG011|Overall Study|Other|0
984486|NCT01295827|1992559|FG012|Overall Study|Other|0
984487|NCT01295827|1992560|FG013|Overall Study|Other|0
984488|NCT01295827|1992561|FG014|Overall Study|Other|0
984489|NCT01295905|1992626|FG000|Overall Study|Did not meet inclusion criteria|1
984490|NCT01295905|1992627|FG001|Overall Study|Did not meet inclusion criteria|0
984491|NCT01295905|1992626|FG000|Overall Study|Met exclusion criteria|1
984492|NCT01295905|1992627|FG001|Overall Study|Met exclusion criteria|0
984493|NCT01296035|1992633|FG000|Overall Study|Withdrawal by Subject|1
984494|NCT01296152|1992637|FG000|Overall Study|Unwilling to adhere to study requirement|1
984495|NCT01296347|1992652|FG000|Allocation|Withdrawal by Subject|1
984496|NCT01296347|1992653|FG001|Allocation|Withdrawal by Subject|2
984497|NCT01296347|1992652|FG000|Allocation|Lack of Efficacy|1
984498|NCT01296347|1992653|FG001|Allocation|Lack of Efficacy|2
984499|NCT01296347|1992652|FG000|Allocation|not received infusion|1
984500|NCT01296347|1992653|FG001|Allocation|not received infusion|0
984501|NCT01296347|1992652|FG000|6 Week Follow up|Death|0
984502|NCT01296347|1992653|FG001|6 Week Follow up|Death|1
984503|NCT01296347|1992652|FG000|3 Month Follow up|Death|1
984504|NCT01296347|1992653|FG001|3 Month Follow up|Death|0
984505|NCT01296347|1992652|FG000|3 Month Follow up|Lost to Follow-up|0
984506|NCT01296347|1992653|FG001|3 Month Follow up|Lost to Follow-up|1
984507|NCT01296347|1992652|FG000|6 Month Follow up|Death|2
984508|NCT01296347|1992653|FG001|6 Month Follow up|Death|1
984509|NCT01296347|1992652|FG000|6 Month Follow up|Lost to Follow-up|0
984510|NCT01296347|1992653|FG001|6 Month Follow up|Lost to Follow-up|1
984511|NCT01296347|1992652|FG000|12 Month Follow up|Lost to Follow-up|3
984512|NCT01296347|1992653|FG001|12 Month Follow up|Lost to Follow-up|1
984513|NCT01296347|1992652|FG000|12 Month Follow up|Death|1
984514|NCT01296347|1992653|FG001|12 Month Follow up|Death|1
984515|NCT01296347|1992652|FG000|12 Month Follow up|Withdrawal by Subject|0
984516|NCT01296347|1992653|FG001|12 Month Follow up|Withdrawal by Subject|1
984517|NCT01296412|1992673|FG000|Overall Study|Adverse Event|8
984518|NCT01296412|1992674|FG001|Overall Study|Adverse Event|29
984519|NCT01296412|1992673|FG000|Overall Study|Lack of Efficacy|1
984520|NCT01296412|1992674|FG001|Overall Study|Lack of Efficacy|0
984521|NCT01296412|1992673|FG000|Overall Study|Lost to Follow-up|10
984522|NCT01296412|1992674|FG001|Overall Study|Lost to Follow-up|7
912739|NCT00806585|1890261|FG001|Overall Study|Completion status unknown|14
912740|NCT00806585|1890262|FG002|Overall Study|Completion status unknown|12
912741|NCT00806585|1890263|FG003|Overall Study|Completion status unknown|4
912742|NCT00806585|1890264|FG004|Overall Study|Completion status unknown|12
912743|NCT00806624|1890283|FG000|Overall Study|Adverse Event|2
912744|NCT00806624|1890284|FG001|Overall Study|Adverse Event|8
912745|NCT00806624|1890285|FG002|Overall Study|Adverse Event|0
912746|NCT00806624|1890283|FG000|Overall Study|Death|0
912747|NCT00806624|1890284|FG001|Overall Study|Death|1
912748|NCT00806624|1890285|FG002|Overall Study|Death|1
912749|NCT00806624|1890283|FG000|Overall Study|Lost to Follow-up|1
912750|NCT00806624|1890284|FG001|Overall Study|Lost to Follow-up|0
984523|NCT01296412|1992673|FG000|Overall Study|Non-compliance with study drug|1
984524|NCT01296412|1992674|FG001|Overall Study|Non-compliance with study drug|2
984525|NCT01296412|1992673|FG000|Overall Study|Other reason not specified|20
984526|NCT01296412|1992674|FG001|Overall Study|Other reason not specified|15
984527|NCT01296412|1992673|FG000|Overall Study|Physician Decision|1
984528|NCT01296412|1992674|FG001|Overall Study|Physician Decision|3
984529|NCT01296412|1992673|FG000|Overall Study|Pregnancy|0
984530|NCT01296412|1992674|FG001|Overall Study|Pregnancy|1
984531|NCT01296412|1992673|FG000|Overall Study|Withdrawal by Subject|10
984532|NCT01296412|1992674|FG001|Overall Study|Withdrawal by Subject|13
984533|NCT01296568|1992689|FG000|Continued Access Phase|Lost to Follow-up|1
984534|NCT01296568|1992689|FG000|Continued Access Phase|Withdrawal by Subject|1
984535|NCT01296568|1992689|FG000|Continued Access Phase|Disease Progression|1
984536|NCT01296672|1992706|FG000|Overall Study|Lost to Follow-up|73
984537|NCT01296672|1992707|FG001|Overall Study|Lost to Follow-up|18
984538|NCT01296698|1992717|FG000|Overall Study|Adverse Event|1
984539|NCT01296698|1992718|FG001|Overall Study|Adverse Event|0
984540|NCT01296698|1992717|FG000|Overall Study|Death|1
984541|NCT01296698|1992718|FG001|Overall Study|Death|0
984542|NCT01296698|1992717|FG000|Overall Study|Lost to Follow-up|19
984543|NCT01296698|1992718|FG001|Overall Study|Lost to Follow-up|1
984544|NCT01296698|1992717|FG000|Overall Study|Withdrawal by Subject|12
984545|NCT01296698|1992718|FG001|Overall Study|Withdrawal by Subject|0
984546|NCT01296698|1992717|FG000|Overall Study|Difficulty Contacting Subject|2
984547|NCT01296698|1992718|FG001|Overall Study|Difficulty Contacting Subject|0
984548|NCT01296698|1992717|FG000|Overall Study|Study Terminated by Sponsor|209
984549|NCT01296698|1992718|FG001|Overall Study|Study Terminated by Sponsor|12
984550|NCT01296932|1992766|FG000|Overall Study|Dose limiting toxicity|0
984551|NCT01296932|1992767|FG001|Overall Study|Dose limiting toxicity|0
984552|NCT01296932|1992768|FG002|Overall Study|Dose limiting toxicity|0
984553|NCT01296932|1992769|FG003|Overall Study|Dose limiting toxicity|0
984554|NCT01296932|1992770|FG004|Overall Study|Dose limiting toxicity|0
984555|NCT01296932|1992771|FG005|Overall Study|Dose limiting toxicity|0
984556|NCT01296932|1992772|FG006|Overall Study|Dose limiting toxicity|1
984557|NCT01296932|1992773|FG007|Overall Study|Dose limiting toxicity|0
984558|NCT01296932|1992774|FG008|Overall Study|Dose limiting toxicity|1
984559|NCT01296932|1992766|FG000|Overall Study|Progressive disease|2
984560|NCT01296932|1992767|FG001|Overall Study|Progressive disease|0
984561|NCT01296932|1992768|FG002|Overall Study|Progressive disease|1
984562|NCT01296932|1992769|FG003|Overall Study|Progressive disease|1
984563|NCT01296932|1992770|FG004|Overall Study|Progressive disease|2
984564|NCT01296932|1992771|FG005|Overall Study|Progressive disease|3
984565|NCT01296932|1992772|FG006|Overall Study|Progressive disease|1
984566|NCT01296932|1992773|FG007|Overall Study|Progressive disease|0
984567|NCT01296932|1992774|FG008|Overall Study|Progressive disease|0
984568|NCT01296932|1992766|FG000|Overall Study|Withdrawal by Subject|0
984569|NCT01296932|1992767|FG001|Overall Study|Withdrawal by Subject|0
984570|NCT01296932|1992768|FG002|Overall Study|Withdrawal by Subject|1
984571|NCT01296932|1992769|FG003|Overall Study|Withdrawal by Subject|1
984572|NCT01296932|1992770|FG004|Overall Study|Withdrawal by Subject|0
984573|NCT01296932|1992771|FG005|Overall Study|Withdrawal by Subject|0
984574|NCT01296932|1992772|FG006|Overall Study|Withdrawal by Subject|3
984575|NCT01296932|1992773|FG007|Overall Study|Withdrawal by Subject|0
984576|NCT01296932|1992774|FG008|Overall Study|Withdrawal by Subject|0
984577|NCT01296932|1992766|FG000|Overall Study|Adverse Event|1
984578|NCT01296932|1992767|FG001|Overall Study|Adverse Event|1
984579|NCT01296932|1992768|FG002|Overall Study|Adverse Event|1
984580|NCT01296932|1992769|FG003|Overall Study|Adverse Event|2
984581|NCT01296932|1992770|FG004|Overall Study|Adverse Event|1
984582|NCT01296932|1992771|FG005|Overall Study|Adverse Event|0
984583|NCT01296932|1992772|FG006|Overall Study|Adverse Event|0
984584|NCT01296932|1992773|FG007|Overall Study|Adverse Event|0
984585|NCT01296932|1992774|FG008|Overall Study|Adverse Event|1
984586|NCT01296932|1992766|FG000|Overall Study|Investigator decision|0
984587|NCT01296932|1992767|FG001|Overall Study|Investigator decision|1
984588|NCT01296932|1992768|FG002|Overall Study|Investigator decision|0
984589|NCT01296932|1992769|FG003|Overall Study|Investigator decision|1
984590|NCT01296932|1992770|FG004|Overall Study|Investigator decision|0
984591|NCT01296932|1992771|FG005|Overall Study|Investigator decision|0
984592|NCT01296932|1992772|FG006|Overall Study|Investigator decision|1
984593|NCT01296932|1992773|FG007|Overall Study|Investigator decision|0
984594|NCT01296932|1992774|FG008|Overall Study|Investigator decision|1
984595|NCT01296932|1992766|FG000|Overall Study|No clinical benefit anymore|0
984596|NCT01296932|1992767|FG001|Overall Study|No clinical benefit anymore|1
984597|NCT01296932|1992768|FG002|Overall Study|No clinical benefit anymore|0
984598|NCT01296932|1992769|FG003|Overall Study|No clinical benefit anymore|0
984599|NCT01296932|1992770|FG004|Overall Study|No clinical benefit anymore|0
984600|NCT01296932|1992771|FG005|Overall Study|No clinical benefit anymore|0
984601|NCT01296932|1992772|FG006|Overall Study|No clinical benefit anymore|0
984602|NCT01296932|1992773|FG007|Overall Study|No clinical benefit anymore|0
984603|NCT01296932|1992774|FG008|Overall Study|No clinical benefit anymore|0
984604|NCT01296932|1992766|FG000|Overall Study|Physician Decision|0
984605|NCT01296932|1992767|FG001|Overall Study|Physician Decision|0
984606|NCT01296932|1992768|FG002|Overall Study|Physician Decision|1
984607|NCT01296932|1992769|FG003|Overall Study|Physician Decision|0
984608|NCT01296932|1992770|FG004|Overall Study|Physician Decision|0
984609|NCT01296932|1992771|FG005|Overall Study|Physician Decision|0
984610|NCT01296932|1992772|FG006|Overall Study|Physician Decision|0
984611|NCT01296932|1992773|FG007|Overall Study|Physician Decision|0
984612|NCT01296932|1992774|FG008|Overall Study|Physician Decision|0
984613|NCT01296932|1992766|FG000|Overall Study|IV problems, administration not possible|0
984614|NCT01296932|1992767|FG001|Overall Study|IV problems, administration not possible|0
984615|NCT01296932|1992768|FG002|Overall Study|IV problems, administration not possible|1
984616|NCT01296932|1992769|FG003|Overall Study|IV problems, administration not possible|0
984617|NCT01296932|1992770|FG004|Overall Study|IV problems, administration not possible|0
984618|NCT01296932|1992771|FG005|Overall Study|IV problems, administration not possible|0
984619|NCT01296932|1992772|FG006|Overall Study|IV problems, administration not possible|0
984620|NCT01296932|1992773|FG007|Overall Study|IV problems, administration not possible|0
984621|NCT01296932|1992774|FG008|Overall Study|IV problems, administration not possible|0
984622|NCT01296932|1992766|FG000|Overall Study|per protocol|0
984623|NCT01296932|1992767|FG001|Overall Study|per protocol|0
984624|NCT01296932|1992768|FG002|Overall Study|per protocol|1
984625|NCT01296932|1992769|FG003|Overall Study|per protocol|1
984626|NCT01296932|1992770|FG004|Overall Study|per protocol|0
984627|NCT01296932|1992771|FG005|Overall Study|per protocol|0
984628|NCT01296932|1992772|FG006|Overall Study|per protocol|0
984629|NCT01296932|1992773|FG007|Overall Study|per protocol|0
984630|NCT01296932|1992774|FG008|Overall Study|per protocol|0
984631|NCT01296932|1992766|FG000|Overall Study|Low benefit and too many side effects|0
984632|NCT01296932|1992767|FG001|Overall Study|Low benefit and too many side effects|0
984633|NCT01296932|1992768|FG002|Overall Study|Low benefit and too many side effects|0
984634|NCT01296932|1992769|FG003|Overall Study|Low benefit and too many side effects|0
984635|NCT01296932|1992770|FG004|Overall Study|Low benefit and too many side effects|0
984636|NCT01296932|1992771|FG005|Overall Study|Low benefit and too many side effects|0
984637|NCT01296932|1992772|FG006|Overall Study|Low benefit and too many side effects|0
984638|NCT01296932|1992773|FG007|Overall Study|Low benefit and too many side effects|1
984639|NCT01296932|1992774|FG008|Overall Study|Low benefit and too many side effects|0
984640|NCT01296932|1992766|FG000|Overall Study|No adequate treatment response|0
984641|NCT01296932|1992767|FG001|Overall Study|No adequate treatment response|0
984642|NCT01296932|1992768|FG002|Overall Study|No adequate treatment response|0
984643|NCT01296932|1992769|FG003|Overall Study|No adequate treatment response|0
984644|NCT01296932|1992770|FG004|Overall Study|No adequate treatment response|0
984645|NCT01296932|1992771|FG005|Overall Study|No adequate treatment response|0
984646|NCT01296932|1992772|FG006|Overall Study|No adequate treatment response|0
984647|NCT01296932|1992773|FG007|Overall Study|No adequate treatment response|1
984648|NCT01296932|1992774|FG008|Overall Study|No adequate treatment response|0
984649|NCT01296932|1992766|FG000|Overall Study|Dosage already reduced, AE still present|0
984650|NCT01296932|1992767|FG001|Overall Study|Dosage already reduced, AE still present|0
984651|NCT01296932|1992768|FG002|Overall Study|Dosage already reduced, AE still present|0
984652|NCT01296932|1992769|FG003|Overall Study|Dosage already reduced, AE still present|0
984653|NCT01296932|1992770|FG004|Overall Study|Dosage already reduced, AE still present|0
984654|NCT01296932|1992771|FG005|Overall Study|Dosage already reduced, AE still present|0
984655|NCT01296932|1992772|FG006|Overall Study|Dosage already reduced, AE still present|0
984656|NCT01296932|1992773|FG007|Overall Study|Dosage already reduced, AE still present|0
984657|NCT01296932|1992774|FG008|Overall Study|Dosage already reduced, AE still present|1
984658|NCT01297062|1992801|FG000|Overall Study|Adverse Event|2
984659|NCT01297062|1992802|FG001|Overall Study|Adverse Event|0
984660|NCT01297062|1992803|FG002|Overall Study|Adverse Event|1
984661|NCT01297062|1992804|FG003|Overall Study|Adverse Event|0
984662|NCT01297062|1992805|FG004|Overall Study|Adverse Event|0
984663|NCT01297062|1992806|FG005|Overall Study|Adverse Event|0
984664|NCT01297062|1992807|FG006|Overall Study|Adverse Event|0
984665|NCT01297062|1992801|FG000|Overall Study|Physician Decision|1
984666|NCT01297062|1992802|FG001|Overall Study|Physician Decision|0
984667|NCT01297062|1992803|FG002|Overall Study|Physician Decision|1
984668|NCT01297062|1992804|FG003|Overall Study|Physician Decision|0
984669|NCT01297062|1992805|FG004|Overall Study|Physician Decision|0
984670|NCT01297062|1992806|FG005|Overall Study|Physician Decision|0
984671|NCT01297062|1992807|FG006|Overall Study|Physician Decision|6
984672|NCT01297062|1992801|FG000|Overall Study|Protocol Violation|0
984673|NCT01297062|1992802|FG001|Overall Study|Protocol Violation|0
984674|NCT01297062|1992803|FG002|Overall Study|Protocol Violation|0
984675|NCT01297062|1992804|FG003|Overall Study|Protocol Violation|0
984676|NCT01297062|1992805|FG004|Overall Study|Protocol Violation|1
984677|NCT01297062|1992806|FG005|Overall Study|Protocol Violation|0
984678|NCT01297062|1992807|FG006|Overall Study|Protocol Violation|0
984679|NCT01297062|1992801|FG000|Overall Study|Subject Decision|1
984680|NCT01297062|1992802|FG001|Overall Study|Subject Decision|1
984681|NCT01297062|1992803|FG002|Overall Study|Subject Decision|0
984682|NCT01297062|1992804|FG003|Overall Study|Subject Decision|1
984683|NCT01297062|1992805|FG004|Overall Study|Subject Decision|1
984684|NCT01297062|1992806|FG005|Overall Study|Subject Decision|1
984685|NCT01297062|1992807|FG006|Overall Study|Subject Decision|2
984686|NCT01297244|1992817|FG000|Overall Study|Progressive disease|22
984687|NCT01297244|1992818|FG001|Overall Study|Progressive disease|3
984688|NCT01297244|1992817|FG000|Overall Study|Adverse Event|9
984689|NCT01297244|1992818|FG001|Overall Study|Adverse Event|1
984690|NCT01297244|1992817|FG000|Overall Study|Death|1
984691|NCT01297244|1992818|FG001|Overall Study|Death|1
984692|NCT01297244|1992817|FG000|Overall Study|Clinical progression|1
984693|NCT01297244|1992818|FG001|Overall Study|Clinical progression|1
984694|NCT01297244|1992817|FG000|Overall Study|Withdrawal by Subject|2
984695|NCT01297244|1992818|FG001|Overall Study|Withdrawal by Subject|0
984696|NCT01297270|1992833|FG000|Overall Study|Adverse Event|19
984697|NCT01297270|1992834|FG001|Overall Study|Adverse Event|32
984698|NCT01297270|1992835|FG002|Overall Study|Adverse Event|5
984699|NCT01297270|1992833|FG000|Overall Study|Lack of Efficacy|15
984700|NCT01297270|1992834|FG001|Overall Study|Lack of Efficacy|17
984701|NCT01297270|1992835|FG002|Overall Study|Lack of Efficacy|15
984702|NCT01297270|1992833|FG000|Overall Study|Lost to Follow-up|1
984703|NCT01297270|1992834|FG001|Overall Study|Lost to Follow-up|2
984704|NCT01297270|1992835|FG002|Overall Study|Lost to Follow-up|1
984705|NCT01297270|1992833|FG000|Overall Study|Protocol Violation|0
984706|NCT01297270|1992834|FG001|Overall Study|Protocol Violation|2
984707|NCT01297270|1992835|FG002|Overall Study|Protocol Violation|0
984708|NCT01297270|1992833|FG000|Overall Study|Withdrawal by Subject|7
984709|NCT01297270|1992834|FG001|Overall Study|Withdrawal by Subject|15
984710|NCT01297270|1992835|FG002|Overall Study|Withdrawal by Subject|7
984711|NCT01297270|1992833|FG000|Overall Study|Other reason not defined above|3
984712|NCT01297270|1992834|FG001|Overall Study|Other reason not defined above|3
984713|NCT01297270|1992835|FG002|Overall Study|Other reason not defined above|1
984714|NCT01297270|1992833|FG000|Overall Study|Not treated|0
984715|NCT01297270|1992834|FG001|Overall Study|Not treated|1
984716|NCT01297270|1992835|FG002|Overall Study|Not treated|0
984717|NCT01297309|1992847|FG000|Overall Study|Eligibility failure|2
984718|NCT01297309|1992847|FG000|Overall Study|Screen failure|2
984719|NCT01297309|1992847|FG000|Overall Study|Withdrawal by Subject|5
984720|NCT01297309|1992847|FG000|Overall Study|Adverse Event|1
984721|NCT01297309|1992847|FG000|Overall Study|Investigator Decision|2
984722|NCT01297309|1992847|FG000|Overall Study|Death|1
984723|NCT01297309|1992847|FG000|Overall Study|Participant not entering extensionperiod|1
984724|NCT01297322|1992853|FG000|Overall Study|Lost to Follow-up|1
984725|NCT01297322|1992854|FG001|Overall Study|Lost to Follow-up|0
984726|NCT01297322|1992853|FG000|Overall Study|Withdrawal by Subject|0
984727|NCT01297322|1992854|FG001|Overall Study|Withdrawal by Subject|1
984728|NCT01297322|1992853|FG000|Overall Study|Protocol Violation|0
984729|NCT01297322|1992854|FG001|Overall Study|Protocol Violation|3
984730|NCT01297465|1992879|FG000|Overall Study|Lack of Ovarian Response|1
984731|NCT01297465|1992880|FG001|Overall Study|Lack of Ovarian Response|1
984732|NCT01297465|1992879|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0
984733|NCT01297465|1992880|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
984734|NCT01297465|1992879|FG000|Overall Study|No Oocytes Retrieved|1
984735|NCT01297465|1992880|FG001|Overall Study|No Oocytes Retrieved|1
984736|NCT01297465|1992879|FG000|Overall Study|Poor oocyte quality|0
984737|NCT01297465|1992880|FG001|Overall Study|Poor oocyte quality|1
984738|NCT01297465|1992879|FG000|Overall Study|No Fertilization|6
984739|NCT01297465|1992880|FG001|Overall Study|No Fertilization|4
984740|NCT01297465|1992879|FG000|Overall Study|All Embryos Discarded|0
984741|NCT01297465|1992880|FG001|Overall Study|All Embryos Discarded|1
984742|NCT01297465|1992879|FG000|Overall Study|Intention to Freeze all Embryos|0
984743|NCT01297465|1992880|FG001|Overall Study|Intention to Freeze all Embryos|1
984744|NCT01297491|1992888|FG000|Overall Study|Adverse Event|11
984745|NCT01297491|1992889|FG001|Overall Study|Adverse Event|6
984746|NCT01297491|1992888|FG000|Overall Study|Physician Decision|3
984747|NCT01297491|1992889|FG001|Overall Study|Physician Decision|2
984748|NCT01297491|1992888|FG000|Overall Study|Progressive disease|11
984749|NCT01297491|1992889|FG001|Overall Study|Progressive disease|20
984750|NCT01297491|1992888|FG000|Overall Study|Patient/Guardian decision|3
984751|NCT01297491|1992889|FG001|Overall Study|Patient/Guardian decision|4
984752|NCT01297491|1992888|FG000|Overall Study|Death|2
984753|NCT01297491|1992889|FG001|Overall Study|Death|1
984754|NCT01297504|1992895|FG000|Overall Study|Invalid Consent|1
984755|NCT01297504|1992895|FG000|Overall Study|Received Palivizumab in Previous Season|1
984756|NCT01297504|1992895|FG000|Overall Study|No Study Visits|4
984757|NCT01297504|1992895|FG000|Overall Study|Death|3
984758|NCT01297504|1992895|FG000|Overall Study|Lost to Follow-up|43
984759|NCT01297504|1992895|FG000|Overall Study|Withdrawal by Subject|9
984760|NCT01297504|1992895|FG000|Overall Study|Site Closure|3
984761|NCT01297504|1992895|FG000|Overall Study|Protocol Violation|3
984762|NCT01297517|1992906|FG000|Overall Study|Adverse Event|21
984763|NCT01297517|1992907|FG001|Overall Study|Adverse Event|7
984764|NCT01297517|1992908|FG002|Overall Study|Adverse Event|16
984765|NCT01297517|1992906|FG000|Overall Study|Lost to Follow-up|1
984766|NCT01297517|1992907|FG001|Overall Study|Lost to Follow-up|0
984767|NCT01297517|1992908|FG002|Overall Study|Lost to Follow-up|1
984768|NCT01297517|1992906|FG000|Overall Study|Patient Decision Unrelated to AE|2
984769|NCT01297517|1992907|FG001|Overall Study|Patient Decision Unrelated to AE|3
984770|NCT01297517|1992908|FG002|Overall Study|Patient Decision Unrelated to AE|7
984771|NCT01297517|1992906|FG000|Overall Study|Noncompliance|1
984772|NCT01297517|1992907|FG001|Overall Study|Noncompliance|0
984773|NCT01297517|1992908|FG002|Overall Study|Noncompliance|0
984774|NCT01297517|1992906|FG000|Overall Study|Protocol Violation|1
984775|NCT01297517|1992907|FG001|Overall Study|Protocol Violation|1
984776|NCT01297517|1992908|FG002|Overall Study|Protocol Violation|1
984777|NCT01297517|1992906|FG000|Overall Study|Inadequate Control of IOP|1
984778|NCT01297517|1992907|FG001|Overall Study|Inadequate Control of IOP|1
984779|NCT01297517|1992908|FG002|Overall Study|Inadequate Control of IOP|2
984780|NCT01297920|1992926|FG000|Overall Study|Adverse Event|42
984781|NCT01297920|1992927|FG001|Overall Study|Adverse Event|10
984782|NCT01297920|1992928|FG002|Overall Study|Adverse Event|38
984783|NCT01297920|1992926|FG000|Overall Study|Patient Decision Unrelated to AE|6
984784|NCT01297920|1992927|FG001|Overall Study|Patient Decision Unrelated to AE|5
984785|NCT01297920|1992928|FG002|Overall Study|Patient Decision Unrelated to AE|2
984786|NCT01297920|1992926|FG000|Overall Study|Noncompliance|1
984787|NCT01297920|1992927|FG001|Overall Study|Noncompliance|0
984788|NCT01297920|1992928|FG002|Overall Study|Noncompliance|0
984789|NCT01297920|1992926|FG000|Overall Study|Protocol Violation|1
984790|NCT01297920|1992927|FG001|Overall Study|Protocol Violation|3
984791|NCT01297920|1992928|FG002|Overall Study|Protocol Violation|0
984792|NCT01297920|1992926|FG000|Overall Study|Inadequate Control of IOP|7
984793|NCT01297920|1992927|FG001|Overall Study|Inadequate Control of IOP|9
984794|NCT01297920|1992928|FG002|Overall Study|Inadequate Control of IOP|17
984795|NCT01297920|1992926|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1
984796|NCT01297920|1992927|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0
984797|NCT01297920|1992928|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0
984798|NCT01297959|1992938|FG000|Overall Study|Adverse Event|0
984799|NCT01297959|1992939|FG001|Overall Study|Adverse Event|1
984800|NCT01297959|1992938|FG000|Overall Study|Protocol Violation|2
984801|NCT01297959|1992939|FG001|Overall Study|Protocol Violation|1
984802|NCT01297959|1992938|FG000|Overall Study|Withdrawal by Subject|5
984803|NCT01297959|1992939|FG001|Overall Study|Withdrawal by Subject|4
984804|NCT01297959|1992938|FG000|Overall Study|Physician Decision|0
984805|NCT01297959|1992939|FG001|Overall Study|Physician Decision|1
984806|NCT01297959|1992938|FG000|Overall Study|Unrelated medical illness / complication|0
984807|NCT01297959|1992939|FG001|Overall Study|Unrelated medical illness / complication|2
984808|NCT01297959|1992938|FG000|Overall Study|Other|13
984809|NCT01297959|1992939|FG001|Overall Study|Other|7
984810|NCT01298141|1992985|FG000|Overall Study|Adverse Event|3
984811|NCT01298141|1992985|FG000|Overall Study|Refusal of Required Study Procedures|1
912751|NCT00806624|1890285|FG002|Overall Study|Lost to Follow-up|1
912752|NCT00806624|1890283|FG000|Overall Study|Withdrawal by Subject|6
912753|NCT00806624|1890284|FG001|Overall Study|Withdrawal by Subject|3
912754|NCT00806624|1890285|FG002|Overall Study|Withdrawal by Subject|3
912755|NCT00806624|1890283|FG000|Overall Study|discontinued before start of treatment|0
912756|NCT00806624|1890284|FG001|Overall Study|discontinued before start of treatment|0
912757|NCT00806624|1890285|FG002|Overall Study|discontinued before start of treatment|1
912758|NCT00806819|1890309|FG000|Overall Study|progressive disease (modified RECIST )|217
912759|NCT00806819|1890310|FG001|Overall Study|progressive disease (modified RECIST )|216
912760|NCT00806819|1890309|FG000|Overall Study|Worsening or AE of underlying disease|18
912761|NCT00806819|1890310|FG001|Overall Study|Worsening or AE of underlying disease|25
912762|NCT00806819|1890309|FG000|Overall Study|Other AE|38
912763|NCT00806819|1890310|FG001|Overall Study|Other AE|40
912764|NCT00806819|1890309|FG000|Overall Study|Protocol Violation|9
912765|NCT00806819|1890310|FG001|Overall Study|Protocol Violation|4
912766|NCT00806819|1890309|FG000|Overall Study|Lost to Follow-up|1
912767|NCT00806819|1890310|FG001|Overall Study|Lost to Follow-up|0
912768|NCT00806819|1890309|FG000|Overall Study|Withdrawal by Subject|32
912769|NCT00806819|1890310|FG001|Overall Study|Withdrawal by Subject|29
912770|NCT00806819|1890309|FG000|Overall Study|Not treated|6
912771|NCT00806819|1890310|FG001|Overall Study|Not treated|3
912772|NCT00806819|1890309|FG000|Overall Study|Reasons other than stated above|25
984812|NCT01298141|1992985|FG000|Overall Study|Withdrawal by Subject|6
984813|NCT01298141|1992985|FG000|Overall Study|Termination of Study by the Investigator|5
984814|NCT01298141|1992985|FG000|Overall Study|Other|5
984815|NCT01298141|1992985|FG000|Overall Study|Lost to Follow-up|1
984816|NCT01298141|1992985|FG000|Overall Study|Death|6
984817|NCT01298141|1992985|FG000|Overall Study|Not treated|4
984818|NCT01298193|1992998|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2
984819|NCT01298193|1992998|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16
984820|NCT01298193|1992998|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
984821|NCT01298193|1992998|FG000|Efficacy Phase (Second Cycle)|Death|1
984822|NCT01298323|1993016|FG000|Overall Study|Adverse Event|2
984823|NCT01298323|1993017|FG001|Overall Study|Adverse Event|4
984824|NCT01298323|1993016|FG000|Overall Study|Death|11
984825|NCT01298323|1993017|FG001|Overall Study|Death|16
984826|NCT01298323|1993016|FG000|Overall Study|Lost to Follow-up|1
984827|NCT01298323|1993017|FG001|Overall Study|Lost to Follow-up|0
984828|NCT01298323|1993016|FG000|Overall Study|Withdrawal by Subject|6
984829|NCT01298323|1993017|FG001|Overall Study|Withdrawal by Subject|3
984830|NCT01298323|1993016|FG000|Overall Study|Protocol Violation|1
984831|NCT01298323|1993017|FG001|Overall Study|Protocol Violation|0
984832|NCT01298323|1993016|FG000|Overall Study|Other|10
984833|NCT01298323|1993017|FG001|Overall Study|Other|9
984834|NCT01298323|1993016|FG000|Overall Study|Ongoing|55
984835|NCT01298323|1993017|FG001|Overall Study|Ongoing|55
984836|NCT01298323|1993016|FG000|Overall Study|Eligibility criteria not fulfilled|0
984837|NCT01298323|1993017|FG001|Overall Study|Eligibility criteria not fulfilled|1
984838|NCT01298362|1993025|FG000|Overall Study|Did not provide 12month BMD measurements|38
984839|NCT01298362|1993026|FG001|Overall Study|Did not provide 12month BMD measurements|43
984840|NCT01298492|1993034|FG000|Overall Study|Death|2
984841|NCT01298492|1993034|FG000|Overall Study|Insufficient Clinical Response|22
984842|NCT01298492|1993034|FG000|Overall Study|Lost to Follow-up|12
984843|NCT01298492|1993034|FG000|Overall Study|Withdrawal by Subject|47
984844|NCT01298492|1993034|FG000|Overall Study|Other (Unspecified)|7
984845|NCT01298492|1993034|FG000|Overall Study|Withdrawn Due to Pregnancy|1
984846|NCT01298492|1993034|FG000|Overall Study|Protocol Violation|2
984847|NCT01298492|1993034|FG000|Overall Study|Adverse Event(Related to Study Drug)|8
984848|NCT01298492|1993034|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18
984849|NCT01298518|1993041|FG000|Overall Study|Withdrawal by Subject|0
984850|NCT01298518|1993042|FG001|Overall Study|Withdrawal by Subject|0
984851|NCT01298518|1993043|FG002|Overall Study|Withdrawal by Subject|1
984852|NCT01298531|1993053|FG000|Overall Study|Lack of Efficacy|0
984853|NCT01298531|1993054|FG001|Overall Study|Lack of Efficacy|1
984854|NCT01298531|1993053|FG000|Overall Study|Lost to Follow-up|2
984855|NCT01298531|1993054|FG001|Overall Study|Lost to Follow-up|0
984856|NCT01298531|1993053|FG000|Overall Study|Protocol Violation|1
984857|NCT01298531|1993054|FG001|Overall Study|Protocol Violation|1
984858|NCT01298531|1993053|FG000|Overall Study|Adverse Event|4
984859|NCT01298531|1993054|FG001|Overall Study|Adverse Event|3
984860|NCT01298531|1993053|FG000|Overall Study|Does not meet entrance criteria|0
984861|NCT01298531|1993054|FG001|Overall Study|Does not meet entrance criteria|1
984862|NCT01298531|1993053|FG000|Overall Study|Other|2
984863|NCT01298531|1993054|FG001|Overall Study|Other|1
984864|NCT01298570|1993069|FG000|Overall Study|Disease progression, relapse during acti|64
984865|NCT01298570|1993070|FG001|Overall Study|Disease progression, relapse during acti|40
984866|NCT01298570|1993069|FG000|Overall Study|Adverse Event|20
984867|NCT01298570|1993070|FG001|Overall Study|Adverse Event|2
984868|NCT01298570|1993069|FG000|Overall Study|Withdrawal by Subject|21
984869|NCT01298570|1993070|FG001|Overall Study|Withdrawal by Subject|6
984870|NCT01298570|1993069|FG000|Overall Study|Treatment delay > 4 weeks|4
984871|NCT01298570|1993070|FG001|Overall Study|Treatment delay > 4 weeks|5
984872|NCT01298570|1993069|FG000|Overall Study|Physician Decision|4
984873|NCT01298570|1993070|FG001|Overall Study|Physician Decision|2
984874|NCT01298570|1993069|FG000|Overall Study|Other complicating disease|2
984875|NCT01298570|1993070|FG001|Overall Study|Other complicating disease|1
984876|NCT01298570|1993069|FG000|Overall Study|Surgery|2
984877|NCT01298570|1993070|FG001|Overall Study|Surgery|1
984878|NCT01298570|1993069|FG000|Overall Study|Symptomatic progression/deterioration|3
984879|NCT01298570|1993070|FG001|Overall Study|Symptomatic progression/deterioration|2
984880|NCT01298570|1993069|FG000|Overall Study|Death|0
984881|NCT01298570|1993070|FG001|Overall Study|Death|1
984882|NCT01298570|1993069|FG000|Overall Study|Ineligibility|0
984883|NCT01298570|1993070|FG001|Overall Study|Ineligibility|1
984884|NCT01298596|1993078|FG000|Overall Study|Withdrawal by Subject|1
984885|NCT01298596|1993079|FG001|Overall Study|Withdrawal by Subject|1
984886|NCT01298596|1993078|FG000|Overall Study|Death|5
984887|NCT01298596|1993079|FG001|Overall Study|Death|3
984888|NCT01298596|1993078|FG000|Overall Study|Lost to Follow-up|6
984889|NCT01298596|1993079|FG001|Overall Study|Lost to Follow-up|14
984890|NCT01298596|1993078|FG000|Overall Study|Referred for further management|16
984891|NCT01298596|1993079|FG001|Overall Study|Referred for further management|15
984892|NCT01298648|1993085|FG000|Overall Study|Withdrawal by Subject|2
984893|NCT01298648|1993085|FG000|Overall Study|Lost to Follow-up|21
984894|NCT01298661|1993092|FG000|Overall Study|Withdrawal by Subject|2
984895|NCT01298661|1993093|FG001|Overall Study|Withdrawal by Subject|0
984896|NCT01298661|1993094|FG002|Overall Study|Withdrawal by Subject|2
984897|NCT01298700|1993105|FG000|Overall Study|Adverse Event|50
984898|NCT01298700|1993106|FG001|Overall Study|Adverse Event|51
984899|NCT01298700|1993105|FG000|Overall Study|Lack of Efficacy|9
984900|NCT01298700|1993106|FG001|Overall Study|Lack of Efficacy|14
984901|NCT01298700|1993105|FG000|Overall Study|Lost to Follow-up|5
984902|NCT01298700|1993106|FG001|Overall Study|Lost to Follow-up|2
984903|NCT01298700|1993105|FG000|Overall Study|Withdrawal by Subject|12
984904|NCT01298700|1993106|FG001|Overall Study|Withdrawal by Subject|9
984905|NCT01298700|1993105|FG000|Overall Study|Protocol Violation|6
984906|NCT01298700|1993106|FG001|Overall Study|Protocol Violation|4
984907|NCT01298700|1993105|FG000|Overall Study|Other Miscellaneous Reasons|16
984908|NCT01298700|1993106|FG001|Overall Study|Other Miscellaneous Reasons|15
984909|NCT01298700|1993105|FG000|Overall Study|Did not Receive Study Drug|3
984910|NCT01298700|1993106|FG001|Overall Study|Did not Receive Study Drug|5
984911|NCT01298765|1993121|FG000|Titration Period|Adverse Event|26
984912|NCT01298765|1993121|FG000|Titration Period|Death|1
984913|NCT01298765|1993121|FG000|Titration Period|Lack of Efficacy|21
984914|NCT01298765|1993121|FG000|Titration Period|Lost to Follow-up|9
984915|NCT01298765|1993121|FG000|Titration Period|Physician Decision|1
984916|NCT01298765|1993121|FG000|Titration Period|Withdrawal by Subject|10
984917|NCT01298765|1993121|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8
984918|NCT01298765|1993121|FG000|Long-Term Treatment Period|Adverse Event|19
984919|NCT01298765|1993121|FG000|Long-Term Treatment Period|Lack of Efficacy|6
984920|NCT01298765|1993121|FG000|Long-Term Treatment Period|Lost to Follow-up|8
984921|NCT01298765|1993121|FG000|Long-Term Treatment Period|Withdrawal by Subject|19
984922|NCT01298765|1993121|FG000|Long-Term Treatment Period|Physician Decision|1
984923|NCT01298765|1993121|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
984924|NCT01298778|1993127|FG000|Overall Study|Lost to Follow-up|2
984925|NCT01298778|1993128|FG001|Overall Study|Lost to Follow-up|3
984926|NCT01298778|1993127|FG000|Overall Study|Incorrect use of VAS|1
984927|NCT01298778|1993128|FG001|Overall Study|Incorrect use of VAS|0
984928|NCT01298778|1993127|FG000|Overall Study|Withdrawal by Subject|0
984929|NCT01298778|1993128|FG001|Overall Study|Withdrawal by Subject|1
984930|NCT01298778|1993127|FG000|Overall Study|Protocol Violation|0
984931|NCT01298778|1993128|FG001|Overall Study|Protocol Violation|1
984932|NCT01298778|1993127|FG000|Overall Study|not meet inclusion/exclusion criteria|0
984933|NCT01298778|1993128|FG001|Overall Study|not meet inclusion/exclusion criteria|1
984934|NCT01298999|1993138|FG000|Overall Study|Physician Decision|0
984935|NCT01298999|1993139|FG001|Overall Study|Physician Decision|1
984936|NCT01298999|1993138|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3
984937|NCT01298999|1993139|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0
984938|NCT01299025|1993147|FG000|Overall Study|Withdrawal by Subject|2
984939|NCT01299025|1993148|FG001|Overall Study|Withdrawal by Subject|1
984940|NCT01299025|1993147|FG000|Overall Study|Lost to Follow-up|1
984941|NCT01299025|1993148|FG001|Overall Study|Lost to Follow-up|0
984942|NCT01299038|1993156|FG000|Overall Study|Withdrawal by Subject|1
984943|NCT01299038|1993157|FG001|Overall Study|Withdrawal by Subject|0
984944|NCT01299116|1993187|FG000|Overall Study|Lost to Follow-up|65
984945|NCT01299116|1993188|FG001|Overall Study|Lost to Follow-up|9
984946|NCT01299116|1993189|FG002|Overall Study|Lost to Follow-up|11
984947|NCT01299272|1993200|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140
984948|NCT01299272|1993201|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0
984949|NCT01299272|1993202|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0
984950|NCT01299272|1993203|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0
984951|NCT01299272|1993200|FG000|Acute Open-label (OL) Period|Adverse Event|140
984952|NCT01299272|1993201|FG001|Acute Open-label (OL) Period|Adverse Event|0
984953|NCT01299272|1993202|FG002|Acute Open-label (OL) Period|Adverse Event|0
984954|NCT01299272|1993203|FG003|Acute Open-label (OL) Period|Adverse Event|0
984955|NCT01299272|1993200|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56
984956|NCT01299272|1993201|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0
984957|NCT01299272|1993202|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0
984958|NCT01299272|1993203|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0
984959|NCT01299272|1993200|FG000|Acute Open-label (OL) Period|Protocol Violation|36
984960|NCT01299272|1993201|FG001|Acute Open-label (OL) Period|Protocol Violation|0
984961|NCT01299272|1993202|FG002|Acute Open-label (OL) Period|Protocol Violation|0
984962|NCT01299272|1993203|FG003|Acute Open-label (OL) Period|Protocol Violation|0
984963|NCT01299272|1993200|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14
984964|NCT01299272|1993201|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0
984965|NCT01299272|1993202|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0
984966|NCT01299272|1993203|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0
984967|NCT01299272|1993200|FG000|Acute Open-label (OL) Period|Sponsor Decision|13
984968|NCT01299272|1993201|FG001|Acute Open-label (OL) Period|Sponsor Decision|0
984969|NCT01299272|1993202|FG002|Acute Open-label (OL) Period|Sponsor Decision|0
984970|NCT01299272|1993203|FG003|Acute Open-label (OL) Period|Sponsor Decision|0
984971|NCT01299272|1993200|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10
984972|NCT01299272|1993201|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0
984973|NCT01299272|1993202|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0
984974|NCT01299272|1993203|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0
984975|NCT01299272|1993200|FG000|Acute Open-label (OL) Period|Physician Decision|5
984976|NCT01299272|1993201|FG001|Acute Open-label (OL) Period|Physician Decision|0
984977|NCT01299272|1993202|FG002|Acute Open-label (OL) Period|Physician Decision|0
984978|NCT01299272|1993203|FG003|Acute Open-label (OL) Period|Physician Decision|0
984979|NCT01299272|1993200|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
984980|NCT01299272|1993201|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
984981|NCT01299272|1993202|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
984982|NCT01299272|1993203|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
984983|NCT01299272|1993200|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0
984984|NCT01299272|1993201|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44
984985|NCT01299272|1993202|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0
984986|NCT01299272|1993203|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0
984987|NCT01299272|1993200|FG000|Stabilization Open-label (OL) Period|Adverse Event|0
984988|NCT01299272|1993201|FG001|Stabilization Open-label (OL) Period|Adverse Event|42
984989|NCT01299272|1993202|FG002|Stabilization Open-label (OL) Period|Adverse Event|0
984990|NCT01299272|1993203|FG003|Stabilization Open-label (OL) Period|Adverse Event|0
984991|NCT01299272|1993200|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
984992|NCT01299272|1993201|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
984993|NCT01299272|1993202|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
984994|NCT01299272|1993203|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
984995|NCT01299272|1993200|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0
984996|NCT01299272|1993201|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12
984997|NCT01299272|1993202|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0
984998|NCT01299272|1993203|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0
984999|NCT01299272|1993200|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0
985000|NCT01299272|1993201|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11
985001|NCT01299272|1993202|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0
985002|NCT01299272|1993203|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0
985003|NCT01299272|1993200|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0
985004|NCT01299272|1993201|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9
985005|NCT01299272|1993202|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0
985006|NCT01299272|1993203|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0
985007|NCT01299272|1993200|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
985008|NCT01299272|1993201|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
985009|NCT01299272|1993202|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
985010|NCT01299272|1993203|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
985011|NCT01299272|1993200|FG000|Stabilization Open-label (OL) Period|Physician Decision|0
985012|NCT01299272|1993201|FG001|Stabilization Open-label (OL) Period|Physician Decision|3
985013|NCT01299272|1993202|FG002|Stabilization Open-label (OL) Period|Physician Decision|0
985014|NCT01299272|1993203|FG003|Stabilization Open-label (OL) Period|Physician Decision|0
985015|NCT01299272|1993200|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
985016|NCT01299272|1993201|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
985017|NCT01299272|1993202|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
985018|NCT01299272|1993203|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
985019|NCT01299272|1993200|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0
985020|NCT01299272|1993201|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0
985021|NCT01299272|1993202|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20
985022|NCT01299272|1993203|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10
985023|NCT01299272|1993200|FG000|Double-blind (DB) Randomized Period|Adverse Event|0
985024|NCT01299272|1993201|FG001|Double-blind (DB) Randomized Period|Adverse Event|0
985025|NCT01299272|1993202|FG002|Double-blind (DB) Randomized Period|Adverse Event|8
985026|NCT01299272|1993203|FG003|Double-blind (DB) Randomized Period|Adverse Event|9
985027|NCT01299272|1993200|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0
985028|NCT01299272|1993201|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0
985029|NCT01299272|1993202|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8
985030|NCT01299272|1993203|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7
985031|NCT01299272|1993200|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0
985032|NCT01299272|1993201|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0
985033|NCT01299272|1993202|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5
985034|NCT01299272|1993203|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5
985035|NCT01299272|1993200|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
985036|NCT01299272|1993201|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
985037|NCT01299272|1993202|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
985038|NCT01299272|1993203|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
985039|NCT01299272|1993200|FG000|Double-blind (DB) Randomized Period|Physician Decision|0
985040|NCT01299272|1993201|FG001|Double-blind (DB) Randomized Period|Physician Decision|0
985041|NCT01299272|1993202|FG002|Double-blind (DB) Randomized Period|Physician Decision|2
985042|NCT01299272|1993203|FG003|Double-blind (DB) Randomized Period|Physician Decision|1
985043|NCT01299272|1993200|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0
985044|NCT01299272|1993201|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0
985045|NCT01299272|1993202|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1
985046|NCT01299272|1993203|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1
985047|NCT01299376|1993225|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
985048|NCT01299376|1993226|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
985049|NCT01299376|1993225|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
985050|NCT01299376|1993226|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
985051|NCT01299376|1993225|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
985052|NCT01299376|1993226|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
985053|NCT01299376|1993225|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
985054|NCT01299376|1993226|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
985055|NCT01299376|1993225|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
985056|NCT01299376|1993226|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
985057|NCT01299376|1993225|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
985058|NCT01299376|1993226|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
985059|NCT01299376|1993225|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
985060|NCT01299376|1993226|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
985061|NCT01299376|1993225|FG000|Extension (Weeks 9 to 52)|Adverse Event|2
985062|NCT01299376|1993226|FG001|Extension (Weeks 9 to 52)|Adverse Event|3
985063|NCT01299376|1993225|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1
985064|NCT01299376|1993226|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2
985065|NCT01299376|1993225|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
985066|NCT01299376|1993226|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
985067|NCT01299376|1993225|FG000|Extension (Weeks 9 to 52)|Physician Decision|1
985068|NCT01299376|1993226|FG001|Extension (Weeks 9 to 52)|Physician Decision|0
985069|NCT01299389|1993238|FG000|Double-blind|Adverse Event|45
985070|NCT01299389|1993239|FG001|Double-blind|Adverse Event|27
985071|NCT01299389|1993240|FG002|Double-blind|Adverse Event|0
985072|NCT01299389|1993241|FG003|Double-blind|Adverse Event|0
985073|NCT01299389|1993238|FG000|Double-blind|Lack of Efficacy|45
985074|NCT01299389|1993239|FG001|Double-blind|Lack of Efficacy|21
985075|NCT01299389|1993240|FG002|Double-blind|Lack of Efficacy|0
985076|NCT01299389|1993241|FG003|Double-blind|Lack of Efficacy|0
985077|NCT01299389|1993238|FG000|Double-blind|Lost to Follow-up|2
985078|NCT01299389|1993239|FG001|Double-blind|Lost to Follow-up|1
985079|NCT01299389|1993240|FG002|Double-blind|Lost to Follow-up|0
985080|NCT01299389|1993241|FG003|Double-blind|Lost to Follow-up|0
985081|NCT01299389|1993238|FG000|Double-blind|Withdrawal by Subject|16
985082|NCT01299389|1993239|FG001|Double-blind|Withdrawal by Subject|13
985083|NCT01299389|1993240|FG002|Double-blind|Withdrawal by Subject|0
985084|NCT01299389|1993241|FG003|Double-blind|Withdrawal by Subject|0
985085|NCT01299389|1993238|FG000|Double-blind|Other|1
985086|NCT01299389|1993239|FG001|Double-blind|Other|1
985087|NCT01299389|1993240|FG002|Double-blind|Other|0
985088|NCT01299389|1993241|FG003|Double-blind|Other|0
985089|NCT01299389|1993238|FG000|Double-blind|"fail to meet study population criteria"|0
985090|NCT01299389|1993239|FG001|Double-blind|"fail to meet study population criteria"|1
985091|NCT01299389|1993240|FG002|Double-blind|"fail to meet study population criteria"|0
985092|NCT01299389|1993241|FG003|Double-blind|"fail to meet study population criteria"|0
985093|NCT01299389|1993238|FG000|Post-observational|Other|0
985094|NCT01299389|1993239|FG001|Post-observational|Other|0
985095|NCT01299389|1993240|FG002|Post-observational|Other|12
985096|NCT01299389|1993241|FG003|Post-observational|Other|6
985097|NCT01299480|1993298|FG000|Overall Study|No longer willing to participate|19
985098|NCT01299480|1993299|FG001|Overall Study|No longer willing to participate|17
985099|NCT01299480|1993300|FG002|Overall Study|No longer willing to participate|14
985100|NCT01299480|1993301|FG003|Overall Study|No longer willing to participate|13
985101|NCT01299480|1993302|FG004|Overall Study|No longer willing to participate|10
985102|NCT01299480|1993298|FG000|Overall Study|Protocol Violation|7
985103|NCT01299480|1993299|FG001|Overall Study|Protocol Violation|5
985104|NCT01299480|1993300|FG002|Overall Study|Protocol Violation|8
985105|NCT01299480|1993301|FG003|Overall Study|Protocol Violation|1
985106|NCT01299480|1993302|FG004|Overall Study|Protocol Violation|1
985107|NCT01299480|1993298|FG000|Overall Study|Withdrawal by Subject|3
985108|NCT01299480|1993299|FG001|Overall Study|Withdrawal by Subject|4
985109|NCT01299480|1993300|FG002|Overall Study|Withdrawal by Subject|7
985110|NCT01299480|1993301|FG003|Overall Study|Withdrawal by Subject|3
985111|NCT01299480|1993302|FG004|Overall Study|Withdrawal by Subject|4
985112|NCT01299480|1993298|FG000|Overall Study|Adverse Event|6
985113|NCT01299480|1993299|FG001|Overall Study|Adverse Event|4
985114|NCT01299480|1993300|FG002|Overall Study|Adverse Event|5
985115|NCT01299480|1993301|FG003|Overall Study|Adverse Event|4
985116|NCT01299480|1993302|FG004|Overall Study|Adverse Event|0
985117|NCT01299480|1993298|FG000|Overall Study|Withdrawal due to pregnancy|0
985118|NCT01299480|1993299|FG001|Overall Study|Withdrawal due to pregnancy|1
985119|NCT01299480|1993300|FG002|Overall Study|Withdrawal due to pregnancy|1
985120|NCT01299480|1993301|FG003|Overall Study|Withdrawal due to pregnancy|0
985121|NCT01299480|1993302|FG004|Overall Study|Withdrawal due to pregnancy|0
985122|NCT01299480|1993298|FG000|Overall Study|Physician Decision|1
985123|NCT01299480|1993299|FG001|Overall Study|Physician Decision|1
985124|NCT01299480|1993300|FG002|Overall Study|Physician Decision|0
985125|NCT01299480|1993301|FG003|Overall Study|Physician Decision|2
985126|NCT01299480|1993302|FG004|Overall Study|Physician Decision|0
985127|NCT01299480|1993298|FG000|Overall Study|Lost to Follow-up|3
985128|NCT01299480|1993299|FG001|Overall Study|Lost to Follow-up|1
985129|NCT01299480|1993300|FG002|Overall Study|Lost to Follow-up|2
985130|NCT01299480|1993301|FG003|Overall Study|Lost to Follow-up|1
985131|NCT01299480|1993302|FG004|Overall Study|Lost to Follow-up|2
985132|NCT01299480|1993298|FG000|Overall Study|Other|3
985133|NCT01299480|1993299|FG001|Overall Study|Other|2
985134|NCT01299480|1993300|FG002|Overall Study|Other|3
985135|NCT01299480|1993301|FG003|Overall Study|Other|0
985136|NCT01299480|1993302|FG004|Overall Study|Other|3
985137|NCT01299480|1993298|FG000|Overall Study|Started, but not vaccinated|0
985138|NCT01299480|1993299|FG001|Overall Study|Started, but not vaccinated|0
985139|NCT01299480|1993300|FG002|Overall Study|Started, but not vaccinated|1
985140|NCT01299480|1993301|FG003|Overall Study|Started, but not vaccinated|1
985141|NCT01299480|1993302|FG004|Overall Study|Started, but not vaccinated|0
985142|NCT01299571|1993315|FG000|Overall Study|Protocol Violation|107
985143|NCT01299584|1993320|FG000|Overall Study|Protocol Violation|9
985144|NCT01299727|1993344|FG000|Overall Study|Withdrawal by Subject|1
985145|NCT01299727|1993345|FG001|Overall Study|Withdrawal by Subject|0
985146|NCT01299727|1993346|FG002|Overall Study|Withdrawal by Subject|0
985147|NCT01299727|1993344|FG000|Overall Study|Adverse Event|0
985148|NCT01299727|1993345|FG001|Overall Study|Adverse Event|0
985149|NCT01299727|1993346|FG002|Overall Study|Adverse Event|1
985150|NCT01299727|1993344|FG000|Overall Study|Completed the Treatment Period|3
985151|NCT01299727|1993345|FG001|Overall Study|Completed the Treatment Period|4
985152|NCT01299727|1993346|FG002|Overall Study|Completed the Treatment Period|3
985153|NCT01299766|1993356|FG000|Overall Study|Death|5
985154|NCT01299766|1993357|FG001|Overall Study|Death|4
985155|NCT01299766|1993356|FG000|Overall Study|Withdrawal by Subject|29
985156|NCT01299766|1993357|FG001|Overall Study|Withdrawal by Subject|19
985157|NCT01299805|1993365|FG000|Overall Study|Adverse Event|2
985158|NCT01299805|1993366|FG001|Overall Study|Adverse Event|0
985159|NCT01299896|1993374|FG000|Overall Study|Withdrawal by Subject|1
985160|NCT01299896|1993375|FG001|Overall Study|Withdrawal by Subject|7
985161|NCT01299896|1993374|FG000|Overall Study|Lost to Follow-up|0
985162|NCT01299896|1993375|FG001|Overall Study|Lost to Follow-up|11
985163|NCT01299909|1993384|FG000|Overall Study|Lost to Follow-up|22
985164|NCT01299909|1993385|FG001|Overall Study|Lost to Follow-up|18
985165|NCT01299909|1993386|FG002|Overall Study|Lost to Follow-up|17
985166|NCT01299961|1993393|FG000|Overall Study|Adverse Event|3
985167|NCT01299961|1993393|FG000|Overall Study|Lack of Efficacy|2
985168|NCT01299961|1993393|FG000|Overall Study|Lost to Follow-up|1
985169|NCT01300052|1993399|FG000|Overall Study|Adverse Event|3
985170|NCT01300052|1993400|FG001|Overall Study|Adverse Event|0
985171|NCT01300052|1993399|FG000|Overall Study|Withdrawal by Subject|2
985172|NCT01300052|1993400|FG001|Overall Study|Withdrawal by Subject|2
985173|NCT01300052|1993399|FG000|Overall Study|Protocol Violation|1
985174|NCT01300052|1993400|FG001|Overall Study|Protocol Violation|1
985175|NCT01300234|1993417|FG000|Overall Study|Adverse Event|1
985176|NCT01300234|1993418|FG001|Overall Study|Adverse Event|1
985177|NCT01300234|1993417|FG000|Overall Study|Protocol Violation|2
985178|NCT01300234|1993418|FG001|Overall Study|Protocol Violation|3
985179|NCT01300234|1993417|FG000|Overall Study|Withdrawal by Subject|5
985180|NCT01300234|1993418|FG001|Overall Study|Withdrawal by Subject|9
985181|NCT01300234|1993417|FG000|Overall Study|Lost to Follow-up|14
985182|NCT01300234|1993418|FG001|Overall Study|Lost to Follow-up|12
985183|NCT01300234|1993417|FG000|Overall Study|Pregnancy|2
985184|NCT01300234|1993418|FG001|Overall Study|Pregnancy|1
985185|NCT01300234|1993417|FG000|Overall Study|Participant reached stopping critera|2
985186|NCT01300234|1993418|FG001|Overall Study|Participant reached stopping critera|0
985187|NCT01300234|1993417|FG000|Overall Study|Participant stopped medication|1
985188|NCT01300234|1993418|FG001|Overall Study|Participant stopped medication|1
985189|NCT01300234|1993417|FG000|Overall Study|Participant refused return to hospital|1
985190|NCT01300234|1993418|FG001|Overall Study|Participant refused return to hospital|0
985191|NCT01300247|1993437|FG000|Overall Study|Death|1
985192|NCT01300247|1993438|FG001|Overall Study|Death|1
985193|NCT01300247|1993437|FG000|Overall Study|Lost to Follow-up|2
985194|NCT01300247|1993438|FG001|Overall Study|Lost to Follow-up|0
985195|NCT01300247|1993437|FG000|Overall Study|Withdrawal by Subject|1
985196|NCT01300247|1993438|FG001|Overall Study|Withdrawal by Subject|0
985197|NCT01300247|1993437|FG000|Overall Study|Non-Compliance|0
985198|NCT01300247|1993438|FG001|Overall Study|Non-Compliance|1
985199|NCT01300260|1993446|FG000|Period 1 of Study: First Intervention|Adverse Event|0
985200|NCT01300260|1993447|FG001|Period 1 of Study: First Intervention|Adverse Event|1
985201|NCT01300260|1993446|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1
985202|NCT01300260|1993447|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0
985203|NCT01300260|1993446|FG000|Period 2 of Study: Second Intervention|Adverse Event|0
985204|NCT01300260|1993447|FG001|Period 2 of Study: Second Intervention|Adverse Event|1
985205|NCT01300286|1993464|FG000|Overall Study|did not get dosed|1
985206|NCT01300338|1993471|FG000|Overall Study|Lost to Follow-up|5
985207|NCT01300338|1993472|FG001|Overall Study|Lost to Follow-up|0
985208|NCT01300351|1993480|FG000|Overall Study|Did not receive treatment|2
985209|NCT01300351|1993481|FG001|Overall Study|Did not receive treatment|0
985210|NCT01300351|1993480|FG000|Overall Study|Ongoing treatment at data cut-off|27
985211|NCT01300351|1993481|FG001|Overall Study|Ongoing treatment at data cut-off|23
985212|NCT01300351|1993480|FG000|Overall Study|Lost to Follow-up|0
985213|NCT01300351|1993481|FG001|Overall Study|Lost to Follow-up|1
985214|NCT01300351|1993480|FG000|Overall Study|Adverse Event|0
985215|NCT01300351|1993481|FG001|Overall Study|Adverse Event|4
985216|NCT01300351|1993480|FG000|Overall Study|Withdrawal by Subject|7
985217|NCT01300351|1993481|FG001|Overall Study|Withdrawal by Subject|10
985218|NCT01300455|1993489|FG000|Washout|Withdrawal by Subject|1
985219|NCT01300455|1993490|FG001|Washout|Withdrawal by Subject|0
985220|NCT01300546|1993498|FG000|Overall Study|Withdrawal by Subject|1
985221|NCT01300546|1993499|FG001|Overall Study|Withdrawal by Subject|0
985222|NCT01300546|1993498|FG000|Overall Study|Lost to Follow-up|0
985223|NCT01300546|1993499|FG001|Overall Study|Lost to Follow-up|2
985224|NCT01300546|1993498|FG000|Overall Study|Lack of Efficacy|0
985225|NCT01300546|1993499|FG001|Overall Study|Lack of Efficacy|3
985226|NCT01300546|1993498|FG000|Overall Study|Adverse Event|0
985227|NCT01300546|1993499|FG001|Overall Study|Adverse Event|1
985228|NCT01300572|1993514|FG000|Overall Study|HAMA + post dosimetry|1
985229|NCT01300650|1993524|FG000|Overall Study|Adverse Event|1
985230|NCT01300728|1993531|FG000|Overall Study|Withdrawal by Subject|1
985231|NCT01300728|1993532|FG001|Overall Study|Withdrawal by Subject|1
985232|NCT01300728|1993531|FG000|Overall Study|Physician Decision|1
985233|NCT01300728|1993532|FG001|Overall Study|Physician Decision|0
985234|NCT01300741|1993538|FG000|Overall Study|Lens deposits|1
985235|NCT01300741|1993538|FG000|Overall Study|Lost to Follow-up|1
985236|NCT01300741|1993538|FG000|Overall Study|Discomfort|1
985237|NCT01300767|1993544|FG000|Overall Study|Discomfort|2
985238|NCT01300767|1993544|FG000|Overall Study|Biomicroscopy|1
985239|NCT01300767|1993544|FG000|Overall Study|Unacceptable fit|1
985240|NCT01300819|1993552|FG000|Overall Study|Adverse Event|9
985241|NCT01300819|1993553|FG001|Overall Study|Adverse Event|27
985242|NCT01300819|1993552|FG000|Overall Study|Lack of Efficacy|2
985243|NCT01300819|1993553|FG001|Overall Study|Lack of Efficacy|1
985244|NCT01300819|1993552|FG000|Overall Study|Withdrawal by Subject|10
985245|NCT01300819|1993553|FG001|Overall Study|Withdrawal by Subject|12
985246|NCT01300819|1993552|FG000|Overall Study|Patient was 1 month late for Visit 10|0
985247|NCT01300819|1993553|FG001|Overall Study|Patient was 1 month late for Visit 10|1
985248|NCT01300819|1993552|FG000|Overall Study|Refusal to down titrate study drug|0
985249|NCT01300819|1993553|FG001|Overall Study|Refusal to down titrate study drug|1
985250|NCT01300819|1993552|FG000|Overall Study|Administrative reason|0
985251|NCT01300819|1993553|FG001|Overall Study|Administrative reason|1
985252|NCT01300819|1993552|FG000|Overall Study|Safety follow up not done by mistake|0
985253|NCT01300819|1993553|FG001|Overall Study|Safety follow up not done by mistake|1
985254|NCT01300819|1993552|FG000|Overall Study|Follow up call was not done|1
985255|NCT01300819|1993553|FG001|Overall Study|Follow up call was not done|0
985256|NCT01300923|1993559|FG000|Overall Study|Physician Decision|0
985257|NCT01300923|1993560|FG001|Overall Study|Physician Decision|2
985258|NCT01301001|1993578|FG000|First Intervention|Lost to Follow-up|4
985259|NCT01301001|1993579|FG001|First Intervention|Lost to Follow-up|4
985260|NCT01301001|1993578|FG000|First Intervention|Withdrawal by Subject|1
985261|NCT01301001|1993579|FG001|First Intervention|Withdrawal by Subject|4
985262|NCT01301001|1993578|FG000|First Intervention|Adverse Event|5
985263|NCT01301001|1993579|FG001|First Intervention|Adverse Event|0
985264|NCT01301001|1993578|FG000|First Intervention|Protocol Violation|0
985265|NCT01301001|1993579|FG001|First Intervention|Protocol Violation|1
985266|NCT01301001|1993578|FG000|Second Intervention|Adverse Event|2
985267|NCT01301001|1993579|FG001|Second Intervention|Adverse Event|0
985268|NCT01301001|1993578|FG000|Second Intervention|Withdrawal by Subject|2
985269|NCT01301001|1993579|FG001|Second Intervention|Withdrawal by Subject|0
985270|NCT01301027|1993588|FG000|Overall Study|Physician Decision|2
985271|NCT01301027|1993589|FG001|Overall Study|Physician Decision|0
985272|NCT01301027|1993588|FG000|Overall Study|Withdrawal by Subject|2
985273|NCT01301027|1993589|FG001|Overall Study|Withdrawal by Subject|3
985274|NCT01301027|1993588|FG000|Overall Study|Adverse Event|0
985275|NCT01301027|1993589|FG001|Overall Study|Adverse Event|2
985276|NCT01301027|1993588|FG000|Overall Study|Fracture|1
985277|NCT01301027|1993589|FG001|Overall Study|Fracture|3
985278|NCT01301027|1993588|FG000|Overall Study|Transplant|0
985279|NCT01301027|1993589|FG001|Overall Study|Transplant|2
985280|NCT01301027|1993588|FG000|Overall Study|Volume Overload|3
985281|NCT01301027|1993589|FG001|Overall Study|Volume Overload|0
985282|NCT01301066|1993597|FG000|Overall Study|Lost to Follow-up|5
985283|NCT01301066|1993598|FG001|Overall Study|Lost to Follow-up|11
985284|NCT01301066|1993597|FG000|Overall Study|Protocol Violation|8
985285|NCT01301066|1993598|FG001|Overall Study|Protocol Violation|7
985286|NCT01301066|1993597|FG000|Overall Study|Withdrawal by Subject|4
985287|NCT01301066|1993598|FG001|Overall Study|Withdrawal by Subject|9
985288|NCT01301066|1993597|FG000|Overall Study|Adverse Event|6
985289|NCT01301066|1993598|FG001|Overall Study|Adverse Event|6
985290|NCT01301066|1993597|FG000|Overall Study|Sponsor Decision|2
985291|NCT01301066|1993598|FG001|Overall Study|Sponsor Decision|1
985292|NCT01301066|1993597|FG000|Overall Study|Physician Decision|0
985293|NCT01301066|1993598|FG001|Overall Study|Physician Decision|1
985294|NCT01301066|1993597|FG000|Overall Study|Other|2
985295|NCT01301066|1993598|FG001|Overall Study|Other|0
985296|NCT01301079|1993606|FG000|Overall Study|Lost to Follow-up|2
985297|NCT01301079|1993607|FG001|Overall Study|Lost to Follow-up|2
985298|NCT01301092|1993620|FG000|Overall Study|Lost to Follow-up|0
985299|NCT01301092|1993621|FG001|Overall Study|Lost to Follow-up|0
985300|NCT01301092|1993622|FG002|Overall Study|Lost to Follow-up|1
985301|NCT01301274|1993646|FG000|Overall Study|Physician Decision|2
985302|NCT01301274|1993647|FG001|Overall Study|Physician Decision|1
985303|NCT01301391|1993658|FG000|Overall Study|Death|13
985304|NCT01301391|1993658|FG000|Overall Study|Lost to Follow-up|3
985305|NCT01301391|1993658|FG000|Overall Study|Physician Decision|2
985306|NCT01301391|1993658|FG000|Overall Study|Sponsor's decision|8
985307|NCT01301456|1993674|FG000|Stage 1|Withdrawal by Subject|0
985308|NCT01301456|1993675|FG001|Stage 1|Withdrawal by Subject|0
985309|NCT01301456|1993676|FG002|Stage 1|Withdrawal by Subject|1
985310|NCT01301456|1993677|FG003|Stage 1|Withdrawal by Subject|0
985311|NCT01301456|1993678|FG004|Stage 1|Withdrawal by Subject|1
985312|NCT01301456|1993679|FG005|Stage 1|Withdrawal by Subject|0
985313|NCT01301456|1993680|FG006|Stage 1|Withdrawal by Subject|0
985314|NCT01301456|1993681|FG007|Stage 1|Withdrawal by Subject|0
985315|NCT01301456|1993682|FG008|Stage 1|Withdrawal by Subject|0
985316|NCT01301456|1993683|FG009|Stage 1|Withdrawal by Subject|0
985317|NCT01301456|1993684|FG010|Stage 1|Withdrawal by Subject|0
985318|NCT01301456|1993685|FG011|Stage 1|Withdrawal by Subject|0
985319|NCT01301456|1993674|FG000|Stage 1|Randomized but not treated|0
985320|NCT01301456|1993675|FG001|Stage 1|Randomized but not treated|0
985321|NCT01301456|1993676|FG002|Stage 1|Randomized but not treated|0
985322|NCT01301456|1993677|FG003|Stage 1|Randomized but not treated|0
985323|NCT01301456|1993678|FG004|Stage 1|Randomized but not treated|0
985324|NCT01301456|1993679|FG005|Stage 1|Randomized but not treated|0
985325|NCT01301456|1993680|FG006|Stage 1|Randomized but not treated|1
985326|NCT01301456|1993681|FG007|Stage 1|Randomized but not treated|0
985327|NCT01301456|1993682|FG008|Stage 1|Randomized but not treated|0
985328|NCT01301456|1993683|FG009|Stage 1|Randomized but not treated|0
985329|NCT01301456|1993684|FG010|Stage 1|Randomized but not treated|0
985330|NCT01301456|1993685|FG011|Stage 1|Randomized but not treated|0
985331|NCT01301456|1993674|FG000|Stage 2|Adverse Event|0
985332|NCT01301456|1993675|FG001|Stage 2|Adverse Event|0
985333|NCT01301456|1993676|FG002|Stage 2|Adverse Event|0
985334|NCT01301456|1993677|FG003|Stage 2|Adverse Event|0
985335|NCT01301456|1993678|FG004|Stage 2|Adverse Event|0
985336|NCT01301456|1993679|FG005|Stage 2|Adverse Event|0
985337|NCT01301456|1993680|FG006|Stage 2|Adverse Event|0
985338|NCT01301456|1993681|FG007|Stage 2|Adverse Event|0
985339|NCT01301456|1993682|FG008|Stage 2|Adverse Event|0
985340|NCT01301456|1993683|FG009|Stage 2|Adverse Event|0
985341|NCT01301456|1993684|FG010|Stage 2|Adverse Event|1
985342|NCT01301456|1993685|FG011|Stage 2|Adverse Event|0
985343|NCT01301508|1993731|FG000|Overall Study|Withdrawal by Subject|1
985344|NCT01301508|1993732|FG001|Overall Study|Withdrawal by Subject|2
985345|NCT01301508|1993731|FG000|Overall Study|Lost to Follow-up|0
985346|NCT01301508|1993732|FG001|Overall Study|Lost to Follow-up|1
985347|NCT01301625|1993738|FG000|Overall Study|Death|5
985348|NCT01301625|1993738|FG000|Overall Study|Not Due|21
985349|NCT01301625|1993738|FG000|Overall Study|Expected|8
985350|NCT01301625|1993738|FG000|Overall Study|Lost to Follow-up|1
985351|NCT01301729|1993742|FG000|Overall Study|Withdrawal by Subject|2
985352|NCT01301729|1993742|FG000|Overall Study|Participant did not Return for Treatment|1
985353|NCT01301729|1993742|FG000|Overall Study|Violated Selection Criteria|1
985354|NCT01301833|1993759|FG000|Overall Study|Adverse Event|7
985355|NCT01301833|1993760|FG001|Overall Study|Adverse Event|5
985356|NCT01301833|1993761|FG002|Overall Study|Adverse Event|5
985357|NCT01301833|1993762|FG003|Overall Study|Adverse Event|5
985358|NCT01301833|1993759|FG000|Overall Study|Lack of Efficacy|1
985359|NCT01301833|1993760|FG001|Overall Study|Lack of Efficacy|1
985360|NCT01301833|1993761|FG002|Overall Study|Lack of Efficacy|0
985361|NCT01301833|1993762|FG003|Overall Study|Lack of Efficacy|0
985362|NCT01301833|1993759|FG000|Overall Study|Physician Decision|3
985363|NCT01301833|1993760|FG001|Overall Study|Physician Decision|1
985364|NCT01301833|1993761|FG002|Overall Study|Physician Decision|1
985365|NCT01301833|1993762|FG003|Overall Study|Physician Decision|0
985366|NCT01301833|1993759|FG000|Overall Study|Withdrawal by Subject|3
985367|NCT01301833|1993760|FG001|Overall Study|Withdrawal by Subject|1
985368|NCT01301833|1993761|FG002|Overall Study|Withdrawal by Subject|1
985369|NCT01301833|1993762|FG003|Overall Study|Withdrawal by Subject|2
985370|NCT01301833|1993759|FG000|Overall Study|Personal matter|1
985371|NCT01301833|1993760|FG001|Overall Study|Personal matter|0
985372|NCT01301833|1993761|FG002|Overall Study|Personal matter|0
985373|NCT01301833|1993762|FG003|Overall Study|Personal matter|0
985374|NCT01301950|1993774|FG000|Overall Study|Surgery was cancelled by patient|0
985375|NCT01301950|1993775|FG001|Overall Study|Surgery was cancelled by patient|1
985376|NCT01302041|1993781|FG000|Overall Study|Death|5
985377|NCT01302041|1993781|FG000|Overall Study|Withdrawal by Subject|4
985378|NCT01302041|1993781|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29
985379|NCT01302041|1993781|FG000|Overall Study|Other-Miscellaneous Reason|2
985380|NCT01302054|1993786|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
985381|NCT01302054|1993787|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
985382|NCT01302054|1993788|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
985383|NCT01302054|1993786|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
985384|NCT01302054|1993787|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
985385|NCT01302054|1993788|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
985386|NCT01302054|1993786|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
985387|NCT01302054|1993787|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
985388|NCT01302054|1993788|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
985389|NCT01302054|1993786|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
985390|NCT01302054|1993787|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
985391|NCT01302054|1993788|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
985392|NCT01302054|1993786|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13
985393|NCT01302054|1993787|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0
985394|NCT01302054|1993788|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0
985395|NCT01302054|1993786|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
985396|NCT01302054|1993787|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
985397|NCT01302054|1993788|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
985398|NCT01302054|1993786|FG000|Tolterodine Open-Label Run-In Phase|Other|7
985399|NCT01302054|1993787|FG001|Tolterodine Open-Label Run-In Phase|Other|0
985400|NCT01302054|1993788|FG002|Tolterodine Open-Label Run-In Phase|Other|0
985401|NCT01302054|1993786|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
985402|NCT01302054|1993787|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
985403|NCT01302054|1993788|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
985404|NCT01302054|1993786|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0
985405|NCT01302054|1993787|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2
985406|NCT01302054|1993788|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4
985407|NCT01302054|1993786|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
985408|NCT01302054|1993787|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
985409|NCT01302054|1993788|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
985410|NCT01302054|1993786|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
985411|NCT01302054|1993787|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6
985412|NCT01302054|1993788|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14
985413|NCT01302054|1993786|FG000|Double-Blind Treatment Phase|Protocol Violation|0
985414|NCT01302054|1993787|FG001|Double-Blind Treatment Phase|Protocol Violation|3
985415|NCT01302054|1993788|FG002|Double-Blind Treatment Phase|Protocol Violation|6
985416|NCT01302054|1993786|FG000|Double-Blind Treatment Phase|Adverse Event|0
985417|NCT01302054|1993787|FG001|Double-Blind Treatment Phase|Adverse Event|10
985418|NCT01302054|1993788|FG002|Double-Blind Treatment Phase|Adverse Event|10
985419|NCT01302054|1993786|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
985420|NCT01302054|1993787|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
985421|NCT01302054|1993788|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
985422|NCT01302054|1993786|FG000|Double-Blind Treatment Phase|Other|0
985423|NCT01302054|1993787|FG001|Double-Blind Treatment Phase|Other|4
985424|NCT01302054|1993788|FG002|Double-Blind Treatment Phase|Other|9
985425|NCT01302067|1993800|FG000|Overall Study|Death|0
985426|NCT01302067|1993801|FG001|Overall Study|Death|0
985427|NCT01302067|1993802|FG002|Overall Study|Death|1
985428|NCT01302067|1993800|FG000|Overall Study|Physician Decision|9
985429|NCT01302067|1993801|FG001|Overall Study|Physician Decision|5
985430|NCT01302067|1993802|FG002|Overall Study|Physician Decision|14
985431|NCT01302067|1993800|FG000|Overall Study|Lack of Efficacy|8
985432|NCT01302067|1993801|FG001|Overall Study|Lack of Efficacy|4
985433|NCT01302067|1993802|FG002|Overall Study|Lack of Efficacy|2
985434|NCT01302067|1993800|FG000|Overall Study|Lost to Follow-up|9
985435|NCT01302067|1993801|FG001|Overall Study|Lost to Follow-up|4
985436|NCT01302067|1993802|FG002|Overall Study|Lost to Follow-up|15
985437|NCT01302067|1993800|FG000|Overall Study|Withdrawal by Subject|13
985438|NCT01302067|1993801|FG001|Overall Study|Withdrawal by Subject|6
985439|NCT01302067|1993802|FG002|Overall Study|Withdrawal by Subject|10
985440|NCT01302067|1993800|FG000|Overall Study|Other|1
985441|NCT01302067|1993801|FG001|Overall Study|Other|1
985442|NCT01302067|1993802|FG002|Overall Study|Other|3
985443|NCT01302067|1993800|FG000|Overall Study|Protocol Violation|11
985444|NCT01302067|1993801|FG001|Overall Study|Protocol Violation|0
985445|NCT01302067|1993802|FG002|Overall Study|Protocol Violation|8
985446|NCT01302067|1993800|FG000|Overall Study|Adverse Event|27
985447|NCT01302067|1993801|FG001|Overall Study|Adverse Event|14
985448|NCT01302067|1993802|FG002|Overall Study|Adverse Event|45
985449|NCT01302080|1993813|FG000|Overall Study|Withdrew Consent|92
985450|NCT01302080|1993814|FG001|Overall Study|Withdrew Consent|39
985451|NCT01302080|1993813|FG000|Overall Study|Patient/Family Moved|28
985452|NCT01302080|1993814|FG001|Overall Study|Patient/Family Moved|3
985453|NCT01302080|1993813|FG000|Overall Study|Lost to Follow-up|192
985454|NCT01302080|1993814|FG001|Overall Study|Lost to Follow-up|93
985455|NCT01302080|1993813|FG000|Overall Study|Death|1
985456|NCT01302080|1993814|FG001|Overall Study|Death|0
985457|NCT01302080|1993813|FG000|Overall Study|Other|52
985458|NCT01302080|1993814|FG001|Overall Study|Other|8
985459|NCT01302080|1993813|FG000|Overall Study|Reason Missing For Discontinuation|1
985460|NCT01302080|1993814|FG001|Overall Study|Reason Missing For Discontinuation|0
985461|NCT01302119|1993846|FG000|Overall Study|Withdrawal by Subject|30
985462|NCT01302119|1993847|FG001|Overall Study|Withdrawal by Subject|20
985463|NCT01302119|1993846|FG000|Overall Study|Lost to Follow-up|10
985464|NCT01302119|1993847|FG001|Overall Study|Lost to Follow-up|4
985465|NCT01302119|1993846|FG000|Overall Study|Adverse Event|2
985466|NCT01302119|1993847|FG001|Overall Study|Adverse Event|1
985467|NCT01302119|1993846|FG000|Overall Study|Non-compliance|4
985468|NCT01302119|1993847|FG001|Overall Study|Non-compliance|2
985469|NCT01302119|1993846|FG000|Overall Study|Non-specific|4
985470|NCT01302119|1993847|FG001|Overall Study|Non-specific|1
985471|NCT01302366|1993853|FG000|Overall Study|patient choice or noncompliance|5
985472|NCT01302392|1993874|FG000|Overall Study|Lost to Follow-up|1
985473|NCT01302392|1993875|FG001|Overall Study|Lost to Follow-up|0
985474|NCT01302392|1993874|FG000|Overall Study|Withdrawal by Subject|6
985475|NCT01302392|1993875|FG001|Overall Study|Withdrawal by Subject|1
985476|NCT01302418|1993881|FG000|Overall Study|Protocol Violation|9
985477|NCT01302418|1993881|FG000|Overall Study|Non-evaluable|9
985478|NCT01302548|1993902|FG000|Overall Study|Lost to Follow-up|2
985479|NCT01302548|1993903|FG001|Overall Study|Lost to Follow-up|1
985480|NCT01302691|1993911|FG000|Overall Study|Adverse Event|2
985481|NCT01302691|1993912|FG001|Overall Study|Adverse Event|0
985482|NCT01302691|1993911|FG000|Overall Study|Death|0
985483|NCT01302691|1993912|FG001|Overall Study|Death|1
985484|NCT01302691|1993911|FG000|Overall Study|Lost to Follow-up|1
985485|NCT01302691|1993912|FG001|Overall Study|Lost to Follow-up|0
985486|NCT01302691|1993911|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6
985487|NCT01302691|1993912|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4
985488|NCT01302691|1993911|FG000|Overall Study|Physician Decision|0
985489|NCT01302691|1993912|FG001|Overall Study|Physician Decision|1
985490|NCT01302691|1993911|FG000|Overall Study|Protocol Violation|1
985491|NCT01302691|1993912|FG001|Overall Study|Protocol Violation|0
985492|NCT01302834|1993952|FG000|Overall Study|Protocol Violation|17
985493|NCT01302834|1993953|FG001|Overall Study|Protocol Violation|23
985494|NCT01302834|1993952|FG000|Overall Study|HIV positive|1
985495|NCT01302834|1993953|FG001|Overall Study|HIV positive|3
985496|NCT01302899|1993965|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
985497|NCT01302899|1993966|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
985498|NCT01302899|1993965|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
985499|NCT01302899|1993966|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
985500|NCT01302938|1993978|FG000|Overall Study|Withdrawal by Subject|1
985501|NCT01302938|1993979|FG001|Overall Study|Withdrawal by Subject|0
985502|NCT01302938|1993978|FG000|Overall Study|Adverse Event|1
985503|NCT01302938|1993979|FG001|Overall Study|Adverse Event|0
985504|NCT01302964|1993988|FG000|Overall Study|Adverse Event|1
985505|NCT01302964|1993989|FG001|Overall Study|Adverse Event|0
985506|NCT01303159|1994004|FG000|Overall Study|Death|16
985507|NCT01303159|1994004|FG000|Overall Study|Study Termination|7
985508|NCT01303172|1994010|FG000|Overall Study|Physician Decision|9
985509|NCT01303172|1994011|FG001|Overall Study|Physician Decision|6
985510|NCT01303172|1994010|FG000|Overall Study|Adverse Event|5
985511|NCT01303172|1994011|FG001|Overall Study|Adverse Event|2
985512|NCT01303172|1994010|FG000|Overall Study|Withdrawal by Subject|4
985513|NCT01303172|1994011|FG001|Overall Study|Withdrawal by Subject|2
985514|NCT01303172|1994010|FG000|Overall Study|Death|20
985515|NCT01303172|1994011|FG001|Overall Study|Death|7
985516|NCT01303172|1994010|FG000|Overall Study|Lack of Efficacy|25
985517|NCT01303172|1994011|FG001|Overall Study|Lack of Efficacy|17
985518|NCT01303380|1994035|FG000|Overall Study|Lack of compliance to study procedures|1
985519|NCT01303419|1994048|FG000|Overall Study|Discontinuation of study|60
985520|NCT01303419|1994048|FG000|Overall Study|Did not complete both imaging methods|5
985521|NCT01303419|1994048|FG000|Overall Study|Did not meet all I/E after screening|31
985522|NCT01303445|1994052|FG000|First Intervention (7 Days)|Withdrawal by Subject|1
985523|NCT01303445|1994053|FG001|First Intervention (7 Days)|Withdrawal by Subject|0
985524|NCT01303445|1994052|FG000|Second Intervention (7 Days)|Adverse Event|0
985525|NCT01303445|1994053|FG001|Second Intervention (7 Days)|Adverse Event|2
985526|NCT01303445|1994052|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
985527|NCT01303445|1994053|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
985528|NCT01303445|1994052|FG000|Washout (14 Days)|Protocol Violation|1
985529|NCT01303445|1994053|FG001|Washout (14 Days)|Protocol Violation|0
985530|NCT01303445|1994052|FG000|Washout (14 Days)|Lost to Follow-up|0
985531|NCT01303445|1994053|FG001|Washout (14 Days)|Lost to Follow-up|2
985532|NCT01303445|1994052|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1
985533|NCT01303445|1994053|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0
985534|NCT01303445|1994052|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0
985535|NCT01303445|1994053|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1
985536|NCT01303510|1994065|FG000|Overall Study|Lost to Follow-up|1
985537|NCT01303510|1994066|FG001|Overall Study|Lost to Follow-up|0
985538|NCT01303627|1994074|FG000|Overall Study|the failure while performing URS|0
985539|NCT01303627|1994075|FG001|Overall Study|the failure while performing URS|1
985540|NCT01303861|1994112|FG000|Overall Study|Lost to Follow-up|34
985541|NCT01303861|1994113|FG001|Overall Study|Lost to Follow-up|14
985542|NCT01303861|1994114|FG002|Overall Study|Lost to Follow-up|27
985543|NCT01303861|1994115|FG003|Overall Study|Lost to Follow-up|31
985544|NCT01303861|1994112|FG000|Overall Study|Lack of Efficacy|3
985545|NCT01303861|1994113|FG001|Overall Study|Lack of Efficacy|2
985546|NCT01303861|1994114|FG002|Overall Study|Lack of Efficacy|1
985547|NCT01303861|1994115|FG003|Overall Study|Lack of Efficacy|0
985548|NCT01303861|1994112|FG000|Overall Study|Withdrawal by Subject|16
985549|NCT01303861|1994113|FG001|Overall Study|Withdrawal by Subject|8
985550|NCT01303861|1994114|FG002|Overall Study|Withdrawal by Subject|8
985551|NCT01303861|1994115|FG003|Overall Study|Withdrawal by Subject|23
985552|NCT01303861|1994112|FG000|Overall Study|Adverse Event|4
985553|NCT01303861|1994113|FG001|Overall Study|Adverse Event|1
985554|NCT01303861|1994114|FG002|Overall Study|Adverse Event|0
985555|NCT01303861|1994115|FG003|Overall Study|Adverse Event|5
985556|NCT01303861|1994112|FG000|Overall Study|Pregnancy|1
985557|NCT01303861|1994113|FG001|Overall Study|Pregnancy|0
985558|NCT01303861|1994114|FG002|Overall Study|Pregnancy|0
985559|NCT01303861|1994115|FG003|Overall Study|Pregnancy|0
985560|NCT01303965|1994139|FG000|Overall Study|Adverse Event|1
985561|NCT01303965|1994140|FG001|Overall Study|Adverse Event|1
985562|NCT01303965|1994139|FG000|Overall Study|Death|0
985563|NCT01303965|1994140|FG001|Overall Study|Death|3
985564|NCT01303965|1994139|FG000|Overall Study|Withdrawal by Subject|1
985565|NCT01303965|1994140|FG001|Overall Study|Withdrawal by Subject|0
985566|NCT01303965|1994139|FG000|Overall Study|Disease Progression|1
985567|NCT01303965|1994140|FG001|Overall Study|Disease Progression|6
985568|NCT01304147|1994158|FG000|Second Intervention (7days)|Withdrawal by Subject|1
985569|NCT01304147|1994159|FG001|Second Intervention (7days)|Withdrawal by Subject|1
985570|NCT01304329|1994218|FG000|Third Intervention (3 Days)|Adverse Event|0
985571|NCT01304329|1994219|FG001|Third Intervention (3 Days)|Adverse Event|1
985572|NCT01304329|1994220|FG002|Third Intervention (3 Days)|Adverse Event|0
985573|NCT01304329|1994221|FG003|Third Intervention (3 Days)|Adverse Event|0
985574|NCT01304329|1994222|FG004|Third Intervention (3 Days)|Adverse Event|0
985575|NCT01304329|1994223|FG005|Third Intervention (3 Days)|Adverse Event|0
985576|NCT01304498|1994237|FG000|Overall Study|Adverse Event|1
985577|NCT01304498|1994238|FG001|Overall Study|Adverse Event|1
985578|NCT01304498|1994237|FG000|Overall Study|Withdrawal by Subject|2
985579|NCT01304498|1994238|FG001|Overall Study|Withdrawal by Subject|3
985580|NCT01304498|1994237|FG000|Overall Study|Protocol Violation|1
985581|NCT01304498|1994238|FG001|Overall Study|Protocol Violation|0
985582|NCT01304498|1994237|FG000|Overall Study|Lost to Follow-up|2
985583|NCT01304498|1994238|FG001|Overall Study|Lost to Follow-up|1
985584|NCT01304693|1994263|FG000|Overall Study|Adverse Event|0
985585|NCT01304693|1994264|FG001|Overall Study|Adverse Event|0
985586|NCT01304693|1994265|FG002|Overall Study|Adverse Event|0
985587|NCT01304693|1994266|FG003|Overall Study|Adverse Event|0
985588|NCT01304693|1994267|FG004|Overall Study|Adverse Event|1
985589|NCT01304693|1994263|FG000|Overall Study|Decision Unrelated to an Adverse Event|0
985590|NCT01304693|1994264|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
985591|NCT01304693|1994265|FG002|Overall Study|Decision Unrelated to an Adverse Event|1
985592|NCT01304693|1994266|FG003|Overall Study|Decision Unrelated to an Adverse Event|1
985593|NCT01304693|1994267|FG004|Overall Study|Decision Unrelated to an Adverse Event|0
985594|NCT01304706|1994279|FG000|Overall Study|Adverse Event|2
985595|NCT01304706|1994279|FG000|Overall Study|Lack of Efficacy|1
985596|NCT01304706|1994279|FG000|Overall Study|Death|3
985597|NCT01304706|1994279|FG000|Overall Study|Withdrawal by Subject|3
985598|NCT01304706|1994279|FG000|Overall Study|Lost to Follow-up|7
985599|NCT01304706|1994279|FG000|Overall Study|Discontinued due to failed drug admin.|1
985600|NCT01304940|1994285|FG000|Overall Study|not meet symptom severity requirement|3
985601|NCT01304940|1994286|FG001|Overall Study|not meet symptom severity requirement|0
985602|NCT01305044|1994300|FG000|Overall Study|Withdrawal by Subject|3
985603|NCT01305044|1994301|FG001|Overall Study|Withdrawal by Subject|6
985604|NCT01305200|1994310|FG000|Overall Study|Physician Decision|4
985605|NCT01305200|1994311|FG001|Overall Study|Physician Decision|6
985606|NCT01305200|1994312|FG002|Overall Study|Physician Decision|1
985607|NCT01305200|1994310|FG000|Overall Study|Withdrawal by Subject|24
985608|NCT01305200|1994311|FG001|Overall Study|Withdrawal by Subject|21
985609|NCT01305200|1994312|FG002|Overall Study|Withdrawal by Subject|1
985610|NCT01305200|1994310|FG000|Overall Study|Ineligible|1
985611|NCT01305200|1994311|FG001|Overall Study|Ineligible|2
985612|NCT01305200|1994312|FG002|Overall Study|Ineligible|1
985613|NCT01305200|1994310|FG000|Overall Study|Death|0
985614|NCT01305200|1994311|FG001|Overall Study|Death|2
985615|NCT01305200|1994312|FG002|Overall Study|Death|0
985616|NCT01305239|1994330|FG000|Overall Study|Adverse Event|22
985617|NCT01305239|1994330|FG000|Overall Study|Exemestane taken prior to inclusion only|1
985618|NCT01305408|1994367|FG000|Overall Study|Adverse Event|10
985619|NCT01305408|1994368|FG001|Overall Study|Adverse Event|7
985620|NCT01305408|1994367|FG000|Overall Study|Lack of Efficacy|3
985621|NCT01305408|1994368|FG001|Overall Study|Lack of Efficacy|4
985622|NCT01305408|1994367|FG000|Overall Study|Withdrawal by Subject|9
985623|NCT01305408|1994368|FG001|Overall Study|Withdrawal by Subject|9
985624|NCT01305408|1994367|FG000|Overall Study|Protocol Violation|4
985625|NCT01305408|1994368|FG001|Overall Study|Protocol Violation|6
985626|NCT01305408|1994367|FG000|Overall Study|Lost to Follow-up|5
985627|NCT01305408|1994368|FG001|Overall Study|Lost to Follow-up|3
985628|NCT01305408|1994367|FG000|Overall Study|Noncompliance with study medication|0
985629|NCT01305408|1994368|FG001|Overall Study|Noncompliance with study medication|1
985630|NCT01305408|1994367|FG000|Overall Study|Noncompliance with study procedures|0
985631|NCT01305408|1994368|FG001|Overall Study|Noncompliance with study procedures|1
985632|NCT01305408|1994367|FG000|Overall Study|Other|1
985633|NCT01305408|1994368|FG001|Overall Study|Other|0
985634|NCT01305564|1994378|FG000|Overall Study|Death|21
985635|NCT01305564|1994378|FG000|Overall Study|Lost to Follow-up|12
985636|NCT01305564|1994378|FG000|Overall Study|Withdrawal by Subject|1
985637|NCT01305564|1994378|FG000|Overall Study|Physician Decision|3
985638|NCT01305577|1994396|FG000|Overall Study|Adverse Event|2
985639|NCT01305577|1994397|FG001|Overall Study|Adverse Event|2
985640|NCT01305577|1994398|FG002|Overall Study|Adverse Event|1
985641|NCT01305577|1994396|FG000|Overall Study|Withdrawal by Subject|7
985642|NCT01305577|1994397|FG001|Overall Study|Withdrawal by Subject|5
985643|NCT01305577|1994398|FG002|Overall Study|Withdrawal by Subject|6
985644|NCT01305577|1994396|FG000|Overall Study|Lost to Follow-up|4
985645|NCT01305577|1994397|FG001|Overall Study|Lost to Follow-up|3
985646|NCT01305577|1994398|FG002|Overall Study|Lost to Follow-up|2
985647|NCT01305577|1994396|FG000|Overall Study|Protocol Deviation|0
985648|NCT01305577|1994397|FG001|Overall Study|Protocol Deviation|1
985649|NCT01305577|1994398|FG002|Overall Study|Protocol Deviation|1
985650|NCT01305941|1994429|FG000|Overall Study|Adverse Event|6
985651|NCT01305941|1994429|FG000|Overall Study|Clinical decline|2
985652|NCT01305941|1994429|FG000|Overall Study|Withdrawal by Subject|1
985653|NCT01305941|1994429|FG000|Overall Study|Death|1
985654|NCT01306032|1994439|FG000|First Intervention|Adverse Event|1
985655|NCT01306032|1994440|FG001|First Intervention|Adverse Event|0
985656|NCT01306032|1994441|FG002|First Intervention|Adverse Event|1
985657|NCT01306032|1994442|FG003|First Intervention|Adverse Event|0
985658|NCT01306032|1994443|FG004|First Intervention|Adverse Event|0
985659|NCT01306032|1994444|FG005|First Intervention|Adverse Event|1
985660|NCT01306032|1994439|FG000|First Intervention|Withdrawal by Subject|0
985661|NCT01306032|1994440|FG001|First Intervention|Withdrawal by Subject|2
985662|NCT01306032|1994441|FG002|First Intervention|Withdrawal by Subject|0
985663|NCT01306032|1994442|FG003|First Intervention|Withdrawal by Subject|1
985664|NCT01306032|1994443|FG004|First Intervention|Withdrawal by Subject|0
985665|NCT01306032|1994444|FG005|First Intervention|Withdrawal by Subject|0
985666|NCT01306032|1994439|FG000|First Intervention|Death|0
985667|NCT01306032|1994440|FG001|First Intervention|Death|0
985668|NCT01306032|1994441|FG002|First Intervention|Death|1
985669|NCT01306032|1994442|FG003|First Intervention|Death|0
985670|NCT01306032|1994443|FG004|First Intervention|Death|0
985671|NCT01306032|1994444|FG005|First Intervention|Death|0
985672|NCT01306032|1994439|FG000|First Intervention|Ineligible|0
985673|NCT01306032|1994440|FG001|First Intervention|Ineligible|0
985674|NCT01306032|1994441|FG002|First Intervention|Ineligible|0
985675|NCT01306032|1994442|FG003|First Intervention|Ineligible|0
985676|NCT01306032|1994443|FG004|First Intervention|Ineligible|0
985677|NCT01306032|1994444|FG005|First Intervention|Ineligible|1
985678|NCT01306032|1994439|FG000|First Intervention|Progressive disease|0
985679|NCT01306032|1994440|FG001|First Intervention|Progressive disease|0
985680|NCT01306032|1994441|FG002|First Intervention|Progressive disease|0
985681|NCT01306032|1994442|FG003|First Intervention|Progressive disease|0
985682|NCT01306032|1994443|FG004|First Intervention|Progressive disease|2
985683|NCT01306032|1994444|FG005|First Intervention|Progressive disease|0
985684|NCT01306032|1994439|FG000|Disease Progression/Crossover|Withdrawal by Subject|0
985685|NCT01306032|1994440|FG001|Disease Progression/Crossover|Withdrawal by Subject|0
985686|NCT01306032|1994441|FG002|Disease Progression/Crossover|Withdrawal by Subject|0
985687|NCT01306032|1994442|FG003|Disease Progression/Crossover|Withdrawal by Subject|1
985688|NCT01306032|1994443|FG004|Disease Progression/Crossover|Withdrawal by Subject|0
985689|NCT01306032|1994444|FG005|Disease Progression/Crossover|Withdrawal by Subject|0
985690|NCT01306032|1994439|FG000|Disease Progression/Crossover|other/symptomatic progression|0
985691|NCT01306032|1994440|FG001|Disease Progression/Crossover|other/symptomatic progression|2
985692|NCT01306032|1994441|FG002|Disease Progression/Crossover|other/symptomatic progression|0
985693|NCT01306032|1994442|FG003|Disease Progression/Crossover|other/symptomatic progression|2
985694|NCT01306032|1994443|FG004|Disease Progression/Crossover|other/symptomatic progression|0
985695|NCT01306032|1994444|FG005|Disease Progression/Crossover|other/symptomatic progression|0
985696|NCT01306058|1994470|FG000|Overall Study|Death|1
985697|NCT01306058|1994470|FG000|Overall Study|Enrolled but did not get treatment|1
985698|NCT01306162|1994478|FG000|Period 1|Adverse Event|0
985699|NCT01306162|1994479|FG001|Period 1|Adverse Event|0
985700|NCT01306162|1994480|FG002|Period 1|Adverse Event|0
985701|NCT01306162|1994481|FG003|Period 1|Adverse Event|1
985702|NCT01306162|1994478|FG000|Washout 1|Non-compliance to protocol|0
985703|NCT01306162|1994479|FG001|Washout 1|Non-compliance to protocol|1
985704|NCT01306162|1994480|FG002|Washout 1|Non-compliance to protocol|0
985705|NCT01306162|1994481|FG003|Washout 1|Non-compliance to protocol|0
985706|NCT01306201|1994500|FG000|Overall Study|Arrhythmia|4
985707|NCT01306201|1994500|FG000|Overall Study|Files could not be processed|3
985708|NCT01306201|1994500|FG000|Overall Study|Files unreadable|3
985709|NCT01306214|1994511|FG000|Overall Study|Death|0
985710|NCT01306214|1994512|FG001|Overall Study|Death|0
985711|NCT01306214|1994513|FG002|Overall Study|Death|1
985712|NCT01306214|1994511|FG000|Overall Study|Lost to Follow-up|3
985713|NCT01306214|1994512|FG001|Overall Study|Lost to Follow-up|5
985714|NCT01306214|1994513|FG002|Overall Study|Lost to Follow-up|4
985715|NCT01306214|1994511|FG000|Overall Study|Withdrawal by Subject|24
985716|NCT01306214|1994512|FG001|Overall Study|Withdrawal by Subject|22
985717|NCT01306214|1994513|FG002|Overall Study|Withdrawal by Subject|16
985718|NCT01306214|1994511|FG000|Overall Study|Not treated|1
985719|NCT01306214|1994512|FG001|Overall Study|Not treated|1
985720|NCT01306214|1994513|FG002|Overall Study|Not treated|1
985721|NCT01306253|1994523|FG000|Overall Study|Lost to Follow-up|1
985722|NCT01306253|1994524|FG001|Overall Study|Lost to Follow-up|1
985723|NCT01306305|1994545|FG000|Overall Study|Lost to Follow-up|1
985724|NCT01306305|1994546|FG001|Overall Study|Lost to Follow-up|0
985725|NCT01306305|1994545|FG000|Overall Study|Withdrew consent|1
985726|NCT01306305|1994546|FG001|Overall Study|Withdrew consent|0
985727|NCT01306331|1994554|FG000|Overall Study|Adverse Event|28
985728|NCT01306331|1994555|FG001|Overall Study|Adverse Event|25
985729|NCT01306331|1994554|FG000|Overall Study|Lost to Follow-up|321
985730|NCT01306331|1994555|FG001|Overall Study|Lost to Follow-up|323
985731|NCT01306331|1994554|FG000|Overall Study|Physician Decision|26
985732|NCT01306331|1994555|FG001|Overall Study|Physician Decision|22
985733|NCT01306331|1994554|FG000|Overall Study|Pregnancy|136
985734|NCT01306331|1994555|FG001|Overall Study|Pregnancy|151
985735|NCT01306331|1994554|FG000|Overall Study|Protocol Violation|154
985736|NCT01306331|1994555|FG001|Overall Study|Protocol Violation|124
985737|NCT01306331|1994554|FG000|Overall Study|Withdrawal by Subject|163
985738|NCT01306331|1994555|FG001|Overall Study|Withdrawal by Subject|152
985739|NCT01306331|1994554|FG000|Overall Study|Not sexually active|29
985740|NCT01306331|1994555|FG001|Overall Study|Not sexually active|28
985741|NCT01306331|1994554|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10
985742|NCT01306331|1994555|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20
985743|NCT01306331|1994554|FG000|Overall Study|Other|34
985744|NCT01306331|1994555|FG001|Overall Study|Other|32
985745|NCT01306617|1994564|FG000|Overall Study|Adverse Event|1
985746|NCT01306617|1994565|FG001|Overall Study|Adverse Event|0
985747|NCT01306617|1994566|FG002|Overall Study|Adverse Event|0
985748|NCT01306617|1994564|FG000|Overall Study|Virologic Failure|0
985749|NCT01306617|1994565|FG001|Overall Study|Virologic Failure|0
985750|NCT01306617|1994566|FG002|Overall Study|Virologic Failure|5
985751|NCT01306617|1994564|FG000|Overall Study|Non-compliance|0
985752|NCT01306617|1994565|FG001|Overall Study|Non-compliance|1
985753|NCT01306617|1994566|FG002|Overall Study|Non-compliance|0
985754|NCT01306643|1994574|FG000|Overall Study|Adverse Event|5
985755|NCT01306643|1994574|FG000|Overall Study|Disease Progression|7
985756|NCT01306643|1994574|FG000|Overall Study|Other: Change in Eligibility Status|1
985757|NCT01306656|1994580|FG000|Overall Study|Lost to Follow-up|1
985758|NCT01306656|1994581|FG001|Overall Study|Lost to Follow-up|0
985759|NCT01306877|1994591|FG000|Overall Study|Lost to Follow-up|3
985760|NCT01306877|1994592|FG001|Overall Study|Lost to Follow-up|3
985761|NCT01306877|1994591|FG000|Overall Study|Physician Decision|0
985762|NCT01306877|1994592|FG001|Overall Study|Physician Decision|1
985763|NCT01306890|1994598|FG000|Overall Study|Adverse Event|2
985764|NCT01306890|1994598|FG000|Overall Study|Death|1223
985765|NCT01306890|1994598|FG000|Overall Study|Lost to Follow-up|58
985766|NCT01306890|1994598|FG000|Overall Study|Withdrawal by Subject|88
985767|NCT01306890|1994598|FG000|Overall Study|Unspecified reasons|104
985768|NCT01306890|1994598|FG000|Overall Study|Study Termination|3
985769|NCT01306890|1994598|FG000|Overall Study|No discontinuation documentation|41
985770|NCT01306942|1994605|FG000|Phase I|Adverse Event|2
985771|NCT01306942|1994606|FG001|Phase I|Adverse Event|2
985772|NCT01306942|1994607|FG002|Phase I|Adverse Event|0
985773|NCT01306942|1994608|FG003|Phase I|Adverse Event|0
985774|NCT01306942|1994605|FG000|Phase I|Physician Decision|3
985775|NCT01306942|1994606|FG001|Phase I|Physician Decision|1
985776|NCT01306942|1994607|FG002|Phase I|Physician Decision|0
985777|NCT01306942|1994608|FG003|Phase I|Physician Decision|0
985778|NCT01306942|1994605|FG000|Phase II|Adverse Event|0
985779|NCT01306942|1994606|FG001|Phase II|Adverse Event|0
985780|NCT01306942|1994607|FG002|Phase II|Adverse Event|0
985781|NCT01306942|1994608|FG003|Phase II|Adverse Event|6
985782|NCT01306942|1994605|FG000|Phase II|Physician Decision|2
985783|NCT01306942|1994606|FG001|Phase II|Physician Decision|0
985784|NCT01306942|1994607|FG002|Phase II|Physician Decision|0
985785|NCT01306942|1994608|FG003|Phase II|Physician Decision|5
985786|NCT01306942|1994605|FG000|Phase II|Withdrawal by Subject|0
985787|NCT01306942|1994606|FG001|Phase II|Withdrawal by Subject|0
985788|NCT01306942|1994607|FG002|Phase II|Withdrawal by Subject|0
985789|NCT01306942|1994608|FG003|Phase II|Withdrawal by Subject|2
985790|NCT01306942|1994605|FG000|Phase II|Death|0
985791|NCT01306942|1994606|FG001|Phase II|Death|0
985792|NCT01306942|1994607|FG002|Phase II|Death|0
985793|NCT01306942|1994608|FG003|Phase II|Death|1
985794|NCT01306942|1994605|FG000|Phase II|Not finished treatment|0
985795|NCT01306942|1994606|FG001|Phase II|Not finished treatment|0
985796|NCT01306942|1994607|FG002|Phase II|Not finished treatment|0
985797|NCT01306942|1994608|FG003|Phase II|Not finished treatment|1
985798|NCT01306942|1994605|FG000|Phase II|Protocol Violation|0
985799|NCT01306942|1994606|FG001|Phase II|Protocol Violation|0
985800|NCT01306942|1994607|FG002|Phase II|Protocol Violation|0
985801|NCT01306942|1994608|FG003|Phase II|Protocol Violation|1
985802|NCT01306968|1994624|FG000|Overall Study|Lost to Follow-up|1
985803|NCT01306968|1994625|FG001|Overall Study|Lost to Follow-up|1
985804|NCT01306968|1994626|FG002|Overall Study|Lost to Follow-up|0
985805|NCT01306968|1994627|FG003|Overall Study|Lost to Follow-up|0
985806|NCT01306968|1994624|FG000|Overall Study|Physician Decision|0
985807|NCT01306968|1994625|FG001|Overall Study|Physician Decision|1
985808|NCT01306968|1994626|FG002|Overall Study|Physician Decision|0
985809|NCT01306968|1994627|FG003|Overall Study|Physician Decision|0
985810|NCT01306968|1994624|FG000|Overall Study|Relocated and left active duty|0
985811|NCT01306968|1994625|FG001|Overall Study|Relocated and left active duty|1
985812|NCT01306968|1994626|FG002|Overall Study|Relocated and left active duty|1
985813|NCT01306968|1994627|FG003|Overall Study|Relocated and left active duty|1
985814|NCT01306968|1994624|FG000|Overall Study|Withdrew - time commitment|0
985815|NCT01306968|1994625|FG001|Overall Study|Withdrew - time commitment|0
985816|NCT01306968|1994626|FG002|Overall Study|Withdrew - time commitment|0
985817|NCT01306968|1994627|FG003|Overall Study|Withdrew - time commitment|2
985818|NCT01306968|1994624|FG000|Overall Study|Withdrew over privacy concerns|0
985819|NCT01306968|1994625|FG001|Overall Study|Withdrew over privacy concerns|0
985820|NCT01306968|1994626|FG002|Overall Study|Withdrew over privacy concerns|0
985821|NCT01306968|1994627|FG003|Overall Study|Withdrew over privacy concerns|1
985822|NCT01307020|1994658|FG000|Overall Study|Lost to Follow-up|0
985823|NCT01307020|1994659|FG001|Overall Study|Lost to Follow-up|0
985824|NCT01307020|1994660|FG002|Overall Study|Lost to Follow-up|1
985825|NCT01307020|1994661|FG003|Overall Study|Lost to Follow-up|1
985826|NCT01307020|1994662|FG004|Overall Study|Lost to Follow-up|0
985827|NCT01307020|1994663|FG005|Overall Study|Lost to Follow-up|0
985828|NCT01307020|1994664|FG006|Overall Study|Lost to Follow-up|1
985829|NCT01307020|1994665|FG007|Overall Study|Lost to Follow-up|0
985830|NCT01307020|1994666|FG008|Overall Study|Lost to Follow-up|0
985831|NCT01307020|1994667|FG009|Overall Study|Lost to Follow-up|0
985832|NCT01307020|1994658|FG000|Overall Study|Electronic data capture failure|0
985833|NCT01307020|1994659|FG001|Overall Study|Electronic data capture failure|1
985834|NCT01307020|1994660|FG002|Overall Study|Electronic data capture failure|0
985835|NCT01307020|1994661|FG003|Overall Study|Electronic data capture failure|0
985836|NCT01307020|1994662|FG004|Overall Study|Electronic data capture failure|0
985837|NCT01307020|1994663|FG005|Overall Study|Electronic data capture failure|0
985838|NCT01307020|1994664|FG006|Overall Study|Electronic data capture failure|0
985839|NCT01307020|1994665|FG007|Overall Study|Electronic data capture failure|0
985840|NCT01307020|1994666|FG008|Overall Study|Electronic data capture failure|0
985841|NCT01307020|1994667|FG009|Overall Study|Electronic data capture failure|0
985842|NCT01307033|1994691|FG000|8-week Double-blind Period|Adverse Event|2
985843|NCT01307033|1994692|FG001|8-week Double-blind Period|Adverse Event|0
985844|NCT01307033|1994693|FG002|8-week Double-blind Period|Adverse Event|0
985845|NCT01307033|1994694|FG003|8-week Double-blind Period|Adverse Event|0
985846|NCT01307033|1994691|FG000|8-week Double-blind Period|Withdrawal by Subject|4
985847|NCT01307033|1994692|FG001|8-week Double-blind Period|Withdrawal by Subject|1
985848|NCT01307033|1994693|FG002|8-week Double-blind Period|Withdrawal by Subject|0
985849|NCT01307033|1994694|FG003|8-week Double-blind Period|Withdrawal by Subject|0
985850|NCT01307033|1994691|FG000|8-week Double-blind Period|Lack of Efficacy|1
985851|NCT01307033|1994692|FG001|8-week Double-blind Period|Lack of Efficacy|0
985852|NCT01307033|1994693|FG002|8-week Double-blind Period|Lack of Efficacy|0
985853|NCT01307033|1994694|FG003|8-week Double-blind Period|Lack of Efficacy|0
985854|NCT01307033|1994691|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
985855|NCT01307033|1994692|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
985856|NCT01307033|1994693|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
985857|NCT01307033|1994694|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
985858|NCT01307033|1994691|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
985859|NCT01307033|1994692|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
985860|NCT01307033|1994693|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
985861|NCT01307033|1994694|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
985862|NCT01307033|1994691|FG000|44-week Open-label Extension|Adverse Event|0
985863|NCT01307033|1994692|FG001|44-week Open-label Extension|Adverse Event|0
985864|NCT01307033|1994693|FG002|44-week Open-label Extension|Adverse Event|2
985865|NCT01307033|1994694|FG003|44-week Open-label Extension|Adverse Event|1
985866|NCT01307033|1994691|FG000|44-week Open-label Extension|Withdrawal by Subject|0
985867|NCT01307033|1994692|FG001|44-week Open-label Extension|Withdrawal by Subject|0
985868|NCT01307033|1994693|FG002|44-week Open-label Extension|Withdrawal by Subject|2
985869|NCT01307033|1994694|FG003|44-week Open-label Extension|Withdrawal by Subject|1
985870|NCT01307033|1994691|FG000|44-week Open-label Extension|Physician Decision|0
985871|NCT01307033|1994692|FG001|44-week Open-label Extension|Physician Decision|0
985872|NCT01307033|1994693|FG002|44-week Open-label Extension|Physician Decision|1
985873|NCT01307033|1994694|FG003|44-week Open-label Extension|Physician Decision|0
985874|NCT01307033|1994691|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
985875|NCT01307033|1994692|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
985876|NCT01307033|1994693|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
985877|NCT01307033|1994694|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
985878|NCT01307033|1994691|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
985879|NCT01307033|1994692|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
985880|NCT01307033|1994693|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
985881|NCT01307033|1994694|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
985882|NCT01307033|1994691|FG000|44-week Open-label Extension|Death|0
985883|NCT01307033|1994692|FG001|44-week Open-label Extension|Death|0
985884|NCT01307033|1994693|FG002|44-week Open-label Extension|Death|0
985885|NCT01307033|1994694|FG003|44-week Open-label Extension|Death|1
985886|NCT01307046|1994708|FG000|Overall Study|Adverse Event|3
985887|NCT01307046|1994709|FG001|Overall Study|Adverse Event|3
985888|NCT01307046|1994708|FG000|Overall Study|Lack of Efficacy|0
985889|NCT01307046|1994709|FG001|Overall Study|Lack of Efficacy|2
985890|NCT01307046|1994708|FG000|Overall Study|Physician Decision|2
985891|NCT01307046|1994709|FG001|Overall Study|Physician Decision|0
985892|NCT01307046|1994708|FG000|Overall Study|Withdrawal by Subject|1
985893|NCT01307046|1994709|FG001|Overall Study|Withdrawal by Subject|1
985894|NCT01307046|1994708|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4
985895|NCT01307046|1994709|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2
985896|NCT01307046|1994708|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2
985897|NCT01307046|1994709|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3
985898|NCT01307111|1994731|FG000|IUD Insertion|Lost to Follow-up|2
985899|NCT01307111|1994732|FG001|IUD Insertion|Lost to Follow-up|0
985900|NCT01307111|1994731|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2
985901|NCT01307111|1994732|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2
985902|NCT01307267|1994761|FG000|Overall Study|Death|4
985903|NCT01307267|1994762|FG001|Overall Study|Death|3
985904|NCT01307267|1994763|FG002|Overall Study|Death|5
985905|NCT01307267|1994764|FG003|Overall Study|Death|3
985906|NCT01307267|1994765|FG004|Overall Study|Death|1
985907|NCT01307267|1994766|FG005|Overall Study|Death|26
985908|NCT01307267|1994767|FG006|Overall Study|Death|2
985909|NCT01307267|1994768|FG007|Overall Study|Death|2
985910|NCT01307267|1994769|FG008|Overall Study|Death|21
985911|NCT01307267|1994770|FG009|Overall Study|Death|2
985912|NCT01307267|1994771|FG010|Overall Study|Death|3
985913|NCT01307267|1994772|FG011|Overall Study|Death|9
985914|NCT01307267|1994773|FG012|Overall Study|Death|0
985915|NCT01307267|1994774|FG013|Overall Study|Death|0
985916|NCT01307267|1994775|FG014|Overall Study|Death|0
985917|NCT01307267|1994776|FG015|Overall Study|Death|0
985918|NCT01307267|1994777|FG016|Overall Study|Death|1
985919|NCT01307267|1994778|FG017|Overall Study|Death|1
985920|NCT01307267|1994779|FG018|Overall Study|Death|2
985921|NCT01307267|1994780|FG019|Overall Study|Death|8
985922|NCT01307267|1994781|FG020|Overall Study|Death|1
985923|NCT01307267|1994782|FG021|Overall Study|Death|2
985924|NCT01307267|1994783|FG022|Overall Study|Death|2
985925|NCT01307267|1994761|FG000|Overall Study|Lost to Follow-up|0
985926|NCT01307267|1994762|FG001|Overall Study|Lost to Follow-up|0
985927|NCT01307267|1994763|FG002|Overall Study|Lost to Follow-up|0
985928|NCT01307267|1994764|FG003|Overall Study|Lost to Follow-up|0
985929|NCT01307267|1994765|FG004|Overall Study|Lost to Follow-up|0
985930|NCT01307267|1994766|FG005|Overall Study|Lost to Follow-up|7
985931|NCT01307267|1994767|FG006|Overall Study|Lost to Follow-up|0
985932|NCT01307267|1994768|FG007|Overall Study|Lost to Follow-up|0
985933|NCT01307267|1994769|FG008|Overall Study|Lost to Follow-up|1
985934|NCT01307267|1994770|FG009|Overall Study|Lost to Follow-up|2
985935|NCT01307267|1994771|FG010|Overall Study|Lost to Follow-up|1
985936|NCT01307267|1994772|FG011|Overall Study|Lost to Follow-up|0
985937|NCT01307267|1994773|FG012|Overall Study|Lost to Follow-up|0
985938|NCT01307267|1994774|FG013|Overall Study|Lost to Follow-up|0
985939|NCT01307267|1994775|FG014|Overall Study|Lost to Follow-up|0
985940|NCT01307267|1994776|FG015|Overall Study|Lost to Follow-up|0
985941|NCT01307267|1994777|FG016|Overall Study|Lost to Follow-up|0
985942|NCT01307267|1994778|FG017|Overall Study|Lost to Follow-up|0
985943|NCT01307267|1994779|FG018|Overall Study|Lost to Follow-up|0
985944|NCT01307267|1994780|FG019|Overall Study|Lost to Follow-up|2
985945|NCT01307267|1994781|FG020|Overall Study|Lost to Follow-up|0
985946|NCT01307267|1994782|FG021|Overall Study|Lost to Follow-up|0
985947|NCT01307267|1994783|FG022|Overall Study|Lost to Follow-up|0
985948|NCT01307267|1994761|FG000|Overall Study|Withdrawal by Subject|0
985949|NCT01307267|1994762|FG001|Overall Study|Withdrawal by Subject|0
985950|NCT01307267|1994763|FG002|Overall Study|Withdrawal by Subject|0
985951|NCT01307267|1994764|FG003|Overall Study|Withdrawal by Subject|0
985952|NCT01307267|1994765|FG004|Overall Study|Withdrawal by Subject|0
985953|NCT01307267|1994766|FG005|Overall Study|Withdrawal by Subject|1
985954|NCT01307267|1994767|FG006|Overall Study|Withdrawal by Subject|0
985955|NCT01307267|1994768|FG007|Overall Study|Withdrawal by Subject|1
985956|NCT01307267|1994769|FG008|Overall Study|Withdrawal by Subject|5
985957|NCT01307267|1994770|FG009|Overall Study|Withdrawal by Subject|1
985958|NCT01307267|1994771|FG010|Overall Study|Withdrawal by Subject|1
985959|NCT01307267|1994772|FG011|Overall Study|Withdrawal by Subject|1
985960|NCT01307267|1994773|FG012|Overall Study|Withdrawal by Subject|0
985961|NCT01307267|1994774|FG013|Overall Study|Withdrawal by Subject|0
985962|NCT01307267|1994775|FG014|Overall Study|Withdrawal by Subject|0
985963|NCT01307267|1994776|FG015|Overall Study|Withdrawal by Subject|0
985964|NCT01307267|1994777|FG016|Overall Study|Withdrawal by Subject|0
985965|NCT01307267|1994778|FG017|Overall Study|Withdrawal by Subject|0
985966|NCT01307267|1994779|FG018|Overall Study|Withdrawal by Subject|0
985967|NCT01307267|1994780|FG019|Overall Study|Withdrawal by Subject|3
985968|NCT01307267|1994781|FG020|Overall Study|Withdrawal by Subject|0
985969|NCT01307267|1994782|FG021|Overall Study|Withdrawal by Subject|0
985970|NCT01307267|1994783|FG022|Overall Study|Withdrawal by Subject|0
985971|NCT01307267|1994761|FG000|Overall Study|Other|0
985972|NCT01307267|1994762|FG001|Overall Study|Other|0
985973|NCT01307267|1994763|FG002|Overall Study|Other|0
985974|NCT01307267|1994764|FG003|Overall Study|Other|0
985975|NCT01307267|1994765|FG004|Overall Study|Other|0
985976|NCT01307267|1994766|FG005|Overall Study|Other|7
985977|NCT01307267|1994767|FG006|Overall Study|Other|0
985978|NCT01307267|1994768|FG007|Overall Study|Other|1
985979|NCT01307267|1994769|FG008|Overall Study|Other|3
985980|NCT01307267|1994770|FG009|Overall Study|Other|0
985981|NCT01307267|1994771|FG010|Overall Study|Other|1
985982|NCT01307267|1994772|FG011|Overall Study|Other|1
985983|NCT01307267|1994773|FG012|Overall Study|Other|1
985984|NCT01307267|1994774|FG013|Overall Study|Other|0
985985|NCT01307267|1994775|FG014|Overall Study|Other|2
985986|NCT01307267|1994776|FG015|Overall Study|Other|1
985987|NCT01307267|1994777|FG016|Overall Study|Other|0
985988|NCT01307267|1994778|FG017|Overall Study|Other|0
985989|NCT01307267|1994779|FG018|Overall Study|Other|0
985990|NCT01307267|1994780|FG019|Overall Study|Other|19
985991|NCT01307267|1994781|FG020|Overall Study|Other|2
985992|NCT01307267|1994782|FG021|Overall Study|Other|3
985993|NCT01307267|1994783|FG022|Overall Study|Other|2
985994|NCT01307319|1994845|FG000|Overall Study|Adverse Event|2
985995|NCT01307319|1994846|FG001|Overall Study|Adverse Event|2
985996|NCT01307319|1994847|FG002|Overall Study|Adverse Event|1
985997|NCT01307319|1994845|FG000|Overall Study|Lost to Follow-up|1
985998|NCT01307319|1994846|FG001|Overall Study|Lost to Follow-up|0
985999|NCT01307319|1994847|FG002|Overall Study|Lost to Follow-up|1
986000|NCT01307319|1994845|FG000|Overall Study|Protocol Violation|1
986001|NCT01307319|1994846|FG001|Overall Study|Protocol Violation|1
986002|NCT01307319|1994847|FG002|Overall Study|Protocol Violation|0
986003|NCT01307319|1994845|FG000|Overall Study|Withdrawal by Subject|0
986004|NCT01307319|1994846|FG001|Overall Study|Withdrawal by Subject|1
986005|NCT01307319|1994847|FG002|Overall Study|Withdrawal by Subject|2
986006|NCT01307319|1994845|FG000|Overall Study|Other|0
986007|NCT01307319|1994846|FG001|Overall Study|Other|4
986008|NCT01307319|1994847|FG002|Overall Study|Other|3
986009|NCT01307423|1994862|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
986010|NCT01307423|1994863|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
986011|NCT01307423|1994864|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
986012|NCT01307423|1994865|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
986013|NCT01307423|1994866|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
986014|NCT01307423|1994867|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
986015|NCT01307423|1994868|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
986016|NCT01307423|1994869|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
986017|NCT01307423|1994870|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
986018|NCT01307423|1994862|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
986019|NCT01307423|1994863|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
986020|NCT01307423|1994864|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
986021|NCT01307423|1994865|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
986022|NCT01307423|1994866|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
986023|NCT01307423|1994867|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
986024|NCT01307423|1994868|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
986025|NCT01307423|1994869|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
986026|NCT01307423|1994870|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
986027|NCT01307423|1994862|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
986028|NCT01307423|1994863|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
986029|NCT01307423|1994864|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
986030|NCT01307423|1994865|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
986031|NCT01307423|1994866|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
986032|NCT01307423|1994867|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
986033|NCT01307423|1994868|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
986034|NCT01307423|1994869|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
986035|NCT01307423|1994870|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
986036|NCT01307423|1994862|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
986037|NCT01307423|1994863|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
986038|NCT01307423|1994864|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
986039|NCT01307423|1994865|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
986040|NCT01307423|1994866|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
986041|NCT01307423|1994867|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
986042|NCT01307423|1994868|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
986043|NCT01307423|1994869|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
986044|NCT01307423|1994870|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
986045|NCT01307423|1994862|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
986046|NCT01307423|1994863|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
986047|NCT01307423|1994864|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
986048|NCT01307423|1994865|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
986049|NCT01307423|1994866|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
986050|NCT01307423|1994867|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
986051|NCT01307423|1994868|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
986052|NCT01307423|1994869|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
986053|NCT01307423|1994870|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
986054|NCT01307423|1994862|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
986055|NCT01307423|1994863|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
986056|NCT01307423|1994864|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
986057|NCT01307423|1994865|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
986058|NCT01307423|1994866|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
986059|NCT01307423|1994867|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
986060|NCT01307423|1994868|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
986061|NCT01307423|1994869|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
986062|NCT01307423|1994870|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
986063|NCT01307423|1994862|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
986064|NCT01307423|1994863|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
986065|NCT01307423|1994864|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
986066|NCT01307423|1994865|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
986067|NCT01307423|1994866|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
986068|NCT01307423|1994867|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
986069|NCT01307423|1994868|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
986070|NCT01307423|1994869|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
986071|NCT01307423|1994870|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
986072|NCT01307423|1994862|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
986073|NCT01307423|1994863|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
986074|NCT01307423|1994864|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
986075|NCT01307423|1994865|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
986076|NCT01307423|1994866|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
986077|NCT01307423|1994867|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
986078|NCT01307423|1994868|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
986079|NCT01307423|1994869|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
986080|NCT01307423|1994870|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
986081|NCT01307423|1994862|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0
986082|NCT01307423|1994863|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3
986083|NCT01307423|1994864|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2
986084|NCT01307423|1994865|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2
986085|NCT01307423|1994866|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2
986086|NCT01307423|1994867|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0
986087|NCT01307423|1994868|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0
986088|NCT01307423|1994869|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0
986089|NCT01307423|1994870|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0
986090|NCT01307423|1994862|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
986091|NCT01307423|1994863|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
986092|NCT01307423|1994864|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
986093|NCT01307423|1994865|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
986094|NCT01307423|1994866|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
986095|NCT01307423|1994867|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
986096|NCT01307423|1994868|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
986097|NCT01307423|1994869|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
986098|NCT01307423|1994870|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
986099|NCT01307423|1994862|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
986100|NCT01307423|1994863|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
986101|NCT01307423|1994864|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
986102|NCT01307423|1994865|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
986103|NCT01307423|1994866|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
986104|NCT01307423|1994867|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
986105|NCT01307423|1994868|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1006720|NCT01469052|2025440|FG004|Overall Study|Lack of Efficacy|0
986106|NCT01307423|1994869|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
986107|NCT01307423|1994870|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
986108|NCT01307423|1994862|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
986109|NCT01307423|1994863|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
986110|NCT01307423|1994864|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
986111|NCT01307423|1994865|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
986112|NCT01307423|1994866|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
986113|NCT01307423|1994867|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
986114|NCT01307423|1994868|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
986115|NCT01307423|1994869|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
986116|NCT01307423|1994870|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
986117|NCT01307423|1994862|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
986118|NCT01307423|1994863|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
986119|NCT01307423|1994864|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
986120|NCT01307423|1994865|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
986121|NCT01307423|1994866|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
986122|NCT01307423|1994867|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
986123|NCT01307423|1994868|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
986124|NCT01307423|1994869|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
986125|NCT01307423|1994870|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
986126|NCT01307423|1994862|FG000|Active Treatment Phase (Week 25-52)|Other|0
986127|NCT01307423|1994863|FG001|Active Treatment Phase (Week 25-52)|Other|0
986128|NCT01307423|1994864|FG002|Active Treatment Phase (Week 25-52)|Other|0
986129|NCT01307423|1994865|FG003|Active Treatment Phase (Week 25-52)|Other|1
986130|NCT01307423|1994866|FG004|Active Treatment Phase (Week 25-52)|Other|0
986131|NCT01307423|1994867|FG005|Active Treatment Phase (Week 25-52)|Other|0
986132|NCT01307423|1994868|FG006|Active Treatment Phase (Week 25-52)|Other|0
986133|NCT01307423|1994869|FG007|Active Treatment Phase (Week 25-52)|Other|0
986134|NCT01307423|1994870|FG008|Active Treatment Phase (Week 25-52)|Other|0
986135|NCT01307423|1994862|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0
986136|NCT01307423|1994863|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0
986137|NCT01307423|1994864|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0
986138|NCT01307423|1994865|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0
986139|NCT01307423|1994866|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0
986140|NCT01307423|1994867|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1
986141|NCT01307423|1994868|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0
986142|NCT01307423|1994869|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0
986143|NCT01307423|1994870|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0
986144|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
986145|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2
986146|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7
986147|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
986148|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
986149|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
986150|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
986151|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1
986152|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1
986153|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
986154|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
986155|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
986156|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
986157|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
986158|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
986159|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
986160|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
986161|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
986162|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
986163|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
986164|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
986165|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
986166|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
986167|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
986168|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
986169|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
986170|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
986171|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
986172|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
986173|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
986174|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
986175|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
986176|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
986177|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
986178|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
986179|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
986180|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
986181|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1
986182|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0
986183|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
986184|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
986185|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
986186|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
986187|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1
986188|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
986189|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
986190|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1
986191|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
986192|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
986193|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
986194|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
986195|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
986196|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3
986197|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4
986198|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
986199|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
986200|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
986201|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
986202|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
986203|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
986204|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
986205|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
986206|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
986207|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
986208|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
986209|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
986210|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
986211|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
986212|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
986213|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
986214|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
986215|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
986216|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
986217|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
986218|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
986219|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
986220|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
986221|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
986222|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
986223|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
986224|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
986225|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
986226|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
986227|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
986228|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
986229|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
986230|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
986231|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
986232|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
986233|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
986234|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
986235|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1
986236|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0
986237|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
986238|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
986239|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
986240|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
986241|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
986242|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0
986243|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
986244|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2
986245|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0
986246|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
986247|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
986248|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
986249|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
986250|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
986251|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0
986252|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
986253|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
986254|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
986255|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
986256|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
986257|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
986258|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
986259|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
986260|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
986261|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
986262|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
986263|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
986264|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
986265|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
986266|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
986267|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
986268|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
986269|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
986270|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
986271|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
986272|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
986273|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
986274|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
986275|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
986276|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
986277|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
986278|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
986279|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
986280|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0
986281|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
986282|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
986283|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
986284|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
986285|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
986286|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1
986287|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0
986288|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
986289|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1
986290|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1
986291|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
986292|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
986293|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
986294|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
986295|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
986296|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
986297|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
986298|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
986299|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
986300|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
986301|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
986302|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
986303|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
986304|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
986305|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
986306|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
986307|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
986308|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
986309|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
986310|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
986311|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
986312|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
986313|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
986314|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
986315|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
986316|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
986317|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
986318|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
986319|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
986320|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
986321|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
986322|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
986323|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
986324|NCT01307423|1994862|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
986325|NCT01307423|1994863|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
986326|NCT01307423|1994864|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2
986327|NCT01307423|1994865|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
986328|NCT01307423|1994866|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
986329|NCT01307423|1994867|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
986330|NCT01307423|1994868|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
986331|NCT01307423|1994869|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1
986332|NCT01307423|1994870|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1
986333|NCT01307449|1994906|FG000|Overall Study|Adverse Event|1
986334|NCT01307449|1994907|FG001|Overall Study|Adverse Event|0
986335|NCT01307449|1994908|FG002|Overall Study|Adverse Event|0
986336|NCT01307449|1994909|FG003|Overall Study|Adverse Event|0
986337|NCT01307501|1994923|FG000|Overall Study|Treatment Failure|1
986338|NCT01307501|1994923|FG000|Overall Study|Death|20
986339|NCT01307501|1994923|FG000|Overall Study|Lost to Follow-up|1
986340|NCT01307501|1994923|FG000|Overall Study|Starting Hospice|1
986341|NCT01307579|1994929|FG000|Overall Study|Death|3
986342|NCT01307579|1994930|FG001|Overall Study|Death|6
986343|NCT01307579|1994929|FG000|Overall Study|Physician Decision|26
986344|NCT01307579|1994930|FG001|Overall Study|Physician Decision|29
986345|NCT01307579|1994929|FG000|Overall Study|Withdrawal by Subject|7
986346|NCT01307579|1994930|FG001|Overall Study|Withdrawal by Subject|3
986347|NCT01307579|1994929|FG000|Overall Study|Institutional diagnosis of IFD|21
986348|NCT01307579|1994930|FG001|Overall Study|Institutional diagnosis of IFD|36
986349|NCT01307579|1994929|FG000|Overall Study|Begin conditioning for HSCT|42
986350|NCT01307579|1994930|FG001|Overall Study|Begin conditioning for HSCT|44
986351|NCT01307579|1994929|FG000|Overall Study|Refractory or relapsed AML|38
986352|NCT01307579|1994930|FG001|Overall Study|Refractory or relapsed AML|23
986353|NCT01307579|1994929|FG000|Overall Study|Ineligible|3
986354|NCT01307579|1994930|FG001|Overall Study|Ineligible|4
986357|NCT01307891|1994987|FG000|Overall Study|Progressive Disease|3
986358|NCT01307891|1994988|FG001|Overall Study|Progressive Disease|1
986359|NCT01308008|1995004|FG000|4 Weeks|Illness, disinterest, time|9
986360|NCT01308008|1995005|FG001|4 Weeks|Illness, disinterest, time|2
986361|NCT01308424|1995039|FG000|Baseline Eligibility|Screen Failures|71
986362|NCT01308424|1995040|FG001|Baseline Eligibility|Screen Failures|0
986363|NCT01308424|1995041|FG002|Baseline Eligibility|Screen Failures|0
986364|NCT01308424|1995039|FG000|Randomization|Adverse Event|0
986365|NCT01308424|1995040|FG001|Randomization|Adverse Event|1
986366|NCT01308424|1995041|FG002|Randomization|Adverse Event|1
986367|NCT01308424|1995039|FG000|Randomization|Lost to Follow-up|0
986368|NCT01308424|1995040|FG001|Randomization|Lost to Follow-up|1
986369|NCT01308424|1995041|FG002|Randomization|Lost to Follow-up|0
986370|NCT01308424|1995039|FG000|Randomization|Physician Decision|0
986371|NCT01308424|1995040|FG001|Randomization|Physician Decision|1
986372|NCT01308424|1995041|FG002|Randomization|Physician Decision|1
986373|NCT01308463|1995052|FG000|Overall Study|Study Discontinued|23
986374|NCT01308463|1995052|FG000|Overall Study|Death|4
986375|NCT01308463|1995052|FG000|Overall Study|Revision|2
986376|NCT01308476|1995058|FG000|Overall Study|Lost to Follow-up|2
986377|NCT01308476|1995059|FG001|Overall Study|Lost to Follow-up|2
986378|NCT01308476|1995058|FG000|Overall Study|Other|1
986379|NCT01308476|1995059|FG001|Overall Study|Other|0
986380|NCT01308567|1995068|FG000|Overall Study|Lost to Follow-up|2
986381|NCT01308567|1995069|FG001|Overall Study|Lost to Follow-up|4
986382|NCT01308567|1995070|FG002|Overall Study|Lost to Follow-up|4
986383|NCT01308580|1995080|FG000|Overall Study|Lost to Follow-up|12
986384|NCT01308580|1995081|FG001|Overall Study|Lost to Follow-up|7
986385|NCT01308736|1995101|FG000|Overall Study|Did not attend a single session|6
986386|NCT01308736|1995102|FG001|Overall Study|Did not attend a single session|5
986387|NCT01308749|1995110|FG000|Period 1: Double Blind Treatment|Adverse Event|1
986388|NCT01308749|1995111|FG001|Period 1: Double Blind Treatment|Adverse Event|0
986389|NCT01308749|1995110|FG000|Period 2: Open Label Treatment|Adverse Event|0
986390|NCT01308749|1995111|FG001|Period 2: Open Label Treatment|Adverse Event|1
986391|NCT01308749|1995110|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0
986392|NCT01308749|1995111|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1
986393|NCT01308762|1995134|FG000|Overall Study|Protocol Violation|0
986394|NCT01308762|1995135|FG001|Overall Study|Protocol Violation|1
986395|NCT01308762|1995136|FG002|Overall Study|Protocol Violation|0
986396|NCT01308788|1995149|FG000|2-year Treatment|medication change by treating physician|4
986397|NCT01308788|1995150|FG001|2-year Treatment|medication change by treating physician|11
986398|NCT01308853|1995169|FG000|Overall Study|Adverse Event|1
986399|NCT01308853|1995169|FG000|Overall Study|Lost to Follow-up|2
986400|NCT01308853|1995169|FG000|Overall Study|Insertion of permanent implants|1
986401|NCT01309100|1995177|FG000|Overall Study|Protocol Violation|1
986402|NCT01309100|1995177|FG000|Overall Study|Positive Slit lamp finding|1
986403|NCT01309165|1995186|FG000|Overall Study|Lost to Follow-up|4
986404|NCT01309165|1995187|FG001|Overall Study|Lost to Follow-up|3
986405|NCT01309165|1995186|FG000|Overall Study|Return to work|1
986406|NCT01309165|1995187|FG001|Overall Study|Return to work|2
986407|NCT01309165|1995186|FG000|Overall Study|Left country|0
986408|NCT01309165|1995187|FG001|Overall Study|Left country|1
986409|NCT01309165|1995186|FG000|Overall Study|No transportation|0
986410|NCT01309165|1995187|FG001|Overall Study|No transportation|1
986411|NCT01309165|1995186|FG000|Overall Study|Admitted to hospital for second stroke|1
986412|NCT01309165|1995187|FG001|Overall Study|Admitted to hospital for second stroke|0
986413|NCT01309204|1995196|FG000|Overall Study|Adverse Event|48
986414|NCT01309204|1995197|FG001|Overall Study|Adverse Event|58
986415|NCT01309204|1995196|FG000|Overall Study|Lost to Follow-up|2
986416|NCT01309204|1995197|FG001|Overall Study|Lost to Follow-up|2
986417|NCT01309204|1995196|FG000|Overall Study|Subject's decision unrelated to an AE|9
986418|NCT01309204|1995197|FG001|Overall Study|Subject's decision unrelated to an AE|10
986419|NCT01309204|1995196|FG000|Overall Study|Inadequate control of IOP|4
986420|NCT01309204|1995197|FG001|Overall Study|Inadequate control of IOP|4
986421|NCT01309204|1995196|FG000|Overall Study|Other|4
986422|NCT01309204|1995197|FG001|Overall Study|Other|1
986423|NCT01309243|1995205|FG000|Randomized Phase Through Week 96|Randomized but not treated|6
986424|NCT01309243|1995206|FG001|Randomized Phase Through Week 96|Randomized but not treated|7
986425|NCT01309243|1995205|FG000|Randomized Phase Through Week 96|Adverse Event|12
986426|NCT01309243|1995206|FG001|Randomized Phase Through Week 96|Adverse Event|43
986427|NCT01309243|1995205|FG000|Randomized Phase Through Week 96|Death|0
986428|NCT01309243|1995206|FG001|Randomized Phase Through Week 96|Death|1
986429|NCT01309243|1995205|FG000|Randomized Phase Through Week 96|Pregnancy|2
986430|NCT01309243|1995206|FG001|Randomized Phase Through Week 96|Pregnancy|0
986431|NCT01309243|1995205|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16
986432|NCT01309243|1995206|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4
986433|NCT01309243|1995205|FG000|Randomized Phase Through Week 96|Investigators Discretion|3
986434|NCT01309243|1995206|FG001|Randomized Phase Through Week 96|Investigators Discretion|6
986435|NCT01309243|1995205|FG000|Randomized Phase Through Week 96|Withdrew Consent|12
986436|NCT01309243|1995206|FG001|Randomized Phase Through Week 96|Withdrew Consent|18
986437|NCT01309243|1995205|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23
986438|NCT01309243|1995206|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22
986439|NCT01309243|1995205|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9
986440|NCT01309243|1995206|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7
986441|NCT01309243|1995205|FG000|Randomized Phase Through Week 96|Protocol Violation|1
986442|NCT01309243|1995206|FG001|Randomized Phase Through Week 96|Protocol Violation|1
986443|NCT01309243|1995205|FG000|Extension Phase|Lost to Follow-up|6
986444|NCT01309243|1995206|FG001|Extension Phase|Lost to Follow-up|0
986445|NCT01309269|1995212|FG000|Overall Study|Adverse Event|56
986446|NCT01309269|1995212|FG000|Overall Study|Withdrawal by Subject|25
986447|NCT01309269|1995212|FG000|Overall Study|Lack of Acceptance|15
986448|NCT01309269|1995212|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119
986449|NCT01309269|1995212|FG000|Overall Study|Kidney Transplant|25
986450|NCT01309269|1995212|FG000|Overall Study|Administrative Problems|141
986451|NCT01309269|1995212|FG000|Overall Study|Other|256
986452|NCT01309269|1995212|FG000|Overall Study|Other|1
986453|NCT01309269|1995212|FG000|Overall Study|Study Completion Data Not Recorded|95
986454|NCT01309269|1995212|FG000|Overall Study|Enrolled but not Treated|107
986455|NCT01309282|1995216|FG000|Overall Study|Lost to Follow-up|1
986456|NCT01309308|1995222|FG000|Overall Study|Lost to Follow-up|6
986457|NCT01309308|1995223|FG001|Overall Study|Lost to Follow-up|4
986458|NCT01309386|1995244|FG000|Overall Study|Other|2
986459|NCT01309386|1995245|FG001|Overall Study|Other|0
986460|NCT01309386|1995244|FG000|Overall Study|Withdrawal by Subject|2
986461|NCT01309386|1995245|FG001|Overall Study|Withdrawal by Subject|0
986462|NCT01309386|1995244|FG000|Overall Study|Progressive disease|9
986463|NCT01309386|1995245|FG001|Overall Study|Progressive disease|11
986464|NCT01309386|1995244|FG000|Overall Study|Physician Decision|1
986465|NCT01309386|1995245|FG001|Overall Study|Physician Decision|1
986466|NCT01309386|1995244|FG000|Overall Study|Lack of Efficacy|3
986467|NCT01309386|1995245|FG001|Overall Study|Lack of Efficacy|1
986468|NCT01309386|1995244|FG000|Overall Study|Adverse Event|5
986469|NCT01309386|1995245|FG001|Overall Study|Adverse Event|8
986470|NCT01309659|1995273|FG000|Overall Study|Protocol Violation|0
986471|NCT01309659|1995274|FG001|Overall Study|Protocol Violation|1
986472|NCT01309737|1995283|FG000|Week 0 to 16|Death|1
986473|NCT01309737|1995284|FG001|Week 0 to 16|Death|0
986474|NCT01309737|1995285|FG002|Week 0 to 16|Death|1
986475|NCT01309737|1995286|FG003|Week 0 to 16|Death|0
986476|NCT01309737|1995287|FG004|Week 0 to 16|Death|0
986477|NCT01309737|1995283|FG000|Week 0 to 16|Adverse Event|11
986478|NCT01309737|1995284|FG001|Week 0 to 16|Adverse Event|10
986479|NCT01309737|1995285|FG002|Week 0 to 16|Adverse Event|5
986480|NCT01309737|1995286|FG003|Week 0 to 16|Adverse Event|0
986481|NCT01309737|1995287|FG004|Week 0 to 16|Adverse Event|0
986482|NCT01309737|1995283|FG000|Week 0 to 16|Lack of Efficacy|15
986483|NCT01309737|1995284|FG001|Week 0 to 16|Lack of Efficacy|2
986484|NCT01309737|1995285|FG002|Week 0 to 16|Lack of Efficacy|24
986485|NCT01309737|1995286|FG003|Week 0 to 16|Lack of Efficacy|0
986486|NCT01309737|1995287|FG004|Week 0 to 16|Lack of Efficacy|0
986487|NCT01309737|1995283|FG000|Week 0 to 16|Lost to Follow-up|7
986488|NCT01309737|1995284|FG001|Week 0 to 16|Lost to Follow-up|8
986489|NCT01309737|1995285|FG002|Week 0 to 16|Lost to Follow-up|3
986490|NCT01309737|1995286|FG003|Week 0 to 16|Lost to Follow-up|0
986491|NCT01309737|1995287|FG004|Week 0 to 16|Lost to Follow-up|0
986492|NCT01309737|1995283|FG000|Week 0 to 16|Withdrawal by Subject|7
986493|NCT01309737|1995284|FG001|Week 0 to 16|Withdrawal by Subject|6
986494|NCT01309737|1995285|FG002|Week 0 to 16|Withdrawal by Subject|7
986495|NCT01309737|1995286|FG003|Week 0 to 16|Withdrawal by Subject|0
986496|NCT01309737|1995287|FG004|Week 0 to 16|Withdrawal by Subject|0
986497|NCT01309737|1995283|FG000|Week 0 to 16|Other|10
986498|NCT01309737|1995284|FG001|Week 0 to 16|Other|14
986499|NCT01309737|1995285|FG002|Week 0 to 16|Other|4
986500|NCT01309737|1995286|FG003|Week 0 to 16|Other|0
986501|NCT01309737|1995287|FG004|Week 0 to 16|Other|0
986502|NCT01309737|1995283|FG000|Week 0 to 16|Randomized, but not treated|1
986503|NCT01309737|1995284|FG001|Week 0 to 16|Randomized, but not treated|0
986504|NCT01309737|1995285|FG002|Week 0 to 16|Randomized, but not treated|0
986505|NCT01309737|1995286|FG003|Week 0 to 16|Randomized, but not treated|0
986506|NCT01309737|1995287|FG004|Week 0 to 16|Randomized, but not treated|0
986507|NCT01309737|1995283|FG000|Week 16 to 52|Death|0
986508|NCT01309737|1995284|FG001|Week 16 to 52|Death|0
986509|NCT01309737|1995285|FG002|Week 16 to 52|Death|0
986510|NCT01309737|1995286|FG003|Week 16 to 52|Death|0
986511|NCT01309737|1995287|FG004|Week 16 to 52|Death|1
986512|NCT01309737|1995283|FG000|Week 16 to 52|Adverse Event|7
986513|NCT01309737|1995284|FG001|Week 16 to 52|Adverse Event|7
986514|NCT01309737|1995285|FG002|Week 16 to 52|Adverse Event|0
986515|NCT01309737|1995286|FG003|Week 16 to 52|Adverse Event|6
986516|NCT01309737|1995287|FG004|Week 16 to 52|Adverse Event|5
986517|NCT01309737|1995283|FG000|Week 16 to 52|Lack of Efficacy|107
986518|NCT01309737|1995284|FG001|Week 16 to 52|Lack of Efficacy|76
986519|NCT01309737|1995285|FG002|Week 16 to 52|Lack of Efficacy|0
986520|NCT01309737|1995286|FG003|Week 16 to 52|Lack of Efficacy|25
986521|NCT01309737|1995287|FG004|Week 16 to 52|Lack of Efficacy|21
986522|NCT01309737|1995283|FG000|Week 16 to 52|Lost to Follow-up|4
986523|NCT01309737|1995284|FG001|Week 16 to 52|Lost to Follow-up|2
986524|NCT01309737|1995285|FG002|Week 16 to 52|Lost to Follow-up|0
986525|NCT01309737|1995286|FG003|Week 16 to 52|Lost to Follow-up|1
986526|NCT01309737|1995287|FG004|Week 16 to 52|Lost to Follow-up|4
986527|NCT01309737|1995283|FG000|Week 16 to 52|Withdrawal by Subject|5
986528|NCT01309737|1995284|FG001|Week 16 to 52|Withdrawal by Subject|6
986529|NCT01309737|1995285|FG002|Week 16 to 52|Withdrawal by Subject|0
986530|NCT01309737|1995286|FG003|Week 16 to 52|Withdrawal by Subject|0
986531|NCT01309737|1995287|FG004|Week 16 to 52|Withdrawal by Subject|2
986532|NCT01309737|1995283|FG000|Week 16 to 52|Other|10
986533|NCT01309737|1995284|FG001|Week 16 to 52|Other|12
986534|NCT01309737|1995285|FG002|Week 16 to 52|Other|0
986535|NCT01309737|1995286|FG003|Week 16 to 52|Other|2
986536|NCT01309737|1995287|FG004|Week 16 to 52|Other|0
986537|NCT01309828|1995321|FG000|Overall Study|Adverse Event|10
986538|NCT01309828|1995322|FG001|Overall Study|Adverse Event|11
986539|NCT01309828|1995321|FG000|Overall Study|Voluntary Withdrawal|5
986540|NCT01309828|1995322|FG001|Overall Study|Voluntary Withdrawal|4
986541|NCT01309828|1995321|FG000|Overall Study|Major Protocol Deviation|0
986542|NCT01309828|1995322|FG001|Overall Study|Major Protocol Deviation|1
986543|NCT01309828|1995321|FG000|Overall Study|Other|1
986544|NCT01309828|1995322|FG001|Overall Study|Other|0
986545|NCT01309841|1995331|FG000|Overall Study|Other|0
986546|NCT01309841|1995332|FG001|Overall Study|Other|1
986547|NCT01309841|1995333|FG002|Overall Study|Other|1
986548|NCT01309841|1995331|FG000|Overall Study|Lost to Follow-up|7
986549|NCT01309841|1995332|FG001|Overall Study|Lost to Follow-up|6
986550|NCT01309841|1995333|FG002|Overall Study|Lost to Follow-up|4
986551|NCT01309841|1995331|FG000|Overall Study|Study-Specific Withdrawal Criteria|3
986552|NCT01309841|1995332|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
986553|NCT01309841|1995333|FG002|Overall Study|Study-Specific Withdrawal Criteria|2
986554|NCT01309841|1995331|FG000|Overall Study|Lack of Efficacy|0
986555|NCT01309841|1995332|FG001|Overall Study|Lack of Efficacy|0
986556|NCT01309841|1995333|FG002|Overall Study|Lack of Efficacy|2
986557|NCT01309841|1995331|FG000|Overall Study|Adverse Event|9
986558|NCT01309841|1995332|FG001|Overall Study|Adverse Event|22
986559|NCT01309841|1995333|FG002|Overall Study|Adverse Event|11
986560|NCT01309841|1995331|FG000|Overall Study|Death|1
986561|NCT01309841|1995332|FG001|Overall Study|Death|0
986562|NCT01309841|1995333|FG002|Overall Study|Death|0
986563|NCT01309841|1995331|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
986564|NCT01309841|1995332|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
986565|NCT01309841|1995333|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
986566|NCT01309841|1995331|FG000|Overall Study|Withdrawal by Subject|17
986567|NCT01309841|1995332|FG001|Overall Study|Withdrawal by Subject|6
986568|NCT01309841|1995333|FG002|Overall Study|Withdrawal by Subject|13
986569|NCT01309841|1995331|FG000|Overall Study|Did Not Receive Treatment|2
986570|NCT01309841|1995332|FG001|Overall Study|Did Not Receive Treatment|0
986571|NCT01309841|1995333|FG002|Overall Study|Did Not Receive Treatment|1
986572|NCT01309841|1995331|FG000|Overall Study|Severe non-compliance with protocol|0
986573|NCT01309841|1995332|FG001|Overall Study|Severe non-compliance with protocol|5
986574|NCT01309841|1995333|FG002|Overall Study|Severe non-compliance with protocol|2
986575|NCT01309893|1995355|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1
986576|NCT01309893|1995356|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0
986577|NCT01309893|1995355|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0
986578|NCT01309893|1995356|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1
986579|NCT01309919|1995371|FG000|Overall Study|Did not receive a postpartum IUD|17
986580|NCT01309919|1995372|FG001|Overall Study|Did not receive a postpartum IUD|48
986581|NCT01309997|1995380|FG000|Overall Study|Adverse Event|1
986582|NCT01309997|1995381|FG001|Overall Study|Adverse Event|0
986583|NCT01309997|1995380|FG000|Overall Study|Death|1
986584|NCT01309997|1995381|FG001|Overall Study|Death|3
986585|NCT01309997|1995380|FG000|Overall Study|Lack of Efficacy|2
986586|NCT01309997|1995381|FG001|Overall Study|Lack of Efficacy|2
986587|NCT01309997|1995380|FG000|Overall Study|Withdrawal by Subject|1
986588|NCT01309997|1995381|FG001|Overall Study|Withdrawal by Subject|1
986589|NCT01310036|1995398|FG000|Overall Study|Administrative/other|10
986590|NCT01310036|1995398|FG000|Overall Study|Withdrew Consent|11
986591|NCT01310036|1995398|FG000|Overall Study|Refused Treatment/Did not Cooperate|4
986592|NCT01310036|1995398|FG000|Overall Study|Progression of Disease|164
986593|NCT01310036|1995398|FG000|Overall Study|Death|1
986594|NCT01310036|1995398|FG000|Overall Study|Adverse event or intercurrent illness|12
986595|NCT01310075|1995404|FG000|Overall Study|Lost to Follow-up|1
986596|NCT01310075|1995405|FG001|Overall Study|Lost to Follow-up|0
986597|NCT01310075|1995404|FG000|Overall Study|Physician Decision|10
986598|NCT01310075|1995405|FG001|Overall Study|Physician Decision|7
986599|NCT01310075|1995404|FG000|Overall Study|Protocol Violation|2
986600|NCT01310075|1995405|FG001|Overall Study|Protocol Violation|2
986601|NCT01310075|1995404|FG000|Overall Study|Withdrawal by Subject|1
986602|NCT01310075|1995405|FG001|Overall Study|Withdrawal by Subject|1
986603|NCT01310127|1995413|FG000|Overall Study|Protocol Violation|1
986604|NCT01310127|1995414|FG001|Overall Study|Protocol Violation|1
986605|NCT01310127|1995413|FG000|Overall Study|advanced psc cataract outlier|1
986606|NCT01310127|1995414|FG001|Overall Study|advanced psc cataract outlier|0
986607|NCT01310413|1995455|FG000|Day 0 to Day 385|Withdrawal by Subject|5
986608|NCT01310413|1995456|FG001|Day 0 to Day 385|Withdrawal by Subject|2
986609|NCT01310413|1995457|FG002|Day 0 to Day 385|Withdrawal by Subject|0
986610|NCT01310413|1995458|FG003|Day 0 to Day 385|Withdrawal by Subject|2
986611|NCT01310413|1995459|FG004|Day 0 to Day 385|Withdrawal by Subject|1
986612|NCT01310413|1995460|FG005|Day 0 to Day 385|Withdrawal by Subject|1
986613|NCT01310413|1995461|FG006|Day 0 to Day 385|Withdrawal by Subject|0
986614|NCT01310413|1995455|FG000|Day 0 to Day 385|Lost to Follow-up|18
986615|NCT01310413|1995456|FG001|Day 0 to Day 385|Lost to Follow-up|3
986616|NCT01310413|1995457|FG002|Day 0 to Day 385|Lost to Follow-up|3
986617|NCT01310413|1995458|FG003|Day 0 to Day 385|Lost to Follow-up|5
986618|NCT01310413|1995459|FG004|Day 0 to Day 385|Lost to Follow-up|1
986619|NCT01310413|1995460|FG005|Day 0 to Day 385|Lost to Follow-up|2
986620|NCT01310413|1995461|FG006|Day 0 to Day 385|Lost to Follow-up|0
986621|NCT01310413|1995455|FG000|Day 0 to Day 385|Migrated/moved from study area|3
986622|NCT01310413|1995456|FG001|Day 0 to Day 385|Migrated/moved from study area|3
986623|NCT01310413|1995457|FG002|Day 0 to Day 385|Migrated/moved from study area|1
986624|NCT01310413|1995458|FG003|Day 0 to Day 385|Migrated/moved from study area|1
986625|NCT01310413|1995459|FG004|Day 0 to Day 385|Migrated/moved from study area|1
986626|NCT01310413|1995460|FG005|Day 0 to Day 385|Migrated/moved from study area|0
986627|NCT01310413|1995461|FG006|Day 0 to Day 385|Migrated/moved from study area|0
986628|NCT01310413|1995455|FG000|Day 0 to Day 385|Other|1
986629|NCT01310413|1995456|FG001|Day 0 to Day 385|Other|0
986630|NCT01310413|1995457|FG002|Day 0 to Day 385|Other|3
986631|NCT01310413|1995458|FG003|Day 0 to Day 385|Other|0
986632|NCT01310413|1995459|FG004|Day 0 to Day 385|Other|0
986633|NCT01310413|1995460|FG005|Day 0 to Day 385|Other|0
986634|NCT01310413|1995461|FG006|Day 0 to Day 385|Other|0
986635|NCT01310413|1995455|FG000|From Day U0 to Day U385|Withdrawal by Subject|0
986636|NCT01310413|1995456|FG001|From Day U0 to Day U385|Withdrawal by Subject|0
986637|NCT01310413|1995457|FG002|From Day U0 to Day U385|Withdrawal by Subject|0
986638|NCT01310413|1995458|FG003|From Day U0 to Day U385|Withdrawal by Subject|0
986639|NCT01310413|1995459|FG004|From Day U0 to Day U385|Withdrawal by Subject|0
986640|NCT01310413|1995460|FG005|From Day U0 to Day U385|Withdrawal by Subject|0
986641|NCT01310413|1995461|FG006|From Day U0 to Day U385|Withdrawal by Subject|1
986642|NCT01310413|1995455|FG000|From Day U0 to Day U385|Lost to Follow-up|0
986643|NCT01310413|1995456|FG001|From Day U0 to Day U385|Lost to Follow-up|0
986644|NCT01310413|1995457|FG002|From Day U0 to Day U385|Lost to Follow-up|0
986645|NCT01310413|1995458|FG003|From Day U0 to Day U385|Lost to Follow-up|0
986646|NCT01310413|1995459|FG004|From Day U0 to Day U385|Lost to Follow-up|0
986647|NCT01310413|1995460|FG005|From Day U0 to Day U385|Lost to Follow-up|0
986648|NCT01310413|1995461|FG006|From Day U0 to Day U385|Lost to Follow-up|2
986649|NCT01310699|1995501|FG000|Overall Study|Patients did not complete tandem.|4
986650|NCT01310699|1995502|FG001|Overall Study|Patients did not complete tandem.|6
986651|NCT01310777|1995513|FG000|Overall Study|Adverse Event|23
986652|NCT01310777|1995514|FG001|Overall Study|Adverse Event|1
986653|NCT01310777|1995515|FG002|Overall Study|Adverse Event|15
986654|NCT01310777|1995513|FG000|Overall Study|Lost to Follow-up|0
986655|NCT01310777|1995514|FG001|Overall Study|Lost to Follow-up|4
986656|NCT01310777|1995515|FG002|Overall Study|Lost to Follow-up|1
986657|NCT01310777|1995513|FG000|Overall Study|Patient's Decision Unrelated to AE|1
986658|NCT01310777|1995514|FG001|Overall Study|Patient's Decision Unrelated to AE|1
986659|NCT01310777|1995515|FG002|Overall Study|Patient's Decision Unrelated to AE|2
986660|NCT01310777|1995513|FG000|Overall Study|Inadequate Control of IOP|5
986661|NCT01310777|1995514|FG001|Overall Study|Inadequate Control of IOP|7
986662|NCT01310777|1995515|FG002|Overall Study|Inadequate Control of IOP|10
986663|NCT01310777|1995513|FG000|Overall Study|Other|4
986664|NCT01310777|1995514|FG001|Overall Study|Other|1
986665|NCT01310777|1995515|FG002|Overall Study|Other|2
986666|NCT01310868|1995532|FG000|Overall Study|Do not have histologically confirmed GBM|13
986667|NCT01311024|1995538|FG000|Overall Study|Protocol Violation|35
986668|NCT01311024|1995539|FG001|Overall Study|Protocol Violation|22
986669|NCT01311505|1995565|FG000|First Intervention Period|Protocol Violation|0
986670|NCT01311505|1995566|FG001|First Intervention Period|Protocol Violation|1
986671|NCT01311557|1995577|FG000|Overall Study|Serious adverse event|0
986672|NCT01311557|1995578|FG001|Overall Study|Serious adverse event|1
986673|NCT01311557|1995577|FG000|Overall Study|Protocol Violation|4
986674|NCT01311557|1995578|FG001|Overall Study|Protocol Violation|2
986675|NCT01311557|1995577|FG000|Overall Study|Lost to Follow-up|0
986676|NCT01311557|1995578|FG001|Overall Study|Lost to Follow-up|1
986677|NCT01311557|1995577|FG000|Overall Study|Withdrawal by Subject|1
986678|NCT01311557|1995578|FG001|Overall Study|Withdrawal by Subject|2
986679|NCT01311648|1995587|FG000|Main Study|Protocol Violation|0
986680|NCT01311648|1995588|FG001|Main Study|Protocol Violation|1
986681|NCT01311648|1995587|FG000|Main Study|Adverse Event|0
986682|NCT01311648|1995588|FG001|Main Study|Adverse Event|1
986683|NCT01311648|1995587|FG000|Main Study|Inhibitor management|0
986684|NCT01311648|1995588|FG001|Main Study|Inhibitor management|17
986685|NCT01311648|1995587|FG000|Main Study|Withdrawal by Subject|0
986686|NCT01311648|1995588|FG001|Main Study|Withdrawal by Subject|2
986687|NCT01311648|1995587|FG000|Extension Study|Physician Decision|0
986688|NCT01311648|1995588|FG001|Extension Study|Physician Decision|1
986689|NCT01311648|1995587|FG000|Extension Study|ITI therapy with marketed product|0
986690|NCT01311648|1995588|FG001|Extension Study|ITI therapy with marketed product|1
986691|NCT01311648|1995587|FG000|Extension Study|Incorrect visit planning|0
986692|NCT01311648|1995588|FG001|Extension Study|Incorrect visit planning|1
986693|NCT01311648|1995587|FG000|Extension Study|Family's decision|0
986694|NCT01311648|1995588|FG001|Extension Study|Family's decision|1
986695|NCT01311648|1995587|FG000|Extension Study|Failure of ITI therapy|0
986696|NCT01311648|1995588|FG001|Extension Study|Failure of ITI therapy|3
986697|NCT01311648|1995587|FG000|Extension Study|Long travel|0
986698|NCT01311648|1995588|FG001|Extension Study|Long travel|1
986699|NCT01311648|1995587|FG000|Extension Study|Diagnosed with von Willebrand disease|1
986700|NCT01311648|1995588|FG001|Extension Study|Diagnosed with von Willebrand disease|0
986701|NCT01311648|1995587|FG000|Extension Study|Withdrawal by Subject|0
986702|NCT01311648|1995588|FG001|Extension Study|Withdrawal by Subject|1
986703|NCT01311648|1995587|FG000|Extension Study|Inhibitor management|0
986704|NCT01311648|1995588|FG001|Extension Study|Inhibitor management|2
986705|NCT01311661|1995601|FG000|Overall Study|Adverse Event|2
986706|NCT01311661|1995601|FG000|Overall Study|Protocol Violation|3
986707|NCT01311661|1995601|FG000|Overall Study|Withdrawal by Subject|2
986708|NCT01312129|1995655|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0
986709|NCT01312129|1995656|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1
986710|NCT01312467|1995710|FG000|Overall Study|Adverse Event|4
986711|NCT01312467|1995710|FG000|Overall Study|Lost to Follow-up|1
986712|NCT01312467|1995710|FG000|Overall Study|Withdrawal by Subject|2
986713|NCT01312467|1995710|FG000|Overall Study|Deported to country of origin|1
986714|NCT01312467|1995710|FG000|Overall Study|Another medical condition|1
986715|NCT01312467|1995710|FG000|Overall Study|Ineligible|4
986716|NCT01312779|1995742|FG000|Overall Study|Withdrawal by Subject|2
986717|NCT01312779|1995742|FG000|Overall Study|Death|3
986718|NCT01312779|1995742|FG000|Overall Study|Not Implanted with Device|27
986719|NCT01312909|1995782|FG000|Overall Study|Randomized but not treated|1
986720|NCT01312909|1995783|FG001|Overall Study|Randomized but not treated|3
986721|NCT01312909|1995784|FG002|Overall Study|Randomized but not treated|1
986722|NCT01312909|1995782|FG000|Overall Study|Adverse Event|1
986723|NCT01312909|1995783|FG001|Overall Study|Adverse Event|0
986724|NCT01312909|1995784|FG002|Overall Study|Adverse Event|3
986725|NCT01312909|1995782|FG000|Overall Study|Protocol Violation|2
986726|NCT01312909|1995783|FG001|Overall Study|Protocol Violation|0
986727|NCT01312909|1995784|FG002|Overall Study|Protocol Violation|2
986728|NCT01312909|1995782|FG000|Overall Study|Other|9
986729|NCT01312909|1995783|FG001|Overall Study|Other|6
986730|NCT01312909|1995784|FG002|Overall Study|Other|11
986731|NCT01312909|1995782|FG000|Overall Study|Withdrawal by Subject|8
986732|NCT01312909|1995783|FG001|Overall Study|Withdrawal by Subject|10
986733|NCT01312909|1995784|FG002|Overall Study|Withdrawal by Subject|7
986734|NCT01312909|1995782|FG000|Overall Study|Lost to Follow-up|21
986735|NCT01312909|1995783|FG001|Overall Study|Lost to Follow-up|17
986736|NCT01312909|1995784|FG002|Overall Study|Lost to Follow-up|20
986737|NCT01312909|1995782|FG000|Overall Study|Insufficient clinical response|0
986738|NCT01312909|1995783|FG001|Overall Study|Insufficient clinical response|0
986739|NCT01312909|1995784|FG002|Overall Study|Insufficient clinical response|1
986740|NCT01312909|1995782|FG000|Overall Study|Entrance criteria not met|0
986741|NCT01312909|1995783|FG001|Overall Study|Entrance criteria not met|0
986742|NCT01312909|1995784|FG002|Overall Study|Entrance criteria not met|2
986743|NCT01312961|1995801|FG000|Overall Study|Adverse Event|3
986744|NCT01312961|1995802|FG001|Overall Study|Adverse Event|3
986745|NCT01312961|1995801|FG000|Overall Study|Lack of Efficacy|11
986746|NCT01312961|1995802|FG001|Overall Study|Lack of Efficacy|1
986747|NCT01312961|1995801|FG000|Overall Study|Poor compliance to protocol|1
986748|NCT01312961|1995802|FG001|Overall Study|Poor compliance to protocol|0
986749|NCT01312961|1995801|FG000|Overall Study|Other than specified above|2
986750|NCT01312961|1995802|FG001|Overall Study|Other than specified above|3
986751|NCT01313039|1995809|FG000|Overall Study|Physician Decision|1
986752|NCT01313039|1995809|FG000|Overall Study|Adverse Event|1
986753|NCT01313078|1995813|FG000|Overall Study|Death|1
986754|NCT01313078|1995813|FG000|Overall Study|Discontinued study drug|1
986755|NCT01313078|1995813|FG000|Overall Study|Withdrawal by Subject|1
986756|NCT01313117|1995817|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
986757|NCT01313117|1995817|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
986758|NCT01313182|1995824|FG000|Overall Study|Protocol Violation|66
986759|NCT01313182|1995825|FG001|Overall Study|Protocol Violation|92
986760|NCT01313208|1995833|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
986761|NCT01313208|1995834|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
986762|NCT01313208|1995833|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
986763|NCT01313208|1995834|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
986764|NCT01313208|1995833|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
986765|NCT01313208|1995834|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
986766|NCT01313208|1995833|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
986767|NCT01313208|1995834|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
986768|NCT01313208|1995833|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
986769|NCT01313208|1995834|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
986770|NCT01313208|1995833|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
986771|NCT01313208|1995834|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
986772|NCT01313208|1995833|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
986773|NCT01313208|1995834|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
986774|NCT01313208|1995833|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
986775|NCT01313208|1995834|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
986776|NCT01313208|1995833|FG000|Open-label Phase (Weeks 13 - 24)|Other|2
986777|NCT01313208|1995834|FG001|Open-label Phase (Weeks 13 - 24)|Other|0
986778|NCT01313221|1995845|FG000|Overall Study|Protocol Violation|0
986779|NCT01313221|1995846|FG001|Overall Study|Protocol Violation|1
986780|NCT01313221|1995847|FG002|Overall Study|Protocol Violation|1
986781|NCT01313221|1995845|FG000|Overall Study|Non-compliance|3
986782|NCT01313221|1995846|FG001|Overall Study|Non-compliance|0
986783|NCT01313221|1995847|FG002|Overall Study|Non-compliance|2
986784|NCT01313221|1995845|FG000|Overall Study|Withdrawal by Subject|2
986785|NCT01313221|1995846|FG001|Overall Study|Withdrawal by Subject|3
986786|NCT01313221|1995847|FG002|Overall Study|Withdrawal by Subject|5
986787|NCT01313221|1995845|FG000|Overall Study|Requirement for alternative therapy|0
986788|NCT01313221|1995846|FG001|Overall Study|Requirement for alternative therapy|1
986789|NCT01313221|1995847|FG002|Overall Study|Requirement for alternative therapy|1
986790|NCT01313221|1995845|FG000|Overall Study|Lost to Follow-up|6
986791|NCT01313221|1995846|FG001|Overall Study|Lost to Follow-up|3
986792|NCT01313221|1995847|FG002|Overall Study|Lost to Follow-up|1
986793|NCT01313221|1995845|FG000|Overall Study|Other|1
986794|NCT01313221|1995846|FG001|Overall Study|Other|0
986795|NCT01313221|1995847|FG002|Overall Study|Other|0
986796|NCT01313221|1995845|FG000|Overall Study|Adverse Event|0
986797|NCT01313221|1995846|FG001|Overall Study|Adverse Event|0
986798|NCT01313221|1995847|FG002|Overall Study|Adverse Event|7
986799|NCT01313221|1995845|FG000|Overall Study|Disease progression|0
986800|NCT01313221|1995846|FG001|Overall Study|Disease progression|0
986801|NCT01313221|1995847|FG002|Overall Study|Disease progression|2
986802|NCT01313221|1995845|FG000|Overall Study|Physician Decision|0
986803|NCT01313221|1995846|FG001|Overall Study|Physician Decision|0
986804|NCT01313221|1995847|FG002|Overall Study|Physician Decision|2
986805|NCT01313221|1995845|FG000|Overall Study|Pregnancy|0
986806|NCT01313221|1995846|FG001|Overall Study|Pregnancy|0
986807|NCT01313221|1995847|FG002|Overall Study|Pregnancy|2
986808|NCT01313286|1995855|FG000|Period 1|Withdrawal by Subject|2
986809|NCT01313286|1995856|FG001|Period 1|Withdrawal by Subject|0
986810|NCT01313299|1995865|FG000|Overall Study|Adverse Event|3
986811|NCT01313299|1995866|FG001|Overall Study|Adverse Event|1
986812|NCT01313299|1995867|FG002|Overall Study|Adverse Event|1
986813|NCT01313299|1995865|FG000|Overall Study|Lost to Follow-up|1
986814|NCT01313299|1995866|FG001|Overall Study|Lost to Follow-up|0
986815|NCT01313299|1995867|FG002|Overall Study|Lost to Follow-up|0
986816|NCT01313299|1995865|FG000|Overall Study|Protocol Violation|2
986817|NCT01313299|1995866|FG001|Overall Study|Protocol Violation|0
986818|NCT01313299|1995867|FG002|Overall Study|Protocol Violation|0
986819|NCT01313299|1995865|FG000|Overall Study|Withdrawal by Subject|1
986820|NCT01313299|1995866|FG001|Overall Study|Withdrawal by Subject|0
986821|NCT01313299|1995867|FG002|Overall Study|Withdrawal by Subject|2
986822|NCT01313299|1995865|FG000|Overall Study|Family reason and moved out of state|0
986823|NCT01313299|1995866|FG001|Overall Study|Family reason and moved out of state|2
986824|NCT01313299|1995867|FG002|Overall Study|Family reason and moved out of state|0
986825|NCT01313299|1995865|FG000|Overall Study|Lack of subject compliance|0
986826|NCT01313299|1995866|FG001|Overall Study|Lack of subject compliance|0
986827|NCT01313299|1995867|FG002|Overall Study|Lack of subject compliance|1
986828|NCT01313312|1995875|FG000|Overall Study|Adverse Event|5
986829|NCT01313312|1995875|FG000|Overall Study|Withdrawal by Subject|18
986830|NCT01313312|1995875|FG000|Overall Study|Lack of Efficacy|3
986831|NCT01313312|1995875|FG000|Overall Study|Investigator Decision|1
986832|NCT01313312|1995875|FG000|Overall Study|Observational Phase|1
986833|NCT01313312|1995875|FG000|Overall Study|Subject Withdrawn Early in Error|4
986834|NCT01313312|1995875|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4
986835|NCT01313559|1995905|FG000|Overall Study|Withdrawal by Subject|1
986836|NCT01313559|1995906|FG001|Overall Study|Withdrawal by Subject|2
986837|NCT01313559|1995905|FG000|Overall Study|Disease progression|1
986838|NCT01313559|1995906|FG001|Overall Study|Disease progression|0
986839|NCT01313559|1995905|FG000|Overall Study|Rising PSA|2
986840|NCT01313559|1995906|FG001|Overall Study|Rising PSA|0
986841|NCT01313624|1995914|FG000|Double-Blind Phase|Adverse Event|27
986842|NCT01313624|1995915|FG001|Double-Blind Phase|Adverse Event|4
986843|NCT01313624|1995914|FG000|Double-Blind Phase|Withdrawal by Subject|9
986844|NCT01313624|1995915|FG001|Double-Blind Phase|Withdrawal by Subject|4
986845|NCT01313624|1995914|FG000|Double-Blind Phase|Lost to Follow-up|0
986846|NCT01313624|1995915|FG001|Double-Blind Phase|Lost to Follow-up|2
986847|NCT01313624|1995914|FG000|Double-Blind Phase|Physician Decision|1
986848|NCT01313624|1995915|FG001|Double-Blind Phase|Physician Decision|0
986849|NCT01313624|1995914|FG000|Double-Blind Phase|Lack of Efficacy|1
986850|NCT01313624|1995915|FG001|Double-Blind Phase|Lack of Efficacy|0
986851|NCT01313624|1995914|FG000|Open-Label Phase|Adverse Event|1
986852|NCT01313624|1995915|FG001|Open-Label Phase|Adverse Event|10
986853|NCT01313624|1995914|FG000|Open-Label Phase|Withdrawal by Subject|2
986854|NCT01313624|1995915|FG001|Open-Label Phase|Withdrawal by Subject|2
986855|NCT01313624|1995914|FG000|Open-Label Phase|Lost to Follow-up|1
986856|NCT01313624|1995915|FG001|Open-Label Phase|Lost to Follow-up|1
986857|NCT01313637|1995927|FG000|Overall Study|Adverse Event|17
986858|NCT01313637|1995928|FG001|Overall Study|Adverse Event|24
986859|NCT01313637|1995929|FG002|Overall Study|Adverse Event|25
986860|NCT01313637|1995930|FG003|Overall Study|Adverse Event|18
986861|NCT01313637|1995927|FG000|Overall Study|Lack of Efficacy|44
986862|NCT01313637|1995928|FG001|Overall Study|Lack of Efficacy|38
986863|NCT01313637|1995929|FG002|Overall Study|Lack of Efficacy|37
986864|NCT01313637|1995930|FG003|Overall Study|Lack of Efficacy|24
986865|NCT01313637|1995927|FG000|Overall Study|Protocol Violation|4
986866|NCT01313637|1995928|FG001|Overall Study|Protocol Violation|3
986867|NCT01313637|1995929|FG002|Overall Study|Protocol Violation|11
986868|NCT01313637|1995930|FG003|Overall Study|Protocol Violation|5
986869|NCT01313637|1995927|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16
986870|NCT01313637|1995928|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15
986871|NCT01313637|1995929|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14
986872|NCT01313637|1995930|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13
986873|NCT01313637|1995927|FG000|Overall Study|Lost to Follow-up|0
986874|NCT01313637|1995928|FG001|Overall Study|Lost to Follow-up|2
986875|NCT01313637|1995929|FG002|Overall Study|Lost to Follow-up|1
986876|NCT01313637|1995930|FG003|Overall Study|Lost to Follow-up|3
986877|NCT01313637|1995927|FG000|Overall Study|Withdrawal by Subject|11
986878|NCT01313637|1995928|FG001|Overall Study|Withdrawal by Subject|13
986879|NCT01313637|1995929|FG002|Overall Study|Withdrawal by Subject|18
986880|NCT01313637|1995930|FG003|Overall Study|Withdrawal by Subject|15
986881|NCT01313650|1995944|FG000|Overall Study|Adverse Event|9
986882|NCT01313650|1995945|FG001|Overall Study|Adverse Event|34
986883|NCT01313650|1995946|FG002|Overall Study|Adverse Event|24
986884|NCT01313650|1995947|FG003|Overall Study|Adverse Event|23
986885|NCT01313650|1995944|FG000|Overall Study|Lack of Efficacy|37
986886|NCT01313650|1995945|FG001|Overall Study|Lack of Efficacy|20
986887|NCT01313650|1995946|FG002|Overall Study|Lack of Efficacy|32
986888|NCT01313650|1995947|FG003|Overall Study|Lack of Efficacy|20
986889|NCT01313650|1995944|FG000|Overall Study|Lost to Follow-up|1
986890|NCT01313650|1995945|FG001|Overall Study|Lost to Follow-up|0
986891|NCT01313650|1995946|FG002|Overall Study|Lost to Follow-up|3
986892|NCT01313650|1995947|FG003|Overall Study|Lost to Follow-up|2
986893|NCT01313650|1995944|FG000|Overall Study|Withdrawal by Subject|16
986894|NCT01313650|1995945|FG001|Overall Study|Withdrawal by Subject|20
986895|NCT01313650|1995946|FG002|Overall Study|Withdrawal by Subject|15
986896|NCT01313650|1995947|FG003|Overall Study|Withdrawal by Subject|15
986897|NCT01313650|1995944|FG000|Overall Study|Protocol Violation|4
986898|NCT01313650|1995945|FG001|Overall Study|Protocol Violation|7
986899|NCT01313650|1995946|FG002|Overall Study|Protocol Violation|5
986900|NCT01313650|1995947|FG003|Overall Study|Protocol Violation|6
986901|NCT01313650|1995944|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9
986902|NCT01313650|1995945|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13
986903|NCT01313650|1995946|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24
986904|NCT01313650|1995947|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15
986905|NCT01313663|1995959|FG000|Overall Study|Study Closed/Terminated|2
986906|NCT01313663|1995960|FG001|Overall Study|Study Closed/Terminated|4
986907|NCT01313663|1995959|FG000|Overall Study|Lost to Follow-up|0
986908|NCT01313663|1995960|FG001|Overall Study|Lost to Follow-up|1
986909|NCT01313663|1995959|FG000|Overall Study|Physician Decision|0
986910|NCT01313663|1995960|FG001|Overall Study|Physician Decision|2
986911|NCT01313663|1995959|FG000|Overall Study|Withdrawal by Subject|2
986912|NCT01313663|1995960|FG001|Overall Study|Withdrawal by Subject|1
986913|NCT01313676|1995970|FG000|Overall Study|Adverse Event|395
986914|NCT01313676|1995971|FG001|Overall Study|Adverse Event|365
986915|NCT01313676|1995972|FG002|Overall Study|Adverse Event|372
986916|NCT01313676|1995973|FG003|Overall Study|Adverse Event|333
986917|NCT01313676|1995970|FG000|Overall Study|Lack of Efficacy|98
986918|NCT01313676|1995971|FG001|Overall Study|Lack of Efficacy|90
986919|NCT01313676|1995972|FG002|Overall Study|Lack of Efficacy|65
986920|NCT01313676|1995973|FG003|Overall Study|Lack of Efficacy|46
986921|NCT01313676|1995970|FG000|Overall Study|Protocol Violation|37
986922|NCT01313676|1995971|FG001|Overall Study|Protocol Violation|44
986923|NCT01313676|1995972|FG002|Overall Study|Protocol Violation|46
986924|NCT01313676|1995973|FG003|Overall Study|Protocol Violation|44
986925|NCT01313676|1995970|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3
986926|NCT01313676|1995971|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4
986927|NCT01313676|1995972|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2
986928|NCT01313676|1995973|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11
986929|NCT01313676|1995970|FG000|Overall Study|Study Closed/terminated|7
986930|NCT01313676|1995971|FG001|Overall Study|Study Closed/terminated|6
986931|NCT01313676|1995972|FG002|Overall Study|Study Closed/terminated|9
986932|NCT01313676|1995973|FG003|Overall Study|Study Closed/terminated|9
986933|NCT01313676|1995970|FG000|Overall Study|Lost to Follow-up|0
986934|NCT01313676|1995971|FG001|Overall Study|Lost to Follow-up|0
986935|NCT01313676|1995972|FG002|Overall Study|Lost to Follow-up|1
986936|NCT01313676|1995973|FG003|Overall Study|Lost to Follow-up|0
986937|NCT01313676|1995970|FG000|Overall Study|Physician Decision|53
986938|NCT01313676|1995971|FG001|Overall Study|Physician Decision|64
986939|NCT01313676|1995972|FG002|Overall Study|Physician Decision|62
986940|NCT01313676|1995973|FG003|Overall Study|Physician Decision|48
986941|NCT01313676|1995970|FG000|Overall Study|Decision by Participant or Proxy|643
986942|NCT01313676|1995971|FG001|Overall Study|Decision by Participant or Proxy|527
986943|NCT01313676|1995972|FG002|Overall Study|Decision by Participant or Proxy|515
986944|NCT01313676|1995973|FG003|Overall Study|Decision by Participant or Proxy|492
986945|NCT01313676|1995970|FG000|Overall Study|Sponsor Terminated Study Treatment|1
986946|NCT01313676|1995971|FG001|Overall Study|Sponsor Terminated Study Treatment|1
986947|NCT01313676|1995972|FG002|Overall Study|Sponsor Terminated Study Treatment|0
986948|NCT01313676|1995973|FG003|Overall Study|Sponsor Terminated Study Treatment|1
986949|NCT01313676|1995970|FG000|Overall Study|Investigator Site Closed|12
986950|NCT01313676|1995971|FG001|Overall Study|Investigator Site Closed|11
986951|NCT01313676|1995972|FG002|Overall Study|Investigator Site Closed|15
986952|NCT01313676|1995973|FG003|Overall Study|Investigator Site Closed|10
986953|NCT01313676|1995970|FG000|Overall Study|Missing|1
986954|NCT01313676|1995971|FG001|Overall Study|Missing|1
986955|NCT01313676|1995972|FG002|Overall Study|Missing|1
986956|NCT01313676|1995973|FG003|Overall Study|Missing|0
986957|NCT01313728|1996012|FG000|Informed Consent to Baseline|Withdrawal by Subject|1
986958|NCT01313767|1996019|FG000|Overall Study|Adverse Event|1
986959|NCT01313767|1996020|FG001|Overall Study|Adverse Event|0
986960|NCT01313767|1996019|FG000|Overall Study|Lost to Follow-up|1
986961|NCT01313767|1996020|FG001|Overall Study|Lost to Follow-up|0
986962|NCT01313767|1996019|FG000|Overall Study|Withdrawal by Subject|2
986963|NCT01313767|1996020|FG001|Overall Study|Withdrawal by Subject|1
986964|NCT01313767|1996019|FG000|Overall Study|Protocol Violation|3
986965|NCT01313767|1996020|FG001|Overall Study|Protocol Violation|1
986966|NCT01313780|1996028|FG000|Overall Study|Lack of Efficacy|4
986967|NCT01313780|1996029|FG001|Overall Study|Lack of Efficacy|2
986968|NCT01313780|1996028|FG000|Overall Study|Adverse Event|6
986969|NCT01313780|1996029|FG001|Overall Study|Adverse Event|11
986970|NCT01313780|1996028|FG000|Overall Study|Withdrawal by Subject|2
986971|NCT01313780|1996029|FG001|Overall Study|Withdrawal by Subject|8
986972|NCT01313780|1996028|FG000|Overall Study|Protocol Violation|10
986973|NCT01313780|1996029|FG001|Overall Study|Protocol Violation|4
986974|NCT01313780|1996028|FG000|Overall Study|missing data|3
986975|NCT01313780|1996029|FG001|Overall Study|missing data|3
986976|NCT01313858|1996038|FG000|Overall Study|Premature Treatment Termination|251
986977|NCT01313858|1996039|FG001|Overall Study|Premature Treatment Termination|219
986978|NCT01313858|1996040|FG002|Overall Study|Premature Treatment Termination|191
986979|NCT01313858|1996038|FG000|Overall Study|Lost to Follow-up|35
986980|NCT01313858|1996039|FG001|Overall Study|Lost to Follow-up|51
986981|NCT01313858|1996040|FG002|Overall Study|Lost to Follow-up|47
986982|NCT01313884|1996046|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
986983|NCT01314105|1996101|FG000|Overall Study|Progressive Disease|6
986984|NCT01314105|1996102|FG001|Overall Study|Progressive Disease|10
986985|NCT01314105|1996101|FG000|Overall Study|Refused to continue taking medication|0
986986|NCT01314105|1996102|FG001|Overall Study|Refused to continue taking medication|1
986987|NCT01314105|1996101|FG000|Overall Study|Other Adverse Event|1
986988|NCT01314105|1996102|FG001|Overall Study|Other Adverse Event|1
986997|NCT01314261|1996118|FG000|Overall Study|Adverse Event|1
986998|NCT01314261|1996119|FG001|Overall Study|Adverse Event|0
986999|NCT01314261|1996120|FG002|Overall Study|Adverse Event|0
987000|NCT01314261|1996121|FG003|Overall Study|Adverse Event|0
987001|NCT01314261|1996118|FG000|Overall Study|Withdrawal by Subject|0
987002|NCT01314261|1996119|FG001|Overall Study|Withdrawal by Subject|3
987003|NCT01314261|1996120|FG002|Overall Study|Withdrawal by Subject|1
987004|NCT01314261|1996121|FG003|Overall Study|Withdrawal by Subject|0
987005|NCT01314261|1996118|FG000|Overall Study|Lost to Follow-up|1
987006|NCT01314261|1996119|FG001|Overall Study|Lost to Follow-up|0
987007|NCT01314261|1996120|FG002|Overall Study|Lost to Follow-up|2
987008|NCT01314261|1996121|FG003|Overall Study|Lost to Follow-up|2
987009|NCT01314261|1996118|FG000|Overall Study|Virologic Failure|0
987010|NCT01314261|1996119|FG001|Overall Study|Virologic Failure|1
987011|NCT01314261|1996120|FG002|Overall Study|Virologic Failure|0
987012|NCT01314261|1996121|FG003|Overall Study|Virologic Failure|1
987013|NCT01314443|1996150|FG000|Overall Study|Withdrawal by Subject|2
987014|NCT01314443|1996151|FG001|Overall Study|Withdrawal by Subject|1
987015|NCT01314443|1996152|FG002|Overall Study|Withdrawal by Subject|1
987016|NCT01314443|1996153|FG003|Overall Study|Withdrawal by Subject|1
987017|NCT01314443|1996150|FG000|Overall Study|Protocol Violation|2
987018|NCT01314443|1996151|FG001|Overall Study|Protocol Violation|2
987019|NCT01314443|1996152|FG002|Overall Study|Protocol Violation|1
987020|NCT01314443|1996153|FG003|Overall Study|Protocol Violation|1
987021|NCT01314703|1996163|FG000|Overall Study|screen failure and closed enrollment|8
987022|NCT01314716|1996170|FG000|Double-Blind Phase|Randomized but not treated|1
987023|NCT01314716|1996171|FG001|Double-Blind Phase|Randomized but not treated|1
987024|NCT01314716|1996170|FG000|Double-Blind Phase|Adverse Event|10
987025|NCT01314716|1996171|FG001|Double-Blind Phase|Adverse Event|4
987026|NCT01314716|1996170|FG000|Double-Blind Phase|Withdrawal by Subject|5
987027|NCT01314716|1996171|FG001|Double-Blind Phase|Withdrawal by Subject|6
987028|NCT01314716|1996170|FG000|Double-Blind Phase|Lost to Follow-up|0
987029|NCT01314716|1996171|FG001|Double-Blind Phase|Lost to Follow-up|1
987030|NCT01314716|1996170|FG000|Double-Blind Phase|Sponsor request|1
987031|NCT01314716|1996171|FG001|Double-Blind Phase|Sponsor request|2
987032|NCT01314716|1996170|FG000|Double-Blind Phase|Physician Decision|0
987033|NCT01314716|1996171|FG001|Double-Blind Phase|Physician Decision|1
987034|NCT01314716|1996170|FG000|Open-Label Phase|Adverse Event|4
987035|NCT01314716|1996171|FG001|Open-Label Phase|Adverse Event|6
987036|NCT01314716|1996170|FG000|Open-Label Phase|Withdrawal by Subject|1
987037|NCT01314716|1996171|FG001|Open-Label Phase|Withdrawal by Subject|2
987038|NCT01314716|1996170|FG000|Open-Label Phase|Physician Decision|5
987039|NCT01314716|1996171|FG001|Open-Label Phase|Physician Decision|4
987040|NCT01314872|1996201|FG000|Treatment Period 1|Protocol Violation|2
987041|NCT01314872|1996202|FG001|Treatment Period 1|Protocol Violation|1
987042|NCT01314872|1996203|FG002|Treatment Period 1|Protocol Violation|1
987043|NCT01314872|1996204|FG003|Treatment Period 1|Protocol Violation|0
987044|NCT01314872|1996205|FG004|Treatment Period 1|Protocol Violation|1
987045|NCT01314872|1996206|FG005|Treatment Period 1|Protocol Violation|0
987046|NCT01314872|1996207|FG006|Treatment Period 1|Protocol Violation|0
987047|NCT01314872|1996208|FG007|Treatment Period 1|Protocol Violation|0
987048|NCT01314872|1996209|FG008|Treatment Period 1|Protocol Violation|0
987049|NCT01314872|1996210|FG009|Treatment Period 1|Protocol Violation|1
987050|NCT01314872|1996211|FG010|Treatment Period 1|Protocol Violation|1
987051|NCT01314872|1996212|FG011|Treatment Period 1|Protocol Violation|0
987052|NCT01314872|1996213|FG012|Treatment Period 1|Protocol Violation|0
987053|NCT01314872|1996214|FG013|Treatment Period 1|Protocol Violation|0
987054|NCT01314872|1996215|FG014|Treatment Period 1|Protocol Violation|0
987055|NCT01314872|1996201|FG000|Treatment Period 1|Physician Decision|0
987056|NCT01314872|1996202|FG001|Treatment Period 1|Physician Decision|1
987057|NCT01314872|1996203|FG002|Treatment Period 1|Physician Decision|0
987058|NCT01314872|1996204|FG003|Treatment Period 1|Physician Decision|1
987059|NCT01314872|1996205|FG004|Treatment Period 1|Physician Decision|0
987060|NCT01314872|1996206|FG005|Treatment Period 1|Physician Decision|0
987061|NCT01314872|1996207|FG006|Treatment Period 1|Physician Decision|0
987062|NCT01314872|1996208|FG007|Treatment Period 1|Physician Decision|0
987063|NCT01314872|1996209|FG008|Treatment Period 1|Physician Decision|0
987064|NCT01314872|1996210|FG009|Treatment Period 1|Physician Decision|1
987065|NCT01314872|1996211|FG010|Treatment Period 1|Physician Decision|0
987066|NCT01314872|1996212|FG011|Treatment Period 1|Physician Decision|0
987067|NCT01314872|1996213|FG012|Treatment Period 1|Physician Decision|0
987068|NCT01314872|1996214|FG013|Treatment Period 1|Physician Decision|0
987069|NCT01314872|1996215|FG014|Treatment Period 1|Physician Decision|0
987070|NCT01314872|1996201|FG000|Treatment Period 1|Lack of Efficacy|1
987071|NCT01314872|1996202|FG001|Treatment Period 1|Lack of Efficacy|0
987072|NCT01314872|1996203|FG002|Treatment Period 1|Lack of Efficacy|0
987073|NCT01314872|1996204|FG003|Treatment Period 1|Lack of Efficacy|0
987074|NCT01314872|1996205|FG004|Treatment Period 1|Lack of Efficacy|0
987075|NCT01314872|1996206|FG005|Treatment Period 1|Lack of Efficacy|1
987076|NCT01314872|1996207|FG006|Treatment Period 1|Lack of Efficacy|0
987077|NCT01314872|1996208|FG007|Treatment Period 1|Lack of Efficacy|2
987078|NCT01314872|1996209|FG008|Treatment Period 1|Lack of Efficacy|0
987079|NCT01314872|1996210|FG009|Treatment Period 1|Lack of Efficacy|0
987080|NCT01314872|1996211|FG010|Treatment Period 1|Lack of Efficacy|0
987081|NCT01314872|1996212|FG011|Treatment Period 1|Lack of Efficacy|0
987082|NCT01314872|1996213|FG012|Treatment Period 1|Lack of Efficacy|0
987083|NCT01314872|1996214|FG013|Treatment Period 1|Lack of Efficacy|0
987084|NCT01314872|1996215|FG014|Treatment Period 1|Lack of Efficacy|0
987085|NCT01314872|1996201|FG000|Treatment Period 1|Adverse event, non-fatal|4
987086|NCT01314872|1996202|FG001|Treatment Period 1|Adverse event, non-fatal|2
987087|NCT01314872|1996203|FG002|Treatment Period 1|Adverse event, non-fatal|3
987088|NCT01314872|1996204|FG003|Treatment Period 1|Adverse event, non-fatal|2
987089|NCT01314872|1996205|FG004|Treatment Period 1|Adverse event, non-fatal|2
987090|NCT01314872|1996206|FG005|Treatment Period 1|Adverse event, non-fatal|4
987091|NCT01314872|1996207|FG006|Treatment Period 1|Adverse event, non-fatal|4
987092|NCT01314872|1996208|FG007|Treatment Period 1|Adverse event, non-fatal|2
987093|NCT01314872|1996209|FG008|Treatment Period 1|Adverse event, non-fatal|3
987094|NCT01314872|1996210|FG009|Treatment Period 1|Adverse event, non-fatal|0
987095|NCT01314872|1996211|FG010|Treatment Period 1|Adverse event, non-fatal|1
987096|NCT01314872|1996212|FG011|Treatment Period 1|Adverse event, non-fatal|0
987097|NCT01314872|1996213|FG012|Treatment Period 1|Adverse event, non-fatal|0
987098|NCT01314872|1996214|FG013|Treatment Period 1|Adverse event, non-fatal|0
987099|NCT01314872|1996215|FG014|Treatment Period 1|Adverse event, non-fatal|0
987100|NCT01314872|1996201|FG000|Treatment Period 1|Withdrawal by Subject|3
987101|NCT01314872|1996202|FG001|Treatment Period 1|Withdrawal by Subject|1
987102|NCT01314872|1996203|FG002|Treatment Period 1|Withdrawal by Subject|0
987103|NCT01314872|1996204|FG003|Treatment Period 1|Withdrawal by Subject|2
987104|NCT01314872|1996205|FG004|Treatment Period 1|Withdrawal by Subject|3
987105|NCT01314872|1996206|FG005|Treatment Period 1|Withdrawal by Subject|1
987106|NCT01314872|1996207|FG006|Treatment Period 1|Withdrawal by Subject|3
987107|NCT01314872|1996208|FG007|Treatment Period 1|Withdrawal by Subject|2
987108|NCT01314872|1996209|FG008|Treatment Period 1|Withdrawal by Subject|2
987109|NCT01314872|1996210|FG009|Treatment Period 1|Withdrawal by Subject|2
987110|NCT01314872|1996211|FG010|Treatment Period 1|Withdrawal by Subject|1
987111|NCT01314872|1996212|FG011|Treatment Period 1|Withdrawal by Subject|0
987112|NCT01314872|1996213|FG012|Treatment Period 1|Withdrawal by Subject|0
987113|NCT01314872|1996214|FG013|Treatment Period 1|Withdrawal by Subject|0
987114|NCT01314872|1996215|FG014|Treatment Period 1|Withdrawal by Subject|0
987115|NCT01314872|1996201|FG000|Treatment Period 1|Lost to Follow-up|0
987116|NCT01314872|1996202|FG001|Treatment Period 1|Lost to Follow-up|1
987117|NCT01314872|1996203|FG002|Treatment Period 1|Lost to Follow-up|2
987118|NCT01314872|1996204|FG003|Treatment Period 1|Lost to Follow-up|2
987119|NCT01314872|1996205|FG004|Treatment Period 1|Lost to Follow-up|1
987120|NCT01314872|1996206|FG005|Treatment Period 1|Lost to Follow-up|1
987121|NCT01314872|1996207|FG006|Treatment Period 1|Lost to Follow-up|1
987122|NCT01314872|1996208|FG007|Treatment Period 1|Lost to Follow-up|1
987123|NCT01314872|1996209|FG008|Treatment Period 1|Lost to Follow-up|1
987124|NCT01314872|1996210|FG009|Treatment Period 1|Lost to Follow-up|0
987125|NCT01314872|1996211|FG010|Treatment Period 1|Lost to Follow-up|0
987126|NCT01314872|1996212|FG011|Treatment Period 1|Lost to Follow-up|0
987127|NCT01314872|1996213|FG012|Treatment Period 1|Lost to Follow-up|0
987128|NCT01314872|1996214|FG013|Treatment Period 1|Lost to Follow-up|0
987129|NCT01314872|1996215|FG014|Treatment Period 1|Lost to Follow-up|0
987130|NCT01314872|1996201|FG000|Period 2|Protocol Violation|0
987131|NCT01314872|1996202|FG001|Period 2|Protocol Violation|0
987132|NCT01314872|1996203|FG002|Period 2|Protocol Violation|0
987133|NCT01314872|1996204|FG003|Period 2|Protocol Violation|0
987134|NCT01314872|1996205|FG004|Period 2|Protocol Violation|0
987135|NCT01314872|1996206|FG005|Period 2|Protocol Violation|0
987136|NCT01314872|1996207|FG006|Period 2|Protocol Violation|0
987137|NCT01314872|1996208|FG007|Period 2|Protocol Violation|0
987138|NCT01314872|1996209|FG008|Period 2|Protocol Violation|0
987139|NCT01314872|1996210|FG009|Period 2|Protocol Violation|0
987140|NCT01314872|1996211|FG010|Period 2|Protocol Violation|0
987141|NCT01314872|1996212|FG011|Period 2|Protocol Violation|3
987142|NCT01314872|1996213|FG012|Period 2|Protocol Violation|3
987143|NCT01314872|1996214|FG013|Period 2|Protocol Violation|2
987144|NCT01314872|1996215|FG014|Period 2|Protocol Violation|0
987145|NCT01314872|1996201|FG000|Period 2|Non-compliance with study drug|0
987146|NCT01314872|1996202|FG001|Period 2|Non-compliance with study drug|0
987147|NCT01314872|1996203|FG002|Period 2|Non-compliance with study drug|0
987148|NCT01314872|1996204|FG003|Period 2|Non-compliance with study drug|0
987149|NCT01314872|1996205|FG004|Period 2|Non-compliance with study drug|0
987150|NCT01314872|1996206|FG005|Period 2|Non-compliance with study drug|0
987151|NCT01314872|1996207|FG006|Period 2|Non-compliance with study drug|0
987152|NCT01314872|1996208|FG007|Period 2|Non-compliance with study drug|0
987153|NCT01314872|1996209|FG008|Period 2|Non-compliance with study drug|0
912773|NCT00806819|1890310|FG001|Overall Study|Reasons other than stated above|41
912774|NCT00806988|1890319|FG000|Overall Study|Death|15
912775|NCT00806988|1890320|FG001|Overall Study|Death|16
912776|NCT00806988|1890319|FG000|Overall Study|Withdrawal by Subject|8
912777|NCT00806988|1890320|FG001|Overall Study|Withdrawal by Subject|8
912778|NCT00806988|1890319|FG000|Overall Study|Lost to Follow-up|4
912779|NCT00806988|1890320|FG001|Overall Study|Lost to Follow-up|19
912780|NCT00807001|1890331|FG000|Overall Study|Non-compliance|0
912781|NCT00807001|1890332|FG001|Overall Study|Non-compliance|1
912782|NCT00807001|1890333|FG002|Overall Study|Non-compliance|0
912783|NCT00807001|1890334|FG003|Overall Study|Non-compliance|0
912784|NCT00807001|1890335|FG004|Overall Study|Non-compliance|0
912785|NCT00807014|1890349|FG000|Overall Study|Participant Considered Disease Cured|13
912786|NCT00807014|1890350|FG001|Overall Study|Participant Considered Disease Cured|2
912787|NCT00807014|1890349|FG000|Overall Study|Participant Considered Disease Not Cured|2
912788|NCT00807014|1890350|FG001|Overall Study|Participant Considered Disease Not Cured|7
912789|NCT00807014|1890349|FG000|Overall Study|Protocol Violation|2
912790|NCT00807014|1890350|FG001|Overall Study|Protocol Violation|8
912791|NCT00807014|1890349|FG000|Overall Study|Adverse Event|0
987154|NCT01314872|1996210|FG009|Period 2|Non-compliance with study drug|0
987155|NCT01314872|1996211|FG010|Period 2|Non-compliance with study drug|0
987156|NCT01314872|1996212|FG011|Period 2|Non-compliance with study drug|3
987157|NCT01314872|1996213|FG012|Period 2|Non-compliance with study drug|3
987158|NCT01314872|1996214|FG013|Period 2|Non-compliance with study drug|1
987159|NCT01314872|1996215|FG014|Period 2|Non-compliance with study drug|2
987160|NCT01314872|1996201|FG000|Period 2|Lack of Efficacy|0
987161|NCT01314872|1996202|FG001|Period 2|Lack of Efficacy|0
987162|NCT01314872|1996203|FG002|Period 2|Lack of Efficacy|0
987163|NCT01314872|1996204|FG003|Period 2|Lack of Efficacy|0
987164|NCT01314872|1996205|FG004|Period 2|Lack of Efficacy|0
987165|NCT01314872|1996206|FG005|Period 2|Lack of Efficacy|0
987166|NCT01314872|1996207|FG006|Period 2|Lack of Efficacy|0
987167|NCT01314872|1996208|FG007|Period 2|Lack of Efficacy|0
987168|NCT01314872|1996209|FG008|Period 2|Lack of Efficacy|0
987169|NCT01314872|1996210|FG009|Period 2|Lack of Efficacy|0
987170|NCT01314872|1996211|FG010|Period 2|Lack of Efficacy|0
987171|NCT01314872|1996212|FG011|Period 2|Lack of Efficacy|7
987172|NCT01314872|1996213|FG012|Period 2|Lack of Efficacy|12
987173|NCT01314872|1996214|FG013|Period 2|Lack of Efficacy|9
987174|NCT01314872|1996215|FG014|Period 2|Lack of Efficacy|2
987175|NCT01314872|1996201|FG000|Period 2|Pregnancy|0
987176|NCT01314872|1996202|FG001|Period 2|Pregnancy|0
987177|NCT01314872|1996203|FG002|Period 2|Pregnancy|0
987178|NCT01314872|1996204|FG003|Period 2|Pregnancy|0
987179|NCT01314872|1996205|FG004|Period 2|Pregnancy|0
987180|NCT01314872|1996206|FG005|Period 2|Pregnancy|0
987181|NCT01314872|1996207|FG006|Period 2|Pregnancy|0
987182|NCT01314872|1996208|FG007|Period 2|Pregnancy|0
987183|NCT01314872|1996209|FG008|Period 2|Pregnancy|0
987184|NCT01314872|1996210|FG009|Period 2|Pregnancy|0
987185|NCT01314872|1996211|FG010|Period 2|Pregnancy|0
987186|NCT01314872|1996212|FG011|Period 2|Pregnancy|0
987187|NCT01314872|1996213|FG012|Period 2|Pregnancy|0
987188|NCT01314872|1996214|FG013|Period 2|Pregnancy|0
987189|NCT01314872|1996215|FG014|Period 2|Pregnancy|1
987190|NCT01314872|1996201|FG000|Period 2|Study terminated by Sponsor|0
987191|NCT01314872|1996202|FG001|Period 2|Study terminated by Sponsor|0
987192|NCT01314872|1996203|FG002|Period 2|Study terminated by Sponsor|0
987193|NCT01314872|1996204|FG003|Period 2|Study terminated by Sponsor|0
987194|NCT01314872|1996205|FG004|Period 2|Study terminated by Sponsor|0
987195|NCT01314872|1996206|FG005|Period 2|Study terminated by Sponsor|0
987196|NCT01314872|1996207|FG006|Period 2|Study terminated by Sponsor|0
987197|NCT01314872|1996208|FG007|Period 2|Study terminated by Sponsor|0
987198|NCT01314872|1996209|FG008|Period 2|Study terminated by Sponsor|0
987199|NCT01314872|1996210|FG009|Period 2|Study terminated by Sponsor|0
987200|NCT01314872|1996211|FG010|Period 2|Study terminated by Sponsor|0
987201|NCT01314872|1996212|FG011|Period 2|Study terminated by Sponsor|2
987202|NCT01314872|1996213|FG012|Period 2|Study terminated by Sponsor|2
987203|NCT01314872|1996214|FG013|Period 2|Study terminated by Sponsor|3
987204|NCT01314872|1996215|FG014|Period 2|Study terminated by Sponsor|0
987205|NCT01314872|1996201|FG000|Period 2|Adverse event, non-fatal|0
987206|NCT01314872|1996202|FG001|Period 2|Adverse event, non-fatal|0
987207|NCT01314872|1996203|FG002|Period 2|Adverse event, non-fatal|0
987208|NCT01314872|1996204|FG003|Period 2|Adverse event, non-fatal|0
987209|NCT01314872|1996205|FG004|Period 2|Adverse event, non-fatal|0
987210|NCT01314872|1996206|FG005|Period 2|Adverse event, non-fatal|0
987211|NCT01314872|1996207|FG006|Period 2|Adverse event, non-fatal|0
987212|NCT01314872|1996208|FG007|Period 2|Adverse event, non-fatal|0
987213|NCT01314872|1996209|FG008|Period 2|Adverse event, non-fatal|0
987214|NCT01314872|1996210|FG009|Period 2|Adverse event, non-fatal|0
987215|NCT01314872|1996211|FG010|Period 2|Adverse event, non-fatal|0
987216|NCT01314872|1996212|FG011|Period 2|Adverse event, non-fatal|13
987217|NCT01314872|1996213|FG012|Period 2|Adverse event, non-fatal|16
987218|NCT01314872|1996214|FG013|Period 2|Adverse event, non-fatal|24
987219|NCT01314872|1996215|FG014|Period 2|Adverse event, non-fatal|9
987220|NCT01314872|1996201|FG000|Period 2|Withdrawal by Subject|0
987221|NCT01314872|1996202|FG001|Period 2|Withdrawal by Subject|0
987222|NCT01314872|1996203|FG002|Period 2|Withdrawal by Subject|0
987223|NCT01314872|1996204|FG003|Period 2|Withdrawal by Subject|0
987224|NCT01314872|1996205|FG004|Period 2|Withdrawal by Subject|0
987225|NCT01314872|1996206|FG005|Period 2|Withdrawal by Subject|0
987226|NCT01314872|1996207|FG006|Period 2|Withdrawal by Subject|0
987227|NCT01314872|1996208|FG007|Period 2|Withdrawal by Subject|0
987228|NCT01314872|1996209|FG008|Period 2|Withdrawal by Subject|0
987229|NCT01314872|1996210|FG009|Period 2|Withdrawal by Subject|0
987230|NCT01314872|1996211|FG010|Period 2|Withdrawal by Subject|0
987231|NCT01314872|1996212|FG011|Period 2|Withdrawal by Subject|14
987232|NCT01314872|1996213|FG012|Period 2|Withdrawal by Subject|17
987233|NCT01314872|1996214|FG013|Period 2|Withdrawal by Subject|12
987234|NCT01314872|1996215|FG014|Period 2|Withdrawal by Subject|4
987235|NCT01314872|1996201|FG000|Period 2|Lost to Follow-up|0
987236|NCT01314872|1996202|FG001|Period 2|Lost to Follow-up|0
987237|NCT01314872|1996203|FG002|Period 2|Lost to Follow-up|0
987238|NCT01314872|1996204|FG003|Period 2|Lost to Follow-up|0
987239|NCT01314872|1996205|FG004|Period 2|Lost to Follow-up|0
987240|NCT01314872|1996206|FG005|Period 2|Lost to Follow-up|0
987241|NCT01314872|1996207|FG006|Period 2|Lost to Follow-up|0
987242|NCT01314872|1996208|FG007|Period 2|Lost to Follow-up|0
987243|NCT01314872|1996209|FG008|Period 2|Lost to Follow-up|0
987244|NCT01314872|1996210|FG009|Period 2|Lost to Follow-up|0
987245|NCT01314872|1996211|FG010|Period 2|Lost to Follow-up|0
987246|NCT01314872|1996212|FG011|Period 2|Lost to Follow-up|6
987247|NCT01314872|1996213|FG012|Period 2|Lost to Follow-up|7
987248|NCT01314872|1996214|FG013|Period 2|Lost to Follow-up|2
987249|NCT01314872|1996215|FG014|Period 2|Lost to Follow-up|6
987250|NCT01314911|1996249|FG000|Overall Study|Lost to Follow-up|3
987251|NCT01314911|1996250|FG001|Overall Study|Lost to Follow-up|2
987252|NCT01314911|1996249|FG000|Overall Study|Withdrawal by Subject|1
987253|NCT01314911|1996250|FG001|Overall Study|Withdrawal by Subject|3
987254|NCT01314911|1996249|FG000|Overall Study|Received Non-randomized Study Drug|0
987255|NCT01314911|1996250|FG001|Overall Study|Received Non-randomized Study Drug|1
987256|NCT01314911|1996249|FG000|Overall Study|Never Started Treatment|1
987257|NCT01314911|1996250|FG001|Overall Study|Never Started Treatment|0
987258|NCT01315028|1996271|FG000|Overall Study|Lost to Follow-up|1
987259|NCT01315028|1996272|FG001|Overall Study|Lost to Follow-up|0
987260|NCT01315028|1996271|FG000|Overall Study|Death|0
987261|NCT01315028|1996272|FG001|Overall Study|Death|1
987262|NCT01315132|1996278|FG000|Overall Study|not treated due to disease progression|1
987263|NCT01315236|1996302|FG000|Double-blind Phase|Death|1
987264|NCT01315236|1996303|FG001|Double-blind Phase|Death|0
987265|NCT01315236|1996302|FG000|Double-blind Phase|Adverse Event|1
987266|NCT01315236|1996303|FG001|Double-blind Phase|Adverse Event|0
987267|NCT01315236|1996302|FG000|Double-blind Phase|Withdrawal of Consent|1
987268|NCT01315236|1996303|FG001|Double-blind Phase|Withdrawal of Consent|0
987269|NCT01315236|1996302|FG000|Double-blind Phase|Lost to Follow-up|1
987270|NCT01315236|1996303|FG001|Double-blind Phase|Lost to Follow-up|0
987271|NCT01315236|1996302|FG000|Open-label Phase|Death|1
987272|NCT01315236|1996303|FG001|Open-label Phase|Death|0
987273|NCT01315236|1996302|FG000|Open-label Phase|Adverse Event|0
987274|NCT01315236|1996303|FG001|Open-label Phase|Adverse Event|1
987275|NCT01315236|1996302|FG000|Open-label Phase|Other|0
987276|NCT01315236|1996303|FG001|Open-label Phase|Other|1
987277|NCT01315236|1996302|FG000|12-Month Follow-up Period|Death|0
987278|NCT01315236|1996303|FG001|12-Month Follow-up Period|Death|1
987279|NCT01315236|1996302|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1
987280|NCT01315236|1996303|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0
987281|NCT01315249|1996313|FG000|Overall Study|Adverse Event|22
987282|NCT01315249|1996314|FG001|Overall Study|Adverse Event|26
987283|NCT01315249|1996313|FG000|Overall Study|Withdrawal by Subject|11
987284|NCT01315249|1996314|FG001|Overall Study|Withdrawal by Subject|10
987285|NCT01315249|1996313|FG000|Overall Study|Protocol Violation|8
987286|NCT01315249|1996314|FG001|Overall Study|Protocol Violation|5
987287|NCT01315249|1996313|FG000|Overall Study|Abnormal test results|1
987288|NCT01315249|1996314|FG001|Overall Study|Abnormal test results|2
987289|NCT01315249|1996313|FG000|Overall Study|Administrative problems|1
987290|NCT01315249|1996314|FG001|Overall Study|Administrative problems|0
987291|NCT01315249|1996313|FG000|Overall Study|inability to use device|1
987292|NCT01315249|1996314|FG001|Overall Study|inability to use device|0
987293|NCT01315249|1996313|FG000|Overall Study|Lack of Efficacy|0
987294|NCT01315249|1996314|FG001|Overall Study|Lack of Efficacy|1
987295|NCT01315249|1996313|FG000|Overall Study|Lost to Follow-up|0
987296|NCT01315249|1996314|FG001|Overall Study|Lost to Follow-up|2
987297|NCT01315249|1996313|FG000|Overall Study|Death|0
987298|NCT01315249|1996314|FG001|Overall Study|Death|1
987299|NCT01315678|1996355|FG000|Overall Study|Withdrawal by Subject|7
987300|NCT01315678|1996356|FG001|Overall Study|Withdrawal by Subject|3
987301|NCT01315678|1996355|FG000|Overall Study|Adverse Event|3
987302|NCT01315678|1996356|FG001|Overall Study|Adverse Event|1
987303|NCT01315678|1996355|FG000|Overall Study|Lost to Follow-up|1
987304|NCT01315678|1996356|FG001|Overall Study|Lost to Follow-up|0
987305|NCT01315678|1996355|FG000|Overall Study|similar reason to those listed above|3
987306|NCT01315678|1996356|FG001|Overall Study|similar reason to those listed above|2
987307|NCT01315847|1996366|FG000|Part I, Period 1|Reached maximum number of arterial lines|3
987308|NCT01315847|1996367|FG001|Part I, Period 1|Reached maximum number of arterial lines|0
987309|NCT01315847|1996366|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0
987310|NCT01315847|1996367|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1
987311|NCT01316055|1996385|FG000|Overall Study|Lost to Follow-up|1
987312|NCT01316055|1996386|FG001|Overall Study|Lost to Follow-up|0
987313|NCT01316055|1996387|FG002|Overall Study|Lost to Follow-up|0
987314|NCT01316224|1996407|FG000|Overall Study|Protocol Violation|3
987315|NCT01316224|1996407|FG000|Overall Study|Adverse Event|3
987316|NCT01316224|1996407|FG000|Overall Study|Lack of Efficacy|1
987317|NCT01316224|1996407|FG000|Overall Study|Withdrawal by Subject|1
987318|NCT01316224|1996407|FG000|Overall Study|Adverse Event With Treatment Failure|1
987319|NCT01316224|1996407|FG000|Overall Study|Other|1
987320|NCT01316276|1996422|FG000|Overall Study|Death|1
912792|NCT00807014|1890350|FG001|Overall Study|Adverse Event|2
912793|NCT00807014|1890349|FG000|Overall Study|Lost to Follow-up|9
912794|NCT00807014|1890350|FG001|Overall Study|Lost to Follow-up|7
987321|NCT01316276|1996422|FG000|Overall Study|Adverse Event|19
987322|NCT01316276|1996422|FG000|Overall Study|Withdrawal of consent|24
987323|NCT01316276|1996422|FG000|Overall Study|Lost to Follow-up|1
987324|NCT01316276|1996422|FG000|Overall Study|Other|22
987325|NCT01316380|1996474|FG000|Overall Study|Adverse Event|0
987326|NCT01316380|1996475|FG001|Overall Study|Adverse Event|2
987327|NCT01316380|1996476|FG002|Overall Study|Adverse Event|1
987328|NCT01316380|1996474|FG000|Overall Study|Protocol Violation|0
987329|NCT01316380|1996475|FG001|Overall Study|Protocol Violation|0
987330|NCT01316380|1996476|FG002|Overall Study|Protocol Violation|1
987331|NCT01316380|1996474|FG000|Overall Study|Withdrawal by Subject|1
987332|NCT01316380|1996475|FG001|Overall Study|Withdrawal by Subject|2
987333|NCT01316380|1996476|FG002|Overall Study|Withdrawal by Subject|0
987334|NCT01316380|1996474|FG000|Overall Study|Other|0
987335|NCT01316380|1996475|FG001|Overall Study|Other|1
987336|NCT01316380|1996476|FG002|Overall Study|Other|1
987337|NCT01316380|1996474|FG000|Overall Study|Not treated|1
987338|NCT01316380|1996475|FG001|Overall Study|Not treated|0
987339|NCT01316380|1996476|FG002|Overall Study|Not treated|0
987340|NCT01316419|1996484|FG000|Overall Study|Not treated|103
987341|NCT01316419|1996484|FG000|Overall Study|Violated inclusion/exclusion criterion|143
987342|NCT01316419|1996484|FG000|Overall Study|Lost to Follow-up|19
987343|NCT01316575|1996499|FG000|Overall Study|Withdrawal by Subject|2
987344|NCT01316575|1996500|FG001|Overall Study|Withdrawal by Subject|0
987345|NCT01316575|1996499|FG000|Overall Study|Required alternate treatment|0
987346|NCT01316575|1996500|FG001|Overall Study|Required alternate treatment|1
987347|NCT01316614|1996506|FG000|Overall Study|No solid lesion and FNA not indicated|25
987348|NCT01316614|1996506|FG000|Overall Study|Cytology slides not available for review|4
987349|NCT01316614|1996506|FG000|Overall Study|Cystic lesion|5
987350|NCT01316614|1996506|FG000|Overall Study|Inadequate number of passes|2
987351|NCT01316614|1996506|FG000|Overall Study|Medically unstable|1
987352|NCT01316692|1996511|FG000|Overall Study|Adverse Event|5
987353|NCT01316692|1996511|FG000|Overall Study|Disease Progression|7
987354|NCT01316887|1996529|FG000|Overall Study|Adverse Event|13
987355|NCT01316887|1996530|FG001|Overall Study|Adverse Event|21
987356|NCT01316887|1996531|FG002|Overall Study|Adverse Event|17
987357|NCT01316887|1996529|FG000|Overall Study|Lack of Efficacy|9
987358|NCT01316887|1996530|FG001|Overall Study|Lack of Efficacy|3
987359|NCT01316887|1996531|FG002|Overall Study|Lack of Efficacy|1
987360|NCT01316887|1996529|FG000|Overall Study|Protocol Violation|2
987361|NCT01316887|1996530|FG001|Overall Study|Protocol Violation|6
912795|NCT00807014|1890349|FG000|Overall Study|Recovery|1
912796|NCT00807014|1890350|FG001|Overall Study|Recovery|0
912797|NCT00807014|1890349|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0
912798|NCT00807014|1890350|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1
912799|NCT00807040|1890358|FG000|Overall Study|Death|24
912800|NCT00807040|1890359|FG001|Overall Study|Death|29
987362|NCT01316887|1996531|FG002|Overall Study|Protocol Violation|6
987363|NCT01316887|1996529|FG000|Overall Study|Protocol-defined Stopping Criteria|8
987364|NCT01316887|1996530|FG001|Overall Study|Protocol-defined Stopping Criteria|37
987365|NCT01316887|1996531|FG002|Overall Study|Protocol-defined Stopping Criteria|36
987366|NCT01316887|1996529|FG000|Overall Study|Study Closed/Terminated|2
987367|NCT01316887|1996530|FG001|Overall Study|Study Closed/Terminated|4
987368|NCT01316887|1996531|FG002|Overall Study|Study Closed/Terminated|3
987369|NCT01316887|1996529|FG000|Overall Study|Lost to Follow-up|1
987370|NCT01316887|1996530|FG001|Overall Study|Lost to Follow-up|7
987371|NCT01316887|1996531|FG002|Overall Study|Lost to Follow-up|5
987372|NCT01316887|1996529|FG000|Overall Study|Withdrawal by Subject|8
987373|NCT01316887|1996530|FG001|Overall Study|Withdrawal by Subject|16
987374|NCT01316887|1996531|FG002|Overall Study|Withdrawal by Subject|15
987375|NCT01316900|1996544|FG000|Overall Study|Adverse Event|10
987376|NCT01316900|1996545|FG001|Overall Study|Adverse Event|10
987377|NCT01316900|1996546|FG002|Overall Study|Adverse Event|15
987378|NCT01316900|1996547|FG003|Overall Study|Adverse Event|9
987379|NCT01316900|1996544|FG000|Overall Study|Lack of Efficacy|17
987380|NCT01316900|1996545|FG001|Overall Study|Lack of Efficacy|9
987381|NCT01316900|1996546|FG002|Overall Study|Lack of Efficacy|5
987382|NCT01316900|1996547|FG003|Overall Study|Lack of Efficacy|7
987383|NCT01316900|1996544|FG000|Overall Study|Protocol Violation|7
987384|NCT01316900|1996545|FG001|Overall Study|Protocol Violation|1
987385|NCT01316900|1996546|FG002|Overall Study|Protocol Violation|4
987386|NCT01316900|1996547|FG003|Overall Study|Protocol Violation|0
987387|NCT01316900|1996544|FG000|Overall Study|Protocol-defined Stopping Criteria|2
987388|NCT01316900|1996545|FG001|Overall Study|Protocol-defined Stopping Criteria|3
987389|NCT01316900|1996546|FG002|Overall Study|Protocol-defined Stopping Criteria|10
987390|NCT01316900|1996547|FG003|Overall Study|Protocol-defined Stopping Criteria|5
987391|NCT01316900|1996544|FG000|Overall Study|Lost to Follow-up|1
987392|NCT01316900|1996545|FG001|Overall Study|Lost to Follow-up|0
987393|NCT01316900|1996546|FG002|Overall Study|Lost to Follow-up|1
987394|NCT01316900|1996547|FG003|Overall Study|Lost to Follow-up|1
987395|NCT01316900|1996544|FG000|Overall Study|Withdrawal by Subject|7
987396|NCT01316900|1996545|FG001|Overall Study|Withdrawal by Subject|8
987397|NCT01316900|1996546|FG002|Overall Study|Withdrawal by Subject|6
987398|NCT01316900|1996547|FG003|Overall Study|Withdrawal by Subject|9
987399|NCT01316913|1996561|FG000|Overall Study|Adverse Event|17
987400|NCT01316913|1996562|FG001|Overall Study|Adverse Event|20
987401|NCT01316913|1996563|FG002|Overall Study|Adverse Event|15
987402|NCT01316913|1996564|FG003|Overall Study|Adverse Event|11
987403|NCT01316913|1996561|FG000|Overall Study|Lack of Efficacy|22
987404|NCT01316913|1996562|FG001|Overall Study|Lack of Efficacy|12
987405|NCT01316913|1996563|FG002|Overall Study|Lack of Efficacy|9
987406|NCT01316913|1996564|FG003|Overall Study|Lack of Efficacy|13
987407|NCT01316913|1996561|FG000|Overall Study|Protocol Violation|1
987408|NCT01316913|1996562|FG001|Overall Study|Protocol Violation|4
987409|NCT01316913|1996563|FG002|Overall Study|Protocol Violation|4
987410|NCT01316913|1996564|FG003|Overall Study|Protocol Violation|1
987411|NCT01316913|1996561|FG000|Overall Study|Protocol-defined Stopping Criteria|7
987412|NCT01316913|1996562|FG001|Overall Study|Protocol-defined Stopping Criteria|8
987413|NCT01316913|1996563|FG002|Overall Study|Protocol-defined Stopping Criteria|11
987414|NCT01316913|1996564|FG003|Overall Study|Protocol-defined Stopping Criteria|6
987415|NCT01316913|1996561|FG000|Overall Study|Lost to Follow-up|0
987416|NCT01316913|1996562|FG001|Overall Study|Lost to Follow-up|1
987417|NCT01316913|1996563|FG002|Overall Study|Lost to Follow-up|0
987418|NCT01316913|1996564|FG003|Overall Study|Lost to Follow-up|2
987419|NCT01316913|1996561|FG000|Overall Study|Withdrawal by Subject|10
987420|NCT01316913|1996562|FG001|Overall Study|Withdrawal by Subject|9
987421|NCT01316913|1996563|FG002|Overall Study|Withdrawal by Subject|10
987422|NCT01316913|1996564|FG003|Overall Study|Withdrawal by Subject|6
987423|NCT01316939|1996586|FG000|Overall Study|Study closed/terminated|26
987424|NCT01316939|1996587|FG001|Overall Study|Study closed/terminated|25
987425|NCT01316939|1996588|FG002|Overall Study|Study closed/terminated|23
987426|NCT01316939|1996586|FG000|Overall Study|Lack of Efficacy|24
987427|NCT01316939|1996587|FG001|Overall Study|Lack of Efficacy|25
987428|NCT01316939|1996588|FG002|Overall Study|Lack of Efficacy|25
987429|NCT01316939|1996586|FG000|Overall Study|Adverse Event|9
987430|NCT01316939|1996587|FG001|Overall Study|Adverse Event|12
987431|NCT01316939|1996588|FG002|Overall Study|Adverse Event|11
987432|NCT01316939|1996586|FG000|Overall Study|Withdrawal by Subject|1
987433|NCT01316939|1996587|FG001|Overall Study|Withdrawal by Subject|3
987434|NCT01316939|1996588|FG002|Overall Study|Withdrawal by Subject|6
987435|NCT01316939|1996586|FG000|Overall Study|Physician Decision|2
987436|NCT01316939|1996587|FG001|Overall Study|Physician Decision|2
987437|NCT01316939|1996588|FG002|Overall Study|Physician Decision|1
987438|NCT01316939|1996586|FG000|Overall Study|Lost to Follow-up|0
987439|NCT01316939|1996587|FG001|Overall Study|Lost to Follow-up|0
987440|NCT01316939|1996588|FG002|Overall Study|Lost to Follow-up|2
987441|NCT01316939|1996586|FG000|Overall Study|Met Liver chemistry stopping criteria|1
987442|NCT01316939|1996587|FG001|Overall Study|Met Liver chemistry stopping criteria|0
987443|NCT01316939|1996588|FG002|Overall Study|Met Liver chemistry stopping criteria|1
987444|NCT01316939|1996586|FG000|Overall Study|Protocol Violation|0
987445|NCT01316939|1996587|FG001|Overall Study|Protocol Violation|1
987446|NCT01316939|1996588|FG002|Overall Study|Protocol Violation|0
987447|NCT01317004|1996598|FG000|Overall Study|Withdrawal by Subject|1
987448|NCT01317004|1996599|FG001|Overall Study|Withdrawal by Subject|4
987449|NCT01317004|1996598|FG000|Overall Study|Protocol Violation|0
987450|NCT01317004|1996599|FG001|Overall Study|Protocol Violation|2
987451|NCT01317004|1996598|FG000|Overall Study|Adverse Event|3
987452|NCT01317004|1996599|FG001|Overall Study|Adverse Event|3
987453|NCT01317160|1996625|FG000|Overall Study|Incorrect inclusion|1
987454|NCT01317160|1996626|FG001|Overall Study|Incorrect inclusion|1
987455|NCT01317160|1996625|FG000|Overall Study|Lost to Follow-up|3
987456|NCT01317160|1996626|FG001|Overall Study|Lost to Follow-up|3
987457|NCT01317160|1996625|FG000|Overall Study|Withdrawal by Subject|0
987458|NCT01317160|1996626|FG001|Overall Study|Withdrawal by Subject|2
987459|NCT01317199|1996636|FG000|Dose-escalation Phase 1|Physician Decision|5
987460|NCT01317199|1996637|FG001|Dose-escalation Phase 1|Physician Decision|0
987461|NCT01317199|1996638|FG002|Dose-escalation Phase 1|Physician Decision|0
987462|NCT01317199|1996639|FG003|Dose-escalation Phase 1|Physician Decision|0
987463|NCT01317199|1996636|FG000|Dose-escalation Phase 1|Disease progression|1
987464|NCT01317199|1996637|FG001|Dose-escalation Phase 1|Disease progression|0
987465|NCT01317199|1996638|FG002|Dose-escalation Phase 1|Disease progression|0
987466|NCT01317199|1996639|FG003|Dose-escalation Phase 1|Disease progression|0
987467|NCT01317199|1996636|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
987468|NCT01317199|1996637|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
987469|NCT01317199|1996638|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
987470|NCT01317199|1996639|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
987471|NCT01317199|1996636|FG000|Randomized Phase 2|Disease progression|0
987472|NCT01317199|1996637|FG001|Randomized Phase 2|Disease progression|3
987473|NCT01317199|1996638|FG002|Randomized Phase 2|Disease progression|7
987474|NCT01317199|1996639|FG003|Randomized Phase 2|Disease progression|5
987475|NCT01317199|1996636|FG000|Randomized Phase 2|Withdrawal by Subject|0
987476|NCT01317199|1996637|FG001|Randomized Phase 2|Withdrawal by Subject|3
987477|NCT01317199|1996638|FG002|Randomized Phase 2|Withdrawal by Subject|5
987478|NCT01317199|1996639|FG003|Randomized Phase 2|Withdrawal by Subject|4
987479|NCT01317199|1996636|FG000|Randomized Phase 2|Adverse Event|0
987480|NCT01317199|1996637|FG001|Randomized Phase 2|Adverse Event|0
987481|NCT01317199|1996638|FG002|Randomized Phase 2|Adverse Event|0
987482|NCT01317199|1996639|FG003|Randomized Phase 2|Adverse Event|1
987483|NCT01317199|1996636|FG000|Randomized Phase 2|Comorbidities|0
987484|NCT01317199|1996637|FG001|Randomized Phase 2|Comorbidities|2
987485|NCT01317199|1996638|FG002|Randomized Phase 2|Comorbidities|2
987486|NCT01317199|1996639|FG003|Randomized Phase 2|Comorbidities|2
987487|NCT01317199|1996636|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0
987488|NCT01317199|1996637|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2
987489|NCT01317199|1996638|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5
987490|NCT01317199|1996639|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2
987491|NCT01317199|1996636|FG000|Randomized Phase 2|Disenrolled before treatment|0
987492|NCT01317199|1996637|FG001|Randomized Phase 2|Disenrolled before treatment|1
987493|NCT01317199|1996638|FG002|Randomized Phase 2|Disenrolled before treatment|1
987494|NCT01317199|1996639|FG003|Randomized Phase 2|Disenrolled before treatment|2
987495|NCT01317199|1996636|FG000|Randomized Phase 2|Patient stopped taking study drug|0
987496|NCT01317199|1996637|FG001|Randomized Phase 2|Patient stopped taking study drug|0
987497|NCT01317199|1996638|FG002|Randomized Phase 2|Patient stopped taking study drug|0
987498|NCT01317199|1996639|FG003|Randomized Phase 2|Patient stopped taking study drug|1
987499|NCT01317199|1996636|FG000|Randomized Phase 2|Patient transferred to other facility|0
987500|NCT01317199|1996637|FG001|Randomized Phase 2|Patient transferred to other facility|0
987501|NCT01317199|1996638|FG002|Randomized Phase 2|Patient transferred to other facility|1
987502|NCT01317199|1996639|FG003|Randomized Phase 2|Patient transferred to other facility|0
987503|NCT01317277|1996658|FG000|Overall Study|Lost to Follow-up|3
987504|NCT01317277|1996659|FG001|Overall Study|Lost to Follow-up|1
987505|NCT01317277|1996658|FG000|Overall Study|Lost MEMS|1
987506|NCT01317277|1996659|FG001|Overall Study|Lost MEMS|1
987507|NCT01317277|1996658|FG000|Overall Study|Unable to comply with intervention|1
987508|NCT01317277|1996659|FG001|Overall Study|Unable to comply with intervention|0
987509|NCT01317277|1996658|FG000|Overall Study|Withdrawal by Subject|1
987510|NCT01317277|1996659|FG001|Overall Study|Withdrawal by Subject|0
987511|NCT01317277|1996658|FG000|Overall Study|Adverse Event|1
987512|NCT01317277|1996659|FG001|Overall Study|Adverse Event|0
987513|NCT01317472|1996667|FG000|Overall Study|Withdrawal by Subject|1
987514|NCT01317472|1996668|FG001|Overall Study|Withdrawal by Subject|0
987515|NCT01317472|1996667|FG000|Overall Study|Unrelated hospitalization|1
987516|NCT01317472|1996668|FG001|Overall Study|Unrelated hospitalization|0
987517|NCT01317550|1996678|FG000|Overall Study|Withdrawal by Subject|1
987518|NCT01317550|1996679|FG001|Overall Study|Withdrawal by Subject|0
987519|NCT01317550|1996680|FG002|Overall Study|Withdrawal by Subject|0
987520|NCT01317550|1996681|FG003|Overall Study|Withdrawal by Subject|0
987521|NCT01317550|1996678|FG000|Overall Study|Lack of compliance study med|1
987522|NCT01317550|1996679|FG001|Overall Study|Lack of compliance study med|0
987523|NCT01317550|1996680|FG002|Overall Study|Lack of compliance study med|0
987524|NCT01317550|1996681|FG003|Overall Study|Lack of compliance study med|0
987525|NCT01317615|1996691|FG000|Overall Study|Disease progression|25
987526|NCT01317615|1996691|FG000|Overall Study|New cancer therapy|5
987527|NCT01317615|1996691|FG000|Overall Study|Death|6
987528|NCT01317615|1996691|FG000|Overall Study|Withdrawal by Subject|5
987529|NCT01317615|1996691|FG000|Overall Study|Abnormal laboratory value(s)|1
987530|NCT01317615|1996691|FG000|Overall Study|Adverse Event|7
987531|NCT01317641|1996704|FG000|Overall Study|Not treated|0
987532|NCT01317641|1996705|FG001|Overall Study|Not treated|0
987533|NCT01317641|1996706|FG002|Overall Study|Not treated|0
987534|NCT01317641|1996707|FG003|Overall Study|Not treated|0
987535|NCT01317641|1996708|FG004|Overall Study|Not treated|0
987536|NCT01317641|1996709|FG005|Overall Study|Not treated|0
987537|NCT01317641|1996710|FG006|Overall Study|Not treated|0
987538|NCT01317641|1996711|FG007|Overall Study|Not treated|1
987539|NCT01317641|1996712|FG008|Overall Study|Not treated|1
987540|NCT01317641|1996704|FG000|Overall Study|Adverse Event|0
987541|NCT01317641|1996705|FG001|Overall Study|Adverse Event|1
987542|NCT01317641|1996706|FG002|Overall Study|Adverse Event|0
987543|NCT01317641|1996707|FG003|Overall Study|Adverse Event|1
987544|NCT01317641|1996708|FG004|Overall Study|Adverse Event|0
987545|NCT01317641|1996709|FG005|Overall Study|Adverse Event|0
987546|NCT01317641|1996710|FG006|Overall Study|Adverse Event|2
987547|NCT01317641|1996711|FG007|Overall Study|Adverse Event|1
987548|NCT01317641|1996712|FG008|Overall Study|Adverse Event|0
987549|NCT01317641|1996704|FG000|Overall Study|Protocol Violation|1
987550|NCT01317641|1996705|FG001|Overall Study|Protocol Violation|0
987551|NCT01317641|1996706|FG002|Overall Study|Protocol Violation|0
987552|NCT01317641|1996707|FG003|Overall Study|Protocol Violation|0
987553|NCT01317641|1996708|FG004|Overall Study|Protocol Violation|0
987554|NCT01317641|1996709|FG005|Overall Study|Protocol Violation|0
987555|NCT01317641|1996710|FG006|Overall Study|Protocol Violation|0
987556|NCT01317641|1996711|FG007|Overall Study|Protocol Violation|0
987557|NCT01317641|1996712|FG008|Overall Study|Protocol Violation|0
987558|NCT01317641|1996704|FG000|Overall Study|Disease progression|0
987559|NCT01317641|1996705|FG001|Overall Study|Disease progression|0
987560|NCT01317641|1996706|FG002|Overall Study|Disease progression|0
987561|NCT01317641|1996707|FG003|Overall Study|Disease progression|0
987562|NCT01317641|1996708|FG004|Overall Study|Disease progression|0
987563|NCT01317641|1996709|FG005|Overall Study|Disease progression|0
987564|NCT01317641|1996710|FG006|Overall Study|Disease progression|0
987565|NCT01317641|1996711|FG007|Overall Study|Disease progression|3
987566|NCT01317641|1996712|FG008|Overall Study|Disease progression|4
987567|NCT01317641|1996704|FG000|Overall Study|Withdrawal by Subject|0
987568|NCT01317641|1996705|FG001|Overall Study|Withdrawal by Subject|0
987569|NCT01317641|1996706|FG002|Overall Study|Withdrawal by Subject|0
987570|NCT01317641|1996707|FG003|Overall Study|Withdrawal by Subject|0
987571|NCT01317641|1996708|FG004|Overall Study|Withdrawal by Subject|0
987572|NCT01317641|1996709|FG005|Overall Study|Withdrawal by Subject|0
987573|NCT01317641|1996710|FG006|Overall Study|Withdrawal by Subject|1
987574|NCT01317641|1996711|FG007|Overall Study|Withdrawal by Subject|0
987575|NCT01317641|1996712|FG008|Overall Study|Withdrawal by Subject|0
987576|NCT01317797|1996764|FG000|Overall Study|Other|0
987577|NCT01317797|1996765|FG001|Overall Study|Other|1
987578|NCT01317797|1996766|FG002|Overall Study|Other|0
987579|NCT01317797|1996764|FG000|Overall Study|Withdrawal of Patient|0
987580|NCT01317797|1996765|FG001|Overall Study|Withdrawal of Patient|0
987581|NCT01317797|1996766|FG002|Overall Study|Withdrawal of Patient|1
987582|NCT01317940|1996789|FG000|Overall Study|Death|1
987583|NCT01317940|1996790|FG001|Overall Study|Death|0
987584|NCT01317940|1996791|FG002|Overall Study|Death|1
987585|NCT01317940|1996792|FG003|Overall Study|Death|0
987586|NCT01317940|1996793|FG004|Overall Study|Death|0
987587|NCT01317940|1996794|FG005|Overall Study|Death|0
987588|NCT01317940|1996789|FG000|Overall Study|Lost to Follow-up|0
987589|NCT01317940|1996790|FG001|Overall Study|Lost to Follow-up|0
987590|NCT01317940|1996791|FG002|Overall Study|Lost to Follow-up|1
987591|NCT01317940|1996792|FG003|Overall Study|Lost to Follow-up|1
987592|NCT01317940|1996793|FG004|Overall Study|Lost to Follow-up|1
987593|NCT01317940|1996794|FG005|Overall Study|Lost to Follow-up|0
987594|NCT01317940|1996789|FG000|Overall Study|Change in therapy plan|0
987595|NCT01317940|1996790|FG001|Overall Study|Change in therapy plan|0
987596|NCT01317940|1996791|FG002|Overall Study|Change in therapy plan|3
987597|NCT01317940|1996792|FG003|Overall Study|Change in therapy plan|0
987598|NCT01317940|1996793|FG004|Overall Study|Change in therapy plan|0
987599|NCT01317940|1996794|FG005|Overall Study|Change in therapy plan|0
987600|NCT01318070|1996821|FG000|Overall Study|Adverse Event|1
987601|NCT01318070|1996822|FG001|Overall Study|Adverse Event|1
987602|NCT01318070|1996823|FG002|Overall Study|Adverse Event|5
987603|NCT01318070|1996821|FG000|Overall Study|Withdrawal by Subject|0
987604|NCT01318070|1996822|FG001|Overall Study|Withdrawal by Subject|1
987605|NCT01318070|1996823|FG002|Overall Study|Withdrawal by Subject|1
987606|NCT01318070|1996821|FG000|Overall Study|Lack of Efficacy|0
987607|NCT01318070|1996822|FG001|Overall Study|Lack of Efficacy|0
987608|NCT01318070|1996823|FG002|Overall Study|Lack of Efficacy|1
987609|NCT01318070|1996821|FG000|Overall Study|Principal Investigator Discretion|1
987610|NCT01318070|1996822|FG001|Overall Study|Principal Investigator Discretion|0
987611|NCT01318070|1996823|FG002|Overall Study|Principal Investigator Discretion|0
987612|NCT01318083|1996834|FG000|Overall Study|Adverse Event|4
987613|NCT01318083|1996835|FG001|Overall Study|Adverse Event|1
987614|NCT01318083|1996836|FG002|Overall Study|Adverse Event|2
987615|NCT01318083|1996834|FG000|Overall Study|Withdrawal by Subject|1
987616|NCT01318083|1996835|FG001|Overall Study|Withdrawal by Subject|0
987617|NCT01318083|1996836|FG002|Overall Study|Withdrawal by Subject|2
987618|NCT01318083|1996834|FG000|Overall Study|Lack of Efficacy|0
987619|NCT01318083|1996835|FG001|Overall Study|Lack of Efficacy|0
987620|NCT01318083|1996836|FG002|Overall Study|Lack of Efficacy|1
987621|NCT01318083|1996834|FG000|Overall Study|Treatment Complications|1
987622|NCT01318083|1996835|FG001|Overall Study|Treatment Complications|0
987623|NCT01318083|1996836|FG002|Overall Study|Treatment Complications|0
987624|NCT01318083|1996834|FG000|Overall Study|Lack of Study Medication Compliance|0
987625|NCT01318083|1996835|FG001|Overall Study|Lack of Study Medication Compliance|1
987626|NCT01318083|1996836|FG002|Overall Study|Lack of Study Medication Compliance|0
987627|NCT01318109|1996847|FG000|Overall Study|Adverse Event|0
987628|NCT01318109|1996848|FG001|Overall Study|Adverse Event|2
987629|NCT01318109|1996849|FG002|Overall Study|Adverse Event|0
987630|NCT01318109|1996847|FG000|Overall Study|Withdrawal by Subject|1
987631|NCT01318109|1996848|FG001|Overall Study|Withdrawal by Subject|0
987632|NCT01318109|1996849|FG002|Overall Study|Withdrawal by Subject|0
987633|NCT01318109|1996847|FG000|Overall Study|Schedule Conflict|0
987634|NCT01318109|1996848|FG001|Overall Study|Schedule Conflict|1
987635|NCT01318109|1996849|FG002|Overall Study|Schedule Conflict|0
987636|NCT01318122|1996859|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
987637|NCT01318122|1996860|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
987638|NCT01318122|1996861|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2
987639|NCT01318122|1996862|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
987640|NCT01318122|1996859|FG000|Enrolled - Long-Term Extension Study|Other|1
987641|NCT01318122|1996860|FG001|Enrolled - Long-Term Extension Study|Other|0
987642|NCT01318122|1996861|FG002|Enrolled - Long-Term Extension Study|Other|0
987643|NCT01318122|1996862|FG003|Enrolled - Long-Term Extension Study|Other|0
987644|NCT01318122|1996859|FG000|Entered - Long-Term Extension Study|Adverse Event|6
987645|NCT01318122|1996860|FG001|Entered - Long-Term Extension Study|Adverse Event|6
987646|NCT01318122|1996861|FG002|Entered - Long-Term Extension Study|Adverse Event|2
987647|NCT01318122|1996862|FG003|Entered - Long-Term Extension Study|Adverse Event|4
987648|NCT01318122|1996859|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1
987649|NCT01318122|1996860|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0
987650|NCT01318122|1996861|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
987651|NCT01318122|1996862|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
987652|NCT01318122|1996859|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
987653|NCT01318122|1996860|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3
987654|NCT01318122|1996861|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1
987655|NCT01318122|1996862|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
987656|NCT01318122|1996859|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0
987657|NCT01318122|1996860|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2
987658|NCT01318122|1996861|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3
987659|NCT01318122|1996862|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
987660|NCT01318135|1996872|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1
987661|NCT01318135|1996873|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
987662|NCT01318135|1996874|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
987663|NCT01318135|1996875|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0
987664|NCT01318135|1996876|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0
987665|NCT01318135|1996877|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
987666|NCT01318135|1996878|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
987667|NCT01318135|1996879|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
987668|NCT01318135|1996872|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1
987669|NCT01318135|1996873|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0
987670|NCT01318135|1996874|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0
987671|NCT01318135|1996875|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0
987672|NCT01318135|1996876|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0
987673|NCT01318135|1996877|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0
987674|NCT01318135|1996878|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0
987675|NCT01318135|1996879|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0
987676|NCT01318135|1996872|FG000|Entered - Long-Term Extension Study|Adverse Event|9
987677|NCT01318135|1996873|FG001|Entered - Long-Term Extension Study|Adverse Event|3
987678|NCT01318135|1996874|FG002|Entered - Long-Term Extension Study|Adverse Event|4
987679|NCT01318135|1996875|FG003|Entered - Long-Term Extension Study|Adverse Event|3
987680|NCT01318135|1996876|FG004|Entered - Long-Term Extension Study|Adverse Event|4
987681|NCT01318135|1996877|FG005|Entered - Long-Term Extension Study|Adverse Event|2
987682|NCT01318135|1996878|FG006|Entered - Long-Term Extension Study|Adverse Event|0
987683|NCT01318135|1996879|FG007|Entered - Long-Term Extension Study|Adverse Event|0
987684|NCT01318135|1996872|FG000|Entered - Long-Term Extension Study|Protocol Violation|1
987685|NCT01318135|1996873|FG001|Entered - Long-Term Extension Study|Protocol Violation|1
987686|NCT01318135|1996874|FG002|Entered - Long-Term Extension Study|Protocol Violation|0
987687|NCT01318135|1996875|FG003|Entered - Long-Term Extension Study|Protocol Violation|0
987688|NCT01318135|1996876|FG004|Entered - Long-Term Extension Study|Protocol Violation|1
987689|NCT01318135|1996877|FG005|Entered - Long-Term Extension Study|Protocol Violation|0
987690|NCT01318135|1996878|FG006|Entered - Long-Term Extension Study|Protocol Violation|0
987691|NCT01318135|1996879|FG007|Entered - Long-Term Extension Study|Protocol Violation|0
987692|NCT01318135|1996872|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
987693|NCT01318135|1996873|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
987694|NCT01318135|1996874|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2
987695|NCT01318135|1996875|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1
987696|NCT01318135|1996876|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2
987697|NCT01318135|1996877|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0
987698|NCT01318135|1996878|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0
987699|NCT01318135|1996879|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1
987700|NCT01318135|1996872|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5
987701|NCT01318135|1996873|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7
987702|NCT01318135|1996874|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2
987703|NCT01318135|1996875|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3
987704|NCT01318135|1996876|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2
987705|NCT01318135|1996877|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2
987706|NCT01318135|1996878|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1
987707|NCT01318135|1996879|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1
987708|NCT01318135|1996872|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0
987709|NCT01318135|1996873|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0
987710|NCT01318135|1996874|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0
987711|NCT01318135|1996875|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0
987712|NCT01318135|1996876|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0
987713|NCT01318135|1996877|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0
987714|NCT01318135|1996878|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0
987715|NCT01318135|1996879|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1
987716|NCT01318382|1996916|FG000|Overall Study|Physician Decision|2
987717|NCT01318382|1996916|FG000|Overall Study|Device Malfunction|10
987718|NCT01318382|1996916|FG000|Overall Study|Protocol Violation|1
987719|NCT01318499|1996928|FG000|Overall Study|Adverse Event|16
987720|NCT01318499|1996929|FG001|Overall Study|Adverse Event|11
987721|NCT01318499|1996930|FG002|Overall Study|Adverse Event|6
987722|NCT01318499|1996928|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1
987723|NCT01318499|1996929|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1
987724|NCT01318499|1996930|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2
987725|NCT01318499|1996928|FG000|Overall Study|Noncompliance|2
987726|NCT01318499|1996929|FG001|Overall Study|Noncompliance|3
987727|NCT01318499|1996930|FG002|Overall Study|Noncompliance|0
987728|NCT01318499|1996928|FG000|Overall Study|Treatment Failure|19
987729|NCT01318499|1996929|FG001|Overall Study|Treatment Failure|19
987730|NCT01318499|1996930|FG002|Overall Study|Treatment Failure|101
987731|NCT01318499|1996928|FG000|Overall Study|Protocol Violation|2
987732|NCT01318499|1996929|FG001|Overall Study|Protocol Violation|4
987733|NCT01318499|1996930|FG002|Overall Study|Protocol Violation|2
987734|NCT01318499|1996928|FG000|Overall Study|Patient Did Not Use Study Medication|18
987735|NCT01318499|1996929|FG001|Overall Study|Patient Did Not Use Study Medication|28
987736|NCT01318499|1996930|FG002|Overall Study|Patient Did Not Use Study Medication|14
987737|NCT01318499|1996928|FG000|Overall Study|Other|7
987738|NCT01318499|1996929|FG001|Overall Study|Other|10
987739|NCT01318499|1996930|FG002|Overall Study|Other|22
987740|NCT01318512|1996940|FG000|Maintenance Period (6 Months)|Death|2
987741|NCT01318512|1996940|FG000|Maintenance Period (6 Months)|Protocol Violation|9
987742|NCT01318811|1996990|FG000|Overall Study|Physician Decision|1
987743|NCT01318811|1996991|FG001|Overall Study|Physician Decision|1
987744|NCT01318811|1996990|FG000|Overall Study|CRRT stopped for head CT|0
987745|NCT01318811|1996991|FG001|Overall Study|CRRT stopped for head CT|1
987746|NCT01318811|1996990|FG000|Overall Study|Death|0
987747|NCT01318811|1996991|FG001|Overall Study|Death|1
987748|NCT01318811|1996990|FG000|Overall Study|CRRT stopped for head MRI|0
987749|NCT01318811|1996991|FG001|Overall Study|CRRT stopped for head MRI|1
987750|NCT01318876|1996997|FG000|Day 8 Survey|email address invalid|96
987751|NCT01318876|1996997|FG000|Day 8 Survey|survey not completed-don't know why|1724
987752|NCT01318876|1996997|FG000|Day 29 Survey|survey not completed-don't know why|1825
987753|NCT01318902|1997005|FG000|Overall Study|Symptomatic Deterioration|0
987754|NCT01318902|1997006|FG001|Overall Study|Symptomatic Deterioration|1
987755|NCT01318902|1997007|FG002|Overall Study|Symptomatic Deterioration|1
987756|NCT01318902|1997008|FG003|Overall Study|Symptomatic Deterioration|2
987757|NCT01318902|1997005|FG000|Overall Study|Withdrawal by Patient|0
987758|NCT01318902|1997006|FG001|Overall Study|Withdrawal by Patient|1
987759|NCT01318902|1997007|FG002|Overall Study|Withdrawal by Patient|0
987760|NCT01318902|1997008|FG003|Overall Study|Withdrawal by Patient|3
987761|NCT01318902|1997005|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
987762|NCT01318902|1997006|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
987763|NCT01318902|1997007|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
987764|NCT01318902|1997008|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
987765|NCT01318902|1997005|FG000|Overall Study|Adverse Event|0
987766|NCT01318902|1997006|FG001|Overall Study|Adverse Event|1
987767|NCT01318902|1997007|FG002|Overall Study|Adverse Event|0
987768|NCT01318902|1997008|FG003|Overall Study|Adverse Event|0
987769|NCT01318902|1997005|FG000|Overall Study|Terminated by Sponsor|0
987770|NCT01318902|1997006|FG001|Overall Study|Terminated by Sponsor|0
987771|NCT01318902|1997007|FG002|Overall Study|Terminated by Sponsor|1
987772|NCT01318902|1997008|FG003|Overall Study|Terminated by Sponsor|0
987773|NCT01318915|1997020|FG000|Overall Study|Lost to Follow-up|1
987774|NCT01319383|1997052|FG000|Overall Study|No ex vivo or in vivo response|4
987775|NCT01319383|1997053|FG001|Overall Study|No ex vivo or in vivo response|0
987776|NCT01319383|1997052|FG000|Overall Study|Physician Decision|3
987777|NCT01319383|1997053|FG001|Overall Study|Physician Decision|0
987778|NCT01319383|1997052|FG000|Overall Study|Lack of Efficacy|5
987779|NCT01319383|1997053|FG001|Overall Study|Lack of Efficacy|9
987780|NCT01319383|1997052|FG000|Overall Study|No in vivo response to interval doses|0
987781|NCT01319383|1997053|FG001|Overall Study|No in vivo response to interval doses|1
987782|NCT01319422|1997076|FG000|Overall Study|Withdrawal by Subject|1
987783|NCT01319422|1997077|FG001|Overall Study|Withdrawal by Subject|0
987784|NCT01319721|1997114|FG000|Overall Study|Lost to Follow-up|1
987785|NCT01319721|1997115|FG001|Overall Study|Lost to Follow-up|6
987786|NCT01319877|1997166|FG000|Overall Study|Lost to Follow-up|100
987787|NCT01319877|1997167|FG001|Overall Study|Lost to Follow-up|37
987788|NCT01319877|1997166|FG000|Overall Study|Physician Decision|2
987789|NCT01319877|1997167|FG001|Overall Study|Physician Decision|0
987790|NCT01319877|1997166|FG000|Overall Study|Disease Progression|2
987791|NCT01319877|1997167|FG001|Overall Study|Disease Progression|2
987792|NCT01319877|1997166|FG000|Overall Study|Withdrawal by Subject|0
987793|NCT01319877|1997167|FG001|Overall Study|Withdrawal by Subject|1
987794|NCT01319877|1997166|FG000|Overall Study|Reason Not Specified|4
987795|NCT01319877|1997167|FG001|Overall Study|Reason Not Specified|5
987796|NCT01319929|1997174|FG000|First Treatment Period (4 Weeks)|Adverse Event|2
987797|NCT01319929|1997175|FG001|First Treatment Period (4 Weeks)|Adverse Event|0
987798|NCT01319929|1997174|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
987799|NCT01319929|1997175|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
987800|NCT01319929|1997174|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0
987801|NCT01319929|1997175|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1
987802|NCT01319929|1997174|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1
987803|NCT01319929|1997175|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0
987804|NCT01319929|1997174|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0
987805|NCT01319929|1997175|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1
987806|NCT01319994|1997184|FG000|Overall Study|Protocol Violation|7
987807|NCT01319994|1997185|FG001|Overall Study|Protocol Violation|6
987808|NCT01320033|1997194|FG000|Overall Study|Lack of Efficacy|0
987809|NCT01320033|1997195|FG001|Overall Study|Lack of Efficacy|0
987810|NCT01320033|1997196|FG002|Overall Study|Lack of Efficacy|1
987811|NCT01320033|1997194|FG000|Overall Study|Adverse Event|9
987812|NCT01320033|1997195|FG001|Overall Study|Adverse Event|7
987813|NCT01320033|1997196|FG002|Overall Study|Adverse Event|8
987814|NCT01320033|1997194|FG000|Overall Study|Withdrawal by Subject|22
987815|NCT01320033|1997195|FG001|Overall Study|Withdrawal by Subject|23
987816|NCT01320033|1997196|FG002|Overall Study|Withdrawal by Subject|23
987817|NCT01320033|1997194|FG000|Overall Study|Protocol Violation|3
987818|NCT01320033|1997195|FG001|Overall Study|Protocol Violation|5
987819|NCT01320033|1997196|FG002|Overall Study|Protocol Violation|3
987820|NCT01320033|1997194|FG000|Overall Study|Lost to Follow-up|22
987821|NCT01320033|1997195|FG001|Overall Study|Lost to Follow-up|26
987822|NCT01320033|1997196|FG002|Overall Study|Lost to Follow-up|17
987823|NCT01320033|1997194|FG000|Overall Study|Other|2
987824|NCT01320033|1997195|FG001|Overall Study|Other|3
987825|NCT01320033|1997196|FG002|Overall Study|Other|1
987826|NCT01320085|1997217|FG000|Overall Study|Treatment Ongoing|0
987827|NCT01320085|1997218|FG001|Overall Study|Treatment Ongoing|13
912801|NCT00807040|1890358|FG000|Overall Study|Withdrawal by Subject|8
912802|NCT00807040|1890359|FG001|Overall Study|Withdrawal by Subject|6
912803|NCT00807040|1890358|FG000|Overall Study|Lost to Follow-up|4
912804|NCT00807040|1890359|FG001|Overall Study|Lost to Follow-up|6
912805|NCT00807092|1890367|FG000|Overall Study|Adverse Event|0
912806|NCT00807092|1890368|FG001|Overall Study|Adverse Event|1
912807|NCT00807092|1890367|FG000|Overall Study|Protocol Violation|0
912808|NCT00807092|1890368|FG001|Overall Study|Protocol Violation|2
912809|NCT00807092|1890367|FG000|Overall Study|Withdrawal by Subject|1
912810|NCT00807092|1890368|FG001|Overall Study|Withdrawal by Subject|0
912811|NCT00807092|1890367|FG000|Overall Study|CGMS data collection failed|0
912812|NCT00807092|1890368|FG001|Overall Study|CGMS data collection failed|1
912813|NCT00807144|1890376|FG000|Overall Study|Lost to Follow-up|0
912814|NCT00807144|1890377|FG001|Overall Study|Lost to Follow-up|1
912815|NCT00807235|1890398|FG000|Overall Study|Adverse Event|1
912816|NCT00807235|1890399|FG001|Overall Study|Adverse Event|0
912817|NCT00807248|1890409|FG000|Overall Study|Adverse Event|1
987828|NCT01320085|1997219|FG002|Overall Study|Treatment Ongoing|2
987829|NCT01320085|1997217|FG000|Overall Study|Disease Progression|26
987830|NCT01320085|1997218|FG001|Overall Study|Disease Progression|86
987831|NCT01320085|1997219|FG002|Overall Study|Disease Progression|16
987832|NCT01320085|1997217|FG000|Overall Study|Adverse Event|12
987833|NCT01320085|1997218|FG001|Overall Study|Adverse Event|14
987834|NCT01320085|1997219|FG002|Overall Study|Adverse Event|5
987835|NCT01320085|1997217|FG000|Overall Study|Withdrawal by Subject|2
987836|NCT01320085|1997218|FG001|Overall Study|Withdrawal by Subject|4
987837|NCT01320085|1997219|FG002|Overall Study|Withdrawal by Subject|1
987838|NCT01320085|1997217|FG000|Overall Study|Protocol Deviation|1
987839|NCT01320085|1997218|FG001|Overall Study|Protocol Deviation|0
987840|NCT01320085|1997219|FG002|Overall Study|Protocol Deviation|1
987841|NCT01320150|1997238|FG000|Overall Study|Protocol Violation|15
987842|NCT01320150|1997238|FG000|Overall Study|Withdrawal by Subject|5
987843|NCT01320150|1997238|FG000|Overall Study|Death|2
987844|NCT01320150|1997238|FG000|Overall Study|Lost to Follow-up|44
987845|NCT01320202|1997244|FG000|Overall Study|Adverse Event|5
987846|NCT01320202|1997245|FG001|Overall Study|Adverse Event|5
987847|NCT01320202|1997244|FG000|Overall Study|Death|5
987848|NCT01320202|1997245|FG001|Overall Study|Death|3
987849|NCT01320202|1997244|FG000|Overall Study|Lost to Follow-up|1
987850|NCT01320202|1997245|FG001|Overall Study|Lost to Follow-up|0
987851|NCT01320202|1997244|FG000|Overall Study|Physician Decision|3
987852|NCT01320202|1997245|FG001|Overall Study|Physician Decision|1
987853|NCT01320202|1997244|FG000|Overall Study|Protocol Violation|2
987854|NCT01320202|1997245|FG001|Overall Study|Protocol Violation|1
987855|NCT01320202|1997244|FG000|Overall Study|Withdrawal by Subject|10
987856|NCT01320202|1997245|FG001|Overall Study|Withdrawal by Subject|3
987857|NCT01320202|1997244|FG000|Overall Study|non-protocol change to ESA or IV iron|17
987858|NCT01320202|1997245|FG001|Overall Study|non-protocol change to ESA or IV iron|20
987859|NCT01320202|1997244|FG000|Overall Study|kidney transplant|1
987860|NCT01320202|1997245|FG001|Overall Study|kidney transplant|2
987861|NCT01320202|1997244|FG000|Overall Study|blood transfusion|1
987862|NCT01320202|1997245|FG001|Overall Study|blood transfusion|7
987863|NCT01320202|1997244|FG000|Overall Study|moved/changed dialysis|5
987864|NCT01320202|1997245|FG001|Overall Study|moved/changed dialysis|2
987865|NCT01320202|1997244|FG000|Overall Study|sponsor request|2
987866|NCT01320202|1997245|FG001|Overall Study|sponsor request|0
987867|NCT01320202|1997244|FG000|Overall Study|ineligible|3
987868|NCT01320202|1997245|FG001|Overall Study|ineligible|0
987869|NCT01320202|1997244|FG000|Overall Study|regained renal function|1
987870|NCT01320202|1997245|FG001|Overall Study|regained renal function|0
987871|NCT01320293|1997254|FG000|Overall Study|Lack of Efficacy|1
987872|NCT01320293|1997254|FG000|Overall Study|Adverse Event|1
987873|NCT01320722|1997280|FG000|Overall Study|Did not Receive Intervention|3
987874|NCT01320722|1997281|FG001|Overall Study|Did not Receive Intervention|2
987875|NCT01320722|1997282|FG002|Overall Study|Did not Receive Intervention|1
987876|NCT01320722|1997283|FG003|Overall Study|Did not Receive Intervention|1
987877|NCT01320722|1997284|FG004|Overall Study|Did not Receive Intervention|2
987878|NCT01320722|1997280|FG000|Overall Study|Lost to Follow-up|0
987879|NCT01320722|1997281|FG001|Overall Study|Lost to Follow-up|1
987880|NCT01320722|1997282|FG002|Overall Study|Lost to Follow-up|0
987881|NCT01320722|1997283|FG003|Overall Study|Lost to Follow-up|1
987882|NCT01320722|1997284|FG004|Overall Study|Lost to Follow-up|3
987883|NCT01320722|1997280|FG000|Overall Study|Not Available for the 8 Week Visit|0
987884|NCT01320722|1997281|FG001|Overall Study|Not Available for the 8 Week Visit|3
987885|NCT01320722|1997282|FG002|Overall Study|Not Available for the 8 Week Visit|0
987886|NCT01320722|1997283|FG003|Overall Study|Not Available for the 8 Week Visit|0
987887|NCT01320722|1997284|FG004|Overall Study|Not Available for the 8 Week Visit|0
987888|NCT01320722|1997280|FG000|Overall Study|Participant Developed a Rash|0
987889|NCT01320722|1997281|FG001|Overall Study|Participant Developed a Rash|0
987890|NCT01320722|1997282|FG002|Overall Study|Participant Developed a Rash|2
987891|NCT01320722|1997283|FG003|Overall Study|Participant Developed a Rash|1
987892|NCT01320722|1997284|FG004|Overall Study|Participant Developed a Rash|1
987893|NCT01320722|1997280|FG000|Overall Study|Non-compliant with Medication|0
987894|NCT01320722|1997281|FG001|Overall Study|Non-compliant with Medication|0
987895|NCT01320722|1997282|FG002|Overall Study|Non-compliant with Medication|1
987896|NCT01320722|1997283|FG003|Overall Study|Non-compliant with Medication|0
987897|NCT01320722|1997284|FG004|Overall Study|Non-compliant with Medication|0
987898|NCT01320722|1997280|FG000|Overall Study|Adverse Event|0
987899|NCT01320722|1997281|FG001|Overall Study|Adverse Event|0
987900|NCT01320722|1997282|FG002|Overall Study|Adverse Event|3
987901|NCT01320722|1997283|FG003|Overall Study|Adverse Event|6
987902|NCT01320722|1997284|FG004|Overall Study|Adverse Event|0
987903|NCT01320722|1997280|FG000|Overall Study|Not Compliant with Study Procedures|0
987904|NCT01320722|1997281|FG001|Overall Study|Not Compliant with Study Procedures|0
987905|NCT01320722|1997282|FG002|Overall Study|Not Compliant with Study Procedures|0
987906|NCT01320722|1997283|FG003|Overall Study|Not Compliant with Study Procedures|4
987907|NCT01320722|1997284|FG004|Overall Study|Not Compliant with Study Procedures|0
987908|NCT01320722|1997280|FG000|Overall Study|Pregnancy|0
987909|NCT01320722|1997281|FG001|Overall Study|Pregnancy|0
987910|NCT01320722|1997282|FG002|Overall Study|Pregnancy|0
987911|NCT01320722|1997283|FG003|Overall Study|Pregnancy|1
987912|NCT01320722|1997284|FG004|Overall Study|Pregnancy|0
987913|NCT01320722|1997280|FG000|Overall Study|Started an Exclusionary Medication|0
987914|NCT01320722|1997281|FG001|Overall Study|Started an Exclusionary Medication|0
987915|NCT01320722|1997282|FG002|Overall Study|Started an Exclusionary Medication|0
987916|NCT01320722|1997283|FG003|Overall Study|Started an Exclusionary Medication|0
987917|NCT01320722|1997284|FG004|Overall Study|Started an Exclusionary Medication|1
987918|NCT01320722|1997280|FG000|Overall Study|Withdrew due to Health Condition|0
987919|NCT01320722|1997281|FG001|Overall Study|Withdrew due to Health Condition|0
987920|NCT01320722|1997282|FG002|Overall Study|Withdrew due to Health Condition|0
987921|NCT01320722|1997283|FG003|Overall Study|Withdrew due to Health Condition|0
987922|NCT01320722|1997284|FG004|Overall Study|Withdrew due to Health Condition|1
987923|NCT01320735|1997299|FG000|Overall Study|Adverse Event|3
987924|NCT01320735|1997299|FG000|Overall Study|Withdrawal by Subject|3
987925|NCT01320735|1997299|FG000|Overall Study|Lost to Follow-up|13
987926|NCT01320735|1997299|FG000|Overall Study|Administrative Reason|6
987927|NCT01320735|1997299|FG000|Overall Study|Progression/Hormone-Refractory Pca|55
987928|NCT01320735|1997299|FG000|Overall Study|Protocol Violation|1
987929|NCT01320735|1997299|FG000|Overall Study|Other|1
987930|NCT01320735|1997299|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7
987931|NCT01320735|1997299|FG000|Overall Study|Investigator Unable to be Contacted|17
987932|NCT01320943|1997320|FG000|Overall Study|Lost to Follow-up|1
987933|NCT01320943|1997321|FG001|Overall Study|Lost to Follow-up|0
987934|NCT01320943|1997320|FG000|Overall Study|Physician Decision|0
987935|NCT01320943|1997321|FG001|Overall Study|Physician Decision|1
987936|NCT01320943|1997320|FG000|Overall Study|Randomized but not Treated|0
987937|NCT01320943|1997321|FG001|Overall Study|Randomized but not Treated|1
987938|NCT01321073|1997334|FG000|Overall Study|Did not attempt implant|4
987939|NCT01321073|1997334|FG000|Overall Study|Death|3
987940|NCT01321606|1997384|FG000|Overall Study|Lost to Follow-up|0
987941|NCT01321606|1997385|FG001|Overall Study|Lost to Follow-up|0
987942|NCT01321606|1997386|FG002|Overall Study|Lost to Follow-up|0
987943|NCT01321606|1997387|FG003|Overall Study|Lost to Follow-up|1
987944|NCT01321710|1997400|FG000|Overall Study|Lost to Follow-up|4
987945|NCT01321710|1997401|FG001|Overall Study|Lost to Follow-up|5
987946|NCT01321710|1997402|FG002|Overall Study|Lost to Follow-up|0
987947|NCT01321723|1997415|FG000|Overall Study|Adverse Event|3
987948|NCT01321723|1997416|FG001|Overall Study|Adverse Event|5
987949|NCT01321723|1997417|FG002|Overall Study|Adverse Event|2
987950|NCT01321723|1997415|FG000|Overall Study|Withdrawal by Subject|2
987951|NCT01321723|1997416|FG001|Overall Study|Withdrawal by Subject|0
987952|NCT01321723|1997417|FG002|Overall Study|Withdrawal by Subject|2
987953|NCT01321749|1997427|FG000|Overall Study|Lost to Follow-up|4
987954|NCT01321749|1997428|FG001|Overall Study|Lost to Follow-up|11
987955|NCT01321749|1997427|FG000|Overall Study|Protocol Violation|4
987956|NCT01321749|1997428|FG001|Overall Study|Protocol Violation|7
987957|NCT01321749|1997427|FG000|Overall Study|Withdrawal by Subject|5
987958|NCT01321749|1997428|FG001|Overall Study|Withdrawal by Subject|4
987959|NCT01321879|1997434|FG000|Overall Study|Lack of Efficacy|5
987960|NCT01321879|1997434|FG000|Overall Study|Adverse Event|5
987961|NCT01321879|1997434|FG000|Overall Study|Death|3
987962|NCT01321879|1997434|FG000|Overall Study|Withdrawal by Subject|1
987963|NCT01322009|1997440|FG000|Overall Study|Death|0
987964|NCT01322009|1997441|FG001|Overall Study|Death|1
987965|NCT01322009|1997440|FG000|Overall Study|Adverse Event|0
987966|NCT01322009|1997441|FG001|Overall Study|Adverse Event|1
987967|NCT01322009|1997440|FG000|Overall Study|ng tube discontinued|0
987968|NCT01322009|1997441|FG001|Overall Study|ng tube discontinued|1
987969|NCT01322347|1997467|FG000|Overall Study|Adverse Event|7
987970|NCT01322347|1997468|FG001|Overall Study|Adverse Event|2
987971|NCT01322347|1997467|FG000|Overall Study|Death|5
987972|NCT01322347|1997468|FG001|Overall Study|Death|3
987973|NCT01322347|1997467|FG000|Overall Study|Physician Decision|2
987974|NCT01322347|1997468|FG001|Overall Study|Physician Decision|1
987975|NCT01322347|1997467|FG000|Overall Study|Protocol Violation|5
987976|NCT01322347|1997468|FG001|Overall Study|Protocol Violation|2
987977|NCT01322347|1997467|FG000|Overall Study|Withdrawal by Subject|1
987978|NCT01322347|1997468|FG001|Overall Study|Withdrawal by Subject|4
987979|NCT01322347|1997467|FG000|Overall Study|non-protocol change to ESA or IV iron|14
987980|NCT01322347|1997468|FG001|Overall Study|non-protocol change to ESA or IV iron|6
987981|NCT01322347|1997467|FG000|Overall Study|blood transfusion|5
987982|NCT01322347|1997468|FG001|Overall Study|blood transfusion|5
987983|NCT01322347|1997467|FG000|Overall Study|sponsor decision|1
987984|NCT01322347|1997468|FG001|Overall Study|sponsor decision|3
987985|NCT01322347|1997467|FG000|Overall Study|ineligible|6
987986|NCT01322347|1997468|FG001|Overall Study|ineligible|3
987987|NCT01322347|1997467|FG000|Overall Study|kidney transplant|3
987988|NCT01322347|1997468|FG001|Overall Study|kidney transplant|1
987989|NCT01322347|1997467|FG000|Overall Study|study drug withheld > 12 wks|0
987990|NCT01322347|1997468|FG001|Overall Study|study drug withheld > 12 wks|1
987991|NCT01322347|1997467|FG000|Overall Study|moved/changed dialysis|2
987992|NCT01322347|1997468|FG001|Overall Study|moved/changed dialysis|4
987993|NCT01322386|1997482|FG000|Overall Study|Protocol Violation|0
987994|NCT01322386|1997483|FG001|Overall Study|Protocol Violation|1
987995|NCT01322386|1997482|FG000|Overall Study|Physician Decision|0
987996|NCT01322386|1997483|FG001|Overall Study|Physician Decision|1
987997|NCT01322490|1997494|FG000|Treatment Period|Adverse Event|12
987998|NCT01322490|1997495|FG001|Treatment Period|Adverse Event|18
987999|NCT01322490|1997496|FG002|Treatment Period|Adverse Event|15
988000|NCT01322490|1997494|FG000|Treatment Period|Death|5
988001|NCT01322490|1997495|FG001|Treatment Period|Death|7
988002|NCT01322490|1997496|FG002|Treatment Period|Death|3
988003|NCT01322490|1997494|FG000|Treatment Period|Lack of Efficacy|89
988004|NCT01322490|1997495|FG001|Treatment Period|Lack of Efficacy|100
988005|NCT01322490|1997496|FG002|Treatment Period|Lack of Efficacy|112
988006|NCT01322490|1997494|FG000|Treatment Period|Physician Decision|0
988007|NCT01322490|1997495|FG001|Treatment Period|Physician Decision|2
988008|NCT01322490|1997496|FG002|Treatment Period|Physician Decision|1
988009|NCT01322490|1997494|FG000|Treatment Period|Protocol Violation|7
988010|NCT01322490|1997495|FG001|Treatment Period|Protocol Violation|5
988011|NCT01322490|1997496|FG002|Treatment Period|Protocol Violation|4
988012|NCT01322490|1997494|FG000|Treatment Period|Withdrawal by Subject|14
988013|NCT01322490|1997495|FG001|Treatment Period|Withdrawal by Subject|16
988014|NCT01322490|1997496|FG002|Treatment Period|Withdrawal by Subject|11
988015|NCT01322490|1997494|FG000|Treatment Period|Non-compliance with study drug|0
988016|NCT01322490|1997495|FG001|Treatment Period|Non-compliance with study drug|0
988017|NCT01322490|1997496|FG002|Treatment Period|Non-compliance with study drug|1
988018|NCT01322490|1997494|FG000|Treatment Period|Other per report|2
988019|NCT01322490|1997495|FG001|Treatment Period|Other per report|2
988020|NCT01322490|1997496|FG002|Treatment Period|Other per report|1
988021|NCT01322490|1997494|FG000|Treatment Period|Randomized but Not Treated|3
988022|NCT01322490|1997495|FG001|Treatment Period|Randomized but Not Treated|3
988023|NCT01322490|1997496|FG002|Treatment Period|Randomized but Not Treated|5
988024|NCT01322490|1997494|FG000|Long Term Follow-up Period|Death|235
988025|NCT01322490|1997495|FG001|Long Term Follow-up Period|Death|239
988026|NCT01322490|1997496|FG002|Long Term Follow-up Period|Death|236
988027|NCT01322490|1997494|FG000|Long Term Follow-up Period|Lost to Follow-up|2
988028|NCT01322490|1997495|FG001|Long Term Follow-up Period|Lost to Follow-up|2
988029|NCT01322490|1997496|FG002|Long Term Follow-up Period|Lost to Follow-up|3
988030|NCT01322490|1997494|FG000|Long Term Follow-up Period|Withdrawal by Subject|9
988031|NCT01322490|1997495|FG001|Long Term Follow-up Period|Withdrawal by Subject|6
988032|NCT01322490|1997496|FG002|Long Term Follow-up Period|Withdrawal by Subject|6
988033|NCT01322490|1997494|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160
988034|NCT01322490|1997495|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158
988035|NCT01322490|1997496|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165
988036|NCT01322490|1997494|FG000|Long Term Follow-up Period|Other per report|3
988037|NCT01322490|1997495|FG001|Long Term Follow-up Period|Other per report|2
988038|NCT01322490|1997496|FG002|Long Term Follow-up Period|Other per report|2
988039|NCT01322490|1997494|FG000|Long Term Follow-up Period|Unknown/Missing|0
988040|NCT01322490|1997495|FG001|Long Term Follow-up Period|Unknown/Missing|1
988041|NCT01322490|1997496|FG002|Long Term Follow-up Period|Unknown/Missing|1
988042|NCT01323192|1997612|FG000|Overall Study|Adverse Event|6
988043|NCT01323192|1997613|FG001|Overall Study|Adverse Event|1
988044|NCT01323192|1997612|FG000|Overall Study|Withdrawal by Subject|3
988045|NCT01323192|1997613|FG001|Overall Study|Withdrawal by Subject|1
988046|NCT01323192|1997612|FG000|Overall Study|Noncompliance with study medication|0
988047|NCT01323192|1997613|FG001|Overall Study|Noncompliance with study medication|3
988048|NCT01323192|1997612|FG000|Overall Study|Nonmedical reasons|0
988049|NCT01323192|1997613|FG001|Overall Study|Nonmedical reasons|1
988050|NCT01323270|1997621|FG000|Overall Study|Withdrawal by Subject|19
988051|NCT01323270|1997622|FG001|Overall Study|Withdrawal by Subject|10
988052|NCT01323270|1997621|FG000|Overall Study|Protocol Violation|9
988053|NCT01323270|1997622|FG001|Overall Study|Protocol Violation|7
988054|NCT01323270|1997621|FG000|Overall Study|Lost to Follow-up|4
988055|NCT01323270|1997622|FG001|Overall Study|Lost to Follow-up|6
988056|NCT01323270|1997621|FG000|Overall Study|Adverse Event|8
988057|NCT01323270|1997622|FG001|Overall Study|Adverse Event|0
988058|NCT01323270|1997621|FG000|Overall Study|Other|0
988059|NCT01323270|1997622|FG001|Overall Study|Other|3
988060|NCT01323270|1997621|FG000|Overall Study|Physician Decision|0
988061|NCT01323270|1997622|FG001|Overall Study|Physician Decision|2
988062|NCT01323270|1997621|FG000|Overall Study|Not eligible|1
988063|NCT01323270|1997622|FG001|Overall Study|Not eligible|1
988064|NCT01323270|1997621|FG000|Overall Study|Death|1
988065|NCT01323270|1997622|FG001|Overall Study|Death|0
988066|NCT01323270|1997621|FG000|Overall Study|Randomized, but not vaccinated|1
988067|NCT01323270|1997622|FG001|Overall Study|Randomized, but not vaccinated|0
988068|NCT01323387|1997629|FG000|Overall Study|Withdrawal by Subject|41
988069|NCT01323387|1997629|FG000|Overall Study|Radiographic Data Unavailable|1
988070|NCT01323387|1997629|FG000|Overall Study|Revision|14
988071|NCT01323387|1997629|FG000|Overall Study|Protocol Violation|12
988072|NCT01323387|1997629|FG000|Overall Study|Randomized but Never Treated|16
988073|NCT01323478|1997635|FG000|Overall Study|Adverse Event|7
988074|NCT01323478|1997635|FG000|Overall Study|Lack of Efficacy|4
988075|NCT01323478|1997635|FG000|Overall Study|Non-compliance With Study Product|3
988076|NCT01323478|1997635|FG000|Overall Study|Protocol Violation|1
988077|NCT01323478|1997635|FG000|Overall Study|Withdrawal of Consent|1
988078|NCT01323478|1997635|FG000|Overall Study|Administrative or Other Reasons|8
988079|NCT01323530|1997650|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2
988080|NCT01323530|1997651|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0
988081|NCT01323530|1997652|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0
988082|NCT01323530|1997653|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0
988083|NCT01323530|1997654|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0
988084|NCT01323530|1997655|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2
988085|NCT01323530|1997656|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0
988086|NCT01323530|1997650|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
988087|NCT01323530|1997651|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
988088|NCT01323530|1997652|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
988089|NCT01323530|1997653|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
988090|NCT01323530|1997654|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2
988091|NCT01323530|1997655|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
988092|NCT01323530|1997656|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
988093|NCT01323530|1997650|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
988094|NCT01323530|1997651|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
988095|NCT01323530|1997652|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
988096|NCT01323530|1997653|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
988097|NCT01323530|1997654|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
988098|NCT01323530|1997655|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
988099|NCT01323530|1997656|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
988100|NCT01323530|1997650|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
988101|NCT01323530|1997651|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
988102|NCT01323530|1997652|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
988103|NCT01323530|1997653|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
988104|NCT01323530|1997654|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
988105|NCT01323530|1997655|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
988106|NCT01323530|1997656|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2
988107|NCT01323530|1997650|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
988108|NCT01323530|1997651|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
988109|NCT01323530|1997652|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
988110|NCT01323530|1997653|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
988111|NCT01323530|1997654|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
988112|NCT01323530|1997655|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
988113|NCT01323530|1997656|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3
988114|NCT01323530|1997650|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
988115|NCT01323530|1997651|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
988116|NCT01323530|1997652|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
988117|NCT01323530|1997653|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
988118|NCT01323530|1997654|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
988119|NCT01323530|1997655|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
988120|NCT01323530|1997656|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8
988121|NCT01323530|1997650|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
988122|NCT01323530|1997651|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
988123|NCT01323530|1997652|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
988124|NCT01323530|1997653|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
988125|NCT01323530|1997654|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
988126|NCT01323530|1997655|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
988127|NCT01323530|1997656|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3
988128|NCT01323530|1997650|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
988129|NCT01323530|1997651|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
988130|NCT01323530|1997652|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
988131|NCT01323530|1997653|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
988132|NCT01323530|1997654|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
988133|NCT01323530|1997655|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
988134|NCT01323530|1997656|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1
988135|NCT01323582|1997675|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2
988136|NCT01323582|1997676|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2
988137|NCT01323582|1997675|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0
988138|NCT01323582|1997676|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1
988139|NCT01323582|1997675|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
988140|NCT01323582|1997676|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
988141|NCT01323621|1997697|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
988142|NCT01323621|1997698|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
1006721|NCT01469052|2025441|FG005|Overall Study|Lack of Efficacy|2
988143|NCT01323621|1997699|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
988144|NCT01323621|1997697|FG000|2-week, Single-blind Run In Period|Physician Decision|7
988145|NCT01323621|1997698|FG001|2-week, Single-blind Run In Period|Physician Decision|0
988146|NCT01323621|1997699|FG002|2-week, Single-blind Run In Period|Physician Decision|0
988147|NCT01323621|1997697|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12
988148|NCT01323621|1997698|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0
988149|NCT01323621|1997699|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0
988150|NCT01323621|1997697|FG000|2-week, Single-blind Run In Period|Protocol Violation|1
988151|NCT01323621|1997698|FG001|2-week, Single-blind Run In Period|Protocol Violation|0
988152|NCT01323621|1997699|FG002|2-week, Single-blind Run In Period|Protocol Violation|0
988153|NCT01323621|1997697|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1
988154|NCT01323621|1997698|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0
988155|NCT01323621|1997699|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0
988156|NCT01323621|1997697|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
988157|NCT01323621|1997698|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
988158|NCT01323621|1997699|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
988159|NCT01323621|1997697|FG000|12-week, Double-blind Treatment Period|Adverse Event|0
988160|NCT01323621|1997698|FG001|12-week, Double-blind Treatment Period|Adverse Event|1
988161|NCT01323621|1997699|FG002|12-week, Double-blind Treatment Period|Adverse Event|5
988162|NCT01323621|1997697|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0
988163|NCT01323621|1997698|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2
988164|NCT01323621|1997699|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6
988165|NCT01323621|1997697|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0
988166|NCT01323621|1997698|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4
988167|NCT01323621|1997699|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4
988168|NCT01323621|1997697|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0
988169|NCT01323621|1997698|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1
988170|NCT01323621|1997699|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0
988171|NCT01323621|1997697|FG000|12-week, Double-blind Treatment Period|Physician Decision|0
988172|NCT01323621|1997698|FG001|12-week, Double-blind Treatment Period|Physician Decision|2
988173|NCT01323621|1997699|FG002|12-week, Double-blind Treatment Period|Physician Decision|1
988174|NCT01323621|1997697|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
988175|NCT01323621|1997698|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
988176|NCT01323621|1997699|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
988177|NCT01323634|1997707|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
988178|NCT01323634|1997708|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
988179|NCT01323634|1997709|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
988180|NCT01323634|1997707|FG000|2-week Run-in Period|Continuation Criteria not Met|73
988181|NCT01323634|1997708|FG001|2-week Run-in Period|Continuation Criteria not Met|0
988182|NCT01323634|1997709|FG002|2-week Run-in Period|Continuation Criteria not Met|0
988183|NCT01323634|1997707|FG000|2-week Run-in Period|Withdrawal by Subject|7
988184|NCT01323634|1997708|FG001|2-week Run-in Period|Withdrawal by Subject|0
988185|NCT01323634|1997709|FG002|2-week Run-in Period|Withdrawal by Subject|0
988186|NCT01323634|1997707|FG000|2-week Run-in Period|Physician Decision|5
988187|NCT01323634|1997708|FG001|2-week Run-in Period|Physician Decision|0
988188|NCT01323634|1997709|FG002|2-week Run-in Period|Physician Decision|0
988189|NCT01323634|1997707|FG000|2-week Run-in Period|Protocol Violation|1
988190|NCT01323634|1997708|FG001|2-week Run-in Period|Protocol Violation|0
988191|NCT01323634|1997709|FG002|2-week Run-in Period|Protocol Violation|0
988192|NCT01323634|1997707|FG000|2-week Run-in Period|Adverse Event|1
988193|NCT01323634|1997708|FG001|2-week Run-in Period|Adverse Event|0
988194|NCT01323634|1997709|FG002|2-week Run-in Period|Adverse Event|0
988195|NCT01323634|1997707|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0
988196|NCT01323634|1997708|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8
988197|NCT01323634|1997709|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4
988198|NCT01323634|1997707|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
988199|NCT01323634|1997708|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
988200|NCT01323634|1997709|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
988201|NCT01323634|1997707|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0
988202|NCT01323634|1997708|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6
988203|NCT01323634|1997709|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7
988204|NCT01323634|1997707|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
988205|NCT01323634|1997708|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
988206|NCT01323634|1997709|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
988207|NCT01323634|1997707|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0
988208|NCT01323634|1997708|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2
988209|NCT01323634|1997709|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3
988210|NCT01323634|1997707|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
988211|NCT01323634|1997708|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
988212|NCT01323634|1997709|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
988213|NCT01323634|1997707|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
988214|NCT01323634|1997708|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
988215|NCT01323634|1997709|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
988216|NCT01323647|1997717|FG000|Overall Study|Migrated/moved from study area|2
988217|NCT01323647|1997718|FG001|Overall Study|Migrated/moved from study area|0
988218|NCT01323647|1997717|FG000|Overall Study|Withdrawal by Subject|5
988219|NCT01323647|1997718|FG001|Overall Study|Withdrawal by Subject|0
988220|NCT01323647|1997717|FG000|Overall Study|Lost to Follow-up|2
988221|NCT01323647|1997718|FG001|Overall Study|Lost to Follow-up|0
988222|NCT01323660|1997724|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6
988223|NCT01323660|1997725|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
988224|NCT01323660|1997726|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
988225|NCT01323660|1997727|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
988226|NCT01323660|1997728|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3
988227|NCT01323660|1997729|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4
988228|NCT01323660|1997724|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
988229|NCT01323660|1997725|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
988230|NCT01323660|1997726|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
988231|NCT01323660|1997727|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
988232|NCT01323660|1997728|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
988233|NCT01323660|1997729|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
988234|NCT01323660|1997724|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
988235|NCT01323660|1997725|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
988236|NCT01323660|1997726|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1
988237|NCT01323660|1997727|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
988238|NCT01323660|1997728|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1
988239|NCT01323660|1997729|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2
988240|NCT01323660|1997724|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
988241|NCT01323660|1997725|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
988242|NCT01323660|1997726|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
988243|NCT01323660|1997727|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
988244|NCT01323660|1997728|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
988245|NCT01323660|1997729|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
988246|NCT01323660|1997724|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
988247|NCT01323660|1997725|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
988248|NCT01323660|1997726|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
988249|NCT01323660|1997727|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
988250|NCT01323660|1997728|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
988251|NCT01323660|1997729|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
988252|NCT01323660|1997724|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
988253|NCT01323660|1997725|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
988254|NCT01323660|1997726|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
988255|NCT01323660|1997727|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
988256|NCT01323660|1997728|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
988257|NCT01323660|1997729|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
988258|NCT01323660|1997724|FG000|Washout Period (14 Days)|Adverse Event|0
988259|NCT01323660|1997725|FG001|Washout Period (14 Days)|Adverse Event|0
988260|NCT01323660|1997726|FG002|Washout Period (14 Days)|Adverse Event|0
988261|NCT01323660|1997727|FG003|Washout Period (14 Days)|Adverse Event|0
988262|NCT01323660|1997728|FG004|Washout Period (14 Days)|Adverse Event|1
988263|NCT01323660|1997729|FG005|Washout Period (14 Days)|Adverse Event|0
988264|NCT01323660|1997724|FG000|Washout Period (14 Days)|Lack of Efficacy|0
988265|NCT01323660|1997725|FG001|Washout Period (14 Days)|Lack of Efficacy|0
988266|NCT01323660|1997726|FG002|Washout Period (14 Days)|Lack of Efficacy|1
988267|NCT01323660|1997727|FG003|Washout Period (14 Days)|Lack of Efficacy|3
988268|NCT01323660|1997728|FG004|Washout Period (14 Days)|Lack of Efficacy|2
988269|NCT01323660|1997729|FG005|Washout Period (14 Days)|Lack of Efficacy|2
988270|NCT01323660|1997724|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1
988271|NCT01323660|1997725|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
988272|NCT01323660|1997726|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0
988273|NCT01323660|1997727|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
988274|NCT01323660|1997728|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
988275|NCT01323660|1997729|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2
988276|NCT01323660|1997724|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
988277|NCT01323660|1997725|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
988278|NCT01323660|1997726|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
988279|NCT01323660|1997727|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
988280|NCT01323660|1997728|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
988281|NCT01323660|1997729|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
988282|NCT01323660|1997724|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
988283|NCT01323660|1997725|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
988284|NCT01323660|1997726|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
988285|NCT01323660|1997727|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
988286|NCT01323660|1997728|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
988287|NCT01323660|1997729|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
988288|NCT01323660|1997724|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
988289|NCT01323660|1997725|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
988290|NCT01323660|1997726|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
988291|NCT01323660|1997727|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
988292|NCT01323660|1997728|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
988293|NCT01323660|1997729|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
988294|NCT01323660|1997724|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
988295|NCT01323660|1997725|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
988296|NCT01323660|1997726|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
988297|NCT01323660|1997727|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
988298|NCT01323660|1997728|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
988299|NCT01323660|1997729|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
988300|NCT01323673|1997745|FG000|Overall Study|Adverse Event|0
988301|NCT01323673|1997746|FG001|Overall Study|Adverse Event|1
988302|NCT01323673|1997745|FG000|Overall Study|Lost to Follow-up|0
988303|NCT01323673|1997746|FG001|Overall Study|Lost to Follow-up|1
988304|NCT01323673|1997745|FG000|Overall Study|Protocol Violation|1
988305|NCT01323673|1997746|FG001|Overall Study|Protocol Violation|0
988306|NCT01323673|1997745|FG000|Overall Study|Withdrawal by Subject|2
988307|NCT01323673|1997746|FG001|Overall Study|Withdrawal by Subject|3
988308|NCT01323790|1997766|FG000|Overall Study|Other|3
988309|NCT01323790|1997767|FG001|Overall Study|Other|2
988310|NCT01323790|1997768|FG002|Overall Study|Other|1
988311|NCT01323790|1997766|FG000|Overall Study|Lost to Follow-up|11
988312|NCT01323790|1997767|FG001|Overall Study|Lost to Follow-up|9
988313|NCT01323790|1997768|FG002|Overall Study|Lost to Follow-up|9
988314|NCT01323790|1997766|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
988315|NCT01323790|1997767|FG001|Overall Study|Study-Specific Withdrawal Criteria|3
988316|NCT01323790|1997768|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
988317|NCT01323790|1997766|FG000|Overall Study|Lack of Efficacy|3
988318|NCT01323790|1997767|FG001|Overall Study|Lack of Efficacy|0
988319|NCT01323790|1997768|FG002|Overall Study|Lack of Efficacy|3
988320|NCT01323790|1997766|FG000|Overall Study|Adverse Event|11
988321|NCT01323790|1997767|FG001|Overall Study|Adverse Event|24
988322|NCT01323790|1997768|FG002|Overall Study|Adverse Event|12
988323|NCT01323790|1997766|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
988324|NCT01323790|1997767|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
988325|NCT01323790|1997768|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
988326|NCT01323790|1997766|FG000|Overall Study|Withdrawal by Subject|23
988327|NCT01323790|1997767|FG001|Overall Study|Withdrawal by Subject|20
988328|NCT01323790|1997768|FG002|Overall Study|Withdrawal by Subject|13
988329|NCT01323790|1997766|FG000|Overall Study|Did Not Receive Treatment|2
988330|NCT01323790|1997767|FG001|Overall Study|Did Not Receive Treatment|0
988331|NCT01323790|1997768|FG002|Overall Study|Did Not Receive Treatment|1
988332|NCT01323790|1997766|FG000|Overall Study|Severe non-compliance with protocol|2
988333|NCT01323790|1997767|FG001|Overall Study|Severe non-compliance with protocol|2
988334|NCT01323790|1997768|FG002|Overall Study|Severe non-compliance with protocol|2
988335|NCT01323920|1997797|FG000|Overall Study|Death|5
988336|NCT01323920|1997797|FG000|Overall Study|Withdrawal by Subject|1
988337|NCT01323946|1997804|FG000|Overall Study|Lost to Follow-up|0
988338|NCT01323946|1997805|FG001|Overall Study|Lost to Follow-up|1
988339|NCT01323946|1997806|FG002|Overall Study|Lost to Follow-up|0
988340|NCT01323946|1997804|FG000|Overall Study|Parents refused the last blood draw|1
988341|NCT01323946|1997805|FG001|Overall Study|Parents refused the last blood draw|0
988342|NCT01323946|1997806|FG002|Overall Study|Parents refused the last blood draw|0
988343|NCT01323946|1997804|FG000|Overall Study|Withdrawal by Subject|2
988344|NCT01323946|1997805|FG001|Overall Study|Withdrawal by Subject|2
988345|NCT01323946|1997806|FG002|Overall Study|Withdrawal by Subject|0
988346|NCT01323972|1997833|FG000|Overall Study|Withdrawal by Subject|1
988347|NCT01323972|1997834|FG001|Overall Study|Withdrawal by Subject|0
988348|NCT01323972|1997835|FG002|Overall Study|Withdrawal by Subject|1
988349|NCT01323972|1997836|FG003|Overall Study|Withdrawal by Subject|0
988350|NCT01323972|1997833|FG000|Overall Study|Migrated/moved from study area|1
988351|NCT01323972|1997834|FG001|Overall Study|Migrated/moved from study area|2
988352|NCT01323972|1997835|FG002|Overall Study|Migrated/moved from study area|0
988353|NCT01323972|1997836|FG003|Overall Study|Migrated/moved from study area|0
988354|NCT01323972|1997833|FG000|Overall Study|Lost to Follow-up|0
988355|NCT01323972|1997834|FG001|Overall Study|Lost to Follow-up|1
988356|NCT01323972|1997835|FG002|Overall Study|Lost to Follow-up|1
988357|NCT01323972|1997836|FG003|Overall Study|Lost to Follow-up|1
988358|NCT01324024|1997869|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2
988359|NCT01324024|1997870|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
988360|NCT01324102|1997882|FG000|Overall Study|illness|1
988361|NCT01324102|1997883|FG001|Overall Study|illness|6
988362|NCT01324232|1997923|FG000|Overall Study|Protocol Violation|0
988363|NCT01324232|1997924|FG001|Overall Study|Protocol Violation|0
988364|NCT01324232|1997925|FG002|Overall Study|Protocol Violation|0
988365|NCT01324232|1997926|FG003|Overall Study|Protocol Violation|2
988366|NCT01324232|1997923|FG000|Overall Study|Missing|0
988367|NCT01324232|1997924|FG001|Overall Study|Missing|0
988368|NCT01324232|1997925|FG002|Overall Study|Missing|1
988369|NCT01324232|1997926|FG003|Overall Study|Missing|0
988370|NCT01324232|1997923|FG000|Overall Study|Participant's Personal Reason/Decision|0
988371|NCT01324232|1997924|FG001|Overall Study|Participant's Personal Reason/Decision|1
988372|NCT01324232|1997925|FG002|Overall Study|Participant's Personal Reason/Decision|0
988373|NCT01324232|1997926|FG003|Overall Study|Participant's Personal Reason/Decision|0
988374|NCT01324232|1997923|FG000|Overall Study|Lack of Efficacy|2
988375|NCT01324232|1997924|FG001|Overall Study|Lack of Efficacy|1
988376|NCT01324232|1997925|FG002|Overall Study|Lack of Efficacy|2
988377|NCT01324232|1997926|FG003|Overall Study|Lack of Efficacy|2
988378|NCT01324232|1997923|FG000|Overall Study|Participant Refused Medication|0
988379|NCT01324232|1997924|FG001|Overall Study|Participant Refused Medication|1
988380|NCT01324232|1997925|FG002|Overall Study|Participant Refused Medication|0
988381|NCT01324232|1997926|FG003|Overall Study|Participant Refused Medication|0
988382|NCT01324232|1997923|FG000|Overall Study|Intercurrent illness|0
988383|NCT01324232|1997924|FG001|Overall Study|Intercurrent illness|0
988384|NCT01324232|1997925|FG002|Overall Study|Intercurrent illness|0
988385|NCT01324232|1997926|FG003|Overall Study|Intercurrent illness|1
988386|NCT01324232|1997923|FG000|Overall Study|Adverse Event|2
988387|NCT01324232|1997924|FG001|Overall Study|Adverse Event|5
988388|NCT01324232|1997925|FG002|Overall Study|Adverse Event|6
988389|NCT01324232|1997926|FG003|Overall Study|Adverse Event|6
988390|NCT01324232|1997923|FG000|Overall Study|Withdrawal by Subject|0
988391|NCT01324232|1997924|FG001|Overall Study|Withdrawal by Subject|3
988392|NCT01324232|1997925|FG002|Overall Study|Withdrawal by Subject|4
988393|NCT01324232|1997926|FG003|Overall Study|Withdrawal by Subject|0
988394|NCT01324232|1997923|FG000|Overall Study|Lost to Follow-up|1
988395|NCT01324232|1997924|FG001|Overall Study|Lost to Follow-up|0
988396|NCT01324232|1997925|FG002|Overall Study|Lost to Follow-up|0
988397|NCT01324232|1997926|FG003|Overall Study|Lost to Follow-up|0
988398|NCT01324271|1997941|FG000|Overall Study|Lost to Follow-up|3
988399|NCT01324271|1997942|FG001|Overall Study|Lost to Follow-up|0
988400|NCT01324271|1997941|FG000|Overall Study|Physician Decision|1
988401|NCT01324271|1997942|FG001|Overall Study|Physician Decision|0
988402|NCT01324310|1997948|FG000|Overall Study|Adverse Event|1
988403|NCT01324310|1997948|FG000|Overall Study|Disease Progression|1
988404|NCT01324323|1997954|FG000|Overall Study|Withdrawal by Subject|1
988405|NCT01324349|1997968|FG000|Overall Study|Death|1
988406|NCT01324349|1997969|FG001|Overall Study|Death|1
988407|NCT01324349|1997968|FG000|Overall Study|Withdrawal by Subject|0
988408|NCT01324349|1997969|FG001|Overall Study|Withdrawal by Subject|1
988409|NCT01324388|1997978|FG000|Part 1 of Study|Adverse Event|2
988410|NCT01324388|1997979|FG001|Part 1 of Study|Adverse Event|0
988411|NCT01324388|1997980|FG002|Part 1 of Study|Adverse Event|0
988412|NCT01324388|1997981|FG003|Part 1 of Study|Adverse Event|0
988413|NCT01324388|1997978|FG000|Part 1 of Study|Protocol Violation|1
988414|NCT01324388|1997979|FG001|Part 1 of Study|Protocol Violation|2
988415|NCT01324388|1997980|FG002|Part 1 of Study|Protocol Violation|0
988416|NCT01324388|1997981|FG003|Part 1 of Study|Protocol Violation|0
988417|NCT01324388|1997978|FG000|Part 1 of Study|Physician Decision|1
988418|NCT01324388|1997979|FG001|Part 1 of Study|Physician Decision|0
988419|NCT01324388|1997980|FG002|Part 1 of Study|Physician Decision|0
988420|NCT01324388|1997981|FG003|Part 1 of Study|Physician Decision|0
988421|NCT01324388|1997978|FG000|Part 2 of Study: First Intervention|Protocol Violation|0
988422|NCT01324388|1997979|FG001|Part 2 of Study: First Intervention|Protocol Violation|0
988423|NCT01324388|1997980|FG002|Part 2 of Study: First Intervention|Protocol Violation|0
988424|NCT01324388|1997981|FG003|Part 2 of Study: First Intervention|Protocol Violation|1
988425|NCT01324388|1997978|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
988426|NCT01324388|1997979|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
988427|NCT01324388|1997980|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
988428|NCT01324388|1997981|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
988429|NCT01324401|1997995|FG000|Overall Study|Withdrawn before any treatment|0
988430|NCT01324401|1997996|FG001|Overall Study|Withdrawn before any treatment|3
988431|NCT01324401|1997995|FG000|Overall Study|Adverse Event|1
988432|NCT01324401|1997996|FG001|Overall Study|Adverse Event|3
988433|NCT01324440|1998004|FG000|Overall Study|Subject moved|0
988434|NCT01324440|1998005|FG001|Overall Study|Subject moved|1
988435|NCT01324570|1998035|FG000|Overall Study|Adverse Event|4
988436|NCT01324570|1998036|FG001|Overall Study|Adverse Event|7
988437|NCT01324570|1998035|FG000|Overall Study|Withdrawal by Subject|0
988438|NCT01324570|1998036|FG001|Overall Study|Withdrawal by Subject|3
988439|NCT01324570|1998035|FG000|Overall Study|Lack of Efficacy|0
988440|NCT01324570|1998036|FG001|Overall Study|Lack of Efficacy|1
988441|NCT01324570|1998035|FG000|Overall Study|Confirmed or suspected diversion|0
988442|NCT01324570|1998036|FG001|Overall Study|Confirmed or suspected diversion|1
988443|NCT01324570|1998035|FG000|Overall Study|Administrative|0
988444|NCT01324570|1998036|FG001|Overall Study|Administrative|2
988445|NCT01324622|1998046|FG000|Overall Study|Lost to Follow-up|7
988446|NCT01324622|1998047|FG001|Overall Study|Lost to Follow-up|7
988447|NCT01324622|1998046|FG000|Overall Study|Death|1
988448|NCT01324622|1998047|FG001|Overall Study|Death|0
988449|NCT01324622|1998046|FG000|Overall Study|Lack of Efficacy|1
988450|NCT01324622|1998047|FG001|Overall Study|Lack of Efficacy|0
988451|NCT01324830|1998099|FG000|Overall Study|Progressive Disease|3
988452|NCT01324830|1998100|FG001|Overall Study|Progressive Disease|2
988453|NCT01324830|1998101|FG002|Overall Study|Progressive Disease|3
988454|NCT01324830|1998102|FG003|Overall Study|Progressive Disease|3
988455|NCT01324830|1998103|FG004|Overall Study|Progressive Disease|6
988456|NCT01324830|1998104|FG005|Overall Study|Progressive Disease|6
988457|NCT01324830|1998105|FG006|Overall Study|Progressive Disease|3
988458|NCT01324830|1998106|FG007|Overall Study|Progressive Disease|3
988459|NCT01324830|1998107|FG008|Overall Study|Progressive Disease|3
988460|NCT01324830|1998108|FG009|Overall Study|Progressive Disease|6
988461|NCT01324830|1998109|FG010|Overall Study|Progressive Disease|2
988462|NCT01324830|1998110|FG011|Overall Study|Progressive Disease|1
988463|NCT01324830|1998111|FG012|Overall Study|Progressive Disease|1
988464|NCT01324830|1998112|FG013|Overall Study|Progressive Disease|1
988465|NCT01324830|1998113|FG014|Overall Study|Progressive Disease|1
988466|NCT01324830|1998114|FG015|Overall Study|Progressive Disease|3
988467|NCT01324830|1998115|FG016|Overall Study|Progressive Disease|2
988468|NCT01324830|1998116|FG017|Overall Study|Progressive Disease|3
988469|NCT01324830|1998117|FG018|Overall Study|Progressive Disease|4
988470|NCT01324830|1998099|FG000|Overall Study|Dose limiting toxicity|0
988471|NCT01324830|1998100|FG001|Overall Study|Dose limiting toxicity|0
988472|NCT01324830|1998101|FG002|Overall Study|Dose limiting toxicity|0
988473|NCT01324830|1998102|FG003|Overall Study|Dose limiting toxicity|0
988474|NCT01324830|1998103|FG004|Overall Study|Dose limiting toxicity|1
988475|NCT01324830|1998104|FG005|Overall Study|Dose limiting toxicity|0
988476|NCT01324830|1998105|FG006|Overall Study|Dose limiting toxicity|0
988477|NCT01324830|1998106|FG007|Overall Study|Dose limiting toxicity|0
988478|NCT01324830|1998107|FG008|Overall Study|Dose limiting toxicity|0
988479|NCT01324830|1998108|FG009|Overall Study|Dose limiting toxicity|0
988480|NCT01324830|1998109|FG010|Overall Study|Dose limiting toxicity|0
988481|NCT01324830|1998110|FG011|Overall Study|Dose limiting toxicity|0
988482|NCT01324830|1998111|FG012|Overall Study|Dose limiting toxicity|0
988483|NCT01324830|1998112|FG013|Overall Study|Dose limiting toxicity|0
988484|NCT01324830|1998113|FG014|Overall Study|Dose limiting toxicity|0
988485|NCT01324830|1998114|FG015|Overall Study|Dose limiting toxicity|0
988486|NCT01324830|1998115|FG016|Overall Study|Dose limiting toxicity|1
988487|NCT01324830|1998116|FG017|Overall Study|Dose limiting toxicity|1
988488|NCT01324830|1998117|FG018|Overall Study|Dose limiting toxicity|1
988489|NCT01324830|1998099|FG000|Overall Study|Reason not mentioned above|0
988490|NCT01324830|1998100|FG001|Overall Study|Reason not mentioned above|0
988491|NCT01324830|1998101|FG002|Overall Study|Reason not mentioned above|0
988492|NCT01324830|1998102|FG003|Overall Study|Reason not mentioned above|0
988493|NCT01324830|1998103|FG004|Overall Study|Reason not mentioned above|0
988494|NCT01324830|1998104|FG005|Overall Study|Reason not mentioned above|0
988495|NCT01324830|1998105|FG006|Overall Study|Reason not mentioned above|0
988496|NCT01324830|1998106|FG007|Overall Study|Reason not mentioned above|0
988497|NCT01324830|1998107|FG008|Overall Study|Reason not mentioned above|0
988498|NCT01324830|1998108|FG009|Overall Study|Reason not mentioned above|0
988499|NCT01324830|1998109|FG010|Overall Study|Reason not mentioned above|0
988500|NCT01324830|1998110|FG011|Overall Study|Reason not mentioned above|0
988501|NCT01324830|1998111|FG012|Overall Study|Reason not mentioned above|0
988502|NCT01324830|1998112|FG013|Overall Study|Reason not mentioned above|0
988503|NCT01324830|1998113|FG014|Overall Study|Reason not mentioned above|0
988504|NCT01324830|1998114|FG015|Overall Study|Reason not mentioned above|0
988505|NCT01324830|1998115|FG016|Overall Study|Reason not mentioned above|0
988506|NCT01324830|1998116|FG017|Overall Study|Reason not mentioned above|1
988507|NCT01324830|1998117|FG018|Overall Study|Reason not mentioned above|0
988508|NCT01324830|1998099|FG000|Overall Study|Adverse Event, serious fatal|0
988509|NCT01324830|1998100|FG001|Overall Study|Adverse Event, serious fatal|1
988510|NCT01324830|1998101|FG002|Overall Study|Adverse Event, serious fatal|0
988511|NCT01324830|1998102|FG003|Overall Study|Adverse Event, serious fatal|0
988512|NCT01324830|1998103|FG004|Overall Study|Adverse Event, serious fatal|0
988513|NCT01324830|1998104|FG005|Overall Study|Adverse Event, serious fatal|0
988514|NCT01324830|1998105|FG006|Overall Study|Adverse Event, serious fatal|0
988515|NCT01324830|1998106|FG007|Overall Study|Adverse Event, serious fatal|0
988516|NCT01324830|1998107|FG008|Overall Study|Adverse Event, serious fatal|0
988517|NCT01324830|1998108|FG009|Overall Study|Adverse Event, serious fatal|0
988518|NCT01324830|1998109|FG010|Overall Study|Adverse Event, serious fatal|0
988519|NCT01324830|1998110|FG011|Overall Study|Adverse Event, serious fatal|0
988520|NCT01324830|1998111|FG012|Overall Study|Adverse Event, serious fatal|0
988521|NCT01324830|1998112|FG013|Overall Study|Adverse Event, serious fatal|0
988522|NCT01324830|1998113|FG014|Overall Study|Adverse Event, serious fatal|0
988523|NCT01324830|1998114|FG015|Overall Study|Adverse Event, serious fatal|0
988524|NCT01324830|1998115|FG016|Overall Study|Adverse Event, serious fatal|0
988525|NCT01324830|1998116|FG017|Overall Study|Adverse Event, serious fatal|0
988526|NCT01324830|1998117|FG018|Overall Study|Adverse Event, serious fatal|0
988527|NCT01324830|1998099|FG000|Overall Study|Adverse Event, non-fatal|0
988528|NCT01324830|1998100|FG001|Overall Study|Adverse Event, non-fatal|0
988529|NCT01324830|1998101|FG002|Overall Study|Adverse Event, non-fatal|0
988530|NCT01324830|1998102|FG003|Overall Study|Adverse Event, non-fatal|0
988531|NCT01324830|1998103|FG004|Overall Study|Adverse Event, non-fatal|0
988532|NCT01324830|1998104|FG005|Overall Study|Adverse Event, non-fatal|0
988533|NCT01324830|1998105|FG006|Overall Study|Adverse Event, non-fatal|0
988534|NCT01324830|1998106|FG007|Overall Study|Adverse Event, non-fatal|0
988535|NCT01324830|1998107|FG008|Overall Study|Adverse Event, non-fatal|2
988536|NCT01324830|1998108|FG009|Overall Study|Adverse Event, non-fatal|0
988537|NCT01324830|1998109|FG010|Overall Study|Adverse Event, non-fatal|1
988538|NCT01324830|1998110|FG011|Overall Study|Adverse Event, non-fatal|0
988539|NCT01324830|1998111|FG012|Overall Study|Adverse Event, non-fatal|0
988540|NCT01324830|1998112|FG013|Overall Study|Adverse Event, non-fatal|0
988541|NCT01324830|1998113|FG014|Overall Study|Adverse Event, non-fatal|0
988542|NCT01324830|1998114|FG015|Overall Study|Adverse Event, non-fatal|0
988543|NCT01324830|1998115|FG016|Overall Study|Adverse Event, non-fatal|0
988544|NCT01324830|1998116|FG017|Overall Study|Adverse Event, non-fatal|1
988545|NCT01324830|1998117|FG018|Overall Study|Adverse Event, non-fatal|0
988546|NCT01324830|1998099|FG000|Overall Study|Withdrawal by Subject|0
988547|NCT01324830|1998100|FG001|Overall Study|Withdrawal by Subject|0
988548|NCT01324830|1998101|FG002|Overall Study|Withdrawal by Subject|0
988549|NCT01324830|1998102|FG003|Overall Study|Withdrawal by Subject|0
988550|NCT01324830|1998103|FG004|Overall Study|Withdrawal by Subject|0
988551|NCT01324830|1998104|FG005|Overall Study|Withdrawal by Subject|1
988552|NCT01324830|1998105|FG006|Overall Study|Withdrawal by Subject|0
988553|NCT01324830|1998106|FG007|Overall Study|Withdrawal by Subject|0
988554|NCT01324830|1998107|FG008|Overall Study|Withdrawal by Subject|0
988555|NCT01324830|1998108|FG009|Overall Study|Withdrawal by Subject|0
988556|NCT01324830|1998109|FG010|Overall Study|Withdrawal by Subject|1
988557|NCT01324830|1998110|FG011|Overall Study|Withdrawal by Subject|0
988558|NCT01324830|1998111|FG012|Overall Study|Withdrawal by Subject|0
988559|NCT01324830|1998112|FG013|Overall Study|Withdrawal by Subject|0
988560|NCT01324830|1998113|FG014|Overall Study|Withdrawal by Subject|0
988561|NCT01324830|1998114|FG015|Overall Study|Withdrawal by Subject|0
988562|NCT01324830|1998115|FG016|Overall Study|Withdrawal by Subject|0
988563|NCT01324830|1998116|FG017|Overall Study|Withdrawal by Subject|0
988564|NCT01324830|1998117|FG018|Overall Study|Withdrawal by Subject|1
988565|NCT01324947|1998174|FG000|Overall Study|Adverse Event|7
988566|NCT01324947|1998174|FG000|Overall Study|Death|10
988567|NCT01324947|1998174|FG000|Overall Study|Other|3
988568|NCT01324947|1998174|FG000|Overall Study|Progressive Disease|50
988569|NCT01324947|1998174|FG000|Overall Study|Withdrawal by Subject|3
988570|NCT01324947|1998174|FG000|Overall Study|1 discontinued before starting drug|1
988571|NCT01324999|1998180|FG000|Overall Study|Adverse Event|3
988572|NCT01324999|1998180|FG000|Overall Study|Withdrawal by Subject|2
988573|NCT01325207|1998199|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
988574|NCT01325207|1998200|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
988575|NCT01325207|1998201|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
988576|NCT01325207|1998202|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
988577|NCT01325207|1998203|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
988578|NCT01325207|1998204|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
988579|NCT01325207|1998199|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
988580|NCT01325207|1998200|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
988581|NCT01325207|1998201|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
988582|NCT01325207|1998202|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
988583|NCT01325207|1998203|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
988584|NCT01325207|1998204|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
988585|NCT01325207|1998199|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
988586|NCT01325207|1998200|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
988587|NCT01325207|1998201|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
988588|NCT01325207|1998202|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
988589|NCT01325207|1998203|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
988590|NCT01325207|1998204|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
988591|NCT01325207|1998199|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
988592|NCT01325207|1998200|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
988593|NCT01325207|1998201|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
988594|NCT01325207|1998202|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
988595|NCT01325207|1998203|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
988596|NCT01325207|1998204|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
988597|NCT01325207|1998199|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
988598|NCT01325207|1998200|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
988599|NCT01325207|1998201|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
988600|NCT01325207|1998202|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
988601|NCT01325207|1998203|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
988602|NCT01325207|1998204|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
988603|NCT01325207|1998199|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
988604|NCT01325207|1998200|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
988605|NCT01325207|1998201|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
988606|NCT01325207|1998202|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
988607|NCT01325207|1998203|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
988608|NCT01325207|1998204|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
988609|NCT01325207|1998199|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
988610|NCT01325207|1998200|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
988611|NCT01325207|1998201|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
988612|NCT01325207|1998202|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
988613|NCT01325207|1998203|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
988614|NCT01325207|1998204|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
988615|NCT01325337|1998233|FG000|Overall Study|Adverse Event|0
988616|NCT01325337|1998234|FG001|Overall Study|Adverse Event|2
988617|NCT01325337|1998235|FG002|Overall Study|Adverse Event|2
988618|NCT01325337|1998236|FG003|Overall Study|Adverse Event|1
988619|NCT01325337|1998237|FG004|Overall Study|Adverse Event|2
988620|NCT01325337|1998233|FG000|Overall Study|Lost to Follow-up|2
988621|NCT01325337|1998234|FG001|Overall Study|Lost to Follow-up|2
988622|NCT01325337|1998235|FG002|Overall Study|Lost to Follow-up|2
988623|NCT01325337|1998236|FG003|Overall Study|Lost to Follow-up|1
988624|NCT01325337|1998237|FG004|Overall Study|Lost to Follow-up|2
988625|NCT01325337|1998233|FG000|Overall Study|Personal Reasons|2
988626|NCT01325337|1998234|FG001|Overall Study|Personal Reasons|5
988627|NCT01325337|1998235|FG002|Overall Study|Personal Reasons|4
988628|NCT01325337|1998236|FG003|Overall Study|Personal Reasons|8
988629|NCT01325337|1998237|FG004|Overall Study|Personal Reasons|3
988630|NCT01325337|1998233|FG000|Overall Study|Withdrawal by Subject|1
988631|NCT01325337|1998234|FG001|Overall Study|Withdrawal by Subject|0
988632|NCT01325337|1998235|FG002|Overall Study|Withdrawal by Subject|1
988633|NCT01325337|1998236|FG003|Overall Study|Withdrawal by Subject|0
988634|NCT01325337|1998237|FG004|Overall Study|Withdrawal by Subject|1
988635|NCT01325350|1998254|FG000|Overall Study|Adverse Event|3
988636|NCT01325350|1998255|FG001|Overall Study|Adverse Event|3
988637|NCT01325350|1998256|FG002|Overall Study|Adverse Event|3
988638|NCT01325350|1998257|FG003|Overall Study|Adverse Event|1
988639|NCT01325350|1998258|FG004|Overall Study|Adverse Event|2
988640|NCT01325350|1998254|FG000|Overall Study|Pregnancy|0
988641|NCT01325350|1998255|FG001|Overall Study|Pregnancy|0
988642|NCT01325350|1998256|FG002|Overall Study|Pregnancy|1
988643|NCT01325350|1998257|FG003|Overall Study|Pregnancy|0
988644|NCT01325350|1998258|FG004|Overall Study|Pregnancy|1
988645|NCT01325350|1998254|FG000|Overall Study|Lost to Follow-up|1
988646|NCT01325350|1998255|FG001|Overall Study|Lost to Follow-up|0
988647|NCT01325350|1998256|FG002|Overall Study|Lost to Follow-up|5
988648|NCT01325350|1998257|FG003|Overall Study|Lost to Follow-up|1
988649|NCT01325350|1998258|FG004|Overall Study|Lost to Follow-up|5
988650|NCT01325350|1998254|FG000|Overall Study|Personal Reasons|2
988651|NCT01325350|1998255|FG001|Overall Study|Personal Reasons|1
988652|NCT01325350|1998256|FG002|Overall Study|Personal Reasons|6
988653|NCT01325350|1998257|FG003|Overall Study|Personal Reasons|5
988654|NCT01325350|1998258|FG004|Overall Study|Personal Reasons|3
988655|NCT01325350|1998254|FG000|Overall Study|Protocol Violation|0
988656|NCT01325350|1998255|FG001|Overall Study|Protocol Violation|0
988657|NCT01325350|1998256|FG002|Overall Study|Protocol Violation|0
988658|NCT01325350|1998257|FG003|Overall Study|Protocol Violation|1
988659|NCT01325350|1998258|FG004|Overall Study|Protocol Violation|0
988660|NCT01325350|1998254|FG000|Overall Study|Withdrawal by Subject|0
988661|NCT01325350|1998255|FG001|Overall Study|Withdrawal by Subject|0
988662|NCT01325350|1998256|FG002|Overall Study|Withdrawal by Subject|1
988663|NCT01325350|1998257|FG003|Overall Study|Withdrawal by Subject|1
988664|NCT01325350|1998258|FG004|Overall Study|Withdrawal by Subject|0
988665|NCT01325350|1998254|FG000|Overall Study|Did Not Receive Treatment|0
988666|NCT01325350|1998255|FG001|Overall Study|Did Not Receive Treatment|1
988667|NCT01325350|1998256|FG002|Overall Study|Did Not Receive Treatment|1
988668|NCT01325350|1998257|FG003|Overall Study|Did Not Receive Treatment|0
988669|NCT01325350|1998258|FG004|Overall Study|Did Not Receive Treatment|1
988670|NCT01325428|1998270|FG000|Part A|Progressive disease according to RECIST|9
988671|NCT01325428|1998270|FG000|Part A|Clinical signs, symptoms of progression|2
988672|NCT01325428|1998270|FG000|Part A|Other adverse event|1
988673|NCT01325428|1998270|FG000|Part A|Refused continue taking trial medication|2
988674|NCT01325428|1998270|FG000|Part A|Other reason not defined above|2
988675|NCT01325428|1998270|FG000|Part B|Refused continue taking trial medication|2
988676|NCT01325428|1998270|FG000|Part B|Other reason not defined above|1
988677|NCT01325493|1998281|FG000|Overall Study|Protocol Violation|0
988678|NCT01325493|1998282|FG001|Overall Study|Protocol Violation|1
988679|NCT01325493|1998281|FG000|Overall Study|loss of neuromonitoring signals|0
988680|NCT01325493|1998282|FG001|Overall Study|loss of neuromonitoring signals|2
988681|NCT01325493|1998281|FG000|Overall Study|Allergy|1
988682|NCT01325493|1998282|FG001|Overall Study|Allergy|0
988683|NCT01325532|1998290|FG000|Overall Study|Withdrawal by Subject|2
988684|NCT01325532|1998291|FG001|Overall Study|Withdrawal by Subject|0
988685|NCT01325584|1998297|FG000|Overall Study|Death|1
988686|NCT01325623|1998301|FG000|Overall Study|Withdrawal by Subject|3
988687|NCT01325701|1998340|FG000|Overall Study|Adverse Event|12
988688|NCT01325701|1998341|FG001|Overall Study|Adverse Event|0
988689|NCT01325701|1998340|FG000|Overall Study|Protocol Violation|1
988690|NCT01325701|1998341|FG001|Overall Study|Protocol Violation|0
988691|NCT01325701|1998340|FG000|Overall Study|Physician Decision|2
988692|NCT01325701|1998341|FG001|Overall Study|Physician Decision|2
988693|NCT01325701|1998340|FG000|Overall Study|Withdrawal by Subject|2
988694|NCT01325701|1998341|FG001|Overall Study|Withdrawal by Subject|1
988695|NCT01325701|1998340|FG000|Overall Study|Rollerover Extension Study|4
988696|NCT01325701|1998341|FG001|Overall Study|Rollerover Extension Study|0
988697|NCT01326026|1998378|FG000|Overall Study|Adverse Event|4
988698|NCT01326026|1998379|FG001|Overall Study|Adverse Event|3
988699|NCT01326026|1998378|FG000|Overall Study|Withdrawal Criteria|5
988700|NCT01326026|1998379|FG001|Overall Study|Withdrawal Criteria|7
988701|NCT01326026|1998378|FG000|Overall Study|Other|3
988702|NCT01326026|1998379|FG001|Overall Study|Other|3
988703|NCT01326481|1998385|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
988704|NCT01326533|1998393|FG000|Overall Study|Lost to Follow-up|2
988705|NCT01326533|1998394|FG001|Overall Study|Lost to Follow-up|0
988706|NCT01326533|1998393|FG000|Overall Study|Withdrawal by Subject|1
988707|NCT01326533|1998394|FG001|Overall Study|Withdrawal by Subject|0
988708|NCT01326533|1998393|FG000|Overall Study|Adverse Event|1
988709|NCT01326533|1998394|FG001|Overall Study|Adverse Event|0
988710|NCT01326546|1998402|FG000|Overall Study|Lost to Follow-up|8
988711|NCT01326546|1998403|FG001|Overall Study|Lost to Follow-up|7
988712|NCT01326546|1998402|FG000|Overall Study|Protocol Violation|3
988713|NCT01326546|1998403|FG001|Overall Study|Protocol Violation|4
988714|NCT01326546|1998402|FG000|Overall Study|Pregnancy|0
988715|NCT01326546|1998403|FG001|Overall Study|Pregnancy|1
988716|NCT01326546|1998402|FG000|Overall Study|Adverse Event|1
988717|NCT01326546|1998403|FG001|Overall Study|Adverse Event|0
988718|NCT01326546|1998402|FG000|Overall Study|Withdrawal by Subject|5
988719|NCT01326546|1998403|FG001|Overall Study|Withdrawal by Subject|1
988720|NCT01326702|1998416|FG000|Overall Study|Other|1
988721|NCT01326702|1998417|FG001|Overall Study|Other|0
988722|NCT01326702|1998418|FG002|Overall Study|Other|0
988723|NCT01326702|1998419|FG003|Overall Study|Other|0
988724|NCT01326702|1998420|FG004|Overall Study|Other|0
988725|NCT01326702|1998421|FG005|Overall Study|Other|1
988726|NCT01326702|1998422|FG006|Overall Study|Other|0
988727|NCT01326702|1998416|FG000|Overall Study|progressive disease|1
988728|NCT01326702|1998417|FG001|Overall Study|progressive disease|1
988729|NCT01326702|1998418|FG002|Overall Study|progressive disease|3
988730|NCT01326702|1998419|FG003|Overall Study|progressive disease|1
988731|NCT01326702|1998420|FG004|Overall Study|progressive disease|3
988732|NCT01326702|1998421|FG005|Overall Study|progressive disease|2
988733|NCT01326702|1998422|FG006|Overall Study|progressive disease|3
988734|NCT01326702|1998416|FG000|Overall Study|Death|0
988735|NCT01326702|1998417|FG001|Overall Study|Death|1
988736|NCT01326702|1998418|FG002|Overall Study|Death|0
988737|NCT01326702|1998419|FG003|Overall Study|Death|0
988738|NCT01326702|1998420|FG004|Overall Study|Death|0
988739|NCT01326702|1998421|FG005|Overall Study|Death|0
988740|NCT01326702|1998422|FG006|Overall Study|Death|0
988741|NCT01326702|1998416|FG000|Overall Study|Adverse Event|0
988742|NCT01326702|1998417|FG001|Overall Study|Adverse Event|0
988743|NCT01326702|1998418|FG002|Overall Study|Adverse Event|1
988744|NCT01326702|1998419|FG003|Overall Study|Adverse Event|1
988745|NCT01326702|1998420|FG004|Overall Study|Adverse Event|0
988746|NCT01326702|1998421|FG005|Overall Study|Adverse Event|3
988747|NCT01326702|1998422|FG006|Overall Study|Adverse Event|1
988748|NCT01326702|1998416|FG000|Overall Study|Withdrawal by Subject|0
988749|NCT01326702|1998417|FG001|Overall Study|Withdrawal by Subject|0
988750|NCT01326702|1998418|FG002|Overall Study|Withdrawal by Subject|1
988751|NCT01326702|1998419|FG003|Overall Study|Withdrawal by Subject|0
988752|NCT01326702|1998420|FG004|Overall Study|Withdrawal by Subject|1
988753|NCT01326702|1998421|FG005|Overall Study|Withdrawal by Subject|1
988754|NCT01326702|1998422|FG006|Overall Study|Withdrawal by Subject|3
988755|NCT01326702|1998416|FG000|Overall Study|Not Treated|0
988756|NCT01326702|1998417|FG001|Overall Study|Not Treated|0
988757|NCT01326702|1998418|FG002|Overall Study|Not Treated|0
988758|NCT01326702|1998419|FG003|Overall Study|Not Treated|1
988759|NCT01326702|1998420|FG004|Overall Study|Not Treated|0
988760|NCT01326702|1998421|FG005|Overall Study|Not Treated|1
988761|NCT01326702|1998422|FG006|Overall Study|Not Treated|0
988762|NCT01326728|1998443|FG000|Overall Study|Death|13
988763|NCT01326728|1998444|FG001|Overall Study|Death|0
988764|NCT01326728|1998443|FG000|Overall Study|Early closure of study|34
988765|NCT01326728|1998444|FG001|Overall Study|Early closure of study|9
988766|NCT01326910|1998468|FG000|Overall Study|Withdrawal by Subject|3
988767|NCT01326910|1998469|FG001|Overall Study|Withdrawal by Subject|2
988768|NCT01326910|1998468|FG000|Overall Study|Protocol Violation|1
988769|NCT01326910|1998469|FG001|Overall Study|Protocol Violation|1
988770|NCT01326962|1998475|FG000|Overall Study|Adverse Event|1
988771|NCT01326962|1998475|FG000|Overall Study|Withdrawal by Subject|1
988772|NCT01326962|1998475|FG000|Overall Study|Lost to Follow-up|3
988773|NCT01326962|1998475|FG000|Overall Study|Other|2
988774|NCT01327053|1998481|FG000|Overall Study|Adverse Event|23
988775|NCT01327053|1998482|FG001|Overall Study|Adverse Event|57
988776|NCT01327053|1998481|FG000|Overall Study|Patient/guardian decision|11
988777|NCT01327053|1998482|FG001|Overall Study|Patient/guardian decision|35
988778|NCT01327053|1998481|FG000|Overall Study|Physician Decision|10
988779|NCT01327053|1998482|FG001|Overall Study|Physician Decision|14
988780|NCT01327053|1998481|FG000|Overall Study|Death|1
988781|NCT01327053|1998482|FG001|Overall Study|Death|5
988782|NCT01327053|1998481|FG000|Overall Study|Lost to Follow-up|2
988783|NCT01327053|1998482|FG001|Overall Study|Lost to Follow-up|4
988784|NCT01327053|1998481|FG000|Overall Study|Non-compliance with study treatment|0
988785|NCT01327053|1998482|FG001|Overall Study|Non-compliance with study treatment|5
988786|NCT01327053|1998481|FG000|Overall Study|Study terminated by Sponsor|1
988787|NCT01327053|1998482|FG001|Overall Study|Study terminated by Sponsor|3
988788|NCT01327053|1998481|FG000|Overall Study|Progressive disease|31
988789|NCT01327053|1998482|FG001|Overall Study|Progressive disease|26
988790|NCT01327053|1998481|FG000|Overall Study|Protocol Violation|0
988791|NCT01327053|1998482|FG001|Overall Study|Protocol Violation|1
988792|NCT01327053|1998481|FG000|Overall Study|Untreated|0
988793|NCT01327053|1998482|FG001|Overall Study|Untreated|1
988794|NCT01327300|1998511|FG000|Washout (3 Weeks)|Withdrawal by Subject|1
988795|NCT01327300|1998512|FG001|Washout (3 Weeks)|Withdrawal by Subject|0
988796|NCT01327339|1998545|FG000|Overall Study|Protocol Violation|8
988797|NCT01327482|1998549|FG000|Overall Study|Adverse Event|1
988798|NCT01327495|1998559|FG000|Overall Study|Adverse Event|2
988799|NCT01327495|1998560|FG001|Overall Study|Adverse Event|1
988800|NCT01327495|1998561|FG002|Overall Study|Adverse Event|1
988801|NCT01327495|1998562|FG003|Overall Study|Adverse Event|0
988802|NCT01327495|1998563|FG004|Overall Study|Adverse Event|0
988803|NCT01327495|1998564|FG005|Overall Study|Adverse Event|2
988804|NCT01327495|1998559|FG000|Overall Study|Withdrawal by Subject|0
988805|NCT01327495|1998560|FG001|Overall Study|Withdrawal by Subject|1
988806|NCT01327495|1998561|FG002|Overall Study|Withdrawal by Subject|1
988807|NCT01327495|1998562|FG003|Overall Study|Withdrawal by Subject|0
988808|NCT01327495|1998563|FG004|Overall Study|Withdrawal by Subject|1
988809|NCT01327495|1998564|FG005|Overall Study|Withdrawal by Subject|0
988810|NCT01327495|1998559|FG000|Overall Study|Physician Decision|0
988811|NCT01327495|1998560|FG001|Overall Study|Physician Decision|0
988812|NCT01327495|1998561|FG002|Overall Study|Physician Decision|0
988813|NCT01327495|1998562|FG003|Overall Study|Physician Decision|0
988814|NCT01327495|1998563|FG004|Overall Study|Physician Decision|2
988815|NCT01327495|1998564|FG005|Overall Study|Physician Decision|0
988816|NCT01327547|1998595|FG000|Overall Study|Adverse Event|4
988817|NCT01327547|1998596|FG001|Overall Study|Adverse Event|1
988818|NCT01327547|1998595|FG000|Overall Study|Death|1
988819|NCT01327547|1998596|FG001|Overall Study|Death|2
988820|NCT01327547|1998595|FG000|Overall Study|Lost to Follow-up|6
988821|NCT01327547|1998596|FG001|Overall Study|Lost to Follow-up|6
988822|NCT01327547|1998595|FG000|Overall Study|Non-Compliance With Study Treatment|0
988823|NCT01327547|1998596|FG001|Overall Study|Non-Compliance With Study Treatment|2
988824|NCT01327547|1998595|FG000|Overall Study|Withdrawal by Subject|3
988825|NCT01327547|1998596|FG001|Overall Study|Withdrawal by Subject|7
988826|NCT01327547|1998595|FG000|Overall Study|Does Not Meet Entrance Criteria|2
988827|NCT01327547|1998596|FG001|Overall Study|Does Not Meet Entrance Criteria|2
988828|NCT01327547|1998595|FG000|Overall Study|Protocol Violation|1
988829|NCT01327547|1998596|FG001|Overall Study|Protocol Violation|0
988830|NCT01327547|1998595|FG000|Overall Study|Non-compliance due to alcohol intake|0
988831|NCT01327547|1998596|FG001|Overall Study|Non-compliance due to alcohol intake|1
988832|NCT01327547|1998595|FG000|Overall Study|Required prohibited medication|2
988833|NCT01327547|1998596|FG001|Overall Study|Required prohibited medication|0
988834|NCT01327547|1998595|FG000|Overall Study|Non-compliance with study procedures|1
988835|NCT01327547|1998596|FG001|Overall Study|Non-compliance with study procedures|0
988836|NCT01327547|1998595|FG000|Overall Study|By investigator in subject's interest|0
988837|NCT01327547|1998596|FG001|Overall Study|By investigator in subject's interest|1
988838|NCT01327573|1998613|FG000|Overall Study|Physician Decision|3
988839|NCT01327573|1998614|FG001|Overall Study|Physician Decision|1
988840|NCT01327599|1998621|FG000|Overall Study|Adverse Event|1
988841|NCT01327599|1998621|FG000|Overall Study|Could Not Attend Visit|1
988842|NCT01327599|1998621|FG000|Overall Study|Withdrawal of Consent|1
988843|NCT01327612|1998632|FG000|Overall Study|Withdrawal by Subject|0
988844|NCT01327612|1998633|FG001|Overall Study|Withdrawal by Subject|0
988845|NCT01327612|1998634|FG002|Overall Study|Withdrawal by Subject|0
988846|NCT01327612|1998635|FG003|Overall Study|Withdrawal by Subject|0
988847|NCT01327612|1998636|FG004|Overall Study|Withdrawal by Subject|0
988848|NCT01327612|1998637|FG005|Overall Study|Withdrawal by Subject|1
988849|NCT01327612|1998638|FG006|Overall Study|Withdrawal by Subject|0
988850|NCT01327612|1998632|FG000|Overall Study|Disease Progression|1
988851|NCT01327612|1998633|FG001|Overall Study|Disease Progression|1
988852|NCT01327612|1998634|FG002|Overall Study|Disease Progression|1
988853|NCT01327612|1998635|FG003|Overall Study|Disease Progression|0
988854|NCT01327612|1998636|FG004|Overall Study|Disease Progression|1
988855|NCT01327612|1998637|FG005|Overall Study|Disease Progression|2
988856|NCT01327612|1998638|FG006|Overall Study|Disease Progression|2
988857|NCT01327612|1998632|FG000|Overall Study|Administrative Decision|0
988858|NCT01327612|1998633|FG001|Overall Study|Administrative Decision|0
988859|NCT01327612|1998634|FG002|Overall Study|Administrative Decision|0
988860|NCT01327612|1998635|FG003|Overall Study|Administrative Decision|1
988861|NCT01327612|1998636|FG004|Overall Study|Administrative Decision|0
988862|NCT01327612|1998637|FG005|Overall Study|Administrative Decision|0
988863|NCT01327612|1998638|FG006|Overall Study|Administrative Decision|0
988864|NCT01327612|1998632|FG000|Overall Study|Death|0
988865|NCT01327612|1998633|FG001|Overall Study|Death|0
988866|NCT01327612|1998634|FG002|Overall Study|Death|0
988867|NCT01327612|1998635|FG003|Overall Study|Death|0
988868|NCT01327612|1998636|FG004|Overall Study|Death|1
988869|NCT01327612|1998637|FG005|Overall Study|Death|0
988870|NCT01327612|1998638|FG006|Overall Study|Death|0
988871|NCT01327651|1998664|FG000|Self-administered Dosing Period|Lost to Follow-up|3
988872|NCT01327651|1998665|FG001|Self-administered Dosing Period|Lost to Follow-up|2
988873|NCT01327651|1998666|FG002|Self-administered Dosing Period|Lost to Follow-up|4
988874|NCT01327651|1998667|FG003|Self-administered Dosing Period|Lost to Follow-up|2
988875|NCT01327651|1998668|FG004|Self-administered Dosing Period|Lost to Follow-up|3
988876|NCT01327651|1998669|FG005|Self-administered Dosing Period|Lost to Follow-up|0
988877|NCT01327651|1998670|FG006|Self-administered Dosing Period|Lost to Follow-up|8
988878|NCT01327651|1998671|FG007|Self-administered Dosing Period|Lost to Follow-up|9
988879|NCT01327651|1998672|FG008|Self-administered Dosing Period|Lost to Follow-up|10
988880|NCT01327651|1998664|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1
988881|NCT01327651|1998665|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0
988882|NCT01327651|1998666|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0
988883|NCT01327651|1998667|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0
988884|NCT01327651|1998668|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0
988885|NCT01327651|1998669|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0
988886|NCT01327651|1998670|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0
988887|NCT01327651|1998671|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0
988888|NCT01327651|1998672|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0
988889|NCT01327651|1998664|FG000|Self-administered Dosing Period|Withdrawal by Subject|0
988890|NCT01327651|1998665|FG001|Self-administered Dosing Period|Withdrawal by Subject|1
988891|NCT01327651|1998666|FG002|Self-administered Dosing Period|Withdrawal by Subject|0
988892|NCT01327651|1998667|FG003|Self-administered Dosing Period|Withdrawal by Subject|1
988893|NCT01327651|1998668|FG004|Self-administered Dosing Period|Withdrawal by Subject|0
988894|NCT01327651|1998669|FG005|Self-administered Dosing Period|Withdrawal by Subject|0
988895|NCT01327651|1998670|FG006|Self-administered Dosing Period|Withdrawal by Subject|2
988896|NCT01327651|1998671|FG007|Self-administered Dosing Period|Withdrawal by Subject|1
988897|NCT01327651|1998672|FG008|Self-administered Dosing Period|Withdrawal by Subject|1
988898|NCT01327651|1998664|FG000|Post Study Follow-up|Lost to Follow-up|0
988899|NCT01327651|1998665|FG001|Post Study Follow-up|Lost to Follow-up|1
988900|NCT01327651|1998666|FG002|Post Study Follow-up|Lost to Follow-up|1
988901|NCT01327651|1998667|FG003|Post Study Follow-up|Lost to Follow-up|0
988902|NCT01327651|1998668|FG004|Post Study Follow-up|Lost to Follow-up|0
988903|NCT01327651|1998669|FG005|Post Study Follow-up|Lost to Follow-up|0
988904|NCT01327651|1998670|FG006|Post Study Follow-up|Lost to Follow-up|4
988905|NCT01327651|1998671|FG007|Post Study Follow-up|Lost to Follow-up|1
988906|NCT01327651|1998672|FG008|Post Study Follow-up|Lost to Follow-up|2
988907|NCT01327703|1998722|FG000|Second Treatment Period|Adverse Event|1
988908|NCT01327703|1998723|FG001|Second Treatment Period|Adverse Event|1
988909|NCT01327703|1998722|FG000|Second Treatment Period|Protocol Violation|0
988910|NCT01327703|1998723|FG001|Second Treatment Period|Protocol Violation|1
988911|NCT01327846|1998736|FG000|Core Phase|Subject decision (vital status: missing)|1
988912|NCT01327846|1998737|FG001|Core Phase|Subject decision (vital status: missing)|2
988913|NCT01327846|1998738|FG002|Core Phase|Subject decision (vital status: missing)|2
988914|NCT01327846|1998739|FG003|Core Phase|Subject decision (vital status: missing)|1
988915|NCT01327846|1998736|FG000|Core Phase|Subject decision (vital stat: unkn)|0
988916|NCT01327846|1998737|FG001|Core Phase|Subject decision (vital stat: unkn)|0
988917|NCT01327846|1998738|FG002|Core Phase|Subject decision (vital stat: unkn)|3
988918|NCT01327846|1998739|FG003|Core Phase|Subject decision (vital stat: unkn)|3
988919|NCT01327846|1998736|FG000|Core Phase|Subject decision (vital stat: dead)|1
988920|NCT01327846|1998737|FG001|Core Phase|Subject decision (vital stat: dead)|3
988921|NCT01327846|1998738|FG002|Core Phase|Subject decision (vital stat: dead)|4
988922|NCT01327846|1998739|FG003|Core Phase|Subject decision (vital stat: dead)|4
988923|NCT01327846|1998736|FG000|Core Phase|Subject decision (vital stat: alive)|23
988924|NCT01327846|1998737|FG001|Core Phase|Subject decision (vital stat: alive)|24
988925|NCT01327846|1998738|FG002|Core Phase|Subject decision (vital stat: alive)|13
988926|NCT01327846|1998739|FG003|Core Phase|Subject decision (vital stat: alive)|20
988927|NCT01327846|1998736|FG000|Core Phase|Lost to Follow-up|3
988928|NCT01327846|1998737|FG001|Core Phase|Lost to Follow-up|3
988929|NCT01327846|1998738|FG002|Core Phase|Lost to Follow-up|4
988930|NCT01327846|1998739|FG003|Core Phase|Lost to Follow-up|5
988931|NCT01327846|1998736|FG000|Extension Phase|Study terminated by sponsor|1073
988932|NCT01327846|1998737|FG001|Extension Phase|Study terminated by sponsor|1124
988933|NCT01327846|1998738|FG002|Extension Phase|Study terminated by sponsor|1067
988934|NCT01327846|1998739|FG003|Extension Phase|Study terminated by sponsor|1660
988935|NCT01327846|1998736|FG000|Extension Phase|Withdrawal by Subject|20
988936|NCT01327846|1998737|FG001|Extension Phase|Withdrawal by Subject|13
988937|NCT01327846|1998738|FG002|Extension Phase|Withdrawal by Subject|19
988938|NCT01327846|1998739|FG003|Extension Phase|Withdrawal by Subject|37
988939|NCT01327846|1998736|FG000|Extension Phase|Lost to Follow-up|4
988940|NCT01327846|1998737|FG001|Extension Phase|Lost to Follow-up|3
988941|NCT01327846|1998738|FG002|Extension Phase|Lost to Follow-up|4
988942|NCT01327846|1998739|FG003|Extension Phase|Lost to Follow-up|7
988943|NCT01327846|1998736|FG000|Extension Phase|Technical Problems|2
988944|NCT01327846|1998737|FG001|Extension Phase|Technical Problems|4
988945|NCT01327846|1998738|FG002|Extension Phase|Technical Problems|2
988946|NCT01327846|1998739|FG003|Extension Phase|Technical Problems|2
988947|NCT01327885|1998752|FG000|Overall Study|Disease progression-according to RECIST|173
988948|NCT01327885|1998753|FG001|Overall Study|Disease progression-according to RECIST|165
988949|NCT01327885|1998752|FG000|Overall Study|Clinical progression|24
988950|NCT01327885|1998753|FG001|Overall Study|Clinical progression|27
988951|NCT01327885|1998752|FG000|Overall Study|Adverse Event|14
988952|NCT01327885|1998753|FG001|Overall Study|Adverse Event|10
988953|NCT01327885|1998752|FG000|Overall Study|Subject choice|5
988954|NCT01327885|1998753|FG001|Overall Study|Subject choice|10
988955|NCT01327885|1998752|FG000|Overall Study|Other|8
988956|NCT01327885|1998753|FG001|Overall Study|Other|6
988957|NCT01327885|1998752|FG000|Overall Study|Withdrawal of consent from study|3
988958|NCT01327885|1998753|FG001|Overall Study|Withdrawal of consent from study|4
988959|NCT01327885|1998752|FG000|Overall Study|Not treated|1
988960|NCT01327885|1998753|FG001|Overall Study|Not treated|1
988961|NCT01327885|1998752|FG000|Overall Study|Administrative decision|0
988962|NCT01327885|1998753|FG001|Overall Study|Administrative decision|1
988963|NCT01328002|1998781|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66
988964|NCT01328002|1998782|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0
988965|NCT01328002|1998781|FG000|Open-Label Period|Adverse Event|8
988966|NCT01328002|1998782|FG001|Open-Label Period|Adverse Event|0
988967|NCT01328002|1998781|FG000|Open-Label Period|Lack of Efficacy|3
988968|NCT01328002|1998782|FG001|Open-Label Period|Lack of Efficacy|0
988969|NCT01328002|1998781|FG000|Open-Label Period|Protocol Violation|2
988970|NCT01328002|1998782|FG001|Open-Label Period|Protocol Violation|0
988971|NCT01328002|1998781|FG000|Open-Label Period|Withdrawal by Subject|9
988972|NCT01328002|1998782|FG001|Open-Label Period|Withdrawal by Subject|0
988973|NCT01328002|1998781|FG000|Open-Label Period|Lost to Follow-up|6
988974|NCT01328002|1998782|FG001|Open-Label Period|Lost to Follow-up|0
988975|NCT01328002|1998781|FG000|Open-Label Period|Other Reason|2
988976|NCT01328002|1998782|FG001|Open-Label Period|Other Reason|0
988977|NCT01328002|1998781|FG000|Double-Blind Period|Adverse Event|1
988978|NCT01328002|1998782|FG001|Double-Blind Period|Adverse Event|0
988979|NCT01328002|1998781|FG000|Double-Blind Period|Lack of Efficacy|1
988980|NCT01328002|1998782|FG001|Double-Blind Period|Lack of Efficacy|0
988981|NCT01328041|1998789|FG000|Overall Study|Adverse Event|7
988982|NCT01328041|1998789|FG000|Overall Study|Lack of Efficacy|27
988983|NCT01328041|1998789|FG000|Overall Study|Protocol Violation|7
988984|NCT01328041|1998789|FG000|Overall Study|Lost to Follow-up|7
988985|NCT01328041|1998789|FG000|Overall Study|Physician Decision|2
988986|NCT01328041|1998789|FG000|Overall Study|Withdrawal by Subject|7
988987|NCT01328054|1998793|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
988988|NCT01328054|1998794|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
988989|NCT01328054|1998793|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
988990|NCT01328054|1998794|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
988991|NCT01328054|1998793|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
988992|NCT01328054|1998794|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
988993|NCT01328080|1998806|FG000|Overall Study|Lost to Follow-up|5
988994|NCT01328249|1998825|FG000|Overall Study|Adverse Event|3
988995|NCT01328249|1998826|FG001|Overall Study|Adverse Event|0
988996|NCT01328249|1998825|FG000|Overall Study|Disease progression|1
988997|NCT01328249|1998826|FG001|Overall Study|Disease progression|0
988998|NCT01328249|1998825|FG000|Overall Study|Withdrawal by Subject|1
988999|NCT01328249|1998826|FG001|Overall Study|Withdrawal by Subject|1
989000|NCT01328249|1998825|FG000|Overall Study|Moved before end of treatment visit|1
989001|NCT01328249|1998826|FG001|Overall Study|Moved before end of treatment visit|0
989002|NCT01328249|1998825|FG000|Overall Study|Subject choice|1
989003|NCT01328249|1998826|FG001|Overall Study|Subject choice|1
989004|NCT01328249|1998825|FG000|Overall Study|Protocol Violation|0
989005|NCT01328249|1998826|FG001|Overall Study|Protocol Violation|1
989006|NCT01328366|1998834|FG000|Overall Study|Death|1
989007|NCT01328366|1998834|FG000|Overall Study|Withdrawal by Subject|2
989008|NCT01328366|1998834|FG000|Overall Study|Lost to Follow-up|7
989009|NCT01328431|1998862|FG000|Baseline|Protocol Violation|0
989010|NCT01328431|1998863|FG001|Baseline|Protocol Violation|2
989011|NCT01328431|1998862|FG000|1 Month (1M)|Lost to Follow-up|55
989012|NCT01328431|1998863|FG001|1 Month (1M)|Lost to Follow-up|58
989013|NCT01328431|1998862|FG000|3 Month (3M)|Death|2
989014|NCT01328431|1998863|FG001|3 Month (3M)|Death|2
989015|NCT01328431|1998862|FG000|3 Month (3M)|Lost to Follow-up|75
989016|NCT01328431|1998863|FG001|3 Month (3M)|Lost to Follow-up|70
989017|NCT01328431|1998862|FG000|12 Month (12M)|Death|2
989018|NCT01328431|1998863|FG001|12 Month (12M)|Death|6
989019|NCT01328431|1998862|FG000|12 Month (12M)|Lost to Follow-up|82
989020|NCT01328431|1998863|FG001|12 Month (12M)|Lost to Follow-up|91
989021|NCT01328444|1998869|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3
989022|NCT01328444|1998870|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
989023|NCT01328444|1998871|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
989024|NCT01328444|1998872|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
989025|NCT01328444|1998873|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5
989026|NCT01328444|1998874|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2
989027|NCT01328444|1998869|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
989028|NCT01328444|1998870|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
989029|NCT01328444|1998871|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
989030|NCT01328444|1998872|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
989031|NCT01328444|1998873|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
989032|NCT01328444|1998874|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
989033|NCT01328444|1998869|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0
989034|NCT01328444|1998870|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
989035|NCT01328444|1998871|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0
989036|NCT01328444|1998872|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
989037|NCT01328444|1998873|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0
989038|NCT01328444|1998874|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1
989039|NCT01328444|1998869|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
989040|NCT01328444|1998870|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
989041|NCT01328444|1998871|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
989042|NCT01328444|1998872|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
989043|NCT01328444|1998873|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
989044|NCT01328444|1998874|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
989045|NCT01328444|1998869|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
989046|NCT01328444|1998870|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
989047|NCT01328444|1998871|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
989048|NCT01328444|1998872|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
989049|NCT01328444|1998873|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
989050|NCT01328444|1998874|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
989051|NCT01328444|1998869|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
989052|NCT01328444|1998870|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
989053|NCT01328444|1998871|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
989054|NCT01328444|1998872|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
989055|NCT01328444|1998873|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
989056|NCT01328444|1998874|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
989057|NCT01328444|1998869|FG000|Washout Period (14 Days)|Adverse Event|1
989058|NCT01328444|1998870|FG001|Washout Period (14 Days)|Adverse Event|1
989059|NCT01328444|1998871|FG002|Washout Period (14 Days)|Adverse Event|0
989060|NCT01328444|1998872|FG003|Washout Period (14 Days)|Adverse Event|1
989061|NCT01328444|1998873|FG004|Washout Period (14 Days)|Adverse Event|1
989062|NCT01328444|1998874|FG005|Washout Period (14 Days)|Adverse Event|2
989063|NCT01328444|1998869|FG000|Washout Period (14 Days)|Lack of Efficacy|0
989064|NCT01328444|1998870|FG001|Washout Period (14 Days)|Lack of Efficacy|0
989065|NCT01328444|1998871|FG002|Washout Period (14 Days)|Lack of Efficacy|0
989066|NCT01328444|1998872|FG003|Washout Period (14 Days)|Lack of Efficacy|0
989067|NCT01328444|1998873|FG004|Washout Period (14 Days)|Lack of Efficacy|0
989068|NCT01328444|1998874|FG005|Washout Period (14 Days)|Lack of Efficacy|1
989069|NCT01328444|1998869|FG000|Washout Period (14 Days)|Withdrawal by Subject|0
989070|NCT01328444|1998870|FG001|Washout Period (14 Days)|Withdrawal by Subject|0
989071|NCT01328444|1998871|FG002|Washout Period (14 Days)|Withdrawal by Subject|0
989072|NCT01328444|1998872|FG003|Washout Period (14 Days)|Withdrawal by Subject|0
989073|NCT01328444|1998873|FG004|Washout Period (14 Days)|Withdrawal by Subject|0
989074|NCT01328444|1998874|FG005|Washout Period (14 Days)|Withdrawal by Subject|1
989075|NCT01328444|1998869|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5
989076|NCT01328444|1998870|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
989077|NCT01328444|1998871|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1
989078|NCT01328444|1998872|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
989079|NCT01328444|1998873|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
989080|NCT01328444|1998874|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0
989081|NCT01328444|1998869|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
989082|NCT01328444|1998870|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
989083|NCT01328444|1998871|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
989084|NCT01328444|1998872|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
989085|NCT01328444|1998873|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
989086|NCT01328444|1998874|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
989087|NCT01328444|1998869|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1
989088|NCT01328444|1998870|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0
989089|NCT01328444|1998871|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0
989090|NCT01328444|1998872|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0
989091|NCT01328444|1998873|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1
989092|NCT01328444|1998874|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0
989093|NCT01328444|1998869|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
989094|NCT01328444|1998870|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
989095|NCT01328444|1998871|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
989096|NCT01328444|1998872|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
989097|NCT01328444|1998873|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
989098|NCT01328444|1998874|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
989099|NCT01328444|1998869|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
989100|NCT01328444|1998870|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
989101|NCT01328444|1998871|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
989102|NCT01328444|1998872|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
989103|NCT01328444|1998873|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
989104|NCT01328444|1998874|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
989105|NCT01328444|1998869|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
989106|NCT01328444|1998870|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
989107|NCT01328444|1998871|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
989108|NCT01328444|1998872|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
989109|NCT01328444|1998873|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
989110|NCT01328444|1998874|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
989111|NCT01328496|1998890|FG000|Overall Study|Significant Change in Health Status|1
989112|NCT01328496|1998891|FG001|Overall Study|Significant Change in Health Status|0
989113|NCT01328535|1998900|FG000|Overall Study|Ineligible|1
989114|NCT01328548|1998908|FG000|Overall Study|Death|3
989115|NCT01328548|1998909|FG001|Overall Study|Death|0
989116|NCT01328548|1998908|FG000|Overall Study|Protocol Violation|1
989117|NCT01328548|1998909|FG001|Overall Study|Protocol Violation|0
989118|NCT01328574|1998915|FG000|Overall Study|Refused further treatment|1
989119|NCT01328717|1998928|FG000|Overall Study|Adverse Event|1
989120|NCT01328756|1998941|FG000|Overall Study|Protocol Violation|4
989121|NCT01328756|1998941|FG000|Overall Study|Adverse Event|39
989122|NCT01328756|1998941|FG000|Overall Study|Lack of Efficacy|5
989123|NCT01328756|1998941|FG000|Overall Study|Withdrawal by Subject|41
989124|NCT01328756|1998941|FG000|Overall Study|Lost to Follow-up|5
989125|NCT01328756|1998941|FG000|Overall Study|Other|29
989126|NCT01328951|1998975|FG000|Overall Study|Disease Progression|17
989127|NCT01328951|1998976|FG001|Overall Study|Disease Progression|14
989128|NCT01328951|1998975|FG000|Overall Study|Adverse Event|2
989129|NCT01328951|1998976|FG001|Overall Study|Adverse Event|0
989130|NCT01328951|1998975|FG000|Overall Study|Death|243
989131|NCT01328951|1998976|FG001|Overall Study|Death|258
989132|NCT01328951|1998975|FG000|Overall Study|Lost to Follow-up|6
989133|NCT01328951|1998976|FG001|Overall Study|Lost to Follow-up|7
989134|NCT01328951|1998975|FG000|Overall Study|Withdrawal by Subject|6
989135|NCT01328951|1998976|FG001|Overall Study|Withdrawal by Subject|6
989136|NCT01328951|1998975|FG000|Overall Study|Study Closed by the Sponsor|36
989137|NCT01328951|1998976|FG001|Overall Study|Study Closed by the Sponsor|31
989138|NCT01328951|1998975|FG000|Overall Study|Other|11
989139|NCT01328951|1998976|FG001|Overall Study|Other|6
989140|NCT01329029|1999001|FG000|Overall Study|Withdrawal by Subject|117
989141|NCT01329029|1999002|FG001|Overall Study|Withdrawal by Subject|87
989142|NCT01329029|1999001|FG000|Overall Study|Adverse Event|82
989143|NCT01329029|1999002|FG001|Overall Study|Adverse Event|29
989144|NCT01329029|1999001|FG000|Overall Study|Death|16
989145|NCT01329029|1999002|FG001|Overall Study|Death|19
989146|NCT01329029|1999001|FG000|Overall Study|Other|14
989147|NCT01329029|1999002|FG001|Overall Study|Other|20
989148|NCT01329029|1999001|FG000|Overall Study|COPD Exacerbation|11
989149|NCT01329029|1999002|FG001|Overall Study|COPD Exacerbation|18
989150|NCT01329029|1999001|FG000|Overall Study|Physician Decision|16
989151|NCT01329029|1999002|FG001|Overall Study|Physician Decision|13
989152|NCT01329029|1999001|FG000|Overall Study|Lost to Follow-up|8
989153|NCT01329029|1999002|FG001|Overall Study|Lost to Follow-up|5
989154|NCT01329029|1999001|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5
989155|NCT01329029|1999002|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1
989156|NCT01329263|1999033|FG000|Overall Study|Lost to Follow-up|4
989157|NCT01329263|1999034|FG001|Overall Study|Lost to Follow-up|21
989158|NCT01329263|1999033|FG000|Overall Study|Withdrawal by Subject|1
989159|NCT01329263|1999034|FG001|Overall Study|Withdrawal by Subject|2
989160|NCT01329328|1999045|FG000|Overall Study|Withdrawal by Subject|2
989161|NCT01329328|1999046|FG001|Overall Study|Withdrawal by Subject|4
989162|NCT01329328|1999047|FG002|Overall Study|Withdrawal by Subject|3
989163|NCT01329419|1999059|FG000|Overall Study|Protocol Violation|235
989164|NCT01329562|1999066|FG000|Overall Study|Protocol Violation|5
989165|NCT01329562|1999067|FG001|Overall Study|Protocol Violation|3
989166|NCT01329562|1999066|FG000|Overall Study|Lost to Follow-up|1
989167|NCT01329562|1999067|FG001|Overall Study|Lost to Follow-up|1
989168|NCT01329562|1999066|FG000|Overall Study|Subject withdrew due to personal issues.|3
989169|NCT01329562|1999067|FG001|Overall Study|Subject withdrew due to personal issues.|2
989170|NCT01329562|1999066|FG000|Overall Study|Physician Decision|0
989171|NCT01329562|1999067|FG001|Overall Study|Physician Decision|1
989172|NCT01329900|1999088|FG000|Overall Study|Elevated creatinine/renal function|1
989173|NCT01329939|1999096|FG000|Overall Study|Lost to Follow-up|3
989174|NCT01329939|1999097|FG001|Overall Study|Lost to Follow-up|0
989175|NCT01329939|1999098|FG002|Overall Study|Lost to Follow-up|1
989176|NCT01329939|1999099|FG003|Overall Study|Lost to Follow-up|2
989177|NCT01329939|1999096|FG000|Overall Study|Withdrawal by Subject|0
989178|NCT01329939|1999097|FG001|Overall Study|Withdrawal by Subject|1
989179|NCT01329939|1999098|FG002|Overall Study|Withdrawal by Subject|0
989180|NCT01329939|1999099|FG003|Overall Study|Withdrawal by Subject|0
989181|NCT01329939|1999096|FG000|Overall Study|Adverse Event|0
989182|NCT01329939|1999097|FG001|Overall Study|Adverse Event|0
989183|NCT01329939|1999098|FG002|Overall Study|Adverse Event|0
989184|NCT01329939|1999099|FG003|Overall Study|Adverse Event|3
989185|NCT01329978|1999112|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
989186|NCT01329978|1999113|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
989187|NCT01329978|1999114|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
989188|NCT01329978|1999115|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
989189|NCT01329978|1999116|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
989190|NCT01329978|1999112|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
989191|NCT01329978|1999113|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
989192|NCT01329978|1999114|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
989193|NCT01329978|1999115|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
989194|NCT01329978|1999116|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
989195|NCT01329978|1999112|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
989196|NCT01329978|1999113|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
989197|NCT01329978|1999114|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
989198|NCT01329978|1999115|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
989199|NCT01329978|1999116|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
989200|NCT01329978|1999112|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
989201|NCT01329978|1999113|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
989202|NCT01329978|1999114|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
989203|NCT01329978|1999115|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
989204|NCT01329978|1999116|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
989205|NCT01329978|1999112|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
989206|NCT01329978|1999113|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
989207|NCT01329978|1999114|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
989208|NCT01329978|1999115|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
989209|NCT01329978|1999116|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
989210|NCT01329978|1999112|FG000|Rerandomization Treatment Period|Lost to Follow-up|0
989211|NCT01329978|1999113|FG001|Rerandomization Treatment Period|Lost to Follow-up|0
989212|NCT01329978|1999114|FG002|Rerandomization Treatment Period|Lost to Follow-up|0
989213|NCT01329978|1999115|FG003|Rerandomization Treatment Period|Lost to Follow-up|5
989214|NCT01329978|1999116|FG004|Rerandomization Treatment Period|Lost to Follow-up|3
989215|NCT01329978|1999112|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0
989216|NCT01329978|1999113|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0
989217|NCT01329978|1999114|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0
989218|NCT01329978|1999115|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0
989219|NCT01329978|1999116|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1
989220|NCT01330017|1999133|FG000|Overall Study|Adverse Event|0
989221|NCT01330017|1999134|FG001|Overall Study|Adverse Event|1
989222|NCT01330017|1999135|FG002|Overall Study|Adverse Event|1
989223|NCT01330017|1999136|FG003|Overall Study|Adverse Event|4
989224|NCT01330017|1999137|FG004|Overall Study|Adverse Event|0
989225|NCT01330017|1999133|FG000|Overall Study|Withdrawal by Subject|0
989226|NCT01330017|1999134|FG001|Overall Study|Withdrawal by Subject|0
989227|NCT01330017|1999135|FG002|Overall Study|Withdrawal by Subject|1
989228|NCT01330017|1999136|FG003|Overall Study|Withdrawal by Subject|0
989229|NCT01330017|1999137|FG004|Overall Study|Withdrawal by Subject|1
989230|NCT01330017|1999133|FG000|Overall Study|Lost to Follow-up|0
989231|NCT01330017|1999134|FG001|Overall Study|Lost to Follow-up|0
989232|NCT01330017|1999135|FG002|Overall Study|Lost to Follow-up|1
989233|NCT01330017|1999136|FG003|Overall Study|Lost to Follow-up|0
989234|NCT01330017|1999137|FG004|Overall Study|Lost to Follow-up|0
989235|NCT01330017|1999133|FG000|Overall Study|Protocol Violation|0
989236|NCT01330017|1999134|FG001|Overall Study|Protocol Violation|0
989237|NCT01330017|1999135|FG002|Overall Study|Protocol Violation|0
989238|NCT01330017|1999136|FG003|Overall Study|Protocol Violation|1
989239|NCT01330017|1999137|FG004|Overall Study|Protocol Violation|0
989240|NCT01330017|1999133|FG000|Overall Study|Unknown Reason|5
989241|NCT01330017|1999134|FG001|Overall Study|Unknown Reason|3
989242|NCT01330017|1999135|FG002|Overall Study|Unknown Reason|5
989243|NCT01330017|1999136|FG003|Overall Study|Unknown Reason|7
989244|NCT01330017|1999137|FG004|Overall Study|Unknown Reason|2
989245|NCT01330030|1999151|FG000|Overall Study|Lost to Follow-up|16
989246|NCT01330030|1999152|FG001|Overall Study|Lost to Follow-up|17
989247|NCT01330108|1999167|FG000|Overall Study|Withdrawal by Subject|4
912818|NCT00807248|1890410|FG001|Overall Study|Adverse Event|2
912819|NCT00807248|1890411|FG002|Overall Study|Adverse Event|2
912820|NCT00807248|1890412|FG003|Overall Study|Adverse Event|6
912821|NCT00807248|1890409|FG000|Overall Study|Lack of Efficacy|14
912822|NCT00807248|1890410|FG001|Overall Study|Lack of Efficacy|4
989248|NCT01330303|1999184|FG000|Period 1|Adverse Event|1
989249|NCT01330303|1999185|FG001|Period 1|Adverse Event|0
989250|NCT01330303|1999184|FG000|Period 1|Protocol Violation|0
989251|NCT01330303|1999185|FG001|Period 1|Protocol Violation|1
989252|NCT01330303|1999184|FG000|Period 1|Withdrawal by Subject|0
989253|NCT01330303|1999185|FG001|Period 1|Withdrawal by Subject|1
989254|NCT01330316|1999194|FG000|Overall Study|Adverse Event|2
989255|NCT01330316|1999195|FG001|Overall Study|Adverse Event|2
989256|NCT01330316|1999194|FG000|Overall Study|Lack of Efficacy|0
989257|NCT01330316|1999195|FG001|Overall Study|Lack of Efficacy|10
989258|NCT01330316|1999194|FG000|Overall Study|Lost to Follow-up|0
989259|NCT01330316|1999195|FG001|Overall Study|Lost to Follow-up|1
989260|NCT01330316|1999194|FG000|Overall Study|Withdrawal by Subject|0
989261|NCT01330316|1999195|FG001|Overall Study|Withdrawal by Subject|1
989262|NCT01330316|1999194|FG000|Overall Study|other than above|0
989263|NCT01330316|1999195|FG001|Overall Study|other than above|1
989264|NCT01330381|1999212|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
989265|NCT01330381|1999213|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
989266|NCT01330381|1999214|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
989267|NCT01330381|1999212|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
989268|NCT01330381|1999213|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
989269|NCT01330381|1999214|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
989270|NCT01330381|1999212|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
989271|NCT01330381|1999213|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
989272|NCT01330381|1999214|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
989273|NCT01330381|1999212|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
989274|NCT01330381|1999213|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
989275|NCT01330381|1999214|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
989276|NCT01330381|1999212|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
912823|NCT00807248|1890411|FG002|Overall Study|Lack of Efficacy|8
912824|NCT00807248|1890412|FG003|Overall Study|Lack of Efficacy|3
912825|NCT00807248|1890409|FG000|Overall Study|Protocol Violation|0
912826|NCT00807248|1890410|FG001|Overall Study|Protocol Violation|1
912827|NCT00807248|1890411|FG002|Overall Study|Protocol Violation|1
912828|NCT00807248|1890412|FG003|Overall Study|Protocol Violation|0
912829|NCT00807248|1890409|FG000|Overall Study|Withdrawal of Consent|5
912830|NCT00807248|1890410|FG001|Overall Study|Withdrawal of Consent|5
912831|NCT00807248|1890411|FG002|Overall Study|Withdrawal of Consent|5
912832|NCT00807248|1890412|FG003|Overall Study|Withdrawal of Consent|5
912833|NCT00807248|1890409|FG000|Overall Study|Lost to Follow-up|1
912834|NCT00807248|1890410|FG001|Overall Study|Lost to Follow-up|0
912835|NCT00807248|1890411|FG002|Overall Study|Lost to Follow-up|0
912836|NCT00807248|1890412|FG003|Overall Study|Lost to Follow-up|0
912837|NCT00807248|1890409|FG000|Overall Study|Other Reason|0
912838|NCT00807248|1890410|FG001|Overall Study|Other Reason|0
912839|NCT00807248|1890411|FG002|Overall Study|Other Reason|2
912840|NCT00807248|1890412|FG003|Overall Study|Other Reason|0
912841|NCT00807495|1890431|FG000|Overall Study|Adverse Event|6
912842|NCT00807495|1890432|FG001|Overall Study|Adverse Event|3
912843|NCT00807495|1890433|FG002|Overall Study|Adverse Event|1
912844|NCT00807495|1890434|FG003|Overall Study|Adverse Event|1
989277|NCT01330381|1999213|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
989278|NCT01330381|1999214|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
989279|NCT01330381|1999212|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
989280|NCT01330381|1999213|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
989281|NCT01330381|1999214|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
989282|NCT01330381|1999212|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
989283|NCT01330381|1999213|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
989284|NCT01330381|1999214|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
989285|NCT01330381|1999212|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2
989286|NCT01330381|1999213|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0
989287|NCT01330381|1999214|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0
989288|NCT01330381|1999212|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
989289|NCT01330381|1999213|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
989290|NCT01330381|1999214|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
989291|NCT01330381|1999212|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0
989292|NCT01330381|1999213|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0
989293|NCT01330381|1999214|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1
989294|NCT01330433|1999238|FG000|Overall Study|Death|1
989295|NCT01330433|1999239|FG001|Overall Study|Death|3
989296|NCT01330433|1999238|FG000|Overall Study|Lost to Follow-up|1
989297|NCT01330433|1999239|FG001|Overall Study|Lost to Follow-up|0
989298|NCT01330459|1999247|FG000|Overall Study|Physician Decision|0
989299|NCT01330459|1999248|FG001|Overall Study|Physician Decision|2
989300|NCT01330628|1999258|FG000|Overall Study|Death|2
989301|NCT01330628|1999259|FG001|Overall Study|Death|3
989302|NCT01330628|1999258|FG000|Overall Study|Lost to Follow-up|5
989303|NCT01330628|1999259|FG001|Overall Study|Lost to Follow-up|6
989304|NCT01330628|1999258|FG000|Overall Study|Adverse Event|44
989305|NCT01330628|1999259|FG001|Overall Study|Adverse Event|25
989306|NCT01330628|1999258|FG000|Overall Study|Withdrawn|18
989307|NCT01330628|1999259|FG001|Overall Study|Withdrawn|6
989308|NCT01330628|1999258|FG000|Overall Study|Didn't receive study treatment|1
989309|NCT01330628|1999259|FG001|Overall Study|Didn't receive study treatment|0
989310|NCT01330914|1999265|FG000|Overall Study|Withdrawal by Subject|4
989311|NCT01330914|1999265|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3
989312|NCT01331005|1999301|FG000|Overall Study|Lost to Follow-up|2
989313|NCT01331005|1999302|FG001|Overall Study|Lost to Follow-up|1
989314|NCT01331005|1999301|FG000|Overall Study|Withdrawal by Subject|2
989315|NCT01331005|1999302|FG001|Overall Study|Withdrawal by Subject|3
989316|NCT01331109|1999317|FG000|Overall Study|Adverse Event|6
989317|NCT01331109|1999317|FG000|Overall Study|Lack of Efficacy|2
989318|NCT01331109|1999317|FG000|Overall Study|Protocol Violation|3
989319|NCT01331109|1999317|FG000|Overall Study|Withdrawal by Subject|7
989320|NCT01331109|1999317|FG000|Overall Study|Lost to Follow-up|1
989321|NCT01331109|1999317|FG000|Overall Study|Study Terminated by Sponsor|38
989322|NCT01331161|1999323|FG000|Overall Study|Physician Decision|1
989323|NCT01331161|1999324|FG001|Overall Study|Physician Decision|0
989324|NCT01331161|1999323|FG000|Overall Study|Lost to Follow-up|0
989325|NCT01331161|1999324|FG001|Overall Study|Lost to Follow-up|1
989326|NCT01331161|1999323|FG000|Overall Study|Pregnancy|0
989327|NCT01331161|1999324|FG001|Overall Study|Pregnancy|1
989328|NCT01331239|1999343|FG000|Part II: Core Study|Adverse Event|0
989329|NCT01331239|1999344|FG001|Part II: Core Study|Adverse Event|3
989330|NCT01331239|1999345|FG002|Part II: Core Study|Adverse Event|0
989331|NCT01331239|1999343|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0
989332|NCT01331239|1999344|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2
989333|NCT01331239|1999345|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1
989334|NCT01331239|1999343|FG000|Part II: Core Study|Withdrawal by Subject|0
989335|NCT01331239|1999344|FG001|Part II: Core Study|Withdrawal by Subject|2
989336|NCT01331239|1999345|FG002|Part II: Core Study|Withdrawal by Subject|0
989337|NCT01331239|1999343|FG000|Part II: Core Study|Administrative problems|0
989338|NCT01331239|1999344|FG001|Part II: Core Study|Administrative problems|1
989339|NCT01331239|1999345|FG002|Part II: Core Study|Administrative problems|0
989340|NCT01331291|1999363|FG000|Overall Study|Lack of Efficacy|2
989341|NCT01331291|1999364|FG001|Overall Study|Lack of Efficacy|8
989342|NCT01331291|1999363|FG000|Overall Study|Death|0
989343|NCT01331291|1999364|FG001|Overall Study|Death|1
989344|NCT01331681|1999386|FG000|Overall Study|Adverse Event|10
989345|NCT01331681|1999387|FG001|Overall Study|Adverse Event|13
989346|NCT01331681|1999388|FG002|Overall Study|Adverse Event|10
989347|NCT01331681|1999386|FG000|Overall Study|Death|6
989348|NCT01331681|1999387|FG001|Overall Study|Death|6
989349|NCT01331681|1999388|FG002|Overall Study|Death|2
989350|NCT01331681|1999386|FG000|Overall Study|Lack of Efficacy|0
989351|NCT01331681|1999387|FG001|Overall Study|Lack of Efficacy|1
989352|NCT01331681|1999388|FG002|Overall Study|Lack of Efficacy|0
989353|NCT01331681|1999386|FG000|Overall Study|Withdrawal by Subject|12
989354|NCT01331681|1999387|FG001|Overall Study|Withdrawal by Subject|8
989355|NCT01331681|1999388|FG002|Overall Study|Withdrawal by Subject|15
989356|NCT01331681|1999386|FG000|Overall Study|Protocol Violation|1
989357|NCT01331681|1999387|FG001|Overall Study|Protocol Violation|1
989358|NCT01331681|1999388|FG002|Overall Study|Protocol Violation|0
989359|NCT01331681|1999386|FG000|Overall Study|Lost to Follow-up|2
989360|NCT01331681|1999387|FG001|Overall Study|Lost to Follow-up|4
989361|NCT01331681|1999388|FG002|Overall Study|Lost to Follow-up|1
989362|NCT01331681|1999386|FG000|Overall Study|Physician Decision|2
989363|NCT01331681|1999387|FG001|Overall Study|Physician Decision|0
989364|NCT01331681|1999388|FG002|Overall Study|Physician Decision|4
989365|NCT01331681|1999386|FG000|Overall Study|Therapeutic procedure required|1
989366|NCT01331681|1999387|FG001|Overall Study|Therapeutic procedure required|0
989367|NCT01331681|1999388|FG002|Overall Study|Therapeutic procedure required|0
989368|NCT01331681|1999386|FG000|Overall Study|Sponsor decision|1
989369|NCT01331681|1999387|FG001|Overall Study|Sponsor decision|1
989370|NCT01331681|1999388|FG002|Overall Study|Sponsor decision|0
989371|NCT01331681|1999386|FG000|Overall Study|Switching to other therapy|0
989372|NCT01331681|1999387|FG001|Overall Study|Switching to other therapy|0
989373|NCT01331681|1999388|FG002|Overall Study|Switching to other therapy|1
989374|NCT01331681|1999386|FG000|Overall Study|Not Received Study Treatment|0
989375|NCT01331681|1999387|FG001|Overall Study|Not Received Study Treatment|0
989376|NCT01331681|1999388|FG002|Overall Study|Not Received Study Treatment|2
989377|NCT01331824|1999421|FG000|Overall Study|Adverse Event|2
989378|NCT01331824|1999421|FG000|Overall Study|Death|1
989379|NCT01331824|1999421|FG000|Overall Study|Disease Progression|9
989380|NCT01331824|1999421|FG000|Overall Study|Withdrawal by Subject|1
989381|NCT01331837|1999427|FG000|Overall Study|Death|30
989382|NCT01331837|1999428|FG001|Overall Study|Death|34
989383|NCT01331837|1999427|FG000|Overall Study|Lost to Follow-up|3
989384|NCT01331837|1999428|FG001|Overall Study|Lost to Follow-up|1
989385|NCT01331837|1999427|FG000|Overall Study|Info not recorded|10
989386|NCT01331837|1999428|FG001|Overall Study|Info not recorded|16
989387|NCT01331837|1999427|FG000|Overall Study|Withdrawal by Subject|13
989388|NCT01331837|1999428|FG001|Overall Study|Withdrawal by Subject|16
989389|NCT01332019|1999436|FG000|Overall Study|Was Not Dosed|1
989390|NCT01332019|1999437|FG001|Overall Study|Was Not Dosed|0
989391|NCT01332019|1999436|FG000|Overall Study|Other|16
989392|NCT01332019|1999437|FG001|Overall Study|Other|18
989393|NCT01332019|1999436|FG000|Overall Study|Death|2
989394|NCT01332019|1999437|FG001|Overall Study|Death|1
989395|NCT01332019|1999436|FG000|Overall Study|Physician Decision|4
989396|NCT01332019|1999437|FG001|Overall Study|Physician Decision|3
989397|NCT01332019|1999436|FG000|Overall Study|Withdrawal by Subject|73
989398|NCT01332019|1999437|FG001|Overall Study|Withdrawal by Subject|71
989399|NCT01332019|1999436|FG000|Overall Study|Lost to Follow-up|4
989400|NCT01332019|1999437|FG001|Overall Study|Lost to Follow-up|7
989401|NCT01332019|1999436|FG000|Overall Study|Adverse Event|13
989402|NCT01332019|1999437|FG001|Overall Study|Adverse Event|22
989403|NCT01332149|1999459|FG000|Overall Study|Adverse Event|11
989404|NCT01332149|1999460|FG001|Overall Study|Adverse Event|9
989405|NCT01332149|1999459|FG000|Overall Study|Other unspecified|5
989406|NCT01332149|1999460|FG001|Overall Study|Other unspecified|7
989407|NCT01332149|1999459|FG000|Overall Study|Protocol Violation|1
989408|NCT01332149|1999460|FG001|Overall Study|Protocol Violation|3
989409|NCT01332149|1999459|FG000|Overall Study|Withdrawal by Subject|4
989410|NCT01332149|1999460|FG001|Overall Study|Withdrawal by Subject|5
989411|NCT01332149|1999459|FG000|Overall Study|Lost to Follow-up|1
989412|NCT01332149|1999460|FG001|Overall Study|Lost to Follow-up|1
989413|NCT01332149|1999459|FG000|Overall Study|Insufficient clinical response|4
989414|NCT01332149|1999460|FG001|Overall Study|Insufficient clinical response|7
989415|NCT01332149|1999459|FG000|Overall Study|Did not meet entrance criteria|3
989416|NCT01332149|1999460|FG001|Overall Study|Did not meet entrance criteria|4
989417|NCT01332149|1999459|FG000|Overall Study|Randomized but not treated|1
989418|NCT01332149|1999460|FG001|Overall Study|Randomized but not treated|2
989419|NCT01332227|1999485|FG000|Overall Study|Adverse Event|4
989420|NCT01332227|1999486|FG001|Overall Study|Adverse Event|1
989421|NCT01332227|1999485|FG000|Overall Study|Withdrawal by Subject|5
989422|NCT01332227|1999486|FG001|Overall Study|Withdrawal by Subject|1
989423|NCT01332227|1999485|FG000|Overall Study|Lost to Follow-up|2
989424|NCT01332227|1999486|FG001|Overall Study|Lost to Follow-up|0
989425|NCT01332227|1999485|FG000|Overall Study|Lack of Efficacy|3
989426|NCT01332227|1999486|FG001|Overall Study|Lack of Efficacy|1
989427|NCT01332227|1999485|FG000|Overall Study|Poor compliance/noncompliance|1
989428|NCT01332227|1999486|FG001|Overall Study|Poor compliance/noncompliance|1
989429|NCT01332227|1999485|FG000|Overall Study|Patient moved from area|1
989430|NCT01332227|1999486|FG001|Overall Study|Patient moved from area|0
989431|NCT01332227|1999485|FG000|Overall Study|Patient began prohibited medication|0
989432|NCT01332227|1999486|FG001|Overall Study|Patient began prohibited medication|1
989433|NCT01332292|1999501|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
989434|NCT01332292|1999502|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
989435|NCT01332292|1999501|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
989436|NCT01332292|1999502|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1
989437|NCT01332292|1999501|FG000|Treatment Period 2 (14 Days)|Physician Decision|1
989438|NCT01332292|1999502|FG001|Treatment Period 2 (14 Days)|Physician Decision|1
989439|NCT01332305|1999515|FG000|Overall Study|Adverse Event|1
989440|NCT01332305|1999516|FG001|Overall Study|Adverse Event|4
989441|NCT01332305|1999517|FG002|Overall Study|Adverse Event|6
989442|NCT01332305|1999518|FG003|Overall Study|Adverse Event|3
989443|NCT01332305|1999519|FG004|Overall Study|Adverse Event|5
989444|NCT01332305|1999515|FG000|Overall Study|Withdrawal by Subject|6
989445|NCT01332305|1999516|FG001|Overall Study|Withdrawal by Subject|5
989446|NCT01332305|1999517|FG002|Overall Study|Withdrawal by Subject|4
989447|NCT01332305|1999518|FG003|Overall Study|Withdrawal by Subject|1
989448|NCT01332305|1999519|FG004|Overall Study|Withdrawal by Subject|0
989449|NCT01332305|1999515|FG000|Overall Study|Lost to Follow-up|0
989450|NCT01332305|1999516|FG001|Overall Study|Lost to Follow-up|2
989451|NCT01332305|1999517|FG002|Overall Study|Lost to Follow-up|3
989452|NCT01332305|1999518|FG003|Overall Study|Lost to Follow-up|2
989453|NCT01332305|1999519|FG004|Overall Study|Lost to Follow-up|3
989454|NCT01332305|1999515|FG000|Overall Study|Protocol Violation|1
989455|NCT01332305|1999516|FG001|Overall Study|Protocol Violation|2
989456|NCT01332305|1999517|FG002|Overall Study|Protocol Violation|1
989457|NCT01332305|1999518|FG003|Overall Study|Protocol Violation|0
989458|NCT01332305|1999519|FG004|Overall Study|Protocol Violation|3
989459|NCT01332305|1999515|FG000|Overall Study|Withdrawal by Sponsor|1
989460|NCT01332305|1999516|FG001|Overall Study|Withdrawal by Sponsor|0
989461|NCT01332305|1999517|FG002|Overall Study|Withdrawal by Sponsor|0
989462|NCT01332305|1999518|FG003|Overall Study|Withdrawal by Sponsor|1
989463|NCT01332305|1999519|FG004|Overall Study|Withdrawal by Sponsor|1
989464|NCT01332305|1999515|FG000|Overall Study|Treatment Failure|1
989465|NCT01332305|1999516|FG001|Overall Study|Treatment Failure|1
989466|NCT01332305|1999517|FG002|Overall Study|Treatment Failure|0
989467|NCT01332305|1999518|FG003|Overall Study|Treatment Failure|0
989468|NCT01332305|1999519|FG004|Overall Study|Treatment Failure|0
989469|NCT01332305|1999515|FG000|Overall Study|Physician Decision|0
989470|NCT01332305|1999516|FG001|Overall Study|Physician Decision|0
989471|NCT01332305|1999517|FG002|Overall Study|Physician Decision|0
989472|NCT01332305|1999518|FG003|Overall Study|Physician Decision|1
989473|NCT01332305|1999519|FG004|Overall Study|Physician Decision|0
989474|NCT01332318|1999535|FG000|Overall Study|Adverse Event|0
989475|NCT01332318|1999536|FG001|Overall Study|Adverse Event|3
989476|NCT01332318|1999537|FG002|Overall Study|Adverse Event|0
989477|NCT01332318|1999538|FG003|Overall Study|Adverse Event|0
989478|NCT01332318|1999535|FG000|Overall Study|Withdrawal by Subject|1
989479|NCT01332318|1999536|FG001|Overall Study|Withdrawal by Subject|1
989480|NCT01332318|1999537|FG002|Overall Study|Withdrawal by Subject|0
989481|NCT01332318|1999538|FG003|Overall Study|Withdrawal by Subject|1
989482|NCT01332318|1999535|FG000|Overall Study|Protocol Violation|1
989483|NCT01332318|1999536|FG001|Overall Study|Protocol Violation|0
989484|NCT01332318|1999537|FG002|Overall Study|Protocol Violation|1
989485|NCT01332318|1999538|FG003|Overall Study|Protocol Violation|1
989486|NCT01332331|1999551|FG000|Overall Study|Lost to Follow-up|0
989487|NCT01332331|1999552|FG001|Overall Study|Lost to Follow-up|1
989488|NCT01332331|1999551|FG000|Overall Study|Adverse Event|1
989489|NCT01332331|1999552|FG001|Overall Study|Adverse Event|1
989490|NCT01332331|1999551|FG000|Overall Study|Physician Decision|1
989491|NCT01332331|1999552|FG001|Overall Study|Physician Decision|0
989492|NCT01332630|1999624|FG000|Overall Study|Withdrawal by Subject|3
989493|NCT01332851|1999634|FG000|Overall Study|Withdrawal by Subject|4
989494|NCT01332851|1999635|FG001|Overall Study|Withdrawal by Subject|2
989495|NCT01332851|1999634|FG000|Overall Study|Lost to Follow-up|7
989496|NCT01332851|1999635|FG001|Overall Study|Lost to Follow-up|11
912845|NCT00807495|1890435|FG004|Overall Study|Adverse Event|2
912846|NCT00807495|1890431|FG000|Overall Study|Withdrawal by Patient|2
912847|NCT00807495|1890432|FG001|Overall Study|Withdrawal by Patient|0
912848|NCT00807495|1890433|FG002|Overall Study|Withdrawal by Patient|1
912849|NCT00807495|1890434|FG003|Overall Study|Withdrawal by Patient|0
912850|NCT00807495|1890435|FG004|Overall Study|Withdrawal by Patient|0
912851|NCT00807495|1890431|FG000|Overall Study|Reason Not Specified|0
912852|NCT00807495|1890432|FG001|Overall Study|Reason Not Specified|3
912853|NCT00807495|1890433|FG002|Overall Study|Reason Not Specified|2
912854|NCT00807495|1890434|FG003|Overall Study|Reason Not Specified|0
912855|NCT00807495|1890435|FG004|Overall Study|Reason Not Specified|3
912856|NCT00807573|1890456|FG000|Overall Study|Withdrawal by Subject|1
912857|NCT00807573|1890456|FG000|Overall Study|Adverse Event|1
912858|NCT00807599|1890471|FG000|Overall Study|Not treated on protocol study|0
989681|NCT01332994|1999669|FG000|Overall Study|Adverse Event|34
989682|NCT01332994|1999669|FG000|Overall Study|Death|1
989683|NCT01332994|1999669|FG000|Overall Study|Lack of Efficacy|1
989684|NCT01332994|1999669|FG000|Overall Study|Lost to Follow-up|4
989685|NCT01332994|1999669|FG000|Overall Study|Protocol Violation|6
989686|NCT01332994|1999669|FG000|Overall Study|Withdrawal by Subject|15
989687|NCT01332994|1999669|FG000|Overall Study|Administrative Problem|2
989688|NCT01332994|1999669|FG000|Overall Study|Other|8
989689|NCT01333033|1999675|FG000|Overall Study|Ineligible|0
989690|NCT01333033|1999676|FG001|Overall Study|Ineligible|0
989691|NCT01333033|1999677|FG002|Overall Study|Ineligible|0
989692|NCT01333033|1999678|FG003|Overall Study|Ineligible|0
989693|NCT01333033|1999679|FG004|Overall Study|Ineligible|6
989694|NCT01333033|1999680|FG005|Overall Study|Ineligible|8
989695|NCT01333033|1999675|FG000|Overall Study|Withdrawal by Subject|0
989696|NCT01333033|1999676|FG001|Overall Study|Withdrawal by Subject|0
989697|NCT01333033|1999677|FG002|Overall Study|Withdrawal by Subject|0
989698|NCT01333033|1999678|FG003|Overall Study|Withdrawal by Subject|0
989699|NCT01333033|1999679|FG004|Overall Study|Withdrawal by Subject|4
989700|NCT01333033|1999680|FG005|Overall Study|Withdrawal by Subject|2
989701|NCT01333033|1999675|FG000|Overall Study|PET inevaluable|0
989702|NCT01333033|1999676|FG001|Overall Study|PET inevaluable|0
989703|NCT01333033|1999677|FG002|Overall Study|PET inevaluable|0
989704|NCT01333033|1999678|FG003|Overall Study|PET inevaluable|0
989705|NCT01333033|1999679|FG004|Overall Study|PET inevaluable|2
989706|NCT01333033|1999680|FG005|Overall Study|PET inevaluable|4
989707|NCT01333033|1999675|FG000|Overall Study|Adverse Event|0
989708|NCT01333033|1999676|FG001|Overall Study|Adverse Event|0
989709|NCT01333033|1999677|FG002|Overall Study|Adverse Event|0
989710|NCT01333033|1999678|FG003|Overall Study|Adverse Event|0
989711|NCT01333033|1999679|FG004|Overall Study|Adverse Event|2
989712|NCT01333033|1999680|FG005|Overall Study|Adverse Event|1
989713|NCT01333033|1999675|FG000|Overall Study|Progression|0
989714|NCT01333033|1999676|FG001|Overall Study|Progression|0
989715|NCT01333033|1999677|FG002|Overall Study|Progression|0
989716|NCT01333033|1999678|FG003|Overall Study|Progression|0
989717|NCT01333033|1999679|FG004|Overall Study|Progression|0
989718|NCT01333033|1999680|FG005|Overall Study|Progression|1
989719|NCT01333033|1999675|FG000|Overall Study|MD Decision|0
989720|NCT01333033|1999676|FG001|Overall Study|MD Decision|0
989721|NCT01333033|1999677|FG002|Overall Study|MD Decision|0
989722|NCT01333033|1999678|FG003|Overall Study|MD Decision|0
989723|NCT01333033|1999679|FG004|Overall Study|MD Decision|0
989724|NCT01333033|1999680|FG005|Overall Study|MD Decision|2
989725|NCT01333059|1999700|FG000|Overall Study|Physician Decision|3
989726|NCT01333059|1999701|FG001|Overall Study|Physician Decision|3
989727|NCT01333059|1999700|FG000|Overall Study|Protocol Violation|3
989728|NCT01333059|1999701|FG001|Overall Study|Protocol Violation|0
989729|NCT01333072|1999711|FG000|Overall Study|Lost to Follow-up|3
989730|NCT01333072|1999712|FG001|Overall Study|Lost to Follow-up|0
989731|NCT01333072|1999711|FG000|Overall Study|Adverse Event|2
989732|NCT01333072|1999712|FG001|Overall Study|Adverse Event|4
989733|NCT01333072|1999711|FG000|Overall Study|Physician Decision|1
989734|NCT01333072|1999712|FG001|Overall Study|Physician Decision|0
989735|NCT01333111|1999727|FG000|Overall Study|patient undergoing major surgery|0
989736|NCT01333111|1999728|FG001|Overall Study|patient undergoing major surgery|2
912859|NCT00807599|1890472|FG001|Overall Study|Not treated on protocol study|0
912860|NCT00807599|1890473|FG002|Overall Study|Not treated on protocol study|2
912861|NCT00807599|1890471|FG000|Overall Study|Adverse Event|0
912862|NCT00807599|1890472|FG001|Overall Study|Adverse Event|0
912863|NCT00807599|1890473|FG002|Overall Study|Adverse Event|5
912864|NCT00807599|1890471|FG000|Overall Study|Inadequate response to induction|0
912865|NCT00807599|1890472|FG001|Overall Study|Inadequate response to induction|0
912866|NCT00807599|1890473|FG002|Overall Study|Inadequate response to induction|9
912867|NCT00807599|1890471|FG000|Overall Study|Withdrawal by Subject|0
912868|NCT00807599|1890472|FG001|Overall Study|Withdrawal by Subject|0
912869|NCT00807599|1890473|FG002|Overall Study|Withdrawal by Subject|1
912870|NCT00807742|1890491|FG000|Overall Study|Death|9
912871|NCT00807742|1890492|FG001|Overall Study|Death|2
912872|NCT00807742|1890491|FG000|Overall Study|Withdrawal by Subject|2
912873|NCT00807742|1890492|FG001|Overall Study|Withdrawal by Subject|1
912874|NCT00807742|1890491|FG000|Overall Study|Lost to Follow-up|35
912875|NCT00807742|1890492|FG001|Overall Study|Lost to Follow-up|51
912876|NCT00807846|1890509|FG000|Overall Study|Adverse Event|5
912877|NCT00807846|1890510|FG001|Overall Study|Adverse Event|0
989737|NCT01333111|1999729|FG002|Overall Study|patient undergoing major surgery|0
989738|NCT01333111|1999727|FG000|Overall Study|personal reasons|0
989739|NCT01333111|1999728|FG001|Overall Study|personal reasons|0
989740|NCT01333111|1999729|FG002|Overall Study|personal reasons|1
989741|NCT01333111|1999727|FG000|Overall Study|unclassified|1
989742|NCT01333111|1999728|FG001|Overall Study|unclassified|0
989743|NCT01333111|1999729|FG002|Overall Study|unclassified|0
989744|NCT01333111|1999727|FG000|Overall Study|withdrawal criteria|0
989745|NCT01333111|1999728|FG001|Overall Study|withdrawal criteria|1
989746|NCT01333111|1999729|FG002|Overall Study|withdrawal criteria|0
989747|NCT01333111|1999727|FG000|Overall Study|Non-compliance|1
989748|NCT01333111|1999728|FG001|Overall Study|Non-compliance|0
989749|NCT01333111|1999729|FG002|Overall Study|Non-compliance|0
989750|NCT01333111|1999727|FG000|Overall Study|Ineffective therapy|0
989751|NCT01333111|1999728|FG001|Overall Study|Ineffective therapy|0
989752|NCT01333111|1999729|FG002|Overall Study|Ineffective therapy|1
989753|NCT01333189|1999739|FG000|Overall Study|Time constraints|1
989754|NCT01333189|1999740|FG001|Overall Study|Time constraints|0
989755|NCT01333189|1999739|FG000|Overall Study|Adverse Event|1
989756|NCT01333189|1999740|FG001|Overall Study|Adverse Event|0
989757|NCT01333189|1999739|FG000|Overall Study|Transportation difficulties|0
989758|NCT01333189|1999740|FG001|Overall Study|Transportation difficulties|1
989759|NCT01333189|1999739|FG000|Overall Study|Moved from region|0
989760|NCT01333189|1999740|FG001|Overall Study|Moved from region|1
989761|NCT01333397|1999751|FG000|Overall Study|Lost to Follow-up|1
989762|NCT01333397|1999752|FG001|Overall Study|Lost to Follow-up|0
989763|NCT01333397|1999753|FG002|Overall Study|Lost to Follow-up|0
989764|NCT01333397|1999754|FG003|Overall Study|Lost to Follow-up|1
989765|NCT01333397|1999755|FG004|Overall Study|Lost to Follow-up|0
989766|NCT01333475|1999787|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1
989767|NCT01333475|1999788|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0
989768|NCT01333475|1999787|FG000|Overall Study|Toxicity|1
989769|NCT01333475|1999788|FG001|Overall Study|Toxicity|3
989770|NCT01333501|1999811|FG000|Overall Study|Adverse Event|3
989771|NCT01333501|1999812|FG001|Overall Study|Adverse Event|1
989772|NCT01333501|1999811|FG000|Overall Study|Abnormal laboratory value|2
989773|NCT01333501|1999812|FG001|Overall Study|Abnormal laboratory value|1
989774|NCT01333501|1999811|FG000|Overall Study|Unsatisfactory therapeutic effect|1
989775|NCT01333501|1999812|FG001|Overall Study|Unsatisfactory therapeutic effect|7
989776|NCT01333501|1999811|FG000|Overall Study|Withdrawn consent|3
989777|NCT01333501|1999812|FG001|Overall Study|Withdrawn consent|12
989778|NCT01333722|1999838|FG000|Overall Study|Lack of Efficacy|0
989779|NCT01333722|1999839|FG001|Overall Study|Lack of Efficacy|2
989780|NCT01333722|1999838|FG000|Overall Study|Withdrawal by Subject|0
989781|NCT01333722|1999839|FG001|Overall Study|Withdrawal by Subject|1
989782|NCT01333865|1999851|FG000|Overall Study|Adverse Event|2
989783|NCT01333943|1999857|FG000|Overall Study|Known neuropathy|1
989784|NCT01333943|1999858|FG001|Overall Study|Known neuropathy|0
989785|NCT01333956|1999868|FG000|Overall Study|Lost to Follow-up|1
989786|NCT01333956|1999869|FG001|Overall Study|Lost to Follow-up|2
989787|NCT01333956|1999870|FG002|Overall Study|Lost to Follow-up|0
989788|NCT01333956|1999871|FG003|Overall Study|Lost to Follow-up|1
989789|NCT01333956|1999868|FG000|Overall Study|Unable to complete study procedure|1
989790|NCT01333956|1999869|FG001|Overall Study|Unable to complete study procedure|0
989791|NCT01333956|1999870|FG002|Overall Study|Unable to complete study procedure|0
989792|NCT01333956|1999871|FG003|Overall Study|Unable to complete study procedure|1
989793|NCT01333956|1999868|FG000|Overall Study|Withdrawal by Subject|0
989794|NCT01333956|1999869|FG001|Overall Study|Withdrawal by Subject|2
989795|NCT01333956|1999870|FG002|Overall Study|Withdrawal by Subject|1
989796|NCT01333956|1999871|FG003|Overall Study|Withdrawal by Subject|0
989797|NCT01334125|1999888|FG000|Overall Study|Lost to Follow-up|3
989798|NCT01334125|1999889|FG001|Overall Study|Lost to Follow-up|3
989799|NCT01334515|1999916|FG000|Overall Study|Adverse Event|1
989800|NCT01334515|1999917|FG001|Overall Study|Adverse Event|6
989801|NCT01334515|1999916|FG000|Overall Study|Death|1
989802|NCT01334515|1999917|FG001|Overall Study|Death|0
989803|NCT01334515|1999916|FG000|Overall Study|Lack of Efficacy|8
989804|NCT01334515|1999917|FG001|Overall Study|Lack of Efficacy|21
989805|NCT01334515|1999916|FG000|Overall Study|Physician Decision|1
989806|NCT01334515|1999917|FG001|Overall Study|Physician Decision|1
989807|NCT01334515|1999916|FG000|Overall Study|Withdrawal by Subject|1
989808|NCT01334515|1999917|FG001|Overall Study|Withdrawal by Subject|1
989809|NCT01334554|1999925|FG000|Overall Study|Adverse Event|4
989810|NCT01334554|1999926|FG001|Overall Study|Adverse Event|2
989811|NCT01334710|1999934|FG000|Overall Study|Trial was terminated|3
989812|NCT01334866|1999968|FG000|Overall Study|Withdrawal by Subject|10
989813|NCT01334866|1999968|FG000|Overall Study|Lost to Follow-up|3
989814|NCT01334866|1999968|FG000|Overall Study|Physician Decision|3
989815|NCT01334866|1999968|FG000|Overall Study|medically necessary prior to procedure|2
989816|NCT01334866|1999968|FG000|Overall Study|medically necessary post-procedure|1
989817|NCT01334918|1999976|FG000|Overall Study|Did not receive study drug|6
989818|NCT01334918|1999977|FG001|Overall Study|Did not receive study drug|0
989819|NCT01334918|1999976|FG000|Overall Study|Adverse Event|2
989820|NCT01334918|1999977|FG001|Overall Study|Adverse Event|0
989821|NCT01334918|1999976|FG000|Overall Study|Withdrawal by Subject|0
989822|NCT01334918|1999977|FG001|Overall Study|Withdrawal by Subject|1
989823|NCT01335009|2000010|FG000|Overall Study|Too ill to travel to study sites|1
989824|NCT01335009|2000011|FG001|Overall Study|Too ill to travel to study sites|0
989825|NCT01335009|2000010|FG000|Overall Study|Death|28
989826|NCT01335009|2000011|FG001|Overall Study|Death|32
989827|NCT01335009|2000010|FG000|Overall Study|Withdrawal by Subject|1
989828|NCT01335009|2000011|FG001|Overall Study|Withdrawal by Subject|1
989829|NCT01335009|2000010|FG000|Overall Study|Lost to Follow-up|1
989830|NCT01335009|2000011|FG001|Overall Study|Lost to Follow-up|0
989831|NCT01335399|2000073|FG000|Pre-treatment Period|No longer meeting study criteria|0
989832|NCT01335399|2000074|FG001|Pre-treatment Period|No longer meeting study criteria|1
989833|NCT01335399|2000073|FG000|Pre-treatment Period|Participant request to discontinue|0
989834|NCT01335399|2000074|FG001|Pre-treatment Period|Participant request to discontinue|1
989835|NCT01335399|2000073|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0
989836|NCT01335399|2000074|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1
989837|NCT01335399|2000073|FG000|Pre-treatment Period|Consent withdrawal|3
989838|NCT01335399|2000074|FG001|Pre-treatment Period|Consent withdrawal|0
989839|NCT01335399|2000073|FG000|Treatment Period|Disease progression|114
989840|NCT01335399|2000074|FG001|Treatment Period|Disease progression|141
989841|NCT01335399|2000073|FG000|Treatment Period|Adverse event unrelated to study drug|105
989842|NCT01335399|2000074|FG001|Treatment Period|Adverse event unrelated to study drug|65
989843|NCT01335399|2000073|FG000|Treatment Period|Study drug toxicity|51
989844|NCT01335399|2000074|FG001|Treatment Period|Study drug toxicity|64
989845|NCT01335399|2000073|FG000|Treatment Period|Participant request to discontinue|27
989846|NCT01335399|2000074|FG001|Treatment Period|Participant request to discontinue|21
989847|NCT01335399|2000073|FG000|Treatment Period|Other reasons|14
989848|NCT01335399|2000074|FG001|Treatment Period|Other reasons|26
989849|NCT01335399|2000073|FG000|Treatment Period|Consent withdrawal|10
989850|NCT01335399|2000074|FG001|Treatment Period|Consent withdrawal|6
989851|NCT01335399|2000073|FG000|Treatment Period|Death|7
989852|NCT01335399|2000074|FG001|Treatment Period|Death|8
989853|NCT01335399|2000073|FG000|Treatment Period|Poor/Non-compliance|3
989854|NCT01335399|2000074|FG001|Treatment Period|Poor/Non-compliance|4
989855|NCT01335399|2000073|FG000|Treatment Period|Lost to Follow-up|0
989856|NCT01335399|2000074|FG001|Treatment Period|Lost to Follow-up|2
989857|NCT01335399|2000073|FG000|Treatment Period|Maximum clinical benefit|1
989858|NCT01335399|2000074|FG001|Treatment Period|Maximum clinical benefit|1
989859|NCT01335399|2000073|FG000|Treatment Period|No longer meet study criteria|0
989860|NCT01335399|2000074|FG001|Treatment Period|No longer meet study criteria|1
989861|NCT01335399|2000073|FG000|Treatment Period|Not reported|1
989862|NCT01335399|2000074|FG001|Treatment Period|Not reported|0
989863|NCT01335464|2000082|FG000|Overall Study|Adverse Event|15
989864|NCT01335464|2000083|FG001|Overall Study|Adverse Event|25
989865|NCT01335464|2000082|FG000|Overall Study|Non compliant with protocol|2
989866|NCT01335464|2000083|FG001|Overall Study|Non compliant with protocol|0
989867|NCT01335464|2000082|FG000|Overall Study|Consent withdrawn, not due to AE|12
989868|NCT01335464|2000083|FG001|Overall Study|Consent withdrawn, not due to AE|23
989869|NCT01335464|2000082|FG000|Overall Study|Not treated|2
989870|NCT01335464|2000083|FG001|Overall Study|Not treated|0
989871|NCT01335464|2000082|FG000|Overall Study|Reason other than those stated above|1
989872|NCT01335464|2000083|FG001|Overall Study|Reason other than those stated above|1
989873|NCT01335477|2000091|FG000|Overall Study|Adverse Event|30
989874|NCT01335477|2000092|FG001|Overall Study|Adverse Event|42
989875|NCT01335477|2000091|FG000|Overall Study|Non compliant with protocol|0
989876|NCT01335477|2000092|FG001|Overall Study|Non compliant with protocol|2
989877|NCT01335477|2000091|FG000|Overall Study|Lost to Follow-up|1
989878|NCT01335477|2000092|FG001|Overall Study|Lost to Follow-up|2
989879|NCT01335477|2000091|FG000|Overall Study|Consent withdrawn, not due to AE|7
989880|NCT01335477|2000092|FG001|Overall Study|Consent withdrawn, not due to AE|9
989881|NCT01335477|2000091|FG000|Overall Study|Not treated|1
989882|NCT01335477|2000092|FG001|Overall Study|Not treated|2
989883|NCT01335477|2000091|FG000|Overall Study|Reason other than those stated above|2
989884|NCT01335477|2000092|FG001|Overall Study|Reason other than those stated above|2
989885|NCT01335698|2000154|FG000|Treatment Stage 1|Lack of Efficacy|3
989886|NCT01335698|2000155|FG001|Treatment Stage 1|Lack of Efficacy|1
989887|NCT01335698|2000156|FG002|Treatment Stage 1|Lack of Efficacy|3
989888|NCT01335698|2000157|FG003|Treatment Stage 1|Lack of Efficacy|3
989889|NCT01335698|2000158|FG004|Treatment Stage 1|Lack of Efficacy|1
989890|NCT01335698|2000154|FG000|Treatment Stage 1|Adverse Event|1
989891|NCT01335698|2000155|FG001|Treatment Stage 1|Adverse Event|2
989892|NCT01335698|2000156|FG002|Treatment Stage 1|Adverse Event|2
989893|NCT01335698|2000157|FG003|Treatment Stage 1|Adverse Event|1
989894|NCT01335698|2000158|FG004|Treatment Stage 1|Adverse Event|1
989895|NCT01335698|2000154|FG000|Treatment Stage 1|Withdrawal by Subject|1
989896|NCT01335698|2000155|FG001|Treatment Stage 1|Withdrawal by Subject|2
989897|NCT01335698|2000156|FG002|Treatment Stage 1|Withdrawal by Subject|0
989898|NCT01335698|2000157|FG003|Treatment Stage 1|Withdrawal by Subject|1
989899|NCT01335698|2000158|FG004|Treatment Stage 1|Withdrawal by Subject|0
989900|NCT01335698|2000154|FG000|Treatment Stage 1|Lost to Follow-up|1
989901|NCT01335698|2000155|FG001|Treatment Stage 1|Lost to Follow-up|1
989902|NCT01335698|2000156|FG002|Treatment Stage 1|Lost to Follow-up|0
989903|NCT01335698|2000157|FG003|Treatment Stage 1|Lost to Follow-up|0
989904|NCT01335698|2000158|FG004|Treatment Stage 1|Lost to Follow-up|0
989905|NCT01335698|2000154|FG000|Treatment Stage 1|Poor compliance/noncompliance|0
989906|NCT01335698|2000155|FG001|Treatment Stage 1|Poor compliance/noncompliance|1
989907|NCT01335698|2000156|FG002|Treatment Stage 1|Poor compliance/noncompliance|0
989908|NCT01335698|2000157|FG003|Treatment Stage 1|Poor compliance/noncompliance|2
989909|NCT01335698|2000158|FG004|Treatment Stage 1|Poor compliance/noncompliance|0
989910|NCT01335698|2000154|FG000|Treatment Stage 1|No longer meets study criteria|1
989911|NCT01335698|2000155|FG001|Treatment Stage 1|No longer meets study criteria|1
989912|NCT01335698|2000156|FG002|Treatment Stage 1|No longer meets study criteria|0
989913|NCT01335698|2000157|FG003|Treatment Stage 1|No longer meets study criteria|1
989914|NCT01335698|2000158|FG004|Treatment Stage 1|No longer meets study criteria|0
989915|NCT01335698|2000154|FG000|Treatment Stage 1|Other|1
989916|NCT01335698|2000155|FG001|Treatment Stage 1|Other|0
989917|NCT01335698|2000156|FG002|Treatment Stage 1|Other|0
989918|NCT01335698|2000157|FG003|Treatment Stage 1|Other|1
989919|NCT01335698|2000158|FG004|Treatment Stage 1|Other|0
989920|NCT01335698|2000154|FG000|Treatment Stage 2|Lack of Efficacy|2
989921|NCT01335698|2000155|FG001|Treatment Stage 2|Lack of Efficacy|1
989922|NCT01335698|2000156|FG002|Treatment Stage 2|Lack of Efficacy|3
989923|NCT01335698|2000157|FG003|Treatment Stage 2|Lack of Efficacy|1
989924|NCT01335698|2000158|FG004|Treatment Stage 2|Lack of Efficacy|0
989925|NCT01335698|2000154|FG000|Treatment Stage 2|Adverse Event|2
989926|NCT01335698|2000155|FG001|Treatment Stage 2|Adverse Event|0
989927|NCT01335698|2000156|FG002|Treatment Stage 2|Adverse Event|0
989928|NCT01335698|2000157|FG003|Treatment Stage 2|Adverse Event|3
989929|NCT01335698|2000158|FG004|Treatment Stage 2|Adverse Event|0
989930|NCT01335698|2000154|FG000|Treatment Stage 2|Withdrawal by Subject|3
989931|NCT01335698|2000155|FG001|Treatment Stage 2|Withdrawal by Subject|1
989932|NCT01335698|2000156|FG002|Treatment Stage 2|Withdrawal by Subject|1
989933|NCT01335698|2000157|FG003|Treatment Stage 2|Withdrawal by Subject|0
989934|NCT01335698|2000158|FG004|Treatment Stage 2|Withdrawal by Subject|0
989935|NCT01335698|2000154|FG000|Treatment Stage 2|Poor compliance/noncompliance|1
989936|NCT01335698|2000155|FG001|Treatment Stage 2|Poor compliance/noncompliance|0
989937|NCT01335698|2000156|FG002|Treatment Stage 2|Poor compliance/noncompliance|1
989938|NCT01335698|2000157|FG003|Treatment Stage 2|Poor compliance/noncompliance|3
989939|NCT01335698|2000158|FG004|Treatment Stage 2|Poor compliance/noncompliance|1
989940|NCT01335698|2000154|FG000|Treatment Stage 2|Lost to Follow-up|1
989941|NCT01335698|2000155|FG001|Treatment Stage 2|Lost to Follow-up|0
989942|NCT01335698|2000156|FG002|Treatment Stage 2|Lost to Follow-up|0
989943|NCT01335698|2000157|FG003|Treatment Stage 2|Lost to Follow-up|0
989944|NCT01335698|2000158|FG004|Treatment Stage 2|Lost to Follow-up|0
989945|NCT01335698|2000154|FG000|Treatment Stage 2|Capsules received at state hospital|1
989946|NCT01335698|2000155|FG001|Treatment Stage 2|Capsules received at state hospital|0
989947|NCT01335698|2000156|FG002|Treatment Stage 2|Capsules received at state hospital|0
989948|NCT01335698|2000157|FG003|Treatment Stage 2|Capsules received at state hospital|0
989949|NCT01335698|2000158|FG004|Treatment Stage 2|Capsules received at state hospital|0
989950|NCT01335698|2000154|FG000|Treatment Stage 2|Subject no longer meets study criteria|0
989951|NCT01335698|2000155|FG001|Treatment Stage 2|Subject no longer meets study criteria|0
989952|NCT01335698|2000156|FG002|Treatment Stage 2|Subject no longer meets study criteria|0
989953|NCT01335698|2000157|FG003|Treatment Stage 2|Subject no longer meets study criteria|1
989954|NCT01335698|2000158|FG004|Treatment Stage 2|Subject no longer meets study criteria|0
989955|NCT01335698|2000154|FG000|Treatment Stage 2|Switched to another formulation|1
989956|NCT01335698|2000155|FG001|Treatment Stage 2|Switched to another formulation|1
989957|NCT01335698|2000156|FG002|Treatment Stage 2|Switched to another formulation|0
989958|NCT01335698|2000157|FG003|Treatment Stage 2|Switched to another formulation|0
989959|NCT01335698|2000158|FG004|Treatment Stage 2|Switched to another formulation|0
989960|NCT01335971|2000230|FG000|Overall Study|Withdrawal by Subject|1
989961|NCT01335971|2000231|FG001|Overall Study|Withdrawal by Subject|0
989962|NCT01335971|2000232|FG002|Overall Study|Withdrawal by Subject|0
989963|NCT01335971|2000230|FG000|Overall Study|Did not complete bronchoscopy|1
989964|NCT01335971|2000231|FG001|Overall Study|Did not complete bronchoscopy|1
989965|NCT01335971|2000232|FG002|Overall Study|Did not complete bronchoscopy|1
989966|NCT01336023|2000243|FG000|Week 0 to Week 26|Adverse Event|8
989967|NCT01336023|2000244|FG001|Week 0 to Week 26|Adverse Event|10
912878|NCT00807846|1890509|FG000|Overall Study|Lack of Efficacy|2
912879|NCT00807846|1890510|FG001|Overall Study|Lack of Efficacy|0
912880|NCT00807846|1890509|FG000|Overall Study|Protocol Violation|2
912881|NCT00807846|1890510|FG001|Overall Study|Protocol Violation|1
912882|NCT00807846|1890509|FG000|Overall Study|Withdrawal by Subject|2
912883|NCT00807846|1890510|FG001|Overall Study|Withdrawal by Subject|1
912884|NCT00807846|1890509|FG000|Overall Study|Other|1
912885|NCT00807846|1890510|FG001|Overall Study|Other|2
912886|NCT00807885|1890525|FG000|Overall Study|Lost to Follow-up|0
912887|NCT00807885|1890526|FG001|Overall Study|Lost to Follow-up|0
912888|NCT00807885|1890527|FG002|Overall Study|Lost to Follow-up|0
912889|NCT00807885|1890528|FG003|Overall Study|Lost to Follow-up|0
912890|NCT00807885|1890529|FG004|Overall Study|Lost to Follow-up|0
989968|NCT01336023|2000245|FG002|Week 0 to Week 26|Adverse Event|24
989969|NCT01336023|2000243|FG000|Week 0 to Week 26|Lack of Efficacy|0
989970|NCT01336023|2000244|FG001|Week 0 to Week 26|Lack of Efficacy|1
989971|NCT01336023|2000245|FG002|Week 0 to Week 26|Lack of Efficacy|0
989972|NCT01336023|2000243|FG000|Week 0 to Week 26|Protocol Violation|1
989973|NCT01336023|2000244|FG001|Week 0 to Week 26|Protocol Violation|2
989974|NCT01336023|2000245|FG002|Week 0 to Week 26|Protocol Violation|0
989975|NCT01336023|2000243|FG000|Week 0 to Week 26|Withdrawal Criteria|34
989976|NCT01336023|2000244|FG001|Week 0 to Week 26|Withdrawal Criteria|69
989977|NCT01336023|2000245|FG002|Week 0 to Week 26|Withdrawal Criteria|40
989978|NCT01336023|2000243|FG000|Week 0 to Week 26|Unclassified|5
989979|NCT01336023|2000244|FG001|Week 0 to Week 26|Unclassified|16
989980|NCT01336023|2000245|FG002|Week 0 to Week 26|Unclassified|9
989981|NCT01336023|2000243|FG000|Week 27 to 52|Adverse Event|1
989982|NCT01336023|2000244|FG001|Week 27 to 52|Adverse Event|5
989983|NCT01336023|2000245|FG002|Week 27 to 52|Adverse Event|2
989984|NCT01336023|2000243|FG000|Week 27 to 52|Protocol Violation|0
989985|NCT01336023|2000244|FG001|Week 27 to 52|Protocol Violation|2
989986|NCT01336023|2000245|FG002|Week 27 to 52|Protocol Violation|1
989987|NCT01336023|2000243|FG000|Week 27 to 52|Withdrawal Criteria|14
989988|NCT01336023|2000244|FG001|Week 27 to 52|Withdrawal Criteria|19
989989|NCT01336023|2000245|FG002|Week 27 to 52|Withdrawal Criteria|16
989990|NCT01336023|2000243|FG000|Week 27 to 52|Unclassified|13
989991|NCT01336023|2000244|FG001|Week 27 to 52|Unclassified|18
989992|NCT01336023|2000245|FG002|Week 27 to 52|Unclassified|9
989993|NCT01336205|2000264|FG000|Overall Study|Other|22
989994|NCT01336205|2000265|FG001|Overall Study|Other|9
989995|NCT01336205|2000264|FG000|Overall Study|Lost to Follow-up|40
989996|NCT01336205|2000265|FG001|Overall Study|Lost to Follow-up|20
989997|NCT01336205|2000264|FG000|Overall Study|Study-Specific Withdrawal Criteria|16
989998|NCT01336205|2000265|FG001|Overall Study|Study-Specific Withdrawal Criteria|7
989999|NCT01336205|2000264|FG000|Overall Study|Lack of Efficacy|4
990000|NCT01336205|2000265|FG001|Overall Study|Lack of Efficacy|0
990001|NCT01336205|2000264|FG000|Overall Study|Severe noncompliance with protocol|9
990002|NCT01336205|2000265|FG001|Overall Study|Severe noncompliance with protocol|2
990003|NCT01336205|2000264|FG000|Overall Study|Adverse Event|56
990004|NCT01336205|2000265|FG001|Overall Study|Adverse Event|6
990005|NCT01336205|2000264|FG000|Overall Study|Death|1
990006|NCT01336205|2000265|FG001|Overall Study|Death|1
990007|NCT01336205|2000264|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9
990008|NCT01336205|2000265|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
990009|NCT01336205|2000264|FG000|Overall Study|Withdrawal by Subject|72
990010|NCT01336205|2000265|FG001|Overall Study|Withdrawal by Subject|38
990011|NCT01336205|2000264|FG000|Overall Study|Did not receive treatment|4
990012|NCT01336205|2000265|FG001|Overall Study|Did not receive treatment|0
990013|NCT01336569|2000291|FG000|Overall Study|Lost to Follow-up|4
990014|NCT01336608|2000298|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
990015|NCT01336608|2000299|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
990016|NCT01336608|2000300|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
990017|NCT01336608|2000301|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
990018|NCT01336608|2000298|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
990019|NCT01336608|2000299|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
990020|NCT01336608|2000300|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
990021|NCT01336608|2000301|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
990022|NCT01336608|2000298|FG000|2-week, Single-blind Run-In Period|Adverse Event|1
990023|NCT01336608|2000299|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
990024|NCT01336608|2000300|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
990025|NCT01336608|2000301|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
912891|NCT00807885|1890530|FG005|Overall Study|Lost to Follow-up|1
912892|NCT00807885|1890531|FG006|Overall Study|Lost to Follow-up|0
912893|NCT00807885|1890532|FG007|Overall Study|Lost to Follow-up|0
912894|NCT00807885|1890533|FG008|Overall Study|Lost to Follow-up|0
912895|NCT00807937|1890557|FG000|Overall Study|Adverse Event|12
912896|NCT00807937|1890558|FG001|Overall Study|Adverse Event|12
912897|NCT00807937|1890559|FG002|Overall Study|Adverse Event|5
912898|NCT00807937|1890560|FG003|Overall Study|Adverse Event|4
912899|NCT00807937|1890557|FG000|Overall Study|Protocol Violation|4
912900|NCT00807937|1890558|FG001|Overall Study|Protocol Violation|5
912901|NCT00807937|1890559|FG002|Overall Study|Protocol Violation|3
912902|NCT00807937|1890560|FG003|Overall Study|Protocol Violation|3
912903|NCT00807937|1890557|FG000|Overall Study|Withdrawal by Subject|5
912904|NCT00807937|1890558|FG001|Overall Study|Withdrawal by Subject|4
912905|NCT00807937|1890559|FG002|Overall Study|Withdrawal by Subject|1
912906|NCT00807937|1890560|FG003|Overall Study|Withdrawal by Subject|4
912907|NCT00807937|1890557|FG000|Overall Study|Lost to Follow-up|4
912908|NCT00807937|1890558|FG001|Overall Study|Lost to Follow-up|0
912909|NCT00807937|1890559|FG002|Overall Study|Lost to Follow-up|2
912910|NCT00807937|1890560|FG003|Overall Study|Lost to Follow-up|1
912911|NCT00807937|1890557|FG000|Overall Study|Lack of Efficacy|0
912912|NCT00807937|1890558|FG001|Overall Study|Lack of Efficacy|0
912913|NCT00807937|1890559|FG002|Overall Study|Lack of Efficacy|1
912914|NCT00807937|1890560|FG003|Overall Study|Lack of Efficacy|2
990026|NCT01336608|2000298|FG000|2-week, Single-blind Run-In Period|Physician Decision|1
990027|NCT01336608|2000299|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
990028|NCT01336608|2000300|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
990029|NCT01336608|2000301|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
990030|NCT01336608|2000298|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2
990031|NCT01336608|2000299|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
990032|NCT01336608|2000300|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
990033|NCT01336608|2000301|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
990034|NCT01336608|2000298|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
990035|NCT01336608|2000299|FG001|24-week, Double-blind Treatment Period|Adverse Event|8
990036|NCT01336608|2000300|FG002|24-week, Double-blind Treatment Period|Adverse Event|6
990037|NCT01336608|2000301|FG003|24-week, Double-blind Treatment Period|Adverse Event|7
990038|NCT01336608|2000298|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
990039|NCT01336608|2000299|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
990040|NCT01336608|2000300|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
990041|NCT01336608|2000301|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
990042|NCT01336608|2000298|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
990043|NCT01336608|2000299|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
990044|NCT01336608|2000300|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
990045|NCT01336608|2000301|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
990046|NCT01336608|2000298|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
990047|NCT01336608|2000299|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4
990048|NCT01336608|2000300|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3
990049|NCT01336608|2000301|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3
990050|NCT01336608|2000298|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
990051|NCT01336608|2000299|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
990052|NCT01336608|2000300|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
990053|NCT01336608|2000301|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
990054|NCT01336608|2000298|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
990055|NCT01336608|2000299|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
990056|NCT01336608|2000300|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
990057|NCT01336608|2000301|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
990058|NCT01336608|2000298|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
990059|NCT01336608|2000299|FG001|24-week, Double-blind Treatment Period|Physician Decision|3
990060|NCT01336608|2000300|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
990061|NCT01336608|2000301|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
990062|NCT01336608|2000298|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
990063|NCT01336608|2000299|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
990064|NCT01336608|2000300|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
990065|NCT01336608|2000301|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
990066|NCT01336634|2000319|FG000|Overall Study|Death|60
990067|NCT01336634|2000320|FG001|Overall Study|Death|33
990068|NCT01336634|2000321|FG002|Overall Study|Death|10
990069|NCT01336634|2000319|FG000|Overall Study|Lost to Follow-up|2
990070|NCT01336634|2000320|FG001|Overall Study|Lost to Follow-up|1
990071|NCT01336634|2000321|FG002|Overall Study|Lost to Follow-up|1
990072|NCT01336634|2000319|FG000|Overall Study|Withdrawal by Subject|6
990073|NCT01336634|2000320|FG001|Overall Study|Withdrawal by Subject|0
990074|NCT01336634|2000321|FG002|Overall Study|Withdrawal by Subject|1
990075|NCT01336634|2000319|FG000|Overall Study|Physician Decision|1
990076|NCT01336634|2000320|FG001|Overall Study|Physician Decision|1
990077|NCT01336634|2000321|FG002|Overall Study|Physician Decision|0
990078|NCT01336634|2000319|FG000|Overall Study|Ongoing|15
990079|NCT01336634|2000320|FG001|Overall Study|Ongoing|22
990080|NCT01336634|2000321|FG002|Overall Study|Ongoing|24
990081|NCT01336647|2000335|FG000|Overall Study|Lost to Follow-up|4
990082|NCT01336647|2000336|FG001|Overall Study|Lost to Follow-up|1
990083|NCT01336647|2000337|FG002|Overall Study|Lost to Follow-up|3
990084|NCT01336712|2000347|FG000|Overall Study|Death|2
990085|NCT01336712|2000347|FG000|Overall Study|Lack of Efficacy|1
990086|NCT01336738|2000356|FG000|Overall Study|Adverse Event|0
990087|NCT01336738|2000357|FG001|Overall Study|Adverse Event|3
990088|NCT01336738|2000358|FG002|Overall Study|Adverse Event|2
990089|NCT01336738|2000359|FG003|Overall Study|Adverse Event|1
990090|NCT01336738|2000360|FG004|Overall Study|Adverse Event|3
990091|NCT01336738|2000356|FG000|Overall Study|Lost to Follow-up|2
990092|NCT01336738|2000357|FG001|Overall Study|Lost to Follow-up|1
990093|NCT01336738|2000358|FG002|Overall Study|Lost to Follow-up|2
990094|NCT01336738|2000359|FG003|Overall Study|Lost to Follow-up|2
990095|NCT01336738|2000360|FG004|Overall Study|Lost to Follow-up|2
990096|NCT01336738|2000356|FG000|Overall Study|Did not meet entrance criteria|0
990097|NCT01336738|2000357|FG001|Overall Study|Did not meet entrance criteria|1
990098|NCT01336738|2000358|FG002|Overall Study|Did not meet entrance criteria|0
990099|NCT01336738|2000359|FG003|Overall Study|Did not meet entrance criteria|0
990100|NCT01336738|2000360|FG004|Overall Study|Did not meet entrance criteria|0
990101|NCT01336738|2000356|FG000|Overall Study|Protocol Violation|0
990102|NCT01336738|2000357|FG001|Overall Study|Protocol Violation|1
990103|NCT01336738|2000358|FG002|Overall Study|Protocol Violation|0
990104|NCT01336738|2000359|FG003|Overall Study|Protocol Violation|0
990105|NCT01336738|2000360|FG004|Overall Study|Protocol Violation|0
990106|NCT01336738|2000356|FG000|Overall Study|Withdrawal by Subject|2
990107|NCT01336738|2000357|FG001|Overall Study|Withdrawal by Subject|0
990108|NCT01336738|2000358|FG002|Overall Study|Withdrawal by Subject|2
990109|NCT01336738|2000359|FG003|Overall Study|Withdrawal by Subject|1
990110|NCT01336738|2000360|FG004|Overall Study|Withdrawal by Subject|1
990111|NCT01336738|2000356|FG000|Overall Study|Other|3
990112|NCT01336738|2000357|FG001|Overall Study|Other|3
990113|NCT01336738|2000358|FG002|Overall Study|Other|2
990114|NCT01336738|2000359|FG003|Overall Study|Other|3
990115|NCT01336738|2000360|FG004|Overall Study|Other|4
990116|NCT01336764|2000374|FG000|Overall Study|Withdrawal by Subject|5
990117|NCT01336764|2000375|FG001|Overall Study|Withdrawal by Subject|5
990118|NCT01336894|2000395|FG000|Follow-up|Study terminated prematurely|2
990119|NCT01336894|2000396|FG001|Follow-up|Study terminated prematurely|7
990120|NCT01336972|2000426|FG000|Overall Study|Adverse Event|1
990121|NCT01336972|2000427|FG001|Overall Study|Adverse Event|1
990122|NCT01336972|2000428|FG002|Overall Study|Adverse Event|0
990123|NCT01337050|2000440|FG000|Overall Study|Death|0
990124|NCT01337050|2000441|FG001|Overall Study|Death|0
990125|NCT01337050|2000442|FG002|Overall Study|Death|4
990126|NCT01337050|2000440|FG000|Overall Study|Other|4
990127|NCT01337050|2000441|FG001|Overall Study|Other|6
990128|NCT01337050|2000442|FG002|Overall Study|Other|8
990129|NCT01337050|2000440|FG000|Overall Study|Participants refused further follow-up|0
990130|NCT01337050|2000441|FG001|Overall Study|Participants refused further follow-up|7
990131|NCT01337050|2000442|FG002|Overall Study|Participants refused further follow-up|7
990132|NCT01337089|2000455|FG000|Overall Study|Adverse Event|237
990133|NCT01337089|2000455|FG000|Overall Study|Withdrawal by Subject|129
990134|NCT01337089|2000455|FG000|Overall Study|Withdrawal by Investigator|33
990135|NCT01337089|2000455|FG000|Overall Study|Met Withdrawal Criteria|3
990136|NCT01337089|2000455|FG000|Overall Study|Lost to Follow-up|2
990137|NCT01337115|2000461|FG000|Overall Study|Protocol Violation|2
990138|NCT01337115|2000462|FG001|Overall Study|Protocol Violation|0
990139|NCT01337167|2000472|FG000|Infant Series|Adverse Event|1
990140|NCT01337167|2000473|FG001|Infant Series|Adverse Event|1
990141|NCT01337167|2000472|FG000|Infant Series|Death|1
990142|NCT01337167|2000473|FG001|Infant Series|Death|1
990143|NCT01337167|2000472|FG000|Infant Series|Lost to Follow-up|13
990144|NCT01337167|2000473|FG001|Infant Series|Lost to Follow-up|7
990145|NCT01337167|2000472|FG000|Infant Series|Non-compliance with study drug|2
990146|NCT01337167|2000473|FG001|Infant Series|Non-compliance with study drug|1
990147|NCT01337167|2000472|FG000|Infant Series|Physician Decision|3
990148|NCT01337167|2000473|FG001|Infant Series|Physician Decision|1
990149|NCT01337167|2000472|FG000|Infant Series|Protocol Violation|22
990150|NCT01337167|2000473|FG001|Infant Series|Protocol Violation|9
990151|NCT01337167|2000472|FG000|Infant Series|Withdrawal by Subject|15
990152|NCT01337167|2000473|FG001|Infant Series|Withdrawal by Subject|4
990153|NCT01337167|2000472|FG000|Infant Series|Randomized but not vaccinated|5
990154|NCT01337167|2000473|FG001|Infant Series|Randomized but not vaccinated|3
990155|NCT01337167|2000472|FG000|Interim Period|Lost to Follow-up|51
990156|NCT01337167|2000473|FG001|Interim Period|Lost to Follow-up|23
990157|NCT01337167|2000472|FG000|Interim Period|Non-compliance with study drug|1
990158|NCT01337167|2000473|FG001|Interim Period|Non-compliance with study drug|0
990159|NCT01337167|2000472|FG000|Interim Period|Physician Decision|6
990160|NCT01337167|2000473|FG001|Interim Period|Physician Decision|3
990161|NCT01337167|2000472|FG000|Interim Period|Protocol Violation|5
990162|NCT01337167|2000473|FG001|Interim Period|Protocol Violation|3
990163|NCT01337167|2000472|FG000|Interim Period|Withdrawal by Subject|18
990164|NCT01337167|2000473|FG001|Interim Period|Withdrawal by Subject|10
990165|NCT01337167|2000472|FG000|Interim Period|Other protocol criterion not met|0
990166|NCT01337167|2000473|FG001|Interim Period|Other protocol criterion not met|1
990167|NCT01337167|2000472|FG000|Toddler Vaccinations|Lost to Follow-up|11
990168|NCT01337167|2000473|FG001|Toddler Vaccinations|Lost to Follow-up|12
990169|NCT01337167|2000472|FG000|Toddler Vaccinations|Protocol Violation|0
990170|NCT01337167|2000473|FG001|Toddler Vaccinations|Protocol Violation|1
990171|NCT01337167|2000472|FG000|Toddler Vaccinations|Withdrawal by Subject|3
990172|NCT01337167|2000473|FG001|Toddler Vaccinations|Withdrawal by Subject|0
990173|NCT01337297|2000481|FG000|Overall Study|They entered to single anodal tDCS|4
990174|NCT01337297|2000482|FG001|Overall Study|They entered to single anodal tDCS|3
990175|NCT01337297|2000481|FG000|Overall Study|Lost to Follow-up|1
990176|NCT01337297|2000482|FG001|Overall Study|Lost to Follow-up|3
990177|NCT01337596|2000506|FG000|Overall Study|Withdrawal by Subject|0
990178|NCT01337596|2000507|FG001|Overall Study|Withdrawal by Subject|0
990179|NCT01337596|2000508|FG002|Overall Study|Withdrawal by Subject|0
990180|NCT01337596|2000509|FG003|Overall Study|Withdrawal by Subject|0
990181|NCT01337596|2000510|FG004|Overall Study|Withdrawal by Subject|2
990182|NCT01337596|2000511|FG005|Overall Study|Withdrawal by Subject|0
990183|NCT01337596|2000512|FG006|Overall Study|Withdrawal by Subject|0
990184|NCT01337596|2000513|FG007|Overall Study|Withdrawal by Subject|0
990185|NCT01337596|2000514|FG008|Overall Study|Withdrawal by Subject|0
990186|NCT01337635|2000539|FG000|Overall Study|Lost to Follow-up|0
990187|NCT01337635|2000540|FG001|Overall Study|Lost to Follow-up|1
990188|NCT01337674|2000548|FG000|Treatment Period 1|Adverse Event|0
990189|NCT01337674|2000549|FG001|Treatment Period 1|Adverse Event|1
990190|NCT01337674|2000550|FG002|Treatment Period 1|Adverse Event|0
990191|NCT01337674|2000551|FG003|Treatment Period 1|Adverse Event|0
990192|NCT01337674|2000548|FG000|Treatment Period 1|Discontinued due to blood draws|0
990193|NCT01337674|2000549|FG001|Treatment Period 1|Discontinued due to blood draws|0
990194|NCT01337674|2000550|FG002|Treatment Period 1|Discontinued due to blood draws|0
990195|NCT01337674|2000551|FG003|Treatment Period 1|Discontinued due to blood draws|1
990196|NCT01337674|2000548|FG000|Treatment Period 2|Withdrawal by Subject|0
990197|NCT01337674|2000549|FG001|Treatment Period 2|Withdrawal by Subject|0
990198|NCT01337674|2000550|FG002|Treatment Period 2|Withdrawal by Subject|1
990199|NCT01337674|2000551|FG003|Treatment Period 2|Withdrawal by Subject|0
990200|NCT01337960|2000594|FG000|Overall Study|Lost to Follow-up|1
990201|NCT01337960|2000595|FG001|Overall Study|Lost to Follow-up|0
990202|NCT01337960|2000596|FG002|Overall Study|Lost to Follow-up|0
990203|NCT01337960|2000594|FG000|Overall Study|Withdrawal by Subject|1
990204|NCT01337960|2000595|FG001|Overall Study|Withdrawal by Subject|0
990205|NCT01337960|2000596|FG002|Overall Study|Withdrawal by Subject|0
990206|NCT01337973|2000607|FG000|Overall Study|Lost to Follow-up|2
990207|NCT01337973|2000608|FG001|Overall Study|Lost to Follow-up|4
990208|NCT01337973|2000609|FG002|Overall Study|Lost to Follow-up|3
990209|NCT01337973|2000607|FG000|Overall Study|Death|1
990210|NCT01337973|2000608|FG001|Overall Study|Death|2
990211|NCT01337973|2000609|FG002|Overall Study|Death|1
990212|NCT01337973|2000607|FG000|Overall Study|Withdrawal by Subject|10
990213|NCT01337973|2000608|FG001|Overall Study|Withdrawal by Subject|8
990214|NCT01337973|2000609|FG002|Overall Study|Withdrawal by Subject|4
990215|NCT01337973|2000607|FG000|Overall Study|missing data on primary outcome|3
990216|NCT01337973|2000608|FG001|Overall Study|missing data on primary outcome|1
990217|NCT01337973|2000609|FG002|Overall Study|missing data on primary outcome|3
990218|NCT01337986|2000619|FG000|Overall Study|Adverse Event|2
990219|NCT01337986|2000620|FG001|Overall Study|Adverse Event|2
990220|NCT01337986|2000619|FG000|Overall Study|Lost to Follow-up|1
990221|NCT01337986|2000620|FG001|Overall Study|Lost to Follow-up|0
990222|NCT01337986|2000619|FG000|Overall Study|Protocol Violation|0
990223|NCT01337986|2000620|FG001|Overall Study|Protocol Violation|3
990224|NCT01338012|2000642|FG000|Overall Study|Death|4
990225|NCT01338012|2000642|FG000|Overall Study|Study terminated|4
990226|NCT01338025|2000648|FG000|Overall Study|Unexpected closure of study|10
990227|NCT01338025|2000649|FG001|Overall Study|Unexpected closure of study|9
990228|NCT01338025|2000648|FG000|Overall Study|Withdrawal by Subject|0
990229|NCT01338025|2000649|FG001|Overall Study|Withdrawal by Subject|2
990230|NCT01338025|2000648|FG000|Overall Study|Found ineligible after starting|1
990231|NCT01338025|2000649|FG001|Overall Study|Found ineligible after starting|0
990232|NCT01338298|2000657|FG000|Overall Study|Withdrawal by Subject|1
990233|NCT01338298|2000658|FG001|Overall Study|Withdrawal by Subject|1
990234|NCT01338298|2000657|FG000|Overall Study|Abdominal Pain and scheduled surgery|0
990235|NCT01338298|2000658|FG001|Overall Study|Abdominal Pain and scheduled surgery|1
990236|NCT01338298|2000657|FG000|Overall Study|Administrative error|0
990237|NCT01338298|2000658|FG001|Overall Study|Administrative error|1
990238|NCT01338298|2000657|FG000|Overall Study|Positive symptom worsening|1
990239|NCT01338298|2000658|FG001|Overall Study|Positive symptom worsening|0
990240|NCT01338298|2000657|FG000|Overall Study|Depressive symptoms and nausea|1
990241|NCT01338298|2000658|FG001|Overall Study|Depressive symptoms and nausea|0
990242|NCT01338298|2000657|FG000|Overall Study|Non-adherence|1
990243|NCT01338298|2000658|FG001|Overall Study|Non-adherence|0
990244|NCT01338415|2000666|FG000|Core + Extension|Adverse Event|8
990245|NCT01338415|2000667|FG001|Core + Extension|Adverse Event|6
990246|NCT01338415|2000668|FG002|Core + Extension|Adverse Event|0
990247|NCT01338415|2000666|FG000|Core + Extension|Withdrawal by Subject|1
990248|NCT01338415|2000667|FG001|Core + Extension|Withdrawal by Subject|1
990249|NCT01338415|2000668|FG002|Core + Extension|Withdrawal by Subject|0
990250|NCT01338415|2000666|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0
990251|NCT01338415|2000667|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2
990252|NCT01338415|2000668|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0
990253|NCT01338415|2000666|FG000|Core + Extension|Other (administrative reason)|1
990254|NCT01338415|2000667|FG001|Core + Extension|Other (administrative reason)|0
990255|NCT01338415|2000668|FG002|Core + Extension|Other (administrative reason)|0
990256|NCT01338415|2000666|FG000|Exceptional Use Treatment Period|Administrative decision|0
990257|NCT01338415|2000667|FG001|Exceptional Use Treatment Period|Administrative decision|0
990258|NCT01338415|2000668|FG002|Exceptional Use Treatment Period|Administrative decision|1
990259|NCT01338415|2000666|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
990260|NCT01338415|2000667|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
990261|NCT01338415|2000668|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3
990262|NCT01338415|2000666|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0
1006722|NCT01469052|2025436|FG000|Overall Study|Moved to rollover protocol|1
990263|NCT01338415|2000667|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0
990264|NCT01338415|2000668|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1
990265|NCT01338415|2000666|FG000|Exceptional Use Treatment Period|Death|0
990266|NCT01338415|2000667|FG001|Exceptional Use Treatment Period|Death|0
990267|NCT01338415|2000668|FG002|Exceptional Use Treatment Period|Death|1
990268|NCT01338493|2000676|FG000|Enrolled|Withdrawal by Subject|1
990269|NCT01338493|2000676|FG000|Enrolled|Patient not implanted|4
990270|NCT01338493|2000676|FG000|Discharge|Death|1
990271|NCT01338493|2000676|FG000|Discharge|Missed visit|1
990272|NCT01338493|2000676|FG000|6 Months Follow up|Lost to Follow-up|11
990273|NCT01338493|2000676|FG000|6 Months Follow up|Missed visit|8
990274|NCT01338493|2000676|FG000|12 Months Follow up|Lost to Follow-up|9
990275|NCT01338610|2000696|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1
990276|NCT01338610|2000697|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1
990277|NCT01338610|2000698|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0
990278|NCT01338610|2000696|FG000|Overall Study|Protocol Violation|1
990279|NCT01338610|2000697|FG001|Overall Study|Protocol Violation|0
990280|NCT01338610|2000698|FG002|Overall Study|Protocol Violation|1
990281|NCT01338610|2000696|FG000|Overall Study|Adverse Event|3
990282|NCT01338610|2000697|FG001|Overall Study|Adverse Event|0
990283|NCT01338610|2000698|FG002|Overall Study|Adverse Event|0
990285|NCT01338792|2000718|FG000|Overall Study|Adverse Event|2
990286|NCT01338792|2000718|FG000|Overall Study|Death|1
990287|NCT01338792|2000718|FG000|Overall Study|Withdrawal by Subject|1
990288|NCT01338818|2000722|FG000|Overall Study|Adverse Event|8
990289|NCT01338818|2000722|FG000|Overall Study|Lack of Efficacy|5
990290|NCT01338818|2000722|FG000|Overall Study|no longer require study drug|1
990291|NCT01338818|2000722|FG000|Overall Study|Withdrawal by Subject|11
990292|NCT01338818|2000722|FG000|Overall Study|Lost to Follow-up|4
990293|NCT01338818|2000722|FG000|Overall Study|Administrative problems|3
990294|NCT01338818|2000722|FG000|Overall Study|Protocol Deviation|4
990295|NCT01338870|2000736|FG000|Overall Study|Lost to Follow-up|0
990296|NCT01338870|2000737|FG001|Overall Study|Lost to Follow-up|0
990297|NCT01338870|2000738|FG002|Overall Study|Lost to Follow-up|1
990298|NCT01338870|2000739|FG003|Overall Study|Lost to Follow-up|0
990299|NCT01338870|2000740|FG004|Overall Study|Lost to Follow-up|1
990300|NCT01338870|2000741|FG005|Overall Study|Lost to Follow-up|0
990301|NCT01338870|2000736|FG000|Overall Study|Withdrawal by Subject|2
990302|NCT01338870|2000737|FG001|Overall Study|Withdrawal by Subject|3
990303|NCT01338870|2000738|FG002|Overall Study|Withdrawal by Subject|4
990304|NCT01338870|2000739|FG003|Overall Study|Withdrawal by Subject|0
990305|NCT01338870|2000740|FG004|Overall Study|Withdrawal by Subject|0
990306|NCT01338870|2000741|FG005|Overall Study|Withdrawal by Subject|2
990307|NCT01338870|2000736|FG000|Overall Study|Other|3
990308|NCT01338870|2000737|FG001|Overall Study|Other|3
990309|NCT01338870|2000738|FG002|Overall Study|Other|3
990310|NCT01338870|2000739|FG003|Overall Study|Other|2
990311|NCT01338870|2000740|FG004|Overall Study|Other|0
990312|NCT01338870|2000741|FG005|Overall Study|Other|2
990313|NCT01338870|2000736|FG000|Overall Study|Protocol Violation|0
990314|NCT01338870|2000737|FG001|Overall Study|Protocol Violation|2
990315|NCT01338870|2000738|FG002|Overall Study|Protocol Violation|2
990316|NCT01338870|2000739|FG003|Overall Study|Protocol Violation|2
990317|NCT01338870|2000740|FG004|Overall Study|Protocol Violation|1
990318|NCT01338870|2000741|FG005|Overall Study|Protocol Violation|1
990319|NCT01338870|2000736|FG000|Overall Study|Adverse Event|4
990320|NCT01338870|2000737|FG001|Overall Study|Adverse Event|4
990321|NCT01338870|2000738|FG002|Overall Study|Adverse Event|1
990322|NCT01338870|2000739|FG003|Overall Study|Adverse Event|5
990323|NCT01338870|2000740|FG004|Overall Study|Adverse Event|4
990324|NCT01338870|2000741|FG005|Overall Study|Adverse Event|1
990325|NCT01338987|2000760|FG000|Overall Study|enrolled on new protocol|0
990326|NCT01338987|2000761|FG001|Overall Study|enrolled on new protocol|0
990327|NCT01338987|2000762|FG002|Overall Study|enrolled on new protocol|1
990328|NCT01338987|2000763|FG003|Overall Study|enrolled on new protocol|0
990329|NCT01338987|2000764|FG004|Overall Study|enrolled on new protocol|0
990330|NCT01338987|2000760|FG000|Overall Study|Disease progression on study|2
990331|NCT01338987|2000761|FG001|Overall Study|Disease progression on study|1
990332|NCT01338987|2000762|FG002|Overall Study|Disease progression on study|1
990333|NCT01338987|2000763|FG003|Overall Study|Disease progression on study|0
990334|NCT01338987|2000764|FG004|Overall Study|Disease progression on study|0
990335|NCT01339000|2000780|FG000|Overall Study|study closed due to lack of drug supply|1
990336|NCT01339000|2000781|FG001|Overall Study|study closed due to lack of drug supply|0
990337|NCT01339052|2000796|FG000|Overall Study|Disease progression|13
990338|NCT01339052|2000797|FG001|Overall Study|Disease progression|46
990339|NCT01339052|2000796|FG000|Overall Study|Adverse Event|1
990340|NCT01339052|2000797|FG001|Overall Study|Adverse Event|1
990341|NCT01339052|2000796|FG000|Overall Study|Withdrawal by Subject|0
990342|NCT01339052|2000797|FG001|Overall Study|Withdrawal by Subject|3
990343|NCT01339052|2000796|FG000|Overall Study|Physician Decision|1
990344|NCT01339052|2000797|FG001|Overall Study|Physician Decision|0
990345|NCT01339273|2000835|FG000|Overall Study|Lost to Follow-up|8
990346|NCT01339273|2000836|FG001|Overall Study|Lost to Follow-up|8
990347|NCT01339390|2000853|FG000|Overall Study|Death|32
990348|NCT01339390|2000854|FG001|Overall Study|Death|29
990349|NCT01339390|2000853|FG000|Overall Study|Lost to Follow-up|125
990350|NCT01339390|2000854|FG001|Overall Study|Lost to Follow-up|127
990351|NCT01339429|2000873|FG000|Overall Study|Withdrawal by Subject|1
990352|NCT01339429|2000873|FG000|Overall Study|Physician Decision|3
990353|NCT01339559|2000877|FG000|Overall Study|Adverse Event|92
990354|NCT01339559|2000877|FG000|Overall Study|Death|5
990355|NCT01339559|2000877|FG000|Overall Study|Lack of Efficacy|164
990356|NCT01339559|2000877|FG000|Overall Study|Lost to Follow-up|22
990357|NCT01339559|2000877|FG000|Overall Study|Subject choice|89
990358|NCT01339559|2000877|FG000|Overall Study|Protocol Violation|15
990359|NCT01339559|2000877|FG000|Overall Study|Study closure at site|1
990360|NCT01339559|2000877|FG000|Overall Study|Incarcerated|2
990361|NCT01339559|2000877|FG000|Overall Study|Epilepsy surgery|1
990362|NCT01339559|2000877|FG000|Overall Study|Pregnancy planned|2
990363|NCT01339559|2000877|FG000|Overall Study|Left the country|1
990364|NCT01339559|2000877|FG000|Overall Study|Investigator decision|2
990365|NCT01339559|2000877|FG000|Overall Study|Patient didn't wish to continue|1
990366|NCT01339559|2000877|FG000|Overall Study|PI decision|1
990367|NCT01339832|2000882|FG000|Overall Study|Lost to Follow-up|3
990368|NCT01339832|2000882|FG000|Overall Study|Death|11
990369|NCT01339897|2000901|FG000|Overall Study|Adverse Event|1
990370|NCT01339897|2000902|FG001|Overall Study|Adverse Event|0
990371|NCT01339897|2000903|FG002|Overall Study|Adverse Event|0
990372|NCT01339897|2000904|FG003|Overall Study|Adverse Event|1
990373|NCT01339910|2000918|FG000|Overall Study|Withdrawal by Subject|1
990374|NCT01339910|2000919|FG001|Overall Study|Withdrawal by Subject|0
990375|NCT01339910|2000918|FG000|Overall Study|Physician Decision|1
990376|NCT01339910|2000919|FG001|Overall Study|Physician Decision|0
990377|NCT01339910|2000918|FG000|Overall Study|Disease relapse|1
990378|NCT01339910|2000919|FG001|Overall Study|Disease relapse|4
990379|NCT01339923|2000932|FG000|Overall Study|Adverse Event|1
990380|NCT01339923|2000933|FG001|Overall Study|Adverse Event|1
990381|NCT01339923|2000934|FG002|Overall Study|Adverse Event|1
990382|NCT01339923|2000935|FG003|Overall Study|Adverse Event|0
990383|NCT01339923|2000936|FG004|Overall Study|Adverse Event|0
990384|NCT01339923|2000937|FG005|Overall Study|Adverse Event|0
990385|NCT01339923|2000938|FG006|Overall Study|Adverse Event|1
990386|NCT01339923|2000932|FG000|Overall Study|Inappropriate Enrollment|1
990387|NCT01339923|2000933|FG001|Overall Study|Inappropriate Enrollment|0
990388|NCT01339923|2000934|FG002|Overall Study|Inappropriate Enrollment|0
990389|NCT01339923|2000935|FG003|Overall Study|Inappropriate Enrollment|0
990390|NCT01339923|2000936|FG004|Overall Study|Inappropriate Enrollment|0
990391|NCT01339923|2000937|FG005|Overall Study|Inappropriate Enrollment|1
990392|NCT01339923|2000938|FG006|Overall Study|Inappropriate Enrollment|0
990393|NCT01339923|2000932|FG000|Overall Study|Lost to Follow-up|4
990394|NCT01339923|2000933|FG001|Overall Study|Lost to Follow-up|4
990395|NCT01339923|2000934|FG002|Overall Study|Lost to Follow-up|0
990396|NCT01339923|2000935|FG003|Overall Study|Lost to Follow-up|3
990397|NCT01339923|2000936|FG004|Overall Study|Lost to Follow-up|1
912915|NCT00807937|1890557|FG000|Overall Study|Intake of prohibited medicine|0
912916|NCT00807937|1890558|FG001|Overall Study|Intake of prohibited medicine|0
912917|NCT00807937|1890559|FG002|Overall Study|Intake of prohibited medicine|2
912918|NCT00807937|1890560|FG003|Overall Study|Intake of prohibited medicine|0
912919|NCT00807937|1890557|FG000|Overall Study|All other reasons (not provided)|2
912920|NCT00807937|1890558|FG001|Overall Study|All other reasons (not provided)|4
912921|NCT00807937|1890559|FG002|Overall Study|All other reasons (not provided)|0
912922|NCT00807937|1890560|FG003|Overall Study|All other reasons (not provided)|1
912923|NCT00808015|1890579|FG000|Overall Study|Death|1
912924|NCT00808015|1890579|FG000|Overall Study|Lack of Efficacy|58
912925|NCT00808015|1890579|FG000|Overall Study|Lost to Follow-up|76
912926|NCT00808015|1890579|FG000|Overall Study|Participants not willing to participate|158
912927|NCT00808015|1890579|FG000|Overall Study|Adverse Event|22
912928|NCT00808015|1890579|FG000|Overall Study|Other|25
912929|NCT00808015|1890579|FG000|Overall Study|Enrolled but not treated|4
912930|NCT00808028|1890587|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3
912931|NCT00808028|1890588|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0
912932|NCT00808028|1890589|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2
912933|NCT00808028|1890590|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5
912934|NCT00808028|1890587|FG000|Stage 1 (6 Months)|Other|1
912935|NCT00808028|1890588|FG001|Stage 1 (6 Months)|Other|0
912936|NCT00808028|1890589|FG002|Stage 1 (6 Months)|Other|2
912937|NCT00808028|1890590|FG003|Stage 1 (6 Months)|Other|4
912938|NCT00808028|1890587|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0
912939|NCT00808028|1890588|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1
912940|NCT00808028|1890589|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1
912941|NCT00808028|1890590|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3
912942|NCT00808028|1890587|FG000|Stage 1 (6 Months)|Adverse Event|0
912943|NCT00808028|1890588|FG001|Stage 1 (6 Months)|Adverse Event|0
912944|NCT00808028|1890589|FG002|Stage 1 (6 Months)|Adverse Event|1
912945|NCT00808028|1890590|FG003|Stage 1 (6 Months)|Adverse Event|2
912946|NCT00808028|1890587|FG000|Stage 1 (6 Months)|Lost to Follow-up|1
912947|NCT00808028|1890588|FG001|Stage 1 (6 Months)|Lost to Follow-up|0
990398|NCT01339923|2000937|FG005|Overall Study|Lost to Follow-up|1
990399|NCT01339923|2000938|FG006|Overall Study|Lost to Follow-up|5
990400|NCT01339923|2000932|FG000|Overall Study|Protocol Violation|0
990401|NCT01339923|2000933|FG001|Overall Study|Protocol Violation|0
990402|NCT01339923|2000934|FG002|Overall Study|Protocol Violation|0
990403|NCT01339923|2000935|FG003|Overall Study|Protocol Violation|0
990404|NCT01339923|2000936|FG004|Overall Study|Protocol Violation|0
990405|NCT01339923|2000937|FG005|Overall Study|Protocol Violation|3
990406|NCT01339923|2000938|FG006|Overall Study|Protocol Violation|1
990407|NCT01339923|2000932|FG000|Overall Study|Unable to Classify|1
990408|NCT01339923|2000933|FG001|Overall Study|Unable to Classify|0
990409|NCT01339923|2000934|FG002|Overall Study|Unable to Classify|1
990410|NCT01339923|2000935|FG003|Overall Study|Unable to Classify|0
990411|NCT01339923|2000936|FG004|Overall Study|Unable to Classify|0
990412|NCT01339923|2000937|FG005|Overall Study|Unable to Classify|1
990413|NCT01339923|2000938|FG006|Overall Study|Unable to Classify|5
990414|NCT01339923|2000932|FG000|Overall Study|Withdrawal by Subject|7
990415|NCT01339923|2000933|FG001|Overall Study|Withdrawal by Subject|11
990416|NCT01339923|2000934|FG002|Overall Study|Withdrawal by Subject|6
990417|NCT01339923|2000935|FG003|Overall Study|Withdrawal by Subject|1
990418|NCT01339923|2000936|FG004|Overall Study|Withdrawal by Subject|4
990419|NCT01339923|2000937|FG005|Overall Study|Withdrawal by Subject|3
990420|NCT01339923|2000938|FG006|Overall Study|Withdrawal by Subject|2
990421|NCT01340014|2000973|FG000|Period 1, First 7 Days|Adverse Event|1
990422|NCT01340014|2000974|FG001|Period 1, First 7 Days|Adverse Event|0
990423|NCT01340014|2000973|FG000|Period 1, First 7 Days|Personal Reasons|1
990424|NCT01340014|2000974|FG001|Period 1, First 7 Days|Personal Reasons|0
990425|NCT01340014|2000973|FG000|Period 2, Second 7 Days|Adverse Event|0
990426|NCT01340014|2000974|FG001|Period 2, Second 7 Days|Adverse Event|1
990427|NCT01340027|2000992|FG000|Overall Study|Randomized but Never Received Study Drug|0
990428|NCT01340027|2000993|FG001|Overall Study|Randomized but Never Received Study Drug|0
990429|NCT01340027|2000994|FG002|Overall Study|Randomized but Never Received Study Drug|1
990430|NCT01340027|2000995|FG003|Overall Study|Randomized but Never Received Study Drug|0
990431|NCT01340027|2000996|FG004|Overall Study|Randomized but Never Received Study Drug|0
990432|NCT01340027|2000997|FG005|Overall Study|Randomized but Never Received Study Drug|0
990433|NCT01340027|2000998|FG006|Overall Study|Randomized but Never Received Study Drug|0
990434|NCT01340027|2000999|FG007|Overall Study|Randomized but Never Received Study Drug|0
990435|NCT01340027|2001000|FG008|Overall Study|Randomized but Never Received Study Drug|0
990436|NCT01340027|2001001|FG009|Overall Study|Randomized but Never Received Study Drug|0
990437|NCT01340027|2001002|FG010|Overall Study|Randomized but Never Received Study Drug|0
990438|NCT01340027|2001003|FG011|Overall Study|Randomized but Never Received Study Drug|0
990439|NCT01340027|2000992|FG000|Overall Study|Adverse Event|0
990440|NCT01340027|2000993|FG001|Overall Study|Adverse Event|1
990441|NCT01340027|2000994|FG002|Overall Study|Adverse Event|2
990442|NCT01340027|2000995|FG003|Overall Study|Adverse Event|0
990443|NCT01340027|2000996|FG004|Overall Study|Adverse Event|1
990444|NCT01340027|2000997|FG005|Overall Study|Adverse Event|2
990445|NCT01340027|2000998|FG006|Overall Study|Adverse Event|2
990446|NCT01340027|2000999|FG007|Overall Study|Adverse Event|1
990447|NCT01340027|2001000|FG008|Overall Study|Adverse Event|4
990448|NCT01340027|2001001|FG009|Overall Study|Adverse Event|1
990449|NCT01340027|2001002|FG010|Overall Study|Adverse Event|1
990450|NCT01340027|2001003|FG011|Overall Study|Adverse Event|3
990451|NCT01340027|2000992|FG000|Overall Study|Lack of Efficacy|0
990452|NCT01340027|2000993|FG001|Overall Study|Lack of Efficacy|0
990453|NCT01340027|2000994|FG002|Overall Study|Lack of Efficacy|0
990454|NCT01340027|2000995|FG003|Overall Study|Lack of Efficacy|0
990455|NCT01340027|2000996|FG004|Overall Study|Lack of Efficacy|0
990456|NCT01340027|2000997|FG005|Overall Study|Lack of Efficacy|0
990457|NCT01340027|2000998|FG006|Overall Study|Lack of Efficacy|1
990458|NCT01340027|2000999|FG007|Overall Study|Lack of Efficacy|1
990459|NCT01340027|2001000|FG008|Overall Study|Lack of Efficacy|1
990460|NCT01340027|2001001|FG009|Overall Study|Lack of Efficacy|0
990461|NCT01340027|2001002|FG010|Overall Study|Lack of Efficacy|0
990462|NCT01340027|2001003|FG011|Overall Study|Lack of Efficacy|0
990463|NCT01340027|2000992|FG000|Overall Study|Lost to Follow-up|0
990464|NCT01340027|2000993|FG001|Overall Study|Lost to Follow-up|1
912948|NCT00808028|1890589|FG002|Stage 1 (6 Months)|Lost to Follow-up|1
912949|NCT00808028|1890590|FG003|Stage 1 (6 Months)|Lost to Follow-up|0
912950|NCT00808028|1890587|FG000|Stage 1 (6 Months)|Protocol Violation|0
912951|NCT00808028|1890588|FG001|Stage 1 (6 Months)|Protocol Violation|0
912952|NCT00808028|1890589|FG002|Stage 1 (6 Months)|Protocol Violation|0
912953|NCT00808028|1890590|FG003|Stage 1 (6 Months)|Protocol Violation|1
912954|NCT00808028|1890587|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
912955|NCT00808028|1890588|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
912956|NCT00808028|1890589|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
912957|NCT00808028|1890590|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
912958|NCT00808028|1890587|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
912959|NCT00808028|1890588|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
912960|NCT00808028|1890589|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
912961|NCT00808028|1890590|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
912962|NCT00808028|1890587|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
990465|NCT01340027|2000994|FG002|Overall Study|Lost to Follow-up|0
990466|NCT01340027|2000995|FG003|Overall Study|Lost to Follow-up|0
990467|NCT01340027|2000996|FG004|Overall Study|Lost to Follow-up|0
990468|NCT01340027|2000997|FG005|Overall Study|Lost to Follow-up|0
990469|NCT01340027|2000998|FG006|Overall Study|Lost to Follow-up|1
990470|NCT01340027|2000999|FG007|Overall Study|Lost to Follow-up|0
990471|NCT01340027|2001000|FG008|Overall Study|Lost to Follow-up|0
990472|NCT01340027|2001001|FG009|Overall Study|Lost to Follow-up|1
990473|NCT01340027|2001002|FG010|Overall Study|Lost to Follow-up|0
990474|NCT01340027|2001003|FG011|Overall Study|Lost to Follow-up|0
990475|NCT01340027|2000992|FG000|Overall Study|Protocol Violation|1
990476|NCT01340027|2000993|FG001|Overall Study|Protocol Violation|2
990477|NCT01340027|2000994|FG002|Overall Study|Protocol Violation|0
990478|NCT01340027|2000995|FG003|Overall Study|Protocol Violation|0
990479|NCT01340027|2000996|FG004|Overall Study|Protocol Violation|6
990480|NCT01340027|2000997|FG005|Overall Study|Protocol Violation|0
990481|NCT01340027|2000998|FG006|Overall Study|Protocol Violation|0
990482|NCT01340027|2000999|FG007|Overall Study|Protocol Violation|1
990483|NCT01340027|2001000|FG008|Overall Study|Protocol Violation|2
990484|NCT01340027|2001001|FG009|Overall Study|Protocol Violation|2
990485|NCT01340027|2001002|FG010|Overall Study|Protocol Violation|0
990486|NCT01340027|2001003|FG011|Overall Study|Protocol Violation|0
990487|NCT01340027|2000992|FG000|Overall Study|Withdrawal by Subject|4
990488|NCT01340027|2000993|FG001|Overall Study|Withdrawal by Subject|3
990489|NCT01340027|2000994|FG002|Overall Study|Withdrawal by Subject|1
990490|NCT01340027|2000995|FG003|Overall Study|Withdrawal by Subject|3
990491|NCT01340027|2000996|FG004|Overall Study|Withdrawal by Subject|3
912963|NCT00808028|1890588|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
912964|NCT00808028|1890589|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
912965|NCT00808028|1890590|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
912966|NCT00808028|1890587|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2
912967|NCT00808028|1890588|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0
912968|NCT00808028|1890589|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5
912969|NCT00808028|1890590|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4
912970|NCT00808028|1890587|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1
912971|NCT00808028|1890588|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0
912972|NCT00808028|1890589|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1
912973|NCT00808028|1890590|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0
912974|NCT00808028|1890587|FG000|Stage 2 (Followed up to 48 Months )|Other|0
912975|NCT00808028|1890588|FG001|Stage 2 (Followed up to 48 Months )|Other|0
912976|NCT00808028|1890589|FG002|Stage 2 (Followed up to 48 Months )|Other|1
912977|NCT00808028|1890590|FG003|Stage 2 (Followed up to 48 Months )|Other|1
912978|NCT00808028|1890587|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
912979|NCT00808028|1890588|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
912980|NCT00808028|1890589|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
912981|NCT00808028|1890590|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
912982|NCT00808028|1890587|FG000|Stage 2 (Followed up to 48 Months )|Death|0
912983|NCT00808028|1890588|FG001|Stage 2 (Followed up to 48 Months )|Death|0
912984|NCT00808028|1890589|FG002|Stage 2 (Followed up to 48 Months )|Death|1
912985|NCT00808028|1890590|FG003|Stage 2 (Followed up to 48 Months )|Death|0
912986|NCT00808028|1890587|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0
912987|NCT00808028|1890588|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0
912988|NCT00808028|1890589|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1
912989|NCT00808028|1890590|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0
912990|NCT00808067|1890612|FG000|Overall Study|Major/minor bleed|30
912991|NCT00808067|1890613|FG001|Overall Study|Major/minor bleed|44
912992|NCT00808067|1890612|FG000|Overall Study|Outcome event - other|33
912993|NCT00808067|1890613|FG001|Overall Study|Outcome event - other|25
912994|NCT00808067|1890612|FG000|Overall Study|Adverse Event|111
912995|NCT00808067|1890613|FG001|Overall Study|Adverse Event|121
912996|NCT00808067|1890612|FG000|Overall Study|Hospitalization (not including surgery)|18
912997|NCT00808067|1890613|FG001|Overall Study|Hospitalization (not including surgery)|17
912998|NCT00808067|1890612|FG000|Overall Study|Hospitalization due to surgery|37
912999|NCT00808067|1890613|FG001|Overall Study|Hospitalization due to surgery|40
913000|NCT00808067|1890612|FG000|Overall Study|Reduced creatinine clearance|53
913001|NCT00808067|1890613|FG001|Overall Study|Reduced creatinine clearance|55
913002|NCT00808067|1890612|FG000|Overall Study|Elevated LFT results|7
913003|NCT00808067|1890613|FG001|Overall Study|Elevated LFT results|3
913004|NCT00808067|1890612|FG000|Overall Study|Patient refused to take study medication|65
913005|NCT00808067|1890613|FG001|Overall Study|Patient refused to take study medication|76
913006|NCT00808067|1890612|FG000|Overall Study|Missing|1
913007|NCT00808067|1890613|FG001|Overall Study|Missing|0
913008|NCT00808067|1890612|FG000|Overall Study|Death|1
913009|NCT00808067|1890613|FG001|Overall Study|Death|1
913010|NCT00808067|1890612|FG000|Overall Study|Procedure|6
913011|NCT00808067|1890613|FG001|Overall Study|Procedure|7
913012|NCT00808067|1890612|FG000|Overall Study|Withdrawal by Subject|21
913013|NCT00808067|1890613|FG001|Overall Study|Withdrawal by Subject|25
913014|NCT00808067|1890612|FG000|Overall Study|Site closed|4
913015|NCT00808067|1890613|FG001|Overall Study|Site closed|3
913016|NCT00808067|1890612|FG000|Overall Study|Physician Decision|47
990492|NCT01340027|2000997|FG005|Overall Study|Withdrawal by Subject|2
990493|NCT01340027|2000998|FG006|Overall Study|Withdrawal by Subject|3
990494|NCT01340027|2000999|FG007|Overall Study|Withdrawal by Subject|4
990495|NCT01340027|2001000|FG008|Overall Study|Withdrawal by Subject|1
990496|NCT01340027|2001001|FG009|Overall Study|Withdrawal by Subject|2
990497|NCT01340027|2001002|FG010|Overall Study|Withdrawal by Subject|0
990498|NCT01340027|2001003|FG011|Overall Study|Withdrawal by Subject|1
990499|NCT01340027|2000992|FG000|Overall Study|Miscellaneous|0
990500|NCT01340027|2000993|FG001|Overall Study|Miscellaneous|0
990501|NCT01340027|2000994|FG002|Overall Study|Miscellaneous|0
990502|NCT01340027|2000995|FG003|Overall Study|Miscellaneous|1
990503|NCT01340027|2000996|FG004|Overall Study|Miscellaneous|0
990504|NCT01340027|2000997|FG005|Overall Study|Miscellaneous|0
990505|NCT01340027|2000998|FG006|Overall Study|Miscellaneous|0
990506|NCT01340027|2000999|FG007|Overall Study|Miscellaneous|0
990507|NCT01340027|2001000|FG008|Overall Study|Miscellaneous|0
990508|NCT01340027|2001001|FG009|Overall Study|Miscellaneous|0
990509|NCT01340027|2001002|FG010|Overall Study|Miscellaneous|1
990510|NCT01340027|2001003|FG011|Overall Study|Miscellaneous|0
990511|NCT01340066|2001048|FG000|Placebo Run in Period|Screen Failures|27
990512|NCT01340066|2001049|FG001|Placebo Run in Period|Screen Failures|0
990513|NCT01340066|2001050|FG002|Placebo Run in Period|Screen Failures|0
990514|NCT01340066|2001048|FG000|5 Week Double Blind Randomization Period|Adverse Event|0
990515|NCT01340066|2001049|FG001|5 Week Double Blind Randomization Period|Adverse Event|2
990516|NCT01340066|2001050|FG002|5 Week Double Blind Randomization Period|Adverse Event|2
913017|NCT00808067|1890613|FG001|Overall Study|Physician Decision|38
913018|NCT00808067|1890612|FG000|Overall Study|Protocol Violation|3
913019|NCT00808067|1890613|FG001|Overall Study|Protocol Violation|11
913020|NCT00808067|1890612|FG000|Overall Study|Patient elected|7
913021|NCT00808067|1890613|FG001|Overall Study|Patient elected|9
913022|NCT00808067|1890612|FG000|Overall Study|Site closed for cause|19
913023|NCT00808067|1890613|FG001|Overall Study|Site closed for cause|19
913024|NCT00808067|1890612|FG000|Overall Study|Other reason not defined above|5
913025|NCT00808067|1890613|FG001|Overall Study|Other reason not defined above|5
913026|NCT00808067|1890612|FG000|Overall Study|Excluded from analysis|13
913027|NCT00808067|1890613|FG001|Overall Study|Excluded from analysis|19
913028|NCT00808132|1890624|FG000|Overall Study|Adverse Event|34
913029|NCT00808132|1890625|FG001|Overall Study|Adverse Event|33
913030|NCT00808132|1890626|FG002|Overall Study|Adverse Event|16
913031|NCT00808132|1890627|FG003|Overall Study|Adverse Event|31
913032|NCT00808132|1890628|FG004|Overall Study|Adverse Event|33
913033|NCT00808132|1890624|FG000|Overall Study|Death|0
913034|NCT00808132|1890625|FG001|Overall Study|Death|0
913035|NCT00808132|1890626|FG002|Overall Study|Death|0
913036|NCT00808132|1890627|FG003|Overall Study|Death|0
913037|NCT00808132|1890628|FG004|Overall Study|Death|1
913038|NCT00808132|1890624|FG000|Overall Study|Physician Decision|0
913039|NCT00808132|1890625|FG001|Overall Study|Physician Decision|1
913040|NCT00808132|1890626|FG002|Overall Study|Physician Decision|0
913041|NCT00808132|1890627|FG003|Overall Study|Physician Decision|0
913042|NCT00808132|1890628|FG004|Overall Study|Physician Decision|0
913043|NCT00808132|1890624|FG000|Overall Study|Lost to Follow-up|8
913044|NCT00808132|1890625|FG001|Overall Study|Lost to Follow-up|10
913045|NCT00808132|1890626|FG002|Overall Study|Lost to Follow-up|11
913046|NCT00808132|1890627|FG003|Overall Study|Lost to Follow-up|8
913047|NCT00808132|1890628|FG004|Overall Study|Lost to Follow-up|9
913048|NCT00808132|1890624|FG000|Overall Study|Protocol Violation|8
913049|NCT00808132|1890625|FG001|Overall Study|Protocol Violation|9
913050|NCT00808132|1890626|FG002|Overall Study|Protocol Violation|4
913051|NCT00808132|1890627|FG003|Overall Study|Protocol Violation|9
913052|NCT00808132|1890628|FG004|Overall Study|Protocol Violation|5
913053|NCT00808132|1890624|FG000|Overall Study|Withdrawal by Subject|27
913054|NCT00808132|1890625|FG001|Overall Study|Withdrawal by Subject|18
913055|NCT00808132|1890626|FG002|Overall Study|Withdrawal by Subject|2
913056|NCT00808132|1890627|FG003|Overall Study|Withdrawal by Subject|7
913057|NCT00808132|1890628|FG004|Overall Study|Withdrawal by Subject|16
913058|NCT00808132|1890624|FG000|Overall Study|Other|6
913059|NCT00808132|1890625|FG001|Overall Study|Other|4
913060|NCT00808132|1890626|FG002|Overall Study|Other|6
913061|NCT00808132|1890627|FG003|Overall Study|Other|2
913062|NCT00808132|1890628|FG004|Overall Study|Other|15
913063|NCT00808132|1890624|FG000|Overall Study|Randomized, but not treated|10
913064|NCT00808132|1890625|FG001|Overall Study|Randomized, but not treated|7
913065|NCT00808132|1890626|FG002|Overall Study|Randomized, but not treated|9
913066|NCT00808132|1890627|FG003|Overall Study|Randomized, but not treated|8
913067|NCT00808132|1890628|FG004|Overall Study|Randomized, but not treated|9
913068|NCT00808132|1890624|FG000|Overall Study|Unsatisfactory response|5
913069|NCT00808132|1890625|FG001|Overall Study|Unsatisfactory response|6
913070|NCT00808132|1890626|FG002|Overall Study|Unsatisfactory response|6
913071|NCT00808132|1890627|FG003|Overall Study|Unsatisfactory response|4
913072|NCT00808132|1890628|FG004|Overall Study|Unsatisfactory response|12
913073|NCT00808210|1890642|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3
913074|NCT00808210|1890643|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7
913075|NCT00808210|1890642|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6
990517|NCT01340066|2001048|FG000|5 Week Double Blind Randomization Period|Physician Decision|0
990518|NCT01340066|2001049|FG001|5 Week Double Blind Randomization Period|Physician Decision|1
990519|NCT01340066|2001050|FG002|5 Week Double Blind Randomization Period|Physician Decision|0
990520|NCT01340066|2001048|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
990521|NCT01340066|2001049|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
990522|NCT01340066|2001050|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
990523|NCT01340196|2001066|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2
990524|NCT01340209|2001078|FG000|Overall Study|Adverse Event|1
990525|NCT01340209|2001079|FG001|Overall Study|Adverse Event|1
990526|NCT01340209|2001080|FG002|Overall Study|Adverse Event|2
990527|NCT01340209|2001078|FG000|Overall Study|Protocol Violation|1
990528|NCT01340209|2001079|FG001|Overall Study|Protocol Violation|2
990529|NCT01340209|2001080|FG002|Overall Study|Protocol Violation|1
990530|NCT01340209|2001078|FG000|Overall Study|Withdrawal by Subject|0
990531|NCT01340209|2001079|FG001|Overall Study|Withdrawal by Subject|0
990532|NCT01340209|2001080|FG002|Overall Study|Withdrawal by Subject|1
990533|NCT01340209|2001078|FG000|Overall Study|Other reason not defined above|3
990534|NCT01340209|2001079|FG001|Overall Study|Other reason not defined above|5
990535|NCT01340209|2001080|FG002|Overall Study|Other reason not defined above|4
990536|NCT01340300|2001092|FG000|Overall Study|Lost to Follow-up|3
990537|NCT01340300|2001093|FG001|Overall Study|Lost to Follow-up|0
990538|NCT01340300|2001094|FG002|Overall Study|Lost to Follow-up|5
990539|NCT01340300|2001095|FG003|Overall Study|Lost to Follow-up|10
990540|NCT01340300|2001092|FG000|Overall Study|Withdrawal by Subject|5
990541|NCT01340300|2001093|FG001|Overall Study|Withdrawal by Subject|6
990542|NCT01340300|2001094|FG002|Overall Study|Withdrawal by Subject|6
990543|NCT01340300|2001095|FG003|Overall Study|Withdrawal by Subject|3
990544|NCT01340300|2001092|FG000|Overall Study|Adverse Event|1
990545|NCT01340300|2001093|FG001|Overall Study|Adverse Event|0
990546|NCT01340300|2001094|FG002|Overall Study|Adverse Event|4
990547|NCT01340300|2001095|FG003|Overall Study|Adverse Event|0
990548|NCT01340300|2001092|FG000|Overall Study|Physician Decision|0
990549|NCT01340300|2001093|FG001|Overall Study|Physician Decision|1
990550|NCT01340300|2001094|FG002|Overall Study|Physician Decision|0
990551|NCT01340300|2001095|FG003|Overall Study|Physician Decision|0
990552|NCT01340300|2001092|FG000|Overall Study|Unrelated sickness|0
913076|NCT00808210|1890643|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2
913077|NCT00808210|1890642|FG000|Double-Blind TX Period|Adverse Event|0
913078|NCT00808210|1890643|FG001|Double-Blind TX Period|Adverse Event|1
913079|NCT00808210|1890642|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1
913080|NCT00808210|1890643|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1
913081|NCT00808210|1890642|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1
913082|NCT00808210|1890643|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1
913083|NCT00808210|1890642|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9
913084|NCT00808210|1890643|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4
913085|NCT00808236|1890651|FG000|Overall Study|Was not resuscitated|50
913086|NCT00808236|1890652|FG001|Overall Study|Was not resuscitated|56
913087|NCT00808236|1890651|FG000|Overall Study|Pre-defined exclusion|13
913088|NCT00808236|1890652|FG001|Overall Study|Pre-defined exclusion|3
913089|NCT00808236|1890651|FG000|Overall Study|Lost to Follow-up|1
913090|NCT00808236|1890652|FG001|Overall Study|Lost to Follow-up|1
913091|NCT00808236|1890651|FG000|Overall Study|Physician Decision|0
913092|NCT00808236|1890652|FG001|Overall Study|Physician Decision|1
913093|NCT00808236|1890651|FG000|Overall Study|Death|18
913094|NCT00808236|1890652|FG001|Overall Study|Death|30
913095|NCT00808249|1890662|FG000|Overall Study|Adverse Event|4
913096|NCT00808249|1890663|FG001|Overall Study|Adverse Event|7
913097|NCT00808249|1890664|FG002|Overall Study|Adverse Event|10
913098|NCT00808249|1890665|FG003|Overall Study|Adverse Event|6
913099|NCT00808249|1890662|FG000|Overall Study|Lost to Follow-up|2
913100|NCT00808249|1890663|FG001|Overall Study|Lost to Follow-up|3
913101|NCT00808249|1890664|FG002|Overall Study|Lost to Follow-up|3
913102|NCT00808249|1890665|FG003|Overall Study|Lost to Follow-up|5
913103|NCT00808249|1890662|FG000|Overall Study|Withdrawal by Subject|4
913104|NCT00808249|1890663|FG001|Overall Study|Withdrawal by Subject|0
913105|NCT00808249|1890664|FG002|Overall Study|Withdrawal by Subject|2
913106|NCT00808249|1890665|FG003|Overall Study|Withdrawal by Subject|4
913107|NCT00808249|1890662|FG000|Overall Study|Protocol Violation|3
913108|NCT00808249|1890663|FG001|Overall Study|Protocol Violation|3
913109|NCT00808249|1890664|FG002|Overall Study|Protocol Violation|3
913110|NCT00808249|1890665|FG003|Overall Study|Protocol Violation|0
913111|NCT00808249|1890662|FG000|Overall Study|Lack of Efficacy|1
913112|NCT00808249|1890663|FG001|Overall Study|Lack of Efficacy|1
913113|NCT00808249|1890664|FG002|Overall Study|Lack of Efficacy|0
913114|NCT00808249|1890665|FG003|Overall Study|Lack of Efficacy|0
913115|NCT00808249|1890662|FG000|Overall Study|study specific discontinuation criteria|1
913116|NCT00808249|1890663|FG001|Overall Study|study specific discontinuation criteria|0
913117|NCT00808249|1890664|FG002|Overall Study|study specific discontinuation criteria|1
913118|NCT00808249|1890665|FG003|Overall Study|study specific discontinuation criteria|0
913119|NCT00808249|1890662|FG000|Overall Study|All other reasons|2
990553|NCT01340300|2001093|FG001|Overall Study|Unrelated sickness|2
990554|NCT01340300|2001094|FG002|Overall Study|Unrelated sickness|0
990555|NCT01340300|2001095|FG003|Overall Study|Unrelated sickness|1
990556|NCT01340482|2001108|FG000|Overall Study|Adverse Event|2
990557|NCT01340482|2001109|FG001|Overall Study|Adverse Event|0
990558|NCT01340482|2001110|FG002|Overall Study|Adverse Event|0
990559|NCT01340495|2001120|FG000|Overall Study|Withdrawal by Subject|1
990560|NCT01340625|2001140|FG000|First Intervention|Adverse Event|1
990561|NCT01340625|2001141|FG001|First Intervention|Adverse Event|0
990562|NCT01340625|2001140|FG000|Washout Period of 28 Days|Withdrawal by Subject|1
990563|NCT01340625|2001141|FG001|Washout Period of 28 Days|Withdrawal by Subject|0
990564|NCT01340651|2001147|FG000|Overall Study|Adverse Event|3
990565|NCT01340651|2001147|FG000|Overall Study|Consent Withdrawn|2
990566|NCT01340651|2001147|FG000|Overall Study|Commercial Supply per Sponsor|12
990567|NCT01340664|2001156|FG000|Overall Study|Adverse Event|0
990568|NCT01340664|2001157|FG001|Overall Study|Adverse Event|1
990569|NCT01340664|2001158|FG002|Overall Study|Adverse Event|7
990570|NCT01340664|2001156|FG000|Overall Study|Lost to Follow-up|2
990571|NCT01340664|2001157|FG001|Overall Study|Lost to Follow-up|0
990572|NCT01340664|2001158|FG002|Overall Study|Lost to Follow-up|2
990573|NCT01340664|2001156|FG000|Overall Study|Withdrawal by Subject|2
990574|NCT01340664|2001157|FG001|Overall Study|Withdrawal by Subject|4
990575|NCT01340664|2001158|FG002|Overall Study|Withdrawal by Subject|0
990576|NCT01340664|2001156|FG000|Overall Study|Glycemic withdrawal criteria|2
990577|NCT01340664|2001157|FG001|Overall Study|Glycemic withdrawal criteria|0
990578|NCT01340664|2001158|FG002|Overall Study|Glycemic withdrawal criteria|0
990579|NCT01340664|2001156|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0
990580|NCT01340664|2001157|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1
990581|NCT01340664|2001158|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2
990582|NCT01340664|2001156|FG000|Overall Study|Other|1
990583|NCT01340664|2001157|FG001|Overall Study|Other|2
990584|NCT01340664|2001158|FG002|Overall Study|Other|2
990585|NCT01340768|2001168|FG000|Overall Study|Lost to Follow-up|10
990586|NCT01340768|2001169|FG001|Overall Study|Lost to Follow-up|4
990587|NCT01340768|2001168|FG000|Overall Study|Withdrawal by Subject|5
990588|NCT01340768|2001169|FG001|Overall Study|Withdrawal by Subject|1
990589|NCT01340768|2001168|FG000|Overall Study|Other|2
990590|NCT01340768|2001169|FG001|Overall Study|Other|0
990591|NCT01340794|2001177|FG000|Overall Study|Withdrawal by Subject|0
990592|NCT01340794|2001178|FG001|Overall Study|Withdrawal by Subject|1
990593|NCT01340872|2001188|FG000|Double-blind Phase|Adverse Event|6
990594|NCT01340872|2001189|FG001|Double-blind Phase|Adverse Event|4
990595|NCT01340872|2001190|FG002|Double-blind Phase|Adverse Event|0
990596|NCT01340872|2001191|FG003|Double-blind Phase|Adverse Event|0
990597|NCT01340872|2001188|FG000|Double-blind Phase|Withdrawal by Subject|3
990598|NCT01340872|2001189|FG001|Double-blind Phase|Withdrawal by Subject|5
990599|NCT01340872|2001190|FG002|Double-blind Phase|Withdrawal by Subject|0
990600|NCT01340872|2001191|FG003|Double-blind Phase|Withdrawal by Subject|0
990601|NCT01340872|2001188|FG000|Double-blind Phase|Lost to Follow-up|0
990602|NCT01340872|2001189|FG001|Double-blind Phase|Lost to Follow-up|1
990603|NCT01340872|2001190|FG002|Double-blind Phase|Lost to Follow-up|0
990604|NCT01340872|2001191|FG003|Double-blind Phase|Lost to Follow-up|0
990605|NCT01340872|2001188|FG000|Double-blind Phase|Protocol Violation|0
990606|NCT01340872|2001189|FG001|Double-blind Phase|Protocol Violation|1
990607|NCT01340872|2001190|FG002|Double-blind Phase|Protocol Violation|0
990608|NCT01340872|2001191|FG003|Double-blind Phase|Protocol Violation|0
990609|NCT01340872|2001188|FG000|Open-label Phase|Physician Decision|0
990610|NCT01340872|2001189|FG001|Open-label Phase|Physician Decision|0
990611|NCT01340872|2001190|FG002|Open-label Phase|Physician Decision|2
990612|NCT01340872|2001191|FG003|Open-label Phase|Physician Decision|1
990613|NCT01340872|2001188|FG000|Open-label Phase|Pregnancy|0
990614|NCT01340872|2001189|FG001|Open-label Phase|Pregnancy|0
990615|NCT01340872|2001190|FG002|Open-label Phase|Pregnancy|1
990616|NCT01340872|2001191|FG003|Open-label Phase|Pregnancy|0
990617|NCT01340872|2001188|FG000|Open-label Phase|Adverse Event|0
990618|NCT01340872|2001189|FG001|Open-label Phase|Adverse Event|0
990619|NCT01340872|2001190|FG002|Open-label Phase|Adverse Event|8
990620|NCT01340872|2001191|FG003|Open-label Phase|Adverse Event|4
990621|NCT01340872|2001188|FG000|Open-label Phase|Withdrawal by Subject|0
990622|NCT01340872|2001189|FG001|Open-label Phase|Withdrawal by Subject|0
990623|NCT01340872|2001190|FG002|Open-label Phase|Withdrawal by Subject|1
990624|NCT01340872|2001191|FG003|Open-label Phase|Withdrawal by Subject|6
990625|NCT01340872|2001188|FG000|Open-label Phase|Worsening of IBD|0
990626|NCT01340872|2001189|FG001|Open-label Phase|Worsening of IBD|0
990627|NCT01340872|2001190|FG002|Open-label Phase|Worsening of IBD|1
990628|NCT01340872|2001191|FG003|Open-label Phase|Worsening of IBD|0
990629|NCT01340898|2001206|FG000|Primary Phase|Serious Adverse Events|0
990630|NCT01340898|2001207|FG001|Primary Phase|Serious Adverse Events|0
990631|NCT01340898|2001208|FG002|Primary Phase|Serious Adverse Events|1
990632|NCT01340898|2001206|FG000|Primary Phase|Withdrawal by Subject|8
990633|NCT01340898|2001207|FG001|Primary Phase|Withdrawal by Subject|7
990634|NCT01340898|2001208|FG002|Primary Phase|Withdrawal by Subject|5
990635|NCT01340898|2001206|FG000|Primary Phase|Migrated/moved from study area|4
1006723|NCT01469052|2025437|FG001|Overall Study|Moved to rollover protocol|0
990636|NCT01340898|2001207|FG001|Primary Phase|Migrated/moved from study area|1
990637|NCT01340898|2001208|FG002|Primary Phase|Migrated/moved from study area|0
990638|NCT01340898|2001206|FG000|Primary Phase|Lost to Follow-up|4
990639|NCT01340898|2001207|FG001|Primary Phase|Lost to Follow-up|1
990640|NCT01340898|2001208|FG002|Primary Phase|Lost to Follow-up|0
990641|NCT01340898|2001206|FG000|Booster Phase|Withdrawal by Subject|3
990642|NCT01340898|2001207|FG001|Booster Phase|Withdrawal by Subject|0
990643|NCT01340898|2001208|FG002|Booster Phase|Withdrawal by Subject|4
990644|NCT01340898|2001206|FG000|Booster Phase|Migrated/moved from study area|3
990645|NCT01340898|2001207|FG001|Booster Phase|Migrated/moved from study area|0
990646|NCT01340898|2001208|FG002|Booster Phase|Migrated/moved from study area|0
990647|NCT01340898|2001206|FG000|Booster Phase|Lost to Follow-up|4
990648|NCT01340898|2001207|FG001|Booster Phase|Lost to Follow-up|2
990649|NCT01340898|2001208|FG002|Booster Phase|Lost to Follow-up|3
990650|NCT01340937|2001222|FG000|Period 1: Infant Series|Other protocol criterion not met|0
990651|NCT01340937|2001223|FG001|Period 1: Infant Series|Other protocol criterion not met|1
990652|NCT01340937|2001224|FG002|Period 1: Infant Series|Other protocol criterion not met|1
990653|NCT01340937|2001225|FG003|Period 1: Infant Series|Other protocol criterion not met|0
990654|NCT01340937|2001222|FG000|Period 1: Infant Series|Adverse Event|0
990655|NCT01340937|2001223|FG001|Period 1: Infant Series|Adverse Event|1
990656|NCT01340937|2001224|FG002|Period 1: Infant Series|Adverse Event|4
990657|NCT01340937|2001225|FG003|Period 1: Infant Series|Adverse Event|0
990658|NCT01340937|2001222|FG000|Period 1: Infant Series|Death|2
990659|NCT01340937|2001223|FG001|Period 1: Infant Series|Death|0
990660|NCT01340937|2001224|FG002|Period 1: Infant Series|Death|2
990661|NCT01340937|2001225|FG003|Period 1: Infant Series|Death|0
990662|NCT01340937|2001222|FG000|Period 1: Infant Series|Lost to Follow-up|20
990663|NCT01340937|2001223|FG001|Period 1: Infant Series|Lost to Follow-up|14
990664|NCT01340937|2001224|FG002|Period 1: Infant Series|Lost to Follow-up|12
990665|NCT01340937|2001225|FG003|Period 1: Infant Series|Lost to Follow-up|13
990666|NCT01340937|2001222|FG000|Period 1: Infant Series|Physician Decision|2
990667|NCT01340937|2001223|FG001|Period 1: Infant Series|Physician Decision|3
990668|NCT01340937|2001224|FG002|Period 1: Infant Series|Physician Decision|1
990669|NCT01340937|2001225|FG003|Period 1: Infant Series|Physician Decision|0
990670|NCT01340937|2001222|FG000|Period 1: Infant Series|Protocol Violation|1
990671|NCT01340937|2001223|FG001|Period 1: Infant Series|Protocol Violation|4
990672|NCT01340937|2001224|FG002|Period 1: Infant Series|Protocol Violation|4
990673|NCT01340937|2001225|FG003|Period 1: Infant Series|Protocol Violation|3
990674|NCT01340937|2001222|FG000|Period 1: Infant Series|Withdrawal by Subject|33
990675|NCT01340937|2001223|FG001|Period 1: Infant Series|Withdrawal by Subject|32
990676|NCT01340937|2001224|FG002|Period 1: Infant Series|Withdrawal by Subject|30
990677|NCT01340937|2001225|FG003|Period 1: Infant Series|Withdrawal by Subject|15
990678|NCT01340937|2001222|FG000|Period 1: Infant Series|Randomized but not vaccinated|0
990679|NCT01340937|2001223|FG001|Period 1: Infant Series|Randomized but not vaccinated|5
990680|NCT01340937|2001224|FG002|Period 1: Infant Series|Randomized but not vaccinated|2
990681|NCT01340937|2001225|FG003|Period 1: Infant Series|Randomized but not vaccinated|1
990682|NCT01340937|2001222|FG000|Period 2: Interim Period|Withdrawal by Subject|28
990683|NCT01340937|2001223|FG001|Period 2: Interim Period|Withdrawal by Subject|23
990684|NCT01340937|2001224|FG002|Period 2: Interim Period|Withdrawal by Subject|17
990685|NCT01340937|2001225|FG003|Period 2: Interim Period|Withdrawal by Subject|12
990686|NCT01340937|2001222|FG000|Period 2: Interim Period|Adverse Event|1
990687|NCT01340937|2001223|FG001|Period 2: Interim Period|Adverse Event|0
990688|NCT01340937|2001224|FG002|Period 2: Interim Period|Adverse Event|1
990689|NCT01340937|2001225|FG003|Period 2: Interim Period|Adverse Event|0
990690|NCT01340937|2001222|FG000|Period 2: Interim Period|Lost to Follow-up|29
990691|NCT01340937|2001223|FG001|Period 2: Interim Period|Lost to Follow-up|48
990692|NCT01340937|2001224|FG002|Period 2: Interim Period|Lost to Follow-up|53
990693|NCT01340937|2001225|FG003|Period 2: Interim Period|Lost to Follow-up|23
990694|NCT01340937|2001222|FG000|Period 2: Interim Period|Physician Decision|0
990695|NCT01340937|2001223|FG001|Period 2: Interim Period|Physician Decision|1
990696|NCT01340937|2001224|FG002|Period 2: Interim Period|Physician Decision|1
990697|NCT01340937|2001225|FG003|Period 2: Interim Period|Physician Decision|0
990698|NCT01340937|2001222|FG000|Period 2: Interim Period|Protocol Violation|5
990699|NCT01340937|2001223|FG001|Period 2: Interim Period|Protocol Violation|3
990700|NCT01340937|2001224|FG002|Period 2: Interim Period|Protocol Violation|6
990701|NCT01340937|2001225|FG003|Period 2: Interim Period|Protocol Violation|3
990702|NCT01340937|2001222|FG000|Period 2: Interim Period|Technical problems|4
990703|NCT01340937|2001223|FG001|Period 2: Interim Period|Technical problems|4
990704|NCT01340937|2001224|FG002|Period 2: Interim Period|Technical problems|6
990705|NCT01340937|2001225|FG003|Period 2: Interim Period|Technical problems|3
990706|NCT01340937|2001222|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
990707|NCT01340937|2001223|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
990708|NCT01340937|2001224|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
990709|NCT01340937|2001225|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
990710|NCT01340937|2001222|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6
1006724|NCT01469052|2025438|FG002|Overall Study|Moved to rollover protocol|1
990711|NCT01340937|2001223|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14
990712|NCT01340937|2001224|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7
990713|NCT01340937|2001225|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8
990714|NCT01340937|2001222|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0
990715|NCT01340937|2001223|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0
990716|NCT01340937|2001224|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0
990717|NCT01340937|2001225|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1
990718|NCT01340937|2001222|FG000|Period 3: Toddler Vaccinations|Technical problem|1
990719|NCT01340937|2001223|FG001|Period 3: Toddler Vaccinations|Technical problem|1
990720|NCT01340937|2001224|FG002|Period 3: Toddler Vaccinations|Technical problem|1
990721|NCT01340937|2001225|FG003|Period 3: Toddler Vaccinations|Technical problem|0
990722|NCT01340976|2001247|FG000|Overall Study|Physician Decision|2
990723|NCT01340976|2001248|FG001|Overall Study|Physician Decision|0
990724|NCT01340976|2001249|FG002|Overall Study|Physician Decision|1
990725|NCT01340976|2001250|FG003|Overall Study|Physician Decision|1
990726|NCT01340976|2001251|FG004|Overall Study|Physician Decision|1
990727|NCT01340976|2001252|FG005|Overall Study|Physician Decision|0
990728|NCT01340976|2001247|FG000|Overall Study|Death|0
990729|NCT01340976|2001248|FG001|Overall Study|Death|1
990730|NCT01340976|2001249|FG002|Overall Study|Death|0
990731|NCT01340976|2001250|FG003|Overall Study|Death|0
990732|NCT01340976|2001251|FG004|Overall Study|Death|0
990733|NCT01340976|2001252|FG005|Overall Study|Death|0
990734|NCT01340976|2001247|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1
990735|NCT01340976|2001248|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0
990736|NCT01340976|2001249|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0
990737|NCT01340976|2001250|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0
990738|NCT01340976|2001251|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0
990739|NCT01340976|2001252|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0
990740|NCT01340976|2001247|FG000|Overall Study|Withdrawal by Subject|0
990741|NCT01340976|2001248|FG001|Overall Study|Withdrawal by Subject|0
990742|NCT01340976|2001249|FG002|Overall Study|Withdrawal by Subject|0
990743|NCT01340976|2001250|FG003|Overall Study|Withdrawal by Subject|1
990744|NCT01340976|2001251|FG004|Overall Study|Withdrawal by Subject|1
990745|NCT01340976|2001252|FG005|Overall Study|Withdrawal by Subject|0
990746|NCT01340976|2001247|FG000|Overall Study|Other anemia treatment|1
990747|NCT01340976|2001248|FG001|Overall Study|Other anemia treatment|0
990748|NCT01340976|2001249|FG002|Overall Study|Other anemia treatment|2
990749|NCT01340976|2001250|FG003|Overall Study|Other anemia treatment|1
990750|NCT01340976|2001251|FG004|Overall Study|Other anemia treatment|0
990751|NCT01340976|2001252|FG005|Overall Study|Other anemia treatment|1
990752|NCT01340976|2001247|FG000|Overall Study|Adverse Event|0
990753|NCT01340976|2001248|FG001|Overall Study|Adverse Event|1
990754|NCT01340976|2001249|FG002|Overall Study|Adverse Event|0
990755|NCT01340976|2001250|FG003|Overall Study|Adverse Event|0
990756|NCT01340976|2001251|FG004|Overall Study|Adverse Event|0
990757|NCT01340976|2001252|FG005|Overall Study|Adverse Event|0
990758|NCT01341457|2001293|FG000|Overall Study|Adverse Event|2
990759|NCT01341457|2001294|FG001|Overall Study|Adverse Event|0
990760|NCT01341470|2001307|FG000|Overall Study|Sponsor decision|0
990761|NCT01341470|2001308|FG001|Overall Study|Sponsor decision|0
990762|NCT01341470|2001309|FG002|Overall Study|Sponsor decision|1
990763|NCT01341470|2001310|FG003|Overall Study|Sponsor decision|1
990764|NCT01341470|2001311|FG004|Overall Study|Sponsor decision|0
990765|NCT01341470|2001312|FG005|Overall Study|Sponsor decision|1
990766|NCT01341639|2001343|FG000|Infant Series|Protocol Violation|1
990767|NCT01341639|2001344|FG001|Infant Series|Protocol Violation|0
990768|NCT01341639|2001343|FG000|Infant Series|Not Vaccinated|0
990769|NCT01341639|2001344|FG001|Infant Series|Not Vaccinated|1
990770|NCT01341639|2001343|FG000|Infant Series|Adverse Event|0
990771|NCT01341639|2001344|FG001|Infant Series|Adverse Event|5
990772|NCT01341639|2001343|FG000|Infant Series|Withdrawal by Subject|11
990773|NCT01341639|2001344|FG001|Infant Series|Withdrawal by Subject|8
913120|NCT00808249|1890663|FG001|Overall Study|All other reasons|1
913121|NCT00808249|1890664|FG002|Overall Study|All other reasons|3
913122|NCT00808249|1890665|FG003|Overall Study|All other reasons|1
913123|NCT00808444|1890699|FG000|Overall Study|Withdrawal by Subject|1
913124|NCT00808444|1890700|FG001|Overall Study|Withdrawal by Subject|0
913125|NCT00808444|1890699|FG000|Overall Study|Lost to Follow-up|0
913126|NCT00808444|1890700|FG001|Overall Study|Lost to Follow-up|1
913127|NCT00808483|1890721|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
913128|NCT00808483|1890722|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
913129|NCT00808483|1890721|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1
913130|NCT00808483|1890722|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0
913131|NCT00808483|1890721|FG000|From 5 Months to 12 Months|Lack of Efficacy|1
913132|NCT00808483|1890722|FG001|From 5 Months to 12 Months|Lack of Efficacy|0
913133|NCT00808509|1890737|FG000|Randomized Phase|Did not meet eligibility criteria|1
913134|NCT00808509|1890738|FG001|Randomized Phase|Did not meet eligibility criteria|0
913135|NCT00808509|1890737|FG000|Randomized Phase|Reduced methotrexate dose|1
913136|NCT00808509|1890738|FG001|Randomized Phase|Reduced methotrexate dose|2
913137|NCT00808509|1890737|FG000|Randomized Phase|Patient refused rescue therapy|0
990774|NCT01341639|2001343|FG000|Infant Series|Lost to Follow-up|0
990775|NCT01341639|2001344|FG001|Infant Series|Lost to Follow-up|2
990776|NCT01341639|2001343|FG000|Infant Series|Site 0048 Participants|17
990777|NCT01341639|2001344|FG001|Infant Series|Site 0048 Participants|16
990778|NCT01341639|2001343|FG000|Interim Period|Withdrawal by Subject|6
990779|NCT01341639|2001344|FG001|Interim Period|Withdrawal by Subject|7
990780|NCT01341639|2001343|FG000|Interim Period|Lost to Follow-up|2
990781|NCT01341639|2001344|FG001|Interim Period|Lost to Follow-up|0
990782|NCT01341639|2001343|FG000|Interim Period|Physician Decision|0
990783|NCT01341639|2001344|FG001|Interim Period|Physician Decision|1
990784|NCT01341639|2001343|FG000|Interim Period|Protocol Violation|0
990785|NCT01341639|2001344|FG001|Interim Period|Protocol Violation|1
990786|NCT01341639|2001343|FG000|Post-Treatment|Withdrawal by Subject|0
990787|NCT01341639|2001344|FG001|Post-Treatment|Withdrawal by Subject|1
990788|NCT01341639|2001343|FG000|Post-Treatment|Adverse Event|0
990789|NCT01341639|2001344|FG001|Post-Treatment|Adverse Event|2
990790|NCT01341652|2001352|FG000|Overall Study|Incorrect Random Assignment|0
990791|NCT01341652|2001353|FG001|Overall Study|Incorrect Random Assignment|1
990792|NCT01341652|2001352|FG000|Overall Study|ineligible; presence metastatic disease|0
990793|NCT01341652|2001353|FG001|Overall Study|ineligible; presence metastatic disease|1
990794|NCT01341782|2001372|FG000|Overall Study|Adverse Event|1
990795|NCT01341782|2001373|FG001|Overall Study|Adverse Event|1
990796|NCT01341782|2001372|FG000|Overall Study|Withdrawal by Subject|6
990797|NCT01341782|2001373|FG001|Overall Study|Withdrawal by Subject|5
990798|NCT01341782|2001372|FG000|Overall Study|Missed 3 consecutive doses|0
990799|NCT01341782|2001373|FG001|Overall Study|Missed 3 consecutive doses|4
990800|NCT01341782|2001372|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
990801|NCT01341782|2001373|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
990802|NCT01341782|2001372|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
990803|NCT01341782|2001373|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
990804|NCT01341782|2001372|FG000|Overall Study|Other|5
990805|NCT01341782|2001373|FG001|Overall Study|Other|0
990806|NCT01341990|2001394|FG000|Overall Study|Adverse Event|0
990807|NCT01341990|2001395|FG001|Overall Study|Adverse Event|1
990808|NCT01341990|2001394|FG000|Overall Study|Torn Study Lens|1
990809|NCT01341990|2001395|FG001|Overall Study|Torn Study Lens|0
990810|NCT01341990|2001394|FG000|Overall Study|Withdrawal by Subject|2
990811|NCT01341990|2001395|FG001|Overall Study|Withdrawal by Subject|0
990812|NCT01342081|2001413|FG000|Overall Study|Did not receive allocated intervention|0
990813|NCT01342081|2001414|FG001|Overall Study|Did not receive allocated intervention|0
990814|NCT01342081|2001415|FG002|Overall Study|Did not receive allocated intervention|1
990815|NCT01342081|2001413|FG000|Overall Study|Adverse Event|1
990816|NCT01342081|2001414|FG001|Overall Study|Adverse Event|0
990817|NCT01342081|2001415|FG002|Overall Study|Adverse Event|0
990818|NCT01342081|2001413|FG000|Overall Study|Physician Decision|0
990819|NCT01342081|2001414|FG001|Overall Study|Physician Decision|1
990820|NCT01342081|2001415|FG002|Overall Study|Physician Decision|0
990821|NCT01342081|2001413|FG000|Overall Study|Withdrawal by Subject|1
990822|NCT01342081|2001414|FG001|Overall Study|Withdrawal by Subject|1
990823|NCT01342081|2001415|FG002|Overall Study|Withdrawal by Subject|0
990824|NCT01342094|2001425|FG000|Overall Study|Adverse Event|5
990825|NCT01342094|2001426|FG001|Overall Study|Adverse Event|0
990826|NCT01342094|2001425|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
990827|NCT01342094|2001426|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
990828|NCT01342094|2001425|FG000|Overall Study|Withdrawal by Subject|0
990829|NCT01342094|2001426|FG001|Overall Study|Withdrawal by Subject|2
990830|NCT01342211|2001451|FG000|Overall Study|Lost to Follow-up|0
990831|NCT01342211|2001452|FG001|Overall Study|Lost to Follow-up|0
990832|NCT01342211|2001453|FG002|Overall Study|Lost to Follow-up|0
990833|NCT01342211|2001454|FG003|Overall Study|Lost to Follow-up|1
913138|NCT00808509|1890738|FG001|Randomized Phase|Patient refused rescue therapy|3
913139|NCT00808639|1890746|FG000|Overall Study|Disease progression before surgery.|1
913140|NCT00808665|1890752|FG000|Overall Study|Withdrawal by Subject|1
913141|NCT00808665|1890753|FG001|Overall Study|Withdrawal by Subject|0
913142|NCT00808665|1890752|FG000|Overall Study|only required minimally invasive surgery|1
913143|NCT00808665|1890753|FG001|Overall Study|only required minimally invasive surgery|0
913144|NCT00808665|1890752|FG000|Overall Study|surgery cancelled|1
913145|NCT00808665|1890753|FG001|Overall Study|surgery cancelled|0
913146|NCT00808665|1890752|FG000|Overall Study|required an additional procedure|0
913147|NCT00808665|1890753|FG001|Overall Study|required an additional procedure|1
913148|NCT00808665|1890752|FG000|Overall Study|Physician Decision|3
913149|NCT00808665|1890753|FG001|Overall Study|Physician Decision|1
913150|NCT00808665|1890752|FG000|Overall Study|Medication stopped by resident|0
913151|NCT00808665|1890753|FG001|Overall Study|Medication stopped by resident|1
913152|NCT00808808|1890762|FG000|Overall Study|Vaccinated; survey not completed|131
913153|NCT00808808|1890763|FG001|Overall Study|Vaccinated; survey not completed|169
913154|NCT00808808|1890764|FG002|Overall Study|Vaccinated; survey not completed|302
913155|NCT00808808|1890762|FG000|Overall Study|Employee was not vaccinated.|2686
913156|NCT00808808|1890763|FG001|Overall Study|Employee was not vaccinated.|2268
913157|NCT00808808|1890764|FG002|Overall Study|Employee was not vaccinated.|2255
913158|NCT00809094|1890796|FG000|Overall Study|Lost to Follow-up|0
990834|NCT01342211|2001455|FG004|Overall Study|Lost to Follow-up|0
990835|NCT01342211|2001451|FG000|Overall Study|Adverse Event|0
990836|NCT01342211|2001452|FG001|Overall Study|Adverse Event|0
990837|NCT01342211|2001453|FG002|Overall Study|Adverse Event|0
990838|NCT01342211|2001454|FG003|Overall Study|Adverse Event|0
990839|NCT01342211|2001455|FG004|Overall Study|Adverse Event|1
990840|NCT01342211|2001451|FG000|Overall Study|Withdrawal by Subject|0
990841|NCT01342211|2001452|FG001|Overall Study|Withdrawal by Subject|0
990842|NCT01342211|2001453|FG002|Overall Study|Withdrawal by Subject|0
990843|NCT01342211|2001454|FG003|Overall Study|Withdrawal by Subject|1
990844|NCT01342211|2001455|FG004|Overall Study|Withdrawal by Subject|0
990845|NCT01342211|2001451|FG000|Overall Study|Randomized, but not Treated|0
990846|NCT01342211|2001452|FG001|Overall Study|Randomized, but not Treated|2
990847|NCT01342211|2001453|FG002|Overall Study|Randomized, but not Treated|0
990848|NCT01342211|2001454|FG003|Overall Study|Randomized, but not Treated|0
990849|NCT01342211|2001455|FG004|Overall Study|Randomized, but not Treated|1
990850|NCT01342341|2001473|FG000|Overall Study|Lost to Follow-up|4
990851|NCT01342341|2001474|FG001|Overall Study|Lost to Follow-up|4
990852|NCT01342367|2001482|FG000|Overall Study|Death|1
990853|NCT01342367|2001483|FG001|Overall Study|Death|0
990854|NCT01342367|2001482|FG000|Overall Study|Withdrawal by Subject|1
990855|NCT01342367|2001483|FG001|Overall Study|Withdrawal by Subject|2
990856|NCT01342445|2001491|FG000|Overall Study|Experienced side effects|0
990857|NCT01342445|2001492|FG001|Overall Study|Experienced side effects|2
990858|NCT01342484|2001537|FG000|Overall Study|Other Reasons|1
990859|NCT01342484|2001538|FG001|Overall Study|Other Reasons|0
990860|NCT01342484|2001539|FG002|Overall Study|Other Reasons|0
990861|NCT01342484|2001537|FG000|Overall Study|Protocol Violation|0
990862|NCT01342484|2001538|FG001|Overall Study|Protocol Violation|0
990863|NCT01342484|2001539|FG002|Overall Study|Protocol Violation|1
990864|NCT01342484|2001537|FG000|Overall Study|Withdrawal by Subject|1
990865|NCT01342484|2001538|FG001|Overall Study|Withdrawal by Subject|0
990866|NCT01342484|2001539|FG002|Overall Study|Withdrawal by Subject|0
990867|NCT01342510|2001551|FG000|Overall Study|Protocol Violation|12
990868|NCT01342510|2001552|FG001|Overall Study|Protocol Violation|6
990869|NCT01342510|2001553|FG002|Overall Study|Protocol Violation|13
990870|NCT01342510|2001554|FG003|Overall Study|Protocol Violation|11
990871|NCT01342640|2001653|FG000|Overall Study|Adverse Event|3
990872|NCT01342640|2001653|FG000|Overall Study|Protocol Violation|16
990873|NCT01342640|2001653|FG000|Overall Study|Lost to Follow-up|21
990874|NCT01342640|2001653|FG000|Overall Study|Other|1
990875|NCT01342796|2001676|FG000|Overall Study|Withdrawal by Subject|2
990876|NCT01342796|2001677|FG001|Overall Study|Withdrawal by Subject|0
990877|NCT01342796|2001676|FG000|Overall Study|Lost to Follow-up|0
990878|NCT01342796|2001677|FG001|Overall Study|Lost to Follow-up|3
990879|NCT01342796|2001676|FG000|Overall Study|Inappropriate enrollment|1
990880|NCT01342796|2001677|FG001|Overall Study|Inappropriate enrollment|0
990881|NCT01342887|2001683|FG000|Overall Study|Death|2
990882|NCT01342913|2001689|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
990883|NCT01342913|2001690|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
990884|NCT01342913|2001691|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
990885|NCT01342913|2001689|FG000|2-week Run-in Period|Physician Decision|6
990886|NCT01342913|2001690|FG001|2-week Run-in Period|Physician Decision|0
990887|NCT01342913|2001691|FG002|2-week Run-in Period|Physician Decision|0
990888|NCT01342913|2001689|FG000|2-week Run-in Period|Withdrawal by Subject|7
990889|NCT01342913|2001690|FG001|2-week Run-in Period|Withdrawal by Subject|0
990890|NCT01342913|2001691|FG002|2-week Run-in Period|Withdrawal by Subject|0
990891|NCT01342913|2001689|FG000|2-week Run-in Period|Adverse Event|2
990892|NCT01342913|2001690|FG001|2-week Run-in Period|Adverse Event|0
990893|NCT01342913|2001691|FG002|2-week Run-in Period|Adverse Event|0
990894|NCT01342913|2001689|FG000|2-week Run-in Period|Protocol Violation|5
990895|NCT01342913|2001690|FG001|2-week Run-in Period|Protocol Violation|0
990896|NCT01342913|2001691|FG002|2-week Run-in Period|Protocol Violation|0
990897|NCT01342913|2001689|FG000|2-week Run-in Period|Continuation Criteria Not Met|88
990898|NCT01342913|2001690|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
990899|NCT01342913|2001691|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
990900|NCT01342913|2001689|FG000|Double-Blind Treatment Period|Adverse Event|0
990901|NCT01342913|2001690|FG001|Double-Blind Treatment Period|Adverse Event|3
990902|NCT01342913|2001691|FG002|Double-Blind Treatment Period|Adverse Event|6
990903|NCT01342913|2001689|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
990904|NCT01342913|2001690|FG001|Double-Blind Treatment Period|Lack of Efficacy|2
990905|NCT01342913|2001691|FG002|Double-Blind Treatment Period|Lack of Efficacy|3
990906|NCT01342913|2001689|FG000|Double-Blind Treatment Period|Protocol Violation|0
990907|NCT01342913|2001690|FG001|Double-Blind Treatment Period|Protocol Violation|6
990908|NCT01342913|2001691|FG002|Double-Blind Treatment Period|Protocol Violation|9
990909|NCT01342913|2001689|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
990910|NCT01342913|2001690|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
990911|NCT01342913|2001691|FG002|Double-Blind Treatment Period|Lost to Follow-up|3
990912|NCT01342913|2001689|FG000|Double-Blind Treatment Period|Physician Decision|0
990913|NCT01342913|2001690|FG001|Double-Blind Treatment Period|Physician Decision|2
990914|NCT01342913|2001691|FG002|Double-Blind Treatment Period|Physician Decision|0
990915|NCT01342913|2001689|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
990916|NCT01342913|2001690|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2
990917|NCT01342913|2001691|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2
990918|NCT01342926|2001701|FG000|Overall Study|Adverse Event|5
990919|NCT01342926|2001702|FG001|Overall Study|Adverse Event|8
990920|NCT01342926|2001703|FG002|Overall Study|Adverse Event|10
990921|NCT01342926|2001704|FG003|Overall Study|Adverse Event|7
990922|NCT01342926|2001701|FG000|Overall Study|Lost to Follow-up|0
990923|NCT01342926|2001702|FG001|Overall Study|Lost to Follow-up|1
990924|NCT01342926|2001703|FG002|Overall Study|Lost to Follow-up|1
990925|NCT01342926|2001704|FG003|Overall Study|Lost to Follow-up|0
990926|NCT01342926|2001701|FG000|Overall Study|Investigator Discretion|2
913159|NCT00809094|1890797|FG001|Overall Study|Lost to Follow-up|1
913160|NCT00809133|1890817|FG000|Overall Study|Progressive disease|2
913161|NCT00809133|1890818|FG001|Overall Study|Progressive disease|5
913162|NCT00809133|1890819|FG002|Overall Study|Progressive disease|5
913163|NCT00809133|1890820|FG003|Overall Study|Progressive disease|3
913164|NCT00809133|1890821|FG004|Overall Study|Progressive disease|4
913165|NCT00809133|1890822|FG005|Overall Study|Progressive disease|1
913166|NCT00809133|1890823|FG006|Overall Study|Progressive disease|3
913167|NCT00809133|1890824|FG007|Overall Study|Progressive disease|3
913168|NCT00809133|1890825|FG008|Overall Study|Progressive disease|3
913169|NCT00809133|1890826|FG009|Overall Study|Progressive disease|9
913170|NCT00809133|1890827|FG010|Overall Study|Progressive disease|5
913171|NCT00809133|1890828|FG011|Overall Study|Progressive disease|7
913172|NCT00809133|1890829|FG012|Overall Study|Progressive disease|5
913173|NCT00809133|1890830|FG013|Overall Study|Progressive disease|4
913174|NCT00809133|1890817|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0
913175|NCT00809133|1890818|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
913176|NCT00809133|1890819|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
913177|NCT00809133|1890820|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
913178|NCT00809133|1890821|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
913179|NCT00809133|1890822|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1
913180|NCT00809133|1890823|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1
913181|NCT00809133|1890824|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1
913182|NCT00809133|1890825|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0
913183|NCT00809133|1890826|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0
913184|NCT00809133|1890827|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0
913185|NCT00809133|1890828|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0
913186|NCT00809133|1890829|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0
913187|NCT00809133|1890830|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2
913188|NCT00809133|1890817|FG000|Overall Study|Other adverse event|1
913189|NCT00809133|1890818|FG001|Overall Study|Other adverse event|1
913190|NCT00809133|1890819|FG002|Overall Study|Other adverse event|1
913191|NCT00809133|1890820|FG003|Overall Study|Other adverse event|0
913192|NCT00809133|1890821|FG004|Overall Study|Other adverse event|0
913193|NCT00809133|1890822|FG005|Overall Study|Other adverse event|3
913194|NCT00809133|1890823|FG006|Overall Study|Other adverse event|2
913195|NCT00809133|1890824|FG007|Overall Study|Other adverse event|4
913196|NCT00809133|1890825|FG008|Overall Study|Other adverse event|0
913197|NCT00809133|1890826|FG009|Overall Study|Other adverse event|0
913198|NCT00809133|1890827|FG010|Overall Study|Other adverse event|1
913199|NCT00809133|1890828|FG011|Overall Study|Other adverse event|1
913200|NCT00809133|1890829|FG012|Overall Study|Other adverse event|0
913201|NCT00809133|1890830|FG013|Overall Study|Other adverse event|1
913202|NCT00809133|1890817|FG000|Overall Study|Lost to Follow-up|0
913203|NCT00809133|1890818|FG001|Overall Study|Lost to Follow-up|0
913204|NCT00809133|1890819|FG002|Overall Study|Lost to Follow-up|0
913205|NCT00809133|1890820|FG003|Overall Study|Lost to Follow-up|0
913206|NCT00809133|1890821|FG004|Overall Study|Lost to Follow-up|0
913207|NCT00809133|1890822|FG005|Overall Study|Lost to Follow-up|1
913208|NCT00809133|1890823|FG006|Overall Study|Lost to Follow-up|0
913209|NCT00809133|1890824|FG007|Overall Study|Lost to Follow-up|0
913210|NCT00809133|1890825|FG008|Overall Study|Lost to Follow-up|0
913211|NCT00809133|1890826|FG009|Overall Study|Lost to Follow-up|0
913212|NCT00809133|1890827|FG010|Overall Study|Lost to Follow-up|0
913213|NCT00809133|1890828|FG011|Overall Study|Lost to Follow-up|0
913214|NCT00809133|1890829|FG012|Overall Study|Lost to Follow-up|0
913215|NCT00809133|1890830|FG013|Overall Study|Lost to Follow-up|0
913216|NCT00809133|1890817|FG000|Overall Study|Consent withdrawn|0
913217|NCT00809133|1890818|FG001|Overall Study|Consent withdrawn|0
913218|NCT00809133|1890819|FG002|Overall Study|Consent withdrawn|0
913219|NCT00809133|1890820|FG003|Overall Study|Consent withdrawn|0
913220|NCT00809133|1890821|FG004|Overall Study|Consent withdrawn|1
913221|NCT00809133|1890822|FG005|Overall Study|Consent withdrawn|0
913222|NCT00809133|1890823|FG006|Overall Study|Consent withdrawn|0
913223|NCT00809133|1890824|FG007|Overall Study|Consent withdrawn|0
913224|NCT00809133|1890825|FG008|Overall Study|Consent withdrawn|0
913225|NCT00809133|1890826|FG009|Overall Study|Consent withdrawn|0
913226|NCT00809133|1890827|FG010|Overall Study|Consent withdrawn|0
913227|NCT00809133|1890828|FG011|Overall Study|Consent withdrawn|0
913228|NCT00809133|1890829|FG012|Overall Study|Consent withdrawn|0
913229|NCT00809133|1890830|FG013|Overall Study|Consent withdrawn|0
913230|NCT00809133|1890817|FG000|Overall Study|Other not mentioned above|0
913231|NCT00809133|1890818|FG001|Overall Study|Other not mentioned above|1
990927|NCT01342926|2001702|FG001|Overall Study|Investigator Discretion|2
990928|NCT01342926|2001703|FG002|Overall Study|Investigator Discretion|0
990929|NCT01342926|2001704|FG003|Overall Study|Investigator Discretion|0
990930|NCT01342926|2001701|FG000|Overall Study|Withdrawal by Subject|2
990931|NCT01342926|2001702|FG001|Overall Study|Withdrawal by Subject|4
990932|NCT01342926|2001703|FG002|Overall Study|Withdrawal by Subject|3
990933|NCT01342926|2001704|FG003|Overall Study|Withdrawal by Subject|5
990934|NCT01342965|2001716|FG000|Overall Study|Death|58
990935|NCT01342965|2001717|FG001|Overall Study|Death|57
990936|NCT01342965|2001716|FG000|Overall Study|Lost to Follow-up|5
990937|NCT01342965|2001717|FG001|Overall Study|Lost to Follow-up|3
990938|NCT01342965|2001716|FG000|Overall Study|Other Reasons- Unspecified|44
990939|NCT01342965|2001717|FG001|Overall Study|Other Reasons- Unspecified|38
990940|NCT01342965|2001716|FG000|Overall Study|Withdrawal by Subject|2
990941|NCT01342965|2001717|FG001|Overall Study|Withdrawal by Subject|9
990942|NCT01343043|2001740|FG000|Overall Study|Disease progression before treatment|1
990943|NCT01343043|2001741|FG001|Overall Study|Disease progression before treatment|0
990944|NCT01343043|2001742|FG002|Overall Study|Disease progression before treatment|0
990945|NCT01343043|2001743|FG003|Overall Study|Disease progression before treatment|0
990946|NCT01343043|2001740|FG000|Overall Study|Withdrawal by Subject|1
990947|NCT01343043|2001741|FG001|Overall Study|Withdrawal by Subject|0
990948|NCT01343043|2001742|FG002|Overall Study|Withdrawal by Subject|0
990949|NCT01343043|2001743|FG003|Overall Study|Withdrawal by Subject|0
990950|NCT01343043|2001740|FG000|Overall Study|Death|1
990951|NCT01343043|2001741|FG001|Overall Study|Death|1
990952|NCT01343043|2001742|FG002|Overall Study|Death|0
990953|NCT01343043|2001743|FG003|Overall Study|Death|1
990954|NCT01343056|2001760|FG000|Overall Study|Lost to Follow-up|7
990955|NCT01343056|2001761|FG001|Overall Study|Lost to Follow-up|5
990956|NCT01343056|2001762|FG002|Overall Study|Lost to Follow-up|3
990957|NCT01343056|2001763|FG003|Overall Study|Lost to Follow-up|9
990958|NCT01343082|2001777|FG000|The run-in Period|Not meeting criteria|3
990959|NCT01343082|2001778|FG001|The run-in Period|Not meeting criteria|4
990960|NCT01343082|2001779|FG002|The run-in Period|Not meeting criteria|5
990961|NCT01343082|2001777|FG000|Treatment Period , Switched to DE-111|Adverse Event|1
990962|NCT01343082|2001778|FG001|Treatment Period , Switched to DE-111|Adverse Event|4
990963|NCT01343082|2001779|FG002|Treatment Period , Switched to DE-111|Adverse Event|3
990964|NCT01343082|2001777|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0
990965|NCT01343082|2001778|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1
990966|NCT01343082|2001779|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2
990967|NCT01343082|2001777|FG000|Treatment Period , Switched to DE-111|Physician Decision|0
990968|NCT01343082|2001778|FG001|Treatment Period , Switched to DE-111|Physician Decision|2
990969|NCT01343082|2001779|FG002|Treatment Period , Switched to DE-111|Physician Decision|2
990970|NCT01343082|2001777|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
990971|NCT01343082|2001778|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
990972|NCT01343082|2001779|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
990973|NCT01343277|2001817|FG000|Overall Study|Other|3
990974|NCT01343277|2001818|FG001|Overall Study|Other|3
913232|NCT00809133|1890819|FG002|Overall Study|Other not mentioned above|0
913233|NCT00809133|1890820|FG003|Overall Study|Other not mentioned above|0
913234|NCT00809133|1890821|FG004|Overall Study|Other not mentioned above|0
913235|NCT00809133|1890822|FG005|Overall Study|Other not mentioned above|1
913236|NCT00809133|1890823|FG006|Overall Study|Other not mentioned above|0
913237|NCT00809133|1890824|FG007|Overall Study|Other not mentioned above|0
913238|NCT00809133|1890825|FG008|Overall Study|Other not mentioned above|0
913239|NCT00809133|1890826|FG009|Overall Study|Other not mentioned above|0
913240|NCT00809133|1890827|FG010|Overall Study|Other not mentioned above|0
913241|NCT00809133|1890828|FG011|Overall Study|Other not mentioned above|0
913242|NCT00809133|1890829|FG012|Overall Study|Other not mentioned above|0
913243|NCT00809133|1890830|FG013|Overall Study|Other not mentioned above|0
913244|NCT00809159|1890886|FG000|Part 1|Adverse Event|1
913245|NCT00809159|1890887|FG001|Part 1|Adverse Event|1
913246|NCT00809159|1890888|FG002|Part 1|Adverse Event|0
913247|NCT00809159|1890889|FG003|Part 1|Adverse Event|0
913248|NCT00809159|1890890|FG004|Part 1|Adverse Event|0
913249|NCT00809159|1890891|FG005|Part 1|Adverse Event|0
913250|NCT00809159|1890886|FG000|Part 1|Lost to Follow-up|1
913251|NCT00809159|1890887|FG001|Part 1|Lost to Follow-up|0
913252|NCT00809159|1890888|FG002|Part 1|Lost to Follow-up|0
913253|NCT00809159|1890889|FG003|Part 1|Lost to Follow-up|0
913254|NCT00809159|1890890|FG004|Part 1|Lost to Follow-up|0
913255|NCT00809159|1890891|FG005|Part 1|Lost to Follow-up|0
913256|NCT00809159|1890886|FG000|Part 1|Withdrawal by Subject|3
913257|NCT00809159|1890887|FG001|Part 1|Withdrawal by Subject|1
913258|NCT00809159|1890888|FG002|Part 1|Withdrawal by Subject|0
913259|NCT00809159|1890889|FG003|Part 1|Withdrawal by Subject|0
913260|NCT00809159|1890890|FG004|Part 1|Withdrawal by Subject|0
913261|NCT00809159|1890891|FG005|Part 1|Withdrawal by Subject|0
913262|NCT00809159|1890886|FG000|Part 1|Unsatisfactory therapeutic effect|3
913263|NCT00809159|1890887|FG001|Part 1|Unsatisfactory therapeutic effect|1
913264|NCT00809159|1890888|FG002|Part 1|Unsatisfactory therapeutic effect|0
990975|NCT01343277|2001817|FG000|Overall Study|Withdrawal by Subject|18
990976|NCT01343277|2001818|FG001|Overall Study|Withdrawal by Subject|13
990977|NCT01343277|2001817|FG000|Overall Study|Physician Decision|1
990978|NCT01343277|2001818|FG001|Overall Study|Physician Decision|2
990979|NCT01343277|2001817|FG000|Overall Study|Death|10
990980|NCT01343277|2001818|FG001|Overall Study|Death|1
990981|NCT01343277|2001817|FG000|Overall Study|Adverse Event|67
990982|NCT01343277|2001818|FG001|Overall Study|Adverse Event|13
990983|NCT01343277|2001817|FG000|Overall Study|Disease progression|270
990984|NCT01343277|2001818|FG001|Overall Study|Disease progression|138
990985|NCT01343277|2001817|FG000|Overall Study|Randomized not treated|6
990986|NCT01343277|2001818|FG001|Overall Study|Randomized not treated|21
990987|NCT01343277|2001817|FG000|Overall Study|Treatment ongoing|8
990988|NCT01343277|2001818|FG001|Overall Study|Treatment ongoing|2
990989|NCT01343277|2001817|FG000|Overall Study|Subsequent anticancer therapy|1
990990|NCT01343277|2001818|FG001|Overall Study|Subsequent anticancer therapy|0
990991|NCT01343368|2001826|FG000|Overall Study|Death|1
990992|NCT01343368|2001827|FG001|Overall Study|Death|0
990993|NCT01343368|2001826|FG000|Overall Study|Lost to Follow-up|1
990994|NCT01343368|2001827|FG001|Overall Study|Lost to Follow-up|0
990995|NCT01343407|2001833|FG000|Second Treatment Period (Part 2)|Adverse Event|0
990996|NCT01343407|2001834|FG001|Second Treatment Period (Part 2)|Adverse Event|0
990997|NCT01343407|2001835|FG002|Second Treatment Period (Part 2)|Adverse Event|1
990998|NCT01343407|2001836|FG003|Second Treatment Period (Part 2)|Adverse Event|0
990999|NCT01343407|2001837|FG004|Second Treatment Period (Part 2)|Adverse Event|0
991000|NCT01343407|2001838|FG005|Second Treatment Period (Part 2)|Adverse Event|0
991001|NCT01343407|2001833|FG000|Second Washout (Part 2)|Withdrawal by Subject|0
991002|NCT01343407|2001834|FG001|Second Washout (Part 2)|Withdrawal by Subject|0
991003|NCT01343407|2001835|FG002|Second Washout (Part 2)|Withdrawal by Subject|1
991004|NCT01343407|2001836|FG003|Second Washout (Part 2)|Withdrawal by Subject|0
991005|NCT01343407|2001837|FG004|Second Washout (Part 2)|Withdrawal by Subject|0
991006|NCT01343407|2001838|FG005|Second Washout (Part 2)|Withdrawal by Subject|0
991007|NCT01343693|2001864|FG000|Overall Study|Lost to Follow-up|9
991008|NCT01343823|2001872|FG000|Overall Study|Study Terminated|1
991009|NCT01343823|2001873|FG001|Overall Study|Study Terminated|0
991010|NCT01343823|2001874|FG002|Overall Study|Study Terminated|0
991011|NCT01343823|2001875|FG003|Overall Study|Study Terminated|1
991012|NCT01343823|2001872|FG000|Overall Study|Withdrawal by Subject|1
991013|NCT01343823|2001873|FG001|Overall Study|Withdrawal by Subject|0
991014|NCT01343823|2001874|FG002|Overall Study|Withdrawal by Subject|0
991015|NCT01343823|2001875|FG003|Overall Study|Withdrawal by Subject|0
991016|NCT01343888|2001888|FG000|Overall Study|Adverse Event|12
991017|NCT01343888|2001889|FG001|Overall Study|Adverse Event|22
991018|NCT01343888|2001890|FG002|Overall Study|Adverse Event|5
991019|NCT01343888|2001888|FG000|Overall Study|Lack of Efficacy|9
991020|NCT01343888|2001889|FG001|Overall Study|Lack of Efficacy|9
991021|NCT01343888|2001890|FG002|Overall Study|Lack of Efficacy|13
991022|NCT01343888|2001888|FG000|Overall Study|Lost to Follow-up|0
991023|NCT01343888|2001889|FG001|Overall Study|Lost to Follow-up|2
991024|NCT01343888|2001890|FG002|Overall Study|Lost to Follow-up|1
991025|NCT01343888|2001888|FG000|Overall Study|Protocol Violation|0
991026|NCT01343888|2001889|FG001|Overall Study|Protocol Violation|2
991027|NCT01343888|2001890|FG002|Overall Study|Protocol Violation|0
991028|NCT01343888|2001888|FG000|Overall Study|Withdrawal by Subject|4
991029|NCT01343888|2001889|FG001|Overall Study|Withdrawal by Subject|4
991030|NCT01343888|2001890|FG002|Overall Study|Withdrawal by Subject|2
991031|NCT01343888|2001888|FG000|Overall Study|other than stated above|0
991032|NCT01343888|2001889|FG001|Overall Study|other than stated above|0
991033|NCT01343888|2001890|FG002|Overall Study|other than stated above|1
991034|NCT01343901|2001898|FG000|Overall Study|Death|85
991035|NCT01343901|2001898|FG000|Overall Study|Physician Decision|4
991036|NCT01343901|2001898|FG000|Overall Study|Lost to Follow-up|12
991037|NCT01343901|2001898|FG000|Overall Study|Management by another medical team|11
991038|NCT01343901|2001898|FG000|Overall Study|Participant decision|1
991039|NCT01344057|2001902|FG000|Overall Study|Premature Withdrawal|1
991040|NCT01344161|2001908|FG000|Overall Study|Lost to Follow-up|4
991041|NCT01344161|2001909|FG001|Overall Study|Lost to Follow-up|1
991042|NCT01344161|2001908|FG000|Overall Study|Pregnancy|0
991043|NCT01344161|2001909|FG001|Overall Study|Pregnancy|1
991044|NCT01344161|2001908|FG000|Overall Study|Protocol Violation|1
991045|NCT01344161|2001909|FG001|Overall Study|Protocol Violation|1
991046|NCT01344226|2001915|FG000|Overall Study|Protocol Violation|2
991047|NCT01344226|2001915|FG000|Overall Study|Withdrawal by Subject|3
991048|NCT01344226|2001915|FG000|Overall Study|Lack of Efficacy|3
991049|NCT01344356|2001921|FG000|Overall Study|Physician Decision|0
991050|NCT01344356|2001922|FG001|Overall Study|Physician Decision|3
991051|NCT01344356|2001921|FG000|Overall Study|Lost to Follow-up|0
991052|NCT01344356|2001922|FG001|Overall Study|Lost to Follow-up|6
991053|NCT01344369|2001932|FG000|Washout of 28 Days|Withdrawal by Subject|1
991054|NCT01344369|2001933|FG001|Washout of 28 Days|Withdrawal by Subject|0
991055|NCT01344369|2001932|FG000|Washout of 28 Days|Physician Decision|0
991056|NCT01344369|2001933|FG001|Washout of 28 Days|Physician Decision|1
991057|NCT01344369|2001932|FG000|Second Intervention|Emesis within 2 x Tmax|0
991058|NCT01344369|2001933|FG001|Second Intervention|Emesis within 2 x Tmax|1
991059|NCT01344447|2001939|FG000|Overall Study|Adverse Event|1
991060|NCT01344447|2001939|FG000|Overall Study|Protocol Violation|1
991061|NCT01344447|2001939|FG000|Overall Study|Withdrawal by Subject|1
991062|NCT01344447|2001939|FG000|Overall Study|The contrast was not seen|1
991063|NCT01344447|2001939|FG000|Overall Study|Physician Decision|1
991064|NCT01344447|2001939|FG000|Overall Study|MRA unsuccessful|1
991065|NCT01344447|2001939|FG000|Overall Study|Bolus tracking failed|1
991066|NCT01344447|2001939|FG000|Overall Study|Error of power injector|1
991067|NCT01344460|2001947|FG000|Overall Study|Withdrawal by Subject|1
991068|NCT01344460|2001947|FG000|Overall Study|Lost to Follow-up|2
991069|NCT01344538|2001957|FG000|Overall Study|Adverse Event|1
991070|NCT01344538|2001958|FG001|Overall Study|Adverse Event|1
991071|NCT01344538|2001957|FG000|Overall Study|Lost to Follow-up|1
991072|NCT01344538|2001958|FG001|Overall Study|Lost to Follow-up|0
991073|NCT01344629|2001975|FG000|Crossover Period 2|Withdrawal by Subject|0
991074|NCT01344629|2001976|FG001|Crossover Period 2|Withdrawal by Subject|1
991075|NCT01344759|2001984|FG000|Overall Study|Patients failed to reach sedation level|0
991076|NCT01344759|2001985|FG001|Overall Study|Patients failed to reach sedation level|2
991077|NCT01344824|2001997|FG000|Overall Study|Adverse Event|15
991078|NCT01344824|2001997|FG000|Overall Study|Withdrawal by Subject|6
991079|NCT01344824|2001997|FG000|Overall Study|Other complicating disease|1
991080|NCT01344824|2001997|FG000|Overall Study|Progression|15
991081|NCT01344876|2002002|FG000|Overall Study|Adverse Event|0
991082|NCT01344876|2002003|FG001|Overall Study|Adverse Event|0
991083|NCT01344876|2002004|FG002|Overall Study|Adverse Event|0
991084|NCT01344876|2002005|FG003|Overall Study|Adverse Event|0
991085|NCT01344876|2002006|FG004|Overall Study|Adverse Event|1
991086|NCT01344876|2002002|FG000|Overall Study|Withdrawal by Subject|0
991087|NCT01344876|2002003|FG001|Overall Study|Withdrawal by Subject|0
991088|NCT01344876|2002004|FG002|Overall Study|Withdrawal by Subject|1
991089|NCT01344876|2002005|FG003|Overall Study|Withdrawal by Subject|0
991090|NCT01344876|2002006|FG004|Overall Study|Withdrawal by Subject|0
991091|NCT01344876|2002002|FG000|Overall Study|Definite progression of primary disease|1
991092|NCT01344876|2002003|FG001|Overall Study|Definite progression of primary disease|0
991093|NCT01344876|2002004|FG002|Overall Study|Definite progression of primary disease|0
991094|NCT01344876|2002005|FG003|Overall Study|Definite progression of primary disease|3
991095|NCT01344876|2002006|FG004|Overall Study|Definite progression of primary disease|0
991096|NCT01345019|2002021|FG000|Blinded Treatment Phase|Death|147
991097|NCT01345019|2002022|FG001|Blinded Treatment Phase|Death|137
991098|NCT01345019|2002021|FG000|Blinded Treatment Phase|Withdrawal by Subject|103
991099|NCT01345019|2002022|FG001|Blinded Treatment Phase|Withdrawal by Subject|112
991100|NCT01345019|2002021|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21
991101|NCT01345019|2002022|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9
991102|NCT01345019|2002021|FG000|Blinded Treatment Phase|Disease Progression|12
991103|NCT01345019|2002022|FG001|Blinded Treatment Phase|Disease Progression|10
991104|NCT01345019|2002021|FG000|Blinded Treatment Phase|Adverse Event|6
991105|NCT01345019|2002022|FG001|Blinded Treatment Phase|Adverse Event|13
991106|NCT01345019|2002021|FG000|Blinded Treatment Phase|Administrative Decision|10
991107|NCT01345019|2002022|FG001|Blinded Treatment Phase|Administrative Decision|8
991108|NCT01345019|2002021|FG000|Blinded Treatment Phase|Noncompliance|5
991109|NCT01345019|2002022|FG001|Blinded Treatment Phase|Noncompliance|3
991110|NCT01345019|2002021|FG000|Blinded Treatment Phase|Ineligibility Determined|1
991111|NCT01345019|2002022|FG001|Blinded Treatment Phase|Ineligibility Determined|6
991112|NCT01345019|2002021|FG000|Blinded Treatment Phase|Protocol Deviation|5
991113|NCT01345019|2002022|FG001|Blinded Treatment Phase|Protocol Deviation|0
991114|NCT01345019|2002021|FG000|Blinded Treatment Phase|Other, Not Specified|2
991115|NCT01345019|2002022|FG001|Blinded Treatment Phase|Other, Not Specified|3
913265|NCT00809159|1890889|FG003|Part 1|Unsatisfactory therapeutic effect|0
913266|NCT00809159|1890890|FG004|Part 1|Unsatisfactory therapeutic effect|0
913267|NCT00809159|1890891|FG005|Part 1|Unsatisfactory therapeutic effect|0
913268|NCT00809159|1890886|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0
913269|NCT00809159|1890887|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0
913270|NCT00809159|1890888|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4
913271|NCT00809159|1890889|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3
913272|NCT00809159|1890890|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5
913273|NCT00809159|1890891|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1
913274|NCT00809159|1890886|FG000|Part 1 and 2|Administrative problems|0
913275|NCT00809159|1890887|FG001|Part 1 and 2|Administrative problems|0
913276|NCT00809159|1890888|FG002|Part 1 and 2|Administrative problems|0
913277|NCT00809159|1890889|FG003|Part 1 and 2|Administrative problems|1
913278|NCT00809159|1890890|FG004|Part 1 and 2|Administrative problems|0
913279|NCT00809159|1890891|FG005|Part 1 and 2|Administrative problems|0
913280|NCT00809159|1890886|FG000|Part 1 and 2|Adverse Event|0
913281|NCT00809159|1890887|FG001|Part 1 and 2|Adverse Event|0
913282|NCT00809159|1890888|FG002|Part 1 and 2|Adverse Event|1
991116|NCT01345019|2002021|FG000|Blinded Treatment Phase|Lost to Follow-up|6
991117|NCT01345019|2002022|FG001|Blinded Treatment Phase|Lost to Follow-up|3
991118|NCT01345019|2002021|FG000|Open Label Treatment Phase|Death|49
991119|NCT01345019|2002022|FG001|Open Label Treatment Phase|Death|48
991120|NCT01345019|2002021|FG000|Open Label Treatment Phase|Withdrawal by Subject|49
991121|NCT01345019|2002022|FG001|Open Label Treatment Phase|Withdrawal by Subject|47
991122|NCT01345019|2002021|FG000|Open Label Treatment Phase|Adverse Event|30
991123|NCT01345019|2002022|FG001|Open Label Treatment Phase|Adverse Event|51
991124|NCT01345019|2002021|FG000|Open Label Treatment Phase|Administrative Decision|30
991125|NCT01345019|2002022|FG001|Open Label Treatment Phase|Administrative Decision|15
991126|NCT01345019|2002021|FG000|Open Label Treatment Phase|Disease Progression|17
991127|NCT01345019|2002022|FG001|Open Label Treatment Phase|Disease Progression|18
991128|NCT01345019|2002021|FG000|Open Label Treatment Phase|Noncompliance|5
991129|NCT01345019|2002022|FG001|Open Label Treatment Phase|Noncompliance|4
991130|NCT01345019|2002021|FG000|Open Label Treatment Phase|Lost to Follow-up|1
991131|NCT01345019|2002022|FG001|Open Label Treatment Phase|Lost to Follow-up|2
991132|NCT01345019|2002021|FG000|Open Label Treatment Phase|Pregnancy|1
991133|NCT01345019|2002022|FG001|Open Label Treatment Phase|Pregnancy|0
991134|NCT01345019|2002021|FG000|Open Label Treatment Phase|Other, Not Specified|9
991135|NCT01345019|2002022|FG001|Open Label Treatment Phase|Other, Not Specified|7
991136|NCT01345019|2002021|FG000|Open Label Treatment Phase|Protocol Violation|0
991137|NCT01345019|2002022|FG001|Open Label Treatment Phase|Protocol Violation|1
991138|NCT01345058|2002032|FG000|Overall Study|Withdrawal by Subject|1
991139|NCT01345058|2002033|FG001|Overall Study|Withdrawal by Subject|0
991140|NCT01345058|2002032|FG000|Overall Study|Participant Reported Increase in Events|1
991141|NCT01345058|2002033|FG001|Overall Study|Participant Reported Increase in Events|0
991142|NCT01345058|2002032|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1
991143|NCT01345058|2002033|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0
991144|NCT01345058|2002032|FG000|Overall Study|Participant Stopped Taking Study Drug|1
991145|NCT01345058|2002033|FG001|Overall Study|Participant Stopped Taking Study Drug|0
991146|NCT01345058|2002032|FG000|Overall Study|Participant No-Show at Multiple Visits|1
991147|NCT01345058|2002033|FG001|Overall Study|Participant No-Show at Multiple Visits|0
991148|NCT01345123|2002042|FG000|Overall Study|participants no longer with health plan|79
991149|NCT01345123|2002043|FG001|Overall Study|participants no longer with health plan|85
991150|NCT01345123|2002044|FG002|Overall Study|participants no longer with health plan|88
991151|NCT01345162|2002055|FG000|Overall Study|Protocol Violation|2
991152|NCT01345162|2002056|FG001|Overall Study|Protocol Violation|4
991153|NCT01345188|2002062|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
991154|NCT01345188|2002062|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
991155|NCT01345253|2002101|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
991156|NCT01345253|2002102|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
991157|NCT01345253|2002101|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
991158|NCT01345253|2002102|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
991159|NCT01345253|2002101|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
991160|NCT01345253|2002102|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
991161|NCT01345253|2002101|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
991162|NCT01345253|2002102|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
991163|NCT01345253|2002101|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
991164|NCT01345253|2002102|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
991165|NCT01345253|2002101|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
991166|NCT01345253|2002102|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
991167|NCT01345253|2002101|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
991168|NCT01345253|2002102|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
991169|NCT01345253|2002101|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
991170|NCT01345253|2002102|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
991171|NCT01345253|2002101|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0
991172|NCT01345253|2002102|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1
991173|NCT01345253|2002101|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
991174|NCT01345253|2002102|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
991175|NCT01345253|2002101|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
991176|NCT01345253|2002102|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
991177|NCT01345253|2002101|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
991178|NCT01345253|2002102|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
991179|NCT01345253|2002101|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
991180|NCT01345253|2002102|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
913283|NCT00809159|1890889|FG003|Part 1 and 2|Adverse Event|0
913284|NCT00809159|1890890|FG004|Part 1 and 2|Adverse Event|1
913285|NCT00809159|1890891|FG005|Part 1 and 2|Adverse Event|1
913286|NCT00809159|1890886|FG000|Part 1 and 2|Lost to Follow-up|0
913287|NCT00809159|1890887|FG001|Part 1 and 2|Lost to Follow-up|0
913288|NCT00809159|1890888|FG002|Part 1 and 2|Lost to Follow-up|1
913289|NCT00809159|1890889|FG003|Part 1 and 2|Lost to Follow-up|1
913290|NCT00809159|1890890|FG004|Part 1 and 2|Lost to Follow-up|0
913291|NCT00809159|1890891|FG005|Part 1 and 2|Lost to Follow-up|0
991181|NCT01345253|2002101|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
991182|NCT01345253|2002102|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
991183|NCT01345253|2002101|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
991184|NCT01345253|2002102|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
991185|NCT01345292|2002113|FG000|Overall Study|Withdrawal by Subject|2
991186|NCT01345292|2002114|FG001|Overall Study|Withdrawal by Subject|0
991187|NCT01345292|2002115|FG002|Overall Study|Withdrawal by Subject|1
991188|NCT01345318|2002123|FG000|Overall Study|Adverse Event|16
991189|NCT01345318|2002123|FG000|Overall Study|Lack of Efficacy|17
991190|NCT01345318|2002123|FG000|Overall Study|Lost to Follow-up|2
991191|NCT01345318|2002123|FG000|Overall Study|Protocol Violation|1
991192|NCT01345318|2002123|FG000|Overall Study|Withdrawal by Subject|41
991193|NCT01345318|2002123|FG000|Overall Study|Other|3
991194|NCT01345591|2002132|FG000|Overall Study|Lost to Follow-up|1
991195|NCT01345630|2002143|FG000|Overall Study|Adverse Event|22
991196|NCT01345630|2002144|FG001|Overall Study|Adverse Event|23
991197|NCT01345630|2002143|FG000|Overall Study|Lost to Follow-up|17
991198|NCT01345630|2002144|FG001|Overall Study|Lost to Follow-up|16
991199|NCT01345630|2002143|FG000|Overall Study|Protocol Violation|4
991200|NCT01345630|2002144|FG001|Overall Study|Protocol Violation|1
991201|NCT01345630|2002143|FG000|Overall Study|Medication error without associated AE|0
991202|NCT01345630|2002144|FG001|Overall Study|Medication error without associated AE|1
991203|NCT01345630|2002143|FG000|Overall Study|Study terminated by sponsor|254
991204|NCT01345630|2002144|FG001|Overall Study|Study terminated by sponsor|285
991205|NCT01345630|2002143|FG000|Overall Study|Other reasons|6
991206|NCT01345630|2002144|FG001|Overall Study|Other reasons|8
991207|NCT01345630|2002143|FG000|Overall Study|Withdrawn due to pregnancy|1
991208|NCT01345630|2002144|FG001|Overall Study|Withdrawn due to pregnancy|2
991209|NCT01345630|2002143|FG000|Overall Study|No longer willing to participate|9
991210|NCT01345630|2002144|FG001|Overall Study|No longer willing to participate|12
991211|NCT01345630|2002143|FG000|Overall Study|Insufficient clinical response|48
991212|NCT01345630|2002144|FG001|Overall Study|Insufficient clinical response|11
991213|NCT01345669|2002156|FG000|Overall Study|Primary tumour recurrence|53
991214|NCT01345669|2002157|FG001|Overall Study|Primary tumour recurrence|32
991215|NCT01345669|2002156|FG000|Overall Study|Second primary tumour|4
991216|NCT01345669|2002157|FG001|Overall Study|Second primary tumour|3
991217|NCT01345669|2002156|FG000|Overall Study|Adverse Event|63
991218|NCT01345669|2002157|FG001|Overall Study|Adverse Event|9
991219|NCT01345669|2002156|FG000|Overall Study|Protocol Violation|3
991220|NCT01345669|2002157|FG001|Overall Study|Protocol Violation|1
991221|NCT01345669|2002156|FG000|Overall Study|Lost to Follow-up|1
991222|NCT01345669|2002157|FG001|Overall Study|Lost to Follow-up|1
991223|NCT01345669|2002156|FG000|Overall Study|Withdrawal by Subject|52
991224|NCT01345669|2002157|FG001|Overall Study|Withdrawal by Subject|13
991225|NCT01345669|2002156|FG000|Overall Study|Other Reasons|111
991226|NCT01345669|2002157|FG001|Overall Study|Other Reasons|60
991227|NCT01345682|2002165|FG000|Overall Study|Progressive disease per RECIST|226
991228|NCT01345682|2002166|FG001|Overall Study|Progressive disease per RECIST|93
991229|NCT01345682|2002165|FG000|Overall Study|Worsening of underlying cancer disease|23
991230|NCT01345682|2002166|FG001|Overall Study|Worsening of underlying cancer disease|12
991231|NCT01345682|2002165|FG000|Overall Study|Adverse Event|51
991232|NCT01345682|2002166|FG001|Overall Study|Adverse Event|41
991233|NCT01345682|2002165|FG000|Overall Study|Non-compliance with protocol|0
991234|NCT01345682|2002166|FG001|Overall Study|Non-compliance with protocol|1
991235|NCT01345682|2002165|FG000|Overall Study|Lost to Follow-up|0
991236|NCT01345682|2002166|FG001|Overall Study|Lost to Follow-up|1
991237|NCT01345682|2002165|FG000|Overall Study|Refused to continue trial medication|16
991238|NCT01345682|2002166|FG001|Overall Study|Refused to continue trial medication|9
991239|NCT01345682|2002165|FG000|Overall Study|Not treated|2
991240|NCT01345682|2002166|FG001|Overall Study|Not treated|1
991241|NCT01345682|2002165|FG000|Overall Study|Reason other than those specified above|4
991242|NCT01345682|2002166|FG001|Overall Study|Reason other than those specified above|3
991243|NCT01345786|2002193|FG000|Overall Study|Adverse Event|0
991244|NCT01345786|2002194|FG001|Overall Study|Adverse Event|1
991245|NCT01345786|2002195|FG002|Overall Study|Adverse Event|3
991246|NCT01345786|2002196|FG003|Overall Study|Adverse Event|1
913292|NCT00809159|1890886|FG000|Part 1 and 2|Withdrawal by Subject|0
913293|NCT00809159|1890887|FG001|Part 1 and 2|Withdrawal by Subject|0
913294|NCT00809159|1890888|FG002|Part 1 and 2|Withdrawal by Subject|4
913295|NCT00809159|1890889|FG003|Part 1 and 2|Withdrawal by Subject|0
913296|NCT00809159|1890890|FG004|Part 1 and 2|Withdrawal by Subject|0
913297|NCT00809159|1890891|FG005|Part 1 and 2|Withdrawal by Subject|1
913298|NCT00809328|1890914|FG000|Overall Study|Lack of Efficacy|18
913299|NCT00809328|1890914|FG000|Overall Study|Adverse Event|6
913300|NCT00809328|1890914|FG000|Overall Study|Protocol Violation|3
913301|NCT00809328|1890914|FG000|Overall Study|Withdrawal by Subject|2
913302|NCT00809354|1890928|FG000|Overall Study|Adverse Event|32
913303|NCT00809354|1890929|FG001|Overall Study|Adverse Event|45
913304|NCT00809354|1890930|FG002|Overall Study|Adverse Event|37
913305|NCT00809354|1890931|FG003|Overall Study|Adverse Event|53
913306|NCT00809354|1890932|FG004|Overall Study|Adverse Event|26
913307|NCT00809354|1890933|FG005|Overall Study|Adverse Event|33
991247|NCT01345786|2002193|FG000|Overall Study|Subject withdrew consent|2
991248|NCT01345786|2002194|FG001|Overall Study|Subject withdrew consent|2
991249|NCT01345786|2002195|FG002|Overall Study|Subject withdrew consent|1
991250|NCT01345786|2002196|FG003|Overall Study|Subject withdrew consent|0
991251|NCT01345786|2002193|FG000|Overall Study|Noncompliance with protocol|1
991252|NCT01345786|2002194|FG001|Overall Study|Noncompliance with protocol|0
991253|NCT01345786|2002195|FG002|Overall Study|Noncompliance with protocol|1
991254|NCT01345786|2002196|FG003|Overall Study|Noncompliance with protocol|0
991255|NCT01345786|2002193|FG000|Overall Study|Administrative|3
991256|NCT01345786|2002194|FG001|Overall Study|Administrative|5
991257|NCT01345786|2002195|FG002|Overall Study|Administrative|0
991258|NCT01345786|2002196|FG003|Overall Study|Administrative|0
991259|NCT01345786|2002193|FG000|Overall Study|Lost to Follow-up|0
991260|NCT01345786|2002194|FG001|Overall Study|Lost to Follow-up|0
991261|NCT01345786|2002195|FG002|Overall Study|Lost to Follow-up|0
991262|NCT01345786|2002196|FG003|Overall Study|Lost to Follow-up|2
991263|NCT01345929|2002208|FG000|Overall Study|Withdrawal by Subject|9
991264|NCT01345929|2002209|FG001|Overall Study|Withdrawal by Subject|8
991265|NCT01345929|2002208|FG000|Overall Study|Lost to Follow-up|9
991266|NCT01345929|2002209|FG001|Overall Study|Lost to Follow-up|9
991267|NCT01345929|2002208|FG000|Overall Study|Adverse Event|0
991268|NCT01345929|2002209|FG001|Overall Study|Adverse Event|1
991269|NCT01345929|2002208|FG000|Overall Study|Didn't meet eligibility criteria|2
991270|NCT01345929|2002209|FG001|Overall Study|Didn't meet eligibility criteria|0
991271|NCT01345929|2002208|FG000|Overall Study|40,000 CFU/ML|1
991272|NCT01345929|2002209|FG001|Overall Study|40,000 CFU/ML|0
991273|NCT01345929|2002208|FG000|Overall Study|Patient withdrawal|0
991274|NCT01345929|2002209|FG001|Overall Study|Patient withdrawal|1
991275|NCT01346059|2002217|FG000|Overall Study|Withdrawal by Subject|1
991276|NCT01346059|2002218|FG001|Overall Study|Withdrawal by Subject|0
991277|NCT01346176|2002240|FG000|Recruited|Protocol Violation|1
991278|NCT01346176|2002241|FG001|Recruited|Protocol Violation|0
991279|NCT01346176|2002242|FG002|Recruited|Protocol Violation|0
913308|NCT00809354|1890934|FG006|Overall Study|Adverse Event|44
913309|NCT00809354|1890935|FG007|Overall Study|Adverse Event|40
913310|NCT00809354|1890936|FG008|Overall Study|Adverse Event|46
913311|NCT00809354|1890937|FG009|Overall Study|Adverse Event|26
913312|NCT00809354|1890928|FG000|Overall Study|Lack of Efficacy|23
913313|NCT00809354|1890929|FG001|Overall Study|Lack of Efficacy|23
913314|NCT00809354|1890930|FG002|Overall Study|Lack of Efficacy|22
913315|NCT00809354|1890931|FG003|Overall Study|Lack of Efficacy|15
913316|NCT00809354|1890932|FG004|Overall Study|Lack of Efficacy|40
913317|NCT00809354|1890933|FG005|Overall Study|Lack of Efficacy|19
913318|NCT00809354|1890934|FG006|Overall Study|Lack of Efficacy|21
913319|NCT00809354|1890935|FG007|Overall Study|Lack of Efficacy|15
913320|NCT00809354|1890936|FG008|Overall Study|Lack of Efficacy|18
913321|NCT00809354|1890937|FG009|Overall Study|Lack of Efficacy|38
913322|NCT00809354|1890928|FG000|Overall Study|Lost to Follow-up|10
913323|NCT00809354|1890929|FG001|Overall Study|Lost to Follow-up|11
913324|NCT00809354|1890930|FG002|Overall Study|Lost to Follow-up|8
913325|NCT00809354|1890931|FG003|Overall Study|Lost to Follow-up|13
913326|NCT00809354|1890932|FG004|Overall Study|Lost to Follow-up|6
913327|NCT00809354|1890933|FG005|Overall Study|Lost to Follow-up|2
913328|NCT00809354|1890934|FG006|Overall Study|Lost to Follow-up|0
913329|NCT00809354|1890935|FG007|Overall Study|Lost to Follow-up|5
913330|NCT00809354|1890936|FG008|Overall Study|Lost to Follow-up|4
913331|NCT00809354|1890937|FG009|Overall Study|Lost to Follow-up|0
913332|NCT00809354|1890928|FG000|Overall Study|Protocol Violation|7
913333|NCT00809354|1890929|FG001|Overall Study|Protocol Violation|14
913334|NCT00809354|1890930|FG002|Overall Study|Protocol Violation|14
913335|NCT00809354|1890931|FG003|Overall Study|Protocol Violation|12
913336|NCT00809354|1890932|FG004|Overall Study|Protocol Violation|14
913337|NCT00809354|1890933|FG005|Overall Study|Protocol Violation|6
913338|NCT00809354|1890934|FG006|Overall Study|Protocol Violation|4
913339|NCT00809354|1890935|FG007|Overall Study|Protocol Violation|6
913340|NCT00809354|1890936|FG008|Overall Study|Protocol Violation|9
913341|NCT00809354|1890937|FG009|Overall Study|Protocol Violation|3
913342|NCT00809354|1890928|FG000|Overall Study|Withdrawal by Subject|32
913343|NCT00809354|1890929|FG001|Overall Study|Withdrawal by Subject|27
913344|NCT00809354|1890930|FG002|Overall Study|Withdrawal by Subject|31
913345|NCT00809354|1890931|FG003|Overall Study|Withdrawal by Subject|33
913346|NCT00809354|1890932|FG004|Overall Study|Withdrawal by Subject|34
913347|NCT00809354|1890933|FG005|Overall Study|Withdrawal by Subject|29
913348|NCT00809354|1890934|FG006|Overall Study|Withdrawal by Subject|27
913349|NCT00809354|1890935|FG007|Overall Study|Withdrawal by Subject|19
913350|NCT00809354|1890936|FG008|Overall Study|Withdrawal by Subject|18
913351|NCT00809354|1890937|FG009|Overall Study|Withdrawal by Subject|20
913352|NCT00809354|1890928|FG000|Overall Study|Other|10
913353|NCT00809354|1890929|FG001|Overall Study|Other|2
913354|NCT00809354|1890930|FG002|Overall Study|Other|7
913355|NCT00809354|1890931|FG003|Overall Study|Other|10
913356|NCT00809354|1890932|FG004|Overall Study|Other|5
913357|NCT00809354|1890933|FG005|Overall Study|Other|3
913358|NCT00809354|1890934|FG006|Overall Study|Other|2
913359|NCT00809354|1890935|FG007|Overall Study|Other|3
913360|NCT00809354|1890936|FG008|Overall Study|Other|4
913361|NCT00809354|1890937|FG009|Overall Study|Other|3
991280|NCT01346176|2002240|FG000|Completed Advance Directive|Death|3
991281|NCT01346176|2002241|FG001|Completed Advance Directive|Death|2
991282|NCT01346176|2002242|FG002|Completed Advance Directive|Death|2
991283|NCT01346176|2002240|FG000|Completed Advance Directive|Became Ineligible|3
991284|NCT01346176|2002241|FG001|Completed Advance Directive|Became Ineligible|0
991285|NCT01346176|2002242|FG002|Completed Advance Directive|Became Ineligible|1
991286|NCT01346176|2002240|FG000|Completed Advance Directive|Other reason did not complete AD|7
991287|NCT01346176|2002241|FG001|Completed Advance Directive|Other reason did not complete AD|12
991288|NCT01346176|2002242|FG002|Completed Advance Directive|Other reason did not complete AD|7
991289|NCT01346176|2002240|FG000|Completed Satisfaction Survey|Death|3
991290|NCT01346176|2002241|FG001|Completed Satisfaction Survey|Death|0
991291|NCT01346176|2002242|FG002|Completed Satisfaction Survey|Death|2
991292|NCT01346176|2002240|FG000|Completed Satisfaction Survey|Lost to Follow-up|3
991293|NCT01346176|2002241|FG001|Completed Satisfaction Survey|Lost to Follow-up|4
991294|NCT01346176|2002242|FG002|Completed Satisfaction Survey|Lost to Follow-up|4
991295|NCT01346189|2002254|FG000|Overall Study|Withdrawal by Subject|7
991296|NCT01346189|2002255|FG001|Overall Study|Withdrawal by Subject|5
991297|NCT01346189|2002256|FG002|Overall Study|Withdrawal by Subject|3
991298|NCT01346189|2002257|FG003|Overall Study|Withdrawal by Subject|5
991299|NCT01346189|2002254|FG000|Overall Study|Physician Decision|4
991300|NCT01346189|2002255|FG001|Overall Study|Physician Decision|0
991301|NCT01346189|2002256|FG002|Overall Study|Physician Decision|0
991302|NCT01346189|2002257|FG003|Overall Study|Physician Decision|0
991303|NCT01346189|2002254|FG000|Overall Study|Moved|3
991304|NCT01346189|2002255|FG001|Overall Study|Moved|0
991305|NCT01346189|2002256|FG002|Overall Study|Moved|4
991306|NCT01346189|2002257|FG003|Overall Study|Moved|0
991307|NCT01346189|2002254|FG000|Overall Study|Other|2
991308|NCT01346189|2002255|FG001|Overall Study|Other|4
991309|NCT01346189|2002256|FG002|Overall Study|Other|7
991310|NCT01346189|2002257|FG003|Overall Study|Other|3
991311|NCT01346189|2002254|FG000|Overall Study|Death|0
991312|NCT01346189|2002255|FG001|Overall Study|Death|3
991313|NCT01346189|2002256|FG002|Overall Study|Death|0
991314|NCT01346189|2002257|FG003|Overall Study|Death|0
991315|NCT01346189|2002254|FG000|Overall Study|Non-health system primary care physician|0
991316|NCT01346189|2002255|FG001|Overall Study|Non-health system primary care physician|5
991317|NCT01346189|2002256|FG002|Overall Study|Non-health system primary care physician|0
991318|NCT01346189|2002257|FG003|Overall Study|Non-health system primary care physician|0
991319|NCT01346189|2002254|FG000|Overall Study|Travel|0
991320|NCT01346189|2002255|FG001|Overall Study|Travel|0
991321|NCT01346189|2002256|FG002|Overall Study|Travel|0
991322|NCT01346189|2002257|FG003|Overall Study|Travel|3
991323|NCT01346293|2002278|FG000|Overall Study|Protocol Violation|30
991324|NCT01346293|2002279|FG001|Overall Study|Protocol Violation|9
991325|NCT01346293|2002278|FG000|Overall Study|Lost to Follow-up|21
991326|NCT01346293|2002279|FG001|Overall Study|Lost to Follow-up|8
991327|NCT01346293|2002278|FG000|Overall Study|Withdrawal by Subject|15
991328|NCT01346293|2002279|FG001|Overall Study|Withdrawal by Subject|4
991329|NCT01346293|2002278|FG000|Overall Study|Other|1
991330|NCT01346293|2002279|FG001|Overall Study|Other|0
991331|NCT01346371|2002289|FG000|Overall Study|Lost to Follow-up|2
991332|NCT01346371|2002290|FG001|Overall Study|Lost to Follow-up|0
913362|NCT00809354|1890928|FG000|Overall Study|Study terminated by sponsor|138
913363|NCT00809354|1890929|FG001|Overall Study|Study terminated by sponsor|134
913364|NCT00809354|1890930|FG002|Overall Study|Study terminated by sponsor|129
913365|NCT00809354|1890931|FG003|Overall Study|Study terminated by sponsor|120
913366|NCT00809354|1890932|FG004|Overall Study|Study terminated by sponsor|126
913367|NCT00809354|1890933|FG005|Overall Study|Study terminated by sponsor|133
913368|NCT00809354|1890934|FG006|Overall Study|Study terminated by sponsor|124
913369|NCT00809354|1890935|FG007|Overall Study|Study terminated by sponsor|148
913370|NCT00809354|1890936|FG008|Overall Study|Study terminated by sponsor|127
913371|NCT00809354|1890937|FG009|Overall Study|Study terminated by sponsor|135
913372|NCT00809354|1890928|FG000|Overall Study|Withdrawn due to pregnancy|0
913373|NCT00809354|1890929|FG001|Overall Study|Withdrawn due to pregnancy|1
913374|NCT00809354|1890930|FG002|Overall Study|Withdrawn due to pregnancy|0
913375|NCT00809354|1890931|FG003|Overall Study|Withdrawn due to pregnancy|0
913376|NCT00809354|1890932|FG004|Overall Study|Withdrawn due to pregnancy|0
913377|NCT00809354|1890933|FG005|Overall Study|Withdrawn due to pregnancy|0
913378|NCT00809354|1890934|FG006|Overall Study|Withdrawn due to pregnancy|0
913379|NCT00809354|1890935|FG007|Overall Study|Withdrawn due to pregnancy|0
913380|NCT00809354|1890936|FG008|Overall Study|Withdrawn due to pregnancy|0
913381|NCT00809354|1890937|FG009|Overall Study|Withdrawn due to pregnancy|0
913382|NCT00809354|1890928|FG000|Overall Study|Randomized but not Treated|3
913383|NCT00809354|1890929|FG001|Overall Study|Randomized but not Treated|1
991333|NCT01346410|2002305|FG000|Overall Study|Death|1
991334|NCT01346475|2002311|FG000|First Intervention|Lost to Follow-up|4
991335|NCT01346475|2002312|FG001|First Intervention|Lost to Follow-up|3
991336|NCT01346501|2002324|FG000|Overall Study|Initiated Other Biological Agents|3
991337|NCT01346501|2002325|FG001|Overall Study|Initiated Other Biological Agents|1
991338|NCT01346501|2002324|FG000|Overall Study|Other|8
991339|NCT01346501|2002325|FG001|Overall Study|Other|12
991340|NCT01346514|2002335|FG000|Overall Study|Lost to Follow-up|19
991341|NCT01346514|2002336|FG001|Overall Study|Lost to Follow-up|30
991342|NCT01346514|2002335|FG000|Overall Study|Withdrawal by Subject|7
991343|NCT01346514|2002336|FG001|Overall Study|Withdrawal by Subject|3
991344|NCT01346514|2002335|FG000|Overall Study|Death|3
991345|NCT01346514|2002336|FG001|Overall Study|Death|4
991346|NCT01346540|2002346|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3
991347|NCT01346540|2002347|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8
991348|NCT01346540|2002346|FG000|Overall Study|Adverse Event|0
991349|NCT01346540|2002347|FG001|Overall Study|Adverse Event|4
991350|NCT01346592|2002357|FG000|Overall Study|Lost to Follow-up|62
991351|NCT01346592|2002358|FG001|Overall Study|Lost to Follow-up|29
991352|NCT01346592|2002359|FG002|Overall Study|Lost to Follow-up|29
991353|NCT01346592|2002357|FG000|Overall Study|Protocol Violation|2
991354|NCT01346592|2002358|FG001|Overall Study|Protocol Violation|1
991355|NCT01346592|2002359|FG002|Overall Study|Protocol Violation|0
991356|NCT01346592|2002357|FG000|Overall Study|Death|1
991357|NCT01346592|2002358|FG001|Overall Study|Death|3
991358|NCT01346592|2002359|FG002|Overall Study|Death|4
991359|NCT01346592|2002357|FG000|Overall Study|Adverse Event|0
991360|NCT01346592|2002358|FG001|Overall Study|Adverse Event|1
991361|NCT01346592|2002359|FG002|Overall Study|Adverse Event|0
991362|NCT01346592|2002357|FG000|Overall Study|Withdrawal by Subject|77
991363|NCT01346592|2002358|FG001|Overall Study|Withdrawal by Subject|51
991364|NCT01346592|2002359|FG002|Overall Study|Withdrawal by Subject|38
991365|NCT01346592|2002357|FG000|Overall Study|Inappropriate enrollment|3
991366|NCT01346592|2002358|FG001|Overall Study|Inappropriate enrollment|1
991367|NCT01346592|2002359|FG002|Overall Study|Inappropriate enrollment|1
991368|NCT01346592|2002357|FG000|Overall Study|Administrative reason|1
991369|NCT01346592|2002358|FG001|Overall Study|Administrative reason|0
991370|NCT01346592|2002359|FG002|Overall Study|Administrative reason|0
991371|NCT01346592|2002357|FG000|Overall Study|Unable to Classify|7
991372|NCT01346592|2002358|FG001|Overall Study|Unable to Classify|3
991373|NCT01346592|2002359|FG002|Overall Study|Unable to Classify|6
991374|NCT01346696|2002388|FG000|Overall Study|Death|1
991375|NCT01346774|2002394|FG000|Overall Study|Did not take a single dose|6
991376|NCT01346774|2002395|FG001|Overall Study|Did not take a single dose|4
991377|NCT01346774|2002394|FG000|Overall Study|Lost to Follow-up|3
991378|NCT01346774|2002395|FG001|Overall Study|Lost to Follow-up|4
991379|NCT01346774|2002394|FG000|Overall Study|Withdrawal by Subject|1
991380|NCT01346774|2002395|FG001|Overall Study|Withdrawal by Subject|4
991381|NCT01346774|2002394|FG000|Overall Study|Protocol Violation|2
991382|NCT01346774|2002395|FG001|Overall Study|Protocol Violation|3
991383|NCT01346774|2002394|FG000|Overall Study|Adverse Event|1
991384|NCT01346774|2002395|FG001|Overall Study|Adverse Event|2
991385|NCT01346969|2002423|FG000|Overall Study|Withdrawal by Subject|0
991386|NCT01346969|2002424|FG001|Overall Study|Withdrawal by Subject|0
991387|NCT01346969|2002425|FG002|Overall Study|Withdrawal by Subject|1
991388|NCT01346969|2002426|FG003|Overall Study|Withdrawal by Subject|0
991389|NCT01346969|2002423|FG000|Overall Study|Lost to Follow-up|1
991390|NCT01346969|2002424|FG001|Overall Study|Lost to Follow-up|0
991391|NCT01346969|2002425|FG002|Overall Study|Lost to Follow-up|2
991392|NCT01346969|2002426|FG003|Overall Study|Lost to Follow-up|0
991393|NCT01346969|2002423|FG000|Overall Study|Physician Decision|0
991394|NCT01346969|2002424|FG001|Overall Study|Physician Decision|0
991395|NCT01346969|2002425|FG002|Overall Study|Physician Decision|0
991396|NCT01346969|2002426|FG003|Overall Study|Physician Decision|1
991397|NCT01346969|2002423|FG000|Overall Study|Randomized but not treated|1
991398|NCT01346969|2002424|FG001|Overall Study|Randomized but not treated|0
991399|NCT01346969|2002425|FG002|Overall Study|Randomized but not treated|0
991400|NCT01346969|2002426|FG003|Overall Study|Randomized but not treated|0
991401|NCT01347073|2002463|FG000|Overall Study|Adverse Event|1
991402|NCT01347073|2002463|FG000|Overall Study|Liver Transplant|1
991403|NCT01347086|2002483|FG000|Overall Study|failed screening visit|0
991404|NCT01347086|2002484|FG001|Overall Study|failed screening visit|0
991405|NCT01347086|2002485|FG002|Overall Study|failed screening visit|1
991406|NCT01347086|2002486|FG003|Overall Study|failed screening visit|0
991407|NCT01347086|2002487|FG004|Overall Study|failed screening visit|0
991408|NCT01347086|2002488|FG005|Overall Study|failed screening visit|0
991409|NCT01347086|2002489|FG006|Overall Study|failed screening visit|1
991410|NCT01347086|2002490|FG007|Overall Study|failed screening visit|1
991411|NCT01347086|2002491|FG008|Overall Study|failed screening visit|0
991412|NCT01347086|2002492|FG009|Overall Study|failed screening visit|1
991413|NCT01347112|2002526|FG000|Overall Study|Withdrawal by Subject|1
991414|NCT01347112|2002527|FG001|Overall Study|Withdrawal by Subject|7
991415|NCT01347112|2002526|FG000|Overall Study|Lost to Follow-up|3
991416|NCT01347112|2002527|FG001|Overall Study|Lost to Follow-up|5
991417|NCT01347307|2002543|FG000|Overall Study|Death|0
991418|NCT01347307|2002544|FG001|Overall Study|Death|4
991419|NCT01347307|2002543|FG000|Overall Study|Physician Decision|0
991420|NCT01347307|2002544|FG001|Overall Study|Physician Decision|1
991421|NCT01347554|2002570|FG000|Overall Study|Lack of Efficacy|7
991422|NCT01347554|2002571|FG001|Overall Study|Lack of Efficacy|11
991423|NCT01347580|2002579|FG000|Overall Study|Withdrawal by Subject|13
991424|NCT01347580|2002580|FG001|Overall Study|Withdrawal by Subject|23
991425|NCT01347580|2002579|FG000|Overall Study|Death|30
991426|NCT01347580|2002580|FG001|Overall Study|Death|19
991427|NCT01347580|2002579|FG000|Overall Study|Protocol Violation|10
991428|NCT01347580|2002580|FG001|Overall Study|Protocol Violation|7
991429|NCT01347580|2002579|FG000|Overall Study|Lost to Follow-up|3
991430|NCT01347580|2002580|FG001|Overall Study|Lost to Follow-up|1
991431|NCT01347580|2002579|FG000|Overall Study|Had other reason|9
991432|NCT01347580|2002580|FG001|Overall Study|Had other reason|6
991433|NCT01347710|2002586|FG000|Overall Study|Withdrawal by Subject|2
991434|NCT01347710|2002586|FG000|Overall Study|Adverse Event|4
991435|NCT01347710|2002586|FG000|Overall Study|Angio or SPECT not completed|18
991436|NCT01347710|2002586|FG000|Overall Study|issue with vitals prior to dosing|1
991437|NCT01347710|2002586|FG000|Overall Study|Lost to Follow-up|1
991438|NCT01347710|2002586|FG000|Overall Study|Physician Decision|2
991439|NCT01347710|2002586|FG000|Overall Study|Other|3
991440|NCT01347762|2002598|FG000|Overall Study|Lost to Follow-up|0
991441|NCT01347762|2002599|FG001|Overall Study|Lost to Follow-up|1
991442|NCT01347762|2002600|FG002|Overall Study|Lost to Follow-up|6
991443|NCT01347762|2002601|FG003|Overall Study|Lost to Follow-up|5
991444|NCT01347762|2002598|FG000|Overall Study|Withdrawal by Subject|4
991445|NCT01347762|2002599|FG001|Overall Study|Withdrawal by Subject|1
991446|NCT01347762|2002600|FG002|Overall Study|Withdrawal by Subject|3
991447|NCT01347762|2002601|FG003|Overall Study|Withdrawal by Subject|3
991448|NCT01347866|2002638|FG000|Overall Study|Death|0
991449|NCT01347866|2002639|FG001|Overall Study|Death|0
991450|NCT01347866|2002640|FG002|Overall Study|Death|0
991451|NCT01347866|2002641|FG003|Overall Study|Death|1
991452|NCT01347866|2002642|FG004|Overall Study|Death|2
991453|NCT01347866|2002643|FG005|Overall Study|Death|2
991454|NCT01347866|2002644|FG006|Overall Study|Death|1
991455|NCT01347866|2002645|FG007|Overall Study|Death|0
991456|NCT01347866|2002646|FG008|Overall Study|Death|4
991457|NCT01347866|2002647|FG009|Overall Study|Death|1
991458|NCT01347866|2002648|FG010|Overall Study|Death|3
991459|NCT01347866|2002649|FG011|Overall Study|Death|1
991460|NCT01347866|2002650|FG012|Overall Study|Death|2
991461|NCT01347866|2002651|FG013|Overall Study|Death|0
991462|NCT01347866|2002652|FG014|Overall Study|Death|0
991463|NCT01347866|2002653|FG015|Overall Study|Death|1
991464|NCT01347866|2002654|FG016|Overall Study|Death|0
991465|NCT01347866|2002638|FG000|Overall Study|Lost to Follow-up|0
991466|NCT01347866|2002639|FG001|Overall Study|Lost to Follow-up|0
991467|NCT01347866|2002640|FG002|Overall Study|Lost to Follow-up|0
991468|NCT01347866|2002641|FG003|Overall Study|Lost to Follow-up|0
991469|NCT01347866|2002642|FG004|Overall Study|Lost to Follow-up|0
991470|NCT01347866|2002643|FG005|Overall Study|Lost to Follow-up|0
991471|NCT01347866|2002644|FG006|Overall Study|Lost to Follow-up|0
991472|NCT01347866|2002645|FG007|Overall Study|Lost to Follow-up|1
991473|NCT01347866|2002646|FG008|Overall Study|Lost to Follow-up|1
991474|NCT01347866|2002647|FG009|Overall Study|Lost to Follow-up|0
991475|NCT01347866|2002648|FG010|Overall Study|Lost to Follow-up|0
991476|NCT01347866|2002649|FG011|Overall Study|Lost to Follow-up|0
991477|NCT01347866|2002650|FG012|Overall Study|Lost to Follow-up|0
991478|NCT01347866|2002651|FG013|Overall Study|Lost to Follow-up|0
991479|NCT01347866|2002652|FG014|Overall Study|Lost to Follow-up|0
991480|NCT01347866|2002653|FG015|Overall Study|Lost to Follow-up|0
991481|NCT01347866|2002654|FG016|Overall Study|Lost to Follow-up|0
991482|NCT01347866|2002638|FG000|Overall Study|Other|3
991483|NCT01347866|2002639|FG001|Overall Study|Other|1
991484|NCT01347866|2002640|FG002|Overall Study|Other|1
991485|NCT01347866|2002641|FG003|Overall Study|Other|4
991486|NCT01347866|2002642|FG004|Overall Study|Other|5
991487|NCT01347866|2002643|FG005|Overall Study|Other|0
991488|NCT01347866|2002644|FG006|Overall Study|Other|5
991489|NCT01347866|2002645|FG007|Overall Study|Other|3
991490|NCT01347866|2002646|FG008|Overall Study|Other|22
991491|NCT01347866|2002647|FG009|Overall Study|Other|5
991492|NCT01347866|2002648|FG010|Overall Study|Other|0
991493|NCT01347866|2002649|FG011|Overall Study|Other|3
991494|NCT01347866|2002650|FG012|Overall Study|Other|4
991495|NCT01347866|2002651|FG013|Overall Study|Other|4
991496|NCT01347866|2002652|FG014|Overall Study|Other|2
991497|NCT01347866|2002653|FG015|Overall Study|Other|3
991498|NCT01347866|2002654|FG016|Overall Study|Other|0
991499|NCT01347866|2002638|FG000|Overall Study|Subject refused further follow-up|2
991500|NCT01347866|2002639|FG001|Overall Study|Subject refused further follow-up|0
991501|NCT01347866|2002640|FG002|Overall Study|Subject refused further follow-up|0
991502|NCT01347866|2002641|FG003|Overall Study|Subject refused further follow-up|2
991503|NCT01347866|2002642|FG004|Overall Study|Subject refused further follow-up|0
991504|NCT01347866|2002643|FG005|Overall Study|Subject refused further follow-up|1
991505|NCT01347866|2002644|FG006|Overall Study|Subject refused further follow-up|0
991506|NCT01347866|2002645|FG007|Overall Study|Subject refused further follow-up|0
991507|NCT01347866|2002646|FG008|Overall Study|Subject refused further follow-up|4
991508|NCT01347866|2002647|FG009|Overall Study|Subject refused further follow-up|1
991509|NCT01347866|2002648|FG010|Overall Study|Subject refused further follow-up|0
991510|NCT01347866|2002649|FG011|Overall Study|Subject refused further follow-up|0
991511|NCT01347866|2002650|FG012|Overall Study|Subject refused further follow-up|1
991512|NCT01347866|2002651|FG013|Overall Study|Subject refused further follow-up|3
991513|NCT01347866|2002652|FG014|Overall Study|Subject refused further follow-up|1
991514|NCT01347866|2002653|FG015|Overall Study|Subject refused further follow-up|0
991515|NCT01347866|2002654|FG016|Overall Study|Subject refused further follow-up|2
991516|NCT01347879|2002727|FG000|Overall Study|Adverse Event|0
991517|NCT01347879|2002728|FG001|Overall Study|Adverse Event|12
991518|NCT01347879|2002727|FG000|Overall Study|Lost to Follow-up|2
991519|NCT01347879|2002728|FG001|Overall Study|Lost to Follow-up|0
991520|NCT01347879|2002727|FG000|Overall Study|Withdrawal by Subject|3
991521|NCT01347879|2002728|FG001|Overall Study|Withdrawal by Subject|2
991522|NCT01347879|2002727|FG000|Overall Study|Other|2
991523|NCT01347879|2002728|FG001|Overall Study|Other|3
991524|NCT01347931|2002734|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1
991525|NCT01348087|2002740|FG000|Overall Study|Unsatisfactory therapeutic effect|35
991526|NCT01348087|2002740|FG000|Overall Study|Administrative problems|79
991527|NCT01348087|2002740|FG000|Overall Study|protocol deviation|1
991528|NCT01348087|2002740|FG000|Overall Study|Lost to Follow-up|1
991529|NCT01348087|2002740|FG000|Overall Study|Subject withdrew consent|7
991530|NCT01348087|2002740|FG000|Overall Study|Adverse Event|25
991531|NCT01348100|2002761|FG000|Overall Study|Subject Withdrew Consent|0
991532|NCT01348100|2002762|FG001|Overall Study|Subject Withdrew Consent|0
991533|NCT01348100|2002763|FG002|Overall Study|Subject Withdrew Consent|2
991534|NCT01348100|2002764|FG003|Overall Study|Subject Withdrew Consent|0
913384|NCT00809354|1890930|FG002|Overall Study|Randomized but not Treated|6
913385|NCT00809354|1890931|FG003|Overall Study|Randomized but not Treated|0
913386|NCT00809354|1890932|FG004|Overall Study|Randomized but not Treated|5
913387|NCT00809354|1890933|FG005|Overall Study|Randomized but not Treated|0
913388|NCT00809354|1890934|FG006|Overall Study|Randomized but not Treated|1
913389|NCT00809354|1890935|FG007|Overall Study|Randomized but not Treated|1
913390|NCT00809354|1890936|FG008|Overall Study|Randomized but not Treated|2
913391|NCT00809354|1890937|FG009|Overall Study|Randomized but not Treated|1
913392|NCT00809354|1890928|FG000|Overall Study|Death|0
913393|NCT00809354|1890929|FG001|Overall Study|Death|0
913394|NCT00809354|1890930|FG002|Overall Study|Death|0
913395|NCT00809354|1890931|FG003|Overall Study|Death|0
913396|NCT00809354|1890932|FG004|Overall Study|Death|0
913397|NCT00809354|1890933|FG005|Overall Study|Death|0
913398|NCT00809354|1890934|FG006|Overall Study|Death|0
913399|NCT00809354|1890935|FG007|Overall Study|Death|1
913400|NCT00809354|1890936|FG008|Overall Study|Death|0
913401|NCT00809354|1890937|FG009|Overall Study|Death|0
913402|NCT00809445|1890967|FG000|1 Month Follow-up|Lost contact|1
913403|NCT00809445|1890968|FG001|1 Month Follow-up|Lost contact|2
913404|NCT00809445|1890969|FG002|1 Month Follow-up|Lost contact|1
913405|NCT00809445|1890967|FG000|1 Month Follow-up|Withdrew consent|1
913406|NCT00809445|1890968|FG001|1 Month Follow-up|Withdrew consent|1
913407|NCT00809445|1890969|FG002|1 Month Follow-up|Withdrew consent|1
913408|NCT00809445|1890967|FG000|1 Month Follow-up|Death|0
913409|NCT00809445|1890968|FG001|1 Month Follow-up|Death|1
913410|NCT00809445|1890969|FG002|1 Month Follow-up|Death|1
913411|NCT00809445|1890967|FG000|1 Month Follow-up|Incarcerated|0
913412|NCT00809445|1890968|FG001|1 Month Follow-up|Incarcerated|0
913413|NCT00809445|1890969|FG002|1 Month Follow-up|Incarcerated|1
913414|NCT00809445|1890967|FG000|6 Month Follow-up|Lost contact|16
913415|NCT00809445|1890968|FG001|6 Month Follow-up|Lost contact|14
913416|NCT00809445|1890969|FG002|6 Month Follow-up|Lost contact|14
913417|NCT00809445|1890967|FG000|6 Month Follow-up|Death|2
913418|NCT00809445|1890968|FG001|6 Month Follow-up|Death|1
913419|NCT00809445|1890969|FG002|6 Month Follow-up|Death|1
913420|NCT00809445|1890967|FG000|6 Month Follow-up|Incarcerated|6
913421|NCT00809445|1890968|FG001|6 Month Follow-up|Incarcerated|8
913422|NCT00809445|1890969|FG002|6 Month Follow-up|Incarcerated|8
913423|NCT00809445|1890967|FG000|6 Month Follow-up|Withdrew consent|0
913424|NCT00809445|1890968|FG001|6 Month Follow-up|Withdrew consent|0
913425|NCT00809445|1890969|FG002|6 Month Follow-up|Withdrew consent|1
913426|NCT00809471|1890980|FG000|Overall Study|Protocol non-compliance|15
913427|NCT00809471|1890981|FG001|Overall Study|Protocol non-compliance|15
913428|NCT00809471|1890982|FG002|Overall Study|Protocol non-compliance|6
913429|NCT00809471|1890980|FG000|Overall Study|Lost to Follow-up|4
913430|NCT00809471|1890981|FG001|Overall Study|Lost to Follow-up|2
913431|NCT00809471|1890982|FG002|Overall Study|Lost to Follow-up|9
913432|NCT00809471|1890980|FG000|Overall Study|Adverse Event|0
913433|NCT00809471|1890981|FG001|Overall Study|Adverse Event|2
913434|NCT00809471|1890982|FG002|Overall Study|Adverse Event|2
913435|NCT00809471|1890980|FG000|Overall Study|Requirement for restricted medication|1
913436|NCT00809471|1890981|FG001|Overall Study|Requirement for restricted medication|1
913437|NCT00809471|1890982|FG002|Overall Study|Requirement for restricted medication|0
913438|NCT00809614|1891001|FG000|Overall Study|Lack of Efficacy|2
913439|NCT00809614|1891002|FG001|Overall Study|Lack of Efficacy|3
913440|NCT00809614|1891001|FG000|Overall Study|Withdrawal by Subject|1
991535|NCT01348100|2002765|FG004|Overall Study|Subject Withdrew Consent|1
991536|NCT01348100|2002766|FG005|Overall Study|Subject Withdrew Consent|0
991537|NCT01348100|2002767|FG006|Overall Study|Subject Withdrew Consent|1
991538|NCT01348100|2002761|FG000|Overall Study|Protocol Deviation|0
991539|NCT01348100|2002762|FG001|Overall Study|Protocol Deviation|0
991540|NCT01348100|2002763|FG002|Overall Study|Protocol Deviation|0
991541|NCT01348100|2002764|FG003|Overall Study|Protocol Deviation|1
991542|NCT01348100|2002765|FG004|Overall Study|Protocol Deviation|0
991543|NCT01348100|2002766|FG005|Overall Study|Protocol Deviation|0
991544|NCT01348100|2002767|FG006|Overall Study|Protocol Deviation|0
991545|NCT01348100|2002761|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
991546|NCT01348100|2002762|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
991547|NCT01348100|2002763|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0
991548|NCT01348100|2002764|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
991549|NCT01348100|2002765|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0
991550|NCT01348100|2002766|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1
991551|NCT01348100|2002767|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0
991552|NCT01348100|2002761|FG000|Overall Study|Lost to Follow-up|0
991553|NCT01348100|2002762|FG001|Overall Study|Lost to Follow-up|0
991554|NCT01348100|2002763|FG002|Overall Study|Lost to Follow-up|0
991555|NCT01348100|2002764|FG003|Overall Study|Lost to Follow-up|0
991556|NCT01348100|2002765|FG004|Overall Study|Lost to Follow-up|0
991557|NCT01348100|2002766|FG005|Overall Study|Lost to Follow-up|0
991558|NCT01348100|2002767|FG006|Overall Study|Lost to Follow-up|1
991559|NCT01348100|2002761|FG000|Overall Study|Administrative Problems|0
991560|NCT01348100|2002762|FG001|Overall Study|Administrative Problems|0
991561|NCT01348100|2002763|FG002|Overall Study|Administrative Problems|0
991562|NCT01348100|2002764|FG003|Overall Study|Administrative Problems|0
991563|NCT01348100|2002765|FG004|Overall Study|Administrative Problems|0
991564|NCT01348100|2002766|FG005|Overall Study|Administrative Problems|1
991565|NCT01348100|2002767|FG006|Overall Study|Administrative Problems|1
991566|NCT01348139|2002788|FG000|Period 1|Adverse Event|1
991567|NCT01348139|2002789|FG001|Period 1|Adverse Event|0
991568|NCT01348139|2002790|FG002|Period 1|Adverse Event|0
991569|NCT01348139|2002791|FG003|Period 1|Adverse Event|0
991570|NCT01348139|2002792|FG004|Period 1|Adverse Event|0
991571|NCT01348139|2002793|FG005|Period 1|Adverse Event|0
991572|NCT01348165|2002814|FG000|Overall Study|Adverse Event|0
991573|NCT01348165|2002815|FG001|Overall Study|Adverse Event|0
991574|NCT01348165|2002816|FG002|Overall Study|Adverse Event|0
991575|NCT01348165|2002817|FG003|Overall Study|Adverse Event|0
991576|NCT01348165|2002818|FG004|Overall Study|Adverse Event|0
991577|NCT01348165|2002819|FG005|Overall Study|Adverse Event|0
991578|NCT01348165|2002820|FG006|Overall Study|Adverse Event|1
991579|NCT01348347|2002843|FG000|Overall Study|Withdrawal by Subject|1
991580|NCT01348347|2002844|FG001|Overall Study|Withdrawal by Subject|1
991581|NCT01348347|2002845|FG002|Overall Study|Withdrawal by Subject|1
991582|NCT01348347|2002843|FG000|Overall Study|Progressive disease|2
991583|NCT01348347|2002844|FG001|Overall Study|Progressive disease|5
991584|NCT01348347|2002845|FG002|Overall Study|Progressive disease|5
991585|NCT01348425|2002856|FG000|Overall Study|Imaging was not taken.|1
991586|NCT01348425|2002857|FG001|Overall Study|Imaging was not taken.|1
991587|NCT01348490|2002862|FG000|Overall Study|Death|1
991588|NCT01348490|2002862|FG000|Overall Study|Adverse Event|3
991589|NCT01348490|2002862|FG000|Overall Study|Consent withdrawn|7
913441|NCT00809614|1891002|FG001|Overall Study|Withdrawal by Subject|1
913442|NCT00809757|1891011|FG000|Overall Study|Adverse Event|2
913443|NCT00809757|1891012|FG001|Overall Study|Adverse Event|3
913444|NCT00809757|1891013|FG002|Overall Study|Adverse Event|3
913445|NCT00809757|1891011|FG000|Overall Study|Lost to Follow-up|0
913446|NCT00809757|1891012|FG001|Overall Study|Lost to Follow-up|0
913447|NCT00809757|1891013|FG002|Overall Study|Lost to Follow-up|1
913448|NCT00809757|1891011|FG000|Overall Study|Protocol Violation|1
913449|NCT00809757|1891012|FG001|Overall Study|Protocol Violation|1
913450|NCT00809757|1891013|FG002|Overall Study|Protocol Violation|1
913451|NCT00809757|1891011|FG000|Overall Study|Withdrawal by Subject|2
913452|NCT00809757|1891012|FG001|Overall Study|Withdrawal by Subject|1
913453|NCT00809757|1891013|FG002|Overall Study|Withdrawal by Subject|3
913454|NCT00809757|1891011|FG000|Overall Study|Subject Uncooperative|1
913455|NCT00809757|1891012|FG001|Overall Study|Subject Uncooperative|0
913456|NCT00809757|1891013|FG002|Overall Study|Subject Uncooperative|2
913457|NCT00809757|1891011|FG000|Overall Study|Noncompliance with Medication|0
913458|NCT00809757|1891012|FG001|Overall Study|Noncompliance with Medication|0
913459|NCT00809757|1891013|FG002|Overall Study|Noncompliance with Medication|1
913460|NCT00809783|1891030|FG000|Overall Study|Death|1
913461|NCT00809783|1891031|FG001|Overall Study|Death|0
913462|NCT00809783|1891032|FG002|Overall Study|Death|0
913463|NCT00809783|1891030|FG000|Overall Study|Adverse Event|34
913464|NCT00809783|1891031|FG001|Overall Study|Adverse Event|52
913465|NCT00809783|1891032|FG002|Overall Study|Adverse Event|71
913466|NCT00809783|1891030|FG000|Overall Study|Lack of Efficacy|39
913467|NCT00809783|1891031|FG001|Overall Study|Lack of Efficacy|52
913468|NCT00809783|1891032|FG002|Overall Study|Lack of Efficacy|63
913469|NCT00809783|1891030|FG000|Overall Study|Lost to Follow-up|0
913470|NCT00809783|1891031|FG001|Overall Study|Lost to Follow-up|3
991590|NCT01348490|2002862|FG000|Overall Study|Disease progression|3
991591|NCT01348490|2002862|FG000|Overall Study|Lost to Follow-up|1
991592|NCT01348490|2002862|FG000|Overall Study|Termination of clinical trial by sponsor|1
991593|NCT01348490|2002862|FG000|Overall Study|Other Unspecified|8
991594|NCT01348542|2002885|FG000|Overall Study|Withdrawal by Subject|3
991595|NCT01348542|2002886|FG001|Overall Study|Withdrawal by Subject|0
991596|NCT01348698|2002905|FG000|Overall Study|Does not meet lesion size criteria|1
991597|NCT01348698|2002905|FG000|Overall Study|Death|3
991598|NCT01348698|2002905|FG000|Overall Study|PI decision to close study|68
991599|NCT01348763|2002909|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
991600|NCT01348763|2002909|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
991601|NCT01348776|2002913|FG000|Overall Study|Lost to Follow-up|3
991602|NCT01348789|2002926|FG000|Overall Study|Protocol Violation|2
991603|NCT01348789|2002926|FG000|Overall Study|Withdrawal by Subject|2
991604|NCT01348828|2002937|FG000|Overall Study|Death|20
991605|NCT01348828|2002937|FG000|Overall Study|Withdrawals/Lost to Follow-up|10
991606|NCT01348828|2002937|FG000|Overall Study|Conversion|2
991607|NCT01348828|2002937|FG000|Overall Study|missed visit|1
991608|NCT01348854|2002943|FG000|Overall Study|Lost to Follow-up|2
991609|NCT01348854|2002944|FG001|Overall Study|Lost to Follow-up|1
991610|NCT01348854|2002943|FG000|Overall Study|Withdrawal by Subject|1
991611|NCT01348854|2002944|FG001|Overall Study|Withdrawal by Subject|0
991612|NCT01349036|2002952|FG000|Overall Study|Disease progression|13
991613|NCT01349036|2002953|FG001|Overall Study|Disease progression|22
991614|NCT01349036|2002952|FG000|Overall Study|Other|1
991615|NCT01349036|2002953|FG001|Overall Study|Other|0
991616|NCT01349036|2002952|FG000|Overall Study|Withdrawal by Subject|0
991617|NCT01349036|2002953|FG001|Overall Study|Withdrawal by Subject|2
991618|NCT01349049|2002972|FG000|Overall Study|Disease progression|3
991619|NCT01349049|2002973|FG001|Overall Study|Disease progression|5
991620|NCT01349049|2002974|FG002|Overall Study|Disease progression|3
991621|NCT01349049|2002975|FG003|Overall Study|Disease progression|2
991622|NCT01349049|2002976|FG004|Overall Study|Disease progression|2
991623|NCT01349049|2002977|FG005|Overall Study|Disease progression|2
991624|NCT01349049|2002978|FG006|Overall Study|Disease progression|3
991625|NCT01349049|2002979|FG007|Overall Study|Disease progression|2
991626|NCT01349049|2002980|FG008|Overall Study|Disease progression|33
991627|NCT01349049|2002972|FG000|Overall Study|Adverse Event|0
991628|NCT01349049|2002973|FG001|Overall Study|Adverse Event|1
991629|NCT01349049|2002974|FG002|Overall Study|Adverse Event|0
991630|NCT01349049|2002975|FG003|Overall Study|Adverse Event|0
913471|NCT00809783|1891032|FG002|Overall Study|Lost to Follow-up|4
913472|NCT00809783|1891030|FG000|Overall Study|Withdrawal by Subject|47
913473|NCT00809783|1891031|FG001|Overall Study|Withdrawal by Subject|72
913474|NCT00809783|1891032|FG002|Overall Study|Withdrawal by Subject|64
913475|NCT00809783|1891030|FG000|Overall Study|Protocol Violation|2
913476|NCT00809783|1891031|FG001|Overall Study|Protocol Violation|6
913477|NCT00809783|1891032|FG002|Overall Study|Protocol Violation|5
913478|NCT00809783|1891030|FG000|Overall Study|Randomized, but not treated|3
913479|NCT00809783|1891031|FG001|Overall Study|Randomized, but not treated|0
913480|NCT00809783|1891032|FG002|Overall Study|Randomized, but not treated|2
913481|NCT00809783|1891030|FG000|Overall Study|Study Terminated by Sponsor|378
913482|NCT00809783|1891031|FG001|Overall Study|Study Terminated by Sponsor|626
913483|NCT00809783|1891032|FG002|Overall Study|Study Terminated by Sponsor|565
913484|NCT00809783|1891030|FG000|Overall Study|Other|21
913485|NCT00809783|1891031|FG001|Overall Study|Other|21
913486|NCT00809783|1891032|FG002|Overall Study|Other|16
913487|NCT00809835|1891053|FG000|Overall Study|Lost to Follow-up|7
913488|NCT00809835|1891054|FG001|Overall Study|Lost to Follow-up|6
913489|NCT00809835|1891055|FG002|Overall Study|Lost to Follow-up|10
913490|NCT00809835|1891056|FG003|Overall Study|Lost to Follow-up|2
913491|NCT00809835|1891053|FG000|Overall Study|Withdrawal by Subject|1
913492|NCT00809835|1891054|FG001|Overall Study|Withdrawal by Subject|1
913493|NCT00809835|1891055|FG002|Overall Study|Withdrawal by Subject|1
913494|NCT00809835|1891056|FG003|Overall Study|Withdrawal by Subject|0
913495|NCT00809926|1891090|FG000|Overall Study|Adverse Event|18
913496|NCT00809926|1891091|FG001|Overall Study|Adverse Event|10
913497|NCT00809926|1891090|FG000|Overall Study|Unsatisfactory therapeutic effect|3
913498|NCT00809926|1891091|FG001|Overall Study|Unsatisfactory therapeutic effect|3
913499|NCT00809926|1891090|FG000|Overall Study|Patient withdrew consent|8
913500|NCT00809926|1891091|FG001|Overall Study|Patient withdrew consent|6
913501|NCT00809926|1891090|FG000|Overall Study|Lost to Follow-up|2
913502|NCT00809926|1891091|FG001|Overall Study|Lost to Follow-up|1
913503|NCT00809926|1891090|FG000|Overall Study|Administrative Problems|0
913504|NCT00809926|1891091|FG001|Overall Study|Administrative Problems|1
913505|NCT00809926|1891090|FG000|Overall Study|Protocol deviation|0
913506|NCT00809926|1891091|FG001|Overall Study|Protocol deviation|2
913507|NCT00809965|1891100|FG000|Overall Study|Death|194
913508|NCT00809965|1891101|FG001|Overall Study|Death|147
913509|NCT00809965|1891102|FG002|Overall Study|Death|196
913510|NCT00809965|1891100|FG000|Overall Study|Lost to Follow-up|17
913511|NCT00809965|1891101|FG001|Overall Study|Lost to Follow-up|10
913512|NCT00809965|1891102|FG002|Overall Study|Lost to Follow-up|18
913513|NCT00809965|1891100|FG000|Overall Study|Withdrawal by Subject|405
913514|NCT00809965|1891101|FG001|Overall Study|Withdrawal by Subject|448
991631|NCT01349049|2002976|FG004|Overall Study|Adverse Event|0
991632|NCT01349049|2002977|FG005|Overall Study|Adverse Event|3
991633|NCT01349049|2002978|FG006|Overall Study|Adverse Event|1
991634|NCT01349049|2002979|FG007|Overall Study|Adverse Event|0
991635|NCT01349049|2002980|FG008|Overall Study|Adverse Event|4
991636|NCT01349049|2002972|FG000|Overall Study|Physician Decision|0
991637|NCT01349049|2002973|FG001|Overall Study|Physician Decision|1
991638|NCT01349049|2002974|FG002|Overall Study|Physician Decision|0
991639|NCT01349049|2002975|FG003|Overall Study|Physician Decision|0
991640|NCT01349049|2002976|FG004|Overall Study|Physician Decision|0
991641|NCT01349049|2002977|FG005|Overall Study|Physician Decision|0
991642|NCT01349049|2002978|FG006|Overall Study|Physician Decision|0
991643|NCT01349049|2002979|FG007|Overall Study|Physician Decision|0
991644|NCT01349049|2002980|FG008|Overall Study|Physician Decision|2
991645|NCT01349049|2002972|FG000|Overall Study|Protocol Violation|0
991646|NCT01349049|2002973|FG001|Overall Study|Protocol Violation|0
991647|NCT01349049|2002974|FG002|Overall Study|Protocol Violation|0
991648|NCT01349049|2002975|FG003|Overall Study|Protocol Violation|0
991649|NCT01349049|2002976|FG004|Overall Study|Protocol Violation|0
991650|NCT01349049|2002977|FG005|Overall Study|Protocol Violation|0
991651|NCT01349049|2002978|FG006|Overall Study|Protocol Violation|0
991652|NCT01349049|2002979|FG007|Overall Study|Protocol Violation|0
991653|NCT01349049|2002980|FG008|Overall Study|Protocol Violation|1
991654|NCT01349049|2002972|FG000|Overall Study|Hematopoietic stem cell transplant|0
991655|NCT01349049|2002973|FG001|Overall Study|Hematopoietic stem cell transplant|0
991656|NCT01349049|2002974|FG002|Overall Study|Hematopoietic stem cell transplant|0
991657|NCT01349049|2002975|FG003|Overall Study|Hematopoietic stem cell transplant|0
991658|NCT01349049|2002976|FG004|Overall Study|Hematopoietic stem cell transplant|1
991659|NCT01349049|2002977|FG005|Overall Study|Hematopoietic stem cell transplant|0
991660|NCT01349049|2002978|FG006|Overall Study|Hematopoietic stem cell transplant|1
991661|NCT01349049|2002979|FG007|Overall Study|Hematopoietic stem cell transplant|1
991662|NCT01349049|2002980|FG008|Overall Study|Hematopoietic stem cell transplant|0
991663|NCT01349049|2002972|FG000|Overall Study|Other|0
991664|NCT01349049|2002973|FG001|Overall Study|Other|0
991665|NCT01349049|2002974|FG002|Overall Study|Other|0
991666|NCT01349049|2002975|FG003|Overall Study|Other|0
991667|NCT01349049|2002976|FG004|Overall Study|Other|0
991668|NCT01349049|2002977|FG005|Overall Study|Other|1
991669|NCT01349049|2002978|FG006|Overall Study|Other|0
991670|NCT01349049|2002979|FG007|Overall Study|Other|0
991671|NCT01349049|2002980|FG008|Overall Study|Other|4
913515|NCT00809965|1891102|FG002|Overall Study|Withdrawal by Subject|441
913516|NCT00809965|1891100|FG000|Overall Study|Other Reason|167
913517|NCT00809965|1891101|FG001|Overall Study|Other Reason|170
913518|NCT00809965|1891102|FG002|Overall Study|Other Reason|189
913519|NCT00810043|1891112|FG000|Overall Study|Withdrawal by Subject|1
913520|NCT00810043|1891113|FG001|Overall Study|Withdrawal by Subject|0
913521|NCT00810043|1891114|FG002|Overall Study|Withdrawal by Subject|2
913522|NCT00810043|1891112|FG000|Overall Study|Lost to Follow-up|1
913523|NCT00810043|1891113|FG001|Overall Study|Lost to Follow-up|0
913524|NCT00810043|1891114|FG002|Overall Study|Lost to Follow-up|0
913525|NCT00810043|1891112|FG000|Overall Study|Physician Decision|0
913526|NCT00810043|1891113|FG001|Overall Study|Physician Decision|0
913527|NCT00810043|1891114|FG002|Overall Study|Physician Decision|2
913528|NCT00810043|1891112|FG000|Overall Study|Death|2
913529|NCT00810043|1891113|FG001|Overall Study|Death|0
913530|NCT00810043|1891114|FG002|Overall Study|Death|0
913531|NCT00810043|1891112|FG000|Overall Study|Unrelated medical problem|0
913532|NCT00810043|1891113|FG001|Overall Study|Unrelated medical problem|1
913533|NCT00810043|1891114|FG002|Overall Study|Unrelated medical problem|0
913534|NCT00810043|1891112|FG000|Overall Study|Non-medical problem|0
913535|NCT00810043|1891113|FG001|Overall Study|Non-medical problem|0
913536|NCT00810043|1891114|FG002|Overall Study|Non-medical problem|1
913537|NCT00810043|1891112|FG000|Overall Study|No longer met enrollment criteria|0
913538|NCT00810043|1891113|FG001|Overall Study|No longer met enrollment criteria|0
913539|NCT00810043|1891114|FG002|Overall Study|No longer met enrollment criteria|3
913540|NCT00810069|1891125|FG000|Lead-in Period I|Adverse Event|43
913541|NCT00810069|1891126|FG001|Lead-in Period I|Adverse Event|0
913542|NCT00810069|1891127|FG002|Lead-in Period I|Adverse Event|0
913543|NCT00810069|1891125|FG000|Lead-in Period I|Lack of Efficacy|1
913544|NCT00810069|1891126|FG001|Lead-in Period I|Lack of Efficacy|0
913545|NCT00810069|1891127|FG002|Lead-in Period I|Lack of Efficacy|0
913546|NCT00810069|1891125|FG000|Lead-in Period I|Lost to Follow-up|19
913547|NCT00810069|1891126|FG001|Lead-in Period I|Lost to Follow-up|0
913548|NCT00810069|1891127|FG002|Lead-in Period I|Lost to Follow-up|0
913549|NCT00810069|1891125|FG000|Lead-in Period I|Physician Decision|1
913550|NCT00810069|1891126|FG001|Lead-in Period I|Physician Decision|0
913551|NCT00810069|1891127|FG002|Lead-in Period I|Physician Decision|0
913552|NCT00810069|1891125|FG000|Lead-in Period I|Protocol Violation|1
913553|NCT00810069|1891126|FG001|Lead-in Period I|Protocol Violation|0
913554|NCT00810069|1891127|FG002|Lead-in Period I|Protocol Violation|0
913555|NCT00810069|1891125|FG000|Lead-in Period I|Withdrawal by Subject|46
913556|NCT00810069|1891126|FG001|Lead-in Period I|Withdrawal by Subject|0
913557|NCT00810069|1891127|FG002|Lead-in Period I|Withdrawal by Subject|0
913558|NCT00810069|1891125|FG000|Lead-in Period I|Protocol entry criterion not met|5
991672|NCT01349049|2002972|FG000|Overall Study|Death|0
991673|NCT01349049|2002973|FG001|Overall Study|Death|0
991674|NCT01349049|2002974|FG002|Overall Study|Death|0
913559|NCT00810069|1891126|FG001|Lead-in Period I|Protocol entry criterion not met|0
991675|NCT01349049|2002975|FG003|Overall Study|Death|0
991676|NCT01349049|2002976|FG004|Overall Study|Death|0
991677|NCT01349049|2002977|FG005|Overall Study|Death|0
991678|NCT01349049|2002978|FG006|Overall Study|Death|0
991679|NCT01349049|2002979|FG007|Overall Study|Death|1
991680|NCT01349049|2002980|FG008|Overall Study|Death|5
991681|NCT01349049|2002972|FG000|Overall Study|Non-compliance|0
991682|NCT01349049|2002973|FG001|Overall Study|Non-compliance|0
991683|NCT01349049|2002974|FG002|Overall Study|Non-compliance|0
991684|NCT01349049|2002975|FG003|Overall Study|Non-compliance|1
991685|NCT01349049|2002976|FG004|Overall Study|Non-compliance|0
991686|NCT01349049|2002977|FG005|Overall Study|Non-compliance|0
991687|NCT01349049|2002978|FG006|Overall Study|Non-compliance|0
991688|NCT01349049|2002979|FG007|Overall Study|Non-compliance|0
991689|NCT01349049|2002980|FG008|Overall Study|Non-compliance|0
991690|NCT01349049|2002972|FG000|Overall Study|Withdrawal by Subject|0
991691|NCT01349049|2002973|FG001|Overall Study|Withdrawal by Subject|0
991692|NCT01349049|2002974|FG002|Overall Study|Withdrawal by Subject|0
991693|NCT01349049|2002975|FG003|Overall Study|Withdrawal by Subject|0
991694|NCT01349049|2002976|FG004|Overall Study|Withdrawal by Subject|0
991695|NCT01349049|2002977|FG005|Overall Study|Withdrawal by Subject|0
991696|NCT01349049|2002978|FG006|Overall Study|Withdrawal by Subject|0
991697|NCT01349049|2002979|FG007|Overall Study|Withdrawal by Subject|0
991698|NCT01349049|2002980|FG008|Overall Study|Withdrawal by Subject|6
991699|NCT01349192|2003029|FG000|Overall Study|Protocol Violation|0
991700|NCT01349192|2003030|FG001|Overall Study|Protocol Violation|1
991701|NCT01349192|2003029|FG000|Overall Study|Withdrawal by Subject|0
913560|NCT00810069|1891127|FG002|Lead-in Period I|Protocol entry criterion not met|0
913561|NCT00810069|1891125|FG000|Lead-in Period I|Randomization criteria not met|158
913562|NCT00810069|1891126|FG001|Lead-in Period I|Randomization criteria not met|0
913563|NCT00810069|1891127|FG002|Lead-in Period I|Randomization criteria not met|0
913564|NCT00810069|1891125|FG000|Double-Blind Period II|Adverse Event|0
913565|NCT00810069|1891126|FG001|Double-Blind Period II|Adverse Event|9
913566|NCT00810069|1891127|FG002|Double-Blind Period II|Adverse Event|8
913567|NCT00810069|1891125|FG000|Double-Blind Period II|Lack of Efficacy|0
913568|NCT00810069|1891126|FG001|Double-Blind Period II|Lack of Efficacy|7
913569|NCT00810069|1891127|FG002|Double-Blind Period II|Lack of Efficacy|12
913570|NCT00810069|1891125|FG000|Double-Blind Period II|Lost to Follow-up|0
913571|NCT00810069|1891126|FG001|Double-Blind Period II|Lost to Follow-up|9
913572|NCT00810069|1891127|FG002|Double-Blind Period II|Lost to Follow-up|9
913573|NCT00810069|1891125|FG000|Double-Blind Period II|Physician Decision|0
913574|NCT00810069|1891126|FG001|Double-Blind Period II|Physician Decision|0
913575|NCT00810069|1891127|FG002|Double-Blind Period II|Physician Decision|1
913576|NCT00810069|1891125|FG000|Double-Blind Period II|Withdrawal by Subject|0
913577|NCT00810069|1891126|FG001|Double-Blind Period II|Withdrawal by Subject|21
913578|NCT00810069|1891127|FG002|Double-Blind Period II|Withdrawal by Subject|35
913579|NCT00810069|1891125|FG000|Double-Blind Period II|Protocol entry criterion not met|0
913580|NCT00810069|1891126|FG001|Double-Blind Period II|Protocol entry criterion not met|0
913581|NCT00810069|1891127|FG002|Double-Blind Period II|Protocol entry criterion not met|1
913582|NCT00810069|1891125|FG000|Double-Blind Period II|Clinical relapse|0
913583|NCT00810069|1891126|FG001|Double-Blind Period II|Clinical relapse|3
913584|NCT00810069|1891127|FG002|Double-Blind Period II|Clinical relapse|0
913585|NCT00810069|1891125|FG000|Double-Blind Period II|Protocol Violation|0
913586|NCT00810069|1891126|FG001|Double-Blind Period II|Protocol Violation|7
913587|NCT00810069|1891127|FG002|Double-Blind Period II|Protocol Violation|6
913588|NCT00810082|1891138|FG000|Overall Study|Lost to Follow-up|0
913589|NCT00810082|1891139|FG001|Overall Study|Lost to Follow-up|4
913590|NCT00810108|1891151|FG000|Overall Study|Withdrawal by Subject|1
913591|NCT00810108|1891152|FG001|Overall Study|Withdrawal by Subject|0
913592|NCT00810199|1891159|FG000|Overall Study|Adverse Event|24
913593|NCT00810199|1891160|FG001|Overall Study|Adverse Event|26
913594|NCT00810199|1891159|FG000|Overall Study|Death|4
913595|NCT00810199|1891160|FG001|Overall Study|Death|6
913596|NCT00810199|1891159|FG000|Overall Study|Withdrew consent|9
913597|NCT00810199|1891160|FG001|Overall Study|Withdrew consent|12
913598|NCT00810199|1891159|FG000|Overall Study|Insufficient therapeutic response|5
913599|NCT00810199|1891160|FG001|Overall Study|Insufficient therapeutic response|14
913600|NCT00810199|1891159|FG000|Overall Study|Refused treatment/Did not cooperate|7
913601|NCT00810199|1891160|FG001|Overall Study|Refused treatment/Did not cooperate|7
913602|NCT00810199|1891159|FG000|Overall Study|Administrative/Other|5
913603|NCT00810199|1891160|FG001|Overall Study|Administrative/Other|6
913604|NCT00810199|1891159|FG000|Overall Study|Protocol Violation|2
913605|NCT00810199|1891160|FG001|Overall Study|Protocol Violation|6
913606|NCT00810199|1891159|FG000|Overall Study|Failure to return|1
913607|NCT00810199|1891160|FG001|Overall Study|Failure to return|4
913608|NCT00810199|1891159|FG000|Overall Study|Did not receive study drug|2
913609|NCT00810199|1891160|FG001|Overall Study|Did not receive study drug|1
913610|NCT00810264|1891172|FG000|Overall Study|Lost to Follow-up|191
913611|NCT00810264|1891172|FG000|Overall Study|Withdrawal by subject or physician|721
991702|NCT01349192|2003030|FG001|Overall Study|Withdrawal by Subject|2
991703|NCT01349192|2003029|FG000|Overall Study|Lost to Follow-up|1
991704|NCT01349192|2003030|FG001|Overall Study|Lost to Follow-up|3
991705|NCT01349192|2003029|FG000|Overall Study|Failure to adhere to Protocol|2
991706|NCT01349192|2003030|FG001|Overall Study|Failure to adhere to Protocol|0
991707|NCT01349465|2003044|FG000|Overall Study|Adverse Event|1
991708|NCT01349465|2003045|FG001|Overall Study|Adverse Event|0
991709|NCT01349465|2003044|FG000|Overall Study|Death|3
991710|NCT01349465|2003045|FG001|Overall Study|Death|0
991711|NCT01349465|2003044|FG000|Overall Study|Lost to Follow-up|10
991712|NCT01349465|2003045|FG001|Overall Study|Lost to Follow-up|1
991713|NCT01349465|2003044|FG000|Overall Study|Withdrawal by Subject|4
991714|NCT01349465|2003045|FG001|Overall Study|Withdrawal by Subject|2
991715|NCT01349465|2003044|FG000|Overall Study|Subject Ineligible To Continue The Trial|0
991716|NCT01349465|2003045|FG001|Overall Study|Subject Ineligible To Continue The Trial|19
991717|NCT01349569|2003062|FG000|Overall Study|Lack of Efficacy|4
991718|NCT01349660|2003072|FG000|Overall Study|Still Receiving Study Treatment|0
991719|NCT01349660|2003073|FG001|Overall Study|Still Receiving Study Treatment|0
991720|NCT01349660|2003074|FG002|Overall Study|Still Receiving Study Treatment|1
991721|NCT01349660|2003072|FG000|Overall Study|Disease Progression|2
991722|NCT01349660|2003073|FG001|Overall Study|Disease Progression|4
991723|NCT01349660|2003074|FG002|Overall Study|Disease Progression|50
991724|NCT01349660|2003072|FG000|Overall Study|Adverse Event|1
991725|NCT01349660|2003073|FG001|Overall Study|Adverse Event|1
991726|NCT01349660|2003074|FG002|Overall Study|Adverse Event|12
991727|NCT01349660|2003072|FG000|Overall Study|Withdrawal by Subject|2
991728|NCT01349660|2003073|FG001|Overall Study|Withdrawal by Subject|0
991729|NCT01349660|2003074|FG002|Overall Study|Withdrawal by Subject|9
991730|NCT01349660|2003072|FG000|Overall Study|Death|1
991731|NCT01349660|2003073|FG001|Overall Study|Death|1
991732|NCT01349660|2003074|FG002|Overall Study|Death|0
991733|NCT01349660|2003072|FG000|Overall Study|Non-Permitted Interventions|0
991734|NCT01349660|2003073|FG001|Overall Study|Non-Permitted Interventions|0
991735|NCT01349660|2003074|FG002|Overall Study|Non-Permitted Interventions|2
991736|NCT01349660|2003072|FG000|Overall Study|Study Compliance|0
991737|NCT01349660|2003073|FG001|Overall Study|Study Compliance|0
991738|NCT01349660|2003074|FG002|Overall Study|Study Compliance|1
991739|NCT01349660|2003072|FG000|Overall Study|Declining Performance Status|0
991740|NCT01349660|2003073|FG001|Overall Study|Declining Performance Status|0
991741|NCT01349660|2003074|FG002|Overall Study|Declining Performance Status|1
991742|NCT01349673|2003089|FG000|Overall Study|Progression Of Disease Past 40 cm|1
991743|NCT01349673|2003089|FG000|Overall Study|No Longer Qualified For Study|1
991744|NCT01349673|2003089|FG000|Overall Study|Site Closure|10
991745|NCT01349673|2003089|FG000|Overall Study|Withdrawal by Subject|21
991746|NCT01349673|2003089|FG000|Overall Study|Lost to Follow-up|6
991747|NCT01349673|2003089|FG000|Overall Study|Adverse Event|17
991748|NCT01349673|2003089|FG000|Overall Study|Study Terminated By Sponsor|50
991749|NCT01349673|2003089|FG000|Overall Study|Lack of Efficacy|8
991750|NCT01349790|2003093|FG000|Overall Study|Investigator Judgement|3
991751|NCT01349790|2003093|FG000|Overall Study|Death|2
991752|NCT01349790|2003093|FG000|Overall Study|Withdrawal by Patient|2
991753|NCT01349790|2003093|FG000|Overall Study|Adverse Event|1
991754|NCT01349790|2003093|FG000|Overall Study|Lost to Follow-up|1
991755|NCT01349803|2003101|FG000|Overall Study|Adverse Event|0
991756|NCT01349803|2003102|FG001|Overall Study|Adverse Event|0
991757|NCT01349803|2003103|FG002|Overall Study|Adverse Event|0
991758|NCT01349803|2003104|FG003|Overall Study|Adverse Event|2
991759|NCT01349803|2003101|FG000|Overall Study|Withdrawal by Subject|1
991760|NCT01349803|2003102|FG001|Overall Study|Withdrawal by Subject|0
991761|NCT01349803|2003103|FG002|Overall Study|Withdrawal by Subject|0
991762|NCT01349803|2003104|FG003|Overall Study|Withdrawal by Subject|0
991763|NCT01349803|2003101|FG000|Overall Study|Protocol-specified criteria|0
991764|NCT01349803|2003102|FG001|Overall Study|Protocol-specified criteria|1
991765|NCT01349803|2003103|FG002|Overall Study|Protocol-specified criteria|3
991766|NCT01349803|2003104|FG003|Overall Study|Protocol-specified criteria|0
913612|NCT00810264|1891172|FG000|Overall Study|Death|641
913613|NCT00810277|1891180|FG000|Overall Study|Adverse Event|1
913614|NCT00810342|1891194|FG000|Month 1 Follow-up|Lost to Follow-up|4
913615|NCT00810342|1891195|FG001|Month 1 Follow-up|Lost to Follow-up|2
913616|NCT00810342|1891194|FG000|Month 1 Follow-up|Pregnancy|1
913617|NCT00810342|1891195|FG001|Month 1 Follow-up|Pregnancy|0
913618|NCT00810342|1891194|FG000|6-month Follow-up|Lost to Follow-up|18
913619|NCT00810342|1891195|FG001|6-month Follow-up|Lost to Follow-up|6
913620|NCT00810342|1891194|FG000|6-month Follow-up|Pregnancy|6
913621|NCT00810342|1891195|FG001|6-month Follow-up|Pregnancy|2
913622|NCT00810342|1891194|FG000|12-month Followup|Pregnancy|9
913623|NCT00810342|1891195|FG001|12-month Followup|Pregnancy|10
913624|NCT00810342|1891194|FG000|12-month Followup|Lost to Follow-up|3
913625|NCT00810342|1891195|FG001|12-month Followup|Lost to Follow-up|1
913626|NCT00810355|1891206|FG000|Overall Study|Lost to Follow-up|13
913627|NCT00810355|1891207|FG001|Overall Study|Lost to Follow-up|17
913628|NCT00810355|1891208|FG002|Overall Study|Lost to Follow-up|11
913629|NCT00810355|1891206|FG000|Overall Study|Withdrawal by Subject|1
913630|NCT00810355|1891207|FG001|Overall Study|Withdrawal by Subject|0
991767|NCT01349816|2003122|FG000|Overall Study|Withdrawal by Subject|4
991768|NCT01349816|2003122|FG000|Overall Study|Physician Decision|1
991769|NCT01349816|2003122|FG000|Overall Study|Adverse Event|14
991770|NCT01349816|2003122|FG000|Overall Study|Lost to Follow-up|2
991771|NCT01349816|2003122|FG000|Overall Study|Protocol Violation|1
991772|NCT01349816|2003122|FG000|Overall Study|Protocol-specified criteria|8
991773|NCT01349829|2003138|FG000|Overall Study|Lost to Follow-up|4
991774|NCT01349829|2003139|FG001|Overall Study|Lost to Follow-up|8
991775|NCT01349829|2003138|FG000|Overall Study|Consent withdrawal|3
991776|NCT01349829|2003139|FG001|Overall Study|Consent withdrawal|8
991777|NCT01349829|2003138|FG000|Overall Study|Migrated/moved|2
991778|NCT01349829|2003139|FG001|Overall Study|Migrated/moved|7
991779|NCT01349907|2003149|FG000|Overall Study|Adverse Event|37
991780|NCT01349907|2003150|FG001|Overall Study|Adverse Event|11
991781|NCT01349907|2003149|FG000|Overall Study|Treatment failure|13
991782|NCT01349907|2003150|FG001|Overall Study|Treatment failure|4
991783|NCT01349907|2003149|FG000|Overall Study|Lost to Follow-up|25
991784|NCT01349907|2003150|FG001|Overall Study|Lost to Follow-up|6
991785|NCT01349907|2003149|FG000|Overall Study|Withdrawal by Subject|30
991786|NCT01349907|2003150|FG001|Overall Study|Withdrawal by Subject|8
991787|NCT01349907|2003149|FG000|Overall Study|Protocol Violation|33
991788|NCT01349907|2003150|FG001|Overall Study|Protocol Violation|13
991789|NCT01349907|2003149|FG000|Overall Study|Administrative|1
991790|NCT01349907|2003150|FG001|Overall Study|Administrative|1
991792|NCT01350102|2003183|FG000|Overall Study|Adverse Event|0
991793|NCT01350102|2003184|FG001|Overall Study|Adverse Event|0
991794|NCT01350102|2003185|FG002|Overall Study|Adverse Event|1
991795|NCT01350102|2003186|FG003|Overall Study|Adverse Event|0
991796|NCT01350115|2003198|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
913631|NCT00810355|1891208|FG002|Overall Study|Withdrawal by Subject|0
913632|NCT00810368|1891218|FG000|Overall Study|Lost to Follow-up|4
913633|NCT00810368|1891219|FG001|Overall Study|Lost to Follow-up|2
913634|NCT00810368|1891218|FG000|Overall Study|Lack of Efficacy|2
913635|NCT00810368|1891219|FG001|Overall Study|Lack of Efficacy|0
913636|NCT00810394|1891227|FG000|Overall Study|Withdrawal by Subject|3
913637|NCT00810407|1891231|FG000|Overall Study|Protocol Violation|3
913638|NCT00810407|1891231|FG000|Overall Study|No Visit After First Day of Treatment|3
913639|NCT00810511|1891256|FG000|Overall Study|Protocol Violation|0
913640|NCT00810511|1891257|FG001|Overall Study|Protocol Violation|1
913641|NCT00810511|1891256|FG000|Overall Study|Lack of Efficacy|9
913642|NCT00810511|1891257|FG001|Overall Study|Lack of Efficacy|1
913643|NCT00810511|1891256|FG000|Overall Study|death in the family|0
913644|NCT00810511|1891257|FG001|Overall Study|death in the family|1
913645|NCT00810511|1891256|FG000|Overall Study|Lost to Follow-up|1
913646|NCT00810511|1891257|FG001|Overall Study|Lost to Follow-up|0
913647|NCT00810511|1891256|FG000|Overall Study|deposits on contact lens|0
913648|NCT00810511|1891257|FG001|Overall Study|deposits on contact lens|1
913649|NCT00810602|1891267|FG000|Overall Study|Withdrawal by Subject|8
913650|NCT00810602|1891268|FG001|Overall Study|Withdrawal by Subject|3
913651|NCT00810615|1891274|FG000|Overall Study|Withdrawal by Subject|1
913652|NCT00810615|1891275|FG001|Overall Study|Withdrawal by Subject|1
913653|NCT00810641|1891296|FG000|Overall Study|Withdrawal by Subject|0
913654|NCT00810641|1891297|FG001|Overall Study|Withdrawal by Subject|1
913655|NCT00810641|1891298|FG002|Overall Study|Withdrawal by Subject|2
913656|NCT00810693|1891309|FG000|Treatment Period|Adverse Event|8
913657|NCT00810693|1891310|FG001|Treatment Period|Adverse Event|1
913658|NCT00810693|1891311|FG002|Treatment Period|Adverse Event|7
913659|NCT00810693|1891309|FG000|Treatment Period|Death|0
913660|NCT00810693|1891310|FG001|Treatment Period|Death|1
913661|NCT00810693|1891311|FG002|Treatment Period|Death|2
913662|NCT00810693|1891309|FG000|Treatment Period|Lack of Efficacy|0
913663|NCT00810693|1891310|FG001|Treatment Period|Lack of Efficacy|0
913664|NCT00810693|1891311|FG002|Treatment Period|Lack of Efficacy|1
913665|NCT00810693|1891309|FG000|Treatment Period|Lost to Follow-up|1
913666|NCT00810693|1891310|FG001|Treatment Period|Lost to Follow-up|0
913667|NCT00810693|1891311|FG002|Treatment Period|Lost to Follow-up|0
913668|NCT00810693|1891309|FG000|Treatment Period|Non-compliance|1
913669|NCT00810693|1891310|FG001|Treatment Period|Non-compliance|0
913670|NCT00810693|1891311|FG002|Treatment Period|Non-compliance|0
913671|NCT00810693|1891309|FG000|Treatment Period|Protocol Violation|1
913672|NCT00810693|1891310|FG001|Treatment Period|Protocol Violation|2
913673|NCT00810693|1891311|FG002|Treatment Period|Protocol Violation|2
913674|NCT00810693|1891309|FG000|Treatment Period|Withdrawal by Subject|6
913675|NCT00810693|1891310|FG001|Treatment Period|Withdrawal by Subject|2
913676|NCT00810693|1891311|FG002|Treatment Period|Withdrawal by Subject|3
913677|NCT00810693|1891309|FG000|Treatment Period|Not treated|0
913678|NCT00810693|1891310|FG001|Treatment Period|Not treated|1
913679|NCT00810693|1891311|FG002|Treatment Period|Not treated|1
913680|NCT00810693|1891309|FG000|Follow-up Period (FUP)|Adverse Event|3
913681|NCT00810693|1891310|FG001|Follow-up Period (FUP)|Adverse Event|1
913682|NCT00810693|1891311|FG002|Follow-up Period (FUP)|Adverse Event|1
913683|NCT00810693|1891309|FG000|Follow-up Period (FUP)|Death|2
913684|NCT00810693|1891310|FG001|Follow-up Period (FUP)|Death|0
913685|NCT00810693|1891311|FG002|Follow-up Period (FUP)|Death|1
913686|NCT00810693|1891309|FG000|Follow-up Period (FUP)|Lost to Follow-up|1
991797|NCT01350115|2003199|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
991798|NCT01350115|2003198|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0
991799|NCT01350115|2003199|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1
991800|NCT01350115|2003198|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
991801|NCT01350115|2003199|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
913687|NCT00810693|1891310|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
913688|NCT00810693|1891311|FG002|Follow-up Period (FUP)|Lost to Follow-up|2
913689|NCT00810693|1891309|FG000|Follow-up Period (FUP)|Protocol Violation|0
913690|NCT00810693|1891310|FG001|Follow-up Period (FUP)|Protocol Violation|1
913691|NCT00810693|1891311|FG002|Follow-up Period (FUP)|Protocol Violation|0
913692|NCT00810693|1891309|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2
913693|NCT00810693|1891310|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1
913694|NCT00810693|1891311|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0
913695|NCT00810810|1891346|FG000|Overall Study|Withdrawal by Subject|0
913696|NCT00810810|1891347|FG001|Overall Study|Withdrawal by Subject|8
913697|NCT00810810|1891348|FG002|Overall Study|Withdrawal by Subject|10
913698|NCT00810810|1891349|FG003|Overall Study|Withdrawal by Subject|8
913699|NCT00810810|1891346|FG000|Overall Study|Physician Decision|0
913700|NCT00810810|1891347|FG001|Overall Study|Physician Decision|3
913701|NCT00810810|1891348|FG002|Overall Study|Physician Decision|1
913702|NCT00810810|1891349|FG003|Overall Study|Physician Decision|5
913703|NCT00810901|1891374|FG000|Overall Study|Lost to Follow-up|88
913704|NCT00810901|1891375|FG001|Overall Study|Lost to Follow-up|58
913705|NCT00811018|1891381|FG000|Overall Study|Additional Chronic Treatment|31
913706|NCT00811018|1891381|FG000|Overall Study|Adverse Event|79
913707|NCT00811018|1891381|FG000|Overall Study|Death|147
913708|NCT00811018|1891381|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
913709|NCT00811018|1891381|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
913710|NCT00811018|1891381|FG000|Overall Study|Investigator Decision|57
913711|NCT00811018|1891381|FG000|Overall Study|Lost to Follow-up|19
913712|NCT00811018|1891381|FG000|Overall Study|Pregnancy|6
913713|NCT00811018|1891381|FG000|Overall Study|Sponsor Decision|450
913714|NCT00811018|1891381|FG000|Overall Study|Withdrawal by Subject|70
913715|NCT00811018|1891381|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9
913716|NCT00811018|1891381|FG000|Overall Study|Other|26
913717|NCT00811057|1891388|FG000|Overall Study|Protocol Violation|5
913718|NCT00811057|1891389|FG001|Overall Study|Protocol Violation|10
913719|NCT00811057|1891390|FG002|Overall Study|Protocol Violation|10
913720|NCT00811070|1891404|FG000|Overall Study|Death|0
913721|NCT00811070|1891405|FG001|Overall Study|Death|0
913722|NCT00811070|1891406|FG002|Overall Study|Death|0
913723|NCT00811070|1891407|FG003|Overall Study|Death|2
913724|NCT00811070|1891408|FG004|Overall Study|Death|5
913725|NCT00811070|1891409|FG005|Overall Study|Death|0
913726|NCT00811070|1891404|FG000|Overall Study|Other|1
913727|NCT00811070|1891405|FG001|Overall Study|Other|0
913728|NCT00811070|1891406|FG002|Overall Study|Other|0
913729|NCT00811070|1891407|FG003|Overall Study|Other|0
913730|NCT00811070|1891408|FG004|Overall Study|Other|0
913731|NCT00811070|1891409|FG005|Overall Study|Other|0
913732|NCT00811070|1891404|FG000|Overall Study|Withdrawal by Subject|0
913733|NCT00811070|1891405|FG001|Overall Study|Withdrawal by Subject|1
913734|NCT00811070|1891406|FG002|Overall Study|Withdrawal by Subject|0
913735|NCT00811070|1891407|FG003|Overall Study|Withdrawal by Subject|0
913736|NCT00811070|1891408|FG004|Overall Study|Withdrawal by Subject|0
913737|NCT00811070|1891409|FG005|Overall Study|Withdrawal by Subject|0
913738|NCT00811070|1891404|FG000|Overall Study|Physician Decision|0
913739|NCT00811070|1891405|FG001|Overall Study|Physician Decision|0
913740|NCT00811070|1891406|FG002|Overall Study|Physician Decision|0
913741|NCT00811070|1891407|FG003|Overall Study|Physician Decision|0
913742|NCT00811070|1891408|FG004|Overall Study|Physician Decision|0
913743|NCT00811070|1891409|FG005|Overall Study|Physician Decision|1
913744|NCT00811135|1891425|FG000|Overall Study|Adverse Event/Intercurrent Illness|8
913745|NCT00811135|1891425|FG000|Overall Study|Death|3
913746|NCT00811135|1891425|FG000|Overall Study|Protocol Violation|2
913747|NCT00811135|1891425|FG000|Overall Study|Violation of Selection Criteria|1
913748|NCT00811135|1891425|FG000|Overall Study|Refused Treatment|1
913749|NCT00811135|1891425|FG000|Overall Study|Withdrawal by Subject|3
913750|NCT00811135|1891425|FG000|Overall Study|Administrative/Other Unspecified|11
913751|NCT00811135|1891425|FG000|Overall Study|Ongoing|59
913752|NCT00811174|1891429|FG000|Overall Study|Protocol Violation|2
913753|NCT00811174|1891429|FG000|Overall Study|Sponsors Decision|1
913754|NCT00811187|1891435|FG000|Overall Study|Unable to place device / procedure abort|3
913755|NCT00811187|1891436|FG001|Overall Study|Unable to place device / procedure abort|3
913756|NCT00811252|1891445|FG000|Overall Study|Adverse Event|6
913757|NCT00811252|1891446|FG001|Overall Study|Adverse Event|10
913758|NCT00811252|1891447|FG002|Overall Study|Adverse Event|15
913759|NCT00811252|1891445|FG000|Overall Study|Lack of Efficacy|7
913760|NCT00811252|1891446|FG001|Overall Study|Lack of Efficacy|2
913761|NCT00811252|1891447|FG002|Overall Study|Lack of Efficacy|0
913762|NCT00811252|1891445|FG000|Overall Study|Protocol Violation|3
913763|NCT00811252|1891446|FG001|Overall Study|Protocol Violation|3
913764|NCT00811252|1891447|FG002|Overall Study|Protocol Violation|2
913765|NCT00811252|1891445|FG000|Overall Study|Withdrawal of Consent|1
991802|NCT01350128|2003207|FG000|Overall Study|Withdrawal by Subject|3
991803|NCT01350128|2003207|FG000|Overall Study|Protocol discontinuation criteria|8
991804|NCT01350128|2003207|FG000|Overall Study|Physician Decision|1
991805|NCT01350128|2003207|FG000|Overall Study|Lost to Follow-up|2
991806|NCT01350141|2003224|FG000|Overall Study|Lost to Follow-up|1
991807|NCT01350141|2003225|FG001|Overall Study|Lost to Follow-up|0
991808|NCT01350141|2003226|FG002|Overall Study|Lost to Follow-up|1
991809|NCT01350141|2003224|FG000|Overall Study|Withdrawal by Subject|1
991810|NCT01350141|2003225|FG001|Overall Study|Withdrawal by Subject|0
991811|NCT01350141|2003226|FG002|Overall Study|Withdrawal by Subject|0
991812|NCT01350141|2003224|FG000|Overall Study|Randomized but not treated|1
991813|NCT01350141|2003225|FG001|Overall Study|Randomized but not treated|0
991814|NCT01350141|2003226|FG002|Overall Study|Randomized but not treated|0
991815|NCT01350271|2003243|FG000|Overall Study|Lost to Follow-up|21
991816|NCT01350271|2003244|FG001|Overall Study|Lost to Follow-up|17
991817|NCT01350271|2003245|FG002|Overall Study|Lost to Follow-up|26
991818|NCT01350336|2003256|FG000|Overall Study|Lost to Follow-up|31
991819|NCT01350336|2003256|FG000|Overall Study|Withdrawal by Subject|14
991820|NCT01350336|2003256|FG000|Overall Study|Physician Decision|8
991821|NCT01350336|2003256|FG000|Overall Study|Death|4
991822|NCT01350414|2003322|FG000|Overall Study|Lost to Follow-up|13
991823|NCT01350414|2003322|FG000|Overall Study|Withdrawal by Subject|4
991824|NCT01350414|2003322|FG000|Overall Study|Physician Decision|2
991825|NCT01350492|2003354|FG000|Intervention|Lost to Follow-up|2
991826|NCT01350492|2003355|FG001|Intervention|Lost to Follow-up|5
991827|NCT01350492|2003354|FG000|Intervention|Withdrawal by Subject|3
991828|NCT01350492|2003355|FG001|Intervention|Withdrawal by Subject|1
991829|NCT01350492|2003354|FG000|Post Intervention Follow-Up|Lost to Follow-up|6
991830|NCT01350492|2003355|FG001|Post Intervention Follow-Up|Lost to Follow-up|1
991831|NCT01350492|2003354|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0
991832|NCT01350492|2003355|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1
991833|NCT01350505|2003361|FG000|Overall Study|Lost to Follow-up|4
991834|NCT01350544|2003367|FG000|Overall Study|Administrative Withdrawal|0
991835|NCT01350544|2003368|FG001|Overall Study|Administrative Withdrawal|1
991836|NCT01350544|2003367|FG000|Overall Study|Death|1
913766|NCT00811252|1891446|FG001|Overall Study|Withdrawal of Consent|2
913767|NCT00811252|1891447|FG002|Overall Study|Withdrawal of Consent|2
913768|NCT00811252|1891445|FG000|Overall Study|Lost to Follow-up|0
913769|NCT00811252|1891446|FG001|Overall Study|Lost to Follow-up|0
913770|NCT00811252|1891447|FG002|Overall Study|Lost to Follow-up|2
913771|NCT00811252|1891445|FG000|Overall Study|Administrative or Other Reasons|0
913772|NCT00811252|1891446|FG001|Overall Study|Administrative or Other Reasons|3
913773|NCT00811252|1891447|FG002|Overall Study|Administrative or Other Reasons|2
913774|NCT00811395|1891476|FG000|Extension Treatment|Adverse Event|1
913775|NCT00811395|1891477|FG001|Extension Treatment|Adverse Event|2
913776|NCT00811395|1891478|FG002|Extension Treatment|Adverse Event|2
913777|NCT00811395|1891479|FG003|Extension Treatment|Adverse Event|2
913778|NCT00811395|1891480|FG004|Extension Treatment|Adverse Event|0
913779|NCT00811395|1891481|FG005|Extension Treatment|Adverse Event|1
913780|NCT00811395|1891476|FG000|Extension Treatment|Progressive disease|1
913781|NCT00811395|1891477|FG001|Extension Treatment|Progressive disease|1
913782|NCT00811395|1891478|FG002|Extension Treatment|Progressive disease|0
913783|NCT00811395|1891479|FG003|Extension Treatment|Progressive disease|0
913784|NCT00811395|1891480|FG004|Extension Treatment|Progressive disease|0
913785|NCT00811395|1891481|FG005|Extension Treatment|Progressive disease|0
913786|NCT00811395|1891476|FG000|Extension Treatment|Participant did not wish to continue|0
913787|NCT00811395|1891477|FG001|Extension Treatment|Participant did not wish to continue|3
913788|NCT00811395|1891478|FG002|Extension Treatment|Participant did not wish to continue|0
913789|NCT00811395|1891479|FG003|Extension Treatment|Participant did not wish to continue|1
913790|NCT00811395|1891480|FG004|Extension Treatment|Participant did not wish to continue|0
913791|NCT00811395|1891481|FG005|Extension Treatment|Participant did not wish to continue|1
913792|NCT00811395|1891476|FG000|Extension Treatment|Other than above|0
913793|NCT00811395|1891477|FG001|Extension Treatment|Other than above|0
913794|NCT00811395|1891478|FG002|Extension Treatment|Other than above|1
913795|NCT00811395|1891479|FG003|Extension Treatment|Other than above|0
913796|NCT00811395|1891480|FG004|Extension Treatment|Other than above|0
913797|NCT00811395|1891481|FG005|Extension Treatment|Other than above|0
913798|NCT00811473|1891508|FG000|Overall Study|Adverse Event|3
913799|NCT00811473|1891509|FG001|Overall Study|Adverse Event|12
913800|NCT00811473|1891508|FG000|Overall Study|Lost to Follow-up|5
913801|NCT00811473|1891509|FG001|Overall Study|Lost to Follow-up|1
913802|NCT00811473|1891508|FG000|Overall Study|Withdrawal by Subject|2
913803|NCT00811473|1891509|FG001|Overall Study|Withdrawal by Subject|4
913804|NCT00811473|1891508|FG000|Overall Study|Severe non-compliance to protocol|2
913805|NCT00811473|1891509|FG001|Overall Study|Severe non-compliance to protocol|4
913806|NCT00811473|1891508|FG000|Overall Study|Lack of therapeutic response|4
913807|NCT00811473|1891509|FG001|Overall Study|Lack of therapeutic response|1
913808|NCT00811473|1891508|FG000|Overall Study|Condition under investigation worsened|1
913809|NCT00811473|1891509|FG001|Overall Study|Condition under investigation worsened|3
913810|NCT00811473|1891508|FG000|Overall Study|Other 2|4
913811|NCT00811473|1891509|FG001|Overall Study|Other 2|1
913812|NCT00811473|1891508|FG000|Overall Study|Incorrect Enrollment|1
991837|NCT01350544|2003368|FG001|Overall Study|Death|2
991838|NCT01350544|2003367|FG000|Overall Study|Moved out of LA County|2
991839|NCT01350544|2003368|FG001|Overall Study|Moved out of LA County|2
991840|NCT01350544|2003367|FG000|Overall Study|Medical Issues|1
991841|NCT01350544|2003368|FG001|Overall Study|Medical Issues|1
991842|NCT01350544|2003367|FG000|Overall Study|Withdrawal by Subject|0
991843|NCT01350544|2003368|FG001|Overall Study|Withdrawal by Subject|1
991844|NCT01350544|2003367|FG000|Overall Study|Incarceration|1
991845|NCT01350544|2003368|FG001|Overall Study|Incarceration|0
991846|NCT01350544|2003367|FG000|Overall Study|Lost to Follow-up|18
991847|NCT01350544|2003368|FG001|Overall Study|Lost to Follow-up|15
991848|NCT01350804|2003378|FG000|Core Study|Withdrawal by Subject|11
991849|NCT01350804|2003379|FG001|Core Study|Withdrawal by Subject|17
991850|NCT01350804|2003380|FG002|Core Study|Withdrawal by Subject|16
991851|NCT01350804|2003381|FG003|Core Study|Withdrawal by Subject|7
991852|NCT01350804|2003378|FG000|Core Study|Study terminated by Sponsor|0
991853|NCT01350804|2003379|FG001|Core Study|Study terminated by Sponsor|0
991854|NCT01350804|2003380|FG002|Core Study|Study terminated by Sponsor|0
991855|NCT01350804|2003381|FG003|Core Study|Study terminated by Sponsor|2
991856|NCT01350804|2003378|FG000|Core Study|Protocol deviation|1
991857|NCT01350804|2003379|FG001|Core Study|Protocol deviation|0
991858|NCT01350804|2003380|FG002|Core Study|Protocol deviation|1
991859|NCT01350804|2003381|FG003|Core Study|Protocol deviation|0
991860|NCT01350804|2003378|FG000|Core Study|Physician Decision|1
991861|NCT01350804|2003379|FG001|Core Study|Physician Decision|0
991862|NCT01350804|2003380|FG002|Core Study|Physician Decision|1
991863|NCT01350804|2003381|FG003|Core Study|Physician Decision|3
991864|NCT01350804|2003378|FG000|Core Study|Lost to Follow-up|3
991865|NCT01350804|2003379|FG001|Core Study|Lost to Follow-up|0
991866|NCT01350804|2003380|FG002|Core Study|Lost to Follow-up|2
991867|NCT01350804|2003381|FG003|Core Study|Lost to Follow-up|1
991868|NCT01350804|2003378|FG000|Core Study|Lack of Efficacy|16
991869|NCT01350804|2003379|FG001|Core Study|Lack of Efficacy|19
991870|NCT01350804|2003380|FG002|Core Study|Lack of Efficacy|18
991871|NCT01350804|2003381|FG003|Core Study|Lack of Efficacy|5
991872|NCT01350804|2003378|FG000|Core Study|Death|1
991873|NCT01350804|2003379|FG001|Core Study|Death|1
991874|NCT01350804|2003380|FG002|Core Study|Death|1
991875|NCT01350804|2003381|FG003|Core Study|Death|0
991876|NCT01350804|2003378|FG000|Core Study|Adverse Event|8
991877|NCT01350804|2003379|FG001|Core Study|Adverse Event|10
991878|NCT01350804|2003380|FG002|Core Study|Adverse Event|8
991879|NCT01350804|2003381|FG003|Core Study|Adverse Event|8
991880|NCT01350804|2003378|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
991881|NCT01350804|2003379|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
991882|NCT01350804|2003380|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
991883|NCT01350804|2003381|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
991884|NCT01350804|2003378|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
991885|NCT01350804|2003379|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
991886|NCT01350804|2003380|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
991887|NCT01350804|2003381|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
991888|NCT01350804|2003378|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1
991889|NCT01350804|2003379|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0
991890|NCT01350804|2003380|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2
991891|NCT01350804|2003381|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0
991892|NCT01350804|2003378|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
991893|NCT01350804|2003379|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
991894|NCT01350804|2003380|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
991895|NCT01350804|2003381|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
991896|NCT01350804|2003378|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
991897|NCT01350804|2003379|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
991898|NCT01350804|2003380|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
991899|NCT01350804|2003381|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
991900|NCT01350804|2003378|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3
991901|NCT01350804|2003379|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1
991902|NCT01350804|2003380|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2
991903|NCT01350804|2003381|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3
991904|NCT01350934|2003403|FG000|Base Study|Adverse Event|6
991905|NCT01350934|2003404|FG001|Base Study|Adverse Event|0
991906|NCT01350934|2003403|FG000|Base Study|Lost to Follow-up|1
991907|NCT01350934|2003404|FG001|Base Study|Lost to Follow-up|0
991908|NCT01350934|2003403|FG000|Base Study|Protocol Violation|1
991909|NCT01350934|2003404|FG001|Base Study|Protocol Violation|1
991910|NCT01350934|2003403|FG000|Base Study|Withdrawal by Subject|1
991911|NCT01350934|2003404|FG001|Base Study|Withdrawal by Subject|2
991912|NCT01350934|2003403|FG000|Base Study|Non-Compliance With Study Drug|2
991913|NCT01350934|2003404|FG001|Base Study|Non-Compliance With Study Drug|0
991914|NCT01350934|2003403|FG000|Extension Study|Adverse Event|2
991915|NCT01350934|2003404|FG001|Extension Study|Adverse Event|1
991916|NCT01350934|2003403|FG000|Extension Study|Lost to Follow-up|2
991917|NCT01350934|2003404|FG001|Extension Study|Lost to Follow-up|0
991918|NCT01350934|2003403|FG000|Extension Study|Protocol Violation|1
991919|NCT01350934|2003404|FG001|Extension Study|Protocol Violation|1
991920|NCT01350934|2003403|FG000|Extension Study|Lack of Efficacy|0
991921|NCT01350934|2003404|FG001|Extension Study|Lack of Efficacy|1
991922|NCT01350934|2003403|FG000|Extension Study|Withdrawal by Subject|0
991923|NCT01350934|2003404|FG001|Extension Study|Withdrawal by Subject|1
991924|NCT01350973|2003417|FG000|Overall Study|Adverse Event|4
991925|NCT01350973|2003418|FG001|Overall Study|Adverse Event|7
991926|NCT01350973|2003419|FG002|Overall Study|Adverse Event|7
991927|NCT01350973|2003417|FG000|Overall Study|Voluntary Withdrawal|2
991928|NCT01350973|2003418|FG001|Overall Study|Voluntary Withdrawal|1
991929|NCT01350973|2003419|FG002|Overall Study|Voluntary Withdrawal|1
991930|NCT01350999|2003430|FG000|Overall Study|Adverse Event|4
991931|NCT01350999|2003431|FG001|Overall Study|Adverse Event|9
991932|NCT01350999|2003432|FG002|Overall Study|Adverse Event|10
991933|NCT01350999|2003430|FG000|Overall Study|Voluntary withdrawal|3
991934|NCT01350999|2003431|FG001|Overall Study|Voluntary withdrawal|4
991935|NCT01350999|2003432|FG002|Overall Study|Voluntary withdrawal|6
991936|NCT01350999|2003430|FG000|Overall Study|Difficulty Making it to Study Visit|1
991937|NCT01350999|2003431|FG001|Overall Study|Difficulty Making it to Study Visit|1
991938|NCT01350999|2003432|FG002|Overall Study|Difficulty Making it to Study Visit|5
991939|NCT01351025|2003442|FG000|Week 0 - 20|Lost to Follow-up|2
913813|NCT00811473|1891509|FG001|Overall Study|Incorrect Enrollment|0
913814|NCT00811473|1891508|FG000|Overall Study|Safety Reasons|1
913815|NCT00811473|1891509|FG001|Overall Study|Safety Reasons|0
913816|NCT00811577|1891526|FG000|Overall Study|Lost to Follow-up|7
913817|NCT00811577|1891527|FG001|Overall Study|Lost to Follow-up|1
913818|NCT00811577|1891526|FG000|Overall Study|Withdrawal by Subject|3
913819|NCT00811577|1891527|FG001|Overall Study|Withdrawal by Subject|0
913820|NCT00811642|1891576|FG000|Overall Study|Adverse Event|3
913821|NCT00811642|1891576|FG000|Overall Study|Protocol Violation|1
913822|NCT00811642|1891576|FG000|Overall Study|Death|2
913823|NCT00811642|1891576|FG000|Overall Study|Withdrawal by Subject|7
913824|NCT00811642|1891576|FG000|Overall Study|Cumulative use of antifungal agent|2
913825|NCT00811655|1891580|FG000|Overall Study|Physician Decision|1
913826|NCT00811720|1891586|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
913827|NCT00811720|1891587|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4
913828|NCT00811720|1891586|FG000|All Treated Patients|Adverse Event|20
913829|NCT00811720|1891587|FG001|All Treated Patients|Adverse Event|62
913830|NCT00811720|1891586|FG000|All Treated Patients|Lack of Efficacy|22
913831|NCT00811720|1891587|FG001|All Treated Patients|Lack of Efficacy|18
913832|NCT00811720|1891586|FG000|All Treated Patients|Non-compliance|0
913833|NCT00811720|1891587|FG001|All Treated Patients|Non-compliance|14
913834|NCT00811720|1891586|FG000|All Treated Patients|Protocol Violation|9
913835|NCT00811720|1891587|FG001|All Treated Patients|Protocol Violation|16
913836|NCT00811720|1891586|FG000|All Treated Patients|Withdrawal by Subject|28
913837|NCT00811720|1891587|FG001|All Treated Patients|Withdrawal by Subject|34
913838|NCT00811720|1891586|FG000|All Treated Patients|Lost to Follow-up|10
913839|NCT00811720|1891587|FG001|All Treated Patients|Lost to Follow-up|16
913840|NCT00811720|1891586|FG000|All Treated Patients|Other Reason|7
913841|NCT00811720|1891587|FG001|All Treated Patients|Other Reason|4
913842|NCT00811733|1891595|FG000|Overall Study|Investigator Discretion|10
913843|NCT00811733|1891596|FG001|Overall Study|Investigator Discretion|8
913844|NCT00811733|1891595|FG000|Overall Study|Withdrawal by Subject|1
913845|NCT00811733|1891596|FG001|Overall Study|Withdrawal by Subject|2
913846|NCT00811928|1891614|FG000|Overall Study|AEs and SAEs Including Death|7
913847|NCT00811928|1891615|FG001|Overall Study|AEs and SAEs Including Death|11
913848|NCT00811928|1891614|FG000|Overall Study|Withdrawal by Subject|18
913849|NCT00811928|1891615|FG001|Overall Study|Withdrawal by Subject|12
913850|NCT00811928|1891614|FG000|Overall Study|Did Not Take Study Drug|3
913851|NCT00811928|1891615|FG001|Overall Study|Did Not Take Study Drug|0
913852|NCT00811928|1891614|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7
913853|NCT00811928|1891615|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4
913854|NCT00811928|1891614|FG000|Overall Study|Investigator Decision|2
913855|NCT00811928|1891615|FG001|Overall Study|Investigator Decision|1
913856|NCT00811928|1891614|FG000|Overall Study|Poor Compliance|2
913857|NCT00811928|1891615|FG001|Overall Study|Poor Compliance|5
913858|NCT00811941|1891623|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
913859|NCT00811941|1891624|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8
913860|NCT00811941|1891623|FG000|All Treated Patients|Adverse Event|2
913861|NCT00811941|1891624|FG001|All Treated Patients|Adverse Event|43
913862|NCT00811941|1891623|FG000|All Treated Patients|Lack of Efficacy|2
913863|NCT00811941|1891624|FG001|All Treated Patients|Lack of Efficacy|3
913864|NCT00811941|1891623|FG000|All Treated Patients|Non-compliance|1
913865|NCT00811941|1891624|FG001|All Treated Patients|Non-compliance|8
913866|NCT00811941|1891623|FG000|All Treated Patients|Protocol Violation|5
913867|NCT00811941|1891624|FG001|All Treated Patients|Protocol Violation|17
913868|NCT00811941|1891623|FG000|All Treated Patients|Withdrawal by Subject|35
913869|NCT00811941|1891624|FG001|All Treated Patients|Withdrawal by Subject|94
913870|NCT00811941|1891623|FG000|All Treated Patients|Lost to Follow-up|3
913871|NCT00811941|1891624|FG001|All Treated Patients|Lost to Follow-up|12
913872|NCT00811941|1891623|FG000|All Treated Patients|Other Reason|4
913873|NCT00811941|1891624|FG001|All Treated Patients|Other Reason|14
991940|NCT01351025|2003443|FG001|Week 0 - 20|Lost to Follow-up|1
991941|NCT01351025|2003442|FG000|Week 0 - 20|Withdrawal by Subject|1
991942|NCT01351025|2003443|FG001|Week 0 - 20|Withdrawal by Subject|0
991943|NCT01351025|2003442|FG000|Week 24 - 44|Lost to Follow-up|0
991944|NCT01351025|2003443|FG001|Week 24 - 44|Lost to Follow-up|2
991945|NCT01351025|2003442|FG000|Week 24 - 44|Site closed|0
991946|NCT01351025|2003443|FG001|Week 24 - 44|Site closed|1
991947|NCT01351025|2003442|FG000|Week 24 - 44|unable to get to clinic|1
991948|NCT01351025|2003443|FG001|Week 24 - 44|unable to get to clinic|1
991949|NCT01351350|2003496|FG000|Overall Study|Disease Progression|5
991950|NCT01351350|2003497|FG001|Overall Study|Disease Progression|13
991951|NCT01351350|2003498|FG002|Overall Study|Disease Progression|6
991952|NCT01351350|2003499|FG003|Overall Study|Disease Progression|8
991953|NCT01351350|2003500|FG004|Overall Study|Disease Progression|5
991954|NCT01351350|2003496|FG000|Overall Study|Adverse Event|1
991955|NCT01351350|2003497|FG001|Overall Study|Adverse Event|10
991956|NCT01351350|2003498|FG002|Overall Study|Adverse Event|1
991957|NCT01351350|2003499|FG003|Overall Study|Adverse Event|2
991958|NCT01351350|2003500|FG004|Overall Study|Adverse Event|0
991959|NCT01351350|2003496|FG000|Overall Study|Participant Decision|2
991960|NCT01351350|2003497|FG001|Overall Study|Participant Decision|6
991961|NCT01351350|2003498|FG002|Overall Study|Participant Decision|3
991962|NCT01351350|2003499|FG003|Overall Study|Participant Decision|3
991963|NCT01351350|2003500|FG004|Overall Study|Participant Decision|2
991964|NCT01351350|2003496|FG000|Overall Study|Enrolled but not Treated|0
991965|NCT01351350|2003497|FG001|Overall Study|Enrolled but not Treated|0
991966|NCT01351350|2003498|FG002|Overall Study|Enrolled but not Treated|1
991967|NCT01351350|2003499|FG003|Overall Study|Enrolled but not Treated|0
991968|NCT01351350|2003500|FG004|Overall Study|Enrolled but not Treated|0
991969|NCT01351415|2003536|FG000|Overall Study|Withdrawal by Subject|15
991970|NCT01351415|2003537|FG001|Overall Study|Withdrawal by Subject|17
991971|NCT01351415|2003536|FG000|Overall Study|Trial termination by the Sponsor|28
991972|NCT01351415|2003537|FG001|Overall Study|Trial termination by the Sponsor|19
991973|NCT01351415|2003536|FG000|Overall Study|Lost to Follow-up|5
991974|NCT01351415|2003537|FG001|Overall Study|Lost to Follow-up|7
991975|NCT01351415|2003536|FG000|Overall Study|Death|190
991976|NCT01351415|2003537|FG001|Overall Study|Death|187
991977|NCT01351415|2003536|FG000|Overall Study|Physician Decision|2
991978|NCT01351415|2003537|FG001|Overall Study|Physician Decision|3
991979|NCT01351415|2003536|FG000|Overall Study|Reason unknown|0
991980|NCT01351415|2003537|FG001|Overall Study|Reason unknown|2
991981|NCT01351415|2003536|FG000|Overall Study|Never Started|5
991982|NCT01351415|2003537|FG001|Overall Study|Never Started|5
991983|NCT01351623|2003555|FG000|Overall Study|Protocol Violation|2
991984|NCT01351623|2003555|FG000|Overall Study|Adverse Event|4
991985|NCT01351623|2003555|FG000|Overall Study|Withdrawal by Subject|1
913874|NCT00811954|1891633|FG000|Overall Study|Death|10
913875|NCT00811954|1891634|FG001|Overall Study|Death|6
913876|NCT00811954|1891635|FG002|Overall Study|Death|13
913877|NCT00811954|1891633|FG000|Overall Study|Lost to Follow-up|29
913878|NCT00811954|1891634|FG001|Overall Study|Lost to Follow-up|23
913879|NCT00811954|1891635|FG002|Overall Study|Lost to Follow-up|34
913880|NCT00811954|1891633|FG000|Overall Study|Not able to get to clinic|28
913881|NCT00811954|1891634|FG001|Overall Study|Not able to get to clinic|35
913882|NCT00811954|1891635|FG002|Overall Study|Not able to get to clinic|30
913883|NCT00811954|1891633|FG000|Overall Study|Not willing to adhere to requirements|12
913884|NCT00811954|1891634|FG001|Overall Study|Not willing to adhere to requirements|2
913885|NCT00811954|1891635|FG002|Overall Study|Not willing to adhere to requirements|16
913886|NCT00811954|1891633|FG000|Overall Study|Withdraw consent prior study completion|4
913887|NCT00811954|1891634|FG001|Overall Study|Withdraw consent prior study completion|6
913888|NCT00811954|1891635|FG002|Overall Study|Withdraw consent prior study completion|5
913889|NCT00811954|1891633|FG000|Overall Study|Site Closure|4
913890|NCT00811954|1891634|FG001|Overall Study|Site Closure|0
913891|NCT00811954|1891635|FG002|Overall Study|Site Closure|1
913892|NCT00811954|1891633|FG000|Overall Study|Severe Debilitation|2
913893|NCT00811954|1891634|FG001|Overall Study|Severe Debilitation|0
913894|NCT00811954|1891635|FG002|Overall Study|Severe Debilitation|1
913895|NCT00811954|1891633|FG000|Overall Study|Complete Protocol: No follow-up|0
913896|NCT00811954|1891634|FG001|Overall Study|Complete Protocol: No follow-up|0
913897|NCT00811954|1891635|FG002|Overall Study|Complete Protocol: No follow-up|1
913898|NCT00812006|1891646|FG000|Overall Study|Lost to Follow-up|0
913899|NCT00812006|1891647|FG001|Overall Study|Lost to Follow-up|0
913900|NCT00812006|1891648|FG002|Overall Study|Lost to Follow-up|2
913901|NCT00812006|1891646|FG000|Overall Study|Physician Decision|0
913902|NCT00812006|1891647|FG001|Overall Study|Physician Decision|0
913903|NCT00812006|1891648|FG002|Overall Study|Physician Decision|1
913904|NCT00812006|1891646|FG000|Overall Study|Withdrawal by Subject|2
913905|NCT00812006|1891647|FG001|Overall Study|Withdrawal by Subject|1
913906|NCT00812006|1891648|FG002|Overall Study|Withdrawal by Subject|1
913907|NCT00812006|1891646|FG000|Overall Study|Lack of Qualifying Event|4
913908|NCT00812006|1891647|FG001|Overall Study|Lack of Qualifying Event|2
913909|NCT00812006|1891648|FG002|Overall Study|Lack of Qualifying Event|2
913910|NCT00812097|1891658|FG000|Overall Study|Death|3
913911|NCT00812097|1891659|FG001|Overall Study|Death|10
991986|NCT01351623|2003555|FG000|Overall Study|Death|2
991987|NCT01352117|2003623|FG000|Overall Study|Death|15
991988|NCT01352117|2003624|FG001|Overall Study|Death|16
991989|NCT01352117|2003623|FG000|Overall Study|Withdrawal by Subject|1
991990|NCT01352117|2003624|FG001|Overall Study|Withdrawal by Subject|0
991991|NCT01352117|2003623|FG000|Overall Study|Lost to Follow-up|2
991992|NCT01352117|2003624|FG001|Overall Study|Lost to Follow-up|7
991993|NCT01352117|2003623|FG000|Overall Study|Non-adherent to study requirements|1
991994|NCT01352117|2003624|FG001|Overall Study|Non-adherent to study requirements|1
991995|NCT01352117|2003623|FG000|Overall Study|Did not initiate study treatment|1
991996|NCT01352117|2003624|FG001|Overall Study|Did not initiate study treatment|0
991997|NCT01352117|2003623|FG000|Overall Study|Ineligible (no KS diagnosis)|1
991998|NCT01352117|2003624|FG001|Overall Study|Ineligible (no KS diagnosis)|0
991999|NCT01352221|2003646|FG000|Double-blind Phase|Adverse Event|6
992000|NCT01352221|2003647|FG001|Double-blind Phase|Adverse Event|4
992001|NCT01352221|2003648|FG002|Double-blind Phase|Adverse Event|0
992002|NCT01352221|2003649|FG003|Double-blind Phase|Adverse Event|0
992003|NCT01352221|2003646|FG000|Double-blind Phase|Withdrawal by Subject|3
992004|NCT01352221|2003647|FG001|Double-blind Phase|Withdrawal by Subject|5
992005|NCT01352221|2003648|FG002|Double-blind Phase|Withdrawal by Subject|0
992006|NCT01352221|2003649|FG003|Double-blind Phase|Withdrawal by Subject|0
992007|NCT01352221|2003646|FG000|Double-blind Phase|Lost to Follow-up|0
992008|NCT01352221|2003647|FG001|Double-blind Phase|Lost to Follow-up|1
992009|NCT01352221|2003648|FG002|Double-blind Phase|Lost to Follow-up|0
992010|NCT01352221|2003649|FG003|Double-blind Phase|Lost to Follow-up|0
992011|NCT01352221|2003646|FG000|Double-blind Phase|Protocol Violation|0
992012|NCT01352221|2003647|FG001|Double-blind Phase|Protocol Violation|1
992013|NCT01352221|2003648|FG002|Double-blind Phase|Protocol Violation|0
992014|NCT01352221|2003649|FG003|Double-blind Phase|Protocol Violation|0
992015|NCT01352221|2003646|FG000|Open-label Phase|Physician Decision|0
992016|NCT01352221|2003647|FG001|Open-label Phase|Physician Decision|0
992017|NCT01352221|2003648|FG002|Open-label Phase|Physician Decision|2
992018|NCT01352221|2003649|FG003|Open-label Phase|Physician Decision|1
992019|NCT01352221|2003646|FG000|Open-label Phase|Pregnancy|0
992020|NCT01352221|2003647|FG001|Open-label Phase|Pregnancy|0
992021|NCT01352221|2003648|FG002|Open-label Phase|Pregnancy|1
992022|NCT01352221|2003649|FG003|Open-label Phase|Pregnancy|0
992023|NCT01352221|2003646|FG000|Open-label Phase|Adverse Event|0
913912|NCT00812097|1891660|FG002|Overall Study|Death|3
913913|NCT00812097|1891661|FG003|Overall Study|Death|3
913914|NCT00812097|1891658|FG000|Overall Study|Withdrawal by Subject|14
913915|NCT00812097|1891659|FG001|Overall Study|Withdrawal by Subject|12
913916|NCT00812097|1891660|FG002|Overall Study|Withdrawal by Subject|8
913917|NCT00812097|1891661|FG003|Overall Study|Withdrawal by Subject|2
913918|NCT00812097|1891658|FG000|Overall Study|Lost to Follow-up|90
913919|NCT00812097|1891659|FG001|Overall Study|Lost to Follow-up|14
913920|NCT00812097|1891660|FG002|Overall Study|Lost to Follow-up|17
913921|NCT00812097|1891661|FG003|Overall Study|Lost to Follow-up|5
913922|NCT00812097|1891658|FG000|Overall Study|Explantation of study device(s)|27
913923|NCT00812097|1891659|FG001|Overall Study|Explantation of study device(s)|29
913924|NCT00812097|1891660|FG002|Overall Study|Explantation of study device(s)|14
913925|NCT00812097|1891661|FG003|Overall Study|Explantation of study device(s)|20
913926|NCT00812097|1891658|FG000|Overall Study|Unknown reasons and patient/doctor moves|111
913927|NCT00812097|1891659|FG001|Overall Study|Unknown reasons and patient/doctor moves|24
913928|NCT00812097|1891660|FG002|Overall Study|Unknown reasons and patient/doctor moves|15
913929|NCT00812097|1891661|FG003|Overall Study|Unknown reasons and patient/doctor moves|5
913930|NCT00812253|1891677|FG000|Overall Study|Withdrawal by Subject|3
913931|NCT00812253|1891678|FG001|Overall Study|Withdrawal by Subject|2
913932|NCT00812253|1891677|FG000|Overall Study|Protocol Violation|1
913933|NCT00812253|1891678|FG001|Overall Study|Protocol Violation|1
913934|NCT00812253|1891677|FG000|Overall Study|Lost to Follow-up|2
913935|NCT00812253|1891678|FG001|Overall Study|Lost to Follow-up|0
913936|NCT00812331|1891689|FG000|Overall Study|Adverse Event|1
913937|NCT00812331|1891690|FG001|Overall Study|Adverse Event|0
913938|NCT00812331|1891691|FG002|Overall Study|Adverse Event|0
913939|NCT00812331|1891692|FG003|Overall Study|Adverse Event|0
913940|NCT00812331|1891693|FG004|Overall Study|Adverse Event|0
913941|NCT00812461|1891703|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23
913942|NCT00812461|1891704|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17
913943|NCT00812461|1891703|FG000|All Treated Patients|Adverse Event|8
913944|NCT00812461|1891704|FG001|All Treated Patients|Adverse Event|15
913945|NCT00812461|1891703|FG000|All Treated Patients|Lack of Efficacy|13
913946|NCT00812461|1891704|FG001|All Treated Patients|Lack of Efficacy|7
913947|NCT00812461|1891703|FG000|All Treated Patients|Non-compliance|6
913948|NCT00812461|1891704|FG001|All Treated Patients|Non-compliance|9
913949|NCT00812461|1891703|FG000|All Treated Patients|Protocol Violation|36
913950|NCT00812461|1891704|FG001|All Treated Patients|Protocol Violation|27
913951|NCT00812461|1891703|FG000|All Treated Patients|Withdrawal by Subject|45
913952|NCT00812461|1891704|FG001|All Treated Patients|Withdrawal by Subject|54
913953|NCT00812461|1891703|FG000|All Treated Patients|Lost to Follow-up|11
913954|NCT00812461|1891704|FG001|All Treated Patients|Lost to Follow-up|14
913955|NCT00812461|1891703|FG000|All Treated Patients|Other Reason|13
992024|NCT01352221|2003647|FG001|Open-label Phase|Adverse Event|0
992025|NCT01352221|2003648|FG002|Open-label Phase|Adverse Event|8
992026|NCT01352221|2003649|FG003|Open-label Phase|Adverse Event|4
992027|NCT01352221|2003646|FG000|Open-label Phase|Withdrawal by Subject|0
992028|NCT01352221|2003647|FG001|Open-label Phase|Withdrawal by Subject|0
992029|NCT01352221|2003648|FG002|Open-label Phase|Withdrawal by Subject|1
992030|NCT01352221|2003649|FG003|Open-label Phase|Withdrawal by Subject|6
992031|NCT01352221|2003646|FG000|Open-label Phase|Worsening of IBD|0
992032|NCT01352221|2003647|FG001|Open-label Phase|Worsening of IBD|0
992033|NCT01352221|2003648|FG002|Open-label Phase|Worsening of IBD|1
992034|NCT01352221|2003649|FG003|Open-label Phase|Worsening of IBD|0
992035|NCT01352507|2003681|FG000|Treatment Period 1|Adverse Event|3
992036|NCT01352507|2003682|FG001|Treatment Period 1|Adverse Event|0
992037|NCT01352507|2003681|FG000|Treatment Period 1|Lost to Follow-up|3
992038|NCT01352507|2003682|FG001|Treatment Period 1|Lost to Follow-up|4
992039|NCT01352507|2003681|FG000|Treatment Period 1|Withdrawal by Subject|7
992040|NCT01352507|2003682|FG001|Treatment Period 1|Withdrawal by Subject|5
992041|NCT01352507|2003681|FG000|Treatment Period 1|Physician Decision|1
992042|NCT01352507|2003682|FG001|Treatment Period 1|Physician Decision|0
992043|NCT01352507|2003681|FG000|Washout Period|Withdrawal by Subject|0
992044|NCT01352507|2003682|FG001|Washout Period|Withdrawal by Subject|1
992045|NCT01352507|2003681|FG000|Treatment Period 2|Entry Criteria Not Met|1
992046|NCT01352507|2003682|FG001|Treatment Period 2|Entry Criteria Not Met|0
992047|NCT01352507|2003681|FG000|Treatment Period 2|Withdrawal by Subject|4
992048|NCT01352507|2003682|FG001|Treatment Period 2|Withdrawal by Subject|3
992049|NCT01352507|2003681|FG000|Treatment Period 2|Lack of Efficacy|1
992050|NCT01352507|2003682|FG001|Treatment Period 2|Lack of Efficacy|0
992051|NCT01352585|2003700|FG000|Overall Study|Adverse Event|2
992052|NCT01352585|2003701|FG001|Overall Study|Adverse Event|1
992053|NCT01352585|2003700|FG000|Overall Study|Lost to Follow-up|1
992054|NCT01352585|2003701|FG001|Overall Study|Lost to Follow-up|0
992055|NCT01352585|2003700|FG000|Overall Study|Other|5
992056|NCT01352585|2003701|FG001|Overall Study|Other|2
992057|NCT01352715|2003731|FG000|Overall Study|Death|3
992058|NCT01352715|2003732|FG001|Overall Study|Death|3
992059|NCT01352715|2003731|FG000|Overall Study|Lost to Follow-up|5
992060|NCT01352715|2003732|FG001|Overall Study|Lost to Follow-up|7
992061|NCT01352715|2003731|FG000|Overall Study|Withdrawal by Subject|4
913956|NCT00812461|1891704|FG001|All Treated Patients|Other Reason|21
913957|NCT00812487|1891712|FG000|Overall Study|Lost to Follow-up|2
913958|NCT00812487|1891713|FG001|Overall Study|Lost to Follow-up|0
913959|NCT00812487|1891712|FG000|Overall Study|Withdrawal by Subject|3
913960|NCT00812487|1891713|FG001|Overall Study|Withdrawal by Subject|2
913961|NCT00812487|1891712|FG000|Overall Study|Transfer to ICU prior to intervention|1
913962|NCT00812487|1891713|FG001|Overall Study|Transfer to ICU prior to intervention|0
913963|NCT00812487|1891712|FG000|Overall Study|Protocol Violation|0
913964|NCT00812487|1891713|FG001|Overall Study|Protocol Violation|1
913965|NCT00812565|1891727|FG000|Overall Study|Did Not Receive Study Medication|1
913966|NCT00812565|1891728|FG001|Overall Study|Did Not Receive Study Medication|1
913967|NCT00812565|1891729|FG002|Overall Study|Did Not Receive Study Medication|0
913968|NCT00812565|1891730|FG003|Overall Study|Did Not Receive Study Medication|0
913969|NCT00812565|1891731|FG004|Overall Study|Did Not Receive Study Medication|0
913970|NCT00812565|1891732|FG005|Overall Study|Did Not Receive Study Medication|0
913971|NCT00812565|1891733|FG006|Overall Study|Did Not Receive Study Medication|0
913972|NCT00812565|1891734|FG007|Overall Study|Did Not Receive Study Medication|0
913973|NCT00812565|1891727|FG000|Overall Study|Adverse Event|0
913974|NCT00812565|1891728|FG001|Overall Study|Adverse Event|0
913975|NCT00812565|1891729|FG002|Overall Study|Adverse Event|0
913976|NCT00812565|1891730|FG003|Overall Study|Adverse Event|2
913977|NCT00812565|1891731|FG004|Overall Study|Adverse Event|0
913978|NCT00812565|1891732|FG005|Overall Study|Adverse Event|0
913979|NCT00812565|1891733|FG006|Overall Study|Adverse Event|0
913980|NCT00812565|1891734|FG007|Overall Study|Adverse Event|1
913981|NCT00812565|1891727|FG000|Overall Study|Did Not Come to Study Visit|1
913982|NCT00812565|1891728|FG001|Overall Study|Did Not Come to Study Visit|0
913983|NCT00812565|1891729|FG002|Overall Study|Did Not Come to Study Visit|0
913984|NCT00812565|1891730|FG003|Overall Study|Did Not Come to Study Visit|0
913985|NCT00812565|1891731|FG004|Overall Study|Did Not Come to Study Visit|0
913986|NCT00812565|1891732|FG005|Overall Study|Did Not Come to Study Visit|0
913987|NCT00812565|1891733|FG006|Overall Study|Did Not Come to Study Visit|0
913988|NCT00812565|1891734|FG007|Overall Study|Did Not Come to Study Visit|0
913989|NCT00812565|1891727|FG000|Overall Study|Withdrawal of Consent|1
913990|NCT00812565|1891728|FG001|Overall Study|Withdrawal of Consent|0
913991|NCT00812565|1891729|FG002|Overall Study|Withdrawal of Consent|0
913992|NCT00812565|1891730|FG003|Overall Study|Withdrawal of Consent|0
913993|NCT00812565|1891731|FG004|Overall Study|Withdrawal of Consent|1
913994|NCT00812565|1891732|FG005|Overall Study|Withdrawal of Consent|0
913995|NCT00812565|1891733|FG006|Overall Study|Withdrawal of Consent|0
913996|NCT00812565|1891734|FG007|Overall Study|Withdrawal of Consent|0
913997|NCT00812565|1891727|FG000|Overall Study|Reason Not Specified|0
913998|NCT00812565|1891728|FG001|Overall Study|Reason Not Specified|0
913999|NCT00812565|1891729|FG002|Overall Study|Reason Not Specified|0
914000|NCT00812565|1891730|FG003|Overall Study|Reason Not Specified|0
992062|NCT01352715|2003732|FG001|Overall Study|Withdrawal by Subject|8
992063|NCT01352715|2003731|FG000|Overall Study|site closure|16
992064|NCT01352715|2003732|FG001|Overall Study|site closure|15
992065|NCT01352715|2003731|FG000|Overall Study|no final visit in closeout period|15
992066|NCT01352715|2003732|FG001|Overall Study|no final visit in closeout period|12
992067|NCT01352715|2003731|FG000|Overall Study|major ineligibility|2
992068|NCT01352715|2003732|FG001|Overall Study|major ineligibility|1
992069|NCT01352741|2003738|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4
992070|NCT01352741|2003739|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0
992071|NCT01352741|2003738|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19
992072|NCT01352741|2003739|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0
992073|NCT01352741|2003738|FG000|Open-label Tapentadol Titration Period|Adverse Event|34
992074|NCT01352741|2003739|FG001|Open-label Tapentadol Titration Period|Adverse Event|0
992075|NCT01352741|2003738|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7
992076|NCT01352741|2003739|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0
992077|NCT01352741|2003738|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
992078|NCT01352741|2003739|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
992079|NCT01352741|2003738|FG000|Open-label Tapentadol Titration Period|Other|4
992080|NCT01352741|2003739|FG001|Open-label Tapentadol Titration Period|Other|0
992081|NCT01352741|2003738|FG000|Double-blind Comparative Period|Protocol Violation|2
992082|NCT01352741|2003739|FG001|Double-blind Comparative Period|Protocol Violation|0
992083|NCT01352741|2003738|FG000|Double-blind Comparative Period|Lack of Efficacy|0
992084|NCT01352741|2003739|FG001|Double-blind Comparative Period|Lack of Efficacy|3
992085|NCT01352741|2003738|FG000|Double-blind Comparative Period|Adverse Event|16
992086|NCT01352741|2003739|FG001|Double-blind Comparative Period|Adverse Event|17
992087|NCT01352741|2003738|FG000|Double-blind Comparative Period|Lost to Follow-up|1
992088|NCT01352741|2003739|FG001|Double-blind Comparative Period|Lost to Follow-up|0
992089|NCT01352741|2003738|FG000|Double-blind Comparative Period|Death|0
992090|NCT01352741|2003739|FG001|Double-blind Comparative Period|Death|1
992091|NCT01352741|2003738|FG000|Double-blind Comparative Period|Withdrawal of consent|8
992092|NCT01352741|2003739|FG001|Double-blind Comparative Period|Withdrawal of consent|3
992093|NCT01352741|2003738|FG000|Double-blind Comparative Period|Other|1
992094|NCT01352741|2003739|FG001|Double-blind Comparative Period|Other|2
992095|NCT01352741|2003738|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4
992096|NCT01352741|2003739|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0
992097|NCT01352741|2003738|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
992098|NCT01352741|2003739|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
992099|NCT01352741|2003738|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
992100|NCT01352741|2003739|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
992101|NCT01352741|2003738|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
992102|NCT01352741|2003739|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
992103|NCT01352793|2003761|FG000|Overall Study|Lost to Follow-up|289
992104|NCT01352793|2003762|FG001|Overall Study|Lost to Follow-up|125
992105|NCT01352793|2003761|FG000|Overall Study|Withdrawal by Subject|120
992106|NCT01352793|2003762|FG001|Overall Study|Withdrawal by Subject|55
992107|NCT01352793|2003761|FG000|Overall Study|Protocol Violation|44
992108|NCT01352793|2003762|FG001|Overall Study|Protocol Violation|23
992109|NCT01352793|2003761|FG000|Overall Study|Adverse Event|44
992110|NCT01352793|2003762|FG001|Overall Study|Adverse Event|10
992111|NCT01352793|2003761|FG000|Overall Study|Physician Decision|1
992112|NCT01352793|2003762|FG001|Overall Study|Physician Decision|0
992113|NCT01352793|2003761|FG000|Overall Study|Pregnancy|26
992114|NCT01352793|2003762|FG001|Overall Study|Pregnancy|8
992115|NCT01352793|2003761|FG000|Overall Study|Other|25
992116|NCT01352793|2003762|FG001|Overall Study|Other|7
992117|NCT01352793|2003761|FG000|Overall Study|Medication error|2
992118|NCT01352793|2003762|FG001|Overall Study|Medication error|2
914001|NCT00812565|1891731|FG004|Overall Study|Reason Not Specified|0
914002|NCT00812565|1891732|FG005|Overall Study|Reason Not Specified|1
914003|NCT00812565|1891733|FG006|Overall Study|Reason Not Specified|0
914004|NCT00812565|1891734|FG007|Overall Study|Reason Not Specified|0
914010|NCT00812812|1891768|FG000|Overall Study|Adverse Event|2
914011|NCT00812812|1891769|FG001|Overall Study|Adverse Event|1
914012|NCT00812812|1891768|FG000|Overall Study|Lack of Efficacy|1
914013|NCT00812812|1891769|FG001|Overall Study|Lack of Efficacy|0
914014|NCT00812812|1891768|FG000|Overall Study|Lost to Follow-up|0
914015|NCT00812812|1891769|FG001|Overall Study|Lost to Follow-up|1
914016|NCT00812812|1891768|FG000|Overall Study|Withdrawal by Subject|0
914017|NCT00812812|1891769|FG001|Overall Study|Withdrawal by Subject|2
914018|NCT00812929|1891803|FG000|Washout Period 1 (7 Days)|Physician Decision|0
914019|NCT00812929|1891804|FG001|Washout Period 1 (7 Days)|Physician Decision|0
914020|NCT00812929|1891805|FG002|Washout Period 1 (7 Days)|Physician Decision|1
914021|NCT00812929|1891806|FG003|Washout Period 1 (7 Days)|Physician Decision|0
992119|NCT01352793|2003761|FG000|Overall Study|Death|1
992120|NCT01352793|2003762|FG001|Overall Study|Death|0
992121|NCT01352793|2003761|FG000|Overall Study|Randomized but not vaccinated|8
992122|NCT01352793|2003762|FG001|Overall Study|Randomized but not vaccinated|0
992123|NCT01352793|2003761|FG000|Overall Study|No longer meets eligibility criteria|25
992124|NCT01352793|2003762|FG001|Overall Study|No longer meets eligibility criteria|15
992125|NCT01352845|2003770|FG000|Overall Study|Lost to Follow-up|313
992126|NCT01352845|2003771|FG001|Overall Study|Lost to Follow-up|92
992127|NCT01352845|2003770|FG000|Overall Study|No Longer Willing to Participate|205
992128|NCT01352845|2003771|FG001|Overall Study|No Longer Willing to Participate|58
992129|NCT01352845|2003770|FG000|Overall Study|Withdrawal by Subject|48
992130|NCT01352845|2003771|FG001|Overall Study|Withdrawal by Subject|16
992131|NCT01352845|2003770|FG000|Overall Study|No Longer Meets Eligibility Criteria|24
992132|NCT01352845|2003771|FG001|Overall Study|No Longer Meets Eligibility Criteria|11
992133|NCT01352845|2003770|FG000|Overall Study|Pregnancy|27
992134|NCT01352845|2003771|FG001|Overall Study|Pregnancy|7
992135|NCT01352845|2003770|FG000|Overall Study|Adverse Event|22
992136|NCT01352845|2003771|FG001|Overall Study|Adverse Event|6
992137|NCT01352845|2003770|FG000|Overall Study|Other|17
992138|NCT01352845|2003771|FG001|Overall Study|Other|7
992139|NCT01352845|2003770|FG000|Overall Study|Protocol Violation|12
992140|NCT01352845|2003771|FG001|Overall Study|Protocol Violation|6
992141|NCT01352845|2003770|FG000|Overall Study|Death|3
992142|NCT01352845|2003771|FG001|Overall Study|Death|0
992143|NCT01353222|2003810|FG000|Overall Study|Death|30
992144|NCT01353222|2003811|FG001|Overall Study|Death|30
992145|NCT01353222|2003810|FG000|Overall Study|Withdrawal by Subject|8
992146|NCT01353222|2003811|FG001|Overall Study|Withdrawal by Subject|5
992147|NCT01353222|2003810|FG000|Overall Study|Study Terminated|31
992148|NCT01353222|2003811|FG001|Overall Study|Study Terminated|37
992149|NCT01353222|2003810|FG000|Overall Study|Site closed research department|1
992150|NCT01353222|2003811|FG001|Overall Study|Site closed research department|0
992151|NCT01353274|2003817|FG000|Overall Study|No case report form (CRF) collected|28
992152|NCT01353508|2003834|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0
992153|NCT01353508|2003835|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0
992154|NCT01353508|2003836|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0
992155|NCT01353508|2003837|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1
992156|NCT01353508|2003834|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
992157|NCT01353508|2003835|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
992158|NCT01353508|2003836|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
992159|NCT01353508|2003837|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
992160|NCT01353586|2003849|FG000|Overall Study|Procedure terminated prior to ablation|3
992161|NCT01353586|2003850|FG001|Overall Study|Procedure terminated prior to ablation|0
992162|NCT01353586|2003849|FG000|Overall Study|Never had insertion of study catheter|4
992163|NCT01353586|2003850|FG001|Overall Study|Never had insertion of study catheter|1
992164|NCT01353586|2003849|FG000|Overall Study|Neurological exam not done|0
992165|NCT01353586|2003850|FG001|Overall Study|Neurological exam not done|1
992166|NCT01353664|2003859|FG000|Overall Study|Other|3
992167|NCT01353664|2003859|FG000|Overall Study|Disease Progression|16
992168|NCT01353703|2003865|FG000|Overall Study|Migrated/moved from study area|1
992169|NCT01353703|2003866|FG001|Overall Study|Migrated/moved from study area|0
992170|NCT01353859|2003874|FG000|Overall Study|Adverse Event|3
992171|NCT01353859|2003874|FG000|Overall Study|Lack of Efficacy|1
992172|NCT01353898|2003884|FG000|Overall Study|Study site terminated|0
992173|NCT01353898|2003885|FG001|Overall Study|Study site terminated|0
992174|NCT01353898|2003886|FG002|Overall Study|Study site terminated|0
992175|NCT01353898|2003887|FG003|Overall Study|Study site terminated|0
992176|NCT01353898|2003888|FG004|Overall Study|Study site terminated|0
992177|NCT01353898|2003889|FG005|Overall Study|Study site terminated|1
992178|NCT01353911|2003911|FG000|Overall Study|Lost to Follow-up|2
992179|NCT01353911|2003912|FG001|Overall Study|Lost to Follow-up|6
992180|NCT01353911|2003913|FG002|Overall Study|Lost to Follow-up|4
992181|NCT01353911|2003914|FG003|Overall Study|Lost to Follow-up|0
992182|NCT01353911|2003915|FG004|Overall Study|Lost to Follow-up|4
992183|NCT01353911|2003916|FG005|Overall Study|Lost to Follow-up|4
992184|NCT01353911|2003917|FG006|Overall Study|Lost to Follow-up|3
992185|NCT01353911|2003918|FG007|Overall Study|Lost to Follow-up|6
992186|NCT01353911|2003911|FG000|Overall Study|Withdrawal by Subject|2
992187|NCT01353911|2003912|FG001|Overall Study|Withdrawal by Subject|3
992188|NCT01353911|2003913|FG002|Overall Study|Withdrawal by Subject|4
992189|NCT01353911|2003914|FG003|Overall Study|Withdrawal by Subject|2
992190|NCT01353911|2003915|FG004|Overall Study|Withdrawal by Subject|2
992191|NCT01353911|2003916|FG005|Overall Study|Withdrawal by Subject|3
992192|NCT01353911|2003917|FG006|Overall Study|Withdrawal by Subject|3
992193|NCT01353911|2003918|FG007|Overall Study|Withdrawal by Subject|9
992194|NCT01353911|2003911|FG000|Overall Study|Status Not Recorded|4
992195|NCT01353911|2003912|FG001|Overall Study|Status Not Recorded|0
992196|NCT01353911|2003913|FG002|Overall Study|Status Not Recorded|1
992197|NCT01353911|2003914|FG003|Overall Study|Status Not Recorded|0
992198|NCT01353911|2003915|FG004|Overall Study|Status Not Recorded|0
992199|NCT01353911|2003916|FG005|Overall Study|Status Not Recorded|0
992200|NCT01353911|2003917|FG006|Overall Study|Status Not Recorded|0
992201|NCT01353911|2003918|FG007|Overall Study|Status Not Recorded|0
992202|NCT01353963|2003936|FG000|Overall Study|Adverse Event|2
992203|NCT01354028|2003958|FG000|Overall Study|Physician Decision|0
992204|NCT01354028|2003959|FG001|Overall Study|Physician Decision|2
992205|NCT01354028|2003958|FG000|Overall Study|Discharged before study start|2
992206|NCT01354028|2003959|FG001|Overall Study|Discharged before study start|2
992207|NCT01354028|2003958|FG000|Overall Study|No quiet alert state|0
992208|NCT01354028|2003959|FG001|Overall Study|No quiet alert state|1
992209|NCT01354106|2003971|FG000|Overall Study|Withdrawal by Subject|2
992210|NCT01354132|2003979|FG000|Randomization|Physician Decision|1
992211|NCT01354132|2003980|FG001|Randomization|Physician Decision|0
992212|NCT01354132|2003979|FG000|Randomization|Withdrawal by Subject|0
992213|NCT01354132|2003980|FG001|Randomization|Withdrawal by Subject|1
992214|NCT01354132|2003979|FG000|Double Blind (Visits 1-7)|Adverse Event|1
992215|NCT01354132|2003980|FG001|Double Blind (Visits 1-7)|Adverse Event|0
992216|NCT01354132|2003979|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8
992217|NCT01354132|2003980|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11
992218|NCT01354132|2003979|FG000|1 Month Post Study Medication|Withdrawal by Subject|1
992219|NCT01354132|2003980|FG001|1 Month Post Study Medication|Withdrawal by Subject|3
992220|NCT01354223|2004007|FG000|Overall Study|Withdrawal by Subject|3
992221|NCT01354223|2004008|FG001|Overall Study|Withdrawal by Subject|1
992222|NCT01354314|2004018|FG000|Overall Study|Lost to Follow-up|1
992223|NCT01354314|2004019|FG001|Overall Study|Lost to Follow-up|0
992224|NCT01354314|2004020|FG002|Overall Study|Lost to Follow-up|1
992225|NCT01354314|2004021|FG003|Overall Study|Lost to Follow-up|1
992226|NCT01354314|2004018|FG000|Overall Study|Withdrawal by Subject|0
992227|NCT01354314|2004019|FG001|Overall Study|Withdrawal by Subject|0
992228|NCT01354314|2004020|FG002|Overall Study|Withdrawal by Subject|1
992229|NCT01354314|2004021|FG003|Overall Study|Withdrawal by Subject|0
992230|NCT01354314|2004018|FG000|Overall Study|Adverse Event|0
992231|NCT01354314|2004019|FG001|Overall Study|Adverse Event|0
992232|NCT01354314|2004020|FG002|Overall Study|Adverse Event|0
992233|NCT01354314|2004021|FG003|Overall Study|Adverse Event|1
992234|NCT01354314|2004018|FG000|Overall Study|Protocol Violation|1
992235|NCT01354314|2004019|FG001|Overall Study|Protocol Violation|1
992236|NCT01354314|2004020|FG002|Overall Study|Protocol Violation|0
992237|NCT01354314|2004021|FG003|Overall Study|Protocol Violation|0
992238|NCT01354314|2004018|FG000|Overall Study|Less than 90% Adherence|4
992239|NCT01354314|2004019|FG001|Overall Study|Less than 90% Adherence|2
992240|NCT01354314|2004020|FG002|Overall Study|Less than 90% Adherence|6
992241|NCT01354314|2004021|FG003|Overall Study|Less than 90% Adherence|4
992242|NCT01354353|2004039|FG000|Overall Study|Adverse Event|1
992243|NCT01354353|2004040|FG001|Overall Study|Adverse Event|0
992244|NCT01354353|2004041|FG002|Overall Study|Adverse Event|0
992245|NCT01354353|2004042|FG003|Overall Study|Adverse Event|4
992246|NCT01354353|2004043|FG004|Overall Study|Adverse Event|0
992247|NCT01354353|2004044|FG005|Overall Study|Adverse Event|5
992248|NCT01354353|2004039|FG000|Overall Study|Entry Criteria Not Met|0
992249|NCT01354353|2004040|FG001|Overall Study|Entry Criteria Not Met|0
992250|NCT01354353|2004041|FG002|Overall Study|Entry Criteria Not Met|0
992251|NCT01354353|2004042|FG003|Overall Study|Entry Criteria Not Met|1
992252|NCT01354353|2004043|FG004|Overall Study|Entry Criteria Not Met|1
992253|NCT01354353|2004044|FG005|Overall Study|Entry Criteria Not Met|0
992254|NCT01354353|2004039|FG000|Overall Study|Physician Decision|0
992255|NCT01354353|2004040|FG001|Overall Study|Physician Decision|1
992256|NCT01354353|2004041|FG002|Overall Study|Physician Decision|1
992257|NCT01354353|2004042|FG003|Overall Study|Physician Decision|0
992258|NCT01354353|2004043|FG004|Overall Study|Physician Decision|0
992259|NCT01354353|2004044|FG005|Overall Study|Physician Decision|0
992260|NCT01354353|2004039|FG000|Overall Study|Withdrawal by Subject|2
992261|NCT01354353|2004040|FG001|Overall Study|Withdrawal by Subject|0
992262|NCT01354353|2004041|FG002|Overall Study|Withdrawal by Subject|1
992263|NCT01354353|2004042|FG003|Overall Study|Withdrawal by Subject|0
992264|NCT01354353|2004043|FG004|Overall Study|Withdrawal by Subject|0
992265|NCT01354353|2004044|FG005|Overall Study|Withdrawal by Subject|1
992266|NCT01354431|2004068|FG000|Randomized to Enter Treatment Period|No longer met criteria|1
992267|NCT01354431|2004069|FG001|Randomized to Enter Treatment Period|No longer met criteria|0
992268|NCT01354431|2004070|FG002|Randomized to Enter Treatment Period|No longer met criteria|0
992269|NCT01354431|2004068|FG000|Participants Treated|Continuing Treatment|6
992270|NCT01354431|2004069|FG001|Participants Treated|Continuing Treatment|2
992271|NCT01354431|2004070|FG002|Participants Treated|Continuing Treatment|4
992272|NCT01354431|2004068|FG000|Participants Treated|Disease Progression|49
992273|NCT01354431|2004069|FG001|Participants Treated|Disease Progression|40
992274|NCT01354431|2004070|FG002|Participants Treated|Disease Progression|41
992275|NCT01354431|2004068|FG000|Participants Treated|Study Drug Toxicity|2
992276|NCT01354431|2004069|FG001|Participants Treated|Study Drug Toxicity|7
992277|NCT01354431|2004070|FG002|Participants Treated|Study Drug Toxicity|4
992278|NCT01354431|2004068|FG000|Participants Treated|Death|0
992279|NCT01354431|2004069|FG001|Participants Treated|Death|1
992280|NCT01354431|2004070|FG002|Participants Treated|Death|0
992281|NCT01354431|2004068|FG000|Participants Treated|Adverse Event|1
992282|NCT01354431|2004069|FG001|Participants Treated|Adverse Event|2
992283|NCT01354431|2004070|FG002|Participants Treated|Adverse Event|4
992284|NCT01354431|2004068|FG000|Participants Treated|Withdrawal by Subject|1
992285|NCT01354431|2004069|FG001|Participants Treated|Withdrawal by Subject|2
992286|NCT01354431|2004070|FG002|Participants Treated|Withdrawal by Subject|1
992287|NCT01354496|2004095|FG000|Period 1|Adverse Event|0
992288|NCT01354496|2004096|FG001|Period 1|Adverse Event|0
992289|NCT01354496|2004097|FG002|Period 1|Adverse Event|1
992290|NCT01354496|2004098|FG003|Period 1|Adverse Event|0
992291|NCT01354496|2004099|FG004|Period 1|Adverse Event|0
992292|NCT01354496|2004100|FG005|Period 1|Adverse Event|0
992293|NCT01354496|2004095|FG000|Period 1|Physician Decision|0
992294|NCT01354496|2004096|FG001|Period 1|Physician Decision|0
992295|NCT01354496|2004097|FG002|Period 1|Physician Decision|1
992296|NCT01354496|2004098|FG003|Period 1|Physician Decision|0
992297|NCT01354496|2004099|FG004|Period 1|Physician Decision|0
992298|NCT01354496|2004100|FG005|Period 1|Physician Decision|0
992299|NCT01354496|2004095|FG000|Period 2|Adverse Event|0
992300|NCT01354496|2004096|FG001|Period 2|Adverse Event|0
992301|NCT01354496|2004097|FG002|Period 2|Adverse Event|0
992302|NCT01354496|2004098|FG003|Period 2|Adverse Event|1
992303|NCT01354496|2004099|FG004|Period 2|Adverse Event|0
992304|NCT01354496|2004100|FG005|Period 2|Adverse Event|0
992305|NCT01354496|2004095|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0
992306|NCT01354496|2004096|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1
992307|NCT01354496|2004097|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0
992308|NCT01354496|2004098|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1
992309|NCT01354496|2004099|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0
992310|NCT01354496|2004100|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0
992311|NCT01354899|2004144|FG000|Overall Study|discharge from the hospital|2
992312|NCT01354899|2004144|FG000|Overall Study|Protocol Violation|1
992313|NCT01354938|2004148|FG000|Overall Study|Lost to Follow-up|1
992314|NCT01354964|2004154|FG000|Overall Study|Lost to Follow-up|2
992315|NCT01354964|2004155|FG001|Overall Study|Lost to Follow-up|0
992316|NCT01354964|2004154|FG000|Overall Study|IV access issues|1
992317|NCT01354964|2004155|FG001|Overall Study|IV access issues|1
992318|NCT01354964|2004154|FG000|Overall Study|Physician Decision|1
992319|NCT01354964|2004155|FG001|Overall Study|Physician Decision|0
992320|NCT01355068|2004167|FG000|First Intervention Period|Adverse Event|0
992321|NCT01355068|2004168|FG001|First Intervention Period|Adverse Event|1
992322|NCT01355068|2004167|FG000|First Intervention Period|Withdrawal by Subject|0
992323|NCT01355068|2004168|FG001|First Intervention Period|Withdrawal by Subject|1
992324|NCT01355081|2004177|FG000|Overall Study|Pretreatment Event or Adverse Event|3
992325|NCT01355081|2004178|FG001|Overall Study|Pretreatment Event or Adverse Event|4
992326|NCT01355081|2004179|FG002|Overall Study|Pretreatment Event or Adverse Event|6
992327|NCT01355081|2004177|FG000|Overall Study|Major Protocol Deviation|0
992328|NCT01355081|2004178|FG001|Overall Study|Major Protocol Deviation|1
992329|NCT01355081|2004179|FG002|Overall Study|Major Protocol Deviation|0
992330|NCT01355081|2004177|FG000|Overall Study|Lost to Follow-up|0
992331|NCT01355081|2004178|FG001|Overall Study|Lost to Follow-up|0
992332|NCT01355081|2004179|FG002|Overall Study|Lost to Follow-up|1
992333|NCT01355081|2004177|FG000|Overall Study|Withdrawal of Consent|2
992334|NCT01355081|2004178|FG001|Overall Study|Withdrawal of Consent|3
992335|NCT01355081|2004179|FG002|Overall Study|Withdrawal of Consent|3
992336|NCT01355081|2004177|FG000|Overall Study|Lack of Efficacy|2
992337|NCT01355081|2004178|FG001|Overall Study|Lack of Efficacy|1
992338|NCT01355081|2004179|FG002|Overall Study|Lack of Efficacy|1
992339|NCT01355081|2004177|FG000|Overall Study|Non Compliance with Study Medication|0
992340|NCT01355081|2004178|FG001|Overall Study|Non Compliance with Study Medication|1
992341|NCT01355081|2004179|FG002|Overall Study|Non Compliance with Study Medication|0
992342|NCT01355159|2004189|FG000|Overall Study|Withdrew consent|39
992343|NCT01355159|2004190|FG001|Overall Study|Withdrew consent|47
992344|NCT01355159|2004189|FG000|Overall Study|No primary outcome data|17
992345|NCT01355159|2004190|FG001|Overall Study|No primary outcome data|11
992346|NCT01355159|2004189|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22
992347|NCT01355159|2004190|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15
992348|NCT01355159|2004189|FG000|Overall Study|Early intrauterine fetal death|6
992349|NCT01355159|2004190|FG001|Overall Study|Early intrauterine fetal death|6
992350|NCT01355289|2004225|FG000|Core Study|Adverse Event, Non-Fatal|1
992351|NCT01355289|2004226|FG001|Core Study|Adverse Event, Non-Fatal|0
992352|NCT01355289|2004227|FG002|Core Study|Adverse Event, Non-Fatal|0
992353|NCT01355289|2004228|FG003|Core Study|Adverse Event, Non-Fatal|0
992354|NCT01355289|2004229|FG004|Core Study|Adverse Event, Non-Fatal|0
992355|NCT01355289|2004225|FG000|Core Study|Inadequate Therapeutic Effect|0
992356|NCT01355289|2004226|FG001|Core Study|Inadequate Therapeutic Effect|0
992357|NCT01355289|2004227|FG002|Core Study|Inadequate Therapeutic Effect|0
992358|NCT01355289|2004228|FG003|Core Study|Inadequate Therapeutic Effect|1
992359|NCT01355289|2004229|FG004|Core Study|Inadequate Therapeutic Effect|0
992360|NCT01355289|2004225|FG000|Core Study|Other|0
992361|NCT01355289|2004226|FG001|Core Study|Other|0
992362|NCT01355289|2004227|FG002|Core Study|Other|0
992363|NCT01355289|2004228|FG003|Core Study|Other|1
992364|NCT01355289|2004229|FG004|Core Study|Other|0
992365|NCT01355289|2004225|FG000|Open Label Extension|Adverse Event, Non-Fatal|0
992366|NCT01355289|2004226|FG001|Open Label Extension|Adverse Event, Non-Fatal|0
992367|NCT01355289|2004227|FG002|Open Label Extension|Adverse Event, Non-Fatal|0
992368|NCT01355289|2004228|FG003|Open Label Extension|Adverse Event, Non-Fatal|0
992369|NCT01355289|2004229|FG004|Open Label Extension|Adverse Event, Non-Fatal|1
992370|NCT01355289|2004225|FG000|Open Label Extension|Lost to Follow-up|0
992371|NCT01355289|2004226|FG001|Open Label Extension|Lost to Follow-up|0
992372|NCT01355289|2004227|FG002|Open Label Extension|Lost to Follow-up|0
992373|NCT01355289|2004228|FG003|Open Label Extension|Lost to Follow-up|0
992374|NCT01355289|2004229|FG004|Open Label Extension|Lost to Follow-up|1
992375|NCT01355289|2004225|FG000|Open Label Extension|Inadequate Therapeutic Effect|0
992376|NCT01355289|2004226|FG001|Open Label Extension|Inadequate Therapeutic Effect|0
992377|NCT01355289|2004227|FG002|Open Label Extension|Inadequate Therapeutic Effect|0
992378|NCT01355289|2004228|FG003|Open Label Extension|Inadequate Therapeutic Effect|0
992379|NCT01355289|2004229|FG004|Open Label Extension|Inadequate Therapeutic Effect|29
992380|NCT01355289|2004225|FG000|Open Label Extension|Other|0
992381|NCT01355289|2004226|FG001|Open Label Extension|Other|0
992382|NCT01355289|2004227|FG002|Open Label Extension|Other|0
992383|NCT01355289|2004228|FG003|Open Label Extension|Other|0
992384|NCT01355289|2004229|FG004|Open Label Extension|Other|3
992385|NCT01355302|2004242|FG000|Phase 1b|Death|4
992386|NCT01355302|2004243|FG001|Phase 1b|Death|0
992387|NCT01355302|2004244|FG002|Phase 1b|Death|0
992388|NCT01355302|2004242|FG000|Phase 1b|Study terminated by sponsor|2
992389|NCT01355302|2004243|FG001|Phase 1b|Study terminated by sponsor|0
992390|NCT01355302|2004244|FG002|Phase 1b|Study terminated by sponsor|0
992391|NCT01355497|2004285|FG000|Overall Study|Death|19
992392|NCT01355497|2004286|FG001|Overall Study|Death|18
992393|NCT01355497|2004285|FG000|Overall Study|Lost to Follow-up|3
992394|NCT01355497|2004286|FG001|Overall Study|Lost to Follow-up|0
992395|NCT01355497|2004285|FG000|Overall Study|Protocol Violation|0
992396|NCT01355497|2004286|FG001|Overall Study|Protocol Violation|1
992397|NCT01355497|2004285|FG000|Overall Study|other-not provided|9
992398|NCT01355497|2004286|FG001|Overall Study|other-not provided|4
992399|NCT01355497|2004285|FG000|Overall Study|Withdrawal by Subject|12
992400|NCT01355497|2004286|FG001|Overall Study|Withdrawal by Subject|20
992401|NCT01355497|2004285|FG000|Overall Study|noncompliance|1
992402|NCT01355497|2004286|FG001|Overall Study|noncompliance|2
992403|NCT01355497|2004285|FG000|Overall Study|progressive disease|11
992404|NCT01355497|2004286|FG001|Overall Study|progressive disease|8
992405|NCT01355497|2004285|FG000|Overall Study|Adverse Event|11
992406|NCT01355497|2004286|FG001|Overall Study|Adverse Event|10
992407|NCT01355523|2004294|FG000|Overall Study|Withdrawal by Subject|1
992408|NCT01355523|2004295|FG001|Overall Study|Withdrawal by Subject|4
992409|NCT01355523|2004294|FG000|Overall Study|Lost to Follow-up|0
992410|NCT01355523|2004295|FG001|Overall Study|Lost to Follow-up|2
992411|NCT01355523|2004294|FG000|Overall Study|Protocol Violation|0
992412|NCT01355523|2004295|FG001|Overall Study|Protocol Violation|2
992413|NCT01355523|2004294|FG000|Overall Study|Adverse Event|0
992414|NCT01355523|2004295|FG001|Overall Study|Adverse Event|2
992415|NCT01355575|2004301|FG000|Overall Study|Withdrawal by Subject|2
992416|NCT01355627|2004328|FG000|Overall Study|Request By the Patient to Discontinue|5
992417|NCT01355627|2004329|FG001|Overall Study|Request By the Patient to Discontinue|7
992418|NCT01355627|2004328|FG000|Overall Study|Lost to Follow-up|8
992419|NCT01355627|2004329|FG001|Overall Study|Lost to Follow-up|7
992420|NCT01355627|2004328|FG000|Overall Study|Fatal Adverse Event|19
992421|NCT01355627|2004329|FG001|Overall Study|Fatal Adverse Event|23
992422|NCT01355627|2004328|FG000|Overall Study|Other|1
992423|NCT01355627|2004329|FG001|Overall Study|Other|1
992424|NCT01355679|2004335|FG000|Overall Study|benign tumor types found at biopsy|2
992425|NCT01356407|2004378|FG000|Overall Study|Lost to Follow-up|2
992426|NCT01356407|2004379|FG001|Overall Study|Lost to Follow-up|0
992427|NCT01356407|2004378|FG000|Overall Study|Patient Withdrew Consent|2
992428|NCT01356407|2004379|FG001|Overall Study|Patient Withdrew Consent|1
992429|NCT01356407|2004378|FG000|Overall Study|Could not afford IMP administration|0
992430|NCT01356407|2004379|FG001|Overall Study|Could not afford IMP administration|1
992431|NCT01356407|2004378|FG000|Overall Study|Not complete Endoscopy|2
992432|NCT01356407|2004379|FG001|Overall Study|Not complete Endoscopy|2
992433|NCT01356589|2004416|FG000|Overall Study|Enrolled, but not treated|3
992434|NCT01356589|2004416|FG000|Overall Study|Dose data not recorded|2
992435|NCT01356602|2004423|FG000|Overall Study|Protocol Deviation|0
992436|NCT01356602|2004424|FG001|Overall Study|Protocol Deviation|1
992437|NCT01356602|2004425|FG002|Overall Study|Protocol Deviation|1
992438|NCT01356602|2004423|FG000|Overall Study|Administrative Problems|1
992439|NCT01356602|2004424|FG001|Overall Study|Administrative Problems|4
992440|NCT01356602|2004425|FG002|Overall Study|Administrative Problems|5
992441|NCT01356602|2004423|FG000|Overall Study|Lost to Follow-up|4
992442|NCT01356602|2004424|FG001|Overall Study|Lost to Follow-up|5
992443|NCT01356602|2004425|FG002|Overall Study|Lost to Follow-up|6
992444|NCT01356602|2004423|FG000|Overall Study|Withdrawal by Subject|4
992445|NCT01356602|2004424|FG001|Overall Study|Withdrawal by Subject|3
992446|NCT01356602|2004425|FG002|Overall Study|Withdrawal by Subject|7
992447|NCT01356602|2004423|FG000|Overall Study|Lack of Efficacy|0
992448|NCT01356602|2004424|FG001|Overall Study|Lack of Efficacy|1
992449|NCT01356602|2004425|FG002|Overall Study|Lack of Efficacy|4
992450|NCT01356602|2004423|FG000|Overall Study|Adverse Event|0
992451|NCT01356602|2004424|FG001|Overall Study|Adverse Event|1
992452|NCT01356602|2004425|FG002|Overall Study|Adverse Event|1
992453|NCT01356940|2004439|FG000|First Intervention (28 Days)|Adverse Event|1
992454|NCT01356940|2004440|FG001|First Intervention (28 Days)|Adverse Event|0
992455|NCT01356940|2004439|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1
992456|NCT01356940|2004440|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0
992457|NCT01356966|2004450|FG000|Overall Study|Withdrawal by Subject|1
992458|NCT01356966|2004451|FG001|Overall Study|Withdrawal by Subject|2
992459|NCT01356966|2004450|FG000|Overall Study|Physician Decision|1
992460|NCT01356966|2004451|FG001|Overall Study|Physician Decision|0
992461|NCT01357161|2004477|FG000|Part 1 (Open Label Run-in)|Death|5
992462|NCT01357161|2004478|FG001|Part 1 (Open Label Run-in)|Death|0
992463|NCT01357161|2004479|FG002|Part 1 (Open Label Run-in)|Death|0
992464|NCT01357161|2004477|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3
992465|NCT01357161|2004478|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0
992466|NCT01357161|2004479|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0
992467|NCT01357161|2004477|FG000|Part 1 (Open Label Run-in)|Physician Decision|1
992468|NCT01357161|2004478|FG001|Part 1 (Open Label Run-in)|Physician Decision|0
992469|NCT01357161|2004479|FG002|Part 1 (Open Label Run-in)|Physician Decision|0
992470|NCT01357161|2004477|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
992471|NCT01357161|2004478|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
992472|NCT01357161|2004479|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
992473|NCT01357161|2004477|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
992474|NCT01357161|2004478|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
992475|NCT01357161|2004479|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
992476|NCT01357161|2004477|FG000|Part 2 (Double-Blind Comparison)|Death|0
992477|NCT01357161|2004478|FG001|Part 2 (Double-Blind Comparison)|Death|22
992478|NCT01357161|2004479|FG002|Part 2 (Double-Blind Comparison)|Death|19
992479|NCT01357161|2004477|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
992480|NCT01357161|2004478|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
992481|NCT01357161|2004479|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
992482|NCT01357161|2004477|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0
992483|NCT01357161|2004478|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1
992484|NCT01357161|2004479|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4
992485|NCT01357161|2004477|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0
992486|NCT01357161|2004478|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1
992487|NCT01357161|2004479|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3
992488|NCT01357161|2004477|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
992489|NCT01357161|2004478|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
992490|NCT01357161|2004479|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
992491|NCT01357161|2004477|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
992492|NCT01357161|2004478|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
992493|NCT01357161|2004479|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
992494|NCT01357239|2004491|FG000|Stratum: All Patients|Adverse Event|0
992495|NCT01357239|2004492|FG001|Stratum: All Patients|Adverse Event|0
992496|NCT01357239|2004493|FG002|Stratum: All Patients|Adverse Event|1
992497|NCT01357239|2004494|FG003|Stratum: All Patients|Adverse Event|1
992498|NCT01357239|2004491|FG000|Stratum: All Patients|Subject withdrew consent|0
992499|NCT01357239|2004492|FG001|Stratum: All Patients|Subject withdrew consent|0
992500|NCT01357239|2004493|FG002|Stratum: All Patients|Subject withdrew consent|1
992501|NCT01357239|2004494|FG003|Stratum: All Patients|Subject withdrew consent|1
992502|NCT01357239|2004491|FG000|Stratum I: Fully-Methylated|Adverse Event|0
992503|NCT01357239|2004492|FG001|Stratum I: Fully-Methylated|Adverse Event|0
992504|NCT01357239|2004493|FG002|Stratum I: Fully-Methylated|Adverse Event|1
992505|NCT01357239|2004494|FG003|Stratum I: Fully-Methylated|Adverse Event|0
992506|NCT01357239|2004491|FG000|Stratum II: Partially-Methylated|Adverse Event|0
992507|NCT01357239|2004492|FG001|Stratum II: Partially-Methylated|Adverse Event|0
992508|NCT01357239|2004493|FG002|Stratum II: Partially-Methylated|Adverse Event|0
992509|NCT01357239|2004494|FG003|Stratum II: Partially-Methylated|Adverse Event|1
992510|NCT01357239|2004491|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0
992511|NCT01357239|2004492|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0
992512|NCT01357239|2004493|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1
992513|NCT01357239|2004494|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1
992514|NCT01357551|2004541|FG000|Overall Study|Withdrawal by Subject|6
992515|NCT01357551|2004542|FG001|Overall Study|Withdrawal by Subject|4
992516|NCT01357551|2004541|FG000|Overall Study|Death|0
992517|NCT01357551|2004542|FG001|Overall Study|Death|1
992518|NCT01357551|2004541|FG000|Overall Study|Lost to Follow-up|16
992519|NCT01357551|2004542|FG001|Overall Study|Lost to Follow-up|6
992520|NCT01357577|2004564|FG000|Overall Study|Lost to Follow-up|20
992521|NCT01357577|2004565|FG001|Overall Study|Lost to Follow-up|16
992522|NCT01357577|2004564|FG000|Overall Study|Withdrawal by Subject|16
992523|NCT01357577|2004565|FG001|Overall Study|Withdrawal by Subject|8
992524|NCT01357577|2004564|FG000|Overall Study|look at data in database?|1
992525|NCT01357577|2004565|FG001|Overall Study|look at data in database?|2
992526|NCT01357616|2004574|FG000|Overall Study|Adverse Event|1
992527|NCT01357616|2004575|FG001|Overall Study|Adverse Event|1
992528|NCT01357616|2004574|FG000|Overall Study|Lost to Follow-up|4
992529|NCT01357616|2004575|FG001|Overall Study|Lost to Follow-up|3
992530|NCT01357616|2004574|FG000|Overall Study|Protocol Violation|0
992531|NCT01357616|2004575|FG001|Overall Study|Protocol Violation|2
992532|NCT01357616|2004574|FG000|Overall Study|Inadequate Control of IOP|1
992533|NCT01357616|2004575|FG001|Overall Study|Inadequate Control of IOP|2
992534|NCT01357616|2004574|FG000|Overall Study|Decision Unrelated to Adverse Event|3
992535|NCT01357616|2004575|FG001|Overall Study|Decision Unrelated to Adverse Event|1
992536|NCT01357616|2004574|FG000|Overall Study|Withdrawal by Subject|1
992537|NCT01357616|2004575|FG001|Overall Study|Withdrawal by Subject|0
992538|NCT01357655|2004583|FG000|Overall Study|Administrative Reason by Sponsor|45
992539|NCT01357655|2004584|FG001|Overall Study|Administrative Reason by Sponsor|0
992540|NCT01357655|2004583|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3
992541|NCT01357655|2004584|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0
992542|NCT01357655|2004583|FG000|Overall Study|Disease Progression|1
992543|NCT01357655|2004584|FG001|Overall Study|Disease Progression|0
992544|NCT01357655|2004583|FG000|Overall Study|Lost to Follow-up|2
992545|NCT01357655|2004584|FG001|Overall Study|Lost to Follow-up|0
992546|NCT01357655|2004583|FG000|Overall Study|Maximum Clinical Benefit|2
992547|NCT01357655|2004584|FG001|Overall Study|Maximum Clinical Benefit|0
992548|NCT01357655|2004583|FG000|Overall Study|Reason Unspecified|1
992549|NCT01357655|2004584|FG001|Overall Study|Reason Unspecified|0
992550|NCT01357655|2004583|FG000|Overall Study|Study Drug Toxicity|11
992551|NCT01357655|2004584|FG001|Overall Study|Study Drug Toxicity|0
992552|NCT01357655|2004583|FG000|Overall Study|Subject Withdrew Consent|1
992553|NCT01357655|2004584|FG001|Overall Study|Subject Withdrew Consent|0
992554|NCT01357850|2004602|FG000|Overall Study|Lost to Follow-up|1
992555|NCT01357850|2004603|FG001|Overall Study|Lost to Follow-up|0
992556|NCT01357850|2004604|FG002|Overall Study|Lost to Follow-up|0
992557|NCT01357850|2004605|FG003|Overall Study|Lost to Follow-up|0
992558|NCT01357889|2004618|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
992559|NCT01357889|2004619|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
992560|NCT01357889|2004618|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
992561|NCT01357889|2004619|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
992562|NCT01357889|2004618|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
992563|NCT01357889|2004619|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
992564|NCT01357889|2004618|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
992565|NCT01357889|2004619|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
992566|NCT01357889|2004618|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
992567|NCT01357889|2004619|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
992568|NCT01357889|2004618|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
992569|NCT01357889|2004619|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
992570|NCT01357889|2004618|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
992571|NCT01357889|2004619|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
992572|NCT01357889|2004618|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
992573|NCT01357889|2004619|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
992574|NCT01357889|2004618|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
992575|NCT01357889|2004619|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
992576|NCT01357889|2004618|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
992577|NCT01357889|2004619|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
992578|NCT01357889|2004618|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
992579|NCT01357889|2004619|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
992580|NCT01357889|2004618|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
992581|NCT01357889|2004619|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
992582|NCT01357889|2004618|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
992583|NCT01357889|2004619|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
992584|NCT01357915|2004629|FG000|Overall Study|Lost to Follow-up|3
992585|NCT01357915|2004630|FG001|Overall Study|Lost to Follow-up|0
992586|NCT01357980|2004640|FG000|Overall Study|Lack of Efficacy|0
992587|NCT01357980|2004641|FG001|Overall Study|Lack of Efficacy|1
992588|NCT01357980|2004642|FG002|Overall Study|Lack of Efficacy|0
992589|NCT01357980|2004643|FG003|Overall Study|Lack of Efficacy|0
992590|NCT01357980|2004640|FG000|Overall Study|Consent withdrawn|0
992591|NCT01357980|2004641|FG001|Overall Study|Consent withdrawn|0
992592|NCT01357980|2004642|FG002|Overall Study|Consent withdrawn|1
992593|NCT01357980|2004643|FG003|Overall Study|Consent withdrawn|0
992594|NCT01358175|2004656|FG000|Overall Study|Death|1
992595|NCT01358175|2004657|FG001|Overall Study|Death|0
992596|NCT01358175|2004658|FG002|Overall Study|Death|1
992597|NCT01358175|2004656|FG000|Overall Study|Withdrawal by Subject|9
992598|NCT01358175|2004657|FG001|Overall Study|Withdrawal by Subject|5
992599|NCT01358175|2004658|FG002|Overall Study|Withdrawal by Subject|10
992600|NCT01358175|2004656|FG000|Overall Study|Technical issues|0
992601|NCT01358175|2004657|FG001|Overall Study|Technical issues|1
992602|NCT01358175|2004658|FG002|Overall Study|Technical issues|0
992603|NCT01358175|2004656|FG000|Overall Study|Pregnancy|0
992604|NCT01358175|2004657|FG001|Overall Study|Pregnancy|1
992605|NCT01358175|2004658|FG002|Overall Study|Pregnancy|0
992606|NCT01358175|2004656|FG000|Overall Study|Physician Decision|1
992607|NCT01358175|2004657|FG001|Overall Study|Physician Decision|0
992608|NCT01358175|2004658|FG002|Overall Study|Physician Decision|0
992609|NCT01358175|2004656|FG000|Overall Study|Non Compliance with Study Treatment|0
992610|NCT01358175|2004657|FG001|Overall Study|Non Compliance with Study Treatment|1
992611|NCT01358175|2004658|FG002|Overall Study|Non Compliance with Study Treatment|1
992612|NCT01358175|2004656|FG000|Overall Study|Lost to Follow-up|1
992613|NCT01358175|2004657|FG001|Overall Study|Lost to Follow-up|1
992614|NCT01358175|2004658|FG002|Overall Study|Lost to Follow-up|3
992615|NCT01358175|2004656|FG000|Overall Study|Lack of Efficacy|3
992616|NCT01358175|2004657|FG001|Overall Study|Lack of Efficacy|8
992617|NCT01358175|2004658|FG002|Overall Study|Lack of Efficacy|6
992618|NCT01358175|2004656|FG000|Overall Study|Adverse Event|6
992619|NCT01358175|2004657|FG001|Overall Study|Adverse Event|11
992620|NCT01358175|2004658|FG002|Overall Study|Adverse Event|11
992621|NCT01358331|2004690|FG000|Overall Study|Lost to Follow-up|0
992622|NCT01358331|2004691|FG001|Overall Study|Lost to Follow-up|0
992623|NCT01358331|2004692|FG002|Overall Study|Lost to Follow-up|0
992624|NCT01358331|2004693|FG003|Overall Study|Lost to Follow-up|1
992625|NCT01358331|2004694|FG004|Overall Study|Lost to Follow-up|0
992626|NCT01358331|2004695|FG005|Overall Study|Lost to Follow-up|0
992627|NCT01358331|2004690|FG000|Overall Study|Withdrawal by Subject|0
992628|NCT01358331|2004691|FG001|Overall Study|Withdrawal by Subject|0
992629|NCT01358331|2004692|FG002|Overall Study|Withdrawal by Subject|0
992630|NCT01358331|2004693|FG003|Overall Study|Withdrawal by Subject|1
992631|NCT01358331|2004694|FG004|Overall Study|Withdrawal by Subject|1
992632|NCT01358331|2004695|FG005|Overall Study|Withdrawal by Subject|1
992633|NCT01358331|2004690|FG000|Overall Study|Adverse Events|1
992634|NCT01358331|2004691|FG001|Overall Study|Adverse Events|1
992635|NCT01358331|2004692|FG002|Overall Study|Adverse Events|1
992636|NCT01358331|2004693|FG003|Overall Study|Adverse Events|0
992637|NCT01358331|2004694|FG004|Overall Study|Adverse Events|1
992638|NCT01358331|2004695|FG005|Overall Study|Adverse Events|5
992639|NCT01358331|2004690|FG000|Overall Study|Symptomatic Deterioration|0
992640|NCT01358331|2004691|FG001|Overall Study|Symptomatic Deterioration|0
992641|NCT01358331|2004692|FG002|Overall Study|Symptomatic Deterioration|0
992642|NCT01358331|2004693|FG003|Overall Study|Symptomatic Deterioration|0
992643|NCT01358331|2004694|FG004|Overall Study|Symptomatic Deterioration|1
992644|NCT01358331|2004695|FG005|Overall Study|Symptomatic Deterioration|0
992645|NCT01358331|2004690|FG000|Overall Study|Participants did not wish to continue|0
992646|NCT01358331|2004691|FG001|Overall Study|Participants did not wish to continue|0
992647|NCT01358331|2004692|FG002|Overall Study|Participants did not wish to continue|0
992648|NCT01358331|2004693|FG003|Overall Study|Participants did not wish to continue|0
992649|NCT01358331|2004694|FG004|Overall Study|Participants did not wish to continue|1
992650|NCT01358331|2004695|FG005|Overall Study|Participants did not wish to continue|0
992651|NCT01358331|2004690|FG000|Overall Study|Progress of disease under investigation|1
992652|NCT01358331|2004691|FG001|Overall Study|Progress of disease under investigation|2
992653|NCT01358331|2004692|FG002|Overall Study|Progress of disease under investigation|3
992654|NCT01358331|2004693|FG003|Overall Study|Progress of disease under investigation|1
992655|NCT01358331|2004694|FG004|Overall Study|Progress of disease under investigation|3
992656|NCT01358331|2004695|FG005|Overall Study|Progress of disease under investigation|0
992657|NCT01358357|2004711|FG000|Open Label Phase|Adverse Event|0
992658|NCT01358357|2004712|FG001|Open Label Phase|Adverse Event|0
992659|NCT01358357|2004713|FG002|Open Label Phase|Adverse Event|59
992660|NCT01358357|2004711|FG000|Open Label Phase|Lack of Efficacy|0
992661|NCT01358357|2004712|FG001|Open Label Phase|Lack of Efficacy|0
992662|NCT01358357|2004713|FG002|Open Label Phase|Lack of Efficacy|107
992663|NCT01358357|2004711|FG000|Open Label Phase|Lost to Follow-up|0
992664|NCT01358357|2004712|FG001|Open Label Phase|Lost to Follow-up|0
992665|NCT01358357|2004713|FG002|Open Label Phase|Lost to Follow-up|76
992666|NCT01358357|2004711|FG000|Open Label Phase|Protocol Violation|0
992667|NCT01358357|2004712|FG001|Open Label Phase|Protocol Violation|0
992668|NCT01358357|2004713|FG002|Open Label Phase|Protocol Violation|45
992669|NCT01358357|2004711|FG000|Open Label Phase|Withdrawal by Subject|0
992670|NCT01358357|2004712|FG001|Open Label Phase|Withdrawal by Subject|0
992671|NCT01358357|2004713|FG002|Open Label Phase|Withdrawal by Subject|112
992672|NCT01358357|2004711|FG000|Open Label Phase|Did not meet criteria for DB phase|0
992673|NCT01358357|2004712|FG001|Open Label Phase|Did not meet criteria for DB phase|0
992674|NCT01358357|2004713|FG002|Open Label Phase|Did not meet criteria for DB phase|16
992675|NCT01358357|2004711|FG000|Open Label Phase|Terminated at study completion|0
992676|NCT01358357|2004712|FG001|Open Label Phase|Terminated at study completion|0
992677|NCT01358357|2004713|FG002|Open Label Phase|Terminated at study completion|5
992678|NCT01358357|2004711|FG000|Open Label Phase|Mood episode|0
992679|NCT01358357|2004712|FG001|Open Label Phase|Mood episode|0
992680|NCT01358357|2004713|FG002|Open Label Phase|Mood episode|42
992681|NCT01358357|2004711|FG000|Double-Blind Phase|Adverse Event|8
992682|NCT01358357|2004712|FG001|Double-Blind Phase|Adverse Event|5
992683|NCT01358357|2004713|FG002|Double-Blind Phase|Adverse Event|0
992684|NCT01358357|2004711|FG000|Double-Blind Phase|Lost to Follow-up|5
992685|NCT01358357|2004712|FG001|Double-Blind Phase|Lost to Follow-up|7
992686|NCT01358357|2004713|FG002|Double-Blind Phase|Lost to Follow-up|0
992687|NCT01358357|2004711|FG000|Double-Blind Phase|Protocol Violation|1
992688|NCT01358357|2004712|FG001|Double-Blind Phase|Protocol Violation|11
992689|NCT01358357|2004713|FG002|Double-Blind Phase|Protocol Violation|0
992690|NCT01358357|2004711|FG000|Double-Blind Phase|Protocol Violation|16
992691|NCT01358357|2004712|FG001|Double-Blind Phase|Protocol Violation|12
992692|NCT01358357|2004713|FG002|Double-Blind Phase|Protocol Violation|0
992693|NCT01358357|2004711|FG000|Double-Blind Phase|Terminated at study completion|2
992694|NCT01358357|2004712|FG001|Double-Blind Phase|Terminated at study completion|0
992695|NCT01358357|2004713|FG002|Double-Blind Phase|Terminated at study completion|0
992696|NCT01358357|2004711|FG000|Double-Blind Phase|Recurrence of mood event|48
992697|NCT01358357|2004712|FG001|Double-Blind Phase|Recurrence of mood event|64
992698|NCT01358357|2004713|FG002|Double-Blind Phase|Recurrence of mood event|0
992699|NCT01358357|2004711|FG000|Double-Blind Phase|Administrative|0
992700|NCT01358357|2004712|FG001|Double-Blind Phase|Administrative|1
992701|NCT01358357|2004713|FG002|Double-Blind Phase|Administrative|0
992702|NCT01358526|2004722|FG000|Open-label Titration Period|Adverse Event|95
992703|NCT01358526|2004723|FG001|Open-label Titration Period|Adverse Event|0
992704|NCT01358526|2004724|FG002|Open-label Titration Period|Adverse Event|0
992705|NCT01358526|2004722|FG000|Open-label Titration Period|Withdrawal by Subject|65
992706|NCT01358526|2004723|FG001|Open-label Titration Period|Withdrawal by Subject|0
992707|NCT01358526|2004724|FG002|Open-label Titration Period|Withdrawal by Subject|0
992708|NCT01358526|2004722|FG000|Open-label Titration Period|Lost to Follow-up|25
992709|NCT01358526|2004723|FG001|Open-label Titration Period|Lost to Follow-up|0
992710|NCT01358526|2004724|FG002|Open-label Titration Period|Lost to Follow-up|0
992711|NCT01358526|2004722|FG000|Open-label Titration Period|Lack of Efficacy|107
992712|NCT01358526|2004723|FG001|Open-label Titration Period|Lack of Efficacy|0
992713|NCT01358526|2004724|FG002|Open-label Titration Period|Lack of Efficacy|0
992714|NCT01358526|2004722|FG000|Open-label Titration Period|Confirmed or suspected diversion|16
992715|NCT01358526|2004723|FG001|Open-label Titration Period|Confirmed or suspected diversion|0
992716|NCT01358526|2004724|FG002|Open-label Titration Period|Confirmed or suspected diversion|0
992717|NCT01358526|2004722|FG000|Open-label Titration Period|Administrative|8
992718|NCT01358526|2004723|FG001|Open-label Titration Period|Administrative|0
992719|NCT01358526|2004724|FG002|Open-label Titration Period|Administrative|0
992720|NCT01358526|2004722|FG000|Open-label Titration Period|Did not qualify|178
992721|NCT01358526|2004723|FG001|Open-label Titration Period|Did not qualify|0
992722|NCT01358526|2004724|FG002|Open-label Titration Period|Did not qualify|0
992723|NCT01358526|2004722|FG000|Double-blind Phase|Adverse Event|0
992724|NCT01358526|2004723|FG001|Double-blind Phase|Adverse Event|24
992725|NCT01358526|2004724|FG002|Double-blind Phase|Adverse Event|23
992726|NCT01358526|2004722|FG000|Double-blind Phase|Withdrawal by Subject|0
992727|NCT01358526|2004723|FG001|Double-blind Phase|Withdrawal by Subject|10
992728|NCT01358526|2004724|FG002|Double-blind Phase|Withdrawal by Subject|8
992729|NCT01358526|2004722|FG000|Double-blind Phase|Lost to Follow-up|0
992730|NCT01358526|2004723|FG001|Double-blind Phase|Lost to Follow-up|4
992731|NCT01358526|2004724|FG002|Double-blind Phase|Lost to Follow-up|1
992732|NCT01358526|2004722|FG000|Double-blind Phase|Lack of Efficacy|0
992733|NCT01358526|2004723|FG001|Double-blind Phase|Lack of Efficacy|31
992734|NCT01358526|2004724|FG002|Double-blind Phase|Lack of Efficacy|73
992735|NCT01358526|2004722|FG000|Double-blind Phase|Confirmed or suspected diversion|0
992736|NCT01358526|2004723|FG001|Double-blind Phase|Confirmed or suspected diversion|5
992737|NCT01358526|2004724|FG002|Double-blind Phase|Confirmed or suspected diversion|6
992738|NCT01358526|2004722|FG000|Double-blind Phase|Administrative|0
992739|NCT01358526|2004723|FG001|Double-blind Phase|Administrative|6
992740|NCT01358526|2004724|FG002|Double-blind Phase|Administrative|10
992741|NCT01358578|2004735|FG000|Induction Period|Adverse Event|2
992742|NCT01358578|2004736|FG001|Induction Period|Adverse Event|4
992743|NCT01358578|2004737|FG002|Induction Period|Adverse Event|2
992744|NCT01358578|2004738|FG003|Induction Period|Adverse Event|6
992745|NCT01358578|2004739|FG004|Induction Period|Adverse Event|0
992746|NCT01358578|2004740|FG005|Induction Period|Adverse Event|0
992747|NCT01358578|2004735|FG000|Induction Period|Lack of Efficacy|0
992748|NCT01358578|2004736|FG001|Induction Period|Lack of Efficacy|0
992749|NCT01358578|2004737|FG002|Induction Period|Lack of Efficacy|9
992750|NCT01358578|2004738|FG003|Induction Period|Lack of Efficacy|1
992751|NCT01358578|2004739|FG004|Induction Period|Lack of Efficacy|0
992752|NCT01358578|2004740|FG005|Induction Period|Lack of Efficacy|0
992753|NCT01358578|2004735|FG000|Induction Period|Lost to Follow-up|0
992754|NCT01358578|2004736|FG001|Induction Period|Lost to Follow-up|0
992755|NCT01358578|2004737|FG002|Induction Period|Lost to Follow-up|1
992756|NCT01358578|2004738|FG003|Induction Period|Lost to Follow-up|4
992757|NCT01358578|2004739|FG004|Induction Period|Lost to Follow-up|0
992758|NCT01358578|2004740|FG005|Induction Period|Lost to Follow-up|0
992759|NCT01358578|2004735|FG000|Induction Period|Physician Decision|2
992760|NCT01358578|2004736|FG001|Induction Period|Physician Decision|1
992761|NCT01358578|2004737|FG002|Induction Period|Physician Decision|2
992762|NCT01358578|2004738|FG003|Induction Period|Physician Decision|0
992763|NCT01358578|2004739|FG004|Induction Period|Physician Decision|0
992764|NCT01358578|2004740|FG005|Induction Period|Physician Decision|0
992765|NCT01358578|2004735|FG000|Induction Period|Protocol Deviation|3
992766|NCT01358578|2004736|FG001|Induction Period|Protocol Deviation|5
992767|NCT01358578|2004737|FG002|Induction Period|Protocol Deviation|0
992768|NCT01358578|2004738|FG003|Induction Period|Protocol Deviation|3
992769|NCT01358578|2004739|FG004|Induction Period|Protocol Deviation|0
992770|NCT01358578|2004740|FG005|Induction Period|Protocol Deviation|0
992771|NCT01358578|2004735|FG000|Induction Period|technical problems|0
992772|NCT01358578|2004736|FG001|Induction Period|technical problems|0
992773|NCT01358578|2004737|FG002|Induction Period|technical problems|1
992774|NCT01358578|2004738|FG003|Induction Period|technical problems|1
992775|NCT01358578|2004739|FG004|Induction Period|technical problems|0
992776|NCT01358578|2004740|FG005|Induction Period|technical problems|0
992777|NCT01358578|2004735|FG000|Induction Period|Withdrawal by Subject|5
992778|NCT01358578|2004736|FG001|Induction Period|Withdrawal by Subject|5
992779|NCT01358578|2004737|FG002|Induction Period|Withdrawal by Subject|10
992780|NCT01358578|2004738|FG003|Induction Period|Withdrawal by Subject|6
992781|NCT01358578|2004739|FG004|Induction Period|Withdrawal by Subject|0
992782|NCT01358578|2004740|FG005|Induction Period|Withdrawal by Subject|0
992783|NCT01358578|2004735|FG000|Maintenance Period|Adverse Event|2
992784|NCT01358578|2004736|FG001|Maintenance Period|Adverse Event|7
992785|NCT01358578|2004737|FG002|Maintenance Period|Adverse Event|0
992786|NCT01358578|2004738|FG003|Maintenance Period|Adverse Event|6
992787|NCT01358578|2004739|FG004|Maintenance Period|Adverse Event|4
992788|NCT01358578|2004740|FG005|Maintenance Period|Adverse Event|3
992789|NCT01358578|2004735|FG000|Maintenance Period|Lack of Efficacy|10
992790|NCT01358578|2004736|FG001|Maintenance Period|Lack of Efficacy|2
992791|NCT01358578|2004737|FG002|Maintenance Period|Lack of Efficacy|0
992792|NCT01358578|2004738|FG003|Maintenance Period|Lack of Efficacy|11
992793|NCT01358578|2004739|FG004|Maintenance Period|Lack of Efficacy|3
992794|NCT01358578|2004740|FG005|Maintenance Period|Lack of Efficacy|0
992795|NCT01358578|2004735|FG000|Maintenance Period|Lost to Follow-up|4
992796|NCT01358578|2004736|FG001|Maintenance Period|Lost to Follow-up|0
992797|NCT01358578|2004737|FG002|Maintenance Period|Lost to Follow-up|0
992798|NCT01358578|2004738|FG003|Maintenance Period|Lost to Follow-up|5
992799|NCT01358578|2004739|FG004|Maintenance Period|Lost to Follow-up|1
992800|NCT01358578|2004740|FG005|Maintenance Period|Lost to Follow-up|1
992801|NCT01358578|2004735|FG000|Maintenance Period|Non-compliance with study treatment|3
992802|NCT01358578|2004736|FG001|Maintenance Period|Non-compliance with study treatment|1
992803|NCT01358578|2004737|FG002|Maintenance Period|Non-compliance with study treatment|0
992804|NCT01358578|2004738|FG003|Maintenance Period|Non-compliance with study treatment|2
992805|NCT01358578|2004739|FG004|Maintenance Period|Non-compliance with study treatment|1
992806|NCT01358578|2004740|FG005|Maintenance Period|Non-compliance with study treatment|2
992807|NCT01358578|2004735|FG000|Maintenance Period|Physician Decision|0
992808|NCT01358578|2004736|FG001|Maintenance Period|Physician Decision|1
992809|NCT01358578|2004737|FG002|Maintenance Period|Physician Decision|0
992810|NCT01358578|2004738|FG003|Maintenance Period|Physician Decision|1
992811|NCT01358578|2004739|FG004|Maintenance Period|Physician Decision|0
992812|NCT01358578|2004740|FG005|Maintenance Period|Physician Decision|0
992813|NCT01358578|2004735|FG000|Maintenance Period|Pregnancy|1
992814|NCT01358578|2004736|FG001|Maintenance Period|Pregnancy|0
992815|NCT01358578|2004737|FG002|Maintenance Period|Pregnancy|0
992816|NCT01358578|2004738|FG003|Maintenance Period|Pregnancy|0
992817|NCT01358578|2004739|FG004|Maintenance Period|Pregnancy|0
992818|NCT01358578|2004740|FG005|Maintenance Period|Pregnancy|0
992819|NCT01358578|2004735|FG000|Maintenance Period|Protocol deviation|7
992820|NCT01358578|2004736|FG001|Maintenance Period|Protocol deviation|4
992821|NCT01358578|2004737|FG002|Maintenance Period|Protocol deviation|0
992822|NCT01358578|2004738|FG003|Maintenance Period|Protocol deviation|2
992823|NCT01358578|2004739|FG004|Maintenance Period|Protocol deviation|2
992824|NCT01358578|2004740|FG005|Maintenance Period|Protocol deviation|2
992825|NCT01358578|2004735|FG000|Maintenance Period|Withdrawal by Subject|12
992826|NCT01358578|2004736|FG001|Maintenance Period|Withdrawal by Subject|7
992827|NCT01358578|2004737|FG002|Maintenance Period|Withdrawal by Subject|2
992828|NCT01358578|2004738|FG003|Maintenance Period|Withdrawal by Subject|15
992829|NCT01358578|2004739|FG004|Maintenance Period|Withdrawal by Subject|6
992830|NCT01358578|2004740|FG005|Maintenance Period|Withdrawal by Subject|3
992831|NCT01358578|2004735|FG000|Follow-up Period|Adverse Event|1
992832|NCT01358578|2004736|FG001|Follow-up Period|Adverse Event|1
992833|NCT01358578|2004737|FG002|Follow-up Period|Adverse Event|0
992834|NCT01358578|2004738|FG003|Follow-up Period|Adverse Event|0
992835|NCT01358578|2004739|FG004|Follow-up Period|Adverse Event|0
992836|NCT01358578|2004740|FG005|Follow-up Period|Adverse Event|0
992837|NCT01358578|2004735|FG000|Follow-up Period|Lack of Efficacy|3
992838|NCT01358578|2004736|FG001|Follow-up Period|Lack of Efficacy|0
992839|NCT01358578|2004737|FG002|Follow-up Period|Lack of Efficacy|4
992840|NCT01358578|2004738|FG003|Follow-up Period|Lack of Efficacy|1
992841|NCT01358578|2004739|FG004|Follow-up Period|Lack of Efficacy|0
992842|NCT01358578|2004740|FG005|Follow-up Period|Lack of Efficacy|0
992843|NCT01358578|2004735|FG000|Follow-up Period|Lost to Follow-up|0
992844|NCT01358578|2004736|FG001|Follow-up Period|Lost to Follow-up|1
992845|NCT01358578|2004737|FG002|Follow-up Period|Lost to Follow-up|0
992846|NCT01358578|2004738|FG003|Follow-up Period|Lost to Follow-up|4
992847|NCT01358578|2004739|FG004|Follow-up Period|Lost to Follow-up|0
992848|NCT01358578|2004740|FG005|Follow-up Period|Lost to Follow-up|0
992849|NCT01358578|2004735|FG000|Follow-up Period|non- compliance with study treatment|1
992850|NCT01358578|2004736|FG001|Follow-up Period|non- compliance with study treatment|0
992851|NCT01358578|2004737|FG002|Follow-up Period|non- compliance with study treatment|0
992852|NCT01358578|2004738|FG003|Follow-up Period|non- compliance with study treatment|0
992853|NCT01358578|2004739|FG004|Follow-up Period|non- compliance with study treatment|0
992854|NCT01358578|2004740|FG005|Follow-up Period|non- compliance with study treatment|0
992855|NCT01358578|2004735|FG000|Follow-up Period|Pregnancy|1
992856|NCT01358578|2004736|FG001|Follow-up Period|Pregnancy|0
992857|NCT01358578|2004737|FG002|Follow-up Period|Pregnancy|0
992858|NCT01358578|2004738|FG003|Follow-up Period|Pregnancy|0
992859|NCT01358578|2004739|FG004|Follow-up Period|Pregnancy|0
992860|NCT01358578|2004740|FG005|Follow-up Period|Pregnancy|0
992861|NCT01358578|2004735|FG000|Follow-up Period|Withdrawal by Subject|3
992862|NCT01358578|2004736|FG001|Follow-up Period|Withdrawal by Subject|3
992863|NCT01358578|2004737|FG002|Follow-up Period|Withdrawal by Subject|1
992864|NCT01358578|2004738|FG003|Follow-up Period|Withdrawal by Subject|12
992865|NCT01358578|2004739|FG004|Follow-up Period|Withdrawal by Subject|0
992866|NCT01358578|2004740|FG005|Follow-up Period|Withdrawal by Subject|0
992867|NCT01358578|2004735|FG000|Follow-up Period|Physician Decision|1
992868|NCT01358578|2004736|FG001|Follow-up Period|Physician Decision|1
992869|NCT01358578|2004737|FG002|Follow-up Period|Physician Decision|0
992870|NCT01358578|2004738|FG003|Follow-up Period|Physician Decision|2
992871|NCT01358578|2004739|FG004|Follow-up Period|Physician Decision|0
992872|NCT01358578|2004740|FG005|Follow-up Period|Physician Decision|0
992873|NCT01358708|2004770|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2
992874|NCT01358708|2004771|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
992875|NCT01358708|2004770|FG000|Double-Blind Treatment Phase|Protocol Violation|1
992876|NCT01358708|2004771|FG001|Double-Blind Treatment Phase|Protocol Violation|0
992877|NCT01358721|2004785|FG000|Overall Study|Withdrawal by Subject|0
992878|NCT01358721|2004786|FG001|Overall Study|Withdrawal by Subject|0
992879|NCT01358721|2004787|FG002|Overall Study|Withdrawal by Subject|0
992880|NCT01358721|2004788|FG003|Overall Study|Withdrawal by Subject|1
992881|NCT01358721|2004785|FG000|Overall Study|Death|0
992882|NCT01358721|2004786|FG001|Overall Study|Death|2
992883|NCT01358721|2004787|FG002|Overall Study|Death|0
992884|NCT01358721|2004788|FG003|Overall Study|Death|0
992885|NCT01358721|2004785|FG000|Overall Study|Study Drug Toxicity|1
992886|NCT01358721|2004786|FG001|Overall Study|Study Drug Toxicity|3
992887|NCT01358721|2004787|FG002|Overall Study|Study Drug Toxicity|4
992888|NCT01358721|2004788|FG003|Overall Study|Study Drug Toxicity|5
992889|NCT01358721|2004785|FG000|Overall Study|SUBJ request to discontinue study TRT|0
992890|NCT01358721|2004786|FG001|Overall Study|SUBJ request to discontinue study TRT|0
992891|NCT01358721|2004787|FG002|Overall Study|SUBJ request to discontinue study TRT|0
992892|NCT01358721|2004788|FG003|Overall Study|SUBJ request to discontinue study TRT|1
992893|NCT01358721|2004785|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
992894|NCT01358721|2004786|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
992895|NCT01358721|2004787|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
992896|NCT01358721|2004788|FG003|Overall Study|Subject No Longer Meets Study Criteria|1
992897|NCT01358721|2004785|FG000|Overall Study|Adverse Event related to study drug|1
992898|NCT01358721|2004786|FG001|Overall Study|Adverse Event related to study drug|0
992899|NCT01358721|2004787|FG002|Overall Study|Adverse Event related to study drug|0
992900|NCT01358721|2004788|FG003|Overall Study|Adverse Event related to study drug|1
992901|NCT01358721|2004785|FG000|Overall Study|Disease Progression|19
992902|NCT01358721|2004786|FG001|Overall Study|Disease Progression|15
992903|NCT01358721|2004787|FG002|Overall Study|Disease Progression|17
992904|NCT01358721|2004788|FG003|Overall Study|Disease Progression|15
992905|NCT01358721|2004785|FG000|Overall Study|Out of State/Unmet Criteria|0
992906|NCT01358721|2004786|FG001|Overall Study|Out of State/Unmet Criteria|0
992907|NCT01358721|2004787|FG002|Overall Study|Out of State/Unmet Criteria|1
992908|NCT01358721|2004788|FG003|Overall Study|Out of State/Unmet Criteria|0
992909|NCT01358734|2004801|FG000|Overall Study|Adverse Event|4
992910|NCT01358734|2004802|FG001|Overall Study|Adverse Event|7
992911|NCT01358734|2004803|FG002|Overall Study|Adverse Event|3
992912|NCT01358734|2004801|FG000|Overall Study|Lack of Efficacy|0
992913|NCT01358734|2004802|FG001|Overall Study|Lack of Efficacy|1
992914|NCT01358734|2004803|FG002|Overall Study|Lack of Efficacy|3
992915|NCT01358734|2004801|FG000|Overall Study|Withdrawal by Subject|1
992916|NCT01358734|2004802|FG001|Overall Study|Withdrawal by Subject|6
992917|NCT01358734|2004803|FG002|Overall Study|Withdrawal by Subject|3
992918|NCT01358734|2004801|FG000|Overall Study|Death|3
992919|NCT01358734|2004802|FG001|Overall Study|Death|7
992920|NCT01358734|2004803|FG002|Overall Study|Death|2
992921|NCT01358734|2004801|FG000|Overall Study|Progressive Disease|5
992922|NCT01358734|2004802|FG001|Overall Study|Progressive Disease|13
992923|NCT01358734|2004803|FG002|Overall Study|Progressive Disease|16
992924|NCT01358734|2004801|FG000|Overall Study|Non-compliance with study drug|0
992925|NCT01358734|2004802|FG001|Overall Study|Non-compliance with study drug|0
992926|NCT01358734|2004803|FG002|Overall Study|Non-compliance with study drug|1
992927|NCT01358734|2004801|FG000|Overall Study|Other|2
992928|NCT01358734|2004802|FG001|Overall Study|Other|5
992929|NCT01358734|2004803|FG002|Overall Study|Other|4
992930|NCT01358734|2004801|FG000|Overall Study|Protocol Violation|0
992931|NCT01358734|2004802|FG001|Overall Study|Protocol Violation|0
992932|NCT01358734|2004803|FG002|Overall Study|Protocol Violation|2
992933|NCT01358760|2004814|FG000|Overall Study|Adverse Event|3
992934|NCT01358760|2004815|FG001|Overall Study|Adverse Event|4
992935|NCT01358760|2004816|FG002|Overall Study|Adverse Event|3
992936|NCT01358760|2004814|FG000|Overall Study|Lost to Follow-up|1
992937|NCT01358760|2004815|FG001|Overall Study|Lost to Follow-up|1
992938|NCT01358760|2004816|FG002|Overall Study|Lost to Follow-up|3
992939|NCT01358760|2004814|FG000|Overall Study|Withdrawal by Subject|5
992940|NCT01358760|2004815|FG001|Overall Study|Withdrawal by Subject|3
992941|NCT01358760|2004816|FG002|Overall Study|Withdrawal by Subject|2
992942|NCT01358760|2004814|FG000|Overall Study|Physician Decision|1
992943|NCT01358760|2004815|FG001|Overall Study|Physician Decision|0
992944|NCT01358760|2004816|FG002|Overall Study|Physician Decision|1
992945|NCT01358760|2004814|FG000|Overall Study|Entry criteria not met/Non-compliance|12
992946|NCT01358760|2004815|FG001|Overall Study|Entry criteria not met/Non-compliance|12
992947|NCT01358760|2004816|FG002|Overall Study|Entry criteria not met/Non-compliance|16
992948|NCT01358825|2004826|FG000|Overall Study|Blood sample not drawn|0
992949|NCT01358825|2004827|FG001|Overall Study|Blood sample not drawn|1
992950|NCT01358864|2004841|FG000|Overall Study|Adverse Event|0
992951|NCT01358864|2004842|FG001|Overall Study|Adverse Event|6
992952|NCT01358864|2004843|FG002|Overall Study|Adverse Event|9
992953|NCT01358864|2004844|FG003|Overall Study|Adverse Event|0
992954|NCT01358864|2004845|FG004|Overall Study|Adverse Event|4
992955|NCT01358864|2004846|FG005|Overall Study|Adverse Event|8
992956|NCT01358864|2004847|FG006|Overall Study|Adverse Event|12
992957|NCT01358864|2004848|FG007|Overall Study|Adverse Event|7
992958|NCT01358864|2004841|FG000|Overall Study|Lack of Efficacy|26
992959|NCT01358864|2004842|FG001|Overall Study|Lack of Efficacy|3
992960|NCT01358864|2004843|FG002|Overall Study|Lack of Efficacy|4
992961|NCT01358864|2004844|FG003|Overall Study|Lack of Efficacy|19
992962|NCT01358864|2004845|FG004|Overall Study|Lack of Efficacy|7
992963|NCT01358864|2004846|FG005|Overall Study|Lack of Efficacy|4
992964|NCT01358864|2004847|FG006|Overall Study|Lack of Efficacy|49
992965|NCT01358864|2004848|FG007|Overall Study|Lack of Efficacy|44
992966|NCT01358864|2004841|FG000|Overall Study|Lost to Follow-up|0
992967|NCT01358864|2004842|FG001|Overall Study|Lost to Follow-up|0
992968|NCT01358864|2004843|FG002|Overall Study|Lost to Follow-up|1
992969|NCT01358864|2004844|FG003|Overall Study|Lost to Follow-up|0
992970|NCT01358864|2004845|FG004|Overall Study|Lost to Follow-up|0
992971|NCT01358864|2004846|FG005|Overall Study|Lost to Follow-up|0
992972|NCT01358864|2004847|FG006|Overall Study|Lost to Follow-up|0
992973|NCT01358864|2004848|FG007|Overall Study|Lost to Follow-up|1
992974|NCT01358864|2004841|FG000|Overall Study|Withdrawal by Subject|3
992975|NCT01358864|2004842|FG001|Overall Study|Withdrawal by Subject|4
992976|NCT01358864|2004843|FG002|Overall Study|Withdrawal by Subject|2
992977|NCT01358864|2004844|FG003|Overall Study|Withdrawal by Subject|0
992978|NCT01358864|2004845|FG004|Overall Study|Withdrawal by Subject|0
992979|NCT01358864|2004846|FG005|Overall Study|Withdrawal by Subject|1
992980|NCT01358864|2004847|FG006|Overall Study|Withdrawal by Subject|1
992981|NCT01358864|2004848|FG007|Overall Study|Withdrawal by Subject|3
992982|NCT01358864|2004841|FG000|Overall Study|Other reason not defined above|2
992983|NCT01358864|2004842|FG001|Overall Study|Other reason not defined above|0
992984|NCT01358864|2004843|FG002|Overall Study|Other reason not defined above|0
992985|NCT01358864|2004844|FG003|Overall Study|Other reason not defined above|0
992986|NCT01358864|2004845|FG004|Overall Study|Other reason not defined above|0
992987|NCT01358864|2004846|FG005|Overall Study|Other reason not defined above|0
992988|NCT01358864|2004847|FG006|Overall Study|Other reason not defined above|2
992989|NCT01358864|2004848|FG007|Overall Study|Other reason not defined above|0
992990|NCT01358864|2004841|FG000|Overall Study|Not treated|0
992991|NCT01358864|2004842|FG001|Overall Study|Not treated|0
992992|NCT01358864|2004843|FG002|Overall Study|Not treated|0
992993|NCT01358864|2004844|FG003|Overall Study|Not treated|0
992994|NCT01358864|2004845|FG004|Overall Study|Not treated|0
992995|NCT01358864|2004846|FG005|Overall Study|Not treated|0
992996|NCT01358864|2004847|FG006|Overall Study|Not treated|1
992997|NCT01358864|2004848|FG007|Overall Study|Not treated|0
992998|NCT01358877|2004870|FG000|Overall Study|Death|80
992999|NCT01358877|2004871|FG001|Overall Study|Death|89
993000|NCT01358877|2004870|FG000|Overall Study|Ongoing follow-up for post-recurrence|87
993001|NCT01358877|2004871|FG001|Overall Study|Ongoing follow-up for post-recurrence|108
993002|NCT01358877|2004870|FG000|Overall Study|Ongoing follow-up for IDFS event|2084
993003|NCT01358877|2004871|FG001|Overall Study|Ongoing follow-up for IDFS event|2073
993004|NCT01358877|2004870|FG000|Overall Study|Ongoing follow-up for overall survival|7
993005|NCT01358877|2004871|FG001|Overall Study|Ongoing follow-up for overall survival|5
993006|NCT01358877|2004870|FG000|Overall Study|Other|142
993007|NCT01358877|2004871|FG001|Overall Study|Other|129
993008|NCT01358968|2004877|FG000|Period 2|Adverse Event|0
993009|NCT01358968|2004878|FG001|Period 2|Adverse Event|1
993010|NCT01358968|2004879|FG002|Period 2|Adverse Event|0
993011|NCT01358968|2004880|FG003|Period 2|Adverse Event|0
993012|NCT01358968|2004877|FG000|Continued Access Phase|Progression of Disease|0
993013|NCT01358968|2004878|FG001|Continued Access Phase|Progression of Disease|0
993014|NCT01358968|2004879|FG002|Continued Access Phase|Progression of Disease|8
993015|NCT01358968|2004880|FG003|Continued Access Phase|Progression of Disease|4
993016|NCT01358968|2004877|FG000|Continued Access Phase|Protocol Violation|0
993017|NCT01358968|2004878|FG001|Continued Access Phase|Protocol Violation|0
993018|NCT01358968|2004879|FG002|Continued Access Phase|Protocol Violation|0
993019|NCT01358968|2004880|FG003|Continued Access Phase|Protocol Violation|2
993020|NCT01358968|2004877|FG000|Continued Access Phase|Withdrawal by Subject|0
993021|NCT01358968|2004878|FG001|Continued Access Phase|Withdrawal by Subject|0
993022|NCT01358968|2004879|FG002|Continued Access Phase|Withdrawal by Subject|3
993023|NCT01358968|2004880|FG003|Continued Access Phase|Withdrawal by Subject|0
993024|NCT01358968|2004877|FG000|Continued Access Phase|Death|0
993025|NCT01358968|2004878|FG001|Continued Access Phase|Death|0
993026|NCT01358968|2004879|FG002|Continued Access Phase|Death|1
993027|NCT01358968|2004880|FG003|Continued Access Phase|Death|1
993028|NCT01358981|2004897|FG000|Period 1|Withdrawal by Subject|0
993029|NCT01358981|2004898|FG001|Period 1|Withdrawal by Subject|0
993030|NCT01358981|2004899|FG002|Period 1|Withdrawal by Subject|0
993031|NCT01358981|2004900|FG003|Period 1|Withdrawal by Subject|1
993032|NCT01358981|2004901|FG004|Period 1|Withdrawal by Subject|0
993033|NCT01358981|2004902|FG005|Period 1|Withdrawal by Subject|0
993034|NCT01358981|2004903|FG006|Period 1|Withdrawal by Subject|0
993035|NCT01359046|2004935|FG000|Overall Study|Did not receive allocated intervention|6
993036|NCT01359046|2004936|FG001|Overall Study|Did not receive allocated intervention|6
993037|NCT01359046|2004935|FG000|Overall Study|Physician Decision|1
993038|NCT01359046|2004936|FG001|Overall Study|Physician Decision|11
993039|NCT01359150|2004950|FG000|Overall Study|Lack of Efficacy|1
993040|NCT01359150|2004951|FG001|Overall Study|Lack of Efficacy|1
993041|NCT01359150|2004950|FG000|Overall Study|Withdrawal by Subject|1
993042|NCT01359150|2004951|FG001|Overall Study|Withdrawal by Subject|1
993043|NCT01359150|2004950|FG000|Overall Study|Adverse Event|4
993044|NCT01359150|2004951|FG001|Overall Study|Adverse Event|3
993045|NCT01359150|2004950|FG000|Overall Study|Other|1
993046|NCT01359150|2004951|FG001|Overall Study|Other|0
993047|NCT01359449|2004977|FG000|Overall Study|Lost to Follow-up|1
993048|NCT01359449|2004978|FG001|Overall Study|Lost to Follow-up|0
993049|NCT01359449|2004977|FG000|Overall Study|Protocol Violation|0
993050|NCT01359449|2004978|FG001|Overall Study|Protocol Violation|2
993051|NCT01359449|2004977|FG000|Overall Study|Withdrawal by Subject|3
993052|NCT01359449|2004978|FG001|Overall Study|Withdrawal by Subject|2
993053|NCT01359592|2004984|FG000|Initial Registration|Adverse Event|1
993054|NCT01359592|2004985|FG001|Initial Registration|Adverse Event|0
993055|NCT01359592|2004986|FG002|Initial Registration|Adverse Event|0
993056|NCT01359592|2004987|FG003|Initial Registration|Adverse Event|0
993057|NCT01359592|2004984|FG000|Initial Registration|Death|1
993058|NCT01359592|2004985|FG001|Initial Registration|Death|0
993059|NCT01359592|2004986|FG002|Initial Registration|Death|0
993060|NCT01359592|2004987|FG003|Initial Registration|Death|0
993061|NCT01359592|2004984|FG000|Initial Registration|Other reason not protocol specified|1
993062|NCT01359592|2004985|FG001|Initial Registration|Other reason not protocol specified|0
993063|NCT01359592|2004986|FG002|Initial Registration|Other reason not protocol specified|0
993064|NCT01359592|2004987|FG003|Initial Registration|Other reason not protocol specified|0
993065|NCT01359592|2004984|FG000|Initial Registration|Ineligible|26
993066|NCT01359592|2004985|FG001|Initial Registration|Ineligible|0
993067|NCT01359592|2004986|FG002|Initial Registration|Ineligible|0
993068|NCT01359592|2004987|FG003|Initial Registration|Ineligible|0
993069|NCT01359592|2004984|FG000|PET-Directed Therapy|Adverse Event|0
993070|NCT01359592|2004985|FG001|PET-Directed Therapy|Adverse Event|0
993071|NCT01359592|2004986|FG002|PET-Directed Therapy|Adverse Event|1
993072|NCT01359592|2004987|FG003|PET-Directed Therapy|Adverse Event|0
993073|NCT01359592|2004984|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0
993074|NCT01359592|2004985|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0
993075|NCT01359592|2004986|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1
993076|NCT01359592|2004987|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0
993077|NCT01359592|2004984|FG000|PET-Directed Therapy|Ineligible|0
993078|NCT01359592|2004985|FG001|PET-Directed Therapy|Ineligible|0
993079|NCT01359592|2004986|FG002|PET-Directed Therapy|Ineligible|24
993080|NCT01359592|2004987|FG003|PET-Directed Therapy|Ineligible|0
993081|NCT01359644|2005012|FG000|Treatment Period|Lack of Efficacy|0
993082|NCT01359644|2005013|FG001|Treatment Period|Lack of Efficacy|1
993083|NCT01359644|2005014|FG002|Treatment Period|Lack of Efficacy|0
993084|NCT01359644|2005015|FG003|Treatment Period|Lack of Efficacy|0
993085|NCT01359644|2005016|FG004|Treatment Period|Lack of Efficacy|0
993086|NCT01359644|2005017|FG005|Treatment Period|Lack of Efficacy|0
993087|NCT01359644|2005018|FG006|Treatment Period|Lack of Efficacy|0
993088|NCT01359644|2005019|FG007|Treatment Period|Lack of Efficacy|0
993089|NCT01359644|2005020|FG008|Treatment Period|Lack of Efficacy|0
993090|NCT01359644|2005021|FG009|Treatment Period|Lack of Efficacy|0
993091|NCT01359644|2005012|FG000|Treatment Period|Adverse Event|0
993092|NCT01359644|2005013|FG001|Treatment Period|Adverse Event|0
993093|NCT01359644|2005014|FG002|Treatment Period|Adverse Event|1
993094|NCT01359644|2005015|FG003|Treatment Period|Adverse Event|0
993095|NCT01359644|2005016|FG004|Treatment Period|Adverse Event|0
993096|NCT01359644|2005017|FG005|Treatment Period|Adverse Event|1
993097|NCT01359644|2005018|FG006|Treatment Period|Adverse Event|0
993098|NCT01359644|2005019|FG007|Treatment Period|Adverse Event|0
993099|NCT01359644|2005020|FG008|Treatment Period|Adverse Event|0
993100|NCT01359644|2005021|FG009|Treatment Period|Adverse Event|0
993101|NCT01359644|2005012|FG000|Treatment Period|Lost to Follow-up|0
993102|NCT01359644|2005013|FG001|Treatment Period|Lost to Follow-up|0
993103|NCT01359644|2005014|FG002|Treatment Period|Lost to Follow-up|0
993104|NCT01359644|2005015|FG003|Treatment Period|Lost to Follow-up|0
993105|NCT01359644|2005016|FG004|Treatment Period|Lost to Follow-up|0
993106|NCT01359644|2005017|FG005|Treatment Period|Lost to Follow-up|1
993107|NCT01359644|2005018|FG006|Treatment Period|Lost to Follow-up|0
993108|NCT01359644|2005019|FG007|Treatment Period|Lost to Follow-up|0
993109|NCT01359644|2005020|FG008|Treatment Period|Lost to Follow-up|0
993110|NCT01359644|2005021|FG009|Treatment Period|Lost to Follow-up|0
993111|NCT01359644|2005012|FG000|Follow-up Period|Withdrawal by Subject|0
993112|NCT01359644|2005013|FG001|Follow-up Period|Withdrawal by Subject|0
993113|NCT01359644|2005014|FG002|Follow-up Period|Withdrawal by Subject|0
993114|NCT01359644|2005015|FG003|Follow-up Period|Withdrawal by Subject|0
993115|NCT01359644|2005016|FG004|Follow-up Period|Withdrawal by Subject|0
993116|NCT01359644|2005017|FG005|Follow-up Period|Withdrawal by Subject|1
993117|NCT01359644|2005018|FG006|Follow-up Period|Withdrawal by Subject|0
993118|NCT01359644|2005019|FG007|Follow-up Period|Withdrawal by Subject|0
993119|NCT01359644|2005020|FG008|Follow-up Period|Withdrawal by Subject|0
993120|NCT01359644|2005021|FG009|Follow-up Period|Withdrawal by Subject|0
993121|NCT01359644|2005012|FG000|Follow-up Period|Lost to Follow-up|0
993122|NCT01359644|2005013|FG001|Follow-up Period|Lost to Follow-up|0
993123|NCT01359644|2005014|FG002|Follow-up Period|Lost to Follow-up|0
993124|NCT01359644|2005015|FG003|Follow-up Period|Lost to Follow-up|0
993125|NCT01359644|2005016|FG004|Follow-up Period|Lost to Follow-up|0
993126|NCT01359644|2005017|FG005|Follow-up Period|Lost to Follow-up|0
993127|NCT01359644|2005018|FG006|Follow-up Period|Lost to Follow-up|1
993128|NCT01359644|2005019|FG007|Follow-up Period|Lost to Follow-up|2
993129|NCT01359644|2005020|FG008|Follow-up Period|Lost to Follow-up|0
993130|NCT01359644|2005021|FG009|Follow-up Period|Lost to Follow-up|0
993131|NCT01359904|2005080|FG000|Overall Study|Withdrawal by Subject|1
993132|NCT01359904|2005081|FG001|Overall Study|Withdrawal by Subject|0
993133|NCT01359943|2005090|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
993134|NCT01359943|2005091|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
993135|NCT01359943|2005092|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
993136|NCT01359943|2005090|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1
993137|NCT01359943|2005091|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2
993138|NCT01359943|2005092|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0
993139|NCT01359943|2005090|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
993140|NCT01359943|2005091|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
993141|NCT01359943|2005092|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
993142|NCT01359943|2005090|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
993143|NCT01359943|2005091|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
993144|NCT01359943|2005092|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
993145|NCT01359943|2005090|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
993146|NCT01359943|2005091|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
993147|NCT01359943|2005092|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
993148|NCT01359943|2005090|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
993149|NCT01359943|2005091|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
993150|NCT01359943|2005092|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
993151|NCT01359943|2005090|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
993152|NCT01359943|2005091|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
993153|NCT01359943|2005092|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
993154|NCT01359943|2005090|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
993155|NCT01359943|2005091|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
993156|NCT01359943|2005092|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
993157|NCT01359943|2005090|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
993158|NCT01359943|2005091|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
993159|NCT01359943|2005092|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
993160|NCT01359943|2005090|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
993161|NCT01359943|2005091|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
993162|NCT01359943|2005092|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
993163|NCT01359943|2005090|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1
993164|NCT01359943|2005091|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0
993165|NCT01359943|2005092|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0
993166|NCT01359943|2005090|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0
993167|NCT01359943|2005091|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1
993168|NCT01359943|2005092|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0
993169|NCT01359943|2005090|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
993170|NCT01359943|2005091|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
993171|NCT01359943|2005092|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
993172|NCT01359943|2005090|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
993173|NCT01359943|2005091|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
993174|NCT01359943|2005092|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
993175|NCT01359943|2005090|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3
993176|NCT01359943|2005091|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5
993177|NCT01359943|2005092|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1
993178|NCT01359956|2005106|FG000|Overall Study|Death|61
993179|NCT01359956|2005107|FG001|Overall Study|Death|64
993180|NCT01359956|2005108|FG002|Overall Study|Death|67
993181|NCT01359956|2005109|FG003|Overall Study|Death|58
993182|NCT01360021|2005122|FG000|Overall Study|Eligibility criteria + other|2
993183|NCT01360021|2005123|FG001|Overall Study|Eligibility criteria + other|1
993184|NCT01360021|2005124|FG002|Overall Study|Eligibility criteria + other|1
993185|NCT01360021|2005122|FG000|Overall Study|Protocol Violation|0
993186|NCT01360021|2005123|FG001|Overall Study|Protocol Violation|0
993187|NCT01360021|2005124|FG002|Overall Study|Protocol Violation|1
993188|NCT01360021|2005122|FG000|Overall Study|Withdrawal by Subject|4
993189|NCT01360021|2005123|FG001|Overall Study|Withdrawal by Subject|0
993190|NCT01360021|2005124|FG002|Overall Study|Withdrawal by Subject|2
993191|NCT01360021|2005122|FG000|Overall Study|Adverse Event|2
993192|NCT01360021|2005123|FG001|Overall Study|Adverse Event|3
993193|NCT01360021|2005124|FG002|Overall Study|Adverse Event|3
993194|NCT01360398|2005141|FG000|Overall Study|Withdrawal by Subject|14
993195|NCT01360398|2005141|FG000|Overall Study|Other|7
993196|NCT01360398|2005141|FG000|Overall Study|Migrated/moved from study area|1
993197|NCT01360554|2005157|FG000|Overall Study|Death|359
993198|NCT01360554|2005158|FG001|Overall Study|Death|371
993199|NCT01360554|2005157|FG000|Overall Study|Lost to Follow-up|4
993200|NCT01360554|2005158|FG001|Overall Study|Lost to Follow-up|4
993201|NCT01360554|2005157|FG000|Overall Study|Withdrawal by Subject|23
993202|NCT01360554|2005158|FG001|Overall Study|Withdrawal by Subject|24
993203|NCT01360554|2005157|FG000|Overall Study|Study terminated by sponsor|49
993204|NCT01360554|2005158|FG001|Overall Study|Study terminated by sponsor|37
993205|NCT01360554|2005157|FG000|Overall Study|Other, not specified|1
993206|NCT01360554|2005158|FG001|Overall Study|Other, not specified|0
993207|NCT01360554|2005157|FG000|Overall Study|Randomized but not treated.|3
993208|NCT01360554|2005158|FG001|Overall Study|Randomized but not treated.|3
993209|NCT01360632|2005167|FG000|Phase A (8 Weeks)|Lost to Follow-up|27
993210|NCT01360632|2005168|FG001|Phase A (8 Weeks)|Lost to Follow-up|0
993211|NCT01360632|2005169|FG002|Phase A (8 Weeks)|Lost to Follow-up|0
993212|NCT01360632|2005170|FG003|Phase A (8 Weeks)|Lost to Follow-up|0
993213|NCT01360632|2005171|FG004|Phase A (8 Weeks)|Lost to Follow-up|0
993214|NCT01360632|2005167|FG000|Phase A (8 Weeks)|Adverse Event|60
993215|NCT01360632|2005168|FG001|Phase A (8 Weeks)|Adverse Event|0
993216|NCT01360632|2005169|FG002|Phase A (8 Weeks)|Adverse Event|0
993217|NCT01360632|2005170|FG003|Phase A (8 Weeks)|Adverse Event|0
993218|NCT01360632|2005171|FG004|Phase A (8 Weeks)|Adverse Event|0
993219|NCT01360632|2005167|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45
993220|NCT01360632|2005168|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0
993221|NCT01360632|2005169|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0
993222|NCT01360632|2005170|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0
993223|NCT01360632|2005171|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0
993224|NCT01360632|2005167|FG000|Phase A (8 Weeks)|Physician Decision|10
993225|NCT01360632|2005168|FG001|Phase A (8 Weeks)|Physician Decision|0
993226|NCT01360632|2005169|FG002|Phase A (8 Weeks)|Physician Decision|0
993227|NCT01360632|2005170|FG003|Phase A (8 Weeks)|Physician Decision|0
993228|NCT01360632|2005171|FG004|Phase A (8 Weeks)|Physician Decision|0
993229|NCT01360632|2005167|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74
993230|NCT01360632|2005168|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0
993231|NCT01360632|2005169|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0
993232|NCT01360632|2005170|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0
993233|NCT01360632|2005171|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0
993234|NCT01360632|2005167|FG000|Phase A (8 Weeks)|Protocol Deviation|39
993235|NCT01360632|2005168|FG001|Phase A (8 Weeks)|Protocol Deviation|0
993236|NCT01360632|2005169|FG002|Phase A (8 Weeks)|Protocol Deviation|0
993237|NCT01360632|2005170|FG003|Phase A (8 Weeks)|Protocol Deviation|0
993238|NCT01360632|2005171|FG004|Phase A (8 Weeks)|Protocol Deviation|0
993239|NCT01360632|2005167|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
993240|NCT01360632|2005168|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
993241|NCT01360632|2005169|FG002|Phase B (6 Weeks)|Lost to Follow-up|1
993242|NCT01360632|2005170|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
993243|NCT01360632|2005171|FG004|Phase B (6 Weeks)|Lost to Follow-up|0
993244|NCT01360632|2005167|FG000|Phase B (6 Weeks)|Adverse Event|0
993245|NCT01360632|2005168|FG001|Phase B (6 Weeks)|Adverse Event|3
993246|NCT01360632|2005169|FG002|Phase B (6 Weeks)|Adverse Event|9
993247|NCT01360632|2005170|FG003|Phase B (6 Weeks)|Adverse Event|3
993248|NCT01360632|2005171|FG004|Phase B (6 Weeks)|Adverse Event|0
993249|NCT01360632|2005167|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
993250|NCT01360632|2005168|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0
993251|NCT01360632|2005169|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
993252|NCT01360632|2005170|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1
993253|NCT01360632|2005171|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0
993254|NCT01360632|2005167|FG000|Phase B (6 Weeks)|Physician Decision|0
993255|NCT01360632|2005168|FG001|Phase B (6 Weeks)|Physician Decision|0
993256|NCT01360632|2005169|FG002|Phase B (6 Weeks)|Physician Decision|0
993257|NCT01360632|2005170|FG003|Phase B (6 Weeks)|Physician Decision|1
993258|NCT01360632|2005171|FG004|Phase B (6 Weeks)|Physician Decision|0
993259|NCT01360632|2005167|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
993260|NCT01360632|2005168|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4
993261|NCT01360632|2005169|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4
993262|NCT01360632|2005170|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7
993263|NCT01360632|2005171|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0
993264|NCT01360632|2005167|FG000|Phase B (6 Weeks)|Protocol Deviation|0
993265|NCT01360632|2005168|FG001|Phase B (6 Weeks)|Protocol Deviation|1
993266|NCT01360632|2005169|FG002|Phase B (6 Weeks)|Protocol Deviation|4
993267|NCT01360632|2005170|FG003|Phase B (6 Weeks)|Protocol Deviation|1
993268|NCT01360632|2005171|FG004|Phase B (6 Weeks)|Protocol Deviation|0
993269|NCT01360632|2005167|FG000|Phase B (6 Weeks)|Lack of Efficacy|0
993270|NCT01360632|2005168|FG001|Phase B (6 Weeks)|Lack of Efficacy|1
993271|NCT01360632|2005169|FG002|Phase B (6 Weeks)|Lack of Efficacy|0
993272|NCT01360632|2005170|FG003|Phase B (6 Weeks)|Lack of Efficacy|0
993273|NCT01360632|2005171|FG004|Phase B (6 Weeks)|Lack of Efficacy|0
993274|NCT01360632|2005167|FG000|Phase A+|Lost to Follow-up|0
993275|NCT01360632|2005168|FG001|Phase A+|Lost to Follow-up|0
993276|NCT01360632|2005169|FG002|Phase A+|Lost to Follow-up|0
993277|NCT01360632|2005170|FG003|Phase A+|Lost to Follow-up|0
993278|NCT01360632|2005171|FG004|Phase A+|Lost to Follow-up|2
993279|NCT01360632|2005167|FG000|Phase A+|Adverse Event|0
993280|NCT01360632|2005168|FG001|Phase A+|Adverse Event|0
993281|NCT01360632|2005169|FG002|Phase A+|Adverse Event|0
993282|NCT01360632|2005170|FG003|Phase A+|Adverse Event|0
993283|NCT01360632|2005171|FG004|Phase A+|Adverse Event|2
993284|NCT01360632|2005167|FG000|Phase A+|Met Withdrawal Criteria|0
993285|NCT01360632|2005168|FG001|Phase A+|Met Withdrawal Criteria|0
993286|NCT01360632|2005169|FG002|Phase A+|Met Withdrawal Criteria|0
993287|NCT01360632|2005170|FG003|Phase A+|Met Withdrawal Criteria|0
993288|NCT01360632|2005171|FG004|Phase A+|Met Withdrawal Criteria|7
993289|NCT01360632|2005167|FG000|Phase A+|Physician Decision|0
993290|NCT01360632|2005168|FG001|Phase A+|Physician Decision|0
993291|NCT01360632|2005169|FG002|Phase A+|Physician Decision|0
993292|NCT01360632|2005170|FG003|Phase A+|Physician Decision|0
993293|NCT01360632|2005171|FG004|Phase A+|Physician Decision|3
993294|NCT01360632|2005167|FG000|Phase A+|Withdrawal by Subject|0
993295|NCT01360632|2005168|FG001|Phase A+|Withdrawal by Subject|0
993296|NCT01360632|2005169|FG002|Phase A+|Withdrawal by Subject|0
993297|NCT01360632|2005170|FG003|Phase A+|Withdrawal by Subject|0
993298|NCT01360632|2005171|FG004|Phase A+|Withdrawal by Subject|8
993299|NCT01360632|2005167|FG000|Phase A+|Protocol Deviation|0
993300|NCT01360632|2005168|FG001|Phase A+|Protocol Deviation|0
993301|NCT01360632|2005169|FG002|Phase A+|Protocol Deviation|0
993302|NCT01360632|2005170|FG003|Phase A+|Protocol Deviation|0
993303|NCT01360632|2005171|FG004|Phase A+|Protocol Deviation|3
993304|NCT01360645|2005181|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
993305|NCT01360645|2005182|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
993306|NCT01360645|2005183|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
993307|NCT01360645|2005184|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
993308|NCT01360645|2005181|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
993309|NCT01360645|2005182|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
993310|NCT01360645|2005183|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
993311|NCT01360645|2005184|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
993312|NCT01360645|2005181|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
993313|NCT01360645|2005182|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
993314|NCT01360645|2005183|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
993315|NCT01360645|2005184|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
993316|NCT01360645|2005181|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
993317|NCT01360645|2005182|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
993318|NCT01360645|2005183|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
993319|NCT01360645|2005184|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
993320|NCT01360645|2005181|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
993321|NCT01360645|2005182|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
993322|NCT01360645|2005183|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
993323|NCT01360645|2005184|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
993324|NCT01360645|2005181|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
993325|NCT01360645|2005182|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
993326|NCT01360645|2005183|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
993327|NCT01360645|2005184|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
993328|NCT01360645|2005181|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
993329|NCT01360645|2005182|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
993330|NCT01360645|2005183|FG002|Phase B (6 Weeks)|Lost to Follow-up|0
993331|NCT01360645|2005184|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
993332|NCT01360645|2005181|FG000|Phase B (6 Weeks)|Adverse Event|0
993333|NCT01360645|2005182|FG001|Phase B (6 Weeks)|Adverse Event|6
993334|NCT01360645|2005183|FG002|Phase B (6 Weeks)|Adverse Event|0
993335|NCT01360645|2005184|FG003|Phase B (6 Weeks)|Adverse Event|0
993336|NCT01360645|2005181|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
993337|NCT01360645|2005182|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3
993338|NCT01360645|2005183|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
993339|NCT01360645|2005184|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0
993340|NCT01360645|2005181|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
993341|NCT01360645|2005182|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3
993342|NCT01360645|2005183|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8
993343|NCT01360645|2005184|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0
993344|NCT01360645|2005181|FG000|Phase B (6 Weeks)|Protocol Deviation|0
993345|NCT01360645|2005182|FG001|Phase B (6 Weeks)|Protocol Deviation|1
993346|NCT01360645|2005183|FG002|Phase B (6 Weeks)|Protocol Deviation|3
993347|NCT01360645|2005184|FG003|Phase B (6 Weeks)|Protocol Deviation|0
993348|NCT01360645|2005181|FG000|Phase A+|Lost to Follow-up|0
993349|NCT01360645|2005182|FG001|Phase A+|Lost to Follow-up|0
993350|NCT01360645|2005183|FG002|Phase A+|Lost to Follow-up|0
993351|NCT01360645|2005184|FG003|Phase A+|Lost to Follow-up|7
993352|NCT01360645|2005181|FG000|Phase A+|Adverse Event|0
993353|NCT01360645|2005182|FG001|Phase A+|Adverse Event|0
993354|NCT01360645|2005183|FG002|Phase A+|Adverse Event|0
993355|NCT01360645|2005184|FG003|Phase A+|Adverse Event|2
993356|NCT01360645|2005181|FG000|Phase A+|Met Withdrawal Criteria|0
993357|NCT01360645|2005182|FG001|Phase A+|Met Withdrawal Criteria|0
993358|NCT01360645|2005183|FG002|Phase A+|Met Withdrawal Criteria|0
993359|NCT01360645|2005184|FG003|Phase A+|Met Withdrawal Criteria|4
993360|NCT01360645|2005181|FG000|Phase A+|Physician Decision|0
993361|NCT01360645|2005182|FG001|Phase A+|Physician Decision|0
993362|NCT01360645|2005183|FG002|Phase A+|Physician Decision|0
993363|NCT01360645|2005184|FG003|Phase A+|Physician Decision|2
993364|NCT01360645|2005181|FG000|Phase A+|Withdrawal by Subject|0
993365|NCT01360645|2005182|FG001|Phase A+|Withdrawal by Subject|0
993366|NCT01360645|2005183|FG002|Phase A+|Withdrawal by Subject|0
993367|NCT01360645|2005184|FG003|Phase A+|Withdrawal by Subject|5
993368|NCT01360645|2005181|FG000|Phase A+|Protocol Deviation|0
993369|NCT01360645|2005182|FG001|Phase A+|Protocol Deviation|0
993370|NCT01360645|2005183|FG002|Phase A+|Protocol Deviation|0
993371|NCT01360645|2005184|FG003|Phase A+|Protocol Deviation|4
993372|NCT01360762|2005190|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7
993373|NCT01360762|2005190|FG000|Main Study Period (12-month Treatment)|Death|5
993374|NCT01360762|2005190|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
993375|NCT01360762|2005190|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15
993376|NCT01360762|2005190|FG000|Main Study Period (12-month Treatment)|Discontinuation|1
993377|NCT01360762|2005190|FG000|Whole Study Period|Lost to Follow-up|10
993378|NCT01360762|2005190|FG000|Whole Study Period|Death|7
993379|NCT01360762|2005190|FG000|Whole Study Period|Patient relapsed|18
993380|NCT01360762|2005190|FG000|Whole Study Period|Discontinuation of study drug for safety|1
993381|NCT01360840|2005197|FG000|Overall Study|Ongoing at data cut-off|10
993382|NCT01360840|2005198|FG001|Overall Study|Ongoing at data cut-off|10
993383|NCT01360840|2005199|FG002|Overall Study|Ongoing at data cut-off|9
993384|NCT01360866|2005213|FG000|Overall Study|Lost to Follow-up|11
993385|NCT01360866|2005214|FG001|Overall Study|Lost to Follow-up|28
993386|NCT01360866|2005215|FG002|Overall Study|Lost to Follow-up|41
993387|NCT01360866|2005216|FG003|Overall Study|Lost to Follow-up|0
993388|NCT01360866|2005213|FG000|Overall Study|Adverse Event|56
993389|NCT01360866|2005214|FG001|Overall Study|Adverse Event|61
993390|NCT01360866|2005215|FG002|Overall Study|Adverse Event|134
993391|NCT01360866|2005216|FG003|Overall Study|Adverse Event|6
993392|NCT01360866|2005213|FG000|Overall Study|Paticipant met withdrawal criteria|11
993393|NCT01360866|2005214|FG001|Overall Study|Paticipant met withdrawal criteria|28
993394|NCT01360866|2005215|FG002|Overall Study|Paticipant met withdrawal criteria|54
993395|NCT01360866|2005216|FG003|Overall Study|Paticipant met withdrawal criteria|0
993396|NCT01360866|2005213|FG000|Overall Study|Withdrawn by Investigator|9
993397|NCT01360866|2005214|FG001|Overall Study|Withdrawn by Investigator|8
993398|NCT01360866|2005215|FG002|Overall Study|Withdrawn by Investigator|31
993399|NCT01360866|2005216|FG003|Overall Study|Withdrawn by Investigator|2
993400|NCT01360866|2005213|FG000|Overall Study|Withdrawal by participant|79
993401|NCT01360866|2005214|FG001|Overall Study|Withdrawal by participant|89
993402|NCT01360866|2005215|FG002|Overall Study|Withdrawal by participant|168
993403|NCT01360866|2005216|FG003|Overall Study|Withdrawal by participant|8
993404|NCT01360866|2005213|FG000|Overall Study|Protocol Deviation|25
993405|NCT01360866|2005214|FG001|Overall Study|Protocol Deviation|33
993406|NCT01360866|2005215|FG002|Overall Study|Protocol Deviation|61
993407|NCT01360866|2005216|FG003|Overall Study|Protocol Deviation|2
993408|NCT01360866|2005213|FG000|Overall Study|Lack of Efficacy|30
993409|NCT01360866|2005214|FG001|Overall Study|Lack of Efficacy|40
993410|NCT01360866|2005215|FG002|Overall Study|Lack of Efficacy|30
993411|NCT01360866|2005216|FG003|Overall Study|Lack of Efficacy|4
993412|NCT01360996|2005229|FG000|Overall Study|Withdrawal by Subject|4
993413|NCT01360996|2005230|FG001|Overall Study|Withdrawal by Subject|3
993414|NCT01360996|2005231|FG002|Overall Study|Withdrawal by Subject|2
993415|NCT01360996|2005229|FG000|Overall Study|Noncompliant|2
993416|NCT01360996|2005230|FG001|Overall Study|Noncompliant|0
993417|NCT01360996|2005231|FG002|Overall Study|Noncompliant|0
993418|NCT01361009|2005238|FG000|Overall Study|Protocol Violation|116
993419|NCT01361126|2005266|FG000|Overall Study|Sponsor decision|0
993420|NCT01361126|2005267|FG001|Overall Study|Sponsor decision|2
993421|NCT01361178|2005276|FG000|Overall Study|Death|13
993422|NCT01361178|2005277|FG001|Overall Study|Death|0
993423|NCT01361308|2005291|FG000|Overall Study|Withdrawal by Subject|9
993424|NCT01361308|2005292|FG001|Overall Study|Withdrawal by Subject|13
993425|NCT01361308|2005291|FG000|Overall Study|Physician Decision|3
993426|NCT01361308|2005292|FG001|Overall Study|Physician Decision|3
993427|NCT01361308|2005291|FG000|Overall Study|Lack of Efficacy|2
993428|NCT01361308|2005292|FG001|Overall Study|Lack of Efficacy|0
993429|NCT01361308|2005291|FG000|Overall Study|Protocol Violation|1
993430|NCT01361308|2005292|FG001|Overall Study|Protocol Violation|0
993431|NCT01361308|2005291|FG000|Overall Study|Lost to Follow-up|5
993432|NCT01361308|2005292|FG001|Overall Study|Lost to Follow-up|4
993433|NCT01361308|2005291|FG000|Overall Study|Adverse Event|8
993434|NCT01361308|2005292|FG001|Overall Study|Adverse Event|4
993435|NCT01361308|2005291|FG000|Overall Study|Eligibility Criteria Not Met|2
993436|NCT01361308|2005292|FG001|Overall Study|Eligibility Criteria Not Met|3
993437|NCT01361308|2005291|FG000|Overall Study|Failed C-SSRS|5
993438|NCT01361308|2005292|FG001|Overall Study|Failed C-SSRS|2
993439|NCT01361308|2005291|FG000|Overall Study|Other|0
993440|NCT01361308|2005292|FG001|Overall Study|Other|1
993441|NCT01361464|2005298|FG000|Overall Study|Death|1
993442|NCT01361464|2005298|FG000|Overall Study|Withdrawal by Subject|2
993443|NCT01361568|2005308|FG000|Overall Study|Adverse Event|0
993444|NCT01361568|2005309|FG001|Overall Study|Adverse Event|0
993445|NCT01361568|2005310|FG002|Overall Study|Adverse Event|0
993446|NCT01361568|2005311|FG003|Overall Study|Adverse Event|0
993447|NCT01361568|2005312|FG004|Overall Study|Adverse Event|1
993448|NCT01361568|2005313|FG005|Overall Study|Adverse Event|0
993449|NCT01361568|2005308|FG000|Overall Study|Physician Decision|0
993450|NCT01361568|2005309|FG001|Overall Study|Physician Decision|0
993451|NCT01361568|2005310|FG002|Overall Study|Physician Decision|0
993452|NCT01361568|2005311|FG003|Overall Study|Physician Decision|0
993453|NCT01361568|2005312|FG004|Overall Study|Physician Decision|0
993454|NCT01361568|2005313|FG005|Overall Study|Physician Decision|1
993455|NCT01361568|2005308|FG000|Overall Study|Withdrawal by Subject|2
993456|NCT01361568|2005309|FG001|Overall Study|Withdrawal by Subject|1
993457|NCT01361568|2005310|FG002|Overall Study|Withdrawal by Subject|0
993458|NCT01361568|2005311|FG003|Overall Study|Withdrawal by Subject|0
993459|NCT01361568|2005312|FG004|Overall Study|Withdrawal by Subject|0
993460|NCT01361568|2005313|FG005|Overall Study|Withdrawal by Subject|1
993461|NCT01361594|2005330|FG000|Overall Study|Withdrawal by Subject|1
993462|NCT01361594|2005331|FG001|Overall Study|Withdrawal by Subject|2
993463|NCT01361607|2005339|FG000|Overall Study|Adverse Event|38
993464|NCT01361607|2005340|FG001|Overall Study|Adverse Event|29
993465|NCT01361607|2005339|FG000|Overall Study|Withdrawal by Subject|19
993466|NCT01361607|2005340|FG001|Overall Study|Withdrawal by Subject|8
993467|NCT01361607|2005339|FG000|Overall Study|Withdrawal by Investigator|5
993468|NCT01361607|2005340|FG001|Overall Study|Withdrawal by Investigator|3
993469|NCT01361607|2005339|FG000|Overall Study|Lost to Follow-up|1
993470|NCT01361607|2005340|FG001|Overall Study|Lost to Follow-up|0
993471|NCT01361607|2005339|FG000|Overall Study|Met Withdrawal Criteria|1
993472|NCT01361607|2005340|FG001|Overall Study|Met Withdrawal Criteria|1
993473|NCT01361711|2005362|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1
993474|NCT01361711|2005362|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1
993475|NCT01361711|2005362|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7
993476|NCT01361711|2005362|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2
993477|NCT01361711|2005362|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1
993478|NCT01361711|2005362|FG000|Completed Week 18 of Treatment|Complete Remission|2
993479|NCT01361711|2005362|FG000|Completed Week 18 of Treatment|Other|9
993480|NCT01361711|2005362|FG000|10 Year Follow-up|Still in follow-up|22
993481|NCT01361711|2005362|FG000|10 Year Follow-up|Death|7
993482|NCT01361711|2005362|FG000|10 Year Follow-up|Developed new cancer|1
993483|NCT01361711|2005362|FG000|10 Year Follow-up|Lost to Follow-up|2
993484|NCT01361711|2005362|FG000|10 Year Follow-up|New treatment started|6
993485|NCT01361711|2005362|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11
993486|NCT01361711|2005362|FG000|10 Year Follow-up|Progressive Disease|1
993487|NCT01361919|2005380|FG000|Overall Study|technical issues|10
993488|NCT01361919|2005381|FG001|Overall Study|technical issues|12
993489|NCT01361919|2005382|FG002|Overall Study|technical issues|10
993490|NCT01362049|2005394|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3
993491|NCT01362049|2005395|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3
993492|NCT01362049|2005396|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2
993493|NCT01362049|2005397|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1
993494|NCT01362049|2005394|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
993495|NCT01362049|2005395|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
993496|NCT01362049|2005396|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
993497|NCT01362049|2005397|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
993498|NCT01362062|2005413|FG000|Overall Study|Adverse Event|1
993499|NCT01362062|2005414|FG001|Overall Study|Adverse Event|0
993500|NCT01362062|2005413|FG000|Overall Study|Lost to Follow-up|11
993501|NCT01362062|2005414|FG001|Overall Study|Lost to Follow-up|0
993502|NCT01362062|2005413|FG000|Overall Study|Withdrawal by Subject|2
993503|NCT01362062|2005414|FG001|Overall Study|Withdrawal by Subject|0
993504|NCT01362062|2005413|FG000|Overall Study|Non-compliant participant|2
993505|NCT01362062|2005414|FG001|Overall Study|Non-compliant participant|0
993506|NCT01362062|2005413|FG000|Overall Study|Detected with Spondylo-arthritis|1
993507|NCT01362062|2005414|FG001|Overall Study|Detected with Spondylo-arthritis|0
993508|NCT01362062|2005413|FG000|Overall Study|Had significant improvement|9
993509|NCT01362062|2005414|FG001|Overall Study|Had significant improvement|0
993510|NCT01362140|2005430|FG000|Overall Study|Noncompliance|1
993511|NCT01362140|2005431|FG001|Overall Study|Noncompliance|0
993512|NCT01362140|2005430|FG000|Overall Study|Adverse Event|2
993513|NCT01362140|2005431|FG001|Overall Study|Adverse Event|2
993514|NCT01362140|2005430|FG000|Overall Study|Withdrawal by Subject|3
993515|NCT01362140|2005431|FG001|Overall Study|Withdrawal by Subject|3
993516|NCT01362140|2005430|FG000|Overall Study|Administrative Decision|0
993517|NCT01362140|2005431|FG001|Overall Study|Administrative Decision|1
993518|NCT01362140|2005430|FG000|Overall Study|Death|2
993519|NCT01362140|2005431|FG001|Overall Study|Death|1
993520|NCT01362140|2005430|FG000|Overall Study|Other|1
993521|NCT01362140|2005431|FG001|Overall Study|Other|1
993522|NCT01362140|2005430|FG000|Overall Study|Protocol-specified Criteria|1
993523|NCT01362140|2005431|FG001|Overall Study|Protocol-specified Criteria|2
993524|NCT01362140|2005430|FG000|Overall Study|Discontinued Without Receiving Treatment|0
993525|NCT01362140|2005431|FG001|Overall Study|Discontinued Without Receiving Treatment|1
993526|NCT01362244|2005452|FG000|Overall Study|Adverse Event|3
993527|NCT01362244|2005453|FG001|Overall Study|Adverse Event|5
993528|NCT01362244|2005452|FG000|Overall Study|Lack of Efficacy|5
993529|NCT01362244|2005453|FG001|Overall Study|Lack of Efficacy|11
993530|NCT01362244|2005452|FG000|Overall Study|Lost to Follow-up|0
993531|NCT01362244|2005453|FG001|Overall Study|Lost to Follow-up|2
993532|NCT01362244|2005452|FG000|Overall Study|Protocol Violation|5
993533|NCT01362244|2005453|FG001|Overall Study|Protocol Violation|1
993534|NCT01362244|2005452|FG000|Overall Study|Withdrawal by Subject|2
993535|NCT01362244|2005453|FG001|Overall Study|Withdrawal by Subject|1
993536|NCT01362244|2005452|FG000|Overall Study|Did not Meet Continuation Criteria|17
993537|NCT01362244|2005453|FG001|Overall Study|Did not Meet Continuation Criteria|11
993538|NCT01362244|2005452|FG000|Overall Study|Protocol Defined Stopping Criteria|0
993539|NCT01362244|2005453|FG001|Overall Study|Protocol Defined Stopping Criteria|1
993540|NCT01362270|2005461|FG000|Overall Study|Withdrawal by Subject|1
993541|NCT01362270|2005462|FG001|Overall Study|Withdrawal by Subject|0
993542|NCT01362270|2005461|FG000|Overall Study|Met exclusion criteria after 1st session|0
993543|NCT01362270|2005462|FG001|Overall Study|Met exclusion criteria after 1st session|1
993544|NCT01362270|2005461|FG000|Overall Study|Met excl. criteria before 1st session|1
993545|NCT01362270|2005462|FG001|Overall Study|Met excl. criteria before 1st session|1
993546|NCT01362296|2005470|FG000|Randomized Phase (RP)|PD including Death due to PD|56
993547|NCT01362296|2005471|FG001|Randomized Phase (RP)|PD including Death due to PD|28
993548|NCT01362296|2005472|FG002|Randomized Phase (RP)|PD including Death due to PD|0
993549|NCT01362296|2005473|FG003|Randomized Phase (RP)|PD including Death due to PD|0
993550|NCT01362296|2005470|FG000|Randomized Phase (RP)|Physician Decision|1
993551|NCT01362296|2005471|FG001|Randomized Phase (RP)|Physician Decision|9
993552|NCT01362296|2005472|FG002|Randomized Phase (RP)|Physician Decision|0
993553|NCT01362296|2005473|FG003|Randomized Phase (RP)|Physician Decision|0
993554|NCT01362296|2005470|FG000|Randomized Phase (RP)|Withdrawal by Subject|2
993555|NCT01362296|2005471|FG001|Randomized Phase (RP)|Withdrawal by Subject|1
993556|NCT01362296|2005472|FG002|Randomized Phase (RP)|Withdrawal by Subject|0
993557|NCT01362296|2005473|FG003|Randomized Phase (RP)|Withdrawal by Subject|0
993558|NCT01362296|2005470|FG000|Randomized Phase (RP)|Adverse Event|20
993559|NCT01362296|2005471|FG001|Randomized Phase (RP)|Adverse Event|4
993560|NCT01362296|2005472|FG002|Randomized Phase (RP)|Adverse Event|0
993561|NCT01362296|2005473|FG003|Randomized Phase (RP)|Adverse Event|0
993562|NCT01362296|2005470|FG000|Randomized Phase (RP)|Study Closed/Terminated|8
993563|NCT01362296|2005471|FG001|Randomized Phase (RP)|Study Closed/Terminated|1
993564|NCT01362296|2005472|FG002|Randomized Phase (RP)|Study Closed/Terminated|0
993565|NCT01362296|2005473|FG003|Randomized Phase (RP)|Study Closed/Terminated|0
993566|NCT01362296|2005470|FG000|Crossover Phase|PD including Death due to PD|0
993567|NCT01362296|2005471|FG001|Crossover Phase|PD including Death due to PD|0
993568|NCT01362296|2005472|FG002|Crossover Phase|PD including Death due to PD|16
993569|NCT01362296|2005473|FG003|Crossover Phase|PD including Death due to PD|1
993570|NCT01362296|2005470|FG000|Crossover Phase|Withdrawal by Subject|0
993571|NCT01362296|2005471|FG001|Crossover Phase|Withdrawal by Subject|0
993572|NCT01362296|2005472|FG002|Crossover Phase|Withdrawal by Subject|2
993573|NCT01362296|2005473|FG003|Crossover Phase|Withdrawal by Subject|1
993574|NCT01362296|2005470|FG000|Crossover Phase|Adverse Event|0
993575|NCT01362296|2005471|FG001|Crossover Phase|Adverse Event|0
993576|NCT01362296|2005472|FG002|Crossover Phase|Adverse Event|4
993577|NCT01362296|2005473|FG003|Crossover Phase|Adverse Event|0
993578|NCT01362296|2005470|FG000|Crossover Phase|Study Closed/Terminated|0
993579|NCT01362296|2005471|FG001|Crossover Phase|Study Closed/Terminated|0
993580|NCT01362296|2005472|FG002|Crossover Phase|Study Closed/Terminated|1
993581|NCT01362296|2005473|FG003|Crossover Phase|Study Closed/Terminated|0
993582|NCT01362322|2005485|FG000|Overall Study|Withdrawal by Subject|3
993583|NCT01362322|2005486|FG001|Overall Study|Withdrawal by Subject|1
993584|NCT01362322|2005485|FG000|Overall Study|Lost to Follow-up|2
993585|NCT01362322|2005486|FG001|Overall Study|Lost to Follow-up|6
993586|NCT01362348|2005492|FG000|Overall Study|Protocol-defined stopping criteria|9
993587|NCT01362348|2005492|FG000|Overall Study|Study closed/terminated|5
993588|NCT01362439|2005496|FG000|Overall Study|Adverse Event|1
993589|NCT01362439|2005496|FG000|Overall Study|Lack of Efficacy|3
993590|NCT01362439|2005496|FG000|Overall Study|Lost to Follow-up|2
993591|NCT01362439|2005496|FG000|Overall Study|Study medication non-compliant|1
993592|NCT01362439|2005496|FG000|Overall Study|Participant who withdrew consent|8
993593|NCT01362491|2005504|FG000|Overall Study|Ineligible|1
993594|NCT01362491|2005505|FG001|Overall Study|Ineligible|0
993595|NCT01362491|2005506|FG002|Overall Study|Ineligible|0
993596|NCT01362517|2005515|FG000|Overall Study|Protocol Violation|1
993597|NCT01362517|2005515|FG000|Overall Study|Lost to Follow-up|1
993598|NCT01362530|2005524|FG000|Base Study (Cycle 1)|Adverse Event|2
993599|NCT01362530|2005525|FG001|Base Study (Cycle 1)|Adverse Event|0
993600|NCT01362530|2005524|FG000|Base Study (Cycle 1)|Physician Decision|0
993601|NCT01362530|2005525|FG001|Base Study (Cycle 1)|Physician Decision|1
993602|NCT01362530|2005524|FG000|Base Study (Cycle 1)|Protocol Violation|2
993603|NCT01362530|2005525|FG001|Base Study (Cycle 1)|Protocol Violation|0
993604|NCT01362530|2005524|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1
993605|NCT01362530|2005525|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2
993606|NCT01362530|2005524|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2
993607|NCT01362530|2005525|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0
993608|NCT01362530|2005524|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
993609|NCT01362530|2005525|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
993610|NCT01362530|2005524|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
993611|NCT01362530|2005525|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
993612|NCT01362530|2005524|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
993613|NCT01362530|2005525|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
993614|NCT01362530|2005524|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
993615|NCT01362530|2005525|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
993616|NCT01362530|2005524|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
993617|NCT01362530|2005525|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
993618|NCT01362530|2005524|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19
993619|NCT01362530|2005525|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0
993620|NCT01362530|2005524|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4
993621|NCT01362530|2005525|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0
993622|NCT01362530|2005524|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
993623|NCT01362530|2005525|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
993624|NCT01362608|2005534|FG000|Overall Study|Protocol Violation|0
993625|NCT01362608|2005535|FG001|Overall Study|Protocol Violation|1
993626|NCT01362608|2005534|FG000|Overall Study|Lost to Follow-up|3
993627|NCT01362608|2005535|FG001|Overall Study|Lost to Follow-up|1
993628|NCT01362608|2005534|FG000|Overall Study|Withdrawal by Subject|1
993629|NCT01362608|2005535|FG001|Overall Study|Withdrawal by Subject|2
993630|NCT01362608|2005534|FG000|Overall Study|Lack of Efficacy|0
993631|NCT01362608|2005535|FG001|Overall Study|Lack of Efficacy|2
993632|NCT01362608|2005534|FG000|Overall Study|Adverse Event|0
993633|NCT01362608|2005535|FG001|Overall Study|Adverse Event|2
993634|NCT01362790|2005560|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
993635|NCT01362790|2005561|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
993636|NCT01362790|2005562|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
993637|NCT01362790|2005563|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
993638|NCT01362790|2005564|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
993639|NCT01362790|2005565|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
993640|NCT01362790|2005566|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
993641|NCT01362790|2005560|FG000|Pilot Phase & Phase 2|Adverse Event|0
993642|NCT01362790|2005561|FG001|Pilot Phase & Phase 2|Adverse Event|1
993643|NCT01362790|2005562|FG002|Pilot Phase & Phase 2|Adverse Event|0
993644|NCT01362790|2005563|FG003|Pilot Phase & Phase 2|Adverse Event|1
993645|NCT01362790|2005564|FG004|Pilot Phase & Phase 2|Adverse Event|0
993646|NCT01362790|2005565|FG005|Pilot Phase & Phase 2|Adverse Event|2
993647|NCT01362790|2005566|FG006|Pilot Phase & Phase 2|Adverse Event|0
993648|NCT01362790|2005560|FG000|Pilot Phase & Phase 2|Physician Decision|0
993649|NCT01362790|2005561|FG001|Pilot Phase & Phase 2|Physician Decision|0
993650|NCT01362790|2005562|FG002|Pilot Phase & Phase 2|Physician Decision|0
993651|NCT01362790|2005563|FG003|Pilot Phase & Phase 2|Physician Decision|1
993652|NCT01362790|2005564|FG004|Pilot Phase & Phase 2|Physician Decision|0
993653|NCT01362790|2005565|FG005|Pilot Phase & Phase 2|Physician Decision|0
993654|NCT01362790|2005566|FG006|Pilot Phase & Phase 2|Physician Decision|0
993655|NCT01362790|2005560|FG000|Pilot Phase & Phase 2|Developed antibodies|7
993656|NCT01362790|2005561|FG001|Pilot Phase & Phase 2|Developed antibodies|2
993657|NCT01362790|2005562|FG002|Pilot Phase & Phase 2|Developed antibodies|3
993658|NCT01362790|2005563|FG003|Pilot Phase & Phase 2|Developed antibodies|8
993659|NCT01362790|2005564|FG004|Pilot Phase & Phase 2|Developed antibodies|0
993660|NCT01362790|2005565|FG005|Pilot Phase & Phase 2|Developed antibodies|0
993661|NCT01362790|2005566|FG006|Pilot Phase & Phase 2|Developed antibodies|0
993662|NCT01362790|2005560|FG000|Pilot Phase & Phase 2|Refused further treatment|0
993663|NCT01362790|2005561|FG001|Pilot Phase & Phase 2|Refused further treatment|1
993664|NCT01362790|2005562|FG002|Pilot Phase & Phase 2|Refused further treatment|0
993665|NCT01362790|2005563|FG003|Pilot Phase & Phase 2|Refused further treatment|0
993666|NCT01362790|2005564|FG004|Pilot Phase & Phase 2|Refused further treatment|0
993667|NCT01362790|2005565|FG005|Pilot Phase & Phase 2|Refused further treatment|0
993668|NCT01362790|2005566|FG006|Pilot Phase & Phase 2|Refused further treatment|0
993669|NCT01362790|2005560|FG000|Pilot Phase & Phase 2|Progressive disease|1
993670|NCT01362790|2005561|FG001|Pilot Phase & Phase 2|Progressive disease|2
993671|NCT01362790|2005562|FG002|Pilot Phase & Phase 2|Progressive disease|2
993672|NCT01362790|2005563|FG003|Pilot Phase & Phase 2|Progressive disease|3
993673|NCT01362790|2005564|FG004|Pilot Phase & Phase 2|Progressive disease|0
993674|NCT01362790|2005565|FG005|Pilot Phase & Phase 2|Progressive disease|2
993675|NCT01362790|2005566|FG006|Pilot Phase & Phase 2|Progressive disease|0
993676|NCT01362790|2005560|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
993677|NCT01362790|2005561|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
993678|NCT01362790|2005562|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
993679|NCT01362790|2005563|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
993680|NCT01362790|2005564|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
993681|NCT01362790|2005565|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
993682|NCT01362790|2005566|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
993683|NCT01362790|2005560|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
993684|NCT01362790|2005561|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
993685|NCT01362790|2005562|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
993686|NCT01362790|2005563|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
993687|NCT01362790|2005564|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
993688|NCT01362790|2005565|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
993689|NCT01362790|2005566|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
993690|NCT01362790|2005560|FG000|Pilot Phase & Phase 2|Death on study|0
993691|NCT01362790|2005561|FG001|Pilot Phase & Phase 2|Death on study|0
993692|NCT01362790|2005562|FG002|Pilot Phase & Phase 2|Death on study|0
993693|NCT01362790|2005563|FG003|Pilot Phase & Phase 2|Death on study|1
993694|NCT01362790|2005564|FG004|Pilot Phase & Phase 2|Death on study|0
993695|NCT01362790|2005565|FG005|Pilot Phase & Phase 2|Death on study|0
993696|NCT01362790|2005566|FG006|Pilot Phase & Phase 2|Death on study|0
993697|NCT01362790|2005560|FG000|Dose De-escalation of Regimen A|Adverse Event|0
993698|NCT01362790|2005561|FG001|Dose De-escalation of Regimen A|Adverse Event|0
993699|NCT01362790|2005562|FG002|Dose De-escalation of Regimen A|Adverse Event|0
993700|NCT01362790|2005563|FG003|Dose De-escalation of Regimen A|Adverse Event|0
993701|NCT01362790|2005564|FG004|Dose De-escalation of Regimen A|Adverse Event|1
993702|NCT01362790|2005565|FG005|Dose De-escalation of Regimen A|Adverse Event|0
993703|NCT01362790|2005566|FG006|Dose De-escalation of Regimen A|Adverse Event|0
993704|NCT01362790|2005560|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0
993705|NCT01362790|2005561|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0
993706|NCT01362790|2005562|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0
993707|NCT01362790|2005563|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0
993708|NCT01362790|2005564|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3
993709|NCT01362790|2005565|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0
993710|NCT01362790|2005566|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0
993711|NCT01362790|2005560|FG000|Dose De-escalation of Regimen A|Progressive disease|0
993712|NCT01362790|2005561|FG001|Dose De-escalation of Regimen A|Progressive disease|0
993713|NCT01362790|2005562|FG002|Dose De-escalation of Regimen A|Progressive disease|0
993714|NCT01362790|2005563|FG003|Dose De-escalation of Regimen A|Progressive disease|0
993715|NCT01362790|2005564|FG004|Dose De-escalation of Regimen A|Progressive disease|2
993716|NCT01362790|2005565|FG005|Dose De-escalation of Regimen A|Progressive disease|0
993717|NCT01362790|2005566|FG006|Dose De-escalation of Regimen A|Progressive disease|0
993718|NCT01363011|2005618|FG000|Main Study|Adverse Event|2
993719|NCT01363011|2005619|FG001|Main Study|Adverse Event|3
993720|NCT01363011|2005618|FG000|Main Study|Investigator's Discretion|1
993721|NCT01363011|2005619|FG001|Main Study|Investigator's Discretion|1
993722|NCT01363011|2005618|FG000|Main Study|Withdrew Consent|1
993723|NCT01363011|2005619|FG001|Main Study|Withdrew Consent|4
993724|NCT01363011|2005618|FG000|Main Study|Protocol Violation|0
993725|NCT01363011|2005619|FG001|Main Study|Protocol Violation|1
993726|NCT01363011|2005618|FG000|Extension Phase|Adverse Event|1
993727|NCT01363011|2005619|FG001|Extension Phase|Adverse Event|1
993728|NCT01363011|2005618|FG000|Extension Phase|Lack of Efficacy|0
993729|NCT01363011|2005619|FG001|Extension Phase|Lack of Efficacy|1
993730|NCT01363011|2005618|FG000|Extension Phase|Investigator's Discretion|2
993731|NCT01363011|2005619|FG001|Extension Phase|Investigator's Discretion|2
993732|NCT01363011|2005618|FG000|Extension Phase|Withdrew Consent|0
993733|NCT01363011|2005619|FG001|Extension Phase|Withdrew Consent|1
993734|NCT01363011|2005618|FG000|Extension Phase|Lost to Follow-up|0
993735|NCT01363011|2005619|FG001|Extension Phase|Lost to Follow-up|2
993736|NCT01363011|2005618|FG000|Extension Phase|Rolled Over to Another Gilead Study|2
993737|NCT01363011|2005619|FG001|Extension Phase|Rolled Over to Another Gilead Study|1
993738|NCT01363076|2005633|FG000|Overall Study|Withdrawal by Subject|0
993739|NCT01363076|2005634|FG001|Overall Study|Withdrawal by Subject|1
993740|NCT01363297|2005658|FG000|Overall Study|Other|0
993741|NCT01363297|2005659|FG001|Overall Study|Other|0
993742|NCT01363297|2005660|FG002|Overall Study|Other|0
993743|NCT01363297|2005661|FG003|Overall Study|Other|0
993744|NCT01363297|2005662|FG004|Overall Study|Other|1
993745|NCT01363297|2005658|FG000|Overall Study|Death|3
993746|NCT01363297|2005659|FG001|Overall Study|Death|6
993747|NCT01363297|2005660|FG002|Overall Study|Death|6
993748|NCT01363297|2005661|FG003|Overall Study|Death|10
993749|NCT01363297|2005662|FG004|Overall Study|Death|30
993750|NCT01363349|2005681|FG000|Overall Study|Adverse Event|6
993751|NCT01363349|2005682|FG001|Overall Study|Adverse Event|7
993752|NCT01363349|2005681|FG000|Overall Study|Lack of Efficacy|3
993753|NCT01363349|2005682|FG001|Overall Study|Lack of Efficacy|10
993754|NCT01363349|2005681|FG000|Overall Study|Non compliance/Protocol deviations|2
993755|NCT01363349|2005682|FG001|Overall Study|Non compliance/Protocol deviations|2
993756|NCT01363349|2005681|FG000|Overall Study|Withdrawal by Subject|14
993757|NCT01363349|2005682|FG001|Overall Study|Withdrawal by Subject|6
993758|NCT01363349|2005681|FG000|Overall Study|Lost to Follow-up|5
993759|NCT01363349|2005682|FG001|Overall Study|Lost to Follow-up|6
993760|NCT01363349|2005681|FG000|Overall Study|Not reported|36
993761|NCT01363349|2005682|FG001|Overall Study|Not reported|37
993762|NCT01363349|2005681|FG000|Overall Study|missing|1
993763|NCT01363349|2005682|FG001|Overall Study|missing|2
993764|NCT01363440|2005713|FG000|Overall Study|Adverse Event|5
993765|NCT01363440|2005714|FG001|Overall Study|Adverse Event|4
993766|NCT01363440|2005715|FG002|Overall Study|Adverse Event|4
993767|NCT01363440|2005713|FG000|Overall Study|Death|3
993768|NCT01363440|2005714|FG001|Overall Study|Death|7
993769|NCT01363440|2005715|FG002|Overall Study|Death|5
993770|NCT01363440|2005713|FG000|Overall Study|Withdrawal by Subject|9
993771|NCT01363440|2005714|FG001|Overall Study|Withdrawal by Subject|11
993772|NCT01363440|2005715|FG002|Overall Study|Withdrawal by Subject|11
993773|NCT01363440|2005713|FG000|Overall Study|Lost to Follow-up|2
993774|NCT01363440|2005714|FG001|Overall Study|Lost to Follow-up|4
993775|NCT01363440|2005715|FG002|Overall Study|Lost to Follow-up|5
993776|NCT01363440|2005713|FG000|Overall Study|Other|4
993777|NCT01363440|2005714|FG001|Overall Study|Other|5
993778|NCT01363440|2005715|FG002|Overall Study|Other|2
993779|NCT01363661|2005743|FG000|Overall Study|Adverse Event|9
993780|NCT01363661|2005744|FG001|Overall Study|Adverse Event|2
993781|NCT01363661|2005743|FG000|Overall Study|Withdrawal by Subject|1
993782|NCT01363661|2005744|FG001|Overall Study|Withdrawal by Subject|1
993783|NCT01363661|2005743|FG000|Overall Study|Protocol Violation|1
993784|NCT01363661|2005744|FG001|Overall Study|Protocol Violation|0
993785|NCT01363661|2005743|FG000|Overall Study|Lost to Follow-up|3
993786|NCT01363661|2005744|FG001|Overall Study|Lost to Follow-up|1
993787|NCT01363700|2005753|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0
993788|NCT01363700|2005754|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1
993789|NCT01363700|2005755|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0
993790|NCT01363700|2005756|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0
993791|NCT01363700|2005757|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0
993792|NCT01363713|2005768|FG000|Overall Study|Adverse Event|1
993793|NCT01363713|2005768|FG000|Overall Study|Protocol Violation|3
993794|NCT01363713|2005768|FG000|Overall Study|Withdrawal by Subject|2
993795|NCT01363765|2005774|FG000|Overall Study|non-diagnostic|2621
993796|NCT01363765|2005775|FG001|Overall Study|non-diagnostic|1124
993797|NCT01363765|2005774|FG000|Overall Study|duplicate records|736
993798|NCT01363765|2005775|FG001|Overall Study|duplicate records|3177
993799|NCT01363765|2005774|FG000|Overall Study|non-resident|156
993800|NCT01363765|2005775|FG001|Overall Study|non-resident|76
993801|NCT01363765|2005774|FG000|Overall Study|age not recorded (used for cross-linkage|117
993802|NCT01363765|2005775|FG001|Overall Study|age not recorded (used for cross-linkage|354
993803|NCT01363765|2005774|FG000|Overall Study|smear during intervention|2170
993804|NCT01363765|2005775|FG001|Overall Study|smear during intervention|0
993805|NCT01363908|2005790|FG000|Chronic Dosing (CD) Phase|Adverse Event|1
993806|NCT01363908|2005791|FG001|Chronic Dosing (CD) Phase|Adverse Event|1
993807|NCT01363908|2005790|FG000|Chronic Dosing (CD) Phase|Patient decision|0
993808|NCT01363908|2005791|FG001|Chronic Dosing (CD) Phase|Patient decision|1
993809|NCT01363908|2005790|FG000|Chronic Dosing (CD) Phase|Physician Decision|0
993810|NCT01363908|2005791|FG001|Chronic Dosing (CD) Phase|Physician Decision|1
993811|NCT01363908|2005790|FG000|Chronic Dosing (CD) Phase|Early study termination|9
993812|NCT01363908|2005791|FG001|Chronic Dosing (CD) Phase|Early study termination|3
993813|NCT01363986|2005797|FG000|Overall Study|Disease progression|1
993814|NCT01364233|2005828|FG000|Overall Study|Lost to Follow-up|1
993815|NCT01364298|2005843|FG000|Overall Study|Adverse Event|3
993816|NCT01364298|2005844|FG001|Overall Study|Adverse Event|4
993817|NCT01364298|2005843|FG000|Overall Study|Lack of adherence to treatment|1
993818|NCT01364298|2005844|FG001|Overall Study|Lack of adherence to treatment|3
993819|NCT01364298|2005843|FG000|Overall Study|Lack of Efficacy|1
993820|NCT01364298|2005844|FG001|Overall Study|Lack of Efficacy|0
993821|NCT01364298|2005843|FG000|Overall Study|Lost to Follow-up|5
993822|NCT01364298|2005844|FG001|Overall Study|Lost to Follow-up|10
993823|NCT01364298|2005843|FG000|Overall Study|Withdrawal by Subject|3
993824|NCT01364298|2005844|FG001|Overall Study|Withdrawal by Subject|3
993825|NCT01364298|2005843|FG000|Overall Study|Other|1
993826|NCT01364298|2005844|FG001|Overall Study|Other|3
993827|NCT01364389|2005853|FG000|Overall Study|Withdrawal by Subject|0
993828|NCT01364389|2005854|FG001|Overall Study|Withdrawal by Subject|1
993829|NCT01364389|2005855|FG002|Overall Study|Withdrawal by Subject|0
993830|NCT01364389|2005853|FG000|Overall Study|Protocol deviation|0
993831|NCT01364389|2005854|FG001|Overall Study|Protocol deviation|0
993832|NCT01364389|2005855|FG002|Overall Study|Protocol deviation|1
993833|NCT01364389|2005853|FG000|Overall Study|Administrative problems|1
993834|NCT01364389|2005854|FG001|Overall Study|Administrative problems|0
993835|NCT01364389|2005855|FG002|Overall Study|Administrative problems|0
993836|NCT01364389|2005853|FG000|Overall Study|Adverse Event|1
993837|NCT01364389|2005854|FG001|Overall Study|Adverse Event|0
993838|NCT01364389|2005855|FG002|Overall Study|Adverse Event|0
993839|NCT01364428|2005865|FG000|Overall Study|Adverse Event|1
993840|NCT01364428|2005866|FG001|Overall Study|Adverse Event|2
993841|NCT01364428|2005865|FG000|Overall Study|Protocol Violation|2
993842|NCT01364428|2005866|FG001|Overall Study|Protocol Violation|0
993843|NCT01364428|2005865|FG000|Overall Study|Withdrawal Criteria|14
993844|NCT01364428|2005866|FG001|Overall Study|Withdrawal Criteria|10
993845|NCT01364428|2005865|FG000|Overall Study|Other|3
993846|NCT01364428|2005866|FG001|Overall Study|Other|3
993847|NCT01364467|2005874|FG000|Overall Study|Lost to Follow-up|1
993848|NCT01364467|2005875|FG001|Overall Study|Lost to Follow-up|2
993849|NCT01364649|2005925|FG000|Overall Study|Pretreatment Event or Adverse Event|20
993850|NCT01364649|2005926|FG001|Overall Study|Pretreatment Event or Adverse Event|14
993851|NCT01364649|2005925|FG000|Overall Study|Lack of Efficacy|6
993852|NCT01364649|2005926|FG001|Overall Study|Lack of Efficacy|0
993853|NCT01364649|2005925|FG000|Overall Study|Non-compliance with Investigational Drug|1
993854|NCT01364649|2005926|FG001|Overall Study|Non-compliance with Investigational Drug|0
993855|NCT01364649|2005925|FG000|Overall Study|Protocol Deviations|4
993856|NCT01364649|2005926|FG001|Overall Study|Protocol Deviations|8
993857|NCT01364649|2005925|FG000|Overall Study|Withdrawal of Consent|9
993858|NCT01364649|2005926|FG001|Overall Study|Withdrawal of Consent|7
993859|NCT01364649|2005925|FG000|Overall Study|Lost to Follow-up|12
993860|NCT01364649|2005926|FG001|Overall Study|Lost to Follow-up|13
993861|NCT01364649|2005925|FG000|Overall Study|Other|4
993862|NCT01364649|2005926|FG001|Overall Study|Other|1
993863|NCT01364727|2005932|FG000|Overall Study|Not Eligible|2
993864|NCT01364870|2005946|FG000|Overall Study|Withdrawal by Subject|13
993865|NCT01364870|2005947|FG001|Overall Study|Withdrawal by Subject|24
993866|NCT01364870|2005948|FG002|Overall Study|Withdrawal by Subject|10
993867|NCT01364870|2005946|FG000|Overall Study|Adverse Event|8
993868|NCT01364870|2005947|FG001|Overall Study|Adverse Event|6
993869|NCT01364870|2005948|FG002|Overall Study|Adverse Event|4
993870|NCT01364870|2005946|FG000|Overall Study|Protocol Violation|1
993871|NCT01364870|2005947|FG001|Overall Study|Protocol Violation|0
993872|NCT01364870|2005948|FG002|Overall Study|Protocol Violation|0
993873|NCT01364922|2005963|FG000|Open-label (OL) Period|Adverse Event|7
993874|NCT01364922|2005964|FG001|Open-label (OL) Period|Adverse Event|0
993875|NCT01364922|2005965|FG002|Open-label (OL) Period|Adverse Event|0
993876|NCT01364922|2005963|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
993877|NCT01364922|2005964|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
993878|NCT01364922|2005965|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
993879|NCT01364922|2005963|FG000|Open-label (OL) Period|Withdrawal by Subject|4
993880|NCT01364922|2005964|FG001|Open-label (OL) Period|Withdrawal by Subject|0
993881|NCT01364922|2005965|FG002|Open-label (OL) Period|Withdrawal by Subject|0
993882|NCT01364922|2005963|FG000|Open-label (OL) Period|Lack of Efficacy|3
993883|NCT01364922|2005964|FG001|Open-label (OL) Period|Lack of Efficacy|0
993884|NCT01364922|2005965|FG002|Open-label (OL) Period|Lack of Efficacy|0
993885|NCT01364922|2005963|FG000|Open-label (OL) Period|Lost to Follow-up|1
993886|NCT01364922|2005964|FG001|Open-label (OL) Period|Lost to Follow-up|0
993887|NCT01364922|2005965|FG002|Open-label (OL) Period|Lost to Follow-up|0
993888|NCT01364922|2005963|FG000|Open-label (OL) Period|Other, Unspecified|1
993889|NCT01364922|2005964|FG001|Open-label (OL) Period|Other, Unspecified|0
993890|NCT01364922|2005965|FG002|Open-label (OL) Period|Other, Unspecified|0
993891|NCT01364922|2005963|FG000|Double-Blind (DB) Period|Lack of Efficacy|0
993892|NCT01364922|2005964|FG001|Double-Blind (DB) Period|Lack of Efficacy|3
993893|NCT01364922|2005965|FG002|Double-Blind (DB) Period|Lack of Efficacy|4
993894|NCT01364922|2005963|FG000|Double-Blind (DB) Period|Subject Noncompliant|0
993895|NCT01364922|2005964|FG001|Double-Blind (DB) Period|Subject Noncompliant|1
993896|NCT01364922|2005965|FG002|Double-Blind (DB) Period|Subject Noncompliant|0
993897|NCT01364922|2005963|FG000|Double-Blind (DB) Period|Adverse Event|0
993898|NCT01364922|2005964|FG001|Double-Blind (DB) Period|Adverse Event|0
993899|NCT01364922|2005965|FG002|Double-Blind (DB) Period|Adverse Event|1
993900|NCT01364922|2005963|FG000|Double-Blind (DB) Period|Other, Unspecified|0
993901|NCT01364922|2005964|FG001|Double-Blind (DB) Period|Other, Unspecified|1
993902|NCT01364922|2005965|FG002|Double-Blind (DB) Period|Other, Unspecified|0
993903|NCT01365039|2005974|FG000|Overall Study|Study related symptoms and complaints|1
993904|NCT01365039|2005975|FG001|Overall Study|Study related symptoms and complaints|0
993905|NCT01365052|2005984|FG000|Overall Study|Adverse Event|4
993906|NCT01365052|2005985|FG001|Overall Study|Adverse Event|4
993907|NCT01365091|2005995|FG000|Period 1|Adverse Event|1
993908|NCT01365091|2005996|FG001|Period 1|Adverse Event|0
993909|NCT01365091|2005997|FG002|Period 1|Adverse Event|2
993910|NCT01365091|2005998|FG003|Period 1|Adverse Event|3
993911|NCT01365091|2005995|FG000|Period 1|Positive test result for drugs of abuse|1
993912|NCT01365091|2005996|FG001|Period 1|Positive test result for drugs of abuse|0
993913|NCT01365091|2005997|FG002|Period 1|Positive test result for drugs of abuse|0
993914|NCT01365091|2005998|FG003|Period 1|Positive test result for drugs of abuse|0
993915|NCT01365091|2005995|FG000|Period 1|No longer met study criteria|0
993916|NCT01365091|2005996|FG001|Period 1|No longer met study criteria|1
993917|NCT01365091|2005997|FG002|Period 1|No longer met study criteria|0
993918|NCT01365091|2005998|FG003|Period 1|No longer met study criteria|0
993919|NCT01365091|2005995|FG000|Period 1|Withdrawal by Subject|0
993920|NCT01365091|2005996|FG001|Period 1|Withdrawal by Subject|1
993921|NCT01365091|2005997|FG002|Period 1|Withdrawal by Subject|0
993922|NCT01365091|2005998|FG003|Period 1|Withdrawal by Subject|0
993923|NCT01365091|2005995|FG000|Period 1|Personal reasons|0
993924|NCT01365091|2005996|FG001|Period 1|Personal reasons|0
993925|NCT01365091|2005997|FG002|Period 1|Personal reasons|1
993926|NCT01365091|2005998|FG003|Period 1|Personal reasons|0
993927|NCT01365091|2005995|FG000|Period 2|Withdrawal by Subject|1
993928|NCT01365091|2005996|FG001|Period 2|Withdrawal by Subject|0
993929|NCT01365091|2005997|FG002|Period 2|Withdrawal by Subject|0
993930|NCT01365091|2005998|FG003|Period 2|Withdrawal by Subject|0
993931|NCT01365091|2005995|FG000|Period 2|Adverse Event|0
993932|NCT01365091|2005996|FG001|Period 2|Adverse Event|0
993933|NCT01365091|2005997|FG002|Period 2|Adverse Event|1
993934|NCT01365091|2005998|FG003|Period 2|Adverse Event|0
993935|NCT01365130|2006022|FG000|Overall Study|Progression/worsening of Dx prior to txt|2
993936|NCT01365273|2006028|FG000|Overall Study|Lost to Follow-up|1
993937|NCT01365273|2006029|FG001|Overall Study|Lost to Follow-up|0
993938|NCT01365273|2006028|FG000|Overall Study|Protocol Violation|0
993939|NCT01365273|2006029|FG001|Overall Study|Protocol Violation|1
993940|NCT01365273|2006028|FG000|Overall Study|Physician Decision|1
993941|NCT01365273|2006029|FG001|Overall Study|Physician Decision|0
993942|NCT01365455|2006038|FG000|Induction Period|Adverse Event|5
993943|NCT01365455|2006039|FG001|Induction Period|Adverse Event|3
993944|NCT01365455|2006040|FG002|Induction Period|Adverse Event|4
993945|NCT01365455|2006041|FG003|Induction Period|Adverse Event|0
993946|NCT01365455|2006042|FG004|Induction Period|Adverse Event|0
993947|NCT01365455|2006038|FG000|Induction Period|Lack of Efficacy|1
993948|NCT01365455|2006039|FG001|Induction Period|Lack of Efficacy|1
993949|NCT01365455|2006040|FG002|Induction Period|Lack of Efficacy|0
993950|NCT01365455|2006041|FG003|Induction Period|Lack of Efficacy|0
993951|NCT01365455|2006042|FG004|Induction Period|Lack of Efficacy|0
993952|NCT01365455|2006038|FG000|Induction Period|Pregnancy|0
993953|NCT01365455|2006039|FG001|Induction Period|Pregnancy|1
993954|NCT01365455|2006040|FG002|Induction Period|Pregnancy|0
993955|NCT01365455|2006041|FG003|Induction Period|Pregnancy|0
993956|NCT01365455|2006042|FG004|Induction Period|Pregnancy|0
993957|NCT01365455|2006038|FG000|Induction Period|Protocol deviation|0
993958|NCT01365455|2006039|FG001|Induction Period|Protocol deviation|1
993959|NCT01365455|2006040|FG002|Induction Period|Protocol deviation|1
993960|NCT01365455|2006041|FG003|Induction Period|Protocol deviation|0
993961|NCT01365455|2006042|FG004|Induction Period|Protocol deviation|0
993962|NCT01365455|2006038|FG000|Induction Period|Subject/guardian decision|9
993963|NCT01365455|2006039|FG001|Induction Period|Subject/guardian decision|1
993964|NCT01365455|2006040|FG002|Induction Period|Subject/guardian decision|8
993965|NCT01365455|2006041|FG003|Induction Period|Subject/guardian decision|0
993966|NCT01365455|2006042|FG004|Induction Period|Subject/guardian decision|0
993967|NCT01365455|2006038|FG000|Induction Period|Lost to Follow-up|0
993968|NCT01365455|2006039|FG001|Induction Period|Lost to Follow-up|0
993969|NCT01365455|2006040|FG002|Induction Period|Lost to Follow-up|3
993970|NCT01365455|2006041|FG003|Induction Period|Lost to Follow-up|0
993971|NCT01365455|2006042|FG004|Induction Period|Lost to Follow-up|0
993972|NCT01365455|2006038|FG000|Maintenance Period|Adverse Event|12
993973|NCT01365455|2006039|FG001|Maintenance Period|Adverse Event|5
993974|NCT01365455|2006040|FG002|Maintenance Period|Adverse Event|1
993975|NCT01365455|2006041|FG003|Maintenance Period|Adverse Event|2
993976|NCT01365455|2006042|FG004|Maintenance Period|Adverse Event|4
993977|NCT01365455|2006038|FG000|Maintenance Period|Lack of Efficacy|10
993978|NCT01365455|2006039|FG001|Maintenance Period|Lack of Efficacy|2
993979|NCT01365455|2006040|FG002|Maintenance Period|Lack of Efficacy|0
993980|NCT01365455|2006041|FG003|Maintenance Period|Lack of Efficacy|2
993981|NCT01365455|2006042|FG004|Maintenance Period|Lack of Efficacy|2
993982|NCT01365455|2006038|FG000|Maintenance Period|Lost to Follow-up|2
993983|NCT01365455|2006039|FG001|Maintenance Period|Lost to Follow-up|4
993984|NCT01365455|2006040|FG002|Maintenance Period|Lost to Follow-up|0
993985|NCT01365455|2006041|FG003|Maintenance Period|Lost to Follow-up|0
993986|NCT01365455|2006042|FG004|Maintenance Period|Lost to Follow-up|3
993987|NCT01365455|2006038|FG000|Maintenance Period|Non-compliance with study treatment|0
993988|NCT01365455|2006039|FG001|Maintenance Period|Non-compliance with study treatment|0
993989|NCT01365455|2006040|FG002|Maintenance Period|Non-compliance with study treatment|0
993990|NCT01365455|2006041|FG003|Maintenance Period|Non-compliance with study treatment|1
993991|NCT01365455|2006042|FG004|Maintenance Period|Non-compliance with study treatment|0
993992|NCT01365455|2006038|FG000|Maintenance Period|Physician Decision|0
993993|NCT01365455|2006039|FG001|Maintenance Period|Physician Decision|1
993994|NCT01365455|2006040|FG002|Maintenance Period|Physician Decision|0
993995|NCT01365455|2006041|FG003|Maintenance Period|Physician Decision|0
993996|NCT01365455|2006042|FG004|Maintenance Period|Physician Decision|1
993997|NCT01365455|2006038|FG000|Maintenance Period|Pregnancy|0
993998|NCT01365455|2006039|FG001|Maintenance Period|Pregnancy|4
993999|NCT01365455|2006040|FG002|Maintenance Period|Pregnancy|0
994000|NCT01365455|2006041|FG003|Maintenance Period|Pregnancy|0
994001|NCT01365455|2006042|FG004|Maintenance Period|Pregnancy|2
994002|NCT01365455|2006038|FG000|Maintenance Period|Protocol deviation|1
994003|NCT01365455|2006039|FG001|Maintenance Period|Protocol deviation|1
994004|NCT01365455|2006040|FG002|Maintenance Period|Protocol deviation|0
994005|NCT01365455|2006041|FG003|Maintenance Period|Protocol deviation|0
994006|NCT01365455|2006042|FG004|Maintenance Period|Protocol deviation|0
994007|NCT01365455|2006038|FG000|Maintenance Period|Subject/guardian decision|4
994008|NCT01365455|2006039|FG001|Maintenance Period|Subject/guardian decision|6
994009|NCT01365455|2006040|FG002|Maintenance Period|Subject/guardian decision|2
994010|NCT01365455|2006041|FG003|Maintenance Period|Subject/guardian decision|4
994011|NCT01365455|2006042|FG004|Maintenance Period|Subject/guardian decision|1
994012|NCT01365468|2006062|FG000|Overall Study|Physician Decision|1
994013|NCT01365468|2006063|FG001|Overall Study|Physician Decision|0
994014|NCT01365468|2006062|FG000|Overall Study|Disease progression|1
994015|NCT01365468|2006063|FG001|Overall Study|Disease progression|0
994016|NCT01365468|2006062|FG000|Overall Study|Lost to Follow-up|2
994017|NCT01365468|2006063|FG001|Overall Study|Lost to Follow-up|0
994018|NCT01365481|2006074|FG000|Overall Study|Adverse Event|6
994019|NCT01365481|2006075|FG001|Overall Study|Adverse Event|9
994020|NCT01365481|2006076|FG002|Overall Study|Adverse Event|0
994021|NCT01365481|2006077|FG003|Overall Study|Adverse Event|2
994022|NCT01365481|2006074|FG000|Overall Study|Withdrawal by Subject|0
994023|NCT01365481|2006075|FG001|Overall Study|Withdrawal by Subject|2
994024|NCT01365481|2006076|FG002|Overall Study|Withdrawal by Subject|1
994025|NCT01365481|2006077|FG003|Overall Study|Withdrawal by Subject|1
994026|NCT01365481|2006074|FG000|Overall Study|Lost to Follow-up|1
994027|NCT01365481|2006075|FG001|Overall Study|Lost to Follow-up|1
994028|NCT01365481|2006076|FG002|Overall Study|Lost to Follow-up|2
994029|NCT01365481|2006077|FG003|Overall Study|Lost to Follow-up|3
994030|NCT01365481|2006074|FG000|Overall Study|Abnormal laboratory value(s)|0
994031|NCT01365481|2006075|FG001|Overall Study|Abnormal laboratory value(s)|1
994032|NCT01365481|2006076|FG002|Overall Study|Abnormal laboratory value(s)|0
994033|NCT01365481|2006077|FG003|Overall Study|Abnormal laboratory value(s)|0
994034|NCT01365481|2006074|FG000|Overall Study|Administrative problems|0
994035|NCT01365481|2006075|FG001|Overall Study|Administrative problems|1
994036|NCT01365481|2006076|FG002|Overall Study|Administrative problems|0
994037|NCT01365481|2006077|FG003|Overall Study|Administrative problems|0
994038|NCT01365481|2006074|FG000|Overall Study|Protocol deviation|0
994039|NCT01365481|2006075|FG001|Overall Study|Protocol deviation|1
994040|NCT01365481|2006076|FG002|Overall Study|Protocol deviation|0
994041|NCT01365481|2006077|FG003|Overall Study|Protocol deviation|1
994042|NCT01365481|2006074|FG000|Overall Study|Unsatisfactory therapeutic effect|0
994043|NCT01365481|2006075|FG001|Overall Study|Unsatisfactory therapeutic effect|0
994044|NCT01365481|2006076|FG002|Overall Study|Unsatisfactory therapeutic effect|1
994045|NCT01365481|2006077|FG003|Overall Study|Unsatisfactory therapeutic effect|0
994046|NCT01365494|2006089|FG000|Overall Study|Adverse Event|1
994047|NCT01365494|2006090|FG001|Overall Study|Adverse Event|0
994048|NCT01365494|2006089|FG000|Overall Study|Withdrawal by Subject|0
994049|NCT01365494|2006090|FG001|Overall Study|Withdrawal by Subject|1
994050|NCT01365494|2006089|FG000|Overall Study|Lost to Follow-up|1
994051|NCT01365494|2006090|FG001|Overall Study|Lost to Follow-up|2
994052|NCT01365507|2006099|FG000|Overall Study|Withdrawal Criteria|8
994053|NCT01365507|2006100|FG001|Overall Study|Withdrawal Criteria|5
994054|NCT01365507|2006099|FG000|Overall Study|Unclassified|1
994055|NCT01365507|2006100|FG001|Overall Study|Unclassified|4
994056|NCT01365546|2006106|FG000|Overall Study|Withdrawal by Subject|1
994057|NCT01365546|2006106|FG000|Overall Study|Screen failure|9
994058|NCT01365546|2006106|FG000|Overall Study|Study termination|1
994059|NCT01365910|2006174|FG000|Overall Study|Withdrawal by Subject|7
994060|NCT01365910|2006174|FG000|Overall Study|disease progression|18
994061|NCT01365910|2006174|FG000|Overall Study|Adverse Event|3
994062|NCT01365910|2006174|FG000|Overall Study|other complicating disease|1
994063|NCT01365910|2006174|FG000|Overall Study|pt did not get tx, nausea/vomiting|1
994064|NCT01366092|2006178|FG000|Overall Study|Progressive cGVHD|2
994065|NCT01366092|2006178|FG000|Overall Study|Physician Decision|1
994066|NCT01366092|2006178|FG000|Overall Study|Withdrawal by Subject|1
994067|NCT01366209|2006193|FG000|Overall Study|Adverse Event|6
994068|NCT01366209|2006194|FG001|Overall Study|Adverse Event|7
994069|NCT01366209|2006193|FG000|Overall Study|Withdrawal by Subject|4
994070|NCT01366209|2006194|FG001|Overall Study|Withdrawal by Subject|4
994071|NCT01366209|2006193|FG000|Overall Study|Death|12
994072|NCT01366209|2006194|FG001|Overall Study|Death|19
994073|NCT01366209|2006193|FG000|Overall Study|Lung transplantation|6
994074|NCT01366209|2006194|FG001|Overall Study|Lung transplantation|1
994075|NCT01366209|2006193|FG000|Overall Study|Lost to Follow-up|2
994076|NCT01366209|2006194|FG001|Overall Study|Lost to Follow-up|1
994077|NCT01366209|2006193|FG000|Overall Study|Physician Decision|1
994078|NCT01366209|2006194|FG001|Overall Study|Physician Decision|0
994079|NCT01366209|2006193|FG000|Overall Study|Sponsors decision|0
994080|NCT01366209|2006194|FG001|Overall Study|Sponsors decision|1
994081|NCT01366209|2006193|FG000|Overall Study|Withdrew consent|4
994082|NCT01366209|2006194|FG001|Overall Study|Withdrew consent|3
994083|NCT01366443|2006205|FG000|Overall Study|Lost to Follow-up|2
994084|NCT01366443|2006205|FG000|Overall Study|Under 18 yo|1
994085|NCT01366521|2006231|FG000|Overall Study|Adverse Event|1
994086|NCT01366521|2006232|FG001|Overall Study|Adverse Event|0
994087|NCT01366521|2006233|FG002|Overall Study|Adverse Event|0
994088|NCT01366521|2006234|FG003|Overall Study|Adverse Event|0
994089|NCT01366521|2006231|FG000|Overall Study|Protocol Violation|0
994090|NCT01366521|2006232|FG001|Overall Study|Protocol Violation|0
994091|NCT01366521|2006233|FG002|Overall Study|Protocol Violation|1
994092|NCT01366521|2006234|FG003|Overall Study|Protocol Violation|0
994093|NCT01366521|2006231|FG000|Overall Study|Physician Decision|0
994094|NCT01366521|2006232|FG001|Overall Study|Physician Decision|0
994095|NCT01366521|2006233|FG002|Overall Study|Physician Decision|1
994096|NCT01366521|2006234|FG003|Overall Study|Physician Decision|0
994097|NCT01366521|2006231|FG000|Overall Study|Withdrawal by Subject|0
994098|NCT01366521|2006232|FG001|Overall Study|Withdrawal by Subject|1
994099|NCT01366521|2006233|FG002|Overall Study|Withdrawal by Subject|0
994100|NCT01366521|2006234|FG003|Overall Study|Withdrawal by Subject|0
994101|NCT01366534|2006249|FG000|Overall Study|Lost to Follow-up|1
994102|NCT01366534|2006250|FG001|Overall Study|Lost to Follow-up|0
994103|NCT01366534|2006251|FG002|Overall Study|Lost to Follow-up|0
994104|NCT01366534|2006249|FG000|Overall Study|Migrated|1
994105|NCT01366534|2006250|FG001|Overall Study|Migrated|1
994106|NCT01366534|2006251|FG002|Overall Study|Migrated|0
994107|NCT01366534|2006249|FG000|Overall Study|Declined challenged|0
994108|NCT01366534|2006250|FG001|Overall Study|Declined challenged|1
994109|NCT01366534|2006251|FG002|Overall Study|Declined challenged|0
994110|NCT01366638|2006262|FG000|Overall Study|Withdrawal by Subject|0
994111|NCT01366638|2006263|FG001|Overall Study|Withdrawal by Subject|0
994112|NCT01366638|2006264|FG002|Overall Study|Withdrawal by Subject|6
994113|NCT01366638|2006262|FG000|Overall Study|Other|1
994114|NCT01366638|2006263|FG001|Overall Study|Other|0
994115|NCT01366638|2006264|FG002|Overall Study|Other|0
994116|NCT01366846|2006276|FG000|Overall Study|Withdrawal by Subject|2
994117|NCT01366846|2006277|FG001|Overall Study|Withdrawal by Subject|0
994118|NCT01366846|2006278|FG002|Overall Study|Withdrawal by Subject|0
994119|NCT01366846|2006279|FG003|Overall Study|Withdrawal by Subject|0
994120|NCT01366846|2006276|FG000|Overall Study|Communication Difficulties|1
994121|NCT01366846|2006277|FG001|Overall Study|Communication Difficulties|4
994122|NCT01366846|2006278|FG002|Overall Study|Communication Difficulties|0
994123|NCT01366846|2006279|FG003|Overall Study|Communication Difficulties|1
994124|NCT01366846|2006276|FG000|Overall Study|Scheduling Conflicts|0
994125|NCT01366846|2006277|FG001|Overall Study|Scheduling Conflicts|0
994126|NCT01366846|2006278|FG002|Overall Study|Scheduling Conflicts|1
994127|NCT01366846|2006279|FG003|Overall Study|Scheduling Conflicts|0
994128|NCT01367119|2006322|FG000|Overall Study|Adverse Event|1
994129|NCT01367119|2006323|FG001|Overall Study|Adverse Event|0
994130|NCT01367119|2006322|FG000|Overall Study|Withdrawal by Subject|1
994131|NCT01367119|2006323|FG001|Overall Study|Withdrawal by Subject|1
994132|NCT01367158|2006340|FG000|Overall Study|Withdrew consent|0
994133|NCT01367158|2006341|FG001|Overall Study|Withdrew consent|2
994134|NCT01367158|2006342|FG002|Overall Study|Withdrew consent|1
994135|NCT01367158|2006343|FG003|Overall Study|Withdrew consent|0
994136|NCT01367158|2006344|FG004|Overall Study|Withdrew consent|2
994137|NCT01367158|2006345|FG005|Overall Study|Withdrew consent|0
994138|NCT01367158|2006346|FG006|Overall Study|Withdrew consent|0
994139|NCT01367158|2006347|FG007|Overall Study|Withdrew consent|1
994140|NCT01367158|2006348|FG008|Overall Study|Withdrew consent|0
994141|NCT01367158|2006349|FG009|Overall Study|Withdrew consent|0
994142|NCT01367158|2006350|FG010|Overall Study|Withdrew consent|0
994143|NCT01367158|2006340|FG000|Overall Study|Lost to Follow-up|0
994144|NCT01367158|2006341|FG001|Overall Study|Lost to Follow-up|0
994145|NCT01367158|2006342|FG002|Overall Study|Lost to Follow-up|0
994146|NCT01367158|2006343|FG003|Overall Study|Lost to Follow-up|1
994147|NCT01367158|2006344|FG004|Overall Study|Lost to Follow-up|0
994148|NCT01367158|2006345|FG005|Overall Study|Lost to Follow-up|2
994149|NCT01367158|2006346|FG006|Overall Study|Lost to Follow-up|0
994150|NCT01367158|2006347|FG007|Overall Study|Lost to Follow-up|1
994151|NCT01367158|2006348|FG008|Overall Study|Lost to Follow-up|0
994152|NCT01367158|2006349|FG009|Overall Study|Lost to Follow-up|0
994153|NCT01367158|2006350|FG010|Overall Study|Lost to Follow-up|1
994154|NCT01367158|2006340|FG000|Overall Study|Protocol Violation|0
994155|NCT01367158|2006341|FG001|Overall Study|Protocol Violation|1
994156|NCT01367158|2006342|FG002|Overall Study|Protocol Violation|0
994157|NCT01367158|2006343|FG003|Overall Study|Protocol Violation|0
994158|NCT01367158|2006344|FG004|Overall Study|Protocol Violation|0
994159|NCT01367158|2006345|FG005|Overall Study|Protocol Violation|0
994160|NCT01367158|2006346|FG006|Overall Study|Protocol Violation|0
994161|NCT01367158|2006347|FG007|Overall Study|Protocol Violation|0
994162|NCT01367158|2006348|FG008|Overall Study|Protocol Violation|0
994163|NCT01367158|2006349|FG009|Overall Study|Protocol Violation|0
994164|NCT01367158|2006350|FG010|Overall Study|Protocol Violation|0
994165|NCT01367236|2006387|FG000|Overall Study|Withdrawal by Subject|3
994166|NCT01367236|2006388|FG001|Overall Study|Withdrawal by Subject|1
994167|NCT01367249|2006396|FG000|Overall Study|Withdrawal by Subject|6
994168|NCT01367249|2006397|FG001|Overall Study|Withdrawal by Subject|6
994169|NCT01367249|2006396|FG000|Overall Study|Other|3
994170|NCT01367249|2006397|FG001|Overall Study|Other|10
994171|NCT01367275|2006407|FG000|Overall Study|Ineligible|1
994172|NCT01367275|2006407|FG000|Overall Study|Disease Progression|2
994173|NCT01367457|2006443|FG000|Overall Study|Death|2
994174|NCT01367457|2006444|FG001|Overall Study|Death|0
994175|NCT01367457|2006445|FG002|Overall Study|Death|0
994176|NCT01367457|2006443|FG000|Overall Study|Investigator's decision|2
994177|NCT01367457|2006444|FG001|Overall Study|Investigator's decision|0
994178|NCT01367457|2006445|FG002|Overall Study|Investigator's decision|0
994179|NCT01367457|2006443|FG000|Overall Study|Clinical decline (CD)|2
994180|NCT01367457|2006444|FG001|Overall Study|Clinical decline (CD)|0
994181|NCT01367457|2006445|FG002|Overall Study|Clinical decline (CD)|0
994182|NCT01367457|2006443|FG000|Overall Study|Progression and death|8
994183|NCT01367457|2006444|FG001|Overall Study|Progression and death|0
994184|NCT01367457|2006445|FG002|Overall Study|Progression and death|0
994185|NCT01367457|2006443|FG000|Overall Study|Toxicity|16
994186|NCT01367457|2006444|FG001|Overall Study|Toxicity|0
994187|NCT01367457|2006445|FG002|Overall Study|Toxicity|0
994188|NCT01367457|2006443|FG000|Overall Study|Progression|137
994189|NCT01367457|2006444|FG001|Overall Study|Progression|0
994190|NCT01367457|2006445|FG002|Overall Study|Progression|0
914022|NCT00812929|1891807|FG004|Washout Period 1 (7 Days)|Physician Decision|0
914023|NCT00812929|1891808|FG005|Washout Period 1 (7 Days)|Physician Decision|0
914024|NCT00812929|1891809|FG006|Washout Period 1 (7 Days)|Physician Decision|0
914025|NCT00812929|1891810|FG007|Washout Period 1 (7 Days)|Physician Decision|0
914026|NCT00812929|1891811|FG008|Washout Period 1 (7 Days)|Physician Decision|0
914027|NCT00812929|1891812|FG009|Washout Period 1 (7 Days)|Physician Decision|0
914028|NCT00812929|1891803|FG000|Washout Period 2 (7 Days)|Physician Decision|0
914029|NCT00812929|1891804|FG001|Washout Period 2 (7 Days)|Physician Decision|0
994191|NCT01367457|2006443|FG000|Overall Study|Patient asks for rest + slow progression|1
994192|NCT01367457|2006444|FG001|Overall Study|Patient asks for rest + slow progression|0
994193|NCT01367457|2006445|FG002|Overall Study|Patient asks for rest + slow progression|0
994194|NCT01367457|2006443|FG000|Overall Study|Investigator's opinion, stable disease|1
994195|NCT01367457|2006444|FG001|Overall Study|Investigator's opinion, stable disease|0
994196|NCT01367457|2006445|FG002|Overall Study|Investigator's opinion, stable disease|0
994197|NCT01367457|2006443|FG000|Overall Study|Bleeding from cavernous haemangioma|1
994198|NCT01367457|2006444|FG001|Overall Study|Bleeding from cavernous haemangioma|0
994199|NCT01367457|2006445|FG002|Overall Study|Bleeding from cavernous haemangioma|0
1006725|NCT01469052|2025439|FG003|Overall Study|Moved to rollover protocol|0
914030|NCT00812929|1891805|FG002|Washout Period 2 (7 Days)|Physician Decision|0
914031|NCT00812929|1891806|FG003|Washout Period 2 (7 Days)|Physician Decision|0
994200|NCT01367457|2006443|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1
994201|NCT01367457|2006444|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0
994202|NCT01367457|2006445|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0
994203|NCT01367457|2006443|FG000|Overall Study|low grade toxicities + stable disease|1
994204|NCT01367457|2006444|FG001|Overall Study|low grade toxicities + stable disease|0
994205|NCT01367457|2006445|FG002|Overall Study|low grade toxicities + stable disease|0
994206|NCT01367457|2006443|FG000|Overall Study|Choledocolithiasis and pancreatitis|1
994207|NCT01367457|2006444|FG001|Overall Study|Choledocolithiasis and pancreatitis|0
994208|NCT01367457|2006445|FG002|Overall Study|Choledocolithiasis and pancreatitis|0
994209|NCT01367457|2006443|FG000|Overall Study|Withdrawal by Subject|1
994210|NCT01367457|2006444|FG001|Overall Study|Withdrawal by Subject|0
994211|NCT01367457|2006445|FG002|Overall Study|Withdrawal by Subject|0
994212|NCT01367457|2006443|FG000|Overall Study|CD, associated leukaemia|1
994213|NCT01367457|2006444|FG001|Overall Study|CD, associated leukaemia|0
994214|NCT01367457|2006445|FG002|Overall Study|CD, associated leukaemia|0
994215|NCT01367457|2006443|FG000|Overall Study|Uncontrolled pain|1
994216|NCT01367457|2006444|FG001|Overall Study|Uncontrolled pain|0
994217|NCT01367457|2006445|FG002|Overall Study|Uncontrolled pain|0
994218|NCT01367457|2006443|FG000|Overall Study|Overall status worsens to grade 4|1
994219|NCT01367457|2006444|FG001|Overall Study|Overall status worsens to grade 4|0
994220|NCT01367457|2006445|FG002|Overall Study|Overall status worsens to grade 4|0
994221|NCT01367457|2006443|FG000|Overall Study|Stabilisation + frequent infections|1
994222|NCT01367457|2006444|FG001|Overall Study|Stabilisation + frequent infections|0
994223|NCT01367457|2006445|FG002|Overall Study|Stabilisation + frequent infections|0
994224|NCT01367457|2006443|FG000|Overall Study|No clinical benefit|1
994225|NCT01367457|2006444|FG001|Overall Study|No clinical benefit|0
994226|NCT01367457|2006445|FG002|Overall Study|No clinical benefit|0
994227|NCT01367457|2006443|FG000|Overall Study|Intestinal obstruction with necrosis|1
994228|NCT01367457|2006444|FG001|Overall Study|Intestinal obstruction with necrosis|0
994229|NCT01367457|2006445|FG002|Overall Study|Intestinal obstruction with necrosis|0
994230|NCT01367457|2006443|FG000|Overall Study|Overall decline|1
994231|NCT01367457|2006444|FG001|Overall Study|Overall decline|0
994232|NCT01367457|2006445|FG002|Overall Study|Overall decline|0
994233|NCT01367457|2006443|FG000|Overall Study|Rejection of treatment|1
994234|NCT01367457|2006444|FG001|Overall Study|Rejection of treatment|0
994235|NCT01367457|2006445|FG002|Overall Study|Rejection of treatment|0
994236|NCT01367457|2006443|FG000|Overall Study|Lost to Follow-up|1
994237|NCT01367457|2006444|FG001|Overall Study|Lost to Follow-up|0
994238|NCT01367457|2006445|FG002|Overall Study|Lost to Follow-up|0
994239|NCT01367457|2006443|FG000|Overall Study|Death from septic shock|1
994240|NCT01367457|2006444|FG001|Overall Study|Death from septic shock|0
994241|NCT01367457|2006445|FG002|Overall Study|Death from septic shock|0
994242|NCT01367457|2006443|FG000|Overall Study|CD, Suspected disease progression (DP)|1
994243|NCT01367457|2006444|FG001|Overall Study|CD, Suspected disease progression (DP)|0
994244|NCT01367457|2006445|FG002|Overall Study|CD, Suspected disease progression (DP)|0
994245|NCT01367457|2006443|FG000|Overall Study|Patient's Wish|1
994246|NCT01367457|2006444|FG001|Overall Study|Patient's Wish|0
994247|NCT01367457|2006445|FG002|Overall Study|Patient's Wish|0
994248|NCT01367457|2006443|FG000|Overall Study|Palliative. Overall decline|1
994249|NCT01367457|2006444|FG001|Overall Study|Palliative. Overall decline|0
994250|NCT01367457|2006445|FG002|Overall Study|Palliative. Overall decline|0
994251|NCT01367457|2006443|FG000|Overall Study|Suspected DP/suspected active infection|1
994252|NCT01367457|2006444|FG001|Overall Study|Suspected DP/suspected active infection|0
994253|NCT01367457|2006445|FG002|Overall Study|Suspected DP/suspected active infection|0
994254|NCT01367665|2006455|FG000|Overall Study|Death|102
994255|NCT01367665|2006456|FG001|Overall Study|Death|19
994256|NCT01367665|2006455|FG000|Overall Study|Lost to Follow-up|222
994257|NCT01367665|2006456|FG001|Overall Study|Lost to Follow-up|22
994258|NCT01367665|2006455|FG000|Overall Study|Not Done|118
994259|NCT01367665|2006456|FG001|Overall Study|Not Done|14
994260|NCT01367704|2006465|FG000|Overall Study|Lost to Follow-up|47
994261|NCT01367704|2006466|FG001|Overall Study|Lost to Follow-up|161
994262|NCT01367834|2006474|FG000|Overall Study|Withdrawal by Subject|2
994263|NCT01367834|2006475|FG001|Overall Study|Withdrawal by Subject|2
994264|NCT01367834|2006474|FG000|Overall Study|Study was ended.|0
994265|NCT01367834|2006475|FG001|Overall Study|Study was ended.|1
994266|NCT01367847|2006483|FG000|Overall Study|Withdrawal by Subject|2
994267|NCT01367847|2006484|FG001|Overall Study|Withdrawal by Subject|2
994268|NCT01367886|2006500|FG000|Overall Study|Lost to Follow-up|4
994269|NCT01367886|2006500|FG000|Overall Study|Lack of Efficacy|2
994270|NCT01367886|2006500|FG000|Overall Study|Death|1
994271|NCT01368042|2006505|FG000|Overall Study|Death|14
994272|NCT01368042|2006505|FG000|Overall Study|Protocol Violation|11
994273|NCT01368042|2006505|FG000|Overall Study|Lost to Follow-up|4
994274|NCT01368042|2006505|FG000|Overall Study|Transplanted|1
994275|NCT01368081|2006522|FG000|Overall Study|Adverse Event|4
994276|NCT01368081|2006523|FG001|Overall Study|Adverse Event|4
994277|NCT01368081|2006524|FG002|Overall Study|Adverse Event|3
994278|NCT01368081|2006525|FG003|Overall Study|Adverse Event|2
994279|NCT01368081|2006526|FG004|Overall Study|Adverse Event|2
994280|NCT01368081|2006527|FG005|Overall Study|Adverse Event|5
994281|NCT01368081|2006528|FG006|Overall Study|Adverse Event|6
994282|NCT01368081|2006529|FG007|Overall Study|Adverse Event|2
994283|NCT01368081|2006530|FG008|Overall Study|Adverse Event|3
994284|NCT01368081|2006531|FG009|Overall Study|Adverse Event|5
994285|NCT01368081|2006532|FG010|Overall Study|Adverse Event|6
994286|NCT01368081|2006533|FG011|Overall Study|Adverse Event|1
994287|NCT01368081|2006534|FG012|Overall Study|Adverse Event|3
994288|NCT01368081|2006522|FG000|Overall Study|Lack of Efficacy|0
994289|NCT01368081|2006523|FG001|Overall Study|Lack of Efficacy|1
994290|NCT01368081|2006524|FG002|Overall Study|Lack of Efficacy|0
994291|NCT01368081|2006525|FG003|Overall Study|Lack of Efficacy|1
994292|NCT01368081|2006526|FG004|Overall Study|Lack of Efficacy|0
994293|NCT01368081|2006527|FG005|Overall Study|Lack of Efficacy|0
994294|NCT01368081|2006528|FG006|Overall Study|Lack of Efficacy|0
994295|NCT01368081|2006529|FG007|Overall Study|Lack of Efficacy|2
994296|NCT01368081|2006530|FG008|Overall Study|Lack of Efficacy|0
994297|NCT01368081|2006531|FG009|Overall Study|Lack of Efficacy|0
994298|NCT01368081|2006532|FG010|Overall Study|Lack of Efficacy|0
994299|NCT01368081|2006533|FG011|Overall Study|Lack of Efficacy|0
994300|NCT01368081|2006534|FG012|Overall Study|Lack of Efficacy|0
994301|NCT01368081|2006522|FG000|Overall Study|Protocol Violation|0
994302|NCT01368081|2006523|FG001|Overall Study|Protocol Violation|0
994303|NCT01368081|2006524|FG002|Overall Study|Protocol Violation|0
994304|NCT01368081|2006525|FG003|Overall Study|Protocol Violation|0
994305|NCT01368081|2006526|FG004|Overall Study|Protocol Violation|0
994306|NCT01368081|2006527|FG005|Overall Study|Protocol Violation|1
994307|NCT01368081|2006528|FG006|Overall Study|Protocol Violation|0
994308|NCT01368081|2006529|FG007|Overall Study|Protocol Violation|1
994309|NCT01368081|2006530|FG008|Overall Study|Protocol Violation|0
994310|NCT01368081|2006531|FG009|Overall Study|Protocol Violation|0
994311|NCT01368081|2006532|FG010|Overall Study|Protocol Violation|0
994312|NCT01368081|2006533|FG011|Overall Study|Protocol Violation|0
994313|NCT01368081|2006534|FG012|Overall Study|Protocol Violation|0
994314|NCT01368081|2006522|FG000|Overall Study|Lost to Follow-up|0
994315|NCT01368081|2006523|FG001|Overall Study|Lost to Follow-up|0
994316|NCT01368081|2006524|FG002|Overall Study|Lost to Follow-up|0
994317|NCT01368081|2006525|FG003|Overall Study|Lost to Follow-up|0
994318|NCT01368081|2006526|FG004|Overall Study|Lost to Follow-up|0
994319|NCT01368081|2006527|FG005|Overall Study|Lost to Follow-up|0
994320|NCT01368081|2006528|FG006|Overall Study|Lost to Follow-up|0
994321|NCT01368081|2006529|FG007|Overall Study|Lost to Follow-up|0
994322|NCT01368081|2006530|FG008|Overall Study|Lost to Follow-up|0
994323|NCT01368081|2006531|FG009|Overall Study|Lost to Follow-up|0
994324|NCT01368081|2006532|FG010|Overall Study|Lost to Follow-up|0
994325|NCT01368081|2006533|FG011|Overall Study|Lost to Follow-up|0
994326|NCT01368081|2006534|FG012|Overall Study|Lost to Follow-up|1
994327|NCT01368081|2006522|FG000|Overall Study|Withdrawal by Subject|4
994328|NCT01368081|2006523|FG001|Overall Study|Withdrawal by Subject|4
994329|NCT01368081|2006524|FG002|Overall Study|Withdrawal by Subject|1
994330|NCT01368081|2006525|FG003|Overall Study|Withdrawal by Subject|1
994331|NCT01368081|2006526|FG004|Overall Study|Withdrawal by Subject|0
994332|NCT01368081|2006527|FG005|Overall Study|Withdrawal by Subject|3
994333|NCT01368081|2006528|FG006|Overall Study|Withdrawal by Subject|4
994334|NCT01368081|2006529|FG007|Overall Study|Withdrawal by Subject|2
994335|NCT01368081|2006530|FG008|Overall Study|Withdrawal by Subject|5
994336|NCT01368081|2006531|FG009|Overall Study|Withdrawal by Subject|4
994337|NCT01368081|2006532|FG010|Overall Study|Withdrawal by Subject|3
994338|NCT01368081|2006533|FG011|Overall Study|Withdrawal by Subject|2
994339|NCT01368081|2006534|FG012|Overall Study|Withdrawal by Subject|0
994340|NCT01368081|2006522|FG000|Overall Study|Other reason not defined above|2
994341|NCT01368081|2006523|FG001|Overall Study|Other reason not defined above|0
994342|NCT01368081|2006524|FG002|Overall Study|Other reason not defined above|0
994343|NCT01368081|2006525|FG003|Overall Study|Other reason not defined above|1
994344|NCT01368081|2006526|FG004|Overall Study|Other reason not defined above|0
994345|NCT01368081|2006527|FG005|Overall Study|Other reason not defined above|1
994346|NCT01368081|2006528|FG006|Overall Study|Other reason not defined above|2
994347|NCT01368081|2006529|FG007|Overall Study|Other reason not defined above|0
994348|NCT01368081|2006530|FG008|Overall Study|Other reason not defined above|0
994349|NCT01368081|2006531|FG009|Overall Study|Other reason not defined above|1
994350|NCT01368081|2006532|FG010|Overall Study|Other reason not defined above|0
994351|NCT01368081|2006533|FG011|Overall Study|Other reason not defined above|0
994352|NCT01368081|2006534|FG012|Overall Study|Other reason not defined above|3
994353|NCT01368211|2006568|FG000|Second Platelets Transfusion|No need for additional transfusion|1
994354|NCT01368211|2006569|FG001|Second Platelets Transfusion|No need for additional transfusion|2
994355|NCT01368276|2006590|FG000|Overall Study|Death|1
994356|NCT01368276|2006591|FG001|Overall Study|Death|10
994357|NCT01368406|2006599|FG000|Overall Study|Lost to Follow-up|8
994358|NCT01368406|2006600|FG001|Overall Study|Lost to Follow-up|4
994359|NCT01368406|2006599|FG000|Overall Study|Withdrawal by Subject|8
994360|NCT01368406|2006600|FG001|Overall Study|Withdrawal by Subject|4
994361|NCT01368406|2006599|FG000|Overall Study|relapse of the disease|3
994362|NCT01368406|2006600|FG001|Overall Study|relapse of the disease|2
994363|NCT01368406|2006599|FG000|Overall Study|started working|2
994364|NCT01368406|2006600|FG001|Overall Study|started working|3
994365|NCT01368432|2006608|FG000|Overall Study|Lost to Follow-up|0
994366|NCT01368432|2006609|FG001|Overall Study|Lost to Follow-up|1
994367|NCT01368497|2006629|FG000|Overall Study|Lost to Follow-up|2
994368|NCT01368536|2006636|FG000|Overall Study|Adverse Event|5
994369|NCT01368536|2006637|FG001|Overall Study|Adverse Event|6
994370|NCT01368536|2006638|FG002|Overall Study|Adverse Event|8
994371|NCT01368536|2006636|FG000|Overall Study|Abnormal laboratory value(s)|0
994372|NCT01368536|2006637|FG001|Overall Study|Abnormal laboratory value(s)|1
994373|NCT01368536|2006638|FG002|Overall Study|Abnormal laboratory value(s)|2
994374|NCT01368536|2006636|FG000|Overall Study|Abnormal test procedure result(s)|0
994375|NCT01368536|2006637|FG001|Overall Study|Abnormal test procedure result(s)|0
994376|NCT01368536|2006638|FG002|Overall Study|Abnormal test procedure result(s)|1
994377|NCT01368536|2006636|FG000|Overall Study|Unsatisfactory therapeutic effect|7
994378|NCT01368536|2006637|FG001|Overall Study|Unsatisfactory therapeutic effect|2
994379|NCT01368536|2006638|FG002|Overall Study|Unsatisfactory therapeutic effect|2
994380|NCT01368536|2006636|FG000|Overall Study|No longer required study medication|0
994381|NCT01368536|2006637|FG001|Overall Study|No longer required study medication|0
994382|NCT01368536|2006638|FG002|Overall Study|No longer required study medication|1
994383|NCT01368536|2006636|FG000|Overall Study|Withdrawal by Subject|2
994384|NCT01368536|2006637|FG001|Overall Study|Withdrawal by Subject|5
994385|NCT01368536|2006638|FG002|Overall Study|Withdrawal by Subject|4
994386|NCT01368536|2006636|FG000|Overall Study|Lost to Follow-up|3
994387|NCT01368536|2006637|FG001|Overall Study|Lost to Follow-up|3
994388|NCT01368536|2006638|FG002|Overall Study|Lost to Follow-up|5
994389|NCT01368536|2006636|FG000|Overall Study|Administrative problems|34
994390|NCT01368536|2006637|FG001|Overall Study|Administrative problems|39
994391|NCT01368536|2006638|FG002|Overall Study|Administrative problems|35
994392|NCT01368536|2006636|FG000|Overall Study|Protocol deviation|0
994393|NCT01368536|2006637|FG001|Overall Study|Protocol deviation|3
994394|NCT01368536|2006638|FG002|Overall Study|Protocol deviation|1
994395|NCT01368562|2006647|FG000|Overall Study|Adverse Event|1
994396|NCT01368562|2006647|FG000|Overall Study|Disease progression|1
994397|NCT01368562|2006647|FG000|Overall Study|Lost to Follow-up|1
994398|NCT01368562|2006647|FG000|Overall Study|Death|6
994399|NCT01368562|2006647|FG000|Overall Study|Unresponsive to treatment|5
994400|NCT01368562|2006647|FG000|Overall Study|Other|3
994401|NCT01368562|2006647|FG000|Overall Study|Other than specified|2
994402|NCT01368614|2006651|FG000|Screening Period|Screen Failure|58
994403|NCT01368614|2006652|FG001|Screening Period|Screen Failure|0
994404|NCT01368614|2006653|FG002|Screening Period|Screen Failure|0
994405|NCT01368614|2006654|FG003|Screening Period|Screen Failure|0
994406|NCT01368614|2006651|FG000|Study Period|Withdrawal by Subject|0
994407|NCT01368614|2006652|FG001|Study Period|Withdrawal by Subject|1
994408|NCT01368614|2006653|FG002|Study Period|Withdrawal by Subject|1
994409|NCT01368614|2006654|FG003|Study Period|Withdrawal by Subject|3
994410|NCT01368614|2006651|FG000|Study Period|Lost to Follow-up|0
994411|NCT01368614|2006652|FG001|Study Period|Lost to Follow-up|0
994412|NCT01368614|2006653|FG002|Study Period|Lost to Follow-up|1
994413|NCT01368614|2006654|FG003|Study Period|Lost to Follow-up|0
994414|NCT01368835|2006687|FG000|Overall Study|Inclusion criteria/photography quality|22
994415|NCT01368835|2006687|FG000|Overall Study|Lost to Follow-up|11
994416|NCT01368900|2006739|FG000|Overall Study|Lost to Follow-up|7
994417|NCT01368965|2006745|FG000|Overall Study|Lost to Follow-up|12
994418|NCT01369069|2006757|FG000|Overall Study|Lost to Follow-up|8
994419|NCT01369069|2006758|FG001|Overall Study|Lost to Follow-up|9
994420|NCT01369069|2006757|FG000|Overall Study|Withdrawal by Subject|9
994421|NCT01369069|2006758|FG001|Overall Study|Withdrawal by Subject|7
994422|NCT01369199|2006769|FG000|Overall Study|Withdrawal by Subject|1
994423|NCT01369199|2006769|FG000|Overall Study|Lost to Follow-up|2
994424|NCT01369225|2006779|FG000|Overall Study|Withdrawal by Subject|1
994425|NCT01369225|2006780|FG001|Overall Study|Withdrawal by Subject|0
994426|NCT01369225|2006781|FG002|Overall Study|Withdrawal by Subject|2
994427|NCT01369225|2006782|FG003|Overall Study|Withdrawal by Subject|1
994428|NCT01369225|2006783|FG004|Overall Study|Withdrawal by Subject|0
994429|NCT01369225|2006784|FG005|Overall Study|Withdrawal by Subject|0
994430|NCT01369225|2006779|FG000|Overall Study|Does Not Meet Entrance Criteria|0
994431|NCT01369225|2006780|FG001|Overall Study|Does Not Meet Entrance Criteria|0
994432|NCT01369225|2006781|FG002|Overall Study|Does Not Meet Entrance Criteria|1
994433|NCT01369225|2006782|FG003|Overall Study|Does Not Meet Entrance Criteria|0
994434|NCT01369225|2006783|FG004|Overall Study|Does Not Meet Entrance Criteria|0
994435|NCT01369225|2006784|FG005|Overall Study|Does Not Meet Entrance Criteria|0
994436|NCT01369225|2006779|FG000|Overall Study|Other|1
994437|NCT01369225|2006780|FG001|Overall Study|Other|0
994438|NCT01369225|2006781|FG002|Overall Study|Other|0
994439|NCT01369225|2006782|FG003|Overall Study|Other|0
994440|NCT01369225|2006783|FG004|Overall Study|Other|1
994441|NCT01369225|2006784|FG005|Overall Study|Other|0
994442|NCT01369225|2006779|FG000|Overall Study|Adverse Event|0
994443|NCT01369225|2006780|FG001|Overall Study|Adverse Event|0
994444|NCT01369225|2006781|FG002|Overall Study|Adverse Event|0
994445|NCT01369225|2006782|FG003|Overall Study|Adverse Event|1
994446|NCT01369225|2006783|FG004|Overall Study|Adverse Event|1
994447|NCT01369225|2006784|FG005|Overall Study|Adverse Event|0
994448|NCT01369329|2006801|FG000|Overall Study|Withdrawal by Subject|8
994449|NCT01369329|2006802|FG001|Overall Study|Withdrawal by Subject|6
994450|NCT01369329|2006803|FG002|Overall Study|Withdrawal by Subject|10
994451|NCT01369329|2006801|FG000|Overall Study|Lost to Follow-up|2
994452|NCT01369329|2006802|FG001|Overall Study|Lost to Follow-up|2
994453|NCT01369329|2006803|FG002|Overall Study|Lost to Follow-up|2
994454|NCT01369329|2006801|FG000|Overall Study|Other|2
994455|NCT01369329|2006802|FG001|Overall Study|Other|3
994456|NCT01369329|2006803|FG002|Overall Study|Other|2
994457|NCT01369342|2006814|FG000|Overall Study|Withdrawal by Subject|7
994458|NCT01369342|2006815|FG001|Overall Study|Withdrawal by Subject|7
994459|NCT01369342|2006816|FG002|Overall Study|Withdrawal by Subject|2
994460|NCT01369342|2006814|FG000|Overall Study|Lost to Follow-up|5
994461|NCT01369342|2006815|FG001|Overall Study|Lost to Follow-up|2
994462|NCT01369342|2006816|FG002|Overall Study|Lost to Follow-up|1
994463|NCT01369342|2006814|FG000|Overall Study|Not Treated|1
994464|NCT01369342|2006815|FG001|Overall Study|Not Treated|0
994465|NCT01369342|2006816|FG002|Overall Study|Not Treated|0
994466|NCT01369355|2006830|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9
994467|NCT01369355|2006831|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12
994468|NCT01369355|2006832|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6
994469|NCT01369355|2006833|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7
994470|NCT01369355|2006834|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14
994471|NCT01369355|2006835|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25
994472|NCT01369355|2006836|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0
994473|NCT01369355|2006837|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0
994474|NCT01369355|2006838|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0
994475|NCT01369355|2006830|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
994476|NCT01369355|2006831|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14
994477|NCT01369355|2006832|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
994478|NCT01369355|2006833|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
994479|NCT01369355|2006834|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126
994480|NCT01369355|2006835|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217
994481|NCT01369355|2006836|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
994482|NCT01369355|2006837|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
994483|NCT01369355|2006838|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
994484|NCT01369355|2006830|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
994485|NCT01369355|2006831|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
994486|NCT01369355|2006832|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
994487|NCT01369355|2006833|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
994488|NCT01369355|2006834|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
994489|NCT01369355|2006835|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2
994490|NCT01369355|2006836|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
994491|NCT01369355|2006837|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
994492|NCT01369355|2006838|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
994493|NCT01369355|2006830|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
994494|NCT01369355|2006831|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
994495|NCT01369355|2006832|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
994496|NCT01369355|2006833|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2
994497|NCT01369355|2006834|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5
994498|NCT01369355|2006835|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6
994499|NCT01369355|2006836|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
994500|NCT01369355|2006837|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
994501|NCT01369355|2006838|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
994502|NCT01369355|2006830|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
994503|NCT01369355|2006831|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2
994504|NCT01369355|2006832|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7
994505|NCT01369355|2006833|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
994506|NCT01369355|2006834|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8
994507|NCT01369355|2006835|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22
994508|NCT01369355|2006836|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
994509|NCT01369355|2006837|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
994510|NCT01369355|2006838|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
994511|NCT01369355|2006830|FG000|Week 0 - Week 44 (Maintenance)|Other|0
994512|NCT01369355|2006831|FG001|Week 0 - Week 44 (Maintenance)|Other|0
994513|NCT01369355|2006832|FG002|Week 0 - Week 44 (Maintenance)|Other|1
994514|NCT01369355|2006833|FG003|Week 0 - Week 44 (Maintenance)|Other|0
994515|NCT01369355|2006834|FG004|Week 0 - Week 44 (Maintenance)|Other|1
994516|NCT01369355|2006835|FG005|Week 0 - Week 44 (Maintenance)|Other|0
994517|NCT01369355|2006836|FG006|Week 0 - Week 44 (Maintenance)|Other|0
994518|NCT01369355|2006837|FG007|Week 0 - Week 44 (Maintenance)|Other|0
994519|NCT01369355|2006838|FG008|Week 0 - Week 44 (Maintenance)|Other|0
994520|NCT01369355|2006830|FG000|Long-term Extension (Week 44-272)|Adverse Event|0
994521|NCT01369355|2006831|FG001|Long-term Extension (Week 44-272)|Adverse Event|0
994522|NCT01369355|2006832|FG002|Long-term Extension (Week 44-272)|Adverse Event|0
994523|NCT01369355|2006833|FG003|Long-term Extension (Week 44-272)|Adverse Event|0
994524|NCT01369355|2006834|FG004|Long-term Extension (Week 44-272)|Adverse Event|0
994525|NCT01369355|2006835|FG005|Long-term Extension (Week 44-272)|Adverse Event|0
994526|NCT01369355|2006836|FG006|Long-term Extension (Week 44-272)|Adverse Event|15
994527|NCT01369355|2006837|FG007|Long-term Extension (Week 44-272)|Adverse Event|29
994528|NCT01369355|2006838|FG008|Long-term Extension (Week 44-272)|Adverse Event|53
994529|NCT01369355|2006830|FG000|Long-term Extension (Week 44-272)|Death|0
994530|NCT01369355|2006831|FG001|Long-term Extension (Week 44-272)|Death|0
994531|NCT01369355|2006832|FG002|Long-term Extension (Week 44-272)|Death|0
994532|NCT01369355|2006833|FG003|Long-term Extension (Week 44-272)|Death|0
994533|NCT01369355|2006834|FG004|Long-term Extension (Week 44-272)|Death|0
994534|NCT01369355|2006835|FG005|Long-term Extension (Week 44-272)|Death|0
994535|NCT01369355|2006836|FG006|Long-term Extension (Week 44-272)|Death|0
994536|NCT01369355|2006837|FG007|Long-term Extension (Week 44-272)|Death|1
994537|NCT01369355|2006838|FG008|Long-term Extension (Week 44-272)|Death|3
994538|NCT01369355|2006830|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0
994539|NCT01369355|2006831|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0
994540|NCT01369355|2006832|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0
994541|NCT01369355|2006833|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0
994542|NCT01369355|2006834|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0
994543|NCT01369355|2006835|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0
994544|NCT01369355|2006836|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12
994545|NCT01369355|2006837|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26
994546|NCT01369355|2006838|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29
994547|NCT01369355|2006830|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0
994548|NCT01369355|2006831|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0
994549|NCT01369355|2006832|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0
994550|NCT01369355|2006833|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0
994551|NCT01369355|2006834|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0
994552|NCT01369355|2006835|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0
994553|NCT01369355|2006836|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0
994554|NCT01369355|2006837|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1
994555|NCT01369355|2006838|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2
994556|NCT01369355|2006830|FG000|Long-term Extension (Week 44-272)|Physician Decision|0
994557|NCT01369355|2006831|FG001|Long-term Extension (Week 44-272)|Physician Decision|0
994558|NCT01369355|2006832|FG002|Long-term Extension (Week 44-272)|Physician Decision|0
994559|NCT01369355|2006833|FG003|Long-term Extension (Week 44-272)|Physician Decision|0
994560|NCT01369355|2006834|FG004|Long-term Extension (Week 44-272)|Physician Decision|0
994561|NCT01369355|2006835|FG005|Long-term Extension (Week 44-272)|Physician Decision|0
994562|NCT01369355|2006836|FG006|Long-term Extension (Week 44-272)|Physician Decision|1
994563|NCT01369355|2006837|FG007|Long-term Extension (Week 44-272)|Physician Decision|5
994564|NCT01369355|2006838|FG008|Long-term Extension (Week 44-272)|Physician Decision|11
994565|NCT01369355|2006830|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0
994566|NCT01369355|2006831|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0
994567|NCT01369355|2006832|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0
994568|NCT01369355|2006833|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0
994569|NCT01369355|2006834|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0
994570|NCT01369355|2006835|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0
994571|NCT01369355|2006836|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1
994572|NCT01369355|2006837|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5
994573|NCT01369355|2006838|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9
994574|NCT01369355|2006830|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
994575|NCT01369355|2006831|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
994576|NCT01369355|2006832|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
994577|NCT01369355|2006833|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
994578|NCT01369355|2006834|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
994579|NCT01369355|2006835|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
994580|NCT01369355|2006836|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12
994581|NCT01369355|2006837|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30
994582|NCT01369355|2006838|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47
994583|NCT01369355|2006830|FG000|Long-term Extension (Week 44-272)|Other|0
994584|NCT01369355|2006831|FG001|Long-term Extension (Week 44-272)|Other|0
994585|NCT01369355|2006832|FG002|Long-term Extension (Week 44-272)|Other|0
994586|NCT01369355|2006833|FG003|Long-term Extension (Week 44-272)|Other|0
994587|NCT01369355|2006834|FG004|Long-term Extension (Week 44-272)|Other|0
994588|NCT01369355|2006835|FG005|Long-term Extension (Week 44-272)|Other|0
994589|NCT01369355|2006836|FG006|Long-term Extension (Week 44-272)|Other|110
994590|NCT01369355|2006837|FG007|Long-term Extension (Week 44-272)|Other|9
994591|NCT01369355|2006838|FG008|Long-term Extension (Week 44-272)|Other|17
994592|NCT01369433|2006857|FG000|Overall Study|Adverse Event|31
994593|NCT01369433|2006858|FG001|Overall Study|Adverse Event|1
994594|NCT01369433|2006857|FG000|Overall Study|Required significant surgical procedure|1
994595|NCT01369433|2006858|FG001|Overall Study|Required significant surgical procedure|0
994596|NCT01369433|2006857|FG000|Overall Study|Non-compliance|1
994597|NCT01369433|2006858|FG001|Overall Study|Non-compliance|0
994598|NCT01369433|2006857|FG000|Overall Study|Withdrawal by Subject|5
994599|NCT01369433|2006858|FG001|Overall Study|Withdrawal by Subject|2
994600|NCT01369433|2006857|FG000|Overall Study|Study terminated by Sponsor|67
994601|NCT01369433|2006858|FG001|Overall Study|Study terminated by Sponsor|0
994602|NCT01369433|2006857|FG000|Overall Study|Lost to Follow-up|1
994603|NCT01369433|2006858|FG001|Overall Study|Lost to Follow-up|0
994604|NCT01369433|2006857|FG000|Overall Study|Death|5
994605|NCT01369433|2006858|FG001|Overall Study|Death|0
994606|NCT01369433|2006857|FG000|Overall Study|Investigator discretion|6
994607|NCT01369433|2006858|FG001|Overall Study|Investigator discretion|1
994608|NCT01369433|2006857|FG000|Overall Study|Progressive Disease|92
994609|NCT01369433|2006858|FG001|Overall Study|Progressive Disease|12
994610|NCT01369485|2006866|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
994611|NCT01369485|2006867|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
994612|NCT01369485|2006866|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
994613|NCT01369485|2006867|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
994614|NCT01369485|2006866|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
994615|NCT01369485|2006867|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
994616|NCT01369485|2006866|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2
994617|NCT01369485|2006867|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0
994618|NCT01369485|2006866|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
994619|NCT01369485|2006867|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
994620|NCT01369485|2006866|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
994621|NCT01369485|2006867|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
994622|NCT01369485|2006866|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
994623|NCT01369485|2006867|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
994624|NCT01369485|2006866|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
994625|NCT01369485|2006867|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
994626|NCT01369485|2006866|FG000|Open Label Phase (Week 12 to Month 12)|Death|0
994627|NCT01369485|2006867|FG001|Open Label Phase (Week 12 to Month 12)|Death|1
994628|NCT01369485|2006866|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
994629|NCT01369485|2006867|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
994630|NCT01369498|2006885|FG000|Overall Study|Lack of Efficacy|9
994631|NCT01369498|2006886|FG001|Overall Study|Lack of Efficacy|9
994632|NCT01369498|2006887|FG002|Overall Study|Lack of Efficacy|1
994633|NCT01369498|2006888|FG003|Overall Study|Lack of Efficacy|3
994634|NCT01369498|2006885|FG000|Overall Study|Adverse Event|1
994635|NCT01369498|2006886|FG001|Overall Study|Adverse Event|2
994636|NCT01369498|2006887|FG002|Overall Study|Adverse Event|0
994637|NCT01369498|2006888|FG003|Overall Study|Adverse Event|1
994638|NCT01369498|2006885|FG000|Overall Study|Withdrawal of Consent|0
994639|NCT01369498|2006886|FG001|Overall Study|Withdrawal of Consent|1
994640|NCT01369498|2006887|FG002|Overall Study|Withdrawal of Consent|1
994641|NCT01369498|2006888|FG003|Overall Study|Withdrawal of Consent|1
994642|NCT01369498|2006885|FG000|Overall Study|Death|0
994643|NCT01369498|2006886|FG001|Overall Study|Death|0
994644|NCT01369498|2006887|FG002|Overall Study|Death|1
994645|NCT01369498|2006888|FG003|Overall Study|Death|0
994646|NCT01369498|2006885|FG000|Overall Study|Investigator's Discretion|1
994647|NCT01369498|2006886|FG001|Overall Study|Investigator's Discretion|0
994648|NCT01369498|2006887|FG002|Overall Study|Investigator's Discretion|1
994649|NCT01369498|2006888|FG003|Overall Study|Investigator's Discretion|3
994650|NCT01369498|2006885|FG000|Overall Study|Unknown Reason|1
994651|NCT01369498|2006886|FG001|Overall Study|Unknown Reason|0
994652|NCT01369498|2006887|FG002|Overall Study|Unknown Reason|11
994653|NCT01369498|2006888|FG003|Overall Study|Unknown Reason|6
994654|NCT01369498|2006885|FG000|Overall Study|Disease Progression|0
994655|NCT01369498|2006886|FG001|Overall Study|Disease Progression|0
994656|NCT01369498|2006887|FG002|Overall Study|Disease Progression|0
994657|NCT01369498|2006888|FG003|Overall Study|Disease Progression|1
994658|NCT01369511|2006903|FG000|Overall Study|Adverse Event|1
994659|NCT01369511|2006904|FG001|Overall Study|Adverse Event|1
994660|NCT01369511|2006905|FG002|Overall Study|Adverse Event|5
994661|NCT01369511|2006906|FG003|Overall Study|Adverse Event|0
994662|NCT01369511|2006903|FG000|Overall Study|Entry criteria not met|2
994663|NCT01369511|2006904|FG001|Overall Study|Entry criteria not met|0
994664|NCT01369511|2006905|FG002|Overall Study|Entry criteria not met|0
994665|NCT01369511|2006906|FG003|Overall Study|Entry criteria not met|1
994666|NCT01369511|2006903|FG000|Overall Study|Lost to Follow-up|0
994667|NCT01369511|2006904|FG001|Overall Study|Lost to Follow-up|1
994668|NCT01369511|2006905|FG002|Overall Study|Lost to Follow-up|1
994669|NCT01369511|2006906|FG003|Overall Study|Lost to Follow-up|2
994670|NCT01369511|2006903|FG000|Overall Study|Protocol Violation|0
994671|NCT01369511|2006904|FG001|Overall Study|Protocol Violation|1
994672|NCT01369511|2006905|FG002|Overall Study|Protocol Violation|0
994673|NCT01369511|2006906|FG003|Overall Study|Protocol Violation|2
994674|NCT01369511|2006903|FG000|Overall Study|Physician Decision|3
994675|NCT01369511|2006904|FG001|Overall Study|Physician Decision|4
994676|NCT01369511|2006905|FG002|Overall Study|Physician Decision|0
994677|NCT01369511|2006906|FG003|Overall Study|Physician Decision|0
994678|NCT01369511|2006903|FG000|Overall Study|Sponsor decision|2
994679|NCT01369511|2006904|FG001|Overall Study|Sponsor decision|0
994680|NCT01369511|2006905|FG002|Overall Study|Sponsor decision|1
994681|NCT01369511|2006906|FG003|Overall Study|Sponsor decision|0
994682|NCT01369511|2006903|FG000|Overall Study|Withdrawal by Subject|5
994683|NCT01369511|2006904|FG001|Overall Study|Withdrawal by Subject|6
994684|NCT01369511|2006905|FG002|Overall Study|Withdrawal by Subject|4
994685|NCT01369511|2006906|FG003|Overall Study|Withdrawal by Subject|6
994686|NCT01369615|2006918|FG000|Overall Study|Withdrawal by Subject|0
994687|NCT01369615|2006919|FG001|Overall Study|Withdrawal by Subject|1
994688|NCT01369615|2006918|FG000|Overall Study|Lost to Follow-up|0
994689|NCT01369615|2006919|FG001|Overall Study|Lost to Follow-up|1
994690|NCT01369680|2006929|FG000|Overall Study|Lost to Follow-up|0
994691|NCT01369680|2006930|FG001|Overall Study|Lost to Follow-up|0
994692|NCT01369680|2006931|FG002|Overall Study|Lost to Follow-up|1
994693|NCT01369680|2006932|FG003|Overall Study|Lost to Follow-up|2
994694|NCT01369784|2006991|FG000|Overall Study|Protocol Violation|12
994695|NCT01369849|2006998|FG000|Overall Study|Ineligible prior to treatment|0
994696|NCT01369849|2006999|FG001|Overall Study|Ineligible prior to treatment|0
994697|NCT01369849|2007000|FG002|Overall Study|Ineligible prior to treatment|1
994698|NCT01369849|2006998|FG000|Overall Study|Ineligible after receiving treatment|0
994699|NCT01369849|2006999|FG001|Overall Study|Ineligible after receiving treatment|1
994700|NCT01369849|2007000|FG002|Overall Study|Ineligible after receiving treatment|0
994701|NCT01370005|2007035|FG000|Overall Study|Not treated|1
994702|NCT01370005|2007036|FG001|Overall Study|Not treated|0
994703|NCT01370005|2007037|FG002|Overall Study|Not treated|0
994704|NCT01370005|2007035|FG000|Overall Study|Adverse Event|5
994705|NCT01370005|2007036|FG001|Overall Study|Adverse Event|5
994706|NCT01370005|2007037|FG002|Overall Study|Adverse Event|6
994707|NCT01370005|2007035|FG000|Overall Study|Lack of Efficacy|1
994708|NCT01370005|2007036|FG001|Overall Study|Lack of Efficacy|0
994709|NCT01370005|2007037|FG002|Overall Study|Lack of Efficacy|0
994710|NCT01370005|2007035|FG000|Overall Study|Non compliant with protocol|0
994711|NCT01370005|2007036|FG001|Overall Study|Non compliant with protocol|1
994712|NCT01370005|2007037|FG002|Overall Study|Non compliant with protocol|2
994713|NCT01370005|2007035|FG000|Overall Study|Lost to Follow-up|1
994714|NCT01370005|2007036|FG001|Overall Study|Lost to Follow-up|1
994715|NCT01370005|2007037|FG002|Overall Study|Lost to Follow-up|1
994716|NCT01370005|2007035|FG000|Overall Study|Patient refusal to continue,not due toAE|5
994717|NCT01370005|2007036|FG001|Overall Study|Patient refusal to continue,not due toAE|4
994718|NCT01370005|2007037|FG002|Overall Study|Patient refusal to continue,not due toAE|0
994719|NCT01370005|2007035|FG000|Overall Study|Other reason not defined above|3
994720|NCT01370005|2007036|FG001|Overall Study|Other reason not defined above|0
994721|NCT01370005|2007037|FG002|Overall Study|Other reason not defined above|2
994722|NCT01370018|2007045|FG000|Overall Study|Did not meet criteria for analysis|1
994723|NCT01370083|2007051|FG000|Overall Study|Lost to Follow-up|2
994724|NCT01370083|2007052|FG001|Overall Study|Lost to Follow-up|0
994725|NCT01370083|2007051|FG000|Overall Study|Adverse Event|0
994726|NCT01370083|2007052|FG001|Overall Study|Adverse Event|1
994727|NCT01370213|2007078|FG000|Overall Study|Early Death|1
994728|NCT01370213|2007079|FG001|Overall Study|Early Death|0
994729|NCT01370213|2007080|FG002|Overall Study|Early Death|0
994730|NCT01370213|2007078|FG000|Overall Study|Not evaluable|0
994731|NCT01370213|2007079|FG001|Overall Study|Not evaluable|2
994732|NCT01370213|2007080|FG002|Overall Study|Not evaluable|0
994733|NCT01370265|2007087|FG000|First Intervention|Adverse Event|1
994734|NCT01370265|2007088|FG001|First Intervention|Adverse Event|1
994735|NCT01370317|2007097|FG000|Overall Study|Participant withdrew consent|1
994736|NCT01370317|2007098|FG001|Overall Study|Participant withdrew consent|0
994737|NCT01370317|2007097|FG000|Overall Study|Protocol deviation|0
994738|NCT01370317|2007098|FG001|Overall Study|Protocol deviation|1
994739|NCT01370356|2007106|FG000|Overall Study|Death|1
994740|NCT01370356|2007107|FG001|Overall Study|Death|0
994741|NCT01370356|2007106|FG000|Overall Study|Lack of Efficacy|6
994742|NCT01370356|2007107|FG001|Overall Study|Lack of Efficacy|28
994743|NCT01370356|2007106|FG000|Overall Study|Lost to Follow-up|76
994744|NCT01370356|2007107|FG001|Overall Study|Lost to Follow-up|81
994745|NCT01370356|2007106|FG000|Overall Study|Withdrawal by Subject|54
994746|NCT01370356|2007107|FG001|Overall Study|Withdrawal by Subject|59
994747|NCT01370356|2007106|FG000|Overall Study|Reason not specified|39
994748|NCT01370356|2007107|FG001|Overall Study|Reason not specified|43
994749|NCT01370356|2007106|FG000|Overall Study|Protocol Violation|3
994750|NCT01370356|2007107|FG001|Overall Study|Protocol Violation|3
994751|NCT01370356|2007106|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12
994752|NCT01370356|2007107|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9
994753|NCT01370356|2007106|FG000|Overall Study|AE Not Related to Study Drug|1
994754|NCT01370356|2007107|FG001|Overall Study|AE Not Related to Study Drug|4
994755|NCT01370408|2007126|FG000|Overall Study|treatment failure|9
994756|NCT01370499|2007142|FG000|Overall Study|Adverse Event|38
994757|NCT01370499|2007143|FG001|Overall Study|Adverse Event|12
994758|NCT01370499|2007142|FG000|Overall Study|Lack of Efficacy|4
994759|NCT01370499|2007143|FG001|Overall Study|Lack of Efficacy|2
994760|NCT01370499|2007142|FG000|Overall Study|Lost to Follow-up|2
994761|NCT01370499|2007143|FG001|Overall Study|Lost to Follow-up|1
994762|NCT01370499|2007142|FG000|Overall Study|Physician Decision|3
994763|NCT01370499|2007143|FG001|Overall Study|Physician Decision|3
994764|NCT01370499|2007142|FG000|Overall Study|Protocol Violation|5
994765|NCT01370499|2007143|FG001|Overall Study|Protocol Violation|4
994766|NCT01370499|2007142|FG000|Overall Study|Withdrawal by Subject|18
994767|NCT01370499|2007143|FG001|Overall Study|Withdrawal by Subject|7
994768|NCT01370499|2007142|FG000|Overall Study|Sponsor Decision|41
994769|NCT01370499|2007143|FG001|Overall Study|Sponsor Decision|15
994770|NCT01370525|2007153|FG000|Overall Study|Voluntary Discontinuation by Subject|2
994771|NCT01370525|2007154|FG001|Overall Study|Voluntary Discontinuation by Subject|3
994772|NCT01370525|2007153|FG000|Overall Study|Eligibility criteria not fulfilled|2
994773|NCT01370525|2007154|FG001|Overall Study|Eligibility criteria not fulfilled|0
994774|NCT01370525|2007153|FG000|Overall Study|Adverse Event|0
994775|NCT01370525|2007154|FG001|Overall Study|Adverse Event|1
994776|NCT01370525|2007153|FG000|Overall Study|Protocol Violation|2
994777|NCT01370525|2007154|FG001|Overall Study|Protocol Violation|1
994778|NCT01370525|2007153|FG000|Overall Study|Lost to follow up|2
994779|NCT01370525|2007154|FG001|Overall Study|Lost to follow up|6
994780|NCT01370538|2007162|FG000|Overall Study|Voluntary Discontinuation by Subject|3
994781|NCT01370538|2007163|FG001|Overall Study|Voluntary Discontinuation by Subject|2
994782|NCT01370538|2007162|FG000|Overall Study|Eligibility criteria not fulfilled|0
994783|NCT01370538|2007163|FG001|Overall Study|Eligibility criteria not fulfilled|1
994784|NCT01370538|2007162|FG000|Overall Study|Adverse Event|1
994785|NCT01370538|2007163|FG001|Overall Study|Adverse Event|0
994786|NCT01370538|2007162|FG000|Overall Study|Protocol Violation|8
994787|NCT01370538|2007163|FG001|Overall Study|Protocol Violation|5
994788|NCT01370538|2007162|FG000|Overall Study|Development of study specific withdrawal|1
994789|NCT01370538|2007163|FG001|Overall Study|Development of study specific withdrawal|1
994790|NCT01370538|2007162|FG000|Overall Study|Lost to follow up|6
994791|NCT01370538|2007163|FG001|Overall Study|Lost to follow up|10
994792|NCT01370590|2007175|FG000|Period 1|Adverse Event|8
994793|NCT01370590|2007176|FG001|Period 1|Adverse Event|4
994794|NCT01370590|2007175|FG000|Period 1|Lost to Follow-up|2
994795|NCT01370590|2007176|FG001|Period 1|Lost to Follow-up|2
994796|NCT01370590|2007175|FG000|Period 1|Protocol Violation|2
994797|NCT01370590|2007176|FG001|Period 1|Protocol Violation|2
994798|NCT01370590|2007175|FG000|Period 1|Withdrawal by Subject|4
994799|NCT01370590|2007176|FG001|Period 1|Withdrawal by Subject|2
994800|NCT01370590|2007175|FG000|Period 1|Could not access randomization system|0
994801|NCT01370590|2007176|FG001|Period 1|Could not access randomization system|1
994802|NCT01370590|2007175|FG000|Crossover Washout Period|Adverse Event|1
994803|NCT01370590|2007176|FG001|Crossover Washout Period|Adverse Event|4
994804|NCT01370590|2007175|FG000|Crossover Washout Period|Lost to Follow-up|2
994805|NCT01370590|2007176|FG001|Crossover Washout Period|Lost to Follow-up|0
994806|NCT01370590|2007175|FG000|Crossover Washout Period|Non-compliance with Study Drug|1
994807|NCT01370590|2007176|FG001|Crossover Washout Period|Non-compliance with Study Drug|0
994808|NCT01370590|2007175|FG000|Crossover Washout Period|Withdrawal by Subject|2
994809|NCT01370590|2007176|FG001|Crossover Washout Period|Withdrawal by Subject|2
994810|NCT01370590|2007175|FG000|Period 2|Adverse Event|0
994811|NCT01370590|2007176|FG001|Period 2|Adverse Event|1
994812|NCT01370590|2007175|FG000|Period 2|Withdrawal by Subject|1
994813|NCT01370590|2007176|FG001|Period 2|Withdrawal by Subject|1
994814|NCT01370603|2007184|FG000|Period 1|Adverse Event|5
994815|NCT01370603|2007185|FG001|Period 1|Adverse Event|3
994816|NCT01370603|2007184|FG000|Period 1|Lost to Follow-up|2
994817|NCT01370603|2007185|FG001|Period 1|Lost to Follow-up|0
994818|NCT01370603|2007184|FG000|Period 1|Protocol Violation|2
994819|NCT01370603|2007185|FG001|Period 1|Protocol Violation|2
994820|NCT01370603|2007184|FG000|Period 1|Withdrawal by Subject|5
994821|NCT01370603|2007185|FG001|Period 1|Withdrawal by Subject|5
994822|NCT01370603|2007184|FG000|Crossover Washout|Adverse Event|2
994823|NCT01370603|2007185|FG001|Crossover Washout|Adverse Event|1
994824|NCT01370603|2007184|FG000|Crossover Washout|Lost to Follow-up|2
994825|NCT01370603|2007185|FG001|Crossover Washout|Lost to Follow-up|0
994826|NCT01370603|2007184|FG000|Crossover Washout|Protocol Violation|1
994827|NCT01370603|2007185|FG001|Crossover Washout|Protocol Violation|0
994828|NCT01370603|2007184|FG000|Crossover Washout|Withdrawal by Subject|4
994829|NCT01370603|2007185|FG001|Crossover Washout|Withdrawal by Subject|1
994830|NCT01370603|2007184|FG000|Crossover Washout|Non-compliance with Study Drug|0
994831|NCT01370603|2007185|FG001|Crossover Washout|Non-compliance with Study Drug|2
994832|NCT01370603|2007184|FG000|Period 2|Adverse Event|1
994833|NCT01370603|2007185|FG001|Period 2|Adverse Event|4
994834|NCT01370603|2007184|FG000|Period 2|Lost to Follow-up|1
994835|NCT01370603|2007185|FG001|Period 2|Lost to Follow-up|0
994836|NCT01370603|2007184|FG000|Period 2|Withdrawal by Subject|1
994837|NCT01370603|2007185|FG001|Period 2|Withdrawal by Subject|0
994838|NCT01370616|2007193|FG000|Overall Study|Adverse Event|11
994839|NCT01370616|2007194|FG001|Overall Study|Adverse Event|16
994840|NCT01370616|2007193|FG000|Overall Study|Death|1
994841|NCT01370616|2007194|FG001|Overall Study|Death|0
994842|NCT01370616|2007193|FG000|Overall Study|Lack of Efficacy|6
994843|NCT01370616|2007194|FG001|Overall Study|Lack of Efficacy|2
994844|NCT01370616|2007193|FG000|Overall Study|Lost to Follow-up|0
994845|NCT01370616|2007194|FG001|Overall Study|Lost to Follow-up|3
994846|NCT01370616|2007193|FG000|Overall Study|Physician Decision|6
994847|NCT01370616|2007194|FG001|Overall Study|Physician Decision|6
994848|NCT01370616|2007193|FG000|Overall Study|Progressive Disease|0
994849|NCT01370616|2007194|FG001|Overall Study|Progressive Disease|1
994850|NCT01370616|2007193|FG000|Overall Study|Recovery|1
994851|NCT01370616|2007194|FG001|Overall Study|Recovery|0
994852|NCT01370616|2007193|FG000|Overall Study|Technical Problems|3
994853|NCT01370616|2007194|FG001|Overall Study|Technical Problems|5
994854|NCT01370616|2007193|FG000|Overall Study|Withdrawal by Subject|34
994855|NCT01370616|2007194|FG001|Overall Study|Withdrawal by Subject|34
994856|NCT01370642|2007207|FG000|Overall Study|Adverse Event|2
994857|NCT01370642|2007208|FG001|Overall Study|Adverse Event|1
994858|NCT01370642|2007209|FG002|Overall Study|Adverse Event|1
994859|NCT01370642|2007207|FG000|Overall Study|Detectable HCV RNA|0
994860|NCT01370642|2007208|FG001|Overall Study|Detectable HCV RNA|0
994861|NCT01370642|2007209|FG002|Overall Study|Detectable HCV RNA|22
994862|NCT01370642|2007207|FG000|Overall Study|Lost to Follow-up|0
994863|NCT01370642|2007208|FG001|Overall Study|Lost to Follow-up|0
994864|NCT01370642|2007209|FG002|Overall Study|Lost to Follow-up|1
994865|NCT01370642|2007207|FG000|Overall Study|Physician Decision|4
994866|NCT01370642|2007208|FG001|Overall Study|Physician Decision|1
994867|NCT01370642|2007209|FG002|Overall Study|Physician Decision|2
994868|NCT01370642|2007207|FG000|Overall Study|Withdrawal by Subject|2
994869|NCT01370642|2007208|FG001|Overall Study|Withdrawal by Subject|4
994870|NCT01370642|2007209|FG002|Overall Study|Withdrawal by Subject|3
994871|NCT01370655|2007229|FG000|Period 1|Adverse Event|2
994872|NCT01370655|2007230|FG001|Period 1|Adverse Event|0
994873|NCT01370655|2007231|FG002|Period 1|Adverse Event|0
994874|NCT01370655|2007232|FG003|Period 1|Adverse Event|0
994875|NCT01370655|2007233|FG004|Period 1|Adverse Event|0
994876|NCT01370655|2007234|FG005|Period 1|Adverse Event|0
994877|NCT01370655|2007235|FG006|Period 1|Adverse Event|1
994878|NCT01370655|2007236|FG007|Period 1|Adverse Event|0
994879|NCT01370655|2007237|FG008|Period 1|Adverse Event|0
994880|NCT01370655|2007238|FG009|Period 1|Adverse Event|0
994881|NCT01370655|2007239|FG010|Period 1|Adverse Event|0
994882|NCT01370655|2007240|FG011|Period 1|Adverse Event|0
994883|NCT01370655|2007229|FG000|Period 2|Adverse Event|0
994884|NCT01370655|2007230|FG001|Period 2|Adverse Event|0
994885|NCT01370655|2007231|FG002|Period 2|Adverse Event|1
994886|NCT01370655|2007232|FG003|Period 2|Adverse Event|0
994887|NCT01370655|2007233|FG004|Period 2|Adverse Event|1
994888|NCT01370655|2007234|FG005|Period 2|Adverse Event|0
994889|NCT01370655|2007235|FG006|Period 2|Adverse Event|0
994890|NCT01370655|2007236|FG007|Period 2|Adverse Event|1
994891|NCT01370655|2007237|FG008|Period 2|Adverse Event|0
994892|NCT01370655|2007238|FG009|Period 2|Adverse Event|0
994893|NCT01370655|2007239|FG010|Period 2|Adverse Event|0
994894|NCT01370655|2007240|FG011|Period 2|Adverse Event|0
994895|NCT01370655|2007229|FG000|Period 2|met protocol specified stopping criteria|0
994896|NCT01370655|2007230|FG001|Period 2|met protocol specified stopping criteria|0
994897|NCT01370655|2007231|FG002|Period 2|met protocol specified stopping criteria|1
994898|NCT01370655|2007232|FG003|Period 2|met protocol specified stopping criteria|0
994899|NCT01370655|2007233|FG004|Period 2|met protocol specified stopping criteria|0
994900|NCT01370655|2007234|FG005|Period 2|met protocol specified stopping criteria|0
994901|NCT01370655|2007235|FG006|Period 2|met protocol specified stopping criteria|1
994902|NCT01370655|2007236|FG007|Period 2|met protocol specified stopping criteria|0
994903|NCT01370655|2007237|FG008|Period 2|met protocol specified stopping criteria|1
994904|NCT01370655|2007238|FG009|Period 2|met protocol specified stopping criteria|0
994905|NCT01370655|2007239|FG010|Period 2|met protocol specified stopping criteria|1
994906|NCT01370655|2007240|FG011|Period 2|met protocol specified stopping criteria|0
994907|NCT01370655|2007229|FG000|Period 2|Withdrawal by Subject|0
994908|NCT01370655|2007230|FG001|Period 2|Withdrawal by Subject|0
994909|NCT01370655|2007231|FG002|Period 2|Withdrawal by Subject|0
994910|NCT01370655|2007232|FG003|Period 2|Withdrawal by Subject|0
994911|NCT01370655|2007233|FG004|Period 2|Withdrawal by Subject|0
994912|NCT01370655|2007234|FG005|Period 2|Withdrawal by Subject|0
994913|NCT01370655|2007235|FG006|Period 2|Withdrawal by Subject|0
994914|NCT01370655|2007236|FG007|Period 2|Withdrawal by Subject|0
994915|NCT01370655|2007237|FG008|Period 2|Withdrawal by Subject|1
994916|NCT01370655|2007238|FG009|Period 2|Withdrawal by Subject|0
994917|NCT01370655|2007239|FG010|Period 2|Withdrawal by Subject|0
994918|NCT01370655|2007240|FG011|Period 2|Withdrawal by Subject|0
994919|NCT01370694|2007250|FG000|Overall Study|Switched to rituximab|4
994920|NCT01370694|2007250|FG000|Overall Study|Progressive disease|2
994921|NCT01370733|2007256|FG000|Overall Study|Withdrawal by Subject|8
994922|NCT01370733|2007257|FG001|Overall Study|Withdrawal by Subject|8
994923|NCT01370733|2007256|FG000|Overall Study|Lost to Follow-up|3
994924|NCT01370733|2007257|FG001|Overall Study|Lost to Follow-up|0
994925|NCT01370733|2007256|FG000|Overall Study|Adverse Event|2
994926|NCT01370733|2007257|FG001|Overall Study|Adverse Event|4
994927|NCT01370733|2007256|FG000|Overall Study|Lack of Efficacy|3
994928|NCT01370733|2007257|FG001|Overall Study|Lack of Efficacy|5
994929|NCT01370733|2007256|FG000|Overall Study|Physician Decision|0
994930|NCT01370733|2007257|FG001|Overall Study|Physician Decision|2
994931|NCT01370733|2007256|FG000|Overall Study|Protocol Violation|1
994932|NCT01370733|2007257|FG001|Overall Study|Protocol Violation|3
994933|NCT01370863|2007278|FG000|Overall Study|Adverse Event|1
994934|NCT01370863|2007279|FG001|Overall Study|Adverse Event|1
994935|NCT01370863|2007278|FG000|Overall Study|Did not want second pH/MII monitoring|1
994936|NCT01370863|2007279|FG001|Overall Study|Did not want second pH/MII monitoring|1
994937|NCT01370863|2007278|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
994938|NCT01370863|2007279|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
994939|NCT01371006|2007287|FG000|Overall Study|Adverse Event|1
994940|NCT01371006|2007288|FG001|Overall Study|Adverse Event|0
994941|NCT01371539|2007360|FG000|Period One: One Week|Lost to Follow-up|0
994942|NCT01371539|2007361|FG001|Period One: One Week|Lost to Follow-up|1
994943|NCT01371539|2007360|FG000|Period Two: One Week|Lost to Follow-up|0
994944|NCT01371539|2007361|FG001|Period Two: One Week|Lost to Follow-up|1
994945|NCT01371539|2007360|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0
994946|NCT01371539|2007361|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1
994947|NCT01371539|2007360|FG000|Period Two: One Week|Time/job conflict|0
994948|NCT01371539|2007361|FG001|Period Two: One Week|Time/job conflict|1
994949|NCT01371552|2007367|FG000|Part 1, First 3 Days|Inconvenience|0
994950|NCT01371552|2007368|FG001|Part 1, First 3 Days|Inconvenience|0
994951|NCT01371552|2007369|FG002|Part 1, First 3 Days|Inconvenience|1
994952|NCT01371552|2007370|FG003|Part 1, First 3 Days|Inconvenience|0
994953|NCT01371552|2007371|FG004|Part 1, First 3 Days|Inconvenience|0
994954|NCT01371552|2007372|FG005|Part 1, First 3 Days|Inconvenience|0
994955|NCT01371565|2007381|FG000|Overall Study|Withdrawal by Subject|1
994956|NCT01371565|2007381|FG000|Overall Study|Death|1
994957|NCT01371565|2007381|FG000|Overall Study|Resection of neuroendocrine tumor|1
994958|NCT01371643|2007387|FG000|Overall Study|Withdrawal by Subject|3
994959|NCT01371643|2007388|FG001|Overall Study|Withdrawal by Subject|0
994960|NCT01371656|2007396|FG000|Overall Study|Death|7
994961|NCT01371656|2007397|FG001|Overall Study|Death|4
994962|NCT01371656|2007396|FG000|Overall Study|Physician Decision|46
994963|NCT01371656|2007397|FG001|Overall Study|Physician Decision|7
994964|NCT01371656|2007396|FG000|Overall Study|Withdrawal by Subject|7
994965|NCT01371656|2007397|FG001|Overall Study|Withdrawal by Subject|0
994966|NCT01371656|2007396|FG000|Overall Study|Ineligible|4
994967|NCT01371656|2007397|FG001|Overall Study|Ineligible|3
994968|NCT01371708|2007406|FG000|Overall Study|Insufficient clinical response|3
994969|NCT01371708|2007407|FG001|Overall Study|Insufficient clinical response|2
994970|NCT01371708|2007408|FG002|Overall Study|Insufficient clinical response|0
994971|NCT01371708|2007406|FG000|Overall Study|Lost to Follow-up|5
994972|NCT01371708|2007407|FG001|Overall Study|Lost to Follow-up|9
994973|NCT01371708|2007408|FG002|Overall Study|Lost to Follow-up|7
994974|NCT01371708|2007406|FG000|Overall Study|Protocol Violation|2
994975|NCT01371708|2007407|FG001|Overall Study|Protocol Violation|1
994976|NCT01371708|2007408|FG002|Overall Study|Protocol Violation|2
994977|NCT01371708|2007406|FG000|Overall Study|No longer willing to participate|7
994978|NCT01371708|2007407|FG001|Overall Study|No longer willing to participate|7
994979|NCT01371708|2007408|FG002|Overall Study|No longer willing to participate|13
994980|NCT01371708|2007406|FG000|Overall Study|Medication error/not related to AE|0
994981|NCT01371708|2007407|FG001|Overall Study|Medication error/not related to AE|1
994982|NCT01371708|2007408|FG002|Overall Study|Medication error/not related to AE|0
994983|NCT01371708|2007406|FG000|Overall Study|Other|3
994984|NCT01371708|2007407|FG001|Overall Study|Other|2
994985|NCT01371708|2007408|FG002|Overall Study|Other|4
994986|NCT01371708|2007406|FG000|Overall Study|Adverse Event|5
994987|NCT01371708|2007407|FG001|Overall Study|Adverse Event|8
994988|NCT01371708|2007408|FG002|Overall Study|Adverse Event|12
994989|NCT01371708|2007406|FG000|Overall Study|Started but did not receive treatment|1
994990|NCT01371708|2007407|FG001|Overall Study|Started but did not receive treatment|0
994991|NCT01371708|2007408|FG002|Overall Study|Started but did not receive treatment|1
994992|NCT01371721|2007421|FG000|Overall Study|Adverse Event|5
994993|NCT01371721|2007422|FG001|Overall Study|Adverse Event|4
994994|NCT01371721|2007423|FG002|Overall Study|Adverse Event|5
994995|NCT01371721|2007421|FG000|Overall Study|Protocol Violation|6
994996|NCT01371721|2007422|FG001|Overall Study|Protocol Violation|4
994997|NCT01371721|2007423|FG002|Overall Study|Protocol Violation|5
994998|NCT01371721|2007421|FG000|Overall Study|Lost to Follow-up|8
994999|NCT01371721|2007422|FG001|Overall Study|Lost to Follow-up|2
995000|NCT01371721|2007423|FG002|Overall Study|Lost to Follow-up|6
995001|NCT01371721|2007421|FG000|Overall Study|Withdrawal by Subject|5
995002|NCT01371721|2007422|FG001|Overall Study|Withdrawal by Subject|7
995003|NCT01371721|2007423|FG002|Overall Study|Withdrawal by Subject|11
995004|NCT01371721|2007421|FG000|Overall Study|Other|2
995005|NCT01371721|2007422|FG001|Overall Study|Other|3
995006|NCT01371721|2007423|FG002|Overall Study|Other|0
995007|NCT01371721|2007421|FG000|Overall Study|Lack of Efficacy|2
995008|NCT01371721|2007422|FG001|Overall Study|Lack of Efficacy|4
995009|NCT01371721|2007423|FG002|Overall Study|Lack of Efficacy|3
995010|NCT01371721|2007421|FG000|Overall Study|Randomized but not treated|1
995011|NCT01371721|2007422|FG001|Overall Study|Randomized but not treated|0
995012|NCT01371721|2007423|FG002|Overall Study|Randomized but not treated|0
995013|NCT01371734|2007436|FG000|Overall Study|Other|2
995014|NCT01371734|2007437|FG001|Overall Study|Other|1
995015|NCT01371734|2007438|FG002|Overall Study|Other|2
995016|NCT01371734|2007436|FG000|Overall Study|Withdrawal by Subject|3
995017|NCT01371734|2007437|FG001|Overall Study|Withdrawal by Subject|4
995018|NCT01371734|2007438|FG002|Overall Study|Withdrawal by Subject|9
995019|NCT01371734|2007436|FG000|Overall Study|Lost to Follow-up|5
995020|NCT01371734|2007437|FG001|Overall Study|Lost to Follow-up|3
995021|NCT01371734|2007438|FG002|Overall Study|Lost to Follow-up|1
995022|NCT01371734|2007436|FG000|Overall Study|Protocol Violation|3
995023|NCT01371734|2007437|FG001|Overall Study|Protocol Violation|1
995024|NCT01371734|2007438|FG002|Overall Study|Protocol Violation|2
995025|NCT01371734|2007436|FG000|Overall Study|Adverse Event|8
995026|NCT01371734|2007437|FG001|Overall Study|Adverse Event|8
995027|NCT01371734|2007438|FG002|Overall Study|Adverse Event|3
995028|NCT01371734|2007436|FG000|Overall Study|Lack of Efficacy|2
995029|NCT01371734|2007437|FG001|Overall Study|Lack of Efficacy|2
995030|NCT01371734|2007438|FG002|Overall Study|Lack of Efficacy|0
995031|NCT01371747|2007452|FG000|Overall Study|Adverse Event|4
995032|NCT01371747|2007453|FG001|Overall Study|Adverse Event|2
995033|NCT01371747|2007454|FG002|Overall Study|Adverse Event|7
995034|NCT01371747|2007455|FG003|Overall Study|Adverse Event|2
995035|NCT01371747|2007456|FG004|Overall Study|Adverse Event|2
995036|NCT01371747|2007457|FG005|Overall Study|Adverse Event|2
995037|NCT01371747|2007452|FG000|Overall Study|Death|1
995038|NCT01371747|2007453|FG001|Overall Study|Death|0
995039|NCT01371747|2007454|FG002|Overall Study|Death|4
995040|NCT01371747|2007455|FG003|Overall Study|Death|1
995041|NCT01371747|2007456|FG004|Overall Study|Death|2
995042|NCT01371747|2007457|FG005|Overall Study|Death|0
995043|NCT01371747|2007452|FG000|Overall Study|Abnormal Renal Function|0
995044|NCT01371747|2007453|FG001|Overall Study|Abnormal Renal Function|2
995045|NCT01371747|2007454|FG002|Overall Study|Abnormal Renal Function|0
995046|NCT01371747|2007455|FG003|Overall Study|Abnormal Renal Function|1
995047|NCT01371747|2007456|FG004|Overall Study|Abnormal Renal Function|0
995048|NCT01371747|2007457|FG005|Overall Study|Abnormal Renal Function|1
995049|NCT01371747|2007452|FG000|Overall Study|High Serum Potassium Results|1
995050|NCT01371747|2007453|FG001|Overall Study|High Serum Potassium Results|1
995051|NCT01371747|2007454|FG002|Overall Study|High Serum Potassium Results|1
995052|NCT01371747|2007455|FG003|Overall Study|High Serum Potassium Results|2
995053|NCT01371747|2007456|FG004|Overall Study|High Serum Potassium Results|0
995054|NCT01371747|2007457|FG005|Overall Study|High Serum Potassium Results|2
995055|NCT01371747|2007452|FG000|Overall Study|Low Serum Potassium Results|1
995056|NCT01371747|2007453|FG001|Overall Study|Low Serum Potassium Results|1
995057|NCT01371747|2007454|FG002|Overall Study|Low Serum Potassium Results|1
995058|NCT01371747|2007455|FG003|Overall Study|Low Serum Potassium Results|1
995059|NCT01371747|2007456|FG004|Overall Study|Low Serum Potassium Results|0
995060|NCT01371747|2007457|FG005|Overall Study|Low Serum Potassium Results|3
995061|NCT01371747|2007452|FG000|Overall Study|Protocol Violation|0
995062|NCT01371747|2007453|FG001|Overall Study|Protocol Violation|0
995063|NCT01371747|2007454|FG002|Overall Study|Protocol Violation|1
995064|NCT01371747|2007455|FG003|Overall Study|Protocol Violation|0
995065|NCT01371747|2007456|FG004|Overall Study|Protocol Violation|0
995066|NCT01371747|2007457|FG005|Overall Study|Protocol Violation|0
995067|NCT01371747|2007452|FG000|Overall Study|Non-Compliance|3
995068|NCT01371747|2007453|FG001|Overall Study|Non-Compliance|4
995069|NCT01371747|2007454|FG002|Overall Study|Non-Compliance|3
995070|NCT01371747|2007455|FG003|Overall Study|Non-Compliance|0
995071|NCT01371747|2007456|FG004|Overall Study|Non-Compliance|0
995072|NCT01371747|2007457|FG005|Overall Study|Non-Compliance|1
995073|NCT01371747|2007452|FG000|Overall Study|Physician Decision|0
995074|NCT01371747|2007453|FG001|Overall Study|Physician Decision|0
995075|NCT01371747|2007454|FG002|Overall Study|Physician Decision|0
995076|NCT01371747|2007455|FG003|Overall Study|Physician Decision|0
995077|NCT01371747|2007456|FG004|Overall Study|Physician Decision|1
995078|NCT01371747|2007457|FG005|Overall Study|Physician Decision|0
995079|NCT01371747|2007452|FG000|Overall Study|Withdrawal by Subject|6
995080|NCT01371747|2007453|FG001|Overall Study|Withdrawal by Subject|12
995081|NCT01371747|2007454|FG002|Overall Study|Withdrawal by Subject|5
995082|NCT01371747|2007455|FG003|Overall Study|Withdrawal by Subject|2
995083|NCT01371747|2007456|FG004|Overall Study|Withdrawal by Subject|2
995084|NCT01371747|2007457|FG005|Overall Study|Withdrawal by Subject|4
995085|NCT01371747|2007452|FG000|Overall Study|Other Reasons|2
995086|NCT01371747|2007453|FG001|Overall Study|Other Reasons|1
995087|NCT01371747|2007454|FG002|Overall Study|Other Reasons|2
995088|NCT01371747|2007455|FG003|Overall Study|Other Reasons|0
995089|NCT01371747|2007456|FG004|Overall Study|Other Reasons|0
995090|NCT01371747|2007457|FG005|Overall Study|Other Reasons|1
995091|NCT01371825|2007481|FG000|Overall Study|Death|4
995092|NCT01371838|2007487|FG000|Overall Study|Withdrawal by Subject|27
995093|NCT01371838|2007488|FG001|Overall Study|Withdrawal by Subject|33
995094|NCT01371838|2007487|FG000|Overall Study|Lost to Follow-up|10
995095|NCT01371838|2007488|FG001|Overall Study|Lost to Follow-up|20
995096|NCT01371838|2007487|FG000|Overall Study|Death|3
995097|NCT01371838|2007488|FG001|Overall Study|Death|4
995098|NCT01371838|2007487|FG000|Overall Study|Protocol Violation|3
995099|NCT01371838|2007488|FG001|Overall Study|Protocol Violation|0
995100|NCT01371838|2007487|FG000|Overall Study|Investigator Decision|3
995101|NCT01371838|2007488|FG001|Overall Study|Investigator Decision|8
995102|NCT01371838|2007487|FG000|Overall Study|Last follow-up visit not conducted|2
995103|NCT01371838|2007488|FG001|Overall Study|Last follow-up visit not conducted|0
995104|NCT01371838|2007487|FG000|Overall Study|Lack of therapeutic response|0
995105|NCT01371838|2007488|FG001|Overall Study|Lack of therapeutic response|1
995106|NCT01371838|2007487|FG000|Overall Study|Surgery|1
995107|NCT01371838|2007488|FG001|Overall Study|Surgery|0
995108|NCT01371851|2007496|FG000|Overall Study|Lost to Follow-up|5
995109|NCT01371851|2007497|FG001|Overall Study|Lost to Follow-up|8
995110|NCT01371851|2007496|FG000|Overall Study|was arrested and put in jail|0
995111|NCT01371851|2007497|FG001|Overall Study|was arrested and put in jail|1
995112|NCT01371851|2007496|FG000|Overall Study|non study related adverse event|1
995113|NCT01371851|2007497|FG001|Overall Study|non study related adverse event|0
995114|NCT01371851|2007496|FG000|Overall Study|Blood Pressure outside study parameters|2
995115|NCT01371851|2007497|FG001|Overall Study|Blood Pressure outside study parameters|0
995116|NCT01371877|2007505|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0
995117|NCT01371877|2007506|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4
995160|NCT01371994|2007544|FG000|Overall Study|Adverse Event|3
995161|NCT01371994|2007545|FG001|Overall Study|Adverse Event|6
995162|NCT01371994|2007544|FG000|Overall Study|Lack of Efficacy|3
995163|NCT01371994|2007545|FG001|Overall Study|Lack of Efficacy|0
995164|NCT01371994|2007544|FG000|Overall Study|Withdrawal by Subject|13
995165|NCT01371994|2007545|FG001|Overall Study|Withdrawal by Subject|7
995166|NCT01371994|2007544|FG000|Overall Study|Lost to Follow-up|1
995167|NCT01371994|2007545|FG001|Overall Study|Lost to Follow-up|1
995168|NCT01371994|2007544|FG000|Overall Study|Protocol Violation|24
995169|NCT01371994|2007545|FG001|Overall Study|Protocol Violation|17
995170|NCT01371994|2007544|FG000|Overall Study|Randomized but Never Received Study Drug|6
995171|NCT01371994|2007545|FG001|Overall Study|Randomized but Never Received Study Drug|6
995172|NCT01371994|2007544|FG000|Overall Study|Physician Decision|1
995173|NCT01371994|2007545|FG001|Overall Study|Physician Decision|1
995174|NCT01371994|2007544|FG000|Overall Study|Miscellaneous Reasons|6
995175|NCT01371994|2007545|FG001|Overall Study|Miscellaneous Reasons|4
995176|NCT01372085|2007561|FG000|Washout Period 2|Physician Decision|0
995177|NCT01372085|2007562|FG001|Washout Period 2|Physician Decision|0
995178|NCT01372085|2007563|FG002|Washout Period 2|Physician Decision|0
995179|NCT01372085|2007564|FG003|Washout Period 2|Physician Decision|0
995180|NCT01372085|2007565|FG004|Washout Period 2|Physician Decision|1
995181|NCT01372085|2007566|FG005|Washout Period 2|Physician Decision|0
995182|NCT01372085|2007567|FG006|Washout Period 2|Physician Decision|0
995183|NCT01372085|2007568|FG007|Washout Period 2|Physician Decision|0
995184|NCT01372085|2007569|FG008|Washout Period 2|Physician Decision|0
995185|NCT01372085|2007570|FG009|Washout Period 2|Physician Decision|0
995186|NCT01372085|2007561|FG000|Washout Period 3|Withdrawal by Subject|0
995187|NCT01372085|2007562|FG001|Washout Period 3|Withdrawal by Subject|0
995188|NCT01372085|2007563|FG002|Washout Period 3|Withdrawal by Subject|0
995189|NCT01372085|2007564|FG003|Washout Period 3|Withdrawal by Subject|0
995190|NCT01372085|2007565|FG004|Washout Period 3|Withdrawal by Subject|0
995191|NCT01372085|2007566|FG005|Washout Period 3|Withdrawal by Subject|2
995192|NCT01372085|2007567|FG006|Washout Period 3|Withdrawal by Subject|0
995193|NCT01372085|2007568|FG007|Washout Period 3|Withdrawal by Subject|0
995194|NCT01372085|2007569|FG008|Washout Period 3|Withdrawal by Subject|0
995195|NCT01372085|2007570|FG009|Washout Period 3|Withdrawal by Subject|0
995196|NCT01372150|2007597|FG000|Overall Study|Lack of Efficacy|3
995197|NCT01372150|2007598|FG001|Overall Study|Lack of Efficacy|0
995198|NCT01372150|2007599|FG002|Overall Study|Lack of Efficacy|1
995199|NCT01372150|2007597|FG000|Overall Study|Lost to Follow-up|4
995200|NCT01372150|2007598|FG001|Overall Study|Lost to Follow-up|5
995201|NCT01372150|2007599|FG002|Overall Study|Lost to Follow-up|6
995202|NCT01372150|2007597|FG000|Overall Study|Protocol Violation|1
995203|NCT01372150|2007598|FG001|Overall Study|Protocol Violation|0
995204|NCT01372150|2007599|FG002|Overall Study|Protocol Violation|3
995205|NCT01372150|2007597|FG000|Overall Study|Withdrawal by Subject|2
995206|NCT01372150|2007598|FG001|Overall Study|Withdrawal by Subject|7
995207|NCT01372150|2007599|FG002|Overall Study|Withdrawal by Subject|2
995208|NCT01372150|2007597|FG000|Overall Study|Other|1
995209|NCT01372150|2007598|FG001|Overall Study|Other|0
995210|NCT01372150|2007599|FG002|Overall Study|Other|2
995211|NCT01372150|2007597|FG000|Overall Study|Adverse Event|2
995212|NCT01372150|2007598|FG001|Overall Study|Adverse Event|1
995213|NCT01372150|2007599|FG002|Overall Study|Adverse Event|2
995214|NCT01372150|2007597|FG000|Overall Study|Randomized but not treated|0
995215|NCT01372150|2007598|FG001|Overall Study|Randomized but not treated|1
995216|NCT01372150|2007599|FG002|Overall Study|Randomized but not treated|0
995217|NCT01372384|2007634|FG000|Overall Study|Progression of disease|3
995218|NCT01372410|2007638|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1
995219|NCT01372410|2007639|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1
995220|NCT01372410|2007640|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0
995221|NCT01372410|2007641|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0
995222|NCT01372410|2007642|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1
995223|NCT01372410|2007643|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0
995224|NCT01372410|2007644|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0
995225|NCT01372410|2007645|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0
995226|NCT01372410|2007638|FG000|Treatment Period 1 (7 Days)|Adverse Event|0
995227|NCT01372410|2007639|FG001|Treatment Period 1 (7 Days)|Adverse Event|1
995228|NCT01372410|2007640|FG002|Treatment Period 1 (7 Days)|Adverse Event|0
995229|NCT01372410|2007641|FG003|Treatment Period 1 (7 Days)|Adverse Event|0
995230|NCT01372410|2007642|FG004|Treatment Period 1 (7 Days)|Adverse Event|0
995231|NCT01372410|2007643|FG005|Treatment Period 1 (7 Days)|Adverse Event|0
995232|NCT01372410|2007644|FG006|Treatment Period 1 (7 Days)|Adverse Event|1
995233|NCT01372410|2007645|FG007|Treatment Period 1 (7 Days)|Adverse Event|0
995234|NCT01372410|2007638|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0
995235|NCT01372410|2007639|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
995236|NCT01372410|2007640|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
995237|NCT01372410|2007641|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
995238|NCT01372410|2007642|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1
995239|NCT01372410|2007643|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
995240|NCT01372410|2007644|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0
995241|NCT01372410|2007645|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0
995242|NCT01372410|2007638|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
995243|NCT01372410|2007639|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
995244|NCT01372410|2007640|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
995245|NCT01372410|2007641|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
995246|NCT01372410|2007642|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
995247|NCT01372410|2007643|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
995248|NCT01372410|2007644|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
995249|NCT01372410|2007645|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
995250|NCT01372410|2007638|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
995251|NCT01372410|2007639|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
995252|NCT01372410|2007640|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
995253|NCT01372410|2007641|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
995254|NCT01372410|2007642|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
995255|NCT01372410|2007643|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
995256|NCT01372410|2007644|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
995257|NCT01372410|2007645|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
995258|NCT01372410|2007638|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0
995259|NCT01372410|2007639|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0
995260|NCT01372410|2007640|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0
995261|NCT01372410|2007641|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0
995262|NCT01372410|2007642|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1
995263|NCT01372410|2007643|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0
995264|NCT01372410|2007644|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0
995265|NCT01372410|2007645|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0
995266|NCT01372410|2007638|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
995267|NCT01372410|2007639|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
995268|NCT01372410|2007640|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
995269|NCT01372410|2007641|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
995270|NCT01372410|2007642|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
995271|NCT01372410|2007643|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
995272|NCT01372410|2007644|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
995273|NCT01372410|2007645|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
995274|NCT01372410|2007638|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
995275|NCT01372410|2007639|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
995276|NCT01372410|2007640|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
995277|NCT01372410|2007641|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
995278|NCT01372410|2007642|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
995279|NCT01372410|2007643|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
995280|NCT01372410|2007644|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
995281|NCT01372410|2007645|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
995282|NCT01372410|2007638|FG000|Treatment Period 3 (7 Days)|Adverse Event|0
995283|NCT01372410|2007639|FG001|Treatment Period 3 (7 Days)|Adverse Event|0
995284|NCT01372410|2007640|FG002|Treatment Period 3 (7 Days)|Adverse Event|1
995285|NCT01372410|2007641|FG003|Treatment Period 3 (7 Days)|Adverse Event|0
995286|NCT01372410|2007642|FG004|Treatment Period 3 (7 Days)|Adverse Event|0
995287|NCT01372410|2007643|FG005|Treatment Period 3 (7 Days)|Adverse Event|0
995288|NCT01372410|2007644|FG006|Treatment Period 3 (7 Days)|Adverse Event|0
995289|NCT01372410|2007645|FG007|Treatment Period 3 (7 Days)|Adverse Event|0
995290|NCT01372410|2007638|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0
995291|NCT01372410|2007639|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0
995292|NCT01372410|2007640|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0
995293|NCT01372410|2007641|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0
995294|NCT01372410|2007642|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0
995295|NCT01372410|2007643|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1
995296|NCT01372410|2007644|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0
995297|NCT01372410|2007645|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0
995298|NCT01372501|2007674|FG000|Overall Study|Adverse Event|4
995299|NCT01372501|2007674|FG000|Overall Study|Device migration|1
995300|NCT01372605|2007681|FG000|Overall Study|Death|1
995301|NCT01372605|2007682|FG001|Overall Study|Death|2
995302|NCT01372605|2007681|FG000|Overall Study|Lost to Follow-up|2
995303|NCT01372605|2007682|FG001|Overall Study|Lost to Follow-up|1
995304|NCT01372605|2007681|FG000|Overall Study|Withdrawal by Subject|4
995305|NCT01372605|2007682|FG001|Overall Study|Withdrawal by Subject|7
995306|NCT01372605|2007681|FG000|Overall Study|Moved|3
995307|NCT01372605|2007682|FG001|Overall Study|Moved|0
995308|NCT01372605|2007681|FG000|Overall Study|Changed medical home|2
995309|NCT01372605|2007682|FG001|Overall Study|Changed medical home|0
995310|NCT01372748|2007690|FG000|Overall Study|Lost to Follow-up|16
995311|NCT01372748|2007691|FG001|Overall Study|Lost to Follow-up|34
995312|NCT01372748|2007690|FG000|Overall Study|Withdrawal by Subject|7
995313|NCT01372748|2007691|FG001|Overall Study|Withdrawal by Subject|5
995314|NCT01372774|2007699|FG000|Overall Study|Withdrawal prior to treatment|4
995315|NCT01372774|2007700|FG001|Overall Study|Withdrawal prior to treatment|5
995316|NCT01372878|2007712|FG000|Overall Study|Withdrawal by Subject|63
995317|NCT01372878|2007712|FG000|Overall Study|Protocol Violation|17
995318|NCT01372878|2007712|FG000|Overall Study|incomplete study procedure|104
995319|NCT01372995|2007719|FG000|Overall Study|Spouse withdrew participant from study|0
995320|NCT01372995|2007720|FG001|Overall Study|Spouse withdrew participant from study|1
995321|NCT01372995|2007721|FG002|Overall Study|Spouse withdrew participant from study|0
995322|NCT01372995|2007719|FG000|Overall Study|Physician Decision|0
995323|NCT01372995|2007720|FG001|Overall Study|Physician Decision|0
995324|NCT01372995|2007721|FG002|Overall Study|Physician Decision|1
995325|NCT01373164|2007734|FG000|Overall Study|Lost to Follow-up|0
995326|NCT01373164|2007735|FG001|Overall Study|Lost to Follow-up|0
995327|NCT01373164|2007736|FG002|Overall Study|Lost to Follow-up|1
995328|NCT01373164|2007737|FG003|Overall Study|Lost to Follow-up|2
995329|NCT01373164|2007738|FG004|Overall Study|Lost to Follow-up|0
995330|NCT01373164|2007734|FG000|Overall Study|Withdrawal by Subject|0
995331|NCT01373164|2007735|FG001|Overall Study|Withdrawal by Subject|1
995332|NCT01373164|2007736|FG002|Overall Study|Withdrawal by Subject|0
995333|NCT01373164|2007737|FG003|Overall Study|Withdrawal by Subject|10
995334|NCT01373164|2007738|FG004|Overall Study|Withdrawal by Subject|2
995335|NCT01373229|2007753|FG000|Overall Study|Death|3
995336|NCT01373229|2007753|FG000|Overall Study|Physician Decision|3
995337|NCT01373281|2007765|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
995338|NCT01373281|2007766|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
995339|NCT01373281|2007765|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
995340|NCT01373281|2007766|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
995341|NCT01373281|2007765|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
995342|NCT01373281|2007766|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
995343|NCT01373281|2007765|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
995344|NCT01373281|2007766|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
995345|NCT01373281|2007765|FG000|Surveillance Expansion Period|Withdrawal by Subject|180
995346|NCT01373281|2007766|FG001|Surveillance Expansion Period|Withdrawal by Subject|105
995347|NCT01373281|2007765|FG000|Surveillance Expansion Period|Protocol Violation|9
995348|NCT01373281|2007766|FG001|Surveillance Expansion Period|Protocol Violation|1
995349|NCT01373281|2007765|FG000|Surveillance Expansion Period|Lost to Follow-up|10
995350|NCT01373281|2007766|FG001|Surveillance Expansion Period|Lost to Follow-up|8
995351|NCT01373281|2007765|FG000|Surveillance Expansion Period|Serious adverse event|3
995352|NCT01373281|2007766|FG001|Surveillance Expansion Period|Serious adverse event|4
995353|NCT01373294|2007781|FG000|Overall Study|Adverse Event|1
995354|NCT01373294|2007782|FG001|Overall Study|Adverse Event|0
995355|NCT01373346|2007788|FG000|Overall Study|Death|1
995356|NCT01373918|2007836|FG000|Overall Study|Physician Decision|0
995357|NCT01373918|2007837|FG001|Overall Study|Physician Decision|1
995358|NCT01373931|2007845|FG000|Lead-in Period|Adverse Event|2
995359|NCT01373931|2007846|FG001|Lead-in Period|Adverse Event|0
995360|NCT01373931|2007845|FG000|Period 1|Adverse Event|2
995361|NCT01373931|2007846|FG001|Period 1|Adverse Event|0
995362|NCT01373931|2007845|FG000|Period 1|Withdrawal by Subject|0
995363|NCT01373931|2007846|FG001|Period 1|Withdrawal by Subject|2
995364|NCT01374087|2007855|FG000|Overall Study|Adverse Event|1
995365|NCT01374087|2007856|FG001|Overall Study|Adverse Event|0
995366|NCT01374087|2007855|FG000|Overall Study|Disease progression|2
995367|NCT01374087|2007856|FG001|Overall Study|Disease progression|2
995368|NCT01374087|2007855|FG000|Overall Study|Study discontinued|13
995369|NCT01374087|2007856|FG001|Overall Study|Study discontinued|13
995370|NCT01374178|2007862|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1
995371|NCT01374178|2007863|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0
995372|NCT01374178|2007862|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
995373|NCT01374178|2007863|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
995374|NCT01374217|2007869|FG000|Overall Study|Lack of Efficacy|13
995375|NCT01374269|2007875|FG000|Overall Study|Withdrawal by Subject|4
995376|NCT01374269|2007876|FG001|Overall Study|Withdrawal by Subject|0
995377|NCT01374269|2007875|FG000|Overall Study|Lost to Follow-up|1
995378|NCT01374269|2007876|FG001|Overall Study|Lost to Follow-up|3
995379|NCT01374269|2007875|FG000|Overall Study|closed research|1
995380|NCT01374269|2007876|FG001|Overall Study|closed research|2
995381|NCT01374425|2007884|FG000|Overall Study|Radiographic Disease Progression|86
995382|NCT01374425|2007885|FG001|Overall Study|Radiographic Disease Progression|81
995383|NCT01374425|2007884|FG000|Overall Study|Clinical Disease Progression|9
995384|NCT01374425|2007885|FG001|Overall Study|Clinical Disease Progression|6
995385|NCT01374425|2007884|FG000|Overall Study|Adverse Event|29
995386|NCT01374425|2007885|FG001|Overall Study|Adverse Event|18
995387|NCT01374425|2007884|FG000|Overall Study|Death (Progression of Disease)|1
995388|NCT01374425|2007885|FG001|Overall Study|Death (Progression of Disease)|0
995389|NCT01374425|2007884|FG000|Overall Study|Death (Adverse Event)|2
995390|NCT01374425|2007885|FG001|Overall Study|Death (Adverse Event)|4
995391|NCT01374425|2007884|FG000|Overall Study|Withdrawal by Subject|6
995392|NCT01374425|2007885|FG001|Overall Study|Withdrawal by Subject|7
995393|NCT01374425|2007884|FG000|Overall Study|Refused Treatment|10
995394|NCT01374425|2007885|FG001|Overall Study|Refused Treatment|24
995395|NCT01374425|2007884|FG000|Overall Study|Protocol Violation|2
995396|NCT01374425|2007885|FG001|Overall Study|Protocol Violation|3
995397|NCT01374425|2007884|FG000|Overall Study|Sponsor Decision|0
995398|NCT01374425|2007885|FG001|Overall Study|Sponsor Decision|1
995399|NCT01374425|2007884|FG000|Overall Study|Lost to Follow-up|2
995400|NCT01374425|2007885|FG001|Overall Study|Lost to Follow-up|1
995401|NCT01374425|2007884|FG000|Overall Study|Other|41
995402|NCT01374425|2007885|FG001|Overall Study|Other|43
995403|NCT01374451|2007923|FG000|Overall Study|Administrative problems|1
995404|NCT01374451|2007924|FG001|Overall Study|Administrative problems|0
995405|NCT01374516|2007936|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
995406|NCT01374516|2007937|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
995407|NCT01374516|2007936|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3
995408|NCT01374516|2007937|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0
995409|NCT01374516|2007936|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
995410|NCT01374516|2007937|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
995411|NCT01374516|2007936|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
995412|NCT01374516|2007937|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
995413|NCT01374516|2007936|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
995414|NCT01374516|2007937|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
995415|NCT01374516|2007936|FG000|Surveillance Expansion Period|Protocol Violation|386
995416|NCT01374516|2007937|FG001|Surveillance Expansion Period|Protocol Violation|217
995417|NCT01374516|2007936|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870
995418|NCT01374516|2007937|FG001|Surveillance Expansion Period|Withdrawal by Subject|986
995419|NCT01374516|2007936|FG000|Surveillance Expansion Period|Lost to Follow-up|73
995420|NCT01374516|2007937|FG001|Surveillance Expansion Period|Lost to Follow-up|45
995421|NCT01374516|2007936|FG000|Surveillance Expansion Period|Serious adverse event|20
995422|NCT01374516|2007937|FG001|Surveillance Expansion Period|Serious adverse event|5
995423|NCT01374568|2007952|FG000|Overall Study|Lab unable to analyze BTM|0
995424|NCT01374568|2007953|FG001|Overall Study|Lab unable to analyze BTM|2
995425|NCT01374906|2007967|FG000|Overall Study|Abnormal laboratory value(s)|0
995426|NCT01374906|2007968|FG001|Overall Study|Abnormal laboratory value(s)|3
995427|NCT01374906|2007967|FG000|Overall Study|Administrative problems|2
995428|NCT01374906|2007968|FG001|Overall Study|Administrative problems|2
995429|NCT01374906|2007967|FG000|Overall Study|Adverse Event|10
995430|NCT01374906|2007968|FG001|Overall Study|Adverse Event|11
995431|NCT01374906|2007967|FG000|Overall Study|Death|0
995432|NCT01374906|2007968|FG001|Overall Study|Death|2
995433|NCT01374906|2007967|FG000|Overall Study|Protocol Violation|2
995434|NCT01374906|2007968|FG001|Overall Study|Protocol Violation|2
995435|NCT01374906|2007967|FG000|Overall Study|Withdrawal by Subject|15
995436|NCT01374906|2007968|FG001|Overall Study|Withdrawal by Subject|9
995437|NCT01374906|2007967|FG000|Overall Study|Unsatisfactory therapeutic effect|11
995438|NCT01374906|2007968|FG001|Overall Study|Unsatisfactory therapeutic effect|19
995439|NCT01374919|2007978|FG000|Overall Study|Withdrawal by Subject|2
995440|NCT01374971|2007982|FG000|Overall Study|Withdrawal by Subject|1
995441|NCT01375010|2007988|FG000|Overall Study|Lost to Follow-up|8
995442|NCT01375010|2007989|FG001|Overall Study|Lost to Follow-up|2
995443|NCT01375010|2007988|FG000|Overall Study|Withdrawal by Subject|4
995444|NCT01375010|2007989|FG001|Overall Study|Withdrawal by Subject|2
995445|NCT01375049|2007995|FG000|Overall Study|Adverse Event|2
995446|NCT01375049|2007995|FG000|Overall Study|Lost to Follow-up|1
995447|NCT01375049|2007995|FG000|Overall Study|Withdrawal by Subject|2
995448|NCT01375049|2007995|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45
995449|NCT01375075|2008009|FG000|Overall Study|Adverse Event|0
995450|NCT01375075|2008010|FG001|Overall Study|Adverse Event|0
995451|NCT01375075|2008011|FG002|Overall Study|Adverse Event|3
995452|NCT01375075|2008012|FG003|Overall Study|Adverse Event|1
995453|NCT01375075|2008013|FG004|Overall Study|Adverse Event|0
995454|NCT01375075|2008014|FG005|Overall Study|Adverse Event|1
995455|NCT01375075|2008009|FG000|Overall Study|Entry Criterion Not Met|1
995456|NCT01375075|2008010|FG001|Overall Study|Entry Criterion Not Met|0
995457|NCT01375075|2008011|FG002|Overall Study|Entry Criterion Not Met|0
995458|NCT01375075|2008012|FG003|Overall Study|Entry Criterion Not Met|0
995459|NCT01375075|2008013|FG004|Overall Study|Entry Criterion Not Met|0
995460|NCT01375075|2008014|FG005|Overall Study|Entry Criterion Not Met|1
995461|NCT01375075|2008009|FG000|Overall Study|Withdrawal by Subject|0
995462|NCT01375075|2008010|FG001|Overall Study|Withdrawal by Subject|1
995463|NCT01375075|2008011|FG002|Overall Study|Withdrawal by Subject|0
995464|NCT01375075|2008012|FG003|Overall Study|Withdrawal by Subject|0
995465|NCT01375075|2008013|FG004|Overall Study|Withdrawal by Subject|0
995466|NCT01375075|2008014|FG005|Overall Study|Withdrawal by Subject|1
995467|NCT01375205|2008063|FG000|Overall Study|Lost to Follow-up|15
995468|NCT01375205|2008064|FG001|Overall Study|Lost to Follow-up|12
995469|NCT01375205|2008063|FG000|Overall Study|Withdrawal by Subject|6
995470|NCT01375205|2008064|FG001|Overall Study|Withdrawal by Subject|1
995471|NCT01375374|2008070|FG000|Overall Study|Adverse Event|1
995472|NCT01375608|2008090|FG000|Overall Study|Withdrawal by Subject|2
995473|NCT01375673|2008106|FG000|Overall Study|Withdrawal by Subject|0
995474|NCT01375673|2008107|FG001|Overall Study|Withdrawal by Subject|1
995475|NCT01375751|2008116|FG000|Overall Study|Other|0
995476|NCT01375751|2008117|FG001|Overall Study|Other|1
995477|NCT01375751|2008118|FG002|Overall Study|Other|0
995478|NCT01375764|2008131|FG000|Overall Study|Lost to Follow-up|0
995479|NCT01375764|2008132|FG001|Overall Study|Lost to Follow-up|1
995480|NCT01375764|2008133|FG002|Overall Study|Lost to Follow-up|0
995481|NCT01375764|2008134|FG003|Overall Study|Lost to Follow-up|0
995482|NCT01375764|2008135|FG004|Overall Study|Lost to Follow-up|0
995483|NCT01375764|2008131|FG000|Overall Study|Withdrawal by Subject|2
995484|NCT01375764|2008132|FG001|Overall Study|Withdrawal by Subject|0
995485|NCT01375764|2008133|FG002|Overall Study|Withdrawal by Subject|0
995486|NCT01375764|2008134|FG003|Overall Study|Withdrawal by Subject|0
995487|NCT01375764|2008135|FG004|Overall Study|Withdrawal by Subject|1
995488|NCT01375764|2008131|FG000|Overall Study|Other|0
995489|NCT01375764|2008132|FG001|Overall Study|Other|0
995490|NCT01375764|2008133|FG002|Overall Study|Other|0
995491|NCT01375764|2008134|FG003|Overall Study|Other|1
995492|NCT01375764|2008135|FG004|Overall Study|Other|0
995493|NCT01375777|2008156|FG000|Overall Study|Withdrawal by Subject|0
995494|NCT01375777|2008157|FG001|Overall Study|Withdrawal by Subject|2
995495|NCT01375777|2008158|FG002|Overall Study|Withdrawal by Subject|1
995496|NCT01375777|2008159|FG003|Overall Study|Withdrawal by Subject|0
995497|NCT01375777|2008160|FG004|Overall Study|Withdrawal by Subject|1
995498|NCT01375777|2008161|FG005|Overall Study|Withdrawal by Subject|1
995499|NCT01375777|2008162|FG006|Overall Study|Withdrawal by Subject|1
995500|NCT01375777|2008163|FG007|Overall Study|Withdrawal by Subject|2
995501|NCT01375777|2008164|FG008|Overall Study|Withdrawal by Subject|1
995502|NCT01375777|2008156|FG000|Overall Study|Lost to Follow-up|1
995503|NCT01375777|2008157|FG001|Overall Study|Lost to Follow-up|0
995504|NCT01375777|2008158|FG002|Overall Study|Lost to Follow-up|0
995505|NCT01375777|2008159|FG003|Overall Study|Lost to Follow-up|0
995506|NCT01375777|2008160|FG004|Overall Study|Lost to Follow-up|0
995507|NCT01375777|2008161|FG005|Overall Study|Lost to Follow-up|0
995508|NCT01375777|2008162|FG006|Overall Study|Lost to Follow-up|1
995509|NCT01375777|2008163|FG007|Overall Study|Lost to Follow-up|0
995510|NCT01375777|2008164|FG008|Overall Study|Lost to Follow-up|0
995511|NCT01375777|2008156|FG000|Overall Study|Other|1
995512|NCT01375777|2008157|FG001|Overall Study|Other|1
995513|NCT01375777|2008158|FG002|Overall Study|Other|0
995514|NCT01375777|2008159|FG003|Overall Study|Other|0
995515|NCT01375777|2008160|FG004|Overall Study|Other|0
995516|NCT01375777|2008161|FG005|Overall Study|Other|0
995517|NCT01375777|2008162|FG006|Overall Study|Other|0
995518|NCT01375777|2008163|FG007|Overall Study|Other|0
995519|NCT01375777|2008164|FG008|Overall Study|Other|1
995526|NCT01376037|2008204|FG000|Overall Study|Lost to Follow-up|0
995527|NCT01376037|2008205|FG001|Overall Study|Lost to Follow-up|2
995528|NCT01376089|2008222|FG000|Overall Study|Patient received no contrast media|3
995529|NCT01376089|2008223|FG001|Overall Study|Patient received no contrast media|4
995530|NCT01376167|2008236|FG000|Overall Study|Lost to Follow-up|2
995531|NCT01376167|2008237|FG001|Overall Study|Lost to Follow-up|4
995532|NCT01376167|2008238|FG002|Overall Study|Lost to Follow-up|2
995533|NCT01376167|2008236|FG000|Overall Study|Physician Decision|1
995534|NCT01376167|2008237|FG001|Overall Study|Physician Decision|1
995535|NCT01376167|2008238|FG002|Overall Study|Physician Decision|0
995536|NCT01376167|2008236|FG000|Overall Study|Withdrawal by Subject|1
995537|NCT01376167|2008237|FG001|Overall Study|Withdrawal by Subject|5
995538|NCT01376167|2008238|FG002|Overall Study|Withdrawal by Subject|4
995539|NCT01376245|2008253|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
995540|NCT01376245|2008254|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
995541|NCT01376245|2008255|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
995542|NCT01376245|2008256|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
995543|NCT01376245|2008257|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
995544|NCT01376245|2008253|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
995545|NCT01376245|2008254|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
995546|NCT01376245|2008255|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
995547|NCT01376245|2008256|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
995548|NCT01376245|2008257|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
995549|NCT01376245|2008253|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
995550|NCT01376245|2008254|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
995551|NCT01376245|2008255|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
995552|NCT01376245|2008256|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
995553|NCT01376245|2008257|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
995554|NCT01376245|2008253|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
995555|NCT01376245|2008254|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
995556|NCT01376245|2008255|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
995557|NCT01376245|2008256|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
995558|NCT01376245|2008257|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
995559|NCT01376245|2008253|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
995560|NCT01376245|2008254|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
995561|NCT01376245|2008255|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
995562|NCT01376245|2008256|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
995563|NCT01376245|2008257|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
995564|NCT01376245|2008253|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
995565|NCT01376245|2008254|FG001|24-week, Double-blind Treatment Period|Adverse Event|16
995566|NCT01376245|2008255|FG002|24-week, Double-blind Treatment Period|Adverse Event|7
995567|NCT01376245|2008256|FG003|24-week, Double-blind Treatment Period|Adverse Event|8
995568|NCT01376245|2008257|FG004|24-week, Double-blind Treatment Period|Adverse Event|18
995569|NCT01376245|2008253|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0
995570|NCT01376245|2008254|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4
995571|NCT01376245|2008255|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5
995572|NCT01376245|2008256|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4
995573|NCT01376245|2008257|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3
995574|NCT01376245|2008253|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
995575|NCT01376245|2008254|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2
995576|NCT01376245|2008255|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0
995577|NCT01376245|2008256|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
995578|NCT01376245|2008257|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
995579|NCT01376245|2008253|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
995580|NCT01376245|2008254|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
995581|NCT01376245|2008255|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
995582|NCT01376245|2008256|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
995583|NCT01376245|2008257|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
995584|NCT01376245|2008253|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
995585|NCT01376245|2008254|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2
995586|NCT01376245|2008255|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
995587|NCT01376245|2008256|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1
995588|NCT01376245|2008257|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
995589|NCT01376245|2008253|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
995590|NCT01376245|2008254|FG001|24-week, Double-blind Treatment Period|Physician Decision|0
995591|NCT01376245|2008255|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
995592|NCT01376245|2008256|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
995593|NCT01376245|2008257|FG004|24-week, Double-blind Treatment Period|Physician Decision|0
995594|NCT01376245|2008253|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
995595|NCT01376245|2008254|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
995596|NCT01376245|2008255|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
995597|NCT01376245|2008256|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
995598|NCT01376245|2008257|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
995599|NCT01376310|2008278|FG000|Overall Study|Study closed/terminated|1
995600|NCT01376310|2008279|FG001|Overall Study|Study closed/terminated|2
995601|NCT01376310|2008278|FG000|Overall Study|Withdrawal by Subject|8
995602|NCT01376310|2008279|FG001|Overall Study|Withdrawal by Subject|2
995603|NCT01376310|2008278|FG000|Overall Study|Physician Decision|26
995604|NCT01376310|2008279|FG001|Overall Study|Physician Decision|7
995605|NCT01376310|2008278|FG000|Overall Study|Lost to Follow-up|1
995606|NCT01376310|2008279|FG001|Overall Study|Lost to Follow-up|0
995607|NCT01376349|2008319|FG000|Raondomized Treatment|Withdrawal by Subject|10
995608|NCT01376349|2008320|FG001|Raondomized Treatment|Withdrawal by Subject|16
995609|NCT01376349|2008321|FG002|Raondomized Treatment|Withdrawal by Subject|13
995610|NCT01376349|2008319|FG000|Raondomized Treatment|Adverse Event|13
995611|NCT01376349|2008320|FG001|Raondomized Treatment|Adverse Event|17
995612|NCT01376349|2008321|FG002|Raondomized Treatment|Adverse Event|14
995613|NCT01376349|2008319|FG000|Raondomized Treatment|Unkown|1
995614|NCT01376349|2008320|FG001|Raondomized Treatment|Unkown|2
995615|NCT01376349|2008321|FG002|Raondomized Treatment|Unkown|1
995616|NCT01376349|2008319|FG000|Raondomized Treatment|Alternative Treatment|0
995617|NCT01376349|2008320|FG001|Raondomized Treatment|Alternative Treatment|0
995618|NCT01376349|2008321|FG002|Raondomized Treatment|Alternative Treatment|1
995619|NCT01376388|2008334|FG000|Overall Study|Adverse Event|13
995620|NCT01376388|2008334|FG000|Overall Study|Lack of Efficacy|2
995621|NCT01376388|2008334|FG000|Overall Study|Withdrawal by Subject|3
995622|NCT01376700|2008359|FG000|Overall Study|Sponsor terminated study early|8
995623|NCT01376700|2008359|FG000|Overall Study|Low or high titer inhibitor|8
995624|NCT01376804|2008366|FG000|Treatment Period|Withdrawal by Subject|1
995625|NCT01376804|2008366|FG000|Treatment Period|Adverse Event|6
995626|NCT01376804|2008366|FG000|Treatment Period|Patient did not receive study drug|1
995627|NCT01376908|2008372|FG000|Overall Study|Protocol Violation|1
995628|NCT01376908|2008373|FG001|Overall Study|Protocol Violation|1
995629|NCT01376908|2008372|FG000|Overall Study|Withdrawal by Subject|1
995630|NCT01376908|2008373|FG001|Overall Study|Withdrawal by Subject|2
995631|NCT01377012|2008389|FG000|Core Study|Study terminated by Sponsor|47
995632|NCT01377012|2008390|FG001|Core Study|Study terminated by Sponsor|54
995633|NCT01377012|2008391|FG002|Core Study|Study terminated by Sponsor|46
995634|NCT01377012|2008389|FG000|Core Study|Technical problems|1
995635|NCT01377012|2008390|FG001|Core Study|Technical problems|0
995636|NCT01377012|2008391|FG002|Core Study|Technical problems|0
995637|NCT01377012|2008389|FG000|Core Study|Withdrawal by Subject|15
995638|NCT01377012|2008390|FG001|Core Study|Withdrawal by Subject|23
995639|NCT01377012|2008391|FG002|Core Study|Withdrawal by Subject|18
995640|NCT01377012|2008389|FG000|Core Study|Protocol Violation|7
995641|NCT01377012|2008390|FG001|Core Study|Protocol Violation|3
995642|NCT01377012|2008391|FG002|Core Study|Protocol Violation|2
995643|NCT01377012|2008389|FG000|Core Study|Pregnancy|0
995644|NCT01377012|2008390|FG001|Core Study|Pregnancy|0
995645|NCT01377012|2008391|FG002|Core Study|Pregnancy|1
995646|NCT01377012|2008389|FG000|Core Study|Physician Decision|5
995647|NCT01377012|2008390|FG001|Core Study|Physician Decision|4
995648|NCT01377012|2008391|FG002|Core Study|Physician Decision|10
995649|NCT01377012|2008389|FG000|Core Study|Non-Compliant with study treatment|0
995650|NCT01377012|2008390|FG001|Core Study|Non-Compliant with study treatment|0
995651|NCT01377012|2008391|FG002|Core Study|Non-Compliant with study treatment|1
995652|NCT01377012|2008389|FG000|Core Study|No Longer require treatment|0
995653|NCT01377012|2008390|FG001|Core Study|No Longer require treatment|0
995654|NCT01377012|2008391|FG002|Core Study|No Longer require treatment|1
995655|NCT01377012|2008389|FG000|Core Study|Lost to Follow-up|7
995656|NCT01377012|2008390|FG001|Core Study|Lost to Follow-up|5
995657|NCT01377012|2008391|FG002|Core Study|Lost to Follow-up|4
995658|NCT01377012|2008389|FG000|Core Study|Lack of Efficacy|41
995659|NCT01377012|2008390|FG001|Core Study|Lack of Efficacy|28
995660|NCT01377012|2008391|FG002|Core Study|Lack of Efficacy|37
995661|NCT01377012|2008389|FG000|Core Study|Death|1
995662|NCT01377012|2008390|FG001|Core Study|Death|1
995663|NCT01377012|2008391|FG002|Core Study|Death|1
995664|NCT01377012|2008389|FG000|Core Study|Adverse Event|10
995665|NCT01377012|2008390|FG001|Core Study|Adverse Event|14
995666|NCT01377012|2008391|FG002|Core Study|Adverse Event|13
995667|NCT01377012|2008389|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3
995668|NCT01377012|2008390|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0
995669|NCT01377012|2008391|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0
995670|NCT01377012|2008389|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52
995671|NCT01377012|2008390|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69
995672|NCT01377012|2008391|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63
995673|NCT01377012|2008389|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1
995674|NCT01377012|2008390|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0
995675|NCT01377012|2008391|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3
995676|NCT01377012|2008389|FG000|Extension Study, Weeks 104-260|Physician Decision|1
995677|NCT01377012|2008390|FG001|Extension Study, Weeks 104-260|Physician Decision|0
995678|NCT01377012|2008391|FG002|Extension Study, Weeks 104-260|Physician Decision|0
995679|NCT01377012|2008389|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0
995680|NCT01377012|2008390|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0
995681|NCT01377012|2008391|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1
995682|NCT01377012|2008389|FG000|Extension Study, Weeks 104-260|Adverse Event|0
995683|NCT01377012|2008390|FG001|Extension Study, Weeks 104-260|Adverse Event|2
995684|NCT01377012|2008391|FG002|Extension Study, Weeks 104-260|Adverse Event|1
995685|NCT01377194|2008402|FG000|Overall Study|Adverse Event|3
995686|NCT01377194|2008403|FG001|Overall Study|Adverse Event|12
995687|NCT01377194|2008404|FG002|Overall Study|Adverse Event|19
995688|NCT01377194|2008402|FG000|Overall Study|Lack of Efficacy|3
995689|NCT01377194|2008403|FG001|Overall Study|Lack of Efficacy|3
995690|NCT01377194|2008404|FG002|Overall Study|Lack of Efficacy|3
995691|NCT01377194|2008402|FG000|Overall Study|Protocol Violation|4
995692|NCT01377194|2008403|FG001|Overall Study|Protocol Violation|10
995693|NCT01377194|2008404|FG002|Overall Study|Protocol Violation|6
995694|NCT01377194|2008402|FG000|Overall Study|Withdrawal by Subject|8
995695|NCT01377194|2008403|FG001|Overall Study|Withdrawal by Subject|10
995696|NCT01377194|2008404|FG002|Overall Study|Withdrawal by Subject|7
995697|NCT01377194|2008402|FG000|Overall Study|Lost to Follow-up|14
995698|NCT01377194|2008403|FG001|Overall Study|Lost to Follow-up|8
995699|NCT01377194|2008404|FG002|Overall Study|Lost to Follow-up|11
995700|NCT01377233|2008420|FG000|Open-label|Adverse Event|1
995701|NCT01377233|2008421|FG001|Open-label|Adverse Event|0
995702|NCT01377233|2008422|FG002|Open-label|Adverse Event|0
995703|NCT01377233|2008423|FG003|Open-label|Adverse Event|0
995704|NCT01377233|2008424|FG004|Open-label|Adverse Event|0
995705|NCT01377233|2008420|FG000|Open-label|Withdrawal by Subject|3
995706|NCT01377233|2008421|FG001|Open-label|Withdrawal by Subject|0
995707|NCT01377233|2008422|FG002|Open-label|Withdrawal by Subject|0
995708|NCT01377233|2008423|FG003|Open-label|Withdrawal by Subject|0
995709|NCT01377233|2008424|FG004|Open-label|Withdrawal by Subject|0
995710|NCT01377233|2008420|FG000|Double-blind|Adverse Event|0
995711|NCT01377233|2008421|FG001|Double-blind|Adverse Event|1
995712|NCT01377233|2008422|FG002|Double-blind|Adverse Event|2
995713|NCT01377233|2008423|FG003|Double-blind|Adverse Event|2
995714|NCT01377233|2008424|FG004|Double-blind|Adverse Event|0
995715|NCT01377233|2008420|FG000|Double-blind|Protocol Violation|0
995716|NCT01377233|2008421|FG001|Double-blind|Protocol Violation|0
995717|NCT01377233|2008422|FG002|Double-blind|Protocol Violation|0
995718|NCT01377233|2008423|FG003|Double-blind|Protocol Violation|0
995719|NCT01377233|2008424|FG004|Double-blind|Protocol Violation|1
995720|NCT01377233|2008420|FG000|Double-blind|Withdrawal by Subject|0
995721|NCT01377233|2008421|FG001|Double-blind|Withdrawal by Subject|0
995722|NCT01377233|2008422|FG002|Double-blind|Withdrawal by Subject|0
995723|NCT01377233|2008423|FG003|Double-blind|Withdrawal by Subject|1
995724|NCT01377233|2008424|FG004|Double-blind|Withdrawal by Subject|0
995725|NCT01377233|2008420|FG000|Double-blind|Administrative or other|0
995726|NCT01377233|2008421|FG001|Double-blind|Administrative or other|0
995727|NCT01377233|2008422|FG002|Double-blind|Administrative or other|0
995728|NCT01377233|2008423|FG003|Double-blind|Administrative or other|1
995729|NCT01377233|2008424|FG004|Double-blind|Administrative or other|1
995730|NCT01377389|2008440|FG000|Overall Study|Withdrawal by Subject|1
995731|NCT01377389|2008440|FG000|Overall Study|Screen failure|2
995732|NCT01377480|2008463|FG000|Overall Study|Protocol Violation|0
995733|NCT01377480|2008464|FG001|Overall Study|Protocol Violation|0
995734|NCT01377480|2008465|FG002|Overall Study|Protocol Violation|0
995735|NCT01377480|2008466|FG003|Overall Study|Protocol Violation|4
995736|NCT01377480|2008463|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0
995737|NCT01377480|2008464|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1
995738|NCT01377480|2008465|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1
995739|NCT01377480|2008466|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0
995740|NCT01377480|2008463|FG000|Overall Study|Withdrawal by Subject|0
995741|NCT01377480|2008464|FG001|Overall Study|Withdrawal by Subject|0
995742|NCT01377480|2008465|FG002|Overall Study|Withdrawal by Subject|1
995743|NCT01377480|2008466|FG003|Overall Study|Withdrawal by Subject|0
995744|NCT01377480|2008463|FG000|Overall Study|Serious adverse event|0
995745|NCT01377480|2008464|FG001|Overall Study|Serious adverse event|0
995746|NCT01377480|2008465|FG002|Overall Study|Serious adverse event|1
995747|NCT01377480|2008466|FG003|Overall Study|Serious adverse event|1
995748|NCT01377480|2008463|FG000|Overall Study|Other|0
995749|NCT01377480|2008464|FG001|Overall Study|Other|0
995750|NCT01377480|2008465|FG002|Overall Study|Other|7
995751|NCT01377480|2008466|FG003|Overall Study|Other|6
995752|NCT01377844|2008521|FG000|Overall Study|Withdrawal by Subject|25
995753|NCT01377844|2008522|FG001|Overall Study|Withdrawal by Subject|28
995754|NCT01377844|2008521|FG000|Overall Study|Protocol Violation|2
995755|NCT01377844|2008522|FG001|Overall Study|Protocol Violation|3
995756|NCT01377844|2008521|FG000|Overall Study|Adverse Event|3
995757|NCT01377844|2008522|FG001|Overall Study|Adverse Event|0
995758|NCT01377844|2008521|FG000|Overall Study|Physician Decision|6
995759|NCT01377844|2008522|FG001|Overall Study|Physician Decision|3
995760|NCT01377844|2008521|FG000|Overall Study|Study terminated by Sponsor|0
995761|NCT01377844|2008522|FG001|Overall Study|Study terminated by Sponsor|1
995762|NCT01377922|2008531|FG000|Overall Study|rescue tx after part 2, entered part 4|1
995763|NCT01377922|2008532|FG001|Overall Study|rescue tx after part 2, entered part 4|0
995764|NCT01377987|2008538|FG000|Washout (7 Days)|Withdrawal by Subject|1
995765|NCT01377987|2008539|FG001|Washout (7 Days)|Withdrawal by Subject|1
995766|NCT01378104|2008551|FG000|Overall Study|Adverse Event|8
995767|NCT01378104|2008552|FG001|Overall Study|Adverse Event|8
995768|NCT01378104|2008551|FG000|Overall Study|Lack of Efficacy|7
995769|NCT01378104|2008552|FG001|Overall Study|Lack of Efficacy|5
995770|NCT01378104|2008551|FG000|Overall Study|Withdrawal by Subject|12
995771|NCT01378104|2008552|FG001|Overall Study|Withdrawal by Subject|13
995772|NCT01378117|2008563|FG000|Overall Study|withdrawal|2
995773|NCT01378117|2008564|FG001|Overall Study|withdrawal|1
995774|NCT01378117|2008565|FG002|Overall Study|withdrawal|2
995775|NCT01378117|2008563|FG000|Overall Study|discharged before med given|2
995776|NCT01378117|2008564|FG001|Overall Study|discharged before med given|0
995777|NCT01378117|2008565|FG002|Overall Study|discharged before med given|1
995778|NCT01378195|2008580|FG000|Overall Study|Lost to Follow-up|29
995779|NCT01378195|2008581|FG001|Overall Study|Lost to Follow-up|18
995780|NCT01378325|2008641|FG000|Overall Study|Protocol Violation|0
995781|NCT01378325|2008642|FG001|Overall Study|Protocol Violation|1
995782|NCT01378429|2008672|FG000|Overall Study|Noncompliance with study drug|1
995783|NCT01378429|2008673|FG001|Overall Study|Noncompliance with study drug|0
995784|NCT01378858|2008691|FG000|Overall Study|Withdrawal by Subject|4
995785|NCT01378858|2008692|FG001|Overall Study|Withdrawal by Subject|4
995786|NCT01378962|2008698|FG000|Overall Study|Death|14
995787|NCT01378962|2008698|FG000|Overall Study|Lost to Follow-up|1
995788|NCT01378962|2008698|FG000|Overall Study|Other|2
995789|NCT01378975|2008704|FG000|Overall Study|Death|77
995790|NCT01378975|2008705|FG001|Overall Study|Death|46
995791|NCT01378975|2008704|FG000|Overall Study|Investigator Request|1
995792|NCT01378975|2008705|FG001|Overall Study|Investigator Request|0
995793|NCT01378975|2008704|FG000|Overall Study|Lost to Follow-up|4
995794|NCT01378975|2008705|FG001|Overall Study|Lost to Follow-up|1
995795|NCT01378975|2008704|FG000|Overall Study|Withdrew Consent|4
995796|NCT01378975|2008705|FG001|Overall Study|Withdrew Consent|3
995797|NCT01379508|2008740|FG000|Treatment to Week 104|Adverse Event|2
995798|NCT01379508|2008741|FG001|Treatment to Week 104|Adverse Event|0
995799|NCT01379508|2008742|FG002|Treatment to Week 104|Adverse Event|5
995800|NCT01379508|2008743|FG003|Treatment to Week 104|Adverse Event|0
995801|NCT01379508|2008740|FG000|Treatment to Week 104|Abnormal lab value|1
995802|NCT01379508|2008741|FG001|Treatment to Week 104|Abnormal lab value|0
995803|NCT01379508|2008742|FG002|Treatment to Week 104|Abnormal lab value|0
995804|NCT01379508|2008743|FG003|Treatment to Week 104|Abnormal lab value|0
995805|NCT01379508|2008740|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1
995806|NCT01379508|2008741|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0
995807|NCT01379508|2008742|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0
995808|NCT01379508|2008743|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0
995809|NCT01379508|2008740|FG000|Treatment to Week 104|Withdrawal by Subject|6
995810|NCT01379508|2008741|FG001|Treatment to Week 104|Withdrawal by Subject|1
995811|NCT01379508|2008742|FG002|Treatment to Week 104|Withdrawal by Subject|4
995812|NCT01379508|2008743|FG003|Treatment to Week 104|Withdrawal by Subject|0
995813|NCT01379508|2008740|FG000|Treatment to Week 104|Lost to Follow-up|5
995814|NCT01379508|2008741|FG001|Treatment to Week 104|Lost to Follow-up|0
995815|NCT01379508|2008742|FG002|Treatment to Week 104|Lost to Follow-up|3
995816|NCT01379508|2008743|FG003|Treatment to Week 104|Lost to Follow-up|0
995817|NCT01379508|2008740|FG000|Treatment to Week 104|Administrative problems|3
995818|NCT01379508|2008741|FG001|Treatment to Week 104|Administrative problems|1
995819|NCT01379508|2008742|FG002|Treatment to Week 104|Administrative problems|0
995820|NCT01379508|2008743|FG003|Treatment to Week 104|Administrative problems|0
995821|NCT01379508|2008740|FG000|Treatment to Week 104|Protocol Violation|1
995822|NCT01379508|2008741|FG001|Treatment to Week 104|Protocol Violation|1
995823|NCT01379508|2008742|FG002|Treatment to Week 104|Protocol Violation|1
995824|NCT01379508|2008743|FG003|Treatment to Week 104|Protocol Violation|0
995825|NCT01379508|2008740|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8
995826|NCT01379508|2008741|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1
995827|NCT01379508|2008742|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8
995828|NCT01379508|2008743|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0
995829|NCT01379508|2008740|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6
995830|NCT01379508|2008741|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1
995831|NCT01379508|2008742|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5
995832|NCT01379508|2008743|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0
995833|NCT01379508|2008740|FG000|Extension Period Weeks 109-156|Administrative problems|3
995834|NCT01379508|2008741|FG001|Extension Period Weeks 109-156|Administrative problems|0
995835|NCT01379508|2008742|FG002|Extension Period Weeks 109-156|Administrative problems|1
995836|NCT01379508|2008743|FG003|Extension Period Weeks 109-156|Administrative problems|0
995837|NCT01379508|2008740|FG000|Extension Period Weeks 109-156|Protocol Violation|2
995838|NCT01379508|2008741|FG001|Extension Period Weeks 109-156|Protocol Violation|1
995839|NCT01379508|2008742|FG002|Extension Period Weeks 109-156|Protocol Violation|0
995840|NCT01379508|2008743|FG003|Extension Period Weeks 109-156|Protocol Violation|0
995841|NCT01379521|2008759|FG000|Overall Study -Treatment Period|Adverse Event|3
995842|NCT01379521|2008760|FG001|Overall Study -Treatment Period|Adverse Event|0
995843|NCT01379521|2008759|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0
995844|NCT01379521|2008760|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1
995845|NCT01379521|2008759|FG000|Overall Study -Treatment Period|Disease Progression|23
995846|NCT01379521|2008760|FG001|Overall Study -Treatment Period|Disease Progression|22
995847|NCT01379521|2008759|FG000|Overall Study -Treatment Period|New Cancer Therapy|1
995848|NCT01379521|2008760|FG001|Overall Study -Treatment Period|New Cancer Therapy|0
995849|NCT01379521|2008759|FG000|Overall Study -Treatment Period|Protocol Deviation|0
995850|NCT01379521|2008760|FG001|Overall Study -Treatment Period|Protocol Deviation|2
995851|NCT01379521|2008759|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3
995852|NCT01379521|2008760|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0
995853|NCT01379521|2008759|FG000|Overall Study -Treatment Period|Administrative Problems|1
995854|NCT01379521|2008760|FG001|Overall Study -Treatment Period|Administrative Problems|0
995855|NCT01379521|2008759|FG000|Overall Study -Treatment Period|Death|2
995856|NCT01379521|2008760|FG001|Overall Study -Treatment Period|Death|1
995857|NCT01379521|2008759|FG000|Post-Treatment Evaluations|Disease Progression|22
995858|NCT01379521|2008760|FG001|Post-Treatment Evaluations|Disease Progression|20
995859|NCT01379521|2008759|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2
995860|NCT01379521|2008760|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1
995861|NCT01379521|2008759|FG000|Post-Treatment Evaluations|Death|1
995862|NCT01379521|2008760|FG001|Post-Treatment Evaluations|Death|0
995863|NCT01379534|2008768|FG000|Treatment Phase|Withdrawal by Subject|2
995864|NCT01379534|2008769|FG001|Treatment Phase|Withdrawal by Subject|2
995865|NCT01379534|2008768|FG000|Treatment Phase|Progressive disease|13
995866|NCT01379534|2008769|FG001|Treatment Phase|Progressive disease|22
995867|NCT01379534|2008768|FG000|Treatment Phase|Adverse Event|7
995868|NCT01379534|2008769|FG001|Treatment Phase|Adverse Event|7
995869|NCT01379534|2008768|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0
995870|NCT01379534|2008769|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1
995871|NCT01379534|2008768|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
995872|NCT01379534|2008769|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
995873|NCT01379534|2008768|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
995874|NCT01379534|2008769|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
995875|NCT01379534|2008768|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
995876|NCT01379534|2008769|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
995877|NCT01379573|2008775|FG000|Overall Study|Lost to Follow-up|1
995878|NCT01379573|2008775|FG000|Overall Study|Screen Failure|10
995879|NCT01379703|2008806|FG000|Study Start Through 9 Months|Lost to Follow-up|2
995880|NCT01379703|2008807|FG001|Study Start Through 9 Months|Lost to Follow-up|61
995881|NCT01379703|2008808|FG002|Study Start Through 9 Months|Lost to Follow-up|104
995882|NCT01379703|2008806|FG000|Study Start Through 9 Months|Adverse Event|0
995883|NCT01379703|2008807|FG001|Study Start Through 9 Months|Adverse Event|14
995884|NCT01379703|2008808|FG002|Study Start Through 9 Months|Adverse Event|10
995885|NCT01379703|2008806|FG000|Study Start Through 9 Months|Withdrawal by Subject|0
995886|NCT01379703|2008807|FG001|Study Start Through 9 Months|Withdrawal by Subject|6
995887|NCT01379703|2008808|FG002|Study Start Through 9 Months|Withdrawal by Subject|1
995888|NCT01379703|2008806|FG000|Study Start Through 9 Months|Treatment Failure|0
995889|NCT01379703|2008807|FG001|Study Start Through 9 Months|Treatment Failure|2
995890|NCT01379703|2008808|FG002|Study Start Through 9 Months|Treatment Failure|2
995891|NCT01379703|2008806|FG000|Study Start Through 9 Months|Patient Noncompliance|0
995892|NCT01379703|2008807|FG001|Study Start Through 9 Months|Patient Noncompliance|0
995893|NCT01379703|2008808|FG002|Study Start Through 9 Months|Patient Noncompliance|1
995894|NCT01379703|2008806|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0
995895|NCT01379703|2008807|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4
995896|NCT01379703|2008808|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0
995897|NCT01379703|2008806|FG000|Study Start Through 9 Months|Medication not available|0
995898|NCT01379703|2008807|FG001|Study Start Through 9 Months|Medication not available|2
995899|NCT01379703|2008808|FG002|Study Start Through 9 Months|Medication not available|1
995900|NCT01379703|2008806|FG000|Study Start Through 9 Months|Poor general condition|0
995901|NCT01379703|2008807|FG001|Study Start Through 9 Months|Poor general condition|1
995902|NCT01379703|2008808|FG002|Study Start Through 9 Months|Poor general condition|0
995903|NCT01379703|2008806|FG000|Study Start Through 9 Months|Increased triglycerides|0
995904|NCT01379703|2008807|FG001|Study Start Through 9 Months|Increased triglycerides|1
995905|NCT01379703|2008808|FG002|Study Start Through 9 Months|Increased triglycerides|0
995906|NCT01379703|2008806|FG000|Study Start Through 9 Months|Reason unknown|2
995907|NCT01379703|2008807|FG001|Study Start Through 9 Months|Reason unknown|31
995908|NCT01379703|2008808|FG002|Study Start Through 9 Months|Reason unknown|24
995909|NCT01379703|2008806|FG000|9 Months Through 18 Months|Lost to Follow-up|0
995910|NCT01379703|2008807|FG001|9 Months Through 18 Months|Lost to Follow-up|178
995911|NCT01379703|2008808|FG002|9 Months Through 18 Months|Lost to Follow-up|0
995912|NCT01379703|2008806|FG000|9 Months Through 18 Months|Withdrawal by Subject|0
995913|NCT01379703|2008807|FG001|9 Months Through 18 Months|Withdrawal by Subject|11
995914|NCT01379703|2008808|FG002|9 Months Through 18 Months|Withdrawal by Subject|0
995915|NCT01379703|2008806|FG000|9 Months Through 18 Months|Adverse Event|0
995916|NCT01379703|2008807|FG001|9 Months Through 18 Months|Adverse Event|6
995917|NCT01379703|2008808|FG002|9 Months Through 18 Months|Adverse Event|0
995918|NCT01379703|2008806|FG000|9 Months Through 18 Months|Treatment failure|0
995919|NCT01379703|2008807|FG001|9 Months Through 18 Months|Treatment failure|5
995920|NCT01379703|2008808|FG002|9 Months Through 18 Months|Treatment failure|0
995921|NCT01379703|2008806|FG000|9 Months Through 18 Months|Patient Noncompliance|0
995922|NCT01379703|2008807|FG001|9 Months Through 18 Months|Patient Noncompliance|4
995923|NCT01379703|2008808|FG002|9 Months Through 18 Months|Patient Noncompliance|0
995924|NCT01379703|2008806|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0
995925|NCT01379703|2008807|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2
995926|NCT01379703|2008808|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0
995927|NCT01379703|2008806|FG000|9 Months Through 18 Months|Fatigue|0
995928|NCT01379703|2008807|FG001|9 Months Through 18 Months|Fatigue|1
995929|NCT01379703|2008808|FG002|9 Months Through 18 Months|Fatigue|0
995930|NCT01379703|2008806|FG000|9 Months Through 18 Months|Reason Unknown|0
995931|NCT01379703|2008807|FG001|9 Months Through 18 Months|Reason Unknown|23
995932|NCT01379703|2008808|FG002|9 Months Through 18 Months|Reason Unknown|0
995933|NCT01379768|2008820|FG000|Overall Study|Adverse Event|1
995934|NCT01379768|2008821|FG001|Overall Study|Adverse Event|1
995935|NCT01379768|2008822|FG002|Overall Study|Adverse Event|0
995936|NCT01379768|2008820|FG000|Overall Study|Lost to Follow-up|2
995937|NCT01379768|2008821|FG001|Overall Study|Lost to Follow-up|0
995938|NCT01379768|2008822|FG002|Overall Study|Lost to Follow-up|0
995939|NCT01379781|2008832|FG000|Overall Study|Lost to Follow-up|11
995940|NCT01379781|2008833|FG001|Overall Study|Lost to Follow-up|8
995941|NCT01379937|2008855|FG000|Overall Study|Protocol Violation|0
995942|NCT01379937|2008856|FG001|Overall Study|Protocol Violation|0
995943|NCT01379937|2008857|FG002|Overall Study|Protocol Violation|0
995944|NCT01379937|2008858|FG003|Overall Study|Protocol Violation|1
995945|NCT01379937|2008855|FG000|Overall Study|Consent withdrawal|0
995946|NCT01379937|2008856|FG001|Overall Study|Consent withdrawal|1
995947|NCT01379937|2008857|FG002|Overall Study|Consent withdrawal|0
995948|NCT01379937|2008858|FG003|Overall Study|Consent withdrawal|0
995949|NCT01379937|2008855|FG000|Overall Study|Lost to Follow-up|1
995950|NCT01379937|2008856|FG001|Overall Study|Lost to Follow-up|2
995951|NCT01379937|2008857|FG002|Overall Study|Lost to Follow-up|2
995952|NCT01379937|2008858|FG003|Overall Study|Lost to Follow-up|0
995953|NCT01380080|2008879|FG000|Overall Study|Death|36
995954|NCT01380080|2008880|FG001|Overall Study|Death|44
995955|NCT01380080|2008879|FG000|Overall Study|Site is closing|28
995956|NCT01380080|2008880|FG001|Overall Study|Site is closing|31
995957|NCT01380080|2008879|FG000|Overall Study|Not able to get to clinic|7
995958|NCT01380080|2008880|FG001|Overall Study|Not able to get to clinic|1
995959|NCT01380080|2008879|FG000|Overall Study|Not willing to adhere to requirements|6
995960|NCT01380080|2008880|FG001|Overall Study|Not willing to adhere to requirements|2
995961|NCT01380080|2008879|FG000|Overall Study|Withdrawal by Subject|5
995962|NCT01380080|2008880|FG001|Overall Study|Withdrawal by Subject|2
995963|NCT01380080|2008879|FG000|Overall Study|Lost to Follow-up|3
995964|NCT01380080|2008880|FG001|Overall Study|Lost to Follow-up|3
995965|NCT01380093|2008886|FG000|Naloxone Challenge Phase|Screen failures|21
995966|NCT01380093|2008887|FG001|Naloxone Challenge Phase|Screen failures|0
995967|NCT01380093|2008888|FG002|Naloxone Challenge Phase|Screen failures|0
995968|NCT01380093|2008889|FG003|Naloxone Challenge Phase|Screen failures|0
995969|NCT01380093|2008890|FG004|Naloxone Challenge Phase|Screen failures|0
995970|NCT01380093|2008891|FG005|Naloxone Challenge Phase|Screen failures|0
995971|NCT01380093|2008892|FG006|Naloxone Challenge Phase|Screen failures|0
995972|NCT01380093|2008893|FG007|Naloxone Challenge Phase|Screen failures|0
995973|NCT01380093|2008894|FG008|Naloxone Challenge Phase|Screen failures|0
995974|NCT01380093|2008886|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0
995975|NCT01380093|2008887|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1
995976|NCT01380093|2008888|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0
995977|NCT01380093|2008889|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0
995978|NCT01380093|2008890|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0
995979|NCT01380093|2008891|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0
995980|NCT01380093|2008892|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0
995981|NCT01380093|2008893|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0
995982|NCT01380093|2008894|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0
995983|NCT01380093|2008886|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0
995984|NCT01380093|2008887|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3
995985|NCT01380093|2008888|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1
995986|NCT01380093|2008889|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0
995987|NCT01380093|2008890|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0
995988|NCT01380093|2008891|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0
995989|NCT01380093|2008892|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0
995990|NCT01380093|2008893|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0
995991|NCT01380093|2008894|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0
995992|NCT01380093|2008886|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
995993|NCT01380093|2008887|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
995994|NCT01380093|2008888|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
995995|NCT01380093|2008889|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
995996|NCT01380093|2008890|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
995997|NCT01380093|2008891|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
995998|NCT01380093|2008892|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
995999|NCT01380093|2008893|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
996000|NCT01380093|2008894|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
996001|NCT01380093|2008886|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0
996002|NCT01380093|2008887|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4
996003|NCT01380093|2008888|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9
996004|NCT01380093|2008889|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0
996005|NCT01380093|2008890|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0
996006|NCT01380093|2008891|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0
996007|NCT01380093|2008892|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0
996008|NCT01380093|2008893|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0
996009|NCT01380093|2008894|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0
996010|NCT01380093|2008886|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
996011|NCT01380093|2008887|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
996012|NCT01380093|2008888|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
996013|NCT01380093|2008889|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
996014|NCT01380093|2008890|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
996015|NCT01380093|2008891|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
996016|NCT01380093|2008892|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
996017|NCT01380093|2008893|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
996018|NCT01380093|2008894|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
996019|NCT01380093|2008886|FG000|Drug Discrimination Phase: Day 2|Backup participant|0
996020|NCT01380093|2008887|FG001|Drug Discrimination Phase: Day 2|Backup participant|0
996021|NCT01380093|2008888|FG002|Drug Discrimination Phase: Day 2|Backup participant|1
996022|NCT01380093|2008889|FG003|Drug Discrimination Phase: Day 2|Backup participant|0
996023|NCT01380093|2008890|FG004|Drug Discrimination Phase: Day 2|Backup participant|0
996024|NCT01380093|2008891|FG005|Drug Discrimination Phase: Day 2|Backup participant|0
996025|NCT01380093|2008892|FG006|Drug Discrimination Phase: Day 2|Backup participant|0
996026|NCT01380093|2008893|FG007|Drug Discrimination Phase: Day 2|Backup participant|0
996027|NCT01380093|2008894|FG008|Drug Discrimination Phase: Day 2|Backup participant|0
996028|NCT01380093|2008886|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0
996029|NCT01380093|2008887|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0
996030|NCT01380093|2008888|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1
996031|NCT01380093|2008889|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0
996032|NCT01380093|2008890|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0
996033|NCT01380093|2008891|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0
996034|NCT01380093|2008892|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0
996035|NCT01380093|2008893|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0
996036|NCT01380093|2008894|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0
996037|NCT01380093|2008886|FG000|Treatment Phase: Second Intervention|Other|0
996038|NCT01380093|2008887|FG001|Treatment Phase: Second Intervention|Other|0
996039|NCT01380093|2008888|FG002|Treatment Phase: Second Intervention|Other|0
996040|NCT01380093|2008889|FG003|Treatment Phase: Second Intervention|Other|1
996041|NCT01380093|2008890|FG004|Treatment Phase: Second Intervention|Other|0
996042|NCT01380093|2008891|FG005|Treatment Phase: Second Intervention|Other|0
996043|NCT01380093|2008892|FG006|Treatment Phase: Second Intervention|Other|0
996044|NCT01380093|2008893|FG007|Treatment Phase: Second Intervention|Other|0
996045|NCT01380093|2008894|FG008|Treatment Phase: Second Intervention|Other|0
996046|NCT01380093|2008886|FG000|Treatment Phase: Third Intervention|Non-compliance|0
996047|NCT01380093|2008887|FG001|Treatment Phase: Third Intervention|Non-compliance|0
996048|NCT01380093|2008888|FG002|Treatment Phase: Third Intervention|Non-compliance|0
996049|NCT01380093|2008889|FG003|Treatment Phase: Third Intervention|Non-compliance|0
996050|NCT01380093|2008890|FG004|Treatment Phase: Third Intervention|Non-compliance|0
996051|NCT01380093|2008891|FG005|Treatment Phase: Third Intervention|Non-compliance|0
996052|NCT01380093|2008892|FG006|Treatment Phase: Third Intervention|Non-compliance|0
996053|NCT01380093|2008893|FG007|Treatment Phase: Third Intervention|Non-compliance|0
996054|NCT01380093|2008894|FG008|Treatment Phase: Third Intervention|Non-compliance|1
996055|NCT01380093|2008886|FG000|Treatment Phase: Third Intervention|Other|0
996056|NCT01380093|2008887|FG001|Treatment Phase: Third Intervention|Other|0
996057|NCT01380093|2008888|FG002|Treatment Phase: Third Intervention|Other|0
996058|NCT01380093|2008889|FG003|Treatment Phase: Third Intervention|Other|0
996059|NCT01380093|2008890|FG004|Treatment Phase: Third Intervention|Other|0
996060|NCT01380093|2008891|FG005|Treatment Phase: Third Intervention|Other|0
996061|NCT01380093|2008892|FG006|Treatment Phase: Third Intervention|Other|0
996062|NCT01380093|2008893|FG007|Treatment Phase: Third Intervention|Other|0
996063|NCT01380093|2008894|FG008|Treatment Phase: Third Intervention|Other|1
996064|NCT01380145|2008917|FG000|Overall Study|Progressive disease|4
996065|NCT01380184|2008923|FG000|Part 1 (19 Days)|Adverse Event|1
996066|NCT01380184|2008923|FG000|Part 2|Adverse Event|5
996067|NCT01380184|2008923|FG000|Part 2|Disease Progression|8
996068|NCT01380184|2008923|FG000|Part 2|Lost to Follow-up|1
996069|NCT01380327|2008939|FG000|Overall Study|Lost to Follow-up|0
996070|NCT01380327|2008940|FG001|Overall Study|Lost to Follow-up|1
996071|NCT01380327|2008941|FG002|Overall Study|Lost to Follow-up|1
996072|NCT01380327|2008939|FG000|Overall Study|Protocol Violation|3
996073|NCT01380327|2008940|FG001|Overall Study|Protocol Violation|2
996074|NCT01380327|2008941|FG002|Overall Study|Protocol Violation|3
996075|NCT01380327|2008939|FG000|Overall Study|Withdrawal by Subject|0
996076|NCT01380327|2008940|FG001|Overall Study|Withdrawal by Subject|0
996077|NCT01380327|2008941|FG002|Overall Study|Withdrawal by Subject|1
996078|NCT01380327|2008939|FG000|Overall Study|Housing situation precluded ability to k|0
996079|NCT01380327|2008940|FG001|Overall Study|Housing situation precluded ability to k|0
996080|NCT01380327|2008941|FG002|Overall Study|Housing situation precluded ability to k|1
996081|NCT01380327|2008939|FG000|Overall Study|Questionable onset of epilepsy|0
996082|NCT01380327|2008940|FG001|Overall Study|Questionable onset of epilepsy|0
996083|NCT01380327|2008941|FG002|Overall Study|Questionable onset of epilepsy|1
996084|NCT01380379|2008954|FG000|Overall Study|Pregnancy|1
996085|NCT01380535|2008960|FG000|Overall Study|Adverse Event|3
996086|NCT01380535|2008961|FG001|Overall Study|Adverse Event|3
996087|NCT01380535|2008960|FG000|Overall Study|Death|3
996088|NCT01380535|2008961|FG001|Overall Study|Death|0
996089|NCT01380535|2008960|FG000|Overall Study|Study site closed|0
996090|NCT01380535|2008961|FG001|Overall Study|Study site closed|5
996091|NCT01380535|2008960|FG000|Overall Study|Withdrawal by Subject|1
996092|NCT01380535|2008961|FG001|Overall Study|Withdrawal by Subject|2
996093|NCT01380535|2008960|FG000|Overall Study|Protocol Violation|0
996094|NCT01380535|2008961|FG001|Overall Study|Protocol Violation|2
996095|NCT01380535|2008960|FG000|Overall Study|Lack of Efficacy|0
996096|NCT01380535|2008961|FG001|Overall Study|Lack of Efficacy|3
996097|NCT01380691|2008976|FG000|Washout (7 Days)|Protocol Violation|0
996098|NCT01380691|2008977|FG001|Washout (7 Days)|Protocol Violation|0
996099|NCT01380691|2008978|FG002|Washout (7 Days)|Protocol Violation|0
996100|NCT01380691|2008979|FG003|Washout (7 Days)|Protocol Violation|1
996101|NCT01380691|2008976|FG000|Washout (7 Days)|Withdrawal by Subject|0
996102|NCT01380691|2008977|FG001|Washout (7 Days)|Withdrawal by Subject|0
996103|NCT01380691|2008978|FG002|Washout (7 Days)|Withdrawal by Subject|1
996104|NCT01380691|2008979|FG003|Washout (7 Days)|Withdrawal by Subject|0
996105|NCT01380730|2008998|FG000|Overall Study|Death|0
996106|NCT01380730|2008999|FG001|Overall Study|Death|0
996107|NCT01380730|2009000|FG002|Overall Study|Death|0
996108|NCT01380730|2009001|FG003|Overall Study|Death|0
996109|NCT01380730|2009002|FG004|Overall Study|Death|1
996110|NCT01380730|2009003|FG005|Overall Study|Death|0
996111|NCT01380730|2009004|FG006|Overall Study|Death|0
996112|NCT01380730|2009005|FG007|Overall Study|Death|0
996113|NCT01380769|2009042|FG000|Overall Study|Withdrawal by Subject|7
996114|NCT01380769|2009043|FG001|Overall Study|Withdrawal by Subject|11
996115|NCT01380769|2009042|FG000|Overall Study|Physician Decision|1
996116|NCT01380769|2009043|FG001|Overall Study|Physician Decision|1
996117|NCT01380769|2009042|FG000|Overall Study|Adverse Event|1
996118|NCT01380769|2009043|FG001|Overall Study|Adverse Event|1
996119|NCT01380769|2009042|FG000|Overall Study|Protocol Violation|0
996120|NCT01380769|2009043|FG001|Overall Study|Protocol Violation|1
996121|NCT01380782|2009051|FG000|Overall Study|Adverse Event|0
996122|NCT01380782|2009052|FG001|Overall Study|Adverse Event|1
996123|NCT01380782|2009053|FG002|Overall Study|Adverse Event|0
996124|NCT01380782|2009054|FG003|Overall Study|Adverse Event|0
996125|NCT01380782|2009051|FG000|Overall Study|Death|1
996126|NCT01380782|2009052|FG001|Overall Study|Death|0
996127|NCT01380782|2009053|FG002|Overall Study|Death|0
996128|NCT01380782|2009054|FG003|Overall Study|Death|0
996129|NCT01380782|2009051|FG000|Overall Study|Lack of Efficacy|10
996130|NCT01380782|2009052|FG001|Overall Study|Lack of Efficacy|9
996131|NCT01380782|2009053|FG002|Overall Study|Lack of Efficacy|10
996132|NCT01380782|2009054|FG003|Overall Study|Lack of Efficacy|3
996133|NCT01380782|2009051|FG000|Overall Study|Physician Decision|1
996134|NCT01380782|2009052|FG001|Overall Study|Physician Decision|0
996135|NCT01380782|2009053|FG002|Overall Study|Physician Decision|0
996136|NCT01380782|2009054|FG003|Overall Study|Physician Decision|0
996137|NCT01380782|2009051|FG000|Overall Study|Withdrawal by Subject|0
996138|NCT01380782|2009052|FG001|Overall Study|Withdrawal by Subject|0
996139|NCT01380782|2009053|FG002|Overall Study|Withdrawal by Subject|1
996140|NCT01380782|2009054|FG003|Overall Study|Withdrawal by Subject|1
996141|NCT01380834|2009068|FG000|Overall Study|Physician Decision|1
996142|NCT01380834|2009069|FG001|Overall Study|Physician Decision|0
996143|NCT01380990|2009090|FG000|Overall Study|Treatment Failure|1
996144|NCT01380990|2009091|FG001|Overall Study|Treatment Failure|0
996145|NCT01380990|2009090|FG000|Overall Study|Death|0
996146|NCT01380990|2009091|FG001|Overall Study|Death|1
996147|NCT01381016|2009103|FG000|Overall Study|Lost to Follow-up|1
996148|NCT01381016|2009104|FG001|Overall Study|Lost to Follow-up|1
996149|NCT01381016|2009103|FG000|Overall Study|Screen Failure|2
996150|NCT01381016|2009104|FG001|Overall Study|Screen Failure|2
996151|NCT01381016|2009103|FG000|Overall Study|Withdrawal by Subject|0
996152|NCT01381016|2009104|FG001|Overall Study|Withdrawal by Subject|1
996153|NCT01381016|2009103|FG000|Overall Study|Physician Decision|0
996154|NCT01381016|2009104|FG001|Overall Study|Physician Decision|2
996155|NCT01381068|2009114|FG000|Overall Study|Death|1
996156|NCT01381068|2009115|FG001|Overall Study|Death|0
996157|NCT01381549|2009155|FG000|Overall Study|Ineligible: No organisms isolated|0
996158|NCT01381549|2009156|FG001|Overall Study|Ineligible: No organisms isolated|0
996159|NCT01381549|2009157|FG002|Overall Study|Ineligible: No organisms isolated|1
996160|NCT01381562|2009169|FG000|Overall Study|Adverse Event|0
996161|NCT01381562|2009170|FG001|Overall Study|Adverse Event|1
996162|NCT01381562|2009171|FG002|Overall Study|Adverse Event|0
996163|NCT01381575|2009182|FG000|Overall Study|Serious Adverse Event|1
996164|NCT01381575|2009183|FG001|Overall Study|Serious Adverse Event|0
996165|NCT01381575|2009184|FG002|Overall Study|Serious Adverse Event|0
996166|NCT01381575|2009182|FG000|Overall Study|Non-Serious Adverse Event|0
996167|NCT01381575|2009183|FG001|Overall Study|Non-Serious Adverse Event|0
996168|NCT01381575|2009184|FG002|Overall Study|Non-Serious Adverse Event|1
996169|NCT01381575|2009182|FG000|Overall Study|Protocol Violation|0
996170|NCT01381575|2009183|FG001|Overall Study|Protocol Violation|1
996171|NCT01381575|2009184|FG002|Overall Study|Protocol Violation|1
996172|NCT01381575|2009182|FG000|Overall Study|Withdrawal by Subject|15
996173|NCT01381575|2009183|FG001|Overall Study|Withdrawal by Subject|9
996174|NCT01381575|2009184|FG002|Overall Study|Withdrawal by Subject|7
996175|NCT01381575|2009182|FG000|Overall Study|Migrated/moved from study area|2
996176|NCT01381575|2009183|FG001|Overall Study|Migrated/moved from study area|12
996177|NCT01381575|2009184|FG002|Overall Study|Migrated/moved from study area|2
996178|NCT01381575|2009182|FG000|Overall Study|Lost to Follow-up|8
996179|NCT01381575|2009183|FG001|Overall Study|Lost to Follow-up|17
996180|NCT01381575|2009184|FG002|Overall Study|Lost to Follow-up|9
996181|NCT01381679|2009193|FG000|Overall Study|Adverse Event|3
996182|NCT01381679|2009193|FG000|Overall Study|Lost to Follow-up|885
996183|NCT01381692|2009199|FG000|Overall Study|Adverse Event|1
996184|NCT01381692|2009200|FG001|Overall Study|Adverse Event|0
996185|NCT01381692|2009201|FG002|Overall Study|Adverse Event|0
996186|NCT01381692|2009202|FG003|Overall Study|Adverse Event|0
996187|NCT01381692|2009203|FG004|Overall Study|Adverse Event|0
996188|NCT01381692|2009204|FG005|Overall Study|Adverse Event|0
996189|NCT01381718|2009214|FG000|Overall Study|Withdrawal by Subject|2
996190|NCT01381718|2009215|FG001|Overall Study|Withdrawal by Subject|5
996191|NCT01381718|2009214|FG000|Overall Study|Lost to Follow-up|3
996192|NCT01381718|2009215|FG001|Overall Study|Lost to Follow-up|5
996193|NCT01381718|2009214|FG000|Overall Study|Toxicity, side effects or complications related to study|0
996194|NCT01381718|2009215|FG001|Overall Study|Toxicity, side effects or complications related to study|3
996195|NCT01381874|2009228|FG000|Overall Study|Lost to Follow-up|1
996196|NCT01381874|2009229|FG001|Overall Study|Lost to Follow-up|1
996197|NCT01381874|2009230|FG002|Overall Study|Lost to Follow-up|0
996198|NCT01381874|2009228|FG000|Overall Study|Withdrawal by Subject|9
996199|NCT01381874|2009229|FG001|Overall Study|Withdrawal by Subject|10
996200|NCT01381874|2009230|FG002|Overall Study|Withdrawal by Subject|9
996201|NCT01381874|2009228|FG000|Overall Study|Other|67
996202|NCT01381874|2009229|FG001|Overall Study|Other|52
996203|NCT01381874|2009230|FG002|Overall Study|Other|67
996204|NCT01381900|2009241|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2
996205|NCT01381900|2009242|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0
996206|NCT01381900|2009243|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0
996207|NCT01381900|2009241|FG000|Overall Study|Adverse Event|4
996208|NCT01381900|2009242|FG001|Overall Study|Adverse Event|6
996209|NCT01381900|2009243|FG002|Overall Study|Adverse Event|7
996210|NCT01381900|2009241|FG000|Overall Study|Noncompliance with study drug|0
996211|NCT01381900|2009242|FG001|Overall Study|Noncompliance with study drug|0
996212|NCT01381900|2009243|FG002|Overall Study|Noncompliance with study drug|1
996213|NCT01381900|2009241|FG000|Overall Study|Physician Decision|0
996214|NCT01381900|2009242|FG001|Overall Study|Physician Decision|1
996215|NCT01381900|2009243|FG002|Overall Study|Physician Decision|1
996216|NCT01381900|2009241|FG000|Overall Study|Protocol Violation|0
996217|NCT01381900|2009242|FG001|Overall Study|Protocol Violation|1
996218|NCT01381900|2009243|FG002|Overall Study|Protocol Violation|1
996219|NCT01381900|2009241|FG000|Overall Study|Withdrawal by Subject|0
996220|NCT01381900|2009242|FG001|Overall Study|Withdrawal by Subject|0
996221|NCT01381900|2009243|FG002|Overall Study|Withdrawal by Subject|1
996222|NCT01381900|2009241|FG000|Overall Study|Early withdraw|3
996223|NCT01381900|2009242|FG001|Overall Study|Early withdraw|1
996224|NCT01381900|2009243|FG002|Overall Study|Early withdraw|1
996225|NCT01381926|2009253|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
996226|NCT01381926|2009254|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
996227|NCT01381926|2009253|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
996228|NCT01381926|2009254|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
996229|NCT01382212|2009290|FG000|Overall Study|Kidney transplant|1
996230|NCT01382212|2009290|FG000|Overall Study|Withdrew consent|1
996231|NCT01382225|2009296|FG000|Overall Study|Adverse Event|3
996232|NCT01382225|2009297|FG001|Overall Study|Adverse Event|2
996233|NCT01382225|2009296|FG000|Overall Study|Protocol Violation|2
996234|NCT01382225|2009297|FG001|Overall Study|Protocol Violation|1
996235|NCT01382225|2009296|FG000|Overall Study|Subject Withdrew Consent|5
996236|NCT01382225|2009297|FG001|Overall Study|Subject Withdrew Consent|2
996237|NCT01382225|2009296|FG000|Overall Study|Other|4
996238|NCT01382225|2009297|FG001|Overall Study|Other|2
996239|NCT01382251|2009305|FG000|Overall Study|Surgeries cancelled or delayed|16
996240|NCT01382251|2009306|FG001|Overall Study|Surgeries cancelled or delayed|16
996241|NCT01382251|2009305|FG000|Overall Study|Lost to Follow-up|4
996242|NCT01382251|2009306|FG001|Overall Study|Lost to Follow-up|4
996243|NCT01382251|2009305|FG000|Overall Study|Contacted after study closed|1
996244|NCT01382251|2009306|FG001|Overall Study|Contacted after study closed|1
996245|NCT01382446|2009322|FG000|Overall Study|Withdrawal by Subject|0
996246|NCT01382446|2009323|FG001|Overall Study|Withdrawal by Subject|1
996247|NCT01382446|2009322|FG000|Overall Study|Removal from Mechanical Ventilation|3
996248|NCT01382446|2009323|FG001|Overall Study|Removal from Mechanical Ventilation|3
996249|NCT01382602|2009331|FG000|Overall Study|Protocol Violation|0
996250|NCT01382602|2009332|FG001|Overall Study|Protocol Violation|3
996251|NCT01382602|2009331|FG000|Overall Study|Withdrawal by Subject|0
996252|NCT01382602|2009332|FG001|Overall Study|Withdrawal by Subject|1
996253|NCT01382940|2009364|FG000|Overall Study|Adverse Event|19
996254|NCT01382940|2009364|FG000|Overall Study|Lost to Follow-up|4
996255|NCT01382940|2009364|FG000|Overall Study|Physician Decision|7
996256|NCT01382940|2009364|FG000|Overall Study|Withdrawal by Subject|23
996257|NCT01382940|2009364|FG000|Overall Study|Protocol Violation|20
996258|NCT01383018|2009377|FG000|Overall Study|Adverse Event|14
996259|NCT01383018|2009377|FG000|Overall Study|Death|10
996260|NCT01383018|2009377|FG000|Overall Study|Lost to Follow-up|5
996261|NCT01383018|2009377|FG000|Overall Study|Physician Decision|5
996262|NCT01383018|2009377|FG000|Overall Study|Withdrawal by Subject|9
996263|NCT01383018|2009377|FG000|Overall Study|Subject not implanted|76
996264|NCT01383018|2009377|FG000|Overall Study|Missed Visit|247
996265|NCT01383018|2009377|FG000|Overall Study|Site closed early-not compliance related|7
996266|NCT01383018|2009377|FG000|Overall Study|Patient moved away from site|1
996267|NCT01383018|2009377|FG000|Overall Study|Subject Incarcerated|1
996268|NCT01383096|2009394|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
996269|NCT01383096|2009395|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
996270|NCT01383096|2009396|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
996271|NCT01383096|2009394|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
996272|NCT01383096|2009395|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
996273|NCT01383096|2009396|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
996274|NCT01383096|2009394|FG000|Third Intervention (8 Days)|Elevated AST|0
996275|NCT01383096|2009395|FG001|Third Intervention (8 Days)|Elevated AST|1
996276|NCT01383096|2009396|FG002|Third Intervention (8 Days)|Elevated AST|0
996277|NCT01383096|2009394|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
996278|NCT01383096|2009395|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
996279|NCT01383096|2009396|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
996280|NCT01383096|2009394|FG000|Third Intervention (8 Days)|Adverse Event|1
996281|NCT01383096|2009395|FG001|Third Intervention (8 Days)|Adverse Event|0
996282|NCT01383096|2009396|FG002|Third Intervention (8 Days)|Adverse Event|0
996283|NCT01383096|2009394|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1
996284|NCT01383096|2009395|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0
996285|NCT01383096|2009396|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0
996286|NCT01383096|2009394|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
996287|NCT01383096|2009395|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
996288|NCT01383096|2009396|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
996289|NCT01383096|2009394|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
996290|NCT01383096|2009395|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
996291|NCT01383096|2009396|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
996292|NCT01383096|2009394|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
996293|NCT01383096|2009395|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
996294|NCT01383096|2009396|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
996295|NCT01383096|2009394|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1
996296|NCT01383096|2009395|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0
996297|NCT01383096|2009396|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0
996298|NCT01383096|2009394|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
996299|NCT01383096|2009395|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
996300|NCT01383096|2009396|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
996301|NCT01383161|2009435|FG000|Overall Study|Adverse Event|5
996302|NCT01383161|2009436|FG001|Overall Study|Adverse Event|1
996303|NCT01383161|2009435|FG000|Overall Study|Withdrawal by Subject|0
996304|NCT01383161|2009436|FG001|Overall Study|Withdrawal by Subject|2
996305|NCT01383161|2009435|FG000|Overall Study|Lack of Efficacy|0
996306|NCT01383161|2009436|FG001|Overall Study|Lack of Efficacy|1
996307|NCT01383174|2009444|FG000|3 Month Assessment|Death|0
996308|NCT01383174|2009445|FG001|3 Month Assessment|Death|1
996309|NCT01383174|2009444|FG000|3 Month Assessment|Lost to Follow-up|2
996310|NCT01383174|2009445|FG001|3 Month Assessment|Lost to Follow-up|0
996311|NCT01383174|2009444|FG000|3 Month Assessment|Refused to complete|4
996312|NCT01383174|2009445|FG001|3 Month Assessment|Refused to complete|0
996313|NCT01383174|2009444|FG000|6 Month Assessment|Lost to Follow-up|1
996314|NCT01383174|2009445|FG001|6 Month Assessment|Lost to Follow-up|1
996315|NCT01383174|2009444|FG000|6 Month Assessment|Refused to complete|4
996316|NCT01383174|2009445|FG001|6 Month Assessment|Refused to complete|0
996317|NCT01383317|2009471|FG000|Overall Study|Lost to Follow-up|2
996318|NCT01383317|2009472|FG001|Overall Study|Lost to Follow-up|1
996319|NCT01383317|2009471|FG000|Overall Study|Death|1
996320|NCT01383317|2009472|FG001|Overall Study|Death|0
996321|NCT01383317|2009471|FG000|Overall Study|Adverse Event|0
996322|NCT01383317|2009472|FG001|Overall Study|Adverse Event|1
996323|NCT01383356|2009478|FG000|Period 1|Adverse Event|5
996324|NCT01383356|2009479|FG001|Period 1|Adverse Event|3
996325|NCT01383356|2009478|FG000|Period 1|Non-compliance|3
996326|NCT01383356|2009479|FG001|Period 1|Non-compliance|0
996327|NCT01383356|2009478|FG000|Period 1|Out of Range Mid-study-Test|0
996328|NCT01383356|2009479|FG001|Period 1|Out of Range Mid-study-Test|1
996329|NCT01383356|2009478|FG000|Period 1|Personal|0
996330|NCT01383356|2009479|FG001|Period 1|Personal|2
996331|NCT01383486|2009493|FG000|Overall Study|Lost to Follow-up|10
996332|NCT01383486|2009493|FG000|Overall Study|Incomplete information for analysis|2
996333|NCT01383486|2009493|FG000|Overall Study|Did not take any product|6
996334|NCT01383499|2009498|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1
996335|NCT01383499|2009499|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0
996336|NCT01383499|2009500|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
996337|NCT01383499|2009501|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
996338|NCT01383707|2009527|FG000|Overall Study|Consent withdrawal|6
996339|NCT01383707|2009527|FG000|Overall Study|Death|19
996340|NCT01383707|2009527|FG000|Overall Study|Other|8
996341|NCT01383707|2009527|FG000|Overall Study|Sponsor's decision|2
996342|NCT01383707|2009527|FG000|Overall Study|Adverse Event|14
996343|NCT01383707|2009527|FG000|Overall Study|Progressive disease|23
996344|NCT01383928|2009547|FG000|Overall Study|Initiation of ASCT|2
996345|NCT01383928|2009548|FG001|Overall Study|Initiation of ASCT|1
996346|NCT01383928|2009549|FG002|Overall Study|Initiation of ASCT|18
996347|NCT01383928|2009547|FG000|Overall Study|Adverse Event|1
996348|NCT01383928|2009548|FG001|Overall Study|Adverse Event|2
996349|NCT01383928|2009549|FG002|Overall Study|Adverse Event|8
996350|NCT01383928|2009547|FG000|Overall Study|Other|1
996351|NCT01383928|2009548|FG001|Overall Study|Other|3
996352|NCT01383928|2009549|FG002|Overall Study|Other|4
996353|NCT01383928|2009547|FG000|Overall Study|Progressive Disease|1
996354|NCT01383928|2009548|FG001|Overall Study|Progressive Disease|1
996355|NCT01383928|2009549|FG002|Overall Study|Progressive Disease|5
996356|NCT01383928|2009547|FG000|Overall Study|Withdrawal by Subject|0
996357|NCT01383928|2009548|FG001|Overall Study|Withdrawal by Subject|0
996358|NCT01383928|2009549|FG002|Overall Study|Withdrawal by Subject|4
996359|NCT01383928|2009547|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
996360|NCT01383928|2009548|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
996361|NCT01383928|2009549|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
996362|NCT01383954|2009559|FG000|Overall Study|Lack of Efficacy|2
996363|NCT01383954|2009559|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2
996364|NCT01383954|2009559|FG000|Overall Study|Adverse Event|1
996365|NCT01383954|2009559|FG000|Overall Study|Reason Not Specified|9
996366|NCT01383993|2009566|FG000|Overall Study|Adverse Event|1
996367|NCT01383993|2009567|FG001|Overall Study|Adverse Event|1
996368|NCT01383993|2009568|FG002|Overall Study|Adverse Event|0
996369|NCT01383993|2009566|FG000|Overall Study|Withdrawal by Subject|0
996370|NCT01383993|2009567|FG001|Overall Study|Withdrawal by Subject|0
996371|NCT01383993|2009568|FG002|Overall Study|Withdrawal by Subject|1
996372|NCT01383993|2009566|FG000|Overall Study|Marketed voriconazole in post-therapy|2
996373|NCT01383993|2009567|FG001|Overall Study|Marketed voriconazole in post-therapy|0
996374|NCT01383993|2009568|FG002|Overall Study|Marketed voriconazole in post-therapy|0
996375|NCT01384019|2009579|FG000|Overall Study|Withdrawal by Subject|3
996376|NCT01384019|2009580|FG001|Overall Study|Withdrawal by Subject|0
996377|NCT01384019|2009579|FG000|Overall Study|Death|1
996378|NCT01384019|2009580|FG001|Overall Study|Death|0
996379|NCT01384019|2009579|FG000|Overall Study|MRI refusal|6
996380|NCT01384019|2009580|FG001|Overall Study|MRI refusal|6
996381|NCT01384292|2009589|FG000|Part B|Severe non-compliance to protocol|1
996382|NCT01384292|2009590|FG001|Part B|Severe non-compliance to protocol|0
996383|NCT01384292|2009591|FG002|Part B|Severe non-compliance to protocol|0
996384|NCT01384734|2009628|FG000|Overall Study|Adverse Event|0
996385|NCT01384734|2009629|FG001|Overall Study|Adverse Event|3
996386|NCT01384734|2009630|FG002|Overall Study|Adverse Event|0
996387|NCT01384734|2009631|FG003|Overall Study|Adverse Event|2
996388|NCT01384734|2009632|FG004|Overall Study|Adverse Event|7
996389|NCT01384734|2009628|FG000|Overall Study|Death|1
996390|NCT01384734|2009629|FG001|Overall Study|Death|0
996391|NCT01384734|2009630|FG002|Overall Study|Death|1
996392|NCT01384734|2009631|FG003|Overall Study|Death|0
996393|NCT01384734|2009632|FG004|Overall Study|Death|0
996394|NCT01384734|2009628|FG000|Overall Study|Continuation criteria not met|0
996395|NCT01384734|2009629|FG001|Overall Study|Continuation criteria not met|0
996396|NCT01384734|2009630|FG002|Overall Study|Continuation criteria not met|1
996397|NCT01384734|2009631|FG003|Overall Study|Continuation criteria not met|1
996398|NCT01384734|2009632|FG004|Overall Study|Continuation criteria not met|0
996399|NCT01384734|2009628|FG000|Overall Study|Lack of Efficacy|3
996400|NCT01384734|2009629|FG001|Overall Study|Lack of Efficacy|7
996401|NCT01384734|2009630|FG002|Overall Study|Lack of Efficacy|4
996402|NCT01384734|2009631|FG003|Overall Study|Lack of Efficacy|4
996403|NCT01384734|2009632|FG004|Overall Study|Lack of Efficacy|2
996404|NCT01384734|2009628|FG000|Overall Study|Lost to Follow-up|5
996405|NCT01384734|2009629|FG001|Overall Study|Lost to Follow-up|3
996406|NCT01384734|2009630|FG002|Overall Study|Lost to Follow-up|3
996407|NCT01384734|2009631|FG003|Overall Study|Lost to Follow-up|8
996408|NCT01384734|2009632|FG004|Overall Study|Lost to Follow-up|5
996409|NCT01384734|2009628|FG000|Overall Study|Non-compliance with study drug|1
996410|NCT01384734|2009629|FG001|Overall Study|Non-compliance with study drug|2
996411|NCT01384734|2009630|FG002|Overall Study|Non-compliance with study drug|6
996412|NCT01384734|2009631|FG003|Overall Study|Non-compliance with study drug|0
996413|NCT01384734|2009632|FG004|Overall Study|Non-compliance with study drug|2
996414|NCT01384734|2009628|FG000|Overall Study|Pregnancy|0
996415|NCT01384734|2009629|FG001|Overall Study|Pregnancy|1
996416|NCT01384734|2009630|FG002|Overall Study|Pregnancy|0
996417|NCT01384734|2009631|FG003|Overall Study|Pregnancy|0
996418|NCT01384734|2009632|FG004|Overall Study|Pregnancy|1
996419|NCT01384734|2009628|FG000|Overall Study|Sponsor terminated|0
996420|NCT01384734|2009629|FG001|Overall Study|Sponsor terminated|0
996421|NCT01384734|2009630|FG002|Overall Study|Sponsor terminated|0
996422|NCT01384734|2009631|FG003|Overall Study|Sponsor terminated|0
996423|NCT01384734|2009632|FG004|Overall Study|Sponsor terminated|1
996424|NCT01384734|2009628|FG000|Overall Study|Withdrawal by Subject|5
996425|NCT01384734|2009629|FG001|Overall Study|Withdrawal by Subject|5
996426|NCT01384734|2009630|FG002|Overall Study|Withdrawal by Subject|6
996427|NCT01384734|2009631|FG003|Overall Study|Withdrawal by Subject|7
996428|NCT01384734|2009632|FG004|Overall Study|Withdrawal by Subject|9
996429|NCT01384734|2009628|FG000|Overall Study|Investigator relocating|0
996430|NCT01384734|2009629|FG001|Overall Study|Investigator relocating|2
996431|NCT01384734|2009630|FG002|Overall Study|Investigator relocating|0
996432|NCT01384734|2009631|FG003|Overall Study|Investigator relocating|3
996433|NCT01384734|2009632|FG004|Overall Study|Investigator relocating|1
996434|NCT01384734|2009628|FG000|Overall Study|Unable to come back for visit|1
996435|NCT01384734|2009629|FG001|Overall Study|Unable to come back for visit|0
996436|NCT01384734|2009630|FG002|Overall Study|Unable to come back for visit|1
996437|NCT01384734|2009631|FG003|Overall Study|Unable to come back for visit|1
996438|NCT01384734|2009632|FG004|Overall Study|Unable to come back for visit|0
996439|NCT01384734|2009628|FG000|Overall Study|Prison|0
996440|NCT01384734|2009629|FG001|Overall Study|Prison|0
996441|NCT01384734|2009630|FG002|Overall Study|Prison|1
996442|NCT01384734|2009631|FG003|Overall Study|Prison|0
996443|NCT01384734|2009632|FG004|Overall Study|Prison|0
996444|NCT01384734|2009628|FG000|Overall Study|As per Exclusion criteria|0
996445|NCT01384734|2009629|FG001|Overall Study|As per Exclusion criteria|1
996446|NCT01384734|2009630|FG002|Overall Study|As per Exclusion criteria|0
996447|NCT01384734|2009631|FG003|Overall Study|As per Exclusion criteria|0
996448|NCT01384734|2009632|FG004|Overall Study|As per Exclusion criteria|0
996449|NCT01384734|2009628|FG000|Overall Study|Missed End of treatment visit|0
996450|NCT01384734|2009629|FG001|Overall Study|Missed End of treatment visit|0
996451|NCT01384734|2009630|FG002|Overall Study|Missed End of treatment visit|0
996452|NCT01384734|2009631|FG003|Overall Study|Missed End of treatment visit|1
996453|NCT01384734|2009632|FG004|Overall Study|Missed End of treatment visit|0
996454|NCT01384734|2009628|FG000|Overall Study|Adhesion problem|0
996455|NCT01384734|2009629|FG001|Overall Study|Adhesion problem|0
996456|NCT01384734|2009630|FG002|Overall Study|Adhesion problem|0
996457|NCT01384734|2009631|FG003|Overall Study|Adhesion problem|1
996458|NCT01384734|2009632|FG004|Overall Study|Adhesion problem|0
996459|NCT01384734|2009628|FG000|Overall Study|Early termination|0
996460|NCT01384734|2009629|FG001|Overall Study|Early termination|0
996461|NCT01384734|2009630|FG002|Overall Study|Early termination|0
996462|NCT01384734|2009631|FG003|Overall Study|Early termination|0
996463|NCT01384734|2009632|FG004|Overall Study|Early termination|1
996464|NCT01384734|2009628|FG000|Overall Study|Physician Decision|1
996465|NCT01384734|2009629|FG001|Overall Study|Physician Decision|0
996466|NCT01384734|2009630|FG002|Overall Study|Physician Decision|0
996467|NCT01384734|2009631|FG003|Overall Study|Physician Decision|0
996468|NCT01384734|2009632|FG004|Overall Study|Physician Decision|0
996469|NCT01384760|2009643|FG000|Overall Study|Lost to Follow-up|0
996470|NCT01384760|2009644|FG001|Overall Study|Lost to Follow-up|6
996471|NCT01384760|2009643|FG000|Overall Study|Protocol Violation|16
996472|NCT01384760|2009644|FG001|Overall Study|Protocol Violation|0
996473|NCT01384877|2009652|FG000|Treatment 2|Lost to Follow-up|2
996474|NCT01384877|2009653|FG001|Treatment 2|Lost to Follow-up|2
996475|NCT01385098|2009659|FG000|Overall Study|Adverse Event|10
996476|NCT01385098|2009659|FG000|Overall Study|Lost to Follow-up|4
996487|NCT01385202|2009716|FG000|Overall Study|Lost to Follow-up|6
996488|NCT01385202|2009716|FG000|Overall Study|Not Eligible|11
996489|NCT01385202|2009716|FG000|Overall Study|Withdrawn|1
996490|NCT01385371|2009732|FG000|Overall Study|Adverse Event|54
996491|NCT01385371|2009733|FG001|Overall Study|Adverse Event|19
996492|NCT01385371|2009732|FG000|Overall Study|Lost to Follow-up|16
996493|NCT01385371|2009733|FG001|Overall Study|Lost to Follow-up|16
996494|NCT01385371|2009732|FG000|Overall Study|Withdrawal by Subject|52
996495|NCT01385371|2009733|FG001|Overall Study|Withdrawal by Subject|39
996496|NCT01385371|2009732|FG000|Overall Study|Protocol Violation|25
996497|NCT01385371|2009733|FG001|Overall Study|Protocol Violation|21
996498|NCT01385371|2009732|FG000|Overall Study|Administrative|2
996499|NCT01385371|2009733|FG001|Overall Study|Administrative|2
996500|NCT01385566|2009745|FG000|Overall Study|Lost to Follow-up|1
996501|NCT01385566|2009746|FG001|Overall Study|Lost to Follow-up|0
996502|NCT01385566|2009747|FG002|Overall Study|Lost to Follow-up|0
996503|NCT01385566|2009748|FG003|Overall Study|Lost to Follow-up|0
996504|NCT01385566|2009749|FG004|Overall Study|Lost to Follow-up|0
996505|NCT01385566|2009750|FG005|Overall Study|Lost to Follow-up|0
996506|NCT01385566|2009745|FG000|Overall Study|Withdrawal by Subject|0
996507|NCT01385566|2009746|FG001|Overall Study|Withdrawal by Subject|0
996508|NCT01385566|2009747|FG002|Overall Study|Withdrawal by Subject|0
996509|NCT01385566|2009748|FG003|Overall Study|Withdrawal by Subject|1
996510|NCT01385566|2009749|FG004|Overall Study|Withdrawal by Subject|0
996511|NCT01385566|2009750|FG005|Overall Study|Withdrawal by Subject|0
996512|NCT01385748|2009795|FG000|Overall Study|Withdrawal by Subject|7
996513|NCT01385748|2009796|FG001|Overall Study|Withdrawal by Subject|4
996514|NCT01385748|2009797|FG002|Overall Study|Withdrawal by Subject|5
996515|NCT01385748|2009795|FG000|Overall Study|Noncompliance|3
996516|NCT01385748|2009796|FG001|Overall Study|Noncompliance|1
996517|NCT01385748|2009797|FG002|Overall Study|Noncompliance|6
996518|NCT01385748|2009795|FG000|Overall Study|Other|1
996519|NCT01385748|2009796|FG001|Overall Study|Other|7
996520|NCT01385748|2009797|FG002|Overall Study|Other|1
996521|NCT01385748|2009795|FG000|Overall Study|Adverse Event|4
996522|NCT01385748|2009796|FG001|Overall Study|Adverse Event|2
996523|NCT01385748|2009797|FG002|Overall Study|Adverse Event|1
996524|NCT01385995|2009811|FG000|Period 1, 2 Months|Physician Decision|1
996525|NCT01385995|2009812|FG001|Period 1, 2 Months|Physician Decision|0
996526|NCT01386008|2009820|FG000|Overall Study|exited w/o incident /study discontinued|17
996527|NCT01386008|2009820|FG000|Overall Study|Adverse Event|3
996528|NCT01386125|2009826|FG000|Overall Study|Lost to Follow-up|3
996529|NCT01386125|2009827|FG001|Overall Study|Lost to Follow-up|9
996530|NCT01386125|2009826|FG000|Overall Study|Physician Decision|0
996531|NCT01386125|2009827|FG001|Overall Study|Physician Decision|1
996532|NCT01386125|2009826|FG000|Overall Study|Protocol Violation|5
996533|NCT01386125|2009827|FG001|Overall Study|Protocol Violation|7
996534|NCT01386125|2009826|FG000|Overall Study|Disease Progress|1
996535|NCT01386125|2009827|FG001|Overall Study|Disease Progress|2
996536|NCT01386125|2009826|FG000|Overall Study|Withdrawal by Subject|13
996537|NCT01386125|2009827|FG001|Overall Study|Withdrawal by Subject|12
996538|NCT01386125|2009826|FG000|Overall Study|Adverse Event|2
996539|NCT01386125|2009827|FG001|Overall Study|Adverse Event|5
996540|NCT01386125|2009826|FG000|Overall Study|Lack of Efficacy|0
996541|NCT01386125|2009827|FG001|Overall Study|Lack of Efficacy|1
996542|NCT01386125|2009826|FG000|Overall Study|Participant Leaving Country|1
996543|NCT01386125|2009827|FG001|Overall Study|Participant Leaving Country|0
996544|NCT01386385|2009838|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1
996545|NCT01386385|2009839|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0
996546|NCT01386385|2009840|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0
996547|NCT01386385|2009841|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0
996548|NCT01386385|2009842|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0
996549|NCT01386385|2009843|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0
996550|NCT01386385|2009844|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0
996551|NCT01386385|2009845|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0
996552|NCT01386385|2009838|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1
996553|NCT01386385|2009839|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
996554|NCT01386385|2009840|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
996555|NCT01386385|2009841|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
996556|NCT01386385|2009842|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
996557|NCT01386385|2009843|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
996558|NCT01386385|2009844|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
996559|NCT01386385|2009845|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
996560|NCT01386385|2009838|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0
996561|NCT01386385|2009839|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0
996562|NCT01386385|2009840|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2
996563|NCT01386385|2009841|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0
996564|NCT01386385|2009842|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0
996565|NCT01386385|2009843|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0
996566|NCT01386385|2009844|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0
996567|NCT01386385|2009845|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0
996568|NCT01386385|2009838|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
996569|NCT01386385|2009839|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
996570|NCT01386385|2009840|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
996571|NCT01386385|2009841|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
996572|NCT01386385|2009842|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1
996573|NCT01386385|2009843|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
996574|NCT01386385|2009844|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
996575|NCT01386385|2009845|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
996576|NCT01386385|2009838|FG000|Phase II Concurrent CRT|Adverse Event|0
996577|NCT01386385|2009839|FG001|Phase II Concurrent CRT|Adverse Event|0
996578|NCT01386385|2009840|FG002|Phase II Concurrent CRT|Adverse Event|0
996579|NCT01386385|2009841|FG003|Phase II Concurrent CRT|Adverse Event|0
996580|NCT01386385|2009842|FG004|Phase II Concurrent CRT|Adverse Event|0
996581|NCT01386385|2009843|FG005|Phase II Concurrent CRT|Adverse Event|0
996582|NCT01386385|2009844|FG006|Phase II Concurrent CRT|Adverse Event|3
996583|NCT01386385|2009845|FG007|Phase II Concurrent CRT|Adverse Event|3
996584|NCT01386385|2009838|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0
996585|NCT01386385|2009839|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0
996586|NCT01386385|2009840|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0
996587|NCT01386385|2009841|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0
996588|NCT01386385|2009842|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0
996589|NCT01386385|2009843|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0
996590|NCT01386385|2009844|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3
996591|NCT01386385|2009845|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0
996592|NCT01386385|2009838|FG000|Phase II: Consolidation Therapy|Adverse Event|0
996593|NCT01386385|2009839|FG001|Phase II: Consolidation Therapy|Adverse Event|0
996594|NCT01386385|2009840|FG002|Phase II: Consolidation Therapy|Adverse Event|0
996595|NCT01386385|2009841|FG003|Phase II: Consolidation Therapy|Adverse Event|0
996596|NCT01386385|2009842|FG004|Phase II: Consolidation Therapy|Adverse Event|0
996597|NCT01386385|2009843|FG005|Phase II: Consolidation Therapy|Adverse Event|0
996598|NCT01386385|2009844|FG006|Phase II: Consolidation Therapy|Adverse Event|2
996599|NCT01386385|2009845|FG007|Phase II: Consolidation Therapy|Adverse Event|1
996600|NCT01386385|2009838|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
996601|NCT01386385|2009839|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
996602|NCT01386385|2009840|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
996603|NCT01386385|2009841|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
996604|NCT01386385|2009842|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
996605|NCT01386385|2009843|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
996606|NCT01386385|2009844|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2
996607|NCT01386385|2009845|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
996608|NCT01386385|2009838|FG000|Phase II: Consolidation Therapy|Progression/relapse|0
996609|NCT01386385|2009839|FG001|Phase II: Consolidation Therapy|Progression/relapse|0
996610|NCT01386385|2009840|FG002|Phase II: Consolidation Therapy|Progression/relapse|0
996611|NCT01386385|2009841|FG003|Phase II: Consolidation Therapy|Progression/relapse|0
996612|NCT01386385|2009842|FG004|Phase II: Consolidation Therapy|Progression/relapse|0
996613|NCT01386385|2009843|FG005|Phase II: Consolidation Therapy|Progression/relapse|0
996614|NCT01386385|2009844|FG006|Phase II: Consolidation Therapy|Progression/relapse|1
996615|NCT01386385|2009845|FG007|Phase II: Consolidation Therapy|Progression/relapse|1
996616|NCT01386554|2009873|FG000|Overall Study|Lost to Follow-up|0
996617|NCT01386554|2009874|FG001|Overall Study|Lost to Follow-up|0
996618|NCT01386554|2009875|FG002|Overall Study|Lost to Follow-up|1
996619|NCT01386554|2009873|FG000|Overall Study|Adverse Event|2
996620|NCT01386554|2009874|FG001|Overall Study|Adverse Event|5
996621|NCT01386554|2009875|FG002|Overall Study|Adverse Event|2
996622|NCT01386554|2009873|FG000|Overall Study|Progressive disease|1
996623|NCT01386554|2009874|FG001|Overall Study|Progressive disease|2
996624|NCT01386554|2009875|FG002|Overall Study|Progressive disease|2
996625|NCT01386554|2009873|FG000|Overall Study|Administration of live vaccines|0
996626|NCT01386554|2009874|FG001|Overall Study|Administration of live vaccines|1
996627|NCT01386554|2009875|FG002|Overall Study|Administration of live vaccines|0
996628|NCT01386554|2009873|FG000|Overall Study|Investigator discretion|0
996629|NCT01386554|2009874|FG001|Overall Study|Investigator discretion|0
996630|NCT01386554|2009875|FG002|Overall Study|Investigator discretion|1
996631|NCT01386554|2009873|FG000|Overall Study|Reason not collected|0
996632|NCT01386554|2009874|FG001|Overall Study|Reason not collected|1
996633|NCT01386554|2009875|FG002|Overall Study|Reason not collected|0
996634|NCT01386606|2009889|FG000|Overall Study|Adverse Event|0
996635|NCT01386606|2009890|FG001|Overall Study|Adverse Event|1
996636|NCT01386606|2009891|FG002|Overall Study|Adverse Event|0
996637|NCT01386606|2009892|FG003|Overall Study|Adverse Event|0
996638|NCT01386606|2009889|FG000|Overall Study|Withdrawal by Subject|0
996639|NCT01386606|2009890|FG001|Overall Study|Withdrawal by Subject|1
996640|NCT01386606|2009891|FG002|Overall Study|Withdrawal by Subject|1
996641|NCT01386606|2009892|FG003|Overall Study|Withdrawal by Subject|0
996642|NCT01386606|2009889|FG000|Overall Study|Protocol Violation|1
996643|NCT01386606|2009890|FG001|Overall Study|Protocol Violation|0
996644|NCT01386606|2009891|FG002|Overall Study|Protocol Violation|1
996645|NCT01386606|2009892|FG003|Overall Study|Protocol Violation|1
996646|NCT01386606|2009889|FG000|Overall Study|Lost to Follow-up|2
996647|NCT01386606|2009890|FG001|Overall Study|Lost to Follow-up|0
996648|NCT01386606|2009891|FG002|Overall Study|Lost to Follow-up|0
996649|NCT01386606|2009892|FG003|Overall Study|Lost to Follow-up|0
996650|NCT01386606|2009889|FG000|Overall Study|Subject incarcerated|0
996651|NCT01386606|2009890|FG001|Overall Study|Subject incarcerated|1
996652|NCT01386606|2009891|FG002|Overall Study|Subject incarcerated|0
996653|NCT01386606|2009892|FG003|Overall Study|Subject incarcerated|0
996654|NCT01386606|2009889|FG000|Overall Study|Unable to draw PK|1
996655|NCT01386606|2009890|FG001|Overall Study|Unable to draw PK|0
914032|NCT00812929|1891807|FG004|Washout Period 2 (7 Days)|Physician Decision|0
914033|NCT00812929|1891808|FG005|Washout Period 2 (7 Days)|Physician Decision|0
914034|NCT00812929|1891809|FG006|Washout Period 2 (7 Days)|Physician Decision|0
914035|NCT00812929|1891810|FG007|Washout Period 2 (7 Days)|Physician Decision|0
914036|NCT00812929|1891811|FG008|Washout Period 2 (7 Days)|Physician Decision|0
914037|NCT00812929|1891812|FG009|Washout Period 2 (7 Days)|Physician Decision|1
914038|NCT00812929|1891803|FG000|Washout Period 3 (7 Days)|Adverse Event|0
914039|NCT00812929|1891804|FG001|Washout Period 3 (7 Days)|Adverse Event|0
914040|NCT00812929|1891805|FG002|Washout Period 3 (7 Days)|Adverse Event|0
914041|NCT00812929|1891806|FG003|Washout Period 3 (7 Days)|Adverse Event|0
914042|NCT00812929|1891807|FG004|Washout Period 3 (7 Days)|Adverse Event|0
914043|NCT00812929|1891808|FG005|Washout Period 3 (7 Days)|Adverse Event|1
914044|NCT00812929|1891809|FG006|Washout Period 3 (7 Days)|Adverse Event|0
914045|NCT00812929|1891810|FG007|Washout Period 3 (7 Days)|Adverse Event|0
914046|NCT00812929|1891811|FG008|Washout Period 3 (7 Days)|Adverse Event|0
914047|NCT00812929|1891812|FG009|Washout Period 3 (7 Days)|Adverse Event|0
914048|NCT00812955|1891833|FG000|Overall Study|Adverse Event|7
996656|NCT01386606|2009891|FG002|Overall Study|Unable to draw PK|0
996657|NCT01386606|2009892|FG003|Overall Study|Unable to draw PK|0
996658|NCT01386606|2009889|FG000|Overall Study|T levels too high|0
996659|NCT01386606|2009890|FG001|Overall Study|T levels too high|1
996660|NCT01386606|2009891|FG002|Overall Study|T levels too high|1
996661|NCT01386606|2009892|FG003|Overall Study|T levels too high|0
996662|NCT01386645|2009918|FG000|Overall Study|Physician Decision|0
996663|NCT01386645|2009919|FG001|Overall Study|Physician Decision|0
996664|NCT01386645|2009920|FG002|Overall Study|Physician Decision|1
996665|NCT01386645|2009918|FG000|Overall Study|Withdrawal by Subject|0
996666|NCT01386645|2009919|FG001|Overall Study|Withdrawal by Subject|1
996667|NCT01386645|2009920|FG002|Overall Study|Withdrawal by Subject|1
996668|NCT01386788|2009945|FG000|Overall Study|Lost to Follow-up|2
996669|NCT01386944|2009949|FG000|Overall Study|Adverse Event|26
996670|NCT01386944|2009949|FG000|Overall Study|Lack of Efficacy|14
996671|NCT01386944|2009949|FG000|Overall Study|Lost to Follow-up|8
996672|NCT01386944|2009949|FG000|Overall Study|Unspecified reason|8
996673|NCT01386970|2009955|FG000|Overall Study|Withdrawal by Subject|0
996674|NCT01386970|2009956|FG001|Overall Study|Withdrawal by Subject|1
996675|NCT01386970|2009955|FG000|Overall Study|Adverse Event|4
996676|NCT01386970|2009956|FG001|Overall Study|Adverse Event|1
996677|NCT01387022|2009975|FG000|Overall Study|Death|1
996678|NCT01387022|2009976|FG001|Overall Study|Death|1
996679|NCT01387022|2009975|FG000|Overall Study|Lost to Follow-up|0
996680|NCT01387022|2009976|FG001|Overall Study|Lost to Follow-up|3
996681|NCT01387074|2009982|FG000|Overall Study|Lost to Follow-up|7
996682|NCT01387074|2009982|FG000|Overall Study|Lack of Efficacy|1
996683|NCT01387230|2010008|FG000|Overall Study|Adverse Event|0
996684|NCT01387230|2010009|FG001|Overall Study|Adverse Event|1
996685|NCT01387230|2010010|FG002|Overall Study|Adverse Event|3
996686|NCT01387230|2010008|FG000|Overall Study|Lack of Efficacy|8
996687|NCT01387230|2010009|FG001|Overall Study|Lack of Efficacy|5
996688|NCT01387230|2010010|FG002|Overall Study|Lack of Efficacy|4
996689|NCT01387230|2010008|FG000|Overall Study|Protocol-defined Stopping Criteria|6
996690|NCT01387230|2010009|FG001|Overall Study|Protocol-defined Stopping Criteria|0
996691|NCT01387230|2010010|FG002|Overall Study|Protocol-defined Stopping Criteria|5
996692|NCT01387230|2010008|FG000|Overall Study|Lost to Follow-up|0
996693|NCT01387230|2010009|FG001|Overall Study|Lost to Follow-up|0
996694|NCT01387230|2010010|FG002|Overall Study|Lost to Follow-up|1
996695|NCT01387230|2010008|FG000|Overall Study|Withdrawal by Subject|4
996696|NCT01387230|2010009|FG001|Overall Study|Withdrawal by Subject|1
996697|NCT01387230|2010010|FG002|Overall Study|Withdrawal by Subject|0
996698|NCT01387269|2010020|FG000|Overall Study|Death|38
996699|NCT01387269|2010021|FG001|Overall Study|Death|20
996700|NCT01387269|2010020|FG000|Overall Study|Other|8
996701|NCT01387269|2010021|FG001|Overall Study|Other|7
996702|NCT01387269|2010020|FG000|Overall Study|Unrelated AE|12
996703|NCT01387269|2010021|FG001|Overall Study|Unrelated AE|3
996704|NCT01387269|2010020|FG000|Overall Study|Withdrawal by patient|32
996705|NCT01387269|2010021|FG001|Overall Study|Withdrawal by patient|10
996706|NCT01387269|2010020|FG000|Overall Study|Study drug-related AE|1
996707|NCT01387269|2010021|FG001|Overall Study|Study drug-related AE|0
996708|NCT01387269|2010020|FG000|Overall Study|Lost to Follow-up|1
996709|NCT01387269|2010021|FG001|Overall Study|Lost to Follow-up|0
996710|NCT01387282|2010029|FG000|Overall Study|Death|47
996711|NCT01387282|2010030|FG001|Overall Study|Death|16
996712|NCT01387282|2010029|FG000|Overall Study|Other|5
996713|NCT01387282|2010030|FG001|Overall Study|Other|1
996714|NCT01387282|2010029|FG000|Overall Study|Unrelated AE|6
996715|NCT01387282|2010030|FG001|Overall Study|Unrelated AE|4
996716|NCT01387282|2010029|FG000|Overall Study|Withdrawal by patient|33
996717|NCT01387282|2010030|FG001|Overall Study|Withdrawal by patient|23
996718|NCT01387282|2010029|FG000|Overall Study|Study drug-related AE|2
996719|NCT01387282|2010030|FG001|Overall Study|Study drug-related AE|2
996720|NCT01387282|2010029|FG000|Overall Study|Lost to Follow-up|4
996721|NCT01387282|2010030|FG001|Overall Study|Lost to Follow-up|1
996722|NCT01387347|2010038|FG000|Overall Study|Lost to Follow-up|2
996723|NCT01387347|2010039|FG001|Overall Study|Lost to Follow-up|1
996724|NCT01387516|2010062|FG000|Overall Study|Lost to Follow-up|4
996725|NCT01387516|2010063|FG001|Overall Study|Lost to Follow-up|4
996726|NCT01387516|2010064|FG002|Overall Study|Lost to Follow-up|2
996727|NCT01387516|2010065|FG003|Overall Study|Lost to Follow-up|3
996728|NCT01387516|2010062|FG000|Overall Study|Withdrawal by Subject|1
996729|NCT01387516|2010063|FG001|Overall Study|Withdrawal by Subject|1
996730|NCT01387516|2010064|FG002|Overall Study|Withdrawal by Subject|2
996731|NCT01387516|2010065|FG003|Overall Study|Withdrawal by Subject|0
996732|NCT01387516|2010062|FG000|Overall Study|Death|0
996733|NCT01387516|2010063|FG001|Overall Study|Death|0
996734|NCT01387516|2010064|FG002|Overall Study|Death|0
996735|NCT01387516|2010065|FG003|Overall Study|Death|1
996736|NCT01387542|2010075|FG000|Overall Study|Adverse Event|3
996737|NCT01387542|2010075|FG000|Overall Study|Withdrawal by Subject|1
996738|NCT01387542|2010075|FG000|Overall Study|Changed diagnosis|1
996739|NCT01387542|2010075|FG000|Overall Study|Insufficient response|1
996740|NCT01387542|2010075|FG000|Overall Study|Non-compliant|1
996741|NCT01387542|2010075|FG000|Overall Study|Lost to Follow-up|1
996742|NCT01387594|2010094|FG000|Overall Study|Withdrawal by Subject|0
996743|NCT01387594|2010095|FG001|Overall Study|Withdrawal by Subject|2
996744|NCT01387594|2010094|FG000|Overall Study|Lost to Follow-up|0
996745|NCT01387594|2010095|FG001|Overall Study|Lost to Follow-up|1
996746|NCT01387607|2010106|FG000|Overall Study|Adverse Event|23
996747|NCT01387607|2010107|FG001|Overall Study|Adverse Event|11
996748|NCT01387607|2010106|FG000|Overall Study|Lack of Efficacy|8
996749|NCT01387607|2010107|FG001|Overall Study|Lack of Efficacy|6
996750|NCT01387607|2010106|FG000|Overall Study|Lost to Follow-up|2
996751|NCT01387607|2010107|FG001|Overall Study|Lost to Follow-up|1
996752|NCT01387607|2010106|FG000|Overall Study|No longer meets eligibility criteria|0
996753|NCT01387607|2010107|FG001|Overall Study|No longer meets eligibility criteria|1
996754|NCT01387607|2010106|FG000|Overall Study|Protocol Violation|1
996755|NCT01387607|2010107|FG001|Overall Study|Protocol Violation|5
996756|NCT01387607|2010106|FG000|Overall Study|Withdrawal by Subject|13
996757|NCT01387607|2010107|FG001|Overall Study|Withdrawal by Subject|14
996758|NCT01387607|2010106|FG000|Overall Study|Other|1
996759|NCT01387607|2010107|FG001|Overall Study|Other|1
996760|NCT01387607|2010106|FG000|Overall Study|Randomized, not treated|3
996761|NCT01387607|2010107|FG001|Overall Study|Randomized, not treated|6
996762|NCT01387737|2010141|FG000|Overall Study|Adverse Event|20
996763|NCT01387737|2010142|FG001|Overall Study|Adverse Event|30
996764|NCT01387737|2010141|FG000|Overall Study|Lack of Efficacy|1
996765|NCT01387737|2010142|FG001|Overall Study|Lack of Efficacy|0
996766|NCT01387737|2010141|FG000|Overall Study|Physician Decision|3
996767|NCT01387737|2010142|FG001|Overall Study|Physician Decision|10
996768|NCT01387737|2010141|FG000|Overall Study|Withdrawal by Subject|27
996769|NCT01387737|2010142|FG001|Overall Study|Withdrawal by Subject|31
996770|NCT01387737|2010141|FG000|Overall Study|Clearly not eligible for the study|1
996771|NCT01387737|2010142|FG001|Overall Study|Clearly not eligible for the study|3
996772|NCT01387789|2010148|FG000|Overall Study|Adverse Event|5
996773|NCT01387789|2010148|FG000|Overall Study|Lack of Efficacy|2
996774|NCT01387789|2010148|FG000|Overall Study|Lost to Follow-up|1
996775|NCT01387932|2010163|FG000|Randomized and Treated|Physician Decision|3
996776|NCT01387932|2010164|FG001|Randomized and Treated|Physician Decision|2
996777|NCT01387932|2010163|FG000|Randomized and Treated|Withdrawal by Subject|4
996778|NCT01387932|2010164|FG001|Randomized and Treated|Withdrawal by Subject|2
996779|NCT01387932|2010163|FG000|Survival Follow-up|Liver Transplant|24
996780|NCT01387932|2010164|FG001|Survival Follow-up|Liver Transplant|28
996781|NCT01387932|2010163|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52
996782|NCT01387932|2010164|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53
996783|NCT01387932|2010163|FG000|Survival Follow-up|Withdrawal by Subject|2
996784|NCT01387932|2010164|FG001|Survival Follow-up|Withdrawal by Subject|4
996785|NCT01387932|2010163|FG000|Survival Follow-up|Lost to Follow-up|6
996786|NCT01387932|2010164|FG001|Survival Follow-up|Lost to Follow-up|5
996787|NCT01388166|2010172|FG000|Overall Study|Adverse Event|16
914049|NCT00812955|1891834|FG001|Overall Study|Adverse Event|6
914050|NCT00812955|1891835|FG002|Overall Study|Adverse Event|3
914051|NCT00812955|1891836|FG003|Overall Study|Adverse Event|4
914052|NCT00812955|1891833|FG000|Overall Study|Lost to Follow-up|2
914053|NCT00812955|1891834|FG001|Overall Study|Lost to Follow-up|1
914054|NCT00812955|1891835|FG002|Overall Study|Lost to Follow-up|1
914055|NCT00812955|1891836|FG003|Overall Study|Lost to Follow-up|2
914056|NCT00812955|1891833|FG000|Overall Study|Withdrawal by Subject|1
914057|NCT00812955|1891834|FG001|Overall Study|Withdrawal by Subject|0
914058|NCT00812955|1891835|FG002|Overall Study|Withdrawal by Subject|1
914059|NCT00812955|1891836|FG003|Overall Study|Withdrawal by Subject|2
914060|NCT00812955|1891833|FG000|Overall Study|randomized in error|0
914061|NCT00812955|1891834|FG001|Overall Study|randomized in error|0
914062|NCT00812955|1891835|FG002|Overall Study|randomized in error|1
914063|NCT00812955|1891836|FG003|Overall Study|randomized in error|0
914064|NCT00812968|1891850|FG000|Overall Study|Relapse after erythroid response|6
914065|NCT00812968|1891850|FG000|Overall Study|Disease progression|1
914066|NCT00812968|1891850|FG000|Overall Study|No further treatment required|1
914067|NCT00812968|1891850|FG000|Overall Study|Study closed due to marketing approval|3
914068|NCT00812981|1891858|FG000|Overall Study|Other|0
914069|NCT00812981|1891859|FG001|Overall Study|Other|1
914070|NCT00813098|1891868|FG000|Overall Study|Adverse Event|2
914071|NCT00813098|1891869|FG001|Overall Study|Adverse Event|4
914072|NCT00813098|1891870|FG002|Overall Study|Adverse Event|1
914073|NCT00813098|1891868|FG000|Overall Study|Withdrawal by Subject|0
914074|NCT00813098|1891869|FG001|Overall Study|Withdrawal by Subject|1
914075|NCT00813098|1891870|FG002|Overall Study|Withdrawal by Subject|0
914076|NCT00813098|1891868|FG000|Overall Study|Inability to complete study procedures|1
914077|NCT00813098|1891869|FG001|Overall Study|Inability to complete study procedures|0
914078|NCT00813098|1891870|FG002|Overall Study|Inability to complete study procedures|0
914079|NCT00813098|1891868|FG000|Overall Study|Lost to Follow-up|0
914080|NCT00813098|1891869|FG001|Overall Study|Lost to Follow-up|1
914081|NCT00813098|1891870|FG002|Overall Study|Lost to Follow-up|0
914082|NCT00813098|1891868|FG000|Overall Study|Protocol Violation|0
914083|NCT00813098|1891869|FG001|Overall Study|Protocol Violation|0
996788|NCT01388166|2010172|FG000|Overall Study|Lost to Follow-up|30
996789|NCT01388166|2010172|FG000|Overall Study|Others than specified above|13
996790|NCT01388335|2010176|FG000|Period 1|Progressive Disease|1
996791|NCT01388335|2010176|FG000|Period 2|Progressive Disease|2
996792|NCT01388335|2010176|FG000|Period 2|Sponsor Decision|1
996793|NCT01388335|2010176|FG000|Safety Extension|Progressive Disease|7
996794|NCT01388361|2010191|FG000|Overall Study|Adverse Event|0
996795|NCT01388361|2010192|FG001|Overall Study|Adverse Event|5
996796|NCT01388361|2010193|FG002|Overall Study|Adverse Event|1
996797|NCT01388361|2010191|FG000|Overall Study|Protocol Violation|0
996798|NCT01388361|2010192|FG001|Overall Study|Protocol Violation|0
996799|NCT01388361|2010193|FG002|Overall Study|Protocol Violation|2
996800|NCT01388361|2010191|FG000|Overall Study|Withdrawal criteria|12
996801|NCT01388361|2010192|FG001|Overall Study|Withdrawal criteria|7
996802|NCT01388361|2010193|FG002|Overall Study|Withdrawal criteria|10
996803|NCT01388361|2010191|FG000|Overall Study|Unclassified|0
996804|NCT01388361|2010192|FG001|Overall Study|Unclassified|0
996805|NCT01388361|2010193|FG002|Overall Study|Unclassified|1
996806|NCT01388478|2010201|FG000|Overall Study|Adverse Event|4
996807|NCT01388478|2010201|FG000|Overall Study|Withdrawal by Subject|1
996822|NCT01388530|2010214|FG000|Overall Study|Lost to Follow-up|5
996823|NCT01388543|2010220|FG000|Day 14|Adverse Event|1
996824|NCT01388543|2010221|FG001|Day 14|Adverse Event|4
996825|NCT01388647|2010229|FG000|Overall Study|Adverse Event|1
996826|NCT01388647|2010230|FG001|Overall Study|Adverse Event|2
996827|NCT01388790|2010241|FG000|Overall Study|Ongoing at data cut-off date|8
996828|NCT01388816|2010249|FG000|Overall Study|Adverse Event|0
996829|NCT01388816|2010250|FG001|Overall Study|Adverse Event|2
996830|NCT01388816|2010251|FG002|Overall Study|Adverse Event|0
996831|NCT01388816|2010252|FG003|Overall Study|Adverse Event|0
996832|NCT01388816|2010249|FG000|Overall Study|Lost to Follow-up|0
996833|NCT01388816|2010250|FG001|Overall Study|Lost to Follow-up|1
996834|NCT01388816|2010251|FG002|Overall Study|Lost to Follow-up|0
996835|NCT01388816|2010252|FG003|Overall Study|Lost to Follow-up|0
996836|NCT01388816|2010249|FG000|Overall Study|Withdrawal by Subject|2
996837|NCT01388816|2010250|FG001|Overall Study|Withdrawal by Subject|1
996838|NCT01388816|2010251|FG002|Overall Study|Withdrawal by Subject|1
996839|NCT01388816|2010252|FG003|Overall Study|Withdrawal by Subject|0
996840|NCT01388816|2010249|FG000|Overall Study|Protocol Violation|0
996841|NCT01388816|2010250|FG001|Overall Study|Protocol Violation|0
996842|NCT01388816|2010251|FG002|Overall Study|Protocol Violation|2
996843|NCT01388816|2010252|FG003|Overall Study|Protocol Violation|0
996844|NCT01388907|2010267|FG000|Overall Study|Adverse Event|2
996845|NCT01388907|2010268|FG001|Overall Study|Adverse Event|0
996846|NCT01388985|2010287|FG000|Overall Study|Death|0
996847|NCT01388985|2010288|FG001|Overall Study|Death|1
996848|NCT01388985|2010287|FG000|Overall Study|Lost to Follow-up|30
996849|NCT01388985|2010288|FG001|Overall Study|Lost to Follow-up|30
996850|NCT01388985|2010287|FG000|Overall Study|Withdrawal by Subject|13
996851|NCT01388985|2010288|FG001|Overall Study|Withdrawal by Subject|4
996852|NCT01388985|2010287|FG000|Overall Study|Subject unavailable|1
996853|NCT01388985|2010288|FG001|Overall Study|Subject unavailable|1
996854|NCT01388985|2010287|FG000|Overall Study|Other (no reason)|0
996855|NCT01388985|2010288|FG001|Overall Study|Other (no reason)|1
996856|NCT01388985|2010287|FG000|Overall Study|Error of nurse|5
996857|NCT01388985|2010288|FG001|Overall Study|Error of nurse|1
996858|NCT01389102|2010304|FG000|Overall Study|Adverse Event|1
996859|NCT01389102|2010305|FG001|Overall Study|Adverse Event|3
996860|NCT01389102|2010306|FG002|Overall Study|Adverse Event|2
996861|NCT01389102|2010307|FG003|Overall Study|Adverse Event|2
996862|NCT01389102|2010308|FG004|Overall Study|Adverse Event|2
996863|NCT01389102|2010309|FG005|Overall Study|Adverse Event|2
996864|NCT01389102|2010304|FG000|Overall Study|Hurricane Katrina|4
996865|NCT01389102|2010305|FG001|Overall Study|Hurricane Katrina|2
996866|NCT01389102|2010306|FG002|Overall Study|Hurricane Katrina|3
996867|NCT01389102|2010307|FG003|Overall Study|Hurricane Katrina|0
996868|NCT01389102|2010308|FG004|Overall Study|Hurricane Katrina|3
996869|NCT01389102|2010309|FG005|Overall Study|Hurricane Katrina|1
996870|NCT01389102|2010304|FG000|Overall Study|Lost to Follow-up|4
996871|NCT01389102|2010305|FG001|Overall Study|Lost to Follow-up|1
996872|NCT01389102|2010306|FG002|Overall Study|Lost to Follow-up|1
996873|NCT01389102|2010307|FG003|Overall Study|Lost to Follow-up|2
996874|NCT01389102|2010308|FG004|Overall Study|Lost to Follow-up|4
996875|NCT01389102|2010309|FG005|Overall Study|Lost to Follow-up|1
996876|NCT01389102|2010304|FG000|Overall Study|Protocol Violation|0
996877|NCT01389102|2010305|FG001|Overall Study|Protocol Violation|0
996878|NCT01389102|2010306|FG002|Overall Study|Protocol Violation|3
996879|NCT01389102|2010307|FG003|Overall Study|Protocol Violation|0
996880|NCT01389102|2010308|FG004|Overall Study|Protocol Violation|1
996881|NCT01389102|2010309|FG005|Overall Study|Protocol Violation|1
996882|NCT01389102|2010304|FG000|Overall Study|Withdrawal by Subject|7
996883|NCT01389102|2010305|FG001|Overall Study|Withdrawal by Subject|4
996884|NCT01389102|2010306|FG002|Overall Study|Withdrawal by Subject|9
996885|NCT01389102|2010307|FG003|Overall Study|Withdrawal by Subject|2
996886|NCT01389102|2010308|FG004|Overall Study|Withdrawal by Subject|3
996887|NCT01389102|2010309|FG005|Overall Study|Withdrawal by Subject|3
996888|NCT01389102|2010304|FG000|Overall Study|Subject Traveling Out of Country|0
996889|NCT01389102|2010305|FG001|Overall Study|Subject Traveling Out of Country|0
996890|NCT01389102|2010306|FG002|Overall Study|Subject Traveling Out of Country|0
996891|NCT01389102|2010307|FG003|Overall Study|Subject Traveling Out of Country|1
996892|NCT01389102|2010308|FG004|Overall Study|Subject Traveling Out of Country|0
996893|NCT01389102|2010309|FG005|Overall Study|Subject Traveling Out of Country|0
996894|NCT01389102|2010304|FG000|Overall Study|Subject Moved|2
996895|NCT01389102|2010305|FG001|Overall Study|Subject Moved|0
996896|NCT01389102|2010306|FG002|Overall Study|Subject Moved|1
996897|NCT01389102|2010307|FG003|Overall Study|Subject Moved|0
996898|NCT01389102|2010308|FG004|Overall Study|Subject Moved|0
996899|NCT01389102|2010309|FG005|Overall Study|Subject Moved|0
996900|NCT01389102|2010304|FG000|Overall Study|Unavailable due to husband's illness|0
996901|NCT01389102|2010305|FG001|Overall Study|Unavailable due to husband's illness|1
996902|NCT01389102|2010306|FG002|Overall Study|Unavailable due to husband's illness|0
996903|NCT01389102|2010307|FG003|Overall Study|Unavailable due to husband's illness|0
996904|NCT01389102|2010308|FG004|Overall Study|Unavailable due to husband's illness|0
996905|NCT01389102|2010309|FG005|Overall Study|Unavailable due to husband's illness|0
996906|NCT01389102|2010304|FG000|Overall Study|Investigator Judgement|0
996907|NCT01389102|2010305|FG001|Overall Study|Investigator Judgement|1
996908|NCT01389102|2010306|FG002|Overall Study|Investigator Judgement|0
996909|NCT01389102|2010307|FG003|Overall Study|Investigator Judgement|0
996910|NCT01389102|2010308|FG004|Overall Study|Investigator Judgement|0
996911|NCT01389102|2010309|FG005|Overall Study|Investigator Judgement|0
996912|NCT01389128|2010331|FG000|Overall Study|Fetal distress|1
996913|NCT01389128|2010332|FG001|Overall Study|Fetal distress|0
996914|NCT01389128|2010331|FG000|Overall Study|Cervix dilation stop|1
996915|NCT01389128|2010332|FG001|Overall Study|Cervix dilation stop|2
996916|NCT01389128|2010331|FG000|Overall Study|Rapid labor evolution|3
996917|NCT01389128|2010332|FG001|Overall Study|Rapid labor evolution|2
996918|NCT01389128|2010331|FG000|Overall Study|Intolerance to procedure|0
996919|NCT01389128|2010332|FG001|Overall Study|Intolerance to procedure|2
996920|NCT01389232|2010342|FG000|Overall Study|Had scaffold removed|15
996921|NCT01389232|2010342|FG000|Overall Study|Personal reasons|2
996922|NCT01389232|2010342|FG000|Overall Study|Adverse Event|1
996923|NCT01389232|2010342|FG000|Overall Study|Death|1
996924|NCT01389245|2010356|FG000|Overall Study|Protocol Violation|10
996925|NCT01389245|2010356|FG000|Overall Study|Lost to Follow-up|3
996926|NCT01389245|2010356|FG000|Overall Study|Withdrawal by Subject|2
996927|NCT01389258|2010360|FG000|Overall Study|Lost to Follow-up|5
996928|NCT01389323|2010377|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
996929|NCT01389323|2010377|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24
996930|NCT01389323|2010377|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
996931|NCT01389323|2010377|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
996932|NCT01389323|2010377|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
996933|NCT01389323|2010377|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
996934|NCT01389323|2010377|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
996935|NCT01389323|2010377|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
996936|NCT01389323|2010377|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
996937|NCT01389323|2010377|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
996938|NCT01389323|2010377|FG000|Follow-up Period (up to 48 Weeks)|Other|3
996939|NCT01389596|2010391|FG000|Overall Study|Protocol Violation|3
996940|NCT01389596|2010392|FG001|Overall Study|Protocol Violation|4
996941|NCT01389596|2010393|FG002|Overall Study|Protocol Violation|3
996942|NCT01389596|2010391|FG000|Overall Study|Withdrawal by Subject|1
996943|NCT01389596|2010392|FG001|Overall Study|Withdrawal by Subject|2
996944|NCT01389596|2010393|FG002|Overall Study|Withdrawal by Subject|2
996945|NCT01389596|2010391|FG000|Overall Study|Insufficient Clinical Response|3
996946|NCT01389596|2010392|FG001|Overall Study|Insufficient Clinical Response|4
996947|NCT01389596|2010393|FG002|Overall Study|Insufficient Clinical Response|5
996948|NCT01389596|2010391|FG000|Overall Study|Adverse Event|1
996949|NCT01389596|2010392|FG001|Overall Study|Adverse Event|4
996950|NCT01389596|2010393|FG002|Overall Study|Adverse Event|0
996951|NCT01389596|2010391|FG000|Overall Study|Death|0
996952|NCT01389596|2010392|FG001|Overall Study|Death|1
996953|NCT01389596|2010393|FG002|Overall Study|Death|0
996954|NCT01389596|2010391|FG000|Overall Study|Other Unspecified|2
996955|NCT01389596|2010392|FG001|Overall Study|Other Unspecified|1
996956|NCT01389596|2010393|FG002|Overall Study|Other Unspecified|0
996957|NCT01389752|2010401|FG000|Study Period 1|Sponsor decision|0
996958|NCT01389752|2010402|FG001|Study Period 1|Sponsor decision|2
996959|NCT01389752|2010401|FG000|Study Period 2|Sponsor decision|1
996960|NCT01389752|2010402|FG001|Study Period 2|Sponsor decision|0
996961|NCT01389882|2010427|FG000|Overall Study|Respiratory rate > 80/min during study|1
996962|NCT01389882|2010428|FG001|Overall Study|Respiratory rate > 80/min during study|3
996963|NCT01389882|2010427|FG000|Overall Study|Withdrawal by Subject|0
996964|NCT01389882|2010428|FG001|Overall Study|Withdrawal by Subject|1
996965|NCT01389973|2010434|FG000|Overall Study|Lost to Follow-up|1
996966|NCT01389973|2010434|FG000|Overall Study|Trial Stopped by Sponsor|9
996967|NCT01389973|2010434|FG000|Overall Study|Other|10
996968|NCT01390038|2010438|FG000|Overall Study|Death|1
996969|NCT01390038|2010438|FG000|Overall Study|Lost to Follow-up|1
996970|NCT01390038|2010438|FG000|Overall Study|Withdrawal by Subject|4
996971|NCT01390038|2010438|FG000|Overall Study|Simpliciti System Removal|2
996972|NCT01390220|2010460|FG000|Test Dose Phase|Adverse Event|17
996973|NCT01390220|2010461|FG001|Test Dose Phase|Adverse Event|0
996974|NCT01390220|2010462|FG002|Test Dose Phase|Adverse Event|0
996975|NCT01390220|2010460|FG000|Test Dose Phase|Withdrawal by Subject|8
996976|NCT01390220|2010461|FG001|Test Dose Phase|Withdrawal by Subject|0
996977|NCT01390220|2010462|FG002|Test Dose Phase|Withdrawal by Subject|0
996978|NCT01390220|2010460|FG000|Test Dose Phase|Lost to Follow-up|2
996979|NCT01390220|2010461|FG001|Test Dose Phase|Lost to Follow-up|0
996980|NCT01390220|2010462|FG002|Test Dose Phase|Lost to Follow-up|0
996981|NCT01390220|2010460|FG000|Test Dose Phase|Protocol Violation|8
996982|NCT01390220|2010461|FG001|Test Dose Phase|Protocol Violation|0
996983|NCT01390220|2010462|FG002|Test Dose Phase|Protocol Violation|0
996984|NCT01390220|2010460|FG000|Test Dose Phase|No treated seizure cluster episode|37
996985|NCT01390220|2010461|FG001|Test Dose Phase|No treated seizure cluster episode|0
996986|NCT01390220|2010462|FG002|Test Dose Phase|No treated seizure cluster episode|0
996987|NCT01390220|2010460|FG000|Test Dose Phase|Study/Site closure|6
996988|NCT01390220|2010461|FG001|Test Dose Phase|Study/Site closure|0
996989|NCT01390220|2010462|FG002|Test Dose Phase|Study/Site closure|0
996990|NCT01390220|2010460|FG000|Test Dose Phase|Caregiver no longer available|5
996991|NCT01390220|2010461|FG001|Test Dose Phase|Caregiver no longer available|0
996992|NCT01390220|2010462|FG002|Test Dose Phase|Caregiver no longer available|0
996993|NCT01390220|2010460|FG000|Test Dose Phase|Noncompliance|2
996994|NCT01390220|2010461|FG001|Test Dose Phase|Noncompliance|0
996995|NCT01390220|2010462|FG002|Test Dose Phase|Noncompliance|0
996996|NCT01390220|2010460|FG000|Test Dose Phase|Logistical|6
996997|NCT01390220|2010461|FG001|Test Dose Phase|Logistical|0
996998|NCT01390220|2010462|FG002|Test Dose Phase|Logistical|0
996999|NCT01390220|2010460|FG000|Comparative Phase|Withdrawal by Subject|0
997000|NCT01390220|2010461|FG001|Comparative Phase|Withdrawal by Subject|1
997001|NCT01390220|2010462|FG002|Comparative Phase|Withdrawal by Subject|0
997002|NCT01390272|2010501|FG000|Overall Study|Death|3
997003|NCT01390272|2010502|FG001|Overall Study|Death|2
997004|NCT01390272|2010501|FG000|Overall Study|Withdrawal by Subject|9
997005|NCT01390272|2010502|FG001|Overall Study|Withdrawal by Subject|5
997006|NCT01390272|2010501|FG000|Overall Study|Patient moved, no longer eligible|5
997007|NCT01390272|2010502|FG001|Overall Study|Patient moved, no longer eligible|8
997008|NCT01390298|2010508|FG000|Overall Study|Death|1
997009|NCT01390298|2010508|FG000|Overall Study|long term ICU admission|1
997010|NCT01390298|2010508|FG000|Overall Study|Withdrawal by Subject|14
997011|NCT01390298|2010508|FG000|Overall Study|Lost to Follow-up|7
997012|NCT01390298|2010508|FG000|Overall Study|Surgery cancelled|1
997013|NCT01390389|2010514|FG000|Overall Study|Withdrawal by Subject|2
997014|NCT01390389|2010515|FG001|Overall Study|Withdrawal by Subject|0
997015|NCT01390389|2010514|FG000|Overall Study|Screen Fail|2
997016|NCT01390389|2010515|FG001|Overall Study|Screen Fail|1
997017|NCT01390402|2010525|FG000|Overall Study|Death|1
997018|NCT01390402|2010525|FG000|Overall Study|Disease Progression|4
997019|NCT01390428|2010544|FG000|Overall Study|Elective Surgery|0
997020|NCT01390428|2010545|FG001|Overall Study|Elective Surgery|0
997021|NCT01390428|2010546|FG002|Overall Study|Elective Surgery|0
997022|NCT01390428|2010547|FG003|Overall Study|Elective Surgery|0
997023|NCT01390428|2010548|FG004|Overall Study|Elective Surgery|1
997024|NCT01390428|2010549|FG005|Overall Study|Elective Surgery|0
997025|NCT01390428|2010544|FG000|Overall Study|Withdrawal by Subject|0
997026|NCT01390428|2010545|FG001|Overall Study|Withdrawal by Subject|0
997027|NCT01390428|2010546|FG002|Overall Study|Withdrawal by Subject|1
997028|NCT01390428|2010547|FG003|Overall Study|Withdrawal by Subject|0
997029|NCT01390428|2010548|FG004|Overall Study|Withdrawal by Subject|0
997030|NCT01390428|2010549|FG005|Overall Study|Withdrawal by Subject|0
997031|NCT01390441|2010568|FG000|Treatment Period|Protocol Violation|0
997032|NCT01390441|2010569|FG001|Treatment Period|Protocol Violation|1
997033|NCT01390441|2010570|FG002|Treatment Period|Protocol Violation|0
997034|NCT01390441|2010571|FG003|Treatment Period|Protocol Violation|0
997035|NCT01390441|2010572|FG004|Treatment Period|Protocol Violation|0
997036|NCT01390441|2010568|FG000|Treatment Period|Physician Decision|0
997037|NCT01390441|2010569|FG001|Treatment Period|Physician Decision|0
997038|NCT01390441|2010570|FG002|Treatment Period|Physician Decision|0
997039|NCT01390441|2010571|FG003|Treatment Period|Physician Decision|1
997040|NCT01390441|2010572|FG004|Treatment Period|Physician Decision|0
997041|NCT01390441|2010568|FG000|Treatment Period|Lack of Efficacy|0
997042|NCT01390441|2010569|FG001|Treatment Period|Lack of Efficacy|0
997043|NCT01390441|2010570|FG002|Treatment Period|Lack of Efficacy|0
997044|NCT01390441|2010571|FG003|Treatment Period|Lack of Efficacy|0
997045|NCT01390441|2010572|FG004|Treatment Period|Lack of Efficacy|1
997046|NCT01390441|2010568|FG000|Treatment Period|Unknown due to early stopping of study|0
997047|NCT01390441|2010569|FG001|Treatment Period|Unknown due to early stopping of study|0
997048|NCT01390441|2010570|FG002|Treatment Period|Unknown due to early stopping of study|8
997049|NCT01390441|2010571|FG003|Treatment Period|Unknown due to early stopping of study|11
997050|NCT01390441|2010572|FG004|Treatment Period|Unknown due to early stopping of study|7
997051|NCT01390441|2010568|FG000|Treatment Period|Adverse Event|0
997052|NCT01390441|2010569|FG001|Treatment Period|Adverse Event|0
997053|NCT01390441|2010570|FG002|Treatment Period|Adverse Event|1
997054|NCT01390441|2010571|FG003|Treatment Period|Adverse Event|1
997055|NCT01390441|2010572|FG004|Treatment Period|Adverse Event|2
997056|NCT01390441|2010568|FG000|Treatment Period|Withdrawal by Subject|0
997057|NCT01390441|2010569|FG001|Treatment Period|Withdrawal by Subject|0
997058|NCT01390441|2010570|FG002|Treatment Period|Withdrawal by Subject|1
997059|NCT01390441|2010571|FG003|Treatment Period|Withdrawal by Subject|0
997060|NCT01390441|2010572|FG004|Treatment Period|Withdrawal by Subject|1
997061|NCT01390441|2010568|FG000|Treatment Period|Lost to Follow-up|1
997062|NCT01390441|2010569|FG001|Treatment Period|Lost to Follow-up|0
997063|NCT01390441|2010570|FG002|Treatment Period|Lost to Follow-up|0
997064|NCT01390441|2010571|FG003|Treatment Period|Lost to Follow-up|0
997065|NCT01390441|2010572|FG004|Treatment Period|Lost to Follow-up|0
997066|NCT01390441|2010568|FG000|Extension Period|Protocol Violation|3
997067|NCT01390441|2010569|FG001|Extension Period|Protocol Violation|1
997068|NCT01390441|2010570|FG002|Extension Period|Protocol Violation|0
997069|NCT01390441|2010571|FG003|Extension Period|Protocol Violation|1
997070|NCT01390441|2010572|FG004|Extension Period|Protocol Violation|0
997071|NCT01390584|2010612|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
997072|NCT01390584|2010613|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
997073|NCT01390584|2010614|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1
997074|NCT01390649|2010623|FG000|Overall Study|Physician Decision|1
997075|NCT01390779|2010627|FG000|Overall Study|Physician Decision|1
997076|NCT01390844|2010764|FG000|Treatment Phase|Adverse Event|12
997077|NCT01390844|2010765|FG001|Treatment Phase|Adverse Event|2
997078|NCT01390844|2010766|FG002|Treatment Phase|Adverse Event|3
997079|NCT01390844|2010767|FG003|Treatment Phase|Adverse Event|2
997080|NCT01390844|2010764|FG000|Treatment Phase|Treatment Failure|23
997081|NCT01390844|2010765|FG001|Treatment Phase|Treatment Failure|25
997082|NCT01390844|2010766|FG002|Treatment Phase|Treatment Failure|10
997083|NCT01390844|2010767|FG003|Treatment Phase|Treatment Failure|13
997084|NCT01390844|2010764|FG000|Treatment Phase|Non-Medical Reasons|5
997085|NCT01390844|2010765|FG001|Treatment Phase|Non-Medical Reasons|1
997086|NCT01390844|2010766|FG002|Treatment Phase|Non-Medical Reasons|8
997087|NCT01390844|2010767|FG003|Treatment Phase|Non-Medical Reasons|1
997088|NCT01390844|2010764|FG000|Treatment Phase|Non-GCP Compliant|0
997089|NCT01390844|2010765|FG001|Treatment Phase|Non-GCP Compliant|0
997090|NCT01390844|2010766|FG002|Treatment Phase|Non-GCP Compliant|10
997091|NCT01390844|2010767|FG003|Treatment Phase|Non-GCP Compliant|3
997092|NCT01390844|2010764|FG000|Follow-Up Phase|Non-Medical Reasons|1
997093|NCT01390844|2010765|FG001|Follow-Up Phase|Non-Medical Reasons|1
997094|NCT01390844|2010766|FG002|Follow-Up Phase|Non-Medical Reasons|1
997095|NCT01390844|2010767|FG003|Follow-Up Phase|Non-Medical Reasons|0
997096|NCT01390857|2010777|FG000|Overall Study|Protocol Violation|2
997097|NCT01390857|2010777|FG000|Overall Study|Lost to Follow-up|1
997098|NCT01390857|2010777|FG000|Overall Study|No Visit after the First Visit|7
997099|NCT01390948|2010817|FG000|Overall Study|End of Study|1
997100|NCT01390948|2010818|FG001|Overall Study|End of Study|0
997101|NCT01390948|2010819|FG002|Overall Study|End of Study|0
997102|NCT01390948|2010817|FG000|Overall Study|Withdrew consent|2
997103|NCT01390948|2010818|FG001|Overall Study|Withdrew consent|2
997104|NCT01390948|2010819|FG002|Overall Study|Withdrew consent|0
997105|NCT01390948|2010817|FG000|Overall Study|Progressive Disease|2
997106|NCT01390948|2010818|FG001|Overall Study|Progressive Disease|5
997107|NCT01390948|2010819|FG002|Overall Study|Progressive Disease|0
997108|NCT01390948|2010817|FG000|Overall Study|Death during follow-up|10
997109|NCT01390948|2010818|FG001|Overall Study|Death during follow-up|11
997110|NCT01390948|2010819|FG002|Overall Study|Death during follow-up|1
997111|NCT01391000|2010828|FG000|Overall Study|Lost to Follow-up|2
997112|NCT01391000|2010829|FG001|Overall Study|Lost to Follow-up|0
997113|NCT01391130|2010846|FG000|Overall Study|Withdrawal by Subject|3
997114|NCT01391130|2010847|FG001|Overall Study|Withdrawal by Subject|2
997115|NCT01391130|2010846|FG000|Overall Study|Physician Decision|2
997116|NCT01391130|2010847|FG001|Overall Study|Physician Decision|3
997117|NCT01391130|2010846|FG000|Overall Study|Did not Receive Drug|1
997118|NCT01391130|2010847|FG001|Overall Study|Did not Receive Drug|1
997119|NCT01391507|2010924|FG000|Overall Study|Death|0
997120|NCT01391507|2010925|FG001|Overall Study|Death|0
997121|NCT01391507|2010926|FG002|Overall Study|Death|0
997122|NCT01391507|2010927|FG003|Overall Study|Death|1
997123|NCT01391507|2010924|FG000|Overall Study|Adverse Event|1
997124|NCT01391507|2010925|FG001|Overall Study|Adverse Event|1
997125|NCT01391507|2010926|FG002|Overall Study|Adverse Event|2
997126|NCT01391507|2010927|FG003|Overall Study|Adverse Event|2
997127|NCT01391507|2010924|FG000|Overall Study|Withdrawal by Subject|1
997128|NCT01391507|2010925|FG001|Overall Study|Withdrawal by Subject|2
997129|NCT01391507|2010926|FG002|Overall Study|Withdrawal by Subject|1
997130|NCT01391507|2010927|FG003|Overall Study|Withdrawal by Subject|1
997131|NCT01391507|2010924|FG000|Overall Study|Lack of Efficacy|0
997132|NCT01391507|2010925|FG001|Overall Study|Lack of Efficacy|0
997133|NCT01391507|2010926|FG002|Overall Study|Lack of Efficacy|0
997134|NCT01391507|2010927|FG003|Overall Study|Lack of Efficacy|1
997135|NCT01391507|2010924|FG000|Overall Study|Protocol Violation|2
997136|NCT01391507|2010925|FG001|Overall Study|Protocol Violation|1
997137|NCT01391507|2010926|FG002|Overall Study|Protocol Violation|1
997138|NCT01391507|2010927|FG003|Overall Study|Protocol Violation|2
997139|NCT01391546|2010939|FG000|Overall Study|History of Herpes Zoster (HZ)|1
997140|NCT01391546|2010940|FG001|Overall Study|History of Herpes Zoster (HZ)|0
997141|NCT01391663|2010962|FG000|Overall Study|Withdrawal by Subject|0
997142|NCT01391663|2010963|FG001|Overall Study|Withdrawal by Subject|0
997143|NCT01391663|2010964|FG002|Overall Study|Withdrawal by Subject|1
997144|NCT01391663|2010965|FG003|Overall Study|Withdrawal by Subject|0
997145|NCT01391793|2010977|FG000|Overall Study|Ineligible|3
997146|NCT01391793|2010978|FG001|Overall Study|Ineligible|0
997147|NCT01391793|2010977|FG000|Overall Study|Urine Culture Negative or Indeterminate|71
997148|NCT01391793|2010978|FG001|Overall Study|Urine Culture Negative or Indeterminate|87
997149|NCT01391793|2010977|FG000|Overall Study|No DMSA|73
997150|NCT01391793|2010978|FG001|Overall Study|No DMSA|57
997151|NCT01391819|2010984|FG000|Overall Study|Withdrawal by Subject|56
997152|NCT01391819|2010984|FG000|Overall Study|Migrated/moved from study area|82
997153|NCT01391819|2010984|FG000|Overall Study|Lost to Follow-up|252
997154|NCT01391819|2010984|FG000|Overall Study|Death|3
997155|NCT01391819|2010984|FG000|Overall Study|Other|9
997156|NCT01391832|2010993|FG000|Overall Study|Withdrawal by Subject|21
997157|NCT01391832|2010994|FG001|Overall Study|Withdrawal by Subject|22
997158|NCT01391832|2010993|FG000|Overall Study|Lost to Follow-up|0
997159|NCT01391832|2010994|FG001|Overall Study|Lost to Follow-up|1
997160|NCT01392183|2011020|FG000|First Drug Administration|Adverse Event|3
997161|NCT01392183|2011021|FG001|First Drug Administration|Adverse Event|2
997162|NCT01392183|2011020|FG000|First Drug Administration|Death|1
997163|NCT01392183|2011021|FG001|First Drug Administration|Death|0
997164|NCT01392183|2011020|FG000|First Drug Administration|Withdrawal by Subject|10
997165|NCT01392183|2011021|FG001|First Drug Administration|Withdrawal by Subject|17
997166|NCT01392300|2011031|FG000|Main Period (MP)|Predefined discontinuation criteria|2
997167|NCT01392300|2011032|FG001|Main Period (MP)|Predefined discontinuation criteria|3
997168|NCT01392300|2011033|FG002|Main Period (MP)|Predefined discontinuation criteria|0
997169|NCT01392300|2011031|FG000|Main Period (MP)|Withdrawal by Subject|5
997170|NCT01392300|2011032|FG001|Main Period (MP)|Withdrawal by Subject|1
997171|NCT01392300|2011033|FG002|Main Period (MP)|Withdrawal by Subject|0
997172|NCT01392300|2011031|FG000|Main Period (MP)|Lost to Follow-up|3
997173|NCT01392300|2011032|FG001|Main Period (MP)|Lost to Follow-up|3
997174|NCT01392300|2011033|FG002|Main Period (MP)|Lost to Follow-up|0
997175|NCT01392300|2011031|FG000|Main Period (MP)|Non-compliance|1
997176|NCT01392300|2011032|FG001|Main Period (MP)|Non-compliance|0
997177|NCT01392300|2011033|FG002|Main Period (MP)|Non-compliance|0
997178|NCT01392300|2011031|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0
997179|NCT01392300|2011032|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0
997180|NCT01392300|2011033|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13
997181|NCT01392300|2011031|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0
997182|NCT01392300|2011032|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0
997183|NCT01392300|2011033|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3
997184|NCT01392300|2011031|FG000|Open Label Extension (OLEX) Period|Non-compliance|0
997185|NCT01392300|2011032|FG001|Open Label Extension (OLEX) Period|Non-compliance|0
997186|NCT01392300|2011033|FG002|Open Label Extension (OLEX) Period|Non-compliance|1
997187|NCT01392300|2011031|FG000|Open Label Extension (OLEX) Period|Death|0
997188|NCT01392300|2011032|FG001|Open Label Extension (OLEX) Period|Death|0
997189|NCT01392300|2011033|FG002|Open Label Extension (OLEX) Period|Death|4
997190|NCT01392300|2011031|FG000|Open Label Extension (OLEX) Period|Adverse Event|0
997191|NCT01392300|2011032|FG001|Open Label Extension (OLEX) Period|Adverse Event|0
997192|NCT01392300|2011033|FG002|Open Label Extension (OLEX) Period|Adverse Event|7
997193|NCT01392300|2011031|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
997194|NCT01392300|2011032|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
997195|NCT01392300|2011033|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
997196|NCT01392300|2011031|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0
997197|NCT01392300|2011032|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0
997198|NCT01392300|2011033|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6
997199|NCT01392326|2011043|FG000|Overall Study|Death|2
997200|NCT01392326|2011044|FG001|Overall Study|Death|0
997201|NCT01392326|2011045|FG002|Overall Study|Death|0
997202|NCT01392326|2011043|FG000|Overall Study|Withdrawal by Subject|12
997203|NCT01392326|2011044|FG001|Overall Study|Withdrawal by Subject|11
997204|NCT01392326|2011045|FG002|Overall Study|Withdrawal by Subject|15
997205|NCT01392326|2011043|FG000|Overall Study|Protocol Violation|2
997206|NCT01392326|2011044|FG001|Overall Study|Protocol Violation|0
997207|NCT01392326|2011045|FG002|Overall Study|Protocol Violation|0
997208|NCT01392326|2011043|FG000|Overall Study|Pregnancy|0
997209|NCT01392326|2011044|FG001|Overall Study|Pregnancy|0
997210|NCT01392326|2011045|FG002|Overall Study|Pregnancy|1
997211|NCT01392326|2011043|FG000|Overall Study|Physician Decision|7
997212|NCT01392326|2011044|FG001|Overall Study|Physician Decision|5
997213|NCT01392326|2011045|FG002|Overall Study|Physician Decision|2
997214|NCT01392326|2011043|FG000|Overall Study|Lost to Follow-up|1
997215|NCT01392326|2011044|FG001|Overall Study|Lost to Follow-up|3
997216|NCT01392326|2011045|FG002|Overall Study|Lost to Follow-up|4
997217|NCT01392326|2011043|FG000|Overall Study|Lack of Efficacy|14
997218|NCT01392326|2011044|FG001|Overall Study|Lack of Efficacy|10
997219|NCT01392326|2011045|FG002|Overall Study|Lack of Efficacy|15
997220|NCT01392326|2011043|FG000|Overall Study|Adverse Event|9
997221|NCT01392326|2011044|FG001|Overall Study|Adverse Event|6
997222|NCT01392326|2011045|FG002|Overall Study|Adverse Event|11
997223|NCT01392378|2011058|FG000|Infant Series|Adverse Event|0
997224|NCT01392378|2011059|FG001|Infant Series|Adverse Event|0
997225|NCT01392378|2011060|FG002|Infant Series|Adverse Event|0
997226|NCT01392378|2011061|FG003|Infant Series|Adverse Event|1
997227|NCT01392378|2011062|FG004|Infant Series|Adverse Event|0
997228|NCT01392378|2011058|FG000|Infant Series|Lost to Follow-up|0
997229|NCT01392378|2011059|FG001|Infant Series|Lost to Follow-up|0
997230|NCT01392378|2011060|FG002|Infant Series|Lost to Follow-up|0
997231|NCT01392378|2011061|FG003|Infant Series|Lost to Follow-up|1
997232|NCT01392378|2011062|FG004|Infant Series|Lost to Follow-up|0
997233|NCT01392378|2011058|FG000|Infant Series|Protocol Violation|0
997234|NCT01392378|2011059|FG001|Infant Series|Protocol Violation|1
997235|NCT01392378|2011060|FG002|Infant Series|Protocol Violation|0
997236|NCT01392378|2011061|FG003|Infant Series|Protocol Violation|0
997237|NCT01392378|2011062|FG004|Infant Series|Protocol Violation|0
997238|NCT01392378|2011058|FG000|Infant Series|Withdrawal by Parent|4
997239|NCT01392378|2011059|FG001|Infant Series|Withdrawal by Parent|1
997240|NCT01392378|2011060|FG002|Infant Series|Withdrawal by Parent|0
997241|NCT01392378|2011061|FG003|Infant Series|Withdrawal by Parent|0
997242|NCT01392378|2011062|FG004|Infant Series|Withdrawal by Parent|0
997243|NCT01392378|2011058|FG000|After Infant Series|Lost to Follow-up|0
997244|NCT01392378|2011059|FG001|After Infant Series|Lost to Follow-up|0
997245|NCT01392378|2011060|FG002|After Infant Series|Lost to Follow-up|1
997246|NCT01392378|2011061|FG003|After Infant Series|Lost to Follow-up|0
997247|NCT01392378|2011062|FG004|After Infant Series|Lost to Follow-up|0
997248|NCT01392378|2011058|FG000|After Infant Series|Withdrawal by Parent|0
997249|NCT01392378|2011059|FG001|After Infant Series|Withdrawal by Parent|1
997250|NCT01392378|2011060|FG002|After Infant Series|Withdrawal by Parent|1
997251|NCT01392378|2011061|FG003|After Infant Series|Withdrawal by Parent|0
997252|NCT01392378|2011062|FG004|After Infant Series|Withdrawal by Parent|1
997253|NCT01392378|2011058|FG000|Toddler Dose|Lost to Follow-up|0
997254|NCT01392378|2011059|FG001|Toddler Dose|Lost to Follow-up|0
997255|NCT01392378|2011060|FG002|Toddler Dose|Lost to Follow-up|0
997256|NCT01392378|2011061|FG003|Toddler Dose|Lost to Follow-up|1
997257|NCT01392378|2011062|FG004|Toddler Dose|Lost to Follow-up|0
997258|NCT01392378|2011058|FG000|Toddler Dose|Withdrawal by Parent|0
997259|NCT01392378|2011059|FG001|Toddler Dose|Withdrawal by Parent|1
997260|NCT01392378|2011060|FG002|Toddler Dose|Withdrawal by Parent|0
997261|NCT01392378|2011061|FG003|Toddler Dose|Withdrawal by Parent|1
997262|NCT01392378|2011062|FG004|Toddler Dose|Withdrawal by Parent|1
997263|NCT01392443|2011084|FG000|Overall Study|Disease progression|30
997264|NCT01392443|2011084|FG000|Overall Study|Adverse Event|24
997265|NCT01392443|2011084|FG000|Overall Study|Death|7
997266|NCT01392443|2011084|FG000|Overall Study|Withdrawal by Subject|5
997267|NCT01392443|2011084|FG000|Overall Study|Lost to Follow-up|1
997268|NCT01392443|2011084|FG000|Overall Study|Protocol Violation|1
997269|NCT01392469|2011088|FG000|Overall Study|Adverse Event|2
997270|NCT01392469|2011088|FG000|Overall Study|Withdrawal by Subject|1
997271|NCT01392469|2011088|FG000|Overall Study|Protocol Violation|1
997272|NCT01392495|2011103|FG000|Overall Study|Death|3
997273|NCT01392495|2011103|FG000|Overall Study|Administrative problems|8
997274|NCT01392495|2011103|FG000|Overall Study|Withdrawal by Subject|2
997275|NCT01392495|2011103|FG000|Overall Study|Adverse Event|3
997276|NCT01392547|2011109|FG000|Overall Study|Adverse Event|2
997277|NCT01392547|2011109|FG000|Overall Study|Non-compliance|2
997278|NCT01392547|2011109|FG000|Overall Study|Withdrawal criteria|3
997279|NCT01392547|2011109|FG000|Overall Study|Unclassified|1
997280|NCT01392560|2011115|FG000|Overall Study|Adverse Event|2
997281|NCT01392560|2011115|FG000|Overall Study|not entered|8
997282|NCT01392560|2011115|FG000|Overall Study|discontinued during placebo run-in|2
997283|NCT01392573|2011123|FG000|Overall Study|Adverse Event|1
997284|NCT01392573|2011124|FG001|Overall Study|Adverse Event|3
997285|NCT01392573|2011123|FG000|Overall Study|Lack of Efficacy|1
997286|NCT01392573|2011124|FG001|Overall Study|Lack of Efficacy|2
997287|NCT01392573|2011123|FG000|Overall Study|Protocol Violation|0
997288|NCT01392573|2011124|FG001|Overall Study|Protocol Violation|2
997289|NCT01392573|2011123|FG000|Overall Study|Withdrawal Criteria|13
997290|NCT01392573|2011124|FG001|Overall Study|Withdrawal Criteria|15
997291|NCT01392573|2011123|FG000|Overall Study|Site closure|8
997292|NCT01392573|2011124|FG001|Overall Study|Site closure|7
997293|NCT01392573|2011123|FG000|Overall Study|Unclassified|9
997294|NCT01392573|2011124|FG001|Overall Study|Unclassified|6
997295|NCT01392677|2011141|FG000|Overall Study|Adverse Event|3
997296|NCT01392677|2011142|FG001|Overall Study|Adverse Event|1
997297|NCT01392677|2011141|FG000|Overall Study|Withdrawal by Subject|0
997298|NCT01392677|2011142|FG001|Overall Study|Withdrawal by Subject|2
997299|NCT01392677|2011141|FG000|Overall Study|Incorrect enrollment|2
997300|NCT01392677|2011142|FG001|Overall Study|Incorrect enrollment|3
997301|NCT01392677|2011141|FG000|Overall Study|Other reason|3
997302|NCT01392677|2011142|FG001|Overall Study|Other reason|2
997303|NCT01392742|2011160|FG000|Overall Study|Premature study termination|42
997304|NCT01392742|2011160|FG000|Overall Study|Failure to return|35
997305|NCT01392742|2011160|FG000|Overall Study|No treatment/no cooperation/withdrew|12
997306|NCT01392742|2011160|FG000|Overall Study|Lost to Follow-up|34
997307|NCT01392742|2011160|FG000|Overall Study|Insufficient therapeutic response (ITR)|30
997308|NCT01392742|2011160|FG000|Overall Study|ITR and Protocol deviation|1
997309|NCT01392742|2011160|FG000|Overall Study|Adverse event/intercurrent illness|17
997310|NCT01392742|2011160|FG000|Overall Study|Protocol Violation|14
997311|NCT01392742|2011160|FG000|Overall Study|Other|3
997312|NCT01392742|2011160|FG000|Overall Study|Missing information|13
997313|NCT01392963|2011174|FG000|Week 0 (First Intervention)|Lost to Follow-up|0
997314|NCT01392963|2011175|FG001|Week 0 (First Intervention)|Lost to Follow-up|1
997315|NCT01392963|2011174|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0
997316|NCT01392963|2011175|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1
997317|NCT01392963|2011174|FG000|Week 24 Follow-up|Lost to Follow-up|2
997318|NCT01392963|2011175|FG001|Week 24 Follow-up|Lost to Follow-up|0
997319|NCT01393106|2011188|FG000|Overall Study|Adverse Event|3
997320|NCT01393106|2011188|FG000|Overall Study|Withdrawal by Subject|1
997321|NCT01393106|2011188|FG000|Overall Study|Lack of Efficacy|1
997322|NCT01393158|2011205|FG000|Overall Study|Adverse Event|1
997323|NCT01393158|2011206|FG001|Overall Study|Adverse Event|0
997324|NCT01393301|2011220|FG000|Overall Study|Lost to Follow-up|5
997325|NCT01393301|2011221|FG001|Overall Study|Lost to Follow-up|3
997326|NCT01393301|2011220|FG000|Overall Study|Withdrawal by Subject|2
997327|NCT01393301|2011221|FG001|Overall Study|Withdrawal by Subject|0
997328|NCT01393301|2011220|FG000|Overall Study|Completed <7 sessions (intervention)|2
997329|NCT01393301|2011221|FG001|Overall Study|Completed <7 sessions (intervention)|0
997330|NCT01393405|2011236|FG000|Induction Period (week1-16)|Lack of Efficacy|70
997331|NCT01393405|2011237|FG001|Induction Period (week1-16)|Lack of Efficacy|0
997332|NCT01393405|2011238|FG002|Induction Period (week1-16)|Lack of Efficacy|0
997333|NCT01393405|2011236|FG000|Induction Period (week1-16)|Adverse Event|16
997334|NCT01393405|2011237|FG001|Induction Period (week1-16)|Adverse Event|0
997335|NCT01393405|2011238|FG002|Induction Period (week1-16)|Adverse Event|0
997336|NCT01393405|2011236|FG000|Induction Period (week1-16)|Withdrawal by Subject|9
997337|NCT01393405|2011237|FG001|Induction Period (week1-16)|Withdrawal by Subject|0
997338|NCT01393405|2011238|FG002|Induction Period (week1-16)|Withdrawal by Subject|0
997339|NCT01393405|2011236|FG000|Maintenance Period Week|Lack of Efficacy|0
997340|NCT01393405|2011237|FG001|Maintenance Period Week|Lack of Efficacy|22
997341|NCT01393405|2011238|FG002|Maintenance Period Week|Lack of Efficacy|22
997342|NCT01393405|2011236|FG000|Maintenance Period Week|Adverse Event|0
997343|NCT01393405|2011237|FG001|Maintenance Period Week|Adverse Event|5
997344|NCT01393405|2011238|FG002|Maintenance Period Week|Adverse Event|2
997345|NCT01393405|2011236|FG000|Maintenance Period Week|Withdrawal by Subject|0
997346|NCT01393405|2011237|FG001|Maintenance Period Week|Withdrawal by Subject|1
997347|NCT01393405|2011238|FG002|Maintenance Period Week|Withdrawal by Subject|0
997348|NCT01393405|2011236|FG000|Maintenance Period Week|Lost to Follow-up|0
997349|NCT01393405|2011237|FG001|Maintenance Period Week|Lost to Follow-up|1
997350|NCT01393405|2011238|FG002|Maintenance Period Week|Lost to Follow-up|0
997351|NCT01393444|2011248|FG000|Overall Study|Withdrawal by Subject|1
997352|NCT01393444|2011248|FG000|Overall Study|Determined ineligible during screening.|2
997353|NCT01393600|2011269|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
997354|NCT01393600|2011270|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
997355|NCT01393600|2011271|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
997356|NCT01393600|2011272|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
997357|NCT01393600|2011269|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
997358|NCT01393600|2011270|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
997359|NCT01393600|2011271|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
997360|NCT01393600|2011272|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
997361|NCT01393600|2011269|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
997362|NCT01393600|2011270|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
997363|NCT01393600|2011271|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
997364|NCT01393600|2011272|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
997365|NCT01393600|2011269|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
997366|NCT01393600|2011270|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
997367|NCT01393600|2011271|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
997368|NCT01393600|2011272|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
997369|NCT01393600|2011269|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
997370|NCT01393600|2011270|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
997371|NCT01393600|2011271|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
997372|NCT01393600|2011272|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
997373|NCT01393600|2011269|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
997374|NCT01393600|2011270|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
997375|NCT01393600|2011271|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
997376|NCT01393600|2011272|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
997377|NCT01393600|2011269|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
997378|NCT01393600|2011270|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
997379|NCT01393600|2011271|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
997380|NCT01393600|2011272|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
997381|NCT01393613|2011288|FG000|Overall Study|Adverse Event|11
997382|NCT01393613|2011289|FG001|Overall Study|Adverse Event|11
997383|NCT01393613|2011290|FG002|Overall Study|Adverse Event|13
997384|NCT01393613|2011291|FG003|Overall Study|Adverse Event|22
997385|NCT01393613|2011288|FG000|Overall Study|Participant Met Withdrawal Criteria|0
997386|NCT01393613|2011289|FG001|Overall Study|Participant Met Withdrawal Criteria|0
997387|NCT01393613|2011290|FG002|Overall Study|Participant Met Withdrawal Criteria|2
997388|NCT01393613|2011291|FG003|Overall Study|Participant Met Withdrawal Criteria|1
997389|NCT01393613|2011288|FG000|Overall Study|Physician Decision|2
997390|NCT01393613|2011289|FG001|Overall Study|Physician Decision|0
997391|NCT01393613|2011290|FG002|Overall Study|Physician Decision|0
997392|NCT01393613|2011291|FG003|Overall Study|Physician Decision|1
997393|NCT01393613|2011288|FG000|Overall Study|Withdrawal by Subject|15
997394|NCT01393613|2011289|FG001|Overall Study|Withdrawal by Subject|25
997395|NCT01393613|2011290|FG002|Overall Study|Withdrawal by Subject|23
997396|NCT01393613|2011291|FG003|Overall Study|Withdrawal by Subject|21
997397|NCT01393613|2011288|FG000|Overall Study|Protocol Deviation|2
997398|NCT01393613|2011289|FG001|Overall Study|Protocol Deviation|1
997399|NCT01393613|2011290|FG002|Overall Study|Protocol Deviation|0
997400|NCT01393613|2011291|FG003|Overall Study|Protocol Deviation|0
997401|NCT01393613|2011288|FG000|Overall Study|Lack of Efficacy|9
997402|NCT01393613|2011289|FG001|Overall Study|Lack of Efficacy|20
997403|NCT01393613|2011290|FG002|Overall Study|Lack of Efficacy|16
997404|NCT01393613|2011291|FG003|Overall Study|Lack of Efficacy|21
997405|NCT01393626|2011307|FG000|Overall Study|Adverse Event|2
997406|NCT01393626|2011308|FG001|Overall Study|Adverse Event|1
997407|NCT01393626|2011309|FG002|Overall Study|Adverse Event|5
997408|NCT01393626|2011310|FG003|Overall Study|Adverse Event|0
997409|NCT01393626|2011307|FG000|Overall Study|Did not meet entrance criteria|1
997410|NCT01393626|2011308|FG001|Overall Study|Did not meet entrance criteria|0
997411|NCT01393626|2011309|FG002|Overall Study|Did not meet entrance criteria|0
997412|NCT01393626|2011310|FG003|Overall Study|Did not meet entrance criteria|0
997413|NCT01393626|2011307|FG000|Overall Study|Lack of Efficacy|6
997414|NCT01393626|2011308|FG001|Overall Study|Lack of Efficacy|6
997415|NCT01393626|2011309|FG002|Overall Study|Lack of Efficacy|4
997416|NCT01393626|2011310|FG003|Overall Study|Lack of Efficacy|1
997417|NCT01393626|2011307|FG000|Overall Study|Lost to Follow-up|1
997418|NCT01393626|2011308|FG001|Overall Study|Lost to Follow-up|1
997419|NCT01393626|2011309|FG002|Overall Study|Lost to Follow-up|1
997420|NCT01393626|2011310|FG003|Overall Study|Lost to Follow-up|0
997421|NCT01393626|2011307|FG000|Overall Study|Withdrawal by Subject|6
997422|NCT01393626|2011308|FG001|Overall Study|Withdrawal by Subject|4
914084|NCT00813098|1891870|FG002|Overall Study|Protocol Violation|1
914085|NCT00813098|1891868|FG000|Overall Study|Principal Investigator decision|0
914086|NCT00813098|1891869|FG001|Overall Study|Principal Investigator decision|1
914087|NCT00813098|1891870|FG002|Overall Study|Principal Investigator decision|0
997423|NCT01393626|2011309|FG002|Overall Study|Withdrawal by Subject|0
997424|NCT01393626|2011310|FG003|Overall Study|Withdrawal by Subject|0
997425|NCT01393626|2011307|FG000|Overall Study|Other|1
997426|NCT01393626|2011308|FG001|Overall Study|Other|0
997427|NCT01393626|2011309|FG002|Overall Study|Other|0
997428|NCT01393626|2011310|FG003|Overall Study|Other|0
997429|NCT01393626|2011307|FG000|Overall Study|Protocol Violation|1
997430|NCT01393626|2011308|FG001|Overall Study|Protocol Violation|0
997431|NCT01393626|2011309|FG002|Overall Study|Protocol Violation|2
997432|NCT01393626|2011310|FG003|Overall Study|Protocol Violation|0
997433|NCT01393730|2011347|FG000|Overall Study|Withdrawal by Subject|3
997434|NCT01393730|2011347|FG000|Overall Study|Other|2
914088|NCT00813098|1891868|FG000|Overall Study|Withdrew Consent|0
914089|NCT00813098|1891869|FG001|Overall Study|Withdrew Consent|1
914090|NCT00813098|1891870|FG002|Overall Study|Withdrew Consent|0
914091|NCT00813124|1891887|FG000|Overall Study|Death|2
914092|NCT00813124|1891887|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9
914093|NCT00813124|1891887|FG000|Overall Study|Withdrawal by Subject|1
997435|NCT01393730|2011347|FG000|Overall Study|Adverse Event|1
997436|NCT01393743|2011353|FG000|Core Study|Adverse Event|5
997437|NCT01393743|2011354|FG001|Core Study|Adverse Event|9
997438|NCT01393743|2011355|FG002|Core Study|Adverse Event|0
997439|NCT01393743|2011353|FG000|Core Study|Lost to Follow-up|1
997440|NCT01393743|2011354|FG001|Core Study|Lost to Follow-up|1
997441|NCT01393743|2011355|FG002|Core Study|Lost to Follow-up|0
997442|NCT01393743|2011353|FG000|Core Study|Participant's Choice|2
997443|NCT01393743|2011354|FG001|Core Study|Participant's Choice|3
997444|NCT01393743|2011355|FG002|Core Study|Participant's Choice|0
997445|NCT01393743|2011353|FG000|Core Study|Inadequate therapeutic effect|2
997446|NCT01393743|2011354|FG001|Core Study|Inadequate therapeutic effect|0
997447|NCT01393743|2011355|FG002|Core Study|Inadequate therapeutic effect|0
997448|NCT01393743|2011353|FG000|Extension Phase|Adverse Event|0
997449|NCT01393743|2011354|FG001|Extension Phase|Adverse Event|0
997450|NCT01393743|2011355|FG002|Extension Phase|Adverse Event|12
997451|NCT01393743|2011353|FG000|Extension Phase|Lost to Follow-up|0
997452|NCT01393743|2011354|FG001|Extension Phase|Lost to Follow-up|0
997453|NCT01393743|2011355|FG002|Extension Phase|Lost to Follow-up|2
997454|NCT01393743|2011353|FG000|Extension Phase|Participant choice|0
997455|NCT01393743|2011354|FG001|Extension Phase|Participant choice|0
997456|NCT01393743|2011355|FG002|Extension Phase|Participant choice|16
997457|NCT01393743|2011353|FG000|Extension Phase|Inadequate therapeutic effect|0
997458|NCT01393743|2011354|FG001|Extension Phase|Inadequate therapeutic effect|0
997459|NCT01393743|2011355|FG002|Extension Phase|Inadequate therapeutic effect|7
997460|NCT01393743|2011353|FG000|Extension Phase|Withdrawal by Subject|0
997461|NCT01393743|2011354|FG001|Extension Phase|Withdrawal by Subject|0
997462|NCT01393743|2011355|FG002|Extension Phase|Withdrawal by Subject|8
997463|NCT01393743|2011353|FG000|Extension Phase|Pregnancy|0
997464|NCT01393743|2011354|FG001|Extension Phase|Pregnancy|0
997465|NCT01393743|2011355|FG002|Extension Phase|Pregnancy|1
997466|NCT01393743|2011353|FG000|Extension Phase|Other|0
997467|NCT01393743|2011354|FG001|Extension Phase|Other|0
997468|NCT01393743|2011355|FG002|Extension Phase|Other|14
997469|NCT01393821|2011368|FG000|Overall Study|Cancel|1
997470|NCT01393821|2011369|FG001|Overall Study|Cancel|1
997471|NCT01393821|2011368|FG000|Overall Study|not evaluable for primary endpoint|4
997472|NCT01393821|2011369|FG001|Overall Study|not evaluable for primary endpoint|2
997473|NCT01393899|2011378|FG000|Overall Study|Study terminated by sponsor|1
997474|NCT01393899|2011379|FG001|Overall Study|Study terminated by sponsor|0
997475|NCT01393899|2011380|FG002|Overall Study|Study terminated by sponsor|1
997476|NCT01393899|2011378|FG000|Overall Study|Other|1
997477|NCT01393899|2011379|FG001|Overall Study|Other|0
997478|NCT01393899|2011380|FG002|Overall Study|Other|0
997479|NCT01393899|2011378|FG000|Overall Study|Withdrawal by Subject|2
997480|NCT01393899|2011379|FG001|Overall Study|Withdrawal by Subject|2
997481|NCT01393899|2011380|FG002|Overall Study|Withdrawal by Subject|1
997482|NCT01393899|2011378|FG000|Overall Study|Lost to Follow-up|0
997483|NCT01393899|2011379|FG001|Overall Study|Lost to Follow-up|0
997484|NCT01393899|2011380|FG002|Overall Study|Lost to Follow-up|1
997485|NCT01393899|2011378|FG000|Overall Study|Does not meet entrance criteria|1
997486|NCT01393899|2011379|FG001|Overall Study|Does not meet entrance criteria|0
997487|NCT01393899|2011380|FG002|Overall Study|Does not meet entrance criteria|1
997488|NCT01393899|2011378|FG000|Overall Study|Lack of Efficacy|26
997489|NCT01393899|2011379|FG001|Overall Study|Lack of Efficacy|21
997490|NCT01393899|2011380|FG002|Overall Study|Lack of Efficacy|16
997491|NCT01393899|2011378|FG000|Overall Study|Adverse Event|1
997492|NCT01393899|2011379|FG001|Overall Study|Adverse Event|5
997493|NCT01393899|2011380|FG002|Overall Study|Adverse Event|3
997494|NCT01393964|2011393|FG000|Overall Study|Disease Progression|4
997495|NCT01393964|2011394|FG001|Overall Study|Disease Progression|3
997496|NCT01393964|2011395|FG002|Overall Study|Disease Progression|5
997497|NCT01393964|2011393|FG000|Overall Study|Study drug toxicity|1
997498|NCT01393964|2011394|FG001|Overall Study|Study drug toxicity|0
997499|NCT01393964|2011395|FG002|Overall Study|Study drug toxicity|0
997500|NCT01393964|2011393|FG000|Overall Study|Withdrawal by Subject|0
997501|NCT01393964|2011394|FG001|Overall Study|Withdrawal by Subject|0
997502|NCT01393964|2011395|FG002|Overall Study|Withdrawal by Subject|1
997503|NCT01393964|2011393|FG000|Overall Study|Adverse event unrelated to study drug|0
997504|NCT01393964|2011394|FG001|Overall Study|Adverse event unrelated to study drug|3
997505|NCT01393964|2011395|FG002|Overall Study|Adverse event unrelated to study drug|0
997506|NCT01393964|2011393|FG000|Overall Study|Subject request stop study treatment|0
997507|NCT01393964|2011394|FG001|Overall Study|Subject request stop study treatment|1
997508|NCT01393964|2011395|FG002|Overall Study|Subject request stop study treatment|0
997509|NCT01393964|2011393|FG000|Overall Study|Subject decided to move to transplant|1
997510|NCT01393964|2011394|FG001|Overall Study|Subject decided to move to transplant|0
997511|NCT01393964|2011395|FG002|Overall Study|Subject decided to move to transplant|0
997512|NCT01393964|2011393|FG000|Overall Study|Subject switched to commercial supply|1
997513|NCT01393964|2011394|FG001|Overall Study|Subject switched to commercial supply|0
997514|NCT01393964|2011395|FG002|Overall Study|Subject switched to commercial supply|2
997515|NCT01393964|2011393|FG000|Overall Study|Subject plateaued in terms of effect|1
997516|NCT01393964|2011394|FG001|Overall Study|Subject plateaued in terms of effect|0
997517|NCT01393964|2011395|FG002|Overall Study|Subject plateaued in terms of effect|0
997518|NCT01393964|2011393|FG000|Overall Study|Investigator removed subject from study|0
997519|NCT01393964|2011394|FG001|Overall Study|Investigator removed subject from study|1
997520|NCT01393964|2011395|FG002|Overall Study|Investigator removed subject from study|0
997521|NCT01393964|2011393|FG000|Overall Study|Subject converted to roll-over study|0
997522|NCT01393964|2011394|FG001|Overall Study|Subject converted to roll-over study|1
997523|NCT01393964|2011395|FG002|Overall Study|Subject converted to roll-over study|0
997524|NCT01393964|2011393|FG000|Overall Study|Subject to receive non-protocol therapy|0
997525|NCT01393964|2011394|FG001|Overall Study|Subject to receive non-protocol therapy|0
997526|NCT01393964|2011395|FG002|Overall Study|Subject to receive non-protocol therapy|1
997527|NCT01393990|2011427|FG000|Overall Study|Adverse Event|0
997528|NCT01393990|2011428|FG001|Overall Study|Adverse Event|0
997529|NCT01393990|2011429|FG002|Overall Study|Adverse Event|0
997530|NCT01393990|2011430|FG003|Overall Study|Adverse Event|0
997531|NCT01393990|2011431|FG004|Overall Study|Adverse Event|0
997532|NCT01393990|2011432|FG005|Overall Study|Adverse Event|0
997533|NCT01393990|2011433|FG006|Overall Study|Adverse Event|0
997534|NCT01393990|2011434|FG007|Overall Study|Adverse Event|0
997535|NCT01393990|2011435|FG008|Overall Study|Adverse Event|0
997536|NCT01393990|2011436|FG009|Overall Study|Adverse Event|0
997537|NCT01393990|2011437|FG010|Overall Study|Adverse Event|0
997538|NCT01393990|2011438|FG011|Overall Study|Adverse Event|0
997539|NCT01393990|2011439|FG012|Overall Study|Adverse Event|0
997540|NCT01393990|2011440|FG013|Overall Study|Adverse Event|0
997541|NCT01393990|2011441|FG014|Overall Study|Adverse Event|1
997542|NCT01393990|2011442|FG015|Overall Study|Adverse Event|1
997543|NCT01393990|2011443|FG016|Overall Study|Adverse Event|0
997544|NCT01393990|2011444|FG017|Overall Study|Adverse Event|0
997545|NCT01393990|2011427|FG000|Overall Study|Progressive Disease|1
997546|NCT01393990|2011428|FG001|Overall Study|Progressive Disease|0
997547|NCT01393990|2011429|FG002|Overall Study|Progressive Disease|0
997548|NCT01393990|2011430|FG003|Overall Study|Progressive Disease|1
997549|NCT01393990|2011431|FG004|Overall Study|Progressive Disease|1
997550|NCT01393990|2011432|FG005|Overall Study|Progressive Disease|1
997551|NCT01393990|2011433|FG006|Overall Study|Progressive Disease|1
997552|NCT01393990|2011434|FG007|Overall Study|Progressive Disease|1
997553|NCT01393990|2011435|FG008|Overall Study|Progressive Disease|3
997554|NCT01393990|2011436|FG009|Overall Study|Progressive Disease|1
997555|NCT01393990|2011437|FG010|Overall Study|Progressive Disease|0
997556|NCT01393990|2011438|FG011|Overall Study|Progressive Disease|0
997557|NCT01393990|2011439|FG012|Overall Study|Progressive Disease|0
997558|NCT01393990|2011440|FG013|Overall Study|Progressive Disease|1
997559|NCT01393990|2011441|FG014|Overall Study|Progressive Disease|6
997560|NCT01393990|2011442|FG015|Overall Study|Progressive Disease|1
997561|NCT01393990|2011443|FG016|Overall Study|Progressive Disease|0
997562|NCT01393990|2011444|FG017|Overall Study|Progressive Disease|0
997563|NCT01393990|2011427|FG000|Overall Study|Death|0
997564|NCT01393990|2011428|FG001|Overall Study|Death|0
997565|NCT01393990|2011429|FG002|Overall Study|Death|0
997566|NCT01393990|2011430|FG003|Overall Study|Death|0
997567|NCT01393990|2011431|FG004|Overall Study|Death|1
997568|NCT01393990|2011432|FG005|Overall Study|Death|0
997569|NCT01393990|2011433|FG006|Overall Study|Death|0
997570|NCT01393990|2011434|FG007|Overall Study|Death|0
997571|NCT01393990|2011435|FG008|Overall Study|Death|0
997572|NCT01393990|2011436|FG009|Overall Study|Death|0
997573|NCT01393990|2011437|FG010|Overall Study|Death|0
997574|NCT01393990|2011438|FG011|Overall Study|Death|0
997575|NCT01393990|2011439|FG012|Overall Study|Death|0
997576|NCT01393990|2011440|FG013|Overall Study|Death|1
997577|NCT01393990|2011441|FG014|Overall Study|Death|1
997578|NCT01393990|2011442|FG015|Overall Study|Death|0
997579|NCT01393990|2011443|FG016|Overall Study|Death|0
997580|NCT01393990|2011444|FG017|Overall Study|Death|0
997581|NCT01393990|2011427|FG000|Overall Study|Withdrawal by Subject|0
997582|NCT01393990|2011428|FG001|Overall Study|Withdrawal by Subject|0
997583|NCT01393990|2011429|FG002|Overall Study|Withdrawal by Subject|0
997584|NCT01393990|2011430|FG003|Overall Study|Withdrawal by Subject|0
997585|NCT01393990|2011431|FG004|Overall Study|Withdrawal by Subject|0
997586|NCT01393990|2011432|FG005|Overall Study|Withdrawal by Subject|0
997587|NCT01393990|2011433|FG006|Overall Study|Withdrawal by Subject|0
997588|NCT01393990|2011434|FG007|Overall Study|Withdrawal by Subject|0
997589|NCT01393990|2011435|FG008|Overall Study|Withdrawal by Subject|0
997590|NCT01393990|2011436|FG009|Overall Study|Withdrawal by Subject|0
997591|NCT01393990|2011437|FG010|Overall Study|Withdrawal by Subject|0
997592|NCT01393990|2011438|FG011|Overall Study|Withdrawal by Subject|0
997593|NCT01393990|2011439|FG012|Overall Study|Withdrawal by Subject|0
997594|NCT01393990|2011440|FG013|Overall Study|Withdrawal by Subject|0
997595|NCT01393990|2011441|FG014|Overall Study|Withdrawal by Subject|1
997596|NCT01393990|2011442|FG015|Overall Study|Withdrawal by Subject|1
997597|NCT01393990|2011443|FG016|Overall Study|Withdrawal by Subject|0
997598|NCT01393990|2011444|FG017|Overall Study|Withdrawal by Subject|0
997599|NCT01394185|2011552|FG000|Overall Study|Withdrawal by Subject|2
997600|NCT01394185|2011553|FG001|Overall Study|Withdrawal by Subject|0
997601|NCT01394185|2011554|FG002|Overall Study|Withdrawal by Subject|0
997602|NCT01394185|2011555|FG003|Overall Study|Withdrawal by Subject|0
997603|NCT01394185|2011556|FG004|Overall Study|Withdrawal by Subject|1
997604|NCT01394185|2011557|FG005|Overall Study|Withdrawal by Subject|0
997605|NCT01394185|2011552|FG000|Overall Study|Change in protocol|3
997606|NCT01394185|2011553|FG001|Overall Study|Change in protocol|0
997607|NCT01394185|2011554|FG002|Overall Study|Change in protocol|0
997608|NCT01394185|2011555|FG003|Overall Study|Change in protocol|0
997609|NCT01394185|2011556|FG004|Overall Study|Change in protocol|3
997610|NCT01394185|2011557|FG005|Overall Study|Change in protocol|0
997611|NCT01394185|2011552|FG000|Overall Study|Protocol Violation|1
997612|NCT01394185|2011553|FG001|Overall Study|Protocol Violation|0
997613|NCT01394185|2011554|FG002|Overall Study|Protocol Violation|0
997614|NCT01394185|2011555|FG003|Overall Study|Protocol Violation|1
997615|NCT01394185|2011556|FG004|Overall Study|Protocol Violation|0
997616|NCT01394185|2011557|FG005|Overall Study|Protocol Violation|1
997617|NCT01394250|2011567|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
997618|NCT01394250|2011568|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
997619|NCT01394250|2011567|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
997620|NCT01394250|2011568|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
997621|NCT01394276|2011574|FG000|Overall Study|Related Adverse event (AEs)|15
997622|NCT01394276|2011574|FG000|Overall Study|Not related AEs|9
997623|NCT01394276|2011574|FG000|Overall Study|Remission of disease|2
997624|NCT01394276|2011574|FG000|Overall Study|Insufficient therapeutic effect|17
997625|NCT01394276|2011574|FG000|Overall Study|Insufficient compliance|9
997626|NCT01394276|2011574|FG000|Overall Study|Lost to Follow-up|5
997627|NCT01394276|2011574|FG000|Overall Study|Participant moved to another site|1
997628|NCT01394276|2011574|FG000|Overall Study|Pregnancy|1
997629|NCT01394276|2011574|FG000|Overall Study|unavailability of drug at the Hospital|2
997630|NCT01394276|2011574|FG000|Overall Study|Symptoms of concurrent diseases|1
997631|NCT01394523|2011590|FG000|Overall Study|Unable to place block|1
997632|NCT01394523|2011591|FG001|Overall Study|Unable to place block|0
997633|NCT01394523|2011592|FG002|Overall Study|Unable to place block|0
997634|NCT01394627|2011609|FG000|First Intervention (1 Day)|poor intravenous access|0
997635|NCT01394627|2011610|FG001|First Intervention (1 Day)|poor intravenous access|1
997636|NCT01394627|2011609|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1
997637|NCT01394627|2011610|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0
997638|NCT01394718|2011637|FG000|Overall Study|Met protocol-specific stopping criteria|2
997639|NCT01394718|2011638|FG001|Overall Study|Met protocol-specific stopping criteria|1
997640|NCT01394939|2011648|FG000|Overall Study|Adverse Event|1
997641|NCT01394939|2011649|FG001|Overall Study|Adverse Event|3
997642|NCT01394939|2011650|FG002|Overall Study|Adverse Event|0
997643|NCT01394939|2011651|FG003|Overall Study|Adverse Event|2
997644|NCT01394939|2011648|FG000|Overall Study|Death|0
997645|NCT01394939|2011649|FG001|Overall Study|Death|2
997646|NCT01394939|2011650|FG002|Overall Study|Death|0
997647|NCT01394939|2011651|FG003|Overall Study|Death|0
997648|NCT01394939|2011648|FG000|Overall Study|Physician Decision|0
997649|NCT01394939|2011649|FG001|Overall Study|Physician Decision|1
997650|NCT01394939|2011650|FG002|Overall Study|Physician Decision|0
997651|NCT01394939|2011651|FG003|Overall Study|Physician Decision|0
997652|NCT01394939|2011648|FG000|Overall Study|Withdrawal by Subject|0
997653|NCT01394939|2011649|FG001|Overall Study|Withdrawal by Subject|2
997654|NCT01394939|2011650|FG002|Overall Study|Withdrawal by Subject|0
997655|NCT01394939|2011651|FG003|Overall Study|Withdrawal by Subject|2
997656|NCT01394939|2011648|FG000|Overall Study|Others|0
997657|NCT01394939|2011649|FG001|Overall Study|Others|2
997658|NCT01394939|2011650|FG002|Overall Study|Others|0
997659|NCT01394939|2011651|FG003|Overall Study|Others|3
997660|NCT01394952|2011663|FG000|Overall Study|Lost to Follow-up|0
997661|NCT01394952|2011664|FG001|Overall Study|Lost to Follow-up|5
997662|NCT01394952|2011663|FG000|Overall Study|Withdrawal by Subject|10
997663|NCT01394952|2011664|FG001|Overall Study|Withdrawal by Subject|5
997664|NCT01394952|2011663|FG000|Overall Study|Physician Decision|2
997665|NCT01394952|2011664|FG001|Overall Study|Physician Decision|0
997666|NCT01394952|2011663|FG000|Overall Study|Sponsor Decision|5
997667|NCT01394952|2011664|FG001|Overall Study|Sponsor Decision|7
997668|NCT01394978|2011673|FG000|Overall Study|Withdrawal by Subject|2
997669|NCT01394978|2011674|FG001|Overall Study|Withdrawal by Subject|4
997670|NCT01394978|2011673|FG000|Overall Study|Lost to Follow-up|13
997671|NCT01394978|2011674|FG001|Overall Study|Lost to Follow-up|20
997672|NCT01394978|2011673|FG000|Overall Study|Death|6
997673|NCT01394978|2011674|FG001|Overall Study|Death|7
997674|NCT01394991|2011683|FG000|Overall Study|Adverse Event|0
997675|NCT01394991|2011684|FG001|Overall Study|Adverse Event|4
997676|NCT01394991|2011683|FG000|Overall Study|Lack of Efficacy|5
997677|NCT01394991|2011684|FG001|Overall Study|Lack of Efficacy|7
997678|NCT01394991|2011683|FG000|Overall Study|Lost to Follow-up|6
997679|NCT01394991|2011684|FG001|Overall Study|Lost to Follow-up|8
997680|NCT01394991|2011683|FG000|Overall Study|Physician Decision|1
997681|NCT01394991|2011684|FG001|Overall Study|Physician Decision|3
997682|NCT01394991|2011683|FG000|Overall Study|Protocol Violation|1
997683|NCT01394991|2011684|FG001|Overall Study|Protocol Violation|1
997684|NCT01394991|2011683|FG000|Overall Study|Withdrawal by Subject|20
997685|NCT01394991|2011684|FG001|Overall Study|Withdrawal by Subject|17
997686|NCT01394991|2011683|FG000|Overall Study|Chemotherapy Termination|10
997687|NCT01394991|2011684|FG001|Overall Study|Chemotherapy Termination|15
997688|NCT01394991|2011683|FG000|Overall Study|Disease Progression|7
997689|NCT01394991|2011684|FG001|Overall Study|Disease Progression|7
997690|NCT01394991|2011683|FG000|Overall Study|Prematurely Termination of Trial|9
997691|NCT01394991|2011684|FG001|Overall Study|Prematurely Termination of Trial|10
997692|NCT01395017|2011692|FG000|Overall Study|Lost to Follow-up|1
997693|NCT01395017|2011693|FG001|Overall Study|Lost to Follow-up|0
997694|NCT01395017|2011692|FG000|Overall Study|Adverse Event|26
997695|NCT01395017|2011693|FG001|Overall Study|Adverse Event|12
997696|NCT01395017|2011692|FG000|Overall Study|Physician Decision|11
997697|NCT01395017|2011693|FG001|Overall Study|Physician Decision|15
997698|NCT01395017|2011692|FG000|Overall Study|Withdrawal by Subject|14
997699|NCT01395017|2011693|FG001|Overall Study|Withdrawal by Subject|8
997700|NCT01395017|2011692|FG000|Overall Study|Protocol deviation|1
997701|NCT01395017|2011693|FG001|Overall Study|Protocol deviation|2
997702|NCT01395017|2011692|FG000|Overall Study|Death|4
997703|NCT01395017|2011693|FG001|Overall Study|Death|3
997704|NCT01395017|2011692|FG000|Overall Study|Disease progression|42
997705|NCT01395017|2011693|FG001|Overall Study|Disease progression|58
997706|NCT01395017|2011692|FG000|Overall Study|Sponsor discontinued study|1
997707|NCT01395017|2011693|FG001|Overall Study|Sponsor discontinued study|4
997708|NCT01395030|2011700|FG000|Overall Study|Did not complete FCH PET/CT|7
997709|NCT01395316|2011722|FG000|Overall Study|Lost to Follow-up|2
997710|NCT01395316|2011722|FG000|Overall Study|poor MRI quality|1
997711|NCT01395368|2011742|FG000|Overall Study|Physician Decision|14
997712|NCT01395368|2011742|FG000|Overall Study|Withdrawal by Subject|2
997713|NCT01395394|2011749|FG000|Baseline Study Visit|Protocol Violation|1
997714|NCT01395394|2011750|FG001|Baseline Study Visit|Protocol Violation|0
997715|NCT01395394|2011751|FG002|Baseline Study Visit|Protocol Violation|0
997716|NCT01395524|2011762|FG000|Overall Study|Non-compliance with study schedule|1
997717|NCT01395524|2011763|FG001|Overall Study|Non-compliance with study schedule|0
997718|NCT01395524|2011764|FG002|Overall Study|Non-compliance with study schedule|1
997719|NCT01395524|2011762|FG000|Overall Study|Lost to Follow-up|3
997720|NCT01395524|2011763|FG001|Overall Study|Lost to Follow-up|1
997721|NCT01395524|2011764|FG002|Overall Study|Lost to Follow-up|1
997722|NCT01395524|2011762|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
997723|NCT01395524|2011763|FG001|Overall Study|Study-Specific Withdrawal Criteria|2
997724|NCT01395524|2011764|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
997725|NCT01395524|2011762|FG000|Overall Study|Severe noncompliance with protocol|1
997726|NCT01395524|2011763|FG001|Overall Study|Severe noncompliance with protocol|0
997727|NCT01395524|2011764|FG002|Overall Study|Severe noncompliance with protocol|0
997728|NCT01395524|2011762|FG000|Overall Study|Adverse Event|4
997729|NCT01395524|2011763|FG001|Overall Study|Adverse Event|4
997730|NCT01395524|2011764|FG002|Overall Study|Adverse Event|3
997731|NCT01395524|2011762|FG000|Overall Study|Death|1
997732|NCT01395524|2011763|FG001|Overall Study|Death|0
997733|NCT01395524|2011764|FG002|Overall Study|Death|0
997734|NCT01395524|2011762|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
997735|NCT01395524|2011763|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
997736|NCT01395524|2011764|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0
997737|NCT01395524|2011762|FG000|Overall Study|Withdrawal by Subject|4
997738|NCT01395524|2011763|FG001|Overall Study|Withdrawal by Subject|8
997739|NCT01395524|2011764|FG002|Overall Study|Withdrawal by Subject|8
997740|NCT01395524|2011762|FG000|Overall Study|Did not receive treatment|1
997741|NCT01395524|2011763|FG001|Overall Study|Did not receive treatment|1
997742|NCT01395524|2011764|FG002|Overall Study|Did not receive treatment|3
997743|NCT01395524|2011762|FG000|Overall Study|Subject had spinal surgery|0
997744|NCT01395524|2011763|FG001|Overall Study|Subject had spinal surgery|0
997745|NCT01395524|2011764|FG002|Overall Study|Subject had spinal surgery|1
997746|NCT01395758|2011778|FG000|Open-label Treatment Period|Withdrawal by Subject|4
997747|NCT01395758|2011779|FG001|Open-label Treatment Period|Withdrawal by Subject|0
997748|NCT01395758|2011780|FG002|Open-label Treatment Period|Withdrawal by Subject|0
997749|NCT01395784|2011787|FG000|Overall Study|Lost to Follow-up|7
997750|NCT01395784|2011787|FG000|Overall Study|Withdrawal by Subject|3
997751|NCT01395784|2011787|FG000|Overall Study|Physician Decision|5
997752|NCT01395810|2011826|FG000|Overall Study|Adverse Event|0
997753|NCT01395810|2011827|FG001|Overall Study|Adverse Event|1
997754|NCT01395810|2011828|FG002|Overall Study|Adverse Event|0
997755|NCT01395810|2011829|FG003|Overall Study|Adverse Event|0
997756|NCT01395810|2011826|FG000|Overall Study|Lack of Efficacy|0
997757|NCT01395810|2011827|FG001|Overall Study|Lack of Efficacy|1
997758|NCT01395810|2011828|FG002|Overall Study|Lack of Efficacy|0
997759|NCT01395810|2011829|FG003|Overall Study|Lack of Efficacy|0
997760|NCT01395810|2011826|FG000|Overall Study|Withdrawal criteria|0
997761|NCT01395810|2011827|FG001|Overall Study|Withdrawal criteria|2
997762|NCT01395810|2011828|FG002|Overall Study|Withdrawal criteria|0
997763|NCT01395810|2011829|FG003|Overall Study|Withdrawal criteria|0
997764|NCT01395810|2011826|FG000|Overall Study|Unclassified|2
997765|NCT01395810|2011827|FG001|Overall Study|Unclassified|0
997766|NCT01395810|2011828|FG002|Overall Study|Unclassified|0
997767|NCT01395810|2011829|FG003|Overall Study|Unclassified|0
997768|NCT01395823|2011842|FG000|Overall Study|Death|4
997769|NCT01395823|2011843|FG001|Overall Study|Death|4
997770|NCT01395823|2011842|FG000|Overall Study|Physician Decision|3
997771|NCT01395823|2011843|FG001|Overall Study|Physician Decision|1
997772|NCT01395823|2011842|FG000|Overall Study|Lost to Follow-up|1
997773|NCT01395823|2011843|FG001|Overall Study|Lost to Follow-up|0
997774|NCT01395823|2011842|FG000|Overall Study|Transplant|1
997775|NCT01395823|2011843|FG001|Overall Study|Transplant|0
997776|NCT01395823|2011842|FG000|Overall Study|GI symptoms|1
997777|NCT01395823|2011843|FG001|Overall Study|GI symptoms|0
997778|NCT01395823|2011842|FG000|Overall Study|Withdrawal by Subject|5
997779|NCT01395823|2011843|FG001|Overall Study|Withdrawal by Subject|4
997780|NCT01395888|2011851|FG000|2-week Run-in Period|Adverse Event|2
997781|NCT01395888|2011852|FG001|2-week Run-in Period|Adverse Event|0
997782|NCT01395888|2011853|FG002|2-week Run-in Period|Adverse Event|0
997783|NCT01395888|2011851|FG000|2-week Run-in Period|Continuation Criteria Not Met|13
997784|NCT01395888|2011852|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
997785|NCT01395888|2011853|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
997786|NCT01395888|2011851|FG000|2-week Run-in Period|Lost to Follow-up|1
997787|NCT01395888|2011852|FG001|2-week Run-in Period|Lost to Follow-up|0
997788|NCT01395888|2011853|FG002|2-week Run-in Period|Lost to Follow-up|0
997789|NCT01395888|2011851|FG000|2-week Run-in Period|Protocol Violation|2
997790|NCT01395888|2011852|FG001|2-week Run-in Period|Protocol Violation|0
997791|NCT01395888|2011853|FG002|2-week Run-in Period|Protocol Violation|0
997792|NCT01395888|2011851|FG000|2-week Run-in Period|Withdrawal by Subject|4
997793|NCT01395888|2011852|FG001|2-week Run-in Period|Withdrawal by Subject|0
997794|NCT01395888|2011853|FG002|2-week Run-in Period|Withdrawal by Subject|0
997795|NCT01395888|2011851|FG000|Treatment Period (TP)|Adverse Event|0
997796|NCT01395888|2011852|FG001|Treatment Period (TP)|Adverse Event|7
997797|NCT01395888|2011853|FG002|Treatment Period (TP)|Adverse Event|6
997798|NCT01395888|2011851|FG000|Treatment Period (TP)|Lack of Efficacy|0
997799|NCT01395888|2011852|FG001|Treatment Period (TP)|Lack of Efficacy|4
997800|NCT01395888|2011853|FG002|Treatment Period (TP)|Lack of Efficacy|3
997801|NCT01395888|2011851|FG000|Treatment Period (TP)|Protocol Violation|0
997802|NCT01395888|2011852|FG001|Treatment Period (TP)|Protocol Violation|1
997803|NCT01395888|2011853|FG002|Treatment Period (TP)|Protocol Violation|5
997804|NCT01395888|2011851|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
997805|NCT01395888|2011852|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
997806|NCT01395888|2011853|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
997807|NCT01395888|2011851|FG000|Treatment Period (TP)|Withdrawal by Subject|0
997808|NCT01395888|2011852|FG001|Treatment Period (TP)|Withdrawal by Subject|2
997809|NCT01395888|2011853|FG002|Treatment Period (TP)|Withdrawal by Subject|3
997810|NCT01395901|2011861|FG000|Overall Study|Lost to Follow-up|4
997811|NCT01395901|2011862|FG001|Overall Study|Lost to Follow-up|0
997812|NCT01395901|2011861|FG000|Overall Study|Randomized but not received study drug|5
997813|NCT01395901|2011862|FG001|Overall Study|Randomized but not received study drug|4
997814|NCT01395901|2011861|FG000|Overall Study|Adverse Event|0
997815|NCT01395901|2011862|FG001|Overall Study|Adverse Event|1
997816|NCT01395901|2011861|FG000|Overall Study|Withdrawal of consent|1
997817|NCT01395901|2011862|FG001|Overall Study|Withdrawal of consent|0
997818|NCT01395914|2011870|FG000|Overall Study|Unrelated to study drug AE|6
997819|NCT01395914|2011871|FG001|Overall Study|Unrelated to study drug AE|1
997820|NCT01395914|2011870|FG000|Overall Study|Death|23
997821|NCT01395914|2011871|FG001|Overall Study|Death|17
997822|NCT01395914|2011870|FG000|Overall Study|Other|9
997823|NCT01395914|2011871|FG001|Overall Study|Other|3
997824|NCT01395914|2011870|FG000|Overall Study|Withdrawal by patient|27
997825|NCT01395914|2011871|FG001|Overall Study|Withdrawal by patient|14
997826|NCT01395914|2011870|FG000|Overall Study|Study drug-related AE|1
997827|NCT01395914|2011871|FG001|Overall Study|Study drug-related AE|0
997828|NCT01395914|2011870|FG000|Overall Study|Lost to Follow-up|6
997829|NCT01395914|2011871|FG001|Overall Study|Lost to Follow-up|2
997830|NCT01396005|2011892|FG000|Overall Study|Withdrawal by Subject|0
997831|NCT01396005|2011893|FG001|Overall Study|Withdrawal by Subject|1
997832|NCT01396005|2011892|FG000|Overall Study|Non-compliance with protocol|0
997833|NCT01396005|2011893|FG001|Overall Study|Non-compliance with protocol|1
997834|NCT01396057|2011912|FG000|Overall Study|Adverse Event|2
997835|NCT01396057|2011913|FG001|Overall Study|Adverse Event|6
997836|NCT01396057|2011912|FG000|Overall Study|Unsatisfactory therapeutic effect|2
997837|NCT01396057|2011913|FG001|Overall Study|Unsatisfactory therapeutic effect|6
997838|NCT01396057|2011912|FG000|Overall Study|Protocol deviation|4
997839|NCT01396057|2011913|FG001|Overall Study|Protocol deviation|4
997840|NCT01396057|2011912|FG000|Overall Study|Consent withdrawn|3
997841|NCT01396057|2011913|FG001|Overall Study|Consent withdrawn|2
997842|NCT01396070|2011919|FG000|Overall Study|Withdrawal by Subject|2
997843|NCT01396070|2011919|FG000|Overall Study|Death|2
997844|NCT01396070|2011919|FG000|Overall Study|Adverse Event|8
997845|NCT01396070|2011919|FG000|Overall Study|Physician Decision|3
997846|NCT01396070|2011919|FG000|Overall Study|Lack of Efficacy|4
997847|NCT01396083|2011926|FG000|Overall Study|Adverse Event|2
997848|NCT01396083|2011927|FG001|Overall Study|Adverse Event|28
997849|NCT01396083|2011926|FG000|Overall Study|Unsatisfactory therapeutic effect|2
997850|NCT01396083|2011927|FG001|Overall Study|Unsatisfactory therapeutic effect|13
997851|NCT01396083|2011926|FG000|Overall Study|Consent withdrawn|4
997852|NCT01396083|2011927|FG001|Overall Study|Consent withdrawn|5
997853|NCT01396083|2011926|FG000|Overall Study|Protocol deviation(s)|0
997854|NCT01396083|2011927|FG001|Overall Study|Protocol deviation(s)|1
997855|NCT01396083|2011926|FG000|Overall Study|Abnormal laboratory value(s)|1
997856|NCT01396083|2011927|FG001|Overall Study|Abnormal laboratory value(s)|0
997857|NCT01396083|2011926|FG000|Overall Study|Administrative problems|1
997858|NCT01396083|2011927|FG001|Overall Study|Administrative problems|0
997859|NCT01396083|2011926|FG000|Overall Study|Lost to Follow-up|1
997860|NCT01396083|2011927|FG001|Overall Study|Lost to Follow-up|0
997861|NCT01396148|2011933|FG000|Overall Study|Patient Decision|1
997862|NCT01396161|2011946|FG000|Overall Study|Withdrawal by Subject|0
997863|NCT01396161|2011947|FG001|Overall Study|Withdrawal by Subject|0
997864|NCT01396161|2011948|FG002|Overall Study|Withdrawal by Subject|0
997865|NCT01396161|2011949|FG003|Overall Study|Withdrawal by Subject|0
997866|NCT01396161|2011950|FG004|Overall Study|Withdrawal by Subject|1
997867|NCT01396161|2011951|FG005|Overall Study|Withdrawal by Subject|0
997868|NCT01396161|2011952|FG006|Overall Study|Withdrawal by Subject|0
997869|NCT01396161|2011946|FG000|Overall Study|Other|0
997870|NCT01396161|2011947|FG001|Overall Study|Other|0
997871|NCT01396161|2011948|FG002|Overall Study|Other|0
997872|NCT01396161|2011949|FG003|Overall Study|Other|0
997873|NCT01396161|2011950|FG004|Overall Study|Other|0
997874|NCT01396161|2011951|FG005|Overall Study|Other|0
997875|NCT01396161|2011952|FG006|Overall Study|Other|1
997876|NCT01396187|2011978|FG000|Overall Study|Adverse Event|0
997877|NCT01396187|2011979|FG001|Overall Study|Adverse Event|1
997878|NCT01396187|2011980|FG002|Overall Study|Adverse Event|0
997879|NCT01396187|2011981|FG003|Overall Study|Adverse Event|0
997880|NCT01396187|2011982|FG004|Overall Study|Adverse Event|0
997881|NCT01396187|2011978|FG000|Overall Study|Withdrawal by Subject|0
997882|NCT01396187|2011979|FG001|Overall Study|Withdrawal by Subject|1
997883|NCT01396187|2011980|FG002|Overall Study|Withdrawal by Subject|1
997884|NCT01396187|2011981|FG003|Overall Study|Withdrawal by Subject|0
997885|NCT01396187|2011982|FG004|Overall Study|Withdrawal by Subject|0
997886|NCT01396187|2011978|FG000|Overall Study|Other|1
997887|NCT01396187|2011979|FG001|Overall Study|Other|1
997888|NCT01396187|2011980|FG002|Overall Study|Other|0
997889|NCT01396187|2011981|FG003|Overall Study|Other|0
997890|NCT01396187|2011982|FG004|Overall Study|Other|1
997891|NCT01396265|2012030|FG000|Rifa+Afatinib|Withdrawal by Subject|1
997892|NCT01396317|2012038|FG000|Overall Study|Adverse Event|1
997893|NCT01396317|2012039|FG001|Overall Study|Adverse Event|0
997894|NCT01396395|2012054|FG000|Overall Study|Withdrawal by Subject|10
997895|NCT01396395|2012055|FG001|Overall Study|Withdrawal by Subject|12
997896|NCT01396395|2012054|FG000|Overall Study|Protocol Violation|3
997897|NCT01396395|2012055|FG001|Overall Study|Protocol Violation|1
997898|NCT01396395|2012054|FG000|Overall Study|Adverse Event|10
997899|NCT01396395|2012055|FG001|Overall Study|Adverse Event|2
997900|NCT01396395|2012054|FG000|Overall Study|Lost to Follow-up|17
997901|NCT01396395|2012055|FG001|Overall Study|Lost to Follow-up|11
997902|NCT01396395|2012054|FG000|Overall Study|Other|0
997903|NCT01396395|2012055|FG001|Overall Study|Other|1
997904|NCT01396421|2012067|FG000|Overall Study|Lost to Follow-up|0
997905|NCT01396421|2012068|FG001|Overall Study|Lost to Follow-up|0
997906|NCT01396421|2012069|FG002|Overall Study|Lost to Follow-up|0
997907|NCT01396421|2012070|FG003|Overall Study|Lost to Follow-up|1
997908|NCT01396421|2012067|FG000|Overall Study|Adverse Event|17
997909|NCT01396421|2012068|FG001|Overall Study|Adverse Event|15
997910|NCT01396421|2012069|FG002|Overall Study|Adverse Event|12
997911|NCT01396421|2012070|FG003|Overall Study|Adverse Event|32
997912|NCT01396421|2012067|FG000|Overall Study|Participant Met Withdrawal Criteria|1
997913|NCT01396421|2012068|FG001|Overall Study|Participant Met Withdrawal Criteria|0
997914|NCT01396421|2012069|FG002|Overall Study|Participant Met Withdrawal Criteria|1
997915|NCT01396421|2012070|FG003|Overall Study|Participant Met Withdrawal Criteria|0
997916|NCT01396421|2012067|FG000|Overall Study|Physician Decision|1
997917|NCT01396421|2012068|FG001|Overall Study|Physician Decision|1
997918|NCT01396421|2012069|FG002|Overall Study|Physician Decision|0
997919|NCT01396421|2012070|FG003|Overall Study|Physician Decision|3
997920|NCT01396421|2012067|FG000|Overall Study|Withdrawal by Subject|31
997921|NCT01396421|2012068|FG001|Overall Study|Withdrawal by Subject|24
997922|NCT01396421|2012069|FG002|Overall Study|Withdrawal by Subject|13
997923|NCT01396421|2012070|FG003|Overall Study|Withdrawal by Subject|21
997924|NCT01396421|2012067|FG000|Overall Study|Protocol Deviation|2
997925|NCT01396421|2012068|FG001|Overall Study|Protocol Deviation|1
997926|NCT01396421|2012069|FG002|Overall Study|Protocol Deviation|1
997927|NCT01396421|2012070|FG003|Overall Study|Protocol Deviation|0
997928|NCT01396421|2012067|FG000|Overall Study|Lack of Efficacy|7
997929|NCT01396421|2012068|FG001|Overall Study|Lack of Efficacy|17
997930|NCT01396421|2012069|FG002|Overall Study|Lack of Efficacy|7
997931|NCT01396421|2012070|FG003|Overall Study|Lack of Efficacy|18
997932|NCT01396434|2012097|FG000|Overall Study|Lost to Follow-up|1
997933|NCT01396434|2012098|FG001|Overall Study|Lost to Follow-up|0
997934|NCT01396434|2012099|FG002|Overall Study|Lost to Follow-up|0
997935|NCT01396434|2012097|FG000|Overall Study|Other|10
997936|NCT01396434|2012098|FG001|Overall Study|Other|0
997937|NCT01396434|2012099|FG002|Overall Study|Other|0
997938|NCT01396447|2012111|FG000|Overall Study|Did Not Receive Treatment|3
997939|NCT01396447|2012112|FG001|Overall Study|Did Not Receive Treatment|2
997940|NCT01396447|2012113|FG002|Overall Study|Did Not Receive Treatment|1
997941|NCT01396447|2012114|FG003|Overall Study|Did Not Receive Treatment|0
997942|NCT01396447|2012111|FG000|Overall Study|Adverse Event|15
997943|NCT01396447|2012112|FG001|Overall Study|Adverse Event|12
997944|NCT01396447|2012113|FG002|Overall Study|Adverse Event|12
997945|NCT01396447|2012114|FG003|Overall Study|Adverse Event|17
997946|NCT01396447|2012111|FG000|Overall Study|Insufficient Therapeutic Response|5
997947|NCT01396447|2012112|FG001|Overall Study|Insufficient Therapeutic Response|5
997948|NCT01396447|2012113|FG002|Overall Study|Insufficient Therapeutic Response|2
997949|NCT01396447|2012114|FG003|Overall Study|Insufficient Therapeutic Response|4
997950|NCT01396447|2012111|FG000|Overall Study|Protocol Violation|5
997951|NCT01396447|2012112|FG001|Overall Study|Protocol Violation|2
997952|NCT01396447|2012113|FG002|Overall Study|Protocol Violation|3
997953|NCT01396447|2012114|FG003|Overall Study|Protocol Violation|7
997954|NCT01396447|2012111|FG000|Overall Study|Withdrawal of Consent|11
997955|NCT01396447|2012112|FG001|Overall Study|Withdrawal of Consent|9
997956|NCT01396447|2012113|FG002|Overall Study|Withdrawal of Consent|4
997957|NCT01396447|2012114|FG003|Overall Study|Withdrawal of Consent|15
997958|NCT01396447|2012111|FG000|Overall Study|Lost to Follow-up|4
997959|NCT01396447|2012112|FG001|Overall Study|Lost to Follow-up|8
997960|NCT01396447|2012113|FG002|Overall Study|Lost to Follow-up|7
997961|NCT01396447|2012114|FG003|Overall Study|Lost to Follow-up|9
997962|NCT01396447|2012111|FG000|Overall Study|Other Miscellaneous Reasons|0
997963|NCT01396447|2012112|FG001|Overall Study|Other Miscellaneous Reasons|2
997964|NCT01396447|2012113|FG002|Overall Study|Other Miscellaneous Reasons|1
997965|NCT01396447|2012114|FG003|Overall Study|Other Miscellaneous Reasons|0
997966|NCT01396512|2012139|FG000|Overall Study|Withdrawal by Subject|0
997967|NCT01396512|2012140|FG001|Overall Study|Withdrawal by Subject|1
997968|NCT01396525|2012146|FG000|Overall Study|Withdrawal by Subject|8
997969|NCT01396525|2012146|FG000|Overall Study|Death|14
997970|NCT01396525|2012146|FG000|Overall Study|Lost to Follow-up|4
997971|NCT01397084|2012170|FG000|Overall Study|Severe Non-Compliance to Protocol|1
997972|NCT01397084|2012170|FG000|Overall Study|Protocol Violation|2
997973|NCT01397084|2012170|FG000|Overall Study|Adverse Event|2
997974|NCT01397084|2012170|FG000|Overall Study|Withdrawal by Subject|1
997975|NCT01397084|2012170|FG000|Overall Study|Lost to Follow-up|1
997976|NCT01397084|2012170|FG000|Overall Study|Used other proton pump inhibitor|1
997977|NCT01397253|2012176|FG000|Overall Study|Reviewed by only 1 pharmacist|126
997978|NCT01397253|2012177|FG001|Overall Study|Reviewed by only 1 pharmacist|149
997979|NCT01397409|2012193|FG000|Stage 2|Adverse Event|0
997980|NCT01397409|2012194|FG001|Stage 2|Adverse Event|0
997981|NCT01397409|2012195|FG002|Stage 2|Adverse Event|0
997982|NCT01397409|2012196|FG003|Stage 2|Adverse Event|0
997983|NCT01397409|2012197|FG004|Stage 2|Adverse Event|6
997984|NCT01397409|2012198|FG005|Stage 2|Adverse Event|3
997985|NCT01397409|2012199|FG006|Stage 2|Adverse Event|0
997986|NCT01397409|2012200|FG007|Stage 2|Adverse Event|0
997987|NCT01397409|2012201|FG008|Stage 2|Adverse Event|0
997988|NCT01397409|2012202|FG009|Stage 2|Adverse Event|0
997989|NCT01397409|2012193|FG000|Stage 2|Personal Reasons|0
997990|NCT01397409|2012194|FG001|Stage 2|Personal Reasons|0
997991|NCT01397409|2012195|FG002|Stage 2|Personal Reasons|0
997992|NCT01397409|2012196|FG003|Stage 2|Personal Reasons|0
997993|NCT01397409|2012197|FG004|Stage 2|Personal Reasons|1
997994|NCT01397409|2012198|FG005|Stage 2|Personal Reasons|0
997995|NCT01397409|2012199|FG006|Stage 2|Personal Reasons|0
997996|NCT01397409|2012200|FG007|Stage 2|Personal Reasons|0
997997|NCT01397409|2012201|FG008|Stage 2|Personal Reasons|0
997998|NCT01397409|2012202|FG009|Stage 2|Personal Reasons|0
997999|NCT01397409|2012193|FG000|Stage 2|Other Miscellaneous Reasons|0
998000|NCT01397409|2012194|FG001|Stage 2|Other Miscellaneous Reasons|0
998001|NCT01397409|2012195|FG002|Stage 2|Other Miscellaneous Reasons|0
998002|NCT01397409|2012196|FG003|Stage 2|Other Miscellaneous Reasons|0
998003|NCT01397409|2012197|FG004|Stage 2|Other Miscellaneous Reasons|1
998004|NCT01397409|2012198|FG005|Stage 2|Other Miscellaneous Reasons|1
998005|NCT01397409|2012199|FG006|Stage 2|Other Miscellaneous Reasons|0
998006|NCT01397409|2012200|FG007|Stage 2|Other Miscellaneous Reasons|0
998007|NCT01397409|2012201|FG008|Stage 2|Other Miscellaneous Reasons|0
998008|NCT01397409|2012202|FG009|Stage 2|Other Miscellaneous Reasons|0
998009|NCT01397409|2012193|FG000|Stage 3|Adverse Event|0
998010|NCT01397409|2012194|FG001|Stage 3|Adverse Event|0
998011|NCT01397409|2012195|FG002|Stage 3|Adverse Event|0
998012|NCT01397409|2012196|FG003|Stage 3|Adverse Event|0
998013|NCT01397409|2012197|FG004|Stage 3|Adverse Event|0
998014|NCT01397409|2012198|FG005|Stage 3|Adverse Event|0
998015|NCT01397409|2012199|FG006|Stage 3|Adverse Event|0
998016|NCT01397409|2012200|FG007|Stage 3|Adverse Event|1
998017|NCT01397409|2012201|FG008|Stage 3|Adverse Event|0
998018|NCT01397409|2012202|FG009|Stage 3|Adverse Event|0
998019|NCT01397409|2012193|FG000|Stage 3|Other Miscellaneous Reasons|0
998020|NCT01397409|2012194|FG001|Stage 3|Other Miscellaneous Reasons|0
998021|NCT01397409|2012195|FG002|Stage 3|Other Miscellaneous Reasons|0
998022|NCT01397409|2012196|FG003|Stage 3|Other Miscellaneous Reasons|0
998023|NCT01397409|2012197|FG004|Stage 3|Other Miscellaneous Reasons|0
998024|NCT01397409|2012198|FG005|Stage 3|Other Miscellaneous Reasons|0
998025|NCT01397409|2012199|FG006|Stage 3|Other Miscellaneous Reasons|0
998026|NCT01397409|2012200|FG007|Stage 3|Other Miscellaneous Reasons|1
998027|NCT01397409|2012201|FG008|Stage 3|Other Miscellaneous Reasons|0
998028|NCT01397409|2012202|FG009|Stage 3|Other Miscellaneous Reasons|0
998029|NCT01397422|2012229|FG000|Overall Study|Adverse Event|0
998030|NCT01397422|2012230|FG001|Overall Study|Adverse Event|3
998031|NCT01397422|2012231|FG002|Overall Study|Adverse Event|3
998032|NCT01397422|2012232|FG003|Overall Study|Adverse Event|8
998033|NCT01397422|2012229|FG000|Overall Study|Withdrawal by Subject|1
998034|NCT01397422|2012230|FG001|Overall Study|Withdrawal by Subject|0
998035|NCT01397422|2012231|FG002|Overall Study|Withdrawal by Subject|0
998036|NCT01397422|2012232|FG003|Overall Study|Withdrawal by Subject|0
998037|NCT01397422|2012229|FG000|Overall Study|Increased bradykinesia related to PD|1
998038|NCT01397422|2012230|FG001|Overall Study|Increased bradykinesia related to PD|0
998039|NCT01397422|2012231|FG002|Overall Study|Increased bradykinesia related to PD|0
998040|NCT01397422|2012232|FG003|Overall Study|Increased bradykinesia related to PD|0
998041|NCT01397448|2012247|FG000|Overall Study|Adverse Event|4
998042|NCT01397448|2012248|FG001|Overall Study|Adverse Event|4
998043|NCT01397448|2012249|FG002|Overall Study|Adverse Event|6
998044|NCT01397448|2012247|FG000|Overall Study|Withdrawal by Subject|4
998045|NCT01397448|2012248|FG001|Overall Study|Withdrawal by Subject|4
998046|NCT01397448|2012249|FG002|Overall Study|Withdrawal by Subject|3
998047|NCT01397448|2012247|FG000|Overall Study|Lack of Efficacy|2
998048|NCT01397448|2012248|FG001|Overall Study|Lack of Efficacy|0
998049|NCT01397448|2012249|FG002|Overall Study|Lack of Efficacy|5
998050|NCT01397448|2012247|FG000|Overall Study|Other|8
998051|NCT01397448|2012248|FG001|Overall Study|Other|7
998052|NCT01397448|2012249|FG002|Overall Study|Other|4
998053|NCT01397461|2012260|FG000|Overall Study|Withdrawal by Subject|2
998054|NCT01397461|2012261|FG001|Overall Study|Withdrawal by Subject|1
998055|NCT01397461|2012262|FG002|Overall Study|Withdrawal by Subject|0
998056|NCT01397461|2012260|FG000|Overall Study|Lost to Follow-up|0
998057|NCT01397461|2012261|FG001|Overall Study|Lost to Follow-up|2
998058|NCT01397461|2012262|FG002|Overall Study|Lost to Follow-up|1
998059|NCT01397461|2012260|FG000|Overall Study|Lack of Efficacy|0
998060|NCT01397461|2012261|FG001|Overall Study|Lack of Efficacy|3
998061|NCT01397461|2012262|FG002|Overall Study|Lack of Efficacy|0
998062|NCT01397461|2012260|FG000|Overall Study|Not treated|0
998063|NCT01397461|2012261|FG001|Overall Study|Not treated|0
998064|NCT01397461|2012262|FG002|Overall Study|Not treated|1
998065|NCT01397747|2012302|FG000|Overall Study|Multitarget DNA test excluded|689
998066|NCT01397747|2012302|FG000|Overall Study|Colonoscopy excluded|304
998067|NCT01397747|2012302|FG000|Overall Study|FIT excluded|34
998068|NCT01397786|2012310|FG000|Phase A|Lost to Follow-up|0
998069|NCT01397786|2012311|FG001|Phase A|Lost to Follow-up|0
998070|NCT01397786|2012312|FG002|Phase A|Lost to Follow-up|6
998071|NCT01397786|2012310|FG000|Phase A|Adverse Event|0
998072|NCT01397786|2012311|FG001|Phase A|Adverse Event|0
998073|NCT01397786|2012312|FG002|Phase A|Adverse Event|8
998074|NCT01397786|2012310|FG000|Phase A|Subject Met Withdrawal Criteria|0
998075|NCT01397786|2012311|FG001|Phase A|Subject Met Withdrawal Criteria|0
998076|NCT01397786|2012312|FG002|Phase A|Subject Met Withdrawal Criteria|7
998077|NCT01397786|2012310|FG000|Phase A|Physician Decision|0
998078|NCT01397786|2012311|FG001|Phase A|Physician Decision|0
998079|NCT01397786|2012312|FG002|Phase A|Physician Decision|1
998080|NCT01397786|2012310|FG000|Phase A|Withdrawal by Subject|0
998081|NCT01397786|2012311|FG001|Phase A|Withdrawal by Subject|0
998082|NCT01397786|2012312|FG002|Phase A|Withdrawal by Subject|5
998083|NCT01397786|2012310|FG000|Phase A|Lack of Efficacy|0
998084|NCT01397786|2012311|FG001|Phase A|Lack of Efficacy|0
998085|NCT01397786|2012312|FG002|Phase A|Lack of Efficacy|1
998086|NCT01397786|2012310|FG000|Phase B|Lost to Follow-up|22
998087|NCT01397786|2012311|FG001|Phase B|Lost to Follow-up|12
998088|NCT01397786|2012312|FG002|Phase B|Lost to Follow-up|22
998089|NCT01397786|2012310|FG000|Phase B|Adverse Event|109
998090|NCT01397786|2012311|FG001|Phase B|Adverse Event|23
998091|NCT01397786|2012312|FG002|Phase B|Adverse Event|27
998092|NCT01397786|2012310|FG000|Phase B|Subject Met Withdrawal Criteria|38
998093|NCT01397786|2012311|FG001|Phase B|Subject Met Withdrawal Criteria|5
998094|NCT01397786|2012312|FG002|Phase B|Subject Met Withdrawal Criteria|38
998095|NCT01397786|2012310|FG000|Phase B|Physician Decision|9
998096|NCT01397786|2012311|FG001|Phase B|Physician Decision|1
998097|NCT01397786|2012312|FG002|Phase B|Physician Decision|3
998098|NCT01397786|2012310|FG000|Phase B|Withdrawal by Subject|102
998099|NCT01397786|2012311|FG001|Phase B|Withdrawal by Subject|45
998100|NCT01397786|2012312|FG002|Phase B|Withdrawal by Subject|30
998101|NCT01397786|2012310|FG000|Phase B|Protocol Deviation|1
998102|NCT01397786|2012311|FG001|Phase B|Protocol Deviation|2
998103|NCT01397786|2012312|FG002|Phase B|Protocol Deviation|4
998104|NCT01397786|2012310|FG000|Phase B|Lack of Efficacy|22
998105|NCT01397786|2012311|FG001|Phase B|Lack of Efficacy|7
998106|NCT01397786|2012312|FG002|Phase B|Lack of Efficacy|14
998107|NCT01397825|2012328|FG000|Overall Study|Progressive Disease|10
998108|NCT01397825|2012329|FG001|Overall Study|Progressive Disease|3
998109|NCT01397825|2012330|FG002|Overall Study|Progressive Disease|11
998110|NCT01397825|2012331|FG003|Overall Study|Progressive Disease|1
998111|NCT01397825|2012332|FG004|Overall Study|Progressive Disease|0
998112|NCT01397825|2012328|FG000|Overall Study|Symptomatic Deterioration|2
998113|NCT01397825|2012329|FG001|Overall Study|Symptomatic Deterioration|0
998114|NCT01397825|2012330|FG002|Overall Study|Symptomatic Deterioration|4
998115|NCT01397825|2012331|FG003|Overall Study|Symptomatic Deterioration|0
998116|NCT01397825|2012332|FG004|Overall Study|Symptomatic Deterioration|0
998117|NCT01397825|2012328|FG000|Overall Study|Adverse Event|0
998118|NCT01397825|2012329|FG001|Overall Study|Adverse Event|1
998119|NCT01397825|2012330|FG002|Overall Study|Adverse Event|5
998120|NCT01397825|2012331|FG003|Overall Study|Adverse Event|1
998121|NCT01397825|2012332|FG004|Overall Study|Adverse Event|0
998122|NCT01397825|2012328|FG000|Overall Study|Withdrawal by Subject|1
998123|NCT01397825|2012329|FG001|Overall Study|Withdrawal by Subject|0
998124|NCT01397825|2012330|FG002|Overall Study|Withdrawal by Subject|5
998125|NCT01397825|2012331|FG003|Overall Study|Withdrawal by Subject|1
998126|NCT01397825|2012332|FG004|Overall Study|Withdrawal by Subject|0
998127|NCT01397890|2012357|FG000|Overall Study|Withdrawal by Subject|7
998128|NCT01397890|2012358|FG001|Overall Study|Withdrawal by Subject|11
998129|NCT01397890|2012357|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7
998130|NCT01397890|2012358|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
998131|NCT01397890|2012357|FG000|Overall Study|Death|2
998132|NCT01397890|2012358|FG001|Overall Study|Death|3
998133|NCT01397890|2012357|FG000|Overall Study|Lost to Follow-up|1
998134|NCT01397890|2012358|FG001|Overall Study|Lost to Follow-up|4
998135|NCT01397890|2012357|FG000|Overall Study|Condition under Investigation Worsened|1
998136|NCT01397890|2012358|FG001|Overall Study|Condition under Investigation Worsened|3
998137|NCT01397890|2012357|FG000|Overall Study|Adverse Event|1
998138|NCT01397890|2012358|FG001|Overall Study|Adverse Event|2
998139|NCT01397890|2012357|FG000|Overall Study|Severe Non-Compliance to Protocol|2
998140|NCT01397890|2012358|FG001|Overall Study|Severe Non-Compliance to Protocol|1
998141|NCT01397890|2012357|FG000|Overall Study|Others|2
998142|NCT01397890|2012358|FG001|Overall Study|Others|1
998143|NCT01398176|2012379|FG000|Overall Study|Lost to Follow-up|1
998144|NCT01398176|2012380|FG001|Overall Study|Lost to Follow-up|3
998145|NCT01398176|2012379|FG000|Overall Study|Physician Decision|2
998146|NCT01398176|2012380|FG001|Overall Study|Physician Decision|3
998147|NCT01398358|2012398|FG000|Overall Study|Lost to Follow-up|11
998148|NCT01398358|2012399|FG001|Overall Study|Lost to Follow-up|21
998149|NCT01398358|2012400|FG002|Overall Study|Lost to Follow-up|18
998150|NCT01398358|2012398|FG000|Overall Study|Withdrawal by Subject|3
998151|NCT01398358|2012399|FG001|Overall Study|Withdrawal by Subject|2
998152|NCT01398358|2012400|FG002|Overall Study|Withdrawal by Subject|2
998153|NCT01398358|2012398|FG000|Overall Study|no longer eligible|1
998154|NCT01398358|2012399|FG001|Overall Study|no longer eligible|0
998155|NCT01398358|2012400|FG002|Overall Study|no longer eligible|1
998156|NCT01398410|2012410|FG000|Overall Study|Adverse Event|12
998157|NCT01398410|2012411|FG001|Overall Study|Adverse Event|16
998158|NCT01398410|2012410|FG000|Overall Study|Participants Choice|8
998159|NCT01398410|2012411|FG001|Overall Study|Participants Choice|11
998160|NCT01398410|2012410|FG000|Overall Study|Inadequate Therapeutic Effect|2
998161|NCT01398410|2012411|FG001|Overall Study|Inadequate Therapeutic Effect|0
998162|NCT01398410|2012410|FG000|Overall Study|Other|36
998163|NCT01398410|2012411|FG001|Overall Study|Other|29
998164|NCT01398514|2012432|FG000|Overall Study|Adverse Event|1
998165|NCT01398514|2012433|FG001|Overall Study|Adverse Event|0
998166|NCT01398514|2012432|FG000|Overall Study|Non-compliance with study procedures|2
998167|NCT01398514|2012433|FG001|Overall Study|Non-compliance with study procedures|0
998168|NCT01398514|2012432|FG000|Overall Study|Physiologic non-responsiveness|1
998169|NCT01398514|2012433|FG001|Overall Study|Physiologic non-responsiveness|3
998170|NCT01398514|2012432|FG000|Overall Study|Failure to show a conditioned response|4
998171|NCT01398514|2012433|FG001|Overall Study|Failure to show a conditioned response|3
998172|NCT01398787|2012445|FG000|Overall Study|Adverse Event|1
998173|NCT01398956|2012464|FG000|Overall Study|Withdrawal by Subject|4
998174|NCT01398956|2012464|FG000|Overall Study|AE, non-serious non-fatal|4
998175|NCT01398956|2012464|FG000|Overall Study|Withdrawal Criteria No.3|1
998176|NCT01398956|2012464|FG000|Overall Study|Subject moved a long distance|1
998177|NCT01399047|2012493|FG000|Overall Study|Withdrawal by Subject|0
998178|NCT01399047|2012494|FG001|Overall Study|Withdrawal by Subject|1
998179|NCT01399099|2012502|FG000|Overall Study|Lost to Follow-up|11
998180|NCT01399099|2012502|FG000|Overall Study|Physician Decision|1
998181|NCT01399099|2012502|FG000|Overall Study|Protocol Violation|1
998182|NCT01399099|2012502|FG000|Overall Study|Skin Irritation|13
998183|NCT01399099|2012502|FG000|Overall Study|Infection|1
998184|NCT01399099|2012502|FG000|Overall Study|Miscellaneous|4
998185|NCT01399125|2012509|FG000|Overall Study|Adverse Event|32
998186|NCT01399125|2012510|FG001|Overall Study|Adverse Event|30
998187|NCT01399125|2012509|FG000|Overall Study|Abnormal Lab values|0
998188|NCT01399125|2012510|FG001|Overall Study|Abnormal Lab values|1
998189|NCT01399125|2012509|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
998190|NCT01399125|2012510|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4
998191|NCT01399125|2012509|FG000|Overall Study|Withdrawal by Subject|5
998192|NCT01399125|2012510|FG001|Overall Study|Withdrawal by Subject|8
998193|NCT01399125|2012509|FG000|Overall Study|Lost to Follow-up|2
998194|NCT01399125|2012510|FG001|Overall Study|Lost to Follow-up|3
998195|NCT01399125|2012509|FG000|Overall Study|Administrative Problems|7
998196|NCT01399125|2012510|FG001|Overall Study|Administrative Problems|11
998197|NCT01399125|2012509|FG000|Overall Study|Death|0
998198|NCT01399125|2012510|FG001|Overall Study|Death|1
998199|NCT01399125|2012509|FG000|Overall Study|Protocol Deviation|5
998200|NCT01399125|2012510|FG001|Overall Study|Protocol Deviation|2
998201|NCT01399190|2012516|FG000|Overall Study|Not Eligible for Final Analysis|5
998202|NCT01399190|2012516|FG000|Overall Study|Adverse Event|8
998203|NCT01399190|2012516|FG000|Overall Study|Participant's Request|5
998204|NCT01399190|2012516|FG000|Overall Study|Physician Decision|2
998205|NCT01399372|2012537|FG000|Overall Study|Protocol Violation|3
998206|NCT01399372|2012538|FG001|Overall Study|Protocol Violation|1
998207|NCT01399593|2012546|FG000|Overall Study|Physician Decision|1
998208|NCT01399593|2012547|FG001|Overall Study|Physician Decision|0
998209|NCT01399593|2012546|FG000|Overall Study|Adverse Event|1
998210|NCT01399593|2012547|FG001|Overall Study|Adverse Event|0
998211|NCT01399593|2012546|FG000|Overall Study|Death|1
998212|NCT01399593|2012547|FG001|Overall Study|Death|1
998213|NCT01399593|2012546|FG000|Overall Study|Transplantectomy|0
998214|NCT01399593|2012547|FG001|Overall Study|Transplantectomy|1
998215|NCT01399619|2012555|FG000|Overall Study|Adverse Event|10
998216|NCT01399619|2012556|FG001|Overall Study|Adverse Event|0
998217|NCT01399619|2012557|FG002|Overall Study|Adverse Event|4
998218|NCT01399619|2012558|FG003|Overall Study|Adverse Event|10
998219|NCT01399619|2012555|FG000|Overall Study|Lack of Efficacy|9
998220|NCT01399619|2012556|FG001|Overall Study|Lack of Efficacy|0
998221|NCT01399619|2012557|FG002|Overall Study|Lack of Efficacy|5
998222|NCT01399619|2012558|FG003|Overall Study|Lack of Efficacy|0
998223|NCT01399619|2012555|FG000|Overall Study|Withdrawal by Subject|6
998224|NCT01399619|2012556|FG001|Overall Study|Withdrawal by Subject|0
998225|NCT01399619|2012557|FG002|Overall Study|Withdrawal by Subject|3
998226|NCT01399619|2012558|FG003|Overall Study|Withdrawal by Subject|4
998227|NCT01399619|2012555|FG000|Overall Study|Protocol Violation|0
998228|NCT01399619|2012556|FG001|Overall Study|Protocol Violation|0
998229|NCT01399619|2012557|FG002|Overall Study|Protocol Violation|0
998230|NCT01399619|2012558|FG003|Overall Study|Protocol Violation|1
998231|NCT01399619|2012555|FG000|Overall Study|Not treated|0
998232|NCT01399619|2012556|FG001|Overall Study|Not treated|0
998233|NCT01399619|2012557|FG002|Overall Study|Not treated|0
998234|NCT01399619|2012558|FG003|Overall Study|Not treated|2
998235|NCT01399697|2012576|FG000|Overall Study|Adverse Event|13
998236|NCT01399697|2012577|FG001|Overall Study|Adverse Event|3
998237|NCT01399697|2012578|FG002|Overall Study|Adverse Event|1
998238|NCT01399697|2012576|FG000|Overall Study|Lost to Follow-up|2
998239|NCT01399697|2012577|FG001|Overall Study|Lost to Follow-up|0
998240|NCT01399697|2012578|FG002|Overall Study|Lost to Follow-up|0
998241|NCT01399697|2012576|FG000|Overall Study|Withdrawal by Subject|8
998242|NCT01399697|2012577|FG001|Overall Study|Withdrawal by Subject|0
998243|NCT01399697|2012578|FG002|Overall Study|Withdrawal by Subject|0
998244|NCT01399697|2012576|FG000|Overall Study|Investigator Decisión|1
998245|NCT01399697|2012577|FG001|Overall Study|Investigator Decisión|0
998246|NCT01399697|2012578|FG002|Overall Study|Investigator Decisión|2
998247|NCT01399697|2012576|FG000|Overall Study|Lack of Efficacy|9
998248|NCT01399697|2012577|FG001|Overall Study|Lack of Efficacy|0
998249|NCT01399697|2012578|FG002|Overall Study|Lack of Efficacy|1
998250|NCT01399697|2012576|FG000|Overall Study|Protocol Violation|2
998251|NCT01399697|2012577|FG001|Overall Study|Protocol Violation|0
998252|NCT01399697|2012578|FG002|Overall Study|Protocol Violation|0
998253|NCT01399697|2012576|FG000|Overall Study|Non-Compliant|1
998254|NCT01399697|2012577|FG001|Overall Study|Non-Compliant|0
998255|NCT01399697|2012578|FG002|Overall Study|Non-Compliant|0
998256|NCT01399697|2012576|FG000|Overall Study|Inclusion Error|2
998257|NCT01399697|2012577|FG001|Overall Study|Inclusion Error|0
998258|NCT01399697|2012578|FG002|Overall Study|Inclusion Error|0
998259|NCT01399697|2012576|FG000|Overall Study|Positive result for hepatitis B|1
998260|NCT01399697|2012577|FG001|Overall Study|Positive result for hepatitis B|0
998261|NCT01399697|2012578|FG002|Overall Study|Positive result for hepatitis B|0
998262|NCT01399697|2012576|FG000|Overall Study|Clinical RA remission|1
998263|NCT01399697|2012577|FG001|Overall Study|Clinical RA remission|0
998264|NCT01399697|2012578|FG002|Overall Study|Clinical RA remission|0
998265|NCT01399697|2012576|FG000|Overall Study|Sponsor Decision|1
998266|NCT01399697|2012577|FG001|Overall Study|Sponsor Decision|0
998267|NCT01399697|2012578|FG002|Overall Study|Sponsor Decision|0
998268|NCT01399723|2012591|FG000|Overall Study|Lost to Follow-up|0
998269|NCT01399723|2012592|FG001|Overall Study|Lost to Follow-up|1
998270|NCT01399736|2012601|FG000|Overall Study|Withdrawal by Subject|4
998271|NCT01399736|2012602|FG001|Overall Study|Withdrawal by Subject|2
998272|NCT01399736|2012601|FG000|Overall Study|Lost to Follow-up|0
998273|NCT01399736|2012602|FG001|Overall Study|Lost to Follow-up|2
998274|NCT01399788|2012616|FG000|First Intervention Period|Adverse Event|1
998275|NCT01399788|2012617|FG001|First Intervention Period|Adverse Event|0
998276|NCT01399905|2012643|FG000|Overall Study|Withdrawal by Subject|1
998277|NCT01399905|2012644|FG001|Overall Study|Withdrawal by Subject|1
998278|NCT01400113|2012657|FG000|Overall Study|Withdrawal by Subject|1
998279|NCT01400113|2012658|FG001|Overall Study|Withdrawal by Subject|1
998280|NCT01400139|2012664|FG000|HYD Core Study|Adverse Event|210
998281|NCT01400139|2012664|FG000|HYD Core Study|Lack of Efficacy|59
998282|NCT01400139|2012664|FG000|HYD Core Study|Withdrawal by Subject|114
998283|NCT01400139|2012664|FG000|HYD Core Study|Lost to Follow-up|39
998284|NCT01400139|2012664|FG000|HYD Core Study|Confirmed or suspected diversion|20
998285|NCT01400139|2012664|FG000|HYD Core Study|Administrative|56
998286|NCT01400139|2012664|FG000|HYD Core Study|Did not qualify for Maintenance Period|14
998287|NCT01400139|2012664|FG000|HYD Extension Period|Adverse Event|8
998288|NCT01400139|2012664|FG000|HYD Extension Period|Withdrawal by Subject|5
998289|NCT01400139|2012664|FG000|HYD Extension Period|Administrative|10
998290|NCT01400243|2012672|FG000|Overall Study|Protocol Violation|8
998291|NCT01400243|2012673|FG001|Overall Study|Protocol Violation|11
998292|NCT01400412|2012683|FG000|Overall Study|Lost to Follow-up|4
998293|NCT01400412|2012684|FG001|Overall Study|Lost to Follow-up|7
998294|NCT01400412|2012683|FG000|Overall Study|Withdrawal by Subject|3
998295|NCT01400412|2012684|FG001|Overall Study|Withdrawal by Subject|4
998296|NCT01400412|2012683|FG000|Overall Study|Unable to complete|3
998297|NCT01400412|2012684|FG001|Overall Study|Unable to complete|3
998298|NCT01400412|2012683|FG000|Overall Study|Never started study treatment|0
998299|NCT01400412|2012684|FG001|Overall Study|Never started study treatment|3
998300|NCT01400425|2012692|FG000|Overall Study|Withdrawal by Subject|10
998301|NCT01400451|2012701|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2
998302|NCT01400451|2012702|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1
998303|NCT01400451|2012703|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1
998304|NCT01400451|2012701|FG000|Combination Treatment (or Intended)|Drug Toxicity|0
998305|NCT01400451|2012702|FG001|Combination Treatment (or Intended)|Drug Toxicity|1
998306|NCT01400451|2012703|FG002|Combination Treatment (or Intended)|Drug Toxicity|0
998307|NCT01400451|2012701|FG000|Combination Treatment (or Intended)|Adverse Event|1
998308|NCT01400451|2012702|FG001|Combination Treatment (or Intended)|Adverse Event|0
998309|NCT01400451|2012703|FG002|Combination Treatment (or Intended)|Adverse Event|0
998310|NCT01400451|2012701|FG000|Combination Treatment (or Intended)|Disease Progression|3
998311|NCT01400451|2012702|FG001|Combination Treatment (or Intended)|Disease Progression|1
998312|NCT01400451|2012703|FG002|Combination Treatment (or Intended)|Disease Progression|1
998313|NCT01400451|2012701|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0
998314|NCT01400451|2012702|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1
998315|NCT01400451|2012703|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0
998316|NCT01400503|2012725|FG000|Overall Study|Withdrawal by Subject|1
998317|NCT01400503|2012725|FG000|Overall Study|Study Terminated by Sponsor|58
998318|NCT01400503|2012725|FG000|Overall Study|Other|1
998319|NCT01400516|2012731|FG000|Primary Trial|Withdrawal by Subject|0
998320|NCT01400516|2012732|FG001|Primary Trial|Withdrawal by Subject|2
998321|NCT01400698|2012742|FG000|Overall Study|Lost to Follow-up|2
998322|NCT01400698|2012743|FG001|Overall Study|Lost to Follow-up|5
998323|NCT01400698|2012744|FG002|Overall Study|Lost to Follow-up|2
998324|NCT01400698|2012745|FG003|Overall Study|Lost to Follow-up|1
998325|NCT01400698|2012746|FG004|Overall Study|Lost to Follow-up|4
998326|NCT01400698|2012747|FG005|Overall Study|Lost to Follow-up|3
998327|NCT01400698|2012742|FG000|Overall Study|Withdrawal by Subject|8
998328|NCT01400698|2012743|FG001|Overall Study|Withdrawal by Subject|2
998329|NCT01400698|2012744|FG002|Overall Study|Withdrawal by Subject|0
998330|NCT01400698|2012745|FG003|Overall Study|Withdrawal by Subject|4
998331|NCT01400698|2012746|FG004|Overall Study|Withdrawal by Subject|1
998332|NCT01400698|2012747|FG005|Overall Study|Withdrawal by Subject|3
998333|NCT01400698|2012742|FG000|Overall Study|Protocol Violation|0
998334|NCT01400698|2012743|FG001|Overall Study|Protocol Violation|1
998335|NCT01400698|2012744|FG002|Overall Study|Protocol Violation|0
998336|NCT01400698|2012745|FG003|Overall Study|Protocol Violation|0
998337|NCT01400698|2012746|FG004|Overall Study|Protocol Violation|1
998338|NCT01400698|2012747|FG005|Overall Study|Protocol Violation|0
998339|NCT01400698|2012742|FG000|Overall Study|Non-compliance|0
998340|NCT01400698|2012743|FG001|Overall Study|Non-compliance|1
998341|NCT01400698|2012744|FG002|Overall Study|Non-compliance|0
998342|NCT01400698|2012745|FG003|Overall Study|Non-compliance|1
998343|NCT01400698|2012746|FG004|Overall Study|Non-compliance|0
998344|NCT01400698|2012747|FG005|Overall Study|Non-compliance|0
998345|NCT01400698|2012742|FG000|Overall Study|Adverse Event|1
998346|NCT01400698|2012743|FG001|Overall Study|Adverse Event|0
998347|NCT01400698|2012744|FG002|Overall Study|Adverse Event|0
998348|NCT01400698|2012745|FG003|Overall Study|Adverse Event|0
998349|NCT01400698|2012746|FG004|Overall Study|Adverse Event|0
998350|NCT01400698|2012747|FG005|Overall Study|Adverse Event|0
998351|NCT01400698|2012742|FG000|Overall Study|Other|4
998352|NCT01400698|2012743|FG001|Overall Study|Other|2
998353|NCT01400698|2012744|FG002|Overall Study|Other|0
998354|NCT01400698|2012745|FG003|Overall Study|Other|2
998355|NCT01400698|2012746|FG004|Overall Study|Other|1
998356|NCT01400698|2012747|FG005|Overall Study|Other|0
998357|NCT01400815|2012759|FG000|Overall Study|Adverse Event|3
998358|NCT01400815|2012760|FG001|Overall Study|Adverse Event|0
998359|NCT01400815|2012759|FG000|Overall Study|Death|0
998360|NCT01400815|2012760|FG001|Overall Study|Death|1
998361|NCT01400815|2012759|FG000|Overall Study|Lost to Follow-up|18
998362|NCT01400815|2012760|FG001|Overall Study|Lost to Follow-up|11
998363|NCT01400815|2012759|FG000|Overall Study|Protocol Violation|0
998364|NCT01400815|2012760|FG001|Overall Study|Protocol Violation|1
998365|NCT01400815|2012759|FG000|Overall Study|Physician Decision|1
998366|NCT01400815|2012760|FG001|Overall Study|Physician Decision|0
998367|NCT01400815|2012759|FG000|Overall Study|Withdrawal by Subject|15
998368|NCT01400815|2012760|FG001|Overall Study|Withdrawal by Subject|8
998369|NCT01400815|2012759|FG000|Overall Study|Subject in jail|1
998370|NCT01400815|2012760|FG001|Overall Study|Subject in jail|0
998371|NCT01400841|2012766|FG000|Initial Study Phase (6 Months)|Death|1
998372|NCT01400841|2012766|FG000|Extended Study Phase (2 Years)|Adverse Event|2
998373|NCT01400893|2012776|FG000|Overall Study|Death|27
998374|NCT01400893|2012777|FG001|Overall Study|Death|21
998375|NCT01400893|2012776|FG000|Overall Study|Lost to Follow-up|0
998376|NCT01400893|2012777|FG001|Overall Study|Lost to Follow-up|6
998377|NCT01400919|2012798|FG000|Overall Study|Withdrawal by Subject|4
998378|NCT01400919|2012798|FG000|Overall Study|Lost to Follow-up|2
998379|NCT01400919|2012798|FG000|Overall Study|Missed visit|2
998380|NCT01400932|2012804|FG000|Overall Study|Adverse Event|10
998381|NCT01400932|2012805|FG001|Overall Study|Adverse Event|5
998382|NCT01400932|2012804|FG000|Overall Study|Lack of Efficacy|0
998383|NCT01400932|2012805|FG001|Overall Study|Lack of Efficacy|3
998384|NCT01400932|2012804|FG000|Overall Study|Withdrawal by Subject|2
998385|NCT01400932|2012805|FG001|Overall Study|Withdrawal by Subject|6
998386|NCT01400932|2012804|FG000|Overall Study|Lost to Follow-up|1
998387|NCT01400932|2012805|FG001|Overall Study|Lost to Follow-up|0
998388|NCT01400932|2012804|FG000|Overall Study|Protocol Deviation|0
998389|NCT01400932|2012805|FG001|Overall Study|Protocol Deviation|1
998390|NCT01400932|2012804|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
998391|NCT01400932|2012805|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
998392|NCT01400958|2012813|FG000|Overall Study|Physician Decision|0
998393|NCT01400958|2012814|FG001|Overall Study|Physician Decision|1
998394|NCT01400958|2012813|FG000|Overall Study|Withdrawal by Subject|0
998395|NCT01400958|2012814|FG001|Overall Study|Withdrawal by Subject|1
998396|NCT01400958|2012813|FG000|Overall Study|Adverse Event|1
998397|NCT01400958|2012814|FG001|Overall Study|Adverse Event|0
998398|NCT01400971|2012820|FG000|Overall Study|Death|82
998399|NCT01400971|2012820|FG000|Overall Study|Lost to Follow-up|196
998400|NCT01400971|2012820|FG000|Overall Study|Lost to follow up + Subject Decision|2
998401|NCT01400971|2012820|FG000|Overall Study|Physician Decision|57
998402|NCT01400971|2012820|FG000|Overall Study|Withdrawal by Subject|158
998403|NCT01400971|2012820|FG000|Overall Study|Other|422
998404|NCT01401010|2012826|FG000|Overall Study|Could not interpret assay results|1
998405|NCT01401010|2012827|FG001|Overall Study|Could not interpret assay results|0
998406|NCT01401062|2012846|FG000|Overall Study|Death|9
998407|NCT01401062|2012847|FG001|Overall Study|Death|7
998408|NCT01401062|2012846|FG000|Overall Study|Physician Decision|1
998409|NCT01401062|2012847|FG001|Overall Study|Physician Decision|0
998410|NCT01401062|2012846|FG000|Overall Study|Withdrawal by Subject|1
998411|NCT01401062|2012847|FG001|Overall Study|Withdrawal by Subject|1
998412|NCT01401153|2012864|FG000|First Test Day|Learning disabilities; illness|1
998413|NCT01401153|2012865|FG001|First Test Day|Learning disabilities; illness|10
998414|NCT01401153|2012864|FG000|Second Test Day|illness|0
998415|NCT01401153|2012865|FG001|Second Test Day|illness|5
998416|NCT01401283|2012913|FG000|Overall Study|surgery cancelled|5
998417|NCT01401283|2012914|FG001|Overall Study|surgery cancelled|8
998418|NCT01401283|2012913|FG000|Overall Study|preoperative arrhythmia|5
998419|NCT01401283|2012914|FG001|Overall Study|preoperative arrhythmia|0
998420|NCT01401283|2012913|FG000|Overall Study|no central venous access|0
998421|NCT01401283|2012914|FG001|Overall Study|no central venous access|1
998422|NCT01401283|2012913|FG000|Overall Study|suspicion of malignant hyperthermia|0
998423|NCT01401283|2012914|FG001|Overall Study|suspicion of malignant hyperthermia|1
998424|NCT01401322|2012920|FG000|Overall Study|Withdrawal by Subject|1
998425|NCT01401322|2012920|FG000|Overall Study|Physician Decision|1
998426|NCT01401361|2012924|FG000|Overall Study|Withdrawal by Subject|16
998427|NCT01401361|2012924|FG000|Overall Study|Lack of Efficacy|6
998428|NCT01401361|2012924|FG000|Overall Study|Physician Decision|1
998429|NCT01401361|2012924|FG000|Overall Study|Lost to Follow-up|3
998430|NCT01401361|2012924|FG000|Overall Study|Subject/family decision post procedure|2
998431|NCT01401452|2012928|FG000|Overall Study|Adverse reaction|9
998432|NCT01401452|2012928|FG000|Overall Study|Lost to Follow-up|12
998433|NCT01401452|2012928|FG000|Overall Study|Lack of Efficacy|30
998434|NCT01401452|2012928|FG000|Overall Study|Participant developed breast cancer|1
998435|NCT01401452|2012928|FG000|Overall Study|Tx stopped due to financial reasons|1
998436|NCT01401452|2012928|FG000|Overall Study|Tx stopped by psychiatrist|1
998437|NCT01401452|2012928|FG000|Overall Study|No more visits within the 36 wk followup|4
998438|NCT01401452|2012928|FG000|Overall Study|Subject did not come to follow up visits|2
998439|NCT01401452|2012928|FG000|Overall Study|Subject didn't return for routine visits|1
998440|NCT01401452|2012928|FG000|Overall Study|Subject moved to another city|1
998441|NCT01401452|2012928|FG000|Overall Study|Subject's wife wants to get pregnant|1
998442|NCT01401452|2012928|FG000|Overall Study|Psoriatic arthritis|1
998443|NCT01401452|2012928|FG000|Overall Study|Participant stopped Tx|2
998444|NCT01401452|2012928|FG000|Overall Study|Discontinuation for personal reasons|1
998445|NCT01401452|2012928|FG000|Overall Study|Treatment failure|1
998446|NCT01401452|2012928|FG000|Overall Study|Unsatisfactory output|1
998447|NCT01401452|2012928|FG000|Overall Study|Subject withdrew because of Tx success|1
998448|NCT01401452|2012928|FG000|Overall Study|Subject chose to discontinue treatment|1
998449|NCT01401452|2012928|FG000|Overall Study|Participant withdrew consent|1
998450|NCT01401465|2012934|FG000|Treatment Period 1|Adverse Event|4
998451|NCT01401465|2012935|FG001|Treatment Period 1|Adverse Event|1
998452|NCT01401465|2012934|FG000|Treatment Period 1|Pregnancy|0
998453|NCT01401465|2012935|FG001|Treatment Period 1|Pregnancy|1
998454|NCT01401465|2012934|FG000|Treatment Period 1|Protocol Violation|5
998455|NCT01401465|2012935|FG001|Treatment Period 1|Protocol Violation|0
998456|NCT01401465|2012934|FG000|Treatment Period 1|Withdrawal by Subject|1
998457|NCT01401465|2012935|FG001|Treatment Period 1|Withdrawal by Subject|4
998458|NCT01401465|2012934|FG000|Treatment Period 1|Non-Compliance to Study Drug|1
998459|NCT01401465|2012935|FG001|Treatment Period 1|Non-Compliance to Study Drug|0
998460|NCT01401465|2012934|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3
998461|NCT01401465|2012935|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9
998462|NCT01401465|2012934|FG000|Treatment Period 1|Scheduling Difficulties|1
998463|NCT01401465|2012935|FG001|Treatment Period 1|Scheduling Difficulties|1
998464|NCT01401465|2012934|FG000|Treatment Period 2|Lost to Follow-up|0
998465|NCT01401465|2012935|FG001|Treatment Period 2|Lost to Follow-up|1
998466|NCT01401465|2012934|FG000|Treatment Period 2|Withdrawal by Subject|0
998467|NCT01401465|2012935|FG001|Treatment Period 2|Withdrawal by Subject|1
998468|NCT01401478|2012944|FG000|Overall Study|Study drug not available|6
998469|NCT01401478|2012944|FG000|Overall Study|Adverse Event|5
998470|NCT01401478|2012944|FG000|Overall Study|Hyperphosphatemia|5
998471|NCT01401478|2012944|FG000|Overall Study|Lost to Follow-up|5
998472|NCT01401478|2012944|FG000|Overall Study|Kidney transplantation|3
998473|NCT01401478|2012944|FG000|Overall Study|Withdrawal by Subject|3
998474|NCT01401478|2012944|FG000|Overall Study|Blood samples not available|1
998475|NCT01401478|2012944|FG000|Overall Study|Hyperphosphatemia and adverse event|1
998476|NCT01401478|2012944|FG000|Overall Study|Low intact parathyroid hormone|1
998477|NCT01401478|2012944|FG000|Overall Study|Serious adverse event|1
998478|NCT01401530|2012964|FG000|Overall Study|Disease Progression|1
998479|NCT01401530|2012965|FG001|Overall Study|Disease Progression|2
998480|NCT01401530|2012966|FG002|Overall Study|Disease Progression|1
998481|NCT01401530|2012964|FG000|Overall Study|Adverse Event|1
998482|NCT01401530|2012965|FG001|Overall Study|Adverse Event|1
998483|NCT01401530|2012966|FG002|Overall Study|Adverse Event|1
998484|NCT01401530|2012964|FG000|Overall Study|Participant Choice|1
998485|NCT01401530|2012965|FG001|Overall Study|Participant Choice|2
998486|NCT01401530|2012966|FG002|Overall Study|Participant Choice|1
998487|NCT01401530|2012964|FG000|Overall Study|Physician Decision|0
998488|NCT01401530|2012965|FG001|Overall Study|Physician Decision|1
998489|NCT01401530|2012966|FG002|Overall Study|Physician Decision|0
998490|NCT01401647|2013018|FG000|Overall Study|Withdrawal by Subject|1
998491|NCT01401647|2013019|FG001|Overall Study|Withdrawal by Subject|5
998492|NCT01401647|2013020|FG002|Overall Study|Withdrawal by Subject|2
998493|NCT01401647|2013018|FG000|Overall Study|Lost to Follow-up|3
998494|NCT01401647|2013019|FG001|Overall Study|Lost to Follow-up|3
998495|NCT01401647|2013020|FG002|Overall Study|Lost to Follow-up|1
998496|NCT01401842|2013034|FG000|Overall Study|Withdrawal by Subject|3
998497|NCT01401842|2013035|FG001|Overall Study|Withdrawal by Subject|2
998498|NCT01401842|2013034|FG000|Overall Study|academic reason|4
998499|NCT01401842|2013035|FG001|Overall Study|academic reason|1
998500|NCT01401842|2013034|FG000|Overall Study|changed companies|20
998501|NCT01401842|2013035|FG001|Overall Study|changed companies|34
998502|NCT01401842|2013034|FG000|Overall Study|discharged from US Army|3
998503|NCT01401842|2013035|FG001|Overall Study|discharged from US Army|4
998504|NCT01401842|2013034|FG000|Overall Study|invalid follow-up strength data|1
998505|NCT01401842|2013035|FG001|Overall Study|invalid follow-up strength data|4
998506|NCT01401842|2013034|FG000|Overall Study|on profile|9
998507|NCT01401842|2013035|FG001|Overall Study|on profile|5
998508|NCT01401842|2013034|FG000|Overall Study|other/unknown|28
998509|NCT01401842|2013035|FG001|Overall Study|other/unknown|17
998510|NCT01401959|2013055|FG000|Enrolled|Withdrawal by Subject|1
998511|NCT01401959|2013056|FG001|Enrolled|Withdrawal by Subject|0
998512|NCT01401959|2013057|FG002|Enrolled|Withdrawal by Subject|0
998513|NCT01401959|2013055|FG000|Treated|Disease Progression|2
998514|NCT01401959|2013056|FG001|Treated|Disease Progression|2
998515|NCT01401959|2013057|FG002|Treated|Disease Progression|1
998516|NCT01401959|2013055|FG000|Treated|Adverse Event|4
998517|NCT01401959|2013056|FG001|Treated|Adverse Event|3
998518|NCT01401959|2013057|FG002|Treated|Adverse Event|2
998519|NCT01401959|2013055|FG000|Treated|Withdrawal by Subject|1
998520|NCT01401959|2013056|FG001|Treated|Withdrawal by Subject|2
998521|NCT01401959|2013057|FG002|Treated|Withdrawal by Subject|2
998522|NCT01401959|2013055|FG000|Treated|Protocol Violation|0
998523|NCT01401959|2013056|FG001|Treated|Protocol Violation|1
998524|NCT01401959|2013057|FG002|Treated|Protocol Violation|0
998525|NCT01402011|2013070|FG000|Delayed Treatment Period|Withdrawal by Subject|1
998526|NCT01402011|2013071|FG001|Delayed Treatment Period|Withdrawal by Subject|0
998527|NCT01402011|2013072|FG002|Delayed Treatment Period|Withdrawal by Subject|0
998528|NCT01402011|2013070|FG000|Active Treatment Period|Withdrawal by Subject|1
998529|NCT01402011|2013071|FG001|Active Treatment Period|Withdrawal by Subject|3
998530|NCT01402011|2013072|FG002|Active Treatment Period|Withdrawal by Subject|0
998531|NCT01402011|2013070|FG000|Nine Month Follow-up|Withdrawal by Subject|0
998532|NCT01402011|2013071|FG001|Nine Month Follow-up|Withdrawal by Subject|1
998533|NCT01402011|2013072|FG002|Nine Month Follow-up|Withdrawal by Subject|0
998534|NCT01402063|2013094|FG000|Overall Study|Withdrawal by Subject|3
998535|NCT01402063|2013095|FG001|Overall Study|Withdrawal by Subject|3
998536|NCT01402102|2013103|FG000|Overall Study|Protocol Violation|1
998537|NCT01402102|2013104|FG001|Overall Study|Protocol Violation|0
998538|NCT01402102|2013103|FG000|Overall Study|Insufficiency of compliance|1
998539|NCT01402102|2013104|FG001|Overall Study|Insufficiency of compliance|1
998540|NCT01402102|2013103|FG000|Overall Study|Withdrawal by Subject|0
998541|NCT01402102|2013104|FG001|Overall Study|Withdrawal by Subject|2
998542|NCT01402284|2013140|FG000|Overall Study|Withdrawal consent|2
998543|NCT01402284|2013140|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1
998544|NCT01402284|2013140|FG000|Overall Study|Physician Decision|1
998545|NCT01402284|2013140|FG000|Overall Study|Disease progression on study|10
998546|NCT01402492|2013181|FG000|Overall Study|Withdrawal by Subject|17
998547|NCT01402492|2013182|FG001|Overall Study|Withdrawal by Subject|11
998548|NCT01402492|2013183|FG002|Overall Study|Withdrawal by Subject|11
998549|NCT01402492|2013181|FG000|Overall Study|Adverse Event|2
998550|NCT01402492|2013182|FG001|Overall Study|Adverse Event|3
998551|NCT01402492|2013183|FG002|Overall Study|Adverse Event|4
998552|NCT01402492|2013181|FG000|Overall Study|Physician Decision|0
998553|NCT01402492|2013182|FG001|Overall Study|Physician Decision|3
998554|NCT01402492|2013183|FG002|Overall Study|Physician Decision|0
998555|NCT01402492|2013181|FG000|Overall Study|Incarcerated (N=3)|2
998556|NCT01402492|2013182|FG001|Overall Study|Incarcerated (N=3)|0
998557|NCT01402492|2013183|FG002|Overall Study|Incarcerated (N=3)|1
998558|NCT01402544|2013191|FG000|Overall Study|Withdrawal by Subject|6
998559|NCT01402570|2013195|FG000|Overall Study|Adverse Event|1
998560|NCT01402700|2013200|FG000|Overall Study|Death|3
998561|NCT01402700|2013200|FG000|Overall Study|Withdrawal by Subject|3
998562|NCT01402700|2013200|FG000|Overall Study|Missed Visit|1
998563|NCT01402817|2013204|FG000|Overall Study|Withdrawal by Subject|3
998564|NCT01402817|2013204|FG000|Overall Study|Study Suspended by FDA|8
998565|NCT01402869|2013212|FG000|Overall Study|Required Tooth Extraction|0
998566|NCT01402869|2013213|FG001|Overall Study|Required Tooth Extraction|0
998567|NCT01402869|2013214|FG002|Overall Study|Required Tooth Extraction|1
998568|NCT01402908|2013224|FG000|Overall Study|Withdrawal by Subject|30
998569|NCT01402908|2013225|FG001|Overall Study|Withdrawal by Subject|17
998570|NCT01402908|2013224|FG000|Overall Study|Lost to Follow-up|3
998571|NCT01402908|2013225|FG001|Overall Study|Lost to Follow-up|1
998572|NCT01402908|2013224|FG000|Overall Study|Physician Decision|1
998573|NCT01402908|2013225|FG001|Overall Study|Physician Decision|0
998574|NCT01402947|2013233|FG000|First Intervention|Adverse Event|0
998575|NCT01402947|2013234|FG001|First Intervention|Adverse Event|1
998576|NCT01402986|2013244|FG000|Overall Study|Withdrawal by Subject|7
998577|NCT01402986|2013245|FG001|Overall Study|Withdrawal by Subject|10
998578|NCT01402986|2013246|FG002|Overall Study|Withdrawal by Subject|7
998579|NCT01402986|2013247|FG003|Overall Study|Withdrawal by Subject|13
998580|NCT01402986|2013244|FG000|Overall Study|Death|0
998581|NCT01402986|2013245|FG001|Overall Study|Death|0
998582|NCT01402986|2013246|FG002|Overall Study|Death|0
998583|NCT01402986|2013247|FG003|Overall Study|Death|2
998584|NCT01402986|2013244|FG000|Overall Study|Lost to Follow-up|0
998585|NCT01402986|2013245|FG001|Overall Study|Lost to Follow-up|0
998586|NCT01402986|2013246|FG002|Overall Study|Lost to Follow-up|0
998587|NCT01402986|2013247|FG003|Overall Study|Lost to Follow-up|1
998588|NCT01402986|2013244|FG000|Overall Study|Other|2
998589|NCT01402986|2013245|FG001|Overall Study|Other|5
998590|NCT01402986|2013246|FG002|Overall Study|Other|1
998591|NCT01402986|2013247|FG003|Overall Study|Other|6
998592|NCT01403051|2013259|FG000|Overall Study|Protocol Violation|2
998593|NCT01403051|2013260|FG001|Overall Study|Protocol Violation|0
998594|NCT01403051|2013259|FG000|Overall Study|Death|1
998595|NCT01403051|2013260|FG001|Overall Study|Death|0
998596|NCT01403051|2013259|FG000|Overall Study|Withdrawal by Subject|2
998597|NCT01403051|2013260|FG001|Overall Study|Withdrawal by Subject|1
998598|NCT01403051|2013259|FG000|Overall Study|Lost to Follow-up|5
998599|NCT01403051|2013260|FG001|Overall Study|Lost to Follow-up|5
998600|NCT01403064|2013271|FG000|Overall Study|Death|0
998601|NCT01403064|2013272|FG001|Overall Study|Death|0
998602|NCT01403064|2013273|FG002|Overall Study|Death|1
998603|NCT01403064|2013274|FG003|Overall Study|Death|1
998604|NCT01403064|2013271|FG000|Overall Study|Withdrawal by Subject|0
998605|NCT01403064|2013272|FG001|Overall Study|Withdrawal by Subject|0
998606|NCT01403064|2013273|FG002|Overall Study|Withdrawal by Subject|1
998607|NCT01403064|2013274|FG003|Overall Study|Withdrawal by Subject|1
998608|NCT01403064|2013271|FG000|Overall Study|Other|1
998609|NCT01403064|2013272|FG001|Overall Study|Other|0
998610|NCT01403064|2013273|FG002|Overall Study|Other|2
998611|NCT01403064|2013274|FG003|Overall Study|Other|1
998612|NCT01403116|2013295|FG000|Overall Study|Adverse Event|7
998613|NCT01403116|2013296|FG001|Overall Study|Adverse Event|4
998614|NCT01403116|2013295|FG000|Overall Study|Lost to Follow-up|7
998615|NCT01403116|2013296|FG001|Overall Study|Lost to Follow-up|5
998616|NCT01403116|2013295|FG000|Overall Study|Withdrawal by Subject|12
998617|NCT01403116|2013296|FG001|Overall Study|Withdrawal by Subject|15
998618|NCT01403116|2013295|FG000|Overall Study|Non-compliance of study drug|3
998619|NCT01403116|2013296|FG001|Overall Study|Non-compliance of study drug|0
998620|NCT01403116|2013295|FG000|Overall Study|Protocol Violation|0
998621|NCT01403116|2013296|FG001|Overall Study|Protocol Violation|1
998622|NCT01403116|2013295|FG000|Overall Study|undisclosed Hx of Prostate Ca|1
998623|NCT01403116|2013296|FG001|Overall Study|undisclosed Hx of Prostate Ca|0
998624|NCT01403116|2013295|FG000|Overall Study|Hct >54%|2
998625|NCT01403116|2013296|FG001|Overall Study|Hct >54%|0
998626|NCT01403116|2013295|FG000|Overall Study|unable to keep appointments|0
998627|NCT01403116|2013296|FG001|Overall Study|unable to keep appointments|2
998628|NCT01403610|2013336|FG000|Overall Study|Withdrawal by Subject|2
998629|NCT01403610|2013337|FG001|Overall Study|Withdrawal by Subject|0
998630|NCT01403610|2013338|FG002|Overall Study|Withdrawal by Subject|0
998631|NCT01403610|2013339|FG003|Overall Study|Withdrawal by Subject|0
998632|NCT01403610|2013336|FG000|Overall Study|Didn't recover from surgery sufficiently|0
998633|NCT01403610|2013337|FG001|Overall Study|Didn't recover from surgery sufficiently|3
998634|NCT01403610|2013338|FG002|Overall Study|Didn't recover from surgery sufficiently|0
998635|NCT01403610|2013339|FG003|Overall Study|Didn't recover from surgery sufficiently|0
998636|NCT01403805|2013351|FG000|Overall Study|Withdrawal by Subject|0
998637|NCT01403805|2013352|FG001|Overall Study|Withdrawal by Subject|4
998638|NCT01403805|2013351|FG000|Overall Study|Lost to Follow-up|0
998639|NCT01403805|2013352|FG001|Overall Study|Lost to Follow-up|2
998640|NCT01403805|2013351|FG000|Overall Study|Death|0
998641|NCT01403805|2013352|FG001|Overall Study|Death|1
998642|NCT01403987|2013410|FG000|Overall Study|Residents forgot their secret PIN|18
998643|NCT01403987|2013411|FG001|Overall Study|Residents forgot their secret PIN|17
998644|NCT01403987|2013412|FG002|Overall Study|Residents forgot their secret PIN|18
998645|NCT01404208|2013476|FG000|Overall Study|Discontinued|3
998646|NCT01404208|2013477|FG001|Overall Study|Discontinued|0
998647|NCT01404234|2013483|FG000|Overall Study|Withdrawal by Subject|2
998648|NCT01404325|2013508|FG000|Overall Study|Lost to Follow-up|1
998649|NCT01404325|2013509|FG001|Overall Study|Lost to Follow-up|0
998650|NCT01404325|2013508|FG000|Overall Study|Death|2
998651|NCT01404325|2013509|FG001|Overall Study|Death|0
998652|NCT01404325|2013508|FG000|Overall Study|Graft loss/Retransplantation|1
998653|NCT01404325|2013509|FG001|Overall Study|Graft loss/Retransplantation|0
998654|NCT01404325|2013508|FG000|Overall Study|non-specified reason|0
998655|NCT01404325|2013509|FG001|Overall Study|non-specified reason|2
998656|NCT01404949|2013585|FG000|Overall Study|Not Treated|1
998657|NCT01404988|2013592|FG000|Overall Study|Death|2
998658|NCT01404988|2013593|FG001|Overall Study|Death|0
998659|NCT01404988|2013594|FG002|Overall Study|Death|2
998660|NCT01404988|2013592|FG000|Overall Study|Adverse Event|1
998661|NCT01404988|2013593|FG001|Overall Study|Adverse Event|0
998662|NCT01404988|2013594|FG002|Overall Study|Adverse Event|0
998663|NCT01404988|2013592|FG000|Overall Study|Withdrawal by Subject|2
998664|NCT01404988|2013593|FG001|Overall Study|Withdrawal by Subject|2
998665|NCT01404988|2013594|FG002|Overall Study|Withdrawal by Subject|0
998666|NCT01404988|2013592|FG000|Overall Study|Lost to Follow-up|1
998667|NCT01404988|2013593|FG001|Overall Study|Lost to Follow-up|2
998668|NCT01404988|2013594|FG002|Overall Study|Lost to Follow-up|1
998669|NCT01405027|2013607|FG000|Overall Study|Withdrawn consent|3
998670|NCT01405027|2013608|FG001|Overall Study|Withdrawn consent|0
998671|NCT01405027|2013607|FG000|Overall Study|Lost to Follow-up|16
998672|NCT01405027|2013608|FG001|Overall Study|Lost to Follow-up|24
998673|NCT01405027|2013607|FG000|Overall Study|Investigator judgement|0
998674|NCT01405027|2013608|FG001|Overall Study|Investigator judgement|2
998675|NCT01405027|2013607|FG000|Overall Study|Death|1
998676|NCT01405027|2013608|FG001|Overall Study|Death|0
998677|NCT01405027|2013607|FG000|Overall Study|Other or Unknown|12
998678|NCT01405027|2013608|FG001|Overall Study|Other or Unknown|25
998679|NCT01405053|2013618|FG000|Overall Study|Adverse Event|3
998680|NCT01405053|2013619|FG001|Overall Study|Adverse Event|0
998681|NCT01405053|2013618|FG000|Overall Study|Lost to Follow-up|0
998682|NCT01405053|2013619|FG001|Overall Study|Lost to Follow-up|1
998683|NCT01405053|2013618|FG000|Overall Study|Participant choice|2
998684|NCT01405053|2013619|FG001|Overall Study|Participant choice|1
998685|NCT01405053|2013618|FG000|Overall Study|Inadequate therapeutic effect|2
998686|NCT01405053|2013619|FG001|Overall Study|Inadequate therapeutic effect|1
998687|NCT01405053|2013618|FG000|Overall Study|Withdrawal by Subject|3
998688|NCT01405053|2013619|FG001|Overall Study|Withdrawal by Subject|4
998689|NCT01405053|2013618|FG000|Overall Study|Other|0
998690|NCT01405053|2013619|FG001|Overall Study|Other|1
998691|NCT01405196|2013629|FG000|Overall Study|Study Terminated by Sponsor|0
998692|NCT01405196|2013630|FG001|Overall Study|Study Terminated by Sponsor|0
998693|NCT01405196|2013631|FG002|Overall Study|Study Terminated by Sponsor|9
998694|NCT01405196|2013632|FG003|Overall Study|Study Terminated by Sponsor|0
998695|NCT01405196|2013629|FG000|Overall Study|Other|2
998696|NCT01405196|2013630|FG001|Overall Study|Other|2
998697|NCT01405196|2013631|FG002|Overall Study|Other|5
998698|NCT01405196|2013632|FG003|Overall Study|Other|0
998699|NCT01405196|2013629|FG000|Overall Study|Withdrawal by Subject|4
998700|NCT01405196|2013630|FG001|Overall Study|Withdrawal by Subject|6
998701|NCT01405196|2013631|FG002|Overall Study|Withdrawal by Subject|3
998702|NCT01405196|2013632|FG003|Overall Study|Withdrawal by Subject|6
998703|NCT01405196|2013629|FG000|Overall Study|Adverse Event|2
998704|NCT01405196|2013630|FG001|Overall Study|Adverse Event|2
998705|NCT01405196|2013631|FG002|Overall Study|Adverse Event|0
998706|NCT01405196|2013632|FG003|Overall Study|Adverse Event|2
998707|NCT01405196|2013629|FG000|Overall Study|Death|1
998708|NCT01405196|2013630|FG001|Overall Study|Death|0
998709|NCT01405196|2013631|FG002|Overall Study|Death|3
998710|NCT01405196|2013632|FG003|Overall Study|Death|0
998711|NCT01405196|2013629|FG000|Overall Study|Lost to Follow-up|2
998712|NCT01405196|2013630|FG001|Overall Study|Lost to Follow-up|2
998713|NCT01405196|2013631|FG002|Overall Study|Lost to Follow-up|3
998714|NCT01405196|2013632|FG003|Overall Study|Lost to Follow-up|1
998715|NCT01405456|2013653|FG000|Overall Study|Lost to Follow-up|2
998716|NCT01405456|2013654|FG001|Overall Study|Lost to Follow-up|1
998717|NCT01405456|2013653|FG000|Overall Study|Physician Decision|1
998718|NCT01405456|2013654|FG001|Overall Study|Physician Decision|0
998719|NCT01405508|2013669|FG000|Overall Study|AE, non-serious non-fatal|1
998720|NCT01405508|2013670|FG001|Overall Study|AE, non-serious non-fatal|1
998721|NCT01405508|2013671|FG002|Overall Study|AE, non-serious non-fatal|0
998722|NCT01405508|2013672|FG003|Overall Study|AE, non-serious non-fatal|0
998723|NCT01405560|2013682|FG000|Overall Study|Physician Decision|1
998724|NCT01405742|2013686|FG000|Overall Study|Lost to Follow-up|1
998725|NCT01405742|2013687|FG001|Overall Study|Lost to Follow-up|0
998726|NCT01405768|2013695|FG000|Overall Study|Didn't complete questionnaire correctly|4
998727|NCT01405768|2013696|FG001|Overall Study|Didn't complete questionnaire correctly|0
998728|NCT01405820|2013714|FG000|Randomized Treatment Period|Adverse Event|3
998729|NCT01405820|2013715|FG001|Randomized Treatment Period|Adverse Event|3
998730|NCT01405820|2013716|FG002|Randomized Treatment Period|Adverse Event|3
998731|NCT01405820|2013717|FG003|Randomized Treatment Period|Adverse Event|0
998732|NCT01405820|2013718|FG004|Randomized Treatment Period|Adverse Event|2
998733|NCT01405820|2013719|FG005|Randomized Treatment Period|Adverse Event|1
998734|NCT01405820|2013714|FG000|Randomized Treatment Period|Withdrawal by Subject|6
998735|NCT01405820|2013715|FG001|Randomized Treatment Period|Withdrawal by Subject|2
998736|NCT01405820|2013716|FG002|Randomized Treatment Period|Withdrawal by Subject|2
998737|NCT01405820|2013717|FG003|Randomized Treatment Period|Withdrawal by Subject|2
998738|NCT01405820|2013718|FG004|Randomized Treatment Period|Withdrawal by Subject|0
998739|NCT01405820|2013719|FG005|Randomized Treatment Period|Withdrawal by Subject|0
998740|NCT01405820|2013714|FG000|Randomized Treatment Period|Other|2
998741|NCT01405820|2013715|FG001|Randomized Treatment Period|Other|2
998742|NCT01405820|2013716|FG002|Randomized Treatment Period|Other|1
998743|NCT01405820|2013717|FG003|Randomized Treatment Period|Other|1
998744|NCT01405820|2013718|FG004|Randomized Treatment Period|Other|0
998745|NCT01405820|2013719|FG005|Randomized Treatment Period|Other|0
998746|NCT01405820|2013714|FG000|Randomized Treatment Period|Physician Decision|0
998747|NCT01405820|2013715|FG001|Randomized Treatment Period|Physician Decision|2
998748|NCT01405820|2013716|FG002|Randomized Treatment Period|Physician Decision|1
998749|NCT01405820|2013717|FG003|Randomized Treatment Period|Physician Decision|0
998750|NCT01405820|2013718|FG004|Randomized Treatment Period|Physician Decision|0
998751|NCT01405820|2013719|FG005|Randomized Treatment Period|Physician Decision|0
998752|NCT01405820|2013714|FG000|Randomized Treatment Period|Rescue|0
998753|NCT01405820|2013715|FG001|Randomized Treatment Period|Rescue|1
998754|NCT01405820|2013716|FG002|Randomized Treatment Period|Rescue|13
998755|NCT01405820|2013717|FG003|Randomized Treatment Period|Rescue|10
998756|NCT01405820|2013718|FG004|Randomized Treatment Period|Rescue|8
998757|NCT01405820|2013719|FG005|Randomized Treatment Period|Rescue|8
998758|NCT01405820|2013714|FG000|Randomized Treatment Period|Incorrect Study Treatment|0
998759|NCT01405820|2013715|FG001|Randomized Treatment Period|Incorrect Study Treatment|0
998760|NCT01405820|2013716|FG002|Randomized Treatment Period|Incorrect Study Treatment|3
998761|NCT01405820|2013717|FG003|Randomized Treatment Period|Incorrect Study Treatment|0
998762|NCT01405820|2013718|FG004|Randomized Treatment Period|Incorrect Study Treatment|2
998763|NCT01405820|2013719|FG005|Randomized Treatment Period|Incorrect Study Treatment|0
998764|NCT01405820|2013714|FG000|Randomized Treatment Period|Treatment Arm Closed|0
998765|NCT01405820|2013715|FG001|Randomized Treatment Period|Treatment Arm Closed|0
998766|NCT01405820|2013716|FG002|Randomized Treatment Period|Treatment Arm Closed|20
998767|NCT01405820|2013717|FG003|Randomized Treatment Period|Treatment Arm Closed|36
998768|NCT01405820|2013718|FG004|Randomized Treatment Period|Treatment Arm Closed|33
998769|NCT01405820|2013719|FG005|Randomized Treatment Period|Treatment Arm Closed|28
998770|NCT01405820|2013714|FG000|Randomized Treatment Period|Death|0
998771|NCT01405820|2013715|FG001|Randomized Treatment Period|Death|0
998772|NCT01405820|2013716|FG002|Randomized Treatment Period|Death|0
998773|NCT01405820|2013717|FG003|Randomized Treatment Period|Death|1
998774|NCT01405820|2013718|FG004|Randomized Treatment Period|Death|0
998775|NCT01405820|2013719|FG005|Randomized Treatment Period|Death|0
998776|NCT01405820|2013714|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0
1006726|NCT01469052|2025440|FG004|Overall Study|Moved to rollover protocol|0
998777|NCT01405820|2013715|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0
998778|NCT01405820|2013716|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0
998779|NCT01405820|2013717|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1
998780|NCT01405820|2013718|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0
998781|NCT01405820|2013719|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0
998782|NCT01405820|2013714|FG000|Open-Label Treatment Period|Withdrawal by Subject|3
998783|NCT01405820|2013715|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
998784|NCT01405820|2013716|FG002|Open-Label Treatment Period|Withdrawal by Subject|1
998785|NCT01405820|2013717|FG003|Open-Label Treatment Period|Withdrawal by Subject|1
998786|NCT01405820|2013718|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
998787|NCT01405820|2013719|FG005|Open-Label Treatment Period|Withdrawal by Subject|1
998788|NCT01405820|2013714|FG000|Open-Label Treatment Period|Other|1
998789|NCT01405820|2013715|FG001|Open-Label Treatment Period|Other|1
998790|NCT01405820|2013716|FG002|Open-Label Treatment Period|Other|1
998791|NCT01405820|2013717|FG003|Open-Label Treatment Period|Other|1
998792|NCT01405820|2013718|FG004|Open-Label Treatment Period|Other|1
998793|NCT01405820|2013719|FG005|Open-Label Treatment Period|Other|1
998794|NCT01405820|2013714|FG000|Open-Label Treatment Period|Physician Decision|0
998795|NCT01405820|2013715|FG001|Open-Label Treatment Period|Physician Decision|0
998796|NCT01405820|2013716|FG002|Open-Label Treatment Period|Physician Decision|1
998797|NCT01405820|2013717|FG003|Open-Label Treatment Period|Physician Decision|2
998798|NCT01405820|2013718|FG004|Open-Label Treatment Period|Physician Decision|1
998799|NCT01405820|2013719|FG005|Open-Label Treatment Period|Physician Decision|0
998800|NCT01405820|2013714|FG000|Open-Label Treatment Period|Adverse Event|0
998801|NCT01405820|2013715|FG001|Open-Label Treatment Period|Adverse Event|0
998802|NCT01405820|2013716|FG002|Open-Label Treatment Period|Adverse Event|0
998803|NCT01405820|2013717|FG003|Open-Label Treatment Period|Adverse Event|1
998804|NCT01405820|2013718|FG004|Open-Label Treatment Period|Adverse Event|0
998805|NCT01405820|2013719|FG005|Open-Label Treatment Period|Adverse Event|0
998806|NCT01405898|2013741|FG000|Overall Study|Withdrawal by Subject|2
998807|NCT01405898|2013742|FG001|Overall Study|Withdrawal by Subject|2
998808|NCT01405911|2013751|FG000|Overall Study|Pre-treatment lab AE|0
998809|NCT01405911|2013752|FG001|Overall Study|Pre-treatment lab AE|1
998810|NCT01405911|2013753|FG002|Overall Study|Pre-treatment lab AE|0
998811|NCT01405911|2013751|FG000|Overall Study|Lost to Follow-up|0
998812|NCT01405911|2013752|FG001|Overall Study|Lost to Follow-up|1
998813|NCT01405911|2013753|FG002|Overall Study|Lost to Follow-up|0
998814|NCT01405911|2013751|FG000|Overall Study|Protocol Violation|1
998815|NCT01405911|2013752|FG001|Overall Study|Protocol Violation|0
998816|NCT01405911|2013753|FG002|Overall Study|Protocol Violation|0
998817|NCT01405911|2013751|FG000|Overall Study|Withdrawal by Subject|3
998818|NCT01405911|2013752|FG001|Overall Study|Withdrawal by Subject|1
998819|NCT01405911|2013753|FG002|Overall Study|Withdrawal by Subject|1
998820|NCT01405924|2013761|FG000|Overall Study|Protocol Violation|8
998821|NCT01405924|2013761|FG000|Overall Study|Missing/Incomplete Data|2
998822|NCT01405950|2013778|FG000|Overall Study|Withdrawal by Subject|1
998823|NCT01405950|2013779|FG001|Overall Study|Withdrawal by Subject|0
998824|NCT01405950|2013780|FG002|Overall Study|Withdrawal by Subject|0
998825|NCT01405950|2013781|FG003|Overall Study|Withdrawal by Subject|0
998826|NCT01406015|2013791|FG000|Overall Study|Withdrawal by Subject|3
998827|NCT01406015|2013792|FG001|Overall Study|Withdrawal by Subject|3
998828|NCT01406574|2013828|FG000|Overall Study|Adverse Event|0
998829|NCT01406574|2013829|FG001|Overall Study|Adverse Event|0
998830|NCT01406574|2013830|FG002|Overall Study|Adverse Event|1
998831|NCT01406574|2013831|FG003|Overall Study|Adverse Event|3
998832|NCT01406574|2013828|FG000|Overall Study|Physician Decision|0
998833|NCT01406574|2013829|FG001|Overall Study|Physician Decision|0
998834|NCT01406574|2013830|FG002|Overall Study|Physician Decision|0
998835|NCT01406574|2013831|FG003|Overall Study|Physician Decision|1
998836|NCT01406574|2013828|FG000|Overall Study|Withdrawal by Subject|0
998837|NCT01406574|2013829|FG001|Overall Study|Withdrawal by Subject|1
998838|NCT01406574|2013830|FG002|Overall Study|Withdrawal by Subject|0
998839|NCT01406574|2013831|FG003|Overall Study|Withdrawal by Subject|0
998840|NCT01406574|2013828|FG000|Overall Study|Definite progression of primary disease|1
998841|NCT01406574|2013829|FG001|Overall Study|Definite progression of primary disease|0
998842|NCT01406574|2013830|FG002|Overall Study|Definite progression of primary disease|0
998843|NCT01406574|2013831|FG003|Overall Study|Definite progression of primary disease|0
998844|NCT01406652|2013844|FG000|Overall Study|Lost-to-follow-up|3
998845|NCT01406652|2013845|FG001|Overall Study|Lost-to-follow-up|4
998846|NCT01406652|2013844|FG000|Overall Study|Withdrawal by Subject|2
998847|NCT01406652|2013845|FG001|Overall Study|Withdrawal by Subject|2
998848|NCT01406652|2013844|FG000|Overall Study|Insufficient follow-up|5
998849|NCT01406652|2013845|FG001|Overall Study|Insufficient follow-up|4
998850|NCT01406652|2013844|FG000|Overall Study|Infection not sure|10
998851|NCT01406652|2013845|FG001|Overall Study|Infection not sure|10
998852|NCT01406717|2013855|FG000|Overall Study|Subject non-compliance|4
998853|NCT01406717|2013856|FG001|Overall Study|Subject non-compliance|3
998854|NCT01406717|2013855|FG000|Overall Study|Protocol Violation|5
998855|NCT01406717|2013856|FG001|Overall Study|Protocol Violation|1
998856|NCT01406717|2013855|FG000|Overall Study|Lost to Follow-up|14
998857|NCT01406717|2013856|FG001|Overall Study|Lost to Follow-up|8
998858|NCT01406717|2013855|FG000|Overall Study|Withdrawal by Subject|19
998859|NCT01406717|2013856|FG001|Overall Study|Withdrawal by Subject|15
998860|NCT01406717|2013855|FG000|Overall Study|Adverse Event|1
998861|NCT01406717|2013856|FG001|Overall Study|Adverse Event|2
998862|NCT01406717|2013855|FG000|Overall Study|Lack of Efficacy|0
998863|NCT01406717|2013856|FG001|Overall Study|Lack of Efficacy|1
998864|NCT01406717|2013855|FG000|Overall Study|Non-completion of visit activity|0
998865|NCT01406717|2013856|FG001|Overall Study|Non-completion of visit activity|1
998866|NCT01406795|2013872|FG000|Overall Study|Withdrawal by Subject|1
998867|NCT01406873|2013878|FG000|Overall Study|Withdrawal by Subject|1
998868|NCT01406873|2013879|FG001|Overall Study|Withdrawal by Subject|1
998869|NCT01406938|2013897|FG000|Induction Period|Subject/guardian decision|6
998870|NCT01406938|2013898|FG001|Induction Period|Subject/guardian decision|8
998871|NCT01406938|2013899|FG002|Induction Period|Subject/guardian decision|0
998872|NCT01406938|2013900|FG003|Induction Period|Subject/guardian decision|0
998873|NCT01406938|2013901|FG004|Induction Period|Subject/guardian decision|0
998874|NCT01406938|2013902|FG005|Induction Period|Subject/guardian decision|0
998875|NCT01406938|2013897|FG000|Induction Period|Protocol deviation|1
998876|NCT01406938|2013898|FG001|Induction Period|Protocol deviation|0
998877|NCT01406938|2013899|FG002|Induction Period|Protocol deviation|0
998878|NCT01406938|2013900|FG003|Induction Period|Protocol deviation|0
998879|NCT01406938|2013901|FG004|Induction Period|Protocol deviation|0
998880|NCT01406938|2013902|FG005|Induction Period|Protocol deviation|0
998881|NCT01406938|2013897|FG000|Induction Period|Adverse Event|8
998882|NCT01406938|2013898|FG001|Induction Period|Adverse Event|9
998883|NCT01406938|2013899|FG002|Induction Period|Adverse Event|0
998884|NCT01406938|2013900|FG003|Induction Period|Adverse Event|0
998885|NCT01406938|2013901|FG004|Induction Period|Adverse Event|0
998886|NCT01406938|2013902|FG005|Induction Period|Adverse Event|0
998887|NCT01406938|2013897|FG000|Induction Period|Lack of Efficacy|1
998888|NCT01406938|2013898|FG001|Induction Period|Lack of Efficacy|0
998889|NCT01406938|2013899|FG002|Induction Period|Lack of Efficacy|0
998890|NCT01406938|2013900|FG003|Induction Period|Lack of Efficacy|0
998891|NCT01406938|2013901|FG004|Induction Period|Lack of Efficacy|0
998892|NCT01406938|2013902|FG005|Induction Period|Lack of Efficacy|0
998893|NCT01406938|2013897|FG000|Induction Period|Lost to Follow-up|2
998894|NCT01406938|2013898|FG001|Induction Period|Lost to Follow-up|3
998895|NCT01406938|2013899|FG002|Induction Period|Lost to Follow-up|0
998896|NCT01406938|2013900|FG003|Induction Period|Lost to Follow-up|0
998897|NCT01406938|2013901|FG004|Induction Period|Lost to Follow-up|0
998898|NCT01406938|2013902|FG005|Induction Period|Lost to Follow-up|0
998899|NCT01406938|2013897|FG000|Maintenance Period|Adverse Event|0
998900|NCT01406938|2013898|FG001|Maintenance Period|Adverse Event|0
998901|NCT01406938|2013899|FG002|Maintenance Period|Adverse Event|2
998902|NCT01406938|2013900|FG003|Maintenance Period|Adverse Event|8
998903|NCT01406938|2013901|FG004|Maintenance Period|Adverse Event|4
998904|NCT01406938|2013902|FG005|Maintenance Period|Adverse Event|2
998905|NCT01406938|2013897|FG000|Maintenance Period|Death|0
998906|NCT01406938|2013898|FG001|Maintenance Period|Death|0
998907|NCT01406938|2013899|FG002|Maintenance Period|Death|0
998908|NCT01406938|2013900|FG003|Maintenance Period|Death|0
998909|NCT01406938|2013901|FG004|Maintenance Period|Death|1
998910|NCT01406938|2013902|FG005|Maintenance Period|Death|0
998911|NCT01406938|2013897|FG000|Maintenance Period|Subject/guardian decision|0
998912|NCT01406938|2013898|FG001|Maintenance Period|Subject/guardian decision|0
998913|NCT01406938|2013899|FG002|Maintenance Period|Subject/guardian decision|11
998914|NCT01406938|2013900|FG003|Maintenance Period|Subject/guardian decision|7
998915|NCT01406938|2013901|FG004|Maintenance Period|Subject/guardian decision|10
998916|NCT01406938|2013902|FG005|Maintenance Period|Subject/guardian decision|7
998917|NCT01406938|2013897|FG000|Maintenance Period|Protocol Violation|0
998918|NCT01406938|2013898|FG001|Maintenance Period|Protocol Violation|0
998919|NCT01406938|2013899|FG002|Maintenance Period|Protocol Violation|2
998920|NCT01406938|2013900|FG003|Maintenance Period|Protocol Violation|2
998921|NCT01406938|2013901|FG004|Maintenance Period|Protocol Violation|2
998922|NCT01406938|2013902|FG005|Maintenance Period|Protocol Violation|2
998923|NCT01406938|2013897|FG000|Maintenance Period|Pregnancy|0
998924|NCT01406938|2013898|FG001|Maintenance Period|Pregnancy|0
998925|NCT01406938|2013899|FG002|Maintenance Period|Pregnancy|0
998926|NCT01406938|2013900|FG003|Maintenance Period|Pregnancy|0
998927|NCT01406938|2013901|FG004|Maintenance Period|Pregnancy|1
998928|NCT01406938|2013902|FG005|Maintenance Period|Pregnancy|0
998929|NCT01406938|2013897|FG000|Maintenance Period|Lost to Follow-up|0
998930|NCT01406938|2013898|FG001|Maintenance Period|Lost to Follow-up|0
998931|NCT01406938|2013899|FG002|Maintenance Period|Lost to Follow-up|0
998932|NCT01406938|2013900|FG003|Maintenance Period|Lost to Follow-up|0
998933|NCT01406938|2013901|FG004|Maintenance Period|Lost to Follow-up|4
998934|NCT01406938|2013902|FG005|Maintenance Period|Lost to Follow-up|0
998935|NCT01406938|2013897|FG000|Maintenance Period|Lack of Efficacy|0
998936|NCT01406938|2013898|FG001|Maintenance Period|Lack of Efficacy|0
998937|NCT01406938|2013899|FG002|Maintenance Period|Lack of Efficacy|2
998938|NCT01406938|2013900|FG003|Maintenance Period|Lack of Efficacy|1
998939|NCT01406938|2013901|FG004|Maintenance Period|Lack of Efficacy|3
998940|NCT01406938|2013902|FG005|Maintenance Period|Lack of Efficacy|5
998941|NCT01406938|2013897|FG000|Follow up|Lack of Efficacy|3
998942|NCT01406938|2013898|FG001|Follow up|Lack of Efficacy|2
998943|NCT01406938|2013899|FG002|Follow up|Lack of Efficacy|1
998944|NCT01406938|2013900|FG003|Follow up|Lack of Efficacy|0
998945|NCT01406938|2013901|FG004|Follow up|Lack of Efficacy|0
998946|NCT01406938|2013902|FG005|Follow up|Lack of Efficacy|0
998947|NCT01406938|2013897|FG000|Follow up|Patient/guardian decision|4
998948|NCT01406938|2013898|FG001|Follow up|Patient/guardian decision|2
998949|NCT01406938|2013899|FG002|Follow up|Patient/guardian decision|4
998950|NCT01406938|2013900|FG003|Follow up|Patient/guardian decision|2
998951|NCT01406938|2013901|FG004|Follow up|Patient/guardian decision|4
998952|NCT01406938|2013902|FG005|Follow up|Patient/guardian decision|1
998953|NCT01406938|2013897|FG000|Follow up|Protocol Violation|0
998954|NCT01406938|2013898|FG001|Follow up|Protocol Violation|0
998955|NCT01406938|2013899|FG002|Follow up|Protocol Violation|1
998956|NCT01406938|2013900|FG003|Follow up|Protocol Violation|0
998957|NCT01406938|2013901|FG004|Follow up|Protocol Violation|0
998958|NCT01406938|2013902|FG005|Follow up|Protocol Violation|0
998959|NCT01406938|2013897|FG000|Follow up|Physician Decision|0
998960|NCT01406938|2013898|FG001|Follow up|Physician Decision|0
998961|NCT01406938|2013899|FG002|Follow up|Physician Decision|2
998962|NCT01406938|2013900|FG003|Follow up|Physician Decision|0
998963|NCT01406938|2013901|FG004|Follow up|Physician Decision|3
998964|NCT01406938|2013902|FG005|Follow up|Physician Decision|1
998965|NCT01406938|2013897|FG000|Follow up|Lost to Follow-up|1
998966|NCT01406938|2013898|FG001|Follow up|Lost to Follow-up|1
998967|NCT01406938|2013899|FG002|Follow up|Lost to Follow-up|0
998968|NCT01406938|2013900|FG003|Follow up|Lost to Follow-up|1
998969|NCT01406938|2013901|FG004|Follow up|Lost to Follow-up|2
998970|NCT01406938|2013902|FG005|Follow up|Lost to Follow-up|1
998971|NCT01407276|2013966|FG000|Overall Study|Withdrawal by Subject|0
998972|NCT01407276|2013967|FG001|Overall Study|Withdrawal by Subject|0
998973|NCT01407276|2013968|FG002|Overall Study|Withdrawal by Subject|0
998974|NCT01407276|2013969|FG003|Overall Study|Withdrawal by Subject|0
998975|NCT01407276|2013970|FG004|Overall Study|Withdrawal by Subject|0
998976|NCT01407276|2013971|FG005|Overall Study|Withdrawal by Subject|0
998977|NCT01407276|2013972|FG006|Overall Study|Withdrawal by Subject|0
998978|NCT01407276|2013973|FG007|Overall Study|Withdrawal by Subject|1
998979|NCT01407354|2013998|FG000|First Intervention|Withdrawal by Subject|0
998980|NCT01407354|2013999|FG001|First Intervention|Withdrawal by Subject|2
998981|NCT01407354|2013998|FG000|First Intervention|Adverse Event|1
998982|NCT01407354|2013999|FG001|First Intervention|Adverse Event|0
998983|NCT01407354|2013998|FG000|First Intervention|Physician Decision|1
998984|NCT01407354|2013999|FG001|First Intervention|Physician Decision|0
998985|NCT01407367|2014008|FG000|Overall Study|Death|24
998986|NCT01407367|2014009|FG001|Overall Study|Death|32
998987|NCT01407367|2014008|FG000|Overall Study|Renal Replacement Therapy (RRT)|12
998988|NCT01407367|2014009|FG001|Overall Study|Renal Replacement Therapy (RRT)|29
998989|NCT01407367|2014008|FG000|Overall Study|Withdrawal by Subject|4
998990|NCT01407367|2014009|FG001|Overall Study|Withdrawal by Subject|15
998991|NCT01407367|2014008|FG000|Overall Study|Lost to Follow-up|0
998992|NCT01407367|2014009|FG001|Overall Study|Lost to Follow-up|2
998993|NCT01407926|2014033|FG000|Overall Study|Lost to Follow-up|55
998994|NCT01408030|2014051|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1
998995|NCT01408030|2014052|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0
998996|NCT01408030|2014053|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1
998997|NCT01408030|2014054|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0
998998|NCT01408030|2014051|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2
998999|NCT01408030|2014052|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6
999000|NCT01408030|2014053|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0
999001|NCT01408030|2014054|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3
999002|NCT01408030|2014051|FG000|Treatment Phase (on Drug)|Protocol Violation|0
999003|NCT01408030|2014052|FG001|Treatment Phase (on Drug)|Protocol Violation|1
999004|NCT01408030|2014053|FG002|Treatment Phase (on Drug)|Protocol Violation|0
999005|NCT01408030|2014054|FG003|Treatment Phase (on Drug)|Protocol Violation|0
999006|NCT01408030|2014051|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0
999007|NCT01408030|2014052|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2
999008|NCT01408030|2014053|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2
999009|NCT01408030|2014054|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0
999010|NCT01408030|2014051|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3
999011|NCT01408030|2014052|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2
999012|NCT01408030|2014053|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1
999013|NCT01408030|2014054|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3
999014|NCT01408030|2014051|FG000|Observation Phase (Off Drug)|Physician Decision|0
999015|NCT01408030|2014052|FG001|Observation Phase (Off Drug)|Physician Decision|1
999016|NCT01408030|2014053|FG002|Observation Phase (Off Drug)|Physician Decision|2
999017|NCT01408030|2014054|FG003|Observation Phase (Off Drug)|Physician Decision|0
999018|NCT01408030|2014051|FG000|Observation Phase (Off Drug)|Other|1
999019|NCT01408030|2014052|FG001|Observation Phase (Off Drug)|Other|1
999020|NCT01408030|2014053|FG002|Observation Phase (Off Drug)|Other|1
999021|NCT01408030|2014054|FG003|Observation Phase (Off Drug)|Other|1
999022|NCT01408043|2014064|FG000|Overall Study|unable to collect cells|1
999023|NCT01408147|2014070|FG000|Overall Study|Withdrawal by Subject|0
999024|NCT01408147|2014071|FG001|Overall Study|Withdrawal by Subject|1
999025|NCT01408277|2014079|FG000|Overall Study|Adverse Event|3
999026|NCT01408277|2014080|FG001|Overall Study|Adverse Event|4
999027|NCT01408277|2014079|FG000|Overall Study|Lost to Follow-up|1
999028|NCT01408277|2014080|FG001|Overall Study|Lost to Follow-up|0
999029|NCT01408277|2014079|FG000|Overall Study|Withdrawal by Subject|2
999030|NCT01408277|2014080|FG001|Overall Study|Withdrawal by Subject|0
999031|NCT01408277|2014079|FG000|Overall Study|Protocol Violation|2
999032|NCT01408277|2014080|FG001|Overall Study|Protocol Violation|0
999033|NCT01408303|2014089|FG000|Overall Study|Adverse Event|3
999034|NCT01408303|2014090|FG001|Overall Study|Adverse Event|7
999035|NCT01408303|2014091|FG002|Overall Study|Adverse Event|2
999036|NCT01408303|2014089|FG000|Overall Study|Lost to Follow-up|0
999037|NCT01408303|2014090|FG001|Overall Study|Lost to Follow-up|1
999038|NCT01408303|2014091|FG002|Overall Study|Lost to Follow-up|2
999039|NCT01408303|2014089|FG000|Overall Study|Withdrawal by Subject|2
999040|NCT01408303|2014090|FG001|Overall Study|Withdrawal by Subject|3
999041|NCT01408303|2014091|FG002|Overall Study|Withdrawal by Subject|1
999042|NCT01408303|2014089|FG000|Overall Study|Protocol Violation|0
999043|NCT01408303|2014090|FG001|Overall Study|Protocol Violation|1
999044|NCT01408303|2014091|FG002|Overall Study|Protocol Violation|0
999045|NCT01408303|2014089|FG000|Overall Study|Noncompliance|1
999046|NCT01408303|2014090|FG001|Overall Study|Noncompliance|0
999047|NCT01408303|2014091|FG002|Overall Study|Noncompliance|1
999048|NCT01408459|2014110|FG000|Overall Study|Withdrawal by Subject|1
999049|NCT01408459|2014111|FG001|Overall Study|Withdrawal by Subject|1
999050|NCT01408485|2014118|FG000|Overall Study|Withdrawal by Subject|21
999051|NCT01408537|2014122|FG000|Overall Study|Withdrawal by Subject|2
999052|NCT01408537|2014122|FG000|Overall Study|Protocol Violation|3
999053|NCT01408537|2014122|FG000|Overall Study|Lost to Follow-up|3
999054|NCT01408563|2014137|FG000|Overall Study|Ineligible after consent/ registration|2
999055|NCT01408576|2014144|FG000|Overall Study|Lack of Efficacy|17
999056|NCT01408576|2014145|FG001|Overall Study|Lack of Efficacy|30
999057|NCT01408576|2014146|FG002|Overall Study|Lack of Efficacy|48
999058|NCT01408576|2014144|FG000|Overall Study|Protocol Violation|1
999059|NCT01408576|2014145|FG001|Overall Study|Protocol Violation|2
999060|NCT01408576|2014146|FG002|Overall Study|Protocol Violation|2
999061|NCT01408576|2014144|FG000|Overall Study|Lost to Follow-up|10
999062|NCT01408576|2014145|FG001|Overall Study|Lost to Follow-up|9
999063|NCT01408576|2014146|FG002|Overall Study|Lost to Follow-up|17
999064|NCT01408576|2014144|FG000|Overall Study|Withdrawal by Subject|34
999065|NCT01408576|2014145|FG001|Overall Study|Withdrawal by Subject|60
999066|NCT01408576|2014146|FG002|Overall Study|Withdrawal by Subject|66
999067|NCT01408576|2014144|FG000|Overall Study|Sponsor terminated study|89
999068|NCT01408576|2014145|FG001|Overall Study|Sponsor terminated study|333
999069|NCT01408576|2014146|FG002|Overall Study|Sponsor terminated study|330
999070|NCT01408576|2014144|FG000|Overall Study|AE, serious fatal|4
999071|NCT01408576|2014145|FG001|Overall Study|AE, serious fatal|4
999072|NCT01408576|2014146|FG002|Overall Study|AE, serious fatal|1
999073|NCT01408576|2014144|FG000|Overall Study|SAE, non-fatal|11
999074|NCT01408576|2014145|FG001|Overall Study|SAE, non-fatal|23
999075|NCT01408576|2014146|FG002|Overall Study|SAE, non-fatal|14
999076|NCT01408576|2014144|FG000|Overall Study|AE, non-serious non-fatal|12
999077|NCT01408576|2014145|FG001|Overall Study|AE, non-serious non-fatal|19
999078|NCT01408576|2014146|FG002|Overall Study|AE, non-serious non-fatal|11
999079|NCT01408576|2014144|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
999080|NCT01408576|2014145|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
999081|NCT01408576|2014146|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
999082|NCT01408576|2014144|FG000|Overall Study|AE, unknown type|0
999083|NCT01408576|2014145|FG001|Overall Study|AE, unknown type|1
999084|NCT01408576|2014146|FG002|Overall Study|AE, unknown type|0
999085|NCT01408576|2014144|FG000|Overall Study|Other|10
999086|NCT01408576|2014145|FG001|Overall Study|Other|16
999087|NCT01408576|2014146|FG002|Overall Study|Other|18
999088|NCT01408628|2014166|FG000|Consented|Withdrawal by Subject|12
999089|NCT01408628|2014166|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3
999090|NCT01408628|2014166|FG000|Completed 6 Month Follow-Up|Protocol Violation|6
999091|NCT01408628|2014166|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5
999092|NCT01408706|2014173|FG000|Overall Study|Physician Decision|1
999093|NCT01408706|2014174|FG001|Overall Study|Physician Decision|0
999094|NCT01408732|2014231|FG000|Overall Study|Withdrawal by Subject|2
999095|NCT01408732|2014232|FG001|Overall Study|Withdrawal by Subject|2
999096|NCT01408888|2014243|FG000|First Intervention|Adverse Event|0
999097|NCT01408888|2014244|FG001|First Intervention|Adverse Event|1
999098|NCT01408888|2014243|FG000|First Intervention|Withdrawal by Subject|0
999099|NCT01408888|2014244|FG001|First Intervention|Withdrawal by Subject|2
999100|NCT01408888|2014243|FG000|Second Intervention|Withdrawal by Subject|1
999101|NCT01408888|2014244|FG001|Second Intervention|Withdrawal by Subject|0
999102|NCT01408888|2014243|FG000|Second Intervention|Adverse Event|1
999103|NCT01408888|2014244|FG001|Second Intervention|Adverse Event|0
999104|NCT01408901|2014264|FG000|6-Week Follow-Up|Lost to Follow-up|2
999105|NCT01408901|2014265|FG001|6-Week Follow-Up|Lost to Follow-up|1
999106|NCT01408901|2014266|FG002|6-Week Follow-Up|Lost to Follow-up|3
999107|NCT01408901|2014267|FG003|6-Week Follow-Up|Lost to Follow-up|2
999108|NCT01408901|2014264|FG000|6-Week Follow-Up|Death|1
999109|NCT01408901|2014265|FG001|6-Week Follow-Up|Death|0
999110|NCT01408901|2014266|FG002|6-Week Follow-Up|Death|0
999111|NCT01408901|2014267|FG003|6-Week Follow-Up|Death|0
999112|NCT01408901|2014264|FG000|6-Week Follow-Up|Cancelled visit|0
999113|NCT01408901|2014265|FG001|6-Week Follow-Up|Cancelled visit|1
999114|NCT01408901|2014266|FG002|6-Week Follow-Up|Cancelled visit|0
999115|NCT01408901|2014267|FG003|6-Week Follow-Up|Cancelled visit|2
999116|NCT01408901|2014264|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
999117|NCT01408901|2014265|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
999118|NCT01408901|2014266|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
999119|NCT01408901|2014267|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
999120|NCT01408901|2014264|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1
999121|NCT01408901|2014265|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0
999122|NCT01408901|2014266|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0
999123|NCT01408901|2014267|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0
999124|NCT01408901|2014264|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
999125|NCT01408901|2014265|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
999126|NCT01408901|2014266|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
999127|NCT01408901|2014267|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
999128|NCT01408901|2014264|FG000|26-Week Follow-Up|Lost to Follow-up|1
999129|NCT01408901|2014265|FG001|26-Week Follow-Up|Lost to Follow-up|1
999130|NCT01408901|2014266|FG002|26-Week Follow-Up|Lost to Follow-up|0
999131|NCT01408901|2014267|FG003|26-Week Follow-Up|Lost to Follow-up|1
999132|NCT01408901|2014264|FG000|26-Week Follow-Up|Death|0
999133|NCT01408901|2014265|FG001|26-Week Follow-Up|Death|1
999134|NCT01408901|2014266|FG002|26-Week Follow-Up|Death|0
999135|NCT01408901|2014267|FG003|26-Week Follow-Up|Death|0
999136|NCT01408914|2014282|FG000|Overall Study|Could not complete tx in protocol period|5
999137|NCT01408914|2014283|FG001|Overall Study|Could not complete tx in protocol period|5
999138|NCT01408914|2014284|FG002|Overall Study|Could not complete tx in protocol period|6
999139|NCT01408914|2014282|FG000|Overall Study|Lost to Follow-up|4
999140|NCT01408914|2014283|FG001|Overall Study|Lost to Follow-up|1
999141|NCT01408914|2014284|FG002|Overall Study|Lost to Follow-up|2
999142|NCT01408914|2014282|FG000|Overall Study|Physician Decision|1
999143|NCT01408914|2014283|FG001|Overall Study|Physician Decision|1
999144|NCT01408914|2014284|FG002|Overall Study|Physician Decision|0
999145|NCT01408914|2014282|FG000|Overall Study|Withdrawal by Subject|1
999146|NCT01408914|2014283|FG001|Overall Study|Withdrawal by Subject|0
999147|NCT01408914|2014284|FG002|Overall Study|Withdrawal by Subject|1
999148|NCT01408914|2014282|FG000|Overall Study|Moved out of study jurisdiction|1
999149|NCT01408914|2014283|FG001|Overall Study|Moved out of study jurisdiction|1
999150|NCT01408914|2014284|FG002|Overall Study|Moved out of study jurisdiction|0
999151|NCT01408914|2014282|FG000|Overall Study|Late exclusion|0
999152|NCT01408914|2014283|FG001|Overall Study|Late exclusion|3
999153|NCT01408914|2014284|FG002|Overall Study|Late exclusion|3
999154|NCT01408914|2014282|FG000|Overall Study|Change in local TB/HIV norms|0
999155|NCT01408914|2014283|FG001|Overall Study|Change in local TB/HIV norms|1
999156|NCT01408914|2014284|FG002|Overall Study|Change in local TB/HIV norms|1
999157|NCT01409382|2014337|FG000|Overall Study|Lost to Follow-up|1
999158|NCT01409382|2014338|FG001|Overall Study|Lost to Follow-up|1
999159|NCT01409382|2014337|FG000|Overall Study|Protocol Violation|0
999160|NCT01409382|2014338|FG001|Overall Study|Protocol Violation|3
999161|NCT01409382|2014337|FG000|Overall Study|Multiple pregnancy|2
999162|NCT01409382|2014338|FG001|Overall Study|Multiple pregnancy|4
999163|NCT01409382|2014337|FG000|Overall Study|Still pregnant when study ended|13
999164|NCT01409382|2014338|FG001|Overall Study|Still pregnant when study ended|2
999165|NCT01409382|2014337|FG000|Overall Study|Did not manage to get pregnant|64
999166|NCT01409382|2014338|FG001|Overall Study|Did not manage to get pregnant|70
999167|NCT01409382|2014337|FG000|Overall Study|Had a 2nd trimester loss after accident|1
999168|NCT01409382|2014338|FG001|Overall Study|Had a 2nd trimester loss after accident|0
999169|NCT01409434|2014348|FG000|Overall Study|Protocol Violation|4
999170|NCT01409564|2014354|FG000|Overall Study|low medication compliance|4
999171|NCT01409564|2014355|FG001|Overall Study|low medication compliance|3
999172|NCT01409564|2014354|FG000|Overall Study|brain abnormalities found in T1 MR|1
999173|NCT01409564|2014355|FG001|Overall Study|brain abnormalities found in T1 MR|2
999174|NCT01409707|2014368|FG000|Overall Study|Withdrawal by Subject|5
999175|NCT01409707|2014369|FG001|Overall Study|Withdrawal by Subject|17
999176|NCT01409707|2014370|FG002|Overall Study|Withdrawal by Subject|16
999177|NCT01409811|2014377|FG000|Overall Study|Insurance denial|1
999178|NCT01409837|2014383|FG000|Overall Study|Withdrawal by Subject|2
999179|NCT01409837|2014384|FG001|Overall Study|Withdrawal by Subject|1
999180|NCT01409837|2014383|FG000|Overall Study|Lost to Follow-up|1
999181|NCT01409837|2014384|FG001|Overall Study|Lost to Follow-up|0
999182|NCT01409837|2014383|FG000|Overall Study|Physician Decision|0
999183|NCT01409837|2014384|FG001|Overall Study|Physician Decision|1
999184|NCT01409915|2014394|FG000|Overall Study|Adverse Event|0
999185|NCT01409915|2014395|FG001|Overall Study|Adverse Event|2
999186|NCT01409915|2014394|FG000|Overall Study|Withdrawal by Subject|0
999187|NCT01409915|2014395|FG001|Overall Study|Withdrawal by Subject|1
999188|NCT01409915|2014394|FG000|Overall Study|Protocol Violation|1
999189|NCT01409915|2014395|FG001|Overall Study|Protocol Violation|0
999190|NCT01409928|2014401|FG000|Overall Study|Physician Decision|12
999191|NCT01409993|2014407|FG000|Overall Study|Adverse Event|4
999192|NCT01409993|2014408|FG001|Overall Study|Adverse Event|4
999193|NCT01409993|2014409|FG002|Overall Study|Adverse Event|3
999194|NCT01409993|2014410|FG003|Overall Study|Adverse Event|1
999195|NCT01409993|2014407|FG000|Overall Study|Withdrawal by Subject|0
999196|NCT01409993|2014408|FG001|Overall Study|Withdrawal by Subject|0
999197|NCT01409993|2014409|FG002|Overall Study|Withdrawal by Subject|0
999198|NCT01409993|2014410|FG003|Overall Study|Withdrawal by Subject|4
999199|NCT01409993|2014407|FG000|Overall Study|Lost to Follow-up|0
999200|NCT01409993|2014408|FG001|Overall Study|Lost to Follow-up|1
999201|NCT01409993|2014409|FG002|Overall Study|Lost to Follow-up|0
999202|NCT01409993|2014410|FG003|Overall Study|Lost to Follow-up|0
999203|NCT01410110|2014455|FG000|Overall Study|Withdrawal by Subject|4
999204|NCT01410110|2014456|FG001|Overall Study|Withdrawal by Subject|2
999205|NCT01410227|2014462|FG000|Overall Study|Adverse Event|1
999206|NCT01410227|2014463|FG001|Overall Study|Adverse Event|0
999207|NCT01410227|2014464|FG002|Overall Study|Adverse Event|0
999208|NCT01410227|2014465|FG003|Overall Study|Adverse Event|0
999209|NCT01410227|2014462|FG000|Overall Study|Withdrawal by Subject|3
999210|NCT01410227|2014463|FG001|Overall Study|Withdrawal by Subject|0
999211|NCT01410227|2014464|FG002|Overall Study|Withdrawal by Subject|1
999212|NCT01410227|2014465|FG003|Overall Study|Withdrawal by Subject|0
999213|NCT01410227|2014462|FG000|Overall Study|Pregnancy|0
999214|NCT01410227|2014463|FG001|Overall Study|Pregnancy|0
999215|NCT01410227|2014464|FG002|Overall Study|Pregnancy|0
999216|NCT01410227|2014465|FG003|Overall Study|Pregnancy|1
999217|NCT01410227|2014462|FG000|Overall Study|Met Excl. Criteria After Starting Study|0
999218|NCT01410227|2014463|FG001|Overall Study|Met Excl. Criteria After Starting Study|0
999219|NCT01410227|2014464|FG002|Overall Study|Met Excl. Criteria After Starting Study|1
999220|NCT01410227|2014465|FG003|Overall Study|Met Excl. Criteria After Starting Study|0
999221|NCT01410240|2014478|FG000|Overall Study|Physician Decision|0
999222|NCT01410240|2014479|FG001|Overall Study|Physician Decision|0
999223|NCT01410240|2014480|FG002|Overall Study|Physician Decision|1
999224|NCT01410240|2014478|FG000|Overall Study|Missed week 6 assessments|1
999225|NCT01410240|2014479|FG001|Overall Study|Missed week 6 assessments|1
999226|NCT01410240|2014480|FG002|Overall Study|Missed week 6 assessments|1
999227|NCT01410357|2014497|FG000|Overall Study|Death|2
999228|NCT01410357|2014498|FG001|Overall Study|Death|1
999229|NCT01410357|2014497|FG000|Overall Study|Withdrawal by Subject|1
999230|NCT01410357|2014498|FG001|Overall Study|Withdrawal by Subject|2
999231|NCT01410357|2014497|FG000|Overall Study|Lost to Follow-up|23
999232|NCT01410357|2014498|FG001|Overall Study|Lost to Follow-up|21
999233|NCT01410448|2014517|FG000|Overall Study|No conversion to everolimus|0
999234|NCT01410448|2014518|FG001|Overall Study|No conversion to everolimus|24
999235|NCT01410448|2014517|FG000|Overall Study|Graft loss|4
999236|NCT01410448|2014518|FG001|Overall Study|Graft loss|1
999237|NCT01410448|2014517|FG000|Overall Study|Administrative issues|2
999238|NCT01410448|2014518|FG001|Overall Study|Administrative issues|1
999239|NCT01410448|2014517|FG000|Overall Study|Lost to Follow-up|1
999240|NCT01410448|2014518|FG001|Overall Study|Lost to Follow-up|0
999241|NCT01410448|2014517|FG000|Overall Study|Withdrawal by Subject|3
999242|NCT01410448|2014518|FG001|Overall Study|Withdrawal by Subject|2
999243|NCT01410448|2014517|FG000|Overall Study|Protocol Violation|0
999244|NCT01410448|2014518|FG001|Overall Study|Protocol Violation|4
999245|NCT01410448|2014517|FG000|Overall Study|Death|2
999246|NCT01410448|2014518|FG001|Overall Study|Death|3
999247|NCT01410474|2014526|FG000|Overall Study|Withdrawal by Subject|0
999248|NCT01410474|2014527|FG001|Overall Study|Withdrawal by Subject|1
999249|NCT01410604|2014556|FG000|Overall Study|Adverse Event|2
999250|NCT01410604|2014557|FG001|Overall Study|Adverse Event|1
999251|NCT01410604|2014556|FG000|Overall Study|Lost to Follow-up|1
999252|NCT01410604|2014557|FG001|Overall Study|Lost to Follow-up|0
999253|NCT01410604|2014556|FG000|Overall Study|Physician Decision|0
999254|NCT01410604|2014557|FG001|Overall Study|Physician Decision|1
999255|NCT01410890|2014582|FG000|Overall Study|Withdrawal by Subject|0
999256|NCT01410890|2014583|FG001|Overall Study|Withdrawal by Subject|1
999257|NCT01411085|2014591|FG000|Overall Study|Physician Decision|1
999258|NCT01411085|2014591|FG000|Overall Study|Protocol Violation|1
999259|NCT01411085|2014591|FG000|Overall Study|Adverse Event|1
999260|NCT01411215|2014612|FG000|Overall Study|Adverse Event|1
999261|NCT01411215|2014613|FG001|Overall Study|Adverse Event|2
999262|NCT01411215|2014612|FG000|Overall Study|Lack of Efficacy|2
999263|NCT01411215|2014613|FG001|Overall Study|Lack of Efficacy|4
999264|NCT01411215|2014612|FG000|Overall Study|Lost to Follow-up|12
999265|NCT01411215|2014613|FG001|Overall Study|Lost to Follow-up|18
999266|NCT01411215|2014612|FG000|Overall Study|Did not meet entrance criteria|0
999267|NCT01411215|2014613|FG001|Overall Study|Did not meet entrance criteria|1
999268|NCT01411215|2014612|FG000|Overall Study|Study terminated by sponsor|2
999269|NCT01411215|2014613|FG001|Overall Study|Study terminated by sponsor|15
999270|NCT01411215|2014612|FG000|Overall Study|Protocol Violation|3
999271|NCT01411215|2014613|FG001|Overall Study|Protocol Violation|5
999272|NCT01411215|2014612|FG000|Overall Study|Withdrawal by Subject|34
999273|NCT01411215|2014613|FG001|Overall Study|Withdrawal by Subject|21
999274|NCT01411215|2014612|FG000|Overall Study|Other|12
999275|NCT01411215|2014613|FG001|Overall Study|Other|17
999276|NCT01411215|2014612|FG000|Overall Study|Screen failure|0
999277|NCT01411215|2014613|FG001|Overall Study|Screen failure|1
999278|NCT01411228|2014622|FG000|Overall Study|Lost to Follow-up|0
999279|NCT01411228|2014623|FG001|Overall Study|Lost to Follow-up|0
999280|NCT01411228|2014624|FG002|Overall Study|Lost to Follow-up|1
999281|NCT01411228|2014622|FG000|Overall Study|Withdrawal by Subject|1
999282|NCT01411228|2014623|FG001|Overall Study|Withdrawal by Subject|0
999283|NCT01411228|2014624|FG002|Overall Study|Withdrawal by Subject|0
999284|NCT01411241|2014634|FG000|Overall Study|Protocol Violation|0
999285|NCT01411241|2014635|FG001|Overall Study|Protocol Violation|5
999286|NCT01411241|2014634|FG000|Overall Study|Withdrawal by Subject|9
999287|NCT01411241|2014635|FG001|Overall Study|Withdrawal by Subject|10
999288|NCT01411241|2014634|FG000|Overall Study|Serious Adverse Event|0
999289|NCT01411241|2014635|FG001|Overall Study|Serious Adverse Event|3
999290|NCT01411241|2014634|FG000|Overall Study|Lost to Follow-up|2
999291|NCT01411241|2014635|FG001|Overall Study|Lost to Follow-up|4
999292|NCT01411319|2014674|FG000|Overall Study|Lost to Follow-up|1
999299|NCT01411774|2014736|FG000|Overall Study|Withdrawal by Subject|0
999300|NCT01411774|2014737|FG001|Overall Study|Withdrawal by Subject|3
999301|NCT01411839|2014745|FG000|Overall Study|Lost to Follow-up|4
999302|NCT01411839|2014746|FG001|Overall Study|Lost to Follow-up|3
999303|NCT01411852|2014754|FG000|Prehospital Intervention Phase|No qualifying SBP|5
999304|NCT01411852|2014755|FG001|Prehospital Intervention Phase|No qualifying SBP|4
999305|NCT01411852|2014754|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
999306|NCT01411852|2014755|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
999307|NCT01411852|2014754|FG000|Prehospital Intervention Phase|Found to be under age|0
999308|NCT01411852|2014755|FG001|Prehospital Intervention Phase|Found to be under age|1
999309|NCT01411852|2014754|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
999310|NCT01411852|2014755|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
999311|NCT01411852|2014754|FG000|Hospital Intervention Phase|Severe head injury|5
999312|NCT01411852|2014755|FG001|Hospital Intervention Phase|Severe head injury|4
999313|NCT01411852|2014754|FG000|Hospital Intervention Phase|No qualifying SBP|5
999314|NCT01411852|2014755|FG001|Hospital Intervention Phase|No qualifying SBP|1
999315|NCT01411852|2014754|FG000|Hospital Intervention Phase|Miscommunication error|1
999316|NCT01411852|2014755|FG001|Hospital Intervention Phase|Miscommunication error|2
999317|NCT01411852|2014754|FG000|Hospital Intervention Phase|CPR administered|3
999318|NCT01411852|2014755|FG001|Hospital Intervention Phase|CPR administered|1
999319|NCT01411852|2014754|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4
999320|NCT01411852|2014755|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1
999321|NCT01411852|2014754|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0
999322|NCT01411852|2014755|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2
999323|NCT01411852|2014754|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0
999324|NCT01411852|2014755|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1
999325|NCT01411852|2014754|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
999326|NCT01411852|2014755|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
999327|NCT01411852|2014754|FG000|Hospital Intervention Phase|Other ineligible|2
999328|NCT01411852|2014755|FG001|Hospital Intervention Phase|Other ineligible|2
999329|NCT01411852|2014754|FG000|Hospital Intervention Phase|Spinal cord injury|2
999330|NCT01411852|2014755|FG001|Hospital Intervention Phase|Spinal cord injury|0
999331|NCT01411852|2014754|FG000|Hospital Intervention Phase|Withdrawal by Subject|1
999332|NCT01411852|2014755|FG001|Hospital Intervention Phase|Withdrawal by Subject|0
999333|NCT01411852|2014754|FG000|Hospital Intervention Phase|Vascular access failed|1
999334|NCT01411852|2014755|FG001|Hospital Intervention Phase|Vascular access failed|0
999335|NCT01411891|2014765|FG000|Overall Study|Catheter dislodgement or loss to follow-|3
999336|NCT01411891|2014766|FG001|Overall Study|Catheter dislodgement or loss to follow-|2
999337|NCT01411917|2014774|FG000|Overall Study|Patient did not undergo scheduled surger|0
999338|NCT01411917|2014775|FG001|Overall Study|Patient did not undergo scheduled surger|1
999339|NCT01411995|2014783|FG000|Overall Study|Failed IUD insertion|0
999340|NCT01411995|2014784|FG001|Overall Study|Failed IUD insertion|1
999341|NCT01412021|2014790|FG000|Overall Study|Case Report Forms Not Retrieved|7
999342|NCT01412021|2014790|FG000|Overall Study|Treatment Prior to Approval|3
999343|NCT01412021|2014790|FG000|Overall Study|Transferred to Other Hospital|9
999344|NCT01412060|2014794|FG000|Open-label Run-in Period (RIP)|Adverse Event|86
999345|NCT01412060|2014795|FG001|Open-label Run-in Period (RIP)|Adverse Event|0
999346|NCT01412060|2014796|FG002|Open-label Run-in Period (RIP)|Adverse Event|0
999347|NCT01412060|2014794|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
999348|NCT01412060|2014795|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
999349|NCT01412060|2014796|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
999350|NCT01412060|2014794|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27
999351|NCT01412060|2014795|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0
999352|NCT01412060|2014796|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0
999353|NCT01412060|2014794|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
999354|NCT01412060|2014795|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
999355|NCT01412060|2014796|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
999356|NCT01412060|2014794|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32
999357|NCT01412060|2014795|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0
999358|NCT01412060|2014796|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0
999359|NCT01412060|2014794|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
999360|NCT01412060|2014795|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
999361|NCT01412060|2014796|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
999362|NCT01412060|2014794|FG000|Period Between RIP and SP|Adverse Event|4
999363|NCT01412060|2014795|FG001|Period Between RIP and SP|Adverse Event|0
999364|NCT01412060|2014796|FG002|Period Between RIP and SP|Adverse Event|0
999365|NCT01412060|2014794|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19
999366|NCT01412060|2014795|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0
999367|NCT01412060|2014796|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0
999368|NCT01412060|2014794|FG000|Period Between RIP and SP|Protocol Violation|2
999369|NCT01412060|2014795|FG001|Period Between RIP and SP|Protocol Violation|0
999370|NCT01412060|2014796|FG002|Period Between RIP and SP|Protocol Violation|0
999371|NCT01412060|2014794|FG000|Period Between RIP and SP|Withdrawal of Consent|1
999372|NCT01412060|2014795|FG001|Period Between RIP and SP|Withdrawal of Consent|0
999373|NCT01412060|2014796|FG002|Period Between RIP and SP|Withdrawal of Consent|0
999374|NCT01412060|2014794|FG000|Period Between RIP and SP|Lost to Follow-up|5
999375|NCT01412060|2014795|FG001|Period Between RIP and SP|Lost to Follow-up|0
999376|NCT01412060|2014796|FG002|Period Between RIP and SP|Lost to Follow-up|0
999377|NCT01412060|2014794|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23
999378|NCT01412060|2014795|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0
999379|NCT01412060|2014796|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0
999380|NCT01412060|2014794|FG000|Open-label Stabilization Period (SP)|Adverse Event|9
999381|NCT01412060|2014795|FG001|Open-label Stabilization Period (SP)|Adverse Event|0
999382|NCT01412060|2014796|FG002|Open-label Stabilization Period (SP)|Adverse Event|0
999383|NCT01412060|2014794|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
999384|NCT01412060|2014795|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
999385|NCT01412060|2014796|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
999386|NCT01412060|2014794|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14
999387|NCT01412060|2014795|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0
999388|NCT01412060|2014796|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0
999389|NCT01412060|2014794|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
999390|NCT01412060|2014795|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
999391|NCT01412060|2014796|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
999392|NCT01412060|2014794|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9
999393|NCT01412060|2014795|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0
999394|NCT01412060|2014796|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0
999395|NCT01412060|2014794|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
999396|NCT01412060|2014795|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
999397|NCT01412060|2014796|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
999398|NCT01412060|2014794|FG000|Period Between SP and DBP|Protocol Violation|2
999399|NCT01412060|2014795|FG001|Period Between SP and DBP|Protocol Violation|0
999400|NCT01412060|2014796|FG002|Period Between SP and DBP|Protocol Violation|0
999401|NCT01412060|2014794|FG000|Period Between SP and DBP|Withdrawal of Consent|2
999402|NCT01412060|2014795|FG001|Period Between SP and DBP|Withdrawal of Consent|0
999403|NCT01412060|2014796|FG002|Period Between SP and DBP|Withdrawal of Consent|0
999404|NCT01412060|2014794|FG000|Period Between SP and DBP|Lost to Follow-up|1
999405|NCT01412060|2014795|FG001|Period Between SP and DBP|Lost to Follow-up|0
999406|NCT01412060|2014796|FG002|Period Between SP and DBP|Lost to Follow-up|0
999407|NCT01412060|2014794|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
999408|NCT01412060|2014795|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
999409|NCT01412060|2014796|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
999410|NCT01412060|2014794|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55
999411|NCT01412060|2014795|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0
999412|NCT01412060|2014796|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0
999413|NCT01412060|2014794|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0
999414|NCT01412060|2014795|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5
999415|NCT01412060|2014796|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6
999416|NCT01412060|2014794|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0
999417|NCT01412060|2014795|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4
999418|NCT01412060|2014796|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5
999419|NCT01412060|2014794|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
999420|NCT01412060|2014795|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
999421|NCT01412060|2014796|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
999422|NCT01412060|2014794|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
999423|NCT01412060|2014795|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
999424|NCT01412060|2014796|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
999425|NCT01412060|2014794|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
999426|NCT01412060|2014795|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
999427|NCT01412060|2014796|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
999428|NCT01412060|2014794|FG000|Double-blind Treatment Phase (DBP)|Relapse|0
999429|NCT01412060|2014795|FG001|Double-blind Treatment Phase (DBP)|Relapse|47
999430|NCT01412060|2014796|FG002|Double-blind Treatment Phase (DBP)|Relapse|25
999431|NCT01412151|2014810|FG000|Week 0 - 306 - Treatment Period|Death|1
999432|NCT01412151|2014810|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
999433|NCT01412151|2014810|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
999434|NCT01412151|2014810|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
999435|NCT01412229|2014820|FG000|Overall Study|Physician Decision|1
999458|NCT01412424|2014861|FG000|Core Treatment Period|Treatment Failure|24
999459|NCT01412424|2014861|FG000|Core Treatment Period|Adverse Event|21
999460|NCT01412424|2014861|FG000|Core Treatment Period|Patient Request|5
999461|NCT01412424|2014861|FG000|Core Treatment Period|Lost to Follow-up|2
999462|NCT01412424|2014861|FG000|Core Treatment Period|Sponsor Request|1
999463|NCT01412424|2014861|FG000|Extension Treatment Period|Adverse Event|2
999464|NCT01412424|2014861|FG000|Extension Treatment Period|Treatment Failure|2
999465|NCT01412424|2014861|FG000|Extension Treatment Period|Patient Request|2
999466|NCT01412801|2014902|FG000|Overall Study|Death|0
999467|NCT01412801|2014903|FG001|Overall Study|Death|1
999468|NCT01412801|2014904|FG002|Overall Study|Death|0
999469|NCT01412801|2014905|FG003|Overall Study|Death|4
999470|NCT01412801|2014906|FG004|Overall Study|Death|2
999471|NCT01412801|2014907|FG005|Overall Study|Death|2
999472|NCT01412801|2014902|FG000|Overall Study|Lost to Follow-up|1
999473|NCT01412801|2014903|FG001|Overall Study|Lost to Follow-up|2
999474|NCT01412801|2014904|FG002|Overall Study|Lost to Follow-up|4
999475|NCT01412801|2014905|FG003|Overall Study|Lost to Follow-up|0
999476|NCT01412801|2014906|FG004|Overall Study|Lost to Follow-up|1
999477|NCT01412801|2014907|FG005|Overall Study|Lost to Follow-up|1
999478|NCT01412801|2014902|FG000|Overall Study|Withdrawal by Subject|3
999479|NCT01412801|2014903|FG001|Overall Study|Withdrawal by Subject|2
999480|NCT01412801|2014904|FG002|Overall Study|Withdrawal by Subject|1
999481|NCT01412801|2014905|FG003|Overall Study|Withdrawal by Subject|0
999482|NCT01412801|2014906|FG004|Overall Study|Withdrawal by Subject|0
999483|NCT01412801|2014907|FG005|Overall Study|Withdrawal by Subject|0
999484|NCT01412801|2014902|FG000|Overall Study|Relocated to another area|0
999485|NCT01412801|2014903|FG001|Overall Study|Relocated to another area|0
999486|NCT01412801|2014904|FG002|Overall Study|Relocated to another area|2
999487|NCT01412801|2014905|FG003|Overall Study|Relocated to another area|0
999488|NCT01412801|2014906|FG004|Overall Study|Relocated to another area|0
999489|NCT01412801|2014907|FG005|Overall Study|Relocated to another area|0
999490|NCT01412879|2014941|FG000|Initial Registration (Induction Therapy)|Adverse Event|5
999491|NCT01412879|2014942|FG001|Initial Registration (Induction Therapy)|Adverse Event|3
999492|NCT01412879|2014943|FG002|Initial Registration (Induction Therapy)|Adverse Event|0
999493|NCT01412879|2014941|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
999494|NCT01412879|2014942|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
999495|NCT01412879|2014943|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
999496|NCT01412879|2014941|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0
999497|NCT01412879|2014942|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1
999498|NCT01412879|2014943|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0
999499|NCT01412879|2014941|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
999500|NCT01412879|2014942|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
999501|NCT01412879|2014943|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
999502|NCT01412879|2014941|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1
999503|NCT01412879|2014942|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0
999504|NCT01412879|2014943|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0
999505|NCT01412944|2014965|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
999506|NCT01412944|2014966|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
999507|NCT01412944|2014967|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
999508|NCT01412944|2014968|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
999509|NCT01412944|2014969|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
999510|NCT01412944|2014970|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
999511|NCT01412944|2014965|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
999512|NCT01412944|2014966|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
999513|NCT01412944|2014967|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
999514|NCT01412944|2014968|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
999515|NCT01412944|2014969|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
999516|NCT01412944|2014970|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
999517|NCT01412944|2014965|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
999518|NCT01412944|2014966|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
999519|NCT01412944|2014967|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
999520|NCT01412944|2014968|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
999521|NCT01412944|2014969|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
999522|NCT01412944|2014970|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
999523|NCT01412944|2014965|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1
999524|NCT01412944|2014966|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0
999525|NCT01412944|2014967|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0
999526|NCT01412944|2014968|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0
999527|NCT01412944|2014969|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0
999528|NCT01412944|2014970|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0
999529|NCT01412944|2014965|FG000|IV: Per CAIN457A2307|Protocol deviation|0
999530|NCT01412944|2014966|FG001|IV: Per CAIN457A2307|Protocol deviation|1
999531|NCT01412944|2014967|FG002|IV: Per CAIN457A2307|Protocol deviation|0
999532|NCT01412944|2014968|FG003|IV: Per CAIN457A2307|Protocol deviation|0
999533|NCT01412944|2014969|FG004|IV: Per CAIN457A2307|Protocol deviation|0
999534|NCT01412944|2014970|FG005|IV: Per CAIN457A2307|Protocol deviation|0
999535|NCT01412944|2014965|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0
999536|NCT01412944|2014966|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1
999537|NCT01412944|2014967|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0
999538|NCT01412944|2014968|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0
999539|NCT01412944|2014969|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0
999540|NCT01412944|2014970|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0
999541|NCT01412944|2014965|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0
999542|NCT01412944|2014966|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0
999543|NCT01412944|2014967|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1
999544|NCT01412944|2014968|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1
999545|NCT01412944|2014969|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1
999546|NCT01412944|2014970|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
999547|NCT01412944|2014965|FG000|Entire: IV + Maintenance|Adverse Event|0
999548|NCT01412944|2014966|FG001|Entire: IV + Maintenance|Adverse Event|0
999549|NCT01412944|2014967|FG002|Entire: IV + Maintenance|Adverse Event|0
999550|NCT01412944|2014968|FG003|Entire: IV + Maintenance|Adverse Event|0
999551|NCT01412944|2014969|FG004|Entire: IV + Maintenance|Adverse Event|1
999552|NCT01412944|2014970|FG005|Entire: IV + Maintenance|Adverse Event|0
999553|NCT01412944|2014965|FG000|Entire: IV + Maintenance|Protocol deviation|0
914094|NCT00813150|1891893|FG000|Treatment Period|Adverse Event|16
914095|NCT00813150|1891894|FG001|Treatment Period|Adverse Event|15
914096|NCT00813150|1891893|FG000|Treatment Period|Death|2
914097|NCT00813150|1891894|FG001|Treatment Period|Death|0
914098|NCT00813150|1891893|FG000|Treatment Period|Progressive disease|1
914099|NCT00813150|1891894|FG001|Treatment Period|Progressive disease|0
914100|NCT00813150|1891893|FG000|Treatment Period|Complete response|0
914101|NCT00813150|1891894|FG001|Treatment Period|Complete response|1
914102|NCT00813150|1891893|FG000|Treatment Period|Stable disease|1
914103|NCT00813150|1891894|FG001|Treatment Period|Stable disease|2
914104|NCT00813150|1891893|FG000|Treatment Period|Protocol Violation|3
914105|NCT00813150|1891894|FG001|Treatment Period|Protocol Violation|4
914106|NCT00813150|1891893|FG000|Treatment Period|Withdrawal by Subject|5
914107|NCT00813150|1891894|FG001|Treatment Period|Withdrawal by Subject|3
914108|NCT00813150|1891893|FG000|Treatment Period|Non compliance|0
914109|NCT00813150|1891894|FG001|Treatment Period|Non compliance|1
999554|NCT01412944|2014966|FG001|Entire: IV + Maintenance|Protocol deviation|0
999555|NCT01412944|2014967|FG002|Entire: IV + Maintenance|Protocol deviation|0
999556|NCT01412944|2014968|FG003|Entire: IV + Maintenance|Protocol deviation|0
999557|NCT01412944|2014969|FG004|Entire: IV + Maintenance|Protocol deviation|0
999558|NCT01412944|2014970|FG005|Entire: IV + Maintenance|Protocol deviation|1
999559|NCT01412944|2014965|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
999560|NCT01412944|2014966|FG001|Entire: IV + Maintenance|Lost to Follow-up|0
999561|NCT01412944|2014967|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
999562|NCT01412944|2014968|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
999563|NCT01412944|2014969|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
999564|NCT01412944|2014970|FG005|Entire: IV + Maintenance|Lost to Follow-up|1
999565|NCT01412944|2014965|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
999566|NCT01412944|2014966|FG001|Entire: IV + Maintenance|Lack of Efficacy|0
999567|NCT01412944|2014967|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
999568|NCT01412944|2014968|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
999569|NCT01412944|2014969|FG004|Entire: IV + Maintenance|Lack of Efficacy|1
999570|NCT01412944|2014970|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
999571|NCT01412944|2014965|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2
999572|NCT01412944|2014966|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1
999573|NCT01412944|2014967|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0
999574|NCT01412944|2014968|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0
999575|NCT01412944|2014969|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0
999576|NCT01412944|2014970|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
999577|NCT01412944|2014965|FG000|Entire: IV + Maintenance|Protocol deviation|0
999578|NCT01412944|2014966|FG001|Entire: IV + Maintenance|Protocol deviation|1
999579|NCT01412944|2014967|FG002|Entire: IV + Maintenance|Protocol deviation|0
999580|NCT01412944|2014968|FG003|Entire: IV + Maintenance|Protocol deviation|0
999581|NCT01412944|2014969|FG004|Entire: IV + Maintenance|Protocol deviation|0
999582|NCT01412944|2014970|FG005|Entire: IV + Maintenance|Protocol deviation|0
999583|NCT01412944|2014965|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
999584|NCT01412944|2014966|FG001|Entire: IV + Maintenance|Lost to Follow-up|1
999585|NCT01412944|2014967|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
999586|NCT01412944|2014968|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
999587|NCT01412944|2014969|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
999588|NCT01412944|2014970|FG005|Entire: IV + Maintenance|Lost to Follow-up|0
999589|NCT01412944|2014965|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
999590|NCT01412944|2014966|FG001|Entire: IV + Maintenance|Lack of Efficacy|1
999591|NCT01412944|2014967|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
999592|NCT01412944|2014968|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
999593|NCT01412944|2014969|FG004|Entire: IV + Maintenance|Lack of Efficacy|0
999594|NCT01412944|2014970|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
999595|NCT01412944|2014965|FG000|Entire: IV + Maintenance|Adverse Event|0
999596|NCT01412944|2014966|FG001|Entire: IV + Maintenance|Adverse Event|1
999597|NCT01412944|2014967|FG002|Entire: IV + Maintenance|Adverse Event|0
999598|NCT01412944|2014968|FG003|Entire: IV + Maintenance|Adverse Event|0
999599|NCT01412944|2014969|FG004|Entire: IV + Maintenance|Adverse Event|0
999600|NCT01412944|2014970|FG005|Entire: IV + Maintenance|Adverse Event|0
999601|NCT01412957|2014988|FG000|Overall Study|Withdrawal by Subject|6
999602|NCT01412957|2014989|FG001|Overall Study|Withdrawal by Subject|22
999603|NCT01412957|2014988|FG000|Overall Study|Lost to Follow-up|7
999604|NCT01412957|2014989|FG001|Overall Study|Lost to Follow-up|2
999605|NCT01412957|2014988|FG000|Overall Study|Death|136
999606|NCT01412957|2014989|FG001|Overall Study|Death|133
999607|NCT01412983|2014995|FG000|1st Period|Ineligible|0
999608|NCT01412983|2014996|FG001|1st Period|Ineligible|1
999609|NCT01412983|2014995|FG000|1st Period|Positive slit lamp finding|0
999610|NCT01412983|2014996|FG001|1st Period|Positive slit lamp finding|1
999611|NCT01412983|2014995|FG000|1st Period|Unacceptable lens movement|0
999612|NCT01412983|2014996|FG001|1st Period|Unacceptable lens movement|1
999613|NCT01412983|2014995|FG000|1st Period|Inability to maintain wear|0
999614|NCT01412983|2014996|FG001|1st Period|Inability to maintain wear|1
999615|NCT01413178|2015014|FG000|Overall Study|Toxicity|1
999616|NCT01413178|2015015|FG001|Overall Study|Toxicity|0
999617|NCT01413178|2015014|FG000|Overall Study|Ineligible|0
999618|NCT01413178|2015015|FG001|Overall Study|Ineligible|2
999619|NCT01413191|2015021|FG000|Overall Study|Lost to Follow-up|5
999620|NCT01413191|2015021|FG000|Overall Study|Disease Progression|5
999621|NCT01413191|2015021|FG000|Overall Study|Death|1
999622|NCT01413204|2015028|FG000|Overall Study|Adverse Event|1
999623|NCT01413204|2015029|FG001|Overall Study|Adverse Event|2
999624|NCT01413204|2015030|FG002|Overall Study|Adverse Event|2
999625|NCT01413204|2015028|FG000|Overall Study|Physician Decision|3
999626|NCT01413204|2015029|FG001|Overall Study|Physician Decision|0
999627|NCT01413204|2015030|FG002|Overall Study|Physician Decision|2
999628|NCT01413204|2015028|FG000|Overall Study|Withdrawal by Subject|1
999629|NCT01413204|2015029|FG001|Overall Study|Withdrawal by Subject|4
999630|NCT01413204|2015030|FG002|Overall Study|Withdrawal by Subject|4
999631|NCT01413204|2015028|FG000|Overall Study|Clearly not eligible for the study|0
999632|NCT01413204|2015029|FG001|Overall Study|Clearly not eligible for the study|0
1006727|NCT01469052|2025441|FG005|Overall Study|Moved to rollover protocol|1
999633|NCT01413204|2015030|FG002|Overall Study|Clearly not eligible for the study|1
999634|NCT01413204|2015028|FG000|Overall Study|Fasting plasma glucose level increased|1
999635|NCT01413204|2015029|FG001|Overall Study|Fasting plasma glucose level increased|0
999636|NCT01413204|2015030|FG002|Overall Study|Fasting plasma glucose level increased|10
999637|NCT01413360|2015038|FG000|Overall Study|Lost to Follow-up|2
999638|NCT01413360|2015038|FG000|Overall Study|Adverse Event|1
999639|NCT01413503|2015042|FG000|Overall Study|Lost to Follow-up|1
999640|NCT01413542|2015057|FG000|Overall Study|Physician Decision|1
999641|NCT01413542|2015058|FG001|Overall Study|Physician Decision|0
999642|NCT01413542|2015059|FG002|Overall Study|Physician Decision|3
999643|NCT01413542|2015060|FG003|Overall Study|Physician Decision|0
999644|NCT01413542|2015057|FG000|Overall Study|Adverse Event|0
999645|NCT01413542|2015058|FG001|Overall Study|Adverse Event|0
999646|NCT01413542|2015059|FG002|Overall Study|Adverse Event|0
999647|NCT01413542|2015060|FG003|Overall Study|Adverse Event|1
999648|NCT01413958|2015092|FG000|Overall Study|Lost to Follow-up|0
999649|NCT01413958|2015093|FG001|Overall Study|Lost to Follow-up|1
999650|NCT01414075|2015136|FG000|Overall Study|Adverse Event|1
999651|NCT01414075|2015137|FG001|Overall Study|Adverse Event|0
999652|NCT01414075|2015138|FG002|Overall Study|Adverse Event|1
999653|NCT01414075|2015139|FG003|Overall Study|Adverse Event|0
999654|NCT01414075|2015136|FG000|Overall Study|Death|1
999655|NCT01414075|2015137|FG001|Overall Study|Death|0
999656|NCT01414075|2015138|FG002|Overall Study|Death|0
999657|NCT01414075|2015139|FG003|Overall Study|Death|1
999658|NCT01414075|2015136|FG000|Overall Study|Withdrawal by Subject|0
999659|NCT01414075|2015137|FG001|Overall Study|Withdrawal by Subject|0
999660|NCT01414075|2015138|FG002|Overall Study|Withdrawal by Subject|0
999661|NCT01414075|2015139|FG003|Overall Study|Withdrawal by Subject|1
999662|NCT01414075|2015136|FG000|Overall Study|Other than specified|1
999663|NCT01414075|2015137|FG001|Overall Study|Other than specified|0
999664|NCT01414075|2015138|FG002|Overall Study|Other than specified|1
999665|NCT01414075|2015139|FG003|Overall Study|Other than specified|0
999666|NCT01414114|2015149|FG000|Overall Study|Adverse Event|2
999667|NCT01414114|2015149|FG000|Overall Study|Withdrawal by Subject|1
999668|NCT01414114|2015149|FG000|Overall Study|Other|2
999669|NCT01414205|2015195|FG000|Overall Study|Death|5
999670|NCT01414205|2015196|FG001|Overall Study|Death|1
999671|NCT01414205|2015195|FG000|Overall Study|Lost to Follow-up|1
999672|NCT01414205|2015196|FG001|Overall Study|Lost to Follow-up|4
999673|NCT01414205|2015195|FG000|Overall Study|Physician Decision|0
999674|NCT01414205|2015196|FG001|Overall Study|Physician Decision|1
999675|NCT01414205|2015195|FG000|Overall Study|Randomized but not Treated|1
999676|NCT01414205|2015196|FG001|Overall Study|Randomized but not Treated|1
999677|NCT01414257|2015211|FG000|Overall Study|No Visit After First Day of Treatment|12
999678|NCT01414257|2015211|FG000|Overall Study|Protocol Violation|10
999679|NCT01414738|2015251|FG000|Overall Study|Death|26
999680|NCT01414738|2015251|FG000|Overall Study|Refused testing|5
999681|NCT01414738|2015251|FG000|Overall Study|Lost to Follow-up|2
999682|NCT01414738|2015251|FG000|Overall Study|Refused, disease progression|8
999683|NCT01414738|2015251|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3
999684|NCT01414855|2015255|FG000|Overall Study|Death|17
999685|NCT01414855|2015255|FG000|Overall Study|Lost to Follow-up|5
999686|NCT01414855|2015255|FG000|Overall Study|Withdrawal by Subject|7
999687|NCT01415349|2015263|FG000|Treatment Period 1|Adverse Event|0
999688|NCT01415349|2015264|FG001|Treatment Period 1|Adverse Event|1
999689|NCT01415349|2015263|FG000|Treatment Period 1|Withdrawal by Subject|0
999690|NCT01415349|2015264|FG001|Treatment Period 1|Withdrawal by Subject|1
999691|NCT01415401|2015270|FG000|Overall Study|Adverse Event|5
999692|NCT01415401|2015270|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1
999693|NCT01415401|2015270|FG000|Overall Study|Terminated by Sponsor|1
999694|NCT01415440|2015296|FG000|Overall Study|Lost to Follow-up|0
999695|NCT01415440|2015297|FG001|Overall Study|Lost to Follow-up|1
999696|NCT01415440|2015298|FG002|Overall Study|Lost to Follow-up|2
999697|NCT01415440|2015296|FG000|Overall Study|Physician Decision|3
999698|NCT01415440|2015297|FG001|Overall Study|Physician Decision|0
999699|NCT01415440|2015298|FG002|Overall Study|Physician Decision|0
999700|NCT01415440|2015296|FG000|Overall Study|Withdrawal by Subject|1
999701|NCT01415440|2015297|FG001|Overall Study|Withdrawal by Subject|0
999702|NCT01415440|2015298|FG002|Overall Study|Withdrawal by Subject|0
999703|NCT01415518|2015311|FG000|Overall Study|Withdrawal by Subject|2
999704|NCT01415518|2015312|FG001|Overall Study|Withdrawal by Subject|12
999705|NCT01415518|2015311|FG000|Overall Study|Protocol Violation|6
999706|NCT01415518|2015312|FG001|Overall Study|Protocol Violation|8
999707|NCT01415518|2015311|FG000|Overall Study|Lost to Follow-up|3
999708|NCT01415518|2015312|FG001|Overall Study|Lost to Follow-up|5
999709|NCT01415518|2015311|FG000|Overall Study|Adverse Event|3
999710|NCT01415518|2015312|FG001|Overall Study|Adverse Event|4
999711|NCT01415518|2015311|FG000|Overall Study|Death|1
999712|NCT01415518|2015312|FG001|Overall Study|Death|1
999713|NCT01415518|2015311|FG000|Overall Study|Condition under Investigation Worsened|1
999714|NCT01415518|2015312|FG001|Overall Study|Condition under Investigation Worsened|1
999715|NCT01415531|2015320|FG000|Overall Study|Adverse Event|7
999716|NCT01415531|2015321|FG001|Overall Study|Adverse Event|10
999717|NCT01415531|2015320|FG000|Overall Study|Lack of Efficacy|3
999718|NCT01415531|2015321|FG001|Overall Study|Lack of Efficacy|2
999719|NCT01415531|2015320|FG000|Overall Study|Protocol Violation|0
999720|NCT01415531|2015321|FG001|Overall Study|Protocol Violation|1
999721|NCT01415531|2015320|FG000|Overall Study|Withdrawal by Subject|5
999722|NCT01415531|2015321|FG001|Overall Study|Withdrawal by Subject|4
999723|NCT01415531|2015320|FG000|Overall Study|Lost to Follow-up|6
999724|NCT01415531|2015321|FG001|Overall Study|Lost to Follow-up|14
999725|NCT01415531|2015320|FG000|Overall Study|Lack of Compliance|1
999726|NCT01415531|2015321|FG001|Overall Study|Lack of Compliance|4
999727|NCT01415531|2015320|FG000|Overall Study|Other Reasons|3
999728|NCT01415531|2015321|FG001|Overall Study|Other Reasons|2
999729|NCT01415908|2015338|FG000|Overall Study|Withdrawal by Subject|1
999730|NCT01415908|2015339|FG001|Overall Study|Withdrawal by Subject|0
999731|NCT01415921|2015347|FG000|Overall Study|Adverse Event|0
999732|NCT01415921|2015348|FG001|Overall Study|Adverse Event|1
999733|NCT01415921|2015347|FG000|Overall Study|Physician Decision|1
999734|NCT01415921|2015348|FG001|Overall Study|Physician Decision|1
999735|NCT01415921|2015347|FG000|Overall Study|Withdrawal by Subject|0
999736|NCT01415921|2015348|FG001|Overall Study|Withdrawal by Subject|1
999737|NCT01415921|2015347|FG000|Overall Study|Other|2
999738|NCT01415921|2015348|FG001|Overall Study|Other|0
999739|NCT01416142|2015385|FG000|PureVision2 HD|Inability to maintain lens wear|0
999740|NCT01416142|2015386|FG001|PureVision2 HD|Inability to maintain lens wear|0
999741|NCT01416142|2015387|FG002|PureVision2 HD|Inability to maintain lens wear|1
999742|NCT01416155|2015395|FG000|Overall Study|Adverse Event|8
999743|NCT01416155|2015395|FG000|Overall Study|Positive for anti-BG00002 antibodies|2
999744|NCT01416155|2015395|FG000|Overall Study|Withdrawal by Subject|33
999745|NCT01416155|2015395|FG000|Overall Study|Investigator decision|8
999746|NCT01416155|2015395|FG000|Overall Study|Other|7
999747|NCT01416181|2015401|FG000|Part 1|Other|10
999748|NCT01416181|2015402|FG001|Part 1|Other|24
999749|NCT01416181|2015401|FG000|Part 1|Death|0
999750|NCT01416181|2015402|FG001|Part 1|Death|1
999751|NCT01416181|2015401|FG000|Part 1|Investigator Decision|7
999752|NCT01416181|2015402|FG001|Part 1|Investigator Decision|6
999753|NCT01416181|2015401|FG000|Part 1|Withdrawal by Subject|74
999754|NCT01416181|2015402|FG001|Part 1|Withdrawal by Subject|48
999755|NCT01416181|2015401|FG000|Part 1|Lack of Efficacy|16
999756|NCT01416181|2015402|FG001|Part 1|Lack of Efficacy|8
999757|NCT01416181|2015401|FG000|Part 1|Lost to Follow-up|1
999758|NCT01416181|2015402|FG001|Part 1|Lost to Follow-up|1
999759|NCT01416181|2015401|FG000|Part 1|Adverse Event|15
999760|NCT01416181|2015402|FG001|Part 1|Adverse Event|18
999761|NCT01416181|2015401|FG000|Part 1|Ongoing in Follow-Up|14
999762|NCT01416181|2015402|FG001|Part 1|Ongoing in Follow-Up|8
999763|NCT01416181|2015401|FG000|Part 2|Adverse Event|11
999764|NCT01416181|2015402|FG001|Part 2|Adverse Event|4
999765|NCT01416181|2015401|FG000|Part 2|Other|234
999766|NCT01416181|2015402|FG001|Part 2|Other|267
999767|NCT01416181|2015401|FG000|Part 2|Investigator Decision|6
999768|NCT01416181|2015402|FG001|Part 2|Investigator Decision|7
999769|NCT01416181|2015401|FG000|Part 2|Withdrawal by Subject|14
999770|NCT01416181|2015402|FG001|Part 2|Withdrawal by Subject|5
999771|NCT01416181|2015401|FG000|Part 2|Lack of Efficacy|4
999772|NCT01416181|2015402|FG001|Part 2|Lack of Efficacy|1
999773|NCT01416181|2015401|FG000|Part 2|Lost to Follow-up|2
999774|NCT01416181|2015402|FG001|Part 2|Lost to Follow-up|2
999775|NCT01416389|2015425|FG000|Overall Study|Lost to Follow-up|1
999776|NCT01416389|2015426|FG001|Overall Study|Lost to Follow-up|0
999777|NCT01416389|2015425|FG000|Overall Study|Started New Therapy|2
999778|NCT01416389|2015426|FG001|Overall Study|Started New Therapy|0
999779|NCT01416441|2015434|FG000|Overall Study|Lost to Follow-up|5
999780|NCT01416441|2015434|FG000|Overall Study|Adverse Event|6
999781|NCT01416441|2015434|FG000|Overall Study|Sponsor Discontinued Trial Site|43
999782|NCT01416441|2015434|FG000|Overall Study|Subject Met Withdrawal Criteria|10
999783|NCT01416441|2015434|FG000|Overall Study|Investigator Withdrew Subject|2
999784|NCT01416441|2015434|FG000|Overall Study|Subject Withdrew Consent|12
999785|NCT01416441|2015434|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3
999786|NCT01416571|2015438|FG000|Overall Study|Lost to Follow-up|2
999787|NCT01416610|2015461|FG000|Overall Study|Adverse Event|4
999788|NCT01416610|2015461|FG000|Overall Study|Adverse Event -Patient decision|3
999789|NCT01416610|2015461|FG000|Overall Study|Lack of Efficacy|4
999790|NCT01416610|2015461|FG000|Overall Study|No reason given|5
999791|NCT01416610|2015461|FG000|Overall Study|Withdrawal by Subject|13
999792|NCT01416610|2015461|FG000|Overall Study|Lost to Follow-up|7
999793|NCT01416610|2015461|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7
999794|NCT01416805|2015480|FG000|Overall Study|Lost to Follow-up|4
999795|NCT01416805|2015481|FG001|Overall Study|Lost to Follow-up|4
999796|NCT01417000|2015493|FG000|Overall Study|Death|59
999797|NCT01417000|2015494|FG001|Overall Study|Death|28
999798|NCT01417000|2015493|FG000|Overall Study|Lost to Follow-up|1
999799|NCT01417000|2015494|FG001|Overall Study|Lost to Follow-up|0
999800|NCT01417000|2015493|FG000|Overall Study|Study Terminated by Sponsor|1
999801|NCT01417000|2015494|FG001|Overall Study|Study Terminated by Sponsor|1
999802|NCT01417078|2015509|FG000|Overall Study|Withdrawal by Subject|1
999803|NCT01417104|2015517|FG000|Overall Study|Withdrawal by Subject|5
999804|NCT01417104|2015518|FG001|Overall Study|Withdrawal by Subject|1
914110|NCT00813150|1891893|FG000|Treatment Period|Reason not specified|3
914111|NCT00813150|1891894|FG001|Treatment Period|Reason not specified|4
914112|NCT00813150|1891893|FG000|Treatment Period|Data not available|1
914113|NCT00813150|1891894|FG001|Treatment Period|Data not available|2
914114|NCT00813150|1891893|FG000|Long Term Follow-up|Death|0
914115|NCT00813150|1891894|FG001|Long Term Follow-up|Death|4
914116|NCT00813150|1891893|FG000|Long Term Follow-up|Other|0
914117|NCT00813150|1891894|FG001|Long Term Follow-up|Other|3
914118|NCT00813150|1891893|FG000|Long Term Follow-up|Lost to Follow-up|2
914119|NCT00813150|1891894|FG001|Long Term Follow-up|Lost to Follow-up|0
914120|NCT00813150|1891893|FG000|Long Term Follow-up|Progression/Relapse|22
914121|NCT00813150|1891894|FG001|Long Term Follow-up|Progression/Relapse|24
914122|NCT00813293|1891913|FG000|Overall Study|Intercurrent illness|1
914123|NCT00813293|1891914|FG001|Overall Study|Intercurrent illness|0
914124|NCT00813293|1891913|FG000|Overall Study|Adverse Event|0
914125|NCT00813293|1891914|FG001|Overall Study|Adverse Event|1
914126|NCT00813358|1891929|FG000|Overall Study|Death|32
914127|NCT00813358|1891929|FG000|Overall Study|Lost to Follow-up|12
914128|NCT00813358|1891929|FG000|Overall Study|other endpoints|5
914129|NCT00813358|1891929|FG000|Overall Study|Withdrawal by Subject|20
914130|NCT00813488|1891933|FG000|Titration Period 1|Adverse Event|6
914131|NCT00813488|1891934|FG001|Titration Period 1|Adverse Event|1
914132|NCT00813488|1891933|FG000|Titration Period 1|Lack of Efficacy|9
999805|NCT01417104|2015517|FG000|Overall Study|Failure to make contact|0
999806|NCT01417104|2015518|FG001|Overall Study|Failure to make contact|1
999807|NCT01417104|2015517|FG000|Overall Study|Adverse Event|1
999808|NCT01417104|2015518|FG001|Overall Study|Adverse Event|0
999809|NCT01417156|2015524|FG000|Overall Study|Adverse Event|12
999810|NCT01417156|2015524|FG000|Overall Study|Protocol Violation|2
999811|NCT01417195|2015530|FG000|Overall Study|Stimulation failure|1
999812|NCT01417195|2015531|FG001|Overall Study|Stimulation failure|0
999813|NCT01417195|2015530|FG000|Overall Study|No embryos for transfer|0
999814|NCT01417195|2015531|FG001|Overall Study|No embryos for transfer|1
999815|NCT01417195|2015530|FG000|Overall Study|No transfer due to risk of OHSS|1
999816|NCT01417195|2015531|FG001|Overall Study|No transfer due to risk of OHSS|0
999817|NCT01417195|2015530|FG000|Overall Study|No transfer due to elevated progesterone|1
999818|NCT01417195|2015531|FG001|Overall Study|No transfer due to elevated progesterone|0
999819|NCT01417234|2015538|FG000|Overall Study|Subject non-compliant|3
999820|NCT01417481|2015577|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0
999821|NCT01417481|2015578|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2
999822|NCT01418209|2015618|FG000|Overall Study|Withdrawal by Subject|1
999823|NCT01418209|2015619|FG001|Overall Study|Withdrawal by Subject|0
999824|NCT01418209|2015620|FG002|Overall Study|Withdrawal by Subject|1
999825|NCT01418209|2015618|FG000|Overall Study|Did not provide hot flash diary data|1
999826|NCT01418209|2015619|FG001|Overall Study|Did not provide hot flash diary data|3
999827|NCT01418209|2015620|FG002|Overall Study|Did not provide hot flash diary data|3
999828|NCT01418339|2015630|FG000|Overall Study|Adverse Event|5
999829|NCT01418339|2015631|FG001|Overall Study|Adverse Event|2
999830|NCT01418339|2015630|FG000|Overall Study|Subject Withdrew Consent|1
999831|NCT01418339|2015631|FG001|Overall Study|Subject Withdrew Consent|2
999832|NCT01418339|2015630|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6
999833|NCT01418339|2015631|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6
999834|NCT01418352|2015641|FG000|Overall Study|Lost to Follow-up|2
999835|NCT01418352|2015642|FG001|Overall Study|Lost to Follow-up|0
999836|NCT01418352|2015643|FG002|Overall Study|Lost to Follow-up|0
999837|NCT01418352|2015644|FG003|Overall Study|Lost to Follow-up|0
999838|NCT01418352|2015641|FG000|Overall Study|Adverse Event|0
999839|NCT01418352|2015642|FG001|Overall Study|Adverse Event|1
999840|NCT01418352|2015643|FG002|Overall Study|Adverse Event|0
999841|NCT01418352|2015644|FG003|Overall Study|Adverse Event|0
999842|NCT01418352|2015641|FG000|Overall Study|Sponsor Discontinued Trial Site|0
999843|NCT01418352|2015642|FG001|Overall Study|Sponsor Discontinued Trial Site|2
999844|NCT01418352|2015643|FG002|Overall Study|Sponsor Discontinued Trial Site|2
999845|NCT01418352|2015644|FG003|Overall Study|Sponsor Discontinued Trial Site|2
999846|NCT01418352|2015641|FG000|Overall Study|Subject Withdrew Consent|0
999847|NCT01418352|2015642|FG001|Overall Study|Subject Withdrew Consent|1
999848|NCT01418352|2015643|FG002|Overall Study|Subject Withdrew Consent|2
999849|NCT01418352|2015644|FG003|Overall Study|Subject Withdrew Consent|1
999850|NCT01418352|2015641|FG000|Overall Study|Protocol Deviation|0
999851|NCT01418352|2015642|FG001|Overall Study|Protocol Deviation|0
999852|NCT01418352|2015643|FG002|Overall Study|Protocol Deviation|1
999853|NCT01418352|2015644|FG003|Overall Study|Protocol Deviation|0
999854|NCT01418352|2015641|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1
999855|NCT01418352|2015642|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0
999856|NCT01418352|2015643|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0
999857|NCT01418352|2015644|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0
999858|NCT01418365|2015656|FG000|First Intervention|Withdrawal by Subject|0
999859|NCT01418365|2015657|FG001|First Intervention|Withdrawal by Subject|1
914133|NCT00813488|1891934|FG001|Titration Period 1|Lack of Efficacy|7
999860|NCT01418365|2015656|FG000|First Intervention|Non-compliance|1
999861|NCT01418365|2015657|FG001|First Intervention|Non-compliance|0
999862|NCT01418365|2015656|FG000|Second Intervention|Withdrawal by Subject|0
999863|NCT01418365|2015657|FG001|Second Intervention|Withdrawal by Subject|1
999864|NCT01418378|2015665|FG000|Overall Study|Death|1
999865|NCT01418378|2015666|FG001|Overall Study|Death|2
999866|NCT01418378|2015665|FG000|Overall Study|Physician Decision|0
999867|NCT01418378|2015666|FG001|Overall Study|Physician Decision|1
999868|NCT01418378|2015665|FG000|Overall Study|ligament imbalance|0
999869|NCT01418378|2015666|FG001|Overall Study|ligament imbalance|1
999870|NCT01418378|2015665|FG000|Overall Study|developed chronic myopathy|0
999871|NCT01418378|2015666|FG001|Overall Study|developed chronic myopathy|1
999872|NCT01418937|2015688|FG000|Overall Study|Lost to Follow-up|5
999873|NCT01418937|2015688|FG000|Overall Study|Protocol Violation|1
999874|NCT01418937|2015688|FG000|Overall Study|Pregnancy|1
999875|NCT01418937|2015688|FG000|Overall Study|Withdrawal by Subject|1
999876|NCT01419015|2015692|FG000|Overall Study|Death|2
999877|NCT01419080|2015700|FG000|Overall Study|Withdrawal by Subject|75
999878|NCT01419080|2015700|FG000|Overall Study|Death|30
999879|NCT01419080|2015700|FG000|Overall Study|Lost to Follow-up|23
999880|NCT01419080|2015700|FG000|Overall Study|Too Ill|3
999881|NCT01419184|2015712|FG000|Overall Study|Site data not available|3
999882|NCT01419184|2015713|FG001|Overall Study|Site data not available|2
999883|NCT01419184|2015712|FG000|Overall Study|No IRLOS-No in-patient end date reported|3
999884|NCT01419184|2015713|FG001|Overall Study|No IRLOS-No in-patient end date reported|6
999885|NCT01419184|2015712|FG000|Overall Study|No IRLOS-randomized, not treated|2
999886|NCT01419184|2015713|FG001|Overall Study|No IRLOS-randomized, not treated|4
999887|NCT01419184|2015712|FG000|Overall Study|No IRLOS-non trial antibiotic used|1
999888|NCT01419184|2015713|FG001|Overall Study|No IRLOS-non trial antibiotic used|2
999889|NCT01419184|2015712|FG000|Overall Study|No IRLOS-No adverse event treatment date|0
999890|NCT01419184|2015713|FG001|Overall Study|No IRLOS-No adverse event treatment date|1
999891|NCT01419184|2015712|FG000|Overall Study|Participant randomized, not treated|1
999892|NCT01419184|2015713|FG001|Overall Study|Participant randomized, not treated|0
999893|NCT01419197|2015721|FG000|Overall Study|Death|247
999894|NCT01419197|2015722|FG001|Overall Study|Death|122
999895|NCT01419197|2015721|FG000|Overall Study|Physician Decision|4
999896|NCT01419197|2015722|FG001|Overall Study|Physician Decision|4
999897|NCT01419197|2015721|FG000|Overall Study|Non-compliance|3
999898|NCT01419197|2015722|FG001|Overall Study|Non-compliance|1
999899|NCT01419197|2015721|FG000|Overall Study|Withdrawal by Subject|33
999900|NCT01419197|2015722|FG001|Overall Study|Withdrawal by Subject|32
999901|NCT01419197|2015721|FG000|Overall Study|Study Completed by Sponsor|103
999902|NCT01419197|2015722|FG001|Overall Study|Study Completed by Sponsor|34
999903|NCT01419197|2015721|FG000|Overall Study|Reason Not Specified|0
999904|NCT01419197|2015722|FG001|Overall Study|Reason Not Specified|1
999905|NCT01419197|2015721|FG000|Overall Study|Lost to Follow-up|14
999906|NCT01419197|2015722|FG001|Overall Study|Lost to Follow-up|4
999907|NCT01419236|2015731|FG000|Overall Study|Adverse Event|1
999908|NCT01419236|2015732|FG001|Overall Study|Adverse Event|0
999909|NCT01419236|2015731|FG000|Overall Study|Lack of Efficacy|0
999910|NCT01419236|2015732|FG001|Overall Study|Lack of Efficacy|1
999911|NCT01419236|2015731|FG000|Overall Study|Lost to Follow-up|1
999912|NCT01419236|2015732|FG001|Overall Study|Lost to Follow-up|0
999913|NCT01419236|2015731|FG000|Overall Study|Physician Decision|1
999914|NCT01419236|2015732|FG001|Overall Study|Physician Decision|0
999915|NCT01419236|2015731|FG000|Overall Study|Withdrawal by Subject|1
999916|NCT01419236|2015732|FG001|Overall Study|Withdrawal by Subject|4
999917|NCT01419236|2015731|FG000|Overall Study|Entry Criteria Not Met|1
999918|NCT01419236|2015732|FG001|Overall Study|Entry Criteria Not Met|0
999919|NCT01419314|2015754|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
999920|NCT01419314|2015755|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
999921|NCT01419314|2015754|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
999922|NCT01419314|2015755|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
999923|NCT01419314|2015754|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
999924|NCT01419314|2015755|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
999925|NCT01419535|2015767|FG000|Overall Study|could not maintain iv line|1
999926|NCT01419535|2015768|FG001|Overall Study|could not maintain iv line|1
999927|NCT01419535|2015767|FG000|Overall Study|Withdrawal by Subject|0
999928|NCT01419535|2015768|FG001|Overall Study|Withdrawal by Subject|1
999929|NCT01419626|2015777|FG000|Overall Study|Protocol Violation|3
999930|NCT01419626|2015778|FG001|Overall Study|Protocol Violation|2
999931|NCT01419626|2015779|FG002|Overall Study|Protocol Violation|2
999932|NCT01419626|2015777|FG000|Overall Study|Withdrawal by Subject|1
999933|NCT01419626|2015778|FG001|Overall Study|Withdrawal by Subject|0
999934|NCT01419626|2015779|FG002|Overall Study|Withdrawal by Subject|0
999935|NCT01419626|2015777|FG000|Overall Study|Lost to Follow-up|0
999936|NCT01419626|2015778|FG001|Overall Study|Lost to Follow-up|1
999937|NCT01419626|2015779|FG002|Overall Study|Lost to Follow-up|1
999938|NCT01419665|2015793|FG000|Combination Treatment|Adverse Event|7
999939|NCT01419665|2015794|FG001|Combination Treatment|Adverse Event|10
999940|NCT01419665|2015793|FG000|Combination Treatment|Physician Decision|5
999941|NCT01419665|2015794|FG001|Combination Treatment|Physician Decision|8
999942|NCT01419665|2015793|FG000|Combination Treatment|Protocol Violation|6
999943|NCT01419665|2015794|FG001|Combination Treatment|Protocol Violation|2
999944|NCT01419665|2015793|FG000|Combination Treatment|disease progression|10
999945|NCT01419665|2015794|FG001|Combination Treatment|disease progression|9
999946|NCT01419665|2015793|FG000|Combination Treatment|Death|5
999947|NCT01419665|2015794|FG001|Combination Treatment|Death|7
999948|NCT01419665|2015793|FG000|Combination Treatment|administrative problems|0
999949|NCT01419665|2015794|FG001|Combination Treatment|administrative problems|1
999950|NCT01419665|2015793|FG000|Combination Treatment|Withdrawal by Subject|5
999951|NCT01419665|2015794|FG001|Combination Treatment|Withdrawal by Subject|4
999952|NCT01419665|2015793|FG000|Maintenance Treatment and/or Follow up|switch to open label|44
999953|NCT01419665|2015794|FG001|Maintenance Treatment and/or Follow up|switch to open label|39
999954|NCT01419665|2015793|FG000|Maintenance Treatment and/or Follow up|administrative problems|0
999955|NCT01419665|2015794|FG001|Maintenance Treatment and/or Follow up|administrative problems|6
999956|NCT01419665|2015793|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
999957|NCT01419665|2015794|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
999958|NCT01419665|2015793|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1
999959|NCT01419665|2015794|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1
999960|NCT01419665|2015793|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5
999961|NCT01419665|2015794|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2
999962|NCT01419665|2015793|FG000|Maintenance Treatment and/or Follow up|disease progression|53
999963|NCT01419665|2015794|FG001|Maintenance Treatment and/or Follow up|disease progression|37
999964|NCT01419665|2015793|FG000|Maintenance Treatment and/or Follow up|Death|1
999965|NCT01419665|2015794|FG001|Maintenance Treatment and/or Follow up|Death|2
999966|NCT01419665|2015793|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11
999967|NCT01419665|2015794|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7
999968|NCT01419665|2015793|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1
999969|NCT01419665|2015794|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2
999970|NCT01419665|2015793|FG000|Open Label Phase|Death|1
999971|NCT01419665|2015794|FG001|Open Label Phase|Death|0
999972|NCT01419665|2015793|FG000|Open Label Phase|disease progression|0
999973|NCT01419665|2015794|FG001|Open Label Phase|disease progression|1
999974|NCT01419717|2015802|FG000|Overall Study|Protocol-specified Criteria|62
999975|NCT01419717|2015802|FG000|Overall Study|Adverse Event|19
999976|NCT01419717|2015802|FG000|Overall Study|Death|17
999977|NCT01419717|2015802|FG000|Overall Study|Withdrawal by Subject|10
999978|NCT01419717|2015802|FG000|Overall Study|Disease Progression|9
999979|NCT01419717|2015802|FG000|Overall Study|Other|4
999980|NCT01419717|2015802|FG000|Overall Study|Lost to Follow-up|2
999981|NCT01419717|2015802|FG000|Overall Study|Administrative Decision|1
999982|NCT01419717|2015802|FG000|Overall Study|Noncompliance|1
999983|NCT01419769|2015806|FG000|Overall Study|Did not receive the AXIOS stent|3
999984|NCT01419769|2015806|FG000|Overall Study|Not evaluable due to pigtail stents|1
999985|NCT01420068|2015841|FG000|Overall Study|Administrative problems|1
999986|NCT01420068|2015842|FG001|Overall Study|Administrative problems|3
999987|NCT01420068|2015841|FG000|Overall Study|Withdrawal by Subject|1
999988|NCT01420068|2015842|FG001|Overall Study|Withdrawal by Subject|2
999989|NCT01420081|2015857|FG000|Overall Study|Death|1
999990|NCT01420081|2015858|FG001|Overall Study|Death|0
999991|NCT01420081|2015859|FG002|Overall Study|Death|8
999992|NCT01420081|2015860|FG003|Overall Study|Death|0
999993|NCT01420081|2015861|FG004|Overall Study|Death|7
999994|NCT01420081|2015862|FG005|Overall Study|Death|12
999995|NCT01420081|2015863|FG006|Overall Study|Death|0
999996|NCT01420081|2015864|FG007|Overall Study|Death|1
999997|NCT01420081|2015865|FG008|Overall Study|Death|1
999998|NCT01420081|2015857|FG000|Overall Study|Lost to Follow-up|0
999999|NCT01420081|2015858|FG001|Overall Study|Lost to Follow-up|0
1000000|NCT01420081|2015859|FG002|Overall Study|Lost to Follow-up|0
1000001|NCT01420081|2015860|FG003|Overall Study|Lost to Follow-up|0
1000002|NCT01420081|2015861|FG004|Overall Study|Lost to Follow-up|1
1000003|NCT01420081|2015862|FG005|Overall Study|Lost to Follow-up|1
1000004|NCT01420081|2015863|FG006|Overall Study|Lost to Follow-up|0
1000005|NCT01420081|2015864|FG007|Overall Study|Lost to Follow-up|0
1000006|NCT01420081|2015865|FG008|Overall Study|Lost to Follow-up|0
1000007|NCT01420081|2015857|FG000|Overall Study|Study Terminated by Sponsor|2
1000008|NCT01420081|2015858|FG001|Overall Study|Study Terminated by Sponsor|1
1000009|NCT01420081|2015859|FG002|Overall Study|Study Terminated by Sponsor|1
1000010|NCT01420081|2015860|FG003|Overall Study|Study Terminated by Sponsor|3
1000011|NCT01420081|2015861|FG004|Overall Study|Study Terminated by Sponsor|11
1000012|NCT01420081|2015862|FG005|Overall Study|Study Terminated by Sponsor|7
1000013|NCT01420081|2015863|FG006|Overall Study|Study Terminated by Sponsor|3
1000014|NCT01420081|2015864|FG007|Overall Study|Study Terminated by Sponsor|2
1000015|NCT01420081|2015865|FG008|Overall Study|Study Terminated by Sponsor|2
1000016|NCT01420081|2015857|FG000|Overall Study|Subject Refused Futher Follow-up|0
1000017|NCT01420081|2015858|FG001|Overall Study|Subject Refused Futher Follow-up|0
1000018|NCT01420081|2015859|FG002|Overall Study|Subject Refused Futher Follow-up|1
1000019|NCT01420081|2015860|FG003|Overall Study|Subject Refused Futher Follow-up|0
1000020|NCT01420081|2015861|FG004|Overall Study|Subject Refused Futher Follow-up|1
1000021|NCT01420081|2015862|FG005|Overall Study|Subject Refused Futher Follow-up|0
1000022|NCT01420081|2015863|FG006|Overall Study|Subject Refused Futher Follow-up|0
1000023|NCT01420081|2015864|FG007|Overall Study|Subject Refused Futher Follow-up|0
1000024|NCT01420081|2015865|FG008|Overall Study|Subject Refused Futher Follow-up|0
1000025|NCT01420081|2015857|FG000|Overall Study|Other Reasons|0
1000026|NCT01420081|2015858|FG001|Overall Study|Other Reasons|0
1000027|NCT01420081|2015859|FG002|Overall Study|Other Reasons|1
1000028|NCT01420081|2015860|FG003|Overall Study|Other Reasons|0
1000029|NCT01420081|2015861|FG004|Overall Study|Other Reasons|0
1000030|NCT01420081|2015862|FG005|Overall Study|Other Reasons|0
1000031|NCT01420081|2015863|FG006|Overall Study|Other Reasons|0
1000032|NCT01420081|2015864|FG007|Overall Study|Other Reasons|0
1000033|NCT01420081|2015865|FG008|Overall Study|Other Reasons|0
1000034|NCT01420536|2015896|FG000|Period 1 (30 Days)|Withdrawal by Subject|3
1000035|NCT01420536|2015897|FG001|Period 1 (30 Days)|Withdrawal by Subject|0
1000036|NCT01420549|2015907|FG000|Overall Study|Adverse Event|1
1000037|NCT01420549|2015908|FG001|Overall Study|Adverse Event|1
1000038|NCT01420549|2015907|FG000|Overall Study|Lost to Follow-up|2
1000039|NCT01420549|2015908|FG001|Overall Study|Lost to Follow-up|2
1000040|NCT01420549|2015907|FG000|Overall Study|Protocol Violation|0
1000041|NCT01420549|2015908|FG001|Overall Study|Protocol Violation|1
1000042|NCT01420549|2015907|FG000|Overall Study|Non-adherence to medication|4
1000043|NCT01420549|2015908|FG001|Overall Study|Non-adherence to medication|1
1000044|NCT01420627|2015914|FG000|EZN-2279 Treatment Period|Adverse Event|1
1000045|NCT01420679|2015941|FG000|Overall Study|Disease Progression|3
1000046|NCT01420679|2015942|FG001|Overall Study|Disease Progression|2
1000047|NCT01420679|2015941|FG000|Overall Study|Adverse Event|4
1000048|NCT01420679|2015942|FG001|Overall Study|Adverse Event|0
1000049|NCT01420679|2015941|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1
1000050|NCT01420679|2015942|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0
1000051|NCT01420679|2015941|FG000|Overall Study|Patient Decision|1
1000052|NCT01420679|2015942|FG001|Overall Study|Patient Decision|0
1000053|NCT01420679|2015941|FG000|Overall Study|Investigator Decision|1
1000054|NCT01420679|2015942|FG001|Overall Study|Investigator Decision|2
1000055|NCT01420679|2015941|FG000|Overall Study|Sponsor Decision|3
1000056|NCT01420679|2015942|FG001|Overall Study|Sponsor Decision|3
1000057|NCT01420679|2015941|FG000|Overall Study|Other|1
1000058|NCT01420679|2015942|FG001|Overall Study|Other|0
1000059|NCT01420926|2015963|FG000|Overall Study|Adverse Event|6
1000060|NCT01420926|2015964|FG001|Overall Study|Adverse Event|4
1000061|NCT01420926|2015963|FG000|Overall Study|Death|18
1000062|NCT01420926|2015964|FG001|Overall Study|Death|17
1000063|NCT01420926|2015963|FG000|Overall Study|Withdrawal by Subject|11
1000064|NCT01420926|2015964|FG001|Overall Study|Withdrawal by Subject|16
1000065|NCT01420926|2015963|FG000|Overall Study|Non-protocol treatment|17
1000066|NCT01420926|2015964|FG001|Overall Study|Non-protocol treatment|20
1000067|NCT01420926|2015963|FG000|Overall Study|Physician Decision|7
1000068|NCT01420926|2015964|FG001|Overall Study|Physician Decision|5
1000069|NCT01420926|2015963|FG000|Overall Study|Continues on active treatment|1
1000070|NCT01420926|2015964|FG001|Overall Study|Continues on active treatment|3
1000071|NCT01421017|2015973|FG000|Overall Study|Withdrawal by Subject|2
1000072|NCT01421017|2015974|FG001|Overall Study|Withdrawal by Subject|0
1000073|NCT01421017|2015975|FG002|Overall Study|Withdrawal by Subject|0
1000074|NCT01421017|2015973|FG000|Overall Study|POD|0
1000075|NCT01421017|2015974|FG001|Overall Study|POD|6
1000076|NCT01421017|2015975|FG002|Overall Study|POD|3
1000077|NCT01421134|2015985|FG000|Overall Study|Adverse Event|3
1000078|NCT01421134|2015986|FG001|Overall Study|Adverse Event|5
1000079|NCT01421134|2015985|FG000|Overall Study|Lack of Efficacy|2
1000080|NCT01421134|2015986|FG001|Overall Study|Lack of Efficacy|4
1000081|NCT01421134|2015985|FG000|Overall Study|Protocol Violation|0
1000082|NCT01421134|2015986|FG001|Overall Study|Protocol Violation|3
1000083|NCT01421134|2015985|FG000|Overall Study|Withdrawal by Subject|1
1000084|NCT01421134|2015986|FG001|Overall Study|Withdrawal by Subject|1
1000085|NCT01421134|2015985|FG000|Overall Study|Administrative|0
1000086|NCT01421134|2015986|FG001|Overall Study|Administrative|1
1000087|NCT01421134|2015985|FG000|Overall Study|Lost to Follow-up|1
1000088|NCT01421134|2015986|FG001|Overall Study|Lost to Follow-up|1
1000089|NCT01421147|2015994|FG000|Treatment Period|Adverse Event|2
1000090|NCT01421147|2015995|FG001|Treatment Period|Adverse Event|3
1000091|NCT01421147|2015994|FG000|Treatment Period|Lost to Follow-up|2
1000092|NCT01421147|2015995|FG001|Treatment Period|Lost to Follow-up|1
1000093|NCT01421147|2015994|FG000|Treatment Period|Physician Decision|2
1000094|NCT01421147|2015995|FG001|Treatment Period|Physician Decision|2
1000095|NCT01421147|2015994|FG000|Treatment Period|Withdrawal by Subject|10
1000096|NCT01421147|2015995|FG001|Treatment Period|Withdrawal by Subject|5
1000097|NCT01421147|2015994|FG000|Extension Period|Adverse Event|0
1000098|NCT01421147|2015995|FG001|Extension Period|Adverse Event|2
1000099|NCT01421147|2015994|FG000|Extension Period|Death|0
1000100|NCT01421147|2015995|FG001|Extension Period|Death|1
1000101|NCT01421147|2015994|FG000|Extension Period|Lost to Follow-up|2
1000102|NCT01421147|2015995|FG001|Extension Period|Lost to Follow-up|5
1000103|NCT01421147|2015994|FG000|Extension Period|Physician Decision|1
1000104|NCT01421147|2015995|FG001|Extension Period|Physician Decision|0
1000105|NCT01421147|2015994|FG000|Extension Period|Withdrawal by Subject|5
1000106|NCT01421147|2015995|FG001|Extension Period|Withdrawal by Subject|3
1000107|NCT01421225|2016030|FG000|Overall Study|Withdrawal by Subject|0
1000108|NCT01421225|2016031|FG001|Overall Study|Withdrawal by Subject|1
1000109|NCT01421277|2016040|FG000|Overall Study|Lack of qualifying event|0
1000110|NCT01421277|2016041|FG001|Overall Study|Lack of qualifying event|61
1000111|NCT01421277|2016040|FG000|Overall Study|Incomplete baseline data|0
1000112|NCT01421277|2016041|FG001|Overall Study|Incomplete baseline data|31
1000113|NCT01421303|2016047|FG000|Overall Study|Lost to Follow-up|13
1000114|NCT01421303|2016047|FG000|Overall Study|Non compliance with study procedure|1
1000115|NCT01421303|2016047|FG000|Overall Study|Other|7
1000116|NCT01421303|2016047|FG000|Overall Study|Withdrawal by Subject|1
1000117|NCT01421342|2016054|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
1000118|NCT01421342|2016055|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
1000119|NCT01421342|2016056|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
1000120|NCT01421342|2016054|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53
1000121|NCT01421342|2016055|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38
1000122|NCT01421342|2016056|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27
1000123|NCT01421342|2016054|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
1000124|NCT01421342|2016055|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
1000125|NCT01421342|2016056|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
1000126|NCT01421342|2016054|FG000|Acute Treatment Phase (12 Weeks)|Death|0
1000127|NCT01421342|2016055|FG001|Acute Treatment Phase (12 Weeks)|Death|0
1000128|NCT01421342|2016056|FG002|Acute Treatment Phase (12 Weeks)|Death|3
1000129|NCT01421342|2016054|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
1000130|NCT01421342|2016055|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
1000131|NCT01421342|2016056|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
1000132|NCT01421342|2016054|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15
1000133|NCT01421342|2016055|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7
1000134|NCT01421342|2016056|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13
1000135|NCT01421342|2016054|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
1000136|NCT01421342|2016055|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
1000137|NCT01421342|2016056|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
1000138|NCT01421342|2016054|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1
1000139|NCT01421342|2016055|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6
1000140|NCT01421342|2016056|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1
1000141|NCT01421342|2016054|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
1000142|NCT01421342|2016055|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
1000143|NCT01421342|2016056|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
1000144|NCT01421342|2016054|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
1000145|NCT01421342|2016055|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
1000146|NCT01421342|2016056|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
1000147|NCT01421342|2016054|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
1000148|NCT01421342|2016055|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
1000149|NCT01421342|2016056|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
1000150|NCT01421342|2016054|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4
1000151|NCT01421342|2016055|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3
1000152|NCT01421342|2016056|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6
1000153|NCT01421342|2016054|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
1000154|NCT01421342|2016055|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
1000155|NCT01421342|2016056|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
1000156|NCT01421342|2016054|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
1000157|NCT01421342|2016055|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
1000158|NCT01421342|2016056|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
1000159|NCT01421342|2016054|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5
1000160|NCT01421342|2016055|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4
1000161|NCT01421342|2016056|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5
1000162|NCT01421342|2016054|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
1000163|NCT01421342|2016055|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
1000164|NCT01421342|2016056|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
1000165|NCT01421342|2016054|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
1000166|NCT01421342|2016055|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
1000167|NCT01421342|2016056|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
1000168|NCT01421342|2016054|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
1000169|NCT01421342|2016055|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
1000170|NCT01421342|2016056|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
1000171|NCT01421342|2016054|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0
1000172|NCT01421342|2016055|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0
1000173|NCT01421342|2016056|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2
1000174|NCT01421342|2016054|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
1000175|NCT01421342|2016055|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
1000176|NCT01421342|2016056|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
1000177|NCT01421342|2016054|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
1006728|NCT01469052|2025436|FG000|Overall Study|Other|0
1000178|NCT01421342|2016055|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
1000179|NCT01421342|2016056|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
1000180|NCT01421342|2016054|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
1000181|NCT01421342|2016055|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
1000182|NCT01421342|2016056|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
1000183|NCT01421342|2016054|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
1000184|NCT01421342|2016055|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
1000185|NCT01421342|2016056|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
1000186|NCT01421342|2016054|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
1000187|NCT01421342|2016055|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
1000188|NCT01421342|2016056|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
1000189|NCT01421342|2016054|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
1000190|NCT01421342|2016055|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
1000191|NCT01421342|2016056|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
1000192|NCT01421342|2016054|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
1000193|NCT01421342|2016055|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
1000194|NCT01421342|2016056|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
1000195|NCT01421342|2016054|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1000196|NCT01421342|2016055|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1000197|NCT01421342|2016056|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1000198|NCT01421342|2016054|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
1000199|NCT01421342|2016055|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
1000200|NCT01421342|2016056|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
1000201|NCT01421459|2016070|FG000|Overall Study|Adverse Event|6
1000202|NCT01421459|2016071|FG001|Overall Study|Adverse Event|10
1000203|NCT01421459|2016070|FG000|Overall Study|Death|1
1000204|NCT01421459|2016071|FG001|Overall Study|Death|1
1000205|NCT01421459|2016070|FG000|Overall Study|Lack of Efficacy|1
1000206|NCT01421459|2016071|FG001|Overall Study|Lack of Efficacy|2
1000207|NCT01421459|2016070|FG000|Overall Study|Lost to Follow-up|8
1000208|NCT01421459|2016071|FG001|Overall Study|Lost to Follow-up|9
1000209|NCT01421459|2016070|FG000|Overall Study|Physician Decision|9
1000210|NCT01421459|2016071|FG001|Overall Study|Physician Decision|9
1000211|NCT01421459|2016070|FG000|Overall Study|Protocol Violation|8
1000212|NCT01421459|2016071|FG001|Overall Study|Protocol Violation|5
1000213|NCT01421459|2016070|FG000|Overall Study|Withdrawal by Subject|12
1000214|NCT01421459|2016071|FG001|Overall Study|Withdrawal by Subject|16
1000215|NCT01421511|2016105|FG000|Overall Study|Lost to Follow-up|11
1000216|NCT01421511|2016106|FG001|Overall Study|Lost to Follow-up|14
1000217|NCT01421511|2016105|FG000|Overall Study|Randomized but didn't receive study drug|1
1000218|NCT01421511|2016106|FG001|Overall Study|Randomized but didn't receive study drug|7
1000219|NCT01421511|2016105|FG000|Overall Study|Physician Decision|0
1000220|NCT01421511|2016106|FG001|Overall Study|Physician Decision|1
1000221|NCT01421511|2016105|FG000|Overall Study|Withdrawal by Subject|6
1000222|NCT01421511|2016106|FG001|Overall Study|Withdrawal by Subject|5
1000223|NCT01421511|2016105|FG000|Overall Study|Death|1
1000224|NCT01421511|2016106|FG001|Overall Study|Death|1
1000225|NCT01421641|2016120|FG000|Overall Study|Protocol Violation|2
1000226|NCT01421641|2016121|FG001|Overall Study|Protocol Violation|2
1000227|NCT01421667|2016140|FG000|Overall Study|Withdrawal by Subject|0
1000228|NCT01421667|2016141|FG001|Overall Study|Withdrawal by Subject|1
1000229|NCT01421667|2016142|FG002|Overall Study|Withdrawal by Subject|2
1000230|NCT01421667|2016143|FG003|Overall Study|Withdrawal by Subject|1
1000231|NCT01421667|2016140|FG000|Overall Study|Lost to Follow-up|0
1000232|NCT01421667|2016141|FG001|Overall Study|Lost to Follow-up|1
1000233|NCT01421667|2016142|FG002|Overall Study|Lost to Follow-up|0
1000234|NCT01421667|2016143|FG003|Overall Study|Lost to Follow-up|0
1000235|NCT01421719|2016161|FG000|Overall Study|Withdrawal by Subject|4
1000236|NCT01422187|2016205|FG000|Overall Study|Personal reason|1
1000237|NCT01422187|2016206|FG001|Overall Study|Personal reason|0
1000238|NCT01422187|2016207|FG002|Overall Study|Personal reason|0
1000239|NCT01422187|2016205|FG000|Overall Study|Lost to Follow-up|0
1000240|NCT01422187|2016206|FG001|Overall Study|Lost to Follow-up|1
1000241|NCT01422187|2016207|FG002|Overall Study|Lost to Follow-up|0
1000242|NCT01422213|2016229|FG000|Overall Study|Adverse Event|8
1000243|NCT01422213|2016230|FG001|Overall Study|Adverse Event|7
1000244|NCT01422213|2016231|FG002|Overall Study|Adverse Event|11
1000245|NCT01422213|2016229|FG000|Overall Study|Lack of Efficacy|10
1000246|NCT01422213|2016230|FG001|Overall Study|Lack of Efficacy|2
1000247|NCT01422213|2016231|FG002|Overall Study|Lack of Efficacy|2
1000248|NCT01422213|2016229|FG000|Overall Study|Non-compliance with study drug|0
1000249|NCT01422213|2016230|FG001|Overall Study|Non-compliance with study drug|1
1000250|NCT01422213|2016231|FG002|Overall Study|Non-compliance with study drug|0
1000251|NCT01422213|2016229|FG000|Overall Study|Protocol Violation|0
1000252|NCT01422213|2016230|FG001|Overall Study|Protocol Violation|2
1000253|NCT01422213|2016231|FG002|Overall Study|Protocol Violation|4
1000254|NCT01422213|2016229|FG000|Overall Study|Withdrawal of Consent|7
1000255|NCT01422213|2016230|FG001|Overall Study|Withdrawal of Consent|3
1000256|NCT01422213|2016231|FG002|Overall Study|Withdrawal of Consent|5
1000257|NCT01422213|2016229|FG000|Overall Study|Lost to Follow-up|3
1000258|NCT01422213|2016230|FG001|Overall Study|Lost to Follow-up|3
1000259|NCT01422213|2016231|FG002|Overall Study|Lost to Follow-up|5
1000260|NCT01422213|2016229|FG000|Overall Study|Administrative or Other Reason(s)|5
1000261|NCT01422213|2016230|FG001|Overall Study|Administrative or Other Reason(s)|4
1000262|NCT01422213|2016231|FG002|Overall Study|Administrative or Other Reason(s)|2
1000263|NCT01422239|2016250|FG000|Overall Study|Lost to Follow-up|4
1000264|NCT01422239|2016251|FG001|Overall Study|Lost to Follow-up|3
1000265|NCT01422304|2016259|FG000|Overall Study|Adverse Event|0
1000266|NCT01422304|2016260|FG001|Overall Study|Adverse Event|1
1000267|NCT01422304|2016259|FG000|Overall Study|Lost to Follow-up|14
1000268|NCT01422304|2016260|FG001|Overall Study|Lost to Follow-up|20
1000269|NCT01422304|2016259|FG000|Overall Study|Never Entered Follow-up|2
1000270|NCT01422304|2016260|FG001|Overall Study|Never Entered Follow-up|1
1000271|NCT01422304|2016259|FG000|Overall Study|Protocol Violation|1
1000272|NCT01422304|2016260|FG001|Overall Study|Protocol Violation|0
1000273|NCT01422304|2016259|FG000|Overall Study|Withdrawal by Subject|4
1000274|NCT01422304|2016260|FG001|Overall Study|Withdrawal by Subject|2
1000275|NCT01422304|2016259|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
1000276|NCT01422304|2016260|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
1000277|NCT01422304|2016259|FG000|Overall Study|Not Treated|3
1000278|NCT01422304|2016260|FG001|Overall Study|Not Treated|11
1000279|NCT01422382|2016275|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
1000280|NCT01422408|2016279|FG000|Overall Study|Adverse Event|1
1000281|NCT01422408|2016279|FG000|Overall Study|Withdrawal by Subject|3
1000282|NCT01422538|2016299|FG000|Overall Study|Lost to Follow-up|0
1000283|NCT01422538|2016300|FG001|Overall Study|Lost to Follow-up|1
1000284|NCT01422538|2016301|FG002|Overall Study|Lost to Follow-up|1
1000285|NCT01422538|2016299|FG000|Overall Study|Missed visit|0
1000286|NCT01422538|2016300|FG001|Overall Study|Missed visit|1
1000287|NCT01422538|2016301|FG002|Overall Study|Missed visit|1
1000288|NCT01422720|2016310|FG000|Overall Study|Adverse Event|16
1000289|NCT01422720|2016310|FG000|Overall Study|Lack of Efficacy|1
1000290|NCT01422720|2016310|FG000|Overall Study|Withdrawal by Subject|4
1000291|NCT01422720|2016310|FG000|Overall Study|Ineligibility|1
1000292|NCT01422824|2016318|FG000|Overall Study|Case record form not evaluated|1
1000293|NCT01422824|2016318|FG000|Overall Study|Lost to Follow-up|37
1000294|NCT01422850|2016322|FG000|Overall Study|Physician Decision|3
1000295|NCT01422876|2016338|FG000|Week 24|Lost to Follow-up|1
1000296|NCT01422876|2016339|FG001|Week 24|Lost to Follow-up|1
1000297|NCT01422876|2016340|FG002|Week 24|Lost to Follow-up|2
1000298|NCT01422876|2016341|FG003|Week 24|Lost to Follow-up|4
1000299|NCT01422876|2016342|FG004|Week 24|Lost to Follow-up|2
1000300|NCT01422876|2016343|FG005|Week 24|Lost to Follow-up|0
1000301|NCT01422876|2016344|FG006|Week 24|Lost to Follow-up|1
1000302|NCT01422876|2016345|FG007|Week 24|Lost to Follow-up|3
1000303|NCT01422876|2016346|FG008|Week 24|Lost to Follow-up|3
1000304|NCT01422876|2016347|FG009|Week 24|Lost to Follow-up|4
1000305|NCT01422876|2016338|FG000|Week 24|Consent withdrawn|5
1000306|NCT01422876|2016339|FG001|Week 24|Consent withdrawn|1
1000307|NCT01422876|2016340|FG002|Week 24|Consent withdrawn|3
1000308|NCT01422876|2016341|FG003|Week 24|Consent withdrawn|4
1000309|NCT01422876|2016342|FG004|Week 24|Consent withdrawn|5
1000310|NCT01422876|2016343|FG005|Week 24|Consent withdrawn|6
1000311|NCT01422876|2016344|FG006|Week 24|Consent withdrawn|5
1000312|NCT01422876|2016345|FG007|Week 24|Consent withdrawn|4
1000313|NCT01422876|2016346|FG008|Week 24|Consent withdrawn|3
1000314|NCT01422876|2016347|FG009|Week 24|Consent withdrawn|6
1000315|NCT01422876|2016338|FG000|Week 24|Death|0
1000316|NCT01422876|2016339|FG001|Week 24|Death|1
1000317|NCT01422876|2016340|FG002|Week 24|Death|0
1000318|NCT01422876|2016341|FG003|Week 24|Death|0
1000319|NCT01422876|2016342|FG004|Week 24|Death|0
1000320|NCT01422876|2016343|FG005|Week 24|Death|0
1000321|NCT01422876|2016344|FG006|Week 24|Death|0
1000322|NCT01422876|2016345|FG007|Week 24|Death|0
1000323|NCT01422876|2016346|FG008|Week 24|Death|0
1000324|NCT01422876|2016347|FG009|Week 24|Death|0
1000325|NCT01422876|2016338|FG000|Week 52|Lost to Follow-up|3
1000326|NCT01422876|2016339|FG001|Week 52|Lost to Follow-up|5
1000327|NCT01422876|2016340|FG002|Week 52|Lost to Follow-up|7
1000328|NCT01422876|2016341|FG003|Week 52|Lost to Follow-up|5
1000329|NCT01422876|2016342|FG004|Week 52|Lost to Follow-up|8
1000330|NCT01422876|2016343|FG005|Week 52|Lost to Follow-up|5
1000331|NCT01422876|2016344|FG006|Week 52|Lost to Follow-up|5
1000332|NCT01422876|2016345|FG007|Week 52|Lost to Follow-up|8
1000333|NCT01422876|2016346|FG008|Week 52|Lost to Follow-up|7
1000334|NCT01422876|2016347|FG009|Week 52|Lost to Follow-up|8
1000335|NCT01422876|2016338|FG000|Week 52|Consent withdrawn|9
1000336|NCT01422876|2016339|FG001|Week 52|Consent withdrawn|4
1000337|NCT01422876|2016340|FG002|Week 52|Consent withdrawn|6
1000338|NCT01422876|2016341|FG003|Week 52|Consent withdrawn|12
1000339|NCT01422876|2016342|FG004|Week 52|Consent withdrawn|7
1000340|NCT01422876|2016343|FG005|Week 52|Consent withdrawn|12
1000341|NCT01422876|2016344|FG006|Week 52|Consent withdrawn|10
1000342|NCT01422876|2016345|FG007|Week 52|Consent withdrawn|12
1000343|NCT01422876|2016346|FG008|Week 52|Consent withdrawn|13
1000344|NCT01422876|2016347|FG009|Week 52|Consent withdrawn|9
1000345|NCT01422876|2016338|FG000|Week 52|Death|0
1000346|NCT01422876|2016339|FG001|Week 52|Death|1
1000347|NCT01422876|2016340|FG002|Week 52|Death|0
1000348|NCT01422876|2016341|FG003|Week 52|Death|1
1000349|NCT01422876|2016342|FG004|Week 52|Death|0
1000350|NCT01422876|2016343|FG005|Week 52|Death|0
1000351|NCT01422876|2016344|FG006|Week 52|Death|1
1000352|NCT01422876|2016345|FG007|Week 52|Death|3
1000353|NCT01422876|2016346|FG008|Week 52|Death|1
1000354|NCT01422876|2016347|FG009|Week 52|Death|0
1000355|NCT01422889|2016365|FG000|Overall Study|No Data Entered for Study Stent|9
1000356|NCT01422915|2016369|FG000|Overall Study|Adverse Event|1
1000357|NCT01423084|2016376|FG000|Overall Study|Adverse Event|0
1000358|NCT01423084|2016377|FG001|Overall Study|Adverse Event|1
1000359|NCT01423084|2016376|FG000|Overall Study|Withdrawal by Subject|2
1000360|NCT01423084|2016377|FG001|Overall Study|Withdrawal by Subject|3
1000361|NCT01423253|2016393|FG000|Overall Study|Adverse Event|2
1000362|NCT01423253|2016393|FG000|Overall Study|Lack of Efficacy|2
1000363|NCT01423253|2016393|FG000|Overall Study|Lost to Follow-up|1
1000364|NCT01423253|2016393|FG000|Overall Study|Protocol Violation|2
1000365|NCT01423253|2016393|FG000|Overall Study|Withdrawal by Subject|2
1000366|NCT01423604|2016400|FG000|Safety Run-In|Adverse Event|3
1000367|NCT01423604|2016401|FG001|Safety Run-In|Adverse Event|0
1000368|NCT01423604|2016400|FG000|Safety Run-In|Death|1
1000369|NCT01423604|2016401|FG001|Safety Run-In|Death|0
1000370|NCT01423604|2016400|FG000|Safety Run-In|Physician Decision|1
1000371|NCT01423604|2016401|FG001|Safety Run-In|Physician Decision|0
1000372|NCT01423604|2016400|FG000|Safety Run-In|Disease progression|3
1000373|NCT01423604|2016401|FG001|Safety Run-In|Disease progression|0
1000374|NCT01423604|2016400|FG000|Safety Run-In|Patient decision|1
1000375|NCT01423604|2016401|FG001|Safety Run-In|Patient decision|0
1000376|NCT01423604|2016400|FG000|Randomized|Adverse Event|4
1000377|NCT01423604|2016401|FG001|Randomized|Adverse Event|10
1000378|NCT01423604|2016400|FG000|Randomized|Death|1
1000379|NCT01423604|2016401|FG001|Randomized|Death|0
1000380|NCT01423604|2016400|FG000|Randomized|Physician Decision|16
1000381|NCT01423604|2016401|FG001|Randomized|Physician Decision|13
1000382|NCT01423604|2016400|FG000|Randomized|Other - unspecified|37
1000383|NCT01423604|2016401|FG001|Randomized|Other - unspecified|31
1000384|NCT01423604|2016400|FG000|Randomized|Patient decision|5
1000385|NCT01423604|2016401|FG001|Randomized|Patient decision|9
1000386|NCT01423617|2016410|FG000|Overall Study|Lost to Follow-up|0
1000387|NCT01423617|2016411|FG001|Overall Study|Lost to Follow-up|1
1000388|NCT01423812|2016435|FG000|Overall Study|Lost to Follow-up|2
1000389|NCT01423812|2016436|FG001|Overall Study|Lost to Follow-up|2
1000390|NCT01423812|2016435|FG000|Overall Study|Withdrawal by Subject|1
1000391|NCT01423812|2016436|FG001|Overall Study|Withdrawal by Subject|2
1000392|NCT01423916|2016447|FG000|Overall Study|Adverse Event|5
1000393|NCT01423916|2016448|FG001|Overall Study|Adverse Event|9
1000394|NCT01423916|2016449|FG002|Overall Study|Adverse Event|2
1000395|NCT01423916|2016447|FG000|Overall Study|Met Withdrawal Criteria|1
1000396|NCT01423916|2016448|FG001|Overall Study|Met Withdrawal Criteria|1
1000397|NCT01423916|2016449|FG002|Overall Study|Met Withdrawal Criteria|1
1000398|NCT01423916|2016447|FG000|Overall Study|Physician Decision|1
1000399|NCT01423916|2016448|FG001|Overall Study|Physician Decision|0
1000400|NCT01423916|2016449|FG002|Overall Study|Physician Decision|1
1000401|NCT01423916|2016447|FG000|Overall Study|Withdrawal by Subject|3
1000402|NCT01423916|2016448|FG001|Overall Study|Withdrawal by Subject|10
1000403|NCT01423916|2016449|FG002|Overall Study|Withdrawal by Subject|3
1000404|NCT01423916|2016447|FG000|Overall Study|Protocol Deviation|1
1000405|NCT01423916|2016448|FG001|Overall Study|Protocol Deviation|0
1000406|NCT01423916|2016449|FG002|Overall Study|Protocol Deviation|0
1000407|NCT01424189|2016487|FG000|Overall Study|Adverse Event|1
1000408|NCT01424189|2016488|FG001|Overall Study|Adverse Event|0
1000409|NCT01424189|2016487|FG000|Overall Study|Lost to Follow-up|4
1000410|NCT01424189|2016488|FG001|Overall Study|Lost to Follow-up|1
1000411|NCT01424189|2016487|FG000|Overall Study|Withdrawal by Subject|4
1000412|NCT01424189|2016488|FG001|Overall Study|Withdrawal by Subject|4
1000413|NCT01424189|2016487|FG000|Overall Study|Subject moved|1
1000414|NCT01424189|2016488|FG001|Overall Study|Subject moved|0
1000415|NCT01424189|2016487|FG000|Overall Study|Death|3
1000416|NCT01424189|2016488|FG001|Overall Study|Death|1
1000417|NCT01424228|2016505|FG000|Overall Study|Withdrawal by Subject|27
1000418|NCT01424228|2016506|FG001|Overall Study|Withdrawal by Subject|11
1000419|NCT01424228|2016505|FG000|Overall Study|Adverse Event|10
1000420|NCT01424228|2016506|FG001|Overall Study|Adverse Event|14
1000421|NCT01424228|2016505|FG000|Overall Study|Sponsor's decision|9
1000422|NCT01424228|2016506|FG001|Overall Study|Sponsor's decision|12
1000423|NCT01424228|2016505|FG000|Overall Study|Lack of Efficacy|5
1000424|NCT01424228|2016506|FG001|Overall Study|Lack of Efficacy|7
1000425|NCT01424228|2016505|FG000|Overall Study|inclusion/exclusion criteria not met|2
1000426|NCT01424228|2016506|FG001|Overall Study|inclusion/exclusion criteria not met|2
1000427|NCT01424228|2016505|FG000|Overall Study|Non-compliance|2
1000428|NCT01424228|2016506|FG001|Overall Study|Non-compliance|0
1000429|NCT01424228|2016505|FG000|Overall Study|Worsening of symptoms|1
1000430|NCT01424228|2016506|FG001|Overall Study|Worsening of symptoms|0
1000431|NCT01424228|2016505|FG000|Overall Study|Unplanned journey|0
1000432|NCT01424228|2016506|FG001|Overall Study|Unplanned journey|1
1000433|NCT01424306|2016516|FG000|Overall Study|Protocol Violation|0
1000434|NCT01424306|2016517|FG001|Overall Study|Protocol Violation|0
1000435|NCT01424306|2016518|FG002|Overall Study|Protocol Violation|0
1000436|NCT01424306|2016519|FG003|Overall Study|Protocol Violation|0
1000437|NCT01424306|2016520|FG004|Overall Study|Protocol Violation|1
1000438|NCT01424306|2016521|FG005|Overall Study|Protocol Violation|0
1000439|NCT01424397|2016565|FG000|Period-2 (8 Days)|Withdrawal by Subject|0
1000440|NCT01424397|2016566|FG001|Period-2 (8 Days)|Withdrawal by Subject|0
1000441|NCT01424397|2016567|FG002|Period-2 (8 Days)|Withdrawal by Subject|1
1000442|NCT01424397|2016568|FG003|Period-2 (8 Days)|Withdrawal by Subject|0
1000443|NCT01424397|2016569|FG004|Period-2 (8 Days)|Withdrawal by Subject|0
1000444|NCT01424397|2016570|FG005|Period-2 (8 Days)|Withdrawal by Subject|0
1000445|NCT01424397|2016571|FG006|Period-2 (8 Days)|Withdrawal by Subject|0
1000446|NCT01424397|2016572|FG007|Period-2 (8 Days)|Withdrawal by Subject|0
1000447|NCT01424397|2016573|FG008|Period-2 (8 Days)|Withdrawal by Subject|0
1000448|NCT01424397|2016574|FG009|Period-2 (8 Days)|Withdrawal by Subject|0
1000449|NCT01424397|2016575|FG010|Period-2 (8 Days)|Withdrawal by Subject|0
1000450|NCT01424397|2016576|FG011|Period-2 (8 Days)|Withdrawal by Subject|0
1000451|NCT01424501|2016596|FG000|Overall Study|Withdrawal by Subject|1
1000452|NCT01424501|2016597|FG001|Overall Study|Withdrawal by Subject|0
1000453|NCT01424501|2016598|FG002|Overall Study|Withdrawal by Subject|1
1000454|NCT01424501|2016599|FG003|Overall Study|Withdrawal by Subject|0
1000455|NCT01424501|2016600|FG004|Overall Study|Withdrawal by Subject|0
1000456|NCT01424501|2016601|FG005|Overall Study|Withdrawal by Subject|0
1000457|NCT01424501|2016596|FG000|Overall Study|Lost to Follow-up|0
1000458|NCT01424501|2016597|FG001|Overall Study|Lost to Follow-up|1
1000459|NCT01424501|2016598|FG002|Overall Study|Lost to Follow-up|1
1000460|NCT01424501|2016599|FG003|Overall Study|Lost to Follow-up|0
1000461|NCT01424501|2016600|FG004|Overall Study|Lost to Follow-up|0
1000462|NCT01424501|2016601|FG005|Overall Study|Lost to Follow-up|0
1000463|NCT01424514|2016616|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
1000464|NCT01424514|2016617|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
1000465|NCT01424514|2016616|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
1000466|NCT01424514|2016617|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
1000467|NCT01424566|2016628|FG000|Single-blind Treatment|Adverse Event|71
1000468|NCT01424566|2016629|FG001|Single-blind Treatment|Adverse Event|0
1000469|NCT01424566|2016630|FG002|Single-blind Treatment|Adverse Event|0
1000470|NCT01424566|2016628|FG000|Single-blind Treatment|Withdrawal by Subject|16
1000471|NCT01424566|2016629|FG001|Single-blind Treatment|Withdrawal by Subject|0
1000472|NCT01424566|2016630|FG002|Single-blind Treatment|Withdrawal by Subject|0
1000473|NCT01424566|2016628|FG000|Single-blind Treatment|Withdrawal by Investigator|2
1000474|NCT01424566|2016629|FG001|Single-blind Treatment|Withdrawal by Investigator|0
1000475|NCT01424566|2016630|FG002|Single-blind Treatment|Withdrawal by Investigator|0
1000476|NCT01424566|2016628|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
1000477|NCT01424566|2016629|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
1000478|NCT01424566|2016630|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
1000479|NCT01424566|2016628|FG000|Single-blind Treatment|Met Exclusion Criteria|1
1000480|NCT01424566|2016629|FG001|Single-blind Treatment|Met Exclusion Criteria|0
1000481|NCT01424566|2016630|FG002|Single-blind Treatment|Met Exclusion Criteria|0
1000482|NCT01424566|2016628|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2
1000483|NCT01424566|2016629|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0
1000484|NCT01424566|2016630|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0
1000485|NCT01424566|2016628|FG000|Double-blind Treatment|Adverse Event|0
1000486|NCT01424566|2016629|FG001|Double-blind Treatment|Adverse Event|21
1000487|NCT01424566|2016630|FG002|Double-blind Treatment|Adverse Event|13
1000488|NCT01424566|2016628|FG000|Double-blind Treatment|Withdrawal by Subject|0
1000489|NCT01424566|2016629|FG001|Double-blind Treatment|Withdrawal by Subject|2
1000490|NCT01424566|2016630|FG002|Double-blind Treatment|Withdrawal by Subject|0
1000491|NCT01424566|2016628|FG000|Double-blind Treatment|Withdrawal by Investigator|0
1000492|NCT01424566|2016629|FG001|Double-blind Treatment|Withdrawal by Investigator|1
1000493|NCT01424566|2016630|FG002|Double-blind Treatment|Withdrawal by Investigator|1
1000494|NCT01424566|2016628|FG000|Double-blind Treatment|Lack of Efficacy|0
1000495|NCT01424566|2016629|FG001|Double-blind Treatment|Lack of Efficacy|1
1000496|NCT01424566|2016630|FG002|Double-blind Treatment|Lack of Efficacy|1
1000497|NCT01424644|2016639|FG000|Overall Study|Adverse Event|2
1000498|NCT01424644|2016640|FG001|Overall Study|Adverse Event|0
1000499|NCT01424644|2016639|FG000|Overall Study|Withdrawal by Subject|9
1000500|NCT01424644|2016640|FG001|Overall Study|Withdrawal by Subject|12
1000501|NCT01424644|2016639|FG000|Overall Study|Lost to Follow-up|16
1000502|NCT01424644|2016640|FG001|Overall Study|Lost to Follow-up|12
1000503|NCT01424644|2016639|FG000|Overall Study|Protocol Violation|4
1000504|NCT01424644|2016640|FG001|Overall Study|Protocol Violation|3
1000505|NCT01424644|2016639|FG000|Overall Study|Administrative Reason|1
1000506|NCT01424644|2016640|FG001|Overall Study|Administrative Reason|0
1000507|NCT01424644|2016639|FG000|Overall Study|Unable to Classify|1
1000508|NCT01424644|2016640|FG001|Overall Study|Unable to Classify|0
1000509|NCT01424670|2016648|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2
1000510|NCT01424670|2016649|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2
1000511|NCT01424670|2016648|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
1000512|NCT01424670|2016649|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
1006729|NCT01469052|2025437|FG001|Overall Study|Other|1
1000513|NCT01424670|2016648|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
1000514|NCT01424670|2016649|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
1000515|NCT01424670|2016648|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2
1000516|NCT01424670|2016649|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3
1000517|NCT01424670|2016648|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
1000518|NCT01424670|2016649|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
1000519|NCT01424670|2016648|FG000|Continuation Period|Adverse Event|13
1000520|NCT01424670|2016649|FG001|Continuation Period|Adverse Event|5
1000521|NCT01424670|2016648|FG000|Continuation Period|Lost to Follow-up|2
1000522|NCT01424670|2016649|FG001|Continuation Period|Lost to Follow-up|0
1000523|NCT01424670|2016648|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1
1000524|NCT01424670|2016649|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1
1000525|NCT01424670|2016648|FG000|Continuation Period|Physician Decision|5
1000526|NCT01424670|2016649|FG001|Continuation Period|Physician Decision|4
1000527|NCT01424670|2016648|FG000|Continuation Period|Withdrawal by Subject|13
1000528|NCT01424670|2016649|FG001|Continuation Period|Withdrawal by Subject|4
1000529|NCT01424722|2016657|FG000|Overall Study|Sponsor terminated investigation|2258
1000530|NCT01424813|2016663|FG000|Overall Study|Withdrawal by Subject|3
1000531|NCT01424813|2016664|FG001|Overall Study|Withdrawal by Subject|0
1000532|NCT01424813|2016663|FG000|Overall Study|Protocol Violation|1
1000533|NCT01424813|2016664|FG001|Overall Study|Protocol Violation|0
1000534|NCT01424813|2016663|FG000|Overall Study|Other|1
1000535|NCT01424813|2016664|FG001|Overall Study|Other|2
1000536|NCT01424930|2016672|FG000|Overall Study|Adverse Event|0
1000537|NCT01424930|2016673|FG001|Overall Study|Adverse Event|1
1000538|NCT01424930|2016672|FG000|Overall Study|Death|1
1000539|NCT01424930|2016673|FG001|Overall Study|Death|0
1000540|NCT01424930|2016672|FG000|Overall Study|Progressive Disease|3
1000541|NCT01424930|2016673|FG001|Overall Study|Progressive Disease|6
1000542|NCT01424930|2016672|FG000|Overall Study|Screen Failure|0
1000543|NCT01424930|2016673|FG001|Overall Study|Screen Failure|1
1000544|NCT01424930|2016672|FG000|Overall Study|Reason not specified|0
1000545|NCT01424930|2016673|FG001|Overall Study|Reason not specified|6
1000546|NCT01425190|2016781|FG000|Overall Study|Full dose not consumed.|1
1000547|NCT01425190|2016782|FG001|Overall Study|Full dose not consumed.|0
1000548|NCT01425190|2016783|FG002|Overall Study|Full dose not consumed.|0
1000549|NCT01425203|2016793|FG000|Treatment Phase|DC during PR Lead-in Phase|3
1000550|NCT01425203|2016794|FG001|Treatment Phase|DC during PR Lead-in Phase|1
1000551|NCT01425203|2016795|FG002|Treatment Phase|DC during PR Lead-in Phase|0
1000552|NCT01425203|2016793|FG000|Treatment Phase|Failure at futility timepoint|8
1000553|NCT01425203|2016794|FG001|Treatment Phase|Failure at futility timepoint|27
1000554|NCT01425203|2016795|FG002|Treatment Phase|Failure at futility timepoint|0
1000555|NCT01425203|2016793|FG000|Treatment Phase|Other virologic failure criteria|5
1000556|NCT01425203|2016794|FG001|Treatment Phase|Other virologic failure criteria|3
1000557|NCT01425203|2016795|FG002|Treatment Phase|Other virologic failure criteria|0
1000558|NCT01425203|2016793|FG000|Treatment Phase|Unidentified reasons|11
1000559|NCT01425203|2016794|FG001|Treatment Phase|Unidentified reasons|5
1000560|NCT01425203|2016795|FG002|Treatment Phase|Unidentified reasons|0
1000561|NCT01425203|2016793|FG000|Treatment Phase|Did not receive treatment|0
1000562|NCT01425203|2016794|FG001|Treatment Phase|Did not receive treatment|1
1000563|NCT01425203|2016795|FG002|Treatment Phase|Did not receive treatment|0
1000564|NCT01425203|2016793|FG000|Crossover Phase|Failure at futility timepoint|0
1000565|NCT01425203|2016794|FG001|Crossover Phase|Failure at futility timepoint|0
1000566|NCT01425203|2016795|FG002|Crossover Phase|Failure at futility timepoint|3
1000567|NCT01425203|2016793|FG000|Crossover Phase|Other virologic failure criteria|0
1000568|NCT01425203|2016794|FG001|Crossover Phase|Other virologic failure criteria|0
1000569|NCT01425203|2016795|FG002|Crossover Phase|Other virologic failure criteria|3
1000570|NCT01425268|2016813|FG000|Overall Study|Withdrawal by Subject|2
1000571|NCT01425268|2016814|FG001|Overall Study|Withdrawal by Subject|0
1000572|NCT01425268|2016813|FG000|Overall Study|Sponsor Decision|5
1000573|NCT01425268|2016814|FG001|Overall Study|Sponsor Decision|0
1000574|NCT01425268|2016813|FG000|Overall Study|Physician Decision|1
1000575|NCT01425268|2016814|FG001|Overall Study|Physician Decision|0
1000576|NCT01425281|2016822|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1
1000577|NCT01425281|2016823|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0
1000578|NCT01425281|2016822|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3
1000579|NCT01425281|2016823|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0
1000580|NCT01425281|2016822|FG000|At 180-day Clinical Follow-up|Death|0
1000581|NCT01425281|2016823|FG001|At 180-day Clinical Follow-up|Death|1
1000582|NCT01425281|2016822|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1
1000583|NCT01425281|2016823|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1
1000584|NCT01425281|2016822|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
1000585|NCT01425281|2016823|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
1000586|NCT01425281|2016822|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2
1000587|NCT01425281|2016823|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1
1000588|NCT01425281|2016822|FG000|At 2-year Clinical Follow-up|Death|2
1000589|NCT01425281|2016823|FG001|At 2-year Clinical Follow-up|Death|0
1000590|NCT01425281|2016822|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1
1000591|NCT01425281|2016823|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0
1000592|NCT01425281|2016822|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
1000593|NCT01425281|2016823|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
1000594|NCT01425281|2016822|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3
1000595|NCT01425281|2016823|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3
1000596|NCT01425281|2016822|FG000|At 3-year Clinical Follow-up|Death|2
1000597|NCT01425281|2016823|FG001|At 3-year Clinical Follow-up|Death|3
1000598|NCT01425281|2016822|FG000|At 4-year Clinical Follow-up|Death|7
1000599|NCT01425281|2016823|FG001|At 4-year Clinical Follow-up|Death|3
1000600|NCT01425281|2016822|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3
1000601|NCT01425281|2016823|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2
1000602|NCT01425281|2016822|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
1000603|NCT01425281|2016823|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
1000604|NCT01425281|2016822|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
1000605|NCT01425281|2016823|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
1000606|NCT01425281|2016822|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4
1000607|NCT01425281|2016823|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1
1000608|NCT01425281|2016822|FG000|At 5-year Clinical Follow-up|Death|2
1000609|NCT01425281|2016823|FG001|At 5-year Clinical Follow-up|Death|0
1000610|NCT01425281|2016822|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2
1000611|NCT01425281|2016823|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1
1000612|NCT01425281|2016822|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
1000613|NCT01425281|2016823|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
1000614|NCT01425281|2016822|FG000|At 5-year Clinical Follow-up|Refused/terminated|9
1000615|NCT01425281|2016823|FG001|At 5-year Clinical Follow-up|Refused/terminated|3
1000616|NCT01425359|2016843|FG000|Overall Study|Randomized but Not Treated|2
1000617|NCT01425359|2016844|FG001|Overall Study|Randomized but Not Treated|3
1000618|NCT01425359|2016843|FG000|Overall Study|Adverse Event|9
1000619|NCT01425359|2016844|FG001|Overall Study|Adverse Event|8
1000620|NCT01425359|2016843|FG000|Overall Study|Revascularization|0
1000621|NCT01425359|2016844|FG001|Overall Study|Revascularization|1
1000622|NCT01425359|2016843|FG000|Overall Study|Death|0
1000623|NCT01425359|2016844|FG001|Overall Study|Death|1
1000624|NCT01425359|2016843|FG000|Overall Study|Unsatisfactory Response|1
1000625|NCT01425359|2016844|FG001|Overall Study|Unsatisfactory Response|0
1000626|NCT01425359|2016843|FG000|Overall Study|Protocol Violation|1
1000627|NCT01425359|2016844|FG001|Overall Study|Protocol Violation|2
1000628|NCT01425359|2016843|FG000|Overall Study|Subject Withdrew Consent|1
1000629|NCT01425359|2016844|FG001|Overall Study|Subject Withdrew Consent|2
1000630|NCT01425359|2016843|FG000|Overall Study|Investigator's Discretion|2
1000631|NCT01425359|2016844|FG001|Overall Study|Investigator's Discretion|0
1000632|NCT01425359|2016843|FG000|Overall Study|Did Not Meet Qualifying Criteria|3
1000633|NCT01425359|2016844|FG001|Overall Study|Did Not Meet Qualifying Criteria|5
1000634|NCT01425463|2016853|FG000|Overall Study|Adverse Event|5
1000635|NCT01425463|2016854|FG001|Overall Study|Adverse Event|7
1000636|NCT01425463|2016853|FG000|Overall Study|Lack of Efficacy|1
1000637|NCT01425463|2016854|FG001|Overall Study|Lack of Efficacy|1
1000638|NCT01425463|2016853|FG000|Overall Study|Protocol Violation|2
1000639|NCT01425463|2016854|FG001|Overall Study|Protocol Violation|2
1000640|NCT01425463|2016853|FG000|Overall Study|Lost to Follow-up|5
1000641|NCT01425463|2016854|FG001|Overall Study|Lost to Follow-up|2
1000642|NCT01425463|2016853|FG000|Overall Study|Withdrawal by Subject|7
1000643|NCT01425463|2016854|FG001|Overall Study|Withdrawal by Subject|5
1000644|NCT01425463|2016853|FG000|Overall Study|Unknown Reason|4
1000645|NCT01425463|2016854|FG001|Overall Study|Unknown Reason|7
1000646|NCT01425528|2016862|FG000|Overall Study|Withdrawal by Subject|1
1000647|NCT01425528|2016863|FG001|Overall Study|Withdrawal by Subject|1
1000648|NCT01425632|2016872|FG000|Overall Study|Adverse Event|0
1000649|NCT01425632|2016873|FG001|Overall Study|Adverse Event|1
1000650|NCT01425632|2016874|FG002|Overall Study|Adverse Event|1
1000651|NCT01425632|2016872|FG000|Overall Study|Physician Decision|1
1000652|NCT01425632|2016873|FG001|Overall Study|Physician Decision|0
1000653|NCT01425632|2016874|FG002|Overall Study|Physician Decision|0
1000654|NCT01425632|2016872|FG000|Overall Study|Protocol Violation|0
1000655|NCT01425632|2016873|FG001|Overall Study|Protocol Violation|0
914134|NCT00813488|1891933|FG000|Titration Period 1|Withdrawal by Subject|2
914135|NCT00813488|1891934|FG001|Titration Period 1|Withdrawal by Subject|2
914136|NCT00813488|1891933|FG000|Titration Period 1|Protocol Violation|4
914137|NCT00813488|1891934|FG001|Titration Period 1|Protocol Violation|3
914138|NCT00813488|1891933|FG000|Titration Period 1|Non-compliance to study medication|4
914139|NCT00813488|1891934|FG001|Titration Period 1|Non-compliance to study medication|1
914140|NCT00813488|1891933|FG000|Titration Period 1|Non-compliance to study procedures|2
914141|NCT00813488|1891934|FG001|Titration Period 1|Non-compliance to study procedures|2
914142|NCT00813488|1891933|FG000|Titration Period 1|Technical Difficulties|0
914143|NCT00813488|1891934|FG001|Titration Period 1|Technical Difficulties|1
914144|NCT00813488|1891933|FG000|Titration Period 2|Adverse Event|2
914145|NCT00813488|1891934|FG001|Titration Period 2|Adverse Event|3
914146|NCT00813488|1891933|FG000|Titration Period 2|Lack of Efficacy|8
914147|NCT00813488|1891934|FG001|Titration Period 2|Lack of Efficacy|4
1000656|NCT01425632|2016874|FG002|Overall Study|Protocol Violation|2
1000657|NCT01425632|2016872|FG000|Overall Study|Withdrawal by Subject|0
1000658|NCT01425632|2016873|FG001|Overall Study|Withdrawal by Subject|0
1000659|NCT01425632|2016874|FG002|Overall Study|Withdrawal by Subject|1
1000660|NCT01425723|2016884|FG000|Overall Study|Lack of Efficacy|0
1000661|NCT01425723|2016885|FG001|Overall Study|Lack of Efficacy|1
1000662|NCT01425723|2016884|FG000|Overall Study|Withdrawal by Subject|1
1000663|NCT01425723|2016885|FG001|Overall Study|Withdrawal by Subject|4
1000664|NCT01425723|2016884|FG000|Overall Study|Lost to Follow-up|0
1000665|NCT01425723|2016885|FG001|Overall Study|Lost to Follow-up|3
1000666|NCT01425723|2016884|FG000|Overall Study|Physician Decision|2
1000667|NCT01425723|2016885|FG001|Overall Study|Physician Decision|0
1000668|NCT01425723|2016884|FG000|Overall Study|Other|1
1000669|NCT01425723|2016885|FG001|Overall Study|Other|10
1000670|NCT01425749|2016902|FG000|Overall Study|progression of melanoma|0
1000671|NCT01425749|2016903|FG001|Overall Study|progression of melanoma|1
1000672|NCT01425801|2016912|FG000|Period 1|Withdrawal by Subject|0
1000673|NCT01425801|2016913|FG001|Period 1|Withdrawal by Subject|0
1000674|NCT01425801|2016914|FG002|Period 1|Withdrawal by Subject|0
1000675|NCT01425801|2016915|FG003|Period 1|Withdrawal by Subject|0
1000676|NCT01425801|2016916|FG004|Period 1|Withdrawal by Subject|1
1000677|NCT01425801|2016917|FG005|Period 1|Withdrawal by Subject|0
1000678|NCT01425801|2016912|FG000|Period 2|Withdrawal by Subject|0
1000679|NCT01425801|2016913|FG001|Period 2|Withdrawal by Subject|0
1000680|NCT01425801|2016914|FG002|Period 2|Withdrawal by Subject|0
1000681|NCT01425801|2016915|FG003|Period 2|Withdrawal by Subject|0
1000682|NCT01425801|2016916|FG004|Period 2|Withdrawal by Subject|1
1000683|NCT01425801|2016917|FG005|Period 2|Withdrawal by Subject|0
1000684|NCT01425801|2016912|FG000|Period 3|Stability criteria not fullfilled|0
1000685|NCT01425801|2016913|FG001|Period 3|Stability criteria not fullfilled|0
1000686|NCT01425801|2016914|FG002|Period 3|Stability criteria not fullfilled|1
1000687|NCT01425801|2016915|FG003|Period 3|Stability criteria not fullfilled|0
1000688|NCT01425801|2016916|FG004|Period 3|Stability criteria not fullfilled|0
1000689|NCT01425801|2016917|FG005|Period 3|Stability criteria not fullfilled|0
1000690|NCT01425801|2016912|FG000|Period 4|Not able to maintain visit schedule|0
1000691|NCT01425801|2016913|FG001|Period 4|Not able to maintain visit schedule|0
1000692|NCT01425801|2016914|FG002|Period 4|Not able to maintain visit schedule|1
1000693|NCT01425801|2016915|FG003|Period 4|Not able to maintain visit schedule|0
1000694|NCT01425801|2016916|FG004|Period 4|Not able to maintain visit schedule|0
1000695|NCT01425801|2016917|FG005|Period 4|Not able to maintain visit schedule|0
1000696|NCT01425814|2016931|FG000|Period 1|Stability criteria not fulfilled|0
1000697|NCT01425814|2016932|FG001|Period 1|Stability criteria not fulfilled|1
1000698|NCT01425814|2016933|FG002|Period 1|Stability criteria not fulfilled|0
1000699|NCT01425814|2016934|FG003|Period 1|Stability criteria not fulfilled|0
1000700|NCT01425814|2016935|FG004|Period 1|Stability criteria not fulfilled|0
1000701|NCT01425814|2016936|FG005|Period 1|Stability criteria not fulfilled|0
1000702|NCT01425814|2016931|FG000|Period 2|Stability criteria not fulfilled|0
1000703|NCT01425814|2016932|FG001|Period 2|Stability criteria not fulfilled|1
1000704|NCT01425814|2016933|FG002|Period 2|Stability criteria not fulfilled|0
1000705|NCT01425814|2016934|FG003|Period 2|Stability criteria not fulfilled|0
1000706|NCT01425814|2016935|FG004|Period 2|Stability criteria not fulfilled|0
1000707|NCT01425814|2016936|FG005|Period 2|Stability criteria not fulfilled|0
1000708|NCT01425814|2016931|FG000|Period 3|Adverse Event|0
1000709|NCT01425814|2016932|FG001|Period 3|Adverse Event|0
1000710|NCT01425814|2016933|FG002|Period 3|Adverse Event|0
1000711|NCT01425814|2016934|FG003|Period 3|Adverse Event|0
1000712|NCT01425814|2016935|FG004|Period 3|Adverse Event|0
1000713|NCT01425814|2016936|FG005|Period 3|Adverse Event|1
1000714|NCT01425814|2016931|FG000|Period 4|Adverse Event|1
1000715|NCT01425814|2016932|FG001|Period 4|Adverse Event|0
1000716|NCT01425814|2016933|FG002|Period 4|Adverse Event|1
1000717|NCT01425814|2016934|FG003|Period 4|Adverse Event|0
1000718|NCT01425814|2016935|FG004|Period 4|Adverse Event|0
1000719|NCT01425814|2016936|FG005|Period 4|Adverse Event|0
1000720|NCT01425814|2016931|FG000|Period 5|Stability criteria not fulfilled|0
1000721|NCT01425814|2016932|FG001|Period 5|Stability criteria not fulfilled|0
1000722|NCT01425814|2016933|FG002|Period 5|Stability criteria not fulfilled|1
1000723|NCT01425814|2016934|FG003|Period 5|Stability criteria not fulfilled|0
1000724|NCT01425814|2016935|FG004|Period 5|Stability criteria not fulfilled|0
1000725|NCT01425814|2016936|FG005|Period 5|Stability criteria not fulfilled|1
1000726|NCT01426009|2016964|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1
1000727|NCT01426009|2016964|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1
1000728|NCT01426009|2016964|FG000|Washout 1|Withdrawal by Subject|1
1000729|NCT01426009|2016964|FG000|Washout 1|Personal Reasons|1
1000730|NCT01426009|2016964|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4
1000731|NCT01426009|2016964|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1
1000732|NCT01426009|2016964|FG000|Washout 2|electrive surgery|1
1000733|NCT01426009|2016964|FG000|Washout 3|personal reasons|1
1000734|NCT01426009|2016964|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1
1000735|NCT01426009|2016964|FG000|Washout 4|Lost to Follow-up|1
1000736|NCT01426217|2016986|FG000|Overall Study|lost sample|8
1000737|NCT01426217|2016987|FG001|Overall Study|lost sample|14
1000738|NCT01426269|2017001|FG000|Period 1: 12 Weeks|Adverse Event|5
1000739|NCT01426269|2017002|FG001|Period 1: 12 Weeks|Adverse Event|0
1000740|NCT01426269|2017003|FG002|Period 1: 12 Weeks|Adverse Event|0
1000741|NCT01426269|2017001|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22
1000742|NCT01426269|2017002|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0
1000743|NCT01426269|2017003|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0
1000744|NCT01426269|2017001|FG000|Period 1: 12 Weeks|Protocol Violation|5
1000745|NCT01426269|2017002|FG001|Period 1: 12 Weeks|Protocol Violation|0
1000746|NCT01426269|2017003|FG002|Period 1: 12 Weeks|Protocol Violation|0
1000747|NCT01426269|2017001|FG000|Period 1: 12 Weeks|Lost to Follow-up|22
1000748|NCT01426269|2017002|FG001|Period 1: 12 Weeks|Lost to Follow-up|0
1000749|NCT01426269|2017003|FG002|Period 1: 12 Weeks|Lost to Follow-up|0
1000750|NCT01426269|2017001|FG000|Period 1: 12 Weeks|Pregnancy|1
1000751|NCT01426269|2017002|FG001|Period 1: 12 Weeks|Pregnancy|0
1000752|NCT01426269|2017003|FG002|Period 1: 12 Weeks|Pregnancy|0
1000753|NCT01426269|2017001|FG000|Eligibility for Period 2, Randomization|Did not qualify|42
1000754|NCT01426269|2017002|FG001|Eligibility for Period 2, Randomization|Did not qualify|0
1000755|NCT01426269|2017003|FG002|Eligibility for Period 2, Randomization|Did not qualify|0
1000756|NCT01426269|2017001|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8
1000757|NCT01426269|2017002|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0
1000758|NCT01426269|2017003|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0
1000759|NCT01426269|2017001|FG000|Period 2: 40 Weeks|Adverse Event|0
1000760|NCT01426269|2017002|FG001|Period 2: 40 Weeks|Adverse Event|1
1000761|NCT01426269|2017003|FG002|Period 2: 40 Weeks|Adverse Event|2
1000762|NCT01426269|2017001|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0
1000763|NCT01426269|2017002|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9
1000764|NCT01426269|2017003|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11
1000765|NCT01426269|2017001|FG000|Period 2: 40 Weeks|Protocol Violation|0
1000766|NCT01426269|2017002|FG001|Period 2: 40 Weeks|Protocol Violation|5
1000767|NCT01426269|2017003|FG002|Period 2: 40 Weeks|Protocol Violation|5
1000768|NCT01426269|2017001|FG000|Period 2: 40 Weeks|Lost to Follow-up|0
1000769|NCT01426269|2017002|FG001|Period 2: 40 Weeks|Lost to Follow-up|8
1000770|NCT01426269|2017003|FG002|Period 2: 40 Weeks|Lost to Follow-up|6
1000771|NCT01426269|2017001|FG000|Period 2: 40 Weeks|Site closed|0
1000772|NCT01426269|2017002|FG001|Period 2: 40 Weeks|Site closed|6
1000773|NCT01426269|2017003|FG002|Period 2: 40 Weeks|Site closed|5
1000774|NCT01426269|2017001|FG000|Period 2: 40 Weeks|Relapsed|0
1000775|NCT01426269|2017002|FG001|Period 2: 40 Weeks|Relapsed|9
1000776|NCT01426269|2017003|FG002|Period 2: 40 Weeks|Relapsed|18
1000777|NCT01426347|2017016|FG000|Overall Study|Lost to Follow-up|0
1000778|NCT01426347|2017017|FG001|Overall Study|Lost to Follow-up|3
1000779|NCT01426347|2017016|FG000|Overall Study|Protocol Violation|2
1000780|NCT01426347|2017017|FG001|Overall Study|Protocol Violation|0
1000781|NCT01426347|2017016|FG000|Overall Study|Withdrawal by Subject|5
1000782|NCT01426347|2017017|FG001|Overall Study|Withdrawal by Subject|0
1000783|NCT01426373|2017032|FG000|Overall Study|Adverse Event|6
1000784|NCT01426373|2017032|FG000|Overall Study|Lost to Follow-up|14
1000785|NCT01426373|2017032|FG000|Overall Study|Participant Convenience|10
1000786|NCT01426373|2017032|FG000|Overall Study|Miscellaneous Reasons|4
1000787|NCT01426386|2017044|FG000|Overall Study|Adverse Event|0
1000788|NCT01426386|2017045|FG001|Overall Study|Adverse Event|1
1000789|NCT01426386|2017046|FG002|Overall Study|Adverse Event|0
1000790|NCT01426386|2017047|FG003|Overall Study|Adverse Event|0
1000791|NCT01426386|2017048|FG004|Overall Study|Adverse Event|0
1000792|NCT01426386|2017049|FG005|Overall Study|Adverse Event|0
1000793|NCT01426386|2017044|FG000|Overall Study|Did not attend scheduled visit|1
1000794|NCT01426386|2017045|FG001|Overall Study|Did not attend scheduled visit|4
1000795|NCT01426386|2017046|FG002|Overall Study|Did not attend scheduled visit|0
1000796|NCT01426386|2017047|FG003|Overall Study|Did not attend scheduled visit|0
1000797|NCT01426386|2017048|FG004|Overall Study|Did not attend scheduled visit|2
1000798|NCT01426386|2017049|FG005|Overall Study|Did not attend scheduled visit|1
1000799|NCT01426386|2017044|FG000|Overall Study|Poor response|2
1000800|NCT01426386|2017045|FG001|Overall Study|Poor response|1
1000801|NCT01426386|2017046|FG002|Overall Study|Poor response|2
1000802|NCT01426386|2017047|FG003|Overall Study|Poor response|0
1000803|NCT01426386|2017048|FG004|Overall Study|Poor response|1
1000804|NCT01426386|2017049|FG005|Overall Study|Poor response|0
1000805|NCT01426386|2017044|FG000|Overall Study|Personal reasons|0
1000806|NCT01426386|2017045|FG001|Overall Study|Personal reasons|0
1000807|NCT01426386|2017046|FG002|Overall Study|Personal reasons|0
1000808|NCT01426386|2017047|FG003|Overall Study|Personal reasons|0
1000809|NCT01426386|2017048|FG004|Overall Study|Personal reasons|1
1000810|NCT01426386|2017049|FG005|Overall Study|Personal reasons|0
1000811|NCT01426412|2017072|FG000|Overall Study|Withdrawal by Subject|1
1000812|NCT01426412|2017073|FG001|Overall Study|Withdrawal by Subject|0
1000813|NCT01426412|2017074|FG002|Overall Study|Withdrawal by Subject|0
1000814|NCT01426412|2017075|FG003|Overall Study|Withdrawal by Subject|0
1000815|NCT01426412|2017076|FG004|Overall Study|Withdrawal by Subject|1
1000816|NCT01426412|2017077|FG005|Overall Study|Withdrawal by Subject|0
1000817|NCT01426412|2017078|FG006|Overall Study|Withdrawal by Subject|0
1000818|NCT01426412|2017079|FG007|Overall Study|Withdrawal by Subject|3
1000819|NCT01426412|2017080|FG008|Overall Study|Withdrawal by Subject|1
1000820|NCT01426425|2017111|FG000|Overall Study|Exited prior to EP study|22
1000821|NCT01426425|2017111|FG000|Overall Study|Inclusion/exclusion criteria not met|151
1000822|NCT01426425|2017111|FG000|Overall Study|Met inclusion/exclusion, not treated|2
1000823|NCT01426438|2017118|FG000|Overall Study|Lost to Follow-up|1
1000824|NCT01426438|2017119|FG001|Overall Study|Lost to Follow-up|3
1000825|NCT01426438|2017118|FG000|Overall Study|Off study Treatment|9
1000826|NCT01426438|2017119|FG001|Overall Study|Off study Treatment|3
1000827|NCT01426438|2017118|FG000|Overall Study|Poor scan quality|3
1000828|NCT01426438|2017119|FG001|Overall Study|Poor scan quality|2
1000829|NCT01426438|2017118|FG000|Overall Study|Missed Scan|2
1000830|NCT01426438|2017119|FG001|Overall Study|Missed Scan|2
1000831|NCT01426789|2017149|FG000|Part 1|Protocol deviation|0
1000832|NCT01426789|2017150|FG001|Part 1|Protocol deviation|1
1000833|NCT01426789|2017151|FG002|Part 1|Protocol deviation|0
1000834|NCT01426789|2017152|FG003|Part 1|Protocol deviation|0
1000835|NCT01426789|2017153|FG004|Part 1|Protocol deviation|0
1000836|NCT01426789|2017154|FG005|Part 1|Protocol deviation|0
1000837|NCT01426789|2017149|FG000|Part 1|Lost to Follow-up|1
1000838|NCT01426789|2017150|FG001|Part 1|Lost to Follow-up|2
1000839|NCT01426789|2017151|FG002|Part 1|Lost to Follow-up|0
1000840|NCT01426789|2017152|FG003|Part 1|Lost to Follow-up|0
1000841|NCT01426789|2017153|FG004|Part 1|Lost to Follow-up|0
1000842|NCT01426789|2017154|FG005|Part 1|Lost to Follow-up|0
1000843|NCT01426789|2017149|FG000|Part 1|Lack of Efficacy|2
1000844|NCT01426789|2017150|FG001|Part 1|Lack of Efficacy|1
1000845|NCT01426789|2017151|FG002|Part 1|Lack of Efficacy|0
1000846|NCT01426789|2017152|FG003|Part 1|Lack of Efficacy|0
1000847|NCT01426789|2017153|FG004|Part 1|Lack of Efficacy|0
1000848|NCT01426789|2017154|FG005|Part 1|Lack of Efficacy|0
1000849|NCT01426789|2017149|FG000|Part 1|Adverse Event|3
1000850|NCT01426789|2017150|FG001|Part 1|Adverse Event|0
1000851|NCT01426789|2017151|FG002|Part 1|Adverse Event|0
1000852|NCT01426789|2017152|FG003|Part 1|Adverse Event|0
1000853|NCT01426789|2017153|FG004|Part 1|Adverse Event|0
1000854|NCT01426789|2017154|FG005|Part 1|Adverse Event|0
1000855|NCT01426789|2017149|FG000|Part 2|Protocol deviation|0
1000856|NCT01426789|2017150|FG001|Part 2|Protocol deviation|0
1000857|NCT01426789|2017151|FG002|Part 2|Protocol deviation|1
1000858|NCT01426789|2017152|FG003|Part 2|Protocol deviation|0
1000859|NCT01426789|2017153|FG004|Part 2|Protocol deviation|0
1000860|NCT01426789|2017154|FG005|Part 2|Protocol deviation|0
1000861|NCT01426789|2017149|FG000|Part 2|Death|0
1000862|NCT01426789|2017150|FG001|Part 2|Death|0
1000863|NCT01426789|2017151|FG002|Part 2|Death|1
1000864|NCT01426789|2017152|FG003|Part 2|Death|0
1000865|NCT01426789|2017153|FG004|Part 2|Death|1
1000866|NCT01426789|2017154|FG005|Part 2|Death|0
1000867|NCT01426789|2017149|FG000|Part 2|Administrative problems|0
1000868|NCT01426789|2017150|FG001|Part 2|Administrative problems|0
1000869|NCT01426789|2017151|FG002|Part 2|Administrative problems|2
1000870|NCT01426789|2017152|FG003|Part 2|Administrative problems|0
1000871|NCT01426789|2017153|FG004|Part 2|Administrative problems|1
1000872|NCT01426789|2017154|FG005|Part 2|Administrative problems|0
1000873|NCT01426789|2017149|FG000|Part 2|Lost to Follow-up|0
1000874|NCT01426789|2017150|FG001|Part 2|Lost to Follow-up|0
1000875|NCT01426789|2017151|FG002|Part 2|Lost to Follow-up|4
1000876|NCT01426789|2017152|FG003|Part 2|Lost to Follow-up|0
1000877|NCT01426789|2017153|FG004|Part 2|Lost to Follow-up|1
1000878|NCT01426789|2017154|FG005|Part 2|Lost to Follow-up|0
1000879|NCT01426789|2017149|FG000|Part 2|Withdrawal by Subject|0
1000880|NCT01426789|2017150|FG001|Part 2|Withdrawal by Subject|0
1000881|NCT01426789|2017151|FG002|Part 2|Withdrawal by Subject|0
1000882|NCT01426789|2017152|FG003|Part 2|Withdrawal by Subject|1
1000883|NCT01426789|2017153|FG004|Part 2|Withdrawal by Subject|2
1000884|NCT01426789|2017154|FG005|Part 2|Withdrawal by Subject|0
1000885|NCT01426789|2017149|FG000|Part 2|Lack of Efficacy|0
1000886|NCT01426789|2017150|FG001|Part 2|Lack of Efficacy|0
1000887|NCT01426789|2017151|FG002|Part 2|Lack of Efficacy|5
1000888|NCT01426789|2017152|FG003|Part 2|Lack of Efficacy|0
1000889|NCT01426789|2017153|FG004|Part 2|Lack of Efficacy|2
1000890|NCT01426789|2017154|FG005|Part 2|Lack of Efficacy|0
1000891|NCT01426789|2017149|FG000|Part 2|Adverse Event|0
1000892|NCT01426789|2017150|FG001|Part 2|Adverse Event|0
1000893|NCT01426789|2017151|FG002|Part 2|Adverse Event|2
1000894|NCT01426789|2017152|FG003|Part 2|Adverse Event|0
1000895|NCT01426789|2017153|FG004|Part 2|Adverse Event|1
1000896|NCT01426789|2017154|FG005|Part 2|Adverse Event|0
1000897|NCT01426854|2017173|FG000|Overall Study|Adverse Event|1
1000898|NCT01426854|2017174|FG001|Overall Study|Adverse Event|5
1000899|NCT01426854|2017173|FG000|Overall Study|Subject Decision Unrelated to AE|5
1000900|NCT01426854|2017174|FG001|Overall Study|Subject Decision Unrelated to AE|6
1000901|NCT01426854|2017173|FG000|Overall Study|Lost to Follow-up|3
1000902|NCT01426854|2017174|FG001|Overall Study|Lost to Follow-up|0
1000903|NCT01426854|2017173|FG000|Overall Study|Noncompliance|0
1000904|NCT01426854|2017174|FG001|Overall Study|Noncompliance|1
1000905|NCT01426854|2017173|FG000|Overall Study|Treatment Failure|0
1000906|NCT01426854|2017174|FG001|Overall Study|Treatment Failure|16
1000907|NCT01426854|2017173|FG000|Overall Study|Protocol Deviation|0
1000908|NCT01426854|2017174|FG001|Overall Study|Protocol Deviation|1
1000909|NCT01426854|2017173|FG000|Overall Study|Other|3
1000910|NCT01426854|2017174|FG001|Overall Study|Other|2
1000911|NCT01426958|2017193|FG000|Overall Study|Adverse Event|2
1000912|NCT01427309|2017214|FG000|Overall Study|Lost to Follow-up|130
1000913|NCT01427309|2017215|FG001|Overall Study|Lost to Follow-up|145
1000914|NCT01427309|2017216|FG002|Overall Study|Lost to Follow-up|122
1000915|NCT01427309|2017217|FG003|Overall Study|Lost to Follow-up|135
1000916|NCT01427309|2017214|FG000|Overall Study|Protocol Violation|42
1000917|NCT01427309|2017215|FG001|Overall Study|Protocol Violation|69
1000918|NCT01427309|2017216|FG002|Overall Study|Protocol Violation|125
1000919|NCT01427309|2017217|FG003|Overall Study|Protocol Violation|124
1000920|NCT01427309|2017214|FG000|Overall Study|Adverse Event|0
1000921|NCT01427309|2017215|FG001|Overall Study|Adverse Event|0
1000922|NCT01427309|2017216|FG002|Overall Study|Adverse Event|3
1000923|NCT01427309|2017217|FG003|Overall Study|Adverse Event|1
1000924|NCT01427309|2017214|FG000|Overall Study|Serious adverse event|52
1000925|NCT01427309|2017215|FG001|Overall Study|Serious adverse event|45
1000926|NCT01427309|2017216|FG002|Overall Study|Serious adverse event|50
1000927|NCT01427309|2017217|FG003|Overall Study|Serious adverse event|61
1000928|NCT01427309|2017214|FG000|Overall Study|Withdrawal by Subject|148
1000929|NCT01427309|2017215|FG001|Overall Study|Withdrawal by Subject|148
1000930|NCT01427309|2017216|FG002|Overall Study|Withdrawal by Subject|61
1000931|NCT01427309|2017217|FG003|Overall Study|Withdrawal by Subject|55
1000932|NCT01427608|2017274|FG000|Overall Study|Death|1
1000933|NCT01427608|2017275|FG001|Overall Study|Death|0
1000934|NCT01427608|2017274|FG000|Overall Study|Withdrawal by Subject|7
1000935|NCT01427608|2017275|FG001|Overall Study|Withdrawal by Subject|3
1000936|NCT01427608|2017274|FG000|Overall Study|Relapsed-all cause|13
1000937|NCT01427608|2017275|FG001|Overall Study|Relapsed-all cause|34
1000938|NCT01427608|2017274|FG000|Overall Study|Events not attributed to study meds|0
1000939|NCT01427608|2017275|FG001|Overall Study|Events not attributed to study meds|1
1000940|NCT01427738|2017285|FG000|Overall Study|Death|12
1000941|NCT01427738|2017286|FG001|Overall Study|Death|9
1000942|NCT01427738|2017285|FG000|Overall Study|Severe debilitation, unable to continue|0
1000943|NCT01427738|2017286|FG001|Overall Study|Severe debilitation, unable to continue|1
1000944|NCT01427738|2017285|FG000|Overall Study|Subject unable to get to clinic|5
1000945|NCT01427738|2017286|FG001|Overall Study|Subject unable to get to clinic|2
1000946|NCT01427738|2017285|FG000|Overall Study|Withdrawal by Subject|0
1000947|NCT01427738|2017286|FG001|Overall Study|Withdrawal by Subject|2
1000948|NCT01427738|2017285|FG000|Overall Study|Subject not willing to adhere to reqs|1
1000949|NCT01427738|2017286|FG001|Overall Study|Subject not willing to adhere to reqs|2
1000950|NCT01427738|2017285|FG000|Overall Study|Lost to Follow-up|1
1000951|NCT01427738|2017286|FG001|Overall Study|Lost to Follow-up|5
1000952|NCT01427751|2017294|FG000|Overall Study|Adverse Event|18
1000953|NCT01427751|2017295|FG001|Overall Study|Adverse Event|2
1000954|NCT01427751|2017294|FG000|Overall Study|No further treatment benefit expected|5
1000955|NCT01427751|2017295|FG001|Overall Study|No further treatment benefit expected|1
1000956|NCT01427751|2017294|FG000|Overall Study|Lost to Follow-up|3
1000957|NCT01427751|2017295|FG001|Overall Study|Lost to Follow-up|1
1000958|NCT01427751|2017294|FG000|Overall Study|Withdrawal of consent|2
1000959|NCT01427751|2017295|FG001|Overall Study|Withdrawal of consent|2
1000960|NCT01427751|2017294|FG000|Overall Study|Protocol Violation|6
1000961|NCT01427751|2017295|FG001|Overall Study|Protocol Violation|4
1000962|NCT01427751|2017294|FG000|Overall Study|Death|2
1000963|NCT01427751|2017295|FG001|Overall Study|Death|0
1000964|NCT01427751|2017294|FG000|Overall Study|Other miscellaneous reasons|6
1000965|NCT01427751|2017295|FG001|Overall Study|Other miscellaneous reasons|4
1000966|NCT01427803|2017303|FG000|Overall Study|Lost to Follow-up|32
1000967|NCT01427803|2017304|FG001|Overall Study|Lost to Follow-up|26
1000968|NCT01427803|2017303|FG000|Overall Study|Withdrawal by Subject|20
1000969|NCT01427803|2017304|FG001|Overall Study|Withdrawal by Subject|0
1000970|NCT01427803|2017303|FG000|Overall Study|Unable to complete full treatment period|6
1000971|NCT01427803|2017304|FG001|Overall Study|Unable to complete full treatment period|0
1000972|NCT01427803|2017303|FG000|Overall Study|Protocol Violation|1
1000973|NCT01427803|2017304|FG001|Overall Study|Protocol Violation|0
1000974|NCT01427803|2017303|FG000|Overall Study|Physician Decision|3
1000975|NCT01427803|2017304|FG001|Overall Study|Physician Decision|0
1000976|NCT01427803|2017303|FG000|Overall Study|did not take product|1
1000977|NCT01427803|2017304|FG001|Overall Study|did not take product|0
1000978|NCT01427907|2017314|FG000|Overall Study|Withdrawal by Subject|3
1000979|NCT01427907|2017315|FG001|Overall Study|Withdrawal by Subject|4
1000980|NCT01427920|2017323|FG000|Overall Study|Adverse Event|1
1000981|NCT01427920|2017324|FG001|Overall Study|Adverse Event|2
1000982|NCT01427920|2017323|FG000|Overall Study|Lack of Efficacy|1
1000983|NCT01427920|2017324|FG001|Overall Study|Lack of Efficacy|0
1000984|NCT01427920|2017323|FG000|Overall Study|Protocol Violation|1
1000985|NCT01427920|2017324|FG001|Overall Study|Protocol Violation|3
1000986|NCT01427920|2017323|FG000|Overall Study|Withdrawal Criteria|4
1000987|NCT01427920|2017324|FG001|Overall Study|Withdrawal Criteria|4
1000988|NCT01427920|2017323|FG000|Overall Study|Unclassified|2
1000989|NCT01427920|2017324|FG001|Overall Study|Unclassified|8
1000990|NCT01427933|2017332|FG000|Overall Study|Withdrawal by Subject|5
1000991|NCT01427933|2017333|FG001|Overall Study|Withdrawal by Subject|8
1000992|NCT01427933|2017332|FG000|Overall Study|Lost to Follow-up|1
1000993|NCT01427933|2017333|FG001|Overall Study|Lost to Follow-up|5
1000994|NCT01427933|2017332|FG000|Overall Study|Other|1
1000995|NCT01427933|2017333|FG001|Overall Study|Other|0
1000996|NCT01427933|2017332|FG000|Overall Study|Investigator's Decision|1
1000997|NCT01427933|2017333|FG001|Overall Study|Investigator's Decision|0
1000998|NCT01427972|2017352|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0
1000999|NCT01427972|2017353|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0
1001000|NCT01427972|2017354|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0
1001001|NCT01427972|2017355|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0
1001002|NCT01427972|2017356|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0
1001003|NCT01427972|2017357|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0
1001004|NCT01427972|2017358|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0
1001005|NCT01427972|2017359|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1
1001006|NCT01427972|2017360|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0
1001007|NCT01427972|2017361|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0
1001008|NCT01427972|2017362|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0
1001009|NCT01427972|2017363|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0
1001010|NCT01427972|2017352|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0
1001011|NCT01427972|2017353|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0
1001012|NCT01427972|2017354|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0
1001013|NCT01427972|2017355|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0
1001014|NCT01427972|2017356|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0
1001015|NCT01427972|2017357|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2
1001016|NCT01427972|2017358|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0
1001017|NCT01427972|2017359|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0
1001018|NCT01427972|2017360|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0
1001019|NCT01427972|2017361|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0
1001020|NCT01427972|2017362|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0
1001021|NCT01427972|2017363|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0
1001022|NCT01427972|2017352|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1001023|NCT01427972|2017353|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
1001024|NCT01427972|2017354|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1001025|NCT01427972|2017355|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1001026|NCT01427972|2017356|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1001027|NCT01427972|2017357|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1001028|NCT01427972|2017358|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1001029|NCT01427972|2017359|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1001030|NCT01427972|2017360|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1001031|NCT01427972|2017361|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1001032|NCT01427972|2017362|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1001033|NCT01427972|2017363|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1001034|NCT01428063|2017396|FG000|Overall Study|Lack of Efficacy|8
1001035|NCT01428063|2017397|FG001|Overall Study|Lack of Efficacy|4
1001036|NCT01428063|2017398|FG002|Overall Study|Lack of Efficacy|1
1001037|NCT01428063|2017396|FG000|Overall Study|Adverse Event|2
1001038|NCT01428063|2017397|FG001|Overall Study|Adverse Event|3
1001039|NCT01428063|2017398|FG002|Overall Study|Adverse Event|0
1001040|NCT01428063|2017396|FG000|Overall Study|Lost to Follow-up|0
1001041|NCT01428063|2017397|FG001|Overall Study|Lost to Follow-up|2
1001042|NCT01428063|2017398|FG002|Overall Study|Lost to Follow-up|0
1001043|NCT01428063|2017396|FG000|Overall Study|No longer meets study criteria|0
1001044|NCT01428063|2017397|FG001|Overall Study|No longer meets study criteria|1
1001045|NCT01428063|2017398|FG002|Overall Study|No longer meets study criteria|0
1001046|NCT01428076|2017419|FG000|Overall Study|Adverse Event|0
1001047|NCT01428076|2017420|FG001|Overall Study|Adverse Event|1
1001048|NCT01428115|2017428|FG000|Overall Study|Lack of Efficacy|3
1001049|NCT01428115|2017428|FG000|Overall Study|Lost to Follow-up|10
1001050|NCT01428115|2017428|FG000|Overall Study|Pregnancy|1
1001051|NCT01428115|2017428|FG000|Overall Study|Protocol Violation|3
1001052|NCT01428115|2017428|FG000|Overall Study|Withdrawal by Subject|4
1001053|NCT01428128|2017433|FG000|Overall Study|Withdrawal by Subject|4
1001054|NCT01428128|2017433|FG000|Overall Study|Screen failure by p53|10
1001055|NCT01428128|2017433|FG000|Overall Study|Received Neulasta in one cycle|2
1001056|NCT01428128|2017433|FG000|Overall Study|Adverse Event|1
1001057|NCT01428193|2017438|FG000|Overall Study|Physician Decision|1
1001058|NCT01428193|2017438|FG000|Overall Study|Elevated screening liver enzymes|1
1001059|NCT01428219|2017442|FG000|Overall Study|25 patients enrolled, 3 were not treated|3
1001060|NCT01428258|2017452|FG000|Intervention 1|Withdrawal by Subject|2
1001061|NCT01428258|2017453|FG001|Intervention 1|Withdrawal by Subject|0
1001062|NCT01428453|2017481|FG000|Overall Study|Adverse Event|2
1001063|NCT01428453|2017482|FG001|Overall Study|Adverse Event|7
1001064|NCT01428453|2017481|FG000|Overall Study|Protocol Violation|1
1001065|NCT01428453|2017482|FG001|Overall Study|Protocol Violation|0
1001066|NCT01428453|2017481|FG000|Overall Study|Lost to Follow-up|0
1001067|NCT01428453|2017482|FG001|Overall Study|Lost to Follow-up|1
1001068|NCT01428453|2017481|FG000|Overall Study|Withdrawal by Subject|3
1001069|NCT01428453|2017482|FG001|Overall Study|Withdrawal by Subject|1
1001070|NCT01428583|2017490|FG000|Overall Study|Adverse Event|75
1001071|NCT01428583|2017490|FG000|Overall Study|Withdrawal by Subject|51
1001072|NCT01428583|2017490|FG000|Overall Study|Lack of Efficacy|37
1001073|NCT01428583|2017490|FG000|Overall Study|Lost to Follow-up|17
1001074|NCT01428583|2017490|FG000|Overall Study|Death|1
1001075|NCT01428583|2017490|FG000|Overall Study|Pregnancy|1
1001076|NCT01428583|2017490|FG000|Overall Study|Protocol Violation|1
1001077|NCT01428583|2017490|FG000|Overall Study|Physician Decision|12
1001078|NCT01428583|2017490|FG000|Overall Study|Non-compliant|25
1001079|NCT01428583|2017490|FG000|Overall Study|Confirmed positive urine drug test|8
1001080|NCT01428583|2017490|FG000|Overall Study|Sponsor's request|3
1001081|NCT01428583|2017490|FG000|Overall Study|Other|6
1001082|NCT01428661|2017497|FG000|Double-Masked Phase|Protocol Violation|9
1001083|NCT01428661|2017498|FG001|Double-Masked Phase|Protocol Violation|4
1001084|NCT01428661|2017499|FG002|Double-Masked Phase|Protocol Violation|0
1001085|NCT01428661|2017497|FG000|Double-Masked Phase|Adverse Event|13
1001086|NCT01428661|2017498|FG001|Double-Masked Phase|Adverse Event|4
1001087|NCT01428661|2017499|FG002|Double-Masked Phase|Adverse Event|0
1001088|NCT01428661|2017497|FG000|Double-Masked Phase|Lost to Follow-up|14
1001089|NCT01428661|2017498|FG001|Double-Masked Phase|Lost to Follow-up|14
1001090|NCT01428661|2017499|FG002|Double-Masked Phase|Lost to Follow-up|0
1001091|NCT01428661|2017497|FG000|Double-Masked Phase|Withdrawal by Subject|18
1001092|NCT01428661|2017498|FG001|Double-Masked Phase|Withdrawal by Subject|20
1001093|NCT01428661|2017499|FG002|Double-Masked Phase|Withdrawal by Subject|0
1001094|NCT01428661|2017497|FG000|Double-Masked Phase|Lack of Efficacy|2
1001095|NCT01428661|2017498|FG001|Double-Masked Phase|Lack of Efficacy|1
1001096|NCT01428661|2017499|FG002|Double-Masked Phase|Lack of Efficacy|0
1001097|NCT01428661|2017497|FG000|Double-Masked Phase|*Various|1
1001098|NCT01428661|2017498|FG001|Double-Masked Phase|*Various|6
1001099|NCT01428661|2017499|FG002|Double-Masked Phase|*Various|0
1001100|NCT01428661|2017497|FG000|Open Label Extension|Protocol Violation|0
1001101|NCT01428661|2017498|FG001|Open Label Extension|Protocol Violation|0
1001102|NCT01428661|2017499|FG002|Open Label Extension|Protocol Violation|9
1001103|NCT01428661|2017497|FG000|Open Label Extension|Adverse Event|0
1001104|NCT01428661|2017498|FG001|Open Label Extension|Adverse Event|0
1001105|NCT01428661|2017499|FG002|Open Label Extension|Adverse Event|15
1001106|NCT01428661|2017497|FG000|Open Label Extension|Lost to Follow-up|0
1001107|NCT01428661|2017498|FG001|Open Label Extension|Lost to Follow-up|0
1001108|NCT01428661|2017499|FG002|Open Label Extension|Lost to Follow-up|38
1001109|NCT01428661|2017497|FG000|Open Label Extension|Withdrawal by Subject|0
1001110|NCT01428661|2017498|FG001|Open Label Extension|Withdrawal by Subject|0
1001111|NCT01428661|2017499|FG002|Open Label Extension|Withdrawal by Subject|49
1001112|NCT01428661|2017497|FG000|Open Label Extension|Lack of Efficacy|0
1001113|NCT01428661|2017498|FG001|Open Label Extension|Lack of Efficacy|0
1001114|NCT01428661|2017499|FG002|Open Label Extension|Lack of Efficacy|24
1001115|NCT01428661|2017497|FG000|Open Label Extension|**Various|0
1001116|NCT01428661|2017498|FG001|Open Label Extension|**Various|0
1001117|NCT01428661|2017499|FG002|Open Label Extension|**Various|185
1001118|NCT01428713|2017507|FG000|Overall Study|Non-compliance|2
1001119|NCT01428713|2017508|FG001|Overall Study|Non-compliance|2
1001120|NCT01428713|2017507|FG000|Overall Study|Withdrawal by Subject|1
1001121|NCT01428713|2017508|FG001|Overall Study|Withdrawal by Subject|1
1001122|NCT01428713|2017507|FG000|Overall Study|Adverse Event|0
1001123|NCT01428713|2017508|FG001|Overall Study|Adverse Event|2
1001124|NCT01428882|2017520|FG000|Overall Study|Lack of Efficacy|2
1001125|NCT01428882|2017521|FG001|Overall Study|Lack of Efficacy|7
1001126|NCT01428882|2017520|FG000|Overall Study|Protocol Violation|4
1001127|NCT01428882|2017521|FG001|Overall Study|Protocol Violation|3
1001128|NCT01429051|2017527|FG000|Titration Phase|Death|1
1001129|NCT01429051|2017527|FG000|Titration Phase|Withdrawal by Subject|7
1001130|NCT01429051|2017527|FG000|Titration Phase|Physician Decision|1
1001131|NCT01429051|2017527|FG000|Titration Phase|Unsuccessful titration at any dose|1
1001132|NCT01429051|2017527|FG000|Titration Phase|Less than 3 BTP episodes per week|2
1001133|NCT01429051|2017527|FG000|Efficacy Phase|Adverse Event|1
1001134|NCT01429051|2017527|FG000|Efficacy Phase|Death|1
1001135|NCT01429051|2017527|FG000|Tolerability Phase|Death|5
1001136|NCT01429051|2017527|FG000|Tolerability Phase|Adverse Event|2
1001137|NCT01429051|2017527|FG000|Tolerability Phase|Withdrawal by Subject|5
1001138|NCT01429051|2017527|FG000|Tolerability Phase|Physician Decision|1
1001139|NCT01429051|2017527|FG000|Tolerability Phase|Other|2
1001140|NCT01429077|2017557|FG000|Overall Study|Lost to Follow-up|0
1001141|NCT01429077|2017558|FG001|Overall Study|Lost to Follow-up|3
1001142|NCT01429285|2017587|FG000|Overall Study|Protocol Violation|9
1001143|NCT01429285|2017588|FG001|Overall Study|Protocol Violation|4
1001144|NCT01429285|2017587|FG000|Overall Study|Missing Data|5
1001145|NCT01429285|2017588|FG001|Overall Study|Missing Data|3
1001146|NCT01429285|2017587|FG000|Overall Study|Erroneously Enrolled Twice|8
1001147|NCT01429285|2017588|FG001|Overall Study|Erroneously Enrolled Twice|2
1001148|NCT01429298|2017596|FG000|Overall Study|Protocol Violation|4
1001149|NCT01429298|2017597|FG001|Overall Study|Protocol Violation|6
1001150|NCT01429441|2017614|FG000|Overall Study|Adverse Event|5
1001151|NCT01429441|2017615|FG001|Overall Study|Adverse Event|1
1001152|NCT01429441|2017614|FG000|Overall Study|Death|0
1001153|NCT01429441|2017615|FG001|Overall Study|Death|2
1001154|NCT01429441|2017614|FG000|Overall Study|Lost to Follow-up|5
1001155|NCT01429441|2017615|FG001|Overall Study|Lost to Follow-up|2
1001156|NCT01429441|2017614|FG000|Overall Study|Physician Decision|1
1001157|NCT01429441|2017615|FG001|Overall Study|Physician Decision|0
1001158|NCT01429441|2017614|FG000|Overall Study|Withdrawal by Subject|27
1001159|NCT01429441|2017615|FG001|Overall Study|Withdrawal by Subject|18
1001160|NCT01429584|2017646|FG000|Overall Study|Withdrawal by Subject|1
1001161|NCT01429584|2017647|FG001|Overall Study|Withdrawal by Subject|0
1001162|NCT01429584|2017646|FG000|Overall Study|Protocol Violation|0
1001163|NCT01429584|2017647|FG001|Overall Study|Protocol Violation|1
1001164|NCT01429623|2017655|FG000|Overall Study|Death|1
1001165|NCT01429623|2017656|FG001|Overall Study|Death|0
1001166|NCT01429623|2017655|FG000|Overall Study|Adverse Event|7
1001167|NCT01429623|2017656|FG001|Overall Study|Adverse Event|14
1001168|NCT01429623|2017655|FG000|Overall Study|Withdrawal by Subject|19
1001169|NCT01429623|2017656|FG001|Overall Study|Withdrawal by Subject|13
1001170|NCT01429623|2017655|FG000|Overall Study|Physician Decision|2
1001171|NCT01429623|2017656|FG001|Overall Study|Physician Decision|3
1001172|NCT01429623|2017655|FG000|Overall Study|Protocol Violation|3
1001173|NCT01429623|2017656|FG001|Overall Study|Protocol Violation|2
1001174|NCT01429623|2017655|FG000|Overall Study|Assorted|1
1001175|NCT01429623|2017656|FG001|Overall Study|Assorted|2
1001176|NCT01429623|2017655|FG000|Overall Study|Conversion to Alzheimer's disease|14
1001177|NCT01429623|2017656|FG001|Overall Study|Conversion to Alzheimer's disease|21
1001178|NCT01429623|2017655|FG000|Overall Study|No post baseline data|4
1001179|NCT01429623|2017656|FG001|Overall Study|No post baseline data|4
1001180|NCT01429792|2017662|FG000|Overall Study|Other Reasons|67
1001181|NCT01429792|2017662|FG000|Overall Study|Unknown Disposition|94
1001182|NCT01429792|2017662|FG000|Overall Study|Negative HCV-RNA at Week 4|1
1001183|NCT01429792|2017662|FG000|Overall Study|Negative HCV-RNA at Week 12|4
1001184|NCT01429792|2017662|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32
1001185|NCT01429792|2017662|FG000|Overall Study|Positive HCV-RNA at Week 24|50
1001186|NCT01429792|2017662|FG000|Overall Study|Withdrawal by Subject|70
1001187|NCT01429792|2017662|FG000|Overall Study|Lost to Follow-up|88
1001188|NCT01430104|2017697|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1
1001189|NCT01430130|2017704|FG000|Overall Study|Lost to Follow-up|1
1001190|NCT01430130|2017704|FG000|Overall Study|Infection on Control Side of Incision|1
1001191|NCT01430403|2017752|FG000|Overall Study|Lost to Follow-up|5
1001192|NCT01430403|2017753|FG001|Overall Study|Lost to Follow-up|5
1001193|NCT01430403|2017754|FG002|Overall Study|Lost to Follow-up|3
1001194|NCT01430403|2017752|FG000|Overall Study|Physician Decision|1
1001195|NCT01430403|2017753|FG001|Overall Study|Physician Decision|0
1001196|NCT01430403|2017754|FG002|Overall Study|Physician Decision|0
1001197|NCT01430403|2017752|FG000|Overall Study|Protocol Violation|2
1001198|NCT01430403|2017753|FG001|Overall Study|Protocol Violation|3
1001199|NCT01430403|2017754|FG002|Overall Study|Protocol Violation|2
1001200|NCT01430403|2017752|FG000|Overall Study|Withdrawal by Subject|9
1001201|NCT01430403|2017753|FG001|Overall Study|Withdrawal by Subject|1
1001202|NCT01430403|2017754|FG002|Overall Study|Withdrawal by Subject|3
1001203|NCT01430442|2017775|FG000|Overall Study|Subject Withdrew Consent|3
1001204|NCT01430442|2017776|FG001|Overall Study|Subject Withdrew Consent|0
1001205|NCT01430442|2017777|FG002|Overall Study|Subject Withdrew Consent|1
1001206|NCT01430442|2017778|FG003|Overall Study|Subject Withdrew Consent|0
1001207|NCT01430442|2017779|FG004|Overall Study|Subject Withdrew Consent|2
1001208|NCT01430442|2017780|FG005|Overall Study|Subject Withdrew Consent|1
1001209|NCT01430442|2017781|FG006|Overall Study|Subject Withdrew Consent|5
1001210|NCT01430442|2017782|FG007|Overall Study|Subject Withdrew Consent|2
1001211|NCT01430442|2017775|FG000|Overall Study|Lost to Follow-up|2
1001212|NCT01430442|2017776|FG001|Overall Study|Lost to Follow-up|0
1001213|NCT01430442|2017777|FG002|Overall Study|Lost to Follow-up|1
1001214|NCT01430442|2017778|FG003|Overall Study|Lost to Follow-up|2
1001215|NCT01430442|2017779|FG004|Overall Study|Lost to Follow-up|2
1001216|NCT01430442|2017780|FG005|Overall Study|Lost to Follow-up|1
1001217|NCT01430442|2017781|FG006|Overall Study|Lost to Follow-up|5
1001218|NCT01430442|2017782|FG007|Overall Study|Lost to Follow-up|1
1001219|NCT01430442|2017775|FG000|Overall Study|Pregnancy|1
1001220|NCT01430442|2017776|FG001|Overall Study|Pregnancy|0
1001221|NCT01430442|2017777|FG002|Overall Study|Pregnancy|0
1001222|NCT01430442|2017778|FG003|Overall Study|Pregnancy|0
1001223|NCT01430442|2017779|FG004|Overall Study|Pregnancy|0
1001224|NCT01430442|2017780|FG005|Overall Study|Pregnancy|1
1001225|NCT01430442|2017781|FG006|Overall Study|Pregnancy|0
1001226|NCT01430442|2017782|FG007|Overall Study|Pregnancy|0
1001227|NCT01430442|2017775|FG000|Overall Study|Patient No Longer Meets Study Criteria|7
1001228|NCT01430442|2017776|FG001|Overall Study|Patient No Longer Meets Study Criteria|6
1001229|NCT01430442|2017777|FG002|Overall Study|Patient No Longer Meets Study Criteria|3
1001230|NCT01430442|2017778|FG003|Overall Study|Patient No Longer Meets Study Criteria|2
1001231|NCT01430442|2017779|FG004|Overall Study|Patient No Longer Meets Study Criteria|5
1001232|NCT01430442|2017780|FG005|Overall Study|Patient No Longer Meets Study Criteria|5
1001233|NCT01430442|2017781|FG006|Overall Study|Patient No Longer Meets Study Criteria|9
1001234|NCT01430442|2017782|FG007|Overall Study|Patient No Longer Meets Study Criteria|6
1001235|NCT01430455|2017800|FG000|Overall Study|Withdrawal by Subject|1
1001236|NCT01430455|2017800|FG000|Overall Study|Switched to follow-up phase|1
1001237|NCT01430468|2017806|FG000|Overall Study|Physician Decision|2
1001238|NCT01430468|2017807|FG001|Overall Study|Physician Decision|1
1001239|NCT01430468|2017806|FG000|Overall Study|Withdrawal by Subject|5
1001240|NCT01430468|2017807|FG001|Overall Study|Withdrawal by Subject|5
1001241|NCT01430559|2017815|FG000|Overall Study|Adverse Event|7
1001242|NCT01430559|2017816|FG001|Overall Study|Adverse Event|3
1001243|NCT01430559|2017815|FG000|Overall Study|Entry criteria not met|1
1001244|NCT01430559|2017816|FG001|Overall Study|Entry criteria not met|1
1001245|NCT01430559|2017815|FG000|Overall Study|Lost to Follow-up|1
1001246|NCT01430559|2017816|FG001|Overall Study|Lost to Follow-up|0
1001247|NCT01430559|2017815|FG000|Overall Study|Medication error|1
1001248|NCT01430559|2017816|FG001|Overall Study|Medication error|0
1001249|NCT01430559|2017815|FG000|Overall Study|Withdrawal by Subject|3
1001250|NCT01430559|2017816|FG001|Overall Study|Withdrawal by Subject|2
1001251|NCT01430559|2017815|FG000|Overall Study|Protocol Violation|1
1001252|NCT01430559|2017816|FG001|Overall Study|Protocol Violation|0
1001253|NCT01430559|2017815|FG000|Overall Study|Other|3
1001254|NCT01430559|2017816|FG001|Overall Study|Other|3
1001255|NCT01430559|2017815|FG000|Overall Study|Randomized, Not Treated|3
1001256|NCT01430559|2017816|FG001|Overall Study|Randomized, Not Treated|3
1001257|NCT01430585|2017827|FG000|Overall Study|Death|1
1001258|NCT01430585|2017827|FG000|Overall Study|Objective Progression or Relapse|3
1001259|NCT01430585|2017827|FG000|Overall Study|Study Terminated by Sponsor|3
1001260|NCT01430585|2017827|FG000|Overall Study|Other|7
1001261|NCT01430611|2017839|FG000|Overall Study|Adverse Event|0
1001262|NCT01430611|2017840|FG001|Overall Study|Adverse Event|1
1001263|NCT01430611|2017839|FG000|Overall Study|Protocol Violation|1
1001264|NCT01430611|2017840|FG001|Overall Study|Protocol Violation|0
1001265|NCT01430611|2017839|FG000|Overall Study|Lost to Follow-up|1
1001266|NCT01430611|2017840|FG001|Overall Study|Lost to Follow-up|0
1001267|NCT01430611|2017839|FG000|Overall Study|Withdrawal by Subject|15
1001268|NCT01430611|2017840|FG001|Overall Study|Withdrawal by Subject|14
1001269|NCT01430624|2017849|FG000|Overall Study|Lost to Follow-up|23
1001270|NCT01430624|2017850|FG001|Overall Study|Lost to Follow-up|29
1001271|NCT01430624|2017851|FG002|Overall Study|Lost to Follow-up|27
1001272|NCT01430624|2017849|FG000|Overall Study|technical or eligibility|5
1001273|NCT01430624|2017850|FG001|Overall Study|technical or eligibility|5
1001274|NCT01430624|2017851|FG002|Overall Study|technical or eligibility|2
1001275|NCT01430754|2017883|FG000|Run-In Phase|Circadian Period Ineligible|24
1001276|NCT01430754|2017884|FG001|Run-In Phase|Circadian Period Ineligible|0
1001277|NCT01430754|2017883|FG000|Run-In Phase|Protocol Violation|6
1001278|NCT01430754|2017884|FG001|Run-In Phase|Protocol Violation|0
1001279|NCT01430754|2017883|FG000|Run-In Phase|Adverse Event|2
1001280|NCT01430754|2017884|FG001|Run-In Phase|Adverse Event|0
1001281|NCT01430754|2017883|FG000|Run-In Phase|Other|2
1001282|NCT01430754|2017884|FG001|Run-In Phase|Other|0
1001283|NCT01430754|2017883|FG000|Run-In Phase|Withdrawal by Subject|2
1001284|NCT01430754|2017884|FG001|Run-In Phase|Withdrawal by Subject|0
1001285|NCT01430754|2017883|FG000|Run-In Phase|Lost to Follow-up|1
1001286|NCT01430754|2017884|FG001|Run-In Phase|Lost to Follow-up|0
1001287|NCT01431079|2017912|FG000|Overall Study|Lost to Follow-up|35
1001288|NCT01431079|2017913|FG001|Overall Study|Lost to Follow-up|39
1001289|NCT01431144|2017958|FG000|Overall Study|Implant mobility and removal|2
1001290|NCT01431144|2017959|FG001|Overall Study|Implant mobility and removal|0
1001291|NCT01431274|2017998|FG000|Overall Study|Adverse Event|51
1001292|NCT01431274|2017999|FG001|Overall Study|Adverse Event|37
1001293|NCT01431274|2018000|FG002|Overall Study|Adverse Event|43
1001294|NCT01431274|2018001|FG003|Overall Study|Adverse Event|30
1001295|NCT01431274|2018002|FG004|Overall Study|Adverse Event|37
1001296|NCT01431274|2017998|FG000|Overall Study|Consent withdrawn not due to AE|29
1001297|NCT01431274|2017999|FG001|Overall Study|Consent withdrawn not due to AE|20
1001298|NCT01431274|2018000|FG002|Overall Study|Consent withdrawn not due to AE|17
1001299|NCT01431274|2018001|FG003|Overall Study|Consent withdrawn not due to AE|20
1001300|NCT01431274|2018002|FG004|Overall Study|Consent withdrawn not due to AE|11
1001301|NCT01431274|2017998|FG000|Overall Study|Non compliant with protocol|5
1001302|NCT01431274|2017999|FG001|Overall Study|Non compliant with protocol|8
1001303|NCT01431274|2018000|FG002|Overall Study|Non compliant with protocol|4
1001304|NCT01431274|2018001|FG003|Overall Study|Non compliant with protocol|4
1001305|NCT01431274|2018002|FG004|Overall Study|Non compliant with protocol|4
1001306|NCT01431274|2017998|FG000|Overall Study|Lost to Follow-up|6
1001307|NCT01431274|2017999|FG001|Overall Study|Lost to Follow-up|7
1001308|NCT01431274|2018000|FG002|Overall Study|Lost to Follow-up|1
1001309|NCT01431274|2018001|FG003|Overall Study|Lost to Follow-up|4
1001310|NCT01431274|2018002|FG004|Overall Study|Lost to Follow-up|0
1001311|NCT01431274|2017998|FG000|Overall Study|Other reason not stated above|6
1001312|NCT01431274|2017999|FG001|Overall Study|Other reason not stated above|5
1001313|NCT01431274|2018000|FG002|Overall Study|Other reason not stated above|7
1001314|NCT01431274|2018001|FG003|Overall Study|Other reason not stated above|2
1001315|NCT01431274|2018002|FG004|Overall Study|Other reason not stated above|4
1001316|NCT01431287|2018019|FG000|Overall Study|not treated|0
1001317|NCT01431287|2018020|FG001|Overall Study|not treated|0
1001318|NCT01431287|2018021|FG002|Overall Study|not treated|1
1001319|NCT01431287|2018022|FG003|Overall Study|not treated|0
1001320|NCT01431287|2018023|FG004|Overall Study|not treated|0
1001321|NCT01431287|2018019|FG000|Overall Study|Adverse Event|59
1001322|NCT01431287|2018020|FG001|Overall Study|Adverse Event|57
1001323|NCT01431287|2018021|FG002|Overall Study|Adverse Event|53
1001324|NCT01431287|2018022|FG003|Overall Study|Adverse Event|33
1001325|NCT01431287|2018023|FG004|Overall Study|Adverse Event|41
1001326|NCT01431287|2018019|FG000|Overall Study|Non compliant with protocol|6
1001327|NCT01431287|2018020|FG001|Overall Study|Non compliant with protocol|6
1001328|NCT01431287|2018021|FG002|Overall Study|Non compliant with protocol|5
1001329|NCT01431287|2018022|FG003|Overall Study|Non compliant with protocol|6
1001330|NCT01431287|2018023|FG004|Overall Study|Non compliant with protocol|5
1001331|NCT01431287|2018019|FG000|Overall Study|Lost to Follow-up|0
1001332|NCT01431287|2018020|FG001|Overall Study|Lost to Follow-up|3
1001333|NCT01431287|2018021|FG002|Overall Study|Lost to Follow-up|2
1001334|NCT01431287|2018022|FG003|Overall Study|Lost to Follow-up|3
1001335|NCT01431287|2018023|FG004|Overall Study|Lost to Follow-up|1
1001336|NCT01431287|2018019|FG000|Overall Study|Consent withdrawn not due to AE|29
1001337|NCT01431287|2018020|FG001|Overall Study|Consent withdrawn not due to AE|30
1001338|NCT01431287|2018021|FG002|Overall Study|Consent withdrawn not due to AE|34
1001339|NCT01431287|2018022|FG003|Overall Study|Consent withdrawn not due to AE|19
1001340|NCT01431287|2018023|FG004|Overall Study|Consent withdrawn not due to AE|29
1001341|NCT01431287|2018019|FG000|Overall Study|not stated above|4
1001342|NCT01431287|2018020|FG001|Overall Study|not stated above|2
1001343|NCT01431287|2018021|FG002|Overall Study|not stated above|2
1001344|NCT01431287|2018022|FG003|Overall Study|not stated above|2
1001345|NCT01431287|2018023|FG004|Overall Study|not stated above|1
1001346|NCT01431508|2018081|FG000|Overall Study|Lack of Efficacy|1
1001347|NCT01431508|2018081|FG000|Overall Study|Unable to Follow Protocol Procedures|1
1001348|NCT01431521|2018089|FG000|Overall Study|Withdrawal by Subject|0
1001349|NCT01431521|2018090|FG001|Overall Study|Withdrawal by Subject|0
1001350|NCT01431521|2018091|FG002|Overall Study|Withdrawal by Subject|1
1001351|NCT01431521|2018092|FG003|Overall Study|Withdrawal by Subject|0
1001352|NCT01431534|2018104|FG000|Treatment Phase|Adverse Event|0
1001353|NCT01431534|2018105|FG001|Treatment Phase|Adverse Event|0
1001354|NCT01431534|2018106|FG002|Treatment Phase|Adverse Event|1
1001355|NCT01431534|2018104|FG000|Treatment Phase|Progressive Disease|4
1001356|NCT01431534|2018105|FG001|Treatment Phase|Progressive Disease|3
1001357|NCT01431534|2018106|FG002|Treatment Phase|Progressive Disease|10
1001358|NCT01431638|2018121|FG000|Overall Study|Adverse Event|1
1001359|NCT01431638|2018122|FG001|Overall Study|Adverse Event|3
1001360|NCT01431638|2018123|FG002|Overall Study|Adverse Event|1
1001361|NCT01431638|2018121|FG000|Overall Study|Unsatisfactory therapeutic effect|2
1001362|NCT01431638|2018122|FG001|Overall Study|Unsatisfactory therapeutic effect|2
1001363|NCT01431638|2018123|FG002|Overall Study|Unsatisfactory therapeutic effect|4
1001364|NCT01431638|2018121|FG000|Overall Study|Participants condition no longer requires study drug|0
1001365|NCT01431638|2018122|FG001|Overall Study|Participants condition no longer requires study drug|1
1001366|NCT01431638|2018123|FG002|Overall Study|Participants condition no longer requires study drug|0
1001367|NCT01431638|2018121|FG000|Overall Study|Participant withdrew consent|14
1001368|NCT01431638|2018122|FG001|Overall Study|Participant withdrew consent|5
1001369|NCT01431638|2018123|FG002|Overall Study|Participant withdrew consent|8
1001370|NCT01431638|2018121|FG000|Overall Study|Lost to Follow-up|7
1001371|NCT01431638|2018122|FG001|Overall Study|Lost to Follow-up|9
1001372|NCT01431638|2018123|FG002|Overall Study|Lost to Follow-up|7
1001373|NCT01431638|2018121|FG000|Overall Study|Administrative problems|1
1001374|NCT01431638|2018122|FG001|Overall Study|Administrative problems|4
1001375|NCT01431638|2018123|FG002|Overall Study|Administrative problems|6
1001376|NCT01431638|2018121|FG000|Overall Study|Death|1
1001377|NCT01431638|2018122|FG001|Overall Study|Death|0
1001378|NCT01431638|2018123|FG002|Overall Study|Death|0
1001379|NCT01431638|2018121|FG000|Overall Study|Protocol deviation|1
1001380|NCT01431638|2018122|FG001|Overall Study|Protocol deviation|1
1001381|NCT01431638|2018123|FG002|Overall Study|Protocol deviation|4
1001382|NCT01431638|2018121|FG000|Overall Study|Participants Did not enter extension study from core study|39
1001383|NCT01431638|2018122|FG001|Overall Study|Participants Did not enter extension study from core study|46
1001384|NCT01431638|2018123|FG002|Overall Study|Participants Did not enter extension study from core study|32
1001385|NCT01431716|2018135|FG000|Overall Study|Withdrawal of consent|1
1001386|NCT01431950|2018181|FG000|Overall Study|Study Site Closed/Terminated|7
1001387|NCT01431950|2018182|FG001|Overall Study|Study Site Closed/Terminated|3
1001388|NCT01431950|2018181|FG000|Overall Study|Withdrawal by Subject|4
1001389|NCT01431950|2018182|FG001|Overall Study|Withdrawal by Subject|3
1001390|NCT01431950|2018181|FG000|Overall Study|Protocol Violation|2
1001391|NCT01431950|2018182|FG001|Overall Study|Protocol Violation|3
1001392|NCT01431950|2018181|FG000|Overall Study|Adverse Event|2
1001393|NCT01431950|2018182|FG001|Overall Study|Adverse Event|2
1001394|NCT01431950|2018181|FG000|Overall Study|Physician Decision|2
1001395|NCT01431950|2018182|FG001|Overall Study|Physician Decision|1
1001396|NCT01431950|2018181|FG000|Overall Study|Lack of Efficacy|2
1001397|NCT01431950|2018182|FG001|Overall Study|Lack of Efficacy|1
1001398|NCT01431950|2018181|FG000|Overall Study|Lost to Follow-up|0
1001399|NCT01431950|2018182|FG001|Overall Study|Lost to Follow-up|1
1001400|NCT01431950|2018181|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0
1001401|NCT01431950|2018182|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
1001402|NCT01431963|2018188|FG000|Overall Study|Adverse Event|18
1001403|NCT01431963|2018188|FG000|Overall Study|Lack of Efficacy|7
1001404|NCT01431963|2018188|FG000|Overall Study|Protocol Violation|1
1001405|NCT01431963|2018188|FG000|Overall Study|Protocol-defined Stopping Criteria|2
1001406|NCT01431963|2018188|FG000|Overall Study|Physician Decision|4
1001407|NCT01431963|2018188|FG000|Overall Study|Withdrawal by Subject|3
1001408|NCT01431976|2018192|FG000|Overall Study|Adverse Event|6
1001409|NCT01431976|2018192|FG000|Overall Study|Lack of Efficacy|2
1001410|NCT01431976|2018192|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4
1001411|NCT01431976|2018192|FG000|Overall Study|Physician Decision|1
1001412|NCT01431976|2018192|FG000|Overall Study|Withdrawal by Subject|1
1001413|NCT01432171|2018218|FG000|Overall Study|Death|1
1001414|NCT01432171|2018219|FG001|Overall Study|Death|2
1001415|NCT01432171|2018218|FG000|Overall Study|Lost to Follow-up|6
1001416|NCT01432171|2018219|FG001|Overall Study|Lost to Follow-up|5
1001417|NCT01432171|2018218|FG000|Overall Study|Withdrawal by Subject|3
1001418|NCT01432171|2018219|FG001|Overall Study|Withdrawal by Subject|1
1001419|NCT01432171|2018218|FG000|Overall Study|Noncompliance|2
1001420|NCT01432171|2018219|FG001|Overall Study|Noncompliance|3
1001421|NCT01432171|2018218|FG000|Overall Study|Insurance denial trial coverage|1
1001422|NCT01432171|2018219|FG001|Overall Study|Insurance denial trial coverage|0
1001423|NCT01432171|2018218|FG000|Overall Study|Patient moved to palliative care|1
1001424|NCT01432171|2018219|FG001|Overall Study|Patient moved to palliative care|0
1001425|NCT01432262|2018243|FG000|Overall Study|Withdrawal by Subject|2
1001426|NCT01432262|2018244|FG001|Overall Study|Withdrawal by Subject|1
1001427|NCT01432275|2018250|FG000|First BG Meter System (7 Days)|Adverse Event|0
1001428|NCT01432275|2018251|FG001|First BG Meter System (7 Days)|Adverse Event|2
1001429|NCT01432275|2018250|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0
1001430|NCT01432275|2018251|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1
1001431|NCT01432275|2018250|FG000|Second BG Meter System (7 Days)|Adverse Event|1
1001432|NCT01432275|2018251|FG001|Second BG Meter System (7 Days)|Adverse Event|1
1001433|NCT01432275|2018250|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1
1001434|NCT01432275|2018251|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0
1001435|NCT01432275|2018250|FG000|Second BG Meter System (7 Days)|Physician Decision|0
1001436|NCT01432275|2018251|FG001|Second BG Meter System (7 Days)|Physician Decision|1
1001437|NCT01432275|2018250|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0
1001438|NCT01432275|2018251|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1
1001439|NCT01432275|2018250|FG000|ADC With Calculator (10 Days)|Physician Decision|1
1001440|NCT01432275|2018251|FG001|ADC With Calculator (10 Days)|Physician Decision|1
1001441|NCT01432275|2018250|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2
1001442|NCT01432275|2018251|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0
1001443|NCT01432275|2018250|FG000|ADC With Calculator (10 Days)|Protocol Violation|0
1001444|NCT01432275|2018251|FG001|ADC With Calculator (10 Days)|Protocol Violation|1
1001445|NCT01432327|2018261|FG000|Posttest 3 Months|depression|3
1001446|NCT01432327|2018262|FG001|Posttest 3 Months|depression|0
1001447|NCT01432327|2018263|FG002|Posttest 3 Months|depression|0
1001448|NCT01432327|2018264|FG003|Posttest 3 Months|depression|0
1001449|NCT01432327|2018261|FG000|Posttest 3 Months|Lost to Follow-up|1
1001450|NCT01432327|2018262|FG001|Posttest 3 Months|Lost to Follow-up|0
1001451|NCT01432327|2018263|FG002|Posttest 3 Months|Lost to Follow-up|2
1001452|NCT01432327|2018264|FG003|Posttest 3 Months|Lost to Follow-up|1
1001453|NCT01432327|2018261|FG000|Posttest 3 Months|Allergic reaction|0
1001454|NCT01432327|2018262|FG001|Posttest 3 Months|Allergic reaction|2
1001455|NCT01432327|2018263|FG002|Posttest 3 Months|Allergic reaction|0
1001456|NCT01432327|2018264|FG003|Posttest 3 Months|Allergic reaction|0
1001457|NCT01432327|2018261|FG000|Posttest 6 Months|Lost to Follow-up|0
1001458|NCT01432327|2018262|FG001|Posttest 6 Months|Lost to Follow-up|0
1001459|NCT01432327|2018263|FG002|Posttest 6 Months|Lost to Follow-up|3
1001460|NCT01432327|2018264|FG003|Posttest 6 Months|Lost to Follow-up|2
1001461|NCT01432327|2018261|FG000|Posttest 6 Months|Allergic reaction|0
1001462|NCT01432327|2018262|FG001|Posttest 6 Months|Allergic reaction|0
1001463|NCT01432327|2018263|FG002|Posttest 6 Months|Allergic reaction|1
1001464|NCT01432327|2018264|FG003|Posttest 6 Months|Allergic reaction|0
1001465|NCT01432327|2018261|FG000|Posttest 6 Months|Withdrawal by Subject|0
1001466|NCT01432327|2018262|FG001|Posttest 6 Months|Withdrawal by Subject|0
1001467|NCT01432327|2018263|FG002|Posttest 6 Months|Withdrawal by Subject|1
1001468|NCT01432327|2018264|FG003|Posttest 6 Months|Withdrawal by Subject|0
1001469|NCT01432327|2018261|FG000|Posttest 1 Year|Measurement have to take place in future|24
1001470|NCT01432327|2018262|FG001|Posttest 1 Year|Measurement have to take place in future|28
1001471|NCT01432327|2018263|FG002|Posttest 1 Year|Measurement have to take place in future|15
1001472|NCT01432327|2018264|FG003|Posttest 1 Year|Measurement have to take place in future|20
1001473|NCT01432327|2018261|FG000|Posttest 1 Year|Lost to Follow-up|0
1001474|NCT01432327|2018262|FG001|Posttest 1 Year|Lost to Follow-up|0
1001475|NCT01432327|2018263|FG002|Posttest 1 Year|Lost to Follow-up|4
1001476|NCT01432327|2018264|FG003|Posttest 1 Year|Lost to Follow-up|2
1001477|NCT01432327|2018261|FG000|Posttest 1 Year|Allergic reaction|0
1001478|NCT01432327|2018262|FG001|Posttest 1 Year|Allergic reaction|0
1001479|NCT01432327|2018263|FG002|Posttest 1 Year|Allergic reaction|1
1001480|NCT01432327|2018264|FG003|Posttest 1 Year|Allergic reaction|1
1001481|NCT01432366|2018274|FG000|Overall Study|Non-Responder|7
1001482|NCT01432366|2018274|FG000|Overall Study|Adverse Event|8
1001483|NCT01432366|2018274|FG000|Overall Study|Withdrawal Due to Non-Compliance|3
1001484|NCT01432366|2018274|FG000|Overall Study|Pregnancy|1
1001485|NCT01432366|2018274|FG000|Overall Study|Lost to Follow-up|13
1001486|NCT01432366|2018274|FG000|Overall Study|Lack of Efficacy|1
1001487|NCT01432366|2018274|FG000|Overall Study|Site Closed|20
1001488|NCT01432366|2018274|FG000|Overall Study|Investigator Forget to Complete Visits|1
1001489|NCT01432366|2018274|FG000|Overall Study|Other|14
1001490|NCT01432444|2018291|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10
1001491|NCT01432444|2018292|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0
1001492|NCT01432444|2018293|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0
1001493|NCT01432444|2018291|FG000|Tolerability/Cross-titration Phase|Adverse Event|16
1001494|NCT01432444|2018292|FG001|Tolerability/Cross-titration Phase|Adverse Event|0
1001495|NCT01432444|2018293|FG002|Tolerability/Cross-titration Phase|Adverse Event|0
1001496|NCT01432444|2018291|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
1001497|NCT01432444|2018292|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
1001498|NCT01432444|2018293|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
1001499|NCT01432444|2018291|FG000|Tolerability/Cross-titration Phase|Physician Decision|8
1001500|NCT01432444|2018292|FG001|Tolerability/Cross-titration Phase|Physician Decision|0
1001501|NCT01432444|2018293|FG002|Tolerability/Cross-titration Phase|Physician Decision|0
1001502|NCT01432444|2018291|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
1001503|NCT01432444|2018292|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
1001504|NCT01432444|2018293|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
1001505|NCT01432444|2018291|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1
1001506|NCT01432444|2018292|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0
1001507|NCT01432444|2018293|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0
1001508|NCT01432444|2018291|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5
1001509|NCT01432444|2018292|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0
1001510|NCT01432444|2018293|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0
1001511|NCT01432444|2018291|FG000|Treatment Phase|Lost to Follow-up|0
1001512|NCT01432444|2018292|FG001|Treatment Phase|Lost to Follow-up|33
1001513|NCT01432444|2018293|FG002|Treatment Phase|Lost to Follow-up|0
1001514|NCT01432444|2018291|FG000|Treatment Phase|Adverse Event|0
1001515|NCT01432444|2018292|FG001|Treatment Phase|Adverse Event|37
1001516|NCT01432444|2018293|FG002|Treatment Phase|Adverse Event|0
1001517|NCT01432444|2018291|FG000|Treatment Phase|Met Withdrawal Criteria|0
1001518|NCT01432444|2018292|FG001|Treatment Phase|Met Withdrawal Criteria|11
1001519|NCT01432444|2018293|FG002|Treatment Phase|Met Withdrawal Criteria|0
1001520|NCT01432444|2018291|FG000|Treatment Phase|Physician Decision|0
1001521|NCT01432444|2018292|FG001|Treatment Phase|Physician Decision|5
1001522|NCT01432444|2018293|FG002|Treatment Phase|Physician Decision|0
1001523|NCT01432444|2018291|FG000|Treatment Phase|Withdrawal by Subject|0
1001524|NCT01432444|2018292|FG001|Treatment Phase|Withdrawal by Subject|41
1001525|NCT01432444|2018293|FG002|Treatment Phase|Withdrawal by Subject|0
1001526|NCT01432444|2018291|FG000|Treatment Phase|Protocol Deviation|0
1001527|NCT01432444|2018292|FG001|Treatment Phase|Protocol Deviation|3
1001528|NCT01432444|2018293|FG002|Treatment Phase|Protocol Deviation|0
1001529|NCT01432444|2018291|FG000|Treatment Phase|Lack of Efficacy|0
1001530|NCT01432444|2018292|FG001|Treatment Phase|Lack of Efficacy|10
1001531|NCT01432444|2018293|FG002|Treatment Phase|Lack of Efficacy|0
1001532|NCT01432444|2018291|FG000|Extension Phase|Lost to Follow-up|0
1001533|NCT01432444|2018292|FG001|Extension Phase|Lost to Follow-up|0
1001534|NCT01432444|2018293|FG002|Extension Phase|Lost to Follow-up|17
1001535|NCT01432444|2018291|FG000|Extension Phase|Adverse Event|0
1001536|NCT01432444|2018292|FG001|Extension Phase|Adverse Event|0
1001537|NCT01432444|2018293|FG002|Extension Phase|Adverse Event|10
1001538|NCT01432444|2018291|FG000|Extension Phase|Sponsor Discontinued Trial|0
1001539|NCT01432444|2018292|FG001|Extension Phase|Sponsor Discontinued Trial|0
1001540|NCT01432444|2018293|FG002|Extension Phase|Sponsor Discontinued Trial|7
1001541|NCT01432444|2018291|FG000|Extension Phase|Met Withdrawal Criteria|0
1001542|NCT01432444|2018292|FG001|Extension Phase|Met Withdrawal Criteria|0
1001543|NCT01432444|2018293|FG002|Extension Phase|Met Withdrawal Criteria|144
1001544|NCT01432444|2018291|FG000|Extension Phase|Physician Decision|0
1001545|NCT01432444|2018292|FG001|Extension Phase|Physician Decision|0
1001546|NCT01432444|2018293|FG002|Extension Phase|Physician Decision|1
1001547|NCT01432444|2018291|FG000|Extension Phase|Withdrawal by Subject|0
1001548|NCT01432444|2018292|FG001|Extension Phase|Withdrawal by Subject|0
1001549|NCT01432444|2018293|FG002|Extension Phase|Withdrawal by Subject|13
1001550|NCT01432457|2018301|FG000|Overall Study|Adverse Event|7
1001551|NCT01432457|2018302|FG001|Overall Study|Adverse Event|10
1001552|NCT01432457|2018303|FG002|Overall Study|Adverse Event|16
1001553|NCT01432457|2018301|FG000|Overall Study|Lack of Efficacy|2
1001554|NCT01432457|2018302|FG001|Overall Study|Lack of Efficacy|1
1001555|NCT01432457|2018303|FG002|Overall Study|Lack of Efficacy|1
1001556|NCT01432457|2018301|FG000|Overall Study|Lost to Follow-up|11
1001557|NCT01432457|2018302|FG001|Overall Study|Lost to Follow-up|15
1001558|NCT01432457|2018303|FG002|Overall Study|Lost to Follow-up|20
1001559|NCT01432457|2018301|FG000|Overall Study|Protocol Violation|3
1001560|NCT01432457|2018302|FG001|Overall Study|Protocol Violation|2
1001561|NCT01432457|2018303|FG002|Overall Study|Protocol Violation|6
1001562|NCT01432457|2018301|FG000|Overall Study|Withdrawal by Subject|6
1001563|NCT01432457|2018302|FG001|Overall Study|Withdrawal by Subject|11
1001564|NCT01432457|2018303|FG002|Overall Study|Withdrawal by Subject|9
1001565|NCT01432457|2018301|FG000|Overall Study|Reasons not defined|2
1001566|NCT01432457|2018302|FG001|Overall Study|Reasons not defined|3
1001567|NCT01432457|2018303|FG002|Overall Study|Reasons not defined|4
1001568|NCT01432457|2018301|FG000|Overall Study|Did not take study drug|6
1001569|NCT01432457|2018302|FG001|Overall Study|Did not take study drug|6
1001570|NCT01432457|2018303|FG002|Overall Study|Did not take study drug|3
1001571|NCT01432574|2018328|FG000|Overall Study|Moved|2
1001572|NCT01432574|2018328|FG000|Overall Study|Not interested|1
1001573|NCT01432600|2018337|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0
1001574|NCT01432600|2018338|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1
1001575|NCT01432600|2018339|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1
1001576|NCT01432626|2018349|FG000|Overall Study|LV function recovered|2
1001577|NCT01432626|2018349|FG000|Overall Study|Withdrawal by Subject|2
1001578|NCT01432626|2018349|FG000|Overall Study|Only 1 image competed|2
1001579|NCT01432626|2018349|FG000|Overall Study|Imaging agent not available|1
1001580|NCT01432730|2018353|FG000|Period 1|Adverse Event|2
1001581|NCT01432730|2018354|FG001|Period 1|Adverse Event|0
1001582|NCT01432730|2018353|FG000|Period 2|Adverse Event|0
1001583|NCT01432730|2018354|FG001|Period 2|Adverse Event|4
1001584|NCT01432756|2018364|FG000|Overall Study|Lost to Follow-up|1
1001585|NCT01432756|2018365|FG001|Overall Study|Lost to Follow-up|0
1001586|NCT01432756|2018366|FG002|Overall Study|Lost to Follow-up|2
1001587|NCT01432756|2018367|FG003|Overall Study|Lost to Follow-up|1
1001588|NCT01432938|2018385|FG000|First Intervention|Protocol Violation|1
1001589|NCT01432938|2018386|FG001|First Intervention|Protocol Violation|0
1001590|NCT01432938|2018385|FG000|First Intervention|Physician Decision|1
1001591|NCT01432938|2018386|FG001|First Intervention|Physician Decision|0
1001592|NCT01432938|2018385|FG000|Second Intervention|Adverse Event|1
1001593|NCT01432938|2018386|FG001|Second Intervention|Adverse Event|0
1001594|NCT01432951|2018393|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1
1001595|NCT01433055|2018408|FG000|Overall Study|Diagnosed with cancer unrelated to study|1
1001596|NCT01433055|2018409|FG001|Overall Study|Diagnosed with cancer unrelated to study|0
1001597|NCT01433055|2018408|FG000|Overall Study|Severely elevated triglycerides at entry|1
1001598|NCT01433055|2018409|FG001|Overall Study|Severely elevated triglycerides at entry|0
1001599|NCT01433159|2018436|FG000|Overall Study|Adverse Event|1
1001600|NCT01433159|2018437|FG001|Overall Study|Adverse Event|0
1001601|NCT01433159|2018436|FG000|Overall Study|Physician Decision|1
1001602|NCT01433159|2018437|FG001|Overall Study|Physician Decision|0
1001603|NCT01433159|2018436|FG000|Overall Study|Protocol Violation|0
1001604|NCT01433159|2018437|FG001|Overall Study|Protocol Violation|1
1001605|NCT01433172|2018446|FG000|Overall Study|Withdrawal by Subject|0
1001606|NCT01433172|2018447|FG001|Overall Study|Withdrawal by Subject|1
1001607|NCT01433172|2018448|FG002|Overall Study|Withdrawal by Subject|0
1001608|NCT01433172|2018446|FG000|Overall Study|Disease Progression|0
1001609|NCT01433172|2018447|FG001|Overall Study|Disease Progression|0
1001610|NCT01433172|2018448|FG002|Overall Study|Disease Progression|1
1001611|NCT01433172|2018446|FG000|Overall Study|Death|0
1001612|NCT01433172|2018447|FG001|Overall Study|Death|2
1001613|NCT01433172|2018448|FG002|Overall Study|Death|0
1001614|NCT01433250|2018458|FG000|Overall Study|Protocol Violation|0
1001615|NCT01433250|2018459|FG001|Overall Study|Protocol Violation|1
1001616|NCT01433250|2018458|FG000|Overall Study|Withdrawal by Subject|3
1001617|NCT01433250|2018459|FG001|Overall Study|Withdrawal by Subject|2
1001618|NCT01433263|2018467|FG000|Overall Study|Adverse Event|3
1001619|NCT01433263|2018468|FG001|Overall Study|Adverse Event|1
1001620|NCT01433263|2018467|FG000|Overall Study|Death|5
1001621|NCT01433263|2018468|FG001|Overall Study|Death|3
1001622|NCT01433263|2018467|FG000|Overall Study|Lost to Follow-up|0
1001623|NCT01433263|2018468|FG001|Overall Study|Lost to Follow-up|1
1001624|NCT01433263|2018467|FG000|Overall Study|Protocol Deviation|1
1001625|NCT01433263|2018468|FG001|Overall Study|Protocol Deviation|0
1001626|NCT01433263|2018467|FG000|Overall Study|Withdrawal by Subject|10
1001627|NCT01433263|2018468|FG001|Overall Study|Withdrawal by Subject|7
1001628|NCT01433354|2018477|FG000|Overall Study|Adverse Event|6
1001629|NCT01433354|2018477|FG000|Overall Study|Lost to Follow-up|1
1001630|NCT01433354|2018477|FG000|Overall Study|Administrative problems|90
1001631|NCT01433354|2018477|FG000|Overall Study|Protocol Violation|2
1001632|NCT01433354|2018477|FG000|Overall Study|Lack of Efficacy|17
1001633|NCT01433354|2018477|FG000|Overall Study|Subject Withdrew Consent|3
1001634|NCT01433549|2018491|FG000|Phase 2: Second Study Product|Adverse Event|0
1001635|NCT01433549|2018492|FG001|Phase 2: Second Study Product|Adverse Event|1
1001636|NCT01433978|2018525|FG000|Core Study|Adverse Event, Non-Fatal|0
1001637|NCT01433978|2018526|FG001|Core Study|Adverse Event, Non-Fatal|1
1001638|NCT01433978|2018527|FG002|Core Study|Adverse Event, Non-Fatal|0
1001639|NCT01433978|2018525|FG000|Core Study|Lack of Efficacy|5
1001640|NCT01433978|2018526|FG001|Core Study|Lack of Efficacy|1
1001641|NCT01433978|2018527|FG002|Core Study|Lack of Efficacy|0
1001642|NCT01433978|2018525|FG000|Core Study|Study Terminated by Sponsor|6
1001643|NCT01433978|2018526|FG001|Core Study|Study Terminated by Sponsor|9
1001644|NCT01433978|2018527|FG002|Core Study|Study Terminated by Sponsor|0
1001645|NCT01433978|2018525|FG000|Extension Phase|Adverse Event, Non-Fatal|0
1001646|NCT01433978|2018526|FG001|Extension Phase|Adverse Event, Non-Fatal|0
1001647|NCT01433978|2018527|FG002|Extension Phase|Adverse Event, Non-Fatal|1
1001648|NCT01433978|2018525|FG000|Extension Phase|Lack of Efficacy|0
1001649|NCT01433978|2018526|FG001|Extension Phase|Lack of Efficacy|0
1001650|NCT01433978|2018527|FG002|Extension Phase|Lack of Efficacy|1
1001651|NCT01433978|2018525|FG000|Extension Phase|Study Terminated by Sponsor|0
1001652|NCT01433978|2018526|FG001|Extension Phase|Study Terminated by Sponsor|0
1001653|NCT01433978|2018527|FG002|Extension Phase|Study Terminated by Sponsor|4
1001654|NCT01433991|2018538|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2
1001655|NCT01433991|2018539|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
1001656|NCT01433991|2018540|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
914148|NCT00813488|1891933|FG000|Titration Period 2|Protocol Violation|3
914149|NCT00813488|1891934|FG001|Titration Period 2|Protocol Violation|2
914150|NCT00813488|1891933|FG000|Titration Period 2|Lost to Follow-up|1
914151|NCT00813488|1891934|FG001|Titration Period 2|Lost to Follow-up|0
914152|NCT00813488|1891933|FG000|Titration Period 2|Non-compliance with study procedures|2
914153|NCT00813488|1891934|FG001|Titration Period 2|Non-compliance with study procedures|1
1001657|NCT01433991|2018541|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
1001658|NCT01433991|2018538|FG000|Treatment Phase (Combination Agent)|Adverse Event|1
1001659|NCT01433991|2018539|FG001|Treatment Phase (Combination Agent)|Adverse Event|0
1001660|NCT01433991|2018540|FG002|Treatment Phase (Combination Agent)|Adverse Event|3
1001661|NCT01433991|2018541|FG003|Treatment Phase (Combination Agent)|Adverse Event|1
1001662|NCT01433991|2018538|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0
1001663|NCT01433991|2018539|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0
1001664|NCT01433991|2018540|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0
1001665|NCT01433991|2018541|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1
1001666|NCT01433991|2018538|FG000|Treatment Phase (Combination Agent)|Participant Choice|0
1001667|NCT01433991|2018539|FG001|Treatment Phase (Combination Agent)|Participant Choice|0
1001668|NCT01433991|2018540|FG002|Treatment Phase (Combination Agent)|Participant Choice|0
1001669|NCT01433991|2018541|FG003|Treatment Phase (Combination Agent)|Participant Choice|1
1001670|NCT01433991|2018538|FG000|Treatment Phase (Combination Agent)|Clinical progression|0
1001671|NCT01433991|2018539|FG001|Treatment Phase (Combination Agent)|Clinical progression|1
1001672|NCT01433991|2018540|FG002|Treatment Phase (Combination Agent)|Clinical progression|2
1001673|NCT01433991|2018541|FG003|Treatment Phase (Combination Agent)|Clinical progression|3
1001674|NCT01433991|2018538|FG000|Treatment Phase (Combination Agent)|Progressive disease|1
1001675|NCT01433991|2018539|FG001|Treatment Phase (Combination Agent)|Progressive disease|0
914154|NCT00813488|1891933|FG000|Double-blind Treatment Period 1|Adverse Event|1
914155|NCT00813488|1891934|FG001|Double-blind Treatment Period 1|Adverse Event|1
914156|NCT00813488|1891933|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0
914157|NCT00813488|1891934|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1
914158|NCT00813488|1891933|FG000|Double-blind Treatment Period 1|Protocol Violation|0
914159|NCT00813488|1891934|FG001|Double-blind Treatment Period 1|Protocol Violation|2
914160|NCT00813488|1891933|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0
914161|NCT00813488|1891934|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1
914162|NCT00813488|1891933|FG000|Double-blind Treatment Period 2|Adverse Event|1
914163|NCT00813488|1891934|FG001|Double-blind Treatment Period 2|Adverse Event|0
914164|NCT00813488|1891933|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1
914165|NCT00813488|1891934|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1
914166|NCT00813488|1891933|FG000|Double-blind Treatment Period 2|Protocol Violation|2
914167|NCT00813488|1891934|FG001|Double-blind Treatment Period 2|Protocol Violation|0
914168|NCT00813488|1891933|FG000|Double-blind Treatment Period 2|Other|1
914169|NCT00813488|1891934|FG001|Double-blind Treatment Period 2|Other|0
914170|NCT00813488|1891933|FG000|Open-label Extension|Adverse Event|1
914171|NCT00813488|1891934|FG001|Open-label Extension|Adverse Event|2
914172|NCT00813488|1891933|FG000|Open-label Extension|Lack of Efficacy|3
914173|NCT00813488|1891934|FG001|Open-label Extension|Lack of Efficacy|0
914174|NCT00813488|1891933|FG000|Open-label Extension|Withdrawal by Subject|0
1001676|NCT01433991|2018540|FG002|Treatment Phase (Combination Agent)|Progressive disease|0
1001677|NCT01433991|2018541|FG003|Treatment Phase (Combination Agent)|Progressive disease|0
1001678|NCT01433991|2018538|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0
1001679|NCT01433991|2018539|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0
1001680|NCT01433991|2018540|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1
1001681|NCT01433991|2018541|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0
1001682|NCT01434290|2018589|FG000|Overall Study|Protocol Violation|6
1001683|NCT01434290|2018590|FG001|Overall Study|Protocol Violation|3
1001684|NCT01434290|2018589|FG000|Overall Study|No protocol treatment|2
1001685|NCT01434290|2018590|FG001|Overall Study|No protocol treatment|4
1001686|NCT01434654|2018616|FG000|Overall Study|Withdrawal by Subject|1
1001687|NCT01434654|2018617|FG001|Overall Study|Withdrawal by Subject|0
1001688|NCT01434654|2018616|FG000|Overall Study|Lost to Follow-up|1
1001689|NCT01434654|2018617|FG001|Overall Study|Lost to Follow-up|0
1001690|NCT01434667|2018627|FG000|Overall Study|Lost to Follow-up|5
1001691|NCT01434667|2018628|FG001|Overall Study|Lost to Follow-up|10
1001692|NCT01434680|2018638|FG000|Overall Study|Withdrawal by Subject|1
1001693|NCT01434680|2018639|FG001|Overall Study|Withdrawal by Subject|0
1001694|NCT01434680|2018640|FG002|Overall Study|Withdrawal by Subject|2
1001695|NCT01434680|2018641|FG003|Overall Study|Withdrawal by Subject|0
1001696|NCT01434680|2018638|FG000|Overall Study|Lost to Follow-up|1
1001697|NCT01434680|2018639|FG001|Overall Study|Lost to Follow-up|1
1001698|NCT01434680|2018640|FG002|Overall Study|Lost to Follow-up|0
1001699|NCT01434680|2018641|FG003|Overall Study|Lost to Follow-up|0
1001700|NCT01434680|2018638|FG000|Overall Study|Protocol Violation|1
1001701|NCT01434680|2018639|FG001|Overall Study|Protocol Violation|1
1001702|NCT01434680|2018640|FG002|Overall Study|Protocol Violation|0
1001703|NCT01434680|2018641|FG003|Overall Study|Protocol Violation|0
1001704|NCT01434693|2018655|FG000|Overall Study|Adverse Event|1
1001705|NCT01434693|2018656|FG001|Overall Study|Adverse Event|0
1001706|NCT01434693|2018657|FG002|Overall Study|Adverse Event|0
1001707|NCT01434693|2018658|FG003|Overall Study|Adverse Event|0
1001708|NCT01434693|2018655|FG000|Overall Study|Withdrawal by Subject|1
1001709|NCT01434693|2018656|FG001|Overall Study|Withdrawal by Subject|0
1001710|NCT01434693|2018657|FG002|Overall Study|Withdrawal by Subject|1
1001711|NCT01434693|2018658|FG003|Overall Study|Withdrawal by Subject|1
1001712|NCT01434693|2018655|FG000|Overall Study|Lost to Follow-up|1
1001713|NCT01434693|2018656|FG001|Overall Study|Lost to Follow-up|0
1001714|NCT01434693|2018657|FG002|Overall Study|Lost to Follow-up|0
1001715|NCT01434693|2018658|FG003|Overall Study|Lost to Follow-up|0
1001716|NCT01434810|2018670|FG000|Overall Study|Did not receive treatment|11
1001717|NCT01434810|2018671|FG001|Overall Study|Did not receive treatment|3
1001718|NCT01434810|2018670|FG000|Overall Study|Missing data/received <5hr phototherapy|12
1001719|NCT01434810|2018671|FG001|Overall Study|Missing data/received <5hr phototherapy|7
1001720|NCT01434823|2018679|FG000|Overall Study|Incomplete data in medical record|4
1001721|NCT01434823|2018680|FG001|Overall Study|Incomplete data in medical record|7
1001722|NCT01435018|2018690|FG000|Overall Study|Death|37
1001723|NCT01435018|2018691|FG001|Overall Study|Death|18
1001724|NCT01435018|2018692|FG002|Overall Study|Death|25
1001725|NCT01435018|2018690|FG000|Overall Study|Site is closing|4
1001726|NCT01435018|2018691|FG001|Overall Study|Site is closing|9
1001727|NCT01435018|2018692|FG002|Overall Study|Site is closing|7
1001728|NCT01435018|2018690|FG000|Overall Study|Withdrew consent|0
1001729|NCT01435018|2018691|FG001|Overall Study|Withdrew consent|3
1001730|NCT01435018|2018692|FG002|Overall Study|Withdrew consent|1
1001731|NCT01435018|2018690|FG000|Overall Study|Not willing to adhere to requirements|0
1001732|NCT01435018|2018691|FG001|Overall Study|Not willing to adhere to requirements|2
1001733|NCT01435018|2018692|FG002|Overall Study|Not willing to adhere to requirements|3
1001734|NCT01435018|2018690|FG000|Overall Study|Not able to get to clinic|2
1001735|NCT01435018|2018691|FG001|Overall Study|Not able to get to clinic|0
1001736|NCT01435018|2018692|FG002|Overall Study|Not able to get to clinic|2
1001737|NCT01435018|2018690|FG000|Overall Study|Severe debilitation, unable to continue|0
1001738|NCT01435018|2018691|FG001|Overall Study|Severe debilitation, unable to continue|0
1001739|NCT01435018|2018692|FG002|Overall Study|Severe debilitation, unable to continue|1
1001740|NCT01435018|2018690|FG000|Overall Study|Unable to contact participant/parent|1
1001741|NCT01435018|2018691|FG001|Overall Study|Unable to contact participant/parent|1
1001742|NCT01435018|2018692|FG002|Overall Study|Unable to contact participant/parent|1
1001743|NCT01435018|2018690|FG000|Overall Study|Enrollment Violation|0
1001744|NCT01435018|2018691|FG001|Overall Study|Enrollment Violation|1
1001745|NCT01435018|2018692|FG002|Overall Study|Enrollment Violation|0
1001746|NCT01435018|2018690|FG000|Overall Study|Never started chemotherapy|3
1001747|NCT01435018|2018691|FG001|Overall Study|Never started chemotherapy|0
1001748|NCT01435018|2018692|FG002|Overall Study|Never started chemotherapy|1
1001749|NCT01435031|2018702|FG000|ITT at 1 Month|Withdrawal by Subject|1
1001750|NCT01435031|2018702|FG000|ITT at 1 Month|Death|1
1001751|NCT01435031|2018702|FG000|ITT at 1 Month|Lost to Follow-up|4
1001752|NCT01435031|2018702|FG000|ITT at 6 Months|Death|2
1001753|NCT01435031|2018702|FG000|ITT at 6 Months|Lost to Follow-up|3
1001754|NCT01435031|2018702|FG000|ITT at 1 Year|Death|1
1001755|NCT01435031|2018702|FG000|ITT at 1 Year|Withdrawal by Subject|2
1001756|NCT01435031|2018702|FG000|ITT at 1 Year|Lost to Follow-up|6
1001757|NCT01435031|2018702|FG000|ITT at 2 Years|Death|7
1001758|NCT01435031|2018702|FG000|ITT at 2 Years|Withdrawal by Subject|2
1001759|NCT01435031|2018702|FG000|ITT at 2 Years|Lost to Follow-up|4
1001760|NCT01435031|2018702|FG000|ITT at 3 Years|Death|5
1001761|NCT01435031|2018702|FG000|ITT at 3 Years|Withdrawal by Subject|2
1001762|NCT01435031|2018702|FG000|ITT at 3 Years|Lost to Follow-up|4
1001763|NCT01435031|2018702|FG000|ITT at 4 Years|Death|4
1001764|NCT01435031|2018702|FG000|ITT at 4 Years|Withdrawal by Subject|2
1001765|NCT01435031|2018702|FG000|ITT at 4 Years|Lost to Follow-up|1
1001766|NCT01435122|2018706|FG000|Overall Study|Early withdrawal due to toxicity|8
1001767|NCT01435265|2018716|FG000|Overall Study|Lost to Follow-up|0
1001768|NCT01435265|2018717|FG001|Overall Study|Lost to Follow-up|1
1001769|NCT01435356|2018734|FG000|Overall Study|Adverse Event|2
1001770|NCT01435356|2018735|FG001|Overall Study|Adverse Event|0
1001771|NCT01435356|2018734|FG000|Overall Study|Disease progression/recurrence|17
1001772|NCT01435356|2018735|FG001|Overall Study|Disease progression/recurrence|10
1001773|NCT01435356|2018734|FG000|Overall Study|Protocol Violation|0
1001774|NCT01435356|2018735|FG001|Overall Study|Protocol Violation|1
1001775|NCT01435356|2018734|FG000|Overall Study|Study Discontinuation, amendment 4|5
1001776|NCT01435356|2018735|FG001|Overall Study|Study Discontinuation, amendment 4|11
1001777|NCT01435356|2018734|FG000|Overall Study|Withdrawal by Subject|1
1001778|NCT01435356|2018735|FG001|Overall Study|Withdrawal by Subject|1
1001779|NCT01435356|2018734|FG000|Overall Study|Facial palsy|1
1001780|NCT01435356|2018735|FG001|Overall Study|Facial palsy|0
1001781|NCT01435356|2018734|FG000|Overall Study|IC withdrawal due to study cancellation|1
1001782|NCT01435356|2018735|FG001|Overall Study|IC withdrawal due to study cancellation|0
1001783|NCT01435356|2018734|FG000|Overall Study|Physician Decision|1
1001784|NCT01435356|2018735|FG001|Overall Study|Physician Decision|0
1001785|NCT01435356|2018734|FG000|Overall Study|Patient decision|3
1001786|NCT01435356|2018735|FG001|Overall Study|Patient decision|0
1001787|NCT01435356|2018734|FG000|Overall Study|Patient moved to another city|1
1001788|NCT01435356|2018735|FG001|Overall Study|Patient moved to another city|1
1001789|NCT01435382|2018745|FG000|Overall Study|Lost to Follow-up|1
1001790|NCT01435382|2018746|FG001|Overall Study|Lost to Follow-up|0
1001791|NCT01435382|2018747|FG002|Overall Study|Lost to Follow-up|1
1001792|NCT01435382|2018748|FG003|Overall Study|Lost to Follow-up|0
1001793|NCT01435382|2018745|FG000|Overall Study|Withdrawal by Subject|0
1001794|NCT01435382|2018746|FG001|Overall Study|Withdrawal by Subject|2
1001795|NCT01435382|2018747|FG002|Overall Study|Withdrawal by Subject|0
1001796|NCT01435382|2018748|FG003|Overall Study|Withdrawal by Subject|1
1001797|NCT01435460|2018766|FG000|Overall Study|Adverse Event|2
1001798|NCT01435460|2018767|FG001|Overall Study|Adverse Event|1
1001799|NCT01435460|2018766|FG000|Overall Study|Lost to Follow-up|6
1001800|NCT01435460|2018767|FG001|Overall Study|Lost to Follow-up|1
1001801|NCT01435460|2018766|FG000|Overall Study|Withdrawal by Subject|1
1001802|NCT01435460|2018767|FG001|Overall Study|Withdrawal by Subject|3
1001803|NCT01435460|2018766|FG000|Overall Study|Protocol Violation|0
1001804|NCT01435460|2018767|FG001|Overall Study|Protocol Violation|1
1001805|NCT01435460|2018766|FG000|Overall Study|Did not meet eligibility criteria|2
1001806|NCT01435460|2018767|FG001|Overall Study|Did not meet eligibility criteria|0
1001807|NCT01435577|2018784|FG000|Overall Study|Adverse Event|10
1001808|NCT01435577|2018785|FG001|Overall Study|Adverse Event|0
1001809|NCT01435577|2018784|FG000|Overall Study|Lack of Efficacy|7
1001810|NCT01435577|2018785|FG001|Overall Study|Lack of Efficacy|51
1001811|NCT01435577|2018784|FG000|Overall Study|Alternative treatment started|0
1001812|NCT01435577|2018785|FG001|Overall Study|Alternative treatment started|1
1001813|NCT01435616|2018806|FG000|Overall Study|Adverse Event|39
1001814|NCT01435616|2018807|FG001|Overall Study|Adverse Event|21
1001815|NCT01435616|2018806|FG000|Overall Study|Death|7
1001816|NCT01435616|2018807|FG001|Overall Study|Death|2
1001817|NCT01435616|2018806|FG000|Overall Study|Lost to Follow-up|22
1001818|NCT01435616|2018807|FG001|Overall Study|Lost to Follow-up|13
1001819|NCT01435616|2018806|FG000|Overall Study|Protocol Violation|16
1001820|NCT01435616|2018807|FG001|Overall Study|Protocol Violation|13
1001821|NCT01435616|2018806|FG000|Overall Study|Withdrawal by Subject|66
1001822|NCT01435616|2018807|FG001|Overall Study|Withdrawal by Subject|24
1001823|NCT01435616|2018806|FG000|Overall Study|Physician Decision|20
1001824|NCT01435616|2018807|FG001|Overall Study|Physician Decision|7
1001825|NCT01435616|2018806|FG000|Overall Study|Sponsor Decision|1
1001826|NCT01435616|2018807|FG001|Overall Study|Sponsor Decision|0
1001827|NCT01435655|2018815|FG000|Overall Study|Death|2
1001828|NCT01435655|2018815|FG000|Overall Study|Other|1
1001829|NCT01435759|2018824|FG000|Antidepressant Lead-in Phase|Adverse Event|40
1001830|NCT01435759|2018825|FG001|Antidepressant Lead-in Phase|Adverse Event|0
1001831|NCT01435759|2018826|FG002|Antidepressant Lead-in Phase|Adverse Event|0
1001832|NCT01435759|2018827|FG003|Antidepressant Lead-in Phase|Adverse Event|0
1001833|NCT01435759|2018828|FG004|Antidepressant Lead-in Phase|Adverse Event|0
1001834|NCT01435759|2018829|FG005|Antidepressant Lead-in Phase|Adverse Event|0
1001835|NCT01435759|2018824|FG000|Antidepressant Lead-in Phase|Protocol Violation|16
1001836|NCT01435759|2018825|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
1001837|NCT01435759|2018826|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
1001838|NCT01435759|2018827|FG003|Antidepressant Lead-in Phase|Protocol Violation|0
1001839|NCT01435759|2018828|FG004|Antidepressant Lead-in Phase|Protocol Violation|0
1001840|NCT01435759|2018829|FG005|Antidepressant Lead-in Phase|Protocol Violation|0
1001841|NCT01435759|2018824|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74
1001842|NCT01435759|2018825|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1001843|NCT01435759|2018826|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1001844|NCT01435759|2018827|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1001845|NCT01435759|2018828|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1001846|NCT01435759|2018829|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1001847|NCT01435759|2018824|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83
1001848|NCT01435759|2018825|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
1001849|NCT01435759|2018826|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
1001850|NCT01435759|2018827|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0
1001851|NCT01435759|2018828|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0
1001852|NCT01435759|2018829|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0
1001853|NCT01435759|2018824|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
1001854|NCT01435759|2018825|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1001855|NCT01435759|2018826|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1001856|NCT01435759|2018827|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1001857|NCT01435759|2018828|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1001858|NCT01435759|2018829|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1001859|NCT01435759|2018824|FG000|Antidepressant Lead-in Phase|Other|119
1001860|NCT01435759|2018825|FG001|Antidepressant Lead-in Phase|Other|0
1001861|NCT01435759|2018826|FG002|Antidepressant Lead-in Phase|Other|0
1001862|NCT01435759|2018827|FG003|Antidepressant Lead-in Phase|Other|0
1001863|NCT01435759|2018828|FG004|Antidepressant Lead-in Phase|Other|0
1001864|NCT01435759|2018829|FG005|Antidepressant Lead-in Phase|Other|0
1001865|NCT01435759|2018824|FG000|Double-blind Phase|Adverse Event|7
1001866|NCT01435759|2018825|FG001|Double-blind Phase|Adverse Event|0
1001867|NCT01435759|2018826|FG002|Double-blind Phase|Adverse Event|1
1001868|NCT01435759|2018827|FG003|Double-blind Phase|Adverse Event|1
1001869|NCT01435759|2018828|FG004|Double-blind Phase|Adverse Event|1
1001870|NCT01435759|2018829|FG005|Double-blind Phase|Adverse Event|3
1001871|NCT01435759|2018824|FG000|Double-blind Phase|Protocol Violation|2
1001872|NCT01435759|2018825|FG001|Double-blind Phase|Protocol Violation|0
1001873|NCT01435759|2018826|FG002|Double-blind Phase|Protocol Violation|1
1001874|NCT01435759|2018827|FG003|Double-blind Phase|Protocol Violation|2
1001875|NCT01435759|2018828|FG004|Double-blind Phase|Protocol Violation|0
1001876|NCT01435759|2018829|FG005|Double-blind Phase|Protocol Violation|1
1001877|NCT01435759|2018824|FG000|Double-blind Phase|Withdrawal by Subject|17
1001878|NCT01435759|2018825|FG001|Double-blind Phase|Withdrawal by Subject|4
1001879|NCT01435759|2018826|FG002|Double-blind Phase|Withdrawal by Subject|3
1001880|NCT01435759|2018827|FG003|Double-blind Phase|Withdrawal by Subject|4
1001881|NCT01435759|2018828|FG004|Double-blind Phase|Withdrawal by Subject|2
1001882|NCT01435759|2018829|FG005|Double-blind Phase|Withdrawal by Subject|2
1001883|NCT01435759|2018824|FG000|Double-blind Phase|Lost to Follow-up|31
1001884|NCT01435759|2018825|FG001|Double-blind Phase|Lost to Follow-up|1
1001885|NCT01435759|2018826|FG002|Double-blind Phase|Lost to Follow-up|2
1001886|NCT01435759|2018827|FG003|Double-blind Phase|Lost to Follow-up|0
1001887|NCT01435759|2018828|FG004|Double-blind Phase|Lost to Follow-up|3
1001888|NCT01435759|2018829|FG005|Double-blind Phase|Lost to Follow-up|3
1001889|NCT01435759|2018824|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
1001890|NCT01435759|2018825|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1001891|NCT01435759|2018826|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1001892|NCT01435759|2018827|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1001893|NCT01435759|2018828|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
1001894|NCT01435759|2018829|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1001895|NCT01435759|2018824|FG000|Double-blind Phase|Other|8
1001896|NCT01435759|2018825|FG001|Double-blind Phase|Other|2
1001897|NCT01435759|2018826|FG002|Double-blind Phase|Other|0
1001898|NCT01435759|2018827|FG003|Double-blind Phase|Other|2
1001899|NCT01435759|2018828|FG004|Double-blind Phase|Other|0
1001900|NCT01435759|2018829|FG005|Double-blind Phase|Other|0
1001901|NCT01435772|2018844|FG000|Overall Study|Adverse Event|1
1001902|NCT01435772|2018845|FG001|Overall Study|Adverse Event|0
1001903|NCT01435772|2018846|FG002|Overall Study|Adverse Event|2
1001904|NCT01435772|2018844|FG000|Overall Study|Withdrawal by Subject|0
1001905|NCT01435772|2018845|FG001|Overall Study|Withdrawal by Subject|1
1001906|NCT01435772|2018846|FG002|Overall Study|Withdrawal by Subject|3
1001907|NCT01435772|2018844|FG000|Overall Study|Other - study termination|2
1001908|NCT01435772|2018845|FG001|Overall Study|Other - study termination|2
1001909|NCT01435772|2018846|FG002|Overall Study|Other - study termination|10
1001910|NCT01435798|2018855|FG000|Overall Study|Withdrawal by Subject|1
1001911|NCT01435928|2018874|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83
1001912|NCT01435928|2018875|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0
1001913|NCT01435928|2018876|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0
1001914|NCT01435928|2018874|FG000|Open Label Phase - up to 24 Weeks|Death|1
1001915|NCT01435928|2018875|FG001|Open Label Phase - up to 24 Weeks|Death|0
1001916|NCT01435928|2018876|FG002|Open Label Phase - up to 24 Weeks|Death|0
1001917|NCT01435928|2018874|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
1001918|NCT01435928|2018875|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
1001919|NCT01435928|2018876|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
1001920|NCT01435928|2018874|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
1001921|NCT01435928|2018875|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
1001922|NCT01435928|2018876|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
1001923|NCT01435928|2018874|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39
1001924|NCT01435928|2018875|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0
1001925|NCT01435928|2018876|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0
1001926|NCT01435928|2018874|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
1001927|NCT01435928|2018875|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
1001928|NCT01435928|2018876|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
1001929|NCT01435928|2018874|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
1001930|NCT01435928|2018875|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
1001931|NCT01435928|2018876|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
1001932|NCT01435928|2018874|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
1001933|NCT01435928|2018875|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
1001934|NCT01435928|2018876|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
1001935|NCT01435928|2018874|FG000|Open Label Phase - up to 24 Weeks|Administrative|14
1001936|NCT01435928|2018875|FG001|Open Label Phase - up to 24 Weeks|Administrative|0
1001937|NCT01435928|2018876|FG002|Open Label Phase - up to 24 Weeks|Administrative|0
1001938|NCT01435928|2018874|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0
1001939|NCT01435928|2018875|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3
1001940|NCT01435928|2018876|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1
1001941|NCT01435928|2018874|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
1001942|NCT01435928|2018875|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
1001943|NCT01435928|2018876|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
1001944|NCT01435928|2018874|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0
1001945|NCT01435928|2018875|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11
1001946|NCT01435928|2018876|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4
1001947|NCT01435928|2018874|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
1001948|NCT01435928|2018875|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
1001949|NCT01435928|2018876|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
1001950|NCT01435928|2018874|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0
1001951|NCT01435928|2018875|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47
1001952|NCT01435928|2018876|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39
1001953|NCT01435928|2018874|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0
1001954|NCT01435928|2018875|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43
1001955|NCT01435928|2018876|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58
1001956|NCT01435928|2018874|FG000|Double Blind Phase - 28 Weeks|Administrative|0
1001957|NCT01435928|2018875|FG001|Double Blind Phase - 28 Weeks|Administrative|5
1001958|NCT01435928|2018876|FG002|Double Blind Phase - 28 Weeks|Administrative|2
1001959|NCT01436071|2018904|FG000|Overall Study|Adverse Event|1
1001960|NCT01436071|2018905|FG001|Overall Study|Adverse Event|0
1001961|NCT01436071|2018904|FG000|Overall Study|Lack of Efficacy|16
1001962|NCT01436071|2018905|FG001|Overall Study|Lack of Efficacy|7
1001963|NCT01436071|2018904|FG000|Overall Study|Protocol Violation|0
1001964|NCT01436071|2018905|FG001|Overall Study|Protocol Violation|1
1001965|NCT01436071|2018904|FG000|Overall Study|Lost to Follow-up|3
1001966|NCT01436071|2018905|FG001|Overall Study|Lost to Follow-up|1
1001967|NCT01436071|2018904|FG000|Overall Study|Physician Decision|1
1001968|NCT01436071|2018905|FG001|Overall Study|Physician Decision|0
1001969|NCT01436071|2018904|FG000|Overall Study|Withdrawal by Subject|2
1001970|NCT01436071|2018905|FG001|Overall Study|Withdrawal by Subject|2
1001971|NCT01436071|2018904|FG000|Overall Study|Did Not Receive Trial Medication|3
1001972|NCT01436071|2018905|FG001|Overall Study|Did Not Receive Trial Medication|3
1001973|NCT01436110|2018914|FG000|Overall Study|Lack of Efficacy|23
1001974|NCT01436110|2018915|FG001|Overall Study|Lack of Efficacy|14
1001975|NCT01436110|2018916|FG002|Overall Study|Lack of Efficacy|9
1001976|NCT01436110|2018914|FG000|Overall Study|Withdrawal by Subject|6
1001977|NCT01436110|2018915|FG001|Overall Study|Withdrawal by Subject|8
1001978|NCT01436110|2018916|FG002|Overall Study|Withdrawal by Subject|4
1001979|NCT01436110|2018914|FG000|Overall Study|Adverse Event|2
1001980|NCT01436110|2018915|FG001|Overall Study|Adverse Event|1
1001981|NCT01436110|2018916|FG002|Overall Study|Adverse Event|2
1001982|NCT01436110|2018914|FG000|Overall Study|Physician Decision|3
1001983|NCT01436110|2018915|FG001|Overall Study|Physician Decision|1
1001984|NCT01436110|2018916|FG002|Overall Study|Physician Decision|1
1001985|NCT01436110|2018914|FG000|Overall Study|Lost to Follow-up|1
1001986|NCT01436110|2018915|FG001|Overall Study|Lost to Follow-up|1
1001987|NCT01436110|2018916|FG002|Overall Study|Lost to Follow-up|3
1001988|NCT01436110|2018914|FG000|Overall Study|Protocol Violation|3
1001989|NCT01436110|2018915|FG001|Overall Study|Protocol Violation|1
1001990|NCT01436110|2018916|FG002|Overall Study|Protocol Violation|1
1001991|NCT01436110|2018914|FG000|Overall Study|Did Not Receive Trial Medication|1
1001992|NCT01436110|2018915|FG001|Overall Study|Did Not Receive Trial Medication|0
1001993|NCT01436110|2018916|FG002|Overall Study|Did Not Receive Trial Medication|3
1001994|NCT01436149|2018926|FG000|Antidepressant Lead-in Phase|Adverse Event|39
1001995|NCT01436149|2018927|FG001|Antidepressant Lead-in Phase|Adverse Event|0
1001996|NCT01436149|2018928|FG002|Antidepressant Lead-in Phase|Adverse Event|0
1001997|NCT01436149|2018926|FG000|Antidepressant Lead-in Phase|Protocol Violation|29
1001998|NCT01436149|2018927|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
1001999|NCT01436149|2018928|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
1002000|NCT01436149|2018926|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61
1002001|NCT01436149|2018927|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1002002|NCT01436149|2018928|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1002003|NCT01436149|2018926|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96
1002004|NCT01436149|2018927|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
1002005|NCT01436149|2018928|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
1002006|NCT01436149|2018926|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
1002007|NCT01436149|2018927|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
1002008|NCT01436149|2018928|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
1002009|NCT01436149|2018926|FG000|Antidepressant Lead-in Phase|Other|119
1002010|NCT01436149|2018927|FG001|Antidepressant Lead-in Phase|Other|0
1002011|NCT01436149|2018928|FG002|Antidepressant Lead-in Phase|Other|0
1002012|NCT01436149|2018926|FG000|Randomized Phase|Adverse Event|9
1002013|NCT01436149|2018927|FG001|Randomized Phase|Adverse Event|10
1002014|NCT01436149|2018928|FG002|Randomized Phase|Adverse Event|11
1002015|NCT01436149|2018926|FG000|Randomized Phase|Protocol Violation|4
1002016|NCT01436149|2018927|FG001|Randomized Phase|Protocol Violation|5
1002017|NCT01436149|2018928|FG002|Randomized Phase|Protocol Violation|0
1002018|NCT01436149|2018926|FG000|Randomized Phase|Withdrawal by Subject|16
1002019|NCT01436149|2018927|FG001|Randomized Phase|Withdrawal by Subject|10
1002020|NCT01436149|2018928|FG002|Randomized Phase|Withdrawal by Subject|10
1002021|NCT01436149|2018926|FG000|Randomized Phase|Lost to Follow-up|34
1002022|NCT01436149|2018927|FG001|Randomized Phase|Lost to Follow-up|5
1002023|NCT01436149|2018928|FG002|Randomized Phase|Lost to Follow-up|6
1002024|NCT01436149|2018926|FG000|Randomized Phase|Lack of Efficacy|0
1002025|NCT01436149|2018927|FG001|Randomized Phase|Lack of Efficacy|0
1002026|NCT01436149|2018928|FG002|Randomized Phase|Lack of Efficacy|1
1002027|NCT01436149|2018926|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
1002028|NCT01436149|2018927|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
1002029|NCT01436149|2018928|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
1002030|NCT01436149|2018926|FG000|Randomized Phase|Other|12
1002031|NCT01436149|2018927|FG001|Randomized Phase|Other|5
1002032|NCT01436149|2018928|FG002|Randomized Phase|Other|11
1002033|NCT01436162|2018936|FG000|Single-blind Lead-in Phase|Adverse Event|26
1002034|NCT01436162|2018937|FG001|Single-blind Lead-in Phase|Adverse Event|0
1002035|NCT01436162|2018938|FG002|Single-blind Lead-in Phase|Adverse Event|0
1002036|NCT01436162|2018936|FG000|Single-blind Lead-in Phase|Protocol Violation|24
1002037|NCT01436162|2018937|FG001|Single-blind Lead-in Phase|Protocol Violation|0
1002038|NCT01436162|2018938|FG002|Single-blind Lead-in Phase|Protocol Violation|0
1002039|NCT01436162|2018936|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69
1002040|NCT01436162|2018937|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0
1002041|NCT01436162|2018938|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0
1002042|NCT01436162|2018936|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43
1002043|NCT01436162|2018937|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0
1002044|NCT01436162|2018938|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0
1002045|NCT01436162|2018936|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
1002046|NCT01436162|2018937|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1002047|NCT01436162|2018938|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1002048|NCT01436162|2018936|FG000|Single-blind Lead-in Phase|Other|107
1002049|NCT01436162|2018937|FG001|Single-blind Lead-in Phase|Other|0
1002050|NCT01436162|2018938|FG002|Single-blind Lead-in Phase|Other|0
1002051|NCT01436162|2018936|FG000|Randomized Phase|Adverse Event|1
1002052|NCT01436162|2018937|FG001|Randomized Phase|Adverse Event|5
1002053|NCT01436162|2018938|FG002|Randomized Phase|Adverse Event|6
1002054|NCT01436162|2018936|FG000|Randomized Phase|Protocol Violation|4
1002055|NCT01436162|2018937|FG001|Randomized Phase|Protocol Violation|4
1002056|NCT01436162|2018938|FG002|Randomized Phase|Protocol Violation|2
1002057|NCT01436162|2018936|FG000|Randomized Phase|Withdrawal by Subject|16
1002058|NCT01436162|2018937|FG001|Randomized Phase|Withdrawal by Subject|9
1002059|NCT01436162|2018938|FG002|Randomized Phase|Withdrawal by Subject|8
1002060|NCT01436162|2018936|FG000|Randomized Phase|Lost to Follow-up|17
1002061|NCT01436162|2018937|FG001|Randomized Phase|Lost to Follow-up|5
1002062|NCT01436162|2018938|FG002|Randomized Phase|Lost to Follow-up|4
1002063|NCT01436162|2018936|FG000|Randomized Phase|Lack of Efficacy|0
1002064|NCT01436162|2018937|FG001|Randomized Phase|Lack of Efficacy|1
1002065|NCT01436162|2018938|FG002|Randomized Phase|Lack of Efficacy|1
1002066|NCT01436162|2018936|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
1002067|NCT01436162|2018937|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
1002068|NCT01436162|2018938|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
914175|NCT00813488|1891934|FG001|Open-label Extension|Withdrawal by Subject|2
914176|NCT00813488|1891933|FG000|Open-label Extension|Protocol Violation|1
914177|NCT00813488|1891934|FG001|Open-label Extension|Protocol Violation|2
914178|NCT00813488|1891933|FG000|Open-label Extension|Non-compliance study medication|4
1002069|NCT01436162|2018936|FG000|Randomized Phase|Other|2
1002070|NCT01436162|2018937|FG001|Randomized Phase|Other|5
1002071|NCT01436162|2018938|FG002|Randomized Phase|Other|4
1002072|NCT01436175|2018946|FG000|Overall Study|Adverse Event|111
1002073|NCT01436175|2018946|FG000|Overall Study|Protocol Violation|49
1002074|NCT01436175|2018946|FG000|Overall Study|Withdrawal by Subject|108
1002075|NCT01436175|2018946|FG000|Overall Study|Lost to Follow-up|89
1002076|NCT01436175|2018946|FG000|Overall Study|Lack of Efficacy|24
1002077|NCT01436175|2018946|FG000|Overall Study|Met blood pressure or pulse withdrawal|63
1002078|NCT01436175|2018946|FG000|Overall Study|Other|826
1002079|NCT01436201|2018951|FG000|Overall Study|Adverse Event|2
1002080|NCT01436201|2018951|FG000|Overall Study|Withdrawal by Subject|1
1002081|NCT01436201|2018951|FG000|Overall Study|Protocol Violation|1
1002082|NCT01436253|2018957|FG000|Overall Study|Lost to Follow-up|182
1002083|NCT01436253|2018957|FG000|Overall Study|Not meeting all eligibility criteria|117
1002084|NCT01436305|2018984|FG000|Overall Study|Death|1
1002085|NCT01436305|2018985|FG001|Overall Study|Death|0
1002086|NCT01436305|2018986|FG002|Overall Study|Death|0
1002087|NCT01436305|2018984|FG000|Overall Study|Lost to Follow-up|0
1002088|NCT01436305|2018985|FG001|Overall Study|Lost to Follow-up|1
1002089|NCT01436305|2018986|FG002|Overall Study|Lost to Follow-up|0
1002090|NCT01436305|2018984|FG000|Overall Study|Withdrawal by Subject|1
1002091|NCT01436305|2018985|FG001|Overall Study|Withdrawal by Subject|3
1002092|NCT01436305|2018986|FG002|Overall Study|Withdrawal by Subject|0
1002093|NCT01436357|2018996|FG000|Overall Study|Death|5
1002094|NCT01436357|2018997|FG001|Overall Study|Death|1
1002095|NCT01436357|2018996|FG000|Overall Study|Enrolled but not vaccinated|1
1002096|NCT01436357|2018997|FG001|Overall Study|Enrolled but not vaccinated|1
1002097|NCT01436357|2018996|FG000|Overall Study|Incarceration|18
1002098|NCT01436357|2018997|FG001|Overall Study|Incarceration|20
1002099|NCT01436357|2018996|FG000|Overall Study|Lost to Follow-up|67
1002100|NCT01436357|2018997|FG001|Overall Study|Lost to Follow-up|61
1002101|NCT01436357|2018996|FG000|Overall Study|Protocol Violation|1
1002102|NCT01436357|2018997|FG001|Overall Study|Protocol Violation|0
1002103|NCT01436357|2018996|FG000|Overall Study|Withdrawal by Subject|26
1002104|NCT01436357|2018997|FG001|Overall Study|Withdrawal by Subject|38
1002105|NCT01436357|2018996|FG000|Overall Study|Physician Decision|3
1002106|NCT01436357|2018997|FG001|Overall Study|Physician Decision|4
1002107|NCT01436357|2018996|FG000|Overall Study|Moved out of area|1
1002108|NCT01436357|2018997|FG001|Overall Study|Moved out of area|2
1002109|NCT01436357|2018996|FG000|Overall Study|Subject in rehab|0
1002110|NCT01436357|2018997|FG001|Overall Study|Subject in rehab|1
1002111|NCT01436370|2019011|FG000|Overall Study|Lost to Follow-up|0
1002112|NCT01436370|2019012|FG001|Overall Study|Lost to Follow-up|0
1002113|NCT01436370|2019013|FG002|Overall Study|Lost to Follow-up|0
1002114|NCT01436370|2019014|FG003|Overall Study|Lost to Follow-up|0
1002115|NCT01436370|2019015|FG004|Overall Study|Lost to Follow-up|1
1002116|NCT01436370|2019016|FG005|Overall Study|Lost to Follow-up|0
1002117|NCT01436370|2019017|FG006|Overall Study|Lost to Follow-up|0
1002118|NCT01436370|2019018|FG007|Overall Study|Lost to Follow-up|0
1002119|NCT01436396|2019046|FG000|Overall Study|Protocol Violation|7
1002120|NCT01436396|2019047|FG001|Overall Study|Protocol Violation|5
1002121|NCT01436396|2019046|FG000|Overall Study|Adverse Event|1
1002122|NCT01436396|2019047|FG001|Overall Study|Adverse Event|2
1002123|NCT01436396|2019046|FG000|Overall Study|Withdrawal by Subject|19
1002124|NCT01436396|2019047|FG001|Overall Study|Withdrawal by Subject|29
1002125|NCT01436396|2019046|FG000|Overall Study|Serious adverse event|2
1002126|NCT01436396|2019047|FG001|Overall Study|Serious adverse event|3
1002127|NCT01436396|2019046|FG000|Overall Study|Lost to Follow-up|3
1002128|NCT01436396|2019047|FG001|Overall Study|Lost to Follow-up|3
1002129|NCT01436500|2019059|FG000|Overall Study|Death|1
1002130|NCT01436500|2019060|FG001|Overall Study|Death|0
914179|NCT00813488|1891934|FG001|Open-label Extension|Non-compliance study medication|0
914180|NCT00813488|1891933|FG000|Open-label Extension|Non-compliance study procedures|2
914181|NCT00813488|1891934|FG001|Open-label Extension|Non-compliance study procedures|1
914182|NCT00813488|1891933|FG000|Open-label Extension|Other|1
914183|NCT00813488|1891934|FG001|Open-label Extension|Other|0
914184|NCT00813592|1891944|FG000|Overall Study|Disease assessment was not completed per|2
914185|NCT00813709|1891952|FG000|Double Blind Period|Adverse Event|4
914186|NCT00813709|1891953|FG001|Double Blind Period|Adverse Event|1
914187|NCT00813709|1891954|FG002|Double Blind Period|Adverse Event|4
914188|NCT00813709|1891955|FG003|Double Blind Period|Adverse Event|0
914189|NCT00813709|1891956|FG004|Double Blind Period|Adverse Event|0
914190|NCT00813709|1891957|FG005|Double Blind Period|Adverse Event|0
914191|NCT00813709|1891952|FG000|Double Blind Period|Lost to Follow-up|3
914192|NCT00813709|1891953|FG001|Double Blind Period|Lost to Follow-up|2
914193|NCT00813709|1891954|FG002|Double Blind Period|Lost to Follow-up|2
1002131|NCT01436500|2019061|FG002|Overall Study|Death|0
1002132|NCT01436500|2019062|FG003|Overall Study|Death|0
1002133|NCT01436500|2019063|FG004|Overall Study|Death|0
1002134|NCT01436500|2019059|FG000|Overall Study|Adverse Event|0
1002135|NCT01436500|2019060|FG001|Overall Study|Adverse Event|2
1002136|NCT01436500|2019061|FG002|Overall Study|Adverse Event|2
1002137|NCT01436500|2019062|FG003|Overall Study|Adverse Event|0
1002138|NCT01436500|2019063|FG004|Overall Study|Adverse Event|1
1002139|NCT01436500|2019059|FG000|Overall Study|Withdrawal by Subject|0
1002140|NCT01436500|2019060|FG001|Overall Study|Withdrawal by Subject|0
1002141|NCT01436500|2019061|FG002|Overall Study|Withdrawal by Subject|2
1002142|NCT01436500|2019062|FG003|Overall Study|Withdrawal by Subject|0
1002143|NCT01436500|2019063|FG004|Overall Study|Withdrawal by Subject|2
1002144|NCT01436500|2019059|FG000|Overall Study|Physician Decision|0
1002145|NCT01436500|2019060|FG001|Overall Study|Physician Decision|0
1002146|NCT01436500|2019061|FG002|Overall Study|Physician Decision|1
1002147|NCT01436500|2019062|FG003|Overall Study|Physician Decision|0
1002148|NCT01436500|2019063|FG004|Overall Study|Physician Decision|0
1002149|NCT01436500|2019059|FG000|Overall Study|liver transplant|1
1002150|NCT01436500|2019060|FG001|Overall Study|liver transplant|0
1002151|NCT01436500|2019061|FG002|Overall Study|liver transplant|0
1002152|NCT01436500|2019062|FG003|Overall Study|liver transplant|0
1002153|NCT01436500|2019063|FG004|Overall Study|liver transplant|0
1002154|NCT01436500|2019059|FG000|Overall Study|initiation of dialysis|0
1002155|NCT01436500|2019060|FG001|Overall Study|initiation of dialysis|0
1002156|NCT01436500|2019061|FG002|Overall Study|initiation of dialysis|0
1002157|NCT01436500|2019062|FG003|Overall Study|initiation of dialysis|0
1002158|NCT01436500|2019063|FG004|Overall Study|initiation of dialysis|1
1002159|NCT01436500|2019059|FG000|Overall Study|discontinued study drug|1
1002160|NCT01436500|2019060|FG001|Overall Study|discontinued study drug|0
1002161|NCT01436500|2019061|FG002|Overall Study|discontinued study drug|0
1002162|NCT01436500|2019062|FG003|Overall Study|discontinued study drug|0
1002163|NCT01436500|2019063|FG004|Overall Study|discontinued study drug|0
1002164|NCT01436500|2019059|FG000|Overall Study|Other|0
1002165|NCT01436500|2019060|FG001|Overall Study|Other|1
1002166|NCT01436500|2019061|FG002|Overall Study|Other|0
1002167|NCT01436500|2019062|FG003|Overall Study|Other|1
1002168|NCT01436500|2019063|FG004|Overall Study|Other|0
1002169|NCT01436643|2019088|FG000|2-week Pre-treatment|Abnormal test result|0
1002170|NCT01436643|2019089|FG001|2-week Pre-treatment|Abnormal test result|0
1002171|NCT01436643|2019090|FG002|2-week Pre-treatment|Abnormal test result|0
1002172|NCT01436643|2019091|FG003|2-week Pre-treatment|Abnormal test result|1
1002173|NCT01436643|2019088|FG000|2-week Pre-treatment|Adverse Event|0
1002174|NCT01436643|2019089|FG001|2-week Pre-treatment|Adverse Event|0
1002175|NCT01436643|2019090|FG002|2-week Pre-treatment|Adverse Event|0
1002176|NCT01436643|2019091|FG003|2-week Pre-treatment|Adverse Event|5
1002177|NCT01436643|2019088|FG000|2-week Pre-treatment|Protocol Violation|0
1002178|NCT01436643|2019089|FG001|2-week Pre-treatment|Protocol Violation|0
1002179|NCT01436643|2019090|FG002|2-week Pre-treatment|Protocol Violation|0
1002180|NCT01436643|2019091|FG003|2-week Pre-treatment|Protocol Violation|4
1002181|NCT01436643|2019088|FG000|Core Phase (16 Weeks)|Adverse Event|0
1002182|NCT01436643|2019089|FG001|Core Phase (16 Weeks)|Adverse Event|3
1002183|NCT01436643|2019090|FG002|Core Phase (16 Weeks)|Adverse Event|1
1002184|NCT01436643|2019091|FG003|Core Phase (16 Weeks)|Adverse Event|0
1002185|NCT01436643|2019088|FG000|Core Phase (16 Weeks)|Abnormal Test result|0
1002186|NCT01436643|2019089|FG001|Core Phase (16 Weeks)|Abnormal Test result|0
1002187|NCT01436643|2019090|FG002|Core Phase (16 Weeks)|Abnormal Test result|1
1002188|NCT01436643|2019091|FG003|Core Phase (16 Weeks)|Abnormal Test result|0
1002189|NCT01436643|2019088|FG000|Core Phase (16 Weeks)|Protocol Violation|1
1002190|NCT01436643|2019089|FG001|Core Phase (16 Weeks)|Protocol Violation|1
1002191|NCT01436643|2019090|FG002|Core Phase (16 Weeks)|Protocol Violation|1
1002192|NCT01436643|2019091|FG003|Core Phase (16 Weeks)|Protocol Violation|0
1002193|NCT01437111|2019122|FG000|Overall Study|Adverse Event|2
1002194|NCT01437111|2019122|FG000|Overall Study|Withdrawal by Subject|4
1002195|NCT01437111|2019122|FG000|Overall Study|Not reported|5
1002196|NCT01437111|2019122|FG000|Overall Study|Physician Decision|1
1002197|NCT01437111|2019122|FG000|Overall Study|Lost to Follow-up|5
1002198|NCT01437111|2019122|FG000|Overall Study|Protocol Violation|1
1002199|NCT01437267|2019139|FG000|Overall Study|Withdrawal by Subject|0
1002200|NCT01437267|2019140|FG001|Overall Study|Withdrawal by Subject|0
1002201|NCT01437267|2019141|FG002|Overall Study|Withdrawal by Subject|0
1002202|NCT01437267|2019142|FG003|Overall Study|Withdrawal by Subject|1
1002203|NCT01437267|2019143|FG004|Overall Study|Withdrawal by Subject|0
1002204|NCT01437267|2019144|FG005|Overall Study|Withdrawal by Subject|0
1002205|NCT01437267|2019139|FG000|Overall Study|Protocol Violation|0
1002206|NCT01437267|2019140|FG001|Overall Study|Protocol Violation|1
1002207|NCT01437267|2019141|FG002|Overall Study|Protocol Violation|0
1002208|NCT01437267|2019142|FG003|Overall Study|Protocol Violation|0
1002209|NCT01437267|2019143|FG004|Overall Study|Protocol Violation|0
1002210|NCT01437267|2019144|FG005|Overall Study|Protocol Violation|0
1002211|NCT01437319|2019158|FG000|Phase I|Lost to Follow-up|2
1002212|NCT01437319|2019159|FG001|Phase I|Lost to Follow-up|0
1002213|NCT01437319|2019160|FG002|Phase I|Lost to Follow-up|0
1002214|NCT01437319|2019158|FG000|Phase I|Protocol Violation|1
1002215|NCT01437319|2019159|FG001|Phase I|Protocol Violation|0
1002216|NCT01437319|2019160|FG002|Phase I|Protocol Violation|0
1002217|NCT01437319|2019158|FG000|Phase I|Study related symptoms/complaints|27
1002218|NCT01437319|2019159|FG001|Phase I|Study related symptoms/complaints|0
1002219|NCT01437319|2019160|FG002|Phase I|Study related symptoms/complaints|0
1002220|NCT01437319|2019158|FG000|Phase I|Withdrawal by Subject|25
1002221|NCT01437319|2019159|FG001|Phase I|Withdrawal by Subject|0
1002222|NCT01437319|2019160|FG002|Phase I|Withdrawal by Subject|0
1002223|NCT01437319|2019158|FG000|Phase II|Withdrawal by Subject|0
1002224|NCT01437319|2019159|FG001|Phase II|Withdrawal by Subject|8
1002225|NCT01437319|2019160|FG002|Phase II|Withdrawal by Subject|16
1002226|NCT01437319|2019158|FG000|Phase II|Lost to Follow-up|0
1002227|NCT01437319|2019159|FG001|Phase II|Lost to Follow-up|7
1002228|NCT01437319|2019160|FG002|Phase II|Lost to Follow-up|2
1002229|NCT01437319|2019158|FG000|Phase II|Study related symptoms/complaints|0
1002230|NCT01437319|2019159|FG001|Phase II|Study related symptoms/complaints|28
1002231|NCT01437319|2019160|FG002|Phase II|Study related symptoms/complaints|19
1002232|NCT01437319|2019158|FG000|Phase II|Protocol Violation|0
1002233|NCT01437319|2019159|FG001|Phase II|Protocol Violation|1
1002234|NCT01437319|2019160|FG002|Phase II|Protocol Violation|0
1002235|NCT01437397|2019174|FG000|Overall Study|Lost to Follow-up|9
1002236|NCT01437397|2019175|FG001|Overall Study|Lost to Follow-up|4
1002237|NCT01437397|2019176|FG002|Overall Study|Lost to Follow-up|2
1002238|NCT01437397|2019177|FG003|Overall Study|Lost to Follow-up|4
1002239|NCT01437397|2019178|FG004|Overall Study|Lost to Follow-up|5
1002240|NCT01437397|2019174|FG000|Overall Study|Withdrawal by Subject|11
1002241|NCT01437397|2019175|FG001|Overall Study|Withdrawal by Subject|12
1002242|NCT01437397|2019176|FG002|Overall Study|Withdrawal by Subject|24
1002243|NCT01437397|2019177|FG003|Overall Study|Withdrawal by Subject|11
1002244|NCT01437397|2019178|FG004|Overall Study|Withdrawal by Subject|22
1002245|NCT01437397|2019174|FG000|Overall Study|Protocol Violation|10
1002246|NCT01437397|2019175|FG001|Overall Study|Protocol Violation|12
1002247|NCT01437397|2019176|FG002|Overall Study|Protocol Violation|13
1002248|NCT01437397|2019177|FG003|Overall Study|Protocol Violation|21
1002249|NCT01437397|2019178|FG004|Overall Study|Protocol Violation|19
1002250|NCT01437397|2019174|FG000|Overall Study|Lack of Efficacy|5
1002251|NCT01437397|2019175|FG001|Overall Study|Lack of Efficacy|4
1002252|NCT01437397|2019176|FG002|Overall Study|Lack of Efficacy|8
1002253|NCT01437397|2019177|FG003|Overall Study|Lack of Efficacy|10
1002254|NCT01437397|2019178|FG004|Overall Study|Lack of Efficacy|20
1002255|NCT01437397|2019174|FG000|Overall Study|Adverse Event|21
1002256|NCT01437397|2019175|FG001|Overall Study|Adverse Event|22
1002257|NCT01437397|2019176|FG002|Overall Study|Adverse Event|16
1002258|NCT01437397|2019177|FG003|Overall Study|Adverse Event|14
1002259|NCT01437397|2019178|FG004|Overall Study|Adverse Event|21
1002260|NCT01437397|2019174|FG000|Overall Study|Site termination/COPD exacerbation/other|10
1002261|NCT01437397|2019175|FG001|Overall Study|Site termination/COPD exacerbation/other|8
1002262|NCT01437397|2019176|FG002|Overall Study|Site termination/COPD exacerbation/other|9
1002263|NCT01437397|2019177|FG003|Overall Study|Site termination/COPD exacerbation/other|9
1002264|NCT01437397|2019178|FG004|Overall Study|Site termination/COPD exacerbation/other|14
1002265|NCT01437423|2019190|FG000|Overall Study|Lost to Follow-up|12
1002266|NCT01437423|2019190|FG000|Overall Study|Off label usage|3
1002267|NCT01437540|2019218|FG000|Overall Study|Not listed below|7
1002268|NCT01437540|2019219|FG001|Overall Study|Not listed below|6
1002269|NCT01437540|2019218|FG000|Overall Study|COPD exacerbation|13
1002270|NCT01437540|2019219|FG001|Overall Study|COPD exacerbation|3
1002271|NCT01437540|2019218|FG000|Overall Study|Lost to Follow-up|3
1002272|NCT01437540|2019219|FG001|Overall Study|Lost to Follow-up|5
1002273|NCT01437540|2019218|FG000|Overall Study|Lack of Efficacy|23
1002274|NCT01437540|2019219|FG001|Overall Study|Lack of Efficacy|11
1002275|NCT01437540|2019218|FG000|Overall Study|Protocol Violation|24
1002276|NCT01437540|2019219|FG001|Overall Study|Protocol Violation|12
1002277|NCT01437540|2019218|FG000|Overall Study|Adverse Event|26
1002278|NCT01437540|2019219|FG001|Overall Study|Adverse Event|13
1002279|NCT01437540|2019218|FG000|Overall Study|Withdrawal by Subject|31
1002280|NCT01437540|2019219|FG001|Overall Study|Withdrawal by Subject|15
1002281|NCT01437878|2019241|FG000|Overall Study|Withdrawal by Subject|1
1002282|NCT01437878|2019242|FG001|Overall Study|Withdrawal by Subject|0
1002283|NCT01437943|2019250|FG000|Overall Study|Aliskiren trials terminated by Novartis|4
1002284|NCT01437943|2019251|FG001|Overall Study|Aliskiren trials terminated by Novartis|2
1002285|NCT01437943|2019250|FG000|Overall Study|Subject expressed pregnancy plans|1
1002286|NCT01437943|2019251|FG001|Overall Study|Subject expressed pregnancy plans|0
1002287|NCT01437943|2019250|FG000|Overall Study|Adverse Event|2
1002288|NCT01437943|2019251|FG001|Overall Study|Adverse Event|0
1002289|NCT01437995|2019260|FG000|Overall Study|Lost to Follow-up|11
1002290|NCT01437995|2019261|FG001|Overall Study|Lost to Follow-up|18
1002291|NCT01437995|2019262|FG002|Overall Study|Lost to Follow-up|20
1002292|NCT01438060|2019281|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
1002293|NCT01438060|2019282|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
1002294|NCT01438060|2019281|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
1002295|NCT01438060|2019282|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
1002296|NCT01438060|2019281|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
1002297|NCT01438060|2019282|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
1002298|NCT01438060|2019281|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
1002299|NCT01438060|2019282|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
1002300|NCT01438060|2019281|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0
1002301|NCT01438060|2019282|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2
1002302|NCT01438060|2019281|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
1002303|NCT01438060|2019282|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
1002304|NCT01438060|2019281|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15
1002305|NCT01438060|2019282|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16
1002306|NCT01438060|2019281|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
1002307|NCT01438060|2019282|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
1002308|NCT01438060|2019281|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
1002309|NCT01438060|2019282|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
1002310|NCT01438060|2019281|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
1002311|NCT01438060|2019282|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
1002312|NCT01438060|2019281|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
1002313|NCT01438060|2019282|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
1002314|NCT01438060|2019281|FG000|Extension Phase: Week 10 to Week 130|Death|22
1002315|NCT01438060|2019282|FG001|Extension Phase: Week 10 to Week 130|Death|12
1002316|NCT01438060|2019281|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7
1002317|NCT01438060|2019282|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15
1002318|NCT01438060|2019281|FG000|On Study Beyond Week 140|Adverse Event|0
1002319|NCT01438060|2019282|FG001|On Study Beyond Week 140|Adverse Event|2
1002320|NCT01438060|2019281|FG000|On Study Beyond Week 140|Lack of Efficacy|0
1002321|NCT01438060|2019282|FG001|On Study Beyond Week 140|Lack of Efficacy|1
1002322|NCT01438060|2019281|FG000|On Study Beyond Week 140|Withdrawal by Subject|0
1002323|NCT01438060|2019282|FG001|On Study Beyond Week 140|Withdrawal by Subject|1
1002324|NCT01438060|2019281|FG000|On Study Beyond Week 140|Death|0
1002325|NCT01438060|2019282|FG001|On Study Beyond Week 140|Death|1
1002326|NCT01438060|2019281|FG000|On Study Beyond Week 140|Other Reason|0
1002327|NCT01438060|2019282|FG001|On Study Beyond Week 140|Other Reason|3
1002328|NCT01438151|2019293|FG000|Overall Study|study terminated|8
1002329|NCT01438177|2019297|FG000|Overall Study|Withdrawal by Subject|1
1002330|NCT01438177|2019297|FG000|Overall Study|Initiation of new therapy|1
1002331|NCT01438294|2019307|FG000|Overall Study|Lost to Follow-up|3
1002332|NCT01438294|2019308|FG001|Overall Study|Lost to Follow-up|7
1002333|NCT01438307|2019316|FG000|Overall Study|Death|1
1002334|NCT01438307|2019317|FG001|Overall Study|Death|1
1002335|NCT01438411|2019323|FG000|Overall Study|Adverse Event|8
1002336|NCT01438411|2019323|FG000|Overall Study|Lost to Follow-up|1
1002337|NCT01438411|2019323|FG000|Overall Study|Lack of Efficacy|1
1002338|NCT01438411|2019323|FG000|Overall Study|Withdrawal by Subject|3
1002339|NCT01438424|2019327|FG000|Overall Study|Continuing treatment|29
1002340|NCT01438424|2019327|FG000|Overall Study|Minimal virologic response|95
1002341|NCT01438424|2019327|FG000|Overall Study|Not identified|55
1002342|NCT01438424|2019327|FG000|Overall Study|Withdrawal by Subject|104
1002343|NCT01438424|2019327|FG000|Overall Study|Progression of chronic hepatitis B|22
1002344|NCT01438424|2019327|FG000|Overall Study|Death|22
1002345|NCT01438424|2019327|FG000|Overall Study|Adverse Event|17
1002346|NCT01438424|2019327|FG000|Overall Study|Lost to Follow-up|17
1002347|NCT01438424|2019327|FG000|Overall Study|Abnormal laboratory test result|14
1002348|NCT01438424|2019327|FG000|Overall Study|Need for drug prohibited by protocol|14
1002349|NCT01438424|2019327|FG000|Overall Study|Pregnancy|7
1002350|NCT01438424|2019327|FG000|Overall Study|No longer met inclusion criteria|1
1002351|NCT01438424|2019327|FG000|Overall Study|Participant noncompliance|20
1002352|NCT01438476|2019343|FG000|Overall Study|Protocol Violation|1
1002353|NCT01438476|2019344|FG001|Overall Study|Protocol Violation|0
1002354|NCT01438476|2019343|FG000|Overall Study|Withdrawal by Subject|1
1002355|NCT01438476|2019344|FG001|Overall Study|Withdrawal by Subject|0
1002356|NCT01438476|2019343|FG000|Overall Study|No Surgery- Disease|8
1002357|NCT01438476|2019344|FG001|Overall Study|No Surgery- Disease|10
1002358|NCT01438476|2019343|FG000|Overall Study|Communication barrier|0
1002359|NCT01438476|2019344|FG001|Overall Study|Communication barrier|1
1002360|NCT01438489|2019353|FG000|Overall Study|Lost to Follow-up|4
1002361|NCT01438489|2019354|FG001|Overall Study|Lost to Follow-up|2
1002362|NCT01438489|2019355|FG002|Overall Study|Lost to Follow-up|2
1002363|NCT01438489|2019353|FG000|Overall Study|Withdrawal by Subject|11
1002364|NCT01438489|2019354|FG001|Overall Study|Withdrawal by Subject|3
1002365|NCT01438489|2019355|FG002|Overall Study|Withdrawal by Subject|8
1002366|NCT01438489|2019353|FG000|Overall Study|Death|0
1002367|NCT01438489|2019354|FG001|Overall Study|Death|0
1002368|NCT01438489|2019355|FG002|Overall Study|Death|1
1002369|NCT01438489|2019353|FG000|Overall Study|Sponsor decision|4
1002370|NCT01438489|2019354|FG001|Overall Study|Sponsor decision|1
1002371|NCT01438489|2019355|FG002|Overall Study|Sponsor decision|4
1002372|NCT01438489|2019353|FG000|Overall Study|Subject choice/Subject moved|2
1002373|NCT01438489|2019354|FG001|Overall Study|Subject choice/Subject moved|1
1002374|NCT01438489|2019355|FG002|Overall Study|Subject choice/Subject moved|1
1002375|NCT01438489|2019353|FG000|Overall Study|Investigator decision|0
1002376|NCT01438489|2019354|FG001|Overall Study|Investigator decision|1
1002377|NCT01438489|2019355|FG002|Overall Study|Investigator decision|0
1002378|NCT01438489|2019353|FG000|Overall Study|AE/SAEs|2
1002379|NCT01438489|2019354|FG001|Overall Study|AE/SAEs|1
1002380|NCT01438489|2019355|FG002|Overall Study|AE/SAEs|1
1002381|NCT01438489|2019353|FG000|Overall Study|Received prohibited medication|1
1002382|NCT01438489|2019354|FG001|Overall Study|Received prohibited medication|0
1002383|NCT01438489|2019355|FG002|Overall Study|Received prohibited medication|0
1002384|NCT01438489|2019353|FG000|Overall Study|Did not complete all 3 follow-up visits|2
1002385|NCT01438489|2019354|FG001|Overall Study|Did not complete all 3 follow-up visits|5
1002386|NCT01438489|2019355|FG002|Overall Study|Did not complete all 3 follow-up visits|2
1002387|NCT01438489|2019353|FG000|Overall Study|Inadequate venous access|0
1002388|NCT01438489|2019354|FG001|Overall Study|Inadequate venous access|2
1002389|NCT01438489|2019355|FG002|Overall Study|Inadequate venous access|0
1002390|NCT01438541|2019365|FG000|Overall Study|Physician Decision|1
1002391|NCT01438541|2019365|FG000|Overall Study|Withdrawal by Subject|1
1002392|NCT01438541|2019365|FG000|Overall Study|discharge from the hospital|5
1002393|NCT01438814|2019377|FG000|Overall Study|Adverse Event|3
1002394|NCT01438814|2019378|FG001|Overall Study|Adverse Event|3
1002395|NCT01438814|2019377|FG000|Overall Study|Protocol Violation|1
1002396|NCT01438814|2019378|FG001|Overall Study|Protocol Violation|2
1002397|NCT01438814|2019377|FG000|Overall Study|Lost to Follow-up|4
1002398|NCT01438814|2019378|FG001|Overall Study|Lost to Follow-up|3
1002399|NCT01438814|2019377|FG000|Overall Study|Withdrawal by Subject|4
1002400|NCT01438814|2019378|FG001|Overall Study|Withdrawal by Subject|2
1002401|NCT01438814|2019377|FG000|Overall Study|Other|2
1002402|NCT01438814|2019378|FG001|Overall Study|Other|4
1002403|NCT01438840|2019386|FG000|Core Study|Adverse Event|0
1002404|NCT01438840|2019387|FG001|Core Study|Adverse Event|3
1002405|NCT01438840|2019388|FG002|Core Study|Adverse Event|0
1002406|NCT01438840|2019386|FG000|Core Study|Lack of Efficacy|15
1002407|NCT01438840|2019387|FG001|Core Study|Lack of Efficacy|7
1002408|NCT01438840|2019388|FG002|Core Study|Lack of Efficacy|0
1002409|NCT01438840|2019386|FG000|Core Study|Withdrawal of consent|1
1002410|NCT01438840|2019387|FG001|Core Study|Withdrawal of consent|0
1002411|NCT01438840|2019388|FG002|Core Study|Withdrawal of consent|0
1002412|NCT01438840|2019386|FG000|Extension Phase|Adverse Event|0
1002413|NCT01438840|2019387|FG001|Extension Phase|Adverse Event|0
1002414|NCT01438840|2019388|FG002|Extension Phase|Adverse Event|3
1002415|NCT01438840|2019386|FG000|Extension Phase|Lost to Follow-up|0
1002416|NCT01438840|2019387|FG001|Extension Phase|Lost to Follow-up|0
1002417|NCT01438840|2019388|FG002|Extension Phase|Lost to Follow-up|1
1002418|NCT01438840|2019386|FG000|Extension Phase|Withdrawal by Subject|0
1002419|NCT01438840|2019387|FG001|Extension Phase|Withdrawal by Subject|0
1002420|NCT01438840|2019388|FG002|Extension Phase|Withdrawal by Subject|3
1002421|NCT01438840|2019386|FG000|Extension Phase|Lack of Efficacy|0
1002422|NCT01438840|2019387|FG001|Extension Phase|Lack of Efficacy|0
1002423|NCT01438840|2019388|FG002|Extension Phase|Lack of Efficacy|2
1002424|NCT01438840|2019386|FG000|Extension Phase|Other|0
1002425|NCT01438840|2019387|FG001|Extension Phase|Other|0
1002426|NCT01438840|2019388|FG002|Extension Phase|Other|1
1002427|NCT01438957|2019400|FG000|Overall Study|Physician Decision|1
1002428|NCT01438957|2019401|FG001|Overall Study|Physician Decision|1
1002429|NCT01438957|2019402|FG002|Overall Study|Physician Decision|0
1002430|NCT01438957|2019403|FG003|Overall Study|Physician Decision|1
1002431|NCT01438957|2019404|FG004|Overall Study|Physician Decision|0
1002432|NCT01438996|2019419|FG000|Overall Study|Not meeting Inclusion Criteria|4
1002433|NCT01438996|2019420|FG001|Overall Study|Not meeting Inclusion Criteria|1
1002434|NCT01438996|2019421|FG002|Overall Study|Not meeting Inclusion Criteria|0
1002435|NCT01439009|2019431|FG000|Overall Study|Physician Decision|5
1002436|NCT01439009|2019432|FG001|Overall Study|Physician Decision|3
1002437|NCT01439009|2019431|FG000|Overall Study|Protocol Violation|2
1002438|NCT01439009|2019432|FG001|Overall Study|Protocol Violation|0
1002439|NCT01439009|2019431|FG000|Overall Study|Deviation of exclusion criteria|1
1002440|NCT01439009|2019432|FG001|Overall Study|Deviation of exclusion criteria|0
1002441|NCT01439074|2019444|FG000|Overall Study|Lost to Follow-up|3
1002442|NCT01439074|2019445|FG001|Overall Study|Lost to Follow-up|4
1002443|NCT01439074|2019444|FG000|Overall Study|Subject shedding|1
1002444|NCT01439074|2019445|FG001|Overall Study|Subject shedding|0
1002445|NCT01439074|2019444|FG000|Overall Study|Withdrawal by Subject|1
1002446|NCT01439074|2019445|FG001|Overall Study|Withdrawal by Subject|5
1002447|NCT01439074|2019444|FG000|Overall Study|Other|4
1002448|NCT01439074|2019445|FG001|Overall Study|Other|4
1002449|NCT01439126|2019457|FG000|Overall Study|Adverse Event|2
1002450|NCT01439126|2019458|FG001|Overall Study|Adverse Event|0
1002451|NCT01439126|2019457|FG000|Overall Study|Withdrawal by Subject|5
1002452|NCT01439126|2019458|FG001|Overall Study|Withdrawal by Subject|21
1002453|NCT01439126|2019457|FG000|Overall Study|Protocol Violation|6
1002454|NCT01439126|2019458|FG001|Overall Study|Protocol Violation|4
1002455|NCT01439126|2019457|FG000|Overall Study|Lost to Follow-up|6
1002456|NCT01439126|2019458|FG001|Overall Study|Lost to Follow-up|3
1002457|NCT01439126|2019457|FG000|Overall Study|Other-Use of prohibited treatment|0
1002458|NCT01439126|2019458|FG001|Overall Study|Other-Use of prohibited treatment|2
1002459|NCT01439126|2019457|FG000|Overall Study|Other-Miscellaneous|12
1002460|NCT01439126|2019458|FG001|Overall Study|Other-Miscellaneous|12
1002461|NCT01439165|2019466|FG000|Overall Study|Protocol Violation|3
1002462|NCT01439165|2019467|FG001|Overall Study|Protocol Violation|0
1002463|NCT01439165|2019466|FG000|Overall Study|Lost to Follow-up|11
1002464|NCT01439165|2019467|FG001|Overall Study|Lost to Follow-up|1
1002465|NCT01439165|2019466|FG000|Overall Study|Withdrawal by Subject|7
1002466|NCT01439165|2019467|FG001|Overall Study|Withdrawal by Subject|1
1002467|NCT01439204|2019475|FG000|Overall Study|Withdrawal by Subject|0
1002468|NCT01439204|2019476|FG001|Overall Study|Withdrawal by Subject|1
1002469|NCT01439204|2019475|FG000|Overall Study|Lost to Follow-up|0
1002470|NCT01439204|2019476|FG001|Overall Study|Lost to Follow-up|2
1002471|NCT01439204|2019475|FG000|Overall Study|No longer meets study criteria|1
1002472|NCT01439204|2019476|FG001|Overall Study|No longer meets study criteria|0
1002473|NCT01439204|2019475|FG000|Overall Study|poor/non-compliance|3
1002474|NCT01439204|2019476|FG001|Overall Study|poor/non-compliance|0
1002475|NCT01439282|2019484|FG000|Overall Study|Adverse Event|5
1002476|NCT01439282|2019485|FG001|Overall Study|Adverse Event|0
1002477|NCT01439282|2019484|FG000|Overall Study|Withdrawal by Subject|2
1002478|NCT01439282|2019485|FG001|Overall Study|Withdrawal by Subject|0
1002479|NCT01439282|2019484|FG000|Overall Study|Other|1
1002480|NCT01439282|2019485|FG001|Overall Study|Other|1
1002481|NCT01439360|2019494|FG000|Overall Study|Adverse Event|4
1002482|NCT01439360|2019495|FG001|Overall Study|Adverse Event|16
1002483|NCT01439360|2019494|FG000|Overall Study|Lost to Follow-up|43
1002484|NCT01439360|2019495|FG001|Overall Study|Lost to Follow-up|58
1002485|NCT01439360|2019494|FG000|Overall Study|Others|10
1002486|NCT01439360|2019495|FG001|Overall Study|Others|5
1002487|NCT01439360|2019494|FG000|Overall Study|Protocol Violation|1
1002488|NCT01439360|2019495|FG001|Overall Study|Protocol Violation|0
1002489|NCT01439360|2019494|FG000|Overall Study|Withdrawal by Subject|140
1002490|NCT01439360|2019495|FG001|Overall Study|Withdrawal by Subject|129
1002491|NCT01439373|2019503|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
1002492|NCT01439373|2019504|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
1002493|NCT01439373|2019503|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
1002494|NCT01439373|2019504|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
1002495|NCT01439555|2019514|FG000|Overall Study|Protocol Violation|1
1002496|NCT01439568|2019520|FG000|Overall Study|Lost to Follow-up|1
1002497|NCT01439568|2019521|FG001|Overall Study|Lost to Follow-up|0
1002498|NCT01439568|2019520|FG000|Overall Study|Withdrawal by Subject|2
1002499|NCT01439568|2019521|FG001|Overall Study|Withdrawal by Subject|2
1002500|NCT01439711|2019552|FG000|Overall Study|Ineligible|13
1002501|NCT01439711|2019552|FG000|Overall Study|Cancel|3
1002502|NCT01439711|2019552|FG000|Overall Study|Progression Prior to Beginning Tx|1
1002503|NCT01439711|2019552|FG000|Overall Study|Adverse Event|5
1002504|NCT01439711|2019552|FG000|Overall Study|Withdrawal by Subject|3
1002505|NCT01439711|2019552|FG000|Overall Study|Progression During Active Tx|3
1002506|NCT01439711|2019552|FG000|Overall Study|Noncompliance|3
1002507|NCT01439711|2019552|FG000|Overall Study|No MRI|9
1002508|NCT01439724|2019558|FG000|Overall Study|missing consultation|9
1002509|NCT01439724|2019559|FG001|Overall Study|missing consultation|8
1002510|NCT01439867|2019585|FG000|Overall Study|Non-compliance|0
1002511|NCT01439867|2019586|FG001|Overall Study|Non-compliance|1
1002512|NCT01439867|2019585|FG000|Overall Study|Withdrawal by Subject|1
1002513|NCT01439867|2019586|FG001|Overall Study|Withdrawal by Subject|2
1002514|NCT01439867|2019585|FG000|Overall Study|Administrative Decision|4
1002515|NCT01439867|2019586|FG001|Overall Study|Administrative Decision|5
1002516|NCT01439867|2019585|FG000|Overall Study|Protocol-specified Criteria|1
1002517|NCT01439867|2019586|FG001|Overall Study|Protocol-specified Criteria|0
1002518|NCT01439880|2019596|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
1002519|NCT01439880|2019597|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
1002520|NCT01439880|2019596|FG000|SOC-controlled Period (Year 1)|Death|2
1002521|NCT01439880|2019597|FG001|SOC-controlled Period (Year 1)|Death|1
1002522|NCT01439880|2019596|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0
1002523|NCT01439880|2019597|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1
1002524|NCT01439880|2019596|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10
1002525|NCT01439880|2019597|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5
1002526|NCT01439880|2019596|FG000|SOC-controlled Period (Year 1)|Other|8
1002527|NCT01439880|2019597|FG001|SOC-controlled Period (Year 1)|Other|13
1002528|NCT01439880|2019596|FG000|SOC-controlled Period (Year 1)|Reason Missing|0
1002529|NCT01439880|2019597|FG001|SOC-controlled Period (Year 1)|Reason Missing|2
1002530|NCT01439880|2019596|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
1002531|NCT01439880|2019597|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
1002532|NCT01439880|2019596|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
1002533|NCT01439880|2019597|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
1002534|NCT01439880|2019596|FG000|All-IP Period (Years 2 to 5)|Death|3
1002535|NCT01439880|2019597|FG001|All-IP Period (Years 2 to 5)|Death|13
1002536|NCT01439880|2019596|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1
1002537|NCT01439880|2019597|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0
1002538|NCT01439880|2019596|FG000|All-IP Period (Years 2 to 5)|Other|14
1002539|NCT01439880|2019597|FG001|All-IP Period (Years 2 to 5)|Other|31
1002540|NCT01439880|2019596|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1
1002541|NCT01439880|2019597|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0
1002542|NCT01439945|2019617|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3
1002543|NCT01439945|2019618|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3
1002544|NCT01439945|2019619|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3
1002545|NCT01439945|2019620|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1
1002546|NCT01439945|2019617|FG000|Double-Blind Treatment Phase|Ineligible|1
1002547|NCT01439945|2019618|FG001|Double-Blind Treatment Phase|Ineligible|2
1002548|NCT01439945|2019619|FG002|Double-Blind Treatment Phase|Ineligible|0
1002549|NCT01439945|2019620|FG003|Double-Blind Treatment Phase|Ineligible|1
1002550|NCT01439971|2019636|FG000|Overall Study|Required number in cohort dosed|0
1002551|NCT01439971|2019637|FG001|Overall Study|Required number in cohort dosed|1
1002552|NCT01439971|2019638|FG002|Overall Study|Required number in cohort dosed|2
1002553|NCT01439971|2019639|FG003|Overall Study|Required number in cohort dosed|0
1002554|NCT01439971|2019640|FG004|Overall Study|Required number in cohort dosed|1
1002555|NCT01440049|2019652|FG000|Overall Study|Adverse Event|5
1002556|NCT01440101|2019659|FG000|Overall Study|Adverse Event|2
1002557|NCT01440101|2019660|FG001|Overall Study|Adverse Event|0
1002558|NCT01440101|2019661|FG002|Overall Study|Adverse Event|0
1002559|NCT01440101|2019659|FG000|Overall Study|Withdrawal by Subject|0
1002560|NCT01440101|2019660|FG001|Overall Study|Withdrawal by Subject|3
1002561|NCT01440101|2019661|FG002|Overall Study|Withdrawal by Subject|1
1002562|NCT01440101|2019659|FG000|Overall Study|Other|0
1002563|NCT01440101|2019660|FG001|Overall Study|Other|1
1002564|NCT01440101|2019661|FG002|Overall Study|Other|0
1002565|NCT01440283|2019670|FG000|Overall Study|Death|3
1002566|NCT01440283|2019670|FG000|Overall Study|Withdrawal by Subject|4
1002567|NCT01440283|2019670|FG000|Overall Study|Physician Decision|3
1002568|NCT01440322|2019682|FG000|Overall Study|Discomfort|2
1002569|NCT01440322|2019683|FG001|Overall Study|Discomfort|0
1002570|NCT01440322|2019682|FG000|Overall Study|Biomicroscopy|1
1002571|NCT01440322|2019683|FG001|Overall Study|Biomicroscopy|0
1002572|NCT01440322|2019682|FG000|Overall Study|Symptoms and Problems|1
1002573|NCT01440322|2019683|FG001|Overall Study|Symptoms and Problems|0
1002574|NCT01440322|2019682|FG000|Overall Study|Unacceptable Subjective Vision|1
1002575|NCT01440322|2019683|FG001|Overall Study|Unacceptable Subjective Vision|0
1002576|NCT01440322|2019682|FG000|Overall Study|Other Product Related|1
1002577|NCT01440322|2019683|FG001|Overall Study|Other Product Related|0
1002578|NCT01440322|2019682|FG000|Overall Study|Unrelated Medical Problem|0
1002579|NCT01440322|2019683|FG001|Overall Study|Unrelated Medical Problem|1
1002580|NCT01440322|2019682|FG000|Overall Study|Other Non-Product Related|1
1002581|NCT01440322|2019683|FG001|Overall Study|Other Non-Product Related|0
1002582|NCT01440374|2019692|FG000|Part 1: Open-label Phase|Adverse Event|5
1002583|NCT01440374|2019693|FG001|Part 1: Open-label Phase|Adverse Event|0
1002584|NCT01440374|2019694|FG002|Part 1: Open-label Phase|Adverse Event|0
1002585|NCT01440374|2019695|FG003|Part 1: Open-label Phase|Adverse Event|0
1002586|NCT01440374|2019692|FG000|Part 1: Open-label Phase|Physician Decision|1
1002587|NCT01440374|2019693|FG001|Part 1: Open-label Phase|Physician Decision|0
1002588|NCT01440374|2019694|FG002|Part 1: Open-label Phase|Physician Decision|0
1002589|NCT01440374|2019695|FG003|Part 1: Open-label Phase|Physician Decision|0
1002590|NCT01440374|2019692|FG000|Part 2; Double-blind Phase|Physician Decision|0
1002591|NCT01440374|2019693|FG001|Part 2; Double-blind Phase|Physician Decision|8
1002592|NCT01440374|2019694|FG002|Part 2; Double-blind Phase|Physician Decision|17
1002593|NCT01440374|2019695|FG003|Part 2; Double-blind Phase|Physician Decision|0
1002594|NCT01440374|2019692|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0
1002595|NCT01440374|2019693|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4
1002596|NCT01440374|2019694|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5
1002597|NCT01440374|2019695|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0
1002598|NCT01440374|2019692|FG000|Part 2; Double-blind Phase|Protocol Violation|0
1002599|NCT01440374|2019693|FG001|Part 2; Double-blind Phase|Protocol Violation|0
1002600|NCT01440374|2019694|FG002|Part 2; Double-blind Phase|Protocol Violation|1
1002601|NCT01440374|2019695|FG003|Part 2; Double-blind Phase|Protocol Violation|0
1002602|NCT01440374|2019692|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0
1002603|NCT01440374|2019693|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1
1002604|NCT01440374|2019694|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0
1002605|NCT01440374|2019695|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0
1002606|NCT01440374|2019692|FG000|Part 2; Double-blind Phase|Adverse Event|0
1002607|NCT01440374|2019693|FG001|Part 2; Double-blind Phase|Adverse Event|7
1002608|NCT01440374|2019694|FG002|Part 2; Double-blind Phase|Adverse Event|31
1002609|NCT01440374|2019695|FG003|Part 2; Double-blind Phase|Adverse Event|0
1002610|NCT01440374|2019692|FG000|Part 2; Double-blind Phase|Not treated|0
1002611|NCT01440374|2019693|FG001|Part 2; Double-blind Phase|Not treated|0
1002612|NCT01440374|2019694|FG002|Part 2; Double-blind Phase|Not treated|1
1002613|NCT01440374|2019695|FG003|Part 2; Double-blind Phase|Not treated|0
1002614|NCT01440374|2019692|FG000|Part 3: Extension|Withdrawal by Subject|0
1002615|NCT01440374|2019693|FG001|Part 3: Extension|Withdrawal by Subject|0
1002616|NCT01440374|2019694|FG002|Part 3: Extension|Withdrawal by Subject|0
1002617|NCT01440374|2019695|FG003|Part 3: Extension|Withdrawal by Subject|5
1002618|NCT01440374|2019692|FG000|Part 3: Extension|Adverse Event|0
1002619|NCT01440374|2019693|FG001|Part 3: Extension|Adverse Event|0
1002620|NCT01440374|2019694|FG002|Part 3: Extension|Adverse Event|0
1002621|NCT01440374|2019695|FG003|Part 3: Extension|Adverse Event|13
1002622|NCT01440374|2019692|FG000|Part 3: Extension|Physician Decision|0
1002623|NCT01440374|2019693|FG001|Part 3: Extension|Physician Decision|0
1002624|NCT01440374|2019694|FG002|Part 3: Extension|Physician Decision|0
1002625|NCT01440374|2019695|FG003|Part 3: Extension|Physician Decision|14
1002626|NCT01440569|2019735|FG000|Main Study|Enrolled but not treated|1
1002627|NCT01440569|2019736|FG001|Main Study|Enrolled but not treated|0
1002628|NCT01440569|2019735|FG000|Main Study|Adverse Event|9
1002629|NCT01440569|2019736|FG001|Main Study|Adverse Event|0
1002630|NCT01440569|2019735|FG000|Main Study|Pregnancy|1
1002631|NCT01440569|2019736|FG001|Main Study|Pregnancy|0
1002632|NCT01440569|2019735|FG000|Main Study|Investigator's Discretion|1
1002633|NCT01440569|2019736|FG001|Main Study|Investigator's Discretion|1
1002634|NCT01440569|2019735|FG000|Main Study|Withdrew Consent|7
1002635|NCT01440569|2019736|FG001|Main Study|Withdrew Consent|1
1002636|NCT01440569|2019735|FG000|Main Study|Lost to Follow-up|13
1002637|NCT01440569|2019736|FG001|Main Study|Lost to Follow-up|2
1002638|NCT01440569|2019735|FG000|Main Study|Subject Non-Compliance|3
1002639|NCT01440569|2019736|FG001|Main Study|Subject Non-Compliance|0
1002640|NCT01440569|2019735|FG000|Main Study|Protocol Violation|1
1002641|NCT01440569|2019736|FG001|Main Study|Protocol Violation|0
1002642|NCT01440569|2019735|FG000|Open-Label Rollover Phase|Adverse Event|3
1002643|NCT01440569|2019736|FG001|Open-Label Rollover Phase|Adverse Event|0
1002644|NCT01440569|2019735|FG000|Open-Label Rollover Phase|Pregnancy|1
1002645|NCT01440569|2019736|FG001|Open-Label Rollover Phase|Pregnancy|0
1002646|NCT01440569|2019735|FG000|Open-Label Rollover Phase|Lack of Efficacy|2
1002647|NCT01440569|2019736|FG001|Open-Label Rollover Phase|Lack of Efficacy|0
1002648|NCT01440569|2019735|FG000|Open-Label Rollover Phase|Investigator's Discretion|3
1002649|NCT01440569|2019736|FG001|Open-Label Rollover Phase|Investigator's Discretion|1
1002650|NCT01440569|2019735|FG000|Open-Label Rollover Phase|Withdrew Consent|11
1002651|NCT01440569|2019736|FG001|Open-Label Rollover Phase|Withdrew Consent|1
1002652|NCT01440569|2019735|FG000|Open-Label Rollover Phase|Lost to Follow-up|26
1002653|NCT01440569|2019736|FG001|Open-Label Rollover Phase|Lost to Follow-up|3
1002654|NCT01440569|2019735|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1
1002655|NCT01440569|2019736|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1
1002656|NCT01440647|2019753|FG000|Overall Study|Death|2
1002657|NCT01440647|2019754|FG001|Overall Study|Death|3
1002658|NCT01440803|2019788|FG000|Overall Study|Met study stopping rule|2
1002659|NCT01440803|2019789|FG001|Overall Study|Met study stopping rule|1
1002660|NCT01440803|2019788|FG000|Overall Study|Lost to Follow-up|0
1002661|NCT01440803|2019789|FG001|Overall Study|Lost to Follow-up|2
1002662|NCT01440803|2019788|FG000|Overall Study|Withdrawal by Subject|0
1002663|NCT01440803|2019789|FG001|Overall Study|Withdrawal by Subject|1
1002664|NCT01440816|2019798|FG000|Overall Study|Disease Progression|0
1002665|NCT01440816|2019799|FG001|Overall Study|Disease Progression|9
1002666|NCT01440816|2019798|FG000|Overall Study|To Be Seen By Local Oncologist|1
1002667|NCT01440816|2019799|FG001|Overall Study|To Be Seen By Local Oncologist|2
1002668|NCT01440881|2019809|FG000|Overall Study|Death|0
1002669|NCT01440881|2019810|FG001|Overall Study|Death|1
1002670|NCT01440946|2019832|FG000|Overall Study|Lost to Follow-up|1
1002671|NCT01440946|2019833|FG001|Overall Study|Lost to Follow-up|1
1002672|NCT01440946|2019832|FG000|Overall Study|Physician Decision|1
1002673|NCT01440946|2019833|FG001|Overall Study|Physician Decision|0
1002674|NCT01440972|2019846|FG000|Overall Study|Withdrawal by Subject|3
1002675|NCT01440972|2019847|FG001|Overall Study|Withdrawal by Subject|2
1006730|NCT01469052|2025438|FG002|Overall Study|Other|0
1006731|NCT01469052|2025439|FG003|Overall Study|Other|0
1006732|NCT01469052|2025440|FG004|Overall Study|Other|1
1006733|NCT01469052|2025441|FG005|Overall Study|Other|0
1006734|NCT01469065|2025458|FG000|Overall Study|Lack of Efficacy|0
1006735|NCT01469065|2025459|FG001|Overall Study|Lack of Efficacy|0
1006736|NCT01469065|2025460|FG002|Overall Study|Lack of Efficacy|0
1006737|NCT01469065|2025461|FG003|Overall Study|Lack of Efficacy|0
1006738|NCT01469065|2025462|FG004|Overall Study|Lack of Efficacy|1
1006739|NCT01469065|2025458|FG000|Overall Study|Other|0
1006740|NCT01469065|2025459|FG001|Overall Study|Other|1
1006741|NCT01469065|2025460|FG002|Overall Study|Other|0
1006742|NCT01469065|2025461|FG003|Overall Study|Other|0
1006743|NCT01469065|2025462|FG004|Overall Study|Other|0
1006744|NCT01469182|2025480|FG000|Overall Study|Adverse Event|21
1006745|NCT01469182|2025481|FG001|Overall Study|Adverse Event|3
1006746|NCT01469182|2025480|FG000|Overall Study|Lost to Follow-up|3
1006747|NCT01469182|2025481|FG001|Overall Study|Lost to Follow-up|0
1006748|NCT01469182|2025480|FG000|Overall Study|Withdrawal by Subject|4
1006749|NCT01469182|2025481|FG001|Overall Study|Withdrawal by Subject|1
1006750|NCT01469182|2025480|FG000|Overall Study|Protocol Violation|4
1006751|NCT01469182|2025481|FG001|Overall Study|Protocol Violation|2
1006752|NCT01469182|2025480|FG000|Overall Study|Did not meet Protocol Eligibility|3
1006753|NCT01469182|2025481|FG001|Overall Study|Did not meet Protocol Eligibility|0
1006754|NCT01469221|2025489|FG000|Double Blind Phase|Protocol Violation|1
1006755|NCT01469221|2025490|FG001|Double Blind Phase|Protocol Violation|0
1006756|NCT01469221|2025491|FG002|Double Blind Phase|Protocol Violation|0
1006757|NCT01469221|2025489|FG000|Double Blind Phase|Physician Decision|1
1006758|NCT01469221|2025490|FG001|Double Blind Phase|Physician Decision|1
1006759|NCT01469221|2025491|FG002|Double Blind Phase|Physician Decision|0
1002676|NCT01441063|2019857|FG000|Tocilizumab Alone|Required AZT/VGC addition|3
1002677|NCT01441063|2019857|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1
1002678|NCT01441102|2019868|FG000|Overall Study|Adverse Event|1
1002679|NCT01441102|2019868|FG000|Overall Study|Withdrawal by Subject|2
1002680|NCT01441180|2019875|FG000|Overall Study|Lost to Follow-up|1
1002681|NCT01441180|2019876|FG001|Overall Study|Lost to Follow-up|1
1002682|NCT01441180|2019877|FG002|Overall Study|Lost to Follow-up|1
1002683|NCT01441180|2019875|FG000|Overall Study|Discontinued|0
1002684|NCT01441180|2019876|FG001|Overall Study|Discontinued|0
1002685|NCT01441180|2019877|FG002|Overall Study|Discontinued|2
1002686|NCT01441414|2019931|FG000|Overall Study|Participant died|9
1002687|NCT01441414|2019931|FG000|Overall Study|Other reasons|3
1002688|NCT01441414|2019931|FG000|Overall Study|Study terminated by sponsor|2
1002689|NCT01441414|2019931|FG000|Overall Study|Subject refused further follow-up|1
1002690|NCT01441440|2019950|FG000|Overall Study|Death|1
1002691|NCT01441440|2019951|FG001|Overall Study|Death|0
1002692|NCT01441440|2019952|FG002|Overall Study|Death|1
1002693|NCT01441440|2019950|FG000|Overall Study|Adverse Event|2
1002694|NCT01441440|2019951|FG001|Overall Study|Adverse Event|9
1002695|NCT01441440|2019952|FG002|Overall Study|Adverse Event|9
1002696|NCT01441440|2019950|FG000|Overall Study|Lost to Follow-up|0
1002697|NCT01441440|2019951|FG001|Overall Study|Lost to Follow-up|2
1002698|NCT01441440|2019952|FG002|Overall Study|Lost to Follow-up|1
1002699|NCT01441440|2019950|FG000|Overall Study|Withdrawal by Subject|11
1002700|NCT01441440|2019951|FG001|Overall Study|Withdrawal by Subject|9
1002701|NCT01441440|2019952|FG002|Overall Study|Withdrawal by Subject|9
1002702|NCT01441440|2019950|FG000|Overall Study|Pregnancy|1
1002703|NCT01441440|2019951|FG001|Overall Study|Pregnancy|0
1002704|NCT01441440|2019952|FG002|Overall Study|Pregnancy|0
1002705|NCT01441440|2019950|FG000|Overall Study|Lack of Efficacy|1
1002706|NCT01441440|2019951|FG001|Overall Study|Lack of Efficacy|0
1002707|NCT01441440|2019952|FG002|Overall Study|Lack of Efficacy|1
1002708|NCT01441440|2019950|FG000|Overall Study|Moving|0
1002709|NCT01441440|2019951|FG001|Overall Study|Moving|1
1002710|NCT01441440|2019952|FG002|Overall Study|Moving|1
1002711|NCT01441440|2019950|FG000|Overall Study|Work-related matter|0
1002712|NCT01441440|2019951|FG001|Overall Study|Work-related matter|1
1002713|NCT01441440|2019952|FG002|Overall Study|Work-related matter|0
1002714|NCT01441440|2019950|FG000|Overall Study|Difficllty in keeping the schedule|1
1002715|NCT01441440|2019951|FG001|Overall Study|Difficllty in keeping the schedule|1
1002716|NCT01441440|2019952|FG002|Overall Study|Difficllty in keeping the schedule|0
1002717|NCT01441596|2019993|FG000|Overall Study|Other reason not defined below|0
1002718|NCT01441596|2019994|FG001|Overall Study|Other reason not defined below|2
1002719|NCT01441596|2019995|FG002|Overall Study|Other reason not defined below|1
1002720|NCT01441596|2019993|FG000|Overall Study|Withdrawal by Subject|4
1002721|NCT01441596|2019994|FG001|Overall Study|Withdrawal by Subject|0
1002722|NCT01441596|2019995|FG002|Overall Study|Withdrawal by Subject|2
1002723|NCT01441596|2019993|FG000|Overall Study|Not treated|0
1002724|NCT01441596|2019994|FG001|Overall Study|Not treated|1
1002725|NCT01441596|2019995|FG002|Overall Study|Not treated|1
1002726|NCT01441635|2020013|FG000|Overall Study|Adverse Event|4
1002727|NCT01441635|2020014|FG001|Overall Study|Adverse Event|3
1002728|NCT01441635|2020015|FG002|Overall Study|Adverse Event|1
1002729|NCT01441635|2020016|FG003|Overall Study|Adverse Event|5
1002730|NCT01441635|2020017|FG004|Overall Study|Adverse Event|1
1002731|NCT01441635|2020018|FG005|Overall Study|Adverse Event|2
1002732|NCT01441635|2020019|FG006|Overall Study|Adverse Event|2
1002733|NCT01441635|2020020|FG007|Overall Study|Adverse Event|2
1002734|NCT01441635|2020021|FG008|Overall Study|Adverse Event|1
1002735|NCT01441635|2020022|FG009|Overall Study|Adverse Event|0
1002736|NCT01441635|2020013|FG000|Overall Study|Withdrawal by Subject|1
1002737|NCT01441635|2020014|FG001|Overall Study|Withdrawal by Subject|1
1002738|NCT01441635|2020015|FG002|Overall Study|Withdrawal by Subject|0
1002739|NCT01441635|2020016|FG003|Overall Study|Withdrawal by Subject|1
1002740|NCT01441635|2020017|FG004|Overall Study|Withdrawal by Subject|0
1002741|NCT01441635|2020018|FG005|Overall Study|Withdrawal by Subject|0
1002742|NCT01441635|2020019|FG006|Overall Study|Withdrawal by Subject|2
1002743|NCT01441635|2020020|FG007|Overall Study|Withdrawal by Subject|0
1002744|NCT01441635|2020021|FG008|Overall Study|Withdrawal by Subject|1
1002745|NCT01441635|2020022|FG009|Overall Study|Withdrawal by Subject|1
1002746|NCT01441635|2020013|FG000|Overall Study|Lost to Follow-up|0
1002747|NCT01441635|2020014|FG001|Overall Study|Lost to Follow-up|1
1002748|NCT01441635|2020015|FG002|Overall Study|Lost to Follow-up|1
1002749|NCT01441635|2020016|FG003|Overall Study|Lost to Follow-up|1
1002750|NCT01441635|2020017|FG004|Overall Study|Lost to Follow-up|1
1002751|NCT01441635|2020018|FG005|Overall Study|Lost to Follow-up|3
1002752|NCT01441635|2020019|FG006|Overall Study|Lost to Follow-up|1
1002753|NCT01441635|2020020|FG007|Overall Study|Lost to Follow-up|1
1002754|NCT01441635|2020021|FG008|Overall Study|Lost to Follow-up|0
1002755|NCT01441635|2020022|FG009|Overall Study|Lost to Follow-up|1
1002756|NCT01441635|2020013|FG000|Overall Study|Noncompliance|0
1002757|NCT01441635|2020014|FG001|Overall Study|Noncompliance|1
1002758|NCT01441635|2020015|FG002|Overall Study|Noncompliance|0
1002759|NCT01441635|2020016|FG003|Overall Study|Noncompliance|0
1002760|NCT01441635|2020017|FG004|Overall Study|Noncompliance|0
1002761|NCT01441635|2020018|FG005|Overall Study|Noncompliance|0
1002762|NCT01441635|2020019|FG006|Overall Study|Noncompliance|1
1002763|NCT01441635|2020020|FG007|Overall Study|Noncompliance|0
1002764|NCT01441635|2020021|FG008|Overall Study|Noncompliance|0
1002765|NCT01441635|2020022|FG009|Overall Study|Noncompliance|0
1002766|NCT01441635|2020013|FG000|Overall Study|Surgery or Invasive Intervention|0
1002767|NCT01441635|2020014|FG001|Overall Study|Surgery or Invasive Intervention|0
1002768|NCT01441635|2020015|FG002|Overall Study|Surgery or Invasive Intervention|1
1002769|NCT01441635|2020016|FG003|Overall Study|Surgery or Invasive Intervention|0
1002770|NCT01441635|2020017|FG004|Overall Study|Surgery or Invasive Intervention|0
1002771|NCT01441635|2020018|FG005|Overall Study|Surgery or Invasive Intervention|0
1002772|NCT01441635|2020019|FG006|Overall Study|Surgery or Invasive Intervention|0
1002773|NCT01441635|2020020|FG007|Overall Study|Surgery or Invasive Intervention|0
1002774|NCT01441635|2020021|FG008|Overall Study|Surgery or Invasive Intervention|0
1002775|NCT01441635|2020022|FG009|Overall Study|Surgery or Invasive Intervention|0
1002776|NCT01441635|2020013|FG000|Overall Study|Received Exclusionary Medication|1
1002777|NCT01441635|2020014|FG001|Overall Study|Received Exclusionary Medication|0
1002778|NCT01441635|2020015|FG002|Overall Study|Received Exclusionary Medication|0
1002779|NCT01441635|2020016|FG003|Overall Study|Received Exclusionary Medication|0
1002780|NCT01441635|2020017|FG004|Overall Study|Received Exclusionary Medication|0
1002781|NCT01441635|2020018|FG005|Overall Study|Received Exclusionary Medication|0
1002782|NCT01441635|2020019|FG006|Overall Study|Received Exclusionary Medication|0
1002783|NCT01441635|2020020|FG007|Overall Study|Received Exclusionary Medication|0
1002784|NCT01441635|2020021|FG008|Overall Study|Received Exclusionary Medication|0
1002785|NCT01441635|2020022|FG009|Overall Study|Received Exclusionary Medication|0
1002786|NCT01441635|2020013|FG000|Overall Study|Other|0
1002787|NCT01441635|2020014|FG001|Overall Study|Other|0
1002788|NCT01441635|2020015|FG002|Overall Study|Other|0
1002789|NCT01441635|2020016|FG003|Overall Study|Other|0
1002790|NCT01441635|2020017|FG004|Overall Study|Other|0
1002791|NCT01441635|2020018|FG005|Overall Study|Other|0
1002792|NCT01441635|2020019|FG006|Overall Study|Other|0
1002793|NCT01441635|2020020|FG007|Overall Study|Other|1
1002794|NCT01441635|2020021|FG008|Overall Study|Other|0
1002795|NCT01441635|2020022|FG009|Overall Study|Other|0
1002796|NCT01441765|2020046|FG000|Overall Study|Death|1
1002797|NCT01441765|2020047|FG001|Overall Study|Death|0
1002798|NCT01441960|2020066|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
1002799|NCT01441960|2020067|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
1002800|NCT01441960|2020066|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1
1002801|NCT01441960|2020067|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1
1002802|NCT01441960|2020066|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
1002803|NCT01441960|2020067|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
1002804|NCT01441973|2020079|FG000|Overall Study|Disease progression|8
1002805|NCT01441973|2020080|FG001|Overall Study|Disease progression|6
1002806|NCT01441973|2020079|FG000|Overall Study|Adverse event unrelated to study drug|3
1002807|NCT01441973|2020080|FG001|Overall Study|Adverse event unrelated to study drug|2
1002808|NCT01441973|2020079|FG000|Overall Study|Participant request to discontinue|1
1002809|NCT01441973|2020080|FG001|Overall Study|Participant request to discontinue|1
1002810|NCT01441973|2020079|FG000|Overall Study|Poor compliance/noncompliance|0
1002811|NCT01441973|2020080|FG001|Overall Study|Poor compliance/noncompliance|1
1002812|NCT01441973|2020079|FG000|Overall Study|Administrative reason by sponsor|3
1002813|NCT01441973|2020080|FG001|Overall Study|Administrative reason by sponsor|5
1002814|NCT01441973|2020079|FG000|Overall Study|Participant withdrew consent|0
1002815|NCT01441973|2020080|FG001|Overall Study|Participant withdrew consent|1
1002816|NCT01442038|2020089|FG000|Overall Study|Death|35
1002817|NCT01442038|2020090|FG001|Overall Study|Death|29
1002818|NCT01442038|2020089|FG000|Overall Study|Investigator-Initiated Early Closure|44
1002819|NCT01442038|2020090|FG001|Overall Study|Investigator-Initiated Early Closure|43
1002820|NCT01442038|2020089|FG000|Overall Study|Participant Withdrew Consent|137
1002821|NCT01442038|2020090|FG001|Overall Study|Participant Withdrew Consent|102
1002822|NCT01442038|2020089|FG000|Overall Study|Lost to Follow-up|37
1002823|NCT01442038|2020090|FG001|Overall Study|Lost to Follow-up|51
1002824|NCT01442038|2020089|FG000|Overall Study|Adverse Event|26
1002825|NCT01442038|2020090|FG001|Overall Study|Adverse Event|15
1002826|NCT01442038|2020089|FG000|Overall Study|Protocol Deviation|9
1002827|NCT01442038|2020090|FG001|Overall Study|Protocol Deviation|20
1002828|NCT01442038|2020089|FG000|Overall Study|Investigator's Discretion|13
1002829|NCT01442038|2020090|FG001|Overall Study|Investigator's Discretion|16
1002830|NCT01442038|2020089|FG000|Overall Study|Study Terminated By Sponsor|2
1002831|NCT01442038|2020090|FG001|Overall Study|Study Terminated By Sponsor|3
1002832|NCT01442064|2020102|FG000|Overall Study|Adverse Event|2
1002833|NCT01442064|2020103|FG001|Overall Study|Adverse Event|2
1002834|NCT01442064|2020104|FG002|Overall Study|Adverse Event|2
1002835|NCT01442064|2020105|FG003|Overall Study|Adverse Event|1
1002836|NCT01442064|2020106|FG004|Overall Study|Adverse Event|2
1002837|NCT01442064|2020107|FG005|Overall Study|Adverse Event|0
1002838|NCT01442064|2020102|FG000|Overall Study|Death|0
1002839|NCT01442064|2020103|FG001|Overall Study|Death|1
1002840|NCT01442064|2020104|FG002|Overall Study|Death|3
1002841|NCT01442064|2020105|FG003|Overall Study|Death|3
1002842|NCT01442064|2020106|FG004|Overall Study|Death|1
1002843|NCT01442064|2020107|FG005|Overall Study|Death|3
1002844|NCT01442064|2020102|FG000|Overall Study|Lost to Follow-up|5
1002845|NCT01442064|2020103|FG001|Overall Study|Lost to Follow-up|5
1002846|NCT01442064|2020104|FG002|Overall Study|Lost to Follow-up|1
1002847|NCT01442064|2020105|FG003|Overall Study|Lost to Follow-up|1
1002848|NCT01442064|2020106|FG004|Overall Study|Lost to Follow-up|3
1002849|NCT01442064|2020107|FG005|Overall Study|Lost to Follow-up|3
1002850|NCT01442064|2020102|FG000|Overall Study|Physician Decision|1
1002851|NCT01442064|2020103|FG001|Overall Study|Physician Decision|1
1002852|NCT01442064|2020104|FG002|Overall Study|Physician Decision|2
1002853|NCT01442064|2020105|FG003|Overall Study|Physician Decision|3
1002854|NCT01442064|2020106|FG004|Overall Study|Physician Decision|3
1002855|NCT01442064|2020107|FG005|Overall Study|Physician Decision|1
1002856|NCT01442064|2020102|FG000|Overall Study|Withdrawal by Subject|6
1002857|NCT01442064|2020103|FG001|Overall Study|Withdrawal by Subject|3
1002858|NCT01442064|2020104|FG002|Overall Study|Withdrawal by Subject|2
1002859|NCT01442064|2020105|FG003|Overall Study|Withdrawal by Subject|2
1002860|NCT01442064|2020106|FG004|Overall Study|Withdrawal by Subject|2
1002861|NCT01442064|2020107|FG005|Overall Study|Withdrawal by Subject|1
1002862|NCT01442064|2020102|FG000|Overall Study|Sponsor decision|82
1002863|NCT01442064|2020103|FG001|Overall Study|Sponsor decision|88
1002864|NCT01442064|2020104|FG002|Overall Study|Sponsor decision|92
1002865|NCT01442064|2020105|FG003|Overall Study|Sponsor decision|88
1002866|NCT01442064|2020106|FG004|Overall Study|Sponsor decision|95
1002867|NCT01442064|2020107|FG005|Overall Study|Sponsor decision|87
1002868|NCT01442064|2020102|FG000|Overall Study|Subject non-compliance|0
1002869|NCT01442064|2020103|FG001|Overall Study|Subject non-compliance|0
1002870|NCT01442064|2020104|FG002|Overall Study|Subject non-compliance|0
1002871|NCT01442064|2020105|FG003|Overall Study|Subject non-compliance|0
1002872|NCT01442064|2020106|FG004|Overall Study|Subject non-compliance|0
1002873|NCT01442064|2020107|FG005|Overall Study|Subject non-compliance|2
1002874|NCT01442064|2020102|FG000|Overall Study|Condition mandated other intervention|1
1002875|NCT01442064|2020103|FG001|Overall Study|Condition mandated other intervention|1
1002876|NCT01442064|2020104|FG002|Overall Study|Condition mandated other intervention|2
1002877|NCT01442064|2020105|FG003|Overall Study|Condition mandated other intervention|0
1002878|NCT01442064|2020106|FG004|Overall Study|Condition mandated other intervention|0
1002879|NCT01442064|2020107|FG005|Overall Study|Condition mandated other intervention|2
1002880|NCT01442103|2020124|FG000|Overall Study|Lost to Follow-up|2
1002881|NCT01442155|2020137|FG000|Overall Study|Complete remission|35
1002882|NCT01442155|2020137|FG000|Overall Study|Recurrence|26
1002883|NCT01442155|2020137|FG000|Overall Study|Adverse Event|2
1002884|NCT01442155|2020137|FG000|Overall Study|Lost to Follow-up|2
1002885|NCT01442181|2020143|FG000|Overall Study|patient refused surgery|1
1002886|NCT01442181|2020144|FG001|Overall Study|patient refused surgery|0
1002887|NCT01442181|2020143|FG000|Overall Study|no insurance for surgery|1
1002888|NCT01442181|2020144|FG001|Overall Study|no insurance for surgery|0
1002889|NCT01442181|2020143|FG000|Overall Study|low ejection factor|0
1002890|NCT01442181|2020144|FG001|Overall Study|low ejection factor|1
1002891|NCT01442181|2020143|FG000|Overall Study|Lost to Follow-up|1
1002892|NCT01442181|2020144|FG001|Overall Study|Lost to Follow-up|1
1002893|NCT01442181|2020143|FG000|Overall Study|patient in an additional study|1
1002894|NCT01442181|2020144|FG001|Overall Study|patient in an additional study|0
1002895|NCT01442181|2020143|FG000|Overall Study|atrial fibrillation not noted|0
1002896|NCT01442181|2020144|FG001|Overall Study|atrial fibrillation not noted|1
1002897|NCT01442376|2020154|FG000|Overall Study|Adverse Event|0
1002898|NCT01442376|2020155|FG001|Overall Study|Adverse Event|3
1002899|NCT01442376|2020156|FG002|Overall Study|Adverse Event|2
1002900|NCT01442376|2020154|FG000|Overall Study|Death|0
1002901|NCT01442376|2020155|FG001|Overall Study|Death|1
1002902|NCT01442376|2020156|FG002|Overall Study|Death|1
1002903|NCT01442376|2020154|FG000|Overall Study|Withdrawal of consent|0
1002904|NCT01442376|2020155|FG001|Overall Study|Withdrawal of consent|0
1002905|NCT01442376|2020156|FG002|Overall Study|Withdrawal of consent|1
1002906|NCT01442376|2020154|FG000|Overall Study|Patients not treated|2
1002907|NCT01442376|2020155|FG001|Overall Study|Patients not treated|3
1002908|NCT01442376|2020156|FG002|Overall Study|Patients not treated|1
1002909|NCT01442376|2020154|FG000|Overall Study|Not eligible for subsequent cycles|1
1002910|NCT01442376|2020155|FG001|Overall Study|Not eligible for subsequent cycles|2
1002911|NCT01442376|2020156|FG002|Overall Study|Not eligible for subsequent cycles|0
1002912|NCT01442493|2020166|FG000|Overall Study|withdrawn from study|3
1002913|NCT01442493|2020167|FG001|Overall Study|withdrawn from study|2
1002914|NCT01442675|2020173|FG000|Overall Study|Protocol Violation|6
1002915|NCT01442675|2020173|FG000|Overall Study|Lost to Follow-up|2
1002916|NCT01442675|2020173|FG000|Overall Study|Withdrawal by Subject|4
1002917|NCT01442688|2020180|FG000|First Intervention|Withdrawal by Subject|1
1002918|NCT01442688|2020181|FG001|First Intervention|Withdrawal by Subject|0
1002919|NCT01442688|2020180|FG000|First Intervention|subject incarcerated|1
1002920|NCT01442688|2020181|FG001|First Intervention|subject incarcerated|0
1002921|NCT01442688|2020180|FG000|Second Intervention|Adverse Event|1
1002922|NCT01442688|2020181|FG001|Second Intervention|Adverse Event|0
1002923|NCT01442714|2020187|FG000|Overall Study|Death|11
1002924|NCT01442714|2020187|FG000|Overall Study|Withdrawal by Subject|1
1002925|NCT01442779|2020193|FG000|Overall Study|Withdrawal by Subject|3
1002926|NCT01442779|2020193|FG000|Overall Study|Death|3
1002927|NCT01442779|2020193|FG000|Overall Study|Non-compliance|1
1002928|NCT01443026|2020208|FG000|Overall Study|Physician Decision|1
1002929|NCT01443026|2020209|FG001|Overall Study|Physician Decision|0
1002930|NCT01443026|2020208|FG000|Overall Study|Death|0
1002931|NCT01443026|2020209|FG001|Overall Study|Death|1
1002932|NCT01443026|2020208|FG000|Overall Study|Withdrawal by Subject|0
1002933|NCT01443026|2020209|FG001|Overall Study|Withdrawal by Subject|3
1002934|NCT01443026|2020208|FG000|Overall Study|Lost to Follow-up|2
1002935|NCT01443026|2020209|FG001|Overall Study|Lost to Follow-up|1
1002936|NCT01443078|2020215|FG000|Overall Study|Responded to neoadjuvant platinum txt|27
1002937|NCT01443078|2020215|FG000|Overall Study|Withdrawal by Subject|1
1002938|NCT01443078|2020215|FG000|Overall Study|Patient had brain mets|1
1002939|NCT01443130|2020225|FG000|Overall Study|Lost to Follow-up|44
1002940|NCT01443130|2020226|FG001|Overall Study|Lost to Follow-up|42
1002941|NCT01443130|2020227|FG002|Overall Study|Lost to Follow-up|50
1002942|NCT01443130|2020228|FG003|Overall Study|Lost to Follow-up|23
1002943|NCT01443130|2020229|FG004|Overall Study|Lost to Follow-up|25
1002944|NCT01443130|2020230|FG005|Overall Study|Lost to Follow-up|21
1002945|NCT01443130|2020225|FG000|Overall Study|Death|0
1002946|NCT01443130|2020226|FG001|Overall Study|Death|1
1002947|NCT01443130|2020227|FG002|Overall Study|Death|0
1002948|NCT01443130|2020228|FG003|Overall Study|Death|7
1002949|NCT01443130|2020229|FG004|Overall Study|Death|10
1002950|NCT01443130|2020230|FG005|Overall Study|Death|8
1002951|NCT01443130|2020225|FG000|Overall Study|Adverse Event|2
1002952|NCT01443130|2020226|FG001|Overall Study|Adverse Event|1
1002953|NCT01443130|2020227|FG002|Overall Study|Adverse Event|1
1002954|NCT01443130|2020228|FG003|Overall Study|Adverse Event|0
1002955|NCT01443130|2020229|FG004|Overall Study|Adverse Event|0
1002956|NCT01443130|2020230|FG005|Overall Study|Adverse Event|0
1002957|NCT01443130|2020225|FG000|Overall Study|Protocol Violation|2
1002958|NCT01443130|2020226|FG001|Overall Study|Protocol Violation|1
1002959|NCT01443130|2020227|FG002|Overall Study|Protocol Violation|3
1002960|NCT01443130|2020228|FG003|Overall Study|Protocol Violation|2
1002961|NCT01443130|2020229|FG004|Overall Study|Protocol Violation|2
1002962|NCT01443130|2020230|FG005|Overall Study|Protocol Violation|3
1002963|NCT01443130|2020225|FG000|Overall Study|Withdrawal by Subject|15
1002964|NCT01443130|2020226|FG001|Overall Study|Withdrawal by Subject|14
1002965|NCT01443130|2020227|FG002|Overall Study|Withdrawal by Subject|12
1002966|NCT01443130|2020228|FG003|Overall Study|Withdrawal by Subject|7
1002967|NCT01443130|2020229|FG004|Overall Study|Withdrawal by Subject|7
1002968|NCT01443130|2020230|FG005|Overall Study|Withdrawal by Subject|2
1002969|NCT01443130|2020225|FG000|Overall Study|Death of Subject's Infant|5
1002970|NCT01443130|2020226|FG001|Overall Study|Death of Subject's Infant|10
1002971|NCT01443130|2020227|FG002|Overall Study|Death of Subject's Infant|11
1002972|NCT01443130|2020228|FG003|Overall Study|Death of Subject's Infant|0
1002973|NCT01443130|2020229|FG004|Overall Study|Death of Subject's Infant|0
1002974|NCT01443130|2020230|FG005|Overall Study|Death of Subject's Infant|0
1002975|NCT01443364|2020244|FG000|Overall Study|Lack of Efficacy|14
1002976|NCT01443364|2020244|FG000|Overall Study|Lost to Follow-up|3
1002977|NCT01443364|2020244|FG000|Overall Study|Withdrawal by Subject|5
1002978|NCT01443364|2020244|FG000|Overall Study|Other Reason|4
1002979|NCT01443364|2020244|FG000|Overall Study|SAE, non-fatal|6
1002980|NCT01443364|2020244|FG000|Overall Study|AE, non-serious non-fatal|8
1002981|NCT01443364|2020244|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1002982|NCT01443403|2020252|FG000|Overall Study|Adverse Event|1
1002983|NCT01443403|2020253|FG001|Overall Study|Adverse Event|1
1002984|NCT01443403|2020254|FG002|Overall Study|Adverse Event|4
1002985|NCT01443403|2020255|FG003|Overall Study|Adverse Event|5
1002986|NCT01443403|2020252|FG000|Overall Study|Withdrawal by Subject|0
1002987|NCT01443403|2020253|FG001|Overall Study|Withdrawal by Subject|1
1002988|NCT01443403|2020254|FG002|Overall Study|Withdrawal by Subject|2
1002989|NCT01443403|2020255|FG003|Overall Study|Withdrawal by Subject|1
1002990|NCT01443403|2020252|FG000|Overall Study|Lost to Follow-up|0
1002991|NCT01443403|2020253|FG001|Overall Study|Lost to Follow-up|0
1002992|NCT01443403|2020254|FG002|Overall Study|Lost to Follow-up|0
1002993|NCT01443403|2020255|FG003|Overall Study|Lost to Follow-up|1
1002994|NCT01443403|2020252|FG000|Overall Study|Protocol Violation|2
1002995|NCT01443403|2020253|FG001|Overall Study|Protocol Violation|1
1002996|NCT01443403|2020254|FG002|Overall Study|Protocol Violation|1
1002997|NCT01443403|2020255|FG003|Overall Study|Protocol Violation|1
1002998|NCT01443403|2020252|FG000|Overall Study|Use of Prohibited Treatment|2
1002999|NCT01443403|2020253|FG001|Overall Study|Use of Prohibited Treatment|3
1003000|NCT01443403|2020254|FG002|Overall Study|Use of Prohibited Treatment|0
1003001|NCT01443403|2020255|FG003|Overall Study|Use of Prohibited Treatment|0
1003002|NCT01443403|2020252|FG000|Overall Study|Other - Miscellaneous|1
1003003|NCT01443403|2020253|FG001|Overall Study|Other - Miscellaneous|0
1003004|NCT01443403|2020254|FG002|Overall Study|Other - Miscellaneous|0
1003005|NCT01443403|2020255|FG003|Overall Study|Other - Miscellaneous|1
1003006|NCT01443845|2020298|FG000|Overall Study|Protocol Violation|43
1003007|NCT01443845|2020299|FG001|Overall Study|Protocol Violation|45
1003008|NCT01443845|2020298|FG000|Overall Study|Other reasons, such as COPD exacerbation|44
1003009|NCT01443845|2020299|FG001|Overall Study|Other reasons, such as COPD exacerbation|44
1003010|NCT01443845|2020298|FG000|Overall Study|Deterioration in pulmonary function|1
1003011|NCT01443845|2020299|FG001|Overall Study|Deterioration in pulmonary function|4
1003012|NCT01443845|2020298|FG000|Overall Study|Lack of Efficacy|10
1003013|NCT01443845|2020299|FG001|Overall Study|Lack of Efficacy|5
1003014|NCT01443845|2020298|FG000|Overall Study|Adverse Event|64
1003015|NCT01443845|2020299|FG001|Overall Study|Adverse Event|138
1003016|NCT01443845|2020298|FG000|Overall Study|Withdrawal by Subject|63
1003017|NCT01443845|2020299|FG001|Overall Study|Withdrawal by Subject|67
1003018|NCT01443845|2020298|FG000|Overall Study|Military Conflict - Site Terminated|20
1003019|NCT01443845|2020299|FG001|Overall Study|Military Conflict - Site Terminated|21
1003020|NCT01443845|2020298|FG000|Overall Study|Lost to Follow-up|9
1003021|NCT01443845|2020299|FG001|Overall Study|Lost to Follow-up|13
1003022|NCT01443858|2020308|FG000|Overall Study|Withdrawal by Subject|9
1003023|NCT01443858|2020309|FG001|Overall Study|Withdrawal by Subject|8
1003024|NCT01443858|2020310|FG002|Overall Study|Withdrawal by Subject|5
1003025|NCT01443858|2020308|FG000|Overall Study|Lack of Efficacy|1
1003026|NCT01443858|2020309|FG001|Overall Study|Lack of Efficacy|0
1003027|NCT01443858|2020310|FG002|Overall Study|Lack of Efficacy|0
1003028|NCT01443858|2020308|FG000|Overall Study|Lost to Follow-up|5
1003029|NCT01443858|2020309|FG001|Overall Study|Lost to Follow-up|5
1003030|NCT01443858|2020310|FG002|Overall Study|Lost to Follow-up|2
1003031|NCT01444027|2020321|FG000|Overall Study|Withdrawal by Subject|4
1003032|NCT01444027|2020322|FG001|Overall Study|Withdrawal by Subject|10
1003033|NCT01444027|2020323|FG002|Overall Study|Withdrawal by Subject|24
1003034|NCT01444027|2020321|FG000|Overall Study|Lost to Follow-up|26
1003035|NCT01444027|2020322|FG001|Overall Study|Lost to Follow-up|20
1003036|NCT01444027|2020323|FG002|Overall Study|Lost to Follow-up|14
1003041|NCT01444300|2020351|FG000|Overall Study|Adverse Event|4
1003042|NCT01444300|2020352|FG001|Overall Study|Adverse Event|0
1003043|NCT01444378|2020359|FG000|Overall Study|Lost to Follow-up|1
1003044|NCT01444378|2020359|FG000|Overall Study|Withdrawal by Subject|1
1003045|NCT01444378|2020359|FG000|Overall Study|Death|3
1003046|NCT01444378|2020359|FG000|Overall Study|Administrative Closure Of The Study|2
1003047|NCT01444378|2020359|FG000|Overall Study|Missed Visits|10
1003048|NCT01444391|2020366|FG000|Overall Study|Death|1
1003049|NCT01444417|2020372|FG000|Overall Study|Ineligibility Determined|0
1003050|NCT01444417|2020373|FG001|Overall Study|Ineligibility Determined|1
1003051|NCT01444417|2020372|FG000|Overall Study|Withdrawal by Subject|2
1003052|NCT01444417|2020373|FG001|Overall Study|Withdrawal by Subject|0
1003053|NCT01444430|2020381|FG000|Overall Study|Withdrawal by Subject|53
1003054|NCT01444430|2020382|FG001|Overall Study|Withdrawal by Subject|72
1003055|NCT01444430|2020381|FG000|Overall Study|Death|6
1003056|NCT01444430|2020382|FG001|Overall Study|Death|8
1003057|NCT01444430|2020381|FG000|Overall Study|Lost to Follow-up|2
1003058|NCT01444430|2020382|FG001|Overall Study|Lost to Follow-up|0
1003059|NCT01444430|2020381|FG000|Overall Study|CRF termination module not completed.|0
1003060|NCT01444430|2020382|FG001|Overall Study|CRF termination module not completed.|1
1003061|NCT01444456|2020388|FG000|Overall Study|Withdrawal by Subject|21
1003062|NCT01444456|2020388|FG000|Overall Study|Physician Decision|9
1003063|NCT01444456|2020388|FG000|Overall Study|Lost to Follow-up|37
1003064|NCT01444456|2020388|FG000|Overall Study|Death|73
1003065|NCT01444456|2020388|FG000|Overall Study|Ineligibility determined|23
1003066|NCT01444456|2020388|FG000|Overall Study|Other|18
1003067|NCT01444456|2020388|FG000|Overall Study|Not treated|104
1003068|NCT01444651|2020394|FG000|Overall Study|Adverse Event|3
1003069|NCT01444651|2020395|FG001|Overall Study|Adverse Event|2
1003070|NCT01444651|2020394|FG000|Overall Study|Lost to Follow-up|5
1003071|NCT01444651|2020395|FG001|Overall Study|Lost to Follow-up|5
1003072|NCT01444651|2020394|FG000|Overall Study|Non-fasting|2
1003073|NCT01444651|2020395|FG001|Overall Study|Non-fasting|1
1003074|NCT01444651|2020394|FG000|Overall Study|Missing data|1
1003075|NCT01444651|2020395|FG001|Overall Study|Missing data|1
914194|NCT00813709|1891955|FG003|Double Blind Period|Lost to Follow-up|0
914195|NCT00813709|1891956|FG004|Double Blind Period|Lost to Follow-up|0
914196|NCT00813709|1891957|FG005|Double Blind Period|Lost to Follow-up|0
914197|NCT00813709|1891952|FG000|Double Blind Period|Switched to open label phase|9
914198|NCT00813709|1891953|FG001|Double Blind Period|Switched to open label phase|26
914199|NCT00813709|1891954|FG002|Double Blind Period|Switched to open label phase|18
914200|NCT00813709|1891955|FG003|Double Blind Period|Switched to open label phase|0
914201|NCT00813709|1891956|FG004|Double Blind Period|Switched to open label phase|0
914202|NCT00813709|1891957|FG005|Double Blind Period|Switched to open label phase|0
914203|NCT00813709|1891952|FG000|Double Blind Period|Randomized but not treated|1
914204|NCT00813709|1891953|FG001|Double Blind Period|Randomized but not treated|3
914205|NCT00813709|1891954|FG002|Double Blind Period|Randomized but not treated|1
914206|NCT00813709|1891955|FG003|Double Blind Period|Randomized but not treated|0
914207|NCT00813709|1891956|FG004|Double Blind Period|Randomized but not treated|0
914208|NCT00813709|1891957|FG005|Double Blind Period|Randomized but not treated|0
914209|NCT00813709|1891952|FG000|Double Blind Period|Other|14
914210|NCT00813709|1891953|FG001|Double Blind Period|Other|9
914211|NCT00813709|1891954|FG002|Double Blind Period|Other|6
1003076|NCT01444742|2020405|FG000|Overall Study|Death|1
1003077|NCT01444781|2020412|FG000|Overall Study|Lost to Follow-up|0
1003078|NCT01444781|2020413|FG001|Overall Study|Lost to Follow-up|3
1003079|NCT01444781|2020414|FG002|Overall Study|Lost to Follow-up|1
1003080|NCT01444781|2020412|FG000|Overall Study|Withdrawal by Subject|3
1003081|NCT01444781|2020413|FG001|Overall Study|Withdrawal by Subject|1
1003082|NCT01444781|2020414|FG002|Overall Study|Withdrawal by Subject|2
1003083|NCT01444898|2020429|FG000|Overall Study|Withdrawal by Subject|1
1003084|NCT01445080|2020469|FG000|Overall Study|Adverse Event|5
1003085|NCT01445080|2020470|FG001|Overall Study|Adverse Event|3
1003086|NCT01445080|2020471|FG002|Overall Study|Adverse Event|11
1003087|NCT01445080|2020472|FG003|Overall Study|Adverse Event|6
1003088|NCT01445080|2020473|FG004|Overall Study|Adverse Event|2
1003089|NCT01445080|2020474|FG005|Overall Study|Adverse Event|3
1003090|NCT01445080|2020475|FG006|Overall Study|Adverse Event|0
1003091|NCT01445080|2020476|FG007|Overall Study|Adverse Event|3
1003092|NCT01445080|2020477|FG008|Overall Study|Adverse Event|10
1003093|NCT01445080|2020469|FG000|Overall Study|Physician Decision|0
1003094|NCT01445080|2020470|FG001|Overall Study|Physician Decision|0
1003095|NCT01445080|2020471|FG002|Overall Study|Physician Decision|1
1003096|NCT01445080|2020472|FG003|Overall Study|Physician Decision|0
1003097|NCT01445080|2020473|FG004|Overall Study|Physician Decision|0
1003098|NCT01445080|2020474|FG005|Overall Study|Physician Decision|3
1003099|NCT01445080|2020475|FG006|Overall Study|Physician Decision|2
1003100|NCT01445080|2020476|FG007|Overall Study|Physician Decision|2
1003101|NCT01445080|2020477|FG008|Overall Study|Physician Decision|0
1003102|NCT01445080|2020469|FG000|Overall Study|Withdrawal by Subject|1
1003103|NCT01445080|2020470|FG001|Overall Study|Withdrawal by Subject|0
1003104|NCT01445080|2020471|FG002|Overall Study|Withdrawal by Subject|0
1003105|NCT01445080|2020472|FG003|Overall Study|Withdrawal by Subject|1
1003106|NCT01445080|2020473|FG004|Overall Study|Withdrawal by Subject|0
1003107|NCT01445080|2020474|FG005|Overall Study|Withdrawal by Subject|0
1003108|NCT01445080|2020475|FG006|Overall Study|Withdrawal by Subject|0
1003109|NCT01445080|2020476|FG007|Overall Study|Withdrawal by Subject|0
1003110|NCT01445080|2020477|FG008|Overall Study|Withdrawal by Subject|2
1003111|NCT01445080|2020469|FG000|Overall Study|Ineligible/Inevaluable|1
1003112|NCT01445080|2020470|FG001|Overall Study|Ineligible/Inevaluable|2
1003113|NCT01445080|2020471|FG002|Overall Study|Ineligible/Inevaluable|0
1003114|NCT01445080|2020472|FG003|Overall Study|Ineligible/Inevaluable|1
1003115|NCT01445080|2020473|FG004|Overall Study|Ineligible/Inevaluable|2
1003116|NCT01445080|2020474|FG005|Overall Study|Ineligible/Inevaluable|3
1003117|NCT01445080|2020475|FG006|Overall Study|Ineligible/Inevaluable|0
1003118|NCT01445080|2020476|FG007|Overall Study|Ineligible/Inevaluable|0
1003119|NCT01445080|2020477|FG008|Overall Study|Ineligible/Inevaluable|6
1003120|NCT01445171|2020512|FG000|Overall Study|Lost to Follow-up|11
1003121|NCT01445171|2020512|FG000|Overall Study|Withdrawal by Subject|16
1003122|NCT01445171|2020512|FG000|Overall Study|Death|51
1003123|NCT01445171|2020512|FG000|Overall Study|Subjects declined to return for followup|9
1003124|NCT01445171|2020512|FG000|Overall Study|Consented but did not receive device|8
1003125|NCT01445301|2020521|FG000|Overall Study|Adverse Event|15
1003126|NCT01445301|2020522|FG001|Overall Study|Adverse Event|25
1003127|NCT01445301|2020523|FG002|Overall Study|Adverse Event|4
1003128|NCT01445301|2020521|FG000|Overall Study|Lack of Efficacy|0
1003129|NCT01445301|2020522|FG001|Overall Study|Lack of Efficacy|1
1003130|NCT01445301|2020523|FG002|Overall Study|Lack of Efficacy|0
1003131|NCT01445301|2020521|FG000|Overall Study|Protocol Violation|1
1003132|NCT01445301|2020522|FG001|Overall Study|Protocol Violation|0
1003133|NCT01445301|2020523|FG002|Overall Study|Protocol Violation|0
1003134|NCT01445301|2020521|FG000|Overall Study|Protocol-Defined Stopping Criteria|0
1003135|NCT01445301|2020522|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
1003136|NCT01445301|2020523|FG002|Overall Study|Protocol-Defined Stopping Criteria|1
1003137|NCT01445301|2020521|FG000|Overall Study|Physician Decision|0
1003138|NCT01445301|2020522|FG001|Overall Study|Physician Decision|2
1003139|NCT01445301|2020523|FG002|Overall Study|Physician Decision|0
1003140|NCT01445301|2020521|FG000|Overall Study|Withdrawal by Subject|5
1003141|NCT01445301|2020522|FG001|Overall Study|Withdrawal by Subject|6
1003142|NCT01445301|2020523|FG002|Overall Study|Withdrawal by Subject|4
1003143|NCT01445535|2020535|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0
1003144|NCT01445535|2020536|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0
1003145|NCT01445535|2020537|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0
1003146|NCT01445535|2020538|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1
1003147|NCT01445535|2020535|FG000|Overall Study|Disease progression|1
1003148|NCT01445535|2020536|FG001|Overall Study|Disease progression|0
1003149|NCT01445535|2020537|FG002|Overall Study|Disease progression|1
1003150|NCT01445535|2020538|FG003|Overall Study|Disease progression|0
1003151|NCT01445535|2020535|FG000|Overall Study|PI discretion|0
1003152|NCT01445535|2020536|FG001|Overall Study|PI discretion|0
1003153|NCT01445535|2020537|FG002|Overall Study|PI discretion|0
1003154|NCT01445535|2020538|FG003|Overall Study|PI discretion|1
1003155|NCT01445548|2020549|FG000|Overall Study|Adverse Event|1
1003156|NCT01445613|2020553|FG000|30-day Follow-up|Withdrawal by Subject|6
1003157|NCT01445613|2020553|FG000|30-day Follow-up|Physician Decision|3
1003158|NCT01445613|2020553|FG000|30-day Follow-up|Missed visit|23
1003159|NCT01445613|2020553|FG000|30-day Follow-up|Death|3
1003160|NCT01445613|2020553|FG000|1-year Follow-up|Withdrawal by Subject|12
1003161|NCT01445613|2020553|FG000|1-year Follow-up|Missed visit|29
1003162|NCT01445613|2020553|FG000|1-year Follow-up|Lost to Follow-up|2
1003163|NCT01445613|2020553|FG000|1-year Follow-up|Death|30
1003164|NCT01445613|2020553|FG000|1-year Follow-up|Physician Decision|2
1003165|NCT01445613|2020553|FG000|1-year Follow-up|Received a non-study stent|2
1003166|NCT01445652|2020569|FG000|Overall Study|Not comfortable in lenses|5
1003167|NCT01445652|2020570|FG001|Overall Study|Not comfortable in lenses|0
1003168|NCT01445652|2020569|FG000|Overall Study|Failed to attend scheduled visit|2
1003169|NCT01445652|2020570|FG001|Overall Study|Failed to attend scheduled visit|3
1003170|NCT01445652|2020569|FG000|Overall Study|Failed teach session|2
1003171|NCT01445652|2020570|FG001|Overall Study|Failed teach session|0
1003172|NCT01445652|2020569|FG000|Overall Study|Adverse Event|1
1003173|NCT01445652|2020570|FG001|Overall Study|Adverse Event|0
1003174|NCT01445678|2020578|FG000|Overall Study|Adverse Event|12
1003175|NCT01445678|2020579|FG001|Overall Study|Adverse Event|8
1003176|NCT01445678|2020578|FG000|Overall Study|Lack of Efficacy|0
1003177|NCT01445678|2020579|FG001|Overall Study|Lack of Efficacy|2
1003178|NCT01445678|2020578|FG000|Overall Study|Lost to Follow-up|8
1003179|NCT01445678|2020579|FG001|Overall Study|Lost to Follow-up|5
1003180|NCT01445678|2020578|FG000|Overall Study|Protocol Violation|1
1003181|NCT01445678|2020579|FG001|Overall Study|Protocol Violation|1
1003182|NCT01445678|2020578|FG000|Overall Study|Withdrawal by Subject|9
1003183|NCT01445678|2020579|FG001|Overall Study|Withdrawal by Subject|5
1003184|NCT01445730|2020585|FG000|Overall Study|Adverse Event|1
1003185|NCT01445730|2020585|FG000|Overall Study|For the advice of a dentist|1
1003186|NCT01445730|2020585|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9
1003187|NCT01445769|2020589|FG000|Overall Study|Consent Withdrawn|2
1003188|NCT01445769|2020589|FG000|Overall Study|Disease Progression|1
1003189|NCT01445769|2020589|FG000|Overall Study|Lost to Follow-up|5
1003190|NCT01445847|2020606|FG000|Overall Study|Protocol Violation|13
1003191|NCT01445847|2020607|FG001|Overall Study|Protocol Violation|14
1003192|NCT01445847|2020606|FG000|Overall Study|Missed Data|1
1003193|NCT01445847|2020607|FG001|Overall Study|Missed Data|0
1003194|NCT01445886|2020617|FG000|Overall Study|Lost to Follow-up|2
1003195|NCT01445886|2020617|FG000|Overall Study|Protocol Violation|3
1003196|NCT01445951|2020626|FG000|Overall Study|Adverse Event|16
1003197|NCT01445951|2020627|FG001|Overall Study|Adverse Event|9
1003198|NCT01445951|2020628|FG002|Overall Study|Adverse Event|0
1003199|NCT01445951|2020626|FG000|Overall Study|Protocol Violation|2
1003200|NCT01445951|2020627|FG001|Overall Study|Protocol Violation|2
1003201|NCT01445951|2020628|FG002|Overall Study|Protocol Violation|2
1003202|NCT01445951|2020626|FG000|Overall Study|Withdrawal by Subject|21
1003203|NCT01445951|2020627|FG001|Overall Study|Withdrawal by Subject|16
1003204|NCT01445951|2020628|FG002|Overall Study|Withdrawal by Subject|8
1003205|NCT01445951|2020626|FG000|Overall Study|Physician Decision|3
1003206|NCT01445951|2020627|FG001|Overall Study|Physician Decision|1
1003207|NCT01445951|2020628|FG002|Overall Study|Physician Decision|0
1003208|NCT01445951|2020626|FG000|Overall Study|Lost to Follow-up|1
1003209|NCT01445951|2020627|FG001|Overall Study|Lost to Follow-up|2
1003210|NCT01445951|2020628|FG002|Overall Study|Lost to Follow-up|4
1003211|NCT01445951|2020626|FG000|Overall Study|Pregnancy|0
1003212|NCT01445951|2020627|FG001|Overall Study|Pregnancy|1
1003213|NCT01445951|2020628|FG002|Overall Study|Pregnancy|4
1003214|NCT01445951|2020626|FG000|Overall Study|Death|0
1003215|NCT01445951|2020627|FG001|Overall Study|Death|0
1003216|NCT01445951|2020628|FG002|Overall Study|Death|1
1003217|NCT01445951|2020626|FG000|Overall Study|Non-compliance with study drug|1
1003218|NCT01445951|2020627|FG001|Overall Study|Non-compliance with study drug|2
1003219|NCT01445951|2020628|FG002|Overall Study|Non-compliance with study drug|0
1003220|NCT01445951|2020626|FG000|Overall Study|Non-compliance with protocol|0
1003221|NCT01445951|2020627|FG001|Overall Study|Non-compliance with protocol|1
1003222|NCT01445951|2020628|FG002|Overall Study|Non-compliance with protocol|0
1003223|NCT01445951|2020626|FG000|Overall Study|Sponsor decision - subject travel|0
1003224|NCT01445951|2020627|FG001|Overall Study|Sponsor decision - subject travel|1
1003225|NCT01445951|2020628|FG002|Overall Study|Sponsor decision - subject travel|0
1003226|NCT01445951|2020626|FG000|Overall Study|Cough|0
1003227|NCT01445951|2020627|FG001|Overall Study|Cough|1
1003228|NCT01445951|2020628|FG002|Overall Study|Cough|0
1003229|NCT01446003|2020636|FG000|Period 1|Protocol Violation|2
1003230|NCT01446003|2020637|FG001|Period 1|Protocol Violation|0
1003231|NCT01446003|2020636|FG000|Period 2|Adverse Event|1
1003232|NCT01446003|2020637|FG001|Period 2|Adverse Event|0
1003233|NCT01446042|2020646|FG000|Overall Study|Withdrawal by Subject|12
1003234|NCT01446042|2020647|FG001|Overall Study|Withdrawal by Subject|2
1003235|NCT01446042|2020648|FG002|Overall Study|Withdrawal by Subject|4
1003236|NCT01446042|2020646|FG000|Overall Study|Adverse Event|1
1003237|NCT01446042|2020647|FG001|Overall Study|Adverse Event|0
1003238|NCT01446042|2020648|FG002|Overall Study|Adverse Event|4
1003239|NCT01446042|2020646|FG000|Overall Study|Lost to Follow-up|5
1003240|NCT01446042|2020647|FG001|Overall Study|Lost to Follow-up|0
1003241|NCT01446042|2020648|FG002|Overall Study|Lost to Follow-up|0
1003242|NCT01446042|2020646|FG000|Overall Study|Other reasons|2
1003243|NCT01446042|2020647|FG001|Overall Study|Other reasons|1
1003244|NCT01446042|2020648|FG002|Overall Study|Other reasons|1
1003245|NCT01446159|2020660|FG000|Overall Study|Withdrawal by Subject|1
1003246|NCT01446159|2020661|FG001|Overall Study|Withdrawal by Subject|0
1003247|NCT01446159|2020662|FG002|Overall Study|Withdrawal by Subject|14
1003248|NCT01446159|2020663|FG003|Overall Study|Withdrawal by Subject|11
1003249|NCT01446159|2020660|FG000|Overall Study|Lost to Follow-up|0
1003250|NCT01446159|2020661|FG001|Overall Study|Lost to Follow-up|0
1003251|NCT01446159|2020662|FG002|Overall Study|Lost to Follow-up|1
1003252|NCT01446159|2020663|FG003|Overall Study|Lost to Follow-up|2
1003253|NCT01446159|2020660|FG000|Overall Study|Death|2
1003254|NCT01446159|2020661|FG001|Overall Study|Death|3
1003255|NCT01446159|2020662|FG002|Overall Study|Death|43
1003256|NCT01446159|2020663|FG003|Overall Study|Death|36
1003257|NCT01446159|2020660|FG000|Overall Study|Other|0
1003258|NCT01446159|2020661|FG001|Overall Study|Other|0
1003259|NCT01446159|2020662|FG002|Overall Study|Other|13
1003260|NCT01446159|2020663|FG003|Overall Study|Other|13
1003261|NCT01446237|2020675|FG000|Overall Study|Adverse Event|1
1003262|NCT01446237|2020675|FG000|Overall Study|Lost to Follow-up|2
1003263|NCT01446237|2020675|FG000|Overall Study|Withdrawal by Subject|7
1003264|NCT01446289|2020683|FG000|Overall Study|Withdrawal by Subject|1
1003265|NCT01446289|2020684|FG001|Overall Study|Withdrawal by Subject|0
1003266|NCT01446289|2020685|FG002|Overall Study|Withdrawal by Subject|1
1003267|NCT01446289|2020686|FG003|Overall Study|Withdrawal by Subject|0
1003268|NCT01446419|2020700|FG000|Overall Study|Death|1
1003269|NCT01446419|2020701|FG001|Overall Study|Death|0
1003270|NCT01446419|2020700|FG000|Overall Study|Withdrawal by Subject|1
1003271|NCT01446419|2020701|FG001|Overall Study|Withdrawal by Subject|1
1003272|NCT01446419|2020700|FG000|Overall Study|Terminated per protocol|3
1003273|NCT01446419|2020701|FG001|Overall Study|Terminated per protocol|0
1003274|NCT01446809|2020733|FG000|Overall Study|Adverse Event|0
1003275|NCT01446809|2020734|FG001|Overall Study|Adverse Event|0
1003276|NCT01446809|2020735|FG002|Overall Study|Adverse Event|1
1003277|NCT01446809|2020733|FG000|Overall Study|Failure to complete study procedures|0
1003278|NCT01446809|2020734|FG001|Overall Study|Failure to complete study procedures|0
1003279|NCT01446809|2020735|FG002|Overall Study|Failure to complete study procedures|1
1003280|NCT01446874|2020747|FG000|Overall Study|Not eligible|1
1003281|NCT01446874|2020748|FG001|Overall Study|Not eligible|0
1003282|NCT01446874|2020749|FG002|Overall Study|Not eligible|0
1003283|NCT01446874|2020747|FG000|Overall Study|No surgery/No qualifying surgery|1
1003284|NCT01446874|2020748|FG001|Overall Study|No surgery/No qualifying surgery|0
1003285|NCT01446874|2020749|FG002|Overall Study|No surgery/No qualifying surgery|12
1003286|NCT01446874|2020747|FG000|Overall Study|Non-compliance|0
1003287|NCT01446874|2020748|FG001|Overall Study|Non-compliance|4
1003288|NCT01446874|2020749|FG002|Overall Study|Non-compliance|0
1003289|NCT01446874|2020747|FG000|Overall Study|Antibiotics for pre-op infection|0
1003290|NCT01446874|2020748|FG001|Overall Study|Antibiotics for pre-op infection|0
1003291|NCT01446874|2020749|FG002|Overall Study|Antibiotics for pre-op infection|2
1003292|NCT01446874|2020747|FG000|Overall Study|Withdrawal by Subject|0
1003293|NCT01446874|2020748|FG001|Overall Study|Withdrawal by Subject|0
1003294|NCT01446874|2020749|FG002|Overall Study|Withdrawal by Subject|4
1003295|NCT01446913|2020760|FG000|Overall Study|Significant illness|1
1003296|NCT01446913|2020761|FG001|Overall Study|Significant illness|1
1003297|NCT01446913|2020762|FG002|Overall Study|Significant illness|1
1003298|NCT01446913|2020760|FG000|Overall Study|Withdrawal by Subject|5
1003299|NCT01446913|2020761|FG001|Overall Study|Withdrawal by Subject|3
1003300|NCT01446913|2020762|FG002|Overall Study|Withdrawal by Subject|5
1003301|NCT01446913|2020760|FG000|Overall Study|Physician Decision|0
1003302|NCT01446913|2020761|FG001|Overall Study|Physician Decision|0
1003303|NCT01446913|2020762|FG002|Overall Study|Physician Decision|2
1003304|NCT01446913|2020760|FG000|Overall Study|Lost to Follow-up|3
1003305|NCT01446913|2020761|FG001|Overall Study|Lost to Follow-up|5
1003306|NCT01446913|2020762|FG002|Overall Study|Lost to Follow-up|3
1003307|NCT01446965|2020778|FG000|Randominization|One site was dismissed due to IRB irregularity|30
1003308|NCT01446965|2020779|FG001|Randominization|One site was dismissed due to IRB irregularity|16
1003309|NCT01446965|2020778|FG000|Participants Followed and Analyzed|Lost to Follow-up|10
1003310|NCT01446965|2020779|FG001|Participants Followed and Analyzed|Lost to Follow-up|12
1003311|NCT01447407|2020848|FG000|Overall Study|Withdrawal by Subject|2
1003312|NCT01447407|2020849|FG001|Overall Study|Withdrawal by Subject|0
1003313|NCT01447407|2020850|FG002|Overall Study|Withdrawal by Subject|0
1003314|NCT01447407|2020851|FG003|Overall Study|Withdrawal by Subject|1
1003315|NCT01447407|2020848|FG000|Overall Study|Physician Decision|0
1003316|NCT01447407|2020849|FG001|Overall Study|Physician Decision|0
1003317|NCT01447407|2020850|FG002|Overall Study|Physician Decision|1
1003318|NCT01447407|2020851|FG003|Overall Study|Physician Decision|1
1003319|NCT01447420|2020864|FG000|Overall Study|Adverse Event|2
1003320|NCT01447420|2020865|FG001|Overall Study|Adverse Event|4
1003321|NCT01447420|2020866|FG002|Overall Study|Adverse Event|2
1003322|NCT01447420|2020864|FG000|Overall Study|Protocol Violation|3
1003323|NCT01447420|2020865|FG001|Overall Study|Protocol Violation|3
1003324|NCT01447420|2020866|FG002|Overall Study|Protocol Violation|0
1003325|NCT01447420|2020864|FG000|Overall Study|Withdrawal by Subject|4
1003326|NCT01447420|2020865|FG001|Overall Study|Withdrawal by Subject|1
1003327|NCT01447420|2020866|FG002|Overall Study|Withdrawal by Subject|0
1003328|NCT01447420|2020864|FG000|Overall Study|Lack of Efficacy|1
1003329|NCT01447420|2020865|FG001|Overall Study|Lack of Efficacy|19
1003330|NCT01447420|2020866|FG002|Overall Study|Lack of Efficacy|8
1003331|NCT01447433|2020875|FG000|Overall Study|Lost to Follow-up|0
1003332|NCT01447433|2020876|FG001|Overall Study|Lost to Follow-up|2
1003333|NCT01447433|2020875|FG000|Overall Study|Withdrawal by Subject|3
1003334|NCT01447433|2020876|FG001|Overall Study|Withdrawal by Subject|3
1003335|NCT01447433|2020875|FG000|Overall Study|Protocol Violation|1
1003336|NCT01447433|2020876|FG001|Overall Study|Protocol Violation|1
1003337|NCT01447446|2020888|FG000|Overall Study|Death|6
1003338|NCT01447446|2020889|FG001|Overall Study|Death|3
1003339|NCT01447446|2020890|FG002|Overall Study|Death|2
1003340|NCT01447446|2020891|FG003|Overall Study|Death|1
1003341|NCT01447446|2020892|FG004|Overall Study|Death|7
1003342|NCT01447446|2020893|FG005|Overall Study|Death|0
1003343|NCT01447446|2020888|FG000|Overall Study|Adverse Event|3
1003344|NCT01447446|2020889|FG001|Overall Study|Adverse Event|0
1003345|NCT01447446|2020890|FG002|Overall Study|Adverse Event|1
1003346|NCT01447446|2020891|FG003|Overall Study|Adverse Event|0
1003347|NCT01447446|2020892|FG004|Overall Study|Adverse Event|2
1003348|NCT01447446|2020893|FG005|Overall Study|Adverse Event|0
1003349|NCT01447446|2020888|FG000|Overall Study|Failure to Return/Consent Withdrawn|357
1003350|NCT01447446|2020889|FG001|Overall Study|Failure to Return/Consent Withdrawn|78
1003351|NCT01447446|2020890|FG002|Overall Study|Failure to Return/Consent Withdrawn|31
1003352|NCT01447446|2020891|FG003|Overall Study|Failure to Return/Consent Withdrawn|7
1003353|NCT01447446|2020892|FG004|Overall Study|Failure to Return/Consent Withdrawn|69
1003354|NCT01447446|2020893|FG005|Overall Study|Failure to Return/Consent Withdrawn|9
1003355|NCT01447446|2020888|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
1003356|NCT01447446|2020889|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
1003357|NCT01447446|2020890|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
1003358|NCT01447446|2020891|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
1003359|NCT01447446|2020892|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
1003360|NCT01447446|2020893|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
1003361|NCT01447446|2020888|FG000|Overall Study|Administrative/Other|34
1003362|NCT01447446|2020889|FG001|Overall Study|Administrative/Other|9
1003363|NCT01447446|2020890|FG002|Overall Study|Administrative/Other|10
1003364|NCT01447446|2020891|FG003|Overall Study|Administrative/Other|2
1003365|NCT01447446|2020892|FG004|Overall Study|Administrative/Other|33
1003366|NCT01447446|2020893|FG005|Overall Study|Administrative/Other|4
1003367|NCT01447446|2020888|FG000|Overall Study|SVR12 Assessment|13
1003368|NCT01447446|2020889|FG001|Overall Study|SVR12 Assessment|1
1003369|NCT01447446|2020890|FG002|Overall Study|SVR12 Assessment|2
1003370|NCT01447446|2020891|FG003|Overall Study|SVR12 Assessment|1
1003371|NCT01447446|2020892|FG004|Overall Study|SVR12 Assessment|5
1003372|NCT01447446|2020893|FG005|Overall Study|SVR12 Assessment|5
1003373|NCT01447446|2020888|FG000|Overall Study|New Treatment Started|8
1003374|NCT01447446|2020889|FG001|Overall Study|New Treatment Started|2
1003375|NCT01447446|2020890|FG002|Overall Study|New Treatment Started|1
1003376|NCT01447446|2020891|FG003|Overall Study|New Treatment Started|0
1003377|NCT01447446|2020892|FG004|Overall Study|New Treatment Started|2
1003378|NCT01447446|2020893|FG005|Overall Study|New Treatment Started|0
1003379|NCT01447446|2020888|FG000|Overall Study|Reason not Specified|1
1003380|NCT01447446|2020889|FG001|Overall Study|Reason not Specified|1
1003381|NCT01447446|2020890|FG002|Overall Study|Reason not Specified|1
1003382|NCT01447446|2020891|FG003|Overall Study|Reason not Specified|1
1003383|NCT01447446|2020892|FG004|Overall Study|Reason not Specified|1
1003384|NCT01447446|2020893|FG005|Overall Study|Reason not Specified|0
1003385|NCT01447576|2020934|FG000|Overall Study|Lost to Follow-up|52
1003386|NCT01447576|2020934|FG000|Overall Study|Adverse Event|127
1003387|NCT01447576|2020934|FG000|Overall Study|Participant met withdrawal criteria|40
1003388|NCT01447576|2020934|FG000|Overall Study|Withdrawal by Subject|100
1003389|NCT01447576|2020934|FG000|Overall Study|Protocol deviation|83
1003390|NCT01447576|2020934|FG000|Overall Study|Lack of Efficacy|68
1003391|NCT01447576|2020934|FG000|Overall Study|Physician Decision|6
1003392|NCT01447719|2020951|FG000|Overall Study|Image acquisition failure|2
1003393|NCT01447719|2020951|FG000|Overall Study|Invalid image or not imaged|3
1003394|NCT01447719|2020951|FG000|Overall Study|Subject still living at end of study|79
1003395|NCT01447719|2020951|FG000|Overall Study|Withdrawal by Subject|2
1003396|NCT01447719|2020951|FG000|Overall Study|Family withdrew autopsy consent|7
1003397|NCT01447927|2020992|FG000|Overall Study|Adverse Event|4
1003398|NCT01447927|2020993|FG001|Overall Study|Adverse Event|3
1003399|NCT01447927|2020992|FG000|Overall Study|Withdrawal by Subject|1
1003400|NCT01447927|2020993|FG001|Overall Study|Withdrawal by Subject|0
1003401|NCT01448044|2021001|FG000|Treatment Period|Adverse Event|4
1003402|NCT01448044|2021002|FG001|Treatment Period|Adverse Event|3
1003403|NCT01448044|2021001|FG000|Treatment Period|Lack of Efficacy|5
1003404|NCT01448044|2021002|FG001|Treatment Period|Lack of Efficacy|12
1003405|NCT01448044|2021001|FG000|Treatment Period|Subject requested discontinue study drug|1
1003406|NCT01448044|2021002|FG001|Treatment Period|Subject requested discontinue study drug|0
1003407|NCT01448044|2021001|FG000|Treatment Period|Completed 24 weeks treatment period only|8
1003408|NCT01448044|2021002|FG001|Treatment Period|Completed 24 weeks treatment period only|0
1003409|NCT01448044|2021001|FG000|Treatment Period|Participant does not meet study criteria|1
1003410|NCT01448044|2021002|FG001|Treatment Period|Participant does not meet study criteria|0
1003411|NCT01448044|2021001|FG000|Treatment Period|Lost to Follow-up|2
1003412|NCT01448044|2021002|FG001|Treatment Period|Lost to Follow-up|1
1003413|NCT01448044|2021001|FG000|Treatment Period|Other reason|2
1003414|NCT01448044|2021002|FG001|Treatment Period|Other reason|0
1003415|NCT01448044|2021001|FG000|Follow Up Period|Withdrawal by Subject|1
1003416|NCT01448044|2021002|FG001|Follow Up Period|Withdrawal by Subject|1
1003417|NCT01448044|2021001|FG000|Follow Up Period|Lost to Follow-up|6
1003418|NCT01448044|2021002|FG001|Follow Up Period|Lost to Follow-up|2
1003419|NCT01448044|2021001|FG000|Follow Up Period|Other|5
1003420|NCT01448044|2021002|FG001|Follow Up Period|Other|11
1003421|NCT01448057|2021010|FG000|Overall Study|Protocol Violation|3
1003422|NCT01448057|2021011|FG001|Overall Study|Protocol Violation|2
1003423|NCT01448057|2021010|FG000|Overall Study|Lost to Follow-up|3
1003424|NCT01448057|2021011|FG001|Overall Study|Lost to Follow-up|0
1003425|NCT01448057|2021010|FG000|Overall Study|Adverse Event|0
1003426|NCT01448057|2021011|FG001|Overall Study|Adverse Event|2
1003427|NCT01448057|2021010|FG000|Overall Study|Withdrawal by Subject|2
1003428|NCT01448057|2021011|FG001|Overall Study|Withdrawal by Subject|0
1003429|NCT01448213|2021019|FG000|Overall Study|Lost to Follow-up|12
1003430|NCT01448213|2021020|FG001|Overall Study|Lost to Follow-up|10
1003431|NCT01448213|2021019|FG000|Overall Study|Adverse Event|4
1003432|NCT01448213|2021020|FG001|Overall Study|Adverse Event|10
1003433|NCT01448213|2021019|FG000|Overall Study|Protocol Violation|1
1003434|NCT01448213|2021020|FG001|Overall Study|Protocol Violation|2
1003435|NCT01448616|2021065|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3
1003436|NCT01448616|2021066|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0
1003437|NCT01448616|2021067|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0
1003438|NCT01448616|2021068|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0
1003439|NCT01448616|2021065|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6
1003440|NCT01448616|2021066|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1003441|NCT01448616|2021067|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1003442|NCT01448616|2021068|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1003443|NCT01448616|2021065|FG000|Study Drug (Treatment Phase)|Adverse Event|0
1003444|NCT01448616|2021066|FG001|Study Drug (Treatment Phase)|Adverse Event|1
1003445|NCT01448616|2021067|FG002|Study Drug (Treatment Phase)|Adverse Event|1
1003446|NCT01448616|2021068|FG003|Study Drug (Treatment Phase)|Adverse Event|0
1003447|NCT01448616|2021065|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0
1003448|NCT01448616|2021066|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0
1003449|NCT01448616|2021067|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1
1003450|NCT01448616|2021068|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2
1003451|NCT01448616|2021065|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0
1003452|NCT01448616|2021066|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1
1003453|NCT01448616|2021067|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2
1003454|NCT01448616|2021068|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2
1003455|NCT01448707|2021083|FG000|Overall Study|Adverse Event|3
1003456|NCT01448707|2021084|FG001|Overall Study|Adverse Event|1
1003457|NCT01448707|2021083|FG000|Overall Study|Lost to Follow-up|2
1003458|NCT01448707|2021084|FG001|Overall Study|Lost to Follow-up|6
1003459|NCT01448707|2021083|FG000|Overall Study|Withdrawal by Subject|6
1003460|NCT01448707|2021084|FG001|Overall Study|Withdrawal by Subject|7
1003461|NCT01448707|2021083|FG000|Overall Study|Other|7
1003462|NCT01448707|2021084|FG001|Overall Study|Other|4
1003463|NCT01448824|2021098|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1003464|NCT01448824|2021099|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1003465|NCT01448824|2021100|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1003466|NCT01448824|2021101|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1003467|NCT01448824|2021102|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1003468|NCT01448824|2021103|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1003469|NCT01448824|2021104|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
1003470|NCT01448824|2021105|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1003471|NCT01448824|2021098|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
1003472|NCT01448824|2021099|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
1003473|NCT01448824|2021100|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
1003474|NCT01448824|2021101|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
1003475|NCT01448824|2021102|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
1003476|NCT01448824|2021103|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
1003477|NCT01448824|2021104|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
1003478|NCT01448824|2021105|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
1003479|NCT01448824|2021098|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1003480|NCT01448824|2021099|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1003481|NCT01448824|2021100|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1003482|NCT01448824|2021101|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1003483|NCT01448824|2021102|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1003484|NCT01448824|2021103|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
1003485|NCT01448824|2021104|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1090776|NCT02248818|2158523|FG005|Screening|Withdrawal by Subject|0
1003486|NCT01448824|2021105|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1003487|NCT01448824|2021098|FG000|Part 1: Washout Period|Lost to Follow-up|1
1003488|NCT01448824|2021099|FG001|Part 1: Washout Period|Lost to Follow-up|0
1003489|NCT01448824|2021100|FG002|Part 1: Washout Period|Lost to Follow-up|0
1003490|NCT01448824|2021101|FG003|Part 1: Washout Period|Lost to Follow-up|0
1003491|NCT01448824|2021102|FG004|Part 1: Washout Period|Lost to Follow-up|0
1003492|NCT01448824|2021103|FG005|Part 1: Washout Period|Lost to Follow-up|0
1003493|NCT01448824|2021104|FG006|Part 1: Washout Period|Lost to Follow-up|0
1003494|NCT01448824|2021105|FG007|Part 1: Washout Period|Lost to Follow-up|0
1003495|NCT01448824|2021098|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1003496|NCT01448824|2021099|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1003497|NCT01448824|2021100|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1003498|NCT01448824|2021101|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1003499|NCT01448824|2021102|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1003500|NCT01448824|2021103|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1003501|NCT01448824|2021104|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1003502|NCT01448824|2021105|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
1003503|NCT01448824|2021098|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1003504|NCT01448824|2021099|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1003505|NCT01448824|2021100|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1003506|NCT01448824|2021101|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1003507|NCT01448824|2021102|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1003508|NCT01448824|2021103|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1003509|NCT01448824|2021104|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1003510|NCT01448824|2021105|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
1003511|NCT01448824|2021098|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1003512|NCT01448824|2021099|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1003513|NCT01448824|2021100|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1003514|NCT01448824|2021101|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1003515|NCT01448824|2021102|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1003516|NCT01448824|2021103|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1003517|NCT01448824|2021104|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1003518|NCT01448824|2021105|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
1003519|NCT01448824|2021098|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1003520|NCT01448824|2021099|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1003521|NCT01448824|2021100|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1003522|NCT01448824|2021101|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1003523|NCT01448824|2021102|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1003524|NCT01448824|2021103|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1003525|NCT01448824|2021104|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1003526|NCT01448824|2021105|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
1003527|NCT01448850|2021135|FG000|Overall Study|Death|3
1003528|NCT01448850|2021136|FG001|Overall Study|Death|6
1003529|NCT01448850|2021135|FG000|Overall Study|Withdrawal by Subject|13
1003530|NCT01448850|2021136|FG001|Overall Study|Withdrawal by Subject|21
1003531|NCT01448850|2021135|FG000|Overall Study|Lost to Follow-up|3
1003532|NCT01448850|2021136|FG001|Overall Study|Lost to Follow-up|1
1003533|NCT01448850|2021135|FG000|Overall Study|Other|15
1003534|NCT01448850|2021136|FG001|Overall Study|Other|12
1003535|NCT01449006|2021145|FG000|Overall Study|Lost to Follow-up|1
1003536|NCT01449006|2021146|FG001|Overall Study|Lost to Follow-up|0
1003537|NCT01449006|2021145|FG000|Overall Study|Withdrawal by Subject|1
1003538|NCT01449006|2021146|FG001|Overall Study|Withdrawal by Subject|0
1003539|NCT01449006|2021145|FG000|Overall Study|Protocol Violation|1
1003540|NCT01449006|2021146|FG001|Overall Study|Protocol Violation|0
1003541|NCT01449279|2021160|FG000|Overall Study|Lack of Efficacy|5
1003542|NCT01449279|2021160|FG000|Overall Study|Toxicity|2
1003543|NCT01449370|2021193|FG000|Overall Study|Disease Progression|5
1003544|NCT01449370|2021194|FG001|Overall Study|Disease Progression|4
1003545|NCT01449370|2021195|FG002|Overall Study|Disease Progression|8
1003546|NCT01449370|2021196|FG003|Overall Study|Disease Progression|3
1003547|NCT01449370|2021197|FG004|Overall Study|Disease Progression|3
1003548|NCT01449370|2021198|FG005|Overall Study|Disease Progression|3
1003549|NCT01449370|2021199|FG006|Overall Study|Disease Progression|3
1003550|NCT01449370|2021200|FG007|Overall Study|Disease Progression|2
1003551|NCT01449370|2021201|FG008|Overall Study|Disease Progression|9
1003552|NCT01449370|2021202|FG009|Overall Study|Disease Progression|1
1003553|NCT01449370|2021203|FG010|Overall Study|Disease Progression|3
1003554|NCT01449370|2021204|FG011|Overall Study|Disease Progression|3
1003555|NCT01449370|2021205|FG012|Overall Study|Disease Progression|2
1003556|NCT01449370|2021206|FG013|Overall Study|Disease Progression|8
1003557|NCT01449370|2021207|FG014|Overall Study|Disease Progression|3
1003558|NCT01449370|2021208|FG015|Overall Study|Disease Progression|1
1003559|NCT01449370|2021209|FG016|Overall Study|Disease Progression|4
1003560|NCT01449370|2021210|FG017|Overall Study|Disease Progression|3
1003561|NCT01449370|2021211|FG018|Overall Study|Disease Progression|1
1003562|NCT01449370|2021212|FG019|Overall Study|Disease Progression|2
1003563|NCT01449370|2021213|FG020|Overall Study|Disease Progression|5
1003564|NCT01449370|2021214|FG021|Overall Study|Disease Progression|2
1003565|NCT01449370|2021215|FG022|Overall Study|Disease Progression|3
1003566|NCT01449370|2021216|FG023|Overall Study|Disease Progression|7
1003567|NCT01449370|2021217|FG024|Overall Study|Disease Progression|3
1003568|NCT01449370|2021193|FG000|Overall Study|Adverse Event|1
1003569|NCT01449370|2021194|FG001|Overall Study|Adverse Event|2
1003570|NCT01449370|2021195|FG002|Overall Study|Adverse Event|0
1003571|NCT01449370|2021196|FG003|Overall Study|Adverse Event|1
1003572|NCT01449370|2021197|FG004|Overall Study|Adverse Event|0
1003573|NCT01449370|2021198|FG005|Overall Study|Adverse Event|0
1003574|NCT01449370|2021199|FG006|Overall Study|Adverse Event|0
1003575|NCT01449370|2021200|FG007|Overall Study|Adverse Event|0
1003576|NCT01449370|2021201|FG008|Overall Study|Adverse Event|1
1003577|NCT01449370|2021202|FG009|Overall Study|Adverse Event|1
1003578|NCT01449370|2021203|FG010|Overall Study|Adverse Event|0
1003579|NCT01449370|2021204|FG011|Overall Study|Adverse Event|0
1003580|NCT01449370|2021205|FG012|Overall Study|Adverse Event|0
1003581|NCT01449370|2021206|FG013|Overall Study|Adverse Event|2
1003582|NCT01449370|2021207|FG014|Overall Study|Adverse Event|0
1003583|NCT01449370|2021208|FG015|Overall Study|Adverse Event|1
1003584|NCT01449370|2021209|FG016|Overall Study|Adverse Event|0
1003585|NCT01449370|2021210|FG017|Overall Study|Adverse Event|0
1003586|NCT01449370|2021211|FG018|Overall Study|Adverse Event|1
1003587|NCT01449370|2021212|FG019|Overall Study|Adverse Event|1
1003588|NCT01449370|2021213|FG020|Overall Study|Adverse Event|0
1003589|NCT01449370|2021214|FG021|Overall Study|Adverse Event|1
1003590|NCT01449370|2021215|FG022|Overall Study|Adverse Event|0
1003591|NCT01449370|2021216|FG023|Overall Study|Adverse Event|1
1003592|NCT01449370|2021217|FG024|Overall Study|Adverse Event|3
1003593|NCT01449370|2021193|FG000|Overall Study|Participant Decision|0
1003594|NCT01449370|2021194|FG001|Overall Study|Participant Decision|0
1003595|NCT01449370|2021195|FG002|Overall Study|Participant Decision|0
1003596|NCT01449370|2021196|FG003|Overall Study|Participant Decision|0
1003597|NCT01449370|2021197|FG004|Overall Study|Participant Decision|0
1003598|NCT01449370|2021198|FG005|Overall Study|Participant Decision|0
1003599|NCT01449370|2021199|FG006|Overall Study|Participant Decision|0
1003600|NCT01449370|2021200|FG007|Overall Study|Participant Decision|1
1003601|NCT01449370|2021201|FG008|Overall Study|Participant Decision|1
1003602|NCT01449370|2021202|FG009|Overall Study|Participant Decision|0
1003603|NCT01449370|2021203|FG010|Overall Study|Participant Decision|0
1003604|NCT01449370|2021204|FG011|Overall Study|Participant Decision|0
1003605|NCT01449370|2021205|FG012|Overall Study|Participant Decision|1
1003606|NCT01449370|2021206|FG013|Overall Study|Participant Decision|1
1003607|NCT01449370|2021207|FG014|Overall Study|Participant Decision|0
1003608|NCT01449370|2021208|FG015|Overall Study|Participant Decision|1
1003609|NCT01449370|2021209|FG016|Overall Study|Participant Decision|3
1003610|NCT01449370|2021210|FG017|Overall Study|Participant Decision|0
1003611|NCT01449370|2021211|FG018|Overall Study|Participant Decision|1
1003612|NCT01449370|2021212|FG019|Overall Study|Participant Decision|0
1003613|NCT01449370|2021213|FG020|Overall Study|Participant Decision|0
1003614|NCT01449370|2021214|FG021|Overall Study|Participant Decision|1
1003615|NCT01449370|2021215|FG022|Overall Study|Participant Decision|0
1003616|NCT01449370|2021216|FG023|Overall Study|Participant Decision|0
1003617|NCT01449370|2021217|FG024|Overall Study|Participant Decision|1
1003618|NCT01449370|2021193|FG000|Overall Study|Lost to Follow-up|0
1003619|NCT01449370|2021194|FG001|Overall Study|Lost to Follow-up|0
1003620|NCT01449370|2021195|FG002|Overall Study|Lost to Follow-up|0
1003621|NCT01449370|2021196|FG003|Overall Study|Lost to Follow-up|0
1003622|NCT01449370|2021197|FG004|Overall Study|Lost to Follow-up|0
1003623|NCT01449370|2021198|FG005|Overall Study|Lost to Follow-up|0
1003624|NCT01449370|2021199|FG006|Overall Study|Lost to Follow-up|0
1003625|NCT01449370|2021200|FG007|Overall Study|Lost to Follow-up|0
1003626|NCT01449370|2021201|FG008|Overall Study|Lost to Follow-up|0
1003627|NCT01449370|2021202|FG009|Overall Study|Lost to Follow-up|0
1003628|NCT01449370|2021203|FG010|Overall Study|Lost to Follow-up|0
1003629|NCT01449370|2021204|FG011|Overall Study|Lost to Follow-up|0
1003630|NCT01449370|2021205|FG012|Overall Study|Lost to Follow-up|0
1003631|NCT01449370|2021206|FG013|Overall Study|Lost to Follow-up|0
1003632|NCT01449370|2021207|FG014|Overall Study|Lost to Follow-up|0
1003633|NCT01449370|2021208|FG015|Overall Study|Lost to Follow-up|0
1003634|NCT01449370|2021209|FG016|Overall Study|Lost to Follow-up|0
1003635|NCT01449370|2021210|FG017|Overall Study|Lost to Follow-up|0
1003636|NCT01449370|2021211|FG018|Overall Study|Lost to Follow-up|0
1003637|NCT01449370|2021212|FG019|Overall Study|Lost to Follow-up|0
1003638|NCT01449370|2021213|FG020|Overall Study|Lost to Follow-up|1
1003639|NCT01449370|2021214|FG021|Overall Study|Lost to Follow-up|0
1003640|NCT01449370|2021215|FG022|Overall Study|Lost to Follow-up|0
1003641|NCT01449370|2021216|FG023|Overall Study|Lost to Follow-up|0
1003642|NCT01449370|2021217|FG024|Overall Study|Lost to Follow-up|0
1003643|NCT01449370|2021193|FG000|Overall Study|Other|0
1003644|NCT01449370|2021194|FG001|Overall Study|Other|0
1003645|NCT01449370|2021195|FG002|Overall Study|Other|0
1003646|NCT01449370|2021196|FG003|Overall Study|Other|0
1003647|NCT01449370|2021197|FG004|Overall Study|Other|0
1003648|NCT01449370|2021198|FG005|Overall Study|Other|0
1003649|NCT01449370|2021199|FG006|Overall Study|Other|0
1003650|NCT01449370|2021200|FG007|Overall Study|Other|0
1003651|NCT01449370|2021201|FG008|Overall Study|Other|1
1003652|NCT01449370|2021202|FG009|Overall Study|Other|1
1003653|NCT01449370|2021203|FG010|Overall Study|Other|0
1003654|NCT01449370|2021204|FG011|Overall Study|Other|0
1003655|NCT01449370|2021205|FG012|Overall Study|Other|0
1003656|NCT01449370|2021206|FG013|Overall Study|Other|0
1003657|NCT01449370|2021207|FG014|Overall Study|Other|0
1003658|NCT01449370|2021208|FG015|Overall Study|Other|0
1003659|NCT01449370|2021209|FG016|Overall Study|Other|0
1003660|NCT01449370|2021210|FG017|Overall Study|Other|0
1003661|NCT01449370|2021211|FG018|Overall Study|Other|0
1003662|NCT01449370|2021212|FG019|Overall Study|Other|0
1003663|NCT01449370|2021213|FG020|Overall Study|Other|0
1003664|NCT01449370|2021214|FG021|Overall Study|Other|0
1003665|NCT01449370|2021215|FG022|Overall Study|Other|1
1003666|NCT01449370|2021216|FG023|Overall Study|Other|1
1003667|NCT01449370|2021217|FG024|Overall Study|Other|0
1003668|NCT01449370|2021193|FG000|Overall Study|Medication Prohibited by Protocol|0
1003669|NCT01449370|2021194|FG001|Overall Study|Medication Prohibited by Protocol|0
1003670|NCT01449370|2021195|FG002|Overall Study|Medication Prohibited by Protocol|0
1003671|NCT01449370|2021196|FG003|Overall Study|Medication Prohibited by Protocol|0
1003672|NCT01449370|2021197|FG004|Overall Study|Medication Prohibited by Protocol|0
1003673|NCT01449370|2021198|FG005|Overall Study|Medication Prohibited by Protocol|0
1003674|NCT01449370|2021199|FG006|Overall Study|Medication Prohibited by Protocol|0
1003675|NCT01449370|2021200|FG007|Overall Study|Medication Prohibited by Protocol|0
1003676|NCT01449370|2021201|FG008|Overall Study|Medication Prohibited by Protocol|0
1003677|NCT01449370|2021202|FG009|Overall Study|Medication Prohibited by Protocol|0
1003678|NCT01449370|2021203|FG010|Overall Study|Medication Prohibited by Protocol|0
1003679|NCT01449370|2021204|FG011|Overall Study|Medication Prohibited by Protocol|0
1003680|NCT01449370|2021205|FG012|Overall Study|Medication Prohibited by Protocol|0
1003681|NCT01449370|2021206|FG013|Overall Study|Medication Prohibited by Protocol|0
1003682|NCT01449370|2021207|FG014|Overall Study|Medication Prohibited by Protocol|0
1003683|NCT01449370|2021208|FG015|Overall Study|Medication Prohibited by Protocol|0
1003684|NCT01449370|2021209|FG016|Overall Study|Medication Prohibited by Protocol|0
1003685|NCT01449370|2021210|FG017|Overall Study|Medication Prohibited by Protocol|0
1003686|NCT01449370|2021211|FG018|Overall Study|Medication Prohibited by Protocol|0
1003687|NCT01449370|2021212|FG019|Overall Study|Medication Prohibited by Protocol|0
1003688|NCT01449370|2021213|FG020|Overall Study|Medication Prohibited by Protocol|0
1003689|NCT01449370|2021214|FG021|Overall Study|Medication Prohibited by Protocol|0
1003690|NCT01449370|2021215|FG022|Overall Study|Medication Prohibited by Protocol|0
1003691|NCT01449370|2021216|FG023|Overall Study|Medication Prohibited by Protocol|1
1003692|NCT01449370|2021217|FG024|Overall Study|Medication Prohibited by Protocol|0
1003693|NCT01449370|2021193|FG000|Overall Study|Death|0
1003694|NCT01449370|2021194|FG001|Overall Study|Death|0
1003695|NCT01449370|2021195|FG002|Overall Study|Death|0
1003696|NCT01449370|2021196|FG003|Overall Study|Death|0
1003697|NCT01449370|2021197|FG004|Overall Study|Death|0
1003698|NCT01449370|2021198|FG005|Overall Study|Death|0
1003699|NCT01449370|2021199|FG006|Overall Study|Death|0
1003700|NCT01449370|2021200|FG007|Overall Study|Death|0
1003701|NCT01449370|2021201|FG008|Overall Study|Death|0
1003702|NCT01449370|2021202|FG009|Overall Study|Death|0
1003703|NCT01449370|2021203|FG010|Overall Study|Death|0
1003704|NCT01449370|2021204|FG011|Overall Study|Death|0
1003705|NCT01449370|2021205|FG012|Overall Study|Death|0
1003706|NCT01449370|2021206|FG013|Overall Study|Death|0
1003707|NCT01449370|2021207|FG014|Overall Study|Death|0
1003708|NCT01449370|2021208|FG015|Overall Study|Death|0
1003709|NCT01449370|2021209|FG016|Overall Study|Death|0
1003710|NCT01449370|2021210|FG017|Overall Study|Death|0
1003711|NCT01449370|2021211|FG018|Overall Study|Death|0
1003712|NCT01449370|2021212|FG019|Overall Study|Death|0
1003713|NCT01449370|2021213|FG020|Overall Study|Death|0
1003714|NCT01449370|2021214|FG021|Overall Study|Death|0
1003715|NCT01449370|2021215|FG022|Overall Study|Death|0
1003716|NCT01449370|2021216|FG023|Overall Study|Death|0
1003717|NCT01449370|2021217|FG024|Overall Study|Death|1
1003718|NCT01449461|2021296|FG000|Overall Study|Adverse Event|0
1003719|NCT01449461|2021297|FG001|Overall Study|Adverse Event|3
1003720|NCT01449461|2021298|FG002|Overall Study|Adverse Event|2
1003721|NCT01449461|2021299|FG003|Overall Study|Adverse Event|3
1003722|NCT01449461|2021300|FG004|Overall Study|Adverse Event|4
1003723|NCT01449461|2021301|FG005|Overall Study|Adverse Event|4
1003724|NCT01449461|2021296|FG000|Overall Study|Death|0
1003725|NCT01449461|2021297|FG001|Overall Study|Death|2
1003726|NCT01449461|2021298|FG002|Overall Study|Death|0
1003727|NCT01449461|2021299|FG003|Overall Study|Death|0
1003728|NCT01449461|2021300|FG004|Overall Study|Death|7
1003729|NCT01449461|2021301|FG005|Overall Study|Death|1
1003730|NCT01449461|2021296|FG000|Overall Study|Physician Decision|0
1003731|NCT01449461|2021297|FG001|Overall Study|Physician Decision|1
1003732|NCT01449461|2021298|FG002|Overall Study|Physician Decision|0
1003733|NCT01449461|2021299|FG003|Overall Study|Physician Decision|4
1003734|NCT01449461|2021300|FG004|Overall Study|Physician Decision|1
1003735|NCT01449461|2021301|FG005|Overall Study|Physician Decision|0
1003736|NCT01449461|2021296|FG000|Overall Study|Documented Progressive Disease|4
1003737|NCT01449461|2021297|FG001|Overall Study|Documented Progressive Disease|7
1003738|NCT01449461|2021298|FG002|Overall Study|Documented Progressive Disease|14
1003739|NCT01449461|2021299|FG003|Overall Study|Documented Progressive Disease|15
1003740|NCT01449461|2021300|FG004|Overall Study|Documented Progressive Disease|24
1003741|NCT01449461|2021301|FG005|Overall Study|Documented Progressive Disease|5
1003742|NCT01449461|2021296|FG000|Overall Study|Clinical Progressive Disease|2
1003743|NCT01449461|2021297|FG001|Overall Study|Clinical Progressive Disease|2
1003744|NCT01449461|2021298|FG002|Overall Study|Clinical Progressive Disease|0
1003745|NCT01449461|2021299|FG003|Overall Study|Clinical Progressive Disease|3
1003746|NCT01449461|2021300|FG004|Overall Study|Clinical Progressive Disease|4
1003747|NCT01449461|2021301|FG005|Overall Study|Clinical Progressive Disease|2
1003748|NCT01449461|2021296|FG000|Overall Study|Protocol Violation|0
1003749|NCT01449461|2021297|FG001|Overall Study|Protocol Violation|0
1003750|NCT01449461|2021298|FG002|Overall Study|Protocol Violation|0
1003751|NCT01449461|2021299|FG003|Overall Study|Protocol Violation|1
1003752|NCT01449461|2021300|FG004|Overall Study|Protocol Violation|0
1003753|NCT01449461|2021301|FG005|Overall Study|Protocol Violation|0
1003754|NCT01449461|2021296|FG000|Overall Study|Site Terminated by Sponsor|0
1003755|NCT01449461|2021297|FG001|Overall Study|Site Terminated by Sponsor|1
1003756|NCT01449461|2021298|FG002|Overall Study|Site Terminated by Sponsor|2
1003757|NCT01449461|2021299|FG003|Overall Study|Site Terminated by Sponsor|3
1003758|NCT01449461|2021300|FG004|Overall Study|Site Terminated by Sponsor|4
1003759|NCT01449461|2021301|FG005|Overall Study|Site Terminated by Sponsor|1
1003760|NCT01449461|2021296|FG000|Overall Study|Withdrawal by Subject|0
1003761|NCT01449461|2021297|FG001|Overall Study|Withdrawal by Subject|1
1003762|NCT01449461|2021298|FG002|Overall Study|Withdrawal by Subject|0
1003763|NCT01449461|2021299|FG003|Overall Study|Withdrawal by Subject|0
1003764|NCT01449461|2021300|FG004|Overall Study|Withdrawal by Subject|2
1003765|NCT01449461|2021301|FG005|Overall Study|Withdrawal by Subject|1
1003766|NCT01449461|2021296|FG000|Overall Study|Reason not Specified|0
1003767|NCT01449461|2021297|FG001|Overall Study|Reason not Specified|1
1003768|NCT01449461|2021298|FG002|Overall Study|Reason not Specified|0
1003769|NCT01449461|2021299|FG003|Overall Study|Reason not Specified|3
1003770|NCT01449461|2021300|FG004|Overall Study|Reason not Specified|2
1003771|NCT01449461|2021301|FG005|Overall Study|Reason not Specified|1
1003772|NCT01449526|2021335|FG000|Overall Study|Lost to Follow-up|1
1003773|NCT01449526|2021336|FG001|Overall Study|Lost to Follow-up|2
1003774|NCT01449526|2021335|FG000|Overall Study|Withdrawal by Subject|1
1003775|NCT01449526|2021336|FG001|Overall Study|Withdrawal by Subject|1
1003776|NCT01449526|2021335|FG000|Overall Study|Symptoms/complaints|0
1003777|NCT01449526|2021336|FG001|Overall Study|Symptoms/complaints|1
1003778|NCT01449526|2021335|FG000|Overall Study|Lack of Motivation|0
1003779|NCT01449526|2021336|FG001|Overall Study|Lack of Motivation|1
1003780|NCT01449526|2021335|FG000|Overall Study|Cannot maintain visits|0
1003781|NCT01449526|2021336|FG001|Overall Study|Cannot maintain visits|1
1003782|NCT01449539|2021342|FG000|Overall Study|Withdrawal by Subject|3
1003783|NCT01449539|2021342|FG000|Overall Study|Toxicity not study related|1
1003784|NCT01449630|2021355|FG000|Period 1|Physician Decision|1
1003785|NCT01449630|2021356|FG001|Period 1|Physician Decision|0
1003786|NCT01449630|2021357|FG002|Period 1|Physician Decision|0
1003787|NCT01449630|2021358|FG003|Period 1|Physician Decision|1
1003788|NCT01449630|2021359|FG004|Period 1|Physician Decision|0
1003789|NCT01449630|2021360|FG005|Period 1|Physician Decision|0
1003790|NCT01449630|2021361|FG006|Period 1|Physician Decision|0
1003791|NCT01449630|2021362|FG007|Period 1|Physician Decision|0
1003792|NCT01449630|2021363|FG008|Period 1|Physician Decision|0
1003793|NCT01449630|2021355|FG000|Period 1|Sponsor Decision|0
1003794|NCT01449630|2021356|FG001|Period 1|Sponsor Decision|0
1003795|NCT01449630|2021357|FG002|Period 1|Sponsor Decision|0
1003796|NCT01449630|2021358|FG003|Period 1|Sponsor Decision|0
1003797|NCT01449630|2021359|FG004|Period 1|Sponsor Decision|0
1003798|NCT01449630|2021360|FG005|Period 1|Sponsor Decision|1
1003799|NCT01449630|2021361|FG006|Period 1|Sponsor Decision|0
1003800|NCT01449630|2021362|FG007|Period 1|Sponsor Decision|0
1003801|NCT01449630|2021363|FG008|Period 1|Sponsor Decision|0
1003802|NCT01449630|2021355|FG000|Period 2|Sponsor Decision|0
1003803|NCT01449630|2021356|FG001|Period 2|Sponsor Decision|0
1003804|NCT01449630|2021357|FG002|Period 2|Sponsor Decision|0
1003805|NCT01449630|2021358|FG003|Period 2|Sponsor Decision|0
1003806|NCT01449630|2021359|FG004|Period 2|Sponsor Decision|0
1003807|NCT01449630|2021360|FG005|Period 2|Sponsor Decision|0
1003808|NCT01449630|2021361|FG006|Period 2|Sponsor Decision|1
1003809|NCT01449630|2021362|FG007|Period 2|Sponsor Decision|0
1003810|NCT01449630|2021363|FG008|Period 2|Sponsor Decision|0
1003811|NCT01449682|2021387|FG000|Overall Study|Death|0
1003812|NCT01449682|2021388|FG001|Overall Study|Death|1
1003813|NCT01449682|2021387|FG000|Overall Study|Adverse Event|1
1003814|NCT01449682|2021388|FG001|Overall Study|Adverse Event|0
1003815|NCT01449708|2021396|FG000|Overall Study|Protocol Violation|0
1003816|NCT01449708|2021397|FG001|Overall Study|Protocol Violation|1
1003817|NCT01449708|2021396|FG000|Overall Study|surgical complication|1
1003818|NCT01449708|2021397|FG001|Overall Study|surgical complication|2
1003819|NCT01449708|2021396|FG000|Overall Study|respiratory failure|1
1003820|NCT01449708|2021397|FG001|Overall Study|respiratory failure|0
1003821|NCT01449721|2021408|FG000|Overall Study|Physician Decision|0
1003822|NCT01449721|2021409|FG001|Overall Study|Physician Decision|1
1003823|NCT01449721|2021408|FG000|Overall Study|Physician Decision|0
1003824|NCT01449721|2021409|FG001|Overall Study|Physician Decision|1
1003825|NCT01449812|2021431|FG000|Overall Study|Migrated/moved from study area|1
1003826|NCT01449812|2021432|FG001|Overall Study|Migrated/moved from study area|0
1003827|NCT01449812|2021433|FG002|Overall Study|Migrated/moved from study area|0
1003828|NCT01449812|2021431|FG000|Overall Study|Withdrawal by Subject|0
1003829|NCT01449812|2021432|FG001|Overall Study|Withdrawal by Subject|0
1003830|NCT01449812|2021433|FG002|Overall Study|Withdrawal by Subject|1
1003831|NCT01449812|2021431|FG000|Overall Study|Lost to Follow-up|1
1003832|NCT01449812|2021432|FG001|Overall Study|Lost to Follow-up|0
1003833|NCT01449812|2021433|FG002|Overall Study|Lost to Follow-up|0
1003834|NCT01449929|2021447|FG000|Randomization Phase 96 Week|Adverse Event|5
1003835|NCT01449929|2021448|FG001|Randomization Phase 96 Week|Adverse Event|13
1003836|NCT01449929|2021449|FG002|Randomization Phase 96 Week|Adverse Event|0
1003837|NCT01449929|2021447|FG000|Randomization Phase 96 Week|Lack of Efficacy|3
1003838|NCT01449929|2021448|FG001|Randomization Phase 96 Week|Lack of Efficacy|4
1003839|NCT01449929|2021449|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
1003840|NCT01449929|2021447|FG000|Randomization Phase 96 Week|Protocol Violation|5
1003841|NCT01449929|2021448|FG001|Randomization Phase 96 Week|Protocol Violation|6
1003842|NCT01449929|2021449|FG002|Randomization Phase 96 Week|Protocol Violation|0
1003843|NCT01449929|2021447|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
1003844|NCT01449929|2021448|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
1003845|NCT01449929|2021449|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
1003846|NCT01449929|2021447|FG000|Randomization Phase 96 Week|Lost to Follow-up|15
1003847|NCT01449929|2021448|FG001|Randomization Phase 96 Week|Lost to Follow-up|18
1003848|NCT01449929|2021449|FG002|Randomization Phase 96 Week|Lost to Follow-up|0
1003849|NCT01449929|2021447|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
1003850|NCT01449929|2021448|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8
1003851|NCT01449929|2021449|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0
1003852|NCT01449929|2021447|FG000|Randomization Phase 96 Week|Physician Decision|2
1003853|NCT01449929|2021448|FG001|Randomization Phase 96 Week|Physician Decision|3
1003854|NCT01449929|2021449|FG002|Randomization Phase 96 Week|Physician Decision|0
1003855|NCT01449929|2021447|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0
1003856|NCT01449929|2021448|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1
1003857|NCT01449929|2021449|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0
1003858|NCT01449929|2021447|FG000|Extension Phase Approximately 3 Years|Adverse Event|0
1003859|NCT01449929|2021448|FG001|Extension Phase Approximately 3 Years|Adverse Event|0
1003860|NCT01449929|2021449|FG002|Extension Phase Approximately 3 Years|Adverse Event|2
1003861|NCT01449929|2021447|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0
1003862|NCT01449929|2021448|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0
1003863|NCT01449929|2021449|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2
1003864|NCT01449929|2021447|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0
1003865|NCT01449929|2021448|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0
1003866|NCT01449929|2021449|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4
1003867|NCT01449955|2021461|FG000|Overall Study|Withdrawal by Subject|1
1003868|NCT01449955|2021462|FG001|Overall Study|Withdrawal by Subject|2
1003869|NCT01450007|2021478|FG000|Overall Study|Late exclusion before treatment|2
1003870|NCT01450007|2021479|FG001|Overall Study|Late exclusion before treatment|3
1003871|NCT01450007|2021480|FG002|Overall Study|Late exclusion before treatment|2
1003872|NCT01450007|2021478|FG000|Overall Study|Protocol Violation|0
1003873|NCT01450007|2021479|FG001|Overall Study|Protocol Violation|1
1003874|NCT01450007|2021480|FG002|Overall Study|Protocol Violation|1
1003875|NCT01450007|2021478|FG000|Overall Study|Adverse Event|0
1003876|NCT01450007|2021479|FG001|Overall Study|Adverse Event|1
1003877|NCT01450007|2021480|FG002|Overall Study|Adverse Event|0
1003878|NCT01450098|2021490|FG000|Period 3|Protocol Violation|0
1003879|NCT01450098|2021491|FG001|Period 3|Protocol Violation|1
1003880|NCT01450098|2021490|FG000|Period 3|Withdrawal by Subject|0
1003881|NCT01450098|2021491|FG001|Period 3|Withdrawal by Subject|2
1003882|NCT01450137|2021506|FG000|Up to Week 12|Adverse Event|2
1003883|NCT01450137|2021507|FG001|Up to Week 12|Adverse Event|1
1003884|NCT01450137|2021506|FG000|Up to Week 12|Withdrawal by Subject|0
1003885|NCT01450137|2021507|FG001|Up to Week 12|Withdrawal by Subject|2
1003886|NCT01450137|2021506|FG000|Week 12 to Study End|Death|0
1003887|NCT01450137|2021507|FG001|Week 12 to Study End|Death|1
1003888|NCT01450137|2021506|FG000|Week 12 to Study End|Withdrawal by Subject|0
1003889|NCT01450137|2021507|FG001|Week 12 to Study End|Withdrawal by Subject|1
1003890|NCT01450540|2021552|FG000|Overall Study|Withdrawal by Subject|19
1003891|NCT01450540|2021553|FG001|Overall Study|Withdrawal by Subject|13
1003892|NCT01450540|2021552|FG000|Overall Study|protocol deviation|3
1003893|NCT01450540|2021553|FG001|Overall Study|protocol deviation|23
1003894|NCT01450631|2021563|FG000|Overall Study|Lost to Follow-up|2
1003895|NCT01450631|2021564|FG001|Overall Study|Lost to Follow-up|4
1003896|NCT01450631|2021563|FG000|Overall Study|Withdrawal by Subject|1
1003897|NCT01450631|2021564|FG001|Overall Study|Withdrawal by Subject|0
1003898|NCT01450683|2021570|FG000|Overall Study|Adverse Event|2
1003899|NCT01450696|2021576|FG000|Overall Study|Never Treated|1
1003900|NCT01450696|2021577|FG001|Overall Study|Never Treated|1
1003901|NCT01450696|2021576|FG000|Overall Study|Death|77
1003902|NCT01450696|2021577|FG001|Overall Study|Death|84
1003903|NCT01450696|2021576|FG000|Overall Study|Lost to Follow-up|3
1003904|NCT01450696|2021577|FG001|Overall Study|Lost to Follow-up|3
1003905|NCT01450696|2021576|FG000|Overall Study|Non-Compliance|1
1003906|NCT01450696|2021577|FG001|Overall Study|Non-Compliance|0
1003907|NCT01450696|2021576|FG000|Overall Study|Withdrawal by Subject|13
1003908|NCT01450696|2021577|FG001|Overall Study|Withdrawal by Subject|2
1003909|NCT01450696|2021576|FG000|Overall Study|Study Terminated by Sponsor|53
1003910|NCT01450696|2021577|FG001|Overall Study|Study Terminated by Sponsor|58
1003911|NCT01450761|2021585|FG000|Randomization|Subject no longer meets study criteria|1
1003912|NCT01450761|2021586|FG001|Randomization|Subject no longer meets study criteria|2
1003913|NCT01450761|2021585|FG000|Randomization|Withdrawal by Subject|2
1003914|NCT01450761|2021586|FG001|Randomization|Withdrawal by Subject|0
1003915|NCT01450761|2021585|FG000|Randomization|Disease progression|0
1003916|NCT01450761|2021586|FG001|Randomization|Disease progression|2
1003917|NCT01450761|2021585|FG000|Randomization|Adverse Event unrelated to study drug|1
1003918|NCT01450761|2021586|FG001|Randomization|Adverse Event unrelated to study drug|0
1003919|NCT01450761|2021585|FG000|Randomization|Other|0
1003920|NCT01450761|2021586|FG001|Randomization|Other|1
1003921|NCT01450761|2021585|FG000|Lead-in Chemotherapy|Disease progression|33
1003922|NCT01450761|2021586|FG001|Lead-in Chemotherapy|Disease progression|32
1003923|NCT01450761|2021585|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
1003924|NCT01450761|2021586|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
1003925|NCT01450761|2021585|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14
1003926|NCT01450761|2021586|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12
1003927|NCT01450761|2021585|FG000|Lead-in Chemotherapy|Study drug toxicity|6
1003928|NCT01450761|2021586|FG001|Lead-in Chemotherapy|Study drug toxicity|10
1003929|NCT01450761|2021585|FG000|Lead-in Chemotherapy|No longer meets study criteria|3
1003930|NCT01450761|2021586|FG001|Lead-in Chemotherapy|No longer meets study criteria|7
1003931|NCT01450761|2021585|FG000|Lead-in Chemotherapy|Death|3
1003932|NCT01450761|2021586|FG001|Lead-in Chemotherapy|Death|3
1003933|NCT01450761|2021585|FG000|Lead-in Chemotherapy|Other|2
1003934|NCT01450761|2021586|FG001|Lead-in Chemotherapy|Other|2
1003935|NCT01450761|2021585|FG000|Lead-in Chemotherapy|Lost to Follow-up|2
1003936|NCT01450761|2021586|FG001|Lead-in Chemotherapy|Lost to Follow-up|0
1003937|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Disease progression|318
1003938|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Disease progression|415
1003939|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87
1003940|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9
1003941|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
1003942|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
1003943|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
1003944|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
1003945|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
1003946|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
1003947|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Death|5
1003948|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Death|6
1003949|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5
1003950|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4
1003951|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2
1003952|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1
1003953|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
1003954|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
1003955|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1
1003956|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2
1003957|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Not reported|2
1003958|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Not reported|2
1003959|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1
1003960|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0
1003961|NCT01450761|2021585|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
1003962|NCT01450761|2021586|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
1003963|NCT01450800|2021603|FG000|Overall Study|Protocol Violation|1
1003964|NCT01450800|2021604|FG001|Overall Study|Protocol Violation|3
1003965|NCT01450813|2021616|FG000|Overall Study|Physician Decision|1
1003966|NCT01450813|2021617|FG001|Overall Study|Physician Decision|1
1003967|NCT01450813|2021618|FG002|Overall Study|Physician Decision|0
1003968|NCT01450813|2021619|FG003|Overall Study|Physician Decision|3
1003969|NCT01450943|2021643|FG000|Overall Study|Screen failure, loss to follow-up|2
1003970|NCT01450943|2021644|FG001|Overall Study|Screen failure, loss to follow-up|7
1003971|NCT01450943|2021645|FG002|Overall Study|Screen failure, loss to follow-up|6
1003972|NCT01451164|2021661|FG000|Overall Study|Adverse Event|19
1003973|NCT01451164|2021662|FG001|Overall Study|Adverse Event|12
1003974|NCT01451164|2021663|FG002|Overall Study|Adverse Event|18
1003975|NCT01451164|2021664|FG003|Overall Study|Adverse Event|21
1003976|NCT01451164|2021661|FG000|Overall Study|Withdrawal Criteria|1
1003977|NCT01451164|2021662|FG001|Overall Study|Withdrawal Criteria|1
1003978|NCT01451164|2021663|FG002|Overall Study|Withdrawal Criteria|1
1003979|NCT01451164|2021664|FG003|Overall Study|Withdrawal Criteria|1
1003980|NCT01451164|2021661|FG000|Overall Study|Physician Decision|2
1003981|NCT01451164|2021662|FG001|Overall Study|Physician Decision|0
1003982|NCT01451164|2021663|FG002|Overall Study|Physician Decision|1
1003983|NCT01451164|2021664|FG003|Overall Study|Physician Decision|0
1003984|NCT01451164|2021661|FG000|Overall Study|Withdrawal by Subject|14
1003985|NCT01451164|2021662|FG001|Overall Study|Withdrawal by Subject|11
1003986|NCT01451164|2021663|FG002|Overall Study|Withdrawal by Subject|16
1003987|NCT01451164|2021664|FG003|Overall Study|Withdrawal by Subject|17
1003988|NCT01451164|2021661|FG000|Overall Study|Protocol Violation|0
1003989|NCT01451164|2021662|FG001|Overall Study|Protocol Violation|1
1003990|NCT01451164|2021663|FG002|Overall Study|Protocol Violation|0
1003991|NCT01451164|2021664|FG003|Overall Study|Protocol Violation|0
1003992|NCT01451164|2021661|FG000|Overall Study|Lack of Efficacy|7
1003993|NCT01451164|2021662|FG001|Overall Study|Lack of Efficacy|9
1003994|NCT01451164|2021663|FG002|Overall Study|Lack of Efficacy|9
1003995|NCT01451164|2021664|FG003|Overall Study|Lack of Efficacy|7
1003996|NCT01451203|2021676|FG000|Double-blind Treatment Period|Did not receive treatment|1
1003997|NCT01451203|2021677|FG001|Double-blind Treatment Period|Did not receive treatment|2
1003998|NCT01451203|2021676|FG000|Double-blind Treatment Period|Consent Withdrawn|3
1003999|NCT01451203|2021677|FG001|Double-blind Treatment Period|Consent Withdrawn|2
1004000|NCT01451203|2021676|FG000|Double-blind Treatment Period|Lack of Efficacy|71
1004001|NCT01451203|2021677|FG001|Double-blind Treatment Period|Lack of Efficacy|36
1004002|NCT01451203|2021676|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
1004003|NCT01451203|2021677|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
1004004|NCT01451203|2021676|FG000|Double-blind Treatment Period|Adverse Event|6
1004005|NCT01451203|2021677|FG001|Double-blind Treatment Period|Adverse Event|9
1004006|NCT01451203|2021676|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1
1004007|NCT01451203|2021677|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0
1004008|NCT01451203|2021676|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1
1004009|NCT01451203|2021677|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0
1004010|NCT01451203|2021676|FG000|Double-blind Treatment Period|Investigator decision|2
1004011|NCT01451203|2021677|FG001|Double-blind Treatment Period|Investigator decision|0
1004012|NCT01451203|2021676|FG000|Post-treatment Period|Consent withdrawn|2
1004013|NCT01451203|2021677|FG001|Post-treatment Period|Consent withdrawn|4
1004014|NCT01451203|2021676|FG000|Post-treatment Period|Lack of Efficacy|12
1004015|NCT01451203|2021677|FG001|Post-treatment Period|Lack of Efficacy|28
1004016|NCT01451203|2021676|FG000|Post-treatment Period|Adverse Event|0
1004017|NCT01451203|2021677|FG001|Post-treatment Period|Adverse Event|1
1004018|NCT01451203|2021676|FG000|Post-treatment Period|Investigator decision|0
1004019|NCT01451203|2021677|FG001|Post-treatment Period|Investigator decision|1
1004020|NCT01451398|2021693|FG000|Overall Study|Adverse Event|7
1004021|NCT01451398|2021694|FG001|Overall Study|Adverse Event|9
1004022|NCT01451398|2021693|FG000|Overall Study|Protocol Violation|1
1004023|NCT01451398|2021694|FG001|Overall Study|Protocol Violation|2
1004024|NCT01451398|2021693|FG000|Overall Study|Physician Decision|1
1004025|NCT01451398|2021694|FG001|Overall Study|Physician Decision|1
1004026|NCT01451398|2021693|FG000|Overall Study|Withdrawal by Subject|10
1004027|NCT01451398|2021694|FG001|Overall Study|Withdrawal by Subject|14
1004028|NCT01451398|2021693|FG000|Overall Study|Lost to Follow-up|6
1004029|NCT01451398|2021694|FG001|Overall Study|Lost to Follow-up|4
1004030|NCT01451398|2021693|FG000|Overall Study|Non-compliance with study drug|1
1004031|NCT01451398|2021694|FG001|Overall Study|Non-compliance with study drug|3
1004032|NCT01451398|2021693|FG000|Overall Study|Non-compliance with protocol|1
1004033|NCT01451398|2021694|FG001|Overall Study|Non-compliance with protocol|1
1004034|NCT01451398|2021693|FG000|Overall Study|Moved out of country|0
1004035|NCT01451398|2021694|FG001|Overall Study|Moved out of country|1
1004036|NCT01451398|2021693|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0
1004037|NCT01451398|2021694|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1
1004038|NCT01451398|2021693|FG000|Overall Study|Lack of Efficacy|0
1004039|NCT01451398|2021694|FG001|Overall Study|Lack of Efficacy|1
1004040|NCT01451424|2021713|FG000|Overall Study|Withdrawal by Subject|1
1004041|NCT01451424|2021714|FG001|Overall Study|Withdrawal by Subject|1
1004042|NCT01451424|2021715|FG002|Overall Study|Withdrawal by Subject|0
1004043|NCT01451424|2021716|FG003|Overall Study|Withdrawal by Subject|2
1004044|NCT01451424|2021713|FG000|Overall Study|Lost to Follow-up|0
1004045|NCT01451424|2021714|FG001|Overall Study|Lost to Follow-up|1
1004046|NCT01451424|2021715|FG002|Overall Study|Lost to Follow-up|0
1004047|NCT01451424|2021716|FG003|Overall Study|Lost to Follow-up|1
1004048|NCT01451424|2021713|FG000|Overall Study|Physician Decision|0
1004049|NCT01451424|2021714|FG001|Overall Study|Physician Decision|0
1004050|NCT01451424|2021715|FG002|Overall Study|Physician Decision|1
1004051|NCT01451424|2021716|FG003|Overall Study|Physician Decision|1
1004052|NCT01451424|2021713|FG000|Overall Study|Adverse Event|0
1004053|NCT01451424|2021714|FG001|Overall Study|Adverse Event|0
1004054|NCT01451424|2021715|FG002|Overall Study|Adverse Event|0
1004055|NCT01451424|2021716|FG003|Overall Study|Adverse Event|1
1004056|NCT01451437|2021740|FG000|Overall Study|Adverse Event|0
1004057|NCT01451437|2021741|FG001|Overall Study|Adverse Event|0
1004058|NCT01451437|2021742|FG002|Overall Study|Adverse Event|0
1004059|NCT01451437|2021743|FG003|Overall Study|Adverse Event|0
1004060|NCT01451437|2021744|FG004|Overall Study|Adverse Event|0
1004061|NCT01451437|2021745|FG005|Overall Study|Adverse Event|1
1004062|NCT01451437|2021746|FG006|Overall Study|Adverse Event|1
1004063|NCT01451437|2021747|FG007|Overall Study|Adverse Event|2
1004064|NCT01451437|2021748|FG008|Overall Study|Adverse Event|1
1004065|NCT01451437|2021740|FG000|Overall Study|Physician Decision|1
1004066|NCT01451437|2021741|FG001|Overall Study|Physician Decision|1
1004067|NCT01451437|2021742|FG002|Overall Study|Physician Decision|2
1004068|NCT01451437|2021743|FG003|Overall Study|Physician Decision|0
1004069|NCT01451437|2021744|FG004|Overall Study|Physician Decision|0
1004070|NCT01451437|2021745|FG005|Overall Study|Physician Decision|0
1004071|NCT01451437|2021746|FG006|Overall Study|Physician Decision|0
1004072|NCT01451437|2021747|FG007|Overall Study|Physician Decision|0
1004073|NCT01451437|2021748|FG008|Overall Study|Physician Decision|0
1004074|NCT01451437|2021740|FG000|Overall Study|Disease Progression|0
1004075|NCT01451437|2021741|FG001|Overall Study|Disease Progression|0
1004076|NCT01451437|2021742|FG002|Overall Study|Disease Progression|1
1004077|NCT01451437|2021743|FG003|Overall Study|Disease Progression|1
1004078|NCT01451437|2021744|FG004|Overall Study|Disease Progression|3
1004079|NCT01451437|2021745|FG005|Overall Study|Disease Progression|2
1004080|NCT01451437|2021746|FG006|Overall Study|Disease Progression|3
1004081|NCT01451437|2021747|FG007|Overall Study|Disease Progression|1
1004082|NCT01451437|2021748|FG008|Overall Study|Disease Progression|3
1004083|NCT01451437|2021740|FG000|Overall Study|Protocol Violation|0
1004084|NCT01451437|2021741|FG001|Overall Study|Protocol Violation|0
1004085|NCT01451437|2021742|FG002|Overall Study|Protocol Violation|0
1004086|NCT01451437|2021743|FG003|Overall Study|Protocol Violation|0
1004087|NCT01451437|2021744|FG004|Overall Study|Protocol Violation|0
1004088|NCT01451437|2021745|FG005|Overall Study|Protocol Violation|0
1004089|NCT01451437|2021746|FG006|Overall Study|Protocol Violation|1
1004090|NCT01451437|2021747|FG007|Overall Study|Protocol Violation|0
1004091|NCT01451437|2021748|FG008|Overall Study|Protocol Violation|0
1004092|NCT01451437|2021740|FG000|Overall Study|Withdrawal by Subject|0
1004093|NCT01451437|2021741|FG001|Overall Study|Withdrawal by Subject|0
1004094|NCT01451437|2021742|FG002|Overall Study|Withdrawal by Subject|0
1004095|NCT01451437|2021743|FG003|Overall Study|Withdrawal by Subject|0
1004096|NCT01451437|2021744|FG004|Overall Study|Withdrawal by Subject|1
1004097|NCT01451437|2021745|FG005|Overall Study|Withdrawal by Subject|0
1004098|NCT01451437|2021746|FG006|Overall Study|Withdrawal by Subject|1
1004099|NCT01451437|2021747|FG007|Overall Study|Withdrawal by Subject|0
1004100|NCT01451437|2021748|FG008|Overall Study|Withdrawal by Subject|0
1004101|NCT01451541|2021789|FG000|Overall Study|Adverse Event|4
1004102|NCT01451541|2021790|FG001|Overall Study|Adverse Event|3
1004103|NCT01451541|2021791|FG002|Overall Study|Adverse Event|6
1004104|NCT01451541|2021789|FG000|Overall Study|Lack of Efficacy|2
1004105|NCT01451541|2021790|FG001|Overall Study|Lack of Efficacy|0
1004106|NCT01451541|2021791|FG002|Overall Study|Lack of Efficacy|0
1004107|NCT01451541|2021789|FG000|Overall Study|Lost to Follow-up|4
1004108|NCT01451541|2021790|FG001|Overall Study|Lost to Follow-up|4
1004109|NCT01451541|2021791|FG002|Overall Study|Lost to Follow-up|7
1004110|NCT01451541|2021789|FG000|Overall Study|Withdrawal by Subject|15
1004111|NCT01451541|2021790|FG001|Overall Study|Withdrawal by Subject|8
1004112|NCT01451541|2021791|FG002|Overall Study|Withdrawal by Subject|6
1004113|NCT01451541|2021789|FG000|Overall Study|randomization error, noncompliance|11
1004114|NCT01451541|2021790|FG001|Overall Study|randomization error, noncompliance|10
1004115|NCT01451541|2021791|FG002|Overall Study|randomization error, noncompliance|8
1004116|NCT01451554|2021803|FG000|Overall Study|Withdrawal by Subject|14
1004117|NCT01451554|2021804|FG001|Overall Study|Withdrawal by Subject|9
1004118|NCT01451606|2021812|FG000|Overall Study|Withdrawal by Subject|4
1004119|NCT01451606|2021813|FG001|Overall Study|Withdrawal by Subject|3
1004120|NCT01451645|2021857|FG000|Overall Study|Protocol Violation|1
1004121|NCT01451645|2021858|FG001|Overall Study|Protocol Violation|0
1004122|NCT01451645|2021857|FG000|Overall Study|Adverse Event|0
1004123|NCT01451645|2021858|FG001|Overall Study|Adverse Event|3
1004124|NCT01451645|2021857|FG000|Overall Study|Withdrawal by Subject|4
1004125|NCT01451645|2021858|FG001|Overall Study|Withdrawal by Subject|2
1004126|NCT01451645|2021857|FG000|Overall Study|Lost to Follow-up|4
1004127|NCT01451645|2021858|FG001|Overall Study|Lost to Follow-up|3
1004128|NCT01451749|2021866|FG000|Overall Study|Protocol Violation|14
1004129|NCT01451749|2021867|FG001|Overall Study|Protocol Violation|7
1004130|NCT01451749|2021866|FG000|Overall Study|Lost to Follow-up|15
1004131|NCT01451749|2021867|FG001|Overall Study|Lost to Follow-up|5
1004132|NCT01451749|2021866|FG000|Overall Study|Meet the exclusion criteria,and|1
1004133|NCT01451749|2021867|FG001|Overall Study|Meet the exclusion criteria,and|1
1004134|NCT01451749|2021866|FG000|Overall Study|Adverse Event|2
1004135|NCT01451749|2021867|FG001|Overall Study|Adverse Event|0
1004136|NCT01451749|2021866|FG000|Overall Study|Withdrawal by Subject|0
1004137|NCT01451749|2021867|FG001|Overall Study|Withdrawal by Subject|1
1004138|NCT01451762|2021878|FG000|Overall Study|Lost to Follow-up|3
1004139|NCT01451762|2021879|FG001|Overall Study|Lost to Follow-up|6
1004140|NCT01451762|2021880|FG002|Overall Study|Lost to Follow-up|6
1004141|NCT01451814|2021903|FG000|Overall Study|Withdrawal by Subject|1
1004142|NCT01451814|2021904|FG001|Overall Study|Withdrawal by Subject|1
1004143|NCT01451814|2021903|FG000|Overall Study|Lost to Follow-up|5
1004144|NCT01451814|2021904|FG001|Overall Study|Lost to Follow-up|4
1004145|NCT01451827|2021914|FG000|Overall Study|Adverse Event|2
1004146|NCT01451827|2021915|FG001|Overall Study|Adverse Event|0
1004147|NCT01451827|2021916|FG002|Overall Study|Adverse Event|1
1004148|NCT01451827|2021917|FG003|Overall Study|Adverse Event|1
1004149|NCT01451827|2021914|FG000|Overall Study|Protocol deviation|1
1004150|NCT01451827|2021915|FG001|Overall Study|Protocol deviation|0
1004151|NCT01451827|2021916|FG002|Overall Study|Protocol deviation|0
1004152|NCT01451827|2021917|FG003|Overall Study|Protocol deviation|0
1004153|NCT01451827|2021914|FG000|Overall Study|Lost to Follow-up|0
1004154|NCT01451827|2021915|FG001|Overall Study|Lost to Follow-up|3
1004155|NCT01451827|2021916|FG002|Overall Study|Lost to Follow-up|0
1004156|NCT01451827|2021917|FG003|Overall Study|Lost to Follow-up|2
1004157|NCT01451827|2021914|FG000|Overall Study|Participant met withdrawal criteria|0
1004158|NCT01451827|2021915|FG001|Overall Study|Participant met withdrawal criteria|2
1004159|NCT01451827|2021916|FG002|Overall Study|Participant met withdrawal criteria|0
1004160|NCT01451827|2021917|FG003|Overall Study|Participant met withdrawal criteria|0
1004161|NCT01451827|2021914|FG000|Overall Study|Withdrawal by Subject|0
1004162|NCT01451827|2021915|FG001|Overall Study|Withdrawal by Subject|0
1004163|NCT01451827|2021916|FG002|Overall Study|Withdrawal by Subject|1
1004164|NCT01451827|2021917|FG003|Overall Study|Withdrawal by Subject|1
1004165|NCT01451931|2021930|FG000|Overall Study|Lost to Follow-up|17
1004166|NCT01451931|2021931|FG001|Overall Study|Lost to Follow-up|36
1004167|NCT01451931|2021932|FG002|Overall Study|Lost to Follow-up|21
1004168|NCT01451931|2021930|FG000|Overall Study|Withdrawal by Subject|16
1004169|NCT01451931|2021931|FG001|Overall Study|Withdrawal by Subject|22
1004170|NCT01451931|2021932|FG002|Overall Study|Withdrawal by Subject|22
1004171|NCT01452152|2021986|FG000|Overall Study|Study termination by sponsor|5
1004172|NCT01452152|2021987|FG001|Overall Study|Study termination by sponsor|0
1004173|NCT01452152|2021988|FG002|Overall Study|Study termination by sponsor|4
1004174|NCT01452347|2022020|FG000|Overall Study|Adverse Event|2
1004175|NCT01452347|2022021|FG001|Overall Study|Adverse Event|1
1004176|NCT01452347|2022020|FG000|Overall Study|Non compliance protocol|2
1004177|NCT01452347|2022021|FG001|Overall Study|Non compliance protocol|0
1004178|NCT01452347|2022020|FG000|Overall Study|Lost to Follow-up|2
1004179|NCT01452347|2022021|FG001|Overall Study|Lost to Follow-up|0
1004180|NCT01452347|2022020|FG000|Overall Study|Withdrawal by Subject|3
1004181|NCT01452347|2022021|FG001|Overall Study|Withdrawal by Subject|3
1004182|NCT01452347|2022020|FG000|Overall Study|Not treated|6
1004183|NCT01452347|2022021|FG001|Overall Study|Not treated|3
1004184|NCT01452347|2022020|FG000|Overall Study|Other reason not defined above|2
1004185|NCT01452347|2022021|FG001|Overall Study|Other reason not defined above|0
1004186|NCT01452412|2022031|FG000|Overall Study|Withdrawal by Subject|15
1004187|NCT01452412|2022032|FG001|Overall Study|Withdrawal by Subject|11
1004188|NCT01452412|2022031|FG000|Overall Study|Adverse Event|4
1004189|NCT01452412|2022032|FG001|Overall Study|Adverse Event|3
1004190|NCT01452412|2022031|FG000|Overall Study|Lost to Follow-up|5
1004191|NCT01452412|2022032|FG001|Overall Study|Lost to Follow-up|3
1004192|NCT01452412|2022031|FG000|Overall Study|Death|1
1004193|NCT01452412|2022032|FG001|Overall Study|Death|0
1004194|NCT01452412|2022031|FG000|Overall Study|Initiated dialysis|1
1004195|NCT01452412|2022032|FG001|Overall Study|Initiated dialysis|0
1004196|NCT01452412|2022031|FG000|Overall Study|Other|2
1004197|NCT01452412|2022032|FG001|Overall Study|Other|0
1004198|NCT01452529|2022045|FG000|Run-in Period|Adverse Event|96
1004199|NCT01452529|2022046|FG001|Run-in Period|Adverse Event|0
1004200|NCT01452529|2022047|FG002|Run-in Period|Adverse Event|0
1004201|NCT01452529|2022045|FG000|Run-in Period|Withdrawal by Subject|49
1004202|NCT01452529|2022046|FG001|Run-in Period|Withdrawal by Subject|0
1004203|NCT01452529|2022047|FG002|Run-in Period|Withdrawal by Subject|0
1004204|NCT01452529|2022045|FG000|Run-in Period|Lost to Follow-up|19
1004205|NCT01452529|2022046|FG001|Run-in Period|Lost to Follow-up|0
1004206|NCT01452529|2022047|FG002|Run-in Period|Lost to Follow-up|0
1004207|NCT01452529|2022045|FG000|Run-in Period|Lack of Efficacy|46
1004208|NCT01452529|2022046|FG001|Run-in Period|Lack of Efficacy|0
1004209|NCT01452529|2022047|FG002|Run-in Period|Lack of Efficacy|0
1004210|NCT01452529|2022045|FG000|Run-in Period|Confirmed or suspected diversion|23
1004211|NCT01452529|2022046|FG001|Run-in Period|Confirmed or suspected diversion|0
1004212|NCT01452529|2022047|FG002|Run-in Period|Confirmed or suspected diversion|0
1004213|NCT01452529|2022045|FG000|Run-in Period|Administrative|21
1004214|NCT01452529|2022046|FG001|Run-in Period|Administrative|0
1004215|NCT01452529|2022047|FG002|Run-in Period|Administrative|0
1090777|NCT02248818|2158524|FG006|Screening|Withdrawal by Subject|0
1004216|NCT01452529|2022045|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59
1004217|NCT01452529|2022046|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0
1004218|NCT01452529|2022047|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0
1004219|NCT01452529|2022045|FG000|Double-blind (DB) Period|Adverse Event|0
1004220|NCT01452529|2022046|FG001|Double-blind (DB) Period|Adverse Event|18
1004221|NCT01452529|2022047|FG002|Double-blind (DB) Period|Adverse Event|11
1004222|NCT01452529|2022045|FG000|Double-blind (DB) Period|Withdrawal by Subject|0
1004223|NCT01452529|2022046|FG001|Double-blind (DB) Period|Withdrawal by Subject|15
1004224|NCT01452529|2022047|FG002|Double-blind (DB) Period|Withdrawal by Subject|14
1004225|NCT01452529|2022045|FG000|Double-blind (DB) Period|Lost to Follow-up|0
1004226|NCT01452529|2022046|FG001|Double-blind (DB) Period|Lost to Follow-up|5
1004227|NCT01452529|2022047|FG002|Double-blind (DB) Period|Lost to Follow-up|3
1004228|NCT01452529|2022045|FG000|Double-blind (DB) Period|Lack of Efficacy|0
1004229|NCT01452529|2022046|FG001|Double-blind (DB) Period|Lack of Efficacy|16
1004230|NCT01452529|2022047|FG002|Double-blind (DB) Period|Lack of Efficacy|44
1004231|NCT01452529|2022045|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0
1004232|NCT01452529|2022046|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2
1004233|NCT01452529|2022047|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3
1004234|NCT01452529|2022045|FG000|Double-blind (DB) Period|Administrative|0
1004235|NCT01452529|2022046|FG001|Double-blind (DB) Period|Administrative|11
1004236|NCT01452529|2022047|FG002|Double-blind (DB) Period|Administrative|7
1004237|NCT01452789|2022056|FG000|Overall Study|Withdrawal by Subject|3
1004238|NCT01452789|2022057|FG001|Overall Study|Withdrawal by Subject|2
1004239|NCT01452919|2022063|FG000|Open-Label Treatment|Adverse Event|5
1004240|NCT01452919|2022064|FG001|Open-Label Treatment|Adverse Event|0
1004241|NCT01452919|2022065|FG002|Open-Label Treatment|Adverse Event|0
1004242|NCT01452919|2022063|FG000|Open-Label Treatment|Lost to Follow-up|4
1004243|NCT01452919|2022064|FG001|Open-Label Treatment|Lost to Follow-up|0
1004244|NCT01452919|2022065|FG002|Open-Label Treatment|Lost to Follow-up|0
1004245|NCT01452919|2022063|FG000|Open-Label Treatment|Perceived lack of efficacy|3
1004246|NCT01452919|2022064|FG001|Open-Label Treatment|Perceived lack of efficacy|0
1004247|NCT01452919|2022065|FG002|Open-Label Treatment|Perceived lack of efficacy|0
1004248|NCT01452919|2022063|FG000|Open-Label Treatment|Protocol Violation|4
1004249|NCT01452919|2022064|FG001|Open-Label Treatment|Protocol Violation|0
1004250|NCT01452919|2022065|FG002|Open-Label Treatment|Protocol Violation|0
1004251|NCT01452919|2022063|FG000|Open-Label Treatment|Sponsor Decision|1
1004252|NCT01452919|2022064|FG001|Open-Label Treatment|Sponsor Decision|0
1004253|NCT01452919|2022065|FG002|Open-Label Treatment|Sponsor Decision|0
1004254|NCT01452919|2022063|FG000|Open-Label Treatment|Withdrawal by Subject|2
1004255|NCT01452919|2022064|FG001|Open-Label Treatment|Withdrawal by Subject|0
1004256|NCT01452919|2022065|FG002|Open-Label Treatment|Withdrawal by Subject|0
1004257|NCT01452919|2022063|FG000|Open-Label Treatment|Subject is moving or has moved|1
1004258|NCT01452919|2022064|FG001|Open-Label Treatment|Subject is moving or has moved|0
1004259|NCT01452919|2022065|FG002|Open-Label Treatment|Subject is moving or has moved|0
1004260|NCT01452919|2022063|FG000|Randomization Treatment|Adverse Event|0
1004261|NCT01452919|2022064|FG001|Randomization Treatment|Adverse Event|0
1004262|NCT01452919|2022065|FG002|Randomization Treatment|Adverse Event|2
1004263|NCT01452919|2022063|FG000|Randomization Treatment|Sponsor Decision|0
1004264|NCT01452919|2022064|FG001|Randomization Treatment|Sponsor Decision|1
1004265|NCT01452919|2022065|FG002|Randomization Treatment|Sponsor Decision|0
1004266|NCT01452919|2022063|FG000|Randomization Treatment|Withdrawal by Subject|0
1004267|NCT01452919|2022064|FG001|Randomization Treatment|Withdrawal by Subject|1
1004268|NCT01452919|2022065|FG002|Randomization Treatment|Withdrawal by Subject|0
1004269|NCT01452919|2022063|FG000|Randomization Treatment|Subject is moving or has moved|0
1004270|NCT01452919|2022064|FG001|Randomization Treatment|Subject is moving or has moved|1
1004271|NCT01452919|2022065|FG002|Randomization Treatment|Subject is moving or has moved|0
1004272|NCT01453023|2022075|FG000|Treatment Period (TP) 1|Protocol Violation|1
1004273|NCT01453023|2022076|FG001|Treatment Period (TP) 1|Protocol Violation|0
1004274|NCT01453023|2022075|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
1004275|NCT01453023|2022076|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
1004276|NCT01453023|2022075|FG000|Treatment Period 2|Protocol Violation|0
1004277|NCT01453023|2022076|FG001|Treatment Period 2|Protocol Violation|1
1004278|NCT01453036|2022085|FG000|Overall Study|Lost to Follow-up|26
1004279|NCT01453036|2022086|FG001|Overall Study|Lost to Follow-up|115
1004280|NCT01453036|2022087|FG002|Overall Study|Lost to Follow-up|31
1004281|NCT01453049|2022097|FG000|Overall Study|Protocol Violation|2
1004282|NCT01453049|2022098|FG001|Overall Study|Protocol Violation|5
1004283|NCT01453049|2022097|FG000|Overall Study|Lost to Follow-up|2
1004284|NCT01453049|2022098|FG001|Overall Study|Lost to Follow-up|1
1004285|NCT01453049|2022097|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35
1004286|NCT01453049|2022098|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36
1004287|NCT01453049|2022097|FG000|Overall Study|Withdrawal by Subject|1
1004288|NCT01453049|2022098|FG001|Overall Study|Withdrawal by Subject|0
1004289|NCT01453049|2022097|FG000|Overall Study|Randomized in Error|1
1004290|NCT01453049|2022098|FG001|Overall Study|Randomized in Error|0
1004291|NCT01453153|2022116|FG000|Overall Study|Physician Decision|0
1004292|NCT01453153|2022117|FG001|Overall Study|Physician Decision|0
1004293|NCT01453153|2022118|FG002|Overall Study|Physician Decision|1
1004294|NCT01453153|2022116|FG000|Overall Study|Progressive Disease|3
1004295|NCT01453153|2022117|FG001|Overall Study|Progressive Disease|2
1004296|NCT01453153|2022118|FG002|Overall Study|Progressive Disease|16
1004297|NCT01453153|2022116|FG000|Overall Study|Withdrawal by Subject|0
1004298|NCT01453153|2022117|FG001|Overall Study|Withdrawal by Subject|1
1004299|NCT01453153|2022118|FG002|Overall Study|Withdrawal by Subject|2
1004300|NCT01453153|2022116|FG000|Overall Study|Adverse Event|1
1004301|NCT01453153|2022117|FG001|Overall Study|Adverse Event|1
1004302|NCT01453153|2022118|FG002|Overall Study|Adverse Event|1
1004303|NCT01453205|2022146|FG000|Overall Study|Lost to Follow-up|3
1004304|NCT01453205|2022147|FG001|Overall Study|Lost to Follow-up|0
1004305|NCT01453205|2022148|FG002|Overall Study|Lost to Follow-up|1
1004306|NCT01453205|2022146|FG000|Overall Study|Withdrawal by Subject|8
1004307|NCT01453205|2022147|FG001|Overall Study|Withdrawal by Subject|3
1004308|NCT01453205|2022148|FG002|Overall Study|Withdrawal by Subject|0
1004309|NCT01453205|2022146|FG000|Overall Study|Death|24
1004310|NCT01453205|2022147|FG001|Overall Study|Death|22
1004311|NCT01453205|2022148|FG002|Overall Study|Death|18
1004312|NCT01453205|2022146|FG000|Overall Study|Other|45
1004313|NCT01453205|2022147|FG001|Overall Study|Other|27
1004314|NCT01453205|2022148|FG002|Overall Study|Other|35
1004315|NCT01453296|2022159|FG000|Treatment Period 1|Adverse Event|0
1004316|NCT01453296|2022160|FG001|Treatment Period 1|Adverse Event|1
1004317|NCT01453296|2022159|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
1004318|NCT01453296|2022160|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
1004319|NCT01453296|2022159|FG000|Treatment Period 2|Adverse Event|1
1004320|NCT01453296|2022160|FG001|Treatment Period 2|Adverse Event|0
1004321|NCT01453296|2022159|FG000|Treatment Period 2|Withdrawal by Subject|1
1004322|NCT01453296|2022160|FG001|Treatment Period 2|Withdrawal by Subject|0
1004323|NCT01453348|2022169|FG000|Overall Study|Death|0
1004324|NCT01453348|2022170|FG001|Overall Study|Death|0
1004325|NCT01453348|2022171|FG002|Overall Study|Death|1
1004326|NCT01453348|2022169|FG000|Overall Study|Withdrawal by Subject|0
1004327|NCT01453348|2022170|FG001|Overall Study|Withdrawal by Subject|1
1004328|NCT01453348|2022171|FG002|Overall Study|Withdrawal by Subject|0
1004329|NCT01453348|2022169|FG000|Overall Study|Protocol Violation|1
1004330|NCT01453348|2022170|FG001|Overall Study|Protocol Violation|0
1004331|NCT01453348|2022171|FG002|Overall Study|Protocol Violation|0
1004332|NCT01453361|2022182|FG000|Overall Study|Disease Progression|6
1004333|NCT01453361|2022182|FG000|Overall Study|Screen-Failures|10
1004334|NCT01453374|2022186|FG000|Overall Study|Adverse Event|7
1004335|NCT01453374|2022186|FG000|Overall Study|Lack of Efficacy|1
1004336|NCT01453374|2022186|FG000|Overall Study|Lost to Follow-up|3
1004337|NCT01453374|2022186|FG000|Overall Study|Withdrawal by Subject|5
1004338|NCT01453374|2022186|FG000|Overall Study|Incarcerated|2
1004339|NCT01453439|2022224|FG000|Treatment Phase|Withdrawal by Subject|13
1004340|NCT01453439|2022225|FG001|Treatment Phase|Withdrawal by Subject|10
1004341|NCT01453439|2022224|FG000|Treatment Phase|Suicidal Ideation|2
1004342|NCT01453439|2022225|FG001|Treatment Phase|Suicidal Ideation|0
1004343|NCT01453439|2022224|FG000|Treatment Phase|Need for higher level of care|1
1004344|NCT01453439|2022225|FG001|Treatment Phase|Need for higher level of care|1
1004345|NCT01453439|2022224|FG000|Treatment Phase|Therapist conflict of interest|1
1004346|NCT01453439|2022225|FG001|Treatment Phase|Therapist conflict of interest|0
1004347|NCT01453439|2022224|FG000|Follow-up|Withdrawal by Subject|0
1004348|NCT01453439|2022225|FG001|Follow-up|Withdrawal by Subject|1
1004349|NCT01453439|2022224|FG000|Follow-up|Lost to Follow-up|5
1004350|NCT01453439|2022225|FG001|Follow-up|Lost to Follow-up|10
1004351|NCT01453595|2022247|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
1004352|NCT01453595|2022248|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1
1004353|NCT01453595|2022249|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
1004354|NCT01453725|2022257|FG000|Overall Study|Adverse Event|3
1004355|NCT01453725|2022258|FG001|Overall Study|Adverse Event|3
1004356|NCT01453725|2022257|FG000|Overall Study|Lost to Follow-up|4
1004357|NCT01453725|2022258|FG001|Overall Study|Lost to Follow-up|0
1004358|NCT01453725|2022257|FG000|Overall Study|Non-compliance With Protocol|1
1004359|NCT01453725|2022258|FG001|Overall Study|Non-compliance With Protocol|2
1004360|NCT01453725|2022257|FG000|Overall Study|Protocol Violation|1
1004361|NCT01453725|2022258|FG001|Overall Study|Protocol Violation|0
1004362|NCT01453725|2022257|FG000|Overall Study|Withdrawal by Subject|2
1004363|NCT01453725|2022258|FG001|Overall Study|Withdrawal by Subject|3
1004364|NCT01453725|2022257|FG000|Overall Study|Pregnancy Wish|0
1004365|NCT01453725|2022258|FG001|Overall Study|Pregnancy Wish|2
1004366|NCT01453725|2022257|FG000|Overall Study|Pregnancy|1
1004367|NCT01453725|2022258|FG001|Overall Study|Pregnancy|0
1004368|NCT01453725|2022257|FG000|Overall Study|Physician Decision|1
1004369|NCT01453725|2022258|FG001|Overall Study|Physician Decision|1
1004370|NCT01453855|2022268|FG000|Overall Study|Adverse Event|3
1004371|NCT01453855|2022269|FG001|Overall Study|Adverse Event|4
1004372|NCT01453855|2022268|FG000|Overall Study|Lost to Follow-up|2
1004373|NCT01453855|2022269|FG001|Overall Study|Lost to Follow-up|1
1004374|NCT01453855|2022268|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3
1004375|NCT01453855|2022269|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3
1004376|NCT01453855|2022268|FG000|Overall Study|Noncompliance|1
1004377|NCT01453855|2022269|FG001|Overall Study|Noncompliance|0
1004378|NCT01453855|2022268|FG000|Overall Study|Inadequate Control of IOP|1
1004379|NCT01453855|2022269|FG001|Overall Study|Inadequate Control of IOP|5
1004380|NCT01453855|2022268|FG000|Overall Study|Other|0
1004381|NCT01453855|2022269|FG001|Overall Study|Other|1
1004386|NCT01453998|2022291|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1
1004387|NCT01453998|2022292|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0
1004388|NCT01453998|2022293|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0
1004389|NCT01454063|2022306|FG000|Randomized|Adverse Event|1
1004390|NCT01454063|2022307|FG001|Randomized|Adverse Event|1
1004391|NCT01454063|2022306|FG000|Randomized|Protocol Violation|0
1004392|NCT01454063|2022307|FG001|Randomized|Protocol Violation|1
1004393|NCT01454076|2022318|FG000|Overall Study|Other|2
1004394|NCT01454076|2022319|FG001|Overall Study|Other|0
1004395|NCT01454076|2022320|FG002|Overall Study|Other|0
1004396|NCT01454076|2022321|FG003|Overall Study|Other|1
1004397|NCT01454076|2022322|FG004|Overall Study|Other|2
1004398|NCT01454076|2022318|FG000|Overall Study|Withdrawal by Subject|3
1004399|NCT01454076|2022319|FG001|Overall Study|Withdrawal by Subject|4
1004400|NCT01454076|2022320|FG002|Overall Study|Withdrawal by Subject|2
1004401|NCT01454076|2022321|FG003|Overall Study|Withdrawal by Subject|1
1004402|NCT01454076|2022322|FG004|Overall Study|Withdrawal by Subject|2
1004403|NCT01454076|2022318|FG000|Overall Study|Adverse Event|8
1004404|NCT01454076|2022319|FG001|Overall Study|Adverse Event|2
1004405|NCT01454076|2022320|FG002|Overall Study|Adverse Event|7
1004406|NCT01454076|2022321|FG003|Overall Study|Adverse Event|0
1004407|NCT01454076|2022322|FG004|Overall Study|Adverse Event|2
1004408|NCT01454102|2022359|FG000|Overall Study|Continuing in the treatment period|0
1004409|NCT01454102|2022360|FG001|Overall Study|Continuing in the treatment period|0
1004410|NCT01454102|2022361|FG002|Overall Study|Continuing in the treatment period|0
1004411|NCT01454102|2022362|FG003|Overall Study|Continuing in the treatment period|0
1004412|NCT01454102|2022363|FG004|Overall Study|Continuing in the treatment period|3
1004413|NCT01454102|2022364|FG005|Overall Study|Continuing in the treatment period|3
1004414|NCT01454102|2022365|FG006|Overall Study|Continuing in the treatment period|2
1004415|NCT01454102|2022366|FG007|Overall Study|Continuing in the treatment period|0
1004416|NCT01454102|2022367|FG008|Overall Study|Continuing in the treatment period|1
1004417|NCT01454102|2022368|FG009|Overall Study|Continuing in the treatment period|0
1004418|NCT01454102|2022369|FG010|Overall Study|Continuing in the treatment period|0
1004419|NCT01454102|2022370|FG011|Overall Study|Continuing in the treatment period|4
1004420|NCT01454102|2022371|FG012|Overall Study|Continuing in the treatment period|7
1004421|NCT01454102|2022372|FG013|Overall Study|Continuing in the treatment period|4
1004422|NCT01454102|2022373|FG014|Overall Study|Continuing in the treatment period|3
1004423|NCT01454102|2022374|FG015|Overall Study|Continuing in the treatment period|1
1004424|NCT01454284|2022417|FG000|Overall Study|Adverse Event|20
1004425|NCT01454284|2022418|FG001|Overall Study|Adverse Event|7
1004426|NCT01454284|2022417|FG000|Overall Study|Death|0
1004427|NCT01454284|2022418|FG001|Overall Study|Death|3
1004428|NCT01454284|2022417|FG000|Overall Study|Lost to Follow-up|13
1004429|NCT01454284|2022418|FG001|Overall Study|Lost to Follow-up|8
1004430|NCT01454284|2022417|FG000|Overall Study|Protocol Violation|9
1004431|NCT01454284|2022418|FG001|Overall Study|Protocol Violation|6
1004432|NCT01454284|2022417|FG000|Overall Study|Withdrawal by Subject|58
1004433|NCT01454284|2022418|FG001|Overall Study|Withdrawal by Subject|36
1004434|NCT01454284|2022417|FG000|Overall Study|Physician Decision|16
1004435|NCT01454284|2022418|FG001|Overall Study|Physician Decision|11
1004436|NCT01454284|2022417|FG000|Overall Study|Sponsor Decision|0
1004437|NCT01454284|2022418|FG001|Overall Study|Sponsor Decision|2
1004438|NCT01454401|2022435|FG000|Overall Study|Death|1
1004439|NCT01454401|2022435|FG000|Overall Study|hospitalised|1
1004440|NCT01454401|2022435|FG000|Overall Study|osteomyelitis|2
1004441|NCT01454401|2022435|FG000|Overall Study|non-adherence|1
1004442|NCT01454531|2022464|FG000|Overall Study|Adverse Event|14
1004443|NCT01454531|2022464|FG000|Overall Study|Withdrawal by Subject|5
1004444|NCT01454531|2022464|FG000|Overall Study|Lost to Follow-up|1
1004445|NCT01454531|2022464|FG000|Overall Study|Physician Decision|1
1004446|NCT01454531|2022464|FG000|Overall Study|Delay in IMP administration|1
1004447|NCT01454531|2022464|FG000|Overall Study|Other|1
1004448|NCT01454570|2022468|FG000|Overall Study|Withdrawal by Subject|2
1004449|NCT01454570|2022468|FG000|Overall Study|Screen Failure|7
1004450|NCT01454583|2022475|FG000|1st Year|Lost to Follow-up|1057
1004451|NCT01454583|2022476|FG001|1st Year|Lost to Follow-up|318
1004452|NCT01454583|2022477|FG002|1st Year|Lost to Follow-up|180
1004453|NCT01454583|2022475|FG000|2nd Year|Lost to Follow-up|3965
1004454|NCT01454583|2022476|FG001|2nd Year|Lost to Follow-up|1049
1004455|NCT01454583|2022477|FG002|2nd Year|Lost to Follow-up|737
1004456|NCT01454583|2022475|FG000|3rd Year|Lost to Follow-up|1959
1004457|NCT01454583|2022476|FG001|3rd Year|Lost to Follow-up|512
1004458|NCT01454583|2022477|FG002|3rd Year|Lost to Follow-up|297
1004459|NCT01454596|2022497|FG000|Overall Study|Death|0
1004460|NCT01454596|2022498|FG001|Overall Study|Death|0
1004461|NCT01454596|2022499|FG002|Overall Study|Death|0
1004462|NCT01454596|2022500|FG003|Overall Study|Death|0
1004463|NCT01454596|2022501|FG004|Overall Study|Death|0
1004464|NCT01454596|2022502|FG005|Overall Study|Death|0
1004465|NCT01454596|2022503|FG006|Overall Study|Death|0
1004466|NCT01454596|2022504|FG007|Overall Study|Death|0
1004467|NCT01454596|2022505|FG008|Overall Study|Death|0
1004468|NCT01454596|2022506|FG009|Overall Study|Death|1
1004469|NCT01454596|2022507|FG010|Overall Study|Death|1
1004470|NCT01454596|2022508|FG011|Overall Study|Death|0
1004471|NCT01454726|2022536|FG000|Overall Study|Withdrawal by Subject|0
1004472|NCT01454726|2022537|FG001|Overall Study|Withdrawal by Subject|1
1004473|NCT01454739|2022545|FG000|Overall Study|Protocol Violation|2
1004474|NCT01454739|2022546|FG001|Overall Study|Protocol Violation|3
1004475|NCT01454739|2022545|FG000|Overall Study|Withdrawal by Subject|2
1004476|NCT01454739|2022546|FG001|Overall Study|Withdrawal by Subject|6
1004477|NCT01454739|2022545|FG000|Overall Study|Other|3
1004478|NCT01454739|2022546|FG001|Overall Study|Other|5
1004479|NCT01454739|2022545|FG000|Overall Study|Physician Decision|0
1004480|NCT01454739|2022546|FG001|Overall Study|Physician Decision|5
1004481|NCT01454739|2022545|FG000|Overall Study|Lost to Follow-up|0
1004482|NCT01454739|2022546|FG001|Overall Study|Lost to Follow-up|1
1004483|NCT01454739|2022545|FG000|Overall Study|Adverse Event|0
1004484|NCT01454739|2022546|FG001|Overall Study|Adverse Event|1
1004485|NCT01454778|2022559|FG000|Overall Study|Lost to Follow-up|2
1004486|NCT01454778|2022559|FG000|Overall Study|Death|1
1004487|NCT01454830|2022576|FG000|Overall Study|Withdrawal by Subject|4
1004488|NCT01454830|2022577|FG001|Overall Study|Withdrawal by Subject|4
1004489|NCT01454830|2022576|FG000|Overall Study|Post-allocation Exclude- AHI<10|18
1004490|NCT01454830|2022577|FG001|Overall Study|Post-allocation Exclude- AHI<10|12
1004491|NCT01454830|2022576|FG000|Overall Study|Post-allocation Exclude-refused PAP|0
1004492|NCT01454830|2022577|FG001|Overall Study|Post-allocation Exclude-refused PAP|2
1004493|NCT01454830|2022576|FG000|Overall Study|Post-allocation Exclude-other treatment|6
1004494|NCT01454830|2022577|FG001|Overall Study|Post-allocation Exclude-other treatment|7
1004495|NCT01454830|2022576|FG000|Overall Study|Withdrawal - no polysomnography|3
1004496|NCT01454830|2022577|FG001|Overall Study|Withdrawal - no polysomnography|2
1004497|NCT01454934|2022585|FG000|Overall Study|Clinical progression|28
1004498|NCT01454934|2022586|FG001|Overall Study|Clinical progression|25
1004499|NCT01454934|2022585|FG000|Overall Study|Other|6
1004500|NCT01454934|2022586|FG001|Overall Study|Other|17
1004501|NCT01454934|2022585|FG000|Overall Study|Adverse Event|28
1004502|NCT01454934|2022586|FG001|Overall Study|Adverse Event|24
1004503|NCT01454934|2022585|FG000|Overall Study|Withdrawn consent|2
1004504|NCT01454934|2022586|FG001|Overall Study|Withdrawn consent|5
1004505|NCT01454934|2022585|FG000|Overall Study|Withdrawal by Subject|11
1004506|NCT01454934|2022586|FG001|Overall Study|Withdrawal by Subject|15
1004507|NCT01454934|2022585|FG000|Overall Study|Disease progression|194
1004508|NCT01454934|2022586|FG001|Overall Study|Disease progression|181
1004509|NCT01454934|2022585|FG000|Overall Study|Lost to Follow-up|0
1004510|NCT01454934|2022586|FG001|Overall Study|Lost to Follow-up|1
1004511|NCT01454934|2022585|FG000|Overall Study|Not treated|1
1004512|NCT01454934|2022586|FG001|Overall Study|Not treated|2
1004513|NCT01455012|2022627|FG000|Overall Study|Adverse Event|0
1004514|NCT01455012|2022628|FG001|Overall Study|Adverse Event|2
1004515|NCT01455012|2022627|FG000|Overall Study|Lack of Efficacy|6
1004516|NCT01455012|2022628|FG001|Overall Study|Lack of Efficacy|1
1004517|NCT01455012|2022627|FG000|Overall Study|Withdrawal by Subject|3
1004518|NCT01455012|2022628|FG001|Overall Study|Withdrawal by Subject|1
1004519|NCT01455012|2022627|FG000|Overall Study|Unknown reason|2
1004520|NCT01455012|2022628|FG001|Overall Study|Unknown reason|0
1004521|NCT01455194|2022645|FG000|Overall Study|Screen Failure|20
1004522|NCT01455194|2022646|FG001|Overall Study|Screen Failure|0
1004523|NCT01455194|2022647|FG002|Overall Study|Screen Failure|0
1004524|NCT01455194|2022648|FG003|Overall Study|Screen Failure|0
1004525|NCT01455194|2022645|FG000|Overall Study|Randomisation Failure|90
1004526|NCT01455194|2022646|FG001|Overall Study|Randomisation Failure|0
1004527|NCT01455194|2022647|FG002|Overall Study|Randomisation Failure|0
1004528|NCT01455194|2022648|FG003|Overall Study|Randomisation Failure|0
1004529|NCT01455194|2022645|FG000|Overall Study|Deterioration in asthma|12
1004530|NCT01455194|2022646|FG001|Overall Study|Deterioration in asthma|6
1004531|NCT01455194|2022647|FG002|Overall Study|Deterioration in asthma|14
1004532|NCT01455194|2022648|FG003|Overall Study|Deterioration in asthma|9
1004533|NCT01455194|2022645|FG000|Overall Study|Adverse Event|1
1004534|NCT01455194|2022646|FG001|Overall Study|Adverse Event|1
1004535|NCT01455194|2022647|FG002|Overall Study|Adverse Event|1
1004536|NCT01455194|2022648|FG003|Overall Study|Adverse Event|3
1004537|NCT01455194|2022645|FG000|Overall Study|Withdrawal by Subject|21
1004538|NCT01455194|2022646|FG001|Overall Study|Withdrawal by Subject|16
1004539|NCT01455194|2022647|FG002|Overall Study|Withdrawal by Subject|12
1004540|NCT01455194|2022648|FG003|Overall Study|Withdrawal by Subject|9
1004541|NCT01455194|2022645|FG000|Overall Study|Lost to Follow-up|2
1004542|NCT01455194|2022646|FG001|Overall Study|Lost to Follow-up|0
1004543|NCT01455194|2022647|FG002|Overall Study|Lost to Follow-up|1
1004544|NCT01455194|2022648|FG003|Overall Study|Lost to Follow-up|1
1004545|NCT01455194|2022645|FG000|Overall Study|Pregnancy|0
1004546|NCT01455194|2022646|FG001|Overall Study|Pregnancy|1
1004547|NCT01455194|2022647|FG002|Overall Study|Pregnancy|1
1004548|NCT01455194|2022648|FG003|Overall Study|Pregnancy|0
1004549|NCT01455194|2022645|FG000|Overall Study|Discontinuation criterion fulfilled|3
1004550|NCT01455194|2022646|FG001|Overall Study|Discontinuation criterion fulfilled|2
1004551|NCT01455194|2022647|FG002|Overall Study|Discontinuation criterion fulfilled|0
1004552|NCT01455194|2022648|FG003|Overall Study|Discontinuation criterion fulfilled|2
1004553|NCT01455194|2022645|FG000|Overall Study|Miscellaneous|4
1004554|NCT01455194|2022646|FG001|Overall Study|Miscellaneous|5
1004555|NCT01455194|2022647|FG002|Overall Study|Miscellaneous|1
1004556|NCT01455194|2022648|FG003|Overall Study|Miscellaneous|4
1004557|NCT01455220|2022661|FG000|Overall Study|screen fail|30
1004558|NCT01455415|2022670|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9
1004559|NCT01455415|2022671|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6
1004560|NCT01455415|2022670|FG000|Period 1|Lost To Follow-up Related to Study Drug|3
1004561|NCT01455415|2022671|FG001|Period 1|Lost To Follow-up Related to Study Drug|3
1004562|NCT01455415|2022670|FG000|Period 1|Drug Error not Associated to AE|0
1004563|NCT01455415|2022671|FG001|Period 1|Drug Error not Associated to AE|1
1004564|NCT01455415|2022670|FG000|Period 1|AE Not Related to Study Drug|2
1004565|NCT01455415|2022671|FG001|Period 1|AE Not Related to Study Drug|6
1004566|NCT01455415|2022670|FG000|Period 1|Withdrawal by Subject|4
1004567|NCT01455415|2022671|FG001|Period 1|Withdrawal by Subject|5
1004568|NCT01455415|2022670|FG000|Period 1|Unspecified Reason|1
1004569|NCT01455415|2022671|FG001|Period 1|Unspecified Reason|1
1004570|NCT01455415|2022670|FG000|Period 1|Protocol Violation|0
1004571|NCT01455415|2022671|FG001|Period 1|Protocol Violation|2
1004572|NCT01455415|2022670|FG000|Washout|AE Related to Study Drug|2
1004573|NCT01455415|2022671|FG001|Washout|AE Related to Study Drug|0
1004574|NCT01455415|2022670|FG000|Washout|Lost to Follow-up|1
1004575|NCT01455415|2022671|FG001|Washout|Lost to Follow-up|0
1004576|NCT01455415|2022670|FG000|Washout|Drug Error not Associated to AE|2
1004577|NCT01455415|2022671|FG001|Washout|Drug Error not Associated to AE|1
1004578|NCT01455415|2022670|FG000|Washout|AE Not Related to Study Drug|2
1004579|NCT01455415|2022671|FG001|Washout|AE Not Related to Study Drug|3
1004580|NCT01455415|2022670|FG000|Washout|Unspecified Reason|1
1004581|NCT01455415|2022671|FG001|Washout|Unspecified Reason|2
1004582|NCT01455415|2022670|FG000|Washout|Protocol Violation|0
1004583|NCT01455415|2022671|FG001|Washout|Protocol Violation|1
1004584|NCT01455415|2022670|FG000|Period 2|AE Related to Study Drug|1
1004585|NCT01455415|2022671|FG001|Period 2|AE Related to Study Drug|2
1004586|NCT01455415|2022670|FG000|Period 2|Lost to Follow-up|2
1004587|NCT01455415|2022671|FG001|Period 2|Lost to Follow-up|1
1004588|NCT01455415|2022670|FG000|Period 2|AE Not Related to Study Drug|2
1004589|NCT01455415|2022671|FG001|Period 2|AE Not Related to Study Drug|1
1004590|NCT01455415|2022670|FG000|Period 2|Lack of Efficacy|2
1004591|NCT01455415|2022671|FG001|Period 2|Lack of Efficacy|0
1004592|NCT01455415|2022670|FG000|Period 2|Withdrawal by Subject|2
1004593|NCT01455415|2022671|FG001|Period 2|Withdrawal by Subject|3
1004594|NCT01455415|2022670|FG000|Period 2|Unspecified Reason|2
1004595|NCT01455415|2022671|FG001|Period 2|Unspecified Reason|3
1004596|NCT01455415|2022670|FG000|Period 2|Protocol Violation|2
1004597|NCT01455415|2022671|FG001|Period 2|Protocol Violation|0
1004598|NCT01455415|2022670|FG000|Follow-up|AE Related to Study Drug|0
1004599|NCT01455415|2022671|FG001|Follow-up|AE Related to Study Drug|1
1004600|NCT01455415|2022670|FG000|Follow-up|Lack of Efficacy|0
1004601|NCT01455415|2022671|FG001|Follow-up|Lack of Efficacy|1
1004602|NCT01455415|2022670|FG000|Follow-up|Withdrawal by Subject|2
1004603|NCT01455415|2022671|FG001|Follow-up|Withdrawal by Subject|0
1004604|NCT01455415|2022670|FG000|Follow-up|Unspecified Reason|1
1004605|NCT01455415|2022671|FG001|Follow-up|Unspecified Reason|0
1004606|NCT01455428|2022679|FG000|Overall Study|Protocol Violation|2
1004607|NCT01455428|2022680|FG001|Overall Study|Protocol Violation|1
1004608|NCT01455428|2022679|FG000|Overall Study|Adverse Event|6
1004609|NCT01455428|2022680|FG001|Overall Study|Adverse Event|2
1004610|NCT01455428|2022679|FG000|Overall Study|Lost to Follow-up|1
1004611|NCT01455428|2022680|FG001|Overall Study|Lost to Follow-up|1
1004612|NCT01455428|2022679|FG000|Overall Study|Withdrawal by Subject|2
1004613|NCT01455428|2022680|FG001|Overall Study|Withdrawal by Subject|5
1004614|NCT01455428|2022679|FG000|Overall Study|Did not meet entrance criteria|0
1004615|NCT01455428|2022680|FG001|Overall Study|Did not meet entrance criteria|2
1004616|NCT01455428|2022679|FG000|Overall Study|Insufficient clinical response|0
1004617|NCT01455428|2022680|FG001|Overall Study|Insufficient clinical response|2
1004618|NCT01455428|2022679|FG000|Overall Study|Did not receive treatment|1
1004619|NCT01455428|2022680|FG001|Overall Study|Did not receive treatment|1
1004620|NCT01455428|2022679|FG000|Overall Study|Other|2
1004621|NCT01455428|2022680|FG001|Overall Study|Other|4
1004622|NCT01456039|2022723|FG000|Phase 1 (First Step)|Disease Progression|1
1004623|NCT01456039|2022724|FG001|Phase 1 (First Step)|Disease Progression|1
1004624|NCT01456039|2022725|FG002|Phase 1 (First Step)|Disease Progression|0
1004625|NCT01456039|2022723|FG000|Phase 1 (First Step)|Withdrawal by Subject|1
1004626|NCT01456039|2022724|FG001|Phase 1 (First Step)|Withdrawal by Subject|2
1004627|NCT01456039|2022725|FG002|Phase 1 (First Step)|Withdrawal by Subject|0
1004628|NCT01456039|2022723|FG000|Phase 1 (First Step)|Adverse Event|0
1004629|NCT01456039|2022724|FG001|Phase 1 (First Step)|Adverse Event|3
1004630|NCT01456039|2022725|FG002|Phase 1 (First Step)|Adverse Event|0
1004631|NCT01456039|2022723|FG000|Phase 1 (First Step)|Other|0
1004632|NCT01456039|2022724|FG001|Phase 1 (First Step)|Other|1
1004633|NCT01456039|2022725|FG002|Phase 1 (First Step)|Other|0
1004634|NCT01456039|2022723|FG000|Phase 2 (Second Step)|Disease Progression|0
1004635|NCT01456039|2022724|FG001|Phase 2 (Second Step)|Disease Progression|0
1004636|NCT01456039|2022725|FG002|Phase 2 (Second Step)|Disease Progression|17
1004637|NCT01456039|2022723|FG000|Phase 2 (Second Step)|Adverse Event|0
1004638|NCT01456039|2022724|FG001|Phase 2 (Second Step)|Adverse Event|0
1004639|NCT01456039|2022725|FG002|Phase 2 (Second Step)|Adverse Event|10
1004640|NCT01456039|2022723|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0
1004641|NCT01456039|2022724|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0
1004642|NCT01456039|2022725|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4
1004643|NCT01456039|2022723|FG000|Phase 2 (Second Step)|Protocol Violation|0
1004644|NCT01456039|2022724|FG001|Phase 2 (Second Step)|Protocol Violation|0
1004645|NCT01456039|2022725|FG002|Phase 2 (Second Step)|Protocol Violation|1
1004646|NCT01456039|2022723|FG000|Phase 2 (Second Step)|Other|0
1004647|NCT01456039|2022724|FG001|Phase 2 (Second Step)|Other|0
1004648|NCT01456039|2022725|FG002|Phase 2 (Second Step)|Other|1
1004649|NCT01456052|2022744|FG000|Overall Study|Adverse Event|1
1004650|NCT01456052|2022745|FG001|Overall Study|Adverse Event|1
1004651|NCT01456052|2022746|FG002|Overall Study|Adverse Event|2
1004652|NCT01456052|2022744|FG000|Overall Study|Consent withdrawn|0
1004653|NCT01456052|2022745|FG001|Overall Study|Consent withdrawn|2
1004654|NCT01456052|2022746|FG002|Overall Study|Consent withdrawn|1
1004655|NCT01456052|2022744|FG000|Overall Study|Protocol Violation|0
1004656|NCT01456052|2022745|FG001|Overall Study|Protocol Violation|1
1004657|NCT01456052|2022746|FG002|Overall Study|Protocol Violation|0
1004658|NCT01456052|2022744|FG000|Overall Study|Physician Decision|1
1004659|NCT01456052|2022745|FG001|Overall Study|Physician Decision|0
1004660|NCT01456052|2022746|FG002|Overall Study|Physician Decision|1
1004661|NCT01456052|2022744|FG000|Overall Study|Treatment Failure|0
1004662|NCT01456052|2022745|FG001|Overall Study|Treatment Failure|1
1004663|NCT01456052|2022746|FG002|Overall Study|Treatment Failure|1
1004664|NCT01456130|2022755|FG000|Overall Study|Adverse Event|4
1004665|NCT01456130|2022755|FG000|Overall Study|Voluntary Withdrawal|1
1004666|NCT01456130|2022755|FG000|Overall Study|Lack of Efficacy|4
1004667|NCT01456130|2022755|FG000|Overall Study|Other|1
1004668|NCT01456169|2022766|FG000|Overall Study|Adverse Event|1
1004669|NCT01456169|2022767|FG001|Overall Study|Adverse Event|2
1004670|NCT01456169|2022768|FG002|Overall Study|Adverse Event|7
1004671|NCT01456169|2022766|FG000|Overall Study|Major Protocol Deviation|3
1004672|NCT01456169|2022767|FG001|Overall Study|Major Protocol Deviation|2
1004673|NCT01456169|2022768|FG002|Overall Study|Major Protocol Deviation|3
1004674|NCT01456169|2022766|FG000|Overall Study|Voluntary Withdrawal|3
1004675|NCT01456169|2022767|FG001|Overall Study|Voluntary Withdrawal|0
1004676|NCT01456169|2022768|FG002|Overall Study|Voluntary Withdrawal|2
1004677|NCT01456169|2022766|FG000|Overall Study|Lack of Efficacy|2
1004678|NCT01456169|2022767|FG001|Overall Study|Lack of Efficacy|0
1004679|NCT01456169|2022768|FG002|Overall Study|Lack of Efficacy|0
1004680|NCT01456169|2022766|FG000|Overall Study|Other|1
1004681|NCT01456169|2022767|FG001|Overall Study|Other|1
1004682|NCT01456169|2022768|FG002|Overall Study|Other|0
1004683|NCT01456195|2022780|FG000|Overall Study|Pretreatment Event/Adverse Event|1
1004684|NCT01456195|2022781|FG001|Overall Study|Pretreatment Event/Adverse Event|4
1004685|NCT01456195|2022782|FG002|Overall Study|Pretreatment Event/Adverse Event|1
1004686|NCT01456195|2022780|FG000|Overall Study|Lost to Follow-up|3
1004687|NCT01456195|2022781|FG001|Overall Study|Lost to Follow-up|1
1004688|NCT01456195|2022782|FG002|Overall Study|Lost to Follow-up|3
1004689|NCT01456195|2022780|FG000|Overall Study|Voluntary Withdrawal|5
1004690|NCT01456195|2022781|FG001|Overall Study|Voluntary Withdrawal|3
1004691|NCT01456195|2022782|FG002|Overall Study|Voluntary Withdrawal|7
1004692|NCT01456195|2022780|FG000|Overall Study|Lack of Efficacy|0
1004693|NCT01456195|2022781|FG001|Overall Study|Lack of Efficacy|1
1004694|NCT01456195|2022782|FG002|Overall Study|Lack of Efficacy|0
1004695|NCT01456195|2022780|FG000|Overall Study|Other Reasons|2
1004696|NCT01456195|2022781|FG001|Overall Study|Other Reasons|1
1004697|NCT01456195|2022782|FG002|Overall Study|Other Reasons|3
1004698|NCT01456221|2022792|FG000|Overall Study|Withdrawal by Subject|56
1004699|NCT01456221|2022793|FG001|Overall Study|Withdrawal by Subject|49
1004700|NCT01456221|2022792|FG000|Overall Study|Lost to Follow-up|1
1004701|NCT01456221|2022793|FG001|Overall Study|Lost to Follow-up|4
1004702|NCT01456221|2022792|FG000|Overall Study|Received medication|3
1004703|NCT01456221|2022793|FG001|Overall Study|Received medication|2
1004704|NCT01456221|2022792|FG000|Overall Study|Incomplete data|4
1004705|NCT01456221|2022793|FG001|Overall Study|Incomplete data|2
1004706|NCT01456780|2022824|FG000|Overall Study|Lost to Follow-up|3
1004707|NCT01456780|2022825|FG001|Overall Study|Lost to Follow-up|3
1004708|NCT01456780|2022826|FG002|Overall Study|Lost to Follow-up|0
1004709|NCT01456897|2022836|FG000|Overall Study|Adverse Event|19
1004710|NCT01456897|2022837|FG001|Overall Study|Adverse Event|22
1004711|NCT01456897|2022836|FG000|Overall Study|Protocol Violation|3
1004712|NCT01456897|2022837|FG001|Overall Study|Protocol Violation|4
1004713|NCT01456897|2022836|FG000|Overall Study|Physician Decision|5
1004714|NCT01456897|2022837|FG001|Overall Study|Physician Decision|3
1004715|NCT01456897|2022836|FG000|Overall Study|Withdrawal by Subject|44
1004716|NCT01456897|2022837|FG001|Overall Study|Withdrawal by Subject|17
1004717|NCT01456897|2022836|FG000|Overall Study|Lack of Efficacy|4
1004718|NCT01456897|2022837|FG001|Overall Study|Lack of Efficacy|11
1004719|NCT01456936|2022847|FG000|Overall Study|Other reason|41
1004720|NCT01456936|2022848|FG001|Overall Study|Other reason|30
1004721|NCT01456936|2022849|FG002|Overall Study|Other reason|36
1004722|NCT01456936|2022850|FG003|Overall Study|Other reason|33
1004723|NCT01456936|2022847|FG000|Overall Study|No longer meets eligibility criteria|4
1004724|NCT01456936|2022848|FG001|Overall Study|No longer meets eligibility criteria|8
1004725|NCT01456936|2022849|FG002|Overall Study|No longer meets eligibility criteria|6
1004726|NCT01456936|2022850|FG003|Overall Study|No longer meets eligibility criteria|5
1004727|NCT01456936|2022847|FG000|Overall Study|Protocol Violation|4
1004728|NCT01456936|2022848|FG001|Overall Study|Protocol Violation|2
1004729|NCT01456936|2022849|FG002|Overall Study|Protocol Violation|5
1004730|NCT01456936|2022850|FG003|Overall Study|Protocol Violation|5
1004731|NCT01456936|2022847|FG000|Overall Study|Pregnancy|1
1004732|NCT01456936|2022848|FG001|Overall Study|Pregnancy|0
1004733|NCT01456936|2022849|FG002|Overall Study|Pregnancy|0
1004734|NCT01456936|2022850|FG003|Overall Study|Pregnancy|1
1004735|NCT01456936|2022847|FG000|Overall Study|Insufficient clinical response|4
1004736|NCT01456936|2022848|FG001|Overall Study|Insufficient clinical response|4
1004737|NCT01456936|2022849|FG002|Overall Study|Insufficient clinical response|14
1004738|NCT01456936|2022850|FG003|Overall Study|Insufficient clinical response|13
1004739|NCT01456936|2022847|FG000|Overall Study|No longer willing to participate|195
1004740|NCT01456936|2022848|FG001|Overall Study|No longer willing to participate|218
1004741|NCT01456936|2022849|FG002|Overall Study|No longer willing to participate|224
1004742|NCT01456936|2022850|FG003|Overall Study|No longer willing to participate|248
1004743|NCT01456936|2022847|FG000|Overall Study|Lost to Follow-up|135
1004744|NCT01456936|2022848|FG001|Overall Study|Lost to Follow-up|126
1004745|NCT01456936|2022849|FG002|Overall Study|Lost to Follow-up|144
1004746|NCT01456936|2022850|FG003|Overall Study|Lost to Follow-up|127
1004747|NCT01456936|2022847|FG000|Overall Study|Medication error|0
1004748|NCT01456936|2022848|FG001|Overall Study|Medication error|1
1004749|NCT01456936|2022849|FG002|Overall Study|Medication error|0
1004750|NCT01456936|2022850|FG003|Overall Study|Medication error|1
1004751|NCT01456936|2022847|FG000|Overall Study|Adverse event (study drug)|25
1004752|NCT01456936|2022848|FG001|Overall Study|Adverse event (study drug)|21
1004753|NCT01456936|2022849|FG002|Overall Study|Adverse event (study drug)|26
1004754|NCT01456936|2022850|FG003|Overall Study|Adverse event (study drug)|17
1004755|NCT01456936|2022847|FG000|Overall Study|Adverse event (study drug unrelated)|9
1004756|NCT01456936|2022848|FG001|Overall Study|Adverse event (study drug unrelated)|7
1004757|NCT01456936|2022849|FG002|Overall Study|Adverse event (study drug unrelated)|9
1004758|NCT01456936|2022850|FG003|Overall Study|Adverse event (study drug unrelated)|9
1004759|NCT01456936|2022847|FG000|Overall Study|Death|0
1004760|NCT01456936|2022848|FG001|Overall Study|Death|3
1004761|NCT01456936|2022849|FG002|Overall Study|Death|1
1004762|NCT01456936|2022850|FG003|Overall Study|Death|3
1004763|NCT01456936|2022847|FG000|Overall Study|Randomized but not treated|21
1004764|NCT01456936|2022848|FG001|Overall Study|Randomized but not treated|28
1004765|NCT01456936|2022849|FG002|Overall Study|Randomized but not treated|16
1004766|NCT01456936|2022850|FG003|Overall Study|Randomized but not treated|21
1004767|NCT01456949|2022860|FG000|Enrollment|PI death- incomplete data|6
1004768|NCT01456949|2022860|FG000|Enrollment|Death|1
1004769|NCT01456949|2022860|FG000|Enrollment|I/E criteria not met prior to procedure|13
1004770|NCT01456949|2022860|FG000|Enrollment|Physician Decision|10
1004771|NCT01456949|2022860|FG000|Enrollment|Withdrawal by Subject|7
1004772|NCT01456949|2022860|FG000|Study Cryoablation Procedure & Follow-up|Death|5
1004773|NCT01456949|2022860|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
1004774|NCT01456949|2022860|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
1004775|NCT01456949|2022860|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1
1004776|NCT01456949|2022860|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
1004777|NCT01456949|2022860|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
1004778|NCT01456949|2022860|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
1004779|NCT01456949|2022860|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
1004780|NCT01456962|2022866|FG000|Overall Study|Lost to Follow-up|2
1004781|NCT01456962|2022867|FG001|Overall Study|Lost to Follow-up|1
1004782|NCT01457014|2022873|FG000|First Night|Didn't meet inclusion/exclusion criteria|37
1004783|NCT01457014|2022874|FG001|First Night|Didn't meet inclusion/exclusion criteria|0
1004784|NCT01457014|2022875|FG002|First Night|Didn't meet inclusion/exclusion criteria|0
1004785|NCT01457014|2022876|FG003|First Night|Didn't meet inclusion/exclusion criteria|0
1004786|NCT01457014|2022873|FG000|First Night|Withdrawal by Subject|3
1004787|NCT01457014|2022874|FG001|First Night|Withdrawal by Subject|0
1004788|NCT01457014|2022875|FG002|First Night|Withdrawal by Subject|0
1004789|NCT01457014|2022876|FG003|First Night|Withdrawal by Subject|0
1004790|NCT01457118|2022888|FG000|Overall Study|Adverse Event|1
1004791|NCT01457118|2022889|FG001|Overall Study|Adverse Event|0
1004792|NCT01457118|2022890|FG002|Overall Study|Adverse Event|0
1004793|NCT01457118|2022891|FG003|Overall Study|Adverse Event|1
1004794|NCT01457118|2022888|FG000|Overall Study|Clinical Progression|0
1004795|NCT01457118|2022889|FG001|Overall Study|Clinical Progression|1
1004796|NCT01457118|2022890|FG002|Overall Study|Clinical Progression|0
1004797|NCT01457118|2022891|FG003|Overall Study|Clinical Progression|1
1004798|NCT01457118|2022888|FG000|Overall Study|Physician Decision|2
1004799|NCT01457118|2022889|FG001|Overall Study|Physician Decision|0
1004800|NCT01457118|2022890|FG002|Overall Study|Physician Decision|0
1004801|NCT01457118|2022891|FG003|Overall Study|Physician Decision|0
1004802|NCT01457118|2022888|FG000|Overall Study|Progressive Disease by RECIST|12
1004803|NCT01457118|2022889|FG001|Overall Study|Progressive Disease by RECIST|3
1004804|NCT01457118|2022890|FG002|Overall Study|Progressive Disease by RECIST|1
1004805|NCT01457118|2022891|FG003|Overall Study|Progressive Disease by RECIST|0
1004806|NCT01457118|2022888|FG000|Overall Study|Withdrawal by Subject|5
1004807|NCT01457118|2022889|FG001|Overall Study|Withdrawal by Subject|0
1004808|NCT01457118|2022890|FG002|Overall Study|Withdrawal by Subject|0
1004809|NCT01457118|2022891|FG003|Overall Study|Withdrawal by Subject|0
1004810|NCT01457339|2022909|FG000|Period 3 (100 mg)|Adverse Event|0
1004811|NCT01457339|2022910|FG001|Period 3 (100 mg)|Adverse Event|1
1004812|NCT01457339|2022909|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
1004813|NCT01457339|2022910|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
1004814|NCT01457339|2022909|FG000|Period 6 (250 mg)|Family Emergency|1
1004815|NCT01457339|2022910|FG001|Period 6 (250 mg)|Family Emergency|0
1004816|NCT01457339|2022909|FG000|Period 6 (250 mg)|Personal appointment|0
1004817|NCT01457339|2022910|FG001|Period 6 (250 mg)|Personal appointment|1
1004818|NCT01457352|2022935|FG000|Period 1|Adverse Event|2
1004819|NCT01457352|2022936|FG001|Period 1|Adverse Event|0
1004820|NCT01457352|2022935|FG000|Period 1|Withdrawal by Subject|2
1004821|NCT01457352|2022936|FG001|Period 1|Withdrawal by Subject|0
1004822|NCT01457352|2022935|FG000|Period 1|Physician Decision|2
1004823|NCT01457352|2022936|FG001|Period 1|Physician Decision|0
1004824|NCT01457352|2022935|FG000|Period 1|MS related disease progression|1
1004825|NCT01457352|2022936|FG001|Period 1|MS related disease progression|0
1004826|NCT01457352|2022935|FG000|Period 1|Withdrawn|1
1004827|NCT01457352|2022936|FG001|Period 1|Withdrawn|0
1004828|NCT01457352|2022935|FG000|Period 1|withdrew per sponsor|1
1004829|NCT01457352|2022936|FG001|Period 1|withdrew per sponsor|0
1004830|NCT01457352|2022935|FG000|Period 1|Protocol Violation|4
1004831|NCT01457352|2022936|FG001|Period 1|Protocol Violation|0
1004832|NCT01457352|2022935|FG000|Period 1|Did not meet eligibility criteria|3
1004833|NCT01457352|2022936|FG001|Period 1|Did not meet eligibility criteria|0
1004834|NCT01457352|2022935|FG000|Period 2|Withdrawal by Subject|23
1004835|NCT01457352|2022936|FG001|Period 2|Withdrawal by Subject|0
1004836|NCT01457352|2022935|FG000|Period 2|Adverse Event|22
1004837|NCT01457352|2022936|FG001|Period 2|Adverse Event|0
1004838|NCT01457352|2022935|FG000|Period 2|no analysis|10
1004839|NCT01457352|2022936|FG001|Period 2|no analysis|0
1004840|NCT01457352|2022935|FG000|Period 2|Lack of Efficacy|8
1004841|NCT01457352|2022936|FG001|Period 2|Lack of Efficacy|0
1004842|NCT01457352|2022935|FG000|Period 2|Protocol Violation|4
1004843|NCT01457352|2022936|FG001|Period 2|Protocol Violation|0
1004844|NCT01457352|2022935|FG000|Period 2|Sponsor's withdrawal|7
1004845|NCT01457352|2022936|FG001|Period 2|Sponsor's withdrawal|0
1004846|NCT01457352|2022935|FG000|Period 2|Lost to Follow-up|1
1004847|NCT01457352|2022936|FG001|Period 2|Lost to Follow-up|0
1004848|NCT01457352|2022935|FG000|Period 2|dose change|1
1004849|NCT01457352|2022936|FG001|Period 2|dose change|0
1004850|NCT01457352|2022935|FG000|Period 2|Physician Decision|1
1004851|NCT01457352|2022936|FG001|Period 2|Physician Decision|0
1004852|NCT01457352|2022935|FG000|Period 2|Did not meet eligibility criteria|3
1004853|NCT01457352|2022936|FG001|Period 2|Did not meet eligibility criteria|0
1004854|NCT01457352|2022935|FG000|Period 3|Adverse Event|1
1004855|NCT01457352|2022936|FG001|Period 3|Adverse Event|1
1004856|NCT01457352|2022935|FG000|Period 3|Withdrawal by Subject|0
1004857|NCT01457352|2022936|FG001|Period 3|Withdrawal by Subject|2
1004858|NCT01457352|2022935|FG000|Period 3|incorrect treatment|0
1004859|NCT01457352|2022936|FG001|Period 3|incorrect treatment|1
1004860|NCT01457352|2022935|FG000|Period 3|Sponsor's withdrawal|0
1004861|NCT01457352|2022936|FG001|Period 3|Sponsor's withdrawal|1
1004862|NCT01457703|2022990|FG000|Overall Study|Screen Failure|5
1004863|NCT01457703|2022991|FG001|Overall Study|Screen Failure|7
1004864|NCT01457703|2022990|FG000|Overall Study|Withdrawal by Subject|1
1004865|NCT01457703|2022991|FG001|Overall Study|Withdrawal by Subject|4
1004866|NCT01457846|2023001|FG000|Overall Study|Death before treatment|1
1004867|NCT01457846|2023002|FG001|Overall Study|Death before treatment|2
1004868|NCT01457846|2023001|FG000|Overall Study|Did not receive treatment|0
1004869|NCT01457846|2023002|FG001|Overall Study|Did not receive treatment|1
1004870|NCT01457846|2023001|FG000|Overall Study|Death|27
1004871|NCT01457846|2023002|FG001|Overall Study|Death|16
1004872|NCT01457846|2023001|FG000|Overall Study|Unclassified reason for not completed|11
1004873|NCT01457846|2023002|FG001|Overall Study|Unclassified reason for not completed|10
1004874|NCT01457846|2023001|FG000|Overall Study|Withdrawal by Subject|1
1004875|NCT01457846|2023002|FG001|Overall Study|Withdrawal by Subject|1
1004876|NCT01457846|2023001|FG000|Overall Study|Lost to Follow-up|1
1004877|NCT01457846|2023002|FG001|Overall Study|Lost to Follow-up|0
1004878|NCT01457924|2023017|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0
1004879|NCT01457924|2023018|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4
1004880|NCT01457924|2023019|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1
1004881|NCT01457924|2023020|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0
1004882|NCT01457924|2023021|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2
1004883|NCT01457924|2023017|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0
1004884|NCT01457924|2023018|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0
1004885|NCT01457924|2023019|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0
1004886|NCT01457924|2023020|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0
1004887|NCT01457924|2023021|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1
1004888|NCT01457924|2023017|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
1004889|NCT01457924|2023018|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1004890|NCT01457924|2023019|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1004891|NCT01457924|2023020|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1004892|NCT01457924|2023021|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1004893|NCT01457924|2023017|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1
1004894|NCT01457924|2023018|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1004895|NCT01457924|2023019|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1
1004896|NCT01457924|2023020|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1004897|NCT01457924|2023021|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1004898|NCT01457924|2023017|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1004899|NCT01457924|2023018|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1004900|NCT01457924|2023019|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1004901|NCT01457924|2023020|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
1004902|NCT01457924|2023021|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
1004903|NCT01457924|2023017|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
1004904|NCT01457924|2023018|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
1004905|NCT01457924|2023019|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
1004906|NCT01457924|2023020|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
1004907|NCT01457924|2023021|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
1004908|NCT01457924|2023017|FG000|FUP (Weeks 24-48)|Adverse Event|0
1004909|NCT01457924|2023018|FG001|FUP (Weeks 24-48)|Adverse Event|0
1004910|NCT01457924|2023019|FG002|FUP (Weeks 24-48)|Adverse Event|1
1004911|NCT01457924|2023020|FG003|FUP (Weeks 24-48)|Adverse Event|0
1004912|NCT01457924|2023021|FG004|FUP (Weeks 24-48)|Adverse Event|0
1004913|NCT01457924|2023017|FG000|FUP (Weeks 24-48)|Physician Decision|1
1004914|NCT01457924|2023018|FG001|FUP (Weeks 24-48)|Physician Decision|0
1004915|NCT01457924|2023019|FG002|FUP (Weeks 24-48)|Physician Decision|1
1004916|NCT01457924|2023020|FG003|FUP (Weeks 24-48)|Physician Decision|0
1004917|NCT01457924|2023021|FG004|FUP (Weeks 24-48)|Physician Decision|0
1004918|NCT01457924|2023017|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0
1004919|NCT01457924|2023018|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0
1004920|NCT01457924|2023019|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0
1004921|NCT01457924|2023020|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1
1004922|NCT01457924|2023021|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0
1004923|NCT01457924|2023017|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2
1004924|NCT01457924|2023018|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1
1004925|NCT01457924|2023019|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0
1004926|NCT01457924|2023020|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0
1004927|NCT01457924|2023021|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2
1004928|NCT01457924|2023017|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
1004929|NCT01457924|2023018|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1004930|NCT01457924|2023019|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
1004931|NCT01457924|2023020|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1004932|NCT01457924|2023021|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1004933|NCT01457924|2023017|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
1004934|NCT01457924|2023018|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
1004935|NCT01457924|2023019|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
1004936|NCT01457924|2023020|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
1004937|NCT01457924|2023021|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
1004938|NCT01457924|2023017|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1004939|NCT01457924|2023018|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
1004940|NCT01457924|2023019|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1004941|NCT01457924|2023020|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
1004942|NCT01457924|2023021|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1004943|NCT01457950|2023035|FG000|Double-Blind Phase|Continuation Criteria Not Met|1
1004944|NCT01457950|2023036|FG001|Double-Blind Phase|Continuation Criteria Not Met|0
1004945|NCT01457950|2023037|FG002|Double-Blind Phase|Continuation Criteria Not Met|0
1004946|NCT01457950|2023038|FG003|Double-Blind Phase|Continuation Criteria Not Met|0
1004947|NCT01457950|2023035|FG000|Double-Blind Phase|Protocol Violation|2
1004948|NCT01457950|2023036|FG001|Double-Blind Phase|Protocol Violation|1
1004949|NCT01457950|2023037|FG002|Double-Blind Phase|Protocol Violation|0
1004950|NCT01457950|2023038|FG003|Double-Blind Phase|Protocol Violation|0
1004951|NCT01457950|2023035|FG000|Double-Blind Phase|Withdrawal by Subject|6
1004952|NCT01457950|2023036|FG001|Double-Blind Phase|Withdrawal by Subject|2
1004953|NCT01457950|2023037|FG002|Double-Blind Phase|Withdrawal by Subject|0
1004954|NCT01457950|2023038|FG003|Double-Blind Phase|Withdrawal by Subject|0
1004955|NCT01457950|2023035|FG000|Open-Label Phase|Adverse Event|0
1004956|NCT01457950|2023036|FG001|Open-Label Phase|Adverse Event|0
1004957|NCT01457950|2023037|FG002|Open-Label Phase|Adverse Event|0
1004958|NCT01457950|2023038|FG003|Open-Label Phase|Adverse Event|1
1004959|NCT01457950|2023035|FG000|Open-Label Phase|Protocol Violation|0
1004960|NCT01457950|2023036|FG001|Open-Label Phase|Protocol Violation|0
1004961|NCT01457950|2023037|FG002|Open-Label Phase|Protocol Violation|0
1004962|NCT01457950|2023038|FG003|Open-Label Phase|Protocol Violation|1
1004963|NCT01457950|2023035|FG000|Open-Label Phase|Withdrawal by Subject|0
1004964|NCT01457950|2023036|FG001|Open-Label Phase|Withdrawal by Subject|0
1004965|NCT01457950|2023037|FG002|Open-Label Phase|Withdrawal by Subject|2
1004966|NCT01457950|2023038|FG003|Open-Label Phase|Withdrawal by Subject|0
1004967|NCT01458106|2023051|FG000|Overall Study|Withdrawal by Subject|2
1004968|NCT01458106|2023052|FG001|Overall Study|Withdrawal by Subject|0
1004969|NCT01458106|2023051|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1
1004970|NCT01458106|2023052|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0
1004971|NCT01458106|2023051|FG000|Overall Study|Withdrawn Per Protocol|0
1004972|NCT01458106|2023052|FG001|Overall Study|Withdrawn Per Protocol|1
1004973|NCT01458119|2023061|FG000|Overall Study|Physician Decision|4
1004974|NCT01458119|2023061|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1
1004975|NCT01458119|2023061|FG000|Overall Study|Pregnancy|1
1004976|NCT01458119|2023061|FG000|Overall Study|Death|2
1004977|NCT01458119|2023061|FG000|Overall Study|Adverse Event|1
1004978|NCT01458119|2023061|FG000|Overall Study|Consent Withdrawn by Participant|8
1004979|NCT01458119|2023061|FG000|Overall Study|Non-compliance With Study Drug|3
1004980|NCT01458132|2023068|FG000|Overall Study|Other|15
1004981|NCT01458132|2023069|FG001|Overall Study|Other|3
1004982|NCT01458171|2023075|FG000|Overall Study|Adverse Event|1
1004983|NCT01458210|2023081|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
1004984|NCT01458210|2023081|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
1004985|NCT01458210|2023081|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
1004986|NCT01458210|2023081|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
1004987|NCT01458249|2023090|FG000|Overall Study|Not treated|1
1004988|NCT01458249|2023090|FG000|Overall Study|Adverse Event|4
1004989|NCT01458249|2023090|FG000|Overall Study|Other|2
1004990|NCT01458249|2023090|FG000|Overall Study|Ongoing|1
1004991|NCT01458275|2023098|FG000|Overall Study|Adverse Event|3
1004992|NCT01458275|2023099|FG001|Overall Study|Adverse Event|4
1004993|NCT01458275|2023100|FG002|Overall Study|Adverse Event|1
1004994|NCT01458275|2023098|FG000|Overall Study|Lost to Follow-up|3
1004995|NCT01458275|2023099|FG001|Overall Study|Lost to Follow-up|2
1004996|NCT01458275|2023100|FG002|Overall Study|Lost to Follow-up|5
1004997|NCT01458275|2023098|FG000|Overall Study|Protocol Violation|5
1004998|NCT01458275|2023099|FG001|Overall Study|Protocol Violation|5
1004999|NCT01458275|2023100|FG002|Overall Study|Protocol Violation|2
1005000|NCT01458275|2023098|FG000|Overall Study|Withdrawal by Subject|3
1005001|NCT01458275|2023099|FG001|Overall Study|Withdrawal by Subject|2
1005002|NCT01458275|2023100|FG002|Overall Study|Withdrawal by Subject|1
1005003|NCT01458366|2023125|FG000|Period 1: 70mg/m^2|Physician Decision|2
1005004|NCT01458366|2023126|FG001|Period 1: 70mg/m^2|Physician Decision|0
1005005|NCT01458366|2023127|FG002|Period 1: 70mg/m^2|Physician Decision|0
1005006|NCT01458366|2023128|FG003|Period 1: 70mg/m^2|Physician Decision|0
1005007|NCT01458366|2023129|FG004|Period 1: 70mg/m^2|Physician Decision|0
1005008|NCT01458366|2023125|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
1005009|NCT01458366|2023126|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
1005010|NCT01458366|2023127|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
1005011|NCT01458366|2023128|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
1005012|NCT01458366|2023129|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
1005013|NCT01458392|2023140|FG000|Overall Study|Death|2
1005014|NCT01458392|2023141|FG001|Overall Study|Death|11
1005015|NCT01458392|2023142|FG002|Overall Study|Death|22
1005016|NCT01458392|2023140|FG000|Overall Study|At the discretion of the sponsor|0
1005017|NCT01458392|2023141|FG001|Overall Study|At the discretion of the sponsor|2
1005018|NCT01458392|2023142|FG002|Overall Study|At the discretion of the sponsor|7
1090778|NCT02248818|2158525|FG007|Screening|Withdrawal by Subject|0
1005019|NCT01458392|2023140|FG000|Overall Study|Patient unwilling to comply with protoco|0
1005020|NCT01458392|2023141|FG001|Overall Study|Patient unwilling to comply with protoco|0
1005021|NCT01458392|2023142|FG002|Overall Study|Patient unwilling to comply with protoco|2
1005022|NCT01458522|2023173|FG000|Overall Study|Withdrawal by Subject|2
1005023|NCT01458522|2023174|FG001|Overall Study|Withdrawal by Subject|2
1005024|NCT01458522|2023173|FG000|Overall Study|Physician Decision|1
1005025|NCT01458522|2023174|FG001|Overall Study|Physician Decision|9
1005026|NCT01458535|2023192|FG000|Overall Study|Other|0
1005027|NCT01458535|2023193|FG001|Overall Study|Other|0
1005028|NCT01458535|2023194|FG002|Overall Study|Other|0
1005029|NCT01458535|2023195|FG003|Overall Study|Other|0
1005030|NCT01458535|2023196|FG004|Overall Study|Other|1
1005031|NCT01458535|2023197|FG005|Overall Study|Other|1
1005032|NCT01458535|2023192|FG000|Overall Study|Withdrawal by Subject|0
1005033|NCT01458535|2023193|FG001|Overall Study|Withdrawal by Subject|0
1005034|NCT01458535|2023194|FG002|Overall Study|Withdrawal by Subject|2
1005035|NCT01458535|2023195|FG003|Overall Study|Withdrawal by Subject|0
1005036|NCT01458535|2023196|FG004|Overall Study|Withdrawal by Subject|1
1005037|NCT01458535|2023197|FG005|Overall Study|Withdrawal by Subject|1
1005038|NCT01458535|2023192|FG000|Overall Study|Lost to Follow-up|0
1005039|NCT01458535|2023193|FG001|Overall Study|Lost to Follow-up|2
1005040|NCT01458535|2023194|FG002|Overall Study|Lost to Follow-up|0
1005041|NCT01458535|2023195|FG003|Overall Study|Lost to Follow-up|3
1005042|NCT01458535|2023196|FG004|Overall Study|Lost to Follow-up|2
1005043|NCT01458535|2023197|FG005|Overall Study|Lost to Follow-up|2
1005044|NCT01458535|2023192|FG000|Overall Study|Adverse Event|0
1005045|NCT01458535|2023193|FG001|Overall Study|Adverse Event|0
1005046|NCT01458535|2023194|FG002|Overall Study|Adverse Event|0
1005047|NCT01458535|2023195|FG003|Overall Study|Adverse Event|1
1005048|NCT01458535|2023196|FG004|Overall Study|Adverse Event|0
1005049|NCT01458535|2023197|FG005|Overall Study|Adverse Event|0
1005050|NCT01458574|2023253|FG000|Overall Study|Adverse Event|5
1005051|NCT01458574|2023254|FG001|Overall Study|Adverse Event|9
1005052|NCT01458574|2023255|FG002|Overall Study|Adverse Event|7
1005053|NCT01458574|2023253|FG000|Overall Study|Lack of Efficacy|70
1005054|NCT01458574|2023254|FG001|Overall Study|Lack of Efficacy|53
1005055|NCT01458574|2023255|FG002|Overall Study|Lack of Efficacy|132
1005056|NCT01458574|2023253|FG000|Overall Study|Lost to Follow-up|3
1005057|NCT01458574|2023254|FG001|Overall Study|Lost to Follow-up|2
1005058|NCT01458574|2023255|FG002|Overall Study|Lost to Follow-up|1
1005059|NCT01458574|2023253|FG000|Overall Study|Pregnancy|1
1005060|NCT01458574|2023254|FG001|Overall Study|Pregnancy|1
1005061|NCT01458574|2023255|FG002|Overall Study|Pregnancy|0
1005062|NCT01458574|2023253|FG000|Overall Study|Protocol Violation|0
1005063|NCT01458574|2023254|FG001|Overall Study|Protocol Violation|1
1005064|NCT01458574|2023255|FG002|Overall Study|Protocol Violation|0
1005065|NCT01458574|2023253|FG000|Overall Study|Withdrawal by Subject|6
1005066|NCT01458574|2023254|FG001|Overall Study|Withdrawal by Subject|3
1005067|NCT01458574|2023255|FG002|Overall Study|Withdrawal by Subject|5
1005068|NCT01458574|2023253|FG000|Overall Study|Other|2
1005069|NCT01458574|2023254|FG001|Overall Study|Other|1
1005070|NCT01458574|2023255|FG002|Overall Study|Other|0
1005071|NCT01458574|2023253|FG000|Overall Study|Randomized but not treated|0
1005072|NCT01458574|2023254|FG001|Overall Study|Randomized but not treated|1
1005073|NCT01458574|2023255|FG002|Overall Study|Randomized but not treated|0
1005074|NCT01458587|2023265|FG000|Overall Study|Withdrawal by Subject|1
1005075|NCT01458587|2023266|FG001|Overall Study|Withdrawal by Subject|0
1005076|NCT01458639|2023274|FG000|Overall Study|Physician Decision|4
1005077|NCT01458639|2023274|FG000|Overall Study|Equipment issue|1
1005078|NCT01458639|2023274|FG000|Overall Study|Inability to obtain subject blood sample|1
1005079|NCT01458951|2023281|FG000|Overall Study|Other|1
1005080|NCT01458951|2023282|FG001|Overall Study|Other|0
1005081|NCT01458951|2023283|FG002|Overall Study|Other|0
1005082|NCT01458951|2023281|FG000|Overall Study|Protocol Violation|5
1005083|NCT01458951|2023282|FG001|Overall Study|Protocol Violation|1
1005084|NCT01458951|2023283|FG002|Overall Study|Protocol Violation|0
1005085|NCT01458951|2023281|FG000|Overall Study|Withdrawal by Subject|2
1005086|NCT01458951|2023282|FG001|Overall Study|Withdrawal by Subject|0
1005087|NCT01458951|2023283|FG002|Overall Study|Withdrawal by Subject|2
1005088|NCT01458951|2023281|FG000|Overall Study|Adverse Event|7
1005089|NCT01458951|2023282|FG001|Overall Study|Adverse Event|0
1005090|NCT01458951|2023283|FG002|Overall Study|Adverse Event|2
1005091|NCT01458951|2023281|FG000|Overall Study|Insufficient Clinical Response|17
1005092|NCT01458951|2023282|FG001|Overall Study|Insufficient Clinical Response|0
1005093|NCT01458951|2023283|FG002|Overall Study|Insufficient Clinical Response|11
1005094|NCT01459016|2023301|FG000|Overall Study|Withdrawal by Subject|11
1005095|NCT01459016|2023301|FG000|Overall Study|Amendment Discontinuation Criteria|4
1005096|NCT01459068|2023307|FG000|Overall Study|Withdrawal by Subject|8
1005097|NCT01459068|2023308|FG001|Overall Study|Withdrawal by Subject|18
1005098|NCT01459068|2023307|FG000|Overall Study|Lost to Follow-up|31
1005099|NCT01459068|2023308|FG001|Overall Study|Lost to Follow-up|15
1005100|NCT01459068|2023307|FG000|Overall Study|Death|0
1005101|NCT01459068|2023308|FG001|Overall Study|Death|1
1005102|NCT01459614|2023333|FG000|Overall Study|Adverse Event|1
1005103|NCT01459614|2023334|FG001|Overall Study|Adverse Event|0
1005104|NCT01459718|2023424|FG000|Overall Study|Physician Decision|1
1005105|NCT01459718|2023424|FG000|Overall Study|Lost to Follow-up|1
1005106|NCT01459718|2023424|FG000|Overall Study|Adverse Event|1
1005107|NCT01459783|2023430|FG000|Baseline to 6 Months|Death|1
1005108|NCT01459783|2023431|FG001|Baseline to 6 Months|Death|0
1005109|NCT01459783|2023430|FG000|Baseline to 6 Months|Withdrawal by Subject|12
1005110|NCT01459783|2023431|FG001|Baseline to 6 Months|Withdrawal by Subject|6
1005111|NCT01459783|2023430|FG000|Baseline to 6 Months|Lost to Follow-up|19
1005112|NCT01459783|2023431|FG001|Baseline to 6 Months|Lost to Follow-up|14
1005113|NCT01459783|2023430|FG000|6 Months to 12 Months|Death|0
1005114|NCT01459783|2023431|FG001|6 Months to 12 Months|Death|1
1005115|NCT01459783|2023430|FG000|6 Months to 12 Months|Withdrawal by Subject|6
1005116|NCT01459783|2023431|FG001|6 Months to 12 Months|Withdrawal by Subject|5
1005117|NCT01459783|2023430|FG000|6 Months to 12 Months|Lost to Follow-up|2
1005118|NCT01459783|2023431|FG001|6 Months to 12 Months|Lost to Follow-up|7
1005119|NCT01459783|2023430|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11
1005120|NCT01459783|2023431|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17
1005121|NCT01459796|2023439|FG000|Overall Study|Non compliance with protocol|2
1005122|NCT01459796|2023440|FG001|Overall Study|Non compliance with protocol|4
1005123|NCT01459796|2023439|FG000|Overall Study|Adverse Event|5
1005124|NCT01459796|2023440|FG001|Overall Study|Adverse Event|5
1005125|NCT01459796|2023439|FG000|Overall Study|Withdrawal by Subject|6
1005126|NCT01459796|2023440|FG001|Overall Study|Withdrawal by Subject|3
1005127|NCT01459796|2023439|FG000|Overall Study|Lost to Follow-up|5
1005128|NCT01459796|2023440|FG001|Overall Study|Lost to Follow-up|4
1005129|NCT01459796|2023439|FG000|Overall Study|Reason unspecified|1
1005130|NCT01459796|2023440|FG001|Overall Study|Reason unspecified|2
1005131|NCT01459796|2023439|FG000|Overall Study|Decision by the sponsor|75
1005132|NCT01459796|2023440|FG001|Overall Study|Decision by the sponsor|108
1005133|NCT01459913|2023450|FG000|Overall Study|Adverse Event|0
1005134|NCT01459913|2023451|FG001|Overall Study|Adverse Event|0
1005135|NCT01459913|2023452|FG002|Overall Study|Adverse Event|0
1005136|NCT01459913|2023453|FG003|Overall Study|Adverse Event|3
1005137|NCT01459913|2023450|FG000|Overall Study|Withdrawal by Subject|4
1005138|NCT01459913|2023451|FG001|Overall Study|Withdrawal by Subject|0
1005139|NCT01459913|2023452|FG002|Overall Study|Withdrawal by Subject|0
1005140|NCT01459913|2023453|FG003|Overall Study|Withdrawal by Subject|5
1005141|NCT01459913|2023450|FG000|Overall Study|Lost to Follow-up|7
1005142|NCT01459913|2023451|FG001|Overall Study|Lost to Follow-up|4
1005143|NCT01459913|2023452|FG002|Overall Study|Lost to Follow-up|1
1005144|NCT01459913|2023453|FG003|Overall Study|Lost to Follow-up|8
1005145|NCT01459913|2023450|FG000|Overall Study|Death|0
1005146|NCT01459913|2023451|FG001|Overall Study|Death|0
1005147|NCT01459913|2023452|FG002|Overall Study|Death|0
1005148|NCT01459913|2023453|FG003|Overall Study|Death|1
1005149|NCT01459913|2023450|FG000|Overall Study|Non- Compliance|0
1005150|NCT01459913|2023451|FG001|Overall Study|Non- Compliance|0
1005151|NCT01459913|2023452|FG002|Overall Study|Non- Compliance|0
1005152|NCT01459913|2023453|FG003|Overall Study|Non- Compliance|3
1005153|NCT01459913|2023450|FG000|Overall Study|Physician Decision|0
1005154|NCT01459913|2023451|FG001|Overall Study|Physician Decision|1
1005155|NCT01459913|2023452|FG002|Overall Study|Physician Decision|0
1005156|NCT01459913|2023453|FG003|Overall Study|Physician Decision|0
1005157|NCT01459913|2023450|FG000|Overall Study|Study Terminated by Sponsor|30
1005158|NCT01459913|2023451|FG001|Overall Study|Study Terminated by Sponsor|15
1005159|NCT01459913|2023452|FG002|Overall Study|Study Terminated by Sponsor|9
1005160|NCT01459913|2023453|FG003|Overall Study|Study Terminated by Sponsor|11
1005161|NCT01459913|2023450|FG000|Overall Study|Other|0
1005162|NCT01459913|2023451|FG001|Overall Study|Other|0
1005163|NCT01459913|2023452|FG002|Overall Study|Other|3
1005164|NCT01459913|2023453|FG003|Overall Study|Other|1
1005165|NCT01459913|2023450|FG000|Overall Study|Did Not Meet Inclusion Criteria|0
1005166|NCT01459913|2023451|FG001|Overall Study|Did Not Meet Inclusion Criteria|0
1005167|NCT01459913|2023452|FG002|Overall Study|Did Not Meet Inclusion Criteria|0
1005168|NCT01459913|2023453|FG003|Overall Study|Did Not Meet Inclusion Criteria|1
1005195|NCT01460290|2023480|FG000|Overall Study|Adverse Event|3
1005196|NCT01460290|2023480|FG000|Overall Study|Elevated liver function|1
1005197|NCT01460342|2023496|FG000|Overall Study|Adverse Event|5
1005198|NCT01460342|2023497|FG001|Overall Study|Adverse Event|4
1005199|NCT01460342|2023496|FG000|Overall Study|Lost to Follow-up|1
1005200|NCT01460342|2023497|FG001|Overall Study|Lost to Follow-up|2
1005201|NCT01460342|2023496|FG000|Overall Study|Protocol Violation|0
1005202|NCT01460342|2023497|FG001|Overall Study|Protocol Violation|1
1005203|NCT01460342|2023496|FG000|Overall Study|Withdrawal by Subject|3
1005204|NCT01460342|2023497|FG001|Overall Study|Withdrawal by Subject|4
1005205|NCT01460342|2023496|FG000|Overall Study|Physician Decision|1
1005206|NCT01460342|2023497|FG001|Overall Study|Physician Decision|3
1005207|NCT01460342|2023496|FG000|Overall Study|Lack of Efficacy|1
1005208|NCT01460342|2023497|FG001|Overall Study|Lack of Efficacy|0
1005209|NCT01460368|2023505|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1005210|NCT01460368|2023506|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1005211|NCT01460368|2023507|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1005212|NCT01460368|2023508|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1005213|NCT01460368|2023509|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1
1005214|NCT01460368|2023510|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1005215|NCT01460368|2023511|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1005216|NCT01460368|2023505|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1005217|NCT01460368|2023506|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
1005218|NCT01460368|2023507|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1005219|NCT01460368|2023508|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1005220|NCT01460368|2023509|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1005221|NCT01460368|2023510|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1005222|NCT01460368|2023511|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
1005223|NCT01460368|2023505|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1005224|NCT01460368|2023506|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
1005225|NCT01460368|2023507|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1005226|NCT01460368|2023508|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1005227|NCT01460368|2023509|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1005228|NCT01460368|2023510|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1005229|NCT01460368|2023511|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1005230|NCT01460368|2023505|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0
1005231|NCT01460368|2023506|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0
1005232|NCT01460368|2023507|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1
1005233|NCT01460368|2023508|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0
1005234|NCT01460368|2023509|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0
1005235|NCT01460368|2023510|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0
1005236|NCT01460368|2023511|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0
1005237|NCT01460368|2023505|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1005238|NCT01460368|2023506|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1005239|NCT01460368|2023507|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
1005240|NCT01460368|2023508|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
1005241|NCT01460368|2023509|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1005242|NCT01460368|2023510|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
1005243|NCT01460368|2023511|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1005244|NCT01460381|2023522|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1
1005245|NCT01460381|2023523|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0
1005246|NCT01460407|2023531|FG000|Period 2: Day 6 to Day 14|Adverse Event|0
1005247|NCT01460407|2023532|FG001|Period 2: Day 6 to Day 14|Adverse Event|1
1005248|NCT01460446|2023541|FG000|Overall Study|Non-compliance|2
1005249|NCT01460446|2023542|FG001|Overall Study|Non-compliance|9
1005250|NCT01460446|2023541|FG000|Overall Study|Consent Withdrawn|0
1005251|NCT01460446|2023542|FG001|Overall Study|Consent Withdrawn|4
1005252|NCT01460446|2023541|FG000|Overall Study|Non-compliance & Consent Withdrawn|1
1005253|NCT01460446|2023542|FG001|Overall Study|Non-compliance & Consent Withdrawn|3
1005254|NCT01460446|2023541|FG000|Overall Study|Surgery/Illness|1
1005255|NCT01460446|2023542|FG001|Overall Study|Surgery/Illness|1
1005256|NCT01460446|2023541|FG000|Overall Study|Pregnancy|1
1005257|NCT01460446|2023542|FG001|Overall Study|Pregnancy|0
1005258|NCT01460446|2023541|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
1005259|NCT01460446|2023542|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
1005260|NCT01460628|2023549|FG000|Overall Study|Adverse Event|3
1005261|NCT01460628|2023549|FG000|Overall Study|Withdrawal by Subject|2
1005262|NCT01460719|2023553|FG000|Overall Study|Adverse Event|1
1005263|NCT01460719|2023553|FG000|Overall Study|Withdrawal by Subject|1
1005264|NCT01460901|2023567|FG000|Overall Study|Withdrawal by Subject|2
1005265|NCT01461005|2023586|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1
1005266|NCT01461044|2023593|FG000|Overall Study|Death|58
1005267|NCT01461044|2023594|FG001|Overall Study|Death|35
1005268|NCT01461044|2023593|FG000|Overall Study|Lost to Follow-up|12
1005269|NCT01461044|2023594|FG001|Overall Study|Lost to Follow-up|5
1005270|NCT01461057|2023605|FG000|Overall Study|Death|10
1005271|NCT01461057|2023606|FG001|Overall Study|Death|9
1005272|NCT01461057|2023605|FG000|Overall Study|Withdrawal by Subject|2
1005273|NCT01461057|2023606|FG001|Overall Study|Withdrawal by Subject|3
1005274|NCT01461057|2023605|FG000|Overall Study|Physician Decision|0
1005275|NCT01461057|2023606|FG001|Overall Study|Physician Decision|2
1005276|NCT01461057|2023605|FG000|Overall Study|Adverse Event|0
1005277|NCT01461057|2023606|FG001|Overall Study|Adverse Event|1
1005278|NCT01461057|2023605|FG000|Overall Study|Progression of Disease|1
1005279|NCT01461057|2023606|FG001|Overall Study|Progression of Disease|0
1005280|NCT01461057|2023605|FG000|Overall Study|Study Terminated by Sponsor|2
1005281|NCT01461057|2023606|FG001|Overall Study|Study Terminated by Sponsor|0
1005282|NCT01461096|2023614|FG000|Overall Study|Death|3
1005283|NCT01461096|2023615|FG001|Overall Study|Death|6
1005284|NCT01461096|2023614|FG000|Overall Study|Severe debilitation, unable to continue|1
1005285|NCT01461096|2023615|FG001|Overall Study|Severe debilitation, unable to continue|1
1005286|NCT01461096|2023614|FG000|Overall Study|Subj not able to get to clinic|15
1005287|NCT01461096|2023615|FG001|Overall Study|Subj not able to get to clinic|13
1005288|NCT01461096|2023614|FG000|Overall Study|Site is closing|27
1005289|NCT01461096|2023615|FG001|Overall Study|Site is closing|30
1005290|NCT01461096|2023614|FG000|Overall Study|Withdrawal by Subject|5
1005291|NCT01461096|2023615|FG001|Overall Study|Withdrawal by Subject|3
1005292|NCT01461096|2023614|FG000|Overall Study|Subj not willing to adhere to reqs|3
1005293|NCT01461096|2023615|FG001|Overall Study|Subj not willing to adhere to reqs|4
1005294|NCT01461096|2023614|FG000|Overall Study|Lost to Follow-up|8
1005295|NCT01461096|2023615|FG001|Overall Study|Lost to Follow-up|4
1005296|NCT01461369|2023625|FG000|Overall Study|Lack of Efficacy|2
1005297|NCT01461369|2023626|FG001|Overall Study|Lack of Efficacy|0
1005298|NCT01461369|2023627|FG002|Overall Study|Lack of Efficacy|6
1005299|NCT01461369|2023625|FG000|Overall Study|Lost to Follow-up|0
1005300|NCT01461369|2023626|FG001|Overall Study|Lost to Follow-up|0
1005301|NCT01461369|2023627|FG002|Overall Study|Lost to Follow-up|3
1005302|NCT01461369|2023625|FG000|Overall Study|Adverse Event|9
1005303|NCT01461369|2023626|FG001|Overall Study|Adverse Event|12
1005304|NCT01461369|2023627|FG002|Overall Study|Adverse Event|4
1005305|NCT01461369|2023625|FG000|Overall Study|Protocol Violation|1
1005306|NCT01461369|2023626|FG001|Overall Study|Protocol Violation|2
1005307|NCT01461369|2023627|FG002|Overall Study|Protocol Violation|2
1005308|NCT01461369|2023625|FG000|Overall Study|Withdrawal by Subject|1
1005309|NCT01461369|2023626|FG001|Overall Study|Withdrawal by Subject|3
1005310|NCT01461369|2023627|FG002|Overall Study|Withdrawal by Subject|2
1005311|NCT01461538|2023658|FG000|Overall Study|Death|15
1005312|NCT01461538|2023659|FG001|Overall Study|Death|6
1005313|NCT01461538|2023660|FG002|Overall Study|Death|2
1005314|NCT01461538|2023658|FG000|Overall Study|Study Stopped by Sponsor|2
1005315|NCT01461538|2023659|FG001|Overall Study|Study Stopped by Sponsor|1
1005316|NCT01461538|2023660|FG002|Overall Study|Study Stopped by Sponsor|0
1005317|NCT01461538|2023658|FG000|Overall Study|Withdrawal by Subject|1
1005318|NCT01461538|2023659|FG001|Overall Study|Withdrawal by Subject|1
1005319|NCT01461538|2023660|FG002|Overall Study|Withdrawal by Subject|0
1005320|NCT01461551|2023673|FG000|Overall Study|Physician Decision|2
1005321|NCT01461551|2023674|FG001|Overall Study|Physician Decision|1
1005322|NCT01461551|2023675|FG002|Overall Study|Physician Decision|2
1005323|NCT01461707|2023699|FG000|Overall Study|Withdrawal by Subject|1
1005324|NCT01461707|2023700|FG001|Overall Study|Withdrawal by Subject|0
1005325|NCT01461811|2023717|FG000|Overall Study|Adverse Event|2
1005326|NCT01461811|2023718|FG001|Overall Study|Adverse Event|1
1005327|NCT01461811|2023717|FG000|Overall Study|Subject decision unrelated to an AE|1
1005328|NCT01461811|2023718|FG001|Overall Study|Subject decision unrelated to an AE|1
1005329|NCT01461811|2023717|FG000|Overall Study|Noncompliance|1
1005330|NCT01461811|2023718|FG001|Overall Study|Noncompliance|1
1005331|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Adverse Event|76
1005332|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Adverse Event|0
1005333|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Adverse Event|0
1005334|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Death|3
1005335|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Death|0
1005336|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Death|0
1005337|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Lost to Follow-up|5
1005338|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Lost to Follow-up|0
1005339|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Lost to Follow-up|0
1005340|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Physician Decision|9
1005341|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Physician Decision|0
1005342|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Physician Decision|0
1005343|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18
1005344|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0
1005345|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0
1005346|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Disease progression|45
1005347|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Disease progression|0
1005348|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Disease progression|0
1005349|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10
1005350|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0
1005351|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0
1005352|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
1005353|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
1005354|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
1005355|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Not responding to treatment|11
1005356|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Not responding to treatment|0
1005357|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Not responding to treatment|0
1005358|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1
1005359|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0
1005360|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0
1005361|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
1005362|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
1005363|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
1005364|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Sponsor decision|1
1005365|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Sponsor decision|0
1005366|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Sponsor decision|0
1005367|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Protocol deviation|2
1005368|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Protocol deviation|0
1005369|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Protocol deviation|0
1005370|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
1005371|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
1005372|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
1005373|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
1005374|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
1005375|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
1005376|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Promotor request|1
1005377|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Promotor request|0
1005378|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Promotor request|0
1005379|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
1005380|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
1005381|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
1005382|NCT01461928|2023748|FG000|Induction (up to 8 Months)|Medical advisor request|1
1005383|NCT01461928|2023749|FG001|Induction (up to 8 Months)|Medical advisor request|0
1005384|NCT01461928|2023750|FG002|Induction (up to 8 Months)|Medical advisor request|0
1005385|NCT01461928|2023748|FG000|Maintenance I (24 Months)|Death|3
1005386|NCT01461928|2023749|FG001|Maintenance I (24 Months)|Death|0
1005387|NCT01461928|2023750|FG002|Maintenance I (24 Months)|Death|0
1005388|NCT01461928|2023748|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32
1005389|NCT01461928|2023749|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0
1005390|NCT01461928|2023750|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0
1005391|NCT01461928|2023748|FG000|Maintenance I (24 Months)|Lost to Follow-up|2
1005392|NCT01461928|2023749|FG001|Maintenance I (24 Months)|Lost to Follow-up|0
1005393|NCT01461928|2023750|FG002|Maintenance I (24 Months)|Lost to Follow-up|0
1005394|NCT01461928|2023748|FG000|Maintenance I (24 Months)|Diseases progression|91
1005395|NCT01461928|2023749|FG001|Maintenance I (24 Months)|Diseases progression|0
1005396|NCT01461928|2023750|FG002|Maintenance I (24 Months)|Diseases progression|0
1005397|NCT01461928|2023748|FG000|Maintenance I (24 Months)|Adverse Event|70
1005398|NCT01461928|2023749|FG001|Maintenance I (24 Months)|Adverse Event|0
1005399|NCT01461928|2023750|FG002|Maintenance I (24 Months)|Adverse Event|0
1005400|NCT01461928|2023748|FG000|Maintenance I (24 Months)|Physician Decision|9
1005401|NCT01461928|2023749|FG001|Maintenance I (24 Months)|Physician Decision|0
1005402|NCT01461928|2023750|FG002|Maintenance I (24 Months)|Physician Decision|0
1005403|NCT01461928|2023748|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2
1005404|NCT01461928|2023749|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0
1005405|NCT01461928|2023750|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0
1005406|NCT01461928|2023748|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2
1005407|NCT01461928|2023749|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0
1005408|NCT01461928|2023750|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0
1005409|NCT01461928|2023748|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1
1005410|NCT01461928|2023749|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0
1005411|NCT01461928|2023750|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0
1005412|NCT01461928|2023748|FG000|Maintenance I (24 Months)|Not compliant|1
1005413|NCT01461928|2023749|FG001|Maintenance I (24 Months)|Not compliant|0
1005414|NCT01461928|2023750|FG002|Maintenance I (24 Months)|Not compliant|0
1005415|NCT01461928|2023748|FG000|Maintenance I (24 Months)|Did not meet criteria|5
1005416|NCT01461928|2023749|FG001|Maintenance I (24 Months)|Did not meet criteria|0
914212|NCT00813709|1891955|FG003|Double Blind Period|Other|0
914213|NCT00813709|1891956|FG004|Double Blind Period|Other|0
914214|NCT00813709|1891957|FG005|Double Blind Period|Other|0
914215|NCT00813709|1891952|FG000|Open Label Period|Adverse Event|0
914216|NCT00813709|1891953|FG001|Open Label Period|Adverse Event|0
914217|NCT00813709|1891954|FG002|Open Label Period|Adverse Event|0
914218|NCT00813709|1891955|FG003|Open Label Period|Adverse Event|5
914219|NCT00813709|1891956|FG004|Open Label Period|Adverse Event|4
914220|NCT00813709|1891957|FG005|Open Label Period|Adverse Event|3
914221|NCT00813709|1891952|FG000|Open Label Period|Lack of Efficacy|0
1005417|NCT01461928|2023750|FG002|Maintenance I (24 Months)|Did not meet criteria|0
1005418|NCT01461928|2023748|FG000|Maintenance II (15 Months)|Adverse Event|0
1005419|NCT01461928|2023749|FG001|Maintenance II (15 Months)|Adverse Event|2
1005420|NCT01461928|2023750|FG002|Maintenance II (15 Months)|Adverse Event|0
1005421|NCT01461928|2023748|FG000|Maintenance II (15 Months)|Death|0
1005422|NCT01461928|2023749|FG001|Maintenance II (15 Months)|Death|10
1005423|NCT01461928|2023750|FG002|Maintenance II (15 Months)|Death|8
1005424|NCT01461928|2023748|FG000|Maintenance II (15 Months)|Physician Decision|0
1005425|NCT01461928|2023749|FG001|Maintenance II (15 Months)|Physician Decision|0
1005426|NCT01461928|2023750|FG002|Maintenance II (15 Months)|Physician Decision|4
1005427|NCT01461928|2023748|FG000|Maintenance II (15 Months)|Lost to Follow-up|0
1005428|NCT01461928|2023749|FG001|Maintenance II (15 Months)|Lost to Follow-up|1
1005429|NCT01461928|2023750|FG002|Maintenance II (15 Months)|Lost to Follow-up|0
1005430|NCT01461928|2023748|FG000|Maintenance II (15 Months)|Moved to another town|0
1005431|NCT01461928|2023749|FG001|Maintenance II (15 Months)|Moved to another town|1
1005432|NCT01461928|2023750|FG002|Maintenance II (15 Months)|Moved to another town|0
1005433|NCT01461928|2023748|FG000|Maintenance II (15 Months)|Disease progression|0
1005434|NCT01461928|2023749|FG001|Maintenance II (15 Months)|Disease progression|0
1005435|NCT01461928|2023750|FG002|Maintenance II (15 Months)|Disease progression|3
1005436|NCT01461928|2023748|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0
1005437|NCT01461928|2023749|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9
1005438|NCT01461928|2023750|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8
1005439|NCT01461928|2023748|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0
1005440|NCT01461928|2023749|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0
1005441|NCT01461928|2023750|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1
1005442|NCT01461928|2023748|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0
1005443|NCT01461928|2023749|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0
1005444|NCT01461928|2023750|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1
1005445|NCT01461928|2023748|FG000|Maintenance II (15 Months)|Withdrew informed consent|0
1005446|NCT01461928|2023749|FG001|Maintenance II (15 Months)|Withdrew informed consent|0
1005447|NCT01461928|2023750|FG002|Maintenance II (15 Months)|Withdrew informed consent|1
1005448|NCT01461928|2023748|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0
1005449|NCT01461928|2023749|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0
1005450|NCT01461928|2023750|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1
1005451|NCT01461980|2023764|FG000|Overall Study|Other|9
1005452|NCT01461980|2023765|FG001|Overall Study|Other|8
1005453|NCT01461980|2023766|FG002|Overall Study|Other|6
1005454|NCT01461980|2023764|FG000|Overall Study|Medication error|7
1005455|NCT01461980|2023765|FG001|Overall Study|Medication error|5
1005456|NCT01461980|2023766|FG002|Overall Study|Medication error|6
1005457|NCT01461980|2023764|FG000|Overall Study|Adverse Event|12
1005458|NCT01461980|2023765|FG001|Overall Study|Adverse Event|5
1005459|NCT01461980|2023766|FG002|Overall Study|Adverse Event|6
1005460|NCT01461980|2023764|FG000|Overall Study|Protocol Violation|12
1005461|NCT01461980|2023765|FG001|Overall Study|Protocol Violation|19
1005462|NCT01461980|2023766|FG002|Overall Study|Protocol Violation|16
1005463|NCT01461980|2023764|FG000|Overall Study|No longer meets eligibility criteria|18
1005464|NCT01461980|2023765|FG001|Overall Study|No longer meets eligibility criteria|9
1005465|NCT01461980|2023766|FG002|Overall Study|No longer meets eligibility criteria|19
1005466|NCT01461980|2023764|FG000|Overall Study|Lost to Follow-up|52
1005467|NCT01461980|2023765|FG001|Overall Study|Lost to Follow-up|53
1005468|NCT01461980|2023766|FG002|Overall Study|Lost to Follow-up|51
1005469|NCT01461980|2023764|FG000|Overall Study|No longer willing to participate|52
1005470|NCT01461980|2023765|FG001|Overall Study|No longer willing to participate|38
1005471|NCT01461980|2023766|FG002|Overall Study|No longer willing to participate|54
1005472|NCT01461980|2023764|FG000|Overall Study|Randomized but not vaccinated|4
1005473|NCT01461980|2023765|FG001|Overall Study|Randomized but not vaccinated|8
1005474|NCT01461980|2023766|FG002|Overall Study|Randomized but not vaccinated|7
1005475|NCT01461993|2023778|FG000|Overall Study|Withdrawal by Subject|60
1005476|NCT01461993|2023779|FG001|Overall Study|Withdrawal by Subject|53
1005477|NCT01461993|2023780|FG002|Overall Study|Withdrawal by Subject|16
1005478|NCT01461993|2023778|FG000|Overall Study|Lost to Follow-up|44
1005479|NCT01461993|2023779|FG001|Overall Study|Lost to Follow-up|48
1005480|NCT01461993|2023780|FG002|Overall Study|Lost to Follow-up|22
1005481|NCT01461993|2023778|FG000|Overall Study|Protocol Violation|10
914222|NCT00813709|1891953|FG001|Open Label Period|Lack of Efficacy|0
1005482|NCT01461993|2023779|FG001|Overall Study|Protocol Violation|9
1005483|NCT01461993|2023780|FG002|Overall Study|Protocol Violation|7
1005484|NCT01461993|2023778|FG000|Overall Study|Adverse Event|9
1005485|NCT01461993|2023779|FG001|Overall Study|Adverse Event|11
1005486|NCT01461993|2023780|FG002|Overall Study|Adverse Event|3
1005487|NCT01461993|2023778|FG000|Overall Study|No longer met eligibility criteria|13
1005488|NCT01461993|2023779|FG001|Overall Study|No longer met eligibility criteria|18
1005489|NCT01461993|2023780|FG002|Overall Study|No longer met eligibility criteria|10
1005490|NCT01461993|2023778|FG000|Overall Study|Did not meet entrance criteria|2
1005491|NCT01461993|2023779|FG001|Overall Study|Did not meet entrance criteria|3
1005492|NCT01461993|2023780|FG002|Overall Study|Did not meet entrance criteria|0
1005493|NCT01461993|2023778|FG000|Overall Study|Other|13
1005494|NCT01461993|2023779|FG001|Overall Study|Other|15
1005495|NCT01461993|2023780|FG002|Overall Study|Other|6
1005496|NCT01462045|2023792|FG000|Overall Study|Family matter|0
1005497|NCT01462045|2023793|FG001|Overall Study|Family matter|1
1005498|NCT01462045|2023794|FG002|Overall Study|Family matter|0
1005499|NCT01462084|2023802|FG000|Overall Study|Withdrawal by Subject|1
1005500|NCT01462084|2023803|FG001|Overall Study|Withdrawal by Subject|0
1005501|NCT01462084|2023802|FG000|Overall Study|Protocol Violation|1
1005502|NCT01462084|2023803|FG001|Overall Study|Protocol Violation|1
1005503|NCT01462110|2023812|FG000|Overall Study|Adverse Event|1
1005504|NCT01462110|2023813|FG001|Overall Study|Adverse Event|0
1005505|NCT01462162|2023819|FG000|Overall Study|Adverse Event|5
1005506|NCT01462162|2023819|FG000|Overall Study|Lack of Efficacy|4
1005507|NCT01462162|2023819|FG000|Overall Study|Abnormal laboratory parameters|1
1005508|NCT01462162|2023819|FG000|Overall Study|Other|2
1005509|NCT01462227|2023826|FG000|Second Assignment|Lost to Follow-up|1
1005510|NCT01462227|2023827|FG001|Second Assignment|Lost to Follow-up|0
1005511|NCT01462227|2023828|FG002|Second Assignment|Lost to Follow-up|0
1005512|NCT01462227|2023829|FG003|Second Assignment|Lost to Follow-up|0
1005513|NCT01462227|2023826|FG000|Second Assignment|Protocol Violation|0
1005514|NCT01462227|2023827|FG001|Second Assignment|Protocol Violation|1
1005515|NCT01462227|2023828|FG002|Second Assignment|Protocol Violation|1
1005516|NCT01462227|2023829|FG003|Second Assignment|Protocol Violation|0
1005517|NCT01462266|2023843|FG000|Overall Study|Adverse Event|7
1005518|NCT01462266|2023844|FG001|Overall Study|Adverse Event|6
1005519|NCT01462266|2023843|FG000|Overall Study|Death|2
1005520|NCT01462266|2023844|FG001|Overall Study|Death|1
1005521|NCT01462266|2023843|FG000|Overall Study|Lack of Efficacy|0
1005522|NCT01462266|2023844|FG001|Overall Study|Lack of Efficacy|2
1005523|NCT01462266|2023843|FG000|Overall Study|Lost to Follow-up|4
1005524|NCT01462266|2023844|FG001|Overall Study|Lost to Follow-up|3
1005525|NCT01462266|2023843|FG000|Overall Study|Non-compliance with study drug|3
1005526|NCT01462266|2023844|FG001|Overall Study|Non-compliance with study drug|0
1005527|NCT01462266|2023843|FG000|Overall Study|Creatinine and eGFR, excluded medication|8
1005528|NCT01462266|2023844|FG001|Overall Study|Creatinine and eGFR, excluded medication|4
1005529|NCT01462266|2023843|FG000|Overall Study|Physician Decision|2
1005530|NCT01462266|2023844|FG001|Overall Study|Physician Decision|5
1005531|NCT01462266|2023843|FG000|Overall Study|Protocol Violation|1
1005532|NCT01462266|2023844|FG001|Overall Study|Protocol Violation|3
1005533|NCT01462266|2023843|FG000|Overall Study|Withdrawal by Subject|7
1005534|NCT01462266|2023844|FG001|Overall Study|Withdrawal by Subject|2
1005535|NCT01462266|2023843|FG000|Overall Study|Screen failure|1
1005536|NCT01462266|2023844|FG001|Overall Study|Screen failure|1
1005537|NCT01462318|2023881|FG000|Main Study / TP-DI Study|Other|2
1005538|NCT01462318|2023882|FG001|Main Study / TP-DI Study|Other|0
1005539|NCT01462318|2023883|FG002|Main Study / TP-DI Study|Other|0
1005540|NCT01462318|2023881|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2
1005541|NCT01462318|2023882|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0
1005542|NCT01462318|2023883|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0
1005543|NCT01462318|2023881|FG000|Main Study / TP-DI Study|Adverse Event|4
1005544|NCT01462318|2023882|FG001|Main Study / TP-DI Study|Adverse Event|0
1005545|NCT01462318|2023883|FG002|Main Study / TP-DI Study|Adverse Event|0
1005546|NCT01462318|2023881|FG000|Extension Phase|Lost to Follow-up|0
1005547|NCT01462318|2023882|FG001|Extension Phase|Lost to Follow-up|0
1005548|NCT01462318|2023883|FG002|Extension Phase|Lost to Follow-up|1
1005549|NCT01462318|2023881|FG000|Extension Phase|Other|0
1005550|NCT01462318|2023882|FG001|Extension Phase|Other|0
1005551|NCT01462318|2023883|FG002|Extension Phase|Other|1
1005552|NCT01462318|2023881|FG000|Extension Phase|Disease Progression|0
1005553|NCT01462318|2023882|FG001|Extension Phase|Disease Progression|0
1005554|NCT01462318|2023883|FG002|Extension Phase|Disease Progression|1
1005555|NCT01462318|2023881|FG000|Extension Phase|Withdrawal by Subject|0
1005556|NCT01462318|2023882|FG001|Extension Phase|Withdrawal by Subject|0
1005557|NCT01462318|2023883|FG002|Extension Phase|Withdrawal by Subject|15
1005558|NCT01462318|2023881|FG000|Extension Phase|Investigator Decision|0
1005559|NCT01462318|2023882|FG001|Extension Phase|Investigator Decision|0
1005560|NCT01462318|2023883|FG002|Extension Phase|Investigator Decision|5
1005561|NCT01462318|2023881|FG000|Extension Phase|Adverse Event|0
1005562|NCT01462318|2023882|FG001|Extension Phase|Adverse Event|0
1005563|NCT01462318|2023883|FG002|Extension Phase|Adverse Event|22
1005564|NCT01462344|2023890|FG000|Overall Study|Withdrawal by Subject|245
1005565|NCT01462344|2023891|FG001|Overall Study|Withdrawal by Subject|226
1005566|NCT01462344|2023890|FG000|Overall Study|Adverse Event|24
1005567|NCT01462344|2023891|FG001|Overall Study|Adverse Event|23
1005568|NCT01462344|2023890|FG000|Overall Study|Asthma Exacerbation|34
1005569|NCT01462344|2023891|FG001|Overall Study|Asthma Exacerbation|35
1005570|NCT01462344|2023890|FG000|Overall Study|Lack of Efficacy|5
1005571|NCT01462344|2023891|FG001|Overall Study|Lack of Efficacy|6
1005572|NCT01462344|2023890|FG000|Overall Study|Protocol Violation|68
1005573|NCT01462344|2023891|FG001|Overall Study|Protocol Violation|53
1005574|NCT01462344|2023890|FG000|Overall Study|Lost to Follow-up|7
1005575|NCT01462344|2023891|FG001|Overall Study|Lost to Follow-up|7
1005576|NCT01462357|2023900|FG000|Overall Study|Death|0
1005577|NCT01462357|2023901|FG001|Overall Study|Death|0
1005578|NCT01462357|2023902|FG002|Overall Study|Death|1
1005579|NCT01462357|2023900|FG000|Overall Study|Withdrawal by Subject|3
1005580|NCT01462357|2023901|FG001|Overall Study|Withdrawal by Subject|11
1005581|NCT01462357|2023902|FG002|Overall Study|Withdrawal by Subject|3
1005582|NCT01462357|2023900|FG000|Overall Study|Migrated/moved from study area|2
1005583|NCT01462357|2023901|FG001|Overall Study|Migrated/moved from study area|3
1005584|NCT01462357|2023902|FG002|Overall Study|Migrated/moved from study area|1
1005585|NCT01462357|2023900|FG000|Overall Study|Lost to Follow-up|3
1005586|NCT01462357|2023901|FG001|Overall Study|Lost to Follow-up|5
1005587|NCT01462357|2023902|FG002|Overall Study|Lost to Follow-up|7
1005588|NCT01462370|2023910|FG000|Overall Study|Lack of Qualifying Event|1
1005589|NCT01462370|2023911|FG001|Overall Study|Lack of Qualifying Event|1
1005590|NCT01462370|2023910|FG000|Overall Study|Physician Decision|0
1005591|NCT01462370|2023911|FG001|Overall Study|Physician Decision|1
1005592|NCT01462370|2023910|FG000|Overall Study|Withdrawal by Subject|0
1005593|NCT01462370|2023911|FG001|Overall Study|Withdrawal by Subject|3
1005594|NCT01462435|2023921|FG000|Overall Study|Lack of Efficacy|1
1005595|NCT01462435|2023922|FG001|Overall Study|Lack of Efficacy|0
1005596|NCT01462435|2023923|FG002|Overall Study|Lack of Efficacy|0
1005597|NCT01462435|2023924|FG003|Overall Study|Lack of Efficacy|3
1005598|NCT01462435|2023921|FG000|Overall Study|Physician Decision|0
1005599|NCT01462435|2023922|FG001|Overall Study|Physician Decision|0
1005600|NCT01462435|2023923|FG002|Overall Study|Physician Decision|1
1005601|NCT01462435|2023924|FG003|Overall Study|Physician Decision|0
1005602|NCT01462435|2023921|FG000|Overall Study|Withdrawal by Subject|0
1005603|NCT01462435|2023922|FG001|Overall Study|Withdrawal by Subject|0
1005604|NCT01462435|2023923|FG002|Overall Study|Withdrawal by Subject|0
1005605|NCT01462435|2023924|FG003|Overall Study|Withdrawal by Subject|1
1005606|NCT01462435|2023921|FG000|Overall Study|Lost to Follow-up|0
1005607|NCT01462435|2023922|FG001|Overall Study|Lost to Follow-up|0
1005608|NCT01462435|2023923|FG002|Overall Study|Lost to Follow-up|0
1005609|NCT01462435|2023924|FG003|Overall Study|Lost to Follow-up|1
1005610|NCT01462695|2023940|FG000|Overall Study|Adverse Event|1
1005611|NCT01462695|2023941|FG001|Overall Study|Adverse Event|1
1005612|NCT01462695|2023940|FG000|Overall Study|Death|2
1005613|NCT01462695|2023941|FG001|Overall Study|Death|0
1005614|NCT01462695|2023940|FG000|Overall Study|Lack of Efficacy|6
1005615|NCT01462695|2023941|FG001|Overall Study|Lack of Efficacy|12
1005616|NCT01462695|2023940|FG000|Overall Study|Physician Decision|5
1005617|NCT01462695|2023941|FG001|Overall Study|Physician Decision|0
1005618|NCT01462695|2023940|FG000|Overall Study|Withdrawal by Subject|2
1005619|NCT01462695|2023941|FG001|Overall Study|Withdrawal by Subject|0
1005620|NCT01462695|2023940|FG000|Overall Study|Inevaluable (did not receive study drug)|1
1005621|NCT01462695|2023941|FG001|Overall Study|Inevaluable (did not receive study drug)|0
1005622|NCT01462929|2023968|FG000|Overall Study|Adverse Event|3
1005623|NCT01462929|2023969|FG001|Overall Study|Adverse Event|3
1005624|NCT01462929|2023970|FG002|Overall Study|Adverse Event|4
1005625|NCT01462929|2023968|FG000|Overall Study|Withdrawal by Subject|2
1005626|NCT01462929|2023969|FG001|Overall Study|Withdrawal by Subject|1
1005627|NCT01462929|2023970|FG002|Overall Study|Withdrawal by Subject|0
1005628|NCT01462929|2023968|FG000|Overall Study|Lack of Efficacy|0
1005629|NCT01462929|2023969|FG001|Overall Study|Lack of Efficacy|0
1005630|NCT01462929|2023970|FG002|Overall Study|Lack of Efficacy|1
1005631|NCT01462942|2023983|FG000|Overall Study|Adverse Event|7
1005632|NCT01462942|2023984|FG001|Overall Study|Adverse Event|12
1005633|NCT01462942|2023985|FG002|Overall Study|Adverse Event|10
1005634|NCT01462942|2023986|FG003|Overall Study|Adverse Event|11
1005635|NCT01462942|2023987|FG004|Overall Study|Adverse Event|11
1005636|NCT01462942|2023983|FG000|Overall Study|Other, including COPD exacerbation|3
1005637|NCT01462942|2023984|FG001|Overall Study|Other, including COPD exacerbation|5
1005638|NCT01462942|2023985|FG002|Overall Study|Other, including COPD exacerbation|2
1005639|NCT01462942|2023986|FG003|Overall Study|Other, including COPD exacerbation|8
1005640|NCT01462942|2023987|FG004|Overall Study|Other, including COPD exacerbation|5
1005641|NCT01462942|2023983|FG000|Overall Study|Withdrawal by Subject|14
1005642|NCT01462942|2023984|FG001|Overall Study|Withdrawal by Subject|10
1005643|NCT01462942|2023985|FG002|Overall Study|Withdrawal by Subject|14
1005644|NCT01462942|2023986|FG003|Overall Study|Withdrawal by Subject|16
1005645|NCT01462942|2023987|FG004|Overall Study|Withdrawal by Subject|19
1005646|NCT01462942|2023983|FG000|Overall Study|Lack of Efficacy|6
1005647|NCT01462942|2023984|FG001|Overall Study|Lack of Efficacy|0
1005648|NCT01462942|2023985|FG002|Overall Study|Lack of Efficacy|4
1005649|NCT01462942|2023986|FG003|Overall Study|Lack of Efficacy|5
1005650|NCT01462942|2023987|FG004|Overall Study|Lack of Efficacy|3
1005651|NCT01462942|2023983|FG000|Overall Study|Lost to Follow-up|0
1005652|NCT01462942|2023984|FG001|Overall Study|Lost to Follow-up|1
1005653|NCT01462942|2023985|FG002|Overall Study|Lost to Follow-up|1
1005654|NCT01462942|2023986|FG003|Overall Study|Lost to Follow-up|1
1005655|NCT01462942|2023987|FG004|Overall Study|Lost to Follow-up|1
1005656|NCT01462942|2023983|FG000|Overall Study|Protocol Violation|4
1005657|NCT01462942|2023984|FG001|Overall Study|Protocol Violation|6
1005658|NCT01462942|2023985|FG002|Overall Study|Protocol Violation|9
1005659|NCT01462942|2023986|FG003|Overall Study|Protocol Violation|9
1005660|NCT01462942|2023987|FG004|Overall Study|Protocol Violation|6
1005661|NCT01463007|2023999|FG000|Overall Study|Physician Decision|1
1005662|NCT01463033|2024006|FG000|Overall Study|Lost to Follow-up|4
1005663|NCT01463033|2024007|FG001|Overall Study|Lost to Follow-up|4
1005664|NCT01463033|2024006|FG000|Overall Study|Death|3
1005665|NCT01463033|2024007|FG001|Overall Study|Death|2
1005666|NCT01463098|2024028|FG000|Part A (11 Days)|Participant Choice|2
1005667|NCT01463098|2024029|FG001|Part A (11 Days)|Participant Choice|0
1005668|NCT01463098|2024030|FG002|Part A (11 Days)|Participant Choice|0
1005669|NCT01463098|2024031|FG003|Part A (11 Days)|Participant Choice|0
1005670|NCT01463098|2024032|FG004|Part A (11 Days)|Participant Choice|0
1005671|NCT01463098|2024033|FG005|Part A (11 Days)|Participant Choice|0
1005672|NCT01463098|2024034|FG006|Part A (11 Days)|Participant Choice|0
1005673|NCT01463098|2024035|FG007|Part A (11 Days)|Participant Choice|0
1005674|NCT01463098|2024036|FG008|Part A (11 Days)|Participant Choice|1
1005675|NCT01463098|2024037|FG009|Part A (11 Days)|Participant Choice|0
1005676|NCT01463098|2024038|FG010|Part A (11 Days)|Participant Choice|0
1005677|NCT01463098|2024039|FG011|Part A (11 Days)|Participant Choice|0
1005678|NCT01463098|2024040|FG012|Part A (11 Days)|Participant Choice|0
1005679|NCT01463098|2024041|FG013|Part A (11 Days)|Participant Choice|0
1005680|NCT01463098|2024028|FG000|Part A (11 Days)|Lost to Follow-up|0
1005681|NCT01463098|2024029|FG001|Part A (11 Days)|Lost to Follow-up|0
1005682|NCT01463098|2024030|FG002|Part A (11 Days)|Lost to Follow-up|0
1005683|NCT01463098|2024031|FG003|Part A (11 Days)|Lost to Follow-up|0
1005684|NCT01463098|2024032|FG004|Part A (11 Days)|Lost to Follow-up|1
1005685|NCT01463098|2024033|FG005|Part A (11 Days)|Lost to Follow-up|0
1005686|NCT01463098|2024034|FG006|Part A (11 Days)|Lost to Follow-up|0
1005687|NCT01463098|2024035|FG007|Part A (11 Days)|Lost to Follow-up|0
1005688|NCT01463098|2024036|FG008|Part A (11 Days)|Lost to Follow-up|0
1005689|NCT01463098|2024037|FG009|Part A (11 Days)|Lost to Follow-up|0
1005690|NCT01463098|2024038|FG010|Part A (11 Days)|Lost to Follow-up|0
1005691|NCT01463098|2024039|FG011|Part A (11 Days)|Lost to Follow-up|0
1005692|NCT01463098|2024040|FG012|Part A (11 Days)|Lost to Follow-up|0
1005693|NCT01463098|2024041|FG013|Part A (11 Days)|Lost to Follow-up|0
1005694|NCT01463098|2024028|FG000|Part B (11 Days)|Participant Choice|0
1005695|NCT01463098|2024029|FG001|Part B (11 Days)|Participant Choice|0
1005696|NCT01463098|2024030|FG002|Part B (11 Days)|Participant Choice|0
1005697|NCT01463098|2024031|FG003|Part B (11 Days)|Participant Choice|0
1005698|NCT01463098|2024032|FG004|Part B (11 Days)|Participant Choice|0
1005699|NCT01463098|2024033|FG005|Part B (11 Days)|Participant Choice|0
1005700|NCT01463098|2024034|FG006|Part B (11 Days)|Participant Choice|0
1005701|NCT01463098|2024035|FG007|Part B (11 Days)|Participant Choice|0
1005702|NCT01463098|2024036|FG008|Part B (11 Days)|Participant Choice|0
1005703|NCT01463098|2024037|FG009|Part B (11 Days)|Participant Choice|0
1005704|NCT01463098|2024038|FG010|Part B (11 Days)|Participant Choice|0
1005705|NCT01463098|2024039|FG011|Part B (11 Days)|Participant Choice|1
1005706|NCT01463098|2024040|FG012|Part B (11 Days)|Participant Choice|0
1005707|NCT01463098|2024041|FG013|Part B (11 Days)|Participant Choice|0
1005708|NCT01463111|2024090|FG000|Overall Study|Withdrawal by Subject|2
1005709|NCT01463111|2024090|FG000|Overall Study|Lost to Follow-up|5
1005710|NCT01463111|2024090|FG000|Overall Study|Physician Decision|2
1005711|NCT01463306|2024123|FG000|Overall Study|Adverse Event|6
1005712|NCT01463306|2024124|FG001|Overall Study|Adverse Event|9
1005713|NCT01463306|2024125|FG002|Overall Study|Adverse Event|3
1005714|NCT01463306|2024123|FG000|Overall Study|Death|3
1005715|NCT01463306|2024124|FG001|Overall Study|Death|3
1005716|NCT01463306|2024125|FG002|Overall Study|Death|0
1005717|NCT01463306|2024123|FG000|Overall Study|Lack of Efficacy|22
1005718|NCT01463306|2024124|FG001|Overall Study|Lack of Efficacy|16
1005719|NCT01463306|2024125|FG002|Overall Study|Lack of Efficacy|1
1005720|NCT01463306|2024123|FG000|Overall Study|Lost to Follow-up|5
1005721|NCT01463306|2024124|FG001|Overall Study|Lost to Follow-up|2
1005722|NCT01463306|2024125|FG002|Overall Study|Lost to Follow-up|0
1005723|NCT01463306|2024123|FG000|Overall Study|Protocol Violation|4
1005724|NCT01463306|2024124|FG001|Overall Study|Protocol Violation|0
1005725|NCT01463306|2024125|FG002|Overall Study|Protocol Violation|0
1005726|NCT01463306|2024123|FG000|Overall Study|Withdrawal by Subject|19
1005727|NCT01463306|2024124|FG001|Overall Study|Withdrawal by Subject|9
1005728|NCT01463306|2024125|FG002|Overall Study|Withdrawal by Subject|1
1005729|NCT01463306|2024123|FG000|Overall Study|Other|26
1005730|NCT01463306|2024124|FG001|Overall Study|Other|13
1005731|NCT01463306|2024125|FG002|Overall Study|Other|0
1005732|NCT01463306|2024123|FG000|Overall Study|Approval expiry at site|1
1005733|NCT01463306|2024124|FG001|Overall Study|Approval expiry at site|0
1005734|NCT01463306|2024125|FG002|Overall Study|Approval expiry at site|0
1005735|NCT01463527|2024150|FG000|Overall Study|Protocol Violation|1
1005736|NCT01463527|2024151|FG001|Overall Study|Protocol Violation|1
1005737|NCT01463527|2024150|FG000|Overall Study|Crying >20% of sedation|5
1005738|NCT01463527|2024151|FG001|Overall Study|Crying >20% of sedation|6
1005739|NCT01463631|2024161|FG000|Overall Study|Withdrawal by Subject|0
1005740|NCT01463631|2024162|FG001|Overall Study|Withdrawal by Subject|0
1005741|NCT01463631|2024163|FG002|Overall Study|Withdrawal by Subject|0
1005742|NCT01463631|2024164|FG003|Overall Study|Withdrawal by Subject|1
1005743|NCT01463631|2024161|FG000|Overall Study|Death|0
1005744|NCT01463631|2024162|FG001|Overall Study|Death|0
1005745|NCT01463631|2024163|FG002|Overall Study|Death|1
1005746|NCT01463631|2024164|FG003|Overall Study|Death|0
1005747|NCT01463631|2024161|FG000|Overall Study|Progressive Disease|0
1005748|NCT01463631|2024162|FG001|Overall Study|Progressive Disease|0
1005749|NCT01463631|2024163|FG002|Overall Study|Progressive Disease|0
1005750|NCT01463631|2024164|FG003|Overall Study|Progressive Disease|5
1005751|NCT01463683|2024179|FG000|Overall Study|Adverse Event|2
1005752|NCT01463683|2024180|FG001|Overall Study|Adverse Event|0
1005753|NCT01463683|2024181|FG002|Overall Study|Adverse Event|0
1005754|NCT01463683|2024179|FG000|Overall Study|Lost to Follow-up|10
1005755|NCT01463683|2024180|FG001|Overall Study|Lost to Follow-up|9
1005756|NCT01463683|2024181|FG002|Overall Study|Lost to Follow-up|7
1005757|NCT01463683|2024179|FG000|Overall Study|Physician Decision|0
1005758|NCT01463683|2024180|FG001|Overall Study|Physician Decision|3
1005759|NCT01463683|2024181|FG002|Overall Study|Physician Decision|1
1005760|NCT01463683|2024179|FG000|Overall Study|Pregnancy|2
1005761|NCT01463683|2024180|FG001|Overall Study|Pregnancy|2
1005762|NCT01463683|2024181|FG002|Overall Study|Pregnancy|1
1005763|NCT01463683|2024179|FG000|Overall Study|Withdrawal by Subject|5
1005764|NCT01463683|2024180|FG001|Overall Study|Withdrawal by Subject|17
1005765|NCT01463683|2024181|FG002|Overall Study|Withdrawal by Subject|2
1005766|NCT01463696|2024197|FG000|Overall Study|Adverse Event|0
1005767|NCT01463696|2024198|FG001|Overall Study|Adverse Event|1
1005768|NCT01463696|2024199|FG002|Overall Study|Adverse Event|0
1005769|NCT01463696|2024200|FG003|Overall Study|Adverse Event|2
1005770|NCT01463696|2024201|FG004|Overall Study|Adverse Event|0
1005771|NCT01463696|2024202|FG005|Overall Study|Adverse Event|1
1005772|NCT01463696|2024203|FG006|Overall Study|Adverse Event|3
1005773|NCT01463696|2024204|FG007|Overall Study|Adverse Event|2
1005774|NCT01463696|2024197|FG000|Overall Study|Lost to Follow-up|0
1005775|NCT01463696|2024198|FG001|Overall Study|Lost to Follow-up|0
1005776|NCT01463696|2024199|FG002|Overall Study|Lost to Follow-up|1
1005777|NCT01463696|2024200|FG003|Overall Study|Lost to Follow-up|0
1005778|NCT01463696|2024201|FG004|Overall Study|Lost to Follow-up|0
1005779|NCT01463696|2024202|FG005|Overall Study|Lost to Follow-up|0
1005780|NCT01463696|2024203|FG006|Overall Study|Lost to Follow-up|0
1005781|NCT01463696|2024204|FG007|Overall Study|Lost to Follow-up|0
1005782|NCT01463696|2024197|FG000|Overall Study|Progressive Disease|0
1005783|NCT01463696|2024198|FG001|Overall Study|Progressive Disease|1
1005784|NCT01463696|2024199|FG002|Overall Study|Progressive Disease|0
1005785|NCT01463696|2024200|FG003|Overall Study|Progressive Disease|1
1005786|NCT01463696|2024201|FG004|Overall Study|Progressive Disease|0
1005787|NCT01463696|2024202|FG005|Overall Study|Progressive Disease|1
1005788|NCT01463696|2024203|FG006|Overall Study|Progressive Disease|4
1005789|NCT01463696|2024204|FG007|Overall Study|Progressive Disease|2
1005790|NCT01463696|2024197|FG000|Overall Study|Withdrawal by Subject|0
1005791|NCT01463696|2024198|FG001|Overall Study|Withdrawal by Subject|0
1005792|NCT01463696|2024199|FG002|Overall Study|Withdrawal by Subject|0
1005793|NCT01463696|2024200|FG003|Overall Study|Withdrawal by Subject|1
1005794|NCT01463696|2024201|FG004|Overall Study|Withdrawal by Subject|1
1005795|NCT01463696|2024202|FG005|Overall Study|Withdrawal by Subject|1
1005796|NCT01463696|2024203|FG006|Overall Study|Withdrawal by Subject|2
1005797|NCT01463696|2024204|FG007|Overall Study|Withdrawal by Subject|0
1005798|NCT01463696|2024197|FG000|Overall Study|Not Treated|0
1005799|NCT01463696|2024198|FG001|Overall Study|Not Treated|0
1005800|NCT01463696|2024199|FG002|Overall Study|Not Treated|0
1005801|NCT01463696|2024200|FG003|Overall Study|Not Treated|0
1005802|NCT01463696|2024201|FG004|Overall Study|Not Treated|0
1005803|NCT01463696|2024202|FG005|Overall Study|Not Treated|0
1005804|NCT01463696|2024203|FG006|Overall Study|Not Treated|1
1005805|NCT01463696|2024204|FG007|Overall Study|Not Treated|0
1005806|NCT01463878|2024224|FG000|Overall Study|no longer met criteria for tube feed|2
1005807|NCT01463878|2024225|FG001|Overall Study|no longer met criteria for tube feed|2
1005808|NCT01463982|2024235|FG000|Overall Study|Withdrawal by Subject|0
1005809|NCT01463982|2024236|FG001|Overall Study|Withdrawal by Subject|1
1005810|NCT01463982|2024237|FG002|Overall Study|Withdrawal by Subject|1
1005811|NCT01463982|2024238|FG003|Overall Study|Withdrawal by Subject|0
1005812|NCT01463982|2024235|FG000|Overall Study|Treatment delay over 5 week|0
1005813|NCT01463982|2024236|FG001|Overall Study|Treatment delay over 5 week|0
1005814|NCT01463982|2024237|FG002|Overall Study|Treatment delay over 5 week|1
1005815|NCT01463982|2024238|FG003|Overall Study|Treatment delay over 5 week|0
1005816|NCT01464021|2024248|FG000|Overall Study|Withdrawal by Subject|13
1005817|NCT01464021|2024248|FG000|Overall Study|Lost to Follow-up|1
1005818|NCT01464021|2024248|FG000|Overall Study|Lack of Efficacy|1
1005819|NCT01464021|2024248|FG000|Overall Study|various|11
1005820|NCT01464255|2024272|FG000|Overall Study|unresolve corneal staining|0
1005821|NCT01464255|2024273|FG001|Overall Study|unresolve corneal staining|1
1005822|NCT01464307|2024282|FG000|Main Period|Death|0
1005823|NCT01464307|2024283|FG001|Main Period|Death|1
1005824|NCT01464307|2024282|FG000|Main Period|Adverse Event|6
1005825|NCT01464307|2024283|FG001|Main Period|Adverse Event|1
1005826|NCT01464307|2024282|FG000|Main Period|Lack of Efficacy|2
1005827|NCT01464307|2024283|FG001|Main Period|Lack of Efficacy|0
1005828|NCT01464307|2024282|FG000|Main Period|Withdrawal by Subject|5
1005829|NCT01464307|2024283|FG001|Main Period|Withdrawal by Subject|2
1005830|NCT01464307|2024282|FG000|Main Period|Predefined discontinuation criteria|2
1005831|NCT01464307|2024283|FG001|Main Period|Predefined discontinuation criteria|1
1005832|NCT01464307|2024282|FG000|Open-Label Extension Period|Adverse Event|15
1005833|NCT01464307|2024283|FG001|Open-Label Extension Period|Adverse Event|0
1005834|NCT01464307|2024282|FG000|Open-Label Extension Period|Withdrawal by Subject|14
1005835|NCT01464307|2024283|FG001|Open-Label Extension Period|Withdrawal by Subject|0
1005836|NCT01464307|2024282|FG000|Open-Label Extension Period|Lack of Efficacy|5
1005837|NCT01464307|2024283|FG001|Open-Label Extension Period|Lack of Efficacy|0
1005838|NCT01464307|2024282|FG000|Open-Label Extension Period|Death|1
1005839|NCT01464307|2024283|FG001|Open-Label Extension Period|Death|0
1005840|NCT01464307|2024282|FG000|Open-Label Extension Period|Lost to Follow-up|1
1005841|NCT01464307|2024283|FG001|Open-Label Extension Period|Lost to Follow-up|0
1005842|NCT01464307|2024282|FG000|Open-Label Extension Period|Non-compliance|9
1005843|NCT01464307|2024283|FG001|Open-Label Extension Period|Non-compliance|0
1005844|NCT01464307|2024282|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6
1005845|NCT01464307|2024283|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0
1005846|NCT01464333|2024290|FG000|Overall Study|Adverse Event|34
1005847|NCT01464333|2024290|FG000|Overall Study|Lack of Efficacy|72
1005848|NCT01464333|2024290|FG000|Overall Study|Withdrawal by Subject|11
1005849|NCT01464333|2024290|FG000|Overall Study|Other|4
1005850|NCT01464333|2024290|FG000|Overall Study|No Hospital Visit|42
1005851|NCT01464346|2024294|FG000|Overall Study|Withdrawal by Subject|0
1005852|NCT01464346|2024295|FG001|Overall Study|Withdrawal by Subject|0
1005853|NCT01464346|2024296|FG002|Overall Study|Withdrawal by Subject|1
1005854|NCT01464424|2024308|FG000|Period 1, First 6 Weeks|Adverse Event|0
1005855|NCT01464424|2024309|FG001|Period 1, First 6 Weeks|Adverse Event|1
1005856|NCT01464619|2024317|FG000|Overall Study|Lost to Follow-up|3
1005857|NCT01464619|2024318|FG001|Overall Study|Lost to Follow-up|4
1005858|NCT01464788|2024349|FG000|Overall Study|Lost to Follow-up|0
1005859|NCT01464788|2024350|FG001|Overall Study|Lost to Follow-up|1
1005860|NCT01464788|2024351|FG002|Overall Study|Lost to Follow-up|0
1005861|NCT01464788|2024349|FG000|Overall Study|Patient had hemorrhage after tPA started|0
1005862|NCT01464788|2024350|FG001|Overall Study|Patient had hemorrhage after tPA started|1
1005863|NCT01464788|2024351|FG002|Overall Study|Patient had hemorrhage after tPA started|0
1005864|NCT01464827|2024375|FG000|Overall Study|Adverse Event|0
1005865|NCT01464827|2024376|FG001|Overall Study|Adverse Event|0
1005866|NCT01464827|2024377|FG002|Overall Study|Adverse Event|0
1005867|NCT01464827|2024378|FG003|Overall Study|Adverse Event|0
1005868|NCT01464827|2024379|FG004|Overall Study|Adverse Event|0
1005869|NCT01464827|2024380|FG005|Overall Study|Adverse Event|0
1005870|NCT01464827|2024381|FG006|Overall Study|Adverse Event|0
1005871|NCT01464827|2024382|FG007|Overall Study|Adverse Event|0
1005872|NCT01464827|2024383|FG008|Overall Study|Adverse Event|0
1005873|NCT01464827|2024384|FG009|Overall Study|Adverse Event|0
1005874|NCT01464827|2024385|FG010|Overall Study|Adverse Event|0
1005875|NCT01464827|2024386|FG011|Overall Study|Adverse Event|0
1005876|NCT01464827|2024387|FG012|Overall Study|Adverse Event|1
1005877|NCT01464827|2024388|FG013|Overall Study|Adverse Event|0
1005878|NCT01464827|2024375|FG000|Overall Study|Withdrawal by Subject|1
1005879|NCT01464827|2024376|FG001|Overall Study|Withdrawal by Subject|0
1005880|NCT01464827|2024377|FG002|Overall Study|Withdrawal by Subject|0
1005881|NCT01464827|2024378|FG003|Overall Study|Withdrawal by Subject|0
1005882|NCT01464827|2024379|FG004|Overall Study|Withdrawal by Subject|1
1005883|NCT01464827|2024380|FG005|Overall Study|Withdrawal by Subject|0
1005884|NCT01464827|2024381|FG006|Overall Study|Withdrawal by Subject|0
1005885|NCT01464827|2024382|FG007|Overall Study|Withdrawal by Subject|1
1005886|NCT01464827|2024383|FG008|Overall Study|Withdrawal by Subject|0
1005887|NCT01464827|2024384|FG009|Overall Study|Withdrawal by Subject|0
1005888|NCT01464827|2024385|FG010|Overall Study|Withdrawal by Subject|0
1005889|NCT01464827|2024386|FG011|Overall Study|Withdrawal by Subject|0
1005890|NCT01464827|2024387|FG012|Overall Study|Withdrawal by Subject|0
1005891|NCT01464827|2024388|FG013|Overall Study|Withdrawal by Subject|0
1005892|NCT01464827|2024375|FG000|Overall Study|Lost to Follow-up|0
1005893|NCT01464827|2024376|FG001|Overall Study|Lost to Follow-up|2
1005894|NCT01464827|2024377|FG002|Overall Study|Lost to Follow-up|0
1005895|NCT01464827|2024378|FG003|Overall Study|Lost to Follow-up|2
1005896|NCT01464827|2024379|FG004|Overall Study|Lost to Follow-up|3
1005897|NCT01464827|2024380|FG005|Overall Study|Lost to Follow-up|1
1005898|NCT01464827|2024381|FG006|Overall Study|Lost to Follow-up|2
1005899|NCT01464827|2024382|FG007|Overall Study|Lost to Follow-up|2
1005900|NCT01464827|2024383|FG008|Overall Study|Lost to Follow-up|0
1005901|NCT01464827|2024384|FG009|Overall Study|Lost to Follow-up|0
1005902|NCT01464827|2024385|FG010|Overall Study|Lost to Follow-up|0
1005903|NCT01464827|2024386|FG011|Overall Study|Lost to Follow-up|1
1005904|NCT01464827|2024387|FG012|Overall Study|Lost to Follow-up|0
1005905|NCT01464827|2024388|FG013|Overall Study|Lost to Follow-up|1
1005906|NCT01464827|2024375|FG000|Overall Study|Other|2
1005907|NCT01464827|2024376|FG001|Overall Study|Other|3
1005908|NCT01464827|2024377|FG002|Overall Study|Other|0
1005909|NCT01464827|2024378|FG003|Overall Study|Other|2
1005910|NCT01464827|2024379|FG004|Overall Study|Other|3
1005911|NCT01464827|2024380|FG005|Overall Study|Other|0
1005912|NCT01464827|2024381|FG006|Overall Study|Other|1
1005913|NCT01464827|2024382|FG007|Overall Study|Other|0
1005914|NCT01464827|2024383|FG008|Overall Study|Other|3
1005915|NCT01464827|2024384|FG009|Overall Study|Other|1
1005916|NCT01464827|2024385|FG010|Overall Study|Other|2
1005917|NCT01464827|2024386|FG011|Overall Study|Other|0
1005918|NCT01464827|2024387|FG012|Overall Study|Other|1
1005919|NCT01464827|2024388|FG013|Overall Study|Other|0
1005920|NCT01464827|2024375|FG000|Overall Study|Not Treated|0
1005921|NCT01464827|2024376|FG001|Overall Study|Not Treated|2
1005922|NCT01464827|2024377|FG002|Overall Study|Not Treated|0
1005923|NCT01464827|2024378|FG003|Overall Study|Not Treated|0
1005924|NCT01464827|2024379|FG004|Overall Study|Not Treated|1
1005925|NCT01464827|2024380|FG005|Overall Study|Not Treated|0
1005926|NCT01464827|2024381|FG006|Overall Study|Not Treated|1
1005927|NCT01464827|2024382|FG007|Overall Study|Not Treated|0
1005928|NCT01464827|2024383|FG008|Overall Study|Not Treated|0
1005929|NCT01464827|2024384|FG009|Overall Study|Not Treated|2
1005930|NCT01464827|2024385|FG010|Overall Study|Not Treated|0
1005931|NCT01464827|2024386|FG011|Overall Study|Not Treated|1
1005932|NCT01464827|2024387|FG012|Overall Study|Not Treated|0
1005933|NCT01464827|2024388|FG013|Overall Study|Not Treated|2
1005934|NCT01464879|2024442|FG000|Overall Study|Physician Decision|1
1005935|NCT01464879|2024442|FG000|Overall Study|Non-compliance|1
1005936|NCT01464931|2024454|FG000|Overall Study|Withdrawal by Subject|1
1005937|NCT01464931|2024455|FG001|Overall Study|Withdrawal by Subject|0
1005938|NCT01465022|2024477|FG000|Overall Study|Lost to Follow-up|15
1005939|NCT01465022|2024478|FG001|Overall Study|Lost to Follow-up|14
1005940|NCT01465022|2024479|FG002|Overall Study|Lost to Follow-up|0
1005941|NCT01465022|2024477|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8
1005942|NCT01465022|2024478|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9
1005943|NCT01465022|2024479|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0
1005944|NCT01465022|2024477|FG000|Overall Study|Not Randomized|0
1005945|NCT01465022|2024478|FG001|Overall Study|Not Randomized|0
1005946|NCT01465022|2024479|FG002|Overall Study|Not Randomized|70
1005947|NCT01465178|2024500|FG000|Overall Study|Withdrawal by Subject|1
1005948|NCT01465178|2024501|FG001|Overall Study|Withdrawal by Subject|0
1005949|NCT01465191|2024510|FG000|Overall Study|Protocol Violation|6
1005950|NCT01465191|2024511|FG001|Overall Study|Protocol Violation|3
1005951|NCT01465191|2024512|FG002|Overall Study|Protocol Violation|3
1005952|NCT01465191|2024510|FG000|Overall Study|Lost to Follow-up|3
1005953|NCT01465191|2024511|FG001|Overall Study|Lost to Follow-up|6
1005954|NCT01465191|2024512|FG002|Overall Study|Lost to Follow-up|4
1005955|NCT01465334|2024525|FG000|Overall Study|Disease Progression|1
1005956|NCT01465334|2024526|FG001|Overall Study|Disease Progression|0
1005957|NCT01465334|2024525|FG000|Overall Study|Adverse Event|1
1005958|NCT01465334|2024526|FG001|Overall Study|Adverse Event|0
1005959|NCT01465334|2024525|FG000|Overall Study|Richter's transformation|0
1005960|NCT01465334|2024526|FG001|Overall Study|Richter's transformation|3
1005961|NCT01465334|2024525|FG000|Overall Study|Refractory Disease|0
1005962|NCT01465334|2024526|FG001|Overall Study|Refractory Disease|3
1005963|NCT01465347|2024532|FG000|Overall Study|Withdrawal by Subject|1
1005964|NCT01465347|2024533|FG001|Overall Study|Withdrawal by Subject|1
1005965|NCT01465347|2024532|FG000|Overall Study|Physician Decision|0
1005966|NCT01465347|2024533|FG001|Overall Study|Physician Decision|1
1005967|NCT01465347|2024532|FG000|Overall Study|Admitted to hospice|0
1005968|NCT01465347|2024533|FG001|Overall Study|Admitted to hospice|1
1005969|NCT01465386|2024542|FG000|Overall Study|Lack of Efficacy|3
1005970|NCT01465386|2024542|FG000|Overall Study|Adverse Event|1
1005971|NCT01465464|2024565|FG000|Overall Study|Adverse Event|96
1005972|NCT01465464|2024566|FG001|Overall Study|Adverse Event|49
1005973|NCT01465464|2024565|FG000|Overall Study|Lack of Efficacy|139
1005974|NCT01465464|2024566|FG001|Overall Study|Lack of Efficacy|190
1005975|NCT01465464|2024565|FG000|Overall Study|Physician Decision|13
1005976|NCT01465464|2024566|FG001|Overall Study|Physician Decision|5
1005977|NCT01465464|2024565|FG000|Overall Study|Protocol Violation|1
1005978|NCT01465464|2024566|FG001|Overall Study|Protocol Violation|1
1005979|NCT01465464|2024565|FG000|Overall Study|Withdrawal by Subject|46
1005980|NCT01465464|2024566|FG001|Overall Study|Withdrawal by Subject|30
1005981|NCT01465464|2024565|FG000|Overall Study|Other|9
1005982|NCT01465464|2024566|FG001|Overall Study|Other|3
1005983|NCT01465464|2024565|FG000|Overall Study|Ongoing treatment at cutoff date|140
1005984|NCT01465464|2024566|FG001|Overall Study|Ongoing treatment at cutoff date|166
1005985|NCT01465659|2024576|FG000|Completed 1 Cycle of Treatment|Death|0
1005986|NCT01465659|2024577|FG001|Completed 1 Cycle of Treatment|Death|1
1005987|NCT01465659|2024578|FG002|Completed 1 Cycle of Treatment|Death|0
1005988|NCT01465659|2024579|FG003|Completed 1 Cycle of Treatment|Death|0
1005989|NCT01465659|2024576|FG000|Completed 1 Cycle of Treatment|Adverse Event|0
1005990|NCT01465659|2024577|FG001|Completed 1 Cycle of Treatment|Adverse Event|0
1005991|NCT01465659|2024578|FG002|Completed 1 Cycle of Treatment|Adverse Event|0
1005992|NCT01465659|2024579|FG003|Completed 1 Cycle of Treatment|Adverse Event|1
1005993|NCT01465659|2024576|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
1005994|NCT01465659|2024577|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0
1005995|NCT01465659|2024578|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
1005996|NCT01465659|2024579|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
1005997|NCT01465659|2024576|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
1005998|NCT01465659|2024577|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
1005999|NCT01465659|2024578|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
1006000|NCT01465659|2024579|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
1006001|NCT01465659|2024576|FG000|Completed Follow for 1 Year|Death|6
1006002|NCT01465659|2024577|FG001|Completed Follow for 1 Year|Death|3
1006003|NCT01465659|2024578|FG002|Completed Follow for 1 Year|Death|2
1006004|NCT01465659|2024579|FG003|Completed Follow for 1 Year|Death|4
1006005|NCT01465763|2024595|FG000|Overall Study|Withdrawal by Subject|4
1006006|NCT01465763|2024596|FG001|Overall Study|Withdrawal by Subject|0
1006007|NCT01465763|2024597|FG002|Overall Study|Withdrawal by Subject|1
1006008|NCT01465763|2024595|FG000|Overall Study|Insufficient Clinical Response|11
1006009|NCT01465763|2024596|FG001|Overall Study|Insufficient Clinical Response|0
1006010|NCT01465763|2024597|FG002|Overall Study|Insufficient Clinical Response|1
1006011|NCT01465763|2024595|FG000|Overall Study|Adverse Event|9
1006012|NCT01465763|2024596|FG001|Overall Study|Adverse Event|0
1006013|NCT01465763|2024597|FG002|Overall Study|Adverse Event|1
1006014|NCT01465763|2024595|FG000|Overall Study|Other|2
1006015|NCT01465763|2024596|FG001|Overall Study|Other|0
1006016|NCT01465763|2024597|FG002|Overall Study|Other|0
1006017|NCT01465763|2024595|FG000|Overall Study|Protocol Violation|4
1006018|NCT01465763|2024596|FG001|Overall Study|Protocol Violation|1
1006019|NCT01465763|2024597|FG002|Overall Study|Protocol Violation|1
1006020|NCT01465763|2024595|FG000|Overall Study|Death|1
1006021|NCT01465763|2024596|FG001|Overall Study|Death|0
1006022|NCT01465763|2024597|FG002|Overall Study|Death|0
1006023|NCT01465802|2024609|FG000|Overall Study|Study terminated by sponsor|1
1006024|NCT01465802|2024610|FG001|Overall Study|Study terminated by sponsor|0
1006025|NCT01465802|2024611|FG002|Overall Study|Study terminated by sponsor|0
1006026|NCT01465802|2024612|FG003|Overall Study|Study terminated by sponsor|1
1006027|NCT01465802|2024613|FG004|Overall Study|Study terminated by sponsor|7
1006028|NCT01465802|2024609|FG000|Overall Study|Withdrawal by Subject|7
1006029|NCT01465802|2024610|FG001|Overall Study|Withdrawal by Subject|7
1006030|NCT01465802|2024611|FG002|Overall Study|Withdrawal by Subject|0
1006031|NCT01465802|2024612|FG003|Overall Study|Withdrawal by Subject|8
1006032|NCT01465802|2024613|FG004|Overall Study|Withdrawal by Subject|1
1006033|NCT01465802|2024609|FG000|Overall Study|Lost to Follow-up|1
1006034|NCT01465802|2024610|FG001|Overall Study|Lost to Follow-up|1
1006035|NCT01465802|2024611|FG002|Overall Study|Lost to Follow-up|0
1006036|NCT01465802|2024612|FG003|Overall Study|Lost to Follow-up|0
1006037|NCT01465802|2024613|FG004|Overall Study|Lost to Follow-up|0
1006038|NCT01465802|2024609|FG000|Overall Study|Reason not specified|9
1006039|NCT01465802|2024610|FG001|Overall Study|Reason not specified|4
1006040|NCT01465802|2024611|FG002|Overall Study|Reason not specified|0
1006041|NCT01465802|2024612|FG003|Overall Study|Reason not specified|10
1006042|NCT01465802|2024613|FG004|Overall Study|Reason not specified|2
1006043|NCT01465802|2024609|FG000|Overall Study|Death|15
1006044|NCT01465802|2024610|FG001|Overall Study|Death|12
1006045|NCT01465802|2024611|FG002|Overall Study|Death|0
1006046|NCT01465802|2024612|FG003|Overall Study|Death|10
1006047|NCT01465802|2024613|FG004|Overall Study|Death|2
1006048|NCT01465958|2024631|FG000|Run-in Phase|Protocol Violation|1
1006049|NCT01465958|2024632|FG001|Run-in Phase|Protocol Violation|0
1006050|NCT01465958|2024631|FG000|Subcutaneous (SC) Phase|Adverse Event|0
1006051|NCT01465958|2024632|FG001|Subcutaneous (SC) Phase|Adverse Event|1
1006052|NCT01465997|2024641|FG000|Overall Study|Adverse Event|12
1006053|NCT01465997|2024642|FG001|Overall Study|Adverse Event|22
1006054|NCT01465997|2024641|FG000|Overall Study|Lack of Efficacy|13
1006055|NCT01465997|2024642|FG001|Overall Study|Lack of Efficacy|1
1006056|NCT01465997|2024641|FG000|Overall Study|Protocol Violation|1
1006057|NCT01465997|2024642|FG001|Overall Study|Protocol Violation|4
1006058|NCT01465997|2024641|FG000|Overall Study|Lost to Follow-up|6
1006059|NCT01465997|2024642|FG001|Overall Study|Lost to Follow-up|9
1006060|NCT01465997|2024641|FG000|Overall Study|Withdrawal by Subject|32
1006061|NCT01465997|2024642|FG001|Overall Study|Withdrawal by Subject|35
1006062|NCT01465997|2024641|FG000|Overall Study|investigator's decision|1
1006063|NCT01465997|2024642|FG001|Overall Study|investigator's decision|1
1006064|NCT01465997|2024641|FG000|Overall Study|Death|0
1006065|NCT01465997|2024642|FG001|Overall Study|Death|1
1006066|NCT01465997|2024641|FG000|Overall Study|sponsor's decision|1
1006067|NCT01465997|2024642|FG001|Overall Study|sponsor's decision|1
1006068|NCT01465997|2024641|FG000|Overall Study|subject withdrew consent|1
1006069|NCT01465997|2024642|FG001|Overall Study|subject withdrew consent|0
1006070|NCT01465997|2024641|FG000|Overall Study|local lab unblinded site|1
1006071|NCT01465997|2024642|FG001|Overall Study|local lab unblinded site|0
1006072|NCT01465997|2024641|FG000|Overall Study|withdrew before follow-up|0
1006073|NCT01465997|2024642|FG001|Overall Study|withdrew before follow-up|13
1006074|NCT01465997|2024641|FG000|Overall Study|decision by site staff|0
1006075|NCT01465997|2024642|FG001|Overall Study|decision by site staff|1
1006076|NCT01465997|2024641|FG000|Overall Study|subject left participation SP0993|0
1006077|NCT01465997|2024642|FG001|Overall Study|subject left participation SP0993|1
1006078|NCT01466062|2024650|FG000|Overall Study|Adverse Event|1
1006079|NCT01466062|2024650|FG000|Overall Study|Withdrawal by Subject|1
1006080|NCT01466153|2024670|FG000|Overall Study|Disease Progression|2
1006081|NCT01466153|2024671|FG001|Overall Study|Disease Progression|2
1006082|NCT01466153|2024672|FG002|Overall Study|Disease Progression|0
1006083|NCT01466153|2024670|FG000|Overall Study|Adverse Event|14
1006084|NCT01466153|2024671|FG001|Overall Study|Adverse Event|13
1006085|NCT01466153|2024672|FG002|Overall Study|Adverse Event|17
1006086|NCT01466153|2024670|FG000|Overall Study|Withdrawal of Consent|2
1006087|NCT01466153|2024671|FG001|Overall Study|Withdrawal of Consent|0
1006088|NCT01466153|2024672|FG002|Overall Study|Withdrawal of Consent|0
1006089|NCT01466153|2024670|FG000|Overall Study|Investigator Discretion|3
1006090|NCT01466153|2024671|FG001|Overall Study|Investigator Discretion|2
1006091|NCT01466153|2024672|FG002|Overall Study|Investigator Discretion|2
1006092|NCT01466153|2024670|FG000|Overall Study|Randomized-Not Treated|2
1006093|NCT01466153|2024671|FG001|Overall Study|Randomized-Not Treated|3
1006094|NCT01466153|2024672|FG002|Overall Study|Randomized-Not Treated|4
1006095|NCT01466153|2024670|FG000|Overall Study|Other-Unspecified|6
1006096|NCT01466153|2024671|FG001|Overall Study|Other-Unspecified|4
1006097|NCT01466153|2024672|FG002|Overall Study|Other-Unspecified|2
1006098|NCT01466166|2024682|FG000|Overall Study|Death|1
1006099|NCT01466166|2024682|FG000|Overall Study|Lost to Follow-up|7
1006100|NCT01466166|2024682|FG000|Overall Study|Infusion Reaction (IR)|27
1006101|NCT01466166|2024682|FG000|Overall Study|Adverse Event (Other than IR)|11
1006102|NCT01466166|2024682|FG000|Overall Study|Elevated Serum Uric Acid|78
1006103|NCT01466166|2024682|FG000|Overall Study|Withdrawal by Subject|13
1006104|NCT01466166|2024682|FG000|Overall Study|Sponsor Decision|4
1006105|NCT01466166|2024682|FG000|Overall Study|Protocol Violation/Noncompliance|2
1006106|NCT01466166|2024682|FG000|Overall Study|Other|20
1006107|NCT01466179|2024686|FG000|Overall Study|Ongoing in core study|2
1006108|NCT01466179|2024686|FG000|Overall Study|Physician Decision|46
1006109|NCT01466179|2024686|FG000|Overall Study|Progressive disease|43
1006110|NCT01466179|2024686|FG000|Overall Study|Adverse Event|32
1006111|NCT01466179|2024686|FG000|Overall Study|Disease relapse|23
1006112|NCT01466179|2024686|FG000|Overall Study|Lack of Efficacy|14
1006113|NCT01466179|2024686|FG000|Overall Study|Death|7
1006114|NCT01466179|2024686|FG000|Overall Study|Withdrawal by Subject|7
1006115|NCT01466179|2024686|FG000|Overall Study|Protocol Violation|2
1006116|NCT01466179|2024686|FG000|Overall Study|Other|3
1006117|NCT01466192|2024693|FG000|Overall Study|Physician Decision|1
1006118|NCT01466192|2024693|FG000|Overall Study|Withdrawal by Subject|3
1006119|NCT01466270|2024699|FG000|Overall Study|Withdrawal by Subject|4
1006120|NCT01466270|2024700|FG001|Overall Study|Withdrawal by Subject|1
1006121|NCT01466270|2024699|FG000|Overall Study|Physician Decision|1
1006122|NCT01466270|2024700|FG001|Overall Study|Physician Decision|0
1006123|NCT01466270|2024699|FG000|Overall Study|Lost to Follow-up|1
1006124|NCT01466270|2024700|FG001|Overall Study|Lost to Follow-up|3
1006125|NCT01466270|2024699|FG000|Overall Study|Progression|1
1006126|NCT01466270|2024700|FG001|Overall Study|Progression|0
1006127|NCT01466270|2024699|FG000|Overall Study|Toxicity|4
1006128|NCT01466270|2024700|FG001|Overall Study|Toxicity|1
1006129|NCT01466270|2024699|FG000|Overall Study|Multiple|1
1006130|NCT01466270|2024700|FG001|Overall Study|Multiple|1
1006131|NCT01466348|2024708|FG000|Period I - First Intervention|Withdrawal by Subject|0
1006132|NCT01466348|2024709|FG001|Period I - First Intervention|Withdrawal by Subject|1
1006133|NCT01466387|2024745|FG000|Overall Study|Adverse Event|0
1006134|NCT01466387|2024746|FG001|Overall Study|Adverse Event|0
1006135|NCT01466387|2024747|FG002|Overall Study|Adverse Event|1
1006136|NCT01466387|2024748|FG003|Overall Study|Adverse Event|1
1006137|NCT01466387|2024749|FG004|Overall Study|Adverse Event|0
1006138|NCT01466387|2024750|FG005|Overall Study|Adverse Event|0
1006139|NCT01466387|2024745|FG000|Overall Study|Lost to Follow-up|0
1006140|NCT01466387|2024746|FG001|Overall Study|Lost to Follow-up|0
1006141|NCT01466387|2024747|FG002|Overall Study|Lost to Follow-up|0
1006142|NCT01466387|2024748|FG003|Overall Study|Lost to Follow-up|0
1006143|NCT01466387|2024749|FG004|Overall Study|Lost to Follow-up|0
1006144|NCT01466387|2024750|FG005|Overall Study|Lost to Follow-up|1
1006145|NCT01466387|2024745|FG000|Overall Study|Protocol Violation|1
1006146|NCT01466387|2024746|FG001|Overall Study|Protocol Violation|0
1006147|NCT01466387|2024747|FG002|Overall Study|Protocol Violation|0
1006148|NCT01466387|2024748|FG003|Overall Study|Protocol Violation|1
1006149|NCT01466387|2024749|FG004|Overall Study|Protocol Violation|0
1006150|NCT01466387|2024750|FG005|Overall Study|Protocol Violation|0
1006151|NCT01466491|2024777|FG000|Overall Study|Protocol Violation|0
1006152|NCT01466491|2024778|FG001|Overall Study|Protocol Violation|3
1006153|NCT01466491|2024779|FG002|Overall Study|Protocol Violation|2
1006154|NCT01466491|2024780|FG003|Overall Study|Protocol Violation|0
1006155|NCT01466491|2024777|FG000|Overall Study|Missing Data|0
1006156|NCT01466491|2024778|FG001|Overall Study|Missing Data|0
1006157|NCT01466491|2024779|FG002|Overall Study|Missing Data|1
1006158|NCT01466491|2024780|FG003|Overall Study|Missing Data|0
1006159|NCT01466595|2024792|FG000|Overall Study|Withdrawal by Subject|0
1006160|NCT01466595|2024793|FG001|Overall Study|Withdrawal by Subject|1
1006161|NCT01466660|2024801|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120
1006162|NCT01466660|2024802|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127
1006163|NCT01466660|2024801|FG000|Overall Study|Worsening of underlying cancer disease|5
1006164|NCT01466660|2024802|FG001|Overall Study|Worsening of underlying cancer disease|2
1006165|NCT01466660|2024801|FG000|Overall Study|Other adverse event|19
1006166|NCT01466660|2024802|FG001|Overall Study|Other adverse event|18
1006167|NCT01466660|2024801|FG000|Overall Study|Protocol Violation|2
1006168|NCT01466660|2024802|FG001|Overall Study|Protocol Violation|1
1006169|NCT01466660|2024801|FG000|Overall Study|Refused continuation of trial medication|4
1006170|NCT01466660|2024802|FG001|Overall Study|Refused continuation of trial medication|3
1006171|NCT01466660|2024801|FG000|Overall Study|Other reason not defined above|10
1006172|NCT01466660|2024802|FG001|Overall Study|Other reason not defined above|8
1006173|NCT01466673|2024810|FG000|Overall Study|Non-compliance with study treatment|2
1006174|NCT01466673|2024811|FG001|Overall Study|Non-compliance with study treatment|0
1006175|NCT01466673|2024810|FG000|Overall Study|Lost to Follow-up|3
1006176|NCT01466673|2024811|FG001|Overall Study|Lost to Follow-up|5
1006177|NCT01466673|2024810|FG000|Overall Study|Adverse Event|2
1006178|NCT01466673|2024811|FG001|Overall Study|Adverse Event|1
1006179|NCT01466790|2024845|FG000|Overall Study|Adverse Event|1
1006180|NCT01466790|2024846|FG001|Overall Study|Adverse Event|0
1006181|NCT01466790|2024847|FG002|Overall Study|Adverse Event|0
1006182|NCT01466790|2024848|FG003|Overall Study|Adverse Event|0
1006183|NCT01466790|2024849|FG004|Overall Study|Adverse Event|2
1006184|NCT01466790|2024850|FG005|Overall Study|Adverse Event|0
1006185|NCT01466790|2024851|FG006|Overall Study|Adverse Event|0
1006186|NCT01466790|2024852|FG007|Overall Study|Adverse Event|0
1006187|NCT01466790|2024845|FG000|Overall Study|Lost to Follow-up|2
1006188|NCT01466790|2024846|FG001|Overall Study|Lost to Follow-up|0
1006189|NCT01466790|2024847|FG002|Overall Study|Lost to Follow-up|0
1006190|NCT01466790|2024848|FG003|Overall Study|Lost to Follow-up|0
1006191|NCT01466790|2024849|FG004|Overall Study|Lost to Follow-up|0
1006192|NCT01466790|2024850|FG005|Overall Study|Lost to Follow-up|0
1006193|NCT01466790|2024851|FG006|Overall Study|Lost to Follow-up|0
1006194|NCT01466790|2024852|FG007|Overall Study|Lost to Follow-up|0
1006195|NCT01466790|2024845|FG000|Overall Study|Withdrawal by Subject|1
1006196|NCT01466790|2024846|FG001|Overall Study|Withdrawal by Subject|1
1006197|NCT01466790|2024847|FG002|Overall Study|Withdrawal by Subject|0
1006198|NCT01466790|2024848|FG003|Overall Study|Withdrawal by Subject|0
1006199|NCT01466790|2024849|FG004|Overall Study|Withdrawal by Subject|1
1006200|NCT01466790|2024850|FG005|Overall Study|Withdrawal by Subject|0
1006201|NCT01466790|2024851|FG006|Overall Study|Withdrawal by Subject|1
1006202|NCT01466790|2024852|FG007|Overall Study|Withdrawal by Subject|1
1006203|NCT01466881|2024866|FG000|Overall Study|Ineligible|5
1006204|NCT01466881|2024866|FG000|Overall Study|Adverse Event|6
1006205|NCT01466881|2024866|FG000|Overall Study|Progression/relapse|20
1006206|NCT01466881|2024866|FG000|Overall Study|Death|4
1006207|NCT01466881|2024866|FG000|Overall Study|Other reason not protocol specified|5
1006208|NCT01467076|2024909|FG000|Overall Study|Lost to Follow-up|1
1006209|NCT01467076|2024910|FG001|Overall Study|Lost to Follow-up|0
1006210|NCT01467076|2024911|FG002|Overall Study|Lost to Follow-up|0
1006211|NCT01467271|2024919|FG000|Overall Study|Death|84
1006212|NCT01467271|2024919|FG000|Overall Study|Lost to Follow-up|83
1006213|NCT01467271|2024919|FG000|Overall Study|Retraction of patient's consent|21
1006214|NCT01467271|2024919|FG000|Overall Study|Other reason|14
1006215|NCT01467427|2024925|FG000|Overall Study|Withdrawal by Subject|1
1006216|NCT01467427|2024926|FG001|Overall Study|Withdrawal by Subject|0
1006217|NCT01467427|2024925|FG000|Overall Study|Entered extension phase|11
1006218|NCT01467427|2024926|FG001|Overall Study|Entered extension phase|11
1006219|NCT01467427|2024925|FG000|Overall Study|Not continuing in extension phase|0
1006220|NCT01467427|2024926|FG001|Overall Study|Not continuing in extension phase|2
1006221|NCT01467466|2024936|FG000|Overall Study|Withdrawal by Subject|15
1006222|NCT01467466|2024937|FG001|Overall Study|Withdrawal by Subject|18
1006223|NCT01467466|2024938|FG002|Overall Study|Withdrawal by Subject|13
1006224|NCT01467466|2024939|FG003|Overall Study|Withdrawal by Subject|11
1006225|NCT01467466|2024936|FG000|Overall Study|Revoked Consent Prior To Procedure|10
1006226|NCT01467466|2024937|FG001|Overall Study|Revoked Consent Prior To Procedure|9
1006227|NCT01467466|2024938|FG002|Overall Study|Revoked Consent Prior To Procedure|15
1006228|NCT01467466|2024939|FG003|Overall Study|Revoked Consent Prior To Procedure|5
1006229|NCT01467466|2024936|FG000|Overall Study|Procedure Cancelled|46
1006230|NCT01467466|2024937|FG001|Overall Study|Procedure Cancelled|45
1006231|NCT01467466|2024938|FG002|Overall Study|Procedure Cancelled|25
1006232|NCT01467466|2024939|FG003|Overall Study|Procedure Cancelled|29
1006233|NCT01467466|2024936|FG000|Overall Study|No Endpoint Blood Draw|38
1006234|NCT01467466|2024937|FG001|Overall Study|No Endpoint Blood Draw|32
1006235|NCT01467466|2024938|FG002|Overall Study|No Endpoint Blood Draw|51
1006236|NCT01467466|2024939|FG003|Overall Study|No Endpoint Blood Draw|43
1006237|NCT01467479|2024952|FG000|Overall Study|No Study Medication|1
1006238|NCT01467479|2024953|FG001|Overall Study|No Study Medication|0
1006239|NCT01467479|2024954|FG002|Overall Study|No Study Medication|2
1006240|NCT01467479|2024952|FG000|Overall Study|Adverse Event|1
1006241|NCT01467479|2024953|FG001|Overall Study|Adverse Event|2
1006242|NCT01467479|2024954|FG002|Overall Study|Adverse Event|0
1006243|NCT01467479|2024952|FG000|Overall Study|Death|0
1006244|NCT01467479|2024953|FG001|Overall Study|Death|0
1006245|NCT01467479|2024954|FG002|Overall Study|Death|1
1006246|NCT01467479|2024952|FG000|Overall Study|Lost to Follow-up|2
1006247|NCT01467479|2024953|FG001|Overall Study|Lost to Follow-up|5
1006248|NCT01467479|2024954|FG002|Overall Study|Lost to Follow-up|3
1006249|NCT01467479|2024952|FG000|Overall Study|Withdrawal of Consent|3
1006250|NCT01467479|2024953|FG001|Overall Study|Withdrawal of Consent|7
1006251|NCT01467479|2024954|FG002|Overall Study|Withdrawal of Consent|7
1006252|NCT01467479|2024952|FG000|Overall Study|Study Terminated by Sponsor|1
1006253|NCT01467479|2024953|FG001|Overall Study|Study Terminated by Sponsor|3
1006254|NCT01467479|2024954|FG002|Overall Study|Study Terminated by Sponsor|3
1006255|NCT01467479|2024952|FG000|Overall Study|Other|1
1006256|NCT01467479|2024953|FG001|Overall Study|Other|0
1006257|NCT01467479|2024954|FG002|Overall Study|Other|0
1006258|NCT01467492|2024965|FG000|Overall Study|Withdrawal by Subject|6
1006259|NCT01467492|2024966|FG001|Overall Study|Withdrawal by Subject|4
1006260|NCT01467492|2024965|FG000|Overall Study|Study Terminated by Sponsor|6
1006261|NCT01467492|2024966|FG001|Overall Study|Study Terminated by Sponsor|4
1006262|NCT01467492|2024965|FG000|Overall Study|Adverse Event|4
1006263|NCT01467492|2024966|FG001|Overall Study|Adverse Event|3
1006264|NCT01467492|2024965|FG000|Overall Study|Lost to Follow-up|3
1006265|NCT01467492|2024966|FG001|Overall Study|Lost to Follow-up|2
1006266|NCT01467492|2024965|FG000|Overall Study|Undefined|2
1006267|NCT01467492|2024966|FG001|Overall Study|Undefined|0
1006268|NCT01467492|2024965|FG000|Overall Study|Enrolled But Not Treated|1
1006269|NCT01467492|2024966|FG001|Overall Study|Enrolled But Not Treated|0
1006270|NCT01467505|2024975|FG000|Overall Study|Adverse Event|1
1006271|NCT01467505|2024976|FG001|Overall Study|Adverse Event|0
1006272|NCT01467505|2024975|FG000|Overall Study|Withdrawal by Subject|4
1006273|NCT01467505|2024976|FG001|Overall Study|Withdrawal by Subject|0
1006274|NCT01467505|2024975|FG000|Overall Study|Study Terminated by Sponsor|28
1006275|NCT01467505|2024976|FG001|Overall Study|Study Terminated by Sponsor|3
1006276|NCT01467570|2024993|FG000|Overall Study|Lost to Follow-up|8
1006277|NCT01467570|2024994|FG001|Overall Study|Lost to Follow-up|9
1006278|NCT01467583|2025005|FG000|Overall Study|Death|1
1006279|NCT01467583|2025006|FG001|Overall Study|Death|1
1006280|NCT01467583|2025007|FG002|Overall Study|Death|0
1006281|NCT01467583|2025005|FG000|Overall Study|Withdrawal by Subject|1
1006282|NCT01467583|2025006|FG001|Overall Study|Withdrawal by Subject|0
1006283|NCT01467583|2025007|FG002|Overall Study|Withdrawal by Subject|0
1006284|NCT01467583|2025005|FG000|Overall Study|Protocol Violation|0
1006285|NCT01467583|2025006|FG001|Overall Study|Protocol Violation|0
1006286|NCT01467583|2025007|FG002|Overall Study|Protocol Violation|2
1006287|NCT01467661|2025018|FG000|Overall Study|Adverse Event|16
1006288|NCT01467661|2025018|FG000|Overall Study|Withdrawal by Subject|1
1006289|NCT01467661|2025018|FG000|Overall Study|Lack of Efficacy|3
1006290|NCT01467661|2025018|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
1006291|NCT01467700|2025028|FG000|Overall Study|Pretreatment Event or Adverse Event|6
1006292|NCT01467700|2025029|FG001|Overall Study|Pretreatment Event or Adverse Event|4
1006293|NCT01467700|2025030|FG002|Overall Study|Pretreatment Event or Adverse Event|2
1006294|NCT01467700|2025031|FG003|Overall Study|Pretreatment Event or Adverse Event|3
1006295|NCT01467700|2025028|FG000|Overall Study|Major Protocol Deviation|3
1006296|NCT01467700|2025029|FG001|Overall Study|Major Protocol Deviation|3
1006297|NCT01467700|2025030|FG002|Overall Study|Major Protocol Deviation|2
1006298|NCT01467700|2025031|FG003|Overall Study|Major Protocol Deviation|3
1006299|NCT01467700|2025028|FG000|Overall Study|Lost to Follow-up|6
1006300|NCT01467700|2025029|FG001|Overall Study|Lost to Follow-up|5
1006301|NCT01467700|2025030|FG002|Overall Study|Lost to Follow-up|2
1006302|NCT01467700|2025031|FG003|Overall Study|Lost to Follow-up|3
1006303|NCT01467700|2025028|FG000|Overall Study|Voluntary Withdrawal|5
1006304|NCT01467700|2025029|FG001|Overall Study|Voluntary Withdrawal|7
1006305|NCT01467700|2025030|FG002|Overall Study|Voluntary Withdrawal|6
1006306|NCT01467700|2025031|FG003|Overall Study|Voluntary Withdrawal|2
1006307|NCT01467700|2025028|FG000|Overall Study|Study Termination|6
1006308|NCT01467700|2025029|FG001|Overall Study|Study Termination|5
1006309|NCT01467700|2025030|FG002|Overall Study|Study Termination|10
1006310|NCT01467700|2025031|FG003|Overall Study|Study Termination|7
1006311|NCT01467700|2025028|FG000|Overall Study|Pregnancy|0
1006312|NCT01467700|2025029|FG001|Overall Study|Pregnancy|1
1006313|NCT01467700|2025030|FG002|Overall Study|Pregnancy|1
1006314|NCT01467700|2025031|FG003|Overall Study|Pregnancy|0
1006315|NCT01467700|2025028|FG000|Overall Study|Lack of Efficacy|2
1006316|NCT01467700|2025029|FG001|Overall Study|Lack of Efficacy|0
1006317|NCT01467700|2025030|FG002|Overall Study|Lack of Efficacy|2
1006318|NCT01467700|2025031|FG003|Overall Study|Lack of Efficacy|1
1006319|NCT01467700|2025028|FG000|Overall Study|Reason not Specified|1
1006320|NCT01467700|2025029|FG001|Overall Study|Reason not Specified|3
1006321|NCT01467700|2025030|FG002|Overall Study|Reason not Specified|2
1006322|NCT01467700|2025031|FG003|Overall Study|Reason not Specified|8
1006323|NCT01467713|2025045|FG000|Overall Study|Pretreatment Event or Adverse Event|9
1006324|NCT01467713|2025046|FG001|Overall Study|Pretreatment Event or Adverse Event|4
1006325|NCT01467713|2025047|FG002|Overall Study|Pretreatment Event or Adverse Event|6
1006326|NCT01467713|2025048|FG003|Overall Study|Pretreatment Event or Adverse Event|5
1006327|NCT01467713|2025045|FG000|Overall Study|Major Protocol Deviation|2
1006328|NCT01467713|2025046|FG001|Overall Study|Major Protocol Deviation|4
1006329|NCT01467713|2025047|FG002|Overall Study|Major Protocol Deviation|4
1006330|NCT01467713|2025048|FG003|Overall Study|Major Protocol Deviation|1
1006331|NCT01467713|2025045|FG000|Overall Study|Lost to Follow-up|9
1006332|NCT01467713|2025046|FG001|Overall Study|Lost to Follow-up|12
1006333|NCT01467713|2025047|FG002|Overall Study|Lost to Follow-up|6
1006334|NCT01467713|2025048|FG003|Overall Study|Lost to Follow-up|9
1006335|NCT01467713|2025045|FG000|Overall Study|Voluntary Withdrawal|18
1006336|NCT01467713|2025046|FG001|Overall Study|Voluntary Withdrawal|14
1006337|NCT01467713|2025047|FG002|Overall Study|Voluntary Withdrawal|21
1006338|NCT01467713|2025048|FG003|Overall Study|Voluntary Withdrawal|20
1006339|NCT01467713|2025045|FG000|Overall Study|Study Termination|23
1006340|NCT01467713|2025046|FG001|Overall Study|Study Termination|33
1006341|NCT01467713|2025047|FG002|Overall Study|Study Termination|28
1006342|NCT01467713|2025048|FG003|Overall Study|Study Termination|29
1006343|NCT01467713|2025045|FG000|Overall Study|Pregnancy|0
1006344|NCT01467713|2025046|FG001|Overall Study|Pregnancy|1
1006345|NCT01467713|2025047|FG002|Overall Study|Pregnancy|1
1006346|NCT01467713|2025048|FG003|Overall Study|Pregnancy|3
1006347|NCT01467713|2025045|FG000|Overall Study|Relapse|35
1006348|NCT01467713|2025046|FG001|Overall Study|Relapse|25
1006349|NCT01467713|2025047|FG002|Overall Study|Relapse|28
1006350|NCT01467713|2025048|FG003|Overall Study|Relapse|35
1006351|NCT01467713|2025045|FG000|Overall Study|Reason not Specified|6
1006352|NCT01467713|2025046|FG001|Overall Study|Reason not Specified|11
1006353|NCT01467713|2025047|FG002|Overall Study|Reason not Specified|8
1006354|NCT01467713|2025048|FG003|Overall Study|Reason not Specified|7
1006355|NCT01467960|2025092|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0
1006356|NCT01467960|2025093|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0
1006357|NCT01467960|2025094|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0
1006358|NCT01467960|2025095|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30
1006359|NCT01467960|2025096|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30
1006360|NCT01467960|2025097|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30
1006361|NCT01468077|2025131|FG000|Overall Study|Adverse Event|2
1006362|NCT01468077|2025132|FG001|Overall Study|Adverse Event|2
1006363|NCT01468077|2025131|FG000|Overall Study|Lack of Efficacy|1
1006364|NCT01468077|2025132|FG001|Overall Study|Lack of Efficacy|1
1006365|NCT01468077|2025131|FG000|Overall Study|Physician Decision|1
1006366|NCT01468077|2025132|FG001|Overall Study|Physician Decision|0
1006367|NCT01468181|2025143|FG000|Overall Study|Adverse Event|8
1006368|NCT01468181|2025144|FG001|Overall Study|Adverse Event|1
1006369|NCT01468181|2025145|FG002|Overall Study|Adverse Event|6
1006370|NCT01468181|2025146|FG003|Overall Study|Adverse Event|2
1006371|NCT01468181|2025147|FG004|Overall Study|Adverse Event|2
1006372|NCT01468181|2025143|FG000|Overall Study|Protocol Violation|2
1006373|NCT01468181|2025144|FG001|Overall Study|Protocol Violation|0
1006374|NCT01468181|2025145|FG002|Overall Study|Protocol Violation|1
1006375|NCT01468181|2025146|FG003|Overall Study|Protocol Violation|0
1006376|NCT01468181|2025147|FG004|Overall Study|Protocol Violation|1
1006377|NCT01468181|2025143|FG000|Overall Study|Physician Decision|0
1006378|NCT01468181|2025144|FG001|Overall Study|Physician Decision|0
1006379|NCT01468181|2025145|FG002|Overall Study|Physician Decision|0
1006380|NCT01468181|2025146|FG003|Overall Study|Physician Decision|1
1006381|NCT01468181|2025147|FG004|Overall Study|Physician Decision|1
1006382|NCT01468181|2025143|FG000|Overall Study|Lost to Follow-up|0
1006383|NCT01468181|2025144|FG001|Overall Study|Lost to Follow-up|0
1006384|NCT01468181|2025145|FG002|Overall Study|Lost to Follow-up|1
1006385|NCT01468181|2025146|FG003|Overall Study|Lost to Follow-up|0
1006386|NCT01468181|2025147|FG004|Overall Study|Lost to Follow-up|1
1006387|NCT01468181|2025143|FG000|Overall Study|Withdrawal by Subject|0
1006388|NCT01468181|2025144|FG001|Overall Study|Withdrawal by Subject|1
1006389|NCT01468181|2025145|FG002|Overall Study|Withdrawal by Subject|0
1006390|NCT01468181|2025146|FG003|Overall Study|Withdrawal by Subject|0
1006391|NCT01468181|2025147|FG004|Overall Study|Withdrawal by Subject|0
1006392|NCT01468207|2025161|FG000|Treatment Period 1|Adverse Event|1
1006393|NCT01468207|2025162|FG001|Treatment Period 1|Adverse Event|0
1006394|NCT01468207|2025163|FG002|Treatment Period 1|Adverse Event|0
1006395|NCT01468207|2025164|FG003|Treatment Period 1|Adverse Event|0
1006396|NCT01468207|2025165|FG004|Treatment Period 1|Adverse Event|0
1006397|NCT01468207|2025166|FG005|Treatment Period 1|Adverse Event|0
1006398|NCT01468207|2025161|FG000|Treatment Period 1|Protocol Violation|1
1006399|NCT01468207|2025162|FG001|Treatment Period 1|Protocol Violation|1
1006400|NCT01468207|2025163|FG002|Treatment Period 1|Protocol Violation|0
1006401|NCT01468207|2025164|FG003|Treatment Period 1|Protocol Violation|0
1006402|NCT01468207|2025165|FG004|Treatment Period 1|Protocol Violation|0
1006403|NCT01468207|2025166|FG005|Treatment Period 1|Protocol Violation|0
1006404|NCT01468207|2025161|FG000|Treatment Period 1|Withdrawal by Subject|5
1006405|NCT01468207|2025162|FG001|Treatment Period 1|Withdrawal by Subject|4
1006406|NCT01468207|2025163|FG002|Treatment Period 1|Withdrawal by Subject|0
1006407|NCT01468207|2025164|FG003|Treatment Period 1|Withdrawal by Subject|0
1006408|NCT01468207|2025165|FG004|Treatment Period 1|Withdrawal by Subject|0
1006409|NCT01468207|2025166|FG005|Treatment Period 1|Withdrawal by Subject|0
1006410|NCT01468207|2025161|FG000|Treatment Period 1|Lost to Follow-up|2
1006411|NCT01468207|2025162|FG001|Treatment Period 1|Lost to Follow-up|1
1006412|NCT01468207|2025163|FG002|Treatment Period 1|Lost to Follow-up|0
1006413|NCT01468207|2025164|FG003|Treatment Period 1|Lost to Follow-up|0
1006414|NCT01468207|2025165|FG004|Treatment Period 1|Lost to Follow-up|0
1006415|NCT01468207|2025166|FG005|Treatment Period 1|Lost to Follow-up|0
1006416|NCT01468207|2025161|FG000|Treatment Period 1|Other|0
1006417|NCT01468207|2025162|FG001|Treatment Period 1|Other|2
1006418|NCT01468207|2025163|FG002|Treatment Period 1|Other|0
1006419|NCT01468207|2025164|FG003|Treatment Period 1|Other|0
1006420|NCT01468207|2025165|FG004|Treatment Period 1|Other|0
1006421|NCT01468207|2025166|FG005|Treatment Period 1|Other|0
1006422|NCT01468207|2025161|FG000|Treatment Period 2|Adverse Event|0
1006423|NCT01468207|2025162|FG001|Treatment Period 2|Adverse Event|0
1006424|NCT01468207|2025163|FG002|Treatment Period 2|Adverse Event|6
1006425|NCT01468207|2025164|FG003|Treatment Period 2|Adverse Event|1
1006426|NCT01468207|2025165|FG004|Treatment Period 2|Adverse Event|2
1006427|NCT01468207|2025166|FG005|Treatment Period 2|Adverse Event|1
1006428|NCT01468207|2025161|FG000|Treatment Period 2|Lack of Efficacy|0
1006429|NCT01468207|2025162|FG001|Treatment Period 2|Lack of Efficacy|0
1006430|NCT01468207|2025163|FG002|Treatment Period 2|Lack of Efficacy|1
1006431|NCT01468207|2025164|FG003|Treatment Period 2|Lack of Efficacy|1
1006432|NCT01468207|2025165|FG004|Treatment Period 2|Lack of Efficacy|0
1006433|NCT01468207|2025166|FG005|Treatment Period 2|Lack of Efficacy|2
1006434|NCT01468207|2025161|FG000|Treatment Period 2|Withdrawal by Subject|0
1006435|NCT01468207|2025162|FG001|Treatment Period 2|Withdrawal by Subject|0
1006436|NCT01468207|2025163|FG002|Treatment Period 2|Withdrawal by Subject|5
1006437|NCT01468207|2025164|FG003|Treatment Period 2|Withdrawal by Subject|0
1006438|NCT01468207|2025165|FG004|Treatment Period 2|Withdrawal by Subject|0
1006439|NCT01468207|2025166|FG005|Treatment Period 2|Withdrawal by Subject|2
1006440|NCT01468207|2025161|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0
1006441|NCT01468207|2025162|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0
1006442|NCT01468207|2025163|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30
1006443|NCT01468207|2025164|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23
1006444|NCT01468207|2025165|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18
1006445|NCT01468207|2025166|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13
1006446|NCT01468207|2025161|FG000|Treatment Period 2|Lost to Follow-up|0
1006447|NCT01468207|2025162|FG001|Treatment Period 2|Lost to Follow-up|0
1006448|NCT01468207|2025163|FG002|Treatment Period 2|Lost to Follow-up|5
1006449|NCT01468207|2025164|FG003|Treatment Period 2|Lost to Follow-up|1
1006450|NCT01468207|2025165|FG004|Treatment Period 2|Lost to Follow-up|0
1006451|NCT01468207|2025166|FG005|Treatment Period 2|Lost to Follow-up|0
1006452|NCT01468207|2025161|FG000|Treatment Period 2|Other|0
1006453|NCT01468207|2025162|FG001|Treatment Period 2|Other|0
1006454|NCT01468207|2025163|FG002|Treatment Period 2|Other|5
1006455|NCT01468207|2025164|FG003|Treatment Period 2|Other|1
1006456|NCT01468207|2025165|FG004|Treatment Period 2|Other|1
1006457|NCT01468207|2025166|FG005|Treatment Period 2|Other|2
1006458|NCT01468233|2025186|FG000|Treatment Period 1|Adverse Event|5
1006459|NCT01468233|2025187|FG001|Treatment Period 1|Adverse Event|3
1006460|NCT01468233|2025188|FG002|Treatment Period 1|Adverse Event|0
1006461|NCT01468233|2025189|FG003|Treatment Period 1|Adverse Event|0
1006462|NCT01468233|2025190|FG004|Treatment Period 1|Adverse Event|0
1006463|NCT01468233|2025191|FG005|Treatment Period 1|Adverse Event|0
1006464|NCT01468233|2025186|FG000|Treatment Period 1|Withdrawal by Subject|3
1006465|NCT01468233|2025187|FG001|Treatment Period 1|Withdrawal by Subject|4
1006466|NCT01468233|2025188|FG002|Treatment Period 1|Withdrawal by Subject|0
1006467|NCT01468233|2025189|FG003|Treatment Period 1|Withdrawal by Subject|0
1006468|NCT01468233|2025190|FG004|Treatment Period 1|Withdrawal by Subject|0
1006469|NCT01468233|2025191|FG005|Treatment Period 1|Withdrawal by Subject|0
1006470|NCT01468233|2025186|FG000|Treatment Period 1|Lost to Follow-up|3
1006471|NCT01468233|2025187|FG001|Treatment Period 1|Lost to Follow-up|0
1006472|NCT01468233|2025188|FG002|Treatment Period 1|Lost to Follow-up|0
1006473|NCT01468233|2025189|FG003|Treatment Period 1|Lost to Follow-up|0
1006474|NCT01468233|2025190|FG004|Treatment Period 1|Lost to Follow-up|0
1006475|NCT01468233|2025191|FG005|Treatment Period 1|Lost to Follow-up|0
1006476|NCT01468233|2025186|FG000|Treatment Period 1|Other|1
1006477|NCT01468233|2025187|FG001|Treatment Period 1|Other|1
1006478|NCT01468233|2025188|FG002|Treatment Period 1|Other|0
1006479|NCT01468233|2025189|FG003|Treatment Period 1|Other|0
1006480|NCT01468233|2025190|FG004|Treatment Period 1|Other|0
1006481|NCT01468233|2025191|FG005|Treatment Period 1|Other|0
1006482|NCT01468233|2025186|FG000|Treatment Period 2|Adverse Event|0
1006483|NCT01468233|2025187|FG001|Treatment Period 2|Adverse Event|0
1006484|NCT01468233|2025188|FG002|Treatment Period 2|Adverse Event|3
1006485|NCT01468233|2025189|FG003|Treatment Period 2|Adverse Event|0
1006486|NCT01468233|2025190|FG004|Treatment Period 2|Adverse Event|2
1006487|NCT01468233|2025191|FG005|Treatment Period 2|Adverse Event|1
1006488|NCT01468233|2025186|FG000|Treatment Period 2|Lack of Efficacy|0
1006489|NCT01468233|2025187|FG001|Treatment Period 2|Lack of Efficacy|0
1006490|NCT01468233|2025188|FG002|Treatment Period 2|Lack of Efficacy|9
1006491|NCT01468233|2025189|FG003|Treatment Period 2|Lack of Efficacy|2
1006492|NCT01468233|2025190|FG004|Treatment Period 2|Lack of Efficacy|0
1006493|NCT01468233|2025191|FG005|Treatment Period 2|Lack of Efficacy|1
1006494|NCT01468233|2025186|FG000|Treatment Period 2|Withdrawal by Subject|0
1006495|NCT01468233|2025187|FG001|Treatment Period 2|Withdrawal by Subject|0
1006496|NCT01468233|2025188|FG002|Treatment Period 2|Withdrawal by Subject|9
1006497|NCT01468233|2025189|FG003|Treatment Period 2|Withdrawal by Subject|1
1006498|NCT01468233|2025190|FG004|Treatment Period 2|Withdrawal by Subject|1
1006499|NCT01468233|2025191|FG005|Treatment Period 2|Withdrawal by Subject|1
1006500|NCT01468233|2025186|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0
1006501|NCT01468233|2025187|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0
1006502|NCT01468233|2025188|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84
1006503|NCT01468233|2025189|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25
1006504|NCT01468233|2025190|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22
1006505|NCT01468233|2025191|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20
1006506|NCT01468233|2025186|FG000|Treatment Period 2|Lost to Follow-up|0
1006507|NCT01468233|2025187|FG001|Treatment Period 2|Lost to Follow-up|0
1006508|NCT01468233|2025188|FG002|Treatment Period 2|Lost to Follow-up|3
1006509|NCT01468233|2025189|FG003|Treatment Period 2|Lost to Follow-up|0
1006510|NCT01468233|2025190|FG004|Treatment Period 2|Lost to Follow-up|2
1006511|NCT01468233|2025191|FG005|Treatment Period 2|Lost to Follow-up|0
1006512|NCT01468233|2025186|FG000|Treatment Period 2|Other|0
1006513|NCT01468233|2025187|FG001|Treatment Period 2|Other|0
1006514|NCT01468233|2025188|FG002|Treatment Period 2|Other|3
1006515|NCT01468233|2025189|FG003|Treatment Period 2|Other|0
1006516|NCT01468233|2025190|FG004|Treatment Period 2|Other|1
1006517|NCT01468233|2025191|FG005|Treatment Period 2|Other|0
1006518|NCT01468311|2025209|FG000|Overall Study|mobilization failure|1
1006519|NCT01468311|2025209|FG000|Overall Study|Withdrawal by Subject|1
1006520|NCT01468454|2025234|FG000|Overall Study|Did not have surgery after PET|9
1006521|NCT01468597|2025255|FG000|Overall Study|Found ineligible|17
1006522|NCT01468597|2025255|FG000|Overall Study|concomitant valves|12
1006523|NCT01468597|2025255|FG000|Overall Study|off-pump CABG|1
1006524|NCT01468597|2025255|FG000|Overall Study|no platelet function data|5
1006525|NCT01468701|2025285|FG000|Overall Study|Not eligible|91
1006526|NCT01468701|2025286|FG001|Overall Study|Not eligible|140
1006527|NCT01468701|2025287|FG002|Overall Study|Not eligible|29
1006528|NCT01468701|2025288|FG003|Overall Study|Not eligible|12
1006529|NCT01468701|2025289|FG004|Overall Study|Not eligible|22
1006530|NCT01468701|2025290|FG005|Overall Study|Not eligible|2
1006531|NCT01468701|2025291|FG006|Overall Study|Not eligible|39
1006532|NCT01468701|2025292|FG007|Overall Study|Not eligible|1
1006533|NCT01468701|2025293|FG008|Overall Study|Not eligible|40
1006534|NCT01468701|2025294|FG009|Overall Study|Not eligible|126
1006535|NCT01468701|2025295|FG010|Overall Study|Not eligible|39
1006536|NCT01468701|2025296|FG011|Overall Study|Not eligible|33
1006537|NCT01468701|2025297|FG012|Overall Study|Not eligible|1
1006538|NCT01468701|2025298|FG013|Overall Study|Not eligible|19
1006539|NCT01468701|2025299|FG014|Overall Study|Not eligible|1
1006540|NCT01468701|2025300|FG015|Overall Study|Not eligible|32
1006541|NCT01468701|2025301|FG016|Overall Study|Not eligible|0
1006542|NCT01468701|2025285|FG000|Overall Study|Lost to Follow-up|306
1006543|NCT01468701|2025286|FG001|Overall Study|Lost to Follow-up|0
1006544|NCT01468701|2025287|FG002|Overall Study|Lost to Follow-up|0
1006545|NCT01468701|2025288|FG003|Overall Study|Lost to Follow-up|0
1006546|NCT01468701|2025289|FG004|Overall Study|Lost to Follow-up|0
1006547|NCT01468701|2025290|FG005|Overall Study|Lost to Follow-up|0
1006548|NCT01468701|2025291|FG006|Overall Study|Lost to Follow-up|0
1006549|NCT01468701|2025292|FG007|Overall Study|Lost to Follow-up|0
1006550|NCT01468701|2025293|FG008|Overall Study|Lost to Follow-up|215
1006551|NCT01468701|2025294|FG009|Overall Study|Lost to Follow-up|309
1006552|NCT01468701|2025295|FG010|Overall Study|Lost to Follow-up|224
1006553|NCT01468701|2025296|FG011|Overall Study|Lost to Follow-up|212
1006554|NCT01468701|2025297|FG012|Overall Study|Lost to Follow-up|11
1006555|NCT01468701|2025298|FG013|Overall Study|Lost to Follow-up|164
1006556|NCT01468701|2025299|FG014|Overall Study|Lost to Follow-up|17
1006557|NCT01468701|2025300|FG015|Overall Study|Lost to Follow-up|127
1006558|NCT01468701|2025301|FG016|Overall Study|Lost to Follow-up|1
1006559|NCT01468701|2025285|FG000|Overall Study|Withdrawal by Subject|165
1006560|NCT01468701|2025286|FG001|Overall Study|Withdrawal by Subject|0
1006561|NCT01468701|2025287|FG002|Overall Study|Withdrawal by Subject|0
1006562|NCT01468701|2025288|FG003|Overall Study|Withdrawal by Subject|0
1006563|NCT01468701|2025289|FG004|Overall Study|Withdrawal by Subject|0
1006564|NCT01468701|2025290|FG005|Overall Study|Withdrawal by Subject|0
1006565|NCT01468701|2025291|FG006|Overall Study|Withdrawal by Subject|0
1006566|NCT01468701|2025292|FG007|Overall Study|Withdrawal by Subject|0
1006567|NCT01468701|2025293|FG008|Overall Study|Withdrawal by Subject|83
1006568|NCT01468701|2025294|FG009|Overall Study|Withdrawal by Subject|88
1006569|NCT01468701|2025295|FG010|Overall Study|Withdrawal by Subject|100
1006570|NCT01468701|2025296|FG011|Overall Study|Withdrawal by Subject|114
1006571|NCT01468701|2025297|FG012|Overall Study|Withdrawal by Subject|9
1006572|NCT01468701|2025298|FG013|Overall Study|Withdrawal by Subject|47
1006573|NCT01468701|2025299|FG014|Overall Study|Withdrawal by Subject|6
1006574|NCT01468701|2025300|FG015|Overall Study|Withdrawal by Subject|31
1006575|NCT01468701|2025301|FG016|Overall Study|Withdrawal by Subject|0
1006576|NCT01468701|2025285|FG000|Overall Study|Other reasons than listed|437
1006577|NCT01468701|2025286|FG001|Overall Study|Other reasons than listed|0
1006578|NCT01468701|2025287|FG002|Overall Study|Other reasons than listed|0
1006760|NCT01469221|2025489|FG000|Double Blind Phase|Sponsor Terminate Study|12
1006761|NCT01469221|2025490|FG001|Double Blind Phase|Sponsor Terminate Study|16
1006762|NCT01469221|2025491|FG002|Double Blind Phase|Sponsor Terminate Study|0
1006763|NCT01469364|2025511|FG000|Overall Study|Adverse Event|1
1006764|NCT01469364|2025511|FG000|Overall Study|Withdrawal by Subject|1
1006765|NCT01469377|2025518|FG000|Overall Study|Protocol Deviation|7
1006766|NCT01469377|2025519|FG001|Overall Study|Protocol Deviation|10
1006767|NCT01469377|2025520|FG002|Overall Study|Protocol Deviation|10
1006768|NCT01469377|2025518|FG000|Overall Study|Lost to Follow-up|3
1006769|NCT01469377|2025519|FG001|Overall Study|Lost to Follow-up|2
1006770|NCT01469377|2025520|FG002|Overall Study|Lost to Follow-up|5
1006771|NCT01469377|2025518|FG000|Overall Study|Withdrawal of Consent|12
1006772|NCT01469377|2025519|FG001|Overall Study|Withdrawal of Consent|14
1006773|NCT01469377|2025520|FG002|Overall Study|Withdrawal of Consent|15
1006774|NCT01469377|2025518|FG000|Overall Study|Adverse Event|8
1006775|NCT01469377|2025519|FG001|Overall Study|Adverse Event|18
1006776|NCT01469377|2025520|FG002|Overall Study|Adverse Event|36
1006777|NCT01469377|2025518|FG000|Overall Study|Insufficient Therapeutic Response|3
1006778|NCT01469377|2025519|FG001|Overall Study|Insufficient Therapeutic Response|4
1006779|NCT01469377|2025520|FG002|Overall Study|Insufficient Therapeutic Response|0
1006780|NCT01469377|2025518|FG000|Overall Study|Other Miscellaneous Reasons|2
1006781|NCT01469377|2025519|FG001|Overall Study|Other Miscellaneous Reasons|0
1006782|NCT01469377|2025520|FG002|Overall Study|Other Miscellaneous Reasons|0
1006783|NCT01469546|2025528|FG000|Received 5 mg Dose|Adverse Event|13
1006784|NCT01469546|2025528|FG000|Received 5 mg Dose|Death|2
1006785|NCT01469546|2025528|FG000|Received 5 mg Dose|Protocol Violation|2
1006786|NCT01469546|2025528|FG000|Received 5 mg Dose|Progressive Disease|3
1006787|NCT01469546|2025528|FG000|Received 5 mg Dose|Physician Decision|3
1006788|NCT01469637|2025545|FG000|First Intervention|Unacceptable behavior|0
1006789|NCT01469637|2025546|FG001|First Intervention|Unacceptable behavior|1
1006790|NCT01469637|2025545|FG000|Second Intervention|Incarcerated|1
1006791|NCT01469637|2025546|FG001|Second Intervention|Incarcerated|0
1006792|NCT01469819|2025560|FG000|Overall Study|Withdrawal by Subject|1
1006793|NCT01469819|2025560|FG000|Overall Study|Did not meet inclusionary criteria|2
1006794|NCT01469819|2025560|FG000|Overall Study|Could not swallow SmartPill|2
1006795|NCT01469819|2025560|FG000|Overall Study|Technical malfunction of SmartPill data|3
1006796|NCT01470001|2025572|FG000|Overall Study|Lost to Follow-up|1
1006797|NCT01470001|2025573|FG001|Overall Study|Lost to Follow-up|1
1006798|NCT01470001|2025572|FG000|Overall Study|Physician Decision|2
1006799|NCT01470001|2025573|FG001|Overall Study|Physician Decision|0
1006800|NCT01470001|2025572|FG000|Overall Study|Withdrawal by Subject|2
1006801|NCT01470001|2025573|FG001|Overall Study|Withdrawal by Subject|1
1006802|NCT01470144|2025614|FG000|Overall Study|Adverse Event|2
1006803|NCT01470144|2025614|FG000|Overall Study|Death|1
1006804|NCT01470144|2025614|FG000|Overall Study|Lung transplant|6
1006805|NCT01470144|2025614|FG000|Overall Study|Patient's and investigator's decision|1
1006806|NCT01470248|2025643|FG000|Overall Study|Withdrawal by Subject|1
1006807|NCT01470417|2025653|FG000|Overall Study|Disease progression|0
1006808|NCT01470417|2025654|FG001|Overall Study|Disease progression|2
1006809|NCT01470469|2025662|FG000|Overall Study|Withdrawal by Subject|4
1006810|NCT01470469|2025663|FG001|Overall Study|Withdrawal by Subject|6
1006811|NCT01470469|2025662|FG000|Overall Study|Lack of Efficacy|1
1006812|NCT01470469|2025663|FG001|Overall Study|Lack of Efficacy|7
1006813|NCT01470469|2025662|FG000|Overall Study|Adverse Event|0
1006814|NCT01470469|2025663|FG001|Overall Study|Adverse Event|7
1006815|NCT01470469|2025662|FG000|Overall Study|Lost to Follow-up|2
1006816|NCT01470469|2025663|FG001|Overall Study|Lost to Follow-up|2
1006817|NCT01470469|2025662|FG000|Overall Study|Protocol Violation|1
1006818|NCT01470469|2025663|FG001|Overall Study|Protocol Violation|1
1006819|NCT01470469|2025662|FG000|Overall Study|Other|2
1006820|NCT01470469|2025663|FG001|Overall Study|Other|1
1006821|NCT01470599|2025671|FG000|Overall Study|Did not meet entrance criteria|1
1006822|NCT01470599|2025672|FG001|Overall Study|Did not meet entrance criteria|0
1006823|NCT01470599|2025671|FG000|Overall Study|Lost to Follow-up|2
1006824|NCT01470599|2025672|FG001|Overall Study|Lost to Follow-up|1
1006825|NCT01470599|2025671|FG000|Overall Study|Withdrawal by Subject|3
1006826|NCT01470599|2025672|FG001|Overall Study|Withdrawal by Subject|4
1006827|NCT01470599|2025671|FG000|Overall Study|Other|1
1006828|NCT01470599|2025672|FG001|Overall Study|Other|0
1006829|NCT01470599|2025671|FG000|Overall Study|Protocol Violation|3
1006830|NCT01470599|2025672|FG001|Overall Study|Protocol Violation|1
1006831|NCT01470599|2025671|FG000|Overall Study|Adverse event related to study drug|2
1006832|NCT01470599|2025672|FG001|Overall Study|Adverse event related to study drug|5
1006833|NCT01470599|2025671|FG000|Overall Study|Insufficient clinical response|6
1006834|NCT01470599|2025672|FG001|Overall Study|Insufficient clinical response|27
1006835|NCT01470599|2025671|FG000|Overall Study|Adverse event not related to study drug|1
1006836|NCT01470599|2025672|FG001|Overall Study|Adverse event not related to study drug|5
1006837|NCT01470612|2025680|FG000|Overall Study|Adverse Event|20
1006838|NCT01470612|2025681|FG001|Overall Study|Adverse Event|80
1006839|NCT01470612|2025680|FG000|Overall Study|Death|0
1006840|NCT01470612|2025681|FG001|Overall Study|Death|1
1006841|NCT01470612|2025680|FG000|Overall Study|Lack of Efficacy|20
1006842|NCT01470612|2025681|FG001|Overall Study|Lack of Efficacy|326
1006843|NCT01470612|2025680|FG000|Overall Study|Lost to Follow-up|2
1006844|NCT01470612|2025681|FG001|Overall Study|Lost to Follow-up|5
1006845|NCT01470612|2025680|FG000|Overall Study|Did not meet entrance criteria|0
1006846|NCT01470612|2025681|FG001|Overall Study|Did not meet entrance criteria|1
1006847|NCT01470612|2025680|FG000|Overall Study|Pregnancy|2
1006848|NCT01470612|2025681|FG001|Overall Study|Pregnancy|10
1006849|NCT01470612|2025680|FG000|Overall Study|Protocol Violation|2
1006850|NCT01470612|2025681|FG001|Overall Study|Protocol Violation|7
1006851|NCT01470612|2025680|FG000|Overall Study|Withdrawal by Subject|24
1006852|NCT01470612|2025681|FG001|Overall Study|Withdrawal by Subject|79
1006853|NCT01470612|2025680|FG000|Overall Study|Other|14
1006854|NCT01470612|2025681|FG001|Overall Study|Other|156
1006855|NCT01470989|2025717|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103
1006856|NCT01470989|2025718|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136
1006857|NCT01470989|2025717|FG000|Overall Study|Adverse Event|2
1006858|NCT01470989|2025718|FG001|Overall Study|Adverse Event|5
1006859|NCT01470989|2025717|FG000|Overall Study|Abnormal laboratory value|1
1006860|NCT01470989|2025718|FG001|Overall Study|Abnormal laboratory value|1
1006861|NCT01470989|2025717|FG000|Overall Study|Unsatisfactory therapeutic effect|0
1006862|NCT01470989|2025718|FG001|Overall Study|Unsatisfactory therapeutic effect|6
1006863|NCT01470989|2025717|FG000|Overall Study|Withdrawal by Subject|19
1006864|NCT01470989|2025718|FG001|Overall Study|Withdrawal by Subject|17
1006865|NCT01470989|2025717|FG000|Overall Study|Lost to Follow-up|18
1006866|NCT01470989|2025718|FG001|Overall Study|Lost to Follow-up|13
1006867|NCT01470989|2025717|FG000|Overall Study|Administrative problems|2
1006868|NCT01470989|2025718|FG001|Overall Study|Administrative problems|4
1006869|NCT01470989|2025717|FG000|Overall Study|Death|2
1006870|NCT01470989|2025718|FG001|Overall Study|Death|2
1006871|NCT01470989|2025717|FG000|Overall Study|Protocol deviation|1
1006872|NCT01470989|2025718|FG001|Overall Study|Protocol deviation|2
1006873|NCT01471015|2025729|FG000|Overall Study|Death|0
1006874|NCT01471015|2025730|FG001|Overall Study|Death|1
1006875|NCT01471015|2025731|FG002|Overall Study|Death|1
1006876|NCT01471028|2025741|FG000|VTI-208|Adverse Event|39
1006877|NCT01471028|2025742|FG001|VTI-208|Adverse Event|41
1006878|NCT01471028|2025741|FG000|VTI-208|Withdrawal by Subject|0
1006879|NCT01471028|2025742|FG001|VTI-208|Withdrawal by Subject|2
1006880|NCT01471028|2025741|FG000|VTI-208|Lost to Follow-up|1
1006881|NCT01471028|2025742|FG001|VTI-208|Lost to Follow-up|1
1006882|NCT01471028|2025741|FG000|VTI-208E|Death|7
1006883|NCT01471028|2025742|FG001|VTI-208E|Death|10
1006884|NCT01471028|2025741|FG000|VTI-208E|Withdrawal by Subject|1
1006885|NCT01471028|2025742|FG001|VTI-208E|Withdrawal by Subject|0
1006886|NCT01471028|2025741|FG000|VTI-208E|Lost to Follow-up|0
1006887|NCT01471028|2025742|FG001|VTI-208E|Lost to Follow-up|2
1006888|NCT01471054|2025757|FG000|Overall Study|Study terminated prematurely|4
1006889|NCT01471054|2025758|FG001|Overall Study|Study terminated prematurely|0
1006890|NCT01471093|2025776|FG000|Overall Study|Adverse Event|1
1006891|NCT01471093|2025777|FG001|Overall Study|Adverse Event|0
1006892|NCT01471093|2025778|FG002|Overall Study|Adverse Event|0
1006893|NCT01471093|2025779|FG003|Overall Study|Adverse Event|0
1006894|NCT01471171|2025785|FG000|Treatment Period 1|Adverse Event|4
1006895|NCT01471171|2025786|FG001|Treatment Period 1|Adverse Event|1
1006896|NCT01471171|2025785|FG000|Treatment Period 2|Adverse Event|1
1006897|NCT01471171|2025786|FG001|Treatment Period 2|Adverse Event|0
1006898|NCT01471197|2025794|FG000|Overall Study|Disease Progression|4
1006899|NCT01471197|2025795|FG001|Overall Study|Disease Progression|2
1006900|NCT01471197|2025794|FG000|Overall Study|Death|1
1006901|NCT01471197|2025795|FG001|Overall Study|Death|0
1006902|NCT01471197|2025794|FG000|Overall Study|Study Drug Toxicity|1
1006903|NCT01471197|2025795|FG001|Overall Study|Study Drug Toxicity|0
1006904|NCT01471340|2025803|FG000|Overall Study|Death|5
1006905|NCT01471340|2025804|FG001|Overall Study|Death|4
1006906|NCT01471340|2025803|FG000|Overall Study|Lost to Follow-up|0
1006907|NCT01471340|2025804|FG001|Overall Study|Lost to Follow-up|1
1006908|NCT01471340|2025803|FG000|Overall Study|Investigational site closure|0
1006909|NCT01471340|2025804|FG001|Overall Study|Investigational site closure|1
1006910|NCT01471340|2025803|FG000|Overall Study|Invalid informed consent|1
1006911|NCT01471340|2025804|FG001|Overall Study|Invalid informed consent|0
1006912|NCT01471353|2025810|FG000|Overall Study|remain on study|3
1006913|NCT01471379|2025817|FG000|Overall Study|Adverse Event|1
1006914|NCT01471379|2025818|FG001|Overall Study|Adverse Event|0
1006915|NCT01471379|2025819|FG002|Overall Study|Adverse Event|0
1006916|NCT01471379|2025817|FG000|Overall Study|Study terminated|0
1006917|NCT01471379|2025818|FG001|Overall Study|Study terminated|1
1006918|NCT01471379|2025819|FG002|Overall Study|Study terminated|0
1006919|NCT01471522|2025839|FG000|Overall Study|Withdrawal by Subject|28
1006920|NCT01471522|2025840|FG001|Overall Study|Withdrawal by Subject|22
1006921|NCT01471522|2025839|FG000|Overall Study|Lost to Follow-up|36
1006922|NCT01471522|2025840|FG001|Overall Study|Lost to Follow-up|26
1006923|NCT01471574|2025851|FG000|Treatment Period|Lack of Efficacy|12
1006924|NCT01471574|2025852|FG001|Treatment Period|Lack of Efficacy|4
1006925|NCT01471574|2025853|FG002|Treatment Period|Lack of Efficacy|14
1006926|NCT01471574|2025854|FG003|Treatment Period|Lack of Efficacy|1
1006927|NCT01471574|2025851|FG000|Treatment Period|Adverse Event|7
1006928|NCT01471574|2025852|FG001|Treatment Period|Adverse Event|3
1006929|NCT01471574|2025853|FG002|Treatment Period|Adverse Event|6
1006930|NCT01471574|2025854|FG003|Treatment Period|Adverse Event|1
1006931|NCT01471574|2025851|FG000|Treatment Period|Withdrawal by Subject|5
1006932|NCT01471574|2025852|FG001|Treatment Period|Withdrawal by Subject|1
1006933|NCT01471574|2025853|FG002|Treatment Period|Withdrawal by Subject|1
1006934|NCT01471574|2025854|FG003|Treatment Period|Withdrawal by Subject|0
1006935|NCT01471574|2025851|FG000|Treatment Period|Patient Requested Discontinue Study drug|4
1006936|NCT01471574|2025852|FG001|Treatment Period|Patient Requested Discontinue Study drug|0
1006937|NCT01471574|2025853|FG002|Treatment Period|Patient Requested Discontinue Study drug|1
1006938|NCT01471574|2025854|FG003|Treatment Period|Patient Requested Discontinue Study drug|1
1006939|NCT01471574|2025851|FG000|Treatment Period|Lost to Follow-up|1
1006940|NCT01471574|2025852|FG001|Treatment Period|Lost to Follow-up|2
1006941|NCT01471574|2025853|FG002|Treatment Period|Lost to Follow-up|2
1006942|NCT01471574|2025854|FG003|Treatment Period|Lost to Follow-up|0
1006943|NCT01471574|2025851|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1
1006944|NCT01471574|2025852|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0
1006945|NCT01471574|2025853|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0
1006946|NCT01471574|2025854|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0
1006947|NCT01471574|2025851|FG000|Treatment Period|Other|1
1006948|NCT01471574|2025852|FG001|Treatment Period|Other|0
1006949|NCT01471574|2025853|FG002|Treatment Period|Other|0
1006950|NCT01471574|2025854|FG003|Treatment Period|Other|0
1006951|NCT01471574|2025851|FG000|Follow-up Period|Withdrawal by Subject|3
1006952|NCT01471574|2025852|FG001|Follow-up Period|Withdrawal by Subject|0
1006953|NCT01471574|2025853|FG002|Follow-up Period|Withdrawal by Subject|3
1006954|NCT01471574|2025854|FG003|Follow-up Period|Withdrawal by Subject|1
1006955|NCT01471574|2025851|FG000|Follow-up Period|Lost to Follow-up|4
1006956|NCT01471574|2025852|FG001|Follow-up Period|Lost to Follow-up|1
1006957|NCT01471574|2025853|FG002|Follow-up Period|Lost to Follow-up|3
1006958|NCT01471574|2025854|FG003|Follow-up Period|Lost to Follow-up|2
1006959|NCT01471574|2025851|FG000|Follow-up Period|Death|0
1006960|NCT01471574|2025852|FG001|Follow-up Period|Death|0
1006961|NCT01471574|2025853|FG002|Follow-up Period|Death|1
1006962|NCT01471574|2025854|FG003|Follow-up Period|Death|0
1006963|NCT01471574|2025851|FG000|Follow-up Period|Follow-up no longer required|0
1006964|NCT01471574|2025852|FG001|Follow-up Period|Follow-up no longer required|1
1006965|NCT01471574|2025853|FG002|Follow-up Period|Follow-up no longer required|0
1006966|NCT01471574|2025854|FG003|Follow-up Period|Follow-up no longer required|0
1006967|NCT01471691|2025880|FG000|Overall Study|Lack of Efficacy|0
1006968|NCT01471691|2025881|FG001|Overall Study|Lack of Efficacy|1
1006969|NCT01471782|2025893|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2
1006970|NCT01471782|2025894|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2
1006971|NCT01471782|2025895|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1
1006972|NCT01471782|2025896|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0
1006973|NCT01471782|2025897|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5
1006974|NCT01471782|2025898|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3
1006975|NCT01471782|2025893|FG000|Overall Study|Lack of Efficacy|1
1006976|NCT01471782|2025894|FG001|Overall Study|Lack of Efficacy|2
1006977|NCT01471782|2025895|FG002|Overall Study|Lack of Efficacy|1
1006978|NCT01471782|2025896|FG003|Overall Study|Lack of Efficacy|1
1006979|NCT01471782|2025897|FG004|Overall Study|Lack of Efficacy|5
1006980|NCT01471782|2025898|FG005|Overall Study|Lack of Efficacy|18
1006981|NCT01471782|2025893|FG000|Overall Study|Adverse Event|1
1006982|NCT01471782|2025894|FG001|Overall Study|Adverse Event|1
1006983|NCT01471782|2025895|FG002|Overall Study|Adverse Event|2
1006984|NCT01471782|2025896|FG003|Overall Study|Adverse Event|2
1006985|NCT01471782|2025897|FG004|Overall Study|Adverse Event|3
1006986|NCT01471782|2025898|FG005|Overall Study|Adverse Event|1
1006987|NCT01471782|2025893|FG000|Overall Study|Other|0
1006988|NCT01471782|2025894|FG001|Overall Study|Other|0
1006989|NCT01471782|2025895|FG002|Overall Study|Other|1
1006990|NCT01471782|2025896|FG003|Overall Study|Other|1
1006991|NCT01471782|2025897|FG004|Overall Study|Other|6
1006992|NCT01471782|2025898|FG005|Overall Study|Other|5
1006993|NCT01471782|2025893|FG000|Overall Study|Change of Chemotherapy|1
1006994|NCT01471782|2025894|FG001|Overall Study|Change of Chemotherapy|1
1006995|NCT01471782|2025895|FG002|Overall Study|Change of Chemotherapy|0
1006996|NCT01471782|2025896|FG003|Overall Study|Change of Chemotherapy|0
1006997|NCT01471782|2025897|FG004|Overall Study|Change of Chemotherapy|1
1006998|NCT01471782|2025898|FG005|Overall Study|Change of Chemotherapy|4
1006999|NCT01471782|2025893|FG000|Overall Study|Disease Relapse|0
1007000|NCT01471782|2025894|FG001|Overall Study|Disease Relapse|0
1007001|NCT01471782|2025895|FG002|Overall Study|Disease Relapse|0
1007002|NCT01471782|2025896|FG003|Overall Study|Disease Relapse|1
1007003|NCT01471782|2025897|FG004|Overall Study|Disease Relapse|2
1007004|NCT01471782|2025898|FG005|Overall Study|Disease Relapse|1
1007005|NCT01471782|2025893|FG000|Overall Study|Physician Decision|0
1007006|NCT01471782|2025894|FG001|Overall Study|Physician Decision|0
1007007|NCT01471782|2025895|FG002|Overall Study|Physician Decision|0
1007008|NCT01471782|2025896|FG003|Overall Study|Physician Decision|0
1007009|NCT01471782|2025897|FG004|Overall Study|Physician Decision|3
1007010|NCT01471782|2025898|FG005|Overall Study|Physician Decision|8
1007011|NCT01471782|2025893|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1007012|NCT01471782|2025894|FG001|Overall Study|Withdrawal by Parent/Guardian|0
1007013|NCT01471782|2025895|FG002|Overall Study|Withdrawal by Parent/Guardian|0
1007014|NCT01471782|2025896|FG003|Overall Study|Withdrawal by Parent/Guardian|0
1007015|NCT01471782|2025897|FG004|Overall Study|Withdrawal by Parent/Guardian|1
1007016|NCT01471782|2025898|FG005|Overall Study|Withdrawal by Parent/Guardian|0
1007017|NCT01471782|2025893|FG000|Overall Study|Death|0
1007018|NCT01471782|2025894|FG001|Overall Study|Death|0
1007019|NCT01471782|2025895|FG002|Overall Study|Death|0
1007020|NCT01471782|2025896|FG003|Overall Study|Death|0
1007021|NCT01471782|2025897|FG004|Overall Study|Death|0
1007022|NCT01471782|2025898|FG005|Overall Study|Death|1
1007023|NCT01472185|2025925|FG000|Overall Study|Randomized but Not Treated|0
1007024|NCT01472185|2025926|FG001|Overall Study|Randomized but Not Treated|1
1007025|NCT01472185|2025925|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3
1007026|NCT01472185|2025926|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10
1007027|NCT01472185|2025925|FG000|Overall Study|Hyperglycemia|5
1007028|NCT01472185|2025926|FG001|Overall Study|Hyperglycemia|2
1007029|NCT01472185|2025925|FG000|Overall Study|Investigator's Discretion|3
1007030|NCT01472185|2025926|FG001|Overall Study|Investigator's Discretion|1
1007031|NCT01472185|2025925|FG000|Overall Study|Lost to Follow-up|4
1007032|NCT01472185|2025926|FG001|Overall Study|Lost to Follow-up|1
1007033|NCT01472185|2025925|FG000|Overall Study|Protocol Violation|5
1007034|NCT01472185|2025926|FG001|Overall Study|Protocol Violation|1
1007035|NCT01472185|2025925|FG000|Overall Study|Subject Noncompliance|8
1007036|NCT01472185|2025926|FG001|Overall Study|Subject Noncompliance|15
1007037|NCT01472185|2025925|FG000|Overall Study|Subject Withdrew Consent|6
1007038|NCT01472185|2025926|FG001|Overall Study|Subject Withdrew Consent|3
1007039|NCT01472289|2025932|FG000|Overall Study|Death|2
1007040|NCT01472341|2025936|FG000|Overall Study|Started insulin therapy|55
1007041|NCT01472341|2025936|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92
1007042|NCT01472341|2025936|FG000|Overall Study|Withdrawal by Subject|39
1007043|NCT01472341|2025936|FG000|Overall Study|Lost to Follow-up|52
1007044|NCT01472341|2025936|FG000|Overall Study|Laboratory parameters unavailable|25
1007045|NCT01472341|2025936|FG000|Overall Study|Death|9
1007046|NCT01472380|2025940|FG000|Efavirenz Alone|Withdrawal by Subject|1
1007047|NCT01472380|2025940|FG000|1 Day Period Between Dosing|Protocol Violation|1
1007048|NCT01472757|2025995|FG000|Overall Study|Withdrawal by Subject|1
1007049|NCT01472757|2025996|FG001|Overall Study|Withdrawal by Subject|2
1007050|NCT01472757|2025997|FG002|Overall Study|Withdrawal by Subject|2
1007051|NCT01472757|2025998|FG003|Overall Study|Withdrawal by Subject|0
1007052|NCT01472757|2025995|FG000|Overall Study|Asthma exacerbation|4
1007053|NCT01472757|2025996|FG001|Overall Study|Asthma exacerbation|1
1007054|NCT01472757|2025997|FG002|Overall Study|Asthma exacerbation|2
1007055|NCT01472757|2025998|FG003|Overall Study|Asthma exacerbation|1
1007056|NCT01472757|2025995|FG000|Overall Study|Treatment period withdrawal criteria met|21
1007057|NCT01472757|2025996|FG001|Overall Study|Treatment period withdrawal criteria met|8
1007058|NCT01472757|2025997|FG002|Overall Study|Treatment period withdrawal criteria met|9
1007059|NCT01472757|2025998|FG003|Overall Study|Treatment period withdrawal criteria met|12
1007060|NCT01472757|2025995|FG000|Overall Study|Protocol Violation|3
1007061|NCT01472757|2025996|FG001|Overall Study|Protocol Violation|2
1007062|NCT01472757|2025997|FG002|Overall Study|Protocol Violation|4
1007063|NCT01472757|2025998|FG003|Overall Study|Protocol Violation|4
1007064|NCT01472757|2025995|FG000|Overall Study|Other reasons|1
1007065|NCT01472757|2025996|FG001|Overall Study|Other reasons|0
1007066|NCT01472757|2025997|FG002|Overall Study|Other reasons|2
1007067|NCT01472757|2025998|FG003|Overall Study|Other reasons|2
1007068|NCT01472835|2026019|FG000|Overall Study|Lost to Follow-up|2
1007069|NCT01472835|2026020|FG001|Overall Study|Lost to Follow-up|0
1007070|NCT01472939|2026037|FG000|Overall Study|Adverse Event|3
1007071|NCT01472939|2026038|FG001|Overall Study|Adverse Event|7
1007072|NCT01472939|2026039|FG002|Overall Study|Adverse Event|7
1007073|NCT01472939|2026040|FG003|Overall Study|Adverse Event|14
1007074|NCT01472939|2026037|FG000|Overall Study|Lack of Efficacy|1
1007075|NCT01472939|2026038|FG001|Overall Study|Lack of Efficacy|0
1007076|NCT01472939|2026039|FG002|Overall Study|Lack of Efficacy|0
1007077|NCT01472939|2026040|FG003|Overall Study|Lack of Efficacy|1
1007078|NCT01472939|2026037|FG000|Overall Study|Lost to Follow-up|3
1007079|NCT01472939|2026038|FG001|Overall Study|Lost to Follow-up|0
1007080|NCT01472939|2026039|FG002|Overall Study|Lost to Follow-up|2
1007081|NCT01472939|2026040|FG003|Overall Study|Lost to Follow-up|0
1007082|NCT01472939|2026037|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0
1007083|NCT01472939|2026038|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0
1007084|NCT01472939|2026039|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1
1007085|NCT01472939|2026040|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0
1007086|NCT01472939|2026037|FG000|Overall Study|Prohibited Medication|0
1007087|NCT01472939|2026038|FG001|Overall Study|Prohibited Medication|1
1007088|NCT01472939|2026039|FG002|Overall Study|Prohibited Medication|0
1007089|NCT01472939|2026040|FG003|Overall Study|Prohibited Medication|0
1007090|NCT01472939|2026037|FG000|Overall Study|Withdrawal By PI|1
1007091|NCT01472939|2026038|FG001|Overall Study|Withdrawal By PI|0
1007092|NCT01472939|2026039|FG002|Overall Study|Withdrawal By PI|0
1007093|NCT01472939|2026040|FG003|Overall Study|Withdrawal By PI|0
1007094|NCT01472939|2026037|FG000|Overall Study|Protocol Violation|3
1007095|NCT01472939|2026038|FG001|Overall Study|Protocol Violation|3
1007096|NCT01472939|2026039|FG002|Overall Study|Protocol Violation|0
1007097|NCT01472939|2026040|FG003|Overall Study|Protocol Violation|1
1007098|NCT01472939|2026037|FG000|Overall Study|Withdrawal by Subject|9
1007099|NCT01472939|2026038|FG001|Overall Study|Withdrawal by Subject|3
1007100|NCT01472939|2026039|FG002|Overall Study|Withdrawal by Subject|1
1007101|NCT01472939|2026040|FG003|Overall Study|Withdrawal by Subject|4
1007102|NCT01472965|2026055|FG000|Overall Study|Withdrawal by Subject|1
1007103|NCT01472965|2026056|FG001|Overall Study|Withdrawal by Subject|0
1007104|NCT01473355|2026068|FG000|Overall Study|Protocol Violation|2
1007105|NCT01473355|2026068|FG000|Overall Study|Adverse Event|2
1007106|NCT01473355|2026068|FG000|Overall Study|Lost to Follow-up|2
1007107|NCT01473381|2026109|FG000|Overall Study|Adverse Event|8
1007108|NCT01473381|2026110|FG001|Overall Study|Adverse Event|20
1007109|NCT01473381|2026111|FG002|Overall Study|Adverse Event|25
1007110|NCT01473381|2026112|FG003|Overall Study|Adverse Event|17
1007111|NCT01473381|2026109|FG000|Overall Study|Insufficient Therapeutic Response|10
1007112|NCT01473381|2026110|FG001|Overall Study|Insufficient Therapeutic Response|1
1007113|NCT01473381|2026111|FG002|Overall Study|Insufficient Therapeutic Response|2
1007114|NCT01473381|2026112|FG003|Overall Study|Insufficient Therapeutic Response|3
1007115|NCT01473381|2026109|FG000|Overall Study|Protocol Violation|17
1007116|NCT01473381|2026110|FG001|Overall Study|Protocol Violation|23
1007117|NCT01473381|2026111|FG002|Overall Study|Protocol Violation|19
1007118|NCT01473381|2026112|FG003|Overall Study|Protocol Violation|17
1007119|NCT01473381|2026109|FG000|Overall Study|Withdrawal of Consent|20
1007120|NCT01473381|2026110|FG001|Overall Study|Withdrawal of Consent|21
1007121|NCT01473381|2026111|FG002|Overall Study|Withdrawal of Consent|20
1007122|NCT01473381|2026112|FG003|Overall Study|Withdrawal of Consent|26
1007123|NCT01473381|2026109|FG000|Overall Study|Lost to Follow-up|25
1007124|NCT01473381|2026110|FG001|Overall Study|Lost to Follow-up|28
1007125|NCT01473381|2026111|FG002|Overall Study|Lost to Follow-up|35
1007126|NCT01473381|2026112|FG003|Overall Study|Lost to Follow-up|23
1007127|NCT01473381|2026109|FG000|Overall Study|Other Reasons|0
1007128|NCT01473381|2026110|FG001|Overall Study|Other Reasons|0
1007129|NCT01473381|2026111|FG002|Overall Study|Other Reasons|1
1007130|NCT01473381|2026112|FG003|Overall Study|Other Reasons|3
1007131|NCT01473394|2026125|FG000|Overall Study|Adverse Event|13
1007132|NCT01473394|2026126|FG001|Overall Study|Adverse Event|16
1007133|NCT01473394|2026125|FG000|Overall Study|Insufficient Therapeutic Response|4
1007134|NCT01473394|2026126|FG001|Overall Study|Insufficient Therapeutic Response|1
1007135|NCT01473394|2026125|FG000|Overall Study|Protocol Violation|7
1007136|NCT01473394|2026126|FG001|Overall Study|Protocol Violation|5
1007137|NCT01473394|2026125|FG000|Overall Study|Withdrew Consent|12
1007138|NCT01473394|2026126|FG001|Overall Study|Withdrew Consent|10
1007139|NCT01473394|2026125|FG000|Overall Study|Lost to Follow-up|9
1007140|NCT01473394|2026126|FG001|Overall Study|Lost to Follow-up|11
1007141|NCT01473407|2026134|FG000|Overall Study|Physician Decision|1
1007142|NCT01473407|2026135|FG001|Overall Study|Physician Decision|4
1007143|NCT01473407|2026134|FG000|Overall Study|Lost to Follow-up|10
1007144|NCT01473407|2026135|FG001|Overall Study|Lost to Follow-up|4
1007145|NCT01473407|2026134|FG000|Overall Study|Adverse Event|8
1007146|NCT01473407|2026135|FG001|Overall Study|Adverse Event|8
1007147|NCT01473407|2026134|FG000|Overall Study|Randomization Error|3
1007148|NCT01473407|2026135|FG001|Overall Study|Randomization Error|1
1007149|NCT01473407|2026134|FG000|Overall Study|Withdrawal by Subject|4
1007150|NCT01473407|2026135|FG001|Overall Study|Withdrawal by Subject|7
1007151|NCT01473407|2026134|FG000|Overall Study|Kidney Transplant|7
1007152|NCT01473407|2026135|FG001|Overall Study|Kidney Transplant|6
1007153|NCT01473407|2026134|FG000|Overall Study|Vacation/Travel|1
1007154|NCT01473407|2026135|FG001|Overall Study|Vacation/Travel|1
1007155|NCT01473407|2026134|FG000|Overall Study|Elevated Hemoglobin|1
1007156|NCT01473407|2026135|FG001|Overall Study|Elevated Hemoglobin|0
1007157|NCT01473407|2026134|FG000|Overall Study|Patient Received Aranesp|1
1007158|NCT01473407|2026135|FG001|Overall Study|Patient Received Aranesp|0
1007159|NCT01473407|2026134|FG000|Overall Study|Patient Lost Green Card Status|1
1007160|NCT01473407|2026135|FG001|Overall Study|Patient Lost Green Card Status|0
1007161|NCT01473407|2026134|FG000|Overall Study|Temperature Excursion|2
1007162|NCT01473407|2026135|FG001|Overall Study|Temperature Excursion|3
1007163|NCT01473407|2026134|FG000|Overall Study|Transfer to Another Facility/Unit|4
1007164|NCT01473407|2026135|FG001|Overall Study|Transfer to Another Facility/Unit|3
1007165|NCT01473407|2026134|FG000|Overall Study|Sponsor's Decision|10
1007166|NCT01473407|2026135|FG001|Overall Study|Sponsor's Decision|10
1007167|NCT01473407|2026134|FG000|Overall Study|Site Closure|1
1007168|NCT01473407|2026135|FG001|Overall Study|Site Closure|0
1007169|NCT01473420|2026143|FG000|Titration Period (18 Weeks)|Adverse Event|4
1007170|NCT01473420|2026144|FG001|Titration Period (18 Weeks)|Adverse Event|6
1007171|NCT01473420|2026143|FG000|Titration Period (18 Weeks)|Did not meet criteria|32
1007172|NCT01473420|2026144|FG001|Titration Period (18 Weeks)|Did not meet criteria|32
1007173|NCT01473420|2026143|FG000|Maintenance Period (16 Weeks)|Adverse Event|3
1007174|NCT01473420|2026144|FG001|Maintenance Period (16 Weeks)|Adverse Event|2
1007175|NCT01473420|2026143|FG000|Maintenance Period (16 Weeks)|Physician Decision|1
1007176|NCT01473420|2026144|FG001|Maintenance Period (16 Weeks)|Physician Decision|2
1007177|NCT01473420|2026143|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0
1007178|NCT01473420|2026144|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2
1007179|NCT01473420|2026143|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3
1007180|NCT01473420|2026144|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1
1007181|NCT01473420|2026143|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1
1007182|NCT01473420|2026144|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2
1007183|NCT01473420|2026143|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
1007184|NCT01473420|2026144|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
1007185|NCT01473420|2026143|FG000|Maintenance Period (16 Weeks)|Site closure|3
1007186|NCT01473420|2026144|FG001|Maintenance Period (16 Weeks)|Site closure|1
1007187|NCT01473420|2026143|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
1007188|NCT01473420|2026144|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
1007189|NCT01473420|2026143|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0
1007190|NCT01473420|2026144|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1
1007191|NCT01473420|2026143|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1
1007192|NCT01473420|2026144|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0
1007193|NCT01473420|2026143|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
1007194|NCT01473420|2026144|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
1007195|NCT01473524|2026159|FG000|DB Phase|Adverse Event|4
1007196|NCT01473524|2026160|FG001|DB Phase|Adverse Event|8
1007197|NCT01473524|2026161|FG002|DB Phase|Adverse Event|2
1007198|NCT01473524|2026162|FG003|DB Phase|Adverse Event|0
1007199|NCT01473524|2026163|FG004|DB Phase|Adverse Event|0
1007200|NCT01473524|2026164|FG005|DB Phase|Adverse Event|0
1007201|NCT01473524|2026159|FG000|DB Phase|Death|1
1007202|NCT01473524|2026160|FG001|DB Phase|Death|0
1007203|NCT01473524|2026161|FG002|DB Phase|Death|0
1007204|NCT01473524|2026162|FG003|DB Phase|Death|0
1007205|NCT01473524|2026163|FG004|DB Phase|Death|0
1007206|NCT01473524|2026164|FG005|DB Phase|Death|0
1007207|NCT01473524|2026159|FG000|DB Phase|Withdrawal by Subject|2
1007208|NCT01473524|2026160|FG001|DB Phase|Withdrawal by Subject|1
1007209|NCT01473524|2026161|FG002|DB Phase|Withdrawal by Subject|1
1007210|NCT01473524|2026162|FG003|DB Phase|Withdrawal by Subject|0
1007211|NCT01473524|2026163|FG004|DB Phase|Withdrawal by Subject|0
1007212|NCT01473524|2026164|FG005|DB Phase|Withdrawal by Subject|0
1007213|NCT01473524|2026159|FG000|LTSE Phase|Withdrawal by Subject|0
1007214|NCT01473524|2026160|FG001|LTSE Phase|Withdrawal by Subject|0
1007215|NCT01473524|2026161|FG002|LTSE Phase|Withdrawal by Subject|0
1007216|NCT01473524|2026162|FG003|LTSE Phase|Withdrawal by Subject|3
1007217|NCT01473524|2026163|FG004|LTSE Phase|Withdrawal by Subject|3
1007218|NCT01473524|2026164|FG005|LTSE Phase|Withdrawal by Subject|6
1007219|NCT01473524|2026159|FG000|LTSE Phase|Death|0
1007220|NCT01473524|2026160|FG001|LTSE Phase|Death|0
1007221|NCT01473524|2026161|FG002|LTSE Phase|Death|0
1007222|NCT01473524|2026162|FG003|LTSE Phase|Death|0
1007223|NCT01473524|2026163|FG004|LTSE Phase|Death|1
1007224|NCT01473524|2026164|FG005|LTSE Phase|Death|0
1007225|NCT01473524|2026159|FG000|LTSE Phase|Adverse Event of Pruritus|0
1007226|NCT01473524|2026160|FG001|LTSE Phase|Adverse Event of Pruritus|0
1007227|NCT01473524|2026161|FG002|LTSE Phase|Adverse Event of Pruritus|0
1007228|NCT01473524|2026162|FG003|LTSE Phase|Adverse Event of Pruritus|1
1007229|NCT01473524|2026163|FG004|LTSE Phase|Adverse Event of Pruritus|5
1007230|NCT01473524|2026164|FG005|LTSE Phase|Adverse Event of Pruritus|2
1007231|NCT01473524|2026159|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
1007232|NCT01473524|2026160|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
1007233|NCT01473524|2026161|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
1007234|NCT01473524|2026162|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2
1007235|NCT01473524|2026163|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4
1007236|NCT01473524|2026164|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6
1007237|NCT01473524|2026159|FG000|LTSE Phase|Lost to Follow-up|0
1007238|NCT01473524|2026160|FG001|LTSE Phase|Lost to Follow-up|0
1007239|NCT01473524|2026161|FG002|LTSE Phase|Lost to Follow-up|0
1007240|NCT01473524|2026162|FG003|LTSE Phase|Lost to Follow-up|1
1007241|NCT01473524|2026163|FG004|LTSE Phase|Lost to Follow-up|3
1007242|NCT01473524|2026164|FG005|LTSE Phase|Lost to Follow-up|2
1007243|NCT01473524|2026159|FG000|LTSE Phase|Principal Investigator Decision|0
1007244|NCT01473524|2026160|FG001|LTSE Phase|Principal Investigator Decision|0
1007245|NCT01473524|2026161|FG002|LTSE Phase|Principal Investigator Decision|0
1007246|NCT01473524|2026162|FG003|LTSE Phase|Principal Investigator Decision|1
1007247|NCT01473524|2026163|FG004|LTSE Phase|Principal Investigator Decision|1
1007248|NCT01473524|2026164|FG005|LTSE Phase|Principal Investigator Decision|3
1007249|NCT01473524|2026159|FG000|LTSE Phase|Liver Transplantation|0
1007250|NCT01473524|2026160|FG001|LTSE Phase|Liver Transplantation|0
1007251|NCT01473524|2026161|FG002|LTSE Phase|Liver Transplantation|0
1007252|NCT01473524|2026162|FG003|LTSE Phase|Liver Transplantation|0
1007253|NCT01473524|2026163|FG004|LTSE Phase|Liver Transplantation|0
1007254|NCT01473524|2026164|FG005|LTSE Phase|Liver Transplantation|1
1007255|NCT01473524|2026159|FG000|LTSE Phase|Pregnancy|0
1007256|NCT01473524|2026160|FG001|LTSE Phase|Pregnancy|0
1007257|NCT01473524|2026161|FG002|LTSE Phase|Pregnancy|0
1007258|NCT01473524|2026162|FG003|LTSE Phase|Pregnancy|1
1007259|NCT01473524|2026163|FG004|LTSE Phase|Pregnancy|0
1007260|NCT01473524|2026164|FG005|LTSE Phase|Pregnancy|0
1007261|NCT01473524|2026159|FG000|LTSE Phase|Protocol Violation|0
1007262|NCT01473524|2026160|FG001|LTSE Phase|Protocol Violation|0
1007263|NCT01473524|2026161|FG002|LTSE Phase|Protocol Violation|0
1007264|NCT01473524|2026162|FG003|LTSE Phase|Protocol Violation|0
1007265|NCT01473524|2026163|FG004|LTSE Phase|Protocol Violation|0
1007266|NCT01473524|2026164|FG005|LTSE Phase|Protocol Violation|1
1007267|NCT01473563|2026186|FG000|Overall Study|Lost to FU post tx discontinuation|1
1007268|NCT01473589|2026192|FG000|Overall Study|Adverse Event|1
1007269|NCT01473589|2026193|FG001|Overall Study|Adverse Event|1
1007270|NCT01473589|2026192|FG000|Overall Study|Death|2
1007271|NCT01473589|2026193|FG001|Overall Study|Death|0
1007272|NCT01473589|2026192|FG000|Overall Study|Lost to Follow-up|2
1007273|NCT01473589|2026193|FG001|Overall Study|Lost to Follow-up|2
1007274|NCT01473589|2026192|FG000|Overall Study|Protocol Violation|1
1007275|NCT01473589|2026193|FG001|Overall Study|Protocol Violation|0
1007276|NCT01473589|2026192|FG000|Overall Study|Withdrawal by Subject|5
1007277|NCT01473589|2026193|FG001|Overall Study|Withdrawal by Subject|11
1007278|NCT01473589|2026192|FG000|Overall Study|Physician Decision|0
1007279|NCT01473589|2026193|FG001|Overall Study|Physician Decision|1
1007280|NCT01473589|2026192|FG000|Overall Study|Entry criteria not met|0
1007281|NCT01473589|2026193|FG001|Overall Study|Entry criteria not met|1
1007282|NCT01473602|2026203|FG000|Overall Study|Adverse Event|1
1007283|NCT01473602|2026204|FG001|Overall Study|Adverse Event|2
1007284|NCT01473602|2026203|FG000|Overall Study|Death|0
1007285|NCT01473602|2026204|FG001|Overall Study|Death|1
1007286|NCT01473602|2026203|FG000|Overall Study|Lost to Follow-up|1
1007287|NCT01473602|2026204|FG001|Overall Study|Lost to Follow-up|1
1007288|NCT01473602|2026203|FG000|Overall Study|Withdrawal by Subject|5
1007289|NCT01473602|2026204|FG001|Overall Study|Withdrawal by Subject|4
1007290|NCT01473602|2026203|FG000|Overall Study|Physician Decision|1
1007291|NCT01473602|2026204|FG001|Overall Study|Physician Decision|0
1007292|NCT01473758|2026223|FG000|Cycle 1|Adverse Event|10
1007293|NCT01473758|2026224|FG001|Cycle 1|Adverse Event|2
1007294|NCT01473758|2026225|FG002|Cycle 1|Adverse Event|0
1007295|NCT01473758|2026226|FG003|Cycle 1|Adverse Event|0
1007296|NCT01473758|2026223|FG000|Cycle 1|Withdrawal by Subject|1
1007297|NCT01473758|2026224|FG001|Cycle 1|Withdrawal by Subject|1
1007298|NCT01473758|2026225|FG002|Cycle 1|Withdrawal by Subject|0
1007299|NCT01473758|2026226|FG003|Cycle 1|Withdrawal by Subject|0
1007300|NCT01473758|2026223|FG000|Cycle 2|Adverse Event|0
1007301|NCT01473758|2026224|FG001|Cycle 2|Adverse Event|0
1007302|NCT01473758|2026225|FG002|Cycle 2|Adverse Event|5
1007303|NCT01473758|2026226|FG003|Cycle 2|Adverse Event|0
1007304|NCT01473836|2026234|FG000|Overall Study|Adverse Event|4
1007305|NCT01473836|2026234|FG000|Overall Study|Lack of Efficacy|1
1007306|NCT01473836|2026234|FG000|Overall Study|Does not meet entrance criteria|1
1007307|NCT01473940|2026242|FG000|Induction Therapy|Death|0
1007308|NCT01473940|2026243|FG001|Induction Therapy|Death|0
1007309|NCT01473940|2026244|FG002|Induction Therapy|Death|1
1007310|NCT01473940|2026245|FG003|Induction Therapy|Death|1
1007311|NCT01473940|2026242|FG000|Induction Therapy|Progressive Disease|0
1007312|NCT01473940|2026243|FG001|Induction Therapy|Progressive Disease|1
1007313|NCT01473940|2026244|FG002|Induction Therapy|Progressive Disease|1
1007314|NCT01473940|2026245|FG003|Induction Therapy|Progressive Disease|0
1007315|NCT01473940|2026242|FG000|Maintenance Therapy|Progressive Disease|1
1007316|NCT01473940|2026243|FG001|Maintenance Therapy|Progressive Disease|2
1007317|NCT01473940|2026244|FG002|Maintenance Therapy|Progressive Disease|1
1007318|NCT01473940|2026245|FG003|Maintenance Therapy|Progressive Disease|4
1007319|NCT01473953|2026263|FG000|Overall Study|Other|1
1007320|NCT01473953|2026264|FG001|Overall Study|Other|0
1007321|NCT01473953|2026265|FG002|Overall Study|Other|0
1007322|NCT01473953|2026266|FG003|Overall Study|Other|0
1007323|NCT01473953|2026267|FG004|Overall Study|Other|0
1007324|NCT01474018|2026293|FG000|Overall Study|Lost to Follow-up|0
1007325|NCT01474018|2026294|FG001|Overall Study|Lost to Follow-up|1
1007326|NCT01474018|2026293|FG000|Overall Study|Withdrawal by Subject|0
1007327|NCT01474018|2026294|FG001|Overall Study|Withdrawal by Subject|2
1007328|NCT01474239|2026352|FG000|Overall Study|Disease Progression|37
1007329|NCT01474239|2026353|FG001|Overall Study|Disease Progression|25
1007330|NCT01474239|2026352|FG000|Overall Study|Adverse Event|12
1007331|NCT01474239|2026353|FG001|Overall Study|Adverse Event|3
1007332|NCT01474239|2026352|FG000|Overall Study|Withdrawal by Subject|1
1007333|NCT01474239|2026353|FG001|Overall Study|Withdrawal by Subject|2
1007334|NCT01474239|2026352|FG000|Overall Study|Death|1
1007335|NCT01474239|2026353|FG001|Overall Study|Death|1
1007336|NCT01474239|2026352|FG000|Overall Study|Clinical Disease Progression|7
1007337|NCT01474239|2026353|FG001|Overall Study|Clinical Disease Progression|1
1007338|NCT01474239|2026352|FG000|Overall Study|Withdrawal for Economic Reason|1
1007339|NCT01474239|2026353|FG001|Overall Study|Withdrawal for Economic Reason|0
1007340|NCT01474291|2026361|FG000|Overall Study|Not Evaluable for Efficacy|26
1007341|NCT01474291|2026361|FG000|Overall Study|Lack of Treatment Efficacy|88
1007342|NCT01474291|2026361|FG000|Overall Study|Adverse Event|53
1007343|NCT01474291|2026361|FG000|Overall Study|Lost to Follow-up|29
1007344|NCT01474291|2026361|FG000|Overall Study|Patient No Longer Wanted to Participate|12
1007345|NCT01474291|2026361|FG000|Overall Study|No Reason Reported|10
1007346|NCT01474291|2026361|FG000|Overall Study|Death|2
1007347|NCT01474317|2026368|FG000|Overall Study|Adverse Event|1
1007348|NCT01474317|2026368|FG000|Overall Study|Subject ineligible for study|1
1007349|NCT01474434|2026376|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
1007350|NCT01474434|2026377|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
1007351|NCT01474434|2026378|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
1007352|NCT01474434|2026379|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
1007353|NCT01474434|2026376|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1007354|NCT01474434|2026377|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1007355|NCT01474434|2026378|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1007356|NCT01474434|2026379|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
1007357|NCT01474434|2026376|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
1007358|NCT01474434|2026377|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1007359|NCT01474434|2026378|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1007360|NCT01474434|2026379|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1007361|NCT01474486|2026393|FG000|Overall Study|Death|2
1007362|NCT01474486|2026393|FG000|Overall Study|Withdrawal by Subject|4
1007363|NCT01474486|2026393|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2
1007364|NCT01474512|2026404|FG000|Induction Period|Adverse Event|6
1007365|NCT01474512|2026405|FG001|Induction Period|Adverse Event|10
1007366|NCT01474512|2026406|FG002|Induction Period|Adverse Event|10
1007367|NCT01474512|2026407|FG003|Induction Period|Adverse Event|0
1007368|NCT01474512|2026408|FG004|Induction Period|Adverse Event|0
1007369|NCT01474512|2026409|FG005|Induction Period|Adverse Event|0
1007370|NCT01474512|2026410|FG006|Induction Period|Adverse Event|0
1007371|NCT01474512|2026411|FG007|Induction Period|Adverse Event|0
1007372|NCT01474512|2026412|FG008|Induction Period|Adverse Event|0
1007373|NCT01474512|2026413|FG009|Induction Period|Adverse Event|0
1007374|NCT01474512|2026414|FG010|Induction Period|Adverse Event|0
1007375|NCT01474512|2026415|FG011|Induction Period|Adverse Event|0
1007376|NCT01474512|2026416|FG012|Induction Period|Adverse Event|0
1007377|NCT01474512|2026417|FG013|Induction Period|Adverse Event|0
1007378|NCT01474512|2026418|FG014|Induction Period|Adverse Event|0
1007379|NCT01474512|2026419|FG015|Induction Period|Adverse Event|0
1007380|NCT01474512|2026420|FG016|Induction Period|Adverse Event|0
1007381|NCT01474512|2026421|FG017|Induction Period|Adverse Event|0
1007382|NCT01474512|2026404|FG000|Induction Period|Lack of Efficacy|7
1007383|NCT01474512|2026405|FG001|Induction Period|Lack of Efficacy|1
1007384|NCT01474512|2026406|FG002|Induction Period|Lack of Efficacy|0
1007385|NCT01474512|2026407|FG003|Induction Period|Lack of Efficacy|0
1007386|NCT01474512|2026408|FG004|Induction Period|Lack of Efficacy|0
1007387|NCT01474512|2026409|FG005|Induction Period|Lack of Efficacy|0
1007388|NCT01474512|2026410|FG006|Induction Period|Lack of Efficacy|0
1007389|NCT01474512|2026411|FG007|Induction Period|Lack of Efficacy|0
1007390|NCT01474512|2026412|FG008|Induction Period|Lack of Efficacy|0
1007391|NCT01474512|2026413|FG009|Induction Period|Lack of Efficacy|0
1007392|NCT01474512|2026414|FG010|Induction Period|Lack of Efficacy|0
1007393|NCT01474512|2026415|FG011|Induction Period|Lack of Efficacy|0
1007394|NCT01474512|2026416|FG012|Induction Period|Lack of Efficacy|0
1007395|NCT01474512|2026417|FG013|Induction Period|Lack of Efficacy|0
1007396|NCT01474512|2026418|FG014|Induction Period|Lack of Efficacy|0
1007397|NCT01474512|2026419|FG015|Induction Period|Lack of Efficacy|0
1007398|NCT01474512|2026420|FG016|Induction Period|Lack of Efficacy|0
1007399|NCT01474512|2026421|FG017|Induction Period|Lack of Efficacy|0
1007400|NCT01474512|2026404|FG000|Induction Period|Withdrawal by Subject|6
1007401|NCT01474512|2026405|FG001|Induction Period|Withdrawal by Subject|6
1007402|NCT01474512|2026406|FG002|Induction Period|Withdrawal by Subject|5
1007403|NCT01474512|2026407|FG003|Induction Period|Withdrawal by Subject|0
1007404|NCT01474512|2026408|FG004|Induction Period|Withdrawal by Subject|0
1007405|NCT01474512|2026409|FG005|Induction Period|Withdrawal by Subject|0
1007406|NCT01474512|2026410|FG006|Induction Period|Withdrawal by Subject|0
1007407|NCT01474512|2026411|FG007|Induction Period|Withdrawal by Subject|0
1007408|NCT01474512|2026412|FG008|Induction Period|Withdrawal by Subject|0
1007409|NCT01474512|2026413|FG009|Induction Period|Withdrawal by Subject|0
1007410|NCT01474512|2026414|FG010|Induction Period|Withdrawal by Subject|0
1007411|NCT01474512|2026415|FG011|Induction Period|Withdrawal by Subject|0
1007412|NCT01474512|2026416|FG012|Induction Period|Withdrawal by Subject|0
1007413|NCT01474512|2026417|FG013|Induction Period|Withdrawal by Subject|0
1007414|NCT01474512|2026418|FG014|Induction Period|Withdrawal by Subject|0
1007415|NCT01474512|2026419|FG015|Induction Period|Withdrawal by Subject|0
1007416|NCT01474512|2026420|FG016|Induction Period|Withdrawal by Subject|0
1007417|NCT01474512|2026421|FG017|Induction Period|Withdrawal by Subject|0
1007418|NCT01474512|2026404|FG000|Induction Period|Protocol Violation|3
1007419|NCT01474512|2026405|FG001|Induction Period|Protocol Violation|6
1007420|NCT01474512|2026406|FG002|Induction Period|Protocol Violation|0
1007421|NCT01474512|2026407|FG003|Induction Period|Protocol Violation|0
1007422|NCT01474512|2026408|FG004|Induction Period|Protocol Violation|0
1007423|NCT01474512|2026409|FG005|Induction Period|Protocol Violation|0
1007424|NCT01474512|2026410|FG006|Induction Period|Protocol Violation|0
1007425|NCT01474512|2026411|FG007|Induction Period|Protocol Violation|0
1007426|NCT01474512|2026412|FG008|Induction Period|Protocol Violation|0
1007427|NCT01474512|2026413|FG009|Induction Period|Protocol Violation|0
1007428|NCT01474512|2026414|FG010|Induction Period|Protocol Violation|0
1007429|NCT01474512|2026415|FG011|Induction Period|Protocol Violation|0
1007430|NCT01474512|2026416|FG012|Induction Period|Protocol Violation|0
1007431|NCT01474512|2026417|FG013|Induction Period|Protocol Violation|0
1007432|NCT01474512|2026418|FG014|Induction Period|Protocol Violation|0
1007433|NCT01474512|2026419|FG015|Induction Period|Protocol Violation|0
1007434|NCT01474512|2026420|FG016|Induction Period|Protocol Violation|0
1007435|NCT01474512|2026421|FG017|Induction Period|Protocol Violation|0
1007436|NCT01474512|2026404|FG000|Induction Period|Sponsor Decision|1
1007437|NCT01474512|2026405|FG001|Induction Period|Sponsor Decision|1
1007438|NCT01474512|2026406|FG002|Induction Period|Sponsor Decision|1
1007439|NCT01474512|2026407|FG003|Induction Period|Sponsor Decision|0
1007440|NCT01474512|2026408|FG004|Induction Period|Sponsor Decision|0
1007441|NCT01474512|2026409|FG005|Induction Period|Sponsor Decision|0
1007442|NCT01474512|2026410|FG006|Induction Period|Sponsor Decision|0
1007443|NCT01474512|2026411|FG007|Induction Period|Sponsor Decision|0
1007444|NCT01474512|2026412|FG008|Induction Period|Sponsor Decision|0
1007445|NCT01474512|2026413|FG009|Induction Period|Sponsor Decision|0
1007446|NCT01474512|2026414|FG010|Induction Period|Sponsor Decision|0
1007447|NCT01474512|2026415|FG011|Induction Period|Sponsor Decision|0
1007448|NCT01474512|2026416|FG012|Induction Period|Sponsor Decision|0
1007449|NCT01474512|2026417|FG013|Induction Period|Sponsor Decision|0
1007450|NCT01474512|2026418|FG014|Induction Period|Sponsor Decision|0
1007451|NCT01474512|2026419|FG015|Induction Period|Sponsor Decision|0
1007452|NCT01474512|2026420|FG016|Induction Period|Sponsor Decision|0
1007453|NCT01474512|2026421|FG017|Induction Period|Sponsor Decision|0
1007454|NCT01474512|2026404|FG000|Induction Period|Lost to Follow-up|1
1007455|NCT01474512|2026405|FG001|Induction Period|Lost to Follow-up|0
1007456|NCT01474512|2026406|FG002|Induction Period|Lost to Follow-up|2
1007457|NCT01474512|2026407|FG003|Induction Period|Lost to Follow-up|0
1007458|NCT01474512|2026408|FG004|Induction Period|Lost to Follow-up|0
1007459|NCT01474512|2026409|FG005|Induction Period|Lost to Follow-up|0
1007460|NCT01474512|2026410|FG006|Induction Period|Lost to Follow-up|0
1007461|NCT01474512|2026411|FG007|Induction Period|Lost to Follow-up|0
1007462|NCT01474512|2026412|FG008|Induction Period|Lost to Follow-up|0
1007463|NCT01474512|2026413|FG009|Induction Period|Lost to Follow-up|0
1007464|NCT01474512|2026414|FG010|Induction Period|Lost to Follow-up|0
1007465|NCT01474512|2026415|FG011|Induction Period|Lost to Follow-up|0
1007466|NCT01474512|2026416|FG012|Induction Period|Lost to Follow-up|0
1007467|NCT01474512|2026417|FG013|Induction Period|Lost to Follow-up|0
1007468|NCT01474512|2026418|FG014|Induction Period|Lost to Follow-up|0
1007469|NCT01474512|2026419|FG015|Induction Period|Lost to Follow-up|0
1007470|NCT01474512|2026420|FG016|Induction Period|Lost to Follow-up|0
1007471|NCT01474512|2026421|FG017|Induction Period|Lost to Follow-up|0
1007472|NCT01474512|2026404|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0
1007473|NCT01474512|2026405|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0
1007474|NCT01474512|2026406|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0
1007475|NCT01474512|2026407|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186
1007476|NCT01474512|2026408|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111
1007477|NCT01474512|2026409|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39
1007478|NCT01474512|2026410|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9
1007479|NCT01474512|2026411|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0
1007480|NCT01474512|2026412|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0
1007481|NCT01474512|2026413|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0
1007482|NCT01474512|2026414|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0
1007483|NCT01474512|2026415|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0
1007484|NCT01474512|2026416|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0
1007485|NCT01474512|2026417|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0
1007486|NCT01474512|2026418|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0
1007487|NCT01474512|2026419|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0
1007488|NCT01474512|2026420|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0
1007489|NCT01474512|2026421|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0
1007490|NCT01474512|2026404|FG000|Maintenance Period|Adverse Event|0
1007491|NCT01474512|2026405|FG001|Maintenance Period|Adverse Event|0
1007492|NCT01474512|2026406|FG002|Maintenance Period|Adverse Event|0
1007493|NCT01474512|2026407|FG003|Maintenance Period|Adverse Event|4
1007494|NCT01474512|2026408|FG004|Maintenance Period|Adverse Event|2
1007495|NCT01474512|2026409|FG005|Maintenance Period|Adverse Event|7
1007496|NCT01474512|2026410|FG006|Maintenance Period|Adverse Event|0
1007497|NCT01474512|2026411|FG007|Maintenance Period|Adverse Event|19
1007498|NCT01474512|2026412|FG008|Maintenance Period|Adverse Event|1
1007499|NCT01474512|2026413|FG009|Maintenance Period|Adverse Event|3
1007500|NCT01474512|2026414|FG010|Maintenance Period|Adverse Event|0
1007501|NCT01474512|2026415|FG011|Maintenance Period|Adverse Event|0
1007502|NCT01474512|2026416|FG012|Maintenance Period|Adverse Event|0
1007503|NCT01474512|2026417|FG013|Maintenance Period|Adverse Event|0
1007504|NCT01474512|2026418|FG014|Maintenance Period|Adverse Event|0
1007505|NCT01474512|2026419|FG015|Maintenance Period|Adverse Event|0
1007506|NCT01474512|2026420|FG016|Maintenance Period|Adverse Event|0
1007507|NCT01474512|2026421|FG017|Maintenance Period|Adverse Event|0
1007508|NCT01474512|2026404|FG000|Maintenance Period|Withdrawal by Subject|0
1007509|NCT01474512|2026405|FG001|Maintenance Period|Withdrawal by Subject|0
1007510|NCT01474512|2026406|FG002|Maintenance Period|Withdrawal by Subject|0
1007511|NCT01474512|2026407|FG003|Maintenance Period|Withdrawal by Subject|6
1007512|NCT01474512|2026408|FG004|Maintenance Period|Withdrawal by Subject|2
1007513|NCT01474512|2026409|FG005|Maintenance Period|Withdrawal by Subject|3
1007514|NCT01474512|2026410|FG006|Maintenance Period|Withdrawal by Subject|1
1007515|NCT01474512|2026411|FG007|Maintenance Period|Withdrawal by Subject|6
1007516|NCT01474512|2026412|FG008|Maintenance Period|Withdrawal by Subject|3
1007517|NCT01474512|2026413|FG009|Maintenance Period|Withdrawal by Subject|1
1007518|NCT01474512|2026414|FG010|Maintenance Period|Withdrawal by Subject|0
1007519|NCT01474512|2026415|FG011|Maintenance Period|Withdrawal by Subject|0
1007520|NCT01474512|2026416|FG012|Maintenance Period|Withdrawal by Subject|0
1007521|NCT01474512|2026417|FG013|Maintenance Period|Withdrawal by Subject|0
1007522|NCT01474512|2026418|FG014|Maintenance Period|Withdrawal by Subject|0
1007523|NCT01474512|2026419|FG015|Maintenance Period|Withdrawal by Subject|0
1007524|NCT01474512|2026420|FG016|Maintenance Period|Withdrawal by Subject|0
1007525|NCT01474512|2026421|FG017|Maintenance Period|Withdrawal by Subject|0
1007526|NCT01474512|2026404|FG000|Maintenance Period|Lost to Follow-up|0
1007527|NCT01474512|2026405|FG001|Maintenance Period|Lost to Follow-up|0
1007528|NCT01474512|2026406|FG002|Maintenance Period|Lost to Follow-up|0
1007529|NCT01474512|2026407|FG003|Maintenance Period|Lost to Follow-up|3
1007530|NCT01474512|2026408|FG004|Maintenance Period|Lost to Follow-up|3
1007531|NCT01474512|2026409|FG005|Maintenance Period|Lost to Follow-up|0
1007532|NCT01474512|2026410|FG006|Maintenance Period|Lost to Follow-up|0
1007533|NCT01474512|2026411|FG007|Maintenance Period|Lost to Follow-up|2
1007534|NCT01474512|2026412|FG008|Maintenance Period|Lost to Follow-up|1
1007535|NCT01474512|2026413|FG009|Maintenance Period|Lost to Follow-up|1
1007536|NCT01474512|2026414|FG010|Maintenance Period|Lost to Follow-up|0
1007537|NCT01474512|2026415|FG011|Maintenance Period|Lost to Follow-up|0
1007538|NCT01474512|2026416|FG012|Maintenance Period|Lost to Follow-up|0
1007539|NCT01474512|2026417|FG013|Maintenance Period|Lost to Follow-up|0
1007540|NCT01474512|2026418|FG014|Maintenance Period|Lost to Follow-up|0
1007541|NCT01474512|2026419|FG015|Maintenance Period|Lost to Follow-up|0
1007542|NCT01474512|2026420|FG016|Maintenance Period|Lost to Follow-up|0
1007543|NCT01474512|2026421|FG017|Maintenance Period|Lost to Follow-up|0
1007544|NCT01474512|2026404|FG000|Maintenance Period|Death|0
1007545|NCT01474512|2026405|FG001|Maintenance Period|Death|0
1007546|NCT01474512|2026406|FG002|Maintenance Period|Death|0
1007547|NCT01474512|2026407|FG003|Maintenance Period|Death|0
1007548|NCT01474512|2026408|FG004|Maintenance Period|Death|0
1007549|NCT01474512|2026409|FG005|Maintenance Period|Death|2
1007550|NCT01474512|2026410|FG006|Maintenance Period|Death|0
1007551|NCT01474512|2026411|FG007|Maintenance Period|Death|0
1007552|NCT01474512|2026412|FG008|Maintenance Period|Death|0
1007553|NCT01474512|2026413|FG009|Maintenance Period|Death|0
1007554|NCT01474512|2026414|FG010|Maintenance Period|Death|0
1007555|NCT01474512|2026415|FG011|Maintenance Period|Death|0
1007556|NCT01474512|2026416|FG012|Maintenance Period|Death|0
1007557|NCT01474512|2026417|FG013|Maintenance Period|Death|0
1007558|NCT01474512|2026418|FG014|Maintenance Period|Death|0
1007559|NCT01474512|2026419|FG015|Maintenance Period|Death|0
1007560|NCT01474512|2026420|FG016|Maintenance Period|Death|0
1007561|NCT01474512|2026421|FG017|Maintenance Period|Death|0
1007562|NCT01474512|2026404|FG000|Maintenance Period|Physician Decision|0
1007563|NCT01474512|2026405|FG001|Maintenance Period|Physician Decision|0
1007564|NCT01474512|2026406|FG002|Maintenance Period|Physician Decision|0
1007565|NCT01474512|2026407|FG003|Maintenance Period|Physician Decision|0
1007566|NCT01474512|2026408|FG004|Maintenance Period|Physician Decision|0
1007567|NCT01474512|2026409|FG005|Maintenance Period|Physician Decision|1
1007568|NCT01474512|2026410|FG006|Maintenance Period|Physician Decision|0
1007569|NCT01474512|2026411|FG007|Maintenance Period|Physician Decision|2
1007570|NCT01474512|2026412|FG008|Maintenance Period|Physician Decision|0
1007571|NCT01474512|2026413|FG009|Maintenance Period|Physician Decision|0
1007572|NCT01474512|2026414|FG010|Maintenance Period|Physician Decision|0
1007573|NCT01474512|2026415|FG011|Maintenance Period|Physician Decision|0
1007574|NCT01474512|2026416|FG012|Maintenance Period|Physician Decision|0
1007575|NCT01474512|2026417|FG013|Maintenance Period|Physician Decision|0
1007576|NCT01474512|2026418|FG014|Maintenance Period|Physician Decision|0
1007577|NCT01474512|2026419|FG015|Maintenance Period|Physician Decision|0
1007578|NCT01474512|2026420|FG016|Maintenance Period|Physician Decision|0
1007579|NCT01474512|2026421|FG017|Maintenance Period|Physician Decision|0
1007580|NCT01474512|2026404|FG000|Maintenance Period|Clinical Relapse|0
1007581|NCT01474512|2026405|FG001|Maintenance Period|Clinical Relapse|0
1007582|NCT01474512|2026406|FG002|Maintenance Period|Clinical Relapse|0
1007583|NCT01474512|2026407|FG003|Maintenance Period|Clinical Relapse|1
1007584|NCT01474512|2026408|FG004|Maintenance Period|Clinical Relapse|0
1007585|NCT01474512|2026409|FG005|Maintenance Period|Clinical Relapse|0
1007586|NCT01474512|2026410|FG006|Maintenance Period|Clinical Relapse|0
1007587|NCT01474512|2026411|FG007|Maintenance Period|Clinical Relapse|0
1007588|NCT01474512|2026412|FG008|Maintenance Period|Clinical Relapse|0
1007589|NCT01474512|2026413|FG009|Maintenance Period|Clinical Relapse|0
1007590|NCT01474512|2026414|FG010|Maintenance Period|Clinical Relapse|0
1007591|NCT01474512|2026415|FG011|Maintenance Period|Clinical Relapse|0
1007592|NCT01474512|2026416|FG012|Maintenance Period|Clinical Relapse|0
1007593|NCT01474512|2026417|FG013|Maintenance Period|Clinical Relapse|0
1007594|NCT01474512|2026418|FG014|Maintenance Period|Clinical Relapse|0
1007595|NCT01474512|2026419|FG015|Maintenance Period|Clinical Relapse|0
1007596|NCT01474512|2026420|FG016|Maintenance Period|Clinical Relapse|0
1007597|NCT01474512|2026421|FG017|Maintenance Period|Clinical Relapse|0
1007598|NCT01474512|2026404|FG000|Maintenance Period|Lack of Efficacy|0
1007599|NCT01474512|2026405|FG001|Maintenance Period|Lack of Efficacy|0
1007600|NCT01474512|2026406|FG002|Maintenance Period|Lack of Efficacy|0
1007601|NCT01474512|2026407|FG003|Maintenance Period|Lack of Efficacy|1
1007602|NCT01474512|2026408|FG004|Maintenance Period|Lack of Efficacy|0
1007603|NCT01474512|2026409|FG005|Maintenance Period|Lack of Efficacy|0
1007604|NCT01474512|2026410|FG006|Maintenance Period|Lack of Efficacy|0
1007605|NCT01474512|2026411|FG007|Maintenance Period|Lack of Efficacy|11
1007606|NCT01474512|2026412|FG008|Maintenance Period|Lack of Efficacy|11
1007607|NCT01474512|2026413|FG009|Maintenance Period|Lack of Efficacy|12
1007608|NCT01474512|2026414|FG010|Maintenance Period|Lack of Efficacy|0
1007609|NCT01474512|2026415|FG011|Maintenance Period|Lack of Efficacy|0
1007610|NCT01474512|2026416|FG012|Maintenance Period|Lack of Efficacy|0
1007611|NCT01474512|2026417|FG013|Maintenance Period|Lack of Efficacy|0
1007612|NCT01474512|2026418|FG014|Maintenance Period|Lack of Efficacy|0
1007613|NCT01474512|2026419|FG015|Maintenance Period|Lack of Efficacy|0
1007614|NCT01474512|2026420|FG016|Maintenance Period|Lack of Efficacy|0
1007615|NCT01474512|2026421|FG017|Maintenance Period|Lack of Efficacy|0
1007616|NCT01474512|2026404|FG000|Maintenance Period|Protocol Violation|0
1007617|NCT01474512|2026405|FG001|Maintenance Period|Protocol Violation|0
1007618|NCT01474512|2026406|FG002|Maintenance Period|Protocol Violation|0
1007619|NCT01474512|2026407|FG003|Maintenance Period|Protocol Violation|1
1007620|NCT01474512|2026408|FG004|Maintenance Period|Protocol Violation|0
1007621|NCT01474512|2026409|FG005|Maintenance Period|Protocol Violation|0
1007622|NCT01474512|2026410|FG006|Maintenance Period|Protocol Violation|0
1007623|NCT01474512|2026411|FG007|Maintenance Period|Protocol Violation|1
1007624|NCT01474512|2026412|FG008|Maintenance Period|Protocol Violation|0
1007625|NCT01474512|2026413|FG009|Maintenance Period|Protocol Violation|1
1007626|NCT01474512|2026414|FG010|Maintenance Period|Protocol Violation|0
1007627|NCT01474512|2026415|FG011|Maintenance Period|Protocol Violation|0
1007628|NCT01474512|2026416|FG012|Maintenance Period|Protocol Violation|0
1007629|NCT01474512|2026417|FG013|Maintenance Period|Protocol Violation|0
1007630|NCT01474512|2026418|FG014|Maintenance Period|Protocol Violation|0
1007631|NCT01474512|2026419|FG015|Maintenance Period|Protocol Violation|0
1007632|NCT01474512|2026420|FG016|Maintenance Period|Protocol Violation|0
1007633|NCT01474512|2026421|FG017|Maintenance Period|Protocol Violation|0
1007634|NCT01474512|2026404|FG000|Maintenance Period|Treated but Discontinued in Induction|0
1007635|NCT01474512|2026405|FG001|Maintenance Period|Treated but Discontinued in Induction|0
1007636|NCT01474512|2026406|FG002|Maintenance Period|Treated but Discontinued in Induction|0
1007637|NCT01474512|2026407|FG003|Maintenance Period|Treated but Discontinued in Induction|0
1007638|NCT01474512|2026408|FG004|Maintenance Period|Treated but Discontinued in Induction|1
1007639|NCT01474512|2026409|FG005|Maintenance Period|Treated but Discontinued in Induction|0
1007640|NCT01474512|2026410|FG006|Maintenance Period|Treated but Discontinued in Induction|0
1007641|NCT01474512|2026411|FG007|Maintenance Period|Treated but Discontinued in Induction|0
1007642|NCT01474512|2026412|FG008|Maintenance Period|Treated but Discontinued in Induction|0
1007643|NCT01474512|2026413|FG009|Maintenance Period|Treated but Discontinued in Induction|0
1007644|NCT01474512|2026414|FG010|Maintenance Period|Treated but Discontinued in Induction|0
1007645|NCT01474512|2026415|FG011|Maintenance Period|Treated but Discontinued in Induction|0
1007646|NCT01474512|2026416|FG012|Maintenance Period|Treated but Discontinued in Induction|0
1007647|NCT01474512|2026417|FG013|Maintenance Period|Treated but Discontinued in Induction|0
1007648|NCT01474512|2026418|FG014|Maintenance Period|Treated but Discontinued in Induction|0
1007649|NCT01474512|2026419|FG015|Maintenance Period|Treated but Discontinued in Induction|0
1007650|NCT01474512|2026420|FG016|Maintenance Period|Treated but Discontinued in Induction|0
1007651|NCT01474512|2026421|FG017|Maintenance Period|Treated but Discontinued in Induction|0
1007652|NCT01474512|2026404|FG000|Long-Term Extension Period|Withdrawal by Subject|0
1007653|NCT01474512|2026405|FG001|Long-Term Extension Period|Withdrawal by Subject|0
1007654|NCT01474512|2026406|FG002|Long-Term Extension Period|Withdrawal by Subject|0
1007655|NCT01474512|2026407|FG003|Long-Term Extension Period|Withdrawal by Subject|0
1007656|NCT01474512|2026408|FG004|Long-Term Extension Period|Withdrawal by Subject|0
1007657|NCT01474512|2026409|FG005|Long-Term Extension Period|Withdrawal by Subject|0
1007658|NCT01474512|2026410|FG006|Long-Term Extension Period|Withdrawal by Subject|0
1007659|NCT01474512|2026411|FG007|Long-Term Extension Period|Withdrawal by Subject|0
1007660|NCT01474512|2026412|FG008|Long-Term Extension Period|Withdrawal by Subject|0
1007661|NCT01474512|2026413|FG009|Long-Term Extension Period|Withdrawal by Subject|0
1007662|NCT01474512|2026414|FG010|Long-Term Extension Period|Withdrawal by Subject|0
1007663|NCT01474512|2026415|FG011|Long-Term Extension Period|Withdrawal by Subject|3
1007664|NCT01474512|2026416|FG012|Long-Term Extension Period|Withdrawal by Subject|61
1007665|NCT01474512|2026417|FG013|Long-Term Extension Period|Withdrawal by Subject|61
1007666|NCT01474512|2026418|FG014|Long-Term Extension Period|Withdrawal by Subject|0
1007667|NCT01474512|2026419|FG015|Long-Term Extension Period|Withdrawal by Subject|0
1007668|NCT01474512|2026420|FG016|Long-Term Extension Period|Withdrawal by Subject|0
1007669|NCT01474512|2026421|FG017|Long-Term Extension Period|Withdrawal by Subject|0
1007670|NCT01474512|2026404|FG000|Long-Term Extension Period|Adverse Event|0
1007671|NCT01474512|2026405|FG001|Long-Term Extension Period|Adverse Event|0
1007672|NCT01474512|2026406|FG002|Long-Term Extension Period|Adverse Event|0
1007673|NCT01474512|2026407|FG003|Long-Term Extension Period|Adverse Event|0
1007674|NCT01474512|2026408|FG004|Long-Term Extension Period|Adverse Event|0
1007675|NCT01474512|2026409|FG005|Long-Term Extension Period|Adverse Event|0
1007676|NCT01474512|2026410|FG006|Long-Term Extension Period|Adverse Event|0
1007677|NCT01474512|2026411|FG007|Long-Term Extension Period|Adverse Event|0
1007678|NCT01474512|2026412|FG008|Long-Term Extension Period|Adverse Event|0
1007679|NCT01474512|2026413|FG009|Long-Term Extension Period|Adverse Event|0
1007680|NCT01474512|2026414|FG010|Long-Term Extension Period|Adverse Event|0
1007681|NCT01474512|2026415|FG011|Long-Term Extension Period|Adverse Event|1
1007682|NCT01474512|2026416|FG012|Long-Term Extension Period|Adverse Event|57
1007683|NCT01474512|2026417|FG013|Long-Term Extension Period|Adverse Event|58
1007684|NCT01474512|2026418|FG014|Long-Term Extension Period|Adverse Event|0
1007685|NCT01474512|2026419|FG015|Long-Term Extension Period|Adverse Event|0
1007686|NCT01474512|2026420|FG016|Long-Term Extension Period|Adverse Event|0
1007687|NCT01474512|2026421|FG017|Long-Term Extension Period|Adverse Event|0
1007688|NCT01474512|2026404|FG000|Long-Term Extension Period|Lost to Follow-up|0
1007689|NCT01474512|2026405|FG001|Long-Term Extension Period|Lost to Follow-up|0
1007690|NCT01474512|2026406|FG002|Long-Term Extension Period|Lost to Follow-up|0
1007691|NCT01474512|2026407|FG003|Long-Term Extension Period|Lost to Follow-up|0
1007692|NCT01474512|2026408|FG004|Long-Term Extension Period|Lost to Follow-up|0
1007693|NCT01474512|2026409|FG005|Long-Term Extension Period|Lost to Follow-up|0
1007694|NCT01474512|2026410|FG006|Long-Term Extension Period|Lost to Follow-up|0
1007695|NCT01474512|2026411|FG007|Long-Term Extension Period|Lost to Follow-up|0
1007696|NCT01474512|2026412|FG008|Long-Term Extension Period|Lost to Follow-up|0
1007697|NCT01474512|2026413|FG009|Long-Term Extension Period|Lost to Follow-up|0
1007698|NCT01474512|2026414|FG010|Long-Term Extension Period|Lost to Follow-up|0
1007699|NCT01474512|2026415|FG011|Long-Term Extension Period|Lost to Follow-up|0
1007700|NCT01474512|2026416|FG012|Long-Term Extension Period|Lost to Follow-up|25
1007701|NCT01474512|2026417|FG013|Long-Term Extension Period|Lost to Follow-up|25
1007702|NCT01474512|2026418|FG014|Long-Term Extension Period|Lost to Follow-up|0
1007703|NCT01474512|2026419|FG015|Long-Term Extension Period|Lost to Follow-up|0
1007704|NCT01474512|2026420|FG016|Long-Term Extension Period|Lost to Follow-up|0
1007705|NCT01474512|2026421|FG017|Long-Term Extension Period|Lost to Follow-up|0
1007706|NCT01474512|2026404|FG000|Long-Term Extension Period|Lack of Efficacy|0
1007707|NCT01474512|2026405|FG001|Long-Term Extension Period|Lack of Efficacy|0
1007708|NCT01474512|2026406|FG002|Long-Term Extension Period|Lack of Efficacy|0
1007709|NCT01474512|2026407|FG003|Long-Term Extension Period|Lack of Efficacy|0
1007710|NCT01474512|2026408|FG004|Long-Term Extension Period|Lack of Efficacy|0
1007711|NCT01474512|2026409|FG005|Long-Term Extension Period|Lack of Efficacy|0
1007712|NCT01474512|2026410|FG006|Long-Term Extension Period|Lack of Efficacy|0
1007713|NCT01474512|2026411|FG007|Long-Term Extension Period|Lack of Efficacy|0
1007714|NCT01474512|2026412|FG008|Long-Term Extension Period|Lack of Efficacy|0
1007715|NCT01474512|2026413|FG009|Long-Term Extension Period|Lack of Efficacy|0
1007716|NCT01474512|2026414|FG010|Long-Term Extension Period|Lack of Efficacy|0
1007717|NCT01474512|2026415|FG011|Long-Term Extension Period|Lack of Efficacy|1
1007718|NCT01474512|2026416|FG012|Long-Term Extension Period|Lack of Efficacy|24
1007719|NCT01474512|2026417|FG013|Long-Term Extension Period|Lack of Efficacy|25
1007720|NCT01474512|2026418|FG014|Long-Term Extension Period|Lack of Efficacy|0
1007721|NCT01474512|2026419|FG015|Long-Term Extension Period|Lack of Efficacy|0
1007722|NCT01474512|2026420|FG016|Long-Term Extension Period|Lack of Efficacy|0
1007723|NCT01474512|2026421|FG017|Long-Term Extension Period|Lack of Efficacy|0
1007724|NCT01474512|2026404|FG000|Long-Term Extension Period|Physician Decision|0
1007725|NCT01474512|2026405|FG001|Long-Term Extension Period|Physician Decision|0
1007726|NCT01474512|2026406|FG002|Long-Term Extension Period|Physician Decision|0
1007727|NCT01474512|2026407|FG003|Long-Term Extension Period|Physician Decision|0
1007728|NCT01474512|2026408|FG004|Long-Term Extension Period|Physician Decision|0
1007729|NCT01474512|2026409|FG005|Long-Term Extension Period|Physician Decision|0
1007730|NCT01474512|2026410|FG006|Long-Term Extension Period|Physician Decision|0
1007731|NCT01474512|2026411|FG007|Long-Term Extension Period|Physician Decision|0
1007732|NCT01474512|2026412|FG008|Long-Term Extension Period|Physician Decision|0
1007733|NCT01474512|2026413|FG009|Long-Term Extension Period|Physician Decision|0
1007734|NCT01474512|2026414|FG010|Long-Term Extension Period|Physician Decision|0
1007735|NCT01474512|2026415|FG011|Long-Term Extension Period|Physician Decision|0
1007736|NCT01474512|2026416|FG012|Long-Term Extension Period|Physician Decision|21
1007737|NCT01474512|2026417|FG013|Long-Term Extension Period|Physician Decision|21
1007738|NCT01474512|2026418|FG014|Long-Term Extension Period|Physician Decision|0
1007739|NCT01474512|2026419|FG015|Long-Term Extension Period|Physician Decision|0
1007740|NCT01474512|2026420|FG016|Long-Term Extension Period|Physician Decision|0
1007741|NCT01474512|2026421|FG017|Long-Term Extension Period|Physician Decision|0
1007742|NCT01474512|2026404|FG000|Long-Term Extension Period|Clinical Relapse|0
1007743|NCT01474512|2026405|FG001|Long-Term Extension Period|Clinical Relapse|0
1007744|NCT01474512|2026406|FG002|Long-Term Extension Period|Clinical Relapse|0
1007745|NCT01474512|2026407|FG003|Long-Term Extension Period|Clinical Relapse|0
1007746|NCT01474512|2026408|FG004|Long-Term Extension Period|Clinical Relapse|0
1007747|NCT01474512|2026409|FG005|Long-Term Extension Period|Clinical Relapse|0
1007748|NCT01474512|2026410|FG006|Long-Term Extension Period|Clinical Relapse|0
1007749|NCT01474512|2026411|FG007|Long-Term Extension Period|Clinical Relapse|0
1007750|NCT01474512|2026412|FG008|Long-Term Extension Period|Clinical Relapse|0
1007751|NCT01474512|2026413|FG009|Long-Term Extension Period|Clinical Relapse|0
1007752|NCT01474512|2026414|FG010|Long-Term Extension Period|Clinical Relapse|0
1007753|NCT01474512|2026415|FG011|Long-Term Extension Period|Clinical Relapse|0
1007754|NCT01474512|2026416|FG012|Long-Term Extension Period|Clinical Relapse|9
1007755|NCT01474512|2026417|FG013|Long-Term Extension Period|Clinical Relapse|9
1007756|NCT01474512|2026418|FG014|Long-Term Extension Period|Clinical Relapse|0
1007757|NCT01474512|2026419|FG015|Long-Term Extension Period|Clinical Relapse|0
1007758|NCT01474512|2026420|FG016|Long-Term Extension Period|Clinical Relapse|0
1007759|NCT01474512|2026421|FG017|Long-Term Extension Period|Clinical Relapse|0
1007760|NCT01474512|2026404|FG000|Long-Term Extension Period|Death|0
1007761|NCT01474512|2026405|FG001|Long-Term Extension Period|Death|0
1007762|NCT01474512|2026406|FG002|Long-Term Extension Period|Death|0
1007763|NCT01474512|2026407|FG003|Long-Term Extension Period|Death|0
1007764|NCT01474512|2026408|FG004|Long-Term Extension Period|Death|0
1007765|NCT01474512|2026409|FG005|Long-Term Extension Period|Death|0
1007766|NCT01474512|2026410|FG006|Long-Term Extension Period|Death|0
1007767|NCT01474512|2026411|FG007|Long-Term Extension Period|Death|0
1007768|NCT01474512|2026412|FG008|Long-Term Extension Period|Death|0
1007769|NCT01474512|2026413|FG009|Long-Term Extension Period|Death|0
1007770|NCT01474512|2026414|FG010|Long-Term Extension Period|Death|0
1007771|NCT01474512|2026415|FG011|Long-Term Extension Period|Death|0
1007772|NCT01474512|2026416|FG012|Long-Term Extension Period|Death|9
1007773|NCT01474512|2026417|FG013|Long-Term Extension Period|Death|9
1007774|NCT01474512|2026418|FG014|Long-Term Extension Period|Death|0
1007775|NCT01474512|2026419|FG015|Long-Term Extension Period|Death|0
1007776|NCT01474512|2026420|FG016|Long-Term Extension Period|Death|0
1007777|NCT01474512|2026421|FG017|Long-Term Extension Period|Death|0
1007778|NCT01474512|2026404|FG000|Long-Term Extension Period|Sponsor Decision|0
1007779|NCT01474512|2026405|FG001|Long-Term Extension Period|Sponsor Decision|0
1007780|NCT01474512|2026406|FG002|Long-Term Extension Period|Sponsor Decision|0
1007781|NCT01474512|2026407|FG003|Long-Term Extension Period|Sponsor Decision|0
1007782|NCT01474512|2026408|FG004|Long-Term Extension Period|Sponsor Decision|0
1007783|NCT01474512|2026409|FG005|Long-Term Extension Period|Sponsor Decision|0
1007784|NCT01474512|2026410|FG006|Long-Term Extension Period|Sponsor Decision|0
1007785|NCT01474512|2026411|FG007|Long-Term Extension Period|Sponsor Decision|0
1007786|NCT01474512|2026412|FG008|Long-Term Extension Period|Sponsor Decision|0
1007787|NCT01474512|2026413|FG009|Long-Term Extension Period|Sponsor Decision|0
1007788|NCT01474512|2026414|FG010|Long-Term Extension Period|Sponsor Decision|0
1007789|NCT01474512|2026415|FG011|Long-Term Extension Period|Sponsor Decision|0
1007790|NCT01474512|2026416|FG012|Long-Term Extension Period|Sponsor Decision|6
1007791|NCT01474512|2026417|FG013|Long-Term Extension Period|Sponsor Decision|6
1007792|NCT01474512|2026418|FG014|Long-Term Extension Period|Sponsor Decision|0
1007793|NCT01474512|2026419|FG015|Long-Term Extension Period|Sponsor Decision|0
1007794|NCT01474512|2026420|FG016|Long-Term Extension Period|Sponsor Decision|0
1007795|NCT01474512|2026421|FG017|Long-Term Extension Period|Sponsor Decision|0
1007796|NCT01474512|2026404|FG000|Long-Term Extension Period|Protocol Violation|0
1007797|NCT01474512|2026405|FG001|Long-Term Extension Period|Protocol Violation|0
1007798|NCT01474512|2026406|FG002|Long-Term Extension Period|Protocol Violation|0
1007799|NCT01474512|2026407|FG003|Long-Term Extension Period|Protocol Violation|0
1007800|NCT01474512|2026408|FG004|Long-Term Extension Period|Protocol Violation|0
1007801|NCT01474512|2026409|FG005|Long-Term Extension Period|Protocol Violation|0
1007802|NCT01474512|2026410|FG006|Long-Term Extension Period|Protocol Violation|0
1007803|NCT01474512|2026411|FG007|Long-Term Extension Period|Protocol Violation|0
1007804|NCT01474512|2026412|FG008|Long-Term Extension Period|Protocol Violation|0
1007805|NCT01474512|2026413|FG009|Long-Term Extension Period|Protocol Violation|0
1007806|NCT01474512|2026414|FG010|Long-Term Extension Period|Protocol Violation|0
1007807|NCT01474512|2026415|FG011|Long-Term Extension Period|Protocol Violation|0
1007808|NCT01474512|2026416|FG012|Long-Term Extension Period|Protocol Violation|5
1007809|NCT01474512|2026417|FG013|Long-Term Extension Period|Protocol Violation|5
1007810|NCT01474512|2026418|FG014|Long-Term Extension Period|Protocol Violation|0
1007811|NCT01474512|2026419|FG015|Long-Term Extension Period|Protocol Violation|0
1007812|NCT01474512|2026420|FG016|Long-Term Extension Period|Protocol Violation|0
1007813|NCT01474512|2026421|FG017|Long-Term Extension Period|Protocol Violation|0
1007814|NCT01474512|2026404|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0
1007815|NCT01474512|2026405|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0
1007816|NCT01474512|2026406|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0
1007817|NCT01474512|2026407|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0
1007818|NCT01474512|2026408|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0
1007819|NCT01474512|2026409|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0
1007820|NCT01474512|2026410|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0
1007821|NCT01474512|2026411|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0
1007822|NCT01474512|2026412|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0
1007823|NCT01474512|2026413|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0
1007824|NCT01474512|2026414|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0
1007825|NCT01474512|2026415|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0
1007826|NCT01474512|2026416|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1
1007827|NCT01474512|2026417|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1
1007828|NCT01474512|2026418|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0
1007829|NCT01474512|2026419|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0
1007830|NCT01474512|2026420|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0
1007831|NCT01474512|2026421|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0
1007832|NCT01474512|2026404|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0
1007833|NCT01474512|2026405|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0
1007834|NCT01474512|2026406|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0
1007835|NCT01474512|2026407|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0
1007836|NCT01474512|2026408|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0
1007837|NCT01474512|2026409|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0
1007838|NCT01474512|2026410|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0
1007839|NCT01474512|2026411|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0
1007840|NCT01474512|2026412|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0
1007841|NCT01474512|2026413|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0
1007842|NCT01474512|2026414|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0
1007843|NCT01474512|2026415|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21
1007844|NCT01474512|2026416|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0
1007845|NCT01474512|2026417|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0
1007846|NCT01474512|2026418|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0
1007847|NCT01474512|2026419|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0
1007848|NCT01474512|2026420|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0
1007849|NCT01474512|2026421|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0
1007850|NCT01474512|2026404|FG000|Post-Treatment Follow-Up|Adverse Event|0
1007851|NCT01474512|2026405|FG001|Post-Treatment Follow-Up|Adverse Event|0
1007852|NCT01474512|2026406|FG002|Post-Treatment Follow-Up|Adverse Event|0
1007853|NCT01474512|2026407|FG003|Post-Treatment Follow-Up|Adverse Event|0
1007854|NCT01474512|2026408|FG004|Post-Treatment Follow-Up|Adverse Event|0
1007855|NCT01474512|2026409|FG005|Post-Treatment Follow-Up|Adverse Event|0
1007856|NCT01474512|2026410|FG006|Post-Treatment Follow-Up|Adverse Event|0
1007857|NCT01474512|2026411|FG007|Post-Treatment Follow-Up|Adverse Event|0
1007858|NCT01474512|2026412|FG008|Post-Treatment Follow-Up|Adverse Event|0
1007859|NCT01474512|2026413|FG009|Post-Treatment Follow-Up|Adverse Event|0
1007860|NCT01474512|2026414|FG010|Post-Treatment Follow-Up|Adverse Event|0
1007861|NCT01474512|2026415|FG011|Post-Treatment Follow-Up|Adverse Event|0
1007862|NCT01474512|2026416|FG012|Post-Treatment Follow-Up|Adverse Event|0
1007863|NCT01474512|2026417|FG013|Post-Treatment Follow-Up|Adverse Event|0
1007864|NCT01474512|2026418|FG014|Post-Treatment Follow-Up|Adverse Event|8
1007865|NCT01474512|2026419|FG015|Post-Treatment Follow-Up|Adverse Event|2
1007866|NCT01474512|2026420|FG016|Post-Treatment Follow-Up|Adverse Event|58
1007867|NCT01474512|2026421|FG017|Post-Treatment Follow-Up|Adverse Event|11
1007868|NCT01474512|2026404|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007869|NCT01474512|2026405|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007870|NCT01474512|2026406|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007871|NCT01474512|2026407|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007872|NCT01474512|2026408|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007873|NCT01474512|2026409|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007874|NCT01474512|2026410|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007875|NCT01474512|2026411|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007876|NCT01474512|2026412|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007877|NCT01474512|2026413|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007878|NCT01474512|2026414|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007879|NCT01474512|2026415|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007880|NCT01474512|2026416|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007881|NCT01474512|2026417|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0
1007882|NCT01474512|2026418|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3
1007883|NCT01474512|2026419|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2
1007884|NCT01474512|2026420|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36
1007885|NCT01474512|2026421|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17
1007886|NCT01474512|2026404|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0
1007887|NCT01474512|2026405|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0
1007888|NCT01474512|2026406|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0
1007889|NCT01474512|2026407|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0
1007890|NCT01474512|2026408|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0
1007891|NCT01474512|2026409|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0
1007892|NCT01474512|2026410|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0
1007893|NCT01474512|2026411|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0
1007894|NCT01474512|2026412|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0
1007895|NCT01474512|2026413|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0
1007896|NCT01474512|2026414|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0
1007897|NCT01474512|2026415|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0
1007898|NCT01474512|2026416|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0
1007899|NCT01474512|2026417|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0
1007900|NCT01474512|2026418|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3
1007901|NCT01474512|2026419|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2
1007902|NCT01474512|2026420|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31
1007903|NCT01474512|2026421|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3
1007904|NCT01474512|2026404|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0
1007905|NCT01474512|2026405|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0
1007906|NCT01474512|2026406|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0
1007907|NCT01474512|2026407|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0
1007908|NCT01474512|2026408|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0
1007909|NCT01474512|2026409|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0
1007910|NCT01474512|2026410|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0
1007911|NCT01474512|2026411|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0
1007912|NCT01474512|2026412|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0
1007913|NCT01474512|2026413|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0
1007914|NCT01474512|2026414|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0
1007915|NCT01474512|2026415|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0
1007916|NCT01474512|2026416|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0
1007917|NCT01474512|2026417|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0
1007918|NCT01474512|2026418|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0
1007919|NCT01474512|2026419|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0
1007920|NCT01474512|2026420|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12
1007921|NCT01474512|2026421|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7
1007922|NCT01474512|2026404|FG000|Post-Treatment Follow-Up|Physician Decision|0
1007923|NCT01474512|2026405|FG001|Post-Treatment Follow-Up|Physician Decision|0
1007924|NCT01474512|2026406|FG002|Post-Treatment Follow-Up|Physician Decision|0
1007925|NCT01474512|2026407|FG003|Post-Treatment Follow-Up|Physician Decision|0
1007926|NCT01474512|2026408|FG004|Post-Treatment Follow-Up|Physician Decision|0
1007927|NCT01474512|2026409|FG005|Post-Treatment Follow-Up|Physician Decision|0
1007928|NCT01474512|2026410|FG006|Post-Treatment Follow-Up|Physician Decision|0
1007929|NCT01474512|2026411|FG007|Post-Treatment Follow-Up|Physician Decision|0
1007930|NCT01474512|2026412|FG008|Post-Treatment Follow-Up|Physician Decision|0
1007931|NCT01474512|2026413|FG009|Post-Treatment Follow-Up|Physician Decision|0
1007932|NCT01474512|2026414|FG010|Post-Treatment Follow-Up|Physician Decision|0
1007933|NCT01474512|2026415|FG011|Post-Treatment Follow-Up|Physician Decision|0
1007934|NCT01474512|2026416|FG012|Post-Treatment Follow-Up|Physician Decision|0
1007935|NCT01474512|2026417|FG013|Post-Treatment Follow-Up|Physician Decision|0
1007936|NCT01474512|2026418|FG014|Post-Treatment Follow-Up|Physician Decision|0
1007937|NCT01474512|2026419|FG015|Post-Treatment Follow-Up|Physician Decision|0
1007938|NCT01474512|2026420|FG016|Post-Treatment Follow-Up|Physician Decision|4
1007939|NCT01474512|2026421|FG017|Post-Treatment Follow-Up|Physician Decision|5
1007940|NCT01474512|2026404|FG000|Post-Treatment Follow-Up|Clinical Relapse|0
1007941|NCT01474512|2026405|FG001|Post-Treatment Follow-Up|Clinical Relapse|0
1007942|NCT01474512|2026406|FG002|Post-Treatment Follow-Up|Clinical Relapse|0
1007943|NCT01474512|2026407|FG003|Post-Treatment Follow-Up|Clinical Relapse|0
1007944|NCT01474512|2026408|FG004|Post-Treatment Follow-Up|Clinical Relapse|0
1007945|NCT01474512|2026409|FG005|Post-Treatment Follow-Up|Clinical Relapse|0
1007946|NCT01474512|2026410|FG006|Post-Treatment Follow-Up|Clinical Relapse|0
1007947|NCT01474512|2026411|FG007|Post-Treatment Follow-Up|Clinical Relapse|0
1007948|NCT01474512|2026412|FG008|Post-Treatment Follow-Up|Clinical Relapse|0
1007949|NCT01474512|2026413|FG009|Post-Treatment Follow-Up|Clinical Relapse|0
1007950|NCT01474512|2026414|FG010|Post-Treatment Follow-Up|Clinical Relapse|0
1007951|NCT01474512|2026415|FG011|Post-Treatment Follow-Up|Clinical Relapse|0
1007952|NCT01474512|2026416|FG012|Post-Treatment Follow-Up|Clinical Relapse|0
1007953|NCT01474512|2026417|FG013|Post-Treatment Follow-Up|Clinical Relapse|0
1007954|NCT01474512|2026418|FG014|Post-Treatment Follow-Up|Clinical Relapse|0
1007955|NCT01474512|2026419|FG015|Post-Treatment Follow-Up|Clinical Relapse|0
1007956|NCT01474512|2026420|FG016|Post-Treatment Follow-Up|Clinical Relapse|6
1007957|NCT01474512|2026421|FG017|Post-Treatment Follow-Up|Clinical Relapse|2
1007958|NCT01474512|2026404|FG000|Post-Treatment Follow-Up|Protocol Violation|0
1007959|NCT01474512|2026405|FG001|Post-Treatment Follow-Up|Protocol Violation|0
1007960|NCT01474512|2026406|FG002|Post-Treatment Follow-Up|Protocol Violation|0
1007961|NCT01474512|2026407|FG003|Post-Treatment Follow-Up|Protocol Violation|0
1007962|NCT01474512|2026408|FG004|Post-Treatment Follow-Up|Protocol Violation|0
1007963|NCT01474512|2026409|FG005|Post-Treatment Follow-Up|Protocol Violation|0
1007964|NCT01474512|2026410|FG006|Post-Treatment Follow-Up|Protocol Violation|0
1007965|NCT01474512|2026411|FG007|Post-Treatment Follow-Up|Protocol Violation|0
1007966|NCT01474512|2026412|FG008|Post-Treatment Follow-Up|Protocol Violation|0
1007967|NCT01474512|2026413|FG009|Post-Treatment Follow-Up|Protocol Violation|0
1007968|NCT01474512|2026414|FG010|Post-Treatment Follow-Up|Protocol Violation|0
1007969|NCT01474512|2026415|FG011|Post-Treatment Follow-Up|Protocol Violation|0
1007970|NCT01474512|2026416|FG012|Post-Treatment Follow-Up|Protocol Violation|0
1007971|NCT01474512|2026417|FG013|Post-Treatment Follow-Up|Protocol Violation|0
1007972|NCT01474512|2026418|FG014|Post-Treatment Follow-Up|Protocol Violation|2
1007973|NCT01474512|2026419|FG015|Post-Treatment Follow-Up|Protocol Violation|2
1007974|NCT01474512|2026420|FG016|Post-Treatment Follow-Up|Protocol Violation|4
1007975|NCT01474512|2026421|FG017|Post-Treatment Follow-Up|Protocol Violation|0
1007976|NCT01474512|2026404|FG000|Post-Treatment Follow-Up|Sponsor Decision|0
1007977|NCT01474512|2026405|FG001|Post-Treatment Follow-Up|Sponsor Decision|0
1007978|NCT01474512|2026406|FG002|Post-Treatment Follow-Up|Sponsor Decision|0
1007979|NCT01474512|2026407|FG003|Post-Treatment Follow-Up|Sponsor Decision|0
1007980|NCT01474512|2026408|FG004|Post-Treatment Follow-Up|Sponsor Decision|0
1007981|NCT01474512|2026409|FG005|Post-Treatment Follow-Up|Sponsor Decision|0
1007982|NCT01474512|2026410|FG006|Post-Treatment Follow-Up|Sponsor Decision|0
1007983|NCT01474512|2026411|FG007|Post-Treatment Follow-Up|Sponsor Decision|0
1007984|NCT01474512|2026412|FG008|Post-Treatment Follow-Up|Sponsor Decision|0
1007985|NCT01474512|2026413|FG009|Post-Treatment Follow-Up|Sponsor Decision|0
1007986|NCT01474512|2026414|FG010|Post-Treatment Follow-Up|Sponsor Decision|0
1007987|NCT01474512|2026415|FG011|Post-Treatment Follow-Up|Sponsor Decision|0
1007988|NCT01474512|2026416|FG012|Post-Treatment Follow-Up|Sponsor Decision|0
1007989|NCT01474512|2026417|FG013|Post-Treatment Follow-Up|Sponsor Decision|0
1007990|NCT01474512|2026418|FG014|Post-Treatment Follow-Up|Sponsor Decision|1
1007991|NCT01474512|2026419|FG015|Post-Treatment Follow-Up|Sponsor Decision|0
1007992|NCT01474512|2026420|FG016|Post-Treatment Follow-Up|Sponsor Decision|4
1007993|NCT01474512|2026421|FG017|Post-Treatment Follow-Up|Sponsor Decision|0
1007994|NCT01474512|2026404|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1007995|NCT01474512|2026405|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1007996|NCT01474512|2026406|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1007997|NCT01474512|2026407|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1007998|NCT01474512|2026408|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1007999|NCT01474512|2026409|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1008000|NCT01474512|2026410|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1008001|NCT01474512|2026411|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1008002|NCT01474512|2026412|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1008003|NCT01474512|2026413|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1008004|NCT01474512|2026414|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1008005|NCT01474512|2026415|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1008006|NCT01474512|2026416|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1008007|NCT01474512|2026417|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1008008|NCT01474512|2026418|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
1008009|NCT01474512|2026419|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1008010|NCT01474512|2026420|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1008011|NCT01474512|2026421|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
1008012|NCT01474512|2026404|FG000|Post-Treatment Follow-Up|Death|0
1008013|NCT01474512|2026405|FG001|Post-Treatment Follow-Up|Death|0
1008014|NCT01474512|2026406|FG002|Post-Treatment Follow-Up|Death|0
1008015|NCT01474512|2026407|FG003|Post-Treatment Follow-Up|Death|0
1008016|NCT01474512|2026408|FG004|Post-Treatment Follow-Up|Death|0
1008017|NCT01474512|2026409|FG005|Post-Treatment Follow-Up|Death|0
1008018|NCT01474512|2026410|FG006|Post-Treatment Follow-Up|Death|0
1008019|NCT01474512|2026411|FG007|Post-Treatment Follow-Up|Death|0
1008020|NCT01474512|2026412|FG008|Post-Treatment Follow-Up|Death|0
1008021|NCT01474512|2026413|FG009|Post-Treatment Follow-Up|Death|0
1008022|NCT01474512|2026414|FG010|Post-Treatment Follow-Up|Death|0
1008023|NCT01474512|2026415|FG011|Post-Treatment Follow-Up|Death|0
1008024|NCT01474512|2026416|FG012|Post-Treatment Follow-Up|Death|0
1008025|NCT01474512|2026417|FG013|Post-Treatment Follow-Up|Death|0
1008026|NCT01474512|2026418|FG014|Post-Treatment Follow-Up|Death|0
1008027|NCT01474512|2026419|FG015|Post-Treatment Follow-Up|Death|0
1008028|NCT01474512|2026420|FG016|Post-Treatment Follow-Up|Death|1
1008029|NCT01474512|2026421|FG017|Post-Treatment Follow-Up|Death|0
1008030|NCT01474538|2026453|FG000|Treatment Period 1|Death|1
1008031|NCT01474538|2026454|FG001|Treatment Period 1|Death|0
1008032|NCT01474538|2026453|FG000|Treatment Period 1|Physician Decision|1
1008033|NCT01474538|2026454|FG001|Treatment Period 1|Physician Decision|0
1008034|NCT01474538|2026453|FG000|Treatment Period 1|Withdrawal by Subject|1
1008035|NCT01474538|2026454|FG001|Treatment Period 1|Withdrawal by Subject|3
1008036|NCT01474538|2026453|FG000|Treatment Period 1|Protocol Violation|0
1008037|NCT01474538|2026454|FG001|Treatment Period 1|Protocol Violation|1
1008038|NCT01474538|2026453|FG000|Treatment Period 2|Death|1
1008039|NCT01474538|2026454|FG001|Treatment Period 2|Death|0
1008040|NCT01474538|2026453|FG000|Treatment Period 2|Adverse Event|1
1008041|NCT01474538|2026454|FG001|Treatment Period 2|Adverse Event|1
1008042|NCT01474538|2026453|FG000|Treatment Period 2|Withdrawal by Subject|2
1008043|NCT01474538|2026454|FG001|Treatment Period 2|Withdrawal by Subject|0
1008044|NCT01474538|2026453|FG000|Treatment Period 2|Sponsor decision|1
1008045|NCT01474538|2026454|FG001|Treatment Period 2|Sponsor decision|0
1008046|NCT01474538|2026453|FG000|Treatment Period 2|Physician Decision|0
1008047|NCT01474538|2026454|FG001|Treatment Period 2|Physician Decision|1
1008048|NCT01474538|2026453|FG000|Treatment Period 2|Protocol Violation|1
1008049|NCT01474538|2026454|FG001|Treatment Period 2|Protocol Violation|0
1008050|NCT01474551|2026460|FG000|Overall Study|Death|1
1008051|NCT01474681|2026475|FG000|Overall Study|Death|0
1008052|NCT01474681|2026476|FG001|Overall Study|Death|3
1008053|NCT01474681|2026477|FG002|Overall Study|Death|2
1008054|NCT01474681|2026478|FG003|Overall Study|Death|6
1008055|NCT01474746|2026494|FG000|Overall Study|Lost to Follow-up|1
1008056|NCT01474746|2026495|FG001|Overall Study|Lost to Follow-up|1
1008057|NCT01474746|2026494|FG000|Overall Study|Withdrawal by Subject|2
1008058|NCT01474746|2026495|FG001|Overall Study|Withdrawal by Subject|1
1008059|NCT01474772|2026503|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6
1008060|NCT01474772|2026504|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1
1008061|NCT01474772|2026503|FG000|Period 1|AE not Related to Study Drug|1
1008062|NCT01474772|2026504|FG001|Period 1|AE not Related to Study Drug|0
1008063|NCT01474772|2026503|FG000|Period 1|Withdrawal by Subject|3
1008064|NCT01474772|2026504|FG001|Period 1|Withdrawal by Subject|1
1008065|NCT01474772|2026503|FG000|Period 1|Lost to Follow-up|1
1008066|NCT01474772|2026504|FG001|Period 1|Lost to Follow-up|0
1008067|NCT01474772|2026503|FG000|Period 1|Reason not Specified|1
1008068|NCT01474772|2026504|FG001|Period 1|Reason not Specified|1
1008069|NCT01474772|2026503|FG000|Washout|AE not Related to Study Drug|2
1008070|NCT01474772|2026504|FG001|Washout|AE not Related to Study Drug|0
1008071|NCT01474772|2026503|FG000|Washout|Withdrawal by Subject|1
1008072|NCT01474772|2026504|FG001|Washout|Withdrawal by Subject|0
1008073|NCT01474772|2026503|FG000|Washout|Lost to Follow-up|0
1008074|NCT01474772|2026504|FG001|Washout|Lost to Follow-up|1
1008075|NCT01474772|2026503|FG000|Washout|Reason not Specified|0
1008076|NCT01474772|2026504|FG001|Washout|Reason not Specified|1
1008077|NCT01474772|2026503|FG000|Period 2|Death|0
1008078|NCT01474772|2026504|FG001|Period 2|Death|1
1008079|NCT01474772|2026503|FG000|Period 2|AE Related to Study Drug|0
1008080|NCT01474772|2026504|FG001|Period 2|AE Related to Study Drug|1
1008081|NCT01474772|2026503|FG000|Period 2|AE not Related to Study Drug|4
1008082|NCT01474772|2026504|FG001|Period 2|AE not Related to Study Drug|1
1008083|NCT01474772|2026503|FG000|Period 2|Lack of Efficacy|1
1008084|NCT01474772|2026504|FG001|Period 2|Lack of Efficacy|0
1008085|NCT01474772|2026503|FG000|Period 2|Withdrawal by Subject|3
1008086|NCT01474772|2026504|FG001|Period 2|Withdrawal by Subject|4
1008087|NCT01474772|2026503|FG000|Period 2|Lost to Follow-up|1
1008088|NCT01474772|2026504|FG001|Period 2|Lost to Follow-up|1
1008089|NCT01474772|2026503|FG000|Period 2|Reason not Specified|0
1008090|NCT01474772|2026504|FG001|Period 2|Reason not Specified|2
1008091|NCT01474772|2026503|FG000|Follow-up|AE not Related to Study Drug|0
1008092|NCT01474772|2026504|FG001|Follow-up|AE not Related to Study Drug|1
1008093|NCT01474876|2026526|FG000|Overall Study|Adverse Event|11
1008094|NCT01474876|2026527|FG001|Overall Study|Adverse Event|5
1008095|NCT01474876|2026528|FG002|Overall Study|Adverse Event|0
1008096|NCT01474876|2026526|FG000|Overall Study|Serious Adverse Event|2
1008097|NCT01474876|2026527|FG001|Overall Study|Serious Adverse Event|3
1008098|NCT01474876|2026528|FG002|Overall Study|Serious Adverse Event|0
1008099|NCT01474876|2026526|FG000|Overall Study|Lost to Follow-up|5
1008100|NCT01474876|2026527|FG001|Overall Study|Lost to Follow-up|4
1008101|NCT01474876|2026528|FG002|Overall Study|Lost to Follow-up|0
1008102|NCT01474876|2026526|FG000|Overall Study|Investigator's decision|28
1008103|NCT01474876|2026527|FG001|Overall Study|Investigator's decision|6
1008104|NCT01474876|2026528|FG002|Overall Study|Investigator's decision|0
1008105|NCT01474876|2026526|FG000|Overall Study|Patient's request|19
1008106|NCT01474876|2026527|FG001|Overall Study|Patient's request|5
1008107|NCT01474876|2026528|FG002|Overall Study|Patient's request|0
1008108|NCT01474876|2026526|FG000|Overall Study|Investigator's decision and pt request|1
1008109|NCT01474876|2026527|FG001|Overall Study|Investigator's decision and pt request|0
1008110|NCT01474876|2026528|FG002|Overall Study|Investigator's decision and pt request|0
1008111|NCT01474993|2026546|FG000|Overall Study|Lost to Follow-up|1
1008112|NCT01474993|2026547|FG001|Overall Study|Lost to Follow-up|2
1008113|NCT01474993|2026546|FG000|Overall Study|Adverse Event|0
1008114|NCT01474993|2026547|FG001|Overall Study|Adverse Event|1
1008115|NCT01475071|2026555|FG000|Overall Study|Physician Decision|1
1008116|NCT01475071|2026555|FG000|Overall Study|Withdrawal by Subject|6
1008117|NCT01475071|2026555|FG000|Overall Study|Lost to Follow-up|1
1008118|NCT01475097|2026563|FG000|Overall Study|Protocol Violation|1
1008119|NCT01475097|2026564|FG001|Overall Study|Protocol Violation|1
1008120|NCT01475136|2026574|FG000|Overall Study|Sponsor Decision|0
1008121|NCT01475136|2026575|FG001|Overall Study|Sponsor Decision|1
1008122|NCT01475136|2026576|FG002|Overall Study|Sponsor Decision|0
1008123|NCT01475136|2026577|FG003|Overall Study|Sponsor Decision|0
1008124|NCT01475136|2026574|FG000|Overall Study|Entry Criteria Not Met|0
1008125|NCT01475136|2026575|FG001|Overall Study|Entry Criteria Not Met|2
1008126|NCT01475136|2026576|FG002|Overall Study|Entry Criteria Not Met|3
1008127|NCT01475136|2026577|FG003|Overall Study|Entry Criteria Not Met|1
1008128|NCT01475136|2026574|FG000|Overall Study|Withdrawal by Subject|0
1008129|NCT01475136|2026575|FG001|Overall Study|Withdrawal by Subject|0
1008130|NCT01475136|2026576|FG002|Overall Study|Withdrawal by Subject|0
1008131|NCT01475136|2026577|FG003|Overall Study|Withdrawal by Subject|2
1008132|NCT01475136|2026574|FG000|Overall Study|Adverse Event|1
1008133|NCT01475136|2026575|FG001|Overall Study|Adverse Event|0
1008134|NCT01475136|2026576|FG002|Overall Study|Adverse Event|0
1008135|NCT01475136|2026577|FG003|Overall Study|Adverse Event|1
1008136|NCT01475136|2026574|FG000|Overall Study|Death|0
1008137|NCT01475136|2026575|FG001|Overall Study|Death|0
1008138|NCT01475136|2026576|FG002|Overall Study|Death|0
1008139|NCT01475136|2026577|FG003|Overall Study|Death|1
1008140|NCT01475162|2026587|FG000|Overall Study|Physician Decision|1
1008141|NCT01475162|2026587|FG000|Overall Study|Death|10
1008142|NCT01475162|2026587|FG000|Overall Study|Study closed for safety|3
1008143|NCT01475214|2026599|FG000|Overall Study|Lost to Follow-up|1
1008144|NCT01475214|2026600|FG001|Overall Study|Lost to Follow-up|0
1008145|NCT01475214|2026601|FG002|Overall Study|Lost to Follow-up|1
1008146|NCT01475214|2026599|FG000|Overall Study|Physician Decision|2
1008147|NCT01475214|2026600|FG001|Overall Study|Physician Decision|0
1008148|NCT01475214|2026601|FG002|Overall Study|Physician Decision|0
1008149|NCT01475214|2026599|FG000|Overall Study|Withdrawal by Subject|2
1008150|NCT01475214|2026600|FG001|Overall Study|Withdrawal by Subject|4
1008151|NCT01475214|2026601|FG002|Overall Study|Withdrawal by Subject|1
1008152|NCT01475253|2026613|FG000|Randomized, Blinded Study|Withdrawal by Subject|1
1008153|NCT01475253|2026614|FG001|Randomized, Blinded Study|Withdrawal by Subject|1
1008154|NCT01475253|2026615|FG002|Randomized, Blinded Study|Withdrawal by Subject|0
1008155|NCT01475253|2026616|FG003|Randomized, Blinded Study|Withdrawal by Subject|0
1008156|NCT01475253|2026613|FG000|Randomized, Blinded Study|Lost to Follow-up|1
1008157|NCT01475253|2026614|FG001|Randomized, Blinded Study|Lost to Follow-up|0
1008158|NCT01475253|2026615|FG002|Randomized, Blinded Study|Lost to Follow-up|0
1008159|NCT01475253|2026616|FG003|Randomized, Blinded Study|Lost to Follow-up|0
1008160|NCT01475331|2026636|FG000|Overall Study|Osteophyte obstruction of the proximal|1
1008161|NCT01475331|2026637|FG001|Overall Study|Osteophyte obstruction of the proximal|0
1008162|NCT01475331|2026636|FG000|Overall Study|excessive main duct communication|1
1008163|NCT01475331|2026637|FG001|Overall Study|excessive main duct communication|1
1008164|NCT01475331|2026636|FG000|Overall Study|Loss of needle positioning due pt. cough|1
1008165|NCT01475331|2026637|FG001|Overall Study|Loss of needle positioning due pt. cough|0
1008166|NCT01475331|2026636|FG000|Overall Study|Sign of malignancy during the procedure|2
1008167|NCT01475331|2026637|FG001|Overall Study|Sign of malignancy during the procedure|0
1008168|NCT01475331|2026636|FG000|Overall Study|cyst found to be prohibitively small|0
1008169|NCT01475331|2026637|FG001|Overall Study|cyst found to be prohibitively small|1
1008170|NCT01475370|2026646|FG000|Overall Study|Exacerbation of primary disease|2
1008171|NCT01475370|2026647|FG001|Overall Study|Exacerbation of primary disease|2
1008172|NCT01475370|2026648|FG002|Overall Study|Exacerbation of primary disease|2
1008173|NCT01475370|2026646|FG000|Overall Study|Study drug administration difficult|0
1008174|NCT01475370|2026647|FG001|Overall Study|Study drug administration difficult|1
1008175|NCT01475370|2026648|FG002|Overall Study|Study drug administration difficult|1
1008176|NCT01475370|2026646|FG000|Overall Study|Other than specified|1
1008177|NCT01475370|2026647|FG001|Overall Study|Other than specified|0
1008178|NCT01475370|2026648|FG002|Overall Study|Other than specified|0
1008179|NCT01475461|2026662|FG000|Run-in Period|Not meet eligibility criteria|16
1008180|NCT01475461|2026663|FG001|Run-in Period|Not meet eligibility criteria|0
1008181|NCT01475461|2026664|FG002|Run-in Period|Not meet eligibility criteria|0
1008182|NCT01475461|2026665|FG003|Run-in Period|Not meet eligibility criteria|0
1008183|NCT01475461|2026666|FG004|Run-in Period|Not meet eligibility criteria|0
1008184|NCT01475461|2026667|FG005|Run-in Period|Not meet eligibility criteria|0
1008185|NCT01475461|2026668|FG006|Run-in Period|Not meet eligibility criteria|0
1008186|NCT01475461|2026662|FG000|Run-in Period|Lost to Follow-up|7
1008187|NCT01475461|2026663|FG001|Run-in Period|Lost to Follow-up|0
1008188|NCT01475461|2026664|FG002|Run-in Period|Lost to Follow-up|0
1008189|NCT01475461|2026665|FG003|Run-in Period|Lost to Follow-up|0
1008190|NCT01475461|2026666|FG004|Run-in Period|Lost to Follow-up|0
1008191|NCT01475461|2026667|FG005|Run-in Period|Lost to Follow-up|0
1008192|NCT01475461|2026668|FG006|Run-in Period|Lost to Follow-up|0
1008193|NCT01475461|2026662|FG000|Run-in Period|Withdrawal by Subject|11
1008194|NCT01475461|2026663|FG001|Run-in Period|Withdrawal by Subject|0
1008195|NCT01475461|2026664|FG002|Run-in Period|Withdrawal by Subject|0
1008196|NCT01475461|2026665|FG003|Run-in Period|Withdrawal by Subject|0
1008197|NCT01475461|2026666|FG004|Run-in Period|Withdrawal by Subject|0
1008198|NCT01475461|2026667|FG005|Run-in Period|Withdrawal by Subject|0
1008199|NCT01475461|2026668|FG006|Run-in Period|Withdrawal by Subject|0
1008200|NCT01475461|2026662|FG000|Run-in Period|Other|3
1008201|NCT01475461|2026663|FG001|Run-in Period|Other|0
1008202|NCT01475461|2026664|FG002|Run-in Period|Other|0
1008203|NCT01475461|2026665|FG003|Run-in Period|Other|0
1008204|NCT01475461|2026666|FG004|Run-in Period|Other|0
1008205|NCT01475461|2026667|FG005|Run-in Period|Other|0
1008206|NCT01475461|2026668|FG006|Run-in Period|Other|0
1008207|NCT01475461|2026662|FG000|Run-in Period|Protocol Violation|4
1008208|NCT01475461|2026663|FG001|Run-in Period|Protocol Violation|0
1008209|NCT01475461|2026664|FG002|Run-in Period|Protocol Violation|0
1008210|NCT01475461|2026665|FG003|Run-in Period|Protocol Violation|0
1008211|NCT01475461|2026666|FG004|Run-in Period|Protocol Violation|0
1008212|NCT01475461|2026667|FG005|Run-in Period|Protocol Violation|0
1008213|NCT01475461|2026668|FG006|Run-in Period|Protocol Violation|0
1008214|NCT01475461|2026662|FG000|Treatment Period|Death|0
1008215|NCT01475461|2026663|FG001|Treatment Period|Death|0
1008216|NCT01475461|2026664|FG002|Treatment Period|Death|0
1008217|NCT01475461|2026665|FG003|Treatment Period|Death|1
1008218|NCT01475461|2026666|FG004|Treatment Period|Death|0
1008219|NCT01475461|2026667|FG005|Treatment Period|Death|0
1008220|NCT01475461|2026668|FG006|Treatment Period|Death|0
1008221|NCT01475461|2026662|FG000|Treatment Period|Lost to Follow-up|0
1008222|NCT01475461|2026663|FG001|Treatment Period|Lost to Follow-up|3
1008223|NCT01475461|2026664|FG002|Treatment Period|Lost to Follow-up|2
1008224|NCT01475461|2026665|FG003|Treatment Period|Lost to Follow-up|3
1008225|NCT01475461|2026666|FG004|Treatment Period|Lost to Follow-up|1
1008226|NCT01475461|2026667|FG005|Treatment Period|Lost to Follow-up|2
1008227|NCT01475461|2026668|FG006|Treatment Period|Lost to Follow-up|1
1008228|NCT01475461|2026662|FG000|Treatment Period|Withdrawal by Subject|0
1008229|NCT01475461|2026663|FG001|Treatment Period|Withdrawal by Subject|2
1008230|NCT01475461|2026664|FG002|Treatment Period|Withdrawal by Subject|2
1008231|NCT01475461|2026665|FG003|Treatment Period|Withdrawal by Subject|0
1008232|NCT01475461|2026666|FG004|Treatment Period|Withdrawal by Subject|2
1008233|NCT01475461|2026667|FG005|Treatment Period|Withdrawal by Subject|2
1008234|NCT01475461|2026668|FG006|Treatment Period|Withdrawal by Subject|0
1008235|NCT01475461|2026662|FG000|Treatment Period|Other|0
1008236|NCT01475461|2026663|FG001|Treatment Period|Other|1
1008237|NCT01475461|2026664|FG002|Treatment Period|Other|0
1008238|NCT01475461|2026665|FG003|Treatment Period|Other|0
1008239|NCT01475461|2026666|FG004|Treatment Period|Other|0
1008240|NCT01475461|2026667|FG005|Treatment Period|Other|0
1008241|NCT01475461|2026668|FG006|Treatment Period|Other|0
1008242|NCT01475461|2026662|FG000|Treatment Period|Protocol Violation|0
1008243|NCT01475461|2026663|FG001|Treatment Period|Protocol Violation|1
1008244|NCT01475461|2026664|FG002|Treatment Period|Protocol Violation|0
1008245|NCT01475461|2026665|FG003|Treatment Period|Protocol Violation|0
1008246|NCT01475461|2026666|FG004|Treatment Period|Protocol Violation|0
1008247|NCT01475461|2026667|FG005|Treatment Period|Protocol Violation|0
1008248|NCT01475461|2026668|FG006|Treatment Period|Protocol Violation|1
1008249|NCT01475461|2026662|FG000|Treatment Period|Lack of Efficacy|0
1008250|NCT01475461|2026663|FG001|Treatment Period|Lack of Efficacy|2
1008251|NCT01475461|2026664|FG002|Treatment Period|Lack of Efficacy|0
1008252|NCT01475461|2026665|FG003|Treatment Period|Lack of Efficacy|2
1008253|NCT01475461|2026666|FG004|Treatment Period|Lack of Efficacy|1
1008254|NCT01475461|2026667|FG005|Treatment Period|Lack of Efficacy|1
1008255|NCT01475461|2026668|FG006|Treatment Period|Lack of Efficacy|0
1008256|NCT01475461|2026662|FG000|Treatment Period|Medication Error|0
1008257|NCT01475461|2026663|FG001|Treatment Period|Medication Error|0
1008258|NCT01475461|2026664|FG002|Treatment Period|Medication Error|0
1008259|NCT01475461|2026665|FG003|Treatment Period|Medication Error|1
1008260|NCT01475461|2026666|FG004|Treatment Period|Medication Error|0
1008261|NCT01475461|2026667|FG005|Treatment Period|Medication Error|0
1008262|NCT01475461|2026668|FG006|Treatment Period|Medication Error|0
1008263|NCT01475461|2026662|FG000|Treatment Period|Adverse Event|0
1008264|NCT01475461|2026663|FG001|Treatment Period|Adverse Event|0
1008265|NCT01475461|2026664|FG002|Treatment Period|Adverse Event|0
1008266|NCT01475461|2026665|FG003|Treatment Period|Adverse Event|1
1008267|NCT01475461|2026666|FG004|Treatment Period|Adverse Event|0
1008268|NCT01475461|2026667|FG005|Treatment Period|Adverse Event|0
1008269|NCT01475461|2026668|FG006|Treatment Period|Adverse Event|0
1008270|NCT01475474|2026701|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
1008271|NCT01475474|2026701|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2
1008272|NCT01475487|2026708|FG000|Overall Study|had to leave early for personal reasons|2
1008273|NCT01475487|2026709|FG001|Overall Study|had to leave early for personal reasons|1
1008274|NCT01475721|2026737|FG000|Overall Study|Death|3
1008275|NCT01475721|2026738|FG001|Overall Study|Death|6
1008276|NCT01475721|2026737|FG000|Overall Study|Withdrawal by Subject|8
1008277|NCT01475721|2026738|FG001|Overall Study|Withdrawal by Subject|8
1008278|NCT01475734|2026746|FG000|Overall Study|Withdrawal by Subject|1
1008279|NCT01475734|2026747|FG001|Overall Study|Withdrawal by Subject|0
1008280|NCT01475734|2026746|FG000|Overall Study|Protocol Violation|1
1008281|NCT01475734|2026747|FG001|Overall Study|Protocol Violation|0
1008282|NCT01475734|2026746|FG000|Overall Study|Physician Decision|0
1008283|NCT01475734|2026747|FG001|Overall Study|Physician Decision|1
1008284|NCT01475825|2026757|FG000|Overall Study|Adverse Event|41
1008285|NCT01475825|2026758|FG001|Overall Study|Adverse Event|15
1008286|NCT01475825|2026759|FG002|Overall Study|Adverse Event|27
1008287|NCT01475825|2026760|FG003|Overall Study|Adverse Event|11
1008288|NCT01475825|2026757|FG000|Overall Study|Death|1
1008289|NCT01475825|2026758|FG001|Overall Study|Death|0
1008290|NCT01475825|2026759|FG002|Overall Study|Death|1
1008291|NCT01475825|2026760|FG003|Overall Study|Death|0
1008292|NCT01475825|2026757|FG000|Overall Study|Lack of Efficacy|0
1008293|NCT01475825|2026758|FG001|Overall Study|Lack of Efficacy|0
1008294|NCT01475825|2026759|FG002|Overall Study|Lack of Efficacy|1
1008295|NCT01475825|2026760|FG003|Overall Study|Lack of Efficacy|0
1008296|NCT01475825|2026757|FG000|Overall Study|Lost to Follow-up|0
1008297|NCT01475825|2026758|FG001|Overall Study|Lost to Follow-up|0
1008298|NCT01475825|2026759|FG002|Overall Study|Lost to Follow-up|3
1008299|NCT01475825|2026760|FG003|Overall Study|Lost to Follow-up|1
1008300|NCT01475825|2026757|FG000|Overall Study|Non-compliance with Study Drug|1
1008301|NCT01475825|2026758|FG001|Overall Study|Non-compliance with Study Drug|2
1008302|NCT01475825|2026759|FG002|Overall Study|Non-compliance with Study Drug|4
1008303|NCT01475825|2026760|FG003|Overall Study|Non-compliance with Study Drug|0
1008304|NCT01475825|2026757|FG000|Overall Study|Other: Not available|0
1008305|NCT01475825|2026758|FG001|Overall Study|Other: Not available|0
1008306|NCT01475825|2026759|FG002|Overall Study|Other: Not available|2
1008307|NCT01475825|2026760|FG003|Overall Study|Other: Not available|0
1008308|NCT01475825|2026757|FG000|Overall Study|Protocol Violation|1
1008309|NCT01475825|2026758|FG001|Overall Study|Protocol Violation|0
1008310|NCT01475825|2026759|FG002|Overall Study|Protocol Violation|0
1008311|NCT01475825|2026760|FG003|Overall Study|Protocol Violation|0
1008312|NCT01475825|2026757|FG000|Overall Study|Physician Decision|0
1008313|NCT01475825|2026758|FG001|Overall Study|Physician Decision|1
1008314|NCT01475825|2026759|FG002|Overall Study|Physician Decision|0
1008315|NCT01475825|2026760|FG003|Overall Study|Physician Decision|0
1008316|NCT01475825|2026757|FG000|Overall Study|Withdrawal by Subject|8
1008317|NCT01475825|2026758|FG001|Overall Study|Withdrawal by Subject|3
1008318|NCT01475825|2026759|FG002|Overall Study|Withdrawal by Subject|11
1008319|NCT01475825|2026760|FG003|Overall Study|Withdrawal by Subject|7
1008320|NCT01475825|2026757|FG000|Overall Study|Did not enter OLC|15
1008321|NCT01475825|2026758|FG001|Overall Study|Did not enter OLC|11
1008322|NCT01475825|2026759|FG002|Overall Study|Did not enter OLC|15
1008323|NCT01475825|2026760|FG003|Overall Study|Did not enter OLC|11
1008324|NCT01475838|2026772|FG000|Randomized Phase|Randomized but Not Treated|0
1008325|NCT01475838|2026773|FG001|Randomized Phase|Randomized but Not Treated|5
1008326|NCT01475838|2026772|FG000|Randomized Phase|Adverse Event|6
1008327|NCT01475838|2026773|FG001|Randomized Phase|Adverse Event|1
1008328|NCT01475838|2026772|FG000|Randomized Phase|Pregnancy|0
1008329|NCT01475838|2026773|FG001|Randomized Phase|Pregnancy|1
1008330|NCT01475838|2026772|FG000|Randomized Phase|Investigators Discretion|1
1008331|NCT01475838|2026773|FG001|Randomized Phase|Investigators Discretion|2
1008332|NCT01475838|2026772|FG000|Randomized Phase|Withdrew Consent|10
1008333|NCT01475838|2026773|FG001|Randomized Phase|Withdrew Consent|14
1008334|NCT01475838|2026772|FG000|Randomized Phase|Lost to Follow-up|3
1008335|NCT01475838|2026773|FG001|Randomized Phase|Lost to Follow-up|4
1008336|NCT01475838|2026772|FG000|Randomized Phase|Participant Noncompliance|1
1008337|NCT01475838|2026773|FG001|Randomized Phase|Participant Noncompliance|5
1008338|NCT01475838|2026772|FG000|Randomized Phase|Protocol Violation|9
1008339|NCT01475838|2026773|FG001|Randomized Phase|Protocol Violation|4
1008340|NCT01475838|2026772|FG000|Extension Phase|Participant Noncompliance|1
1008341|NCT01475838|2026773|FG001|Extension Phase|Participant Noncompliance|0
1008342|NCT01475851|2026782|FG000|Overall Study|Protocol defined stopping criteria|1
1008343|NCT01475851|2026783|FG001|Overall Study|Protocol defined stopping criteria|0
1008344|NCT01476475|2026867|FG000|Overall Study|Adverse Event|6
1008345|NCT01476475|2026868|FG001|Overall Study|Adverse Event|0
1008346|NCT01476475|2026867|FG000|Overall Study|Poor compliance to protocol|1
1008347|NCT01476475|2026868|FG001|Overall Study|Poor compliance to protocol|1
1008348|NCT01476475|2026867|FG000|Overall Study|Other reasons|4
1008349|NCT01476475|2026868|FG001|Overall Study|Other reasons|2
1008350|NCT01476644|2026875|FG000|Overall Study|Death|5
1008351|NCT01476644|2026875|FG000|Overall Study|moved to another state|2
1008352|NCT01476644|2026875|FG000|Overall Study|Lost to Follow-up|19
1008353|NCT01476644|2026875|FG000|Overall Study|Withdrawal by Subject|13
1008354|NCT01476696|2026880|FG000|Overall Study|Sponsor decision|2
1008355|NCT01476696|2026881|FG001|Overall Study|Sponsor decision|1
1008356|NCT01476696|2026882|FG002|Overall Study|Sponsor decision|0
1008357|NCT01476696|2026880|FG000|Overall Study|Withdrawal by Subject|1
1008358|NCT01476696|2026881|FG001|Overall Study|Withdrawal by Subject|0
1008359|NCT01476696|2026882|FG002|Overall Study|Withdrawal by Subject|0
1008360|NCT01476722|2026895|FG000|Overall Study|Adverse Event|1
1008361|NCT01477333|2026921|FG000|Overall Study|Adverse Event|1
1008362|NCT01477333|2026921|FG000|Overall Study|Withdrawal by Subject|1
1008363|NCT01477333|2026921|FG000|Overall Study|Clinical Deterioration|1
1008364|NCT01477749|2026995|FG000|Overall Study|Physician Decision|4
1008365|NCT01477853|2027019|FG000|Phase A|Adverse Event|1
1008366|NCT01477853|2027020|FG001|Phase A|Adverse Event|2
1008367|NCT01477853|2027021|FG002|Phase A|Adverse Event|2
1008368|NCT01477853|2027019|FG000|Phase A|Lost to Follow-up|4
1008369|NCT01477853|2027020|FG001|Phase A|Lost to Follow-up|3
1008370|NCT01477853|2027021|FG002|Phase A|Lost to Follow-up|2
1008371|NCT01477853|2027019|FG000|Phase A|Physician Decision|1
1008372|NCT01477853|2027020|FG001|Phase A|Physician Decision|0
1008373|NCT01477853|2027021|FG002|Phase A|Physician Decision|1
1008374|NCT01477853|2027019|FG000|Phase A|Study terminated by sponsor|37
1008375|NCT01477853|2027020|FG001|Phase A|Study terminated by sponsor|40
1008376|NCT01477853|2027021|FG002|Phase A|Study terminated by sponsor|39
1008377|NCT01477853|2027019|FG000|Phase B|Lost to Follow-up|0
1008378|NCT01477853|2027020|FG001|Phase B|Lost to Follow-up|1
1008379|NCT01477853|2027021|FG002|Phase B|Lost to Follow-up|0
1008380|NCT01477853|2027019|FG000|Phase B|Study terminated by sponsor|12
1008381|NCT01477853|2027020|FG001|Phase B|Study terminated by sponsor|10
1008382|NCT01477853|2027021|FG002|Phase B|Study terminated by sponsor|11
1008383|NCT01477892|2027031|FG000|Overall Study|Withdrawal by Subject|0
1008384|NCT01477892|2027032|FG001|Overall Study|Withdrawal by Subject|2
1008385|NCT01478048|2027049|FG000|Overall Study|Disease Progression|52
1008386|NCT01478048|2027050|FG001|Overall Study|Disease Progression|35
1008387|NCT01478048|2027049|FG000|Overall Study|study drug toxicity|11
1008388|NCT01478048|2027050|FG001|Overall Study|study drug toxicity|14
1008389|NCT01478048|2027049|FG000|Overall Study|Adverse Event|2
1008390|NCT01478048|2027050|FG001|Overall Study|Adverse Event|11
1008391|NCT01478048|2027049|FG000|Overall Study|subject request to discontinue treatment|3
1008392|NCT01478048|2027050|FG001|Overall Study|subject request to discontinue treatment|5
1008393|NCT01478048|2027049|FG000|Overall Study|Withdrawal by Subject|2
1008394|NCT01478048|2027050|FG001|Overall Study|Withdrawal by Subject|5
1008395|NCT01478048|2027049|FG000|Overall Study|non-specified|6
1008396|NCT01478048|2027050|FG001|Overall Study|non-specified|4
1008397|NCT01478048|2027049|FG000|Overall Study|poor/non-compliance|0
1008398|NCT01478048|2027050|FG001|Overall Study|poor/non-compliance|1
1008399|NCT01478048|2027049|FG000|Overall Study|no longer meets study criteria|1
1008400|NCT01478048|2027050|FG001|Overall Study|no longer meets study criteria|0
1008401|NCT01478087|2027056|FG000|Overall Study|due to sponsor closing study|1
1008402|NCT01478321|2027071|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4
1008403|NCT01478321|2027071|FG000|Concurrent Therapy (5 Weeks)|Death|2
1008404|NCT01478321|2027071|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
1008405|NCT01478321|2027071|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5
1008406|NCT01478321|2027071|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1
1008407|NCT01478321|2027071|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1
1008408|NCT01478321|2027071|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
1008409|NCT01478321|2027071|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
1008410|NCT01478347|2027075|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
1008411|NCT01478347|2027075|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
1008412|NCT01478347|2027075|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
1008413|NCT01478360|2027081|FG000|Overall Study|Lost to Follow-up|1
1008414|NCT01478360|2027082|FG001|Overall Study|Lost to Follow-up|0
1008415|NCT01478360|2027081|FG000|Overall Study|Adverse Event|0
1008416|NCT01478360|2027082|FG001|Overall Study|Adverse Event|1
1008417|NCT01478360|2027081|FG000|Overall Study|Administrative problems|1
1008418|NCT01478360|2027082|FG001|Overall Study|Administrative problems|2
1008419|NCT01478373|2027088|FG000|Treatment Phase|Protocol Violation|1
1008420|NCT01478373|2027088|FG000|Survival Phase|Adverse Event|8
1008421|NCT01478373|2027088|FG000|Survival Phase|Protocol Violation|1
1008422|NCT01478373|2027088|FG000|Survival Phase|crossover to another study|2
1008423|NCT01478373|2027088|FG000|Survival Phase|Progressive Disease|27
1008424|NCT01478594|2027115|FG000|Overall Study|Randomized but Never Received Study Drug|0
1008425|NCT01478594|2027116|FG001|Overall Study|Randomized but Never Received Study Drug|1
1008426|NCT01478594|2027115|FG000|Overall Study|Death|45
1008427|NCT01478594|2027116|FG001|Overall Study|Death|18
1008428|NCT01478594|2027115|FG000|Overall Study|Lost to Follow-up|3
1008429|NCT01478594|2027116|FG001|Overall Study|Lost to Follow-up|1
1008430|NCT01478594|2027115|FG000|Overall Study|Withdrawal by Subject|9
1008431|NCT01478594|2027116|FG001|Overall Study|Withdrawal by Subject|3
1008432|NCT01478594|2027115|FG000|Overall Study|Study Closed by Sponsor|8
1008433|NCT01478594|2027116|FG001|Overall Study|Study Closed by Sponsor|5
1008434|NCT01478620|2027175|FG000|Overall Study|Lost to Follow-up|6
1008435|NCT01478828|2027179|FG000|Overall Study|Adverse Event|1
1008436|NCT01478958|2027191|FG000|Overall Study|Withdrawal by Subject|1
1008437|NCT01478958|2027192|FG001|Overall Study|Withdrawal by Subject|1
1008438|NCT01478958|2027193|FG002|Overall Study|Withdrawal by Subject|1
1008439|NCT01478958|2027191|FG000|Overall Study|Weight loss|1
1008440|NCT01478958|2027192|FG001|Overall Study|Weight loss|0
1008441|NCT01478958|2027193|FG002|Overall Study|Weight loss|0
1008442|NCT01478958|2027191|FG000|Overall Study|Re-located|0
1008443|NCT01478958|2027192|FG001|Overall Study|Re-located|1
1008444|NCT01478958|2027193|FG002|Overall Study|Re-located|0
1008445|NCT01478958|2027191|FG000|Overall Study|Unable to comply|0
1008446|NCT01478958|2027192|FG001|Overall Study|Unable to comply|0
1008447|NCT01478958|2027193|FG002|Overall Study|Unable to comply|2
1008448|NCT01478971|2027201|FG000|Standard of Care Period|Adverse Event|1
1008449|NCT01478971|2027201|FG000|Standard of Care Period|Withdrawal by Subject|3
1008450|NCT01478971|2027201|FG000|Standard of Care Period|Death|8
1008451|NCT01478971|2027201|FG000|Standard of Care Period|Lost to Follow-up|9
1008452|NCT01478971|2027201|FG000|Standard of Care Period|Other|4
1008453|NCT01478971|2027201|FG000|Peginesatide Treatment Period|Adverse Event|1
1008454|NCT01478971|2027201|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1
1008455|NCT01478971|2027201|FG000|Peginesatide Treatment Period|Death|4
1008456|NCT01478971|2027201|FG000|Peginesatide Treatment Period|Lost to Follow-up|4
1008457|NCT01478971|2027201|FG000|Peginesatide Treatment Period|Other|4
1008458|NCT01479374|2027237|FG000|Overall Study|Adverse Event|2
1008459|NCT01479374|2027238|FG001|Overall Study|Adverse Event|1
1008460|NCT01479374|2027239|FG002|Overall Study|Adverse Event|0
1008461|NCT01479374|2027237|FG000|Overall Study|Lost to Follow-up|1
1008462|NCT01479374|2027238|FG001|Overall Study|Lost to Follow-up|2
1008463|NCT01479374|2027239|FG002|Overall Study|Lost to Follow-up|0
1008464|NCT01479374|2027237|FG000|Overall Study|Decision Unrelated to Adverse Event|0
1008465|NCT01479374|2027238|FG001|Overall Study|Decision Unrelated to Adverse Event|1
1008466|NCT01479374|2027239|FG002|Overall Study|Decision Unrelated to Adverse Event|0
1008467|NCT01479374|2027237|FG000|Overall Study|Other|0
1008468|NCT01479374|2027238|FG001|Overall Study|Other|4
1008469|NCT01479374|2027239|FG002|Overall Study|Other|5
1008470|NCT01479439|2027259|FG000|Overall Study|Adverse Event|1
1008471|NCT01479439|2027260|FG001|Overall Study|Adverse Event|0
1008472|NCT01479439|2027261|FG002|Overall Study|Adverse Event|0
1008473|NCT01479439|2027259|FG000|Overall Study|Lost to Follow-up|0
1008474|NCT01479439|2027260|FG001|Overall Study|Lost to Follow-up|1
1008475|NCT01479439|2027261|FG002|Overall Study|Lost to Follow-up|0
1008476|NCT01479439|2027259|FG000|Overall Study|Protocol Violation|0
1008477|NCT01479439|2027260|FG001|Overall Study|Protocol Violation|0
1008478|NCT01479439|2027261|FG002|Overall Study|Protocol Violation|2
1008479|NCT01479465|2027276|FG000|Overall Study|Disease Progression|9
1008480|NCT01479465|2027277|FG001|Overall Study|Disease Progression|61
1008481|NCT01479465|2027278|FG002|Overall Study|Disease Progression|65
1008482|NCT01479465|2027279|FG003|Overall Study|Disease Progression|70
1008483|NCT01479465|2027276|FG000|Overall Study|Study Discontinued by Sponsor|0
1008484|NCT01479465|2027277|FG001|Overall Study|Study Discontinued by Sponsor|7
1008485|NCT01479465|2027278|FG002|Overall Study|Study Discontinued by Sponsor|5
1008486|NCT01479465|2027279|FG003|Overall Study|Study Discontinued by Sponsor|3
1008487|NCT01479465|2027276|FG000|Overall Study|Adverse Event|0
1008488|NCT01479465|2027277|FG001|Overall Study|Adverse Event|3
1008489|NCT01479465|2027278|FG002|Overall Study|Adverse Event|6
1008490|NCT01479465|2027279|FG003|Overall Study|Adverse Event|4
1008491|NCT01479465|2027276|FG000|Overall Study|Investigator Discretion|1
1008492|NCT01479465|2027277|FG001|Overall Study|Investigator Discretion|4
1008493|NCT01479465|2027278|FG002|Overall Study|Investigator Discretion|2
1008494|NCT01479465|2027279|FG003|Overall Study|Investigator Discretion|4
1008495|NCT01479465|2027276|FG000|Overall Study|Subject Request|1
1008496|NCT01479465|2027277|FG001|Overall Study|Subject Request|3
1008497|NCT01479465|2027278|FG002|Overall Study|Subject Request|4
1008498|NCT01479465|2027279|FG003|Overall Study|Subject Request|2
1008499|NCT01479465|2027276|FG000|Overall Study|Subject Withdrew Consent|0
1008500|NCT01479465|2027277|FG001|Overall Study|Subject Withdrew Consent|5
1008501|NCT01479465|2027278|FG002|Overall Study|Subject Withdrew Consent|2
1008502|NCT01479465|2027279|FG003|Overall Study|Subject Withdrew Consent|1
1008503|NCT01479465|2027276|FG000|Overall Study|Protocol Violation|0
1008504|NCT01479465|2027277|FG001|Overall Study|Protocol Violation|1
1008505|NCT01479465|2027278|FG002|Overall Study|Protocol Violation|1
1008506|NCT01479465|2027279|FG003|Overall Study|Protocol Violation|0
1008507|NCT01479465|2027276|FG000|Overall Study|Death|0
1008508|NCT01479465|2027277|FG001|Overall Study|Death|0
1008509|NCT01479465|2027278|FG002|Overall Study|Death|0
1008510|NCT01479465|2027279|FG003|Overall Study|Death|1
1008511|NCT01479465|2027276|FG000|Overall Study|Lost to Follow-up|0
1008512|NCT01479465|2027277|FG001|Overall Study|Lost to Follow-up|0
1008513|NCT01479465|2027278|FG002|Overall Study|Lost to Follow-up|1
1008514|NCT01479465|2027279|FG003|Overall Study|Lost to Follow-up|0
1008515|NCT01479530|2027313|FG000|Overall Study|Adverse Event|5
1008516|NCT01479530|2027314|FG001|Overall Study|Adverse Event|6
1008517|NCT01479530|2027313|FG000|Overall Study|Lack of Efficacy|0
1008518|NCT01479530|2027314|FG001|Overall Study|Lack of Efficacy|1
1008519|NCT01479530|2027313|FG000|Overall Study|Protocol Violation|2
1008520|NCT01479530|2027314|FG001|Overall Study|Protocol Violation|3
1008521|NCT01479530|2027313|FG000|Overall Study|Withdrawal of Consent|3
1008522|NCT01479530|2027314|FG001|Overall Study|Withdrawal of Consent|2
1008523|NCT01479595|2027343|FG000|Overall Study|Protocol deviation|0
1008524|NCT01479595|2027344|FG001|Overall Study|Protocol deviation|1
1008525|NCT01479595|2027343|FG000|Overall Study|Adverse Event|2
1008526|NCT01479595|2027344|FG001|Overall Study|Adverse Event|1
1008527|NCT01479621|2027356|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
1008528|NCT01479621|2027357|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1008529|NCT01479621|2027358|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1008530|NCT01479621|2027359|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1008531|NCT01479621|2027360|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1008532|NCT01479621|2027361|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1008533|NCT01479621|2027362|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1008534|NCT01479621|2027356|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
1008535|NCT01479621|2027357|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1008536|NCT01479621|2027358|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1008537|NCT01479621|2027359|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1008538|NCT01479621|2027360|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1008539|NCT01479621|2027361|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1008540|NCT01479621|2027362|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1008541|NCT01479621|2027356|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
1008542|NCT01479621|2027357|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1008543|NCT01479621|2027358|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1008544|NCT01479621|2027359|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1008545|NCT01479621|2027360|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1008546|NCT01479621|2027361|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1008547|NCT01479621|2027362|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1008548|NCT01479621|2027356|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
1008549|NCT01479621|2027357|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1008550|NCT01479621|2027358|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1008551|NCT01479621|2027359|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1008552|NCT01479621|2027360|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1008553|NCT01479621|2027361|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1008554|NCT01479621|2027362|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1008555|NCT01479621|2027356|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
914257|NCT00813761|1891999|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
914258|NCT00813761|1892000|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
914259|NCT00813761|1892001|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
914260|NCT00813761|1892002|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
914261|NCT00813761|1891999|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
914262|NCT00813761|1892000|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
914263|NCT00813761|1892001|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
914264|NCT00813761|1892002|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
914265|NCT00813761|1891999|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
914266|NCT00813761|1892000|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
914267|NCT00813761|1892001|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
914268|NCT00813761|1892002|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
914269|NCT00813761|1891999|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
914270|NCT00813761|1892000|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
914271|NCT00813761|1892001|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
914272|NCT00813761|1892002|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
914273|NCT00813761|1891999|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
914274|NCT00813761|1892000|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
914275|NCT00813761|1892001|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
914276|NCT00813761|1892002|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
914277|NCT00813761|1891999|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
1008556|NCT01479621|2027357|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
1008557|NCT01479621|2027358|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
1008558|NCT01479621|2027359|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
1008559|NCT01479621|2027360|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
1008560|NCT01479621|2027361|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
1008561|NCT01479621|2027362|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
1008562|NCT01479621|2027356|FG000|Treatment Period|Adverse Event|0
1008563|NCT01479621|2027357|FG001|Treatment Period|Adverse Event|0
1008564|NCT01479621|2027358|FG002|Treatment Period|Adverse Event|0
1008565|NCT01479621|2027359|FG003|Treatment Period|Adverse Event|0
1008566|NCT01479621|2027360|FG004|Treatment Period|Adverse Event|1
1008567|NCT01479621|2027361|FG005|Treatment Period|Adverse Event|2
1008568|NCT01479621|2027362|FG006|Treatment Period|Adverse Event|2
1008569|NCT01479621|2027356|FG000|Treatment Period|Withdrawal by Subject|0
1008570|NCT01479621|2027357|FG001|Treatment Period|Withdrawal by Subject|4
1008571|NCT01479621|2027358|FG002|Treatment Period|Withdrawal by Subject|2
1008572|NCT01479621|2027359|FG003|Treatment Period|Withdrawal by Subject|2
1008573|NCT01479621|2027360|FG004|Treatment Period|Withdrawal by Subject|5
1008574|NCT01479621|2027361|FG005|Treatment Period|Withdrawal by Subject|5
1008575|NCT01479621|2027362|FG006|Treatment Period|Withdrawal by Subject|1
1008576|NCT01479621|2027356|FG000|Treatment Period|Physician Decision|0
1008577|NCT01479621|2027357|FG001|Treatment Period|Physician Decision|0
1008578|NCT01479621|2027358|FG002|Treatment Period|Physician Decision|0
1008579|NCT01479621|2027359|FG003|Treatment Period|Physician Decision|0
1008580|NCT01479621|2027360|FG004|Treatment Period|Physician Decision|1
1008581|NCT01479621|2027361|FG005|Treatment Period|Physician Decision|1
1008582|NCT01479621|2027362|FG006|Treatment Period|Physician Decision|0
1008583|NCT01479621|2027356|FG000|Treatment Period|Non-compliance to study drug|0
1008584|NCT01479621|2027357|FG001|Treatment Period|Non-compliance to study drug|1
1008585|NCT01479621|2027358|FG002|Treatment Period|Non-compliance to study drug|0
1008586|NCT01479621|2027359|FG003|Treatment Period|Non-compliance to study drug|0
1008587|NCT01479621|2027360|FG004|Treatment Period|Non-compliance to study drug|0
1008588|NCT01479621|2027361|FG005|Treatment Period|Non-compliance to study drug|0
1008589|NCT01479621|2027362|FG006|Treatment Period|Non-compliance to study drug|1
1008590|NCT01479621|2027356|FG000|Treatment Period|Protocol Violation|0
1008591|NCT01479621|2027357|FG001|Treatment Period|Protocol Violation|9
1008592|NCT01479621|2027358|FG002|Treatment Period|Protocol Violation|6
1008593|NCT01479621|2027359|FG003|Treatment Period|Protocol Violation|5
1008594|NCT01479621|2027360|FG004|Treatment Period|Protocol Violation|2
1008595|NCT01479621|2027361|FG005|Treatment Period|Protocol Violation|10
1008596|NCT01479621|2027362|FG006|Treatment Period|Protocol Violation|6
1008597|NCT01479621|2027356|FG000|Treatment Period|Pregnancy|0
1008598|NCT01479621|2027357|FG001|Treatment Period|Pregnancy|0
1008599|NCT01479621|2027358|FG002|Treatment Period|Pregnancy|2
1008600|NCT01479621|2027359|FG003|Treatment Period|Pregnancy|0
1008601|NCT01479621|2027360|FG004|Treatment Period|Pregnancy|0
1008602|NCT01479621|2027361|FG005|Treatment Period|Pregnancy|0
1008603|NCT01479621|2027362|FG006|Treatment Period|Pregnancy|0
1008604|NCT01479621|2027356|FG000|Treatment Period|Sponsor request subject to be withdrawn|0
1008605|NCT01479621|2027357|FG001|Treatment Period|Sponsor request subject to be withdrawn|2
1008606|NCT01479621|2027358|FG002|Treatment Period|Sponsor request subject to be withdrawn|3
1008607|NCT01479621|2027359|FG003|Treatment Period|Sponsor request subject to be withdrawn|1
1008608|NCT01479621|2027360|FG004|Treatment Period|Sponsor request subject to be withdrawn|1
1008609|NCT01479621|2027361|FG005|Treatment Period|Sponsor request subject to be withdrawn|1
1008610|NCT01479621|2027362|FG006|Treatment Period|Sponsor request subject to be withdrawn|3
1008611|NCT01479621|2027356|FG000|Treatment Period|Lost to Follow-up|0
1008612|NCT01479621|2027357|FG001|Treatment Period|Lost to Follow-up|0
1008613|NCT01479621|2027358|FG002|Treatment Period|Lost to Follow-up|1
1008614|NCT01479621|2027359|FG003|Treatment Period|Lost to Follow-up|0
1008615|NCT01479621|2027360|FG004|Treatment Period|Lost to Follow-up|2
1008616|NCT01479621|2027361|FG005|Treatment Period|Lost to Follow-up|2
1008617|NCT01479621|2027362|FG006|Treatment Period|Lost to Follow-up|1
1008618|NCT01479621|2027356|FG000|Treatment Period|Met stopping criteria|0
1008619|NCT01479621|2027357|FG001|Treatment Period|Met stopping criteria|8
1008620|NCT01479621|2027358|FG002|Treatment Period|Met stopping criteria|7
1008621|NCT01479621|2027359|FG003|Treatment Period|Met stopping criteria|4
1008622|NCT01479621|2027360|FG004|Treatment Period|Met stopping criteria|9
1008623|NCT01479621|2027361|FG005|Treatment Period|Met stopping criteria|20
1008624|NCT01479621|2027362|FG006|Treatment Period|Met stopping criteria|6
1008625|NCT01479764|2027387|FG000|Randomized|Adverse Event|1
1008626|NCT01479764|2027388|FG001|Randomized|Adverse Event|1
1008627|NCT01479764|2027387|FG000|Randomized|Withdrawal by Subject|1
1008628|NCT01479764|2027388|FG001|Randomized|Withdrawal by Subject|0
1008629|NCT01479764|2027387|FG000|Treated|Lost to Follow-up|0
1008630|NCT01479764|2027388|FG001|Treated|Lost to Follow-up|2
1008631|NCT01479777|2027394|FG000|Overall Study|Physician Decision|2
1008632|NCT01479868|2027398|FG000|Overall Study|Adverse Event|1
1008633|NCT01479868|2027398|FG000|Overall Study|Lost to Follow-up|4
1008634|NCT01479868|2027398|FG000|Overall Study|Protocol Violation|1
1008635|NCT01479868|2027398|FG000|Overall Study|Withdrawal by Subject|1
1008636|NCT01479868|2027398|FG000|Overall Study|Sponsor's Decision|1
1008637|NCT01479868|2027398|FG000|Overall Study|Initiation of new HCV Therapy|1
1008638|NCT01479985|2027404|FG000|Overall Study|Tablet malfunction, no data saved|1
1008639|NCT01479985|2027405|FG001|Overall Study|Tablet malfunction, no data saved|1
1008640|NCT01479985|2027404|FG000|Overall Study|No decisional conflict scale responses|0
1008641|NCT01479985|2027405|FG001|Overall Study|No decisional conflict scale responses|2
1008642|NCT01479985|2027404|FG000|Overall Study|No post-visit survey|5
1008643|NCT01479985|2027405|FG001|Overall Study|No post-visit survey|3
1008644|NCT01480076|2027413|FG000|Overall Study|Run-in Failure|52
1008645|NCT01480076|2027413|FG000|Overall Study|Adverse Event|39
1008646|NCT01480076|2027413|FG000|Overall Study|Death|2
1008647|NCT01480076|2027413|FG000|Overall Study|Disease Progression|5
1008648|NCT01480076|2027413|FG000|Overall Study|Non-compliance With Study Protocol|15
1008649|NCT01480076|2027413|FG000|Overall Study|Withdrawal by Subject|105
1008650|NCT01480076|2027413|FG000|Overall Study|Lost to Follow-up|7
1008651|NCT01480076|2027413|FG000|Overall Study|Investigator Decision|13
1008652|NCT01480076|2027413|FG000|Overall Study|Other|52
1008653|NCT01480258|2027494|FG000|Infant Series|Protocol Violation|2
1008654|NCT01480258|2027495|FG001|Infant Series|Protocol Violation|0
1008655|NCT01480258|2027494|FG000|Infant Series|Physician Decision|0
1008656|NCT01480258|2027495|FG001|Infant Series|Physician Decision|1
1008657|NCT01480258|2027494|FG000|Infant Series|Not Vaccinated|3
1008658|NCT01480258|2027495|FG001|Infant Series|Not Vaccinated|0
1008659|NCT01480258|2027494|FG000|Infant Series|Adverse Event|1
1008660|NCT01480258|2027495|FG001|Infant Series|Adverse Event|1
1008661|NCT01480258|2027494|FG000|Infant Series|Withdrawal by Subject|1
1008662|NCT01480258|2027495|FG001|Infant Series|Withdrawal by Subject|6
1008663|NCT01480258|2027494|FG000|Interim Period|Lost to Follow-up|0
1008664|NCT01480258|2027495|FG001|Interim Period|Lost to Follow-up|2
1008665|NCT01480258|2027494|FG000|Interim Period|Physician Decision|1
1008666|NCT01480258|2027495|FG001|Interim Period|Physician Decision|0
1008667|NCT01480258|2027494|FG000|Interim Period|Protocol Violation|0
1008668|NCT01480258|2027495|FG001|Interim Period|Protocol Violation|1
1008669|NCT01480258|2027494|FG000|Interim Period|Withdrawal by Subject|9
1008670|NCT01480258|2027495|FG001|Interim Period|Withdrawal by Subject|6
1008671|NCT01480284|2027503|FG000|Overall Study|Withdrawal by Subject|2
1008672|NCT01480284|2027504|FG001|Overall Study|Withdrawal by Subject|0
1008673|NCT01480284|2027503|FG000|Overall Study|Adverse Event|1
1008674|NCT01480284|2027504|FG001|Overall Study|Adverse Event|0
1008675|NCT01480284|2027503|FG000|Overall Study|Study closed/terminated|3
1008676|NCT01480284|2027504|FG001|Overall Study|Study closed/terminated|0
1008677|NCT01480284|2027503|FG000|Overall Study|Lost to Follow-up|1
1008678|NCT01480284|2027504|FG001|Overall Study|Lost to Follow-up|0
1008679|NCT01480284|2027503|FG000|Overall Study|Physician Decision|1
1008680|NCT01480284|2027504|FG001|Overall Study|Physician Decision|0
1008681|NCT01480596|2027516|FG000|Overall Study|Adverse Event|3
1008682|NCT01480596|2027517|FG001|Overall Study|Adverse Event|0
1008683|NCT01480596|2027516|FG000|Overall Study|MG exacerbation or change in medication|2
1008684|NCT01480596|2027517|FG001|Overall Study|MG exacerbation or change in medication|2
1008685|NCT01480674|2027523|FG000|Overall Study|Death|23
1008686|NCT01480674|2027523|FG000|Overall Study|Lost to Follow-up|2
1008687|NCT01480674|2027523|FG000|Overall Study|visit not done|10
1008688|NCT01481116|2027534|FG000|Overall Study|Adverse Event|26
1008689|NCT01481116|2027535|FG001|Overall Study|Adverse Event|26
1008690|NCT01481116|2027536|FG002|Overall Study|Adverse Event|42
1008691|NCT01481116|2027534|FG000|Overall Study|Major Protocol Deviation|3
1008692|NCT01481116|2027535|FG001|Overall Study|Major Protocol Deviation|7
1008693|NCT01481116|2027536|FG002|Overall Study|Major Protocol Deviation|1
1008694|NCT01481116|2027534|FG000|Overall Study|Lost to Follow-up|8
1008695|NCT01481116|2027535|FG001|Overall Study|Lost to Follow-up|12
1008696|NCT01481116|2027536|FG002|Overall Study|Lost to Follow-up|11
1008697|NCT01481116|2027534|FG000|Overall Study|Withdrawal by Subject|37
1008698|NCT01481116|2027535|FG001|Overall Study|Withdrawal by Subject|33
1008699|NCT01481116|2027536|FG002|Overall Study|Withdrawal by Subject|37
1008700|NCT01481116|2027534|FG000|Overall Study|Study Termination|730
1008701|NCT01481116|2027535|FG001|Overall Study|Study Termination|729
1008702|NCT01481116|2027536|FG002|Overall Study|Study Termination|713
1008703|NCT01481116|2027534|FG000|Overall Study|Pregnancy|0
1008704|NCT01481116|2027535|FG001|Overall Study|Pregnancy|0
1008705|NCT01481116|2027536|FG002|Overall Study|Pregnancy|1
1008706|NCT01481116|2027534|FG000|Overall Study|Lack of Efficacy|3
1008707|NCT01481116|2027535|FG001|Overall Study|Lack of Efficacy|3
1008708|NCT01481116|2027536|FG002|Overall Study|Lack of Efficacy|1
1008709|NCT01481116|2027534|FG000|Overall Study|Contraindications|1
1008710|NCT01481116|2027535|FG001|Overall Study|Contraindications|1
1008711|NCT01481116|2027536|FG002|Overall Study|Contraindications|0
1008712|NCT01481116|2027534|FG000|Overall Study|Other|1
1008713|NCT01481116|2027535|FG001|Overall Study|Other|1
1008714|NCT01481116|2027536|FG002|Overall Study|Other|0
1008715|NCT01481116|2027534|FG000|Overall Study|Participant Started Taking Glipizide|1
1008716|NCT01481116|2027535|FG001|Overall Study|Participant Started Taking Glipizide|0
1008717|NCT01481116|2027536|FG002|Overall Study|Participant Started Taking Glipizide|0
1008718|NCT01481116|2027534|FG000|Overall Study|Participant Moved Out of Area|2
1008719|NCT01481116|2027535|FG001|Overall Study|Participant Moved Out of Area|0
1008720|NCT01481116|2027536|FG002|Overall Study|Participant Moved Out of Area|1
1008721|NCT01481116|2027534|FG000|Overall Study|Participant Moved Out of Country|1
1008722|NCT01481116|2027535|FG001|Overall Study|Participant Moved Out of Country|0
1008723|NCT01481116|2027536|FG002|Overall Study|Participant Moved Out of Country|1
1008724|NCT01481116|2027534|FG000|Overall Study|Investigator Decision|3
1008725|NCT01481116|2027535|FG001|Overall Study|Investigator Decision|2
1008726|NCT01481116|2027536|FG002|Overall Study|Investigator Decision|1
1008727|NCT01481116|2027534|FG000|Overall Study|Sponsor Decision|0
1008728|NCT01481116|2027535|FG001|Overall Study|Sponsor Decision|1
1008729|NCT01481116|2027536|FG002|Overall Study|Sponsor Decision|3
1008730|NCT01481116|2027534|FG000|Overall Study|Non-Compliant With Study Drug|0
1008731|NCT01481116|2027535|FG001|Overall Study|Non-Compliant With Study Drug|1
1008732|NCT01481116|2027536|FG002|Overall Study|Non-Compliant With Study Drug|1
1008733|NCT01481116|2027534|FG000|Overall Study|Investigator's Discretion|2
1008734|NCT01481116|2027535|FG001|Overall Study|Investigator's Discretion|0
1008735|NCT01481116|2027536|FG002|Overall Study|Investigator's Discretion|0
1008736|NCT01481116|2027534|FG000|Overall Study|Death|2
1008737|NCT01481116|2027535|FG001|Overall Study|Death|1
1008738|NCT01481116|2027536|FG002|Overall Study|Death|0
1008739|NCT01481116|2027534|FG000|Overall Study|Hypoglycemic Event|4
1008740|NCT01481116|2027535|FG001|Overall Study|Hypoglycemic Event|0
1008741|NCT01481116|2027536|FG002|Overall Study|Hypoglycemic Event|0
1008742|NCT01481324|2027551|FG000|Overall Study|Missing Data|0
1008743|NCT01481324|2027552|FG001|Overall Study|Missing Data|2
1008744|NCT01481324|2027553|FG002|Overall Study|Missing Data|2
1008745|NCT01481779|2027596|FG000|Overall Study|Adverse Event|23
1008746|NCT01481779|2027597|FG001|Overall Study|Adverse Event|5
1008747|NCT01481779|2027596|FG000|Overall Study|Lost to Follow-up|3
1008748|NCT01481779|2027597|FG001|Overall Study|Lost to Follow-up|2
1008749|NCT01481779|2027596|FG000|Overall Study|Protocol Violation|2
1008750|NCT01481779|2027597|FG001|Overall Study|Protocol Violation|3
1008751|NCT01481779|2027596|FG000|Overall Study|Withdrawal by Subject|26
1008752|NCT01481779|2027597|FG001|Overall Study|Withdrawal by Subject|13
1008753|NCT01481779|2027596|FG000|Overall Study|Physician Decision|13
1008754|NCT01481779|2027597|FG001|Overall Study|Physician Decision|4
1008755|NCT01481779|2027596|FG000|Overall Study|Sponsor Decision|3
1008756|NCT01481779|2027597|FG001|Overall Study|Sponsor Decision|1
1008757|NCT01481896|2027603|FG000|Overall Study|Lost to Follow-up|12
1008758|NCT01482065|2027628|FG000|Overall Study|Withdrawal by Subject|0
1008759|NCT01482065|2027629|FG001|Overall Study|Withdrawal by Subject|1
1008760|NCT01482169|2027644|FG000|Overall Study|Physician Decision|2
1008761|NCT01482221|2027659|FG000|Overall Study|Lack of Efficacy|1
1008762|NCT01482221|2027660|FG001|Overall Study|Lack of Efficacy|0
1008763|NCT01482221|2027661|FG002|Overall Study|Lack of Efficacy|1
1008764|NCT01482221|2027659|FG000|Overall Study|Lost to Follow-up|3
1008765|NCT01482221|2027660|FG001|Overall Study|Lost to Follow-up|2
1008766|NCT01482221|2027661|FG002|Overall Study|Lost to Follow-up|1
1008767|NCT01482221|2027659|FG000|Overall Study|Study-Specific Withdrawal Criteria|2
1008768|NCT01482221|2027660|FG001|Overall Study|Study-Specific Withdrawal Criteria|0
1008769|NCT01482221|2027661|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
1008770|NCT01482221|2027659|FG000|Overall Study|Condition under Investigation Worsened|3
1008771|NCT01482221|2027660|FG001|Overall Study|Condition under Investigation Worsened|2
1008772|NCT01482221|2027661|FG002|Overall Study|Condition under Investigation Worsened|4
1008773|NCT01482221|2027659|FG000|Overall Study|Severe Non-Compliance to Protocol|1
1008774|NCT01482221|2027660|FG001|Overall Study|Severe Non-Compliance to Protocol|0
1008775|NCT01482221|2027661|FG002|Overall Study|Severe Non-Compliance to Protocol|1
1008776|NCT01482221|2027659|FG000|Overall Study|Adverse Event|1
1008777|NCT01482221|2027660|FG001|Overall Study|Adverse Event|7
1008778|NCT01482221|2027661|FG002|Overall Study|Adverse Event|3
1008779|NCT01482221|2027659|FG000|Overall Study|Withdrawal by Subject|10
1008780|NCT01482221|2027660|FG001|Overall Study|Withdrawal by Subject|7
1008781|NCT01482221|2027661|FG002|Overall Study|Withdrawal by Subject|12
1008782|NCT01482221|2027659|FG000|Overall Study|Incorrect randomization|0
1008783|NCT01482221|2027660|FG001|Overall Study|Incorrect randomization|1
1008784|NCT01482221|2027661|FG002|Overall Study|Incorrect randomization|0
1008785|NCT01482221|2027659|FG000|Overall Study|Physician Decision|0
1008786|NCT01482221|2027660|FG001|Overall Study|Physician Decision|1
1008787|NCT01482221|2027661|FG002|Overall Study|Physician Decision|0
1008788|NCT01482312|2027669|FG000|Period 1, 90 Minutes of Wear|Other|1
1008789|NCT01482312|2027670|FG001|Period 1, 90 Minutes of Wear|Other|0
1008790|NCT01482312|2027671|FG002|Period 1, 90 Minutes of Wear|Other|0
1008791|NCT01482312|2027669|FG000|Period 2, 90 Minutes of Wear|Other|1
1008792|NCT01482312|2027670|FG001|Period 2, 90 Minutes of Wear|Other|0
1008793|NCT01482312|2027671|FG002|Period 2, 90 Minutes of Wear|Other|0
1008794|NCT01482429|2027691|FG000|Care Usual|Protocol Violation|0
1008795|NCT01482429|2027692|FG001|Care Usual|Protocol Violation|172
1008796|NCT01482429|2027691|FG000|Care Usual|Lost to Follow-up|0
1008797|NCT01482429|2027692|FG001|Care Usual|Lost to Follow-up|1
1008798|NCT01482429|2027691|FG000|Protocol|Protocol Violation|275
1008799|NCT01482429|2027692|FG001|Protocol|Protocol Violation|0
1008800|NCT01482767|2027766|FG000|Overall Study|Death|1
1008801|NCT01482767|2027767|FG001|Overall Study|Death|1
1008802|NCT01482767|2027766|FG000|Overall Study|Withdrawal by Subject|7
1008803|NCT01482767|2027767|FG001|Overall Study|Withdrawal by Subject|5
1008804|NCT01482767|2027766|FG000|Overall Study|Lost to Follow-up|12
1008805|NCT01482767|2027767|FG001|Overall Study|Lost to Follow-up|6
1008806|NCT01482767|2027766|FG000|Overall Study|Adverse Event|0
1008807|NCT01482767|2027767|FG001|Overall Study|Adverse Event|3
1008808|NCT01482767|2027766|FG000|Overall Study|Site closure|22
1008809|NCT01482767|2027767|FG001|Overall Study|Site closure|14
1008810|NCT01482767|2027766|FG000|Overall Study|Non-adherence to study requirements|4
1008811|NCT01482767|2027767|FG001|Overall Study|Non-adherence to study requirements|7
1008812|NCT01482767|2027766|FG000|Overall Study|Alternate HCV treatment|7
1008813|NCT01482767|2027767|FG001|Overall Study|Alternate HCV treatment|8
1008814|NCT01482767|2027766|FG000|Overall Study|Ineligible|0
1008815|NCT01482767|2027767|FG001|Overall Study|Ineligible|5
1008816|NCT01482767|2027766|FG000|Overall Study|Nurse error|1
1008817|NCT01482767|2027767|FG001|Overall Study|Nurse error|0
1008818|NCT01482819|2027773|FG000|Overall Study|Lost to Follow-up|2
1008819|NCT01482884|2027783|FG000|Overall Study|Medical decision due to lack of efficacy|0
1008820|NCT01482884|2027784|FG001|Overall Study|Medical decision due to lack of efficacy|1
1008821|NCT01482884|2027783|FG000|Overall Study|Protocol Violation|1
1008822|NCT01482884|2027784|FG001|Overall Study|Protocol Violation|0
1008823|NCT01482884|2027783|FG000|Overall Study|Lost to Follow-up|2
1008824|NCT01482884|2027784|FG001|Overall Study|Lost to Follow-up|2
1008825|NCT01482884|2027783|FG000|Overall Study|Lack of Efficacy|0
1008826|NCT01482884|2027784|FG001|Overall Study|Lack of Efficacy|1
1008827|NCT01482884|2027783|FG000|Overall Study|Adverse Event|2
1008828|NCT01482884|2027784|FG001|Overall Study|Adverse Event|1
1008829|NCT01482884|2027783|FG000|Overall Study|Withdrawal by Subject|8
1008830|NCT01482884|2027784|FG001|Overall Study|Withdrawal by Subject|13
1008831|NCT01482910|2027792|FG000|Overall Study|Adverse Event|6
1008832|NCT01482910|2027793|FG001|Overall Study|Adverse Event|5
1008833|NCT01482910|2027792|FG000|Overall Study|Lost to Follow-up|0
1008834|NCT01482910|2027793|FG001|Overall Study|Lost to Follow-up|1
1008835|NCT01482910|2027792|FG000|Overall Study|Protocol Violation|1
1008836|NCT01482910|2027793|FG001|Overall Study|Protocol Violation|1
1008837|NCT01482910|2027792|FG000|Overall Study|Withdrawal by Subject|7
1008838|NCT01482910|2027793|FG001|Overall Study|Withdrawal by Subject|2
1008839|NCT01482910|2027792|FG000|Overall Study|Death|1
1008840|NCT01482910|2027793|FG001|Overall Study|Death|0
1008841|NCT01482962|2027803|FG000|Overall Study|Progressive Disease|65
1008842|NCT01482962|2027804|FG001|Overall Study|Progressive Disease|53
1008843|NCT01482962|2027803|FG000|Overall Study|Unsatisfactory Therapeutic Response|37
1008844|NCT01482962|2027804|FG001|Overall Study|Unsatisfactory Therapeutic Response|23
1008845|NCT01482962|2027803|FG000|Overall Study|Adverse Event|18
1008846|NCT01482962|2027804|FG001|Overall Study|Adverse Event|22
1008847|NCT01482962|2027803|FG000|Overall Study|Withdrawal by Participant|8
1008848|NCT01482962|2027804|FG001|Overall Study|Withdrawal by Participant|13
1008849|NCT01482962|2027803|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3
1008850|NCT01482962|2027804|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9
1008851|NCT01482962|2027803|FG000|Overall Study|Other Reason|1
1008852|NCT01482962|2027804|FG001|Overall Study|Other Reason|5
1008853|NCT01482962|2027803|FG000|Overall Study|Study Terminated by Sponsor|5
1008854|NCT01482962|2027804|FG001|Overall Study|Study Terminated by Sponsor|2
1008855|NCT01482962|2027803|FG000|Overall Study|Did not Receive Study Drug|1
1008856|NCT01482962|2027804|FG001|Overall Study|Did not Receive Study Drug|6
1008857|NCT01483118|2027814|FG000|Overall Study|Lost to Follow-up|12
1008858|NCT01483118|2027815|FG001|Overall Study|Lost to Follow-up|16
1008859|NCT01483144|2027826|FG000|Overall Study|Adverse Event|9
1008860|NCT01483144|2027827|FG001|Overall Study|Adverse Event|4
1008861|NCT01483144|2027828|FG002|Overall Study|Adverse Event|6
1008862|NCT01483144|2027826|FG000|Overall Study|Withdrawal by Subject|0
1008863|NCT01483144|2027827|FG001|Overall Study|Withdrawal by Subject|2
1008864|NCT01483144|2027828|FG002|Overall Study|Withdrawal by Subject|5
1008865|NCT01483144|2027826|FG000|Overall Study|Physician Decision|1
1008866|NCT01483144|2027827|FG001|Overall Study|Physician Decision|0
1008867|NCT01483144|2027828|FG002|Overall Study|Physician Decision|0
1008868|NCT01483144|2027826|FG000|Overall Study|Lost to Follow-up|2
1008869|NCT01483144|2027827|FG001|Overall Study|Lost to Follow-up|4
1008870|NCT01483144|2027828|FG002|Overall Study|Lost to Follow-up|1
1008871|NCT01483144|2027826|FG000|Overall Study|Protocol Violation|3
1008872|NCT01483144|2027827|FG001|Overall Study|Protocol Violation|3
1008873|NCT01483144|2027828|FG002|Overall Study|Protocol Violation|3
1008874|NCT01483183|2027846|FG000|Overall Study|Physician Decision|0
1008875|NCT01483183|2027847|FG001|Overall Study|Physician Decision|0
1008876|NCT01483183|2027848|FG002|Overall Study|Physician Decision|0
1008877|NCT01483183|2027849|FG003|Overall Study|Physician Decision|0
1008878|NCT01483183|2027850|FG004|Overall Study|Physician Decision|0
1008879|NCT01483183|2027851|FG005|Overall Study|Physician Decision|0
1008880|NCT01483183|2027852|FG006|Overall Study|Physician Decision|2
1008881|NCT01483183|2027853|FG007|Overall Study|Physician Decision|0
1008882|NCT01483183|2027854|FG008|Overall Study|Physician Decision|0
1008883|NCT01483183|2027855|FG009|Overall Study|Physician Decision|0
1008884|NCT01483183|2027846|FG000|Overall Study|Withdrawal by Subject|0
1008885|NCT01483183|2027847|FG001|Overall Study|Withdrawal by Subject|0
1008886|NCT01483183|2027848|FG002|Overall Study|Withdrawal by Subject|0
1008887|NCT01483183|2027849|FG003|Overall Study|Withdrawal by Subject|0
1008888|NCT01483183|2027850|FG004|Overall Study|Withdrawal by Subject|0
1008889|NCT01483183|2027851|FG005|Overall Study|Withdrawal by Subject|0
1008890|NCT01483183|2027852|FG006|Overall Study|Withdrawal by Subject|0
1008891|NCT01483183|2027853|FG007|Overall Study|Withdrawal by Subject|0
1008892|NCT01483183|2027854|FG008|Overall Study|Withdrawal by Subject|0
1008893|NCT01483183|2027855|FG009|Overall Study|Withdrawal by Subject|1
1008894|NCT01483599|2027910|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2
1008895|NCT01483599|2027911|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1008896|NCT01483599|2027912|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1008897|NCT01483599|2027913|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1
1008898|NCT01483599|2027914|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1
1008899|NCT01483599|2027915|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4
1008900|NCT01483599|2027916|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3
1008901|NCT01483599|2027917|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1008902|NCT01483599|2027918|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1008903|NCT01483599|2027919|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1008904|NCT01483599|2027920|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1008905|NCT01483599|2027921|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1008906|NCT01483599|2027922|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0
914278|NCT00813761|1892000|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
914279|NCT00813761|1892001|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
914280|NCT00813761|1892002|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
914281|NCT00813761|1891999|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
914282|NCT00813761|1892000|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
914283|NCT00813761|1892001|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
914284|NCT00813761|1892002|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
914285|NCT00813761|1891999|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
914286|NCT00813761|1892000|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
914287|NCT00813761|1892001|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
914288|NCT00813761|1892002|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
1008907|NCT01483599|2027923|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1008908|NCT01483599|2027910|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1008909|NCT01483599|2027911|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1008910|NCT01483599|2027912|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1008911|NCT01483599|2027913|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1008912|NCT01483599|2027914|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1008913|NCT01483599|2027915|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1008914|NCT01483599|2027916|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1008915|NCT01483599|2027917|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1008916|NCT01483599|2027918|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1008917|NCT01483599|2027919|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1008918|NCT01483599|2027920|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1008919|NCT01483599|2027921|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1008920|NCT01483599|2027922|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1008921|NCT01483599|2027923|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1008922|NCT01483599|2027910|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
1008923|NCT01483599|2027911|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008924|NCT01483599|2027912|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008925|NCT01483599|2027913|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008926|NCT01483599|2027914|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008927|NCT01483599|2027915|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008928|NCT01483599|2027916|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008929|NCT01483599|2027917|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008930|NCT01483599|2027918|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008931|NCT01483599|2027919|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008932|NCT01483599|2027920|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008933|NCT01483599|2027921|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008934|NCT01483599|2027922|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008935|NCT01483599|2027923|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1008936|NCT01483599|2027910|FG000|Controlled Period (CP) (up to Week 16)|Other|0
1008937|NCT01483599|2027911|FG001|Controlled Period (CP) (up to Week 16)|Other|2
1008938|NCT01483599|2027912|FG002|Controlled Period (CP) (up to Week 16)|Other|0
1008939|NCT01483599|2027913|FG003|Controlled Period (CP) (up to Week 16)|Other|1
1008940|NCT01483599|2027914|FG004|Controlled Period (CP) (up to Week 16)|Other|1
1008941|NCT01483599|2027915|FG005|Controlled Period (CP) (up to Week 16)|Other|0
1008942|NCT01483599|2027916|FG006|Controlled Period (CP) (up to Week 16)|Other|0
1008943|NCT01483599|2027917|FG007|Controlled Period (CP) (up to Week 16)|Other|0
1008944|NCT01483599|2027918|FG008|Controlled Period (CP) (up to Week 16)|Other|0
1008945|NCT01483599|2027919|FG009|Controlled Period (CP) (up to Week 16)|Other|0
1008946|NCT01483599|2027920|FG010|Controlled Period (CP) (up to Week 16)|Other|0
1008947|NCT01483599|2027921|FG011|Controlled Period (CP) (up to Week 16)|Other|0
1008948|NCT01483599|2027922|FG012|Controlled Period (CP) (up to Week 16)|Other|0
1008949|NCT01483599|2027923|FG013|Controlled Period (CP) (up to Week 16)|Other|0
1008950|NCT01483599|2027910|FG000|After Controlled Period(Week 16-Week 40)|Death|0
1008951|NCT01483599|2027911|FG001|After Controlled Period(Week 16-Week 40)|Death|0
1008952|NCT01483599|2027912|FG002|After Controlled Period(Week 16-Week 40)|Death|0
1008953|NCT01483599|2027913|FG003|After Controlled Period(Week 16-Week 40)|Death|0
1008954|NCT01483599|2027914|FG004|After Controlled Period(Week 16-Week 40)|Death|0
1008955|NCT01483599|2027915|FG005|After Controlled Period(Week 16-Week 40)|Death|0
1008956|NCT01483599|2027916|FG006|After Controlled Period(Week 16-Week 40)|Death|0
1008957|NCT01483599|2027917|FG007|After Controlled Period(Week 16-Week 40)|Death|0
1008958|NCT01483599|2027918|FG008|After Controlled Period(Week 16-Week 40)|Death|1
1008959|NCT01483599|2027919|FG009|After Controlled Period(Week 16-Week 40)|Death|0
1008960|NCT01483599|2027920|FG010|After Controlled Period(Week 16-Week 40)|Death|0
1008961|NCT01483599|2027921|FG011|After Controlled Period(Week 16-Week 40)|Death|0
1008962|NCT01483599|2027922|FG012|After Controlled Period(Week 16-Week 40)|Death|0
1008963|NCT01483599|2027923|FG013|After Controlled Period(Week 16-Week 40)|Death|0
1008964|NCT01483599|2027910|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1008965|NCT01483599|2027911|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1008966|NCT01483599|2027912|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1008967|NCT01483599|2027913|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1008968|NCT01483599|2027914|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1008969|NCT01483599|2027915|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1008970|NCT01483599|2027916|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1008971|NCT01483599|2027917|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1008972|NCT01483599|2027918|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1008973|NCT01483599|2027919|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1008974|NCT01483599|2027920|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1008975|NCT01483599|2027921|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1008976|NCT01483599|2027922|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1008977|NCT01483599|2027923|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1008978|NCT01483599|2027910|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1008979|NCT01483599|2027911|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1008980|NCT01483599|2027912|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1008981|NCT01483599|2027913|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1008982|NCT01483599|2027914|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1008983|NCT01483599|2027915|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1008984|NCT01483599|2027916|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1008985|NCT01483599|2027917|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1008986|NCT01483599|2027918|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1008987|NCT01483599|2027919|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1008988|NCT01483599|2027920|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1008989|NCT01483599|2027921|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1008990|NCT01483599|2027922|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1008991|NCT01483599|2027923|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1008992|NCT01483599|2027910|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1008993|NCT01483599|2027911|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1008994|NCT01483599|2027912|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1008995|NCT01483599|2027913|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1008996|NCT01483599|2027914|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1008997|NCT01483599|2027915|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1008998|NCT01483599|2027916|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1008999|NCT01483599|2027917|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1009000|NCT01483599|2027918|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
1009001|NCT01483599|2027919|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1009002|NCT01483599|2027920|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
1009003|NCT01483599|2027921|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1009004|NCT01483599|2027922|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1009005|NCT01483599|2027923|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
1009006|NCT01483599|2027910|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1009007|NCT01483599|2027911|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1009008|NCT01483599|2027912|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1009009|NCT01483599|2027913|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1009010|NCT01483599|2027914|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1009011|NCT01483599|2027915|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1009012|NCT01483599|2027916|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1009013|NCT01483599|2027917|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1009014|NCT01483599|2027918|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
1009015|NCT01483599|2027919|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1009016|NCT01483599|2027920|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1009017|NCT01483599|2027921|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1009018|NCT01483599|2027922|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
1009019|NCT01483599|2027923|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
1009020|NCT01483599|2027910|FG000|After Controlled Period(Week 16-Week 40)|Other|0
1009021|NCT01483599|2027911|FG001|After Controlled Period(Week 16-Week 40)|Other|0
1009022|NCT01483599|2027912|FG002|After Controlled Period(Week 16-Week 40)|Other|0
1009023|NCT01483599|2027913|FG003|After Controlled Period(Week 16-Week 40)|Other|0
1009024|NCT01483599|2027914|FG004|After Controlled Period(Week 16-Week 40)|Other|0
1009025|NCT01483599|2027915|FG005|After Controlled Period(Week 16-Week 40)|Other|0
1009026|NCT01483599|2027916|FG006|After Controlled Period(Week 16-Week 40)|Other|0
1009027|NCT01483599|2027917|FG007|After Controlled Period(Week 16-Week 40)|Other|1
1009028|NCT01483599|2027918|FG008|After Controlled Period(Week 16-Week 40)|Other|0
1009029|NCT01483599|2027919|FG009|After Controlled Period(Week 16-Week 40)|Other|4
1009030|NCT01483599|2027920|FG010|After Controlled Period(Week 16-Week 40)|Other|0
1009031|NCT01483599|2027921|FG011|After Controlled Period(Week 16-Week 40)|Other|0
1009032|NCT01483599|2027922|FG012|After Controlled Period(Week 16-Week 40)|Other|1
1009033|NCT01483599|2027923|FG013|After Controlled Period(Week 16-Week 40)|Other|0
1009034|NCT01483625|2027954|FG000|Overall Study|Adverse Event|1
1009035|NCT01483625|2027955|FG001|Overall Study|Adverse Event|1
1009036|NCT01483625|2027954|FG000|Overall Study|Refused to continue medication|2
1009037|NCT01483625|2027955|FG001|Overall Study|Refused to continue medication|1
1009038|NCT01483625|2027954|FG000|Overall Study|Due to other reason|1
1009039|NCT01483625|2027955|FG001|Overall Study|Due to other reason|0
1009040|NCT01483651|2027961|FG000|Overall Study|Withdrawal by Subject|0
1009041|NCT01483651|2027962|FG001|Overall Study|Withdrawal by Subject|1
1009042|NCT01483651|2027963|FG002|Overall Study|Withdrawal by Subject|1
1009043|NCT01483651|2027964|FG003|Overall Study|Withdrawal by Subject|0
1009044|NCT01483651|2027965|FG004|Overall Study|Withdrawal by Subject|0
1009045|NCT01483651|2027966|FG005|Overall Study|Withdrawal by Subject|1
1009046|NCT01483690|2027976|FG000|Overall Study|Adverse Event|1
1009047|NCT01483690|2027977|FG001|Overall Study|Adverse Event|2
1009048|NCT01483690|2027976|FG000|Overall Study|clinical deterioration|1
1009049|NCT01483690|2027977|FG001|Overall Study|clinical deterioration|0
1009050|NCT01483690|2027976|FG000|Overall Study|Physician Decision|0
1009051|NCT01483690|2027977|FG001|Overall Study|Physician Decision|2
1009052|NCT01483690|2027976|FG000|Overall Study|exclusionary procedure|0
1009053|NCT01483690|2027977|FG001|Overall Study|exclusionary procedure|1
1009054|NCT01483820|2027992|FG000|Overall Study|Lack of Efficacy|6
1009055|NCT01483820|2027992|FG000|Overall Study|Adverse Event|1
1009056|NCT01483820|2027992|FG000|Overall Study|Death|1
1009057|NCT01483924|2028001|FG000|Overall Study|Withdrawal by Subject|2
1009058|NCT01483924|2028002|FG001|Overall Study|Withdrawal by Subject|0
1009059|NCT01483924|2028003|FG002|Overall Study|Withdrawal by Subject|0
1009060|NCT01483924|2028004|FG003|Overall Study|Withdrawal by Subject|1
1009061|NCT01483924|2028005|FG004|Overall Study|Withdrawal by Subject|1
1009062|NCT01483924|2028001|FG000|Overall Study|Adverse Event|0
1009063|NCT01483924|2028002|FG001|Overall Study|Adverse Event|0
1009064|NCT01483924|2028003|FG002|Overall Study|Adverse Event|1
1009065|NCT01483924|2028004|FG003|Overall Study|Adverse Event|1
1009066|NCT01483924|2028005|FG004|Overall Study|Adverse Event|0
1009067|NCT01483924|2028001|FG000|Overall Study|Non-compliance|0
1009068|NCT01483924|2028002|FG001|Overall Study|Non-compliance|0
1009069|NCT01483924|2028003|FG002|Overall Study|Non-compliance|0
1009070|NCT01483924|2028004|FG003|Overall Study|Non-compliance|1
1009071|NCT01483924|2028005|FG004|Overall Study|Non-compliance|1
1009072|NCT01483924|2028001|FG000|Overall Study|Sponsor concern over ECG result|0
1009073|NCT01483924|2028002|FG001|Overall Study|Sponsor concern over ECG result|0
1009074|NCT01483924|2028003|FG002|Overall Study|Sponsor concern over ECG result|0
1009075|NCT01483924|2028004|FG003|Overall Study|Sponsor concern over ECG result|1
1009076|NCT01483924|2028005|FG004|Overall Study|Sponsor concern over ECG result|0
1009077|NCT01483937|2028028|FG000|Overall Study|Withdrawal by Subject|4
1009078|NCT01483937|2028029|FG001|Overall Study|Withdrawal by Subject|3
1009079|NCT01484028|2028060|FG000|Period 1|Lost to Follow-up|0
1009080|NCT01484028|2028061|FG001|Period 1|Lost to Follow-up|1
1009081|NCT01484028|2028062|FG002|Period 1|Lost to Follow-up|0
1009082|NCT01484028|2028063|FG003|Period 1|Lost to Follow-up|0
1009083|NCT01484028|2028060|FG000|Period 1|Non-Compliance to Protocol|0
1009084|NCT01484028|2028061|FG001|Period 1|Non-Compliance to Protocol|1
1009085|NCT01484028|2028062|FG002|Period 1|Non-Compliance to Protocol|0
1009086|NCT01484028|2028063|FG003|Period 1|Non-Compliance to Protocol|1
1009087|NCT01484028|2028060|FG000|Period 1|Lens Discomfort|0
1009088|NCT01484028|2028061|FG001|Period 1|Lens Discomfort|1
1009089|NCT01484028|2028062|FG002|Period 1|Lens Discomfort|0
1009090|NCT01484028|2028063|FG003|Period 1|Lens Discomfort|0
1009091|NCT01484054|2028075|FG000|Period 1|Withdrawal by Subject|0
1009092|NCT01484054|2028076|FG001|Period 1|Withdrawal by Subject|1
1009093|NCT01484132|2028083|FG000|Overall Study|Lost to Follow-up|8
1009094|NCT01484132|2028083|FG000|Overall Study|Difficulty with time commitment|2
1009095|NCT01484132|2028083|FG000|Overall Study|Ineligible|1
1009096|NCT01484132|2028083|FG000|Overall Study|No pre-treatment urine sample collected|1
1009097|NCT01484132|2028083|FG000|Overall Study|No post-treatment urine sample collected|10
1009098|NCT01484197|2028087|FG000|Treatment Period 1|Adverse Event|1
1009099|NCT01484197|2028088|FG001|Treatment Period 1|Adverse Event|0
1009100|NCT01484197|2028089|FG002|Treatment Period 1|Adverse Event|0
1009101|NCT01484197|2028090|FG003|Treatment Period 1|Adverse Event|0
1009102|NCT01484197|2028087|FG000|Treatment Period 2|Subject withdrew consent|0
1009103|NCT01484197|2028088|FG001|Treatment Period 2|Subject withdrew consent|0
1009104|NCT01484197|2028089|FG002|Treatment Period 2|Subject withdrew consent|0
1009105|NCT01484197|2028090|FG003|Treatment Period 2|Subject withdrew consent|1
1009106|NCT01484275|2028102|FG000|Overall Study|Study terminated by sponsor|28
1009107|NCT01484275|2028103|FG001|Overall Study|Study terminated by sponsor|32
1009108|NCT01484275|2028102|FG000|Overall Study|Other|10
1009109|NCT01484275|2028103|FG001|Overall Study|Other|0
1009110|NCT01484275|2028102|FG000|Overall Study|Death|3
1009111|NCT01484275|2028103|FG001|Overall Study|Death|4
1009112|NCT01484275|2028102|FG000|Overall Study|Withdrawal by Subject|1
1009113|NCT01484275|2028103|FG001|Overall Study|Withdrawal by Subject|5
1009114|NCT01484275|2028102|FG000|Overall Study|Lost to Follow-up|1
1009115|NCT01484275|2028103|FG001|Overall Study|Lost to Follow-up|1
1009116|NCT01484431|2028125|FG000|Period 1: High Dose|Physician Decision|0
1009117|NCT01484431|2028126|FG001|Period 1: High Dose|Physician Decision|1
1009118|NCT01484431|2028127|FG002|Period 1: High Dose|Physician Decision|0
1009119|NCT01484431|2028125|FG000|Period 2|Death|0
1009120|NCT01484431|2028126|FG001|Period 2|Death|1
1009121|NCT01484431|2028127|FG002|Period 2|Death|1
1009122|NCT01484431|2028125|FG000|Period 2|Physician Decision|0
1009123|NCT01484431|2028126|FG001|Period 2|Physician Decision|0
1009124|NCT01484431|2028127|FG002|Period 2|Physician Decision|1
1009125|NCT01484431|2028125|FG000|Period 2|Non-Compliance with Study Drug|1
1009126|NCT01484431|2028126|FG001|Period 2|Non-Compliance with Study Drug|0
1009127|NCT01484431|2028127|FG002|Period 2|Non-Compliance with Study Drug|0
1009128|NCT01484496|2028142|FG000|Period 1|Protocol Violation|3
1009129|NCT01484496|2028143|FG001|Period 1|Protocol Violation|4
1009130|NCT01484496|2028144|FG002|Period 1|Protocol Violation|0
1009131|NCT01484496|2028145|FG003|Period 1|Protocol Violation|0
1009132|NCT01484496|2028142|FG000|Period 1|Physician Decision|5
1009133|NCT01484496|2028143|FG001|Period 1|Physician Decision|1
1009134|NCT01484496|2028144|FG002|Period 1|Physician Decision|0
1009135|NCT01484496|2028145|FG003|Period 1|Physician Decision|0
1009136|NCT01484496|2028142|FG000|Period 1|Lack of Efficacy|10
1009137|NCT01484496|2028143|FG001|Period 1|Lack of Efficacy|15
1009138|NCT01484496|2028144|FG002|Period 1|Lack of Efficacy|0
1009139|NCT01484496|2028145|FG003|Period 1|Lack of Efficacy|0
1009140|NCT01484496|2028142|FG000|Period 1|Adverse Event|25
1009141|NCT01484496|2028143|FG001|Period 1|Adverse Event|40
1009142|NCT01484496|2028144|FG002|Period 1|Adverse Event|0
1009143|NCT01484496|2028145|FG003|Period 1|Adverse Event|0
1009144|NCT01484496|2028142|FG000|Period 1|Withdrawal by Subject|15
1009145|NCT01484496|2028143|FG001|Period 1|Withdrawal by Subject|12
1009146|NCT01484496|2028144|FG002|Period 1|Withdrawal by Subject|0
1009147|NCT01484496|2028145|FG003|Period 1|Withdrawal by Subject|0
1009148|NCT01484496|2028142|FG000|Period 1|Lost to Follow-up|2
1009149|NCT01484496|2028143|FG001|Period 1|Lost to Follow-up|6
1009150|NCT01484496|2028144|FG002|Period 1|Lost to Follow-up|0
1009151|NCT01484496|2028145|FG003|Period 1|Lost to Follow-up|0
1009152|NCT01484496|2028142|FG000|Period 1|Positive Pregnancy|1
1009153|NCT01484496|2028143|FG001|Period 1|Positive Pregnancy|6
1009154|NCT01484496|2028144|FG002|Period 1|Positive Pregnancy|0
1009155|NCT01484496|2028145|FG003|Period 1|Positive Pregnancy|0
1009156|NCT01484496|2028142|FG000|Period 1|Treatment Failure|3
1009157|NCT01484496|2028143|FG001|Period 1|Treatment Failure|6
1009158|NCT01484496|2028144|FG002|Period 1|Treatment Failure|0
1009159|NCT01484496|2028145|FG003|Period 1|Treatment Failure|0
1009160|NCT01484496|2028142|FG000|Period 1|Lack of Compliance|2
1009161|NCT01484496|2028143|FG001|Period 1|Lack of Compliance|1
1009162|NCT01484496|2028144|FG002|Period 1|Lack of Compliance|0
1009163|NCT01484496|2028145|FG003|Period 1|Lack of Compliance|0
1009164|NCT01484496|2028142|FG000|Period 1|Unable to Visit Site|0
1009165|NCT01484496|2028143|FG001|Period 1|Unable to Visit Site|2
1009166|NCT01484496|2028144|FG002|Period 1|Unable to Visit Site|0
1009167|NCT01484496|2028145|FG003|Period 1|Unable to Visit Site|0
1009168|NCT01484496|2028142|FG000|Period 2|Lack of Efficacy|0
1009169|NCT01484496|2028143|FG001|Period 2|Lack of Efficacy|0
1009170|NCT01484496|2028144|FG002|Period 2|Lack of Efficacy|1
1009171|NCT01484496|2028145|FG003|Period 2|Lack of Efficacy|3
1009172|NCT01484496|2028142|FG000|Period 2|Adverse Event|0
1009173|NCT01484496|2028143|FG001|Period 2|Adverse Event|0
1009174|NCT01484496|2028144|FG002|Period 2|Adverse Event|5
1009175|NCT01484496|2028145|FG003|Period 2|Adverse Event|13
1009176|NCT01484496|2028142|FG000|Period 2|Other|0
1009177|NCT01484496|2028143|FG001|Period 2|Other|0
1009178|NCT01484496|2028144|FG002|Period 2|Other|9
1009179|NCT01484496|2028145|FG003|Period 2|Other|6
1009180|NCT01484561|2028155|FG000|Overall Study|Lack of Efficacy|3
1009181|NCT01484561|2028156|FG001|Overall Study|Lack of Efficacy|1
1009182|NCT01484561|2028155|FG000|Overall Study|Lost to Follow-up|1
1009183|NCT01484561|2028156|FG001|Overall Study|Lost to Follow-up|0
1009184|NCT01484561|2028155|FG000|Overall Study|Withdrawal by Subject|3
1009185|NCT01484561|2028156|FG001|Overall Study|Withdrawal by Subject|0
1009186|NCT01484561|2028155|FG000|Overall Study|Other|1
1009187|NCT01484561|2028156|FG001|Overall Study|Other|1
1009188|NCT01484561|2028155|FG000|Overall Study|Adverse Event|1
1009189|NCT01484561|2028156|FG001|Overall Study|Adverse Event|4
1009190|NCT01484834|2028179|FG000|Overall Study|Lost to Follow-up|5
1009191|NCT01484834|2028180|FG001|Overall Study|Lost to Follow-up|8
1009192|NCT01484834|2028181|FG002|Overall Study|Lost to Follow-up|1
1009193|NCT01484834|2028182|FG003|Overall Study|Lost to Follow-up|4
1009194|NCT01484873|2028192|FG000|Overall Study|Withdrawal by Subject|2
1009195|NCT01484912|2028199|FG000|Overall Study|Withdrawal by Subject|1
1009196|NCT01484912|2028200|FG001|Overall Study|Withdrawal by Subject|0
1009197|NCT01484912|2028199|FG000|Overall Study|Physician Decision|0
1009198|NCT01484912|2028200|FG001|Overall Study|Physician Decision|1
1009199|NCT01484938|2028206|FG000|Overall Study|Adverse Event|2
1009200|NCT01484938|2028206|FG000|Overall Study|Lost to Follow-up|1
1009201|NCT01484938|2028206|FG000|Overall Study|Noncompliance|1
1009202|NCT01484951|2028210|FG000|Overall Study|Adverse Event|3
1009203|NCT01484951|2028210|FG000|Overall Study|Personal Reasons|1
1009204|NCT01484951|2028210|FG000|Overall Study|Non-Compliance|1
1009205|NCT01484977|2028214|FG000|Overall Study|Adverse Event|8
1009206|NCT01484977|2028214|FG000|Overall Study|Lack of Efficacy|4
1009207|NCT01484977|2028214|FG000|Overall Study|Protocol Violation|6
1009208|NCT01484977|2028214|FG000|Overall Study|Lost to Follow-up|1
1009209|NCT01484977|2028214|FG000|Overall Study|Withdrawal by Subject|4
1009210|NCT01484977|2028214|FG000|Overall Study|Subject Protocol Non-compliant|1
1009211|NCT01484977|2028214|FG000|Overall Study|Moving Overseas|1
1009212|NCT01484977|2028214|FG000|Overall Study|Low White Blood Cell Count|1
1009213|NCT01484977|2028214|FG000|Overall Study|Lack of Compliance|1
1009214|NCT01485094|2028225|FG000|Overall Study|Adverse Event|1
1009215|NCT01485094|2028226|FG001|Overall Study|Adverse Event|1
1009216|NCT01485094|2028227|FG002|Overall Study|Adverse Event|1
1009217|NCT01485094|2028225|FG000|Overall Study|Lost to Follow-up|1
1009218|NCT01485094|2028226|FG001|Overall Study|Lost to Follow-up|0
1009219|NCT01485094|2028227|FG002|Overall Study|Lost to Follow-up|0
1009220|NCT01485094|2028225|FG000|Overall Study|Withdrawal by Subject|1
1009221|NCT01485094|2028226|FG001|Overall Study|Withdrawal by Subject|1
1009222|NCT01485094|2028227|FG002|Overall Study|Withdrawal by Subject|0
1009223|NCT01485120|2028235|FG000|Overall Study|Withdrawal by Subject|2
1009224|NCT01485172|2028246|FG000|Overall Study|Adverse Event|2
1009225|NCT01485172|2028247|FG001|Overall Study|Adverse Event|1
1009226|NCT01485172|2028248|FG002|Overall Study|Adverse Event|2
1009227|NCT01485172|2028249|FG003|Overall Study|Adverse Event|2
1009228|NCT01485172|2028250|FG004|Overall Study|Adverse Event|1
1009229|NCT01485172|2028251|FG005|Overall Study|Adverse Event|2
1009230|NCT01485172|2028246|FG000|Overall Study|Lack of Efficacy|2
1009231|NCT01485172|2028247|FG001|Overall Study|Lack of Efficacy|0
1009232|NCT01485172|2028248|FG002|Overall Study|Lack of Efficacy|0
1009233|NCT01485172|2028249|FG003|Overall Study|Lack of Efficacy|0
1009234|NCT01485172|2028250|FG004|Overall Study|Lack of Efficacy|0
1009235|NCT01485172|2028251|FG005|Overall Study|Lack of Efficacy|0
1009236|NCT01485172|2028246|FG000|Overall Study|Protocol Violation|0
1009237|NCT01485172|2028247|FG001|Overall Study|Protocol Violation|0
1009238|NCT01485172|2028248|FG002|Overall Study|Protocol Violation|4
1009239|NCT01485172|2028249|FG003|Overall Study|Protocol Violation|5
1009240|NCT01485172|2028250|FG004|Overall Study|Protocol Violation|1
1009241|NCT01485172|2028251|FG005|Overall Study|Protocol Violation|0
1009242|NCT01485172|2028246|FG000|Overall Study|Protocol defined stopping criteria|1
1009243|NCT01485172|2028247|FG001|Overall Study|Protocol defined stopping criteria|0
1009244|NCT01485172|2028248|FG002|Overall Study|Protocol defined stopping criteria|0
1009245|NCT01485172|2028249|FG003|Overall Study|Protocol defined stopping criteria|0
1009246|NCT01485172|2028250|FG004|Overall Study|Protocol defined stopping criteria|1
1009247|NCT01485172|2028251|FG005|Overall Study|Protocol defined stopping criteria|0
1009248|NCT01485172|2028246|FG000|Overall Study|Lost to Follow-up|0
1009249|NCT01485172|2028247|FG001|Overall Study|Lost to Follow-up|0
1009250|NCT01485172|2028248|FG002|Overall Study|Lost to Follow-up|1
1009251|NCT01485172|2028249|FG003|Overall Study|Lost to Follow-up|0
1009252|NCT01485172|2028250|FG004|Overall Study|Lost to Follow-up|0
1009253|NCT01485172|2028251|FG005|Overall Study|Lost to Follow-up|1
1009254|NCT01485172|2028246|FG000|Overall Study|Physician Decision|0
1009255|NCT01485172|2028247|FG001|Overall Study|Physician Decision|0
1009256|NCT01485172|2028248|FG002|Overall Study|Physician Decision|0
1009257|NCT01485172|2028249|FG003|Overall Study|Physician Decision|0
1009258|NCT01485172|2028250|FG004|Overall Study|Physician Decision|1
1009259|NCT01485172|2028251|FG005|Overall Study|Physician Decision|0
1009260|NCT01485172|2028246|FG000|Overall Study|Withdrawal by Subject|2
1009261|NCT01485172|2028247|FG001|Overall Study|Withdrawal by Subject|0
1009262|NCT01485172|2028248|FG002|Overall Study|Withdrawal by Subject|0
1009263|NCT01485172|2028249|FG003|Overall Study|Withdrawal by Subject|1
1009264|NCT01485172|2028250|FG004|Overall Study|Withdrawal by Subject|1
1009265|NCT01485172|2028251|FG005|Overall Study|Withdrawal by Subject|1
1009266|NCT01485354|2028265|FG000|Overall Study|Withdrawal by Subject|5
1009267|NCT01485536|2028281|FG000|Overall Study|Withdrawal by Subject|3
1009268|NCT01485536|2028281|FG000|Overall Study|Adverse Event|1
1009269|NCT01485614|2028304|FG000|Randomization|Not Treated|1
1009270|NCT01485614|2028305|FG001|Randomization|Not Treated|0
1009271|NCT01485614|2028306|FG002|Randomization|Not Treated|0
1009272|NCT01485614|2028307|FG003|Randomization|Not Treated|0
1009273|NCT01485614|2028304|FG000|Weeks 0-20|Lost to Follow-up|2
1009274|NCT01485614|2028305|FG001|Weeks 0-20|Lost to Follow-up|0
1009275|NCT01485614|2028306|FG002|Weeks 0-20|Lost to Follow-up|0
1009276|NCT01485614|2028307|FG003|Weeks 0-20|Lost to Follow-up|0
1009277|NCT01485614|2028304|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5
1009278|NCT01485614|2028305|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2
1009279|NCT01485614|2028306|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0
1009280|NCT01485614|2028307|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0
1009281|NCT01485614|2028304|FG000|Weeks 0-20|Withdrawal by Subject|3
1009282|NCT01485614|2028305|FG001|Weeks 0-20|Withdrawal by Subject|2
1009283|NCT01485614|2028306|FG002|Weeks 0-20|Withdrawal by Subject|1
1009284|NCT01485614|2028307|FG003|Weeks 0-20|Withdrawal by Subject|0
1009285|NCT01485614|2028304|FG000|Weeks 20-54|Lost to Follow-up|4
1009286|NCT01485614|2028305|FG001|Weeks 20-54|Lost to Follow-up|3
1009287|NCT01485614|2028306|FG002|Weeks 20-54|Lost to Follow-up|1
1009288|NCT01485614|2028307|FG003|Weeks 20-54|Lost to Follow-up|0
1009289|NCT01485614|2028304|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2
1009290|NCT01485614|2028305|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2
1009291|NCT01485614|2028306|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1
1009292|NCT01485614|2028307|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0
1009293|NCT01485614|2028304|FG000|Weeks 20-54|Withdrawal by Subject|5
1009294|NCT01485614|2028305|FG001|Weeks 20-54|Withdrawal by Subject|3
1009295|NCT01485614|2028306|FG002|Weeks 20-54|Withdrawal by Subject|0
1009296|NCT01485614|2028307|FG003|Weeks 20-54|Withdrawal by Subject|0
1009297|NCT01485627|2028325|FG000|Overall Study|Patient withdrew|6
1009298|NCT01485627|2028326|FG001|Overall Study|Patient withdrew|5
1009299|NCT01485627|2028325|FG000|Overall Study|Patient died|3
1009300|NCT01485627|2028326|FG001|Overall Study|Patient died|1
1009301|NCT01485627|2028325|FG000|Overall Study|Patient lost to followup|0
1009302|NCT01485627|2028326|FG001|Overall Study|Patient lost to followup|1
1009303|NCT01485627|2028325|FG000|Overall Study|Caregiver withdrew|3
1009304|NCT01485627|2028326|FG001|Overall Study|Caregiver withdrew|3
1009305|NCT01485627|2028325|FG000|Overall Study|Caregiver lost to follow up|11
1009306|NCT01485627|2028326|FG001|Overall Study|Caregiver lost to follow up|12
1009307|NCT01485627|2028325|FG000|Overall Study|Caregiver died|1
1009308|NCT01485627|2028326|FG001|Overall Study|Caregiver died|0
1009309|NCT01485627|2028325|FG000|Overall Study|caregiver was not bereaved|42
1009310|NCT01485627|2028326|FG001|Overall Study|caregiver was not bereaved|35
1009311|NCT01485640|2028336|FG000|Overall Study|Adverse Event|10
1009312|NCT01485640|2028336|FG000|Overall Study|Lack of Efficacy|2
1009313|NCT01485640|2028336|FG000|Overall Study|Protocol Violation|1
1009314|NCT01485640|2028336|FG000|Overall Study|Withdrawal by Subject|14
1009315|NCT01485640|2028336|FG000|Overall Study|Terminated by Sponsor|95
1009316|NCT01485796|2028351|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
1009317|NCT01485796|2028351|FG000|Period 2: Epoch 2|Withdrawal by Subject|6
1009318|NCT01485796|2028351|FG000|Period 2: Epoch 2|Adverse Event|3
1009319|NCT01485796|2028351|FG000|Period 2: Epoch 2|Switch to safety follow-up|26
1009320|NCT01485796|2028351|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
1009321|NCT01485796|2028351|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
1009322|NCT01485796|2028351|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
1009323|NCT01485796|2028351|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
1009324|NCT01485887|2028359|FG000|Overall Study|Withdrawal by Subject|2
1009325|NCT01485887|2028359|FG000|Overall Study|Adverse Event|8
1009326|NCT01485887|2028359|FG000|Overall Study|Deterioration of primary disease|1
1009327|NCT01485887|2028359|FG000|Overall Study|Primary disease markedly improved|1
1009328|NCT01485991|2028365|FG000|Overall Study|Adverse Event|0
1009329|NCT01485991|2028366|FG001|Overall Study|Adverse Event|4
1009330|NCT01485991|2028365|FG000|Overall Study|Lost to Follow-up|13
1009331|NCT01485991|2028366|FG001|Overall Study|Lost to Follow-up|10
1009332|NCT01485991|2028365|FG000|Overall Study|Withdrawal by Subject|13
1009333|NCT01485991|2028366|FG001|Overall Study|Withdrawal by Subject|20
1009334|NCT01485991|2028365|FG000|Overall Study|randomized but not treated|6
1009335|NCT01485991|2028366|FG001|Overall Study|randomized but not treated|2
1009336|NCT01486199|2028378|FG000|Two Year Period Between Study Days|Physician Decision|1
1009337|NCT01486199|2028379|FG001|Two Year Period Between Study Days|Physician Decision|0
1009338|NCT01486238|2028387|FG000|Overall Study|Death|0
1009339|NCT01486238|2028388|FG001|Overall Study|Death|2
1009340|NCT01486238|2028387|FG000|Overall Study|Withdrawal by Subject|2
1009341|NCT01486238|2028388|FG001|Overall Study|Withdrawal by Subject|1
1009342|NCT01486238|2028387|FG000|Overall Study|Lost to Follow-up|0
1009343|NCT01486238|2028388|FG001|Overall Study|Lost to Follow-up|3
1009344|NCT01486264|2028396|FG000|Overall Study|Death|1
1009345|NCT01486264|2028397|FG001|Overall Study|Death|1
1009346|NCT01486264|2028396|FG000|Overall Study|Adverse Event|3
1009347|NCT01486264|2028397|FG001|Overall Study|Adverse Event|3
1009348|NCT01486264|2028396|FG000|Overall Study|Lack of Efficacy|6
1009349|NCT01486264|2028397|FG001|Overall Study|Lack of Efficacy|10
1009350|NCT01486264|2028396|FG000|Overall Study|Withdrawal by Subject|7
1009351|NCT01486264|2028397|FG001|Overall Study|Withdrawal by Subject|18
1009352|NCT01486264|2028396|FG000|Overall Study|Physician Decision|1
1009353|NCT01486264|2028397|FG001|Overall Study|Physician Decision|1
1009354|NCT01486264|2028396|FG000|Overall Study|Protocol Violation|3
1009355|NCT01486264|2028397|FG001|Overall Study|Protocol Violation|0
1009356|NCT01486264|2028396|FG000|Overall Study|Lost to Follow-up|3
1009357|NCT01486264|2028397|FG001|Overall Study|Lost to Follow-up|2
1009358|NCT01486264|2028396|FG000|Overall Study|Other|5
1009359|NCT01486264|2028397|FG001|Overall Study|Other|11
1009360|NCT01486264|2028396|FG000|Overall Study|Not treated|0
1009361|NCT01486264|2028397|FG001|Overall Study|Not treated|1
1009362|NCT01486316|2028406|FG000|Overall Study|Device explanted with/without re-implant|3
1009363|NCT01486316|2028407|FG001|Overall Study|Device explanted with/without re-implant|2
1009364|NCT01486316|2028408|FG002|Overall Study|Device explanted with/without re-implant|0
1009365|NCT01486316|2028409|FG003|Overall Study|Device explanted with/without re-implant|2
1009366|NCT01486316|2028406|FG000|Overall Study|Not meeting eligibility criteria|0
1009367|NCT01486316|2028407|FG001|Overall Study|Not meeting eligibility criteria|0
1009368|NCT01486316|2028408|FG002|Overall Study|Not meeting eligibility criteria|1
1009369|NCT01486316|2028409|FG003|Overall Study|Not meeting eligibility criteria|0
1009370|NCT01486316|2028406|FG000|Overall Study|Withdrawal by Subject|1
1009371|NCT01486316|2028407|FG001|Overall Study|Withdrawal by Subject|0
1009372|NCT01486316|2028408|FG002|Overall Study|Withdrawal by Subject|3
1009373|NCT01486316|2028409|FG003|Overall Study|Withdrawal by Subject|0
1009374|NCT01486316|2028406|FG000|Overall Study|Physician Decision|0
1009375|NCT01486316|2028407|FG001|Overall Study|Physician Decision|0
1009376|NCT01486316|2028408|FG002|Overall Study|Physician Decision|1
1009377|NCT01486316|2028409|FG003|Overall Study|Physician Decision|0
1009378|NCT01486316|2028406|FG000|Overall Study|Death|0
1009379|NCT01486316|2028407|FG001|Overall Study|Death|1
1009380|NCT01486316|2028408|FG002|Overall Study|Death|0
1009381|NCT01486316|2028409|FG003|Overall Study|Death|0
1009382|NCT01486446|2028420|FG000|Overall Study|Adverse Event|1
1009383|NCT01486446|2028421|FG001|Overall Study|Adverse Event|0
1009384|NCT01486758|2028446|FG000|Overall Study|Lost to Follow-up|0
1009385|NCT01486758|2028447|FG001|Overall Study|Lost to Follow-up|1
1009386|NCT01486784|2028460|FG000|Overall Study|Withdrawal by Subject|0
1009387|NCT01486784|2028461|FG001|Overall Study|Withdrawal by Subject|0
1009388|NCT01486784|2028462|FG002|Overall Study|Withdrawal by Subject|1
1009389|NCT01486784|2028463|FG003|Overall Study|Withdrawal by Subject|0
1009390|NCT01486784|2028464|FG004|Overall Study|Withdrawal by Subject|1
1009391|NCT01486784|2028465|FG005|Overall Study|Withdrawal by Subject|2
1009392|NCT01486784|2028460|FG000|Overall Study|Subject did not meet entry criteria|0
1009393|NCT01486784|2028461|FG001|Overall Study|Subject did not meet entry criteria|0
1009394|NCT01486784|2028462|FG002|Overall Study|Subject did not meet entry criteria|0
1009395|NCT01486784|2028463|FG003|Overall Study|Subject did not meet entry criteria|0
1009396|NCT01486784|2028464|FG004|Overall Study|Subject did not meet entry criteria|1
1009397|NCT01486784|2028465|FG005|Overall Study|Subject did not meet entry criteria|0
1009398|NCT01486784|2028460|FG000|Overall Study|Death|0
1009399|NCT01486784|2028461|FG001|Overall Study|Death|0
1009400|NCT01486784|2028462|FG002|Overall Study|Death|0
1009401|NCT01486784|2028463|FG003|Overall Study|Death|0
1009402|NCT01486784|2028464|FG004|Overall Study|Death|0
1009403|NCT01486784|2028465|FG005|Overall Study|Death|1
1009404|NCT01486927|2028483|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1
1009405|NCT01486927|2028483|FG000|Overall Study|Physician Decision|1
1009406|NCT01486927|2028483|FG000|Overall Study|50 Exposure days not reached|2
1009407|NCT01486927|2028483|FG000|Overall Study|Withdrawal by Subject|8
1009408|NCT01486927|2028483|FG000|Overall Study|Subject did not reach 6 mo of treatment|1
1009409|NCT01486966|2028496|FG000|Overall Study|Adverse Event|0
1009410|NCT01486966|2028497|FG001|Overall Study|Adverse Event|1
1009411|NCT01486966|2028496|FG000|Overall Study|Withdrawal by Subject|0
1009412|NCT01486966|2028497|FG001|Overall Study|Withdrawal by Subject|1
1009413|NCT01487161|2028507|FG000|Overall Study|Adverse Event|1
1009414|NCT01487161|2028508|FG001|Overall Study|Adverse Event|0
1009415|NCT01487161|2028509|FG002|Overall Study|Adverse Event|0
1009416|NCT01487161|2028510|FG003|Overall Study|Adverse Event|0
1009417|NCT01487161|2028507|FG000|Overall Study|Withdrawal by Subject|1
1009418|NCT01487161|2028508|FG001|Overall Study|Withdrawal by Subject|1
1009419|NCT01487161|2028509|FG002|Overall Study|Withdrawal by Subject|1
1009420|NCT01487161|2028510|FG003|Overall Study|Withdrawal by Subject|2
1009421|NCT01487161|2028507|FG000|Overall Study|missing data|0
1009422|NCT01487161|2028508|FG001|Overall Study|missing data|1
1009423|NCT01487161|2028509|FG002|Overall Study|missing data|0
1009424|NCT01487161|2028510|FG003|Overall Study|missing data|0
1009425|NCT01487200|2028529|FG000|Overall Study|Withdrawal by Subject|0
1009426|NCT01487200|2028530|FG001|Overall Study|Withdrawal by Subject|1
1009427|NCT01487200|2028531|FG002|Overall Study|Withdrawal by Subject|0
1009428|NCT01487200|2028532|FG003|Overall Study|Withdrawal by Subject|0
1009429|NCT01487265|2028543|FG000|Overall Study|Adverse Event|8
1009430|NCT01487265|2028543|FG000|Overall Study|Withdrawal by Subject|5
1009431|NCT01487265|2028543|FG000|Overall Study|Disease Progression|21
1009432|NCT01487265|2028543|FG000|Overall Study|Death|2
1009433|NCT01487265|2028543|FG000|Overall Study|Still on Treatment|1
1009434|NCT01487525|2028549|FG000|Overall Study|Withdrawal by Subject|0
1009435|NCT01487525|2028550|FG001|Overall Study|Withdrawal by Subject|1
1009436|NCT01487577|2028556|FG000|Overall Study|Became ineligible after signing consent|1
1009437|NCT01487863|2028573|FG000|Overall Study|Death|19
1009438|NCT01487863|2028574|FG001|Overall Study|Death|19
1009439|NCT01488071|2028602|FG000|Overall Study|Adverse Event|15
1009440|NCT01488071|2028603|FG001|Overall Study|Adverse Event|23
1009441|NCT01488071|2028602|FG000|Overall Study|Lack of Efficacy|11
1009442|NCT01488071|2028603|FG001|Overall Study|Lack of Efficacy|17
1009443|NCT01488071|2028602|FG000|Overall Study|Non-compliance with study drug|2
1009444|NCT01488071|2028603|FG001|Overall Study|Non-compliance with study drug|0
1009445|NCT01488071|2028602|FG000|Overall Study|Protocol Violation|5
1009446|NCT01488071|2028603|FG001|Overall Study|Protocol Violation|7
1009447|NCT01488071|2028602|FG000|Overall Study|Withdrawal of Consent|14
1009448|NCT01488071|2028603|FG001|Overall Study|Withdrawal of Consent|12
1009449|NCT01488071|2028602|FG000|Overall Study|Lost to Follow-up|1
1009450|NCT01488071|2028603|FG001|Overall Study|Lost to Follow-up|0
1009451|NCT01488071|2028602|FG000|Overall Study|Administrative or Other Reason(s)|5
1009452|NCT01488071|2028603|FG001|Overall Study|Administrative or Other Reason(s)|4
1009453|NCT01488097|2028609|FG000|Overall Study|Lost to Follow-up|1
1009454|NCT01488370|2028641|FG000|Overall Study|Protocol Violation|0
1009455|NCT01488370|2028642|FG001|Overall Study|Protocol Violation|1
1009456|NCT01488370|2028643|FG002|Overall Study|Protocol Violation|1
1009457|NCT01488448|2028662|FG000|Overall Study|Withdrawal by Subject|3
1009458|NCT01488448|2028663|FG001|Overall Study|Withdrawal by Subject|1
1009459|NCT01488448|2028662|FG000|Overall Study|Adverse Event|9
1009460|NCT01488448|2028663|FG001|Overall Study|Adverse Event|4
1009461|NCT01488448|2028662|FG000|Overall Study|Physician Decision|4
1009462|NCT01488448|2028663|FG001|Overall Study|Physician Decision|9
1009463|NCT01488448|2028662|FG000|Overall Study|Protocol Violation|4
1009464|NCT01488448|2028663|FG001|Overall Study|Protocol Violation|3
1009465|NCT01488487|2028671|FG000|Overall Study|Adverse Event|6
1009466|NCT01488487|2028671|FG000|Overall Study|Death|1
1009467|NCT01488487|2028671|FG000|Overall Study|Withdrawal by Subject|2
1009468|NCT01488578|2028675|FG000|Overall Study|Protocol Violation|1836
1009469|NCT01488890|2028729|FG000|Overall Study|Serious adverse event|2
1009470|NCT01488890|2028730|FG001|Overall Study|Serious adverse event|0
1009471|NCT01488890|2028731|FG002|Overall Study|Serious adverse event|0
1009472|NCT01488890|2028732|FG003|Overall Study|Serious adverse event|0
1009473|NCT01488890|2028729|FG000|Overall Study|Protocol Violation|3
1009474|NCT01488890|2028730|FG001|Overall Study|Protocol Violation|0
1009475|NCT01488890|2028731|FG002|Overall Study|Protocol Violation|4
1009476|NCT01488890|2028732|FG003|Overall Study|Protocol Violation|0
1009477|NCT01488890|2028729|FG000|Overall Study|Lost to Follow-up|13
1009478|NCT01488890|2028730|FG001|Overall Study|Lost to Follow-up|10
1009479|NCT01488890|2028731|FG002|Overall Study|Lost to Follow-up|20
1009480|NCT01488890|2028732|FG003|Overall Study|Lost to Follow-up|3
1009481|NCT01488890|2028729|FG000|Overall Study|Withdrawal by Subject|14
1009482|NCT01488890|2028730|FG001|Overall Study|Withdrawal by Subject|10
1009483|NCT01488890|2028731|FG002|Overall Study|Withdrawal by Subject|11
1009484|NCT01488890|2028732|FG003|Overall Study|Withdrawal by Subject|2
1009485|NCT01488994|2028748|FG000|Overall Study|Withdrawal by Subject|0
1009486|NCT01488994|2028749|FG001|Overall Study|Withdrawal by Subject|1
1009487|NCT01489020|2028766|FG000|Overall Study|Withdrawal by Subject|1
1009488|NCT01489020|2028767|FG001|Overall Study|Withdrawal by Subject|0
1009489|NCT01489020|2028768|FG002|Overall Study|Withdrawal by Subject|0
1009490|NCT01489020|2028769|FG003|Overall Study|Withdrawal by Subject|0
1009491|NCT01489020|2028770|FG004|Overall Study|Withdrawal by Subject|0
1009492|NCT01489020|2028771|FG005|Overall Study|Withdrawal by Subject|0
1009493|NCT01489020|2028766|FG000|Overall Study|Adverse Event|0
1009494|NCT01489020|2028767|FG001|Overall Study|Adverse Event|0
1009495|NCT01489020|2028768|FG002|Overall Study|Adverse Event|3
1009496|NCT01489020|2028769|FG003|Overall Study|Adverse Event|0
1009497|NCT01489020|2028770|FG004|Overall Study|Adverse Event|3
1009498|NCT01489020|2028771|FG005|Overall Study|Adverse Event|0
1009499|NCT01489020|2028766|FG000|Overall Study|Concomitant disease|0
1009500|NCT01489020|2028767|FG001|Overall Study|Concomitant disease|0
1009501|NCT01489020|2028768|FG002|Overall Study|Concomitant disease|0
1009502|NCT01489020|2028769|FG003|Overall Study|Concomitant disease|0
1009503|NCT01489020|2028770|FG004|Overall Study|Concomitant disease|3
1009504|NCT01489020|2028771|FG005|Overall Study|Concomitant disease|0
1009505|NCT01489111|2028791|FG000|Overall Study|Withdrawal criterion|1
1009506|NCT01489189|2028797|FG000|Overall Study|Withdrawal by Subject|20
1009507|NCT01489189|2028798|FG001|Overall Study|Withdrawal by Subject|23
1009508|NCT01489189|2028797|FG000|Overall Study|Death|10
1009509|NCT01489189|2028798|FG001|Overall Study|Death|8
1009510|NCT01489189|2028797|FG000|Overall Study|Missed Visit|1
1009511|NCT01489189|2028798|FG001|Overall Study|Missed Visit|4
1009512|NCT01489254|2028808|FG000|Double-blind Part|Adverse Event|7
1009513|NCT01489254|2028809|FG001|Double-blind Part|Adverse Event|2
1009514|NCT01489254|2028810|FG002|Double-blind Part|Adverse Event|2
1009515|NCT01489254|2028811|FG003|Double-blind Part|Adverse Event|0
1009516|NCT01489254|2028808|FG000|Double-blind Part|Pregnancy|1
1009517|NCT01489254|2028809|FG001|Double-blind Part|Pregnancy|3
1009518|NCT01489254|2028810|FG002|Double-blind Part|Pregnancy|0
1009519|NCT01489254|2028811|FG003|Double-blind Part|Pregnancy|0
1009520|NCT01489254|2028808|FG000|Double-blind Part|Withdrawal by Subject|12
1009521|NCT01489254|2028809|FG001|Double-blind Part|Withdrawal by Subject|20
1009522|NCT01489254|2028810|FG002|Double-blind Part|Withdrawal by Subject|1
1009523|NCT01489254|2028811|FG003|Double-blind Part|Withdrawal by Subject|0
1009524|NCT01489254|2028808|FG000|Double-blind Part|Lost to Follow-up|1
1009525|NCT01489254|2028809|FG001|Double-blind Part|Lost to Follow-up|2
1009526|NCT01489254|2028810|FG002|Double-blind Part|Lost to Follow-up|0
1009527|NCT01489254|2028811|FG003|Double-blind Part|Lost to Follow-up|0
1009528|NCT01489254|2028808|FG000|Double-blind Part|Other reasons for not completing study|4
1009529|NCT01489254|2028809|FG001|Double-blind Part|Other reasons for not completing study|6
1009530|NCT01489254|2028810|FG002|Double-blind Part|Other reasons for not completing study|0
1009531|NCT01489254|2028811|FG003|Double-blind Part|Other reasons for not completing study|0
1009532|NCT01489254|2028808|FG000|Open-label Extension Part|Adverse Event|0
1009533|NCT01489254|2028809|FG001|Open-label Extension Part|Adverse Event|0
1009534|NCT01489254|2028810|FG002|Open-label Extension Part|Adverse Event|0
1009535|NCT01489254|2028811|FG003|Open-label Extension Part|Adverse Event|10
1009536|NCT01489254|2028808|FG000|Open-label Extension Part|Pregnancy|0
1009537|NCT01489254|2028809|FG001|Open-label Extension Part|Pregnancy|0
1009538|NCT01489254|2028810|FG002|Open-label Extension Part|Pregnancy|0
1009539|NCT01489254|2028811|FG003|Open-label Extension Part|Pregnancy|3
1009540|NCT01489254|2028808|FG000|Open-label Extension Part|Withdrawal by Subject|0
1009541|NCT01489254|2028809|FG001|Open-label Extension Part|Withdrawal by Subject|0
1009542|NCT01489254|2028810|FG002|Open-label Extension Part|Withdrawal by Subject|0
1009543|NCT01489254|2028811|FG003|Open-label Extension Part|Withdrawal by Subject|30
1009544|NCT01489254|2028808|FG000|Open-label Extension Part|Protocol Violation|0
1009545|NCT01489254|2028809|FG001|Open-label Extension Part|Protocol Violation|0
1009546|NCT01489254|2028810|FG002|Open-label Extension Part|Protocol Violation|0
1009547|NCT01489254|2028811|FG003|Open-label Extension Part|Protocol Violation|1
1009548|NCT01489254|2028808|FG000|Open-label Extension Part|Lost to Follow-up|0
1009549|NCT01489254|2028809|FG001|Open-label Extension Part|Lost to Follow-up|0
1009550|NCT01489254|2028810|FG002|Open-label Extension Part|Lost to Follow-up|0
1009551|NCT01489254|2028811|FG003|Open-label Extension Part|Lost to Follow-up|9
1009552|NCT01489254|2028808|FG000|Open-label Extension Part|Other reasons for not completing study|0
1009553|NCT01489254|2028809|FG001|Open-label Extension Part|Other reasons for not completing study|0
1009554|NCT01489254|2028810|FG002|Open-label Extension Part|Other reasons for not completing study|0
1009555|NCT01489254|2028811|FG003|Open-label Extension Part|Other reasons for not completing study|5
1009556|NCT01489358|2028823|FG000|Overall Study|Lost to Follow-up|0
1009557|NCT01489358|2028824|FG001|Overall Study|Lost to Follow-up|0
1009558|NCT01489358|2028825|FG002|Overall Study|Lost to Follow-up|2
1009559|NCT01489527|2028835|FG000|Overall Study|Pregnancy|9
1009560|NCT01489527|2028836|FG001|Overall Study|Pregnancy|14
1009561|NCT01489527|2028835|FG000|Overall Study|Participant moved|6
1009562|NCT01489527|2028836|FG001|Overall Study|Participant moved|7
1009563|NCT01489527|2028835|FG000|Overall Study|Withdrawal by Subject|0
1009564|NCT01489527|2028836|FG001|Overall Study|Withdrawal by Subject|4
1009565|NCT01489527|2028835|FG000|Overall Study|Lost to Follow-up|5
1009566|NCT01489527|2028836|FG001|Overall Study|Lost to Follow-up|1
1009567|NCT01489527|2028835|FG000|Overall Study|Procedures|1
1009568|NCT01489527|2028836|FG001|Overall Study|Procedures|0
1009569|NCT01489527|2028835|FG000|Overall Study|Not compliant|1
1009570|NCT01489527|2028836|FG001|Overall Study|Not compliant|0
1009571|NCT01489891|2028904|FG000|Overall Study|Endoscopy failure|1
1009572|NCT01489891|2028905|FG001|Overall Study|Endoscopy failure|0
1009573|NCT01489956|2028913|FG000|Overall Study|Lost to Follow-up|1
1009574|NCT01489956|2028914|FG001|Overall Study|Lost to Follow-up|0
1009575|NCT01489956|2028915|FG002|Overall Study|Lost to Follow-up|0
1009576|NCT01489956|2028913|FG000|Overall Study|Withdrawal by Subject|0
1009577|NCT01489956|2028914|FG001|Overall Study|Withdrawal by Subject|0
1009578|NCT01489956|2028915|FG002|Overall Study|Withdrawal by Subject|1
1009579|NCT01490060|2028938|FG000|Cycle 1|Change of Treatment|0
1009580|NCT01490060|2028939|FG001|Cycle 1|Change of Treatment|1
1009581|NCT01490060|2028940|FG002|Cycle 1|Change of Treatment|1
1009582|NCT01490060|2028941|FG003|Cycle 1|Change of Treatment|1
1009583|NCT01490060|2028938|FG000|Cycle 1|Insurance Denied|0
1009584|NCT01490060|2028939|FG001|Cycle 1|Insurance Denied|0
1009585|NCT01490060|2028940|FG002|Cycle 1|Insurance Denied|2
1009586|NCT01490060|2028941|FG003|Cycle 1|Insurance Denied|0
1009587|NCT01490060|2028938|FG000|Cycle 1|Withdrawal by Subject|0
1009588|NCT01490060|2028939|FG001|Cycle 1|Withdrawal by Subject|0
1009589|NCT01490060|2028940|FG002|Cycle 1|Withdrawal by Subject|0
1009590|NCT01490060|2028941|FG003|Cycle 1|Withdrawal by Subject|1
1009591|NCT01490060|2028938|FG000|Cycle 1|Treatment at Another Facility|0
1009592|NCT01490060|2028939|FG001|Cycle 1|Treatment at Another Facility|0
1009593|NCT01490060|2028940|FG002|Cycle 1|Treatment at Another Facility|0
1009594|NCT01490060|2028941|FG003|Cycle 1|Treatment at Another Facility|1
1009595|NCT01490060|2028938|FG000|Cycle 2|Change of Treatment|1
1009596|NCT01490060|2028939|FG001|Cycle 2|Change of Treatment|1
1009597|NCT01490060|2028940|FG002|Cycle 2|Change of Treatment|0
1009598|NCT01490060|2028941|FG003|Cycle 2|Change of Treatment|0
1009599|NCT01490060|2028938|FG000|Cycle 2|Non-Compliance|0
1009600|NCT01490060|2028939|FG001|Cycle 2|Non-Compliance|0
1009601|NCT01490060|2028940|FG002|Cycle 2|Non-Compliance|1
1009602|NCT01490060|2028941|FG003|Cycle 2|Non-Compliance|0
1009603|NCT01490060|2028938|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1
1009604|NCT01490060|2028939|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0
1009605|NCT01490060|2028940|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0
1009606|NCT01490060|2028941|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0
1009607|NCT01490086|2028963|FG000|Overall Study|Consent withdrawn|4
1009608|NCT01490086|2028964|FG001|Overall Study|Consent withdrawn|4
1009609|NCT01490086|2028965|FG002|Overall Study|Consent withdrawn|3
1009610|NCT01490086|2028966|FG003|Overall Study|Consent withdrawn|0
1009611|NCT01490086|2028967|FG004|Overall Study|Consent withdrawn|1
1009612|NCT01490086|2028963|FG000|Overall Study|Non-compliance|0
1009613|NCT01490086|2028964|FG001|Overall Study|Non-compliance|1
1009614|NCT01490086|2028965|FG002|Overall Study|Non-compliance|0
1009615|NCT01490086|2028966|FG003|Overall Study|Non-compliance|0
1009616|NCT01490086|2028967|FG004|Overall Study|Non-compliance|0
1009617|NCT01490086|2028963|FG000|Overall Study|Abnormal laboratory findings|1
1009618|NCT01490086|2028964|FG001|Overall Study|Abnormal laboratory findings|0
1009619|NCT01490086|2028965|FG002|Overall Study|Abnormal laboratory findings|0
1009620|NCT01490086|2028966|FG003|Overall Study|Abnormal laboratory findings|0
1009621|NCT01490086|2028967|FG004|Overall Study|Abnormal laboratory findings|0
1009622|NCT01490086|2028963|FG000|Overall Study|Lost to Follow-up|0
1009623|NCT01490086|2028964|FG001|Overall Study|Lost to Follow-up|0
1009624|NCT01490086|2028965|FG002|Overall Study|Lost to Follow-up|0
1009625|NCT01490086|2028966|FG003|Overall Study|Lost to Follow-up|0
1009626|NCT01490086|2028967|FG004|Overall Study|Lost to Follow-up|1
1009627|NCT01490086|2028963|FG000|Overall Study|Physician Decision|3
1009628|NCT01490086|2028964|FG001|Overall Study|Physician Decision|4
1009629|NCT01490086|2028965|FG002|Overall Study|Physician Decision|2
1009630|NCT01490086|2028966|FG003|Overall Study|Physician Decision|3
1009631|NCT01490086|2028967|FG004|Overall Study|Physician Decision|1
1009632|NCT01490086|2028963|FG000|Overall Study|Adverse Event|0
1009633|NCT01490086|2028964|FG001|Overall Study|Adverse Event|0
1009634|NCT01490086|2028965|FG002|Overall Study|Adverse Event|1
1009635|NCT01490086|2028966|FG003|Overall Study|Adverse Event|2
1009636|NCT01490086|2028967|FG004|Overall Study|Adverse Event|0
1009637|NCT01490086|2028963|FG000|Overall Study|Lack of Efficacy|0
1009638|NCT01490086|2028964|FG001|Overall Study|Lack of Efficacy|3
1009639|NCT01490086|2028965|FG002|Overall Study|Lack of Efficacy|1
1009640|NCT01490086|2028966|FG003|Overall Study|Lack of Efficacy|0
1009641|NCT01490086|2028967|FG004|Overall Study|Lack of Efficacy|8
1009642|NCT01490086|2028963|FG000|Overall Study|Worsening of symptoms|0
1009643|NCT01490086|2028964|FG001|Overall Study|Worsening of symptoms|1
1009644|NCT01490086|2028965|FG002|Overall Study|Worsening of symptoms|0
1009645|NCT01490086|2028966|FG003|Overall Study|Worsening of symptoms|1
1009646|NCT01490086|2028967|FG004|Overall Study|Worsening of symptoms|0
1009647|NCT01490086|2028963|FG000|Overall Study|Subject uncontrollable and abusive|0
1009648|NCT01490086|2028964|FG001|Overall Study|Subject uncontrollable and abusive|1
1009649|NCT01490086|2028965|FG002|Overall Study|Subject uncontrollable and abusive|0
1009650|NCT01490086|2028966|FG003|Overall Study|Subject uncontrollable and abusive|0
1009651|NCT01490086|2028967|FG004|Overall Study|Subject uncontrollable and abusive|0
1009652|NCT01490086|2028963|FG000|Overall Study|Subject left hospital|0
1009653|NCT01490086|2028964|FG001|Overall Study|Subject left hospital|1
1009654|NCT01490086|2028965|FG002|Overall Study|Subject left hospital|0
1009655|NCT01490086|2028966|FG003|Overall Study|Subject left hospital|1
1009656|NCT01490086|2028967|FG004|Overall Study|Subject left hospital|0
1009657|NCT01490125|2028979|FG000|Period I|Adverse Event|4
1009658|NCT01490125|2028980|FG001|Period I|Adverse Event|1
1009659|NCT01490125|2028981|FG002|Period I|Adverse Event|1
1009660|NCT01490125|2028982|FG003|Period I|Adverse Event|3
1009661|NCT01490125|2028983|FG004|Period I|Adverse Event|2
1009662|NCT01490125|2028984|FG005|Period I|Adverse Event|4
1009663|NCT01490125|2028979|FG000|Period I|Protocol Violation|1
1009664|NCT01490125|2028980|FG001|Period I|Protocol Violation|1
1009665|NCT01490125|2028981|FG002|Period I|Protocol Violation|1
1009666|NCT01490125|2028982|FG003|Period I|Protocol Violation|1
1009667|NCT01490125|2028983|FG004|Period I|Protocol Violation|0
1009668|NCT01490125|2028984|FG005|Period I|Protocol Violation|0
1009669|NCT01490125|2028979|FG000|Period I|Withdrawal by Subject|1
1009670|NCT01490125|2028980|FG001|Period I|Withdrawal by Subject|3
1009671|NCT01490125|2028981|FG002|Period I|Withdrawal by Subject|2
1009672|NCT01490125|2028982|FG003|Period I|Withdrawal by Subject|1
1009673|NCT01490125|2028983|FG004|Period I|Withdrawal by Subject|2
1009674|NCT01490125|2028984|FG005|Period I|Withdrawal by Subject|1
1009675|NCT01490125|2028979|FG000|Period II|Adverse Event|2
1009676|NCT01490125|2028980|FG001|Period II|Adverse Event|3
1009677|NCT01490125|2028981|FG002|Period II|Adverse Event|2
1009678|NCT01490125|2028982|FG003|Period II|Adverse Event|2
1009679|NCT01490125|2028983|FG004|Period II|Adverse Event|4
1009680|NCT01490125|2028984|FG005|Period II|Adverse Event|2
1009681|NCT01490125|2028979|FG000|Period II|Protocol Violation|0
1009682|NCT01490125|2028980|FG001|Period II|Protocol Violation|0
1009683|NCT01490125|2028981|FG002|Period II|Protocol Violation|1
1009684|NCT01490125|2028982|FG003|Period II|Protocol Violation|1
1009685|NCT01490125|2028983|FG004|Period II|Protocol Violation|0
1009686|NCT01490125|2028984|FG005|Period II|Protocol Violation|0
1009687|NCT01490125|2028979|FG000|Period II|Lost to Follow-up|0
1009688|NCT01490125|2028980|FG001|Period II|Lost to Follow-up|1
1009689|NCT01490125|2028981|FG002|Period II|Lost to Follow-up|0
1009690|NCT01490125|2028982|FG003|Period II|Lost to Follow-up|0
1009691|NCT01490125|2028983|FG004|Period II|Lost to Follow-up|0
1009692|NCT01490125|2028984|FG005|Period II|Lost to Follow-up|0
1009693|NCT01490125|2028979|FG000|Period II|Withdrawal by Subject|1
1009694|NCT01490125|2028980|FG001|Period II|Withdrawal by Subject|0
1009695|NCT01490125|2028981|FG002|Period II|Withdrawal by Subject|0
1009696|NCT01490125|2028982|FG003|Period II|Withdrawal by Subject|0
1009697|NCT01490125|2028983|FG004|Period II|Withdrawal by Subject|0
1009698|NCT01490125|2028984|FG005|Period II|Withdrawal by Subject|0
1009699|NCT01490125|2028979|FG000|Period III|Adverse Event|3
1009700|NCT01490125|2028980|FG001|Period III|Adverse Event|1
1009701|NCT01490125|2028981|FG002|Period III|Adverse Event|0
1009702|NCT01490125|2028982|FG003|Period III|Adverse Event|1
1009703|NCT01490125|2028983|FG004|Period III|Adverse Event|0
1009704|NCT01490125|2028984|FG005|Period III|Adverse Event|0
1009705|NCT01490125|2028979|FG000|Period III|Death|0
1009706|NCT01490125|2028980|FG001|Period III|Death|0
1009707|NCT01490125|2028981|FG002|Period III|Death|0
1009708|NCT01490125|2028982|FG003|Period III|Death|1
1009709|NCT01490125|2028983|FG004|Period III|Death|0
1009710|NCT01490125|2028984|FG005|Period III|Death|0
1009711|NCT01490125|2028979|FG000|Period III|Lack of Efficacy|0
1009712|NCT01490125|2028980|FG001|Period III|Lack of Efficacy|0
1009713|NCT01490125|2028981|FG002|Period III|Lack of Efficacy|0
1009714|NCT01490125|2028982|FG003|Period III|Lack of Efficacy|0
1009715|NCT01490125|2028983|FG004|Period III|Lack of Efficacy|1
1009716|NCT01490125|2028984|FG005|Period III|Lack of Efficacy|0
1009717|NCT01490190|2028998|FG000|Overall Study|Withdrawal by Subject|9
1009718|NCT01490190|2028998|FG000|Overall Study|Adverse Event|17
1009719|NCT01490190|2028998|FG000|Overall Study|Protocol Violation|5
1009720|NCT01490190|2028998|FG000|Overall Study|Lost to Follow-up|13
1009721|NCT01490190|2028998|FG000|Overall Study|Relocation|1
1009722|NCT01490190|2028998|FG000|Overall Study|Inconvenience|1
1009723|NCT01490190|2028998|FG000|Overall Study|Ring expulsion|2
1009724|NCT01490294|2029006|FG000|Overall Study|Prematurely discontinuation|4
1009725|NCT01490294|2029007|FG001|Overall Study|Prematurely discontinuation|0
1009726|NCT01490294|2029008|FG002|Overall Study|Prematurely discontinuation|1
1009727|NCT01490294|2029009|FG003|Overall Study|Prematurely discontinuation|1
1009728|NCT01490294|2029006|FG000|Overall Study|Adverse Event|1
1009729|NCT01490294|2029007|FG001|Overall Study|Adverse Event|0
1009730|NCT01490294|2029008|FG002|Overall Study|Adverse Event|0
1009731|NCT01490294|2029009|FG003|Overall Study|Adverse Event|0
1009732|NCT01490450|2029033|FG000|Period 1|Lack of Efficacy|2
1009733|NCT01490450|2029034|FG001|Period 1|Lack of Efficacy|0
1009734|NCT01490450|2029035|FG002|Period 1|Lack of Efficacy|3
1009735|NCT01490450|2029036|FG003|Period 1|Lack of Efficacy|0
1009736|NCT01490450|2029033|FG000|Period 1|Adverse Event|0
1009737|NCT01490450|2029034|FG001|Period 1|Adverse Event|0
1009738|NCT01490450|2029035|FG002|Period 1|Adverse Event|0
1009739|NCT01490450|2029036|FG003|Period 1|Adverse Event|5
1009740|NCT01490450|2029033|FG000|Period 1|Request to discontinue treatment|1
1009741|NCT01490450|2029034|FG001|Period 1|Request to discontinue treatment|0
1009742|NCT01490450|2029035|FG002|Period 1|Request to discontinue treatment|0
1009743|NCT01490450|2029036|FG003|Period 1|Request to discontinue treatment|0
1009744|NCT01490450|2029033|FG000|Period 1|Withdrawal by Subject|0
1009745|NCT01490450|2029034|FG001|Period 1|Withdrawal by Subject|0
1009746|NCT01490450|2029035|FG002|Period 1|Withdrawal by Subject|0
1009747|NCT01490450|2029036|FG003|Period 1|Withdrawal by Subject|3
1009748|NCT01490450|2029033|FG000|Period 1|No longer met study criteria|0
1009749|NCT01490450|2029034|FG001|Period 1|No longer met study criteria|1
1009750|NCT01490450|2029035|FG002|Period 1|No longer met study criteria|1
1009751|NCT01490450|2029036|FG003|Period 1|No longer met study criteria|0
1009752|NCT01490450|2029033|FG000|Period 2|Lack of Efficacy|0
1009753|NCT01490450|2029034|FG001|Period 2|Lack of Efficacy|0
1009754|NCT01490450|2029035|FG002|Period 2|Lack of Efficacy|0
1009755|NCT01490450|2029036|FG003|Period 2|Lack of Efficacy|1
1009756|NCT01490450|2029033|FG000|Period 2|Adverse Event|1
1009757|NCT01490450|2029034|FG001|Period 2|Adverse Event|1
1009758|NCT01490450|2029035|FG002|Period 2|Adverse Event|0
1009759|NCT01490450|2029036|FG003|Period 2|Adverse Event|1
1009760|NCT01490450|2029033|FG000|Period 2|Withdrawal by Subject|1
1009761|NCT01490450|2029034|FG001|Period 2|Withdrawal by Subject|0
1009762|NCT01490450|2029035|FG002|Period 2|Withdrawal by Subject|0
1009763|NCT01490450|2029036|FG003|Period 2|Withdrawal by Subject|0
1009764|NCT01490450|2029033|FG000|Period 2|Lost to Follow-up|0
1009765|NCT01490450|2029034|FG001|Period 2|Lost to Follow-up|0
1009766|NCT01490450|2029035|FG002|Period 2|Lost to Follow-up|0
1009767|NCT01490450|2029036|FG003|Period 2|Lost to Follow-up|2
1009768|NCT01490580|2029051|FG000|Overall Study|Parents withdrew consent|0
1009769|NCT01490580|2029052|FG001|Overall Study|Parents withdrew consent|2
1009770|NCT01490632|2029067|FG000|Part A: Initial Treatment Period|Adverse Event|0
1009771|NCT01490632|2029068|FG001|Part A: Initial Treatment Period|Adverse Event|0
1009772|NCT01490632|2029069|FG002|Part A: Initial Treatment Period|Adverse Event|2
1009773|NCT01490632|2029070|FG003|Part A: Initial Treatment Period|Adverse Event|4
1009774|NCT01490632|2029071|FG004|Part A: Initial Treatment Period|Adverse Event|4
1009775|NCT01490632|2029072|FG005|Part A: Initial Treatment Period|Adverse Event|0
1009776|NCT01490632|2029073|FG006|Part A: Initial Treatment Period|Adverse Event|0
1009777|NCT01490632|2029074|FG007|Part A: Initial Treatment Period|Adverse Event|0
1009778|NCT01490632|2029075|FG008|Part A: Initial Treatment Period|Adverse Event|0
1009779|NCT01490632|2029076|FG009|Part A: Initial Treatment Period|Adverse Event|0
1009780|NCT01490632|2029077|FG010|Part A: Initial Treatment Period|Adverse Event|0
1009781|NCT01490632|2029078|FG011|Part A: Initial Treatment Period|Adverse Event|0
1009782|NCT01490632|2029079|FG012|Part A: Initial Treatment Period|Adverse Event|0
1009783|NCT01490632|2029080|FG013|Part A: Initial Treatment Period|Adverse Event|0
1009784|NCT01490632|2029081|FG014|Part A: Initial Treatment Period|Adverse Event|0
1009785|NCT01490632|2029082|FG015|Part A: Initial Treatment Period|Adverse Event|0
1009786|NCT01490632|2029083|FG016|Part A: Initial Treatment Period|Adverse Event|0
1009787|NCT01490632|2029084|FG017|Part A: Initial Treatment Period|Adverse Event|0
1009788|NCT01490632|2029085|FG018|Part A: Initial Treatment Period|Adverse Event|0
1009789|NCT01490632|2029086|FG019|Part A: Initial Treatment Period|Adverse Event|0
1009790|NCT01490632|2029067|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3
1009791|NCT01490632|2029068|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1
1009792|NCT01490632|2029069|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2
1009793|NCT01490632|2029070|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2
1009794|NCT01490632|2029071|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0
1009795|NCT01490632|2029072|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0
1009796|NCT01490632|2029073|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0
1009797|NCT01490632|2029074|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0
1009798|NCT01490632|2029075|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0
1009799|NCT01490632|2029076|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0
1009800|NCT01490632|2029077|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0
1009801|NCT01490632|2029078|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0
1009802|NCT01490632|2029079|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0
1009803|NCT01490632|2029080|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0
1009804|NCT01490632|2029081|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0
1009805|NCT01490632|2029082|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0
1009806|NCT01490632|2029083|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0
1009807|NCT01490632|2029084|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0
1009808|NCT01490632|2029085|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0
1009809|NCT01490632|2029086|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0
1009810|NCT01490632|2029067|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0
1009811|NCT01490632|2029068|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0
1009812|NCT01490632|2029069|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1
1009813|NCT01490632|2029070|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1
1009814|NCT01490632|2029071|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2
1009815|NCT01490632|2029072|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0
1009816|NCT01490632|2029073|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0
1009817|NCT01490632|2029074|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0
1009818|NCT01490632|2029075|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0
1009819|NCT01490632|2029076|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0
1009820|NCT01490632|2029077|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0
1009821|NCT01490632|2029078|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0
1009822|NCT01490632|2029079|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0
1009823|NCT01490632|2029080|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0
1009824|NCT01490632|2029081|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0
1009825|NCT01490632|2029082|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0
1009826|NCT01490632|2029083|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0
1009827|NCT01490632|2029084|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0
1009828|NCT01490632|2029085|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0
1009829|NCT01490632|2029086|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0
1009830|NCT01490632|2029067|FG000|Part A: Initial Treatment Period|Physician Decision|0
1009831|NCT01490632|2029068|FG001|Part A: Initial Treatment Period|Physician Decision|1
1009832|NCT01490632|2029069|FG002|Part A: Initial Treatment Period|Physician Decision|0
1009833|NCT01490632|2029070|FG003|Part A: Initial Treatment Period|Physician Decision|1
1009834|NCT01490632|2029071|FG004|Part A: Initial Treatment Period|Physician Decision|0
1009835|NCT01490632|2029072|FG005|Part A: Initial Treatment Period|Physician Decision|0
1009836|NCT01490632|2029073|FG006|Part A: Initial Treatment Period|Physician Decision|0
1009837|NCT01490632|2029074|FG007|Part A: Initial Treatment Period|Physician Decision|0
1009838|NCT01490632|2029075|FG008|Part A: Initial Treatment Period|Physician Decision|0
1009839|NCT01490632|2029076|FG009|Part A: Initial Treatment Period|Physician Decision|0
1009840|NCT01490632|2029077|FG010|Part A: Initial Treatment Period|Physician Decision|0
1009841|NCT01490632|2029078|FG011|Part A: Initial Treatment Period|Physician Decision|0
1009842|NCT01490632|2029079|FG012|Part A: Initial Treatment Period|Physician Decision|0
1009843|NCT01490632|2029080|FG013|Part A: Initial Treatment Period|Physician Decision|0
1009844|NCT01490632|2029081|FG014|Part A: Initial Treatment Period|Physician Decision|0
1009845|NCT01490632|2029082|FG015|Part A: Initial Treatment Period|Physician Decision|0
1009846|NCT01490632|2029083|FG016|Part A: Initial Treatment Period|Physician Decision|0
1009847|NCT01490632|2029084|FG017|Part A: Initial Treatment Period|Physician Decision|0
1009848|NCT01490632|2029085|FG018|Part A: Initial Treatment Period|Physician Decision|0
1009849|NCT01490632|2029086|FG019|Part A: Initial Treatment Period|Physician Decision|0
1009850|NCT01490632|2029067|FG000|Part A: Initial Treatment Period|Sponsor Decision|2
1009851|NCT01490632|2029068|FG001|Part A: Initial Treatment Period|Sponsor Decision|0
1009852|NCT01490632|2029069|FG002|Part A: Initial Treatment Period|Sponsor Decision|0
1009853|NCT01490632|2029070|FG003|Part A: Initial Treatment Period|Sponsor Decision|0
1009854|NCT01490632|2029071|FG004|Part A: Initial Treatment Period|Sponsor Decision|0
1009855|NCT01490632|2029072|FG005|Part A: Initial Treatment Period|Sponsor Decision|0
1009856|NCT01490632|2029073|FG006|Part A: Initial Treatment Period|Sponsor Decision|0
1009857|NCT01490632|2029074|FG007|Part A: Initial Treatment Period|Sponsor Decision|0
1009858|NCT01490632|2029075|FG008|Part A: Initial Treatment Period|Sponsor Decision|0
1009859|NCT01490632|2029076|FG009|Part A: Initial Treatment Period|Sponsor Decision|0
1009860|NCT01490632|2029077|FG010|Part A: Initial Treatment Period|Sponsor Decision|0
1009861|NCT01490632|2029078|FG011|Part A: Initial Treatment Period|Sponsor Decision|0
1009862|NCT01490632|2029079|FG012|Part A: Initial Treatment Period|Sponsor Decision|0
1009863|NCT01490632|2029080|FG013|Part A: Initial Treatment Period|Sponsor Decision|0
1009864|NCT01490632|2029081|FG014|Part A: Initial Treatment Period|Sponsor Decision|0
1009865|NCT01490632|2029082|FG015|Part A: Initial Treatment Period|Sponsor Decision|0
1009866|NCT01490632|2029083|FG016|Part A: Initial Treatment Period|Sponsor Decision|0
1009867|NCT01490632|2029084|FG017|Part A: Initial Treatment Period|Sponsor Decision|0
1009868|NCT01490632|2029085|FG018|Part A: Initial Treatment Period|Sponsor Decision|0
1009869|NCT01490632|2029086|FG019|Part A: Initial Treatment Period|Sponsor Decision|0
1009870|NCT01490632|2029067|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2
1009871|NCT01490632|2029068|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2
1009872|NCT01490632|2029069|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009873|NCT01490632|2029070|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1
1009874|NCT01490632|2029071|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2
1009875|NCT01490632|2029072|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009876|NCT01490632|2029073|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009877|NCT01490632|2029074|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009878|NCT01490632|2029075|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009879|NCT01490632|2029076|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009880|NCT01490632|2029077|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009881|NCT01490632|2029078|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009882|NCT01490632|2029079|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009883|NCT01490632|2029080|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009884|NCT01490632|2029081|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009885|NCT01490632|2029082|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009886|NCT01490632|2029083|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009887|NCT01490632|2029084|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009888|NCT01490632|2029085|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009889|NCT01490632|2029086|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0
1009890|NCT01490632|2029067|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009891|NCT01490632|2029068|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009892|NCT01490632|2029069|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009893|NCT01490632|2029070|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009894|NCT01490632|2029071|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
1009895|NCT01490632|2029072|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009896|NCT01490632|2029073|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009897|NCT01490632|2029074|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009898|NCT01490632|2029075|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009899|NCT01490632|2029076|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009900|NCT01490632|2029077|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009901|NCT01490632|2029078|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009902|NCT01490632|2029079|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009903|NCT01490632|2029080|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009904|NCT01490632|2029081|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009905|NCT01490632|2029082|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009906|NCT01490632|2029083|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009907|NCT01490632|2029084|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009908|NCT01490632|2029085|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009909|NCT01490632|2029086|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1009910|NCT01490632|2029067|FG000|Part B: Extension or Step-Up Period|Adverse Event|0
1009911|NCT01490632|2029068|FG001|Part B: Extension or Step-Up Period|Adverse Event|0
1009912|NCT01490632|2029069|FG002|Part B: Extension or Step-Up Period|Adverse Event|0
1009913|NCT01490632|2029070|FG003|Part B: Extension or Step-Up Period|Adverse Event|0
1009914|NCT01490632|2029071|FG004|Part B: Extension or Step-Up Period|Adverse Event|0
1009915|NCT01490632|2029072|FG005|Part B: Extension or Step-Up Period|Adverse Event|2
1009916|NCT01490632|2029073|FG006|Part B: Extension or Step-Up Period|Adverse Event|2
1009917|NCT01490632|2029074|FG007|Part B: Extension or Step-Up Period|Adverse Event|0
1009918|NCT01490632|2029075|FG008|Part B: Extension or Step-Up Period|Adverse Event|0
1009919|NCT01490632|2029076|FG009|Part B: Extension or Step-Up Period|Adverse Event|2
1009920|NCT01490632|2029077|FG010|Part B: Extension or Step-Up Period|Adverse Event|3
1009921|NCT01490632|2029078|FG011|Part B: Extension or Step-Up Period|Adverse Event|1
1009922|NCT01490632|2029079|FG012|Part B: Extension or Step-Up Period|Adverse Event|0
1009923|NCT01490632|2029080|FG013|Part B: Extension or Step-Up Period|Adverse Event|0
1009924|NCT01490632|2029081|FG014|Part B: Extension or Step-Up Period|Adverse Event|0
1009925|NCT01490632|2029082|FG015|Part B: Extension or Step-Up Period|Adverse Event|0
1009926|NCT01490632|2029083|FG016|Part B: Extension or Step-Up Period|Adverse Event|0
1009927|NCT01490632|2029084|FG017|Part B: Extension or Step-Up Period|Adverse Event|0
1009928|NCT01490632|2029085|FG018|Part B: Extension or Step-Up Period|Adverse Event|0
1009929|NCT01490632|2029086|FG019|Part B: Extension or Step-Up Period|Adverse Event|0
1009930|NCT01490632|2029067|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009931|NCT01490632|2029068|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009932|NCT01490632|2029069|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009933|NCT01490632|2029070|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009934|NCT01490632|2029071|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009935|NCT01490632|2029072|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009936|NCT01490632|2029073|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1009937|NCT01490632|2029074|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009938|NCT01490632|2029075|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1009939|NCT01490632|2029076|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3
1009940|NCT01490632|2029077|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1009941|NCT01490632|2029078|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009942|NCT01490632|2029079|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009943|NCT01490632|2029080|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009944|NCT01490632|2029081|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009945|NCT01490632|2029082|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009946|NCT01490632|2029083|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009947|NCT01490632|2029084|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009948|NCT01490632|2029085|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009949|NCT01490632|2029086|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1009950|NCT01490632|2029067|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009951|NCT01490632|2029068|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009952|NCT01490632|2029069|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009953|NCT01490632|2029070|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009954|NCT01490632|2029071|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009955|NCT01490632|2029072|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009956|NCT01490632|2029073|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2
1009957|NCT01490632|2029074|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009958|NCT01490632|2029075|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009959|NCT01490632|2029076|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1
1009960|NCT01490632|2029077|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009961|NCT01490632|2029078|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009962|NCT01490632|2029079|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009963|NCT01490632|2029080|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009964|NCT01490632|2029081|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009965|NCT01490632|2029082|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009966|NCT01490632|2029083|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009967|NCT01490632|2029084|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009968|NCT01490632|2029085|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009969|NCT01490632|2029086|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1009970|NCT01490632|2029067|FG000|Part B: Extension or Step-Up Period|Physician Decision|0
1009971|NCT01490632|2029068|FG001|Part B: Extension or Step-Up Period|Physician Decision|0
1009972|NCT01490632|2029069|FG002|Part B: Extension or Step-Up Period|Physician Decision|0
1009973|NCT01490632|2029070|FG003|Part B: Extension or Step-Up Period|Physician Decision|0
1009974|NCT01490632|2029071|FG004|Part B: Extension or Step-Up Period|Physician Decision|0
1009975|NCT01490632|2029072|FG005|Part B: Extension or Step-Up Period|Physician Decision|0
1009976|NCT01490632|2029073|FG006|Part B: Extension or Step-Up Period|Physician Decision|1
1009977|NCT01490632|2029074|FG007|Part B: Extension or Step-Up Period|Physician Decision|0
1009978|NCT01490632|2029075|FG008|Part B: Extension or Step-Up Period|Physician Decision|0
1009979|NCT01490632|2029076|FG009|Part B: Extension or Step-Up Period|Physician Decision|0
1009980|NCT01490632|2029077|FG010|Part B: Extension or Step-Up Period|Physician Decision|0
1009981|NCT01490632|2029078|FG011|Part B: Extension or Step-Up Period|Physician Decision|0
1009982|NCT01490632|2029079|FG012|Part B: Extension or Step-Up Period|Physician Decision|0
1009983|NCT01490632|2029080|FG013|Part B: Extension or Step-Up Period|Physician Decision|0
1009984|NCT01490632|2029081|FG014|Part B: Extension or Step-Up Period|Physician Decision|0
1009985|NCT01490632|2029082|FG015|Part B: Extension or Step-Up Period|Physician Decision|0
1009986|NCT01490632|2029083|FG016|Part B: Extension or Step-Up Period|Physician Decision|0
1009987|NCT01490632|2029084|FG017|Part B: Extension or Step-Up Period|Physician Decision|0
1009988|NCT01490632|2029085|FG018|Part B: Extension or Step-Up Period|Physician Decision|0
1009989|NCT01490632|2029086|FG019|Part B: Extension or Step-Up Period|Physician Decision|0
1009990|NCT01490632|2029067|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0
1009991|NCT01490632|2029068|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0
1009992|NCT01490632|2029069|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0
1009993|NCT01490632|2029070|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0
1009994|NCT01490632|2029071|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0
1009995|NCT01490632|2029072|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1
1009996|NCT01490632|2029073|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0
1009997|NCT01490632|2029074|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0
1009998|NCT01490632|2029075|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0
1009999|NCT01490632|2029076|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0
1010000|NCT01490632|2029077|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0
1010001|NCT01490632|2029078|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0
1010002|NCT01490632|2029079|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0
1010003|NCT01490632|2029080|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0
1010004|NCT01490632|2029081|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0
1010005|NCT01490632|2029082|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0
1010006|NCT01490632|2029083|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0
1010007|NCT01490632|2029084|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0
1010008|NCT01490632|2029085|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0
1010009|NCT01490632|2029086|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0
1010010|NCT01490632|2029067|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010011|NCT01490632|2029068|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010012|NCT01490632|2029069|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010013|NCT01490632|2029070|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010014|NCT01490632|2029071|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010015|NCT01490632|2029072|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010016|NCT01490632|2029073|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1010017|NCT01490632|2029074|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010018|NCT01490632|2029075|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1010019|NCT01490632|2029076|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010020|NCT01490632|2029077|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1010021|NCT01490632|2029078|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
1010022|NCT01490632|2029079|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010023|NCT01490632|2029080|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010024|NCT01490632|2029081|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010025|NCT01490632|2029082|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010026|NCT01490632|2029083|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010027|NCT01490632|2029084|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010028|NCT01490632|2029085|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010029|NCT01490632|2029086|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1010030|NCT01490632|2029067|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010031|NCT01490632|2029068|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010032|NCT01490632|2029069|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010033|NCT01490632|2029070|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010034|NCT01490632|2029071|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010035|NCT01490632|2029072|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
1010036|NCT01490632|2029073|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
1010037|NCT01490632|2029074|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
1010038|NCT01490632|2029075|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
1010039|NCT01490632|2029076|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
1010040|NCT01490632|2029077|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
1010041|NCT01490632|2029078|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
1010042|NCT01490632|2029079|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010043|NCT01490632|2029080|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010044|NCT01490632|2029081|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010045|NCT01490632|2029082|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010046|NCT01490632|2029083|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010047|NCT01490632|2029084|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010048|NCT01490632|2029085|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010049|NCT01490632|2029086|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1010050|NCT01490632|2029067|FG000|Part C: Washout or Step-Down Period|Adverse Event|0
1010051|NCT01490632|2029068|FG001|Part C: Washout or Step-Down Period|Adverse Event|0
1010052|NCT01490632|2029069|FG002|Part C: Washout or Step-Down Period|Adverse Event|0
1010053|NCT01490632|2029070|FG003|Part C: Washout or Step-Down Period|Adverse Event|0
1010054|NCT01490632|2029071|FG004|Part C: Washout or Step-Down Period|Adverse Event|0
1010055|NCT01490632|2029072|FG005|Part C: Washout or Step-Down Period|Adverse Event|0
1010056|NCT01490632|2029073|FG006|Part C: Washout or Step-Down Period|Adverse Event|0
1010057|NCT01490632|2029074|FG007|Part C: Washout or Step-Down Period|Adverse Event|0
1010058|NCT01490632|2029075|FG008|Part C: Washout or Step-Down Period|Adverse Event|0
1010059|NCT01490632|2029076|FG009|Part C: Washout or Step-Down Period|Adverse Event|0
1010060|NCT01490632|2029077|FG010|Part C: Washout or Step-Down Period|Adverse Event|0
1010061|NCT01490632|2029078|FG011|Part C: Washout or Step-Down Period|Adverse Event|0
1010062|NCT01490632|2029079|FG012|Part C: Washout or Step-Down Period|Adverse Event|0
1010063|NCT01490632|2029080|FG013|Part C: Washout or Step-Down Period|Adverse Event|0
1010064|NCT01490632|2029081|FG014|Part C: Washout or Step-Down Period|Adverse Event|2
1010065|NCT01490632|2029082|FG015|Part C: Washout or Step-Down Period|Adverse Event|2
1010066|NCT01490632|2029083|FG016|Part C: Washout or Step-Down Period|Adverse Event|0
1010067|NCT01490632|2029084|FG017|Part C: Washout or Step-Down Period|Adverse Event|0
1010068|NCT01490632|2029085|FG018|Part C: Washout or Step-Down Period|Adverse Event|0
1010069|NCT01490632|2029086|FG019|Part C: Washout or Step-Down Period|Adverse Event|0
1010070|NCT01490632|2029067|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010071|NCT01490632|2029068|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010072|NCT01490632|2029069|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010073|NCT01490632|2029070|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010074|NCT01490632|2029071|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010075|NCT01490632|2029072|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010076|NCT01490632|2029073|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010077|NCT01490632|2029074|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010078|NCT01490632|2029075|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010079|NCT01490632|2029076|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010080|NCT01490632|2029077|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010081|NCT01490632|2029078|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010082|NCT01490632|2029079|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010083|NCT01490632|2029080|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1
1010084|NCT01490632|2029081|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010085|NCT01490632|2029082|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010086|NCT01490632|2029083|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010087|NCT01490632|2029084|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010088|NCT01490632|2029085|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010089|NCT01490632|2029086|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1010090|NCT01490632|2029067|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010091|NCT01490632|2029068|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010092|NCT01490632|2029069|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010093|NCT01490632|2029070|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010094|NCT01490632|2029071|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010095|NCT01490632|2029072|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010096|NCT01490632|2029073|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010097|NCT01490632|2029074|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010098|NCT01490632|2029075|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010099|NCT01490632|2029076|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010100|NCT01490632|2029077|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010101|NCT01490632|2029078|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010102|NCT01490632|2029079|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010103|NCT01490632|2029080|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010104|NCT01490632|2029081|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
1010105|NCT01490632|2029082|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
1010106|NCT01490632|2029083|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010107|NCT01490632|2029084|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010108|NCT01490632|2029085|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010109|NCT01490632|2029086|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1010110|NCT01490632|2029067|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010111|NCT01490632|2029068|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010112|NCT01490632|2029069|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010113|NCT01490632|2029070|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010114|NCT01490632|2029071|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010115|NCT01490632|2029072|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010116|NCT01490632|2029073|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010117|NCT01490632|2029074|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010118|NCT01490632|2029075|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010119|NCT01490632|2029076|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010120|NCT01490632|2029077|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010121|NCT01490632|2029078|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010122|NCT01490632|2029079|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
1010123|NCT01490632|2029080|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
1010124|NCT01490632|2029081|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
1010125|NCT01490632|2029082|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
1010126|NCT01490632|2029083|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010127|NCT01490632|2029084|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010128|NCT01490632|2029085|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010129|NCT01490632|2029086|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1010130|NCT01490632|2029067|FG000|Part D: Re-Treatment Period|Adverse Event|0
1010131|NCT01490632|2029068|FG001|Part D: Re-Treatment Period|Adverse Event|0
1010132|NCT01490632|2029069|FG002|Part D: Re-Treatment Period|Adverse Event|0
1010133|NCT01490632|2029070|FG003|Part D: Re-Treatment Period|Adverse Event|0
1010134|NCT01490632|2029071|FG004|Part D: Re-Treatment Period|Adverse Event|0
1010135|NCT01490632|2029072|FG005|Part D: Re-Treatment Period|Adverse Event|0
1010136|NCT01490632|2029073|FG006|Part D: Re-Treatment Period|Adverse Event|0
1010137|NCT01490632|2029074|FG007|Part D: Re-Treatment Period|Adverse Event|0
1010138|NCT01490632|2029075|FG008|Part D: Re-Treatment Period|Adverse Event|0
1010139|NCT01490632|2029076|FG009|Part D: Re-Treatment Period|Adverse Event|0
1010140|NCT01490632|2029077|FG010|Part D: Re-Treatment Period|Adverse Event|0
1010141|NCT01490632|2029078|FG011|Part D: Re-Treatment Period|Adverse Event|0
1010142|NCT01490632|2029079|FG012|Part D: Re-Treatment Period|Adverse Event|0
1010143|NCT01490632|2029080|FG013|Part D: Re-Treatment Period|Adverse Event|0
1010144|NCT01490632|2029081|FG014|Part D: Re-Treatment Period|Adverse Event|0
1010145|NCT01490632|2029082|FG015|Part D: Re-Treatment Period|Adverse Event|0
1010146|NCT01490632|2029083|FG016|Part D: Re-Treatment Period|Adverse Event|0
1010147|NCT01490632|2029084|FG017|Part D: Re-Treatment Period|Adverse Event|1
1010148|NCT01490632|2029085|FG018|Part D: Re-Treatment Period|Adverse Event|1
1010149|NCT01490632|2029086|FG019|Part D: Re-Treatment Period|Adverse Event|3
1010150|NCT01490632|2029067|FG000|Part D: Re-Treatment Period|Death|0
1010151|NCT01490632|2029068|FG001|Part D: Re-Treatment Period|Death|0
1010152|NCT01490632|2029069|FG002|Part D: Re-Treatment Period|Death|0
1010153|NCT01490632|2029070|FG003|Part D: Re-Treatment Period|Death|0
1010154|NCT01490632|2029071|FG004|Part D: Re-Treatment Period|Death|0
1010155|NCT01490632|2029072|FG005|Part D: Re-Treatment Period|Death|0
1010156|NCT01490632|2029073|FG006|Part D: Re-Treatment Period|Death|0
1010157|NCT01490632|2029074|FG007|Part D: Re-Treatment Period|Death|0
1010158|NCT01490632|2029075|FG008|Part D: Re-Treatment Period|Death|0
1010159|NCT01490632|2029076|FG009|Part D: Re-Treatment Period|Death|0
1010160|NCT01490632|2029077|FG010|Part D: Re-Treatment Period|Death|0
1010161|NCT01490632|2029078|FG011|Part D: Re-Treatment Period|Death|0
1010162|NCT01490632|2029079|FG012|Part D: Re-Treatment Period|Death|0
1010163|NCT01490632|2029080|FG013|Part D: Re-Treatment Period|Death|0
1010164|NCT01490632|2029081|FG014|Part D: Re-Treatment Period|Death|0
1010165|NCT01490632|2029082|FG015|Part D: Re-Treatment Period|Death|0
1010166|NCT01490632|2029083|FG016|Part D: Re-Treatment Period|Death|0
1010167|NCT01490632|2029084|FG017|Part D: Re-Treatment Period|Death|0
1010168|NCT01490632|2029085|FG018|Part D: Re-Treatment Period|Death|1
1010169|NCT01490632|2029086|FG019|Part D: Re-Treatment Period|Death|0
1010170|NCT01490632|2029067|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0
1010171|NCT01490632|2029068|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0
1010172|NCT01490632|2029069|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0
1010173|NCT01490632|2029070|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0
1010174|NCT01490632|2029071|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0
1010175|NCT01490632|2029072|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0
1010176|NCT01490632|2029073|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0
1010177|NCT01490632|2029074|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0
1010178|NCT01490632|2029075|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0
1010179|NCT01490632|2029076|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0
1010180|NCT01490632|2029077|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0
1010181|NCT01490632|2029078|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0
1010182|NCT01490632|2029079|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0
1010183|NCT01490632|2029080|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0
1010184|NCT01490632|2029081|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0
1010185|NCT01490632|2029082|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0
1010186|NCT01490632|2029083|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0
1010187|NCT01490632|2029084|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3
1010188|NCT01490632|2029085|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1
1010189|NCT01490632|2029086|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2
1010190|NCT01490632|2029067|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0
1010191|NCT01490632|2029068|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0
1010192|NCT01490632|2029069|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0
1010193|NCT01490632|2029070|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0
1010194|NCT01490632|2029071|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0
1010195|NCT01490632|2029072|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0
1010196|NCT01490632|2029073|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0
1010197|NCT01490632|2029074|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0
1010198|NCT01490632|2029075|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0
1010199|NCT01490632|2029076|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0
1010200|NCT01490632|2029077|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0
1010201|NCT01490632|2029078|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0
1010202|NCT01490632|2029079|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0
1010203|NCT01490632|2029080|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0
1010204|NCT01490632|2029081|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0
1010205|NCT01490632|2029082|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0
1010206|NCT01490632|2029083|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0
1010207|NCT01490632|2029084|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0
1010208|NCT01490632|2029085|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1
1010209|NCT01490632|2029086|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0
1010210|NCT01490632|2029067|FG000|Part D: Re-Treatment Period|Physician Decision|0
1010211|NCT01490632|2029068|FG001|Part D: Re-Treatment Period|Physician Decision|0
1010212|NCT01490632|2029069|FG002|Part D: Re-Treatment Period|Physician Decision|0
1010213|NCT01490632|2029070|FG003|Part D: Re-Treatment Period|Physician Decision|0
1010214|NCT01490632|2029071|FG004|Part D: Re-Treatment Period|Physician Decision|0
1010215|NCT01490632|2029072|FG005|Part D: Re-Treatment Period|Physician Decision|0
1010216|NCT01490632|2029073|FG006|Part D: Re-Treatment Period|Physician Decision|0
1010217|NCT01490632|2029074|FG007|Part D: Re-Treatment Period|Physician Decision|0
1010218|NCT01490632|2029075|FG008|Part D: Re-Treatment Period|Physician Decision|0
1010219|NCT01490632|2029076|FG009|Part D: Re-Treatment Period|Physician Decision|0
1010220|NCT01490632|2029077|FG010|Part D: Re-Treatment Period|Physician Decision|0
1010221|NCT01490632|2029078|FG011|Part D: Re-Treatment Period|Physician Decision|0
1010222|NCT01490632|2029079|FG012|Part D: Re-Treatment Period|Physician Decision|0
1010223|NCT01490632|2029080|FG013|Part D: Re-Treatment Period|Physician Decision|0
1010224|NCT01490632|2029081|FG014|Part D: Re-Treatment Period|Physician Decision|0
1010225|NCT01490632|2029082|FG015|Part D: Re-Treatment Period|Physician Decision|0
1010226|NCT01490632|2029083|FG016|Part D: Re-Treatment Period|Physician Decision|0
1010227|NCT01490632|2029084|FG017|Part D: Re-Treatment Period|Physician Decision|0
1010228|NCT01490632|2029085|FG018|Part D: Re-Treatment Period|Physician Decision|1
1010229|NCT01490632|2029086|FG019|Part D: Re-Treatment Period|Physician Decision|1
1010230|NCT01490632|2029067|FG000|Part D: Re-Treatment Period|Protocol Violation|0
1010231|NCT01490632|2029068|FG001|Part D: Re-Treatment Period|Protocol Violation|0
1010232|NCT01490632|2029069|FG002|Part D: Re-Treatment Period|Protocol Violation|0
1010233|NCT01490632|2029070|FG003|Part D: Re-Treatment Period|Protocol Violation|0
1010234|NCT01490632|2029071|FG004|Part D: Re-Treatment Period|Protocol Violation|0
1010235|NCT01490632|2029072|FG005|Part D: Re-Treatment Period|Protocol Violation|0
1010236|NCT01490632|2029073|FG006|Part D: Re-Treatment Period|Protocol Violation|0
1010237|NCT01490632|2029074|FG007|Part D: Re-Treatment Period|Protocol Violation|0
1010238|NCT01490632|2029075|FG008|Part D: Re-Treatment Period|Protocol Violation|0
1010239|NCT01490632|2029076|FG009|Part D: Re-Treatment Period|Protocol Violation|0
1010240|NCT01490632|2029077|FG010|Part D: Re-Treatment Period|Protocol Violation|0
1010241|NCT01490632|2029078|FG011|Part D: Re-Treatment Period|Protocol Violation|0
1010242|NCT01490632|2029079|FG012|Part D: Re-Treatment Period|Protocol Violation|0
1010243|NCT01490632|2029080|FG013|Part D: Re-Treatment Period|Protocol Violation|0
1010244|NCT01490632|2029081|FG014|Part D: Re-Treatment Period|Protocol Violation|0
1010245|NCT01490632|2029082|FG015|Part D: Re-Treatment Period|Protocol Violation|0
1010246|NCT01490632|2029083|FG016|Part D: Re-Treatment Period|Protocol Violation|0
1010247|NCT01490632|2029084|FG017|Part D: Re-Treatment Period|Protocol Violation|0
1010248|NCT01490632|2029085|FG018|Part D: Re-Treatment Period|Protocol Violation|1
1010249|NCT01490632|2029086|FG019|Part D: Re-Treatment Period|Protocol Violation|0
1010250|NCT01490632|2029067|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010251|NCT01490632|2029068|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010252|NCT01490632|2029069|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010253|NCT01490632|2029070|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010254|NCT01490632|2029071|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010255|NCT01490632|2029072|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010256|NCT01490632|2029073|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010257|NCT01490632|2029074|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010258|NCT01490632|2029075|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010259|NCT01490632|2029076|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010260|NCT01490632|2029077|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010261|NCT01490632|2029078|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010262|NCT01490632|2029079|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010263|NCT01490632|2029080|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010264|NCT01490632|2029081|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010265|NCT01490632|2029082|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010266|NCT01490632|2029083|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0
1010267|NCT01490632|2029084|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1
1010268|NCT01490632|2029085|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1
1010269|NCT01490632|2029086|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1
1010270|NCT01490697|2029135|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
1010271|NCT01490697|2029136|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
1010272|NCT01490814|2029161|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3
1010273|NCT01490814|2029162|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3
1010274|NCT01490814|2029161|FG000|Overall Study|Physician Decision|1
1010275|NCT01490814|2029162|FG001|Overall Study|Physician Decision|0
1010276|NCT01490814|2029161|FG000|Overall Study|Withdrawal by Subject|0
1010277|NCT01490814|2029162|FG001|Overall Study|Withdrawal by Subject|5
1010278|NCT01490840|2029170|FG000|Phase 1|Lost to Follow-up|1
1010279|NCT01490840|2029171|FG001|Phase 1|Lost to Follow-up|0
1010280|NCT01490840|2029170|FG000|Phase 1|Adverse Event|2
1010281|NCT01490840|2029171|FG001|Phase 1|Adverse Event|1
1010282|NCT01490840|2029170|FG000|Phase 1|Withdrawal by Subject|6
1010283|NCT01490840|2029171|FG001|Phase 1|Withdrawal by Subject|5
1010284|NCT01490840|2029170|FG000|Phase 1|Visit 6a omitted|1
1010285|NCT01490840|2029171|FG001|Phase 1|Visit 6a omitted|0
1010286|NCT01490840|2029170|FG000|Phase 2|Withdrawal by Subject|4
1010287|NCT01490840|2029171|FG001|Phase 2|Withdrawal by Subject|3
1010288|NCT01490840|2029170|FG000|Phase 2|Permanent interruption of fingolimod|0
1010289|NCT01490840|2029171|FG001|Phase 2|Permanent interruption of fingolimod|1
1010290|NCT01490840|2029170|FG000|Phase 2|Lost to Follow-up|1
1010291|NCT01490840|2029171|FG001|Phase 2|Lost to Follow-up|1
1010292|NCT01490840|2029170|FG000|Phase 2|Adverse Event|1
1010293|NCT01490840|2029171|FG001|Phase 2|Adverse Event|1
1010294|NCT01490866|2029177|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6
1010295|NCT01490866|2029177|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6
1010296|NCT01490866|2029177|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
1010297|NCT01490866|2029177|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
1010298|NCT01490866|2029177|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
1010299|NCT01490866|2029177|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2
1010300|NCT01490866|2029177|FG000|Axitinib Maintenance Therapy|Disease Progression|30
1010301|NCT01490866|2029177|FG000|Axitinib Maintenance Therapy|Adverse Event|12
1010302|NCT01490866|2029177|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3
1010303|NCT01490866|2029177|FG000|Axitinib Maintenance Therapy|Protocol Violation|2
1010304|NCT01490866|2029177|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2
1010305|NCT01490918|2029191|FG000|Overall Study|Lost to Follow-up|2
1010306|NCT01490918|2029192|FG001|Overall Study|Lost to Follow-up|1
1010307|NCT01490918|2029193|FG002|Overall Study|Lost to Follow-up|0
1010308|NCT01490918|2029191|FG000|Overall Study|Withdrawal by Subject|7
1010309|NCT01490918|2029192|FG001|Overall Study|Withdrawal by Subject|8
1010310|NCT01490918|2029193|FG002|Overall Study|Withdrawal by Subject|3
1010311|NCT01490918|2029191|FG000|Overall Study|Adverse Event|0
1010312|NCT01490918|2029192|FG001|Overall Study|Adverse Event|0
1010313|NCT01490918|2029193|FG002|Overall Study|Adverse Event|1
1010314|NCT01490918|2029191|FG000|Overall Study|other cause|4
1010315|NCT01490918|2029192|FG001|Overall Study|other cause|5
1010316|NCT01490918|2029193|FG002|Overall Study|other cause|8
1010317|NCT01491035|2029230|FG000|Overall Study|Lost to Follow-up|0
1010318|NCT01491035|2029231|FG001|Overall Study|Lost to Follow-up|0
1010319|NCT01491035|2029232|FG002|Overall Study|Lost to Follow-up|0
1010320|NCT01491035|2029233|FG003|Overall Study|Lost to Follow-up|0
1010321|NCT01491035|2029234|FG004|Overall Study|Lost to Follow-up|1
1010322|NCT01491035|2029235|FG005|Overall Study|Lost to Follow-up|0
1010323|NCT01491035|2029236|FG006|Overall Study|Lost to Follow-up|0
1010324|NCT01491035|2029237|FG007|Overall Study|Lost to Follow-up|0
1010325|NCT01491178|2029278|FG000|Overall Study|Adverse Event|1016
1010326|NCT01491178|2029278|FG000|Overall Study|Improvement of NVAF|210
1010327|NCT01491178|2029278|FG000|Overall Study|To conduct invasive treatment|59
1010328|NCT01491178|2029278|FG000|Overall Study|Lost to follow-up (unknown reason)|287
1010329|NCT01491178|2029278|FG000|Overall Study|Lost to follow-up (changing hospital)|545
1010330|NCT01491178|2029278|FG000|Overall Study|To take a contraindication|20
1010331|NCT01491178|2029278|FG000|Overall Study|Other than specified above|657
1010332|NCT01491607|2029295|FG000|Overall Study|Lost to Follow-up|7
1010333|NCT01491607|2029295|FG000|Overall Study|Withdrawal by Subject|3
1010334|NCT01491672|2029368|FG000|Overall Study|Lost to Follow-up|0
1010335|NCT01491672|2029369|FG001|Overall Study|Lost to Follow-up|4
1010336|NCT01491672|2029370|FG002|Overall Study|Lost to Follow-up|1
1010337|NCT01491672|2029368|FG000|Overall Study|Withdrawal by Subject|6
1010338|NCT01491672|2029369|FG001|Overall Study|Withdrawal by Subject|7
1010339|NCT01491672|2029370|FG002|Overall Study|Withdrawal by Subject|0
1010340|NCT01491672|2029368|FG000|Overall Study|Adverse Event|8
1010341|NCT01491672|2029369|FG001|Overall Study|Adverse Event|10
1010342|NCT01491672|2029370|FG002|Overall Study|Adverse Event|4
1010343|NCT01491672|2029368|FG000|Overall Study|Disease progression|42
1010344|NCT01491672|2029369|FG001|Overall Study|Disease progression|34
1010345|NCT01491672|2029370|FG002|Overall Study|Disease progression|6
1010346|NCT01491672|2029368|FG000|Overall Study|Protocol deviation|0
1010347|NCT01491672|2029369|FG001|Overall Study|Protocol deviation|1
1010348|NCT01491672|2029370|FG002|Overall Study|Protocol deviation|0
1010349|NCT01491672|2029368|FG000|Overall Study|Death|0
1010350|NCT01491672|2029369|FG001|Overall Study|Death|4
1010351|NCT01491672|2029370|FG002|Overall Study|Death|0
1010352|NCT01491737|2029382|FG000|Overall Study|Withdrawal by Subject|20
1010353|NCT01491737|2029383|FG001|Overall Study|Withdrawal by Subject|17
1010354|NCT01491737|2029382|FG000|Overall Study|Lost to Follow-up|2
1010355|NCT01491737|2029383|FG001|Overall Study|Lost to Follow-up|10
1010356|NCT01491737|2029382|FG000|Overall Study|Death|63
1010357|NCT01491737|2029383|FG001|Overall Study|Death|57
1010358|NCT01491737|2029382|FG000|Overall Study|Study Termination by Sponsor|36
1010359|NCT01491737|2029383|FG001|Overall Study|Study Termination by Sponsor|36
1010360|NCT01491737|2029382|FG000|Overall Study|Reason Not Specified|8
1010361|NCT01491737|2029383|FG001|Overall Study|Reason Not Specified|9
1010362|NCT01491802|2029389|FG000|Overall Study|Adverse Event|1
1010363|NCT01491802|2029390|FG001|Overall Study|Adverse Event|1
1010364|NCT01491802|2029389|FG000|Overall Study|Withdrawal by Subject|0
1010365|NCT01491802|2029390|FG001|Overall Study|Withdrawal by Subject|1
1010366|NCT01491841|2029397|FG000|Overall Study|Screen Failure|10
1010367|NCT01491841|2029397|FG000|Overall Study|Withdrawal by Subject|1
1010368|NCT01491854|2029409|FG000|Overall Study|mainly due to premature termination|93
1010369|NCT01491854|2029409|FG000|Overall Study|Death|1
1010370|NCT01491854|2029409|FG000|Overall Study|Withdrawal by Subject|3
1010371|NCT01491854|2029409|FG000|Overall Study|Lost to Follow-up|33
1010372|NCT01491919|2029441|FG000|Overall Study|Insufficient PK sampling|1
1010373|NCT01491919|2029442|FG001|Overall Study|Insufficient PK sampling|2
1010374|NCT01491919|2029443|FG002|Overall Study|Insufficient PK sampling|1
1010375|NCT01491945|2029453|FG000|Overall Study|Death|30
1010376|NCT01491945|2029453|FG000|Overall Study|Withdrwan/LTF|16
1010377|NCT01491945|2029453|FG000|Overall Study|Conversion|4
1010378|NCT01491945|2029453|FG000|Overall Study|Missed Visit|1
1010379|NCT01492088|2029478|FG000|Overall Study|Withdrawal by Patient|0
1010380|NCT01492088|2029479|FG001|Overall Study|Withdrawal by Patient|2
1010381|NCT01492088|2029480|FG002|Overall Study|Withdrawal by Patient|0
1010382|NCT01492088|2029478|FG000|Overall Study|Death|1
1010383|NCT01492088|2029479|FG001|Overall Study|Death|6
1010384|NCT01492088|2029480|FG002|Overall Study|Death|2
1010385|NCT01492088|2029478|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2
1010386|NCT01492088|2029479|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0
1010387|NCT01492088|2029480|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1
1010388|NCT01492088|2029478|FG000|Overall Study|Alive at Last Follow-up|0
1010389|NCT01492088|2029479|FG001|Overall Study|Alive at Last Follow-up|6
1010390|NCT01492088|2029480|FG002|Overall Study|Alive at Last Follow-up|11
1010391|NCT01492101|2029493|FG000|Overall Study|Death|323
1010392|NCT01492101|2029494|FG001|Overall Study|Death|322
1010393|NCT01492101|2029493|FG000|Overall Study|Withdrawal by Subject|14
1010394|NCT01492101|2029494|FG001|Overall Study|Withdrawal by Subject|18
1010395|NCT01492101|2029493|FG000|Overall Study|Lost to Follow-up|0
1010396|NCT01492101|2029494|FG001|Overall Study|Lost to Follow-up|2
1010397|NCT01492400|2029511|FG000|Overall Study|Miscellaneous Reasons|2
1010398|NCT01492400|2029512|FG001|Overall Study|Miscellaneous Reasons|3
1010399|NCT01492400|2029511|FG000|Overall Study|Personal Reasons|0
1010400|NCT01492400|2029512|FG001|Overall Study|Personal Reasons|5
1010401|NCT01492400|2029511|FG000|Overall Study|Lost to Follow-up|3
1010402|NCT01492400|2029512|FG001|Overall Study|Lost to Follow-up|1
1010403|NCT01492400|2029511|FG000|Overall Study|Pregnancy|0
1010404|NCT01492400|2029512|FG001|Overall Study|Pregnancy|1
1010405|NCT01492400|2029511|FG000|Overall Study|Lack of Efficacy|1
1010406|NCT01492400|2029512|FG001|Overall Study|Lack of Efficacy|1
1010407|NCT01492400|2029511|FG000|Overall Study|Adverse Event|10
1010408|NCT01492400|2029512|FG001|Overall Study|Adverse Event|5
1010409|NCT01492426|2029520|FG000|Treatment|Death|0
1010410|NCT01492426|2029521|FG001|Treatment|Death|1
1010411|NCT01492426|2029520|FG000|Treatment|Other|1
1010412|NCT01492426|2029521|FG001|Treatment|Other|0
1010413|NCT01492426|2029520|FG000|Treatment|Adverse Event|25
1010414|NCT01492426|2029521|FG001|Treatment|Adverse Event|25
1010415|NCT01492426|2029520|FG000|Treatment|Lack of Efficacy|38
1010416|NCT01492426|2029521|FG001|Treatment|Lack of Efficacy|5
1010417|NCT01492426|2029520|FG000|Treatment|Participant withdrew consent|1
1010418|NCT01492426|2029521|FG001|Treatment|Participant withdrew consent|2
1010419|NCT01492426|2029520|FG000|Treatment|Poor compliance/noncompliance|1
1010420|NCT01492426|2029521|FG001|Treatment|Poor compliance/noncompliance|0
1010421|NCT01492426|2029520|FG000|Treatment|Subject requested discontinue study drug|7
1010422|NCT01492426|2029521|FG001|Treatment|Subject requested discontinue study drug|3
1010423|NCT01492426|2029520|FG000|Treatment|Lost to Follow-up|9
1010424|NCT01492426|2029521|FG001|Treatment|Lost to Follow-up|4
1010425|NCT01492426|2029520|FG000|Treatment|Participant does not meet study criteria|1
1010426|NCT01492426|2029521|FG001|Treatment|Participant does not meet study criteria|0
1010427|NCT01492426|2029520|FG000|Follow-Up|Protocol Requires no Follow-Up|2
1010428|NCT01492426|2029521|FG001|Follow-Up|Protocol Requires no Follow-Up|1
1010429|NCT01492426|2029520|FG000|Follow-Up|Death|1
1010430|NCT01492426|2029521|FG001|Follow-Up|Death|0
1010431|NCT01492426|2029520|FG000|Follow-Up|Other|4
1010432|NCT01492426|2029521|FG001|Follow-Up|Other|2
1010433|NCT01492426|2029520|FG000|Follow-Up|Participant Withdrew Consent|6
1010434|NCT01492426|2029521|FG001|Follow-Up|Participant Withdrew Consent|1
1010435|NCT01492426|2029520|FG000|Follow-Up|Lost to Follow-up|12
1010436|NCT01492426|2029521|FG001|Follow-Up|Lost to Follow-up|6
1010437|NCT01492439|2029533|FG000|Overall Study|Withdrew from RTE|4
1010438|NCT01492439|2029534|FG001|Overall Study|Withdrew from RTE|9
1010439|NCT01492686|2029572|FG000|Double-blind Phase|Adverse Event|0
1010440|NCT01492686|2029573|FG001|Double-blind Phase|Adverse Event|2
1010441|NCT01492686|2029572|FG000|Double-blind Phase|Physician Decision|0
1010442|NCT01492686|2029573|FG001|Double-blind Phase|Physician Decision|1
1010443|NCT01492686|2029572|FG000|Double-blind Phase|Withdrawal by Subject|0
1010444|NCT01492686|2029573|FG001|Double-blind Phase|Withdrawal by Subject|2
1010445|NCT01492686|2029572|FG000|Double-blind Phase|Due to a discontinuation criterion|2
1010446|NCT01492686|2029573|FG001|Double-blind Phase|Due to a discontinuation criterion|3
1010447|NCT01492686|2029572|FG000|Open-label Phase|Adverse Event|1
1010448|NCT01492686|2029573|FG001|Open-label Phase|Adverse Event|2
1010449|NCT01492686|2029572|FG000|Open-label Phase|Physician Decision|1
1010450|NCT01492686|2029573|FG001|Open-label Phase|Physician Decision|0
1010451|NCT01492686|2029572|FG000|Open-label Phase|Withdrawal by Subject|6
1010452|NCT01492686|2029573|FG001|Open-label Phase|Withdrawal by Subject|7
1010453|NCT01492686|2029572|FG000|Open-label Phase|Due to a discontinuation criterion|4
1010454|NCT01492686|2029573|FG001|Open-label Phase|Due to a discontinuation criterion|9
1010455|NCT01493089|2029601|FG000|Overall Study|Protocol Violation|2
1010456|NCT01493089|2029602|FG001|Overall Study|Protocol Violation|2
1010457|NCT01493089|2029601|FG000|Overall Study|Withdrawal by Subject|1
1010458|NCT01493089|2029602|FG001|Overall Study|Withdrawal by Subject|0
1010459|NCT01493089|2029601|FG000|Overall Study|Physician Decision|0
1010460|NCT01493089|2029602|FG001|Overall Study|Physician Decision|1
1010461|NCT01493284|2029623|FG000|Overall Study|Death|29
1010462|NCT01493284|2029623|FG000|Overall Study|Withdrawal by Subject|32
1010463|NCT01493414|2029627|FG000|Overall Study|Adverse Event|405
1010464|NCT01493414|2029627|FG000|Overall Study|Disease progression|204
1010465|NCT01493414|2029627|FG000|Overall Study|Death|101
1010466|NCT01493414|2029627|FG000|Overall Study|Physician Decision|93
1010467|NCT01493414|2029627|FG000|Overall Study|Withdrawal by Subject|79
1010468|NCT01493414|2029627|FG000|Overall Study|Protocol deviation|27
1010469|NCT01493414|2029627|FG000|Overall Study|Administrative problems|25
1010470|NCT01493414|2029627|FG000|Overall Study|Lost to Follow-up|16
1010471|NCT01493427|2029635|FG000|Overall Study|Adverse Event|10
1010472|NCT01493427|2029635|FG000|Overall Study|Personal Reasons|4
1010473|NCT01493427|2029635|FG000|Overall Study|Lost to Follow-up|2
1010474|NCT01493427|2029635|FG000|Overall Study|Inability to Follow Instructions|2
1010475|NCT01493427|2029635|FG000|Overall Study|Other|2
1010476|NCT01493531|2029642|FG000|Overall Study|Adverse Event|4
1010477|NCT01493531|2029643|FG001|Overall Study|Adverse Event|12
1010478|NCT01493531|2029644|FG002|Overall Study|Adverse Event|9
1010479|NCT01493531|2029642|FG000|Overall Study|Gout flare|3
1010480|NCT01493531|2029643|FG001|Overall Study|Gout flare|0
1010481|NCT01493531|2029644|FG002|Overall Study|Gout flare|2
1010482|NCT01493531|2029642|FG000|Overall Study|Protocol Violation|8
1010483|NCT01493531|2029643|FG001|Overall Study|Protocol Violation|15
1010484|NCT01493531|2029644|FG002|Overall Study|Protocol Violation|12
1010485|NCT01493531|2029642|FG000|Overall Study|Sponsor terminated study|5
1010486|NCT01493531|2029643|FG001|Overall Study|Sponsor terminated study|2
1010487|NCT01493531|2029644|FG002|Overall Study|Sponsor terminated study|3
1010488|NCT01493531|2029642|FG000|Overall Study|Lost to Follow-up|5
1010489|NCT01493531|2029643|FG001|Overall Study|Lost to Follow-up|7
1010490|NCT01493531|2029644|FG002|Overall Study|Lost to Follow-up|11
1010491|NCT01493531|2029642|FG000|Overall Study|Withdrawal by Subject|16
1010492|NCT01493531|2029643|FG001|Overall Study|Withdrawal by Subject|13
1010493|NCT01493531|2029644|FG002|Overall Study|Withdrawal by Subject|11
1010494|NCT01493531|2029642|FG000|Overall Study|Death|0
1010495|NCT01493531|2029643|FG001|Overall Study|Death|1
1010496|NCT01493531|2029644|FG002|Overall Study|Death|0
1010497|NCT01493557|2029655|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
1010498|NCT01493557|2029656|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
1010499|NCT01493557|2029657|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
1010500|NCT01493557|2029655|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
1010501|NCT01493557|2029656|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
1010502|NCT01493557|2029657|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9
1010503|NCT01493557|2029655|FG000|Not Randomized to Management Strategies|Other adverse event|0
1010504|NCT01493557|2029656|FG001|Not Randomized to Management Strategies|Other adverse event|0
1010505|NCT01493557|2029657|FG002|Not Randomized to Management Strategies|Other adverse event|54
1010506|NCT01493557|2029655|FG000|Not Randomized to Management Strategies|Protocol Violation|0
1010507|NCT01493557|2029656|FG001|Not Randomized to Management Strategies|Protocol Violation|0
1010508|NCT01493557|2029657|FG002|Not Randomized to Management Strategies|Protocol Violation|1
1010509|NCT01493557|2029655|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0
1010510|NCT01493557|2029656|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0
1010511|NCT01493557|2029657|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4
1010512|NCT01493557|2029655|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0
1010513|NCT01493557|2029656|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0
1010514|NCT01493557|2029657|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10
1010515|NCT01493557|2029655|FG000|Not Randomized to Management Strategies|Early termination|0
1010516|NCT01493557|2029656|FG001|Not Randomized to Management Strategies|Early termination|0
1010517|NCT01493557|2029657|FG002|Not Randomized to Management Strategies|Early termination|34
1010518|NCT01493557|2029655|FG000|Not Randomized to Management Strategies|Other than stated above|0
1010519|NCT01493557|2029656|FG001|Not Randomized to Management Strategies|Other than stated above|0
1010520|NCT01493557|2029657|FG002|Not Randomized to Management Strategies|Other than stated above|21
1010521|NCT01493557|2029655|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3
1010522|NCT01493557|2029656|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2
1010523|NCT01493557|2029657|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0
1010524|NCT01493557|2029655|FG000|Randomized to Management Strategies|Other adverse event|8
1010525|NCT01493557|2029656|FG001|Randomized to Management Strategies|Other adverse event|5
1010526|NCT01493557|2029657|FG002|Randomized to Management Strategies|Other adverse event|0
1010527|NCT01493557|2029655|FG000|Randomized to Management Strategies|Protocol Violation|3
1010528|NCT01493557|2029656|FG001|Randomized to Management Strategies|Protocol Violation|0
1010529|NCT01493557|2029657|FG002|Randomized to Management Strategies|Protocol Violation|0
1010530|NCT01493557|2029655|FG000|Randomized to Management Strategies|Withdrawal by Subject|0
1010531|NCT01493557|2029656|FG001|Randomized to Management Strategies|Withdrawal by Subject|1
1010532|NCT01493557|2029657|FG002|Randomized to Management Strategies|Withdrawal by Subject|0
1010533|NCT01493557|2029655|FG000|Randomized to Management Strategies|Other than stated above|1
1010534|NCT01493557|2029656|FG001|Randomized to Management Strategies|Other than stated above|3
1010535|NCT01493557|2029657|FG002|Randomized to Management Strategies|Other than stated above|0
1010536|NCT01493557|2029655|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1
1010537|NCT01493557|2029656|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1
1010538|NCT01493557|2029657|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0
1010539|NCT01493557|2029655|FG000|Adding the Second Strategy|Other adverse event|1
1010540|NCT01493557|2029656|FG001|Adding the Second Strategy|Other adverse event|2
1010541|NCT01493557|2029657|FG002|Adding the Second Strategy|Other adverse event|0
1010542|NCT01493557|2029655|FG000|Adding the Second Strategy|Withdrawal by Subject|0
1010543|NCT01493557|2029656|FG001|Adding the Second Strategy|Withdrawal by Subject|1
1010544|NCT01493557|2029657|FG002|Adding the Second Strategy|Withdrawal by Subject|0
1010545|NCT01493687|2029693|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2
1010546|NCT01493687|2029694|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
1010547|NCT01493687|2029693|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
1010548|NCT01493687|2029694|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
1010549|NCT01493687|2029693|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7
1010550|NCT01493687|2029694|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
1010551|NCT01493687|2029693|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
1010552|NCT01493687|2029694|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
1010553|NCT01493687|2029693|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
1010554|NCT01493687|2029694|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
1010555|NCT01493687|2029693|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
1010556|NCT01493687|2029694|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1010557|NCT01493687|2029693|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
1010558|NCT01493687|2029694|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
1010559|NCT01493687|2029693|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5
1010560|NCT01493687|2029694|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1
1010561|NCT01493687|2029693|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
1010562|NCT01493687|2029694|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
1010563|NCT01493687|2029693|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5
1010564|NCT01493687|2029694|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4
1010565|NCT01493687|2029693|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
1010566|NCT01493687|2029694|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
1010567|NCT01493687|2029693|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
1010568|NCT01493687|2029694|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
1010569|NCT01493687|2029693|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
1010570|NCT01493687|2029694|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
1010571|NCT01493687|2029693|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
1010572|NCT01493687|2029694|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
1010573|NCT01493687|2029693|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0
1010574|NCT01493687|2029694|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1
1010575|NCT01493778|2029706|FG000|Overall Study|Withdrawal by Subject|8
1010576|NCT01493960|2029733|FG000|Overall Study|Adverse Event|0
1010577|NCT01493960|2029734|FG001|Overall Study|Adverse Event|1
1010578|NCT01493960|2029733|FG000|Overall Study|Lack of Efficacy|15
1010579|NCT01493960|2029734|FG001|Overall Study|Lack of Efficacy|9
1010580|NCT01493960|2029733|FG000|Overall Study|Protocol Violation|3
1010581|NCT01493960|2029734|FG001|Overall Study|Protocol Violation|0
1010582|NCT01493960|2029733|FG000|Overall Study|Withdrawal by Subject|10
1010583|NCT01493960|2029734|FG001|Overall Study|Withdrawal by Subject|4
1010584|NCT01493960|2029733|FG000|Overall Study|Non-specified|4
1010585|NCT01493960|2029734|FG001|Overall Study|Non-specified|4
1010586|NCT01494038|2029742|FG000|Overall Study|Protocol Violation|1
1010587|NCT01494038|2029743|FG001|Overall Study|Protocol Violation|1
1010588|NCT01494038|2029742|FG000|Overall Study|Lost to Follow-up|18
1010589|NCT01494038|2029743|FG001|Overall Study|Lost to Follow-up|20
1010590|NCT01494038|2029742|FG000|Overall Study|Withdrawal by Subject|44
1010591|NCT01494038|2029743|FG001|Overall Study|Withdrawal by Subject|34
1010592|NCT01494038|2029742|FG000|Overall Study|Not able to get to clinic|21
1010593|NCT01494038|2029743|FG001|Overall Study|Not able to get to clinic|15
1010594|NCT01494038|2029742|FG000|Overall Study|Not willing to adhere to reqs|2
1010595|NCT01494038|2029743|FG001|Overall Study|Not willing to adhere to reqs|9
1010596|NCT01494038|2029742|FG000|Overall Study|Death|2
1010597|NCT01494038|2029743|FG001|Overall Study|Death|4
1010598|NCT01494298|2029775|FG000|Overall Study|Protocol Violation|2
1010599|NCT01494298|2029776|FG001|Overall Study|Protocol Violation|8
1010600|NCT01494350|2029784|FG000|Overall Study|Worsening of lesion|1
1010601|NCT01494467|2029790|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1
1010602|NCT01494467|2029791|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
1010603|NCT01494467|2029790|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6
1010604|NCT01494467|2029791|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
1010605|NCT01494467|2029790|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
1010606|NCT01494467|2029791|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
1010607|NCT01494467|2029790|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
1010608|NCT01494467|2029791|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
1010609|NCT01494467|2029790|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1010610|NCT01494467|2029791|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1010611|NCT01494467|2029790|FG000|Part A Vehicle Control (12 Weeks)|Other|1
1010612|NCT01494467|2029791|FG001|Part A Vehicle Control (12 Weeks)|Other|1
1010613|NCT01494467|2029790|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
1010614|NCT01494467|2029791|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
1010615|NCT01494467|2029790|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2
1010616|NCT01494467|2029791|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0
1010617|NCT01494467|2029790|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
1010618|NCT01494467|2029791|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
1010619|NCT01494467|2029790|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3
1010620|NCT01494467|2029791|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5
1010621|NCT01494467|2029790|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
1010622|NCT01494467|2029791|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
1010623|NCT01494467|2029790|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
1010624|NCT01494467|2029791|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
1010625|NCT01494467|2029790|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
1010626|NCT01494467|2029791|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
1010627|NCT01494467|2029790|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
1010628|NCT01494467|2029791|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
1010629|NCT01494506|2029806|FG000|Overall Study|Lack of Efficacy|77
1010630|NCT01494506|2029807|FG001|Overall Study|Lack of Efficacy|83
1010631|NCT01494506|2029808|FG002|Overall Study|Lack of Efficacy|57
1010632|NCT01494506|2029806|FG000|Overall Study|Adverse Event|17
1010633|NCT01494506|2029807|FG001|Overall Study|Adverse Event|10
1010634|NCT01494506|2029808|FG002|Overall Study|Adverse Event|11
1010635|NCT01494506|2029806|FG000|Overall Study|Death|9
1010636|NCT01494506|2029807|FG001|Overall Study|Death|5
1010637|NCT01494506|2029808|FG002|Overall Study|Death|2
1010638|NCT01494506|2029806|FG000|Overall Study|Physician Decision|7
1010639|NCT01494506|2029807|FG001|Overall Study|Physician Decision|5
1010640|NCT01494506|2029808|FG002|Overall Study|Physician Decision|4
1010641|NCT01494506|2029806|FG000|Overall Study|Withdrawal by Subject|17
1010642|NCT01494506|2029807|FG001|Overall Study|Withdrawal by Subject|20
1010643|NCT01494506|2029808|FG002|Overall Study|Withdrawal by Subject|14
1010644|NCT01494506|2029806|FG000|Overall Study|Clinical Deterioration|21
1010645|NCT01494506|2029807|FG001|Overall Study|Clinical Deterioration|17
1010646|NCT01494506|2029808|FG002|Overall Study|Clinical Deterioration|13
1010647|NCT01494506|2029806|FG000|Overall Study|Sponsor Decision|0
1010648|NCT01494506|2029807|FG001|Overall Study|Sponsor Decision|0
1010649|NCT01494506|2029808|FG002|Overall Study|Sponsor Decision|1
1010650|NCT01494506|2029806|FG000|Overall Study|Other|0
1010651|NCT01494506|2029807|FG001|Overall Study|Other|3
1010652|NCT01494506|2029808|FG002|Overall Study|Other|1
1010653|NCT01494532|2029824|FG000|Overall Study|Adverse Event|4
1010654|NCT01494532|2029825|FG001|Overall Study|Adverse Event|1
1010655|NCT01494532|2029826|FG002|Overall Study|Adverse Event|8
1010656|NCT01494532|2029827|FG003|Overall Study|Adverse Event|6
1010657|NCT01494532|2029828|FG004|Overall Study|Adverse Event|5
1010658|NCT01494532|2029829|FG005|Overall Study|Adverse Event|0
1010659|NCT01494532|2029824|FG000|Overall Study|Lack of Efficacy|0
1010660|NCT01494532|2029825|FG001|Overall Study|Lack of Efficacy|0
1010661|NCT01494532|2029826|FG002|Overall Study|Lack of Efficacy|0
1010662|NCT01494532|2029827|FG003|Overall Study|Lack of Efficacy|0
1010663|NCT01494532|2029828|FG004|Overall Study|Lack of Efficacy|2
1010664|NCT01494532|2029829|FG005|Overall Study|Lack of Efficacy|0
1010665|NCT01494532|2029824|FG000|Overall Study|Protocol deviation|2
1010666|NCT01494532|2029825|FG001|Overall Study|Protocol deviation|1
1010667|NCT01494532|2029826|FG002|Overall Study|Protocol deviation|3
1010668|NCT01494532|2029827|FG003|Overall Study|Protocol deviation|2
1010669|NCT01494532|2029828|FG004|Overall Study|Protocol deviation|3
1010670|NCT01494532|2029829|FG005|Overall Study|Protocol deviation|0
1010671|NCT01494532|2029824|FG000|Overall Study|Protocol-defined stopping criteria|0
1010672|NCT01494532|2029825|FG001|Overall Study|Protocol-defined stopping criteria|0
1010673|NCT01494532|2029826|FG002|Overall Study|Protocol-defined stopping criteria|1
1010674|NCT01494532|2029827|FG003|Overall Study|Protocol-defined stopping criteria|0
1010675|NCT01494532|2029828|FG004|Overall Study|Protocol-defined stopping criteria|0
1010676|NCT01494532|2029829|FG005|Overall Study|Protocol-defined stopping criteria|0
1010677|NCT01494532|2029824|FG000|Overall Study|Lost to Follow-up|1
1010678|NCT01494532|2029825|FG001|Overall Study|Lost to Follow-up|0
1010679|NCT01494532|2029826|FG002|Overall Study|Lost to Follow-up|0
1010680|NCT01494532|2029827|FG003|Overall Study|Lost to Follow-up|2
1010681|NCT01494532|2029828|FG004|Overall Study|Lost to Follow-up|0
1010682|NCT01494532|2029829|FG005|Overall Study|Lost to Follow-up|0
1010683|NCT01494532|2029824|FG000|Overall Study|Physician Decision|0
1010684|NCT01494532|2029825|FG001|Overall Study|Physician Decision|1
1010685|NCT01494532|2029826|FG002|Overall Study|Physician Decision|1
1010686|NCT01494532|2029827|FG003|Overall Study|Physician Decision|2
1010687|NCT01494532|2029828|FG004|Overall Study|Physician Decision|0
1010688|NCT01494532|2029829|FG005|Overall Study|Physician Decision|0
1010689|NCT01494532|2029824|FG000|Overall Study|Withdrawal by Subject|3
1010690|NCT01494532|2029825|FG001|Overall Study|Withdrawal by Subject|1
1010691|NCT01494532|2029826|FG002|Overall Study|Withdrawal by Subject|4
1010692|NCT01494532|2029827|FG003|Overall Study|Withdrawal by Subject|3
1010693|NCT01494532|2029828|FG004|Overall Study|Withdrawal by Subject|2
1010694|NCT01494532|2029829|FG005|Overall Study|Withdrawal by Subject|0
1010695|NCT01494584|2029851|FG000|Overall Study|Study Closed/Terminated|1
1010696|NCT01494610|2029874|FG000|Period 1|Withdrawal by Subject|1
1010697|NCT01494610|2029875|FG001|Period 1|Withdrawal by Subject|1
1010698|NCT01494610|2029874|FG000|Period 3|Adverse Event|1
1010699|NCT01494610|2029875|FG001|Period 3|Adverse Event|0
1010700|NCT01494610|2029874|FG000|Period 3|Withdrawal by Subject|1
1010701|NCT01494610|2029875|FG001|Period 3|Withdrawal by Subject|0
1010702|NCT01494610|2029874|FG000|Period 4|Protocol Violation|1
1010703|NCT01494610|2029875|FG001|Period 4|Protocol Violation|0
1010704|NCT01494649|2029889|FG000|Overall Study|Lost to Follow-up|0
1010705|NCT01494649|2029890|FG001|Overall Study|Lost to Follow-up|1
1010706|NCT01494818|2029909|FG000|Overall Study|Relocation|1
1010707|NCT01494818|2029910|FG001|Overall Study|Relocation|2
1010708|NCT01494818|2029909|FG000|Overall Study|Lost to Follow-up|1
1010709|NCT01494818|2029910|FG001|Overall Study|Lost to Follow-up|0
1010710|NCT01494922|2029916|FG000|Overall Study|Adverse Event|1
1010711|NCT01494987|2029922|FG000|Overall Study|Adverse Event|6
1010712|NCT01494987|2029923|FG001|Overall Study|Adverse Event|5
1010713|NCT01494987|2029922|FG000|Overall Study|Hyperglycemia|6
1010714|NCT01494987|2029923|FG001|Overall Study|Hyperglycemia|4
1010715|NCT01494987|2029922|FG000|Overall Study|Investigator's Discretion|1
1010716|NCT01494987|2029923|FG001|Overall Study|Investigator's Discretion|2
1010717|NCT01494987|2029922|FG000|Overall Study|Lost to Follow-up|1
1010718|NCT01494987|2029923|FG001|Overall Study|Lost to Follow-up|1
1010719|NCT01494987|2029922|FG000|Overall Study|Protocol Violation|3
1010720|NCT01494987|2029923|FG001|Overall Study|Protocol Violation|3
1010721|NCT01494987|2029922|FG000|Overall Study|Subject Non-Compliance|9
1010722|NCT01494987|2029923|FG001|Overall Study|Subject Non-Compliance|10
1010723|NCT01494987|2029922|FG000|Overall Study|Subject Withdrew Consent|2
1010724|NCT01494987|2029923|FG001|Overall Study|Subject Withdrew Consent|3
1010725|NCT01495000|2029931|FG000|Overall Study|Lost to Follow-up|2
1010726|NCT01495000|2029932|FG001|Overall Study|Lost to Follow-up|2
1010727|NCT01495000|2029931|FG000|Overall Study|Protocol Violation|1
1010728|NCT01495000|2029932|FG001|Overall Study|Protocol Violation|0
1010729|NCT01495000|2029931|FG000|Overall Study|Withdrawal by Subject|10
1010730|NCT01495000|2029932|FG001|Overall Study|Withdrawal by Subject|10
1010731|NCT01495702|2029988|FG000|Randomized Phase|Randomized But Not Treated|1
1010732|NCT01495702|2029989|FG001|Randomized Phase|Randomized But Not Treated|4
1010733|NCT01495702|2029988|FG000|Randomized Phase|Adverse Event|2
1010734|NCT01495702|2029989|FG001|Randomized Phase|Adverse Event|2
1010735|NCT01495702|2029988|FG000|Randomized Phase|Death|1
1010736|NCT01495702|2029989|FG001|Randomized Phase|Death|0
1010737|NCT01495702|2029988|FG000|Randomized Phase|Lack of Efficacy|2
1010738|NCT01495702|2029989|FG001|Randomized Phase|Lack of Efficacy|0
1010739|NCT01495702|2029988|FG000|Randomized Phase|Investigators Discretion|2
1010740|NCT01495702|2029989|FG001|Randomized Phase|Investigators Discretion|0
1010741|NCT01495702|2029988|FG000|Randomized Phase|Withdrew Consent|10
1010742|NCT01495702|2029989|FG001|Randomized Phase|Withdrew Consent|18
1010743|NCT01495702|2029988|FG000|Randomized Phase|Lost to Follow-up|4
1010744|NCT01495702|2029989|FG001|Randomized Phase|Lost to Follow-up|3
1010745|NCT01495702|2029988|FG000|Randomized Phase|Participant Noncompliance|1
1010746|NCT01495702|2029989|FG001|Randomized Phase|Participant Noncompliance|0
1010747|NCT01495702|2029988|FG000|Randomized Phase|Protocol Violation|3
1010748|NCT01495702|2029989|FG001|Randomized Phase|Protocol Violation|1
1010749|NCT01495793|2029996|FG000|Overall Study|Lost to Follow-up|1
1010750|NCT01495793|2029996|FG000|Overall Study|Violation of inclusion criteria|1
1010751|NCT01495975|2030035|FG000|Overall Study|Lost to Follow-up|1
1010752|NCT01495975|2030036|FG001|Overall Study|Lost to Follow-up|0
1010753|NCT01496066|2030044|FG000|Overall Study|Lost to Follow-up|8
1010754|NCT01496066|2030045|FG001|Overall Study|Lost to Follow-up|5
1010755|NCT01496066|2030044|FG000|Overall Study|Explant|3
1010756|NCT01496066|2030045|FG001|Overall Study|Explant|0
1010757|NCT01496066|2030044|FG000|Overall Study|Death|1
1010758|NCT01496066|2030045|FG001|Overall Study|Death|4
1010759|NCT01496183|2030073|FG000|Overall Study|Physician Decision|3
1010760|NCT01496183|2030074|FG001|Overall Study|Physician Decision|1
1010761|NCT01496183|2030073|FG000|Overall Study|Withdrawal by Subject|0
1010762|NCT01496183|2030074|FG001|Overall Study|Withdrawal by Subject|1
1010763|NCT01496274|2030087|FG000|Overall Study|Protocol Violation|0
1010764|NCT01496274|2030088|FG001|Overall Study|Protocol Violation|1
1010765|NCT01496274|2030087|FG000|Overall Study|Adverse Event|1
1010766|NCT01496274|2030088|FG001|Overall Study|Adverse Event|1
1010767|NCT01496274|2030087|FG000|Overall Study|Withdrawal by Subject|2
1010768|NCT01496274|2030088|FG001|Overall Study|Withdrawal by Subject|0
1010769|NCT01496274|2030087|FG000|Overall Study|Lost to Follow-up|0
1010770|NCT01496274|2030088|FG001|Overall Study|Lost to Follow-up|3
1010771|NCT01496287|2030109|FG000|Overall Study|Lost to Follow-up|1
1010772|NCT01496287|2030109|FG000|Overall Study|Incomplete anesthesia|5
1010773|NCT01496365|2030148|FG000|Overall Study|Adverse Event|2
1010774|NCT01496365|2030149|FG001|Overall Study|Adverse Event|3
1010775|NCT01496365|2030150|FG002|Overall Study|Adverse Event|3
1010776|NCT01496365|2030151|FG003|Overall Study|Adverse Event|2
1010777|NCT01496365|2030152|FG004|Overall Study|Adverse Event|5
1010778|NCT01496365|2030153|FG005|Overall Study|Adverse Event|6
1010779|NCT01496365|2030154|FG006|Overall Study|Adverse Event|4
1010780|NCT01496365|2030148|FG000|Overall Study|Withdrawal by Subject|6
1010781|NCT01496365|2030149|FG001|Overall Study|Withdrawal by Subject|6
1010782|NCT01496365|2030150|FG002|Overall Study|Withdrawal by Subject|0
1010783|NCT01496365|2030151|FG003|Overall Study|Withdrawal by Subject|1
1010784|NCT01496365|2030152|FG004|Overall Study|Withdrawal by Subject|3
1010785|NCT01496365|2030153|FG005|Overall Study|Withdrawal by Subject|2
1010786|NCT01496365|2030154|FG006|Overall Study|Withdrawal by Subject|1
1010787|NCT01496365|2030148|FG000|Overall Study|Protocol Violation|2
1010788|NCT01496365|2030149|FG001|Overall Study|Protocol Violation|1
1010789|NCT01496365|2030150|FG002|Overall Study|Protocol Violation|1
1010790|NCT01496365|2030151|FG003|Overall Study|Protocol Violation|0
1010791|NCT01496365|2030152|FG004|Overall Study|Protocol Violation|0
1010792|NCT01496365|2030153|FG005|Overall Study|Protocol Violation|1
1010793|NCT01496365|2030154|FG006|Overall Study|Protocol Violation|0
1010794|NCT01496365|2030148|FG000|Overall Study|Lack of Efficacy|1
1010795|NCT01496365|2030149|FG001|Overall Study|Lack of Efficacy|0
1010796|NCT01496365|2030150|FG002|Overall Study|Lack of Efficacy|0
1010797|NCT01496365|2030151|FG003|Overall Study|Lack of Efficacy|0
1010798|NCT01496365|2030152|FG004|Overall Study|Lack of Efficacy|0
1010799|NCT01496365|2030153|FG005|Overall Study|Lack of Efficacy|1
1010800|NCT01496365|2030154|FG006|Overall Study|Lack of Efficacy|0
1010801|NCT01496365|2030148|FG000|Overall Study|Lost to Follow-up|0
1010802|NCT01496365|2030149|FG001|Overall Study|Lost to Follow-up|1
1010803|NCT01496365|2030150|FG002|Overall Study|Lost to Follow-up|0
1010804|NCT01496365|2030151|FG003|Overall Study|Lost to Follow-up|0
1010805|NCT01496365|2030152|FG004|Overall Study|Lost to Follow-up|2
1010806|NCT01496365|2030153|FG005|Overall Study|Lost to Follow-up|0
1010807|NCT01496365|2030154|FG006|Overall Study|Lost to Follow-up|0
1010808|NCT01496365|2030148|FG000|Overall Study|Other|4
1010809|NCT01496365|2030149|FG001|Overall Study|Other|4
1010810|NCT01496365|2030150|FG002|Overall Study|Other|2
1010811|NCT01496365|2030151|FG003|Overall Study|Other|1
1010812|NCT01496365|2030152|FG004|Overall Study|Other|3
1010813|NCT01496365|2030153|FG005|Overall Study|Other|0
1010814|NCT01496365|2030154|FG006|Overall Study|Other|1
1010815|NCT01496430|2030173|FG000|Overall Study|Adverse Event|0
1010816|NCT01496430|2030174|FG001|Overall Study|Adverse Event|0
1010817|NCT01496430|2030175|FG002|Overall Study|Adverse Event|1
1010818|NCT01496430|2030173|FG000|Overall Study|Major Protocol Deviation|0
1010819|NCT01496430|2030174|FG001|Overall Study|Major Protocol Deviation|0
1010820|NCT01496430|2030175|FG002|Overall Study|Major Protocol Deviation|1
1010821|NCT01496430|2030173|FG000|Overall Study|Lost to Follow-up|2
1010822|NCT01496430|2030174|FG001|Overall Study|Lost to Follow-up|3
1010823|NCT01496430|2030175|FG002|Overall Study|Lost to Follow-up|1
1010824|NCT01496430|2030173|FG000|Overall Study|Voluntary Withdrawal|2
1010825|NCT01496430|2030174|FG001|Overall Study|Voluntary Withdrawal|1
1010826|NCT01496430|2030175|FG002|Overall Study|Voluntary Withdrawal|6
1010827|NCT01496430|2030173|FG000|Overall Study|Principal Investigator Discretion|0
1010828|NCT01496430|2030174|FG001|Overall Study|Principal Investigator Discretion|1
1010829|NCT01496430|2030175|FG002|Overall Study|Principal Investigator Discretion|1
1010830|NCT01496430|2030173|FG000|Overall Study|Other|2
1010831|NCT01496430|2030174|FG001|Overall Study|Other|0
1010832|NCT01496430|2030175|FG002|Overall Study|Other|0
1010833|NCT01496456|2030183|FG000|Overall Study|Protocol Violation|1
1010834|NCT01496456|2030183|FG000|Overall Study|Lost to Follow-up|7
1010835|NCT01496469|2030192|FG000|Overall Study|Adverse Event|1
1010836|NCT01496469|2030193|FG001|Overall Study|Adverse Event|0
1010837|NCT01496469|2030192|FG000|Overall Study|Protocol Violation|2
1010838|NCT01496469|2030193|FG001|Overall Study|Protocol Violation|0
1010839|NCT01496469|2030192|FG000|Overall Study|Lost to Follow-up|1
1010840|NCT01496469|2030193|FG001|Overall Study|Lost to Follow-up|1
1010841|NCT01496469|2030192|FG000|Overall Study|Withdrawal by Subject|4
1010842|NCT01496469|2030193|FG001|Overall Study|Withdrawal by Subject|4
1010843|NCT01496469|2030192|FG000|Overall Study|BP exceeds protocol limits|1
1010844|NCT01496469|2030193|FG001|Overall Study|BP exceeds protocol limits|2
1010845|NCT01496469|2030192|FG000|Overall Study|Other|1
1010846|NCT01496469|2030193|FG001|Overall Study|Other|1
1010847|NCT01496612|2030199|FG000|1st Intervention|Adverse Event|1
1010848|NCT01496612|2030200|FG001|1st Intervention|Adverse Event|0
1010849|NCT01496612|2030199|FG000|1st Intervention|Withdrawal by Subject|1
1010850|NCT01496612|2030200|FG001|1st Intervention|Withdrawal by Subject|0
1010851|NCT01496807|2030208|FG000|Overall Study|Progressive Disease|21
1010852|NCT01496807|2030208|FG000|Overall Study|Participant preference/toxicity|8
1010853|NCT01496807|2030208|FG000|Overall Study|Change in diagnosis|1
1010854|NCT01496846|2030218|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
1010855|NCT01496846|2030219|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
1010856|NCT01496846|2030220|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1010857|NCT01496846|2030221|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1010858|NCT01496846|2030222|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1010859|NCT01496846|2030223|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1010860|NCT01496885|2030234|FG000|Overall Study|Lost to Follow-up|13
1010861|NCT01496885|2030234|FG000|Overall Study|Withdrawal by Subject|7
1010862|NCT01496885|2030234|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2
1010863|NCT01496885|2030234|FG000|Overall Study|Death|1
1010864|NCT01497067|2030238|FG000|Overall Study|Lost to Follow-up|56
1010865|NCT01497067|2030238|FG000|Overall Study|Adverse Event|3
1010866|NCT01497067|2030238|FG000|Overall Study|Patient decision unrel to Adverse Event|10
1010867|NCT01497067|2030238|FG000|Overall Study|Other|13
1010868|NCT01497197|2030245|FG000|Overall Study|Lost to Follow-up|1
1010869|NCT01497197|2030246|FG001|Overall Study|Lost to Follow-up|0
1010870|NCT01497197|2030245|FG000|Overall Study|Protocol Violation|0
1010871|NCT01497197|2030246|FG001|Overall Study|Protocol Violation|2
1010872|NCT01497197|2030245|FG000|Overall Study|Withdrawal by Subject|2
1010873|NCT01497197|2030246|FG001|Overall Study|Withdrawal by Subject|1
1010874|NCT01497197|2030245|FG000|Overall Study|Excessive/lack of response to treatment|1
1010875|NCT01497197|2030246|FG001|Overall Study|Excessive/lack of response to treatment|0
1010876|NCT01497197|2030245|FG000|Overall Study|Risk of OHSS|1
1010877|NCT01497197|2030246|FG001|Overall Study|Risk of OHSS|0
1010878|NCT01497197|2030245|FG000|Overall Study|No oocytes retrieved|3
1010879|NCT01497197|2030246|FG001|Overall Study|No oocytes retrieved|2
1010880|NCT01497197|2030245|FG000|Overall Study|No fertilisation|6
1010881|NCT01497197|2030246|FG001|Overall Study|No fertilisation|5
1010882|NCT01497197|2030245|FG000|Overall Study|Intention to freeze all embryos|0
1010883|NCT01497197|2030246|FG001|Overall Study|Intention to freeze all embryos|1
1010884|NCT01497197|2030245|FG000|Overall Study|All embryos discarded|0
1010885|NCT01497197|2030246|FG001|Overall Study|All embryos discarded|3
1010886|NCT01497197|2030245|FG000|Overall Study|Other|3
1010887|NCT01497197|2030246|FG001|Overall Study|Other|1
1010888|NCT01497262|2030252|FG000|Overall Study|Abnormal Lab Values|4
1010889|NCT01497262|2030252|FG000|Overall Study|Abnormal Test Procedure Result|1
1010890|NCT01497262|2030252|FG000|Overall Study|Physician Decision|1
1010891|NCT01497262|2030252|FG000|Overall Study|Withdrawal by Subject|2
1010892|NCT01497262|2030252|FG000|Overall Study|Adverse Event|2
1010893|NCT01497262|2030252|FG000|Overall Study|Protocol Violation|1
1010894|NCT01497275|2030256|FG000|Overall Study|Death|1
1010895|NCT01497275|2030256|FG000|Overall Study|Adverse Event|1
1010896|NCT01497366|2030262|FG000|Overall Study|Virologic failure|2
1010897|NCT01497366|2030263|FG001|Overall Study|Virologic failure|50
1010898|NCT01497366|2030262|FG000|Overall Study|Lost to Follow-up|11
1010899|NCT01497366|2030263|FG001|Overall Study|Lost to Follow-up|10
1010900|NCT01497366|2030262|FG000|Overall Study|Withdrawal by Subject|6
1010901|NCT01497366|2030263|FG001|Overall Study|Withdrawal by Subject|6
1010902|NCT01497366|2030262|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7
1010903|NCT01497366|2030263|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0
1010904|NCT01497366|2030262|FG000|Overall Study|Other|5
1010905|NCT01497366|2030263|FG001|Overall Study|Other|0
1010906|NCT01497366|2030262|FG000|Overall Study|Death|1
1010907|NCT01497366|2030263|FG001|Overall Study|Death|1
1010908|NCT01497366|2030262|FG000|Overall Study|Randomized but not treated|7
1010909|NCT01497366|2030263|FG001|Overall Study|Randomized but not treated|21
1010910|NCT01497899|2030316|FG000|Double-Blind Phase|Randomized but not Treated|1
1010911|NCT01497899|2030317|FG001|Double-Blind Phase|Randomized but not Treated|0
1010912|NCT01497899|2030318|FG002|Double-Blind Phase|Randomized but not Treated|0
1010913|NCT01497899|2030319|FG003|Double-Blind Phase|Randomized but not Treated|0
1010914|NCT01497899|2030316|FG000|Double-Blind Phase|Adverse Event|1
1010915|NCT01497899|2030317|FG001|Double-Blind Phase|Adverse Event|0
1010916|NCT01497899|2030318|FG002|Double-Blind Phase|Adverse Event|0
1010917|NCT01497899|2030319|FG003|Double-Blind Phase|Adverse Event|0
1010918|NCT01497899|2030316|FG000|Double-Blind Phase|Lack of Efficacy|0
1010919|NCT01497899|2030317|FG001|Double-Blind Phase|Lack of Efficacy|1
1010920|NCT01497899|2030318|FG002|Double-Blind Phase|Lack of Efficacy|0
1010921|NCT01497899|2030319|FG003|Double-Blind Phase|Lack of Efficacy|0
1010922|NCT01497899|2030316|FG000|Double-Blind Phase|Investigator's Discretion|1
1010923|NCT01497899|2030317|FG001|Double-Blind Phase|Investigator's Discretion|0
1010924|NCT01497899|2030318|FG002|Double-Blind Phase|Investigator's Discretion|0
1010925|NCT01497899|2030319|FG003|Double-Blind Phase|Investigator's Discretion|0
1010926|NCT01497899|2030316|FG000|Double-Blind Phase|Withdrew Consent|0
1010927|NCT01497899|2030317|FG001|Double-Blind Phase|Withdrew Consent|1
1010928|NCT01497899|2030318|FG002|Double-Blind Phase|Withdrew Consent|0
1010929|NCT01497899|2030319|FG003|Double-Blind Phase|Withdrew Consent|0
1010930|NCT01497899|2030316|FG000|Double-Blind Phase|Lost to Follow-up|3
1010931|NCT01497899|2030317|FG001|Double-Blind Phase|Lost to Follow-up|2
1010932|NCT01497899|2030318|FG002|Double-Blind Phase|Lost to Follow-up|0
1010933|NCT01497899|2030319|FG003|Double-Blind Phase|Lost to Follow-up|0
1010934|NCT01497899|2030316|FG000|Double-Blind Phase|Subject Non-Compliance|0
1010935|NCT01497899|2030317|FG001|Double-Blind Phase|Subject Non-Compliance|1
1010936|NCT01497899|2030318|FG002|Double-Blind Phase|Subject Non-Compliance|0
1010937|NCT01497899|2030319|FG003|Double-Blind Phase|Subject Non-Compliance|0
1010938|NCT01497899|2030316|FG000|Open-Label Extension Phase|Adverse Event|1
1010939|NCT01497899|2030317|FG001|Open-Label Extension Phase|Adverse Event|0
1010940|NCT01497899|2030318|FG002|Open-Label Extension Phase|Adverse Event|0
1010941|NCT01497899|2030319|FG003|Open-Label Extension Phase|Adverse Event|0
1010942|NCT01497899|2030316|FG000|Open-Label Extension Phase|Death|1
1010943|NCT01497899|2030317|FG001|Open-Label Extension Phase|Death|0
1010944|NCT01497899|2030318|FG002|Open-Label Extension Phase|Death|0
1010945|NCT01497899|2030319|FG003|Open-Label Extension Phase|Death|0
1010946|NCT01497899|2030316|FG000|Open-Label Extension Phase|Withdrew Consent|8
1010947|NCT01497899|2030317|FG001|Open-Label Extension Phase|Withdrew Consent|3
1010948|NCT01497899|2030318|FG002|Open-Label Extension Phase|Withdrew Consent|2
1010949|NCT01497899|2030319|FG003|Open-Label Extension Phase|Withdrew Consent|0
1010950|NCT01497899|2030316|FG000|Open-Label Extension Phase|Pregnancy|0
1010951|NCT01497899|2030317|FG001|Open-Label Extension Phase|Pregnancy|1
1010952|NCT01497899|2030318|FG002|Open-Label Extension Phase|Pregnancy|1
1010953|NCT01497899|2030319|FG003|Open-Label Extension Phase|Pregnancy|0
1010954|NCT01497899|2030316|FG000|Open-Label Extension Phase|Protocol Violation|0
1010955|NCT01497899|2030317|FG001|Open-Label Extension Phase|Protocol Violation|0
1010956|NCT01497899|2030318|FG002|Open-Label Extension Phase|Protocol Violation|1
1010957|NCT01497899|2030319|FG003|Open-Label Extension Phase|Protocol Violation|0
1010958|NCT01497899|2030316|FG000|Open-Label Extension Phase|Lost to Follow-up|9
1010959|NCT01497899|2030317|FG001|Open-Label Extension Phase|Lost to Follow-up|3
1010960|NCT01497899|2030318|FG002|Open-Label Extension Phase|Lost to Follow-up|5
1010961|NCT01497899|2030319|FG003|Open-Label Extension Phase|Lost to Follow-up|5
1010962|NCT01497938|2030328|FG000|Overall Study|Adverse Event|0
1010963|NCT01497938|2030329|FG001|Overall Study|Adverse Event|1
1010964|NCT01497938|2030328|FG000|Overall Study|Physician Decision|0
1010965|NCT01497938|2030329|FG001|Overall Study|Physician Decision|1
1010966|NCT01497938|2030328|FG000|Overall Study|Withdrawal by Subject|4
1010967|NCT01497938|2030329|FG001|Overall Study|Withdrawal by Subject|0
1010968|NCT01497938|2030328|FG000|Overall Study|Device Violation|1
1010969|NCT01497938|2030329|FG001|Overall Study|Device Violation|0
1010970|NCT01498068|2030337|FG000|Overall Study|Withdrawal by Subject|1
1010971|NCT01498068|2030338|FG001|Overall Study|Withdrawal by Subject|1
1010972|NCT01498120|2030344|FG000|Overall Study|Lost to Follow-up|1
1010973|NCT01498120|2030344|FG000|Overall Study|Withdrawal by Subject|5
1010974|NCT01498120|2030344|FG000|Overall Study|AE, non-serious non-fatal|3
1010975|NCT01498120|2030344|FG000|Overall Study|Other|4
1010976|NCT01498185|2030353|FG000|Overall Study|Adverse Event|0
1010977|NCT01498185|2030354|FG001|Overall Study|Adverse Event|0
1010978|NCT01498185|2030355|FG002|Overall Study|Adverse Event|0
1010979|NCT01498185|2030356|FG003|Overall Study|Adverse Event|1
1010980|NCT01498185|2030357|FG004|Overall Study|Adverse Event|0
1010981|NCT01498185|2030353|FG000|Overall Study|Withdrawal by Subject|1
1010982|NCT01498185|2030354|FG001|Overall Study|Withdrawal by Subject|1
1010983|NCT01498185|2030355|FG002|Overall Study|Withdrawal by Subject|0
1010984|NCT01498185|2030356|FG003|Overall Study|Withdrawal by Subject|2
1010985|NCT01498185|2030357|FG004|Overall Study|Withdrawal by Subject|1
1010986|NCT01498185|2030353|FG000|Overall Study|No longer met criteria, etc|0
1010987|NCT01498185|2030354|FG001|Overall Study|No longer met criteria, etc|0
1010988|NCT01498185|2030355|FG002|Overall Study|No longer met criteria, etc|0
1010989|NCT01498185|2030356|FG003|Overall Study|No longer met criteria, etc|0
1010990|NCT01498185|2030357|FG004|Overall Study|No longer met criteria, etc|2
1010991|NCT01498289|2030375|FG000|Overall Study|Adverse Event|16
1010992|NCT01498289|2030376|FG001|Overall Study|Adverse Event|18
1010993|NCT01498289|2030375|FG000|Overall Study|Death|6
1010994|NCT01498289|2030376|FG001|Overall Study|Death|8
1010995|NCT01498289|2030375|FG000|Overall Study|Withdrawal unrelated to AE|16
1010996|NCT01498289|2030376|FG001|Overall Study|Withdrawal unrelated to AE|16
1010997|NCT01498289|2030375|FG000|Overall Study|Progression/relapse|53
1010998|NCT01498289|2030376|FG001|Overall Study|Progression/relapse|59
1010999|NCT01498289|2030375|FG000|Overall Study|Not protocol specified|7
1011000|NCT01498289|2030376|FG001|Overall Study|Not protocol specified|2
1011001|NCT01498289|2030375|FG000|Overall Study|Reason under review|0
1011002|NCT01498289|2030376|FG001|Overall Study|Reason under review|1
1011003|NCT01498445|2030409|FG000|Overall Study|Lack of Efficacy|0
1011004|NCT01498445|2030410|FG001|Overall Study|Lack of Efficacy|0
1011005|NCT01498445|2030411|FG002|Overall Study|Lack of Efficacy|1
1011006|NCT01498445|2030412|FG003|Overall Study|Lack of Efficacy|2
1011007|NCT01498445|2030413|FG004|Overall Study|Lack of Efficacy|0
1011008|NCT01498445|2030414|FG005|Overall Study|Lack of Efficacy|0
1011009|NCT01498445|2030409|FG000|Overall Study|Screen Failure|0
1011010|NCT01498445|2030410|FG001|Overall Study|Screen Failure|0
1011011|NCT01498445|2030411|FG002|Overall Study|Screen Failure|0
1011012|NCT01498445|2030412|FG003|Overall Study|Screen Failure|0
1011013|NCT01498445|2030413|FG004|Overall Study|Screen Failure|1
1011014|NCT01498445|2030414|FG005|Overall Study|Screen Failure|1
1011015|NCT01498458|2030428|FG000|Overall Study|Adverse Event|4
1011016|NCT01498458|2030428|FG000|Overall Study|Physician Decision|3
1011017|NCT01498575|2030448|FG000|Overall Sample|Withdrawal by Subject|60
1011018|NCT01498575|2030449|FG001|Overall Sample|Withdrawal by Subject|14
1011019|NCT01498575|2030448|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
1011020|NCT01498575|2030449|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
1011021|NCT01498575|2030448|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23
1011022|NCT01498575|2030449|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18
1011023|NCT01498640|2030468|FG000|Overall Study|Lost to Follow-up|1
1011024|NCT01498640|2030468|FG000|Overall Study|Death|1
1011025|NCT01498640|2030468|FG000|Overall Study|Other|3
1011026|NCT01498653|2030478|FG000|Overall Study|Adverse Event|2
1011027|NCT01498653|2030479|FG001|Overall Study|Adverse Event|2
1011028|NCT01498653|2030478|FG000|Overall Study|Lack of Efficacy|12
1011029|NCT01498653|2030479|FG001|Overall Study|Lack of Efficacy|26
1011030|NCT01498653|2030478|FG000|Overall Study|Protocol Violation|0
1011031|NCT01498653|2030479|FG001|Overall Study|Protocol Violation|4
1011032|NCT01498653|2030478|FG000|Overall Study|Lost to Follow-up|1
1011033|NCT01498653|2030479|FG001|Overall Study|Lost to Follow-up|0
1011034|NCT01498653|2030478|FG000|Overall Study|Physician Decision|2
1011035|NCT01498653|2030479|FG001|Overall Study|Physician Decision|0
1011036|NCT01498653|2030478|FG000|Overall Study|Withdrawal by Subject|2
1011037|NCT01498653|2030479|FG001|Overall Study|Withdrawal by Subject|3
1011038|NCT01498679|2030487|FG000|Overall Study|Adverse Event|1
1011039|NCT01498679|2030488|FG001|Overall Study|Adverse Event|4
1011040|NCT01498679|2030487|FG000|Overall Study|Lack of Efficacy|72
1011041|NCT01498679|2030488|FG001|Overall Study|Lack of Efficacy|12
1011042|NCT01498679|2030487|FG000|Overall Study|Protocol Violation|4
1011043|NCT01498679|2030488|FG001|Overall Study|Protocol Violation|0
1011044|NCT01498679|2030487|FG000|Overall Study|Physician Decision|0
1011045|NCT01498679|2030488|FG001|Overall Study|Physician Decision|2
1011046|NCT01498679|2030487|FG000|Overall Study|Withdrawal by Subject|12
1011047|NCT01498679|2030488|FG001|Overall Study|Withdrawal by Subject|4
1011048|NCT01498692|2030494|FG000|Overall Study|Death|4
1011049|NCT01498692|2030494|FG000|Overall Study|Withdrawal by Subject|1
1011050|NCT01498692|2030494|FG000|Overall Study|Missed 12-month visit|3
1011051|NCT01498822|2030509|FG000|Overall Study|Protocol Violation|8
1011052|NCT01498822|2030510|FG001|Overall Study|Protocol Violation|4
1011053|NCT01498822|2030509|FG000|Overall Study|Other Reason|5
1011054|NCT01498822|2030510|FG001|Overall Study|Other Reason|2
1011055|NCT01498822|2030509|FG000|Overall Study|Lack of Efficacy|7
1011056|NCT01498822|2030510|FG001|Overall Study|Lack of Efficacy|2
1011057|NCT01498822|2030509|FG000|Overall Study|AE, non-serious non-fatal|8
1011058|NCT01498822|2030510|FG001|Overall Study|AE, non-serious non-fatal|17
1011059|NCT01498822|2030509|FG000|Overall Study|SAE, non-fatal|2
1011060|NCT01498822|2030510|FG001|Overall Study|SAE, non-fatal|2
1011061|NCT01498822|2030509|FG000|Overall Study|Adverse Event, serious fatal|1
1011062|NCT01498822|2030510|FG001|Overall Study|Adverse Event, serious fatal|1
1011063|NCT01498822|2030509|FG000|Overall Study|Withdrawal by Subject|15
1011064|NCT01498822|2030510|FG001|Overall Study|Withdrawal by Subject|25
1011065|NCT01498822|2030509|FG000|Overall Study|Lost to Follow-up|8
1011066|NCT01498822|2030510|FG001|Overall Study|Lost to Follow-up|3
1011067|NCT01498887|2030520|FG000|Overall Study|Administrative problems|1
1011068|NCT01498887|2030521|FG001|Overall Study|Administrative problems|0
1011069|NCT01498887|2030520|FG000|Overall Study|Lost to Follow-up|1
1011070|NCT01498887|2030521|FG001|Overall Study|Lost to Follow-up|1
1011071|NCT01498887|2030520|FG000|Overall Study|Withdrawal by Subject|1
1011072|NCT01498887|2030521|FG001|Overall Study|Withdrawal by Subject|0
1011073|NCT01498887|2030520|FG000|Overall Study|Protocol Violation|1
1011074|NCT01498887|2030521|FG001|Overall Study|Protocol Violation|3
1011075|NCT01498887|2030520|FG000|Overall Study|Lack of Efficacy|5
1011076|NCT01498887|2030521|FG001|Overall Study|Lack of Efficacy|3
1011077|NCT01498887|2030520|FG000|Overall Study|Abnormal result from test procedure|1
1011078|NCT01498887|2030521|FG001|Overall Study|Abnormal result from test procedure|1
1011079|NCT01498887|2030520|FG000|Overall Study|Abnormal laboratory value|2
1011080|NCT01498887|2030521|FG001|Overall Study|Abnormal laboratory value|2
1011081|NCT01498887|2030520|FG000|Overall Study|Adverse Event|4
1011082|NCT01498887|2030521|FG001|Overall Study|Adverse Event|1
1011083|NCT01498952|2030530|FG000|Overall Study|Death|2
1011084|NCT01498952|2030531|FG001|Overall Study|Death|2
1011085|NCT01498952|2030532|FG002|Overall Study|Death|0
1011086|NCT01498952|2030533|FG003|Overall Study|Death|0
1011087|NCT01498952|2030534|FG004|Overall Study|Death|0
1011088|NCT01499043|2030553|FG000|Overall Study|Progressive disease (radiographic)|2
1011089|NCT01499043|2030553|FG000|Overall Study|Progressive disease (clinical)|1
1011090|NCT01499043|2030553|FG000|Overall Study|Withdrawal by Subject|2
1011091|NCT01499043|2030553|FG000|Overall Study|Adverse Event|1
1011092|NCT01499082|2030564|FG000|Overall Study|Randomized but not Treated|0
1011093|NCT01499082|2030565|FG001|Overall Study|Randomized but not Treated|1
1011094|NCT01499082|2030564|FG000|Overall Study|Adverse Event|12
1011095|NCT01499082|2030565|FG001|Overall Study|Adverse Event|16
1011096|NCT01499082|2030564|FG000|Overall Study|Lack of Efficacy|1
1011097|NCT01499082|2030565|FG001|Overall Study|Lack of Efficacy|1
1011098|NCT01499082|2030564|FG000|Overall Study|Protocol Violation|6
1011099|NCT01499082|2030565|FG001|Overall Study|Protocol Violation|8
1011100|NCT01499082|2030564|FG000|Overall Study|Diverse Reasons|18
1011101|NCT01499082|2030565|FG001|Overall Study|Diverse Reasons|14
1011102|NCT01499082|2030564|FG000|Overall Study|Site Closure for Noncompliance|5
1011103|NCT01499082|2030565|FG001|Overall Study|Site Closure for Noncompliance|2
1011104|NCT01499082|2030564|FG000|Overall Study|Hypoglycemia|2
1011105|NCT01499082|2030565|FG001|Overall Study|Hypoglycemia|3
1011106|NCT01499082|2030564|FG000|Overall Study|Lost to Follow-up|1
1011107|NCT01499082|2030565|FG001|Overall Study|Lost to Follow-up|3
1011108|NCT01499095|2030575|FG000|Overall Study|Randomized But Not Treated|1
1011109|NCT01499095|2030576|FG001|Overall Study|Randomized But Not Treated|1
1011110|NCT01499095|2030575|FG000|Overall Study|Adverse Event|12
1011111|NCT01499095|2030576|FG001|Overall Study|Adverse Event|7
1011112|NCT01499095|2030575|FG000|Overall Study|Lack of Efficacy|2
1011113|NCT01499095|2030576|FG001|Overall Study|Lack of Efficacy|1
1011114|NCT01499095|2030575|FG000|Overall Study|Protocol Violation|6
1011115|NCT01499095|2030576|FG001|Overall Study|Protocol Violation|7
1011116|NCT01499095|2030575|FG000|Overall Study|Received Rescue Therapy|32
1011117|NCT01499095|2030576|FG001|Overall Study|Received Rescue Therapy|40
1011118|NCT01499095|2030575|FG000|Overall Study|Diverse Reasons|22
1011119|NCT01499095|2030576|FG001|Overall Study|Diverse Reasons|25
1011120|NCT01499095|2030575|FG000|Overall Study|Lost to Follow-up|6
1011121|NCT01499095|2030576|FG001|Overall Study|Lost to Follow-up|4
1011122|NCT01499095|2030575|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0
1011123|NCT01499095|2030576|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5
1011124|NCT01499095|2030575|FG000|Overall Study|Hypoglycemia|3
1011125|NCT01499095|2030576|FG001|Overall Study|Hypoglycemia|1
1011126|NCT01499095|2030575|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
1011127|NCT01499095|2030576|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
1011128|NCT01499095|2030575|FG000|Overall Study|Change in Injection Schedule|2
1011129|NCT01499095|2030576|FG001|Overall Study|Change in Injection Schedule|0
1011130|NCT01499095|2030575|FG000|Overall Study|Perceived Lack of Efficacy|1
1011131|NCT01499095|2030576|FG001|Overall Study|Perceived Lack of Efficacy|1
1011132|NCT01499134|2030587|FG000|Overall Study|Withdrawal by Subject|0
1011133|NCT01499134|2030588|FG001|Overall Study|Withdrawal by Subject|1
1011134|NCT01499160|2030607|FG000|Overall Study|Adverse Event|1
1011135|NCT01499160|2030607|FG000|Overall Study|Withdrawal by Subject|1
1011136|NCT01499199|2030617|FG000|Overall Study|Adverse Event|1
1011137|NCT01499199|2030617|FG000|Overall Study|Lack of Efficacy|1
1011138|NCT01499277|2030623|FG000|Overall Study|Adverse Event|3
1011139|NCT01499277|2030624|FG001|Overall Study|Adverse Event|6
1011140|NCT01499277|2030623|FG000|Overall Study|Death|3
1011141|NCT01499277|2030624|FG001|Overall Study|Death|2
1011142|NCT01499277|2030623|FG000|Overall Study|Lost to Follow-up|15
1011143|NCT01499277|2030624|FG001|Overall Study|Lost to Follow-up|8
1011144|NCT01499277|2030623|FG000|Overall Study|Protocol Violation|2
1011145|NCT01499277|2030624|FG001|Overall Study|Protocol Violation|3
1011146|NCT01499277|2030623|FG000|Overall Study|Withdrawal by Subject|16
1011147|NCT01499277|2030624|FG001|Overall Study|Withdrawal by Subject|6
1011148|NCT01499277|2030623|FG000|Overall Study|Lack of therapeutic response and other|8
1011149|NCT01499277|2030624|FG001|Overall Study|Lack of therapeutic response and other|7
1011150|NCT01499290|2030632|FG000|Overall Study|Withdrawal by Subject|22
1011151|NCT01499290|2030633|FG001|Overall Study|Withdrawal by Subject|15
1011152|NCT01499290|2030632|FG000|Overall Study|Not specified in study report|11
1011153|NCT01499290|2030633|FG001|Overall Study|Not specified in study report|5
1011154|NCT01499290|2030632|FG000|Overall Study|Condition improved/subject recovered|1
1011155|NCT01499290|2030633|FG001|Overall Study|Condition improved/subject recovered|0
1011156|NCT01499290|2030632|FG000|Overall Study|Lack of Efficacy|7
1011157|NCT01499290|2030633|FG001|Overall Study|Lack of Efficacy|8
1011158|NCT01499290|2030632|FG000|Overall Study|Adverse Event|14
1011159|NCT01499290|2030633|FG001|Overall Study|Adverse Event|7
1011160|NCT01499303|2030660|FG000|Overall Study|Ongoing|2
1011161|NCT01499303|2030661|FG001|Overall Study|Ongoing|1
1011162|NCT01499303|2030660|FG000|Overall Study|Withdrawal by Subject|0
1011163|NCT01499303|2030661|FG001|Overall Study|Withdrawal by Subject|1
1011164|NCT01499303|2030660|FG000|Overall Study|Adverse Event|1
1011165|NCT01499303|2030661|FG001|Overall Study|Adverse Event|4
1011166|NCT01499303|2030660|FG000|Overall Study|Other|0
1011167|NCT01499303|2030661|FG001|Overall Study|Other|1
1011168|NCT01499355|2030667|FG000|Run-In Period|Study Termination|15
1011169|NCT01499355|2030668|FG001|Run-In Period|Study Termination|0
1011170|NCT01499355|2030669|FG002|Run-In Period|Study Termination|0
1011171|NCT01499355|2030670|FG003|Run-In Period|Study Termination|0
1011172|NCT01499355|2030667|FG000|Run-In Period|Other|3
1011173|NCT01499355|2030668|FG001|Run-In Period|Other|0
1011174|NCT01499355|2030669|FG002|Run-In Period|Other|0
1011175|NCT01499355|2030670|FG003|Run-In Period|Other|0
1011176|NCT01499355|2030667|FG000|Run-In Period|Death|2
1011177|NCT01499355|2030668|FG001|Run-In Period|Death|0
1011178|NCT01499355|2030669|FG002|Run-In Period|Death|0
1011179|NCT01499355|2030670|FG003|Run-In Period|Death|0
1011180|NCT01499355|2030667|FG000|Run-In Period|Investigator Decision|2
1011181|NCT01499355|2030668|FG001|Run-In Period|Investigator Decision|0
1011182|NCT01499355|2030669|FG002|Run-In Period|Investigator Decision|0
1011183|NCT01499355|2030670|FG003|Run-In Period|Investigator Decision|0
1011184|NCT01499355|2030667|FG000|Run-In Period|Consent Withdrawn|1
1011185|NCT01499355|2030668|FG001|Run-In Period|Consent Withdrawn|0
1011186|NCT01499355|2030669|FG002|Run-In Period|Consent Withdrawn|0
1011187|NCT01499355|2030670|FG003|Run-In Period|Consent Withdrawn|0
1011188|NCT01499355|2030667|FG000|Run-In Period|Adverse Event|8
1011189|NCT01499355|2030668|FG001|Run-In Period|Adverse Event|0
1011190|NCT01499355|2030669|FG002|Run-In Period|Adverse Event|0
1011191|NCT01499355|2030670|FG003|Run-In Period|Adverse Event|0
1011192|NCT01499355|2030667|FG000|Double-Blind Period|Adverse Event|0
1011193|NCT01499355|2030668|FG001|Double-Blind Period|Adverse Event|2
1011194|NCT01499355|2030669|FG002|Double-Blind Period|Adverse Event|3
1011195|NCT01499355|2030670|FG003|Double-Blind Period|Adverse Event|2
1011196|NCT01499355|2030667|FG000|Double-Blind Period|Study Termination|0
1011197|NCT01499355|2030668|FG001|Double-Blind Period|Study Termination|18
1011198|NCT01499355|2030669|FG002|Double-Blind Period|Study Termination|16
1011199|NCT01499355|2030670|FG003|Double-Blind Period|Study Termination|14
1011200|NCT01499355|2030667|FG000|Double-Blind Period|Other|0
1011201|NCT01499355|2030668|FG001|Double-Blind Period|Other|1
1011202|NCT01499355|2030669|FG002|Double-Blind Period|Other|2
1011203|NCT01499355|2030670|FG003|Double-Blind Period|Other|2
1011204|NCT01499355|2030667|FG000|Double-Blind Period|Death|0
1011205|NCT01499355|2030668|FG001|Double-Blind Period|Death|1
1011206|NCT01499355|2030669|FG002|Double-Blind Period|Death|0
1011207|NCT01499355|2030670|FG003|Double-Blind Period|Death|0
1011208|NCT01499355|2030667|FG000|Double-Blind Period|Investigator Decision|0
1011209|NCT01499355|2030668|FG001|Double-Blind Period|Investigator Decision|0
1011210|NCT01499355|2030669|FG002|Double-Blind Period|Investigator Decision|3
1011211|NCT01499355|2030670|FG003|Double-Blind Period|Investigator Decision|3
1011212|NCT01499355|2030667|FG000|Double-Blind Period|Consent Withdrawn|0
1011213|NCT01499355|2030668|FG001|Double-Blind Period|Consent Withdrawn|0
1011214|NCT01499355|2030669|FG002|Double-Blind Period|Consent Withdrawn|1
1011215|NCT01499355|2030670|FG003|Double-Blind Period|Consent Withdrawn|2
1011216|NCT01499355|2030667|FG000|Double-Blind Period|Lost to Follow-up|0
1011217|NCT01499355|2030668|FG001|Double-Blind Period|Lost to Follow-up|1
1011218|NCT01499355|2030669|FG002|Double-Blind Period|Lost to Follow-up|0
1011219|NCT01499355|2030670|FG003|Double-Blind Period|Lost to Follow-up|0
1011220|NCT01499368|2030683|FG000|Overall Study|Did not meet I/E criteria|8
1011221|NCT01499368|2030684|FG001|Overall Study|Did not meet I/E criteria|4
1011222|NCT01499368|2030685|FG002|Overall Study|Did not meet I/E criteria|4
1011223|NCT01499368|2030683|FG000|Overall Study|Prohibited Concomitant medication|1
1011224|NCT01499368|2030684|FG001|Overall Study|Prohibited Concomitant medication|1
1011225|NCT01499368|2030685|FG002|Overall Study|Prohibited Concomitant medication|0
1011226|NCT01499368|2030683|FG000|Overall Study|Withdrawal by Subject|11
1011227|NCT01499368|2030684|FG001|Overall Study|Withdrawal by Subject|10
1011228|NCT01499368|2030685|FG002|Overall Study|Withdrawal by Subject|8
1011229|NCT01499368|2030683|FG000|Overall Study|Lost to Follow-up|3
1011230|NCT01499368|2030684|FG001|Overall Study|Lost to Follow-up|2
1011231|NCT01499368|2030685|FG002|Overall Study|Lost to Follow-up|5
1011232|NCT01499368|2030683|FG000|Overall Study|Adverse Event|4
1011233|NCT01499368|2030684|FG001|Overall Study|Adverse Event|0
1011234|NCT01499368|2030685|FG002|Overall Study|Adverse Event|2
1011235|NCT01499368|2030683|FG000|Overall Study|Physician Decision|0
1011236|NCT01499368|2030684|FG001|Overall Study|Physician Decision|1
1011237|NCT01499368|2030685|FG002|Overall Study|Physician Decision|0
1011238|NCT01499368|2030683|FG000|Overall Study|Deviation from visit window|0
1011239|NCT01499368|2030684|FG001|Overall Study|Deviation from visit window|0
1011240|NCT01499368|2030685|FG002|Overall Study|Deviation from visit window|1
1011241|NCT01499368|2030683|FG000|Overall Study|Error of Prescriptions|0
1011242|NCT01499368|2030684|FG001|Overall Study|Error of Prescriptions|0
1011243|NCT01499368|2030685|FG002|Overall Study|Error of Prescriptions|1
1011244|NCT01499511|2030702|FG000|Overall Study|Death|1
1011245|NCT01499511|2030703|FG001|Overall Study|Death|0
1011246|NCT01499576|2030710|FG000|Overall Study|Physician Decision|12
1011247|NCT01499576|2030710|FG000|Overall Study|Withdrawal by Subject|9
1011248|NCT01499667|2030728|FG000|Overall Study|administrative problems|4
1011249|NCT01499667|2030729|FG001|Overall Study|administrative problems|5
1011250|NCT01499667|2030730|FG002|Overall Study|administrative problems|5
1011251|NCT01499667|2030728|FG000|Overall Study|Protocol Violation|1
1011252|NCT01499667|2030729|FG001|Overall Study|Protocol Violation|3
1011253|NCT01499667|2030730|FG002|Overall Study|Protocol Violation|2
1011254|NCT01499667|2030728|FG000|Overall Study|Adverse Event|0
1011255|NCT01499667|2030729|FG001|Overall Study|Adverse Event|2
1011256|NCT01499667|2030730|FG002|Overall Study|Adverse Event|2
1011257|NCT01499667|2030728|FG000|Overall Study|Withdrawal by Subject|2
1011258|NCT01499667|2030729|FG001|Overall Study|Withdrawal by Subject|1
1011259|NCT01499667|2030730|FG002|Overall Study|Withdrawal by Subject|1
1011260|NCT01499667|2030728|FG000|Overall Study|Lack of Efficacy|2
1011261|NCT01499667|2030729|FG001|Overall Study|Lack of Efficacy|0
1011262|NCT01499667|2030730|FG002|Overall Study|Lack of Efficacy|0
1011263|NCT01499810|2030738|FG000|Overall Study|Lost to Follow-up|10
1011264|NCT01499810|2030738|FG000|Overall Study|Protocol Violation|1
1011265|NCT01499810|2030738|FG000|Overall Study|Withdrawal by Subject|1
1011266|NCT01499849|2030745|FG000|Overall Study|Adverse Event|28
1011267|NCT01499849|2030746|FG001|Overall Study|Adverse Event|32
1011268|NCT01499849|2030745|FG000|Overall Study|Chemo completed or Change in Therapy|70
1011269|NCT01499849|2030746|FG001|Overall Study|Chemo completed or Change in Therapy|67
1011270|NCT01499849|2030745|FG000|Overall Study|Withdrawal by Subject|43
1011271|NCT01499849|2030746|FG001|Overall Study|Withdrawal by Subject|43
1011272|NCT01499849|2030745|FG000|Overall Study|Death|5
1011273|NCT01499849|2030746|FG001|Overall Study|Death|7
1011274|NCT01499849|2030745|FG000|Overall Study|Disease Progression|11
1011275|NCT01499849|2030746|FG001|Overall Study|Disease Progression|10
1011276|NCT01499849|2030745|FG000|Overall Study|Protocol Violation|11
1011277|NCT01499849|2030746|FG001|Overall Study|Protocol Violation|11
1011278|NCT01499849|2030745|FG000|Overall Study|Physician Decision|20
1011279|NCT01499849|2030746|FG001|Overall Study|Physician Decision|19
1011280|NCT01499849|2030745|FG000|Overall Study|Lack of Efficacy|3
1011281|NCT01499849|2030746|FG001|Overall Study|Lack of Efficacy|4
1011282|NCT01499849|2030745|FG000|Overall Study|Lost to Follow-up|6
1011283|NCT01499849|2030746|FG001|Overall Study|Lost to Follow-up|3
1011284|NCT01499849|2030745|FG000|Overall Study|Other Reasons|27
1011285|NCT01499849|2030746|FG001|Overall Study|Other Reasons|30
1011286|NCT01499940|2030770|FG000|Overall Study|Study was withdrawn before completion.|9
1011287|NCT01500031|2030774|FG000|Overall Study|Death|1
1011288|NCT01500031|2030774|FG000|Overall Study|Withdrawal by Subject|4
1011289|NCT01500057|2030780|FG000|Overall Study|Lost to Follow-up|6
1011290|NCT01500057|2030781|FG001|Overall Study|Lost to Follow-up|4
1011291|NCT01500083|2030789|FG000|Overall Study|Adverse Event|4
1011292|NCT01500083|2030790|FG001|Overall Study|Adverse Event|17
1011293|NCT01500083|2030789|FG000|Overall Study|Death|0
1011294|NCT01500083|2030790|FG001|Overall Study|Death|2
1011295|NCT01500083|2030789|FG000|Overall Study|Lost to Follow-up|1
1011296|NCT01500083|2030790|FG001|Overall Study|Lost to Follow-up|0
1011297|NCT01500083|2030789|FG000|Overall Study|Withdrawal of Consent|0
1011298|NCT01500083|2030790|FG001|Overall Study|Withdrawal of Consent|1
1011299|NCT01500083|2030789|FG000|Overall Study|Disease Progression|2
1011300|NCT01500083|2030790|FG001|Overall Study|Disease Progression|10
1011301|NCT01500083|2030789|FG000|Overall Study|Investigator Discretion|3
1011302|NCT01500083|2030790|FG001|Overall Study|Investigator Discretion|8
1011303|NCT01500083|2030789|FG000|Overall Study|Other Reasons|2
1011304|NCT01500083|2030790|FG001|Overall Study|Other Reasons|5
1011305|NCT01500096|2030800|FG000|Overall Study|Lost to Follow-up|1
1011306|NCT01500096|2030801|FG001|Overall Study|Lost to Follow-up|0
1011307|NCT01500096|2030802|FG002|Overall Study|Lost to Follow-up|0
1011308|NCT01500096|2030803|FG003|Overall Study|Lost to Follow-up|2
1011309|NCT01500135|2030815|FG000|Overall Study|Withdrawal of Consent|4
1011310|NCT01500135|2030816|FG001|Overall Study|Withdrawal of Consent|0
1011311|NCT01500135|2030815|FG000|Overall Study|Lost to Follow-up|6
1011312|NCT01500135|2030816|FG001|Overall Study|Lost to Follow-up|4
1011313|NCT01500135|2030815|FG000|Overall Study|Fatal Adverse Event (AE)|5
1011314|NCT01500135|2030816|FG001|Overall Study|Fatal Adverse Event (AE)|5
1011315|NCT01500135|2030815|FG000|Overall Study|Principal Investigator (PI) Discretion|1
1011316|NCT01500135|2030816|FG001|Overall Study|Principal Investigator (PI) Discretion|0
1011317|NCT01500135|2030815|FG000|Overall Study|Patient Missed Scheduled Appointments|0
1011318|NCT01500135|2030816|FG001|Overall Study|Patient Missed Scheduled Appointments|1
1011319|NCT01500135|2030815|FG000|Overall Study|Participant was a Safety Concern|1
1011320|NCT01500135|2030816|FG001|Overall Study|Participant was a Safety Concern|0
1011321|NCT01500135|2030815|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0
1011322|NCT01500135|2030816|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1
1011323|NCT01500187|2030824|FG000|Overall Study|Lost to Follow-up|6
1011324|NCT01500187|2030825|FG001|Overall Study|Lost to Follow-up|0
1011325|NCT01500200|2030834|FG000|Stage 1|Adverse Event|1
1011326|NCT01500200|2030835|FG001|Stage 1|Adverse Event|4
1011327|NCT01500200|2030836|FG002|Stage 1|Adverse Event|5
1011328|NCT01500200|2030837|FG003|Stage 1|Adverse Event|0
1011329|NCT01500200|2030838|FG004|Stage 1|Adverse Event|0
1011330|NCT01500200|2030839|FG005|Stage 1|Adverse Event|0
1011331|NCT01500200|2030834|FG000|Stage 1|Lost to Follow-up|2
1011332|NCT01500200|2030835|FG001|Stage 1|Lost to Follow-up|2
1011333|NCT01500200|2030836|FG002|Stage 1|Lost to Follow-up|1
1011334|NCT01500200|2030837|FG003|Stage 1|Lost to Follow-up|0
1011335|NCT01500200|2030838|FG004|Stage 1|Lost to Follow-up|0
1011336|NCT01500200|2030839|FG005|Stage 1|Lost to Follow-up|0
1011337|NCT01500200|2030834|FG000|Stage 1|Withdrawal by Subject|3
1011338|NCT01500200|2030835|FG001|Stage 1|Withdrawal by Subject|0
1011339|NCT01500200|2030836|FG002|Stage 1|Withdrawal by Subject|0
1011340|NCT01500200|2030837|FG003|Stage 1|Withdrawal by Subject|0
1011341|NCT01500200|2030838|FG004|Stage 1|Withdrawal by Subject|0
1011342|NCT01500200|2030839|FG005|Stage 1|Withdrawal by Subject|0
1011343|NCT01500200|2030834|FG000|Stage 1|Noncompliance with Study Drug|1
1011344|NCT01500200|2030835|FG001|Stage 1|Noncompliance with Study Drug|0
1011345|NCT01500200|2030836|FG002|Stage 1|Noncompliance with Study Drug|0
1011346|NCT01500200|2030837|FG003|Stage 1|Noncompliance with Study Drug|0
1011347|NCT01500200|2030838|FG004|Stage 1|Noncompliance with Study Drug|0
1011348|NCT01500200|2030839|FG005|Stage 1|Noncompliance with Study Drug|0
1011349|NCT01500200|2030834|FG000|Stage 1|Physician Decision|1
1011350|NCT01500200|2030835|FG001|Stage 1|Physician Decision|0
1011351|NCT01500200|2030836|FG002|Stage 1|Physician Decision|0
1011352|NCT01500200|2030837|FG003|Stage 1|Physician Decision|0
1011353|NCT01500200|2030838|FG004|Stage 1|Physician Decision|0
1011354|NCT01500200|2030839|FG005|Stage 1|Physician Decision|0
1011355|NCT01500200|2030834|FG000|Stage 2|Adverse Event|0
1011356|NCT01500200|2030835|FG001|Stage 2|Adverse Event|0
1011357|NCT01500200|2030836|FG002|Stage 2|Adverse Event|0
1011358|NCT01500200|2030837|FG003|Stage 2|Adverse Event|0
1011359|NCT01500200|2030838|FG004|Stage 2|Adverse Event|5
1011360|NCT01500200|2030839|FG005|Stage 2|Adverse Event|4
1011361|NCT01500213|2030855|FG000|Overall Study|Adverse Event|35
1011362|NCT01500213|2030856|FG001|Overall Study|Adverse Event|35
1011363|NCT01500213|2030855|FG000|Overall Study|Chemo Completed or Change in Therapy|84
1011364|NCT01500213|2030856|FG001|Overall Study|Chemo Completed or Change in Therapy|81
1011365|NCT01500213|2030855|FG000|Overall Study|Withdrawal by Subject|28
914289|NCT00813800|1892018|FG000|Overall Study|Screen Failure after Consent|2
914290|NCT00813800|1892018|FG000|Overall Study|Adverse Event|1
914291|NCT00813800|1892018|FG000|Overall Study|Worsening of depression|2
914292|NCT00813800|1892018|FG000|Overall Study|Physician Decision|1
914293|NCT00813813|1892024|FG000|Overall Study|Withdrawal by Subject|1
914294|NCT00813813|1892025|FG001|Overall Study|Withdrawal by Subject|1
914295|NCT00813813|1892024|FG000|Overall Study|Lost to Follow-up|2
914296|NCT00813813|1892025|FG001|Overall Study|Lost to Follow-up|7
914297|NCT00813813|1892024|FG000|Overall Study|Other|0
914298|NCT00813813|1892025|FG001|Overall Study|Other|1
914299|NCT00813865|1892031|FG000|Overall Study|Failure to Respond|3
914300|NCT00813865|1892031|FG000|Overall Study|Lost to Follow-up|3
1011366|NCT01500213|2030856|FG001|Overall Study|Withdrawal by Subject|37
1011367|NCT01500213|2030855|FG000|Overall Study|Death|7
1011368|NCT01500213|2030856|FG001|Overall Study|Death|3
1011369|NCT01500213|2030855|FG000|Overall Study|Disease Progression|13
1011370|NCT01500213|2030856|FG001|Overall Study|Disease Progression|21
1011371|NCT01500213|2030855|FG000|Overall Study|Protocol Violation|19
1011372|NCT01500213|2030856|FG001|Overall Study|Protocol Violation|19
1011373|NCT01500213|2030855|FG000|Overall Study|Physician Decision|12
1011374|NCT01500213|2030856|FG001|Overall Study|Physician Decision|10
1011375|NCT01500213|2030855|FG000|Overall Study|Lack of Efficacy|9
1011376|NCT01500213|2030856|FG001|Overall Study|Lack of Efficacy|7
1011377|NCT01500213|2030855|FG000|Overall Study|Lost to Follow-up|3
1011378|NCT01500213|2030856|FG001|Overall Study|Lost to Follow-up|6
1011379|NCT01500213|2030855|FG000|Overall Study|Other Reasons|7
1011380|NCT01500213|2030856|FG001|Overall Study|Other Reasons|5
1011381|NCT01500226|2030864|FG000|Overall Study|Adverse Event|31
1011382|NCT01500226|2030865|FG001|Overall Study|Adverse Event|38
1011383|NCT01500226|2030864|FG000|Overall Study|Chemo Completed or Change in Therapy|235
1011384|NCT01500226|2030865|FG001|Overall Study|Chemo Completed or Change in Therapy|237
1011385|NCT01500226|2030864|FG000|Overall Study|Withdrawal by Subject|93
1011386|NCT01500226|2030865|FG001|Overall Study|Withdrawal by Subject|96
1011387|NCT01500226|2030864|FG000|Overall Study|Death|12
1011388|NCT01500226|2030865|FG001|Overall Study|Death|4
1011389|NCT01500226|2030864|FG000|Overall Study|Disease Progression|16
1011390|NCT01500226|2030865|FG001|Overall Study|Disease Progression|14
1011391|NCT01500226|2030864|FG000|Overall Study|Protocol Violation|53
1011392|NCT01500226|2030865|FG001|Overall Study|Protocol Violation|39
1011393|NCT01500226|2030864|FG000|Overall Study|Physician Decision|17
1011394|NCT01500226|2030865|FG001|Overall Study|Physician Decision|15
1011395|NCT01500226|2030864|FG000|Overall Study|Lack of Efficacy|14
1011396|NCT01500226|2030865|FG001|Overall Study|Lack of Efficacy|30
1011397|NCT01500226|2030864|FG000|Overall Study|Lost to Follow-up|9
1011398|NCT01500226|2030865|FG001|Overall Study|Lost to Follow-up|5
1011399|NCT01500226|2030864|FG000|Overall Study|Other Reasons|19
1011400|NCT01500226|2030865|FG001|Overall Study|Other Reasons|16
1011401|NCT01500252|2030873|FG000|Overall Study|Death|4
1011402|NCT01500252|2030874|FG001|Overall Study|Death|2
1011403|NCT01500252|2030873|FG000|Overall Study|Lost to Follow-up|5
1011404|NCT01500252|2030874|FG001|Overall Study|Lost to Follow-up|4
1011405|NCT01500278|2030883|FG000|Week 0 - Week 12|Lack of Efficacy|0
1011406|NCT01500278|2030884|FG001|Week 0 - Week 12|Lack of Efficacy|1
1011407|NCT01500278|2030883|FG000|Week 0 - Week 12|Protocol Violation|10
1011408|NCT01500278|2030884|FG001|Week 0 - Week 12|Protocol Violation|16
1011409|NCT01500278|2030883|FG000|Week 0 - Week 12|Lost to Follow-up|1
1011410|NCT01500278|2030884|FG001|Week 0 - Week 12|Lost to Follow-up|1
1011411|NCT01500278|2030883|FG000|Week 0 - Week 12|Withdrawal by Subject|7
1011412|NCT01500278|2030884|FG001|Week 0 - Week 12|Withdrawal by Subject|2
1011413|NCT01500278|2030883|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1
1011414|NCT01500278|2030884|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0
1011415|NCT01500278|2030883|FG000|Week 0 - Week 12|Patient decision|1
1011416|NCT01500278|2030884|FG001|Week 0 - Week 12|Patient decision|0
1011417|NCT01500278|2030883|FG000|Week 0 - Week 12|Exclusion criteria not met|1
1011418|NCT01500278|2030884|FG001|Week 0 - Week 12|Exclusion criteria not met|0
1011419|NCT01500278|2030883|FG000|Week 0 - Week 12|Investigator decision|1
1011420|NCT01500278|2030884|FG001|Week 0 - Week 12|Investigator decision|0
1011421|NCT01500278|2030883|FG000|Week 0 - Week 12|Prior history of serious disease|1
1011422|NCT01500278|2030884|FG001|Week 0 - Week 12|Prior history of serious disease|0
1011423|NCT01500278|2030883|FG000|Week 0 - Week 12|Sponsor decision|1
1011424|NCT01500278|2030884|FG001|Week 0 - Week 12|Sponsor decision|0
1011425|NCT01500278|2030883|FG000|Week 0 - Week 12|Personal reason|0
1011426|NCT01500278|2030884|FG001|Week 0 - Week 12|Personal reason|1
1011427|NCT01500278|2030883|FG000|Week 0 - Week 12|Other serious disease|0
1011428|NCT01500278|2030884|FG001|Week 0 - Week 12|Other serious disease|1
1011429|NCT01500278|2030883|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7
1011430|NCT01500278|2030884|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8
1011431|NCT01500278|2030883|FG000|Week 13 - Week 104|Lack of Efficacy|11
1011432|NCT01500278|2030884|FG001|Week 13 - Week 104|Lack of Efficacy|12
1011433|NCT01500278|2030883|FG000|Week 13 - Week 104|Protocol Violation|6
1011434|NCT01500278|2030884|FG001|Week 13 - Week 104|Protocol Violation|6
1011435|NCT01500278|2030883|FG000|Week 13 - Week 104|Lost to Follow-up|6
1011436|NCT01500278|2030884|FG001|Week 13 - Week 104|Lost to Follow-up|5
1011437|NCT01500278|2030883|FG000|Week 13 - Week 104|Withdrawal by Subject|22
1011438|NCT01500278|2030884|FG001|Week 13 - Week 104|Withdrawal by Subject|13
1011439|NCT01500278|2030883|FG000|Week 13 - Week 104|Week 24 Non-Responder|20
1011440|NCT01500278|2030884|FG001|Week 13 - Week 104|Week 24 Non-Responder|16
1011441|NCT01500278|2030883|FG000|Week 13 - Week 104|Non/bad compliance|7
1011442|NCT01500278|2030884|FG001|Week 13 - Week 104|Non/bad compliance|5
1011443|NCT01500278|2030883|FG000|Week 13 - Week 104|Recurrent infections|1
1011444|NCT01500278|2030884|FG001|Week 13 - Week 104|Recurrent infections|0
1011445|NCT01500278|2030883|FG000|Week 13 - Week 104|False positive test|1
1011446|NCT01500278|2030884|FG001|Week 13 - Week 104|False positive test|2
1011447|NCT01500278|2030883|FG000|Week 13 - Week 104|Sponsor request|4
1011448|NCT01500278|2030884|FG001|Week 13 - Week 104|Sponsor request|0
1011449|NCT01500278|2030883|FG000|Week 13 - Week 104|Withdrawn in error|1
1011450|NCT01500278|2030884|FG001|Week 13 - Week 104|Withdrawn in error|0
1011451|NCT01500278|2030883|FG000|Week 13 - Week 104|Exclusion criteria not met|1
1011452|NCT01500278|2030884|FG001|Week 13 - Week 104|Exclusion criteria not met|0
1011453|NCT01500278|2030883|FG000|Week 13 - Week 104|Protocol deviation|1
1011454|NCT01500278|2030884|FG001|Week 13 - Week 104|Protocol deviation|0
1011455|NCT01500278|2030883|FG000|Week 13 - Week 104|Principal investigator retiring|1
1011456|NCT01500278|2030884|FG001|Week 13 - Week 104|Principal investigator retiring|0
1011457|NCT01500278|2030883|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
1011458|NCT01500278|2030884|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
1011459|NCT01500278|2030883|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0
1011460|NCT01500278|2030884|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2
1011461|NCT01500278|2030883|FG000|Week 13 - Week 104|Relocation|0
1011462|NCT01500278|2030884|FG001|Week 13 - Week 104|Relocation|1
1011463|NCT01500278|2030883|FG000|Week 13 - Week 104|Sponsor decision|0
1011464|NCT01500278|2030884|FG001|Week 13 - Week 104|Sponsor decision|2
1011465|NCT01500278|2030883|FG000|Week 13 - Week 104|Medical monitor decision|0
1011466|NCT01500278|2030884|FG001|Week 13 - Week 104|Medical monitor decision|2
1011467|NCT01500278|2030883|FG000|Week 13 - Week 104|Personal reason|0
1011468|NCT01500278|2030884|FG001|Week 13 - Week 104|Personal reason|1
1011469|NCT01500278|2030883|FG000|Week 13 - Week 104|Not completed|0
1011470|NCT01500278|2030884|FG001|Week 13 - Week 104|Not completed|1
1011471|NCT01500278|2030883|FG000|Week 13 - Week 104|Death|2
1011472|NCT01500278|2030884|FG001|Week 13 - Week 104|Death|4
1011473|NCT01500278|2030883|FG000|Week 13 - Week 104|Adverse Event|54
1011474|NCT01500278|2030884|FG001|Week 13 - Week 104|Adverse Event|54
1011475|NCT01500317|2030895|FG000|Overall Study|Withdrawal by Subject|3
1011476|NCT01500317|2030896|FG001|Overall Study|Withdrawal by Subject|2
1011477|NCT01500317|2030897|FG002|Overall Study|Withdrawal by Subject|0
1011478|NCT01500382|2030909|FG000|Washout Period|Study site went out of business|0
1011479|NCT01500382|2030910|FG001|Washout Period|Study site went out of business|0
1011480|NCT01500382|2030911|FG002|Washout Period|Study site went out of business|1
1011481|NCT01500382|2030912|FG003|Washout Period|Study site went out of business|0
1011482|NCT01500434|2030922|FG000|Overall Study|Death|1
1011483|NCT01500434|2030922|FG000|Overall Study|Withdrawal by Subject|1
1011484|NCT01500434|2030922|FG000|Overall Study|Missed 12-month follow-up|5
1011485|NCT01500629|2030937|FG000|Washout Period of 14 to 30 Days|Pregnancy|1
1011486|NCT01500629|2030938|FG001|Washout Period of 14 to 30 Days|Pregnancy|0
914301|NCT00813865|1892031|FG000|Overall Study|Withdrawal by Subject|1
914302|NCT00813904|1892035|FG000|Overall Study|Death|1
914303|NCT00813917|1892041|FG000|Overall Study|Adverse Event|0
914304|NCT00813917|1892042|FG001|Overall Study|Adverse Event|1
1011487|NCT01500694|2030953|FG000|Overall Study|Adverse Event|4
1011488|NCT01500694|2030954|FG001|Overall Study|Adverse Event|3
1011489|NCT01500694|2030953|FG000|Overall Study|Protocol Violation|0
1011490|NCT01500694|2030954|FG001|Overall Study|Protocol Violation|1
1011491|NCT01500694|2030953|FG000|Overall Study|Withdrawal by Subject|23
1011492|NCT01500694|2030954|FG001|Overall Study|Withdrawal by Subject|14
1011493|NCT01500694|2030953|FG000|Overall Study|Lost to Follow-up|2
1011494|NCT01500694|2030954|FG001|Overall Study|Lost to Follow-up|3
1011495|NCT01500694|2030953|FG000|Overall Study|Lack of Efficacy|14
1011496|NCT01500694|2030954|FG001|Overall Study|Lack of Efficacy|5
1011497|NCT01500694|2030953|FG000|Overall Study|Other|9
1011498|NCT01500694|2030954|FG001|Overall Study|Other|3
1011499|NCT01500720|2030962|FG000|Overall Study|Randomized But Not Treated|1
1011500|NCT01500720|2030963|FG001|Overall Study|Randomized But Not Treated|1
1011501|NCT01500720|2030962|FG000|Overall Study|Other|4
1011502|NCT01500720|2030963|FG001|Overall Study|Other|8
1011503|NCT01501110|2031007|FG000|Overall Study|Death|0
1011504|NCT01501110|2031008|FG001|Overall Study|Death|1
1011505|NCT01501955|2031032|FG000|Overall Study|Withdrawal by Subject|1
1011506|NCT01501955|2031033|FG001|Overall Study|Withdrawal by Subject|0
1011507|NCT01501955|2031032|FG000|Overall Study|Adverse Event|1
1011508|NCT01501955|2031033|FG001|Overall Study|Adverse Event|3
1011509|NCT01502033|2031039|FG000|Overall Study|1 participant had scalp discomfort|1
1011510|NCT01502033|2031039|FG000|Overall Study|1 participant had worsening depression|1
1011511|NCT01502033|2031039|FG000|Overall Study|1 participant went back to school|1
1011512|NCT01502072|2031048|FG000|Overall Study|Withdrawal by Subject|1
914305|NCT00813917|1892041|FG000|Overall Study|Withdrawal by Subject|3
914306|NCT00813917|1892042|FG001|Overall Study|Withdrawal by Subject|4
914307|NCT00813917|1892041|FG000|Overall Study|Lost to Follow-up|3
914308|NCT00813917|1892042|FG001|Overall Study|Lost to Follow-up|1
914309|NCT00813943|1892051|FG000|Overall Study|Ongoing at cut-off date|5
914310|NCT00813943|1892052|FG001|Overall Study|Ongoing at cut-off date|5
914311|NCT00813943|1892053|FG002|Overall Study|Ongoing at cut-off date|3
914312|NCT00813995|1892070|FG000|Overall Study|Clinical adverse event|9
914313|NCT00813995|1892071|FG001|Overall Study|Clinical adverse event|3
914314|NCT00813995|1892070|FG000|Overall Study|Laboratory adverse event|0
914315|NCT00813995|1892071|FG001|Overall Study|Laboratory adverse event|2
914316|NCT00813995|1892070|FG000|Overall Study|Lack of Efficacy|1
914317|NCT00813995|1892071|FG001|Overall Study|Lack of Efficacy|0
914318|NCT00813995|1892070|FG000|Overall Study|Lost to Follow-up|4
914319|NCT00813995|1892071|FG001|Overall Study|Lost to Follow-up|2
1011513|NCT01502072|2031049|FG001|Overall Study|Withdrawal by Subject|0
1011514|NCT01502072|2031050|FG002|Overall Study|Withdrawal by Subject|0
1011515|NCT01502072|2031048|FG000|Overall Study|Death|0
1011516|NCT01502072|2031049|FG001|Overall Study|Death|1
1011517|NCT01502072|2031050|FG002|Overall Study|Death|0
1011518|NCT01502228|2031058|FG000|Overall Study|Death|1
1011519|NCT01502293|2031065|FG000|Overall Study|Progressive Disease|20
1011520|NCT01502293|2031066|FG001|Overall Study|Progressive Disease|12
1011521|NCT01502293|2031067|FG002|Overall Study|Progressive Disease|2
1011522|NCT01502293|2031065|FG000|Overall Study|Withdrawal by Subject|3
1011523|NCT01502293|2031066|FG001|Overall Study|Withdrawal by Subject|3
1011524|NCT01502293|2031067|FG002|Overall Study|Withdrawal by Subject|1
1011525|NCT01502293|2031065|FG000|Overall Study|Adverse Event|0
1011526|NCT01502293|2031066|FG001|Overall Study|Adverse Event|2
1011527|NCT01502293|2031067|FG002|Overall Study|Adverse Event|0
1011528|NCT01502293|2031065|FG000|Overall Study|Reason Not Specified|2
1011529|NCT01502293|2031066|FG001|Overall Study|Reason Not Specified|0
1011530|NCT01502293|2031067|FG002|Overall Study|Reason Not Specified|0
1011531|NCT01502293|2031065|FG000|Overall Study|Physician Decision|0
1011532|NCT01502293|2031066|FG001|Overall Study|Physician Decision|0
1011533|NCT01502293|2031067|FG002|Overall Study|Physician Decision|1
1011534|NCT01502371|2031105|FG000|Overall Study|Withdrawal by Subject|1
1011535|NCT01502371|2031106|FG001|Overall Study|Withdrawal by Subject|2
1011536|NCT01502371|2031107|FG002|Overall Study|Withdrawal by Subject|1
1011537|NCT01502371|2031108|FG003|Overall Study|Withdrawal by Subject|1
1011538|NCT01502371|2031109|FG004|Overall Study|Withdrawal by Subject|1
1011539|NCT01502371|2031105|FG000|Overall Study|Adverse Event|2
1011540|NCT01502371|2031106|FG001|Overall Study|Adverse Event|1
1011541|NCT01502371|2031107|FG002|Overall Study|Adverse Event|0
1011542|NCT01502371|2031108|FG003|Overall Study|Adverse Event|4
1011543|NCT01502371|2031109|FG004|Overall Study|Adverse Event|3
1011544|NCT01502371|2031105|FG000|Overall Study|Treatment Failure|22
1011545|NCT01502371|2031106|FG001|Overall Study|Treatment Failure|20
1011546|NCT01502371|2031107|FG002|Overall Study|Treatment Failure|12
1011547|NCT01502371|2031108|FG003|Overall Study|Treatment Failure|19
1011548|NCT01502371|2031109|FG004|Overall Study|Treatment Failure|30
1011549|NCT01502371|2031105|FG000|Overall Study|Lack of Efficacy|3
1011550|NCT01502371|2031106|FG001|Overall Study|Lack of Efficacy|3
1011551|NCT01502371|2031107|FG002|Overall Study|Lack of Efficacy|2
1011552|NCT01502371|2031108|FG003|Overall Study|Lack of Efficacy|2
1011553|NCT01502371|2031109|FG004|Overall Study|Lack of Efficacy|4
1011554|NCT01502371|2031105|FG000|Overall Study|Physician Decision|3
1011555|NCT01502371|2031106|FG001|Overall Study|Physician Decision|0
1011556|NCT01502371|2031107|FG002|Overall Study|Physician Decision|0
1011557|NCT01502371|2031108|FG003|Overall Study|Physician Decision|0
1011558|NCT01502371|2031109|FG004|Overall Study|Physician Decision|1
1011559|NCT01502371|2031105|FG000|Overall Study|Noncompliance with Study Drug|0
1011560|NCT01502371|2031106|FG001|Overall Study|Noncompliance with Study Drug|0
1011561|NCT01502371|2031107|FG002|Overall Study|Noncompliance with Study Drug|1
1011562|NCT01502371|2031108|FG003|Overall Study|Noncompliance with Study Drug|2
1011563|NCT01502371|2031109|FG004|Overall Study|Noncompliance with Study Drug|1
1011564|NCT01502371|2031105|FG000|Overall Study|Technical Problems|1
1011565|NCT01502371|2031106|FG001|Overall Study|Technical Problems|0
1011566|NCT01502371|2031107|FG002|Overall Study|Technical Problems|2
1011567|NCT01502371|2031108|FG003|Overall Study|Technical Problems|4
1011568|NCT01502371|2031109|FG004|Overall Study|Technical Problems|1
1011569|NCT01502371|2031105|FG000|Overall Study|Protocol Violation|9
1011570|NCT01502371|2031106|FG001|Overall Study|Protocol Violation|5
1011571|NCT01502371|2031107|FG002|Overall Study|Protocol Violation|6
1011572|NCT01502371|2031108|FG003|Overall Study|Protocol Violation|5
1011573|NCT01502371|2031109|FG004|Overall Study|Protocol Violation|10
1011574|NCT01502371|2031105|FG000|Overall Study|Excluded Medication|0
1011575|NCT01502371|2031106|FG001|Overall Study|Excluded Medication|1
1011576|NCT01502371|2031107|FG002|Overall Study|Excluded Medication|1
1011577|NCT01502371|2031108|FG003|Overall Study|Excluded Medication|0
1011578|NCT01502371|2031109|FG004|Overall Study|Excluded Medication|1
1011579|NCT01502410|2031126|FG000|Overall Study|Adverse Event|1
1011580|NCT01502410|2031127|FG001|Overall Study|Adverse Event|2
1011581|NCT01502410|2031128|FG002|Overall Study|Adverse Event|0
1011582|NCT01502410|2031129|FG003|Overall Study|Adverse Event|0
1011583|NCT01502410|2031126|FG000|Overall Study|Lack of Efficacy|7
1011584|NCT01502410|2031127|FG001|Overall Study|Lack of Efficacy|7
1011585|NCT01502410|2031128|FG002|Overall Study|Lack of Efficacy|0
1011586|NCT01502410|2031129|FG003|Overall Study|Lack of Efficacy|0
1011587|NCT01502410|2031126|FG000|Overall Study|Physician Decision|0
1011588|NCT01502410|2031127|FG001|Overall Study|Physician Decision|1
1011589|NCT01502410|2031128|FG002|Overall Study|Physician Decision|0
1011590|NCT01502410|2031129|FG003|Overall Study|Physician Decision|0
1011591|NCT01502410|2031126|FG000|Overall Study|Withdrawal by Subject|2
1011592|NCT01502410|2031127|FG001|Overall Study|Withdrawal by Subject|0
1011593|NCT01502410|2031128|FG002|Overall Study|Withdrawal by Subject|0
1011594|NCT01502410|2031129|FG003|Overall Study|Withdrawal by Subject|0
1011595|NCT01502423|2031140|FG000|Overall Study|Withdrawal by Subject|0
1011596|NCT01502423|2031141|FG001|Overall Study|Withdrawal by Subject|1
1011597|NCT01502631|2031149|FG000|Overall Study|Adverse Event|5
1011598|NCT01502631|2031150|FG001|Overall Study|Adverse Event|8
1011599|NCT01502631|2031149|FG000|Overall Study|Lost to Follow-up|2
1011600|NCT01502631|2031150|FG001|Overall Study|Lost to Follow-up|2
1011601|NCT01502631|2031149|FG000|Overall Study|Participant withdrew consent|2
1011602|NCT01502631|2031150|FG001|Overall Study|Participant withdrew consent|4
1011603|NCT01502631|2031149|FG000|Overall Study|Participant non-compliant|1
1011604|NCT01502631|2031150|FG001|Overall Study|Participant non-compliant|0
1011605|NCT01502631|2031149|FG000|Overall Study|Investigator's decision|0
1011606|NCT01502631|2031150|FG001|Overall Study|Investigator's decision|1
1011607|NCT01502631|2031149|FG000|Overall Study|Other|10
1011608|NCT01502631|2031150|FG001|Overall Study|Other|5
1011609|NCT01502644|2031159|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
1011610|NCT01502644|2031160|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1011611|NCT01502644|2031161|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1011612|NCT01502644|2031162|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1011613|NCT01502644|2031159|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
1011614|NCT01502644|2031160|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1011615|NCT01502644|2031161|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1011616|NCT01502644|2031162|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1011617|NCT01502644|2031159|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
1011618|NCT01502644|2031160|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1011619|NCT01502644|2031161|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1011620|NCT01502644|2031162|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1011621|NCT01502644|2031159|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0
1011622|NCT01502644|2031160|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6
1011623|NCT01502644|2031161|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2
1011624|NCT01502644|2031162|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7
1011625|NCT01502644|2031159|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
1011626|NCT01502644|2031160|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
1011627|NCT01502644|2031161|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
1011628|NCT01502644|2031162|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
1011629|NCT01502709|2031172|FG000|Overall Study|Lost to Follow-up|4
1011630|NCT01502709|2031173|FG001|Overall Study|Lost to Follow-up|0
1011631|NCT01502956|2031214|FG000|Overall Study|Death|0
1011632|NCT01502956|2031215|FG001|Overall Study|Death|2
1011633|NCT01502956|2031214|FG000|Overall Study|Lost to Follow-up|14
1011634|NCT01502956|2031215|FG001|Overall Study|Lost to Follow-up|11
1011635|NCT01502956|2031214|FG000|Overall Study|Physician Decision|2
1011636|NCT01502956|2031215|FG001|Overall Study|Physician Decision|3
1011637|NCT01502956|2031214|FG000|Overall Study|Withdrawal by Subject|8
1011638|NCT01502956|2031215|FG001|Overall Study|Withdrawal by Subject|10
1011639|NCT01503021|2031223|FG000|Overall Study|Adverse Event|7
1011640|NCT01503021|2031224|FG001|Overall Study|Adverse Event|6
1011641|NCT01503021|2031223|FG000|Overall Study|Death|0
1011642|NCT01503021|2031224|FG001|Overall Study|Death|2
1011643|NCT01503021|2031223|FG000|Overall Study|Lost to Follow-up|2
1011644|NCT01503021|2031224|FG001|Overall Study|Lost to Follow-up|0
1011645|NCT01503021|2031223|FG000|Overall Study|Physician Decision|3
1011646|NCT01503021|2031224|FG001|Overall Study|Physician Decision|0
1011647|NCT01503021|2031223|FG000|Overall Study|Protocol Violation|1
1011648|NCT01503021|2031224|FG001|Overall Study|Protocol Violation|3
1011649|NCT01503021|2031223|FG000|Overall Study|Withdrawal by Subject|9
1011650|NCT01503021|2031224|FG001|Overall Study|Withdrawal by Subject|8
1011651|NCT01503021|2031223|FG000|Overall Study|Moved, received transplant, etc.|5
1011652|NCT01503021|2031224|FG001|Overall Study|Moved, received transplant, etc.|7
1011653|NCT01503164|2031237|FG000|Overall Study|Withdrawal by Subject|2
1011654|NCT01503164|2031238|FG001|Overall Study|Withdrawal by Subject|1
1011655|NCT01503229|2031244|FG000|Overall Study|Withdrew consent|1
1011668|NCT01504204|2031289|FG000|Overall Study|Lost to Follow-up|1
1011669|NCT01504204|2031290|FG001|Overall Study|Lost to Follow-up|1
1011670|NCT01504412|2031301|FG000|Overall Study|Adverse Event|1
1011671|NCT01504412|2031302|FG001|Overall Study|Adverse Event|8
1011672|NCT01504412|2031303|FG002|Overall Study|Adverse Event|1
1011673|NCT01504412|2031304|FG003|Overall Study|Adverse Event|7
1011674|NCT01504412|2031305|FG004|Overall Study|Adverse Event|10
1011675|NCT01504412|2031301|FG000|Overall Study|Withdrawal by Subject|2
1011676|NCT01504412|2031302|FG001|Overall Study|Withdrawal by Subject|1
1011677|NCT01504412|2031303|FG002|Overall Study|Withdrawal by Subject|1
1011678|NCT01504412|2031304|FG003|Overall Study|Withdrawal by Subject|5
1011679|NCT01504412|2031305|FG004|Overall Study|Withdrawal by Subject|1
1011680|NCT01504412|2031301|FG000|Overall Study|Other|2
1011681|NCT01504412|2031302|FG001|Overall Study|Other|1
1011682|NCT01504412|2031303|FG002|Overall Study|Other|1
1011683|NCT01504412|2031304|FG003|Overall Study|Other|6
1011684|NCT01504412|2031305|FG004|Overall Study|Other|1
1011685|NCT01504412|2031301|FG000|Overall Study|Lost to Follow-up|0
1011686|NCT01504412|2031302|FG001|Overall Study|Lost to Follow-up|2
1011687|NCT01504412|2031303|FG002|Overall Study|Lost to Follow-up|0
1011688|NCT01504412|2031304|FG003|Overall Study|Lost to Follow-up|0
1011689|NCT01504412|2031305|FG004|Overall Study|Lost to Follow-up|0
1011690|NCT01504412|2031301|FG000|Overall Study|Lack of Efficacy|0
1011691|NCT01504412|2031302|FG001|Overall Study|Lack of Efficacy|0
1011692|NCT01504412|2031303|FG002|Overall Study|Lack of Efficacy|1
1011693|NCT01504412|2031304|FG003|Overall Study|Lack of Efficacy|0
1011694|NCT01504412|2031305|FG004|Overall Study|Lack of Efficacy|1
1011695|NCT01504412|2031301|FG000|Overall Study|Death|0
1011696|NCT01504412|2031302|FG001|Overall Study|Death|0
1011697|NCT01504412|2031303|FG002|Overall Study|Death|0
1011698|NCT01504412|2031304|FG003|Overall Study|Death|1
1011699|NCT01504412|2031305|FG004|Overall Study|Death|0
1011700|NCT01504841|2031349|FG000|Overall Study|Withdrawal by Subject|1
1011701|NCT01504841|2031350|FG001|Overall Study|Withdrawal by Subject|1
1011702|NCT01504841|2031351|FG002|Overall Study|Withdrawal by Subject|0
1011703|NCT01504867|2031369|FG000|Overall Study|Inclusion criteria not met|2
1011704|NCT01504867|2031370|FG001|Overall Study|Inclusion criteria not met|2
1011705|NCT01504867|2031369|FG000|Overall Study|Consent revoked|5
1011706|NCT01504867|2031370|FG001|Overall Study|Consent revoked|1
1011707|NCT01504971|2031389|FG000|Overall Study|Physician Decision|13
1011708|NCT01505010|2031403|FG000|Overall Study|Protocol Violation|0
1011709|NCT01505010|2031404|FG001|Overall Study|Protocol Violation|1
1011710|NCT01505010|2031403|FG000|Overall Study|Lost to Follow-up|0
1011711|NCT01505010|2031404|FG001|Overall Study|Lost to Follow-up|1
1011712|NCT01505114|2031427|FG000|Overall Study|Withdrawal by Subject|5
1011713|NCT01505114|2031428|FG001|Overall Study|Withdrawal by Subject|4
1011714|NCT01505114|2031429|FG002|Overall Study|Withdrawal by Subject|4
1011715|NCT01505114|2031430|FG003|Overall Study|Withdrawal by Subject|7
1011716|NCT01505114|2031427|FG000|Overall Study|Death|1
1011717|NCT01505114|2031428|FG001|Overall Study|Death|0
1011718|NCT01505114|2031429|FG002|Overall Study|Death|0
1011719|NCT01505114|2031430|FG003|Overall Study|Death|1
1011720|NCT01505114|2031427|FG000|Overall Study|unable to adhere to visit schedule|3
1011721|NCT01505114|2031428|FG001|Overall Study|unable to adhere to visit schedule|2
1011722|NCT01505114|2031429|FG002|Overall Study|unable to adhere to visit schedule|3
1011723|NCT01505114|2031430|FG003|Overall Study|unable to adhere to visit schedule|3
1011724|NCT01505114|2031427|FG000|Overall Study|Lost to Follow-up|11
1011725|NCT01505114|2031428|FG001|Overall Study|Lost to Follow-up|5
1011726|NCT01505114|2031429|FG002|Overall Study|Lost to Follow-up|8
1011727|NCT01505114|2031430|FG003|Overall Study|Lost to Follow-up|7
1011728|NCT01505114|2031427|FG000|Overall Study|relocated|4
1011729|NCT01505114|2031428|FG001|Overall Study|relocated|2
1011730|NCT01505114|2031429|FG002|Overall Study|relocated|2
1011731|NCT01505114|2031430|FG003|Overall Study|relocated|3
1011732|NCT01505114|2031427|FG000|Overall Study|inadvertent enrollment due to peanut all|0
1011733|NCT01505114|2031428|FG001|Overall Study|inadvertent enrollment due to peanut all|0
1011734|NCT01505114|2031429|FG002|Overall Study|inadvertent enrollment due to peanut all|0
1011735|NCT01505114|2031430|FG003|Overall Study|inadvertent enrollment due to peanut all|1
1011736|NCT01505114|2031427|FG000|Overall Study|staff safety concerns|0
1011737|NCT01505114|2031428|FG001|Overall Study|staff safety concerns|0
1011738|NCT01505114|2031429|FG002|Overall Study|staff safety concerns|0
1011739|NCT01505114|2031430|FG003|Overall Study|staff safety concerns|1
1011740|NCT01505114|2031427|FG000|Overall Study|investigator decision|1
1011741|NCT01505114|2031428|FG001|Overall Study|investigator decision|0
1011742|NCT01505114|2031429|FG002|Overall Study|investigator decision|1
1011743|NCT01505114|2031430|FG003|Overall Study|investigator decision|0
1011744|NCT01505374|2031464|FG000|Overall Study|Lost to Follow-up|1
1011745|NCT01505374|2031465|FG001|Overall Study|Lost to Follow-up|0
1011746|NCT01505387|2031474|FG000|Overall Study|Protocol Violation|1
1011747|NCT01505387|2031475|FG001|Overall Study|Protocol Violation|0
1011748|NCT01505387|2031474|FG000|Overall Study|Withdrawal by Subject|1
1011749|NCT01505387|2031475|FG001|Overall Study|Withdrawal by Subject|1
1011750|NCT01505491|2031493|FG000|Overall Study|Other reason not listed|1
1011751|NCT01505491|2031494|FG001|Overall Study|Other reason not listed|0
1011752|NCT01505491|2031495|FG002|Overall Study|Other reason not listed|0
1011753|NCT01505491|2031493|FG000|Overall Study|Withdrawal by Subject|1
1011754|NCT01505491|2031494|FG001|Overall Study|Withdrawal by Subject|1
1011755|NCT01505491|2031495|FG002|Overall Study|Withdrawal by Subject|4
1011756|NCT01505491|2031493|FG000|Overall Study|Lost to Follow-up|0
1011757|NCT01505491|2031494|FG001|Overall Study|Lost to Follow-up|0
1011758|NCT01505491|2031495|FG002|Overall Study|Lost to Follow-up|1
1011759|NCT01505530|2031506|FG000|Overall Study|Progressive Disease|19
1011760|NCT01505530|2031507|FG001|Overall Study|Progressive Disease|17
1011761|NCT01505530|2031508|FG002|Overall Study|Progressive Disease|18
1011762|NCT01505530|2031506|FG000|Overall Study|Adverse Event|1
1011763|NCT01505530|2031507|FG001|Overall Study|Adverse Event|1
1011764|NCT01505530|2031508|FG002|Overall Study|Adverse Event|0
1011765|NCT01505530|2031506|FG000|Overall Study|Withdrawal by Subject|7
1011766|NCT01505530|2031507|FG001|Overall Study|Withdrawal by Subject|8
1011767|NCT01505530|2031508|FG002|Overall Study|Withdrawal by Subject|6
1011768|NCT01505530|2031506|FG000|Overall Study|Physician Decision|6
1011769|NCT01505530|2031507|FG001|Overall Study|Physician Decision|2
1011770|NCT01505530|2031508|FG002|Overall Study|Physician Decision|5
1011771|NCT01505530|2031506|FG000|Overall Study|Sponsor Decision|1
1011772|NCT01505530|2031507|FG001|Overall Study|Sponsor Decision|8
1011773|NCT01505530|2031508|FG002|Overall Study|Sponsor Decision|7
1011774|NCT01505530|2031506|FG000|Overall Study|Death|7
1011775|NCT01505530|2031507|FG001|Overall Study|Death|6
1011776|NCT01505530|2031508|FG002|Overall Study|Death|5
1011777|NCT01505530|2031506|FG000|Overall Study|entry criteria not met|0
1011778|NCT01505530|2031507|FG001|Overall Study|entry criteria not met|1
1011779|NCT01505530|2031508|FG002|Overall Study|entry criteria not met|0
1011780|NCT01505608|2031518|FG000|Phase I|Lack of Efficacy|0
1011781|NCT01505608|2031519|FG001|Phase I|Lack of Efficacy|4
1011782|NCT01505608|2031518|FG000|Phase I|Adverse Event|0
1011783|NCT01505608|2031519|FG001|Phase I|Adverse Event|1
1011784|NCT01505608|2031518|FG000|Phase I|Withdrawal by Subject|0
1011785|NCT01505608|2031519|FG001|Phase I|Withdrawal by Subject|1
1011786|NCT01505608|2031518|FG000|Phase II|Lack of Efficacy|2
1011787|NCT01505608|2031519|FG001|Phase II|Lack of Efficacy|1
1011788|NCT01505608|2031518|FG000|Phase II|Protocol Violation|0
1011789|NCT01505608|2031519|FG001|Phase II|Protocol Violation|1
1011790|NCT01505634|2031531|FG000|Overall Study|Withdrawal by Subject|2
1011791|NCT01505634|2031532|FG001|Overall Study|Withdrawal by Subject|5
1011792|NCT01505634|2031533|FG002|Overall Study|Withdrawal by Subject|1
1011793|NCT01505634|2031531|FG000|Overall Study|Physician Decision|1
1011794|NCT01505634|2031532|FG001|Overall Study|Physician Decision|1
1011795|NCT01505634|2031533|FG002|Overall Study|Physician Decision|0
1011796|NCT01505634|2031531|FG000|Overall Study|Adverse Event|1
1011797|NCT01505634|2031532|FG001|Overall Study|Adverse Event|0
1011798|NCT01505634|2031533|FG002|Overall Study|Adverse Event|0
1011799|NCT01505634|2031531|FG000|Overall Study|Insufficient supply of drug at site|1
1011800|NCT01505634|2031532|FG001|Overall Study|Insufficient supply of drug at site|0
1011801|NCT01505634|2031533|FG002|Overall Study|Insufficient supply of drug at site|0
1011802|NCT01505634|2031531|FG000|Overall Study|Protocol Violation|2
1011803|NCT01505634|2031532|FG001|Overall Study|Protocol Violation|0
1011804|NCT01505634|2031533|FG002|Overall Study|Protocol Violation|0
1011805|NCT01505634|2031531|FG000|Overall Study|Lost to Follow-up|1
1011806|NCT01505634|2031532|FG001|Overall Study|Lost to Follow-up|4
1011807|NCT01505634|2031533|FG002|Overall Study|Lost to Follow-up|4
1011808|NCT01505634|2031531|FG000|Overall Study|Death|1
1011809|NCT01505634|2031532|FG001|Overall Study|Death|0
1011810|NCT01505634|2031533|FG002|Overall Study|Death|0
1011811|NCT01505634|2031531|FG000|Overall Study|In a conflict zone|0
1011812|NCT01505634|2031532|FG001|Overall Study|In a conflict zone|0
1011813|NCT01505634|2031533|FG002|Overall Study|In a conflict zone|1
1011814|NCT01505647|2031543|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
1011815|NCT01505647|2031544|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
1011816|NCT01505647|2031543|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1
1011817|NCT01505647|2031544|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0
1011818|NCT01505647|2031543|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
1011819|NCT01505647|2031544|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
1011820|NCT01505647|2031543|FG000|Day 43 Through Day 182 Follow-up|Death|0
1011821|NCT01505647|2031544|FG001|Day 43 Through Day 182 Follow-up|Death|1
1011822|NCT01505647|2031543|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
1011823|NCT01505647|2031544|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
1011824|NCT01505868|2031574|FG000|Overall Study|Withdrawal by Subject|1
1011825|NCT01505868|2031575|FG001|Overall Study|Withdrawal by Subject|0
1011826|NCT01505868|2031576|FG002|Overall Study|Withdrawal by Subject|0
1011827|NCT01505868|2031577|FG003|Overall Study|Withdrawal by Subject|0
1011828|NCT01505868|2031578|FG004|Overall Study|Withdrawal by Subject|0
1011829|NCT01505881|2031592|FG000|Overall Study|Adverse Event|0
1011830|NCT01505881|2031593|FG001|Overall Study|Adverse Event|1
1011831|NCT01505881|2031592|FG000|Overall Study|Lost to Follow-up|2
1011832|NCT01505881|2031593|FG001|Overall Study|Lost to Follow-up|0
1011833|NCT01505881|2031592|FG000|Overall Study|Withdrawal by Subject|2
1011834|NCT01505881|2031593|FG001|Overall Study|Withdrawal by Subject|0
1011835|NCT01506193|2031612|FG000|Overall Study|Protocol Violation|1
1011836|NCT01506193|2031613|FG001|Overall Study|Protocol Violation|0
1011837|NCT01506193|2031614|FG002|Overall Study|Protocol Violation|1
1011838|NCT01506193|2031612|FG000|Overall Study|Migrated/moved from study area|0
1011839|NCT01506193|2031613|FG001|Overall Study|Migrated/moved from study area|0
1011840|NCT01506193|2031614|FG002|Overall Study|Migrated/moved from study area|1
1011841|NCT01506193|2031612|FG000|Overall Study|Adverse event, non-fatal|0
1011842|NCT01506193|2031613|FG001|Overall Study|Adverse event, non-fatal|0
1011843|NCT01506193|2031614|FG002|Overall Study|Adverse event, non-fatal|1
1011844|NCT01506193|2031612|FG000|Overall Study|Withdrawal by Subject|5
1011845|NCT01506193|2031613|FG001|Overall Study|Withdrawal by Subject|1
1011846|NCT01506193|2031614|FG002|Overall Study|Withdrawal by Subject|8
1011847|NCT01506193|2031612|FG000|Overall Study|Lost to Follow-up|8
1011848|NCT01506193|2031613|FG001|Overall Study|Lost to Follow-up|3
1011849|NCT01506193|2031614|FG002|Overall Study|Lost to Follow-up|3
1011850|NCT01506271|2031626|FG000|Overall Study|Progressive disease|0
1011851|NCT01506271|2031627|FG001|Overall Study|Progressive disease|1
1011852|NCT01506271|2031628|FG002|Overall Study|Progressive disease|0
1011853|NCT01506271|2031626|FG000|Overall Study|Protocol Violation|3
1011854|NCT01506271|2031627|FG001|Overall Study|Protocol Violation|1
1011855|NCT01506271|2031628|FG002|Overall Study|Protocol Violation|0
1011856|NCT01506271|2031626|FG000|Overall Study|Death|0
1011857|NCT01506271|2031627|FG001|Overall Study|Death|1
1011858|NCT01506271|2031628|FG002|Overall Study|Death|0
1011859|NCT01506271|2031626|FG000|Overall Study|Adverse Event|0
1011860|NCT01506271|2031627|FG001|Overall Study|Adverse Event|2
1011861|NCT01506271|2031628|FG002|Overall Study|Adverse Event|0
1011862|NCT01506271|2031626|FG000|Overall Study|Insufficient supply of study drug|1
1011863|NCT01506271|2031627|FG001|Overall Study|Insufficient supply of study drug|0
1011864|NCT01506271|2031628|FG002|Overall Study|Insufficient supply of study drug|0
1011865|NCT01506271|2031626|FG000|Overall Study|Withdrawal by Subject|0
1011866|NCT01506271|2031627|FG001|Overall Study|Withdrawal by Subject|1
1011867|NCT01506271|2031628|FG002|Overall Study|Withdrawal by Subject|1
1011868|NCT01506271|2031626|FG000|Overall Study|Lost to Follow-up|0
1011869|NCT01506271|2031627|FG001|Overall Study|Lost to Follow-up|1
1011870|NCT01506271|2031628|FG002|Overall Study|Lost to Follow-up|2
1011871|NCT01506323|2031638|FG000|Overall Study|Lost to Follow-up|5
1011872|NCT01506323|2031639|FG001|Overall Study|Lost to Follow-up|4
1011873|NCT01506323|2031638|FG000|Overall Study|Withdrawal by Subject|4
1011874|NCT01506323|2031639|FG001|Overall Study|Withdrawal by Subject|4
1011875|NCT01506323|2031638|FG000|Overall Study|Lack of Efficacy|1
1011876|NCT01506323|2031639|FG001|Overall Study|Lack of Efficacy|3
1011877|NCT01506323|2031638|FG000|Overall Study|Moved out of area|5
1011878|NCT01506323|2031639|FG001|Overall Study|Moved out of area|2
1011879|NCT01506323|2031638|FG000|Overall Study|Schedule or Transportation conflict|8
1011880|NCT01506323|2031639|FG001|Overall Study|Schedule or Transportation conflict|0
1011881|NCT01506323|2031638|FG000|Overall Study|Started another treatment|1
1011882|NCT01506323|2031639|FG001|Overall Study|Started another treatment|0
1011883|NCT01506453|2031656|FG000|Overall Study|Withdrawal prior to treatment|0
1011884|NCT01506453|2031657|FG001|Overall Study|Withdrawal prior to treatment|2
1011885|NCT01506479|2031666|FG000|Overall Study|Lost to Follow-up|1
1011886|NCT01506479|2031667|FG001|Overall Study|Lost to Follow-up|2
1011887|NCT01506479|2031668|FG002|Overall Study|Lost to Follow-up|2
1011888|NCT01506479|2031666|FG000|Overall Study|Withdrawal by Subject|1
1011889|NCT01506479|2031667|FG001|Overall Study|Withdrawal by Subject|2
1011890|NCT01506479|2031668|FG002|Overall Study|Withdrawal by Subject|1
1011891|NCT01506479|2031666|FG000|Overall Study|Missing assessment|1
1011892|NCT01506479|2031667|FG001|Overall Study|Missing assessment|0
1011893|NCT01506479|2031668|FG002|Overall Study|Missing assessment|0
1011894|NCT01506479|2031666|FG000|Overall Study|Adverse Event|0
1011895|NCT01506479|2031667|FG001|Overall Study|Adverse Event|1
1011896|NCT01506479|2031668|FG002|Overall Study|Adverse Event|0
1011897|NCT01506596|2031678|FG000|Overall Study|ineligible pathology|1
1011898|NCT01506609|2031688|FG000|Overall Study|Adverse Event Related to Progression|0
1011899|NCT01506609|2031689|FG001|Overall Study|Adverse Event Related to Progression|0
1011900|NCT01506609|2031690|FG002|Overall Study|Adverse Event Related to Progression|0
1011901|NCT01506609|2031691|FG003|Overall Study|Adverse Event Related to Progression|3
1011902|NCT01506609|2031692|FG004|Overall Study|Adverse Event Related to Progression|7
1011903|NCT01506609|2031693|FG005|Overall Study|Adverse Event Related to Progression|3
1011904|NCT01506609|2031688|FG000|Overall Study|Adverse Event Not Related to Progression|0
1011905|NCT01506609|2031689|FG001|Overall Study|Adverse Event Not Related to Progression|1
1011906|NCT01506609|2031690|FG002|Overall Study|Adverse Event Not Related to Progression|0
1011907|NCT01506609|2031691|FG003|Overall Study|Adverse Event Not Related to Progression|6
1011908|NCT01506609|2031692|FG004|Overall Study|Adverse Event Not Related to Progression|10
1011909|NCT01506609|2031693|FG005|Overall Study|Adverse Event Not Related to Progression|5
1011910|NCT01506609|2031688|FG000|Overall Study|Withdrawal by Subject|0
1011911|NCT01506609|2031689|FG001|Overall Study|Withdrawal by Subject|0
1011912|NCT01506609|2031690|FG002|Overall Study|Withdrawal by Subject|0
1011913|NCT01506609|2031691|FG003|Overall Study|Withdrawal by Subject|9
1011914|NCT01506609|2031692|FG004|Overall Study|Withdrawal by Subject|7
1011915|NCT01506609|2031693|FG005|Overall Study|Withdrawal by Subject|7
1011916|NCT01506609|2031688|FG000|Overall Study|Lost to Follow-up|0
1011917|NCT01506609|2031689|FG001|Overall Study|Lost to Follow-up|0
1011918|NCT01506609|2031690|FG002|Overall Study|Lost to Follow-up|0
1011919|NCT01506609|2031691|FG003|Overall Study|Lost to Follow-up|1
1011920|NCT01506609|2031692|FG004|Overall Study|Lost to Follow-up|2
1011921|NCT01506609|2031693|FG005|Overall Study|Lost to Follow-up|0
1011922|NCT01506609|2031688|FG000|Overall Study|Sponsor Discontinued Study|0
1011923|NCT01506609|2031689|FG001|Overall Study|Sponsor Discontinued Study|0
1011924|NCT01506609|2031690|FG002|Overall Study|Sponsor Discontinued Study|0
1011925|NCT01506609|2031691|FG003|Overall Study|Sponsor Discontinued Study|2
1011926|NCT01506609|2031692|FG004|Overall Study|Sponsor Discontinued Study|2
1011927|NCT01506609|2031693|FG005|Overall Study|Sponsor Discontinued Study|0
1011928|NCT01506609|2031688|FG000|Overall Study|Progressive Disease per Protocol|1
1011929|NCT01506609|2031689|FG001|Overall Study|Progressive Disease per Protocol|0
1011930|NCT01506609|2031690|FG002|Overall Study|Progressive Disease per Protocol|0
1011931|NCT01506609|2031691|FG003|Overall Study|Progressive Disease per Protocol|64
1011932|NCT01506609|2031692|FG004|Overall Study|Progressive Disease per Protocol|57
1011933|NCT01506609|2031693|FG005|Overall Study|Progressive Disease per Protocol|74
1011934|NCT01506609|2031688|FG000|Overall Study|Other, Not Specified|0
1011935|NCT01506609|2031689|FG001|Overall Study|Other, Not Specified|0
1011936|NCT01506609|2031690|FG002|Overall Study|Other, Not Specified|0
1011937|NCT01506609|2031691|FG003|Overall Study|Other, Not Specified|10
1011938|NCT01506609|2031692|FG004|Overall Study|Other, Not Specified|7
1011939|NCT01506609|2031693|FG005|Overall Study|Other, Not Specified|3
1011940|NCT01506609|2031688|FG000|Overall Study|Missing / Unknown Reason|1
1011941|NCT01506609|2031689|FG001|Overall Study|Missing / Unknown Reason|0
1011942|NCT01506609|2031690|FG002|Overall Study|Missing / Unknown Reason|1
1011943|NCT01506609|2031691|FG003|Overall Study|Missing / Unknown Reason|4
1011944|NCT01506609|2031692|FG004|Overall Study|Missing / Unknown Reason|4
1011945|NCT01506609|2031693|FG005|Overall Study|Missing / Unknown Reason|2
1011946|NCT01506726|2031706|FG000|Overall Study|Adverse Event|1
1011947|NCT01506726|2031707|FG001|Overall Study|Adverse Event|2
1011948|NCT01506882|2031715|FG000|Overall Study|Lack of Efficacy|4
1011949|NCT01506882|2031716|FG001|Overall Study|Lack of Efficacy|3
1011950|NCT01506882|2031715|FG000|Overall Study|Lost to Follow-up|1
1011951|NCT01506882|2031716|FG001|Overall Study|Lost to Follow-up|0
1011952|NCT01506882|2031715|FG000|Overall Study|Withdrawal by Subject|9
1011953|NCT01506882|2031716|FG001|Overall Study|Withdrawal by Subject|3
1011954|NCT01506882|2031715|FG000|Overall Study|SAE, non-fatal|2
1011955|NCT01506882|2031716|FG001|Overall Study|SAE, non-fatal|0
1011956|NCT01506882|2031715|FG000|Overall Study|AE, non-serious non-fatal|3
1011957|NCT01506882|2031716|FG001|Overall Study|AE, non-serious non-fatal|1
1011958|NCT01506882|2031715|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
1011959|NCT01506882|2031716|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1011960|NCT01506882|2031715|FG000|Overall Study|Other Reason|2
1011961|NCT01506882|2031716|FG001|Overall Study|Other Reason|0
1011962|NCT01506908|2031726|FG000|Overall Study|Adverse Event|1
1011963|NCT01506908|2031727|FG001|Overall Study|Adverse Event|0
1011964|NCT01506947|2031735|FG000|Overall Study|Lost to Follow-up|7
1011965|NCT01506947|2031735|FG000|Overall Study|Adverse Event|5
1011966|NCT01506947|2031735|FG000|Overall Study|Death|1
1011967|NCT01506947|2031735|FG000|Overall Study|Did Not Meet Eligibility Criteria|3
1011968|NCT01506960|2031741|FG000|Overall Study|Did not meet angiographic criteria|47
1011969|NCT01507051|2031751|FG000|Overall Study|Withdrawal by Subject|1
1011970|NCT01507051|2031752|FG001|Overall Study|Withdrawal by Subject|3
1011971|NCT01507051|2031753|FG002|Overall Study|Withdrawal by Subject|1
1011972|NCT01507051|2031754|FG003|Overall Study|Withdrawal by Subject|6
1011973|NCT01507051|2031751|FG000|Overall Study|Physician Decision|0
1011974|NCT01507051|2031752|FG001|Overall Study|Physician Decision|0
1011975|NCT01507051|2031753|FG002|Overall Study|Physician Decision|0
1011976|NCT01507051|2031754|FG003|Overall Study|Physician Decision|1
1011977|NCT01507051|2031751|FG000|Overall Study|Adverse Event|1
1011978|NCT01507051|2031752|FG001|Overall Study|Adverse Event|0
1011979|NCT01507051|2031753|FG002|Overall Study|Adverse Event|0
1011980|NCT01507051|2031754|FG003|Overall Study|Adverse Event|0
1011981|NCT01507090|2031764|FG000|Overall Study|incomplete dataset|18
1011982|NCT01507246|2031812|FG000|Overall Study|Required different surgical procedures|2
1011983|NCT01507246|2031813|FG001|Overall Study|Required different surgical procedures|1
1011984|NCT01507298|2031824|FG000|Overall Study|Protocol Violation|0
1011985|NCT01507298|2031825|FG001|Overall Study|Protocol Violation|6
1011986|NCT01507662|2031847|FG000|Overall Study|Death|26
1011987|NCT01507662|2031848|FG001|Overall Study|Death|18
1011988|NCT01507662|2031847|FG000|Overall Study|Withdrawal by Subject|290
1011989|NCT01507662|2031848|FG001|Overall Study|Withdrawal by Subject|287
1011990|NCT01507662|2031847|FG000|Overall Study|Lost to Follow-up|498
1011991|NCT01507662|2031848|FG001|Overall Study|Lost to Follow-up|523
1011992|NCT01507662|2031847|FG000|Overall Study|Proxy interview done|2
1011993|NCT01507662|2031848|FG001|Overall Study|Proxy interview done|3
1011994|NCT01507831|2031876|FG000|Overall Study|Randomized but not treated|0
1011995|NCT01507831|2031877|FG001|Overall Study|Randomized but not treated|3
1011996|NCT01507831|2031876|FG000|Overall Study|Adverse Event|48
1011997|NCT01507831|2031877|FG001|Overall Study|Adverse Event|113
1011998|NCT01507831|2031876|FG000|Overall Study|Death|6
1011999|NCT01507831|2031877|FG001|Overall Study|Death|2
1012000|NCT01507831|2031876|FG000|Overall Study|Poor compliance to protocol|38
1012001|NCT01507831|2031877|FG001|Overall Study|Poor compliance to protocol|60
1012002|NCT01507831|2031876|FG000|Overall Study|Physician Decision|0
1012003|NCT01507831|2031877|FG001|Overall Study|Physician Decision|4
1012004|NCT01507831|2031876|FG000|Overall Study|Participant moved|5
1012005|NCT01507831|2031877|FG001|Overall Study|Participant moved|19
1012006|NCT01507831|2031876|FG000|Overall Study|Consent withdrawn by participant|34
1012007|NCT01507831|2031877|FG001|Overall Study|Consent withdrawn by participant|72
1012008|NCT01507831|2031876|FG000|Overall Study|Related to study drug administration|5
1012009|NCT01507831|2031877|FG001|Overall Study|Related to study drug administration|14
1012010|NCT01507831|2031876|FG000|Overall Study|Last visit outside protocol visit window|51
1012011|NCT01507831|2031877|FG001|Overall Study|Last visit outside protocol visit window|143
1012012|NCT01507831|2031876|FG000|Overall Study|Selection criteria finally not met|0
1012013|NCT01507831|2031877|FG001|Overall Study|Selection criteria finally not met|1
1012014|NCT01507831|2031876|FG000|Overall Study|Site closure|0
1012015|NCT01507831|2031877|FG001|Overall Study|Site closure|3
1012016|NCT01507831|2031876|FG000|Overall Study|Potential lost to follow-up|3
1012017|NCT01507831|2031877|FG001|Overall Study|Potential lost to follow-up|0
1012018|NCT01507831|2031876|FG000|Overall Study|Other|3
1012019|NCT01507831|2031877|FG001|Overall Study|Other|6
1012020|NCT01507896|2031883|FG000|Overall Study|Withdrawal by Subject|1
1012021|NCT01507896|2031883|FG000|Overall Study|The surgery was denied by the sponsor.|1
1012022|NCT01508130|2031950|FG000|Overall Study|Adverse Event|81
1012023|NCT01508130|2031951|FG001|Overall Study|Adverse Event|28
1012024|NCT01508130|2031950|FG000|Overall Study|Death|3
1012025|NCT01508130|2031951|FG001|Overall Study|Death|1
1012026|NCT01508130|2031950|FG000|Overall Study|Protocol Violation|2
1012027|NCT01508130|2031951|FG001|Overall Study|Protocol Violation|0
1012028|NCT01508130|2031950|FG000|Overall Study|Lost to Follow-up|25
1012029|NCT01508130|2031951|FG001|Overall Study|Lost to Follow-up|2
1012030|NCT01508130|2031950|FG000|Overall Study|Withdrawal by Subject|3
1012031|NCT01508130|2031951|FG001|Overall Study|Withdrawal by Subject|3
1012032|NCT01508130|2031950|FG000|Overall Study|Subject's substantial non-compliance|25
1012033|NCT01508130|2031951|FG001|Overall Study|Subject's substantial non-compliance|9
1012034|NCT01508130|2031950|FG000|Overall Study|Insufficient therapeutic response|74
1012035|NCT01508130|2031951|FG001|Overall Study|Insufficient therapeutic response|23
1012036|NCT01508130|2031950|FG000|Overall Study|Administrative|14
1012037|NCT01508130|2031951|FG001|Overall Study|Administrative|3
1012038|NCT01508169|2031961|FG000|Overall Study|Adverse Event|1
1012039|NCT01508169|2031962|FG001|Overall Study|Adverse Event|0
1012040|NCT01508169|2031961|FG000|Overall Study|Withdrawal by Subject|1
1012041|NCT01508169|2031962|FG001|Overall Study|Withdrawal by Subject|0
1012042|NCT01508169|2031961|FG000|Overall Study|Lost to Follow-up|1
1012043|NCT01508169|2031962|FG001|Overall Study|Lost to Follow-up|2
1012044|NCT01508325|2031976|FG000|Overall Study|Withdrawal by Subject|8
1012045|NCT01508325|2031977|FG001|Overall Study|Withdrawal by Subject|9
1012046|NCT01508325|2031976|FG000|Overall Study|Protocol Violation|0
1012047|NCT01508325|2031977|FG001|Overall Study|Protocol Violation|3
1012048|NCT01508325|2031976|FG000|Overall Study|Physician Decision|2
1012049|NCT01508325|2031977|FG001|Overall Study|Physician Decision|1
1012050|NCT01508325|2031976|FG000|Overall Study|Adverse Event|1
1012051|NCT01508325|2031977|FG001|Overall Study|Adverse Event|0
1012052|NCT01508325|2031976|FG000|Overall Study|Lost to Follow-up|5
1012053|NCT01508325|2031977|FG001|Overall Study|Lost to Follow-up|6
1012054|NCT01508325|2031976|FG000|Overall Study|Other|2
1012055|NCT01508325|2031977|FG001|Overall Study|Other|2
1012056|NCT01508650|2031989|FG000|Overall Study|Lost to Follow-up|0
1012057|NCT01508650|2031990|FG001|Overall Study|Lost to Follow-up|3
1012058|NCT01508676|2031998|FG000|Phase I (2 Weeks)|Medication Exclusion|1
1012059|NCT01508676|2031999|FG001|Phase I (2 Weeks)|Medication Exclusion|1
1012060|NCT01508676|2031998|FG000|Phase I (2 Weeks)|Wrong Pain Type|1
1012061|NCT01508676|2031999|FG001|Phase I (2 Weeks)|Wrong Pain Type|0
1012062|NCT01508676|2031998|FG000|Phase I (2 Weeks)|Positive Drug Screen|0
1012063|NCT01508676|2031999|FG001|Phase I (2 Weeks)|Positive Drug Screen|2
1012064|NCT01508676|2031998|FG000|Phase II (2 Weeks)|Skin Sensitivity|0
1012065|NCT01508676|2031999|FG001|Phase II (2 Weeks)|Skin Sensitivity|1
1012066|NCT01508676|2031998|FG000|Phase II (2 Weeks)|Medication Exclusion|1
1012067|NCT01508676|2031999|FG001|Phase II (2 Weeks)|Medication Exclusion|0
1012068|NCT01508702|2032008|FG000|Overall Study|Adverse Event|7
1012069|NCT01508702|2032009|FG001|Overall Study|Adverse Event|3
1012070|NCT01508702|2032008|FG000|Overall Study|Gout flare|2
1012071|NCT01508702|2032009|FG001|Overall Study|Gout flare|0
1012072|NCT01508702|2032008|FG000|Overall Study|Protocol Violation|2
1012073|NCT01508702|2032009|FG001|Overall Study|Protocol Violation|1
1012074|NCT01508702|2032008|FG000|Overall Study|Lost to Follow-up|1
1012075|NCT01508702|2032009|FG001|Overall Study|Lost to Follow-up|2
1012076|NCT01508702|2032008|FG000|Overall Study|Withdrawal by Subject|11
1012077|NCT01508702|2032009|FG001|Overall Study|Withdrawal by Subject|7
1012078|NCT01508910|2032027|FG000|Treatment|Death|2
1012079|NCT01508910|2032028|FG001|Treatment|Death|3
1012080|NCT01508910|2032029|FG002|Treatment|Death|2
1012081|NCT01508910|2032030|FG003|Treatment|Death|0
1012082|NCT01508910|2032027|FG000|Treatment|Lost to Follow-up|0
1012083|NCT01508910|2032028|FG001|Treatment|Lost to Follow-up|0
1012084|NCT01508910|2032029|FG002|Treatment|Lost to Follow-up|2
1012085|NCT01508910|2032030|FG003|Treatment|Lost to Follow-up|1
1012086|NCT01508910|2032027|FG000|Treatment|Withdrawal by Subject|0
1012087|NCT01508910|2032028|FG001|Treatment|Withdrawal by Subject|1
1012088|NCT01508910|2032029|FG002|Treatment|Withdrawal by Subject|6
1012089|NCT01508910|2032030|FG003|Treatment|Withdrawal by Subject|1
1012090|NCT01508910|2032027|FG000|Treatment|Sponsor Decision|0
1012091|NCT01508910|2032028|FG001|Treatment|Sponsor Decision|0
1012092|NCT01508910|2032029|FG002|Treatment|Sponsor Decision|0
1012093|NCT01508910|2032030|FG003|Treatment|Sponsor Decision|1
1012094|NCT01508936|2032044|FG000|Overall Study|Adverse Event|11
1012095|NCT01508936|2032045|FG001|Overall Study|Adverse Event|32
1012096|NCT01508936|2032044|FG000|Overall Study|Lack of Efficacy|0
1012097|NCT01508936|2032045|FG001|Overall Study|Lack of Efficacy|1
1012098|NCT01508936|2032044|FG000|Overall Study|Withdrawal by Subject|4
1012099|NCT01508936|2032045|FG001|Overall Study|Withdrawal by Subject|18
1012100|NCT01508936|2032044|FG000|Overall Study|Protocol Violation|2
1012101|NCT01508936|2032045|FG001|Overall Study|Protocol Violation|3
1012102|NCT01508936|2032044|FG000|Overall Study|Lost to Follow-up|2
1012103|NCT01508936|2032045|FG001|Overall Study|Lost to Follow-up|9
1012104|NCT01508936|2032044|FG000|Overall Study|Other|0
1012105|NCT01508936|2032045|FG001|Overall Study|Other|5
1012106|NCT01508936|2032044|FG000|Overall Study|Data from 2 sites deemed invalid|4
1012107|NCT01508936|2032045|FG001|Overall Study|Data from 2 sites deemed invalid|11
1012108|NCT01509079|2032073|FG000|Overall Study|Lack of Efficacy|0
1012109|NCT01509079|2032074|FG001|Overall Study|Lack of Efficacy|2
1012110|NCT01509079|2032073|FG000|Overall Study|started an excluded medication|0
1012111|NCT01509079|2032074|FG001|Overall Study|started an excluded medication|1
1012112|NCT01509547|2032106|FG000|Overall Study|Lost to Follow-up|24
1012113|NCT01509547|2032107|FG001|Overall Study|Lost to Follow-up|14
1012114|NCT01509547|2032106|FG000|Overall Study|Withdrawal by Subject|11
1012115|NCT01509547|2032107|FG001|Overall Study|Withdrawal by Subject|24
1012116|NCT01509547|2032106|FG000|Overall Study|Physician Decision|0
1012117|NCT01509547|2032107|FG001|Overall Study|Physician Decision|1
1012118|NCT01509664|2032162|FG000|Overall Study|Lost to Follow-up|15
1012119|NCT01509664|2032163|FG001|Overall Study|Lost to Follow-up|21
1012120|NCT01509846|2032192|FG000|Received Vaccination 2|Withdrawal by Subject|0
1012121|NCT01509846|2032193|FG001|Received Vaccination 2|Withdrawal by Subject|0
1012122|NCT01509846|2032194|FG002|Received Vaccination 2|Withdrawal by Subject|1
1012123|NCT01509846|2032195|FG003|Received Vaccination 2|Withdrawal by Subject|0
1012124|NCT01509846|2032196|FG004|Received Vaccination 2|Withdrawal by Subject|0
1012125|NCT01509846|2032192|FG000|Received Vaccination 2|Illness|0
1012126|NCT01509846|2032193|FG001|Received Vaccination 2|Illness|0
1012127|NCT01509846|2032194|FG002|Received Vaccination 2|Illness|0
1012128|NCT01509846|2032195|FG003|Received Vaccination 2|Illness|0
1012129|NCT01509846|2032196|FG004|Received Vaccination 2|Illness|1
1012130|NCT01509846|2032192|FG000|Received Vaccination 2|Not vaccinated per protocol|5
1012131|NCT01509846|2032193|FG001|Received Vaccination 2|Not vaccinated per protocol|0
1012132|NCT01509846|2032194|FG002|Received Vaccination 2|Not vaccinated per protocol|0
1012133|NCT01509846|2032195|FG003|Received Vaccination 2|Not vaccinated per protocol|0
1012134|NCT01509846|2032196|FG004|Received Vaccination 2|Not vaccinated per protocol|2
1012135|NCT01509846|2032192|FG000|Received Vaccination 3|Withdrawal by Subject|0
1012136|NCT01509846|2032193|FG001|Received Vaccination 3|Withdrawal by Subject|1
1012137|NCT01509846|2032194|FG002|Received Vaccination 3|Withdrawal by Subject|0
1012138|NCT01509846|2032195|FG003|Received Vaccination 3|Withdrawal by Subject|0
1012139|NCT01509846|2032196|FG004|Received Vaccination 3|Withdrawal by Subject|0
1012140|NCT01509846|2032192|FG000|Received Vaccination 3|Pregnancy|0
1012141|NCT01509846|2032193|FG001|Received Vaccination 3|Pregnancy|0
1012142|NCT01509846|2032194|FG002|Received Vaccination 3|Pregnancy|0
1012143|NCT01509846|2032195|FG003|Received Vaccination 3|Pregnancy|1
1012144|NCT01509846|2032196|FG004|Received Vaccination 3|Pregnancy|0
1012145|NCT01509846|2032192|FG000|Received Vaccination 3|Lost to Follow-up|0
1012146|NCT01509846|2032193|FG001|Received Vaccination 3|Lost to Follow-up|0
1012147|NCT01509846|2032194|FG002|Received Vaccination 3|Lost to Follow-up|1
1012148|NCT01509846|2032195|FG003|Received Vaccination 3|Lost to Follow-up|0
1012149|NCT01509846|2032196|FG004|Received Vaccination 3|Lost to Follow-up|0
1012150|NCT01510028|2032240|FG000|Overall Study|Lack of Efficacy|1
1012151|NCT01510028|2032241|FG001|Overall Study|Lack of Efficacy|0
1012152|NCT01510028|2032242|FG002|Overall Study|Lack of Efficacy|0
1012153|NCT01510028|2032243|FG003|Overall Study|Lack of Efficacy|0
1012154|NCT01510145|2032255|FG000|Overall Study|Adverse Event|6
1012155|NCT01510145|2032255|FG000|Overall Study|Lost to Follow-up|5
1012156|NCT01510145|2032255|FG000|Overall Study|Withdrawal by Subject|6
1012157|NCT01510145|2032255|FG000|Overall Study|Relative reported subject withdrew|1
1012158|NCT01510158|2032262|FG000|Overall Study|Adverse Event|7
1012159|NCT01510158|2032263|FG001|Overall Study|Adverse Event|8
1012160|NCT01510158|2032264|FG002|Overall Study|Adverse Event|5
1012161|NCT01510158|2032262|FG000|Overall Study|Gout flare|1
1012162|NCT01510158|2032263|FG001|Overall Study|Gout flare|0
1012163|NCT01510158|2032264|FG002|Overall Study|Gout flare|0
1012164|NCT01510158|2032262|FG000|Overall Study|Protocol Violation|17
1012165|NCT01510158|2032263|FG001|Overall Study|Protocol Violation|16
1012166|NCT01510158|2032264|FG002|Overall Study|Protocol Violation|24
1012167|NCT01510158|2032262|FG000|Overall Study|Sponsor terminated study.|2
1012168|NCT01510158|2032263|FG001|Overall Study|Sponsor terminated study.|0
1012169|NCT01510158|2032264|FG002|Overall Study|Sponsor terminated study.|2
1012170|NCT01510158|2032262|FG000|Overall Study|Lost to Follow-up|13
1012171|NCT01510158|2032263|FG001|Overall Study|Lost to Follow-up|16
1012172|NCT01510158|2032264|FG002|Overall Study|Lost to Follow-up|9
1012173|NCT01510158|2032262|FG000|Overall Study|Withdrawal by Subject|10
1012174|NCT01510158|2032263|FG001|Overall Study|Withdrawal by Subject|13
1012175|NCT01510158|2032264|FG002|Overall Study|Withdrawal by Subject|10
1012176|NCT01510158|2032262|FG000|Overall Study|Death|1
1012177|NCT01510158|2032263|FG001|Overall Study|Death|0
1012178|NCT01510158|2032264|FG002|Overall Study|Death|0
1012179|NCT01510717|2032330|FG000|Overall Study|Adverse Event|1
1012180|NCT01510717|2032331|FG001|Overall Study|Adverse Event|2
1012181|NCT01510717|2032330|FG000|Overall Study|Death|1
1012182|NCT01510717|2032331|FG001|Overall Study|Death|0
1012183|NCT01510717|2032330|FG000|Overall Study|Lost to Follow-up|0
1012184|NCT01510717|2032331|FG001|Overall Study|Lost to Follow-up|1
1012185|NCT01510717|2032330|FG000|Overall Study|Withdrawal by Subject|0
1012186|NCT01510717|2032331|FG001|Overall Study|Withdrawal by Subject|2
1012187|NCT01510769|2032341|FG000|Overall Study|Adverse Event|7
1012188|NCT01510769|2032342|FG001|Overall Study|Adverse Event|6
1012189|NCT01510769|2032343|FG002|Overall Study|Adverse Event|4
1012190|NCT01510769|2032341|FG000|Overall Study|Gout Flare|0
1012191|NCT01510769|2032342|FG001|Overall Study|Gout Flare|3
1012192|NCT01510769|2032343|FG002|Overall Study|Gout Flare|1
1012193|NCT01510769|2032341|FG000|Overall Study|Protocol Violation|11
1012194|NCT01510769|2032342|FG001|Overall Study|Protocol Violation|10
1012195|NCT01510769|2032343|FG002|Overall Study|Protocol Violation|9
1012196|NCT01510769|2032341|FG000|Overall Study|Lost to Follow-up|5
1012197|NCT01510769|2032342|FG001|Overall Study|Lost to Follow-up|1
1012198|NCT01510769|2032343|FG002|Overall Study|Lost to Follow-up|5
1012199|NCT01510769|2032341|FG000|Overall Study|Withdrawal by Subject|3
1012200|NCT01510769|2032342|FG001|Overall Study|Withdrawal by Subject|4
1012201|NCT01510769|2032343|FG002|Overall Study|Withdrawal by Subject|3
1012202|NCT01510769|2032341|FG000|Overall Study|Death|1
1012203|NCT01510769|2032342|FG001|Overall Study|Death|1
1012204|NCT01510769|2032343|FG002|Overall Study|Death|0
1012205|NCT01510912|2032358|FG000|Overall Study|Adverse Event|99
1012206|NCT01510912|2032358|FG000|Overall Study|Lack of Efficacy|12
1012207|NCT01510912|2032358|FG000|Overall Study|Non-compliance with trial drug|23
1012208|NCT01510912|2032358|FG000|Overall Study|Withdrawal by Subject|49
1012209|NCT01510912|2032358|FG000|Overall Study|Physician Decision|1
1012210|NCT01510912|2032358|FG000|Overall Study|Protocol Violation|27
1012211|NCT01510912|2032358|FG000|Overall Study|Lost to Follow-up|26
1012212|NCT01510912|2032358|FG000|Overall Study|Other, including joint replacement|5
1012213|NCT01511055|2032372|FG000|Overall Study|Withdrawal by Subject|6
1012214|NCT01511107|2032382|FG000|Overall Study|Ineligible|3
1012215|NCT01511107|2032383|FG001|Overall Study|Ineligible|2
1012216|NCT01511107|2032382|FG000|Overall Study|Lost to Follow-up|10
1012217|NCT01511107|2032383|FG001|Overall Study|Lost to Follow-up|19
1012218|NCT01511107|2032382|FG000|Overall Study|Withdrawal by Subject|9
1012219|NCT01511107|2032383|FG001|Overall Study|Withdrawal by Subject|20
1012220|NCT01511250|2032399|FG000|Overall Study|Withdrawal of Consent|1
1012221|NCT01511250|2032400|FG001|Overall Study|Withdrawal of Consent|0
1012222|NCT01511250|2032401|FG002|Overall Study|Withdrawal of Consent|0
1012223|NCT01511250|2032402|FG003|Overall Study|Withdrawal of Consent|0
1012224|NCT01511250|2032403|FG004|Overall Study|Withdrawal of Consent|0
1012225|NCT01511250|2032404|FG005|Overall Study|Withdrawal of Consent|0
1012226|NCT01511250|2032405|FG006|Overall Study|Withdrawal of Consent|0
1012227|NCT01511250|2032406|FG007|Overall Study|Withdrawal of Consent|1
1012228|NCT01511250|2032407|FG008|Overall Study|Withdrawal of Consent|1
1012229|NCT01511250|2032408|FG009|Overall Study|Withdrawal of Consent|0
1012230|NCT01511250|2032399|FG000|Overall Study|Sponsor/Investigator Decision|1
1012231|NCT01511250|2032400|FG001|Overall Study|Sponsor/Investigator Decision|0
1012232|NCT01511250|2032401|FG002|Overall Study|Sponsor/Investigator Decision|0
1012233|NCT01511250|2032402|FG003|Overall Study|Sponsor/Investigator Decision|0
1012234|NCT01511250|2032403|FG004|Overall Study|Sponsor/Investigator Decision|0
1012235|NCT01511250|2032404|FG005|Overall Study|Sponsor/Investigator Decision|0
1012236|NCT01511250|2032405|FG006|Overall Study|Sponsor/Investigator Decision|0
1012237|NCT01511250|2032406|FG007|Overall Study|Sponsor/Investigator Decision|0
1012238|NCT01511250|2032407|FG008|Overall Study|Sponsor/Investigator Decision|0
1012239|NCT01511250|2032408|FG009|Overall Study|Sponsor/Investigator Decision|0
1012240|NCT01511250|2032399|FG000|Overall Study|Lost to Follow-up|7
1012241|NCT01511250|2032400|FG001|Overall Study|Lost to Follow-up|3
1012242|NCT01511250|2032401|FG002|Overall Study|Lost to Follow-up|3
1012243|NCT01511250|2032402|FG003|Overall Study|Lost to Follow-up|3
1012244|NCT01511250|2032403|FG004|Overall Study|Lost to Follow-up|0
1012245|NCT01511250|2032404|FG005|Overall Study|Lost to Follow-up|0
1012246|NCT01511250|2032405|FG006|Overall Study|Lost to Follow-up|2
1012247|NCT01511250|2032406|FG007|Overall Study|Lost to Follow-up|3
1012248|NCT01511250|2032407|FG008|Overall Study|Lost to Follow-up|13
1012249|NCT01511250|2032408|FG009|Overall Study|Lost to Follow-up|5
1012250|NCT01511250|2032399|FG000|Overall Study|Protocol Violation|0
1012251|NCT01511250|2032400|FG001|Overall Study|Protocol Violation|2
1012252|NCT01511250|2032401|FG002|Overall Study|Protocol Violation|1
1012253|NCT01511250|2032402|FG003|Overall Study|Protocol Violation|0
1012254|NCT01511250|2032403|FG004|Overall Study|Protocol Violation|0
1012255|NCT01511250|2032404|FG005|Overall Study|Protocol Violation|0
1012256|NCT01511250|2032405|FG006|Overall Study|Protocol Violation|0
1012257|NCT01511250|2032406|FG007|Overall Study|Protocol Violation|0
1012258|NCT01511250|2032407|FG008|Overall Study|Protocol Violation|0
1012259|NCT01511250|2032408|FG009|Overall Study|Protocol Violation|0
1012260|NCT01511419|2032436|FG000|Dose 2|Physician Decision|1
1012261|NCT01511419|2032437|FG001|Dose 2|Physician Decision|0
1012262|NCT01511445|2032469|FG000|Overall Study|Lost to Follow-up|3
1012263|NCT01511445|2032470|FG001|Overall Study|Lost to Follow-up|1
1012264|NCT01511445|2032469|FG000|Overall Study|Protocol Violation|1
1012265|NCT01511445|2032470|FG001|Overall Study|Protocol Violation|3
1012266|NCT01511445|2032469|FG000|Overall Study|Protocol Violation|1
1012267|NCT01511445|2032470|FG001|Overall Study|Protocol Violation|0
1012268|NCT01511536|2032479|FG000|Phase 1|Other|0
1012269|NCT01511536|2032480|FG001|Phase 1|Other|1
1012270|NCT01511536|2032481|FG002|Phase 1|Other|0
1012271|NCT01511536|2032479|FG000|Phase 2|Other|0
1012272|NCT01511536|2032480|FG001|Phase 2|Other|0
1012273|NCT01511536|2032481|FG002|Phase 2|Other|9
1012274|NCT01511939|2032518|FG000|Overall Study|Withdrawal by Subject|2
1012275|NCT01511939|2032519|FG001|Overall Study|Withdrawal by Subject|1
1012276|NCT01511939|2032520|FG002|Overall Study|Withdrawal by Subject|0
1012277|NCT01512108|2032541|FG000|Overall Study|Adverse Event|9
1012278|NCT01512108|2032542|FG001|Overall Study|Adverse Event|4
1012279|NCT01512108|2032541|FG000|Overall Study|Protocol Violation|1
1012280|NCT01512108|2032542|FG001|Overall Study|Protocol Violation|2
1012281|NCT01512108|2032541|FG000|Overall Study|Withdrawal Criteria|1
1012282|NCT01512108|2032542|FG001|Overall Study|Withdrawal Criteria|0
1012283|NCT01512108|2032541|FG000|Overall Study|Unclassified|11
1012284|NCT01512108|2032542|FG001|Overall Study|Unclassified|3
1012285|NCT01512160|2032552|FG000|Overall Study|Lost to Follow-up|1
1012286|NCT01512160|2032553|FG001|Overall Study|Lost to Follow-up|0
1012287|NCT01512160|2032554|FG002|Overall Study|Lost to Follow-up|0
1012288|NCT01512160|2032555|FG003|Overall Study|Lost to Follow-up|0
1012289|NCT01512160|2032552|FG000|Overall Study|Withdrawal by Subject|1
1012290|NCT01512160|2032553|FG001|Overall Study|Withdrawal by Subject|0
1012291|NCT01512160|2032554|FG002|Overall Study|Withdrawal by Subject|0
1012292|NCT01512160|2032555|FG003|Overall Study|Withdrawal by Subject|1
1012293|NCT01512264|2032591|FG000|Overall Study|Lost to Follow-up|0
1012294|NCT01512264|2032592|FG001|Overall Study|Lost to Follow-up|0
1012295|NCT01512264|2032593|FG002|Overall Study|Lost to Follow-up|0
1012296|NCT01512264|2032594|FG003|Overall Study|Lost to Follow-up|1
1012297|NCT01512368|2032604|FG000|Overall Study|Protocol Violation|3
1012298|NCT01512693|2032628|FG000|Overall Study|Withdrawal by Subject|0
1012299|NCT01512693|2032629|FG001|Overall Study|Withdrawal by Subject|1
1012300|NCT01512745|2032637|FG000|Overall Study|Adverse Event|22
1012301|NCT01512745|2032638|FG001|Overall Study|Adverse Event|3
1012302|NCT01512745|2032637|FG000|Overall Study|Death|9
1012303|NCT01512745|2032638|FG001|Overall Study|Death|13
1012304|NCT01512745|2032637|FG000|Overall Study|Withdrawal by Subject|2
1012305|NCT01512745|2032638|FG001|Overall Study|Withdrawal by Subject|2
1012306|NCT01512745|2032637|FG000|Overall Study|Lost to Follow-up|4
1012307|NCT01512745|2032638|FG001|Overall Study|Lost to Follow-up|0
1012308|NCT01512745|2032637|FG000|Overall Study|Lack of Efficacy|2
1012309|NCT01512745|2032638|FG001|Overall Study|Lack of Efficacy|2
1012310|NCT01512745|2032637|FG000|Overall Study|Protocol Violation|1
1012311|NCT01512745|2032638|FG001|Overall Study|Protocol Violation|0
1012312|NCT01512979|2032680|FG000|Overall Study|Adverse Event|2
1012313|NCT01512979|2032681|FG001|Overall Study|Adverse Event|2
1012314|NCT01512979|2032680|FG000|Overall Study|Protocol Violation|1
1012315|NCT01512979|2032681|FG001|Overall Study|Protocol Violation|4
1012316|NCT01512979|2032680|FG000|Overall Study|Lost to Follow-up|2
1012317|NCT01512979|2032681|FG001|Overall Study|Lost to Follow-up|5
1012318|NCT01512979|2032680|FG000|Overall Study|Withdrawal by Subject|1
1012319|NCT01512979|2032681|FG001|Overall Study|Withdrawal by Subject|2
1012320|NCT01512979|2032680|FG000|Overall Study|Reason other than stated above|13
1012321|NCT01512979|2032681|FG001|Overall Study|Reason other than stated above|9
1012322|NCT01513148|2032698|FG000|Overall Study|Protocol Violation|2
1012323|NCT01513148|2032699|FG001|Overall Study|Protocol Violation|2
1012324|NCT01513239|2032748|FG000|Period 1: Main Phase|Adverse Event|1
1012325|NCT01513239|2032749|FG001|Period 1: Main Phase|Adverse Event|1
1012326|NCT01513239|2032750|FG002|Period 1: Main Phase|Adverse Event|2
1012327|NCT01513239|2032751|FG003|Period 1: Main Phase|Adverse Event|0
1012328|NCT01513239|2032752|FG004|Period 1: Main Phase|Adverse Event|0
1012329|NCT01513239|2032753|FG005|Period 1: Main Phase|Adverse Event|0
1012330|NCT01513239|2032748|FG000|Period 1: Main Phase|Death|29
1012331|NCT01513239|2032749|FG001|Period 1: Main Phase|Death|22
1012332|NCT01513239|2032750|FG002|Period 1: Main Phase|Death|32
1012333|NCT01513239|2032751|FG003|Period 1: Main Phase|Death|0
1012334|NCT01513239|2032752|FG004|Period 1: Main Phase|Death|0
1012335|NCT01513239|2032753|FG005|Period 1: Main Phase|Death|0
1012336|NCT01513239|2032748|FG000|Period 1: Main Phase|Lost to Follow-up|11
1012337|NCT01513239|2032749|FG001|Period 1: Main Phase|Lost to Follow-up|10
1012338|NCT01513239|2032750|FG002|Period 1: Main Phase|Lost to Follow-up|6
1012339|NCT01513239|2032751|FG003|Period 1: Main Phase|Lost to Follow-up|0
1012340|NCT01513239|2032752|FG004|Period 1: Main Phase|Lost to Follow-up|0
1012341|NCT01513239|2032753|FG005|Period 1: Main Phase|Lost to Follow-up|0
1012342|NCT01513239|2032748|FG000|Period 1: Main Phase|Physician Decision|4
1012343|NCT01513239|2032749|FG001|Period 1: Main Phase|Physician Decision|4
1012344|NCT01513239|2032750|FG002|Period 1: Main Phase|Physician Decision|4
1012345|NCT01513239|2032751|FG003|Period 1: Main Phase|Physician Decision|0
1012346|NCT01513239|2032752|FG004|Period 1: Main Phase|Physician Decision|0
1012347|NCT01513239|2032753|FG005|Period 1: Main Phase|Physician Decision|0
1012348|NCT01513239|2032748|FG000|Period 1: Main Phase|Protocol Violation|2
1012349|NCT01513239|2032749|FG001|Period 1: Main Phase|Protocol Violation|2
1012350|NCT01513239|2032750|FG002|Period 1: Main Phase|Protocol Violation|2
1012351|NCT01513239|2032751|FG003|Period 1: Main Phase|Protocol Violation|0
1012352|NCT01513239|2032752|FG004|Period 1: Main Phase|Protocol Violation|0
1012353|NCT01513239|2032753|FG005|Period 1: Main Phase|Protocol Violation|0
1012354|NCT01513239|2032748|FG000|Period 1: Main Phase|Technical Problems|1
1012355|NCT01513239|2032749|FG001|Period 1: Main Phase|Technical Problems|2
1012356|NCT01513239|2032750|FG002|Period 1: Main Phase|Technical Problems|0
1012357|NCT01513239|2032751|FG003|Period 1: Main Phase|Technical Problems|0
1012358|NCT01513239|2032752|FG004|Period 1: Main Phase|Technical Problems|0
1012359|NCT01513239|2032753|FG005|Period 1: Main Phase|Technical Problems|0
1012360|NCT01513239|2032748|FG000|Period 1: Main Phase|Withdrawal by Subject|27
1012361|NCT01513239|2032749|FG001|Period 1: Main Phase|Withdrawal by Subject|29
1012362|NCT01513239|2032750|FG002|Period 1: Main Phase|Withdrawal by Subject|42
1012363|NCT01513239|2032751|FG003|Period 1: Main Phase|Withdrawal by Subject|0
1012364|NCT01513239|2032752|FG004|Period 1: Main Phase|Withdrawal by Subject|0
1012365|NCT01513239|2032753|FG005|Period 1: Main Phase|Withdrawal by Subject|0
1012366|NCT01513239|2032748|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1012367|NCT01513239|2032749|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1012368|NCT01513239|2032750|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1012369|NCT01513239|2032751|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
1012370|NCT01513239|2032752|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
1012371|NCT01513239|2032753|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
1012372|NCT01513239|2032748|FG000|Period 2: 9 Month Extension Phase|Death|0
1012373|NCT01513239|2032749|FG001|Period 2: 9 Month Extension Phase|Death|0
1012374|NCT01513239|2032750|FG002|Period 2: 9 Month Extension Phase|Death|0
1012375|NCT01513239|2032751|FG003|Period 2: 9 Month Extension Phase|Death|2
1012376|NCT01513239|2032752|FG004|Period 2: 9 Month Extension Phase|Death|5
1012377|NCT01513239|2032753|FG005|Period 2: 9 Month Extension Phase|Death|2
1012378|NCT01513239|2032748|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1012379|NCT01513239|2032749|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
914320|NCT00813995|1892070|FG000|Overall Study|Other reason|2
914321|NCT00813995|1892071|FG001|Overall Study|Other reason|2
914322|NCT00813995|1892070|FG000|Overall Study|Protocol Violation|3
914323|NCT00813995|1892071|FG001|Overall Study|Protocol Violation|2
914324|NCT00813995|1892070|FG000|Overall Study|Subject moved|4
914325|NCT00813995|1892071|FG001|Overall Study|Subject moved|0
914326|NCT00813995|1892070|FG000|Overall Study|Withdrawal by Subject|0
914327|NCT00813995|1892071|FG001|Overall Study|Withdrawal by Subject|5
914328|NCT00814164|1892092|FG000|Overall Study|Progression|7
914329|NCT00814164|1892092|FG000|Overall Study|not stated|7
914330|NCT00814164|1892092|FG000|Overall Study|Death|5
914331|NCT00814307|1892125|FG000|Overall Study|Randomized but not treated|1
914332|NCT00814307|1892126|FG001|Overall Study|Randomized but not treated|0
914333|NCT00814307|1892127|FG002|Overall Study|Randomized but not treated|0
914334|NCT00814307|1892128|FG003|Overall Study|Randomized but not treated|0
914335|NCT00814307|1892125|FG000|Overall Study|Adverse Event|3
914336|NCT00814307|1892126|FG001|Overall Study|Adverse Event|9
914337|NCT00814307|1892127|FG002|Overall Study|Adverse Event|3
914338|NCT00814307|1892128|FG003|Overall Study|Adverse Event|2
914339|NCT00814307|1892125|FG000|Overall Study|Lack of Efficacy|1
914340|NCT00814307|1892126|FG001|Overall Study|Lack of Efficacy|1
914341|NCT00814307|1892127|FG002|Overall Study|Lack of Efficacy|3
914342|NCT00814307|1892128|FG003|Overall Study|Lack of Efficacy|4
914343|NCT00814307|1892125|FG000|Overall Study|Other|1
914344|NCT00814307|1892126|FG001|Overall Study|Other|2
914345|NCT00814307|1892127|FG002|Overall Study|Other|0
1012380|NCT01513239|2032750|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1012381|NCT01513239|2032751|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
1012382|NCT01513239|2032752|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
1012383|NCT01513239|2032753|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1012384|NCT01513239|2032748|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0
1012385|NCT01513239|2032749|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0
1012386|NCT01513239|2032750|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0
1012387|NCT01513239|2032751|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1
1012388|NCT01513239|2032752|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0
1012389|NCT01513239|2032753|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0
1012390|NCT01513239|2032748|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0
1012391|NCT01513239|2032749|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0
1012392|NCT01513239|2032750|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0
1012393|NCT01513239|2032751|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0
1012394|NCT01513239|2032752|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1
1012395|NCT01513239|2032753|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1
1012396|NCT01513291|2032767|FG000|Treatment Period|Adverse Event|8
1012397|NCT01513291|2032768|FG001|Treatment Period|Adverse Event|4
1012398|NCT01513291|2032769|FG002|Treatment Period|Adverse Event|0
1012399|NCT01513291|2032770|FG003|Treatment Period|Adverse Event|0
1012400|NCT01513291|2032771|FG004|Treatment Period|Adverse Event|0
1012401|NCT01513291|2032767|FG000|Treatment Period|Lack of Efficacy|3
1012402|NCT01513291|2032768|FG001|Treatment Period|Lack of Efficacy|0
1012403|NCT01513291|2032769|FG002|Treatment Period|Lack of Efficacy|0
1012404|NCT01513291|2032770|FG003|Treatment Period|Lack of Efficacy|0
1012405|NCT01513291|2032771|FG004|Treatment Period|Lack of Efficacy|0
1012406|NCT01513291|2032767|FG000|Treatment Period|Lost to Follow-up|2
1012407|NCT01513291|2032768|FG001|Treatment Period|Lost to Follow-up|3
1012408|NCT01513291|2032769|FG002|Treatment Period|Lost to Follow-up|0
1012409|NCT01513291|2032770|FG003|Treatment Period|Lost to Follow-up|0
1012410|NCT01513291|2032771|FG004|Treatment Period|Lost to Follow-up|0
1012411|NCT01513291|2032767|FG000|Treatment Period|Physician Decision|1
1012412|NCT01513291|2032768|FG001|Treatment Period|Physician Decision|0
1012413|NCT01513291|2032769|FG002|Treatment Period|Physician Decision|0
1012414|NCT01513291|2032770|FG003|Treatment Period|Physician Decision|0
1012415|NCT01513291|2032771|FG004|Treatment Period|Physician Decision|0
1012416|NCT01513291|2032767|FG000|Treatment Period|Protocol Violation|1
1012417|NCT01513291|2032768|FG001|Treatment Period|Protocol Violation|2
1012418|NCT01513291|2032769|FG002|Treatment Period|Protocol Violation|0
1012419|NCT01513291|2032770|FG003|Treatment Period|Protocol Violation|0
1012420|NCT01513291|2032771|FG004|Treatment Period|Protocol Violation|0
1012421|NCT01513291|2032767|FG000|Treatment Period|Withdrawal by Subject|8
1012422|NCT01513291|2032768|FG001|Treatment Period|Withdrawal by Subject|5
1012423|NCT01513291|2032769|FG002|Treatment Period|Withdrawal by Subject|0
1012424|NCT01513291|2032770|FG003|Treatment Period|Withdrawal by Subject|0
1012425|NCT01513291|2032771|FG004|Treatment Period|Withdrawal by Subject|0
1012426|NCT01513291|2032767|FG000|Treatment Period|Randomized not treated|0
1012427|NCT01513291|2032768|FG001|Treatment Period|Randomized not treated|2
1012428|NCT01513291|2032769|FG002|Treatment Period|Randomized not treated|0
1012429|NCT01513291|2032770|FG003|Treatment Period|Randomized not treated|0
1012430|NCT01513291|2032771|FG004|Treatment Period|Randomized not treated|0
1012431|NCT01513291|2032767|FG000|Run-out Period|Lost to Follow-up|0
1012432|NCT01513291|2032768|FG001|Run-out Period|Lost to Follow-up|0
1012433|NCT01513291|2032769|FG002|Run-out Period|Lost to Follow-up|0
1012434|NCT01513291|2032770|FG003|Run-out Period|Lost to Follow-up|1
1012435|NCT01513291|2032771|FG004|Run-out Period|Lost to Follow-up|0
1012436|NCT01513291|2032767|FG000|Run-out Period|Withdrawal by Subject|0
1012437|NCT01513291|2032768|FG001|Run-out Period|Withdrawal by Subject|0
1012438|NCT01513291|2032769|FG002|Run-out Period|Withdrawal by Subject|0
1012439|NCT01513291|2032770|FG003|Run-out Period|Withdrawal by Subject|1
1012440|NCT01513291|2032771|FG004|Run-out Period|Withdrawal by Subject|0
1012441|NCT01513317|2032785|FG000|Overall Study|Withdrawal by Subject|15
914346|NCT00814307|1892128|FG003|Overall Study|Other|1
914347|NCT00814307|1892125|FG000|Overall Study|Protocol Violation|2
914348|NCT00814307|1892126|FG001|Overall Study|Protocol Violation|8
914349|NCT00814307|1892127|FG002|Overall Study|Protocol Violation|1
914350|NCT00814307|1892128|FG003|Overall Study|Protocol Violation|1
914351|NCT00814307|1892125|FG000|Overall Study|Withdrawal by Subject|4
914352|NCT00814307|1892126|FG001|Overall Study|Withdrawal by Subject|6
914353|NCT00814307|1892127|FG002|Overall Study|Withdrawal by Subject|0
914354|NCT00814307|1892128|FG003|Overall Study|Withdrawal by Subject|2
914355|NCT00814307|1892125|FG000|Overall Study|Death|0
914356|NCT00814307|1892126|FG001|Overall Study|Death|1
914357|NCT00814307|1892127|FG002|Overall Study|Death|0
914358|NCT00814307|1892128|FG003|Overall Study|Death|0
914359|NCT00814320|1892142|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
914360|NCT00814320|1892143|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
914361|NCT00814320|1892142|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
914362|NCT00814320|1892143|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
1012442|NCT01513317|2032786|FG001|Overall Study|Withdrawal by Subject|4
1012443|NCT01513317|2032785|FG000|Overall Study|Death|1
1012444|NCT01513317|2032786|FG001|Overall Study|Death|1
1012445|NCT01513317|2032785|FG000|Overall Study|Study terminated by sponsor|18
1012446|NCT01513317|2032786|FG001|Overall Study|Study terminated by sponsor|18
1012447|NCT01513317|2032785|FG000|Overall Study|Other|0
1012448|NCT01513317|2032786|FG001|Overall Study|Other|1
1012449|NCT01513330|2032792|FG000|SenSura Mio First,|Adverse Event|2
1012450|NCT01513330|2032793|FG001|SenSura Mio First,|Adverse Event|0
1012451|NCT01513330|2032792|FG000|SenSura Mio First,|Lack of Efficacy|0
1012452|NCT01513330|2032793|FG001|SenSura Mio First,|Lack of Efficacy|1
1012453|NCT01513330|2032792|FG000|SenSura Mio First,|Withdrawal by Subject|1
1012454|NCT01513330|2032793|FG001|SenSura Mio First,|Withdrawal by Subject|1
1012455|NCT01513330|2032792|FG000|SenSura Mio First,|Other|1
1012456|NCT01513330|2032793|FG001|SenSura Mio First,|Other|0
1012457|NCT01513330|2032792|FG000|Standard Care First,|Lack of Efficacy|2
1012458|NCT01513330|2032793|FG001|Standard Care First,|Lack of Efficacy|2
1012459|NCT01513330|2032792|FG000|Standard Care First,|Withdrawal by Subject|1
1012460|NCT01513330|2032793|FG001|Standard Care First,|Withdrawal by Subject|2
1012461|NCT01513330|2032792|FG000|Standard Care First,|Other|1
1012462|NCT01513330|2032793|FG001|Standard Care First,|Other|0
1012463|NCT01513460|2032811|FG000|Overall Study|Death|0
1012464|NCT01513460|2032812|FG001|Overall Study|Death|0
1012465|NCT01513460|2032813|FG002|Overall Study|Death|1
1012466|NCT01513460|2032811|FG000|Overall Study|Lost to Follow-up|0
1012467|NCT01513460|2032812|FG001|Overall Study|Lost to Follow-up|0
1012468|NCT01513460|2032813|FG002|Overall Study|Lost to Follow-up|2
1012469|NCT01513460|2032811|FG000|Overall Study|Abnormal laboratory value|1
1012470|NCT01513460|2032812|FG001|Overall Study|Abnormal laboratory value|0
1012471|NCT01513460|2032813|FG002|Overall Study|Abnormal laboratory value|1
1012472|NCT01513460|2032811|FG000|Overall Study|Lack of Efficacy|1
1012473|NCT01513460|2032812|FG001|Overall Study|Lack of Efficacy|2
1012474|NCT01513460|2032813|FG002|Overall Study|Lack of Efficacy|5
1012475|NCT01513460|2032811|FG000|Overall Study|Protocol deviations|3
1012476|NCT01513460|2032812|FG001|Overall Study|Protocol deviations|4
1012477|NCT01513460|2032813|FG002|Overall Study|Protocol deviations|3
1012478|NCT01513460|2032811|FG000|Overall Study|Withdrawal by Subject|7
1012479|NCT01513460|2032812|FG001|Overall Study|Withdrawal by Subject|8
1012480|NCT01513460|2032813|FG002|Overall Study|Withdrawal by Subject|21
1012481|NCT01513460|2032811|FG000|Overall Study|Adverse Event|16
1012482|NCT01513460|2032812|FG001|Overall Study|Adverse Event|18
1012483|NCT01513460|2032813|FG002|Overall Study|Adverse Event|23
1012484|NCT01513460|2032811|FG000|Overall Study|Abnormal test procedure|1
1012485|NCT01513460|2032812|FG001|Overall Study|Abnormal test procedure|0
1012486|NCT01513460|2032813|FG002|Overall Study|Abnormal test procedure|0
1012487|NCT01513473|2032825|FG000|Main Trial (26 Weeks)|Adverse Event|0
1012488|NCT01513473|2032826|FG001|Main Trial (26 Weeks)|Adverse Event|2
1012489|NCT01513473|2032825|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4
1012490|NCT01513473|2032826|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7
1012491|NCT01513473|2032825|FG000|Main Trial (26 Weeks)|Unclassified|0
1012492|NCT01513473|2032826|FG001|Main Trial (26 Weeks)|Unclassified|2
1012493|NCT01513473|2032825|FG000|Extension Trial (26 Weeks)|Adverse Event|0
1012494|NCT01513473|2032826|FG001|Extension Trial (26 Weeks)|Adverse Event|1
1012495|NCT01513473|2032825|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1
1012496|NCT01513473|2032826|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5
1012497|NCT01513551|2032839|FG000|Overall Study|Death|0
1012498|NCT01513551|2032840|FG001|Overall Study|Death|1
1012499|NCT01513551|2032841|FG002|Overall Study|Death|0
1012500|NCT01513551|2032839|FG000|Overall Study|Lost to Follow-up|3
1012501|NCT01513551|2032840|FG001|Overall Study|Lost to Follow-up|5
1012502|NCT01513551|2032841|FG002|Overall Study|Lost to Follow-up|2
1012503|NCT01513551|2032839|FG000|Overall Study|Withdrawal by Subject|1
1012504|NCT01513551|2032840|FG001|Overall Study|Withdrawal by Subject|0
1012505|NCT01513551|2032841|FG002|Overall Study|Withdrawal by Subject|2
1012506|NCT01513551|2032839|FG000|Overall Study|Randomized but not vaccinated|0
1012507|NCT01513551|2032840|FG001|Overall Study|Randomized but not vaccinated|0
914363|NCT00814320|1892142|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
914364|NCT00814320|1892143|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
914365|NCT00814320|1892142|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
914366|NCT00814320|1892143|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
914367|NCT00814320|1892142|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
914368|NCT00814320|1892143|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
914369|NCT00814320|1892142|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
914370|NCT00814320|1892143|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
914371|NCT00814320|1892142|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
914372|NCT00814320|1892143|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
914373|NCT00814320|1892142|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
914374|NCT00814320|1892143|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
914375|NCT00814320|1892142|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
914376|NCT00814320|1892143|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
1012508|NCT01513551|2032841|FG002|Overall Study|Randomized but not vaccinated|1
1012509|NCT01513590|2032851|FG000|Overall Study|Adverse Event|2
1012510|NCT01513590|2032852|FG001|Overall Study|Adverse Event|3
1012511|NCT01513590|2032851|FG000|Overall Study|Withdrawal Criteria|3
1012512|NCT01513590|2032852|FG001|Overall Study|Withdrawal Criteria|0
1012513|NCT01513590|2032851|FG000|Overall Study|Unclassified|5
1012514|NCT01513590|2032852|FG001|Overall Study|Unclassified|10
1012515|NCT01513759|2032858|FG000|Overall Study|Protocol Violation|4
1012516|NCT01513759|2032858|FG000|Overall Study|Death during catheter placement|1
1012517|NCT01513967|2032883|FG000|Overall Study|Pregnancy|0
1012518|NCT01513967|2032884|FG001|Overall Study|Pregnancy|0
1012519|NCT01513967|2032885|FG002|Overall Study|Pregnancy|0
1012520|NCT01513967|2032886|FG003|Overall Study|Pregnancy|0
1012521|NCT01513967|2032887|FG004|Overall Study|Pregnancy|0
1012522|NCT01513967|2032888|FG005|Overall Study|Pregnancy|0
1012523|NCT01513967|2032889|FG006|Overall Study|Pregnancy|1
1012524|NCT01513967|2032890|FG007|Overall Study|Pregnancy|0
1012525|NCT01513967|2032883|FG000|Overall Study|missed a study visit|0
1012526|NCT01513967|2032884|FG001|Overall Study|missed a study visit|0
1012527|NCT01513967|2032885|FG002|Overall Study|missed a study visit|0
1012528|NCT01513967|2032886|FG003|Overall Study|missed a study visit|0
1012529|NCT01513967|2032887|FG004|Overall Study|missed a study visit|0
1012530|NCT01513967|2032888|FG005|Overall Study|missed a study visit|0
1012531|NCT01513967|2032889|FG006|Overall Study|missed a study visit|1
1012532|NCT01513967|2032890|FG007|Overall Study|missed a study visit|0
1012533|NCT01513967|2032883|FG000|Overall Study|excluded due to positive drug screen|0
1012534|NCT01513967|2032884|FG001|Overall Study|excluded due to positive drug screen|0
1012535|NCT01513967|2032885|FG002|Overall Study|excluded due to positive drug screen|0
1012536|NCT01513967|2032886|FG003|Overall Study|excluded due to positive drug screen|0
1012537|NCT01513967|2032887|FG004|Overall Study|excluded due to positive drug screen|0
1012538|NCT01513967|2032888|FG005|Overall Study|excluded due to positive drug screen|0
1012539|NCT01513967|2032889|FG006|Overall Study|excluded due to positive drug screen|0
1012540|NCT01513967|2032890|FG007|Overall Study|excluded due to positive drug screen|2
1012541|NCT01513967|2032883|FG000|Overall Study|Physician Decision|0
1012542|NCT01513967|2032884|FG001|Overall Study|Physician Decision|0
1012543|NCT01513967|2032885|FG002|Overall Study|Physician Decision|0
1012544|NCT01513967|2032886|FG003|Overall Study|Physician Decision|0
1012545|NCT01513967|2032887|FG004|Overall Study|Physician Decision|0
1012546|NCT01513967|2032888|FG005|Overall Study|Physician Decision|1
1012547|NCT01513967|2032889|FG006|Overall Study|Physician Decision|0
1012548|NCT01513967|2032890|FG007|Overall Study|Physician Decision|0
1012549|NCT01514136|2032910|FG000|Test Period 1; Test A|Protocol Violation|1
1012550|NCT01514136|2032911|FG001|Test Period 1; Test A|Protocol Violation|0
1012551|NCT01514136|2032912|FG002|Test Period 1; Test A|Protocol Violation|0
1012552|NCT01514136|2032913|FG003|Test Period 1; Test A|Protocol Violation|0
1012553|NCT01514136|2032914|FG004|Test Period 1; Test A|Protocol Violation|0
1012554|NCT01514136|2032915|FG005|Test Period 1; Test A|Protocol Violation|0
1012555|NCT01514136|2032916|FG006|Test Period 1; Test A|Protocol Violation|0
1012556|NCT01514136|2032917|FG007|Test Period 1; Test A|Protocol Violation|0
1012557|NCT01514136|2032910|FG000|Test Period 1; Test A|Break from study holiday|2
1012558|NCT01514136|2032911|FG001|Test Period 1; Test A|Break from study holiday|0
1012559|NCT01514136|2032912|FG002|Test Period 1; Test A|Break from study holiday|0
1012560|NCT01514136|2032913|FG003|Test Period 1; Test A|Break from study holiday|0
1012561|NCT01514136|2032914|FG004|Test Period 1; Test A|Break from study holiday|0
1012562|NCT01514136|2032915|FG005|Test Period 1; Test A|Break from study holiday|0
1012563|NCT01514136|2032916|FG006|Test Period 1; Test A|Break from study holiday|0
1012564|NCT01514136|2032917|FG007|Test Period 1; Test A|Break from study holiday|0
1012565|NCT01514136|2032910|FG000|Test Period 1; Test B|Withdrawal by Subject|0
1012566|NCT01514136|2032911|FG001|Test Period 1; Test B|Withdrawal by Subject|1
1012567|NCT01514136|2032912|FG002|Test Period 1; Test B|Withdrawal by Subject|0
1012568|NCT01514136|2032913|FG003|Test Period 1; Test B|Withdrawal by Subject|0
1012569|NCT01514136|2032914|FG004|Test Period 1; Test B|Withdrawal by Subject|0
1012570|NCT01514136|2032915|FG005|Test Period 1; Test B|Withdrawal by Subject|0
1012571|NCT01514136|2032916|FG006|Test Period 1; Test B|Withdrawal by Subject|0
1012572|NCT01514136|2032917|FG007|Test Period 1; Test B|Withdrawal by Subject|0
1012573|NCT01514136|2032910|FG000|Test Period 1; Test D|Subject took a break due to holiday|0
1012574|NCT01514136|2032911|FG001|Test Period 1; Test D|Subject took a break due to holiday|0
1012575|NCT01514136|2032912|FG002|Test Period 1; Test D|Subject took a break due to holiday|0
1012576|NCT01514136|2032913|FG003|Test Period 1; Test D|Subject took a break due to holiday|2
1012577|NCT01514136|2032914|FG004|Test Period 1; Test D|Subject took a break due to holiday|0
1012578|NCT01514136|2032915|FG005|Test Period 1; Test D|Subject took a break due to holiday|0
1012579|NCT01514136|2032916|FG006|Test Period 1; Test D|Subject took a break due to holiday|0
1012580|NCT01514136|2032917|FG007|Test Period 1; Test D|Subject took a break due to holiday|0
1012581|NCT01514136|2032910|FG000|Test Period 2; Test A*|Adverse Event|0
1012582|NCT01514136|2032911|FG001|Test Period 2; Test A*|Adverse Event|0
1012583|NCT01514136|2032912|FG002|Test Period 2; Test A*|Adverse Event|0
1012584|NCT01514136|2032913|FG003|Test Period 2; Test A*|Adverse Event|0
1012585|NCT01514136|2032914|FG004|Test Period 2; Test A*|Adverse Event|1
1012586|NCT01514136|2032915|FG005|Test Period 2; Test A*|Adverse Event|0
1012587|NCT01514136|2032916|FG006|Test Period 2; Test A*|Adverse Event|0
1012588|NCT01514136|2032917|FG007|Test Period 2; Test A*|Adverse Event|0
1012589|NCT01514136|2032910|FG000|Test Period 2; Test A*|Holiday|0
1012590|NCT01514136|2032911|FG001|Test Period 2; Test A*|Holiday|0
1012591|NCT01514136|2032912|FG002|Test Period 2; Test A*|Holiday|0
1012592|NCT01514136|2032913|FG003|Test Period 2; Test A*|Holiday|0
1012593|NCT01514136|2032914|FG004|Test Period 2; Test A*|Holiday|1
1012594|NCT01514136|2032915|FG005|Test Period 2; Test A*|Holiday|0
1012595|NCT01514136|2032916|FG006|Test Period 2; Test A*|Holiday|0
1012596|NCT01514136|2032917|FG007|Test Period 2; Test A*|Holiday|0
1012597|NCT01514136|2032910|FG000|Test Period 2; Test B*|Withdrawal by Subject|0
1012598|NCT01514136|2032911|FG001|Test Period 2; Test B*|Withdrawal by Subject|0
1012599|NCT01514136|2032912|FG002|Test Period 2; Test B*|Withdrawal by Subject|0
1012600|NCT01514136|2032913|FG003|Test Period 2; Test B*|Withdrawal by Subject|0
1012601|NCT01514136|2032914|FG004|Test Period 2; Test B*|Withdrawal by Subject|0
1012602|NCT01514136|2032915|FG005|Test Period 2; Test B*|Withdrawal by Subject|2
1012603|NCT01514136|2032916|FG006|Test Period 2; Test B*|Withdrawal by Subject|0
1012604|NCT01514136|2032917|FG007|Test Period 2; Test B*|Withdrawal by Subject|0
1012605|NCT01514136|2032910|FG000|Test Period 2; Test C*|Withdrawal by Subject|0
1012606|NCT01514136|2032911|FG001|Test Period 2; Test C*|Withdrawal by Subject|0
1012607|NCT01514136|2032912|FG002|Test Period 2; Test C*|Withdrawal by Subject|0
1012608|NCT01514136|2032913|FG003|Test Period 2; Test C*|Withdrawal by Subject|0
1012609|NCT01514136|2032914|FG004|Test Period 2; Test C*|Withdrawal by Subject|0
1012610|NCT01514136|2032915|FG005|Test Period 2; Test C*|Withdrawal by Subject|0
1012611|NCT01514136|2032916|FG006|Test Period 2; Test C*|Withdrawal by Subject|1
1012612|NCT01514136|2032917|FG007|Test Period 2; Test C*|Withdrawal by Subject|0
1012613|NCT01514136|2032910|FG000|Test Period 2; Test C*|holiday|0
1012614|NCT01514136|2032911|FG001|Test Period 2; Test C*|holiday|0
1012615|NCT01514136|2032912|FG002|Test Period 2; Test C*|holiday|0
1012616|NCT01514136|2032913|FG003|Test Period 2; Test C*|holiday|0
1012617|NCT01514136|2032914|FG004|Test Period 2; Test C*|holiday|0
1012618|NCT01514136|2032915|FG005|Test Period 2; Test C*|holiday|0
1012619|NCT01514136|2032916|FG006|Test Period 2; Test C*|holiday|1
1012620|NCT01514136|2032917|FG007|Test Period 2; Test C*|holiday|0
1012621|NCT01514136|2032910|FG000|Test Period 2; Test C*|Protocol Violation|0
1012622|NCT01514136|2032911|FG001|Test Period 2; Test C*|Protocol Violation|0
1012623|NCT01514136|2032912|FG002|Test Period 2; Test C*|Protocol Violation|0
1012624|NCT01514136|2032913|FG003|Test Period 2; Test C*|Protocol Violation|0
1012625|NCT01514136|2032914|FG004|Test Period 2; Test C*|Protocol Violation|0
1012626|NCT01514136|2032915|FG005|Test Period 2; Test C*|Protocol Violation|0
1012627|NCT01514136|2032916|FG006|Test Period 2; Test C*|Protocol Violation|1
1012628|NCT01514136|2032917|FG007|Test Period 2; Test C*|Protocol Violation|0
1012629|NCT01514201|2032972|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
1012630|NCT01514201|2032973|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
1012631|NCT01514201|2032974|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
1012632|NCT01514201|2032975|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
1012633|NCT01514201|2032972|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
1012634|NCT01514201|2032973|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
1012635|NCT01514201|2032974|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
1012636|NCT01514201|2032975|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
1012637|NCT01514201|2032972|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
1012638|NCT01514201|2032973|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
1012639|NCT01514201|2032974|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
1012640|NCT01514201|2032975|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
1012641|NCT01514201|2032972|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
1012642|NCT01514201|2032973|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
1012643|NCT01514201|2032974|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
1012644|NCT01514201|2032975|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
1012645|NCT01514201|2032972|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
1012646|NCT01514201|2032973|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
1012647|NCT01514201|2032974|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
1012648|NCT01514201|2032975|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
1012649|NCT01514201|2032972|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
1012650|NCT01514201|2032973|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
1012651|NCT01514201|2032974|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
1012652|NCT01514201|2032975|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
1012653|NCT01514201|2032972|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0
1012654|NCT01514201|2032973|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0
1012655|NCT01514201|2032974|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0
1012656|NCT01514201|2032975|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1
1012657|NCT01514201|2032972|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
1012658|NCT01514201|2032973|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
1012659|NCT01514201|2032974|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
1012660|NCT01514201|2032975|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
1012661|NCT01514201|2032972|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
1012662|NCT01514201|2032973|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
1012663|NCT01514201|2032974|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
1012664|NCT01514201|2032975|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
1012665|NCT01514201|2032972|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
1012666|NCT01514201|2032973|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
1012667|NCT01514201|2032974|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
1012668|NCT01514201|2032975|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
1012669|NCT01514201|2032972|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
1012670|NCT01514201|2032973|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
1012671|NCT01514201|2032974|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
1012672|NCT01514201|2032975|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
1012673|NCT01514201|2032972|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
1012674|NCT01514201|2032973|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
1012675|NCT01514201|2032974|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
1012676|NCT01514201|2032975|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
1012677|NCT01514240|2032997|FG000|Overall Study|Adverse Event|4
1012678|NCT01514240|2032998|FG001|Overall Study|Adverse Event|4
1012679|NCT01514240|2032997|FG000|Overall Study|Subject Decision|2
1012680|NCT01514240|2032998|FG001|Overall Study|Subject Decision|7
1012681|NCT01514357|2033027|FG000|Overall Study|Screen failure|2
1012682|NCT01514357|2033028|FG001|Overall Study|Screen failure|0
1012683|NCT01514357|2033027|FG000|Overall Study|Withdrawal by Subject|2
1012684|NCT01514357|2033028|FG001|Overall Study|Withdrawal by Subject|0
1012685|NCT01514370|2033036|FG000|Overall Study|Protocol Violation|2
1012686|NCT01514370|2033037|FG001|Overall Study|Protocol Violation|3
1012687|NCT01514370|2033036|FG000|Overall Study|Lost to Follow-up|0
1012688|NCT01514370|2033037|FG001|Overall Study|Lost to Follow-up|2
1012689|NCT01514370|2033036|FG000|Overall Study|Withdrawal by Subject|2
1012690|NCT01514370|2033037|FG001|Overall Study|Withdrawal by Subject|1
1012691|NCT01514370|2033036|FG000|Overall Study|Adverse Event|1
1012692|NCT01514370|2033037|FG001|Overall Study|Adverse Event|3
1012693|NCT01514370|2033036|FG000|Overall Study|Other|6
1012694|NCT01514370|2033037|FG001|Overall Study|Other|7
1012695|NCT01514422|2033054|FG000|Overall Study|Lost to Follow-up|1
1012696|NCT01514448|2033060|FG000|Overall Study|Death|7
1012697|NCT01514448|2033061|FG001|Overall Study|Death|8
1012698|NCT01514448|2033060|FG000|Overall Study|Withdrawal by Subject|2
1012699|NCT01514448|2033061|FG001|Overall Study|Withdrawal by Subject|0
1012700|NCT01514448|2033060|FG000|Overall Study|Lost to Follow-up|2
1012701|NCT01514448|2033061|FG001|Overall Study|Lost to Follow-up|0
1012702|NCT01514448|2033060|FG000|Overall Study|New Cancer Therapy|1
1012703|NCT01514448|2033061|FG001|Overall Study|New Cancer Therapy|0
1012704|NCT01514461|2033071|FG000|Overall Study|Adverse Event|2
1012705|NCT01514461|2033072|FG001|Overall Study|Adverse Event|1
1012706|NCT01514461|2033073|FG002|Overall Study|Adverse Event|3
1012707|NCT01514461|2033071|FG000|Overall Study|Physician Decision|1
1012708|NCT01514461|2033072|FG001|Overall Study|Physician Decision|1
1012709|NCT01514461|2033073|FG002|Overall Study|Physician Decision|0
1012710|NCT01514461|2033071|FG000|Overall Study|Patient/guardian decision|1
1012711|NCT01514461|2033072|FG001|Overall Study|Patient/guardian decision|1
1012712|NCT01514461|2033073|FG002|Overall Study|Patient/guardian decision|1
1012713|NCT01514461|2033071|FG000|Overall Study|Death|1
1012714|NCT01514461|2033072|FG001|Overall Study|Death|0
1012715|NCT01514461|2033073|FG002|Overall Study|Death|0
1012716|NCT01514682|2033099|FG000|Overall Study|Withdrawal by Subject|2
1012717|NCT01514682|2033100|FG001|Overall Study|Withdrawal by Subject|3
1012718|NCT01514682|2033099|FG000|Overall Study|Physician Decision|4
1012719|NCT01514682|2033100|FG001|Overall Study|Physician Decision|3
1012720|NCT01514760|2033110|FG000|Overall Study|Lost to Follow-up|2
1012721|NCT01514864|2033125|FG000|Overall Study|Disease progression|7
1012722|NCT01514864|2033126|FG001|Overall Study|Disease progression|5
1012723|NCT01514864|2033125|FG000|Overall Study|Study drug toxicity|2
1012724|NCT01514864|2033126|FG001|Overall Study|Study drug toxicity|0
1012725|NCT01515189|2033173|FG000|Induction|Disease Progression|109
1012726|NCT01515189|2033174|FG001|Induction|Disease Progression|155
1012727|NCT01515189|2033173|FG000|Induction|Study drug toxicity|86
1012728|NCT01515189|2033174|FG001|Induction|Study drug toxicity|36
1012729|NCT01515189|2033173|FG000|Induction|Death|24
1012730|NCT01515189|2033174|FG001|Induction|Death|17
1012731|NCT01515189|2033173|FG000|Induction|Adverse Event|14
1012732|NCT01515189|2033174|FG001|Induction|Adverse Event|9
1012733|NCT01515189|2033173|FG000|Induction|Withdrawal by Subject|3
1012734|NCT01515189|2033174|FG001|Induction|Withdrawal by Subject|9
1012735|NCT01515189|2033173|FG000|Induction|No longer meets study criteria|0
1012736|NCT01515189|2033174|FG001|Induction|No longer meets study criteria|2
1012737|NCT01515189|2033173|FG000|Induction|Lost to Follow-up|1
1012738|NCT01515189|2033174|FG001|Induction|Lost to Follow-up|0
1012739|NCT01515189|2033173|FG000|Induction|Other|0
1012740|NCT01515189|2033174|FG001|Induction|Other|4
1012741|NCT01515189|2033173|FG000|First Re-Induction Phase|Disease progression|6
1012742|NCT01515189|2033174|FG001|First Re-Induction Phase|Disease progression|14
1012743|NCT01515189|2033173|FG000|First Re-Induction Phase|Study drug toxicity|5
1012744|NCT01515189|2033174|FG001|First Re-Induction Phase|Study drug toxicity|0
1012745|NCT01515189|2033173|FG000|First Re-Induction Phase|Withdrawal by Subject|1
1012746|NCT01515189|2033174|FG001|First Re-Induction Phase|Withdrawal by Subject|1
1012747|NCT01515189|2033173|FG000|First Re-Induction Phase|No longer meets study criteria|1
1012748|NCT01515189|2033174|FG001|First Re-Induction Phase|No longer meets study criteria|0
1012749|NCT01515189|2033173|FG000|First Re-Induction Phase|Other|1
1012750|NCT01515189|2033174|FG001|First Re-Induction Phase|Other|0
1012751|NCT01515306|2033182|FG000|Overall Study|Adverse Event|2
1012752|NCT01515306|2033183|FG001|Overall Study|Adverse Event|0
1012753|NCT01515306|2033182|FG000|Overall Study|Progressive Disease|1
1012754|NCT01515306|2033183|FG001|Overall Study|Progressive Disease|0
1012755|NCT01515306|2033182|FG000|Overall Study|Ongoing receiving treatment|9
1012756|NCT01515306|2033183|FG001|Overall Study|Ongoing receiving treatment|14
1012757|NCT01515319|2033201|FG000|Overall Study|Withdrawal by Subject|0
1012758|NCT01515319|2033202|FG001|Overall Study|Withdrawal by Subject|0
1012759|NCT01515319|2033203|FG002|Overall Study|Withdrawal by Subject|0
1012760|NCT01515319|2033204|FG003|Overall Study|Withdrawal by Subject|0
1012761|NCT01515319|2033205|FG004|Overall Study|Withdrawal by Subject|0
1012762|NCT01515319|2033206|FG005|Overall Study|Withdrawal by Subject|0
1012763|NCT01515319|2033207|FG006|Overall Study|Withdrawal by Subject|1
1012764|NCT01515319|2033208|FG007|Overall Study|Withdrawal by Subject|0
1012765|NCT01515319|2033209|FG008|Overall Study|Withdrawal by Subject|0
1012766|NCT01515319|2033210|FG009|Overall Study|Withdrawal by Subject|0
1012767|NCT01515319|2033201|FG000|Overall Study|Adverse Event|0
1012768|NCT01515319|2033202|FG001|Overall Study|Adverse Event|0
1012769|NCT01515319|2033203|FG002|Overall Study|Adverse Event|0
1012770|NCT01515319|2033204|FG003|Overall Study|Adverse Event|0
1012771|NCT01515319|2033205|FG004|Overall Study|Adverse Event|0
1012772|NCT01515319|2033206|FG005|Overall Study|Adverse Event|0
1012773|NCT01515319|2033207|FG006|Overall Study|Adverse Event|0
1012774|NCT01515319|2033208|FG007|Overall Study|Adverse Event|0
1012775|NCT01515319|2033209|FG008|Overall Study|Adverse Event|3
1012776|NCT01515319|2033210|FG009|Overall Study|Adverse Event|0
1012777|NCT01515319|2033201|FG000|Overall Study|Protocol Violation|0
1012778|NCT01515319|2033202|FG001|Overall Study|Protocol Violation|0
1012779|NCT01515319|2033203|FG002|Overall Study|Protocol Violation|0
1012780|NCT01515319|2033204|FG003|Overall Study|Protocol Violation|0
1012781|NCT01515319|2033205|FG004|Overall Study|Protocol Violation|0
1012782|NCT01515319|2033206|FG005|Overall Study|Protocol Violation|0
1012783|NCT01515319|2033207|FG006|Overall Study|Protocol Violation|0
1012784|NCT01515319|2033208|FG007|Overall Study|Protocol Violation|0
1012785|NCT01515319|2033209|FG008|Overall Study|Protocol Violation|2
1012786|NCT01515319|2033210|FG009|Overall Study|Protocol Violation|0
1012787|NCT01515423|2033250|FG000|Open Label Phase|Adverse Event|57
1012788|NCT01515423|2033251|FG001|Open Label Phase|Adverse Event|0
1012789|NCT01515423|2033252|FG002|Open Label Phase|Adverse Event|0
1012790|NCT01515423|2033250|FG000|Open Label Phase|Death|2
1012791|NCT01515423|2033251|FG001|Open Label Phase|Death|0
1012792|NCT01515423|2033252|FG002|Open Label Phase|Death|0
1012793|NCT01515423|2033250|FG000|Open Label Phase|Lack of Efficacy|117
1012794|NCT01515423|2033251|FG001|Open Label Phase|Lack of Efficacy|0
1012795|NCT01515423|2033252|FG002|Open Label Phase|Lack of Efficacy|0
1012796|NCT01515423|2033250|FG000|Open Label Phase|Lost to Follow-up|21
1012797|NCT01515423|2033251|FG001|Open Label Phase|Lost to Follow-up|0
1012798|NCT01515423|2033252|FG002|Open Label Phase|Lost to Follow-up|0
1012799|NCT01515423|2033250|FG000|Open Label Phase|Withdrawal by Subject|118
1012800|NCT01515423|2033251|FG001|Open Label Phase|Withdrawal by Subject|0
1012801|NCT01515423|2033252|FG002|Open Label Phase|Withdrawal by Subject|0
1012802|NCT01515423|2033250|FG000|Open Label Phase|excluded from DB Phase|70
1012803|NCT01515423|2033251|FG001|Open Label Phase|excluded from DB Phase|0
1012804|NCT01515423|2033252|FG002|Open Label Phase|excluded from DB Phase|0
1012805|NCT01515423|2033250|FG000|Open Label Phase|Other|28
1012806|NCT01515423|2033251|FG001|Open Label Phase|Other|0
1012807|NCT01515423|2033252|FG002|Open Label Phase|Other|0
1012808|NCT01515423|2033250|FG000|DOUBLE BLIND|Adverse Event|0
1012809|NCT01515423|2033251|FG001|DOUBLE BLIND|Adverse Event|15
1012810|NCT01515423|2033252|FG002|DOUBLE BLIND|Adverse Event|13
1012811|NCT01515423|2033250|FG000|DOUBLE BLIND|Death|0
1012812|NCT01515423|2033251|FG001|DOUBLE BLIND|Death|1
1012813|NCT01515423|2033252|FG002|DOUBLE BLIND|Death|2
1012814|NCT01515423|2033250|FG000|DOUBLE BLIND|Lost to Follow-up|0
1012815|NCT01515423|2033251|FG001|DOUBLE BLIND|Lost to Follow-up|7
1012816|NCT01515423|2033252|FG002|DOUBLE BLIND|Lost to Follow-up|12
1012817|NCT01515423|2033250|FG000|DOUBLE BLIND|Pregnancy|0
1012818|NCT01515423|2033251|FG001|DOUBLE BLIND|Pregnancy|2
1012819|NCT01515423|2033252|FG002|DOUBLE BLIND|Pregnancy|0
1012820|NCT01515423|2033250|FG000|DOUBLE BLIND|Withdrawal by Subject|0
1012821|NCT01515423|2033251|FG001|DOUBLE BLIND|Withdrawal by Subject|50
1012822|NCT01515423|2033252|FG002|DOUBLE BLIND|Withdrawal by Subject|53
1012823|NCT01515423|2033250|FG000|DOUBLE BLIND|Other|0
1012824|NCT01515423|2033251|FG001|DOUBLE BLIND|Other|6
1012825|NCT01515423|2033252|FG002|DOUBLE BLIND|Other|12
1012826|NCT01515423|2033250|FG000|DOUBLE BLIND|Blind broken by investigator|0
1012827|NCT01515423|2033251|FG001|DOUBLE BLIND|Blind broken by investigator|1
1012828|NCT01515423|2033252|FG002|DOUBLE BLIND|Blind broken by investigator|0
1012829|NCT01515475|2033263|FG000|Overall Study|Lost to Follow-up|20
1012830|NCT01515475|2033264|FG001|Overall Study|Lost to Follow-up|15
1012831|NCT01515475|2033265|FG002|Overall Study|Lost to Follow-up|12
1012832|NCT01515475|2033266|FG003|Overall Study|Lost to Follow-up|12
1012833|NCT01515748|2033324|FG000|Overall Study|Withdrawal by Subject|32
1012834|NCT01515748|2033325|FG001|Overall Study|Withdrawal by Subject|41
1012835|NCT01515748|2033324|FG000|Overall Study|Lost to Follow-up|2
1012836|NCT01515748|2033325|FG001|Overall Study|Lost to Follow-up|4
1012837|NCT01515748|2033324|FG000|Overall Study|Ongoing|86
1012838|NCT01515748|2033325|FG001|Overall Study|Ongoing|90
1012839|NCT01515865|2033332|FG000|Part A (Open-label)|Other|3
1012840|NCT01515865|2033333|FG001|Part A (Open-label)|Other|0
1012841|NCT01515865|2033334|FG002|Part A (Open-label)|Other|0
1012842|NCT01515865|2033332|FG000|Part B (Open-label)|Withdrawal by Subject|1
1012843|NCT01515865|2033333|FG001|Part B (Open-label)|Withdrawal by Subject|0
1012844|NCT01515865|2033334|FG002|Part B (Open-label)|Withdrawal by Subject|0
1012845|NCT01515865|2033332|FG000|Part B (Open-label)|Other|1
1012846|NCT01515865|2033333|FG001|Part B (Open-label)|Other|0
1012847|NCT01515865|2033334|FG002|Part B (Open-label)|Other|0
1012848|NCT01516008|2033378|FG000|Overall Study|Adverse Event|0
1012849|NCT01516008|2033379|FG001|Overall Study|Adverse Event|2
1012850|NCT01516008|2033380|FG002|Overall Study|Adverse Event|7
1012851|NCT01516008|2033378|FG000|Overall Study|Lack of Efficacy|44
1012852|NCT01516008|2033379|FG001|Overall Study|Lack of Efficacy|14
1012853|NCT01516008|2033380|FG002|Overall Study|Lack of Efficacy|10
1012854|NCT01516008|2033378|FG000|Overall Study|Protocol Violation|1
1012855|NCT01516008|2033379|FG001|Overall Study|Protocol Violation|0
1012856|NCT01516008|2033380|FG002|Overall Study|Protocol Violation|0
1012857|NCT01516008|2033378|FG000|Overall Study|Reason not specified|0
1012858|NCT01516008|2033379|FG001|Overall Study|Reason not specified|0
1012859|NCT01516008|2033380|FG002|Overall Study|Reason not specified|1
1012860|NCT01516437|2033410|FG000|Overall Study|Reason not specified|0
1012861|NCT01516437|2033411|FG001|Overall Study|Reason not specified|0
1012862|NCT01516437|2033412|FG002|Overall Study|Reason not specified|1
1012863|NCT01516437|2033413|FG003|Overall Study|Reason not specified|1
1012864|NCT01516736|2033449|FG000|Overall Study|Withdrawal by Subject|10
1012865|NCT01516736|2033450|FG001|Overall Study|Withdrawal by Subject|4
1012866|NCT01516736|2033449|FG000|Overall Study|Adverse Event|4
1012867|NCT01516736|2033450|FG001|Overall Study|Adverse Event|5
1012868|NCT01516736|2033449|FG000|Overall Study|Death|3
1012869|NCT01516736|2033450|FG001|Overall Study|Death|1
1012870|NCT01516736|2033449|FG000|Overall Study|Physician Decision|2
1012871|NCT01516736|2033450|FG001|Overall Study|Physician Decision|1
1012872|NCT01516736|2033449|FG000|Overall Study|Lack of Efficacy|1
1012873|NCT01516736|2033450|FG001|Overall Study|Lack of Efficacy|0
1012874|NCT01516736|2033449|FG000|Overall Study|Protocol Violation|0
1012875|NCT01516736|2033450|FG001|Overall Study|Protocol Violation|1
1012876|NCT01516736|2033449|FG000|Overall Study|Other (not specified)|0
1012877|NCT01516736|2033450|FG001|Overall Study|Other (not specified)|1
1012878|NCT01516749|2033456|FG000|Active Therapy|Lost to Follow-up|1
1012879|NCT01516749|2033456|FG000|Follow-up Off Therapy|Lost to Follow-up|1
1012880|NCT01516879|2033462|FG000|Overall Study|Withdrawal by Subject|9
1012881|NCT01516879|2033463|FG001|Overall Study|Withdrawal by Subject|11
1012882|NCT01516879|2033462|FG000|Overall Study|Death|0
1012883|NCT01516879|2033463|FG001|Overall Study|Death|2
1012884|NCT01516879|2033462|FG000|Overall Study|Lost to Follow-up|2
1012885|NCT01516879|2033463|FG001|Overall Study|Lost to Follow-up|11
1012886|NCT01516879|2033462|FG000|Overall Study|Other|5
1012887|NCT01516879|2033463|FG001|Overall Study|Other|10
1012888|NCT01516892|2033469|FG000|Overall Study|Adverse Event|25
1012889|NCT01516892|2033469|FG000|Overall Study|Lack of Efficacy|35
1012890|NCT01516892|2033469|FG000|Overall Study|Pregnancy|5
1012891|NCT01516892|2033469|FG000|Overall Study|Lost to Follow-up|82
1012892|NCT01516892|2033469|FG000|Overall Study|Subject Withdrew Consent|92
1012893|NCT01516892|2033469|FG000|Overall Study|Protocol Violation|60
1012894|NCT01516892|2033469|FG000|Overall Study|Other Miscellaneous Reasons|43
1012895|NCT01516892|2033469|FG000|Overall Study|Missing|1
1012896|NCT01516970|2033490|FG000|Overall Study|Lost to Follow-up|7
1012897|NCT01516970|2033491|FG001|Overall Study|Lost to Follow-up|8
1012898|NCT01516970|2033490|FG000|Overall Study|Adverse Event|1
1012899|NCT01516970|2033491|FG001|Overall Study|Adverse Event|5
1012900|NCT01516970|2033490|FG000|Overall Study|Withdrawal by Subject|1
1012901|NCT01516970|2033491|FG001|Overall Study|Withdrawal by Subject|1
1012902|NCT01516970|2033490|FG000|Overall Study|Other|9
1012903|NCT01516970|2033491|FG001|Overall Study|Other|7
1012904|NCT01517178|2033506|FG000|Period 1|Adverse Event|1
1012905|NCT01517178|2033507|FG001|Period 1|Adverse Event|2
1012906|NCT01517178|2033506|FG000|Period 1|Lack of Efficacy|0
1012907|NCT01517178|2033507|FG001|Period 1|Lack of Efficacy|1
1012908|NCT01517178|2033506|FG000|Period 1|E.g. study termination|3
1012909|NCT01517178|2033507|FG001|Period 1|E.g. study termination|1
1012910|NCT01517178|2033506|FG000|Period 1|Withdrawal by Subject|0
1012911|NCT01517178|2033507|FG001|Period 1|Withdrawal by Subject|1
1012912|NCT01517178|2033506|FG000|Period 2|Adverse Event|1
1012913|NCT01517178|2033507|FG001|Period 2|Adverse Event|0
1012914|NCT01517178|2033506|FG000|Period 2|Withdrawal by Subject|3
1012915|NCT01517178|2033507|FG001|Period 2|Withdrawal by Subject|0
1012916|NCT01517178|2033506|FG000|Period 2|E.g. study termination|2
1012917|NCT01517178|2033507|FG001|Period 2|E.g. study termination|2
1012918|NCT01517282|2033517|FG000|Overall Study|Consent withdrawn|0
1012919|NCT01517282|2033518|FG001|Overall Study|Consent withdrawn|1
1012920|NCT01517282|2033519|FG002|Overall Study|Consent withdrawn|1
1012921|NCT01517282|2033520|FG003|Overall Study|Consent withdrawn|1
1012922|NCT01517282|2033517|FG000|Overall Study|Physician Decision|1
1012923|NCT01517282|2033518|FG001|Overall Study|Physician Decision|0
1012924|NCT01517282|2033519|FG002|Overall Study|Physician Decision|0
1012925|NCT01517282|2033520|FG003|Overall Study|Physician Decision|0
1012926|NCT01517295|2033532|FG000|Overall Study|Physician Decision|1
1012927|NCT01517295|2033533|FG001|Overall Study|Physician Decision|0
1012928|NCT01517373|2033544|FG000|Run-in Period|Death|1
1012929|NCT01517373|2033545|FG001|Run-in Period|Death|0
1012930|NCT01517373|2033546|FG002|Run-in Period|Death|0
1012931|NCT01517373|2033547|FG003|Run-in Period|Death|0
1012932|NCT01517373|2033548|FG004|Run-in Period|Death|0
1012933|NCT01517373|2033549|FG005|Run-in Period|Death|0
1012934|NCT01517373|2033544|FG000|Run-in Period|Adverse Event|5
1012935|NCT01517373|2033545|FG001|Run-in Period|Adverse Event|0
1012936|NCT01517373|2033546|FG002|Run-in Period|Adverse Event|0
1012937|NCT01517373|2033547|FG003|Run-in Period|Adverse Event|0
1012938|NCT01517373|2033548|FG004|Run-in Period|Adverse Event|0
1012939|NCT01517373|2033549|FG005|Run-in Period|Adverse Event|0
1012940|NCT01517373|2033544|FG000|Run-in Period|Did not meet eligibility criteria|34
1012941|NCT01517373|2033545|FG001|Run-in Period|Did not meet eligibility criteria|0
1012942|NCT01517373|2033546|FG002|Run-in Period|Did not meet eligibility criteria|0
1012943|NCT01517373|2033547|FG003|Run-in Period|Did not meet eligibility criteria|0
1012944|NCT01517373|2033548|FG004|Run-in Period|Did not meet eligibility criteria|0
1012945|NCT01517373|2033549|FG005|Run-in Period|Did not meet eligibility criteria|0
1012946|NCT01517373|2033544|FG000|Run-in Period|Lost to Follow-up|1
1012947|NCT01517373|2033545|FG001|Run-in Period|Lost to Follow-up|0
1012948|NCT01517373|2033546|FG002|Run-in Period|Lost to Follow-up|0
1012949|NCT01517373|2033547|FG003|Run-in Period|Lost to Follow-up|0
1012950|NCT01517373|2033548|FG004|Run-in Period|Lost to Follow-up|0
1012951|NCT01517373|2033549|FG005|Run-in Period|Lost to Follow-up|0
1012952|NCT01517373|2033544|FG000|Run-in Period|Withdrawal by Subject|12
1012953|NCT01517373|2033545|FG001|Run-in Period|Withdrawal by Subject|0
1012954|NCT01517373|2033546|FG002|Run-in Period|Withdrawal by Subject|0
1012955|NCT01517373|2033547|FG003|Run-in Period|Withdrawal by Subject|0
1012956|NCT01517373|2033548|FG004|Run-in Period|Withdrawal by Subject|0
1012957|NCT01517373|2033549|FG005|Run-in Period|Withdrawal by Subject|0
1012958|NCT01517373|2033544|FG000|Run-in Period|Sponsor Decision|3
1012959|NCT01517373|2033545|FG001|Run-in Period|Sponsor Decision|0
1012960|NCT01517373|2033546|FG002|Run-in Period|Sponsor Decision|0
1012961|NCT01517373|2033547|FG003|Run-in Period|Sponsor Decision|0
1012962|NCT01517373|2033548|FG004|Run-in Period|Sponsor Decision|0
1012963|NCT01517373|2033549|FG005|Run-in Period|Sponsor Decision|0
1012964|NCT01517373|2033544|FG000|Run-in Period|Other|1
1012965|NCT01517373|2033545|FG001|Run-in Period|Other|0
1012966|NCT01517373|2033546|FG002|Run-in Period|Other|0
1012967|NCT01517373|2033547|FG003|Run-in Period|Other|0
1012968|NCT01517373|2033548|FG004|Run-in Period|Other|0
1012969|NCT01517373|2033549|FG005|Run-in Period|Other|0
1012970|NCT01517373|2033544|FG000|Treatment Period|Adverse Event|0
1012971|NCT01517373|2033545|FG001|Treatment Period|Adverse Event|0
1012972|NCT01517373|2033546|FG002|Treatment Period|Adverse Event|0
1012973|NCT01517373|2033547|FG003|Treatment Period|Adverse Event|0
1012974|NCT01517373|2033548|FG004|Treatment Period|Adverse Event|0
1012975|NCT01517373|2033549|FG005|Treatment Period|Adverse Event|2
1012976|NCT01517373|2033544|FG000|Treatment Period|Lost to Follow-up|0
1012977|NCT01517373|2033545|FG001|Treatment Period|Lost to Follow-up|0
1012978|NCT01517373|2033546|FG002|Treatment Period|Lost to Follow-up|1
1012979|NCT01517373|2033547|FG003|Treatment Period|Lost to Follow-up|1
1012980|NCT01517373|2033548|FG004|Treatment Period|Lost to Follow-up|0
1012981|NCT01517373|2033549|FG005|Treatment Period|Lost to Follow-up|0
1012982|NCT01517373|2033544|FG000|Treatment Period|Withdrawal by Subject|0
1012983|NCT01517373|2033545|FG001|Treatment Period|Withdrawal by Subject|3
1012984|NCT01517373|2033546|FG002|Treatment Period|Withdrawal by Subject|2
1012985|NCT01517373|2033547|FG003|Treatment Period|Withdrawal by Subject|2
1012986|NCT01517373|2033548|FG004|Treatment Period|Withdrawal by Subject|2
1012987|NCT01517373|2033549|FG005|Treatment Period|Withdrawal by Subject|3
1012988|NCT01517373|2033544|FG000|Treatment Period|Other|0
1012989|NCT01517373|2033545|FG001|Treatment Period|Other|0
1012990|NCT01517373|2033546|FG002|Treatment Period|Other|0
1012991|NCT01517373|2033547|FG003|Treatment Period|Other|0
1012992|NCT01517373|2033548|FG004|Treatment Period|Other|1
1012993|NCT01517373|2033549|FG005|Treatment Period|Other|0
1012994|NCT01517373|2033544|FG000|Treatment Period|Protocol Violation|0
1012995|NCT01517373|2033545|FG001|Treatment Period|Protocol Violation|0
1012996|NCT01517373|2033546|FG002|Treatment Period|Protocol Violation|0
1012997|NCT01517373|2033547|FG003|Treatment Period|Protocol Violation|0
1012998|NCT01517373|2033548|FG004|Treatment Period|Protocol Violation|1
1012999|NCT01517373|2033549|FG005|Treatment Period|Protocol Violation|0
1013000|NCT01517373|2033544|FG000|Treatment Period|Lack of Efficacy|0
1013001|NCT01517373|2033545|FG001|Treatment Period|Lack of Efficacy|1
1013002|NCT01517373|2033546|FG002|Treatment Period|Lack of Efficacy|1
1013003|NCT01517373|2033547|FG003|Treatment Period|Lack of Efficacy|3
1013004|NCT01517373|2033548|FG004|Treatment Period|Lack of Efficacy|2
1013005|NCT01517373|2033549|FG005|Treatment Period|Lack of Efficacy|0
1013006|NCT01517373|2033544|FG000|Treatment Period|Medication error without AEs|0
1013007|NCT01517373|2033545|FG001|Treatment Period|Medication error without AEs|0
1013008|NCT01517373|2033546|FG002|Treatment Period|Medication error without AEs|2
1013009|NCT01517373|2033547|FG003|Treatment Period|Medication error without AEs|1
1013010|NCT01517373|2033548|FG004|Treatment Period|Medication error without AEs|0
1013011|NCT01517373|2033549|FG005|Treatment Period|Medication error without AEs|2
1013012|NCT01517412|2033564|FG000|Overall Study|Adverse Event|10
1013013|NCT01517412|2033565|FG001|Overall Study|Adverse Event|11
1013014|NCT01517412|2033564|FG000|Overall Study|Lack of Efficacy|10
1013015|NCT01517412|2033565|FG001|Overall Study|Lack of Efficacy|5
1013016|NCT01517412|2033564|FG000|Overall Study|Poor compliance to protocol|8
1013017|NCT01517412|2033565|FG001|Overall Study|Poor compliance to protocol|3
1013018|NCT01517412|2033564|FG000|Overall Study|Other than specified above|8
1013019|NCT01517412|2033565|FG001|Overall Study|Other than specified above|5
1013020|NCT01517750|2033584|FG000|Overall Study|Lost to Follow-up|1
1013021|NCT01517750|2033585|FG001|Overall Study|Lost to Follow-up|2
1013022|NCT01517750|2033586|FG002|Overall Study|Lost to Follow-up|4
1013023|NCT01517750|2033587|FG003|Overall Study|Lost to Follow-up|1
1013024|NCT01517867|2033603|FG000|Overall Study|never started treatment|29
1013025|NCT01517867|2033604|FG001|Overall Study|never started treatment|32
1013026|NCT01517867|2033603|FG000|Overall Study|Withdrawal by Subject|34
1013027|NCT01517867|2033604|FG001|Overall Study|Withdrawal by Subject|30
1013028|NCT01517867|2033603|FG000|Overall Study|Still in treatment at study end|0
1013029|NCT01517867|2033604|FG001|Overall Study|Still in treatment at study end|3
1013030|NCT01517893|2033612|FG000|Overall Study|Withdrawal by Subject|3
1013031|NCT01517893|2033613|FG001|Overall Study|Withdrawal by Subject|0
1013032|NCT01517984|2033622|FG000|Overall Study|Lost to Follow-up|0
1013033|NCT01517984|2033623|FG001|Overall Study|Lost to Follow-up|1
1013034|NCT01517984|2033624|FG002|Overall Study|Lost to Follow-up|0
1013035|NCT01517984|2033625|FG003|Overall Study|Lost to Follow-up|0
1013036|NCT01517984|2033622|FG000|Overall Study|Withdrawal by Subject|1
1013037|NCT01517984|2033623|FG001|Overall Study|Withdrawal by Subject|8
1013038|NCT01517984|2033624|FG002|Overall Study|Withdrawal by Subject|4
1013039|NCT01517984|2033625|FG003|Overall Study|Withdrawal by Subject|1
1013040|NCT01517984|2033622|FG000|Overall Study|Screen Failure|4
1013041|NCT01517984|2033623|FG001|Overall Study|Screen Failure|0
1013042|NCT01517984|2033624|FG002|Overall Study|Screen Failure|0
1013043|NCT01517984|2033625|FG003|Overall Study|Screen Failure|0
1013044|NCT01517984|2033622|FG000|Overall Study|Ineligible for randomization|0
1013045|NCT01517984|2033623|FG001|Overall Study|Ineligible for randomization|14
1013046|NCT01517984|2033624|FG002|Overall Study|Ineligible for randomization|0
1013047|NCT01517984|2033625|FG003|Overall Study|Ineligible for randomization|0
1013048|NCT01518153|2033632|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
1013049|NCT01518153|2033633|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
1013050|NCT01518153|2033634|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
1013051|NCT01518153|2033632|FG000|Stem Cell Transplant|Death|2
1013052|NCT01518153|2033633|FG001|Stem Cell Transplant|Death|0
1013053|NCT01518153|2033634|FG002|Stem Cell Transplant|Death|0
1013054|NCT01518153|2033632|FG000|Stem Cell Transplant|Secondary graft failure|1
1013055|NCT01518153|2033633|FG001|Stem Cell Transplant|Secondary graft failure|0
1013056|NCT01518153|2033634|FG002|Stem Cell Transplant|Secondary graft failure|0
1013057|NCT01518153|2033632|FG000|Stem Cell Transplant|Adverse Event|1
1013058|NCT01518153|2033633|FG001|Stem Cell Transplant|Adverse Event|0
1013059|NCT01518153|2033634|FG002|Stem Cell Transplant|Adverse Event|0
1013060|NCT01518153|2033632|FG000|Donor Lymphocyte Infusion|Death|0
1013061|NCT01518153|2033633|FG001|Donor Lymphocyte Infusion|Death|2
1013062|NCT01518153|2033634|FG002|Donor Lymphocyte Infusion|Death|1
1013063|NCT01518192|2033645|FG000|Overall Study|Lost to Follow-up|29
1013064|NCT01518192|2033646|FG001|Overall Study|Lost to Follow-up|26
1013065|NCT01518192|2033647|FG002|Overall Study|Lost to Follow-up|35
1013066|NCT01518244|2033661|FG000|Overall Study|Adverse Event|3
1013067|NCT01518257|2033667|FG000|Overall Study|Lost to Follow-up|1
1013068|NCT01518257|2033668|FG001|Overall Study|Lost to Follow-up|0
1013069|NCT01518257|2033667|FG000|Overall Study|Other Miscellaneous Reason|1
1013070|NCT01518257|2033668|FG001|Overall Study|Other Miscellaneous Reason|0
1013071|NCT01518309|2033678|FG000|Overall Study|Adverse Event|6
1013072|NCT01518309|2033678|FG000|Overall Study|Death|6
1013073|NCT01518309|2033678|FG000|Overall Study|Lack of Efficacy|7
1013074|NCT01518309|2033678|FG000|Overall Study|Withdrawal by Subject|6
1013075|NCT01518309|2033678|FG000|Overall Study|Physician Decision|3
1013076|NCT01518309|2033678|FG000|Overall Study|Sponsor Decision|2
1013077|NCT01518309|2033678|FG000|Overall Study|Not in Predefined Categories|9
1013078|NCT01518322|2033682|FG000|Overall Study|FeNO measurement was missing|13
1013079|NCT01518374|2033691|FG000|Overall Study|Withdrawal by Subject|2
1013080|NCT01518374|2033691|FG000|Overall Study|Protocol Violation|3
1013081|NCT01518374|2033691|FG000|Overall Study|Lost to Follow-up|2
1013082|NCT01518699|2033705|FG000|Period 2|Protocol Violation|1
1013083|NCT01518699|2033706|FG001|Period 2|Protocol Violation|1
1013084|NCT01518699|2033707|FG002|Period 2|Protocol Violation|0
1013085|NCT01518699|2033708|FG003|Period 2|Protocol Violation|0
1013086|NCT01518699|2033709|FG004|Period 2|Protocol Violation|0
1013087|NCT01518699|2033710|FG005|Period 2|Protocol Violation|0
1013088|NCT01518699|2033705|FG000|Period 2|Lost to Follow-up|0
1013089|NCT01518699|2033706|FG001|Period 2|Lost to Follow-up|1
1013090|NCT01518699|2033707|FG002|Period 2|Lost to Follow-up|0
1013091|NCT01518699|2033708|FG003|Period 2|Lost to Follow-up|0
1013092|NCT01518699|2033709|FG004|Period 2|Lost to Follow-up|0
1013093|NCT01518699|2033710|FG005|Period 2|Lost to Follow-up|0
1013094|NCT01518699|2033705|FG000|Period 2|Adverse Event|1
1013095|NCT01518699|2033706|FG001|Period 2|Adverse Event|0
1013096|NCT01518699|2033707|FG002|Period 2|Adverse Event|0
1013097|NCT01518699|2033708|FG003|Period 2|Adverse Event|0
1013098|NCT01518699|2033709|FG004|Period 2|Adverse Event|0
1013099|NCT01518699|2033710|FG005|Period 2|Adverse Event|0
1013100|NCT01518946|2033727|FG000|Open-label Phase|Other|4
1013101|NCT01518946|2033728|FG001|Open-label Phase|Other|0
1013102|NCT01518946|2033729|FG002|Open-label Phase|Other|0
1013103|NCT01518946|2033727|FG000|Randomized Phase (First Intervention)|Other|0
1013104|NCT01518946|2033728|FG001|Randomized Phase (First Intervention)|Other|1
1013105|NCT01518946|2033729|FG002|Randomized Phase (First Intervention)|Other|0
1013106|NCT01518972|2033738|FG000|Overall Study|Lost to Follow-up|2
1013107|NCT01518972|2033739|FG001|Overall Study|Lost to Follow-up|1
1013108|NCT01518972|2033738|FG000|Overall Study|Withdrawal by Subject|1
1013109|NCT01518972|2033739|FG001|Overall Study|Withdrawal by Subject|0
1013110|NCT01518972|2033738|FG000|Overall Study|Moved from area|1
1013111|NCT01518972|2033739|FG001|Overall Study|Moved from area|0
1013112|NCT01518972|2033738|FG000|Overall Study|Transportation problems|1
1013113|NCT01518972|2033739|FG001|Overall Study|Transportation problems|0
1013114|NCT01518972|2033738|FG000|Overall Study|Exclusionary medical condition|1
1013115|NCT01518972|2033739|FG001|Overall Study|Exclusionary medical condition|0
1013116|NCT01518972|2033738|FG000|Overall Study|Missed safety visits|0
1013117|NCT01518972|2033739|FG001|Overall Study|Missed safety visits|1
1013118|NCT01518972|2033738|FG000|Overall Study|Exclusionary medication|0
1013119|NCT01518972|2033739|FG001|Overall Study|Exclusionary medication|1
1013120|NCT01518972|2033738|FG000|Overall Study|Declined medication starting on day 12|0
1013121|NCT01518972|2033739|FG001|Overall Study|Declined medication starting on day 12|1
1013122|NCT01519089|2033756|FG000|Overall Study|Adverse Event|4
1013123|NCT01519089|2033757|FG001|Overall Study|Adverse Event|4
1013124|NCT01519089|2033756|FG000|Overall Study|Lack of Efficacy|0
1013125|NCT01519089|2033757|FG001|Overall Study|Lack of Efficacy|2
1013126|NCT01519089|2033756|FG000|Overall Study|Lost to Follow-up|1
1013127|NCT01519089|2033757|FG001|Overall Study|Lost to Follow-up|0
1013128|NCT01519089|2033756|FG000|Overall Study|Withdrawal by Subject|0
1013129|NCT01519089|2033757|FG001|Overall Study|Withdrawal by Subject|2
1013130|NCT01519089|2033756|FG000|Overall Study|Other|2
1013131|NCT01519089|2033757|FG001|Overall Study|Other|6
1013132|NCT01519089|2033756|FG000|Overall Study|Not received study drug|0
1013133|NCT01519089|2033757|FG001|Overall Study|Not received study drug|1
1013134|NCT01519167|2033767|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
1013135|NCT01519167|2033768|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
1013136|NCT01519167|2033767|FG000|Overall Study|Adverse Event|0
1013137|NCT01519167|2033768|FG001|Overall Study|Adverse Event|1
1013138|NCT01519167|2033767|FG000|Overall Study|Lack of Efficacy|0
1013139|NCT01519167|2033768|FG001|Overall Study|Lack of Efficacy|1
1013140|NCT01519167|2033767|FG000|Overall Study|Medical condition changes&deep sedation|0
1013141|NCT01519167|2033768|FG001|Overall Study|Medical condition changes&deep sedation|2
1013142|NCT01519167|2033767|FG000|Overall Study|Physician Decision|0
1013143|NCT01519167|2033768|FG001|Overall Study|Physician Decision|1
1013144|NCT01519206|2033774|FG000|Overall Study|Lost to Follow-up|3
1013145|NCT01519206|2033774|FG000|Overall Study|Missed Visit|2
1013146|NCT01519245|2033787|FG000|Overall Study|Met exclusion criteria, not analysed|1
1013147|NCT01519245|2033788|FG001|Overall Study|Met exclusion criteria, not analysed|2
1013148|NCT01519323|2033828|FG000|Overall Study|Death|3
1013149|NCT01519323|2033829|FG001|Overall Study|Death|2
1013150|NCT01519323|2033828|FG000|Overall Study|Study terminated by sponsor|0
1013151|NCT01519323|2033829|FG001|Overall Study|Study terminated by sponsor|1
1013152|NCT01519427|2033850|FG000|Overall Study|disease progression|2
1013153|NCT01519518|2033874|FG000|Overall Study|Consent not available|7
1013154|NCT01519518|2033875|FG001|Overall Study|Consent not available|10
1013155|NCT01519635|2033892|FG000|Overall Study|Withdrawal by Subject|0
1013156|NCT01519635|2033893|FG001|Overall Study|Withdrawal by Subject|1
1013157|NCT01519635|2033892|FG000|Overall Study|No possibility to put a catheter|1
1013158|NCT01519635|2033893|FG001|Overall Study|No possibility to put a catheter|2
1013159|NCT01519661|2033908|FG000|Overall Study|Protocol deviation|6
1013160|NCT01519661|2033908|FG000|Overall Study|Lost to Follow-up|3
1013161|NCT01519661|2033908|FG000|Overall Study|Withdrawal by Subject|17
1013162|NCT01519661|2033908|FG000|Overall Study|Lack of Efficacy|6
1013163|NCT01519661|2033908|FG000|Overall Study|Adverse Event|29
1013164|NCT01519674|2033916|FG000|Overall Study|Adverse Event|3
1013165|NCT01519674|2033917|FG001|Overall Study|Adverse Event|3
1013166|NCT01519674|2033918|FG002|Overall Study|Adverse Event|0
1013167|NCT01519674|2033916|FG000|Overall Study|Lack of Efficacy|1
1013168|NCT01519674|2033917|FG001|Overall Study|Lack of Efficacy|1
1013169|NCT01519674|2033918|FG002|Overall Study|Lack of Efficacy|1
1013170|NCT01519674|2033916|FG000|Overall Study|Protocol Violation|0
1013171|NCT01519674|2033917|FG001|Overall Study|Protocol Violation|3
1013172|NCT01519674|2033918|FG002|Overall Study|Protocol Violation|1
1013173|NCT01519674|2033916|FG000|Overall Study|Withdrawal Criteria|7
1013174|NCT01519674|2033917|FG001|Overall Study|Withdrawal Criteria|2
1013175|NCT01519674|2033918|FG002|Overall Study|Withdrawal Criteria|7
1013176|NCT01519674|2033916|FG000|Overall Study|Unsclassified|10
1013177|NCT01519674|2033917|FG001|Overall Study|Unsclassified|4
1013178|NCT01519674|2033918|FG002|Overall Study|Unsclassified|3
1013179|NCT01519700|2033930|FG000|Overall Study|Death|1
1013180|NCT01519700|2033931|FG001|Overall Study|Death|0
1013181|NCT01519700|2033932|FG002|Overall Study|Death|0
1013182|NCT01519700|2033933|FG003|Overall Study|Death|0
1013183|NCT01519700|2033930|FG000|Overall Study|Lost to Follow-up|0
1013184|NCT01519700|2033931|FG001|Overall Study|Lost to Follow-up|0
1013185|NCT01519700|2033932|FG002|Overall Study|Lost to Follow-up|1
1013186|NCT01519700|2033933|FG003|Overall Study|Lost to Follow-up|1
1013187|NCT01519700|2033930|FG000|Overall Study|Physician Decision|1
1013188|NCT01519700|2033931|FG001|Overall Study|Physician Decision|1
1013189|NCT01519700|2033932|FG002|Overall Study|Physician Decision|3
1013190|NCT01519700|2033933|FG003|Overall Study|Physician Decision|0
1013191|NCT01519700|2033930|FG000|Overall Study|Withdrawal by Subject|5
1013192|NCT01519700|2033931|FG001|Overall Study|Withdrawal by Subject|3
1013193|NCT01519700|2033932|FG002|Overall Study|Withdrawal by Subject|3
1013194|NCT01519700|2033933|FG003|Overall Study|Withdrawal by Subject|2
1013195|NCT01519700|2033930|FG000|Overall Study|Other Reason|2
1013196|NCT01519700|2033931|FG001|Overall Study|Other Reason|2
1013197|NCT01519700|2033932|FG002|Overall Study|Other Reason|0
1013198|NCT01519700|2033933|FG003|Overall Study|Other Reason|4
1013199|NCT01519765|2033964|FG000|Overall Study|Adverse Event|0
1013200|NCT01519765|2033965|FG001|Overall Study|Adverse Event|1
1013201|NCT01519765|2033964|FG000|Overall Study|Lack of Efficacy|2
1013202|NCT01519765|2033965|FG001|Overall Study|Lack of Efficacy|0
1013203|NCT01519765|2033964|FG000|Overall Study|Protocol Violation|1
1013204|NCT01519765|2033965|FG001|Overall Study|Protocol Violation|0
1013205|NCT01519765|2033964|FG000|Overall Study|Withdrawal by Subject|0
1013206|NCT01519765|2033965|FG001|Overall Study|Withdrawal by Subject|1
1013207|NCT01519778|2033972|FG000|Overall Study|Withdrawal by Subject|3
1013208|NCT01519778|2033972|FG000|Overall Study|Lost to Follow-up|10
1013209|NCT01519778|2033972|FG000|Overall Study|Physician Decision|1
1013210|NCT01519791|2033978|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
1013211|NCT01519791|2033979|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
1013212|NCT01519791|2033978|FG000|Overall Study|Protocol Violation|6
1013213|NCT01519791|2033979|FG001|Overall Study|Protocol Violation|19
1013214|NCT01519791|2033978|FG000|Overall Study|Other Reason|87
1013215|NCT01519791|2033979|FG001|Overall Study|Other Reason|222
1013216|NCT01519791|2033978|FG000|Overall Study|subjects randomized in error|2
1013217|NCT01519791|2033979|FG001|Overall Study|subjects randomized in error|0
1013218|NCT01519791|2033978|FG000|Overall Study|Lack of Efficacy|16
1013219|NCT01519791|2033979|FG001|Overall Study|Lack of Efficacy|20
1013220|NCT01519791|2033978|FG000|Overall Study|SAE, non-fatal|6
1013221|NCT01519791|2033979|FG001|Overall Study|SAE, non-fatal|22
1013222|NCT01519791|2033978|FG000|Overall Study|AE, serious fatal|0
1013223|NCT01519791|2033979|FG001|Overall Study|AE, serious fatal|1
914377|NCT00814320|1892142|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
914378|NCT00814320|1892143|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
914379|NCT00814346|1892168|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0
914380|NCT00814346|1892169|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1
914381|NCT00814346|1892168|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0
914382|NCT00814346|1892169|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2
914383|NCT00814346|1892168|FG000|Open Phase (17 Months)|Adverse Event|5
914384|NCT00814346|1892169|FG001|Open Phase (17 Months)|Adverse Event|0
914385|NCT00814346|1892168|FG000|Open Phase (17 Months)|Consent|2
914386|NCT00814346|1892169|FG001|Open Phase (17 Months)|Consent|0
1013224|NCT01519791|2033978|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0
1013225|NCT01519791|2033979|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1
1013226|NCT01519791|2033978|FG000|Overall Study|AE, non-serious non-fatal|12
1013227|NCT01519791|2033979|FG001|Overall Study|AE, non-serious non-fatal|31
1013228|NCT01519791|2033978|FG000|Overall Study|Withdrawal by Subject|15
1013229|NCT01519791|2033979|FG001|Overall Study|Withdrawal by Subject|37
1013230|NCT01519791|2033978|FG000|Overall Study|Lost to Follow-up|6
1013231|NCT01519791|2033979|FG001|Overall Study|Lost to Follow-up|14
1013232|NCT01519817|2033987|FG000|Overall Study|Withdrawal by Subject|1
1013233|NCT01519817|2033988|FG001|Overall Study|Withdrawal by Subject|0
1013234|NCT01519817|2033989|FG002|Overall Study|Withdrawal by Subject|0
1013235|NCT01519817|2033990|FG003|Overall Study|Withdrawal by Subject|0
1013236|NCT01519817|2033987|FG000|Overall Study|Off study due to infection|0
1013237|NCT01519817|2033988|FG001|Overall Study|Off study due to infection|0
1013238|NCT01519817|2033989|FG002|Overall Study|Off study due to infection|0
1013239|NCT01519817|2033990|FG003|Overall Study|Off study due to infection|1
1013240|NCT01519869|2034000|FG000|Overall Study|Lost to Follow-up|1
1013241|NCT01519921|2034015|FG000|Overall Study|Adverse Event|10
1013242|NCT01519921|2034016|FG001|Overall Study|Adverse Event|9
1013243|NCT01519921|2034015|FG000|Overall Study|Lack of Efficacy|4
1013244|NCT01519921|2034016|FG001|Overall Study|Lack of Efficacy|3
1013245|NCT01519921|2034015|FG000|Overall Study|Withdrawal by Subject|3
1013246|NCT01519921|2034016|FG001|Overall Study|Withdrawal by Subject|0
1013247|NCT01519921|2034015|FG000|Overall Study|Lost to Follow-up|2
1013248|NCT01519921|2034016|FG001|Overall Study|Lost to Follow-up|1
1013249|NCT01519921|2034015|FG000|Overall Study|Treatment refusal|2
1013250|NCT01519921|2034016|FG001|Overall Study|Treatment refusal|1
1013251|NCT01519921|2034015|FG000|Overall Study|High alanine aminotransferase (ALT)|0
1013252|NCT01519921|2034016|FG001|Overall Study|High alanine aminotransferase (ALT)|1
1013253|NCT01519934|2034022|FG000|Overall Study|Lost to Follow-up|3
1013254|NCT01519947|2034030|FG000|Overall Study|Death|0
1013255|NCT01519947|2034031|FG001|Overall Study|Death|0
1013256|NCT01519947|2034032|FG002|Overall Study|Death|0
1013257|NCT01519947|2034033|FG003|Overall Study|Death|1
1013258|NCT01519947|2034030|FG000|Overall Study|Protocol Violation|0
1013259|NCT01519947|2034031|FG001|Overall Study|Protocol Violation|0
1013260|NCT01519947|2034032|FG002|Overall Study|Protocol Violation|2
1013261|NCT01519947|2034033|FG003|Overall Study|Protocol Violation|1
1013262|NCT01519947|2034030|FG000|Overall Study|Peritoneal Dialysis Needed|0
1013263|NCT01519947|2034031|FG001|Overall Study|Peritoneal Dialysis Needed|1
1013264|NCT01519947|2034032|FG002|Overall Study|Peritoneal Dialysis Needed|0
1013265|NCT01519947|2034033|FG003|Overall Study|Peritoneal Dialysis Needed|0
1013266|NCT01519947|2034030|FG000|Overall Study|Development of Anemia|0
1013267|NCT01519947|2034031|FG001|Overall Study|Development of Anemia|1
1013268|NCT01519947|2034032|FG002|Overall Study|Development of Anemia|0
1013269|NCT01519947|2034033|FG003|Overall Study|Development of Anemia|1
1013270|NCT01519947|2034030|FG000|Overall Study|Blood Transfusion|0
1013271|NCT01519947|2034031|FG001|Overall Study|Blood Transfusion|1
1013272|NCT01519947|2034032|FG002|Overall Study|Blood Transfusion|1
1013273|NCT01519947|2034033|FG003|Overall Study|Blood Transfusion|0
1013274|NCT01519947|2034030|FG000|Overall Study|Withdrawal by Subject|0
1013275|NCT01519947|2034031|FG001|Overall Study|Withdrawal by Subject|1
1013276|NCT01519947|2034032|FG002|Overall Study|Withdrawal by Subject|0
1013277|NCT01519947|2034033|FG003|Overall Study|Withdrawal by Subject|1
1013278|NCT01519947|2034030|FG000|Overall Study|Lost to Follow-up|0
1013279|NCT01519947|2034031|FG001|Overall Study|Lost to Follow-up|0
1013280|NCT01519947|2034032|FG002|Overall Study|Lost to Follow-up|3
1013281|NCT01519947|2034033|FG003|Overall Study|Lost to Follow-up|2
1013282|NCT01519947|2034030|FG000|Overall Study|Poor Response|1
1013283|NCT01519947|2034031|FG001|Overall Study|Poor Response|0
1013284|NCT01519947|2034032|FG002|Overall Study|Poor Response|0
1013285|NCT01519947|2034033|FG003|Overall Study|Poor Response|1
1013286|NCT01519947|2034030|FG000|Overall Study|Adverse Event|1
1013287|NCT01519947|2034031|FG001|Overall Study|Adverse Event|0
1013288|NCT01519947|2034032|FG002|Overall Study|Adverse Event|1
1013289|NCT01519947|2034033|FG003|Overall Study|Adverse Event|1
914387|NCT00814346|1892168|FG000|Open Phase (17 Months)|Lost to Follow-up|2
914388|NCT00814346|1892169|FG001|Open Phase (17 Months)|Lost to Follow-up|0
914389|NCT00814346|1892168|FG000|Open Phase (17 Months)|Not otherwise specified|1
914390|NCT00814346|1892169|FG001|Open Phase (17 Months)|Not otherwise specified|0
914391|NCT00814463|1892188|FG000|Overall Study|Lost to Follow-up|1
914392|NCT00814489|1892196|FG000|Overall Study|Other|2
914393|NCT00814489|1892197|FG001|Overall Study|Other|0
914394|NCT00814489|1892198|FG002|Overall Study|Other|1
914395|NCT00814502|1892210|FG000|Overall Study|Adverse Event|1
914396|NCT00814502|1892211|FG001|Overall Study|Adverse Event|0
914397|NCT00814502|1892210|FG000|Overall Study|Withdrawal by Subject|0
914398|NCT00814502|1892211|FG001|Overall Study|Withdrawal by Subject|2
914399|NCT00814580|1892221|FG000|Overall Study|Adverse Event|6
1013305|NCT01520324|2034072|FG000|Overall Study|Subject discontinued (moderate illness)|1
1013306|NCT01520363|2034078|FG000|Overall Study|Withdrawal by Subject|2
1013307|NCT01520363|2034079|FG001|Overall Study|Withdrawal by Subject|0
1013308|NCT01520402|2034109|FG000|Overall Study|Withdrawal by Subject|2
1013309|NCT01520402|2034109|FG000|Overall Study|Physician Decision|3
1013310|NCT01520506|2034140|FG000|Overall Study|Missed Visit|4
1013311|NCT01520506|2034140|FG000|Overall Study|Lost to Follow-up|1
1013312|NCT01520506|2034140|FG000|Overall Study|Withdrawal by Subject|1
1013313|NCT01520870|2034216|FG000|Overall Study|Withdrawal by Subject|2
1013314|NCT01520909|2034222|FG000|Part 1 (Randomized Period)|Adverse Event|1
1013315|NCT01520909|2034223|FG001|Part 1 (Randomized Period)|Adverse Event|2
1013316|NCT01520909|2034224|FG002|Part 1 (Randomized Period)|Adverse Event|0
1013317|NCT01520909|2034222|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
1013318|NCT01520909|2034223|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
1013319|NCT01520909|2034224|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
1013320|NCT01520909|2034222|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
1013321|NCT01520909|2034223|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
1013322|NCT01520909|2034224|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
1013323|NCT01520909|2034222|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
1013324|NCT01520909|2034223|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
1013325|NCT01520909|2034224|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
1013326|NCT01520922|2034246|FG000|Treatment Phase|Physician Decision|2
1013327|NCT01520922|2034247|FG001|Treatment Phase|Physician Decision|1
1013328|NCT01520922|2034246|FG000|Treatment Phase|Progression|0
1013329|NCT01520922|2034247|FG001|Treatment Phase|Progression|2
1013330|NCT01520922|2034246|FG000|Treatment Phase|Adverse Event|3
1013331|NCT01520922|2034247|FG001|Treatment Phase|Adverse Event|5
1013332|NCT01520922|2034246|FG000|Follow up|Lost to Follow-up|0
1013333|NCT01520922|2034247|FG001|Follow up|Lost to Follow-up|1
1013334|NCT01520922|2034246|FG000|Survival Follow-up|Withdrawal by Subject|1
1013335|NCT01520922|2034247|FG001|Survival Follow-up|Withdrawal by Subject|0
1013336|NCT01520987|2034261|FG000|Overall Study|Withdrawal by Subject|1
1013337|NCT01520987|2034262|FG001|Overall Study|Withdrawal by Subject|0
1013338|NCT01520987|2034263|FG002|Overall Study|Withdrawal by Subject|0
1013339|NCT01520987|2034264|FG003|Overall Study|Withdrawal by Subject|0
1013340|NCT01520987|2034265|FG004|Overall Study|Withdrawal by Subject|0
1013341|NCT01520987|2034266|FG005|Overall Study|Withdrawal by Subject|1
1013342|NCT01520987|2034267|FG006|Overall Study|Withdrawal by Subject|0
1013343|NCT01520987|2034268|FG007|Overall Study|Withdrawal by Subject|0
1013344|NCT01521117|2034293|FG000|First Intervention (6 Weeks)|Adverse Event|5
1013345|NCT01521117|2034294|FG001|First Intervention (6 Weeks)|Adverse Event|1
1013346|NCT01521117|2034293|FG000|First Intervention (6 Weeks)|Scheduling Issues|0
1013347|NCT01521117|2034294|FG001|First Intervention (6 Weeks)|Scheduling Issues|2
1013348|NCT01521117|2034293|FG000|Second Intervention (6 Weeks)|Adverse Event|0
1013349|NCT01521117|2034294|FG001|Second Intervention (6 Weeks)|Adverse Event|3
1013350|NCT01521364|2034309|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
1013351|NCT01521364|2034309|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
1013352|NCT01521494|2034325|FG000|Overall Study|Adverse Event|1
1013353|NCT01521494|2034326|FG001|Overall Study|Adverse Event|2
1013354|NCT01521494|2034327|FG002|Overall Study|Adverse Event|9
1013355|NCT01521494|2034328|FG003|Overall Study|Adverse Event|6
1013356|NCT01521494|2034329|FG004|Overall Study|Adverse Event|2
1013357|NCT01521494|2034325|FG000|Overall Study|Lack of Efficacy|0
1013358|NCT01521494|2034326|FG001|Overall Study|Lack of Efficacy|0
1013359|NCT01521494|2034327|FG002|Overall Study|Lack of Efficacy|0
1013360|NCT01521494|2034328|FG003|Overall Study|Lack of Efficacy|0
1013361|NCT01521494|2034329|FG004|Overall Study|Lack of Efficacy|2
1013362|NCT01521494|2034325|FG000|Overall Study|Withdrawal by Subject|1
1013363|NCT01521494|2034326|FG001|Overall Study|Withdrawal by Subject|1
1013364|NCT01521494|2034327|FG002|Overall Study|Withdrawal by Subject|0
1013365|NCT01521494|2034328|FG003|Overall Study|Withdrawal by Subject|2
1013366|NCT01521494|2034329|FG004|Overall Study|Withdrawal by Subject|0
1013367|NCT01521494|2034325|FG000|Overall Study|Decrease in serum phosphate|0
1013368|NCT01521494|2034326|FG001|Overall Study|Decrease in serum phosphate|2
1013369|NCT01521494|2034327|FG002|Overall Study|Decrease in serum phosphate|3
1013370|NCT01521494|2034328|FG003|Overall Study|Decrease in serum phosphate|12
1013371|NCT01521494|2034329|FG004|Overall Study|Decrease in serum phosphate|0
1013372|NCT01521494|2034325|FG000|Overall Study|Decrease in serum calcium|0
1013373|NCT01521494|2034326|FG001|Overall Study|Decrease in serum calcium|0
1013374|NCT01521494|2034327|FG002|Overall Study|Decrease in serum calcium|0
1013375|NCT01521494|2034328|FG003|Overall Study|Decrease in serum calcium|1
1013376|NCT01521494|2034329|FG004|Overall Study|Decrease in serum calcium|1
1013377|NCT01521494|2034325|FG000|Overall Study|Physician Decision|0
1013378|NCT01521494|2034326|FG001|Overall Study|Physician Decision|0
1013379|NCT01521494|2034327|FG002|Overall Study|Physician Decision|0
1013380|NCT01521494|2034328|FG003|Overall Study|Physician Decision|0
1013381|NCT01521494|2034329|FG004|Overall Study|Physician Decision|2
1013382|NCT01521507|2034343|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2
1013383|NCT01521507|2034344|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0
1013384|NCT01521507|2034343|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1
1013385|NCT01521507|2034344|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3
1013386|NCT01521507|2034343|FG000|Stage 1: Randomized Design|Lost to Follow-up|0
1013387|NCT01521507|2034344|FG001|Stage 1: Randomized Design|Lost to Follow-up|2
1013388|NCT01521507|2034343|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0
1013389|NCT01521507|2034344|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1
1013390|NCT01521507|2034343|FG000|Stage 2: Observational Design|Withdrawal by Subject|3
1013391|NCT01521507|2034344|FG001|Stage 2: Observational Design|Withdrawal by Subject|1
1013392|NCT01521507|2034343|FG000|Stage 2: Observational Design|Physician Decision|1
1013393|NCT01521507|2034344|FG001|Stage 2: Observational Design|Physician Decision|0
1013394|NCT01521559|2034368|FG000|Overall Study|Adverse Event|0
1013395|NCT01521559|2034369|FG001|Overall Study|Adverse Event|4
1013396|NCT01521559|2034368|FG000|Overall Study|Death|1
1013397|NCT01521559|2034369|FG001|Overall Study|Death|0
1013398|NCT01521559|2034368|FG000|Overall Study|Withdrawal by Subject|9
1013399|NCT01521559|2034369|FG001|Overall Study|Withdrawal by Subject|11
1013400|NCT01521559|2034368|FG000|Overall Study|Lost to Follow-up|3
1013401|NCT01521559|2034369|FG001|Overall Study|Lost to Follow-up|1
1013402|NCT01521559|2034368|FG000|Overall Study|Protocol Violation|1
1013403|NCT01521559|2034369|FG001|Overall Study|Protocol Violation|0
1013404|NCT01521559|2034368|FG000|Overall Study|Other|1
1013405|NCT01521559|2034369|FG001|Overall Study|Other|2
1013406|NCT01521884|2034405|FG000|Overall Study|Non Responders|10
1013407|NCT01521884|2034405|FG000|Overall Study|Adverse Event|5
1013408|NCT01521884|2034405|FG000|Overall Study|Pregnancy|1
1013409|NCT01521884|2034405|FG000|Overall Study|Withdrawal by Subject|1
1013410|NCT01521884|2034405|FG000|Overall Study|Physician Decision|2
1013411|NCT01521884|2034405|FG000|Overall Study|Protocol Violation|3
1013412|NCT01521884|2034405|FG000|Overall Study|Participant non-eligible|1
1013413|NCT01521884|2034405|FG000|Overall Study|Lost to Follow-up|4
1013414|NCT01521897|2034409|FG000|Overall Study|Protocol Violation|18
1013415|NCT01521897|2034409|FG000|Overall Study|Lost to Follow-up|5
1013416|NCT01521923|2034417|FG000|Overall Study|AE, serious fatal|1
1013417|NCT01521923|2034418|FG001|Overall Study|AE, serious fatal|0
1013418|NCT01521923|2034419|FG002|Overall Study|AE, serious fatal|0
1013419|NCT01521923|2034420|FG003|Overall Study|AE, serious fatal|0
1013420|NCT01521923|2034417|FG000|Overall Study|SAE, non-fatal|0
1013421|NCT01521923|2034418|FG001|Overall Study|SAE, non-fatal|2
1013422|NCT01521923|2034419|FG002|Overall Study|SAE, non-fatal|2
1013423|NCT01521923|2034420|FG003|Overall Study|SAE, non-fatal|0
1013424|NCT01521923|2034417|FG000|Overall Study|AE, non-serious, non-fatal|1
1013425|NCT01521923|2034418|FG001|Overall Study|AE, non-serious, non-fatal|3
1013426|NCT01521923|2034419|FG002|Overall Study|AE, non-serious, non-fatal|6
1013427|NCT01521923|2034420|FG003|Overall Study|AE, non-serious, non-fatal|2
1013428|NCT01521923|2034417|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1013429|NCT01521923|2034418|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1013430|NCT01521923|2034419|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1013431|NCT01521923|2034420|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
1013432|NCT01521923|2034417|FG000|Overall Study|Lack of Efficacy|1
1013433|NCT01521923|2034418|FG001|Overall Study|Lack of Efficacy|1
1013434|NCT01521923|2034419|FG002|Overall Study|Lack of Efficacy|0
1013435|NCT01521923|2034420|FG003|Overall Study|Lack of Efficacy|0
1013436|NCT01521923|2034417|FG000|Overall Study|Protocol Violation|0
1013437|NCT01521923|2034418|FG001|Overall Study|Protocol Violation|0
1013438|NCT01521923|2034419|FG002|Overall Study|Protocol Violation|1
1013439|NCT01521923|2034420|FG003|Overall Study|Protocol Violation|0
1013440|NCT01521923|2034417|FG000|Overall Study|Lost to Follow-up|1
1013441|NCT01521923|2034418|FG001|Overall Study|Lost to Follow-up|0
1013442|NCT01521923|2034419|FG002|Overall Study|Lost to Follow-up|2
1013443|NCT01521923|2034420|FG003|Overall Study|Lost to Follow-up|1
1013444|NCT01521923|2034417|FG000|Overall Study|Withdrawal by Subject|1
1013445|NCT01521923|2034418|FG001|Overall Study|Withdrawal by Subject|1
1013446|NCT01521923|2034419|FG002|Overall Study|Withdrawal by Subject|1
1013447|NCT01521923|2034420|FG003|Overall Study|Withdrawal by Subject|2
1013448|NCT01521923|2034417|FG000|Overall Study|Other|2
1013449|NCT01521923|2034418|FG001|Overall Study|Other|1
1013450|NCT01521923|2034419|FG002|Overall Study|Other|3
1013451|NCT01521923|2034420|FG003|Overall Study|Other|6
1013452|NCT01521923|2034417|FG000|Overall Study|AE, captured in Period 1|0
1013453|NCT01521923|2034418|FG001|Overall Study|AE, captured in Period 1|1
1013454|NCT01521923|2034419|FG002|Overall Study|AE, captured in Period 1|0
1013455|NCT01521923|2034420|FG003|Overall Study|AE, captured in Period 1|1
1013456|NCT01522235|2034448|FG000|Overall Study|Physician Decision|1
1013457|NCT01522235|2034449|FG001|Overall Study|Physician Decision|1
1013458|NCT01522248|2034461|FG000|Overall Study|Lost to Follow-up|1
1013459|NCT01522248|2034462|FG001|Overall Study|Lost to Follow-up|0
1013460|NCT01522404|2034489|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1
1013461|NCT01522404|2034490|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0
1013462|NCT01522404|2034489|FG000|First Intervention (up to Week 29)|Adverse Event|1
1013463|NCT01522404|2034490|FG001|First Intervention (up to Week 29)|Adverse Event|0
1013464|NCT01522404|2034489|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1
1013465|NCT01522404|2034490|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0
1013466|NCT01522443|2034519|FG000|Overall Study|No longer receiving clinical benefit|36
1013467|NCT01522443|2034520|FG001|Overall Study|No longer receiving clinical benefit|28
1013468|NCT01522443|2034519|FG000|Overall Study|Adverse Event|10
1013469|NCT01522443|2034520|FG001|Overall Study|Adverse Event|15
1013470|NCT01522443|2034519|FG000|Overall Study|Withdrawal by Subject|5
1013471|NCT01522443|2034520|FG001|Overall Study|Withdrawal by Subject|8
1013472|NCT01522443|2034519|FG000|Overall Study|No study treatment given|1
1013473|NCT01522443|2034520|FG001|Overall Study|No study treatment given|1
1013474|NCT01522443|2034519|FG000|Overall Study|Other|1
1013475|NCT01522443|2034520|FG001|Overall Study|Other|3
1013476|NCT01522456|2034526|FG000|Overall Study|Adverse Event|2
1013477|NCT01522456|2034526|FG000|Overall Study|Lost to Follow-up|2
1013478|NCT01522456|2034526|FG000|Overall Study|Withdrawal by Subject|2
1013479|NCT01522456|2034526|FG000|Overall Study|Pregnancy|1
1013480|NCT01522456|2034526|FG000|Overall Study|Tolerability Assessment|1
1013481|NCT01522651|2034542|FG000|Overall Study|Adverse Event|3
1013482|NCT01522651|2034543|FG001|Overall Study|Adverse Event|4
1013483|NCT01522651|2034544|FG002|Overall Study|Adverse Event|4
1013484|NCT01522651|2034545|FG003|Overall Study|Adverse Event|5
1013485|NCT01522651|2034546|FG004|Overall Study|Adverse Event|4
1013486|NCT01522651|2034542|FG000|Overall Study|Cardioversion|1
1013487|NCT01522651|2034543|FG001|Overall Study|Cardioversion|0
1013488|NCT01522651|2034544|FG002|Overall Study|Cardioversion|0
1013489|NCT01522651|2034545|FG003|Overall Study|Cardioversion|0
1013490|NCT01522651|2034546|FG004|Overall Study|Cardioversion|0
1013491|NCT01522651|2034542|FG000|Overall Study|Device Malfunction|0
1013492|NCT01522651|2034543|FG001|Overall Study|Device Malfunction|1
1013493|NCT01522651|2034544|FG002|Overall Study|Device Malfunction|0
1013494|NCT01522651|2034545|FG003|Overall Study|Device Malfunction|0
1013495|NCT01522651|2034546|FG004|Overall Study|Device Malfunction|0
1013496|NCT01522651|2034542|FG000|Overall Study|Investigator's Discretion|0
1013497|NCT01522651|2034543|FG001|Overall Study|Investigator's Discretion|1
1013498|NCT01522651|2034544|FG002|Overall Study|Investigator's Discretion|0
1013499|NCT01522651|2034545|FG003|Overall Study|Investigator's Discretion|0
1013500|NCT01522651|2034546|FG004|Overall Study|Investigator's Discretion|0
1013501|NCT01522651|2034542|FG000|Overall Study|Protocol Violation|3
914400|NCT00814580|1892222|FG001|Overall Study|Adverse Event|15
914401|NCT00814580|1892221|FG000|Overall Study|Lack of Efficacy|18
914402|NCT00814580|1892222|FG001|Overall Study|Lack of Efficacy|25
914403|NCT00814580|1892221|FG000|Overall Study|Protocol Violation|2
914404|NCT00814580|1892222|FG001|Overall Study|Protocol Violation|0
914405|NCT00814580|1892221|FG000|Overall Study|Withdrawal by Subject|2
914406|NCT00814580|1892222|FG001|Overall Study|Withdrawal by Subject|2
914407|NCT00814580|1892221|FG000|Overall Study|Other|1
914408|NCT00814580|1892222|FG001|Overall Study|Other|3
914409|NCT00814580|1892221|FG000|Overall Study|Did Not Take Drug|2
914410|NCT00814580|1892222|FG001|Overall Study|Did Not Take Drug|2
914411|NCT00814632|1892240|FG000|Overall Study|Lack of Efficacy|2
914412|NCT00814658|1892246|FG000|Overall Study|Lost to Follow-up|0
914413|NCT00814658|1892247|FG001|Overall Study|Lost to Follow-up|1
914414|NCT00814658|1892246|FG000|Overall Study|Physician Decision|1
914415|NCT00814658|1892247|FG001|Overall Study|Physician Decision|0
914416|NCT00814658|1892246|FG000|Overall Study|Adverse Event|3
914417|NCT00814658|1892247|FG001|Overall Study|Adverse Event|3
914418|NCT00814710|1892286|FG000|Overall Study|Adverse Event|1
914419|NCT00814710|1892287|FG001|Overall Study|Adverse Event|0
914420|NCT00814710|1892286|FG000|Overall Study|Lost to Follow-up|7
914421|NCT00814710|1892287|FG001|Overall Study|Lost to Follow-up|3
914422|NCT00814801|1892311|FG000|Overall Study|Adverse Event|15
914423|NCT00814801|1892312|FG001|Overall Study|Adverse Event|16
914424|NCT00814801|1892313|FG002|Overall Study|Adverse Event|19
914425|NCT00814801|1892311|FG000|Overall Study|Withdrawal by Subject|9
914426|NCT00814801|1892312|FG001|Overall Study|Withdrawal by Subject|11
914427|NCT00814801|1892313|FG002|Overall Study|Withdrawal by Subject|14
914428|NCT00814801|1892311|FG000|Overall Study|Inappropriate as a subject|1
914429|NCT00814801|1892312|FG001|Overall Study|Inappropriate as a subject|1
914430|NCT00814801|1892313|FG002|Overall Study|Inappropriate as a subject|1
914431|NCT00814801|1892311|FG000|Overall Study|Change of patients for CIBIC plus-J|1
914432|NCT00814801|1892312|FG001|Overall Study|Change of patients for CIBIC plus-J|1
914433|NCT00814801|1892313|FG002|Overall Study|Change of patients for CIBIC plus-J|0
914434|NCT00814801|1892311|FG000|Overall Study|Missing or change of caregiver|6
914435|NCT00814801|1892312|FG001|Overall Study|Missing or change of caregiver|2
1013502|NCT01522651|2034543|FG001|Overall Study|Protocol Violation|0
1013503|NCT01522651|2034544|FG002|Overall Study|Protocol Violation|0
1013504|NCT01522651|2034545|FG003|Overall Study|Protocol Violation|0
1013505|NCT01522651|2034546|FG004|Overall Study|Protocol Violation|0
1013506|NCT01522651|2034542|FG000|Overall Study|Reason Not Specified|0
1013507|NCT01522651|2034543|FG001|Overall Study|Reason Not Specified|0
1013508|NCT01522651|2034544|FG002|Overall Study|Reason Not Specified|0
1013509|NCT01522651|2034545|FG003|Overall Study|Reason Not Specified|1
1013510|NCT01522651|2034546|FG004|Overall Study|Reason Not Specified|0
1013511|NCT01522651|2034542|FG000|Overall Study|Participant Non-Compliance|1
1013512|NCT01522651|2034543|FG001|Overall Study|Participant Non-Compliance|0
1013513|NCT01522651|2034544|FG002|Overall Study|Participant Non-Compliance|0
1013514|NCT01522651|2034545|FG003|Overall Study|Participant Non-Compliance|0
1013515|NCT01522651|2034546|FG004|Overall Study|Participant Non-Compliance|0
1013516|NCT01522651|2034542|FG000|Overall Study|Withdrew Consent|1
1013517|NCT01522651|2034543|FG001|Overall Study|Withdrew Consent|1
1013518|NCT01522651|2034544|FG002|Overall Study|Withdrew Consent|0
1013519|NCT01522651|2034545|FG003|Overall Study|Withdrew Consent|1
1013520|NCT01522651|2034546|FG004|Overall Study|Withdrew Consent|1
1013521|NCT01522651|2034542|FG000|Overall Study|Randomized but Never Treated|0
1013522|NCT01522651|2034543|FG001|Overall Study|Randomized but Never Treated|1
1013523|NCT01522651|2034544|FG002|Overall Study|Randomized but Never Treated|0
1013524|NCT01522651|2034545|FG003|Overall Study|Randomized but Never Treated|1
1013525|NCT01522651|2034546|FG004|Overall Study|Randomized but Never Treated|1
1013526|NCT01522950|2034588|FG000|Overall Study|Withdrawal by Subject|3
1013527|NCT01522950|2034589|FG001|Overall Study|Withdrawal by Subject|2
1013528|NCT01522950|2034590|FG002|Overall Study|Withdrawal by Subject|1
1013529|NCT01522950|2034588|FG000|Overall Study|Adverse Event|3
1013530|NCT01522950|2034589|FG001|Overall Study|Adverse Event|1
1013531|NCT01522950|2034590|FG002|Overall Study|Adverse Event|1
1013532|NCT01522950|2034588|FG000|Overall Study|Protocol Violation|0
1013533|NCT01522950|2034589|FG001|Overall Study|Protocol Violation|0
1013534|NCT01522950|2034590|FG002|Overall Study|Protocol Violation|2
1013535|NCT01522950|2034588|FG000|Overall Study|Death|0
1013536|NCT01522950|2034589|FG001|Overall Study|Death|1
1013537|NCT01522950|2034590|FG002|Overall Study|Death|1
1013538|NCT01522950|2034588|FG000|Overall Study|Study Medication Sensitivity|0
1013539|NCT01522950|2034589|FG001|Overall Study|Study Medication Sensitivity|1
1013540|NCT01522950|2034590|FG002|Overall Study|Study Medication Sensitivity|0
1013541|NCT01523275|2034615|FG000|Overall Study|Lost to Follow-up|1
1013542|NCT01523275|2034616|FG001|Overall Study|Lost to Follow-up|2
1013543|NCT01523275|2034615|FG000|Overall Study|Withdrawal by Subject|1
1013544|NCT01523275|2034616|FG001|Overall Study|Withdrawal by Subject|0
1013545|NCT01523301|2034624|FG000|Overall Study|Adverse Event|25
1013546|NCT01523301|2034625|FG001|Overall Study|Adverse Event|16
1013547|NCT01523301|2034624|FG000|Overall Study|Lack of Efficacy|0
1013548|NCT01523301|2034625|FG001|Overall Study|Lack of Efficacy|2
1013549|NCT01523301|2034624|FG000|Overall Study|Protocol Violation|3
1013550|NCT01523301|2034625|FG001|Overall Study|Protocol Violation|4
1013551|NCT01523301|2034624|FG000|Overall Study|Lost to Follow-up|1
914436|NCT00814801|1892313|FG002|Overall Study|Missing or change of caregiver|4
914437|NCT00814801|1892311|FG000|Overall Study|Non-compliance|0
914438|NCT00814801|1892312|FG001|Overall Study|Non-compliance|1
914439|NCT00814801|1892313|FG002|Overall Study|Non-compliance|1
914440|NCT00814801|1892311|FG000|Overall Study|Other|2
914441|NCT00814801|1892312|FG001|Overall Study|Other|6
914442|NCT00814801|1892313|FG002|Overall Study|Other|4
914443|NCT00814879|1892323|FG000|By Week 24|Cancer Diagnosis|1
914444|NCT00814879|1892324|FG001|By Week 24|Cancer Diagnosis|0
914445|NCT00814879|1892323|FG000|By Week 24|Incarceration|0
914446|NCT00814879|1892324|FG001|By Week 24|Incarceration|1
914447|NCT00814879|1892323|FG000|By Week 48|Lost to Follow-up|2
914448|NCT00814879|1892324|FG001|By Week 48|Lost to Follow-up|2
914449|NCT00814879|1892323|FG000|By Week 48|Death|0
914450|NCT00814879|1892324|FG001|By Week 48|Death|1
914451|NCT00815191|1892361|FG000|Overall Study|Protocol Violation|1
914452|NCT00815191|1892362|FG001|Overall Study|Protocol Violation|1
914453|NCT00815295|1892371|FG000|Overall Study|Cetuximab hypersensitivity reaction|0
914454|NCT00815295|1892372|FG001|Overall Study|Cetuximab hypersensitivity reaction|1
914455|NCT00815295|1892373|FG002|Overall Study|Cetuximab hypersensitivity reaction|3
914456|NCT00815308|1892381|FG000|Overall Study|Adverse Event|4
914457|NCT00815308|1892381|FG000|Overall Study|Withdrawal by Subject|0
914458|NCT00815308|1892381|FG000|Overall Study|Protocol Violation|6
914459|NCT00815516|1892411|FG000|Overall Study|Death|3
914460|NCT00815516|1892412|FG001|Overall Study|Death|1
914461|NCT00815516|1892411|FG000|Overall Study|Physician Decision|1
914462|NCT00815516|1892412|FG001|Overall Study|Physician Decision|0
914463|NCT00815659|1892418|FG000|Overall Study|Adverse Event|9
914464|NCT00815659|1892418|FG000|Overall Study|Withdrawal by Subject|9
914465|NCT00815659|1892418|FG000|Overall Study|Lost to Follow-up|4
914466|NCT00815659|1892418|FG000|Overall Study|Protocol Violation|1
914467|NCT00815919|1892451|FG000|Overall Study|Unrelated Fungal Infection|1
1013552|NCT01523301|2034625|FG001|Overall Study|Lost to Follow-up|0
1013553|NCT01523301|2034624|FG000|Overall Study|Withdrawal by Subject|6
1013554|NCT01523301|2034625|FG001|Overall Study|Withdrawal by Subject|8
1013555|NCT01523301|2034624|FG000|Overall Study|Other Reason|0
1013556|NCT01523301|2034625|FG001|Overall Study|Other Reason|2
1013557|NCT01523366|2034633|FG000|Treatment Period 1|Withdrawal by Subject|1
1013558|NCT01523366|2034634|FG001|Treatment Period 1|Withdrawal by Subject|0
1013559|NCT01523366|2034633|FG000|Treatment Period 2|Not completed at least 7 days treatment|1
1013560|NCT01523366|2034634|FG001|Treatment Period 2|Not completed at least 7 days treatment|0
1013561|NCT01523392|2034644|FG000|Treatment Period 1|Withdrawal by Subject|2
1013562|NCT01523392|2034645|FG001|Treatment Period 1|Withdrawal by Subject|0
1013563|NCT01523392|2034644|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1
1013564|NCT01523392|2034645|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0
1013565|NCT01523392|2034644|FG000|Washout Period - 10 to 14 Days|Adverse Event|1
1013566|NCT01523392|2034645|FG001|Washout Period - 10 to 14 Days|Adverse Event|0
1013567|NCT01523457|2034655|FG000|Overall Study|Withdrawal by Subject|7
1013568|NCT01523457|2034656|FG001|Overall Study|Withdrawal by Subject|2
1013569|NCT01523587|2034685|FG000|Overall Study|Other than listed|5
1013570|NCT01523587|2034686|FG001|Overall Study|Other than listed|5
1013571|NCT01523587|2034685|FG000|Overall Study|Worsening of underlying cancer disease|19
1013572|NCT01523587|2034686|FG001|Overall Study|Worsening of underlying cancer disease|34
1013573|NCT01523587|2034685|FG000|Overall Study|Adverse Event|68
1013574|NCT01523587|2034686|FG001|Overall Study|Adverse Event|52
1013575|NCT01523587|2034685|FG000|Overall Study|Protocol Violation|5
1013576|NCT01523587|2034686|FG001|Overall Study|Protocol Violation|3
1013577|NCT01523587|2034685|FG000|Overall Study|Lost to Follow-up|2
1013578|NCT01523587|2034686|FG001|Overall Study|Lost to Follow-up|2
1013579|NCT01523587|2034685|FG000|Overall Study|Withdrawal by Subject|28
1013580|NCT01523587|2034686|FG001|Overall Study|Withdrawal by Subject|20
1013581|NCT01523587|2034685|FG000|Overall Study|Withdrew due to Progressive disease|265
1013582|NCT01523587|2034686|FG001|Overall Study|Withdrew due to Progressive disease|279
1013583|NCT01523587|2034685|FG000|Overall Study|Randomised but bot treated|6
1013584|NCT01523587|2034686|FG001|Overall Study|Randomised but bot treated|2
1013585|NCT01523743|2034715|FG000|Period 1|Adverse Event|1
1013586|NCT01523743|2034716|FG001|Period 1|Adverse Event|0
1013587|NCT01523743|2034715|FG000|Period 1|Withdrawal by Subject|6
1013588|NCT01523743|2034716|FG001|Period 1|Withdrawal by Subject|2
1013589|NCT01523743|2034715|FG000|Period 1|Lost to Follow-up|1
1013590|NCT01523743|2034716|FG001|Period 1|Lost to Follow-up|0
1013591|NCT01523743|2034715|FG000|Period 1|Lack of Efficacy|1
1013592|NCT01523743|2034716|FG001|Period 1|Lack of Efficacy|0
1013593|NCT01523743|2034715|FG000|Period 1|Felt unable to empty bladder|1
1013594|NCT01523743|2034716|FG001|Period 1|Felt unable to empty bladder|0
1013595|NCT01523743|2034715|FG000|Period 2|Withdrawal by Subject|0
1013596|NCT01523743|2034716|FG001|Period 2|Withdrawal by Subject|2
1013597|NCT01523743|2034715|FG000|Period 2|Adverse Event|1
1013598|NCT01523743|2034716|FG001|Period 2|Adverse Event|0
1013599|NCT01523756|2034722|FG000|Baseline Period|Adverse Event|0
1013600|NCT01523756|2034723|FG001|Baseline Period|Adverse Event|1
1013601|NCT01523756|2034722|FG000|Test Period 1|Adverse Event|1
1013602|NCT01523756|2034723|FG001|Test Period 1|Adverse Event|0
1013603|NCT01523756|2034722|FG000|Test Period 2|Withdrawal by Subject|0
1013604|NCT01523756|2034723|FG001|Test Period 2|Withdrawal by Subject|1
1013605|NCT01523873|2034788|FG000|Overall Study|Protocol Violation|422
1013606|NCT01523886|2034796|FG000|Overall Study|surgery cancelled|0
1013607|NCT01523886|2034797|FG001|Overall Study|surgery cancelled|1
1013608|NCT01524133|2034833|FG000|Treatment Phase|Withdrawal by Subject|13
1013609|NCT01524133|2034834|FG001|Treatment Phase|Withdrawal by Subject|28
1013610|NCT01524133|2034835|FG002|Treatment Phase|Withdrawal by Subject|31
1013611|NCT01524133|2034833|FG000|Treatment Phase|Physician Decision|6
1013612|NCT01524133|2034834|FG001|Treatment Phase|Physician Decision|3
1013613|NCT01524133|2034835|FG002|Treatment Phase|Physician Decision|3
1013614|NCT01524133|2034833|FG000|Treatment Phase|Lost to Follow-up|0
1013615|NCT01524133|2034834|FG001|Treatment Phase|Lost to Follow-up|1
1013616|NCT01524133|2034835|FG002|Treatment Phase|Lost to Follow-up|2
1013617|NCT01524133|2034833|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4
1013618|NCT01524133|2034834|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5
1013619|NCT01524133|2034835|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10
1013620|NCT01524133|2034833|FG000|Overall Study 52 Weeks|Physician Decision|1
1013621|NCT01524133|2034834|FG001|Overall Study 52 Weeks|Physician Decision|0
1013622|NCT01524133|2034835|FG002|Overall Study 52 Weeks|Physician Decision|2
1013623|NCT01524133|2034833|FG000|Overall Study 52 Weeks|Lost to Follow-up|16
1013624|NCT01524133|2034834|FG001|Overall Study 52 Weeks|Lost to Follow-up|15
1013625|NCT01524133|2034835|FG002|Overall Study 52 Weeks|Lost to Follow-up|15
1013626|NCT01524198|2034845|FG000|Overall Study|Protocol Violation|8
1013627|NCT01524198|2034846|FG001|Overall Study|Protocol Violation|6
1013628|NCT01524198|2034845|FG000|Overall Study|Withdrawal by Subject|15
1013629|NCT01524198|2034846|FG001|Overall Study|Withdrawal by Subject|10
1013630|NCT01524224|2034860|FG000|Overall Study|Progressive Disease|1
1013631|NCT01524224|2034861|FG001|Overall Study|Progressive Disease|0
1013632|NCT01524224|2034862|FG002|Overall Study|Progressive Disease|2
1013633|NCT01524224|2034863|FG003|Overall Study|Progressive Disease|1
1013634|NCT01524224|2034864|FG004|Overall Study|Progressive Disease|2
1013635|NCT01524224|2034865|FG005|Overall Study|Progressive Disease|1
1013636|NCT01524224|2034866|FG006|Overall Study|Progressive Disease|1
1013637|NCT01524224|2034867|FG007|Overall Study|Progressive Disease|5
1013638|NCT01524224|2034860|FG000|Overall Study|Withdrawal by Subject|2
1013639|NCT01524224|2034861|FG001|Overall Study|Withdrawal by Subject|0
1013640|NCT01524224|2034862|FG002|Overall Study|Withdrawal by Subject|0
1013641|NCT01524224|2034863|FG003|Overall Study|Withdrawal by Subject|0
1013642|NCT01524224|2034864|FG004|Overall Study|Withdrawal by Subject|0
1013643|NCT01524224|2034865|FG005|Overall Study|Withdrawal by Subject|0
1013644|NCT01524224|2034866|FG006|Overall Study|Withdrawal by Subject|2
1013645|NCT01524224|2034867|FG007|Overall Study|Withdrawal by Subject|0
1013646|NCT01524224|2034860|FG000|Overall Study|Adverse Event|0
1013647|NCT01524224|2034861|FG001|Overall Study|Adverse Event|1
1013648|NCT01524224|2034862|FG002|Overall Study|Adverse Event|0
1013649|NCT01524224|2034863|FG003|Overall Study|Adverse Event|0
1013650|NCT01524224|2034864|FG004|Overall Study|Adverse Event|0
1013651|NCT01524224|2034865|FG005|Overall Study|Adverse Event|1
1013652|NCT01524224|2034866|FG006|Overall Study|Adverse Event|0
1013653|NCT01524224|2034867|FG007|Overall Study|Adverse Event|0
1013654|NCT01524224|2034860|FG000|Overall Study|Physician Decision|0
1013655|NCT01524224|2034861|FG001|Overall Study|Physician Decision|0
1013656|NCT01524224|2034862|FG002|Overall Study|Physician Decision|0
1013657|NCT01524224|2034863|FG003|Overall Study|Physician Decision|1
1013658|NCT01524224|2034864|FG004|Overall Study|Physician Decision|1
1013659|NCT01524224|2034865|FG005|Overall Study|Physician Decision|0
1013660|NCT01524224|2034866|FG006|Overall Study|Physician Decision|0
1013661|NCT01524224|2034867|FG007|Overall Study|Physician Decision|1
1013662|NCT01524224|2034860|FG000|Overall Study|Sponsor Decision|0
1013663|NCT01524224|2034861|FG001|Overall Study|Sponsor Decision|0
1013664|NCT01524224|2034862|FG002|Overall Study|Sponsor Decision|0
1013665|NCT01524224|2034863|FG003|Overall Study|Sponsor Decision|0
1013666|NCT01524224|2034864|FG004|Overall Study|Sponsor Decision|1
1013667|NCT01524224|2034865|FG005|Overall Study|Sponsor Decision|0
1013668|NCT01524224|2034866|FG006|Overall Study|Sponsor Decision|0
1013669|NCT01524224|2034867|FG007|Overall Study|Sponsor Decision|0
1013670|NCT01524289|2034887|FG000|Overall Study|Lost to Follow-up|0
1013671|NCT01524289|2034888|FG001|Overall Study|Lost to Follow-up|1
1013672|NCT01524289|2034887|FG000|Overall Study|Physician Decision|1
1013673|NCT01524289|2034888|FG001|Overall Study|Physician Decision|0
1013674|NCT01524289|2034887|FG000|Overall Study|Protocol Violation|5
1013675|NCT01524289|2034888|FG001|Overall Study|Protocol Violation|1
1013676|NCT01524289|2034887|FG000|Overall Study|Withdrawal by Subject|11
1013677|NCT01524289|2034888|FG001|Overall Study|Withdrawal by Subject|7
1013678|NCT01524289|2034887|FG000|Overall Study|Adverse Event|12
1013679|NCT01524289|2034888|FG001|Overall Study|Adverse Event|5
1013680|NCT01524289|2034887|FG000|Overall Study|Did not take study medication|1
1013681|NCT01524289|2034888|FG001|Overall Study|Did not take study medication|0
1013682|NCT01524627|2034911|FG000|Overall Study|Physician Decision|0
1013683|NCT01524627|2034912|FG001|Overall Study|Physician Decision|1
1013684|NCT01524627|2034911|FG000|Overall Study|Lost to Follow-up|1
1013685|NCT01524627|2034912|FG001|Overall Study|Lost to Follow-up|1
1013686|NCT01524679|2034920|FG000|Overall Study|Lost to Follow-up|1
1013687|NCT01524679|2034921|FG001|Overall Study|Lost to Follow-up|4
1013688|NCT01524679|2034920|FG000|Overall Study|Withdrawal by Subject|4
1013689|NCT01524679|2034921|FG001|Overall Study|Withdrawal by Subject|4
1013690|NCT01524679|2034920|FG000|Overall Study|Adverse Event|9
1013691|NCT01524679|2034921|FG001|Overall Study|Adverse Event|0
1013692|NCT01524679|2034920|FG000|Overall Study|Protocol Violation|1
1013693|NCT01524679|2034921|FG001|Overall Study|Protocol Violation|0
1013694|NCT01524679|2034920|FG000|Overall Study|Lack of Efficacy|2
1013695|NCT01524679|2034921|FG001|Overall Study|Lack of Efficacy|0
1013696|NCT01524679|2034920|FG000|Overall Study|e.g.wish for children, relocation|6
1013697|NCT01524679|2034921|FG001|Overall Study|e.g.wish for children, relocation|1
1013698|NCT01524692|2034927|FG000|Overall Study|Withdrawal by Subject|3
1013699|NCT01524770|2034932|FG000|First Intervention|Withdrawal by Subject|1
1013700|NCT01524770|2034933|FG001|First Intervention|Withdrawal by Subject|0
1013701|NCT01524770|2034932|FG000|First Intervention|Adverse Event|1
1013702|NCT01524770|2034933|FG001|First Intervention|Adverse Event|1
1013703|NCT01524770|2034932|FG000|First Intervention|Protocol Violation|1
1013704|NCT01524770|2034933|FG001|First Intervention|Protocol Violation|0
1013705|NCT01524783|2034941|FG000|Blinded Period|Adverse Event|64
1013706|NCT01524783|2034942|FG001|Blinded Period|Adverse Event|7
1013707|NCT01524783|2034943|FG002|Blinded Period|Adverse Event|0
1013708|NCT01524783|2034941|FG000|Blinded Period|Disease Progression|89
1013709|NCT01524783|2034942|FG001|Blinded Period|Disease Progression|75
1013710|NCT01524783|2034943|FG002|Blinded Period|Disease Progression|0
1013711|NCT01524783|2034941|FG000|Blinded Period|Withdrawal by Subject|19
1013712|NCT01524783|2034942|FG001|Blinded Period|Withdrawal by Subject|6
1013713|NCT01524783|2034943|FG002|Blinded Period|Withdrawal by Subject|0
1013714|NCT01524783|2034941|FG000|Blinded Period|Protocol deviation|2
1013715|NCT01524783|2034942|FG001|Blinded Period|Protocol deviation|1
1013716|NCT01524783|2034943|FG002|Blinded Period|Protocol deviation|0
1013717|NCT01524783|2034941|FG000|Blinded Period|Death|5
1013718|NCT01524783|2034942|FG001|Blinded Period|Death|2
1013719|NCT01524783|2034943|FG002|Blinded Period|Death|0
1013720|NCT01524783|2034941|FG000|Open-label Period|Disease progression|13
1013721|NCT01524783|2034942|FG001|Open-label Period|Disease progression|0
1013722|NCT01524783|2034943|FG002|Open-label Period|Disease progression|2
1013723|NCT01524783|2034941|FG000|Open-label Period|Administrative problems|5
1013724|NCT01524783|2034942|FG001|Open-label Period|Administrative problems|0
1013725|NCT01524783|2034943|FG002|Open-label Period|Administrative problems|2
1013726|NCT01524783|2034941|FG000|Open-label Period|Adverse Event|5
1013727|NCT01524783|2034942|FG001|Open-label Period|Adverse Event|0
1013728|NCT01524783|2034943|FG002|Open-label Period|Adverse Event|1
1013729|NCT01524783|2034941|FG000|Open-label Period|Withdrawal by Subject|2
1013730|NCT01524783|2034942|FG001|Open-label Period|Withdrawal by Subject|0
1013731|NCT01524783|2034943|FG002|Open-label Period|Withdrawal by Subject|1
1013732|NCT01524783|2034941|FG000|Open-label Period|Protocol deviation|1
1013733|NCT01524783|2034942|FG001|Open-label Period|Protocol deviation|0
1013734|NCT01524783|2034943|FG002|Open-label Period|Protocol deviation|0
1013735|NCT01524796|2034955|FG000|Overall Study|Adverse Event|13
1013736|NCT01524796|2034955|FG000|Overall Study|Lack of Efficacy|3
1013737|NCT01524796|2034955|FG000|Overall Study|Lost to Follow-up|1
1013738|NCT01524796|2034955|FG000|Overall Study|The price|1
1013739|NCT01524796|2034955|FG000|Overall Study|Withdrawal by Subject|4
1013740|NCT01524796|2034955|FG000|Overall Study|Move|1
1013741|NCT01524796|2034955|FG000|Overall Study|Deterioration of pains|1
1013742|NCT01524796|2034955|FG000|Overall Study|Gall stone surgery|1
1013743|NCT01524796|2034955|FG000|Overall Study|Nervous about confidentiality|1
1013744|NCT01524796|2034955|FG000|Overall Study|Switch to carbamazapine|1
1013745|NCT01524796|2034955|FG000|Overall Study|Adverse Event and Lack of Efficacy|1
1013746|NCT01524887|2034962|FG000|Overall Study|Withdrawal by Subject|6
1013747|NCT01524887|2034963|FG001|Overall Study|Withdrawal by Subject|2
1013748|NCT01524887|2034964|FG002|Overall Study|Withdrawal by Subject|3
1013749|NCT01524887|2034962|FG000|Overall Study|Adverse Event|5
1013750|NCT01524887|2034963|FG001|Overall Study|Adverse Event|1
1013751|NCT01524887|2034964|FG002|Overall Study|Adverse Event|1
1013752|NCT01524887|2034962|FG000|Overall Study|Protocol Violation|0
1013753|NCT01524887|2034963|FG001|Overall Study|Protocol Violation|0
1013754|NCT01524887|2034964|FG002|Overall Study|Protocol Violation|1
1013755|NCT01524887|2034962|FG000|Overall Study|Study termination|73
1013756|NCT01524887|2034963|FG001|Overall Study|Study termination|87
1013757|NCT01524887|2034964|FG002|Overall Study|Study termination|79
1013758|NCT01524887|2034962|FG000|Overall Study|Withdrawal by Caregiver|0
1013759|NCT01524887|2034963|FG001|Overall Study|Withdrawal by Caregiver|0
1013760|NCT01524887|2034964|FG002|Overall Study|Withdrawal by Caregiver|2
1013761|NCT01524887|2034962|FG000|Overall Study|Use of prohibited medication|1
1013762|NCT01524887|2034963|FG001|Overall Study|Use of prohibited medication|0
1013763|NCT01524887|2034964|FG002|Overall Study|Use of prohibited medication|0
1013764|NCT01524900|2034977|FG000|Overall Study|Lost to Follow-up|3
1013765|NCT01524900|2034978|FG001|Overall Study|Lost to Follow-up|12
1013766|NCT01524900|2034979|FG002|Overall Study|Lost to Follow-up|1
1013767|NCT01524900|2034980|FG003|Overall Study|Lost to Follow-up|0
1013768|NCT01524900|2034981|FG004|Overall Study|Lost to Follow-up|0
1013769|NCT01524900|2034977|FG000|Overall Study|Other reason than stated above|1
1013770|NCT01524900|2034978|FG001|Overall Study|Other reason than stated above|1
1013771|NCT01524900|2034979|FG002|Overall Study|Other reason than stated above|0
1013772|NCT01524900|2034980|FG003|Overall Study|Other reason than stated above|0
1013773|NCT01524900|2034981|FG004|Overall Study|Other reason than stated above|0
1013774|NCT01524900|2034977|FG000|Overall Study|No reason documented|2
1013775|NCT01524900|2034978|FG001|Overall Study|No reason documented|1
1013776|NCT01524900|2034979|FG002|Overall Study|No reason documented|0
1013777|NCT01524900|2034980|FG003|Overall Study|No reason documented|1
1013778|NCT01524900|2034981|FG004|Overall Study|No reason documented|0
1013779|NCT01524913|2034997|FG000|Overall Study|Lost to Follow-up|4
1013780|NCT01524913|2034998|FG001|Overall Study|Lost to Follow-up|0
1013781|NCT01524913|2034999|FG002|Overall Study|Lost to Follow-up|0
1013782|NCT01524978|2035018|FG000|Overall Study|Other|16
1013783|NCT01524978|2035019|FG001|Overall Study|Other|2
1013784|NCT01524978|2035020|FG002|Overall Study|Other|1
1013785|NCT01524978|2035021|FG003|Overall Study|Other|2
1013786|NCT01524978|2035022|FG004|Overall Study|Other|1
1013787|NCT01524978|2035023|FG005|Overall Study|Other|3
1013788|NCT01524978|2035024|FG006|Overall Study|Other|17
1013789|NCT01524978|2035025|FG007|Overall Study|Other|1
1013790|NCT01524978|2035026|FG008|Overall Study|Other|2
1013791|NCT01524978|2035027|FG009|Overall Study|Other|2
1013792|NCT01524978|2035028|FG010|Overall Study|Other|5
1013793|NCT01524978|2035018|FG000|Overall Study|Withdrawal by Subject|12
1013794|NCT01524978|2035019|FG001|Overall Study|Withdrawal by Subject|0
1013795|NCT01524978|2035020|FG002|Overall Study|Withdrawal by Subject|1
1013796|NCT01524978|2035021|FG003|Overall Study|Withdrawal by Subject|1
1013797|NCT01524978|2035022|FG004|Overall Study|Withdrawal by Subject|3
1013798|NCT01524978|2035023|FG005|Overall Study|Withdrawal by Subject|1
1013799|NCT01524978|2035024|FG006|Overall Study|Withdrawal by Subject|6
1013800|NCT01524978|2035025|FG007|Overall Study|Withdrawal by Subject|2
1013801|NCT01524978|2035026|FG008|Overall Study|Withdrawal by Subject|4
1013802|NCT01524978|2035027|FG009|Overall Study|Withdrawal by Subject|0
1013803|NCT01524978|2035028|FG010|Overall Study|Withdrawal by Subject|5
1013804|NCT01524978|2035018|FG000|Overall Study|Lost to Follow-up|0
1013805|NCT01524978|2035019|FG001|Overall Study|Lost to Follow-up|0
1013806|NCT01524978|2035020|FG002|Overall Study|Lost to Follow-up|3
1013807|NCT01524978|2035021|FG003|Overall Study|Lost to Follow-up|0
1013808|NCT01524978|2035022|FG004|Overall Study|Lost to Follow-up|1
1013809|NCT01524978|2035023|FG005|Overall Study|Lost to Follow-up|1
1013810|NCT01524978|2035024|FG006|Overall Study|Lost to Follow-up|2
1013811|NCT01524978|2035025|FG007|Overall Study|Lost to Follow-up|0
1013812|NCT01524978|2035026|FG008|Overall Study|Lost to Follow-up|1
1013813|NCT01524978|2035027|FG009|Overall Study|Lost to Follow-up|1
1013814|NCT01524978|2035028|FG010|Overall Study|Lost to Follow-up|1
1013815|NCT01524978|2035018|FG000|Overall Study|Death|34
1013816|NCT01524978|2035019|FG001|Overall Study|Death|2
1013817|NCT01524978|2035020|FG002|Overall Study|Death|5
1013818|NCT01524978|2035021|FG003|Overall Study|Death|24
1013819|NCT01524978|2035022|FG004|Overall Study|Death|4
1013820|NCT01524978|2035023|FG005|Overall Study|Death|4
1013821|NCT01524978|2035024|FG006|Overall Study|Death|1
1013822|NCT01524978|2035025|FG007|Overall Study|Death|9
1013823|NCT01524978|2035026|FG008|Overall Study|Death|5
1013824|NCT01524978|2035027|FG009|Overall Study|Death|6
1013825|NCT01524978|2035028|FG010|Overall Study|Death|17
1013826|NCT01524991|2035043|FG000|Overall Study|Adverse Event|12
1013827|NCT01524991|2035043|FG000|Overall Study|Death|1
1013828|NCT01524991|2035043|FG000|Overall Study|Disease ProgressionDu|17
1013829|NCT01524991|2035043|FG000|Overall Study|Other complicating disease|1
1013830|NCT01524991|2035043|FG000|Overall Study|Withdrawal by Subject|2
1013831|NCT01524991|2035043|FG000|Overall Study|Symptomatic Deterioration|1
1013832|NCT01525082|2035047|FG000|Overall Study|Death|1
1013833|NCT01525225|2035063|FG000|Enrollment|No longer met study criteria|1
1013834|NCT01525225|2035063|FG000|Enrollment|Other|1
1013835|NCT01525238|2035070|FG000|Overall Study|Withdrawal by Subject|1
1013836|NCT01525238|2035071|FG001|Overall Study|Withdrawal by Subject|0
1013837|NCT01525238|2035072|FG002|Overall Study|Withdrawal by Subject|0
1013838|NCT01525407|2035095|FG000|Overall Study|Change in recipient treatment plan|2
1013839|NCT01525407|2035096|FG001|Overall Study|Change in recipient treatment plan|2
1013840|NCT01525407|2035095|FG000|Overall Study|Withdrawal by Subject|0
1013841|NCT01525407|2035096|FG001|Overall Study|Withdrawal by Subject|1
1013842|NCT01525407|2035095|FG000|Overall Study|Transplant was delayed|0
1013843|NCT01525407|2035096|FG001|Overall Study|Transplant was delayed|1
1013844|NCT01525407|2035095|FG000|Overall Study|Delay in Transplant|1
1013845|NCT01525407|2035096|FG001|Overall Study|Delay in Transplant|0
1013846|NCT01525550|2035113|FG000|Overall Study|Lost to Follow-up|8
1013847|NCT01525550|2035114|FG001|Overall Study|Lost to Follow-up|2
1013848|NCT01525550|2035113|FG000|Overall Study|Death|19
1013849|NCT01525550|2035114|FG001|Overall Study|Death|28
1013850|NCT01525550|2035113|FG000|Overall Study|Other|0
1013851|NCT01525550|2035114|FG001|Overall Study|Other|4
1013852|NCT01525550|2035113|FG000|Overall Study|Sponsor's Decision|30
1013853|NCT01525550|2035114|FG001|Overall Study|Sponsor's Decision|11
1013854|NCT01525550|2035113|FG000|Overall Study|Withdrawal by Subject|4
1013855|NCT01525550|2035114|FG001|Overall Study|Withdrawal by Subject|0
1013856|NCT01525589|2035127|FG000|Overall Study|Non-treatment-related AE|1
1013857|NCT01525589|2035128|FG001|Overall Study|Non-treatment-related AE|0
1013858|NCT01525589|2035129|FG002|Overall Study|Non-treatment-related AE|0
1013859|NCT01525589|2035127|FG000|Overall Study|Progressive disease|48
1013860|NCT01525589|2035128|FG001|Overall Study|Progressive disease|15
1013861|NCT01525589|2035129|FG002|Overall Study|Progressive disease|29
1013862|NCT01525589|2035127|FG000|Overall Study|Never treated|2
1013863|NCT01525589|2035128|FG001|Overall Study|Never treated|0
1013864|NCT01525589|2035129|FG002|Overall Study|Never treated|0
914468|NCT00815919|1892451|FG000|Overall Study|AML Relapse|1
914469|NCT00815919|1892451|FG000|Overall Study|Lack of Efficacy|2
914470|NCT00816023|1892470|FG000|Overall Study|Lost to Follow-up|1
914471|NCT00816023|1892471|FG001|Overall Study|Lost to Follow-up|1
914472|NCT00816023|1892472|FG002|Overall Study|Lost to Follow-up|0
914473|NCT00816023|1892473|FG003|Overall Study|Lost to Follow-up|0
914474|NCT00816023|1892470|FG000|Overall Study|Withdrawal by Subject|1
914475|NCT00816023|1892471|FG001|Overall Study|Withdrawal by Subject|0
914476|NCT00816023|1892472|FG002|Overall Study|Withdrawal by Subject|0
914477|NCT00816023|1892473|FG003|Overall Study|Withdrawal by Subject|0
914478|NCT00816023|1892470|FG000|Overall Study|Physician Decision|0
914479|NCT00816023|1892471|FG001|Overall Study|Physician Decision|0
914480|NCT00816023|1892472|FG002|Overall Study|Physician Decision|1
914481|NCT00816023|1892473|FG003|Overall Study|Physician Decision|0
914482|NCT00816023|1892470|FG000|Overall Study|assessments complete prior to window|1
914483|NCT00816023|1892471|FG001|Overall Study|assessments complete prior to window|1
914484|NCT00816023|1892472|FG002|Overall Study|assessments complete prior to window|2
914485|NCT00816023|1892473|FG003|Overall Study|assessments complete prior to window|1
914486|NCT00816023|1892470|FG000|Overall Study|Randomized Not Treated|6
914487|NCT00816023|1892471|FG001|Overall Study|Randomized Not Treated|4
914488|NCT00816023|1892472|FG002|Overall Study|Randomized Not Treated|6
914489|NCT00816023|1892473|FG003|Overall Study|Randomized Not Treated|11
914490|NCT00816036|1892485|FG000|Overall Study|Death|47
914491|NCT00816036|1892486|FG001|Overall Study|Death|28
914492|NCT00816036|1892485|FG000|Overall Study|Lost to Follow-up|75
914493|NCT00816036|1892486|FG001|Overall Study|Lost to Follow-up|57
914494|NCT00816036|1892485|FG000|Overall Study|Withdrawal by Subject|54
914495|NCT00816036|1892486|FG001|Overall Study|Withdrawal by Subject|23
914496|NCT00816166|1892512|FG000|Overall Study|Lost to Follow-up|6
1013865|NCT01525589|2035127|FG000|Overall Study|Physician Decision|4
1013866|NCT01525589|2035128|FG001|Overall Study|Physician Decision|2
1013867|NCT01525589|2035129|FG002|Overall Study|Physician Decision|2
1013868|NCT01525589|2035127|FG000|Overall Study|Death|0
1013869|NCT01525589|2035128|FG001|Overall Study|Death|0
1013870|NCT01525589|2035129|FG002|Overall Study|Death|2
1013871|NCT01525589|2035127|FG000|Overall Study|Treatment-related AE|1
1013872|NCT01525589|2035128|FG001|Overall Study|Treatment-related AE|1
1013873|NCT01525589|2035129|FG002|Overall Study|Treatment-related AE|2
1013874|NCT01525589|2035127|FG000|Overall Study|Other reasons|0
1013875|NCT01525589|2035128|FG001|Overall Study|Other reasons|1
1013876|NCT01525589|2035129|FG002|Overall Study|Other reasons|0
1013877|NCT01525589|2035127|FG000|Overall Study|Withdrawal by Subject|0
1013878|NCT01525589|2035128|FG001|Overall Study|Withdrawal by Subject|1
1013879|NCT01525589|2035129|FG002|Overall Study|Withdrawal by Subject|0
1013880|NCT01525602|2035145|FG000|Overall Study|Adverse Event|1
1013881|NCT01525602|2035146|FG001|Overall Study|Adverse Event|0
1013882|NCT01525602|2035147|FG002|Overall Study|Adverse Event|1
1013883|NCT01525602|2035148|FG003|Overall Study|Adverse Event|1
1013884|NCT01525602|2035149|FG004|Overall Study|Adverse Event|3
1013885|NCT01525602|2035150|FG005|Overall Study|Adverse Event|3
1013886|NCT01525602|2035151|FG006|Overall Study|Adverse Event|0
1013887|NCT01525602|2035152|FG007|Overall Study|Adverse Event|1
1013888|NCT01525602|2035145|FG000|Overall Study|Disease progression|6
1013889|NCT01525602|2035146|FG001|Overall Study|Disease progression|3
1013890|NCT01525602|2035147|FG002|Overall Study|Disease progression|2
1013891|NCT01525602|2035148|FG003|Overall Study|Disease progression|5
1013892|NCT01525602|2035149|FG004|Overall Study|Disease progression|22
1013893|NCT01525602|2035150|FG005|Overall Study|Disease progression|2
1013894|NCT01525602|2035151|FG006|Overall Study|Disease progression|3
1013895|NCT01525602|2035152|FG007|Overall Study|Disease progression|3
1013896|NCT01525602|2035145|FG000|Overall Study|Clinical progression|2
1013897|NCT01525602|2035146|FG001|Overall Study|Clinical progression|0
1013898|NCT01525602|2035147|FG002|Overall Study|Clinical progression|0
1013899|NCT01525602|2035148|FG003|Overall Study|Clinical progression|0
1013900|NCT01525602|2035149|FG004|Overall Study|Clinical progression|0
1013901|NCT01525602|2035150|FG005|Overall Study|Clinical progression|0
1013902|NCT01525602|2035151|FG006|Overall Study|Clinical progression|1
1013903|NCT01525602|2035152|FG007|Overall Study|Clinical progression|1
1013904|NCT01525602|2035145|FG000|Overall Study|Non-compliance|0
1013905|NCT01525602|2035146|FG001|Overall Study|Non-compliance|0
1013906|NCT01525602|2035147|FG002|Overall Study|Non-compliance|0
1013907|NCT01525602|2035148|FG003|Overall Study|Non-compliance|0
1013908|NCT01525602|2035149|FG004|Overall Study|Non-compliance|1
1013909|NCT01525602|2035150|FG005|Overall Study|Non-compliance|0
1013910|NCT01525602|2035151|FG006|Overall Study|Non-compliance|0
1013911|NCT01525602|2035152|FG007|Overall Study|Non-compliance|0
1013912|NCT01525602|2035145|FG000|Overall Study|Withdrawal by Subject|0
1013913|NCT01525602|2035146|FG001|Overall Study|Withdrawal by Subject|0
1013914|NCT01525602|2035147|FG002|Overall Study|Withdrawal by Subject|0
1013915|NCT01525602|2035148|FG003|Overall Study|Withdrawal by Subject|0
1013916|NCT01525602|2035149|FG004|Overall Study|Withdrawal by Subject|3
1013917|NCT01525602|2035150|FG005|Overall Study|Withdrawal by Subject|1
1013918|NCT01525602|2035151|FG006|Overall Study|Withdrawal by Subject|0
1013919|NCT01525602|2035152|FG007|Overall Study|Withdrawal by Subject|1
1013920|NCT01525602|2035145|FG000|Overall Study|Physician Decision|0
1013921|NCT01525602|2035146|FG001|Overall Study|Physician Decision|0
1013922|NCT01525602|2035147|FG002|Overall Study|Physician Decision|0
1013923|NCT01525602|2035148|FG003|Overall Study|Physician Decision|0
1013924|NCT01525602|2035149|FG004|Overall Study|Physician Decision|3
1013925|NCT01525602|2035150|FG005|Overall Study|Physician Decision|0
1013926|NCT01525602|2035151|FG006|Overall Study|Physician Decision|1
1013927|NCT01525602|2035152|FG007|Overall Study|Physician Decision|0
1013928|NCT01525602|2035145|FG000|Overall Study|Death|0
1013929|NCT01525602|2035146|FG001|Overall Study|Death|0
1013930|NCT01525602|2035147|FG002|Overall Study|Death|0
1013931|NCT01525602|2035148|FG003|Overall Study|Death|0
1013932|NCT01525602|2035149|FG004|Overall Study|Death|1
1013933|NCT01525602|2035150|FG005|Overall Study|Death|1
1013934|NCT01525602|2035151|FG006|Overall Study|Death|0
1013935|NCT01525602|2035152|FG007|Overall Study|Death|0
1013936|NCT01525602|2035145|FG000|Overall Study|Unqualified based on biopsy; not dosed|0
1013937|NCT01525602|2035146|FG001|Overall Study|Unqualified based on biopsy; not dosed|0
1013938|NCT01525602|2035147|FG002|Overall Study|Unqualified based on biopsy; not dosed|0
1013939|NCT01525602|2035148|FG003|Overall Study|Unqualified based on biopsy; not dosed|0
1013940|NCT01525602|2035149|FG004|Overall Study|Unqualified based on biopsy; not dosed|0
1013941|NCT01525602|2035150|FG005|Overall Study|Unqualified based on biopsy; not dosed|0
1013942|NCT01525602|2035151|FG006|Overall Study|Unqualified based on biopsy; not dosed|1
1013943|NCT01525602|2035152|FG007|Overall Study|Unqualified based on biopsy; not dosed|1
1013944|NCT01525615|2035180|FG000|Overall Study|Adverse Event|11
1013945|NCT01525615|2035181|FG001|Overall Study|Adverse Event|7
1013946|NCT01525615|2035182|FG002|Overall Study|Adverse Event|5
1013947|NCT01525615|2035180|FG000|Overall Study|Lost to Follow-up|1
1013948|NCT01525615|2035181|FG001|Overall Study|Lost to Follow-up|0
1013949|NCT01525615|2035182|FG002|Overall Study|Lost to Follow-up|0
1013950|NCT01525615|2035180|FG000|Overall Study|Withdrawal by Subject|1
1013951|NCT01525615|2035181|FG001|Overall Study|Withdrawal by Subject|0
1013952|NCT01525615|2035182|FG002|Overall Study|Withdrawal by Subject|0
1013953|NCT01525615|2035180|FG000|Overall Study|Other reason not described above|1
1013954|NCT01525615|2035181|FG001|Overall Study|Other reason not described above|0
1013955|NCT01525615|2035182|FG002|Overall Study|Other reason not described above|1
1013956|NCT01525628|2035195|FG000|Overall Study|Adverse Event|1
1013957|NCT01525628|2035196|FG001|Overall Study|Adverse Event|1
1013958|NCT01525628|2035197|FG002|Overall Study|Adverse Event|2
1013959|NCT01525628|2035198|FG003|Overall Study|Adverse Event|0
1013960|NCT01525628|2035199|FG004|Overall Study|Adverse Event|1
1013961|NCT01525628|2035195|FG000|Overall Study|Lack of Efficacy|0
1013962|NCT01525628|2035196|FG001|Overall Study|Lack of Efficacy|2
1013963|NCT01525628|2035197|FG002|Overall Study|Lack of Efficacy|2
1013964|NCT01525628|2035198|FG003|Overall Study|Lack of Efficacy|1
1013965|NCT01525628|2035199|FG004|Overall Study|Lack of Efficacy|2
1013966|NCT01525628|2035195|FG000|Overall Study|Protocol Violation|0
1013967|NCT01525628|2035196|FG001|Overall Study|Protocol Violation|0
1013968|NCT01525628|2035197|FG002|Overall Study|Protocol Violation|1
1013969|NCT01525628|2035198|FG003|Overall Study|Protocol Violation|0
1013970|NCT01525628|2035199|FG004|Overall Study|Protocol Violation|0
1013971|NCT01525628|2035195|FG000|Overall Study|Lost to Follow-up|1
1013972|NCT01525628|2035196|FG001|Overall Study|Lost to Follow-up|1
1013973|NCT01525628|2035197|FG002|Overall Study|Lost to Follow-up|0
1013974|NCT01525628|2035198|FG003|Overall Study|Lost to Follow-up|0
1013975|NCT01525628|2035199|FG004|Overall Study|Lost to Follow-up|0
1013976|NCT01525628|2035195|FG000|Overall Study|Withdrawal by Subject|0
1013977|NCT01525628|2035196|FG001|Overall Study|Withdrawal by Subject|1
1013978|NCT01525628|2035197|FG002|Overall Study|Withdrawal by Subject|0
1013979|NCT01525628|2035198|FG003|Overall Study|Withdrawal by Subject|0
1013980|NCT01525628|2035199|FG004|Overall Study|Withdrawal by Subject|0
1013981|NCT01525628|2035195|FG000|Overall Study|Other reason not defined above|0
1013982|NCT01525628|2035196|FG001|Overall Study|Other reason not defined above|0
1013983|NCT01525628|2035197|FG002|Overall Study|Other reason not defined above|0
1013984|NCT01525628|2035198|FG003|Overall Study|Other reason not defined above|3
1013985|NCT01525628|2035199|FG004|Overall Study|Other reason not defined above|0
1013986|NCT01525641|2035213|FG000|Overall Study|Case report form not collected|25
1013987|NCT01525641|2035213|FG000|Overall Study|No visit since the first visit|16
1013988|NCT01525641|2035213|FG000|Overall Study|Adverse Event|73
1013989|NCT01525641|2035213|FG000|Overall Study|Lack of Efficacy|24
1013990|NCT01525641|2035213|FG000|Overall Study|Improvement|5
1013991|NCT01525641|2035213|FG000|Overall Study|Lost to follow-up (relocation)|1
1013992|NCT01525641|2035213|FG000|Overall Study|Lost to follow-up (Unknown reason)|10
1013993|NCT01525641|2035213|FG000|Overall Study|Lost to follow-up (Changing hospital)|19
1013994|NCT01525641|2035213|FG000|Overall Study|Other than stated above|7
1013995|NCT01525849|2035234|FG000|Overall Study|Lost to Follow-up|3
1013996|NCT01525849|2035235|FG001|Overall Study|Lost to Follow-up|2
1013997|NCT01525849|2035234|FG000|Overall Study|Withdrawal by Subject|1
1013998|NCT01525849|2035235|FG001|Overall Study|Withdrawal by Subject|9
1013999|NCT01525849|2035234|FG000|Overall Study|Unrelated medical issue (not treated)|1
914497|NCT00816166|1892513|FG001|Overall Study|Lost to Follow-up|10
914498|NCT00816166|1892512|FG000|Overall Study|Death|4
914499|NCT00816166|1892513|FG001|Overall Study|Death|2
914500|NCT00816361|1892530|FG000|Overall Study|Withdrawal by Subject|0
914501|NCT00816361|1892531|FG001|Overall Study|Withdrawal by Subject|0
914502|NCT00816361|1892532|FG002|Overall Study|Withdrawal by Subject|0
914503|NCT00816361|1892533|FG003|Overall Study|Withdrawal by Subject|0
914504|NCT00816361|1892534|FG004|Overall Study|Withdrawal by Subject|1
914505|NCT00816361|1892535|FG005|Overall Study|Withdrawal by Subject|2
914506|NCT00816361|1892536|FG006|Overall Study|Withdrawal by Subject|0
914507|NCT00816361|1892537|FG007|Overall Study|Withdrawal by Subject|2
914508|NCT00816361|1892538|FG008|Overall Study|Withdrawal by Subject|1
914509|NCT00816361|1892530|FG000|Overall Study|Death|4
914510|NCT00816361|1892531|FG001|Overall Study|Death|3
914511|NCT00816361|1892532|FG002|Overall Study|Death|3
914512|NCT00816361|1892533|FG003|Overall Study|Death|3
914513|NCT00816361|1892534|FG004|Overall Study|Death|1
914514|NCT00816361|1892535|FG005|Overall Study|Death|1
914515|NCT00816361|1892536|FG006|Overall Study|Death|3
914516|NCT00816361|1892537|FG007|Overall Study|Death|7
914517|NCT00816361|1892538|FG008|Overall Study|Death|8
914518|NCT00816361|1892530|FG000|Overall Study|Other|0
914519|NCT00816361|1892531|FG001|Overall Study|Other|0
914520|NCT00816361|1892532|FG002|Overall Study|Other|0
914521|NCT00816361|1892533|FG003|Overall Study|Other|0
914522|NCT00816361|1892534|FG004|Overall Study|Other|0
914523|NCT00816361|1892535|FG005|Overall Study|Other|0
914524|NCT00816361|1892536|FG006|Overall Study|Other|0
914525|NCT00816361|1892537|FG007|Overall Study|Other|0
914526|NCT00816361|1892538|FG008|Overall Study|Other|1
914527|NCT00816400|1892568|FG000|Overall Study|Death|2
914528|NCT00816400|1892569|FG001|Overall Study|Death|3
914529|NCT00816400|1892570|FG002|Overall Study|Death|3
914530|NCT00816400|1892571|FG003|Overall Study|Death|3
914531|NCT00816400|1892572|FG004|Overall Study|Death|2
1014000|NCT01525849|2035235|FG001|Overall Study|Unrelated medical issue (not treated)|2
1014001|NCT01525849|2035234|FG000|Overall Study|Anatomic exclusion criteria identified|0
1014002|NCT01525849|2035235|FG001|Overall Study|Anatomic exclusion criteria identified|3
1014003|NCT01525875|2035247|FG000|Placebo-controlled Period|Withdrawal by Subject|1
1014004|NCT01525875|2035248|FG001|Placebo-controlled Period|Withdrawal by Subject|2
1014005|NCT01525875|2035247|FG000|Open-label Period|Lost to Follow-up|0
1014006|NCT01525875|2035248|FG001|Open-label Period|Lost to Follow-up|2
1014007|NCT01526057|2035257|FG000|Overall Study|Withdrawal by Subject|3
1014008|NCT01526057|2035258|FG001|Overall Study|Withdrawal by Subject|2
1014009|NCT01526057|2035259|FG002|Overall Study|Withdrawal by Subject|2
1014010|NCT01526057|2035257|FG000|Overall Study|Adverse Event|3
1014011|NCT01526057|2035258|FG001|Overall Study|Adverse Event|1
1014012|NCT01526057|2035259|FG002|Overall Study|Adverse Event|1
1014013|NCT01526057|2035257|FG000|Overall Study|Death|1
1014014|NCT01526057|2035258|FG001|Overall Study|Death|0
1014015|NCT01526057|2035259|FG002|Overall Study|Death|0
1014016|NCT01526057|2035257|FG000|Overall Study|Lost to Follow-up|1
1014017|NCT01526057|2035258|FG001|Overall Study|Lost to Follow-up|0
1014018|NCT01526057|2035259|FG002|Overall Study|Lost to Follow-up|1
1014019|NCT01526057|2035257|FG000|Overall Study|Other|1
1014020|NCT01526057|2035258|FG001|Overall Study|Other|0
1014021|NCT01526057|2035259|FG002|Overall Study|Other|1
1014022|NCT01526057|2035257|FG000|Overall Study|Protocol Violation|0
1014023|NCT01526057|2035258|FG001|Overall Study|Protocol Violation|0
1014024|NCT01526057|2035259|FG002|Overall Study|Protocol Violation|1
1014025|NCT01526148|2035269|FG000|Overall Study|Adverse Event|6
1014026|NCT01526148|2035270|FG001|Overall Study|Adverse Event|5
1014027|NCT01526148|2035269|FG000|Overall Study|Lost to Follow-up|3
1014028|NCT01526148|2035270|FG001|Overall Study|Lost to Follow-up|6
1014029|NCT01526148|2035269|FG000|Overall Study|Withdrawal by Subject|2
1014030|NCT01526148|2035270|FG001|Overall Study|Withdrawal by Subject|0
1014031|NCT01526148|2035269|FG000|Overall Study|Unstable Medical Condition|1
1014032|NCT01526148|2035270|FG001|Overall Study|Unstable Medical Condition|0
1014033|NCT01526148|2035269|FG000|Overall Study|Unable to discontinue concomitant med|1
1014034|NCT01526148|2035270|FG001|Overall Study|Unable to discontinue concomitant med|0
1014035|NCT01526148|2035269|FG000|Overall Study|Moved out of state|1
1014036|NCT01526148|2035270|FG001|Overall Study|Moved out of state|0
1014037|NCT01526148|2035269|FG000|Overall Study|Incarcerated|0
1014038|NCT01526148|2035270|FG001|Overall Study|Incarcerated|2
1014039|NCT01526551|2035328|FG000|Overall Study|Lack of returned parental consent form|424
1014040|NCT01526733|2035353|FG000|Phase 1|Protocol Violation|1
1014041|NCT01526733|2035354|FG001|Phase 1|Protocol Violation|0
1014042|NCT01526733|2035353|FG000|Phase 1|Withdrawal by Subject|1
1014043|NCT01526733|2035354|FG001|Phase 1|Withdrawal by Subject|1
1014044|NCT01526785|2035361|FG000|Overall Study|Study Terminated by Sponsor|8
1014045|NCT01526785|2035361|FG000|Overall Study|Death|2
1014046|NCT01526785|2035361|FG000|Overall Study|Physician Decision|1
1014047|NCT01526785|2035361|FG000|Overall Study|Withdrawal by Subject|2
1014048|NCT01526889|2035367|FG000|Treatment Period|Adverse Event|2
1014049|NCT01526889|2035368|FG001|Treatment Period|Adverse Event|0
1014050|NCT01526889|2035367|FG000|Treatment Extension Period|Administrative problems|1
1014051|NCT01526889|2035368|FG001|Treatment Extension Period|Administrative problems|0
1014052|NCT01526928|2035387|FG000|Overall Study|Progressive Disease|35
1014053|NCT01526928|2035388|FG001|Overall Study|Progressive Disease|17
1014054|NCT01526928|2035389|FG002|Overall Study|Progressive Disease|150
1014055|NCT01526928|2035390|FG003|Overall Study|Progressive Disease|182
1014056|NCT01526928|2035391|FG004|Overall Study|Progressive Disease|76
1014057|NCT01526928|2035392|FG005|Overall Study|Progressive Disease|4
1014058|NCT01526928|2035387|FG000|Overall Study|Adverse Event|2
1014059|NCT01526928|2035388|FG001|Overall Study|Adverse Event|1
1014060|NCT01526928|2035389|FG002|Overall Study|Adverse Event|29
1014061|NCT01526928|2035390|FG003|Overall Study|Adverse Event|40
914532|NCT00816400|1892573|FG005|Overall Study|Death|3
914533|NCT00816400|1892574|FG006|Overall Study|Death|2
914534|NCT00816400|1892575|FG007|Overall Study|Death|5
914535|NCT00816400|1892576|FG008|Overall Study|Death|6
914536|NCT00816400|1892568|FG000|Overall Study|In hospice care at the end of the study|0
914537|NCT00816400|1892569|FG001|Overall Study|In hospice care at the end of the study|0
914538|NCT00816400|1892570|FG002|Overall Study|In hospice care at the end of the study|2
914539|NCT00816400|1892571|FG003|Overall Study|In hospice care at the end of the study|0
914540|NCT00816400|1892572|FG004|Overall Study|In hospice care at the end of the study|0
914541|NCT00816400|1892573|FG005|Overall Study|In hospice care at the end of the study|0
914542|NCT00816400|1892574|FG006|Overall Study|In hospice care at the end of the study|0
914543|NCT00816400|1892575|FG007|Overall Study|In hospice care at the end of the study|0
914544|NCT00816400|1892576|FG008|Overall Study|In hospice care at the end of the study|0
914545|NCT00816556|1892600|FG000|Overall Study|Adverse Event|1
914546|NCT00816556|1892601|FG001|Overall Study|Adverse Event|1
914547|NCT00816556|1892602|FG002|Overall Study|Adverse Event|1
914548|NCT00816556|1892600|FG000|Overall Study|Withdrawal by Subject|1
914549|NCT00816556|1892601|FG001|Overall Study|Withdrawal by Subject|1
914550|NCT00816556|1892602|FG002|Overall Study|Withdrawal by Subject|1
914551|NCT00816556|1892600|FG000|Overall Study|Lost to Follow-up|0
914552|NCT00816556|1892601|FG001|Overall Study|Lost to Follow-up|0
1014062|NCT01526928|2035391|FG004|Overall Study|Adverse Event|13
1014063|NCT01526928|2035392|FG005|Overall Study|Adverse Event|2
1014064|NCT01526928|2035387|FG000|Overall Study|Death|0
1014065|NCT01526928|2035388|FG001|Overall Study|Death|0
1014066|NCT01526928|2035389|FG002|Overall Study|Death|3
1014067|NCT01526928|2035390|FG003|Overall Study|Death|0
1014068|NCT01526928|2035391|FG004|Overall Study|Death|0
1014069|NCT01526928|2035392|FG005|Overall Study|Death|0
1014070|NCT01526928|2035387|FG000|Overall Study|Withdrawal by Subject|1
1014071|NCT01526928|2035388|FG001|Overall Study|Withdrawal by Subject|0
1014072|NCT01526928|2035389|FG002|Overall Study|Withdrawal by Subject|13
1014073|NCT01526928|2035390|FG003|Overall Study|Withdrawal by Subject|11
1014074|NCT01526928|2035391|FG004|Overall Study|Withdrawal by Subject|3
1014075|NCT01526928|2035392|FG005|Overall Study|Withdrawal by Subject|0
1014076|NCT01526928|2035387|FG000|Overall Study|Physician Decision|0
1014077|NCT01526928|2035388|FG001|Overall Study|Physician Decision|0
1014078|NCT01526928|2035389|FG002|Overall Study|Physician Decision|2
1014079|NCT01526928|2035390|FG003|Overall Study|Physician Decision|5
1014080|NCT01526928|2035391|FG004|Overall Study|Physician Decision|0
1014081|NCT01526928|2035392|FG005|Overall Study|Physician Decision|0
1014082|NCT01526928|2035387|FG000|Overall Study|Other Reason|0
1014083|NCT01526928|2035388|FG001|Overall Study|Other Reason|1
1014084|NCT01526928|2035389|FG002|Overall Study|Other Reason|11
1014085|NCT01526928|2035390|FG003|Overall Study|Other Reason|4
1014086|NCT01526928|2035391|FG004|Overall Study|Other Reason|1
1014087|NCT01526928|2035392|FG005|Overall Study|Other Reason|0
1014088|NCT01526928|2035387|FG000|Overall Study|Lost to Follow-up|0
1014089|NCT01526928|2035388|FG001|Overall Study|Lost to Follow-up|0
1014090|NCT01526928|2035389|FG002|Overall Study|Lost to Follow-up|0
1014091|NCT01526928|2035390|FG003|Overall Study|Lost to Follow-up|1
1014092|NCT01526928|2035391|FG004|Overall Study|Lost to Follow-up|0
1014093|NCT01526928|2035392|FG005|Overall Study|Lost to Follow-up|0
1014094|NCT01526928|2035387|FG000|Overall Study|Protocol Deviation|0
1014095|NCT01526928|2035388|FG001|Overall Study|Protocol Deviation|0
1014096|NCT01526928|2035389|FG002|Overall Study|Protocol Deviation|0
1014097|NCT01526928|2035390|FG003|Overall Study|Protocol Deviation|2
1014098|NCT01526928|2035391|FG004|Overall Study|Protocol Deviation|0
1014099|NCT01526928|2035392|FG005|Overall Study|Protocol Deviation|0
1014100|NCT01526928|2035387|FG000|Overall Study|Missing|0
1014101|NCT01526928|2035388|FG001|Overall Study|Missing|0
1014102|NCT01526928|2035389|FG002|Overall Study|Missing|1
1014103|NCT01526928|2035390|FG003|Overall Study|Missing|0
1014104|NCT01526928|2035391|FG004|Overall Study|Missing|2
1014105|NCT01526928|2035392|FG005|Overall Study|Missing|0
1014106|NCT01527006|2035450|FG000|Core Study|Adverse Event|0
1014107|NCT01527006|2035451|FG001|Core Study|Adverse Event|2
1014108|NCT01527006|2035450|FG000|Core Study|Lost to Follow-up|0
1014109|NCT01527006|2035451|FG001|Core Study|Lost to Follow-up|1
1014110|NCT01527006|2035450|FG000|Core Study|Subject Choice|1
1014111|NCT01527006|2035451|FG001|Core Study|Subject Choice|0
1014112|NCT01527006|2035450|FG000|Core Study|Inadequate Therapeutic Effect|1
1014113|NCT01527006|2035451|FG001|Core Study|Inadequate Therapeutic Effect|0
1014114|NCT01527006|2035450|FG000|Core Study|Withdrawal by Subject|0
1014115|NCT01527006|2035451|FG001|Core Study|Withdrawal by Subject|1
1014116|NCT01527006|2035450|FG000|Core Study|Other|0
1014117|NCT01527006|2035451|FG001|Core Study|Other|2
1014118|NCT01527006|2035450|FG000|Extension Phase|Adverse Event|4
1014119|NCT01527006|2035451|FG001|Extension Phase|Adverse Event|2
1014120|NCT01527006|2035450|FG000|Extension Phase|Lost to Follow-up|0
1014121|NCT01527006|2035451|FG001|Extension Phase|Lost to Follow-up|1
1014122|NCT01527006|2035450|FG000|Extension Phase|Subject Choice|1
1014123|NCT01527006|2035451|FG001|Extension Phase|Subject Choice|1
1014124|NCT01527006|2035450|FG000|Extension Phase|Inadequate therapeutic effect|1
1014125|NCT01527006|2035451|FG001|Extension Phase|Inadequate therapeutic effect|1
1014126|NCT01527006|2035450|FG000|Extension Phase|Other|0
1014127|NCT01527006|2035451|FG001|Extension Phase|Other|3
1014128|NCT01527110|2035476|FG000|Overall Study|Adverse Event|1
1014129|NCT01527149|2035480|FG000|Overall Study|Death|2
1014130|NCT01527357|2035495|FG000|Overall Study|Death|8
1014131|NCT01527357|2035496|FG001|Overall Study|Death|2
1014132|NCT01527357|2035495|FG000|Overall Study|Lost to Follow-up|6
1014133|NCT01527357|2035496|FG001|Overall Study|Lost to Follow-up|4
1014134|NCT01527357|2035495|FG000|Overall Study|Withdrew Consent|1
1014135|NCT01527357|2035496|FG001|Overall Study|Withdrew Consent|1
1014136|NCT01527357|2035495|FG000|Overall Study|Non-compliance|0
1014137|NCT01527357|2035496|FG001|Overall Study|Non-compliance|1
1014138|NCT01527357|2035495|FG000|Overall Study|No Day 29 Visit|0
1014139|NCT01527357|2035496|FG001|Overall Study|No Day 29 Visit|1
1014140|NCT01527357|2035495|FG000|Overall Study|Did Not Receive Treatment|2
1014141|NCT01527357|2035496|FG001|Overall Study|Did Not Receive Treatment|0
1014142|NCT01527370|2035502|FG000|Overall Study|Withdrawal by Subject|4
1014143|NCT01527370|2035502|FG000|Overall Study|Physician Decision|1
1014144|NCT01527370|2035502|FG000|Overall Study|Death|1
1014145|NCT01527383|2035508|FG000|Overall Study|Adverse Event|5
1014146|NCT01527383|2035509|FG001|Overall Study|Adverse Event|0
1014147|NCT01527383|2035508|FG000|Overall Study|Lost to Follow-up|3
1014148|NCT01527383|2035509|FG001|Overall Study|Lost to Follow-up|0
1014149|NCT01527383|2035508|FG000|Overall Study|Physician Decision|2
1014150|NCT01527383|2035509|FG001|Overall Study|Physician Decision|0
1014151|NCT01527383|2035508|FG000|Overall Study|Pregnancy|1
1014152|NCT01527383|2035509|FG001|Overall Study|Pregnancy|0
1014153|NCT01527383|2035508|FG000|Overall Study|Protocol Violation|1
1014154|NCT01527383|2035509|FG001|Overall Study|Protocol Violation|0
1014155|NCT01527383|2035508|FG000|Overall Study|Screen failure|1
1014156|NCT01527383|2035509|FG001|Overall Study|Screen failure|0
1014157|NCT01527383|2035508|FG000|Overall Study|Participant moved|0
1014158|NCT01527383|2035509|FG001|Overall Study|Participant moved|1
1014159|NCT01527383|2035508|FG000|Overall Study|Withdrawal by Subject|2
1014160|NCT01527383|2035509|FG001|Overall Study|Withdrawal by Subject|3
1014161|NCT01527487|2035517|FG000|Overall Study|MD Discretion/Lack of Efficacy|3
1014162|NCT01527487|2035518|FG001|Overall Study|MD Discretion/Lack of Efficacy|4
1014163|NCT01527487|2035517|FG000|Overall Study|Disease Progression|4
1014164|NCT01527487|2035518|FG001|Overall Study|Disease Progression|1
1014165|NCT01527487|2035517|FG000|Overall Study|Adverse Event|1
1014166|NCT01527487|2035518|FG001|Overall Study|Adverse Event|1
1014167|NCT01527487|2035517|FG000|Overall Study|Death|0
1014168|NCT01527487|2035518|FG001|Overall Study|Death|1
1014169|NCT01527500|2035533|FG000|Part A|Administrative|11
1014170|NCT01527500|2035534|FG001|Part A|Administrative|7
1014171|NCT01527500|2035533|FG000|Part A|Adverse Event|4
1014172|NCT01527500|2035534|FG001|Part A|Adverse Event|2
1014173|NCT01527500|2035533|FG000|Part A|Death|4
1014174|NCT01527500|2035534|FG001|Part A|Death|1
1014175|NCT01527500|2035533|FG000|Part A|Lost to Follow-up|0
1014176|NCT01527500|2035534|FG001|Part A|Lost to Follow-up|1
1014177|NCT01527500|2035533|FG000|Part A|Protocol Deviation|9
1014178|NCT01527500|2035534|FG001|Part A|Protocol Deviation|2
1014179|NCT01527500|2035533|FG000|Part A|Withdrawal by Subject|2
1014180|NCT01527500|2035534|FG001|Part A|Withdrawal by Subject|0
1014181|NCT01527500|2035533|FG000|Part B|Adverse Event|1
1014182|NCT01527500|2035534|FG001|Part B|Adverse Event|0
1014183|NCT01527682|2035561|FG000|Overall Study|Protocol Violation|8
1014184|NCT01528033|2035567|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8
1014185|NCT01528033|2035568|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7
1014186|NCT01528033|2035567|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
1014187|NCT01528033|2035568|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
1014188|NCT01528033|2035567|FG000|Primary Endpoint Assessment ITT|Death|2
1014189|NCT01528033|2035568|FG001|Primary Endpoint Assessment ITT|Death|2
1014190|NCT01528033|2035567|FG000|Primary Endpoint Assessment ITT|Physician Decision|2
1014191|NCT01528033|2035568|FG001|Primary Endpoint Assessment ITT|Physician Decision|1
1014192|NCT01528033|2035567|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2
1014193|NCT01528033|2035568|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2
1014194|NCT01528033|2035567|FG000|Follow Up|No data available|46
1014195|NCT01528033|2035568|FG001|Follow Up|No data available|44
1014196|NCT01528072|2035574|FG000|Overall Study|Withdrawal by Subject|5
1014197|NCT01528072|2035574|FG000|Overall Study|Physician Decision|1
914553|NCT00816556|1892602|FG002|Overall Study|Lost to Follow-up|1
914554|NCT00816595|1892612|FG000|Overall Study|Withdrawal by Subject|2
914555|NCT00816595|1892613|FG001|Overall Study|Withdrawal by Subject|0
914556|NCT00817063|1892652|FG000|Overall Study|Adverse Event|32
914557|NCT00817063|1892653|FG001|Overall Study|Adverse Event|13
914558|NCT00817063|1892652|FG000|Overall Study|Death|1
914559|NCT00817063|1892653|FG001|Overall Study|Death|1
914560|NCT00817063|1892652|FG000|Overall Study|Lack of Efficacy|33
914561|NCT00817063|1892653|FG001|Overall Study|Lack of Efficacy|86
914562|NCT00817063|1892652|FG000|Overall Study|Failure to Return|13
914563|NCT00817063|1892653|FG001|Overall Study|Failure to Return|12
914564|NCT00817063|1892652|FG000|Overall Study|Violation of Selection at Entry|7
914565|NCT00817063|1892653|FG001|Overall Study|Violation of Selection at Entry|4
914566|NCT00817063|1892652|FG000|Overall Study|Protocol Violation|3
914567|NCT00817063|1892653|FG001|Overall Study|Protocol Violation|8
914568|NCT00817063|1892652|FG000|Overall Study|Withdrawal by Subject|17
914569|NCT00817063|1892653|FG001|Overall Study|Withdrawal by Subject|37
914570|NCT00817063|1892652|FG000|Overall Study|Early Improvement|19
914571|NCT00817063|1892653|FG001|Overall Study|Early Improvement|4
914572|NCT00817063|1892652|FG000|Overall Study|Administrative|10
914573|NCT00817063|1892653|FG001|Overall Study|Administrative|4
914574|NCT00817063|1892652|FG000|Overall Study|Abnormality of Laboratory Test|2
914575|NCT00817063|1892653|FG001|Overall Study|Abnormality of Laboratory Test|1
914576|NCT00817089|1892663|FG000|First Alcohol Challenge|Lost to Follow-up|0
914577|NCT00817089|1892664|FG001|First Alcohol Challenge|Lost to Follow-up|0
914578|NCT00817089|1892665|FG002|First Alcohol Challenge|Lost to Follow-up|0
914579|NCT00817089|1892666|FG003|First Alcohol Challenge|Lost to Follow-up|1
914580|NCT00817089|1892663|FG000|Second Alcohol Challenge|Lost to Follow-up|0
914581|NCT00817089|1892664|FG001|Second Alcohol Challenge|Lost to Follow-up|1
914582|NCT00817089|1892665|FG002|Second Alcohol Challenge|Lost to Follow-up|0
914583|NCT00817089|1892666|FG003|Second Alcohol Challenge|Lost to Follow-up|0
914584|NCT00817206|1892682|FG000|Overall Study|Adverse Event|10
914585|NCT00817206|1892683|FG001|Overall Study|Adverse Event|3
914586|NCT00817206|1892682|FG000|Overall Study|Protocol Violation|0
914587|NCT00817206|1892683|FG001|Overall Study|Protocol Violation|2
914588|NCT00817206|1892682|FG000|Overall Study|Lost to Follow-up|0
914589|NCT00817206|1892683|FG001|Overall Study|Lost to Follow-up|1
914590|NCT00817206|1892682|FG000|Overall Study|Death|2
1014198|NCT01528072|2035574|FG000|Overall Study|Determined not eligible by AEAC|1
1014199|NCT01528072|2035574|FG000|Overall Study|Missed Visit|2
1014200|NCT01528072|2035574|FG000|Overall Study|Lost to Follow-up|5
1014201|NCT01528072|2035574|FG000|Overall Study|Explanted|2
1014202|NCT01528072|2035574|FG000|Overall Study|Site Closure|4
1014203|NCT01528072|2035574|FG000|Overall Study|Death|2
1014204|NCT01528072|2035574|FG000|Overall Study|Early Termination of Study|52
1014205|NCT01528215|2035619|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4
1014206|NCT01528215|2035620|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1
1014207|NCT01528215|2035619|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
1014208|NCT01528215|2035620|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
914591|NCT00817206|1892683|FG001|Overall Study|Death|0
914592|NCT00817206|1892682|FG000|Overall Study|Withdrawal by Subject|7
914593|NCT00817206|1892683|FG001|Overall Study|Withdrawal by Subject|3
914594|NCT00817206|1892682|FG000|Overall Study|Physician Decision|2
914595|NCT00817206|1892683|FG001|Overall Study|Physician Decision|0
914596|NCT00817336|1892695|FG000|Overall Study|Withdrawal by Subject|1
914597|NCT00817336|1892696|FG001|Overall Study|Withdrawal by Subject|1
914598|NCT00817414|1892706|FG000|Overall Study|Adverse Event|1
914599|NCT00817414|1892707|FG001|Overall Study|Adverse Event|1
914600|NCT00817414|1892708|FG002|Overall Study|Adverse Event|1
914601|NCT00817414|1892709|FG003|Overall Study|Adverse Event|0
914602|NCT00817414|1892710|FG004|Overall Study|Adverse Event|0
914603|NCT00817414|1892706|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
914604|NCT00817414|1892707|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1
914605|NCT00817414|1892708|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2
914606|NCT00817414|1892709|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4
914607|NCT00817414|1892710|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
914608|NCT00817414|1892706|FG000|Overall Study|Withdrawal by Subject|1
914609|NCT00817414|1892707|FG001|Overall Study|Withdrawal by Subject|1
914610|NCT00817414|1892708|FG002|Overall Study|Withdrawal by Subject|0
914611|NCT00817414|1892709|FG003|Overall Study|Withdrawal by Subject|0
914612|NCT00817414|1892710|FG004|Overall Study|Withdrawal by Subject|0
914613|NCT00817414|1892706|FG000|Overall Study|Lost to Follow-up|0
914614|NCT00817414|1892707|FG001|Overall Study|Lost to Follow-up|0
914615|NCT00817414|1892708|FG002|Overall Study|Lost to Follow-up|1
914616|NCT00817414|1892709|FG003|Overall Study|Lost to Follow-up|1
914617|NCT00817414|1892710|FG004|Overall Study|Lost to Follow-up|1
914618|NCT00817414|1892706|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
914619|NCT00817414|1892707|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
914620|NCT00817414|1892708|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
914621|NCT00817414|1892709|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7
914622|NCT00817414|1892710|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
914623|NCT00817414|1892706|FG000|Overall Study|Protocol Violation|0
914624|NCT00817414|1892707|FG001|Overall Study|Protocol Violation|0
914625|NCT00817414|1892708|FG002|Overall Study|Protocol Violation|0
914626|NCT00817414|1892709|FG003|Overall Study|Protocol Violation|0
914627|NCT00817414|1892710|FG004|Overall Study|Protocol Violation|1
914628|NCT00817479|1892729|FG000|Overall Study|Physician Decision|1
914629|NCT00817479|1892730|FG001|Overall Study|Physician Decision|1
914630|NCT00817531|1892736|FG000|Overall Study|Adverse Event|1
914631|NCT00817531|1892736|FG000|Overall Study|Lack of Efficacy|1
914632|NCT00817635|1892749|FG000|Overall Study|Adverse Event|1
914633|NCT00817635|1892750|FG001|Overall Study|Adverse Event|0
914634|NCT00817635|1892751|FG002|Overall Study|Adverse Event|0
914635|NCT00817635|1892752|FG003|Overall Study|Adverse Event|1
914636|NCT00817635|1892753|FG004|Overall Study|Adverse Event|1
914637|NCT00817635|1892749|FG000|Overall Study|Abnormal Laboratory Value(s)|1
914638|NCT00817635|1892750|FG001|Overall Study|Abnormal Laboratory Value(s)|1
914639|NCT00817635|1892751|FG002|Overall Study|Abnormal Laboratory Value(s)|0
914640|NCT00817635|1892752|FG003|Overall Study|Abnormal Laboratory Value(s)|0
914641|NCT00817635|1892753|FG004|Overall Study|Abnormal Laboratory Value(s)|1
914642|NCT00817635|1892749|FG000|Overall Study|Withdrawal by Subject|2
914643|NCT00817635|1892750|FG001|Overall Study|Withdrawal by Subject|1
914644|NCT00817635|1892751|FG002|Overall Study|Withdrawal by Subject|0
914645|NCT00817635|1892752|FG003|Overall Study|Withdrawal by Subject|1
914646|NCT00817635|1892753|FG004|Overall Study|Withdrawal by Subject|2
914647|NCT00817635|1892749|FG000|Overall Study|Lost to Follow-up|0
914648|NCT00817635|1892750|FG001|Overall Study|Lost to Follow-up|1
914649|NCT00817635|1892751|FG002|Overall Study|Lost to Follow-up|0
914650|NCT00817635|1892752|FG003|Overall Study|Lost to Follow-up|1
914651|NCT00817635|1892753|FG004|Overall Study|Lost to Follow-up|0
914652|NCT00817635|1892749|FG000|Overall Study|Administrative Problems|0
914653|NCT00817635|1892750|FG001|Overall Study|Administrative Problems|0
914654|NCT00817635|1892751|FG002|Overall Study|Administrative Problems|0
914655|NCT00817635|1892752|FG003|Overall Study|Administrative Problems|0
914656|NCT00817635|1892753|FG004|Overall Study|Administrative Problems|1
914657|NCT00817635|1892749|FG000|Overall Study|Protocol Violation|5
914658|NCT00817635|1892750|FG001|Overall Study|Protocol Violation|1
914659|NCT00817635|1892751|FG002|Overall Study|Protocol Violation|3
1014209|NCT01528215|2035619|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
1014210|NCT01528215|2035620|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
1014211|NCT01528215|2035619|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
1014212|NCT01528215|2035620|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
1014213|NCT01528254|2035637|FG000|Overall Study|Administrative problems|96
1014214|NCT01528254|2035638|FG001|Overall Study|Administrative problems|94
1014215|NCT01528254|2035637|FG000|Overall Study|Adverse Event|28
1014216|NCT01528254|2035638|FG001|Overall Study|Adverse Event|44
1014217|NCT01528254|2035637|FG000|Overall Study|Lost to Follow-up|17
1014218|NCT01528254|2035638|FG001|Overall Study|Lost to Follow-up|24
1014219|NCT01528254|2035637|FG000|Overall Study|Death|13
1014220|NCT01528254|2035638|FG001|Overall Study|Death|9
1014221|NCT01528254|2035637|FG000|Overall Study|Protocol deviation|9
1014222|NCT01528254|2035638|FG001|Overall Study|Protocol deviation|19
1014223|NCT01528254|2035637|FG000|Overall Study|New therapy for study indication|8
1014224|NCT01528254|2035638|FG001|Overall Study|New therapy for study indication|6
1014225|NCT01528254|2035637|FG000|Overall Study|Unsatisfactory therapeutic effect|6
1014226|NCT01528254|2035638|FG001|Overall Study|Unsatisfactory therapeutic effect|8
1014227|NCT01528254|2035637|FG000|Overall Study|Withdrawal by Subject|5
1014228|NCT01528254|2035638|FG001|Overall Study|Withdrawal by Subject|4
1014229|NCT01528254|2035637|FG000|Overall Study|Abnormal laboratory value(s)|3
1014230|NCT01528254|2035638|FG001|Overall Study|Abnormal laboratory value(s)|7
1014231|NCT01528254|2035637|FG000|Overall Study|Abnormal test procedure result(s)|1
1014232|NCT01528254|2035638|FG001|Overall Study|Abnormal test procedure result(s)|0
1014233|NCT01528254|2035637|FG000|Overall Study|No longer requires study drug|1
1014234|NCT01528254|2035638|FG001|Overall Study|No longer requires study drug|1
1014235|NCT01528345|2035660|FG000|Overall Study|Adverse Event|10
1014236|NCT01528345|2035661|FG001|Overall Study|Adverse Event|1
1014237|NCT01528345|2035660|FG000|Overall Study|Death|1
1014238|NCT01528345|2035661|FG001|Overall Study|Death|1
1014239|NCT01528345|2035660|FG000|Overall Study|Non-compliance with study treatment|1
1014240|NCT01528345|2035661|FG001|Overall Study|Non-compliance with study treatment|0
1014241|NCT01528345|2035660|FG000|Overall Study|Progressive Disease|26
1014242|NCT01528345|2035661|FG001|Overall Study|Progressive Disease|40
1014243|NCT01528345|2035660|FG000|Overall Study|Study Terminated by Sponsor|4
1014244|NCT01528345|2035661|FG001|Overall Study|Study Terminated by Sponsor|8
1014245|NCT01528345|2035660|FG000|Overall Study|Subject/Guardian Decision|5
1014246|NCT01528345|2035661|FG001|Overall Study|Subject/Guardian Decision|0
1014247|NCT01528605|2035677|FG000|Overall Study|Lost to Follow-up|1
1014248|NCT01528605|2035678|FG001|Overall Study|Lost to Follow-up|0
1014249|NCT01528605|2035679|FG002|Overall Study|Lost to Follow-up|1
1014250|NCT01528605|2035680|FG003|Overall Study|Lost to Follow-up|1
1014251|NCT01528605|2035681|FG004|Overall Study|Lost to Follow-up|0
1014252|NCT01528605|2035682|FG005|Overall Study|Lost to Follow-up|0
1014253|NCT01528605|2035677|FG000|Overall Study|Death|1
1014254|NCT01528605|2035678|FG001|Overall Study|Death|0
1014255|NCT01528605|2035679|FG002|Overall Study|Death|0
1014256|NCT01528605|2035680|FG003|Overall Study|Death|0
1014257|NCT01528605|2035681|FG004|Overall Study|Death|0
1014258|NCT01528605|2035682|FG005|Overall Study|Death|0
914660|NCT00817635|1892752|FG003|Overall Study|Protocol Violation|2
914661|NCT00817635|1892753|FG004|Overall Study|Protocol Violation|3
914662|NCT00817778|1892774|FG000|Overall Study|Adverse Event|1
914663|NCT00817778|1892775|FG001|Overall Study|Adverse Event|0
914664|NCT00817778|1892774|FG000|Overall Study|Withdrawal by Subject|1
914665|NCT00817778|1892775|FG001|Overall Study|Withdrawal by Subject|1
914666|NCT00817778|1892774|FG000|Overall Study|Protocol Violation|0
914667|NCT00817778|1892775|FG001|Overall Study|Protocol Violation|1
914668|NCT00817778|1892774|FG000|Overall Study|Study-specific discontinuation criteria|0
914669|NCT00817778|1892775|FG001|Overall Study|Study-specific discontinuation criteria|1
914670|NCT00817778|1892774|FG000|Overall Study|Poor venous access|1
914671|NCT00817778|1892775|FG001|Overall Study|Poor venous access|0
914672|NCT00818168|1892811|FG000|Overall Study|Lack of Efficacy|18
914673|NCT00818168|1892811|FG000|Overall Study|Pregnancy|2
914674|NCT00818168|1892811|FG000|Overall Study|Withdrawal by Subject|16
914675|NCT00818168|1892811|FG000|Overall Study|Lost to Follow-up|7
914676|NCT00818168|1892811|FG000|Overall Study|Adverse Event|19
914677|NCT00818168|1892811|FG000|Overall Study|Reason for Non-completion Not reported|6
914678|NCT00818168|1892811|FG000|Overall Study|Participant Moved|2
914679|NCT00818207|1892817|FG000|Overall Study|Adverse Event|6
914680|NCT00818207|1892818|FG001|Overall Study|Adverse Event|0
914681|NCT00818207|1892817|FG000|Overall Study|Lost to Follow-up|160
914682|NCT00818207|1892818|FG001|Overall Study|Lost to Follow-up|146
914683|NCT00818207|1892817|FG000|Overall Study|Multiple reasons|11
914684|NCT00818207|1892818|FG001|Overall Study|Multiple reasons|12
914685|NCT00818207|1892817|FG000|Overall Study|Withdrawal by Subject|42
914686|NCT00818207|1892818|FG001|Overall Study|Withdrawal by Subject|104
914687|NCT00818207|1892817|FG000|Overall Study|Death|3
914688|NCT00818207|1892818|FG001|Overall Study|Death|5
914689|NCT00818246|1892824|FG000|Overall Study|Impossible to match pictures|5
914690|NCT00818259|1892835|FG000|Part I|Withdrawal by Subject|1
914691|NCT00818259|1892836|FG001|Part I|Withdrawal by Subject|0
914692|NCT00818259|1892837|FG002|Part I|Withdrawal by Subject|0
1014259|NCT01528709|2035698|FG000|Overall Study|Death|2
1014260|NCT01528709|2035699|FG001|Overall Study|Death|0
1014261|NCT01528709|2035698|FG000|Overall Study|Withdrawal by Subject|10
1014262|NCT01528709|2035699|FG001|Overall Study|Withdrawal by Subject|15
1014263|NCT01528709|2035698|FG000|Overall Study|allergy|1
1014264|NCT01528709|2035699|FG001|Overall Study|allergy|0
1014265|NCT01528735|2035707|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
1014266|NCT01528735|2035708|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
1014267|NCT01528735|2035707|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
1014268|NCT01528735|2035708|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
1014269|NCT01528787|2035720|FG000|Overall Study|Withdrawal by Subject|0
1014270|NCT01528787|2035721|FG001|Overall Study|Withdrawal by Subject|0
1014271|NCT01528787|2035722|FG002|Overall Study|Withdrawal by Subject|0
1014272|NCT01528787|2035723|FG003|Overall Study|Withdrawal by Subject|1
1014273|NCT01528787|2035720|FG000|Overall Study|Family Emergency|0
1014274|NCT01528787|2035721|FG001|Overall Study|Family Emergency|0
1014275|NCT01528787|2035722|FG002|Overall Study|Family Emergency|1
1014276|NCT01528787|2035723|FG003|Overall Study|Family Emergency|0
1014277|NCT01528969|2035752|FG000|Overall Study|absent from the school at baseline|2
1014278|NCT01528969|2035753|FG001|Overall Study|absent from the school at baseline|0
1014279|NCT01529034|2035759|FG000|Overall Study|Discontinued prior to study treatment|14
1014280|NCT01529034|2035759|FG000|Overall Study|Site closure|62
1014281|NCT01529034|2035759|FG000|Overall Study|Study termination|29
1014282|NCT01529034|2035759|FG000|Overall Study|Withdrawal by Subject|25
1014283|NCT01529034|2035759|FG000|Overall Study|No treated SCs within protocol window|13
1014284|NCT01529034|2035759|FG000|Overall Study|Noncompliance|8
1014285|NCT01529034|2035759|FG000|Overall Study|Caregiver no longer available|7
1014286|NCT01529034|2035759|FG000|Overall Study|Adverse Event|4
1014287|NCT01529034|2035759|FG000|Overall Study|Protocol Violation|4
1014288|NCT01529034|2035759|FG000|Overall Study|Lack of Efficacy|4
1014289|NCT01529034|2035759|FG000|Overall Study|Investigator no longer available|2
1014290|NCT01529034|2035759|FG000|Overall Study|Study drug not available|2
1014291|NCT01529112|2035776|FG000|Overall Study|Adverse Event|2
1014292|NCT01529112|2035777|FG001|Overall Study|Adverse Event|0
1014293|NCT01529112|2035776|FG000|Overall Study|Death|59
914693|NCT00818259|1892838|FG003|Part I|Withdrawal by Subject|0
914694|NCT00818259|1892839|FG004|Part I|Withdrawal by Subject|0
914695|NCT00818259|1892840|FG005|Part I|Withdrawal by Subject|0
914696|NCT00818259|1892841|FG006|Part I|Withdrawal by Subject|0
914697|NCT00818259|1892842|FG007|Part I|Withdrawal by Subject|0
914698|NCT00818259|1892843|FG008|Part I|Withdrawal by Subject|0
914699|NCT00818259|1892835|FG000|Part II|Physician Decision|0
914700|NCT00818259|1892836|FG001|Part II|Physician Decision|0
914701|NCT00818259|1892837|FG002|Part II|Physician Decision|1
914702|NCT00818259|1892838|FG003|Part II|Physician Decision|0
914703|NCT00818259|1892839|FG004|Part II|Physician Decision|0
914704|NCT00818259|1892840|FG005|Part II|Physician Decision|0
914705|NCT00818259|1892841|FG006|Part II|Physician Decision|0
914706|NCT00818259|1892842|FG007|Part II|Physician Decision|0
914707|NCT00818259|1892843|FG008|Part II|Physician Decision|0
914708|NCT00818259|1892835|FG000|Part II|Lack of Efficacy|0
914709|NCT00818259|1892836|FG001|Part II|Lack of Efficacy|0
914710|NCT00818259|1892837|FG002|Part II|Lack of Efficacy|0
914711|NCT00818259|1892838|FG003|Part II|Lack of Efficacy|1
914712|NCT00818259|1892839|FG004|Part II|Lack of Efficacy|0
914713|NCT00818259|1892840|FG005|Part II|Lack of Efficacy|0
914714|NCT00818259|1892841|FG006|Part II|Lack of Efficacy|0
914715|NCT00818259|1892842|FG007|Part II|Lack of Efficacy|0
914716|NCT00818259|1892843|FG008|Part II|Lack of Efficacy|0
914717|NCT00818259|1892835|FG000|Part II|Not Treated|0
914718|NCT00818259|1892836|FG001|Part II|Not Treated|0
914719|NCT00818259|1892837|FG002|Part II|Not Treated|0
914720|NCT00818259|1892838|FG003|Part II|Not Treated|1
914721|NCT00818259|1892839|FG004|Part II|Not Treated|0
914722|NCT00818259|1892840|FG005|Part II|Not Treated|0
914723|NCT00818259|1892841|FG006|Part II|Not Treated|0
914724|NCT00818259|1892842|FG007|Part II|Not Treated|0
914725|NCT00818259|1892843|FG008|Part II|Not Treated|0
914726|NCT00818259|1892835|FG000|Part IV|Physician Decision|0
914727|NCT00818259|1892836|FG001|Part IV|Physician Decision|0
914728|NCT00818259|1892837|FG002|Part IV|Physician Decision|0
914729|NCT00818259|1892838|FG003|Part IV|Physician Decision|0
914730|NCT00818259|1892839|FG004|Part IV|Physician Decision|0
914731|NCT00818259|1892840|FG005|Part IV|Physician Decision|1
914732|NCT00818259|1892841|FG006|Part IV|Physician Decision|0
914733|NCT00818259|1892842|FG007|Part IV|Physician Decision|0
914734|NCT00818259|1892843|FG008|Part IV|Physician Decision|0
914735|NCT00818259|1892835|FG000|Part V|Adverse Event|0
914736|NCT00818259|1892836|FG001|Part V|Adverse Event|0
914737|NCT00818259|1892837|FG002|Part V|Adverse Event|0
914738|NCT00818259|1892838|FG003|Part V|Adverse Event|0
914739|NCT00818259|1892839|FG004|Part V|Adverse Event|0
914740|NCT00818259|1892840|FG005|Part V|Adverse Event|0
914741|NCT00818259|1892841|FG006|Part V|Adverse Event|0
914742|NCT00818259|1892842|FG007|Part V|Adverse Event|1
914743|NCT00818259|1892843|FG008|Part V|Adverse Event|0
914744|NCT00818389|1892883|FG000|Overall Study|Death|1
914745|NCT00818389|1892884|FG001|Overall Study|Death|3
1014294|NCT01529112|2035777|FG001|Overall Study|Death|38
1014295|NCT01529112|2035776|FG000|Overall Study|Protocol Violation|1
1014296|NCT01529112|2035777|FG001|Overall Study|Protocol Violation|0
1014297|NCT01529112|2035776|FG000|Overall Study|Withdrawal by Subject|7
1014298|NCT01529112|2035777|FG001|Overall Study|Withdrawal by Subject|3
1014299|NCT01529268|2035789|FG000|Overall Study|Lost to Follow-up|9
1014300|NCT01529268|2035790|FG001|Overall Study|Lost to Follow-up|3
1014301|NCT01529268|2035789|FG000|Overall Study|Moved|3
1014302|NCT01529268|2035790|FG001|Overall Study|Moved|0
1014303|NCT01529346|2035801|FG000|Overall Study|Lost to Follow-up|2
1014304|NCT01529346|2035802|FG001|Overall Study|Lost to Follow-up|0
1014305|NCT01529346|2035803|FG002|Overall Study|Lost to Follow-up|1
1014306|NCT01529346|2035804|FG003|Overall Study|Lost to Follow-up|0
1014307|NCT01529346|2035805|FG004|Overall Study|Lost to Follow-up|0
1014308|NCT01529346|2035801|FG000|Overall Study|Other|0
1014309|NCT01529346|2035802|FG001|Overall Study|Other|1
1014310|NCT01529346|2035803|FG002|Overall Study|Other|1
1014311|NCT01529346|2035804|FG003|Overall Study|Other|0
1014312|NCT01529346|2035805|FG004|Overall Study|Other|0
1014313|NCT01529385|2035820|FG000|Overall Study|Lost to Follow-up|2
1014314|NCT01529385|2035821|FG001|Overall Study|Lost to Follow-up|1
1014315|NCT01529515|2035858|FG000|TRANSITION PHASE|Adverse Event|16
1014316|NCT01529515|2035859|FG001|TRANSITION PHASE|Adverse Event|0
1014317|NCT01529515|2035860|FG002|TRANSITION PHASE|Adverse Event|0
1014318|NCT01529515|2035861|FG003|TRANSITION PHASE|Adverse Event|0
1014319|NCT01529515|2035858|FG000|TRANSITION PHASE|Death|1
1014320|NCT01529515|2035859|FG001|TRANSITION PHASE|Death|0
1014321|NCT01529515|2035860|FG002|TRANSITION PHASE|Death|0
1014322|NCT01529515|2035861|FG003|TRANSITION PHASE|Death|0
914746|NCT00818389|1892883|FG000|Overall Study|ALS Disease Progression|1
914747|NCT00818389|1892884|FG001|Overall Study|ALS Disease Progression|0
914748|NCT00818389|1892883|FG000|Overall Study|Withdrawal by Subject|2
914749|NCT00818389|1892884|FG001|Overall Study|Withdrawal by Subject|2
914750|NCT00818389|1892883|FG000|Overall Study|Adverse Event|0
914751|NCT00818389|1892884|FG001|Overall Study|Adverse Event|1
914752|NCT00818441|1892892|FG000|Overall Study|Death|69
914753|NCT00818441|1892893|FG001|Overall Study|Death|26
914754|NCT00818441|1892892|FG000|Overall Study|Other|5
914755|NCT00818441|1892893|FG001|Overall Study|Other|0
914756|NCT00818441|1892892|FG000|Overall Study|Lost to Follow-up|2
914757|NCT00818441|1892893|FG001|Overall Study|Lost to Follow-up|1
914758|NCT00818441|1892892|FG000|Overall Study|Withdrawal by Subject|2
914759|NCT00818441|1892893|FG001|Overall Study|Withdrawal by Subject|0
914760|NCT00818441|1892892|FG000|Overall Study|Adverse Event|0
914761|NCT00818441|1892893|FG001|Overall Study|Adverse Event|1
914762|NCT00818441|1892892|FG000|Overall Study|Study terminated by sponsor|11
914763|NCT00818441|1892893|FG001|Overall Study|Study terminated by sponsor|2
914764|NCT00818454|1892900|FG000|Treatment Period 1|Adverse Event|0
914765|NCT00818454|1892901|FG001|Treatment Period 1|Adverse Event|1
914766|NCT00818454|1892902|FG002|Treatment Period 1|Adverse Event|0
914767|NCT00818454|1892903|FG003|Treatment Period 1|Adverse Event|0
914768|NCT00818454|1892900|FG000|Treatment Period 1|Other|3
914769|NCT00818454|1892901|FG001|Treatment Period 1|Other|0
914770|NCT00818454|1892902|FG002|Treatment Period 1|Other|0
914771|NCT00818454|1892903|FG003|Treatment Period 1|Other|0
914772|NCT00818454|1892900|FG000|Washout Period of 1 Week|Adverse Event|1
914773|NCT00818454|1892901|FG001|Washout Period of 1 Week|Adverse Event|1
914774|NCT00818454|1892902|FG002|Washout Period of 1 Week|Adverse Event|0
914775|NCT00818454|1892903|FG003|Washout Period of 1 Week|Adverse Event|0
914776|NCT00818454|1892900|FG000|Washout Period of 1 Week|Protocol Violation|2
914777|NCT00818454|1892901|FG001|Washout Period of 1 Week|Protocol Violation|0
914778|NCT00818454|1892902|FG002|Washout Period of 1 Week|Protocol Violation|0
914779|NCT00818454|1892903|FG003|Washout Period of 1 Week|Protocol Violation|0
914780|NCT00818454|1892900|FG000|Washout Period of 1 Week|Other|1
914781|NCT00818454|1892901|FG001|Washout Period of 1 Week|Other|2
914782|NCT00818454|1892902|FG002|Washout Period of 1 Week|Other|0
914783|NCT00818454|1892903|FG003|Washout Period of 1 Week|Other|0
914784|NCT00818454|1892900|FG000|Treatment Period 2|Other|2
914785|NCT00818454|1892901|FG001|Treatment Period 2|Other|1
914786|NCT00818454|1892902|FG002|Treatment Period 2|Other|0
914787|NCT00818454|1892903|FG003|Treatment Period 2|Other|0
914788|NCT00818454|1892900|FG000|Treatment Period 3|Adverse Event|0
914789|NCT00818454|1892901|FG001|Treatment Period 3|Adverse Event|0
914790|NCT00818454|1892902|FG002|Treatment Period 3|Adverse Event|0
914791|NCT00818454|1892903|FG003|Treatment Period 3|Adverse Event|1
914792|NCT00818519|1892915|FG000|Overall Study|Adverse Event|2
914793|NCT00818519|1892916|FG001|Overall Study|Adverse Event|2
914794|NCT00818519|1892915|FG000|Overall Study|Lost to Follow-up|4
914795|NCT00818519|1892916|FG001|Overall Study|Lost to Follow-up|6
914796|NCT00818519|1892915|FG000|Overall Study|Protocol Violation|2
914797|NCT00818519|1892916|FG001|Overall Study|Protocol Violation|1
914798|NCT00818519|1892915|FG000|Overall Study|Pregnancy|0
914799|NCT00818519|1892916|FG001|Overall Study|Pregnancy|1
914800|NCT00818519|1892915|FG000|Overall Study|Withdrawal by Subject|4
914801|NCT00818519|1892916|FG001|Overall Study|Withdrawal by Subject|9
914802|NCT00818519|1892915|FG000|Overall Study|participant recovered completely|1
1014323|NCT01529515|2035858|FG000|TRANSITION PHASE|Lack of Efficacy|19
1014324|NCT01529515|2035859|FG001|TRANSITION PHASE|Lack of Efficacy|0
1014325|NCT01529515|2035860|FG002|TRANSITION PHASE|Lack of Efficacy|0
1014326|NCT01529515|2035861|FG003|TRANSITION PHASE|Lack of Efficacy|0
1014327|NCT01529515|2035858|FG000|TRANSITION PHASE|Lost to Follow-up|19
1014328|NCT01529515|2035859|FG001|TRANSITION PHASE|Lost to Follow-up|0
1014329|NCT01529515|2035860|FG002|TRANSITION PHASE|Lost to Follow-up|0
1014330|NCT01529515|2035861|FG003|TRANSITION PHASE|Lost to Follow-up|0
1014331|NCT01529515|2035858|FG000|TRANSITION PHASE|Protocol Violation|4
1014332|NCT01529515|2035859|FG001|TRANSITION PHASE|Protocol Violation|0
1014333|NCT01529515|2035860|FG002|TRANSITION PHASE|Protocol Violation|0
1014334|NCT01529515|2035861|FG003|TRANSITION PHASE|Protocol Violation|0
1014335|NCT01529515|2035858|FG000|TRANSITION PHASE|Withdrawal by Subject|51
1014336|NCT01529515|2035859|FG001|TRANSITION PHASE|Withdrawal by Subject|0
1014337|NCT01529515|2035860|FG002|TRANSITION PHASE|Withdrawal by Subject|0
1014338|NCT01529515|2035861|FG003|TRANSITION PHASE|Withdrawal by Subject|0
1014339|NCT01529515|2035858|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
1014340|NCT01529515|2035859|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1014341|NCT01529515|2035860|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1014342|NCT01529515|2035861|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1014343|NCT01529515|2035858|FG000|TRANSITION PHASE|Other|9
1014344|NCT01529515|2035859|FG001|TRANSITION PHASE|Other|0
1014345|NCT01529515|2035860|FG002|TRANSITION PHASE|Other|0
1014346|NCT01529515|2035861|FG003|TRANSITION PHASE|Other|0
1014347|NCT01529515|2035858|FG000|MAINTENANCE PHASE|Adverse Event|0
1014348|NCT01529515|2035859|FG001|MAINTENANCE PHASE|Adverse Event|10
1014349|NCT01529515|2035860|FG002|MAINTENANCE PHASE|Adverse Event|0
1014350|NCT01529515|2035861|FG003|MAINTENANCE PHASE|Adverse Event|0
1014351|NCT01529515|2035858|FG000|MAINTENANCE PHASE|Lack of Efficacy|0
1014352|NCT01529515|2035859|FG001|MAINTENANCE PHASE|Lack of Efficacy|9
1014353|NCT01529515|2035860|FG002|MAINTENANCE PHASE|Lack of Efficacy|0
1014354|NCT01529515|2035861|FG003|MAINTENANCE PHASE|Lack of Efficacy|0
1014355|NCT01529515|2035858|FG000|MAINTENANCE PHASE|Lost to Follow-up|0
1014356|NCT01529515|2035859|FG001|MAINTENANCE PHASE|Lost to Follow-up|5
1014357|NCT01529515|2035860|FG002|MAINTENANCE PHASE|Lost to Follow-up|0
1014358|NCT01529515|2035861|FG003|MAINTENANCE PHASE|Lost to Follow-up|0
914803|NCT00818519|1892916|FG001|Overall Study|participant recovered completely|0
914804|NCT00818519|1892915|FG000|Overall Study|participant will leave for long tme|1
914805|NCT00818519|1892916|FG001|Overall Study|participant will leave for long tme|0
914806|NCT00818623|1892930|FG000|Overall Study|Adverse Event|1
914807|NCT00818623|1892931|FG001|Overall Study|Adverse Event|0
914808|NCT00818623|1892932|FG002|Overall Study|Adverse Event|1
914809|NCT00818623|1892933|FG003|Overall Study|Adverse Event|0
914810|NCT00818623|1892934|FG004|Overall Study|Adverse Event|0
914811|NCT00818623|1892935|FG005|Overall Study|Adverse Event|1
914812|NCT00818623|1892936|FG006|Overall Study|Adverse Event|0
914813|NCT00818623|1892937|FG007|Overall Study|Adverse Event|0
914814|NCT00818623|1892930|FG000|Overall Study|Bad prostate specific antigen response|0
914815|NCT00818623|1892931|FG001|Overall Study|Bad prostate specific antigen response|3
914816|NCT00818623|1892932|FG002|Overall Study|Bad prostate specific antigen response|2
914817|NCT00818623|1892933|FG003|Overall Study|Bad prostate specific antigen response|5
914818|NCT00818623|1892934|FG004|Overall Study|Bad prostate specific antigen response|0
914819|NCT00818623|1892935|FG005|Overall Study|Bad prostate specific antigen response|1
914820|NCT00818623|1892936|FG006|Overall Study|Bad prostate specific antigen response|0
914821|NCT00818623|1892937|FG007|Overall Study|Bad prostate specific antigen response|0
914822|NCT00818623|1892930|FG000|Overall Study|Withdrawal by Subject|0
914823|NCT00818623|1892931|FG001|Overall Study|Withdrawal by Subject|1
914824|NCT00818623|1892932|FG002|Overall Study|Withdrawal by Subject|1
914825|NCT00818623|1892933|FG003|Overall Study|Withdrawal by Subject|0
914826|NCT00818623|1892934|FG004|Overall Study|Withdrawal by Subject|0
914827|NCT00818623|1892935|FG005|Overall Study|Withdrawal by Subject|1
914828|NCT00818623|1892936|FG006|Overall Study|Withdrawal by Subject|1
914829|NCT00818623|1892937|FG007|Overall Study|Withdrawal by Subject|1
914830|NCT00818623|1892930|FG000|Overall Study|Protocol Violation|1
914831|NCT00818623|1892931|FG001|Overall Study|Protocol Violation|0
914832|NCT00818623|1892932|FG002|Overall Study|Protocol Violation|0
914833|NCT00818623|1892933|FG003|Overall Study|Protocol Violation|0
914834|NCT00818623|1892934|FG004|Overall Study|Protocol Violation|1
914835|NCT00818623|1892935|FG005|Overall Study|Protocol Violation|0
914836|NCT00818623|1892936|FG006|Overall Study|Protocol Violation|1
914837|NCT00818623|1892937|FG007|Overall Study|Protocol Violation|0
914838|NCT00818623|1892930|FG000|Overall Study|Need of additional treatment|0
914839|NCT00818623|1892931|FG001|Overall Study|Need of additional treatment|0
914840|NCT00818623|1892932|FG002|Overall Study|Need of additional treatment|0
914841|NCT00818623|1892933|FG003|Overall Study|Need of additional treatment|0
914842|NCT00818623|1892934|FG004|Overall Study|Need of additional treatment|1
914843|NCT00818623|1892935|FG005|Overall Study|Need of additional treatment|0
914844|NCT00818623|1892936|FG006|Overall Study|Need of additional treatment|0
914845|NCT00818623|1892937|FG007|Overall Study|Need of additional treatment|0
914846|NCT00818623|1892930|FG000|Overall Study|Lack of trial drug at site|0
914847|NCT00818623|1892931|FG001|Overall Study|Lack of trial drug at site|0
914848|NCT00818623|1892932|FG002|Overall Study|Lack of trial drug at site|0
914849|NCT00818623|1892933|FG003|Overall Study|Lack of trial drug at site|0
1014359|NCT01529515|2035858|FG000|MAINTENANCE PHASE|Protocol Violation|0
1014360|NCT01529515|2035859|FG001|MAINTENANCE PHASE|Protocol Violation|12
1014361|NCT01529515|2035860|FG002|MAINTENANCE PHASE|Protocol Violation|0
1014362|NCT01529515|2035861|FG003|MAINTENANCE PHASE|Protocol Violation|0
1014363|NCT01529515|2035858|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0
1014364|NCT01529515|2035859|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15
1014365|NCT01529515|2035860|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0
1014366|NCT01529515|2035861|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0
1014367|NCT01529515|2035858|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0
1014368|NCT01529515|2035859|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13
1014369|NCT01529515|2035860|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0
1014370|NCT01529515|2035861|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0
1014371|NCT01529515|2035858|FG000|MAINTENANCE PHASE|Other|0
1014372|NCT01529515|2035859|FG001|MAINTENANCE PHASE|Other|10
1014373|NCT01529515|2035860|FG002|MAINTENANCE PHASE|Other|0
1014374|NCT01529515|2035861|FG003|MAINTENANCE PHASE|Other|0
1014375|NCT01529515|2035858|FG000|DOUBLE BLIND PHASE|Adverse Event|0
1014376|NCT01529515|2035859|FG001|DOUBLE BLIND PHASE|Adverse Event|0
1014377|NCT01529515|2035860|FG002|DOUBLE BLIND PHASE|Adverse Event|1
1014378|NCT01529515|2035861|FG003|DOUBLE BLIND PHASE|Adverse Event|0
1014379|NCT01529515|2035858|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0
1014380|NCT01529515|2035859|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0
1014381|NCT01529515|2035860|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1
1014382|NCT01529515|2035861|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3
1014383|NCT01529515|2035858|FG000|DOUBLE BLIND PHASE|Pregnancy|0
1014384|NCT01529515|2035859|FG001|DOUBLE BLIND PHASE|Pregnancy|0
1014385|NCT01529515|2035860|FG002|DOUBLE BLIND PHASE|Pregnancy|1
1014386|NCT01529515|2035861|FG003|DOUBLE BLIND PHASE|Pregnancy|0
1014387|NCT01529515|2035858|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0
1014388|NCT01529515|2035859|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0
1014389|NCT01529515|2035860|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10
1014390|NCT01529515|2035861|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7
1014391|NCT01529515|2035858|FG000|DOUBLE BLIND PHASE|Protocol Violation|0
1014392|NCT01529515|2035859|FG001|DOUBLE BLIND PHASE|Protocol Violation|0
1014393|NCT01529515|2035860|FG002|DOUBLE BLIND PHASE|Protocol Violation|1
1014394|NCT01529515|2035861|FG003|DOUBLE BLIND PHASE|Protocol Violation|0
914850|NCT00818623|1892934|FG004|Overall Study|Lack of trial drug at site|2
914851|NCT00818623|1892935|FG005|Overall Study|Lack of trial drug at site|0
914852|NCT00818623|1892936|FG006|Overall Study|Lack of trial drug at site|1
914853|NCT00818623|1892937|FG007|Overall Study|Lack of trial drug at site|0
914854|NCT00818623|1892930|FG000|Overall Study|Disease progression|0
914855|NCT00818623|1892931|FG001|Overall Study|Disease progression|0
914856|NCT00818623|1892932|FG002|Overall Study|Disease progression|0
914857|NCT00818623|1892933|FG003|Overall Study|Disease progression|0
914858|NCT00818623|1892934|FG004|Overall Study|Disease progression|0
914859|NCT00818623|1892935|FG005|Overall Study|Disease progression|0
914860|NCT00818623|1892936|FG006|Overall Study|Disease progression|1
914861|NCT00818623|1892937|FG007|Overall Study|Disease progression|0
914862|NCT00818649|1892955|FG000|Overall Study|Declining performance status|2
914863|NCT00818649|1892955|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1
914864|NCT00818649|1892955|FG000|Overall Study|Adverse Event|1
914865|NCT00818662|1892964|FG000|Overall Study|Adverse Event|5
914866|NCT00818662|1892965|FG001|Overall Study|Adverse Event|14
914867|NCT00818662|1892966|FG002|Overall Study|Adverse Event|4
914868|NCT00818662|1892967|FG003|Overall Study|Adverse Event|3
914869|NCT00818662|1892964|FG000|Overall Study|Withdrawal by Subject|5
914870|NCT00818662|1892965|FG001|Overall Study|Withdrawal by Subject|4
914871|NCT00818662|1892966|FG002|Overall Study|Withdrawal by Subject|2
914872|NCT00818662|1892967|FG003|Overall Study|Withdrawal by Subject|2
914873|NCT00818662|1892964|FG000|Overall Study|Death|1
914874|NCT00818662|1892965|FG001|Overall Study|Death|3
914875|NCT00818662|1892966|FG002|Overall Study|Death|0
914876|NCT00818662|1892967|FG003|Overall Study|Death|0
914877|NCT00818662|1892964|FG000|Overall Study|Physician Decision|1
914878|NCT00818662|1892965|FG001|Overall Study|Physician Decision|0
914879|NCT00818662|1892966|FG002|Overall Study|Physician Decision|0
914880|NCT00818662|1892967|FG003|Overall Study|Physician Decision|0
914881|NCT00818662|1892964|FG000|Overall Study|Lost to Follow-up|0
914882|NCT00818662|1892965|FG001|Overall Study|Lost to Follow-up|0
914883|NCT00818662|1892966|FG002|Overall Study|Lost to Follow-up|0
914884|NCT00818662|1892967|FG003|Overall Study|Lost to Follow-up|1
914885|NCT00818662|1892964|FG000|Overall Study|Unwilling or Unable to Participate|4
914886|NCT00818662|1892965|FG001|Overall Study|Unwilling or Unable to Participate|6
914887|NCT00818662|1892966|FG002|Overall Study|Unwilling or Unable to Participate|2
914888|NCT00818662|1892967|FG003|Overall Study|Unwilling or Unable to Participate|4
914889|NCT00818662|1892964|FG000|Overall Study|Protocol Violation|1
914890|NCT00818662|1892965|FG001|Overall Study|Protocol Violation|1
914891|NCT00818662|1892966|FG002|Overall Study|Protocol Violation|0
914892|NCT00818662|1892967|FG003|Overall Study|Protocol Violation|0
914893|NCT00818662|1892964|FG000|Overall Study|Requires a Prohibited Medication|1
914894|NCT00818662|1892965|FG001|Overall Study|Requires a Prohibited Medication|0
914895|NCT00818662|1892966|FG002|Overall Study|Requires a Prohibited Medication|0
914896|NCT00818662|1892967|FG003|Overall Study|Requires a Prohibited Medication|0
914897|NCT00818662|1892964|FG000|Overall Study|Safety Risk|1
1014395|NCT01529515|2035858|FG000|DOUBLE BLIND PHASE|Other|0
1014396|NCT01529515|2035859|FG001|DOUBLE BLIND PHASE|Other|0
1014397|NCT01529515|2035860|FG002|DOUBLE BLIND PHASE|Other|9
1014398|NCT01529515|2035861|FG003|DOUBLE BLIND PHASE|Other|2
1014399|NCT01529606|2035870|FG000|Overall Study|Lost to Follow-up|21
1014400|NCT01529606|2035871|FG001|Overall Study|Lost to Follow-up|18
1014401|NCT01529632|2035879|FG000|Overall Study|Administrative problem|2
1014402|NCT01529632|2035880|FG001|Overall Study|Administrative problem|1
1014403|NCT01529632|2035879|FG000|Overall Study|Protocol Violation|0
1014404|NCT01529632|2035880|FG001|Overall Study|Protocol Violation|1
1014405|NCT01529632|2035879|FG000|Overall Study|Adverse Event|1
1014406|NCT01529632|2035880|FG001|Overall Study|Adverse Event|1
1014407|NCT01529645|2035896|FG000|Overall Study|Lost to Follow-up|0
1014408|NCT01529645|2035897|FG001|Overall Study|Lost to Follow-up|1
1014409|NCT01529645|2035898|FG002|Overall Study|Lost to Follow-up|1
1014410|NCT01529645|2035899|FG003|Overall Study|Lost to Follow-up|1
1014411|NCT01529645|2035900|FG004|Overall Study|Lost to Follow-up|1
1014412|NCT01529645|2035901|FG005|Overall Study|Lost to Follow-up|0
1014413|NCT01529645|2035902|FG006|Overall Study|Lost to Follow-up|2
1014414|NCT01529645|2035903|FG007|Overall Study|Lost to Follow-up|0
1014415|NCT01529645|2035904|FG008|Overall Study|Lost to Follow-up|1
1014416|NCT01529645|2035905|FG009|Overall Study|Lost to Follow-up|0
1014417|NCT01529645|2035896|FG000|Overall Study|SAE - Premature contractions|0
1014418|NCT01529645|2035897|FG001|Overall Study|SAE - Premature contractions|0
1014419|NCT01529645|2035898|FG002|Overall Study|SAE - Premature contractions|1
1014420|NCT01529645|2035899|FG003|Overall Study|SAE - Premature contractions|0
1014421|NCT01529645|2035900|FG004|Overall Study|SAE - Premature contractions|0
1014422|NCT01529645|2035901|FG005|Overall Study|SAE - Premature contractions|0
1014423|NCT01529645|2035902|FG006|Overall Study|SAE - Premature contractions|0
914898|NCT00818662|1892965|FG001|Overall Study|Safety Risk|1
914899|NCT00818662|1892966|FG002|Overall Study|Safety Risk|0
914900|NCT00818662|1892967|FG003|Overall Study|Safety Risk|1
914901|NCT00818662|1892964|FG000|Overall Study|Study Partner Unwilling or Unable|3
914902|NCT00818662|1892965|FG001|Overall Study|Study Partner Unwilling or Unable|2
914903|NCT00818662|1892966|FG002|Overall Study|Study Partner Unwilling or Unable|1
914904|NCT00818662|1892967|FG003|Overall Study|Study Partner Unwilling or Unable|1
914905|NCT00818662|1892964|FG000|Overall Study|Participant's health declined|0
914906|NCT00818662|1892965|FG001|Overall Study|Participant's health declined|0
914907|NCT00818662|1892966|FG002|Overall Study|Participant's health declined|0
914908|NCT00818662|1892967|FG003|Overall Study|Participant's health declined|1
914909|NCT00818662|1892964|FG000|Overall Study|Caregiver to pursue other treatment|0
914910|NCT00818662|1892965|FG001|Overall Study|Caregiver to pursue other treatment|1
914911|NCT00818662|1892966|FG002|Overall Study|Caregiver to pursue other treatment|0
914912|NCT00818662|1892967|FG003|Overall Study|Caregiver to pursue other treatment|0
914913|NCT00818662|1892964|FG000|Overall Study|Moving out of state|0
914914|NCT00818662|1892965|FG001|Overall Study|Moving out of state|0
914915|NCT00818662|1892966|FG002|Overall Study|Moving out of state|0
914916|NCT00818662|1892967|FG003|Overall Study|Moving out of state|1
914917|NCT00818662|1892964|FG000|Overall Study|Declined move to another study site|1
914918|NCT00818662|1892965|FG001|Overall Study|Declined move to another study site|0
914919|NCT00818662|1892966|FG002|Overall Study|Declined move to another study site|0
914920|NCT00818662|1892967|FG003|Overall Study|Declined move to another study site|0
914921|NCT00818662|1892964|FG000|Overall Study|Change in living situation|0
914922|NCT00818662|1892965|FG001|Overall Study|Change in living situation|0
914923|NCT00818662|1892966|FG002|Overall Study|Change in living situation|0
914924|NCT00818662|1892967|FG003|Overall Study|Change in living situation|1
914925|NCT00818662|1892964|FG000|Overall Study|Study partner decision|0
914926|NCT00818662|1892965|FG001|Overall Study|Study partner decision|0
914927|NCT00818662|1892966|FG002|Overall Study|Study partner decision|0
914928|NCT00818662|1892967|FG003|Overall Study|Study partner decision|1
914929|NCT00818662|1892964|FG000|Overall Study|Admitted to long term nursing care|0
914930|NCT00818662|1892965|FG001|Overall Study|Admitted to long term nursing care|1
914931|NCT00818662|1892966|FG002|Overall Study|Admitted to long term nursing care|0
914932|NCT00818662|1892967|FG003|Overall Study|Admitted to long term nursing care|0
914933|NCT00818753|1892981|FG000|Overall Study|Protocol Violation|1
914934|NCT00818753|1892982|FG001|Overall Study|Protocol Violation|0
914935|NCT00818753|1892983|FG002|Overall Study|Protocol Violation|0
914936|NCT00818753|1892981|FG000|Overall Study|Other reason (not specified)|0
914937|NCT00818753|1892982|FG001|Overall Study|Other reason (not specified)|0
914938|NCT00818753|1892983|FG002|Overall Study|Other reason (not specified)|1
914939|NCT00818753|1892981|FG000|Overall Study|Randomised and not treated|2
914940|NCT00818753|1892982|FG001|Overall Study|Randomised and not treated|0
914941|NCT00818753|1892983|FG002|Overall Study|Randomised and not treated|0
914942|NCT00818766|1892993|FG000|Overall Study|Could not be Contacted on Day 28|11
914943|NCT00818766|1892994|FG001|Overall Study|Could not be Contacted on Day 28|10
914944|NCT00818766|1892993|FG000|Overall Study|Death|1
914945|NCT00818766|1892994|FG001|Overall Study|Death|0
914946|NCT00818766|1892993|FG000|Overall Study|Did not Receive Allocated Intervention|3
914947|NCT00818766|1892994|FG001|Overall Study|Did not Receive Allocated Intervention|0
914948|NCT00818779|1893002|FG000|Overall Study|Protocol Violation|1
914949|NCT00818779|1893003|FG001|Overall Study|Protocol Violation|0
1014424|NCT01529645|2035903|FG007|Overall Study|SAE - Premature contractions|0
1014425|NCT01529645|2035904|FG008|Overall Study|SAE - Premature contractions|0
1014426|NCT01529645|2035905|FG009|Overall Study|SAE - Premature contractions|0
1014427|NCT01529645|2035896|FG000|Overall Study|Withdrawal by Subject|2
1014428|NCT01529645|2035897|FG001|Overall Study|Withdrawal by Subject|0
1014429|NCT01529645|2035898|FG002|Overall Study|Withdrawal by Subject|0
1014430|NCT01529645|2035899|FG003|Overall Study|Withdrawal by Subject|1
1014431|NCT01529645|2035900|FG004|Overall Study|Withdrawal by Subject|1
1014432|NCT01529645|2035901|FG005|Overall Study|Withdrawal by Subject|1
1014433|NCT01529645|2035902|FG006|Overall Study|Withdrawal by Subject|0
1014434|NCT01529645|2035903|FG007|Overall Study|Withdrawal by Subject|0
1014435|NCT01529645|2035904|FG008|Overall Study|Withdrawal by Subject|0
1014436|NCT01529645|2035905|FG009|Overall Study|Withdrawal by Subject|0
1014437|NCT01529749|2035939|FG000|Overall Study|Lost to Follow-up|0
1014438|NCT01529749|2035940|FG001|Overall Study|Lost to Follow-up|1
1014439|NCT01529749|2035941|FG002|Overall Study|Lost to Follow-up|1
1014440|NCT01529749|2035942|FG003|Overall Study|Lost to Follow-up|0
1014441|NCT01529749|2035939|FG000|Overall Study|Physician Decision|0
1014442|NCT01529749|2035940|FG001|Overall Study|Physician Decision|0
1014443|NCT01529749|2035941|FG002|Overall Study|Physician Decision|0
1014444|NCT01529749|2035942|FG003|Overall Study|Physician Decision|1
1014445|NCT01529749|2035939|FG000|Overall Study|Withdrawal by Subject|0
1014446|NCT01529749|2035940|FG001|Overall Study|Withdrawal by Subject|1
1014447|NCT01529749|2035941|FG002|Overall Study|Withdrawal by Subject|1
1014448|NCT01529749|2035942|FG003|Overall Study|Withdrawal by Subject|0
1014449|NCT01529749|2035939|FG000|Overall Study|Protocol Violation|0
1014450|NCT01529749|2035940|FG001|Overall Study|Protocol Violation|0
1014451|NCT01529749|2035941|FG002|Overall Study|Protocol Violation|0
1014452|NCT01529749|2035942|FG003|Overall Study|Protocol Violation|1
1014453|NCT01530256|2035987|FG000|Overall Study|Death|2
1014454|NCT01530334|2035991|FG000|Overall Study|Adverse Event|3
1014455|NCT01530334|2035991|FG000|Overall Study|unknown reason|1
1014456|NCT01530334|2035991|FG000|Overall Study|Progressive disease|47
1014457|NCT01530464|2036022|FG000|Washout (24h)|Withdrawal by Subject|1
1014458|NCT01530464|2036023|FG001|Washout (24h)|Withdrawal by Subject|0
1014459|NCT01530464|2036022|FG000|Washout (24h)|Withdrawal by Subject|0
1014460|NCT01530464|2036023|FG001|Washout (24h)|Withdrawal by Subject|1
1014463|NCT01531153|2036059|FG000|Overall Study|Withdrawal by Subject|10
1014464|NCT01531153|2036060|FG001|Overall Study|Withdrawal by Subject|9
1014465|NCT01531153|2036061|FG002|Overall Study|Withdrawal by Subject|15
1014466|NCT01531205|2036072|FG000|Overall Study|Did not proceed to surgery|1
1014467|NCT01531673|2036124|FG000|Overall Study|Non-Compliance|0
1014468|NCT01531673|2036125|FG001|Overall Study|Non-Compliance|0
1014469|NCT01531673|2036126|FG002|Overall Study|Non-Compliance|0
1014470|NCT01531673|2036127|FG003|Overall Study|Non-Compliance|0
1014471|NCT01531673|2036128|FG004|Overall Study|Non-Compliance|0
1014472|NCT01531673|2036129|FG005|Overall Study|Non-Compliance|1
1014473|NCT01531673|2036130|FG006|Overall Study|Non-Compliance|0
1014474|NCT01531673|2036131|FG007|Overall Study|Non-Compliance|0
1014475|NCT01531673|2036132|FG008|Overall Study|Non-Compliance|0
1014476|NCT01531673|2036133|FG009|Overall Study|Non-Compliance|0
1014477|NCT01531673|2036134|FG010|Overall Study|Non-Compliance|0
1014478|NCT01531673|2036135|FG011|Overall Study|Non-Compliance|0
1014479|NCT01531673|2036136|FG012|Overall Study|Non-Compliance|0
1014480|NCT01531673|2036124|FG000|Overall Study|Adverse Event|0
1014481|NCT01531673|2036125|FG001|Overall Study|Adverse Event|1
1014482|NCT01531673|2036126|FG002|Overall Study|Adverse Event|0
1014483|NCT01531673|2036127|FG003|Overall Study|Adverse Event|0
1014484|NCT01531673|2036128|FG004|Overall Study|Adverse Event|0
1014485|NCT01531673|2036129|FG005|Overall Study|Adverse Event|0
1014486|NCT01531673|2036130|FG006|Overall Study|Adverse Event|0
1014487|NCT01531673|2036131|FG007|Overall Study|Adverse Event|0
1014488|NCT01531673|2036132|FG008|Overall Study|Adverse Event|0
1014489|NCT01531673|2036133|FG009|Overall Study|Adverse Event|0
1014490|NCT01531673|2036134|FG010|Overall Study|Adverse Event|0
914950|NCT00818779|1893002|FG000|Overall Study|Lost to Follow-up|1
914951|NCT00818779|1893003|FG001|Overall Study|Lost to Follow-up|0
914952|NCT00818779|1893002|FG000|Overall Study|Adverse Event|4
914953|NCT00818779|1893003|FG001|Overall Study|Adverse Event|1
914954|NCT00818883|1893022|FG000|Overall Study|Adverse Event|28
914955|NCT00818883|1893023|FG001|Overall Study|Adverse Event|19
914956|NCT00818883|1893022|FG000|Overall Study|Protocol Violation|2
914957|NCT00818883|1893023|FG001|Overall Study|Protocol Violation|2
914958|NCT00818883|1893022|FG000|Overall Study|Lost to Follow-up|3
914959|NCT00818883|1893023|FG001|Overall Study|Lost to Follow-up|2
914960|NCT00818883|1893022|FG000|Overall Study|Withdrawal by Subject|16
914961|NCT00818883|1893023|FG001|Overall Study|Withdrawal by Subject|14
914962|NCT00818883|1893022|FG000|Overall Study|Lack of Efficacy|0
914963|NCT00818883|1893023|FG001|Overall Study|Lack of Efficacy|2
914964|NCT00818883|1893022|FG000|Overall Study|Other|2
914965|NCT00818883|1893023|FG001|Overall Study|Other|7
914966|NCT00819013|1893037|FG000|Overall Study|Not meeting continuing study eligibility|2
914967|NCT00819013|1893038|FG001|Overall Study|Not meeting continuing study eligibility|1
1014491|NCT01531673|2036135|FG011|Overall Study|Adverse Event|0
1014492|NCT01531673|2036136|FG012|Overall Study|Adverse Event|0
1014493|NCT01531673|2036124|FG000|Overall Study|Lost to Follow-up|0
1014494|NCT01531673|2036125|FG001|Overall Study|Lost to Follow-up|0
1014495|NCT01531673|2036126|FG002|Overall Study|Lost to Follow-up|0
1014496|NCT01531673|2036127|FG003|Overall Study|Lost to Follow-up|0
1014497|NCT01531673|2036128|FG004|Overall Study|Lost to Follow-up|1
1014498|NCT01531673|2036129|FG005|Overall Study|Lost to Follow-up|0
914968|NCT00819013|1893039|FG002|Overall Study|Not meeting continuing study eligibility|2
914969|NCT00819013|1893040|FG003|Overall Study|Not meeting continuing study eligibility|1
914970|NCT00819013|1893037|FG000|Overall Study|Adverse Event|0
914971|NCT00819013|1893038|FG001|Overall Study|Adverse Event|0
914972|NCT00819013|1893039|FG002|Overall Study|Adverse Event|1
914973|NCT00819013|1893040|FG003|Overall Study|Adverse Event|0
914974|NCT00819013|1893037|FG000|Overall Study|Withdrawal by Subject|1
914975|NCT00819013|1893038|FG001|Overall Study|Withdrawal by Subject|0
914976|NCT00819013|1893039|FG002|Overall Study|Withdrawal by Subject|1
914977|NCT00819013|1893040|FG003|Overall Study|Withdrawal by Subject|0
914978|NCT00819013|1893037|FG000|Overall Study|Lost to Follow-up|0
914979|NCT00819013|1893038|FG001|Overall Study|Lost to Follow-up|0
914980|NCT00819013|1893039|FG002|Overall Study|Lost to Follow-up|1
914981|NCT00819013|1893040|FG003|Overall Study|Lost to Follow-up|2
914982|NCT00819013|1893037|FG000|Overall Study|Death|0
914983|NCT00819013|1893038|FG001|Overall Study|Death|0
914984|NCT00819013|1893039|FG002|Overall Study|Death|0
914985|NCT00819013|1893040|FG003|Overall Study|Death|1
914986|NCT00819039|1893053|FG000|Overall Study|Physician Decision|1
914987|NCT00819039|1893054|FG001|Overall Study|Physician Decision|0
914988|NCT00819039|1893055|FG002|Overall Study|Physician Decision|1
914989|NCT00819039|1893053|FG000|Overall Study|Protocol Violation|1
914990|NCT00819039|1893054|FG001|Overall Study|Protocol Violation|0
914991|NCT00819039|1893055|FG002|Overall Study|Protocol Violation|0
914992|NCT00819052|1893067|FG000|Overall Study|Adverse Event|0
914993|NCT00819052|1893068|FG001|Overall Study|Adverse Event|5
914994|NCT00819052|1893067|FG000|Overall Study|Protocol Violation|1
914995|NCT00819052|1893068|FG001|Overall Study|Protocol Violation|2
914996|NCT00819052|1893067|FG000|Overall Study|Lost to Follow-up|1
914997|NCT00819052|1893068|FG001|Overall Study|Lost to Follow-up|2
914998|NCT00819052|1893067|FG000|Overall Study|Withdrawal by Subject|1
914999|NCT00819052|1893068|FG001|Overall Study|Withdrawal by Subject|2
915000|NCT00819052|1893067|FG000|Overall Study|Lack of Efficacy|1
915001|NCT00819052|1893068|FG001|Overall Study|Lack of Efficacy|1
915002|NCT00819052|1893067|FG000|Overall Study|Pregnancy|1
915003|NCT00819052|1893068|FG001|Overall Study|Pregnancy|2
915004|NCT00819052|1893067|FG000|Overall Study|Death or events leading to death|1
915005|NCT00819052|1893068|FG001|Overall Study|Death or events leading to death|0
915006|NCT00819091|1893079|FG000|Overall Study|Adverse Event|3
915007|NCT00819091|1893080|FG001|Overall Study|Adverse Event|5
915008|NCT00819091|1893079|FG000|Overall Study|Protocol Violation|0
915009|NCT00819091|1893080|FG001|Overall Study|Protocol Violation|1
915010|NCT00819091|1893079|FG000|Overall Study|Lost to Follow-up|2
915011|NCT00819091|1893080|FG001|Overall Study|Lost to Follow-up|0
915012|NCT00819091|1893079|FG000|Overall Study|Withdrawal by Subject|1
915013|NCT00819091|1893080|FG001|Overall Study|Withdrawal by Subject|2
915014|NCT00819091|1893079|FG000|Overall Study|Other|1
915015|NCT00819091|1893080|FG001|Overall Study|Other|2
915016|NCT00819156|1893092|FG000|Overall Study|Adverse Event|1
915017|NCT00819156|1893093|FG001|Overall Study|Adverse Event|4
915018|NCT00819156|1893094|FG002|Overall Study|Adverse Event|2
915019|NCT00819156|1893095|FG003|Overall Study|Adverse Event|1
915020|NCT00819156|1893096|FG004|Overall Study|Adverse Event|2
915021|NCT00819156|1893097|FG005|Overall Study|Adverse Event|3
915022|NCT00819156|1893092|FG000|Overall Study|Withdrawal by Subject|0
915023|NCT00819156|1893093|FG001|Overall Study|Withdrawal by Subject|3
915024|NCT00819156|1893094|FG002|Overall Study|Withdrawal by Subject|2
915025|NCT00819156|1893095|FG003|Overall Study|Withdrawal by Subject|0
915026|NCT00819156|1893096|FG004|Overall Study|Withdrawal by Subject|1
915027|NCT00819156|1893097|FG005|Overall Study|Withdrawal by Subject|0
915028|NCT00819156|1893092|FG000|Overall Study|Protocol Violation|1
915029|NCT00819156|1893093|FG001|Overall Study|Protocol Violation|0
915030|NCT00819156|1893094|FG002|Overall Study|Protocol Violation|1
915031|NCT00819156|1893095|FG003|Overall Study|Protocol Violation|0
915032|NCT00819156|1893096|FG004|Overall Study|Protocol Violation|0
915033|NCT00819156|1893097|FG005|Overall Study|Protocol Violation|1
915034|NCT00819156|1893092|FG000|Overall Study|Lost to Follow-up|0
915035|NCT00819156|1893093|FG001|Overall Study|Lost to Follow-up|1
915036|NCT00819156|1893094|FG002|Overall Study|Lost to Follow-up|0
915037|NCT00819156|1893095|FG003|Overall Study|Lost to Follow-up|0
915038|NCT00819156|1893096|FG004|Overall Study|Lost to Follow-up|0
915039|NCT00819156|1893097|FG005|Overall Study|Lost to Follow-up|2
915040|NCT00819156|1893092|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5
915041|NCT00819156|1893093|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2
915042|NCT00819156|1893094|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1
915043|NCT00819156|1893095|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1
915044|NCT00819156|1893096|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1
1014499|NCT01531673|2036130|FG006|Overall Study|Lost to Follow-up|0
1014500|NCT01531673|2036131|FG007|Overall Study|Lost to Follow-up|0
1014501|NCT01531673|2036132|FG008|Overall Study|Lost to Follow-up|0
1014502|NCT01531673|2036133|FG009|Overall Study|Lost to Follow-up|0
1014503|NCT01531673|2036134|FG010|Overall Study|Lost to Follow-up|0
1014504|NCT01531673|2036135|FG011|Overall Study|Lost to Follow-up|0
1014505|NCT01531673|2036136|FG012|Overall Study|Lost to Follow-up|0
1014506|NCT01531673|2036124|FG000|Overall Study|Other|0
1014507|NCT01531673|2036125|FG001|Overall Study|Other|0
1014508|NCT01531673|2036126|FG002|Overall Study|Other|0
1014509|NCT01531673|2036127|FG003|Overall Study|Other|1
1014510|NCT01531673|2036128|FG004|Overall Study|Other|0
1014511|NCT01531673|2036129|FG005|Overall Study|Other|0
1014512|NCT01531673|2036130|FG006|Overall Study|Other|0
1014513|NCT01531673|2036131|FG007|Overall Study|Other|0
1014514|NCT01531673|2036132|FG008|Overall Study|Other|0
1014515|NCT01531673|2036133|FG009|Overall Study|Other|1
1014516|NCT01531673|2036134|FG010|Overall Study|Other|0
1014517|NCT01531673|2036135|FG011|Overall Study|Other|0
1014518|NCT01531673|2036136|FG012|Overall Study|Other|0
1014519|NCT01531725|2036188|FG000|Overall Study|Protocol Violation|5
1014520|NCT01531894|2036210|FG000|Overall Study|Physician Decision|8
1014521|NCT01531894|2036210|FG000|Overall Study|Death|1
1014522|NCT01531998|2036223|FG000|Overall Study|Withdrawal by Subject|3
1014523|NCT01532388|2036277|FG000|3-month Follow-up|Lost to Follow-up|68
1014524|NCT01532388|2036278|FG001|3-month Follow-up|Lost to Follow-up|68
1014525|NCT01532388|2036277|FG000|6-month Follow-up|Lost to Follow-up|74
1014526|NCT01532388|2036278|FG001|6-month Follow-up|Lost to Follow-up|66
1014527|NCT01532388|2036277|FG000|12-month Follow-up|Lost to Follow-up|69
1014528|NCT01532388|2036278|FG001|12-month Follow-up|Lost to Follow-up|67
1014529|NCT01532414|2036287|FG000|Overall Study|Lost to Follow-up|3
1014530|NCT01532414|2036288|FG001|Overall Study|Lost to Follow-up|0
1014531|NCT01532414|2036289|FG002|Overall Study|Lost to Follow-up|1
1014532|NCT01532414|2036287|FG000|Overall Study|Withdrawal by Subject|3
1014533|NCT01532414|2036288|FG001|Overall Study|Withdrawal by Subject|0
1014534|NCT01532414|2036289|FG002|Overall Study|Withdrawal by Subject|0
1014535|NCT01532414|2036287|FG000|Overall Study|No V6 semen sample|0
1014536|NCT01532414|2036288|FG001|Overall Study|No V6 semen sample|1
1014537|NCT01532414|2036289|FG002|Overall Study|No V6 semen sample|0
1014538|NCT01532414|2036287|FG000|Overall Study|Adverse Event|0
1014539|NCT01532414|2036288|FG001|Overall Study|Adverse Event|1
1014540|NCT01532414|2036289|FG002|Overall Study|Adverse Event|1
1014541|NCT01532414|2036287|FG000|Overall Study|Unable to complete 24 hour PK|0
1014542|NCT01532414|2036288|FG001|Overall Study|Unable to complete 24 hour PK|0
1014543|NCT01532414|2036289|FG002|Overall Study|Unable to complete 24 hour PK|1
1014544|NCT01532414|2036287|FG000|Overall Study|Withdrawn by sponsor|1
1014545|NCT01532414|2036288|FG001|Overall Study|Withdrawn by sponsor|0
1014546|NCT01532414|2036289|FG002|Overall Study|Withdrawn by sponsor|0
1014547|NCT01532570|2036310|FG000|Overall Study|Lack of Efficacy|1
1014548|NCT01532570|2036311|FG001|Overall Study|Lack of Efficacy|0
1014549|NCT01532570|2036312|FG002|Overall Study|Lack of Efficacy|0
1014550|NCT01532570|2036313|FG003|Overall Study|Lack of Efficacy|0
1014551|NCT01532570|2036310|FG000|Overall Study|Withdrawal by Subject|0
1014552|NCT01532570|2036311|FG001|Overall Study|Withdrawal by Subject|1
1014553|NCT01532570|2036312|FG002|Overall Study|Withdrawal by Subject|0
1014554|NCT01532570|2036313|FG003|Overall Study|Withdrawal by Subject|0
1014555|NCT01532648|2036332|FG000|Overall Study|Lost to Follow-up|3
1014556|NCT01532648|2036333|FG001|Overall Study|Lost to Follow-up|4
1014557|NCT01532648|2036332|FG000|Overall Study|Lack of Efficacy|4
1014558|NCT01532648|2036333|FG001|Overall Study|Lack of Efficacy|1
1014559|NCT01532648|2036332|FG000|Overall Study|Protocol Violation|1
1014560|NCT01532648|2036333|FG001|Overall Study|Protocol Violation|1
1014561|NCT01532648|2036332|FG000|Overall Study|Adverse Event|12
1014562|NCT01532648|2036333|FG001|Overall Study|Adverse Event|9
915045|NCT00819156|1893097|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2
915046|NCT00819156|1893092|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3
915047|NCT00819156|1893093|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0
915048|NCT00819156|1893094|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0
915049|NCT00819156|1893095|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0
915050|NCT00819156|1893096|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1
915051|NCT00819156|1893097|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0
915052|NCT00819156|1893092|FG000|Overall Study|Prostate-specific antigen progression|0
915053|NCT00819156|1893093|FG001|Overall Study|Prostate-specific antigen progression|0
915054|NCT00819156|1893094|FG002|Overall Study|Prostate-specific antigen progression|0
915055|NCT00819156|1893095|FG003|Overall Study|Prostate-specific antigen progression|0
915056|NCT00819156|1893096|FG004|Overall Study|Prostate-specific antigen progression|1
915057|NCT00819156|1893097|FG005|Overall Study|Prostate-specific antigen progression|0
915058|NCT00819234|1893132|FG000|Overall Study|Withdrawal by Subject|8
915059|NCT00819234|1893133|FG001|Overall Study|Withdrawal by Subject|13
915060|NCT00819234|1893134|FG002|Overall Study|Withdrawal by Subject|6
915061|NCT00819234|1893135|FG003|Overall Study|Withdrawal by Subject|3
915062|NCT00819234|1893136|FG004|Overall Study|Withdrawal by Subject|0
915063|NCT00819234|1893137|FG005|Overall Study|Withdrawal by Subject|4
915064|NCT00819234|1893138|FG006|Overall Study|Withdrawal by Subject|4
915065|NCT00819234|1893139|FG007|Overall Study|Withdrawal by Subject|8
1014563|NCT01532648|2036332|FG000|Overall Study|Withdrawal by Subject|16
1014564|NCT01532648|2036333|FG001|Overall Study|Withdrawal by Subject|2
1014565|NCT01532687|2036341|FG000|Overall Study|Death|2
1014566|NCT01532687|2036342|FG001|Overall Study|Death|0
1014567|NCT01532687|2036341|FG000|Overall Study|Adverse Event|6
1014568|NCT01532687|2036342|FG001|Overall Study|Adverse Event|1
1014569|NCT01532687|2036341|FG000|Overall Study|Withdrawal by Subject|1
1014570|NCT01532687|2036342|FG001|Overall Study|Withdrawal by Subject|0
1014571|NCT01532687|2036341|FG000|Overall Study|Physician Decision|2
1014572|NCT01532687|2036342|FG001|Overall Study|Physician Decision|1
1014573|NCT01532687|2036341|FG000|Overall Study|Protocol-defined delay > 3 weeks|3
1014574|NCT01532687|2036342|FG001|Overall Study|Protocol-defined delay > 3 weeks|0
1014575|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0
1014576|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1
1014577|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
1014578|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
1014579|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
1014580|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
1014581|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
1014582|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
1014583|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
1014584|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
1014585|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
1014586|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
915066|NCT00819234|1893140|FG008|Overall Study|Withdrawal by Subject|5
915067|NCT00819234|1893141|FG009|Overall Study|Withdrawal by Subject|3
915068|NCT00819234|1893132|FG000|Overall Study|Adverse Event|0
915069|NCT00819234|1893133|FG001|Overall Study|Adverse Event|0
915070|NCT00819234|1893134|FG002|Overall Study|Adverse Event|1
915071|NCT00819234|1893135|FG003|Overall Study|Adverse Event|0
915072|NCT00819234|1893136|FG004|Overall Study|Adverse Event|0
915073|NCT00819234|1893137|FG005|Overall Study|Adverse Event|2
915074|NCT00819234|1893138|FG006|Overall Study|Adverse Event|0
915075|NCT00819234|1893139|FG007|Overall Study|Adverse Event|0
915076|NCT00819234|1893140|FG008|Overall Study|Adverse Event|0
915077|NCT00819234|1893141|FG009|Overall Study|Adverse Event|0
915078|NCT00819234|1893132|FG000|Overall Study|Physician Decision|0
915079|NCT00819234|1893133|FG001|Overall Study|Physician Decision|0
915080|NCT00819234|1893134|FG002|Overall Study|Physician Decision|0
915081|NCT00819234|1893135|FG003|Overall Study|Physician Decision|1
915082|NCT00819234|1893136|FG004|Overall Study|Physician Decision|0
915083|NCT00819234|1893137|FG005|Overall Study|Physician Decision|0
915084|NCT00819234|1893138|FG006|Overall Study|Physician Decision|0
915085|NCT00819234|1893139|FG007|Overall Study|Physician Decision|0
915086|NCT00819234|1893140|FG008|Overall Study|Physician Decision|0
915087|NCT00819234|1893141|FG009|Overall Study|Physician Decision|2
915088|NCT00819234|1893132|FG000|Overall Study|Protocol Violation|0
915089|NCT00819234|1893133|FG001|Overall Study|Protocol Violation|0
915090|NCT00819234|1893134|FG002|Overall Study|Protocol Violation|1
915091|NCT00819234|1893135|FG003|Overall Study|Protocol Violation|0
915092|NCT00819234|1893136|FG004|Overall Study|Protocol Violation|0
915093|NCT00819234|1893137|FG005|Overall Study|Protocol Violation|0
915094|NCT00819234|1893138|FG006|Overall Study|Protocol Violation|0
915095|NCT00819234|1893139|FG007|Overall Study|Protocol Violation|0
915096|NCT00819234|1893140|FG008|Overall Study|Protocol Violation|0
915097|NCT00819234|1893141|FG009|Overall Study|Protocol Violation|0
915098|NCT00819234|1893132|FG000|Overall Study|Lost to Follow-up|2
915099|NCT00819234|1893133|FG001|Overall Study|Lost to Follow-up|2
915100|NCT00819234|1893134|FG002|Overall Study|Lost to Follow-up|0
915101|NCT00819234|1893135|FG003|Overall Study|Lost to Follow-up|2
915102|NCT00819234|1893136|FG004|Overall Study|Lost to Follow-up|1
915103|NCT00819234|1893137|FG005|Overall Study|Lost to Follow-up|1
915104|NCT00819234|1893138|FG006|Overall Study|Lost to Follow-up|1
915105|NCT00819234|1893139|FG007|Overall Study|Lost to Follow-up|1
915106|NCT00819234|1893140|FG008|Overall Study|Lost to Follow-up|1
915107|NCT00819234|1893141|FG009|Overall Study|Lost to Follow-up|2
915108|NCT00819247|1893199|FG000|Overall Study|Adverse Event|0
915109|NCT00819247|1893200|FG001|Overall Study|Adverse Event|5
915110|NCT00819247|1893201|FG002|Overall Study|Adverse Event|3
915111|NCT00819247|1893199|FG000|Overall Study|Insufficient testosterone response|5
915112|NCT00819247|1893200|FG001|Overall Study|Insufficient testosterone response|8
915113|NCT00819247|1893201|FG002|Overall Study|Insufficient testosterone response|10
915114|NCT00819247|1893199|FG000|Overall Study|Withdrawal by Subject|1
915115|NCT00819247|1893200|FG001|Overall Study|Withdrawal by Subject|0
915116|NCT00819247|1893201|FG002|Overall Study|Withdrawal by Subject|0
915117|NCT00819247|1893199|FG000|Overall Study|Protocol Violation|1
915118|NCT00819247|1893200|FG001|Overall Study|Protocol Violation|0
915119|NCT00819247|1893201|FG002|Overall Study|Protocol Violation|1
915120|NCT00819247|1893199|FG000|Overall Study|Mistakenly withdrawn|0
1014587|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0
1014588|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3
1014589|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
1014590|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
1014591|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
1014592|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
1014593|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
1014594|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
1014595|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
1014596|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
1014597|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
1014598|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
1014599|NCT01532869|2036364|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
1014600|NCT01532869|2036365|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
1014601|NCT01532869|2036364|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4
1014602|NCT01532869|2036365|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1
915121|NCT00819247|1893200|FG001|Overall Study|Mistakenly withdrawn|1
915122|NCT00819247|1893201|FG002|Overall Study|Mistakenly withdrawn|0
915123|NCT00819247|1893199|FG000|Overall Study|Bad prostate-specific antigen response|3
915124|NCT00819247|1893200|FG001|Overall Study|Bad prostate-specific antigen response|2
915125|NCT00819247|1893201|FG002|Overall Study|Bad prostate-specific antigen response|0
915126|NCT00819247|1893199|FG000|Overall Study|Other|1
915127|NCT00819247|1893200|FG001|Overall Study|Other|0
915128|NCT00819247|1893201|FG002|Overall Study|Other|0
915129|NCT00819390|1893228|FG000|Overall Study|Lost to Follow-up|1
915130|NCT00819390|1893229|FG001|Overall Study|Lost to Follow-up|1
915131|NCT00819390|1893230|FG002|Overall Study|Lost to Follow-up|0
915132|NCT00819390|1893231|FG003|Overall Study|Lost to Follow-up|0
915133|NCT00819390|1893228|FG000|Overall Study|Withdrawal by Subject|2
915134|NCT00819390|1893229|FG001|Overall Study|Withdrawal by Subject|0
915135|NCT00819390|1893230|FG002|Overall Study|Withdrawal by Subject|0
915136|NCT00819390|1893231|FG003|Overall Study|Withdrawal by Subject|0
915137|NCT00819390|1893228|FG000|Overall Study|Adverse Event|0
915138|NCT00819390|1893229|FG001|Overall Study|Adverse Event|0
915139|NCT00819390|1893230|FG002|Overall Study|Adverse Event|1
915140|NCT00819390|1893231|FG003|Overall Study|Adverse Event|0
915141|NCT00819585|1893265|FG000|Core Study|Adverse Event|2
915142|NCT00819585|1893266|FG001|Core Study|Adverse Event|1
915143|NCT00819585|1893267|FG002|Core Study|Adverse Event|1
915144|NCT00819585|1893268|FG003|Core Study|Adverse Event|4
915145|NCT00819585|1893269|FG004|Core Study|Adverse Event|1
915146|NCT00819585|1893270|FG005|Core Study|Adverse Event|0
915147|NCT00819585|1893271|FG006|Core Study|Adverse Event|2
915148|NCT00819585|1893272|FG007|Core Study|Adverse Event|0
915149|NCT00819585|1893273|FG008|Core Study|Adverse Event|0
915150|NCT00819585|1893274|FG009|Core Study|Adverse Event|0
915151|NCT00819585|1893275|FG010|Core Study|Adverse Event|0
915152|NCT00819585|1893265|FG000|Core Study|Abnormal Laboratory Value(s)|2
915153|NCT00819585|1893266|FG001|Core Study|Abnormal Laboratory Value(s)|0
915154|NCT00819585|1893267|FG002|Core Study|Abnormal Laboratory Value(s)|0
915155|NCT00819585|1893268|FG003|Core Study|Abnormal Laboratory Value(s)|0
915156|NCT00819585|1893269|FG004|Core Study|Abnormal Laboratory Value(s)|0
915157|NCT00819585|1893270|FG005|Core Study|Abnormal Laboratory Value(s)|0
915158|NCT00819585|1893271|FG006|Core Study|Abnormal Laboratory Value(s)|0
915159|NCT00819585|1893272|FG007|Core Study|Abnormal Laboratory Value(s)|0
915160|NCT00819585|1893273|FG008|Core Study|Abnormal Laboratory Value(s)|0
915161|NCT00819585|1893274|FG009|Core Study|Abnormal Laboratory Value(s)|0
915162|NCT00819585|1893275|FG010|Core Study|Abnormal Laboratory Value(s)|0
915163|NCT00819585|1893265|FG000|Core Study|Unsatisfactory Therapeutic Effect|0
915164|NCT00819585|1893266|FG001|Core Study|Unsatisfactory Therapeutic Effect|1
915165|NCT00819585|1893267|FG002|Core Study|Unsatisfactory Therapeutic Effect|0
915166|NCT00819585|1893268|FG003|Core Study|Unsatisfactory Therapeutic Effect|0
915167|NCT00819585|1893269|FG004|Core Study|Unsatisfactory Therapeutic Effect|0
915168|NCT00819585|1893270|FG005|Core Study|Unsatisfactory Therapeutic Effect|0
915169|NCT00819585|1893271|FG006|Core Study|Unsatisfactory Therapeutic Effect|1
915170|NCT00819585|1893272|FG007|Core Study|Unsatisfactory Therapeutic Effect|0
915171|NCT00819585|1893273|FG008|Core Study|Unsatisfactory Therapeutic Effect|0
915172|NCT00819585|1893274|FG009|Core Study|Unsatisfactory Therapeutic Effect|0
915173|NCT00819585|1893275|FG010|Core Study|Unsatisfactory Therapeutic Effect|0
915174|NCT00819585|1893265|FG000|Core Study|Subject No Longer Requires Study Drug|0
915175|NCT00819585|1893266|FG001|Core Study|Subject No Longer Requires Study Drug|0
915176|NCT00819585|1893267|FG002|Core Study|Subject No Longer Requires Study Drug|0
915177|NCT00819585|1893268|FG003|Core Study|Subject No Longer Requires Study Drug|0
915178|NCT00819585|1893269|FG004|Core Study|Subject No Longer Requires Study Drug|1
1014603|NCT01532869|2036364|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1
1014604|NCT01532869|2036365|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0
1014605|NCT01532869|2036364|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
1014606|NCT01532869|2036365|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
1014607|NCT01532869|2036364|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
915179|NCT00819585|1893270|FG005|Core Study|Subject No Longer Requires Study Drug|0
915180|NCT00819585|1893271|FG006|Core Study|Subject No Longer Requires Study Drug|0
915181|NCT00819585|1893272|FG007|Core Study|Subject No Longer Requires Study Drug|0
915182|NCT00819585|1893273|FG008|Core Study|Subject No Longer Requires Study Drug|0
915183|NCT00819585|1893274|FG009|Core Study|Subject No Longer Requires Study Drug|0
915184|NCT00819585|1893275|FG010|Core Study|Subject No Longer Requires Study Drug|0
915185|NCT00819585|1893265|FG000|Core Study|Subject Withdrew Consent|0
915186|NCT00819585|1893266|FG001|Core Study|Subject Withdrew Consent|3
915187|NCT00819585|1893267|FG002|Core Study|Subject Withdrew Consent|2
915188|NCT00819585|1893268|FG003|Core Study|Subject Withdrew Consent|1
915189|NCT00819585|1893269|FG004|Core Study|Subject Withdrew Consent|0
915190|NCT00819585|1893270|FG005|Core Study|Subject Withdrew Consent|0
915191|NCT00819585|1893271|FG006|Core Study|Subject Withdrew Consent|3
915192|NCT00819585|1893272|FG007|Core Study|Subject Withdrew Consent|0
915193|NCT00819585|1893273|FG008|Core Study|Subject Withdrew Consent|0
915194|NCT00819585|1893274|FG009|Core Study|Subject Withdrew Consent|0
915195|NCT00819585|1893275|FG010|Core Study|Subject Withdrew Consent|0
915196|NCT00819585|1893265|FG000|Core Study|Lost to Follow-up|2
915197|NCT00819585|1893266|FG001|Core Study|Lost to Follow-up|1
915198|NCT00819585|1893267|FG002|Core Study|Lost to Follow-up|2
915199|NCT00819585|1893268|FG003|Core Study|Lost to Follow-up|0
915200|NCT00819585|1893269|FG004|Core Study|Lost to Follow-up|1
915201|NCT00819585|1893270|FG005|Core Study|Lost to Follow-up|1
915202|NCT00819585|1893271|FG006|Core Study|Lost to Follow-up|1
915203|NCT00819585|1893272|FG007|Core Study|Lost to Follow-up|0
915204|NCT00819585|1893273|FG008|Core Study|Lost to Follow-up|0
915205|NCT00819585|1893274|FG009|Core Study|Lost to Follow-up|0
915206|NCT00819585|1893275|FG010|Core Study|Lost to Follow-up|0
915207|NCT00819585|1893265|FG000|Core Study|Administrative Problems|0
915208|NCT00819585|1893266|FG001|Core Study|Administrative Problems|0
915209|NCT00819585|1893267|FG002|Core Study|Administrative Problems|0
915210|NCT00819585|1893268|FG003|Core Study|Administrative Problems|0
915211|NCT00819585|1893269|FG004|Core Study|Administrative Problems|0
915212|NCT00819585|1893270|FG005|Core Study|Administrative Problems|0
915213|NCT00819585|1893271|FG006|Core Study|Administrative Problems|2
915214|NCT00819585|1893272|FG007|Core Study|Administrative Problems|0
915215|NCT00819585|1893273|FG008|Core Study|Administrative Problems|0
915216|NCT00819585|1893274|FG009|Core Study|Administrative Problems|0
915217|NCT00819585|1893275|FG010|Core Study|Administrative Problems|0
915218|NCT00819585|1893265|FG000|Core Study|Death|0
915219|NCT00819585|1893266|FG001|Core Study|Death|0
915220|NCT00819585|1893267|FG002|Core Study|Death|0
915221|NCT00819585|1893268|FG003|Core Study|Death|0
915222|NCT00819585|1893269|FG004|Core Study|Death|0
915223|NCT00819585|1893270|FG005|Core Study|Death|0
915224|NCT00819585|1893271|FG006|Core Study|Death|1
915225|NCT00819585|1893272|FG007|Core Study|Death|0
915226|NCT00819585|1893273|FG008|Core Study|Death|0
915227|NCT00819585|1893274|FG009|Core Study|Death|0
915228|NCT00819585|1893275|FG010|Core Study|Death|0
915229|NCT00819585|1893265|FG000|Core Study|Protocol Violation|0
915230|NCT00819585|1893266|FG001|Core Study|Protocol Violation|0
915231|NCT00819585|1893267|FG002|Core Study|Protocol Violation|1
915232|NCT00819585|1893268|FG003|Core Study|Protocol Violation|0
915233|NCT00819585|1893269|FG004|Core Study|Protocol Violation|0
915234|NCT00819585|1893270|FG005|Core Study|Protocol Violation|1
915235|NCT00819585|1893271|FG006|Core Study|Protocol Violation|3
915236|NCT00819585|1893272|FG007|Core Study|Protocol Violation|0
915237|NCT00819585|1893273|FG008|Core Study|Protocol Violation|0
915238|NCT00819585|1893274|FG009|Core Study|Protocol Violation|0
915239|NCT00819585|1893275|FG010|Core Study|Protocol Violation|0
915240|NCT00819585|1893265|FG000|Extension Study|Abnormal Laboratory Value(s)|0
915241|NCT00819585|1893266|FG001|Extension Study|Abnormal Laboratory Value(s)|0
915242|NCT00819585|1893267|FG002|Extension Study|Abnormal Laboratory Value(s)|0
915243|NCT00819585|1893268|FG003|Extension Study|Abnormal Laboratory Value(s)|0
915244|NCT00819585|1893269|FG004|Extension Study|Abnormal Laboratory Value(s)|0
915245|NCT00819585|1893270|FG005|Extension Study|Abnormal Laboratory Value(s)|0
915246|NCT00819585|1893271|FG006|Extension Study|Abnormal Laboratory Value(s)|0
915247|NCT00819585|1893272|FG007|Extension Study|Abnormal Laboratory Value(s)|0
915248|NCT00819585|1893273|FG008|Extension Study|Abnormal Laboratory Value(s)|1
915249|NCT00819585|1893274|FG009|Extension Study|Abnormal Laboratory Value(s)|0
915250|NCT00819585|1893275|FG010|Extension Study|Abnormal Laboratory Value(s)|0
915251|NCT00819585|1893265|FG000|Extension Study|Subject Withdrew Consent|0
915252|NCT00819585|1893266|FG001|Extension Study|Subject Withdrew Consent|0
915253|NCT00819585|1893267|FG002|Extension Study|Subject Withdrew Consent|0
915254|NCT00819585|1893268|FG003|Extension Study|Subject Withdrew Consent|0
915255|NCT00819585|1893269|FG004|Extension Study|Subject Withdrew Consent|0
915256|NCT00819585|1893270|FG005|Extension Study|Subject Withdrew Consent|0
1014608|NCT01532869|2036365|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
1014609|NCT01532908|2036378|FG000|Overall Study|Not Transplanted|1
1014610|NCT01532908|2036379|FG001|Overall Study|Not Transplanted|0
1014611|NCT01532921|2036385|FG000|Overall Study|Death|3
1014612|NCT01532921|2036385|FG000|Overall Study|Withdrawal by Subject|2
1014613|NCT01532921|2036385|FG000|Overall Study|Lost to Follow-up|3
1014614|NCT01532921|2036385|FG000|Overall Study|Physician Decision|7
1014615|NCT01532921|2036385|FG000|Overall Study|Device was explanted during procedure|1
1014616|NCT01532934|2036395|FG000|Overall Study|Lost to Follow-up|11
1014617|NCT01532934|2036396|FG001|Overall Study|Lost to Follow-up|11
1014618|NCT01532934|2036395|FG000|Overall Study|In controlled environment|3
915257|NCT00819585|1893271|FG006|Extension Study|Subject Withdrew Consent|0
915258|NCT00819585|1893272|FG007|Extension Study|Subject Withdrew Consent|0
915259|NCT00819585|1893273|FG008|Extension Study|Subject Withdrew Consent|3
915260|NCT00819585|1893274|FG009|Extension Study|Subject Withdrew Consent|0
915261|NCT00819585|1893275|FG010|Extension Study|Subject Withdrew Consent|1
915262|NCT00819585|1893265|FG000|Extension Study|Lost to Follow-up|0
915263|NCT00819585|1893266|FG001|Extension Study|Lost to Follow-up|0
915264|NCT00819585|1893267|FG002|Extension Study|Lost to Follow-up|0
915265|NCT00819585|1893268|FG003|Extension Study|Lost to Follow-up|0
915266|NCT00819585|1893269|FG004|Extension Study|Lost to Follow-up|0
915267|NCT00819585|1893270|FG005|Extension Study|Lost to Follow-up|0
915268|NCT00819585|1893271|FG006|Extension Study|Lost to Follow-up|0
915269|NCT00819585|1893272|FG007|Extension Study|Lost to Follow-up|0
915270|NCT00819585|1893273|FG008|Extension Study|Lost to Follow-up|2
915271|NCT00819585|1893274|FG009|Extension Study|Lost to Follow-up|1
915272|NCT00819585|1893275|FG010|Extension Study|Lost to Follow-up|1
915273|NCT00819585|1893265|FG000|Extension Study|Death|0
915274|NCT00819585|1893266|FG001|Extension Study|Death|0
915275|NCT00819585|1893267|FG002|Extension Study|Death|0
915276|NCT00819585|1893268|FG003|Extension Study|Death|0
915277|NCT00819585|1893269|FG004|Extension Study|Death|0
915278|NCT00819585|1893270|FG005|Extension Study|Death|0
915279|NCT00819585|1893271|FG006|Extension Study|Death|0
915280|NCT00819585|1893272|FG007|Extension Study|Death|0
915281|NCT00819585|1893273|FG008|Extension Study|Death|2
915282|NCT00819585|1893274|FG009|Extension Study|Death|0
915283|NCT00819585|1893275|FG010|Extension Study|Death|0
915284|NCT00819741|1893318|FG000|Overall Study|Adverse Event|5
915285|NCT00819741|1893319|FG001|Overall Study|Adverse Event|2
915286|NCT00819741|1893318|FG000|Overall Study|Lack of Efficacy|0
915287|NCT00819741|1893319|FG001|Overall Study|Lack of Efficacy|2
915288|NCT00819741|1893318|FG000|Overall Study|Lost to Follow-up|3
915289|NCT00819741|1893319|FG001|Overall Study|Lost to Follow-up|1
915290|NCT00819741|1893318|FG000|Overall Study|Protocol Violation|3
915291|NCT00819741|1893319|FG001|Overall Study|Protocol Violation|4
915292|NCT00819741|1893318|FG000|Overall Study|Withdrawal by Subject|2
915293|NCT00819741|1893319|FG001|Overall Study|Withdrawal by Subject|2
915294|NCT00819741|1893318|FG000|Overall Study|Unclassified|6
915295|NCT00819741|1893319|FG001|Overall Study|Unclassified|0
915296|NCT00819741|1893318|FG000|Overall Study|Reasons unknown|3
915297|NCT00819741|1893319|FG001|Overall Study|Reasons unknown|3
915298|NCT00819767|1893327|FG000|Overall Study|Unsatisfactory therapeutic effect|1
915299|NCT00819767|1893328|FG001|Overall Study|Unsatisfactory therapeutic effect|2
915300|NCT00819780|1893336|FG000|Overall Study|Did not receive study drug|3
915301|NCT00819780|1893337|FG001|Overall Study|Did not receive study drug|4
915302|NCT00819780|1893336|FG000|Overall Study|Still in treatment|25
915303|NCT00819780|1893337|FG001|Overall Study|Still in treatment|17
915304|NCT00819910|1893352|FG000|Overall Study|Adverse Event|0
915305|NCT00819910|1893353|FG001|Overall Study|Adverse Event|0
915306|NCT00819910|1893354|FG002|Overall Study|Adverse Event|2
915307|NCT00819910|1893355|FG003|Overall Study|Adverse Event|1
915308|NCT00819910|1893352|FG000|Overall Study|Withdrawal by Subject|1
915309|NCT00819910|1893353|FG001|Overall Study|Withdrawal by Subject|1
915310|NCT00819910|1893354|FG002|Overall Study|Withdrawal by Subject|1
915311|NCT00819910|1893355|FG003|Overall Study|Withdrawal by Subject|0
915312|NCT00819910|1893352|FG000|Overall Study|Lost to Follow-up|1
915313|NCT00819910|1893353|FG001|Overall Study|Lost to Follow-up|0
915314|NCT00819910|1893354|FG002|Overall Study|Lost to Follow-up|0
915315|NCT00819910|1893355|FG003|Overall Study|Lost to Follow-up|0
915316|NCT00820027|1893371|FG000|Overall Study|Adverse Event|15
915317|NCT00820027|1893372|FG001|Overall Study|Adverse Event|8
915318|NCT00820027|1893373|FG002|Overall Study|Adverse Event|10
915319|NCT00820027|1893374|FG003|Overall Study|Adverse Event|5
915320|NCT00820027|1893371|FG000|Overall Study|Lack of Efficacy|2
915321|NCT00820027|1893372|FG001|Overall Study|Lack of Efficacy|1
915322|NCT00820027|1893373|FG002|Overall Study|Lack of Efficacy|2
915323|NCT00820027|1893374|FG003|Overall Study|Lack of Efficacy|2
915324|NCT00820027|1893371|FG000|Overall Study|Physician Decision|0
915325|NCT00820027|1893372|FG001|Overall Study|Physician Decision|1
915326|NCT00820027|1893373|FG002|Overall Study|Physician Decision|1
915327|NCT00820027|1893374|FG003|Overall Study|Physician Decision|0
915328|NCT00820027|1893371|FG000|Overall Study|Protocol Violation|3
915329|NCT00820027|1893372|FG001|Overall Study|Protocol Violation|0
915330|NCT00820027|1893373|FG002|Overall Study|Protocol Violation|4
915331|NCT00820027|1893374|FG003|Overall Study|Protocol Violation|0
915332|NCT00820027|1893371|FG000|Overall Study|Withdrawal by Subject|6
1014619|NCT01532934|2036396|FG001|Overall Study|In controlled environment|2
1014620|NCT01532986|2036448|FG000|Overall Study|Death|9
1014621|NCT01532986|2036449|FG001|Overall Study|Death|9
1014622|NCT01532986|2036448|FG000|Overall Study|Withdrawal by Subject|7
1014623|NCT01532986|2036449|FG001|Overall Study|Withdrawal by Subject|10
1014624|NCT01532986|2036448|FG000|Overall Study|Physician Decision|7
1014625|NCT01532986|2036449|FG001|Overall Study|Physician Decision|5
1014626|NCT01532999|2036458|FG000|Overall Study|Lost to Follow-up|14
1014627|NCT01532999|2036459|FG001|Overall Study|Lost to Follow-up|8
1014628|NCT01532999|2036458|FG000|Overall Study|Physician Decision|1
1014629|NCT01532999|2036459|FG001|Overall Study|Physician Decision|2
1014630|NCT01532999|2036458|FG000|Overall Study|Withdrawal by Subject|5
1014631|NCT01532999|2036459|FG001|Overall Study|Withdrawal by Subject|0
1014632|NCT01532999|2036458|FG000|Overall Study|Relocated|2
1014633|NCT01532999|2036459|FG001|Overall Study|Relocated|0
1014634|NCT01532999|2036458|FG000|Overall Study|should not have been randomized|1
1014635|NCT01532999|2036459|FG001|Overall Study|should not have been randomized|0
1014636|NCT01532999|2036458|FG000|Overall Study|substantial noncompliance|2
915333|NCT00820027|1893372|FG001|Overall Study|Withdrawal by Subject|4
915334|NCT00820027|1893373|FG002|Overall Study|Withdrawal by Subject|4
915335|NCT00820027|1893374|FG003|Overall Study|Withdrawal by Subject|6
915336|NCT00820040|1893385|FG000|Overall Study|Death|1
915337|NCT00820040|1893385|FG000|Overall Study|Sponsor terminated study|1
915338|NCT00820040|1893385|FG000|Overall Study|Screen failure|1
915339|NCT00820170|1893394|FG000|Overall Study|Adverse Event|0
915340|NCT00820170|1893395|FG001|Overall Study|Adverse Event|0
915341|NCT00820170|1893396|FG002|Overall Study|Adverse Event|0
915342|NCT00820170|1893397|FG003|Overall Study|Adverse Event|0
915343|NCT00820170|1893398|FG004|Overall Study|Adverse Event|2
915344|NCT00820170|1893394|FG000|Overall Study|Progressive Disease|0
915345|NCT00820170|1893395|FG001|Overall Study|Progressive Disease|0
915346|NCT00820170|1893396|FG002|Overall Study|Progressive Disease|0
915347|NCT00820170|1893397|FG003|Overall Study|Progressive Disease|0
915348|NCT00820170|1893398|FG004|Overall Study|Progressive Disease|2
915349|NCT00820222|1893417|FG000|Overall Study|Lost to Follow-up|10
915350|NCT00820222|1893418|FG001|Overall Study|Lost to Follow-up|9
915351|NCT00820222|1893417|FG000|Overall Study|Withdrawal by Subject|19
915352|NCT00820222|1893418|FG001|Overall Study|Withdrawal by Subject|21
915353|NCT00820222|1893417|FG000|Overall Study|Physician Decision|93
915354|NCT00820222|1893418|FG001|Overall Study|Physician Decision|88
915355|NCT00820222|1893417|FG000|Overall Study|Sponsor Terminated Study|43
915356|NCT00820222|1893418|FG001|Overall Study|Sponsor Terminated Study|65
915357|NCT00820222|1893417|FG000|Overall Study|Unkown|11
915358|NCT00820222|1893418|FG001|Overall Study|Unkown|7
915359|NCT00820248|1893439|FG000|Overall Study|No treated|4
915360|NCT00820248|1893440|FG001|Overall Study|No treated|1
915361|NCT00820599|1893486|FG000|Overall Study|Death|129
915362|NCT00820599|1893486|FG000|Overall Study|Withdrawal by Subject|2
915363|NCT00820755|1893512|FG000|Period 1: Combination Therapy Phase|Adverse Event|77
915364|NCT00820755|1893513|FG001|Period 1: Combination Therapy Phase|Adverse Event|0
915365|NCT00820755|1893514|FG002|Period 1: Combination Therapy Phase|Adverse Event|0
915366|NCT00820755|1893512|FG000|Period 1: Combination Therapy Phase|Death|28
915367|NCT00820755|1893513|FG001|Period 1: Combination Therapy Phase|Death|0
915368|NCT00820755|1893514|FG002|Period 1: Combination Therapy Phase|Death|0
915369|NCT00820755|1893512|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4
915370|NCT00820755|1893513|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0
915371|NCT00820755|1893514|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0
915372|NCT00820755|1893512|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1
915373|NCT00820755|1893513|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0
915374|NCT00820755|1893514|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0
915375|NCT00820755|1893512|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
915376|NCT00820755|1893513|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
915377|NCT00820755|1893514|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
915378|NCT00820755|1893512|FG000|Period 1: Combination Therapy Phase|Progressive disease|114
915379|NCT00820755|1893513|FG001|Period 1: Combination Therapy Phase|Progressive disease|0
915380|NCT00820755|1893514|FG002|Period 1: Combination Therapy Phase|Progressive disease|0
915381|NCT00820755|1893512|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
915382|NCT00820755|1893513|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
915383|NCT00820755|1893514|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
915384|NCT00820755|1893512|FG000|Period 1: Combination Therapy Phase|Other|11
915385|NCT00820755|1893513|FG001|Period 1: Combination Therapy Phase|Other|0
915386|NCT00820755|1893514|FG002|Period 1: Combination Therapy Phase|Other|0
915387|NCT00820755|1893512|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
915388|NCT00820755|1893513|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
915389|NCT00820755|1893514|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
915390|NCT00820898|1893526|FG000|Overall Study|Inelgible - wrong primary site|1
915391|NCT00821015|1893536|FG000|Overall Study|Lost to Follow-up|12
915392|NCT00821093|1893551|FG000|Overall Study|Adverse Event|20
915393|NCT00821093|1893552|FG001|Overall Study|Adverse Event|12
915394|NCT00821093|1893551|FG000|Overall Study|Withdrawal by Subject|9
1014637|NCT01532999|2036459|FG001|Overall Study|substantial noncompliance|0
1014638|NCT01532999|2036458|FG000|Overall Study|no show for week 9 assessments|6
1014639|NCT01532999|2036459|FG001|Overall Study|no show for week 9 assessments|4
1014640|NCT01532999|2036458|FG000|Overall Study|Adverse Event|0
1014641|NCT01532999|2036459|FG001|Overall Study|Adverse Event|1
1014642|NCT01532999|2036458|FG000|Overall Study|incarcerated|0
1014643|NCT01532999|2036459|FG001|Overall Study|incarcerated|1
1014644|NCT01532999|2036458|FG000|Overall Study|New job|0
1014645|NCT01532999|2036459|FG001|Overall Study|New job|2
1014646|NCT01533181|2036510|FG000|Overall Study|Disease progression pre-active treatment|0
1014647|NCT01533181|2036511|FG001|Overall Study|Disease progression pre-active treatment|1
1014648|NCT01533181|2036510|FG000|Overall Study|Patient withdrawal pre-active treatment|1
1014649|NCT01533181|2036511|FG001|Overall Study|Patient withdrawal pre-active treatment|0
1014650|NCT01533246|2036526|FG000|Overall Study|Adverse Event|1
1014651|NCT01533246|2036526|FG000|Overall Study|Withdrawal by Subject|1
1014652|NCT01533428|2036536|FG000|Overall Study|Adverse Event|0
1014653|NCT01533428|2036537|FG001|Overall Study|Adverse Event|1
1014654|NCT01533428|2036536|FG000|Overall Study|Lost to Follow-up|2
1014655|NCT01533428|2036537|FG001|Overall Study|Lost to Follow-up|1
1014656|NCT01533428|2036536|FG000|Overall Study|Withdrawal by Subject|7
1014657|NCT01533428|2036537|FG001|Overall Study|Withdrawal by Subject|6
1014658|NCT01533493|2036545|FG000|Overall Study|Adverse Event|2
1014659|NCT01533493|2036546|FG001|Overall Study|Adverse Event|1
1014660|NCT01533493|2036545|FG000|Overall Study|Withdrawal by Subject|1
1014661|NCT01533493|2036546|FG001|Overall Study|Withdrawal by Subject|2
915395|NCT00821093|1893552|FG001|Overall Study|Withdrawal by Subject|13
915396|NCT00821093|1893551|FG000|Overall Study|Lost to Follow-up|9
915397|NCT00821093|1893552|FG001|Overall Study|Lost to Follow-up|3
915398|NCT00821093|1893551|FG000|Overall Study|Protocol deviation|3
915399|NCT00821093|1893552|FG001|Overall Study|Protocol deviation|6
915400|NCT00821093|1893551|FG000|Overall Study|Abnormal laboratory value(s)|2
915401|NCT00821093|1893552|FG001|Overall Study|Abnormal laboratory value(s)|0
915402|NCT00821093|1893551|FG000|Overall Study|Lack of Efficacy|2
915403|NCT00821093|1893552|FG001|Overall Study|Lack of Efficacy|2
915404|NCT00821093|1893551|FG000|Overall Study|Death|2
915405|NCT00821093|1893552|FG001|Overall Study|Death|1
915406|NCT00821093|1893551|FG000|Overall Study|Abnormal test procedure result(s)|1
915407|NCT00821093|1893552|FG001|Overall Study|Abnormal test procedure result(s)|1
915408|NCT00821093|1893551|FG000|Overall Study|Administrative problems|1
915409|NCT00821093|1893552|FG001|Overall Study|Administrative problems|2
915410|NCT00821236|1893583|FG000|Overall Study|Lost to Follow-up|3
915411|NCT00821327|1893591|FG000|Overall Study|Adverse Event|13
915412|NCT00821327|1893591|FG000|Overall Study|Patient Request|1
915413|NCT00821327|1893591|FG000|Overall Study|Investigator Request|2
915414|NCT00821327|1893591|FG000|Overall Study|Sponsor Request|1
915415|NCT00821327|1893591|FG000|Overall Study|Disease Progression|13
915416|NCT00821327|1893591|FG000|Overall Study|Other/Unknown|5
915417|NCT00821431|1893597|FG000|Overall Study|Adverse Event|6
915418|NCT00821431|1893598|FG001|Overall Study|Adverse Event|3
915419|NCT00821431|1893597|FG000|Overall Study|Withdrawal by Subject|5
915420|NCT00821431|1893598|FG001|Overall Study|Withdrawal by Subject|0
915421|NCT00821431|1893597|FG000|Overall Study|Lost to Follow-up|1
915422|NCT00821431|1893598|FG001|Overall Study|Lost to Follow-up|0
915423|NCT00821431|1893597|FG000|Overall Study|Protocol Violation|3
915424|NCT00821431|1893598|FG001|Overall Study|Protocol Violation|1
915425|NCT00821431|1893597|FG000|Overall Study|Physician Decision|0
915426|NCT00821431|1893598|FG001|Overall Study|Physician Decision|1
915427|NCT00821509|1893607|FG000|Overall Study|Withdrawal by Subject|12
915428|NCT00821509|1893608|FG001|Overall Study|Withdrawal by Subject|11
915429|NCT00821509|1893609|FG002|Overall Study|Withdrawal by Subject|34
915430|NCT00821587|1893619|FG000|Overall Study|Physician Decision|0
915431|NCT00821587|1893620|FG001|Overall Study|Physician Decision|1
915432|NCT00821678|1893639|FG000|Overall Study|Withdrawal by Subject|8
915433|NCT00821678|1893640|FG001|Overall Study|Withdrawal by Subject|0
915434|NCT00821678|1893639|FG000|Overall Study|Lost to Follow-up|13
915435|NCT00821678|1893640|FG001|Overall Study|Lost to Follow-up|12
915436|NCT00821678|1893639|FG000|Overall Study|Death|0
915437|NCT00821678|1893640|FG001|Overall Study|Death|2
915438|NCT00821873|1893672|FG000|Overall Study|Lost to Follow-up|4
1014662|NCT01533493|2036545|FG000|Overall Study|Lost to Follow-up|2
1014663|NCT01533493|2036546|FG001|Overall Study|Lost to Follow-up|0
1014664|NCT01533688|2036564|FG000|Overall Study|Withdrawal by Subject|5
1014665|NCT01533688|2036565|FG001|Overall Study|Withdrawal by Subject|4
1014666|NCT01533688|2036566|FG002|Overall Study|Withdrawal by Subject|3
1014667|NCT01533688|2036564|FG000|Overall Study|Medically unstable|1
1014668|NCT01533688|2036565|FG001|Overall Study|Medically unstable|3
1014669|NCT01533688|2036566|FG002|Overall Study|Medically unstable|3
1014670|NCT01533688|2036564|FG000|Overall Study|Had colonoscopy at outside hospital|2
1014671|NCT01533688|2036565|FG001|Overall Study|Had colonoscopy at outside hospital|3
1014672|NCT01533688|2036566|FG002|Overall Study|Had colonoscopy at outside hospital|2
1014673|NCT01533922|2036576|FG000|Overall Study|Adverse Event|5
1014674|NCT01533922|2036577|FG001|Overall Study|Adverse Event|8
1014675|NCT01533922|2036578|FG002|Overall Study|Adverse Event|6
1014676|NCT01533922|2036579|FG003|Overall Study|Adverse Event|3
1014677|NCT01533922|2036580|FG004|Overall Study|Adverse Event|4
1014678|NCT01533922|2036576|FG000|Overall Study|Lack of Efficacy|0
1014679|NCT01533922|2036577|FG001|Overall Study|Lack of Efficacy|0
1014680|NCT01533922|2036578|FG002|Overall Study|Lack of Efficacy|1
1014681|NCT01533922|2036579|FG003|Overall Study|Lack of Efficacy|0
1014682|NCT01533922|2036580|FG004|Overall Study|Lack of Efficacy|0
1014683|NCT01533922|2036576|FG000|Overall Study|Protocol Violation|0
1014684|NCT01533922|2036577|FG001|Overall Study|Protocol Violation|3
1014685|NCT01533922|2036578|FG002|Overall Study|Protocol Violation|0
1014686|NCT01533922|2036579|FG003|Overall Study|Protocol Violation|0
1014687|NCT01533922|2036580|FG004|Overall Study|Protocol Violation|1
1014688|NCT01533922|2036576|FG000|Overall Study|Withdrawal by Subject|3
1014689|NCT01533922|2036577|FG001|Overall Study|Withdrawal by Subject|1
1014690|NCT01533922|2036578|FG002|Overall Study|Withdrawal by Subject|2
915487|NCT00822172|1893734|FG000|Overall Study|Adverse Event|10
915488|NCT00822172|1893735|FG001|Overall Study|Adverse Event|12
915489|NCT00822172|1893734|FG000|Overall Study|Death|1
915490|NCT00822172|1893735|FG001|Overall Study|Death|0
915491|NCT00822172|1893734|FG000|Overall Study|Lost to Follow-up|3
915492|NCT00822172|1893735|FG001|Overall Study|Lost to Follow-up|1
915493|NCT00822172|1893734|FG000|Overall Study|Withdrawal by Subject|1
915494|NCT00822172|1893735|FG001|Overall Study|Withdrawal by Subject|4
915495|NCT00822172|1893734|FG000|Overall Study|site closed|0
915496|NCT00822172|1893735|FG001|Overall Study|site closed|1
915497|NCT00822172|1893734|FG000|Overall Study|Other|0
915498|NCT00822172|1893735|FG001|Overall Study|Other|1
915499|NCT00822237|1893764|FG000|Dose 1 Vaccination|Not vaccinated|3
915500|NCT00822237|1893765|FG001|Dose 1 Vaccination|Not vaccinated|0
915501|NCT00822237|1893764|FG000|Dose 1 Vaccination|Withdrawal by Subject|13
915502|NCT00822237|1893765|FG001|Dose 1 Vaccination|Withdrawal by Subject|14
915503|NCT00822237|1893764|FG000|Dose 1 Vaccination|Lost to Follow-up|9
915504|NCT00822237|1893765|FG001|Dose 1 Vaccination|Lost to Follow-up|12
915505|NCT00822237|1893764|FG000|Dose 2 Vaccination|Withdrawal by Subject|2
915506|NCT00822237|1893765|FG001|Dose 2 Vaccination|Withdrawal by Subject|2
1014691|NCT01533922|2036579|FG003|Overall Study|Withdrawal by Subject|2
1014692|NCT01533922|2036580|FG004|Overall Study|Withdrawal by Subject|1
1014693|NCT01533922|2036576|FG000|Overall Study|Other reason not defined above|2
1014694|NCT01533922|2036577|FG001|Overall Study|Other reason not defined above|0
1014695|NCT01533922|2036578|FG002|Overall Study|Other reason not defined above|1
1014696|NCT01533922|2036579|FG003|Overall Study|Other reason not defined above|0
1014697|NCT01533922|2036580|FG004|Overall Study|Other reason not defined above|0
1014698|NCT01533935|2036592|FG000|Overall Study|Adverse Event|5
1014699|NCT01533935|2036593|FG001|Overall Study|Adverse Event|7
1014700|NCT01533935|2036594|FG002|Overall Study|Adverse Event|1
1014701|NCT01533935|2036595|FG003|Overall Study|Adverse Event|5
915507|NCT00822237|1893764|FG000|Dose 2 Vaccination|Lost to Follow-up|2
915508|NCT00822237|1893765|FG001|Dose 2 Vaccination|Lost to Follow-up|9
915509|NCT00822692|1893833|FG000|Overall Study|Lost to Follow-up|17
915510|NCT00822692|1893834|FG001|Overall Study|Lost to Follow-up|25
915511|NCT00822770|1893851|FG000|Overall Study|Not treated|1
915512|NCT00822770|1893852|FG001|Overall Study|Not treated|0
915513|NCT00822770|1893851|FG000|Overall Study|Complication/Incomplete treatment|1
915514|NCT00822770|1893852|FG001|Overall Study|Complication/Incomplete treatment|0
915515|NCT00822770|1893851|FG000|Overall Study|Death|1
915516|NCT00822770|1893852|FG001|Overall Study|Death|1
915517|NCT00822900|1893860|FG000|Overall Study|Withdrawal by Subject|14
915518|NCT00822900|1893861|FG001|Overall Study|Withdrawal by Subject|14
915519|NCT00822900|1893860|FG000|Overall Study|Lost to Follow-up|9
915520|NCT00822900|1893861|FG001|Overall Study|Lost to Follow-up|9
915521|NCT00822900|1893860|FG000|Overall Study|Death|83
915522|NCT00822900|1893861|FG001|Overall Study|Death|69
915523|NCT00822900|1893860|FG000|Overall Study|Became a ward of the state|2
915524|NCT00822900|1893861|FG001|Overall Study|Became a ward of the state|1
915525|NCT00822926|1893869|FG000|Second Injection Visit|Lost to Follow-up|1
915526|NCT00822926|1893870|FG001|Second Injection Visit|Lost to Follow-up|0
915527|NCT00822926|1893869|FG000|Second Injection Visit|Withdrawal by Subject|0
915528|NCT00822926|1893870|FG001|Second Injection Visit|Withdrawal by Subject|1
915529|NCT00823134|1893901|FG000|Overall Study|Invalid measurement|1
915530|NCT00823199|1893906|FG000|Overall Study|Withdrawal by Subject|2
915531|NCT00823212|1893913|FG000|Overall Study|Death|8
915532|NCT00823212|1893914|FG001|Overall Study|Death|10
915533|NCT00823212|1893913|FG000|Overall Study|Withdrawal by Subject|6
915534|NCT00823212|1893914|FG001|Overall Study|Withdrawal by Subject|1
915535|NCT00823212|1893913|FG000|Overall Study|Incarcerated|0
915536|NCT00823212|1893914|FG001|Overall Study|Incarcerated|1
915537|NCT00823212|1893913|FG000|Overall Study|Missed 12-month visit|21
915538|NCT00823212|1893914|FG001|Overall Study|Missed 12-month visit|21
915539|NCT00823264|1893924|FG000|Overall Study|Protocol Violation|2
915540|NCT00823264|1893925|FG001|Overall Study|Protocol Violation|0
915541|NCT00823472|1893947|FG000|Overall Study|Physician Decision|24
915542|NCT00823472|1893948|FG001|Overall Study|Physician Decision|28
915543|NCT00823615|1893954|FG000|Period 2|Lost to Follow-up|2
915544|NCT00823615|1893955|FG001|Period 2|Lost to Follow-up|0
915545|NCT00823615|1893954|FG000|Period 2|Time/Job Conflict|1
915546|NCT00823615|1893955|FG001|Period 2|Time/Job Conflict|2
915547|NCT00823719|1893963|FG000|Overall Study|Adverse Event|1
915548|NCT00823719|1893964|FG001|Overall Study|Adverse Event|2
915549|NCT00823719|1893963|FG000|Overall Study|Physician Decision|1
915550|NCT00823719|1893964|FG001|Overall Study|Physician Decision|4
915551|NCT00823719|1893963|FG000|Overall Study|Withdrawal by Subject|0
915552|NCT00823719|1893964|FG001|Overall Study|Withdrawal by Subject|1
915553|NCT00823719|1893963|FG000|Overall Study|Disease Progression|4
915554|NCT00823719|1893964|FG001|Overall Study|Disease Progression|4
915555|NCT00823823|1893982|FG000|Overall Study|Lost to Follow-up|3
915556|NCT00823823|1893983|FG001|Overall Study|Lost to Follow-up|1
915557|NCT00823823|1893982|FG000|Overall Study|Protocol Violation|5
915558|NCT00823823|1893983|FG001|Overall Study|Protocol Violation|5
915559|NCT00823836|1893991|FG000|NV and PR/XR Switching Phases|Adverse Event|22
915560|NCT00823836|1893992|FG001|NV and PR/XR Switching Phases|Adverse Event|21
915561|NCT00823836|1893991|FG000|NV and PR/XR Switching Phases|Protocol Violation|1
915562|NCT00823836|1893992|FG001|NV and PR/XR Switching Phases|Protocol Violation|1
915563|NCT00823836|1893991|FG000|NV and PR/XR Switching Phases|Physician Decision|5
915564|NCT00823836|1893992|FG001|NV and PR/XR Switching Phases|Physician Decision|2
915565|NCT00823836|1893991|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4
915566|NCT00823836|1893992|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5
915567|NCT00823836|1893991|FG000|Long-term Phase|Adverse Event|3
915568|NCT00823836|1893992|FG001|Long-term Phase|Adverse Event|2
915569|NCT00823836|1893991|FG000|Long-term Phase|Physician Decision|1
915570|NCT00823836|1893992|FG001|Long-term Phase|Physician Decision|2
915571|NCT00823836|1893991|FG000|Long-term Phase|Withdrawal by Subject|1
915572|NCT00823836|1893992|FG001|Long-term Phase|Withdrawal by Subject|1
915573|NCT00823901|1894003|FG000|Overall Study|Adverse Event|1
915574|NCT00823901|1894004|FG001|Overall Study|Adverse Event|1
915575|NCT00823901|1894003|FG000|Overall Study|Lack of Efficacy|1
915576|NCT00823901|1894004|FG001|Overall Study|Lack of Efficacy|0
915577|NCT00823901|1894003|FG000|Overall Study|Lost to Follow-up|2
915578|NCT00823901|1894004|FG001|Overall Study|Lost to Follow-up|1
915579|NCT00823979|1894017|FG000|Overall Study|Lack of Efficacy|13
1014702|NCT01533935|2036596|FG004|Overall Study|Adverse Event|3
1014703|NCT01533935|2036592|FG000|Overall Study|Protocol Violation|0
1014704|NCT01533935|2036593|FG001|Overall Study|Protocol Violation|2
1014705|NCT01533935|2036594|FG002|Overall Study|Protocol Violation|0
1014706|NCT01533935|2036595|FG003|Overall Study|Protocol Violation|0
1014707|NCT01533935|2036596|FG004|Overall Study|Protocol Violation|0
1014708|NCT01533935|2036592|FG000|Overall Study|Lost to Follow-up|0
1014709|NCT01533935|2036593|FG001|Overall Study|Lost to Follow-up|0
1014710|NCT01533935|2036594|FG002|Overall Study|Lost to Follow-up|1
1014711|NCT01533935|2036595|FG003|Overall Study|Lost to Follow-up|0
1014712|NCT01533935|2036596|FG004|Overall Study|Lost to Follow-up|0
1014713|NCT01533935|2036592|FG000|Overall Study|Withdrawal by Subject|0
1014714|NCT01533935|2036593|FG001|Overall Study|Withdrawal by Subject|4
1014715|NCT01533935|2036594|FG002|Overall Study|Withdrawal by Subject|5
915580|NCT00823979|1894018|FG001|Overall Study|Lack of Efficacy|16
915581|NCT00823979|1894019|FG002|Overall Study|Lack of Efficacy|9
915582|NCT00823979|1894017|FG000|Overall Study|Lost to Follow-up|2
915583|NCT00823979|1894018|FG001|Overall Study|Lost to Follow-up|1
915584|NCT00823979|1894019|FG002|Overall Study|Lost to Follow-up|0
915585|NCT00823979|1894017|FG000|Overall Study|Withdrawal by Subject|2
915586|NCT00823979|1894018|FG001|Overall Study|Withdrawal by Subject|3
915587|NCT00823979|1894019|FG002|Overall Study|Withdrawal by Subject|2
915588|NCT00823979|1894017|FG000|Overall Study|Protocol Violation|1
915589|NCT00823979|1894018|FG001|Overall Study|Protocol Violation|1
915590|NCT00823979|1894019|FG002|Overall Study|Protocol Violation|0
915591|NCT00823979|1894017|FG000|Overall Study|Pregnancy|0
915592|NCT00823979|1894018|FG001|Overall Study|Pregnancy|1
915593|NCT00823979|1894019|FG002|Overall Study|Pregnancy|0
915594|NCT00823979|1894017|FG000|Overall Study|Adverse Event|0
915595|NCT00823979|1894018|FG001|Overall Study|Adverse Event|2
915596|NCT00823979|1894019|FG002|Overall Study|Adverse Event|4
915597|NCT00823979|1894017|FG000|Overall Study|Other|2
915598|NCT00823979|1894018|FG001|Overall Study|Other|0
915599|NCT00823979|1894019|FG002|Overall Study|Other|1
915600|NCT00823979|1894017|FG000|Overall Study|Randomized but not Treated|4
915601|NCT00823979|1894018|FG001|Overall Study|Randomized but not Treated|3
915602|NCT00823979|1894019|FG002|Overall Study|Randomized but not Treated|1
915603|NCT00823979|1894017|FG000|Overall Study|Study Terminated by Sponsor|5
915604|NCT00823979|1894018|FG001|Overall Study|Study Terminated by Sponsor|5
915605|NCT00823979|1894019|FG002|Overall Study|Study Terminated by Sponsor|7
915606|NCT00824005|1894029|FG000|Overall Study|Death|0
915607|NCT00824005|1894030|FG001|Overall Study|Death|1
915608|NCT00824005|1894029|FG000|Overall Study|Lost to Follow-up|0
915609|NCT00824005|1894030|FG001|Overall Study|Lost to Follow-up|1
915610|NCT00824161|1894062|FG000|Overall Study|Withdrawal by Subject|1
915611|NCT00824161|1894062|FG000|Overall Study|Screen Failure|1
915612|NCT00824265|1894069|FG000|Treatment Phase|Adverse Event,non-fatal|50
915613|NCT00824265|1894070|FG001|Treatment Phase|Adverse Event,non-fatal|52
915614|NCT00824265|1894069|FG000|Treatment Phase|Protocol Violation|1
915615|NCT00824265|1894070|FG001|Treatment Phase|Protocol Violation|0
915616|NCT00824265|1894069|FG000|Treatment Phase|Lost to Follow-up|1
915617|NCT00824265|1894070|FG001|Treatment Phase|Lost to Follow-up|1
915618|NCT00824265|1894069|FG000|Treatment Phase|Physician Decision|6
915619|NCT00824265|1894070|FG001|Treatment Phase|Physician Decision|12
915620|NCT00824265|1894069|FG000|Treatment Phase|Withdrawal by Subject|6
915621|NCT00824265|1894070|FG001|Treatment Phase|Withdrawal by Subject|15
915622|NCT00824265|1894069|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
915623|NCT00824265|1894070|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
915624|NCT00824265|1894069|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
915625|NCT00824265|1894070|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
915626|NCT00824291|1894082|FG000|Overall Study|Adverse Event|15
915627|NCT00824291|1894083|FG001|Overall Study|Adverse Event|6
915628|NCT00824291|1894082|FG000|Overall Study|Discontinuation of Study by Sponsor|1
915629|NCT00824291|1894083|FG001|Overall Study|Discontinuation of Study by Sponsor|2
915630|NCT00824291|1894082|FG000|Overall Study|Lost to Follow-up|11
915631|NCT00824291|1894083|FG001|Overall Study|Lost to Follow-up|9
915632|NCT00824291|1894082|FG000|Overall Study|Non-compliance|1
915633|NCT00824291|1894083|FG001|Overall Study|Non-compliance|1
915634|NCT00824291|1894082|FG000|Overall Study|Protocol Violation|4
915635|NCT00824291|1894083|FG001|Overall Study|Protocol Violation|1
915636|NCT00824291|1894082|FG000|Overall Study|Withdrawal by Subject|14
915637|NCT00824291|1894083|FG001|Overall Study|Withdrawal by Subject|8
915638|NCT00824291|1894082|FG000|Overall Study|Lack of Efficacy|7
915639|NCT00824291|1894083|FG001|Overall Study|Lack of Efficacy|8
915640|NCT00824291|1894082|FG000|Overall Study|Participant on prohibited medication|1
915641|NCT00824291|1894083|FG001|Overall Study|Participant on prohibited medication|0
915642|NCT00824369|1894095|FG000|Overall Study|Nolonger willing to participate in study|1
915643|NCT00824369|1894096|FG001|Overall Study|Nolonger willing to participate in study|0
915644|NCT00824369|1894097|FG002|Overall Study|Nolonger willing to participate in study|1
1014716|NCT01533935|2036595|FG003|Overall Study|Withdrawal by Subject|2
1014717|NCT01533935|2036596|FG004|Overall Study|Withdrawal by Subject|4
1014718|NCT01533935|2036592|FG000|Overall Study|Other reason not defined above|1
1014719|NCT01533935|2036593|FG001|Overall Study|Other reason not defined above|0
1014720|NCT01533935|2036594|FG002|Overall Study|Other reason not defined above|1
1014721|NCT01533935|2036595|FG003|Overall Study|Other reason not defined above|0
1014722|NCT01533935|2036596|FG004|Overall Study|Other reason not defined above|1
1014723|NCT01534078|2036634|FG000|Overall Study|Death|1
1014724|NCT01534078|2036634|FG000|Overall Study|Withdrawal by Subject|1
1014725|NCT01534182|2036640|FG000|Overall Study|Administrative problems|1
1014726|NCT01534182|2036641|FG001|Overall Study|Administrative problems|0
1014727|NCT01534182|2036640|FG000|Overall Study|Withdrawal by Subject|4
1014728|NCT01534182|2036641|FG001|Overall Study|Withdrawal by Subject|7
1014729|NCT01534182|2036640|FG000|Overall Study|Adverse Event|7
1014730|NCT01534182|2036641|FG001|Overall Study|Adverse Event|3
1014731|NCT01534195|2036650|FG000|Overall Study|Withdrawal by Subject|1
1014732|NCT01534195|2036651|FG001|Overall Study|Withdrawal by Subject|1
915645|NCT00824369|1894098|FG003|Overall Study|Nolonger willing to participate in study|2
915646|NCT00824369|1894099|FG004|Overall Study|Nolonger willing to participate in study|0
915647|NCT00824369|1894100|FG005|Overall Study|Nolonger willing to participate in study|1
915648|NCT00824369|1894095|FG000|Overall Study|Lost to Follow-up|0
915649|NCT00824369|1894096|FG001|Overall Study|Lost to Follow-up|0
915650|NCT00824369|1894097|FG002|Overall Study|Lost to Follow-up|0
915651|NCT00824369|1894098|FG003|Overall Study|Lost to Follow-up|0
915652|NCT00824369|1894099|FG004|Overall Study|Lost to Follow-up|1
915653|NCT00824369|1894100|FG005|Overall Study|Lost to Follow-up|0
915654|NCT00824382|1894118|FG000|Overall Study|Adverse Event|4
915655|NCT00824382|1894119|FG001|Overall Study|Adverse Event|1
915656|NCT00824382|1894120|FG002|Overall Study|Adverse Event|1
915657|NCT00824382|1894121|FG003|Overall Study|Adverse Event|4
915658|NCT00824382|1894118|FG000|Overall Study|Protocol Violation|1
915659|NCT00824382|1894119|FG001|Overall Study|Protocol Violation|0
915660|NCT00824382|1894120|FG002|Overall Study|Protocol Violation|0
915661|NCT00824382|1894121|FG003|Overall Study|Protocol Violation|1
915662|NCT00824382|1894118|FG000|Overall Study|Investigator's decision|0
915663|NCT00824382|1894119|FG001|Overall Study|Investigator's decision|1
915664|NCT00824382|1894120|FG002|Overall Study|Investigator's decision|2
915665|NCT00824382|1894121|FG003|Overall Study|Investigator's decision|0
915666|NCT00824408|1894138|FG000|Run-in Phase|Progressive disease|4
915667|NCT00824408|1894139|FG001|Run-in Phase|Progressive disease|4
915668|NCT00824408|1894140|FG002|Run-in Phase|Progressive disease|0
915669|NCT00824408|1894141|FG003|Run-in Phase|Progressive disease|0
915670|NCT00824408|1894142|FG004|Run-in Phase|Progressive disease|0
915671|NCT00824408|1894138|FG000|Run-in Phase|Adverse Event|1
915672|NCT00824408|1894139|FG001|Run-in Phase|Adverse Event|1
915673|NCT00824408|1894140|FG002|Run-in Phase|Adverse Event|0
915674|NCT00824408|1894141|FG003|Run-in Phase|Adverse Event|0
915675|NCT00824408|1894142|FG004|Run-in Phase|Adverse Event|0
915676|NCT00824408|1894138|FG000|Run-in Phase|Refused to continue medication|1
915677|NCT00824408|1894139|FG001|Run-in Phase|Refused to continue medication|0
915678|NCT00824408|1894140|FG002|Run-in Phase|Refused to continue medication|0
915679|NCT00824408|1894141|FG003|Run-in Phase|Refused to continue medication|0
915680|NCT00824408|1894142|FG004|Run-in Phase|Refused to continue medication|0
915681|NCT00824408|1894138|FG000|Run-in Phase|Other reason not defined above|0
915682|NCT00824408|1894139|FG001|Run-in Phase|Other reason not defined above|1
915683|NCT00824408|1894140|FG002|Run-in Phase|Other reason not defined above|0
915684|NCT00824408|1894141|FG003|Run-in Phase|Other reason not defined above|0
915685|NCT00824408|1894142|FG004|Run-in Phase|Other reason not defined above|0
915686|NCT00824408|1894138|FG000|Randomized Phase|Not treated|0
915687|NCT00824408|1894139|FG001|Randomized Phase|Not treated|0
915688|NCT00824408|1894140|FG002|Randomized Phase|Not treated|1
915689|NCT00824408|1894141|FG003|Randomized Phase|Not treated|1
915690|NCT00824408|1894142|FG004|Randomized Phase|Not treated|1
915691|NCT00824408|1894138|FG000|Randomized Phase|Progressive disease|0
915692|NCT00824408|1894139|FG001|Randomized Phase|Progressive disease|0
915693|NCT00824408|1894140|FG002|Randomized Phase|Progressive disease|25
915694|NCT00824408|1894141|FG003|Randomized Phase|Progressive disease|36
915695|NCT00824408|1894142|FG004|Randomized Phase|Progressive disease|34
915696|NCT00824408|1894138|FG000|Randomized Phase|Adverse Event|0
915697|NCT00824408|1894139|FG001|Randomized Phase|Adverse Event|0
915698|NCT00824408|1894140|FG002|Randomized Phase|Adverse Event|4
915699|NCT00824408|1894141|FG003|Randomized Phase|Adverse Event|5
915700|NCT00824408|1894142|FG004|Randomized Phase|Adverse Event|5
915701|NCT00824408|1894138|FG000|Randomized Phase|Refused to continue medication|0
915702|NCT00824408|1894139|FG001|Randomized Phase|Refused to continue medication|0
915703|NCT00824408|1894140|FG002|Randomized Phase|Refused to continue medication|2
915704|NCT00824408|1894141|FG003|Randomized Phase|Refused to continue medication|2
915705|NCT00824408|1894142|FG004|Randomized Phase|Refused to continue medication|2
915706|NCT00824408|1894138|FG000|Randomized Phase|Other reason not defined above|0
915707|NCT00824408|1894139|FG001|Randomized Phase|Other reason not defined above|0
915708|NCT00824408|1894140|FG002|Randomized Phase|Other reason not defined above|4
915709|NCT00824408|1894141|FG003|Randomized Phase|Other reason not defined above|2
915710|NCT00824408|1894142|FG004|Randomized Phase|Other reason not defined above|4
915711|NCT00824421|1894163|FG000|Overall Study|Adverse Event|6
915712|NCT00824421|1894164|FG001|Overall Study|Adverse Event|6
915713|NCT00824421|1894165|FG002|Overall Study|Adverse Event|6
1014733|NCT01534208|2036659|FG000|Overall Study|Lost to Follow-up|19
1014734|NCT01534208|2036660|FG001|Overall Study|Lost to Follow-up|14
1014735|NCT01534208|2036659|FG000|Overall Study|Withdrawal by Subject|6
1014736|NCT01534208|2036660|FG001|Overall Study|Withdrawal by Subject|20
1014737|NCT01534208|2036659|FG000|Overall Study|Adverse Event|15
1014738|NCT01534208|2036660|FG001|Overall Study|Adverse Event|8
1014739|NCT01534208|2036659|FG000|Overall Study|Physician Decision|2
1014740|NCT01534208|2036660|FG001|Overall Study|Physician Decision|0
1014741|NCT01534208|2036659|FG000|Overall Study|Lack of Efficacy|0
1014742|NCT01534208|2036660|FG001|Overall Study|Lack of Efficacy|3
915714|NCT00824421|1894163|FG000|Overall Study|Death|0
915715|NCT00824421|1894164|FG001|Overall Study|Death|1
915716|NCT00824421|1894165|FG002|Overall Study|Death|0
915717|NCT00824421|1894163|FG000|Overall Study|Lack of Efficacy|5
915718|NCT00824421|1894164|FG001|Overall Study|Lack of Efficacy|7
915719|NCT00824421|1894165|FG002|Overall Study|Lack of Efficacy|4
915720|NCT00824421|1894163|FG000|Overall Study|Lost to Follow-up|2
915721|NCT00824421|1894164|FG001|Overall Study|Lost to Follow-up|3
915722|NCT00824421|1894165|FG002|Overall Study|Lost to Follow-up|0
915723|NCT00824421|1894163|FG000|Overall Study|Pregnancy|1
915724|NCT00824421|1894164|FG001|Overall Study|Pregnancy|0
915725|NCT00824421|1894165|FG002|Overall Study|Pregnancy|1
915726|NCT00824421|1894163|FG000|Overall Study|Withdrawal by Subject|2
915727|NCT00824421|1894164|FG001|Overall Study|Withdrawal by Subject|3
915728|NCT00824421|1894165|FG002|Overall Study|Withdrawal by Subject|3
915729|NCT00824421|1894163|FG000|Overall Study|Randomized but not Treated|1
915730|NCT00824421|1894164|FG001|Overall Study|Randomized but not Treated|1
915731|NCT00824421|1894165|FG002|Overall Study|Randomized but not Treated|0
915732|NCT00824421|1894163|FG000|Overall Study|Other|0
915733|NCT00824421|1894164|FG001|Overall Study|Other|1
915734|NCT00824421|1894165|FG002|Overall Study|Other|0
915735|NCT00824473|1894214|FG000|Overall Study|Adverse Event|4
915736|NCT00824473|1894215|FG001|Overall Study|Adverse Event|5
915737|NCT00824473|1894214|FG000|Overall Study|Lack of Efficacy|2
915738|NCT00824473|1894215|FG001|Overall Study|Lack of Efficacy|2
915739|NCT00824473|1894214|FG000|Overall Study|Protocol Violation|2
915740|NCT00824473|1894215|FG001|Overall Study|Protocol Violation|0
915741|NCT00824473|1894214|FG000|Overall Study|Non-Compliance|4
915742|NCT00824473|1894215|FG001|Overall Study|Non-Compliance|2
915743|NCT00824473|1894214|FG000|Overall Study|Withdrawal by Subject|2
915744|NCT00824473|1894215|FG001|Overall Study|Withdrawal by Subject|3
915745|NCT00824473|1894214|FG000|Overall Study|Other|1
915746|NCT00824473|1894215|FG001|Overall Study|Other|1
915747|NCT00824564|1894237|FG000|Overall Study|Lost to Follow-up|5
915748|NCT00824564|1894238|FG001|Overall Study|Lost to Follow-up|7
915749|NCT00824564|1894237|FG000|Overall Study|Withdrawal by Subject|1
915750|NCT00824564|1894238|FG001|Overall Study|Withdrawal by Subject|1
915751|NCT00824564|1894237|FG000|Overall Study|Other|1
915752|NCT00824564|1894238|FG001|Overall Study|Other|2
915753|NCT00824564|1894237|FG000|Overall Study|Randomized, but not treated|1
915754|NCT00824564|1894238|FG001|Overall Study|Randomized, but not treated|0
915755|NCT00824616|1894246|FG000|Overall Study|Adverse Event|2
915756|NCT00824616|1894247|FG001|Overall Study|Adverse Event|1
915757|NCT00824616|1894246|FG000|Overall Study|Creatinine/Creatinine Clearance|0
915758|NCT00824616|1894247|FG001|Overall Study|Creatinine/Creatinine Clearance|2
915759|NCT00824616|1894246|FG000|Overall Study|Hyperglycemia|1
915760|NCT00824616|1894247|FG001|Overall Study|Hyperglycemia|1
915761|NCT00824616|1894246|FG000|Overall Study|Lack of Efficacy|2
915762|NCT00824616|1894247|FG001|Overall Study|Lack of Efficacy|1
915763|NCT00824616|1894246|FG000|Overall Study|Lost to Follow-up|0
915764|NCT00824616|1894247|FG001|Overall Study|Lost to Follow-up|1
915765|NCT00824616|1894246|FG000|Overall Study|Withdrawal by Subject|1
915766|NCT00824616|1894247|FG001|Overall Study|Withdrawal by Subject|1
915767|NCT00824655|1894255|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1
915768|NCT00824655|1894256|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0
915769|NCT00824655|1894255|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
915770|NCT00824655|1894256|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
915771|NCT00824720|1894267|FG000|Overall Study|failed plug insertion|3
915772|NCT00824720|1894268|FG001|Overall Study|failed plug insertion|1
915773|NCT00824720|1894269|FG002|Overall Study|failed plug insertion|0
915774|NCT00824720|1894267|FG000|Overall Study|Protocol Violation|0
915775|NCT00824720|1894268|FG001|Overall Study|Protocol Violation|0
915776|NCT00824720|1894269|FG002|Overall Study|Protocol Violation|1
915777|NCT00824772|1894287|FG000|Overall Study|Withdrawal by Subject|8
915778|NCT00824850|1894302|FG000|Overall Study|Withdrawal by Subject|0
915779|NCT00824850|1894303|FG001|Overall Study|Withdrawal by Subject|1
915780|NCT00824993|1894317|FG000|Overall Study|Withdrawal by Subject|1
915781|NCT00824993|1894318|FG001|Overall Study|Withdrawal by Subject|1
915782|NCT00824993|1894317|FG000|Overall Study|Malignancy Relapse|9
915783|NCT00824993|1894318|FG001|Overall Study|Malignancy Relapse|10
915784|NCT00824993|1894317|FG000|Overall Study|Rapid Bone Loss|0
915785|NCT00824993|1894318|FG001|Overall Study|Rapid Bone Loss|1
915786|NCT00824993|1894317|FG000|Overall Study|Non-Compliant|2
915787|NCT00824993|1894318|FG001|Overall Study|Non-Compliant|1
915788|NCT00824993|1894317|FG000|Overall Study|Insurance Issue|2
915789|NCT00824993|1894318|FG001|Overall Study|Insurance Issue|1
915790|NCT00824993|1894317|FG000|Overall Study|Death|0
915791|NCT00824993|1894318|FG001|Overall Study|Death|3
915792|NCT00825162|1894327|FG000|Overall Study|Withdrawal by Subject|11
915793|NCT00825162|1894328|FG001|Overall Study|Withdrawal by Subject|13
915794|NCT00825162|1894329|FG002|Overall Study|Withdrawal by Subject|3
915795|NCT00825162|1894327|FG000|Overall Study|Lost to Follow-up|9
915796|NCT00825162|1894328|FG001|Overall Study|Lost to Follow-up|6
915797|NCT00825162|1894329|FG002|Overall Study|Lost to Follow-up|3
915798|NCT00825162|1894327|FG000|Overall Study|Physician Decision|2
915799|NCT00825162|1894328|FG001|Overall Study|Physician Decision|0
915800|NCT00825162|1894329|FG002|Overall Study|Physician Decision|0
915801|NCT00825162|1894327|FG000|Overall Study|Move away from the study area|1
915802|NCT00825162|1894328|FG001|Overall Study|Move away from the study area|0
915803|NCT00825162|1894329|FG002|Overall Study|Move away from the study area|0
915804|NCT00825162|1894327|FG000|Overall Study|Unable to attend the study visit|5
915805|NCT00825162|1894328|FG001|Overall Study|Unable to attend the study visit|2
915806|NCT00825162|1894329|FG002|Overall Study|Unable to attend the study visit|0
915807|NCT00825175|1894344|FG000|Overall Study|Withdrawal by Subject|0
915808|NCT00825175|1894345|FG001|Overall Study|Withdrawal by Subject|5
915809|NCT00825305|1894362|FG000|Overall Study|Adverse Event|1
915810|NCT00825305|1894363|FG001|Overall Study|Adverse Event|1
915811|NCT00825305|1894362|FG000|Overall Study|Withdrawal by Subject|6
915812|NCT00825305|1894363|FG001|Overall Study|Withdrawal by Subject|12
915813|NCT00825305|1894362|FG000|Overall Study|Inappropriate inclusion|1
915814|NCT00825305|1894363|FG001|Overall Study|Inappropriate inclusion|0
915815|NCT00825305|1894362|FG000|Overall Study|Protocol Violation|9
915816|NCT00825305|1894363|FG001|Overall Study|Protocol Violation|9
915817|NCT00825305|1894362|FG000|Overall Study|Can not be classified|0
915818|NCT00825305|1894363|FG001|Overall Study|Can not be classified|1
915819|NCT00825682|1894437|FG000|Overall Study|personal reasons/ inconvenience|13
915820|NCT00825682|1894438|FG001|Overall Study|personal reasons/ inconvenience|5
915821|NCT00825812|1894465|FG000|Overall Study|Never entered follow up|0
915822|NCT00825812|1894466|FG001|Overall Study|Never entered follow up|0
915823|NCT00825812|1894467|FG002|Overall Study|Never entered follow up|0
915824|NCT00825812|1894468|FG003|Overall Study|Never entered follow up|1
915825|NCT00825812|1894465|FG000|Overall Study|Adverse Event|0
915826|NCT00825812|1894466|FG001|Overall Study|Adverse Event|0
915827|NCT00825812|1894467|FG002|Overall Study|Adverse Event|0
915828|NCT00825812|1894468|FG003|Overall Study|Adverse Event|1
915829|NCT00825812|1894465|FG000|Overall Study|Subject withdrew consent|0
915830|NCT00825812|1894466|FG001|Overall Study|Subject withdrew consent|0
915831|NCT00825812|1894467|FG002|Overall Study|Subject withdrew consent|3
915832|NCT00825812|1894468|FG003|Overall Study|Subject withdrew consent|2
915833|NCT00825812|1894465|FG000|Overall Study|Non-compliance with protocol|0
915834|NCT00825812|1894466|FG001|Overall Study|Non-compliance with protocol|0
915835|NCT00825812|1894467|FG002|Overall Study|Non-compliance with protocol|0
915836|NCT00825812|1894468|FG003|Overall Study|Non-compliance with protocol|1
915837|NCT00825812|1894465|FG000|Overall Study|Administrative|0
915838|NCT00825812|1894466|FG001|Overall Study|Administrative|1
915839|NCT00825812|1894467|FG002|Overall Study|Administrative|3
915840|NCT00825812|1894468|FG003|Overall Study|Administrative|5
915841|NCT00825825|1894478|FG000|First Medication Period (14 Days)|Adverse Event|1
915842|NCT00825825|1894479|FG001|First Medication Period (14 Days)|Adverse Event|0
915843|NCT00825825|1894480|FG002|First Medication Period (14 Days)|Adverse Event|0
915844|NCT00825825|1894481|FG003|First Medication Period (14 Days)|Adverse Event|0
915845|NCT00825825|1894482|FG004|First Medication Period (14 Days)|Adverse Event|0
915846|NCT00825825|1894483|FG005|First Medication Period (14 Days)|Adverse Event|1
915847|NCT00825825|1894478|FG000|First Medication Period (14 Days)|Physician Decision|2
915848|NCT00825825|1894479|FG001|First Medication Period (14 Days)|Physician Decision|0
915849|NCT00825825|1894480|FG002|First Medication Period (14 Days)|Physician Decision|1
915850|NCT00825825|1894481|FG003|First Medication Period (14 Days)|Physician Decision|0
915851|NCT00825825|1894482|FG004|First Medication Period (14 Days)|Physician Decision|0
915852|NCT00825825|1894483|FG005|First Medication Period (14 Days)|Physician Decision|1
915853|NCT00825825|1894478|FG000|Second Medication Period (14 Days)|Physician Decision|1
915854|NCT00825825|1894479|FG001|Second Medication Period (14 Days)|Physician Decision|0
915855|NCT00825825|1894480|FG002|Second Medication Period (14 Days)|Physician Decision|0
915856|NCT00825825|1894481|FG003|Second Medication Period (14 Days)|Physician Decision|2
915857|NCT00825825|1894482|FG004|Second Medication Period (14 Days)|Physician Decision|0
915858|NCT00825825|1894483|FG005|Second Medication Period (14 Days)|Physician Decision|0
915859|NCT00825825|1894478|FG000|Second Medication Period (14 Days)|Protocol Violation|1
915860|NCT00825825|1894479|FG001|Second Medication Period (14 Days)|Protocol Violation|0
915861|NCT00825825|1894480|FG002|Second Medication Period (14 Days)|Protocol Violation|0
915862|NCT00825825|1894481|FG003|Second Medication Period (14 Days)|Protocol Violation|0
915863|NCT00825825|1894482|FG004|Second Medication Period (14 Days)|Protocol Violation|1
915864|NCT00825825|1894483|FG005|Second Medication Period (14 Days)|Protocol Violation|0
915865|NCT00825825|1894478|FG000|Third Medication Period (14 Days)|Adverse Event|0
915866|NCT00825825|1894479|FG001|Third Medication Period (14 Days)|Adverse Event|1
915867|NCT00825825|1894480|FG002|Third Medication Period (14 Days)|Adverse Event|0
915868|NCT00825825|1894481|FG003|Third Medication Period (14 Days)|Adverse Event|0
915869|NCT00825825|1894482|FG004|Third Medication Period (14 Days)|Adverse Event|0
915870|NCT00825825|1894483|FG005|Third Medication Period (14 Days)|Adverse Event|0
915871|NCT00825825|1894478|FG000|Third Medication Period (14 Days)|Protocol Violation|0
915872|NCT00825825|1894479|FG001|Third Medication Period (14 Days)|Protocol Violation|0
915873|NCT00825825|1894480|FG002|Third Medication Period (14 Days)|Protocol Violation|0
915874|NCT00825825|1894481|FG003|Third Medication Period (14 Days)|Protocol Violation|0
915875|NCT00825825|1894482|FG004|Third Medication Period (14 Days)|Protocol Violation|0
915876|NCT00825825|1894483|FG005|Third Medication Period (14 Days)|Protocol Violation|2
915877|NCT00825825|1894478|FG000|Third Medication Period (14 Days)|poor data quality|0
915878|NCT00825825|1894479|FG001|Third Medication Period (14 Days)|poor data quality|1
915879|NCT00825825|1894480|FG002|Third Medication Period (14 Days)|poor data quality|0
915880|NCT00825825|1894481|FG003|Third Medication Period (14 Days)|poor data quality|0
915881|NCT00825825|1894482|FG004|Third Medication Period (14 Days)|poor data quality|0
915882|NCT00825825|1894483|FG005|Third Medication Period (14 Days)|poor data quality|0
915883|NCT00825916|1894493|FG000|Overall Study|Lost to Follow-up|4
915884|NCT00825916|1894494|FG001|Overall Study|Lost to Follow-up|2
915885|NCT00825916|1894495|FG002|Overall Study|Lost to Follow-up|1
915886|NCT00825994|1894536|FG000|Overall Study|Withdrawal by Subject|2
915887|NCT00825994|1894536|FG000|Overall Study|Lost to Follow-up|1
915888|NCT00825994|1894536|FG000|Overall Study|Protocol Violation|1
915889|NCT00825994|1894536|FG000|Overall Study|Placebo Responder at V2|1
915890|NCT00826111|1894554|FG000|Overall Study|Lost to Follow-up|0
915891|NCT00826111|1894555|FG001|Overall Study|Lost to Follow-up|1
915892|NCT00826111|1894554|FG000|Overall Study|Protocol Violation|1
915893|NCT00826111|1894555|FG001|Overall Study|Protocol Violation|0
915894|NCT00826111|1894554|FG000|Overall Study|Withdrawal by Subject|5
915895|NCT00826111|1894555|FG001|Overall Study|Withdrawal by Subject|0
915896|NCT00826111|1894554|FG000|Overall Study|Physician Decision|1
915897|NCT00826111|1894555|FG001|Overall Study|Physician Decision|1
915898|NCT00826176|1894581|FG000|Overall Study|Lost to Follow-up|1
915899|NCT00826176|1894582|FG001|Overall Study|Lost to Follow-up|0
915900|NCT00826176|1894581|FG000|Overall Study|Subject Withdrew Consent|3
915901|NCT00826176|1894582|FG001|Overall Study|Subject Withdrew Consent|0
915902|NCT00826176|1894581|FG000|Overall Study|Administrative|9
915903|NCT00826176|1894582|FG001|Overall Study|Administrative|0
915904|NCT00826228|1894597|FG000|Overall Study|Withdrawal by Subject|1
915905|NCT00826241|1894602|FG000|Overall Study|Withdrawal from Follow-up|1
915906|NCT00826241|1894602|FG000|Overall Study|Withdrew consent|2
915907|NCT00826241|1894602|FG000|Overall Study|Death|4
915908|NCT00826241|1894602|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
915909|NCT00826241|1894602|FG000|Overall Study|Non-compliance|1
915910|NCT00826241|1894602|FG000|Overall Study|Progression of disease|1
915911|NCT00826241|1894602|FG000|Overall Study|Patient refused follow-up|3
915912|NCT00826241|1894602|FG000|Overall Study|Lost to Follow-up|9
915913|NCT00826241|1894602|FG000|Overall Study|Could not obtain records|1
915914|NCT00826241|1894602|FG000|Overall Study|Screen failure|2
915915|NCT00826241|1894602|FG000|Overall Study|Pt unable to proceed to registration|1
915916|NCT00826241|1894602|FG000|Overall Study|Pt opt not to proceed w/trmt|1
915917|NCT00826267|1894609|FG000|Overall Study|Other Adverse Event|1
915918|NCT00826267|1894610|FG001|Overall Study|Other Adverse Event|0
915919|NCT00826267|1894611|FG002|Overall Study|Other Adverse Event|0
915920|NCT00826280|1894623|FG000|Overall Study|Randomized but drug not received|1
915921|NCT00826280|1894624|FG001|Overall Study|Randomized but drug not received|0
915922|NCT00826280|1894625|FG002|Overall Study|Randomized but drug not received|1
915923|NCT00826280|1894623|FG000|Overall Study|Adverse Event|1
915924|NCT00826280|1894624|FG001|Overall Study|Adverse Event|3
915925|NCT00826280|1894625|FG002|Overall Study|Adverse Event|0
915926|NCT00826280|1894623|FG000|Overall Study|Lost to Follow-up|0
915927|NCT00826280|1894624|FG001|Overall Study|Lost to Follow-up|1
915928|NCT00826280|1894625|FG002|Overall Study|Lost to Follow-up|0
915929|NCT00826280|1894623|FG000|Overall Study|Sponsor discontinued subject or study|1
915930|NCT00826280|1894624|FG001|Overall Study|Sponsor discontinued subject or study|0
915931|NCT00826280|1894625|FG002|Overall Study|Sponsor discontinued subject or study|0
915932|NCT00826280|1894623|FG000|Overall Study|Reversible ischemic defect not present|43
915933|NCT00826280|1894624|FG001|Overall Study|Reversible ischemic defect not present|40
915934|NCT00826280|1894625|FG002|Overall Study|Reversible ischemic defect not present|44
915935|NCT00826280|1894623|FG000|Overall Study|Interpretation Failure|1
915936|NCT00826280|1894624|FG001|Overall Study|Interpretation Failure|0
915937|NCT00826280|1894625|FG002|Overall Study|Interpretation Failure|0
915938|NCT00826280|1894623|FG000|Overall Study|Machine Failure|1
915939|NCT00826280|1894624|FG001|Overall Study|Machine Failure|1
915940|NCT00826280|1894625|FG002|Overall Study|Machine Failure|0
915941|NCT00826280|1894623|FG000|Overall Study|One or more non-interpretable scan|0
915942|NCT00826280|1894624|FG001|Overall Study|One or more non-interpretable scan|1
915943|NCT00826280|1894625|FG002|Overall Study|One or more non-interpretable scan|1
915944|NCT00826449|1894635|FG000|Overall Study|Disease Progression|4
915945|NCT00826449|1894635|FG000|Overall Study|Withdrawal by Subject|1
915946|NCT00826514|1894642|FG000|Overall Study|Adverse Event|1
915947|NCT00826514|1894643|FG001|Overall Study|Adverse Event|1
915948|NCT00826514|1894642|FG000|Overall Study|Lack of Efficacy|0
915949|NCT00826514|1894643|FG001|Overall Study|Lack of Efficacy|1
915950|NCT00826514|1894642|FG000|Overall Study|Withdrawal by Subject|2
915951|NCT00826514|1894643|FG001|Overall Study|Withdrawal by Subject|3
915952|NCT00826540|1894649|FG000|Overall Study|ineligible|3
915953|NCT00826540|1894649|FG000|Overall Study|Withdrawal by Subject|1
915954|NCT00826618|1894653|FG000|Overall Study|Withdrawal by Subject|1
915955|NCT00826748|1894660|FG000|Overall Study|Withdrawal by Subject|0
915956|NCT00826748|1894661|FG001|Overall Study|Withdrawal by Subject|0
915957|NCT00826748|1894662|FG002|Overall Study|Withdrawal by Subject|2
915958|NCT00826748|1894660|FG000|Overall Study|Physician Decision|0
915959|NCT00826748|1894661|FG001|Overall Study|Physician Decision|0
915960|NCT00826748|1894662|FG002|Overall Study|Physician Decision|1
915961|NCT00826748|1894660|FG000|Overall Study|Samples Did Not pass QC|0
915962|NCT00826748|1894661|FG001|Overall Study|Samples Did Not pass QC|0
915963|NCT00826748|1894662|FG002|Overall Study|Samples Did Not pass QC|1
915964|NCT00826943|1894674|FG000|Overall Study|Withdrawal by Subject|0
915965|NCT00826943|1894675|FG001|Overall Study|Withdrawal by Subject|0
915966|NCT00826943|1894676|FG002|Overall Study|Withdrawal by Subject|0
915967|NCT00826943|1894677|FG003|Overall Study|Withdrawal by Subject|0
915968|NCT00826943|1894678|FG004|Overall Study|Withdrawal by Subject|1
915969|NCT00826943|1894679|FG005|Overall Study|Withdrawal by Subject|0
915970|NCT00827112|1894702|FG000|Overall Study|Adverse Event|2
915971|NCT00827112|1894703|FG001|Overall Study|Adverse Event|0
915972|NCT00827112|1894702|FG000|Overall Study|Lack of Efficacy|2
915973|NCT00827112|1894703|FG001|Overall Study|Lack of Efficacy|0
915974|NCT00827112|1894702|FG000|Overall Study|Lost to Follow-up|3
915975|NCT00827112|1894703|FG001|Overall Study|Lost to Follow-up|2
915976|NCT00827112|1894702|FG000|Overall Study|Pregnancy|0
915977|NCT00827112|1894703|FG001|Overall Study|Pregnancy|1
915978|NCT00827112|1894702|FG000|Overall Study|Protocol Violation|0
915979|NCT00827112|1894703|FG001|Overall Study|Protocol Violation|2
915980|NCT00827112|1894702|FG000|Overall Study|Withdrawal by Subject|2
915981|NCT00827112|1894703|FG001|Overall Study|Withdrawal by Subject|1
915982|NCT00827112|1894702|FG000|Overall Study|Randomized but not treated|5
915983|NCT00827112|1894703|FG001|Overall Study|Randomized but not treated|3
915984|NCT00827112|1894702|FG000|Overall Study|Other|1
915985|NCT00827112|1894703|FG001|Overall Study|Other|3
915986|NCT00827242|1894711|FG000|Overall Study|Withdrawal by Subject|2
915987|NCT00827242|1894712|FG001|Overall Study|Withdrawal by Subject|4
915988|NCT00827242|1894711|FG000|Overall Study|Protocol Violation|1
915989|NCT00827242|1894712|FG001|Overall Study|Protocol Violation|3
915990|NCT00827242|1894711|FG000|Overall Study|Lost to Follow-up|0
915991|NCT00827242|1894712|FG001|Overall Study|Lost to Follow-up|3
915992|NCT00827242|1894711|FG000|Overall Study|Adverse Event Excluding Death|2
915993|NCT00827242|1894712|FG001|Overall Study|Adverse Event Excluding Death|1
915994|NCT00827242|1894711|FG000|Overall Study|Entry Criteria Not Met|4
915995|NCT00827242|1894712|FG001|Overall Study|Entry Criteria Not Met|1
915996|NCT00827242|1894711|FG000|Overall Study|Physician Decision|2
915997|NCT00827242|1894712|FG001|Overall Study|Physician Decision|0
915998|NCT00827242|1894711|FG000|Overall Study|Death|1
915999|NCT00827242|1894712|FG001|Overall Study|Death|0
916000|NCT00827242|1894711|FG000|Overall Study|Lack of Efficacy|1
916001|NCT00827242|1894712|FG001|Overall Study|Lack of Efficacy|0
916002|NCT00827359|1894722|FG000|Overall Study|Progressive Diseas|19
916003|NCT00827359|1894722|FG000|Overall Study|Unacceptable Toxicity|5
916004|NCT00827359|1894722|FG000|Overall Study|Ineligible|1
916005|NCT00827372|1894726|FG000|Overall Study|Adverse Event|5
916006|NCT00827372|1894726|FG000|Overall Study|Lack of Efficacy|3
916007|NCT00827502|1894731|FG000|Overall Study|randomized but not treated|11
916008|NCT00827502|1894731|FG000|Overall Study|Adverse Event|1
916009|NCT00827502|1894731|FG000|Overall Study|Lost to Follow-up|4
916010|NCT00827502|1894731|FG000|Overall Study|Withdrawal by Subject|5
916011|NCT00827541|1894737|FG000|Overall Study|Exitus|1
916012|NCT00827541|1894738|FG001|Overall Study|Exitus|8
916013|NCT00827541|1894737|FG000|Overall Study|Other|1
916014|NCT00827541|1894738|FG001|Overall Study|Other|3
916015|NCT00827541|1894737|FG000|Overall Study|Pathogen not susceptible|1
916016|NCT00827541|1894738|FG001|Overall Study|Pathogen not susceptible|0
916017|NCT00827541|1894737|FG000|Overall Study|Lack of effectiveness|1
916018|NCT00827541|1894738|FG001|Overall Study|Lack of effectiveness|0
916019|NCT00827606|1894746|FG000|Overall Study|Protocol Violation|4
916020|NCT00827606|1894747|FG001|Overall Study|Protocol Violation|3
916021|NCT00827606|1894746|FG000|Overall Study|Lost to Follow-up|3
916022|NCT00827606|1894747|FG001|Overall Study|Lost to Follow-up|1
916023|NCT00827606|1894746|FG000|Overall Study|Withdrawal by Subject|7
916024|NCT00827606|1894747|FG001|Overall Study|Withdrawal by Subject|6
916025|NCT00827606|1894746|FG000|Overall Study|Pregnancy|0
916026|NCT00827606|1894747|FG001|Overall Study|Pregnancy|1
916027|NCT00827606|1894746|FG000|Overall Study|Other|5
916028|NCT00827606|1894747|FG001|Overall Study|Other|13
916029|NCT00827606|1894746|FG000|Overall Study|LDL below 2.59 mmol/L|4
916030|NCT00827606|1894747|FG001|Overall Study|LDL below 2.59 mmol/L|12
916031|NCT00827606|1894746|FG000|Overall Study|Adverse Event|4
916032|NCT00827606|1894747|FG001|Overall Study|Adverse Event|2
916033|NCT00827632|1894761|FG000|Overall Study|Lost to Follow-up|8
916034|NCT00827632|1894762|FG001|Overall Study|Lost to Follow-up|12
916035|NCT00827632|1894761|FG000|Overall Study|Early withdrawal|14
916036|NCT00827632|1894762|FG001|Overall Study|Early withdrawal|11
916037|NCT00827775|1894770|FG000|Overall Study|Withdrawal by Subject|0
916038|NCT00827775|1894771|FG001|Overall Study|Withdrawal by Subject|5
916039|NCT00827827|1894779|FG000|Overall Study|Lost to Follow-up|3
916040|NCT00827827|1894780|FG001|Overall Study|Lost to Follow-up|0
916041|NCT00827827|1894779|FG000|Overall Study|Fall at home- hospitalization|1
916042|NCT00827827|1894780|FG001|Overall Study|Fall at home- hospitalization|0
916043|NCT00827827|1894779|FG000|Overall Study|Another cerebrovascular accident (CVA)|1
916044|NCT00827827|1894780|FG001|Overall Study|Another cerebrovascular accident (CVA)|0
916045|NCT00827827|1894779|FG000|Overall Study|Gout|1
916046|NCT00827827|1894780|FG001|Overall Study|Gout|0
916047|NCT00827827|1894779|FG000|Overall Study|Transportation issues|1
916048|NCT00827827|1894780|FG001|Overall Study|Transportation issues|0
916049|NCT00827827|1894779|FG000|Overall Study|Burned with water at home|1
916050|NCT00827827|1894780|FG001|Overall Study|Burned with water at home|0
916051|NCT00827918|1894790|FG000|Overall Study|Adverse Event|4
916052|NCT00827918|1894791|FG001|Overall Study|Adverse Event|0
916053|NCT00827918|1894792|FG002|Overall Study|Adverse Event|0
916054|NCT00827918|1894790|FG000|Overall Study|Lack of Efficacy|16
916055|NCT00827918|1894791|FG001|Overall Study|Lack of Efficacy|4
916056|NCT00827918|1894792|FG002|Overall Study|Lack of Efficacy|15
916057|NCT00827918|1894790|FG000|Overall Study|Physician Decision|1
916058|NCT00827918|1894791|FG001|Overall Study|Physician Decision|0
916059|NCT00827918|1894792|FG002|Overall Study|Physician Decision|0
916060|NCT00827918|1894790|FG000|Overall Study|Pregnancy|0
916061|NCT00827918|1894791|FG001|Overall Study|Pregnancy|1
916062|NCT00827918|1894792|FG002|Overall Study|Pregnancy|0
916063|NCT00827918|1894790|FG000|Overall Study|Progressive Disease|1
916064|NCT00827918|1894791|FG001|Overall Study|Progressive Disease|1
916065|NCT00827918|1894792|FG002|Overall Study|Progressive Disease|0
916066|NCT00827918|1894790|FG000|Overall Study|Protocol Violation|0
916067|NCT00827918|1894791|FG001|Overall Study|Protocol Violation|1
916068|NCT00827918|1894792|FG002|Overall Study|Protocol Violation|0
916069|NCT00827918|1894790|FG000|Overall Study|Withdrawal by Subject|6
916070|NCT00827918|1894791|FG001|Overall Study|Withdrawal by Subject|2
916071|NCT00827918|1894792|FG002|Overall Study|Withdrawal by Subject|6
916072|NCT00827931|1894802|FG000|Overall Study|Death|3
916073|NCT00827931|1894803|FG001|Overall Study|Death|5
916074|NCT00827931|1894802|FG000|Overall Study|Adverse Event|1
916075|NCT00827931|1894803|FG001|Overall Study|Adverse Event|0
916076|NCT00827931|1894802|FG000|Overall Study|Lost to Follow-up|1
916077|NCT00827931|1894803|FG001|Overall Study|Lost to Follow-up|0
916078|NCT00827931|1894802|FG000|Overall Study|Withdrawal by Subject|0
916079|NCT00827931|1894803|FG001|Overall Study|Withdrawal by Subject|1
916080|NCT00827931|1894802|FG000|Overall Study|Other|1
916081|NCT00827931|1894803|FG001|Overall Study|Other|0
916082|NCT00828009|1894827|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
916083|NCT00828009|1894827|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2
916084|NCT00828009|1894827|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
916085|NCT00828009|1894827|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
916086|NCT00828009|1894827|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
916087|NCT00828009|1894827|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
916088|NCT00828009|1894827|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
916089|NCT00828009|1894827|FG000|Step 2 - Maintenance Therapy|Progressive disease|12
916090|NCT00828009|1894827|FG000|Step 2 - Maintenance Therapy|Adverse Event|13
916091|NCT00828009|1894827|FG000|Step 2 - Maintenance Therapy|Death|1
916092|NCT00828009|1894827|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
916093|NCT00828009|1894827|FG000|Step 2 - Maintenance Therapy|Complicating disease|2
916094|NCT00828009|1894827|FG000|Step 2 - Maintenance Therapy|Other|1
916095|NCT00828113|1894861|FG000|Overall Study|Withdrawal by Subject|27
916096|NCT00828113|1894862|FG001|Overall Study|Withdrawal by Subject|26
916097|NCT00828113|1894861|FG000|Overall Study|Lost to Follow-up|3
916098|NCT00828113|1894862|FG001|Overall Study|Lost to Follow-up|5
916099|NCT00828139|1894872|FG000|Overall Study|Adverse Event|8
916100|NCT00828139|1894873|FG001|Overall Study|Adverse Event|1
916101|NCT00828139|1894874|FG002|Overall Study|Adverse Event|10
916102|NCT00828139|1894875|FG003|Overall Study|Adverse Event|5
916103|NCT00828139|1894872|FG000|Overall Study|Death|2
916104|NCT00828139|1894873|FG001|Overall Study|Death|1
916105|NCT00828139|1894874|FG002|Overall Study|Death|0
916106|NCT00828139|1894875|FG003|Overall Study|Death|2
916107|NCT00828139|1894872|FG000|Overall Study|Refusal unrelated to toxicity|3
916108|NCT00828139|1894873|FG001|Overall Study|Refusal unrelated to toxicity|4
916109|NCT00828139|1894874|FG002|Overall Study|Refusal unrelated to toxicity|5
916110|NCT00828139|1894875|FG003|Overall Study|Refusal unrelated to toxicity|3
916111|NCT00828139|1894872|FG000|Overall Study|Disease Progression|24
916112|NCT00828139|1894873|FG001|Overall Study|Disease Progression|33
916113|NCT00828139|1894874|FG002|Overall Study|Disease Progression|35
916114|NCT00828139|1894875|FG003|Overall Study|Disease Progression|39
916115|NCT00828139|1894872|FG000|Overall Study|Other|4
916116|NCT00828139|1894873|FG001|Overall Study|Other|2
916117|NCT00828139|1894874|FG002|Overall Study|Other|5
916118|NCT00828139|1894875|FG003|Overall Study|Other|2
916119|NCT00828204|1894907|FG000|Main Study: Prior to Study Suspension|Adverse Event|1
916120|NCT00828204|1894908|FG001|Main Study: Prior to Study Suspension|Adverse Event|0
916121|NCT00828204|1894907|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
916122|NCT00828204|1894908|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
916123|NCT00828204|1894907|FG000|Main Study: Prior to Study Suspension|Study Suspension|11
916124|NCT00828204|1894908|FG001|Main Study: Prior to Study Suspension|Study Suspension|0
916125|NCT00828204|1894907|FG000|Main Study: After Study Restart|Adverse Event|0
916126|NCT00828204|1894908|FG001|Main Study: After Study Restart|Adverse Event|2
916127|NCT00828204|1894907|FG000|Main Study: After Study Restart|Noncompliance|0
916128|NCT00828204|1894908|FG001|Main Study: After Study Restart|Noncompliance|1
916129|NCT00828204|1894907|FG000|Extension Study|Lost to Follow-up|0
916130|NCT00828204|1894908|FG001|Extension Study|Lost to Follow-up|1
916131|NCT00828204|1894907|FG000|Extension Study|Physician Decision|0
916132|NCT00828204|1894908|FG001|Extension Study|Physician Decision|2
916133|NCT00828321|1894930|FG000|Washout of 42 Days|Withdrawal by Subject|2
916134|NCT00828321|1894931|FG001|Washout of 42 Days|Withdrawal by Subject|0
916135|NCT00828321|1894930|FG000|Second Intervention|Protocol Violation|0
916136|NCT00828321|1894931|FG001|Second Intervention|Protocol Violation|1
916137|NCT00828451|1894953|FG000|Overall Study|Death|2
916138|NCT00828451|1894953|FG000|Overall Study|Lack of intravenous line|7
916139|NCT00828451|1894953|FG000|Overall Study|Withdrawal by Subject|1
916140|NCT00828451|1894953|FG000|Overall Study|Deterioration in clinical status|1
916141|NCT00828464|1894957|FG000|Overall Study|Withdrawal by Subject|1
916142|NCT00828516|1894961|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2
916143|NCT00828568|1894977|FG000|Randomized|Withdrawal by Subject|1
916144|NCT00828568|1894978|FG001|Randomized|Withdrawal by Subject|0
916145|NCT00828568|1894979|FG002|Randomized|Withdrawal by Subject|2
916146|NCT00828568|1894977|FG000|Treated - Received at Least One Dose|Adverse Event|11
916147|NCT00828568|1894978|FG001|Treated - Received at Least One Dose|Adverse Event|8
916148|NCT00828568|1894979|FG002|Treated - Received at Least One Dose|Adverse Event|1
916149|NCT00828568|1894977|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9
916150|NCT00828568|1894978|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11
916151|NCT00828568|1894979|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0
916152|NCT00828568|1894977|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1
916153|NCT00828568|1894978|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5
916154|NCT00828568|1894979|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1
916155|NCT00828568|1894977|FG000|Treated - Received at Least One Dose|Protocol Violation|9
916156|NCT00828568|1894978|FG001|Treated - Received at Least One Dose|Protocol Violation|5
916157|NCT00828568|1894979|FG002|Treated - Received at Least One Dose|Protocol Violation|3
916158|NCT00828672|1894990|FG000|Study Treatment|Lost to Follow-up|1
916159|NCT00828672|1894991|FG001|Study Treatment|Lost to Follow-up|0
916160|NCT00828672|1894990|FG000|Study Treatment|Adverse Event|0
916161|NCT00828672|1894991|FG001|Study Treatment|Adverse Event|1
916162|NCT00828672|1894990|FG000|Study Treatment|Complete response, no surgery|1
916163|NCT00828672|1894991|FG001|Study Treatment|Complete response, no surgery|1
916164|NCT00828672|1894990|FG000|Post-surgery (<30 Days)|No central review materials|0
916165|NCT00828672|1894991|FG001|Post-surgery (<30 Days)|No central review materials|1
916166|NCT00828711|1895000|FG000|Overall Study|Lost to Follow-up|1
916167|NCT00828711|1895001|FG001|Overall Study|Lost to Follow-up|0
916168|NCT00828711|1895002|FG002|Overall Study|Lost to Follow-up|0
916169|NCT00828750|1895010|FG000|Overall Study|Lack of Efficacy|3
916170|NCT00828750|1895010|FG000|Overall Study|Normal PC Remained While No Treatment|1
916171|NCT00828945|1895030|FG000|Overall Study|Death|4
916172|NCT00828945|1895030|FG000|Overall Study|Participant was missing|1
916173|NCT00828945|1895030|FG000|Overall Study|Other|36
916174|NCT00828984|1895037|FG000|Overall Study|Adverse Event|2
916175|NCT00828984|1895038|FG001|Overall Study|Adverse Event|3
916176|NCT00828984|1895039|FG002|Overall Study|Adverse Event|0
916177|NCT00828984|1895037|FG000|Overall Study|Lost to Follow-up|5
916178|NCT00828984|1895038|FG001|Overall Study|Lost to Follow-up|3
916179|NCT00828984|1895039|FG002|Overall Study|Lost to Follow-up|1
916180|NCT00828984|1895037|FG000|Overall Study|Withdrawal by Subject|4
916181|NCT00828984|1895038|FG001|Overall Study|Withdrawal by Subject|4
916182|NCT00828984|1895039|FG002|Overall Study|Withdrawal by Subject|4
916183|NCT00828984|1895037|FG000|Overall Study|Ineligable|1
916184|NCT00828984|1895038|FG001|Overall Study|Ineligable|2
916185|NCT00828984|1895039|FG002|Overall Study|Ineligable|0
916186|NCT00828984|1895037|FG000|Overall Study|Medical Contraindication|0
916187|NCT00828984|1895038|FG001|Overall Study|Medical Contraindication|1
916188|NCT00828984|1895039|FG002|Overall Study|Medical Contraindication|0
916189|NCT00828984|1895037|FG000|Overall Study|Noncompliant|1
916190|NCT00828984|1895038|FG001|Overall Study|Noncompliant|2
916191|NCT00828984|1895039|FG002|Overall Study|Noncompliant|3
916192|NCT00828984|1895037|FG000|Overall Study|ConMed|1
916193|NCT00828984|1895038|FG001|Overall Study|ConMed|1
916194|NCT00828984|1895039|FG002|Overall Study|ConMed|1
916195|NCT00829010|1895052|FG000|Overall Study|Adverse Event|1
916196|NCT00829010|1895053|FG001|Overall Study|Adverse Event|0
916197|NCT00829010|1895054|FG002|Overall Study|Adverse Event|0
916198|NCT00829010|1895055|FG003|Overall Study|Adverse Event|0
916199|NCT00829010|1895056|FG004|Overall Study|Adverse Event|0
916200|NCT00829010|1895052|FG000|Overall Study|Withdrawal by Subject|0
916201|NCT00829010|1895053|FG001|Overall Study|Withdrawal by Subject|1
916202|NCT00829010|1895054|FG002|Overall Study|Withdrawal by Subject|1
916203|NCT00829010|1895055|FG003|Overall Study|Withdrawal by Subject|0
916204|NCT00829010|1895056|FG004|Overall Study|Withdrawal by Subject|2
916205|NCT00829010|1895052|FG000|Overall Study|Lost to Follow-up|1
916206|NCT00829010|1895053|FG001|Overall Study|Lost to Follow-up|0
916207|NCT00829010|1895054|FG002|Overall Study|Lost to Follow-up|2
916208|NCT00829010|1895055|FG003|Overall Study|Lost to Follow-up|0
916209|NCT00829010|1895056|FG004|Overall Study|Lost to Follow-up|0
916210|NCT00829010|1895052|FG000|Overall Study|Fatality|5
916211|NCT00829010|1895053|FG001|Overall Study|Fatality|4
916212|NCT00829010|1895054|FG002|Overall Study|Fatality|0
916213|NCT00829010|1895055|FG003|Overall Study|Fatality|3
916214|NCT00829010|1895056|FG004|Overall Study|Fatality|0
916215|NCT00829010|1895052|FG000|Overall Study|Migrated/Moved from study area|3
916216|NCT00829010|1895053|FG001|Overall Study|Migrated/Moved from study area|4
916217|NCT00829010|1895054|FG002|Overall Study|Migrated/Moved from study area|0
916218|NCT00829010|1895055|FG003|Overall Study|Migrated/Moved from study area|5
916219|NCT00829010|1895056|FG004|Overall Study|Migrated/Moved from study area|0
916220|NCT00829166|1895083|FG000|Overall Study|Death|305
916221|NCT00829166|1895084|FG001|Overall Study|Death|333
916222|NCT00829166|1895083|FG000|Overall Study|Lost to Follow-up|5
916223|NCT00829166|1895084|FG001|Overall Study|Lost to Follow-up|4
916224|NCT00829166|1895083|FG000|Overall Study|Physician's Decision|4
916225|NCT00829166|1895084|FG001|Overall Study|Physician's Decision|3
916226|NCT00829166|1895083|FG000|Overall Study|Subject's Decision|41
916227|NCT00829166|1895084|FG001|Overall Study|Subject's Decision|55
916228|NCT00829166|1895083|FG000|Overall Study|Sponsor's Decision|137
916229|NCT00829166|1895084|FG001|Overall Study|Sponsor's Decision|98
916230|NCT00829166|1895083|FG000|Overall Study|Reason Not Specified|3
916231|NCT00829166|1895084|FG001|Overall Study|Reason Not Specified|3
916232|NCT00829179|1895091|FG000|Overall Study|Withdrawal by Subject|1
916233|NCT00829244|1895097|FG000|Overall Study|Adverse Event|1
916234|NCT00829244|1895098|FG001|Overall Study|Adverse Event|3
916235|NCT00829244|1895097|FG000|Overall Study|Protocol Violation|1
916236|NCT00829244|1895098|FG001|Overall Study|Protocol Violation|0
916237|NCT00829244|1895097|FG000|Overall Study|Lack of ovarian response to stimulation|9
916238|NCT00829244|1895098|FG001|Overall Study|Lack of ovarian response to stimulation|5
916239|NCT00829244|1895097|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
916240|NCT00829244|1895098|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
916241|NCT00829244|1895097|FG000|Overall Study|No fertilization|2
916242|NCT00829244|1895098|FG001|Overall Study|No fertilization|2
916243|NCT00829244|1895097|FG000|Overall Study|All embryos discarded|0
916244|NCT00829244|1895098|FG001|Overall Study|All embryos discarded|3
916245|NCT00829244|1895097|FG000|Overall Study|No embryo cleavage|0
916246|NCT00829244|1895098|FG001|Overall Study|No embryo cleavage|2
916247|NCT00829283|1895106|FG000|Overall Study|Lost to Follow-up|7
916248|NCT00829283|1895107|FG001|Overall Study|Lost to Follow-up|25
916249|NCT00829296|1895115|FG000|Overall Study|Adverse Event|5
916250|NCT00829296|1895116|FG001|Overall Study|Adverse Event|4
916251|NCT00829309|1895124|FG000|Washout: 7 Days|Protocol Violation|1
916252|NCT00829309|1895125|FG001|Washout: 7 Days|Protocol Violation|0
916253|NCT00829387|1895131|FG000|Overall Study|Withdrawal by Subject|2
916254|NCT00829387|1895132|FG001|Overall Study|Withdrawal by Subject|3
916255|NCT00829387|1895131|FG000|Overall Study|Disqualified by PI|1
916256|NCT00829387|1895132|FG001|Overall Study|Disqualified by PI|0
916257|NCT00829413|1895138|FG000|Overall Study|No study drug admimnistered|13
916258|NCT00829413|1895138|FG000|Overall Study|Training Patients|67
916259|NCT00829413|1895138|FG000|Overall Study|No truth standard procedure available|9
916260|NCT00829413|1895138|FG000|Overall Study|Technically inadequate truth standard|2
916261|NCT00829413|1895138|FG000|Overall Study|Indeterminate diagnosis from truth stand|3
916262|NCT00829426|1895151|FG000|Washout: 7 Days|Withdrawal by Subject|1
916263|NCT00829426|1895152|FG001|Washout: 7 Days|Withdrawal by Subject|0
916264|NCT00829439|1895156|FG000|Overall Study|Adverse Event|0
916265|NCT00829439|1895157|FG001|Overall Study|Adverse Event|0
916266|NCT00829439|1895158|FG002|Overall Study|Adverse Event|1
916267|NCT00829439|1895159|FG003|Overall Study|Adverse Event|0
916268|NCT00829452|1895165|FG000|First Intervention|Withdrawal by Subject|0
916269|NCT00829452|1895166|FG001|First Intervention|Withdrawal by Subject|1
916270|NCT00829452|1895165|FG000|Washout of 42 Days|Withdrawal by Subject|0
916271|NCT00829452|1895166|FG001|Washout of 42 Days|Withdrawal by Subject|1
916272|NCT00829452|1895165|FG000|Second Intervention|Physician Decision|0
916273|NCT00829452|1895166|FG001|Second Intervention|Physician Decision|1
916274|NCT00829504|1895172|FG000|First Intervention|Adverse Event|1
916275|NCT00829504|1895173|FG001|First Intervention|Adverse Event|0
916276|NCT00829504|1895172|FG000|Washout of 7 Days|Withdrawal by Subject|1
916277|NCT00829504|1895173|FG001|Washout of 7 Days|Withdrawal by Subject|0
916278|NCT00829504|1895172|FG000|Second Intervention|Physician Decision|1
916279|NCT00829504|1895173|FG001|Second Intervention|Physician Decision|0
916280|NCT00829530|1895179|FG000|First Intervention|Adverse Event|0
916281|NCT00829530|1895180|FG001|First Intervention|Adverse Event|1
916282|NCT00829530|1895179|FG000|First Intervention|Intolerance to Venopuncture|0
916283|NCT00829530|1895180|FG001|First Intervention|Intolerance to Venopuncture|1
916284|NCT00829530|1895179|FG000|Second Intervention|Intolerance to Venopuncture|1
916285|NCT00829530|1895180|FG001|Second Intervention|Intolerance to Venopuncture|0
916286|NCT00829621|1895186|FG000|Overall Study|Death|1
916287|NCT00829621|1895187|FG001|Overall Study|Death|0
916288|NCT00829621|1895186|FG000|Overall Study|Lost to Follow-up|3
916289|NCT00829621|1895187|FG001|Overall Study|Lost to Follow-up|4
916290|NCT00829673|1895195|FG000|Washout of 7 Days|Withdrawal by Subject|1
916291|NCT00829673|1895196|FG001|Washout of 7 Days|Withdrawal by Subject|0
916292|NCT00829712|1895209|FG000|Washout of 7 Days|Withdrawal by Subject|0
916293|NCT00829712|1895210|FG001|Washout of 7 Days|Withdrawal by Subject|1
916294|NCT00829764|1895221|FG000|First Intervention|Adverse Event|1
916295|NCT00829764|1895222|FG001|First Intervention|Adverse Event|0
916296|NCT00829764|1895221|FG000|First Intervention|Withdrawal by Subject|1
916297|NCT00829764|1895222|FG001|First Intervention|Withdrawal by Subject|1
916298|NCT00829790|1895228|FG000|Washout of 14 Days|Withdrawal by Subject|0
916299|NCT00829790|1895229|FG001|Washout of 14 Days|Withdrawal by Subject|1
916300|NCT00829829|1895236|FG000|Overall Study|Protocol Violation|0
916301|NCT00829829|1895237|FG001|Overall Study|Protocol Violation|3
916302|NCT00829829|1895238|FG002|Overall Study|Protocol Violation|0
916303|NCT00829829|1895236|FG000|Overall Study|Adverse Event|4
916304|NCT00829829|1895237|FG001|Overall Study|Adverse Event|4
916305|NCT00829829|1895238|FG002|Overall Study|Adverse Event|3
916306|NCT00829829|1895236|FG000|Overall Study|Withdrawal by Subject|8
916307|NCT00829829|1895237|FG001|Overall Study|Withdrawal by Subject|4
916308|NCT00829829|1895238|FG002|Overall Study|Withdrawal by Subject|2
916309|NCT00829829|1895236|FG000|Overall Study|Decision by the Sponsor|1
916310|NCT00829829|1895237|FG001|Overall Study|Decision by the Sponsor|0
916311|NCT00829829|1895238|FG002|Overall Study|Decision by the Sponsor|2
916312|NCT00829829|1895236|FG000|Overall Study|Lost to Follow-up|7
916313|NCT00829829|1895237|FG001|Overall Study|Lost to Follow-up|3
916314|NCT00829829|1895238|FG002|Overall Study|Lost to Follow-up|3
916315|NCT00829829|1895236|FG000|Overall Study|Other than specified above|2
916316|NCT00829829|1895237|FG001|Overall Study|Other than specified above|2
916317|NCT00829829|1895238|FG002|Overall Study|Other than specified above|1
916318|NCT00829868|1895249|FG000|Washout|Physician Decision|1
916319|NCT00829868|1895250|FG001|Washout|Physician Decision|0
916320|NCT00829933|1895258|FG000|Overall Study|Adverse Event|2
916321|NCT00829933|1895259|FG001|Overall Study|Adverse Event|3
916322|NCT00829933|1895260|FG002|Overall Study|Adverse Event|2
916323|NCT00829933|1895261|FG003|Overall Study|Adverse Event|1
916324|NCT00829933|1895258|FG000|Overall Study|Death|0
916325|NCT00829933|1895259|FG001|Overall Study|Death|0
916326|NCT00829933|1895260|FG002|Overall Study|Death|1
916327|NCT00829933|1895261|FG003|Overall Study|Death|1
916328|NCT00829933|1895258|FG000|Overall Study|Lack of Efficacy|0
916329|NCT00829933|1895259|FG001|Overall Study|Lack of Efficacy|1
916330|NCT00829933|1895260|FG002|Overall Study|Lack of Efficacy|0
916331|NCT00829933|1895261|FG003|Overall Study|Lack of Efficacy|0
916332|NCT00829933|1895258|FG000|Overall Study|Physician Decision|5
916333|NCT00829933|1895259|FG001|Overall Study|Physician Decision|7
916334|NCT00829933|1895260|FG002|Overall Study|Physician Decision|8
916335|NCT00829933|1895261|FG003|Overall Study|Physician Decision|1
916336|NCT00829933|1895258|FG000|Overall Study|Pregnancy|0
916337|NCT00829933|1895259|FG001|Overall Study|Pregnancy|0
916338|NCT00829933|1895260|FG002|Overall Study|Pregnancy|0
916339|NCT00829933|1895261|FG003|Overall Study|Pregnancy|2
916340|NCT00829933|1895258|FG000|Overall Study|Protocol Violation|2
916341|NCT00829933|1895259|FG001|Overall Study|Protocol Violation|1
916342|NCT00829933|1895260|FG002|Overall Study|Protocol Violation|0
916343|NCT00829933|1895261|FG003|Overall Study|Protocol Violation|0
916344|NCT00829933|1895258|FG000|Overall Study|withdrew before treatment started|5
916345|NCT00829933|1895259|FG001|Overall Study|withdrew before treatment started|1
916346|NCT00829933|1895260|FG002|Overall Study|withdrew before treatment started|2
916347|NCT00829933|1895261|FG003|Overall Study|withdrew before treatment started|9
916348|NCT00829998|1895282|FG000|Washout|Adverse Event|0
916349|NCT00829998|1895283|FG001|Washout|Adverse Event|1
916350|NCT00830024|1895289|FG000|Washout: 7 Days|Withdrawal by Subject|1
916351|NCT00830024|1895290|FG001|Washout: 7 Days|Withdrawal by Subject|0
916352|NCT00830037|1895296|FG000|Overall Study|Withdrawal by Subject|2
916353|NCT00830037|1895297|FG001|Overall Study|Withdrawal by Subject|3
916354|NCT00830037|1895296|FG000|Overall Study|Lost to Follow-up|1
916355|NCT00830037|1895297|FG001|Overall Study|Lost to Follow-up|2
916356|NCT00830037|1895296|FG000|Overall Study|Active when terminated by DSMB|15
916357|NCT00830037|1895297|FG001|Overall Study|Active when terminated by DSMB|14
916358|NCT00830063|1895307|FG000|Overall Study|Adverse Event|7
916359|NCT00830063|1895308|FG001|Overall Study|Adverse Event|13
916360|NCT00830063|1895309|FG002|Overall Study|Adverse Event|16
916361|NCT00830063|1895310|FG003|Overall Study|Adverse Event|13
916362|NCT00830063|1895307|FG000|Overall Study|Death|1
916363|NCT00830063|1895308|FG001|Overall Study|Death|0
916364|NCT00830063|1895309|FG002|Overall Study|Death|0
916365|NCT00830063|1895310|FG003|Overall Study|Death|0
916366|NCT00830063|1895307|FG000|Overall Study|Lost to Follow-up|0
916367|NCT00830063|1895308|FG001|Overall Study|Lost to Follow-up|0
916368|NCT00830063|1895309|FG002|Overall Study|Lost to Follow-up|3
916369|NCT00830063|1895310|FG003|Overall Study|Lost to Follow-up|1
916370|NCT00830063|1895307|FG000|Overall Study|Preferred Time Entry in Extension Study|119
916371|NCT00830063|1895308|FG001|Overall Study|Preferred Time Entry in Extension Study|139
916372|NCT00830063|1895309|FG002|Overall Study|Preferred Time Entry in Extension Study|127
916373|NCT00830063|1895310|FG003|Overall Study|Preferred Time Entry in Extension Study|126
916374|NCT00830063|1895307|FG000|Overall Study|Lack of Efficacy|51
916375|NCT00830063|1895308|FG001|Overall Study|Lack of Efficacy|23
916376|NCT00830063|1895309|FG002|Overall Study|Lack of Efficacy|25
916377|NCT00830063|1895310|FG003|Overall Study|Lack of Efficacy|32
916378|NCT00830063|1895307|FG000|Overall Study|Other|5
916379|NCT00830063|1895308|FG001|Overall Study|Other|5
916380|NCT00830063|1895309|FG002|Overall Study|Other|8
916381|NCT00830063|1895310|FG003|Overall Study|Other|6
916382|NCT00830063|1895307|FG000|Overall Study|Withdrawal by Subject|16
916383|NCT00830063|1895308|FG001|Overall Study|Withdrawal by Subject|10
916384|NCT00830063|1895309|FG002|Overall Study|Withdrawal by Subject|16
916385|NCT00830063|1895310|FG003|Overall Study|Withdrawal by Subject|13
916386|NCT00830063|1895307|FG000|Overall Study|Protocol Violation|1
916387|NCT00830063|1895308|FG001|Overall Study|Protocol Violation|0
916388|NCT00830063|1895309|FG002|Overall Study|Protocol Violation|3
916389|NCT00830063|1895310|FG003|Overall Study|Protocol Violation|2
916390|NCT00830063|1895307|FG000|Overall Study|Randomized But Not Treated|0
916391|NCT00830063|1895308|FG001|Overall Study|Randomized But Not Treated|2
916392|NCT00830063|1895309|FG002|Overall Study|Randomized But Not Treated|0
916393|NCT00830063|1895310|FG003|Overall Study|Randomized But Not Treated|2
916394|NCT00830115|1895329|FG000|Overall Study|Adverse Event|2
916395|NCT00830115|1895329|FG000|Overall Study|Improvement/recovery|1
916396|NCT00830128|1895335|FG000|Overall Study|Adverse Event|5
916397|NCT00830128|1895335|FG000|Overall Study|Lack of Efficacy|7
916398|NCT00830128|1895335|FG000|Overall Study|Protocol Violation|1
916399|NCT00830128|1895335|FG000|Overall Study|Withdrawal by Subject|2
916400|NCT00830128|1895335|FG000|Overall Study|Family obligation|1
916401|NCT00830128|1895335|FG000|Overall Study|Relocation|1
916402|NCT00830128|1895335|FG000|Overall Study|Work obligation|1
916403|NCT00830128|1895335|FG000|Overall Study|Operating a vehicle|1
916404|NCT00830167|1895341|FG000|Overall Study|Lack of Efficacy|26
916405|NCT00830167|1895342|FG001|Overall Study|Lack of Efficacy|10
916406|NCT00830167|1895341|FG000|Overall Study|Adverse Event|8
916407|NCT00830167|1895342|FG001|Overall Study|Adverse Event|24
916408|NCT00830167|1895341|FG000|Overall Study|Not meeting entrance criteria|2
916409|NCT00830167|1895342|FG001|Overall Study|Not meeting entrance criteria|5
916410|NCT00830167|1895341|FG000|Overall Study|Withdrawal by Subject|2
916411|NCT00830167|1895342|FG001|Overall Study|Withdrawal by Subject|0
916412|NCT00830167|1895341|FG000|Overall Study|Lost to Follow-up|0
916413|NCT00830167|1895342|FG001|Overall Study|Lost to Follow-up|1
916414|NCT00830167|1895341|FG000|Overall Study|Protocol Violation|0
916415|NCT00830167|1895342|FG001|Overall Study|Protocol Violation|1
916416|NCT00830167|1895341|FG000|Overall Study|Other|2
916417|NCT00830167|1895342|FG001|Overall Study|Other|2
916418|NCT00830180|1895348|FG000|Overall Study|Adverse Event|6
916419|NCT00830180|1895348|FG000|Overall Study|Death|11
916420|NCT00830180|1895348|FG000|Overall Study|Insufficient clinical response|1
916421|NCT00830180|1895348|FG000|Overall Study|Withdrawal by Subject|5
916422|NCT00830180|1895348|FG000|Overall Study|Progressive disease|2
916423|NCT00830180|1895348|FG000|Overall Study|Other - Unspecified|1
916424|NCT00830206|1895356|FG000|Washout: 21 Days|Withdrawal by Subject|1
916425|NCT00830206|1895357|FG001|Washout: 21 Days|Withdrawal by Subject|1
916426|NCT00830219|1895363|FG000|Washout of 7 Days|Withdrawal by Subject|1
916427|NCT00830219|1895364|FG001|Washout of 7 Days|Withdrawal by Subject|1
916428|NCT00830258|1895379|FG000|First Intervention|Adverse Event|1
916429|NCT00830258|1895380|FG001|First Intervention|Adverse Event|0
916430|NCT00830258|1895379|FG000|Washout: 7 Days|Protocol Violation|1
916431|NCT00830258|1895380|FG001|Washout: 7 Days|Protocol Violation|0
916432|NCT00830336|1895394|FG000|Washout: 21 Days|Withdrawal by Subject|1
916433|NCT00830336|1895395|FG001|Washout: 21 Days|Withdrawal by Subject|0
916434|NCT00830375|1895408|FG000|Overall Study|Lost to Follow-up|1
916435|NCT00830440|1895418|FG000|Overall Study|Protocol Violation|1
916436|NCT00830440|1895419|FG001|Overall Study|Protocol Violation|0
916437|NCT00830440|1895418|FG000|Overall Study|Withdrawal by Subject|1
916438|NCT00830440|1895419|FG001|Overall Study|Withdrawal by Subject|0
916439|NCT00830440|1895418|FG000|Overall Study|unsuccessful procedure|4
916440|NCT00830440|1895419|FG001|Overall Study|unsuccessful procedure|0
916441|NCT00830440|1895418|FG000|Overall Study|Adverse Event|2
916442|NCT00830440|1895419|FG001|Overall Study|Adverse Event|0
916443|NCT00830518|1895428|FG000|Overall Study|Progressive Disease|18
916444|NCT00830518|1895429|FG001|Overall Study|Progressive Disease|8
916445|NCT00830518|1895428|FG000|Overall Study|Symptomatic Deterioration|4
916446|NCT00830518|1895429|FG001|Overall Study|Symptomatic Deterioration|1
916447|NCT00830518|1895428|FG000|Overall Study|Adverse Event|14
916448|NCT00830518|1895429|FG001|Overall Study|Adverse Event|1
916449|NCT00830518|1895428|FG000|Overall Study|Withdrawal by Patient|2
916450|NCT00830518|1895429|FG001|Overall Study|Withdrawal by Patient|0
916451|NCT00830518|1895428|FG000|Overall Study|Reason not Specified|8
916452|NCT00830518|1895429|FG001|Overall Study|Reason not Specified|1
916453|NCT00830765|1895451|FG000|Overall Study|Protocol Violation|3
916454|NCT00830765|1895452|FG001|Overall Study|Protocol Violation|2
916455|NCT00830804|1895482|FG000|Overall Study|Lost to Follow-up|4
916456|NCT00830804|1895482|FG000|Overall Study|Death|1
916457|NCT00830804|1895482|FG000|Overall Study|Unable to get to clinic|7
916458|NCT00830804|1895482|FG000|Overall Study|Consent withdrawn|2
916459|NCT00830804|1895482|FG000|Overall Study|Unwilling to adhere to study requirement|1
916460|NCT00830869|1895499|FG000|Period 1: Part 1|Symptomatic deterioration|0
916461|NCT00830869|1895500|FG001|Period 1: Part 1|Symptomatic deterioration|0
916462|NCT00830869|1895501|FG002|Period 1: Part 1|Symptomatic deterioration|0
916463|NCT00830869|1895502|FG003|Period 1: Part 1|Symptomatic deterioration|1
916464|NCT00830869|1895503|FG004|Period 1: Part 1|Symptomatic deterioration|0
916465|NCT00830869|1895504|FG005|Period 1: Part 1|Symptomatic deterioration|1
916466|NCT00830869|1895505|FG006|Period 1: Part 1|Symptomatic deterioration|1
916467|NCT00830869|1895506|FG007|Period 1: Part 1|Symptomatic deterioration|0
916468|NCT00830869|1895507|FG008|Period 1: Part 1|Symptomatic deterioration|0
916469|NCT00830869|1895508|FG009|Period 1: Part 1|Symptomatic deterioration|0
916470|NCT00830869|1895509|FG010|Period 1: Part 1|Symptomatic deterioration|0
916471|NCT00830869|1895510|FG011|Period 1: Part 1|Symptomatic deterioration|0
916472|NCT00830869|1895499|FG000|Period 1: Part 1|Withdrawal by Subject|0
916473|NCT00830869|1895500|FG001|Period 1: Part 1|Withdrawal by Subject|1
916474|NCT00830869|1895501|FG002|Period 1: Part 1|Withdrawal by Subject|0
916475|NCT00830869|1895502|FG003|Period 1: Part 1|Withdrawal by Subject|0
916476|NCT00830869|1895503|FG004|Period 1: Part 1|Withdrawal by Subject|0
916477|NCT00830869|1895504|FG005|Period 1: Part 1|Withdrawal by Subject|0
916478|NCT00830869|1895505|FG006|Period 1: Part 1|Withdrawal by Subject|0
916479|NCT00830869|1895506|FG007|Period 1: Part 1|Withdrawal by Subject|0
916480|NCT00830869|1895507|FG008|Period 1: Part 1|Withdrawal by Subject|0
916481|NCT00830869|1895508|FG009|Period 1: Part 1|Withdrawal by Subject|0
916482|NCT00830869|1895509|FG010|Period 1: Part 1|Withdrawal by Subject|0
916483|NCT00830869|1895510|FG011|Period 1: Part 1|Withdrawal by Subject|0
916484|NCT00830869|1895499|FG000|Period 1: Part 1|Adverse Event|0
916485|NCT00830869|1895500|FG001|Period 1: Part 1|Adverse Event|0
916486|NCT00830869|1895501|FG002|Period 1: Part 1|Adverse Event|0
916487|NCT00830869|1895502|FG003|Period 1: Part 1|Adverse Event|0
916488|NCT00830869|1895503|FG004|Period 1: Part 1|Adverse Event|0
916489|NCT00830869|1895504|FG005|Period 1: Part 1|Adverse Event|1
916490|NCT00830869|1895505|FG006|Period 1: Part 1|Adverse Event|1
916491|NCT00830869|1895506|FG007|Period 1: Part 1|Adverse Event|0
916492|NCT00830869|1895507|FG008|Period 1: Part 1|Adverse Event|0
916493|NCT00830869|1895508|FG009|Period 1: Part 1|Adverse Event|0
916494|NCT00830869|1895509|FG010|Period 1: Part 1|Adverse Event|0
916495|NCT00830869|1895510|FG011|Period 1: Part 1|Adverse Event|0
916496|NCT00830869|1895499|FG000|Period 1: Part 1|Progressive disease|1
916497|NCT00830869|1895500|FG001|Period 1: Part 1|Progressive disease|0
916498|NCT00830869|1895501|FG002|Period 1: Part 1|Progressive disease|1
916499|NCT00830869|1895502|FG003|Period 1: Part 1|Progressive disease|6
916500|NCT00830869|1895503|FG004|Period 1: Part 1|Progressive disease|4
916501|NCT00830869|1895504|FG005|Period 1: Part 1|Progressive disease|4
916502|NCT00830869|1895505|FG006|Period 1: Part 1|Progressive disease|1
916503|NCT00830869|1895506|FG007|Period 1: Part 1|Progressive disease|0
916504|NCT00830869|1895507|FG008|Period 1: Part 1|Progressive disease|0
916505|NCT00830869|1895508|FG009|Period 1: Part 1|Progressive disease|0
916506|NCT00830869|1895509|FG010|Period 1: Part 1|Progressive disease|0
916507|NCT00830869|1895510|FG011|Period 1: Part 1|Progressive disease|0
916508|NCT00830869|1895499|FG000|Period 2: Part 2|Protocol Violation|0
916509|NCT00830869|1895500|FG001|Period 2: Part 2|Protocol Violation|0
916510|NCT00830869|1895501|FG002|Period 2: Part 2|Protocol Violation|0
916511|NCT00830869|1895502|FG003|Period 2: Part 2|Protocol Violation|0
916512|NCT00830869|1895503|FG004|Period 2: Part 2|Protocol Violation|0
916513|NCT00830869|1895504|FG005|Period 2: Part 2|Protocol Violation|0
916514|NCT00830869|1895505|FG006|Period 2: Part 2|Protocol Violation|0
916515|NCT00830869|1895506|FG007|Period 2: Part 2|Protocol Violation|1
916516|NCT00830869|1895507|FG008|Period 2: Part 2|Protocol Violation|0
916517|NCT00830869|1895508|FG009|Period 2: Part 2|Protocol Violation|1
916518|NCT00830869|1895509|FG010|Period 2: Part 2|Protocol Violation|0
916519|NCT00830869|1895510|FG011|Period 2: Part 2|Protocol Violation|0
916520|NCT00830869|1895499|FG000|Period 2: Part 2|Withdrawal by Subject|0
916521|NCT00830869|1895500|FG001|Period 2: Part 2|Withdrawal by Subject|0
916522|NCT00830869|1895501|FG002|Period 2: Part 2|Withdrawal by Subject|0
916523|NCT00830869|1895502|FG003|Period 2: Part 2|Withdrawal by Subject|0
916524|NCT00830869|1895503|FG004|Period 2: Part 2|Withdrawal by Subject|0
916525|NCT00830869|1895504|FG005|Period 2: Part 2|Withdrawal by Subject|0
916526|NCT00830869|1895505|FG006|Period 2: Part 2|Withdrawal by Subject|0
916527|NCT00830869|1895506|FG007|Period 2: Part 2|Withdrawal by Subject|1
916528|NCT00830869|1895507|FG008|Period 2: Part 2|Withdrawal by Subject|2
916529|NCT00830869|1895508|FG009|Period 2: Part 2|Withdrawal by Subject|1
916530|NCT00830869|1895509|FG010|Period 2: Part 2|Withdrawal by Subject|0
916531|NCT00830869|1895510|FG011|Period 2: Part 2|Withdrawal by Subject|1
916532|NCT00830869|1895499|FG000|Period 2: Part 2|Adverse Event|0
916533|NCT00830869|1895500|FG001|Period 2: Part 2|Adverse Event|0
916534|NCT00830869|1895501|FG002|Period 2: Part 2|Adverse Event|0
916535|NCT00830869|1895502|FG003|Period 2: Part 2|Adverse Event|0
916536|NCT00830869|1895503|FG004|Period 2: Part 2|Adverse Event|0
916537|NCT00830869|1895504|FG005|Period 2: Part 2|Adverse Event|0
916538|NCT00830869|1895505|FG006|Period 2: Part 2|Adverse Event|0
916539|NCT00830869|1895506|FG007|Period 2: Part 2|Adverse Event|4
916540|NCT00830869|1895507|FG008|Period 2: Part 2|Adverse Event|3
916541|NCT00830869|1895508|FG009|Period 2: Part 2|Adverse Event|2
916542|NCT00830869|1895509|FG010|Period 2: Part 2|Adverse Event|2
916543|NCT00830869|1895510|FG011|Period 2: Part 2|Adverse Event|0
916544|NCT00830869|1895499|FG000|Period 2: Part 2|Symptomatic Deterioration|0
916545|NCT00830869|1895500|FG001|Period 2: Part 2|Symptomatic Deterioration|0
916546|NCT00830869|1895501|FG002|Period 2: Part 2|Symptomatic Deterioration|0
916547|NCT00830869|1895502|FG003|Period 2: Part 2|Symptomatic Deterioration|0
916548|NCT00830869|1895503|FG004|Period 2: Part 2|Symptomatic Deterioration|0
916549|NCT00830869|1895504|FG005|Period 2: Part 2|Symptomatic Deterioration|0
916550|NCT00830869|1895505|FG006|Period 2: Part 2|Symptomatic Deterioration|0
916551|NCT00830869|1895506|FG007|Period 2: Part 2|Symptomatic Deterioration|0
916552|NCT00830869|1895507|FG008|Period 2: Part 2|Symptomatic Deterioration|6
916553|NCT00830869|1895508|FG009|Period 2: Part 2|Symptomatic Deterioration|3
916554|NCT00830869|1895509|FG010|Period 2: Part 2|Symptomatic Deterioration|1
916555|NCT00830869|1895510|FG011|Period 2: Part 2|Symptomatic Deterioration|4
916556|NCT00830869|1895499|FG000|Period 2: Part 2|Progressive disease|0
916557|NCT00830869|1895500|FG001|Period 2: Part 2|Progressive disease|0
916558|NCT00830869|1895501|FG002|Period 2: Part 2|Progressive disease|0
916559|NCT00830869|1895502|FG003|Period 2: Part 2|Progressive disease|0
916560|NCT00830869|1895503|FG004|Period 2: Part 2|Progressive disease|0
916561|NCT00830869|1895504|FG005|Period 2: Part 2|Progressive disease|0
916562|NCT00830869|1895505|FG006|Period 2: Part 2|Progressive disease|0
916563|NCT00830869|1895506|FG007|Period 2: Part 2|Progressive disease|14
916564|NCT00830869|1895507|FG008|Period 2: Part 2|Progressive disease|11
916565|NCT00830869|1895508|FG009|Period 2: Part 2|Progressive disease|12
916566|NCT00830869|1895509|FG010|Period 2: Part 2|Progressive disease|8
916567|NCT00830869|1895510|FG011|Period 2: Part 2|Progressive disease|15
916568|NCT00830869|1895499|FG000|Period 2: Part 2|Other|0
916569|NCT00830869|1895500|FG001|Period 2: Part 2|Other|0
916570|NCT00830869|1895501|FG002|Period 2: Part 2|Other|0
916571|NCT00830869|1895502|FG003|Period 2: Part 2|Other|0
916572|NCT00830869|1895503|FG004|Period 2: Part 2|Other|0
916573|NCT00830869|1895504|FG005|Period 2: Part 2|Other|0
916574|NCT00830869|1895505|FG006|Period 2: Part 2|Other|0
916575|NCT00830869|1895506|FG007|Period 2: Part 2|Other|0
916576|NCT00830869|1895507|FG008|Period 2: Part 2|Other|0
916577|NCT00830869|1895508|FG009|Period 2: Part 2|Other|1
916578|NCT00830869|1895509|FG010|Period 2: Part 2|Other|0
916579|NCT00830869|1895510|FG011|Period 2: Part 2|Other|0
916580|NCT00830947|1895539|FG000|Overall Study|Lost to Follow-up|4
916581|NCT00830947|1895540|FG001|Overall Study|Lost to Follow-up|4
916582|NCT00830960|1895552|FG000|Overall Study|Death|5
916583|NCT00830960|1895553|FG001|Overall Study|Death|4
916584|NCT00830960|1895554|FG002|Overall Study|Death|3
916585|NCT00830960|1895555|FG003|Overall Study|Death|2
916586|NCT00830960|1895556|FG004|Overall Study|Death|6
916587|NCT00830960|1895557|FG005|Overall Study|Death|1
916588|NCT00830960|1895552|FG000|Overall Study|Lost to Follow-up|1
916589|NCT00830960|1895553|FG001|Overall Study|Lost to Follow-up|1
916590|NCT00830960|1895554|FG002|Overall Study|Lost to Follow-up|1
916591|NCT00830960|1895555|FG003|Overall Study|Lost to Follow-up|0
916592|NCT00830960|1895556|FG004|Overall Study|Lost to Follow-up|0
916593|NCT00830960|1895557|FG005|Overall Study|Lost to Follow-up|1
916594|NCT00830960|1895552|FG000|Overall Study|Withdrawal by Subject|19
916595|NCT00830960|1895553|FG001|Overall Study|Withdrawal by Subject|19
916596|NCT00830960|1895554|FG002|Overall Study|Withdrawal by Subject|18
916597|NCT00830960|1895555|FG003|Overall Study|Withdrawal by Subject|23
916598|NCT00830960|1895556|FG004|Overall Study|Withdrawal by Subject|16
916599|NCT00830960|1895557|FG005|Overall Study|Withdrawal by Subject|21
916600|NCT00830960|1895552|FG000|Overall Study|Sponsor Decision|1
916601|NCT00830960|1895553|FG001|Overall Study|Sponsor Decision|2
916602|NCT00830960|1895554|FG002|Overall Study|Sponsor Decision|3
916603|NCT00830960|1895555|FG003|Overall Study|Sponsor Decision|4
916604|NCT00830960|1895556|FG004|Overall Study|Sponsor Decision|5
916605|NCT00830960|1895557|FG005|Overall Study|Sponsor Decision|7
916606|NCT00830960|1895552|FG000|Overall Study|No study drug received|7
916607|NCT00830960|1895553|FG001|Overall Study|No study drug received|2
916608|NCT00830960|1895554|FG002|Overall Study|No study drug received|4
916609|NCT00830960|1895555|FG003|Overall Study|No study drug received|3
916610|NCT00830960|1895556|FG004|Overall Study|No study drug received|5
916611|NCT00830960|1895557|FG005|Overall Study|No study drug received|7
916612|NCT00831129|1895596|FG000|Overall Study|Adverse Event|0
916613|NCT00831129|1895597|FG001|Overall Study|Adverse Event|1
916614|NCT00831129|1895596|FG000|Overall Study|9 lost to follow-up reasons uknown|0
916615|NCT00831129|1895597|FG001|Overall Study|9 lost to follow-up reasons uknown|9
916616|NCT00831181|1895603|FG000|Overall Study|Adverse Event|12
916617|NCT00831233|1895610|FG000|Overall Study|Adverse Event|0
916618|NCT00831233|1895611|FG001|Overall Study|Adverse Event|1
916619|NCT00831233|1895610|FG000|Overall Study|Protocol Violation|1
916620|NCT00831233|1895611|FG001|Overall Study|Protocol Violation|0
916621|NCT00831233|1895610|FG000|Overall Study|Selection Criteria Not Met|2
916622|NCT00831233|1895611|FG001|Overall Study|Selection Criteria Not Met|0
916623|NCT00831311|1895636|FG000|Overall Study|Definitive Contraindication|3
916624|NCT00831311|1895637|FG001|Overall Study|Definitive Contraindication|3
916625|NCT00831311|1895636|FG000|Overall Study|Lost to Follow-up|3
916626|NCT00831311|1895637|FG001|Overall Study|Lost to Follow-up|0
916627|NCT00831311|1895636|FG000|Overall Study|Physician Decision|0
916628|NCT00831311|1895637|FG001|Overall Study|Physician Decision|1
916629|NCT00831311|1895636|FG000|Overall Study|Withdrawal by Subject|6
916630|NCT00831311|1895637|FG001|Overall Study|Withdrawal by Subject|4
916631|NCT00831389|1895646|FG000|Overall Study|Withdrawal by Subject|0
916632|NCT00831389|1895647|FG001|Overall Study|Withdrawal by Subject|1
916633|NCT00831415|1895653|FG000|Overall Study|Adverse Event|14
916634|NCT00831415|1895653|FG000|Overall Study|Failed to return|3
916635|NCT00831415|1895653|FG000|Overall Study|Physician Decision|6
916636|NCT00831415|1895653|FG000|Overall Study|Lost to Follow-up|9
916637|NCT00831415|1895653|FG000|Overall Study|Protocol Violation|3
916638|NCT00831415|1895653|FG000|Overall Study|Withdrawal by Subject|35
916639|NCT00831415|1895653|FG000|Overall Study|Unsatisfactory response - Efficacy|4
916640|NCT00831415|1895653|FG000|Overall Study|Death|1
916641|NCT00831441|1895663|FG000|Randomized|Death|82
916642|NCT00831441|1895664|FG001|Randomized|Death|81
916643|NCT00831441|1895663|FG000|Randomized|Adverse Event|248
916644|NCT00831441|1895664|FG001|Randomized|Adverse Event|321
916645|NCT00831441|1895663|FG000|Randomized|Emergency procedure|2
916646|NCT00831441|1895664|FG001|Randomized|Emergency procedure|2
916647|NCT00831441|1895663|FG000|Randomized|Elective procedure|26
916648|NCT00831441|1895664|FG001|Randomized|Elective procedure|25
916649|NCT00831441|1895663|FG000|Randomized|Physician Decision|26
916650|NCT00831441|1895664|FG001|Randomized|Physician Decision|35
916651|NCT00831441|1895663|FG000|Randomized|No longer met criteria|13
916652|NCT00831441|1895664|FG001|Randomized|No longer met criteria|19
916653|NCT00831441|1895663|FG000|Randomized|Withdrawal by Subject|178
916654|NCT00831441|1895664|FG001|Randomized|Withdrawal by Subject|212
916655|NCT00831441|1895663|FG000|Randomized|Lost to Follow-up|26
916656|NCT00831441|1895664|FG001|Randomized|Lost to Follow-up|35
916657|NCT00831441|1895663|FG000|Randomized|Administrative reason by sponsor|2780
916658|NCT00831441|1895664|FG001|Randomized|Administrative reason by sponsor|2671
916659|NCT00831441|1895663|FG000|Randomized|poor/non-compliance|30
916660|NCT00831441|1895664|FG001|Randomized|poor/non-compliance|38
916661|NCT00831441|1895663|FG000|Randomized|non-specified|276
916662|NCT00831441|1895664|FG001|Randomized|non-specified|266
916663|NCT00831441|1895663|FG000|Follow Up (30 Days)|Withdrawal by Subject|41
916664|NCT00831441|1895664|FG001|Follow Up (30 Days)|Withdrawal by Subject|34
916665|NCT00831441|1895663|FG000|Follow Up (30 Days)|Lost to Follow-up|13
916666|NCT00831441|1895664|FG001|Follow Up (30 Days)|Lost to Follow-up|27
916667|NCT00831441|1895663|FG000|Follow Up (30 Days)|Death|63
916668|NCT00831441|1895664|FG001|Follow Up (30 Days)|Death|86
916669|NCT00831441|1895663|FG000|Follow Up (30 Days)|non-specified|16
916670|NCT00831441|1895664|FG001|Follow Up (30 Days)|non-specified|26
916671|NCT00831441|1895663|FG000|Follow Up (30 Days)|missing end of study status|0
916672|NCT00831441|1895664|FG001|Follow Up (30 Days)|missing end of study status|1
916673|NCT00831493|1895675|FG000|Overall Study|Intractable nausea and vomiting|1
916674|NCT00831701|1895690|FG000|Overall Study|Withdrawal by Subject|2
916675|NCT00831701|1895691|FG001|Overall Study|Withdrawal by Subject|0
916676|NCT00831701|1895690|FG000|Overall Study|Stone expulsion before first medication|2
916677|NCT00831701|1895691|FG001|Overall Study|Stone expulsion before first medication|2
916678|NCT00831701|1895690|FG000|Overall Study|Lost to Follow-up|1
916679|NCT00831701|1895691|FG001|Overall Study|Lost to Follow-up|3
916680|NCT00831779|1895718|FG000|Overall Study|Lost to Follow-up|1
916681|NCT00831779|1895719|FG001|Overall Study|Lost to Follow-up|0
916682|NCT00831779|1895718|FG000|Overall Study|No longer met criteria|0
916683|NCT00831779|1895719|FG001|Overall Study|No longer met criteria|1
916684|NCT00831792|1895725|FG000|Overall Study|Not Eligible|3
916685|NCT00831792|1895725|FG000|Overall Study|Adverse Event|1
916686|NCT00831792|1895725|FG000|Overall Study|Death|1
916687|NCT00831792|1895725|FG000|Overall Study|Lack of Efficacy|1
916688|NCT00831844|1895739|FG000|Overall Study|Adverse Event|2
916689|NCT00831844|1895740|FG001|Overall Study|Adverse Event|0
916690|NCT00831844|1895741|FG002|Overall Study|Adverse Event|0
916691|NCT00831844|1895742|FG003|Overall Study|Adverse Event|0
916692|NCT00831844|1895743|FG004|Overall Study|Adverse Event|1
916693|NCT00831844|1895744|FG005|Overall Study|Adverse Event|1
916694|NCT00831844|1895745|FG006|Overall Study|Adverse Event|2
916695|NCT00831844|1895746|FG007|Overall Study|Adverse Event|0
916696|NCT00831844|1895747|FG008|Overall Study|Adverse Event|0
916697|NCT00831844|1895748|FG009|Overall Study|Adverse Event|0
916698|NCT00831844|1895739|FG000|Overall Study|Death|0
916699|NCT00831844|1895740|FG001|Overall Study|Death|0
916700|NCT00831844|1895741|FG002|Overall Study|Death|0
916701|NCT00831844|1895742|FG003|Overall Study|Death|1
916702|NCT00831844|1895743|FG004|Overall Study|Death|0
916703|NCT00831844|1895744|FG005|Overall Study|Death|0
916704|NCT00831844|1895745|FG006|Overall Study|Death|0
916705|NCT00831844|1895746|FG007|Overall Study|Death|0
916706|NCT00831844|1895747|FG008|Overall Study|Death|0
916707|NCT00831844|1895748|FG009|Overall Study|Death|0
916708|NCT00831844|1895739|FG000|Overall Study|Lack of Efficacy|8
916709|NCT00831844|1895740|FG001|Overall Study|Lack of Efficacy|10
916710|NCT00831844|1895741|FG002|Overall Study|Lack of Efficacy|15
916711|NCT00831844|1895742|FG003|Overall Study|Lack of Efficacy|8
916712|NCT00831844|1895743|FG004|Overall Study|Lack of Efficacy|11
916713|NCT00831844|1895744|FG005|Overall Study|Lack of Efficacy|17
916714|NCT00831844|1895745|FG006|Overall Study|Lack of Efficacy|8
916715|NCT00831844|1895746|FG007|Overall Study|Lack of Efficacy|9
916716|NCT00831844|1895747|FG008|Overall Study|Lack of Efficacy|7
916717|NCT00831844|1895748|FG009|Overall Study|Lack of Efficacy|0
916718|NCT00831844|1895739|FG000|Overall Study|Physician Decision|0
916719|NCT00831844|1895740|FG001|Overall Study|Physician Decision|1
916720|NCT00831844|1895741|FG002|Overall Study|Physician Decision|3
916721|NCT00831844|1895742|FG003|Overall Study|Physician Decision|1
916722|NCT00831844|1895743|FG004|Overall Study|Physician Decision|1
916723|NCT00831844|1895744|FG005|Overall Study|Physician Decision|1
916724|NCT00831844|1895745|FG006|Overall Study|Physician Decision|0
916725|NCT00831844|1895746|FG007|Overall Study|Physician Decision|0
916726|NCT00831844|1895747|FG008|Overall Study|Physician Decision|1
916727|NCT00831844|1895748|FG009|Overall Study|Physician Decision|0
916728|NCT00831844|1895739|FG000|Overall Study|Withdrawal by Subject|0
916729|NCT00831844|1895740|FG001|Overall Study|Withdrawal by Subject|0
916730|NCT00831844|1895741|FG002|Overall Study|Withdrawal by Subject|1
916731|NCT00831844|1895742|FG003|Overall Study|Withdrawal by Subject|0
916732|NCT00831844|1895743|FG004|Overall Study|Withdrawal by Subject|0
916733|NCT00831844|1895744|FG005|Overall Study|Withdrawal by Subject|0
916734|NCT00831844|1895745|FG006|Overall Study|Withdrawal by Subject|0
916735|NCT00831844|1895746|FG007|Overall Study|Withdrawal by Subject|1
916736|NCT00831844|1895747|FG008|Overall Study|Withdrawal by Subject|1
916737|NCT00831844|1895748|FG009|Overall Study|Withdrawal by Subject|0
916738|NCT00831844|1895739|FG000|Overall Study|Ineligible|0
916739|NCT00831844|1895740|FG001|Overall Study|Ineligible|1
916740|NCT00831844|1895741|FG002|Overall Study|Ineligible|1
916741|NCT00831844|1895742|FG003|Overall Study|Ineligible|0
916742|NCT00831844|1895743|FG004|Overall Study|Ineligible|1
916743|NCT00831844|1895744|FG005|Overall Study|Ineligible|0
916744|NCT00831844|1895745|FG006|Overall Study|Ineligible|0
916745|NCT00831844|1895746|FG007|Overall Study|Ineligible|0
916746|NCT00831844|1895747|FG008|Overall Study|Ineligible|0
916747|NCT00831844|1895748|FG009|Overall Study|Ineligible|0
916748|NCT00832000|1895779|FG000|Overall Study|Adverse Event|2
916749|NCT00832000|1895780|FG001|Overall Study|Adverse Event|0
916750|NCT00832000|1895779|FG000|Overall Study|Withdrawal by Subject|1
916751|NCT00832000|1895780|FG001|Overall Study|Withdrawal by Subject|0
916752|NCT00832000|1895779|FG000|Overall Study|No calls to IVR in either period|1
916753|NCT00832000|1895780|FG001|Overall Study|No calls to IVR in either period|1
916754|NCT00832000|1895779|FG000|Overall Study|No calls to IVR in period 2|2
916755|NCT00832000|1895780|FG001|Overall Study|No calls to IVR in period 2|0
916756|NCT00832078|1895815|FG000|Test Day 1-2 Period|Lack of Efficacy|0
916757|NCT00832078|1895816|FG001|Test Day 1-2 Period|Lack of Efficacy|2
916758|NCT00832078|1895815|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1
916759|NCT00832078|1895816|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0
916760|NCT00832091|1895824|FG000|Overall Study|Adverse Event|1
916761|NCT00832091|1895825|FG001|Overall Study|Adverse Event|1
916762|NCT00832091|1895824|FG000|Overall Study|Protocol Violation|1
916763|NCT00832091|1895825|FG001|Overall Study|Protocol Violation|0
916764|NCT00832091|1895824|FG000|Overall Study|Withdrawal by Subject|2
916765|NCT00832091|1895825|FG001|Overall Study|Withdrawal by Subject|1
916766|NCT00832091|1895824|FG000|Overall Study|Prohibited Medication|1
916767|NCT00832091|1895825|FG001|Overall Study|Prohibited Medication|0
916768|NCT00832117|1895833|FG000|Overall Study|Death|1
916769|NCT00832117|1895833|FG000|Overall Study|Disease Progression|11
916770|NCT00832377|1895857|FG000|Overall Study|Protocol Violation|1
916771|NCT00832416|1895878|FG000|Overall Study|Lack of Efficacy|17
916772|NCT00832416|1895879|FG001|Overall Study|Lack of Efficacy|15
916773|NCT00832416|1895880|FG002|Overall Study|Lack of Efficacy|13
916774|NCT00832416|1895881|FG003|Overall Study|Lack of Efficacy|52
916775|NCT00832416|1895878|FG000|Overall Study|Withdrawal by Subject|5
916776|NCT00832416|1895879|FG001|Overall Study|Withdrawal by Subject|7
916777|NCT00832416|1895880|FG002|Overall Study|Withdrawal by Subject|2
916778|NCT00832416|1895881|FG003|Overall Study|Withdrawal by Subject|10
916779|NCT00832416|1895878|FG000|Overall Study|Physician Decision|2
916780|NCT00832416|1895879|FG001|Overall Study|Physician Decision|12
916781|NCT00832416|1895880|FG002|Overall Study|Physician Decision|5
916782|NCT00832416|1895881|FG003|Overall Study|Physician Decision|10
916783|NCT00832416|1895878|FG000|Overall Study|Administrative|0
916784|NCT00832416|1895879|FG001|Overall Study|Administrative|0
916785|NCT00832416|1895880|FG002|Overall Study|Administrative|0
916786|NCT00832416|1895881|FG003|Overall Study|Administrative|1
916787|NCT00832416|1895878|FG000|Overall Study|Adverse Event|21
916788|NCT00832416|1895879|FG001|Overall Study|Adverse Event|19
916789|NCT00832416|1895880|FG002|Overall Study|Adverse Event|41
916790|NCT00832416|1895881|FG003|Overall Study|Adverse Event|10
916791|NCT00832416|1895878|FG000|Overall Study|Death|1
916792|NCT00832416|1895879|FG001|Overall Study|Death|0
916793|NCT00832416|1895880|FG002|Overall Study|Death|0
916794|NCT00832416|1895881|FG003|Overall Study|Death|0
916795|NCT00832455|1895891|FG000|Overall Study|Adverse Event|13
916796|NCT00832455|1895891|FG000|Overall Study|Lost to Follow-up|26
916797|NCT00832455|1895891|FG000|Overall Study|Protocol Violation|4
916798|NCT00832455|1895891|FG000|Overall Study|Withdrawal by Subject|17
916799|NCT00832455|1895891|FG000|Overall Study|Screening Failure|2
916800|NCT00832455|1895891|FG000|Overall Study|Stopped Medication|4
916801|NCT00832455|1895891|FG000|Overall Study|Parent misunderstood study|1
916802|NCT00832455|1895891|FG000|Overall Study|Parent dissatisfied|1
916803|NCT00832455|1895891|FG000|Overall Study|No improvement|3
916804|NCT00832455|1895891|FG000|Overall Study|Patient moved|1
916805|NCT00832585|1895904|FG000|Overall Study|Withdrawal by Subject|1
916806|NCT00832585|1895904|FG000|Overall Study|Lost to Follow-up|1
916807|NCT00832650|1895915|FG000|Overall Study|Randomized but not treated|0
916808|NCT00832650|1895916|FG001|Overall Study|Randomized but not treated|0
916809|NCT00832650|1895917|FG002|Overall Study|Randomized but not treated|1
916810|NCT00832780|1895936|FG000|Overall Study|Death|16
916811|NCT00832780|1895936|FG000|Overall Study|Lost to Follow-up|4
916812|NCT00832780|1895936|FG000|Overall Study|no reason given|2
916813|NCT00832780|1895936|FG000|Overall Study|other complicating condition|2
916814|NCT00832780|1895936|FG000|Overall Study|Physician Decision|1
916815|NCT00832819|1895943|FG000|Overall Study|Adverse Event|0
916816|NCT00832819|1895944|FG001|Overall Study|Adverse Event|1
916817|NCT00832819|1895945|FG002|Overall Study|Adverse Event|0
916818|NCT00832819|1895943|FG000|Overall Study|Protocol Violation|0
916819|NCT00832819|1895944|FG001|Overall Study|Protocol Violation|0
916820|NCT00832819|1895945|FG002|Overall Study|Protocol Violation|1
916821|NCT00832975|1895955|FG000|Overall Study|Lost to Follow-up|7
916822|NCT00832975|1895955|FG000|Overall Study|Protocol Violation|6
916823|NCT00832975|1895955|FG000|Overall Study|Death|5
916824|NCT00832975|1895955|FG000|Overall Study|Physician Decision|4
916825|NCT00832975|1895955|FG000|Overall Study|Withdrawal by Subject|3
916826|NCT00832975|1895955|FG000|Overall Study|Other reasons|14
916827|NCT00833027|1895959|FG000|Overall Study|Adverse Event|33
916828|NCT00833027|1895959|FG000|Overall Study|Death|1
916829|NCT00833027|1895959|FG000|Overall Study|Lack of Efficacy|12
916830|NCT00833027|1895959|FG000|Overall Study|Lost to Follow-up|24
916831|NCT00833027|1895959|FG000|Overall Study|Protocol Violation|115
916832|NCT00833027|1895959|FG000|Overall Study|Withdrawal by Subject|16
916833|NCT00833027|1895959|FG000|Overall Study|Missing|10
916834|NCT00833040|1895963|FG000|Overall Study|Adverse Event|0
916835|NCT00833040|1895964|FG001|Overall Study|Adverse Event|0
916836|NCT00833040|1895965|FG002|Overall Study|Adverse Event|0
916837|NCT00833040|1895966|FG003|Overall Study|Adverse Event|0
916838|NCT00833040|1895967|FG004|Overall Study|Adverse Event|0
916839|NCT00833040|1895968|FG005|Overall Study|Adverse Event|1
916840|NCT00833053|1895975|FG000|Overall Study|Adverse Event|4
916841|NCT00833053|1895976|FG001|Overall Study|Adverse Event|0
916842|NCT00833053|1895975|FG000|Overall Study|Treatment Failure|3
916843|NCT00833053|1895976|FG001|Overall Study|Treatment Failure|1
916844|NCT00833053|1895975|FG000|Overall Study|Withdrawal by Subject|0
916845|NCT00833053|1895976|FG001|Overall Study|Withdrawal by Subject|1
916846|NCT00833053|1895975|FG000|Overall Study|Protocol Violation|2
916847|NCT00833053|1895976|FG001|Overall Study|Protocol Violation|1
916848|NCT00833092|1895984|FG000|Overall Study|Withdrawal by Subject|2
916849|NCT00833092|1895985|FG001|Overall Study|Withdrawal by Subject|3
916850|NCT00833092|1895984|FG000|Overall Study|Protocol Violation|2
916851|NCT00833092|1895985|FG001|Overall Study|Protocol Violation|1
916852|NCT00833092|1895984|FG000|Overall Study|Diarrhea|0
916853|NCT00833092|1895985|FG001|Overall Study|Diarrhea|2
916854|NCT00833092|1895984|FG000|Overall Study|constipation|0
916855|NCT00833092|1895985|FG001|Overall Study|constipation|1
916856|NCT00833105|1895991|FG000|Overall Study|Withdrawal by Subject|1
916857|NCT00833105|1895991|FG000|Overall Study|Adverse Event|2
916858|NCT00833248|1895999|FG000|Overall Study|Adverse Event|3
916859|NCT00833248|1896000|FG001|Overall Study|Adverse Event|0
916860|NCT00833248|1895999|FG000|Overall Study|Protocol Violation|1
916861|NCT00833248|1896000|FG001|Overall Study|Protocol Violation|2
916862|NCT00833248|1895999|FG000|Overall Study|Withdrawal by Subject|0
916863|NCT00833248|1896000|FG001|Overall Study|Withdrawal by Subject|1
916864|NCT00833261|1896006|FG000|Overall Study|Withdrawal by Subject|4
916865|NCT00833417|1896021|FG000|Overall Study|Adverse Event|5
916866|NCT00833417|1896022|FG001|Overall Study|Adverse Event|16
916867|NCT00833417|1896021|FG000|Overall Study|Death|1
916868|NCT00833417|1896022|FG001|Overall Study|Death|3
916869|NCT00833417|1896021|FG000|Overall Study|Lost to Follow-up|1
916870|NCT00833417|1896022|FG001|Overall Study|Lost to Follow-up|2
916871|NCT00833417|1896021|FG000|Overall Study|Physician Decision to Withdraw Patient|3
916872|NCT00833417|1896022|FG001|Overall Study|Physician Decision to Withdraw Patient|7
916873|NCT00833417|1896021|FG000|Overall Study|Patient Decision to Withdraw|4
916874|NCT00833417|1896022|FG001|Overall Study|Patient Decision to Withdraw|23
916875|NCT00833417|1896021|FG000|Overall Study|Sponsor Decision to Terminate Study|1
916876|NCT00833417|1896022|FG001|Overall Study|Sponsor Decision to Terminate Study|2
916877|NCT00833417|1896021|FG000|Overall Study|Disease Progression|18
916878|NCT00833417|1896022|FG001|Overall Study|Disease Progression|17
916879|NCT00833417|1896021|FG000|Overall Study|Reason Not Specified|0
916880|NCT00833417|1896022|FG001|Overall Study|Reason Not Specified|1
916881|NCT00833469|1896040|FG000|Overall Study|Withdrawal by Subject|1
916882|NCT00833469|1896040|FG000|Overall Study|Lost to Follow-up|1
916883|NCT00833482|1896046|FG000|Days 11-20|Adverse Event|0
916884|NCT00833482|1896047|FG001|Days 11-20|Adverse Event|2
916885|NCT00833482|1896048|FG002|Days 11-20|Adverse Event|0
916886|NCT00833482|1896049|FG003|Days 11-20|Adverse Event|0
916887|NCT00833482|1896050|FG004|Days 11-20|Adverse Event|0
916888|NCT00833482|1896051|FG005|Days 11-20|Adverse Event|0
916889|NCT00833482|1896046|FG000|Days 11-20|Withdrawal by Subject|0
916890|NCT00833482|1896047|FG001|Days 11-20|Withdrawal by Subject|1
916891|NCT00833482|1896048|FG002|Days 11-20|Withdrawal by Subject|0
916892|NCT00833482|1896049|FG003|Days 11-20|Withdrawal by Subject|0
916893|NCT00833482|1896050|FG004|Days 11-20|Withdrawal by Subject|0
916894|NCT00833482|1896051|FG005|Days 11-20|Withdrawal by Subject|0
916895|NCT00833482|1896046|FG000|Days 21-30|Adverse Event|0
916896|NCT00833482|1896047|FG001|Days 21-30|Adverse Event|0
916897|NCT00833482|1896048|FG002|Days 21-30|Adverse Event|1
916898|NCT00833482|1896049|FG003|Days 21-30|Adverse Event|0
916899|NCT00833482|1896050|FG004|Days 21-30|Adverse Event|0
916900|NCT00833482|1896051|FG005|Days 21-30|Adverse Event|0
916901|NCT00833482|1896046|FG000|Days 21-30|Withdrawal by Subject|0
916902|NCT00833482|1896047|FG001|Days 21-30|Withdrawal by Subject|0
916903|NCT00833482|1896048|FG002|Days 21-30|Withdrawal by Subject|0
916904|NCT00833482|1896049|FG003|Days 21-30|Withdrawal by Subject|0
916905|NCT00833482|1896050|FG004|Days 21-30|Withdrawal by Subject|1
916906|NCT00833482|1896051|FG005|Days 21-30|Withdrawal by Subject|0
916907|NCT00833547|1896082|FG000|Overall Study|Withdrawal by Subject|2
916908|NCT00833547|1896083|FG001|Overall Study|Withdrawal by Subject|2
916909|NCT00833560|1896089|FG000|Overall Study|Toxicity|13
916910|NCT00833560|1896089|FG000|Overall Study|Adverse Event|11
916911|NCT00833560|1896089|FG000|Overall Study|Protocol Violation|6
916912|NCT00833560|1896089|FG000|Overall Study|Lack of Efficacy|4
916913|NCT00833560|1896089|FG000|Overall Study|Death|2
916914|NCT00833560|1896089|FG000|Overall Study|Pregression of other disease|1
916915|NCT00833560|1896089|FG000|Overall Study|Other|5
916916|NCT00833638|1896103|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1
916917|NCT00833638|1896104|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2
916918|NCT00833638|1896105|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0
916919|NCT00833638|1896103|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
916920|NCT00833638|1896104|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
916921|NCT00833638|1896105|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
916922|NCT00833638|1896103|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
916923|NCT00833638|1896104|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
916924|NCT00833638|1896105|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
916925|NCT00833638|1896103|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1
916926|NCT00833638|1896104|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0
916927|NCT00833638|1896105|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0
916928|NCT00833638|1896103|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
916929|NCT00833638|1896104|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
916930|NCT00833638|1896105|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
916931|NCT00833638|1896103|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
916932|NCT00833638|1896104|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
916933|NCT00833638|1896105|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
916934|NCT00833638|1896103|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
916935|NCT00833638|1896104|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
916936|NCT00833638|1896105|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
916937|NCT00833638|1896103|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
916938|NCT00833638|1896104|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
916939|NCT00833638|1896105|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
916940|NCT00833638|1896103|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0
916941|NCT00833638|1896104|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1
916942|NCT00833638|1896105|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2
916943|NCT00833690|1896131|FG000|Overall Study|Withdrawal by Subject|1
916944|NCT00833690|1896132|FG001|Overall Study|Withdrawal by Subject|0
916945|NCT00833690|1896133|FG002|Overall Study|Withdrawal by Subject|0
916946|NCT00833690|1896131|FG000|Overall Study|Discontinued study drug|3
916947|NCT00833690|1896132|FG001|Overall Study|Discontinued study drug|2
916948|NCT00833690|1896133|FG002|Overall Study|Discontinued study drug|0
916949|NCT00833703|1896143|FG000|Overall Study|Parent(s)/guardian(s)'s request|0
916950|NCT00833703|1896144|FG001|Overall Study|Parent(s)/guardian(s)'s request|1
916951|NCT00833755|1896154|FG000|Overall Study|Physician Decision|4
916952|NCT00833755|1896155|FG001|Overall Study|Physician Decision|4
916953|NCT00833755|1896156|FG002|Overall Study|Physician Decision|2
916954|NCT00833755|1896157|FG003|Overall Study|Physician Decision|6
916955|NCT00833755|1896154|FG000|Overall Study|Subject had scheduling issues|0
916956|NCT00833755|1896155|FG001|Overall Study|Subject had scheduling issues|1
916957|NCT00833755|1896156|FG002|Overall Study|Subject had scheduling issues|0
916958|NCT00833755|1896157|FG003|Overall Study|Subject had scheduling issues|0
916959|NCT00833794|1896178|FG000|Open-label Phase|Adverse Event|225
916960|NCT00833794|1896179|FG001|Open-label Phase|Adverse Event|0
916961|NCT00833794|1896178|FG000|Open-label Phase|Lack of Efficacy|28
916962|NCT00833794|1896179|FG001|Open-label Phase|Lack of Efficacy|0
916963|NCT00833794|1896178|FG000|Open-label Phase|Withdrawal by Subject|48
916964|NCT00833794|1896179|FG001|Open-label Phase|Withdrawal by Subject|0
916965|NCT00833794|1896178|FG000|Open-label Phase|Physician Decision|20
916966|NCT00833794|1896179|FG001|Open-label Phase|Physician Decision|0
916967|NCT00833794|1896178|FG000|Open-label Phase|Administrative reason|1
916968|NCT00833794|1896179|FG001|Open-label Phase|Administrative reason|0
916969|NCT00833794|1896178|FG000|Open-label Phase|Protocol Violation|47
916970|NCT00833794|1896179|FG001|Open-label Phase|Protocol Violation|0
916971|NCT00833794|1896178|FG000|Open-label Phase|Did not complete wash-out period|12
916972|NCT00833794|1896179|FG001|Open-label Phase|Did not complete wash-out period|0
916973|NCT00833794|1896178|FG000|Open-label Phase|enrolled in error (immediately D/C)|1
916974|NCT00833794|1896179|FG001|Open-label Phase|enrolled in error (immediately D/C)|0
916975|NCT00833794|1896178|FG000|Double-blind Phase|Adverse Event|44
916976|NCT00833794|1896179|FG001|Double-blind Phase|Adverse Event|11
916977|NCT00833794|1896178|FG000|Double-blind Phase|Lack of Efficacy|34
916978|NCT00833794|1896179|FG001|Double-blind Phase|Lack of Efficacy|22
916979|NCT00833794|1896178|FG000|Double-blind Phase|Withdrawal by Subject|23
916980|NCT00833794|1896179|FG001|Double-blind Phase|Withdrawal by Subject|6
916981|NCT00833794|1896178|FG000|Double-blind Phase|Physician Decision|4
916982|NCT00833794|1896179|FG001|Double-blind Phase|Physician Decision|7
916983|NCT00833794|1896178|FG000|Double-blind Phase|Administrative reason|1
916984|NCT00833794|1896179|FG001|Double-blind Phase|Administrative reason|3
916985|NCT00833833|1896193|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0
916986|NCT00833833|1896194|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0
916987|NCT00833833|1896195|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2
916988|NCT00833833|1896196|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2
916989|NCT00833833|1896197|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0
916990|NCT00833833|1896198|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0
916991|NCT00833833|1896193|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
916992|NCT00833833|1896194|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
916993|NCT00833833|1896195|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
916994|NCT00833833|1896196|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
916995|NCT00833833|1896197|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
916996|NCT00833833|1896198|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
916997|NCT00833833|1896193|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1
916998|NCT00833833|1896194|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0
916999|NCT00833833|1896195|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2
917000|NCT00833833|1896196|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1
917001|NCT00833833|1896197|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0
917002|NCT00833833|1896198|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0
917003|NCT00833833|1896193|FG000|Phase 1 (as of 01 April 2011)|Death|0
917004|NCT00833833|1896194|FG001|Phase 1 (as of 01 April 2011)|Death|1
917005|NCT00833833|1896195|FG002|Phase 1 (as of 01 April 2011)|Death|2
917006|NCT00833833|1896196|FG003|Phase 1 (as of 01 April 2011)|Death|0
917007|NCT00833833|1896197|FG004|Phase 1 (as of 01 April 2011)|Death|0
917008|NCT00833833|1896198|FG005|Phase 1 (as of 01 April 2011)|Death|0
917009|NCT00833833|1896193|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
917010|NCT00833833|1896194|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
917011|NCT00833833|1896195|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
917012|NCT00833833|1896196|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
917013|NCT00833833|1896197|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
917014|NCT00833833|1896198|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
917015|NCT00833833|1896193|FG000|Phase 1 (as of 01 April 2011)|Other|1
917016|NCT00833833|1896194|FG001|Phase 1 (as of 01 April 2011)|Other|3
917017|NCT00833833|1896195|FG002|Phase 1 (as of 01 April 2011)|Other|0
917018|NCT00833833|1896196|FG003|Phase 1 (as of 01 April 2011)|Other|1
917019|NCT00833833|1896197|FG004|Phase 1 (as of 01 April 2011)|Other|0
917020|NCT00833833|1896198|FG005|Phase 1 (as of 01 April 2011)|Other|0
917021|NCT00833833|1896193|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0
917022|NCT00833833|1896194|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0
917023|NCT00833833|1896195|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0
917024|NCT00833833|1896196|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0
917025|NCT00833833|1896197|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23
917026|NCT00833833|1896198|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22
917027|NCT00833833|1896193|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0
917028|NCT00833833|1896194|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0
917029|NCT00833833|1896195|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0
917030|NCT00833833|1896196|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0
917031|NCT00833833|1896197|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8
917032|NCT00833833|1896198|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13
917033|NCT00833833|1896193|FG000|Phase 2 (as of 01 April 2011)|Death|0
917034|NCT00833833|1896194|FG001|Phase 2 (as of 01 April 2011)|Death|0
917035|NCT00833833|1896195|FG002|Phase 2 (as of 01 April 2011)|Death|0
917036|NCT00833833|1896196|FG003|Phase 2 (as of 01 April 2011)|Death|0
917037|NCT00833833|1896197|FG004|Phase 2 (as of 01 April 2011)|Death|8
917038|NCT00833833|1896198|FG005|Phase 2 (as of 01 April 2011)|Death|9
917039|NCT00833833|1896193|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
917040|NCT00833833|1896194|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
917041|NCT00833833|1896195|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
917042|NCT00833833|1896196|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
917043|NCT00833833|1896197|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
917044|NCT00833833|1896198|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
917045|NCT00833833|1896193|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
917046|NCT00833833|1896194|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
917047|NCT00833833|1896195|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
917048|NCT00833833|1896196|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
917049|NCT00833833|1896197|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
917050|NCT00833833|1896198|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
917051|NCT00833833|1896193|FG000|Phase 2 (as of 01 April 2011)|Other|0
917052|NCT00833833|1896194|FG001|Phase 2 (as of 01 April 2011)|Other|0
917053|NCT00833833|1896195|FG002|Phase 2 (as of 01 April 2011)|Other|0
917054|NCT00833833|1896196|FG003|Phase 2 (as of 01 April 2011)|Other|0
917055|NCT00833833|1896197|FG004|Phase 2 (as of 01 April 2011)|Other|4
917056|NCT00833833|1896198|FG005|Phase 2 (as of 01 April 2011)|Other|3
917057|NCT00833833|1896193|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
917058|NCT00833833|1896194|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
917059|NCT00833833|1896195|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
917060|NCT00833833|1896196|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
917061|NCT00833833|1896197|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
917062|NCT00833833|1896198|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
917063|NCT00833898|1896220|FG000|Overall Study|Withdrawal by Subject|33
917064|NCT00833898|1896221|FG001|Overall Study|Withdrawal by Subject|27
917065|NCT00833898|1896220|FG000|Overall Study|Lost to Follow-up|7
917066|NCT00833898|1896221|FG001|Overall Study|Lost to Follow-up|7
917067|NCT00833898|1896220|FG000|Overall Study|Patient did not receive transplant|0
917068|NCT00833898|1896221|FG001|Overall Study|Patient did not receive transplant|2
917069|NCT00833911|1896227|FG000|Titration|Adverse Event|18
917070|NCT00833911|1896227|FG000|Titration|Withdrawal by Subject|3
917071|NCT00833911|1896227|FG000|Maintenance Phase I|Adverse Event|73
917072|NCT00833911|1896227|FG000|Maintenance Phase I|Withdrawal by Subject|11
917073|NCT00833911|1896227|FG000|Maintenance Phase I|Physician Decision|10
917074|NCT00833911|1896227|FG000|Maintenance Phase I|Lack of Efficacy|4
917075|NCT00833911|1896227|FG000|Maintenance Phase II|Adverse Event|6
917076|NCT00833911|1896227|FG000|Maintenance Phase II|Physician Decision|2
917077|NCT00833911|1896227|FG000|Maintenance Phase II|Withdrawal by Subject|1
917078|NCT00833911|1896227|FG000|Maintenance Phase II|Lack of Efficacy|1
917079|NCT00833924|1896235|FG000|Overall Study|Death|21
917080|NCT00833924|1896235|FG000|Overall Study|Conversion|2
917081|NCT00833924|1896235|FG000|Overall Study|Lost to Follow-up|2
917082|NCT00833924|1896235|FG000|Overall Study|Withdrawal by Subject|13
917083|NCT00833924|1896235|FG000|Overall Study|In study follow-up|71
917084|NCT00833937|1896241|FG000|Washout|Withdrawal by Subject|1
917085|NCT00833937|1896242|FG001|Washout|Withdrawal by Subject|0
917086|NCT00833976|1896246|FG000|Overall Study|Withdrawal by Subject|5
917087|NCT00833976|1896246|FG000|Overall Study|Lost to Follow-up|4
917088|NCT00833976|1896246|FG000|Overall Study|Did not meet eligibility criteria|41
917089|NCT00833976|1896246|FG000|Overall Study|Physician Decision|1
917090|NCT00833989|1896254|FG000|Overall Study|Physician Decision|0
917091|NCT00833989|1896255|FG001|Overall Study|Physician Decision|0
917092|NCT00833989|1896256|FG002|Overall Study|Physician Decision|0
917093|NCT00833989|1896257|FG003|Overall Study|Physician Decision|1
917094|NCT00833989|1896254|FG000|Overall Study|Withdrawal by Subject|3
917095|NCT00833989|1896255|FG001|Overall Study|Withdrawal by Subject|0
917096|NCT00833989|1896256|FG002|Overall Study|Withdrawal by Subject|1
917097|NCT00833989|1896257|FG003|Overall Study|Withdrawal by Subject|1
917098|NCT00834041|1896272|FG000|Overall Study|Withdrawal by Subject|1
917099|NCT00834041|1896273|FG001|Overall Study|Withdrawal by Subject|0
917100|NCT00834041|1896272|FG000|Overall Study|Lost to Follow-up|0
917101|NCT00834041|1896273|FG001|Overall Study|Lost to Follow-up|1
917102|NCT00834067|1896281|FG000|Washout of 21 Days|Protocol Violation|0
917103|NCT00834067|1896282|FG001|Washout of 21 Days|Protocol Violation|1
917104|NCT00834080|1896286|FG000|Overall Study|Adverse Event|7
917105|NCT00834080|1896286|FG000|Overall Study|Lost to Follow-up|7
917106|NCT00834080|1896286|FG000|Overall Study|Withdrawal by Subject|5
917107|NCT00834080|1896286|FG000|Overall Study|Other - Pregnancy|1
917108|NCT00834080|1896286|FG000|Overall Study|Other - False positive tests of the UDS|1
917109|NCT00834080|1896286|FG000|Overall Study|Physician Decision|1
917110|NCT00834080|1896286|FG000|Overall Study|Subject Relocated|1
917111|NCT00834249|1896342|FG000|Washout: 7 Days|Withdrawal by Subject|1
917112|NCT00834249|1896343|FG001|Washout: 7 Days|Withdrawal by Subject|1
917113|NCT00834249|1896342|FG000|Second Intervention|Adverse Event|1
917114|NCT00834249|1896343|FG001|Second Intervention|Adverse Event|0
917115|NCT00834340|1896365|FG000|Washout|Adverse Event|1
917116|NCT00834340|1896366|FG001|Washout|Adverse Event|0
917117|NCT00834340|1896365|FG000|Washout|Withdrawal by Subject|1
917118|NCT00834340|1896366|FG001|Washout|Withdrawal by Subject|0
917119|NCT00834366|1896372|FG000|Treatment Period 1|Adverse Event|1
917120|NCT00834366|1896373|FG001|Treatment Period 1|Adverse Event|1
917121|NCT00834418|1896388|FG000|Overall Study|Adverse Event|0
917122|NCT00834418|1896389|FG001|Overall Study|Adverse Event|2
917123|NCT00834431|1896395|FG000|First Intervention|Adverse Event|0
917124|NCT00834431|1896396|FG001|First Intervention|Adverse Event|1
917125|NCT00834431|1896395|FG000|Washout of 7 Days|Withdrawal by Subject|0
917126|NCT00834431|1896396|FG001|Washout of 7 Days|Withdrawal by Subject|1
917127|NCT00834444|1896402|FG000|First Intervention|Adverse Event|1
917128|NCT00834444|1896403|FG001|First Intervention|Adverse Event|0
917129|NCT00834444|1896402|FG000|First Intervention|Intolerance to Venopuncture|0
917130|NCT00834444|1896403|FG001|First Intervention|Intolerance to Venopuncture|1
917131|NCT00834444|1896402|FG000|Washout of 7 Days|Withdrawal by Subject|0
917132|NCT00834444|1896403|FG001|Washout of 7 Days|Withdrawal by Subject|1
917133|NCT00834444|1896402|FG000|Second Intervention|Adverse Event|1
917134|NCT00834444|1896403|FG001|Second Intervention|Adverse Event|0
917135|NCT00834522|1896418|FG000|Washout|Adverse Event|1
917136|NCT00834522|1896419|FG001|Washout|Adverse Event|0
917137|NCT00834522|1896418|FG000|Washout|Withdrawal by Subject|2
917138|NCT00834522|1896419|FG001|Washout|Withdrawal by Subject|1
917139|NCT00834587|1896446|FG000|Washout: 7 Days|Withdrawal by Subject|1
917140|NCT00834587|1896447|FG001|Washout: 7 Days|Withdrawal by Subject|0
917141|NCT00834613|1896453|FG000|First Intervention|Protocol Violation|1
917142|NCT00834613|1896454|FG001|First Intervention|Protocol Violation|0
917143|NCT00834639|1896465|FG000|Second Intervention|Physician Decision|0
917144|NCT00834639|1896466|FG001|Second Intervention|Physician Decision|2
917145|NCT00834717|1896487|FG000|First Intervention|Adverse Event|1
917146|NCT00834717|1896488|FG001|First Intervention|Adverse Event|0
917147|NCT00834717|1896487|FG000|First Intervention|Withdrawal by Subject|0
917148|NCT00834717|1896488|FG001|First Intervention|Withdrawal by Subject|1
917149|NCT00834743|1896494|FG000|Second Intervention|Withdrawal by Subject|1
917150|NCT00834743|1896495|FG001|Second Intervention|Withdrawal by Subject|0
917151|NCT00834756|1896501|FG000|First Intervention|Adverse Event|1
917152|NCT00834756|1896502|FG001|First Intervention|Adverse Event|0
917153|NCT00834756|1896501|FG000|Washout: 21 Days|Withdrawal by Subject|1
917154|NCT00834756|1896502|FG001|Washout: 21 Days|Withdrawal by Subject|0
917155|NCT00834795|1896508|FG000|Washout: 7 Days|Withdrawal by Subject|0
917156|NCT00834795|1896509|FG001|Washout: 7 Days|Withdrawal by Subject|1
917157|NCT00834795|1896508|FG000|Second Intervention|Adverse Event|1
917158|NCT00834795|1896509|FG001|Second Intervention|Adverse Event|0
917159|NCT00834834|1896528|FG000|Overall Study|Withdrawal by Subject|4
917160|NCT00834834|1896529|FG001|Overall Study|Withdrawal by Subject|3
917161|NCT00834873|1896537|FG000|First Intervention|Adverse Event|0
917162|NCT00834873|1896538|FG001|First Intervention|Adverse Event|1
917163|NCT00834899|1896561|FG000|Overall Study|Withdrawal by Subject|1
917164|NCT00834899|1896562|FG001|Overall Study|Withdrawal by Subject|1
917165|NCT00834912|1896574|FG000|Treatment Period 1|Adverse Event|0
917166|NCT00834912|1896575|FG001|Treatment Period 1|Adverse Event|1
917167|NCT00834912|1896576|FG002|Treatment Period 1|Adverse Event|0
917168|NCT00834912|1896577|FG003|Treatment Period 1|Adverse Event|1
917169|NCT00834912|1896578|FG004|Treatment Period 1|Adverse Event|0
917170|NCT00834912|1896579|FG005|Treatment Period 1|Adverse Event|0
917171|NCT00834912|1896574|FG000|Treatment Period 2|Withdrawal by Subject|0
917172|NCT00834912|1896575|FG001|Treatment Period 2|Withdrawal by Subject|0
917173|NCT00834912|1896576|FG002|Treatment Period 2|Withdrawal by Subject|1
917174|NCT00834912|1896577|FG003|Treatment Period 2|Withdrawal by Subject|0
917175|NCT00834912|1896578|FG004|Treatment Period 2|Withdrawal by Subject|1
917176|NCT00834912|1896579|FG005|Treatment Period 2|Withdrawal by Subject|0
917177|NCT00835042|1896619|FG000|First Intervention|Withdrawal by Subject|3
917178|NCT00835042|1896620|FG001|First Intervention|Withdrawal by Subject|0
917179|NCT00835042|1896619|FG000|First Intervention|Adverse Event|1
917180|NCT00835042|1896620|FG001|First Intervention|Adverse Event|2
917181|NCT00835042|1896619|FG000|Washout of 21 Days|Withdrawal by Subject|0
917182|NCT00835042|1896620|FG001|Washout of 21 Days|Withdrawal by Subject|2
917183|NCT00835068|1896626|FG000|Overall Study|Death|1
917184|NCT00835068|1896627|FG001|Overall Study|Death|0
917185|NCT00835068|1896626|FG000|Overall Study|Adverse Event|0
917186|NCT00835068|1896627|FG001|Overall Study|Adverse Event|1
917187|NCT00835068|1896626|FG000|Overall Study|Other|8
917188|NCT00835068|1896627|FG001|Overall Study|Other|0
917189|NCT00835068|1896626|FG000|Overall Study|Withdrawal by Subject|1
917190|NCT00835068|1896627|FG001|Overall Study|Withdrawal by Subject|0
917191|NCT00835081|1896635|FG000|Washout of 7 Days|Withdrawal by Subject|1
917192|NCT00835081|1896636|FG001|Washout of 7 Days|Withdrawal by Subject|0
917193|NCT00835120|1896640|FG000|Overall Study|Lack of Efficacy|1
917194|NCT00835120|1896640|FG000|Overall Study|Lost to Follow-up|3
917195|NCT00835120|1896640|FG000|Overall Study|Adverse Event|2
917196|NCT00835120|1896640|FG000|Overall Study|Withdrawal by Subject|2
917197|NCT00835172|1896662|FG000|Washout|Protocol Violation|0
917198|NCT00835172|1896663|FG001|Washout|Protocol Violation|1
917199|NCT00835211|1896683|FG000|First Intervention|Withdrawal by Subject|0
917200|NCT00835211|1896684|FG001|First Intervention|Withdrawal by Subject|1
917201|NCT00835211|1896683|FG000|Washout: 7 Days|Adverse Event|2
917202|NCT00835211|1896684|FG001|Washout: 7 Days|Adverse Event|1
917203|NCT00835211|1896683|FG000|Washout: 7 Days|Withdrawal by Subject|1
917204|NCT00835211|1896684|FG001|Washout: 7 Days|Withdrawal by Subject|0
917205|NCT00835237|1896704|FG000|Overall Study|Lost to Follow-up|4
917206|NCT00835237|1896705|FG001|Overall Study|Lost to Follow-up|0
917207|NCT00835237|1896704|FG000|Overall Study|Withdrawal by Subject|2
917208|NCT00835237|1896705|FG001|Overall Study|Withdrawal by Subject|0
917209|NCT00835263|1896713|FG000|Second Intervention|Adverse Event|1
917210|NCT00835263|1896714|FG001|Second Intervention|Adverse Event|0
917211|NCT00835341|1896727|FG000|Overall Study|Lost to Follow-up|3
917212|NCT00835341|1896728|FG001|Overall Study|Lost to Follow-up|12
917213|NCT00835354|1896736|FG000|First Intervention|Adverse Event|0
917214|NCT00835354|1896737|FG001|First Intervention|Adverse Event|1
917215|NCT00835367|1896743|FG000|Washout|Adverse Event|2
917216|NCT00835367|1896744|FG001|Washout|Adverse Event|0
917217|NCT00835367|1896743|FG000|Washout|Withdrawal by Subject|1
917218|NCT00835367|1896744|FG001|Washout|Withdrawal by Subject|0
917219|NCT00835367|1896743|FG000|Second Intervention|Adverse Event|1
917220|NCT00835367|1896744|FG001|Second Intervention|Adverse Event|1
917221|NCT00835380|1896748|FG000|Overall Study|Withdrawal by Subject|2
917222|NCT00835406|1896754|FG000|Period: First Intervention|Adverse Event|0
917223|NCT00835406|1896755|FG001|Period: First Intervention|Adverse Event|1
917224|NCT00835406|1896754|FG000|Period: First Intervention|Withdrawal by Subject|2
917225|NCT00835406|1896755|FG001|Period: First Intervention|Withdrawal by Subject|0
917226|NCT00835406|1896754|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0
917227|NCT00835406|1896755|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2
917228|NCT00835536|1896788|FG000|Washout of 5 Weeks|Withdrawal by Subject|1
917229|NCT00835536|1896789|FG001|Washout of 5 Weeks|Withdrawal by Subject|0
917230|NCT00835549|1896795|FG000|Washout of 7 Days|Withdrawal by Subject|2
917231|NCT00835549|1896796|FG001|Washout of 7 Days|Withdrawal by Subject|0
917232|NCT00835575|1896802|FG000|Washout of 14 Days|Withdrawal by Subject|1
917233|NCT00835575|1896803|FG001|Washout of 14 Days|Withdrawal by Subject|0
917234|NCT00835640|1896823|FG000|Second Intervention|Protocol Violation|1
917235|NCT00835640|1896824|FG001|Second Intervention|Protocol Violation|0
917236|NCT00835666|1896830|FG000|Washout|Protocol Violation|1
917237|NCT00835666|1896831|FG001|Washout|Protocol Violation|0
917238|NCT00835666|1896830|FG000|Washout|Withdrawal by Subject|1
917239|NCT00835666|1896831|FG001|Washout|Withdrawal by Subject|0
917240|NCT00835692|1896837|FG000|First Intervention|Withdrawal by Subject|1
917241|NCT00835692|1896838|FG001|First Intervention|Withdrawal by Subject|0
917242|NCT00835705|1896844|FG000|First Intervention|Difficulty with vein|1
917243|NCT00835705|1896845|FG001|First Intervention|Difficulty with vein|0
917244|NCT00835705|1896844|FG000|Second Intervention|Difficulty with vein|1
917245|NCT00835705|1896845|FG001|Second Intervention|Difficulty with vein|0
917246|NCT00835731|1896851|FG000|Overall Study|Withdrawal by Subject|1
917247|NCT00835731|1896852|FG001|Overall Study|Withdrawal by Subject|0
917248|NCT00835731|1896851|FG000|Overall Study|Physician Decision|1
917249|NCT00835731|1896852|FG001|Overall Study|Physician Decision|1
917250|NCT00835770|1896860|FG000|Overall Study|MS Relapse|17
917251|NCT00835770|1896861|FG001|Overall Study|MS Relapse|23
917252|NCT00835770|1896860|FG000|Overall Study|MS Progression|14
917253|NCT00835770|1896861|FG001|Overall Study|MS Progression|9
917254|NCT00835770|1896860|FG000|Overall Study|Adverse Event|113
917255|NCT00835770|1896861|FG001|Overall Study|Adverse Event|124
917256|NCT00835770|1896860|FG000|Overall Study|Lost to Follow-up|22
917257|NCT00835770|1896861|FG001|Overall Study|Lost to Follow-up|19
917258|NCT00835770|1896860|FG000|Overall Study|Consent Withdrawn|144
917259|NCT00835770|1896861|FG001|Overall Study|Consent Withdrawn|156
917260|NCT00835770|1896860|FG000|Overall Study|Investigator Decision|42
917261|NCT00835770|1896861|FG001|Overall Study|Investigator Decision|42
917262|NCT00835770|1896860|FG000|Overall Study|Participant Non-Compliance|11
917263|NCT00835770|1896861|FG001|Overall Study|Participant Non-Compliance|9
917264|NCT00835770|1896860|FG000|Overall Study|Death|4
917265|NCT00835770|1896861|FG001|Overall Study|Death|6
917266|NCT00835770|1896860|FG000|Overall Study|Other|115
917267|NCT00835770|1896861|FG001|Overall Study|Other|104
917268|NCT00835770|1896860|FG000|Overall Study|Other|2
917269|NCT00835770|1896861|FG001|Overall Study|Other|1
917270|NCT00835796|1896875|FG000|First Intervention|Withdrawal by Subject|0
917271|NCT00835796|1896876|FG001|First Intervention|Withdrawal by Subject|1
917272|NCT00835978|1896911|FG000|Overall Study|Death|33
917273|NCT00835978|1896912|FG001|Overall Study|Death|40
917274|NCT00835978|1896913|FG002|Overall Study|Death|49
917275|NCT00835978|1896914|FG003|Overall Study|Death|4
917276|NCT00835978|1896911|FG000|Overall Study|Lost to Follow-up|3
917277|NCT00835978|1896912|FG001|Overall Study|Lost to Follow-up|4
917278|NCT00835978|1896913|FG002|Overall Study|Lost to Follow-up|2
917279|NCT00835978|1896914|FG003|Overall Study|Lost to Follow-up|1
917280|NCT00835978|1896911|FG000|Overall Study|Other|5
917281|NCT00835978|1896912|FG001|Overall Study|Other|1
917282|NCT00835978|1896913|FG002|Overall Study|Other|8
917283|NCT00835978|1896914|FG003|Overall Study|Other|0
917284|NCT00835978|1896911|FG000|Overall Study|Objective progression or relapse|2
917285|NCT00835978|1896912|FG001|Overall Study|Objective progression or relapse|0
917286|NCT00835978|1896913|FG002|Overall Study|Objective progression or relapse|1
917287|NCT00835978|1896914|FG003|Overall Study|Objective progression or relapse|0
917288|NCT00835978|1896911|FG000|Overall Study|Adverse Event|1
917289|NCT00835978|1896912|FG001|Overall Study|Adverse Event|0
917290|NCT00835978|1896913|FG002|Overall Study|Adverse Event|1
917291|NCT00835978|1896914|FG003|Overall Study|Adverse Event|0
917292|NCT00835978|1896911|FG000|Overall Study|Withdrawal by Subject|0
917293|NCT00835978|1896912|FG001|Overall Study|Withdrawal by Subject|3
917294|NCT00835978|1896913|FG002|Overall Study|Withdrawal by Subject|0
917295|NCT00835978|1896914|FG003|Overall Study|Withdrawal by Subject|5
917296|NCT00835978|1896911|FG000|Overall Study|Study terminated by sponsor|12
917297|NCT00835978|1896912|FG001|Overall Study|Study terminated by sponsor|8
917298|NCT00835978|1896913|FG002|Overall Study|Study terminated by sponsor|30
917299|NCT00835978|1896914|FG003|Overall Study|Study terminated by sponsor|0
917300|NCT00835991|1896931|FG000|First Intervention|Adverse Event|0
917301|NCT00835991|1896932|FG001|First Intervention|Adverse Event|1
917302|NCT00835991|1896931|FG000|Washout|Protocol Violation|0
917303|NCT00835991|1896932|FG001|Washout|Protocol Violation|2
917304|NCT00835991|1896931|FG000|Washout|Withdrawal by Subject|3
917305|NCT00835991|1896932|FG001|Washout|Withdrawal by Subject|1
917306|NCT00836056|1896949|FG000|First Intervention|Adverse Event|1
917307|NCT00836056|1896950|FG001|First Intervention|Adverse Event|0
917308|NCT00836095|1896956|FG000|Overall Study|Physician Decision|0
917309|NCT00836095|1896957|FG001|Overall Study|Physician Decision|3
917310|NCT00836186|1896963|FG000|Overall Study|Blood could not be drawn|1
917311|NCT00836277|1896968|FG000|Overall Study|Not evaluable for response|6
917312|NCT00836472|1897009|FG000|Washout|Adverse Event|1
917313|NCT00836472|1897010|FG001|Washout|Adverse Event|2
917314|NCT00836472|1897009|FG000|Washout|Withdrawal by Subject|1
917315|NCT00836472|1897010|FG001|Washout|Withdrawal by Subject|1
917316|NCT00836498|1897016|FG000|Overall Study|Adverse Event|1
917317|NCT00836498|1897017|FG001|Overall Study|Adverse Event|0
917318|NCT00836498|1897016|FG000|Overall Study|Lost to Follow-up|1
917319|NCT00836498|1897017|FG001|Overall Study|Lost to Follow-up|0
917320|NCT00836498|1897016|FG000|Overall Study|Withdrawal by Subject|2
917321|NCT00836498|1897017|FG001|Overall Study|Withdrawal by Subject|1
917322|NCT00836589|1897024|FG000|Overall Study|Lost to Follow-up|246
917323|NCT00836589|1897024|FG000|Overall Study|Death|429
917324|NCT00836589|1897024|FG000|Overall Study|Withdrawal by Subject or Physician|591
917325|NCT00836693|1897046|FG000|Overall Study|Adverse Event|4
917326|NCT00836693|1897047|FG001|Overall Study|Adverse Event|1
917327|NCT00836693|1897046|FG000|Overall Study|Sponsor Decision|0
917328|NCT00836693|1897047|FG001|Overall Study|Sponsor Decision|1
917329|NCT00836693|1897046|FG000|Overall Study|Physician Decision|2
917330|NCT00836693|1897047|FG001|Overall Study|Physician Decision|0
917331|NCT00836693|1897046|FG000|Overall Study|Withdrawal by Subject|9
917332|NCT00836693|1897047|FG001|Overall Study|Withdrawal by Subject|4
917333|NCT00836693|1897046|FG000|Overall Study|Protocol Violation|1
917334|NCT00836693|1897047|FG001|Overall Study|Protocol Violation|0
917335|NCT00836693|1897046|FG000|Overall Study|Lost to Follow-up|1
917336|NCT00836693|1897047|FG001|Overall Study|Lost to Follow-up|0
917337|NCT00836706|1897055|FG000|Washout: 7 Days|Withdrawal by Subject|0
917338|NCT00836706|1897056|FG001|Washout: 7 Days|Withdrawal by Subject|1
917339|NCT00836745|1897064|FG000|Overall Study|Death|2
917340|NCT00836745|1897064|FG000|Overall Study|Lost to Follow-up|10
917341|NCT00836745|1897064|FG000|Overall Study|Adverse Event|3
917342|NCT00836745|1897064|FG000|Overall Study|Objective progression or relapse|4
917343|NCT00836745|1897064|FG000|Overall Study|Other|2
917344|NCT00836810|1897076|FG000|Overall Study|New diagnosis|1
917345|NCT00836810|1897077|FG001|Overall Study|New diagnosis|0
917346|NCT00836875|1897085|FG000|Overall Study|Death|3
917347|NCT00836875|1897086|FG001|Overall Study|Death|2
917348|NCT00836875|1897085|FG000|Overall Study|Withdrawal by Subject|0
917349|NCT00836875|1897086|FG001|Overall Study|Withdrawal by Subject|1
917350|NCT00836901|1897111|FG000|First Intervention|Withdrawal by Subject|1
917351|NCT00836901|1897112|FG001|First Intervention|Withdrawal by Subject|0
917352|NCT00836927|1897121|FG000|Overall Study|Progressive disease|2
917353|NCT00836927|1897122|FG001|Overall Study|Progressive disease|0
917354|NCT00836927|1897123|FG002|Overall Study|Progressive disease|0
917355|NCT00836927|1897124|FG003|Overall Study|Progressive disease|1
917356|NCT00836927|1897125|FG004|Overall Study|Progressive disease|1
917357|NCT00836927|1897121|FG000|Overall Study|Withdrawal by Subject|1
917358|NCT00836927|1897122|FG001|Overall Study|Withdrawal by Subject|0
917359|NCT00836927|1897123|FG002|Overall Study|Withdrawal by Subject|0
917360|NCT00836927|1897124|FG003|Overall Study|Withdrawal by Subject|0
917361|NCT00836927|1897125|FG004|Overall Study|Withdrawal by Subject|0
917362|NCT00836953|1897139|FG000|Overall Study|Withdrawal by Subject|1
917363|NCT00836953|1897139|FG000|Overall Study|Lost to Follow-up|1
917364|NCT00837096|1897149|FG000|Overall Study|Physician Decision|1
917365|NCT00837096|1897150|FG001|Overall Study|Physician Decision|1
917366|NCT00837096|1897149|FG000|Overall Study|Not reported|9
917367|NCT00837096|1897150|FG001|Overall Study|Not reported|8
917368|NCT00837148|1897156|FG000|Overall Study|Adverse Event|1
917369|NCT00837148|1897156|FG000|Overall Study|Death|1
917370|NCT00837161|1897160|FG000|Overall Study|refused hysterectomy|2
917371|NCT00837213|1897170|FG000|Overall Study|Lost to Follow-up|3
917372|NCT00837213|1897171|FG001|Overall Study|Lost to Follow-up|2
917373|NCT00837213|1897170|FG000|Overall Study|Withdrawal by Subject|2
917374|NCT00837213|1897171|FG001|Overall Study|Withdrawal by Subject|2
917375|NCT00837213|1897170|FG000|Overall Study|not stated|1
917376|NCT00837213|1897171|FG001|Overall Study|not stated|1
917377|NCT00837330|1897183|FG000|Overall Study|Lost to Follow-up|1
917378|NCT00837330|1897184|FG001|Overall Study|Lost to Follow-up|3
917379|NCT00837434|1897192|FG000|Overall Study|Physician Decision|3
917380|NCT00837434|1897193|FG001|Overall Study|Physician Decision|0
917381|NCT00837434|1897192|FG000|Overall Study|Lost to Follow-up|1
917382|NCT00837434|1897193|FG001|Overall Study|Lost to Follow-up|1
917383|NCT00837434|1897192|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1
917384|NCT00837434|1897193|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0
917385|NCT00837434|1897192|FG000|Overall Study|Noncompliant|2
917386|NCT00837434|1897193|FG001|Overall Study|Noncompliant|0
917387|NCT00837434|1897192|FG000|Overall Study|Baseline assessments not done in time|1
917388|NCT00837434|1897193|FG001|Overall Study|Baseline assessments not done in time|0
917389|NCT00837434|1897192|FG000|Overall Study|Unable to obtain study drug|1
917390|NCT00837434|1897193|FG001|Overall Study|Unable to obtain study drug|0
917391|NCT00837473|1897204|FG000|Overall Study|Lost to Follow-up|1
917392|NCT00837473|1897204|FG000|Overall Study|Withdrawal by Subject|2
917393|NCT00837486|1897210|FG000|Blinded-treatment Phase|Physician Decision|1
917394|NCT00837486|1897211|FG001|Blinded-treatment Phase|Physician Decision|0
917395|NCT00837486|1897210|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2
917396|NCT00837486|1897211|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0
917397|NCT00837486|1897210|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
917398|NCT00837486|1897211|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
917399|NCT00837486|1897210|FG000|Long-term Follow-up Phase - Open Label|Death|1
917400|NCT00837486|1897211|FG001|Long-term Follow-up Phase - Open Label|Death|0
917401|NCT00837577|1897228|FG000|Double-blind Period|Clinical Adverse Event|1
917402|NCT00837577|1897229|FG001|Double-blind Period|Clinical Adverse Event|0
917403|NCT00837577|1897228|FG000|Double-blind Period|Withdrawal by Subject|1
917404|NCT00837577|1897229|FG001|Double-blind Period|Withdrawal by Subject|0
917405|NCT00837577|1897228|FG000|Open-label Period|Clinical Adverse Event|2
917406|NCT00837577|1897229|FG001|Open-label Period|Clinical Adverse Event|2
917407|NCT00837577|1897228|FG000|Open-label Period|Laboratory Adverse Event|0
917408|NCT00837577|1897229|FG001|Open-label Period|Laboratory Adverse Event|1
917409|NCT00837577|1897228|FG000|Open-label Period|Lack of Efficacy|4
917410|NCT00837577|1897229|FG001|Open-label Period|Lack of Efficacy|3
917411|NCT00837577|1897228|FG000|Open-label Period|Withdrawal by Subject|1
917412|NCT00837577|1897229|FG001|Open-label Period|Withdrawal by Subject|2
917413|NCT00837577|1897228|FG000|Open-label Period|Other Reason|1
917414|NCT00837577|1897229|FG001|Open-label Period|Other Reason|1
917415|NCT00837616|1897251|FG000|Overall Study|Withdrawal by Subject|0
917416|NCT00837616|1897252|FG001|Overall Study|Withdrawal by Subject|1
917417|NCT00837694|1897264|FG000|Overall Study|Lost to Follow-up|2
917418|NCT00837694|1897265|FG001|Overall Study|Lost to Follow-up|0
917419|NCT00837694|1897266|FG002|Overall Study|Lost to Follow-up|2
917420|NCT00837694|1897267|FG003|Overall Study|Lost to Follow-up|1
917421|NCT00837694|1897268|FG004|Overall Study|Lost to Follow-up|1
917422|NCT00837694|1897269|FG005|Overall Study|Lost to Follow-up|1
917423|NCT00837759|1897283|FG000|Overall Study|Protocol Violation|3
917424|NCT00837759|1897283|FG000|Overall Study|Lost to Follow-up|1
917425|NCT00837811|1897290|FG000|Overall Study|Adverse Event|4
917426|NCT00837811|1897291|FG001|Overall Study|Adverse Event|6
917427|NCT00837811|1897292|FG002|Overall Study|Adverse Event|0
917428|NCT00837811|1897290|FG000|Overall Study|Death|1
917429|NCT00837811|1897291|FG001|Overall Study|Death|1
917430|NCT00837811|1897292|FG002|Overall Study|Death|0
917431|NCT00837811|1897290|FG000|Overall Study|Lack of Efficacy|0
917432|NCT00837811|1897291|FG001|Overall Study|Lack of Efficacy|11
917433|NCT00837811|1897292|FG002|Overall Study|Lack of Efficacy|0
917434|NCT00837811|1897290|FG000|Overall Study|Lost to Follow-up|1
917435|NCT00837811|1897291|FG001|Overall Study|Lost to Follow-up|3
917436|NCT00837811|1897292|FG002|Overall Study|Lost to Follow-up|0
917437|NCT00837811|1897290|FG000|Overall Study|Physician Decision|0
917438|NCT00837811|1897291|FG001|Overall Study|Physician Decision|2
917439|NCT00837811|1897292|FG002|Overall Study|Physician Decision|1
917440|NCT00837811|1897290|FG000|Overall Study|Withdrawal by Subject|1
917441|NCT00837811|1897291|FG001|Overall Study|Withdrawal by Subject|9
917442|NCT00837811|1897292|FG002|Overall Study|Withdrawal by Subject|0
917443|NCT00837811|1897290|FG000|Overall Study|Sponsor Decision|0
917444|NCT00837811|1897291|FG001|Overall Study|Sponsor Decision|2
917445|NCT00837811|1897292|FG002|Overall Study|Sponsor Decision|0
917446|NCT00837876|1897319|FG000|Overall Study|Death|2
917447|NCT00837876|1897319|FG000|Overall Study|Adverse Event|7
917448|NCT00837876|1897319|FG000|Overall Study|Physician Decision|1
917449|NCT00837876|1897319|FG000|Overall Study|Withdrawal by Subject|3
917450|NCT00837876|1897319|FG000|Overall Study|disease progression|24
917451|NCT00837967|1897333|FG000|Washout Period of 7 - 14 Days|Adverse Event|2
917452|NCT00837967|1897334|FG001|Washout Period of 7 - 14 Days|Adverse Event|0
917453|NCT00838097|1897355|FG000|Overall Study|Ineligibility determined|6
917454|NCT00838097|1897355|FG000|Overall Study|Adverse Event|2
917455|NCT00838097|1897355|FG000|Overall Study|Withdrawal by Subject|3
917456|NCT00838097|1897355|FG000|Overall Study|Requirement for alternative therapy|2
917457|NCT00838097|1897355|FG000|Overall Study|Physician Decision|4
917458|NCT00838097|1897355|FG000|Overall Study|Lost to Follow-up|11
917459|NCT00838097|1897355|FG000|Overall Study|Death|6
917460|NCT00838097|1897355|FG000|Overall Study|Protocol-specified criteria|142
917461|NCT00838110|1897361|FG000|Overall Study|Death|0
917462|NCT00838110|1897362|FG001|Overall Study|Death|0
917463|NCT00838110|1897363|FG002|Overall Study|Death|1
917464|NCT00838110|1897364|FG003|Overall Study|Death|2
917465|NCT00838110|1897361|FG000|Overall Study|Adverse Event|11
917466|NCT00838110|1897362|FG001|Overall Study|Adverse Event|10
917467|NCT00838110|1897363|FG002|Overall Study|Adverse Event|8
917468|NCT00838110|1897364|FG003|Overall Study|Adverse Event|7
917469|NCT00838110|1897361|FG000|Overall Study|Withdrawal by Subject|5
917470|NCT00838110|1897362|FG001|Overall Study|Withdrawal by Subject|6
917471|NCT00838110|1897363|FG002|Overall Study|Withdrawal by Subject|3
917472|NCT00838110|1897364|FG003|Overall Study|Withdrawal by Subject|4
917473|NCT00838110|1897361|FG000|Overall Study|Other|3
917474|NCT00838110|1897362|FG001|Overall Study|Other|3
917475|NCT00838110|1897363|FG002|Overall Study|Other|3
917476|NCT00838110|1897364|FG003|Overall Study|Other|2
917477|NCT00838110|1897361|FG000|Overall Study|Protocol Violation|0
917478|NCT00838110|1897362|FG001|Overall Study|Protocol Violation|2
917479|NCT00838110|1897363|FG002|Overall Study|Protocol Violation|1
917480|NCT00838110|1897364|FG003|Overall Study|Protocol Violation|1
917481|NCT00838110|1897361|FG000|Overall Study|Lost to Follow-up|3
917482|NCT00838110|1897362|FG001|Overall Study|Lost to Follow-up|0
917483|NCT00838110|1897363|FG002|Overall Study|Lost to Follow-up|0
917484|NCT00838110|1897364|FG003|Overall Study|Lost to Follow-up|0
917485|NCT00838110|1897361|FG000|Overall Study|Did not meet eligibility criteria|0
917486|NCT00838110|1897362|FG001|Overall Study|Did not meet eligibility criteria|0
917487|NCT00838110|1897363|FG002|Overall Study|Did not meet eligibility criteria|1
917488|NCT00838110|1897364|FG003|Overall Study|Did not meet eligibility criteria|2
917489|NCT00838110|1897361|FG000|Overall Study|Randomized but not treated|0
917490|NCT00838110|1897362|FG001|Overall Study|Randomized but not treated|1
917491|NCT00838110|1897363|FG002|Overall Study|Randomized but not treated|0
917492|NCT00838110|1897364|FG003|Overall Study|Randomized but not treated|0
917493|NCT00838201|1897400|FG000|Overall Study|Investigator decision, or other reasons|2
917494|NCT00838201|1897401|FG001|Overall Study|Investigator decision, or other reasons|3
917495|NCT00838201|1897400|FG000|Overall Study|Noncompliance|0
917496|NCT00838201|1897401|FG001|Overall Study|Noncompliance|1
917497|NCT00838201|1897400|FG000|Overall Study|Administrative decision|1
917498|NCT00838201|1897401|FG001|Overall Study|Administrative decision|2
917499|NCT00838201|1897400|FG000|Overall Study|Disease progression|3
917500|NCT00838201|1897401|FG001|Overall Study|Disease progression|3
917501|NCT00838201|1897400|FG000|Overall Study|Consent withdrawn|16
917502|NCT00838201|1897401|FG001|Overall Study|Consent withdrawn|19
917503|NCT00838201|1897400|FG000|Overall Study|Lost to Follow-up|4
917504|NCT00838201|1897401|FG001|Overall Study|Lost to Follow-up|3
917505|NCT00838201|1897400|FG000|Overall Study|Adverse Event|5
917506|NCT00838201|1897401|FG001|Overall Study|Adverse Event|9
917507|NCT00838201|1897400|FG000|Overall Study|Death|11
917508|NCT00838201|1897401|FG001|Overall Study|Death|13
917509|NCT00838279|1897409|FG000|Washout|Protocol Violation|1
917510|NCT00838279|1897410|FG001|Washout|Protocol Violation|0
917511|NCT00838279|1897409|FG000|Washout|Withdrawal by Subject|0
917512|NCT00838279|1897410|FG001|Washout|Withdrawal by Subject|1
917513|NCT00838331|1897414|FG000|Aged Blood Transfusion|Withdrawal by Subject|9
917514|NCT00838435|1897418|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1
917515|NCT00838435|1897418|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2
917516|NCT00838435|1897418|FG000|Part 2 (7 Years)|Adverse Event|2
917517|NCT00838435|1897418|FG000|Part 2 (7 Years)|Lost to Follow-up|2
917518|NCT00838435|1897418|FG000|Part 2 (7 Years)|Physician Decision|1
917519|NCT00838435|1897418|FG000|Part 2 (7 Years)|Sponsor Decision|6
917520|NCT00838435|1897418|FG000|Part 2 (7 Years)|Withdrawal by Subject|5
917521|NCT00838513|1897425|FG000|Screening Period|Screen Failure|3
917522|NCT00838513|1897425|FG000|Extension Treatment Period|Death|1
917523|NCT00838513|1897425|FG000|Post Treatment Period (Patients Who Disc|Death|1
917524|NCT00838526|1897431|FG000|Overall Study|Adverse Event|3
917525|NCT00838526|1897432|FG001|Overall Study|Adverse Event|12
917526|NCT00838526|1897431|FG000|Overall Study|Lost to Follow-up|4
917527|NCT00838526|1897432|FG001|Overall Study|Lost to Follow-up|12
917528|NCT00838526|1897431|FG000|Overall Study|Withdrawal by Subject|4
917529|NCT00838526|1897432|FG001|Overall Study|Withdrawal by Subject|5
917530|NCT00838526|1897431|FG000|Overall Study|Lack of Efficacy|2
917531|NCT00838526|1897432|FG001|Overall Study|Lack of Efficacy|3
917532|NCT00838526|1897431|FG000|Overall Study|Other|11
917533|NCT00838526|1897432|FG001|Overall Study|Other|7
917534|NCT00838539|1897450|FG000|Overall Study|Disease Progression|2
917535|NCT00838539|1897451|FG001|Overall Study|Disease Progression|4
917536|NCT00838539|1897452|FG002|Overall Study|Disease Progression|3
917537|NCT00838539|1897453|FG003|Overall Study|Disease Progression|2
917538|NCT00838539|1897454|FG004|Overall Study|Disease Progression|4
917539|NCT00838539|1897455|FG005|Overall Study|Disease Progression|2
917540|NCT00838539|1897456|FG006|Overall Study|Disease Progression|3
917541|NCT00838539|1897457|FG007|Overall Study|Disease Progression|4
917542|NCT00838539|1897458|FG008|Overall Study|Disease Progression|4
917543|NCT00838539|1897459|FG009|Overall Study|Disease Progression|5
917544|NCT00838539|1897460|FG010|Overall Study|Disease Progression|1
917545|NCT00838539|1897461|FG011|Overall Study|Disease Progression|4
917546|NCT00838539|1897450|FG000|Overall Study|Adverse Event|1
917547|NCT00838539|1897451|FG001|Overall Study|Adverse Event|1
917548|NCT00838539|1897452|FG002|Overall Study|Adverse Event|1
917549|NCT00838539|1897453|FG003|Overall Study|Adverse Event|1
917550|NCT00838539|1897454|FG004|Overall Study|Adverse Event|2
917551|NCT00838539|1897455|FG005|Overall Study|Adverse Event|1
917552|NCT00838539|1897456|FG006|Overall Study|Adverse Event|0
917553|NCT00838539|1897457|FG007|Overall Study|Adverse Event|2
917554|NCT00838539|1897458|FG008|Overall Study|Adverse Event|0
917555|NCT00838539|1897459|FG009|Overall Study|Adverse Event|1
917556|NCT00838539|1897460|FG010|Overall Study|Adverse Event|2
917557|NCT00838539|1897461|FG011|Overall Study|Adverse Event|0
917558|NCT00838539|1897450|FG000|Overall Study|Withdrawal by Subject|0
917559|NCT00838539|1897451|FG001|Overall Study|Withdrawal by Subject|1
917560|NCT00838539|1897452|FG002|Overall Study|Withdrawal by Subject|0
917561|NCT00838539|1897453|FG003|Overall Study|Withdrawal by Subject|0
917562|NCT00838539|1897454|FG004|Overall Study|Withdrawal by Subject|0
917563|NCT00838539|1897455|FG005|Overall Study|Withdrawal by Subject|0
917564|NCT00838539|1897456|FG006|Overall Study|Withdrawal by Subject|0
917565|NCT00838539|1897457|FG007|Overall Study|Withdrawal by Subject|0
917566|NCT00838539|1897458|FG008|Overall Study|Withdrawal by Subject|0
917567|NCT00838539|1897459|FG009|Overall Study|Withdrawal by Subject|1
917568|NCT00838539|1897460|FG010|Overall Study|Withdrawal by Subject|2
917569|NCT00838539|1897461|FG011|Overall Study|Withdrawal by Subject|0
917570|NCT00838539|1897450|FG000|Overall Study|Death|0
917571|NCT00838539|1897451|FG001|Overall Study|Death|0
917572|NCT00838539|1897452|FG002|Overall Study|Death|0
917573|NCT00838539|1897453|FG003|Overall Study|Death|0
917574|NCT00838539|1897454|FG004|Overall Study|Death|0
917575|NCT00838539|1897455|FG005|Overall Study|Death|0
917576|NCT00838539|1897456|FG006|Overall Study|Death|1
917577|NCT00838539|1897457|FG007|Overall Study|Death|0
917578|NCT00838539|1897458|FG008|Overall Study|Death|0
917579|NCT00838539|1897459|FG009|Overall Study|Death|0
917580|NCT00838539|1897460|FG010|Overall Study|Death|0
917581|NCT00838539|1897461|FG011|Overall Study|Death|0
917582|NCT00838539|1897450|FG000|Overall Study|Physician Decision|0
917583|NCT00838539|1897451|FG001|Overall Study|Physician Decision|0
917584|NCT00838539|1897452|FG002|Overall Study|Physician Decision|0
917585|NCT00838539|1897453|FG003|Overall Study|Physician Decision|0
917586|NCT00838539|1897454|FG004|Overall Study|Physician Decision|0
917587|NCT00838539|1897455|FG005|Overall Study|Physician Decision|0
917588|NCT00838539|1897456|FG006|Overall Study|Physician Decision|0
917589|NCT00838539|1897457|FG007|Overall Study|Physician Decision|0
917590|NCT00838539|1897458|FG008|Overall Study|Physician Decision|1
917591|NCT00838539|1897459|FG009|Overall Study|Physician Decision|0
917592|NCT00838539|1897460|FG010|Overall Study|Physician Decision|0
917593|NCT00838539|1897461|FG011|Overall Study|Physician Decision|0
917594|NCT00838539|1897450|FG000|Overall Study|Clinical Progression|0
917595|NCT00838539|1897451|FG001|Overall Study|Clinical Progression|0
917596|NCT00838539|1897452|FG002|Overall Study|Clinical Progression|0
917597|NCT00838539|1897453|FG003|Overall Study|Clinical Progression|0
917598|NCT00838539|1897454|FG004|Overall Study|Clinical Progression|0
917599|NCT00838539|1897455|FG005|Overall Study|Clinical Progression|0
917600|NCT00838539|1897456|FG006|Overall Study|Clinical Progression|1
917601|NCT00838539|1897457|FG007|Overall Study|Clinical Progression|0
917602|NCT00838539|1897458|FG008|Overall Study|Clinical Progression|0
917603|NCT00838539|1897459|FG009|Overall Study|Clinical Progression|0
917604|NCT00838539|1897460|FG010|Overall Study|Clinical Progression|0
917605|NCT00838539|1897461|FG011|Overall Study|Clinical Progression|0
917606|NCT00838539|1897450|FG000|Overall Study|Symptomatic Deterioration|0
917607|NCT00838539|1897451|FG001|Overall Study|Symptomatic Deterioration|0
917608|NCT00838539|1897452|FG002|Overall Study|Symptomatic Deterioration|1
917609|NCT00838539|1897453|FG003|Overall Study|Symptomatic Deterioration|1
917610|NCT00838539|1897454|FG004|Overall Study|Symptomatic Deterioration|0
917611|NCT00838539|1897455|FG005|Overall Study|Symptomatic Deterioration|1
917612|NCT00838539|1897456|FG006|Overall Study|Symptomatic Deterioration|0
917613|NCT00838539|1897457|FG007|Overall Study|Symptomatic Deterioration|0
917614|NCT00838539|1897458|FG008|Overall Study|Symptomatic Deterioration|0
917615|NCT00838539|1897459|FG009|Overall Study|Symptomatic Deterioration|1
917616|NCT00838539|1897460|FG010|Overall Study|Symptomatic Deterioration|0
917617|NCT00838539|1897461|FG011|Overall Study|Symptomatic Deterioration|0
917618|NCT00838565|1897507|FG000|Overall Study|Withdrawal by Subject|0
917619|NCT00838565|1897508|FG001|Overall Study|Withdrawal by Subject|0
917620|NCT00838565|1897509|FG002|Overall Study|Withdrawal by Subject|1
917621|NCT00838565|1897510|FG003|Overall Study|Withdrawal by Subject|0
917622|NCT00838565|1897511|FG004|Overall Study|Withdrawal by Subject|0
917623|NCT00838565|1897512|FG005|Overall Study|Withdrawal by Subject|2
917624|NCT00838565|1897507|FG000|Overall Study|Other|0
917625|NCT00838565|1897508|FG001|Overall Study|Other|2
917626|NCT00838565|1897509|FG002|Overall Study|Other|0
917627|NCT00838565|1897510|FG003|Overall Study|Other|0
917628|NCT00838565|1897511|FG004|Overall Study|Other|0
917629|NCT00838565|1897512|FG005|Overall Study|Other|0
917630|NCT00838565|1897507|FG000|Overall Study|Randomized but not Treated|0
917631|NCT00838565|1897508|FG001|Overall Study|Randomized but not Treated|1
917632|NCT00838565|1897509|FG002|Overall Study|Randomized but not Treated|0
917633|NCT00838565|1897510|FG003|Overall Study|Randomized but not Treated|0
917634|NCT00838565|1897511|FG004|Overall Study|Randomized but not Treated|0
917635|NCT00838565|1897512|FG005|Overall Study|Randomized but not Treated|0
917636|NCT00838578|1897531|FG000|Overall Study|Protocol Violation|2
917637|NCT00838630|1897541|FG000|First Intervention|Adverse Event|1
917638|NCT00838630|1897542|FG001|First Intervention|Adverse Event|0
917639|NCT00838630|1897541|FG000|Washout: 7 Days|Protocol Violation|1
917640|NCT00838630|1897542|FG001|Washout: 7 Days|Protocol Violation|0
917641|NCT00838682|1897548|FG000|Overall Study|Lost to Follow-up|21
917642|NCT00838682|1897549|FG001|Overall Study|Lost to Follow-up|14
917643|NCT00838682|1897548|FG000|Overall Study|detection of exclusion criteria|4
917644|NCT00838682|1897549|FG001|Overall Study|detection of exclusion criteria|3
917645|NCT00838682|1897548|FG000|Overall Study|Protocol Violation|0
917646|NCT00838682|1897549|FG001|Overall Study|Protocol Violation|1
917647|NCT00838682|1897548|FG000|Overall Study|Withdrawal by Subject|0
917648|NCT00838682|1897549|FG001|Overall Study|Withdrawal by Subject|1
917649|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Adverse Event|5
917650|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Adverse Event|13
917651|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Adverse Event|17
917652|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Adverse Event|25
917653|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Protocol Violation|1
917654|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Protocol Violation|6
917655|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Protocol Violation|6
917656|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Protocol Violation|5
917657|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Noncompliance|9
917658|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Noncompliance|13
917659|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Noncompliance|12
917660|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Noncompliance|6
917661|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
917662|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
917663|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
917664|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
917665|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4
917666|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16
917667|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15
917668|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13
917669|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20
917670|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55
917671|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56
917672|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53
917673|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Physician Decision|1
917674|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Physician Decision|2
917675|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Physician Decision|1
917676|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Physician Decision|2
917677|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
917678|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
917679|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
917680|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
917681|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
917682|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
917683|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
917684|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
917685|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0
917686|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0
917687|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0
917688|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1
917689|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
917690|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
917691|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
917692|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
917693|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Pregnancy|0
917694|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Pregnancy|0
917695|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Pregnancy|1
917696|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Pregnancy|0
917697|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
917698|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
917699|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
917700|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
917701|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Site closed|0
917702|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Site closed|0
917703|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Site closed|1
917704|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Site closed|0
917705|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
917706|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
917707|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
917708|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
917709|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
917710|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
917711|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
917712|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
917713|NCT00838903|1897568|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
917714|NCT00838903|1897569|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
917715|NCT00838903|1897570|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
917716|NCT00838903|1897571|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
917717|NCT00838903|1897568|FG000|Follow-up Period (8 Weeks)|Adverse Event|0
917718|NCT00838903|1897569|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
917719|NCT00838903|1897570|FG002|Follow-up Period (8 Weeks)|Adverse Event|3
917720|NCT00838903|1897571|FG003|Follow-up Period (8 Weeks)|Adverse Event|1
917721|NCT00838903|1897568|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
917722|NCT00838903|1897569|FG001|Follow-up Period (8 Weeks)|Noncompliance|8
917723|NCT00838903|1897570|FG002|Follow-up Period (8 Weeks)|Noncompliance|5
917724|NCT00838903|1897571|FG003|Follow-up Period (8 Weeks)|Noncompliance|5
917725|NCT00838903|1897568|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6
917726|NCT00838903|1897569|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28
917727|NCT00838903|1897570|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22
917728|NCT00838903|1897571|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24
917729|NCT00838903|1897568|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
917730|NCT00838903|1897569|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
917731|NCT00838903|1897570|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
917732|NCT00838903|1897571|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
917733|NCT00838903|1897568|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
917734|NCT00838903|1897569|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
917735|NCT00838903|1897570|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
917736|NCT00838903|1897571|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
917737|NCT00838903|1897568|FG000|Follow-up Period (8 Weeks)|Physician Decision|1
917738|NCT00838903|1897569|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
917739|NCT00838903|1897570|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
917740|NCT00838903|1897571|FG003|Follow-up Period (8 Weeks)|Physician Decision|1
917741|NCT00838903|1897568|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
917742|NCT00838903|1897569|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
917743|NCT00838903|1897570|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
917744|NCT00838903|1897571|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
917745|NCT00838903|1897568|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0
917746|NCT00838903|1897569|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1
917747|NCT00838903|1897570|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0
917748|NCT00838903|1897571|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0
917749|NCT00838903|1897568|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
917750|NCT00838903|1897569|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
917751|NCT00838903|1897570|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
917752|NCT00838903|1897571|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
917753|NCT00838903|1897568|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
917754|NCT00838903|1897569|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
917755|NCT00838903|1897570|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
917756|NCT00838903|1897571|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
917757|NCT00838903|1897568|FG000|Follow-up Period (8 Weeks)|Missing|1
917758|NCT00838903|1897569|FG001|Follow-up Period (8 Weeks)|Missing|2
917759|NCT00838903|1897570|FG002|Follow-up Period (8 Weeks)|Missing|1
917760|NCT00838903|1897571|FG003|Follow-up Period (8 Weeks)|Missing|1
917761|NCT00838916|1897583|FG000|Treatment Period (156 Weeks)|Adverse Event|50
917762|NCT00838916|1897584|FG001|Treatment Period (156 Weeks)|Adverse Event|11
917763|NCT00838916|1897583|FG000|Treatment Period (156 Weeks)|Protocol Violation|12
917764|NCT00838916|1897584|FG001|Treatment Period (156 Weeks)|Protocol Violation|3
917765|NCT00838916|1897583|FG000|Treatment Period (156 Weeks)|Noncompliance|21
917766|NCT00838916|1897584|FG001|Treatment Period (156 Weeks)|Noncompliance|14
917767|NCT00838916|1897583|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
917768|NCT00838916|1897584|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
917769|NCT00838916|1897583|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19
917770|NCT00838916|1897584|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18
917771|NCT00838916|1897583|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81
917772|NCT00838916|1897584|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29
917773|NCT00838916|1897583|FG000|Treatment Period (156 Weeks)|Physician Decision|6
917774|NCT00838916|1897584|FG001|Treatment Period (156 Weeks)|Physician Decision|1
917775|NCT00838916|1897583|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
917776|NCT00838916|1897584|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
917777|NCT00838916|1897583|FG000|Treatment Period (156 Weeks)|Missing|3
917778|NCT00838916|1897584|FG001|Treatment Period (156 Weeks)|Missing|1
917779|NCT00838916|1897583|FG000|Treatment Period (156 Weeks)|Pregnancy|2
917780|NCT00838916|1897584|FG001|Treatment Period (156 Weeks)|Pregnancy|0
917781|NCT00838916|1897583|FG000|Follow-up Period (8 Weeks)|Adverse Event|10
917782|NCT00838916|1897584|FG001|Follow-up Period (8 Weeks)|Adverse Event|5
917783|NCT00838916|1897583|FG000|Follow-up Period (8 Weeks)|Noncompliance|6
917784|NCT00838916|1897584|FG001|Follow-up Period (8 Weeks)|Noncompliance|5
917785|NCT00838916|1897583|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38
917786|NCT00838916|1897584|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22
917787|NCT00838916|1897583|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
917788|NCT00838916|1897584|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
917789|NCT00838916|1897583|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
917790|NCT00838916|1897584|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
917791|NCT00838916|1897583|FG000|Follow-up Period (8 Weeks)|Physician Decision|2
917792|NCT00838916|1897584|FG001|Follow-up Period (8 Weeks)|Physician Decision|0
917793|NCT00838916|1897583|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
917794|NCT00838916|1897584|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
917795|NCT00838916|1897583|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
917796|NCT00838916|1897584|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
917797|NCT00838916|1897583|FG000|Follow-up Period (8 Weeks)|Missing|3
917798|NCT00838916|1897584|FG001|Follow-up Period (8 Weeks)|Missing|0
917799|NCT00838929|1897593|FG000|Overall Study|Protocol Violation|0
917800|NCT00838929|1897594|FG001|Overall Study|Protocol Violation|1
917801|NCT00838929|1897595|FG002|Overall Study|Protocol Violation|0
917802|NCT00838929|1897593|FG000|Overall Study|Disease progression|0
917803|NCT00838929|1897594|FG001|Overall Study|Disease progression|2
917804|NCT00838929|1897595|FG002|Overall Study|Disease progression|1
917805|NCT00839072|1897622|FG000|First Intervention Period|Withdrawal by Subject|1
917806|NCT00839072|1897623|FG001|First Intervention Period|Withdrawal by Subject|0
917807|NCT00839072|1897622|FG000|First Intervention Period|Adverse Event|1
917808|NCT00839072|1897623|FG001|First Intervention Period|Adverse Event|1
917809|NCT00839072|1897622|FG000|Second Intervention Period|Withdrawal by Subject|1
917810|NCT00839072|1897623|FG001|Second Intervention Period|Withdrawal by Subject|0
917811|NCT00839098|1897632|FG000|Overall Study|Withdrawal by Subject|2
917812|NCT00839098|1897633|FG001|Overall Study|Withdrawal by Subject|1
917813|NCT00839098|1897634|FG002|Overall Study|Withdrawal by Subject|7
917814|NCT00839254|1897659|FG000|Overall Study|Protocol Violation|0
917815|NCT00839254|1897660|FG001|Overall Study|Protocol Violation|1
917816|NCT00839254|1897661|FG002|Overall Study|Protocol Violation|1
917817|NCT00839254|1897662|FG003|Overall Study|Protocol Violation|1
917818|NCT00839254|1897663|FG004|Overall Study|Protocol Violation|0
917819|NCT00839254|1897664|FG005|Overall Study|Protocol Violation|0
917820|NCT00839254|1897665|FG006|Overall Study|Protocol Violation|1
917821|NCT00839254|1897666|FG007|Overall Study|Protocol Violation|2
917822|NCT00839254|1897659|FG000|Overall Study|Physician Decision|0
917823|NCT00839254|1897660|FG001|Overall Study|Physician Decision|1
917824|NCT00839254|1897661|FG002|Overall Study|Physician Decision|0
917825|NCT00839254|1897662|FG003|Overall Study|Physician Decision|0
917826|NCT00839254|1897663|FG004|Overall Study|Physician Decision|0
917827|NCT00839254|1897664|FG005|Overall Study|Physician Decision|0
917828|NCT00839254|1897665|FG006|Overall Study|Physician Decision|0
917829|NCT00839254|1897666|FG007|Overall Study|Physician Decision|1
917830|NCT00839254|1897659|FG000|Overall Study|Wrong treatment number allocation|0
917831|NCT00839254|1897660|FG001|Overall Study|Wrong treatment number allocation|1
917832|NCT00839254|1897661|FG002|Overall Study|Wrong treatment number allocation|0
917833|NCT00839254|1897662|FG003|Overall Study|Wrong treatment number allocation|0
917834|NCT00839254|1897663|FG004|Overall Study|Wrong treatment number allocation|0
917835|NCT00839254|1897664|FG005|Overall Study|Wrong treatment number allocation|1
917836|NCT00839254|1897665|FG006|Overall Study|Wrong treatment number allocation|0
917837|NCT00839254|1897666|FG007|Overall Study|Wrong treatment number allocation|0
917838|NCT00839254|1897659|FG000|Overall Study|Adverse Event|12
917839|NCT00839254|1897660|FG001|Overall Study|Adverse Event|6
917840|NCT00839254|1897661|FG002|Overall Study|Adverse Event|3
917841|NCT00839254|1897662|FG003|Overall Study|Adverse Event|5
917842|NCT00839254|1897663|FG004|Overall Study|Adverse Event|2
917843|NCT00839254|1897664|FG005|Overall Study|Adverse Event|1
917844|NCT00839254|1897665|FG006|Overall Study|Adverse Event|0
917845|NCT00839254|1897666|FG007|Overall Study|Adverse Event|1
917846|NCT00839254|1897659|FG000|Overall Study|Withdrawal by Subject|87
917847|NCT00839254|1897660|FG001|Overall Study|Withdrawal by Subject|53
917848|NCT00839254|1897661|FG002|Overall Study|Withdrawal by Subject|54
917849|NCT00839254|1897662|FG003|Overall Study|Withdrawal by Subject|32
917850|NCT00839254|1897663|FG004|Overall Study|Withdrawal by Subject|27
917851|NCT00839254|1897664|FG005|Overall Study|Withdrawal by Subject|15
917852|NCT00839254|1897665|FG006|Overall Study|Withdrawal by Subject|22
917853|NCT00839254|1897666|FG007|Overall Study|Withdrawal by Subject|9
917854|NCT00839254|1897659|FG000|Overall Study|Wrong group allocation|0
917855|NCT00839254|1897660|FG001|Overall Study|Wrong group allocation|0
917856|NCT00839254|1897661|FG002|Overall Study|Wrong group allocation|0
917857|NCT00839254|1897662|FG003|Overall Study|Wrong group allocation|0
917858|NCT00839254|1897663|FG004|Overall Study|Wrong group allocation|0
917859|NCT00839254|1897664|FG005|Overall Study|Wrong group allocation|0
917860|NCT00839254|1897665|FG006|Overall Study|Wrong group allocation|1
917861|NCT00839254|1897666|FG007|Overall Study|Wrong group allocation|0
917862|NCT00839254|1897659|FG000|Overall Study|Parents wanted pneumococcal vaccine|1
917863|NCT00839254|1897660|FG001|Overall Study|Parents wanted pneumococcal vaccine|0
917864|NCT00839254|1897661|FG002|Overall Study|Parents wanted pneumococcal vaccine|0
917865|NCT00839254|1897662|FG003|Overall Study|Parents wanted pneumococcal vaccine|0
917866|NCT00839254|1897663|FG004|Overall Study|Parents wanted pneumococcal vaccine|0
917867|NCT00839254|1897664|FG005|Overall Study|Parents wanted pneumococcal vaccine|1
917868|NCT00839254|1897665|FG006|Overall Study|Parents wanted pneumococcal vaccine|0
917869|NCT00839254|1897666|FG007|Overall Study|Parents wanted pneumococcal vaccine|0
917870|NCT00839254|1897659|FG000|Overall Study|Withdrawn due to non-compliance|2
917871|NCT00839254|1897660|FG001|Overall Study|Withdrawn due to non-compliance|0
917872|NCT00839254|1897661|FG002|Overall Study|Withdrawn due to non-compliance|0
917873|NCT00839254|1897662|FG003|Overall Study|Withdrawn due to non-compliance|0
917874|NCT00839254|1897663|FG004|Overall Study|Withdrawn due to non-compliance|0
917875|NCT00839254|1897664|FG005|Overall Study|Withdrawn due to non-compliance|0
917876|NCT00839254|1897665|FG006|Overall Study|Withdrawn due to non-compliance|0
917877|NCT00839254|1897666|FG007|Overall Study|Withdrawn due to non-compliance|0
917878|NCT00839254|1897659|FG000|Overall Study|Lost to Follow-up|51
917879|NCT00839254|1897660|FG001|Overall Study|Lost to Follow-up|30
917880|NCT00839254|1897661|FG002|Overall Study|Lost to Follow-up|32
917881|NCT00839254|1897662|FG003|Overall Study|Lost to Follow-up|24
917882|NCT00839254|1897663|FG004|Overall Study|Lost to Follow-up|8
917883|NCT00839254|1897664|FG005|Overall Study|Lost to Follow-up|8
917884|NCT00839254|1897665|FG006|Overall Study|Lost to Follow-up|4
917885|NCT00839254|1897666|FG007|Overall Study|Lost to Follow-up|2
917886|NCT00839306|1897717|FG000|Overall Study|Adverse Event|3
917887|NCT00839306|1897718|FG001|Overall Study|Adverse Event|5
917888|NCT00839306|1897717|FG000|Overall Study|Lost to Follow-up|6
917889|NCT00839306|1897718|FG001|Overall Study|Lost to Follow-up|9
917890|NCT00839306|1897717|FG000|Overall Study|Withdrawal by Subject|5
917891|NCT00839306|1897718|FG001|Overall Study|Withdrawal by Subject|7
917892|NCT00839306|1897717|FG000|Overall Study|Lack of Efficacy|5
917893|NCT00839306|1897718|FG001|Overall Study|Lack of Efficacy|4
917894|NCT00839306|1897717|FG000|Overall Study|Other|6
917895|NCT00839306|1897718|FG001|Overall Study|Other|18
917896|NCT00839332|1897749|FG000|Phase 1|Disease Progression|38
917897|NCT00839332|1897750|FG001|Phase 1|Disease Progression|0
917898|NCT00839332|1897751|FG002|Phase 1|Disease Progression|0
917899|NCT00839332|1897749|FG000|Phase 1|Adverse Event|6
917900|NCT00839332|1897750|FG001|Phase 1|Adverse Event|0
917901|NCT00839332|1897751|FG002|Phase 1|Adverse Event|0
917902|NCT00839332|1897749|FG000|Phase 1|Withdrawal by Subject|4
917903|NCT00839332|1897750|FG001|Phase 1|Withdrawal by Subject|0
917904|NCT00839332|1897751|FG002|Phase 1|Withdrawal by Subject|0
917905|NCT00839332|1897749|FG000|Phase 1|Physician Decision|2
917906|NCT00839332|1897750|FG001|Phase 1|Physician Decision|0
917907|NCT00839332|1897751|FG002|Phase 1|Physician Decision|0
917908|NCT00839332|1897749|FG000|Phase 2|Protocol Violation|0
917909|NCT00839332|1897750|FG001|Phase 2|Protocol Violation|1
917910|NCT00839332|1897751|FG002|Phase 2|Protocol Violation|0
917911|NCT00839332|1897749|FG000|Phase 2|Disease Progression|0
917912|NCT00839332|1897750|FG001|Phase 2|Disease Progression|46
917913|NCT00839332|1897751|FG002|Phase 2|Disease Progression|21
917914|NCT00839332|1897749|FG000|Phase 2|Adverse Event|0
917915|NCT00839332|1897750|FG001|Phase 2|Adverse Event|8
917916|NCT00839332|1897751|FG002|Phase 2|Adverse Event|6
917917|NCT00839332|1897749|FG000|Phase 2|Death|0
917918|NCT00839332|1897750|FG001|Phase 2|Death|4
917919|NCT00839332|1897751|FG002|Phase 2|Death|2
917920|NCT00839332|1897749|FG000|Phase 2|Withdrawal by Subject|0
917921|NCT00839332|1897750|FG001|Phase 2|Withdrawal by Subject|5
917922|NCT00839332|1897751|FG002|Phase 2|Withdrawal by Subject|8
917923|NCT00839332|1897749|FG000|Phase 2|Physician Decision|0
917924|NCT00839332|1897750|FG001|Phase 2|Physician Decision|4
917925|NCT00839332|1897751|FG002|Phase 2|Physician Decision|1
917926|NCT00839332|1897749|FG000|Phase 2|Lost to Follow-up|0
917927|NCT00839332|1897750|FG001|Phase 2|Lost to Follow-up|0
917928|NCT00839332|1897751|FG002|Phase 2|Lost to Follow-up|1
917929|NCT00839423|1897764|FG000|Overall Study|Adverse Event|4
917930|NCT00839423|1897765|FG001|Overall Study|Adverse Event|3
917931|NCT00839423|1897766|FG002|Overall Study|Adverse Event|7
917932|NCT00839423|1897767|FG003|Overall Study|Adverse Event|16
917933|NCT00839423|1897764|FG000|Overall Study|Lack of Efficacy|6
917934|NCT00839423|1897765|FG001|Overall Study|Lack of Efficacy|6
917935|NCT00839423|1897766|FG002|Overall Study|Lack of Efficacy|3
917936|NCT00839423|1897767|FG003|Overall Study|Lack of Efficacy|2
917937|NCT00839423|1897764|FG000|Overall Study|Non-compliance|0
917938|NCT00839423|1897765|FG001|Overall Study|Non-compliance|0
917939|NCT00839423|1897766|FG002|Overall Study|Non-compliance|0
917940|NCT00839423|1897767|FG003|Overall Study|Non-compliance|1
917941|NCT00839423|1897764|FG000|Overall Study|Protocol Violation|0
917942|NCT00839423|1897765|FG001|Overall Study|Protocol Violation|1
917943|NCT00839423|1897766|FG002|Overall Study|Protocol Violation|2
917944|NCT00839423|1897767|FG003|Overall Study|Protocol Violation|0
917945|NCT00839423|1897764|FG000|Overall Study|Withdrawal of consent|4
917946|NCT00839423|1897765|FG001|Overall Study|Withdrawal of consent|0
917947|NCT00839423|1897766|FG002|Overall Study|Withdrawal of consent|4
917948|NCT00839423|1897767|FG003|Overall Study|Withdrawal of consent|1
917949|NCT00839423|1897764|FG000|Overall Study|Lost to Follow-up|1
917950|NCT00839423|1897765|FG001|Overall Study|Lost to Follow-up|0
917951|NCT00839423|1897766|FG002|Overall Study|Lost to Follow-up|1
917952|NCT00839423|1897767|FG003|Overall Study|Lost to Follow-up|0
917953|NCT00839423|1897764|FG000|Overall Study|Administrative or other reasons|3
917954|NCT00839423|1897765|FG001|Overall Study|Administrative or other reasons|0
917955|NCT00839423|1897766|FG002|Overall Study|Administrative or other reasons|1
917956|NCT00839423|1897767|FG003|Overall Study|Administrative or other reasons|0
917957|NCT00839436|1897780|FG000|Overall Study|Developed exclusionary condition|1
917958|NCT00839436|1897781|FG001|Overall Study|Developed exclusionary condition|0
917959|NCT00839436|1897782|FG002|Overall Study|Developed exclusionary condition|0
917960|NCT00839436|1897780|FG000|Overall Study|Withdrawal by Subject|0
917961|NCT00839436|1897781|FG001|Overall Study|Withdrawal by Subject|1
917962|NCT00839436|1897782|FG002|Overall Study|Withdrawal by Subject|0
917963|NCT00839436|1897780|FG000|Overall Study|Study drug no longer available|0
917964|NCT00839436|1897781|FG001|Overall Study|Study drug no longer available|0
917965|NCT00839436|1897782|FG002|Overall Study|Study drug no longer available|1
917966|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11
917967|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29
917968|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22
917969|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
917970|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
917971|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
917972|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5
917973|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6
917974|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16
917975|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
917976|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
917977|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
917978|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
917979|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
917980|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
917981|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1
917982|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6
917983|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1
917984|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
917985|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
917986|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
917987|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Missing|0
917988|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Missing|1
917989|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Missing|0
917990|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
917991|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
917992|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
917993|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0
917994|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1
917995|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1
917996|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1
917997|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2
917998|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0
917999|NCT00839527|1897793|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
918000|NCT00839527|1897794|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
918001|NCT00839527|1897795|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
918002|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
918003|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
918004|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
918005|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
918006|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
918007|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
918008|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
918009|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
918010|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
918011|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
918012|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
918013|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
918014|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
918015|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
918016|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
918017|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
918018|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
918019|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
918020|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
918021|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
918022|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
918023|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
918024|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
918025|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
918026|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
918027|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
918028|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
918029|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
918030|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
918031|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
918032|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
918033|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
918034|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
918035|NCT00839527|1897793|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
918036|NCT00839527|1897794|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
918037|NCT00839527|1897795|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
918038|NCT00839800|1897820|FG000|Overall Study|Adverse Event|8
918039|NCT00839800|1897821|FG001|Overall Study|Adverse Event|12
918040|NCT00839800|1897820|FG000|Overall Study|Lost to Follow-up|31
918041|NCT00839800|1897821|FG001|Overall Study|Lost to Follow-up|26
918042|NCT00839800|1897820|FG000|Overall Study|Withdrawal by Subject|28
918043|NCT00839800|1897821|FG001|Overall Study|Withdrawal by Subject|34
918044|NCT00839800|1897820|FG000|Overall Study|Incorrect Enrolment|3
918045|NCT00839800|1897821|FG001|Overall Study|Incorrect Enrolment|3
918046|NCT00839800|1897820|FG000|Overall Study|Study-Specific Discontinuation Criteria|6
918047|NCT00839800|1897821|FG001|Overall Study|Study-Specific Discontinuation Criteria|13
918048|NCT00839800|1897820|FG000|Overall Study|Safety Reasons|2
918049|NCT00839800|1897821|FG001|Overall Study|Safety Reasons|1
918050|NCT00839800|1897820|FG000|Overall Study|Other|8
918051|NCT00839800|1897821|FG001|Overall Study|Other|14
918052|NCT00839800|1897820|FG000|Overall Study|Severe Non-Compliance to Protocol|7
918053|NCT00839800|1897821|FG001|Overall Study|Severe Non-Compliance to Protocol|7
918054|NCT00839852|1897827|FG000|Overall Study|Adverse Event|10
918055|NCT00839852|1897827|FG000|Overall Study|Insufficient Therapeutic Response|3
918056|NCT00839852|1897827|FG000|Overall Study|Protocol Violation|9
918057|NCT00839852|1897827|FG000|Overall Study|Withdrawal of Consent|16
918058|NCT00839852|1897827|FG000|Overall Study|Lost to Follow-up|7
918059|NCT00839852|1897827|FG000|Overall Study|Lack of Compliance While in Jail|1
918060|NCT00839852|1897827|FG000|Overall Study|Pregnancy|1
918061|NCT00839917|1897833|FG000|Overall Study|Lost to Follow-up|1
918062|NCT00839917|1897834|FG001|Overall Study|Lost to Follow-up|0
918063|NCT00839917|1897833|FG000|Overall Study|Did not receive vaccine|0
918064|NCT00839917|1897834|FG001|Overall Study|Did not receive vaccine|1
918065|NCT00839956|1897847|FG000|Overall Study|Adverse Event|2
918066|NCT00839956|1897847|FG000|Overall Study|Lack of Efficacy|6
918067|NCT00839956|1897847|FG000|Overall Study|Physician Decision|1
918068|NCT00839956|1897847|FG000|Overall Study|Withdrawal by Subject|3
918069|NCT00840034|1897864|FG000|Acute Treatment Phase|Adverse Event|6
918070|NCT00840034|1897865|FG001|Acute Treatment Phase|Adverse Event|8
918071|NCT00840034|1897864|FG000|Acute Treatment Phase|Lack of Efficacy|2
918072|NCT00840034|1897865|FG001|Acute Treatment Phase|Lack of Efficacy|0
918073|NCT00840034|1897864|FG000|Acute Treatment Phase|Lost to Follow-up|5
918074|NCT00840034|1897865|FG001|Acute Treatment Phase|Lost to Follow-up|12
918075|NCT00840034|1897864|FG000|Acute Treatment Phase|Physician Decision|0
918076|NCT00840034|1897865|FG001|Acute Treatment Phase|Physician Decision|1
918077|NCT00840034|1897864|FG000|Acute Treatment Phase|Protocol Violation|2
918078|NCT00840034|1897865|FG001|Acute Treatment Phase|Protocol Violation|4
918079|NCT00840034|1897864|FG000|Acute Treatment Phase|Withdrawal by Subject|6
918080|NCT00840034|1897865|FG001|Acute Treatment Phase|Withdrawal by Subject|11
918081|NCT00840034|1897864|FG000|Taper Phase|Adverse Event|1
918082|NCT00840034|1897865|FG001|Taper Phase|Adverse Event|0
918083|NCT00840034|1897864|FG000|Taper Phase|Lost to Follow-up|1
918084|NCT00840034|1897865|FG001|Taper Phase|Lost to Follow-up|1
918085|NCT00840034|1897864|FG000|Taper Phase|Withdrawal by Subject|1
918086|NCT00840034|1897865|FG001|Taper Phase|Withdrawal by Subject|1
918087|NCT00840060|1897875|FG000|Overall Study|Withdrawal by Subject|1
918088|NCT00840060|1897876|FG001|Overall Study|Withdrawal by Subject|0
918089|NCT00840060|1897875|FG000|Overall Study|Change in emotional/behavioral status|0
918090|NCT00840060|1897876|FG001|Overall Study|Change in emotional/behavioral status|1
918091|NCT00840073|1897884|FG000|Second Intervention|Missed 72 hour blood draw|1
918092|NCT00840073|1897885|FG001|Second Intervention|Missed 72 hour blood draw|1
918093|NCT00840086|1897889|FG000|Overall Study|Adverse Event|1
918094|NCT00840086|1897889|FG000|Overall Study|Protocol Violation|2
918095|NCT00840086|1897889|FG000|Overall Study|Lost to Follow-up|1
918096|NCT00840177|1897906|FG000|Overall Study|Adverse Event|5
918097|NCT00840177|1897907|FG001|Overall Study|Adverse Event|1
918098|NCT00840177|1897908|FG002|Overall Study|Adverse Event|1
918099|NCT00840177|1897906|FG000|Overall Study|Refusal unrelated to adverse events|1
918100|NCT00840177|1897907|FG001|Overall Study|Refusal unrelated to adverse events|0
918101|NCT00840177|1897908|FG002|Overall Study|Refusal unrelated to adverse events|1
918102|NCT00840177|1897906|FG000|Overall Study|Progression/relapse|2
918103|NCT00840177|1897907|FG001|Overall Study|Progression/relapse|0
918104|NCT00840177|1897908|FG002|Overall Study|Progression/relapse|0
918105|NCT00840177|1897906|FG000|Overall Study|Death|4
918106|NCT00840177|1897907|FG001|Overall Study|Death|5
918107|NCT00840177|1897908|FG002|Overall Study|Death|5
918108|NCT00840177|1897906|FG000|Overall Study|not protocol specified|6
918109|NCT00840177|1897907|FG001|Overall Study|not protocol specified|3
918110|NCT00840177|1897908|FG002|Overall Study|not protocol specified|0
918111|NCT00840177|1897906|FG000|Overall Study|Ineligible|0
918112|NCT00840177|1897907|FG001|Overall Study|Ineligible|0
918113|NCT00840177|1897908|FG002|Overall Study|Ineligible|3
918114|NCT00840177|1897906|FG000|Overall Study|Did not start treatment|0
918115|NCT00840177|1897907|FG001|Overall Study|Did not start treatment|0
918116|NCT00840177|1897908|FG002|Overall Study|Did not start treatment|1
918117|NCT00840203|1897918|FG000|First Intervention|Protocol Violation|1
918118|NCT00840203|1897919|FG001|First Intervention|Protocol Violation|1
918119|NCT00840203|1897918|FG000|Washout|Protocol Violation|1
918120|NCT00840203|1897919|FG001|Washout|Protocol Violation|0
918121|NCT00840216|1897925|FG000|Washout: 7 Days|Withdrawal by Subject|1
918122|NCT00840216|1897926|FG001|Washout: 7 Days|Withdrawal by Subject|0
918123|NCT00840294|1897939|FG000|Overall Study|Withdrawal by Subject|2
918124|NCT00840294|1897940|FG001|Overall Study|Withdrawal by Subject|1
918125|NCT00840294|1897939|FG000|Overall Study|Protocol Violation|1
918126|NCT00840294|1897940|FG001|Overall Study|Protocol Violation|3
918127|NCT00840294|1897939|FG000|Overall Study|Illness|0
918128|NCT00840294|1897940|FG001|Overall Study|Illness|1
918129|NCT00840411|1897952|FG000|First Intervention|Adverse Event|1
918130|NCT00840411|1897953|FG001|First Intervention|Adverse Event|0
918131|NCT00840411|1897952|FG000|Washout|Withdrawal by Subject|1
918132|NCT00840411|1897953|FG001|Washout|Withdrawal by Subject|0
918133|NCT00840450|1897957|FG000|Overall Study|Adverse Event|1
918134|NCT00840450|1897957|FG000|Overall Study|Lack of Efficacy|2
918135|NCT00840463|1897963|FG000|Overall Study|Adverse Event|1
918136|NCT00840463|1897964|FG001|Overall Study|Adverse Event|0
918137|NCT00840632|1897979|FG000|First Intervention|Withdrawal by Subject|0
918138|NCT00840632|1897980|FG001|First Intervention|Withdrawal by Subject|1
918139|NCT00840632|1897979|FG000|Washout|Withdrawal by Subject|1
918140|NCT00840632|1897980|FG001|Washout|Withdrawal by Subject|1
918141|NCT00840658|1897988|FG000|Overall Study|Death|2
918142|NCT00840658|1897989|FG001|Overall Study|Death|2
918143|NCT00840658|1897990|FG002|Overall Study|Death|3
918144|NCT00840658|1897991|FG003|Overall Study|Death|3
918145|NCT00840658|1897988|FG000|Overall Study|Lost to Follow-up|3
918146|NCT00840658|1897989|FG001|Overall Study|Lost to Follow-up|1
918147|NCT00840658|1897990|FG002|Overall Study|Lost to Follow-up|2
918148|NCT00840658|1897991|FG003|Overall Study|Lost to Follow-up|1
918149|NCT00840749|1898007|FG000|Overall Study|Death|1
918150|NCT00840749|1898008|FG001|Overall Study|Death|2
918151|NCT00840749|1898007|FG000|Overall Study|not treated on study arm|11
918152|NCT00840749|1898008|FG001|Overall Study|not treated on study arm|11
918153|NCT00840749|1898007|FG000|Overall Study|study closed|19
918154|NCT00840749|1898008|FG001|Overall Study|study closed|14
918155|NCT00840879|1898030|FG000|Second Intervention|Withdrawal by Subject|1
918156|NCT00840879|1898031|FG001|Second Intervention|Withdrawal by Subject|0
918157|NCT00840970|1898035|FG000|Overall Study|Adverse Event|0
918158|NCT00840970|1898036|FG001|Overall Study|Adverse Event|0
918159|NCT00840970|1898037|FG002|Overall Study|Adverse Event|1
918160|NCT00840996|1898049|FG000|Overall Study|Withdrawal by Subject|1
918161|NCT00840996|1898050|FG001|Overall Study|Withdrawal by Subject|0
918162|NCT00841100|1898065|FG000|Phase 1 (28 Days)|Adverse Event|1
918163|NCT00841100|1898065|FG000|Phase 1 (28 Days)|Participant non-compliance|2
918164|NCT00841321|1898090|FG000|Overall Study|Lost to Follow-up|1
918165|NCT00841321|1898091|FG001|Overall Study|Lost to Follow-up|1
918166|NCT00841321|1898090|FG000|Overall Study|Adverse Event|0
918167|NCT00841321|1898091|FG001|Overall Study|Adverse Event|2
918168|NCT00841542|1898106|FG000|Period 1|Adverse Event|1
918169|NCT00841542|1898107|FG001|Period 1|Adverse Event|0
918170|NCT00841568|1898122|FG000|Overall Study|Adverse Event|1
918171|NCT00841568|1898122|FG000|Overall Study|Death|1
918172|NCT00841568|1898122|FG000|Overall Study|Withdrawal by Subject|2
918173|NCT00841568|1898122|FG000|Overall Study|Creatinine over the withdrawal criteria|1
918174|NCT00841659|1898132|FG000|Washout: 2 Weeks|Protocol Violation|1
918175|NCT00841659|1898133|FG001|Washout: 2 Weeks|Protocol Violation|0
918176|NCT00841672|1898139|FG000|Overall Study|Adverse Event|7
918177|NCT00841672|1898140|FG001|Overall Study|Adverse Event|16
918178|NCT00841672|1898139|FG000|Overall Study|Abnormal test procedure result(s)|0
918179|NCT00841672|1898140|FG001|Overall Study|Abnormal test procedure result(s)|1
918180|NCT00841672|1898139|FG000|Overall Study|Subject withdrew consent|2
918181|NCT00841672|1898140|FG001|Overall Study|Subject withdrew consent|4
918182|NCT00841672|1898139|FG000|Overall Study|Lost to Follow-up|1
918183|NCT00841672|1898140|FG001|Overall Study|Lost to Follow-up|1
918184|NCT00841672|1898139|FG000|Overall Study|Administrative problems|9
918185|NCT00841672|1898140|FG001|Overall Study|Administrative problems|9
918186|NCT00841672|1898139|FG000|Overall Study|Misrandomized|1
918187|NCT00841672|1898140|FG001|Overall Study|Misrandomized|0
918188|NCT00841672|1898139|FG000|Overall Study|Protocol Deviation|0
918189|NCT00841672|1898140|FG001|Overall Study|Protocol Deviation|1
918190|NCT00841698|1898148|FG000|First Intervention|Withdrawal by Subject|1
918191|NCT00841698|1898149|FG001|First Intervention|Withdrawal by Subject|0
918192|NCT00841763|1898155|FG000|Overall Study|Withdrawal by Subject|60
918193|NCT00841763|1898156|FG001|Overall Study|Withdrawal by Subject|17
918194|NCT00841763|1898157|FG002|Overall Study|Withdrawal by Subject|4
918195|NCT00841763|1898158|FG003|Overall Study|Withdrawal by Subject|1
918196|NCT00841763|1898155|FG000|Overall Study|Adverse Event|9
918197|NCT00841763|1898156|FG001|Overall Study|Adverse Event|10
918198|NCT00841763|1898157|FG002|Overall Study|Adverse Event|3
918199|NCT00841763|1898158|FG003|Overall Study|Adverse Event|2
918200|NCT00841763|1898155|FG000|Overall Study|Lost to Follow-up|63
918201|NCT00841763|1898156|FG001|Overall Study|Lost to Follow-up|25
918202|NCT00841763|1898157|FG002|Overall Study|Lost to Follow-up|0
918203|NCT00841763|1898158|FG003|Overall Study|Lost to Follow-up|0
918204|NCT00841763|1898155|FG000|Overall Study|Protocol Violation|20
918205|NCT00841763|1898156|FG001|Overall Study|Protocol Violation|3
918206|NCT00841763|1898157|FG002|Overall Study|Protocol Violation|1
918207|NCT00841763|1898158|FG003|Overall Study|Protocol Violation|0
918208|NCT00841763|1898155|FG000|Overall Study|Administrative Reasons|3
918209|NCT00841763|1898156|FG001|Overall Study|Administrative Reasons|1
918210|NCT00841763|1898157|FG002|Overall Study|Administrative Reasons|0
918211|NCT00841763|1898158|FG003|Overall Study|Administrative Reasons|0
918212|NCT00841763|1898155|FG000|Overall Study|Unable to Classify|7
918213|NCT00841763|1898156|FG001|Overall Study|Unable to Classify|1
918214|NCT00841763|1898157|FG002|Overall Study|Unable to Classify|0
918215|NCT00841763|1898158|FG003|Overall Study|Unable to Classify|0
918216|NCT00841776|1898205|FG000|Overall Study|Lack of Efficacy|0
918217|NCT00841776|1898206|FG001|Overall Study|Lack of Efficacy|1
918218|NCT00841776|1898205|FG000|Overall Study|Lost to Follow-up|2
918219|NCT00841776|1898206|FG001|Overall Study|Lost to Follow-up|1
918220|NCT00841776|1898205|FG000|Overall Study|Withdrawal by Subject|0
918221|NCT00841776|1898206|FG001|Overall Study|Withdrawal by Subject|1
918222|NCT00841815|1898214|FG000|Washout|Withdrawal by Subject|0
918223|NCT00841815|1898215|FG001|Washout|Withdrawal by Subject|1
918224|NCT00841906|1898233|FG000|Overall Study|Withdrawal by Subject|2
918225|NCT00841906|1898234|FG001|Overall Study|Withdrawal by Subject|0
918226|NCT00842153|1898274|FG000|Overall Study|Adverse Event|0
918227|NCT00842153|1898275|FG001|Overall Study|Adverse Event|1
918228|NCT00842153|1898274|FG000|Overall Study|Lost to Follow-up|1
918229|NCT00842153|1898275|FG001|Overall Study|Lost to Follow-up|2
918230|NCT00842244|1898285|FG000|Overall Study|Death|3
918231|NCT00842244|1898285|FG000|Overall Study|Withdrawal by Subject|1
918232|NCT00842244|1898285|FG000|Overall Study|Other|17
918233|NCT00842257|1898292|FG000|Overall Study|Adverse Event|1
918234|NCT00842309|1898302|FG000|Overall Study|Withdrawal by Subject|3
918235|NCT00842309|1898303|FG001|Overall Study|Withdrawal by Subject|1
918236|NCT00842348|1898317|FG000|Patients Randomised in Study 726|Did not enter Study 729|59
918237|NCT00842348|1898318|FG001|Patients Randomised in Study 726|Did not enter Study 729|56
918238|NCT00842348|1898317|FG000|Study 729|Disease progression/death|19
918239|NCT00842348|1898318|FG001|Study 729|Disease progression/death|30
918240|NCT00842348|1898317|FG000|Study 729|Adverse Event|1
918241|NCT00842348|1898318|FG001|Study 729|Adverse Event|1
918242|NCT00842348|1898317|FG000|Study 729|Protocol Violation|1
918243|NCT00842348|1898318|FG001|Study 729|Protocol Violation|1
918244|NCT00842348|1898317|FG000|Study 729|Withdrawal by Subject|2
918245|NCT00842348|1898318|FG001|Study 729|Withdrawal by Subject|4
918246|NCT00842348|1898317|FG000|Study 729|Due to Sponsor stopping the study|1
918247|NCT00842348|1898318|FG001|Study 729|Due to Sponsor stopping the study|1
918248|NCT00842348|1898317|FG000|Study 729|Due to non-availability of IP|0
918249|NCT00842348|1898318|FG001|Study 729|Due to non-availability of IP|1
918250|NCT00842348|1898317|FG000|Study 729|Sponsor's decision|1
918251|NCT00842348|1898318|FG001|Study 729|Sponsor's decision|0
918252|NCT00842348|1898317|FG000|Study 729|Surgical resection|1
918253|NCT00842348|1898318|FG001|Study 729|Surgical resection|0
918254|NCT00842361|1898330|FG000|Overall Study|Protocol Violation|1
918255|NCT00842361|1898331|FG001|Overall Study|Protocol Violation|0
918256|NCT00842361|1898330|FG000|Overall Study|Unclassified|0
918257|NCT00842361|1898331|FG001|Overall Study|Unclassified|2
918258|NCT00842530|1898339|FG000|Overall Study|Serious adverse event|0
918259|NCT00842530|1898340|FG001|Overall Study|Serious adverse event|6
918260|NCT00842530|1898339|FG000|Overall Study|Other adverse event|6
918261|NCT00842530|1898340|FG001|Overall Study|Other adverse event|1
918262|NCT00842530|1898339|FG000|Overall Study|Protocol Violation|32
918263|NCT00842530|1898340|FG001|Overall Study|Protocol Violation|14
918264|NCT00842530|1898339|FG000|Overall Study|Lost to Follow-up|6
918265|NCT00842530|1898340|FG001|Overall Study|Lost to Follow-up|8
918266|NCT00842530|1898339|FG000|Overall Study|Withdrawal by Subject|73
918267|NCT00842530|1898340|FG001|Overall Study|Withdrawal by Subject|28
918268|NCT00842543|1898351|FG000|Overall Study|Withdrawal by Subject|2
918269|NCT00842543|1898352|FG001|Overall Study|Withdrawal by Subject|0
918270|NCT00842543|1898353|FG002|Overall Study|Withdrawal by Subject|3
918271|NCT00842543|1898354|FG003|Overall Study|Withdrawal by Subject|4
918272|NCT00842712|1898390|FG000|Safety Run-in Part|Adverse Event|0
918273|NCT00842712|1898391|FG001|Safety Run-in Part|Adverse Event|1
918274|NCT00842712|1898392|FG002|Safety Run-in Part|Adverse Event|0
918275|NCT00842712|1898393|FG003|Safety Run-in Part|Adverse Event|0
918276|NCT00842712|1898394|FG004|Safety Run-in Part|Adverse Event|0
918277|NCT00842712|1898395|FG005|Safety Run-in Part|Adverse Event|0
918278|NCT00842712|1898396|FG006|Safety Run-in Part|Adverse Event|0
918279|NCT00842712|1898390|FG000|Safety Run-in Part|Progressive disease|3
918280|NCT00842712|1898391|FG001|Safety Run-in Part|Progressive disease|1
918281|NCT00842712|1898392|FG002|Safety Run-in Part|Progressive disease|0
918282|NCT00842712|1898393|FG003|Safety Run-in Part|Progressive disease|1
918283|NCT00842712|1898394|FG004|Safety Run-in Part|Progressive disease|0
918284|NCT00842712|1898395|FG005|Safety Run-in Part|Progressive disease|0
918285|NCT00842712|1898396|FG006|Safety Run-in Part|Progressive disease|0
918286|NCT00842712|1898390|FG000|Randomized Part|Randomized but not treated|0
918287|NCT00842712|1898391|FG001|Randomized Part|Randomized but not treated|0
918288|NCT00842712|1898392|FG002|Randomized Part|Randomized but not treated|0
918289|NCT00842712|1898393|FG003|Randomized Part|Randomized but not treated|0
918290|NCT00842712|1898394|FG004|Randomized Part|Randomized but not treated|0
918291|NCT00842712|1898395|FG005|Randomized Part|Randomized but not treated|1
918292|NCT00842712|1898396|FG006|Randomized Part|Randomized but not treated|4
918293|NCT00842712|1898390|FG000|Randomized Part|Ongoing at cut-off date|0
918294|NCT00842712|1898391|FG001|Randomized Part|Ongoing at cut-off date|0
918295|NCT00842712|1898392|FG002|Randomized Part|Ongoing at cut-off date|0
918296|NCT00842712|1898393|FG003|Randomized Part|Ongoing at cut-off date|0
918297|NCT00842712|1898394|FG004|Randomized Part|Ongoing at cut-off date|0
918298|NCT00842712|1898395|FG005|Randomized Part|Ongoing at cut-off date|0
918299|NCT00842712|1898396|FG006|Randomized Part|Ongoing at cut-off date|2
918300|NCT00842829|1898431|FG000|Dose Titration Period|Adverse Event|11
918301|NCT00842829|1898432|FG001|Dose Titration Period|Adverse Event|10
918302|NCT00842829|1898433|FG002|Dose Titration Period|Adverse Event|0
918303|NCT00842829|1898431|FG000|Dose Titration Period|Lack of Efficacy|4
918304|NCT00842829|1898432|FG001|Dose Titration Period|Lack of Efficacy|1
918305|NCT00842829|1898433|FG002|Dose Titration Period|Lack of Efficacy|0
918306|NCT00842829|1898431|FG000|Dose Titration Period|Unstable persistent cancer pain|1
918307|NCT00842829|1898432|FG001|Dose Titration Period|Unstable persistent cancer pain|0
918308|NCT00842829|1898433|FG002|Dose Titration Period|Unstable persistent cancer pain|0
918309|NCT00842829|1898431|FG000|Dose Titration Period|Withdrawal by Subject|2
918310|NCT00842829|1898432|FG001|Dose Titration Period|Withdrawal by Subject|6
918311|NCT00842829|1898433|FG002|Dose Titration Period|Withdrawal by Subject|0
918312|NCT00842829|1898431|FG000|Dose Titration Period|Other|5
918313|NCT00842829|1898432|FG001|Dose Titration Period|Other|4
918314|NCT00842829|1898433|FG002|Dose Titration Period|Other|0
918315|NCT00842829|1898431|FG000|Dose Titration Period|Non-compliance to study procedures|1
918316|NCT00842829|1898432|FG001|Dose Titration Period|Non-compliance to study procedures|1
918317|NCT00842829|1898433|FG002|Dose Titration Period|Non-compliance to study procedures|0
918318|NCT00842829|1898431|FG000|Dose Titration Period|Non-compliance to study drug|2
918319|NCT00842829|1898432|FG001|Dose Titration Period|Non-compliance to study drug|1
918320|NCT00842829|1898433|FG002|Dose Titration Period|Non-compliance to study drug|0
918321|NCT00842829|1898431|FG000|Treatment Period|Adverse Event|0
918322|NCT00842829|1898432|FG001|Treatment Period|Adverse Event|0
918323|NCT00842829|1898433|FG002|Treatment Period|Adverse Event|15
918324|NCT00842829|1898431|FG000|Treatment Period|Lack of Efficacy|0
918325|NCT00842829|1898432|FG001|Treatment Period|Lack of Efficacy|0
918326|NCT00842829|1898433|FG002|Treatment Period|Lack of Efficacy|6
918327|NCT00842829|1898431|FG000|Treatment Period|Unstable persistent cancer pain|0
918328|NCT00842829|1898432|FG001|Treatment Period|Unstable persistent cancer pain|0
918329|NCT00842829|1898433|FG002|Treatment Period|Unstable persistent cancer pain|5
918330|NCT00842829|1898431|FG000|Treatment Period|Withdrawal by Subject|0
918331|NCT00842829|1898432|FG001|Treatment Period|Withdrawal by Subject|0
918332|NCT00842829|1898433|FG002|Treatment Period|Withdrawal by Subject|11
918333|NCT00842829|1898431|FG000|Treatment Period|Consistently >4 BTP episodes daily|0
918334|NCT00842829|1898432|FG001|Treatment Period|Consistently >4 BTP episodes daily|0
918335|NCT00842829|1898433|FG002|Treatment Period|Consistently >4 BTP episodes daily|1
918336|NCT00842829|1898431|FG000|Treatment Period|Protocol Violation|0
918337|NCT00842829|1898432|FG001|Treatment Period|Protocol Violation|0
918338|NCT00842829|1898433|FG002|Treatment Period|Protocol Violation|2
918339|NCT00842829|1898431|FG000|Treatment Period|Other|0
918340|NCT00842829|1898432|FG001|Treatment Period|Other|0
918341|NCT00842829|1898433|FG002|Treatment Period|Other|18
918342|NCT00842829|1898431|FG000|Treatment Period|Non-compliance to study procedures|0
918343|NCT00842829|1898432|FG001|Treatment Period|Non-compliance to study procedures|0
918344|NCT00842829|1898433|FG002|Treatment Period|Non-compliance to study procedures|4
918345|NCT00842829|1898431|FG000|Treatment Period|Unclear completion status|0
918346|NCT00842829|1898432|FG001|Treatment Period|Unclear completion status|0
918347|NCT00842829|1898433|FG002|Treatment Period|Unclear completion status|1
918348|NCT00842829|1898431|FG000|Continuation Period|Adverse Event|0
918349|NCT00842829|1898432|FG001|Continuation Period|Adverse Event|0
918350|NCT00842829|1898433|FG002|Continuation Period|Adverse Event|32
918351|NCT00842829|1898431|FG000|Continuation Period|Lack of Efficacy|0
918352|NCT00842829|1898432|FG001|Continuation Period|Lack of Efficacy|0
918353|NCT00842829|1898433|FG002|Continuation Period|Lack of Efficacy|6
918354|NCT00842829|1898431|FG000|Continuation Period|Unstable persistent cancer pain|0
918355|NCT00842829|1898432|FG001|Continuation Period|Unstable persistent cancer pain|0
918356|NCT00842829|1898433|FG002|Continuation Period|Unstable persistent cancer pain|3
918357|NCT00842829|1898431|FG000|Continuation Period|Withdrawal by Subject|0
918358|NCT00842829|1898432|FG001|Continuation Period|Withdrawal by Subject|0
918359|NCT00842829|1898433|FG002|Continuation Period|Withdrawal by Subject|10
918360|NCT00842829|1898431|FG000|Continuation Period|Other|0
918361|NCT00842829|1898432|FG001|Continuation Period|Other|0
918362|NCT00842829|1898433|FG002|Continuation Period|Other|7
918363|NCT00842829|1898431|FG000|Continuation Period|Non-compliance to study procedures|0
918364|NCT00842829|1898432|FG001|Continuation Period|Non-compliance to study procedures|0
918365|NCT00842829|1898433|FG002|Continuation Period|Non-compliance to study procedures|2
918366|NCT00842829|1898431|FG000|Continuation Period|Non-compliance to study drug|0
918367|NCT00842829|1898432|FG001|Continuation Period|Non-compliance to study drug|0
918368|NCT00842829|1898433|FG002|Continuation Period|Non-compliance to study drug|1
918369|NCT00842985|1898454|FG000|Screening|Did not meet entrance requirements|27
918370|NCT00842985|1898454|FG000|First Intervention|Withdrawal by Subject|3
918371|NCT00842985|1898454|FG000|First Intervention|Protocol Violation|3
918372|NCT00842985|1898454|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
918373|NCT00842985|1898454|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
918374|NCT00843024|1898465|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
918375|NCT00843024|1898466|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
918376|NCT00843024|1898467|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
918377|NCT00843024|1898468|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
918378|NCT00843024|1898469|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
918379|NCT00843024|1898470|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
918380|NCT00843024|1898465|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
918381|NCT00843024|1898466|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
918382|NCT00843024|1898467|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
918383|NCT00843024|1898468|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
918384|NCT00843024|1898469|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
918385|NCT00843024|1898470|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
918386|NCT00843024|1898465|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
918387|NCT00843024|1898466|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
918388|NCT00843024|1898467|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
918389|NCT00843024|1898468|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
918390|NCT00843024|1898469|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
918391|NCT00843024|1898470|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
918392|NCT00843024|1898465|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4
918393|NCT00843024|1898466|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5
918394|NCT00843024|1898467|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0
918395|NCT00843024|1898468|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0
918396|NCT00843024|1898469|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0
918397|NCT00843024|1898470|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0
918398|NCT00843024|1898465|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2
918399|NCT00843024|1898466|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6
918400|NCT00843024|1898467|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0
918401|NCT00843024|1898468|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0
918402|NCT00843024|1898469|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0
918403|NCT00843024|1898470|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0
918404|NCT00843024|1898465|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0
918405|NCT00843024|1898466|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1
918406|NCT00843024|1898467|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0
918407|NCT00843024|1898468|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0
918408|NCT00843024|1898469|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0
918409|NCT00843024|1898470|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0
918410|NCT00843024|1898465|FG000|Single-blind Placebo Run-In Phase|Other|0
918411|NCT00843024|1898466|FG001|Single-blind Placebo Run-In Phase|Other|1
918412|NCT00843024|1898467|FG002|Single-blind Placebo Run-In Phase|Other|0
918413|NCT00843024|1898468|FG003|Single-blind Placebo Run-In Phase|Other|0
918414|NCT00843024|1898469|FG004|Single-blind Placebo Run-In Phase|Other|0
918415|NCT00843024|1898470|FG005|Single-blind Placebo Run-In Phase|Other|0
918416|NCT00843024|1898465|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0
918417|NCT00843024|1898466|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0
918418|NCT00843024|1898467|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20
918419|NCT00843024|1898468|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10
918420|NCT00843024|1898469|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13
918421|NCT00843024|1898470|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14
918422|NCT00843024|1898465|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
918423|NCT00843024|1898466|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
918424|NCT00843024|1898467|FG002|Double-blind Treatment Phase|Lost to Follow-up|8
918425|NCT00843024|1898468|FG003|Double-blind Treatment Phase|Lost to Follow-up|4
918426|NCT00843024|1898469|FG004|Double-blind Treatment Phase|Lost to Follow-up|4
918427|NCT00843024|1898470|FG005|Double-blind Treatment Phase|Lost to Follow-up|4
918428|NCT00843024|1898465|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
918429|NCT00843024|1898466|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0
918430|NCT00843024|1898467|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
918431|NCT00843024|1898468|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6
918432|NCT00843024|1898469|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
918433|NCT00843024|1898470|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2
918434|NCT00843024|1898465|FG000|Double-blind Treatment Phase|Protocol Violation|0
918435|NCT00843024|1898466|FG001|Double-blind Treatment Phase|Protocol Violation|0
918436|NCT00843024|1898467|FG002|Double-blind Treatment Phase|Protocol Violation|3
918437|NCT00843024|1898468|FG003|Double-blind Treatment Phase|Protocol Violation|0
918438|NCT00843024|1898469|FG004|Double-blind Treatment Phase|Protocol Violation|0
918439|NCT00843024|1898470|FG005|Double-blind Treatment Phase|Protocol Violation|3
918440|NCT00843024|1898465|FG000|Double-blind Treatment Phase|Physician Decision|0
918441|NCT00843024|1898466|FG001|Double-blind Treatment Phase|Physician Decision|0
918442|NCT00843024|1898467|FG002|Double-blind Treatment Phase|Physician Decision|0
918443|NCT00843024|1898468|FG003|Double-blind Treatment Phase|Physician Decision|3
918444|NCT00843024|1898469|FG004|Double-blind Treatment Phase|Physician Decision|1
918445|NCT00843024|1898470|FG005|Double-blind Treatment Phase|Physician Decision|1
918446|NCT00843024|1898465|FG000|Double-blind Treatment Phase|Adverse Event|0
918447|NCT00843024|1898466|FG001|Double-blind Treatment Phase|Adverse Event|0
918448|NCT00843024|1898467|FG002|Double-blind Treatment Phase|Adverse Event|0
918449|NCT00843024|1898468|FG003|Double-blind Treatment Phase|Adverse Event|0
918450|NCT00843024|1898469|FG004|Double-blind Treatment Phase|Adverse Event|1
918451|NCT00843024|1898470|FG005|Double-blind Treatment Phase|Adverse Event|1
918452|NCT00843024|1898465|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
918453|NCT00843024|1898466|FG001|Double-blind Treatment Phase|Lack of Efficacy|0
918454|NCT00843024|1898467|FG002|Double-blind Treatment Phase|Lack of Efficacy|0
918455|NCT00843024|1898468|FG003|Double-blind Treatment Phase|Lack of Efficacy|0
918456|NCT00843024|1898469|FG004|Double-blind Treatment Phase|Lack of Efficacy|1
918457|NCT00843024|1898470|FG005|Double-blind Treatment Phase|Lack of Efficacy|0
918458|NCT00843115|1898483|FG000|Overall Study|Death|4
918459|NCT00843115|1898483|FG000|Overall Study|Adverse Event|30
918460|NCT00843115|1898483|FG000|Overall Study|Lost to Follow-up|4
918461|NCT00843115|1898483|FG000|Overall Study|Withdrawal by Subject|17
918462|NCT00843115|1898483|FG000|Overall Study|Family wanted meds stopped|1
918463|NCT00843115|1898483|FG000|Overall Study|Family does not want continuation|1
918464|NCT00843115|1898483|FG000|Overall Study|Patient forgot to take meds|1
918465|NCT00843115|1898483|FG000|Overall Study|Does not meet entrance criteria|1
918466|NCT00843115|1898483|FG000|Overall Study|Physician Decision|1
918467|NCT00843115|1898483|FG000|Overall Study|Family discontinued meds|1
918468|NCT00843115|1898483|FG000|Overall Study|patient took for 2 days then stopped|1
918469|NCT00843115|1898483|FG000|Overall Study|patient never took the medication|1
918470|NCT00843115|1898483|FG000|Overall Study|hospitalized due to deterioration|1
918471|NCT00843115|1898483|FG000|Overall Study|week 12 not done|1
918472|NCT00843115|1898483|FG000|Overall Study|Syndrome De Glissement|1
918473|NCT00843167|1898489|FG000|Treatment Period|Adverse Event|1
918474|NCT00843167|1898490|FG001|Treatment Period|Adverse Event|5
918475|NCT00843167|1898489|FG000|Treatment Period|Withdrawal by Subject|2
918476|NCT00843167|1898490|FG001|Treatment Period|Withdrawal by Subject|3
918477|NCT00843193|1898511|FG000|Overall Study|Adverse Event|2
918478|NCT00843193|1898512|FG001|Overall Study|Adverse Event|4
918479|NCT00843193|1898511|FG000|Overall Study|Lack of Efficacy|1
918480|NCT00843193|1898512|FG001|Overall Study|Lack of Efficacy|1
918481|NCT00843193|1898511|FG000|Overall Study|Protocol Violation|1
918482|NCT00843193|1898512|FG001|Overall Study|Protocol Violation|2
918483|NCT00843193|1898511|FG000|Overall Study|Lost to Follow-up|1
918484|NCT00843193|1898512|FG001|Overall Study|Lost to Follow-up|0
918485|NCT00843193|1898511|FG000|Overall Study|Physician Decision|0
918486|NCT00843193|1898512|FG001|Overall Study|Physician Decision|1
918487|NCT00843193|1898511|FG000|Overall Study|Withdrawal by Subject|3
918488|NCT00843193|1898512|FG001|Overall Study|Withdrawal by Subject|3
918489|NCT00843284|1898519|FG000|Overall Study|Adverse Event|39
918490|NCT00843284|1898519|FG000|Overall Study|Lack of Efficacy|5
918491|NCT00843284|1898519|FG000|Overall Study|Lost to Follow-up|11
918492|NCT00843284|1898519|FG000|Overall Study|Other|10
918493|NCT00843284|1898519|FG000|Overall Study|Withdrawal by Subject|4
918494|NCT00843284|1898519|FG000|Overall Study|Death|3
918495|NCT00843492|1898562|FG000|Overall Study|Adverse Event|0
918496|NCT00843492|1898563|FG001|Overall Study|Adverse Event|3
918497|NCT00843492|1898562|FG000|Overall Study|Lost to Follow-up|4
918498|NCT00843492|1898563|FG001|Overall Study|Lost to Follow-up|4
918499|NCT00843492|1898562|FG000|Overall Study|Withdrawal by Subject|0
918500|NCT00843492|1898563|FG001|Overall Study|Withdrawal by Subject|4
918501|NCT00843492|1898562|FG000|Overall Study|Immobilization Stopped|1
918502|NCT00843492|1898563|FG001|Overall Study|Immobilization Stopped|0
918503|NCT00843492|1898562|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1
918504|NCT00843492|1898563|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1
918505|NCT00843492|1898562|FG000|Overall Study|Orthopedic Surgery|0
918506|NCT00843492|1898563|FG001|Overall Study|Orthopedic Surgery|2
918507|NCT00843492|1898562|FG000|Overall Study|Visit Not Performed|1
918508|NCT00843492|1898563|FG001|Overall Study|Visit Not Performed|0
918509|NCT00843492|1898562|FG000|Overall Study|Deep-vein Thrombosis|1
918510|NCT00843492|1898563|FG001|Overall Study|Deep-vein Thrombosis|0
918511|NCT00843518|1898571|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5
918512|NCT00843518|1898572|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3
918513|NCT00843518|1898571|FG000|Period 2 (Double-blind Treatment)|Death|0
918514|NCT00843518|1898572|FG001|Period 2 (Double-blind Treatment)|Death|1
918515|NCT00843518|1898571|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
918516|NCT00843518|1898572|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
918517|NCT00843518|1898571|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2
918518|NCT00843518|1898572|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1
918519|NCT00843518|1898571|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2
918520|NCT00843518|1898572|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5
918521|NCT00843518|1898571|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
918522|NCT00843518|1898572|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
918523|NCT00843518|1898571|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7
918524|NCT00843518|1898572|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7
918525|NCT00843635|1898602|FG000|Overall Study|Adverse Event|2
918526|NCT00843635|1898603|FG001|Overall Study|Adverse Event|2
918527|NCT00843635|1898604|FG002|Overall Study|Adverse Event|0
918528|NCT00843726|1898627|FG000|Overall Study|Death|1
918529|NCT00843726|1898628|FG001|Overall Study|Death|0
918530|NCT00843726|1898627|FG000|Overall Study|Withdrawal by Subject|0
918531|NCT00843726|1898628|FG001|Overall Study|Withdrawal by Subject|1
918532|NCT00843778|1898635|FG000|Overall Study|Adverse Event|15
918533|NCT00843778|1898635|FG000|Overall Study|Lack of Efficacy|14
918534|NCT00843778|1898635|FG000|Overall Study|Loss of efficacy|2
918535|NCT00843778|1898635|FG000|Overall Study|Withdrawal by Subject|4
918536|NCT00843843|1898641|FG000|Overall Study|Physician Decision|1
918537|NCT00843843|1898642|FG001|Overall Study|Physician Decision|1
918538|NCT00843843|1898641|FG000|Overall Study|Protocol Violation|1
918539|NCT00843843|1898642|FG001|Overall Study|Protocol Violation|1
918540|NCT00843856|1898650|FG000|Overall Study|Lost to Follow-up|1
918541|NCT00843856|1898651|FG001|Overall Study|Lost to Follow-up|2
918596|NCT00844194|1898695|FG000|Overall Study|Adverse Event|17
918597|NCT00844194|1898696|FG001|Overall Study|Adverse Event|5
918598|NCT00844194|1898695|FG000|Overall Study|Protocol Violation|1
918599|NCT00844194|1898696|FG001|Overall Study|Protocol Violation|1
918600|NCT00844194|1898695|FG000|Overall Study|Lost to Follow-up|1
918601|NCT00844194|1898696|FG001|Overall Study|Lost to Follow-up|1
918602|NCT00844194|1898695|FG000|Overall Study|Withdrawal by Subject|2
918603|NCT00844194|1898696|FG001|Overall Study|Withdrawal by Subject|1
918604|NCT00844194|1898695|FG000|Overall Study|Lack of Efficacy|3
918605|NCT00844194|1898696|FG001|Overall Study|Lack of Efficacy|0
918606|NCT00844194|1898695|FG000|Overall Study|Other reason (not specified)|1
918607|NCT00844194|1898696|FG001|Overall Study|Other reason (not specified)|0
918608|NCT00844376|1898710|FG000|Period 1: First Intervention|Withdrawal by Subject|1
918609|NCT00844376|1898711|FG001|Period 1: First Intervention|Withdrawal by Subject|0
918610|NCT00844415|1898717|FG000|Overall Study|Withdrawal by Subject|1
918611|NCT00844428|1898722|FG000|Screening Period|Screen Failure|3
918612|NCT00844428|1898722|FG000|Extension Treatment Period|Death|1
918613|NCT00844428|1898722|FG000|Post Treatment Period (Patients Who Disc|Death|1
918614|NCT00844519|1898737|FG000|Overall Study|Withdrawal by Subject|1
918615|NCT00844519|1898738|FG001|Overall Study|Withdrawal by Subject|1
918616|NCT00844519|1898737|FG000|Overall Study|Adverse Event|1
918617|NCT00844519|1898738|FG001|Overall Study|Adverse Event|0
918618|NCT00844532|1898744|FG000|Overall Study|Death|16
918619|NCT00844532|1898744|FG000|Overall Study|Withdrawal by Subject|16
918620|NCT00844532|1898744|FG000|Overall Study|Lost to Follow-up|7
918621|NCT00844545|1898748|FG000|Treatment Period (26 Weeks)|Adverse Event|1
918622|NCT00844545|1898748|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
918623|NCT00844545|1898748|FG000|Extension Treatment Period|Adverse Event|2
918624|NCT00844545|1898748|FG000|Post Treatment Period|Withdrawal by Subject|1
918625|NCT00844558|1898755|FG000|Overall Study|Withdrawal by Subject|9
918626|NCT00844558|1898756|FG001|Overall Study|Withdrawal by Subject|2
918627|NCT00844558|1898755|FG000|Overall Study|Death|1
918628|NCT00844558|1898756|FG001|Overall Study|Death|0
918629|NCT00844558|1898755|FG000|Overall Study|Protocol Violation|1
918630|NCT00844558|1898756|FG001|Overall Study|Protocol Violation|1
918631|NCT00844558|1898755|FG000|Overall Study|Lost to Follow-up|0
918632|NCT00844558|1898756|FG001|Overall Study|Lost to Follow-up|1
918633|NCT00844558|1898755|FG000|Overall Study|Physician Decision|1
918634|NCT00844558|1898756|FG001|Overall Study|Physician Decision|0
918635|NCT00844597|1898773|FG000|Overall Study|Adverse Event|0
918636|NCT00844597|1898774|FG001|Overall Study|Adverse Event|0
918637|NCT00844597|1898775|FG002|Overall Study|Adverse Event|0
918638|NCT00844597|1898776|FG003|Overall Study|Adverse Event|1
918639|NCT00844597|1898777|FG004|Overall Study|Adverse Event|0
918640|NCT00844597|1898778|FG005|Overall Study|Adverse Event|0
918641|NCT00844649|1898796|FG000|Overall Study|Progressive Disease|196
918642|NCT00844649|1898797|FG001|Overall Study|Progressive Disease|245
918643|NCT00844649|1898796|FG000|Overall Study|Adverse Event|128
918644|NCT00844649|1898797|FG001|Overall Study|Adverse Event|73
918645|NCT00844649|1898796|FG000|Overall Study|Physician Decision|25
918646|NCT00844649|1898797|FG001|Overall Study|Physician Decision|18
918647|NCT00844649|1898796|FG000|Overall Study|Protocol Violation|10
918648|NCT00844649|1898797|FG001|Overall Study|Protocol Violation|6
918649|NCT00844649|1898796|FG000|Overall Study|Withdrawal by Subject|28
918650|NCT00844649|1898797|FG001|Overall Study|Withdrawal by Subject|39
918651|NCT00844649|1898796|FG000|Overall Study|Other|7
918652|NCT00844649|1898797|FG001|Overall Study|Other|10
918653|NCT00844649|1898796|FG000|Overall Study|Withdrew prior to starting treatment|11
918654|NCT00844649|1898797|FG001|Overall Study|Withdrew prior to starting treatment|27
918655|NCT00844753|1898813|FG000|Overall Study|Lack of Efficacy|1
918656|NCT00844753|1898814|FG001|Overall Study|Lack of Efficacy|0
918657|NCT00844753|1898815|FG002|Overall Study|Lack of Efficacy|2
918658|NCT00844753|1898816|FG003|Overall Study|Lack of Efficacy|2
918659|NCT00844753|1898813|FG000|Overall Study|Adverse Event|3
918660|NCT00844753|1898814|FG001|Overall Study|Adverse Event|2
918661|NCT00844753|1898815|FG002|Overall Study|Adverse Event|5
918662|NCT00844753|1898816|FG003|Overall Study|Adverse Event|5
918663|NCT00844753|1898813|FG000|Overall Study|Lost to Follow-up|1
918664|NCT00844753|1898814|FG001|Overall Study|Lost to Follow-up|1
918665|NCT00844753|1898815|FG002|Overall Study|Lost to Follow-up|0
918666|NCT00844753|1898816|FG003|Overall Study|Lost to Follow-up|1
918667|NCT00844753|1898813|FG000|Overall Study|could not swallow medication|2
918668|NCT00844753|1898814|FG001|Overall Study|could not swallow medication|0
918669|NCT00844753|1898815|FG002|Overall Study|could not swallow medication|0
918670|NCT00844753|1898816|FG003|Overall Study|could not swallow medication|0
918671|NCT00844753|1898813|FG000|Overall Study|Withdrawal by Subject|1
918672|NCT00844753|1898814|FG001|Overall Study|Withdrawal by Subject|0
918673|NCT00844753|1898815|FG002|Overall Study|Withdrawal by Subject|0
918674|NCT00844753|1898816|FG003|Overall Study|Withdrawal by Subject|3
918675|NCT00844805|1898826|FG000|Treatment Phase|Adverse Event|5
918676|NCT00844805|1898827|FG001|Treatment Phase|Adverse Event|1
918677|NCT00844805|1898828|FG002|Treatment Phase|Adverse Event|0
918678|NCT00844805|1898829|FG003|Treatment Phase|Adverse Event|0
918679|NCT00844805|1898826|FG000|Treatment Phase|Withdrawal by Subject|3
918680|NCT00844805|1898827|FG001|Treatment Phase|Withdrawal by Subject|4
918681|NCT00844805|1898828|FG002|Treatment Phase|Withdrawal by Subject|0
918682|NCT00844805|1898829|FG003|Treatment Phase|Withdrawal by Subject|0
918683|NCT00844805|1898826|FG000|Treatment Phase|Noncompliance With Protocol|1
918684|NCT00844805|1898827|FG001|Treatment Phase|Noncompliance With Protocol|0
918685|NCT00844805|1898828|FG002|Treatment Phase|Noncompliance With Protocol|0
918686|NCT00844805|1898829|FG003|Treatment Phase|Noncompliance With Protocol|0
918687|NCT00844805|1898826|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1
918688|NCT00844805|1898827|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2
918689|NCT00844805|1898828|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0
918690|NCT00844805|1898829|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0
918691|NCT00844805|1898826|FG000|Follow-Up Phase|Adverse Event|0
918692|NCT00844805|1898827|FG001|Follow-Up Phase|Adverse Event|0
918693|NCT00844805|1898828|FG002|Follow-Up Phase|Adverse Event|1
918694|NCT00844805|1898829|FG003|Follow-Up Phase|Adverse Event|0
918695|NCT00844805|1898826|FG000|Follow-Up Phase|Withdrawal by Subject|0
918696|NCT00844805|1898827|FG001|Follow-Up Phase|Withdrawal by Subject|0
918697|NCT00844805|1898828|FG002|Follow-Up Phase|Withdrawal by Subject|6
918698|NCT00844805|1898829|FG003|Follow-Up Phase|Withdrawal by Subject|3
918699|NCT00844805|1898826|FG000|Follow-Up Phase|Noncompliance With Protocol|0
918700|NCT00844805|1898827|FG001|Follow-Up Phase|Noncompliance With Protocol|0
918701|NCT00844805|1898828|FG002|Follow-Up Phase|Noncompliance With Protocol|0
918702|NCT00844805|1898829|FG003|Follow-Up Phase|Noncompliance With Protocol|1
918703|NCT00844805|1898826|FG000|Follow-Up Phase|Relapse/Recurrence|0
918704|NCT00844805|1898827|FG001|Follow-Up Phase|Relapse/Recurrence|0
918705|NCT00844805|1898828|FG002|Follow-Up Phase|Relapse/Recurrence|2
918706|NCT00844805|1898829|FG003|Follow-Up Phase|Relapse/Recurrence|4
918707|NCT00844805|1898826|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
918708|NCT00844805|1898827|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
918709|NCT00844805|1898828|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
918710|NCT00844805|1898829|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
918711|NCT00844831|1898840|FG000|Overall Study|Withdrawal by Subject|4
918712|NCT00844831|1898840|FG000|Overall Study|Adverse Event|1
918713|NCT00844831|1898840|FG000|Overall Study|Physician Decision|1
918714|NCT00844844|1898848|FG000|Treatment Period (26 Weeks)|Adverse Event|1
918715|NCT00844844|1898848|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
918716|NCT00844844|1898848|FG000|Extension Treatment Period|Adverse Event|2
918717|NCT00844844|1898848|FG000|Post Treatment Period|Withdrawal by Subject|1
918718|NCT00844857|1898854|FG000|Overall Study|Adverse Event|24
918719|NCT00844857|1898855|FG001|Overall Study|Adverse Event|5
918720|NCT00844857|1898854|FG000|Overall Study|Sponsor Decision|1
918721|NCT00844857|1898855|FG001|Overall Study|Sponsor Decision|1
918722|NCT00844857|1898854|FG000|Overall Study|Physician Decision|2
918723|NCT00844857|1898855|FG001|Overall Study|Physician Decision|0
918724|NCT00844857|1898854|FG000|Overall Study|Parent/Caregiver Decision|6
918725|NCT00844857|1898855|FG001|Overall Study|Parent/Caregiver Decision|2
918726|NCT00844857|1898854|FG000|Overall Study|Withdrawal by Subject|8
918727|NCT00844857|1898855|FG001|Overall Study|Withdrawal by Subject|7
918728|NCT00844857|1898854|FG000|Overall Study|Protocol Violation|6
918729|NCT00844857|1898855|FG001|Overall Study|Protocol Violation|0
918730|NCT00844857|1898854|FG000|Overall Study|Lack of Efficacy|5
918731|NCT00844857|1898855|FG001|Overall Study|Lack of Efficacy|5
918732|NCT00844857|1898854|FG000|Overall Study|Clinical Relapse|0
918733|NCT00844857|1898855|FG001|Overall Study|Clinical Relapse|1
918734|NCT00844857|1898854|FG000|Overall Study|Entry Criteria Not Met|0
918735|NCT00844857|1898855|FG001|Overall Study|Entry Criteria Not Met|1
918736|NCT00844857|1898854|FG000|Overall Study|Lost to Follow-up|2
918737|NCT00844857|1898855|FG001|Overall Study|Lost to Follow-up|3
918738|NCT00844857|1898854|FG000|Overall Study|Did Not Take Study Drug|3
918739|NCT00844857|1898855|FG001|Overall Study|Did Not Take Study Drug|1
918740|NCT00844857|1898854|FG000|Overall Study|Good Clinical Practice Violations|21
918741|NCT00844857|1898855|FG001|Overall Study|Good Clinical Practice Violations|11
918742|NCT00844883|1898864|FG000|Overall Study|Bridged to liver transplant|3
918743|NCT00844883|1898864|FG000|Overall Study|Bridged to resection|1
918744|NCT00844896|1898870|FG000|Overall Study|Lost to Follow-up|12
918745|NCT00844896|1898871|FG001|Overall Study|Lost to Follow-up|16
918746|NCT00844896|1898870|FG000|Overall Study|Parents did not have time to complete|0
918747|NCT00844896|1898871|FG001|Overall Study|Parents did not have time to complete|1
918748|NCT00845065|1898910|FG000|Overall Study|Adverse Event|3
918749|NCT00845065|1898911|FG001|Overall Study|Adverse Event|23
918750|NCT00845065|1898910|FG000|Overall Study|Lack of Efficacy|43
918751|NCT00845065|1898911|FG001|Overall Study|Lack of Efficacy|21
918752|NCT00845065|1898910|FG000|Overall Study|Non-Medical Reasons|1
918753|NCT00845065|1898911|FG001|Overall Study|Non-Medical Reasons|11
918754|NCT00845182|1898931|FG000|Overall Study|Lost to Follow-up|3
918755|NCT00845182|1898932|FG001|Overall Study|Lost to Follow-up|3
918756|NCT00845182|1898933|FG002|Overall Study|Lost to Follow-up|4
918757|NCT00845182|1898931|FG000|Overall Study|Adverse Event|0
918758|NCT00845182|1898932|FG001|Overall Study|Adverse Event|1
918759|NCT00845182|1898933|FG002|Overall Study|Adverse Event|1
918760|NCT00845182|1898931|FG000|Overall Study|Physician Decision|0
918761|NCT00845182|1898932|FG001|Overall Study|Physician Decision|0
918762|NCT00845182|1898933|FG002|Overall Study|Physician Decision|1
918763|NCT00845429|1898957|FG000|Overall Study|Protocol Violation|5
918764|NCT00845429|1898958|FG001|Overall Study|Protocol Violation|4
918765|NCT00845429|1898959|FG002|Overall Study|Protocol Violation|7
918766|NCT00845429|1898957|FG000|Overall Study|Lost to Follow-up|7
918767|NCT00845429|1898958|FG001|Overall Study|Lost to Follow-up|9
918768|NCT00845429|1898959|FG002|Overall Study|Lost to Follow-up|10
918769|NCT00845429|1898957|FG000|Overall Study|Withdrawal by Subject|2
918770|NCT00845429|1898958|FG001|Overall Study|Withdrawal by Subject|2
918771|NCT00845429|1898959|FG002|Overall Study|Withdrawal by Subject|2
918772|NCT00845429|1898957|FG000|Overall Study|Serious adverse event|0
918773|NCT00845429|1898958|FG001|Overall Study|Serious adverse event|0
918774|NCT00845429|1898959|FG002|Overall Study|Serious adverse event|1
918775|NCT00845520|1898988|FG000|Overall Study|Death|1
918776|NCT00845520|1898989|FG001|Overall Study|Death|2
918777|NCT00845520|1898990|FG002|Overall Study|Death|0
918778|NCT00845520|1898988|FG000|Overall Study|Lost to Follow-up|1
918779|NCT00845520|1898989|FG001|Overall Study|Lost to Follow-up|0
918780|NCT00845520|1898990|FG002|Overall Study|Lost to Follow-up|0
918781|NCT00845520|1898988|FG000|Overall Study|Adverse Event|0
918782|NCT00845520|1898989|FG001|Overall Study|Adverse Event|0
918783|NCT00845520|1898990|FG002|Overall Study|Adverse Event|1
918784|NCT00845650|1899010|FG000|Overall Study|Withdrawal by Subject|0
918785|NCT00845650|1899011|FG001|Overall Study|Withdrawal by Subject|0
918786|NCT00845650|1899012|FG002|Overall Study|Withdrawal by Subject|0
918787|NCT00845650|1899013|FG003|Overall Study|Withdrawal by Subject|0
918788|NCT00845650|1899014|FG004|Overall Study|Withdrawal by Subject|2
918789|NCT00845650|1899015|FG005|Overall Study|Withdrawal by Subject|0
918790|NCT00845650|1899010|FG000|Overall Study|Lost to Follow-up|0
918791|NCT00845650|1899011|FG001|Overall Study|Lost to Follow-up|0
918792|NCT00845650|1899012|FG002|Overall Study|Lost to Follow-up|3
918793|NCT00845650|1899013|FG003|Overall Study|Lost to Follow-up|1
918794|NCT00845650|1899014|FG004|Overall Study|Lost to Follow-up|0
918795|NCT00845650|1899015|FG005|Overall Study|Lost to Follow-up|1
918796|NCT00845650|1899010|FG000|Overall Study|Sponsor hold on dosing|0
918797|NCT00845650|1899011|FG001|Overall Study|Sponsor hold on dosing|0
918798|NCT00845650|1899012|FG002|Overall Study|Sponsor hold on dosing|0
918799|NCT00845650|1899013|FG003|Overall Study|Sponsor hold on dosing|0
918800|NCT00845650|1899014|FG004|Overall Study|Sponsor hold on dosing|1
918801|NCT00845650|1899015|FG005|Overall Study|Sponsor hold on dosing|1
918802|NCT00845650|1899010|FG000|Overall Study|Unable to access IV line|1
918803|NCT00845650|1899011|FG001|Overall Study|Unable to access IV line|0
918804|NCT00845650|1899012|FG002|Overall Study|Unable to access IV line|0
918805|NCT00845650|1899013|FG003|Overall Study|Unable to access IV line|0
918806|NCT00845650|1899014|FG004|Overall Study|Unable to access IV line|0
918807|NCT00845650|1899015|FG005|Overall Study|Unable to access IV line|0
918808|NCT00845676|1899040|FG000|Overall Study|Virologic breakthrough at week 20|1
918809|NCT00845676|1899040|FG000|Overall Study|Adverse Event|1
918810|NCT00845728|1899047|FG000|Overall Study|Abnormal laboratory value (s)|2
918811|NCT00845728|1899048|FG001|Overall Study|Abnormal laboratory value (s)|2
918812|NCT00845728|1899047|FG000|Overall Study|Patient's inability to use the device|4
918813|NCT00845728|1899048|FG001|Overall Study|Patient's inability to use the device|6
918814|NCT00845728|1899047|FG000|Overall Study|Abnormal test procedure result (s)|7
918815|NCT00845728|1899048|FG001|Overall Study|Abnormal test procedure result (s)|2
918816|NCT00845728|1899047|FG000|Overall Study|Lost to Follow-up|22
918817|NCT00845728|1899048|FG001|Overall Study|Lost to Follow-up|13
918818|NCT00845728|1899047|FG000|Overall Study|Death|24
918819|NCT00845728|1899048|FG001|Overall Study|Death|26
918820|NCT00845728|1899047|FG000|Overall Study|Administrative Problems|34
918821|NCT00845728|1899048|FG001|Overall Study|Administrative Problems|26
918822|NCT00845728|1899047|FG000|Overall Study|Protocol Violation|36
918823|NCT00845728|1899048|FG001|Overall Study|Protocol Violation|24
918824|NCT00845728|1899047|FG000|Overall Study|Lack of Efficacy|51
918825|NCT00845728|1899048|FG001|Overall Study|Lack of Efficacy|39
918826|NCT00845728|1899047|FG000|Overall Study|Adverse Event|101
918827|NCT00845728|1899048|FG001|Overall Study|Adverse Event|96
918828|NCT00845728|1899047|FG000|Overall Study|Withdrawal by Subject|105
918829|NCT00845728|1899048|FG001|Overall Study|Withdrawal by Subject|108
918830|NCT00845832|1899057|FG000|Treatment Period|Adverse Event|0
918831|NCT00845832|1899058|FG001|Treatment Period|Adverse Event|2
918832|NCT00845832|1899059|FG002|Treatment Period|Adverse Event|0
918833|NCT00845832|1899057|FG000|Treatment Period|Protocol Violation|1
918834|NCT00845832|1899058|FG001|Treatment Period|Protocol Violation|1
918835|NCT00845832|1899059|FG002|Treatment Period|Protocol Violation|0
918836|NCT00845832|1899057|FG000|Safety Follow-Up|Withdrawal by Subject|1
918837|NCT00845832|1899058|FG001|Safety Follow-Up|Withdrawal by Subject|0
918838|NCT00845832|1899059|FG002|Safety Follow-Up|Withdrawal by Subject|0
918839|NCT00845832|1899057|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0
918840|NCT00845832|1899058|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0
918841|NCT00845832|1899059|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7
918842|NCT00845858|1899070|FG000|Overall Study|Withdrawal by Subject|5
918843|NCT00845858|1899071|FG001|Overall Study|Withdrawal by Subject|1
918844|NCT00845858|1899072|FG002|Overall Study|Withdrawal by Subject|1
918845|NCT00845858|1899070|FG000|Overall Study|Adverse Event|3
918846|NCT00845858|1899071|FG001|Overall Study|Adverse Event|8
918847|NCT00845858|1899072|FG002|Overall Study|Adverse Event|4
918848|NCT00845858|1899070|FG000|Overall Study|Protocol Violation|0
918849|NCT00845858|1899071|FG001|Overall Study|Protocol Violation|0
918850|NCT00845858|1899072|FG002|Overall Study|Protocol Violation|1
918851|NCT00845858|1899070|FG000|Overall Study|not eligible|0
918852|NCT00845858|1899071|FG001|Overall Study|not eligible|3
918853|NCT00845858|1899072|FG002|Overall Study|not eligible|2
918854|NCT00845871|1899083|FG000|Assessment Period|Adverse Event|2
918855|NCT00845871|1899083|FG000|Assessment Period|Abnormal laboratory values|1
918856|NCT00845871|1899083|FG000|Assessment Period|Abnormal test procedure results|1
918857|NCT00845871|1899083|FG000|Assessment Period|Patient withdrew consent|3
918858|NCT00845897|1899110|FG000|Overall Study|Lost to Follow-up|1
918859|NCT00845897|1899111|FG001|Overall Study|Lost to Follow-up|1
918860|NCT00845897|1899112|FG002|Overall Study|Lost to Follow-up|0
918861|NCT00845897|1899110|FG000|Overall Study|Withdrawal by Subject|0
918862|NCT00845897|1899111|FG001|Overall Study|Withdrawal by Subject|3
918863|NCT00845897|1899112|FG002|Overall Study|Withdrawal by Subject|2
918864|NCT00845897|1899110|FG000|Overall Study|Ulcer did not heal|1
918865|NCT00845897|1899111|FG001|Overall Study|Ulcer did not heal|0
918866|NCT00845897|1899112|FG002|Overall Study|Ulcer did not heal|1
918867|NCT00845897|1899110|FG000|Overall Study|Too ill to participate|0
918868|NCT00845897|1899111|FG001|Overall Study|Too ill to participate|1
918869|NCT00845897|1899112|FG002|Overall Study|Too ill to participate|0
918870|NCT00846027|1899129|FG000|Overall Study|Death|3
918871|NCT00846027|1899129|FG000|Overall Study|Disease Progression|30
918872|NCT00846027|1899129|FG000|Overall Study|Toxicity|12
918873|NCT00846027|1899129|FG000|Overall Study|Patient Decision|7
918874|NCT00846027|1899129|FG000|Overall Study|Investigator Discretion|29
918875|NCT00846027|1899129|FG000|Overall Study|Protocol Violation|2
918876|NCT00846027|1899129|FG000|Overall Study|Subject Not Treated|7
918877|NCT00846040|1899136|FG000|Baseline: Days 1-5|Withdrawal by Subject|1
918878|NCT00846040|1899137|FG001|Baseline: Days 1-5|Withdrawal by Subject|0
918879|NCT00846040|1899138|FG002|Baseline: Days 1-5|Withdrawal by Subject|0
918880|NCT00846040|1899136|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
918881|NCT00846040|1899137|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2
918882|NCT00846040|1899138|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
918883|NCT00846053|1899149|FG000|Overall Study|Physician Decision|3
918884|NCT00846053|1899150|FG001|Overall Study|Physician Decision|0
918885|NCT00846365|1899180|FG000|Overall Study|Adverse Event|20
918886|NCT00846365|1899181|FG001|Overall Study|Adverse Event|30
918887|NCT00846365|1899182|FG002|Overall Study|Adverse Event|11
918888|NCT00846365|1899180|FG000|Overall Study|Protocol Violation|5
918889|NCT00846365|1899181|FG001|Overall Study|Protocol Violation|4
918890|NCT00846365|1899182|FG002|Overall Study|Protocol Violation|0
918891|NCT00846365|1899180|FG000|Overall Study|Lost to Follow-up|8
918892|NCT00846365|1899181|FG001|Overall Study|Lost to Follow-up|2
918893|NCT00846365|1899182|FG002|Overall Study|Lost to Follow-up|5
918894|NCT00846365|1899180|FG000|Overall Study|Withdrawal by Subject|11
918895|NCT00846365|1899181|FG001|Overall Study|Withdrawal by Subject|11
918896|NCT00846365|1899182|FG002|Overall Study|Withdrawal by Subject|9
918897|NCT00846365|1899180|FG000|Overall Study|Pregnancy|1
918898|NCT00846365|1899181|FG001|Overall Study|Pregnancy|0
918899|NCT00846365|1899182|FG002|Overall Study|Pregnancy|0
918900|NCT00846365|1899180|FG000|Overall Study|Lack of Efficacy|1
918901|NCT00846365|1899181|FG001|Overall Study|Lack of Efficacy|1
918902|NCT00846365|1899182|FG002|Overall Study|Lack of Efficacy|2
918903|NCT00846365|1899180|FG000|Overall Study|Other|9
918904|NCT00846365|1899181|FG001|Overall Study|Other|1
918905|NCT00846365|1899182|FG002|Overall Study|Other|6
918906|NCT00846391|1899193|FG000|Overall Study|Physician Decision|0
918907|NCT00846391|1899194|FG001|Overall Study|Physician Decision|0
918908|NCT00846391|1899195|FG002|Overall Study|Physician Decision|1
918909|NCT00846391|1899193|FG000|Overall Study|Study Terminated by Sponsor|1
918910|NCT00846391|1899194|FG001|Overall Study|Study Terminated by Sponsor|2
918911|NCT00846391|1899195|FG002|Overall Study|Study Terminated by Sponsor|2
918912|NCT00846495|1899210|FG000|Overall Study|Lost to Follow-up|1
918913|NCT00846495|1899211|FG001|Overall Study|Lost to Follow-up|0
918914|NCT00846495|1899210|FG000|Overall Study|Adverse Event|5
918915|NCT00846495|1899211|FG001|Overall Study|Adverse Event|1
918916|NCT00846495|1899210|FG000|Overall Study|Lack of Efficacy|1
918917|NCT00846495|1899211|FG001|Overall Study|Lack of Efficacy|2
918918|NCT00846495|1899210|FG000|Overall Study|Physician Decision|1
918919|NCT00846495|1899211|FG001|Overall Study|Physician Decision|0
918920|NCT00846521|1899217|FG000|Overall Study|Withdrawal by Subject|5
918921|NCT00846521|1899217|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5
918922|NCT00846521|1899217|FG000|Overall Study|Protocol Violation|1
918923|NCT00846586|1899241|FG000|Overall Study|Adverse Event|20
918924|NCT00846586|1899242|FG001|Overall Study|Adverse Event|10
918925|NCT00846586|1899241|FG000|Overall Study|Subject withdrew consent|8
918926|NCT00846586|1899242|FG001|Overall Study|Subject withdrew consent|10
918927|NCT00846586|1899241|FG000|Overall Study|Administrative problems|5
918928|NCT00846586|1899242|FG001|Overall Study|Administrative problems|4
918929|NCT00846586|1899241|FG000|Overall Study|Death|2
918930|NCT00846586|1899242|FG001|Overall Study|Death|0
918931|NCT00846586|1899241|FG000|Overall Study|Protocol deviation|2
918932|NCT00846586|1899242|FG001|Overall Study|Protocol deviation|6
918933|NCT00846586|1899241|FG000|Overall Study|Abnormal test procedure result(s)|1
918934|NCT00846586|1899242|FG001|Overall Study|Abnormal test procedure result(s)|0
918935|NCT00846586|1899241|FG000|Overall Study|Lost to Follow-up|1
918936|NCT00846586|1899242|FG001|Overall Study|Lost to Follow-up|4
918937|NCT00846586|1899241|FG000|Overall Study|Unsatisfactory therapeutic effect|0
918938|NCT00846586|1899242|FG001|Overall Study|Unsatisfactory therapeutic effect|1
918939|NCT00846742|1899259|FG000|Overall Study|Withdrawal by Subject|1
918940|NCT00846768|1899264|FG000|Overall Study|Adverse Event|0
918941|NCT00846768|1899265|FG001|Overall Study|Adverse Event|1
918942|NCT00846768|1899266|FG002|Overall Study|Adverse Event|0
918943|NCT00846768|1899267|FG003|Overall Study|Adverse Event|0
918944|NCT00846807|1899277|FG000|Overall Study|Adverse Event|270
918945|NCT00846807|1899277|FG000|Overall Study|Lost to Follow-up|94
918946|NCT00846807|1899277|FG000|Overall Study|Withdrawal by Subject|56
918947|NCT00846807|1899277|FG000|Overall Study|Non compliant with European label|7
918948|NCT00846807|1899277|FG000|Overall Study|Switch to other anticoagulants|89
918949|NCT00846807|1899277|FG000|Overall Study|No prescription after hospital discharge|56
918950|NCT00846807|1899277|FG000|Overall Study|Other|60
918951|NCT00846846|1899281|FG000|Overall Study|Death|56
918952|NCT00846846|1899281|FG000|Overall Study|Withdrawal by Subject|19
918953|NCT00847015|1899292|FG000|Overall Study|Withdrawal by Subject|1
918954|NCT00847015|1899292|FG000|Overall Study|declined any surgery|1
918955|NCT00847015|1899292|FG000|Overall Study|partial cystectomy vs radical cystectomy|1
918956|NCT00847132|1899298|FG000|Overall Study|Death|1
918957|NCT00847132|1899299|FG001|Overall Study|Death|1
918958|NCT00847145|1899313|FG000|Overall Study|AE or Death|0
918959|NCT00847145|1899314|FG001|Overall Study|AE or Death|1
918960|NCT00847145|1899315|FG002|Overall Study|AE or Death|1
918961|NCT00847145|1899316|FG003|Overall Study|AE or Death|0
918962|NCT00847145|1899317|FG004|Overall Study|AE or Death|0
918963|NCT00847145|1899318|FG005|Overall Study|AE or Death|0
918964|NCT00847145|1899319|FG006|Overall Study|AE or Death|0
918965|NCT00847145|1899320|FG007|Overall Study|AE or Death|0
918966|NCT00847145|1899313|FG000|Overall Study|Withdrawal by Subject|3
918967|NCT00847145|1899314|FG001|Overall Study|Withdrawal by Subject|4
918968|NCT00847145|1899315|FG002|Overall Study|Withdrawal by Subject|6
918969|NCT00847145|1899316|FG003|Overall Study|Withdrawal by Subject|1
918970|NCT00847145|1899317|FG004|Overall Study|Withdrawal by Subject|0
918971|NCT00847145|1899318|FG005|Overall Study|Withdrawal by Subject|0
918972|NCT00847145|1899319|FG006|Overall Study|Withdrawal by Subject|1
918973|NCT00847145|1899320|FG007|Overall Study|Withdrawal by Subject|1
918974|NCT00847145|1899313|FG000|Overall Study|Lost to Follow-up|3
918975|NCT00847145|1899314|FG001|Overall Study|Lost to Follow-up|1
918976|NCT00847145|1899315|FG002|Overall Study|Lost to Follow-up|1
918977|NCT00847145|1899316|FG003|Overall Study|Lost to Follow-up|0
918978|NCT00847145|1899317|FG004|Overall Study|Lost to Follow-up|4
918979|NCT00847145|1899318|FG005|Overall Study|Lost to Follow-up|4
918980|NCT00847145|1899319|FG006|Overall Study|Lost to Follow-up|8
918981|NCT00847145|1899320|FG007|Overall Study|Lost to Follow-up|2
918982|NCT00847145|1899313|FG000|Overall Study|Inappropriate enrollment|0
918983|NCT00847145|1899314|FG001|Overall Study|Inappropriate enrollment|0
918984|NCT00847145|1899315|FG002|Overall Study|Inappropriate enrollment|0
918985|NCT00847145|1899316|FG003|Overall Study|Inappropriate enrollment|0
918986|NCT00847145|1899317|FG004|Overall Study|Inappropriate enrollment|1
918987|NCT00847145|1899318|FG005|Overall Study|Inappropriate enrollment|0
918988|NCT00847145|1899319|FG006|Overall Study|Inappropriate enrollment|0
918989|NCT00847145|1899320|FG007|Overall Study|Inappropriate enrollment|0
918990|NCT00847145|1899313|FG000|Overall Study|Protocol Violation|0
918991|NCT00847145|1899314|FG001|Overall Study|Protocol Violation|0
918992|NCT00847145|1899315|FG002|Overall Study|Protocol Violation|3
918993|NCT00847145|1899316|FG003|Overall Study|Protocol Violation|0
918994|NCT00847145|1899317|FG004|Overall Study|Protocol Violation|1
918995|NCT00847145|1899318|FG005|Overall Study|Protocol Violation|0
918996|NCT00847145|1899319|FG006|Overall Study|Protocol Violation|0
918997|NCT00847145|1899320|FG007|Overall Study|Protocol Violation|1
918998|NCT00847197|1899354|FG000|Overall Study|Adverse Event|21
918999|NCT00847197|1899355|FG001|Overall Study|Adverse Event|3
919000|NCT00847197|1899354|FG000|Overall Study|Protocol Violation|0
919001|NCT00847197|1899355|FG001|Overall Study|Protocol Violation|1
919002|NCT00847197|1899354|FG000|Overall Study|Withdrawal by Subject|3
919003|NCT00847197|1899355|FG001|Overall Study|Withdrawal by Subject|1
919004|NCT00847301|1899379|FG000|Overall Study|Adverse Event|35
919005|NCT00847301|1899379|FG000|Overall Study|Switch to other anticoagulants|16
919006|NCT00847301|1899379|FG000|Overall Study|Lost to Follow-up|1
919007|NCT00847301|1899379|FG000|Overall Study|No prescription after hospital discharge|1
919008|NCT00847301|1899379|FG000|Overall Study|Other reason not defined above|1
919009|NCT00847379|1899386|FG000|Overall Study|Study terminated by Sponsor|59
919010|NCT00847379|1899387|FG001|Overall Study|Study terminated by Sponsor|57
919011|NCT00847379|1899388|FG002|Overall Study|Study terminated by Sponsor|57
919012|NCT00847405|1899400|FG000|First Intervention|Adverse Event|0
919013|NCT00847405|1899401|FG001|First Intervention|Adverse Event|1
919014|NCT00847405|1899400|FG000|Washout of 7 Days|Withdrawal by Subject|1
919015|NCT00847405|1899401|FG001|Washout of 7 Days|Withdrawal by Subject|0
919016|NCT00847535|1899409|FG000|Overall Study|Withdrawal by Subject|2
919017|NCT00847535|1899410|FG001|Overall Study|Withdrawal by Subject|1
919018|NCT00847535|1899411|FG002|Overall Study|Withdrawal by Subject|1
919019|NCT00847535|1899409|FG000|Overall Study|Lost to Follow-up|0
919020|NCT00847535|1899410|FG001|Overall Study|Lost to Follow-up|1
919021|NCT00847535|1899411|FG002|Overall Study|Lost to Follow-up|0
919022|NCT00847561|1899418|FG000|Overall Study|Withdrawal by Subject|4
919023|NCT00847561|1899419|FG001|Overall Study|Withdrawal by Subject|3
919024|NCT00847561|1899418|FG000|Overall Study|Unable to schedule|9
919025|NCT00847561|1899419|FG001|Overall Study|Unable to schedule|1
919026|NCT00847613|1899438|FG000|Overall Study|Ongoing at cut-off date|250
919027|NCT00847613|1899439|FG001|Overall Study|Ongoing at cut-off date|265
919028|NCT00847613|1899440|FG002|Overall Study|Ongoing at cut-off date|64
919029|NCT00847613|1899441|FG003|Overall Study|Ongoing at cut-off date|64
919030|NCT00847613|1899438|FG000|Overall Study|Death|1
919031|NCT00847613|1899439|FG001|Overall Study|Death|1
919032|NCT00847613|1899440|FG002|Overall Study|Death|0
919033|NCT00847613|1899441|FG003|Overall Study|Death|0
919034|NCT00847613|1899438|FG000|Overall Study|Adverse Event|36
919035|NCT00847613|1899439|FG001|Overall Study|Adverse Event|26
919036|NCT00847613|1899440|FG002|Overall Study|Adverse Event|5
919037|NCT00847613|1899441|FG003|Overall Study|Adverse Event|6
919038|NCT00847613|1899438|FG000|Overall Study|Lack of Efficacy|7
919039|NCT00847613|1899439|FG001|Overall Study|Lack of Efficacy|3
919040|NCT00847613|1899440|FG002|Overall Study|Lack of Efficacy|3
919041|NCT00847613|1899441|FG003|Overall Study|Lack of Efficacy|1
919042|NCT00847613|1899438|FG000|Overall Study|Study terminated by Sponsor|1
919043|NCT00847613|1899439|FG001|Overall Study|Study terminated by Sponsor|0
919044|NCT00847613|1899440|FG002|Overall Study|Study terminated by Sponsor|2
919045|NCT00847613|1899441|FG003|Overall Study|Study terminated by Sponsor|1
919046|NCT00847613|1899438|FG000|Overall Study|Lost to Follow-up|5
919047|NCT00847613|1899439|FG001|Overall Study|Lost to Follow-up|0
919048|NCT00847613|1899440|FG002|Overall Study|Lost to Follow-up|0
919049|NCT00847613|1899441|FG003|Overall Study|Lost to Follow-up|3
919050|NCT00847613|1899438|FG000|Overall Study|Protocol Violation|6
919051|NCT00847613|1899439|FG001|Overall Study|Protocol Violation|6
919052|NCT00847613|1899440|FG002|Overall Study|Protocol Violation|3
919053|NCT00847613|1899441|FG003|Overall Study|Protocol Violation|1
919054|NCT00847613|1899438|FG000|Overall Study|Pregnancy|1
919055|NCT00847613|1899439|FG001|Overall Study|Pregnancy|1
919056|NCT00847613|1899440|FG002|Overall Study|Pregnancy|0
919057|NCT00847613|1899441|FG003|Overall Study|Pregnancy|0
919058|NCT00847613|1899438|FG000|Overall Study|Site closure|1
919059|NCT00847613|1899439|FG001|Overall Study|Site closure|0
919060|NCT00847613|1899440|FG002|Overall Study|Site closure|0
919061|NCT00847613|1899441|FG003|Overall Study|Site closure|1
919062|NCT00847613|1899438|FG000|Overall Study|Withdrawal by Subject|8
919063|NCT00847613|1899439|FG001|Overall Study|Withdrawal by Subject|11
919064|NCT00847613|1899440|FG002|Overall Study|Withdrawal by Subject|2
919065|NCT00847613|1899441|FG003|Overall Study|Withdrawal by Subject|2
919066|NCT00847613|1899438|FG000|Overall Study|Participant moved|4
919067|NCT00847613|1899439|FG001|Overall Study|Participant moved|1
919068|NCT00847613|1899440|FG002|Overall Study|Participant moved|0
919069|NCT00847613|1899441|FG003|Overall Study|Participant moved|0
919070|NCT00847613|1899438|FG000|Overall Study|Sponsor request|0
919071|NCT00847613|1899439|FG001|Overall Study|Sponsor request|1
919072|NCT00847613|1899440|FG002|Overall Study|Sponsor request|0
919073|NCT00847613|1899441|FG003|Overall Study|Sponsor request|0
919074|NCT00847613|1899438|FG000|Overall Study|Randomized, but not treated|0
919075|NCT00847613|1899439|FG001|Overall Study|Randomized, but not treated|3
919076|NCT00847613|1899440|FG002|Overall Study|Randomized, but not treated|0
919077|NCT00847613|1899441|FG003|Overall Study|Randomized, but not treated|0
919078|NCT00847613|1899438|FG000|Overall Study|Other|1
919079|NCT00847613|1899439|FG001|Overall Study|Other|1
919080|NCT00847613|1899440|FG002|Overall Study|Other|2
919081|NCT00847613|1899441|FG003|Overall Study|Other|0
919082|NCT00847626|1899469|FG000|Overall Study|Adverse Event|10
919083|NCT00847626|1899470|FG001|Overall Study|Adverse Event|10
919084|NCT00847626|1899471|FG002|Overall Study|Adverse Event|6
919085|NCT00847626|1899472|FG003|Overall Study|Adverse Event|19
919086|NCT00847626|1899473|FG004|Overall Study|Adverse Event|11
919087|NCT00847626|1899474|FG005|Overall Study|Adverse Event|22
919088|NCT00847626|1899475|FG006|Overall Study|Adverse Event|4
919089|NCT00847626|1899476|FG007|Overall Study|Adverse Event|6
919090|NCT00847626|1899477|FG008|Overall Study|Adverse Event|3
919091|NCT00847626|1899478|FG009|Overall Study|Adverse Event|6
919092|NCT00847626|1899479|FG010|Overall Study|Adverse Event|6
919093|NCT00847626|1899469|FG000|Overall Study|Protocol Violation|2
919094|NCT00847626|1899470|FG001|Overall Study|Protocol Violation|1
919095|NCT00847626|1899471|FG002|Overall Study|Protocol Violation|2
919096|NCT00847626|1899472|FG003|Overall Study|Protocol Violation|1
919097|NCT00847626|1899473|FG004|Overall Study|Protocol Violation|1
919098|NCT00847626|1899474|FG005|Overall Study|Protocol Violation|1
919099|NCT00847626|1899475|FG006|Overall Study|Protocol Violation|1
919100|NCT00847626|1899476|FG007|Overall Study|Protocol Violation|1
919101|NCT00847626|1899477|FG008|Overall Study|Protocol Violation|0
919102|NCT00847626|1899478|FG009|Overall Study|Protocol Violation|1
919103|NCT00847626|1899479|FG010|Overall Study|Protocol Violation|1
919104|NCT00847626|1899469|FG000|Overall Study|Lost to Follow-up|0
919105|NCT00847626|1899470|FG001|Overall Study|Lost to Follow-up|1
919106|NCT00847626|1899471|FG002|Overall Study|Lost to Follow-up|1
919107|NCT00847626|1899472|FG003|Overall Study|Lost to Follow-up|1
919108|NCT00847626|1899473|FG004|Overall Study|Lost to Follow-up|0
919109|NCT00847626|1899474|FG005|Overall Study|Lost to Follow-up|3
919110|NCT00847626|1899475|FG006|Overall Study|Lost to Follow-up|1
919111|NCT00847626|1899476|FG007|Overall Study|Lost to Follow-up|3
919112|NCT00847626|1899477|FG008|Overall Study|Lost to Follow-up|1
919113|NCT00847626|1899478|FG009|Overall Study|Lost to Follow-up|0
919114|NCT00847626|1899479|FG010|Overall Study|Lost to Follow-up|1
919115|NCT00847626|1899469|FG000|Overall Study|Withdrawal by Subject|5
919116|NCT00847626|1899470|FG001|Overall Study|Withdrawal by Subject|5
919117|NCT00847626|1899471|FG002|Overall Study|Withdrawal by Subject|3
919118|NCT00847626|1899472|FG003|Overall Study|Withdrawal by Subject|8
919119|NCT00847626|1899473|FG004|Overall Study|Withdrawal by Subject|12
919120|NCT00847626|1899474|FG005|Overall Study|Withdrawal by Subject|9
919121|NCT00847626|1899475|FG006|Overall Study|Withdrawal by Subject|8
919122|NCT00847626|1899476|FG007|Overall Study|Withdrawal by Subject|4
919123|NCT00847626|1899477|FG008|Overall Study|Withdrawal by Subject|4
919124|NCT00847626|1899478|FG009|Overall Study|Withdrawal by Subject|5
919125|NCT00847626|1899479|FG010|Overall Study|Withdrawal by Subject|2
919126|NCT00847626|1899469|FG000|Overall Study|Lack of Efficacy|3
919127|NCT00847626|1899470|FG001|Overall Study|Lack of Efficacy|1
919128|NCT00847626|1899471|FG002|Overall Study|Lack of Efficacy|0
919129|NCT00847626|1899472|FG003|Overall Study|Lack of Efficacy|1
919130|NCT00847626|1899473|FG004|Overall Study|Lack of Efficacy|2
919131|NCT00847626|1899474|FG005|Overall Study|Lack of Efficacy|0
919132|NCT00847626|1899475|FG006|Overall Study|Lack of Efficacy|6
919133|NCT00847626|1899476|FG007|Overall Study|Lack of Efficacy|2
919134|NCT00847626|1899477|FG008|Overall Study|Lack of Efficacy|5
919135|NCT00847626|1899478|FG009|Overall Study|Lack of Efficacy|1
919136|NCT00847626|1899479|FG010|Overall Study|Lack of Efficacy|7
919137|NCT00847626|1899469|FG000|Overall Study|Other|1
919138|NCT00847626|1899470|FG001|Overall Study|Other|5
919139|NCT00847626|1899471|FG002|Overall Study|Other|4
919140|NCT00847626|1899472|FG003|Overall Study|Other|1
919141|NCT00847626|1899473|FG004|Overall Study|Other|2
919142|NCT00847626|1899474|FG005|Overall Study|Other|2
919143|NCT00847626|1899475|FG006|Overall Study|Other|2
919144|NCT00847626|1899476|FG007|Overall Study|Other|3
919145|NCT00847626|1899477|FG008|Overall Study|Other|1
919146|NCT00847626|1899478|FG009|Overall Study|Other|1
919147|NCT00847626|1899479|FG010|Overall Study|Other|3
919148|NCT00847665|1899508|FG000|Overall Study|Withdrawal by Subject|1
919149|NCT00847665|1899509|FG001|Overall Study|Withdrawal by Subject|0
919150|NCT00847704|1899515|FG000|Overall Study|Withdrawal by Subject|1
919151|NCT00847730|1899519|FG000|Overall Study|Multiple interruptions in therapy|8
919152|NCT00847808|1899523|FG000|Overall Study|Adverse Event|7
919153|NCT00847808|1899523|FG000|Overall Study|Protocol Violation|1
919154|NCT00847808|1899523|FG000|Overall Study|Lost to Follow-up|1
919155|NCT00847808|1899523|FG000|Overall Study|Withdrawal by Subject|4
919156|NCT00847808|1899523|FG000|Overall Study|Participant Reported Lack of Efficacy|1
919157|NCT00847808|1899523|FG000|Overall Study|Participant Took Excluded Medication|1
919158|NCT00847886|1899529|FG000|Overall Study|Adverse Event|0
919159|NCT00847886|1899530|FG001|Overall Study|Adverse Event|1
919160|NCT00847912|1899538|FG000|Overall Study|Protocol Violation|6
919161|NCT00847912|1899539|FG001|Overall Study|Protocol Violation|7
919162|NCT00847912|1899538|FG000|Overall Study|Withdrawal by Subject|3
919163|NCT00847912|1899539|FG001|Overall Study|Withdrawal by Subject|6
919164|NCT00848042|1899570|FG000|Overall Study|Death|1
919165|NCT00848042|1899571|FG001|Overall Study|Death|2
919166|NCT00848042|1899572|FG002|Overall Study|Death|0
919167|NCT00848042|1899570|FG000|Overall Study|Other Therapy|3
919168|NCT00848042|1899571|FG001|Overall Study|Other Therapy|0
919169|NCT00848042|1899572|FG002|Overall Study|Other Therapy|0
919170|NCT00848081|1899582|FG000|Overall Study|Adverse Event|6
919171|NCT00848081|1899583|FG001|Overall Study|Adverse Event|7
919172|NCT00848081|1899582|FG000|Overall Study|Protocol Violation|8
919173|NCT00848081|1899583|FG001|Overall Study|Protocol Violation|5
919174|NCT00848081|1899582|FG000|Overall Study|Lost to Follow-up|1
919175|NCT00848081|1899583|FG001|Overall Study|Lost to Follow-up|0
919176|NCT00848081|1899582|FG000|Overall Study|Physician Decision|0
919177|NCT00848081|1899583|FG001|Overall Study|Physician Decision|3
919178|NCT00848081|1899582|FG000|Overall Study|Withdrawal by Subject|5
919179|NCT00848081|1899583|FG001|Overall Study|Withdrawal by Subject|3
919180|NCT00848107|1899589|FG000|Overall Study|Lost to Follow-up|2
919181|NCT00848107|1899589|FG000|Overall Study|Withdrawal by Subject|8
919182|NCT00848107|1899589|FG000|Overall Study|Adverse Event|9
919183|NCT00848107|1899589|FG000|Overall Study|Death|1
919184|NCT00848107|1899589|FG000|Overall Study|Pregnancy|1
919185|NCT00848120|1899593|FG000|Overall Study|Adverse Event|1
919186|NCT00848198|1899622|FG000|Overall Study|Incomplete Case Report Forms|15
919187|NCT00848211|1899634|FG000|Overall Study|Protocol Violation|0
919188|NCT00848211|1899635|FG001|Overall Study|Protocol Violation|1
919189|NCT00848211|1899636|FG002|Overall Study|Protocol Violation|1
919190|NCT00848211|1899637|FG003|Overall Study|Protocol Violation|0
919191|NCT00848211|1899634|FG000|Overall Study|Adverse Event|0
919192|NCT00848211|1899635|FG001|Overall Study|Adverse Event|0
919193|NCT00848211|1899636|FG002|Overall Study|Adverse Event|0
919194|NCT00848211|1899637|FG003|Overall Study|Adverse Event|0
919195|NCT00848250|1899653|FG000|Overall Study|surgery was completed without cardiopulm|0
919196|NCT00848250|1899654|FG001|Overall Study|surgery was completed without cardiopulm|1
919197|NCT00848354|1899663|FG000|Phase 1|Adverse Event|5
919198|NCT00848354|1899664|FG001|Phase 1|Adverse Event|4
919199|NCT00848354|1899663|FG000|Phase 1|Discontinuation of study by sponsor|2
919200|NCT00848354|1899664|FG001|Phase 1|Discontinuation of study by sponsor|1
919201|NCT00848354|1899663|FG000|Phase 1|Failed to return|0
919202|NCT00848354|1899664|FG001|Phase 1|Failed to return|1
919203|NCT00848354|1899663|FG000|Phase 1|Lost to Follow-up|1
919204|NCT00848354|1899664|FG001|Phase 1|Lost to Follow-up|1
919205|NCT00848354|1899663|FG000|Phase 1|Unspecified Reason|1
919206|NCT00848354|1899664|FG001|Phase 1|Unspecified Reason|1
919207|NCT00848354|1899663|FG000|Phase 1|Protocol Violation|1
919208|NCT00848354|1899664|FG001|Phase 1|Protocol Violation|1
919209|NCT00848354|1899663|FG000|Phase 1|Withdrawal by Subject|2
919210|NCT00848354|1899664|FG001|Phase 1|Withdrawal by Subject|4
919211|NCT00848354|1899663|FG000|Phase 1|Lack of Efficacy|0
919212|NCT00848354|1899664|FG001|Phase 1|Lack of Efficacy|1
919213|NCT00848354|1899663|FG000|Phase 2 Year 1|Adverse Event|7
919214|NCT00848354|1899664|FG001|Phase 2 Year 1|Adverse Event|2
919215|NCT00848354|1899663|FG000|Phase 2 Year 1|Death|1
919216|NCT00848354|1899664|FG001|Phase 2 Year 1|Death|0
919217|NCT00848354|1899663|FG000|Phase 2 Year 1|Failed to Return|1
919218|NCT00848354|1899664|FG001|Phase 2 Year 1|Failed to Return|1
919219|NCT00848354|1899663|FG000|Phase 2 Year 1|Lost to Follow-up|1
919220|NCT00848354|1899664|FG001|Phase 2 Year 1|Lost to Follow-up|0
919221|NCT00848354|1899663|FG000|Phase 2 Year 1|Unspecified Reason|3
919222|NCT00848354|1899664|FG001|Phase 2 Year 1|Unspecified Reason|0
919223|NCT00848354|1899663|FG000|Phase 2 Year 1|Protocol Violation|4
919224|NCT00848354|1899664|FG001|Phase 2 Year 1|Protocol Violation|1
919225|NCT00848354|1899663|FG000|Phase 2 Year 1|Subject Request|1
919226|NCT00848354|1899664|FG001|Phase 2 Year 1|Subject Request|2
919227|NCT00848354|1899663|FG000|Phase 2 Year 2|Adverse Event|12
919228|NCT00848354|1899664|FG001|Phase 2 Year 2|Adverse Event|2
919229|NCT00848354|1899663|FG000|Phase 2 Year 2|Death|2
919230|NCT00848354|1899664|FG001|Phase 2 Year 2|Death|0
919231|NCT00848354|1899663|FG000|Phase 2 Year 2|Failed to return|3
919232|NCT00848354|1899664|FG001|Phase 2 Year 2|Failed to return|0
919233|NCT00848354|1899663|FG000|Phase 2 Year 2|Lost to Follow-up|1
919234|NCT00848354|1899664|FG001|Phase 2 Year 2|Lost to Follow-up|3
919235|NCT00848354|1899663|FG000|Phase 2 Year 2|Unspecified Reason|1
919236|NCT00848354|1899664|FG001|Phase 2 Year 2|Unspecified Reason|0
919237|NCT00848354|1899663|FG000|Phase 2 Year 2|Protocol Violation|1
919238|NCT00848354|1899664|FG001|Phase 2 Year 2|Protocol Violation|1
919239|NCT00848354|1899663|FG000|Phase 2 Year 2|Subject Request|1
919240|NCT00848354|1899664|FG001|Phase 2 Year 2|Subject Request|1
919241|NCT00848354|1899663|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
919242|NCT00848354|1899664|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
919243|NCT00848393|1899688|FG000|Overall Study|Protocol Violation|0
919244|NCT00848393|1899689|FG001|Overall Study|Protocol Violation|0
919245|NCT00848393|1899690|FG002|Overall Study|Protocol Violation|1
919246|NCT00848393|1899688|FG000|Overall Study|surgical complications unrelated to stud|0
919247|NCT00848393|1899689|FG001|Overall Study|surgical complications unrelated to stud|0
919248|NCT00848393|1899690|FG002|Overall Study|surgical complications unrelated to stud|2
919249|NCT00848484|1899704|FG000|First Intervention (Treatment Period 1)|Adverse Event|2
919250|NCT00848484|1899705|FG001|First Intervention (Treatment Period 1)|Adverse Event|1
919251|NCT00848484|1899704|FG000|First Intervention (Treatment Period 1)|Physician Decision|0
919252|NCT00848484|1899705|FG001|First Intervention (Treatment Period 1)|Physician Decision|1
919253|NCT00848484|1899704|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
919254|NCT00848484|1899705|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
919255|NCT00848484|1899704|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0
919256|NCT00848484|1899705|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3
919257|NCT00848484|1899704|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
919258|NCT00848484|1899705|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
919259|NCT00848497|1899713|FG000|Overall Study|Screen failure|2
919260|NCT00848497|1899714|FG001|Overall Study|Screen failure|0
919261|NCT00848497|1899713|FG000|Overall Study|Withdrawal by Subject|0
919262|NCT00848497|1899714|FG001|Overall Study|Withdrawal by Subject|1
919263|NCT00848536|1899741|FG000|Overall Study|Adverse Event|2
919264|NCT00848536|1899742|FG001|Overall Study|Adverse Event|2
919265|NCT00848536|1899741|FG000|Overall Study|Withdrawal by Subject|0
919266|NCT00848536|1899742|FG001|Overall Study|Withdrawal by Subject|1
919267|NCT00848536|1899741|FG000|Overall Study|Protocol Violation|0
919268|NCT00848536|1899742|FG001|Overall Study|Protocol Violation|1
919269|NCT00848536|1899741|FG000|Overall Study|Noncompliance|1
919270|NCT00848536|1899742|FG001|Overall Study|Noncompliance|0
919271|NCT00848536|1899741|FG000|Overall Study|Inadequate Control of IOP|1
919272|NCT00848536|1899742|FG001|Overall Study|Inadequate Control of IOP|1
919273|NCT00848536|1899741|FG000|Overall Study|Patient Moved|0
919274|NCT00848536|1899742|FG001|Overall Study|Patient Moved|2
919275|NCT00848549|1899750|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
919276|NCT00848549|1899751|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
919277|NCT00848549|1899750|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
919278|NCT00848549|1899751|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
919279|NCT00848549|1899750|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
919280|NCT00848549|1899751|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
919281|NCT00848549|1899750|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
919282|NCT00848549|1899751|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
919283|NCT00848549|1899750|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
919284|NCT00848549|1899751|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
919285|NCT00848549|1899750|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
919286|NCT00848549|1899751|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
919287|NCT00848549|1899750|FG000|E2090-E044-310 (Base Study) Disposition|Other|4
919288|NCT00848549|1899751|FG001|E2090-E044-310 (Base Study) Disposition|Other|3
919289|NCT00848549|1899750|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
919290|NCT00848549|1899751|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
919291|NCT00848549|1899750|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2
919292|NCT00848549|1899751|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1
919293|NCT00848549|1899750|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1
919294|NCT00848549|1899751|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2
919295|NCT00848549|1899750|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
919296|NCT00848549|1899751|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
919297|NCT00848549|1899750|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
919298|NCT00848549|1899751|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
919299|NCT00848549|1899750|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0
919300|NCT00848549|1899751|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2
919301|NCT00848549|1899750|FG000|E2090-E044-314 (Extension Study)|Other|5
919302|NCT00848549|1899751|FG001|E2090-E044-314 (Extension Study)|Other|6
919303|NCT00848718|1899772|FG000|Overall Study|Adverse Event|2
919304|NCT00848718|1899773|FG001|Overall Study|Adverse Event|2
919305|NCT00848718|1899774|FG002|Overall Study|Adverse Event|1
919306|NCT00848718|1899775|FG003|Overall Study|Adverse Event|1
919307|NCT00848718|1899776|FG004|Overall Study|Adverse Event|1
919308|NCT00848718|1899777|FG005|Overall Study|Adverse Event|0
919309|NCT00848718|1899778|FG006|Overall Study|Adverse Event|0
919310|NCT00848718|1899779|FG007|Overall Study|Adverse Event|1
919311|NCT00848718|1899780|FG008|Overall Study|Adverse Event|1
919312|NCT00848718|1899781|FG009|Overall Study|Adverse Event|0
919313|NCT00848718|1899782|FG010|Overall Study|Adverse Event|0
919314|NCT00848718|1899783|FG011|Overall Study|Adverse Event|0
919315|NCT00848718|1899784|FG012|Overall Study|Adverse Event|2
919316|NCT00848718|1899772|FG000|Overall Study|Lack of Efficacy|0
919317|NCT00848718|1899773|FG001|Overall Study|Lack of Efficacy|0
919318|NCT00848718|1899774|FG002|Overall Study|Lack of Efficacy|1
919319|NCT00848718|1899775|FG003|Overall Study|Lack of Efficacy|0
919320|NCT00848718|1899776|FG004|Overall Study|Lack of Efficacy|0
919321|NCT00848718|1899777|FG005|Overall Study|Lack of Efficacy|0
919322|NCT00848718|1899778|FG006|Overall Study|Lack of Efficacy|1
919323|NCT00848718|1899779|FG007|Overall Study|Lack of Efficacy|0
919324|NCT00848718|1899780|FG008|Overall Study|Lack of Efficacy|0
919325|NCT00848718|1899781|FG009|Overall Study|Lack of Efficacy|0
919326|NCT00848718|1899782|FG010|Overall Study|Lack of Efficacy|0
919327|NCT00848718|1899783|FG011|Overall Study|Lack of Efficacy|0
919328|NCT00848718|1899784|FG012|Overall Study|Lack of Efficacy|0
919329|NCT00848718|1899772|FG000|Overall Study|Physician Decision|0
919330|NCT00848718|1899773|FG001|Overall Study|Physician Decision|1
919331|NCT00848718|1899774|FG002|Overall Study|Physician Decision|0
919332|NCT00848718|1899775|FG003|Overall Study|Physician Decision|0
919333|NCT00848718|1899776|FG004|Overall Study|Physician Decision|1
919334|NCT00848718|1899777|FG005|Overall Study|Physician Decision|1
919335|NCT00848718|1899778|FG006|Overall Study|Physician Decision|0
919336|NCT00848718|1899779|FG007|Overall Study|Physician Decision|0
919337|NCT00848718|1899780|FG008|Overall Study|Physician Decision|1
919338|NCT00848718|1899781|FG009|Overall Study|Physician Decision|2
919339|NCT00848718|1899782|FG010|Overall Study|Physician Decision|0
919340|NCT00848718|1899783|FG011|Overall Study|Physician Decision|0
919341|NCT00848718|1899784|FG012|Overall Study|Physician Decision|1
919342|NCT00848718|1899772|FG000|Overall Study|Progressive disease before treatment|1
919343|NCT00848718|1899773|FG001|Overall Study|Progressive disease before treatment|5
919344|NCT00848718|1899774|FG002|Overall Study|Progressive disease before treatment|1
919345|NCT00848718|1899775|FG003|Overall Study|Progressive disease before treatment|3
919346|NCT00848718|1899776|FG004|Overall Study|Progressive disease before treatment|4
919347|NCT00848718|1899777|FG005|Overall Study|Progressive disease before treatment|4
919348|NCT00848718|1899778|FG006|Overall Study|Progressive disease before treatment|2
919349|NCT00848718|1899779|FG007|Overall Study|Progressive disease before treatment|1
919350|NCT00848718|1899780|FG008|Overall Study|Progressive disease before treatment|2
919351|NCT00848718|1899781|FG009|Overall Study|Progressive disease before treatment|7
919352|NCT00848718|1899782|FG010|Overall Study|Progressive disease before treatment|3
919353|NCT00848718|1899783|FG011|Overall Study|Progressive disease before treatment|6
919354|NCT00848718|1899784|FG012|Overall Study|Progressive disease before treatment|2
919355|NCT00848718|1899772|FG000|Overall Study|Protocol Violation|0
919356|NCT00848718|1899773|FG001|Overall Study|Protocol Violation|1
919357|NCT00848718|1899774|FG002|Overall Study|Protocol Violation|0
919358|NCT00848718|1899775|FG003|Overall Study|Protocol Violation|0
919359|NCT00848718|1899776|FG004|Overall Study|Protocol Violation|0
919360|NCT00848718|1899777|FG005|Overall Study|Protocol Violation|0
919361|NCT00848718|1899778|FG006|Overall Study|Protocol Violation|0
919362|NCT00848718|1899779|FG007|Overall Study|Protocol Violation|1
919363|NCT00848718|1899780|FG008|Overall Study|Protocol Violation|0
919364|NCT00848718|1899781|FG009|Overall Study|Protocol Violation|0
919365|NCT00848718|1899782|FG010|Overall Study|Protocol Violation|0
919366|NCT00848718|1899783|FG011|Overall Study|Protocol Violation|0
919367|NCT00848718|1899784|FG012|Overall Study|Protocol Violation|1
919368|NCT00848718|1899772|FG000|Overall Study|Withdrawal by Subject|1
919369|NCT00848718|1899773|FG001|Overall Study|Withdrawal by Subject|0
919370|NCT00848718|1899774|FG002|Overall Study|Withdrawal by Subject|0
919371|NCT00848718|1899775|FG003|Overall Study|Withdrawal by Subject|1
919372|NCT00848718|1899776|FG004|Overall Study|Withdrawal by Subject|0
919373|NCT00848718|1899777|FG005|Overall Study|Withdrawal by Subject|0
919374|NCT00848718|1899778|FG006|Overall Study|Withdrawal by Subject|0
919375|NCT00848718|1899779|FG007|Overall Study|Withdrawal by Subject|0
919376|NCT00848718|1899780|FG008|Overall Study|Withdrawal by Subject|0
919377|NCT00848718|1899781|FG009|Overall Study|Withdrawal by Subject|0
919378|NCT00848718|1899782|FG010|Overall Study|Withdrawal by Subject|1
919379|NCT00848718|1899783|FG011|Overall Study|Withdrawal by Subject|0
919380|NCT00848718|1899784|FG012|Overall Study|Withdrawal by Subject|0
919381|NCT00848718|1899772|FG000|Overall Study|Progressive disease during treatment|3
919382|NCT00848718|1899773|FG001|Overall Study|Progressive disease during treatment|0
919383|NCT00848718|1899774|FG002|Overall Study|Progressive disease during treatment|3
919384|NCT00848718|1899775|FG003|Overall Study|Progressive disease during treatment|0
919385|NCT00848718|1899776|FG004|Overall Study|Progressive disease during treatment|0
919386|NCT00848718|1899777|FG005|Overall Study|Progressive disease during treatment|0
919387|NCT00848718|1899778|FG006|Overall Study|Progressive disease during treatment|0
919388|NCT00848718|1899779|FG007|Overall Study|Progressive disease during treatment|2
919389|NCT00848718|1899780|FG008|Overall Study|Progressive disease during treatment|0
919390|NCT00848718|1899781|FG009|Overall Study|Progressive disease during treatment|0
919391|NCT00848718|1899782|FG010|Overall Study|Progressive disease during treatment|0
919392|NCT00848718|1899783|FG011|Overall Study|Progressive disease during treatment|0
919393|NCT00848718|1899784|FG012|Overall Study|Progressive disease during treatment|2
919394|NCT00848926|1899835|FG000|Treatment Period|Progressive disease|45
919395|NCT00848926|1899835|FG000|Treatment Period|Adverse Event|20
919396|NCT00848926|1899835|FG000|Treatment Period|Physician Decision|12
919397|NCT00848926|1899835|FG000|Treatment Period|Withdrawal by Subject|7
919398|NCT00848926|1899835|FG000|Follow-up Period|Lost to Follow-up|7
919399|NCT00848926|1899835|FG000|Follow-up Period|Withdrawal by Subject|3
919400|NCT00848926|1899835|FG000|Follow-up Period|Other|2
919401|NCT00848965|1899839|FG000|Overall Study|Adverse Event|1
919402|NCT00848965|1899839|FG000|Overall Study|Withdrawal by Subject|1
919403|NCT00849017|1899854|FG000|Treatment Period (156 Weeks)|Adverse Event|5
919404|NCT00849017|1899855|FG001|Treatment Period (156 Weeks)|Adverse Event|6
919405|NCT00849017|1899856|FG002|Treatment Period (156 Weeks)|Adverse Event|15
919406|NCT00849017|1899854|FG000|Treatment Period (156 Weeks)|Noncompliance|3
919407|NCT00849017|1899855|FG001|Treatment Period (156 Weeks)|Noncompliance|3
919408|NCT00849017|1899856|FG002|Treatment Period (156 Weeks)|Noncompliance|4
919409|NCT00849017|1899854|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10
919410|NCT00849017|1899855|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7
919411|NCT00849017|1899856|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8
919412|NCT00849017|1899854|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18
919413|NCT00849017|1899855|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14
919414|NCT00849017|1899856|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11
919415|NCT00849017|1899854|FG000|Treatment Period (156 Weeks)|Physician Decision|0
919416|NCT00849017|1899855|FG001|Treatment Period (156 Weeks)|Physician Decision|2
919417|NCT00849017|1899856|FG002|Treatment Period (156 Weeks)|Physician Decision|1
919418|NCT00849017|1899854|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
919419|NCT00849017|1899855|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
919420|NCT00849017|1899856|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
919421|NCT00849017|1899854|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1
919422|NCT00849017|1899855|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0
919423|NCT00849017|1899856|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0
919424|NCT00849017|1899854|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
919425|NCT00849017|1899855|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
919426|NCT00849017|1899856|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
919427|NCT00849017|1899854|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1
919428|NCT00849017|1899855|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0
919429|NCT00849017|1899856|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0
919430|NCT00849017|1899854|FG000|Treatment Period (156 Weeks)|Pregnancy|1
919431|NCT00849017|1899855|FG001|Treatment Period (156 Weeks)|Pregnancy|0
919432|NCT00849017|1899856|FG002|Treatment Period (156 Weeks)|Pregnancy|1
919433|NCT00849017|1899854|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
919434|NCT00849017|1899855|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
919435|NCT00849017|1899856|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
919436|NCT00849017|1899854|FG000|Follow-up Period (8 Weeks)|Adverse Event|1
919437|NCT00849017|1899855|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
919438|NCT00849017|1899856|FG002|Follow-up Period (8 Weeks)|Adverse Event|0
919439|NCT00849017|1899854|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
919440|NCT00849017|1899855|FG001|Follow-up Period (8 Weeks)|Noncompliance|1
919441|NCT00849017|1899856|FG002|Follow-up Period (8 Weeks)|Noncompliance|0
919442|NCT00849017|1899854|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13
919443|NCT00849017|1899855|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
919444|NCT00849017|1899856|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16
919445|NCT00849017|1899854|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
919446|NCT00849017|1899855|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
919447|NCT00849017|1899856|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
919448|NCT00849017|1899854|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
919449|NCT00849017|1899855|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
919450|NCT00849017|1899856|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
919451|NCT00849017|1899854|FG000|Follow-up Period (8 Weeks)|Physician Decision|0
919452|NCT00849017|1899855|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
919453|NCT00849017|1899856|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
919454|NCT00849017|1899854|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
919455|NCT00849017|1899855|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
919456|NCT00849017|1899856|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
919457|NCT00849017|1899854|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
919458|NCT00849017|1899855|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
919459|NCT00849017|1899856|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
919460|NCT00849056|1899870|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13
919461|NCT00849056|1899871|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11
919462|NCT00849056|1899870|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
919463|NCT00849056|1899871|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
919464|NCT00849056|1899870|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3
919465|NCT00849056|1899871|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3
919466|NCT00849056|1899870|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
919467|NCT00849056|1899871|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
919468|NCT00849056|1899870|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
919469|NCT00849056|1899871|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
919470|NCT00849056|1899870|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3
919471|NCT00849056|1899871|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3
919472|NCT00849056|1899870|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
919473|NCT00849056|1899871|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
919474|NCT00849056|1899870|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
919475|NCT00849056|1899871|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
919476|NCT00849056|1899870|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1
919477|NCT00849056|1899871|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0
919478|NCT00849056|1899870|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
919479|NCT00849056|1899871|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
919480|NCT00849056|1899870|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
919481|NCT00849056|1899871|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
919482|NCT00849056|1899870|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
919483|NCT00849056|1899871|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
919484|NCT00849056|1899870|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
919485|NCT00849056|1899871|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
919486|NCT00849056|1899870|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
919487|NCT00849056|1899871|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
919488|NCT00849056|1899870|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
919489|NCT00849056|1899871|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
919490|NCT00849056|1899870|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
919491|NCT00849056|1899871|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
919492|NCT00849108|1899880|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
919493|NCT00849108|1899881|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
919494|NCT00849108|1899880|FG000|Cohort 2 Efficacy|Adverse Event|0
919495|NCT00849108|1899881|FG001|Cohort 2 Efficacy|Adverse Event|1
919496|NCT00849108|1899880|FG000|Cohort 2 Efficacy|Other|0
919497|NCT00849108|1899881|FG001|Cohort 2 Efficacy|Other|9
919498|NCT00849147|1899898|FG000|Overall Study|Withdrawal by Subject|1
919499|NCT00849147|1899898|FG000|Overall Study|Protocol Violation|2
919500|NCT00849147|1899898|FG000|Overall Study|Disease Relapse/Progression|2
919501|NCT00849186|1899902|FG000|Overall Study|Adverse Event|2
919502|NCT00849186|1899902|FG000|Overall Study|Withdrawal by Subject|1
919503|NCT00849186|1899902|FG000|Overall Study|not treated|6
919504|NCT00849186|1899902|FG000|Overall Study|Other|1
919505|NCT00849212|1899907|FG000|Overall Study|Lack of Efficacy|1
919506|NCT00849212|1899907|FG000|Overall Study|Withdrawal by Subject|3
919507|NCT00849212|1899907|FG000|Overall Study|Adverse Event|2
919508|NCT00849212|1899907|FG000|Overall Study|Miscellaneous|1
919509|NCT00849290|1899918|FG000|Overall Study|Adverse Event|3
919510|NCT00849290|1899918|FG000|Overall Study|Death|14
919511|NCT00849290|1899918|FG000|Overall Study|Withdrawal by Subject|11
919512|NCT00849290|1899918|FG000|Overall Study|Lost to Follow-up|2
919513|NCT00849290|1899918|FG000|Overall Study|Protocol Violation|5
919514|NCT00849290|1899918|FG000|Overall Study|Disease Progression|20
919515|NCT00849381|1899922|FG000|Overall Study|Adverse Event|1
919516|NCT00849381|1899922|FG000|Overall Study|Lost to Follow-up|129
919517|NCT00849381|1899922|FG000|Overall Study|Protocol Violation|5
919518|NCT00849381|1899922|FG000|Overall Study|Withdrawal by Subject|6
919519|NCT00849381|1899922|FG000|Overall Study|Other|4
919520|NCT00849472|1899926|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
919521|NCT00849472|1899926|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
919522|NCT00849472|1899926|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
919523|NCT00849472|1899926|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
919524|NCT00849472|1899926|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
919525|NCT00849472|1899926|FG000|Weekly Paclitaxel|Disease Progression|1
919526|NCT00849472|1899926|FG000|Weekly Paclitaxel|Adverse Event|11
919527|NCT00849472|1899926|FG000|Weekly Paclitaxel|Withdrawal by Subject|1
919528|NCT00849472|1899926|FG000|Weekly Paclitaxel|Physician Decision|3
919529|NCT00849472|1899926|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
919530|NCT00849472|1899926|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
919531|NCT00849472|1899926|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
919532|NCT00849472|1899926|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
919533|NCT00849472|1899926|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19
919534|NCT00849472|1899926|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
919535|NCT00849472|1899926|FG000|Pazopanib Postsurgery Treatment|Moved|1
919536|NCT00849472|1899926|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
919537|NCT00849680|1899946|FG000|Overall Study|Adverse Event|0
919538|NCT00849680|1899947|FG001|Overall Study|Adverse Event|0
919539|NCT00849680|1899948|FG002|Overall Study|Adverse Event|0
919540|NCT00849680|1899949|FG003|Overall Study|Adverse Event|0
919541|NCT00849680|1899950|FG004|Overall Study|Adverse Event|0
919542|NCT00849680|1899951|FG005|Overall Study|Adverse Event|0
919543|NCT00849680|1899952|FG006|Overall Study|Adverse Event|2
919544|NCT00849680|1899953|FG007|Overall Study|Adverse Event|0
919545|NCT00849680|1899946|FG000|Overall Study|Lost to Follow-up|7
919546|NCT00849680|1899947|FG001|Overall Study|Lost to Follow-up|3
919547|NCT00849680|1899948|FG002|Overall Study|Lost to Follow-up|12
919548|NCT00849680|1899949|FG003|Overall Study|Lost to Follow-up|11
919549|NCT00849680|1899950|FG004|Overall Study|Lost to Follow-up|8
919550|NCT00849680|1899951|FG005|Overall Study|Lost to Follow-up|11
919551|NCT00849680|1899952|FG006|Overall Study|Lost to Follow-up|12
919552|NCT00849680|1899953|FG007|Overall Study|Lost to Follow-up|5
919553|NCT00849680|1899946|FG000|Overall Study|Subject moved|1
919554|NCT00849680|1899947|FG001|Overall Study|Subject moved|0
919555|NCT00849680|1899948|FG002|Overall Study|Subject moved|3
919556|NCT00849680|1899949|FG003|Overall Study|Subject moved|1
919557|NCT00849680|1899950|FG004|Overall Study|Subject moved|0
919558|NCT00849680|1899951|FG005|Overall Study|Subject moved|2
919559|NCT00849680|1899952|FG006|Overall Study|Subject moved|2
919560|NCT00849680|1899953|FG007|Overall Study|Subject moved|2
919561|NCT00849680|1899946|FG000|Overall Study|Withdrawal by Subject|2
919562|NCT00849680|1899947|FG001|Overall Study|Withdrawal by Subject|0
919563|NCT00849680|1899948|FG002|Overall Study|Withdrawal by Subject|0
919564|NCT00849680|1899949|FG003|Overall Study|Withdrawal by Subject|2
919565|NCT00849680|1899950|FG004|Overall Study|Withdrawal by Subject|2
919566|NCT00849680|1899951|FG005|Overall Study|Withdrawal by Subject|2
919567|NCT00849680|1899952|FG006|Overall Study|Withdrawal by Subject|1
919568|NCT00849680|1899953|FG007|Overall Study|Withdrawal by Subject|1
919569|NCT00849680|1899946|FG000|Overall Study|Subject unable to comply with protocol|1
919570|NCT00849680|1899947|FG001|Overall Study|Subject unable to comply with protocol|0
919571|NCT00849680|1899948|FG002|Overall Study|Subject unable to comply with protocol|0
919572|NCT00849680|1899949|FG003|Overall Study|Subject unable to comply with protocol|0
919573|NCT00849680|1899950|FG004|Overall Study|Subject unable to comply with protocol|0
919574|NCT00849680|1899951|FG005|Overall Study|Subject unable to comply with protocol|0
919575|NCT00849680|1899952|FG006|Overall Study|Subject unable to comply with protocol|0
919576|NCT00849680|1899953|FG007|Overall Study|Subject unable to comply with protocol|0
919577|NCT00849693|1899975|FG000|Acute Treatment Phase|Adverse Event|12
919578|NCT00849693|1899976|FG001|Acute Treatment Phase|Adverse Event|7
919579|NCT00849693|1899977|FG002|Acute Treatment Phase|Adverse Event|6
919580|NCT00849693|1899978|FG003|Acute Treatment Phase|Adverse Event|4
919581|NCT00849693|1899975|FG000|Acute Treatment Phase|Lost to Follow-up|5
919582|NCT00849693|1899976|FG001|Acute Treatment Phase|Lost to Follow-up|8
919583|NCT00849693|1899977|FG002|Acute Treatment Phase|Lost to Follow-up|11
919584|NCT00849693|1899978|FG003|Acute Treatment Phase|Lost to Follow-up|9
919585|NCT00849693|1899975|FG000|Acute Treatment Phase|Protocol Violation|1
919586|NCT00849693|1899976|FG001|Acute Treatment Phase|Protocol Violation|5
919587|NCT00849693|1899977|FG002|Acute Treatment Phase|Protocol Violation|2
919588|NCT00849693|1899978|FG003|Acute Treatment Phase|Protocol Violation|6
919589|NCT00849693|1899975|FG000|Acute Treatment Phase|Withdrawal by Subject|5
919590|NCT00849693|1899976|FG001|Acute Treatment Phase|Withdrawal by Subject|5
919591|NCT00849693|1899977|FG002|Acute Treatment Phase|Withdrawal by Subject|3
919592|NCT00849693|1899978|FG003|Acute Treatment Phase|Withdrawal by Subject|8
919593|NCT00849693|1899975|FG000|Acute Treatment Phase|Parent or caregiver decision|7
919594|NCT00849693|1899976|FG001|Acute Treatment Phase|Parent or caregiver decision|6
919595|NCT00849693|1899977|FG002|Acute Treatment Phase|Parent or caregiver decision|7
919596|NCT00849693|1899978|FG003|Acute Treatment Phase|Parent or caregiver decision|7
919597|NCT00849693|1899975|FG000|Acute Treatment Phase|Physician Decision|2
919598|NCT00849693|1899976|FG001|Acute Treatment Phase|Physician Decision|1
919599|NCT00849693|1899977|FG002|Acute Treatment Phase|Physician Decision|2
919600|NCT00849693|1899978|FG003|Acute Treatment Phase|Physician Decision|1
919601|NCT00849693|1899975|FG000|Acute Treatment Phase|Sponsor decision|0
919602|NCT00849693|1899976|FG001|Acute Treatment Phase|Sponsor decision|0
919603|NCT00849693|1899977|FG002|Acute Treatment Phase|Sponsor decision|1
919604|NCT00849693|1899978|FG003|Acute Treatment Phase|Sponsor decision|0
919605|NCT00849693|1899975|FG000|Acute Treatment Phase|Lack of Efficacy|1
919606|NCT00849693|1899976|FG001|Acute Treatment Phase|Lack of Efficacy|3
919607|NCT00849693|1899977|FG002|Acute Treatment Phase|Lack of Efficacy|1
919608|NCT00849693|1899978|FG003|Acute Treatment Phase|Lack of Efficacy|2
919609|NCT00849693|1899975|FG000|Extension Phase|Adverse Event|4
919610|NCT00849693|1899976|FG001|Extension Phase|Adverse Event|6
919611|NCT00849693|1899977|FG002|Extension Phase|Adverse Event|3
919612|NCT00849693|1899978|FG003|Extension Phase|Adverse Event|7
919613|NCT00849693|1899975|FG000|Extension Phase|Lost to Follow-up|7
919614|NCT00849693|1899976|FG001|Extension Phase|Lost to Follow-up|5
919615|NCT00849693|1899977|FG002|Extension Phase|Lost to Follow-up|6
919616|NCT00849693|1899978|FG003|Extension Phase|Lost to Follow-up|6
919617|NCT00849693|1899975|FG000|Extension Phase|Protocol Violation|0
919618|NCT00849693|1899976|FG001|Extension Phase|Protocol Violation|3
919619|NCT00849693|1899977|FG002|Extension Phase|Protocol Violation|2
919620|NCT00849693|1899978|FG003|Extension Phase|Protocol Violation|3
919621|NCT00849693|1899975|FG000|Extension Phase|Withdrawal by Subject|6
919622|NCT00849693|1899976|FG001|Extension Phase|Withdrawal by Subject|9
919623|NCT00849693|1899977|FG002|Extension Phase|Withdrawal by Subject|10
919624|NCT00849693|1899978|FG003|Extension Phase|Withdrawal by Subject|15
919625|NCT00849693|1899975|FG000|Extension Phase|Parent or caregiver decision|9
919626|NCT00849693|1899976|FG001|Extension Phase|Parent or caregiver decision|4
919627|NCT00849693|1899977|FG002|Extension Phase|Parent or caregiver decision|10
919628|NCT00849693|1899978|FG003|Extension Phase|Parent or caregiver decision|5
919629|NCT00849693|1899975|FG000|Extension Phase|Physician Decision|1
919630|NCT00849693|1899976|FG001|Extension Phase|Physician Decision|1
919631|NCT00849693|1899977|FG002|Extension Phase|Physician Decision|2
919632|NCT00849693|1899978|FG003|Extension Phase|Physician Decision|0
919633|NCT00849693|1899975|FG000|Extension Phase|Sponsor decision|1
919634|NCT00849693|1899976|FG001|Extension Phase|Sponsor decision|0
919635|NCT00849693|1899977|FG002|Extension Phase|Sponsor decision|0
919636|NCT00849693|1899978|FG003|Extension Phase|Sponsor decision|1
919637|NCT00849693|1899975|FG000|Extension Phase|Lack of Efficacy|2
919638|NCT00849693|1899976|FG001|Extension Phase|Lack of Efficacy|2
919639|NCT00849693|1899977|FG002|Extension Phase|Lack of Efficacy|2
919640|NCT00849693|1899978|FG003|Extension Phase|Lack of Efficacy|1
919641|NCT00849797|1900002|FG000|First Intervention|bad veins|1
919642|NCT00849797|1900003|FG001|First Intervention|bad veins|0
919643|NCT00849797|1900002|FG000|First Intervention|Adverse Event|0
919644|NCT00849797|1900003|FG001|First Intervention|Adverse Event|1
919645|NCT00849797|1900002|FG000|Washout: One Week|Withdrawal by Subject|0
919646|NCT00849797|1900003|FG001|Washout: One Week|Withdrawal by Subject|2
919647|NCT00849875|1900022|FG000|Overall Study|Death|28
919648|NCT00849875|1900022|FG000|Overall Study|Ongoing (unknown completion status)|11
919649|NCT00849875|1900022|FG000|Overall Study|Others|6
919650|NCT00849875|1900022|FG000|Overall Study|Lost to Follow-up|2
919651|NCT00849901|1900036|FG000|Acute Treatment Phase|Adverse Event|9
919652|NCT00849901|1900037|FG001|Acute Treatment Phase|Adverse Event|1
919653|NCT00849901|1900038|FG002|Acute Treatment Phase|Adverse Event|3
919654|NCT00849901|1900036|FG000|Acute Treatment Phase|Lost to Follow-up|2
919655|NCT00849901|1900037|FG001|Acute Treatment Phase|Lost to Follow-up|4
919656|NCT00849901|1900038|FG002|Acute Treatment Phase|Lost to Follow-up|1
919657|NCT00849901|1900036|FG000|Acute Treatment Phase|Protocol Violation|0
919658|NCT00849901|1900037|FG001|Acute Treatment Phase|Protocol Violation|2
919659|NCT00849901|1900038|FG002|Acute Treatment Phase|Protocol Violation|1
919660|NCT00849901|1900036|FG000|Acute Treatment Phase|Withdrawal by Subject|4
919661|NCT00849901|1900037|FG001|Acute Treatment Phase|Withdrawal by Subject|10
919662|NCT00849901|1900038|FG002|Acute Treatment Phase|Withdrawal by Subject|4
919663|NCT00849901|1900036|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11
919664|NCT00849901|1900037|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5
919665|NCT00849901|1900038|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4
919666|NCT00849901|1900036|FG000|Acute Treatment Phase|Physician Decision|1
919667|NCT00849901|1900037|FG001|Acute Treatment Phase|Physician Decision|1
919668|NCT00849901|1900038|FG002|Acute Treatment Phase|Physician Decision|1
919669|NCT00849901|1900036|FG000|Acute Treatment Phase|Sponsor Decision|1
919670|NCT00849901|1900037|FG001|Acute Treatment Phase|Sponsor Decision|0
919671|NCT00849901|1900038|FG002|Acute Treatment Phase|Sponsor Decision|0
919672|NCT00849901|1900036|FG000|Acute Treatment Phase|Lack of Efficacy|2
919673|NCT00849901|1900037|FG001|Acute Treatment Phase|Lack of Efficacy|3
919674|NCT00849901|1900038|FG002|Acute Treatment Phase|Lack of Efficacy|2
919675|NCT00849901|1900036|FG000|Extension Phase|Adverse Event|2
919676|NCT00849901|1900037|FG001|Extension Phase|Adverse Event|8
919677|NCT00849901|1900038|FG002|Extension Phase|Adverse Event|4
919678|NCT00849901|1900036|FG000|Extension Phase|Lost to Follow-up|3
919679|NCT00849901|1900037|FG001|Extension Phase|Lost to Follow-up|0
919680|NCT00849901|1900038|FG002|Extension Phase|Lost to Follow-up|1
919681|NCT00849901|1900036|FG000|Extension Phase|Protocol Violation|2
919682|NCT00849901|1900037|FG001|Extension Phase|Protocol Violation|2
919683|NCT00849901|1900038|FG002|Extension Phase|Protocol Violation|4
919684|NCT00849901|1900036|FG000|Extension Phase|Withdrawal by Subject|7
919685|NCT00849901|1900037|FG001|Extension Phase|Withdrawal by Subject|6
919686|NCT00849901|1900038|FG002|Extension Phase|Withdrawal by Subject|3
919687|NCT00849901|1900036|FG000|Extension Phase|Parent or Caregiver Decision|10
919688|NCT00849901|1900037|FG001|Extension Phase|Parent or Caregiver Decision|4
919689|NCT00849901|1900038|FG002|Extension Phase|Parent or Caregiver Decision|4
919690|NCT00849901|1900036|FG000|Extension Phase|Physician Decision|1
919691|NCT00849901|1900037|FG001|Extension Phase|Physician Decision|2
919692|NCT00849901|1900038|FG002|Extension Phase|Physician Decision|0
919693|NCT00849901|1900036|FG000|Extension Phase|Lack of Efficacy|2
919694|NCT00849901|1900037|FG001|Extension Phase|Lack of Efficacy|4
919695|NCT00849901|1900038|FG002|Extension Phase|Lack of Efficacy|1
919696|NCT00849940|1900052|FG000|Overall Study|Physician Decision|4
919697|NCT00850070|1900062|FG000|Overall Study|Lack of Efficacy|1
919698|NCT00850070|1900063|FG001|Overall Study|Lack of Efficacy|1
919699|NCT00850070|1900062|FG000|Overall Study|Adverse Event|2
919700|NCT00850070|1900063|FG001|Overall Study|Adverse Event|0
919701|NCT00850135|1900083|FG000|Overall Study|Physician Decision|1
919702|NCT00850174|1900091|FG000|Washout: One Week|Withdrawal by Subject|0
919703|NCT00850174|1900092|FG001|Washout: One Week|Withdrawal by Subject|2
919704|NCT00850174|1900091|FG000|Second Intervention|Withdrawal by Subject|1
919705|NCT00850174|1900092|FG001|Second Intervention|Withdrawal by Subject|0
919706|NCT00850200|1900096|FG000|Overall Study|Physician Decision|2
919707|NCT00850200|1900096|FG000|Overall Study|Did not recieve treatment|2
919708|NCT00850200|1900096|FG000|Overall Study|Withdrawal by Subject|1
919709|NCT00850343|1900107|FG000|Overall Study|Withdrawal by Subject|11
919710|NCT00850343|1900108|FG001|Overall Study|Withdrawal by Subject|0
919711|NCT00850343|1900109|FG002|Overall Study|Withdrawal by Subject|3
919712|NCT00850343|1900110|FG003|Overall Study|Withdrawal by Subject|2
919713|NCT00850343|1900107|FG000|Overall Study|Adverse Event|15
919714|NCT00850343|1900108|FG001|Overall Study|Adverse Event|2
919715|NCT00850343|1900109|FG002|Overall Study|Adverse Event|6
919716|NCT00850343|1900110|FG003|Overall Study|Adverse Event|6
919717|NCT00850343|1900107|FG000|Overall Study|Pregnancy|0
919718|NCT00850343|1900108|FG001|Overall Study|Pregnancy|0
919719|NCT00850343|1900109|FG002|Overall Study|Pregnancy|0
919720|NCT00850343|1900110|FG003|Overall Study|Pregnancy|1
919721|NCT00850343|1900107|FG000|Overall Study|Lack of Efficacy|17
919722|NCT00850343|1900108|FG001|Overall Study|Lack of Efficacy|0
919723|NCT00850343|1900109|FG002|Overall Study|Lack of Efficacy|3
919724|NCT00850343|1900110|FG003|Overall Study|Lack of Efficacy|2
919725|NCT00850343|1900107|FG000|Overall Study|Non-compliance with Study Procedures|1
919726|NCT00850343|1900108|FG001|Overall Study|Non-compliance with Study Procedures|0
919727|NCT00850343|1900109|FG002|Overall Study|Non-compliance with Study Procedures|1
919728|NCT00850343|1900110|FG003|Overall Study|Non-compliance with Study Procedures|1
919729|NCT00850343|1900107|FG000|Overall Study|Physician Decision|2
919730|NCT00850343|1900108|FG001|Overall Study|Physician Decision|1
919731|NCT00850343|1900109|FG002|Overall Study|Physician Decision|1
919732|NCT00850343|1900110|FG003|Overall Study|Physician Decision|1
919733|NCT00850395|1900120|FG000|Overall Study|Death|1
919734|NCT00850395|1900120|FG000|Overall Study|Adverse Event|1
919735|NCT00850395|1900120|FG000|Overall Study|Insufficient clinical response|3
919736|NCT00850395|1900120|FG000|Overall Study|Other|5
919737|NCT00850460|1900126|FG000|Overall Study|Lost to Follow-up|4
919738|NCT00850460|1900127|FG001|Overall Study|Lost to Follow-up|4
919739|NCT00850499|1900139|FG000|Overall Study|Adverse Event|3
919740|NCT00850499|1900140|FG001|Overall Study|Adverse Event|1
919741|NCT00850499|1900139|FG000|Overall Study|Lack of Efficacy|0
919742|NCT00850499|1900140|FG001|Overall Study|Lack of Efficacy|1
919743|NCT00850538|1900146|FG000|Overall Study|unable/unwilling to complete MRI|13
919744|NCT00850538|1900146|FG000|Overall Study|specimen missed due to scheduling error|14
919745|NCT00850538|1900146|FG000|Overall Study|specimen unusable|7
919746|NCT00850538|1900146|FG000|Overall Study|Withdrawal by Subject|3
919747|NCT00850538|1900146|FG000|Overall Study|radiology error|2
919748|NCT00850538|1900146|FG000|Overall Study|Protocol Violation|2
919749|NCT00850564|1900150|FG000|Overall Study|Withdrawal by Subject|2
919750|NCT00850759|1900193|FG000|Overall Study|Lost to Follow-up|7
919751|NCT00850759|1900194|FG001|Overall Study|Lost to Follow-up|5
919752|NCT00850759|1900195|FG002|Overall Study|Lost to Follow-up|5
919753|NCT00850759|1900196|FG003|Overall Study|Lost to Follow-up|3
919754|NCT00850993|1900217|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1
919755|NCT00850993|1900218|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0
919756|NCT00850993|1900219|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0
919757|NCT00850993|1900220|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1
919758|NCT00851084|1900240|FG000|Overall Study|Randomized but not treated|1
919759|NCT00851084|1900241|FG001|Overall Study|Randomized but not treated|0
919760|NCT00851084|1900240|FG000|Overall Study|Adverse Event|26
919761|NCT00851084|1900241|FG001|Overall Study|Adverse Event|36
919762|NCT00851084|1900240|FG000|Overall Study|Disease progression|52
919763|NCT00851084|1900241|FG001|Overall Study|Disease progression|47
919764|NCT00851084|1900240|FG000|Overall Study|Poor compliance to protocol|1
919765|NCT00851084|1900241|FG001|Overall Study|Poor compliance to protocol|1
919766|NCT00851084|1900240|FG000|Overall Study|Physician Decision|13
919767|NCT00851084|1900241|FG001|Overall Study|Physician Decision|14
919768|NCT00851084|1900240|FG000|Overall Study|Consent withdrawn|0
919769|NCT00851084|1900241|FG001|Overall Study|Consent withdrawn|2
919770|NCT00851084|1900240|FG000|Overall Study|Withdrawal by Subject|11
919771|NCT00851084|1900241|FG001|Overall Study|Withdrawal by Subject|12
919772|NCT00851084|1900240|FG000|Overall Study|Metastatic surgery|6
919773|NCT00851084|1900241|FG001|Overall Study|Metastatic surgery|6
919774|NCT00851084|1900240|FG000|Overall Study|Other|7
919775|NCT00851084|1900241|FG001|Overall Study|Other|1
919776|NCT00851253|1900251|FG000|Overall Study|Disease Progression|1
919777|NCT00851253|1900252|FG001|Overall Study|Disease Progression|0
919778|NCT00851318|1900266|FG000|Overall Study|Withdrawal by Subject|7
919779|NCT00851318|1900267|FG001|Overall Study|Withdrawal by Subject|1
919780|NCT00851318|1900268|FG002|Overall Study|Withdrawal by Subject|5
919781|NCT00851318|1900269|FG003|Overall Study|Withdrawal by Subject|3
919782|NCT00851318|1900266|FG000|Overall Study|Adverse Event|13
919783|NCT00851318|1900267|FG001|Overall Study|Adverse Event|2
919784|NCT00851318|1900268|FG002|Overall Study|Adverse Event|9
919785|NCT00851318|1900269|FG003|Overall Study|Adverse Event|12
919786|NCT00851318|1900266|FG000|Overall Study|Pregnancy|0
919787|NCT00851318|1900267|FG001|Overall Study|Pregnancy|0
919788|NCT00851318|1900268|FG002|Overall Study|Pregnancy|1
919789|NCT00851318|1900269|FG003|Overall Study|Pregnancy|1
919790|NCT00851318|1900266|FG000|Overall Study|Lack of Efficacy|8
919791|NCT00851318|1900267|FG001|Overall Study|Lack of Efficacy|2
919792|NCT00851318|1900268|FG002|Overall Study|Lack of Efficacy|4
919793|NCT00851318|1900269|FG003|Overall Study|Lack of Efficacy|2
919794|NCT00851318|1900266|FG000|Overall Study|Non-compliance with Study Procedures|2
919795|NCT00851318|1900267|FG001|Overall Study|Non-compliance with Study Procedures|0
919796|NCT00851318|1900268|FG002|Overall Study|Non-compliance with Study Procedures|1
919797|NCT00851318|1900269|FG003|Overall Study|Non-compliance with Study Procedures|0
919798|NCT00851318|1900266|FG000|Overall Study|Physician Decision|0
919799|NCT00851318|1900267|FG001|Overall Study|Physician Decision|0
919800|NCT00851318|1900268|FG002|Overall Study|Physician Decision|1
919801|NCT00851318|1900269|FG003|Overall Study|Physician Decision|1
919802|NCT00851630|1900299|FG000|Overall Study|Death|2
919803|NCT00851630|1900300|FG001|Overall Study|Death|1
919804|NCT00851630|1900299|FG000|Overall Study|Clinical failure|0
919805|NCT00851630|1900300|FG001|Overall Study|Clinical failure|1
919806|NCT00851643|1900312|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1
919807|NCT00851643|1900313|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0
919808|NCT00851643|1900314|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0
919809|NCT00851643|1900315|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0
919810|NCT00851643|1900316|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0
919811|NCT00851643|1900317|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0
919812|NCT00851643|1900312|FG000|Base Study (Up to 12 Months)|Other|0
919813|NCT00851643|1900313|FG001|Base Study (Up to 12 Months)|Other|0
919814|NCT00851643|1900314|FG002|Base Study (Up to 12 Months)|Other|0
919815|NCT00851643|1900315|FG003|Base Study (Up to 12 Months)|Other|0
919816|NCT00851643|1900316|FG004|Base Study (Up to 12 Months)|Other|0
919817|NCT00851643|1900317|FG005|Base Study (Up to 12 Months)|Other|1
919818|NCT00851643|1900312|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4
919819|NCT00851643|1900313|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2
919820|NCT00851643|1900314|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4
919821|NCT00851643|1900315|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1
919822|NCT00851643|1900316|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2
919823|NCT00851643|1900317|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0
919824|NCT00851643|1900312|FG000|Extension Study (Up to 36 Months)|Moved|0
919825|NCT00851643|1900313|FG001|Extension Study (Up to 36 Months)|Moved|2
919826|NCT00851643|1900314|FG002|Extension Study (Up to 36 Months)|Moved|1
919827|NCT00851643|1900315|FG003|Extension Study (Up to 36 Months)|Moved|1
919828|NCT00851643|1900316|FG004|Extension Study (Up to 36 Months)|Moved|0
919829|NCT00851643|1900317|FG005|Extension Study (Up to 36 Months)|Moved|1
919830|NCT00851721|1900332|FG000|Overall Study|planned surgery|1
919831|NCT00851721|1900333|FG001|Overall Study|planned surgery|0
919832|NCT00851721|1900332|FG000|Overall Study|Death|1
919833|NCT00851721|1900333|FG001|Overall Study|Death|0
919834|NCT00851721|1900332|FG000|Overall Study|Adverse Event|0
919835|NCT00851721|1900333|FG001|Overall Study|Adverse Event|1
919836|NCT00851786|1900347|FG000|Overall Study|Withdrawal by Subject|0
919837|NCT00851786|1900348|FG001|Overall Study|Withdrawal by Subject|1
919838|NCT00851786|1900347|FG000|Overall Study|Protocol Violation|0
919839|NCT00851786|1900348|FG001|Overall Study|Protocol Violation|1
919840|NCT00851786|1900347|FG000|Overall Study|Lost to Follow-up|1
919841|NCT00851786|1900348|FG001|Overall Study|Lost to Follow-up|0
919842|NCT00851786|1900347|FG000|Overall Study|Incarceration|1
919843|NCT00851786|1900348|FG001|Overall Study|Incarceration|0
919844|NCT00851786|1900347|FG000|Overall Study|Site Closure|1
919845|NCT00851786|1900348|FG001|Overall Study|Site Closure|0
919846|NCT00851786|1900347|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2
919847|NCT00851786|1900348|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0
919848|NCT00851799|1900357|FG000|Overall Study|Death|1
919849|NCT00851799|1900358|FG001|Overall Study|Death|0
919850|NCT00851799|1900359|FG002|Overall Study|Death|1
919851|NCT00851799|1900357|FG000|Overall Study|Lost to Follow-up|5
919852|NCT00851799|1900358|FG001|Overall Study|Lost to Follow-up|3
919853|NCT00851799|1900359|FG002|Overall Study|Lost to Follow-up|10
919854|NCT00851799|1900357|FG000|Overall Study|Not able to get to clinic|8
919855|NCT00851799|1900358|FG001|Overall Study|Not able to get to clinic|5
919856|NCT00851799|1900359|FG002|Overall Study|Not able to get to clinic|9
919857|NCT00851799|1900357|FG000|Overall Study|Not willing to adhere to requirements|1
919858|NCT00851799|1900358|FG001|Overall Study|Not willing to adhere to requirements|2
919859|NCT00851799|1900359|FG002|Overall Study|Not willing to adhere to requirements|2
919860|NCT00851799|1900357|FG000|Overall Study|Withdrew consent prior study completion|1
919861|NCT00851799|1900358|FG001|Overall Study|Withdrew consent prior study completion|2
919862|NCT00851799|1900359|FG002|Overall Study|Withdrew consent prior study completion|1
919863|NCT00851799|1900357|FG000|Overall Study|Severe Debilitation|0
919864|NCT00851799|1900358|FG001|Overall Study|Severe Debilitation|1
919865|NCT00851799|1900359|FG002|Overall Study|Severe Debilitation|0
919866|NCT00851799|1900357|FG000|Overall Study|Completed protocol due to pregnancy|0
919867|NCT00851799|1900358|FG001|Overall Study|Completed protocol due to pregnancy|0
919868|NCT00851799|1900359|FG002|Overall Study|Completed protocol due to pregnancy|1
919869|NCT00851877|1900367|FG000|Phase I-1|Death|1
919870|NCT00851877|1900368|FG001|Phase I-1|Death|0
919871|NCT00851877|1900369|FG002|Phase I-1|Death|0
919872|NCT00851877|1900367|FG000|Phase II|Withdrawal by Subject|0
919873|NCT00851877|1900368|FG001|Phase II|Withdrawal by Subject|0
919874|NCT00851877|1900369|FG002|Phase II|Withdrawal by Subject|3
919875|NCT00851890|1900379|FG000|Overall Study|Lost to Follow-up|0
919876|NCT00851890|1900380|FG001|Overall Study|Lost to Follow-up|1
919877|NCT00851890|1900381|FG002|Overall Study|Lost to Follow-up|0
919878|NCT00851890|1900382|FG003|Overall Study|Lost to Follow-up|1
919879|NCT00851903|1900392|FG000|Overall Study|Withdrawal by Subject|2
919880|NCT00852202|1900408|FG000|Overall Study|Adverse Event|2
919881|NCT00852202|1900409|FG001|Overall Study|Adverse Event|3
919882|NCT00852202|1900410|FG002|Overall Study|Adverse Event|7
919883|NCT00852202|1900408|FG000|Overall Study|Lack of Efficacy|4
919884|NCT00852202|1900409|FG001|Overall Study|Lack of Efficacy|1
919885|NCT00852202|1900410|FG002|Overall Study|Lack of Efficacy|2
919886|NCT00852202|1900408|FG000|Overall Study|Protocol Violation|2
919887|NCT00852202|1900409|FG001|Overall Study|Protocol Violation|2
919888|NCT00852202|1900410|FG002|Overall Study|Protocol Violation|7
919889|NCT00852202|1900408|FG000|Overall Study|Withdrawal by Subject|3
919890|NCT00852202|1900409|FG001|Overall Study|Withdrawal by Subject|1
919891|NCT00852202|1900410|FG002|Overall Study|Withdrawal by Subject|2
919892|NCT00852202|1900408|FG000|Overall Study|Lost to Follow-up|5
919893|NCT00852202|1900409|FG001|Overall Study|Lost to Follow-up|5
919894|NCT00852202|1900410|FG002|Overall Study|Lost to Follow-up|6
919895|NCT00852202|1900408|FG000|Overall Study|pregnancy,moving away and surgery|1
919896|NCT00852202|1900409|FG001|Overall Study|pregnancy,moving away and surgery|0
919897|NCT00852202|1900410|FG002|Overall Study|pregnancy,moving away and surgery|2
919898|NCT00852397|1900422|FG000|Overall Study|Adverse Event|4
919899|NCT00852397|1900423|FG001|Overall Study|Adverse Event|6
919900|NCT00852397|1900424|FG002|Overall Study|Adverse Event|4
919901|NCT00852397|1900422|FG000|Overall Study|Death|0
919902|NCT00852397|1900423|FG001|Overall Study|Death|0
919903|NCT00852397|1900424|FG002|Overall Study|Death|1
919904|NCT00852397|1900422|FG000|Overall Study|Withdrawal by Subject|4
919905|NCT00852397|1900423|FG001|Overall Study|Withdrawal by Subject|1
919906|NCT00852397|1900424|FG002|Overall Study|Withdrawal by Subject|2
919907|NCT00852397|1900422|FG000|Overall Study|Study terminated by sponsor|2
919908|NCT00852397|1900423|FG001|Overall Study|Study terminated by sponsor|1
919909|NCT00852397|1900424|FG002|Overall Study|Study terminated by sponsor|6
919910|NCT00852397|1900422|FG000|Overall Study|Difficulty in study site visit|1
919911|NCT00852397|1900423|FG001|Overall Study|Difficulty in study site visit|0
919912|NCT00852397|1900424|FG002|Overall Study|Difficulty in study site visit|0
919913|NCT00852397|1900422|FG000|Overall Study|Protocol Violation|0
919914|NCT00852397|1900423|FG001|Overall Study|Protocol Violation|0
919915|NCT00852397|1900424|FG002|Overall Study|Protocol Violation|1
919916|NCT00852475|1900434|FG000|Overall Study|Lost to Follow-up|3
919917|NCT00852475|1900435|FG001|Overall Study|Lost to Follow-up|4
919918|NCT00852540|1900451|FG000|Overall Study|Adverse Event|10
919919|NCT00852540|1900452|FG001|Overall Study|Adverse Event|3
919920|NCT00852540|1900451|FG000|Overall Study|Lack of Efficacy|15
919921|NCT00852540|1900452|FG001|Overall Study|Lack of Efficacy|3
919922|NCT00852540|1900451|FG000|Overall Study|Protocol Violation|1
919923|NCT00852540|1900452|FG001|Overall Study|Protocol Violation|2
919924|NCT00852540|1900451|FG000|Overall Study|Lost to Follow-up|2
919925|NCT00852540|1900452|FG001|Overall Study|Lost to Follow-up|3
919926|NCT00852540|1900451|FG000|Overall Study|Investigator Discretion|2
919927|NCT00852540|1900452|FG001|Overall Study|Investigator Discretion|3
919928|NCT00852540|1900451|FG000|Overall Study|Withdrawal by Subject|3
919929|NCT00852540|1900452|FG001|Overall Study|Withdrawal by Subject|1
919930|NCT00852540|1900451|FG000|Overall Study|Did Not Receive Study Drug|3
919931|NCT00852540|1900452|FG001|Overall Study|Did Not Receive Study Drug|3
919932|NCT00852917|1900505|FG000|Overall Study|Adverse Event|13
919933|NCT00852917|1900506|FG001|Overall Study|Adverse Event|20
919934|NCT00852917|1900507|FG002|Overall Study|Adverse Event|35
919935|NCT00852917|1900508|FG003|Overall Study|Adverse Event|17
919936|NCT00852917|1900505|FG000|Overall Study|Lack of Efficacy|21
919937|NCT00852917|1900506|FG001|Overall Study|Lack of Efficacy|11
919938|NCT00852917|1900507|FG002|Overall Study|Lack of Efficacy|11
919939|NCT00852917|1900508|FG003|Overall Study|Lack of Efficacy|47
919940|NCT00852917|1900505|FG000|Overall Study|Withdrawal by Subject|4
919941|NCT00852917|1900506|FG001|Overall Study|Withdrawal by Subject|8
919942|NCT00852917|1900507|FG002|Overall Study|Withdrawal by Subject|10
919943|NCT00852917|1900508|FG003|Overall Study|Withdrawal by Subject|9
919944|NCT00852917|1900505|FG000|Overall Study|Physician Decision|6
919945|NCT00852917|1900506|FG001|Overall Study|Physician Decision|7
919946|NCT00852917|1900507|FG002|Overall Study|Physician Decision|2
919947|NCT00852917|1900508|FG003|Overall Study|Physician Decision|19
919948|NCT00852917|1900505|FG000|Overall Study|Death|0
919949|NCT00852917|1900506|FG001|Overall Study|Death|0
919950|NCT00852917|1900507|FG002|Overall Study|Death|0
919951|NCT00852917|1900508|FG003|Overall Study|Death|1
919952|NCT00852930|1900521|FG000|Overall Study|Withdrawal by Subject|1
919953|NCT00852930|1900522|FG001|Overall Study|Withdrawal by Subject|1
919954|NCT00852930|1900523|FG002|Overall Study|Withdrawal by Subject|1
919955|NCT00852930|1900521|FG000|Overall Study|Physician Decision|0
919956|NCT00852930|1900522|FG001|Overall Study|Physician Decision|0
919957|NCT00852930|1900523|FG002|Overall Study|Physician Decision|1
919958|NCT00852969|1900534|FG000|Overall Study|Adverse Event|0
919959|NCT00852969|1900535|FG001|Overall Study|Adverse Event|1
919960|NCT00852969|1900534|FG000|Overall Study|Lost to Follow-up|0
919961|NCT00852969|1900535|FG001|Overall Study|Lost to Follow-up|1
919962|NCT00852995|1900546|FG000|Overall Study|Adverse Event|1
919963|NCT00852995|1900547|FG001|Overall Study|Adverse Event|0
919964|NCT00852995|1900548|FG002|Overall Study|Adverse Event|4
919965|NCT00852995|1900549|FG003|Overall Study|Adverse Event|0
919966|NCT00852995|1900550|FG004|Overall Study|Adverse Event|0
919967|NCT00852995|1900546|FG000|Overall Study|Lost to Follow-up|0
919968|NCT00852995|1900547|FG001|Overall Study|Lost to Follow-up|1
919969|NCT00852995|1900548|FG002|Overall Study|Lost to Follow-up|1
919970|NCT00852995|1900549|FG003|Overall Study|Lost to Follow-up|0
919971|NCT00852995|1900550|FG004|Overall Study|Lost to Follow-up|0
919972|NCT00852995|1900546|FG000|Overall Study|Withdrawal by Subject|4
919973|NCT00852995|1900547|FG001|Overall Study|Withdrawal by Subject|0
919974|NCT00852995|1900548|FG002|Overall Study|Withdrawal by Subject|0
919975|NCT00852995|1900549|FG003|Overall Study|Withdrawal by Subject|1
919976|NCT00852995|1900550|FG004|Overall Study|Withdrawal by Subject|2
919977|NCT00852995|1900546|FG000|Overall Study|Non-Compliance|0
919978|NCT00852995|1900547|FG001|Overall Study|Non-Compliance|0
919979|NCT00852995|1900548|FG002|Overall Study|Non-Compliance|0
919980|NCT00852995|1900549|FG003|Overall Study|Non-Compliance|2
919981|NCT00852995|1900550|FG004|Overall Study|Non-Compliance|0
919982|NCT00852995|1900546|FG000|Overall Study|Progressive Disease|1
919983|NCT00852995|1900547|FG001|Overall Study|Progressive Disease|0
919984|NCT00852995|1900548|FG002|Overall Study|Progressive Disease|0
919985|NCT00852995|1900549|FG003|Overall Study|Progressive Disease|2
919986|NCT00852995|1900550|FG004|Overall Study|Progressive Disease|1
919987|NCT00852995|1900546|FG000|Overall Study|Physician Decision|1
919988|NCT00852995|1900547|FG001|Overall Study|Physician Decision|0
919989|NCT00852995|1900548|FG002|Overall Study|Physician Decision|0
919990|NCT00852995|1900549|FG003|Overall Study|Physician Decision|0
919991|NCT00852995|1900550|FG004|Overall Study|Physician Decision|0
919992|NCT00852995|1900546|FG000|Overall Study|Protocol Violation|0
919993|NCT00852995|1900547|FG001|Overall Study|Protocol Violation|0
919994|NCT00852995|1900548|FG002|Overall Study|Protocol Violation|0
919995|NCT00852995|1900549|FG003|Overall Study|Protocol Violation|0
919996|NCT00852995|1900550|FG004|Overall Study|Protocol Violation|1
919997|NCT00852995|1900546|FG000|Overall Study|Moved Out of Area|1
919998|NCT00852995|1900547|FG001|Overall Study|Moved Out of Area|0
919999|NCT00852995|1900548|FG002|Overall Study|Moved Out of Area|0
920000|NCT00852995|1900549|FG003|Overall Study|Moved Out of Area|0
920001|NCT00852995|1900550|FG004|Overall Study|Moved Out of Area|0
920002|NCT00853021|1900567|FG000|Overall Study|Adverse Event|2
920003|NCT00853021|1900567|FG000|Overall Study|Withdrawal by Subject|2
920004|NCT00853021|1900567|FG000|Overall Study|Death|1
920005|NCT00853047|1900576|FG000|Core Phase|Participant Request|0
920006|NCT00853047|1900577|FG001|Core Phase|Participant Request|0
920007|NCT00853047|1900578|FG002|Core Phase|Participant Request|0
920008|NCT00853047|1900579|FG003|Core Phase|Participant Request|1
920009|NCT00853047|1900580|FG004|Core Phase|Participant Request|0
920010|NCT00853047|1900581|FG005|Core Phase|Participant Request|0
920011|NCT00853047|1900576|FG000|Open-Label Extension Phase|Participant Request|0
920012|NCT00853047|1900577|FG001|Open-Label Extension Phase|Participant Request|0
920013|NCT00853047|1900578|FG002|Open-Label Extension Phase|Participant Request|0
920014|NCT00853047|1900579|FG003|Open-Label Extension Phase|Participant Request|0
920015|NCT00853047|1900580|FG004|Open-Label Extension Phase|Participant Request|0
920016|NCT00853047|1900581|FG005|Open-Label Extension Phase|Participant Request|7
920017|NCT00853047|1900576|FG000|Open-Label Extension Phase|Lost to Follow-up|0
920018|NCT00853047|1900577|FG001|Open-Label Extension Phase|Lost to Follow-up|0
920019|NCT00853047|1900578|FG002|Open-Label Extension Phase|Lost to Follow-up|0
920020|NCT00853047|1900579|FG003|Open-Label Extension Phase|Lost to Follow-up|0
920021|NCT00853047|1900580|FG004|Open-Label Extension Phase|Lost to Follow-up|0
920022|NCT00853047|1900581|FG005|Open-Label Extension Phase|Lost to Follow-up|1
920023|NCT00853047|1900576|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0
920024|NCT00853047|1900577|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0
920025|NCT00853047|1900578|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0
920026|NCT00853047|1900579|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0
920027|NCT00853047|1900580|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0
920028|NCT00853047|1900581|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2
920029|NCT00853047|1900576|FG000|Open-Label Extension Phase|Investigator Decision|0
920030|NCT00853047|1900577|FG001|Open-Label Extension Phase|Investigator Decision|0
920031|NCT00853047|1900578|FG002|Open-Label Extension Phase|Investigator Decision|0
920032|NCT00853047|1900579|FG003|Open-Label Extension Phase|Investigator Decision|0
920033|NCT00853047|1900580|FG004|Open-Label Extension Phase|Investigator Decision|0
920034|NCT00853047|1900581|FG005|Open-Label Extension Phase|Investigator Decision|1
920035|NCT00853047|1900576|FG000|Open-Label Extension Phase|Reason Not Specified|0
920036|NCT00853047|1900577|FG001|Open-Label Extension Phase|Reason Not Specified|0
920037|NCT00853047|1900578|FG002|Open-Label Extension Phase|Reason Not Specified|0
920038|NCT00853047|1900579|FG003|Open-Label Extension Phase|Reason Not Specified|0
920039|NCT00853047|1900580|FG004|Open-Label Extension Phase|Reason Not Specified|0
920040|NCT00853047|1900581|FG005|Open-Label Extension Phase|Reason Not Specified|6
920041|NCT00853073|1900598|FG000|Overall Study|Withdrawal by Subject|3
920042|NCT00853073|1900599|FG001|Overall Study|Withdrawal by Subject|2
920043|NCT00853099|1900608|FG000|Double-blind Period|Adverse Event|7
920044|NCT00853099|1900609|FG001|Double-blind Period|Adverse Event|9
920045|NCT00853099|1900610|FG002|Double-blind Period|Adverse Event|13
920046|NCT00853099|1900611|FG003|Double-blind Period|Adverse Event|0
920047|NCT00853099|1900608|FG000|Double-blind Period|Withdrawal by Subject|2
920048|NCT00853099|1900609|FG001|Double-blind Period|Withdrawal by Subject|3
920049|NCT00853099|1900610|FG002|Double-blind Period|Withdrawal by Subject|0
920050|NCT00853099|1900611|FG003|Double-blind Period|Withdrawal by Subject|0
920051|NCT00853099|1900608|FG000|Double-blind Period|Lack of Efficacy|14
920052|NCT00853099|1900609|FG001|Double-blind Period|Lack of Efficacy|17
920053|NCT00853099|1900610|FG002|Double-blind Period|Lack of Efficacy|16
920054|NCT00853099|1900611|FG003|Double-blind Period|Lack of Efficacy|0
920055|NCT00853099|1900608|FG000|Double-blind Period|Other|0
920056|NCT00853099|1900609|FG001|Double-blind Period|Other|0
920057|NCT00853099|1900610|FG002|Double-blind Period|Other|1
920058|NCT00853099|1900611|FG003|Double-blind Period|Other|0
920059|NCT00853099|1900608|FG000|Double-blind Period|Mistreated with rescue study drug|0
920060|NCT00853099|1900609|FG001|Double-blind Period|Mistreated with rescue study drug|0
920061|NCT00853099|1900610|FG002|Double-blind Period|Mistreated with rescue study drug|1
920062|NCT00853099|1900611|FG003|Double-blind Period|Mistreated with rescue study drug|0
920063|NCT00853099|1900608|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0
920064|NCT00853099|1900609|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0
920065|NCT00853099|1900610|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0
920066|NCT00853099|1900611|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74
920067|NCT00853099|1900608|FG000|Double-blind + Open-label Periods|Adverse Event|0
920068|NCT00853099|1900609|FG001|Double-blind + Open-label Periods|Adverse Event|0
920069|NCT00853099|1900610|FG002|Double-blind + Open-label Periods|Adverse Event|0
920070|NCT00853099|1900611|FG003|Double-blind + Open-label Periods|Adverse Event|47
920071|NCT00853099|1900608|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0
920072|NCT00853099|1900609|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0
920073|NCT00853099|1900610|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0
920074|NCT00853099|1900611|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20
920075|NCT00853099|1900608|FG000|Double-blind + Open-label Periods|Other|0
920076|NCT00853099|1900609|FG001|Double-blind + Open-label Periods|Other|0
920077|NCT00853099|1900610|FG002|Double-blind + Open-label Periods|Other|0
920078|NCT00853099|1900611|FG003|Double-blind + Open-label Periods|Other|6
920079|NCT00853112|1900628|FG000|Overall Study|Randomized but not treated|0
920080|NCT00853112|1900629|FG001|Overall Study|Randomized but not treated|1
920081|NCT00853112|1900630|FG002|Overall Study|Randomized but not treated|0
920082|NCT00853112|1900631|FG003|Overall Study|Randomized but not treated|2
920083|NCT00853112|1900632|FG004|Overall Study|Randomized but not treated|0
920084|NCT00853112|1900633|FG005|Overall Study|Randomized but not treated|0
920085|NCT00853112|1900634|FG006|Overall Study|Randomized but not treated|1
920086|NCT00853125|1900650|FG000|Overall Study|Study participant's donor was CMV +|1
920087|NCT00853151|1900659|FG000|Overall Study|Adverse Event|1
920088|NCT00853151|1900660|FG001|Overall Study|Adverse Event|4
920089|NCT00853151|1900661|FG002|Overall Study|Adverse Event|2
920090|NCT00853151|1900662|FG003|Overall Study|Adverse Event|0
920091|NCT00853151|1900659|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
920092|NCT00853151|1900660|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
920093|NCT00853151|1900661|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
920094|NCT00853151|1900662|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
920095|NCT00853151|1900659|FG000|Overall Study|Lost to Follow-up|2
920096|NCT00853151|1900660|FG001|Overall Study|Lost to Follow-up|0
920097|NCT00853151|1900661|FG002|Overall Study|Lost to Follow-up|3
920098|NCT00853151|1900662|FG003|Overall Study|Lost to Follow-up|0
920099|NCT00853151|1900659|FG000|Overall Study|Death|1
920100|NCT00853151|1900660|FG001|Overall Study|Death|0
920101|NCT00853151|1900661|FG002|Overall Study|Death|0
920102|NCT00853151|1900662|FG003|Overall Study|Death|1
920103|NCT00853151|1900659|FG000|Overall Study|Protocol Violation|0
920104|NCT00853151|1900660|FG001|Overall Study|Protocol Violation|0
920105|NCT00853151|1900661|FG002|Overall Study|Protocol Violation|0
920106|NCT00853151|1900662|FG003|Overall Study|Protocol Violation|1
920107|NCT00853151|1900659|FG000|Overall Study|Withdrawal by Subject|5
920108|NCT00853151|1900660|FG001|Overall Study|Withdrawal by Subject|4
920109|NCT00853151|1900661|FG002|Overall Study|Withdrawal by Subject|2
920110|NCT00853151|1900662|FG003|Overall Study|Withdrawal by Subject|1
920111|NCT00853151|1900659|FG000|Overall Study|Physician Decision|0
920112|NCT00853151|1900660|FG001|Overall Study|Physician Decision|2
920113|NCT00853151|1900661|FG002|Overall Study|Physician Decision|1
920114|NCT00853151|1900662|FG003|Overall Study|Physician Decision|0
920115|NCT00853151|1900659|FG000|Overall Study|Sponsor Decision|0
920116|NCT00853151|1900660|FG001|Overall Study|Sponsor Decision|3
920117|NCT00853151|1900661|FG002|Overall Study|Sponsor Decision|0
920118|NCT00853151|1900662|FG003|Overall Study|Sponsor Decision|0
920119|NCT00853242|1900682|FG000|Overall Study|Adverse Event|0
920120|NCT00853242|1900683|FG001|Overall Study|Adverse Event|1
920121|NCT00853242|1900684|FG002|Overall Study|Adverse Event|1
920122|NCT00853242|1900685|FG003|Overall Study|Adverse Event|0
920123|NCT00853242|1900686|FG004|Overall Study|Adverse Event|3
920124|NCT00853242|1900687|FG005|Overall Study|Adverse Event|1
920125|NCT00853242|1900688|FG006|Overall Study|Adverse Event|1
920126|NCT00853242|1900682|FG000|Overall Study|Noncompliant|0
920127|NCT00853242|1900683|FG001|Overall Study|Noncompliant|0
920128|NCT00853242|1900684|FG002|Overall Study|Noncompliant|0
920129|NCT00853242|1900685|FG003|Overall Study|Noncompliant|0
920130|NCT00853242|1900686|FG004|Overall Study|Noncompliant|1
920131|NCT00853242|1900687|FG005|Overall Study|Noncompliant|0
920132|NCT00853242|1900688|FG006|Overall Study|Noncompliant|0
920133|NCT00853242|1900682|FG000|Overall Study|Withdrawal by Subject|1
920134|NCT00853242|1900683|FG001|Overall Study|Withdrawal by Subject|2
920135|NCT00853242|1900684|FG002|Overall Study|Withdrawal by Subject|0
920136|NCT00853242|1900685|FG003|Overall Study|Withdrawal by Subject|4
920137|NCT00853242|1900686|FG004|Overall Study|Withdrawal by Subject|0
920138|NCT00853242|1900687|FG005|Overall Study|Withdrawal by Subject|0
920139|NCT00853242|1900688|FG006|Overall Study|Withdrawal by Subject|2
920140|NCT00853242|1900682|FG000|Overall Study|Other|2
920141|NCT00853242|1900683|FG001|Overall Study|Other|0
920142|NCT00853242|1900684|FG002|Overall Study|Other|2
920143|NCT00853242|1900685|FG003|Overall Study|Other|0
920144|NCT00853242|1900686|FG004|Overall Study|Other|0
920145|NCT00853242|1900687|FG005|Overall Study|Other|1
920146|NCT00853242|1900688|FG006|Overall Study|Other|2
920147|NCT00853307|1900712|FG000|Overall Study|Adverse Event|1
920148|NCT00853307|1900713|FG001|Overall Study|Adverse Event|2
920149|NCT00853307|1900712|FG000|Overall Study|Withdrawal by Subject|1
920150|NCT00853307|1900713|FG001|Overall Study|Withdrawal by Subject|2
920151|NCT00853307|1900712|FG000|Overall Study|Reason Not Specified|0
920152|NCT00853307|1900713|FG001|Overall Study|Reason Not Specified|1
920153|NCT00853372|1900734|FG000|Overall Study|Death|30
920154|NCT00853372|1900735|FG001|Overall Study|Death|26
920155|NCT00853372|1900734|FG000|Overall Study|Lost to Follow-up|1
920156|NCT00853372|1900735|FG001|Overall Study|Lost to Follow-up|2
920157|NCT00853372|1900734|FG000|Overall Study|Full Consent Withdrawn|1
920158|NCT00853372|1900735|FG001|Overall Study|Full Consent Withdrawn|1
920159|NCT00853385|1900746|FG000|Overall Study|Death|0
920160|NCT00853385|1900747|FG001|Overall Study|Death|0
920161|NCT00853385|1900748|FG002|Overall Study|Death|0
920162|NCT00853385|1900749|FG003|Overall Study|Death|0
920163|NCT00853385|1900750|FG004|Overall Study|Death|1
920164|NCT00853385|1900746|FG000|Overall Study|Adverse Event|24
920165|NCT00853385|1900747|FG001|Overall Study|Adverse Event|24
920166|NCT00853385|1900748|FG002|Overall Study|Adverse Event|2
920167|NCT00853385|1900749|FG003|Overall Study|Adverse Event|5
920168|NCT00853385|1900750|FG004|Overall Study|Adverse Event|22
920169|NCT00853385|1900746|FG000|Overall Study|Lack of Efficacy|6
920170|NCT00853385|1900747|FG001|Overall Study|Lack of Efficacy|7
920171|NCT00853385|1900748|FG002|Overall Study|Lack of Efficacy|3
920172|NCT00853385|1900749|FG003|Overall Study|Lack of Efficacy|3
920173|NCT00853385|1900750|FG004|Overall Study|Lack of Efficacy|6
920174|NCT00853385|1900746|FG000|Overall Study|Lost to Follow-up|2
920175|NCT00853385|1900747|FG001|Overall Study|Lost to Follow-up|1
920176|NCT00853385|1900748|FG002|Overall Study|Lost to Follow-up|0
920177|NCT00853385|1900749|FG003|Overall Study|Lost to Follow-up|0
920178|NCT00853385|1900750|FG004|Overall Study|Lost to Follow-up|0
920179|NCT00853385|1900746|FG000|Overall Study|Withdrawal by Subject|4
920180|NCT00853385|1900747|FG001|Overall Study|Withdrawal by Subject|2
920181|NCT00853385|1900748|FG002|Overall Study|Withdrawal by Subject|0
920182|NCT00853385|1900749|FG003|Overall Study|Withdrawal by Subject|1
920183|NCT00853385|1900750|FG004|Overall Study|Withdrawal by Subject|1
920184|NCT00853385|1900746|FG000|Overall Study|Other|18
920185|NCT00853385|1900747|FG001|Overall Study|Other|9
920186|NCT00853385|1900748|FG002|Overall Study|Other|4
920187|NCT00853385|1900749|FG003|Overall Study|Other|4
920188|NCT00853385|1900750|FG004|Overall Study|Other|12
920189|NCT00853489|1900774|FG000|Overall Study|Lost to Follow-up|5
920190|NCT00853489|1900775|FG001|Overall Study|Lost to Follow-up|2
920191|NCT00853580|1900783|FG000|Overall Study|Lost to Follow-up|3
920192|NCT00853580|1900784|FG001|Overall Study|Lost to Follow-up|5
920193|NCT00853580|1900783|FG000|Overall Study|Protocol Violation|2
920194|NCT00853580|1900784|FG001|Overall Study|Protocol Violation|1
920195|NCT00853580|1900783|FG000|Overall Study|Withdrawal by Subject|2
920196|NCT00853580|1900784|FG001|Overall Study|Withdrawal by Subject|8
920197|NCT00853580|1900783|FG000|Overall Study|Commenced contraindicated therapy|0
920198|NCT00853580|1900784|FG001|Overall Study|Commenced contraindicated therapy|2
920199|NCT00853593|1900790|FG000|Overall Study|Subjects did not receive a 4396 lead|12
920200|NCT00853593|1900790|FG000|Overall Study|Model 4396 lead not attempted|29
920201|NCT00853593|1900790|FG000|Overall Study|Implant not attempted|4
920202|NCT00853658|1900822|FG000|Overall Study|Death|713
920203|NCT00853658|1900823|FG001|Overall Study|Death|768
920204|NCT00853658|1900824|FG002|Overall Study|Death|753
920205|NCT00853658|1900822|FG000|Overall Study|Lost to Follow-up|11
920206|NCT00853658|1900823|FG001|Overall Study|Lost to Follow-up|6
920207|NCT00853658|1900824|FG002|Overall Study|Lost to Follow-up|11
920208|NCT00853658|1900822|FG000|Overall Study|H.A. Request|26
920209|NCT00853658|1900823|FG001|Overall Study|H.A. Request|23
920210|NCT00853658|1900824|FG002|Overall Study|H.A. Request|19
920211|NCT00853658|1900822|FG000|Overall Study|IRB request|0
920212|NCT00853658|1900823|FG001|Overall Study|IRB request|0
920213|NCT00853658|1900824|FG002|Overall Study|IRB request|2
920214|NCT00853658|1900822|FG000|Overall Study|Vital Status known (alive) at study end|2
920215|NCT00853658|1900823|FG001|Overall Study|Vital Status known (alive) at study end|3
920216|NCT00853658|1900824|FG002|Overall Study|Vital Status known (alive) at study end|3
920217|NCT00853658|1900822|FG000|Overall Study|Vital Status unknown at study end|1
920218|NCT00853658|1900823|FG001|Overall Study|Vital Status unknown at study end|1
920219|NCT00853658|1900824|FG002|Overall Study|Vital Status unknown at study end|0
920220|NCT00853658|1900822|FG000|Overall Study|Vital Status at study end N/A|8
920221|NCT00853658|1900823|FG001|Overall Study|Vital Status at study end N/A|10
920222|NCT00853658|1900824|FG002|Overall Study|Vital Status at study end N/A|10
920223|NCT00853658|1900822|FG000|Overall Study|Patient's request|21
920224|NCT00853658|1900823|FG001|Overall Study|Patient's request|17
920225|NCT00853658|1900824|FG002|Overall Study|Patient's request|11
920226|NCT00853658|1900822|FG000|Overall Study|Missing study completion information|5
920227|NCT00853658|1900823|FG001|Overall Study|Missing study completion information|4
920228|NCT00853658|1900824|FG002|Overall Study|Missing study completion information|6
920229|NCT00853723|1900839|FG000|Overall Study|Adverse Event|3
920230|NCT00853723|1900840|FG001|Overall Study|Adverse Event|4
920231|NCT00853723|1900841|FG002|Overall Study|Adverse Event|1
920232|NCT00853723|1900839|FG000|Overall Study|Withdrawal by Subject|2
920233|NCT00853723|1900840|FG001|Overall Study|Withdrawal by Subject|1
920234|NCT00853723|1900841|FG002|Overall Study|Withdrawal by Subject|0
920235|NCT00853723|1900839|FG000|Overall Study|Protocol Violation|1
920236|NCT00853723|1900840|FG001|Overall Study|Protocol Violation|2
920237|NCT00853723|1900841|FG002|Overall Study|Protocol Violation|1
920238|NCT00853749|1900854|FG000|Overall Study|Lost to Follow-up|0
920239|NCT00853749|1900855|FG001|Overall Study|Lost to Follow-up|1
920240|NCT00853762|1900865|FG000|Overall Study|Premature Termination|16
920241|NCT00853762|1900866|FG001|Overall Study|Premature Termination|15
920242|NCT00853762|1900867|FG002|Overall Study|Premature Termination|14
920243|NCT00853762|1900868|FG003|Overall Study|Premature Termination|21
920244|NCT00853762|1900865|FG000|Overall Study|Protocol Violation|0
920245|NCT00853762|1900866|FG001|Overall Study|Protocol Violation|0
920246|NCT00853762|1900867|FG002|Overall Study|Protocol Violation|0
920247|NCT00853762|1900868|FG003|Overall Study|Protocol Violation|1
920248|NCT00853762|1900865|FG000|Overall Study|Withdrawal by Subject|0
920249|NCT00853762|1900866|FG001|Overall Study|Withdrawal by Subject|0
920250|NCT00853762|1900867|FG002|Overall Study|Withdrawal by Subject|1
920251|NCT00853762|1900868|FG003|Overall Study|Withdrawal by Subject|0
920252|NCT00853762|1900865|FG000|Overall Study|Other|0
920253|NCT00853762|1900866|FG001|Overall Study|Other|2
920254|NCT00853762|1900867|FG002|Overall Study|Other|0
920255|NCT00853762|1900868|FG003|Overall Study|Other|0
920256|NCT00853762|1900865|FG000|Overall Study|Randomised but not Treated|0
920257|NCT00853762|1900866|FG001|Overall Study|Randomised but not Treated|2
920258|NCT00853762|1900867|FG002|Overall Study|Randomised but not Treated|2
920259|NCT00853762|1900868|FG003|Overall Study|Randomised but not Treated|0
920260|NCT00853827|1900880|FG000|Single Blind Period (1 Week)|Other|4
920261|NCT00853827|1900881|FG001|Single Blind Period (1 Week)|Other|0
920262|NCT00853827|1900880|FG000|Single Blind Period (1 Week)|Adverse Event|9
920263|NCT00853827|1900881|FG001|Single Blind Period (1 Week)|Adverse Event|0
920264|NCT00853827|1900880|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3
920265|NCT00853827|1900881|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0
920266|NCT00853827|1900880|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1
920267|NCT00853827|1900881|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0
920268|NCT00853827|1900880|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9
920269|NCT00853827|1900881|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0
920270|NCT00853827|1900880|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1
920271|NCT00853827|1900881|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0
920272|NCT00853827|1900880|FG000|Single Blind Period (1 Week)|Protocol Violation|12
920273|NCT00853827|1900881|FG001|Single Blind Period (1 Week)|Protocol Violation|0
920274|NCT00853827|1900880|FG000|Double Blind Period (103 Weeks)|Adverse Event|25
920275|NCT00853827|1900881|FG001|Double Blind Period (103 Weeks)|Adverse Event|14
920276|NCT00853827|1900880|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
920277|NCT00853827|1900881|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
920278|NCT00853827|1900880|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1
920279|NCT00853827|1900881|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0
920280|NCT00853827|1900880|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3
920281|NCT00853827|1900881|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1
920282|NCT00853827|1900880|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2
920283|NCT00853827|1900881|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1
920284|NCT00853827|1900880|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
920285|NCT00853827|1900881|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
920286|NCT00853827|1900880|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8
920287|NCT00853827|1900881|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10
920288|NCT00853827|1900880|FG000|Double Blind Period (103 Weeks)|Administrative problems|45
920289|NCT00853827|1900881|FG001|Double Blind Period (103 Weeks)|Administrative problems|56
920290|NCT00853827|1900880|FG000|Double Blind Period (103 Weeks)|Death|1
920291|NCT00853827|1900881|FG001|Double Blind Period (103 Weeks)|Death|6
920292|NCT00853905|1900897|FG000|Overall Study|Lost to Follow-up|1
920293|NCT00853905|1900898|FG001|Overall Study|Lost to Follow-up|3
920294|NCT00853905|1900897|FG000|Overall Study|Withdrawal by Subject|0
920295|NCT00853905|1900898|FG001|Overall Study|Withdrawal by Subject|1
920296|NCT00853905|1900897|FG000|Overall Study|never had surgery|1
920297|NCT00853905|1900898|FG001|Overall Study|never had surgery|0
920298|NCT00853957|1900909|FG000|Overall Study|Adverse Event|9
920299|NCT00853957|1900910|FG001|Overall Study|Adverse Event|3
920300|NCT00853957|1900909|FG000|Overall Study|Unsatisfactory therapeutic effect|0
920301|NCT00853957|1900910|FG001|Overall Study|Unsatisfactory therapeutic effect|2
920302|NCT00853957|1900909|FG000|Overall Study|Subject withdrew consent|4
920303|NCT00853957|1900910|FG001|Overall Study|Subject withdrew consent|5
920304|NCT00853957|1900909|FG000|Overall Study|Lost to Follow-up|1
920305|NCT00853957|1900910|FG001|Overall Study|Lost to Follow-up|6
920306|NCT00853957|1900909|FG000|Overall Study|Protocol deviation|0
920307|NCT00853957|1900910|FG001|Overall Study|Protocol deviation|3
920308|NCT00853970|1900918|FG000|Overall Study|Withdrawal by Subject|2
920309|NCT00853970|1900919|FG001|Overall Study|Withdrawal by Subject|1
920310|NCT00853970|1900918|FG000|Overall Study|Cancelled surgery|4
920311|NCT00853970|1900919|FG001|Overall Study|Cancelled surgery|2
920312|NCT00854100|1900947|FG000|Overall Study|Inability to complete the study visits|0
920313|NCT00854100|1900948|FG001|Overall Study|Inability to complete the study visits|0
920314|NCT00854100|1900949|FG002|Overall Study|Inability to complete the study visits|1
920315|NCT00854100|1900947|FG000|Overall Study|Lost to Follow-up|2
920316|NCT00854100|1900948|FG001|Overall Study|Lost to Follow-up|0
920317|NCT00854100|1900949|FG002|Overall Study|Lost to Follow-up|3
920318|NCT00854100|1900947|FG000|Overall Study|Withdrawal by Subject|3
920319|NCT00854100|1900948|FG001|Overall Study|Withdrawal by Subject|1
920320|NCT00854100|1900949|FG002|Overall Study|Withdrawal by Subject|2
920321|NCT00854100|1900947|FG000|Overall Study|Protocol Violation|2
920322|NCT00854100|1900948|FG001|Overall Study|Protocol Violation|4
920323|NCT00854100|1900949|FG002|Overall Study|Protocol Violation|3
920324|NCT00854100|1900947|FG000|Overall Study|Adverse Event|2
920325|NCT00854100|1900948|FG001|Overall Study|Adverse Event|1
920326|NCT00854100|1900949|FG002|Overall Study|Adverse Event|2
920327|NCT00854113|1900969|FG000|Overall Study|Adverse Event|0
920328|NCT00854113|1900970|FG001|Overall Study|Adverse Event|0
920329|NCT00854113|1900971|FG002|Overall Study|Adverse Event|0
920330|NCT00854113|1900972|FG003|Overall Study|Adverse Event|0
920331|NCT00854113|1900973|FG004|Overall Study|Adverse Event|0
920332|NCT00854113|1900974|FG005|Overall Study|Adverse Event|0
920333|NCT00854113|1900975|FG006|Overall Study|Adverse Event|0
920334|NCT00854113|1900976|FG007|Overall Study|Adverse Event|2
920335|NCT00854113|1900977|FG008|Overall Study|Adverse Event|0
920336|NCT00854113|1900978|FG009|Overall Study|Adverse Event|0
920337|NCT00854113|1900979|FG010|Overall Study|Adverse Event|0
920338|NCT00854113|1900969|FG000|Overall Study|Withdrawal by Subject|0
920339|NCT00854113|1900970|FG001|Overall Study|Withdrawal by Subject|0
920340|NCT00854113|1900971|FG002|Overall Study|Withdrawal by Subject|0
920341|NCT00854113|1900972|FG003|Overall Study|Withdrawal by Subject|0
920342|NCT00854113|1900973|FG004|Overall Study|Withdrawal by Subject|0
920343|NCT00854113|1900974|FG005|Overall Study|Withdrawal by Subject|0
920344|NCT00854113|1900975|FG006|Overall Study|Withdrawal by Subject|0
920345|NCT00854113|1900976|FG007|Overall Study|Withdrawal by Subject|1
920346|NCT00854113|1900977|FG008|Overall Study|Withdrawal by Subject|1
920347|NCT00854113|1900978|FG009|Overall Study|Withdrawal by Subject|0
920348|NCT00854113|1900979|FG010|Overall Study|Withdrawal by Subject|0
920349|NCT00854308|1901005|FG000|Overall Study|Disease progression|42
920350|NCT00854308|1901006|FG001|Overall Study|Disease progression|50
920351|NCT00854308|1901005|FG000|Overall Study|Adverse Event|8
920352|NCT00854308|1901006|FG001|Overall Study|Adverse Event|3
920353|NCT00854308|1901005|FG000|Overall Study|Death|2
920354|NCT00854308|1901006|FG001|Overall Study|Death|5
920355|NCT00854308|1901005|FG000|Overall Study|Physician Decision|6
920356|NCT00854308|1901006|FG001|Overall Study|Physician Decision|6
920357|NCT00854308|1901005|FG000|Overall Study|Withdrawal by Subject|4
920358|NCT00854308|1901006|FG001|Overall Study|Withdrawal by Subject|2
920359|NCT00854308|1901005|FG000|Overall Study|Sponsor's decision to terminate study|0
920360|NCT00854308|1901006|FG001|Overall Study|Sponsor's decision to terminate study|1
920361|NCT00854360|1901016|FG000|Overall Study|Adverse Event|0
920362|NCT00854360|1901017|FG001|Overall Study|Adverse Event|1
920363|NCT00854360|1901018|FG002|Overall Study|Adverse Event|2
920364|NCT00854360|1901019|FG003|Overall Study|Adverse Event|6
920365|NCT00854360|1901016|FG000|Overall Study|Withdrawal by Subject|0
920366|NCT00854360|1901017|FG001|Overall Study|Withdrawal by Subject|0
920367|NCT00854360|1901018|FG002|Overall Study|Withdrawal by Subject|0
920368|NCT00854360|1901019|FG003|Overall Study|Withdrawal by Subject|1
920369|NCT00854360|1901016|FG000|Overall Study|Pregnancy|0
920370|NCT00854360|1901017|FG001|Overall Study|Pregnancy|1
920371|NCT00854360|1901018|FG002|Overall Study|Pregnancy|0
920372|NCT00854360|1901019|FG003|Overall Study|Pregnancy|0
920373|NCT00854360|1901016|FG000|Overall Study|Lack of Efficacy|2
920374|NCT00854360|1901017|FG001|Overall Study|Lack of Efficacy|1
920375|NCT00854360|1901018|FG002|Overall Study|Lack of Efficacy|0
920376|NCT00854360|1901019|FG003|Overall Study|Lack of Efficacy|0
920377|NCT00854360|1901016|FG000|Overall Study|Other|0
920378|NCT00854360|1901017|FG001|Overall Study|Other|0
920379|NCT00854360|1901018|FG002|Overall Study|Other|0
920380|NCT00854360|1901019|FG003|Overall Study|Other|3
920381|NCT00854373|1901031|FG000|Overall Study|Withdrawal by Subject|1
920382|NCT00854373|1901032|FG001|Overall Study|Withdrawal by Subject|3
920383|NCT00854373|1901031|FG000|Overall Study|Forgot to take study drug|1
920384|NCT00854373|1901032|FG001|Overall Study|Forgot to take study drug|1
920385|NCT00854581|1901038|FG000|Induction (Up to Day 21)|Lack of Efficacy|4
920386|NCT00854581|1901038|FG000|Induction (Up to Day 21)|Death|1
920387|NCT00854581|1901038|FG000|Induction (Up to Day 21)|Physician Decision|1
920388|NCT00854581|1901038|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
920389|NCT00854607|1901056|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
920390|NCT00854620|1901067|FG000|Overall Study|Adverse Event|1
920391|NCT00854724|1901073|FG000|First Intervention|Withdrawal by Subject|1
920392|NCT00854724|1901074|FG001|First Intervention|Withdrawal by Subject|1
920393|NCT00854724|1901073|FG000|Washout|Protocol Violation|1
920394|NCT00854724|1901074|FG001|Washout|Protocol Violation|0
920395|NCT00854724|1901073|FG000|Washout|Withdrawal by Subject|0
920396|NCT00854724|1901074|FG001|Washout|Withdrawal by Subject|1
920397|NCT00854724|1901073|FG000|Second Intervention|Protocol Violation|1
920398|NCT00854724|1901074|FG001|Second Intervention|Protocol Violation|0
920399|NCT00854724|1901073|FG000|Second Intervention|Physician Decision|0
920400|NCT00854724|1901074|FG001|Second Intervention|Physician Decision|1
920401|NCT00854828|1901084|FG000|Overall Study|Death|1
920402|NCT00854828|1901085|FG001|Overall Study|Death|0
920403|NCT00854828|1901086|FG002|Overall Study|Death|0
920404|NCT00854828|1901087|FG003|Overall Study|Death|0
920405|NCT00854828|1901084|FG000|Overall Study|Withdrawal by Subject|1
920406|NCT00854828|1901085|FG001|Overall Study|Withdrawal by Subject|1
920407|NCT00854828|1901086|FG002|Overall Study|Withdrawal by Subject|0
920408|NCT00854828|1901087|FG003|Overall Study|Withdrawal by Subject|9
920409|NCT00854828|1901084|FG000|Overall Study|Missed 24mo visit|1
920410|NCT00854828|1901085|FG001|Overall Study|Missed 24mo visit|1
920411|NCT00854828|1901086|FG002|Overall Study|Missed 24mo visit|8
920412|NCT00854828|1901087|FG003|Overall Study|Missed 24mo visit|8
920413|NCT00854906|1901097|FG000|Overall Study|One person had no ocular history|1
920414|NCT00855062|1901119|FG000|Step1|Early Study Closure|5
920415|NCT00855062|1901120|FG001|Step1|Early Study Closure|7
920416|NCT00855062|1901119|FG000|Step1|Adverse Event|1
920417|NCT00855062|1901120|FG001|Step1|Adverse Event|1
920418|NCT00855062|1901119|FG000|Step1|Protocol Violation|1
920419|NCT00855062|1901120|FG001|Step1|Protocol Violation|0
920420|NCT00855062|1901119|FG000|Step1|Pregnancy|1
920421|NCT00855062|1901120|FG001|Step1|Pregnancy|0
920422|NCT00855062|1901119|FG000|Step1|Withdrawal by Subject|2
920423|NCT00855062|1901120|FG001|Step1|Withdrawal by Subject|3
920424|NCT00855062|1901119|FG000|Step2|Early Study Closure|6
920425|NCT00855062|1901120|FG001|Step2|Early Study Closure|2
920426|NCT00855062|1901119|FG000|Step2|Adverse Event|0
920427|NCT00855062|1901120|FG001|Step2|Adverse Event|3
920428|NCT00855062|1901119|FG000|Step2|Initiation of antiretroviral therapy/ART|0
920429|NCT00855062|1901120|FG001|Step2|Initiation of antiretroviral therapy/ART|1
920430|NCT00855166|1901128|FG000|Overall Study|Adverse Event|0
920431|NCT00855166|1901129|FG001|Overall Study|Adverse Event|2
920432|NCT00855166|1901128|FG000|Overall Study|Death|0
920433|NCT00855166|1901129|FG001|Overall Study|Death|1
920434|NCT00855166|1901128|FG000|Overall Study|Withdrawal by Subject|1
920435|NCT00855166|1901129|FG001|Overall Study|Withdrawal by Subject|4
920436|NCT00855166|1901128|FG000|Overall Study|Poor/non-compliance|2
920437|NCT00855166|1901129|FG001|Overall Study|Poor/non-compliance|0
920438|NCT00855166|1901128|FG000|Overall Study|Administrative reasons by sponsor|1
920439|NCT00855166|1901129|FG001|Overall Study|Administrative reasons by sponsor|0
920440|NCT00855166|1901128|FG000|Overall Study|Subject no longer meets study criteria|1
920441|NCT00855166|1901129|FG001|Overall Study|Subject no longer meets study criteria|1
920442|NCT00855218|1901139|FG000|Overall Study|Adverse Event|43
920443|NCT00855218|1901140|FG001|Overall Study|Adverse Event|27
920444|NCT00855218|1901139|FG000|Overall Study|Withdrawal by Subject|10
920445|NCT00855218|1901140|FG001|Overall Study|Withdrawal by Subject|6
920446|NCT00855218|1901139|FG000|Overall Study|Physician Decision|18
920447|NCT00855218|1901140|FG001|Overall Study|Physician Decision|11
920448|NCT00855218|1901139|FG000|Overall Study|Lost to Follow-up|0
920449|NCT00855218|1901140|FG001|Overall Study|Lost to Follow-up|1
920450|NCT00855218|1901139|FG000|Overall Study|Protocol Violation|5
920451|NCT00855218|1901140|FG001|Overall Study|Protocol Violation|9
920452|NCT00855218|1901139|FG000|Overall Study|non-compliant with study drug|3
920453|NCT00855218|1901140|FG001|Overall Study|non-compliant with study drug|1
920454|NCT00855218|1901139|FG000|Overall Study|patient convenience|2
920455|NCT00855218|1901140|FG001|Overall Study|patient convenience|0
920456|NCT00855218|1901139|FG000|Overall Study|technical problems|2
920457|NCT00855218|1901140|FG001|Overall Study|technical problems|1
920458|NCT00855218|1901139|FG000|Overall Study|Still treated with study medication|0
920459|NCT00855218|1901140|FG001|Overall Study|Still treated with study medication|1
920460|NCT00855218|1901139|FG000|Overall Study|Untreatable disease progression|54
920461|NCT00855218|1901140|FG001|Overall Study|Untreatable disease progression|67
920462|NCT00855218|1901139|FG000|Overall Study|Second malignancy|0
920463|NCT00855218|1901140|FG001|Overall Study|Second malignancy|1
920464|NCT00855218|1901139|FG000|Overall Study|Progression measurement proven|7
920465|NCT00855218|1901140|FG001|Overall Study|Progression measurement proven|15
920466|NCT00855218|1901139|FG000|Overall Study|Clinical endpoint reached|10
920467|NCT00855218|1901140|FG001|Overall Study|Clinical endpoint reached|13
920468|NCT00855309|1901148|FG000|Overall Study|patient never recieved drug|1
920469|NCT00855309|1901149|FG001|Overall Study|patient never recieved drug|0
920470|NCT00855335|1901160|FG000|Overall Study|Lost to Follow-up|0
920471|NCT00855335|1901161|FG001|Overall Study|Lost to Follow-up|0
920472|NCT00855335|1901162|FG002|Overall Study|Lost to Follow-up|3
920473|NCT00855335|1901163|FG003|Overall Study|Lost to Follow-up|1
920474|NCT00855335|1901164|FG004|Overall Study|Lost to Follow-up|0
920475|NCT00855335|1901160|FG000|Overall Study|Withdrawal by Subject|0
920476|NCT00855335|1901161|FG001|Overall Study|Withdrawal by Subject|0
920477|NCT00855335|1901162|FG002|Overall Study|Withdrawal by Subject|0
920478|NCT00855335|1901163|FG003|Overall Study|Withdrawal by Subject|1
920479|NCT00855335|1901164|FG004|Overall Study|Withdrawal by Subject|0
920480|NCT00855335|1901160|FG000|Overall Study|Adverse Event|2
920481|NCT00855335|1901161|FG001|Overall Study|Adverse Event|0
920482|NCT00855335|1901162|FG002|Overall Study|Adverse Event|0
920483|NCT00855335|1901163|FG003|Overall Study|Adverse Event|0
920484|NCT00855335|1901164|FG004|Overall Study|Adverse Event|0
920485|NCT00855335|1901160|FG000|Overall Study|Physician Decision|1
920486|NCT00855335|1901161|FG001|Overall Study|Physician Decision|1
920487|NCT00855335|1901162|FG002|Overall Study|Physician Decision|0
920488|NCT00855335|1901163|FG003|Overall Study|Physician Decision|0
920489|NCT00855335|1901164|FG004|Overall Study|Physician Decision|0
920490|NCT00855335|1901160|FG000|Overall Study|Other|2
920491|NCT00855335|1901161|FG001|Overall Study|Other|1
920492|NCT00855335|1901162|FG002|Overall Study|Other|2
920493|NCT00855335|1901163|FG003|Overall Study|Other|5
920494|NCT00855335|1901164|FG004|Overall Study|Other|1
920495|NCT00855439|1901195|FG000|Overall Study|Withdrawal by Subject|2
920496|NCT00855439|1901196|FG001|Overall Study|Withdrawal by Subject|0
920497|NCT00855439|1901195|FG000|Overall Study|Pregnancy|1
920498|NCT00855439|1901196|FG001|Overall Study|Pregnancy|0
920499|NCT00855465|1901204|FG000|Treatment Period|Adverse Event|4
920500|NCT00855465|1901205|FG001|Treatment Period|Adverse Event|2
920501|NCT00855465|1901204|FG000|Treatment Period|Death|2
920502|NCT00855465|1901205|FG001|Treatment Period|Death|2
920503|NCT00855465|1901204|FG000|Treatment Period|Lack of Efficacy|2
920504|NCT00855465|1901205|FG001|Treatment Period|Lack of Efficacy|1
920505|NCT00855465|1901204|FG000|Treatment Period|Non-compliance|1
920506|NCT00855465|1901205|FG001|Treatment Period|Non-compliance|0
920507|NCT00855465|1901204|FG000|Treatment Period|Protocol Violation|2
920508|NCT00855465|1901205|FG001|Treatment Period|Protocol Violation|0
920509|NCT00855465|1901204|FG000|Treatment Period|Withdrawal by Subject|2
920510|NCT00855465|1901205|FG001|Treatment Period|Withdrawal by Subject|0
920511|NCT00855465|1901204|FG000|Treatment Period|Not treated|1
920512|NCT00855465|1901205|FG001|Treatment Period|Not treated|0
920513|NCT00855465|1901204|FG000|Follow-up Period (FUP)|Adverse Event|0
920514|NCT00855465|1901205|FG001|Follow-up Period (FUP)|Adverse Event|1
920515|NCT00855465|1901204|FG000|Follow-up Period (FUP)|Death|0
920516|NCT00855465|1901205|FG001|Follow-up Period (FUP)|Death|1
920517|NCT00855465|1901204|FG000|Follow-up Period (FUP)|Lost to Follow-up|3
920518|NCT00855465|1901205|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
920519|NCT00855465|1901204|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4
920520|NCT00855465|1901205|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0
920521|NCT00855465|1901204|FG000|Follow-up Period (FUP)|Missing|1
920522|NCT00855465|1901205|FG001|Follow-up Period (FUP)|Missing|0
920523|NCT00855582|1901214|FG000|Overall Study|Adverse Event|2
920524|NCT00855582|1901215|FG001|Overall Study|Adverse Event|6
920525|NCT00855582|1901216|FG002|Overall Study|Adverse Event|3
920526|NCT00855582|1901214|FG000|Overall Study|Death|1
920527|NCT00855582|1901215|FG001|Overall Study|Death|0
920528|NCT00855582|1901216|FG002|Overall Study|Death|0
920529|NCT00855582|1901214|FG000|Overall Study|Lack of Efficacy|1
920530|NCT00855582|1901215|FG001|Overall Study|Lack of Efficacy|3
920531|NCT00855582|1901216|FG002|Overall Study|Lack of Efficacy|8
920532|NCT00855582|1901214|FG000|Overall Study|Lost to Follow-up|1
920533|NCT00855582|1901215|FG001|Overall Study|Lost to Follow-up|3
920534|NCT00855582|1901216|FG002|Overall Study|Lost to Follow-up|1
920535|NCT00855582|1901214|FG000|Overall Study|Physician Decision|0
920536|NCT00855582|1901215|FG001|Overall Study|Physician Decision|0
920537|NCT00855582|1901216|FG002|Overall Study|Physician Decision|1
920538|NCT00855582|1901214|FG000|Overall Study|Protocol Violation|6
920539|NCT00855582|1901215|FG001|Overall Study|Protocol Violation|2
920540|NCT00855582|1901216|FG002|Overall Study|Protocol Violation|6
920541|NCT00855582|1901214|FG000|Overall Study|Entry Criteria Not Met|8
920542|NCT00855582|1901215|FG001|Overall Study|Entry Criteria Not Met|6
920543|NCT00855582|1901216|FG002|Overall Study|Entry Criteria Not Met|3
920544|NCT00855582|1901214|FG000|Overall Study|Withdrawal by Subject|7
920545|NCT00855582|1901215|FG001|Overall Study|Withdrawal by Subject|4
920546|NCT00855582|1901216|FG002|Overall Study|Withdrawal by Subject|8
920547|NCT00855595|1901229|FG000|Overall Study|Withdrawal by Subject|1
920548|NCT00855595|1901230|FG001|Overall Study|Withdrawal by Subject|2
920549|NCT00855595|1901229|FG000|Overall Study|Lost to Follow-up|3
920550|NCT00855595|1901230|FG001|Overall Study|Lost to Follow-up|3
920551|NCT00855595|1901229|FG000|Overall Study|Adverse Event|1
920552|NCT00855595|1901230|FG001|Overall Study|Adverse Event|1
920553|NCT00855595|1901229|FG000|Overall Study|patient moved out of state|1
920554|NCT00855595|1901230|FG001|Overall Study|patient moved out of state|0
920555|NCT00855595|1901229|FG000|Overall Study|patient left country|0
920556|NCT00855595|1901230|FG001|Overall Study|patient left country|1
920557|NCT00855738|1901236|FG000|Overall Study|Lost to Follow-up|2
920558|NCT00855738|1901236|FG000|Overall Study|Adverse Event|1
920559|NCT00855738|1901236|FG000|Overall Study|Subject Defaulted|1
920560|NCT00855738|1901236|FG000|Overall Study|Death|1
920561|NCT00855816|1901244|FG000|Overall Study|Withdrawal by Subject|22
920562|NCT00855816|1901245|FG001|Overall Study|Withdrawal by Subject|15
920563|NCT00855816|1901244|FG000|Overall Study|Lost to Follow-up|3
920564|NCT00855816|1901245|FG001|Overall Study|Lost to Follow-up|5
920565|NCT00855816|1901244|FG000|Overall Study|Death|1
920566|NCT00855816|1901245|FG001|Overall Study|Death|0
920567|NCT00855816|1901244|FG000|Overall Study|Became ineligible|0
920568|NCT00855816|1901245|FG001|Overall Study|Became ineligible|1
920569|NCT00855894|1901264|FG000|Overall Study|Death|31
920570|NCT00855894|1901264|FG000|Overall Study|Patient's decision|1
920571|NCT00855894|1901264|FG000|Overall Study|Disease progression|1
920572|NCT00855920|1901271|FG000|Overall Study|Protocol Violation|0
920573|NCT00855920|1901272|FG001|Overall Study|Protocol Violation|0
920574|NCT00855920|1901273|FG002|Overall Study|Protocol Violation|2
920575|NCT00855920|1901271|FG000|Overall Study|Adverse Event|2
920576|NCT00855920|1901272|FG001|Overall Study|Adverse Event|1
920577|NCT00855920|1901273|FG002|Overall Study|Adverse Event|1
920578|NCT00855920|1901271|FG000|Overall Study|Lack of Efficacy|2
920579|NCT00855920|1901272|FG001|Overall Study|Lack of Efficacy|2
920580|NCT00855920|1901273|FG002|Overall Study|Lack of Efficacy|2
920581|NCT00855920|1901271|FG000|Overall Study|Withdrawal by Subject|2
920582|NCT00855920|1901272|FG001|Overall Study|Withdrawal by Subject|3
920583|NCT00855920|1901273|FG002|Overall Study|Withdrawal by Subject|2
920584|NCT00855920|1901271|FG000|Overall Study|Lost to Follow-up|1
920585|NCT00855920|1901272|FG001|Overall Study|Lost to Follow-up|0
920586|NCT00855920|1901273|FG002|Overall Study|Lost to Follow-up|2
920587|NCT00855920|1901271|FG000|Overall Study|Death|0
920588|NCT00855920|1901272|FG001|Overall Study|Death|1
920589|NCT00855920|1901273|FG002|Overall Study|Death|0
920590|NCT00855920|1901271|FG000|Overall Study|Decision by the sponsor|0
920591|NCT00855920|1901272|FG001|Overall Study|Decision by the sponsor|1
920592|NCT00855920|1901273|FG002|Overall Study|Decision by the sponsor|1
920593|NCT00855920|1901271|FG000|Overall Study|Other than specified above|1
920594|NCT00855920|1901272|FG001|Overall Study|Other than specified above|1
920595|NCT00855920|1901273|FG002|Overall Study|Other than specified above|1
920596|NCT00855933|1901283|FG000|Overall Study|Withdrawal by Subject|0
920597|NCT00855933|1901284|FG001|Overall Study|Withdrawal by Subject|1
920598|NCT00855959|1901290|FG000|Overall Study|Adverse Event|2
920599|NCT00855959|1901290|FG000|Overall Study|Lost to Follow-up|2
920600|NCT00855959|1901290|FG000|Overall Study|Withdrawal by Subject|3
920601|NCT00855959|1901290|FG000|Overall Study|Pregnancy|1
920602|NCT00855959|1901290|FG000|Overall Study|Incorrect enrolment|1
920603|NCT00856180|1901304|FG000|Overall Study|Adverse Event|4
920604|NCT00856180|1901304|FG000|Overall Study|Progressive Disease|16
920605|NCT00856193|1901310|FG000|Period 2|Abnormal test procedure results|0
920606|NCT00856193|1901311|FG001|Period 2|Abnormal test procedure results|1
920607|NCT00856193|1901310|FG000|Period 2|Lost to Follow-up|0
920608|NCT00856193|1901311|FG001|Period 2|Lost to Follow-up|1
920609|NCT00856206|1901319|FG000|Overall Study|Protocol Violation|6
920610|NCT00856206|1901320|FG001|Overall Study|Protocol Violation|18
920611|NCT00856206|1901319|FG000|Overall Study|Adverse Event|10
920612|NCT00856206|1901320|FG001|Overall Study|Adverse Event|46
920613|NCT00856206|1901319|FG000|Overall Study|Lack of Efficacy|1
920614|NCT00856206|1901320|FG001|Overall Study|Lack of Efficacy|2
920615|NCT00856206|1901319|FG000|Overall Study|Withdrawal by Subject|15
920616|NCT00856206|1901320|FG001|Overall Study|Withdrawal by Subject|36
920617|NCT00856206|1901319|FG000|Overall Study|Lost to Follow-up|13
920618|NCT00856206|1901320|FG001|Overall Study|Lost to Follow-up|39
920619|NCT00856206|1901319|FG000|Overall Study|Death|2
920620|NCT00856206|1901320|FG001|Overall Study|Death|2
920621|NCT00856206|1901319|FG000|Overall Study|Decision by the Sponsor|4
920622|NCT00856206|1901320|FG001|Overall Study|Decision by the Sponsor|8
920623|NCT00856206|1901319|FG000|Overall Study|Other than specified above|3
920624|NCT00856206|1901320|FG001|Overall Study|Other than specified above|10
920625|NCT00856245|1901341|FG000|Overall Study|Was not transplanted|5
920626|NCT00856284|1901348|FG000|Overall Study|Hyperglycemic rescue|231
920627|NCT00856284|1901349|FG001|Overall Study|Hyperglycemic rescue|201
920628|NCT00856284|1901350|FG002|Overall Study|Hyperglycemic rescue|235
920629|NCT00856284|1901348|FG000|Overall Study|Adverse Event|60
920630|NCT00856284|1901349|FG001|Overall Study|Adverse Event|74
920631|NCT00856284|1901350|FG002|Overall Study|Adverse Event|82
920632|NCT00856284|1901348|FG000|Overall Study|Major protocol deviation|24
920633|NCT00856284|1901349|FG001|Overall Study|Major protocol deviation|16
920634|NCT00856284|1901350|FG002|Overall Study|Major protocol deviation|15
920635|NCT00856284|1901348|FG000|Overall Study|Lost to Follow-up|20
920636|NCT00856284|1901349|FG001|Overall Study|Lost to Follow-up|22
920637|NCT00856284|1901350|FG002|Overall Study|Lost to Follow-up|28
920638|NCT00856284|1901348|FG000|Overall Study|Voluntary withdrawal|48
920639|NCT00856284|1901349|FG001|Overall Study|Voluntary withdrawal|52
920640|NCT00856284|1901350|FG002|Overall Study|Voluntary withdrawal|62
920641|NCT00856284|1901348|FG000|Overall Study|Pregnancy|1
920642|NCT00856284|1901349|FG001|Overall Study|Pregnancy|2
920643|NCT00856284|1901350|FG002|Overall Study|Pregnancy|0
920644|NCT00856284|1901348|FG000|Overall Study|Investigator discretion|9
920645|NCT00856284|1901349|FG001|Overall Study|Investigator discretion|8
920646|NCT00856284|1901350|FG002|Overall Study|Investigator discretion|10
920647|NCT00856284|1901348|FG000|Overall Study|Other|15
920648|NCT00856284|1901349|FG001|Overall Study|Other|17
920649|NCT00856284|1901350|FG002|Overall Study|Other|14
920650|NCT00856284|1901348|FG000|Overall Study|Randomized in error|0
920651|NCT00856284|1901349|FG001|Overall Study|Randomized in error|0
920652|NCT00856284|1901350|FG002|Overall Study|Randomized in error|1
920653|NCT00856297|1901363|FG000|Overall Study|Unable to classify|2
920654|NCT00856297|1901364|FG001|Overall Study|Unable to classify|0
920655|NCT00856297|1901365|FG002|Overall Study|Unable to classify|0
920656|NCT00856297|1901366|FG003|Overall Study|Unable to classify|0
920657|NCT00856297|1901367|FG004|Overall Study|Unable to classify|0
920658|NCT00856323|1901384|FG000|Overall Study|Withdrawal by Subject|2
920659|NCT00856349|1901388|FG000|Overall Study|Death|418
920660|NCT00856349|1901388|FG000|Overall Study|Withdrawal by Subject|116
920661|NCT00856349|1901388|FG000|Overall Study|Lost to Follow-up|91
920662|NCT00856349|1901388|FG000|Overall Study|Protocol Violation|38
920663|NCT00856349|1901388|FG000|Overall Study|Physician Decision|13
920664|NCT00856349|1901388|FG000|Overall Study|Subject relocation|104
920665|NCT00856349|1901388|FG000|Overall Study|Device explant|33
920666|NCT00856349|1901388|FG000|Overall Study|Site closure|78
920667|NCT00856349|1901388|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130
920668|NCT00856375|1901396|FG000|Overall Study|Other|0
920669|NCT00856375|1901397|FG001|Overall Study|Other|1
920670|NCT00856375|1901396|FG000|Overall Study|Death|32
920671|NCT00856375|1901397|FG001|Overall Study|Death|30
920672|NCT00856375|1901396|FG000|Overall Study|Sponsor Terminated Study|7
920673|NCT00856375|1901397|FG001|Overall Study|Sponsor Terminated Study|7
920674|NCT00856375|1901396|FG000|Overall Study|Withdrawal by Subject|2
920675|NCT00856375|1901397|FG001|Overall Study|Withdrawal by Subject|1
920676|NCT00856375|1901396|FG000|Overall Study|Lost to Follow-up|1
920677|NCT00856375|1901397|FG001|Overall Study|Lost to Follow-up|2
920678|NCT00856388|1901403|FG000|Overall Study|Other|1
920679|NCT00856492|1901415|FG000|Overall Study|Ineligible or withdrew consent|1
920680|NCT00856492|1901416|FG001|Overall Study|Ineligible or withdrew consent|1
920681|NCT00856492|1901417|FG002|Overall Study|Ineligible or withdrew consent|2
920682|NCT00856518|1901430|FG000|Overall Study|Lost to Follow-up|4
920683|NCT00856518|1901431|FG001|Overall Study|Lost to Follow-up|2
920684|NCT00856544|1901443|FG000|Overall Study|Randomized but not treated|3
920685|NCT00856544|1901444|FG001|Overall Study|Randomized but not treated|0
920686|NCT00856544|1901445|FG002|Overall Study|Randomized but not treated|0
920687|NCT00856544|1901446|FG003|Overall Study|Randomized but not treated|0
920688|NCT00856544|1901443|FG000|Overall Study|Death|0
920689|NCT00856544|1901444|FG001|Overall Study|Death|2
920690|NCT00856544|1901445|FG002|Overall Study|Death|0
920691|NCT00856544|1901446|FG003|Overall Study|Death|0
920692|NCT00856544|1901443|FG000|Overall Study|Adverse Event|20
920693|NCT00856544|1901444|FG001|Overall Study|Adverse Event|29
920694|NCT00856544|1901445|FG002|Overall Study|Adverse Event|2
920695|NCT00856544|1901446|FG003|Overall Study|Adverse Event|3
920696|NCT00856544|1901443|FG000|Overall Study|Lack of Efficacy|16
920697|NCT00856544|1901444|FG001|Overall Study|Lack of Efficacy|12
920698|NCT00856544|1901445|FG002|Overall Study|Lack of Efficacy|3
920699|NCT00856544|1901446|FG003|Overall Study|Lack of Efficacy|3
920700|NCT00856544|1901443|FG000|Overall Study|Other|9
920701|NCT00856544|1901444|FG001|Overall Study|Other|16
920702|NCT00856544|1901445|FG002|Overall Study|Other|1
920703|NCT00856544|1901446|FG003|Overall Study|Other|6
920704|NCT00856544|1901443|FG000|Overall Study|Lost to Follow-up|1
920705|NCT00856544|1901444|FG001|Overall Study|Lost to Follow-up|2
920706|NCT00856544|1901445|FG002|Overall Study|Lost to Follow-up|2
920707|NCT00856544|1901446|FG003|Overall Study|Lost to Follow-up|0
920708|NCT00856544|1901443|FG000|Overall Study|Withdrawal by Subject|8
920709|NCT00856544|1901444|FG001|Overall Study|Withdrawal by Subject|5
920710|NCT00856544|1901445|FG002|Overall Study|Withdrawal by Subject|0
920711|NCT00856544|1901446|FG003|Overall Study|Withdrawal by Subject|1
920712|NCT00856557|1901470|FG000|Overall Study|No patients with contextual flags|12
920713|NCT00856557|1901471|FG001|Overall Study|No patients with contextual flags|16
920714|NCT00856583|1901479|FG000|Overall Study|Lack of Efficacy|389
920715|NCT00856583|1901480|FG001|Overall Study|Lack of Efficacy|377
920716|NCT00856583|1901479|FG000|Overall Study|Serious Adverse Event (SAE)|99
920717|NCT00856583|1901480|FG001|Overall Study|Serious Adverse Event (SAE)|65
920718|NCT00856583|1901479|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
920719|NCT00856583|1901480|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
920720|NCT00856583|1901479|FG000|Overall Study|Non-compliance|305
920721|NCT00856583|1901480|FG001|Overall Study|Non-compliance|262
920722|NCT00856583|1901479|FG000|Overall Study|Withdrawal by Subject|1092
920723|NCT00856583|1901480|FG001|Overall Study|Withdrawal by Subject|919
920724|NCT00856583|1901479|FG000|Overall Study|Physician Decision|59
920725|NCT00856583|1901480|FG001|Overall Study|Physician Decision|82
920726|NCT00856583|1901479|FG000|Overall Study|Pregnancy|14
920727|NCT00856583|1901480|FG001|Overall Study|Pregnancy|5
920728|NCT00856583|1901479|FG000|Overall Study|Other|92
920729|NCT00856583|1901480|FG001|Overall Study|Other|104
920730|NCT00856583|1901479|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694
920731|NCT00856583|1901480|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604
920732|NCT00856609|1901488|FG000|Overall Study|Adverse Event|1
920733|NCT00856609|1901489|FG001|Overall Study|Adverse Event|0
920734|NCT00856635|1901497|FG000|Overall Study|Lost to Follow-up|2
920735|NCT00856635|1901498|FG001|Overall Study|Lost to Follow-up|5
920736|NCT00856635|1901497|FG000|Overall Study|Pregnancy|1
920737|NCT00856635|1901498|FG001|Overall Study|Pregnancy|0
920738|NCT00856635|1901497|FG000|Overall Study|Withdrawal by Subject|3
920739|NCT00856635|1901498|FG001|Overall Study|Withdrawal by Subject|1
920740|NCT00856635|1901497|FG000|Overall Study|Serious Adverse Event|1
920741|NCT00856635|1901498|FG001|Overall Study|Serious Adverse Event|0
920742|NCT00856635|1901497|FG000|Overall Study|Other|1
920743|NCT00856635|1901498|FG001|Overall Study|Other|0
920744|NCT00856635|1901497|FG000|Overall Study|Discontinued at Randomization|2
920745|NCT00856635|1901498|FG001|Overall Study|Discontinued at Randomization|2
920746|NCT00856661|1901508|FG000|Overall Study|Death|15
920747|NCT00856661|1901509|FG001|Overall Study|Death|18
920748|NCT00856661|1901508|FG000|Overall Study|Protocol Violation|2
920749|NCT00856661|1901509|FG001|Overall Study|Protocol Violation|1
920750|NCT00856661|1901508|FG000|Overall Study|Withdrawal by Subject|1
920751|NCT00856661|1901509|FG001|Overall Study|Withdrawal by Subject|2
920752|NCT00856661|1901508|FG000|Overall Study|Lost to Follow-up|1
920753|NCT00856661|1901509|FG001|Overall Study|Lost to Follow-up|3
920754|NCT00856661|1901508|FG000|Overall Study|Physician Judgement|8
920755|NCT00856661|1901509|FG001|Overall Study|Physician Judgement|5
920756|NCT00856778|1901535|FG000|Overall Study|Adverse Event|7
920757|NCT00856778|1901535|FG000|Overall Study|Withdrawal by Subject|10
920758|NCT00856778|1901535|FG000|Overall Study|Study deviation|2
920759|NCT00856778|1901535|FG000|Overall Study|Lost to Follow-up|5
920760|NCT00856830|1901547|FG000|Irinotecan & Bendamustine|Death|0
920761|NCT00856830|1901548|FG001|Irinotecan & Bendamustine|Death|0
920762|NCT00856830|1901549|FG002|Irinotecan & Bendamustine|Death|0
920763|NCT00856830|1901550|FG003|Irinotecan & Bendamustine|Death|2
920764|NCT00856830|1901547|FG000|Irinotecan & Bendamustine|Physician Decision|0
920765|NCT00856830|1901548|FG001|Irinotecan & Bendamustine|Physician Decision|0
920766|NCT00856830|1901549|FG002|Irinotecan & Bendamustine|Physician Decision|0
920767|NCT00856830|1901550|FG003|Irinotecan & Bendamustine|Physician Decision|1
920768|NCT00856843|1901557|FG000|Overall Study|Withdrawal by Subject|1
920769|NCT00856843|1901558|FG001|Overall Study|Withdrawal by Subject|5
920770|NCT00856843|1901557|FG000|Overall Study|Lack of Efficacy|1
920771|NCT00856843|1901558|FG001|Overall Study|Lack of Efficacy|0
920772|NCT00856856|1901564|FG000|2-year Clinical Follow-up|Lost to Follow-up|1
920773|NCT00856856|1901564|FG000|4-year Clinical Follow-up|Missed visit|1
920774|NCT00856908|1901575|FG000|Overall Study|Lost to Follow-up|1
920775|NCT00856908|1901576|FG001|Overall Study|Lost to Follow-up|0
920776|NCT00856973|1901595|FG000|Overall Study|Adverse Event|5
920777|NCT00856973|1901596|FG001|Overall Study|Adverse Event|5
920778|NCT00856973|1901597|FG002|Overall Study|Adverse Event|3
920779|NCT00856973|1901595|FG000|Overall Study|Lost to Follow-up|6
920780|NCT00856973|1901596|FG001|Overall Study|Lost to Follow-up|3
920781|NCT00856973|1901597|FG002|Overall Study|Lost to Follow-up|5
920782|NCT00856973|1901595|FG000|Overall Study|Physician Decision|0
920783|NCT00856973|1901596|FG001|Overall Study|Physician Decision|3
920784|NCT00856973|1901597|FG002|Overall Study|Physician Decision|1
920785|NCT00856973|1901595|FG000|Overall Study|Protocol Violation|1
920786|NCT00856973|1901596|FG001|Overall Study|Protocol Violation|2
920787|NCT00856973|1901597|FG002|Overall Study|Protocol Violation|1
920788|NCT00856973|1901595|FG000|Overall Study|Withdrawal by Subject|13
920789|NCT00856973|1901596|FG001|Overall Study|Withdrawal by Subject|16
920790|NCT00856973|1901597|FG002|Overall Study|Withdrawal by Subject|15
920791|NCT00856973|1901595|FG000|Overall Study|Other|11
920792|NCT00856973|1901596|FG001|Overall Study|Other|12
920793|NCT00856973|1901597|FG002|Overall Study|Other|13
920794|NCT00856986|1901614|FG000|Run-in Period, Weeks -12-0|Adverse Event|0
920795|NCT00856986|1901615|FG001|Run-in Period, Weeks -12-0|Adverse Event|0
920796|NCT00856986|1901616|FG002|Run-in Period, Weeks -12-0|Adverse Event|0
920797|NCT00856986|1901617|FG003|Run-in Period, Weeks -12-0|Adverse Event|92
920798|NCT00856986|1901618|FG004|Run-in Period, Weeks -12-0|Adverse Event|0
920799|NCT00856986|1901614|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0
920800|NCT00856986|1901615|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0
920801|NCT00856986|1901616|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0
920802|NCT00856986|1901617|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24
920803|NCT00856986|1901618|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0
920804|NCT00856986|1901614|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
920805|NCT00856986|1901615|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
920806|NCT00856986|1901616|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
920807|NCT00856986|1901617|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
920808|NCT00856986|1901618|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
920809|NCT00856986|1901614|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0
920810|NCT00856986|1901615|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0
920811|NCT00856986|1901616|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0
920812|NCT00856986|1901617|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11
920813|NCT00856986|1901618|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0
920814|NCT00856986|1901614|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0
920815|NCT00856986|1901615|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0
920816|NCT00856986|1901616|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0
920817|NCT00856986|1901617|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6
920818|NCT00856986|1901618|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0
920819|NCT00856986|1901614|FG000|Run-in Period, Weeks -12-0|Unclassified|0
920820|NCT00856986|1901615|FG001|Run-in Period, Weeks -12-0|Unclassified|0
920821|NCT00856986|1901616|FG002|Run-in Period, Weeks -12-0|Unclassified|0
920822|NCT00856986|1901617|FG003|Run-in Period, Weeks -12-0|Unclassified|24
920823|NCT00856986|1901618|FG004|Run-in Period, Weeks -12-0|Unclassified|0
920824|NCT00856986|1901614|FG000|Main Period, Weeks 0-26|Adverse Event|6
920825|NCT00856986|1901615|FG001|Main Period, Weeks 0-26|Adverse Event|4
920826|NCT00856986|1901616|FG002|Main Period, Weeks 0-26|Adverse Event|9
920827|NCT00856986|1901617|FG003|Main Period, Weeks 0-26|Adverse Event|0
920828|NCT00856986|1901618|FG004|Main Period, Weeks 0-26|Adverse Event|0
920829|NCT00856986|1901614|FG000|Main Period, Weeks 0-26|Protocol Violation|4
920830|NCT00856986|1901615|FG001|Main Period, Weeks 0-26|Protocol Violation|5
920831|NCT00856986|1901616|FG002|Main Period, Weeks 0-26|Protocol Violation|7
920832|NCT00856986|1901617|FG003|Main Period, Weeks 0-26|Protocol Violation|0
920833|NCT00856986|1901618|FG004|Main Period, Weeks 0-26|Protocol Violation|0
920834|NCT00856986|1901614|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11
920835|NCT00856986|1901615|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0
920836|NCT00856986|1901616|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3
920837|NCT00856986|1901617|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0
920838|NCT00856986|1901618|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0
920839|NCT00856986|1901614|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1
920840|NCT00856986|1901615|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1
920841|NCT00856986|1901616|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2
920842|NCT00856986|1901617|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0
920843|NCT00856986|1901618|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0
920844|NCT00856986|1901614|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5
920845|NCT00856986|1901615|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2
920846|NCT00856986|1901616|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0
920847|NCT00856986|1901617|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0
920848|NCT00856986|1901618|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0
920849|NCT00856986|1901614|FG000|Main Period, Weeks 0-26|Unclassified|7
920850|NCT00856986|1901615|FG001|Main Period, Weeks 0-26|Unclassified|6
920851|NCT00856986|1901616|FG002|Main Period, Weeks 0-26|Unclassified|7
920852|NCT00856986|1901617|FG003|Main Period, Weeks 0-26|Unclassified|0
920853|NCT00856986|1901618|FG004|Main Period, Weeks 0-26|Unclassified|0
920854|NCT00856986|1901614|FG000|Extension Period, Weeks 26-52|Adverse Event|3
920855|NCT00856986|1901615|FG001|Extension Period, Weeks 26-52|Adverse Event|3
920856|NCT00856986|1901616|FG002|Extension Period, Weeks 26-52|Adverse Event|10
920857|NCT00856986|1901617|FG003|Extension Period, Weeks 26-52|Adverse Event|0
920858|NCT00856986|1901618|FG004|Extension Period, Weeks 26-52|Adverse Event|0
920859|NCT00856986|1901614|FG000|Extension Period, Weeks 26-52|Protocol Violation|6
920860|NCT00856986|1901615|FG001|Extension Period, Weeks 26-52|Protocol Violation|2
920861|NCT00856986|1901616|FG002|Extension Period, Weeks 26-52|Protocol Violation|5
920862|NCT00856986|1901617|FG003|Extension Period, Weeks 26-52|Protocol Violation|0
920863|NCT00856986|1901618|FG004|Extension Period, Weeks 26-52|Protocol Violation|0
920864|NCT00856986|1901614|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2
920865|NCT00856986|1901615|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0
920866|NCT00856986|1901616|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8
920867|NCT00856986|1901617|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0
920868|NCT00856986|1901618|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0
920869|NCT00856986|1901614|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0
920870|NCT00856986|1901615|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5
920871|NCT00856986|1901616|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2
920872|NCT00856986|1901617|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0
920873|NCT00856986|1901618|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0
920874|NCT00856986|1901614|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4
920875|NCT00856986|1901615|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2
920876|NCT00856986|1901616|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2
920877|NCT00856986|1901617|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0
920878|NCT00856986|1901618|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0
920879|NCT00856986|1901614|FG000|Extension Period, Weeks 26-52|Unclassified|4
920880|NCT00856986|1901615|FG001|Extension Period, Weeks 26-52|Unclassified|2
920881|NCT00856986|1901616|FG002|Extension Period, Weeks 26-52|Unclassified|11
920882|NCT00856986|1901617|FG003|Extension Period, Weeks 26-52|Unclassified|0
920883|NCT00856986|1901618|FG004|Extension Period, Weeks 26-52|Unclassified|0
920884|NCT00856999|1901630|FG000|Overall Study|Withdrawal by Subject|5
920885|NCT00857207|1901637|FG000|Overall Study|Withdrawal by Subject|13
920886|NCT00857207|1901638|FG001|Overall Study|Withdrawal by Subject|0
920887|NCT00857207|1901637|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18
920888|NCT00857207|1901638|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0
920889|NCT00857207|1901637|FG000|Overall Study|Subject chose not to participate after signing consent|3
920890|NCT00857207|1901638|FG001|Overall Study|Subject chose not to participate after signing consent|0
920891|NCT00857220|1901645|FG000|Overall Study|Adverse Event|35
920892|NCT00857220|1901645|FG000|Overall Study|Death|1
920893|NCT00857220|1901645|FG000|Overall Study|Lack of Efficacy|11
920894|NCT00857220|1901645|FG000|Overall Study|Lost to Follow-up|30
920895|NCT00857220|1901645|FG000|Overall Study|Physician Decision|4
920896|NCT00857220|1901645|FG000|Overall Study|Protocol Violation|16
920897|NCT00857220|1901645|FG000|Overall Study|Withdrawal by Subject|67
920898|NCT00857220|1901645|FG000|Overall Study|Clinical Hold|6
920899|NCT00857220|1901645|FG000|Overall Study|Site Closed|5
920900|NCT00857220|1901645|FG000|Overall Study|Miscellaneous|8
920901|NCT00857233|1901649|FG000|Overall Study|Adverse Event|24
920902|NCT00857233|1901649|FG000|Overall Study|Lack of Efficacy|1
920903|NCT00857233|1901649|FG000|Overall Study|Non-compliance|1
920904|NCT00857233|1901649|FG000|Overall Study|Withdrawal of Consent|9
920905|NCT00857233|1901649|FG000|Overall Study|Lost to Follow-up|4
920906|NCT00857233|1901649|FG000|Overall Study|Nursing Home Placement|14
920907|NCT00857233|1901649|FG000|Overall Study|Other Reasons|2
920908|NCT00857246|1901653|FG000|Induction Regimen|Adverse Event|1
920909|NCT00857246|1901653|FG000|Induction Regimen|disease-related complications|1
920910|NCT00857246|1901653|FG000|Induction Regimen|Withdrawal by Subject|1
920911|NCT00857246|1901653|FG000|Surgery (Curative)|disease progression|6
920912|NCT00857246|1901653|FG000|ChemoRT|Withdrawal by Subject|1
920913|NCT00857246|1901653|FG000|ChemoRT|Adverse Event|2
920914|NCT00857259|1901663|FG000|Overall Study|Protocol Violation|1
920915|NCT00857259|1901664|FG001|Overall Study|Protocol Violation|0
920916|NCT00857259|1901665|FG002|Overall Study|Protocol Violation|1
920917|NCT00857285|1901686|FG000|Overall Study|Adverse Event|4
920918|NCT00857285|1901687|FG001|Overall Study|Adverse Event|2
920919|NCT00857285|1901686|FG000|Overall Study|Lack of Efficacy|0
920920|NCT00857285|1901687|FG001|Overall Study|Lack of Efficacy|2
920921|NCT00857285|1901686|FG000|Overall Study|Protocol Violation|3
920922|NCT00857285|1901687|FG001|Overall Study|Protocol Violation|1
920923|NCT00857285|1901686|FG000|Overall Study|Withdrawal by Subject|4
920924|NCT00857285|1901687|FG001|Overall Study|Withdrawal by Subject|0
920925|NCT00857285|1901686|FG000|Overall Study|Randomization criteria not met|1
920926|NCT00857285|1901687|FG001|Overall Study|Randomization criteria not met|1
920927|NCT00857311|1901695|FG000|Overall Study|Lost to Follow-up|1
920928|NCT00857311|1901696|FG001|Overall Study|Lost to Follow-up|0
920929|NCT00857311|1901697|FG002|Overall Study|Lost to Follow-up|0
920930|NCT00857311|1901698|FG003|Overall Study|Lost to Follow-up|0
920931|NCT00857389|1901704|FG000|Overall Study|Did not proceed to transplant|2
920932|NCT00857415|1901710|FG000|Overall Study|Image acquisition failure|2
920933|NCT00857415|1901711|FG001|Overall Study|Image acquisition failure|0
920934|NCT00857415|1901710|FG000|Overall Study|Invalid image or not imaged|3
920935|NCT00857415|1901711|FG001|Overall Study|Invalid image or not imaged|0
920936|NCT00857415|1901710|FG000|Overall Study|Subject still living at end of study|110
920937|NCT00857415|1901711|FG001|Overall Study|Subject still living at end of study|0
920938|NCT00857415|1901710|FG000|Overall Study|Deceased with no autopsy|2
920939|NCT00857415|1901711|FG001|Overall Study|Deceased with no autopsy|0
920940|NCT00857454|1901717|FG000|Overall Study|Withdrawal by Subject|2
920941|NCT00857454|1901717|FG000|Overall Study|Lost to Follow-up|1
920942|NCT00857454|1901717|FG000|Overall Study|Adverse Event|2
920943|NCT00857454|1901717|FG000|Overall Study|Total Testosterone >1050 ng/dL|1
920944|NCT00857454|1901717|FG000|Overall Study|Total Testosterone <300 ng/dL|8
920945|NCT00857454|1901717|FG000|Overall Study|MTE09 enrollment criteria not met|6
920946|NCT00857584|1901773|FG000|Overall Study|Lack of Efficacy|1
920947|NCT00857584|1901774|FG001|Overall Study|Lack of Efficacy|2
920948|NCT00857584|1901773|FG000|Overall Study|Adverse Event|2
920949|NCT00857584|1901774|FG001|Overall Study|Adverse Event|2
920950|NCT00857584|1901773|FG000|Overall Study|Physician Decision|1
920951|NCT00857584|1901774|FG001|Overall Study|Physician Decision|1
920952|NCT00857623|1901782|FG000|Overall Study|Adverse Event|5
920953|NCT00857623|1901783|FG001|Overall Study|Adverse Event|2
920954|NCT00857623|1901782|FG000|Overall Study|Study-specific discontinuation criteria|5
920955|NCT00857623|1901783|FG001|Overall Study|Study-specific discontinuation criteria|3
920956|NCT00857623|1901782|FG000|Overall Study|Withdrawal by Subject|2
920957|NCT00857623|1901783|FG001|Overall Study|Withdrawal by Subject|1
920958|NCT00857623|1901782|FG000|Overall Study|Lack of Efficacy|1
920959|NCT00857623|1901783|FG001|Overall Study|Lack of Efficacy|1
920960|NCT00857623|1901782|FG000|Overall Study|Severe non-compliance to protocol|1
920961|NCT00857623|1901783|FG001|Overall Study|Severe non-compliance to protocol|1
920962|NCT00857623|1901782|FG000|Overall Study|Intake of prohibited medication|0
920963|NCT00857623|1901783|FG001|Overall Study|Intake of prohibited medication|1
920964|NCT00857623|1901782|FG000|Overall Study|Positive for HEP C|0
920965|NCT00857623|1901783|FG001|Overall Study|Positive for HEP C|1
920966|NCT00857649|1901791|FG000|Overall Study|Adverse Event|15
920967|NCT00857649|1901792|FG001|Overall Study|Adverse Event|10
920968|NCT00857649|1901791|FG000|Overall Study|Non-compliance|1
920969|NCT00857649|1901792|FG001|Overall Study|Non-compliance|1
920970|NCT00857649|1901791|FG000|Overall Study|Protocol Violation|2
920971|NCT00857649|1901792|FG001|Overall Study|Protocol Violation|2
920972|NCT00857649|1901791|FG000|Overall Study|Withdrawal of Consent|10
920973|NCT00857649|1901792|FG001|Overall Study|Withdrawal of Consent|7
920974|NCT00857649|1901791|FG000|Overall Study|Nursing Home Placement|2
920975|NCT00857649|1901792|FG001|Overall Study|Nursing Home Placement|9
920976|NCT00857649|1901791|FG000|Overall Study|Other Reasons|1
920977|NCT00857649|1901792|FG001|Overall Study|Other Reasons|3
920978|NCT00857766|1901813|FG000|Overall Study|Adverse Event|13
920979|NCT00857766|1901814|FG001|Overall Study|Adverse Event|12
920980|NCT00857766|1901813|FG000|Overall Study|Protocol Violation|11
920981|NCT00857766|1901814|FG001|Overall Study|Protocol Violation|11
920982|NCT00857766|1901813|FG000|Overall Study|Lost to Follow-up|1
920983|NCT00857766|1901814|FG001|Overall Study|Lost to Follow-up|0
920984|NCT00857766|1901813|FG000|Overall Study|Investigator Discretion|2
920985|NCT00857766|1901814|FG001|Overall Study|Investigator Discretion|3
920986|NCT00857766|1901813|FG000|Overall Study|Participant Withdrew Consent|4
920987|NCT00857766|1901814|FG001|Overall Study|Participant Withdrew Consent|4
920988|NCT00857792|1901820|FG000|Overall Study|inadequate image quality for analysis|12
920989|NCT00857818|1901826|FG000|Overall Study|Lack of Efficacy|1
920990|NCT00857818|1901827|FG001|Overall Study|Lack of Efficacy|0
920991|NCT00857818|1901826|FG000|Overall Study|Adverse Event|3
920992|NCT00857818|1901827|FG001|Overall Study|Adverse Event|0
920993|NCT00857818|1901826|FG000|Overall Study|Withdrawal by Subject|0
920994|NCT00857818|1901827|FG001|Overall Study|Withdrawal by Subject|4
920995|NCT00857818|1901826|FG000|Overall Study|Sponsor terminated study|6
920996|NCT00857818|1901827|FG001|Overall Study|Sponsor terminated study|4
920997|NCT00857818|1901826|FG000|Overall Study|Investigator decision|1
920998|NCT00857818|1901827|FG001|Overall Study|Investigator decision|0
920999|NCT00857896|1901845|FG000|Baseline to Week 4|Withdrawal by Subject|1
921000|NCT00857948|1901854|FG000|Overall Study|Withdrawal by Subject|2
921001|NCT00857948|1901855|FG001|Overall Study|Withdrawal by Subject|0
921002|NCT00857948|1901856|FG002|Overall Study|Withdrawal by Subject|0
921003|NCT00857948|1901857|FG003|Overall Study|Withdrawal by Subject|0
921004|NCT00857948|1901854|FG000|Overall Study|Protocol Violation|1
921005|NCT00857948|1901855|FG001|Overall Study|Protocol Violation|0
921006|NCT00857948|1901856|FG002|Overall Study|Protocol Violation|1
921007|NCT00857948|1901857|FG003|Overall Study|Protocol Violation|0
921008|NCT00858117|1901886|FG000|Treatment on Study|Adverse Event|2
921009|NCT00858117|1901886|FG000|Follow up for 5 Years|Death|4
921010|NCT00858117|1901886|FG000|Follow up for 5 Years|No further data collected for study|9
921011|NCT00858143|1901895|FG000|Overall Study|Adverse Event|16
921012|NCT00858143|1901895|FG000|Overall Study|Lack of Efficacy|4
921013|NCT00858143|1901895|FG000|Overall Study|Death|7
921014|NCT00858143|1901895|FG000|Overall Study|Other|23
921015|NCT00858208|1901899|FG000|Overall Study|Adverse Event|3
921016|NCT00858208|1901899|FG000|Overall Study|Lost to Follow-up|26
921017|NCT00858208|1901899|FG000|Overall Study|Participant refused|40
921018|NCT00858208|1901899|FG000|Overall Study|Other|10
921019|NCT00858234|1901903|FG000|Overall Study|Adverse Event|6
921020|NCT00858234|1901903|FG000|Overall Study|Progressive disease|2
921021|NCT00858234|1901903|FG000|Overall Study|Status unknown|1
921022|NCT00858247|1901909|FG000|Baseline Assessment|Withdrawal by Subject|1
921023|NCT00858247|1901910|FG001|Baseline Assessment|Withdrawal by Subject|1
921024|NCT00858247|1901909|FG000|Baseline Assessment|Poor IV access|1
921025|NCT00858247|1901910|FG001|Baseline Assessment|Poor IV access|0
921026|NCT00858247|1901909|FG000|Baseline Assessment|Protocol Violation|0
921027|NCT00858247|1901910|FG001|Baseline Assessment|Protocol Violation|1
921028|NCT00858247|1901909|FG000|Week 12 Follow-up|Withdrawal by Subject|0
921029|NCT00858247|1901910|FG001|Week 12 Follow-up|Withdrawal by Subject|1
921030|NCT00858364|1901918|FG000|Overall Study|Administrative Decision|3
921031|NCT00858364|1901919|FG001|Overall Study|Administrative Decision|2
921032|NCT00858364|1901918|FG000|Overall Study|Adverse Event|5
921033|NCT00858364|1901919|FG001|Overall Study|Adverse Event|2
921034|NCT00858364|1901918|FG000|Overall Study|Withdrawal by Subject|44
921035|NCT00858364|1901919|FG001|Overall Study|Withdrawal by Subject|118
921036|NCT00858364|1901918|FG000|Overall Study|Ineligibility Determined|1
921037|NCT00858364|1901919|FG001|Overall Study|Ineligibility Determined|10
921038|NCT00858364|1901918|FG000|Overall Study|Lost to Follow-up|24
921039|NCT00858364|1901919|FG001|Overall Study|Lost to Follow-up|54
921040|NCT00858364|1901918|FG000|Overall Study|Noncompliance|3
921041|NCT00858364|1901919|FG001|Overall Study|Noncompliance|4
921042|NCT00858364|1901918|FG000|Overall Study|Protocol Deviation|0
921043|NCT00858364|1901919|FG001|Overall Study|Protocol Deviation|2
921044|NCT00858364|1901918|FG000|Overall Study|Other|9
921045|NCT00858364|1901919|FG001|Overall Study|Other|17
921046|NCT00858364|1901918|FG000|Overall Study|Missing|1
921047|NCT00858364|1901919|FG001|Overall Study|Missing|1
921048|NCT00858364|1901918|FG000|Overall Study|Still on-study|114
921049|NCT00858364|1901919|FG001|Overall Study|Still on-study|247
921050|NCT00858403|1901934|FG000|Overall Study|Withdrawal by Subject|1
921051|NCT00858403|1901934|FG000|Overall Study|Death|3
921052|NCT00858403|1901934|FG000|Overall Study|Disease Progression|1
921053|NCT00858442|1901940|FG000|Compression:Start to Finish|Lost to Follow-up|1
921054|NCT00858442|1901941|FG001|Compression:Start to Finish|Lost to Follow-up|3
921055|NCT00858637|1901972|FG000|Active Comparison Phase|Adverse Event|14
921056|NCT00858637|1901973|FG001|Active Comparison Phase|Adverse Event|0
921057|NCT00858637|1901974|FG002|Active Comparison Phase|Adverse Event|0
921058|NCT00858637|1901975|FG003|Active Comparison Phase|Adverse Event|9
921059|NCT00858637|1901976|FG004|Active Comparison Phase|Adverse Event|0
921060|NCT00858637|1901977|FG005|Active Comparison Phase|Adverse Event|0
921061|NCT00858637|1901972|FG000|Active Comparison Phase|Death|1
921062|NCT00858637|1901973|FG001|Active Comparison Phase|Death|0
921063|NCT00858637|1901974|FG002|Active Comparison Phase|Death|0
921064|NCT00858637|1901975|FG003|Active Comparison Phase|Death|1
921065|NCT00858637|1901976|FG004|Active Comparison Phase|Death|0
921066|NCT00858637|1901977|FG005|Active Comparison Phase|Death|0
921067|NCT00858637|1901972|FG000|Active Comparison Phase|Physician Decision|1
921068|NCT00858637|1901973|FG001|Active Comparison Phase|Physician Decision|0
921069|NCT00858637|1901974|FG002|Active Comparison Phase|Physician Decision|0
921070|NCT00858637|1901975|FG003|Active Comparison Phase|Physician Decision|1
921071|NCT00858637|1901976|FG004|Active Comparison Phase|Physician Decision|0
921072|NCT00858637|1901977|FG005|Active Comparison Phase|Physician Decision|0
921073|NCT00858637|1901972|FG000|Active Comparison Phase|Withdrawal by Subject|7
921074|NCT00858637|1901973|FG001|Active Comparison Phase|Withdrawal by Subject|0
921075|NCT00858637|1901974|FG002|Active Comparison Phase|Withdrawal by Subject|0
921076|NCT00858637|1901975|FG003|Active Comparison Phase|Withdrawal by Subject|6
921077|NCT00858637|1901976|FG004|Active Comparison Phase|Withdrawal by Subject|0
921078|NCT00858637|1901977|FG005|Active Comparison Phase|Withdrawal by Subject|0
921079|NCT00858637|1901972|FG000|Active Comparison Phase|Other Reasons|1
921080|NCT00858637|1901973|FG001|Active Comparison Phase|Other Reasons|0
921081|NCT00858637|1901974|FG002|Active Comparison Phase|Other Reasons|0
921082|NCT00858637|1901975|FG003|Active Comparison Phase|Other Reasons|1
921083|NCT00858637|1901976|FG004|Active Comparison Phase|Other Reasons|0
921084|NCT00858637|1901977|FG005|Active Comparison Phase|Other Reasons|0
921085|NCT00858637|1901972|FG000|Placebo-controlled Withdrawal Phase|Death|0
921086|NCT00858637|1901973|FG001|Placebo-controlled Withdrawal Phase|Death|0
921087|NCT00858637|1901974|FG002|Placebo-controlled Withdrawal Phase|Death|1
921088|NCT00858637|1901975|FG003|Placebo-controlled Withdrawal Phase|Death|0
921089|NCT00858637|1901976|FG004|Placebo-controlled Withdrawal Phase|Death|1
921090|NCT00858637|1901977|FG005|Placebo-controlled Withdrawal Phase|Death|0
921091|NCT00858637|1901972|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
921092|NCT00858637|1901973|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
921093|NCT00858637|1901974|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
921094|NCT00858637|1901975|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
921095|NCT00858637|1901976|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
921096|NCT00858637|1901977|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
921097|NCT00858702|1901993|FG000|Overall Study|Lack of Efficacy|1
921098|NCT00858702|1901994|FG001|Overall Study|Lack of Efficacy|0
921099|NCT00858702|1901993|FG000|Overall Study|Protocol Violation|1
921100|NCT00858702|1901994|FG001|Overall Study|Protocol Violation|1
921101|NCT00858702|1901993|FG000|Overall Study|Other|2
921102|NCT00858702|1901994|FG001|Overall Study|Other|1
921103|NCT00858702|1901993|FG000|Overall Study|Withdrawal by Subject|1
921104|NCT00858702|1901994|FG001|Overall Study|Withdrawal by Subject|0
921105|NCT00858780|1902000|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
921106|NCT00858780|1902001|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
921107|NCT00858780|1902002|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
921108|NCT00858780|1902003|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
921109|NCT00858780|1902004|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
921110|NCT00858780|1902000|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
921111|NCT00858780|1902001|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
921112|NCT00858780|1902002|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
921113|NCT00858780|1902003|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
921114|NCT00858780|1902004|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
921115|NCT00858780|1902000|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
921116|NCT00858780|1902001|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
921117|NCT00858780|1902002|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
921118|NCT00858780|1902003|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
921119|NCT00858780|1902004|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
921120|NCT00858780|1902000|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0
921121|NCT00858780|1902001|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1
921122|NCT00858780|1902002|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0
921123|NCT00858780|1902003|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0
921124|NCT00858780|1902004|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0
921125|NCT00858780|1902000|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
921126|NCT00858780|1902001|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
921127|NCT00858780|1902002|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
921128|NCT00858780|1902003|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
921129|NCT00858780|1902004|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
921130|NCT00858780|1902000|FG000|OL Re-Treatment (Failure to Week 48)|Other|0
921131|NCT00858780|1902001|FG001|OL Re-Treatment (Failure to Week 48)|Other|0
921132|NCT00858780|1902002|FG002|OL Re-Treatment (Failure to Week 48)|Other|0
921133|NCT00858780|1902003|FG003|OL Re-Treatment (Failure to Week 48)|Other|0
921134|NCT00858780|1902004|FG004|OL Re-Treatment (Failure to Week 48)|Other|1
921135|NCT00858832|1902016|FG000|Overall Study|became ineligible: delivered vaginally|1
921136|NCT00858832|1902017|FG001|Overall Study|became ineligible: delivered vaginally|0
921137|NCT00858832|1902016|FG000|Overall Study|Adverse Event|0
921138|NCT00858832|1902017|FG001|Overall Study|Adverse Event|1
921139|NCT00858845|1902025|FG000|Overall Study|Patient underwent heart transplant.|0
921140|NCT00858845|1902026|FG001|Overall Study|Patient underwent heart transplant.|1
921141|NCT00858988|1902042|FG000|Analysis|Lactulose unable to be detected in urine|2
921142|NCT00858988|1902043|FG001|Analysis|Lactulose unable to be detected in urine|1
921143|NCT00859014|1902049|FG000|Overall Study|Death|4
921144|NCT00859014|1902049|FG000|Overall Study|Lost to Follow-up|1
921145|NCT00859222|1902100|FG000|Overall Study|Adverse Event|2
921146|NCT00859222|1902101|FG001|Overall Study|Adverse Event|3
921147|NCT00859222|1902102|FG002|Overall Study|Adverse Event|6
921148|NCT00859222|1902103|FG003|Overall Study|Adverse Event|24
921149|NCT00859222|1902104|FG004|Overall Study|Adverse Event|15
921150|NCT00859222|1902100|FG000|Overall Study|DLT|1
921151|NCT00859222|1902101|FG001|Overall Study|DLT|0
921152|NCT00859222|1902102|FG002|Overall Study|DLT|0
921153|NCT00859222|1902103|FG003|Overall Study|DLT|0
921154|NCT00859222|1902104|FG004|Overall Study|DLT|0
921155|NCT00859313|1902119|FG000|Overall Study|Lack of Efficacy|2
921156|NCT00859313|1902119|FG000|Overall Study|Adverse Event|1
921157|NCT00859313|1902119|FG000|Overall Study|staff error|1
921158|NCT00859430|1902129|FG000|First Intervention|Withdrawal by Subject|0
921159|NCT00859430|1902130|FG001|First Intervention|Withdrawal by Subject|1
921160|NCT00859456|1902134|FG000|Overall Study|Adverse Event|3
921161|NCT00859456|1902134|FG000|Overall Study|Progressive disease|2
921162|NCT00859456|1902134|FG000|Overall Study|Non-compliance|3
921163|NCT00859469|1902138|FG000|Overall Study|Adverse Event|2
921164|NCT00859469|1902138|FG000|Overall Study|Lack of Efficacy|9
921165|NCT00859469|1902138|FG000|Overall Study|Withdrawal by Subject|1
921166|NCT00859469|1902138|FG000|Overall Study|Death|16
921167|NCT00859521|1902157|FG000|Washout|Withdrawal by Subject|0
921168|NCT00859521|1902158|FG001|Washout|Withdrawal by Subject|1
921169|NCT00859547|1902162|FG000|Overall Study|Lost to Follow-up|1
921170|NCT00859547|1902162|FG000|Overall Study|Parent withdrew consent|1
921171|NCT00859573|1902168|FG000|Overall Study|Withdrawal by Subject|4
921172|NCT00859573|1902169|FG001|Overall Study|Withdrawal by Subject|1
921173|NCT00859573|1902168|FG000|Overall Study|Physician Decision|1
921174|NCT00859573|1902169|FG001|Overall Study|Physician Decision|1
921175|NCT00859586|1902175|FG000|Overall Study|Donors|4
921176|NCT00859638|1902181|FG000|Overall Study|Lost to Follow-up|6
921177|NCT00859638|1902182|FG001|Overall Study|Lost to Follow-up|1
921178|NCT00859638|1902181|FG000|Overall Study|Withdrawal by Subject|3
921179|NCT00859638|1902182|FG001|Overall Study|Withdrawal by Subject|2
921180|NCT00859638|1902181|FG000|Overall Study|Ill health|1
921181|NCT00859638|1902182|FG001|Overall Study|Ill health|1
921182|NCT00859898|1902205|FG000|Overall Study|Lack of Efficacy|0
921183|NCT00859898|1902206|FG001|Overall Study|Lack of Efficacy|1
921184|NCT00859898|1902207|FG002|Overall Study|Lack of Efficacy|1
921185|NCT00859898|1902205|FG000|Overall Study|Adverse Event|4
921186|NCT00859898|1902206|FG001|Overall Study|Adverse Event|9
921187|NCT00859898|1902207|FG002|Overall Study|Adverse Event|8
921188|NCT00859898|1902205|FG000|Overall Study|Withdrawal by Subject|11
921189|NCT00859898|1902206|FG001|Overall Study|Withdrawal by Subject|8
921190|NCT00859898|1902207|FG002|Overall Study|Withdrawal by Subject|11
921191|NCT00859898|1902205|FG000|Overall Study|Death|0
921192|NCT00859898|1902206|FG001|Overall Study|Death|0
921193|NCT00859898|1902207|FG002|Overall Study|Death|1
921194|NCT00859898|1902205|FG000|Overall Study|Lost to Follow-up|10
921195|NCT00859898|1902206|FG001|Overall Study|Lost to Follow-up|11
921196|NCT00859898|1902207|FG002|Overall Study|Lost to Follow-up|5
921197|NCT00859898|1902205|FG000|Overall Study|poor/non-compliance|2
921198|NCT00859898|1902206|FG001|Overall Study|poor/non-compliance|0
921199|NCT00859898|1902207|FG002|Overall Study|poor/non-compliance|0
921200|NCT00859898|1902205|FG000|Overall Study|No longer meets criteria|0
921201|NCT00859898|1902206|FG001|Overall Study|No longer meets criteria|1
921202|NCT00859898|1902207|FG002|Overall Study|No longer meets criteria|0
921203|NCT00859898|1902205|FG000|Overall Study|non-specified|1
921204|NCT00859898|1902206|FG001|Overall Study|non-specified|1
921205|NCT00859898|1902207|FG002|Overall Study|non-specified|1
921206|NCT00859937|1902218|FG000|Overall Study|Protocol Violation|1
921207|NCT00859937|1902219|FG001|Overall Study|Protocol Violation|0
921208|NCT00860028|1902249|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
921209|NCT00860028|1902250|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
921210|NCT00860067|1902261|FG000|Overall Study|Lost to Follow-up|46
921211|NCT00860067|1902262|FG001|Overall Study|Lost to Follow-up|9
921212|NCT00860067|1902263|FG002|Overall Study|Lost to Follow-up|9
921213|NCT00860067|1902261|FG000|Overall Study|Withdrawal by Subject|4
921214|NCT00860067|1902262|FG001|Overall Study|Withdrawal by Subject|0
921215|NCT00860067|1902263|FG002|Overall Study|Withdrawal by Subject|0
921216|NCT00860067|1902261|FG000|Overall Study|Pregnancy|1
921217|NCT00860067|1902262|FG001|Overall Study|Pregnancy|0
921218|NCT00860067|1902263|FG002|Overall Study|Pregnancy|0
921219|NCT00860262|1902281|FG000|Overall Study|Adverse Event|9
921220|NCT00860262|1902282|FG001|Overall Study|Adverse Event|6
921221|NCT00860262|1902283|FG002|Overall Study|Adverse Event|7
921222|NCT00860262|1902281|FG000|Overall Study|Protocol Violation|0
921223|NCT00860262|1902282|FG001|Overall Study|Protocol Violation|1
921224|NCT00860262|1902283|FG002|Overall Study|Protocol Violation|0
921225|NCT00860262|1902281|FG000|Overall Study|Lost to Follow-up|2
921226|NCT00860262|1902282|FG001|Overall Study|Lost to Follow-up|0
921227|NCT00860262|1902283|FG002|Overall Study|Lost to Follow-up|1
921228|NCT00860262|1902281|FG000|Overall Study|Withdrawal by Subject|4
921229|NCT00860262|1902282|FG001|Overall Study|Withdrawal by Subject|8
921230|NCT00860262|1902283|FG002|Overall Study|Withdrawal by Subject|6
921231|NCT00860262|1902281|FG000|Overall Study|Lack of Efficacy|0
921232|NCT00860262|1902282|FG001|Overall Study|Lack of Efficacy|4
921233|NCT00860262|1902283|FG002|Overall Study|Lack of Efficacy|3
921234|NCT00860262|1902281|FG000|Overall Study|Other|5
921235|NCT00860262|1902282|FG001|Overall Study|Other|3
921236|NCT00860262|1902283|FG002|Overall Study|Other|1
921237|NCT00860405|1902317|FG000|Overall Study|Main reason: Follow-up data not complete|5
921238|NCT00860405|1902318|FG001|Overall Study|Main reason: Follow-up data not complete|4
921239|NCT00860470|1902330|FG000|Overall Study|Death|6
921240|NCT00860470|1902331|FG001|Overall Study|Death|10
921241|NCT00860470|1902330|FG000|Overall Study|Moved away|8
921242|NCT00860470|1902331|FG001|Overall Study|Moved away|10
921243|NCT00860470|1902330|FG000|Overall Study|Lost to Follow-up|34
921244|NCT00860470|1902331|FG001|Overall Study|Lost to Follow-up|39
921245|NCT00860574|1902341|FG000|Overall Study|Death|2
921246|NCT00860574|1902341|FG000|Overall Study|Relapse|1
921247|NCT00860743|1902351|FG000|Overall Study|Withdrawal by Subject|3
921248|NCT00860743|1902352|FG001|Overall Study|Withdrawal by Subject|0
921249|NCT00860951|1902385|FG000|Overall Study|Withdrawal by Subject|2
921250|NCT00860951|1902385|FG000|Overall Study|Lost to Follow-up|5
921251|NCT00861198|1902400|FG000|Overall Study|SpyGlass Failed|5
921252|NCT00861341|1902408|FG000|Overall Study|Withdrawal by Subject|2
921253|NCT00861380|1902419|FG000|Overall Study|Withdrawal Information not recorded|8427
921254|NCT00861380|1902420|FG001|Overall Study|Withdrawal Information not recorded|9112
921255|NCT00861380|1902421|FG002|Overall Study|Withdrawal Information not recorded|8872
921256|NCT00861380|1902422|FG003|Overall Study|Withdrawal Information not recorded|3689
921257|NCT00861380|1902423|FG004|Overall Study|Withdrawal Information not recorded|1812
921258|NCT00861380|1902424|FG005|Overall Study|Withdrawal Information not recorded|6249
921259|NCT00861380|1902425|FG006|Overall Study|Withdrawal Information not recorded|3020
921260|NCT00861471|1902458|FG000|Overall Study|Withdrawal by Subject|1
921261|NCT00861471|1902458|FG000|Overall Study|Adverse Event|2
921262|NCT00861471|1902458|FG000|Overall Study|Lack of Efficacy|3
921263|NCT00861471|1902458|FG000|Overall Study|treatment for lumbar laminectomy|1
921264|NCT00861471|1902458|FG000|Overall Study|Physician Decision|2
921265|NCT00861614|1902480|FG000|Overall Study|Disease Progression|182
921266|NCT00861614|1902481|FG001|Overall Study|Disease Progression|263
921267|NCT00861614|1902480|FG000|Overall Study|Study Drug Toxicity|79
921268|NCT00861614|1902481|FG001|Overall Study|Study Drug Toxicity|6
921269|NCT00861614|1902480|FG000|Overall Study|Death|32
921270|NCT00861614|1902481|FG001|Overall Study|Death|19
921271|NCT00861614|1902480|FG000|Overall Study|Adverse Event|27
921272|NCT00861614|1902481|FG001|Overall Study|Adverse Event|23
921273|NCT00861614|1902480|FG000|Overall Study|Withdrawal by Subject|34
921274|NCT00861614|1902481|FG001|Overall Study|Withdrawal by Subject|35
921275|NCT00861614|1902480|FG000|Overall Study|Other|17
921276|NCT00861614|1902481|FG001|Overall Study|Other|22
921277|NCT00861692|1902487|FG000|Overall Study|Death|6
921282|NCT00861744|1902520|FG000|Overall Study|Adverse Event|0
921283|NCT00861744|1902521|FG001|Overall Study|Adverse Event|0
921284|NCT00861744|1902522|FG002|Overall Study|Adverse Event|0
921285|NCT00861744|1902523|FG003|Overall Study|Adverse Event|1
921286|NCT00861744|1902520|FG000|Overall Study|Lost to Follow-up|7
921287|NCT00861744|1902521|FG001|Overall Study|Lost to Follow-up|19
921288|NCT00861744|1902522|FG002|Overall Study|Lost to Follow-up|17
921289|NCT00861744|1902523|FG003|Overall Study|Lost to Follow-up|12
921290|NCT00861744|1902520|FG000|Overall Study|Withdrawal by Subject|10
921291|NCT00861744|1902521|FG001|Overall Study|Withdrawal by Subject|6
921292|NCT00861744|1902522|FG002|Overall Study|Withdrawal by Subject|6
921293|NCT00861744|1902523|FG003|Overall Study|Withdrawal by Subject|19
921294|NCT00861744|1902520|FG000|Overall Study|Protocol Violation|0
921295|NCT00861744|1902521|FG001|Overall Study|Protocol Violation|1
921296|NCT00861744|1902522|FG002|Overall Study|Protocol Violation|0
921297|NCT00861744|1902523|FG003|Overall Study|Protocol Violation|0
921298|NCT00861744|1902520|FG000|Overall Study|Migration from study area|0
921299|NCT00861744|1902521|FG001|Overall Study|Migration from study area|3
921300|NCT00861744|1902522|FG002|Overall Study|Migration from study area|1
921301|NCT00861744|1902523|FG003|Overall Study|Migration from study area|0
921302|NCT00861744|1902520|FG000|Overall Study|Blood draws|0
921303|NCT00861744|1902521|FG001|Overall Study|Blood draws|0
921304|NCT00861744|1902522|FG002|Overall Study|Blood draws|0
921305|NCT00861744|1902523|FG003|Overall Study|Blood draws|1
921306|NCT00861757|1902537|FG000|Overall Study|Adverse Event|1
921307|NCT00861757|1902538|FG001|Overall Study|Adverse Event|5
921308|NCT00861757|1902539|FG002|Overall Study|Adverse Event|7
921309|NCT00861757|1902540|FG003|Overall Study|Adverse Event|2
921310|NCT00861757|1902537|FG000|Overall Study|Entry Criteria Not Met|1
921311|NCT00861757|1902538|FG001|Overall Study|Entry Criteria Not Met|2
921312|NCT00861757|1902539|FG002|Overall Study|Entry Criteria Not Met|1
921313|NCT00861757|1902540|FG003|Overall Study|Entry Criteria Not Met|1
921314|NCT00861757|1902537|FG000|Overall Study|Lack of Efficacy|3
921315|NCT00861757|1902538|FG001|Overall Study|Lack of Efficacy|1
921316|NCT00861757|1902539|FG002|Overall Study|Lack of Efficacy|0
921317|NCT00861757|1902540|FG003|Overall Study|Lack of Efficacy|1
921318|NCT00861757|1902537|FG000|Overall Study|Lost to Follow-up|1
921319|NCT00861757|1902538|FG001|Overall Study|Lost to Follow-up|0
921320|NCT00861757|1902539|FG002|Overall Study|Lost to Follow-up|1
921321|NCT00861757|1902540|FG003|Overall Study|Lost to Follow-up|1
921322|NCT00861757|1902537|FG000|Overall Study|Physician Decision|0
921323|NCT00861757|1902538|FG001|Overall Study|Physician Decision|0
921324|NCT00861757|1902539|FG002|Overall Study|Physician Decision|0
921325|NCT00861757|1902540|FG003|Overall Study|Physician Decision|1
921326|NCT00861757|1902537|FG000|Overall Study|Protocol Violation|2
921327|NCT00861757|1902538|FG001|Overall Study|Protocol Violation|2
921328|NCT00861757|1902539|FG002|Overall Study|Protocol Violation|4
921329|NCT00861757|1902540|FG003|Overall Study|Protocol Violation|1
921330|NCT00861757|1902537|FG000|Overall Study|Withdrawal by Subject|1
921331|NCT00861757|1902538|FG001|Overall Study|Withdrawal by Subject|5
921332|NCT00861757|1902539|FG002|Overall Study|Withdrawal by Subject|5
921333|NCT00861757|1902540|FG003|Overall Study|Withdrawal by Subject|2
921334|NCT00862082|1902560|FG000|Overall Study|Sponsor decision to terminate the study|5
921335|NCT00862082|1902561|FG001|Overall Study|Sponsor decision to terminate the study|0
921336|NCT00862082|1902560|FG000|Overall Study|Withdrawal by Subject|0
921337|NCT00862082|1902561|FG001|Overall Study|Withdrawal by Subject|1
921338|NCT00862121|1902576|FG000|Overall Study|Adverse Event|1
921339|NCT00862121|1902577|FG001|Overall Study|Adverse Event|2
921340|NCT00862121|1902576|FG000|Overall Study|Lack of Efficacy|0
921341|NCT00862121|1902577|FG001|Overall Study|Lack of Efficacy|3
921342|NCT00862121|1902576|FG000|Overall Study|Protocol Violation|0
921343|NCT00862121|1902577|FG001|Overall Study|Protocol Violation|1
921344|NCT00862121|1902576|FG000|Overall Study|Exclusion criterion violation|0
921345|NCT00862121|1902577|FG001|Overall Study|Exclusion criterion violation|1
921346|NCT00862121|1902576|FG000|Overall Study|Incorrect randomisation|0
921347|NCT00862121|1902577|FG001|Overall Study|Incorrect randomisation|1
921348|NCT00862134|1902585|FG000|Overall Study|Death|1
921349|NCT00862134|1902586|FG001|Overall Study|Death|0
921350|NCT00862134|1902585|FG000|Overall Study|Physician Decision|0
921351|NCT00862134|1902586|FG001|Overall Study|Physician Decision|1
921352|NCT00862134|1902585|FG000|Overall Study|Withdrawal by Subject|1
921353|NCT00862134|1902586|FG001|Overall Study|Withdrawal by Subject|2
921354|NCT00862134|1902585|FG000|Overall Study|Sponsor terminated study|5
921355|NCT00862134|1902586|FG001|Overall Study|Sponsor terminated study|7
921356|NCT00862134|1902585|FG000|Overall Study|Adverse Event|2
921357|NCT00862134|1902586|FG001|Overall Study|Adverse Event|2
921358|NCT00862134|1902585|FG000|Overall Study|Withdrew prior to dosing|2
921359|NCT00862134|1902586|FG001|Overall Study|Withdrew prior to dosing|0
921360|NCT00862251|1902600|FG000|Overall Study|Adverse Event|8
921361|NCT00862251|1902601|FG001|Overall Study|Adverse Event|3
921362|NCT00862251|1902602|FG002|Overall Study|Adverse Event|1
921363|NCT00862251|1902600|FG000|Overall Study|Lost to Follow-up|0
921364|NCT00862251|1902601|FG001|Overall Study|Lost to Follow-up|0
921365|NCT00862251|1902602|FG002|Overall Study|Lost to Follow-up|1
921366|NCT00862251|1902600|FG000|Overall Study|Protocol Violation|2
921367|NCT00862251|1902601|FG001|Overall Study|Protocol Violation|0
921368|NCT00862251|1902602|FG002|Overall Study|Protocol Violation|1
921369|NCT00862251|1902600|FG000|Overall Study|Withdrawal by Subject|9
921370|NCT00862251|1902601|FG001|Overall Study|Withdrawal by Subject|2
921371|NCT00862251|1902602|FG002|Overall Study|Withdrawal by Subject|6
921372|NCT00862277|1902616|FG000|Overall Study|Protocol Violation|1
921373|NCT00862277|1902617|FG001|Overall Study|Protocol Violation|2
921374|NCT00862277|1902618|FG002|Overall Study|Protocol Violation|5
921375|NCT00862459|1902633|FG000|Overall Study|Lost to Follow-up|1
921376|NCT00862459|1902634|FG001|Overall Study|Lost to Follow-up|2
921377|NCT00862459|1902635|FG002|Overall Study|Lost to Follow-up|2
921378|NCT00862459|1902633|FG000|Overall Study|Protocol Violation|1
921379|NCT00862459|1902634|FG001|Overall Study|Protocol Violation|0
921380|NCT00862459|1902635|FG002|Overall Study|Protocol Violation|0
921381|NCT00862459|1902633|FG000|Overall Study|Withdrawal by Subject|1
921382|NCT00862459|1902634|FG001|Overall Study|Withdrawal by Subject|1
921383|NCT00862459|1902635|FG002|Overall Study|Withdrawal by Subject|3
921384|NCT00862459|1902633|FG000|Overall Study|Adverse Event|0
921385|NCT00862459|1902634|FG001|Overall Study|Adverse Event|1
921386|NCT00862459|1902635|FG002|Overall Study|Adverse Event|0
921387|NCT00862459|1902633|FG000|Overall Study|Personal reasons|1
921388|NCT00862459|1902634|FG001|Overall Study|Personal reasons|0
921389|NCT00862459|1902635|FG002|Overall Study|Personal reasons|0
921390|NCT00862459|1902633|FG000|Overall Study|Operation|1
921391|NCT00862459|1902634|FG001|Overall Study|Operation|1
921392|NCT00862459|1902635|FG002|Overall Study|Operation|0
921393|NCT00862459|1902633|FG000|Overall Study|Intravenous (IV) site problems|1
921394|NCT00862459|1902634|FG001|Overall Study|Intravenous (IV) site problems|0
921395|NCT00862459|1902635|FG002|Overall Study|Intravenous (IV) site problems|1
921396|NCT00862459|1902633|FG000|Overall Study|Unable to hold still for imaging|0
921397|NCT00862459|1902634|FG001|Overall Study|Unable to hold still for imaging|1
921398|NCT00862459|1902635|FG002|Overall Study|Unable to hold still for imaging|0
921399|NCT00862459|1902633|FG000|Overall Study|Inclusion/exclusion criteria not met|0
921400|NCT00862459|1902634|FG001|Overall Study|Inclusion/exclusion criteria not met|1
921401|NCT00862459|1902635|FG002|Overall Study|Inclusion/exclusion criteria not met|0
921402|NCT00862459|1902633|FG000|Overall Study|Administrative problems|0
921403|NCT00862459|1902634|FG001|Overall Study|Administrative problems|1
921404|NCT00862459|1902635|FG002|Overall Study|Administrative problems|0
921405|NCT00862641|1902678|FG000|Overall Study|Randomized, but drug not received|1
921406|NCT00862641|1902679|FG001|Overall Study|Randomized, but drug not received|4
921407|NCT00862641|1902680|FG002|Overall Study|Randomized, but drug not received|1
921408|NCT00862641|1902681|FG003|Overall Study|Randomized, but drug not received|4
921409|NCT00862654|1902695|FG000|Overall Study|Lack of Efficacy|1
921410|NCT00862654|1902696|FG001|Overall Study|Lack of Efficacy|0
921411|NCT00862654|1902697|FG002|Overall Study|Lack of Efficacy|1
921412|NCT00862654|1902698|FG003|Overall Study|Lack of Efficacy|0
921413|NCT00862654|1902695|FG000|Overall Study|Lost to Follow-up|1
921414|NCT00862654|1902696|FG001|Overall Study|Lost to Follow-up|2
921415|NCT00862654|1902697|FG002|Overall Study|Lost to Follow-up|1
921416|NCT00862654|1902698|FG003|Overall Study|Lost to Follow-up|3
921417|NCT00862654|1902695|FG000|Overall Study|Adverse Event|0
921418|NCT00862654|1902696|FG001|Overall Study|Adverse Event|1
921419|NCT00862654|1902697|FG002|Overall Study|Adverse Event|1
921420|NCT00862654|1902698|FG003|Overall Study|Adverse Event|0
921421|NCT00862654|1902695|FG000|Overall Study|Pregnancy|1
921422|NCT00862654|1902696|FG001|Overall Study|Pregnancy|1
921423|NCT00862654|1902697|FG002|Overall Study|Pregnancy|0
921424|NCT00862654|1902698|FG003|Overall Study|Pregnancy|0
921425|NCT00862654|1902695|FG000|Overall Study|Withdrawal by Subject|2
921426|NCT00862654|1902696|FG001|Overall Study|Withdrawal by Subject|2
921427|NCT00862654|1902697|FG002|Overall Study|Withdrawal by Subject|2
921428|NCT00862654|1902698|FG003|Overall Study|Withdrawal by Subject|3
921429|NCT00862654|1902695|FG000|Overall Study|Subject mistake|0
921430|NCT00862654|1902696|FG001|Overall Study|Subject mistake|1
921431|NCT00862654|1902697|FG002|Overall Study|Subject mistake|0
921432|NCT00862654|1902698|FG003|Overall Study|Subject mistake|0
921433|NCT00862654|1902695|FG000|Overall Study|Familly constraint|0
921434|NCT00862654|1902696|FG001|Overall Study|Familly constraint|1
921435|NCT00862654|1902697|FG002|Overall Study|Familly constraint|0
921436|NCT00862654|1902698|FG003|Overall Study|Familly constraint|0
921437|NCT00862654|1902695|FG000|Overall Study|Never used study drugs|1
921438|NCT00862654|1902696|FG001|Overall Study|Never used study drugs|0
921439|NCT00862654|1902697|FG002|Overall Study|Never used study drugs|0
921440|NCT00862654|1902698|FG003|Overall Study|Never used study drugs|0
921441|NCT00862654|1902695|FG000|Overall Study|Included after end of inclusions|0
921442|NCT00862654|1902696|FG001|Overall Study|Included after end of inclusions|0
921443|NCT00862654|1902697|FG002|Overall Study|Included after end of inclusions|1
921444|NCT00862654|1902698|FG003|Overall Study|Included after end of inclusions|0
921445|NCT00862719|1902712|FG000|Overall Study|Disease Progression|5
921446|NCT00862719|1902713|FG001|Overall Study|Disease Progression|0
921447|NCT00862719|1902714|FG002|Overall Study|Disease Progression|1
921448|NCT00862719|1902715|FG003|Overall Study|Disease Progression|0
921449|NCT00862719|1902712|FG000|Overall Study|Death|5
921450|NCT00862719|1902713|FG001|Overall Study|Death|6
921451|NCT00862719|1902714|FG002|Overall Study|Death|1
921452|NCT00862719|1902715|FG003|Overall Study|Death|1
921453|NCT00862719|1902712|FG000|Overall Study|Engraftment failure|0
921454|NCT00862719|1902713|FG001|Overall Study|Engraftment failure|0
921455|NCT00862719|1902714|FG002|Overall Study|Engraftment failure|1
921456|NCT00862719|1902715|FG003|Overall Study|Engraftment failure|0
921457|NCT00862719|1902712|FG000|Overall Study|Veno-Occlusive Disease|0
921458|NCT00862719|1902713|FG001|Overall Study|Veno-Occlusive Disease|0
921459|NCT00862719|1902714|FG002|Overall Study|Veno-Occlusive Disease|1
921460|NCT00862719|1902715|FG003|Overall Study|Veno-Occlusive Disease|0
921461|NCT00862823|1902747|FG000|First Intervention|Withdrawal by Subject|1
921462|NCT00862823|1902748|FG001|First Intervention|Withdrawal by Subject|1
921463|NCT00862836|1902753|FG000|Overall Study|Withdrawal by Subject|1
921464|NCT00862849|1902757|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
921465|NCT00862849|1902758|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
921466|NCT00862849|1902759|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
921467|NCT00862849|1902760|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
921468|NCT00862849|1902761|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
921469|NCT00862849|1902762|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
921470|NCT00862849|1902757|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0
921471|NCT00862849|1902758|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1
921472|NCT00862849|1902759|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0
921473|NCT00862849|1902760|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0
921474|NCT00862849|1902761|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0
921475|NCT00862849|1902762|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0
921476|NCT00862940|1902772|FG000|Overall Study|Adverse Event|15
921477|NCT00862940|1902773|FG001|Overall Study|Adverse Event|12
921478|NCT00862940|1902772|FG000|Overall Study|Lack of Efficacy|1
921479|NCT00862940|1902773|FG001|Overall Study|Lack of Efficacy|3
921480|NCT00862940|1902772|FG000|Overall Study|Protocol Violation|2
921481|NCT00862940|1902773|FG001|Overall Study|Protocol Violation|5
921482|NCT00862940|1902772|FG000|Overall Study|Withdrawal by Subject|4
921483|NCT00862940|1902773|FG001|Overall Study|Withdrawal by Subject|6
921484|NCT00862940|1902772|FG000|Overall Study|Non-compliance|4
921485|NCT00862940|1902773|FG001|Overall Study|Non-compliance|0
921486|NCT00862940|1902772|FG000|Overall Study|Lost to Follow-up|0
921487|NCT00862940|1902773|FG001|Overall Study|Lost to Follow-up|1
921488|NCT00862940|1902772|FG000|Overall Study|Administrative or other reason(s)|4
921489|NCT00862940|1902773|FG001|Overall Study|Administrative or other reason(s)|3
921490|NCT00862979|1902781|FG000|Overall Study|Adverse Event|6
921491|NCT00862979|1902782|FG001|Overall Study|Adverse Event|3
921492|NCT00862979|1902781|FG000|Overall Study|Protocol Violation|0
921493|NCT00862979|1902782|FG001|Overall Study|Protocol Violation|1
921494|NCT00862979|1902781|FG000|Overall Study|Patient withdrew consent|2
921495|NCT00862979|1902782|FG001|Overall Study|Patient withdrew consent|1
921496|NCT00862979|1902781|FG000|Overall Study|Administrative problems|0
921497|NCT00862979|1902782|FG001|Overall Study|Administrative problems|1
921498|NCT00862979|1902781|FG000|Overall Study|Death|0
921499|NCT00862979|1902782|FG001|Overall Study|Death|1
921500|NCT00862992|1902791|FG000|Overall Study|Adverse Event|2
921501|NCT00862992|1902792|FG001|Overall Study|Adverse Event|1
921502|NCT00862992|1902793|FG002|Overall Study|Adverse Event|1
921503|NCT00862992|1902791|FG000|Overall Study|Physician Decision|1
921504|NCT00862992|1902792|FG001|Overall Study|Physician Decision|0
921505|NCT00862992|1902793|FG002|Overall Study|Physician Decision|0
921506|NCT00862992|1902791|FG000|Overall Study|Withdrawal by Subject|0
921507|NCT00862992|1902792|FG001|Overall Study|Withdrawal by Subject|0
921508|NCT00862992|1902793|FG002|Overall Study|Withdrawal by Subject|2
921509|NCT00863057|1902805|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
921510|NCT00863057|1902806|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
921511|NCT00863057|1902807|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
921512|NCT00863057|1902808|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
921513|NCT00863057|1902805|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
921514|NCT00863057|1902806|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
921515|NCT00863057|1902807|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
921516|NCT00863057|1902808|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
921517|NCT00863057|1902805|FG000|Period 2 (Weeks 6-10)|Adverse Event|0
921518|NCT00863057|1902806|FG001|Period 2 (Weeks 6-10)|Adverse Event|1
921519|NCT00863057|1902807|FG002|Period 2 (Weeks 6-10)|Adverse Event|1
921520|NCT00863057|1902808|FG003|Period 2 (Weeks 6-10)|Adverse Event|0
921521|NCT00863057|1902805|FG000|Period 2 (Weeks 6-10)|Physician Decision|0
921522|NCT00863057|1902806|FG001|Period 2 (Weeks 6-10)|Physician Decision|0
921523|NCT00863057|1902807|FG002|Period 2 (Weeks 6-10)|Physician Decision|0
921524|NCT00863057|1902808|FG003|Period 2 (Weeks 6-10)|Physician Decision|1
921525|NCT00863304|1902866|FG000|Overall Study|Adverse Event|10
921526|NCT00863304|1902867|FG001|Overall Study|Adverse Event|4
921527|NCT00863304|1902868|FG002|Overall Study|Adverse Event|14
921528|NCT00863304|1902869|FG003|Overall Study|Adverse Event|16
921529|NCT00863304|1902866|FG000|Overall Study|Lost to Follow-up|1
921530|NCT00863304|1902867|FG001|Overall Study|Lost to Follow-up|5
921531|NCT00863304|1902868|FG002|Overall Study|Lost to Follow-up|4
921532|NCT00863304|1902869|FG003|Overall Study|Lost to Follow-up|2
921533|NCT00863304|1902866|FG000|Overall Study|Lack of Efficacy|57
921534|NCT00863304|1902867|FG001|Overall Study|Lack of Efficacy|26
921535|NCT00863304|1902868|FG002|Overall Study|Lack of Efficacy|30
921536|NCT00863304|1902869|FG003|Overall Study|Lack of Efficacy|28
921537|NCT00863304|1902866|FG000|Overall Study|Withdrawal by Subject|19
921538|NCT00863304|1902867|FG001|Overall Study|Withdrawal by Subject|14
921539|NCT00863304|1902868|FG002|Overall Study|Withdrawal by Subject|20
921540|NCT00863304|1902869|FG003|Overall Study|Withdrawal by Subject|18
921541|NCT00863304|1902866|FG000|Overall Study|Other|1
921542|NCT00863304|1902867|FG001|Overall Study|Other|0
921543|NCT00863304|1902868|FG002|Overall Study|Other|0
921544|NCT00863304|1902869|FG003|Overall Study|Other|1
921545|NCT00863304|1902866|FG000|Overall Study|Protocol Violation|2
921546|NCT00863304|1902867|FG001|Overall Study|Protocol Violation|6
921547|NCT00863304|1902868|FG002|Overall Study|Protocol Violation|2
921548|NCT00863304|1902869|FG003|Overall Study|Protocol Violation|0
921549|NCT00863304|1902866|FG000|Overall Study|Randomized, but not Treated|3
921550|NCT00863304|1902867|FG001|Overall Study|Randomized, but not Treated|1
921551|NCT00863304|1902868|FG002|Overall Study|Randomized, but not Treated|4
921552|NCT00863304|1902869|FG003|Overall Study|Randomized, but not Treated|1
921553|NCT00863304|1902866|FG000|Overall Study|Entered extension study|101
921554|NCT00863304|1902867|FG001|Overall Study|Entered extension study|129
921555|NCT00863304|1902868|FG002|Overall Study|Entered extension study|113
921556|NCT00863304|1902869|FG003|Overall Study|Entered extension study|125
921557|NCT00863317|1902883|FG000|Overall Study|Lost to Follow-up|8
921558|NCT00863317|1902884|FG001|Overall Study|Lost to Follow-up|9
921559|NCT00863655|1902915|FG000|Overall Study|Protocol Violation|4
921560|NCT00863655|1902916|FG001|Overall Study|Protocol Violation|0
921561|NCT00863655|1902915|FG000|Overall Study|Adverse Event|52
921562|NCT00863655|1902916|FG001|Overall Study|Adverse Event|8
921563|NCT00863655|1902915|FG000|Overall Study|Withdrawal by Subject|47
921564|NCT00863655|1902916|FG001|Overall Study|Withdrawal by Subject|7
921565|NCT00863655|1902915|FG000|Overall Study|Administrative problems|1
921566|NCT00863655|1902916|FG001|Overall Study|Administrative problems|0
921567|NCT00863655|1902915|FG000|Overall Study|Death|7
921568|NCT00863655|1902916|FG001|Overall Study|Death|1
921569|NCT00863655|1902915|FG000|Overall Study|New cancer therapy|5
921570|NCT00863655|1902916|FG001|Overall Study|New cancer therapy|1
921571|NCT00863655|1902915|FG000|Overall Study|Disease progression|364
921572|NCT00863655|1902916|FG001|Overall Study|Disease progression|221
921573|NCT00863655|1902915|FG000|Overall Study|Treatment completed as per protocol|5
921574|NCT00863655|1902916|FG001|Overall Study|Treatment completed as per protocol|1
921575|NCT00863681|1902925|FG000|Overall Study|Other|2
921576|NCT00863681|1902926|FG001|Overall Study|Other|0
921577|NCT00863681|1902927|FG002|Overall Study|Other|0
921578|NCT00863681|1902925|FG000|Overall Study|Missing|1
921579|NCT00863681|1902926|FG001|Overall Study|Missing|0
921580|NCT00863681|1902927|FG002|Overall Study|Missing|0
921581|NCT00863681|1902925|FG000|Overall Study|Death|40
921582|NCT00863681|1902926|FG001|Overall Study|Death|23
921583|NCT00863681|1902927|FG002|Overall Study|Death|6
921584|NCT00863681|1902925|FG000|Overall Study|Withdrawal by Subject|12
921585|NCT00863681|1902926|FG001|Overall Study|Withdrawal by Subject|5
921586|NCT00863681|1902927|FG002|Overall Study|Withdrawal by Subject|2
921587|NCT00863681|1902925|FG000|Overall Study|Protocol Violation|2
921588|NCT00863681|1902926|FG001|Overall Study|Protocol Violation|0
921589|NCT00863681|1902927|FG002|Overall Study|Protocol Violation|0
921590|NCT00863681|1902925|FG000|Overall Study|Lost to Follow-up|3
921591|NCT00863681|1902926|FG001|Overall Study|Lost to Follow-up|0
921592|NCT00863681|1902927|FG002|Overall Study|Lost to Follow-up|3
921593|NCT00863681|1902925|FG000|Overall Study|Adverse Event|28
921594|NCT00863681|1902926|FG001|Overall Study|Adverse Event|10
921595|NCT00863681|1902927|FG002|Overall Study|Adverse Event|6
921596|NCT00863681|1902925|FG000|Overall Study|Lack of Efficacy|2
921597|NCT00863681|1902926|FG001|Overall Study|Lack of Efficacy|2
921598|NCT00863681|1902927|FG002|Overall Study|Lack of Efficacy|1
921599|NCT00863681|1902925|FG000|Overall Study|Non-compliance with study drug|1
921600|NCT00863681|1902926|FG001|Overall Study|Non-compliance with study drug|3
921601|NCT00863681|1902927|FG002|Overall Study|Non-compliance with study drug|0
921602|NCT00863707|1902937|FG000|Overall Study|Randomized, but drug not received|4
921603|NCT00863707|1902938|FG001|Overall Study|Randomized, but drug not received|3
921604|NCT00863746|1902946|FG000|Treatment|Not treated|4
921605|NCT00863746|1902947|FG001|Treatment|Not treated|2
921606|NCT00863746|1902946|FG000|Treatment|Adverse Event|41
921607|NCT00863746|1902947|FG001|Treatment|Adverse Event|16
921608|NCT00863746|1902946|FG000|Treatment|non-compliant with study medication|4
921609|NCT00863746|1902947|FG001|Treatment|non-compliant with study medication|0
921610|NCT00863746|1902946|FG000|Treatment|Consent withdrawn|15
921611|NCT00863746|1902947|FG001|Treatment|Consent withdrawn|14
921612|NCT00863746|1902946|FG000|Treatment|Lost to Follow-up|1
921613|NCT00863746|1902947|FG001|Treatment|Lost to Follow-up|0
921614|NCT00863746|1902946|FG000|Treatment|Protocol Violation|5
921615|NCT00863746|1902947|FG001|Treatment|Protocol Violation|3
921616|NCT00863746|1902946|FG000|Treatment|Other|1
921617|NCT00863746|1902947|FG001|Treatment|Other|0
921618|NCT00863746|1902946|FG000|Survival Follow up|Death|244
921619|NCT00863746|1902947|FG001|Survival Follow up|Death|271
921620|NCT00863746|1902946|FG000|Survival Follow up|Lost to Follow-up|2
921621|NCT00863746|1902947|FG001|Survival Follow up|Lost to Follow-up|1
921622|NCT00863746|1902946|FG000|Survival Follow up|Consent Withdrawn|7
921623|NCT00863746|1902947|FG001|Survival Follow up|Consent Withdrawn|8
921624|NCT00863772|1902956|FG000|Overall Study|Adverse Event|1
921625|NCT00863772|1902957|FG001|Overall Study|Adverse Event|4
921626|NCT00863772|1902958|FG002|Overall Study|Adverse Event|0
921627|NCT00863772|1902956|FG000|Overall Study|Lack of Efficacy|4
921628|NCT00863772|1902957|FG001|Overall Study|Lack of Efficacy|2
921629|NCT00863772|1902958|FG002|Overall Study|Lack of Efficacy|4
921630|NCT00863772|1902956|FG000|Overall Study|Lost to Follow-up|5
921631|NCT00863772|1902957|FG001|Overall Study|Lost to Follow-up|1
921632|NCT00863772|1902958|FG002|Overall Study|Lost to Follow-up|1
921633|NCT00863772|1902956|FG000|Overall Study|Protocol Violation|2
921634|NCT00863772|1902957|FG001|Overall Study|Protocol Violation|0
921635|NCT00863772|1902958|FG002|Overall Study|Protocol Violation|2
921636|NCT00863772|1902956|FG000|Overall Study|Withdrawal by Subject|4
921637|NCT00863772|1902957|FG001|Overall Study|Withdrawal by Subject|7
921638|NCT00863772|1902958|FG002|Overall Study|Withdrawal by Subject|5
921639|NCT00863772|1902956|FG000|Overall Study|Study terminated by sponsor|44
921640|NCT00863772|1902957|FG001|Overall Study|Study terminated by sponsor|45
921641|NCT00863772|1902958|FG002|Overall Study|Study terminated by sponsor|36
921642|NCT00863772|1902956|FG000|Overall Study|Entered extension study|6
921643|NCT00863772|1902957|FG001|Overall Study|Entered extension study|4
921644|NCT00863772|1902958|FG002|Overall Study|Entered extension study|9
921645|NCT00863772|1902956|FG000|Overall Study|Other|1
921646|NCT00863772|1902957|FG001|Overall Study|Other|2
921647|NCT00863772|1902958|FG002|Overall Study|Other|4
921648|NCT00863772|1902956|FG000|Overall Study|Randomized but not Treated|1
921649|NCT00863772|1902957|FG001|Overall Study|Randomized but not Treated|0
921650|NCT00863772|1902958|FG002|Overall Study|Randomized but not Treated|0
921651|NCT00863798|1902969|FG000|Overall Study|Adverse Event|5
921652|NCT00863798|1902970|FG001|Overall Study|Adverse Event|2
921653|NCT00863798|1902971|FG002|Overall Study|Adverse Event|4
921654|NCT00863798|1902969|FG000|Overall Study|Participant failed to return|2
921655|NCT00863798|1902970|FG001|Overall Study|Participant failed to return|1
921656|NCT00863798|1902971|FG002|Overall Study|Participant failed to return|0
921657|NCT00863798|1902969|FG000|Overall Study|Investigator request|1
921658|NCT00863798|1902970|FG001|Overall Study|Investigator request|2
921659|NCT00863798|1902971|FG002|Overall Study|Investigator request|1
921660|NCT00863798|1902969|FG000|Overall Study|Lack of Efficacy|4
921661|NCT00863798|1902970|FG001|Overall Study|Lack of Efficacy|3
921662|NCT00863798|1902971|FG002|Overall Study|Lack of Efficacy|6
921663|NCT00863798|1902969|FG000|Overall Study|Lost to Follow-up|6
921664|NCT00863798|1902970|FG001|Overall Study|Lost to Follow-up|9
921665|NCT00863798|1902971|FG002|Overall Study|Lost to Follow-up|5
921666|NCT00863798|1902969|FG000|Overall Study|Other|2
921667|NCT00863798|1902970|FG001|Overall Study|Other|3
921668|NCT00863798|1902971|FG002|Overall Study|Other|1
921669|NCT00863798|1902969|FG000|Overall Study|Protocol Violation|0
921670|NCT00863798|1902970|FG001|Overall Study|Protocol Violation|1
921671|NCT00863798|1902971|FG002|Overall Study|Protocol Violation|1
921672|NCT00863798|1902969|FG000|Overall Study|Withdrawal by Subject|8
921673|NCT00863798|1902970|FG001|Overall Study|Withdrawal by Subject|7
921674|NCT00863798|1902971|FG002|Overall Study|Withdrawal by Subject|4
921675|NCT00863798|1902969|FG000|Overall Study|Randomized not treated|4
921676|NCT00863798|1902970|FG001|Overall Study|Randomized not treated|2
921677|NCT00863798|1902971|FG002|Overall Study|Randomized not treated|3
921678|NCT00863928|1902981|FG000|Overall Study|Protocol Violation|26
921679|NCT00863928|1902982|FG001|Overall Study|Protocol Violation|0
921680|NCT00863928|1902981|FG000|Overall Study|Withdrawal by Subject|3
921681|NCT00863928|1902982|FG001|Overall Study|Withdrawal by Subject|0
921682|NCT00863928|1902981|FG000|Overall Study|surgery cancellation|4
921683|NCT00863928|1902982|FG001|Overall Study|surgery cancellation|0
921684|NCT00863928|1902981|FG000|Overall Study|medication allergy|3
921685|NCT00863928|1902982|FG001|Overall Study|medication allergy|0
921686|NCT00864097|1903009|FG000|Overall Study|Death|0
921687|NCT00864097|1903010|FG001|Overall Study|Death|1
921688|NCT00864097|1903011|FG002|Overall Study|Death|0
921689|NCT00864097|1903012|FG003|Overall Study|Death|0
921690|NCT00864097|1903009|FG000|Overall Study|Adverse Event|6
921691|NCT00864097|1903010|FG001|Overall Study|Adverse Event|8
921692|NCT00864097|1903011|FG002|Overall Study|Adverse Event|11
921693|NCT00864097|1903012|FG003|Overall Study|Adverse Event|9
921694|NCT00864097|1903009|FG000|Overall Study|Lack of Efficacy|9
921695|NCT00864097|1903010|FG001|Overall Study|Lack of Efficacy|3
921696|NCT00864097|1903011|FG002|Overall Study|Lack of Efficacy|7
921697|NCT00864097|1903012|FG003|Overall Study|Lack of Efficacy|2
921698|NCT00864097|1903009|FG000|Overall Study|Lost to Follow-up|0
921699|NCT00864097|1903010|FG001|Overall Study|Lost to Follow-up|1
921700|NCT00864097|1903011|FG002|Overall Study|Lost to Follow-up|0
921701|NCT00864097|1903012|FG003|Overall Study|Lost to Follow-up|1
921702|NCT00864097|1903009|FG000|Overall Study|Withdrawal by Subject|15
921703|NCT00864097|1903010|FG001|Overall Study|Withdrawal by Subject|11
921704|NCT00864097|1903011|FG002|Overall Study|Withdrawal by Subject|11
921705|NCT00864097|1903012|FG003|Overall Study|Withdrawal by Subject|12
921706|NCT00864097|1903009|FG000|Overall Study|Protocol Violation|2
921707|NCT00864097|1903010|FG001|Overall Study|Protocol Violation|1
921708|NCT00864097|1903011|FG002|Overall Study|Protocol Violation|0
921709|NCT00864097|1903012|FG003|Overall Study|Protocol Violation|1
921710|NCT00864097|1903009|FG000|Overall Study|Terminated by sponsor|105
921711|NCT00864097|1903010|FG001|Overall Study|Terminated by sponsor|112
921712|NCT00864097|1903011|FG002|Overall Study|Terminated by sponsor|102
921713|NCT00864097|1903012|FG003|Overall Study|Terminated by sponsor|99
921714|NCT00864097|1903009|FG000|Overall Study|Randomized but not treated|2
921715|NCT00864097|1903010|FG001|Overall Study|Randomized but not treated|0
921716|NCT00864097|1903011|FG002|Overall Study|Randomized but not treated|1
921717|NCT00864097|1903012|FG003|Overall Study|Randomized but not treated|0
921718|NCT00864097|1903009|FG000|Overall Study|Other|0
921719|NCT00864097|1903010|FG001|Overall Study|Other|0
921720|NCT00864097|1903011|FG002|Overall Study|Other|0
921721|NCT00864097|1903012|FG003|Overall Study|Other|1
921722|NCT00864253|1903033|FG000|Overall Study|Adverse Event|56
921723|NCT00864253|1903034|FG001|Overall Study|Adverse Event|11
921724|NCT00864253|1903033|FG000|Overall Study|Unrelated Adverse Event|3
921725|NCT00864253|1903034|FG001|Overall Study|Unrelated Adverse Event|1
921726|NCT00864253|1903033|FG000|Overall Study|Physician Decision|11
921727|NCT00864253|1903034|FG001|Overall Study|Physician Decision|15
921728|NCT00864253|1903033|FG000|Overall Study|Protocol Violation|0
921729|NCT00864253|1903034|FG001|Overall Study|Protocol Violation|2
921730|NCT00864253|1903033|FG000|Overall Study|Lost to Follow-up|1
921731|NCT00864253|1903034|FG001|Overall Study|Lost to Follow-up|1
921732|NCT00864253|1903033|FG000|Overall Study|Withdrawal by Subject|18
921733|NCT00864253|1903034|FG001|Overall Study|Withdrawal by Subject|18
921734|NCT00864253|1903033|FG000|Overall Study|Death|1
921735|NCT00864253|1903034|FG001|Overall Study|Death|0
921736|NCT00864253|1903033|FG000|Overall Study|Ongoing|2
921737|NCT00864253|1903034|FG001|Overall Study|Ongoing|3
921738|NCT00864253|1903033|FG000|Overall Study|Untreated|7
921739|NCT00864253|1903034|FG001|Overall Study|Untreated|7
921740|NCT00864513|1903059|FG000|Overall Study|Withdrawal by Subject|3
921741|NCT00864682|1903091|FG000|Overall Study|Protocol Violation|2
921742|NCT00864682|1903092|FG001|Overall Study|Protocol Violation|1
921743|NCT00864682|1903093|FG002|Overall Study|Protocol Violation|2
921744|NCT00864721|1903107|FG000|Overall Study|Patient request|11
921745|NCT00864721|1903107|FG000|Overall Study|Hospitalized|1
921746|NCT00864721|1903107|FG000|Overall Study|Drug hold/delay more than 4 weeks|1
921747|NCT00864721|1903107|FG000|Overall Study|Adverse Event|21
921748|NCT00864851|1903114|FG000|Overall Study|Withdrawal by Subject|0
921749|NCT00864851|1903115|FG001|Overall Study|Withdrawal by Subject|1
921750|NCT00864851|1903116|FG002|Overall Study|Withdrawal by Subject|0
921751|NCT00864851|1903114|FG000|Overall Study|Physician Decision|1
921752|NCT00864851|1903115|FG001|Overall Study|Physician Decision|0
921753|NCT00864851|1903116|FG002|Overall Study|Physician Decision|0
921754|NCT00864851|1903114|FG000|Overall Study|Death|1
921755|NCT00864851|1903115|FG001|Overall Study|Death|0
921756|NCT00864851|1903116|FG002|Overall Study|Death|0
921757|NCT00864851|1903114|FG000|Overall Study|Patient uncooperative|1
921758|NCT00864851|1903115|FG001|Overall Study|Patient uncooperative|0
921759|NCT00864851|1903116|FG002|Overall Study|Patient uncooperative|0
921760|NCT00864916|1903128|FG000|Overall Study|Lost to Follow-up|4
921761|NCT00864916|1903129|FG001|Overall Study|Lost to Follow-up|4
921762|NCT00864916|1903128|FG000|Overall Study|Protocol Violation|1
921763|NCT00864916|1903129|FG001|Overall Study|Protocol Violation|0
921764|NCT00864916|1903128|FG000|Overall Study|Withdrawal by Subject|1
921765|NCT00864916|1903129|FG001|Overall Study|Withdrawal by Subject|0
921766|NCT00865020|1903137|FG000|Overall Study|Withdrawal by Subject|22
921767|NCT00865020|1903138|FG001|Overall Study|Withdrawal by Subject|16
921768|NCT00865020|1903137|FG000|Overall Study|Adverse Event|9
921769|NCT00865020|1903138|FG001|Overall Study|Adverse Event|14
921770|NCT00865020|1903137|FG000|Overall Study|Abnormal test procedure result(s)|6
921771|NCT00865020|1903138|FG001|Overall Study|Abnormal test procedure result(s)|8
921772|NCT00865020|1903137|FG000|Overall Study|Lost to Follow-up|6
921773|NCT00865020|1903138|FG001|Overall Study|Lost to Follow-up|4
921774|NCT00865020|1903137|FG000|Overall Study|Protocol deviation|4
921775|NCT00865020|1903138|FG001|Overall Study|Protocol deviation|1
921776|NCT00865020|1903137|FG000|Overall Study|Administrative problems|0
921777|NCT00865020|1903138|FG001|Overall Study|Administrative problems|2
921778|NCT00865020|1903137|FG000|Overall Study|Abnormal laboratory value(s)|0
921779|NCT00865020|1903138|FG001|Overall Study|Abnormal laboratory value(s)|1
921780|NCT00865020|1903137|FG000|Overall Study|Death|0
921781|NCT00865020|1903138|FG001|Overall Study|Death|1
921782|NCT00865020|1903137|FG000|Overall Study|Randomized but discontinued|2
921783|NCT00865020|1903138|FG001|Overall Study|Randomized but discontinued|4
921784|NCT00865046|1903147|FG000|Overall Study|Lost to Follow-up|1
921785|NCT00865046|1903148|FG001|Overall Study|Lost to Follow-up|4
921786|NCT00865046|1903149|FG002|Overall Study|Lost to Follow-up|0
921787|NCT00865046|1903147|FG000|Overall Study|Death|0
921788|NCT00865046|1903148|FG001|Overall Study|Death|1
921789|NCT00865046|1903149|FG002|Overall Study|Death|1
921790|NCT00865046|1903147|FG000|Overall Study|Withdrawal by Subject|5
921791|NCT00865046|1903148|FG001|Overall Study|Withdrawal by Subject|0
921792|NCT00865046|1903149|FG002|Overall Study|Withdrawal by Subject|0
921793|NCT00865098|1903157|FG000|Overall Study|Progressive disease|1
921794|NCT00865124|1903164|FG000|Overall Study|Physician Decision|2
921795|NCT00865124|1903165|FG001|Overall Study|Physician Decision|1
921796|NCT00865124|1903166|FG002|Overall Study|Physician Decision|0
921797|NCT00865124|1903164|FG000|Overall Study|Withdrawn consent|2
921798|NCT00865124|1903165|FG001|Overall Study|Withdrawn consent|0
921799|NCT00865124|1903166|FG002|Overall Study|Withdrawn consent|0
921800|NCT00865189|1903176|FG000|Overall Study|Other|1
921801|NCT00865189|1903177|FG001|Overall Study|Other|2
921802|NCT00865189|1903176|FG000|Overall Study|Death|4
921803|NCT00865189|1903177|FG001|Overall Study|Death|11
921804|NCT00865189|1903176|FG000|Overall Study|Lost to Follow-up|6
921805|NCT00865189|1903177|FG001|Overall Study|Lost to Follow-up|6
921806|NCT00865189|1903176|FG000|Overall Study|Withdrawal by Subject|1
921807|NCT00865189|1903177|FG001|Overall Study|Withdrawal by Subject|0
921808|NCT00865280|1903195|FG000|Overall Study|Withdrawal by Subject|4
921809|NCT00865280|1903196|FG001|Overall Study|Withdrawal by Subject|1
921810|NCT00865280|1903195|FG000|Overall Study|End of Treatment/Lost to Follow-up|0
921811|NCT00865280|1903196|FG001|Overall Study|End of Treatment/Lost to Follow-up|1
921812|NCT00865280|1903195|FG000|Overall Study|Adverse Event/Lost to Follow-up|1
921813|NCT00865280|1903196|FG001|Overall Study|Adverse Event/Lost to Follow-up|0
921814|NCT00865280|1903195|FG000|Overall Study|Exclusion Condition|1
921815|NCT00865280|1903196|FG001|Overall Study|Exclusion Condition|0
921816|NCT00865280|1903195|FG000|Overall Study|Adverse Event|0
921817|NCT00865280|1903196|FG001|Overall Study|Adverse Event|1
921818|NCT00865306|1903204|FG000|Controlled Trial|Lost to Follow-up|1
921819|NCT00865306|1903205|FG001|Controlled Trial|Lost to Follow-up|1
921820|NCT00865306|1903204|FG000|Controlled Trial|Difficulty commuting|2
921821|NCT00865306|1903205|FG001|Controlled Trial|Difficulty commuting|0
921822|NCT00865306|1903204|FG000|Controlled Trial|Improved btw baseline and first session|1
921823|NCT00865306|1903205|FG001|Controlled Trial|Improved btw baseline and first session|0
921824|NCT00865306|1903204|FG000|Controlled Trial|Sought treatment for conduct disorder|1
921825|NCT00865306|1903205|FG001|Controlled Trial|Sought treatment for conduct disorder|0
921826|NCT00865306|1903204|FG000|Controlled Trial|Withdrawal by Subject|0
921827|NCT00865306|1903205|FG001|Controlled Trial|Withdrawal by Subject|1
921828|NCT00865345|1903211|FG000|Overall Study|Withdrawal by Subject|2
921829|NCT00865566|1903217|FG000|Overall Study|Death|1
921830|NCT00865566|1903218|FG001|Overall Study|Death|11
921831|NCT00865566|1903217|FG000|Overall Study|Lost to Follow-up|314
921832|NCT00865566|1903218|FG001|Overall Study|Lost to Follow-up|315
921833|NCT00865566|1903217|FG000|Overall Study|Withdrawal by Subject|45
921834|NCT00865566|1903218|FG001|Overall Study|Withdrawal by Subject|65
921835|NCT00865566|1903217|FG000|Overall Study|Physician Decision|0
921836|NCT00865566|1903218|FG001|Overall Study|Physician Decision|1
921837|NCT00865566|1903217|FG000|Overall Study|Participant relocated|78
921838|NCT00865566|1903218|FG001|Overall Study|Participant relocated|107
921839|NCT00865566|1903217|FG000|Overall Study|Participant unable to adhere|27
921840|NCT00865566|1903218|FG001|Overall Study|Participant unable to adhere|42
921841|NCT00865566|1903217|FG000|Overall Study|Other; N=245 due to early study closure|154
921842|NCT00865566|1903218|FG001|Overall Study|Other; N=245 due to early study closure|139
921843|NCT00865566|1903217|FG000|Overall Study|HIV infection|5
921844|NCT00865566|1903218|FG001|Overall Study|HIV infection|7
921845|NCT00865709|1903226|FG000|Treatment|Adverse Event|9
921846|NCT00865709|1903227|FG001|Treatment|Adverse Event|6
921847|NCT00865709|1903226|FG000|Treatment|Withdrawal by Subject|10
921848|NCT00865709|1903227|FG001|Treatment|Withdrawal by Subject|7
921849|NCT00865709|1903226|FG000|Treatment|Physician Decision|3
921850|NCT00865709|1903227|FG001|Treatment|Physician Decision|2
921851|NCT00865709|1903226|FG000|Treatment|Surgery|8
921852|NCT00865709|1903227|FG001|Treatment|Surgery|3
921853|NCT00865904|1903240|FG000|Overall Study|Randomized but not Treated|2
921854|NCT00865904|1903241|FG001|Overall Study|Randomized but not Treated|0
921855|NCT00865904|1903242|FG002|Overall Study|Randomized but not Treated|0
921856|NCT00865904|1903243|FG003|Overall Study|Randomized but not Treated|1
921857|NCT00865904|1903244|FG004|Overall Study|Randomized but not Treated|1
1014743|NCT01534208|2036659|FG000|Overall Study|Protocol Violation|2
1014744|NCT01534208|2036660|FG001|Overall Study|Protocol Violation|2
1014745|NCT01534208|2036659|FG000|Overall Study|Sponsor decision|4
1014746|NCT01534208|2036660|FG001|Overall Study|Sponsor decision|1
1014747|NCT01534208|2036659|FG000|Overall Study|Subject relocation|2
1014748|NCT01534208|2036660|FG001|Overall Study|Subject relocation|0
1014749|NCT01534208|2036659|FG000|Overall Study|Lab assessment|2
1014750|NCT01534208|2036660|FG001|Overall Study|Lab assessment|1
1014751|NCT01534208|2036659|FG000|Overall Study|Eligibility error|3
1014752|NCT01534208|2036660|FG001|Overall Study|Eligibility error|0
1014753|NCT01534208|2036659|FG000|Overall Study|PCP decision|1
1014754|NCT01534208|2036660|FG001|Overall Study|PCP decision|0
1014755|NCT01534208|2036659|FG000|Overall Study|Needed prohibited meds|1
1014756|NCT01534208|2036660|FG001|Overall Study|Needed prohibited meds|0
1014757|NCT01534260|2036668|FG000|Overall Study|Adverse Event|1
1014758|NCT01534260|2036669|FG001|Overall Study|Adverse Event|8
1014759|NCT01534260|2036668|FG000|Overall Study|Death|2
1014760|NCT01534260|2036669|FG001|Overall Study|Death|0
1014761|NCT01534260|2036668|FG000|Overall Study|Lack of Efficacy|1
1014762|NCT01534260|2036669|FG001|Overall Study|Lack of Efficacy|1
1014763|NCT01534260|2036668|FG000|Overall Study|Withdrawal by Subject|1
1014764|NCT01534260|2036669|FG001|Overall Study|Withdrawal by Subject|3
1014765|NCT01534260|2036668|FG000|Overall Study|Disease Progression|8
1014766|NCT01534260|2036669|FG001|Overall Study|Disease Progression|6
1014767|NCT01534260|2036668|FG000|Overall Study|Physician Decision|3
1014768|NCT01534260|2036669|FG001|Overall Study|Physician Decision|1
1014769|NCT01534260|2036668|FG000|Overall Study|No treatment, per protocol|0
1014770|NCT01534260|2036669|FG001|Overall Study|No treatment, per protocol|1
1014771|NCT01534273|2036679|FG000|Period 1|Physician Decision|0
1014772|NCT01534273|2036680|FG001|Period 1|Physician Decision|0
1014773|NCT01534273|2036681|FG002|Period 1|Physician Decision|0
1014774|NCT01534273|2036682|FG003|Period 1|Physician Decision|1
1014775|NCT01534273|2036683|FG004|Period 1|Physician Decision|0
1014776|NCT01534273|2036684|FG005|Period 1|Physician Decision|0
1014777|NCT01534273|2036685|FG006|Period 1|Physician Decision|0
1014778|NCT01534351|2036709|FG000|Overall Study|Study Terminated Early|1
1014779|NCT01534351|2036710|FG001|Overall Study|Study Terminated Early|0
1014780|NCT01534351|2036711|FG002|Overall Study|Study Terminated Early|0
1014781|NCT01534520|2036740|FG000|Overall Study|Adverse Event|0
1014782|NCT01534520|2036741|FG001|Overall Study|Adverse Event|1
1014783|NCT01534533|2036755|FG000|Overall Study|Lost to Follow-up|3
1014784|NCT01534533|2036756|FG001|Overall Study|Lost to Follow-up|0
1014785|NCT01534533|2036757|FG002|Overall Study|Lost to Follow-up|4
1014786|NCT01534533|2036758|FG003|Overall Study|Lost to Follow-up|3
1014787|NCT01534533|2036755|FG000|Overall Study|Withdrawal by Subject|5
1014788|NCT01534533|2036756|FG001|Overall Study|Withdrawal by Subject|3
1014789|NCT01534533|2036757|FG002|Overall Study|Withdrawal by Subject|4
1014790|NCT01534533|2036758|FG003|Overall Study|Withdrawal by Subject|1
1014791|NCT01534637|2036770|FG000|Overall Study|Physician Decision|3
1014792|NCT01534637|2036770|FG000|Overall Study|Lack of Efficacy|3
1014793|NCT01534637|2036770|FG000|Overall Study|Withdrawal by Subject|1
1014794|NCT01534637|2036770|FG000|Overall Study|Adverse Event|1
1014795|NCT01534637|2036770|FG000|Overall Study|Liver Mets before treatment|1
1014796|NCT01534663|2036776|FG000|Overall Study|Lost to Follow-up|0
1014797|NCT01534663|2036777|FG001|Overall Study|Lost to Follow-up|2
1014798|NCT01534663|2036776|FG000|Overall Study|Adverse Event|2
1014799|NCT01534663|2036777|FG001|Overall Study|Adverse Event|1
921858|NCT00866047|1903273|FG000|Treatment Period|Progressive disease|13
921859|NCT00866047|1903273|FG000|Treatment Period|Adverse Event|16
921860|NCT00866047|1903273|FG000|Treatment Period|Physician Decision|14
921861|NCT00866047|1903273|FG000|Treatment Period|Withdrawal by Subject|5
921862|NCT00866047|1903273|FG000|Follow-up Period|Lost to Follow-up|5
921863|NCT00866177|1903277|FG000|Overall Study|Withdrawal by Subject|1
921864|NCT00866177|1903277|FG000|Overall Study|Not Treated|151
921865|NCT00866281|1903283|FG000|Overall Study|Adverse Event|1
921866|NCT00866281|1903284|FG001|Overall Study|Adverse Event|0
921867|NCT00866281|1903283|FG000|Overall Study|Withdrawal by participants|3
921868|NCT00866281|1903284|FG001|Overall Study|Withdrawal by participants|0
921869|NCT00866281|1903283|FG000|Overall Study|Disease progression|3
921870|NCT00866281|1903284|FG001|Overall Study|Disease progression|11
921871|NCT00866281|1903283|FG000|Overall Study|New cancer therapy|0
921872|NCT00866281|1903284|FG001|Overall Study|New cancer therapy|4
921873|NCT00866294|1903296|FG000|Overall Study|Adverse Event|12
921874|NCT00866294|1903297|FG001|Overall Study|Adverse Event|13
921875|NCT00866294|1903298|FG002|Overall Study|Adverse Event|9
921876|NCT00866294|1903296|FG000|Overall Study|Lack of Efficacy|7
921877|NCT00866294|1903297|FG001|Overall Study|Lack of Efficacy|1
921878|NCT00866294|1903298|FG002|Overall Study|Lack of Efficacy|0
921879|NCT00866294|1903296|FG000|Overall Study|Protocol Violation|2
921880|NCT00866294|1903297|FG001|Overall Study|Protocol Violation|0
921881|NCT00866294|1903298|FG002|Overall Study|Protocol Violation|0
921882|NCT00866294|1903296|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5
921883|NCT00866294|1903297|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
921884|NCT00866294|1903298|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1
921885|NCT00866294|1903296|FG000|Overall Study|Lost to Follow-up|1
921886|NCT00866294|1903297|FG001|Overall Study|Lost to Follow-up|3
921887|NCT00866294|1903298|FG002|Overall Study|Lost to Follow-up|0
921888|NCT00866294|1903296|FG000|Overall Study|Physician Decision|6
921889|NCT00866294|1903297|FG001|Overall Study|Physician Decision|2
921890|NCT00866294|1903298|FG002|Overall Study|Physician Decision|1
921891|NCT00866307|1903314|FG000|Induction|Adverse Event|5
921892|NCT00866307|1903315|FG001|Induction|Adverse Event|0
921893|NCT00866307|1903316|FG002|Induction|Adverse Event|0
921894|NCT00866307|1903314|FG000|Induction|Death|2
921895|NCT00866307|1903315|FG001|Induction|Death|0
921896|NCT00866307|1903316|FG002|Induction|Death|0
921897|NCT00866307|1903314|FG000|Induction|Physician Decision|5
921898|NCT00866307|1903315|FG001|Induction|Physician Decision|0
921899|NCT00866307|1903316|FG002|Induction|Physician Decision|0
921900|NCT00866307|1903314|FG000|Induction|Progressive Disease|1
921901|NCT00866307|1903315|FG001|Induction|Progressive Disease|0
921902|NCT00866307|1903316|FG002|Induction|Progressive Disease|0
921903|NCT00866307|1903314|FG000|Induction|Identification of Patients with Day 29 M|3
921904|NCT00866307|1903315|FG001|Induction|Identification of Patients with Day 29 M|0
921905|NCT00866307|1903316|FG002|Induction|Identification of Patients with Day 29 M|0
921906|NCT00866307|1903314|FG000|Induction|Inadequate cytognetic samples th|1
921907|NCT00866307|1903315|FG001|Induction|Inadequate cytognetic samples th|0
921908|NCT00866307|1903316|FG002|Induction|Inadequate cytognetic samples th|0
921909|NCT00866307|1903314|FG000|Induction|Improper post-induction consent|2
921910|NCT00866307|1903315|FG001|Induction|Improper post-induction consent|0
921911|NCT00866307|1903316|FG002|Induction|Improper post-induction consent|0
921912|NCT00866307|1903314|FG000|Induction|Study was closed at the time|1
921913|NCT00866307|1903315|FG001|Induction|Study was closed at the time|0
921914|NCT00866307|1903316|FG002|Induction|Study was closed at the time|0
921915|NCT00866307|1903314|FG000|Consolidation/Maintenance|Adverse Event|0
921916|NCT00866307|1903315|FG001|Consolidation/Maintenance|Adverse Event|0
921917|NCT00866307|1903316|FG002|Consolidation/Maintenance|Adverse Event|8
921918|NCT00866307|1903314|FG000|Consolidation/Maintenance|Death|0
921919|NCT00866307|1903315|FG001|Consolidation/Maintenance|Death|0
921920|NCT00866307|1903316|FG002|Consolidation/Maintenance|Death|1
921921|NCT00866307|1903314|FG000|Consolidation/Maintenance|Physician Decision|0
921922|NCT00866307|1903315|FG001|Consolidation/Maintenance|Physician Decision|3
921923|NCT00866307|1903316|FG002|Consolidation/Maintenance|Physician Decision|2
921924|NCT00866307|1903314|FG000|Consolidation/Maintenance|Withdrawal by Subject|0
921925|NCT00866307|1903315|FG001|Consolidation/Maintenance|Withdrawal by Subject|1
921926|NCT00866307|1903316|FG002|Consolidation/Maintenance|Withdrawal by Subject|1
921927|NCT00866307|1903314|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
921928|NCT00866307|1903315|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
921929|NCT00866307|1903316|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
921930|NCT00866307|1903314|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0
921931|NCT00866307|1903315|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3
921932|NCT00866307|1903316|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1
921933|NCT00866307|1903314|FG000|Consolidation/Maintenance|Therapy error|0
921934|NCT00866307|1903315|FG001|Consolidation/Maintenance|Therapy error|1
921935|NCT00866307|1903316|FG002|Consolidation/Maintenance|Therapy error|0
921936|NCT00866307|1903314|FG000|Consolidation/Maintenance|Non-compliance|0
921937|NCT00866307|1903315|FG001|Consolidation/Maintenance|Non-compliance|0
921938|NCT00866307|1903316|FG002|Consolidation/Maintenance|Non-compliance|1
921939|NCT00866307|1903314|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0
921940|NCT00866307|1903315|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1
921941|NCT00866307|1903316|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0
921942|NCT00866320|1903322|FG000|Overall Study|Withdrawal by Subject|4
921943|NCT00866320|1903322|FG000|Overall Study|Death|2
921944|NCT00866333|1903331|FG000|Overall Study|Withdrawal of consent|0
921945|NCT00866333|1903332|FG001|Overall Study|Withdrawal of consent|1
921946|NCT00866333|1903333|FG002|Overall Study|Withdrawal of consent|2
921947|NCT00866333|1903331|FG000|Overall Study|Reason not Specified|3
921948|NCT00866333|1903332|FG001|Overall Study|Reason not Specified|1
921949|NCT00866333|1903333|FG002|Overall Study|Reason not Specified|1
921950|NCT00866333|1903331|FG000|Overall Study|Study Terminated by Sponsor|2
921951|NCT00866333|1903332|FG001|Overall Study|Study Terminated by Sponsor|5
921952|NCT00866333|1903333|FG002|Overall Study|Study Terminated by Sponsor|9
921953|NCT00866359|1903343|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5
921954|NCT00866359|1903344|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4
921955|NCT00866359|1903345|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0
921956|NCT00866359|1903346|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0
921957|NCT00866359|1903343|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
921958|NCT00866359|1903344|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
921959|NCT00866359|1903345|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
921960|NCT00866359|1903346|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
921961|NCT00866359|1903343|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
921962|NCT00866359|1903344|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
921963|NCT00866359|1903345|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
921964|NCT00866359|1903346|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
921965|NCT00866359|1903343|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1
921966|NCT00866359|1903344|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1
921967|NCT00866359|1903345|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0
921968|NCT00866359|1903346|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0
921969|NCT00866359|1903343|FG000|Treatment Phase (Days 1 to 85)|Other|1
921970|NCT00866359|1903344|FG001|Treatment Phase (Days 1 to 85)|Other|0
921971|NCT00866359|1903345|FG002|Treatment Phase (Days 1 to 85)|Other|0
921972|NCT00866359|1903346|FG003|Treatment Phase (Days 1 to 85)|Other|0
921973|NCT00866359|1903343|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0
921974|NCT00866359|1903344|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0
921975|NCT00866359|1903345|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1
921976|NCT00866359|1903346|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3
921977|NCT00866606|1903373|FG000|Overall Study|Lost to Follow-up|3
921978|NCT00866606|1903373|FG000|Overall Study|Adverse Event|1
921979|NCT00866619|1903381|FG000|Overall Study|Adverse Event|112
921980|NCT00866619|1903382|FG001|Overall Study|Adverse Event|106
921981|NCT00866619|1903383|FG002|Overall Study|Adverse Event|47
921982|NCT00866619|1903384|FG003|Overall Study|Adverse Event|44
921983|NCT00866619|1903381|FG000|Overall Study|Protocol Violation|2
921984|NCT00866619|1903382|FG001|Overall Study|Protocol Violation|39
921985|NCT00866619|1903383|FG002|Overall Study|Protocol Violation|2
921986|NCT00866619|1903384|FG003|Overall Study|Protocol Violation|17
921987|NCT00866619|1903381|FG000|Overall Study|Withdrawal by Subject|587
921988|NCT00866619|1903382|FG001|Overall Study|Withdrawal by Subject|295
921989|NCT00866619|1903383|FG002|Overall Study|Withdrawal by Subject|272
921990|NCT00866619|1903384|FG003|Overall Study|Withdrawal by Subject|144
921991|NCT00866619|1903381|FG000|Overall Study|Lost to Follow-up|1145
921992|NCT00866619|1903382|FG001|Overall Study|Lost to Follow-up|830
921993|NCT00866619|1903383|FG002|Overall Study|Lost to Follow-up|568
921994|NCT00866619|1903384|FG003|Overall Study|Lost to Follow-up|425
921995|NCT00866658|1903421|FG000|Overall Study|Adverse Event|5
921996|NCT00866658|1903422|FG001|Overall Study|Adverse Event|14
921997|NCT00866658|1903421|FG000|Overall Study|Lack of Efficacy|2
921998|NCT00866658|1903422|FG001|Overall Study|Lack of Efficacy|1
921999|NCT00866658|1903421|FG000|Overall Study|Withdrawal by Subject|1
922000|NCT00866658|1903422|FG001|Overall Study|Withdrawal by Subject|0
922001|NCT00866658|1903421|FG000|Overall Study|Protocol Violation|1
922002|NCT00866658|1903422|FG001|Overall Study|Protocol Violation|1
922003|NCT00866658|1903421|FG000|Overall Study|Familial and Personal Reasons|4
922004|NCT00866658|1903422|FG001|Overall Study|Familial and Personal Reasons|5
922005|NCT00866697|1903430|FG000|Overall Study|Study closed/terminated|156
922006|NCT00866697|1903431|FG001|Overall Study|Study closed/terminated|138
922007|NCT00866697|1903430|FG000|Overall Study|Lost to Follow-up|22
922008|NCT00866697|1903431|FG001|Overall Study|Lost to Follow-up|28
922009|NCT00866697|1903430|FG000|Overall Study|Physician Decision|3
922010|NCT00866697|1903431|FG001|Overall Study|Physician Decision|5
922011|NCT00866697|1903430|FG000|Overall Study|Withdrawal by Subject|33
922012|NCT00866697|1903431|FG001|Overall Study|Withdrawal by Subject|57
922013|NCT00866723|1903437|FG000|Overall Study|Withdrawal by Subject|1
922014|NCT00866723|1903437|FG000|Overall Study|Disease Progression|4
922015|NCT00866775|1903447|FG000|Overall Study|Adverse Event|5
922016|NCT00866775|1903448|FG001|Overall Study|Adverse Event|19
922017|NCT00866775|1903447|FG000|Overall Study|Death|1
922018|NCT00866775|1903448|FG001|Overall Study|Death|0
922019|NCT00866775|1903447|FG000|Overall Study|Lost to Follow-up|0
922020|NCT00866775|1903448|FG001|Overall Study|Lost to Follow-up|4
922021|NCT00866775|1903447|FG000|Overall Study|Physician Decision|0
922022|NCT00866775|1903448|FG001|Overall Study|Physician Decision|3
922023|NCT00866775|1903447|FG000|Overall Study|Protocol Violation|3
922024|NCT00866775|1903448|FG001|Overall Study|Protocol Violation|4
922025|NCT00866775|1903447|FG000|Overall Study|Withdrawal by Subject|4
922026|NCT00866775|1903448|FG001|Overall Study|Withdrawal by Subject|4
922027|NCT00866775|1903447|FG000|Overall Study|met exit criteria|23
922028|NCT00866775|1903448|FG001|Overall Study|met exit criteria|17
922029|NCT00866775|1903447|FG000|Overall Study|discontinued due to communication error|0
922030|NCT00866775|1903448|FG001|Overall Study|discontinued due to communication error|1
922031|NCT00866788|1903460|FG000|Overall Study|Adverse Event|0
922032|NCT00866788|1903461|FG001|Overall Study|Adverse Event|2
922033|NCT00866788|1903462|FG002|Overall Study|Adverse Event|0
922034|NCT00866788|1903463|FG003|Overall Study|Adverse Event|1
922035|NCT00866788|1903460|FG000|Overall Study|Lost to Follow-up|1
922036|NCT00866788|1903461|FG001|Overall Study|Lost to Follow-up|1
922037|NCT00866788|1903462|FG002|Overall Study|Lost to Follow-up|0
922038|NCT00866788|1903463|FG003|Overall Study|Lost to Follow-up|2
922039|NCT00866788|1903460|FG000|Overall Study|Withdrawal by Subject|2
922040|NCT00866788|1903461|FG001|Overall Study|Withdrawal by Subject|1
922041|NCT00866788|1903462|FG002|Overall Study|Withdrawal by Subject|0
922042|NCT00866788|1903463|FG003|Overall Study|Withdrawal by Subject|1
922043|NCT00866788|1903460|FG000|Overall Study|Pregnancy|0
922044|NCT00866788|1903461|FG001|Overall Study|Pregnancy|1
922045|NCT00866788|1903462|FG002|Overall Study|Pregnancy|0
922046|NCT00866788|1903463|FG003|Overall Study|Pregnancy|0
922047|NCT00866788|1903460|FG000|Overall Study|Disease progression|3
922048|NCT00866788|1903461|FG001|Overall Study|Disease progression|1
922049|NCT00866788|1903462|FG002|Overall Study|Disease progression|1
922050|NCT00866788|1903463|FG003|Overall Study|Disease progression|0
922051|NCT00866788|1903460|FG000|Overall Study|Physician Decision|0
922052|NCT00866788|1903461|FG001|Overall Study|Physician Decision|0
922053|NCT00866788|1903462|FG002|Overall Study|Physician Decision|1
922054|NCT00866788|1903463|FG003|Overall Study|Physician Decision|1
922055|NCT00866814|1903476|FG000|Overall Study|Lost to Follow-up|12
922056|NCT00866814|1903476|FG000|Overall Study|Adverse Event|2
922057|NCT00866814|1903476|FG000|Overall Study|Physician Decision|1
922058|NCT00866814|1903476|FG000|Overall Study|Death|1
922059|NCT00866814|1903476|FG000|Overall Study|No longer wished to participate|1
922060|NCT00866814|1903476|FG000|Overall Study|Unable to meet follow-up requirements|2
922061|NCT00866814|1903476|FG000|Overall Study|Moved to area without study site|1
922062|NCT00866918|1903497|FG000|Overall Study|Death|1
922063|NCT00866918|1903498|FG001|Overall Study|Death|5
922064|NCT00866918|1903497|FG000|Overall Study|Lack of Efficacy|1
922065|NCT00866918|1903498|FG001|Overall Study|Lack of Efficacy|1
922066|NCT00866918|1903497|FG000|Overall Study|Physician Decision|10
922067|NCT00866918|1903498|FG001|Overall Study|Physician Decision|2
922068|NCT00866918|1903497|FG000|Overall Study|Ineligible|2
922069|NCT00866918|1903498|FG001|Overall Study|Ineligible|4
922070|NCT00866918|1903497|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
922071|NCT00866918|1903498|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
922072|NCT00866918|1903497|FG000|Overall Study|Secondary malignancy|1
922073|NCT00866918|1903498|FG001|Overall Study|Secondary malignancy|0
922074|NCT00867009|1903504|FG000|Induction Period|Nonserious Adverse Event|5
922075|NCT00867009|1903504|FG000|Induction Period|Serious Adverse Event|10
922076|NCT00867009|1903504|FG000|Induction Period|Death due to serious adverse event|6
922077|NCT00867009|1903504|FG000|Induction Period|Death due to Study Disease|4
922078|NCT00867009|1903504|FG000|Induction Period|Protocol Violation|1
922079|NCT00867009|1903504|FG000|Induction Period|Withdrawal by Subject|8
922080|NCT00867009|1903504|FG000|Induction Period|Physician Decision|3
922081|NCT00867009|1903504|FG000|Induction Period|Progressive Disease (PD)|25
922082|NCT00867009|1903504|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4
922083|NCT00867035|1903510|FG000|Baseline to 1 Hour|Withdrawal by Subject|1
922084|NCT00867035|1903511|FG001|Baseline to 1 Hour|Withdrawal by Subject|1
922085|NCT00867035|1903510|FG000|Baseline to 1 Week|Withdrawal by Subject|1
922086|NCT00867035|1903511|FG001|Baseline to 1 Week|Withdrawal by Subject|0
922087|NCT00867087|1903517|FG000|Overall Study|Other|1
922088|NCT00867087|1903517|FG000|Overall Study|Withdrawal by Subject|4
922089|NCT00867087|1903517|FG000|Overall Study|Death|37
922090|NCT00867113|1903578|FG000|Treatment Period|Adverse Event|15
922091|NCT00867113|1903578|FG000|Treatment Period|Death|2
922092|NCT00867113|1903578|FG000|Treatment Period|Withdrawal by Subject|19
922093|NCT00867113|1903578|FG000|Treatment Period|Lost to Follow-up|3
922094|NCT00867113|1903578|FG000|Treatment Period|Administrative problems|1
922095|NCT00867113|1903578|FG000|Treatment Period|Disease progression/relapse|1
922096|NCT00867113|1903578|FG000|Treatment Period|Protocol Violation|4
922097|NCT00867113|1903578|FG000|Post Treatment After Survival Follow-up|Death|1
922098|NCT00867113|1903578|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
922099|NCT00867113|1903578|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5
922100|NCT00867113|1903578|FG000|Post Treatment After Survival Follow-up|Administrative problems|4
922101|NCT00867165|1903605|FG000|Overall Study|Adverse Event|3
922102|NCT00867165|1903606|FG001|Overall Study|Adverse Event|0
922103|NCT00867165|1903605|FG000|Overall Study|Withdrawal by Subject|1
922104|NCT00867165|1903606|FG001|Overall Study|Withdrawal by Subject|0
922105|NCT00867308|1903623|FG000|Overall Study|Death|1
922106|NCT00867308|1903624|FG001|Overall Study|Death|0
922107|NCT00867308|1903623|FG000|Overall Study|Adverse Event|1
922108|NCT00867308|1903624|FG001|Overall Study|Adverse Event|4
922109|NCT00867308|1903623|FG000|Overall Study|Lack of Efficacy|6
922110|NCT00867308|1903624|FG001|Overall Study|Lack of Efficacy|12
922111|NCT00867308|1903623|FG000|Overall Study|Withdrawal by Subject|1
922112|NCT00867308|1903624|FG001|Overall Study|Withdrawal by Subject|2
922113|NCT00867334|1903654|FG000|Overall Study|Withdrawal by Subject|0
922114|NCT00867334|1903655|FG001|Overall Study|Withdrawal by Subject|1
922115|NCT00867334|1903654|FG000|Overall Study|Withdrawal by Subject|1
922116|NCT00867334|1903655|FG001|Overall Study|Withdrawal by Subject|0
922117|NCT00867334|1903654|FG000|Overall Study|Withdrawal by Subject|1
922118|NCT00867334|1903655|FG001|Overall Study|Withdrawal by Subject|0
922119|NCT00867360|1903663|FG000|Overall Study|Withdrawal by Subject|1
922120|NCT00867360|1903664|FG001|Overall Study|Withdrawal by Subject|0
922121|NCT00867360|1903663|FG000|Overall Study|Physician Decision|0
922122|NCT00867360|1903664|FG001|Overall Study|Physician Decision|1
922123|NCT00867490|1903684|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5
922124|NCT00867490|1903684|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
922125|NCT00867490|1903684|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
922126|NCT00867490|1903684|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
922127|NCT00867490|1903684|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
922128|NCT00867503|1903691|FG000|Overall Study|Withdrawal by Subject|1
922129|NCT00867568|1903701|FG000|Overall Study|Lack of Efficacy|10
922130|NCT00867568|1903701|FG000|Overall Study|Adverse Event|4
922131|NCT00867568|1903701|FG000|Overall Study|Withdrawal by Subject|1
922132|NCT00867815|1903719|FG000|Overall Study|Lost to Follow-up|1
922133|NCT00868166|1903751|FG000|Overall Study|Death|58
922134|NCT00868166|1903752|FG001|Overall Study|Death|65
922135|NCT00868166|1903751|FG000|Overall Study|Withdrawal by Subject|33
922136|NCT00868166|1903752|FG001|Overall Study|Withdrawal by Subject|25
922137|NCT00868166|1903751|FG000|Overall Study|Protocol Violation|1
922138|NCT00868166|1903752|FG001|Overall Study|Protocol Violation|0
922139|NCT00868166|1903751|FG000|Overall Study|Lost to Follow-up|1
922140|NCT00868166|1903752|FG001|Overall Study|Lost to Follow-up|3
922141|NCT00868166|1903751|FG000|Overall Study|Adverse Event|9
922142|NCT00868166|1903752|FG001|Overall Study|Adverse Event|10
922143|NCT00868166|1903751|FG000|Overall Study|Lack of efficacy, logistics, unwell|9
922144|NCT00868166|1903752|FG001|Overall Study|Lack of efficacy, logistics, unwell|10
922145|NCT00868166|1903751|FG000|Overall Study|Non-compliance with IMP|1
922146|NCT00868166|1903752|FG001|Overall Study|Non-compliance with IMP|1
922147|NCT00868192|1903758|FG000|Overall Study|Ineligible|4
922148|NCT00868231|1903783|FG000|Treatment Period 1|Adverse Event|0
922149|NCT00868231|1903784|FG001|Treatment Period 1|Adverse Event|0
922150|NCT00868231|1903785|FG002|Treatment Period 1|Adverse Event|0
922151|NCT00868231|1903786|FG003|Treatment Period 1|Adverse Event|0
922152|NCT00868231|1903787|FG004|Treatment Period 1|Adverse Event|1
922153|NCT00868231|1903788|FG005|Treatment Period 1|Adverse Event|0
922154|NCT00868231|1903783|FG000|Treatment Period 2|Adverse Event|1
922155|NCT00868231|1903784|FG001|Treatment Period 2|Adverse Event|0
922156|NCT00868231|1903785|FG002|Treatment Period 2|Adverse Event|0
922157|NCT00868231|1903786|FG003|Treatment Period 2|Adverse Event|0
922158|NCT00868231|1903787|FG004|Treatment Period 2|Adverse Event|0
922159|NCT00868231|1903788|FG005|Treatment Period 2|Adverse Event|0
922160|NCT00868231|1903783|FG000|Treatment Period 3|Adverse Event|0
922161|NCT00868231|1903784|FG001|Treatment Period 3|Adverse Event|0
922162|NCT00868231|1903785|FG002|Treatment Period 3|Adverse Event|1
922163|NCT00868231|1903786|FG003|Treatment Period 3|Adverse Event|0
922164|NCT00868231|1903787|FG004|Treatment Period 3|Adverse Event|0
922165|NCT00868231|1903788|FG005|Treatment Period 3|Adverse Event|0
922166|NCT00868296|1903798|FG000|Overall Study|Adverse Event|0
922167|NCT00868296|1903799|FG001|Overall Study|Adverse Event|2
922168|NCT00868296|1903798|FG000|Overall Study|Withdrawal by Subject|0
922169|NCT00868296|1903799|FG001|Overall Study|Withdrawal by Subject|1
922170|NCT00868439|1903834|FG000|Overall Study|Adverse Event|4
922171|NCT00868439|1903835|FG001|Overall Study|Adverse Event|3
922172|NCT00868439|1903834|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
922173|NCT00868439|1903835|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
922174|NCT00868439|1903834|FG000|Overall Study|Death|0
922175|NCT00868439|1903835|FG001|Overall Study|Death|1
922176|NCT00868439|1903834|FG000|Overall Study|Protocol Violation|1
922177|NCT00868439|1903835|FG001|Overall Study|Protocol Violation|1
922178|NCT00868439|1903834|FG000|Overall Study|Physician Decision|1
922179|NCT00868439|1903835|FG001|Overall Study|Physician Decision|0
922180|NCT00868439|1903834|FG000|Overall Study|Withdrawal by Subject|0
922181|NCT00868439|1903835|FG001|Overall Study|Withdrawal by Subject|1
922182|NCT00868517|1903854|FG000|Overall Study|Withdrawal by Subject|3
922183|NCT00868517|1903855|FG001|Overall Study|Withdrawal by Subject|3
922184|NCT00868517|1903856|FG002|Overall Study|Withdrawal by Subject|2
922185|NCT00868517|1903854|FG000|Overall Study|Protocol Violation|1
922186|NCT00868517|1903855|FG001|Overall Study|Protocol Violation|1
922187|NCT00868517|1903856|FG002|Overall Study|Protocol Violation|0
922188|NCT00868530|1903864|FG000|Overall Study|Adverse Event|3
922189|NCT00868530|1903864|FG000|Overall Study|Lost to Follow-up|1
922190|NCT00868608|1903871|FG000|Overall Study|Withdrawal by Subject|3
922191|NCT00868608|1903872|FG001|Overall Study|Withdrawal by Subject|1
922192|NCT00868608|1903873|FG002|Overall Study|Withdrawal by Subject|0
922193|NCT00868608|1903871|FG000|Overall Study|Lost to Follow-up|3
922194|NCT00868608|1903872|FG001|Overall Study|Lost to Follow-up|0
922195|NCT00868608|1903873|FG002|Overall Study|Lost to Follow-up|1
922196|NCT00868608|1903871|FG000|Overall Study|Death|16
922197|NCT00868608|1903872|FG001|Overall Study|Death|2
922198|NCT00868608|1903873|FG002|Overall Study|Death|4
922199|NCT00868608|1903871|FG000|Overall Study|Other - Unspecified|1
922200|NCT00868608|1903872|FG001|Overall Study|Other - Unspecified|0
922201|NCT00868608|1903873|FG002|Overall Study|Other - Unspecified|0
922202|NCT00868790|1903911|FG000|Period 1|Adverse Event|1
922203|NCT00868790|1903912|FG001|Period 1|Adverse Event|0
922204|NCT00868790|1903913|FG002|Period 1|Adverse Event|0
922205|NCT00868790|1903914|FG003|Period 1|Adverse Event|0
922206|NCT00868790|1903915|FG004|Period 1|Adverse Event|0
922207|NCT00868790|1903916|FG005|Period 1|Adverse Event|0
922208|NCT00868790|1903917|FG006|Period 1|Adverse Event|0
922209|NCT00868790|1903918|FG007|Period 1|Adverse Event|3
922210|NCT00868790|1903919|FG008|Period 1|Adverse Event|1
922211|NCT00868790|1903920|FG009|Period 1|Adverse Event|0
922212|NCT00868790|1903921|FG010|Period 1|Adverse Event|0
922213|NCT00868790|1903922|FG011|Period 1|Adverse Event|0
922214|NCT00868790|1903923|FG012|Period 1|Adverse Event|0
922215|NCT00868790|1903924|FG013|Period 1|Adverse Event|1
922216|NCT00868790|1903911|FG000|Period 1|Protocol Violation|1
922217|NCT00868790|1903912|FG001|Period 1|Protocol Violation|0
922218|NCT00868790|1903913|FG002|Period 1|Protocol Violation|0
922219|NCT00868790|1903914|FG003|Period 1|Protocol Violation|0
922220|NCT00868790|1903915|FG004|Period 1|Protocol Violation|0
922221|NCT00868790|1903916|FG005|Period 1|Protocol Violation|0
922222|NCT00868790|1903917|FG006|Period 1|Protocol Violation|0
922223|NCT00868790|1903918|FG007|Period 1|Protocol Violation|0
922224|NCT00868790|1903919|FG008|Period 1|Protocol Violation|0
922225|NCT00868790|1903920|FG009|Period 1|Protocol Violation|0
922226|NCT00868790|1903921|FG010|Period 1|Protocol Violation|0
922227|NCT00868790|1903922|FG011|Period 1|Protocol Violation|0
922228|NCT00868790|1903923|FG012|Period 1|Protocol Violation|0
922229|NCT00868790|1903924|FG013|Period 1|Protocol Violation|0
922230|NCT00868790|1903911|FG000|Period 1|Withdrawal by Subject|0
922231|NCT00868790|1903912|FG001|Period 1|Withdrawal by Subject|1
922232|NCT00868790|1903913|FG002|Period 1|Withdrawal by Subject|0
922233|NCT00868790|1903914|FG003|Period 1|Withdrawal by Subject|0
922234|NCT00868790|1903915|FG004|Period 1|Withdrawal by Subject|0
922235|NCT00868790|1903916|FG005|Period 1|Withdrawal by Subject|0
922236|NCT00868790|1903917|FG006|Period 1|Withdrawal by Subject|0
922237|NCT00868790|1903918|FG007|Period 1|Withdrawal by Subject|0
922238|NCT00868790|1903919|FG008|Period 1|Withdrawal by Subject|0
922239|NCT00868790|1903920|FG009|Period 1|Withdrawal by Subject|0
922240|NCT00868790|1903921|FG010|Period 1|Withdrawal by Subject|0
922241|NCT00868790|1903922|FG011|Period 1|Withdrawal by Subject|0
922242|NCT00868790|1903923|FG012|Period 1|Withdrawal by Subject|0
922243|NCT00868790|1903924|FG013|Period 1|Withdrawal by Subject|1
922244|NCT00868790|1903911|FG000|Period 1|Abnormal Triglycerides|0
922245|NCT00868790|1903912|FG001|Period 1|Abnormal Triglycerides|0
922246|NCT00868790|1903913|FG002|Period 1|Abnormal Triglycerides|0
922247|NCT00868790|1903914|FG003|Period 1|Abnormal Triglycerides|0
922248|NCT00868790|1903915|FG004|Period 1|Abnormal Triglycerides|1
922249|NCT00868790|1903916|FG005|Period 1|Abnormal Triglycerides|0
922250|NCT00868790|1903917|FG006|Period 1|Abnormal Triglycerides|0
922251|NCT00868790|1903918|FG007|Period 1|Abnormal Triglycerides|0
922252|NCT00868790|1903919|FG008|Period 1|Abnormal Triglycerides|0
922253|NCT00868790|1903920|FG009|Period 1|Abnormal Triglycerides|0
922254|NCT00868790|1903921|FG010|Period 1|Abnormal Triglycerides|0
922255|NCT00868790|1903922|FG011|Period 1|Abnormal Triglycerides|0
922256|NCT00868790|1903923|FG012|Period 1|Abnormal Triglycerides|0
922257|NCT00868790|1903924|FG013|Period 1|Abnormal Triglycerides|0
922258|NCT00868790|1903911|FG000|Period 1|Lost to Follow-up|0
922259|NCT00868790|1903912|FG001|Period 1|Lost to Follow-up|0
922260|NCT00868790|1903913|FG002|Period 1|Lost to Follow-up|0
922261|NCT00868790|1903914|FG003|Period 1|Lost to Follow-up|0
922262|NCT00868790|1903915|FG004|Period 1|Lost to Follow-up|0
922263|NCT00868790|1903916|FG005|Period 1|Lost to Follow-up|1
922264|NCT00868790|1903917|FG006|Period 1|Lost to Follow-up|0
922265|NCT00868790|1903918|FG007|Period 1|Lost to Follow-up|0
922266|NCT00868790|1903919|FG008|Period 1|Lost to Follow-up|0
922267|NCT00868790|1903920|FG009|Period 1|Lost to Follow-up|0
922268|NCT00868790|1903921|FG010|Period 1|Lost to Follow-up|0
922269|NCT00868790|1903922|FG011|Period 1|Lost to Follow-up|0
922270|NCT00868790|1903923|FG012|Period 1|Lost to Follow-up|0
922271|NCT00868790|1903924|FG013|Period 1|Lost to Follow-up|0
922272|NCT00868790|1903911|FG000|Period 2|Adverse Event|0
922273|NCT00868790|1903912|FG001|Period 2|Adverse Event|0
922274|NCT00868790|1903913|FG002|Period 2|Adverse Event|0
922275|NCT00868790|1903914|FG003|Period 2|Adverse Event|0
922276|NCT00868790|1903915|FG004|Period 2|Adverse Event|0
922277|NCT00868790|1903916|FG005|Period 2|Adverse Event|0
922278|NCT00868790|1903917|FG006|Period 2|Adverse Event|0
922279|NCT00868790|1903918|FG007|Period 2|Adverse Event|0
922280|NCT00868790|1903919|FG008|Period 2|Adverse Event|1
922281|NCT00868790|1903920|FG009|Period 2|Adverse Event|0
922282|NCT00868790|1903921|FG010|Period 2|Adverse Event|0
922283|NCT00868790|1903922|FG011|Period 2|Adverse Event|0
922284|NCT00868790|1903923|FG012|Period 2|Adverse Event|0
922285|NCT00868790|1903924|FG013|Period 2|Adverse Event|0
922286|NCT00868790|1903911|FG000|Period 2|Lost to Follow-up|0
922287|NCT00868790|1903912|FG001|Period 2|Lost to Follow-up|1
922288|NCT00868790|1903913|FG002|Period 2|Lost to Follow-up|0
922289|NCT00868790|1903914|FG003|Period 2|Lost to Follow-up|0
922290|NCT00868790|1903915|FG004|Period 2|Lost to Follow-up|0
922291|NCT00868790|1903916|FG005|Period 2|Lost to Follow-up|1
922292|NCT00868790|1903917|FG006|Period 2|Lost to Follow-up|0
922293|NCT00868790|1903918|FG007|Period 2|Lost to Follow-up|0
922294|NCT00868790|1903919|FG008|Period 2|Lost to Follow-up|0
922295|NCT00868790|1903920|FG009|Period 2|Lost to Follow-up|0
922296|NCT00868790|1903921|FG010|Period 2|Lost to Follow-up|0
922297|NCT00868790|1903922|FG011|Period 2|Lost to Follow-up|0
922298|NCT00868790|1903923|FG012|Period 2|Lost to Follow-up|0
922299|NCT00868790|1903924|FG013|Period 2|Lost to Follow-up|0
922300|NCT00868790|1903911|FG000|Period 2|Withdrawal by Subject|0
922301|NCT00868790|1903912|FG001|Period 2|Withdrawal by Subject|0
922302|NCT00868790|1903913|FG002|Period 2|Withdrawal by Subject|0
922303|NCT00868790|1903914|FG003|Period 2|Withdrawal by Subject|0
922304|NCT00868790|1903915|FG004|Period 2|Withdrawal by Subject|0
922305|NCT00868790|1903916|FG005|Period 2|Withdrawal by Subject|0
922306|NCT00868790|1903917|FG006|Period 2|Withdrawal by Subject|0
922307|NCT00868790|1903918|FG007|Period 2|Withdrawal by Subject|0
922308|NCT00868790|1903919|FG008|Period 2|Withdrawal by Subject|1
922309|NCT00868790|1903920|FG009|Period 2|Withdrawal by Subject|0
922310|NCT00868790|1903921|FG010|Period 2|Withdrawal by Subject|0
922311|NCT00868790|1903922|FG011|Period 2|Withdrawal by Subject|0
922312|NCT00868790|1903923|FG012|Period 2|Withdrawal by Subject|0
922313|NCT00868790|1903924|FG013|Period 2|Withdrawal by Subject|1
922314|NCT00868790|1903911|FG000|Period 3|Adverse Event|0
922315|NCT00868790|1903912|FG001|Period 3|Adverse Event|0
922316|NCT00868790|1903913|FG002|Period 3|Adverse Event|0
922317|NCT00868790|1903914|FG003|Period 3|Adverse Event|0
922318|NCT00868790|1903915|FG004|Period 3|Adverse Event|0
922319|NCT00868790|1903916|FG005|Period 3|Adverse Event|0
922320|NCT00868790|1903917|FG006|Period 3|Adverse Event|0
922321|NCT00868790|1903918|FG007|Period 3|Adverse Event|0
922322|NCT00868790|1903919|FG008|Period 3|Adverse Event|0
922323|NCT00868790|1903920|FG009|Period 3|Adverse Event|1
922324|NCT00868790|1903921|FG010|Period 3|Adverse Event|0
922325|NCT00868790|1903922|FG011|Period 3|Adverse Event|0
922326|NCT00868790|1903923|FG012|Period 3|Adverse Event|0
922327|NCT00868790|1903924|FG013|Period 3|Adverse Event|0
922328|NCT00868790|1903911|FG000|Period 3|Protocol Violation|0
922329|NCT00868790|1903912|FG001|Period 3|Protocol Violation|0
922330|NCT00868790|1903913|FG002|Period 3|Protocol Violation|0
922331|NCT00868790|1903914|FG003|Period 3|Protocol Violation|0
922332|NCT00868790|1903915|FG004|Period 3|Protocol Violation|0
922333|NCT00868790|1903916|FG005|Period 3|Protocol Violation|0
922334|NCT00868790|1903917|FG006|Period 3|Protocol Violation|0
922335|NCT00868790|1903918|FG007|Period 3|Protocol Violation|0
922336|NCT00868790|1903919|FG008|Period 3|Protocol Violation|0
922337|NCT00868790|1903920|FG009|Period 3|Protocol Violation|0
922338|NCT00868790|1903921|FG010|Period 3|Protocol Violation|1
922339|NCT00868790|1903922|FG011|Period 3|Protocol Violation|0
922340|NCT00868790|1903923|FG012|Period 3|Protocol Violation|0
922341|NCT00868790|1903924|FG013|Period 3|Protocol Violation|0
922342|NCT00868790|1903911|FG000|Period 3|Study Terminated by Sponsor|0
922343|NCT00868790|1903912|FG001|Period 3|Study Terminated by Sponsor|0
922344|NCT00868790|1903913|FG002|Period 3|Study Terminated by Sponsor|0
922345|NCT00868790|1903914|FG003|Period 3|Study Terminated by Sponsor|1
922346|NCT00868790|1903915|FG004|Period 3|Study Terminated by Sponsor|0
922347|NCT00868790|1903916|FG005|Period 3|Study Terminated by Sponsor|0
922348|NCT00868790|1903917|FG006|Period 3|Study Terminated by Sponsor|0
922349|NCT00868790|1903918|FG007|Period 3|Study Terminated by Sponsor|0
922350|NCT00868790|1903919|FG008|Period 3|Study Terminated by Sponsor|0
922351|NCT00868790|1903920|FG009|Period 3|Study Terminated by Sponsor|0
922352|NCT00868790|1903921|FG010|Period 3|Study Terminated by Sponsor|0
922353|NCT00868790|1903922|FG011|Period 3|Study Terminated by Sponsor|0
922354|NCT00868790|1903923|FG012|Period 3|Study Terminated by Sponsor|0
922355|NCT00868790|1903924|FG013|Period 3|Study Terminated by Sponsor|0
922356|NCT00868790|1903911|FG000|Period 4|Adverse Event|0
922357|NCT00868790|1903912|FG001|Period 4|Adverse Event|0
922358|NCT00868790|1903913|FG002|Period 4|Adverse Event|0
922359|NCT00868790|1903914|FG003|Period 4|Adverse Event|0
922360|NCT00868790|1903915|FG004|Period 4|Adverse Event|0
922361|NCT00868790|1903916|FG005|Period 4|Adverse Event|0
922362|NCT00868790|1903917|FG006|Period 4|Adverse Event|0
922363|NCT00868790|1903918|FG007|Period 4|Adverse Event|1
922364|NCT00868790|1903919|FG008|Period 4|Adverse Event|0
922365|NCT00868790|1903920|FG009|Period 4|Adverse Event|0
922366|NCT00868790|1903921|FG010|Period 4|Adverse Event|1
922367|NCT00868790|1903922|FG011|Period 4|Adverse Event|0
922368|NCT00868790|1903923|FG012|Period 4|Adverse Event|1
922369|NCT00868790|1903924|FG013|Period 4|Adverse Event|0
922370|NCT00868790|1903911|FG000|Period 4|Lost to Follow-up|0
922371|NCT00868790|1903912|FG001|Period 4|Lost to Follow-up|0
922372|NCT00868790|1903913|FG002|Period 4|Lost to Follow-up|0
922373|NCT00868790|1903914|FG003|Period 4|Lost to Follow-up|0
922374|NCT00868790|1903915|FG004|Period 4|Lost to Follow-up|0
922375|NCT00868790|1903916|FG005|Period 4|Lost to Follow-up|0
922376|NCT00868790|1903917|FG006|Period 4|Lost to Follow-up|0
922377|NCT00868790|1903918|FG007|Period 4|Lost to Follow-up|1
922378|NCT00868790|1903919|FG008|Period 4|Lost to Follow-up|0
922379|NCT00868790|1903920|FG009|Period 4|Lost to Follow-up|0
922380|NCT00868790|1903921|FG010|Period 4|Lost to Follow-up|0
922381|NCT00868790|1903922|FG011|Period 4|Lost to Follow-up|0
922382|NCT00868790|1903923|FG012|Period 4|Lost to Follow-up|0
922383|NCT00868790|1903924|FG013|Period 4|Lost to Follow-up|0
922384|NCT00868790|1903911|FG000|Period 4|Study Terminated by Sponsor|2
922385|NCT00868790|1903912|FG001|Period 4|Study Terminated by Sponsor|0
922386|NCT00868790|1903913|FG002|Period 4|Study Terminated by Sponsor|0
922387|NCT00868790|1903914|FG003|Period 4|Study Terminated by Sponsor|0
922388|NCT00868790|1903915|FG004|Period 4|Study Terminated by Sponsor|0
922389|NCT00868790|1903916|FG005|Period 4|Study Terminated by Sponsor|0
922390|NCT00868790|1903917|FG006|Period 4|Study Terminated by Sponsor|0
922391|NCT00868790|1903918|FG007|Period 4|Study Terminated by Sponsor|1
922392|NCT00868790|1903919|FG008|Period 4|Study Terminated by Sponsor|2
922393|NCT00868790|1903920|FG009|Period 4|Study Terminated by Sponsor|0
922394|NCT00868790|1903921|FG010|Period 4|Study Terminated by Sponsor|2
922395|NCT00868790|1903922|FG011|Period 4|Study Terminated by Sponsor|1
922396|NCT00868790|1903923|FG012|Period 4|Study Terminated by Sponsor|0
922397|NCT00868790|1903924|FG013|Period 4|Study Terminated by Sponsor|1
922398|NCT00868790|1903911|FG000|Period 4|Abnormal ALT/AST|0
922399|NCT00868790|1903912|FG001|Period 4|Abnormal ALT/AST|0
922400|NCT00868790|1903913|FG002|Period 4|Abnormal ALT/AST|1
922401|NCT00868790|1903914|FG003|Period 4|Abnormal ALT/AST|0
922402|NCT00868790|1903915|FG004|Period 4|Abnormal ALT/AST|0
922403|NCT00868790|1903916|FG005|Period 4|Abnormal ALT/AST|0
922404|NCT00868790|1903917|FG006|Period 4|Abnormal ALT/AST|0
922405|NCT00868790|1903918|FG007|Period 4|Abnormal ALT/AST|0
922406|NCT00868790|1903919|FG008|Period 4|Abnormal ALT/AST|0
922407|NCT00868790|1903920|FG009|Period 4|Abnormal ALT/AST|0
922408|NCT00868790|1903921|FG010|Period 4|Abnormal ALT/AST|0
922409|NCT00868790|1903922|FG011|Period 4|Abnormal ALT/AST|0
922410|NCT00868790|1903923|FG012|Period 4|Abnormal ALT/AST|0
922411|NCT00868790|1903924|FG013|Period 4|Abnormal ALT/AST|0
922412|NCT00868790|1903911|FG000|Post-study|Withdrawal by Subject|0
922413|NCT00868790|1903912|FG001|Post-study|Withdrawal by Subject|0
922414|NCT00868790|1903913|FG002|Post-study|Withdrawal by Subject|0
922415|NCT00868790|1903914|FG003|Post-study|Withdrawal by Subject|0
922416|NCT00868790|1903915|FG004|Post-study|Withdrawal by Subject|1
922417|NCT00868790|1903916|FG005|Post-study|Withdrawal by Subject|0
922418|NCT00868790|1903917|FG006|Post-study|Withdrawal by Subject|0
922419|NCT00868790|1903918|FG007|Post-study|Withdrawal by Subject|0
922420|NCT00868790|1903919|FG008|Post-study|Withdrawal by Subject|0
922421|NCT00868790|1903920|FG009|Post-study|Withdrawal by Subject|0
922422|NCT00868790|1903921|FG010|Post-study|Withdrawal by Subject|0
922423|NCT00868790|1903922|FG011|Post-study|Withdrawal by Subject|0
922424|NCT00868790|1903923|FG012|Post-study|Withdrawal by Subject|0
922425|NCT00868790|1903924|FG013|Post-study|Withdrawal by Subject|0
922426|NCT00868790|1903911|FG000|Post-study|Excluded Medication|0
922427|NCT00868790|1903912|FG001|Post-study|Excluded Medication|0
922428|NCT00868790|1903913|FG002|Post-study|Excluded Medication|0
922429|NCT00868790|1903914|FG003|Post-study|Excluded Medication|0
922430|NCT00868790|1903915|FG004|Post-study|Excluded Medication|0
922431|NCT00868790|1903916|FG005|Post-study|Excluded Medication|0
922432|NCT00868790|1903917|FG006|Post-study|Excluded Medication|0
922433|NCT00868790|1903918|FG007|Post-study|Excluded Medication|2
922434|NCT00868790|1903919|FG008|Post-study|Excluded Medication|0
922435|NCT00868790|1903920|FG009|Post-study|Excluded Medication|1
922436|NCT00868790|1903921|FG010|Post-study|Excluded Medication|0
922437|NCT00868790|1903922|FG011|Post-study|Excluded Medication|0
922438|NCT00868790|1903923|FG012|Post-study|Excluded Medication|0
922439|NCT00868790|1903924|FG013|Post-study|Excluded Medication|0
922440|NCT00869024|1903946|FG000|Overall Study|Death|2
922441|NCT00869024|1903947|FG001|Overall Study|Death|3
922442|NCT00869024|1903946|FG000|Overall Study|Lost to Follow-up|0
922443|NCT00869024|1903947|FG001|Overall Study|Lost to Follow-up|1
922444|NCT00869024|1903946|FG000|Overall Study|Protocol Violation|0
922445|NCT00869024|1903947|FG001|Overall Study|Protocol Violation|1
922446|NCT00869050|1903953|FG000|Overall Study|Screen Failure|3
922447|NCT00869089|1903957|FG000|Overall Study|Lost to Follow-up|1
922448|NCT00869089|1903957|FG000|Overall Study|Withdrawal by Subject|1
922449|NCT00869089|1903957|FG000|Overall Study|Screen Fail|1
922450|NCT00869128|1903961|FG000|Overall Study|lack of Compliance|6
922451|NCT00869128|1903962|FG001|Overall Study|lack of Compliance|6
922452|NCT00869323|1904003|FG000|Maintenance Therapy|concurrent illness|1
922453|NCT00869362|1904018|FG000|Overall Study|Death|0
922454|NCT00869362|1904019|FG001|Overall Study|Death|2
922455|NCT00869362|1904018|FG000|Overall Study|Lost to Follow-up|1
922456|NCT00869362|1904019|FG001|Overall Study|Lost to Follow-up|3
922457|NCT00869401|1904040|FG000|Overall Study|Withdrawal by Subject|0
922458|NCT00869401|1904041|FG001|Overall Study|Withdrawal by Subject|0
922459|NCT00869401|1904042|FG002|Overall Study|Withdrawal by Subject|0
922460|NCT00869401|1904043|FG003|Overall Study|Withdrawal by Subject|5
922461|NCT00869401|1904044|FG004|Overall Study|Withdrawal by Subject|3
922462|NCT00869440|1904060|FG000|Overall Study|Withdrawal by Subject|1
922463|NCT00869440|1904061|FG001|Overall Study|Withdrawal by Subject|0
922464|NCT00869440|1904062|FG002|Overall Study|Withdrawal by Subject|0
922465|NCT00869440|1904063|FG003|Overall Study|Withdrawal by Subject|0
922466|NCT00869440|1904060|FG000|Overall Study|Physician Decision|1
922467|NCT00869440|1904061|FG001|Overall Study|Physician Decision|1
922468|NCT00869440|1904062|FG002|Overall Study|Physician Decision|0
922469|NCT00869440|1904063|FG003|Overall Study|Physician Decision|0
922470|NCT00869518|1904075|FG000|Overall Study|Lost to Follow-up|1
922471|NCT00869518|1904076|FG001|Overall Study|Lost to Follow-up|1
922472|NCT00869557|1904084|FG000|Randomized Phase|Lost to Follow-up|2
922473|NCT00869557|1904085|FG001|Randomized Phase|Lost to Follow-up|1
922474|NCT00869557|1904084|FG000|Randomized Phase|Investigator's Discretion|1
922475|NCT00869557|1904085|FG001|Randomized Phase|Investigator's Discretion|0
922476|NCT00869557|1904084|FG000|Randomized Phase|Withdrew Consent|0
922477|NCT00869557|1904085|FG001|Randomized Phase|Withdrew Consent|1
922478|NCT00869557|1904084|FG000|Extension Phase|Adverse Event|2
922479|NCT00869557|1904085|FG001|Extension Phase|Adverse Event|2
922480|NCT00869557|1904084|FG000|Extension Phase|Lack of Efficacy|1
922481|NCT00869557|1904085|FG001|Extension Phase|Lack of Efficacy|0
922482|NCT00869557|1904084|FG000|Extension Phase|Lost to Follow-up|3
922483|NCT00869557|1904085|FG001|Extension Phase|Lost to Follow-up|1
922484|NCT00869557|1904084|FG000|Extension Phase|Investigator's Discretion|2
922485|NCT00869557|1904085|FG001|Extension Phase|Investigator's Discretion|0
922486|NCT00869557|1904084|FG000|Extension Phase|Withdrew Consent|2
922487|NCT00869557|1904085|FG001|Extension Phase|Withdrew Consent|0
922488|NCT00869778|1904114|FG000|Overall Study|Adverse Event|2
922489|NCT00869778|1904115|FG001|Overall Study|Adverse Event|0
922490|NCT00869778|1904116|FG002|Overall Study|Adverse Event|0
922491|NCT00869778|1904114|FG000|Overall Study|Withdrawal by Subject|3
922492|NCT00869778|1904115|FG001|Overall Study|Withdrawal by Subject|4
922493|NCT00869778|1904116|FG002|Overall Study|Withdrawal by Subject|5
922494|NCT00869778|1904114|FG000|Overall Study|Pregnancy|1
922495|NCT00869778|1904115|FG001|Overall Study|Pregnancy|0
922496|NCT00869778|1904116|FG002|Overall Study|Pregnancy|0
922497|NCT00869778|1904114|FG000|Overall Study|Protocol Violation|5
922498|NCT00869778|1904115|FG001|Overall Study|Protocol Violation|3
922499|NCT00869778|1904116|FG002|Overall Study|Protocol Violation|5
922500|NCT00869778|1904114|FG000|Overall Study|Unblinding|1
922501|NCT00869778|1904115|FG001|Overall Study|Unblinding|0
922502|NCT00869778|1904116|FG002|Overall Study|Unblinding|0
922503|NCT00869960|1904145|FG000|Overall Study|Lost to Follow-up|2
922504|NCT00869999|1904149|FG000|Overall Study|Withdrawal by Subject|1
922505|NCT00869999|1904149|FG000|Overall Study|removed prior to starting therapy|1
922506|NCT00870103|1904153|FG000|Overall Study|Physician Decision|2
922507|NCT00870103|1904153|FG000|Overall Study|Lost to Follow-up|2
922508|NCT00870194|1904159|FG000|Overall Study|Adverse Event|10
922509|NCT00870194|1904160|FG001|Overall Study|Adverse Event|5
922510|NCT00870194|1904159|FG000|Overall Study|Lack of Efficacy|0
922511|NCT00870194|1904160|FG001|Overall Study|Lack of Efficacy|1
922512|NCT00870194|1904159|FG000|Overall Study|Lost to Follow-up|2
922513|NCT00870194|1904160|FG001|Overall Study|Lost to Follow-up|0
922514|NCT00870194|1904159|FG000|Overall Study|Physician Decision|3
922515|NCT00870194|1904160|FG001|Overall Study|Physician Decision|1
922516|NCT00870194|1904159|FG000|Overall Study|Protocol Violation|3
922517|NCT00870194|1904160|FG001|Overall Study|Protocol Violation|3
922518|NCT00870194|1904159|FG000|Overall Study|Entry Criteria Not Met|1
922519|NCT00870194|1904160|FG001|Overall Study|Entry Criteria Not Met|2
922520|NCT00870194|1904159|FG000|Overall Study|Subject Decision|7
922521|NCT00870194|1904160|FG001|Overall Study|Subject Decision|2
922522|NCT00870233|1904166|FG000|Overall Study|Withdrawal by Subject|18
922523|NCT00870233|1904166|FG000|Overall Study|Did not undergo laparotomy|3
922524|NCT00870233|1904166|FG000|Overall Study|Incompatible internet browser|2
922525|NCT00870233|1904166|FG000|Overall Study|Death|1
922526|NCT00870584|1904213|FG000|Overall Study|Adverse Event|3
922527|NCT00870584|1904214|FG001|Overall Study|Adverse Event|3
922528|NCT00870584|1904213|FG000|Overall Study|Withdrawal by Subject|6
922529|NCT00870584|1904214|FG001|Overall Study|Withdrawal by Subject|7
922530|NCT00870584|1904213|FG000|Overall Study|Lost to Follow-up|5
922531|NCT00870584|1904214|FG001|Overall Study|Lost to Follow-up|1
922532|NCT00870584|1904213|FG000|Overall Study|Protocol Deviation|2
922533|NCT00870584|1904214|FG001|Overall Study|Protocol Deviation|2
922534|NCT00870688|1904220|FG000|Overall Study|Lost to Follow-up|2
922535|NCT00870688|1904220|FG000|Overall Study|Death, Unrelated|1
922536|NCT00870688|1904220|FG000|Overall Study|Granules in the Stools|1
922537|NCT00870727|1904225|FG000|Overall Study|Lost to Follow-up|0
922538|NCT00870727|1904226|FG001|Overall Study|Lost to Follow-up|1
922539|NCT00870727|1904225|FG000|Overall Study|Lack of Efficacy|1
922540|NCT00870727|1904226|FG001|Overall Study|Lack of Efficacy|3
922541|NCT00870727|1904225|FG000|Overall Study|Adverse Event|0
922542|NCT00870727|1904226|FG001|Overall Study|Adverse Event|1
922543|NCT00870740|1904238|FG000|Overall Study|Adverse Event|2
922544|NCT00870740|1904239|FG001|Overall Study|Adverse Event|1
922545|NCT00870740|1904240|FG002|Overall Study|Adverse Event|3
922546|NCT00870740|1904241|FG003|Overall Study|Adverse Event|2
922547|NCT00870740|1904242|FG004|Overall Study|Adverse Event|1
922548|NCT00870740|1904243|FG005|Overall Study|Adverse Event|6
922549|NCT00870740|1904238|FG000|Overall Study|Consent Withdrawn|6
922550|NCT00870740|1904239|FG001|Overall Study|Consent Withdrawn|3
922551|NCT00870740|1904240|FG002|Overall Study|Consent Withdrawn|4
922552|NCT00870740|1904241|FG003|Overall Study|Consent Withdrawn|6
922553|NCT00870740|1904242|FG004|Overall Study|Consent Withdrawn|6
922554|NCT00870740|1904243|FG005|Overall Study|Consent Withdrawn|5
922555|NCT00870740|1904238|FG000|Overall Study|Investigator Decision|2
922556|NCT00870740|1904239|FG001|Overall Study|Investigator Decision|0
922557|NCT00870740|1904240|FG002|Overall Study|Investigator Decision|1
922558|NCT00870740|1904241|FG003|Overall Study|Investigator Decision|0
922559|NCT00870740|1904242|FG004|Overall Study|Investigator Decision|0
922560|NCT00870740|1904243|FG005|Overall Study|Investigator Decision|0
922561|NCT00870740|1904238|FG000|Overall Study|Subject Non-compliance|0
922562|NCT00870740|1904239|FG001|Overall Study|Subject Non-compliance|0
922563|NCT00870740|1904240|FG002|Overall Study|Subject Non-compliance|0
922564|NCT00870740|1904241|FG003|Overall Study|Subject Non-compliance|0
922565|NCT00870740|1904242|FG004|Overall Study|Subject Non-compliance|0
922566|NCT00870740|1904243|FG005|Overall Study|Subject Non-compliance|1
922567|NCT00870740|1904238|FG000|Overall Study|Death|0
922568|NCT00870740|1904239|FG001|Overall Study|Death|0
922569|NCT00870740|1904240|FG002|Overall Study|Death|0
922570|NCT00870740|1904241|FG003|Overall Study|Death|0
922571|NCT00870740|1904242|FG004|Overall Study|Death|1
922572|NCT00870740|1904243|FG005|Overall Study|Death|0
922573|NCT00870740|1904238|FG000|Overall Study|Other|2
922574|NCT00870740|1904239|FG001|Overall Study|Other|5
922575|NCT00870740|1904240|FG002|Overall Study|Other|2
922576|NCT00870740|1904241|FG003|Overall Study|Other|4
922577|NCT00870740|1904242|FG004|Overall Study|Other|3
922578|NCT00870740|1904243|FG005|Overall Study|Other|5
922579|NCT00870870|1904272|FG000|Overall Study|Withdrawal by Subject|0
922580|NCT00870870|1904273|FG001|Overall Study|Withdrawal by Subject|1
922581|NCT00870870|1904274|FG002|Overall Study|Withdrawal by Subject|1
922582|NCT00870870|1904275|FG003|Overall Study|Withdrawal by Subject|3
922583|NCT00870870|1904272|FG000|Overall Study|Adverse Event|0
922584|NCT00870870|1904273|FG001|Overall Study|Adverse Event|0
922585|NCT00870870|1904274|FG002|Overall Study|Adverse Event|2
922586|NCT00870870|1904275|FG003|Overall Study|Adverse Event|2
922587|NCT00871000|1904298|FG000|Overall Study|Withdrawal by Subject|1
922588|NCT00871000|1904299|FG001|Overall Study|Withdrawal by Subject|0
922589|NCT00871117|1904307|FG000|Overall Study|Lost to Follow-up|5
922590|NCT00871117|1904308|FG001|Overall Study|Lost to Follow-up|6
922591|NCT00871117|1904307|FG000|Overall Study|Other|0
922592|NCT00871117|1904308|FG001|Overall Study|Other|4
922593|NCT00871169|1904324|FG000|Overall Study|Protocol Violation|1
922594|NCT00871169|1904324|FG000|Overall Study|Patient did not receive study treatment|2
922595|NCT00871234|1904328|FG000|Overall Study|Adverse Event|2
922596|NCT00871234|1904328|FG000|Overall Study|Lost to Follow-up|3
922597|NCT00871338|1904347|FG000|Prior to Booster|Withdrawal by Subject|1
922598|NCT00871338|1904348|FG001|Prior to Booster|Withdrawal by Subject|3
922599|NCT00871338|1904347|FG000|Prior to Booster|Lost to Follow-up|1
922600|NCT00871338|1904348|FG001|Prior to Booster|Lost to Follow-up|0
922601|NCT00871351|1904357|FG000|Overall Study|Withdrawal by Subject|1
922602|NCT00871351|1904358|FG001|Overall Study|Withdrawal by Subject|0
922603|NCT00871351|1904359|FG002|Overall Study|Withdrawal by Subject|0
922604|NCT00871351|1904357|FG000|Overall Study|Adverse Event|3
922605|NCT00871351|1904358|FG001|Overall Study|Adverse Event|1
922606|NCT00871351|1904359|FG002|Overall Study|Adverse Event|0
922607|NCT00871377|1904367|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0
922608|NCT00871377|1904368|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0
922609|NCT00871377|1904369|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1
922610|NCT00871377|1904370|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0
922611|NCT00871377|1904371|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0
922612|NCT00871377|1904372|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0
922613|NCT00871377|1904367|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0
922614|NCT00871377|1904368|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0
922615|NCT00871377|1904369|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0
922616|NCT00871377|1904370|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0
922617|NCT00871377|1904371|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0
922618|NCT00871377|1904372|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1
922619|NCT00871377|1904367|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
922620|NCT00871377|1904368|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
922621|NCT00871377|1904369|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
922622|NCT00871377|1904370|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
922623|NCT00871377|1904371|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
922624|NCT00871377|1904372|FG005|Washout (6 Weeks)|Withdrawal by Subject|0
922625|NCT00871377|1904367|FG000|Washout (6 Weeks)|Withdrawal by Subject|0
922626|NCT00871377|1904368|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
922627|NCT00871377|1904369|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
922628|NCT00871377|1904370|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
922629|NCT00871377|1904371|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
922630|NCT00871377|1904372|FG005|Washout (6 Weeks)|Withdrawal by Subject|1
922631|NCT00871377|1904367|FG000|Third Intervention (10 Weeks)|Death|0
922632|NCT00871377|1904368|FG001|Third Intervention (10 Weeks)|Death|0
922633|NCT00871377|1904369|FG002|Third Intervention (10 Weeks)|Death|0
922634|NCT00871377|1904370|FG003|Third Intervention (10 Weeks)|Death|1
922635|NCT00871377|1904371|FG004|Third Intervention (10 Weeks)|Death|0
922636|NCT00871377|1904372|FG005|Third Intervention (10 Weeks)|Death|0
922637|NCT00871403|1904383|FG000|Combination Treatment Phase|Randomized but Not Treated|1
922638|NCT00871403|1904384|FG001|Combination Treatment Phase|Randomized but Not Treated|1
922639|NCT00871403|1904385|FG002|Combination Treatment Phase|Randomized but Not Treated|1
922640|NCT00871403|1904383|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
922641|NCT00871403|1904384|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
922642|NCT00871403|1904385|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
922643|NCT00871403|1904383|FG000|Combination Treatment Phase|Adverse Event|0
922644|NCT00871403|1904384|FG001|Combination Treatment Phase|Adverse Event|17
922645|NCT00871403|1904385|FG002|Combination Treatment Phase|Adverse Event|2
922646|NCT00871403|1904383|FG000|Combination Treatment Phase|Disease Progression|0
922647|NCT00871403|1904384|FG001|Combination Treatment Phase|Disease Progression|8
922648|NCT00871403|1904385|FG002|Combination Treatment Phase|Disease Progression|5
922649|NCT00871403|1904383|FG000|Combination Treatment Phase|Withdrawal by Subject|0
922650|NCT00871403|1904384|FG001|Combination Treatment Phase|Withdrawal by Subject|3
922651|NCT00871403|1904385|FG002|Combination Treatment Phase|Withdrawal by Subject|1
922652|NCT00871403|1904383|FG000|Combination Treatment Phase|Physician Decision|0
922653|NCT00871403|1904384|FG001|Combination Treatment Phase|Physician Decision|1
922654|NCT00871403|1904385|FG002|Combination Treatment Phase|Physician Decision|3
922655|NCT00871403|1904383|FG000|Monotherapy Treatment Phase|Disease Progression|0
922656|NCT00871403|1904384|FG001|Monotherapy Treatment Phase|Disease Progression|9
922657|NCT00871403|1904385|FG002|Monotherapy Treatment Phase|Disease Progression|1
922658|NCT00871403|1904383|FG000|Monotherapy Treatment Phase|Adverse Event|0
922659|NCT00871403|1904384|FG001|Monotherapy Treatment Phase|Adverse Event|4
922660|NCT00871403|1904385|FG002|Monotherapy Treatment Phase|Adverse Event|0
922661|NCT00871429|1904392|FG000|Overall Study|Lost to Follow-up|6
922662|NCT00871429|1904392|FG000|Overall Study|Withdrawal by Subject|17
922663|NCT00871429|1904392|FG000|Overall Study|Questionnaire not completed|1
922664|NCT00871494|1904400|FG000|Overall Study|Protocol Violation|5
922665|NCT00871494|1904400|FG000|Overall Study|Lack of Efficacy|4
922666|NCT00871494|1904400|FG000|Overall Study|Adverse Event|4
922667|NCT00871494|1904400|FG000|Overall Study|Lost to Follow-up|1
922668|NCT00871572|1904408|FG000|Overall Study|Adverse Event|0
922669|NCT00871572|1904409|FG001|Overall Study|Adverse Event|2
922670|NCT00871572|1904410|FG002|Overall Study|Adverse Event|0
922671|NCT00871572|1904411|FG003|Overall Study|Adverse Event|3
922672|NCT00871572|1904408|FG000|Overall Study|Investigator Decision|0
922673|NCT00871572|1904409|FG001|Overall Study|Investigator Decision|1
922674|NCT00871572|1904410|FG002|Overall Study|Investigator Decision|0
922675|NCT00871572|1904411|FG003|Overall Study|Investigator Decision|1
922676|NCT00871572|1904408|FG000|Overall Study|Lost to Follow-up|0
922677|NCT00871572|1904409|FG001|Overall Study|Lost to Follow-up|1
922678|NCT00871572|1904410|FG002|Overall Study|Lost to Follow-up|0
922679|NCT00871572|1904411|FG003|Overall Study|Lost to Follow-up|1
922680|NCT00871572|1904408|FG000|Overall Study|Protocol Violation|0
922681|NCT00871572|1904409|FG001|Overall Study|Protocol Violation|0
922682|NCT00871572|1904410|FG002|Overall Study|Protocol Violation|1
922683|NCT00871572|1904411|FG003|Overall Study|Protocol Violation|1
922684|NCT00871572|1904408|FG000|Overall Study|Sponsor Decision|1
922685|NCT00871572|1904409|FG001|Overall Study|Sponsor Decision|0
922686|NCT00871572|1904410|FG002|Overall Study|Sponsor Decision|0
922687|NCT00871572|1904411|FG003|Overall Study|Sponsor Decision|0
922688|NCT00871572|1904408|FG000|Overall Study|Withdrawal by Subject|1
922689|NCT00871572|1904409|FG001|Overall Study|Withdrawal by Subject|2
922690|NCT00871572|1904410|FG002|Overall Study|Withdrawal by Subject|3
922691|NCT00871572|1904411|FG003|Overall Study|Withdrawal by Subject|1
922692|NCT00871715|1904439|FG000|Overall Study|Withdrawal by Subject|6
922693|NCT00871715|1904440|FG001|Overall Study|Withdrawal by Subject|10
922694|NCT00871715|1904441|FG002|Overall Study|Withdrawal by Subject|15
922695|NCT00871715|1904439|FG000|Overall Study|Physician Decision|6
922696|NCT00871715|1904440|FG001|Overall Study|Physician Decision|0
922697|NCT00871715|1904441|FG002|Overall Study|Physician Decision|2
922698|NCT00871715|1904439|FG000|Overall Study|Lost to Follow-up|3
922699|NCT00871715|1904440|FG001|Overall Study|Lost to Follow-up|6
922700|NCT00871715|1904441|FG002|Overall Study|Lost to Follow-up|9
922701|NCT00871728|1904450|FG000|Overall Study|Adverse Event|1
922702|NCT00871728|1904450|FG000|Overall Study|Protocol Violation|7
922703|NCT00871728|1904450|FG000|Overall Study|Lost to Follow-up|2
922704|NCT00871728|1904450|FG000|Overall Study|Failed to Visit Hospital|4
922705|NCT00871728|1904450|FG000|Overall Study|Participant Non-compliance|1
922706|NCT00871728|1904450|FG000|Overall Study|Withdrawal of Informed Consent|5
922707|NCT00871741|1904456|FG000|Overall Study|Premature study termination|9
922708|NCT00871741|1904457|FG001|Overall Study|Premature study termination|7
922709|NCT00871780|1904463|FG000|Overall Study|Enrolled But Not Treated|6
922710|NCT00871780|1904463|FG000|Overall Study|Withdrawal by Subject|9
922711|NCT00871780|1904463|FG000|Overall Study|Adverse Event|6
922712|NCT00871780|1904463|FG000|Overall Study|Voluntary Discontinuation|4
922713|NCT00871780|1904463|FG000|Overall Study|Death|1
922714|NCT00871780|1904463|FG000|Overall Study|Physician Decision|1
922715|NCT00871858|1904489|FG000|Overall Study|Protocol Violation|3
922716|NCT00871858|1904490|FG001|Overall Study|Protocol Violation|4
922717|NCT00871858|1904489|FG000|Overall Study|Adverse Event|1
922718|NCT00871858|1904490|FG001|Overall Study|Adverse Event|1
922719|NCT00871858|1904489|FG000|Overall Study|Withdrawal by Subject|1
922720|NCT00871858|1904490|FG001|Overall Study|Withdrawal by Subject|1
922721|NCT00871858|1904489|FG000|Overall Study|Lost to Follow-up|0
922722|NCT00871858|1904490|FG001|Overall Study|Lost to Follow-up|1
922723|NCT00871871|1904498|FG000|Part I|Adverse Event|0
922724|NCT00871871|1904499|FG001|Part I|Adverse Event|2
922725|NCT00871871|1904500|FG002|Part I|Adverse Event|0
922726|NCT00871871|1904501|FG003|Part I|Adverse Event|0
922727|NCT00871871|1904498|FG000|Part I|Withdrawal by Subject|3
922728|NCT00871871|1904499|FG001|Part I|Withdrawal by Subject|0
922729|NCT00871871|1904500|FG002|Part I|Withdrawal by Subject|0
922730|NCT00871871|1904501|FG003|Part I|Withdrawal by Subject|0
922731|NCT00871871|1904498|FG000|Part I|Laboratory abnormality|0
922732|NCT00871871|1904499|FG001|Part I|Laboratory abnormality|1
922733|NCT00871871|1904500|FG002|Part I|Laboratory abnormality|0
922734|NCT00871871|1904501|FG003|Part I|Laboratory abnormality|0
922735|NCT00871871|1904498|FG000|Part II|Lack of Efficacy|0
922736|NCT00871871|1904499|FG001|Part II|Lack of Efficacy|0
922737|NCT00871871|1904500|FG002|Part II|Lack of Efficacy|1
922738|NCT00871871|1904501|FG003|Part II|Lack of Efficacy|0
922739|NCT00871871|1904498|FG000|Part II|Withdrawal by Subject|0
922740|NCT00871871|1904499|FG001|Part II|Withdrawal by Subject|0
922741|NCT00871871|1904500|FG002|Part II|Withdrawal by Subject|2
922742|NCT00871871|1904501|FG003|Part II|Withdrawal by Subject|1
922743|NCT00871871|1904498|FG000|Part II|Adverse Event|0
922744|NCT00871871|1904499|FG001|Part II|Adverse Event|0
922745|NCT00871871|1904500|FG002|Part II|Adverse Event|1
922746|NCT00871871|1904501|FG003|Part II|Adverse Event|2
922747|NCT00871871|1904498|FG000|Part II|Protocol Violation|0
922748|NCT00871871|1904499|FG001|Part II|Protocol Violation|0
922749|NCT00871871|1904500|FG002|Part II|Protocol Violation|0
922750|NCT00871871|1904501|FG003|Part II|Protocol Violation|1
922751|NCT00871923|1904511|FG000|Overall Study|Death|1
922752|NCT00871923|1904511|FG000|Overall Study|Withdrawal by Subject|1
922753|NCT00871975|1904515|FG000|Overall Study|Technical difficulty w155-1ith equipment|3
922754|NCT00871975|1904515|FG000|Overall Study|Catheters could not be inserted|1
922755|NCT00871975|1904515|FG000|Overall Study|Patient unable to void/insufficient vol|13
922756|NCT00871975|1904515|FG000|Overall Study|Motion artifact, tracing uninterpretable|5
922757|NCT00872001|1904521|FG000|Overall Study|Adverse Event|34
922758|NCT00872001|1904522|FG001|Overall Study|Adverse Event|23
922759|NCT00872001|1904521|FG000|Overall Study|Protocol Defined Clinical Event|5
922760|NCT00872001|1904522|FG001|Overall Study|Protocol Defined Clinical Event|7
922761|NCT00872001|1904521|FG000|Overall Study|Lost to Follow-up|13
922762|NCT00872001|1904522|FG001|Overall Study|Lost to Follow-up|12
922763|NCT00872001|1904521|FG000|Overall Study|Withdrawal by Subject|18
922764|NCT00872001|1904522|FG001|Overall Study|Withdrawal by Subject|30
922765|NCT00872001|1904521|FG000|Overall Study|Protocol Violation|5
922766|NCT00872001|1904522|FG001|Overall Study|Protocol Violation|8
922767|NCT00872001|1904521|FG000|Overall Study|Did Not Meet Protocol Eligibility|38
922768|NCT00872001|1904522|FG001|Overall Study|Did Not Meet Protocol Eligibility|36
922769|NCT00872001|1904521|FG000|Overall Study|Administrative|23
922770|NCT00872001|1904522|FG001|Overall Study|Administrative|15
922771|NCT00872170|1904545|FG000|Overall Study|Adverse Event|1
922772|NCT00872170|1904546|FG001|Overall Study|Adverse Event|0
922773|NCT00872521|1904574|FG000|Completed PAD Induction|Patient choice|0
922774|NCT00872521|1904575|FG001|Completed PAD Induction|Patient choice|1
922775|NCT00872521|1904576|FG002|Completed PAD Induction|Patient choice|0
922776|NCT00872521|1904574|FG000|Completed PAD Induction|Disease progression|0
922777|NCT00872521|1904575|FG001|Completed PAD Induction|Disease progression|2
922778|NCT00872521|1904576|FG002|Completed PAD Induction|Disease progression|0
922779|NCT00872521|1904574|FG000|Completed PAD Induction|Adverse Event|4
922780|NCT00872521|1904575|FG001|Completed PAD Induction|Adverse Event|0
922781|NCT00872521|1904576|FG002|Completed PAD Induction|Adverse Event|0
922782|NCT00872521|1904574|FG000|Completed PAD Induction|Death|1
922783|NCT00872521|1904575|FG001|Completed PAD Induction|Death|1
922784|NCT00872521|1904576|FG002|Completed PAD Induction|Death|0
922785|NCT00872521|1904574|FG000|Primary Endpoint Analysis|Other|1
922786|NCT00872521|1904575|FG001|Primary Endpoint Analysis|Other|2
922787|NCT00872521|1904576|FG002|Primary Endpoint Analysis|Other|0
922788|NCT00872521|1904574|FG000|Primary Endpoint Analysis|Patient choice|0
922789|NCT00872521|1904575|FG001|Primary Endpoint Analysis|Patient choice|1
922790|NCT00872521|1904576|FG002|Primary Endpoint Analysis|Patient choice|0
922791|NCT00872521|1904574|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0
922792|NCT00872521|1904575|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2
922793|NCT00872521|1904576|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0
922794|NCT00872521|1904574|FG000|Primary Endpoint Analysis|Patient response missing|0
922795|NCT00872521|1904575|FG001|Primary Endpoint Analysis|Patient response missing|0
922796|NCT00872521|1904576|FG002|Primary Endpoint Analysis|Patient response missing|1
922797|NCT00872521|1904574|FG000|Completed 3-month Follow up|Other|0
922798|NCT00872521|1904575|FG001|Completed 3-month Follow up|Other|2
922799|NCT00872521|1904576|FG002|Completed 3-month Follow up|Other|0
922800|NCT00872521|1904574|FG000|Completed 3-month Follow up|Physician Decision|0
922801|NCT00872521|1904575|FG001|Completed 3-month Follow up|Physician Decision|1
922802|NCT00872521|1904576|FG002|Completed 3-month Follow up|Physician Decision|0
922803|NCT00872521|1904574|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0
922804|NCT00872521|1904575|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2
922805|NCT00872521|1904576|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1
922806|NCT00872599|1904604|FG000|Second Washout Period|Adverse Event|1
922807|NCT00872599|1904605|FG001|Second Washout Period|Adverse Event|1
922808|NCT00872898|1904650|FG000|Part Two - Double Blind|Adverse Event|4
922809|NCT00872898|1904651|FG001|Part Two - Double Blind|Adverse Event|3
922810|NCT00872898|1904650|FG000|Part Two - Double Blind|Lack of Efficacy|1
922811|NCT00872898|1904651|FG001|Part Two - Double Blind|Lack of Efficacy|0
922812|NCT00872898|1904650|FG000|Part Two - Double Blind|Protocol Violation|1
922813|NCT00872898|1904651|FG001|Part Two - Double Blind|Protocol Violation|0
922814|NCT00872898|1904650|FG000|Part Two - Double Blind|Withdrawal by Subject|3
922815|NCT00872898|1904651|FG001|Part Two - Double Blind|Withdrawal by Subject|1
922816|NCT00872898|1904650|FG000|Part Two - Double Blind|Lost to Follow-up|0
922817|NCT00872898|1904651|FG001|Part Two - Double Blind|Lost to Follow-up|2
922818|NCT00872898|1904650|FG000|Part Two - Double Blind|Other reasons|2
922819|NCT00872898|1904651|FG001|Part Two - Double Blind|Other reasons|0
922820|NCT00872989|1904662|FG000|Overall Study|Adverse Event|7
922821|NCT00872989|1904663|FG001|Overall Study|Adverse Event|15
922822|NCT00872989|1904662|FG000|Overall Study|Withdrawal by Subject|8
922823|NCT00872989|1904663|FG001|Overall Study|Withdrawal by Subject|5
922824|NCT00872989|1904662|FG000|Overall Study|Progression/relapse|47
922825|NCT00872989|1904663|FG001|Overall Study|Progression/relapse|35
922826|NCT00872989|1904662|FG000|Overall Study|Not protocol specified|3
922827|NCT00872989|1904663|FG001|Overall Study|Not protocol specified|8
922828|NCT00873015|1904679|FG000|Overall Study|Withdrawal by Subject|0
922829|NCT00873015|1904680|FG001|Overall Study|Withdrawal by Subject|1
922830|NCT00873015|1904681|FG002|Overall Study|Withdrawal by Subject|0
922831|NCT00873015|1904682|FG003|Overall Study|Withdrawal by Subject|0
922832|NCT00873041|1904694|FG000|Core Study|Adverse Event|2
922833|NCT00873041|1904695|FG001|Core Study|Adverse Event|3
922834|NCT00873041|1904696|FG002|Core Study|Adverse Event|1
922835|NCT00873041|1904694|FG000|Core Study|Withdrawal by Subject|1
922836|NCT00873041|1904695|FG001|Core Study|Withdrawal by Subject|2
922837|NCT00873041|1904696|FG002|Core Study|Withdrawal by Subject|2
922838|NCT00873041|1904694|FG000|Core Study|Lost to Follow-up|3
922839|NCT00873041|1904695|FG001|Core Study|Lost to Follow-up|1
922840|NCT00873041|1904696|FG002|Core Study|Lost to Follow-up|0
922841|NCT00873041|1904694|FG000|Core Study|Abnormal laboratory value|0
922842|NCT00873041|1904695|FG001|Core Study|Abnormal laboratory value|0
922843|NCT00873041|1904696|FG002|Core Study|Abnormal laboratory value|1
922844|NCT00873041|1904694|FG000|Core Study|Protocol deviation|1
922845|NCT00873041|1904695|FG001|Core Study|Protocol deviation|0
922846|NCT00873041|1904696|FG002|Core Study|Protocol deviation|1
922847|NCT00873041|1904694|FG000|Extension Study|Adverse Event|1
922848|NCT00873041|1904695|FG001|Extension Study|Adverse Event|0
922849|NCT00873041|1904696|FG002|Extension Study|Adverse Event|1
922850|NCT00873041|1904694|FG000|Extension Study|Administrative reasons|0
922851|NCT00873041|1904695|FG001|Extension Study|Administrative reasons|0
922852|NCT00873041|1904696|FG002|Extension Study|Administrative reasons|1
922853|NCT00873093|1904716|FG000|Overall Study|Adverse Event|0
922854|NCT00873093|1904717|FG001|Overall Study|Adverse Event|2
922855|NCT00873093|1904718|FG002|Overall Study|Adverse Event|0
922856|NCT00873093|1904719|FG003|Overall Study|Adverse Event|0
922857|NCT00873093|1904720|FG004|Overall Study|Adverse Event|0
922858|NCT00873093|1904716|FG000|Overall Study|Death|0
922859|NCT00873093|1904717|FG001|Overall Study|Death|3
922860|NCT00873093|1904718|FG002|Overall Study|Death|2
922861|NCT00873093|1904719|FG003|Overall Study|Death|0
922862|NCT00873093|1904720|FG004|Overall Study|Death|0
922863|NCT00873093|1904716|FG000|Overall Study|Physician Decision|0
922864|NCT00873093|1904717|FG001|Overall Study|Physician Decision|17
922865|NCT00873093|1904718|FG002|Overall Study|Physician Decision|10
922866|NCT00873093|1904719|FG003|Overall Study|Physician Decision|10
922867|NCT00873093|1904720|FG004|Overall Study|Physician Decision|2
922868|NCT00873093|1904716|FG000|Overall Study|Withdrawal by Subject|1
922869|NCT00873093|1904717|FG001|Overall Study|Withdrawal by Subject|4
922870|NCT00873093|1904718|FG002|Overall Study|Withdrawal by Subject|4
922871|NCT00873093|1904719|FG003|Overall Study|Withdrawal by Subject|0
922872|NCT00873093|1904720|FG004|Overall Study|Withdrawal by Subject|0
922873|NCT00873093|1904716|FG000|Overall Study|Ineligible|0
922874|NCT00873093|1904717|FG001|Overall Study|Ineligible|1
922875|NCT00873093|1904718|FG002|Overall Study|Ineligible|0
922876|NCT00873093|1904719|FG003|Overall Study|Ineligible|1
922877|NCT00873093|1904720|FG004|Overall Study|Ineligible|0
922878|NCT00873119|1904744|FG000|Overall Study|Patient request|4
922879|NCT00873119|1904745|FG001|Overall Study|Patient request|2
922880|NCT00873119|1904744|FG000|Overall Study|Adverse Event|8
922881|NCT00873119|1904745|FG001|Overall Study|Adverse Event|0
922882|NCT00873119|1904744|FG000|Overall Study|Progressive disease|26
922883|NCT00873119|1904745|FG001|Overall Study|Progressive disease|18
922884|NCT00873119|1904744|FG000|Overall Study|Death|2
922885|NCT00873119|1904745|FG001|Overall Study|Death|1
922886|NCT00873119|1904744|FG000|Overall Study|Other|2
922887|NCT00873119|1904745|FG001|Overall Study|Other|5
922888|NCT00873119|1904744|FG000|Overall Study|Not treated|2
922889|NCT00873119|1904745|FG001|Overall Study|Not treated|0
922890|NCT00873730|1904765|FG000|Overall Study|Protocol Deviation|5
922891|NCT00873730|1904766|FG001|Overall Study|Protocol Deviation|2
922892|NCT00873730|1904765|FG000|Overall Study|Adverse Event|0
922893|NCT00873730|1904766|FG001|Overall Study|Adverse Event|2
922894|NCT00873730|1904765|FG000|Overall Study|Withdrawal by Subject|0
922895|NCT00873730|1904766|FG001|Overall Study|Withdrawal by Subject|1
922896|NCT00873730|1904765|FG000|Overall Study|Sponsor decision|1
922897|NCT00873730|1904766|FG001|Overall Study|Sponsor decision|0
922898|NCT00873860|1904789|FG000|Overall Study|Lost to Follow-up|1
922899|NCT00873860|1904790|FG001|Overall Study|Lost to Follow-up|0
922900|NCT00873860|1904791|FG002|Overall Study|Lost to Follow-up|0
922901|NCT00873860|1904792|FG003|Overall Study|Lost to Follow-up|1
922902|NCT00873860|1904789|FG000|Overall Study|Withdrawal by Subject|1
922903|NCT00873860|1904790|FG001|Overall Study|Withdrawal by Subject|0
922904|NCT00873860|1904791|FG002|Overall Study|Withdrawal by Subject|2
922905|NCT00873860|1904792|FG003|Overall Study|Withdrawal by Subject|0
922906|NCT00873860|1904789|FG000|Overall Study|Death|1
922907|NCT00873860|1904790|FG001|Overall Study|Death|0
922908|NCT00873860|1904791|FG002|Overall Study|Death|0
922909|NCT00873860|1904792|FG003|Overall Study|Death|0
922910|NCT00873860|1904789|FG000|Overall Study|Other|1
922911|NCT00873860|1904790|FG001|Overall Study|Other|0
922912|NCT00873860|1904791|FG002|Overall Study|Other|1
922913|NCT00873860|1904792|FG003|Overall Study|Other|0
922914|NCT00873912|1904824|FG000|Overall Study|Withdrawal by Subject|1
922915|NCT00873912|1904825|FG001|Overall Study|Withdrawal by Subject|0
922916|NCT00873912|1904824|FG000|Overall Study|Lost to Follow-up|2
922917|NCT00873912|1904825|FG001|Overall Study|Lost to Follow-up|0
922918|NCT00874029|1904831|FG000|Overall Study|Withdrawal by Subject|10
922919|NCT00874029|1904831|FG000|Overall Study|Pregnancy|4
922920|NCT00874029|1904831|FG000|Overall Study|Physician Decision|1
922921|NCT00874029|1904831|FG000|Overall Study|Adverse Event|1
922922|NCT00874029|1904831|FG000|Overall Study|Lost to Follow-up|5
922923|NCT00874120|1904851|FG000|First Intervention|Adverse Event|0
922924|NCT00874120|1904852|FG001|First Intervention|Adverse Event|1
922925|NCT00874120|1904851|FG000|First Intervention|Withdrawal by Subject|2
922926|NCT00874120|1904852|FG001|First Intervention|Withdrawal by Subject|0
922927|NCT00874120|1904851|FG000|First Intervention|Lost to Follow-up|0
922928|NCT00874120|1904852|FG001|First Intervention|Lost to Follow-up|1
922929|NCT00874120|1904851|FG000|First Intervention|Protocol Violation|3
922930|NCT00874120|1904852|FG001|First Intervention|Protocol Violation|0
922931|NCT00874120|1904851|FG000|First Intervention|positive drug test|1
922932|NCT00874120|1904852|FG001|First Intervention|positive drug test|0
922933|NCT00874120|1904851|FG000|Second Intervention|Withdrawal by Subject|1
922934|NCT00874120|1904852|FG001|Second Intervention|Withdrawal by Subject|0
922935|NCT00874120|1904851|FG000|Second Intervention|Protocol Violation|1
922936|NCT00874120|1904852|FG001|Second Intervention|Protocol Violation|0
922937|NCT00874237|1904858|FG000|Overall Study|Physician Decision|0
922938|NCT00874237|1904859|FG001|Overall Study|Physician Decision|1
922939|NCT00874237|1904860|FG002|Overall Study|Physician Decision|0
922940|NCT00874237|1904861|FG003|Overall Study|Physician Decision|0
922941|NCT00874237|1904862|FG004|Overall Study|Physician Decision|0
922942|NCT00874237|1904863|FG005|Overall Study|Physician Decision|0
922943|NCT00874237|1904858|FG000|Overall Study|Withdrawal by Subject|0
922944|NCT00874237|1904859|FG001|Overall Study|Withdrawal by Subject|0
922945|NCT00874237|1904860|FG002|Overall Study|Withdrawal by Subject|1
922946|NCT00874237|1904861|FG003|Overall Study|Withdrawal by Subject|0
922947|NCT00874237|1904862|FG004|Overall Study|Withdrawal by Subject|0
922948|NCT00874237|1904863|FG005|Overall Study|Withdrawal by Subject|0
922949|NCT00874276|1904880|FG000|Overall Study|Withdrawal by Subject|1
922950|NCT00874276|1904881|FG001|Overall Study|Withdrawal by Subject|1
922951|NCT00874432|1904893|FG000|Overall Study|Withdrawal by Subject|1
922952|NCT00874432|1904894|FG001|Overall Study|Withdrawal by Subject|0
922953|NCT00874432|1904895|FG002|Overall Study|Withdrawal by Subject|0
922954|NCT00874432|1904896|FG003|Overall Study|Withdrawal by Subject|0
922955|NCT00874432|1904893|FG000|Overall Study|Physician Decision|1
922956|NCT00874432|1904894|FG001|Overall Study|Physician Decision|0
922957|NCT00874432|1904895|FG002|Overall Study|Physician Decision|0
922958|NCT00874432|1904896|FG003|Overall Study|Physician Decision|0
922959|NCT00874432|1904893|FG000|Overall Study|Other|1
922960|NCT00874432|1904894|FG001|Overall Study|Other|2
922961|NCT00874432|1904895|FG002|Overall Study|Other|8
922962|NCT00874432|1904896|FG003|Overall Study|Other|3
922963|NCT00874497|1904910|FG000|Overall Study|Lost to Follow-up|2
922964|NCT00874497|1904911|FG001|Overall Study|Lost to Follow-up|4
922965|NCT00874497|1904910|FG000|Overall Study|Adverse Event|9
922966|NCT00874497|1904911|FG001|Overall Study|Adverse Event|4
922967|NCT00874497|1904910|FG000|Overall Study|Sponsor Discontinued Trial|7
922968|NCT00874497|1904911|FG001|Overall Study|Sponsor Discontinued Trial|3
922969|NCT00874497|1904910|FG000|Overall Study|Met Withdrawal Criteria|4
922970|NCT00874497|1904911|FG001|Overall Study|Met Withdrawal Criteria|2
922971|NCT00874497|1904910|FG000|Overall Study|Physician Decision|1
922972|NCT00874497|1904911|FG001|Overall Study|Physician Decision|1
922973|NCT00874497|1904910|FG000|Overall Study|Withdrawal by Subject|5
922974|NCT00874497|1904911|FG001|Overall Study|Withdrawal by Subject|4
922975|NCT00874549|1904930|FG000|Overall Study|Adverse Event|0
922976|NCT00874549|1904931|FG001|Overall Study|Adverse Event|0
922977|NCT00874549|1904932|FG002|Overall Study|Adverse Event|1
922978|NCT00874549|1904933|FG003|Overall Study|Adverse Event|0
922979|NCT00874549|1904930|FG000|Overall Study|Protocol Violation|1
922980|NCT00874549|1904931|FG001|Overall Study|Protocol Violation|0
922981|NCT00874549|1904932|FG002|Overall Study|Protocol Violation|2
922982|NCT00874549|1904933|FG003|Overall Study|Protocol Violation|1
922983|NCT00874549|1904930|FG000|Overall Study|Lost to Follow-up|0
922984|NCT00874549|1904931|FG001|Overall Study|Lost to Follow-up|0
922985|NCT00874549|1904932|FG002|Overall Study|Lost to Follow-up|1
922986|NCT00874549|1904933|FG003|Overall Study|Lost to Follow-up|0
922987|NCT00874549|1904930|FG000|Overall Study|Withdrawal by Subject|0
922988|NCT00874549|1904931|FG001|Overall Study|Withdrawal by Subject|1
922989|NCT00874549|1904932|FG002|Overall Study|Withdrawal by Subject|0
922990|NCT00874549|1904933|FG003|Overall Study|Withdrawal by Subject|1
922991|NCT00874731|1904949|FG000|Part 1, Day 1: Placebo|Disease Progression|1
922992|NCT00874731|1904950|FG001|Part 1, Day 1: Placebo|Disease Progression|0
922993|NCT00874731|1904951|FG002|Part 1, Day 1: Placebo|Disease Progression|0
922994|NCT00874731|1904949|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0
922995|NCT00874731|1904950|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0
922996|NCT00874731|1904951|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3
922997|NCT00874731|1904949|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0
922998|NCT00874731|1904950|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0
922999|NCT00874731|1904951|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19
923000|NCT00874770|1904963|FG000|Overall Study|Lack of Efficacy|2
923001|NCT00874770|1904964|FG001|Overall Study|Lack of Efficacy|0
923002|NCT00874770|1904965|FG002|Overall Study|Lack of Efficacy|0
923003|NCT00874770|1904966|FG003|Overall Study|Lack of Efficacy|2
923004|NCT00874770|1904963|FG000|Overall Study|Adverse Event|1
923005|NCT00874770|1904964|FG001|Overall Study|Adverse Event|1
923006|NCT00874770|1904965|FG002|Overall Study|Adverse Event|4
923007|NCT00874770|1904966|FG003|Overall Study|Adverse Event|2
923008|NCT00874770|1904963|FG000|Overall Study|Lost to Follow-up|1
923009|NCT00874770|1904964|FG001|Overall Study|Lost to Follow-up|0
923010|NCT00874770|1904965|FG002|Overall Study|Lost to Follow-up|0
923011|NCT00874770|1904966|FG003|Overall Study|Lost to Follow-up|1
923012|NCT00874770|1904963|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
923013|NCT00874770|1904964|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
923014|NCT00874770|1904965|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
923015|NCT00874770|1904966|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
923016|NCT00874822|1904986|FG000|Overall Study|excluded by criteria|8
923017|NCT00874848|1904992|FG000|Overall Study|Adverse Event|13
923018|NCT00874848|1904993|FG001|Overall Study|Adverse Event|2
923019|NCT00874848|1904992|FG000|Overall Study|Progressive neoplastic disease|38
923020|NCT00874848|1904993|FG001|Overall Study|Progressive neoplastic disease|18
923021|NCT00874848|1904992|FG000|Overall Study|Withdrawal by Subject|7
923022|NCT00874848|1904993|FG001|Overall Study|Withdrawal by Subject|4
923023|NCT00874848|1904992|FG000|Overall Study|Noncompliance|1
923024|NCT00874848|1904993|FG001|Overall Study|Noncompliance|1
923025|NCT00874848|1904992|FG000|Overall Study|Failure to comply with protocol|0
923026|NCT00874848|1904993|FG001|Overall Study|Failure to comply with protocol|1
923027|NCT00874848|1904992|FG000|Overall Study|Physician Decision|0
923028|NCT00874848|1904993|FG001|Overall Study|Physician Decision|2
923029|NCT00875017|1905014|FG000|First Intervention|Withdrawal by Subject|1
923030|NCT00875017|1905015|FG001|First Intervention|Withdrawal by Subject|0
923031|NCT00875017|1905016|FG002|First Intervention|Withdrawal by Subject|1
923032|NCT00875017|1905017|FG003|First Intervention|Withdrawal by Subject|0
923033|NCT00875017|1905018|FG004|First Intervention|Withdrawal by Subject|0
923034|NCT00875017|1905019|FG005|First Intervention|Withdrawal by Subject|0
923035|NCT00875017|1905014|FG000|First Intervention|Adverse Event|0
923036|NCT00875017|1905015|FG001|First Intervention|Adverse Event|0
923037|NCT00875017|1905016|FG002|First Intervention|Adverse Event|0
923038|NCT00875017|1905017|FG003|First Intervention|Adverse Event|1
923039|NCT00875017|1905018|FG004|First Intervention|Adverse Event|0
923040|NCT00875017|1905019|FG005|First Intervention|Adverse Event|0
923041|NCT00875017|1905014|FG000|First Intervention|Problems collecting rectal effluent|1
923042|NCT00875017|1905015|FG001|First Intervention|Problems collecting rectal effluent|0
923043|NCT00875017|1905016|FG002|First Intervention|Problems collecting rectal effluent|0
923044|NCT00875017|1905017|FG003|First Intervention|Problems collecting rectal effluent|0
923045|NCT00875017|1905018|FG004|First Intervention|Problems collecting rectal effluent|0
923046|NCT00875017|1905019|FG005|First Intervention|Problems collecting rectal effluent|0
923047|NCT00875017|1905014|FG000|First Intervention|Intolerance to nasogastric tube|0
923048|NCT00875017|1905015|FG001|First Intervention|Intolerance to nasogastric tube|0
923049|NCT00875017|1905016|FG002|First Intervention|Intolerance to nasogastric tube|0
923050|NCT00875017|1905017|FG003|First Intervention|Intolerance to nasogastric tube|0
923051|NCT00875017|1905018|FG004|First Intervention|Intolerance to nasogastric tube|1
923052|NCT00875017|1905019|FG005|First Intervention|Intolerance to nasogastric tube|0
923053|NCT00875017|1905014|FG000|Washout|Problem collecting rectal effluent|0
923054|NCT00875017|1905015|FG001|Washout|Problem collecting rectal effluent|0
923055|NCT00875017|1905016|FG002|Washout|Problem collecting rectal effluent|1
923056|NCT00875017|1905017|FG003|Washout|Problem collecting rectal effluent|0
923057|NCT00875017|1905018|FG004|Washout|Problem collecting rectal effluent|0
923058|NCT00875017|1905019|FG005|Washout|Problem collecting rectal effluent|0
923059|NCT00875017|1905014|FG000|Second Intervention|Adverse Event|0
923060|NCT00875017|1905015|FG001|Second Intervention|Adverse Event|0
923061|NCT00875017|1905016|FG002|Second Intervention|Adverse Event|0
923062|NCT00875017|1905017|FG003|Second Intervention|Adverse Event|1
923063|NCT00875017|1905018|FG004|Second Intervention|Adverse Event|0
923064|NCT00875017|1905019|FG005|Second Intervention|Adverse Event|0
923065|NCT00875017|1905014|FG000|Washout|Problems collecting rectal effluent|0
923066|NCT00875017|1905015|FG001|Washout|Problems collecting rectal effluent|1
923067|NCT00875017|1905016|FG002|Washout|Problems collecting rectal effluent|0
923068|NCT00875017|1905017|FG003|Washout|Problems collecting rectal effluent|0
923069|NCT00875017|1905018|FG004|Washout|Problems collecting rectal effluent|0
923070|NCT00875017|1905019|FG005|Washout|Problems collecting rectal effluent|0
923071|NCT00875017|1905014|FG000|Third Intervention|Adverse Event|0
923072|NCT00875017|1905015|FG001|Third Intervention|Adverse Event|1
923073|NCT00875017|1905016|FG002|Third Intervention|Adverse Event|1
923074|NCT00875017|1905017|FG003|Third Intervention|Adverse Event|0
923075|NCT00875017|1905018|FG004|Third Intervention|Adverse Event|0
923076|NCT00875017|1905019|FG005|Third Intervention|Adverse Event|0
923077|NCT00875017|1905014|FG000|Washout|Withdrawal by Subject|0
923078|NCT00875017|1905015|FG001|Washout|Withdrawal by Subject|0
923079|NCT00875017|1905016|FG002|Washout|Withdrawal by Subject|0
923080|NCT00875017|1905017|FG003|Washout|Withdrawal by Subject|0
923081|NCT00875017|1905018|FG004|Washout|Withdrawal by Subject|1
923082|NCT00875017|1905019|FG005|Washout|Withdrawal by Subject|0
923083|NCT00875017|1905014|FG000|Fourth Intervention|Inability to comply with fasting|0
923084|NCT00875017|1905015|FG001|Fourth Intervention|Inability to comply with fasting|0
923085|NCT00875017|1905016|FG002|Fourth Intervention|Inability to comply with fasting|0
923086|NCT00875017|1905017|FG003|Fourth Intervention|Inability to comply with fasting|0
923087|NCT00875017|1905018|FG004|Fourth Intervention|Inability to comply with fasting|0
923088|NCT00875017|1905019|FG005|Fourth Intervention|Inability to comply with fasting|1
923089|NCT00875056|1905035|FG000|Overall Study|Adverse Event|6
923090|NCT00875056|1905036|FG001|Overall Study|Adverse Event|1
923091|NCT00875056|1905037|FG002|Overall Study|Adverse Event|2
923092|NCT00875056|1905035|FG000|Overall Study|Progressive Disease|14
923093|NCT00875056|1905036|FG001|Overall Study|Progressive Disease|8
923094|NCT00875056|1905037|FG002|Overall Study|Progressive Disease|3
923095|NCT00875056|1905035|FG000|Overall Study|Withdrawal by Subject|3
923096|NCT00875056|1905036|FG001|Overall Study|Withdrawal by Subject|0
923097|NCT00875056|1905037|FG002|Overall Study|Withdrawal by Subject|1
923098|NCT00875420|1905085|FG000|Overall Study|Adverse Event|0
923099|NCT00875420|1905086|FG001|Overall Study|Adverse Event|1
923100|NCT00875420|1905087|FG002|Overall Study|Adverse Event|1
923101|NCT00875420|1905088|FG003|Overall Study|Adverse Event|0
923102|NCT00875420|1905089|FG004|Overall Study|Adverse Event|0
923103|NCT00875420|1905085|FG000|Overall Study|Inability to complete study procedures|1
923104|NCT00875420|1905086|FG001|Overall Study|Inability to complete study procedures|0
923105|NCT00875420|1905087|FG002|Overall Study|Inability to complete study procedures|1
923106|NCT00875420|1905088|FG003|Overall Study|Inability to complete study procedures|1
923107|NCT00875420|1905089|FG004|Overall Study|Inability to complete study procedures|1
923108|NCT00875420|1905085|FG000|Overall Study|Lost to Follow-up|1
923109|NCT00875420|1905086|FG001|Overall Study|Lost to Follow-up|0
923110|NCT00875420|1905087|FG002|Overall Study|Lost to Follow-up|0
923111|NCT00875420|1905088|FG003|Overall Study|Lost to Follow-up|0
923112|NCT00875420|1905089|FG004|Overall Study|Lost to Follow-up|0
923113|NCT00875420|1905085|FG000|Overall Study|Personal reason|0
923114|NCT00875420|1905086|FG001|Overall Study|Personal reason|0
923115|NCT00875420|1905087|FG002|Overall Study|Personal reason|0
923116|NCT00875420|1905088|FG003|Overall Study|Personal reason|0
923117|NCT00875420|1905089|FG004|Overall Study|Personal reason|1
923118|NCT00875420|1905085|FG000|Overall Study|Prohibited medication|0
923119|NCT00875420|1905086|FG001|Overall Study|Prohibited medication|0
923120|NCT00875420|1905087|FG002|Overall Study|Prohibited medication|0
923121|NCT00875420|1905088|FG003|Overall Study|Prohibited medication|1
923122|NCT00875420|1905089|FG004|Overall Study|Prohibited medication|0
923123|NCT00875420|1905085|FG000|Overall Study|Sponsor decision|0
923124|NCT00875420|1905086|FG001|Overall Study|Sponsor decision|1
923125|NCT00875420|1905087|FG002|Overall Study|Sponsor decision|0
923126|NCT00875420|1905088|FG003|Overall Study|Sponsor decision|0
923127|NCT00875420|1905089|FG004|Overall Study|Sponsor decision|0
923128|NCT00875420|1905085|FG000|Overall Study|Withdrawal by Subject|0
923129|NCT00875420|1905086|FG001|Overall Study|Withdrawal by Subject|0
923130|NCT00875420|1905087|FG002|Overall Study|Withdrawal by Subject|1
923131|NCT00875420|1905088|FG003|Overall Study|Withdrawal by Subject|0
923132|NCT00875420|1905089|FG004|Overall Study|Withdrawal by Subject|0
923133|NCT00875433|1905101|FG000|Overall Study|Progressive disease|41
923134|NCT00875433|1905101|FG000|Overall Study|Other Adverse Event|14
923135|NCT00875433|1905101|FG000|Overall Study|Withdrawal by Subject|2
923136|NCT00875433|1905101|FG000|Overall Study|Other|3
923137|NCT00875485|1905107|FG000|Challenge Dose Epoch|Pregnancy|1
923138|NCT00875485|1905108|FG001|Challenge Dose Epoch|Pregnancy|0
923139|NCT00875524|1905116|FG000|Overall Study|Serious adverse event|0
923140|NCT00875524|1905117|FG001|Overall Study|Serious adverse event|1
923141|NCT00875524|1905116|FG000|Overall Study|Protocol Violation|4
923142|NCT00875524|1905117|FG001|Overall Study|Protocol Violation|0
923143|NCT00875524|1905116|FG000|Overall Study|Lost to Follow-up|1
923144|NCT00875524|1905117|FG001|Overall Study|Lost to Follow-up|0
923145|NCT00875524|1905116|FG000|Overall Study|Withdrawal by Subject|3
923146|NCT00875524|1905117|FG001|Overall Study|Withdrawal by Subject|5
923147|NCT00875563|1905134|FG000|Overall Study|Death|4
923148|NCT00875563|1905134|FG000|Overall Study|Withdrawal by Subject|7
923149|NCT00875563|1905134|FG000|Overall Study|No long-term (3-5 year) consent|6
923150|NCT00875563|1905134|FG000|Overall Study|Still be eligible for follow-up|7
923151|NCT00875615|1905147|FG000|Overall Study|Withdrawal by Subject|1
923152|NCT00875667|1905166|FG000|Overall Study|Adverse Event|29
923153|NCT00875667|1905167|FG001|Overall Study|Adverse Event|10
923154|NCT00875667|1905166|FG000|Overall Study|Withdrawal by Subject|17
923155|NCT00875667|1905167|FG001|Overall Study|Withdrawal by Subject|5
923156|NCT00875667|1905166|FG000|Overall Study|Death|7
923157|NCT00875667|1905167|FG001|Overall Study|Death|2
923158|NCT00875667|1905166|FG000|Overall Study|Protocol Violation|2
923159|NCT00875667|1905167|FG001|Overall Study|Protocol Violation|0
923160|NCT00875667|1905166|FG000|Overall Study|Disease Progression|100
923161|NCT00875667|1905167|FG001|Overall Study|Disease Progression|49
923162|NCT00875667|1905166|FG000|Overall Study|Miscellaneous|12
923163|NCT00875667|1905167|FG001|Overall Study|Miscellaneous|6
923164|NCT00875667|1905166|FG000|Overall Study|Randomized but no Study Drug Given|3
923165|NCT00875667|1905167|FG001|Overall Study|Randomized but no Study Drug Given|1
923166|NCT00875706|1905176|FG000|Overall Study|Withdrawal by Subject|1
923167|NCT00875706|1905177|FG001|Overall Study|Withdrawal by Subject|0
923168|NCT00875706|1905178|FG002|Overall Study|Withdrawal by Subject|0
923169|NCT00875797|1905188|FG000|Overall Study|Protocol Violation|6
923170|NCT00875797|1905189|FG001|Overall Study|Protocol Violation|3
923171|NCT00875810|1905198|FG000|Overall Study|Withdrawal by Subject|1
923172|NCT00875810|1905198|FG000|Overall Study|Physician Decision|3
923173|NCT00875810|1905198|FG000|Overall Study|Lost to Follow-up|39
923174|NCT00875810|1905198|FG000|Overall Study|Patient enroled but not implanted|2
923175|NCT00875810|1905198|FG000|Overall Study|Device explanted|1
923176|NCT00875979|1905213|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
923177|NCT00875979|1905214|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
923178|NCT00875979|1905213|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
923179|NCT00875979|1905214|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
923180|NCT00875979|1905213|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
923181|NCT00875979|1905214|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
923182|NCT00875979|1905213|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
923183|NCT00875979|1905214|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
923184|NCT00875979|1905213|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
923185|NCT00875979|1905214|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
923186|NCT00875979|1905213|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
923187|NCT00875979|1905214|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
923188|NCT00875979|1905213|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
923189|NCT00875979|1905214|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
923190|NCT00875979|1905213|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
923191|NCT00875979|1905214|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
923192|NCT00875979|1905213|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0
923193|NCT00875979|1905214|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1
923194|NCT00876018|1905223|FG000|Overall Study|Lost to Follow-up|0
923195|NCT00876018|1905224|FG001|Overall Study|Lost to Follow-up|1
923196|NCT00876018|1905225|FG002|Overall Study|Lost to Follow-up|1
923197|NCT00876018|1905223|FG000|Overall Study|Withdrew Consent due to Adverse Event|5
923198|NCT00876018|1905224|FG001|Overall Study|Withdrew Consent due to Adverse Event|4
923199|NCT00876018|1905225|FG002|Overall Study|Withdrew Consent due to Adverse Event|2
923200|NCT00876187|1905240|FG000|Overall Study|Adverse Event|14
923201|NCT00876187|1905241|FG001|Overall Study|Adverse Event|12
923202|NCT00876187|1905242|FG002|Overall Study|Adverse Event|19
923203|NCT00876187|1905243|FG003|Overall Study|Adverse Event|29
923204|NCT00876187|1905244|FG004|Overall Study|Adverse Event|10
923205|NCT00876187|1905240|FG000|Overall Study|Lack of Efficacy|59
923206|NCT00876187|1905241|FG001|Overall Study|Lack of Efficacy|34
923207|NCT00876187|1905242|FG002|Overall Study|Lack of Efficacy|45
923208|NCT00876187|1905243|FG003|Overall Study|Lack of Efficacy|34
923209|NCT00876187|1905244|FG004|Overall Study|Lack of Efficacy|59
923210|NCT00876187|1905240|FG000|Overall Study|Lost to Follow-up|9
923211|NCT00876187|1905241|FG001|Overall Study|Lost to Follow-up|10
923212|NCT00876187|1905242|FG002|Overall Study|Lost to Follow-up|8
923213|NCT00876187|1905243|FG003|Overall Study|Lost to Follow-up|8
923214|NCT00876187|1905244|FG004|Overall Study|Lost to Follow-up|11
923215|NCT00876187|1905240|FG000|Overall Study|Protocol Violation|6
923216|NCT00876187|1905241|FG001|Overall Study|Protocol Violation|7
923217|NCT00876187|1905242|FG002|Overall Study|Protocol Violation|7
923218|NCT00876187|1905243|FG003|Overall Study|Protocol Violation|6
923219|NCT00876187|1905244|FG004|Overall Study|Protocol Violation|3
923220|NCT00876187|1905240|FG000|Overall Study|Withdrawal by Subject|16
923221|NCT00876187|1905241|FG001|Overall Study|Withdrawal by Subject|26
923222|NCT00876187|1905242|FG002|Overall Study|Withdrawal by Subject|32
923223|NCT00876187|1905243|FG003|Overall Study|Withdrawal by Subject|38
923224|NCT00876187|1905244|FG004|Overall Study|Withdrawal by Subject|37
923225|NCT00876187|1905240|FG000|Overall Study|Entered extension study|101
923226|NCT00876187|1905241|FG001|Overall Study|Entered extension study|120
923227|NCT00876187|1905242|FG002|Overall Study|Entered extension study|156
923228|NCT00876187|1905243|FG003|Overall Study|Entered extension study|151
923229|NCT00876187|1905244|FG004|Overall Study|Entered extension study|144
923230|NCT00876187|1905240|FG000|Overall Study|Randomized but not treated|3
923231|NCT00876187|1905241|FG001|Overall Study|Randomized but not treated|1
923232|NCT00876187|1905242|FG002|Overall Study|Randomized but not treated|3
923233|NCT00876187|1905243|FG003|Overall Study|Randomized but not treated|2
923234|NCT00876187|1905244|FG004|Overall Study|Randomized but not treated|3
923235|NCT00876187|1905240|FG000|Overall Study|Other|2
923236|NCT00876187|1905241|FG001|Overall Study|Other|5
923237|NCT00876187|1905242|FG002|Overall Study|Other|9
923238|NCT00876187|1905243|FG003|Overall Study|Other|7
923239|NCT00876187|1905244|FG004|Overall Study|Other|4
923240|NCT00876265|1905268|FG000|Overall Study|Miscellaneous reasons|4
923241|NCT00876265|1905268|FG000|Overall Study|Lost to Follow-up|6
923242|NCT00876265|1905268|FG000|Overall Study|Withdrawal by Subject|2
923243|NCT00876343|1905277|FG000|Overall Study|Adverse Event|7
923244|NCT00876343|1905278|FG001|Overall Study|Adverse Event|8
923245|NCT00876343|1905279|FG002|Overall Study|Adverse Event|2
923246|NCT00876343|1905277|FG000|Overall Study|Withdrawal by Subject|4
923247|NCT00876343|1905278|FG001|Overall Study|Withdrawal by Subject|4
923248|NCT00876343|1905279|FG002|Overall Study|Withdrawal by Subject|3
923249|NCT00876343|1905277|FG000|Overall Study|Lack of Efficacy|0
923250|NCT00876343|1905278|FG001|Overall Study|Lack of Efficacy|0
923251|NCT00876343|1905279|FG002|Overall Study|Lack of Efficacy|1
923252|NCT00876343|1905277|FG000|Overall Study|Protocol Violation|4
923253|NCT00876343|1905278|FG001|Overall Study|Protocol Violation|1
923254|NCT00876343|1905279|FG002|Overall Study|Protocol Violation|1
923255|NCT00876343|1905277|FG000|Overall Study|Physician Decision|0
923256|NCT00876343|1905278|FG001|Overall Study|Physician Decision|1
923257|NCT00876343|1905279|FG002|Overall Study|Physician Decision|1
923258|NCT00876343|1905277|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
923259|NCT00876343|1905278|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
923260|NCT00876343|1905279|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
923261|NCT00876343|1905277|FG000|Overall Study|Change of residence or other commitments|2
923262|NCT00876343|1905278|FG001|Overall Study|Change of residence or other commitments|2
923263|NCT00876343|1905279|FG002|Overall Study|Change of residence or other commitments|3
923264|NCT00876395|1905289|FG000|Overall Study|Untreated|8
923265|NCT00876395|1905290|FG001|Overall Study|Untreated|1
923266|NCT00876395|1905289|FG000|Overall Study|Adverse Event|63
923267|NCT00876395|1905290|FG001|Overall Study|Adverse Event|11
923268|NCT00876395|1905289|FG000|Overall Study|Abnormal test procedure result(s)|1
923269|NCT00876395|1905290|FG001|Overall Study|Abnormal test procedure result(s)|0
923270|NCT00876395|1905289|FG000|Overall Study|Disease progression|259
923271|NCT00876395|1905290|FG001|Overall Study|Disease progression|162
923272|NCT00876395|1905289|FG000|Overall Study|New cancer therapy|25
923273|NCT00876395|1905290|FG001|Overall Study|New cancer therapy|7
923274|NCT00876395|1905289|FG000|Overall Study|Protocol Violation|5
923275|NCT00876395|1905290|FG001|Overall Study|Protocol Violation|2
923276|NCT00876395|1905289|FG000|Overall Study|Withdrawal by Subject|66
923277|NCT00876395|1905290|FG001|Overall Study|Withdrawal by Subject|33
923278|NCT00876395|1905289|FG000|Overall Study|Lost to Follow-up|2
923279|NCT00876395|1905290|FG001|Overall Study|Lost to Follow-up|0
923280|NCT00876395|1905289|FG000|Overall Study|Administrative problems|39
923281|NCT00876395|1905290|FG001|Overall Study|Administrative problems|23
923282|NCT00876395|1905289|FG000|Overall Study|Death|12
923283|NCT00876395|1905290|FG001|Overall Study|Death|0
923284|NCT00876447|1905303|FG000|Overall Study|Other miscellaneous reasons|3
923285|NCT00876447|1905304|FG001|Overall Study|Other miscellaneous reasons|8
923286|NCT00876447|1905303|FG000|Overall Study|Site closure|19
923287|NCT00876447|1905304|FG001|Overall Study|Site closure|14
923288|NCT00876447|1905303|FG000|Overall Study|Protocol Violation|9
923289|NCT00876447|1905304|FG001|Overall Study|Protocol Violation|3
923290|NCT00876447|1905303|FG000|Overall Study|Personal reasons|30
923291|NCT00876447|1905304|FG001|Overall Study|Personal reasons|28
923292|NCT00876447|1905303|FG000|Overall Study|Lost to Follow-up|6
923293|NCT00876447|1905304|FG001|Overall Study|Lost to Follow-up|15
923294|NCT00876447|1905303|FG000|Overall Study|Pregnancy|4
923295|NCT00876447|1905304|FG001|Overall Study|Pregnancy|2
923296|NCT00876447|1905303|FG000|Overall Study|Lack of Efficacy|5
923297|NCT00876447|1905304|FG001|Overall Study|Lack of Efficacy|3
923298|NCT00876447|1905303|FG000|Overall Study|Adverse Event|4
923299|NCT00876447|1905304|FG001|Overall Study|Adverse Event|8
923300|NCT00876460|1905342|FG000|Combination Therapy Phase|Progressive disease|2
923301|NCT00876460|1905343|FG001|Combination Therapy Phase|Progressive disease|3
923302|NCT00876460|1905344|FG002|Combination Therapy Phase|Progressive disease|3
923303|NCT00876460|1905345|FG003|Combination Therapy Phase|Progressive disease|3
923304|NCT00876460|1905346|FG004|Combination Therapy Phase|Progressive disease|3
923305|NCT00876460|1905347|FG005|Combination Therapy Phase|Progressive disease|1
923306|NCT00876460|1905348|FG006|Combination Therapy Phase|Progressive disease|1
923307|NCT00876460|1905349|FG007|Combination Therapy Phase|Progressive disease|1
923308|NCT00876460|1905342|FG000|Combination Therapy Phase|Dose limiting toxicity|0
923309|NCT00876460|1905343|FG001|Combination Therapy Phase|Dose limiting toxicity|1
923310|NCT00876460|1905344|FG002|Combination Therapy Phase|Dose limiting toxicity|0
923311|NCT00876460|1905345|FG003|Combination Therapy Phase|Dose limiting toxicity|1
923312|NCT00876460|1905346|FG004|Combination Therapy Phase|Dose limiting toxicity|1
923313|NCT00876460|1905347|FG005|Combination Therapy Phase|Dose limiting toxicity|2
923314|NCT00876460|1905348|FG006|Combination Therapy Phase|Dose limiting toxicity|2
923315|NCT00876460|1905349|FG007|Combination Therapy Phase|Dose limiting toxicity|1
923316|NCT00876460|1905342|FG000|Combination Therapy Phase|Adverse Event|0
923317|NCT00876460|1905343|FG001|Combination Therapy Phase|Adverse Event|2
923318|NCT00876460|1905344|FG002|Combination Therapy Phase|Adverse Event|0
923319|NCT00876460|1905345|FG003|Combination Therapy Phase|Adverse Event|2
923320|NCT00876460|1905346|FG004|Combination Therapy Phase|Adverse Event|2
923321|NCT00876460|1905347|FG005|Combination Therapy Phase|Adverse Event|0
923322|NCT00876460|1905348|FG006|Combination Therapy Phase|Adverse Event|3
923323|NCT00876460|1905349|FG007|Combination Therapy Phase|Adverse Event|2
923324|NCT00876460|1905342|FG000|Combination Therapy Phase|Withdrawal by Subject|1
923325|NCT00876460|1905343|FG001|Combination Therapy Phase|Withdrawal by Subject|1
923326|NCT00876460|1905344|FG002|Combination Therapy Phase|Withdrawal by Subject|0
923327|NCT00876460|1905345|FG003|Combination Therapy Phase|Withdrawal by Subject|0
923328|NCT00876460|1905346|FG004|Combination Therapy Phase|Withdrawal by Subject|1
923329|NCT00876460|1905347|FG005|Combination Therapy Phase|Withdrawal by Subject|0
923330|NCT00876460|1905348|FG006|Combination Therapy Phase|Withdrawal by Subject|0
923331|NCT00876460|1905349|FG007|Combination Therapy Phase|Withdrawal by Subject|0
923332|NCT00876460|1905342|FG000|Combination Therapy Phase|Other reason not defined above|0
923333|NCT00876460|1905343|FG001|Combination Therapy Phase|Other reason not defined above|0
923334|NCT00876460|1905344|FG002|Combination Therapy Phase|Other reason not defined above|0
923335|NCT00876460|1905345|FG003|Combination Therapy Phase|Other reason not defined above|0
923336|NCT00876460|1905346|FG004|Combination Therapy Phase|Other reason not defined above|0
923337|NCT00876460|1905347|FG005|Combination Therapy Phase|Other reason not defined above|0
923338|NCT00876460|1905348|FG006|Combination Therapy Phase|Other reason not defined above|1
923339|NCT00876460|1905349|FG007|Combination Therapy Phase|Other reason not defined above|2
923340|NCT00876460|1905342|FG000|Combination Therapy Phase|Not treated|0
923341|NCT00876460|1905343|FG001|Combination Therapy Phase|Not treated|0
923342|NCT00876460|1905344|FG002|Combination Therapy Phase|Not treated|0
923343|NCT00876460|1905345|FG003|Combination Therapy Phase|Not treated|0
923344|NCT00876460|1905346|FG004|Combination Therapy Phase|Not treated|0
923345|NCT00876460|1905347|FG005|Combination Therapy Phase|Not treated|0
923346|NCT00876460|1905348|FG006|Combination Therapy Phase|Not treated|1
923347|NCT00876460|1905349|FG007|Combination Therapy Phase|Not treated|0
923348|NCT00876460|1905342|FG000|Mono Therapy Phase|Progressive disease|0
923349|NCT00876460|1905343|FG001|Mono Therapy Phase|Progressive disease|0
923350|NCT00876460|1905344|FG002|Mono Therapy Phase|Progressive disease|0
923351|NCT00876460|1905345|FG003|Mono Therapy Phase|Progressive disease|0
923352|NCT00876460|1905346|FG004|Mono Therapy Phase|Progressive disease|2
923353|NCT00876460|1905347|FG005|Mono Therapy Phase|Progressive disease|0
923354|NCT00876460|1905348|FG006|Mono Therapy Phase|Progressive disease|1
923355|NCT00876460|1905349|FG007|Mono Therapy Phase|Progressive disease|3
923356|NCT00876460|1905342|FG000|Mono Therapy Phase|Withdrawal by Subject|0
923357|NCT00876460|1905343|FG001|Mono Therapy Phase|Withdrawal by Subject|1
923358|NCT00876460|1905344|FG002|Mono Therapy Phase|Withdrawal by Subject|0
923359|NCT00876460|1905345|FG003|Mono Therapy Phase|Withdrawal by Subject|0
923360|NCT00876460|1905346|FG004|Mono Therapy Phase|Withdrawal by Subject|0
923361|NCT00876460|1905347|FG005|Mono Therapy Phase|Withdrawal by Subject|0
923362|NCT00876460|1905348|FG006|Mono Therapy Phase|Withdrawal by Subject|0
923363|NCT00876460|1905349|FG007|Mono Therapy Phase|Withdrawal by Subject|0
923364|NCT00876460|1905342|FG000|Mono Therapy Phase|Adverse Event|0
923365|NCT00876460|1905343|FG001|Mono Therapy Phase|Adverse Event|0
923366|NCT00876460|1905344|FG002|Mono Therapy Phase|Adverse Event|0
923367|NCT00876460|1905345|FG003|Mono Therapy Phase|Adverse Event|1
923368|NCT00876460|1905346|FG004|Mono Therapy Phase|Adverse Event|0
923369|NCT00876460|1905347|FG005|Mono Therapy Phase|Adverse Event|0
923370|NCT00876460|1905348|FG006|Mono Therapy Phase|Adverse Event|0
923371|NCT00876460|1905349|FG007|Mono Therapy Phase|Adverse Event|0
923372|NCT00876694|1905381|FG000|Overall Study|Adverse Event|10
923373|NCT00876694|1905382|FG001|Overall Study|Adverse Event|7
923374|NCT00876694|1905381|FG000|Overall Study|Subject withdrew consent|6
923375|NCT00876694|1905382|FG001|Overall Study|Subject withdrew consent|4
923376|NCT00876694|1905381|FG000|Overall Study|Unsatisfactory therapeutic effect|2
923377|NCT00876694|1905382|FG001|Overall Study|Unsatisfactory therapeutic effect|0
923378|NCT00876694|1905381|FG000|Overall Study|Abnormal test procedure result(s)|1
923379|NCT00876694|1905382|FG001|Overall Study|Abnormal test procedure result(s)|0
923380|NCT00876694|1905381|FG000|Overall Study|Administrative problems|1
923381|NCT00876694|1905382|FG001|Overall Study|Administrative problems|1
923382|NCT00876694|1905381|FG000|Overall Study|Death|1
923383|NCT00876694|1905382|FG001|Overall Study|Death|0
923384|NCT00876733|1905392|FG000|Overall Study|Adverse Event|34
923385|NCT00876733|1905393|FG001|Overall Study|Adverse Event|20
923386|NCT00876733|1905394|FG002|Overall Study|Adverse Event|10
923387|NCT00876733|1905395|FG003|Overall Study|Adverse Event|3
923388|NCT00876733|1905392|FG000|Overall Study|Lack of Efficacy|17
923389|NCT00876733|1905393|FG001|Overall Study|Lack of Efficacy|9
923390|NCT00876733|1905394|FG002|Overall Study|Lack of Efficacy|10
923391|NCT00876733|1905395|FG003|Overall Study|Lack of Efficacy|1
923392|NCT00876733|1905392|FG000|Overall Study|Lost to Follow-up|26
923393|NCT00876733|1905393|FG001|Overall Study|Lost to Follow-up|10
923394|NCT00876733|1905394|FG002|Overall Study|Lost to Follow-up|3
923395|NCT00876733|1905395|FG003|Overall Study|Lost to Follow-up|2
923396|NCT00876733|1905392|FG000|Overall Study|Data not available|14
923397|NCT00876733|1905393|FG001|Overall Study|Data not available|3
923398|NCT00876733|1905394|FG002|Overall Study|Data not available|7
923399|NCT00876733|1905395|FG003|Overall Study|Data not available|1
923400|NCT00876928|1905420|FG000|Overall Study|Lost to Follow-up|2
923401|NCT00876928|1905421|FG001|Overall Study|Lost to Follow-up|5
923402|NCT00876928|1905420|FG000|Overall Study|Hypokalemia-affects insulin secretion|1
923403|NCT00876928|1905421|FG001|Overall Study|Hypokalemia-affects insulin secretion|0
923404|NCT00877006|1905452|FG000|Treatment Period|Death|2
923405|NCT00877006|1905453|FG001|Treatment Period|Death|1
923406|NCT00877006|1905452|FG000|Treatment Period|Adverse Event|10
923407|NCT00877006|1905453|FG001|Treatment Period|Adverse Event|3
923408|NCT00877006|1905452|FG000|Treatment Period|Withdrawal by Subject|2
923409|NCT00877006|1905453|FG001|Treatment Period|Withdrawal by Subject|3
923410|NCT00877006|1905452|FG000|Treatment Period|Protocol Violation|1
923411|NCT00877006|1905453|FG001|Treatment Period|Protocol Violation|0
923412|NCT00877006|1905452|FG000|Treatment Period|Lost to Follow-up|0
923413|NCT00877006|1905453|FG001|Treatment Period|Lost to Follow-up|1
923414|NCT00877006|1905452|FG000|Treatment Period|Disease Progression|1
923415|NCT00877006|1905453|FG001|Treatment Period|Disease Progression|2
923416|NCT00877006|1905452|FG000|Treatment Period|Started New Treatment Regimen|2
923417|NCT00877006|1905453|FG001|Treatment Period|Started New Treatment Regimen|5
923418|NCT00877006|1905452|FG000|Treatment Period|Other|4
923419|NCT00877006|1905453|FG001|Treatment Period|Other|4
923420|NCT00877006|1905452|FG000|Treatment Period|Randomized but Not Treated|3
923421|NCT00877006|1905453|FG001|Treatment Period|Randomized but Not Treated|8
923422|NCT00877006|1905452|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12
923423|NCT00877006|1905453|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19
923424|NCT00877006|1905452|FG000|Long-Term Follow-up Period|Lost to Follow-up|8
923425|NCT00877006|1905453|FG001|Long-Term Follow-up Period|Lost to Follow-up|9
923426|NCT00877006|1905452|FG000|Long-Term Follow-up Period|Death|26
923427|NCT00877006|1905453|FG001|Long-Term Follow-up Period|Death|18
923428|NCT00877006|1905452|FG000|Long-Term Follow-up Period|Other|7
923429|NCT00877006|1905453|FG001|Long-Term Follow-up Period|Other|9
923430|NCT00877032|1905468|FG000|Overall Study|Did not meet entrance criteria|0
923431|NCT00877032|1905469|FG001|Overall Study|Did not meet entrance criteria|0
923432|NCT00877032|1905470|FG002|Overall Study|Did not meet entrance criteria|0
923433|NCT00877032|1905471|FG003|Overall Study|Did not meet entrance criteria|1
923434|NCT00877032|1905472|FG004|Overall Study|Did not meet entrance criteria|0
923435|NCT00877032|1905473|FG005|Overall Study|Did not meet entrance criteria|0
923436|NCT00877032|1905474|FG006|Overall Study|Did not meet entrance criteria|2
923437|NCT00877383|1905509|FG000|Overall Study|Adverse Event|13
923438|NCT00877383|1905510|FG001|Overall Study|Adverse Event|14
923439|NCT00877383|1905509|FG000|Overall Study|Lost to Follow-up|5
923440|NCT00877383|1905510|FG001|Overall Study|Lost to Follow-up|3
923441|NCT00877383|1905509|FG000|Overall Study|Subject withdrew consent|3
923442|NCT00877383|1905510|FG001|Overall Study|Subject withdrew consent|12
923443|NCT00877383|1905509|FG000|Overall Study|Subject no longer requires study drug|2
923444|NCT00877383|1905510|FG001|Overall Study|Subject no longer requires study drug|0
923445|NCT00877383|1905509|FG000|Overall Study|Administrative problems|2
923446|NCT00877383|1905510|FG001|Overall Study|Administrative problems|0
923447|NCT00877383|1905509|FG000|Overall Study|Protocol deviation|2
923448|NCT00877383|1905510|FG001|Overall Study|Protocol deviation|6
923449|NCT00877383|1905509|FG000|Overall Study|Unsatisfactory therapeutic effect|1
923450|NCT00877383|1905510|FG001|Overall Study|Unsatisfactory therapeutic effect|0
923451|NCT00877383|1905509|FG000|Overall Study|Death|1
923452|NCT00877383|1905510|FG001|Overall Study|Death|2
923453|NCT00877487|1905545|FG000|Open-label Treatment Phase|Adverse Event|1
923454|NCT00877487|1905546|FG001|Open-label Treatment Phase|Adverse Event|0
923455|NCT00877487|1905545|FG000|Open-label Treatment Phase|Protocol Violation|3
923456|NCT00877487|1905546|FG001|Open-label Treatment Phase|Protocol Violation|0
923457|NCT00877487|1905545|FG000|Open-label Treatment Phase|Withdrawal by Subject|1
923458|NCT00877487|1905546|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
923459|NCT00877487|1905545|FG000|Open-label Treatment Phase|Lost to Follow-up|1
923460|NCT00877487|1905546|FG001|Open-label Treatment Phase|Lost to Follow-up|0
923461|NCT00877487|1905545|FG000|Open-label Treatment Phase|Out of country for business|1
923462|NCT00877487|1905546|FG001|Open-label Treatment Phase|Out of country for business|0
923463|NCT00877487|1905545|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
923464|NCT00877487|1905546|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
923465|NCT00877487|1905545|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0
923466|NCT00877487|1905546|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1
923467|NCT00877487|1905545|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
923468|NCT00877487|1905546|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
923469|NCT00877487|1905545|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1
923470|NCT00877487|1905546|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0
923471|NCT00877773|1905561|FG000|Overall Study|Disease Progression|44
923472|NCT00877799|1905570|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
923473|NCT00877799|1905571|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
923474|NCT00877799|1905572|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
923475|NCT00877799|1905573|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
923476|NCT00877799|1905574|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
923477|NCT00877799|1905570|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
923478|NCT00877799|1905571|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
923479|NCT00877799|1905572|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
923480|NCT00877799|1905573|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
923481|NCT00877799|1905574|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
923482|NCT00877799|1905570|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
923483|NCT00877799|1905571|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
923484|NCT00877799|1905572|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
923485|NCT00877799|1905573|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
923486|NCT00877799|1905574|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
923487|NCT00877799|1905570|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
923488|NCT00877799|1905571|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
923489|NCT00877799|1905572|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
923490|NCT00877799|1905573|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
923491|NCT00877799|1905574|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
923492|NCT00877799|1905570|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
923493|NCT00877799|1905571|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
923494|NCT00877799|1905572|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
923495|NCT00877799|1905573|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
923496|NCT00877799|1905574|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
923497|NCT00877890|1905596|FG000|Overall Study|Adverse Event|6
923498|NCT00877890|1905597|FG001|Overall Study|Adverse Event|6
923499|NCT00877890|1905596|FG000|Overall Study|Lost to Follow-up|5
923500|NCT00877890|1905597|FG001|Overall Study|Lost to Follow-up|5
923501|NCT00877890|1905596|FG000|Overall Study|Protocol Violation|0
923502|NCT00877890|1905597|FG001|Overall Study|Protocol Violation|1
923503|NCT00877890|1905596|FG000|Overall Study|Withdrawal of Consent|6
923504|NCT00877890|1905597|FG001|Overall Study|Withdrawal of Consent|12
923505|NCT00877890|1905596|FG000|Overall Study|Investigator Decision|0
923506|NCT00877890|1905597|FG001|Overall Study|Investigator Decision|2
923507|NCT00877890|1905596|FG000|Overall Study|Loss of Glucose Control|3
923508|NCT00877890|1905597|FG001|Overall Study|Loss of Glucose Control|4
923509|NCT00877929|1905609|FG000|Overall Study|Adverse Event|11
923510|NCT00877929|1905610|FG001|Overall Study|Adverse Event|20
923511|NCT00877929|1905609|FG000|Overall Study|Protocol Violation|3
923512|NCT00877929|1905610|FG001|Overall Study|Protocol Violation|3
923513|NCT00877929|1905609|FG000|Overall Study|Lost to Follow-up|0
923514|NCT00877929|1905610|FG001|Overall Study|Lost to Follow-up|1
923515|NCT00877929|1905609|FG000|Overall Study|Withdrawal by Subject|4
923516|NCT00877929|1905610|FG001|Overall Study|Withdrawal by Subject|4
923517|NCT00877929|1905609|FG000|Overall Study|Lack of Efficacy|0
923518|NCT00877929|1905610|FG001|Overall Study|Lack of Efficacy|1
923519|NCT00877929|1905609|FG000|Overall Study|Other reason (not specified)|2
923520|NCT00877929|1905610|FG001|Overall Study|Other reason (not specified)|6
923521|NCT00878072|1905620|FG000|Overall Study|Withdrew consent|2
923522|NCT00878189|1905631|FG000|Overall Study|Death|0
923523|NCT00878189|1905632|FG001|Overall Study|Death|1
923524|NCT00878189|1905633|FG002|Overall Study|Death|0
923525|NCT00878189|1905634|FG003|Overall Study|Death|1
923526|NCT00878189|1905635|FG004|Overall Study|Death|0
923527|NCT00878189|1905636|FG005|Overall Study|Death|0
923528|NCT00878189|1905637|FG006|Overall Study|Death|0
923529|NCT00878189|1905638|FG007|Overall Study|Death|0
923530|NCT00878189|1905639|FG008|Overall Study|Death|1
923531|NCT00878189|1905631|FG000|Overall Study|Participant Refused to Follow-up|0
923532|NCT00878189|1905632|FG001|Overall Study|Participant Refused to Follow-up|0
923533|NCT00878189|1905633|FG002|Overall Study|Participant Refused to Follow-up|0
923534|NCT00878189|1905634|FG003|Overall Study|Participant Refused to Follow-up|0
923535|NCT00878189|1905635|FG004|Overall Study|Participant Refused to Follow-up|0
923536|NCT00878189|1905636|FG005|Overall Study|Participant Refused to Follow-up|4
923537|NCT00878189|1905637|FG006|Overall Study|Participant Refused to Follow-up|0
923538|NCT00878189|1905638|FG007|Overall Study|Participant Refused to Follow-up|0
923539|NCT00878189|1905639|FG008|Overall Study|Participant Refused to Follow-up|0
923540|NCT00878189|1905631|FG000|Overall Study|Other|3
923541|NCT00878189|1905632|FG001|Overall Study|Other|2
923542|NCT00878189|1905633|FG002|Overall Study|Other|4
923543|NCT00878189|1905634|FG003|Overall Study|Other|7
923544|NCT00878189|1905635|FG004|Overall Study|Other|4
923545|NCT00878189|1905636|FG005|Overall Study|Other|18
923546|NCT00878189|1905637|FG006|Overall Study|Other|15
923547|NCT00878189|1905638|FG007|Overall Study|Other|3
923548|NCT00878189|1905639|FG008|Overall Study|Other|4
923549|NCT00878189|1905631|FG000|Overall Study|Lost to Follow-up|0
923550|NCT00878189|1905632|FG001|Overall Study|Lost to Follow-up|0
923551|NCT00878189|1905633|FG002|Overall Study|Lost to Follow-up|0
923552|NCT00878189|1905634|FG003|Overall Study|Lost to Follow-up|0
923553|NCT00878189|1905635|FG004|Overall Study|Lost to Follow-up|0
923554|NCT00878189|1905636|FG005|Overall Study|Lost to Follow-up|1
923555|NCT00878189|1905637|FG006|Overall Study|Lost to Follow-up|1
923556|NCT00878189|1905638|FG007|Overall Study|Lost to Follow-up|0
923557|NCT00878189|1905639|FG008|Overall Study|Lost to Follow-up|0
923558|NCT00878189|1905631|FG000|Overall Study|Objection Progression or Relapse|0
923559|NCT00878189|1905632|FG001|Overall Study|Objection Progression or Relapse|0
923560|NCT00878189|1905633|FG002|Overall Study|Objection Progression or Relapse|0
923561|NCT00878189|1905634|FG003|Overall Study|Objection Progression or Relapse|0
923562|NCT00878189|1905635|FG004|Overall Study|Objection Progression or Relapse|0
923563|NCT00878189|1905636|FG005|Overall Study|Objection Progression or Relapse|0
923564|NCT00878189|1905637|FG006|Overall Study|Objection Progression or Relapse|0
923565|NCT00878189|1905638|FG007|Overall Study|Objection Progression or Relapse|0
923566|NCT00878189|1905639|FG008|Overall Study|Objection Progression or Relapse|3
923567|NCT00878215|1905677|FG000|Overall Study|Determined to be ineligible|0
923568|NCT00878215|1905678|FG001|Overall Study|Determined to be ineligible|10
923569|NCT00878215|1905679|FG002|Overall Study|Determined to be ineligible|0
923570|NCT00878215|1905680|FG003|Overall Study|Determined to be ineligible|0
923571|NCT00878501|1905711|FG000|Overall Study|Adverse Event|11
923572|NCT00878501|1905712|FG001|Overall Study|Adverse Event|3
923573|NCT00878501|1905713|FG002|Overall Study|Adverse Event|3
923574|NCT00878501|1905711|FG000|Overall Study|Lack of Efficacy|2
923575|NCT00878501|1905712|FG001|Overall Study|Lack of Efficacy|1
923576|NCT00878501|1905713|FG002|Overall Study|Lack of Efficacy|0
923577|NCT00878501|1905711|FG000|Overall Study|Withdrawal by Subject|2
923578|NCT00878501|1905712|FG001|Overall Study|Withdrawal by Subject|1
923579|NCT00878501|1905713|FG002|Overall Study|Withdrawal by Subject|2
923580|NCT00878501|1905711|FG000|Overall Study|Protocol Violation|0
923581|NCT00878501|1905712|FG001|Overall Study|Protocol Violation|0
923582|NCT00878501|1905713|FG002|Overall Study|Protocol Violation|1
923583|NCT00878501|1905711|FG000|Overall Study|Incorrect enrolment|1
923584|NCT00878501|1905712|FG001|Overall Study|Incorrect enrolment|2
923585|NCT00878501|1905713|FG002|Overall Study|Incorrect enrolment|0
923586|NCT00878501|1905711|FG000|Overall Study|Intake of prohibited concom. medication|0
923587|NCT00878501|1905712|FG001|Overall Study|Intake of prohibited concom. medication|0
923588|NCT00878501|1905713|FG002|Overall Study|Intake of prohibited concom. medication|1
923589|NCT00878501|1905711|FG000|Overall Study|Mis-randomisation of patient|1
923590|NCT00878501|1905712|FG001|Overall Study|Mis-randomisation of patient|0
923591|NCT00878501|1905713|FG002|Overall Study|Mis-randomisation of patient|0
923592|NCT00878501|1905711|FG000|Overall Study|Administrative|0
923593|NCT00878501|1905712|FG001|Overall Study|Administrative|0
923594|NCT00878501|1905713|FG002|Overall Study|Administrative|1
923595|NCT00878553|1905725|FG000|Sleep Study|Withdrawal by Subject|2
923596|NCT00878553|1905726|FG001|Sleep Study|Withdrawal by Subject|0
923597|NCT00878553|1905727|FG002|Sleep Study|Withdrawal by Subject|0
923598|NCT00878553|1905728|FG003|Sleep Study|Withdrawal by Subject|0
923599|NCT00878553|1905729|FG004|Sleep Study|Withdrawal by Subject|0
923600|NCT00878553|1905725|FG000|Sleep Study|Lost to Follow-up|1
923601|NCT00878553|1905726|FG001|Sleep Study|Lost to Follow-up|0
923602|NCT00878553|1905727|FG002|Sleep Study|Lost to Follow-up|0
923603|NCT00878553|1905728|FG003|Sleep Study|Lost to Follow-up|0
923604|NCT00878553|1905729|FG004|Sleep Study|Lost to Follow-up|0
923605|NCT00878553|1905725|FG000|Sleep Study|car accident|1
923606|NCT00878553|1905726|FG001|Sleep Study|car accident|0
923607|NCT00878553|1905727|FG002|Sleep Study|car accident|0
923608|NCT00878553|1905728|FG003|Sleep Study|car accident|0
923609|NCT00878553|1905729|FG004|Sleep Study|car accident|0
923610|NCT00878553|1905725|FG000|Sleep Study|family emergency|1
923611|NCT00878553|1905726|FG001|Sleep Study|family emergency|0
923612|NCT00878553|1905727|FG002|Sleep Study|family emergency|0
923613|NCT00878553|1905728|FG003|Sleep Study|family emergency|0
923614|NCT00878553|1905729|FG004|Sleep Study|family emergency|0
923615|NCT00878553|1905725|FG000|PK Study|Withdrawal by Subject|0
923616|NCT00878553|1905726|FG001|PK Study|Withdrawal by Subject|0
923617|NCT00878553|1905727|FG002|PK Study|Withdrawal by Subject|0
923618|NCT00878553|1905728|FG003|PK Study|Withdrawal by Subject|1
923619|NCT00878553|1905729|FG004|PK Study|Withdrawal by Subject|0
923620|NCT00878709|1905757|FG000|Overall Study|Withdrawal by Subject|197
923621|NCT00878709|1905758|FG001|Overall Study|Withdrawal by Subject|120
923622|NCT00878709|1905757|FG000|Overall Study|Lost to Follow-up|35
923623|NCT00878709|1905758|FG001|Overall Study|Lost to Follow-up|33
923624|NCT00878709|1905757|FG000|Overall Study|Other Reasons|93
923625|NCT00878709|1905758|FG001|Overall Study|Other Reasons|84
923626|NCT00878722|1905773|FG000|Overall Study|Progressive disease|3
923627|NCT00878722|1905774|FG001|Overall Study|Progressive disease|3
923628|NCT00878722|1905775|FG002|Overall Study|Progressive disease|3
923629|NCT00878722|1905776|FG003|Overall Study|Progressive disease|7
923630|NCT00878722|1905777|FG004|Overall Study|Progressive disease|7
923631|NCT00878722|1905778|FG005|Overall Study|Progressive disease|1
923632|NCT00878722|1905779|FG006|Overall Study|Progressive disease|4
923633|NCT00878722|1905780|FG007|Overall Study|Progressive disease|3
923634|NCT00878722|1905773|FG000|Overall Study|Death|0
923635|NCT00878722|1905774|FG001|Overall Study|Death|0
923636|NCT00878722|1905775|FG002|Overall Study|Death|0
923637|NCT00878722|1905776|FG003|Overall Study|Death|1
923638|NCT00878722|1905777|FG004|Overall Study|Death|0
923639|NCT00878722|1905778|FG005|Overall Study|Death|1
923640|NCT00878722|1905779|FG006|Overall Study|Death|0
923641|NCT00878722|1905780|FG007|Overall Study|Death|2
923642|NCT00878722|1905773|FG000|Overall Study|Adverse Event|0
923643|NCT00878722|1905774|FG001|Overall Study|Adverse Event|0
923644|NCT00878722|1905775|FG002|Overall Study|Adverse Event|0
923645|NCT00878722|1905776|FG003|Overall Study|Adverse Event|0
923646|NCT00878722|1905777|FG004|Overall Study|Adverse Event|0
923647|NCT00878722|1905778|FG005|Overall Study|Adverse Event|0
923648|NCT00878722|1905779|FG006|Overall Study|Adverse Event|2
923649|NCT00878722|1905780|FG007|Overall Study|Adverse Event|0
923650|NCT00878722|1905773|FG000|Overall Study|Withdrawal by Subject|0
923651|NCT00878722|1905774|FG001|Overall Study|Withdrawal by Subject|0
923652|NCT00878722|1905775|FG002|Overall Study|Withdrawal by Subject|0
923653|NCT00878722|1905776|FG003|Overall Study|Withdrawal by Subject|0
923654|NCT00878722|1905777|FG004|Overall Study|Withdrawal by Subject|0
923655|NCT00878722|1905778|FG005|Overall Study|Withdrawal by Subject|0
923656|NCT00878722|1905779|FG006|Overall Study|Withdrawal by Subject|0
923657|NCT00878722|1905780|FG007|Overall Study|Withdrawal by Subject|2
923658|NCT00878722|1905773|FG000|Overall Study|Relapse|0
923659|NCT00878722|1905774|FG001|Overall Study|Relapse|0
923660|NCT00878722|1905775|FG002|Overall Study|Relapse|0
923661|NCT00878722|1905776|FG003|Overall Study|Relapse|1
923662|NCT00878722|1905777|FG004|Overall Study|Relapse|0
923663|NCT00878722|1905778|FG005|Overall Study|Relapse|0
923664|NCT00878722|1905779|FG006|Overall Study|Relapse|0
923665|NCT00878722|1905780|FG007|Overall Study|Relapse|0
923666|NCT00878800|1905806|FG000|Overall Study|Adverse Event|0
923667|NCT00878800|1905807|FG001|Overall Study|Adverse Event|0
923668|NCT00878800|1905808|FG002|Overall Study|Adverse Event|2
923669|NCT00878800|1905809|FG003|Overall Study|Adverse Event|0
923670|NCT00878800|1905810|FG004|Overall Study|Adverse Event|1
923671|NCT00878800|1905806|FG000|Overall Study|Progressive disease|1
923672|NCT00878800|1905807|FG001|Overall Study|Progressive disease|5
923673|NCT00878800|1905808|FG002|Overall Study|Progressive disease|6
923674|NCT00878800|1905809|FG003|Overall Study|Progressive disease|5
923675|NCT00878800|1905810|FG004|Overall Study|Progressive disease|13
923676|NCT00878800|1905806|FG000|Overall Study|Withdrew consent|1
923677|NCT00878800|1905807|FG001|Overall Study|Withdrew consent|1
923678|NCT00878800|1905808|FG002|Overall Study|Withdrew consent|0
923679|NCT00878800|1905809|FG003|Overall Study|Withdrew consent|1
923680|NCT00878800|1905810|FG004|Overall Study|Withdrew consent|1
923681|NCT00878800|1905806|FG000|Overall Study|Death|0
923682|NCT00878800|1905807|FG001|Overall Study|Death|0
923683|NCT00878800|1905808|FG002|Overall Study|Death|1
923684|NCT00878800|1905809|FG003|Overall Study|Death|0
923685|NCT00878800|1905810|FG004|Overall Study|Death|0
923686|NCT00878800|1905806|FG000|Overall Study|Other|1
923687|NCT00878800|1905807|FG001|Overall Study|Other|1
923688|NCT00878800|1905808|FG002|Overall Study|Other|0
923689|NCT00878800|1905809|FG003|Overall Study|Other|0
923690|NCT00878800|1905810|FG004|Overall Study|Other|1
923691|NCT00878995|1905847|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0
923692|NCT00878995|1905848|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2
923693|NCT00879229|1905881|FG000|Overall Study|Study terminated by Sponsor|13
923694|NCT00879229|1905882|FG001|Overall Study|Study terminated by Sponsor|12
923695|NCT00879229|1905881|FG000|Overall Study|Death|4
923696|NCT00879229|1905882|FG001|Overall Study|Death|2
923697|NCT00879229|1905881|FG000|Overall Study|Adverse Event|2
923698|NCT00879229|1905882|FG001|Overall Study|Adverse Event|0
923699|NCT00879229|1905881|FG000|Overall Study|Withdrawal by Subject|1
923700|NCT00879229|1905882|FG001|Overall Study|Withdrawal by Subject|0
923701|NCT00879229|1905881|FG000|Overall Study|Clinical status did not improve|1
923702|NCT00879229|1905882|FG001|Overall Study|Clinical status did not improve|0
923703|NCT00879229|1905881|FG000|Overall Study|Other|1
923704|NCT00879229|1905882|FG001|Overall Study|Other|0
923705|NCT00879333|1905899|FG000|Overall Study|Adverse Event|94
923706|NCT00879333|1905900|FG001|Overall Study|Adverse Event|34
923707|NCT00879333|1905899|FG000|Overall Study|Abnormal Laboratory Value|1
923708|NCT00879333|1905900|FG001|Overall Study|Abnormal Laboratory Value|0
923709|NCT00879333|1905899|FG000|Overall Study|Withdrawal by Subject|20
923710|NCT00879333|1905900|FG001|Overall Study|Withdrawal by Subject|7
923711|NCT00879333|1905899|FG000|Overall Study|Lost to Follow-up|2
923712|NCT00879333|1905900|FG001|Overall Study|Lost to Follow-up|1
923713|NCT00879333|1905899|FG000|Overall Study|Administrative Problems|2
923714|NCT00879333|1905900|FG001|Overall Study|Administrative Problems|0
923715|NCT00879333|1905899|FG000|Overall Study|Death|16
923716|NCT00879333|1905900|FG001|Overall Study|Death|5
923717|NCT00879333|1905899|FG000|Overall Study|Disease Progression|292
923718|NCT00879333|1905900|FG001|Overall Study|Disease Progression|169
923719|NCT00879333|1905899|FG000|Overall Study|Protocol Violation|1
923720|NCT00879333|1905900|FG001|Overall Study|Protocol Violation|1
923721|NCT00879398|1905913|FG000|Overall Study|Visit Stop|399
923722|NCT00879398|1905913|FG000|Overall Study|Lack of Efficacy|64
923723|NCT00879398|1905913|FG000|Overall Study|Adverse Event|41
923724|NCT00879398|1905913|FG000|Overall Study|Other Reasons|171
923725|NCT00879411|1905917|FG000|Overall Study|lost to follow-up (non-AE)|162
923726|NCT00879437|1905921|FG000|Overall Study|Protocol Violation|0
923727|NCT00879437|1905922|FG001|Overall Study|Protocol Violation|1
923728|NCT00879437|1905921|FG000|Overall Study|Death|1
923729|NCT00879437|1905922|FG001|Overall Study|Death|0
923730|NCT00879645|1905934|FG000|Overall Study|Adverse Event|1
923731|NCT00879645|1905935|FG001|Overall Study|Adverse Event|0
923732|NCT00879645|1905936|FG002|Overall Study|Adverse Event|0
923733|NCT00879645|1905937|FG003|Overall Study|Adverse Event|0
923734|NCT00879658|1905954|FG000|Overall Study|Abnormal laboratory value(s)|3
923735|NCT00879658|1905955|FG001|Overall Study|Abnormal laboratory value(s)|0
923736|NCT00879658|1905956|FG002|Overall Study|Abnormal laboratory value(s)|0
923737|NCT00879658|1905957|FG003|Overall Study|Abnormal laboratory value(s)|1
923738|NCT00879658|1905958|FG004|Overall Study|Abnormal laboratory value(s)|0
923739|NCT00879658|1905959|FG005|Overall Study|Abnormal laboratory value(s)|0
923740|NCT00879658|1905960|FG006|Overall Study|Abnormal laboratory value(s)|0
923741|NCT00879658|1905954|FG000|Overall Study|Administrative problems|2
923742|NCT00879658|1905955|FG001|Overall Study|Administrative problems|1
923743|NCT00879658|1905956|FG002|Overall Study|Administrative problems|0
923744|NCT00879658|1905957|FG003|Overall Study|Administrative problems|1
923745|NCT00879658|1905958|FG004|Overall Study|Administrative problems|0
923746|NCT00879658|1905959|FG005|Overall Study|Administrative problems|0
923747|NCT00879658|1905960|FG006|Overall Study|Administrative problems|0
923748|NCT00879658|1905954|FG000|Overall Study|Adverse Event|6
923749|NCT00879658|1905955|FG001|Overall Study|Adverse Event|4
923750|NCT00879658|1905956|FG002|Overall Study|Adverse Event|3
923751|NCT00879658|1905957|FG003|Overall Study|Adverse Event|1
923752|NCT00879658|1905958|FG004|Overall Study|Adverse Event|2
923753|NCT00879658|1905959|FG005|Overall Study|Adverse Event|0
923754|NCT00879658|1905960|FG006|Overall Study|Adverse Event|0
923755|NCT00879658|1905954|FG000|Overall Study|Protocol Violation|1
923756|NCT00879658|1905955|FG001|Overall Study|Protocol Violation|0
923757|NCT00879658|1905956|FG002|Overall Study|Protocol Violation|0
923758|NCT00879658|1905957|FG003|Overall Study|Protocol Violation|0
923759|NCT00879658|1905958|FG004|Overall Study|Protocol Violation|0
923760|NCT00879658|1905959|FG005|Overall Study|Protocol Violation|0
923761|NCT00879658|1905960|FG006|Overall Study|Protocol Violation|0
923762|NCT00879658|1905954|FG000|Overall Study|Withdrawal by Subject|3
923763|NCT00879658|1905955|FG001|Overall Study|Withdrawal by Subject|0
923764|NCT00879658|1905956|FG002|Overall Study|Withdrawal by Subject|2
923765|NCT00879658|1905957|FG003|Overall Study|Withdrawal by Subject|0
923766|NCT00879658|1905958|FG004|Overall Study|Withdrawal by Subject|0
923767|NCT00879658|1905959|FG005|Overall Study|Withdrawal by Subject|1
923768|NCT00879658|1905960|FG006|Overall Study|Withdrawal by Subject|0
923769|NCT00879658|1905954|FG000|Overall Study|Lack of Efficacy|0
923770|NCT00879658|1905955|FG001|Overall Study|Lack of Efficacy|0
923771|NCT00879658|1905956|FG002|Overall Study|Lack of Efficacy|2
923772|NCT00879658|1905957|FG003|Overall Study|Lack of Efficacy|0
923773|NCT00879658|1905958|FG004|Overall Study|Lack of Efficacy|0
923774|NCT00879658|1905959|FG005|Overall Study|Lack of Efficacy|0
923775|NCT00879658|1905960|FG006|Overall Study|Lack of Efficacy|0
923776|NCT00879658|1905954|FG000|Overall Study|misrandomized (never received study med)|0
923777|NCT00879658|1905955|FG001|Overall Study|misrandomized (never received study med)|0
923778|NCT00879658|1905956|FG002|Overall Study|misrandomized (never received study med)|0
923779|NCT00879658|1905957|FG003|Overall Study|misrandomized (never received study med)|1
923780|NCT00879658|1905958|FG004|Overall Study|misrandomized (never received study med)|0
923781|NCT00879658|1905959|FG005|Overall Study|misrandomized (never received study med)|0
923782|NCT00879658|1905960|FG006|Overall Study|misrandomized (never received study med)|0
923783|NCT00879684|1905982|FG000|Stage 1: Dose Escalation|Adverse Event|1
923784|NCT00879684|1905983|FG001|Stage 1: Dose Escalation|Adverse Event|0
923785|NCT00879684|1905984|FG002|Stage 1: Dose Escalation|Adverse Event|0
923786|NCT00879684|1905985|FG003|Stage 1: Dose Escalation|Adverse Event|0
923787|NCT00879684|1905986|FG004|Stage 1: Dose Escalation|Adverse Event|0
923788|NCT00879684|1905987|FG005|Stage 1: Dose Escalation|Adverse Event|0
923789|NCT00879684|1905988|FG006|Stage 1: Dose Escalation|Adverse Event|0
923790|NCT00879684|1905982|FG000|Stage 1: Dose Escalation|Progressive Disease|2
923791|NCT00879684|1905983|FG001|Stage 1: Dose Escalation|Progressive Disease|3
923792|NCT00879684|1905984|FG002|Stage 1: Dose Escalation|Progressive Disease|0
923793|NCT00879684|1905985|FG003|Stage 1: Dose Escalation|Progressive Disease|4
923794|NCT00879684|1905986|FG004|Stage 1: Dose Escalation|Progressive Disease|3
923795|NCT00879684|1905987|FG005|Stage 1: Dose Escalation|Progressive Disease|3
923796|NCT00879684|1905988|FG006|Stage 1: Dose Escalation|Progressive Disease|0
923797|NCT00879684|1905982|FG000|Stage 1: Dose Escalation|Investigator declined participation|0
923798|NCT00879684|1905983|FG001|Stage 1: Dose Escalation|Investigator declined participation|0
923799|NCT00879684|1905984|FG002|Stage 1: Dose Escalation|Investigator declined participation|2
923800|NCT00879684|1905985|FG003|Stage 1: Dose Escalation|Investigator declined participation|2
923801|NCT00879684|1905986|FG004|Stage 1: Dose Escalation|Investigator declined participation|0
923802|NCT00879684|1905987|FG005|Stage 1: Dose Escalation|Investigator declined participation|0
923803|NCT00879684|1905988|FG006|Stage 1: Dose Escalation|Investigator declined participation|0
923804|NCT00879684|1905982|FG000|Stage 1: Dose Escalation|Death|0
923805|NCT00879684|1905983|FG001|Stage 1: Dose Escalation|Death|0
923806|NCT00879684|1905984|FG002|Stage 1: Dose Escalation|Death|1
923807|NCT00879684|1905985|FG003|Stage 1: Dose Escalation|Death|0
923808|NCT00879684|1905986|FG004|Stage 1: Dose Escalation|Death|0
923809|NCT00879684|1905987|FG005|Stage 1: Dose Escalation|Death|0
923810|NCT00879684|1905988|FG006|Stage 1: Dose Escalation|Death|0
923811|NCT00879684|1905982|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0
923812|NCT00879684|1905983|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0
923813|NCT00879684|1905984|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0
923814|NCT00879684|1905985|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0
923815|NCT00879684|1905986|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0
923816|NCT00879684|1905987|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0
923817|NCT00879684|1905988|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1
923818|NCT00879684|1905982|FG000|Stage 2: Expanded Cohort|Progressive Disease|0
923819|NCT00879684|1905983|FG001|Stage 2: Expanded Cohort|Progressive Disease|0
923820|NCT00879684|1905984|FG002|Stage 2: Expanded Cohort|Progressive Disease|0
923821|NCT00879684|1905985|FG003|Stage 2: Expanded Cohort|Progressive Disease|0
923822|NCT00879684|1905986|FG004|Stage 2: Expanded Cohort|Progressive Disease|0
923823|NCT00879684|1905987|FG005|Stage 2: Expanded Cohort|Progressive Disease|0
923824|NCT00879684|1905988|FG006|Stage 2: Expanded Cohort|Progressive Disease|11
923825|NCT00879684|1905982|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0
923826|NCT00879684|1905983|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0
923827|NCT00879684|1905984|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0
923828|NCT00879684|1905985|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0
923829|NCT00879684|1905986|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0
923830|NCT00879684|1905987|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0
923831|NCT00879684|1905988|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1
923832|NCT00879697|1906009|FG000|Overall Study|Physician Decision|2
923833|NCT00879697|1906010|FG001|Overall Study|Physician Decision|2
923834|NCT00879710|1906018|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2
923835|NCT00879710|1906019|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3
923836|NCT00879710|1906020|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1
923837|NCT00879710|1906021|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4
923838|NCT00879710|1906018|FG000|Phase 1 - 6 Weeks|Adverse Event|0
923839|NCT00879710|1906019|FG001|Phase 1 - 6 Weeks|Adverse Event|0
923840|NCT00879710|1906020|FG002|Phase 1 - 6 Weeks|Adverse Event|1
923841|NCT00879710|1906021|FG003|Phase 1 - 6 Weeks|Adverse Event|0
923842|NCT00879775|1906031|FG000|Overall Study|Lost to Follow-up|2
923843|NCT00879775|1906032|FG001|Overall Study|Lost to Follow-up|1
923844|NCT00879814|1906042|FG000|Overall Study|Adverse Event|0
923845|NCT00879814|1906043|FG001|Overall Study|Adverse Event|1
923846|NCT00879814|1906044|FG002|Overall Study|Adverse Event|0
923847|NCT00879814|1906045|FG003|Overall Study|Adverse Event|0
923848|NCT00879814|1906042|FG000|Overall Study|Lost to Follow-up|1
923849|NCT00879814|1906043|FG001|Overall Study|Lost to Follow-up|0
923850|NCT00879814|1906044|FG002|Overall Study|Lost to Follow-up|0
923851|NCT00879814|1906045|FG003|Overall Study|Lost to Follow-up|2
923852|NCT00879814|1906042|FG000|Overall Study|Participant Failed to Return|0
923853|NCT00879814|1906043|FG001|Overall Study|Participant Failed to Return|0
923854|NCT00879814|1906044|FG002|Overall Study|Participant Failed to Return|0
923855|NCT00879814|1906045|FG003|Overall Study|Participant Failed to Return|1
923856|NCT00879814|1906042|FG000|Overall Study|Withdrawal by Subject|3
923857|NCT00879814|1906043|FG001|Overall Study|Withdrawal by Subject|1
923858|NCT00879814|1906044|FG002|Overall Study|Withdrawal by Subject|1
923859|NCT00879814|1906045|FG003|Overall Study|Withdrawal by Subject|2
923860|NCT00879814|1906042|FG000|Overall Study|Physician Decision|0
923861|NCT00879814|1906043|FG001|Overall Study|Physician Decision|0
923862|NCT00879814|1906044|FG002|Overall Study|Physician Decision|1
923863|NCT00879814|1906045|FG003|Overall Study|Physician Decision|0
923864|NCT00879814|1906042|FG000|Overall Study|Other|0
923865|NCT00879814|1906043|FG001|Overall Study|Other|0
923866|NCT00879814|1906044|FG002|Overall Study|Other|1
923867|NCT00879814|1906045|FG003|Overall Study|Other|0
923868|NCT00879879|1906055|FG000|Overall Study|Death|1
923869|NCT00879879|1906055|FG000|Overall Study|Withdrawal by Subject|1
923870|NCT00879879|1906055|FG000|Overall Study|Physician Decision|1
923871|NCT00879970|1906064|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3
923872|NCT00879970|1906065|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3
923873|NCT00879970|1906066|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4
923874|NCT00879970|1906067|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0
923875|NCT00879970|1906068|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0
923876|NCT00879970|1906064|FG000|Period 1 TZD Randomization|Lost to Follow-up|1
923877|NCT00879970|1906065|FG001|Period 1 TZD Randomization|Lost to Follow-up|0
923878|NCT00879970|1906066|FG002|Period 1 TZD Randomization|Lost to Follow-up|1
923879|NCT00879970|1906067|FG003|Period 1 TZD Randomization|Lost to Follow-up|0
923880|NCT00879970|1906068|FG004|Period 1 TZD Randomization|Lost to Follow-up|0
923881|NCT00879970|1906064|FG000|Period 1 TZD Randomization|Death|2
923882|NCT00879970|1906065|FG001|Period 1 TZD Randomization|Death|1
923883|NCT00879970|1906066|FG002|Period 1 TZD Randomization|Death|0
923884|NCT00879970|1906067|FG003|Period 1 TZD Randomization|Death|0
923885|NCT00879970|1906068|FG004|Period 1 TZD Randomization|Death|0
923886|NCT00879970|1906064|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
923887|NCT00879970|1906065|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
923888|NCT00879970|1906066|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
923889|NCT00879970|1906067|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
923890|NCT00879970|1906068|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
923891|NCT00879970|1906064|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
923892|NCT00879970|1906065|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
923893|NCT00879970|1906066|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
923894|NCT00879970|1906067|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
923895|NCT00879970|1906068|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
923896|NCT00879970|1906064|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0
923897|NCT00879970|1906065|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0
923898|NCT00879970|1906066|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0
923899|NCT00879970|1906067|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0
923900|NCT00879970|1906068|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1
923901|NCT00879970|1906064|FG000|Period 2 Vitamin D Randomization|Death|0
923902|NCT00879970|1906065|FG001|Period 2 Vitamin D Randomization|Death|0
923903|NCT00879970|1906066|FG002|Period 2 Vitamin D Randomization|Death|0
923904|NCT00879970|1906067|FG003|Period 2 Vitamin D Randomization|Death|2
923905|NCT00879970|1906068|FG004|Period 2 Vitamin D Randomization|Death|0
923906|NCT00879996|1906088|FG000|Overall Study|Lost to Follow-up|7
923907|NCT00879996|1906089|FG001|Overall Study|Lost to Follow-up|6
923908|NCT00879996|1906088|FG000|Overall Study|non-compliance|6
923909|NCT00879996|1906089|FG001|Overall Study|non-compliance|4
923910|NCT00879996|1906088|FG000|Overall Study|Physician Decision|1
923911|NCT00879996|1906089|FG001|Overall Study|Physician Decision|2
923912|NCT00879996|1906088|FG000|Overall Study|psychiatric problem|0
923913|NCT00879996|1906089|FG001|Overall Study|psychiatric problem|1
923914|NCT00879996|1906088|FG000|Overall Study|put on parole|1
923915|NCT00879996|1906089|FG001|Overall Study|put on parole|0
923916|NCT00880009|1906097|FG000|Overall Study|Study terminated by sponsor|14
923917|NCT00880009|1906097|FG000|Overall Study|Withdrawal by Subject|1
923918|NCT00880009|1906097|FG000|Overall Study|Protocol Violation|1
923919|NCT00880048|1906118|FG000|Overall Study|Adverse Event|2
923920|NCT00880048|1906119|FG001|Overall Study|Adverse Event|3
923921|NCT00880048|1906120|FG002|Overall Study|Adverse Event|5
923922|NCT00880048|1906118|FG000|Overall Study|Lack of Efficacy|1
923923|NCT00880048|1906119|FG001|Overall Study|Lack of Efficacy|2
923924|NCT00880048|1906120|FG002|Overall Study|Lack of Efficacy|2
923925|NCT00880048|1906118|FG000|Overall Study|Protocol Violation|4
923926|NCT00880048|1906119|FG001|Overall Study|Protocol Violation|6
923927|NCT00880048|1906120|FG002|Overall Study|Protocol Violation|5
923928|NCT00880048|1906118|FG000|Overall Study|Lost to Follow-up|6
923929|NCT00880048|1906119|FG001|Overall Study|Lost to Follow-up|6
923930|NCT00880048|1906120|FG002|Overall Study|Lost to Follow-up|5
923931|NCT00880048|1906118|FG000|Overall Study|Physician Decision|1
923932|NCT00880048|1906119|FG001|Overall Study|Physician Decision|1
923933|NCT00880048|1906120|FG002|Overall Study|Physician Decision|7
923934|NCT00880048|1906118|FG000|Overall Study|Withdrawal by Subject|5
923935|NCT00880048|1906119|FG001|Overall Study|Withdrawal by Subject|8
923936|NCT00880048|1906120|FG002|Overall Study|Withdrawal by Subject|5
923937|NCT00880048|1906118|FG000|Overall Study|Study closed/terminated|9
923938|NCT00880048|1906119|FG001|Overall Study|Study closed/terminated|7
923939|NCT00880048|1906120|FG002|Overall Study|Study closed/terminated|6
923940|NCT00880087|1906130|FG000|Overall Study|Lost to Follow-up|0
923941|NCT00880087|1906131|FG001|Overall Study|Lost to Follow-up|2
923942|NCT00880100|1906137|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
923943|NCT00880100|1906137|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1
923944|NCT00880100|1906137|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2
923945|NCT00880165|1906143|FG000|Overall Study|Withdrawal by Subject|27
923946|NCT00880165|1906144|FG001|Overall Study|Withdrawal by Subject|23
923947|NCT00880165|1906143|FG000|Overall Study|Not diagnosed with OSA|14
923948|NCT00880165|1906144|FG001|Overall Study|Not diagnosed with OSA|8
923949|NCT00880165|1906143|FG000|Overall Study|Required BIPAP or oxygen treatment|12
923950|NCT00880165|1906144|FG001|Overall Study|Required BIPAP or oxygen treatment|4
923951|NCT00880165|1906143|FG000|Overall Study|Lost to follow|9
923952|NCT00880165|1906144|FG001|Overall Study|Lost to follow|15
923953|NCT00880191|1906152|FG000|Overall Study|Refused further treatment|4
923954|NCT00880191|1906153|FG001|Overall Study|Refused further treatment|1
923955|NCT00880191|1906152|FG000|Overall Study|Adverse Event|8
923956|NCT00880191|1906153|FG001|Overall Study|Adverse Event|6
923957|NCT00880191|1906152|FG000|Overall Study|Hospitalization/efficacy|1
923958|NCT00880191|1906153|FG001|Overall Study|Hospitalization/efficacy|1
923959|NCT00880256|1906163|FG000|Overall Study|Lost to Follow-up|28
923960|NCT00880269|1906169|FG000|Overall Study|Protocol Violation|1
923961|NCT00880269|1906170|FG001|Overall Study|Protocol Violation|0
923962|NCT00880269|1906169|FG000|Overall Study|Disease Progression|13
923963|NCT00880269|1906170|FG001|Overall Study|Disease Progression|11
923964|NCT00880269|1906169|FG000|Overall Study|New Cancer Therapy|1
923965|NCT00880269|1906170|FG001|Overall Study|New Cancer Therapy|0
923966|NCT00880269|1906169|FG000|Overall Study|Death|4
923967|NCT00880269|1906170|FG001|Overall Study|Death|2
923968|NCT00880269|1906169|FG000|Overall Study|Lost to Follow-up|0
923969|NCT00880269|1906170|FG001|Overall Study|Lost to Follow-up|1
923970|NCT00880269|1906169|FG000|Overall Study|Withdrawal by Subject|3
923971|NCT00880269|1906170|FG001|Overall Study|Withdrawal by Subject|4
923972|NCT00880269|1906169|FG000|Overall Study|Adverse Event|10
923973|NCT00880269|1906170|FG001|Overall Study|Adverse Event|9
923974|NCT00880334|1906178|FG000|Randomized Phase|Physician Decision|1
923975|NCT00880334|1906179|FG001|Randomized Phase|Physician Decision|0
923976|NCT00880334|1906178|FG000|Randomized Phase|Withdrawal by Subject|2
923977|NCT00880334|1906179|FG001|Randomized Phase|Withdrawal by Subject|1
923978|NCT00880334|1906178|FG000|Randomized Phase|Inadequate Labs|1
923979|NCT00880334|1906179|FG001|Randomized Phase|Inadequate Labs|1
923980|NCT00880334|1906178|FG000|Randomized Phase|Brain Metastasis|0
923981|NCT00880334|1906179|FG001|Randomized Phase|Brain Metastasis|1
923982|NCT00880334|1906178|FG000|Randomized Phase|Crossover Participants|0
923983|NCT00880334|1906179|FG001|Randomized Phase|Crossover Participants|37
923984|NCT00880399|1906197|FG000|Overall Study|Adverse Event|4
923985|NCT00880399|1906198|FG001|Overall Study|Adverse Event|6
923986|NCT00880399|1906199|FG002|Overall Study|Adverse Event|5
923987|NCT00880399|1906197|FG000|Overall Study|Lack of Efficacy|1
923988|NCT00880399|1906198|FG001|Overall Study|Lack of Efficacy|4
923989|NCT00880399|1906199|FG002|Overall Study|Lack of Efficacy|2
923990|NCT00880399|1906197|FG000|Overall Study|Protocol Violation|4
923991|NCT00880399|1906198|FG001|Overall Study|Protocol Violation|4
923992|NCT00880399|1906199|FG002|Overall Study|Protocol Violation|6
923993|NCT00880399|1906197|FG000|Overall Study|Study closed/terminated|3
923994|NCT00880399|1906198|FG001|Overall Study|Study closed/terminated|7
923995|NCT00880399|1906199|FG002|Overall Study|Study closed/terminated|4
923996|NCT00880399|1906197|FG000|Overall Study|Lost to Follow-up|8
923997|NCT00880399|1906198|FG001|Overall Study|Lost to Follow-up|5
923998|NCT00880399|1906199|FG002|Overall Study|Lost to Follow-up|3
923999|NCT00880399|1906197|FG000|Overall Study|Physician Decision|5
924000|NCT00880399|1906198|FG001|Overall Study|Physician Decision|0
924001|NCT00880399|1906199|FG002|Overall Study|Physician Decision|3
924002|NCT00880399|1906197|FG000|Overall Study|Withdrawal by Subject|6
924003|NCT00880399|1906198|FG001|Overall Study|Withdrawal by Subject|3
924004|NCT00880399|1906199|FG002|Overall Study|Withdrawal by Subject|3
924005|NCT00880555|1906221|FG000|Overall Study|Physician Decision|0
924006|NCT00880555|1906222|FG001|Overall Study|Physician Decision|8
924007|NCT00880555|1906223|FG002|Overall Study|Physician Decision|0
924008|NCT00880555|1906224|FG003|Overall Study|Physician Decision|2
924009|NCT00880555|1906225|FG004|Overall Study|Physician Decision|1
924010|NCT00880555|1906226|FG005|Overall Study|Physician Decision|0
924011|NCT00880555|1906221|FG000|Overall Study|Withdrawal by Subject|1
924012|NCT00880555|1906222|FG001|Overall Study|Withdrawal by Subject|1
924013|NCT00880555|1906223|FG002|Overall Study|Withdrawal by Subject|0
924014|NCT00880555|1906224|FG003|Overall Study|Withdrawal by Subject|0
924015|NCT00880555|1906225|FG004|Overall Study|Withdrawal by Subject|0
924016|NCT00880555|1906226|FG005|Overall Study|Withdrawal by Subject|0
924017|NCT00880555|1906221|FG000|Overall Study|Lack of resources (hired rater)|9
924018|NCT00880555|1906222|FG001|Overall Study|Lack of resources (hired rater)|7
924019|NCT00880555|1906223|FG002|Overall Study|Lack of resources (hired rater)|5
924020|NCT00880555|1906224|FG003|Overall Study|Lack of resources (hired rater)|0
924021|NCT00880555|1906225|FG004|Overall Study|Lack of resources (hired rater)|0
924022|NCT00880555|1906226|FG005|Overall Study|Lack of resources (hired rater)|0
924023|NCT00880555|1906221|FG000|Overall Study|Death|0
924024|NCT00880555|1906222|FG001|Overall Study|Death|0
924025|NCT00880555|1906223|FG002|Overall Study|Death|0
924026|NCT00880555|1906224|FG003|Overall Study|Death|0
924027|NCT00880555|1906225|FG004|Overall Study|Death|0
924028|NCT00880555|1906226|FG005|Overall Study|Death|1
924029|NCT00880555|1906221|FG000|Overall Study|Lost to Follow-up|0
924030|NCT00880555|1906222|FG001|Overall Study|Lost to Follow-up|1
924031|NCT00880555|1906223|FG002|Overall Study|Lost to Follow-up|0
924032|NCT00880555|1906224|FG003|Overall Study|Lost to Follow-up|0
924033|NCT00880555|1906225|FG004|Overall Study|Lost to Follow-up|0
924034|NCT00880555|1906226|FG005|Overall Study|Lost to Follow-up|0
924035|NCT00880568|1906246|FG000|Overall Study|Disease progression|3
924036|NCT00880568|1906247|FG001|Overall Study|Disease progression|3
924037|NCT00880568|1906248|FG002|Overall Study|Disease progression|3
924038|NCT00880568|1906249|FG003|Overall Study|Disease progression|1
924039|NCT00880568|1906250|FG004|Overall Study|Disease progression|3
924040|NCT00880568|1906251|FG005|Overall Study|Disease progression|3
924041|NCT00880568|1906252|FG006|Overall Study|Disease progression|5
924042|NCT00880568|1906253|FG007|Overall Study|Disease progression|0
924043|NCT00880568|1906254|FG008|Overall Study|Disease progression|3
924044|NCT00880568|1906246|FG000|Overall Study|Adverse Event|0
924045|NCT00880568|1906247|FG001|Overall Study|Adverse Event|0
924046|NCT00880568|1906248|FG002|Overall Study|Adverse Event|0
924047|NCT00880568|1906249|FG003|Overall Study|Adverse Event|0
924048|NCT00880568|1906250|FG004|Overall Study|Adverse Event|0
924049|NCT00880568|1906251|FG005|Overall Study|Adverse Event|0
924050|NCT00880568|1906252|FG006|Overall Study|Adverse Event|1
924051|NCT00880568|1906253|FG007|Overall Study|Adverse Event|1
924052|NCT00880568|1906254|FG008|Overall Study|Adverse Event|0
924053|NCT00880568|1906246|FG000|Overall Study|Withdrawal by Subject|0
924054|NCT00880568|1906247|FG001|Overall Study|Withdrawal by Subject|0
924055|NCT00880568|1906248|FG002|Overall Study|Withdrawal by Subject|0
924056|NCT00880568|1906249|FG003|Overall Study|Withdrawal by Subject|0
924057|NCT00880568|1906250|FG004|Overall Study|Withdrawal by Subject|0
924058|NCT00880568|1906251|FG005|Overall Study|Withdrawal by Subject|0
924059|NCT00880568|1906252|FG006|Overall Study|Withdrawal by Subject|0
924060|NCT00880568|1906253|FG007|Overall Study|Withdrawal by Subject|1
924061|NCT00880568|1906254|FG008|Overall Study|Withdrawal by Subject|0
924062|NCT00880607|1906285|FG000|Overall Study|Physician Decision|2
924063|NCT00880607|1906286|FG001|Overall Study|Physician Decision|2
924064|NCT00880607|1906285|FG000|Overall Study|Protocol Violation|2
924065|NCT00880607|1906286|FG001|Overall Study|Protocol Violation|1
924066|NCT00880607|1906285|FG000|Overall Study|surgery did not extend past L1 level|3
924067|NCT00880607|1906286|FG001|Overall Study|surgery did not extend past L1 level|0
924068|NCT00880620|1906298|FG000|Overall Study|Adverse Event|4
924069|NCT00880620|1906299|FG001|Overall Study|Adverse Event|5
924070|NCT00880620|1906300|FG002|Overall Study|Adverse Event|15
924071|NCT00880620|1906301|FG003|Overall Study|Adverse Event|15
924072|NCT00880620|1906298|FG000|Overall Study|Death|0
924073|NCT00880620|1906299|FG001|Overall Study|Death|0
924074|NCT00880620|1906300|FG002|Overall Study|Death|1
924075|NCT00880620|1906301|FG003|Overall Study|Death|0
924076|NCT00880620|1906298|FG000|Overall Study|Lack of Efficacy|12
924077|NCT00880620|1906299|FG001|Overall Study|Lack of Efficacy|4
924078|NCT00880620|1906300|FG002|Overall Study|Lack of Efficacy|0
924079|NCT00880620|1906301|FG003|Overall Study|Lack of Efficacy|1
924080|NCT00880620|1906298|FG000|Overall Study|Lost to Follow-up|0
924081|NCT00880620|1906299|FG001|Overall Study|Lost to Follow-up|1
924082|NCT00880620|1906300|FG002|Overall Study|Lost to Follow-up|1
924083|NCT00880620|1906301|FG003|Overall Study|Lost to Follow-up|0
924084|NCT00880620|1906298|FG000|Overall Study|Protocol Violation|0
924085|NCT00880620|1906299|FG001|Overall Study|Protocol Violation|1
924086|NCT00880620|1906300|FG002|Overall Study|Protocol Violation|0
924087|NCT00880620|1906301|FG003|Overall Study|Protocol Violation|2
924088|NCT00880620|1906298|FG000|Overall Study|Withdrawal by Subject|4
924089|NCT00880620|1906299|FG001|Overall Study|Withdrawal by Subject|3
924090|NCT00880620|1906300|FG002|Overall Study|Withdrawal by Subject|1
924091|NCT00880620|1906301|FG003|Overall Study|Withdrawal by Subject|3
924092|NCT00880620|1906298|FG000|Overall Study|Noncompliance|0
924093|NCT00880620|1906299|FG001|Overall Study|Noncompliance|0
924094|NCT00880620|1906300|FG002|Overall Study|Noncompliance|1
924095|NCT00880620|1906301|FG003|Overall Study|Noncompliance|1
924096|NCT00880620|1906298|FG000|Overall Study|Other|1
924097|NCT00880620|1906299|FG001|Overall Study|Other|1
924098|NCT00880620|1906300|FG002|Overall Study|Other|2
924099|NCT00880620|1906301|FG003|Overall Study|Other|2
924100|NCT00880685|1906315|FG000|Memantine 10mg|Lost to Follow-up|2
924101|NCT00880685|1906315|FG000|Memantine 20mg|Withdrawal by Subject|1
924102|NCT00880698|1906326|FG000|Overall Study|Death|0
924103|NCT00880698|1906327|FG001|Overall Study|Death|0
924104|NCT00880698|1906328|FG002|Overall Study|Death|1
924105|NCT00880698|1906329|FG003|Overall Study|Death|2
924106|NCT00880698|1906326|FG000|Overall Study|Lost to Follow-up|1
924107|NCT00880698|1906327|FG001|Overall Study|Lost to Follow-up|3
924108|NCT00880698|1906328|FG002|Overall Study|Lost to Follow-up|0
924109|NCT00880698|1906329|FG003|Overall Study|Lost to Follow-up|1
924110|NCT00880750|1906343|FG000|First Intervention|Adverse Event|1
924111|NCT00880750|1906344|FG001|First Intervention|Adverse Event|0
924112|NCT00880750|1906343|FG000|First Intervention|Unable to collect urine|4
924113|NCT00880750|1906344|FG001|First Intervention|Unable to collect urine|0
924114|NCT00880750|1906343|FG000|First Intervention|Non-compliance with meals|0
924115|NCT00880750|1906344|FG001|First Intervention|Non-compliance with meals|1
924116|NCT00880750|1906343|FG000|First Intervention|Withdrawal by Subject|2
924117|NCT00880750|1906344|FG001|First Intervention|Withdrawal by Subject|0
924118|NCT00880750|1906343|FG000|First Intervention|Lost to Follow-up|2
924119|NCT00880750|1906344|FG001|First Intervention|Lost to Follow-up|0
924120|NCT00880750|1906343|FG000|Second Intervention|Withdrawal by Subject|2
924121|NCT00880750|1906344|FG001|Second Intervention|Withdrawal by Subject|2
924122|NCT00880750|1906343|FG000|Second Intervention|Protocol Violation|1
924123|NCT00880750|1906344|FG001|Second Intervention|Protocol Violation|0
924124|NCT00880750|1906343|FG000|Second Intervention|Unable to collect urine|1
924125|NCT00880750|1906344|FG001|Second Intervention|Unable to collect urine|0
924126|NCT00880763|1906354|FG000|Extension Period (Part 2)|Adverse Event|0
924127|NCT00880763|1906355|FG001|Extension Period (Part 2)|Adverse Event|0
924128|NCT00880763|1906356|FG002|Extension Period (Part 2)|Adverse Event|1
924129|NCT00880763|1906357|FG003|Extension Period (Part 2)|Adverse Event|1
924130|NCT00880763|1906354|FG000|Extension Period (Part 2)|Withdrawal by Subject|0
924131|NCT00880763|1906355|FG001|Extension Period (Part 2)|Withdrawal by Subject|2
924132|NCT00880763|1906356|FG002|Extension Period (Part 2)|Withdrawal by Subject|1
924133|NCT00880763|1906357|FG003|Extension Period (Part 2)|Withdrawal by Subject|1
924134|NCT00880763|1906354|FG000|Extension Period (Part 2)|Physician Decision|0
924135|NCT00880763|1906355|FG001|Extension Period (Part 2)|Physician Decision|1
924136|NCT00880763|1906356|FG002|Extension Period (Part 2)|Physician Decision|1
924137|NCT00880763|1906357|FG003|Extension Period (Part 2)|Physician Decision|0
924138|NCT00880763|1906354|FG000|Extension Period (Part 2)|Lack of Efficacy|0
924139|NCT00880763|1906355|FG001|Extension Period (Part 2)|Lack of Efficacy|0
924140|NCT00880763|1906356|FG002|Extension Period (Part 2)|Lack of Efficacy|0
924141|NCT00880763|1906357|FG003|Extension Period (Part 2)|Lack of Efficacy|1
924142|NCT00880893|1906369|FG000|Overall Study|Protocol Violation|13
924143|NCT00880893|1906370|FG001|Overall Study|Protocol Violation|1
924144|NCT00880893|1906369|FG000|Overall Study|Withdrawal by Subject|15
924145|NCT00880893|1906370|FG001|Overall Study|Withdrawal by Subject|11
924146|NCT00880893|1906369|FG000|Overall Study|Lost to Follow-up|76
924147|NCT00880893|1906370|FG001|Overall Study|Lost to Follow-up|33
924148|NCT00880893|1906369|FG000|Overall Study|Serious adverse event|3
924149|NCT00880893|1906370|FG001|Overall Study|Serious adverse event|0
924150|NCT00880906|1906378|FG000|Overall Study|Lost to Follow-up|0
924151|NCT00880906|1906379|FG001|Overall Study|Lost to Follow-up|1
924152|NCT00880906|1906378|FG000|Overall Study|Did not meet criteria following patholog|12
924153|NCT00880906|1906379|FG001|Overall Study|Did not meet criteria following patholog|6
924154|NCT00881335|1906416|FG000|Overall Study|Lost to Follow-up|3
924155|NCT00881335|1906417|FG001|Overall Study|Lost to Follow-up|2
924156|NCT00881361|1906425|FG000|Overall Study|Terminated prior to surgery|27
924157|NCT00881361|1906426|FG001|Overall Study|Terminated prior to surgery|7
924158|NCT00881361|1906427|FG002|Overall Study|Terminated prior to surgery|0
924159|NCT00881361|1906425|FG000|Overall Study|Ineligible|17
924160|NCT00881361|1906426|FG001|Overall Study|Ineligible|2
924161|NCT00881361|1906427|FG002|Overall Study|Ineligible|2
924162|NCT00881504|1906445|FG000|Overall Study|Withdrawal by Subject|1
924163|NCT00881530|1906455|FG000|Overall Study|Adverse Event|5
924164|NCT00881530|1906456|FG001|Overall Study|Adverse Event|1
924165|NCT00881530|1906457|FG002|Overall Study|Adverse Event|1
924166|NCT00881530|1906458|FG003|Overall Study|Adverse Event|4
924167|NCT00881530|1906459|FG004|Overall Study|Adverse Event|10
924168|NCT00881530|1906460|FG005|Overall Study|Adverse Event|2
924169|NCT00881530|1906455|FG000|Overall Study|Lack of Efficacy|1
924170|NCT00881530|1906456|FG001|Overall Study|Lack of Efficacy|0
924171|NCT00881530|1906457|FG002|Overall Study|Lack of Efficacy|0
924172|NCT00881530|1906458|FG003|Overall Study|Lack of Efficacy|0
924173|NCT00881530|1906459|FG004|Overall Study|Lack of Efficacy|1
924174|NCT00881530|1906460|FG005|Overall Study|Lack of Efficacy|1
924175|NCT00881530|1906455|FG000|Overall Study|Not compliant with the protocol|0
924176|NCT00881530|1906456|FG001|Overall Study|Not compliant with the protocol|0
924177|NCT00881530|1906457|FG002|Overall Study|Not compliant with the protocol|0
924178|NCT00881530|1906458|FG003|Overall Study|Not compliant with the protocol|0
924179|NCT00881530|1906459|FG004|Overall Study|Not compliant with the protocol|2
924180|NCT00881530|1906460|FG005|Overall Study|Not compliant with the protocol|0
924181|NCT00881530|1906455|FG000|Overall Study|Lost to Follow-up|0
924182|NCT00881530|1906456|FG001|Overall Study|Lost to Follow-up|1
924183|NCT00881530|1906457|FG002|Overall Study|Lost to Follow-up|1
924184|NCT00881530|1906458|FG003|Overall Study|Lost to Follow-up|3
924185|NCT00881530|1906459|FG004|Overall Study|Lost to Follow-up|1
924186|NCT00881530|1906460|FG005|Overall Study|Lost to Follow-up|0
924187|NCT00881530|1906455|FG000|Overall Study|Refused to continue medication|7
924188|NCT00881530|1906456|FG001|Overall Study|Refused to continue medication|2
924189|NCT00881530|1906457|FG002|Overall Study|Refused to continue medication|1
924190|NCT00881530|1906458|FG003|Overall Study|Refused to continue medication|2
924191|NCT00881530|1906459|FG004|Overall Study|Refused to continue medication|0
924192|NCT00881530|1906460|FG005|Overall Study|Refused to continue medication|0
924193|NCT00881530|1906455|FG000|Overall Study|Other reason not defined above|1
924194|NCT00881530|1906456|FG001|Overall Study|Other reason not defined above|1
924195|NCT00881530|1906457|FG002|Overall Study|Other reason not defined above|2
924196|NCT00881530|1906458|FG003|Overall Study|Other reason not defined above|0
924197|NCT00881530|1906459|FG004|Overall Study|Other reason not defined above|0
924198|NCT00881530|1906460|FG005|Overall Study|Other reason not defined above|2
924199|NCT00881569|1906476|FG000|Overall Study|Disease progression|1
924200|NCT00881569|1906477|FG001|Overall Study|Disease progression|1
924201|NCT00881621|1906483|FG000|Overall Study|Physician Decision|34
924202|NCT00881712|1906499|FG000|Overall Study|Death|1
924203|NCT00881712|1906500|FG001|Overall Study|Death|0
924204|NCT00881712|1906501|FG002|Overall Study|Death|0
924205|NCT00881712|1906499|FG000|Overall Study|Withdrawal by Subject|1
924206|NCT00881712|1906500|FG001|Overall Study|Withdrawal by Subject|0
924207|NCT00881712|1906501|FG002|Overall Study|Withdrawal by Subject|0
924208|NCT00881751|1906511|FG000|Overall Study|Physician Decision|0
924209|NCT00881751|1906512|FG001|Overall Study|Physician Decision|1
924210|NCT00881751|1906511|FG000|Overall Study|Adverse Event|0
924211|NCT00881751|1906512|FG001|Overall Study|Adverse Event|2
924212|NCT00881751|1906511|FG000|Overall Study|Withdrawal by Subject|0
924213|NCT00881751|1906512|FG001|Overall Study|Withdrawal by Subject|2
924214|NCT00881868|1906520|FG000|Overall Study|Adverse Event|0
924215|NCT00881868|1906521|FG001|Overall Study|Adverse Event|1
924216|NCT00881868|1906520|FG000|Overall Study|Lost to Follow-up|2
924217|NCT00881868|1906521|FG001|Overall Study|Lost to Follow-up|1
924218|NCT00881868|1906520|FG000|Overall Study|Physician Decision|4
924219|NCT00881868|1906521|FG001|Overall Study|Physician Decision|0
924220|NCT00881868|1906520|FG000|Overall Study|Protocol Violation|2
924221|NCT00881868|1906521|FG001|Overall Study|Protocol Violation|0
924222|NCT00881894|1906529|FG000|Overall Study|Consent withdrawn|0
924223|NCT00881894|1906530|FG001|Overall Study|Consent withdrawn|1
924224|NCT00881894|1906529|FG000|Overall Study|Other reasons for premature termination|1
924225|NCT00881894|1906530|FG001|Overall Study|Other reasons for premature termination|2
924226|NCT00881959|1906538|FG000|Overall Study|Lost to Follow-up|2
924227|NCT00881959|1906539|FG001|Overall Study|Lost to Follow-up|4
924228|NCT00882115|1906549|FG000|Overall Study|Withdrawal by Subject|3
924229|NCT00882115|1906549|FG000|Overall Study|did not respond to DEP challe|6
924230|NCT00882362|1906560|FG000|Overall Study|Adverse Event|13
924231|NCT00882362|1906561|FG001|Overall Study|Adverse Event|10
924232|NCT00882362|1906560|FG000|Overall Study|Withdrawal by Subject|13
924233|NCT00882362|1906561|FG001|Overall Study|Withdrawal by Subject|10
924234|NCT00882362|1906560|FG000|Overall Study|Lack of Efficacy|3
924235|NCT00882362|1906561|FG001|Overall Study|Lack of Efficacy|0
924236|NCT00882362|1906560|FG000|Overall Study|Protocol Violation|7
924237|NCT00882362|1906561|FG001|Overall Study|Protocol Violation|2
924238|NCT00882362|1906560|FG000|Overall Study|Pregnancy|1
924239|NCT00882362|1906561|FG001|Overall Study|Pregnancy|0
924240|NCT00882362|1906560|FG000|Overall Study|Physician Decision|5
924241|NCT00882362|1906561|FG001|Overall Study|Physician Decision|1
924242|NCT00882362|1906560|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
924243|NCT00882362|1906561|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
924244|NCT00882362|1906560|FG000|Overall Study|change of residence or other commitments|5
924245|NCT00882362|1906561|FG001|Overall Study|change of residence or other commitments|0
924246|NCT00882440|1906574|FG000|Overall Study|Adverse Event|2
924247|NCT00882440|1906575|FG001|Overall Study|Adverse Event|2
924248|NCT00882440|1906576|FG002|Overall Study|Adverse Event|2
924249|NCT00882440|1906577|FG003|Overall Study|Adverse Event|1
924250|NCT00882440|1906578|FG004|Overall Study|Adverse Event|1
924251|NCT00882440|1906579|FG005|Overall Study|Adverse Event|4
924252|NCT00882440|1906580|FG006|Overall Study|Adverse Event|2
924253|NCT00882440|1906574|FG000|Overall Study|Lack of Efficacy|3
924254|NCT00882440|1906575|FG001|Overall Study|Lack of Efficacy|5
924255|NCT00882440|1906576|FG002|Overall Study|Lack of Efficacy|2
924256|NCT00882440|1906577|FG003|Overall Study|Lack of Efficacy|0
924257|NCT00882440|1906578|FG004|Overall Study|Lack of Efficacy|0
924258|NCT00882440|1906579|FG005|Overall Study|Lack of Efficacy|3
924259|NCT00882440|1906580|FG006|Overall Study|Lack of Efficacy|0
924260|NCT00882440|1906574|FG000|Overall Study|Lost to Follow-up|2
924261|NCT00882440|1906575|FG001|Overall Study|Lost to Follow-up|0
924262|NCT00882440|1906576|FG002|Overall Study|Lost to Follow-up|1
924263|NCT00882440|1906577|FG003|Overall Study|Lost to Follow-up|1
924264|NCT00882440|1906578|FG004|Overall Study|Lost to Follow-up|1
924265|NCT00882440|1906579|FG005|Overall Study|Lost to Follow-up|0
924266|NCT00882440|1906580|FG006|Overall Study|Lost to Follow-up|1
924267|NCT00882440|1906574|FG000|Overall Study|Protocol Violation|0
924268|NCT00882440|1906575|FG001|Overall Study|Protocol Violation|0
924269|NCT00882440|1906576|FG002|Overall Study|Protocol Violation|1
924270|NCT00882440|1906577|FG003|Overall Study|Protocol Violation|1
924271|NCT00882440|1906578|FG004|Overall Study|Protocol Violation|1
924272|NCT00882440|1906579|FG005|Overall Study|Protocol Violation|0
924273|NCT00882440|1906580|FG006|Overall Study|Protocol Violation|0
924274|NCT00882440|1906574|FG000|Overall Study|Withdrawal by Subject|2
924275|NCT00882440|1906575|FG001|Overall Study|Withdrawal by Subject|1
924276|NCT00882440|1906576|FG002|Overall Study|Withdrawal by Subject|1
924277|NCT00882440|1906577|FG003|Overall Study|Withdrawal by Subject|0
924278|NCT00882440|1906578|FG004|Overall Study|Withdrawal by Subject|6
924279|NCT00882440|1906579|FG005|Overall Study|Withdrawal by Subject|0
924280|NCT00882440|1906580|FG006|Overall Study|Withdrawal by Subject|1
924281|NCT00882440|1906574|FG000|Overall Study|Patient Uncooperative|2
924282|NCT00882440|1906575|FG001|Overall Study|Patient Uncooperative|0
924283|NCT00882440|1906576|FG002|Overall Study|Patient Uncooperative|0
924284|NCT00882440|1906577|FG003|Overall Study|Patient Uncooperative|0
924285|NCT00882440|1906578|FG004|Overall Study|Patient Uncooperative|1
924286|NCT00882440|1906579|FG005|Overall Study|Patient Uncooperative|0
924287|NCT00882440|1906580|FG006|Overall Study|Patient Uncooperative|0
924288|NCT00882518|1906591|FG000|Overall Study|Adverse Event|9
924289|NCT00882518|1906592|FG001|Overall Study|Adverse Event|18
924290|NCT00882518|1906591|FG000|Overall Study|Withdrawal by Subject|9
924291|NCT00882518|1906592|FG001|Overall Study|Withdrawal by Subject|13
924292|NCT00882518|1906591|FG000|Overall Study|Lack of Efficacy|12
924293|NCT00882518|1906592|FG001|Overall Study|Lack of Efficacy|9
924294|NCT00882518|1906591|FG000|Overall Study|Severe non-compliance to protocol|3
924295|NCT00882518|1906592|FG001|Overall Study|Severe non-compliance to protocol|1
924296|NCT00882518|1906591|FG000|Overall Study|Incorrect enrolment|4
924297|NCT00882518|1906592|FG001|Overall Study|Incorrect enrolment|2
924298|NCT00882518|1906591|FG000|Overall Study|Central lab closure for National day|1
924299|NCT00882518|1906592|FG001|Overall Study|Central lab closure for National day|0
924300|NCT00882518|1906591|FG000|Overall Study|Allocating random number by mistake|0
924301|NCT00882518|1906592|FG001|Overall Study|Allocating random number by mistake|1
924302|NCT00882557|1906600|FG000|Overall Study|Withdrawal by Subject|1
924303|NCT00882557|1906601|FG001|Overall Study|Withdrawal by Subject|0
924304|NCT00882557|1906600|FG000|Overall Study|Trouble with Vein Access|1
924305|NCT00882557|1906601|FG001|Overall Study|Trouble with Vein Access|0
924306|NCT00882557|1906600|FG000|Overall Study|Randomized Not Treated|0
924307|NCT00882557|1906601|FG001|Overall Study|Randomized Not Treated|1
924308|NCT00882583|1906609|FG000|Overall Study|Physician Decision|1
924309|NCT00882583|1906610|FG001|Overall Study|Physician Decision|0
924310|NCT00882583|1906609|FG000|Overall Study|Adverse Event|0
924311|NCT00882583|1906610|FG001|Overall Study|Adverse Event|1
924312|NCT00882713|1906645|FG000|Overall Study|Adverse Event|2
924313|NCT00882713|1906645|FG000|Overall Study|Death|3
924314|NCT00882713|1906645|FG000|Overall Study|Administrative reasons|4
924315|NCT00882713|1906645|FG000|Overall Study|refused treatment/withdrew consent|4
924316|NCT00882713|1906645|FG000|Overall Study|Blood transfusion|2
924317|NCT00882713|1906645|FG000|Overall Study|Insufficient therapeutic response|3
924318|NCT00882713|1906645|FG000|Overall Study|Failure to return|2
924319|NCT00882713|1906645|FG000|Overall Study|Other - Reasons|2
924320|NCT00882908|1906659|FG000|Overall Study|Adverse Event|0
924321|NCT00882908|1906660|FG001|Overall Study|Adverse Event|0
924322|NCT00882908|1906661|FG002|Overall Study|Adverse Event|1
924323|NCT00882908|1906662|FG003|Overall Study|Adverse Event|0
924324|NCT00882908|1906663|FG004|Overall Study|Adverse Event|1
924325|NCT00882908|1906659|FG000|Overall Study|Lost to Follow-up|3
924326|NCT00882908|1906660|FG001|Overall Study|Lost to Follow-up|5
924327|NCT00882908|1906661|FG002|Overall Study|Lost to Follow-up|3
924328|NCT00882908|1906662|FG003|Overall Study|Lost to Follow-up|1
924329|NCT00882908|1906663|FG004|Overall Study|Lost to Follow-up|2
924330|NCT00882908|1906659|FG000|Overall Study|Protocol Violation|0
924331|NCT00882908|1906660|FG001|Overall Study|Protocol Violation|1
924332|NCT00882908|1906661|FG002|Overall Study|Protocol Violation|0
924333|NCT00882908|1906662|FG003|Overall Study|Protocol Violation|0
924334|NCT00882908|1906663|FG004|Overall Study|Protocol Violation|0
924335|NCT00882908|1906659|FG000|Overall Study|Withdrawal by Subject|0
924336|NCT00882908|1906660|FG001|Overall Study|Withdrawal by Subject|0
924337|NCT00882908|1906661|FG002|Overall Study|Withdrawal by Subject|3
924338|NCT00882908|1906662|FG003|Overall Study|Withdrawal by Subject|5
924339|NCT00882908|1906663|FG004|Overall Study|Withdrawal by Subject|2
924340|NCT00882908|1906659|FG000|Overall Study|Subject reached a virologic endpoint|0
924341|NCT00882908|1906660|FG001|Overall Study|Subject reached a virologic endpoint|0
924342|NCT00882908|1906661|FG002|Overall Study|Subject reached a virologic endpoint|0
924343|NCT00882908|1906662|FG003|Overall Study|Subject reached a virologic endpoint|0
924344|NCT00882908|1906663|FG004|Overall Study|Subject reached a virologic endpoint|1
924345|NCT00882908|1906659|FG000|Overall Study|Study terminated in error|0
924346|NCT00882908|1906660|FG001|Overall Study|Study terminated in error|0
924347|NCT00882908|1906661|FG002|Overall Study|Study terminated in error|0
924348|NCT00882908|1906662|FG003|Overall Study|Study terminated in error|1
924349|NCT00882908|1906663|FG004|Overall Study|Study terminated in error|0
924350|NCT00882921|1906676|FG000|Overall Study|Death|2
924351|NCT00882921|1906676|FG000|Overall Study|Other|3
924352|NCT00882921|1906676|FG000|Overall Study|Lost to Follow-up|2
924353|NCT00882921|1906676|FG000|Overall Study|Termination By Investigator|3
924354|NCT00882921|1906676|FG000|Overall Study|Withdrawal Of Consent|1
924355|NCT00882999|1906688|FG000|Overall Study|Adverse Event|0
924356|NCT00882999|1906689|FG001|Overall Study|Adverse Event|0
924357|NCT00882999|1906690|FG002|Overall Study|Adverse Event|0
924358|NCT00882999|1906691|FG003|Overall Study|Adverse Event|0
924359|NCT00882999|1906692|FG004|Overall Study|Adverse Event|1
924360|NCT00882999|1906693|FG005|Overall Study|Adverse Event|0
924361|NCT00882999|1906694|FG006|Overall Study|Adverse Event|0
924362|NCT00882999|1906688|FG000|Overall Study|Death|0
924363|NCT00882999|1906689|FG001|Overall Study|Death|1
924364|NCT00882999|1906690|FG002|Overall Study|Death|0
924365|NCT00882999|1906691|FG003|Overall Study|Death|0
924366|NCT00882999|1906692|FG004|Overall Study|Death|0
924367|NCT00882999|1906693|FG005|Overall Study|Death|0
924368|NCT00882999|1906694|FG006|Overall Study|Death|0
924369|NCT00882999|1906688|FG000|Overall Study|Withdrawal by Subject|7
924370|NCT00882999|1906689|FG001|Overall Study|Withdrawal by Subject|6
924371|NCT00882999|1906690|FG002|Overall Study|Withdrawal by Subject|3
924372|NCT00882999|1906691|FG003|Overall Study|Withdrawal by Subject|3
924373|NCT00882999|1906692|FG004|Overall Study|Withdrawal by Subject|6
924374|NCT00882999|1906693|FG005|Overall Study|Withdrawal by Subject|5
924375|NCT00882999|1906694|FG006|Overall Study|Withdrawal by Subject|5
924376|NCT00882999|1906688|FG000|Overall Study|Lost to Follow-up|0
924377|NCT00882999|1906689|FG001|Overall Study|Lost to Follow-up|1
924378|NCT00882999|1906690|FG002|Overall Study|Lost to Follow-up|1
924379|NCT00882999|1906691|FG003|Overall Study|Lost to Follow-up|2
924380|NCT00882999|1906692|FG004|Overall Study|Lost to Follow-up|1
924381|NCT00882999|1906693|FG005|Overall Study|Lost to Follow-up|1
924382|NCT00882999|1906694|FG006|Overall Study|Lost to Follow-up|2
924383|NCT00882999|1906688|FG000|Overall Study|Physician Decision|1
924384|NCT00882999|1906689|FG001|Overall Study|Physician Decision|0
924385|NCT00882999|1906690|FG002|Overall Study|Physician Decision|0
924386|NCT00882999|1906691|FG003|Overall Study|Physician Decision|0
924387|NCT00882999|1906692|FG004|Overall Study|Physician Decision|0
924388|NCT00882999|1906693|FG005|Overall Study|Physician Decision|1
924389|NCT00882999|1906694|FG006|Overall Study|Physician Decision|1
924390|NCT00883051|1906722|FG000|Overall Study|Lost to Follow-up|0
924391|NCT00883051|1906723|FG001|Overall Study|Lost to Follow-up|0
924392|NCT00883051|1906724|FG002|Overall Study|Lost to Follow-up|0
924393|NCT00883051|1906725|FG003|Overall Study|Lost to Follow-up|0
924394|NCT00883051|1906726|FG004|Overall Study|Lost to Follow-up|1
924395|NCT00883051|1906722|FG000|Overall Study|Did not use study medication|24
924396|NCT00883051|1906723|FG001|Overall Study|Did not use study medication|22
924397|NCT00883051|1906724|FG002|Overall Study|Did not use study medication|29
924398|NCT00883051|1906725|FG003|Overall Study|Did not use study medication|29
924399|NCT00883051|1906726|FG004|Overall Study|Did not use study medication|17
924400|NCT00883090|1906738|FG000|Overall Study|Sponsor's decision|1
924401|NCT00883090|1906738|FG000|Overall Study|Withdrawal by Subject|1
924402|NCT00883116|1906753|FG000|Overall Study|Adverse event unrelated to study drug|5
924403|NCT00883116|1906754|FG001|Overall Study|Adverse event unrelated to study drug|10
924404|NCT00883116|1906753|FG000|Overall Study|Death|6
924405|NCT00883116|1906754|FG001|Overall Study|Death|2
924406|NCT00883116|1906753|FG000|Overall Study|Disease progression|130
924407|NCT00883116|1906754|FG001|Overall Study|Disease progression|128
924408|NCT00883116|1906753|FG000|Overall Study|Lost to Follow-up|0
924409|NCT00883116|1906754|FG001|Overall Study|Lost to Follow-up|1
924410|NCT00883116|1906753|FG000|Overall Study|Maximum clinical benefit|13
924411|NCT00883116|1906754|FG001|Overall Study|Maximum clinical benefit|46
924412|NCT00883116|1906753|FG000|Overall Study|Not identified|3
924413|NCT00883116|1906754|FG001|Overall Study|Not identified|6
924414|NCT00883116|1906753|FG000|Overall Study|Study drug toxicity|36
924415|NCT00883116|1906754|FG001|Overall Study|Study drug toxicity|16
924416|NCT00883116|1906753|FG000|Overall Study|Withdrawal by Subject|14
924417|NCT00883116|1906754|FG001|Overall Study|Withdrawal by Subject|8
924418|NCT00883116|1906753|FG000|Overall Study|No longer meets study criteria|2
924419|NCT00883116|1906754|FG001|Overall Study|No longer meets study criteria|2
924420|NCT00883129|1906764|FG000|Overall Study|Adverse Event|7
924421|NCT00883129|1906765|FG001|Overall Study|Adverse Event|15
924422|NCT00883129|1906764|FG000|Overall Study|Withdrawal by Subject|8
924423|NCT00883129|1906765|FG001|Overall Study|Withdrawal by Subject|9
924424|NCT00883129|1906764|FG000|Overall Study|Non-compliance|3
924425|NCT00883129|1906765|FG001|Overall Study|Non-compliance|6
924426|NCT00883129|1906764|FG000|Overall Study|Lost to Follow-up|1
924427|NCT00883129|1906765|FG001|Overall Study|Lost to Follow-up|2
924428|NCT00883129|1906764|FG000|Overall Study|Death|1
924429|NCT00883129|1906765|FG001|Overall Study|Death|2
924430|NCT00883129|1906764|FG000|Overall Study|Defined Treatment Failure|0
924431|NCT00883129|1906765|FG001|Overall Study|Defined Treatment Failure|2
924432|NCT00883181|1906788|FG000|Overall Study|Hematological Adverse Event|26
924433|NCT00883181|1906788|FG000|Overall Study|Non-hematological Adverse Event|55
924434|NCT00883181|1906788|FG000|Overall Study|Disease Progression|94
924435|NCT00883181|1906788|FG000|Overall Study|Administrative Reason|24
924436|NCT00883181|1906788|FG000|Overall Study|Withdrawal by Subject|4
924437|NCT00883181|1906788|FG000|Overall Study|Death|31
924438|NCT00883181|1906788|FG000|Overall Study|Other|38
924439|NCT00883181|1906788|FG000|Overall Study|Protocol Deviation|3
924440|NCT00883181|1906788|FG000|Overall Study|Noncompliance|3
924441|NCT00883337|1906835|FG000|Core Treatment Period|Adverse Event|9
924442|NCT00883337|1906836|FG001|Core Treatment Period|Adverse Event|12
924443|NCT00883337|1906837|FG002|Core Treatment Period|Adverse Event|22
924444|NCT00883337|1906835|FG000|Core Treatment Period|Lack of Efficacy|7
924445|NCT00883337|1906836|FG001|Core Treatment Period|Lack of Efficacy|4
924446|NCT00883337|1906837|FG002|Core Treatment Period|Lack of Efficacy|2
924447|NCT00883337|1906835|FG000|Core Treatment Period|Lost to Follow-up|1
924448|NCT00883337|1906836|FG001|Core Treatment Period|Lost to Follow-up|1
924449|NCT00883337|1906837|FG002|Core Treatment Period|Lost to Follow-up|0
924450|NCT00883337|1906835|FG000|Core Treatment Period|Withdrawal by Subject|2
924451|NCT00883337|1906836|FG001|Core Treatment Period|Withdrawal by Subject|2
924452|NCT00883337|1906837|FG002|Core Treatment Period|Withdrawal by Subject|6
924453|NCT00883337|1906835|FG000|Core Treatment Period|Wish to be pregnant|1
924454|NCT00883337|1906836|FG001|Core Treatment Period|Wish to be pregnant|2
924455|NCT00883337|1906837|FG002|Core Treatment Period|Wish to be pregnant|1
924456|NCT00883337|1906835|FG000|Core Treatment Period|Poor compliance to protocol|0
924457|NCT00883337|1906836|FG001|Core Treatment Period|Poor compliance to protocol|0
924458|NCT00883337|1906837|FG002|Core Treatment Period|Poor compliance to protocol|1
924459|NCT00883337|1906835|FG000|Core Treatment Period|Other than above|0
924460|NCT00883337|1906836|FG001|Core Treatment Period|Other than above|1
924461|NCT00883337|1906837|FG002|Core Treatment Period|Other than above|1
924462|NCT00883337|1906835|FG000|Extension Treatment Period|Adverse Event|8
924463|NCT00883337|1906836|FG001|Extension Treatment Period|Adverse Event|5
924464|NCT00883337|1906837|FG002|Extension Treatment Period|Adverse Event|5
924465|NCT00883337|1906835|FG000|Extension Treatment Period|Lack of Efficacy|8
924466|NCT00883337|1906836|FG001|Extension Treatment Period|Lack of Efficacy|8
924467|NCT00883337|1906837|FG002|Extension Treatment Period|Lack of Efficacy|8
924468|NCT00883337|1906835|FG000|Extension Treatment Period|Poor compliance to protocol|1
924469|NCT00883337|1906836|FG001|Extension Treatment Period|Poor compliance to protocol|1
924470|NCT00883337|1906837|FG002|Extension Treatment Period|Poor compliance to protocol|1
924471|NCT00883337|1906835|FG000|Extension Treatment Period|Lost to Follow-up|1
924472|NCT00883337|1906836|FG001|Extension Treatment Period|Lost to Follow-up|0
924473|NCT00883337|1906837|FG002|Extension Treatment Period|Lost to Follow-up|0
924474|NCT00883337|1906835|FG000|Extension Treatment Period|Other than above|10
924475|NCT00883337|1906836|FG001|Extension Treatment Period|Other than above|9
924476|NCT00883337|1906837|FG002|Extension Treatment Period|Other than above|5
924477|NCT00883493|1906861|FG000|Overall Study|Adverse Event|11
924478|NCT00883493|1906862|FG001|Overall Study|Adverse Event|12
924479|NCT00883493|1906861|FG000|Overall Study|Lack of Efficacy|4
924480|NCT00883493|1906862|FG001|Overall Study|Lack of Efficacy|3
924481|NCT00883493|1906861|FG000|Overall Study|Lost to Follow-up|7
924482|NCT00883493|1906862|FG001|Overall Study|Lost to Follow-up|6
924483|NCT00883493|1906861|FG000|Overall Study|Withdrawal by Subject|11
924484|NCT00883493|1906862|FG001|Overall Study|Withdrawal by Subject|20
924485|NCT00883493|1906861|FG000|Overall Study|Eligibility Criteria not fullfilled|6
924486|NCT00883493|1906862|FG001|Overall Study|Eligibility Criteria not fullfilled|6
924487|NCT00883493|1906861|FG000|Overall Study|Study specific disc. criteria|2
924488|NCT00883493|1906862|FG001|Overall Study|Study specific disc. criteria|0
924489|NCT00883493|1906861|FG000|Overall Study|Other|5
924490|NCT00883493|1906862|FG001|Overall Study|Other|3
924491|NCT00883558|1906868|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
924492|NCT00883558|1906869|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
924493|NCT00883558|1906870|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
924494|NCT00883558|1906868|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
924495|NCT00883558|1906869|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
924496|NCT00883558|1906870|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
924497|NCT00883558|1906868|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
924498|NCT00883558|1906869|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
924499|NCT00883558|1906870|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
924500|NCT00883558|1906868|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
924501|NCT00883558|1906869|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
924502|NCT00883558|1906870|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
924503|NCT00883558|1906868|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
924504|NCT00883558|1906869|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
924505|NCT00883558|1906870|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
924506|NCT00883688|1906880|FG000|Overall Study|Ineligible|2
924507|NCT00883740|1906884|FG000|First Intervention|Lost to Follow-up|1
924508|NCT00883740|1906885|FG001|First Intervention|Lost to Follow-up|0
924509|NCT00883740|1906884|FG000|First Intervention|No longer willing to participate|2
924510|NCT00883740|1906885|FG001|First Intervention|No longer willing to participate|0
924511|NCT00883740|1906884|FG000|First Intervention|Protocol Violation|3
924512|NCT00883740|1906885|FG001|First Intervention|Protocol Violation|6
924513|NCT00883740|1906884|FG000|First Intervention|Adverse Event|1
924514|NCT00883740|1906885|FG001|First Intervention|Adverse Event|2
924515|NCT00883740|1906884|FG000|Second Intervention|Protocol Violation|1
924516|NCT00883740|1906885|FG001|Second Intervention|Protocol Violation|0
924517|NCT00883740|1906884|FG000|Second Intervention|No longer willing to participate|0
924518|NCT00883740|1906885|FG001|Second Intervention|No longer willing to participate|1
924519|NCT00883753|1906891|FG000|Overall Study|Adverse Event|37
924520|NCT00883753|1906891|FG000|Overall Study|Death|2
924521|NCT00883753|1906891|FG000|Overall Study|Insufficient therapeutic response|16
924522|NCT00883753|1906891|FG000|Overall Study|Lost to Follow-up|4
924523|NCT00883753|1906891|FG000|Overall Study|Violation of selection criteria at entry|7
924524|NCT00883753|1906891|FG000|Overall Study|Protocol Violation|2
924525|NCT00883753|1906891|FG000|Overall Study|Refused treatment|4
924526|NCT00883753|1906891|FG000|Overall Study|Withdrew consent|10
924527|NCT00883753|1906891|FG000|Overall Study|Investigator's decision|17
924528|NCT00883753|1906891|FG000|Overall Study|Administrative/Other|8
924529|NCT00883779|1906900|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4
924530|NCT00883779|1906901|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4
924531|NCT00883779|1906900|FG000|Primary Study Treatment Phase|Disease progression|75
924532|NCT00883779|1906901|FG001|Primary Study Treatment Phase|Disease progression|59
924533|NCT00883779|1906900|FG000|Primary Study Treatment Phase|Adverse Event|16
924534|NCT00883779|1906901|FG001|Primary Study Treatment Phase|Adverse Event|16
924535|NCT00883779|1906900|FG000|Primary Study Treatment Phase|Death|2
924536|NCT00883779|1906901|FG001|Primary Study Treatment Phase|Death|3
924537|NCT00883779|1906900|FG000|Primary Study Treatment Phase|Refused Treatment|5
924538|NCT00883779|1906901|FG001|Primary Study Treatment Phase|Refused Treatment|4
924539|NCT00883779|1906900|FG000|Primary Study Treatment Phase|Other|3
924540|NCT00883779|1906901|FG001|Primary Study Treatment Phase|Other|0
924541|NCT00883779|1906900|FG000|Post-Study Treatment Phase|Adverse Event|2
924542|NCT00883779|1906901|FG001|Post-Study Treatment Phase|Adverse Event|3
924543|NCT00883779|1906900|FG000|Post-Study Treatment Phase|Death|1
924544|NCT00883779|1906901|FG001|Post-Study Treatment Phase|Death|3
924545|NCT00883779|1906900|FG000|Post-Study Treatment Phase|Protocol Violation|0
924546|NCT00883779|1906901|FG001|Post-Study Treatment Phase|Protocol Violation|1
924547|NCT00883779|1906900|FG000|Post-Study Treatment Phase|Refused Treatment|3
924548|NCT00883779|1906901|FG001|Post-Study Treatment Phase|Refused Treatment|0
924549|NCT00883779|1906900|FG000|Post-Study Treatment Phase|Disease progression|103
924550|NCT00883779|1906901|FG001|Post-Study Treatment Phase|Disease progression|122
924551|NCT00883779|1906900|FG000|Post-Study Treatment Phase|Other|3
924552|NCT00883779|1906901|FG001|Post-Study Treatment Phase|Other|0
924553|NCT00883779|1906900|FG000|Post-Study Treatment Phase|Ongoing in the study|0
924554|NCT00883779|1906901|FG001|Post-Study Treatment Phase|Ongoing in the study|6
924555|NCT00883779|1906900|FG000|Off-study Phase|Death|185
924556|NCT00883779|1906901|FG001|Off-study Phase|Death|174
924557|NCT00883779|1906900|FG000|Off-study Phase|Refused treatment|1
924558|NCT00883779|1906901|FG001|Off-study Phase|Refused treatment|1
924559|NCT00883779|1906900|FG000|Off-study Phase|Failure to return|5
924560|NCT00883779|1906901|FG001|Off-study Phase|Failure to return|6
924561|NCT00883779|1906900|FG000|Off-study Phase|Other|18
924562|NCT00883779|1906901|FG001|Off-study Phase|Other|21
924563|NCT00884039|1906909|FG000|Overall Study|Withdrawal by Subject|0
924564|NCT00884039|1906910|FG001|Overall Study|Withdrawal by Subject|1
924565|NCT00884039|1906909|FG000|Overall Study|Lack of Efficacy|2
924566|NCT00884039|1906910|FG001|Overall Study|Lack of Efficacy|0
924567|NCT00884117|1906932|FG000|Overall Study|Adverse Event|2
924568|NCT00884117|1906932|FG000|Overall Study|Withdrawal by Subject|89
924569|NCT00884117|1906932|FG000|Overall Study|Death|3
924570|NCT00884117|1906932|FG000|Overall Study|Lost to Follow-up|143
924571|NCT00884117|1906932|FG000|Overall Study|Other|12
924572|NCT00884221|1906951|FG000|Overall Study|Withdrawal by Subject|0
924573|NCT00884221|1906952|FG001|Overall Study|Withdrawal by Subject|3
924574|NCT00884221|1906951|FG000|Overall Study|Adverse Event|6
924575|NCT00884221|1906952|FG001|Overall Study|Adverse Event|3
924576|NCT00884221|1906951|FG000|Overall Study|Protocol Violation|16
924577|NCT00884221|1906952|FG001|Overall Study|Protocol Violation|13
924578|NCT00884221|1906951|FG000|Overall Study|Cancellation of Cycle and Other Reason|12
924579|NCT00884221|1906952|FG001|Overall Study|Cancellation of Cycle and Other Reason|13
924580|NCT00884273|1906962|FG000|Overall Study|Adverse Event|0
924581|NCT00884273|1906963|FG001|Overall Study|Adverse Event|2
924582|NCT00884273|1906962|FG000|Overall Study|Protocol Violation|1
924583|NCT00884273|1906963|FG001|Overall Study|Protocol Violation|3
924584|NCT00884273|1906962|FG000|Overall Study|Practical reasons|1
924585|NCT00884273|1906963|FG001|Overall Study|Practical reasons|0
924586|NCT00884286|1906971|FG000|Overall Study|Progressive disease|21
924587|NCT00884286|1906972|FG001|Overall Study|Progressive disease|28
924588|NCT00884286|1906971|FG000|Overall Study|Toxicity|4
924589|NCT00884286|1906972|FG001|Overall Study|Toxicity|1
924590|NCT00884286|1906971|FG000|Overall Study|Death|2
924591|NCT00884286|1906972|FG001|Overall Study|Death|2
924592|NCT00884286|1906971|FG000|Overall Study|Physician Decision|1
924593|NCT00884286|1906972|FG001|Overall Study|Physician Decision|0
924594|NCT00884286|1906971|FG000|Overall Study|Septic shock|1
924595|NCT00884286|1906972|FG001|Overall Study|Septic shock|0
924596|NCT00884286|1906971|FG000|Overall Study|Thrombus in right auricle|1
924597|NCT00884286|1906972|FG001|Overall Study|Thrombus in right auricle|0
924598|NCT00884286|1906971|FG000|Overall Study|Not treated|2
924599|NCT00884286|1906972|FG001|Overall Study|Not treated|1
924600|NCT00884286|1906971|FG000|Overall Study|Comprised lung carcinoma|0
924601|NCT00884286|1906972|FG001|Overall Study|Comprised lung carcinoma|1
924602|NCT00884312|1906981|FG000|Overall Study|Non-fatal Progressive Disease|0
924603|NCT00884312|1906982|FG001|Overall Study|Non-fatal Progressive Disease|8
924604|NCT00884312|1906981|FG000|Overall Study|Fatal Progressive Disease|0
924605|NCT00884312|1906982|FG001|Overall Study|Fatal Progressive Disease|1
924606|NCT00884312|1906981|FG000|Overall Study|Non-fatal Adverse Event|1
924607|NCT00884312|1906982|FG001|Overall Study|Non-fatal Adverse Event|0
924608|NCT00884312|1906981|FG000|Overall Study|Fatal Adverse Event|1
924609|NCT00884312|1906982|FG001|Overall Study|Fatal Adverse Event|4
924610|NCT00884312|1906981|FG000|Overall Study|Withdrawal by Subject|0
924611|NCT00884312|1906982|FG001|Overall Study|Withdrawal by Subject|6
924612|NCT00884312|1906981|FG000|Overall Study|Physician Decision|0
924613|NCT00884312|1906982|FG001|Overall Study|Physician Decision|1
924614|NCT00884312|1906981|FG000|Overall Study|Other|0
924615|NCT00884312|1906982|FG001|Overall Study|Other|4
924616|NCT00884312|1906981|FG000|Overall Study|Did Not Receive Study Drug|0
924617|NCT00884312|1906982|FG001|Overall Study|Did Not Receive Study Drug|1
924618|NCT00884325|1906990|FG000|Overall Study|Lost to Follow-up|1
924619|NCT00884325|1906991|FG001|Overall Study|Lost to Follow-up|2
924620|NCT00884325|1906990|FG000|Overall Study|Lack of Efficacy|0
924621|NCT00884325|1906991|FG001|Overall Study|Lack of Efficacy|1
924622|NCT00884325|1906990|FG000|Overall Study|Withdrawal by Subject|1
924623|NCT00884325|1906991|FG001|Overall Study|Withdrawal by Subject|1
924624|NCT00884325|1906990|FG000|Overall Study|Not provided|1
924625|NCT00884325|1906991|FG001|Overall Study|Not provided|0
924626|NCT00884377|1906999|FG000|Overall Study|Withdrawal by Subject|1
924627|NCT00884377|1907000|FG001|Overall Study|Withdrawal by Subject|0
924628|NCT00884377|1906999|FG000|Overall Study|Could not confirm diagnosis|1
924629|NCT00884377|1907000|FG001|Overall Study|Could not confirm diagnosis|0
924630|NCT00884377|1906999|FG000|Overall Study|Physician Decision|0
924631|NCT00884377|1907000|FG001|Overall Study|Physician Decision|1
924632|NCT00884390|1907014|FG000|Overall Study|Adverse Event|0
924633|NCT00884390|1907015|FG001|Overall Study|Adverse Event|1
924634|NCT00884390|1907014|FG000|Overall Study|Lost to Follow-up|0
924635|NCT00884390|1907015|FG001|Overall Study|Lost to Follow-up|1
924636|NCT00884390|1907014|FG000|Overall Study|Physician Decision|2
924637|NCT00884390|1907015|FG001|Overall Study|Physician Decision|1
924638|NCT00884390|1907014|FG000|Overall Study|Protocol Violation|4
924639|NCT00884390|1907015|FG001|Overall Study|Protocol Violation|1
924640|NCT00884390|1907014|FG000|Overall Study|Withdrawal by Subject|4
924641|NCT00884390|1907015|FG001|Overall Study|Withdrawal by Subject|1
924642|NCT00884390|1907014|FG000|Overall Study|Discontinuation of Study by Sponsor|2
924643|NCT00884390|1907015|FG001|Overall Study|Discontinuation of Study by Sponsor|2
924644|NCT00884390|1907014|FG000|Overall Study|Other|11
924645|NCT00884390|1907015|FG001|Overall Study|Other|1
924646|NCT00884650|1907050|FG000|Overall Study|Did not return complete pain diaries|7
924647|NCT00884650|1907051|FG001|Overall Study|Did not return complete pain diaries|7
924648|NCT00884650|1907050|FG000|Overall Study|Admitted Post-Op|1
924649|NCT00884650|1907051|FG001|Overall Study|Admitted Post-Op|0
924650|NCT00884650|1907050|FG000|Overall Study|Femoral Stress Fracture|1
924651|NCT00884650|1907051|FG001|Overall Study|Femoral Stress Fracture|0
924652|NCT00884650|1907050|FG000|Overall Study|Pain Pump Complication|0
924653|NCT00884650|1907051|FG001|Overall Study|Pain Pump Complication|1
924654|NCT00884741|1907061|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157
924655|NCT00884741|1907062|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0
924656|NCT00884741|1907063|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0
924657|NCT00884741|1907064|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0
924658|NCT00884741|1907061|FG000|Step 1 Registration: Tissue Screening|Death|3
924659|NCT00884741|1907062|FG001|Step 1 Registration: Tissue Screening|Death|0
924660|NCT00884741|1907063|FG002|Step 1 Registration: Tissue Screening|Death|0
924661|NCT00884741|1907064|FG003|Step 1 Registration: Tissue Screening|Death|0
924662|NCT00884741|1907061|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3
924663|NCT00884741|1907062|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0
924664|NCT00884741|1907063|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0
924665|NCT00884741|1907064|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0
924666|NCT00884741|1907061|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105
924667|NCT00884741|1907062|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0
924668|NCT00884741|1907063|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0
924669|NCT00884741|1907064|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0
924670|NCT00884741|1907061|FG000|Step 1 Registration: Tissue Screening|Disease progression|12
924671|NCT00884741|1907062|FG001|Step 1 Registration: Tissue Screening|Disease progression|0
924672|NCT00884741|1907063|FG002|Step 1 Registration: Tissue Screening|Disease progression|0
924673|NCT00884741|1907064|FG003|Step 1 Registration: Tissue Screening|Disease progression|0
924674|NCT00884741|1907061|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32
924675|NCT00884741|1907062|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0
924676|NCT00884741|1907063|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0
924677|NCT00884741|1907064|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0
924678|NCT00884741|1907061|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0
924679|NCT00884741|1907062|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15
924680|NCT00884741|1907063|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0
924681|NCT00884741|1907064|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0
924682|NCT00884741|1907061|FG000|Step 2 Registration: Tissue Analysis|Death|0
924683|NCT00884741|1907062|FG001|Step 2 Registration: Tissue Analysis|Death|1
924684|NCT00884741|1907063|FG002|Step 2 Registration: Tissue Analysis|Death|0
924685|NCT00884741|1907064|FG003|Step 2 Registration: Tissue Analysis|Death|0
924686|NCT00884741|1907061|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0
924687|NCT00884741|1907062|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2
924688|NCT00884741|1907063|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0
924689|NCT00884741|1907064|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0
924690|NCT00884741|1907061|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0
924691|NCT00884741|1907062|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7
924692|NCT00884741|1907063|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0
924693|NCT00884741|1907064|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0
924694|NCT00884741|1907061|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0
924695|NCT00884741|1907062|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4
924696|NCT00884741|1907063|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0
924697|NCT00884741|1907064|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0
924698|NCT00884741|1907061|FG000|Randomization|Protocol Violation|0
924699|NCT00884741|1907062|FG001|Randomization|Protocol Violation|0
924700|NCT00884741|1907063|FG002|Randomization|Protocol Violation|8
924701|NCT00884741|1907064|FG003|Randomization|Protocol Violation|8
924702|NCT00884793|1907080|FG000|Overall Study|Withdrawal by Subject|1
924703|NCT00884832|1907090|FG000|Overall Study|Withdrawal by Subject|0
924704|NCT00884832|1907091|FG001|Overall Study|Withdrawal by Subject|1
924705|NCT00884949|1907110|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
924706|NCT00884949|1907110|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
924707|NCT00885105|1907143|FG000|Overall Study|Withdrawal by Subject|0
924708|NCT00885105|1907144|FG001|Overall Study|Withdrawal by Subject|8
924709|NCT00885105|1907143|FG000|Overall Study|Adverse Event|1
924710|NCT00885105|1907144|FG001|Overall Study|Adverse Event|0
924711|NCT00885105|1907143|FG000|Overall Study|Protocol Violation|0
924712|NCT00885105|1907144|FG001|Overall Study|Protocol Violation|2
924713|NCT00885118|1907155|FG000|Overall Study|Adverse Event|1
924714|NCT00885118|1907156|FG001|Overall Study|Adverse Event|0
924715|NCT00885118|1907157|FG002|Overall Study|Adverse Event|0
924716|NCT00885118|1907158|FG003|Overall Study|Adverse Event|0
924717|NCT00885118|1907159|FG004|Overall Study|Adverse Event|0
924718|NCT00885118|1907155|FG000|Overall Study|Withdrawal by Subject|0
924719|NCT00885118|1907156|FG001|Overall Study|Withdrawal by Subject|0
924720|NCT00885118|1907157|FG002|Overall Study|Withdrawal by Subject|0
924721|NCT00885118|1907158|FG003|Overall Study|Withdrawal by Subject|0
924722|NCT00885118|1907159|FG004|Overall Study|Withdrawal by Subject|1
924723|NCT00885118|1907155|FG000|Overall Study|Other reason not defined above|0
924724|NCT00885118|1907156|FG001|Overall Study|Other reason not defined above|0
924725|NCT00885118|1907157|FG002|Overall Study|Other reason not defined above|1
924726|NCT00885118|1907158|FG003|Overall Study|Other reason not defined above|0
924727|NCT00885118|1907159|FG004|Overall Study|Other reason not defined above|0
924728|NCT00885170|1907177|FG000|Overall Study|Adverse Event|12
924729|NCT00885170|1907178|FG001|Overall Study|Adverse Event|4
924730|NCT00885170|1907177|FG000|Overall Study|Excessive bone loss|6
924731|NCT00885170|1907178|FG001|Overall Study|Excessive bone loss|3
924732|NCT00885170|1907177|FG000|Overall Study|Lost to Follow-up|2
924733|NCT00885170|1907178|FG001|Overall Study|Lost to Follow-up|1
924734|NCT00885170|1907177|FG000|Overall Study|Physician Decision|2
924735|NCT00885170|1907178|FG001|Overall Study|Physician Decision|1
924736|NCT00885170|1907177|FG000|Overall Study|Protocol Violation|3
924737|NCT00885170|1907178|FG001|Overall Study|Protocol Violation|1
924738|NCT00885170|1907177|FG000|Overall Study|Withdrawal by Subject|13
924739|NCT00885170|1907178|FG001|Overall Study|Withdrawal by Subject|13
924740|NCT00885352|1907186|FG000|Overall Study|Adverse Event|2
924741|NCT00885352|1907187|FG001|Overall Study|Adverse Event|3
924742|NCT00885352|1907186|FG000|Overall Study|Lost to Follow-up|2
924743|NCT00885352|1907187|FG001|Overall Study|Lost to Follow-up|2
924744|NCT00885352|1907186|FG000|Overall Study|Physician Decision|0
924745|NCT00885352|1907187|FG001|Overall Study|Physician Decision|3
924746|NCT00885352|1907186|FG000|Overall Study|Protocol Violation|0
924747|NCT00885352|1907187|FG001|Overall Study|Protocol Violation|2
924748|NCT00885352|1907186|FG000|Overall Study|Withdrawal by Subject|1
924749|NCT00885352|1907187|FG001|Overall Study|Withdrawal by Subject|5
924750|NCT00885352|1907186|FG000|Overall Study|Contradiction to study medication|0
924751|NCT00885352|1907187|FG001|Overall Study|Contradiction to study medication|2
924752|NCT00885352|1907186|FG000|Overall Study|Excluded medication|2
924753|NCT00885352|1907187|FG001|Overall Study|Excluded medication|2
924754|NCT00885352|1907186|FG000|Overall Study|Lab abnormalities|1
924755|NCT00885352|1907187|FG001|Overall Study|Lab abnormalities|1
924756|NCT00885365|1907195|FG000|4 Weeks ON Treatment|Adverse Event|2
924757|NCT00885365|1907196|FG001|4 Weeks ON Treatment|Adverse Event|4
924758|NCT00885365|1907195|FG000|4 Weeks ON Treatment|Protocol Violation|1
924759|NCT00885365|1907196|FG001|4 Weeks ON Treatment|Protocol Violation|2
924760|NCT00885365|1907195|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1
924761|NCT00885365|1907196|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0
924762|NCT00885378|1907204|FG000|Overall Study|Lack of Efficacy|2
924763|NCT00885378|1907205|FG001|Overall Study|Lack of Efficacy|2
924764|NCT00885378|1907204|FG000|Overall Study|Withdrawal by Subject|1
924765|NCT00885378|1907205|FG001|Overall Study|Withdrawal by Subject|2
924766|NCT00885378|1907204|FG000|Overall Study|Lost to Follow-up|1
924767|NCT00885378|1907205|FG001|Overall Study|Lost to Follow-up|2
924768|NCT00885378|1907204|FG000|Overall Study|Poor/Noncompliance|2
924769|NCT00885378|1907205|FG001|Overall Study|Poor/Noncompliance|2
924770|NCT00885378|1907204|FG000|Overall Study|Protocol Violation|2
924771|NCT00885378|1907205|FG001|Overall Study|Protocol Violation|0
924772|NCT00885482|1907211|FG000|Overall Study|Pregnancy|1
924773|NCT00885482|1907211|FG000|Overall Study|Lack of Efficacy|1
924774|NCT00885482|1907211|FG000|Overall Study|Death|1
924775|NCT00885482|1907211|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1
924776|NCT00885534|1907215|FG000|Overall Study|Patient deemed ineligible|1
924777|NCT00885677|1907229|FG000|Overall Study|Death|40
924778|NCT00885677|1907230|FG001|Overall Study|Death|34
924779|NCT00885677|1907229|FG000|Overall Study|Lost to Follow-up|15
924780|NCT00885677|1907230|FG001|Overall Study|Lost to Follow-up|13
924781|NCT00885677|1907229|FG000|Overall Study|Protocol Violation|54
924782|NCT00885677|1907230|FG001|Overall Study|Protocol Violation|54
924783|NCT00885677|1907229|FG000|Overall Study|premature study closure|41
924784|NCT00885677|1907230|FG001|Overall Study|premature study closure|44
924785|NCT00885677|1907229|FG000|Overall Study|device/lead revision or replacement|7
924786|NCT00885677|1907230|FG001|Overall Study|device/lead revision or replacement|6
924787|NCT00885677|1907229|FG000|Overall Study|Heart transplantation|1
924788|NCT00885677|1907230|FG001|Overall Study|Heart transplantation|0
924789|NCT00885677|1907229|FG000|Overall Study|Inclusion/exclusion not met|25
924790|NCT00885677|1907230|FG001|Overall Study|Inclusion/exclusion not met|27
924791|NCT00885703|1907243|FG000|Overall Study|Death|9
924792|NCT00885703|1907244|FG001|Overall Study|Death|7
924793|NCT00885703|1907245|FG002|Overall Study|Death|8
924794|NCT00885703|1907246|FG003|Overall Study|Death|7
924795|NCT00885703|1907247|FG004|Overall Study|Death|7
924796|NCT00885703|1907248|FG005|Overall Study|Death|8
924797|NCT00885703|1907249|FG006|Overall Study|Death|4
924798|NCT00885703|1907243|FG000|Overall Study|Lost to Follow-up|0
924799|NCT00885703|1907244|FG001|Overall Study|Lost to Follow-up|0
924800|NCT00885703|1907245|FG002|Overall Study|Lost to Follow-up|1
924801|NCT00885703|1907246|FG003|Overall Study|Lost to Follow-up|0
924802|NCT00885703|1907247|FG004|Overall Study|Lost to Follow-up|0
924803|NCT00885703|1907248|FG005|Overall Study|Lost to Follow-up|1
924804|NCT00885703|1907249|FG006|Overall Study|Lost to Follow-up|0
924805|NCT00885703|1907243|FG000|Overall Study|Withdrawal by Subject|0
924806|NCT00885703|1907244|FG001|Overall Study|Withdrawal by Subject|0
924807|NCT00885703|1907245|FG002|Overall Study|Withdrawal by Subject|0
924808|NCT00885703|1907246|FG003|Overall Study|Withdrawal by Subject|1
924809|NCT00885703|1907247|FG004|Overall Study|Withdrawal by Subject|3
924810|NCT00885703|1907248|FG005|Overall Study|Withdrawal by Subject|1
924811|NCT00885703|1907249|FG006|Overall Study|Withdrawal by Subject|1
924812|NCT00885703|1907243|FG000|Overall Study|Ineligible (no CM)|1
924813|NCT00885703|1907244|FG001|Overall Study|Ineligible (no CM)|3
924814|NCT00885703|1907245|FG002|Overall Study|Ineligible (no CM)|2
924815|NCT00885703|1907246|FG003|Overall Study|Ineligible (no CM)|1
924816|NCT00885703|1907247|FG004|Overall Study|Ineligible (no CM)|2
924817|NCT00885703|1907248|FG005|Overall Study|Ineligible (no CM)|3
924818|NCT00885703|1907249|FG006|Overall Study|Ineligible (no CM)|1
924819|NCT00885755|1907276|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1
924820|NCT00885755|1907277|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0
924821|NCT00885755|1907278|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0
924822|NCT00885755|1907276|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16
924823|NCT00885755|1907277|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0
924824|NCT00885755|1907278|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0
924825|NCT00885755|1907276|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
924826|NCT00885755|1907277|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
924827|NCT00885755|1907278|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
924828|NCT00885755|1907276|FG000|Part I: Trastuzumab+Taxane|Death|0
924829|NCT00885755|1907277|FG001|Part I: Trastuzumab+Taxane|Death|0
924830|NCT00885755|1907278|FG002|Part I: Trastuzumab+Taxane|Death|1
924831|NCT00885755|1907276|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
924832|NCT00885755|1907277|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
924833|NCT00885755|1907278|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
924834|NCT00885846|1907293|FG000|Overall Study|Withdrawal by Subject|2
924835|NCT00885846|1907294|FG001|Overall Study|Withdrawal by Subject|5
924836|NCT00885846|1907295|FG002|Overall Study|Withdrawal by Subject|2
924837|NCT00886015|1907305|FG000|Overall Study|Death|0
924838|NCT00886015|1907306|FG001|Overall Study|Death|2
924839|NCT00886119|1907312|FG000|Period 1|Did not meet inclusion criteria|1
924840|NCT00886119|1907313|FG001|Period 1|Did not meet inclusion criteria|0
924841|NCT00886288|1907349|FG000|Overall Study|no respect of the 12 weeks period|657
924842|NCT00886288|1907350|FG001|Overall Study|no respect of the 12 weeks period|227
924843|NCT00886288|1907349|FG000|Overall Study|Lost to Follow-up|86
924844|NCT00886288|1907350|FG001|Overall Study|Lost to Follow-up|0
924845|NCT00886340|1907360|FG000|Overall Study|Withdrawal by Subject|0
924846|NCT00886340|1907361|FG001|Overall Study|Withdrawal by Subject|7
924847|NCT00886379|1907372|FG000|Overall Study|Transferred Schools|0
924848|NCT00886379|1907373|FG001|Overall Study|Transferred Schools|0
924849|NCT00886379|1907374|FG002|Overall Study|Transferred Schools|2
924850|NCT00886379|1907375|FG003|Overall Study|Transferred Schools|1
924851|NCT00886379|1907376|FG004|Overall Study|Transferred Schools|1
924852|NCT00886379|1907372|FG000|Overall Study|Final blood draw not obtained|3
924853|NCT00886379|1907373|FG001|Overall Study|Final blood draw not obtained|3
924854|NCT00886379|1907374|FG002|Overall Study|Final blood draw not obtained|4
924855|NCT00886379|1907375|FG003|Overall Study|Final blood draw not obtained|2
924856|NCT00886379|1907376|FG004|Overall Study|Final blood draw not obtained|2
924857|NCT00886483|1907390|FG000|Overall Study|Lost to Follow-up|0
924858|NCT00886483|1907391|FG001|Overall Study|Lost to Follow-up|1
924859|NCT00886483|1907390|FG000|Overall Study|Pursue medications|1
924860|NCT00886483|1907391|FG001|Overall Study|Pursue medications|2
924861|NCT00886483|1907390|FG000|Overall Study|Distance to center, poor grades|1
924862|NCT00886483|1907391|FG001|Overall Study|Distance to center, poor grades|0
924863|NCT00886587|1907407|FG000|Overall Study|Adverse Event|2
924864|NCT00886587|1907408|FG001|Overall Study|Adverse Event|1
924865|NCT00886587|1907407|FG000|Overall Study|Protocol Violation|2
924866|NCT00886587|1907408|FG001|Overall Study|Protocol Violation|0
924867|NCT00886587|1907407|FG000|Overall Study|Withdrawal by Subject|0
924868|NCT00886587|1907408|FG001|Overall Study|Withdrawal by Subject|1
924869|NCT00886600|1907418|FG000|Double-blind Monotherapy|Adverse Event|1
924870|NCT00886600|1907419|FG001|Double-blind Monotherapy|Adverse Event|1
924871|NCT00886600|1907420|FG002|Double-blind Monotherapy|Adverse Event|1
924872|NCT00886600|1907421|FG003|Double-blind Monotherapy|Adverse Event|1
924873|NCT00886600|1907418|FG000|Double-blind Monotherapy|Protocol Violation|0
924874|NCT00886600|1907419|FG001|Double-blind Monotherapy|Protocol Violation|0
924875|NCT00886600|1907420|FG002|Double-blind Monotherapy|Protocol Violation|0
924876|NCT00886600|1907421|FG003|Double-blind Monotherapy|Protocol Violation|1
924877|NCT00886600|1907418|FG000|Double-blind Monotherapy|Withdrawal by Subject|1
924878|NCT00886600|1907419|FG001|Double-blind Monotherapy|Withdrawal by Subject|0
924879|NCT00886600|1907420|FG002|Double-blind Monotherapy|Withdrawal by Subject|0
924880|NCT00886600|1907421|FG003|Double-blind Monotherapy|Withdrawal by Subject|0
924881|NCT00886600|1907418|FG000|Combination Therapy Period|Adverse Event|0
924882|NCT00886600|1907419|FG001|Combination Therapy Period|Adverse Event|0
924883|NCT00886600|1907420|FG002|Combination Therapy Period|Adverse Event|1
924884|NCT00886600|1907421|FG003|Combination Therapy Period|Adverse Event|0
924885|NCT00886600|1907418|FG000|Combination Therapy Period|Protocol Violation|0
924886|NCT00886600|1907419|FG001|Combination Therapy Period|Protocol Violation|0
924887|NCT00886600|1907420|FG002|Combination Therapy Period|Protocol Violation|1
924888|NCT00886600|1907421|FG003|Combination Therapy Period|Protocol Violation|0
924889|NCT00886613|1907430|FG000|Overall Study|Protocol deviation (Part B)|1
924890|NCT00886613|1907431|FG001|Overall Study|Protocol deviation (Part B)|0
924891|NCT00886613|1907432|FG002|Overall Study|Protocol deviation (Part B)|0
924892|NCT00886613|1907430|FG000|Overall Study|Lost to follow-up (Part B)|1
924893|NCT00886613|1907431|FG001|Overall Study|Lost to follow-up (Part B)|0
924894|NCT00886613|1907432|FG002|Overall Study|Lost to follow-up (Part B)|1
924895|NCT00886613|1907430|FG000|Overall Study|Subject withdrew consent (Part A)|0
924896|NCT00886613|1907431|FG001|Overall Study|Subject withdrew consent (Part A)|0
924897|NCT00886613|1907432|FG002|Overall Study|Subject withdrew consent (Part A)|2
924898|NCT00886639|1907450|FG000|Overall Study|acute exacerbation|14
924899|NCT00886639|1907450|FG000|Overall Study|non-compliance|2
924900|NCT00886743|1907478|FG000|Overall Study|Adverse Event|3
924901|NCT00886743|1907478|FG000|Overall Study|Other|1
924902|NCT00886769|1907484|FG000|Overall Study|Unsatisfactory therapeutic effect|6
924903|NCT00886769|1907485|FG001|Overall Study|Unsatisfactory therapeutic effect|37
924904|NCT00886795|1907491|FG000|Overall Study|Lack of Efficacy|1
924905|NCT00886821|1907510|FG000|Stage 2|Adverse Event|0
924906|NCT00886821|1907511|FG001|Stage 2|Adverse Event|0
924907|NCT00886821|1907512|FG002|Stage 2|Adverse Event|0
924908|NCT00886821|1907513|FG003|Stage 2|Adverse Event|0
924909|NCT00886821|1907514|FG004|Stage 2|Adverse Event|0
924910|NCT00886821|1907515|FG005|Stage 2|Adverse Event|0
924911|NCT00886821|1907516|FG006|Stage 2|Adverse Event|0
924912|NCT00886821|1907517|FG007|Stage 2|Adverse Event|0
924913|NCT00886821|1907518|FG008|Stage 2|Adverse Event|0
924914|NCT00886821|1907519|FG009|Stage 2|Adverse Event|0
924915|NCT00886821|1907520|FG010|Stage 2|Adverse Event|0
924916|NCT00886821|1907521|FG011|Stage 2|Adverse Event|1
924917|NCT00886821|1907522|FG012|Stage 2|Adverse Event|3
924918|NCT00886821|1907523|FG013|Stage 2|Adverse Event|0
924919|NCT00886821|1907510|FG000|Stage 2|Lost to Follow-up|0
924920|NCT00886821|1907511|FG001|Stage 2|Lost to Follow-up|0
924921|NCT00886821|1907512|FG002|Stage 2|Lost to Follow-up|0
924922|NCT00886821|1907513|FG003|Stage 2|Lost to Follow-up|0
924923|NCT00886821|1907514|FG004|Stage 2|Lost to Follow-up|0
924924|NCT00886821|1907515|FG005|Stage 2|Lost to Follow-up|0
924925|NCT00886821|1907516|FG006|Stage 2|Lost to Follow-up|0
924926|NCT00886821|1907517|FG007|Stage 2|Lost to Follow-up|0
924927|NCT00886821|1907518|FG008|Stage 2|Lost to Follow-up|0
924928|NCT00886821|1907519|FG009|Stage 2|Lost to Follow-up|0
924929|NCT00886821|1907520|FG010|Stage 2|Lost to Follow-up|0
924930|NCT00886821|1907521|FG011|Stage 2|Lost to Follow-up|0
924931|NCT00886821|1907522|FG012|Stage 2|Lost to Follow-up|2
924932|NCT00886821|1907523|FG013|Stage 2|Lost to Follow-up|1
924933|NCT00886834|1907569|FG000|Overall Study|Protocol Violation|0
924934|NCT00886834|1907570|FG001|Overall Study|Protocol Violation|3
924935|NCT00886938|1907580|FG000|Overall Study|Adverse Event|1
924936|NCT00886938|1907580|FG000|Overall Study|Withdrawal by Subject|1
924937|NCT00887068|1907586|FG000|Overall Study|Withdrawal by Subject|2
924938|NCT00887068|1907587|FG001|Overall Study|Withdrawal by Subject|0
924939|NCT00887068|1907586|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4
924940|NCT00887068|1907587|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0
924941|NCT00887159|1907596|FG000|Overall Study|Disease progression|6
924942|NCT00887159|1907597|FG001|Overall Study|Disease progression|39
924943|NCT00887159|1907598|FG002|Overall Study|Disease progression|33
924944|NCT00887159|1907596|FG000|Overall Study|Adverse Event|3
924945|NCT00887159|1907597|FG001|Overall Study|Adverse Event|4
924946|NCT00887159|1907598|FG002|Overall Study|Adverse Event|17
924947|NCT00887159|1907596|FG000|Overall Study|Death|2
924948|NCT00887159|1907597|FG001|Overall Study|Death|2
924949|NCT00887159|1907598|FG002|Overall Study|Death|0
924950|NCT00887159|1907596|FG000|Overall Study|Withdrawal by Subject|4
924951|NCT00887159|1907597|FG001|Overall Study|Withdrawal by Subject|4
924952|NCT00887159|1907598|FG002|Overall Study|Withdrawal by Subject|2
924953|NCT00887159|1907596|FG000|Overall Study|Alternative therapy|2
924954|NCT00887159|1907597|FG001|Overall Study|Alternative therapy|0
924955|NCT00887159|1907598|FG002|Overall Study|Alternative therapy|0
924956|NCT00887159|1907596|FG000|Overall Study|Physician Decision|1
924957|NCT00887159|1907597|FG001|Overall Study|Physician Decision|1
924958|NCT00887159|1907598|FG002|Overall Study|Physician Decision|0
924959|NCT00887159|1907596|FG000|Overall Study|Sympomatic deterioration|1
924960|NCT00887159|1907597|FG001|Overall Study|Sympomatic deterioration|0
924961|NCT00887159|1907598|FG002|Overall Study|Sympomatic deterioration|0
924962|NCT00887159|1907596|FG000|Overall Study|Treatment delayed|1
924963|NCT00887159|1907597|FG001|Overall Study|Treatment delayed|1
924964|NCT00887159|1907598|FG002|Overall Study|Treatment delayed|0
924965|NCT00887159|1907596|FG000|Overall Study|Pt had PD but was SD when re-measured|0
924966|NCT00887159|1907597|FG001|Overall Study|Pt had PD but was SD when re-measured|1
924967|NCT00887159|1907598|FG002|Overall Study|Pt had PD but was SD when re-measured|0
924968|NCT00887159|1907596|FG000|Overall Study|Received more tx instead of observation|1
924969|NCT00887159|1907597|FG001|Overall Study|Received more tx instead of observation|0
924970|NCT00887159|1907598|FG002|Overall Study|Received more tx instead of observation|0
924971|NCT00887159|1907596|FG000|Overall Study|Ineligible|5
924972|NCT00887159|1907597|FG001|Overall Study|Ineligible|1
924973|NCT00887159|1907598|FG002|Overall Study|Ineligible|0
924974|NCT00887159|1907596|FG000|Overall Study|Never started assigned therapy|3
924975|NCT00887159|1907597|FG001|Overall Study|Never started assigned therapy|3
924976|NCT00887159|1907598|FG002|Overall Study|Never started assigned therapy|4
924977|NCT00887198|1907610|FG000|Randomized Period|Ongoing|42
924978|NCT00887198|1907611|FG001|Randomized Period|Ongoing|0
924979|NCT00887198|1907612|FG002|Randomized Period|Ongoing|0
924980|NCT00887198|1907610|FG000|Randomized Period|Adverse Event|50
924981|NCT00887198|1907611|FG001|Randomized Period|Adverse Event|33
924982|NCT00887198|1907612|FG002|Randomized Period|Adverse Event|0
924983|NCT00887198|1907610|FG000|Randomized Period|Lost to Follow-up|1
924984|NCT00887198|1907611|FG001|Randomized Period|Lost to Follow-up|0
924985|NCT00887198|1907612|FG002|Randomized Period|Lost to Follow-up|0
924986|NCT00887198|1907610|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0
924987|NCT00887198|1907611|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51
924988|NCT00887198|1907612|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0
924989|NCT00887198|1907610|FG000|Randomized Period|Withdrawal by Subject|41
924990|NCT00887198|1907611|FG001|Randomized Period|Withdrawal by Subject|56
924991|NCT00887198|1907612|FG002|Randomized Period|Withdrawal by Subject|0
924992|NCT00887198|1907610|FG000|Randomized Period|Progressive disease|366
924993|NCT00887198|1907611|FG001|Randomized Period|Progressive disease|370
924994|NCT00887198|1907612|FG002|Randomized Period|Progressive disease|0
924995|NCT00887198|1907610|FG000|Randomized Period|Other|42
924996|NCT00887198|1907611|FG001|Randomized Period|Other|30
924997|NCT00887198|1907612|FG002|Randomized Period|Other|0
924998|NCT00887198|1907610|FG000|Randomized Period|Randomized, Not treated|4
924999|NCT00887198|1907611|FG001|Randomized Period|Randomized, Not treated|2
925000|NCT00887198|1907612|FG002|Randomized Period|Randomized, Not treated|0
925001|NCT00887198|1907610|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
925002|NCT00887198|1907611|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
925003|NCT00887198|1907612|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
925004|NCT00887198|1907610|FG000|Cross Over (Placebo to AA)|Ongoing|0
925005|NCT00887198|1907611|FG001|Cross Over (Placebo to AA)|Ongoing|0
925006|NCT00887198|1907612|FG002|Cross Over (Placebo to AA)|Ongoing|35
925007|NCT00887198|1907610|FG000|Cross Over (Placebo to AA)|Adverse Event|0
925008|NCT00887198|1907611|FG001|Cross Over (Placebo to AA)|Adverse Event|0
925009|NCT00887198|1907612|FG002|Cross Over (Placebo to AA)|Adverse Event|9
925010|NCT00887198|1907610|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0
925011|NCT00887198|1907611|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0
925012|NCT00887198|1907612|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2
925013|NCT00887198|1907610|FG000|Cross Over (Placebo to AA)|Progressive disease|0
925014|NCT00887198|1907611|FG001|Cross Over (Placebo to AA)|Progressive disease|0
925015|NCT00887198|1907612|FG002|Cross Over (Placebo to AA)|Progressive disease|20
925016|NCT00887198|1907610|FG000|Cross Over (Placebo to AA)|Other|0
925017|NCT00887198|1907611|FG001|Cross Over (Placebo to AA)|Other|0
925018|NCT00887198|1907612|FG002|Cross Over (Placebo to AA)|Other|19
925019|NCT00887224|1907623|FG000|Open-label Response (OLR) Phase|Adverse Event|46
925020|NCT00887224|1907624|FG001|Open-label Response (OLR) Phase|Adverse Event|0
925021|NCT00887224|1907625|FG002|Open-label Response (OLR) Phase|Adverse Event|0
925022|NCT00887224|1907623|FG000|Open-label Response (OLR) Phase|Failed to return|6
925023|NCT00887224|1907624|FG001|Open-label Response (OLR) Phase|Failed to return|0
925024|NCT00887224|1907625|FG002|Open-label Response (OLR) Phase|Failed to return|0
925025|NCT00887224|1907623|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26
925026|NCT00887224|1907624|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0
925027|NCT00887224|1907625|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0
925028|NCT00887224|1907623|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16
925029|NCT00887224|1907624|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0
925030|NCT00887224|1907625|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0
925031|NCT00887224|1907623|FG000|Open-label Response (OLR) Phase|Other|1
925032|NCT00887224|1907624|FG001|Open-label Response (OLR) Phase|Other|0
925033|NCT00887224|1907625|FG002|Open-label Response (OLR) Phase|Other|0
925034|NCT00887224|1907623|FG000|Open-label Response (OLR) Phase|Protocol Violation|12
925035|NCT00887224|1907624|FG001|Open-label Response (OLR) Phase|Protocol Violation|0
925036|NCT00887224|1907625|FG002|Open-label Response (OLR) Phase|Protocol Violation|0
925037|NCT00887224|1907623|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15
925038|NCT00887224|1907624|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0
925039|NCT00887224|1907625|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0
925040|NCT00887224|1907623|FG000|Open-label Stability (OLS) Phase|Adverse Event|22
925041|NCT00887224|1907624|FG001|Open-label Stability (OLS) Phase|Adverse Event|0
925042|NCT00887224|1907625|FG002|Open-label Stability (OLS) Phase|Adverse Event|0
925043|NCT00887224|1907623|FG000|Open-label Stability (OLS) Phase|Failed to return|3
925044|NCT00887224|1907624|FG001|Open-label Stability (OLS) Phase|Failed to return|0
925045|NCT00887224|1907625|FG002|Open-label Stability (OLS) Phase|Failed to return|0
925046|NCT00887224|1907623|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16
925047|NCT00887224|1907624|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0
925048|NCT00887224|1907625|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0
925049|NCT00887224|1907623|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9
925050|NCT00887224|1907624|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0
925051|NCT00887224|1907625|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0
925052|NCT00887224|1907623|FG000|Open-label Stability (OLS) Phase|Other|1
925053|NCT00887224|1907624|FG001|Open-label Stability (OLS) Phase|Other|0
925054|NCT00887224|1907625|FG002|Open-label Stability (OLS) Phase|Other|0
925055|NCT00887224|1907623|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13
925056|NCT00887224|1907624|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0
925057|NCT00887224|1907625|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0
925058|NCT00887224|1907623|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
925059|NCT00887224|1907624|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
925060|NCT00887224|1907625|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
925061|NCT00887224|1907623|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28
925062|NCT00887224|1907624|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0
925063|NCT00887224|1907625|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0
925064|NCT00887224|1907623|FG000|OL Taper Phase / OL Follow Up|Failed to return|17
925065|NCT00887224|1907624|FG001|OL Taper Phase / OL Follow Up|Failed to return|0
925066|NCT00887224|1907625|FG002|OL Taper Phase / OL Follow Up|Failed to return|0
925067|NCT00887224|1907623|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10
925068|NCT00887224|1907624|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0
925069|NCT00887224|1907625|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0
925070|NCT00887224|1907623|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
925071|NCT00887224|1907624|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
925072|NCT00887224|1907625|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
925073|NCT00887224|1907623|FG000|OL Taper Phase / OL Follow Up|Other|30
925074|NCT00887224|1907624|FG001|OL Taper Phase / OL Follow Up|Other|0
925075|NCT00887224|1907625|FG002|OL Taper Phase / OL Follow Up|Other|0
925076|NCT00887224|1907623|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3
925077|NCT00887224|1907624|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0
925078|NCT00887224|1907625|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0
925079|NCT00887224|1907623|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
925080|NCT00887224|1907624|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
925081|NCT00887224|1907625|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
925082|NCT00887224|1907623|FG000|Double-blind (DB) Phase|Adverse Event|0
925083|NCT00887224|1907624|FG001|Double-blind (DB) Phase|Adverse Event|7
925084|NCT00887224|1907625|FG002|Double-blind (DB) Phase|Adverse Event|2
925085|NCT00887224|1907623|FG000|Double-blind (DB) Phase|Failed to return|0
925086|NCT00887224|1907624|FG001|Double-blind (DB) Phase|Failed to return|2
925087|NCT00887224|1907625|FG002|Double-blind (DB) Phase|Failed to return|2
925088|NCT00887224|1907623|FG000|Double-blind (DB) Phase|Lack of Efficacy|0
925089|NCT00887224|1907624|FG001|Double-blind (DB) Phase|Lack of Efficacy|67
925090|NCT00887224|1907625|FG002|Double-blind (DB) Phase|Lack of Efficacy|33
925091|NCT00887224|1907623|FG000|Double-blind (DB) Phase|Lost to Follow-up|0
925092|NCT00887224|1907624|FG001|Double-blind (DB) Phase|Lost to Follow-up|8
925093|NCT00887224|1907625|FG002|Double-blind (DB) Phase|Lost to Follow-up|8
925094|NCT00887224|1907623|FG000|Double-blind (DB) Phase|Other|0
925095|NCT00887224|1907624|FG001|Double-blind (DB) Phase|Other|2
925096|NCT00887224|1907625|FG002|Double-blind (DB) Phase|Other|0
925097|NCT00887224|1907623|FG000|Double-blind (DB) Phase|Protocol Violation|0
925098|NCT00887224|1907624|FG001|Double-blind (DB) Phase|Protocol Violation|8
925099|NCT00887224|1907625|FG002|Double-blind (DB) Phase|Protocol Violation|5
925100|NCT00887224|1907623|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0
925101|NCT00887224|1907624|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6
925102|NCT00887224|1907625|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12
925103|NCT00887224|1907623|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0
925104|NCT00887224|1907624|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5
925105|NCT00887224|1907625|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0
925106|NCT00887224|1907623|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0
925107|NCT00887224|1907624|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5
925108|NCT00887224|1907625|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4
925109|NCT00887224|1907623|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0
925110|NCT00887224|1907624|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6
925111|NCT00887224|1907625|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0
925112|NCT00887224|1907623|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
925113|NCT00887224|1907624|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
925114|NCT00887224|1907625|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
925115|NCT00887224|1907623|FG000|DB Taper Phase / Post Study Follow Up|Other|0
925116|NCT00887224|1907624|FG001|DB Taper Phase / Post Study Follow Up|Other|11
925117|NCT00887224|1907625|FG002|DB Taper Phase / Post Study Follow Up|Other|12
925118|NCT00887224|1907623|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
925119|NCT00887224|1907624|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
925120|NCT00887224|1907625|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
925121|NCT00887224|1907623|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
925122|NCT00887224|1907624|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
925123|NCT00887224|1907625|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
925124|NCT00887250|1907640|FG000|Overall Study|Adverse Event|3
925125|NCT00887250|1907641|FG001|Overall Study|Adverse Event|0
925126|NCT00887250|1907642|FG002|Overall Study|Adverse Event|7
925127|NCT00887250|1907640|FG000|Overall Study|Lack of Efficacy|9
925128|NCT00887250|1907641|FG001|Overall Study|Lack of Efficacy|6
925129|NCT00887250|1907642|FG002|Overall Study|Lack of Efficacy|1
925130|NCT00887250|1907640|FG000|Overall Study|Lost to Follow-up|2
925131|NCT00887250|1907641|FG001|Overall Study|Lost to Follow-up|3
925132|NCT00887250|1907642|FG002|Overall Study|Lost to Follow-up|1
925133|NCT00887250|1907640|FG000|Overall Study|Protocol Violation|2
925134|NCT00887250|1907641|FG001|Overall Study|Protocol Violation|2
925135|NCT00887250|1907642|FG002|Overall Study|Protocol Violation|1
925136|NCT00887250|1907640|FG000|Overall Study|Withdrawal by Subject|2
925137|NCT00887250|1907641|FG001|Overall Study|Withdrawal by Subject|1
925138|NCT00887250|1907642|FG002|Overall Study|Withdrawal by Subject|2
925139|NCT00887250|1907640|FG000|Overall Study|Patient uncooperative|0
925140|NCT00887250|1907641|FG001|Overall Study|Patient uncooperative|0
925141|NCT00887250|1907642|FG002|Overall Study|Patient uncooperative|1
925142|NCT00887289|1907647|FG000|Overall Study|Lack of Efficacy|14
925143|NCT00887289|1907647|FG000|Overall Study|Adverse Event|27
925144|NCT00887289|1907647|FG000|Overall Study|Withdrawal by Subject|26
925145|NCT00887289|1907647|FG000|Overall Study|Lost to Follow-up|8
925146|NCT00887289|1907647|FG000|Overall Study|Other|20
925147|NCT00887341|1907653|FG000|Overall Study|Refused treatment|1
925148|NCT00887341|1907654|FG001|Overall Study|Refused treatment|0
925149|NCT00887341|1907653|FG000|Overall Study|Withdrawal by Subject|1
925150|NCT00887341|1907654|FG001|Overall Study|Withdrawal by Subject|1
925151|NCT00887341|1907653|FG000|Overall Study|Adverse Event|0
925152|NCT00887341|1907654|FG001|Overall Study|Adverse Event|1
925153|NCT00887341|1907653|FG000|Overall Study|Lost to Follow-up|0
925154|NCT00887341|1907654|FG001|Overall Study|Lost to Follow-up|1
925155|NCT00887354|1907662|FG000|Treatment Phase (Week 0 to Week 26)|Death|0
925156|NCT00887354|1907663|FG001|Treatment Phase (Week 0 to Week 26)|Death|1
925157|NCT00887354|1907662|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
925158|NCT00887354|1907663|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
925159|NCT00887354|1907662|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
925160|NCT00887354|1907663|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
925161|NCT00887354|1907662|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
925162|NCT00887354|1907663|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
925163|NCT00887354|1907662|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
925164|NCT00887354|1907663|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
925165|NCT00887354|1907662|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
925166|NCT00887354|1907663|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
925167|NCT00887354|1907662|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
925168|NCT00887354|1907663|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
925169|NCT00887354|1907662|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
925170|NCT00887354|1907663|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
925171|NCT00887354|1907662|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
925172|NCT00887354|1907663|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
925173|NCT00887354|1907662|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5
925174|NCT00887354|1907663|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3
925175|NCT00887354|1907662|FG000|Open Label Phase (Week 26 to Week 78)|Death|0
925176|NCT00887354|1907663|FG001|Open Label Phase (Week 26 to Week 78)|Death|2
925177|NCT00887354|1907662|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
925178|NCT00887354|1907663|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
925179|NCT00887354|1907662|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
925180|NCT00887354|1907663|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
925181|NCT00887354|1907662|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
925182|NCT00887354|1907663|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
925183|NCT00887354|1907662|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
925184|NCT00887354|1907663|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
925185|NCT00887432|1907672|FG000|Overall Study|Start Excluded Therapy|3
925186|NCT00887432|1907673|FG001|Overall Study|Start Excluded Therapy|0
925187|NCT00887432|1907672|FG000|Overall Study|Did not complete treatment|6
925188|NCT00887432|1907673|FG001|Overall Study|Did not complete treatment|8
925189|NCT00887432|1907672|FG000|Overall Study|Protocol Violation|2
925190|NCT00887432|1907673|FG001|Overall Study|Protocol Violation|3
925191|NCT00887432|1907672|FG000|Overall Study|Withdrawal by Subject|3
925192|NCT00887432|1907673|FG001|Overall Study|Withdrawal by Subject|2
925193|NCT00887432|1907672|FG000|Overall Study|Lost to Follow-up|1
925194|NCT00887432|1907673|FG001|Overall Study|Lost to Follow-up|0
925195|NCT00887432|1907672|FG000|Overall Study|No reason provided|0
925196|NCT00887432|1907673|FG001|Overall Study|No reason provided|1
925197|NCT00887484|1907699|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
925198|NCT00887484|1907699|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
925199|NCT00887484|1907699|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
925200|NCT00887549|1907717|FG000|Induction Therapy|Adverse Event|8
925201|NCT00887549|1907717|FG000|Induction Therapy|Physician Decision|1
925202|NCT00887549|1907717|FG000|Induction Therapy|Progressive Disease|13
925203|NCT00887549|1907717|FG000|Induction Therapy|Death due to Study Disease|4
925204|NCT00887549|1907717|FG000|Induction Therapy|Death due to Study Drug Toxicity|1
925205|NCT00887549|1907717|FG000|Maintenance Therapy|Adverse Event|16
925206|NCT00887549|1907717|FG000|Maintenance Therapy|Physician Decision|1
925207|NCT00887549|1907717|FG000|Maintenance Therapy|Progressive Disease|25
925208|NCT00887549|1907717|FG000|Maintenance Therapy|Death due to adverse event|1
925209|NCT00887588|1907745|FG000|Core Period|Death|1
925210|NCT00887588|1907746|FG001|Core Period|Death|1
925211|NCT00887588|1907745|FG000|Core Period|Lost to Follow-up|3
925212|NCT00887588|1907746|FG001|Core Period|Lost to Follow-up|1
925213|NCT00887588|1907745|FG000|Core Period|Withdrawal by Subject|6
925214|NCT00887588|1907746|FG001|Core Period|Withdrawal by Subject|8
925215|NCT00887588|1907745|FG000|Core Period|Adverse Event|9
925216|NCT00887588|1907746|FG001|Core Period|Adverse Event|11
925217|NCT00887588|1907745|FG000|Extension Period|Adverse Event|4
925218|NCT00887588|1907746|FG001|Extension Period|Adverse Event|4
925219|NCT00887588|1907745|FG000|Extension Period|Death|0
925220|NCT00887588|1907746|FG001|Extension Period|Death|1
925221|NCT00887588|1907745|FG000|Extension Period|Protocol deviation|1
925222|NCT00887588|1907746|FG001|Extension Period|Protocol deviation|0
925223|NCT00887588|1907745|FG000|Extension Period|Lost to Follow-up|1
925224|NCT00887588|1907746|FG001|Extension Period|Lost to Follow-up|0
925225|NCT00887679|1907760|FG000|Overall Study|Withdrawal by Subject|1
925226|NCT00887679|1907760|FG000|Overall Study|Lost to Follow-up|4
925227|NCT00887679|1907760|FG000|Overall Study|Physician Decision|5
925228|NCT00887744|1907765|FG000|Overall Study|Adverse Event|3
925229|NCT00887744|1907765|FG000|Overall Study|Death|1
925230|NCT00887744|1907765|FG000|Overall Study|Lost to Follow-up|3
925231|NCT00887744|1907765|FG000|Overall Study|Withdrawal by Subject|18
925232|NCT00887744|1907765|FG000|Overall Study|Various reasons|9
925233|NCT00887809|1907780|FG000|Overall Study|Patient Not Treated|3
925234|NCT00887809|1907781|FG001|Overall Study|Patient Not Treated|0
925235|NCT00887809|1907780|FG000|Overall Study|Death|1
925236|NCT00887809|1907781|FG001|Overall Study|Death|0
925237|NCT00887822|1907789|FG000|Overall Study|Insufficient therapeutic response|53
925238|NCT00887822|1907790|FG001|Overall Study|Insufficient therapeutic response|55
925239|NCT00887822|1907789|FG000|Overall Study|Adverse Event|14
925240|NCT00887822|1907790|FG001|Overall Study|Adverse Event|17
925241|NCT00887822|1907789|FG000|Overall Study|Failure to return|11
925242|NCT00887822|1907790|FG001|Overall Study|Failure to return|11
925243|NCT00887822|1907789|FG000|Overall Study|Refused treatment/Did not cooperate|12
925244|NCT00887822|1907790|FG001|Overall Study|Refused treatment/Did not cooperate|10
925245|NCT00887822|1907789|FG000|Overall Study|Administrative/Other than specified|5
925246|NCT00887822|1907790|FG001|Overall Study|Administrative/Other than specified|4
925247|NCT00887822|1907789|FG000|Overall Study|Death|2
925248|NCT00887822|1907790|FG001|Overall Study|Death|3
925249|NCT00887822|1907789|FG000|Overall Study|Protocol Violation|0
925250|NCT00887822|1907790|FG001|Overall Study|Protocol Violation|1
925251|NCT00887822|1907789|FG000|Overall Study|Randomized but not treated|0
925252|NCT00887822|1907790|FG001|Overall Study|Randomized but not treated|1
925253|NCT00887913|1907796|FG000|Overall Study|Withdrawal by Subject|6
925254|NCT00887926|1907804|FG000|Overall Study|Withdrawal by Subject|0
925255|NCT00887926|1907805|FG001|Overall Study|Withdrawal by Subject|1
925256|NCT00887926|1907806|FG002|Overall Study|Withdrawal by Subject|0
925257|NCT00887926|1907807|FG003|Overall Study|Withdrawal by Subject|0
925258|NCT00887978|1907825|FG000|Overall Study|Adverse Event|18
925259|NCT00887978|1907826|FG001|Overall Study|Adverse Event|5
925260|NCT00887978|1907825|FG000|Overall Study|Clinical Worsening|4
925261|NCT00887978|1907826|FG001|Overall Study|Clinical Worsening|4
925262|NCT00887978|1907825|FG000|Overall Study|Death|2
925263|NCT00887978|1907826|FG001|Overall Study|Death|3
925264|NCT00887978|1907825|FG000|Overall Study|Withdrawal by Subject|1
925265|NCT00887978|1907826|FG001|Overall Study|Withdrawal by Subject|2
925266|NCT00887978|1907825|FG000|Overall Study|Lost to Follow-up|0
925267|NCT00887978|1907826|FG001|Overall Study|Lost to Follow-up|1
925268|NCT00888134|1907832|FG000|Treatment With Study Drug|Withdrawal by Subject|1
925269|NCT00888134|1907832|FG000|Follow-up|being followed for long-term survival|1
925270|NCT00888173|1907837|FG000|Overall Study|Wrong Primary|1
925271|NCT00888173|1907837|FG000|Overall Study|Ineligible: required test not done|1
925272|NCT00888238|1907841|FG000|Washout Period After Period 2|Adverse Event|0
925273|NCT00888238|1907842|FG001|Washout Period After Period 2|Adverse Event|0
925274|NCT00888238|1907843|FG002|Washout Period After Period 2|Adverse Event|1
925275|NCT00888329|1907851|FG000|Overall Study|Physician Decision|6
925276|NCT00888329|1907852|FG001|Overall Study|Physician Decision|9
925277|NCT00888355|1907862|FG000|Overall Study|Adverse Event|10
925278|NCT00888355|1907863|FG001|Overall Study|Adverse Event|0
925279|NCT00888355|1907864|FG002|Overall Study|Adverse Event|3
925280|NCT00888355|1907865|FG003|Overall Study|Adverse Event|3
925281|NCT00888355|1907862|FG000|Overall Study|Lack of Efficacy|9
925282|NCT00888355|1907863|FG001|Overall Study|Lack of Efficacy|2
925283|NCT00888355|1907864|FG002|Overall Study|Lack of Efficacy|5
925284|NCT00888355|1907865|FG003|Overall Study|Lack of Efficacy|2
925285|NCT00888355|1907862|FG000|Overall Study|Lost to Follow-up|0
925286|NCT00888355|1907863|FG001|Overall Study|Lost to Follow-up|2
925287|NCT00888355|1907864|FG002|Overall Study|Lost to Follow-up|2
925288|NCT00888355|1907865|FG003|Overall Study|Lost to Follow-up|0
925289|NCT00888355|1907862|FG000|Overall Study|Protocol Violation|3
925290|NCT00888355|1907863|FG001|Overall Study|Protocol Violation|2
925291|NCT00888355|1907864|FG002|Overall Study|Protocol Violation|1
925292|NCT00888355|1907865|FG003|Overall Study|Protocol Violation|2
925293|NCT00888355|1907862|FG000|Overall Study|Withdrawal by Subject|0
925294|NCT00888355|1907863|FG001|Overall Study|Withdrawal by Subject|3
925295|NCT00888355|1907864|FG002|Overall Study|Withdrawal by Subject|1
925296|NCT00888355|1907865|FG003|Overall Study|Withdrawal by Subject|3
925297|NCT00888381|1907873|FG000|Overall Study|Lost to Follow-up|0
925298|NCT00888381|1907874|FG001|Overall Study|Lost to Follow-up|1
925299|NCT00888433|1907882|FG000|Overall Study|Withdrawal by Subject|1
925300|NCT00888433|1907883|FG001|Overall Study|Withdrawal by Subject|2
925301|NCT00888433|1907882|FG000|Overall Study|Missed Visit|2
925302|NCT00888433|1907883|FG001|Overall Study|Missed Visit|1
925303|NCT00888615|1907902|FG000|Overall Study|No treatment|2
925304|NCT00888654|1907910|FG000|Overall Study|Problems swallowing oral meds.|1
925305|NCT00888654|1907910|FG000|Overall Study|Not enough oral meds before surgery|3
925306|NCT00888654|1907910|FG000|Overall Study|Surgery aborted|2
925307|NCT00888654|1907910|FG000|Overall Study|Withdrawal by Subject|1
925308|NCT00888654|1907910|FG000|Overall Study|Inelig. due to contraindication of med|1
925309|NCT00888654|1907910|FG000|Overall Study|Change in surg date|1
925310|NCT00888654|1907910|FG000|Overall Study|Stopped meds due to headaches|1
925311|NCT00888849|1907916|FG000|Overall Study|Death|4
925312|NCT00888849|1907917|FG001|Overall Study|Death|7
925313|NCT00888849|1907916|FG000|Overall Study|Lost to Follow-up|1
925314|NCT00888849|1907917|FG001|Overall Study|Lost to Follow-up|2
925315|NCT00888927|1907927|FG000|Overall Study|Adverse Event|0
925316|NCT00888927|1907928|FG001|Overall Study|Adverse Event|0
925317|NCT00888927|1907929|FG002|Overall Study|Adverse Event|0
925318|NCT00888927|1907930|FG003|Overall Study|Adverse Event|1
925319|NCT00888927|1907927|FG000|Overall Study|Withdrawal of consent|0
925320|NCT00888927|1907928|FG001|Overall Study|Withdrawal of consent|0
925321|NCT00888927|1907929|FG002|Overall Study|Withdrawal of consent|0
925322|NCT00888927|1907930|FG003|Overall Study|Withdrawal of consent|1
925323|NCT00888940|1907942|FG000|Overall Study|Adverse Event|12
925324|NCT00888940|1907943|FG001|Overall Study|Adverse Event|3
925325|NCT00888940|1907942|FG000|Overall Study|Lost to Follow-up|5
925326|NCT00888940|1907943|FG001|Overall Study|Lost to Follow-up|5
925327|NCT00888940|1907942|FG000|Overall Study|Randomized Not Treated|11
925328|NCT00888940|1907943|FG001|Overall Study|Randomized Not Treated|13
925329|NCT00889005|1907955|FG000|Overall Study|Lost to Follow-up|4
925330|NCT00889005|1907956|FG001|Overall Study|Lost to Follow-up|2
925331|NCT00889005|1907955|FG000|Overall Study|Withdrawal by Subject|4
925332|NCT00889005|1907956|FG001|Overall Study|Withdrawal by Subject|0
925333|NCT00889252|1907990|FG000|Overall Study|Adverse Event|2
925334|NCT00889252|1907991|FG001|Overall Study|Adverse Event|4
925335|NCT00889252|1907990|FG000|Overall Study|Withdrawal by Subject|3
925336|NCT00889252|1907991|FG001|Overall Study|Withdrawal by Subject|0
925337|NCT00889252|1907990|FG000|Overall Study|Protocol Violation|2
925338|NCT00889252|1907991|FG001|Overall Study|Protocol Violation|0
925339|NCT00889265|1907997|FG000|Overall Study|Adverse Event|1
925340|NCT00889265|1907997|FG000|Overall Study|Lost to Follow-up|5
925341|NCT00889265|1907997|FG000|Overall Study|Protocol Violation|1
925342|NCT00889603|1908019|FG000|Overall Study|Adverse Event|7
925343|NCT00889603|1908019|FG000|Overall Study|Death|3
925344|NCT00889603|1908019|FG000|Overall Study|Lost to Follow-up|19
925345|NCT00889603|1908019|FG000|Overall Study|No longer willing to participant in stud|4
925346|NCT00889603|1908019|FG000|Overall Study|Other|4
925347|NCT00889681|1908023|FG000|Overall Study|Not meeting qualification Criteria|2
925348|NCT00889681|1908023|FG000|Overall Study|Insurance disapproval|1
925349|NCT00889707|1908029|FG000|Overall Study|Adverse Event|1
925350|NCT00889707|1908030|FG001|Overall Study|Adverse Event|0
925351|NCT00889707|1908029|FG000|Overall Study|Withdrawal by Subject|4
925352|NCT00889707|1908030|FG001|Overall Study|Withdrawal by Subject|3
925353|NCT00889707|1908029|FG000|Overall Study|Lost to Follow-up|0
925354|NCT00889707|1908030|FG001|Overall Study|Lost to Follow-up|2
925355|NCT00889707|1908029|FG000|Overall Study|Lack of Efficacy|2
925356|NCT00889707|1908030|FG001|Overall Study|Lack of Efficacy|5
925357|NCT00889720|1908036|FG000|Overall Study|Withdrawal by Subject|4
925358|NCT00889720|1908036|FG000|Overall Study|Other|4
925359|NCT00889863|1908044|FG000|Part I: Open Label|Death|1
925360|NCT00889863|1908045|FG001|Part I: Open Label|Death|0
925361|NCT00889863|1908044|FG000|Part I: Open Label|Adverse Event|4
925362|NCT00889863|1908045|FG001|Part I: Open Label|Adverse Event|0
925363|NCT00889863|1908044|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72
925364|NCT00889863|1908045|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0
925365|NCT00889863|1908044|FG000|Part II: Randomized Double Blind|Adverse Event|0
925366|NCT00889863|1908045|FG001|Part II: Randomized Double Blind|Adverse Event|4
925367|NCT00889863|1908044|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
925368|NCT00889863|1908045|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
925369|NCT00889863|1908044|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0
925370|NCT00889863|1908045|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1
925371|NCT00889863|1908044|FG000|Part II: Randomized Double Blind|Protocol deviation|0
925372|NCT00889863|1908045|FG001|Part II: Randomized Double Blind|Protocol deviation|1
925373|NCT00890045|1908076|FG000|Overall Study|Death|0
925374|NCT00890045|1908077|FG001|Overall Study|Death|1
925375|NCT00890045|1908076|FG000|Overall Study|Did not receive HeRO Graft|0
925376|NCT00890045|1908077|FG001|Overall Study|Did not receive HeRO Graft|2
925377|NCT00890045|1908076|FG000|Overall Study|Lost to Follow-up|5
925378|NCT00890045|1908077|FG001|Overall Study|Lost to Follow-up|7
925379|NCT00890084|1908083|FG000|Overall Study|Adverse Event|16
925380|NCT00890084|1908083|FG000|Overall Study|Lost to Follow-up|126
925381|NCT00890097|1908090|FG000|Overall Study|Adverse Event|21
925382|NCT00890097|1908091|FG001|Overall Study|Adverse Event|32
925383|NCT00890097|1908092|FG002|Overall Study|Adverse Event|28
925384|NCT00890097|1908090|FG000|Overall Study|Decision Unrelated to an Adverse Event|15
925385|NCT00890097|1908091|FG001|Overall Study|Decision Unrelated to an Adverse Event|12
925386|NCT00890097|1908092|FG002|Overall Study|Decision Unrelated to an Adverse Event|17
925387|NCT00890097|1908090|FG000|Overall Study|Withdrew Consent|9
925388|NCT00890097|1908091|FG001|Overall Study|Withdrew Consent|6
925389|NCT00890097|1908092|FG002|Overall Study|Withdrew Consent|9
925390|NCT00890097|1908090|FG000|Overall Study|Lost to Follow-up|5
925391|NCT00890097|1908091|FG001|Overall Study|Lost to Follow-up|5
925392|NCT00890097|1908092|FG002|Overall Study|Lost to Follow-up|5
925393|NCT00890097|1908090|FG000|Overall Study|Noncompliance|0
925394|NCT00890097|1908091|FG001|Overall Study|Noncompliance|4
925395|NCT00890097|1908092|FG002|Overall Study|Noncompliance|4
925396|NCT00890097|1908090|FG000|Overall Study|Sponsor Decision|7
925397|NCT00890097|1908091|FG001|Overall Study|Sponsor Decision|11
925398|NCT00890097|1908092|FG002|Overall Study|Sponsor Decision|7
925399|NCT00890097|1908090|FG000|Overall Study|Did not attend final visit|2
925400|NCT00890097|1908091|FG001|Overall Study|Did not attend final visit|3
925401|NCT00890097|1908092|FG002|Overall Study|Did not attend final visit|0
925402|NCT00890097|1908090|FG000|Overall Study|Subject Decision|3
925403|NCT00890097|1908091|FG001|Overall Study|Subject Decision|2
925404|NCT00890097|1908092|FG002|Overall Study|Subject Decision|6
925405|NCT00890097|1908090|FG000|Overall Study|Randomization Error|2
925406|NCT00890097|1908091|FG001|Overall Study|Randomization Error|0
925407|NCT00890097|1908092|FG002|Overall Study|Randomization Error|0
925408|NCT00890097|1908090|FG000|Overall Study|Failed inclusion criteria|3
925409|NCT00890097|1908091|FG001|Overall Study|Failed inclusion criteria|4
925410|NCT00890097|1908092|FG002|Overall Study|Failed inclusion criteria|0
925411|NCT00890097|1908090|FG000|Overall Study|Transportation|0
925412|NCT00890097|1908091|FG001|Overall Study|Transportation|2
925413|NCT00890097|1908092|FG002|Overall Study|Transportation|0
925414|NCT00890097|1908090|FG000|Overall Study|Subject Moved|0
925415|NCT00890097|1908091|FG001|Overall Study|Subject Moved|4
925416|NCT00890097|1908092|FG002|Overall Study|Subject Moved|0
925417|NCT00890097|1908090|FG000|Overall Study|Protocol Deviation|1
925418|NCT00890097|1908091|FG001|Overall Study|Protocol Deviation|1
925419|NCT00890097|1908092|FG002|Overall Study|Protocol Deviation|1
925420|NCT00890201|1908111|FG000|Overall Study|Protocol Violation|5
925421|NCT00890201|1908112|FG001|Overall Study|Protocol Violation|56
925422|NCT00890409|1908132|FG000|Overall Study|Lost to Follow-up|20
925423|NCT00890409|1908133|FG001|Overall Study|Lost to Follow-up|21
925424|NCT00890552|1908137|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1
925425|NCT00890552|1908137|FG000|On-treatment|Early prog disease/ death|10
925426|NCT00890591|1908141|FG000|Overall Study|Lack of Efficacy|20
925427|NCT00890695|1908166|FG000|Overall Study|Protocol Violation|1
925428|NCT00890695|1908167|FG001|Overall Study|Protocol Violation|0
925429|NCT00890825|1908184|FG000|Overall Study|Withdrawal by Subject|1
925430|NCT00890825|1908185|FG001|Overall Study|Withdrawal by Subject|0
925431|NCT00890825|1908184|FG000|Overall Study|Alive at data cut off (DCO)|13
925432|NCT00890825|1908185|FG001|Overall Study|Alive at data cut off (DCO)|14
925433|NCT00890929|1908195|FG000|Overall Study|Death before treatment|2
925434|NCT00890929|1908195|FG000|Overall Study|Withdrawal by Subject|3
925435|NCT00890929|1908195|FG000|Overall Study|Physician Decision|1
925436|NCT00891020|1908211|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11
925437|NCT00891020|1908212|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32
925438|NCT00891020|1908213|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17
925439|NCT00891020|1908211|FG000|24 Week Treatment Period|Death|0
925440|NCT00891020|1908212|FG001|24 Week Treatment Period|Death|2
925441|NCT00891020|1908213|FG002|24 Week Treatment Period|Death|0
925442|NCT00891020|1908211|FG000|24 Week Treatment Period|Insufficient therapeutic response|6
925443|NCT00891020|1908212|FG001|24 Week Treatment Period|Insufficient therapeutic response|9
925444|NCT00891020|1908213|FG002|24 Week Treatment Period|Insufficient therapeutic response|15
925445|NCT00891020|1908211|FG000|24 Week Treatment Period|Failure to return|4
925446|NCT00891020|1908212|FG001|24 Week Treatment Period|Failure to return|5
925447|NCT00891020|1908213|FG002|24 Week Treatment Period|Failure to return|5
925448|NCT00891020|1908211|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1
925449|NCT00891020|1908212|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0
925450|NCT00891020|1908213|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2
925451|NCT00891020|1908211|FG000|24 Week Treatment Period|Other protocol violation|1
925452|NCT00891020|1908212|FG001|24 Week Treatment Period|Other protocol violation|1
925453|NCT00891020|1908213|FG002|24 Week Treatment Period|Other protocol violation|2
925454|NCT00891020|1908211|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3
925455|NCT00891020|1908212|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2
925456|NCT00891020|1908213|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1
925457|NCT00891020|1908211|FG000|24 Week Treatment Period|Withdrew consent|6
925458|NCT00891020|1908212|FG001|24 Week Treatment Period|Withdrew consent|3
925459|NCT00891020|1908213|FG002|24 Week Treatment Period|Withdrew consent|15
925460|NCT00891020|1908211|FG000|24 Week Treatment Period|Administrative/Other|5
925461|NCT00891020|1908212|FG001|24 Week Treatment Period|Administrative/Other|6
925462|NCT00891020|1908213|FG002|24 Week Treatment Period|Administrative/Other|1
925463|NCT00891020|1908211|FG000|Long-term Extension Period|Adverse Event|1
925464|NCT00891020|1908212|FG001|Long-term Extension Period|Adverse Event|11
925465|NCT00891020|1908213|FG002|Long-term Extension Period|Adverse Event|10
925466|NCT00891020|1908211|FG000|Long-term Extension Period|Death|0
925467|NCT00891020|1908212|FG001|Long-term Extension Period|Death|0
925468|NCT00891020|1908213|FG002|Long-term Extension Period|Death|1
925469|NCT00891020|1908211|FG000|Long-term Extension Period|Insufficient therapeutic response|3
925470|NCT00891020|1908212|FG001|Long-term Extension Period|Insufficient therapeutic response|2
925471|NCT00891020|1908213|FG002|Long-term Extension Period|Insufficient therapeutic response|2
925472|NCT00891020|1908211|FG000|Long-term Extension Period|Protocol Violation|0
925473|NCT00891020|1908212|FG001|Long-term Extension Period|Protocol Violation|1
925474|NCT00891020|1908213|FG002|Long-term Extension Period|Protocol Violation|1
925475|NCT00891020|1908211|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1
925476|NCT00891020|1908212|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6
925477|NCT00891020|1908213|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4
925478|NCT00891020|1908211|FG000|Long-term Extension Period|Failure to return|0
925479|NCT00891020|1908212|FG001|Long-term Extension Period|Failure to return|2
925480|NCT00891020|1908213|FG002|Long-term Extension Period|Failure to return|3
925481|NCT00891020|1908211|FG000|Long-term Extension Period|Administrative|1
925482|NCT00891020|1908212|FG001|Long-term Extension Period|Administrative|2
925483|NCT00891020|1908213|FG002|Long-term Extension Period|Administrative|2
925484|NCT00891046|1908228|FG000|Overall Study|Protocol Violation|1
925485|NCT00891046|1908229|FG001|Overall Study|Protocol Violation|1
925486|NCT00891046|1908230|FG002|Overall Study|Protocol Violation|0
925487|NCT00891046|1908231|FG003|Overall Study|Protocol Violation|0
925488|NCT00891046|1908232|FG004|Overall Study|Protocol Violation|1
925489|NCT00891046|1908228|FG000|Overall Study|Unsatisfactory therapeutic effect|5
925490|NCT00891046|1908229|FG001|Overall Study|Unsatisfactory therapeutic effect|2
925491|NCT00891046|1908230|FG002|Overall Study|Unsatisfactory therapeutic effect|19
925492|NCT00891046|1908231|FG003|Overall Study|Unsatisfactory therapeutic effect|2
925493|NCT00891046|1908232|FG004|Overall Study|Unsatisfactory therapeutic effect|20
925494|NCT00891046|1908228|FG000|Overall Study|Administrative problems|0
925495|NCT00891046|1908229|FG001|Overall Study|Administrative problems|0
925496|NCT00891046|1908230|FG002|Overall Study|Administrative problems|0
925497|NCT00891046|1908231|FG003|Overall Study|Administrative problems|0
925498|NCT00891046|1908232|FG004|Overall Study|Administrative problems|1
925499|NCT00891046|1908228|FG000|Overall Study|Participant no longer required drug|0
925500|NCT00891046|1908229|FG001|Overall Study|Participant no longer required drug|2
925501|NCT00891046|1908230|FG002|Overall Study|Participant no longer required drug|0
925502|NCT00891046|1908231|FG003|Overall Study|Participant no longer required drug|0
925503|NCT00891046|1908232|FG004|Overall Study|Participant no longer required drug|1
925504|NCT00891046|1908228|FG000|Overall Study|Adverse Event|4
925505|NCT00891046|1908229|FG001|Overall Study|Adverse Event|3
925506|NCT00891046|1908230|FG002|Overall Study|Adverse Event|2
925507|NCT00891046|1908231|FG003|Overall Study|Adverse Event|0
925508|NCT00891046|1908232|FG004|Overall Study|Adverse Event|14
925509|NCT00891046|1908228|FG000|Overall Study|Withdrawal by Subject|2
925510|NCT00891046|1908229|FG001|Overall Study|Withdrawal by Subject|1
925511|NCT00891046|1908230|FG002|Overall Study|Withdrawal by Subject|2
925512|NCT00891046|1908231|FG003|Overall Study|Withdrawal by Subject|1
925513|NCT00891046|1908232|FG004|Overall Study|Withdrawal by Subject|1
925514|NCT00891046|1908228|FG000|Overall Study|Lost to Follow-up|0
925515|NCT00891046|1908229|FG001|Overall Study|Lost to Follow-up|0
925516|NCT00891046|1908230|FG002|Overall Study|Lost to Follow-up|0
925517|NCT00891046|1908231|FG003|Overall Study|Lost to Follow-up|0
925518|NCT00891046|1908232|FG004|Overall Study|Lost to Follow-up|1
925519|NCT00891202|1908284|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1
925520|NCT00891202|1908285|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0
925521|NCT00891202|1908286|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0
925522|NCT00891202|1908287|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0
925523|NCT00891202|1908284|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
925524|NCT00891202|1908285|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
925525|NCT00891202|1908286|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
925526|NCT00891202|1908287|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
925527|NCT00891202|1908284|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
925528|NCT00891202|1908285|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
925529|NCT00891202|1908286|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
925530|NCT00891202|1908287|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
925531|NCT00891202|1908284|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
925532|NCT00891202|1908285|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
925533|NCT00891202|1908286|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
925534|NCT00891202|1908287|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
925535|NCT00891228|1908298|FG000|Overall Study|Adverse Event|0
925536|NCT00891228|1908299|FG001|Overall Study|Adverse Event|2
925537|NCT00891228|1908300|FG002|Overall Study|Adverse Event|3
925538|NCT00891228|1908298|FG000|Overall Study|Withdrawal by Subject|2
925539|NCT00891228|1908299|FG001|Overall Study|Withdrawal by Subject|4
925540|NCT00891228|1908300|FG002|Overall Study|Withdrawal by Subject|5
925541|NCT00891228|1908298|FG000|Overall Study|Protocol Violation|3
925542|NCT00891228|1908299|FG001|Overall Study|Protocol Violation|1
925543|NCT00891228|1908300|FG002|Overall Study|Protocol Violation|2
925544|NCT00891228|1908298|FG000|Overall Study|Physician Decision|2
925545|NCT00891228|1908299|FG001|Overall Study|Physician Decision|1
925546|NCT00891228|1908300|FG002|Overall Study|Physician Decision|0
925547|NCT00891228|1908298|FG000|Overall Study|Lost to Follow-up|4
925548|NCT00891228|1908299|FG001|Overall Study|Lost to Follow-up|4
925549|NCT00891228|1908300|FG002|Overall Study|Lost to Follow-up|5
925550|NCT00891228|1908298|FG000|Overall Study|Pregnancy|0
925551|NCT00891228|1908299|FG001|Overall Study|Pregnancy|1
925552|NCT00891228|1908300|FG002|Overall Study|Pregnancy|0
925553|NCT00891293|1908308|FG000|Overall Study|Adverse Event|2
925554|NCT00891293|1908308|FG000|Overall Study|Protocol Violation|2
925555|NCT00891293|1908308|FG000|Overall Study|Laboratory abnormality|4
925556|NCT00891293|1908308|FG000|Overall Study|Lost to Follow-up|7
925557|NCT00891293|1908308|FG000|Overall Study|Subject withdrew consent|7
925558|NCT00891293|1908308|FG000|Overall Study|Sponsor termination|62
925559|NCT00891371|1908321|FG000|Pre-assignment|Inclusion/exclusion|5
925560|NCT00891371|1908321|FG000|Pre-assignment|Consent withdrawal|1
925561|NCT00891371|1908321|FG000|Treatment|Lack of Efficacy|5
925562|NCT00891371|1908321|FG000|Treatment|Adverse Event|2
925563|NCT00891371|1908321|FG000|Treatment|Death|1
925564|NCT00891371|1908321|FG000|Treatment|Lost to Follow-up|1
925565|NCT00891462|1908337|FG000|Overall Study|Withdrawal by Subject|9
925566|NCT00891462|1908338|FG001|Overall Study|Withdrawal by Subject|6
925567|NCT00891462|1908339|FG002|Overall Study|Withdrawal by Subject|7
925568|NCT00891462|1908337|FG000|Overall Study|Adverse Event|7
925569|NCT00891462|1908338|FG001|Overall Study|Adverse Event|8
925570|NCT00891462|1908339|FG002|Overall Study|Adverse Event|7
925571|NCT00891462|1908337|FG000|Overall Study|Lack of Efficacy|10
925572|NCT00891462|1908338|FG001|Overall Study|Lack of Efficacy|5
925573|NCT00891462|1908339|FG002|Overall Study|Lack of Efficacy|1
925574|NCT00891462|1908337|FG000|Overall Study|COPD exacerbation|7
925575|NCT00891462|1908338|FG001|Overall Study|COPD exacerbation|4
925576|NCT00891462|1908339|FG002|Overall Study|COPD exacerbation|1
925577|NCT00891462|1908337|FG000|Overall Study|Other Reason|2
925578|NCT00891462|1908338|FG001|Overall Study|Other Reason|5
925579|NCT00891462|1908339|FG002|Overall Study|Other Reason|3
925580|NCT00891462|1908337|FG000|Overall Study|Protocol Violation|2
925581|NCT00891462|1908338|FG001|Overall Study|Protocol Violation|1
925582|NCT00891462|1908339|FG002|Overall Study|Protocol Violation|3
925583|NCT00891462|1908337|FG000|Overall Study|Inclusion/exclusion criteria|0
925584|NCT00891462|1908338|FG001|Overall Study|Inclusion/exclusion criteria|2
925585|NCT00891462|1908339|FG002|Overall Study|Inclusion/exclusion criteria|2
925586|NCT00891462|1908337|FG000|Overall Study|Lost to Follow-up|0
925587|NCT00891462|1908338|FG001|Overall Study|Lost to Follow-up|2
925588|NCT00891462|1908339|FG002|Overall Study|Lost to Follow-up|0
925589|NCT00891527|1908349|FG000|Overall Study|Withdrawal by Subject|2
925590|NCT00891618|1908354|FG000|Overall Study|Withdrawal by Subject|1
925591|NCT00891657|1908360|FG000|Overall Study|Withdrawal by Subject|1
925592|NCT00891657|1908361|FG001|Overall Study|Withdrawal by Subject|1
925593|NCT00891735|1908371|FG000|Overall Study|Adverse Event|2
925594|NCT00891735|1908372|FG001|Overall Study|Adverse Event|0
925595|NCT00891735|1908373|FG002|Overall Study|Adverse Event|2
925596|NCT00891735|1908374|FG003|Overall Study|Adverse Event|0
925597|NCT00891735|1908371|FG000|Overall Study|Death|8
925598|NCT00891735|1908372|FG001|Overall Study|Death|5
925599|NCT00891735|1908373|FG002|Overall Study|Death|4
925600|NCT00891735|1908374|FG003|Overall Study|Death|5
925601|NCT00891735|1908371|FG000|Overall Study|Lost to Follow-up|2
925602|NCT00891735|1908372|FG001|Overall Study|Lost to Follow-up|2
925603|NCT00891735|1908373|FG002|Overall Study|Lost to Follow-up|2
925604|NCT00891735|1908374|FG003|Overall Study|Lost to Follow-up|2
925605|NCT00891735|1908371|FG000|Overall Study|Physician's decision to withdraw patient|1
925606|NCT00891735|1908372|FG001|Overall Study|Physician's decision to withdraw patient|0
925607|NCT00891735|1908373|FG002|Overall Study|Physician's decision to withdraw patient|0
925608|NCT00891735|1908374|FG003|Overall Study|Physician's decision to withdraw patient|0
925609|NCT00891735|1908371|FG000|Overall Study|Patient's decision to withdraw|4
925610|NCT00891735|1908372|FG001|Overall Study|Patient's decision to withdraw|9
925611|NCT00891735|1908373|FG002|Overall Study|Patient's decision to withdraw|4
925612|NCT00891735|1908374|FG003|Overall Study|Patient's decision to withdraw|8
925613|NCT00891774|1908384|FG000|Overall Study|Lost to Follow-up|5
925614|NCT00891774|1908384|FG000|Overall Study|Illness (Self/Mother)|3
925615|NCT00891774|1908384|FG000|Overall Study|Withdrawal by Subject|2
925616|NCT00891774|1908384|FG000|Overall Study|Protocol Violation|4
925617|NCT00891813|1908388|FG000|Overall Study|Adverse Event|3
925618|NCT00891813|1908388|FG000|Overall Study|Withdrawal by Subject|1
925619|NCT00891813|1908388|FG000|Overall Study|Patient Noncompliance|6
925620|NCT00891813|1908388|FG000|Overall Study|Protocol Violation|2
925621|NCT00891839|1908392|FG000|Overall Study|Adverse Event|2
925622|NCT00891839|1908392|FG000|Overall Study|Withdrawal by Subject|2
925623|NCT00891839|1908392|FG000|Overall Study|Disease progression|3
925624|NCT00891930|1908405|FG000|Part 1: Panitumumab +Irinotecan|Death|38
925625|NCT00891930|1908405|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
925626|NCT00891930|1908405|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
925627|NCT00891930|1908405|FG000|Part 2: Panitumumab + Ganitumab|Death|30
925628|NCT00891930|1908405|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
925629|NCT00892008|1908431|FG000|Overall Study|Death|5
925630|NCT00892008|1908431|FG000|Overall Study|Lack of Efficacy|3
925631|NCT00892008|1908431|FG000|Overall Study|Lost to Follow-up|142
925632|NCT00892008|1908431|FG000|Overall Study|Other|378
925633|NCT00892008|1908431|FG000|Overall Study|Adverse Event|37
925634|NCT00892047|1908437|FG000|Overall Study|Adverse Event|2
925635|NCT00892047|1908438|FG001|Overall Study|Adverse Event|2
925636|NCT00892047|1908437|FG000|Overall Study|subject burden|2
925637|NCT00892047|1908438|FG001|Overall Study|subject burden|3
925638|NCT00892047|1908437|FG000|Overall Study|Lack of Efficacy|0
925639|NCT00892047|1908438|FG001|Overall Study|Lack of Efficacy|2
925640|NCT00892099|1908449|FG000|Overall Study|Death|1
925641|NCT00892099|1908450|FG001|Overall Study|Death|0
925642|NCT00892099|1908451|FG002|Overall Study|Death|1
925643|NCT00892099|1908449|FG000|Overall Study|Adverse Event|1
925644|NCT00892099|1908450|FG001|Overall Study|Adverse Event|0
925645|NCT00892099|1908451|FG002|Overall Study|Adverse Event|0
925646|NCT00892099|1908449|FG000|Overall Study|replocated|1
925647|NCT00892099|1908450|FG001|Overall Study|replocated|0
925648|NCT00892099|1908451|FG002|Overall Study|replocated|2
925649|NCT00892099|1908449|FG000|Overall Study|Prolonged hospitalization|1
925650|NCT00892099|1908450|FG001|Overall Study|Prolonged hospitalization|0
925651|NCT00892099|1908451|FG002|Overall Study|Prolonged hospitalization|1
925652|NCT00892099|1908449|FG000|Overall Study|no further details|1
925653|NCT00892099|1908450|FG001|Overall Study|no further details|0
925654|NCT00892099|1908451|FG002|Overall Study|no further details|1
925655|NCT00892099|1908449|FG000|Overall Study|kidney function recovered|0
925656|NCT00892099|1908450|FG001|Overall Study|kidney function recovered|1
925657|NCT00892099|1908451|FG002|Overall Study|kidney function recovered|0
925658|NCT00892099|1908449|FG000|Overall Study|investigator decision|0
925659|NCT00892099|1908450|FG001|Overall Study|investigator decision|0
925660|NCT00892099|1908451|FG002|Overall Study|investigator decision|1
925661|NCT00892099|1908449|FG000|Overall Study|Lost to Follow-up|0
925662|NCT00892099|1908450|FG001|Overall Study|Lost to Follow-up|0
925663|NCT00892099|1908451|FG002|Overall Study|Lost to Follow-up|1
925664|NCT00892151|1908459|FG000|Overall Study|Protocol Violation|1
925665|NCT00892177|1908466|FG000|Phase II|Ineligible|0
925666|NCT00892177|1908467|FG001|Phase II|Ineligible|0
925667|NCT00892177|1908468|FG002|Phase II|Ineligible|0
925668|NCT00892177|1908469|FG003|Phase II|Ineligible|0
925669|NCT00892177|1908470|FG004|Phase II|Ineligible|1
925670|NCT00892177|1908471|FG005|Phase II|Ineligible|1
925671|NCT00892177|1908466|FG000|Phase II|Withdrawal by Subject|0
925672|NCT00892177|1908467|FG001|Phase II|Withdrawal by Subject|0
925673|NCT00892177|1908468|FG002|Phase II|Withdrawal by Subject|0
925674|NCT00892177|1908469|FG003|Phase II|Withdrawal by Subject|0
925675|NCT00892177|1908470|FG004|Phase II|Withdrawal by Subject|4
925676|NCT00892177|1908471|FG005|Phase II|Withdrawal by Subject|1
925677|NCT00892281|1908488|FG000|Overall Study|Adverse Event|65
925678|NCT00892281|1908489|FG001|Overall Study|Adverse Event|8
925679|NCT00892281|1908488|FG000|Overall Study|Lost to Follow-up|81
925680|NCT00892281|1908489|FG001|Overall Study|Lost to Follow-up|8
925681|NCT00892281|1908488|FG000|Overall Study|Pregnancy|1
925682|NCT00892281|1908489|FG001|Overall Study|Pregnancy|0
925683|NCT00892281|1908488|FG000|Overall Study|Protocol Violation|7
925684|NCT00892281|1908489|FG001|Overall Study|Protocol Violation|2
925685|NCT00892281|1908488|FG000|Overall Study|Withdrawal by Subject|86
925686|NCT00892281|1908489|FG001|Overall Study|Withdrawal by Subject|14
925687|NCT00892281|1908488|FG000|Overall Study|Subject failed to return for final visit|2
925688|NCT00892281|1908489|FG001|Overall Study|Subject failed to return for final visit|0
925689|NCT00892281|1908488|FG000|Overall Study|Subject unable to keep follow-up visits|1
925690|NCT00892281|1908489|FG001|Overall Study|Subject unable to keep follow-up visits|0
925691|NCT00892281|1908488|FG000|Overall Study|Final visit completed 4 weeks late|0
925692|NCT00892281|1908489|FG001|Overall Study|Final visit completed 4 weeks late|1
925693|NCT00892281|1908488|FG000|Overall Study|Subject completed day after study closed|1
925694|NCT00892281|1908489|FG001|Overall Study|Subject completed day after study closed|0
925695|NCT00892281|1908488|FG000|Overall Study|Family emergency|1
925696|NCT00892281|1908489|FG001|Overall Study|Family emergency|0
925697|NCT00892281|1908488|FG000|Overall Study|Last visit not done - death in family|1
925698|NCT00892281|1908489|FG001|Overall Study|Last visit not done - death in family|0
925699|NCT00892281|1908488|FG000|Overall Study|Did not meet incl/excl criteria|1
925700|NCT00892281|1908489|FG001|Overall Study|Did not meet incl/excl criteria|0
925701|NCT00892281|1908488|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1
925702|NCT00892281|1908489|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0
925703|NCT00892281|1908488|FG000|Overall Study|Unable to redeem the drug voucher|1
925704|NCT00892281|1908489|FG001|Overall Study|Unable to redeem the drug voucher|0
925705|NCT00892281|1908488|FG000|Overall Study|Subject not good candidate for study|1
925706|NCT00892281|1908489|FG001|Overall Study|Subject not good candidate for study|0
925707|NCT00892281|1908488|FG000|Overall Study|Subject did not return for any visits|1
925708|NCT00892281|1908489|FG001|Overall Study|Subject did not return for any visits|0
925709|NCT00892281|1908488|FG000|Overall Study|Subject missed several visits/lost meds|1
925710|NCT00892281|1908489|FG001|Overall Study|Subject missed several visits/lost meds|0
925711|NCT00892281|1908488|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1
925712|NCT00892281|1908489|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1
925713|NCT00892281|1908488|FG000|Overall Study|Scheduled for knee replacement|0
925714|NCT00892281|1908489|FG001|Overall Study|Scheduled for knee replacement|1
925715|NCT00892281|1908488|FG000|Overall Study|PI complained of inadequate compensation|3
925716|NCT00892281|1908489|FG001|Overall Study|PI complained of inadequate compensation|0
925717|NCT00892281|1908488|FG000|Overall Study|Subject lost interest in program|0
925718|NCT00892281|1908489|FG001|Overall Study|Subject lost interest in program|1
925719|NCT00892281|1908488|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0
925720|NCT00892281|1908489|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1
925721|NCT00892281|1908488|FG000|Overall Study|Death in family|1
925722|NCT00892281|1908489|FG001|Overall Study|Death in family|0
925723|NCT00892281|1908488|FG000|Overall Study|Lack of efficacy of study product|2
925724|NCT00892281|1908489|FG001|Overall Study|Lack of efficacy of study product|0
925725|NCT00892281|1908488|FG000|Overall Study|Subject not seen by PI at final visit|1
925726|NCT00892281|1908489|FG001|Overall Study|Subject not seen by PI at final visit|0
925727|NCT00892281|1908488|FG000|Overall Study|No show Visit 2; prescription not filled|1
925728|NCT00892281|1908489|FG001|Overall Study|No show Visit 2; prescription not filled|0
925729|NCT00892281|1908488|FG000|Overall Study|Missed multiple visits|1
925730|NCT00892281|1908489|FG001|Overall Study|Missed multiple visits|0
925731|NCT00892281|1908488|FG000|Overall Study|Missed visits rescheduled out of window|1
925732|NCT00892281|1908489|FG001|Overall Study|Missed visits rescheduled out of window|0
925733|NCT00892281|1908488|FG000|Overall Study|Non-compliant with visits as scheduled|1
925734|NCT00892281|1908489|FG001|Overall Study|Non-compliant with visits as scheduled|0
925735|NCT00892281|1908488|FG000|Overall Study|Subject had history of drug abuse|1
925736|NCT00892281|1908489|FG001|Overall Study|Subject had history of drug abuse|0
925737|NCT00892281|1908488|FG000|Overall Study|Rash on hand|1
925738|NCT00892281|1908489|FG001|Overall Study|Rash on hand|0
925739|NCT00892281|1908488|FG000|Overall Study|Visit 4 date out of window|1
925740|NCT00892281|1908489|FG001|Overall Study|Visit 4 date out of window|0
925741|NCT00892437|1908497|FG000|Randomized Phase|Randomized but not treated|6
925742|NCT00892437|1908498|FG001|Randomized Phase|Randomized but not treated|0
925743|NCT00892437|1908497|FG000|Randomized Phase|Adverse Event|2
925744|NCT00892437|1908498|FG001|Randomized Phase|Adverse Event|2
925745|NCT00892437|1908497|FG000|Randomized Phase|Lost to Follow-up|1
925746|NCT00892437|1908498|FG001|Randomized Phase|Lost to Follow-up|3
925747|NCT00892437|1908497|FG000|Randomized Phase|Investigator's Discretion|1
925748|NCT00892437|1908498|FG001|Randomized Phase|Investigator's Discretion|0
925749|NCT00892437|1908497|FG000|Randomized Phase|Withdrew Consent|1
925750|NCT00892437|1908498|FG001|Randomized Phase|Withdrew Consent|0
925751|NCT00892437|1908497|FG000|Open-Label Extension Phase|Adverse Event|4
925752|NCT00892437|1908498|FG001|Open-Label Extension Phase|Adverse Event|2
925753|NCT00892437|1908497|FG000|Open-Label Extension Phase|Lack of Efficacy|1
925754|NCT00892437|1908498|FG001|Open-Label Extension Phase|Lack of Efficacy|0
925755|NCT00892437|1908497|FG000|Open-Label Extension Phase|Lost to Follow-up|3
925756|NCT00892437|1908498|FG001|Open-Label Extension Phase|Lost to Follow-up|1
925757|NCT00892437|1908497|FG000|Open-Label Extension Phase|Investigator's Discretion|1
925758|NCT00892437|1908498|FG001|Open-Label Extension Phase|Investigator's Discretion|0
925759|NCT00892437|1908497|FG000|Open-Label Extension Phase|Withdrew Consent|3
925760|NCT00892437|1908498|FG001|Open-Label Extension Phase|Withdrew Consent|1
925761|NCT00892723|1908535|FG000|Overall Study|Lost to Follow-up|1
925762|NCT00892723|1908536|FG001|Overall Study|Lost to Follow-up|3
925763|NCT00892723|1908537|FG002|Overall Study|Lost to Follow-up|1
925764|NCT00892723|1908535|FG000|Overall Study|Withdrawal by Subject|1
925765|NCT00892723|1908536|FG001|Overall Study|Withdrawal by Subject|1
925766|NCT00892723|1908537|FG002|Overall Study|Withdrawal by Subject|1
925767|NCT00892775|1908580|FG000|Overall Study|Protocol Violation|1
925768|NCT00892775|1908581|FG001|Overall Study|Protocol Violation|0
925769|NCT00892775|1908580|FG000|Overall Study|Subject difficulties with blood drawing|1
925770|NCT00892775|1908581|FG001|Overall Study|Subject difficulties with blood drawing|0
925771|NCT00892775|1908580|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
925772|NCT00892775|1908581|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
925773|NCT00892775|1908580|FG000|Overall Study|Migrated/ moved from study area|1
925774|NCT00892775|1908581|FG001|Overall Study|Migrated/ moved from study area|0
925775|NCT00892775|1908580|FG000|Overall Study|Withdrawal by Subject|0
925776|NCT00892775|1908581|FG001|Overall Study|Withdrawal by Subject|1
925777|NCT00892775|1908580|FG000|Overall Study|Lost to Follow-up|1
925778|NCT00892775|1908581|FG001|Overall Study|Lost to Follow-up|0
925779|NCT00892957|1908589|FG000|Between Postoperative Day 1 and Day 14|Death|0
925780|NCT00892957|1908590|FG001|Between Postoperative Day 1 and Day 14|Death|2
925781|NCT00892957|1908589|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
925782|NCT00892957|1908590|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
925783|NCT00893113|1908627|FG000|Overall Study|Lost to Follow-up|4
925784|NCT00893113|1908628|FG001|Overall Study|Lost to Follow-up|8
925785|NCT00893113|1908627|FG000|Overall Study|Early Termination|1
925786|NCT00893113|1908628|FG001|Overall Study|Early Termination|1
925787|NCT00893113|1908627|FG000|Overall Study|Withdrew Consent|8
925788|NCT00893113|1908628|FG001|Overall Study|Withdrew Consent|7
925789|NCT00893464|1908651|FG000|Overall Study|Did not complete therapy/experience PD|0
925790|NCT00893464|1908652|FG001|Overall Study|Did not complete therapy/experience PD|0
925791|NCT00893464|1908653|FG002|Overall Study|Did not complete therapy/experience PD|0
925792|NCT00893464|1908654|FG003|Overall Study|Did not complete therapy/experience PD|0
925793|NCT00893464|1908655|FG004|Overall Study|Did not complete therapy/experience PD|0
925794|NCT00893464|1908656|FG005|Overall Study|Did not complete therapy/experience PD|0
925795|NCT00893464|1908657|FG006|Overall Study|Did not complete therapy/experience PD|2
925796|NCT00893464|1908658|FG007|Overall Study|Did not complete therapy/experience PD|2
925797|NCT00893737|1908681|FG000|Overall Study|Adverse Event|4
925798|NCT00893737|1908681|FG000|Overall Study|Withdrawal by Subject|2
925799|NCT00893737|1908681|FG000|Overall Study|Lost to Follow-up|6
925800|NCT00893763|1908687|FG000|Overall Study|extubated|110
925801|NCT00893763|1908688|FG001|Overall Study|extubated|110
925830|NCT00893971|1908713|FG000|Overall Study|Physician Decision|3
925831|NCT00894166|1908746|FG000|Overall Study|Withdrew or Lost to Follow-Up|61
925832|NCT00894166|1908747|FG001|Overall Study|Withdrew or Lost to Follow-Up|63
925833|NCT00894166|1908748|FG002|Overall Study|Withdrew or Lost to Follow-Up|62
925834|NCT00894166|1908749|FG003|Overall Study|Withdrew or Lost to Follow-Up|68
925835|NCT00894166|1908750|FG004|Overall Study|Withdrew or Lost to Follow-Up|24
925836|NCT00894166|1908751|FG005|Overall Study|Withdrew or Lost to Follow-Up|16
925837|NCT00894166|1908752|FG006|Overall Study|Withdrew or Lost to Follow-Up|16
925838|NCT00894166|1908753|FG007|Overall Study|Withdrew or Lost to Follow-Up|34
925839|NCT00894166|1908746|FG000|Overall Study|Death|0
925840|NCT00894166|1908747|FG001|Overall Study|Death|0
925841|NCT00894166|1908748|FG002|Overall Study|Death|0
925842|NCT00894166|1908749|FG003|Overall Study|Death|1
925843|NCT00894166|1908750|FG004|Overall Study|Death|0
925844|NCT00894166|1908751|FG005|Overall Study|Death|0
925845|NCT00894166|1908752|FG006|Overall Study|Death|0
925846|NCT00894166|1908753|FG007|Overall Study|Death|0
925847|NCT00894322|1908783|FG000|Overall Study|Withdrawal by Subject|1
925848|NCT00894322|1908784|FG001|Overall Study|Withdrawal by Subject|0
925849|NCT00894322|1908785|FG002|Overall Study|Withdrawal by Subject|0
925850|NCT00894361|1908797|FG000|Overall Study|deaths and less than 2 years followup|24
925851|NCT00894361|1908798|FG001|Overall Study|deaths and less than 2 years followup|64
925852|NCT00894387|1908808|FG000|Overall Study|Adverse Event|44
925853|NCT00894387|1908809|FG001|Overall Study|Adverse Event|45
925854|NCT00894387|1908808|FG000|Overall Study|Abnormal Laboratory values|2
925855|NCT00894387|1908809|FG001|Overall Study|Abnormal Laboratory values|2
925856|NCT00894387|1908808|FG000|Overall Study|Unsatisfactory therapeutic effect|0
925857|NCT00894387|1908809|FG001|Overall Study|Unsatisfactory therapeutic effect|1
925858|NCT00894387|1908808|FG000|Overall Study|Lost to Follow-up|3
925859|NCT00894387|1908809|FG001|Overall Study|Lost to Follow-up|5
925860|NCT00894387|1908808|FG000|Overall Study|Administrative problems|2
925861|NCT00894387|1908809|FG001|Overall Study|Administrative problems|2
925862|NCT00894387|1908808|FG000|Overall Study|Death|77
925863|NCT00894387|1908809|FG001|Overall Study|Death|76
925864|NCT00894387|1908808|FG000|Overall Study|Protocol Deviation|4
925865|NCT00894387|1908809|FG001|Overall Study|Protocol Deviation|0
925866|NCT00894387|1908808|FG000|Overall Study|Patient's request|25
925867|NCT00894387|1908809|FG001|Overall Study|Patient's request|30
925868|NCT00894387|1908808|FG000|Overall Study|Other (Missing)|5
925869|NCT00894387|1908809|FG001|Overall Study|Other (Missing)|3
925870|NCT00894387|1908808|FG000|Overall Study|Mis-randomized|13
925871|NCT00894387|1908809|FG001|Overall Study|Mis-randomized|9
925872|NCT00894387|1908808|FG000|Overall Study|GCP non-compliance|0
925873|NCT00894387|1908809|FG001|Overall Study|GCP non-compliance|2
925874|NCT00894413|1908817|FG000|Overall Study|Physician Decision|0
925875|NCT00894413|1908818|FG001|Overall Study|Physician Decision|2
925876|NCT00894413|1908817|FG000|Overall Study|Adverse Event|0
925877|NCT00894413|1908818|FG001|Overall Study|Adverse Event|2
925878|NCT00894413|1908817|FG000|Overall Study|Withdrawal by Subject|0
925879|NCT00894413|1908818|FG001|Overall Study|Withdrawal by Subject|4
925880|NCT00894543|1908860|FG000|Baseline to Week 4|No diary or lost or withdrew|3
925881|NCT00894543|1908861|FG001|Baseline to Week 4|No diary or lost or withdrew|2
925882|NCT00894543|1908860|FG000|Week 4 to Week 8|No diary or lost or withdrew|4
925883|NCT00894543|1908861|FG001|Week 4 to Week 8|No diary or lost or withdrew|2
925884|NCT00894556|1908870|FG000|Baseline Phase|Did not meet Randomization Criteria|0
925885|NCT00894556|1908871|FG001|Baseline Phase|Did not meet Randomization Criteria|0
925886|NCT00894556|1908872|FG002|Baseline Phase|Did not meet Randomization Criteria|0
925887|NCT00894556|1908873|FG003|Baseline Phase|Did not meet Randomization Criteria|85
925888|NCT00894556|1908870|FG000|Treatment Phase|Lost to Follow-up|2
925889|NCT00894556|1908871|FG001|Treatment Phase|Lost to Follow-up|3
925890|NCT00894556|1908872|FG002|Treatment Phase|Lost to Follow-up|1
925891|NCT00894556|1908873|FG003|Treatment Phase|Lost to Follow-up|0
925892|NCT00894556|1908870|FG000|Treatment Phase|Lack of Qualifying Event|2
925893|NCT00894556|1908871|FG001|Treatment Phase|Lack of Qualifying Event|1
925894|NCT00894556|1908872|FG002|Treatment Phase|Lack of Qualifying Event|0
925895|NCT00894556|1908873|FG003|Treatment Phase|Lack of Qualifying Event|0
925896|NCT00894647|1908882|FG000|Overall Study|Adverse Event|5
925897|NCT00894647|1908883|FG001|Overall Study|Adverse Event|4
925898|NCT00894647|1908882|FG000|Overall Study|Withdrawal by Subject|4
925899|NCT00894647|1908883|FG001|Overall Study|Withdrawal by Subject|4
925900|NCT00894647|1908882|FG000|Overall Study|Lost to Follow-up|0
925901|NCT00894647|1908883|FG001|Overall Study|Lost to Follow-up|2
925902|NCT00894647|1908882|FG000|Overall Study|Non-compliance with study procedures|0
925903|NCT00894647|1908883|FG001|Overall Study|Non-compliance with study procedures|2
925904|NCT00894647|1908882|FG000|Overall Study|Other, not due to AE|1
925905|NCT00894647|1908883|FG001|Overall Study|Other, not due to AE|2
925906|NCT00894686|1908889|FG000|Overall Study|Withdrawal by Subject|50
925907|NCT00894686|1908889|FG000|Overall Study|Physician Decision|1
925908|NCT00894686|1908889|FG000|Overall Study|Other|5
925909|NCT00894803|1908913|FG000|Overall Study|Death|20
925910|NCT00894803|1908914|FG001|Overall Study|Death|4
925911|NCT00894803|1908913|FG000|Overall Study|Lost to Follow-up|0
925912|NCT00894803|1908914|FG001|Overall Study|Lost to Follow-up|1
925913|NCT00894933|1908920|FG000|Overall Study|Lost to Follow-up|2
925914|NCT00894933|1908920|FG000|Overall Study|Cancelled Procedure|1
925915|NCT00894933|1908920|FG000|Overall Study|Did not meeting incl/excl criteria|1
925916|NCT00895011|1908927|FG000|Overall Study|Withdrawal by Subject|14
925917|NCT00895011|1908928|FG001|Overall Study|Withdrawal by Subject|7
925918|NCT00895011|1908929|FG002|Overall Study|Withdrawal by Subject|2
925919|NCT00895011|1908927|FG000|Overall Study|Lost to Follow-up|5
925920|NCT00895011|1908928|FG001|Overall Study|Lost to Follow-up|4
925921|NCT00895011|1908929|FG002|Overall Study|Lost to Follow-up|1
925922|NCT00895011|1908927|FG000|Overall Study|Protocol Violation|3
925923|NCT00895011|1908928|FG001|Overall Study|Protocol Violation|1
925924|NCT00895011|1908929|FG002|Overall Study|Protocol Violation|3
925925|NCT00895011|1908927|FG000|Overall Study|Adverse Event|1
925926|NCT00895011|1908928|FG001|Overall Study|Adverse Event|2
925927|NCT00895011|1908929|FG002|Overall Study|Adverse Event|2
925928|NCT00895011|1908927|FG000|Overall Study|schedule conflict|1
925929|NCT00895011|1908928|FG001|Overall Study|schedule conflict|0
925930|NCT00895011|1908929|FG002|Overall Study|schedule conflict|0
925931|NCT00895037|1908941|FG000|Overall Study|Death|0
925932|NCT00895037|1908942|FG001|Overall Study|Death|2
925933|NCT00895037|1908943|FG002|Overall Study|Death|1
925934|NCT00895154|1908953|FG000|Overall Study|Lost to Follow-up|1
925935|NCT00895154|1908954|FG001|Overall Study|Lost to Follow-up|1
925936|NCT00895154|1908953|FG000|Overall Study|Withdrawal by Subject|0
925937|NCT00895154|1908954|FG001|Overall Study|Withdrawal by Subject|1
925938|NCT00895245|1909001|FG000|Overall Study|Lack of Efficacy|6
925939|NCT00895310|1909005|FG000|Overall Study|Withdrawal by Subject|1
925940|NCT00895414|1909009|FG000|First Intervention (14 Days)|Withdrawal by Subject|1
925941|NCT00895414|1909010|FG001|First Intervention (14 Days)|Withdrawal by Subject|0
925942|NCT00895414|1909009|FG000|First Intervention (14 Days)|Physician Decision|0
925943|NCT00895414|1909010|FG001|First Intervention (14 Days)|Physician Decision|1
925944|NCT00895453|1909019|FG000|Overall Study|Lost to Follow-up|25
925945|NCT00895453|1909020|FG001|Overall Study|Lost to Follow-up|25
925946|NCT00895453|1909021|FG002|Overall Study|Lost to Follow-up|23
925947|NCT00895583|1909040|FG000|Overall Study|Adverse Event|28
925948|NCT00895583|1909041|FG001|Overall Study|Adverse Event|4
925949|NCT00895583|1909040|FG000|Overall Study|Death|2
925950|NCT00895583|1909041|FG001|Overall Study|Death|1
925951|NCT00895583|1909040|FG000|Overall Study|Physician Decision|3
925952|NCT00895583|1909041|FG001|Overall Study|Physician Decision|1
925953|NCT00895583|1909040|FG000|Overall Study|Lost to Follow-up|1
925954|NCT00895583|1909041|FG001|Overall Study|Lost to Follow-up|3
925955|NCT00895583|1909040|FG000|Overall Study|Protocol Violation|1
925956|NCT00895583|1909041|FG001|Overall Study|Protocol Violation|0
925957|NCT00895583|1909040|FG000|Overall Study|Withdrawal by Subject|4
925958|NCT00895583|1909041|FG001|Overall Study|Withdrawal by Subject|2
925959|NCT00895583|1909040|FG000|Overall Study|Lack of Efficacy|5
925960|NCT00895583|1909041|FG001|Overall Study|Lack of Efficacy|0
925961|NCT00895583|1909040|FG000|Overall Study|Other|0
925962|NCT00895583|1909041|FG001|Overall Study|Other|1
925963|NCT00895622|1909050|FG000|Overall Study|Protocol Violation|5
925964|NCT00895622|1909051|FG001|Overall Study|Protocol Violation|4
925965|NCT00895622|1909052|FG002|Overall Study|Protocol Violation|4
925966|NCT00895661|1909068|FG000|Overall Study|Death|1
925967|NCT00895661|1909068|FG000|Overall Study|reason unknown|2
925968|NCT00895843|1909110|FG000|Overall Study|Protocol Violation|12
925969|NCT00895843|1909111|FG001|Overall Study|Protocol Violation|12
925970|NCT00895895|1909122|FG000|Period 1|Adverse Event|7
925971|NCT00895895|1909123|FG001|Period 1|Adverse Event|6
925972|NCT00895895|1909124|FG002|Period 1|Adverse Event|4
925973|NCT00895895|1909125|FG003|Period 1|Adverse Event|6
925974|NCT00895895|1909126|FG004|Period 1|Adverse Event|7
925975|NCT00895895|1909122|FG000|Period 1|Death|0
925976|NCT00895895|1909123|FG001|Period 1|Death|0
925977|NCT00895895|1909124|FG002|Period 1|Death|0
925978|NCT00895895|1909125|FG003|Period 1|Death|0
925979|NCT00895895|1909126|FG004|Period 1|Death|1
925980|NCT00895895|1909122|FG000|Period 1|discontinued by sponsor|2
925981|NCT00895895|1909123|FG001|Period 1|discontinued by sponsor|1
925982|NCT00895895|1909124|FG002|Period 1|discontinued by sponsor|2
925983|NCT00895895|1909125|FG003|Period 1|discontinued by sponsor|1
925984|NCT00895895|1909126|FG004|Period 1|discontinued by sponsor|1
925985|NCT00895895|1909122|FG000|Period 1|failed to return|0
925986|NCT00895895|1909123|FG001|Period 1|failed to return|0
925987|NCT00895895|1909124|FG002|Period 1|failed to return|1
925988|NCT00895895|1909125|FG003|Period 1|failed to return|0
925989|NCT00895895|1909126|FG004|Period 1|failed to return|1
925990|NCT00895895|1909122|FG000|Period 1|investigator request|0
925991|NCT00895895|1909123|FG001|Period 1|investigator request|1
925992|NCT00895895|1909124|FG002|Period 1|investigator request|0
925993|NCT00895895|1909125|FG003|Period 1|investigator request|0
925994|NCT00895895|1909126|FG004|Period 1|investigator request|0
925995|NCT00895895|1909122|FG000|Period 1|Lost to Follow-up|2
925996|NCT00895895|1909123|FG001|Period 1|Lost to Follow-up|1
925997|NCT00895895|1909124|FG002|Period 1|Lost to Follow-up|3
925998|NCT00895895|1909125|FG003|Period 1|Lost to Follow-up|2
925999|NCT00895895|1909126|FG004|Period 1|Lost to Follow-up|3
926000|NCT00895895|1909122|FG000|Period 1|Other|1
926001|NCT00895895|1909123|FG001|Period 1|Other|2
926002|NCT00895895|1909124|FG002|Period 1|Other|1
926003|NCT00895895|1909125|FG003|Period 1|Other|1
926004|NCT00895895|1909126|FG004|Period 1|Other|1
926005|NCT00895895|1909122|FG000|Period 1|Protocol Violation|0
926006|NCT00895895|1909123|FG001|Period 1|Protocol Violation|1
926007|NCT00895895|1909124|FG002|Period 1|Protocol Violation|0
926008|NCT00895895|1909125|FG003|Period 1|Protocol Violation|0
926009|NCT00895895|1909126|FG004|Period 1|Protocol Violation|0
926010|NCT00895895|1909122|FG000|Period 1|Withdrawal by Subject|6
926011|NCT00895895|1909123|FG001|Period 1|Withdrawal by Subject|6
926012|NCT00895895|1909124|FG002|Period 1|Withdrawal by Subject|8
926013|NCT00895895|1909125|FG003|Period 1|Withdrawal by Subject|2
926014|NCT00895895|1909126|FG004|Period 1|Withdrawal by Subject|4
926015|NCT00895895|1909122|FG000|Period 1|unsatisfactory response-efficacy|2
926016|NCT00895895|1909123|FG001|Period 1|unsatisfactory response-efficacy|0
926017|NCT00895895|1909124|FG002|Period 1|unsatisfactory response-efficacy|0
926018|NCT00895895|1909125|FG003|Period 1|unsatisfactory response-efficacy|0
926019|NCT00895895|1909126|FG004|Period 1|unsatisfactory response-efficacy|0
926020|NCT00895895|1909122|FG000|Period 1|randomized and not treated|1
926021|NCT00895895|1909123|FG001|Period 1|randomized and not treated|3
926022|NCT00895895|1909124|FG002|Period 1|randomized and not treated|1
926023|NCT00895895|1909125|FG003|Period 1|randomized and not treated|1
926024|NCT00895895|1909126|FG004|Period 1|randomized and not treated|2
926025|NCT00895895|1909122|FG000|After Period 1, Prior to Period 2|Adverse Event|0
926026|NCT00895895|1909123|FG001|After Period 1, Prior to Period 2|Adverse Event|0
926027|NCT00895895|1909124|FG002|After Period 1, Prior to Period 2|Adverse Event|1
926028|NCT00895895|1909125|FG003|After Period 1, Prior to Period 2|Adverse Event|0
926029|NCT00895895|1909126|FG004|After Period 1, Prior to Period 2|Adverse Event|0
926030|NCT00895895|1909122|FG000|After Period 1, Prior to Period 2|Other|0
926031|NCT00895895|1909123|FG001|After Period 1, Prior to Period 2|Other|0
926032|NCT00895895|1909124|FG002|After Period 1, Prior to Period 2|Other|1
926033|NCT00895895|1909125|FG003|After Period 1, Prior to Period 2|Other|0
926034|NCT00895895|1909126|FG004|After Period 1, Prior to Period 2|Other|0
926035|NCT00895895|1909122|FG000|After Period 1, Prior to Period 2|Protocol Violation|0
926036|NCT00895895|1909123|FG001|After Period 1, Prior to Period 2|Protocol Violation|0
926037|NCT00895895|1909124|FG002|After Period 1, Prior to Period 2|Protocol Violation|0
926038|NCT00895895|1909125|FG003|After Period 1, Prior to Period 2|Protocol Violation|0
926039|NCT00895895|1909126|FG004|After Period 1, Prior to Period 2|Protocol Violation|1
926040|NCT00895895|1909122|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0
926041|NCT00895895|1909123|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0
926042|NCT00895895|1909124|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0
926043|NCT00895895|1909125|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0
926044|NCT00895895|1909126|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1
926045|NCT00895895|1909122|FG000|Period 2|Adverse Event|3
926046|NCT00895895|1909123|FG001|Period 2|Adverse Event|3
926047|NCT00895895|1909124|FG002|Period 2|Adverse Event|5
926048|NCT00895895|1909125|FG003|Period 2|Adverse Event|2
926049|NCT00895895|1909126|FG004|Period 2|Adverse Event|5
926050|NCT00895895|1909122|FG000|Period 2|Death|0
926051|NCT00895895|1909123|FG001|Period 2|Death|0
926052|NCT00895895|1909124|FG002|Period 2|Death|1
926053|NCT00895895|1909125|FG003|Period 2|Death|0
926054|NCT00895895|1909126|FG004|Period 2|Death|0
926055|NCT00895895|1909122|FG000|Period 2|discontinued by sponsor|44
926056|NCT00895895|1909123|FG001|Period 2|discontinued by sponsor|44
926057|NCT00895895|1909124|FG002|Period 2|discontinued by sponsor|38
926058|NCT00895895|1909125|FG003|Period 2|discontinued by sponsor|46
926059|NCT00895895|1909126|FG004|Period 2|discontinued by sponsor|37
926060|NCT00895895|1909122|FG000|Period 2|failed to return|2
926061|NCT00895895|1909123|FG001|Period 2|failed to return|0
926062|NCT00895895|1909124|FG002|Period 2|failed to return|0
926063|NCT00895895|1909125|FG003|Period 2|failed to return|0
926064|NCT00895895|1909126|FG004|Period 2|failed to return|0
926065|NCT00895895|1909122|FG000|Period 2|investigator request|2
926066|NCT00895895|1909123|FG001|Period 2|investigator request|0
926067|NCT00895895|1909124|FG002|Period 2|investigator request|0
926068|NCT00895895|1909125|FG003|Period 2|investigator request|0
926069|NCT00895895|1909126|FG004|Period 2|investigator request|0
926070|NCT00895895|1909122|FG000|Period 2|Lost to Follow-up|1
926071|NCT00895895|1909123|FG001|Period 2|Lost to Follow-up|2
926072|NCT00895895|1909124|FG002|Period 2|Lost to Follow-up|1
926073|NCT00895895|1909125|FG003|Period 2|Lost to Follow-up|1
926074|NCT00895895|1909126|FG004|Period 2|Lost to Follow-up|0
926075|NCT00895895|1909122|FG000|Period 2|Other|1
926076|NCT00895895|1909123|FG001|Period 2|Other|1
926077|NCT00895895|1909124|FG002|Period 2|Other|3
926078|NCT00895895|1909125|FG003|Period 2|Other|1
926079|NCT00895895|1909126|FG004|Period 2|Other|1
926080|NCT00895895|1909122|FG000|Period 2|Protocol Violation|1
926081|NCT00895895|1909123|FG001|Period 2|Protocol Violation|0
926082|NCT00895895|1909124|FG002|Period 2|Protocol Violation|1
926083|NCT00895895|1909125|FG003|Period 2|Protocol Violation|1
926084|NCT00895895|1909126|FG004|Period 2|Protocol Violation|1
926085|NCT00895895|1909122|FG000|Period 2|Withdrawal by Subject|0
926086|NCT00895895|1909123|FG001|Period 2|Withdrawal by Subject|2
926087|NCT00895895|1909124|FG002|Period 2|Withdrawal by Subject|0
926088|NCT00895895|1909125|FG003|Period 2|Withdrawal by Subject|3
926089|NCT00895895|1909126|FG004|Period 2|Withdrawal by Subject|5
926090|NCT00895895|1909122|FG000|Period 2|unsatisfactory response-efficacy|2
926091|NCT00895895|1909123|FG001|Period 2|unsatisfactory response-efficacy|1
926092|NCT00895895|1909124|FG002|Period 2|unsatisfactory response-efficacy|0
926093|NCT00895895|1909125|FG003|Period 2|unsatisfactory response-efficacy|0
926094|NCT00895895|1909126|FG004|Period 2|unsatisfactory response-efficacy|0
926095|NCT00895947|1909171|FG000|Overall Study|Adverse Event|3
926096|NCT00895947|1909172|FG001|Overall Study|Adverse Event|4
926097|NCT00895947|1909171|FG000|Overall Study|Lost to Follow-up|3
926098|NCT00895947|1909172|FG001|Overall Study|Lost to Follow-up|4
926099|NCT00895947|1909171|FG000|Overall Study|Protocol Violation|4
926100|NCT00895947|1909172|FG001|Overall Study|Protocol Violation|2
926101|NCT00895947|1909171|FG000|Overall Study|Withdrawal by Subject|2
926102|NCT00895947|1909172|FG001|Overall Study|Withdrawal by Subject|0
926103|NCT00896051|1909198|FG000|Overall Study|Adverse Event|2
926104|NCT00896051|1909199|FG001|Overall Study|Adverse Event|1
926105|NCT00896051|1909198|FG000|Overall Study|Lost to Follow-up|3
926106|NCT00896051|1909199|FG001|Overall Study|Lost to Follow-up|2
926107|NCT00896051|1909198|FG000|Overall Study|Withdrawal by Subject|3
926108|NCT00896051|1909199|FG001|Overall Study|Withdrawal by Subject|2
926109|NCT00896051|1909198|FG000|Overall Study|Subject noncompliant|1
926110|NCT00896051|1909199|FG001|Overall Study|Subject noncompliant|3
926111|NCT00896051|1909198|FG000|Overall Study|Other|1
926112|NCT00896051|1909199|FG001|Overall Study|Other|1
926113|NCT00896168|1909225|FG000|Overall Study|Adverse Event|4
926114|NCT00896168|1909226|FG001|Overall Study|Adverse Event|7
926115|NCT00896168|1909225|FG000|Overall Study|Treatment failure|8
926116|NCT00896168|1909226|FG001|Overall Study|Treatment failure|10
926117|NCT00896168|1909225|FG000|Overall Study|Lost to Follow-up|1
926118|NCT00896168|1909226|FG001|Overall Study|Lost to Follow-up|1
926119|NCT00896168|1909225|FG000|Overall Study|Other|1
926120|NCT00896168|1909226|FG001|Overall Study|Other|1
926121|NCT00896233|1909236|FG000|Overall Study|Claustrophobia during MRI|1
926122|NCT00896337|1909250|FG000|Overall Study|Death|7
926123|NCT00896337|1909250|FG000|Overall Study|Withdrawal by Subject|7
926124|NCT00896337|1909250|FG000|Overall Study|Lost to Follow-up|11
926125|NCT00896363|1909262|FG000|Overall Study|Adverse Event|3
926126|NCT00896363|1909263|FG001|Overall Study|Adverse Event|4
926127|NCT00896363|1909264|FG002|Overall Study|Adverse Event|2
926128|NCT00896363|1909262|FG000|Overall Study|Lack of Efficacy|0
926129|NCT00896363|1909263|FG001|Overall Study|Lack of Efficacy|2
926130|NCT00896363|1909264|FG002|Overall Study|Lack of Efficacy|1
926131|NCT00896363|1909262|FG000|Overall Study|Withdrawal by Subject|3
926132|NCT00896363|1909263|FG001|Overall Study|Withdrawal by Subject|5
926133|NCT00896363|1909264|FG002|Overall Study|Withdrawal by Subject|5
926134|NCT00896454|1909289|FG000|Overall Study|Death|10
926135|NCT00896454|1909289|FG000|Overall Study|Adverse Event|8
926136|NCT00896454|1909289|FG000|Overall Study|Disease Progression|5
926137|NCT00896454|1909289|FG000|Overall Study|Other|4
926138|NCT00896454|1909289|FG000|Overall Study|Requirement for alternative therapy|3
926139|NCT00896454|1909289|FG000|Overall Study|Ongoing in study|2
926140|NCT00896454|1909289|FG000|Overall Study|Withdrawal by Subject|1
926141|NCT00896480|1909293|FG000|Overall Study|Disease progression/recurrence|21
926142|NCT00896532|1909308|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926143|NCT00896532|1909309|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926144|NCT00896532|1909310|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926145|NCT00896532|1909311|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
926146|NCT00896532|1909312|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926147|NCT00896532|1909313|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
926148|NCT00896532|1909314|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926149|NCT00896532|1909315|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926150|NCT00896532|1909316|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926151|NCT00896532|1909317|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926152|NCT00896532|1909318|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926153|NCT00896532|1909319|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926154|NCT00896532|1909320|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926155|NCT00896532|1909321|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926156|NCT00896532|1909322|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926157|NCT00896532|1909323|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926158|NCT00896532|1909324|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926159|NCT00896532|1909325|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926160|NCT00896532|1909326|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926161|NCT00896532|1909327|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926162|NCT00896532|1909328|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926163|NCT00896532|1909329|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926164|NCT00896532|1909330|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
926165|NCT00896532|1909308|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
926166|NCT00896532|1909309|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
926167|NCT00896532|1909310|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
926168|NCT00896532|1909311|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
926169|NCT00896532|1909312|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
926170|NCT00896532|1909313|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
926171|NCT00896532|1909314|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
926172|NCT00896532|1909315|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926173|NCT00896532|1909316|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926174|NCT00896532|1909317|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926175|NCT00896532|1909318|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926176|NCT00896532|1909319|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926177|NCT00896532|1909320|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926178|NCT00896532|1909321|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926179|NCT00896532|1909322|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926180|NCT00896532|1909323|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926181|NCT00896532|1909324|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926182|NCT00896532|1909325|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926183|NCT00896532|1909326|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926184|NCT00896532|1909327|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926185|NCT00896532|1909328|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926186|NCT00896532|1909329|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926187|NCT00896532|1909330|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
926188|NCT00896532|1909308|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
926189|NCT00896532|1909309|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
926190|NCT00896532|1909310|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
926191|NCT00896532|1909311|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
926192|NCT00896532|1909312|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
926193|NCT00896532|1909313|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
926194|NCT00896532|1909314|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
926195|NCT00896532|1909315|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
926196|NCT00896532|1909316|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926197|NCT00896532|1909317|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926198|NCT00896532|1909318|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926199|NCT00896532|1909319|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926200|NCT00896532|1909320|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926201|NCT00896532|1909321|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926202|NCT00896532|1909322|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926203|NCT00896532|1909323|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926204|NCT00896532|1909324|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926205|NCT00896532|1909325|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926206|NCT00896532|1909326|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926207|NCT00896532|1909327|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926208|NCT00896532|1909328|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926209|NCT00896532|1909329|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926210|NCT00896532|1909330|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
926211|NCT00896532|1909308|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926212|NCT00896532|1909309|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926213|NCT00896532|1909310|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
926214|NCT00896532|1909311|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926215|NCT00896532|1909312|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
926216|NCT00896532|1909313|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926217|NCT00896532|1909314|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926218|NCT00896532|1909315|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926219|NCT00896532|1909316|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926220|NCT00896532|1909317|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926221|NCT00896532|1909318|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926222|NCT00896532|1909319|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926223|NCT00896532|1909320|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926224|NCT00896532|1909321|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926225|NCT00896532|1909322|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926226|NCT00896532|1909323|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926227|NCT00896532|1909324|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926228|NCT00896532|1909325|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926229|NCT00896532|1909326|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926230|NCT00896532|1909327|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926231|NCT00896532|1909328|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926232|NCT00896532|1909329|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926233|NCT00896532|1909330|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
926234|NCT00896532|1909308|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1
926235|NCT00896532|1909309|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0
926236|NCT00896532|1909310|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0
926237|NCT00896532|1909311|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1
926238|NCT00896532|1909312|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0
926239|NCT00896532|1909313|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0
926240|NCT00896532|1909314|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0
926241|NCT00896532|1909315|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0
926242|NCT00896532|1909316|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0
926243|NCT00896532|1909317|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0
926244|NCT00896532|1909318|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0
926245|NCT00896532|1909319|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0
926246|NCT00896532|1909320|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0
926247|NCT00896532|1909321|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0
926248|NCT00896532|1909322|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0
926249|NCT00896532|1909323|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0
926250|NCT00896532|1909324|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0
926251|NCT00896532|1909325|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0
926252|NCT00896532|1909326|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0
926253|NCT00896532|1909327|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0
926254|NCT00896532|1909328|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0
926255|NCT00896532|1909329|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0
926256|NCT00896532|1909330|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0
926257|NCT00896532|1909308|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926258|NCT00896532|1909309|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926259|NCT00896532|1909310|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
926260|NCT00896532|1909311|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926261|NCT00896532|1909312|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926262|NCT00896532|1909313|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926263|NCT00896532|1909314|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926264|NCT00896532|1909315|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926265|NCT00896532|1909316|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926266|NCT00896532|1909317|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926267|NCT00896532|1909318|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926268|NCT00896532|1909319|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926269|NCT00896532|1909320|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926270|NCT00896532|1909321|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926271|NCT00896532|1909322|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926272|NCT00896532|1909323|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926273|NCT00896532|1909324|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926274|NCT00896532|1909325|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926275|NCT00896532|1909326|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926276|NCT00896532|1909327|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926277|NCT00896532|1909328|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926278|NCT00896532|1909329|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926279|NCT00896532|1909330|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
926280|NCT00896532|1909308|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926281|NCT00896532|1909309|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926282|NCT00896532|1909310|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
926283|NCT00896532|1909311|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926284|NCT00896532|1909312|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926285|NCT00896532|1909313|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926286|NCT00896532|1909314|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926287|NCT00896532|1909315|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926288|NCT00896532|1909316|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926289|NCT00896532|1909317|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926290|NCT00896532|1909318|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926291|NCT00896532|1909319|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926292|NCT00896532|1909320|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926293|NCT00896532|1909321|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926294|NCT00896532|1909322|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926295|NCT00896532|1909323|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926296|NCT00896532|1909324|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926297|NCT00896532|1909325|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926298|NCT00896532|1909326|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926299|NCT00896532|1909327|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926300|NCT00896532|1909328|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926301|NCT00896532|1909329|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926302|NCT00896532|1909330|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
926303|NCT00896532|1909308|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926304|NCT00896532|1909309|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926305|NCT00896532|1909310|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926306|NCT00896532|1909311|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
926307|NCT00896532|1909312|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926308|NCT00896532|1909313|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926309|NCT00896532|1909314|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926310|NCT00896532|1909315|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926311|NCT00896532|1909316|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926312|NCT00896532|1909317|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926313|NCT00896532|1909318|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926314|NCT00896532|1909319|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926315|NCT00896532|1909320|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926316|NCT00896532|1909321|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926317|NCT00896532|1909322|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926318|NCT00896532|1909323|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926319|NCT00896532|1909324|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926320|NCT00896532|1909325|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926321|NCT00896532|1909326|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926322|NCT00896532|1909327|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926323|NCT00896532|1909328|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926324|NCT00896532|1909329|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926325|NCT00896532|1909330|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
926326|NCT00896532|1909308|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0
926327|NCT00896532|1909309|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1
926328|NCT00896532|1909310|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0
926329|NCT00896532|1909311|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1
926330|NCT00896532|1909312|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1
926331|NCT00896532|1909313|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0
926332|NCT00896532|1909314|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0
926333|NCT00896532|1909315|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0
926334|NCT00896532|1909316|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0
926335|NCT00896532|1909317|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0
926336|NCT00896532|1909318|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0
926337|NCT00896532|1909319|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0
926338|NCT00896532|1909320|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0
926339|NCT00896532|1909321|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0
926340|NCT00896532|1909322|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0
926341|NCT00896532|1909323|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0
926342|NCT00896532|1909324|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0
926343|NCT00896532|1909325|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0
926344|NCT00896532|1909326|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0
926345|NCT00896532|1909327|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0
926346|NCT00896532|1909328|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0
926347|NCT00896532|1909329|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0
926348|NCT00896532|1909330|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0
926349|NCT00896532|1909308|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926350|NCT00896532|1909309|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926351|NCT00896532|1909310|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926352|NCT00896532|1909311|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926353|NCT00896532|1909312|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926354|NCT00896532|1909313|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926355|NCT00896532|1909314|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926356|NCT00896532|1909315|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926357|NCT00896532|1909316|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
926358|NCT00896532|1909317|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926359|NCT00896532|1909318|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926360|NCT00896532|1909319|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926361|NCT00896532|1909320|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926362|NCT00896532|1909321|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926363|NCT00896532|1909322|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926364|NCT00896532|1909323|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926365|NCT00896532|1909324|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926366|NCT00896532|1909325|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926367|NCT00896532|1909326|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926368|NCT00896532|1909327|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926369|NCT00896532|1909328|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926370|NCT00896532|1909329|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926371|NCT00896532|1909330|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
926372|NCT00896532|1909308|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926373|NCT00896532|1909309|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926374|NCT00896532|1909310|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926375|NCT00896532|1909311|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926376|NCT00896532|1909312|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926377|NCT00896532|1909313|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926378|NCT00896532|1909314|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926379|NCT00896532|1909315|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926380|NCT00896532|1909316|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926381|NCT00896532|1909317|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926382|NCT00896532|1909318|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926383|NCT00896532|1909319|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926384|NCT00896532|1909320|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1
926385|NCT00896532|1909321|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926386|NCT00896532|1909322|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926387|NCT00896532|1909323|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926388|NCT00896532|1909324|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926389|NCT00896532|1909325|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926390|NCT00896532|1909326|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926391|NCT00896532|1909327|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926392|NCT00896532|1909328|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926393|NCT00896532|1909329|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926394|NCT00896532|1909330|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0
926395|NCT00896532|1909308|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926396|NCT00896532|1909309|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926397|NCT00896532|1909310|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926398|NCT00896532|1909311|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926399|NCT00896532|1909312|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926400|NCT00896532|1909313|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926401|NCT00896532|1909314|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926402|NCT00896532|1909315|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926403|NCT00896532|1909316|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926404|NCT00896532|1909317|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926405|NCT00896532|1909318|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1
926406|NCT00896532|1909319|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926407|NCT00896532|1909320|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1
926408|NCT00896532|1909321|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926409|NCT00896532|1909322|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926410|NCT00896532|1909323|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926411|NCT00896532|1909324|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926412|NCT00896532|1909325|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926413|NCT00896532|1909326|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926414|NCT00896532|1909327|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926415|NCT00896532|1909328|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926416|NCT00896532|1909329|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926417|NCT00896532|1909330|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0
926418|NCT00896532|1909308|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926419|NCT00896532|1909309|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926420|NCT00896532|1909310|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926421|NCT00896532|1909311|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926422|NCT00896532|1909312|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926423|NCT00896532|1909313|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926424|NCT00896532|1909314|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926425|NCT00896532|1909315|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926426|NCT00896532|1909316|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926427|NCT00896532|1909317|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926428|NCT00896532|1909318|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926429|NCT00896532|1909319|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926430|NCT00896532|1909320|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
926431|NCT00896532|1909321|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
926432|NCT00896532|1909322|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926433|NCT00896532|1909323|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926434|NCT00896532|1909324|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926435|NCT00896532|1909325|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926436|NCT00896532|1909326|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926437|NCT00896532|1909327|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926438|NCT00896532|1909328|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926439|NCT00896532|1909329|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926440|NCT00896532|1909330|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
926441|NCT00896532|1909308|FG000|Months 24-36: Denosumab Extension Phase|Other|0
926442|NCT00896532|1909309|FG001|Months 24-36: Denosumab Extension Phase|Other|0
926443|NCT00896532|1909310|FG002|Months 24-36: Denosumab Extension Phase|Other|0
926444|NCT00896532|1909311|FG003|Months 24-36: Denosumab Extension Phase|Other|0
926445|NCT00896532|1909312|FG004|Months 24-36: Denosumab Extension Phase|Other|0
926446|NCT00896532|1909313|FG005|Months 24-36: Denosumab Extension Phase|Other|0
926447|NCT00896532|1909314|FG006|Months 24-36: Denosumab Extension Phase|Other|0
926448|NCT00896532|1909315|FG007|Months 24-36: Denosumab Extension Phase|Other|0
926449|NCT00896532|1909316|FG008|Months 24-36: Denosumab Extension Phase|Other|0
926450|NCT00896532|1909317|FG009|Months 24-36: Denosumab Extension Phase|Other|0
926451|NCT00896532|1909318|FG010|Months 24-36: Denosumab Extension Phase|Other|1
926452|NCT00896532|1909319|FG011|Months 24-36: Denosumab Extension Phase|Other|2
926453|NCT00896532|1909320|FG012|Months 24-36: Denosumab Extension Phase|Other|2
926454|NCT00896532|1909321|FG013|Months 24-36: Denosumab Extension Phase|Other|1
926455|NCT00896532|1909322|FG014|Months 24-36: Denosumab Extension Phase|Other|0
926456|NCT00896532|1909323|FG015|Months 24-36: Denosumab Extension Phase|Other|0
926457|NCT00896532|1909324|FG016|Months 24-36: Denosumab Extension Phase|Other|0
926458|NCT00896532|1909325|FG017|Months 24-36: Denosumab Extension Phase|Other|0
926459|NCT00896532|1909326|FG018|Months 24-36: Denosumab Extension Phase|Other|0
926460|NCT00896532|1909327|FG019|Months 24-36: Denosumab Extension Phase|Other|0
926461|NCT00896532|1909328|FG020|Months 24-36: Denosumab Extension Phase|Other|0
926462|NCT00896532|1909329|FG021|Months 24-36: Denosumab Extension Phase|Other|0
926463|NCT00896532|1909330|FG022|Months 24-36: Denosumab Extension Phase|Other|0
926464|NCT00896532|1909308|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926465|NCT00896532|1909309|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926466|NCT00896532|1909310|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926467|NCT00896532|1909311|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926468|NCT00896532|1909312|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926469|NCT00896532|1909313|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926470|NCT00896532|1909314|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926471|NCT00896532|1909315|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926472|NCT00896532|1909316|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926473|NCT00896532|1909317|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926474|NCT00896532|1909318|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926475|NCT00896532|1909319|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926476|NCT00896532|1909320|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926477|NCT00896532|1909321|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926478|NCT00896532|1909322|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926479|NCT00896532|1909323|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1
926480|NCT00896532|1909324|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3
926481|NCT00896532|1909325|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926482|NCT00896532|1909326|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926483|NCT00896532|1909327|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926484|NCT00896532|1909328|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926485|NCT00896532|1909329|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926486|NCT00896532|1909330|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0
926487|NCT00896532|1909308|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926488|NCT00896532|1909309|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926489|NCT00896532|1909310|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926490|NCT00896532|1909311|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926491|NCT00896532|1909312|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926492|NCT00896532|1909313|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926493|NCT00896532|1909314|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926494|NCT00896532|1909315|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926495|NCT00896532|1909316|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926496|NCT00896532|1909317|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926497|NCT00896532|1909318|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926498|NCT00896532|1909319|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926499|NCT00896532|1909320|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926500|NCT00896532|1909321|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926501|NCT00896532|1909322|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926502|NCT00896532|1909323|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
926503|NCT00896532|1909324|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
926504|NCT00896532|1909325|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
926505|NCT00896532|1909326|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926506|NCT00896532|1909327|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926507|NCT00896532|1909328|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926508|NCT00896532|1909329|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926509|NCT00896532|1909330|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
926510|NCT00896532|1909308|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926511|NCT00896532|1909309|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926512|NCT00896532|1909310|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926513|NCT00896532|1909311|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926514|NCT00896532|1909312|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926515|NCT00896532|1909313|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926516|NCT00896532|1909314|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926517|NCT00896532|1909315|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926518|NCT00896532|1909316|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926519|NCT00896532|1909317|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926520|NCT00896532|1909318|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926521|NCT00896532|1909319|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926522|NCT00896532|1909320|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926523|NCT00896532|1909321|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926524|NCT00896532|1909322|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926525|NCT00896532|1909323|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926526|NCT00896532|1909324|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
926527|NCT00896532|1909325|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926528|NCT00896532|1909326|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926529|NCT00896532|1909327|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926530|NCT00896532|1909328|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926531|NCT00896532|1909329|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926532|NCT00896532|1909330|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
926533|NCT00896532|1909308|FG000|Months 36-48: Romosozumab Retreatment|Other|0
926534|NCT00896532|1909309|FG001|Months 36-48: Romosozumab Retreatment|Other|0
926535|NCT00896532|1909310|FG002|Months 36-48: Romosozumab Retreatment|Other|0
926536|NCT00896532|1909311|FG003|Months 36-48: Romosozumab Retreatment|Other|0
926537|NCT00896532|1909312|FG004|Months 36-48: Romosozumab Retreatment|Other|0
926538|NCT00896532|1909313|FG005|Months 36-48: Romosozumab Retreatment|Other|0
926539|NCT00896532|1909314|FG006|Months 36-48: Romosozumab Retreatment|Other|0
926540|NCT00896532|1909315|FG007|Months 36-48: Romosozumab Retreatment|Other|0
926541|NCT00896532|1909316|FG008|Months 36-48: Romosozumab Retreatment|Other|0
926542|NCT00896532|1909317|FG009|Months 36-48: Romosozumab Retreatment|Other|0
926543|NCT00896532|1909318|FG010|Months 36-48: Romosozumab Retreatment|Other|0
926544|NCT00896532|1909319|FG011|Months 36-48: Romosozumab Retreatment|Other|0
926545|NCT00896532|1909320|FG012|Months 36-48: Romosozumab Retreatment|Other|0
926546|NCT00896532|1909321|FG013|Months 36-48: Romosozumab Retreatment|Other|0
926547|NCT00896532|1909322|FG014|Months 36-48: Romosozumab Retreatment|Other|0
926548|NCT00896532|1909323|FG015|Months 36-48: Romosozumab Retreatment|Other|0
926549|NCT00896532|1909324|FG016|Months 36-48: Romosozumab Retreatment|Other|0
926550|NCT00896532|1909325|FG017|Months 36-48: Romosozumab Retreatment|Other|1
926551|NCT00896532|1909326|FG018|Months 36-48: Romosozumab Retreatment|Other|0
926552|NCT00896532|1909327|FG019|Months 36-48: Romosozumab Retreatment|Other|0
926553|NCT00896532|1909328|FG020|Months 36-48: Romosozumab Retreatment|Other|0
926554|NCT00896532|1909329|FG021|Months 36-48: Romosozumab Retreatment|Other|0
926555|NCT00896532|1909330|FG022|Months 36-48: Romosozumab Retreatment|Other|0
926556|NCT00896532|1909308|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926557|NCT00896532|1909309|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926558|NCT00896532|1909310|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926559|NCT00896532|1909311|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926560|NCT00896532|1909312|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926561|NCT00896532|1909313|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926562|NCT00896532|1909314|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926563|NCT00896532|1909315|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926564|NCT00896532|1909316|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926565|NCT00896532|1909317|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926566|NCT00896532|1909318|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926567|NCT00896532|1909319|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926568|NCT00896532|1909320|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926569|NCT00896532|1909321|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926570|NCT00896532|1909322|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926571|NCT00896532|1909323|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926572|NCT00896532|1909324|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
926573|NCT00896532|1909325|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926574|NCT00896532|1909326|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926575|NCT00896532|1909327|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926576|NCT00896532|1909328|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926577|NCT00896532|1909329|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926578|NCT00896532|1909330|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
926579|NCT00896532|1909308|FG000|Months 48-72: Follow-on Phase|Death|0
926580|NCT00896532|1909309|FG001|Months 48-72: Follow-on Phase|Death|0
926581|NCT00896532|1909310|FG002|Months 48-72: Follow-on Phase|Death|0
926582|NCT00896532|1909311|FG003|Months 48-72: Follow-on Phase|Death|0
926583|NCT00896532|1909312|FG004|Months 48-72: Follow-on Phase|Death|0
926584|NCT00896532|1909313|FG005|Months 48-72: Follow-on Phase|Death|0
926585|NCT00896532|1909314|FG006|Months 48-72: Follow-on Phase|Death|0
926586|NCT00896532|1909315|FG007|Months 48-72: Follow-on Phase|Death|0
926587|NCT00896532|1909316|FG008|Months 48-72: Follow-on Phase|Death|0
926588|NCT00896532|1909317|FG009|Months 48-72: Follow-on Phase|Death|0
926589|NCT00896532|1909318|FG010|Months 48-72: Follow-on Phase|Death|0
926590|NCT00896532|1909319|FG011|Months 48-72: Follow-on Phase|Death|0
926591|NCT00896532|1909320|FG012|Months 48-72: Follow-on Phase|Death|0
926592|NCT00896532|1909321|FG013|Months 48-72: Follow-on Phase|Death|0
926593|NCT00896532|1909322|FG014|Months 48-72: Follow-on Phase|Death|0
926594|NCT00896532|1909323|FG015|Months 48-72: Follow-on Phase|Death|0
926595|NCT00896532|1909324|FG016|Months 48-72: Follow-on Phase|Death|0
926596|NCT00896532|1909325|FG017|Months 48-72: Follow-on Phase|Death|0
926597|NCT00896532|1909326|FG018|Months 48-72: Follow-on Phase|Death|1
926598|NCT00896532|1909327|FG019|Months 48-72: Follow-on Phase|Death|0
926599|NCT00896532|1909328|FG020|Months 48-72: Follow-on Phase|Death|0
926600|NCT00896532|1909329|FG021|Months 48-72: Follow-on Phase|Death|0
926601|NCT00896532|1909330|FG022|Months 48-72: Follow-on Phase|Death|0
926602|NCT00896532|1909308|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926603|NCT00896532|1909309|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926604|NCT00896532|1909310|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926605|NCT00896532|1909311|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926606|NCT00896532|1909312|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926607|NCT00896532|1909313|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926608|NCT00896532|1909314|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926609|NCT00896532|1909315|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926610|NCT00896532|1909316|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926611|NCT00896532|1909317|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926612|NCT00896532|1909318|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926613|NCT00896532|1909319|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926614|NCT00896532|1909320|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926615|NCT00896532|1909321|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926616|NCT00896532|1909322|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926617|NCT00896532|1909323|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926618|NCT00896532|1909324|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926619|NCT00896532|1909325|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926620|NCT00896532|1909326|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926621|NCT00896532|1909327|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926622|NCT00896532|1909328|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926623|NCT00896532|1909329|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1
926624|NCT00896532|1909330|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0
926625|NCT00896532|1909308|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926626|NCT00896532|1909309|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926627|NCT00896532|1909310|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926628|NCT00896532|1909311|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926629|NCT00896532|1909312|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926630|NCT00896532|1909313|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926631|NCT00896532|1909314|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926632|NCT00896532|1909315|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926633|NCT00896532|1909316|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926634|NCT00896532|1909317|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926635|NCT00896532|1909318|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926636|NCT00896532|1909319|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926637|NCT00896532|1909320|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926638|NCT00896532|1909321|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926639|NCT00896532|1909322|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926640|NCT00896532|1909323|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926641|NCT00896532|1909324|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926642|NCT00896532|1909325|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926643|NCT00896532|1909326|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926644|NCT00896532|1909327|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926645|NCT00896532|1909328|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926646|NCT00896532|1909329|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
926647|NCT00896532|1909330|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
926648|NCT00896649|1909377|FG000|Overall Study|Physician Decision|1
926649|NCT00896649|1909377|FG000|Overall Study|Pregnancy|1
926650|NCT00896649|1909377|FG000|Overall Study|missing documentation|1
926651|NCT00896649|1909377|FG000|Overall Study|technical difficulties|2
926652|NCT00897104|1909394|FG000|Overall Study|Lost to Follow-up|12
926653|NCT00897104|1909395|FG001|Overall Study|Lost to Follow-up|17
926654|NCT00897104|1909396|FG002|Overall Study|Lost to Follow-up|2
926655|NCT00897104|1909394|FG000|Overall Study|Pregnancy|0
926656|NCT00897104|1909395|FG001|Overall Study|Pregnancy|1
926657|NCT00897104|1909396|FG002|Overall Study|Pregnancy|0
926658|NCT00897104|1909394|FG000|Overall Study|Protocol Violation|0
926659|NCT00897104|1909395|FG001|Overall Study|Protocol Violation|1
926660|NCT00897104|1909396|FG002|Overall Study|Protocol Violation|0
926661|NCT00897104|1909394|FG000|Overall Study|Withdrawal by Subject|23
926662|NCT00897104|1909395|FG001|Overall Study|Withdrawal by Subject|27
926663|NCT00897104|1909396|FG002|Overall Study|Withdrawal by Subject|3
926664|NCT00897104|1909394|FG000|Overall Study|Abnormal Prestudy Labs|2
926665|NCT00897104|1909395|FG001|Overall Study|Abnormal Prestudy Labs|0
926666|NCT00897104|1909396|FG002|Overall Study|Abnormal Prestudy Labs|0
926667|NCT00897104|1909394|FG000|Overall Study|Abnormal Baseline ECG|2
926668|NCT00897104|1909395|FG001|Overall Study|Abnormal Baseline ECG|2
926669|NCT00897104|1909396|FG002|Overall Study|Abnormal Baseline ECG|0
926670|NCT00897104|1909394|FG000|Overall Study|Need for Concom. Med.|0
926671|NCT00897104|1909395|FG001|Overall Study|Need for Concom. Med.|1
926672|NCT00897104|1909396|FG002|Overall Study|Need for Concom. Med.|1
926673|NCT00897104|1909394|FG000|Overall Study|Lack of Migraine Attack|20
926674|NCT00897104|1909395|FG001|Overall Study|Lack of Migraine Attack|22
926675|NCT00897104|1909396|FG002|Overall Study|Lack of Migraine Attack|1
926676|NCT00897104|1909394|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
926677|NCT00897104|1909395|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
926678|NCT00897104|1909396|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
926679|NCT00897104|1909394|FG000|Overall Study|Other|3
926680|NCT00897104|1909395|FG001|Overall Study|Other|0
926681|NCT00897104|1909396|FG002|Overall Study|Other|0
926682|NCT00897104|1909394|FG000|Overall Study|Protocol Violation|1
926683|NCT00897104|1909395|FG001|Overall Study|Protocol Violation|0
926684|NCT00897104|1909396|FG002|Overall Study|Protocol Violation|0
926685|NCT00897104|1909394|FG000|Overall Study|Withdrawal by Subject|0
926686|NCT00897104|1909395|FG001|Overall Study|Withdrawal by Subject|0
926687|NCT00897104|1909396|FG002|Overall Study|Withdrawal by Subject|1
926688|NCT00897390|1909404|FG000|Overall Study|Adverse Event|2
926689|NCT00897390|1909404|FG000|Overall Study|No Longer Met Study Criteria|1
926690|NCT00897390|1909404|FG000|Overall Study|Personal Reasons|1
926691|NCT00897390|1909404|FG000|Overall Study|Did not Return for the Clinic Visit|2
926692|NCT00897715|1909431|FG000|Overall Study|Lost to Follow-up|0
926693|NCT00897715|1909432|FG001|Overall Study|Lost to Follow-up|1
926694|NCT00897715|1909431|FG000|Overall Study|Physician Decision|1
926695|NCT00897715|1909432|FG001|Overall Study|Physician Decision|0
926696|NCT00897715|1909431|FG000|Overall Study|increased risk of infection|1
926697|NCT00897715|1909432|FG001|Overall Study|increased risk of infection|0
926698|NCT00897949|1909445|FG000|Overall Study|Adverse Event|1
926699|NCT00897949|1909446|FG001|Overall Study|Adverse Event|1
926700|NCT00897949|1909447|FG002|Overall Study|Adverse Event|0
926701|NCT00897949|1909445|FG000|Overall Study|Lost to Follow-up|0
926702|NCT00897949|1909446|FG001|Overall Study|Lost to Follow-up|2
926703|NCT00897949|1909447|FG002|Overall Study|Lost to Follow-up|1
926704|NCT00897949|1909445|FG000|Overall Study|Protocol Violation|6
926705|NCT00897949|1909446|FG001|Overall Study|Protocol Violation|3
926706|NCT00897949|1909447|FG002|Overall Study|Protocol Violation|1
926707|NCT00897949|1909445|FG000|Overall Study|Withdrawal by Subject|1
926708|NCT00897949|1909446|FG001|Overall Study|Withdrawal by Subject|2
926709|NCT00897949|1909447|FG002|Overall Study|Withdrawal by Subject|0
926710|NCT00897949|1909445|FG000|Overall Study|Patient Uncoorperative|0
926711|NCT00897949|1909446|FG001|Overall Study|Patient Uncoorperative|2
926712|NCT00897949|1909447|FG002|Overall Study|Patient Uncoorperative|1
926713|NCT00897949|1909445|FG000|Overall Study|Lost to Follow-up|30
926714|NCT00897949|1909446|FG001|Overall Study|Lost to Follow-up|23
926715|NCT00897949|1909447|FG002|Overall Study|Lost to Follow-up|17
926716|NCT00897949|1909445|FG000|Overall Study|Withdrawal by Subject|24
926717|NCT00897949|1909446|FG001|Overall Study|Withdrawal by Subject|31
926718|NCT00897949|1909447|FG002|Overall Study|Withdrawal by Subject|17
926719|NCT00897949|1909445|FG000|Overall Study|Abnormal Prestudy Labs|2
926720|NCT00897949|1909446|FG001|Overall Study|Abnormal Prestudy Labs|3
926721|NCT00897949|1909447|FG002|Overall Study|Abnormal Prestudy Labs|4
926722|NCT00897949|1909445|FG000|Overall Study|Abnormal Baseline ECG|2
926723|NCT00897949|1909446|FG001|Overall Study|Abnormal Baseline ECG|2
926724|NCT00897949|1909447|FG002|Overall Study|Abnormal Baseline ECG|4
926725|NCT00897949|1909445|FG000|Overall Study|Need for Concom. Med.|0
926726|NCT00897949|1909446|FG001|Overall Study|Need for Concom. Med.|1
926727|NCT00897949|1909447|FG002|Overall Study|Need for Concom. Med.|1
926728|NCT00897949|1909445|FG000|Overall Study|Lack of Migraine Attack|29
926729|NCT00897949|1909446|FG001|Overall Study|Lack of Migraine Attack|30
926730|NCT00897949|1909447|FG002|Overall Study|Lack of Migraine Attack|19
926731|NCT00897949|1909445|FG000|Overall Study|Did not take study drug|9
926732|NCT00897949|1909446|FG001|Overall Study|Did not take study drug|3
926733|NCT00897949|1909447|FG002|Overall Study|Did not take study drug|4
926734|NCT00898443|1909467|FG000|Overall Study|Withdrawal by Subject|1
926735|NCT00898443|1909468|FG001|Overall Study|Withdrawal by Subject|0
926736|NCT00898677|1909484|FG000|Overall Study|Adverse Event|0
926737|NCT00898677|1909485|FG001|Overall Study|Adverse Event|0
926738|NCT00898677|1909486|FG002|Overall Study|Adverse Event|1
926739|NCT00898677|1909487|FG003|Overall Study|Adverse Event|0
926740|NCT00898677|1909484|FG000|Overall Study|Lost to Follow-up|0
926741|NCT00898677|1909485|FG001|Overall Study|Lost to Follow-up|0
926742|NCT00898677|1909486|FG002|Overall Study|Lost to Follow-up|2
926743|NCT00898677|1909487|FG003|Overall Study|Lost to Follow-up|0
926744|NCT00898677|1909484|FG000|Overall Study|Protocol Violation|1
926745|NCT00898677|1909485|FG001|Overall Study|Protocol Violation|1
926746|NCT00898677|1909486|FG002|Overall Study|Protocol Violation|2
926747|NCT00898677|1909487|FG003|Overall Study|Protocol Violation|0
926748|NCT00898677|1909484|FG000|Overall Study|Withdrawal by Subject|0
926749|NCT00898677|1909485|FG001|Overall Study|Withdrawal by Subject|0
926750|NCT00898677|1909486|FG002|Overall Study|Withdrawal by Subject|0
926751|NCT00898677|1909487|FG003|Overall Study|Withdrawal by Subject|1
926752|NCT00898677|1909484|FG000|Overall Study|Not Treated: Adverse Event|0
926753|NCT00898677|1909485|FG001|Overall Study|Not Treated: Adverse Event|2
926754|NCT00898677|1909486|FG002|Overall Study|Not Treated: Adverse Event|1
926755|NCT00898677|1909487|FG003|Overall Study|Not Treated: Adverse Event|0
926756|NCT00898677|1909484|FG000|Overall Study|Not Treated: Lost to Follow-Up|0
926757|NCT00898677|1909485|FG001|Overall Study|Not Treated: Lost to Follow-Up|5
926758|NCT00898677|1909486|FG002|Overall Study|Not Treated: Lost to Follow-Up|5
926759|NCT00898677|1909487|FG003|Overall Study|Not Treated: Lost to Follow-Up|2
926760|NCT00898677|1909484|FG000|Overall Study|Not Treated: Pregnancy|0
926761|NCT00898677|1909485|FG001|Overall Study|Not Treated: Pregnancy|0
926762|NCT00898677|1909486|FG002|Overall Study|Not Treated: Pregnancy|1
926763|NCT00898677|1909487|FG003|Overall Study|Not Treated: Pregnancy|0
926764|NCT00898677|1909484|FG000|Overall Study|Not Treated: Protocol Violation|2
926765|NCT00898677|1909485|FG001|Overall Study|Not Treated: Protocol Violation|0
926766|NCT00898677|1909486|FG002|Overall Study|Not Treated: Protocol Violation|2
926767|NCT00898677|1909487|FG003|Overall Study|Not Treated: Protocol Violation|0
926768|NCT00898677|1909484|FG000|Overall Study|Not Treated: Withdraw by Subject|2
926769|NCT00898677|1909485|FG001|Overall Study|Not Treated: Withdraw by Subject|16
926770|NCT00898677|1909486|FG002|Overall Study|Not Treated: Withdraw by Subject|11
926771|NCT00898677|1909487|FG003|Overall Study|Not Treated: Withdraw by Subject|3
926772|NCT00898677|1909484|FG000|Overall Study|Not Treated: Patient uncooperative|2
926773|NCT00898677|1909485|FG001|Overall Study|Not Treated: Patient uncooperative|3
926774|NCT00898677|1909486|FG002|Overall Study|Not Treated: Patient uncooperative|1
926775|NCT00898677|1909487|FG003|Overall Study|Not Treated: Patient uncooperative|0
926776|NCT00898677|1909484|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0
926777|NCT00898677|1909485|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0
926778|NCT00898677|1909486|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0
926779|NCT00898677|1909487|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1
926780|NCT00898677|1909484|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1
926781|NCT00898677|1909485|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0
926782|NCT00898677|1909486|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0
926783|NCT00898677|1909487|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0
926784|NCT00898677|1909484|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0
926785|NCT00898677|1909485|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3
926786|NCT00898677|1909486|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1
926787|NCT00898677|1909487|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0
926788|NCT00898677|1909484|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9
926789|NCT00898677|1909485|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39
926790|NCT00898677|1909486|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43
926791|NCT00898677|1909487|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12
926792|NCT00898677|1909484|FG000|Overall Study|Not Treated: Other (Not Specified)|0
926793|NCT00898677|1909485|FG001|Overall Study|Not Treated: Other (Not Specified)|0
926794|NCT00898677|1909486|FG002|Overall Study|Not Treated: Other (Not Specified)|2
926795|NCT00898677|1909487|FG003|Overall Study|Not Treated: Other (Not Specified)|0
926796|NCT00898807|1909499|FG000|Overall Study|Withdrawal by Subject|5
926797|NCT00898807|1909500|FG001|Overall Study|Withdrawal by Subject|3
926798|NCT00898807|1909499|FG000|Overall Study|Family pressure to discontinue|2
926799|NCT00898807|1909500|FG001|Overall Study|Family pressure to discontinue|2
926800|NCT00898807|1909499|FG000|Overall Study|Lost to Follow-up|1
926801|NCT00898807|1909500|FG001|Overall Study|Lost to Follow-up|3
926802|NCT00898807|1909499|FG000|Overall Study|Death|0
926803|NCT00898807|1909500|FG001|Overall Study|Death|1
926804|NCT00899353|1909519|FG000|Overall Study|Adverse Event|2
926805|NCT00899353|1909519|FG000|Overall Study|Lost to Follow-up|1
926806|NCT00899353|1909519|FG000|Overall Study|Withdrawal by Subject|2
926807|NCT00899379|1909545|FG000|Overall Study|Adverse Event|2
926808|NCT00899379|1909546|FG001|Overall Study|Adverse Event|2
926809|NCT00899379|1909547|FG002|Overall Study|Adverse Event|1
926810|NCT00899379|1909548|FG003|Overall Study|Adverse Event|1
926811|NCT00899379|1909549|FG004|Overall Study|Adverse Event|2
926812|NCT00899379|1909545|FG000|Overall Study|Lack of Efficacy|0
926813|NCT00899379|1909546|FG001|Overall Study|Lack of Efficacy|4
926814|NCT00899379|1909547|FG002|Overall Study|Lack of Efficacy|3
926815|NCT00899379|1909548|FG003|Overall Study|Lack of Efficacy|0
926816|NCT00899379|1909549|FG004|Overall Study|Lack of Efficacy|1
926817|NCT00899379|1909545|FG000|Overall Study|Lost to Follow-up|9
926818|NCT00899379|1909546|FG001|Overall Study|Lost to Follow-up|3
926819|NCT00899379|1909547|FG002|Overall Study|Lost to Follow-up|0
926820|NCT00899379|1909548|FG003|Overall Study|Lost to Follow-up|6
926821|NCT00899379|1909549|FG004|Overall Study|Lost to Follow-up|2
926822|NCT00899379|1909545|FG000|Overall Study|Protocol Violation|0
926823|NCT00899379|1909546|FG001|Overall Study|Protocol Violation|0
926824|NCT00899379|1909547|FG002|Overall Study|Protocol Violation|1
926825|NCT00899379|1909548|FG003|Overall Study|Protocol Violation|1
926826|NCT00899379|1909549|FG004|Overall Study|Protocol Violation|0
926827|NCT00899379|1909545|FG000|Overall Study|Withdrawal by Subject|2
926828|NCT00899379|1909546|FG001|Overall Study|Withdrawal by Subject|4
926829|NCT00899379|1909547|FG002|Overall Study|Withdrawal by Subject|2
926830|NCT00899379|1909548|FG003|Overall Study|Withdrawal by Subject|3
926831|NCT00899379|1909549|FG004|Overall Study|Withdrawal by Subject|6
926832|NCT00899379|1909545|FG000|Overall Study|Pregnancy|0
926833|NCT00899379|1909546|FG001|Overall Study|Pregnancy|0
926834|NCT00899379|1909547|FG002|Overall Study|Pregnancy|1
926835|NCT00899379|1909548|FG003|Overall Study|Pregnancy|0
926836|NCT00899379|1909549|FG004|Overall Study|Pregnancy|1
926837|NCT00899379|1909545|FG000|Overall Study|Patient Uncooperative|0
926838|NCT00899379|1909546|FG001|Overall Study|Patient Uncooperative|1
926839|NCT00899379|1909547|FG002|Overall Study|Patient Uncooperative|0
926840|NCT00899379|1909548|FG003|Overall Study|Patient Uncooperative|1
926841|NCT00899379|1909549|FG004|Overall Study|Patient Uncooperative|2
926842|NCT00899379|1909545|FG000|Overall Study|Abnormal Baseline ECG|0
926843|NCT00899379|1909546|FG001|Overall Study|Abnormal Baseline ECG|0
926844|NCT00899379|1909547|FG002|Overall Study|Abnormal Baseline ECG|0
926845|NCT00899379|1909548|FG003|Overall Study|Abnormal Baseline ECG|1
926846|NCT00899379|1909549|FG004|Overall Study|Abnormal Baseline ECG|0
926847|NCT00899379|1909545|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
926848|NCT00899379|1909546|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1
926849|NCT00899379|1909547|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1
926850|NCT00899379|1909548|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
926851|NCT00899379|1909549|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
926852|NCT00899379|1909545|FG000|Overall Study|Not Completed/Entered Extn|5
926853|NCT00899379|1909546|FG001|Overall Study|Not Completed/Entered Extn|1
926854|NCT00899379|1909547|FG002|Overall Study|Not Completed/Entered Extn|6
926855|NCT00899379|1909548|FG003|Overall Study|Not Completed/Entered Extn|4
926856|NCT00899379|1909549|FG004|Overall Study|Not Completed/Entered Extn|3
926857|NCT00899379|1909545|FG000|Overall Study|Study Terminated|3
926858|NCT00899379|1909546|FG001|Overall Study|Study Terminated|0
926859|NCT00899379|1909547|FG002|Overall Study|Study Terminated|3
926860|NCT00899379|1909548|FG003|Overall Study|Study Terminated|3
926861|NCT00899379|1909549|FG004|Overall Study|Study Terminated|1
926862|NCT00899379|1909545|FG000|Overall Study|Lost to Follow-up|3
926863|NCT00899379|1909546|FG001|Overall Study|Lost to Follow-up|1
926864|NCT00899379|1909547|FG002|Overall Study|Lost to Follow-up|0
926865|NCT00899379|1909548|FG003|Overall Study|Lost to Follow-up|2
926866|NCT00899379|1909549|FG004|Overall Study|Lost to Follow-up|5
926867|NCT00899379|1909545|FG000|Overall Study|Withdrawal by Subject|4
926868|NCT00899379|1909546|FG001|Overall Study|Withdrawal by Subject|7
926869|NCT00899379|1909547|FG002|Overall Study|Withdrawal by Subject|4
926870|NCT00899379|1909548|FG003|Overall Study|Withdrawal by Subject|7
926871|NCT00899379|1909549|FG004|Overall Study|Withdrawal by Subject|2
926872|NCT00899379|1909545|FG000|Overall Study|Pregnancy|1
926873|NCT00899379|1909546|FG001|Overall Study|Pregnancy|0
926874|NCT00899379|1909547|FG002|Overall Study|Pregnancy|0
926875|NCT00899379|1909548|FG003|Overall Study|Pregnancy|0
926876|NCT00899379|1909549|FG004|Overall Study|Pregnancy|0
926877|NCT00899379|1909545|FG000|Overall Study|Patient Uncooperative|0
926878|NCT00899379|1909546|FG001|Overall Study|Patient Uncooperative|0
926879|NCT00899379|1909547|FG002|Overall Study|Patient Uncooperative|0
926880|NCT00899379|1909548|FG003|Overall Study|Patient Uncooperative|1
926881|NCT00899379|1909549|FG004|Overall Study|Patient Uncooperative|0
926882|NCT00899379|1909545|FG000|Overall Study|Abnormal Prestudy Labs|0
926883|NCT00899379|1909546|FG001|Overall Study|Abnormal Prestudy Labs|0
926884|NCT00899379|1909547|FG002|Overall Study|Abnormal Prestudy Labs|0
926885|NCT00899379|1909548|FG003|Overall Study|Abnormal Prestudy Labs|0
926886|NCT00899379|1909549|FG004|Overall Study|Abnormal Prestudy Labs|2
926887|NCT00899379|1909545|FG000|Overall Study|Abnormal Baseline ECG|0
926888|NCT00899379|1909546|FG001|Overall Study|Abnormal Baseline ECG|0
926889|NCT00899379|1909547|FG002|Overall Study|Abnormal Baseline ECG|1
926890|NCT00899379|1909548|FG003|Overall Study|Abnormal Baseline ECG|1
926891|NCT00899379|1909549|FG004|Overall Study|Abnormal Baseline ECG|0
926892|NCT00899379|1909545|FG000|Overall Study|No Attack Pretreatment|3
926893|NCT00899379|1909546|FG001|Overall Study|No Attack Pretreatment|5
926894|NCT00899379|1909547|FG002|Overall Study|No Attack Pretreatment|5
926895|NCT00899379|1909548|FG003|Overall Study|No Attack Pretreatment|6
926896|NCT00899379|1909549|FG004|Overall Study|No Attack Pretreatment|4
926897|NCT00899379|1909545|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
926898|NCT00899379|1909546|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
926899|NCT00899379|1909547|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
926900|NCT00899379|1909548|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
926901|NCT00899379|1909549|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
926902|NCT00899379|1909545|FG000|Overall Study|Inc/Exc Criteria Not Met|0
926903|NCT00899379|1909546|FG001|Overall Study|Inc/Exc Criteria Not Met|0
926904|NCT00899379|1909547|FG002|Overall Study|Inc/Exc Criteria Not Met|1
926905|NCT00899379|1909548|FG003|Overall Study|Inc/Exc Criteria Not Met|0
926906|NCT00899379|1909549|FG004|Overall Study|Inc/Exc Criteria Not Met|0
926907|NCT00899392|1909557|FG000|Overall Study|Subject didn't finish/partial pilot data|21
926908|NCT00899392|1909558|FG001|Overall Study|Subject didn't finish/partial pilot data|24
926909|NCT00899431|1909567|FG000|Overall Study|Physician Decision|1
926910|NCT00899431|1909568|FG001|Overall Study|Physician Decision|0
926911|NCT00899431|1909569|FG002|Overall Study|Physician Decision|0
926912|NCT00899548|1909598|FG000|Overall Study|Physician Decision|3
926913|NCT00899678|1909622|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6
926914|NCT00899678|1909623|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0
926915|NCT00899678|1909624|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0
926916|NCT00899678|1909622|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
926917|NCT00899678|1909623|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
926918|NCT00899678|1909624|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
926919|NCT00899678|1909622|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1
926920|NCT00899678|1909623|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0
926921|NCT00899678|1909624|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0
926922|NCT00899678|1909622|FG000|Induction Period (Weeks 0 to 6)|Other reason|1
926923|NCT00899678|1909623|FG001|Induction Period (Weeks 0 to 6)|Other reason|0
926924|NCT00899678|1909624|FG002|Induction Period (Weeks 0 to 6)|Other reason|0
926925|NCT00899678|1909622|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
926926|NCT00899678|1909623|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
926927|NCT00899678|1909624|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
926928|NCT00899678|1909622|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
926929|NCT00899678|1909623|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
926930|NCT00899678|1909624|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
926931|NCT00899678|1909622|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
926932|NCT00899678|1909623|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
926933|NCT00899678|1909624|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
926934|NCT00899678|1909622|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
926935|NCT00899678|1909623|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
926936|NCT00899678|1909624|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
926937|NCT00899678|1909622|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0
926938|NCT00899678|1909623|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2
926939|NCT00899678|1909624|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2
926940|NCT00899847|1909647|FG000|Overall Study|Lack of suitable allogeneic donor|2
926941|NCT00900029|1909658|FG000|Overall Study|Lost to Follow-up|0
926942|NCT00900029|1909659|FG001|Overall Study|Lost to Follow-up|2
926943|NCT00900029|1909660|FG002|Overall Study|Lost to Follow-up|1
926944|NCT00900029|1909661|FG003|Overall Study|Lost to Follow-up|4
926945|NCT00900029|1909662|FG004|Overall Study|Lost to Follow-up|4
926946|NCT00900029|1909658|FG000|Overall Study|Withdrawal by Subject|2
926947|NCT00900029|1909659|FG001|Overall Study|Withdrawal by Subject|2
926948|NCT00900029|1909660|FG002|Overall Study|Withdrawal by Subject|1
926949|NCT00900029|1909661|FG003|Overall Study|Withdrawal by Subject|1
926950|NCT00900029|1909662|FG004|Overall Study|Withdrawal by Subject|1
926951|NCT00900029|1909658|FG000|Overall Study|Adverse Event|0
926952|NCT00900029|1909659|FG001|Overall Study|Adverse Event|0
926953|NCT00900029|1909660|FG002|Overall Study|Adverse Event|1
926954|NCT00900029|1909661|FG003|Overall Study|Adverse Event|1
926955|NCT00900029|1909662|FG004|Overall Study|Adverse Event|1
926956|NCT00900029|1909658|FG000|Overall Study|Death|1
926957|NCT00900029|1909659|FG001|Overall Study|Death|0
926958|NCT00900029|1909660|FG002|Overall Study|Death|0
926959|NCT00900029|1909661|FG003|Overall Study|Death|1
926960|NCT00900029|1909662|FG004|Overall Study|Death|0
926961|NCT00900146|1909679|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
926962|NCT00900146|1909680|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
926963|NCT00900146|1909681|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
926964|NCT00900146|1909682|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
926965|NCT00900146|1909683|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
926966|NCT00900146|1909679|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
926967|NCT00900146|1909680|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
926968|NCT00900146|1909681|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
926969|NCT00900146|1909682|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
926970|NCT00900146|1909683|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
926971|NCT00900146|1909679|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1
926972|NCT00900146|1909680|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0
926973|NCT00900146|1909681|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0
926974|NCT00900146|1909682|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0
926975|NCT00900146|1909683|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0
926976|NCT00900146|1909679|FG000|Intermediate: Period III|Withdrawal by Subject|0
926977|NCT00900146|1909680|FG001|Intermediate: Period III|Withdrawal by Subject|1
926978|NCT00900146|1909681|FG002|Intermediate: Period III|Withdrawal by Subject|0
926979|NCT00900146|1909682|FG003|Intermediate: Period III|Withdrawal by Subject|0
926980|NCT00900146|1909683|FG004|Intermediate: Period III|Withdrawal by Subject|3
926981|NCT00900146|1909679|FG000|Intermediate: Period III|Lost to Follow-up|2
926982|NCT00900146|1909680|FG001|Intermediate: Period III|Lost to Follow-up|0
926983|NCT00900146|1909681|FG002|Intermediate: Period III|Lost to Follow-up|0
926984|NCT00900146|1909682|FG003|Intermediate: Period III|Lost to Follow-up|0
926985|NCT00900146|1909683|FG004|Intermediate: Period III|Lost to Follow-up|1
926986|NCT00900146|1909679|FG000|Intermediate: Period III|Administrative problems|85
926987|NCT00900146|1909680|FG001|Intermediate: Period III|Administrative problems|92
926988|NCT00900146|1909681|FG002|Intermediate: Period III|Administrative problems|84
926989|NCT00900146|1909682|FG003|Intermediate: Period III|Administrative problems|90
926990|NCT00900146|1909683|FG004|Intermediate: Period III|Administrative problems|163
926991|NCT00900159|1909697|FG000|Second Intervention|disempanelled for inappropriate behavior|1
926992|NCT00900159|1909698|FG001|Second Intervention|disempanelled for inappropriate behavior|0
926993|NCT00900562|1909715|FG000|Overall Study|Progressive disease|9
926994|NCT00900562|1909716|FG001|Overall Study|Progressive disease|5
926995|NCT00900562|1909715|FG000|Overall Study|Toxicity|1
926996|NCT00900562|1909716|FG001|Overall Study|Toxicity|0
926997|NCT00900562|1909715|FG000|Overall Study|Death|1
926998|NCT00900562|1909716|FG001|Overall Study|Death|1
926999|NCT00900562|1909715|FG000|Overall Study|Withdrawal by Subject|0
927000|NCT00900562|1909716|FG001|Overall Study|Withdrawal by Subject|1
927001|NCT00900562|1909715|FG000|Overall Study|Unrelated adverse event|1
927002|NCT00900562|1909716|FG001|Overall Study|Unrelated adverse event|0
927003|NCT00900601|1909723|FG000|Overall Study|Physician Decision|1
927004|NCT00900627|1909733|FG000|Overall Study|Condition under investigation worsened|4
927005|NCT00900627|1909734|FG001|Overall Study|Condition under investigation worsened|0
927006|NCT00900627|1909735|FG002|Overall Study|Condition under investigation worsened|5
927007|NCT00900627|1909736|FG003|Overall Study|Condition under investigation worsened|3
927008|NCT00900627|1909737|FG004|Overall Study|Condition under investigation worsened|0
927009|NCT00900627|1909738|FG005|Overall Study|Condition under investigation worsened|0
927010|NCT00900627|1909733|FG000|Overall Study|Withdrawal by Subject|1
927011|NCT00900627|1909734|FG001|Overall Study|Withdrawal by Subject|0
927012|NCT00900627|1909735|FG002|Overall Study|Withdrawal by Subject|1
927013|NCT00900627|1909736|FG003|Overall Study|Withdrawal by Subject|0
927014|NCT00900627|1909737|FG004|Overall Study|Withdrawal by Subject|1
927015|NCT00900627|1909738|FG005|Overall Study|Withdrawal by Subject|2
927016|NCT00900627|1909733|FG000|Overall Study|Adverse Event|1
927017|NCT00900627|1909734|FG001|Overall Study|Adverse Event|2
927018|NCT00900627|1909735|FG002|Overall Study|Adverse Event|0
927019|NCT00900627|1909736|FG003|Overall Study|Adverse Event|3
927020|NCT00900627|1909737|FG004|Overall Study|Adverse Event|0
927021|NCT00900627|1909738|FG005|Overall Study|Adverse Event|0
927022|NCT00900627|1909733|FG000|Overall Study|Death|0
927023|NCT00900627|1909734|FG001|Overall Study|Death|0
927024|NCT00900627|1909735|FG002|Overall Study|Death|0
927025|NCT00900627|1909736|FG003|Overall Study|Death|0
927026|NCT00900627|1909737|FG004|Overall Study|Death|28
927027|NCT00900627|1909738|FG005|Overall Study|Death|24
927028|NCT00900731|1909763|FG000|Overall Study|Adverse Event|31
927029|NCT00900731|1909764|FG001|Overall Study|Adverse Event|27
927030|NCT00900731|1909763|FG000|Overall Study|Withdrawal by Subject|8
927031|NCT00900731|1909764|FG001|Overall Study|Withdrawal by Subject|7
927032|NCT00900731|1909763|FG000|Overall Study|Protocol Deviation|8
927033|NCT00900731|1909764|FG001|Overall Study|Protocol Deviation|11
927034|NCT00900731|1909763|FG000|Overall Study|Administrative Problems|5
927035|NCT00900731|1909764|FG001|Overall Study|Administrative Problems|4
927036|NCT00900731|1909763|FG000|Overall Study|Abnormal Test Procedure Result(s)|3
927037|NCT00900731|1909764|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
927038|NCT00900731|1909763|FG000|Overall Study|Abnormal Laboratory Value(s)|2
927039|NCT00900731|1909764|FG001|Overall Study|Abnormal Laboratory Value(s)|4
927040|NCT00900731|1909763|FG000|Overall Study|Lost to Follow-up|2
927041|NCT00900731|1909764|FG001|Overall Study|Lost to Follow-up|3
927042|NCT00900731|1909763|FG000|Overall Study|Lack of Efficacy|1
927043|NCT00900731|1909764|FG001|Overall Study|Lack of Efficacy|3
927044|NCT00900731|1909763|FG000|Overall Study|Death|0
927045|NCT00900731|1909764|FG001|Overall Study|Death|2
927046|NCT00900757|1909770|FG000|Overall Study|screen failure|19
927047|NCT00900796|1909774|FG000|Phase 1|Lacked sufficient information|4
927048|NCT00900796|1909774|FG000|Phase 1|Missing information at Week 16|7
927049|NCT00900796|1909774|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
927050|NCT00900796|1909774|FG000|Phase 2|Lost to Follow-up|5
927051|NCT00901186|1909795|FG000|Overall Study|Lack of Efficacy|0
927052|NCT00901186|1909796|FG001|Overall Study|Lack of Efficacy|1
927053|NCT00901186|1909795|FG000|Overall Study|Abnormal laboratory values|0
927054|NCT00901186|1909796|FG001|Overall Study|Abnormal laboratory values|1
927055|NCT00901186|1909795|FG000|Overall Study|Lost to Follow-up|2
927056|NCT00901186|1909796|FG001|Overall Study|Lost to Follow-up|0
927057|NCT00901186|1909795|FG000|Overall Study|Adverse Event|2
927058|NCT00901186|1909796|FG001|Overall Study|Adverse Event|4
927059|NCT00901186|1909795|FG000|Overall Study|Administration problems|0
927060|NCT00901186|1909796|FG001|Overall Study|Administration problems|1
927061|NCT00901186|1909795|FG000|Overall Study|Protocol deviations|5
927062|NCT00901186|1909796|FG001|Overall Study|Protocol deviations|4
927063|NCT00901342|1909819|FG000|Overall Study|Adverse Event|1
927064|NCT00901342|1909819|FG000|Overall Study|Death|4
927065|NCT00901342|1909819|FG000|Overall Study|Disease progression|1
927066|NCT00901342|1909819|FG000|Overall Study|Withdrawal by Subject|9
927067|NCT00901394|1909826|FG000|Overall Study|Physician Decision|1
927068|NCT00901394|1909827|FG001|Overall Study|Physician Decision|1
927069|NCT00901394|1909828|FG002|Overall Study|Physician Decision|2
927070|NCT00901459|1909836|FG000|Overall Study|Withdrawal by Subject|6
927071|NCT00901485|1909847|FG000|Overall Study|Lack of Efficacy|0
927072|NCT00901485|1909848|FG001|Overall Study|Lack of Efficacy|2
927073|NCT00901485|1909847|FG000|Overall Study|Withdrawal by Subject|1
927074|NCT00901485|1909848|FG001|Overall Study|Withdrawal by Subject|2
927075|NCT00901576|1909860|FG000|Second Intervention|Withdrawal by Subject|0
927076|NCT00901576|1909861|FG001|Second Intervention|Withdrawal by Subject|0
927077|NCT00901576|1909862|FG002|Second Intervention|Withdrawal by Subject|0
927078|NCT00901576|1909863|FG003|Second Intervention|Withdrawal by Subject|1
927079|NCT00901576|1909864|FG004|Second Intervention|Withdrawal by Subject|0
927080|NCT00901576|1909865|FG005|Second Intervention|Withdrawal by Subject|1
927081|NCT00901576|1909860|FG000|Second Intervention|Physician Decision|1
927082|NCT00901576|1909861|FG001|Second Intervention|Physician Decision|0
927083|NCT00901576|1909862|FG002|Second Intervention|Physician Decision|0
927084|NCT00901576|1909863|FG003|Second Intervention|Physician Decision|0
927085|NCT00901576|1909864|FG004|Second Intervention|Physician Decision|0
927086|NCT00901576|1909865|FG005|Second Intervention|Physician Decision|0
927087|NCT00901628|1909875|FG000|Overall Study|disconnection of catheter|4
927088|NCT00901628|1909876|FG001|Overall Study|disconnection of catheter|8
927089|NCT00901628|1909875|FG000|Overall Study|disconnection of drain|0
927090|NCT00901628|1909876|FG001|Overall Study|disconnection of drain|1
927091|NCT00901628|1909875|FG000|Overall Study|peroneal nerve palsy|0
927092|NCT00901628|1909876|FG001|Overall Study|peroneal nerve palsy|1
927093|NCT00901901|1909884|FG000|Treatment Period|Adverse Event|120
927094|NCT00901901|1909885|FG001|Treatment Period|Adverse Event|128
927095|NCT00901901|1909884|FG000|Treatment Period|Withdrawal by Subject|26
927096|NCT00901901|1909885|FG001|Treatment Period|Withdrawal by Subject|24
927097|NCT00901901|1909884|FG000|Treatment Period|Physician Decision|2
927098|NCT00901901|1909885|FG001|Treatment Period|Physician Decision|2
927099|NCT00901901|1909884|FG000|Treatment Period|Lost to Follow-up|3
927100|NCT00901901|1909885|FG001|Treatment Period|Lost to Follow-up|5
927101|NCT00901901|1909884|FG000|Treatment Period|Noncompliance with study medication|4
927102|NCT00901901|1909885|FG001|Treatment Period|Noncompliance with study medication|1
927103|NCT00901901|1909884|FG000|Treatment Period|Missing|1
927104|NCT00901901|1909885|FG001|Treatment Period|Missing|0
927105|NCT00901901|1909884|FG000|Treatment Period|Never treated|0
927106|NCT00901901|1909885|FG001|Treatment Period|Never treated|3
927107|NCT00901901|1909884|FG000|Treatment Period|Protocol driven decision point|0
927108|NCT00901901|1909885|FG001|Treatment Period|Protocol driven decision point|2
927109|NCT00901901|1909884|FG000|Treatment Period|Study terminated by sponsor|2
927110|NCT00901901|1909885|FG001|Treatment Period|Study terminated by sponsor|0
927111|NCT00901901|1909884|FG000|Treatment Period|Protocol Violation|5
927112|NCT00901901|1909885|FG001|Treatment Period|Protocol Violation|9
927113|NCT00901901|1909884|FG000|Treatment Period|Switch to commercial drug|1
927114|NCT00901901|1909885|FG001|Treatment Period|Switch to commercial drug|1
927115|NCT00901901|1909884|FG000|Treatment Period|Transfer to treatment continuation study|5
927116|NCT00901901|1909885|FG001|Treatment Period|Transfer to treatment continuation study|2
927117|NCT00901901|1909884|FG000|Follow-up Period|Death|181
927118|NCT00901901|1909885|FG001|Follow-up Period|Death|208
927119|NCT00901901|1909884|FG000|Follow-up Period|Protocol driven decision point|47
927120|NCT00901901|1909885|FG001|Follow-up Period|Protocol driven decision point|36
927121|NCT00901901|1909884|FG000|Follow-up Period|Withdrawal by Subject|6
927122|NCT00901901|1909885|FG001|Follow-up Period|Withdrawal by Subject|9
927123|NCT00901901|1909884|FG000|Follow-up Period|Lost to Follow-up|12
927124|NCT00901901|1909885|FG001|Follow-up Period|Lost to Follow-up|8
927125|NCT00901901|1909884|FG000|Follow-up Period|Missing|94
927126|NCT00901901|1909885|FG001|Follow-up Period|Missing|80
927127|NCT00901927|1909893|FG000|Overall Study|Lack of Efficacy|1
927128|NCT00901927|1909893|FG000|Overall Study|Protocol Violation|3
927129|NCT00901927|1909893|FG000|Overall Study|Withdrawal by Subject|2
927130|NCT00902174|1909932|FG000|Overall Study|Adverse Event|27
927131|NCT00902174|1909933|FG001|Overall Study|Adverse Event|7
927132|NCT00902174|1909932|FG000|Overall Study|Lack of Efficacy|1
927133|NCT00902174|1909933|FG001|Overall Study|Lack of Efficacy|5
927134|NCT00902174|1909932|FG000|Overall Study|Death|2
927135|NCT00902174|1909933|FG001|Overall Study|Death|2
927136|NCT00902174|1909932|FG000|Overall Study|Withdrawal by Subject|2
927137|NCT00902174|1909933|FG001|Overall Study|Withdrawal by Subject|1
927138|NCT00902174|1909932|FG000|Overall Study|Abnormal labs|1
927139|NCT00902174|1909933|FG001|Overall Study|Abnormal labs|1
927140|NCT00902174|1909932|FG000|Overall Study|Protocol Violation|1
927141|NCT00902174|1909933|FG001|Overall Study|Protocol Violation|1
927142|NCT00902174|1909932|FG000|Overall Study|Administration problem|0
927143|NCT00902174|1909933|FG001|Overall Study|Administration problem|1
927144|NCT00902265|1909946|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1
927145|NCT00902265|1909946|FG000|Overall Study|Adverse Event|2
927146|NCT00902265|1909946|FG000|Overall Study|Lack of Efficacy|2
927147|NCT00902265|1909946|FG000|Overall Study|Protocol Violation|1
927148|NCT00902278|1909955|FG000|Overall Study|Physician Decision|1
927149|NCT00902278|1909956|FG001|Overall Study|Physician Decision|0
927150|NCT00902278|1909957|FG002|Overall Study|Physician Decision|2
927151|NCT00902278|1909958|FG003|Overall Study|Physician Decision|0
927152|NCT00902278|1909959|FG004|Overall Study|Physician Decision|1
927153|NCT00902278|1909955|FG000|Overall Study|Lost to Follow-up|3
927154|NCT00902278|1909956|FG001|Overall Study|Lost to Follow-up|2
927155|NCT00902278|1909957|FG002|Overall Study|Lost to Follow-up|3
927156|NCT00902278|1909958|FG003|Overall Study|Lost to Follow-up|0
927157|NCT00902278|1909959|FG004|Overall Study|Lost to Follow-up|1
927158|NCT00902304|1909974|FG000|Overall Study|Adverse Event|4
927159|NCT00902304|1909975|FG001|Overall Study|Adverse Event|10
927160|NCT00902304|1909976|FG002|Overall Study|Adverse Event|25
927161|NCT00902304|1909974|FG000|Overall Study|Investigator discretion|3
927162|NCT00902304|1909975|FG001|Overall Study|Investigator discretion|5
927163|NCT00902304|1909976|FG002|Overall Study|Investigator discretion|13
927164|NCT00902304|1909974|FG000|Overall Study|Lost to Follow-up|7
927165|NCT00902304|1909975|FG001|Overall Study|Lost to Follow-up|7
927166|NCT00902304|1909976|FG002|Overall Study|Lost to Follow-up|7
927167|NCT00902304|1909974|FG000|Overall Study|Protocol Violation|9
927168|NCT00902304|1909975|FG001|Overall Study|Protocol Violation|18
927169|NCT00902304|1909976|FG002|Overall Study|Protocol Violation|20
927170|NCT00902304|1909974|FG000|Overall Study|Withdrawal by Subject|32
927171|NCT00902304|1909975|FG001|Overall Study|Withdrawal by Subject|22
927172|NCT00902304|1909976|FG002|Overall Study|Withdrawal by Subject|43
927173|NCT00902304|1909974|FG000|Overall Study|includes pregnancy|3
927174|NCT00902304|1909975|FG001|Overall Study|includes pregnancy|9
927175|NCT00902304|1909976|FG002|Overall Study|includes pregnancy|2
927176|NCT00902330|1909987|FG000|Overall Study|Too overwhelmed by treatment|2
927177|NCT00902330|1909988|FG001|Overall Study|Too overwhelmed by treatment|5
927178|NCT00902330|1909987|FG000|Overall Study|Adverse Event|1
927179|NCT00902330|1909988|FG001|Overall Study|Adverse Event|0
927180|NCT00902330|1909987|FG000|Overall Study|No post baseline data|1
927181|NCT00902330|1909988|FG001|Overall Study|No post baseline data|0
927182|NCT00902486|1910001|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
927183|NCT00902486|1910002|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
927184|NCT00902486|1910003|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
927185|NCT00902486|1910004|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
927186|NCT00902486|1910005|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
927187|NCT00902486|1910006|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
927188|NCT00902486|1910001|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
927189|NCT00902486|1910002|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
927190|NCT00902486|1910003|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
927191|NCT00902486|1910004|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
927192|NCT00902486|1910005|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
927193|NCT00902486|1910006|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
927194|NCT00902486|1910001|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
927195|NCT00902486|1910002|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
927196|NCT00902486|1910003|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
927197|NCT00902486|1910004|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
927198|NCT00902486|1910005|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
927199|NCT00902486|1910006|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
927200|NCT00902486|1910001|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
927201|NCT00902486|1910002|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
927202|NCT00902486|1910003|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
927203|NCT00902486|1910004|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
927204|NCT00902486|1910005|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
927205|NCT00902486|1910006|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
927206|NCT00902486|1910001|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
927207|NCT00902486|1910002|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
927208|NCT00902486|1910003|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
927209|NCT00902486|1910004|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
927210|NCT00902486|1910005|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
927211|NCT00902486|1910006|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
927212|NCT00902486|1910001|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0
927213|NCT00902486|1910002|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0
927214|NCT00902486|1910003|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0
927215|NCT00902486|1910004|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0
927216|NCT00902486|1910005|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1
927217|NCT00902486|1910006|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2
927218|NCT00902486|1910001|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
927219|NCT00902486|1910002|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
927220|NCT00902486|1910003|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
927221|NCT00902486|1910004|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
927222|NCT00902486|1910005|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
927223|NCT00902486|1910006|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
927224|NCT00902486|1910001|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
927225|NCT00902486|1910002|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
927226|NCT00902486|1910003|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
927227|NCT00902486|1910004|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
927228|NCT00902486|1910005|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
927229|NCT00902486|1910006|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
927230|NCT00902486|1910001|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0
927231|NCT00902486|1910002|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0
927232|NCT00902486|1910003|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0
927233|NCT00902486|1910004|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1
927234|NCT00902486|1910005|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0
927235|NCT00902486|1910006|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0
927236|NCT00902486|1910001|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
927237|NCT00902486|1910002|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
927238|NCT00902486|1910003|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
927239|NCT00902486|1910004|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
927240|NCT00902486|1910005|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
927241|NCT00902486|1910006|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
927242|NCT00902486|1910001|FG000|Follow-up (After Week 24)|Lost to Follow-up|0
927243|NCT00902486|1910002|FG001|Follow-up (After Week 24)|Lost to Follow-up|0
927244|NCT00902486|1910003|FG002|Follow-up (After Week 24)|Lost to Follow-up|0
927245|NCT00902486|1910004|FG003|Follow-up (After Week 24)|Lost to Follow-up|1
927246|NCT00902486|1910005|FG004|Follow-up (After Week 24)|Lost to Follow-up|0
927247|NCT00902486|1910006|FG005|Follow-up (After Week 24)|Lost to Follow-up|0
927248|NCT00902538|1910039|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
927249|NCT00902538|1910040|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
927250|NCT00902538|1910041|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
927251|NCT00902538|1910042|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
927252|NCT00902538|1910043|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
927253|NCT00902538|1910044|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
927254|NCT00902538|1910039|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
927255|NCT00902538|1910040|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
927256|NCT00902538|1910041|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
927257|NCT00902538|1910042|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
927258|NCT00902538|1910043|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
927259|NCT00902538|1910044|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
927260|NCT00902538|1910039|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
927261|NCT00902538|1910040|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
927262|NCT00902538|1910041|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
927263|NCT00902538|1910042|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
927264|NCT00902538|1910043|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
927265|NCT00902538|1910044|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
927266|NCT00902538|1910039|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
927267|NCT00902538|1910040|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
927268|NCT00902538|1910041|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
927269|NCT00902538|1910042|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
927270|NCT00902538|1910043|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
927271|NCT00902538|1910044|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
927272|NCT00902538|1910039|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
927273|NCT00902538|1910040|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
927274|NCT00902538|1910041|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
927275|NCT00902538|1910042|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
927276|NCT00902538|1910043|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
927277|NCT00902538|1910044|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
927278|NCT00902538|1910039|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4
927279|NCT00902538|1910040|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2
927280|NCT00902538|1910041|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3
927281|NCT00902538|1910042|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0
927282|NCT00902538|1910043|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0
927283|NCT00902538|1910044|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0
927284|NCT00902538|1910039|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
927285|NCT00902538|1910040|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
927286|NCT00902538|1910041|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
927287|NCT00902538|1910042|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
927288|NCT00902538|1910043|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
927289|NCT00902538|1910044|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
927290|NCT00902538|1910039|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
927291|NCT00902538|1910040|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
927292|NCT00902538|1910041|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
927293|NCT00902538|1910042|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
927294|NCT00902538|1910043|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
927295|NCT00902538|1910044|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
927296|NCT00902538|1910039|FG000|2-Randomized Double-blind 3 Treatments|Other|2
927297|NCT00902538|1910040|FG001|2-Randomized Double-blind 3 Treatments|Other|1
927298|NCT00902538|1910041|FG002|2-Randomized Double-blind 3 Treatments|Other|0
927299|NCT00902538|1910042|FG003|2-Randomized Double-blind 3 Treatments|Other|0
927300|NCT00902538|1910043|FG004|2-Randomized Double-blind 3 Treatments|Other|0
927301|NCT00902538|1910044|FG005|2-Randomized Double-blind 3 Treatments|Other|0
927302|NCT00902538|1910039|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
927303|NCT00902538|1910040|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
927304|NCT00902538|1910041|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
927305|NCT00902538|1910042|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
927306|NCT00902538|1910043|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
927307|NCT00902538|1910044|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
927308|NCT00902538|1910039|FG000|3-Single-blind, Single Treatment|Adverse Event|0
927309|NCT00902538|1910040|FG001|3-Single-blind, Single Treatment|Adverse Event|5
927310|NCT00902538|1910041|FG002|3-Single-blind, Single Treatment|Adverse Event|0
927311|NCT00902538|1910042|FG003|3-Single-blind, Single Treatment|Adverse Event|0
927312|NCT00902538|1910043|FG004|3-Single-blind, Single Treatment|Adverse Event|0
927313|NCT00902538|1910044|FG005|3-Single-blind, Single Treatment|Adverse Event|0
927314|NCT00902538|1910039|FG000|3-Single-blind, Single Treatment|Protocol Violation|0
927315|NCT00902538|1910040|FG001|3-Single-blind, Single Treatment|Protocol Violation|5
927316|NCT00902538|1910041|FG002|3-Single-blind, Single Treatment|Protocol Violation|0
927317|NCT00902538|1910042|FG003|3-Single-blind, Single Treatment|Protocol Violation|0
927318|NCT00902538|1910043|FG004|3-Single-blind, Single Treatment|Protocol Violation|0
927319|NCT00902538|1910044|FG005|3-Single-blind, Single Treatment|Protocol Violation|0
927320|NCT00902538|1910039|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0
927321|NCT00902538|1910040|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4
927322|NCT00902538|1910041|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0
927323|NCT00902538|1910042|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0
927324|NCT00902538|1910043|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0
927325|NCT00902538|1910044|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0
927326|NCT00902538|1910039|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0
927327|NCT00902538|1910040|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1
927328|NCT00902538|1910041|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0
927329|NCT00902538|1910042|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0
927330|NCT00902538|1910043|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0
927331|NCT00902538|1910044|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0
927332|NCT00902538|1910039|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0
927333|NCT00902538|1910040|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0
927334|NCT00902538|1910041|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0
927335|NCT00902538|1910042|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3
927336|NCT00902538|1910043|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1
927337|NCT00902538|1910044|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1
927338|NCT00902538|1910039|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
927339|NCT00902538|1910040|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
927340|NCT00902538|1910041|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
927341|NCT00902538|1910042|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
927342|NCT00902538|1910043|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
927343|NCT00902538|1910044|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
927344|NCT00902538|1910039|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
927345|NCT00902538|1910040|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
927346|NCT00902538|1910041|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
927347|NCT00902538|1910042|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
927348|NCT00902538|1910043|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
927349|NCT00902538|1910044|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
927350|NCT00902564|1910056|FG000|Overall Study|Withdrawal by Subject|2
927351|NCT00902577|1910060|FG000|Overall Study|Withdrawal by Subject|6
927352|NCT00902577|1910060|FG000|Overall Study|FMISO production failure|2
927353|NCT00902746|1910083|FG000|Overall Study|Protocol Violation|7
927354|NCT00902746|1910083|FG000|Overall Study|Withdrawal by Subject|16
927355|NCT00902746|1910083|FG000|Overall Study|Adverse Event|8
927356|NCT00902746|1910083|FG000|Overall Study|Lost to Follow-up|3
927357|NCT00902746|1910083|FG000|Overall Study|Physician Decision|2
927358|NCT00902850|1910089|FG000|Overall Study|Physician Decision|2
927359|NCT00902850|1910090|FG001|Overall Study|Physician Decision|2
927360|NCT00903032|1910098|FG000|Overall Study|Withdrawal by Subject|5
927361|NCT00903032|1910099|FG001|Overall Study|Withdrawal by Subject|3
927362|NCT00903032|1910098|FG000|Overall Study|Lost to Follow-up|2
927363|NCT00903032|1910099|FG001|Overall Study|Lost to Follow-up|2
927364|NCT00903175|1910111|FG000|Period 1 - First Line|Adverse Event|36
927365|NCT00903175|1910112|FG001|Period 1 - First Line|Adverse Event|50
927366|NCT00903175|1910111|FG000|Period 1 - First Line|Abnormal lab value(s)|0
927367|NCT00903175|1910112|FG001|Period 1 - First Line|Abnormal lab value(s)|1
927368|NCT00903175|1910111|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1
927369|NCT00903175|1910112|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0
927370|NCT00903175|1910111|FG000|Period 1 - First Line|Protocol Violation|3
927371|NCT00903175|1910112|FG001|Period 1 - First Line|Protocol Violation|3
927372|NCT00903175|1910111|FG000|Period 1 - First Line|Withdrawal by Subject|8
927373|NCT00903175|1910112|FG001|Period 1 - First Line|Withdrawal by Subject|12
927374|NCT00903175|1910111|FG000|Period 1 - First Line|Administrative problems|12
927375|NCT00903175|1910112|FG001|Period 1 - First Line|Administrative problems|13
927376|NCT00903175|1910111|FG000|Period 1 - First Line|Death|17
927377|NCT00903175|1910112|FG001|Period 1 - First Line|Death|10
927378|NCT00903175|1910111|FG000|Period 2 - Second Line|Missing|1
927379|NCT00903175|1910112|FG001|Period 2 - Second Line|Missing|0
927380|NCT00903175|1910111|FG000|Period 2 - Second Line|Adverse Event|16
927381|NCT00903175|1910112|FG001|Period 2 - Second Line|Adverse Event|20
927382|NCT00903175|1910111|FG000|Period 2 - Second Line|Withdrawal by Subject|7
927383|NCT00903175|1910112|FG001|Period 2 - Second Line|Withdrawal by Subject|5
927384|NCT00903175|1910111|FG000|Period 2 - Second Line|Lost to Follow-up|1
927385|NCT00903175|1910112|FG001|Period 2 - Second Line|Lost to Follow-up|0
927386|NCT00903175|1910111|FG000|Period 2 - Second Line|Administrative problems|19
927387|NCT00903175|1910112|FG001|Period 2 - Second Line|Administrative problems|9
927388|NCT00903175|1910111|FG000|Period 2 - Second Line|Death|5
927389|NCT00903175|1910112|FG001|Period 2 - Second Line|Death|2
927390|NCT00903201|1910121|FG000|Overall Study|Adverse Event|1
927391|NCT00903201|1910122|FG001|Overall Study|Adverse Event|4
927392|NCT00903201|1910123|FG002|Overall Study|Adverse Event|0
927393|NCT00903201|1910121|FG000|Overall Study|Protocol Violation|2
927394|NCT00903201|1910122|FG001|Overall Study|Protocol Violation|1
927395|NCT00903201|1910123|FG002|Overall Study|Protocol Violation|0
927396|NCT00903201|1910121|FG000|Overall Study|Lost to Follow-up|0
927397|NCT00903201|1910122|FG001|Overall Study|Lost to Follow-up|1
927398|NCT00903201|1910123|FG002|Overall Study|Lost to Follow-up|0
927399|NCT00903201|1910121|FG000|Overall Study|Physician Decision|1
927400|NCT00903201|1910122|FG001|Overall Study|Physician Decision|0
927401|NCT00903201|1910123|FG002|Overall Study|Physician Decision|1
927402|NCT00903201|1910121|FG000|Overall Study|Withdrawal by Subject|1
927403|NCT00903201|1910122|FG001|Overall Study|Withdrawal by Subject|0
927404|NCT00903201|1910123|FG002|Overall Study|Withdrawal by Subject|1
927405|NCT00903331|1910135|FG000|Overall Study|Death|4
927406|NCT00903331|1910136|FG001|Overall Study|Death|8
927407|NCT00903331|1910135|FG000|Overall Study|Withdrawal of consent|1
927408|NCT00903331|1910136|FG001|Overall Study|Withdrawal of consent|8
927409|NCT00903331|1910135|FG000|Overall Study|Lung transplant|0
927410|NCT00903331|1910136|FG001|Overall Study|Lung transplant|2
927411|NCT00903344|1910144|FG000|Overall Study|Pregnancy|2
927412|NCT00903344|1910145|FG001|Overall Study|Pregnancy|3
927413|NCT00903344|1910144|FG000|Overall Study|Lost to Follow-up|3
927414|NCT00903344|1910145|FG001|Overall Study|Lost to Follow-up|0
927415|NCT00903357|1910151|FG000|First Intervention|Withdrawal by Subject|5
927416|NCT00903357|1910152|FG001|First Intervention|Withdrawal by Subject|3
927417|NCT00903357|1910151|FG000|First Intervention|Flu|0
927418|NCT00903357|1910152|FG001|First Intervention|Flu|1
927419|NCT00903357|1910151|FG000|Wash Out Period of 2 Weeks|Flu|0
927420|NCT00903357|1910152|FG001|Wash Out Period of 2 Weeks|Flu|1
927421|NCT00903357|1910151|FG000|Second Intervention|Lost to Follow-up|1
927422|NCT00903357|1910152|FG001|Second Intervention|Lost to Follow-up|0
927423|NCT00903370|1910164|FG000|Overall Study|Death|13
927424|NCT00903370|1910165|FG001|Overall Study|Death|10
927425|NCT00903370|1910164|FG000|Overall Study|Withdrawal by Subject|9
927426|NCT00903370|1910165|FG001|Overall Study|Withdrawal by Subject|6
927427|NCT00903370|1910164|FG000|Overall Study|Lost to Follow-up|6
927428|NCT00903370|1910165|FG001|Overall Study|Lost to Follow-up|8
927429|NCT00903383|1910175|FG000|Overall Study|Adverse Event|1
927430|NCT00903383|1910176|FG001|Overall Study|Adverse Event|2
927431|NCT00903383|1910177|FG002|Overall Study|Adverse Event|3
927432|NCT00903383|1910178|FG003|Overall Study|Adverse Event|1
927433|NCT00903383|1910175|FG000|Overall Study|Physician Decision|1
927434|NCT00903383|1910176|FG001|Overall Study|Physician Decision|2
927435|NCT00903383|1910177|FG002|Overall Study|Physician Decision|0
927436|NCT00903383|1910178|FG003|Overall Study|Physician Decision|0
927437|NCT00903383|1910175|FG000|Overall Study|Lost to Follow-up|0
927438|NCT00903383|1910176|FG001|Overall Study|Lost to Follow-up|0
927439|NCT00903383|1910177|FG002|Overall Study|Lost to Follow-up|0
927440|NCT00903383|1910178|FG003|Overall Study|Lost to Follow-up|1
927441|NCT00903383|1910175|FG000|Overall Study|Decision of Sponsor|1
927442|NCT00903383|1910176|FG001|Overall Study|Decision of Sponsor|0
927443|NCT00903383|1910177|FG002|Overall Study|Decision of Sponsor|0
927444|NCT00903383|1910178|FG003|Overall Study|Decision of Sponsor|0
927445|NCT00903383|1910175|FG000|Overall Study|Withdrawal by Subject|4
927446|NCT00903383|1910176|FG001|Overall Study|Withdrawal by Subject|1
927447|NCT00903383|1910177|FG002|Overall Study|Withdrawal by Subject|0
927448|NCT00903383|1910178|FG003|Overall Study|Withdrawal by Subject|2
927449|NCT00903383|1910175|FG000|Overall Study|Patient Decision - Lack of Efficacy|0
927450|NCT00903383|1910176|FG001|Overall Study|Patient Decision - Lack of Efficacy|1
927451|NCT00903383|1910177|FG002|Overall Study|Patient Decision - Lack of Efficacy|0
927452|NCT00903383|1910178|FG003|Overall Study|Patient Decision - Lack of Efficacy|0
927453|NCT00903383|1910175|FG000|Overall Study|Patient Decision|0
927454|NCT00903383|1910176|FG001|Overall Study|Patient Decision|0
927455|NCT00903383|1910177|FG002|Overall Study|Patient Decision|0
927456|NCT00903383|1910178|FG003|Overall Study|Patient Decision|1
927457|NCT00903409|1910190|FG000|Overall Study|Adverse Event|11
927458|NCT00903409|1910191|FG001|Overall Study|Adverse Event|9
927459|NCT00903409|1910190|FG000|Overall Study|Non-compliance with Protocol|1
927460|NCT00903409|1910191|FG001|Overall Study|Non-compliance with Protocol|1
927461|NCT00903409|1910190|FG000|Overall Study|Laboratory Abnormality|2
927462|NCT00903409|1910191|FG001|Overall Study|Laboratory Abnormality|0
927463|NCT00903409|1910190|FG000|Overall Study|Withdrawal by Subject|8
927464|NCT00903409|1910191|FG001|Overall Study|Withdrawal by Subject|8
927465|NCT00903409|1910190|FG000|Overall Study|Other|2
927466|NCT00903409|1910191|FG001|Overall Study|Other|3
927467|NCT00903409|1910190|FG000|Overall Study|Lost to Follow-up|2
927468|NCT00903409|1910191|FG001|Overall Study|Lost to Follow-up|6
927469|NCT00903617|1910210|FG000|Overall Study|Adverse Event|0
927470|NCT00903617|1910211|FG001|Overall Study|Adverse Event|1
927471|NCT00903617|1910212|FG002|Overall Study|Adverse Event|1
927472|NCT00903617|1910213|FG003|Overall Study|Adverse Event|0
927473|NCT00903617|1910210|FG000|Overall Study|Protocol-defined stopping criteria|0
927474|NCT00903617|1910211|FG001|Overall Study|Protocol-defined stopping criteria|2
927475|NCT00903617|1910212|FG002|Overall Study|Protocol-defined stopping criteria|0
927476|NCT00903617|1910213|FG003|Overall Study|Protocol-defined stopping criteria|0
927477|NCT00903617|1910210|FG000|Overall Study|Lost to Follow-up|2
927478|NCT00903617|1910211|FG001|Overall Study|Lost to Follow-up|0
927479|NCT00903617|1910212|FG002|Overall Study|Lost to Follow-up|1
927480|NCT00903617|1910213|FG003|Overall Study|Lost to Follow-up|1
927481|NCT00903617|1910210|FG000|Overall Study|Withdrawal by Subject|1
927482|NCT00903617|1910211|FG001|Overall Study|Withdrawal by Subject|2
927483|NCT00903617|1910212|FG002|Overall Study|Withdrawal by Subject|3
927484|NCT00903617|1910213|FG003|Overall Study|Withdrawal by Subject|0
927485|NCT00903630|1910227|FG000|Phase 2|Adverse Event|0
927486|NCT00903630|1910228|FG001|Phase 2|Adverse Event|0
927487|NCT00903630|1910229|FG002|Phase 2|Adverse Event|1
927488|NCT00903682|1910241|FG000|Overall Study|Adverse Event|6
927489|NCT00903682|1910242|FG001|Overall Study|Adverse Event|13
927490|NCT00903682|1910241|FG000|Overall Study|Lost to Follow-up|1
927491|NCT00903682|1910242|FG001|Overall Study|Lost to Follow-up|0
927492|NCT00903682|1910241|FG000|Overall Study|Withdrawal by Subject|5
927493|NCT00903682|1910242|FG001|Overall Study|Withdrawal by Subject|0
927494|NCT00903682|1910241|FG000|Overall Study|Pregnancy|0
927495|NCT00903682|1910242|FG001|Overall Study|Pregnancy|1
927496|NCT00903682|1910241|FG000|Overall Study|Subject Reached A Virologic Endpoint|1
927497|NCT00903682|1910242|FG001|Overall Study|Subject Reached A Virologic Endpoint|1
927498|NCT00903682|1910241|FG000|Overall Study|Subject Non-Compliant|1
927499|NCT00903682|1910242|FG001|Overall Study|Subject Non-Compliant|0
927500|NCT00903682|1910241|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1
927501|NCT00903682|1910242|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0
927502|NCT00903682|1910241|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
927503|NCT00903682|1910242|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
927504|NCT00903695|1910250|FG000|Overall Study|medical exclusion after 1st testing|1
927505|NCT00903695|1910251|FG001|Overall Study|medical exclusion after 1st testing|0
927506|NCT00903695|1910250|FG000|Overall Study|lung cancer|1
927507|NCT00903695|1910251|FG001|Overall Study|lung cancer|0
927508|NCT00903760|1910261|FG000|Overall Study|Disease Progression/Death|8
927509|NCT00903760|1910262|FG001|Overall Study|Disease Progression/Death|6
927510|NCT00903760|1910261|FG000|Overall Study|Stem Cell Transplant|8
927511|NCT00903760|1910262|FG001|Overall Study|Stem Cell Transplant|4
927512|NCT00903760|1910261|FG000|Overall Study|Physician Decision|1
927513|NCT00903760|1910262|FG001|Overall Study|Physician Decision|2
927514|NCT00903760|1910261|FG000|Overall Study|Death|0
927515|NCT00903760|1910262|FG001|Overall Study|Death|1
927516|NCT00903760|1910261|FG000|Overall Study|Lost to Follow-up|1
927517|NCT00903760|1910262|FG001|Overall Study|Lost to Follow-up|0
927518|NCT00903760|1910261|FG000|Overall Study|Withdrawal by Subject|1
927519|NCT00903760|1910262|FG001|Overall Study|Withdrawal by Subject|2
927520|NCT00903760|1910261|FG000|Overall Study|Off treatment for long period|0
927521|NCT00903760|1910262|FG001|Overall Study|Off treatment for long period|1
927522|NCT00903786|1910268|FG000|Overall Study|Physician Decision|6
927523|NCT00903786|1910268|FG000|Overall Study|Lack of Efficacy|5
927524|NCT00903786|1910268|FG000|Overall Study|Reason other than lack of efficacy|4
927525|NCT00903877|1910273|FG000|Overall Study|Did not meet study criteria|33
927526|NCT00903877|1910273|FG000|Overall Study|Withdrawal by Subject|3
927527|NCT00903877|1910273|FG000|Overall Study|Adverse Event|2
927528|NCT00903877|1910273|FG000|Overall Study|Lost to Follow-up|1
927529|NCT00903877|1910273|FG000|Overall Study|Participation put on hold|4
927530|NCT00903929|1910277|FG000|Overall Study|Withdrawal by Subject|0
927531|NCT00903929|1910278|FG001|Overall Study|Withdrawal by Subject|0
927532|NCT00903929|1910279|FG002|Overall Study|Withdrawal by Subject|1
927533|NCT00903929|1910280|FG003|Overall Study|Withdrawal by Subject|2
927534|NCT00903929|1910277|FG000|Overall Study|Adverse Event|0
927535|NCT00903929|1910278|FG001|Overall Study|Adverse Event|0
927536|NCT00903929|1910279|FG002|Overall Study|Adverse Event|0
927537|NCT00903929|1910280|FG003|Overall Study|Adverse Event|1
927538|NCT00903968|1910287|FG000|Overall Study|Adverse Event|0
927539|NCT00903968|1910288|FG001|Overall Study|Adverse Event|0
927540|NCT00903968|1910289|FG002|Overall Study|Adverse Event|0
927541|NCT00903968|1910290|FG003|Overall Study|Adverse Event|0
927542|NCT00903968|1910291|FG004|Overall Study|Adverse Event|0
927543|NCT00903968|1910292|FG005|Overall Study|Adverse Event|0
927544|NCT00903968|1910293|FG006|Overall Study|Adverse Event|1
927545|NCT00903968|1910294|FG007|Overall Study|Adverse Event|8
927546|NCT00903968|1910287|FG000|Overall Study|DLT|0
927547|NCT00903968|1910288|FG001|Overall Study|DLT|0
927548|NCT00903968|1910289|FG002|Overall Study|DLT|0
927549|NCT00903968|1910290|FG003|Overall Study|DLT|0
927550|NCT00903968|1910291|FG004|Overall Study|DLT|0
927551|NCT00903968|1910292|FG005|Overall Study|DLT|0
927552|NCT00903968|1910293|FG006|Overall Study|DLT|2
927553|NCT00903968|1910294|FG007|Overall Study|DLT|0
927554|NCT00903968|1910287|FG000|Overall Study|Withdrawal by Subject|1
927555|NCT00903968|1910288|FG001|Overall Study|Withdrawal by Subject|0
927556|NCT00903968|1910289|FG002|Overall Study|Withdrawal by Subject|1
927557|NCT00903968|1910290|FG003|Overall Study|Withdrawal by Subject|0
927558|NCT00903968|1910291|FG004|Overall Study|Withdrawal by Subject|1
927559|NCT00903968|1910292|FG005|Overall Study|Withdrawal by Subject|1
927560|NCT00903968|1910293|FG006|Overall Study|Withdrawal by Subject|0
927561|NCT00903968|1910294|FG007|Overall Study|Withdrawal by Subject|4
927562|NCT00903968|1910287|FG000|Overall Study|Non-Compliance|0
927563|NCT00903968|1910288|FG001|Overall Study|Non-Compliance|0
927564|NCT00903968|1910289|FG002|Overall Study|Non-Compliance|0
927565|NCT00903968|1910290|FG003|Overall Study|Non-Compliance|0
927566|NCT00903968|1910291|FG004|Overall Study|Non-Compliance|0
927567|NCT00903968|1910292|FG005|Overall Study|Non-Compliance|1
927568|NCT00903968|1910293|FG006|Overall Study|Non-Compliance|0
927569|NCT00903968|1910294|FG007|Overall Study|Non-Compliance|0
927570|NCT00903968|1910287|FG000|Overall Study|Physician Decision|0
927571|NCT00903968|1910288|FG001|Overall Study|Physician Decision|0
927572|NCT00903968|1910289|FG002|Overall Study|Physician Decision|0
927573|NCT00903968|1910290|FG003|Overall Study|Physician Decision|0
927574|NCT00903968|1910291|FG004|Overall Study|Physician Decision|0
927575|NCT00903968|1910292|FG005|Overall Study|Physician Decision|1
927576|NCT00903968|1910293|FG006|Overall Study|Physician Decision|0
927577|NCT00903968|1910294|FG007|Overall Study|Physician Decision|0
927578|NCT00903968|1910287|FG000|Overall Study|Progressive Disease|2
927579|NCT00903968|1910288|FG001|Overall Study|Progressive Disease|3
927580|NCT00903968|1910289|FG002|Overall Study|Progressive Disease|2
927581|NCT00903968|1910290|FG003|Overall Study|Progressive Disease|3
927582|NCT00903968|1910291|FG004|Overall Study|Progressive Disease|3
927583|NCT00903968|1910292|FG005|Overall Study|Progressive Disease|3
927584|NCT00903968|1910293|FG006|Overall Study|Progressive Disease|0
927585|NCT00903968|1910294|FG007|Overall Study|Progressive Disease|18
927586|NCT00903968|1910287|FG000|Overall Study|Lack of Efficacy|0
927587|NCT00903968|1910288|FG001|Overall Study|Lack of Efficacy|0
927588|NCT00903968|1910289|FG002|Overall Study|Lack of Efficacy|0
927589|NCT00903968|1910290|FG003|Overall Study|Lack of Efficacy|0
927590|NCT00903968|1910291|FG004|Overall Study|Lack of Efficacy|0
927591|NCT00903968|1910292|FG005|Overall Study|Lack of Efficacy|0
927592|NCT00903968|1910293|FG006|Overall Study|Lack of Efficacy|0
927593|NCT00903968|1910294|FG007|Overall Study|Lack of Efficacy|3
927594|NCT00904033|1910330|FG000|Overall Study|Withdrawal by Subject|1
927595|NCT00904033|1910331|FG001|Overall Study|Withdrawal by Subject|1
927596|NCT00904033|1910332|FG002|Overall Study|Withdrawal by Subject|0
927597|NCT00904033|1910333|FG003|Overall Study|Withdrawal by Subject|0
927598|NCT00904033|1910330|FG000|Overall Study|Physician Decision|0
927599|NCT00904033|1910331|FG001|Overall Study|Physician Decision|0
927600|NCT00904033|1910332|FG002|Overall Study|Physician Decision|1
927601|NCT00904033|1910333|FG003|Overall Study|Physician Decision|0
927602|NCT00904033|1910330|FG000|Overall Study|Unable to obtain final blood draw|0
927603|NCT00904033|1910331|FG001|Overall Study|Unable to obtain final blood draw|0
927604|NCT00904033|1910332|FG002|Overall Study|Unable to obtain final blood draw|0
927605|NCT00904033|1910333|FG003|Overall Study|Unable to obtain final blood draw|2
927606|NCT00904150|1910346|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3
927607|NCT00904150|1910347|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0
927608|NCT00904150|1910346|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0
927609|NCT00904150|1910347|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145
927610|NCT00904215|1910353|FG000|Overall Study|Adverse Event|25
927611|NCT00904215|1910353|FG000|Overall Study|Protocol Violation|10
927612|NCT00904215|1910353|FG000|Overall Study|Lost to Follow-up|63
927613|NCT00904215|1910353|FG000|Overall Study|Withdrawal by Subject|9
927614|NCT00904215|1910353|FG000|Overall Study|Other|28
927615|NCT00904371|1910361|FG000|Overall Study|Adverse Event|2
927616|NCT00904371|1910361|FG000|Overall Study|Lost to Follow-up|4
927617|NCT00904371|1910361|FG000|Overall Study|Discontinued at target blood pressure|2
927618|NCT00904371|1910361|FG000|Overall Study|Continued with Tritace|1
927619|NCT00904670|1910381|FG000|Open Label Phase|Withdrawal by Subject|2
927620|NCT00904670|1910382|FG001|Open Label Phase|Withdrawal by Subject|0
927621|NCT00904670|1910381|FG000|Open Label Phase|Adverse Event|2
927622|NCT00904670|1910382|FG001|Open Label Phase|Adverse Event|0
927623|NCT00904670|1910381|FG000|Open Label Phase|Lack of Efficacy|1
927624|NCT00904670|1910382|FG001|Open Label Phase|Lack of Efficacy|0
927625|NCT00904670|1910381|FG000|Open Label Phase|Lost to Follow-up|1
927626|NCT00904670|1910382|FG001|Open Label Phase|Lost to Follow-up|0
927627|NCT00904722|1910390|FG000|Overall Study|Physician Decision|1
927628|NCT00904748|1910394|FG000|Overall Study|Withdrawal by Subject|1
927629|NCT00904748|1910395|FG001|Overall Study|Withdrawal by Subject|1
927630|NCT00904748|1910396|FG002|Overall Study|Withdrawal by Subject|1
927631|NCT00904748|1910397|FG003|Overall Study|Withdrawal by Subject|2
927632|NCT00904748|1910398|FG004|Overall Study|Withdrawal by Subject|0
927633|NCT00904748|1910399|FG005|Overall Study|Withdrawal by Subject|0
927634|NCT00904748|1910394|FG000|Overall Study|Adverse Event|0
927635|NCT00904748|1910395|FG001|Overall Study|Adverse Event|0
927636|NCT00904748|1910396|FG002|Overall Study|Adverse Event|0
927637|NCT00904748|1910397|FG003|Overall Study|Adverse Event|0
927638|NCT00904748|1910398|FG004|Overall Study|Adverse Event|1
927639|NCT00904748|1910399|FG005|Overall Study|Adverse Event|0
927640|NCT00904839|1910446|FG000|Overall Study|Adverse Event|0
927641|NCT00904839|1910447|FG001|Overall Study|Adverse Event|5
927642|NCT00904839|1910448|FG002|Overall Study|Adverse Event|4
927643|NCT00904839|1910446|FG000|Overall Study|Protocol Violation|0
927644|NCT00904839|1910447|FG001|Overall Study|Protocol Violation|1
927645|NCT00904839|1910448|FG002|Overall Study|Protocol Violation|1
927646|NCT00904839|1910446|FG000|Overall Study|Lost to Follow-up|0
927647|NCT00904839|1910447|FG001|Overall Study|Lost to Follow-up|1
927648|NCT00904839|1910448|FG002|Overall Study|Lost to Follow-up|2
927649|NCT00904839|1910446|FG000|Overall Study|Withdrawal by Subject|0
927650|NCT00904839|1910447|FG001|Overall Study|Withdrawal by Subject|2
927651|NCT00904839|1910448|FG002|Overall Study|Withdrawal by Subject|0
927652|NCT00904839|1910446|FG000|Overall Study|Not treated|1
927653|NCT00904839|1910447|FG001|Overall Study|Not treated|0
927654|NCT00904839|1910448|FG002|Overall Study|Not treated|1
927655|NCT00904839|1910446|FG000|Overall Study|Other than above|0
927656|NCT00904839|1910447|FG001|Overall Study|Other than above|9
927657|NCT00904839|1910448|FG002|Overall Study|Other than above|7
927658|NCT00904917|1910463|FG000|Overall Study|Lost to Follow-up|2
927659|NCT00904917|1910464|FG001|Overall Study|Lost to Follow-up|2
927660|NCT00904917|1910465|FG002|Overall Study|Lost to Follow-up|2
927661|NCT00904917|1910466|FG003|Overall Study|Lost to Follow-up|2
927662|NCT00904969|1910486|FG000|Overall Study|Lost to Follow-up|4
927663|NCT00904969|1910486|FG000|Overall Study|Withdrawal by Subject|3
927664|NCT00904969|1910486|FG000|Overall Study|Additional Treatments|11
927665|NCT00904969|1910486|FG000|Overall Study|Case Aborted; Subject Exited|1
927666|NCT00904982|1910509|FG000|Overall Study|Withdrawal by Subject|2
927667|NCT00904982|1910510|FG001|Overall Study|Withdrawal by Subject|0
927668|NCT00904982|1910511|FG002|Overall Study|Withdrawal by Subject|0
927669|NCT00904982|1910512|FG003|Overall Study|Withdrawal by Subject|0
927670|NCT00905021|1910531|FG000|Overall Study|Adverse Event|2
927671|NCT00905034|1910536|FG000|Overall Study|Withdrawal by Subject|1
927672|NCT00905164|1910559|FG000|Period 1|Protocol Violation|0
927673|NCT00905164|1910560|FG001|Period 1|Protocol Violation|1
927674|NCT00905255|1910566|FG000|Overall Study|Adverse Event|7
927675|NCT00905255|1910567|FG001|Overall Study|Adverse Event|5
927676|NCT00905255|1910566|FG000|Overall Study|Withdrawal by Subject|5
927677|NCT00905255|1910567|FG001|Overall Study|Withdrawal by Subject|4
927678|NCT00905255|1910566|FG000|Overall Study|Familial and Personal Reasons|1
927679|NCT00905255|1910567|FG001|Overall Study|Familial and Personal Reasons|0
927680|NCT00905307|1910597|FG000|Overall Study|Switched to Open Label Rescue|7
927681|NCT00905307|1910598|FG001|Overall Study|Switched to Open Label Rescue|17
927682|NCT00905307|1910599|FG002|Overall Study|Switched to Open Label Rescue|11
927683|NCT00905307|1910600|FG003|Overall Study|Switched to Open Label Rescue|11
927684|NCT00905307|1910601|FG004|Overall Study|Switched to Open Label Rescue|4
927685|NCT00905307|1910602|FG005|Overall Study|Switched to Open Label Rescue|15
927686|NCT00905307|1910597|FG000|Overall Study|Lost to Follow-up|0
927687|NCT00905307|1910598|FG001|Overall Study|Lost to Follow-up|0
927688|NCT00905307|1910599|FG002|Overall Study|Lost to Follow-up|0
927689|NCT00905307|1910600|FG003|Overall Study|Lost to Follow-up|0
927690|NCT00905307|1910601|FG004|Overall Study|Lost to Follow-up|1
927691|NCT00905307|1910602|FG005|Overall Study|Lost to Follow-up|1
927692|NCT00905307|1910597|FG000|Overall Study|Adverse Event|3
927693|NCT00905307|1910598|FG001|Overall Study|Adverse Event|4
927694|NCT00905307|1910599|FG002|Overall Study|Adverse Event|5
927695|NCT00905307|1910600|FG003|Overall Study|Adverse Event|11
927696|NCT00905307|1910601|FG004|Overall Study|Adverse Event|3
927697|NCT00905307|1910602|FG005|Overall Study|Adverse Event|5
927698|NCT00905307|1910597|FG000|Overall Study|Withdrawal by Subject|5
927699|NCT00905307|1910598|FG001|Overall Study|Withdrawal by Subject|13
927700|NCT00905307|1910599|FG002|Overall Study|Withdrawal by Subject|15
927701|NCT00905307|1910600|FG003|Overall Study|Withdrawal by Subject|11
927702|NCT00905307|1910601|FG004|Overall Study|Withdrawal by Subject|4
927703|NCT00905307|1910602|FG005|Overall Study|Withdrawal by Subject|13
927704|NCT00905307|1910597|FG000|Overall Study|Protocol Violation|1
927705|NCT00905307|1910598|FG001|Overall Study|Protocol Violation|0
927706|NCT00905307|1910599|FG002|Overall Study|Protocol Violation|1
927707|NCT00905307|1910600|FG003|Overall Study|Protocol Violation|0
927708|NCT00905307|1910601|FG004|Overall Study|Protocol Violation|0
927709|NCT00905307|1910602|FG005|Overall Study|Protocol Violation|0
927710|NCT00905307|1910597|FG000|Overall Study|Lack of Efficacy|6
927711|NCT00905307|1910598|FG001|Overall Study|Lack of Efficacy|3
927712|NCT00905307|1910599|FG002|Overall Study|Lack of Efficacy|5
927713|NCT00905307|1910600|FG003|Overall Study|Lack of Efficacy|4
927714|NCT00905307|1910601|FG004|Overall Study|Lack of Efficacy|4
927715|NCT00905307|1910602|FG005|Overall Study|Lack of Efficacy|8
927716|NCT00905346|1910631|FG000|Period 1|Withdrawal by Subject|1
927717|NCT00905346|1910632|FG001|Period 1|Withdrawal by Subject|0
927718|NCT00905359|1910638|FG000|Overall Study|Lost to Follow-up|17
927719|NCT00905359|1910639|FG001|Overall Study|Lost to Follow-up|10
927720|NCT00905359|1910638|FG000|Overall Study|Death|2
927721|NCT00905359|1910639|FG001|Overall Study|Death|0
927722|NCT00905359|1910638|FG000|Overall Study|Withdrawal consent|5
927723|NCT00905359|1910639|FG001|Overall Study|Withdrawal consent|6
927724|NCT00905424|1910647|FG000|Overall Study|Lost to Follow-up|3
927725|NCT00905424|1910648|FG001|Overall Study|Lost to Follow-up|3
927726|NCT00905424|1910647|FG000|Overall Study|Withdrawal by Subject|1
927727|NCT00905424|1910648|FG001|Overall Study|Withdrawal by Subject|2
927728|NCT00905424|1910647|FG000|Overall Study|Adverse Event|4
927729|NCT00905424|1910648|FG001|Overall Study|Adverse Event|2
927730|NCT00905424|1910647|FG000|Overall Study|Non-compliance with study medication|2
927731|NCT00905424|1910648|FG001|Overall Study|Non-compliance with study medication|0
927732|NCT00905424|1910647|FG000|Overall Study|Sponsor decision|1
927733|NCT00905424|1910648|FG001|Overall Study|Sponsor decision|0
927734|NCT00905424|1910647|FG000|Overall Study|Positive urine drug screen|0
927735|NCT00905424|1910648|FG001|Overall Study|Positive urine drug screen|1
927736|NCT00905424|1910647|FG000|Overall Study|Non-adherence to visit schedule|0
927737|NCT00905424|1910648|FG001|Overall Study|Non-adherence to visit schedule|1
927738|NCT00905437|1910658|FG000|Overall Study|Adverse Event|3
927739|NCT00905437|1910659|FG001|Overall Study|Adverse Event|2
927740|NCT00905437|1910658|FG000|Overall Study|Lost to Follow-up|0
927741|NCT00905437|1910659|FG001|Overall Study|Lost to Follow-up|1
927742|NCT00905437|1910658|FG000|Overall Study|Withdrawal by Subject|0
927743|NCT00905437|1910659|FG001|Overall Study|Withdrawal by Subject|1
927744|NCT00905437|1910658|FG000|Overall Study|Other|5
927745|NCT00905437|1910659|FG001|Overall Study|Other|6
927746|NCT00905489|1910698|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
927747|NCT00905489|1910698|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
927748|NCT00905489|1910698|FG000|Optional Extension Phase (OEP)|Adverse Event|1
927749|NCT00905567|1910731|FG000|Washout|Withdrawal by Subject|0
927750|NCT00905567|1910732|FG001|Washout|Withdrawal by Subject|1
927751|NCT00905606|1910747|FG000|Period 1|Adverse Event|0
927752|NCT00905606|1910748|FG001|Period 1|Adverse Event|1
927753|NCT00905606|1910747|FG000|Washout|Withdrawal by Subject|1
927754|NCT00905606|1910748|FG001|Washout|Withdrawal by Subject|0
927755|NCT00905632|1910759|FG000|Overall Study|Adverse Event|0
927756|NCT00905632|1910760|FG001|Overall Study|Adverse Event|0
927757|NCT00905632|1910761|FG002|Overall Study|Adverse Event|0
927758|NCT00905632|1910762|FG003|Overall Study|Adverse Event|0
927759|NCT00905632|1910763|FG004|Overall Study|Adverse Event|0
927760|NCT00905632|1910764|FG005|Overall Study|Adverse Event|1
927761|NCT00905632|1910765|FG006|Overall Study|Adverse Event|4
927762|NCT00905840|1910801|FG000|Overall Study|Lost to Follow-up|11
927763|NCT00905840|1910801|FG000|Overall Study|Death|3
927764|NCT00905840|1910801|FG000|Overall Study|Withdrawal by Subject|1
927765|NCT00905840|1910801|FG000|Overall Study|Adverse Event|1
927766|NCT00906087|1910817|FG000|Initial Washout|Withdrawal by Subject|1
927767|NCT00906087|1910817|FG000|Initial Washout|Physician Decision|1
927768|NCT00906204|1910844|FG000|Primary Endpoint (Early Safety)|Physician Decision|1
927769|NCT00906204|1910845|FG001|Primary Endpoint (Early Safety)|Physician Decision|0
927770|NCT00906204|1910844|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
927771|NCT00906204|1910845|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
927772|NCT00906204|1910844|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
927773|NCT00906204|1910845|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
927774|NCT00906204|1910844|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2
927775|NCT00906204|1910845|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2
927776|NCT00906204|1910844|FG000|Secondary Endpoints (Long-term Safety)|Death|0
927777|NCT00906204|1910845|FG001|Secondary Endpoints (Long-term Safety)|Death|1
927778|NCT00906282|1910855|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
927779|NCT00906282|1910855|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10
927780|NCT00906282|1910855|FG000|Preoperative Chemotherapy|Progressive disease|6
927781|NCT00906282|1910855|FG000|Preoperative Chemotherapy|Toxicity|1
927782|NCT00906347|1910862|FG000|Received Study Drug|8 cm prior to initiation of study drug|18
927783|NCT00906347|1910863|FG001|Received Study Drug|8 cm prior to initiation of study drug|30
927784|NCT00906347|1910862|FG000|Received Study Drug|Nonreassuring fetal heart rate|13
927785|NCT00906347|1910863|FG001|Received Study Drug|Nonreassuring fetal heart rate|1
927786|NCT00906347|1910862|FG000|Received Study Drug|Refused study drug|1
927787|NCT00906347|1910863|FG001|Received Study Drug|Refused study drug|0
927788|NCT00906347|1910862|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8
927789|NCT00906347|1910863|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0
927790|NCT00906373|1910871|FG000|Overall Study|Withdrawal by Subject|0
927791|NCT00906373|1910872|FG001|Overall Study|Withdrawal by Subject|5
927792|NCT00906373|1910871|FG000|Overall Study|Other|0
927793|NCT00906373|1910872|FG001|Overall Study|Other|1
927794|NCT00906373|1910871|FG000|Overall Study|Still on treatment at cutoff date|0
927795|NCT00906373|1910872|FG001|Overall Study|Still on treatment at cutoff date|2
927796|NCT00906399|1910882|FG000|Year 1|Randomized But Not Treated|0
927797|NCT00906399|1910883|FG001|Year 1|Randomized But Not Treated|1
927798|NCT00906399|1910884|FG002|Year 1|Randomized But Not Treated|3
927799|NCT00906399|1910885|FG003|Year 1|Randomized But Not Treated|0
927800|NCT00906399|1910886|FG004|Year 1|Randomized But Not Treated|0
927801|NCT00906399|1910887|FG005|Year 1|Randomized But Not Treated|0
927802|NCT00906399|1910888|FG006|Year 1|Randomized But Not Treated|0
927803|NCT00906399|1910882|FG000|Year 1|Adverse Event|4
927804|NCT00906399|1910883|FG001|Year 1|Adverse Event|22
927805|NCT00906399|1910884|FG002|Year 1|Adverse Event|24
927806|NCT00906399|1910885|FG003|Year 1|Adverse Event|0
927807|NCT00906399|1910886|FG004|Year 1|Adverse Event|0
927808|NCT00906399|1910887|FG005|Year 1|Adverse Event|0
927809|NCT00906399|1910888|FG006|Year 1|Adverse Event|0
927810|NCT00906399|1910882|FG000|Year 1|Lost to Follow-up|4
927811|NCT00906399|1910883|FG001|Year 1|Lost to Follow-up|4
927812|NCT00906399|1910884|FG002|Year 1|Lost to Follow-up|2
927813|NCT00906399|1910885|FG003|Year 1|Lost to Follow-up|0
927814|NCT00906399|1910886|FG004|Year 1|Lost to Follow-up|0
927815|NCT00906399|1910887|FG005|Year 1|Lost to Follow-up|0
927816|NCT00906399|1910888|FG006|Year 1|Lost to Follow-up|0
927817|NCT00906399|1910882|FG000|Year 1|Withdrawal by Subject|30
927818|NCT00906399|1910883|FG001|Year 1|Withdrawal by Subject|32
927819|NCT00906399|1910884|FG002|Year 1|Withdrawal by Subject|36
927820|NCT00906399|1910885|FG003|Year 1|Withdrawal by Subject|0
927821|NCT00906399|1910886|FG004|Year 1|Withdrawal by Subject|0
927822|NCT00906399|1910887|FG005|Year 1|Withdrawal by Subject|0
927823|NCT00906399|1910888|FG006|Year 1|Withdrawal by Subject|0
927824|NCT00906399|1910882|FG000|Year 1|Physician Decision|0
927825|NCT00906399|1910883|FG001|Year 1|Physician Decision|1
927826|NCT00906399|1910884|FG002|Year 1|Physician Decision|3
927827|NCT00906399|1910885|FG003|Year 1|Physician Decision|0
927828|NCT00906399|1910886|FG004|Year 1|Physician Decision|0
927829|NCT00906399|1910887|FG005|Year 1|Physician Decision|0
927830|NCT00906399|1910888|FG006|Year 1|Physician Decision|0
927831|NCT00906399|1910882|FG000|Year 1|Death|2
927832|NCT00906399|1910883|FG001|Year 1|Death|1
927833|NCT00906399|1910884|FG002|Year 1|Death|1
927834|NCT00906399|1910885|FG003|Year 1|Death|0
927835|NCT00906399|1910886|FG004|Year 1|Death|0
927836|NCT00906399|1910887|FG005|Year 1|Death|0
927837|NCT00906399|1910888|FG006|Year 1|Death|0
927838|NCT00906399|1910882|FG000|Year 1|Other|4
927839|NCT00906399|1910883|FG001|Year 1|Other|2
927840|NCT00906399|1910884|FG002|Year 1|Other|7
927841|NCT00906399|1910885|FG003|Year 1|Other|0
927842|NCT00906399|1910886|FG004|Year 1|Other|0
927843|NCT00906399|1910887|FG005|Year 1|Other|0
927844|NCT00906399|1910888|FG006|Year 1|Other|0
927845|NCT00906399|1910882|FG000|Year 2|Adverse Event|0
927846|NCT00906399|1910883|FG001|Year 2|Adverse Event|0
927847|NCT00906399|1910884|FG002|Year 2|Adverse Event|0
927848|NCT00906399|1910885|FG003|Year 2|Adverse Event|9
927849|NCT00906399|1910886|FG004|Year 2|Adverse Event|8
927850|NCT00906399|1910887|FG005|Year 2|Adverse Event|11
927851|NCT00906399|1910888|FG006|Year 2|Adverse Event|6
927852|NCT00906399|1910882|FG000|Year 2|Lost to Follow-up|0
927853|NCT00906399|1910883|FG001|Year 2|Lost to Follow-up|0
927854|NCT00906399|1910884|FG002|Year 2|Lost to Follow-up|0
927855|NCT00906399|1910885|FG003|Year 2|Lost to Follow-up|1
927856|NCT00906399|1910886|FG004|Year 2|Lost to Follow-up|4
927857|NCT00906399|1910887|FG005|Year 2|Lost to Follow-up|2
927858|NCT00906399|1910888|FG006|Year 2|Lost to Follow-up|4
927859|NCT00906399|1910882|FG000|Year 2|Withdrawal by Subject|0
927860|NCT00906399|1910883|FG001|Year 2|Withdrawal by Subject|0
927861|NCT00906399|1910884|FG002|Year 2|Withdrawal by Subject|0
927862|NCT00906399|1910885|FG003|Year 2|Withdrawal by Subject|17
927863|NCT00906399|1910886|FG004|Year 2|Withdrawal by Subject|18
927864|NCT00906399|1910887|FG005|Year 2|Withdrawal by Subject|27
927865|NCT00906399|1910888|FG006|Year 2|Withdrawal by Subject|13
927866|NCT00906399|1910882|FG000|Year 2|Physician Decision|0
927867|NCT00906399|1910883|FG001|Year 2|Physician Decision|0
927868|NCT00906399|1910884|FG002|Year 2|Physician Decision|0
927869|NCT00906399|1910885|FG003|Year 2|Physician Decision|0
927870|NCT00906399|1910886|FG004|Year 2|Physician Decision|2
927871|NCT00906399|1910887|FG005|Year 2|Physician Decision|6
927872|NCT00906399|1910888|FG006|Year 2|Physician Decision|3
927873|NCT00906399|1910882|FG000|Year 2|Death|0
927874|NCT00906399|1910883|FG001|Year 2|Death|0
927875|NCT00906399|1910884|FG002|Year 2|Death|0
927876|NCT00906399|1910885|FG003|Year 2|Death|1
927877|NCT00906399|1910886|FG004|Year 2|Death|0
927878|NCT00906399|1910887|FG005|Year 2|Death|0
927879|NCT00906399|1910888|FG006|Year 2|Death|3
927880|NCT00906399|1910882|FG000|Year 2|Other|0
927881|NCT00906399|1910883|FG001|Year 2|Other|0
927882|NCT00906399|1910884|FG002|Year 2|Other|0
927883|NCT00906399|1910885|FG003|Year 2|Other|2
927884|NCT00906399|1910886|FG004|Year 2|Other|3
927885|NCT00906399|1910887|FG005|Year 2|Other|1
927886|NCT00906399|1910888|FG006|Year 2|Other|0
927887|NCT00906698|1910919|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
927888|NCT00906698|1910920|FG001|Overall Study|Dose-limiting toxicity (DLT)|6
927889|NCT00906698|1910921|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
927890|NCT00906698|1910922|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
927891|NCT00906698|1910923|FG004|Overall Study|Dose-limiting toxicity (DLT)|1
927892|NCT00906698|1910924|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
927893|NCT00906698|1910919|FG000|Overall Study|Adverse Event|0
927894|NCT00906698|1910920|FG001|Overall Study|Adverse Event|0
927895|NCT00906698|1910921|FG002|Overall Study|Adverse Event|2
927896|NCT00906698|1910922|FG003|Overall Study|Adverse Event|0
927897|NCT00906698|1910923|FG004|Overall Study|Adverse Event|4
927898|NCT00906698|1910924|FG005|Overall Study|Adverse Event|1
927899|NCT00906698|1910919|FG000|Overall Study|Disease progression|3
927900|NCT00906698|1910920|FG001|Overall Study|Disease progression|12
927901|NCT00906698|1910921|FG002|Overall Study|Disease progression|4
927902|NCT00906698|1910922|FG003|Overall Study|Disease progression|4
927903|NCT00906698|1910923|FG004|Overall Study|Disease progression|12
927904|NCT00906698|1910924|FG005|Overall Study|Disease progression|4
927905|NCT00906698|1910919|FG000|Overall Study|Withdrawal by Subject|0
927906|NCT00906698|1910920|FG001|Overall Study|Withdrawal by Subject|0
927907|NCT00906698|1910921|FG002|Overall Study|Withdrawal by Subject|0
927908|NCT00906698|1910922|FG003|Overall Study|Withdrawal by Subject|0
927909|NCT00906698|1910923|FG004|Overall Study|Withdrawal by Subject|1
927910|NCT00906698|1910924|FG005|Overall Study|Withdrawal by Subject|0
927911|NCT00906698|1910919|FG000|Overall Study|incl. non compliance, lost to follow-up|0
927912|NCT00906698|1910920|FG001|Overall Study|incl. non compliance, lost to follow-up|1
927913|NCT00906698|1910921|FG002|Overall Study|incl. non compliance, lost to follow-up|0
927914|NCT00906698|1910922|FG003|Overall Study|incl. non compliance, lost to follow-up|0
927915|NCT00906698|1910923|FG004|Overall Study|incl. non compliance, lost to follow-up|0
927916|NCT00906698|1910924|FG005|Overall Study|incl. non compliance, lost to follow-up|0
927917|NCT00906945|1910976|FG000|Overall Study|Found to be not eligible|0
927918|NCT00906945|1910977|FG001|Overall Study|Found to be not eligible|0
927919|NCT00906945|1910978|FG002|Overall Study|Found to be not eligible|0
927920|NCT00906945|1910979|FG003|Overall Study|Found to be not eligible|1
927921|NCT00906945|1910980|FG004|Overall Study|Found to be not eligible|1
927922|NCT00906945|1910981|FG005|Overall Study|Found to be not eligible|1
927923|NCT00906945|1910976|FG000|Overall Study|Physician Decision|0
927924|NCT00906945|1910977|FG001|Overall Study|Physician Decision|0
927925|NCT00906945|1910978|FG002|Overall Study|Physician Decision|0
927926|NCT00906945|1910979|FG003|Overall Study|Physician Decision|0
927927|NCT00906945|1910980|FG004|Overall Study|Physician Decision|0
927928|NCT00906945|1910981|FG005|Overall Study|Physician Decision|1
927929|NCT00906971|1911008|FG000|Overall Study|Withdrawal by Subject|8
927930|NCT00906971|1911009|FG001|Overall Study|Withdrawal by Subject|2
927931|NCT00906971|1911008|FG000|Overall Study|Lost to Follow-up|0
927932|NCT00906971|1911009|FG001|Overall Study|Lost to Follow-up|1
927933|NCT00907153|1911030|FG000|Overall Study|Lost to Follow-up|1
927934|NCT00907153|1911031|FG001|Overall Study|Lost to Follow-up|1
927935|NCT00907153|1911030|FG000|Overall Study|Withdrawal by Subject|1
927936|NCT00907153|1911031|FG001|Overall Study|Withdrawal by Subject|3
927937|NCT00907257|1911039|FG000|Overall Study|Adverse Event|0
927938|NCT00907257|1911040|FG001|Overall Study|Adverse Event|4
927939|NCT00907257|1911039|FG000|Overall Study|Protocol Violation|1
927940|NCT00907257|1911040|FG001|Overall Study|Protocol Violation|2
927941|NCT00907257|1911039|FG000|Overall Study|Lost to Follow-up|3
927942|NCT00907257|1911040|FG001|Overall Study|Lost to Follow-up|3
927943|NCT00907257|1911039|FG000|Overall Study|Withdrawal by Subject|1
927944|NCT00907257|1911040|FG001|Overall Study|Withdrawal by Subject|2
927945|NCT00907257|1911039|FG000|Overall Study|Per IRB-Subject became vulnerable|1
927946|NCT00907257|1911040|FG001|Overall Study|Per IRB-Subject became vulnerable|0
927947|NCT00907257|1911039|FG000|Overall Study|Moved|1
927948|NCT00907257|1911040|FG001|Overall Study|Moved|0
927949|NCT00907257|1911039|FG000|Overall Study|Personal Reasons|6
927950|NCT00907257|1911040|FG001|Overall Study|Personal Reasons|1
927951|NCT00907296|1911056|FG000|Overall Study|Ineligibility Determined|1
927952|NCT00907296|1911057|FG001|Overall Study|Ineligibility Determined|0
927953|NCT00907296|1911058|FG002|Overall Study|Ineligibility Determined|0
927954|NCT00907296|1911059|FG003|Overall Study|Ineligibility Determined|1
927955|NCT00907296|1911060|FG004|Overall Study|Ineligibility Determined|0
927956|NCT00907296|1911061|FG005|Overall Study|Ineligibility Determined|0
927957|NCT00907296|1911062|FG006|Overall Study|Ineligibility Determined|0
927958|NCT00907296|1911063|FG007|Overall Study|Ineligibility Determined|1
927959|NCT00907296|1911064|FG008|Overall Study|Ineligibility Determined|0
927960|NCT00907296|1911065|FG009|Overall Study|Ineligibility Determined|0
927961|NCT00907296|1911056|FG000|Overall Study|Protocol Deviation|0
927962|NCT00907296|1911057|FG001|Overall Study|Protocol Deviation|1
927963|NCT00907296|1911058|FG002|Overall Study|Protocol Deviation|0
927964|NCT00907296|1911059|FG003|Overall Study|Protocol Deviation|0
927965|NCT00907296|1911060|FG004|Overall Study|Protocol Deviation|0
927966|NCT00907296|1911061|FG005|Overall Study|Protocol Deviation|0
927967|NCT00907296|1911062|FG006|Overall Study|Protocol Deviation|0
927968|NCT00907296|1911063|FG007|Overall Study|Protocol Deviation|0
927969|NCT00907296|1911064|FG008|Overall Study|Protocol Deviation|0
927970|NCT00907296|1911065|FG009|Overall Study|Protocol Deviation|0
927971|NCT00907296|1911056|FG000|Overall Study|Noncompliance|1
927972|NCT00907296|1911057|FG001|Overall Study|Noncompliance|1
927973|NCT00907296|1911058|FG002|Overall Study|Noncompliance|1
927974|NCT00907296|1911059|FG003|Overall Study|Noncompliance|0
927975|NCT00907296|1911060|FG004|Overall Study|Noncompliance|0
927976|NCT00907296|1911061|FG005|Overall Study|Noncompliance|1
927977|NCT00907296|1911062|FG006|Overall Study|Noncompliance|0
927978|NCT00907296|1911063|FG007|Overall Study|Noncompliance|2
927979|NCT00907296|1911064|FG008|Overall Study|Noncompliance|0
927980|NCT00907296|1911065|FG009|Overall Study|Noncompliance|0
927981|NCT00907296|1911056|FG000|Overall Study|Adverse Event|2
927982|NCT00907296|1911057|FG001|Overall Study|Adverse Event|0
927983|NCT00907296|1911058|FG002|Overall Study|Adverse Event|0
927984|NCT00907296|1911059|FG003|Overall Study|Adverse Event|0
927985|NCT00907296|1911060|FG004|Overall Study|Adverse Event|0
927986|NCT00907296|1911061|FG005|Overall Study|Adverse Event|0
927987|NCT00907296|1911062|FG006|Overall Study|Adverse Event|1
927988|NCT00907296|1911063|FG007|Overall Study|Adverse Event|0
927989|NCT00907296|1911064|FG008|Overall Study|Adverse Event|0
927990|NCT00907296|1911065|FG009|Overall Study|Adverse Event|1
927991|NCT00907296|1911056|FG000|Overall Study|Withdrawal by Subject|7
927992|NCT00907296|1911057|FG001|Overall Study|Withdrawal by Subject|2
927993|NCT00907296|1911058|FG002|Overall Study|Withdrawal by Subject|1
927994|NCT00907296|1911059|FG003|Overall Study|Withdrawal by Subject|1
927995|NCT00907296|1911060|FG004|Overall Study|Withdrawal by Subject|1
927996|NCT00907296|1911061|FG005|Overall Study|Withdrawal by Subject|5
927997|NCT00907296|1911062|FG006|Overall Study|Withdrawal by Subject|3
927998|NCT00907296|1911063|FG007|Overall Study|Withdrawal by Subject|2
927999|NCT00907296|1911064|FG008|Overall Study|Withdrawal by Subject|4
928000|NCT00907296|1911065|FG009|Overall Study|Withdrawal by Subject|2
928001|NCT00907296|1911056|FG000|Overall Study|Lost to Follow-up|9
928002|NCT00907296|1911057|FG001|Overall Study|Lost to Follow-up|1
928003|NCT00907296|1911058|FG002|Overall Study|Lost to Follow-up|0
928004|NCT00907296|1911059|FG003|Overall Study|Lost to Follow-up|2
928005|NCT00907296|1911060|FG004|Overall Study|Lost to Follow-up|0
928006|NCT00907296|1911061|FG005|Overall Study|Lost to Follow-up|3
928007|NCT00907296|1911062|FG006|Overall Study|Lost to Follow-up|2
928008|NCT00907296|1911063|FG007|Overall Study|Lost to Follow-up|2
928009|NCT00907296|1911064|FG008|Overall Study|Lost to Follow-up|0
928010|NCT00907296|1911065|FG009|Overall Study|Lost to Follow-up|4
928011|NCT00907335|1911089|FG000|Overall Study|Withdrawal by Subject|2
928012|NCT00907335|1911090|FG001|Overall Study|Withdrawal by Subject|0
928013|NCT00907335|1911089|FG000|Overall Study|Adverse Event|4
928014|NCT00907335|1911090|FG001|Overall Study|Adverse Event|1
928015|NCT00907335|1911089|FG000|Overall Study|Lost to Follow-up|2
928016|NCT00907335|1911090|FG001|Overall Study|Lost to Follow-up|0
928017|NCT00907374|1911098|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2
928018|NCT00907374|1911099|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2
928019|NCT00907478|1911120|FG000|Overall Study|Ineligibility determined|0
928020|NCT00907478|1911121|FG001|Overall Study|Ineligibility determined|0
928021|NCT00907478|1911122|FG002|Overall Study|Ineligibility determined|1
928022|NCT00907478|1911120|FG000|Overall Study|Noncompliance|0
928023|NCT00907478|1911121|FG001|Overall Study|Noncompliance|0
928024|NCT00907478|1911122|FG002|Overall Study|Noncompliance|1
928025|NCT00907478|1911120|FG000|Overall Study|Adverse Event|3
928026|NCT00907478|1911121|FG001|Overall Study|Adverse Event|1
928027|NCT00907478|1911122|FG002|Overall Study|Adverse Event|2
928028|NCT00907478|1911120|FG000|Overall Study|Withdrawal by Subject|8
928029|NCT00907478|1911121|FG001|Overall Study|Withdrawal by Subject|9
928030|NCT00907478|1911122|FG002|Overall Study|Withdrawal by Subject|6
928031|NCT00907478|1911120|FG000|Overall Study|Requirement for alternative therapy|1
928032|NCT00907478|1911121|FG001|Overall Study|Requirement for alternative therapy|2
928033|NCT00907478|1911122|FG002|Overall Study|Requirement for alternative therapy|3
928034|NCT00907478|1911120|FG000|Overall Study|Physician Decision|2
928035|NCT00907478|1911121|FG001|Overall Study|Physician Decision|0
928036|NCT00907478|1911122|FG002|Overall Study|Physician Decision|3
928037|NCT00907478|1911120|FG000|Overall Study|Death|4
928038|NCT00907478|1911121|FG001|Overall Study|Death|2
928039|NCT00907478|1911122|FG002|Overall Study|Death|1
928040|NCT00907478|1911120|FG000|Overall Study|Protocol-specified criteria|5
928041|NCT00907478|1911121|FG001|Overall Study|Protocol-specified criteria|2
928042|NCT00907478|1911122|FG002|Overall Study|Protocol-specified criteria|3
928043|NCT00907478|1911120|FG000|Overall Study|Pregnancy|0
928044|NCT00907478|1911121|FG001|Overall Study|Pregnancy|1
928045|NCT00907478|1911122|FG002|Overall Study|Pregnancy|1
928046|NCT00907478|1911120|FG000|Overall Study|Lost to Follow-up|1
928047|NCT00907478|1911121|FG001|Overall Study|Lost to Follow-up|0
928048|NCT00907478|1911122|FG002|Overall Study|Lost to Follow-up|0
928049|NCT00907478|1911120|FG000|Overall Study|Other|3
928050|NCT00907478|1911121|FG001|Overall Study|Other|0
928051|NCT00907478|1911122|FG002|Overall Study|Other|1
928052|NCT00907517|1911137|FG000|Overall Study|Progressive Disease|3
928053|NCT00907517|1911138|FG001|Overall Study|Progressive Disease|3
928054|NCT00907517|1911139|FG002|Overall Study|Progressive Disease|4
928055|NCT00907517|1911140|FG003|Overall Study|Progressive Disease|4
928056|NCT00907517|1911141|FG004|Overall Study|Progressive Disease|4
928057|NCT00907517|1911137|FG000|Overall Study|Symptomatic Deterioration|0
928058|NCT00907517|1911138|FG001|Overall Study|Symptomatic Deterioration|0
928059|NCT00907517|1911139|FG002|Overall Study|Symptomatic Deterioration|0
928060|NCT00907517|1911140|FG003|Overall Study|Symptomatic Deterioration|0
928061|NCT00907517|1911141|FG004|Overall Study|Symptomatic Deterioration|1
928062|NCT00907621|1911155|FG000|Overall Study|Lost to Follow-up|6
928063|NCT00907621|1911156|FG001|Overall Study|Lost to Follow-up|3
928064|NCT00907621|1911155|FG000|Overall Study|intercurrent febrile illness|1
928065|NCT00907621|1911156|FG001|Overall Study|intercurrent febrile illness|1
928066|NCT00907738|1911167|FG000|Overall Study|Adverse Event|2
928067|NCT00907738|1911168|FG001|Overall Study|Adverse Event|0
928068|NCT00907738|1911169|FG002|Overall Study|Adverse Event|1
928069|NCT00907738|1911170|FG003|Overall Study|Adverse Event|0
928070|NCT00907738|1911171|FG004|Overall Study|Adverse Event|0
928071|NCT00907738|1911167|FG000|Overall Study|not specified or withdrew consent|3
928072|NCT00907738|1911168|FG001|Overall Study|not specified or withdrew consent|0
928073|NCT00907738|1911169|FG002|Overall Study|not specified or withdrew consent|0
928074|NCT00907738|1911170|FG003|Overall Study|not specified or withdrew consent|0
928075|NCT00907738|1911171|FG004|Overall Study|not specified or withdrew consent|0
928076|NCT00907738|1911167|FG000|Overall Study|Disease progression|8
928077|NCT00907738|1911168|FG001|Overall Study|Disease progression|1
928078|NCT00907738|1911169|FG002|Overall Study|Disease progression|6
928079|NCT00907738|1911170|FG003|Overall Study|Disease progression|4
928080|NCT00907738|1911171|FG004|Overall Study|Disease progression|2
928081|NCT00907777|1911189|FG000|Overall Study|Withdrawal by Subject|0
928082|NCT00907777|1911190|FG001|Overall Study|Withdrawal by Subject|1
928083|NCT00907803|1911199|FG000|Overall Study|Withdrawal of consent - long commute|1
928084|NCT00907803|1911200|FG001|Overall Study|Withdrawal of consent - long commute|0
928085|NCT00907803|1911201|FG002|Overall Study|Withdrawal of consent - long commute|0
928086|NCT00907803|1911199|FG000|Overall Study|Adverse Event|2
928087|NCT00907803|1911200|FG001|Overall Study|Adverse Event|0
928088|NCT00907803|1911201|FG002|Overall Study|Adverse Event|0
928089|NCT00907803|1911199|FG000|Overall Study|Withdrawal by Subject|0
928090|NCT00907803|1911200|FG001|Overall Study|Withdrawal by Subject|1
928091|NCT00907803|1911201|FG002|Overall Study|Withdrawal by Subject|0
928092|NCT00907803|1911199|FG000|Overall Study|Lost to Follow-up|0
928093|NCT00907803|1911200|FG001|Overall Study|Lost to Follow-up|1
928094|NCT00907803|1911201|FG002|Overall Study|Lost to Follow-up|0
928095|NCT00907803|1911199|FG000|Overall Study|Protocol Violation|0
928096|NCT00907803|1911200|FG001|Overall Study|Protocol Violation|1
928097|NCT00907803|1911201|FG002|Overall Study|Protocol Violation|0
928098|NCT00907881|1911209|FG000|Overall Study|Lost to Follow-up|59
928099|NCT00907881|1911209|FG000|Overall Study|Noncompliance|5
928100|NCT00907881|1911209|FG000|Overall Study|Withdrawal by Subject|5
928101|NCT00907881|1911209|FG000|Overall Study|Protocol Violation|1
928102|NCT00907881|1911209|FG000|Overall Study|Missing discontinuation information|15
928103|NCT00908011|1911222|FG000|Overall Study|Withdrawal by Subject|2
928104|NCT00908011|1911223|FG001|Overall Study|Withdrawal by Subject|2
928105|NCT00908037|1911236|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0
928106|NCT00908037|1911237|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0
928107|NCT00908037|1911238|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0
928108|NCT00908037|1911239|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0
928109|NCT00908037|1911240|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1
928110|NCT00908037|1911241|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0
928111|NCT00908037|1911242|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3
928112|NCT00908037|1911243|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0
928113|NCT00908037|1911244|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1
928114|NCT00908037|1911245|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0
928115|NCT00908037|1911246|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0
928116|NCT00908037|1911247|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0
928117|NCT00908037|1911236|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
928118|NCT00908037|1911237|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
928119|NCT00908037|1911238|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
928120|NCT00908037|1911239|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
928121|NCT00908037|1911240|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
928122|NCT00908037|1911241|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
928123|NCT00908037|1911242|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
928124|NCT00908037|1911243|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
928125|NCT00908037|1911244|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
928126|NCT00908037|1911245|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
928127|NCT00908037|1911246|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
928128|NCT00908037|1911247|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
928129|NCT00908037|1911236|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
928130|NCT00908037|1911237|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
928131|NCT00908037|1911238|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
928132|NCT00908037|1911239|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
928133|NCT00908037|1911240|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
928134|NCT00908037|1911241|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
928135|NCT00908037|1911242|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
928136|NCT00908037|1911243|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
928137|NCT00908037|1911244|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
928138|NCT00908037|1911245|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
928139|NCT00908037|1911246|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
928140|NCT00908037|1911247|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
928141|NCT00908037|1911236|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
928142|NCT00908037|1911237|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
928143|NCT00908037|1911238|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
928144|NCT00908037|1911239|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
928145|NCT00908037|1911240|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
928146|NCT00908037|1911241|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
928147|NCT00908037|1911242|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
928148|NCT00908037|1911243|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
928149|NCT00908037|1911244|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
928150|NCT00908037|1911245|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
928151|NCT00908037|1911246|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
928152|NCT00908037|1911247|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
928153|NCT00908037|1911236|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
928154|NCT00908037|1911237|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
928155|NCT00908037|1911238|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
928156|NCT00908037|1911239|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
928157|NCT00908037|1911240|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
928158|NCT00908037|1911241|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
928159|NCT00908037|1911242|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
928160|NCT00908037|1911243|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
928161|NCT00908037|1911244|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
928162|NCT00908037|1911245|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
928163|NCT00908037|1911246|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
928164|NCT00908037|1911247|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
928165|NCT00908037|1911236|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
928166|NCT00908037|1911237|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
928167|NCT00908037|1911238|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
928168|NCT00908037|1911239|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
928169|NCT00908037|1911240|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
928170|NCT00908037|1911241|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
928171|NCT00908037|1911242|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
928172|NCT00908037|1911243|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
928173|NCT00908037|1911244|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
928174|NCT00908037|1911245|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
928175|NCT00908037|1911246|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
928176|NCT00908037|1911247|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
928177|NCT00908037|1911236|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
928178|NCT00908037|1911237|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
928179|NCT00908037|1911238|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
928180|NCT00908037|1911239|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
928181|NCT00908037|1911240|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
928182|NCT00908037|1911241|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
928183|NCT00908037|1911242|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
928184|NCT00908037|1911243|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
928185|NCT00908037|1911244|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
928186|NCT00908037|1911245|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
928187|NCT00908037|1911246|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
928188|NCT00908037|1911247|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
928189|NCT00908037|1911236|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
928190|NCT00908037|1911237|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
928191|NCT00908037|1911238|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
928192|NCT00908037|1911239|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
928193|NCT00908037|1911240|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
928194|NCT00908037|1911241|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
928195|NCT00908037|1911242|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
928196|NCT00908037|1911243|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
928197|NCT00908037|1911244|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
928198|NCT00908037|1911245|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
928199|NCT00908037|1911246|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
928200|NCT00908037|1911247|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
928201|NCT00908037|1911236|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
928202|NCT00908037|1911237|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
928203|NCT00908037|1911238|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
928204|NCT00908037|1911239|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
928205|NCT00908037|1911240|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
928206|NCT00908037|1911241|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
928207|NCT00908037|1911242|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
928208|NCT00908037|1911243|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
928209|NCT00908037|1911244|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
928210|NCT00908037|1911245|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
928211|NCT00908037|1911246|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
928212|NCT00908037|1911247|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
928213|NCT00908076|1911301|FG000|Overall Study|Lack of Efficacy|1
928214|NCT00908076|1911302|FG001|Overall Study|Lack of Efficacy|1
928215|NCT00908115|1911308|FG000|Overall Study|Other|14
928216|NCT00908141|1911321|FG000|Overall Study|Withdrawal by Subject|0
928217|NCT00908141|1911322|FG001|Overall Study|Withdrawal by Subject|1
928218|NCT00908232|1911328|FG000|Cycle 1 to 4|Death|5
928219|NCT00908232|1911329|FG001|Cycle 1 to 4|Death|0
928220|NCT00908232|1911330|FG002|Cycle 1 to 4|Death|0
928221|NCT00908232|1911331|FG003|Cycle 1 to 4|Death|0
928222|NCT00908232|1911328|FG000|Cycle 1 to 4|Withdrawal by Subject|4
928223|NCT00908232|1911329|FG001|Cycle 1 to 4|Withdrawal by Subject|0
928224|NCT00908232|1911330|FG002|Cycle 1 to 4|Withdrawal by Subject|0
928225|NCT00908232|1911331|FG003|Cycle 1 to 4|Withdrawal by Subject|0
928226|NCT00908232|1911328|FG000|Cycle 1 to 4|Progressive Disease|6
928227|NCT00908232|1911329|FG001|Cycle 1 to 4|Progressive Disease|0
928228|NCT00908232|1911330|FG002|Cycle 1 to 4|Progressive Disease|0
928229|NCT00908232|1911331|FG003|Cycle 1 to 4|Progressive Disease|0
928230|NCT00908232|1911328|FG000|Cycle 1 to 4|Adverse Event|12
928231|NCT00908232|1911329|FG001|Cycle 1 to 4|Adverse Event|0
928232|NCT00908232|1911330|FG002|Cycle 1 to 4|Adverse Event|0
928233|NCT00908232|1911331|FG003|Cycle 1 to 4|Adverse Event|0
928234|NCT00908232|1911328|FG000|Cycle 1 to 4|Other|1
928235|NCT00908232|1911329|FG001|Cycle 1 to 4|Other|0
928236|NCT00908232|1911330|FG002|Cycle 1 to 4|Other|0
928237|NCT00908232|1911331|FG003|Cycle 1 to 4|Other|0
928238|NCT00908232|1911328|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
928239|NCT00908232|1911329|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
928240|NCT00908232|1911330|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
928241|NCT00908232|1911331|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
928242|NCT00908232|1911328|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
928243|NCT00908232|1911329|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
928244|NCT00908232|1911330|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
928245|NCT00908232|1911331|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
928246|NCT00908232|1911328|FG000|Randomization (Cycle 5) to Cycle 8|Death|2
928247|NCT00908232|1911329|FG001|Randomization (Cycle 5) to Cycle 8|Death|0
928248|NCT00908232|1911330|FG002|Randomization (Cycle 5) to Cycle 8|Death|0
928249|NCT00908232|1911331|FG003|Randomization (Cycle 5) to Cycle 8|Death|0
928250|NCT00908232|1911328|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
928251|NCT00908232|1911329|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
928252|NCT00908232|1911330|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
928253|NCT00908232|1911331|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
928254|NCT00908232|1911328|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
928255|NCT00908232|1911329|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
928256|NCT00908232|1911330|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
928257|NCT00908232|1911331|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
928258|NCT00908232|1911328|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
928259|NCT00908232|1911329|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
928260|NCT00908232|1911330|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
928261|NCT00908232|1911331|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
928262|NCT00908232|1911328|FG000|Randomization (Cycle 5) to Cycle 8|Other|3
928263|NCT00908232|1911329|FG001|Randomization (Cycle 5) to Cycle 8|Other|1
928264|NCT00908232|1911330|FG002|Randomization (Cycle 5) to Cycle 8|Other|0
928265|NCT00908232|1911331|FG003|Randomization (Cycle 5) to Cycle 8|Other|0
928266|NCT00908232|1911328|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
928267|NCT00908232|1911329|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
928268|NCT00908232|1911330|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
928269|NCT00908232|1911331|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
928270|NCT00908310|1911337|FG000|Overall Study|Death|37
928271|NCT00908310|1911337|FG000|Overall Study|Withdrawal by Subject|7
928272|NCT00908310|1911337|FG000|Overall Study|Lost to Follow-up|7
928273|NCT00908310|1911337|FG000|Overall Study|Screening failure|5
928274|NCT00908310|1911337|FG000|Overall Study|Other reasons|4
928275|NCT00908349|1911341|FG000|Overall Study|Adverse Event|10
928276|NCT00908349|1911341|FG000|Overall Study|Withdrawal by Subject|9
928277|NCT00908349|1911341|FG000|Overall Study|Physician Decision|5
928278|NCT00908349|1911341|FG000|Overall Study|Lost to Follow-up|5
928279|NCT00908349|1911341|FG000|Overall Study|Various|6
928280|NCT00908375|1911347|FG000|Overall Study|Withdrawal by Subject|2
928281|NCT00908375|1911348|FG001|Overall Study|Withdrawal by Subject|4
928282|NCT00908375|1911347|FG000|Overall Study|Lost to Follow-up|8
928283|NCT00908375|1911348|FG001|Overall Study|Lost to Follow-up|6
928284|NCT00908544|1911369|FG000|Overall Study|Withdrawal by Subject|2
928285|NCT00908544|1911370|FG001|Overall Study|Withdrawal by Subject|4
928286|NCT00908544|1911369|FG000|Overall Study|Lack of Efficacy|0
928287|NCT00908544|1911370|FG001|Overall Study|Lack of Efficacy|1
928288|NCT00908544|1911369|FG000|Overall Study|Pregnancy|1
928289|NCT00908544|1911370|FG001|Overall Study|Pregnancy|0
928290|NCT00908544|1911369|FG000|Overall Study|Relocation abroad|1
928291|NCT00908544|1911370|FG001|Overall Study|Relocation abroad|1
928292|NCT00908544|1911369|FG000|Overall Study|Unable to visit sutdy center|1
928293|NCT00908544|1911370|FG001|Overall Study|Unable to visit sutdy center|0
928294|NCT00908583|1911376|FG000|Phase 1|Withdrawal by Subject|1
928295|NCT00908583|1911376|FG000|Phase 1|Adverse Event|4
928296|NCT00908583|1911376|FG000|Phase 2|Physician Decision|1
928297|NCT00908583|1911376|FG000|Phase 2|Adverse Event|1
928298|NCT00908583|1911376|FG000|Phase 3|Adverse Event|2
928299|NCT00908583|1911376|FG000|Phase 4|Adverse Event|1
928300|NCT00908583|1911376|FG000|Phase 4|Physician Decision|1
928301|NCT00908583|1911376|FG000|Phase 5|Adverse Event|3
928302|NCT00908596|1911398|FG000|Overall Study|Other reasons|46
928303|NCT00908596|1911399|FG001|Overall Study|Other reasons|6
928304|NCT00908596|1911400|FG002|Overall Study|Other reasons|2
928305|NCT00908596|1911401|FG003|Overall Study|Other reasons|0
928306|NCT00908596|1911398|FG000|Overall Study|Lost to Follow-up|0
928307|NCT00908596|1911399|FG001|Overall Study|Lost to Follow-up|1
928308|NCT00908596|1911400|FG002|Overall Study|Lost to Follow-up|12
928309|NCT00908596|1911401|FG003|Overall Study|Lost to Follow-up|4
928310|NCT00908596|1911398|FG000|Overall Study|Death|0
928311|NCT00908596|1911399|FG001|Overall Study|Death|5
928312|NCT00908596|1911400|FG002|Overall Study|Death|57
928313|NCT00908596|1911401|FG003|Overall Study|Death|32
928314|NCT00908596|1911398|FG000|Overall Study|Protocol Violation|1
928315|NCT00908596|1911399|FG001|Overall Study|Protocol Violation|0
928316|NCT00908596|1911400|FG002|Overall Study|Protocol Violation|0
928317|NCT00908596|1911401|FG003|Overall Study|Protocol Violation|0
928318|NCT00908596|1911398|FG000|Overall Study|Withdrawal by Subject|0
928319|NCT00908596|1911399|FG001|Overall Study|Withdrawal by Subject|1
928320|NCT00908596|1911400|FG002|Overall Study|Withdrawal by Subject|3
928321|NCT00908596|1911401|FG003|Overall Study|Withdrawal by Subject|1
928322|NCT00908895|1911476|FG000|Overall Study|Lost to Follow-up|1
928323|NCT00908895|1911477|FG001|Overall Study|Lost to Follow-up|3
928324|NCT00908895|1911476|FG000|Overall Study|algodystrophy|2
928325|NCT00908895|1911477|FG001|Overall Study|algodystrophy|2
928326|NCT00908895|1911476|FG000|Overall Study|Adverse Event|1
928327|NCT00908895|1911477|FG001|Overall Study|Adverse Event|1
928328|NCT00908960|1911495|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1
928329|NCT00908960|1911496|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1
928330|NCT00908960|1911497|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2
928331|NCT00909038|1911505|FG000|Overall Study|Protocol Violation|187
928332|NCT00909038|1911505|FG000|Overall Study|Non-evaluable Subjects|230
928333|NCT00909090|1911515|FG000|Overall Study|Lost to Follow-up|17
928334|NCT00909090|1911516|FG001|Overall Study|Lost to Follow-up|17
928335|NCT00909181|1911544|FG000|Overall Study|Lost to Follow-up|39
928336|NCT00909181|1911545|FG001|Overall Study|Lost to Follow-up|18
928337|NCT00909181|1911546|FG002|Overall Study|Lost to Follow-up|33
928338|NCT00909363|1911577|FG000|Overall Study|Withdrawal by Subject|1
928339|NCT00909363|1911578|FG001|Overall Study|Withdrawal by Subject|0
928340|NCT00909363|1911579|FG002|Overall Study|Withdrawal by Subject|0
928341|NCT00909363|1911577|FG000|Overall Study|Lack of Efficacy|1
928342|NCT00909363|1911578|FG001|Overall Study|Lack of Efficacy|0
928343|NCT00909363|1911579|FG002|Overall Study|Lack of Efficacy|0
928344|NCT00909389|1911590|FG000|Overall Study|Adverse Event|6
928345|NCT00909389|1911590|FG000|Overall Study|Death|4
928346|NCT00909389|1911590|FG000|Overall Study|Poor Compliance|16
928347|NCT00909389|1911590|FG000|Overall Study|Lost to Follow-up|4
928348|NCT00909389|1911590|FG000|Overall Study|No Information|103
928349|NCT00909428|1911597|FG000|Overall Study|Lost to Follow-up|13
928350|NCT00909428|1911598|FG001|Overall Study|Lost to Follow-up|10
928351|NCT00909428|1911599|FG002|Overall Study|Lost to Follow-up|9
928352|NCT00909480|1911608|FG000|Overall Study|Adverse Event|5
928353|NCT00909480|1911609|FG001|Overall Study|Adverse Event|3
928354|NCT00909480|1911608|FG000|Overall Study|Protocol Violation|6
928355|NCT00909480|1911609|FG001|Overall Study|Protocol Violation|8
928356|NCT00909480|1911608|FG000|Overall Study|Withdrawal criteria|9
928357|NCT00909480|1911609|FG001|Overall Study|Withdrawal criteria|11
928358|NCT00909480|1911608|FG000|Overall Study|Unclassified|18
928359|NCT00909480|1911609|FG001|Overall Study|Unclassified|19
928360|NCT00909532|1911617|FG000|Overall Study|Adverse Event|4
928361|NCT00909532|1911618|FG001|Overall Study|Adverse Event|1
928362|NCT00909532|1911617|FG000|Overall Study|Pregnancy|0
928363|NCT00909532|1911618|FG001|Overall Study|Pregnancy|1
928364|NCT00909532|1911617|FG000|Overall Study|Prohibited Medication|2
928365|NCT00909532|1911618|FG001|Overall Study|Prohibited Medication|1
928366|NCT00909532|1911617|FG000|Overall Study|Withdrawal of Consent|1
928367|NCT00909532|1911618|FG001|Overall Study|Withdrawal of Consent|1
928368|NCT00909532|1911617|FG000|Overall Study|Noncompliance with Study Requirements|0
928369|NCT00909532|1911618|FG001|Overall Study|Noncompliance with Study Requirements|2
928370|NCT00909532|1911617|FG000|Overall Study|Physician Decision|1
928371|NCT00909532|1911618|FG001|Overall Study|Physician Decision|0
928372|NCT00909532|1911617|FG000|Overall Study|Wrong Genotype|1
928373|NCT00909532|1911618|FG001|Overall Study|Wrong Genotype|0
928374|NCT00909532|1911617|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
928375|NCT00909532|1911618|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
928376|NCT00909610|1911645|FG000|Period: First Intervention|Adverse Event|0
928377|NCT00909610|1911646|FG001|Period: First Intervention|Adverse Event|1
928378|NCT00909610|1911645|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3
928379|NCT00909610|1911646|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6
928380|NCT00909610|1911645|FG000|Period: Second Intervention|Adverse Event|1
928381|NCT00909610|1911646|FG001|Period: Second Intervention|Adverse Event|0
928382|NCT00909727|1911660|FG000|Overall Study|Adverse Event|1
928383|NCT00909727|1911661|FG001|Overall Study|Adverse Event|0
928384|NCT00909727|1911660|FG000|Overall Study|Wrong Genotype|1
928385|NCT00909727|1911661|FG001|Overall Study|Wrong Genotype|0
928386|NCT00909727|1911660|FG000|Overall Study|Withdrawal of Consent|1
928387|NCT00909727|1911661|FG001|Overall Study|Withdrawal of Consent|0
928388|NCT00909727|1911660|FG000|Overall Study|Prohibited Medication|1
928389|NCT00909727|1911661|FG001|Overall Study|Prohibited Medication|0
928390|NCT00909753|1911669|FG000|Period: Washout of 28 Days|Protocol Violation|2
928391|NCT00909753|1911670|FG001|Period: Washout of 28 Days|Protocol Violation|3
928392|NCT00909753|1911669|FG000|Period: Second Intervention|Protocol Violation|1
928393|NCT00909753|1911670|FG001|Period: Second Intervention|Protocol Violation|0
928394|NCT00909779|1911676|FG000|Overall Study|Adverse Event|53
928395|NCT00909779|1911677|FG001|Overall Study|Adverse Event|55
928396|NCT00909779|1911676|FG000|Overall Study|Lack of Efficacy|7
928397|NCT00909779|1911677|FG001|Overall Study|Lack of Efficacy|4
928398|NCT00909779|1911676|FG000|Overall Study|Lost to Follow-up|19
928399|NCT00909779|1911677|FG001|Overall Study|Lost to Follow-up|15
928400|NCT00909779|1911676|FG000|Overall Study|Physician Decision|8
928401|NCT00909779|1911677|FG001|Overall Study|Physician Decision|2
928402|NCT00909779|1911676|FG000|Overall Study|Protocol Violation|2
928403|NCT00909779|1911677|FG001|Overall Study|Protocol Violation|5
928404|NCT00909779|1911676|FG000|Overall Study|Withdrawal by Subject|116
928405|NCT00909779|1911677|FG001|Overall Study|Withdrawal by Subject|80
928406|NCT00909779|1911676|FG000|Overall Study|Site Ceasing Operation|2
928407|NCT00909779|1911677|FG001|Overall Study|Site Ceasing Operation|2
928408|NCT00909779|1911676|FG000|Overall Study|Medical Monitor Decision|1
928409|NCT00909779|1911677|FG001|Overall Study|Medical Monitor Decision|0
928410|NCT00909779|1911676|FG000|Overall Study|Noncompliance|1
928411|NCT00909779|1911677|FG001|Overall Study|Noncompliance|1
928412|NCT00909779|1911676|FG000|Overall Study|Randomized in error|1
928413|NCT00909779|1911677|FG001|Overall Study|Randomized in error|1
928414|NCT00909792|1911685|FG000|Period 1|Did not meet inclusion criteria|0
928415|NCT00909792|1911686|FG001|Period 1|Did not meet inclusion criteria|1
928416|NCT00909792|1911685|FG000|Period 2|Biomicroscopy|1
928417|NCT00909792|1911686|FG001|Period 2|Biomicroscopy|0
928418|NCT00909792|1911685|FG000|Period 2|Lost to Follow-up|0
928419|NCT00909792|1911686|FG001|Period 2|Lost to Follow-up|1
928420|NCT00909844|1911692|FG000|Overall Study|Adverse Event|1
928421|NCT00909844|1911692|FG000|Overall Study|Withdrawal by Subject|1
928422|NCT00909844|1911692|FG000|Overall Study|Lost to Follow-up|2
928423|NCT00909857|1911699|FG000|Overall Study|Withdrawal by Subject|6
928424|NCT00909857|1911700|FG001|Overall Study|Withdrawal by Subject|10
928425|NCT00909857|1911699|FG000|Overall Study|Adverse Event|5
928426|NCT00909857|1911700|FG001|Overall Study|Adverse Event|5
928427|NCT00909857|1911699|FG000|Overall Study|Lost to Follow-up|2
928428|NCT00909857|1911700|FG001|Overall Study|Lost to Follow-up|5
928429|NCT00909857|1911699|FG000|Overall Study|Protocol Violation|2
928430|NCT00909857|1911700|FG001|Overall Study|Protocol Violation|1
928431|NCT00909857|1911699|FG000|Overall Study|Pregnancy|1
928432|NCT00909857|1911700|FG001|Overall Study|Pregnancy|0
928433|NCT00909857|1911699|FG000|Overall Study|Other|1
928434|NCT00909857|1911700|FG001|Overall Study|Other|0
928435|NCT00909857|1911699|FG000|Overall Study|Did not receive study medication|19
928436|NCT00909857|1911700|FG001|Overall Study|Did not receive study medication|24
928437|NCT00909870|1911708|FG000|Overall Study|Adverse Event|13
928438|NCT00909870|1911709|FG001|Overall Study|Adverse Event|7
928439|NCT00909870|1911708|FG000|Overall Study|Protocol Violation|1
928440|NCT00909870|1911709|FG001|Overall Study|Protocol Violation|2
928441|NCT00909870|1911708|FG000|Overall Study|Withdrawal by Subject|5
928442|NCT00909870|1911709|FG001|Overall Study|Withdrawal by Subject|8
928443|NCT00909870|1911708|FG000|Overall Study|Lost to Follow-up|3
928444|NCT00909870|1911709|FG001|Overall Study|Lost to Follow-up|3
928445|NCT00909870|1911708|FG000|Overall Study|Physician Decision|0
928446|NCT00909870|1911709|FG001|Overall Study|Physician Decision|2
928447|NCT00909870|1911708|FG000|Overall Study|Other|1
928448|NCT00909870|1911709|FG001|Overall Study|Other|5
928449|NCT00910000|1911722|FG000|Overall Study|Adverse Event|0
928450|NCT00910000|1911723|FG001|Overall Study|Adverse Event|3
928451|NCT00910000|1911724|FG002|Overall Study|Adverse Event|2
928452|NCT00910000|1911725|FG003|Overall Study|Adverse Event|2
928453|NCT00910000|1911726|FG004|Overall Study|Adverse Event|0
928454|NCT00910000|1911727|FG005|Overall Study|Adverse Event|1
928455|NCT00910000|1911722|FG000|Overall Study|Withdrawal by Subject|0
928456|NCT00910000|1911723|FG001|Overall Study|Withdrawal by Subject|0
928457|NCT00910000|1911724|FG002|Overall Study|Withdrawal by Subject|1
928458|NCT00910000|1911725|FG003|Overall Study|Withdrawal by Subject|0
928459|NCT00910000|1911726|FG004|Overall Study|Withdrawal by Subject|1
928460|NCT00910000|1911727|FG005|Overall Study|Withdrawal by Subject|0
928461|NCT00910039|1911737|FG000|Overall Study|Physician Decision|1
928462|NCT00910091|1911744|FG000|Pre-assignment|Withdrawal by Subject|0
928463|NCT00910091|1911745|FG001|Pre-assignment|Withdrawal by Subject|2
928464|NCT00910091|1911744|FG000|Treatment and Survival|Withdrawal by Subject|3
928465|NCT00910091|1911745|FG001|Treatment and Survival|Withdrawal by Subject|4
928466|NCT00910091|1911744|FG000|Treatment and Survival|Adverse Event|1
928467|NCT00910091|1911745|FG001|Treatment and Survival|Adverse Event|0
928468|NCT00910247|1911765|FG000|Overall Study|Adverse Event|15
928469|NCT00910247|1911765|FG000|Overall Study|Death|2
928470|NCT00910247|1911765|FG000|Overall Study|Lost to Follow-up|10
928471|NCT00910247|1911765|FG000|Overall Study|Physician Decision|3
928472|NCT00910247|1911765|FG000|Overall Study|Protocol Violation|10
928473|NCT00910247|1911765|FG000|Overall Study|Withdrawal by Subject|25
928474|NCT00910247|1911765|FG000|Overall Study|Not collected|4
928475|NCT00910273|1911771|FG000|Overall Study|Lack of Efficacy|6
928476|NCT00910273|1911772|FG001|Overall Study|Lack of Efficacy|9
928477|NCT00910273|1911771|FG000|Overall Study|Adverse Event|1
928478|NCT00910273|1911772|FG001|Overall Study|Adverse Event|1
928479|NCT00910273|1911771|FG000|Overall Study|Withdrawal by Subject|1
928480|NCT00910273|1911772|FG001|Overall Study|Withdrawal by Subject|0
928481|NCT00910273|1911771|FG000|Overall Study|Discontinuation of study by sponsor|8
928482|NCT00910273|1911772|FG001|Overall Study|Discontinuation of study by sponsor|2
928483|NCT00910273|1911771|FG000|Overall Study|Protocol Violation|1
928484|NCT00910273|1911772|FG001|Overall Study|Protocol Violation|0
928485|NCT00910273|1911771|FG000|Overall Study|Lost to Follow-up|1
928486|NCT00910273|1911772|FG001|Overall Study|Lost to Follow-up|1
928487|NCT00910299|1911780|FG000|Overall Study|Withdrawal by Subject|16
928488|NCT00910299|1911781|FG001|Overall Study|Withdrawal by Subject|13
928489|NCT00910299|1911780|FG000|Overall Study|Sponsor Decision|58
928490|NCT00910299|1911781|FG001|Overall Study|Sponsor Decision|60
928491|NCT00910299|1911780|FG000|Overall Study|Didn't receive any study drug|2
928492|NCT00910299|1911781|FG001|Overall Study|Didn't receive any study drug|1
928493|NCT00910429|1911789|FG000|Overall Study|Death|18
928494|NCT00910429|1911790|FG001|Overall Study|Death|12
928495|NCT00910429|1911789|FG000|Overall Study|Withdrawal by Subject|3
928496|NCT00910429|1911790|FG001|Overall Study|Withdrawal by Subject|2
928497|NCT00910429|1911789|FG000|Overall Study|Protocol Violation|1
928498|NCT00910429|1911790|FG001|Overall Study|Protocol Violation|0
928499|NCT00910429|1911789|FG000|Overall Study|Lost to Follow-up|2
928500|NCT00910429|1911790|FG001|Overall Study|Lost to Follow-up|1
928501|NCT00910429|1911789|FG000|Overall Study|Adverse Event|10
928502|NCT00910429|1911790|FG001|Overall Study|Adverse Event|5
928503|NCT00910429|1911789|FG000|Overall Study|Drug non-compliance|1
928504|NCT00910429|1911790|FG001|Overall Study|Drug non-compliance|0
928505|NCT00910429|1911789|FG000|Overall Study|Lack of Efficacy|4
928506|NCT00910429|1911790|FG001|Overall Study|Lack of Efficacy|1
928507|NCT00910624|1911818|FG000|Treatment Phase|Adverse Event|2
928508|NCT00910624|1911819|FG001|Treatment Phase|Adverse Event|6
928509|NCT00910624|1911820|FG002|Treatment Phase|Adverse Event|6
928510|NCT00910624|1911821|FG003|Treatment Phase|Adverse Event|0
928511|NCT00910624|1911818|FG000|Treatment Phase|Treatment Failure|23
928512|NCT00910624|1911819|FG001|Treatment Phase|Treatment Failure|10
928513|NCT00910624|1911820|FG002|Treatment Phase|Treatment Failure|0
928514|NCT00910624|1911821|FG003|Treatment Phase|Treatment Failure|0
928515|NCT00910624|1911818|FG000|Treatment Phase|Lost to Follow-up|0
928516|NCT00910624|1911819|FG001|Treatment Phase|Lost to Follow-up|0
928517|NCT00910624|1911820|FG002|Treatment Phase|Lost to Follow-up|1
928518|NCT00910624|1911821|FG003|Treatment Phase|Lost to Follow-up|0
928519|NCT00910624|1911818|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
928520|NCT00910624|1911819|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
928521|NCT00910624|1911820|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
928522|NCT00910624|1911821|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
928523|NCT00910624|1911818|FG000|Treatment Phase|Withdrawal by Subject|2
928524|NCT00910624|1911819|FG001|Treatment Phase|Withdrawal by Subject|1
928525|NCT00910624|1911820|FG002|Treatment Phase|Withdrawal by Subject|0
928526|NCT00910624|1911821|FG003|Treatment Phase|Withdrawal by Subject|0
928527|NCT00910624|1911818|FG000|Treatment Phase|Non-Compliance With Protocol|0
928528|NCT00910624|1911819|FG001|Treatment Phase|Non-Compliance With Protocol|1
928529|NCT00910624|1911820|FG002|Treatment Phase|Non-Compliance With Protocol|1
928530|NCT00910624|1911821|FG003|Treatment Phase|Non-Compliance With Protocol|0
928531|NCT00910624|1911818|FG000|Follow-Up Phase|Adverse Event|0
928532|NCT00910624|1911819|FG001|Follow-Up Phase|Adverse Event|0
928533|NCT00910624|1911820|FG002|Follow-Up Phase|Adverse Event|1
928534|NCT00910624|1911821|FG003|Follow-Up Phase|Adverse Event|0
928535|NCT00910624|1911818|FG000|Follow-Up Phase|Lost to Follow-up|3
928536|NCT00910624|1911819|FG001|Follow-Up Phase|Lost to Follow-up|1
928537|NCT00910624|1911820|FG002|Follow-Up Phase|Lost to Follow-up|2
928538|NCT00910624|1911821|FG003|Follow-Up Phase|Lost to Follow-up|0
928539|NCT00910624|1911818|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
928540|NCT00910624|1911819|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
928541|NCT00910624|1911820|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
928542|NCT00910624|1911821|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
928543|NCT00910624|1911818|FG000|Follow-Up Phase|Withdrawal by Subject|1
928544|NCT00910624|1911819|FG001|Follow-Up Phase|Withdrawal by Subject|0
928545|NCT00910624|1911820|FG002|Follow-Up Phase|Withdrawal by Subject|0
928546|NCT00910624|1911821|FG003|Follow-Up Phase|Withdrawal by Subject|0
928547|NCT00910624|1911818|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
928548|NCT00910624|1911819|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
928549|NCT00910624|1911820|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
928550|NCT00910624|1911821|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
928551|NCT00910624|1911818|FG000|Follow-Up Phase|Administrative|0
928552|NCT00910624|1911819|FG001|Follow-Up Phase|Administrative|1
928553|NCT00910624|1911820|FG002|Follow-Up Phase|Administrative|1
928554|NCT00910624|1911821|FG003|Follow-Up Phase|Administrative|0
928556|NCT00910663|1911835|FG000|Period 1|Withdrawal by Subject|0
928557|NCT00910663|1911836|FG001|Period 1|Withdrawal by Subject|1
928558|NCT00910689|1911846|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
928559|NCT00910689|1911847|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
928560|NCT00910689|1911848|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
928561|NCT00910689|1911849|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
928562|NCT00910689|1911846|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3
928563|NCT00910689|1911847|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4
928564|NCT00910689|1911848|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1
928565|NCT00910689|1911849|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3
928566|NCT00910689|1911846|FG000|Month 2- 4: Treatment Period|Adverse Event|2
928567|NCT00910689|1911847|FG001|Month 2- 4: Treatment Period|Adverse Event|3
928568|NCT00910689|1911848|FG002|Month 2- 4: Treatment Period|Adverse Event|2
928569|NCT00910689|1911849|FG003|Month 2- 4: Treatment Period|Adverse Event|0
928570|NCT00910689|1911846|FG000|Month 2- 4: Treatment Period|Time Demands|1
928571|NCT00910689|1911847|FG001|Month 2- 4: Treatment Period|Time Demands|0
928572|NCT00910689|1911848|FG002|Month 2- 4: Treatment Period|Time Demands|4
928573|NCT00910689|1911849|FG003|Month 2- 4: Treatment Period|Time Demands|8
928574|NCT00910689|1911846|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2
928575|NCT00910689|1911847|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1
928576|NCT00910689|1911848|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0
928577|NCT00910689|1911849|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0
928578|NCT00910689|1911846|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0
928579|NCT00910689|1911847|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0
928580|NCT00910689|1911848|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1
928581|NCT00910689|1911849|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0
928582|NCT00910689|1911846|FG000|Month 2- 4: Treatment Period|Pregnancy|0
928583|NCT00910689|1911847|FG001|Month 2- 4: Treatment Period|Pregnancy|2
928584|NCT00910689|1911848|FG002|Month 2- 4: Treatment Period|Pregnancy|0
928585|NCT00910689|1911849|FG003|Month 2- 4: Treatment Period|Pregnancy|0
928586|NCT00910689|1911846|FG000|Month 2- 4: Treatment Period|Protocol Violation|1
928587|NCT00910689|1911847|FG001|Month 2- 4: Treatment Period|Protocol Violation|0
928588|NCT00910689|1911848|FG002|Month 2- 4: Treatment Period|Protocol Violation|0
928589|NCT00910689|1911849|FG003|Month 2- 4: Treatment Period|Protocol Violation|0
928590|NCT00910689|1911846|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
928591|NCT00910689|1911847|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
928592|NCT00910689|1911848|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
928593|NCT00910689|1911849|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
928594|NCT00910689|1911846|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1
928595|NCT00910689|1911847|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0
928596|NCT00910689|1911848|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2
928597|NCT00910689|1911849|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4
928598|NCT00910689|1911846|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
928599|NCT00910689|1911847|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
928600|NCT00910689|1911848|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
928601|NCT00910689|1911849|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
928602|NCT00910689|1911846|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1
928603|NCT00910689|1911847|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1
928604|NCT00910689|1911848|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0
928605|NCT00910689|1911849|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0
928606|NCT00910689|1911846|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0
928607|NCT00910689|1911847|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0
928608|NCT00910689|1911848|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2
928609|NCT00910689|1911849|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0
928610|NCT00910689|1911846|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0
928611|NCT00910689|1911847|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0
928612|NCT00910689|1911848|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1
928613|NCT00910689|1911849|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1
928614|NCT00910689|1911846|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
928615|NCT00910689|1911847|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
928616|NCT00910689|1911848|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
928617|NCT00910689|1911849|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
928618|NCT00910689|1911846|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2
928619|NCT00910689|1911847|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4
928620|NCT00910689|1911848|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2
928621|NCT00910689|1911849|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2
928622|NCT00910689|1911846|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1
928623|NCT00910689|1911847|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0
928624|NCT00910689|1911848|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0
928625|NCT00910689|1911849|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0
928626|NCT00910689|1911846|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
928627|NCT00910689|1911847|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
928628|NCT00910689|1911848|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
928629|NCT00910689|1911849|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
928630|NCT00910689|1911846|FG000|Months 11- 16: Evaluation Period II|Time Demands|2
928631|NCT00910689|1911847|FG001|Months 11- 16: Evaluation Period II|Time Demands|1
928632|NCT00910689|1911848|FG002|Months 11- 16: Evaluation Period II|Time Demands|0
928633|NCT00910689|1911849|FG003|Months 11- 16: Evaluation Period II|Time Demands|0
928634|NCT00910689|1911846|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0
928635|NCT00910689|1911847|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0
928636|NCT00910689|1911848|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0
928637|NCT00910689|1911849|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1
928638|NCT00910689|1911846|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0
928639|NCT00910689|1911847|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2
928640|NCT00910689|1911848|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1
928641|NCT00910689|1911849|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0
928642|NCT00910715|1911862|FG000|Overall Study|Lost to Follow-up|22
928643|NCT00910715|1911863|FG001|Overall Study|Lost to Follow-up|26
928644|NCT00910715|1911864|FG002|Overall Study|Lost to Follow-up|0
928645|NCT00910728|1911883|FG000|Overall Study|Lack of Efficacy|2
928646|NCT00910728|1911884|FG001|Overall Study|Lack of Efficacy|3
928647|NCT00910728|1911885|FG002|Overall Study|Lack of Efficacy|1
928648|NCT00910728|1911886|FG003|Overall Study|Lack of Efficacy|2
928649|NCT00910728|1911887|FG004|Overall Study|Lack of Efficacy|1
928650|NCT00910728|1911888|FG005|Overall Study|Lack of Efficacy|0
928651|NCT00910728|1911889|FG006|Overall Study|Lack of Efficacy|2
928652|NCT00910728|1911890|FG007|Overall Study|Lack of Efficacy|2
928653|NCT00910728|1911891|FG008|Overall Study|Lack of Efficacy|2
928654|NCT00910728|1911883|FG000|Overall Study|Withdrawal by Subject|0
928655|NCT00910728|1911884|FG001|Overall Study|Withdrawal by Subject|0
928656|NCT00910728|1911885|FG002|Overall Study|Withdrawal by Subject|0
928657|NCT00910728|1911886|FG003|Overall Study|Withdrawal by Subject|0
928658|NCT00910728|1911887|FG004|Overall Study|Withdrawal by Subject|3
928659|NCT00910728|1911888|FG005|Overall Study|Withdrawal by Subject|1
928660|NCT00910728|1911889|FG006|Overall Study|Withdrawal by Subject|2
928661|NCT00910728|1911890|FG007|Overall Study|Withdrawal by Subject|0
928662|NCT00910728|1911891|FG008|Overall Study|Withdrawal by Subject|0
928663|NCT00910728|1911883|FG000|Overall Study|(not specified)|2
928664|NCT00910728|1911884|FG001|Overall Study|(not specified)|0
928665|NCT00910728|1911885|FG002|Overall Study|(not specified)|1
928666|NCT00910728|1911886|FG003|Overall Study|(not specified)|0
928667|NCT00910728|1911887|FG004|Overall Study|(not specified)|1
928668|NCT00910728|1911888|FG005|Overall Study|(not specified)|0
928669|NCT00910728|1911889|FG006|Overall Study|(not specified)|0
928670|NCT00910728|1911890|FG007|Overall Study|(not specified)|0
928671|NCT00910728|1911891|FG008|Overall Study|(not specified)|0
928672|NCT00910728|1911883|FG000|Overall Study|Adverse Event|2
928673|NCT00910728|1911884|FG001|Overall Study|Adverse Event|0
928674|NCT00910728|1911885|FG002|Overall Study|Adverse Event|1
928675|NCT00910728|1911886|FG003|Overall Study|Adverse Event|1
928676|NCT00910728|1911887|FG004|Overall Study|Adverse Event|0
928677|NCT00910728|1911888|FG005|Overall Study|Adverse Event|0
928678|NCT00910728|1911889|FG006|Overall Study|Adverse Event|2
928679|NCT00910728|1911890|FG007|Overall Study|Adverse Event|1
928680|NCT00910728|1911891|FG008|Overall Study|Adverse Event|1
928681|NCT00910858|1911923|FG000|Pharmacokinetic Phase|Adverse Event|1
928682|NCT00910858|1911924|FG001|Pharmacokinetic Phase|Adverse Event|0
928683|NCT00910858|1911925|FG002|Pharmacokinetic Phase|Adverse Event|0
928684|NCT00910858|1911923|FG000|Monotherapy Phase|Adverse Event|3
928685|NCT00910858|1911924|FG001|Monotherapy Phase|Adverse Event|2
928686|NCT00910858|1911925|FG002|Monotherapy Phase|Adverse Event|0
928687|NCT00910858|1911923|FG000|Monotherapy Phase|Lack of therapeutic effect|9
928688|NCT00910858|1911924|FG001|Monotherapy Phase|Lack of therapeutic effect|6
928689|NCT00910858|1911925|FG002|Monotherapy Phase|Lack of therapeutic effect|4
928690|NCT00910858|1911923|FG000|Monotherapy Phase|Withdrawal by Subject|1
928691|NCT00910858|1911924|FG001|Monotherapy Phase|Withdrawal by Subject|3
928692|NCT00910858|1911925|FG002|Monotherapy Phase|Withdrawal by Subject|1
928693|NCT00910858|1911923|FG000|Monotherapy Phase|Protocol Violation|1
928694|NCT00910858|1911924|FG001|Monotherapy Phase|Protocol Violation|0
928695|NCT00910858|1911925|FG002|Monotherapy Phase|Protocol Violation|0
928696|NCT00910858|1911923|FG000|Monotherapy Phase|Other|3
928697|NCT00910858|1911924|FG001|Monotherapy Phase|Other|4
928698|NCT00910858|1911925|FG002|Monotherapy Phase|Other|2
928699|NCT00910858|1911923|FG000|Combined Treatment Phase|Lack of therapeutic effect|8
928700|NCT00910858|1911924|FG001|Combined Treatment Phase|Lack of therapeutic effect|6
928701|NCT00910858|1911925|FG002|Combined Treatment Phase|Lack of therapeutic effect|3
928702|NCT00910858|1911923|FG000|Combined Treatment Phase|Withdrawal by Subject|0
928703|NCT00910858|1911924|FG001|Combined Treatment Phase|Withdrawal by Subject|2
928704|NCT00910858|1911925|FG002|Combined Treatment Phase|Withdrawal by Subject|0
928705|NCT00910858|1911923|FG000|Combined Treatment Phase|Protocol Violation|1
928706|NCT00910858|1911924|FG001|Combined Treatment Phase|Protocol Violation|0
928707|NCT00910858|1911925|FG002|Combined Treatment Phase|Protocol Violation|0
928708|NCT00910858|1911923|FG000|Combined Treatment Phase|Other|0
928709|NCT00910858|1911924|FG001|Combined Treatment Phase|Other|2
928710|NCT00910858|1911925|FG002|Combined Treatment Phase|Other|1
928711|NCT00910871|1911941|FG000|Overall Study|Adverse Event|5
928712|NCT00910871|1911941|FG000|Overall Study|Death|12
928713|NCT00910871|1911941|FG000|Overall Study|Lost to Follow-up|8
928714|NCT00910871|1911941|FG000|Overall Study|Protocol Violation|11
928715|NCT00910871|1911941|FG000|Overall Study|Withdrawal by Subject|12
928716|NCT00910871|1911941|FG000|Overall Study|Subject didn't meet eligibility criteria|5
928717|NCT00910871|1911941|FG000|Overall Study|Undefined|1
928718|NCT00910910|1911947|FG000|Overall Study|Adverse Event|63
928719|NCT00910910|1911948|FG001|Overall Study|Adverse Event|35
928720|NCT00910910|1911947|FG000|Overall Study|PD without histologic change|27
928721|NCT00910910|1911948|FG001|Overall Study|PD without histologic change|23
928722|NCT00910910|1911947|FG000|Overall Study|PD with histologic change|0
928723|NCT00910910|1911948|FG001|Overall Study|PD with histologic change|2
928724|NCT00910910|1911947|FG000|Overall Study|Withdrawal by Subject|7
928725|NCT00910910|1911948|FG001|Overall Study|Withdrawal by Subject|5
928726|NCT00910910|1911947|FG000|Overall Study|Lost to Follow-up|2
928727|NCT00910910|1911948|FG001|Overall Study|Lost to Follow-up|2
928728|NCT00910910|1911947|FG000|Overall Study|Death|9
928729|NCT00910910|1911948|FG001|Overall Study|Death|3
928730|NCT00910910|1911947|FG000|Overall Study|Protocol Violation|2
928731|NCT00910910|1911948|FG001|Overall Study|Protocol Violation|2
928732|NCT00910910|1911947|FG000|Overall Study|Completed 13 cycles of treatment|0
928733|NCT00910910|1911948|FG001|Overall Study|Completed 13 cycles of treatment|118
928734|NCT00910910|1911947|FG000|Overall Study|Other|114
928735|NCT00910910|1911948|FG001|Overall Study|Other|32
928736|NCT00910910|1911947|FG000|Overall Study|Untreated before cycle 1|1
928737|NCT00910910|1911948|FG001|Overall Study|Untreated before cycle 1|2
928738|NCT00910962|1911957|FG000|Overall Study|Adverse Event|5
928739|NCT00910962|1911958|FG001|Overall Study|Adverse Event|20
928740|NCT00910962|1911959|FG002|Overall Study|Adverse Event|17
928741|NCT00910962|1911957|FG000|Overall Study|Protocol Violation|1
928742|NCT00910962|1911958|FG001|Overall Study|Protocol Violation|3
928743|NCT00910962|1911959|FG002|Overall Study|Protocol Violation|3
928744|NCT00910962|1911957|FG000|Overall Study|Lost to Follow-up|0
928745|NCT00910962|1911958|FG001|Overall Study|Lost to Follow-up|3
928746|NCT00910962|1911959|FG002|Overall Study|Lost to Follow-up|1
928747|NCT00910962|1911957|FG000|Overall Study|Physician Decision|0
928748|NCT00910962|1911958|FG001|Overall Study|Physician Decision|6
928749|NCT00910962|1911959|FG002|Overall Study|Physician Decision|6
928750|NCT00910962|1911957|FG000|Overall Study|Withdrawal by Subject|25
928751|NCT00910962|1911958|FG001|Overall Study|Withdrawal by Subject|32
928752|NCT00910962|1911959|FG002|Overall Study|Withdrawal by Subject|32
928753|NCT00910962|1911957|FG000|Overall Study|Reached defined stopping criteria|12
928754|NCT00910962|1911958|FG001|Overall Study|Reached defined stopping criteria|14
928755|NCT00910962|1911959|FG002|Overall Study|Reached defined stopping criteria|17
928756|NCT00910988|1911973|FG000|Overall Study|Lost to Follow-up|2
928757|NCT00910988|1911974|FG001|Overall Study|Lost to Follow-up|4
928758|NCT00910988|1911975|FG002|Overall Study|Lost to Follow-up|3
928759|NCT00910988|1911976|FG003|Overall Study|Lost to Follow-up|0
928760|NCT00911144|1912004|FG000|Overall Study|Withdrawal by Subject|16
928761|NCT00911144|1912005|FG001|Overall Study|Withdrawal by Subject|5
928762|NCT00911157|1912013|FG000|Overall Study|Adverse Event|4
928763|NCT00911157|1912014|FG001|Overall Study|Adverse Event|1
928764|NCT00911157|1912013|FG000|Overall Study|Withdrawal by Subject|1
928765|NCT00911157|1912014|FG001|Overall Study|Withdrawal by Subject|1
928766|NCT00911157|1912013|FG000|Overall Study|Need for prohibited drug (heparin)|1
928767|NCT00911157|1912014|FG001|Overall Study|Need for prohibited drug (heparin)|0
928768|NCT00911157|1912013|FG000|Overall Study|Need to treat for lung cancer|1
928769|NCT00911157|1912014|FG001|Overall Study|Need to treat for lung cancer|0
928770|NCT00911170|1912022|FG000|Treatment Period|Randomized in error|1
928771|NCT00911170|1912023|FG001|Treatment Period|Randomized in error|1
928772|NCT00911170|1912022|FG000|Treatment Period|Ineligibility determined|1
928773|NCT00911170|1912023|FG001|Treatment Period|Ineligibility determined|3
928774|NCT00911170|1912022|FG000|Treatment Period|Protocol deviation|1
928775|NCT00911170|1912023|FG001|Treatment Period|Protocol deviation|2
928776|NCT00911170|1912022|FG000|Treatment Period|Adverse Event|9
928777|NCT00911170|1912023|FG001|Treatment Period|Adverse Event|10
928778|NCT00911170|1912022|FG000|Treatment Period|Withdrawal by Subject|4
928779|NCT00911170|1912023|FG001|Treatment Period|Withdrawal by Subject|4
928780|NCT00911170|1912022|FG000|Treatment Period|Disease progression|0
928781|NCT00911170|1912023|FG001|Treatment Period|Disease progression|2
928782|NCT00911170|1912022|FG000|Treatment Period|Physician Decision|5
928783|NCT00911170|1912023|FG001|Treatment Period|Physician Decision|5
928784|NCT00911170|1912022|FG000|Treatment Period|Lost to Follow-up|0
928785|NCT00911170|1912023|FG001|Treatment Period|Lost to Follow-up|1
928786|NCT00911170|1912022|FG000|Treatment Period|Death|6
928787|NCT00911170|1912023|FG001|Treatment Period|Death|9
928788|NCT00911170|1912022|FG000|Long Term Follow-Up|Continuing in study|274
928789|NCT00911170|1912023|FG001|Long Term Follow-Up|Continuing in study|269
928790|NCT00911170|1912022|FG000|Long Term Follow-Up|Withdrawal by Subject|20
928791|NCT00911170|1912023|FG001|Long Term Follow-Up|Withdrawal by Subject|21
928792|NCT00911170|1912022|FG000|Long Term Follow-Up|Physician Decision|5
928793|NCT00911170|1912023|FG001|Long Term Follow-Up|Physician Decision|4
928794|NCT00911170|1912022|FG000|Long Term Follow-Up|Lost to Follow-up|8
928795|NCT00911170|1912023|FG001|Long Term Follow-Up|Lost to Follow-up|7
928796|NCT00911170|1912022|FG000|Long Term Follow-Up|Death|116
928797|NCT00911170|1912023|FG001|Long Term Follow-Up|Death|121
928798|NCT00911300|1912038|FG000|Overall Study|Primary Endpoint Component Occurred|1
928799|NCT00911300|1912039|FG001|Overall Study|Primary Endpoint Component Occurred|2
928800|NCT00911300|1912038|FG000|Overall Study|Death|1
928801|NCT00911300|1912039|FG001|Overall Study|Death|0
928802|NCT00911300|1912038|FG000|Overall Study|Thrombus Persistant in Second TEE|3
928803|NCT00911300|1912039|FG001|Overall Study|Thrombus Persistant in Second TEE|7
928804|NCT00911300|1912038|FG000|Overall Study|Adverse Event|14
928805|NCT00911300|1912039|FG001|Overall Study|Adverse Event|6
928806|NCT00911300|1912038|FG000|Overall Study|Protocol Violation|3
928807|NCT00911300|1912039|FG001|Overall Study|Protocol Violation|2
928808|NCT00911300|1912038|FG000|Overall Study|Consent Withdrawn|4
928809|NCT00911300|1912039|FG001|Overall Study|Consent Withdrawn|12
928810|NCT00911300|1912038|FG000|Overall Study|Coronary Angiography Performed|1
928811|NCT00911300|1912039|FG001|Overall Study|Coronary Angiography Performed|0
928812|NCT00911300|1912038|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3
928813|NCT00911300|1912039|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3
928814|NCT00911300|1912038|FG000|Overall Study|Received Commercial Treatment|1
928815|NCT00911300|1912039|FG001|Overall Study|Received Commercial Treatment|0
928816|NCT00911300|1912038|FG000|Overall Study|Recurrent Tachyarrhythmia|1
928817|NCT00911300|1912039|FG001|Overall Study|Recurrent Tachyarrhythmia|1
928818|NCT00911300|1912038|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
928819|NCT00911300|1912039|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
928820|NCT00911300|1912038|FG000|Overall Study|Nurse Unavailable in Participant's City|1
928821|NCT00911300|1912039|FG001|Overall Study|Nurse Unavailable in Participant's City|0
928822|NCT00911300|1912038|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
928823|NCT00911300|1912039|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
928824|NCT00911300|1912038|FG000|Overall Study|Participant Could Not Stay in Hospital|0
928825|NCT00911300|1912039|FG001|Overall Study|Participant Could Not Stay in Hospital|1
928826|NCT00911300|1912038|FG000|Overall Study|Investigator's Decision; New AF Episode|0
928827|NCT00911300|1912039|FG001|Overall Study|Investigator's Decision; New AF Episode|1
928828|NCT00911300|1912038|FG000|Overall Study|International Normalized Ratio Too High|0
928829|NCT00911300|1912039|FG001|Overall Study|International Normalized Ratio Too High|1
928830|NCT00911300|1912038|FG000|Overall Study|Participant Refused Hospital Consulation|0
928831|NCT00911300|1912039|FG001|Overall Study|Participant Refused Hospital Consulation|1
928832|NCT00911300|1912038|FG000|Overall Study|Underlying Disease (Myocarditis)|0
928833|NCT00911300|1912039|FG001|Overall Study|Underlying Disease (Myocarditis)|1
928834|NCT00911300|1912038|FG000|Overall Study|Physician Decision|0
928835|NCT00911300|1912039|FG001|Overall Study|Physician Decision|1
928836|NCT00911300|1912038|FG000|Overall Study|Treatment Stopped by Mistake|0
928837|NCT00911300|1912039|FG001|Overall Study|Treatment Stopped by Mistake|1
928838|NCT00911300|1912038|FG000|Overall Study|Randomized; No Study Medication Received|0
928839|NCT00911300|1912039|FG001|Overall Study|Randomized; No Study Medication Received|2
928840|NCT00911508|1912072|FG000|Overall Study|Lost to Follow-up|27
928841|NCT00911508|1912073|FG001|Overall Study|Lost to Follow-up|18
928842|NCT00911508|1912072|FG000|Overall Study|Withdrawal by Subject|79
928843|NCT00911508|1912073|FG001|Overall Study|Withdrawal by Subject|112
928844|NCT00911534|1912081|FG000|Overall Study|Adverse Event|4
928845|NCT00911534|1912082|FG001|Overall Study|Adverse Event|4
928846|NCT00911534|1912081|FG000|Overall Study|Lost to Follow-up|2
928847|NCT00911534|1912082|FG001|Overall Study|Lost to Follow-up|4
928848|NCT00911534|1912081|FG000|Overall Study|Withdrawal by Subject|2
928849|NCT00911534|1912082|FG001|Overall Study|Withdrawal by Subject|1
928850|NCT00911534|1912081|FG000|Overall Study|Lack of Efficacy|4
928851|NCT00911534|1912082|FG001|Overall Study|Lack of Efficacy|1
928852|NCT00911534|1912081|FG000|Overall Study|Withdrawal of consent|1
928853|NCT00911534|1912082|FG001|Overall Study|Withdrawal of consent|4
928854|NCT00911534|1912081|FG000|Overall Study|Other|2
928855|NCT00911534|1912082|FG001|Overall Study|Other|2
928856|NCT00911547|1912092|FG000|Overall Study|Adverse Event|8
928857|NCT00911547|1912093|FG001|Overall Study|Adverse Event|27
928858|NCT00911547|1912094|FG002|Overall Study|Adverse Event|11
928859|NCT00911547|1912095|FG003|Overall Study|Adverse Event|6
928860|NCT00911547|1912092|FG000|Overall Study|Lost to Follow-up|0
928861|NCT00911547|1912093|FG001|Overall Study|Lost to Follow-up|0
928862|NCT00911547|1912094|FG002|Overall Study|Lost to Follow-up|2
928863|NCT00911547|1912095|FG003|Overall Study|Lost to Follow-up|1
928864|NCT00911547|1912092|FG000|Overall Study|Protocol Violation|0
928865|NCT00911547|1912093|FG001|Overall Study|Protocol Violation|5
928866|NCT00911547|1912094|FG002|Overall Study|Protocol Violation|5
928867|NCT00911547|1912095|FG003|Overall Study|Protocol Violation|1
928868|NCT00911547|1912092|FG000|Overall Study|Withdrawal by Subject|3
928869|NCT00911547|1912093|FG001|Overall Study|Withdrawal by Subject|10
928870|NCT00911547|1912094|FG002|Overall Study|Withdrawal by Subject|4
928871|NCT00911547|1912095|FG003|Overall Study|Withdrawal by Subject|8
928872|NCT00911625|1912121|FG000|Overall Study|Lost to Follow-up|7
928873|NCT00911625|1912122|FG001|Overall Study|Lost to Follow-up|0
928874|NCT00911768|1912139|FG000|Overall Study|Protocol Violation|5
928875|NCT00911768|1912140|FG001|Overall Study|Protocol Violation|4
928876|NCT00911768|1912139|FG000|Overall Study|Withdrawal by Subject|1
928877|NCT00911768|1912140|FG001|Overall Study|Withdrawal by Subject|0
928878|NCT00911807|1912149|FG000|Overall Study|Adverse Event|2
928879|NCT00911807|1912150|FG001|Overall Study|Adverse Event|1
928880|NCT00911807|1912151|FG002|Overall Study|Adverse Event|5
928881|NCT00911807|1912149|FG000|Overall Study|Death|0
928882|NCT00911807|1912150|FG001|Overall Study|Death|0
928883|NCT00911807|1912151|FG002|Overall Study|Death|1
928884|NCT00911807|1912149|FG000|Overall Study|Protocol Violation|6
928885|NCT00911807|1912150|FG001|Overall Study|Protocol Violation|4
928886|NCT00911807|1912151|FG002|Overall Study|Protocol Violation|9
928887|NCT00911807|1912149|FG000|Overall Study|Withdrawal by Subject|8
928888|NCT00911807|1912150|FG001|Overall Study|Withdrawal by Subject|10
928889|NCT00911807|1912151|FG002|Overall Study|Withdrawal by Subject|7
928890|NCT00911807|1912149|FG000|Overall Study|Organizational reasons|1
928891|NCT00911807|1912150|FG001|Overall Study|Organizational reasons|3
928892|NCT00911807|1912151|FG002|Overall Study|Organizational reasons|1
928893|NCT00911820|1912161|FG000|Overall Study|RECIST progression|12
928894|NCT00911820|1912162|FG001|Overall Study|RECIST progression|8
928895|NCT00911820|1912161|FG000|Overall Study|Adverse Event|8
928896|NCT00911820|1912162|FG001|Overall Study|Adverse Event|8
928897|NCT00911820|1912161|FG000|Overall Study|Clinical Progression|7
928898|NCT00911820|1912162|FG001|Overall Study|Clinical Progression|5
928899|NCT00911820|1912161|FG000|Overall Study|Physician Decision|5
928900|NCT00911820|1912162|FG001|Overall Study|Physician Decision|9
928901|NCT00911820|1912161|FG000|Overall Study|Decline in Performance Status|4
928902|NCT00911820|1912162|FG001|Overall Study|Decline in Performance Status|2
928903|NCT00911820|1912161|FG000|Overall Study|Withdrawal by Subject|3
928904|NCT00911820|1912162|FG001|Overall Study|Withdrawal by Subject|4
928905|NCT00911820|1912161|FG000|Overall Study|Death|1
928906|NCT00911820|1912162|FG001|Overall Study|Death|2
928907|NCT00911820|1912161|FG000|Overall Study|Pursue surgery|1
928908|NCT00911820|1912162|FG001|Overall Study|Pursue surgery|1
928909|NCT00911820|1912161|FG000|Overall Study|Pursue Radiation|1
928910|NCT00911820|1912162|FG001|Overall Study|Pursue Radiation|0
928911|NCT00911820|1912161|FG000|Overall Study|Still on Therapy|2
928912|NCT00911820|1912162|FG001|Overall Study|Still on Therapy|2
928913|NCT00911820|1912161|FG000|Overall Study|Pathology Not Confirmed|1
928914|NCT00911820|1912162|FG001|Overall Study|Pathology Not Confirmed|0
928915|NCT00911820|1912161|FG000|Overall Study|Withdraw before Receive Treatment|0
928916|NCT00911820|1912162|FG001|Overall Study|Withdraw before Receive Treatment|2
928917|NCT00911859|1912171|FG000|Treatment Period|Adverse Event|3
928918|NCT00911859|1912172|FG001|Treatment Period|Adverse Event|3
928919|NCT00911859|1912173|FG002|Treatment Period|Adverse Event|7
928920|NCT00911859|1912171|FG000|Treatment Period|Death|1
928921|NCT00911859|1912172|FG001|Treatment Period|Death|3
928922|NCT00911859|1912173|FG002|Treatment Period|Death|5
928923|NCT00911859|1912171|FG000|Treatment Period|Lack of Efficacy|1
928924|NCT00911859|1912172|FG001|Treatment Period|Lack of Efficacy|7
928925|NCT00911859|1912173|FG002|Treatment Period|Lack of Efficacy|5
928926|NCT00911859|1912171|FG000|Treatment Period|Physician Decision|3
928927|NCT00911859|1912172|FG001|Treatment Period|Physician Decision|3
928928|NCT00911859|1912173|FG002|Treatment Period|Physician Decision|3
928929|NCT00911859|1912171|FG000|Treatment Period|Withdrawal by Subject|0
928930|NCT00911859|1912172|FG001|Treatment Period|Withdrawal by Subject|4
928931|NCT00911859|1912173|FG002|Treatment Period|Withdrawal by Subject|5
928932|NCT00911859|1912171|FG000|Treatment Period|Did not receive study treatment|0
928933|NCT00911859|1912172|FG001|Treatment Period|Did not receive study treatment|1
928934|NCT00911859|1912173|FG002|Treatment Period|Did not receive study treatment|0
928935|NCT00911859|1912171|FG000|Maintainance Period|Lack of Efficacy|0
928936|NCT00911859|1912172|FG001|Maintainance Period|Lack of Efficacy|0
928937|NCT00911859|1912173|FG002|Maintainance Period|Lack of Efficacy|9
928938|NCT00911859|1912171|FG000|Maintainance Period|Physician Decision|0
928939|NCT00911859|1912172|FG001|Maintainance Period|Physician Decision|0
928940|NCT00911859|1912173|FG002|Maintainance Period|Physician Decision|9
928941|NCT00911859|1912171|FG000|Maintainance Period|Withdrawal by Subject|0
928942|NCT00911859|1912172|FG001|Maintainance Period|Withdrawal by Subject|0
928943|NCT00911859|1912173|FG002|Maintainance Period|Withdrawal by Subject|3
928944|NCT00911859|1912171|FG000|Follow-up Period|Death|5
928945|NCT00911859|1912172|FG001|Follow-up Period|Death|8
928946|NCT00911859|1912173|FG002|Follow-up Period|Death|10
928947|NCT00911859|1912171|FG000|Follow-up Period|Lost to Follow-up|1
928948|NCT00911859|1912172|FG001|Follow-up Period|Lost to Follow-up|1
928949|NCT00911859|1912173|FG002|Follow-up Period|Lost to Follow-up|0
928950|NCT00911859|1912171|FG000|Follow-up Period|Withdrawal by Subject|0
928951|NCT00911859|1912172|FG001|Follow-up Period|Withdrawal by Subject|4
928952|NCT00911859|1912173|FG002|Follow-up Period|Withdrawal by Subject|4
928953|NCT00911859|1912171|FG000|Follow-up Period|Study terminated by sponsor|5
928954|NCT00911859|1912172|FG001|Follow-up Period|Study terminated by sponsor|33
928955|NCT00911859|1912173|FG002|Follow-up Period|Study terminated by sponsor|27
928956|NCT00911937|1912187|FG000|Overall Study|Death|1
928957|NCT00911937|1912188|FG001|Overall Study|Death|0
928958|NCT00911937|1912187|FG000|Overall Study|Lost to Follow-up|8
928959|NCT00911937|1912188|FG001|Overall Study|Lost to Follow-up|5
928960|NCT00911937|1912187|FG000|Overall Study|Withdrawal by Subject|10
928961|NCT00911937|1912188|FG001|Overall Study|Withdrawal by Subject|7
928962|NCT00911937|1912187|FG000|Overall Study|Withdrawn due to pregnancy|1
928963|NCT00911937|1912188|FG001|Overall Study|Withdrawn due to pregnancy|0
928964|NCT00911937|1912187|FG000|Overall Study|Adverse Event|11
928965|NCT00911937|1912188|FG001|Overall Study|Adverse Event|25
928966|NCT00911937|1912187|FG000|Overall Study|Lack of Efficacy|11
928967|NCT00911937|1912188|FG001|Overall Study|Lack of Efficacy|6
928968|NCT00911937|1912187|FG000|Overall Study|Did not meet inclusion criteria|9
928969|NCT00911937|1912188|FG001|Overall Study|Did not meet inclusion criteria|11
928970|NCT00911937|1912187|FG000|Overall Study|Protocol Violation|14
928971|NCT00911937|1912188|FG001|Overall Study|Protocol Violation|23
928972|NCT00911937|1912187|FG000|Overall Study|Randomized but not treated|13
928973|NCT00911937|1912188|FG001|Overall Study|Randomized but not treated|13
928974|NCT00911937|1912187|FG000|Overall Study|Other|9
928975|NCT00911937|1912188|FG001|Overall Study|Other|5
928976|NCT00911989|1912194|FG000|Overall Study|Adverse Event|1
928977|NCT00912015|1912207|FG000|Overall Study|Lack of Efficacy|1
928978|NCT00912015|1912208|FG001|Overall Study|Lack of Efficacy|0
928979|NCT00912015|1912209|FG002|Overall Study|Lack of Efficacy|0
928980|NCT00912015|1912210|FG003|Overall Study|Lack of Efficacy|0
928981|NCT00912015|1912207|FG000|Overall Study|Withdrawal by Subject|8
928982|NCT00912015|1912208|FG001|Overall Study|Withdrawal by Subject|8
928983|NCT00912015|1912209|FG002|Overall Study|Withdrawal by Subject|3
928984|NCT00912015|1912210|FG003|Overall Study|Withdrawal by Subject|0
928985|NCT00912015|1912207|FG000|Overall Study|Protocol Violation|1
928986|NCT00912015|1912208|FG001|Overall Study|Protocol Violation|0
928987|NCT00912015|1912209|FG002|Overall Study|Protocol Violation|0
928988|NCT00912015|1912210|FG003|Overall Study|Protocol Violation|1
928989|NCT00912015|1912207|FG000|Overall Study|Adverse Event|6
928990|NCT00912015|1912208|FG001|Overall Study|Adverse Event|0
928991|NCT00912015|1912209|FG002|Overall Study|Adverse Event|0
928992|NCT00912015|1912210|FG003|Overall Study|Adverse Event|1
928993|NCT00912028|1912223|FG000|Overall Study|Lost to Follow-up|2
928994|NCT00912028|1912224|FG001|Overall Study|Lost to Follow-up|3
928995|NCT00912028|1912225|FG002|Overall Study|Lost to Follow-up|0
928996|NCT00912028|1912226|FG003|Overall Study|Lost to Follow-up|1
928997|NCT00912028|1912227|FG004|Overall Study|Lost to Follow-up|3
928998|NCT00912028|1912223|FG000|Overall Study|Withdrawal by Subject|3
928999|NCT00912028|1912224|FG001|Overall Study|Withdrawal by Subject|0
929000|NCT00912028|1912225|FG002|Overall Study|Withdrawal by Subject|0
929001|NCT00912028|1912226|FG003|Overall Study|Withdrawal by Subject|0
929002|NCT00912028|1912227|FG004|Overall Study|Withdrawal by Subject|0
929003|NCT00912093|1912242|FG000|The Controlled Phase|Death|0
929004|NCT00912093|1912243|FG001|The Controlled Phase|Death|1
929005|NCT00912093|1912244|FG002|The Controlled Phase|Death|0
929006|NCT00912093|1912245|FG003|The Controlled Phase|Death|0
929007|NCT00912093|1912246|FG004|The Controlled Phase|Death|0
929008|NCT00912093|1912242|FG000|The Controlled Phase|Medical Condition|0
929009|NCT00912093|1912243|FG001|The Controlled Phase|Medical Condition|1
929010|NCT00912093|1912244|FG002|The Controlled Phase|Medical Condition|0
929011|NCT00912093|1912245|FG003|The Controlled Phase|Medical Condition|0
929012|NCT00912093|1912246|FG004|The Controlled Phase|Medical Condition|0
929013|NCT00912093|1912242|FG000|The Controlled Phase|Lost to Follow-up|0
929014|NCT00912093|1912243|FG001|The Controlled Phase|Lost to Follow-up|0
929015|NCT00912093|1912244|FG002|The Controlled Phase|Lost to Follow-up|0
929016|NCT00912093|1912245|FG003|The Controlled Phase|Lost to Follow-up|0
929017|NCT00912093|1912246|FG004|The Controlled Phase|Lost to Follow-up|1
929018|NCT00912197|1912266|FG000|Overall Study|Withdrawal by Subject|3
929019|NCT00912197|1912267|FG001|Overall Study|Withdrawal by Subject|3
929023|NCT00912288|1912281|FG000|Overall Study|Death|0
929024|NCT00912288|1912282|FG001|Overall Study|Death|1
929025|NCT00912288|1912281|FG000|Overall Study|Adverse Event|1
929026|NCT00912288|1912282|FG001|Overall Study|Adverse Event|1
929027|NCT00912288|1912281|FG000|Overall Study|Lost to Follow-up|1
929028|NCT00912288|1912282|FG001|Overall Study|Lost to Follow-up|0
929029|NCT00912288|1912281|FG000|Overall Study|Protocol Violation|1
929030|NCT00912288|1912282|FG001|Overall Study|Protocol Violation|0
929031|NCT00912288|1912281|FG000|Overall Study|Withdrawal by Subject|3
929032|NCT00912288|1912282|FG001|Overall Study|Withdrawal by Subject|3
929033|NCT00912288|1912281|FG000|Overall Study|Study terminated by sponsor|34
929034|NCT00912288|1912282|FG001|Overall Study|Study terminated by sponsor|35
929035|NCT00912288|1912281|FG000|Overall Study|Other|1
929036|NCT00912288|1912282|FG001|Overall Study|Other|0
929037|NCT00912340|1912304|FG000|Overall Study|Adverse Event|2
929038|NCT00912340|1912305|FG001|Overall Study|Adverse Event|4
929039|NCT00912340|1912306|FG002|Overall Study|Adverse Event|0
929040|NCT00912340|1912304|FG000|Overall Study|Protocol revised to remove arm|0
929041|NCT00912340|1912305|FG001|Overall Study|Protocol revised to remove arm|0
929042|NCT00912340|1912306|FG002|Overall Study|Protocol revised to remove arm|4
929043|NCT00912405|1912314|FG000|Overall Study|Lost to Follow-up|5
929044|NCT00912509|1912320|FG000|Overall Study|Lost to Follow-up|1
929045|NCT00912509|1912321|FG001|Overall Study|Lost to Follow-up|0
929046|NCT00912509|1912320|FG000|Overall Study|Lack of Efficacy|4
929047|NCT00912509|1912321|FG001|Overall Study|Lack of Efficacy|3
929048|NCT00912743|1912330|FG000|Overall Study|Adverse Event|3
929049|NCT00912743|1912331|FG001|Overall Study|Adverse Event|1
929050|NCT00912743|1912330|FG000|Overall Study|Lack of Efficacy|9
929051|NCT00912743|1912331|FG001|Overall Study|Lack of Efficacy|18
929052|NCT00912743|1912330|FG000|Overall Study|Toxicity|0
929053|NCT00912743|1912331|FG001|Overall Study|Toxicity|1
929054|NCT00912743|1912330|FG000|Overall Study|End of treatment form was not collected|1
929055|NCT00912743|1912331|FG001|Overall Study|End of treatment form was not collected|0
929056|NCT00912782|1912339|FG000|Overall Study|Death|2
929057|NCT00912782|1912340|FG001|Overall Study|Death|1
929058|NCT00912782|1912339|FG000|Overall Study|Lost to Follow-up|0
929059|NCT00912782|1912340|FG001|Overall Study|Lost to Follow-up|1
929060|NCT00912782|1912339|FG000|Overall Study|Did not receive vascular access type|1
929061|NCT00912782|1912340|FG001|Overall Study|Did not receive vascular access type|2
929062|NCT00912782|1912339|FG000|Overall Study|Relocated before study completion|0
929063|NCT00912782|1912340|FG001|Overall Study|Relocated before study completion|1
929064|NCT00912808|1912357|FG000|First Intervention (6 Weeks)|Adverse Event|2
929065|NCT00912808|1912358|FG001|First Intervention (6 Weeks)|Adverse Event|1
929066|NCT00912808|1912357|FG000|Washout|Withdrawal by Subject|0
929067|NCT00912808|1912358|FG001|Washout|Withdrawal by Subject|1
929068|NCT00912808|1912357|FG000|Second Intervention (6 Weeks)|Adverse Event|0
929069|NCT00912808|1912358|FG001|Second Intervention (6 Weeks)|Adverse Event|1
929070|NCT00912808|1912357|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1
929071|NCT00912808|1912358|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0
929072|NCT00912912|1912378|FG000|Overall Study|Withdrawal by Subject|1
929073|NCT00912912|1912378|FG000|Overall Study|Disease Progression|3
929074|NCT00912964|1912394|FG000|Overall Study|Eligibility criterion not met|1
929075|NCT00912964|1912395|FG001|Overall Study|Eligibility criterion not met|1
929076|NCT00912964|1912396|FG002|Overall Study|Eligibility criterion not met|0
929077|NCT00912964|1912394|FG000|Overall Study|Adverse Event|15
929078|NCT00912964|1912395|FG001|Overall Study|Adverse Event|18
929079|NCT00912964|1912396|FG002|Overall Study|Adverse Event|12
929080|NCT00912964|1912394|FG000|Overall Study|Lack of Efficacy|11
929081|NCT00912964|1912395|FG001|Overall Study|Lack of Efficacy|4
929082|NCT00912964|1912396|FG002|Overall Study|Lack of Efficacy|3
929083|NCT00912964|1912394|FG000|Overall Study|Withdrawal by Subject|20
929084|NCT00912964|1912395|FG001|Overall Study|Withdrawal by Subject|12
929085|NCT00912964|1912396|FG002|Overall Study|Withdrawal by Subject|18
929086|NCT00912964|1912394|FG000|Overall Study|Lost to Follow-up|4
929087|NCT00912964|1912395|FG001|Overall Study|Lost to Follow-up|3
929088|NCT00912964|1912396|FG002|Overall Study|Lost to Follow-up|3
929089|NCT00912964|1912394|FG000|Overall Study|Protocol Violation|5
929090|NCT00912964|1912395|FG001|Overall Study|Protocol Violation|3
929091|NCT00912964|1912396|FG002|Overall Study|Protocol Violation|8
929092|NCT00912964|1912394|FG000|Overall Study|Taking exclusionary medications|7
929093|NCT00912964|1912395|FG001|Overall Study|Taking exclusionary medications|4
929094|NCT00912964|1912396|FG002|Overall Study|Taking exclusionary medications|8
929095|NCT00912964|1912394|FG000|Overall Study|Medical History|1
929096|NCT00912964|1912395|FG001|Overall Study|Medical History|0
929097|NCT00912964|1912396|FG002|Overall Study|Medical History|0
929098|NCT00912964|1912394|FG000|Overall Study|Non-compliance with study procedures|2
929099|NCT00912964|1912395|FG001|Overall Study|Non-compliance with study procedures|0
929100|NCT00912964|1912396|FG002|Overall Study|Non-compliance with study procedures|0
929101|NCT00912964|1912394|FG000|Overall Study|Violation of exclusion criterion|0
929102|NCT00912964|1912395|FG001|Overall Study|Violation of exclusion criterion|0
929103|NCT00912964|1912396|FG002|Overall Study|Violation of exclusion criterion|2
929104|NCT00912964|1912394|FG000|Overall Study|Randomized but never received study drug|0
929105|NCT00912964|1912395|FG001|Overall Study|Randomized but never received study drug|1
929106|NCT00912964|1912396|FG002|Overall Study|Randomized but never received study drug|0
929107|NCT00913380|1912455|FG000|Clinical Outcomes|Lost to Follow-up|6
929108|NCT00913380|1912456|FG001|Clinical Outcomes|Lost to Follow-up|6
929109|NCT00913458|1912462|FG000|Phase 1|Non-Responder|54
929110|NCT00913458|1912463|FG001|Phase 1|Non-Responder|0
929111|NCT00913458|1912464|FG002|Phase 1|Non-Responder|0
929112|NCT00913458|1912465|FG003|Phase 1|Non-Responder|0
929113|NCT00913458|1912466|FG004|Phase 1|Non-Responder|0
929114|NCT00913458|1912467|FG005|Phase 1|Non-Responder|0
929115|NCT00913458|1912468|FG006|Phase 1|Non-Responder|0
929116|NCT00913458|1912462|FG000|Phase 1|Subject Request|17
929117|NCT00913458|1912463|FG001|Phase 1|Subject Request|0
929118|NCT00913458|1912464|FG002|Phase 1|Subject Request|0
929119|NCT00913458|1912465|FG003|Phase 1|Subject Request|0
929120|NCT00913458|1912466|FG004|Phase 1|Subject Request|0
929121|NCT00913458|1912467|FG005|Phase 1|Subject Request|0
929122|NCT00913458|1912468|FG006|Phase 1|Subject Request|0
929123|NCT00913458|1912462|FG000|Phase 1|Adverse Event|20
929124|NCT00913458|1912463|FG001|Phase 1|Adverse Event|0
929125|NCT00913458|1912464|FG002|Phase 1|Adverse Event|0
929126|NCT00913458|1912465|FG003|Phase 1|Adverse Event|0
929127|NCT00913458|1912466|FG004|Phase 1|Adverse Event|0
929128|NCT00913458|1912467|FG005|Phase 1|Adverse Event|0
929129|NCT00913458|1912468|FG006|Phase 1|Adverse Event|0
929130|NCT00913458|1912462|FG000|Phase 1|Lost to Follow-up|2
929131|NCT00913458|1912463|FG001|Phase 1|Lost to Follow-up|0
929132|NCT00913458|1912464|FG002|Phase 1|Lost to Follow-up|0
929133|NCT00913458|1912465|FG003|Phase 1|Lost to Follow-up|0
929134|NCT00913458|1912466|FG004|Phase 1|Lost to Follow-up|0
929135|NCT00913458|1912467|FG005|Phase 1|Lost to Follow-up|0
929136|NCT00913458|1912468|FG006|Phase 1|Lost to Follow-up|0
929137|NCT00913458|1912462|FG000|Phase 1|Protocol Violation|10
929138|NCT00913458|1912463|FG001|Phase 1|Protocol Violation|0
929139|NCT00913458|1912464|FG002|Phase 1|Protocol Violation|0
929140|NCT00913458|1912465|FG003|Phase 1|Protocol Violation|0
929141|NCT00913458|1912466|FG004|Phase 1|Protocol Violation|0
929142|NCT00913458|1912467|FG005|Phase 1|Protocol Violation|0
929143|NCT00913458|1912468|FG006|Phase 1|Protocol Violation|0
929144|NCT00913458|1912462|FG000|Phase 1|Sponsor|2
929145|NCT00913458|1912463|FG001|Phase 1|Sponsor|0
929146|NCT00913458|1912464|FG002|Phase 1|Sponsor|0
929147|NCT00913458|1912465|FG003|Phase 1|Sponsor|0
929148|NCT00913458|1912466|FG004|Phase 1|Sponsor|0
929149|NCT00913458|1912467|FG005|Phase 1|Sponsor|0
929150|NCT00913458|1912468|FG006|Phase 1|Sponsor|0
929151|NCT00913458|1912462|FG000|Phase 1|Unsatisfactory Response per Investigator|7
929152|NCT00913458|1912463|FG001|Phase 1|Unsatisfactory Response per Investigator|0
929153|NCT00913458|1912464|FG002|Phase 1|Unsatisfactory Response per Investigator|0
929154|NCT00913458|1912465|FG003|Phase 1|Unsatisfactory Response per Investigator|0
929155|NCT00913458|1912466|FG004|Phase 1|Unsatisfactory Response per Investigator|0
929156|NCT00913458|1912467|FG005|Phase 1|Unsatisfactory Response per Investigator|0
929157|NCT00913458|1912468|FG006|Phase 1|Unsatisfactory Response per Investigator|0
929158|NCT00913458|1912462|FG000|Phase 2|Non-Responder|0
929159|NCT00913458|1912463|FG001|Phase 2|Non-Responder|5
929160|NCT00913458|1912464|FG002|Phase 2|Non-Responder|7
929161|NCT00913458|1912465|FG003|Phase 2|Non-Responder|12
929162|NCT00913458|1912466|FG004|Phase 2|Non-Responder|0
929163|NCT00913458|1912467|FG005|Phase 2|Non-Responder|0
929164|NCT00913458|1912468|FG006|Phase 2|Non-Responder|0
929165|NCT00913458|1912462|FG000|Phase 2|Subject Request|0
929166|NCT00913458|1912463|FG001|Phase 2|Subject Request|0
929167|NCT00913458|1912464|FG002|Phase 2|Subject Request|1
929168|NCT00913458|1912465|FG003|Phase 2|Subject Request|2
929169|NCT00913458|1912466|FG004|Phase 2|Subject Request|0
929170|NCT00913458|1912467|FG005|Phase 2|Subject Request|0
929171|NCT00913458|1912468|FG006|Phase 2|Subject Request|0
929172|NCT00913458|1912462|FG000|Phase 2|Adverse Event|0
929173|NCT00913458|1912463|FG001|Phase 2|Adverse Event|3
929174|NCT00913458|1912464|FG002|Phase 2|Adverse Event|0
929175|NCT00913458|1912465|FG003|Phase 2|Adverse Event|1
929176|NCT00913458|1912466|FG004|Phase 2|Adverse Event|0
929177|NCT00913458|1912467|FG005|Phase 2|Adverse Event|0
929178|NCT00913458|1912468|FG006|Phase 2|Adverse Event|0
929179|NCT00913458|1912462|FG000|Phase 2|Lost to Follow-up|0
929180|NCT00913458|1912463|FG001|Phase 2|Lost to Follow-up|0
929181|NCT00913458|1912464|FG002|Phase 2|Lost to Follow-up|0
929182|NCT00913458|1912465|FG003|Phase 2|Lost to Follow-up|1
929183|NCT00913458|1912466|FG004|Phase 2|Lost to Follow-up|0
929184|NCT00913458|1912467|FG005|Phase 2|Lost to Follow-up|0
929185|NCT00913458|1912468|FG006|Phase 2|Lost to Follow-up|0
929186|NCT00913458|1912462|FG000|Phase 2|Protocol Violation|0
929187|NCT00913458|1912463|FG001|Phase 2|Protocol Violation|2
929188|NCT00913458|1912464|FG002|Phase 2|Protocol Violation|0
929189|NCT00913458|1912465|FG003|Phase 2|Protocol Violation|0
929190|NCT00913458|1912466|FG004|Phase 2|Protocol Violation|0
929191|NCT00913458|1912467|FG005|Phase 2|Protocol Violation|0
929192|NCT00913458|1912468|FG006|Phase 2|Protocol Violation|0
929193|NCT00913458|1912462|FG000|Phase 2|Unsatisfactory Response per Investigator|0
929194|NCT00913458|1912463|FG001|Phase 2|Unsatisfactory Response per Investigator|0
929195|NCT00913458|1912464|FG002|Phase 2|Unsatisfactory Response per Investigator|11
929196|NCT00913458|1912465|FG003|Phase 2|Unsatisfactory Response per Investigator|17
929197|NCT00913458|1912466|FG004|Phase 2|Unsatisfactory Response per Investigator|0
929198|NCT00913458|1912467|FG005|Phase 2|Unsatisfactory Response per Investigator|0
929199|NCT00913458|1912468|FG006|Phase 2|Unsatisfactory Response per Investigator|0
929200|NCT00913458|1912462|FG000|Phase 3|Adverse Event|0
929201|NCT00913458|1912463|FG001|Phase 3|Adverse Event|0
929202|NCT00913458|1912464|FG002|Phase 3|Adverse Event|0
929203|NCT00913458|1912465|FG003|Phase 3|Adverse Event|0
929204|NCT00913458|1912466|FG004|Phase 3|Adverse Event|5
929205|NCT00913458|1912467|FG005|Phase 3|Adverse Event|4
929206|NCT00913458|1912468|FG006|Phase 3|Adverse Event|1
929207|NCT00913458|1912462|FG000|Phase 3|Lost to Follow-up|0
929208|NCT00913458|1912463|FG001|Phase 3|Lost to Follow-up|0
929209|NCT00913458|1912464|FG002|Phase 3|Lost to Follow-up|0
929210|NCT00913458|1912465|FG003|Phase 3|Lost to Follow-up|0
929211|NCT00913458|1912466|FG004|Phase 3|Lost to Follow-up|2
929212|NCT00913458|1912467|FG005|Phase 3|Lost to Follow-up|0
929213|NCT00913458|1912468|FG006|Phase 3|Lost to Follow-up|0
929214|NCT00913458|1912462|FG000|Phase 3|Non-Responder|0
929215|NCT00913458|1912463|FG001|Phase 3|Non-Responder|0
929216|NCT00913458|1912464|FG002|Phase 3|Non-Responder|0
929217|NCT00913458|1912465|FG003|Phase 3|Non-Responder|0
929218|NCT00913458|1912466|FG004|Phase 3|Non-Responder|0
929219|NCT00913458|1912467|FG005|Phase 3|Non-Responder|1
929220|NCT00913458|1912468|FG006|Phase 3|Non-Responder|3
929221|NCT00913458|1912462|FG000|Phase 3|Withdrawal by Subject|0
929222|NCT00913458|1912463|FG001|Phase 3|Withdrawal by Subject|0
929223|NCT00913458|1912464|FG002|Phase 3|Withdrawal by Subject|0
929224|NCT00913458|1912465|FG003|Phase 3|Withdrawal by Subject|0
929225|NCT00913458|1912466|FG004|Phase 3|Withdrawal by Subject|1
929226|NCT00913458|1912467|FG005|Phase 3|Withdrawal by Subject|2
929227|NCT00913458|1912468|FG006|Phase 3|Withdrawal by Subject|0
929228|NCT00913458|1912462|FG000|Phase 3|Unsatisfactory Response per Investigator|0
929229|NCT00913458|1912463|FG001|Phase 3|Unsatisfactory Response per Investigator|0
929230|NCT00913458|1912464|FG002|Phase 3|Unsatisfactory Response per Investigator|0
929231|NCT00913458|1912465|FG003|Phase 3|Unsatisfactory Response per Investigator|0
929232|NCT00913458|1912466|FG004|Phase 3|Unsatisfactory Response per Investigator|14
929233|NCT00913458|1912467|FG005|Phase 3|Unsatisfactory Response per Investigator|11
929234|NCT00913458|1912468|FG006|Phase 3|Unsatisfactory Response per Investigator|4
929235|NCT00913523|1912497|FG000|Overall Study|Withdrawal by Subject|3
929236|NCT00913523|1912498|FG001|Overall Study|Withdrawal by Subject|2
929237|NCT00913523|1912499|FG002|Overall Study|Withdrawal by Subject|2
929238|NCT00913523|1912497|FG000|Overall Study|Lost to Follow-up|1
929239|NCT00913523|1912498|FG001|Overall Study|Lost to Follow-up|1
929240|NCT00913523|1912499|FG002|Overall Study|Lost to Follow-up|1
929241|NCT00913523|1912497|FG000|Overall Study|Adverse Event|1
929242|NCT00913523|1912498|FG001|Overall Study|Adverse Event|0
929243|NCT00913523|1912499|FG002|Overall Study|Adverse Event|0
929244|NCT00913523|1912497|FG000|Overall Study|Protocol Violation|5
929245|NCT00913523|1912498|FG001|Overall Study|Protocol Violation|8
929246|NCT00913523|1912499|FG002|Overall Study|Protocol Violation|8
929247|NCT00913523|1912497|FG000|Overall Study|Pregnancy|1
929248|NCT00913523|1912498|FG001|Overall Study|Pregnancy|3
929249|NCT00913523|1912499|FG002|Overall Study|Pregnancy|0
929250|NCT00913523|1912497|FG000|Overall Study|Inadequate Number of Tampons Used|7
929251|NCT00913523|1912498|FG001|Overall Study|Inadequate Number of Tampons Used|2
929252|NCT00913523|1912499|FG002|Overall Study|Inadequate Number of Tampons Used|3
929253|NCT00913744|1912526|FG000|Overall Study|Adverse Event|2
929254|NCT00913744|1912527|FG001|Overall Study|Adverse Event|0
929255|NCT00913744|1912526|FG000|Overall Study|Withdrawal by Subject|2
929256|NCT00913744|1912527|FG001|Overall Study|Withdrawal by Subject|1
929257|NCT00913744|1912526|FG000|Overall Study|Death|1
929258|NCT00913744|1912527|FG001|Overall Study|Death|0
929259|NCT00913770|1912536|FG000|Overall Study|Unable to contact|24
929260|NCT00913770|1912537|FG001|Overall Study|Unable to contact|19
929261|NCT00913770|1912538|FG002|Overall Study|Unable to contact|13
929262|NCT00913770|1912536|FG000|Overall Study|Refused|11
929263|NCT00913770|1912537|FG001|Overall Study|Refused|10
929264|NCT00913770|1912538|FG002|Overall Study|Refused|8
929265|NCT00913835|1912548|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
929266|NCT00913835|1912549|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
929267|NCT00913835|1912548|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
929268|NCT00913835|1912549|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
929269|NCT00913835|1912548|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
929270|NCT00913835|1912549|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
929271|NCT00913835|1912548|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
929272|NCT00913835|1912549|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
929273|NCT00913835|1912548|FG000|Lip Dox: Olaratumab Monotherapy|Other|0
929274|NCT00913835|1912549|FG001|Lip Dox: Olaratumab Monotherapy|Other|3
929275|NCT00913978|1912568|FG000|Overall Study|Surgeon choice|1
929276|NCT00913978|1912569|FG001|Overall Study|Surgeon choice|3
929277|NCT00914316|1912606|FG000|Phase 1|Physician Decision|4
929278|NCT00914316|1912607|FG001|Phase 1|Physician Decision|0
929279|NCT00914316|1912608|FG002|Phase 1|Physician Decision|1
929280|NCT00914316|1912609|FG003|Phase 1|Physician Decision|2
929281|NCT00914316|1912606|FG000|Phase 1|Withdrawal by Subject|0
929282|NCT00914316|1912607|FG001|Phase 1|Withdrawal by Subject|2
929283|NCT00914316|1912608|FG002|Phase 1|Withdrawal by Subject|4
929284|NCT00914316|1912609|FG003|Phase 1|Withdrawal by Subject|0
929285|NCT00914316|1912606|FG000|Phase 1|Adverse Event|1
929286|NCT00914316|1912607|FG001|Phase 1|Adverse Event|0
929287|NCT00914316|1912608|FG002|Phase 1|Adverse Event|0
929288|NCT00914316|1912609|FG003|Phase 1|Adverse Event|0
929289|NCT00914316|1912606|FG000|Phase 2|Withdrawal by Subject|1
929290|NCT00914316|1912607|FG001|Phase 2|Withdrawal by Subject|0
929291|NCT00914316|1912608|FG002|Phase 2|Withdrawal by Subject|1
929292|NCT00914316|1912609|FG003|Phase 2|Withdrawal by Subject|0
929293|NCT00914459|1912621|FG000|Overall Study|Protocol Violation|0
929294|NCT00914459|1912622|FG001|Overall Study|Protocol Violation|1
929295|NCT00914459|1912621|FG000|Overall Study|Parent/Legal guardian request|1
929296|NCT00914459|1912622|FG001|Overall Study|Parent/Legal guardian request|0
929297|NCT00914589|1912637|FG000|Overall Study|Adverse Event|1
929298|NCT00914589|1912638|FG001|Overall Study|Adverse Event|0
929299|NCT00914589|1912639|FG002|Overall Study|Adverse Event|1
929300|NCT00914589|1912637|FG000|Overall Study|Protocol Violation|8
929301|NCT00914589|1912638|FG001|Overall Study|Protocol Violation|6
929302|NCT00914589|1912639|FG002|Overall Study|Protocol Violation|3
929303|NCT00914589|1912637|FG000|Overall Study|unclassified|16
929304|NCT00914589|1912638|FG001|Overall Study|unclassified|9
929305|NCT00914589|1912639|FG002|Overall Study|unclassified|7
929306|NCT00914589|1912637|FG000|Overall Study|Death|0
929307|NCT00914589|1912638|FG001|Overall Study|Death|1
929308|NCT00914589|1912639|FG002|Overall Study|Death|1
929309|NCT00914628|1912649|FG000|Overall Study|Death|35
929310|NCT00914628|1912650|FG001|Overall Study|Death|17
929311|NCT00914628|1912649|FG000|Overall Study|Medical decision|4
929312|NCT00914628|1912650|FG001|Overall Study|Medical decision|0
929313|NCT00914628|1912649|FG000|Overall Study|Protocol Violation|1
929314|NCT00914628|1912650|FG001|Overall Study|Protocol Violation|0
929315|NCT00914628|1912649|FG000|Overall Study|Lack of Efficacy|1
929316|NCT00914628|1912650|FG001|Overall Study|Lack of Efficacy|0
929317|NCT00914628|1912649|FG000|Overall Study|non-randomized|1
929318|NCT00914628|1912650|FG001|Overall Study|non-randomized|0
929319|NCT00914628|1912649|FG000|Overall Study|Relapse|1
929320|NCT00914628|1912650|FG001|Overall Study|Relapse|2
929321|NCT00914628|1912649|FG000|Overall Study|Study terminated by Sponsor|14
929322|NCT00914628|1912650|FG001|Overall Study|Study terminated by Sponsor|8
929323|NCT00914628|1912649|FG000|Overall Study|Patients who did not receive a single dose|7
929324|NCT00914628|1912650|FG001|Overall Study|Patients who did not receive a single dose|1
929325|NCT00914732|1912663|FG000|Overall Study|Lost to Follow-up|6
929326|NCT00914732|1912664|FG001|Overall Study|Lost to Follow-up|7
929327|NCT00914732|1912665|FG002|Overall Study|Lost to Follow-up|9
929328|NCT00914732|1912663|FG000|Overall Study|Withdrawal by Subject|3
929329|NCT00914732|1912664|FG001|Overall Study|Withdrawal by Subject|0
929330|NCT00914732|1912665|FG002|Overall Study|Withdrawal by Subject|2
929331|NCT00914732|1912663|FG000|Overall Study|Adverse Event|1
929332|NCT00914732|1912664|FG001|Overall Study|Adverse Event|0
929333|NCT00914732|1912665|FG002|Overall Study|Adverse Event|0
929334|NCT00914810|1912676|FG000|Overall Study|Withdrawal by Subject|1
929335|NCT00914810|1912677|FG001|Overall Study|Withdrawal by Subject|0
929336|NCT00914810|1912676|FG000|Overall Study|Relocated out of state|1
929337|NCT00914810|1912677|FG001|Overall Study|Relocated out of state|0
929338|NCT00914810|1912676|FG000|Overall Study|Hospitalized and unable to follow up.|0
929339|NCT00914810|1912677|FG001|Overall Study|Hospitalized and unable to follow up.|1
929340|NCT00914849|1912685|FG000|Overall Study|Withdrawal by Subject|1
929341|NCT00914849|1912686|FG001|Overall Study|Withdrawal by Subject|0
929342|NCT00914849|1912685|FG000|Overall Study|Not eligible|0
929343|NCT00914849|1912686|FG001|Overall Study|Not eligible|1
929344|NCT00914927|1912720|FG000|Overall Study|Adverse Event|0
929345|NCT00914927|1912721|FG001|Overall Study|Adverse Event|0
929346|NCT00914927|1912722|FG002|Overall Study|Adverse Event|0
929347|NCT00914927|1912723|FG003|Overall Study|Adverse Event|0
929348|NCT00914927|1912724|FG004|Overall Study|Adverse Event|1
929349|NCT00914927|1912725|FG005|Overall Study|Adverse Event|0
929350|NCT00914927|1912726|FG006|Overall Study|Adverse Event|0
929351|NCT00914927|1912720|FG000|Overall Study|Withdrawal by Subject|0
929352|NCT00914927|1912721|FG001|Overall Study|Withdrawal by Subject|1
929353|NCT00914927|1912722|FG002|Overall Study|Withdrawal by Subject|0
929354|NCT00914927|1912723|FG003|Overall Study|Withdrawal by Subject|1
929355|NCT00914927|1912724|FG004|Overall Study|Withdrawal by Subject|0
929356|NCT00914927|1912725|FG005|Overall Study|Withdrawal by Subject|0
929357|NCT00914927|1912726|FG006|Overall Study|Withdrawal by Subject|0
929358|NCT00914927|1912720|FG000|Overall Study|Lost to Follow-up|0
929359|NCT00914927|1912721|FG001|Overall Study|Lost to Follow-up|0
929360|NCT00914927|1912722|FG002|Overall Study|Lost to Follow-up|0
929361|NCT00914927|1912723|FG003|Overall Study|Lost to Follow-up|1
929362|NCT00914927|1912724|FG004|Overall Study|Lost to Follow-up|0
929363|NCT00914927|1912725|FG005|Overall Study|Lost to Follow-up|0
929364|NCT00914927|1912726|FG006|Overall Study|Lost to Follow-up|0
929365|NCT00914927|1912720|FG000|Overall Study|Administrative/Other|2
929366|NCT00914927|1912721|FG001|Overall Study|Administrative/Other|1
929367|NCT00914927|1912722|FG002|Overall Study|Administrative/Other|0
929368|NCT00914927|1912723|FG003|Overall Study|Administrative/Other|0
929369|NCT00914927|1912724|FG004|Overall Study|Administrative/Other|1
929370|NCT00914927|1912725|FG005|Overall Study|Administrative/Other|0
929371|NCT00914927|1912726|FG006|Overall Study|Administrative/Other|0
929372|NCT00914940|1912751|FG000|D0 to D100 Post-transplant|Death|2
929373|NCT00914940|1912751|FG000|D101 to 2 Years Post-transplant|Death|8
929374|NCT00914940|1912751|FG000|2 Years to 5 Years Post-transplant|Death|3
929375|NCT00914966|1912755|FG000|Step 1: 1500 Units|Withdrawal by Subject|1
929376|NCT00914966|1912755|FG000|Step 1: 1500 Units|Physician Decision|1
929377|NCT00914966|1912755|FG000|Step 2: 2000 Units|Withdrawal by Subject|1
929378|NCT00915005|1912766|FG000|Overall Study|Withdrawal by Subject|4
929379|NCT00915005|1912767|FG001|Overall Study|Withdrawal by Subject|4
929380|NCT00915005|1912766|FG000|Overall Study|Patient preferred protons therapy|6
929381|NCT00915005|1912767|FG001|Overall Study|Patient preferred protons therapy|0
929382|NCT00915005|1912766|FG000|Overall Study|Insurance denial|3
929383|NCT00915005|1912767|FG001|Overall Study|Insurance denial|15
929384|NCT00915018|1912775|FG000|Overall Study|Death|75
929385|NCT00915018|1912776|FG001|Overall Study|Death|70
929386|NCT00915018|1912775|FG000|Overall Study|Lost to Follow-up|10
929387|NCT00915018|1912776|FG001|Overall Study|Lost to Follow-up|5
929388|NCT00915018|1912775|FG000|Overall Study|Withdrawal by Subject|38
929389|NCT00915018|1912776|FG001|Overall Study|Withdrawal by Subject|27
929390|NCT00915018|1912775|FG000|Overall Study|By Sponsor due to Protocol Amendment|92
929391|NCT00915018|1912776|FG001|Overall Study|By Sponsor due to Protocol Amendment|105
929392|NCT00915278|1912801|FG000|Overall Study|Death|1
929393|NCT00915278|1912802|FG001|Overall Study|Death|0
929394|NCT00915278|1912803|FG002|Overall Study|Death|0
929395|NCT00915278|1912804|FG003|Overall Study|Death|0
929396|NCT00915278|1912805|FG004|Overall Study|Death|0
929397|NCT00915278|1912806|FG005|Overall Study|Death|0
929398|NCT00915278|1912801|FG000|Overall Study|Lost to Follow-up|0
929399|NCT00915278|1912802|FG001|Overall Study|Lost to Follow-up|1
929400|NCT00915278|1912803|FG002|Overall Study|Lost to Follow-up|0
929401|NCT00915278|1912804|FG003|Overall Study|Lost to Follow-up|0
929402|NCT00915278|1912805|FG004|Overall Study|Lost to Follow-up|0
929403|NCT00915278|1912806|FG005|Overall Study|Lost to Follow-up|0
929404|NCT00915278|1912801|FG000|Overall Study|Withdrawal by Subject|0
929405|NCT00915278|1912802|FG001|Overall Study|Withdrawal by Subject|1
929406|NCT00915278|1912803|FG002|Overall Study|Withdrawal by Subject|0
929407|NCT00915278|1912804|FG003|Overall Study|Withdrawal by Subject|0
929408|NCT00915278|1912805|FG004|Overall Study|Withdrawal by Subject|1
929409|NCT00915278|1912806|FG005|Overall Study|Withdrawal by Subject|4
929410|NCT00915278|1912801|FG000|Overall Study|Adverse Event|4
929411|NCT00915278|1912802|FG001|Overall Study|Adverse Event|1
929412|NCT00915278|1912803|FG002|Overall Study|Adverse Event|0
929413|NCT00915278|1912804|FG003|Overall Study|Adverse Event|0
929414|NCT00915278|1912805|FG004|Overall Study|Adverse Event|0
929415|NCT00915278|1912806|FG005|Overall Study|Adverse Event|0
929416|NCT00915278|1912801|FG000|Overall Study|Progressive disease/clinical progression|0
929417|NCT00915278|1912802|FG001|Overall Study|Progressive disease/clinical progression|0
929418|NCT00915278|1912803|FG002|Overall Study|Progressive disease/clinical progression|0
929419|NCT00915278|1912804|FG003|Overall Study|Progressive disease/clinical progression|3
929420|NCT00915278|1912805|FG004|Overall Study|Progressive disease/clinical progression|1
929421|NCT00915278|1912806|FG005|Overall Study|Progressive disease/clinical progression|2
929422|NCT00915278|1912801|FG000|Overall Study|Infusion related AEs|0
929423|NCT00915278|1912802|FG001|Overall Study|Infusion related AEs|0
929424|NCT00915278|1912803|FG002|Overall Study|Infusion related AEs|0
929425|NCT00915278|1912804|FG003|Overall Study|Infusion related AEs|0
929426|NCT00915278|1912805|FG004|Overall Study|Infusion related AEs|0
929427|NCT00915278|1912806|FG005|Overall Study|Infusion related AEs|2
929428|NCT00915278|1912801|FG000|Overall Study|Admission to hospice|0
929429|NCT00915278|1912802|FG001|Overall Study|Admission to hospice|0
929430|NCT00915278|1912803|FG002|Overall Study|Admission to hospice|1
929431|NCT00915278|1912804|FG003|Overall Study|Admission to hospice|0
929432|NCT00915278|1912805|FG004|Overall Study|Admission to hospice|0
929433|NCT00915278|1912806|FG005|Overall Study|Admission to hospice|0
929434|NCT00915343|1912820|FG000|Part B - Open Label Period|Treatment switch|0
929435|NCT00915343|1912821|FG001|Part B - Open Label Period|Treatment switch|0
929436|NCT00915343|1912822|FG002|Part B - Open Label Period|Treatment switch|1
929437|NCT00915343|1912820|FG000|Part B - Open Label Period|Did not attend the last visit|0
929438|NCT00915343|1912821|FG001|Part B - Open Label Period|Did not attend the last visit|0
929439|NCT00915343|1912822|FG002|Part B - Open Label Period|Did not attend the last visit|1
929440|NCT00915356|1912839|FG000|Overall Study|Withdrawal by Subject|1
929441|NCT00915356|1912840|FG001|Overall Study|Withdrawal by Subject|0
929442|NCT00915356|1912841|FG002|Overall Study|Withdrawal by Subject|0
929443|NCT00915356|1912842|FG003|Overall Study|Withdrawal by Subject|0
929444|NCT00915356|1912843|FG004|Overall Study|Withdrawal by Subject|0
929445|NCT00915473|1912857|FG000|Screening|Withdrawal by Subject|1
929446|NCT00915473|1912858|FG001|Screening|Withdrawal by Subject|0
929447|NCT00915473|1912857|FG000|4-week Follow Up|Lost to Follow-up|1
929448|NCT00915473|1912858|FG001|4-week Follow Up|Lost to Follow-up|5
929449|NCT00915525|1912875|FG000|Overall Study|Protocol Violation|9
929450|NCT00915525|1912876|FG001|Overall Study|Protocol Violation|4
929451|NCT00915525|1912875|FG000|Overall Study|Withdrawal by Subject|59
929452|NCT00915525|1912876|FG001|Overall Study|Withdrawal by Subject|21
929453|NCT00915525|1912875|FG000|Overall Study|Lost to Follow-up|27
929454|NCT00915525|1912876|FG001|Overall Study|Lost to Follow-up|16
929455|NCT00915525|1912875|FG000|Overall Study|Pregnancy|2
929456|NCT00915525|1912876|FG001|Overall Study|Pregnancy|0
929457|NCT00915525|1912875|FG000|Overall Study|Lack of Efficacy|15
929458|NCT00915525|1912876|FG001|Overall Study|Lack of Efficacy|32
929459|NCT00915525|1912875|FG000|Overall Study|Adverse Event|29
929460|NCT00915525|1912876|FG001|Overall Study|Adverse Event|13
929461|NCT00915525|1912875|FG000|Overall Study|Missing|12
929462|NCT00915525|1912876|FG001|Overall Study|Missing|1
929463|NCT00915525|1912875|FG000|Overall Study|Other Reason|35
929464|NCT00915525|1912876|FG001|Overall Study|Other Reason|12
929465|NCT00915525|1912875|FG000|Overall Study|Site Closed|27
929466|NCT00915525|1912876|FG001|Overall Study|Site Closed|9
929467|NCT00915525|1912875|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
929468|NCT00915525|1912876|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
929469|NCT00915525|1912875|FG000|Overall Study|Study Burden|28
929470|NCT00915525|1912876|FG001|Overall Study|Study Burden|12
929471|NCT00915525|1912875|FG000|Overall Study|Non-Compliance|3
929472|NCT00915525|1912876|FG001|Overall Study|Non-Compliance|1
929473|NCT00915525|1912875|FG000|Overall Study|Patient Moved|15
929474|NCT00915525|1912876|FG001|Overall Study|Patient Moved|9
929475|NCT00915551|1912915|FG000|Overall Study|Withdrawal by Subject|0
929476|NCT00915551|1912916|FG001|Overall Study|Withdrawal by Subject|1
929477|NCT00915772|1912962|FG000|Overall Study|Adverse Event|12
929478|NCT00915772|1912963|FG001|Overall Study|Adverse Event|13
929479|NCT00915772|1912964|FG002|Overall Study|Adverse Event|11
929480|NCT00915772|1912962|FG000|Overall Study|Protocol Violation|4
929481|NCT00915772|1912963|FG001|Overall Study|Protocol Violation|1
929482|NCT00915772|1912964|FG002|Overall Study|Protocol Violation|2
929483|NCT00915772|1912962|FG000|Overall Study|Lost to Follow-up|1
929484|NCT00915772|1912963|FG001|Overall Study|Lost to Follow-up|2
929485|NCT00915772|1912964|FG002|Overall Study|Lost to Follow-up|2
929486|NCT00915772|1912962|FG000|Overall Study|Lack of Efficacy|9
929487|NCT00915772|1912963|FG001|Overall Study|Lack of Efficacy|15
929488|NCT00915772|1912964|FG002|Overall Study|Lack of Efficacy|3
929489|NCT00915772|1912962|FG000|Overall Study|Refused to continue trial medication|6
929490|NCT00915772|1912963|FG001|Overall Study|Refused to continue trial medication|8
929491|NCT00915772|1912964|FG002|Overall Study|Refused to continue trial medication|4
929492|NCT00915772|1912962|FG000|Overall Study|Any other reason|4
929493|NCT00915772|1912963|FG001|Overall Study|Any other reason|7
929494|NCT00915772|1912964|FG002|Overall Study|Any other reason|7
929495|NCT00915876|1913002|FG000|Overall Study|Adverse Event|0
929496|NCT00915876|1913003|FG001|Overall Study|Adverse Event|1
929497|NCT00916006|1913054|FG000|Overall Study|Adverse Event|1
929498|NCT00916006|1913055|FG001|Overall Study|Adverse Event|1
929499|NCT00916006|1913054|FG000|Overall Study|Withdrawal by Subject|2
929500|NCT00916006|1913055|FG001|Overall Study|Withdrawal by Subject|5
929501|NCT00916006|1913054|FG000|Overall Study|Protocol Violation|0
929502|NCT00916006|1913055|FG001|Overall Study|Protocol Violation|1
929503|NCT00916058|1913075|FG000|Phase 1|Screen Failure|0
929504|NCT00916058|1913076|FG001|Phase 1|Screen Failure|0
929505|NCT00916058|1913077|FG002|Phase 1|Screen Failure|0
929506|NCT00916058|1913078|FG003|Phase 1|Screen Failure|0
929507|NCT00916058|1913079|FG004|Phase 1|Screen Failure|0
929508|NCT00916058|1913080|FG005|Phase 1|Screen Failure|1
929509|NCT00916058|1913081|FG006|Phase 1|Screen Failure|0
929510|NCT00916058|1913075|FG000|Phase 2|Screen Failure|0
929511|NCT00916058|1913076|FG001|Phase 2|Screen Failure|0
929512|NCT00916058|1913077|FG002|Phase 2|Screen Failure|0
929513|NCT00916058|1913078|FG003|Phase 2|Screen Failure|0
929514|NCT00916058|1913079|FG004|Phase 2|Screen Failure|0
929515|NCT00916058|1913080|FG005|Phase 2|Screen Failure|0
929516|NCT00916058|1913081|FG006|Phase 2|Screen Failure|3
929517|NCT00916149|1913111|FG000|Overall Study|Lost to Follow-up|3
929518|NCT00916149|1913112|FG001|Overall Study|Lost to Follow-up|2
929519|NCT00916149|1913113|FG002|Overall Study|Lost to Follow-up|0
929520|NCT00916149|1913111|FG000|Overall Study|Unable to place scalp EEG leads|1
929521|NCT00916149|1913112|FG001|Overall Study|Unable to place scalp EEG leads|0
929522|NCT00916149|1913113|FG002|Overall Study|Unable to place scalp EEG leads|0
929523|NCT00916279|1913120|FG000|Overall Study|Death|2
929524|NCT00916279|1913120|FG000|Overall Study|Lost to Follow-up|2
929525|NCT00916305|1913129|FG000|Overall Study|Lost to Follow-up|21
929526|NCT00916305|1913130|FG001|Overall Study|Lost to Follow-up|27
929527|NCT00916305|1913129|FG000|Overall Study|Withdrawal by Subject|0
929528|NCT00916305|1913130|FG001|Overall Study|Withdrawal by Subject|1
929529|NCT00916344|1913136|FG000|Overall Study|Death|2
929530|NCT00916344|1913136|FG000|Overall Study|ICD upgrade|1
929531|NCT00916344|1913136|FG000|Overall Study|Drop-out|5
929532|NCT00916357|1913140|FG000|Period 1|Withdrawal by Subject|1
929533|NCT00916357|1913141|FG001|Period 1|Withdrawal by Subject|0
929534|NCT00916357|1913142|FG002|Period 1|Withdrawal by Subject|0
929535|NCT00916357|1913143|FG003|Period 1|Withdrawal by Subject|0
929536|NCT00916357|1913144|FG004|Period 1|Withdrawal by Subject|0
929537|NCT00916357|1913145|FG005|Period 1|Withdrawal by Subject|0
929538|NCT00916357|1913140|FG000|Period 2|Weight loss > 3 kilograms (kg)|0
929539|NCT00916357|1913141|FG001|Period 2|Weight loss > 3 kilograms (kg)|0
929540|NCT00916357|1913142|FG002|Period 2|Weight loss > 3 kilograms (kg)|0
929541|NCT00916357|1913143|FG003|Period 2|Weight loss > 3 kilograms (kg)|1
929542|NCT00916357|1913144|FG004|Period 2|Weight loss > 3 kilograms (kg)|0
929543|NCT00916357|1913145|FG005|Period 2|Weight loss > 3 kilograms (kg)|0
929544|NCT00916370|1913156|FG000|Overall Study|Death|3
929545|NCT00916370|1913157|FG001|Overall Study|Death|1
929546|NCT00916370|1913156|FG000|Overall Study|Withdrawal by Subject|2
929547|NCT00916370|1913157|FG001|Overall Study|Withdrawal by Subject|0
929548|NCT00916370|1913156|FG000|Overall Study|Physician Decision|0
929549|NCT00916370|1913157|FG001|Overall Study|Physician Decision|1
929550|NCT00916383|1913164|FG000|Overall Study|Adverse Event|1
929551|NCT00916383|1913164|FG000|Overall Study|Death|1
929552|NCT00916383|1913164|FG000|Overall Study|Protocol Violation|1
929553|NCT00916578|1913181|FG000|Overall Study|Physician Decision|2
929554|NCT00916578|1913181|FG000|Overall Study|Withdrawal by Subject|3
929555|NCT00916578|1913181|FG000|Overall Study|Insurance Denial|2
929556|NCT00916617|1913189|FG000|Overall Study|Adverse Event|3
929557|NCT00916617|1913190|FG001|Overall Study|Adverse Event|2
929558|NCT00916617|1913191|FG002|Overall Study|Adverse Event|6
929559|NCT00916617|1913192|FG003|Overall Study|Adverse Event|3
929560|NCT00916617|1913189|FG000|Overall Study|Withdrawal by Subject|3
929561|NCT00916617|1913190|FG001|Overall Study|Withdrawal by Subject|2
929562|NCT00916617|1913191|FG002|Overall Study|Withdrawal by Subject|0
929563|NCT00916617|1913192|FG003|Overall Study|Withdrawal by Subject|1
929564|NCT00916617|1913189|FG000|Overall Study|Caregiver Request|3
929565|NCT00916617|1913190|FG001|Overall Study|Caregiver Request|2
929566|NCT00916617|1913191|FG002|Overall Study|Caregiver Request|1
929567|NCT00916617|1913192|FG003|Overall Study|Caregiver Request|0
929568|NCT00916617|1913189|FG000|Overall Study|Physician Decision|1
929569|NCT00916617|1913190|FG001|Overall Study|Physician Decision|1
929570|NCT00916617|1913191|FG002|Overall Study|Physician Decision|0
929571|NCT00916617|1913192|FG003|Overall Study|Physician Decision|0
929572|NCT00916617|1913189|FG000|Overall Study|Discontinuation of Study by Sponsor|8
929573|NCT00916617|1913190|FG001|Overall Study|Discontinuation of Study by Sponsor|13
929574|NCT00916617|1913191|FG002|Overall Study|Discontinuation of Study by Sponsor|3
929575|NCT00916617|1913192|FG003|Overall Study|Discontinuation of Study by Sponsor|1
929576|NCT00916617|1913189|FG000|Overall Study|Lost to Follow-up|2
929577|NCT00916617|1913190|FG001|Overall Study|Lost to Follow-up|1
929578|NCT00916617|1913191|FG002|Overall Study|Lost to Follow-up|0
929579|NCT00916617|1913192|FG003|Overall Study|Lost to Follow-up|0
929580|NCT00916617|1913189|FG000|Overall Study|Lack of Efficacy|1
929581|NCT00916617|1913190|FG001|Overall Study|Lack of Efficacy|0
929582|NCT00916617|1913191|FG002|Overall Study|Lack of Efficacy|0
929583|NCT00916617|1913192|FG003|Overall Study|Lack of Efficacy|0
929584|NCT00916617|1913189|FG000|Overall Study|Other|2
929585|NCT00916617|1913190|FG001|Overall Study|Other|0
929586|NCT00916617|1913191|FG002|Overall Study|Other|0
929587|NCT00916617|1913192|FG003|Overall Study|Other|2
929588|NCT00916721|1913208|FG000|Overall Study|Lost to Follow-up|0
929589|NCT00916721|1913209|FG001|Overall Study|Lost to Follow-up|1
929590|NCT00916721|1913208|FG000|Overall Study|Adverse Event|6
929591|NCT00916721|1913209|FG001|Overall Study|Adverse Event|3
929592|NCT00916721|1913208|FG000|Overall Study|Withdrawal by Subject|2
929593|NCT00916721|1913209|FG001|Overall Study|Withdrawal by Subject|2
929594|NCT00916721|1913208|FG000|Overall Study|Protocol Violation|2
929595|NCT00916721|1913209|FG001|Overall Study|Protocol Violation|4
929596|NCT00916929|1913217|FG000|Overall Study|Lost to Follow-up|1
929597|NCT00916929|1913218|FG001|Overall Study|Lost to Follow-up|3
929598|NCT00916929|1913217|FG000|Overall Study|Death|5
929599|NCT00916929|1913218|FG001|Overall Study|Death|10
929600|NCT00916929|1913217|FG000|Overall Study|Withdrawal by Subject|1
929601|NCT00916929|1913218|FG001|Overall Study|Withdrawal by Subject|5
929602|NCT00916929|1913217|FG000|Overall Study|Left ventricular epicardial lead|1
929603|NCT00916929|1913218|FG001|Overall Study|Left ventricular epicardial lead|2
929604|NCT00916929|1913217|FG000|Overall Study|Transferred to hospice care|1
929605|NCT00916929|1913218|FG001|Overall Study|Transferred to hospice care|1
929606|NCT00916929|1913217|FG000|Overall Study|System explant|1
929607|NCT00916929|1913218|FG001|Overall Study|System explant|0
929608|NCT00916929|1913217|FG000|Overall Study|Moved to another state|0
929609|NCT00916929|1913218|FG001|Overall Study|Moved to another state|1
929610|NCT00916929|1913217|FG000|Overall Study|Device unable to process impedance data|0
929611|NCT00916929|1913218|FG001|Overall Study|Device unable to process impedance data|7
929612|NCT00917124|1913228|FG000|Overall Study|Protocol Violation|4
929613|NCT00917124|1913229|FG001|Overall Study|Protocol Violation|6
929614|NCT00917150|1913239|FG000|Overall Study|Adverse Event|12
929615|NCT00917150|1913240|FG001|Overall Study|Adverse Event|7
929616|NCT00917150|1913241|FG002|Overall Study|Adverse Event|12
929617|NCT00917150|1913242|FG003|Overall Study|Adverse Event|11
929618|NCT00917150|1913239|FG000|Overall Study|Death|1
929619|NCT00917150|1913240|FG001|Overall Study|Death|4
929620|NCT00917150|1913241|FG002|Overall Study|Death|3
929621|NCT00917150|1913242|FG003|Overall Study|Death|2
929622|NCT00917150|1913239|FG000|Overall Study|Lost to Follow-up|1
929623|NCT00917150|1913240|FG001|Overall Study|Lost to Follow-up|0
929624|NCT00917150|1913241|FG002|Overall Study|Lost to Follow-up|4
929625|NCT00917150|1913242|FG003|Overall Study|Lost to Follow-up|2
929626|NCT00917150|1913239|FG000|Overall Study|Physician Decision|0
929627|NCT00917150|1913240|FG001|Overall Study|Physician Decision|2
929628|NCT00917150|1913241|FG002|Overall Study|Physician Decision|0
929629|NCT00917150|1913242|FG003|Overall Study|Physician Decision|1
929630|NCT00917150|1913239|FG000|Overall Study|Protocol Violation|5
929631|NCT00917150|1913240|FG001|Overall Study|Protocol Violation|5
929632|NCT00917150|1913241|FG002|Overall Study|Protocol Violation|3
929633|NCT00917150|1913242|FG003|Overall Study|Protocol Violation|5
929634|NCT00917150|1913239|FG000|Overall Study|Withdrawal by Subject|15
929635|NCT00917150|1913240|FG001|Overall Study|Withdrawal by Subject|16
929636|NCT00917150|1913241|FG002|Overall Study|Withdrawal by Subject|18
929637|NCT00917150|1913242|FG003|Overall Study|Withdrawal by Subject|11
929638|NCT00917150|1913239|FG000|Overall Study|Other than specified|3
929639|NCT00917150|1913240|FG001|Overall Study|Other than specified|3
929640|NCT00917150|1913241|FG002|Overall Study|Other than specified|2
929641|NCT00917150|1913242|FG003|Overall Study|Other than specified|2
929642|NCT00917267|1913254|FG000|Overall Study|Adverse Event|15
929643|NCT00917267|1913255|FG001|Overall Study|Adverse Event|36
929644|NCT00917267|1913254|FG000|Overall Study|Physician Decision|2
929645|NCT00917267|1913255|FG001|Overall Study|Physician Decision|4
929646|NCT00917267|1913254|FG000|Overall Study|Protocol Violation|9
929647|NCT00917267|1913255|FG001|Overall Study|Protocol Violation|18
929648|NCT00917267|1913254|FG000|Overall Study|Withdrawal by Subject|5
929649|NCT00917267|1913255|FG001|Overall Study|Withdrawal by Subject|12
929650|NCT00917267|1913254|FG000|Overall Study|Lost to follow up|0
929651|NCT00917267|1913255|FG001|Overall Study|Lost to follow up|2
929652|NCT00917267|1913254|FG000|Overall Study|Entry Criteria Not Met|1
929653|NCT00917267|1913255|FG001|Overall Study|Entry Criteria Not Met|0
929654|NCT00917267|1913254|FG000|Overall Study|Sponsor Decision|5
929655|NCT00917267|1913255|FG001|Overall Study|Sponsor Decision|5
929656|NCT00917267|1913254|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
929657|NCT00917267|1913255|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
929658|NCT00917384|1913267|FG000|Overall Study|Lost to Follow-up|4
929659|NCT00917384|1913268|FG001|Overall Study|Lost to Follow-up|2
929660|NCT00917384|1913267|FG000|Overall Study|Withdrawal by Subject|10
929661|NCT00917384|1913268|FG001|Overall Study|Withdrawal by Subject|2
929662|NCT00917462|1913274|FG000|Overall Study|Clinical Deterioration|1
929663|NCT00917501|1913280|FG000|Overall Study|Lost to Follow-up|4
929664|NCT00917501|1913281|FG001|Overall Study|Lost to Follow-up|1
929665|NCT00917501|1913280|FG000|Overall Study|Withdrawal by Subject|3
929666|NCT00917501|1913281|FG001|Overall Study|Withdrawal by Subject|1
929667|NCT00917501|1913280|FG000|Overall Study|Lack of Efficacy|1
929668|NCT00917501|1913281|FG001|Overall Study|Lack of Efficacy|2
929669|NCT00917501|1913280|FG000|Overall Study|trouble swollowing capsules|0
929670|NCT00917501|1913281|FG001|Overall Study|trouble swollowing capsules|1
929671|NCT00917553|1913289|FG000|Overall Study|Lost to Follow-up|2
929672|NCT00917553|1913290|FG001|Overall Study|Lost to Follow-up|1
929673|NCT00917579|1913296|FG000|Washout >= 2 Weeks|Adverse Event|1
929674|NCT00917579|1913297|FG001|Washout >= 2 Weeks|Adverse Event|0
929675|NCT00917579|1913296|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1
929676|NCT00917579|1913297|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0
929677|NCT00917644|1913303|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
929678|NCT00917644|1913304|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
929679|NCT00917644|1913303|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
929680|NCT00917644|1913304|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
929681|NCT00917644|1913303|FG000|Period 2: Second Intervention|family emergency|1
929682|NCT00917644|1913304|FG001|Period 2: Second Intervention|family emergency|0
929683|NCT00917852|1913319|FG000|Overall Study|Death|6
929684|NCT00918138|1913349|FG000|Overall Study|Subject withdrew consent|1
929685|NCT00918138|1913350|FG001|Overall Study|Subject withdrew consent|1
929686|NCT00918138|1913349|FG000|Overall Study|Death|1
929687|NCT00918138|1913350|FG001|Overall Study|Death|0
929688|NCT00918203|1913358|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1
929689|NCT00918203|1913359|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1
929690|NCT00918203|1913360|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0
929691|NCT00918203|1913358|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2
929692|NCT00918203|1913359|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8
929693|NCT00918203|1913360|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0
929694|NCT00918203|1913358|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2
929695|NCT00918203|1913359|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1
929696|NCT00918203|1913360|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0
929697|NCT00918203|1913358|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1
929698|NCT00918203|1913359|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0
929699|NCT00918203|1913360|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0
929700|NCT00918255|1913379|FG000|Overall Study|Adverse Event|1
929701|NCT00918255|1913380|FG001|Overall Study|Adverse Event|0
929702|NCT00918255|1913381|FG002|Overall Study|Adverse Event|0
929703|NCT00918255|1913379|FG000|Overall Study|Withdrawal by Subject|1
929704|NCT00918255|1913380|FG001|Overall Study|Withdrawal by Subject|0
929705|NCT00918255|1913381|FG002|Overall Study|Withdrawal by Subject|2
929706|NCT00918255|1913379|FG000|Overall Study|Lack of Efficacy|1
929707|NCT00918255|1913380|FG001|Overall Study|Lack of Efficacy|0
929708|NCT00918255|1913381|FG002|Overall Study|Lack of Efficacy|0
929709|NCT00918255|1913379|FG000|Overall Study|Lost to Follow-up|1
929710|NCT00918255|1913380|FG001|Overall Study|Lost to Follow-up|0
929711|NCT00918255|1913381|FG002|Overall Study|Lost to Follow-up|2
929712|NCT00918255|1913379|FG000|Overall Study|Exceeded allowed number of interventions|0
929713|NCT00918255|1913380|FG001|Overall Study|Exceeded allowed number of interventions|0
929714|NCT00918255|1913381|FG002|Overall Study|Exceeded allowed number of interventions|1
929715|NCT00918255|1913379|FG000|Overall Study|Non-compliance|1
929716|NCT00918255|1913380|FG001|Overall Study|Non-compliance|0
929717|NCT00918255|1913381|FG002|Overall Study|Non-compliance|0
929718|NCT00918255|1913379|FG000|Overall Study|Investigator discretion|1
929719|NCT00918255|1913380|FG001|Overall Study|Investigator discretion|0
929720|NCT00918255|1913381|FG002|Overall Study|Investigator discretion|0
929721|NCT00918281|1913389|FG000|Overall Study|Physician Decision|29
929722|NCT00918333|1913398|FG000|Overall Study|Drug not taken per protocol|1
929723|NCT00918333|1913399|FG001|Overall Study|Drug not taken per protocol|0
929724|NCT00918333|1913398|FG000|Overall Study|Inadequate amount of drugs provided|1
929725|NCT00918333|1913399|FG001|Overall Study|Inadequate amount of drugs provided|4
929726|NCT00918333|1913398|FG000|Overall Study|Ineligible|1
929727|NCT00918333|1913399|FG001|Overall Study|Ineligible|0
929728|NCT00918333|1913398|FG000|Overall Study|Withdrawal by Subject|0
929729|NCT00918333|1913399|FG001|Overall Study|Withdrawal by Subject|1
929730|NCT00918346|1913408|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0
929731|NCT00918346|1913409|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1
929732|NCT00918385|1913420|FG000|Monotherapy|Adverse Event|1
929733|NCT00918385|1913421|FG001|Monotherapy|Adverse Event|6
929734|NCT00918385|1913420|FG000|Monotherapy|Complicating illness|1
929735|NCT00918385|1913421|FG001|Monotherapy|Complicating illness|0
929736|NCT00918385|1913420|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1
929737|NCT00918385|1913421|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1
929738|NCT00918385|1913420|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
929739|NCT00918385|1913421|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
929740|NCT00918385|1913420|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1
929741|NCT00918385|1913421|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0
929742|NCT00918385|1913420|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
929743|NCT00918385|1913421|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
929744|NCT00918567|1913431|FG000|Overall Study|Lack of Efficacy|3
929745|NCT00918567|1913432|FG001|Overall Study|Lack of Efficacy|1
929746|NCT00918567|1913431|FG000|Overall Study|Withdrawal by Subject|1
929747|NCT00918567|1913432|FG001|Overall Study|Withdrawal by Subject|1
929748|NCT00918567|1913431|FG000|Overall Study|Adverse Event|1
929749|NCT00918567|1913432|FG001|Overall Study|Adverse Event|0
929750|NCT00918580|1913438|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1
929751|NCT00918580|1913438|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
929752|NCT00918580|1913438|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
929753|NCT00918580|1913438|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
929754|NCT00918580|1913438|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1
929755|NCT00918580|1913438|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
929756|NCT00918580|1913438|FG000|After 6-month FU to 1-year FU|Failed to Return|2
929757|NCT00918684|1913449|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
929758|NCT00918684|1913449|FG000|Treatment Phase|Lack of Efficacy|6
929759|NCT00918684|1913449|FG000|Treatment Phase|Lost to Follow-up|2
929760|NCT00918684|1913449|FG000|Treatment Phase|Physician Decision|8
929761|NCT00918684|1913449|FG000|Treatment Phase|Protocol Violation|1
929762|NCT00918684|1913449|FG000|Treatment Phase|Withdrawal by Subject|8
929763|NCT00918736|1913459|FG000|Overall Study|Withdrawal by Subject|4
929764|NCT00918749|1913466|FG000|Overall Study|Adverse Event|1
929765|NCT00918749|1913467|FG001|Overall Study|Adverse Event|0
929766|NCT00918749|1913468|FG002|Overall Study|Adverse Event|1
929767|NCT00918749|1913466|FG000|Overall Study|Lost to Follow-up|0
929768|NCT00918749|1913467|FG001|Overall Study|Lost to Follow-up|0
929769|NCT00918749|1913468|FG002|Overall Study|Lost to Follow-up|1
929770|NCT00918749|1913466|FG000|Overall Study|Withdrawal by Subject|5
929771|NCT00918749|1913467|FG001|Overall Study|Withdrawal by Subject|3
929772|NCT00918749|1913468|FG002|Overall Study|Withdrawal by Subject|5
929773|NCT00918749|1913466|FG000|Overall Study|No Study Medication Taken|1
929774|NCT00918749|1913467|FG001|Overall Study|No Study Medication Taken|0
929775|NCT00918749|1913468|FG002|Overall Study|No Study Medication Taken|0
929776|NCT00918879|1913487|FG000|Overall Study|Withdrawal by Subject|4
929777|NCT00918879|1913488|FG001|Overall Study|Withdrawal by Subject|4
929778|NCT00918879|1913487|FG000|Overall Study|Lost to Follow-up|1
929779|NCT00918879|1913488|FG001|Overall Study|Lost to Follow-up|1
929780|NCT00918879|1913487|FG000|Overall Study|Severe non-compliance to protocol|1
929781|NCT00918879|1913488|FG001|Overall Study|Severe non-compliance to protocol|1
929782|NCT00918957|1913500|FG000|Overall Study|Adverse Event|2
929783|NCT00918957|1913501|FG001|Overall Study|Adverse Event|0
929784|NCT00918957|1913500|FG000|Overall Study|Withdrawal by Subject|1
929785|NCT00918957|1913501|FG001|Overall Study|Withdrawal by Subject|0
929786|NCT00919061|1913511|FG000|Overall Study|Adverse Event|1
929787|NCT00919061|1913511|FG000|Overall Study|Withdrawal by Subject|1
929788|NCT00919633|1913566|FG000|Overall Study|Adverse Event|1
929789|NCT00919633|1913567|FG001|Overall Study|Adverse Event|9
929790|NCT00919633|1913568|FG002|Overall Study|Adverse Event|12
929791|NCT00919633|1913569|FG003|Overall Study|Adverse Event|10
929792|NCT00919633|1913566|FG000|Overall Study|Death|0
929793|NCT00919633|1913567|FG001|Overall Study|Death|0
929794|NCT00919633|1913568|FG002|Overall Study|Death|2
929795|NCT00919633|1913569|FG003|Overall Study|Death|0
929796|NCT00919633|1913566|FG000|Overall Study|Lack of Efficacy|17
929797|NCT00919633|1913567|FG001|Overall Study|Lack of Efficacy|3
929798|NCT00919633|1913568|FG002|Overall Study|Lack of Efficacy|2
929799|NCT00919633|1913569|FG003|Overall Study|Lack of Efficacy|3
929800|NCT00919633|1913566|FG000|Overall Study|Withdrawal by Subject|1
929801|NCT00919633|1913567|FG001|Overall Study|Withdrawal by Subject|2
929802|NCT00919633|1913568|FG002|Overall Study|Withdrawal by Subject|4
929803|NCT00919633|1913569|FG003|Overall Study|Withdrawal by Subject|3
929804|NCT00919633|1913566|FG000|Overall Study|Lost to Follow-up|3
929805|NCT00919633|1913567|FG001|Overall Study|Lost to Follow-up|1
929806|NCT00919633|1913568|FG002|Overall Study|Lost to Follow-up|0
929807|NCT00919633|1913569|FG003|Overall Study|Lost to Follow-up|2
929808|NCT00919633|1913566|FG000|Overall Study|Withdraw consent post transition to SOC|0
929809|NCT00919633|1913567|FG001|Overall Study|Withdraw consent post transition to SOC|0
929810|NCT00919633|1913568|FG002|Overall Study|Withdraw consent post transition to SOC|1
929811|NCT00919633|1913569|FG003|Overall Study|Withdraw consent post transition to SOC|1
929812|NCT00919633|1913566|FG000|Overall Study|Protocol Violation|0
929813|NCT00919633|1913567|FG001|Overall Study|Protocol Violation|0
929814|NCT00919633|1913568|FG002|Overall Study|Protocol Violation|0
929815|NCT00919633|1913569|FG003|Overall Study|Protocol Violation|1
929816|NCT00919633|1913566|FG000|Overall Study|Physician Decision|0
929817|NCT00919633|1913567|FG001|Overall Study|Physician Decision|0
929818|NCT00919633|1913568|FG002|Overall Study|Physician Decision|0
929819|NCT00919633|1913569|FG003|Overall Study|Physician Decision|1
929820|NCT00919633|1913566|FG000|Overall Study|Request of withdrawal w/o future contact|0
929821|NCT00919633|1913567|FG001|Overall Study|Request of withdrawal w/o future contact|0
929822|NCT00919633|1913568|FG002|Overall Study|Request of withdrawal w/o future contact|1
929823|NCT00919633|1913569|FG003|Overall Study|Request of withdrawal w/o future contact|0
929824|NCT00919633|1913566|FG000|Overall Study|Viral rebound outside protocol timepoint|0
929825|NCT00919633|1913567|FG001|Overall Study|Viral rebound outside protocol timepoint|0
929826|NCT00919633|1913568|FG002|Overall Study|Viral rebound outside protocol timepoint|1
929827|NCT00919633|1913569|FG003|Overall Study|Viral rebound outside protocol timepoint|0
929828|NCT00919711|1913581|FG000|Overall Study|Withdrawal by Subject|15
929829|NCT00919711|1913582|FG001|Overall Study|Withdrawal by Subject|7
929830|NCT00919711|1913581|FG000|Overall Study|Adverse Event|13
929831|NCT00919711|1913582|FG001|Overall Study|Adverse Event|3
929832|NCT00919711|1913581|FG000|Overall Study|Other|1
929833|NCT00919711|1913582|FG001|Overall Study|Other|2
929834|NCT00919711|1913581|FG000|Overall Study|Administrative Decision|0
929835|NCT00919711|1913582|FG001|Overall Study|Administrative Decision|1
929836|NCT00919711|1913581|FG000|Overall Study|Lost to Follow-up|2
929837|NCT00919711|1913582|FG001|Overall Study|Lost to Follow-up|0
929838|NCT00919711|1913581|FG000|Overall Study|Death|1
929839|NCT00919711|1913582|FG001|Overall Study|Death|0
929840|NCT00919711|1913581|FG000|Overall Study|Noncompliance|1
929841|NCT00919711|1913582|FG001|Overall Study|Noncompliance|0
929842|NCT00919854|1913613|FG000|Overall Study|Adverse Event|1
929843|NCT00919867|1913623|FG000|First Intervention|Withdrawal by Subject|0
929844|NCT00919867|1913624|FG001|First Intervention|Withdrawal by Subject|0
929845|NCT00919867|1913625|FG002|First Intervention|Withdrawal by Subject|1
929846|NCT00919867|1913626|FG003|First Intervention|Withdrawal by Subject|0
929847|NCT00919867|1913627|FG004|First Intervention|Withdrawal by Subject|0
929848|NCT00919867|1913628|FG005|First Intervention|Withdrawal by Subject|0
929849|NCT00919867|1913623|FG000|First Intervention|Physician Decision|0
929850|NCT00919867|1913624|FG001|First Intervention|Physician Decision|0
929851|NCT00919867|1913625|FG002|First Intervention|Physician Decision|0
929852|NCT00919867|1913626|FG003|First Intervention|Physician Decision|0
929853|NCT00919867|1913627|FG004|First Intervention|Physician Decision|0
929854|NCT00919867|1913628|FG005|First Intervention|Physician Decision|1
929855|NCT00919893|1913638|FG000|Overall Study|Protocol Violation|19
929856|NCT00919893|1913639|FG001|Overall Study|Protocol Violation|9
929857|NCT00920140|1913665|FG000|Phase 1 (Dose Escalation)|Adverse Event|3
929858|NCT00920140|1913666|FG001|Phase 1 (Dose Escalation)|Adverse Event|3
929859|NCT00920140|1913667|FG002|Phase 1 (Dose Escalation)|Adverse Event|0
929860|NCT00920140|1913668|FG003|Phase 1 (Dose Escalation)|Adverse Event|0
929861|NCT00920140|1913669|FG004|Phase 1 (Dose Escalation)|Adverse Event|0
929862|NCT00920140|1913665|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2
929863|NCT00920140|1913666|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4
929864|NCT00920140|1913667|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0
929865|NCT00920140|1913668|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0
929866|NCT00920140|1913669|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0
929867|NCT00920140|1913665|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
929868|NCT00920140|1913666|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
929869|NCT00920140|1913667|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
929870|NCT00920140|1913668|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
929871|NCT00920140|1913669|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
929872|NCT00920140|1913665|FG000|Phase 2|Adverse Event|0
929873|NCT00920140|1913666|FG001|Phase 2|Adverse Event|0
929874|NCT00920140|1913667|FG002|Phase 2|Adverse Event|14
929875|NCT00920140|1913668|FG003|Phase 2|Adverse Event|2
929876|NCT00920140|1913669|FG004|Phase 2|Adverse Event|3
929877|NCT00920140|1913665|FG000|Phase 2|Lack of Efficacy|0
929878|NCT00920140|1913666|FG001|Phase 2|Lack of Efficacy|0
929879|NCT00920140|1913667|FG002|Phase 2|Lack of Efficacy|29
929880|NCT00920140|1913668|FG003|Phase 2|Lack of Efficacy|14
929881|NCT00920140|1913669|FG004|Phase 2|Lack of Efficacy|5
929882|NCT00920140|1913665|FG000|Phase 2|Lost to Follow-up|0
929883|NCT00920140|1913666|FG001|Phase 2|Lost to Follow-up|0
929884|NCT00920140|1913667|FG002|Phase 2|Lost to Follow-up|0
929885|NCT00920140|1913668|FG003|Phase 2|Lost to Follow-up|1
929886|NCT00920140|1913669|FG004|Phase 2|Lost to Follow-up|0
929887|NCT00920140|1913665|FG000|Phase 2|Physician Decision|0
929888|NCT00920140|1913666|FG001|Phase 2|Physician Decision|0
929889|NCT00920140|1913667|FG002|Phase 2|Physician Decision|3
929890|NCT00920140|1913668|FG003|Phase 2|Physician Decision|3
929891|NCT00920140|1913669|FG004|Phase 2|Physician Decision|2
929892|NCT00920140|1913665|FG000|Phase 2|Withdrawal by Subject|0
929893|NCT00920140|1913666|FG001|Phase 2|Withdrawal by Subject|0
929894|NCT00920140|1913667|FG002|Phase 2|Withdrawal by Subject|4
929895|NCT00920140|1913668|FG003|Phase 2|Withdrawal by Subject|2
929896|NCT00920140|1913669|FG004|Phase 2|Withdrawal by Subject|1
929897|NCT00920218|1913686|FG000|Overall Study|Serious Adverse Event|2
929898|NCT00920218|1913687|FG001|Overall Study|Serious Adverse Event|0
929899|NCT00920218|1913688|FG002|Overall Study|Serious Adverse Event|2
929900|NCT00920218|1913689|FG003|Overall Study|Serious Adverse Event|1
929901|NCT00920218|1913686|FG000|Overall Study|Withdrawal by Subject|0
929902|NCT00920218|1913687|FG001|Overall Study|Withdrawal by Subject|3
929903|NCT00920218|1913688|FG002|Overall Study|Withdrawal by Subject|2
929904|NCT00920218|1913689|FG003|Overall Study|Withdrawal by Subject|0
929905|NCT00920218|1913686|FG000|Overall Study|Migrated/moved from study area|0
929906|NCT00920218|1913687|FG001|Overall Study|Migrated/moved from study area|0
929907|NCT00920218|1913688|FG002|Overall Study|Migrated/moved from study area|1
929908|NCT00920218|1913689|FG003|Overall Study|Migrated/moved from study area|0
929909|NCT00920218|1913686|FG000|Overall Study|Lost to Follow-up|0
929910|NCT00920218|1913687|FG001|Overall Study|Lost to Follow-up|1
929911|NCT00920218|1913688|FG002|Overall Study|Lost to Follow-up|0
929912|NCT00920218|1913689|FG003|Overall Study|Lost to Follow-up|3
929913|NCT00920218|1913686|FG000|Overall Study|Transplant failed/malignancy recurrence|0
929914|NCT00920218|1913687|FG001|Overall Study|Transplant failed/malignancy recurrence|1
929915|NCT00920218|1913688|FG002|Overall Study|Transplant failed/malignancy recurrence|2
929916|NCT00920218|1913689|FG003|Overall Study|Transplant failed/malignancy recurrence|3
929917|NCT00920218|1913686|FG000|Overall Study|Other|0
929918|NCT00920218|1913687|FG001|Overall Study|Other|0
929919|NCT00920218|1913688|FG002|Overall Study|Other|1
929920|NCT00920218|1913689|FG003|Overall Study|Other|0
929921|NCT00920426|1913726|FG000|ITZ111451|Adverse Event|1
929922|NCT00920426|1913727|FG001|ITZ111451|Adverse Event|0
929923|NCT00920426|1913728|FG002|ITZ111451|Adverse Event|0
929924|NCT00920426|1913729|FG003|ITZ111451|Adverse Event|0
929925|NCT00920556|1913745|FG000|Overall Study|Adverse Event|16
929926|NCT00920556|1913745|FG000|Overall Study|Physician Decision|7
929927|NCT00920556|1913745|FG000|Overall Study|Withdrawal by Subject|1
929928|NCT00920621|1913757|FG000|Overall Study|Lost to Follow-up|16
929929|NCT00920621|1913758|FG001|Overall Study|Lost to Follow-up|17
929930|NCT00920621|1913759|FG002|Overall Study|Lost to Follow-up|19
929931|NCT00920621|1913760|FG003|Overall Study|Lost to Follow-up|21
929932|NCT00920621|1913757|FG000|Overall Study|Fetal/neonatal deaths|16
929933|NCT00920621|1913758|FG001|Overall Study|Fetal/neonatal deaths|14
929934|NCT00920621|1913759|FG002|Overall Study|Fetal/neonatal deaths|16
929935|NCT00920621|1913760|FG003|Overall Study|Fetal/neonatal deaths|14
929936|NCT00920621|1913757|FG000|Overall Study|Blood sample not collected|22
929937|NCT00920621|1913758|FG001|Overall Study|Blood sample not collected|14
929938|NCT00920621|1913759|FG002|Overall Study|Blood sample not collected|0
929939|NCT00920621|1913760|FG003|Overall Study|Blood sample not collected|0
929940|NCT00920686|1913801|FG000|Overall Study|Lost to Follow-up|2
929941|NCT00920686|1913802|FG001|Overall Study|Lost to Follow-up|3
929942|NCT00920686|1913803|FG002|Overall Study|Lost to Follow-up|1
929943|NCT00920686|1913801|FG000|Overall Study|Study drug dosing criteria not met|17
929944|NCT00920686|1913802|FG001|Overall Study|Study drug dosing criteria not met|19
929945|NCT00920686|1913803|FG002|Overall Study|Study drug dosing criteria not met|12
929946|NCT00920699|1913818|FG000|Overall Study|Withdrawal by Subject|2
929947|NCT00920699|1913819|FG001|Overall Study|Withdrawal by Subject|0
929948|NCT00920699|1913820|FG002|Overall Study|Withdrawal by Subject|2
929949|NCT00920699|1913818|FG000|Overall Study|no longer met eligibility|0
929950|NCT00920699|1913819|FG001|Overall Study|no longer met eligibility|1
929951|NCT00920699|1913820|FG002|Overall Study|no longer met eligibility|0
929952|NCT00920699|1913818|FG000|Overall Study|Lost to Follow-up|0
929953|NCT00920699|1913819|FG001|Overall Study|Lost to Follow-up|0
929954|NCT00920699|1913820|FG002|Overall Study|Lost to Follow-up|2
929955|NCT00920790|1913828|FG000|Overall Study|aggravation of general condition|14
929956|NCT00920816|1913836|FG000|Overall Study|Death|77
929957|NCT00920816|1913837|FG001|Overall Study|Death|36
929958|NCT00920816|1913838|FG002|Overall Study|Death|58
929959|NCT00920816|1913839|FG003|Overall Study|Death|28
929960|NCT00920816|1913836|FG000|Overall Study|Adverse Event|1
929961|NCT00920816|1913837|FG001|Overall Study|Adverse Event|0
929962|NCT00920816|1913838|FG002|Overall Study|Adverse Event|1
929963|NCT00920816|1913839|FG003|Overall Study|Adverse Event|0
929964|NCT00920816|1913836|FG000|Overall Study|Lost to Follow-up|1
929965|NCT00920816|1913837|FG001|Overall Study|Lost to Follow-up|2
929966|NCT00920816|1913838|FG002|Overall Study|Lost to Follow-up|3
929967|NCT00920816|1913839|FG003|Overall Study|Lost to Follow-up|4
929968|NCT00920816|1913836|FG000|Overall Study|Objective progression or relapse|0
929969|NCT00920816|1913837|FG001|Overall Study|Objective progression or relapse|0
929970|NCT00920816|1913838|FG002|Overall Study|Objective progression or relapse|2
929971|NCT00920816|1913839|FG003|Overall Study|Objective progression or relapse|0
929972|NCT00920816|1913836|FG000|Overall Study|Withdrawal by Subject|7
929973|NCT00920816|1913837|FG001|Overall Study|Withdrawal by Subject|2
929974|NCT00920816|1913838|FG002|Overall Study|Withdrawal by Subject|1
929975|NCT00920816|1913839|FG003|Overall Study|Withdrawal by Subject|1
929976|NCT00920816|1913836|FG000|Overall Study|Ongoing|106
929977|NCT00920816|1913837|FG001|Overall Study|Ongoing|56
929978|NCT00920816|1913838|FG002|Overall Study|Ongoing|70
929979|NCT00920816|1913839|FG003|Overall Study|Ongoing|36
929980|NCT00920829|1913853|FG000|Allocation|No post randomization data|3
929981|NCT00920829|1913854|FG001|Allocation|No post randomization data|1
929982|NCT00920829|1913855|FG002|Allocation|No post randomization data|0
929983|NCT00920829|1913856|FG003|Allocation|No post randomization data|2
929984|NCT00920829|1913853|FG000|Available for Analysis|Withdrawal by Subject|6
929985|NCT00920829|1913854|FG001|Available for Analysis|Withdrawal by Subject|6
929986|NCT00920829|1913855|FG002|Available for Analysis|Withdrawal by Subject|6
929987|NCT00920829|1913856|FG003|Available for Analysis|Withdrawal by Subject|10
929988|NCT00920829|1913853|FG000|Available for Analysis|Required Medical Treatment|0
929989|NCT00920829|1913854|FG001|Available for Analysis|Required Medical Treatment|1
929990|NCT00920829|1913855|FG002|Available for Analysis|Required Medical Treatment|2
929991|NCT00920829|1913856|FG003|Available for Analysis|Required Medical Treatment|0
929992|NCT00920829|1913853|FG000|Available for Analysis|Adverse Event|1
929993|NCT00920829|1913854|FG001|Available for Analysis|Adverse Event|2
929994|NCT00920829|1913855|FG002|Available for Analysis|Adverse Event|1
929995|NCT00920829|1913856|FG003|Available for Analysis|Adverse Event|0
929996|NCT00920829|1913853|FG000|Available for Analysis|Death|1
929997|NCT00920829|1913854|FG001|Available for Analysis|Death|0
929998|NCT00920829|1913855|FG002|Available for Analysis|Death|0
929999|NCT00920829|1913856|FG003|Available for Analysis|Death|0
930000|NCT00920829|1913853|FG000|Available for Analysis|Protocol Violation|0
930001|NCT00920829|1913854|FG001|Available for Analysis|Protocol Violation|0
930002|NCT00920829|1913855|FG002|Available for Analysis|Protocol Violation|1
930003|NCT00920829|1913856|FG003|Available for Analysis|Protocol Violation|0
930004|NCT00920829|1913853|FG000|Available for Analysis|Required more treatment|0
930005|NCT00920829|1913854|FG001|Available for Analysis|Required more treatment|2
930006|NCT00920829|1913855|FG002|Available for Analysis|Required more treatment|0
930007|NCT00920829|1913856|FG003|Available for Analysis|Required more treatment|1
930008|NCT00920855|1913869|FG000|Overall Study|Adverse Event|1
930009|NCT00920855|1913870|FG001|Overall Study|Adverse Event|1
930010|NCT00920855|1913871|FG002|Overall Study|Adverse Event|4
930011|NCT00920855|1913869|FG000|Overall Study|Withdrawal by Subject|2
930012|NCT00920855|1913870|FG001|Overall Study|Withdrawal by Subject|1
930013|NCT00920855|1913871|FG002|Overall Study|Withdrawal by Subject|6
930014|NCT00920855|1913869|FG000|Overall Study|Disease progression|2
930015|NCT00920855|1913870|FG001|Overall Study|Disease progression|1
930016|NCT00920855|1913871|FG002|Overall Study|Disease progression|10
930017|NCT00920855|1913869|FG000|Overall Study|Noncompliance to study medication|0
930018|NCT00920855|1913870|FG001|Overall Study|Noncompliance to study medication|0
930019|NCT00920855|1913871|FG002|Overall Study|Noncompliance to study medication|1
930020|NCT00920855|1913869|FG000|Overall Study|Response plateau; started maintenance|0
930021|NCT00920855|1913870|FG001|Overall Study|Response plateau; started maintenance|0
930022|NCT00920855|1913871|FG002|Overall Study|Response plateau; started maintenance|1
930023|NCT00920907|1913882|FG000|Induction Period|Adverse Event|0
930024|NCT00920907|1913883|FG001|Induction Period|Adverse Event|2
930025|NCT00920907|1913882|FG000|Induction Period|Death|1
930026|NCT00920907|1913883|FG001|Induction Period|Death|1
930027|NCT00920907|1913882|FG000|Induction Period|Disease Progression|12
930028|NCT00920907|1913883|FG001|Induction Period|Disease Progression|11
930029|NCT00920907|1913882|FG000|Induction Period|Study Drug Toxicity|8
930030|NCT00920907|1913883|FG001|Induction Period|Study Drug Toxicity|6
930031|NCT00920907|1913882|FG000|Induction Period|No longer meets study criteria|0
930032|NCT00920907|1913883|FG001|Induction Period|No longer meets study criteria|1
930033|NCT00920907|1913882|FG000|Induction Period|Withdrawal by Subject|1
930034|NCT00920907|1913883|FG001|Induction Period|Withdrawal by Subject|1
930035|NCT00920907|1913882|FG000|Maintenance Period|Disease Progression|3
930036|NCT00920907|1913883|FG001|Maintenance Period|Disease Progression|7
930037|NCT00920907|1913882|FG000|Maintenance Period|Administrative (study closure)|7
930038|NCT00920907|1913883|FG001|Maintenance Period|Administrative (study closure)|2
930039|NCT00920907|1913882|FG000|Maintenance Period|Study Drug Toxicity|0
930040|NCT00920907|1913883|FG001|Maintenance Period|Study Drug Toxicity|2
930041|NCT00920907|1913882|FG000|Maintenance Period|Death|1
930042|NCT00920907|1913883|FG001|Maintenance Period|Death|1
930043|NCT00920907|1913882|FG000|Maintenance Period|Withdrawal by Subject|1
930044|NCT00920907|1913883|FG001|Maintenance Period|Withdrawal by Subject|0
930045|NCT00920907|1913882|FG000|Maintenance Period|Adverse Event|0
930046|NCT00920907|1913883|FG001|Maintenance Period|Adverse Event|1
930047|NCT00921024|1913893|FG000|Overall Study|Lost to Follow-up|2
930048|NCT00921024|1913894|FG001|Overall Study|Lost to Follow-up|0
930049|NCT00921024|1913893|FG000|Overall Study|Received concomittant therapy|2
930050|NCT00921024|1913894|FG001|Overall Study|Received concomittant therapy|0
930051|NCT00921024|1913893|FG000|Overall Study|Withdrawal by Subject|0
930052|NCT00921024|1913894|FG001|Overall Study|Withdrawal by Subject|3
930053|NCT00921557|1913932|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
930054|NCT00921557|1913933|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
930055|NCT00921557|1913934|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
930056|NCT00921557|1913932|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0
930057|NCT00921557|1913933|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1
930058|NCT00921557|1913934|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0
930059|NCT00921557|1913932|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
930060|NCT00921557|1913933|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
930061|NCT00921557|1913934|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
930062|NCT00921557|1913932|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1
930063|NCT00921557|1913933|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0
930064|NCT00921557|1913934|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0
930065|NCT00921557|1913932|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
930066|NCT00921557|1913933|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
930067|NCT00921557|1913934|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
930068|NCT00922116|1913991|FG000|Overall Study|Adverse Event|4
930069|NCT00922116|1913991|FG000|Overall Study|Death|1
930070|NCT00922116|1913991|FG000|Overall Study|Lost to Follow-up|1
930071|NCT00922116|1913991|FG000|Overall Study|Withdrawal by Subject|4
930072|NCT00922116|1913991|FG000|Overall Study|Other|5
930073|NCT00922207|1914002|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
930074|NCT00922207|1914003|FG001|Overall Study|Adverse Event/Intercurrent Illness|0
930075|NCT00922207|1914004|FG002|Overall Study|Adverse Event/Intercurrent Illness|0
930076|NCT00922207|1914002|FG000|Overall Study|Insufficient Therapeutic Response|0
930077|NCT00922207|1914003|FG001|Overall Study|Insufficient Therapeutic Response|0
930078|NCT00922207|1914004|FG002|Overall Study|Insufficient Therapeutic Response|1
930079|NCT00922207|1914002|FG000|Overall Study|Violation of Selection Criteria at Entry|0
930080|NCT00922207|1914003|FG001|Overall Study|Violation of Selection Criteria at Entry|1
930081|NCT00922207|1914004|FG002|Overall Study|Violation of Selection Criteria at Entry|0
930082|NCT00922207|1914002|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
930083|NCT00922207|1914003|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
930084|NCT00922207|1914004|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0
930085|NCT00922207|1914002|FG000|Overall Study|Withdrew Consent|2
930086|NCT00922207|1914003|FG001|Overall Study|Withdrew Consent|5
930087|NCT00922207|1914004|FG002|Overall Study|Withdrew Consent|2
930088|NCT00922207|1914002|FG000|Overall Study|Abnormality of Laboratory Test|0
930089|NCT00922207|1914003|FG001|Overall Study|Abnormality of Laboratory Test|1
930090|NCT00922207|1914004|FG002|Overall Study|Abnormality of Laboratory Test|1
930091|NCT00922272|1914017|FG000|Open-label Phase|Adverse Event|5
930092|NCT00922272|1914018|FG001|Open-label Phase|Adverse Event|0
930093|NCT00922272|1914017|FG000|Open-label Phase|Protocol Violation|1
930094|NCT00922272|1914018|FG001|Open-label Phase|Protocol Violation|0
930095|NCT00922272|1914017|FG000|Open-label Phase|Withdrawal by Subject|11
930096|NCT00922272|1914018|FG001|Open-label Phase|Withdrawal by Subject|0
930097|NCT00922272|1914017|FG000|Open-label Phase|Failure to meet randomization criteria|1
930098|NCT00922272|1914018|FG001|Open-label Phase|Failure to meet randomization criteria|0
930099|NCT00922272|1914017|FG000|Open-label Phase|Withdrawal criteria met|5
930100|NCT00922272|1914018|FG001|Open-label Phase|Withdrawal criteria met|0
930101|NCT00922272|1914017|FG000|Double-blind Phase|Adverse Event|1
930102|NCT00922272|1914018|FG001|Double-blind Phase|Adverse Event|1
930103|NCT00922272|1914017|FG000|Double-blind Phase|Withdrawal by Subject|1
930104|NCT00922272|1914018|FG001|Double-blind Phase|Withdrawal by Subject|1
930105|NCT00922272|1914017|FG000|Double-blind Phase|Lost to Follow-up|2
930106|NCT00922272|1914018|FG001|Double-blind Phase|Lost to Follow-up|1
930107|NCT00922272|1914017|FG000|Double-blind Phase|Withdrawal criteria met|1
930108|NCT00922272|1914018|FG001|Double-blind Phase|Withdrawal criteria met|1
930109|NCT00922272|1914017|FG000|Double-blind Phase|Noncompliance|1
930110|NCT00922272|1914018|FG001|Double-blind Phase|Noncompliance|1
930111|NCT00922272|1914017|FG000|Double-blind Phase|Positive urine drug screen|1
930112|NCT00922272|1914018|FG001|Double-blind Phase|Positive urine drug screen|1
930113|NCT00922428|1914026|FG000|Overall Study|retrospective/extremely implausible data|2
930114|NCT00922428|1914026|FG000|Overall Study|no medication use or questionable use|13
930115|NCT00922441|1914039|FG000|Overall Study|Protocol Violation|0
930116|NCT00922441|1914040|FG001|Overall Study|Protocol Violation|0
930117|NCT00922441|1914041|FG002|Overall Study|Protocol Violation|2
930118|NCT00922441|1914039|FG000|Overall Study|Withdrawal by Subject|0
930119|NCT00922441|1914040|FG001|Overall Study|Withdrawal by Subject|0
930120|NCT00922441|1914041|FG002|Overall Study|Withdrawal by Subject|1
930121|NCT00922480|1914051|FG000|Main Study|Protocol Violation|3
930122|NCT00922480|1914052|FG001|Main Study|Protocol Violation|6
930123|NCT00922480|1914051|FG000|Main Study|Adverse Event|6
930124|NCT00922480|1914052|FG001|Main Study|Adverse Event|7
930125|NCT00922480|1914051|FG000|Main Study|Lack of Efficacy|3
930126|NCT00922480|1914052|FG001|Main Study|Lack of Efficacy|0
930127|NCT00922480|1914051|FG000|Main Study|Withdrawal by Subject|20
930128|NCT00922480|1914052|FG001|Main Study|Withdrawal by Subject|15
930129|NCT00922480|1914051|FG000|Main Study|Lost to Follow-up|5
930130|NCT00922480|1914052|FG001|Main Study|Lost to Follow-up|0
930131|NCT00922480|1914051|FG000|Main Study|Physician Decision|0
930132|NCT00922480|1914052|FG001|Main Study|Physician Decision|1
930133|NCT00922480|1914051|FG000|Extension Study|Protocol Violation|3
930134|NCT00922480|1914052|FG001|Extension Study|Protocol Violation|0
930135|NCT00922480|1914051|FG000|Extension Study|Adverse Event|1
930136|NCT00922480|1914052|FG001|Extension Study|Adverse Event|1
930137|NCT00922480|1914051|FG000|Extension Study|Withdrawal by Subject|1
930138|NCT00922480|1914052|FG001|Extension Study|Withdrawal by Subject|1
930139|NCT00922480|1914051|FG000|Extension Study|Others|0
930140|NCT00922480|1914052|FG001|Extension Study|Others|1
930141|NCT00922623|1914060|FG000|Overall Study|Other|4
930142|NCT00922623|1914060|FG000|Overall Study|Lost to Follow-up|1
930143|NCT00922636|1914071|FG000|Overall Study|Adverse Event|3
930144|NCT00922636|1914072|FG001|Overall Study|Adverse Event|3
930145|NCT00922636|1914073|FG002|Overall Study|Adverse Event|2
930146|NCT00922636|1914074|FG003|Overall Study|Adverse Event|3
930147|NCT00922636|1914075|FG004|Overall Study|Adverse Event|2
930148|NCT00922636|1914071|FG000|Overall Study|Lack of Efficacy|1
930149|NCT00922636|1914072|FG001|Overall Study|Lack of Efficacy|7
930150|NCT00922636|1914073|FG002|Overall Study|Lack of Efficacy|3
930151|NCT00922636|1914074|FG003|Overall Study|Lack of Efficacy|2
930152|NCT00922636|1914075|FG004|Overall Study|Lack of Efficacy|4
930153|NCT00922636|1914071|FG000|Overall Study|Sponsor Decision|0
930154|NCT00922636|1914072|FG001|Overall Study|Sponsor Decision|0
930155|NCT00922636|1914073|FG002|Overall Study|Sponsor Decision|2
930156|NCT00922636|1914074|FG003|Overall Study|Sponsor Decision|0
930157|NCT00922636|1914075|FG004|Overall Study|Sponsor Decision|0
930158|NCT00922636|1914071|FG000|Overall Study|Withdrawal by Subject|0
930159|NCT00922636|1914072|FG001|Overall Study|Withdrawal by Subject|0
930160|NCT00922636|1914073|FG002|Overall Study|Withdrawal by Subject|5
930161|NCT00922636|1914074|FG003|Overall Study|Withdrawal by Subject|2
930162|NCT00922636|1914075|FG004|Overall Study|Withdrawal by Subject|4
930163|NCT00922636|1914071|FG000|Overall Study|Protocol Violation|0
930164|NCT00922636|1914072|FG001|Overall Study|Protocol Violation|0
930165|NCT00922636|1914073|FG002|Overall Study|Protocol Violation|2
930166|NCT00922636|1914074|FG003|Overall Study|Protocol Violation|2
930167|NCT00922636|1914075|FG004|Overall Study|Protocol Violation|0
930168|NCT00922636|1914071|FG000|Overall Study|Entry Criteria Not Met|0
930169|NCT00922636|1914072|FG001|Overall Study|Entry Criteria Not Met|0
930170|NCT00922636|1914073|FG002|Overall Study|Entry Criteria Not Met|1
930171|NCT00922636|1914074|FG003|Overall Study|Entry Criteria Not Met|1
930172|NCT00922636|1914075|FG004|Overall Study|Entry Criteria Not Met|0
930173|NCT00922636|1914071|FG000|Overall Study|Parent/Caregiver Decision|2
930174|NCT00922636|1914072|FG001|Overall Study|Parent/Caregiver Decision|4
930175|NCT00922636|1914073|FG002|Overall Study|Parent/Caregiver Decision|3
930176|NCT00922636|1914074|FG003|Overall Study|Parent/Caregiver Decision|5
930177|NCT00922636|1914075|FG004|Overall Study|Parent/Caregiver Decision|2
930178|NCT00922636|1914071|FG000|Overall Study|Lost to Follow-up|1
930179|NCT00922636|1914072|FG001|Overall Study|Lost to Follow-up|2
930180|NCT00922636|1914073|FG002|Overall Study|Lost to Follow-up|2
930181|NCT00922636|1914074|FG003|Overall Study|Lost to Follow-up|2
930182|NCT00922636|1914075|FG004|Overall Study|Lost to Follow-up|4
930183|NCT00922766|1914096|FG000|Overall Study|Death|3
930184|NCT00922766|1914096|FG000|Overall Study|Withdrawal by Subject|2
930185|NCT00922766|1914096|FG000|Overall Study|Other|1
930186|NCT00922766|1914096|FG000|Overall Study|Adverse Event|1
930187|NCT00922779|1914100|FG000|Overall Study|Adverse Event|67
930188|NCT00922779|1914100|FG000|Overall Study|Pregnancy|7
930189|NCT00922779|1914100|FG000|Overall Study|Withdrawal by Subject|308
930190|NCT00922779|1914100|FG000|Overall Study|Lost to Follow-up|44
930191|NCT00922779|1914100|FG000|Overall Study|Other|27
930192|NCT00922779|1914100|FG000|Overall Study|Missing|1874
930193|NCT00922935|1914111|FG000|Overall Study|Protocol Violation|0
930194|NCT00922935|1914112|FG001|Overall Study|Protocol Violation|3
930195|NCT00922935|1914113|FG002|Overall Study|Protocol Violation|0
930196|NCT00922935|1914111|FG000|Overall Study|Physician Decision|1
930197|NCT00922935|1914112|FG001|Overall Study|Physician Decision|1
930198|NCT00922935|1914113|FG002|Overall Study|Physician Decision|0
930199|NCT00922935|1914111|FG000|Overall Study|Lost to Follow-up|0
930200|NCT00922935|1914112|FG001|Overall Study|Lost to Follow-up|1
930201|NCT00922935|1914113|FG002|Overall Study|Lost to Follow-up|0
930202|NCT00922974|1914124|FG000|Phase II Component|Protocol Violation|2
930203|NCT00922974|1914125|FG001|Phase II Component|Protocol Violation|0
930204|NCT00922974|1914124|FG000|Phase II Component|Not evaluable for treatment review|5
930205|NCT00922974|1914125|FG001|Phase II Component|Not evaluable for treatment review|0
930206|NCT00922974|1914124|FG000|Phase III Component|Protocol Violation|8
930207|NCT00922974|1914125|FG001|Phase III Component|Protocol Violation|6
930208|NCT00922987|1914133|FG000|Overall Study|Insufficient clinical response|1
930209|NCT00922987|1914133|FG000|Overall Study|Protocol Violation|2
930210|NCT00922987|1914133|FG000|Overall Study|Adverse Event|1
930211|NCT00923078|1914140|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
930212|NCT00923078|1914141|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
930213|NCT00923078|1914142|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
930214|NCT00923078|1914140|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0
930215|NCT00923078|1914141|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0
930216|NCT00923078|1914142|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20
930217|NCT00923091|1914157|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
930218|NCT00923091|1914158|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
930219|NCT00923091|1914159|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
930220|NCT00923091|1914160|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
930221|NCT00923091|1914161|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
930222|NCT00923091|1914162|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
930223|NCT00923091|1914163|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
930224|NCT00923091|1914164|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
930225|NCT00923091|1914165|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
930226|NCT00923091|1914166|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
930227|NCT00923091|1914167|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
930228|NCT00923091|1914168|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
930229|NCT00923091|1914169|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
930230|NCT00923091|1914157|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
930231|NCT00923091|1914158|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
930232|NCT00923091|1914159|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
930233|NCT00923091|1914160|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
930234|NCT00923091|1914161|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
930235|NCT00923091|1914162|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
930236|NCT00923091|1914163|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
930237|NCT00923091|1914164|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
930238|NCT00923091|1914165|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
930239|NCT00923091|1914166|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
930240|NCT00923091|1914167|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
930241|NCT00923091|1914168|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
930242|NCT00923091|1914169|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
930243|NCT00923091|1914157|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
930244|NCT00923091|1914158|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
930245|NCT00923091|1914159|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
930246|NCT00923091|1914160|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
930247|NCT00923091|1914161|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
930248|NCT00923091|1914162|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
930249|NCT00923091|1914163|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
930250|NCT00923091|1914164|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
930251|NCT00923091|1914165|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
930252|NCT00923091|1914166|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
930253|NCT00923091|1914167|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
930254|NCT00923091|1914168|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
930255|NCT00923091|1914169|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
930256|NCT00923091|1914157|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930257|NCT00923091|1914158|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930258|NCT00923091|1914159|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930259|NCT00923091|1914160|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930260|NCT00923091|1914161|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930261|NCT00923091|1914162|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
930262|NCT00923091|1914163|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930263|NCT00923091|1914164|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930264|NCT00923091|1914165|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930265|NCT00923091|1914166|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930266|NCT00923091|1914167|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930267|NCT00923091|1914168|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930268|NCT00923091|1914169|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
930269|NCT00923091|1914157|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
930270|NCT00923091|1914158|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
930271|NCT00923091|1914159|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
930272|NCT00923091|1914160|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
930273|NCT00923091|1914161|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
930274|NCT00923091|1914162|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
930275|NCT00923091|1914163|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
930276|NCT00923091|1914164|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
930277|NCT00923091|1914165|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
930278|NCT00923091|1914166|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
930279|NCT00923091|1914167|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
930280|NCT00923091|1914168|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
930281|NCT00923091|1914169|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
930282|NCT00923091|1914157|FG000|Period III (Single-Blind)|Adverse Event|5
930283|NCT00923091|1914158|FG001|Period III (Single-Blind)|Adverse Event|0
930284|NCT00923091|1914159|FG002|Period III (Single-Blind)|Adverse Event|0
930285|NCT00923091|1914160|FG003|Period III (Single-Blind)|Adverse Event|0
930286|NCT00923091|1914161|FG004|Period III (Single-Blind)|Adverse Event|0
930287|NCT00923091|1914162|FG005|Period III (Single-Blind)|Adverse Event|0
930288|NCT00923091|1914163|FG006|Period III (Single-Blind)|Adverse Event|0
930289|NCT00923091|1914164|FG007|Period III (Single-Blind)|Adverse Event|0
930290|NCT00923091|1914165|FG008|Period III (Single-Blind)|Adverse Event|0
930291|NCT00923091|1914166|FG009|Period III (Single-Blind)|Adverse Event|0
930292|NCT00923091|1914167|FG010|Period III (Single-Blind)|Adverse Event|0
930293|NCT00923091|1914168|FG011|Period III (Single-Blind)|Adverse Event|0
930294|NCT00923091|1914169|FG012|Period III (Single-Blind)|Adverse Event|0
930295|NCT00923091|1914157|FG000|Period III (Single-Blind)|Withdrawal by Subject|10
930296|NCT00923091|1914158|FG001|Period III (Single-Blind)|Withdrawal by Subject|0
930297|NCT00923091|1914159|FG002|Period III (Single-Blind)|Withdrawal by Subject|0
930298|NCT00923091|1914160|FG003|Period III (Single-Blind)|Withdrawal by Subject|0
930299|NCT00923091|1914161|FG004|Period III (Single-Blind)|Withdrawal by Subject|0
930300|NCT00923091|1914162|FG005|Period III (Single-Blind)|Withdrawal by Subject|0
930301|NCT00923091|1914163|FG006|Period III (Single-Blind)|Withdrawal by Subject|0
930302|NCT00923091|1914164|FG007|Period III (Single-Blind)|Withdrawal by Subject|0
930303|NCT00923091|1914165|FG008|Period III (Single-Blind)|Withdrawal by Subject|0
930304|NCT00923091|1914166|FG009|Period III (Single-Blind)|Withdrawal by Subject|0
930305|NCT00923091|1914167|FG010|Period III (Single-Blind)|Withdrawal by Subject|0
930306|NCT00923091|1914168|FG011|Period III (Single-Blind)|Withdrawal by Subject|0
930307|NCT00923091|1914169|FG012|Period III (Single-Blind)|Withdrawal by Subject|0
930308|NCT00923091|1914157|FG000|Period III (Single-Blind)|Protocol Violation|3
930309|NCT00923091|1914158|FG001|Period III (Single-Blind)|Protocol Violation|0
930310|NCT00923091|1914159|FG002|Period III (Single-Blind)|Protocol Violation|0
930311|NCT00923091|1914160|FG003|Period III (Single-Blind)|Protocol Violation|0
930312|NCT00923091|1914161|FG004|Period III (Single-Blind)|Protocol Violation|0
930313|NCT00923091|1914162|FG005|Period III (Single-Blind)|Protocol Violation|0
930314|NCT00923091|1914163|FG006|Period III (Single-Blind)|Protocol Violation|0
930315|NCT00923091|1914164|FG007|Period III (Single-Blind)|Protocol Violation|0
930316|NCT00923091|1914165|FG008|Period III (Single-Blind)|Protocol Violation|0
930317|NCT00923091|1914166|FG009|Period III (Single-Blind)|Protocol Violation|0
930318|NCT00923091|1914167|FG010|Period III (Single-Blind)|Protocol Violation|0
930319|NCT00923091|1914168|FG011|Period III (Single-Blind)|Protocol Violation|0
930320|NCT00923091|1914169|FG012|Period III (Single-Blind)|Protocol Violation|0
930321|NCT00923091|1914157|FG000|Period III (Single-Blind)|Lost to Follow-up|2
930322|NCT00923091|1914158|FG001|Period III (Single-Blind)|Lost to Follow-up|0
930323|NCT00923091|1914159|FG002|Period III (Single-Blind)|Lost to Follow-up|0
930324|NCT00923091|1914160|FG003|Period III (Single-Blind)|Lost to Follow-up|0
930325|NCT00923091|1914161|FG004|Period III (Single-Blind)|Lost to Follow-up|0
930326|NCT00923091|1914162|FG005|Period III (Single-Blind)|Lost to Follow-up|0
930327|NCT00923091|1914163|FG006|Period III (Single-Blind)|Lost to Follow-up|0
930328|NCT00923091|1914164|FG007|Period III (Single-Blind)|Lost to Follow-up|0
930329|NCT00923091|1914165|FG008|Period III (Single-Blind)|Lost to Follow-up|0
930330|NCT00923091|1914166|FG009|Period III (Single-Blind)|Lost to Follow-up|0
930331|NCT00923091|1914167|FG010|Period III (Single-Blind)|Lost to Follow-up|0
930332|NCT00923091|1914168|FG011|Period III (Single-Blind)|Lost to Follow-up|0
930333|NCT00923091|1914169|FG012|Period III (Single-Blind)|Lost to Follow-up|0
930334|NCT00923091|1914157|FG000|Period IV (Double-Blind)|Adverse Event|2
930335|NCT00923091|1914158|FG001|Period IV (Double-Blind)|Adverse Event|0
930336|NCT00923091|1914159|FG002|Period IV (Double-Blind)|Adverse Event|0
930337|NCT00923091|1914160|FG003|Period IV (Double-Blind)|Adverse Event|0
930338|NCT00923091|1914161|FG004|Period IV (Double-Blind)|Adverse Event|0
930339|NCT00923091|1914162|FG005|Period IV (Double-Blind)|Adverse Event|0
930340|NCT00923091|1914163|FG006|Period IV (Double-Blind)|Adverse Event|0
930341|NCT00923091|1914164|FG007|Period IV (Double-Blind)|Adverse Event|0
930342|NCT00923091|1914165|FG008|Period IV (Double-Blind)|Adverse Event|0
930343|NCT00923091|1914166|FG009|Period IV (Double-Blind)|Adverse Event|0
930344|NCT00923091|1914167|FG010|Period IV (Double-Blind)|Adverse Event|0
930345|NCT00923091|1914168|FG011|Period IV (Double-Blind)|Adverse Event|0
930346|NCT00923091|1914169|FG012|Period IV (Double-Blind)|Adverse Event|0
930347|NCT00923091|1914157|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0
930348|NCT00923091|1914158|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1
930349|NCT00923091|1914159|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0
930350|NCT00923091|1914160|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0
930351|NCT00923091|1914161|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0
930352|NCT00923091|1914162|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0
930353|NCT00923091|1914163|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0
930354|NCT00923091|1914164|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0
930355|NCT00923091|1914165|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0
930356|NCT00923091|1914166|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0
930357|NCT00923091|1914167|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0
930358|NCT00923091|1914168|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0
930359|NCT00923091|1914169|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0
930360|NCT00923091|1914157|FG000|Period IV (Double-Blind)|Protocol Violation|0
930361|NCT00923091|1914158|FG001|Period IV (Double-Blind)|Protocol Violation|1
930362|NCT00923091|1914159|FG002|Period IV (Double-Blind)|Protocol Violation|0
930363|NCT00923091|1914160|FG003|Period IV (Double-Blind)|Protocol Violation|0
930364|NCT00923091|1914161|FG004|Period IV (Double-Blind)|Protocol Violation|0
930365|NCT00923091|1914162|FG005|Period IV (Double-Blind)|Protocol Violation|0
930366|NCT00923091|1914163|FG006|Period IV (Double-Blind)|Protocol Violation|0
930367|NCT00923091|1914164|FG007|Period IV (Double-Blind)|Protocol Violation|0
930368|NCT00923091|1914165|FG008|Period IV (Double-Blind)|Protocol Violation|0
930369|NCT00923091|1914166|FG009|Period IV (Double-Blind)|Protocol Violation|0
930370|NCT00923091|1914167|FG010|Period IV (Double-Blind)|Protocol Violation|0
930371|NCT00923091|1914168|FG011|Period IV (Double-Blind)|Protocol Violation|0
930372|NCT00923091|1914169|FG012|Period IV (Double-Blind)|Protocol Violation|0
930373|NCT00923091|1914157|FG000|Period V (Double -Blind)|Withdrawal by Subject|0
930374|NCT00923091|1914158|FG001|Period V (Double -Blind)|Withdrawal by Subject|0
930375|NCT00923091|1914159|FG002|Period V (Double -Blind)|Withdrawal by Subject|0
930376|NCT00923091|1914160|FG003|Period V (Double -Blind)|Withdrawal by Subject|0
930377|NCT00923091|1914161|FG004|Period V (Double -Blind)|Withdrawal by Subject|0
930378|NCT00923091|1914162|FG005|Period V (Double -Blind)|Withdrawal by Subject|0
930379|NCT00923091|1914163|FG006|Period V (Double -Blind)|Withdrawal by Subject|0
930380|NCT00923091|1914164|FG007|Period V (Double -Blind)|Withdrawal by Subject|0
930381|NCT00923091|1914165|FG008|Period V (Double -Blind)|Withdrawal by Subject|1
930382|NCT00923091|1914166|FG009|Period V (Double -Blind)|Withdrawal by Subject|0
930383|NCT00923091|1914167|FG010|Period V (Double -Blind)|Withdrawal by Subject|0
930384|NCT00923091|1914168|FG011|Period V (Double -Blind)|Withdrawal by Subject|0
930385|NCT00923091|1914169|FG012|Period V (Double -Blind)|Withdrawal by Subject|1
930386|NCT00923091|1914157|FG000|Period V (Double -Blind)|Protocol Violation|0
930387|NCT00923091|1914158|FG001|Period V (Double -Blind)|Protocol Violation|0
930388|NCT00923091|1914159|FG002|Period V (Double -Blind)|Protocol Violation|0
930389|NCT00923091|1914160|FG003|Period V (Double -Blind)|Protocol Violation|0
930390|NCT00923091|1914161|FG004|Period V (Double -Blind)|Protocol Violation|0
930391|NCT00923091|1914162|FG005|Period V (Double -Blind)|Protocol Violation|0
930392|NCT00923091|1914163|FG006|Period V (Double -Blind)|Protocol Violation|0
930393|NCT00923091|1914164|FG007|Period V (Double -Blind)|Protocol Violation|0
930394|NCT00923091|1914165|FG008|Period V (Double -Blind)|Protocol Violation|0
930395|NCT00923091|1914166|FG009|Period V (Double -Blind)|Protocol Violation|0
930396|NCT00923091|1914167|FG010|Period V (Double -Blind)|Protocol Violation|0
930397|NCT00923091|1914168|FG011|Period V (Double -Blind)|Protocol Violation|0
930398|NCT00923091|1914169|FG012|Period V (Double -Blind)|Protocol Violation|1
930399|NCT00923091|1914157|FG000|Period V (Double -Blind)|Lost to Follow-up|0
930400|NCT00923091|1914158|FG001|Period V (Double -Blind)|Lost to Follow-up|0
930401|NCT00923091|1914159|FG002|Period V (Double -Blind)|Lost to Follow-up|0
930402|NCT00923091|1914160|FG003|Period V (Double -Blind)|Lost to Follow-up|0
930403|NCT00923091|1914161|FG004|Period V (Double -Blind)|Lost to Follow-up|0
930404|NCT00923091|1914162|FG005|Period V (Double -Blind)|Lost to Follow-up|0
930405|NCT00923091|1914163|FG006|Period V (Double -Blind)|Lost to Follow-up|0
930406|NCT00923091|1914164|FG007|Period V (Double -Blind)|Lost to Follow-up|0
930407|NCT00923091|1914165|FG008|Period V (Double -Blind)|Lost to Follow-up|0
930408|NCT00923091|1914166|FG009|Period V (Double -Blind)|Lost to Follow-up|0
930409|NCT00923091|1914167|FG010|Period V (Double -Blind)|Lost to Follow-up|1
930410|NCT00923091|1914168|FG011|Period V (Double -Blind)|Lost to Follow-up|0
930411|NCT00923091|1914169|FG012|Period V (Double -Blind)|Lost to Follow-up|0
930412|NCT00923091|1914157|FG000|Period VI (Open-Label)|Adverse Event|17
930413|NCT00923091|1914158|FG001|Period VI (Open-Label)|Adverse Event|0
930414|NCT00923091|1914159|FG002|Period VI (Open-Label)|Adverse Event|4
930415|NCT00923091|1914160|FG003|Period VI (Open-Label)|Adverse Event|1
930416|NCT00923091|1914161|FG004|Period VI (Open-Label)|Adverse Event|1
930417|NCT00923091|1914162|FG005|Period VI (Open-Label)|Adverse Event|0
930418|NCT00923091|1914163|FG006|Period VI (Open-Label)|Adverse Event|0
930419|NCT00923091|1914164|FG007|Period VI (Open-Label)|Adverse Event|0
930420|NCT00923091|1914165|FG008|Period VI (Open-Label)|Adverse Event|0
930421|NCT00923091|1914166|FG009|Period VI (Open-Label)|Adverse Event|0
930422|NCT00923091|1914167|FG010|Period VI (Open-Label)|Adverse Event|0
930423|NCT00923091|1914168|FG011|Period VI (Open-Label)|Adverse Event|0
930424|NCT00923091|1914169|FG012|Period VI (Open-Label)|Adverse Event|0
930425|NCT00923091|1914157|FG000|Period VI (Open-Label)|Withdrawal by Subject|15
930426|NCT00923091|1914158|FG001|Period VI (Open-Label)|Withdrawal by Subject|7
930427|NCT00923091|1914159|FG002|Period VI (Open-Label)|Withdrawal by Subject|5
930428|NCT00923091|1914160|FG003|Period VI (Open-Label)|Withdrawal by Subject|0
930429|NCT00923091|1914161|FG004|Period VI (Open-Label)|Withdrawal by Subject|1
930430|NCT00923091|1914162|FG005|Period VI (Open-Label)|Withdrawal by Subject|0
930431|NCT00923091|1914163|FG006|Period VI (Open-Label)|Withdrawal by Subject|0
930432|NCT00923091|1914164|FG007|Period VI (Open-Label)|Withdrawal by Subject|0
930433|NCT00923091|1914165|FG008|Period VI (Open-Label)|Withdrawal by Subject|0
930434|NCT00923091|1914166|FG009|Period VI (Open-Label)|Withdrawal by Subject|0
930435|NCT00923091|1914167|FG010|Period VI (Open-Label)|Withdrawal by Subject|0
930436|NCT00923091|1914168|FG011|Period VI (Open-Label)|Withdrawal by Subject|0
930437|NCT00923091|1914169|FG012|Period VI (Open-Label)|Withdrawal by Subject|0
930438|NCT00923091|1914157|FG000|Period VI (Open-Label)|Protocol Violation|6
930439|NCT00923091|1914158|FG001|Period VI (Open-Label)|Protocol Violation|1
930440|NCT00923091|1914159|FG002|Period VI (Open-Label)|Protocol Violation|3
930441|NCT00923091|1914160|FG003|Period VI (Open-Label)|Protocol Violation|1
930442|NCT00923091|1914161|FG004|Period VI (Open-Label)|Protocol Violation|4
930443|NCT00923091|1914162|FG005|Period VI (Open-Label)|Protocol Violation|0
930444|NCT00923091|1914163|FG006|Period VI (Open-Label)|Protocol Violation|0
930445|NCT00923091|1914164|FG007|Period VI (Open-Label)|Protocol Violation|0
930446|NCT00923091|1914165|FG008|Period VI (Open-Label)|Protocol Violation|0
930447|NCT00923091|1914166|FG009|Period VI (Open-Label)|Protocol Violation|0
930448|NCT00923091|1914167|FG010|Period VI (Open-Label)|Protocol Violation|0
930449|NCT00923091|1914168|FG011|Period VI (Open-Label)|Protocol Violation|0
930450|NCT00923091|1914169|FG012|Period VI (Open-Label)|Protocol Violation|0
930451|NCT00923091|1914157|FG000|Period VI (Open-Label)|Lost to Follow-up|1
930452|NCT00923091|1914158|FG001|Period VI (Open-Label)|Lost to Follow-up|0
930453|NCT00923091|1914159|FG002|Period VI (Open-Label)|Lost to Follow-up|1
930454|NCT00923091|1914160|FG003|Period VI (Open-Label)|Lost to Follow-up|0
930455|NCT00923091|1914161|FG004|Period VI (Open-Label)|Lost to Follow-up|0
930456|NCT00923091|1914162|FG005|Period VI (Open-Label)|Lost to Follow-up|0
930457|NCT00923091|1914163|FG006|Period VI (Open-Label)|Lost to Follow-up|0
930458|NCT00923091|1914164|FG007|Period VI (Open-Label)|Lost to Follow-up|0
930459|NCT00923091|1914165|FG008|Period VI (Open-Label)|Lost to Follow-up|0
930460|NCT00923091|1914166|FG009|Period VI (Open-Label)|Lost to Follow-up|0
930461|NCT00923091|1914167|FG010|Period VI (Open-Label)|Lost to Follow-up|0
930462|NCT00923091|1914168|FG011|Period VI (Open-Label)|Lost to Follow-up|0
930463|NCT00923091|1914169|FG012|Period VI (Open-Label)|Lost to Follow-up|0
930464|NCT00923091|1914157|FG000|Period VI (Open-Label)|Other Reason|0
930465|NCT00923091|1914158|FG001|Period VI (Open-Label)|Other Reason|0
930466|NCT00923091|1914159|FG002|Period VI (Open-Label)|Other Reason|0
930467|NCT00923091|1914160|FG003|Period VI (Open-Label)|Other Reason|1
930468|NCT00923091|1914161|FG004|Period VI (Open-Label)|Other Reason|1
930469|NCT00923091|1914162|FG005|Period VI (Open-Label)|Other Reason|0
930470|NCT00923091|1914163|FG006|Period VI (Open-Label)|Other Reason|0
930471|NCT00923091|1914164|FG007|Period VI (Open-Label)|Other Reason|0
930472|NCT00923091|1914165|FG008|Period VI (Open-Label)|Other Reason|0
930473|NCT00923091|1914166|FG009|Period VI (Open-Label)|Other Reason|0
930474|NCT00923091|1914167|FG010|Period VI (Open-Label)|Other Reason|0
930475|NCT00923091|1914168|FG011|Period VI (Open-Label)|Other Reason|0
930476|NCT00923091|1914169|FG012|Period VI (Open-Label)|Other Reason|0
930477|NCT00923130|1914203|FG000|Overall Study|Stopped treatment due to progression|17
930478|NCT00923130|1914203|FG000|Overall Study|Death|1
930479|NCT00923130|1914203|FG000|Overall Study|Discontinued treatment due to toxicities|3
930480|NCT00923130|1914203|FG000|Overall Study|Switched to alternative treatment|2
930481|NCT00923130|1914203|FG000|Overall Study|Refused further treatment|2
930482|NCT00923156|1914210|FG000|Overall Study|Adverse Event|0
930483|NCT00923156|1914211|FG001|Overall Study|Adverse Event|2
930484|NCT00923156|1914212|FG002|Overall Study|Adverse Event|1
930485|NCT00923156|1914210|FG000|Overall Study|Abnormal laboratory values|0
930486|NCT00923156|1914211|FG001|Overall Study|Abnormal laboratory values|0
930487|NCT00923156|1914212|FG002|Overall Study|Abnormal laboratory values|1
930488|NCT00923156|1914210|FG000|Overall Study|Withdrawal by Subject|0
930489|NCT00923156|1914211|FG001|Overall Study|Withdrawal by Subject|1
930490|NCT00923156|1914212|FG002|Overall Study|Withdrawal by Subject|0
930491|NCT00923156|1914210|FG000|Overall Study|Death|0
930492|NCT00923156|1914211|FG001|Overall Study|Death|1
930493|NCT00923156|1914212|FG002|Overall Study|Death|0
930494|NCT00923156|1914210|FG000|Overall Study|Lack of Efficacy|0
930495|NCT00923156|1914211|FG001|Overall Study|Lack of Efficacy|0
930496|NCT00923156|1914212|FG002|Overall Study|Lack of Efficacy|1
930497|NCT00923195|1914222|FG000|Overall Study|Death|0
930498|NCT00923195|1914223|FG001|Overall Study|Death|1
930499|NCT00923260|1914246|FG000|Overall Study|Lost to Follow-up|1
930500|NCT00923260|1914247|FG001|Overall Study|Lost to Follow-up|1
930501|NCT00923273|1914258|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
930502|NCT00923273|1914259|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
930503|NCT00923273|1914260|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
930504|NCT00923273|1914261|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
930505|NCT00923273|1914262|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
930506|NCT00923273|1914258|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
930507|NCT00923273|1914259|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
930508|NCT00923273|1914260|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
930509|NCT00923273|1914261|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
930510|NCT00923273|1914262|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
930511|NCT00923351|1914282|FG000|Overall Study|no apheresis/adequate tumor sample|0
930512|NCT00923351|1914283|FG001|Overall Study|no apheresis/adequate tumor sample|0
930513|NCT00923351|1914284|FG002|Overall Study|no apheresis/adequate tumor sample|12
930514|NCT00923364|1914290|FG000|Overall Study|Death|3
930515|NCT00923364|1914291|FG001|Overall Study|Death|0
930516|NCT00923364|1914290|FG000|Overall Study|Did not go to transplant|1
930517|NCT00923364|1914291|FG001|Overall Study|Did not go to transplant|0
930518|NCT00923559|1914302|FG000|Overall Study|Lost to Follow-up|2
930519|NCT00923559|1914303|FG001|Overall Study|Lost to Follow-up|3
930520|NCT00923845|1914322|FG000|Induction Therapy|Poor performance status|0
930521|NCT00923845|1914323|FG001|Induction Therapy|Poor performance status|2
930522|NCT00923936|1914340|FG000|Overall Study|progressive disease on study|2
930523|NCT00923936|1914341|FG001|Overall Study|progressive disease on study|1
930524|NCT00923936|1914340|FG000|Overall Study|Adverse Event|2
930525|NCT00923936|1914341|FG001|Overall Study|Adverse Event|1
930526|NCT00923936|1914340|FG000|Overall Study|Lost to follow up|2
930527|NCT00923936|1914341|FG001|Overall Study|Lost to follow up|0
930528|NCT00923936|1914340|FG000|Overall Study|Continuing in follow up period|2
930529|NCT00923936|1914341|FG001|Overall Study|Continuing in follow up period|1
930530|NCT00923975|1914353|FG000|Overall Study|Did not meet inclusion criteria|1
930531|NCT00924170|1914398|FG000|Overall Study|Refused further treatment|0
930532|NCT00924170|1914399|FG001|Overall Study|Refused further treatment|1
930533|NCT00924170|1914398|FG000|Overall Study|Physician Decision|0
930534|NCT00924170|1914399|FG001|Overall Study|Physician Decision|1
930535|NCT00924170|1914398|FG000|Overall Study|Progressive disease|3
930536|NCT00924170|1914399|FG001|Overall Study|Progressive disease|6
930537|NCT00924170|1914398|FG000|Overall Study|Stopped due to neutralizing antibodies|3
930538|NCT00924170|1914399|FG001|Overall Study|Stopped due to neutralizing antibodies|0
930539|NCT00924170|1914398|FG000|Overall Study|Death|1
930540|NCT00924170|1914399|FG001|Overall Study|Death|0
930541|NCT00924287|1914415|FG000|Overall Study|Death|1
930542|NCT00924313|1914419|FG000|Overall Study|not imaged due to failed tracer imaging|1
930543|NCT00924404|1914472|FG000|Overall Study|Lost to Follow-up|6
930544|NCT00924404|1914473|FG001|Overall Study|Lost to Follow-up|4
930545|NCT00924443|1914479|FG000|Overall Study|Physician Decision|2
930546|NCT00924443|1914479|FG000|Overall Study|Protocol Violation|1
930547|NCT00924469|1914485|FG000|Overall Study|Adverse Event|2
930548|NCT00924469|1914486|FG001|Overall Study|Adverse Event|0
930549|NCT00924469|1914485|FG000|Overall Study|Withdrawal by Subject|0
930550|NCT00924469|1914486|FG001|Overall Study|Withdrawal by Subject|1
930551|NCT00924469|1914485|FG000|Overall Study|Lost to Follow-up|0
930552|NCT00924469|1914486|FG001|Overall Study|Lost to Follow-up|1
930553|NCT00924508|1914497|FG000|Overall Study|Withdrawal by Subject|3
930554|NCT00924560|1914507|FG000|Overall Study|Did Not Meet Protocol Requirements|4
930555|NCT00924560|1914508|FG001|Overall Study|Did Not Meet Protocol Requirements|2
930556|NCT00924560|1914509|FG002|Overall Study|Did Not Meet Protocol Requirements|1
930557|NCT00924560|1914507|FG000|Overall Study|Non Compliance with the Protocol|20
930558|NCT00924560|1914508|FG001|Overall Study|Non Compliance with the Protocol|15
930559|NCT00924560|1914509|FG002|Overall Study|Non Compliance with the Protocol|4
930560|NCT00924560|1914507|FG000|Overall Study|Physician Decision|2
930561|NCT00924560|1914508|FG001|Overall Study|Physician Decision|3
930562|NCT00924560|1914509|FG002|Overall Study|Physician Decision|4
930563|NCT00924560|1914507|FG000|Overall Study|Withdrawal by Subject|50
930564|NCT00924560|1914508|FG001|Overall Study|Withdrawal by Subject|44
930565|NCT00924560|1914509|FG002|Overall Study|Withdrawal by Subject|18
930566|NCT00924560|1914507|FG000|Overall Study|Adverse Event|39
930567|NCT00924560|1914508|FG001|Overall Study|Adverse Event|33
930568|NCT00924560|1914509|FG002|Overall Study|Adverse Event|0
930569|NCT00924560|1914507|FG000|Overall Study|Pregnancy|5
930570|NCT00924560|1914508|FG001|Overall Study|Pregnancy|7
930571|NCT00924560|1914509|FG002|Overall Study|Pregnancy|1
930572|NCT00924560|1914507|FG000|Overall Study|Lost to Follow-up|78
930573|NCT00924560|1914508|FG001|Overall Study|Lost to Follow-up|94
930574|NCT00924560|1914509|FG002|Overall Study|Lost to Follow-up|45
930575|NCT00924560|1914507|FG000|Overall Study|Miscellaneous Reasons|13
930576|NCT00924560|1914508|FG001|Overall Study|Miscellaneous Reasons|10
930577|NCT00924560|1914509|FG002|Overall Study|Miscellaneous Reasons|10
930578|NCT00924638|1914536|FG000|Overall Study|Death|3
930579|NCT00924638|1914537|FG001|Overall Study|Death|2
930580|NCT00924638|1914536|FG000|Overall Study|Lost to Follow-up|1
930581|NCT00924638|1914537|FG001|Overall Study|Lost to Follow-up|1
930582|NCT00924638|1914536|FG000|Overall Study|Withdrawal by Subject|5
930583|NCT00924638|1914537|FG001|Overall Study|Withdrawal by Subject|7
930584|NCT00924638|1914536|FG000|Overall Study|Physician Decision|3
930585|NCT00924638|1914537|FG001|Overall Study|Physician Decision|3
930586|NCT00924651|1914545|FG000|Overall Study|Chemo started too soon|2
930587|NCT00924651|1914546|FG001|Overall Study|Chemo started too soon|3
930588|NCT00924651|1914545|FG000|Overall Study|No Reason|3
930589|NCT00924651|1914546|FG001|Overall Study|No Reason|7
930590|NCT00924651|1914545|FG000|Overall Study|Overwhelmed|6
930591|NCT00924651|1914546|FG001|Overall Study|Overwhelmed|6
930592|NCT00924651|1914545|FG000|Overall Study|Noncompliant|1
930593|NCT00924651|1914546|FG001|Overall Study|Noncompliant|4
930594|NCT00924651|1914545|FG000|Overall Study|Medical|1
930595|NCT00924651|1914546|FG001|Overall Study|Medical|3
930596|NCT00924651|1914545|FG000|Overall Study|Changed Mind|10
930597|NCT00924651|1914546|FG001|Overall Study|Changed Mind|1
930598|NCT00924651|1914545|FG000|Overall Study|Incomplete Form|2
930599|NCT00924651|1914546|FG001|Overall Study|Incomplete Form|1
930600|NCT00924664|1914554|FG000|Overall Study|Adverse Event|23
930601|NCT00924664|1914555|FG001|Overall Study|Adverse Event|39
930602|NCT00924664|1914554|FG000|Overall Study|Lack of Efficacy|10
930603|NCT00924664|1914555|FG001|Overall Study|Lack of Efficacy|15
930604|NCT00924664|1914554|FG000|Overall Study|Lost to Follow-up|10
930605|NCT00924664|1914555|FG001|Overall Study|Lost to Follow-up|12
930606|NCT00924664|1914554|FG000|Overall Study|Withdrawal by Subject|47
930607|NCT00924664|1914555|FG001|Overall Study|Withdrawal by Subject|71
930608|NCT00924664|1914554|FG000|Overall Study|Protocol Violation|2
930609|NCT00924664|1914555|FG001|Overall Study|Protocol Violation|5
930610|NCT00924664|1914554|FG000|Overall Study|Pregnancy|1
930611|NCT00924664|1914555|FG001|Overall Study|Pregnancy|1
930612|NCT00924664|1914554|FG000|Overall Study|Death|0
930613|NCT00924664|1914555|FG001|Overall Study|Death|2
930614|NCT00924664|1914554|FG000|Overall Study|Study terminated by sponsor|199
930615|NCT00924664|1914555|FG001|Overall Study|Study terminated by sponsor|330
930616|NCT00924664|1914554|FG000|Overall Study|Other|29
930617|NCT00924664|1914555|FG001|Overall Study|Other|52
930618|NCT00924664|1914554|FG000|Overall Study|Randomized but not Treated|1
930619|NCT00924664|1914555|FG001|Overall Study|Randomized but not Treated|0
930620|NCT00924703|1914561|FG000|Overall Study|Withdrawal by Subject|11
930621|NCT00924703|1914561|FG000|Overall Study|Physician Decision|5
930622|NCT00924703|1914561|FG000|Overall Study|Lost to Follow-up|3
930623|NCT00924703|1914561|FG000|Overall Study|Adverse Event|2
930624|NCT00924703|1914561|FG000|Overall Study|Withdrawal by Sponsor|1
930625|NCT00924729|1914567|FG000|Overall Study|insufficient volume for analysis|1
930626|NCT00924729|1914568|FG001|Overall Study|insufficient volume for analysis|0
930627|NCT00924729|1914567|FG000|Overall Study|Protocol Violation|1
930628|NCT00924729|1914568|FG001|Overall Study|Protocol Violation|0
930629|NCT00924781|1914580|FG000|Overall Study|Study terminated by sponsor|12
930630|NCT00924781|1914581|FG001|Overall Study|Study terminated by sponsor|10
930631|NCT00924820|1914597|FG000|Overall Study|Death|2
930632|NCT00924820|1914597|FG000|Overall Study|Ineligible, Screen Failure|5
930633|NCT00924898|1914622|FG000|Overall Study|Withdrawal by Subject|2
930634|NCT00924950|1914631|FG000|Overall Study|Lost to Follow-up|2
930635|NCT00925002|1914641|FG000|Overall Study|Other|1
930636|NCT00925002|1914642|FG001|Overall Study|Other|4
930637|NCT00925002|1914643|FG002|Overall Study|Other|0
930638|NCT00925002|1914641|FG000|Overall Study|Death|1
930639|NCT00925002|1914642|FG001|Overall Study|Death|1
930640|NCT00925002|1914643|FG002|Overall Study|Death|5
930641|NCT00925002|1914641|FG000|Overall Study|Adverse Event|3
930642|NCT00925002|1914642|FG001|Overall Study|Adverse Event|1
930643|NCT00925002|1914643|FG002|Overall Study|Adverse Event|2
930644|NCT00925002|1914641|FG000|Overall Study|Participant withdrew consent|1
930645|NCT00925002|1914642|FG001|Overall Study|Participant withdrew consent|3
930646|NCT00925002|1914643|FG002|Overall Study|Participant withdrew consent|3
930647|NCT00925015|1914655|FG000|Overall Study|Adverse Event|1
930648|NCT00925015|1914656|FG001|Overall Study|Adverse Event|2
930649|NCT00925015|1914657|FG002|Overall Study|Adverse Event|1
930650|NCT00925015|1914655|FG000|Overall Study|Physician Decision|0
930651|NCT00925015|1914656|FG001|Overall Study|Physician Decision|1
930652|NCT00925015|1914657|FG002|Overall Study|Physician Decision|0
930653|NCT00925015|1914655|FG000|Overall Study|Progressive Disease|7
930654|NCT00925015|1914656|FG001|Overall Study|Progressive Disease|3
930655|NCT00925015|1914657|FG002|Overall Study|Progressive Disease|4
930656|NCT00925015|1914655|FG000|Overall Study|Withdrawal by Subject|0
930657|NCT00925015|1914656|FG001|Overall Study|Withdrawal by Subject|0
930658|NCT00925015|1914657|FG002|Overall Study|Withdrawal by Subject|1
930659|NCT00925132|1914695|FG000|Overall Study|Withdrawal by Subject|2
930660|NCT00925132|1914696|FG001|Overall Study|Withdrawal by Subject|0
930661|NCT00925132|1914697|FG002|Overall Study|Withdrawal by Subject|0
930662|NCT00925132|1914698|FG003|Overall Study|Withdrawal by Subject|0
930663|NCT00925132|1914699|FG004|Overall Study|Withdrawal by Subject|1
930664|NCT00925132|1914695|FG000|Overall Study|Removed due to disease progression|0
930665|NCT00925132|1914696|FG001|Overall Study|Removed due to disease progression|0
930666|NCT00925132|1914697|FG002|Overall Study|Removed due to disease progression|0
930667|NCT00925132|1914698|FG003|Overall Study|Removed due to disease progression|0
930668|NCT00925132|1914699|FG004|Overall Study|Removed due to disease progression|4
930669|NCT00925288|1914707|FG000|Overall Study|Lost to Follow-up|9
930670|NCT00925288|1914708|FG001|Overall Study|Lost to Follow-up|7
930671|NCT00925301|1914718|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
930672|NCT00925301|1914719|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
930673|NCT00925301|1914720|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
930674|NCT00925301|1914721|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
930675|NCT00925301|1914718|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0
930676|NCT00925301|1914719|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1
930677|NCT00925301|1914720|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0
930678|NCT00925301|1914721|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0
930679|NCT00925301|1914718|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
930680|NCT00925301|1914719|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
930681|NCT00925301|1914720|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
930682|NCT00925301|1914721|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
930683|NCT00925301|1914718|FG000|6-Month Open-label (Stage 2)|Adverse Event|0
930684|NCT00925301|1914719|FG001|6-Month Open-label (Stage 2)|Adverse Event|0
930685|NCT00925301|1914720|FG002|6-Month Open-label (Stage 2)|Adverse Event|2
930686|NCT00925301|1914721|FG003|6-Month Open-label (Stage 2)|Adverse Event|0
930687|NCT00925301|1914718|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
930688|NCT00925301|1914719|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
930689|NCT00925301|1914720|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
930690|NCT00925301|1914721|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
930691|NCT00925301|1914718|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0
930692|NCT00925301|1914719|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0
930693|NCT00925301|1914720|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0
930694|NCT00925301|1914721|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1
930695|NCT00925301|1914718|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
930696|NCT00925301|1914719|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
930697|NCT00925301|1914720|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
930698|NCT00925301|1914721|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
930699|NCT00925353|1914732|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3
930700|NCT00925522|1914736|FG000|Overall Study|study closed -- business decision|20
930701|NCT00925587|1914742|FG000|Overall Study|Protocol Specified Criteria|6
930702|NCT00925587|1914743|FG001|Overall Study|Protocol Specified Criteria|6
930703|NCT00925587|1914742|FG000|Overall Study|Physician Decision|4
930704|NCT00925587|1914743|FG001|Overall Study|Physician Decision|1
930705|NCT00925587|1914742|FG000|Overall Study|Protocol Violation|6
930706|NCT00925587|1914743|FG001|Overall Study|Protocol Violation|4
930707|NCT00925587|1914742|FG000|Overall Study|Withdrawal by Subject|9
930708|NCT00925587|1914743|FG001|Overall Study|Withdrawal by Subject|6
930709|NCT00925587|1914742|FG000|Overall Study|Death|5
930710|NCT00925587|1914743|FG001|Overall Study|Death|5
930711|NCT00925587|1914742|FG000|Overall Study|Adverse Event|6
930712|NCT00925587|1914743|FG001|Overall Study|Adverse Event|2
930713|NCT00925587|1914742|FG000|Overall Study|Lost to Follow-up|0
930714|NCT00925587|1914743|FG001|Overall Study|Lost to Follow-up|1
930715|NCT00925600|1914751|FG000|Overall Study|Withdrawal by Subject|16
930716|NCT00925600|1914752|FG001|Overall Study|Withdrawal by Subject|14
930717|NCT00925600|1914751|FG000|Overall Study|Death|4
930718|NCT00925600|1914752|FG001|Overall Study|Death|3
930719|NCT00925600|1914751|FG000|Overall Study|Lost to Follow-up|2
930720|NCT00925600|1914752|FG001|Overall Study|Lost to Follow-up|2
930721|NCT00925600|1914751|FG000|Overall Study|Disease Progression|1
930722|NCT00925600|1914752|FG001|Overall Study|Disease Progression|3
930723|NCT00925600|1914751|FG000|Overall Study|Administrative Decision|1
930724|NCT00925600|1914752|FG001|Overall Study|Administrative Decision|1
930725|NCT00925600|1914751|FG000|Overall Study|Noncompliance|2
930726|NCT00925600|1914752|FG001|Overall Study|Noncompliance|0
930727|NCT00925600|1914751|FG000|Overall Study|Ineligibility Determined|2
930728|NCT00925600|1914752|FG001|Overall Study|Ineligibility Determined|0
930729|NCT00925600|1914751|FG000|Overall Study|Protocol Deviation|0
930730|NCT00925600|1914752|FG001|Overall Study|Protocol Deviation|1
930731|NCT00925600|1914751|FG000|Overall Study|Requirement for Alternative Therapy|0
930732|NCT00925600|1914752|FG001|Overall Study|Requirement for Alternative Therapy|1
930733|NCT00925600|1914751|FG000|Overall Study|Other|3
930734|NCT00925600|1914752|FG001|Overall Study|Other|1
930735|NCT00925600|1914751|FG000|Overall Study|Adverse Event|1
930736|NCT00925600|1914752|FG001|Overall Study|Adverse Event|2
930737|NCT00925704|1914768|FG000|First Intervention|Withdrew consent|0
930738|NCT00925704|1914769|FG001|First Intervention|Withdrew consent|0
930739|NCT00925704|1914770|FG002|First Intervention|Withdrew consent|0
930740|NCT00925704|1914771|FG003|First Intervention|Withdrew consent|1
930741|NCT00925704|1914772|FG004|First Intervention|Withdrew consent|1
930742|NCT00925704|1914773|FG005|First Intervention|Withdrew consent|0
930743|NCT00925704|1914768|FG000|Second Intervention|Withdrawal by Subject|1
930744|NCT00925704|1914769|FG001|Second Intervention|Withdrawal by Subject|0
930745|NCT00925704|1914770|FG002|Second Intervention|Withdrawal by Subject|0
930746|NCT00925704|1914771|FG003|Second Intervention|Withdrawal by Subject|0
930747|NCT00925704|1914772|FG004|Second Intervention|Withdrawal by Subject|1
930748|NCT00925704|1914773|FG005|Second Intervention|Withdrawal by Subject|0
930749|NCT00925704|1914768|FG000|Third Intervention|Withdrew consent|0
930750|NCT00925704|1914769|FG001|Third Intervention|Withdrew consent|0
930751|NCT00925704|1914770|FG002|Third Intervention|Withdrew consent|0
930752|NCT00925704|1914771|FG003|Third Intervention|Withdrew consent|0
930753|NCT00925704|1914772|FG004|Third Intervention|Withdrew consent|0
930754|NCT00925704|1914773|FG005|Third Intervention|Withdrew consent|1
930755|NCT00925769|1914788|FG000|Overall Study|Major toxicity|1
930756|NCT00925769|1914789|FG001|Overall Study|Major toxicity|0
930757|NCT00925769|1914790|FG002|Overall Study|Major toxicity|1
930758|NCT00925769|1914791|FG003|Overall Study|Major toxicity|1
930759|NCT00925769|1914792|FG004|Overall Study|Major toxicity|0
930760|NCT00925769|1914793|FG005|Overall Study|Major toxicity|0
930761|NCT00925769|1914788|FG000|Overall Study|Disease progression|4
930762|NCT00925769|1914789|FG001|Overall Study|Disease progression|5
930763|NCT00925769|1914790|FG002|Overall Study|Disease progression|3
930764|NCT00925769|1914791|FG003|Overall Study|Disease progression|4
930765|NCT00925769|1914792|FG004|Overall Study|Disease progression|2
930766|NCT00925769|1914793|FG005|Overall Study|Disease progression|3
930767|NCT00925769|1914788|FG000|Overall Study|Death|0
930768|NCT00925769|1914789|FG001|Overall Study|Death|0
930769|NCT00925769|1914790|FG002|Overall Study|Death|1
930770|NCT00925769|1914791|FG003|Overall Study|Death|0
930771|NCT00925769|1914792|FG004|Overall Study|Death|0
930772|NCT00925769|1914793|FG005|Overall Study|Death|0
930773|NCT00925769|1914788|FG000|Overall Study|Physician Decision|1
930774|NCT00925769|1914789|FG001|Overall Study|Physician Decision|0
930775|NCT00925769|1914790|FG002|Overall Study|Physician Decision|0
930776|NCT00925769|1914791|FG003|Overall Study|Physician Decision|0
930777|NCT00925769|1914792|FG004|Overall Study|Physician Decision|0
930778|NCT00925769|1914793|FG005|Overall Study|Physician Decision|0
930779|NCT00925769|1914788|FG000|Overall Study|Missing documentation|0
930780|NCT00925769|1914789|FG001|Overall Study|Missing documentation|1
930781|NCT00925769|1914790|FG002|Overall Study|Missing documentation|0
930782|NCT00925769|1914791|FG003|Overall Study|Missing documentation|0
930783|NCT00925769|1914792|FG004|Overall Study|Missing documentation|0
930784|NCT00925769|1914793|FG005|Overall Study|Missing documentation|0
930785|NCT00925769|1914788|FG000|Overall Study|End of study visit not done|0
930786|NCT00925769|1914789|FG001|Overall Study|End of study visit not done|0
930787|NCT00925769|1914790|FG002|Overall Study|End of study visit not done|1
930788|NCT00925769|1914791|FG003|Overall Study|End of study visit not done|0
930789|NCT00925769|1914792|FG004|Overall Study|End of study visit not done|0
930790|NCT00925769|1914793|FG005|Overall Study|End of study visit not done|0
930791|NCT00925769|1914788|FG000|Overall Study|Participant is unable to swallow drug|0
930792|NCT00925769|1914789|FG001|Overall Study|Participant is unable to swallow drug|0
930793|NCT00925769|1914790|FG002|Overall Study|Participant is unable to swallow drug|0
930794|NCT00925769|1914791|FG003|Overall Study|Participant is unable to swallow drug|1
930795|NCT00925769|1914792|FG004|Overall Study|Participant is unable to swallow drug|0
930796|NCT00925769|1914793|FG005|Overall Study|Participant is unable to swallow drug|0
930797|NCT00925769|1914788|FG000|Overall Study|Adverse Event|0
930798|NCT00925769|1914789|FG001|Overall Study|Adverse Event|0
930799|NCT00925769|1914790|FG002|Overall Study|Adverse Event|0
930800|NCT00925769|1914791|FG003|Overall Study|Adverse Event|0
930801|NCT00925769|1914792|FG004|Overall Study|Adverse Event|1
930802|NCT00925769|1914793|FG005|Overall Study|Adverse Event|0
930803|NCT00925899|1914819|FG000|Part 1|Death|1
930804|NCT00925899|1914820|FG001|Part 1|Death|2
930805|NCT00925899|1914819|FG000|Part 1|Withdrawal by Subject|10
930806|NCT00925899|1914820|FG001|Part 1|Withdrawal by Subject|9
930807|NCT00925990|1914842|FG000|Overall Study|Adverse Event|1
930808|NCT00925990|1914843|FG001|Overall Study|Adverse Event|3
930809|NCT00925990|1914842|FG000|Overall Study|Withdrawal by Subject|2
930810|NCT00925990|1914843|FG001|Overall Study|Withdrawal by Subject|2
930811|NCT00925990|1914842|FG000|Overall Study|Lost to Follow-up|1
930812|NCT00925990|1914843|FG001|Overall Study|Lost to Follow-up|3
930813|NCT00925990|1914842|FG000|Overall Study|Physician Decision|1
930814|NCT00925990|1914843|FG001|Overall Study|Physician Decision|1
930815|NCT00925990|1914842|FG000|Overall Study|moved out of state, missed medication|0
930816|NCT00925990|1914843|FG001|Overall Study|moved out of state, missed medication|2
930817|NCT00926003|1914852|FG000|Post-Training Evaluation|Withdrawal by Subject|1
930818|NCT00926003|1914853|FG001|Post-Training Evaluation|Withdrawal by Subject|0
930819|NCT00926003|1914854|FG002|Post-Training Evaluation|Withdrawal by Subject|0
930820|NCT00926003|1914852|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1
930821|NCT00926003|1914853|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0
930822|NCT00926003|1914854|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0
930823|NCT00926029|1914865|FG000|Overall Study|Lost to Follow-up|2
930824|NCT00926029|1914866|FG001|Overall Study|Lost to Follow-up|1
930825|NCT00926029|1914867|FG002|Overall Study|Lost to Follow-up|1
930826|NCT00926211|1914894|FG000|Overall Study|Lost to Follow-up|1
930827|NCT00926237|1914899|FG000|Overall Study|Withdrawal by Subject|2
930828|NCT00926237|1914900|FG001|Overall Study|Withdrawal by Subject|1
930829|NCT00926289|1914922|FG000|Overall Study|Adverse Event|9
930830|NCT00926289|1914923|FG001|Overall Study|Adverse Event|11
930831|NCT00926289|1914922|FG000|Overall Study|Protocol Violation|8
930832|NCT00926289|1914923|FG001|Overall Study|Protocol Violation|12
930833|NCT00926289|1914922|FG000|Overall Study|Lost to Follow-up|3
930834|NCT00926289|1914923|FG001|Overall Study|Lost to Follow-up|6
930835|NCT00926289|1914922|FG000|Overall Study|Withdrawal by Subject|4
930836|NCT00926289|1914923|FG001|Overall Study|Withdrawal by Subject|4
930837|NCT00926289|1914922|FG000|Overall Study|Other|1
930838|NCT00926289|1914923|FG001|Overall Study|Other|3
930839|NCT00926328|1914931|FG000|Overall Study|Lost to Follow-up|12
930840|NCT00926328|1914932|FG001|Overall Study|Lost to Follow-up|14
930841|NCT00926367|1914940|FG000|Overall Study|Withdrawal by Subject|0
930842|NCT00926367|1914941|FG001|Overall Study|Withdrawal by Subject|1
930843|NCT00926367|1914940|FG000|Overall Study|Lost to Follow-up|1
930844|NCT00926367|1914941|FG001|Overall Study|Lost to Follow-up|0
930845|NCT00926367|1914940|FG000|Overall Study|Skin Irritation|1
930846|NCT00926367|1914941|FG001|Overall Study|Skin Irritation|2
930847|NCT00926393|1914964|FG000|Overall Study|Withdrawal by Subject|1
930848|NCT00926393|1914965|FG001|Overall Study|Withdrawal by Subject|2
930849|NCT00926393|1914964|FG000|Overall Study|Adverse Event|1
930850|NCT00926393|1914965|FG001|Overall Study|Adverse Event|1
930851|NCT00926536|1914982|FG000|Overall Study|Physician Decision|1
930852|NCT00926536|1914983|FG001|Overall Study|Physician Decision|2
930853|NCT00926783|1915000|FG000|Overall Study|Incomplete CFAE Procedures|3
930854|NCT00926783|1915001|FG001|Overall Study|Incomplete CFAE Procedures|3
930855|NCT00926796|1915009|FG000|Overall Study|Did not receive randomized treatment|4
930856|NCT00926796|1915010|FG001|Overall Study|Did not receive randomized treatment|7
930857|NCT00926796|1915009|FG000|Overall Study|Ineligible, negative for gonorrhea|57
930858|NCT00926796|1915010|FG001|Overall Study|Ineligible, negative for gonorrhea|60
930859|NCT00926796|1915009|FG000|Overall Study|Ineligible, but positive for gonorrhea|1
930860|NCT00926796|1915010|FG001|Overall Study|Ineligible, but positive for gonorrhea|1
930861|NCT00926796|1915009|FG000|Overall Study|Adverse Event|7
930862|NCT00926796|1915010|FG001|Overall Study|Adverse Event|14
930863|NCT00926796|1915009|FG000|Overall Study|Lost to Follow-up|22
930864|NCT00926796|1915010|FG001|Overall Study|Lost to Follow-up|13
930865|NCT00926796|1915009|FG000|Overall Study|Protocol Violation|15
930866|NCT00926796|1915010|FG001|Overall Study|Protocol Violation|11
930867|NCT00926796|1915009|FG000|Overall Study|Withdrawal by Subject|1
930868|NCT00926796|1915010|FG001|Overall Study|Withdrawal by Subject|0
930869|NCT00927069|1915052|FG000|Week 0 to Week 12|Worsening of psoriasis|1
930870|NCT00927069|1915053|FG001|Week 0 to Week 12|Worsening of psoriasis|1
930871|NCT00927069|1915054|FG002|Week 0 to Week 12|Worsening of psoriasis|0
930872|NCT00927069|1915055|FG003|Week 0 to Week 12|Worsening of psoriasis|0
930873|NCT00927069|1915052|FG000|Week 12 to Week 24|Lack of Efficacy|0
930874|NCT00927069|1915053|FG001|Week 12 to Week 24|Lack of Efficacy|0
930875|NCT00927069|1915054|FG002|Week 12 to Week 24|Lack of Efficacy|2
930876|NCT00927069|1915055|FG003|Week 12 to Week 24|Lack of Efficacy|3
930877|NCT00927069|1915052|FG000|Week 12 to Week 24|Lost to Follow-up|0
930878|NCT00927069|1915053|FG001|Week 12 to Week 24|Lost to Follow-up|0
930879|NCT00927069|1915054|FG002|Week 12 to Week 24|Lost to Follow-up|1
930880|NCT00927069|1915055|FG003|Week 12 to Week 24|Lost to Follow-up|0
930881|NCT00927069|1915052|FG000|Week 12 to Week 24|Withdrawal by Subject|1
930882|NCT00927069|1915053|FG001|Week 12 to Week 24|Withdrawal by Subject|0
930883|NCT00927069|1915054|FG002|Week 12 to Week 24|Withdrawal by Subject|0
930884|NCT00927069|1915055|FG003|Week 12 to Week 24|Withdrawal by Subject|0
930885|NCT00927069|1915052|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1
930886|NCT00927069|1915053|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0
930887|NCT00927069|1915054|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0
930888|NCT00927069|1915055|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0
930889|NCT00927082|1915069|FG000|Overall Study|Lost to Follow-up|9
930890|NCT00927082|1915070|FG001|Overall Study|Lost to Follow-up|8
930891|NCT00927082|1915071|FG002|Overall Study|Lost to Follow-up|12
930892|NCT00927082|1915072|FG003|Overall Study|Lost to Follow-up|16
930893|NCT00927082|1915069|FG000|Overall Study|Withdrawal by Subject|3
930894|NCT00927082|1915070|FG001|Overall Study|Withdrawal by Subject|2
930895|NCT00927082|1915071|FG002|Overall Study|Withdrawal by Subject|7
930896|NCT00927082|1915072|FG003|Overall Study|Withdrawal by Subject|2
930897|NCT00927082|1915069|FG000|Overall Study|Death|0
930898|NCT00927082|1915070|FG001|Overall Study|Death|0
930899|NCT00927082|1915071|FG002|Overall Study|Death|1
930900|NCT00927082|1915072|FG003|Overall Study|Death|0
930901|NCT00927082|1915069|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0
930902|NCT00927082|1915070|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0
930903|NCT00927082|1915071|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2
930904|NCT00927082|1915072|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1
930905|NCT00927095|1915089|FG000|Overall Study|Adverse Event|3
930906|NCT00927095|1915090|FG001|Overall Study|Adverse Event|1
930907|NCT00927095|1915091|FG002|Overall Study|Adverse Event|0
930908|NCT00927095|1915089|FG000|Overall Study|Withdrawal by Subject|2
930909|NCT00927095|1915090|FG001|Overall Study|Withdrawal by Subject|1
930910|NCT00927095|1915091|FG002|Overall Study|Withdrawal by Subject|1
930911|NCT00927095|1915089|FG000|Overall Study|Physician Decision|1
930912|NCT00927095|1915090|FG001|Overall Study|Physician Decision|2
930913|NCT00927095|1915091|FG002|Overall Study|Physician Decision|1
930914|NCT00927186|1915110|FG000|12 Months Primary Study|Adverse Event|5
930915|NCT00927186|1915111|FG001|12 Months Primary Study|Adverse Event|2
930916|NCT00927186|1915110|FG000|12 Months Primary Study|Lost to Follow-up|1
930917|NCT00927186|1915111|FG001|12 Months Primary Study|Lost to Follow-up|0
930918|NCT00927186|1915110|FG000|12 Months Primary Study|Protocol Violation|0
930919|NCT00927186|1915111|FG001|12 Months Primary Study|Protocol Violation|1
930920|NCT00927186|1915110|FG000|12 Months Primary Study|Withdrawal by Subject|1
930921|NCT00927186|1915111|FG001|12 Months Primary Study|Withdrawal by Subject|1
930922|NCT00927251|1915120|FG000|Overall Study|Patients not implanted with 4296 lead|8
930923|NCT00927355|1915137|FG000|Overall Study|Adverse Event|1
930924|NCT00927355|1915138|FG001|Overall Study|Adverse Event|1
930925|NCT00927368|1915159|FG000|Overall Study|enrollment in another study|1
930926|NCT00927368|1915160|FG001|Overall Study|enrollment in another study|1
930927|NCT00927368|1915161|FG002|Overall Study|enrollment in another study|2
930928|NCT00927368|1915159|FG000|Overall Study|Lost to Follow-up|4
930929|NCT00927368|1915160|FG001|Overall Study|Lost to Follow-up|0
930930|NCT00927368|1915161|FG002|Overall Study|Lost to Follow-up|0
930931|NCT00927368|1915159|FG000|Overall Study|equipment failure|1
930932|NCT00927368|1915160|FG001|Overall Study|equipment failure|0
930933|NCT00927368|1915161|FG002|Overall Study|equipment failure|0
930934|NCT00927368|1915159|FG000|Overall Study|ineligible post randomization|0
930935|NCT00927368|1915160|FG001|Overall Study|ineligible post randomization|3
930936|NCT00927368|1915161|FG002|Overall Study|ineligible post randomization|1
930937|NCT00927368|1915159|FG000|Overall Study|cancellation of surgery|0
930938|NCT00927368|1915160|FG001|Overall Study|cancellation of surgery|1
930939|NCT00927368|1915161|FG002|Overall Study|cancellation of surgery|2
930940|NCT00927394|1915171|FG000|Overall Study|Adverse Event|14
930941|NCT00927394|1915172|FG001|Overall Study|Adverse Event|9
930942|NCT00927394|1915171|FG000|Overall Study|Unsatisfactory therapeutic effect|17
930943|NCT00927394|1915172|FG001|Overall Study|Unsatisfactory therapeutic effect|23
930944|NCT00927394|1915171|FG000|Overall Study|Withdrawal by Subject|20
930945|NCT00927394|1915172|FG001|Overall Study|Withdrawal by Subject|24
930946|NCT00927394|1915171|FG000|Overall Study|Lost to Follow-up|8
930947|NCT00927394|1915172|FG001|Overall Study|Lost to Follow-up|14
930948|NCT00927394|1915171|FG000|Overall Study|Administrative Problem|1
930949|NCT00927394|1915172|FG001|Overall Study|Administrative Problem|0
930950|NCT00927394|1915171|FG000|Overall Study|Death|1
930951|NCT00927394|1915172|FG001|Overall Study|Death|1
930952|NCT00927394|1915171|FG000|Overall Study|Protocol deviation|16
930953|NCT00927394|1915172|FG001|Overall Study|Protocol deviation|13
930954|NCT00927394|1915171|FG000|Overall Study|Randomized in error|0
930955|NCT00927394|1915172|FG001|Overall Study|Randomized in error|1
930956|NCT00927472|1915181|FG000|Overall Study|Withdrawal by Subject|10
930957|NCT00927472|1915182|FG001|Overall Study|Withdrawal by Subject|11
930958|NCT00927472|1915181|FG000|Overall Study|Lost to Follow-up|1
930959|NCT00927472|1915182|FG001|Overall Study|Lost to Follow-up|6
930960|NCT00927472|1915181|FG000|Overall Study|Protocol Violation|0
930961|NCT00927472|1915182|FG001|Overall Study|Protocol Violation|1
930962|NCT00927472|1915181|FG000|Overall Study|Post treatment Assessment out of window|0
930963|NCT00927472|1915182|FG001|Overall Study|Post treatment Assessment out of window|4
930964|NCT00927485|1915190|FG000|Overall Study|Adverse Event|4
930965|NCT00927485|1915191|FG001|Overall Study|Adverse Event|2
930966|NCT00927485|1915190|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2
930967|NCT00927485|1915191|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2
930968|NCT00927563|1915197|FG000|Overall Study|Lost to Follow-up|1
930969|NCT00927563|1915197|FG000|Overall Study|Withdrawal by Subject|1
930970|NCT00927589|1915209|FG000|Overall Study|Death|1
930971|NCT00927589|1915209|FG000|Overall Study|Physician Decision|1
930972|NCT00927589|1915209|FG000|Overall Study|Withdrawal by Subject|3
930973|NCT00927589|1915209|FG000|Overall Study|Adverse Event|2
930974|NCT00927589|1915209|FG000|Overall Study|Disease Progression|8
930975|NCT00927589|1915209|FG000|Overall Study|Non-compliance|1
930976|NCT00927758|1915213|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
930977|NCT00927758|1915214|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
930978|NCT00927758|1915215|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
930979|NCT00927758|1915216|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
930980|NCT00927758|1915217|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
930981|NCT00927758|1915218|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
930982|NCT00927758|1915213|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
930983|NCT00927758|1915214|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
930984|NCT00927758|1915215|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
930985|NCT00927758|1915216|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
930986|NCT00927758|1915217|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
930987|NCT00927758|1915218|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
930988|NCT00927784|1915228|FG000|Overall Study|Death|1
930989|NCT00927784|1915229|FG001|Overall Study|Death|0
930990|NCT00927784|1915228|FG000|Overall Study|Withdrawal by Subject|1
930991|NCT00927784|1915229|FG001|Overall Study|Withdrawal by Subject|0
930992|NCT00927810|1915239|FG000|Overall Study|Withdrawal by Subject|0
930993|NCT00927810|1915240|FG001|Overall Study|Withdrawal by Subject|3
930994|NCT00927810|1915241|FG002|Overall Study|Withdrawal by Subject|0
930995|NCT00927810|1915242|FG003|Overall Study|Withdrawal by Subject|1
930996|NCT00927810|1915239|FG000|Overall Study|Lost to Follow-up|0
930997|NCT00927810|1915240|FG001|Overall Study|Lost to Follow-up|2
930998|NCT00927810|1915241|FG002|Overall Study|Lost to Follow-up|1
930999|NCT00927810|1915242|FG003|Overall Study|Lost to Follow-up|1
931000|NCT00927810|1915239|FG000|Overall Study|Death|0
931001|NCT00927810|1915240|FG001|Overall Study|Death|2
931002|NCT00927810|1915241|FG002|Overall Study|Death|0
931003|NCT00927810|1915242|FG003|Overall Study|Death|0
931004|NCT00927810|1915239|FG000|Overall Study|Abnormal laboratory value(s)|0
931005|NCT00927810|1915240|FG001|Overall Study|Abnormal laboratory value(s)|1
931006|NCT00927810|1915241|FG002|Overall Study|Abnormal laboratory value(s)|0
931007|NCT00927810|1915242|FG003|Overall Study|Abnormal laboratory value(s)|0
931008|NCT00927823|1915260|FG000|Continuous Dosing Period|Death|0
931009|NCT00927823|1915261|FG001|Continuous Dosing Period|Death|0
931010|NCT00927823|1915262|FG002|Continuous Dosing Period|Death|6
931011|NCT00927823|1915263|FG003|Continuous Dosing Period|Death|0
931012|NCT00927823|1915260|FG000|Continuous Dosing Period|Lost to Follow-up|1
931013|NCT00927823|1915261|FG001|Continuous Dosing Period|Lost to Follow-up|1
931014|NCT00927823|1915262|FG002|Continuous Dosing Period|Lost to Follow-up|9
931015|NCT00927823|1915263|FG003|Continuous Dosing Period|Lost to Follow-up|0
931016|NCT00927823|1915260|FG000|Continuous Dosing Period|Withdrawal by Subject|1
931017|NCT00927823|1915261|FG001|Continuous Dosing Period|Withdrawal by Subject|0
931018|NCT00927823|1915262|FG002|Continuous Dosing Period|Withdrawal by Subject|2
931019|NCT00927823|1915263|FG003|Continuous Dosing Period|Withdrawal by Subject|2
931020|NCT00927823|1915260|FG000|Continuous Dosing Period|Other|1
931021|NCT00927823|1915261|FG001|Continuous Dosing Period|Other|2
931022|NCT00927823|1915262|FG002|Continuous Dosing Period|Other|9
931023|NCT00927823|1915263|FG003|Continuous Dosing Period|Other|3
931024|NCT00927862|1915295|FG000|Overall Study|Missing data needed for endpt analyses|27
931025|NCT00927862|1915296|FG001|Overall Study|Missing data needed for endpt analyses|45
931026|NCT00927901|1915315|FG000|Treatment Period 1|Subject withdrew consent|0
931027|NCT00927901|1915316|FG001|Treatment Period 1|Subject withdrew consent|0
931028|NCT00927901|1915317|FG002|Treatment Period 1|Subject withdrew consent|1
931029|NCT00927901|1915318|FG003|Treatment Period 1|Subject withdrew consent|0
931030|NCT00927901|1915315|FG000|Treatment Period 4|Adverse Event|0
931031|NCT00927901|1915316|FG001|Treatment Period 4|Adverse Event|0
931032|NCT00927901|1915317|FG002|Treatment Period 4|Adverse Event|0
931033|NCT00927901|1915318|FG003|Treatment Period 4|Adverse Event|1
931034|NCT00927901|1915315|FG000|Treatment Period 4|Subject withdrew consent|0
931035|NCT00927901|1915316|FG001|Treatment Period 4|Subject withdrew consent|0
931036|NCT00927901|1915317|FG002|Treatment Period 4|Subject withdrew consent|1
931037|NCT00927901|1915318|FG003|Treatment Period 4|Subject withdrew consent|0
931038|NCT00927927|1915346|FG000|Overall Study|Withdrawal by Subject|0
931039|NCT00927927|1915347|FG001|Overall Study|Withdrawal by Subject|0
931040|NCT00927927|1915348|FG002|Overall Study|Withdrawal by Subject|0
931041|NCT00927927|1915349|FG003|Overall Study|Withdrawal by Subject|0
931042|NCT00927927|1915350|FG004|Overall Study|Withdrawal by Subject|0
931043|NCT00927927|1915351|FG005|Overall Study|Withdrawal by Subject|0
931044|NCT00927927|1915352|FG006|Overall Study|Withdrawal by Subject|0
931045|NCT00927927|1915353|FG007|Overall Study|Withdrawal by Subject|2
931046|NCT00927927|1915354|FG008|Overall Study|Withdrawal by Subject|0
931047|NCT00927927|1915355|FG009|Overall Study|Withdrawal by Subject|0
931048|NCT00927927|1915356|FG010|Overall Study|Withdrawal by Subject|0
931049|NCT00927927|1915357|FG011|Overall Study|Withdrawal by Subject|2
931050|NCT00927927|1915358|FG012|Overall Study|Withdrawal by Subject|0
931051|NCT00927927|1915359|FG013|Overall Study|Withdrawal by Subject|0
931052|NCT00927927|1915360|FG014|Overall Study|Withdrawal by Subject|0
931053|NCT00927940|1915392|FG000|Overall Study|Death|1
931054|NCT00927953|1915399|FG000|Overall Study|Death|2
931055|NCT00927953|1915400|FG001|Overall Study|Death|1
931056|NCT00928018|1915413|FG000|Overall Study|Withdrawal by Subject|1
931057|NCT00928018|1915414|FG001|Overall Study|Withdrawal by Subject|0
931058|NCT00928057|1915426|FG000|Overall Study|Adverse Event|1
931059|NCT00928057|1915427|FG001|Overall Study|Adverse Event|2
931060|NCT00928057|1915426|FG000|Overall Study|Withdrawal by Subject|1
931061|NCT00928057|1915427|FG001|Overall Study|Withdrawal by Subject|0
931062|NCT00928057|1915426|FG000|Overall Study|Lost to Follow-up|0
931063|NCT00928057|1915427|FG001|Overall Study|Lost to Follow-up|1
931064|NCT00928057|1915426|FG000|Overall Study|Protocol Violation|0
931065|NCT00928057|1915427|FG001|Overall Study|Protocol Violation|1
931066|NCT00928070|1915445|FG000|Overall Study|Lost to Follow-up|1
931067|NCT00928070|1915446|FG001|Overall Study|Lost to Follow-up|2
931068|NCT00928070|1915445|FG000|Overall Study|Withdrawal by Subject|10
931069|NCT00928070|1915446|FG001|Overall Study|Withdrawal by Subject|3
931070|NCT00928070|1915445|FG000|Overall Study|Adverse Event|14
931071|NCT00928070|1915446|FG001|Overall Study|Adverse Event|26
931072|NCT00928070|1915445|FG000|Overall Study|Lack of Efficacy|9
931073|NCT00928070|1915446|FG001|Overall Study|Lack of Efficacy|5
931074|NCT00928070|1915445|FG000|Overall Study|Did not meet entrance criteria|16
931075|NCT00928070|1915446|FG001|Overall Study|Did not meet entrance criteria|9
931076|NCT00928070|1915445|FG000|Overall Study|Protocol Violation|6
931077|NCT00928070|1915446|FG001|Overall Study|Protocol Violation|5
931078|NCT00928070|1915445|FG000|Overall Study|Randomized but not treated|2
931079|NCT00928070|1915446|FG001|Overall Study|Randomized but not treated|2
931080|NCT00928070|1915445|FG000|Overall Study|Other|5
931081|NCT00928070|1915446|FG001|Overall Study|Other|5
931082|NCT00928135|1915514|FG000|Overall Study|Withdrawal by Subject|1
931083|NCT00928135|1915515|FG001|Overall Study|Withdrawal by Subject|0
931084|NCT00928187|1915528|FG000|Overall Study|Death|1
931085|NCT00928187|1915529|FG001|Overall Study|Death|2
931086|NCT00928187|1915530|FG002|Overall Study|Death|3
931087|NCT00928187|1915528|FG000|Overall Study|Lost to Follow-up|1
931088|NCT00928187|1915529|FG001|Overall Study|Lost to Follow-up|2
931089|NCT00928187|1915530|FG002|Overall Study|Lost to Follow-up|1
931090|NCT00928187|1915528|FG000|Overall Study|Withdrawal by Subject|0
931091|NCT00928187|1915529|FG001|Overall Study|Withdrawal by Subject|1
931092|NCT00928187|1915530|FG002|Overall Study|Withdrawal by Subject|1
931093|NCT00928187|1915528|FG000|Overall Study|Protocol Violation|0
931094|NCT00928187|1915529|FG001|Overall Study|Protocol Violation|1
931095|NCT00928187|1915530|FG002|Overall Study|Protocol Violation|0
931096|NCT00928252|1915559|FG000|Overall Study|Physician Decision|3
931097|NCT00928408|1915582|FG000|Overall Study|Other|2
931098|NCT00928408|1915582|FG000|Overall Study|Withdrawal by Subject|4
931099|NCT00928408|1915582|FG000|Overall Study|Death|5
931100|NCT00928408|1915582|FG000|Overall Study|Lost to Follow-up|12
931101|NCT00928434|1915593|FG000|Overall Study|Adverse Event|14
931102|NCT00928434|1915594|FG001|Overall Study|Adverse Event|5
931103|NCT00928434|1915595|FG002|Overall Study|Adverse Event|18
931104|NCT00928434|1915593|FG000|Overall Study|Protocol Violation|5
931105|NCT00928434|1915594|FG001|Overall Study|Protocol Violation|0
931106|NCT00928434|1915595|FG002|Overall Study|Protocol Violation|8
931107|NCT00928434|1915593|FG000|Overall Study|Physician Decision|2
931108|NCT00928434|1915594|FG001|Overall Study|Physician Decision|0
931109|NCT00928434|1915595|FG002|Overall Study|Physician Decision|3
931110|NCT00928434|1915593|FG000|Overall Study|Lost to Follow-up|1
931111|NCT00928434|1915594|FG001|Overall Study|Lost to Follow-up|0
931112|NCT00928434|1915595|FG002|Overall Study|Lost to Follow-up|3
931113|NCT00928434|1915593|FG000|Overall Study|Withdrawal by Subject|5
931114|NCT00928434|1915594|FG001|Overall Study|Withdrawal by Subject|3
931115|NCT00928434|1915595|FG002|Overall Study|Withdrawal by Subject|2
931116|NCT00928434|1915593|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
931117|NCT00928434|1915594|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
931118|NCT00928434|1915595|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
931119|NCT00928434|1915593|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2
931120|NCT00928434|1915594|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1
931121|NCT00928434|1915595|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1
931122|NCT00928434|1915593|FG000|Overall Study|Other (not meeting above criteria)|5
931123|NCT00928434|1915594|FG001|Overall Study|Other (not meeting above criteria)|1
931124|NCT00928434|1915595|FG002|Overall Study|Other (not meeting above criteria)|2
931125|NCT00928486|1915611|FG000|Overall Study|Adverse Event|2
931126|NCT00928486|1915611|FG000|Overall Study|Disease Progression|7
931127|NCT00928486|1915611|FG000|Overall Study|Withdrawal by Subject|1
931128|NCT00928512|1915620|FG000|Overall Study|Adverse Event|4
931129|NCT00928512|1915621|FG001|Overall Study|Adverse Event|3
931130|NCT00928512|1915622|FG002|Overall Study|Adverse Event|2
931131|NCT00928512|1915623|FG003|Overall Study|Adverse Event|8
931132|NCT00928512|1915624|FG004|Overall Study|Adverse Event|6
931133|NCT00928512|1915620|FG000|Overall Study|Lack of Efficacy|2
931134|NCT00928512|1915621|FG001|Overall Study|Lack of Efficacy|0
931135|NCT00928512|1915622|FG002|Overall Study|Lack of Efficacy|4
931136|NCT00928512|1915623|FG003|Overall Study|Lack of Efficacy|7
931137|NCT00928512|1915624|FG004|Overall Study|Lack of Efficacy|3
931138|NCT00928512|1915620|FG000|Overall Study|Protocol Violation|0
931139|NCT00928512|1915621|FG001|Overall Study|Protocol Violation|1
931140|NCT00928512|1915622|FG002|Overall Study|Protocol Violation|0
931141|NCT00928512|1915623|FG003|Overall Study|Protocol Violation|1
931142|NCT00928512|1915624|FG004|Overall Study|Protocol Violation|3
931143|NCT00928512|1915620|FG000|Overall Study|Withdrawal by Subject|3
931144|NCT00928512|1915621|FG001|Overall Study|Withdrawal by Subject|0
931145|NCT00928512|1915622|FG002|Overall Study|Withdrawal by Subject|3
931146|NCT00928512|1915623|FG003|Overall Study|Withdrawal by Subject|4
931147|NCT00928512|1915624|FG004|Overall Study|Withdrawal by Subject|0
931148|NCT00928512|1915620|FG000|Overall Study|Lost to Follow-up|1
931149|NCT00928512|1915621|FG001|Overall Study|Lost to Follow-up|1
931150|NCT00928512|1915622|FG002|Overall Study|Lost to Follow-up|2
931151|NCT00928512|1915623|FG003|Overall Study|Lost to Follow-up|1
931152|NCT00928512|1915624|FG004|Overall Study|Lost to Follow-up|3
931153|NCT00928512|1915620|FG000|Overall Study|Administrative Problems|0
931154|NCT00928512|1915621|FG001|Overall Study|Administrative Problems|1
931155|NCT00928512|1915622|FG002|Overall Study|Administrative Problems|0
931156|NCT00928512|1915623|FG003|Overall Study|Administrative Problems|0
931157|NCT00928512|1915624|FG004|Overall Study|Administrative Problems|0
931158|NCT00928564|1915642|FG000|Overall Study|Lost to Follow-up|6
931159|NCT00928564|1915643|FG001|Overall Study|Lost to Follow-up|0
931160|NCT00928668|1915656|FG000|Overall Study|Adverse Event|1
931161|NCT00928668|1915657|FG001|Overall Study|Adverse Event|0
931162|NCT00928668|1915658|FG002|Overall Study|Adverse Event|0
931163|NCT00928668|1915659|FG003|Overall Study|Adverse Event|0
931164|NCT00928668|1915660|FG004|Overall Study|Adverse Event|0
931165|NCT00928668|1915656|FG000|Overall Study|Protocol Violation|0
931166|NCT00928668|1915657|FG001|Overall Study|Protocol Violation|0
931167|NCT00928668|1915658|FG002|Overall Study|Protocol Violation|0
931168|NCT00928668|1915659|FG003|Overall Study|Protocol Violation|0
931169|NCT00928668|1915660|FG004|Overall Study|Protocol Violation|1
931170|NCT00928668|1915656|FG000|Overall Study|Withdrawal by Subject|0
931171|NCT00928668|1915657|FG001|Overall Study|Withdrawal by Subject|1
931172|NCT00928668|1915658|FG002|Overall Study|Withdrawal by Subject|1
931173|NCT00928668|1915659|FG003|Overall Study|Withdrawal by Subject|0
931174|NCT00928668|1915660|FG004|Overall Study|Withdrawal by Subject|0
931175|NCT00928668|1915656|FG000|Overall Study|Other reasons not listed above|0
931176|NCT00928668|1915657|FG001|Overall Study|Other reasons not listed above|0
931177|NCT00928668|1915658|FG002|Overall Study|Other reasons not listed above|0
931178|NCT00928668|1915659|FG003|Overall Study|Other reasons not listed above|1
931179|NCT00928668|1915660|FG004|Overall Study|Other reasons not listed above|0
931180|NCT00928707|1915686|FG000|Overall Study|Protocol Violation|1
931181|NCT00928707|1915687|FG001|Overall Study|Protocol Violation|0
931182|NCT00928746|1915709|FG000|Overall Study|Adverse Event|2
931183|NCT00928746|1915709|FG000|Overall Study|Protocol Violation|1
931184|NCT00928746|1915709|FG000|Overall Study|Withdrawal by Subject|1
931185|NCT00928746|1915709|FG000|Overall Study|Other|2
931186|NCT00928889|1915730|FG000|Overall Study|Lost to Follow-up|3
931187|NCT00928889|1915731|FG001|Overall Study|Lost to Follow-up|1
931188|NCT00928889|1915730|FG000|Overall Study|Protocol Violation|0
931189|NCT00928889|1915731|FG001|Overall Study|Protocol Violation|1
931190|NCT00928889|1915730|FG000|Overall Study|Adverse Event|1
931191|NCT00928889|1915731|FG001|Overall Study|Adverse Event|0
931192|NCT00928889|1915730|FG000|Overall Study|Other|1
931193|NCT00928889|1915731|FG001|Overall Study|Other|0
931194|NCT00929110|1915754|FG000|Overall Study|Adverse Event|40
931195|NCT00929110|1915755|FG001|Overall Study|Adverse Event|29
931196|NCT00929110|1915756|FG002|Overall Study|Adverse Event|18
931197|NCT00929110|1915754|FG000|Overall Study|Subject withdrew consent|40
931198|NCT00929110|1915755|FG001|Overall Study|Subject withdrew consent|23
931199|NCT00929110|1915756|FG002|Overall Study|Subject withdrew consent|26
931200|NCT00929110|1915754|FG000|Overall Study|Unsatisfactory therapeutic effect|20
931201|NCT00929110|1915755|FG001|Overall Study|Unsatisfactory therapeutic effect|9
931202|NCT00929110|1915756|FG002|Overall Study|Unsatisfactory therapeutic effect|6
931203|NCT00929110|1915754|FG000|Overall Study|Lost to Follow-up|7
931204|NCT00929110|1915755|FG001|Overall Study|Lost to Follow-up|7
931205|NCT00929110|1915756|FG002|Overall Study|Lost to Follow-up|3
931206|NCT00929110|1915754|FG000|Overall Study|Protocol deviation|5
931207|NCT00929110|1915755|FG001|Overall Study|Protocol deviation|2
931208|NCT00929110|1915756|FG002|Overall Study|Protocol deviation|4
931209|NCT00929110|1915754|FG000|Overall Study|Administrative problems|4
931210|NCT00929110|1915755|FG001|Overall Study|Administrative problems|1
931211|NCT00929110|1915756|FG002|Overall Study|Administrative problems|2
931212|NCT00929110|1915754|FG000|Overall Study|Death|2
931213|NCT00929110|1915755|FG001|Overall Study|Death|2
931214|NCT00929110|1915756|FG002|Overall Study|Death|2
931215|NCT00929110|1915754|FG000|Overall Study|Abnormal laboratory value(s)|0
931216|NCT00929110|1915755|FG001|Overall Study|Abnormal laboratory value(s)|1
931217|NCT00929110|1915756|FG002|Overall Study|Abnormal laboratory value(s)|0
931218|NCT00929110|1915754|FG000|Overall Study|Abnormal test procedure result(s)|0
931219|NCT00929110|1915755|FG001|Overall Study|Abnormal test procedure result(s)|1
931220|NCT00929110|1915756|FG002|Overall Study|Abnormal test procedure result(s)|1
931221|NCT00929110|1915754|FG000|Overall Study|Patient inability to use the device|0
931222|NCT00929110|1915755|FG001|Overall Study|Patient inability to use the device|1
931223|NCT00929110|1915756|FG002|Overall Study|Patient inability to use the device|0
931224|NCT00929162|1915766|FG000|Overall Study|Adverse Event|8
931225|NCT00929162|1915767|FG001|Overall Study|Adverse Event|5
931226|NCT00929162|1915766|FG000|Overall Study|Withdrawal by Subject|3
931227|NCT00929162|1915767|FG001|Overall Study|Withdrawal by Subject|1
931228|NCT00929162|1915766|FG000|Overall Study|Protocol Violation|32
931229|NCT00929162|1915767|FG001|Overall Study|Protocol Violation|30
931230|NCT00929162|1915766|FG000|Overall Study|Other termination reason|5
931231|NCT00929162|1915767|FG001|Overall Study|Other termination reason|6
931232|NCT00929201|1915773|FG000|Period 1|Withdrawal by Subject|0
931233|NCT00929201|1915774|FG001|Period 1|Withdrawal by Subject|1
931234|NCT00929240|1915781|FG000|Initial Treatment Phase|Adverse Event|31
931235|NCT00929240|1915782|FG001|Initial Treatment Phase|Adverse Event|0
931236|NCT00929240|1915783|FG002|Initial Treatment Phase|Adverse Event|0
931237|NCT00929240|1915781|FG000|Initial Treatment Phase|Disease progression|41
931238|NCT00929240|1915782|FG001|Initial Treatment Phase|Disease progression|0
931239|NCT00929240|1915783|FG002|Initial Treatment Phase|Disease progression|0
931240|NCT00929240|1915781|FG000|Initial Treatment Phase|Withdrawal by Subject|13
931241|NCT00929240|1915782|FG001|Initial Treatment Phase|Withdrawal by Subject|0
931242|NCT00929240|1915783|FG002|Initial Treatment Phase|Withdrawal by Subject|0
931243|NCT00929240|1915781|FG000|Initial Treatment Phase|Protocol Violation|5
931244|NCT00929240|1915782|FG001|Initial Treatment Phase|Protocol Violation|0
931245|NCT00929240|1915783|FG002|Initial Treatment Phase|Protocol Violation|0
931246|NCT00929240|1915781|FG000|Initial Treatment Phase|Death|2
931247|NCT00929240|1915782|FG001|Initial Treatment Phase|Death|0
931248|NCT00929240|1915783|FG002|Initial Treatment Phase|Death|0
931249|NCT00929240|1915781|FG000|Initial Treatment Phase|Health authority/Study termination|3
931250|NCT00929240|1915782|FG001|Initial Treatment Phase|Health authority/Study termination|0
931251|NCT00929240|1915783|FG002|Initial Treatment Phase|Health authority/Study termination|0
931252|NCT00929240|1915781|FG000|Initial Treatment Phase|Physician Decision|4
931253|NCT00929240|1915782|FG001|Initial Treatment Phase|Physician Decision|0
931254|NCT00929240|1915783|FG002|Initial Treatment Phase|Physician Decision|0
931255|NCT00929240|1915781|FG000|Maintenance Phase|Disease progression|0
931256|NCT00929240|1915782|FG001|Maintenance Phase|Disease progression|73
931257|NCT00929240|1915783|FG002|Maintenance Phase|Disease progression|60
931258|NCT00929240|1915781|FG000|Maintenance Phase|Adverse Event|0
931259|NCT00929240|1915782|FG001|Maintenance Phase|Adverse Event|9
931260|NCT00929240|1915783|FG002|Maintenance Phase|Adverse Event|12
931261|NCT00929240|1915781|FG000|Maintenance Phase|Withdrawal by Subject|0
931262|NCT00929240|1915782|FG001|Maintenance Phase|Withdrawal by Subject|2
931263|NCT00929240|1915783|FG002|Maintenance Phase|Withdrawal by Subject|6
931264|NCT00929240|1915781|FG000|Maintenance Phase|Protocol Violation|0
931265|NCT00929240|1915782|FG001|Maintenance Phase|Protocol Violation|1
931266|NCT00929240|1915783|FG002|Maintenance Phase|Protocol Violation|0
931267|NCT00929240|1915781|FG000|Maintenance Phase|Health authority/Study termination|0
931268|NCT00929240|1915782|FG001|Maintenance Phase|Health authority/Study termination|1
931269|NCT00929240|1915783|FG002|Maintenance Phase|Health authority/Study termination|2
931270|NCT00929240|1915781|FG000|Maintenance Phase|Physician Decision|0
931271|NCT00929240|1915782|FG001|Maintenance Phase|Physician Decision|2
931272|NCT00929240|1915783|FG002|Maintenance Phase|Physician Decision|1
931273|NCT00929240|1915781|FG000|Maintenance Phase|Change of treatment|0
931274|NCT00929240|1915782|FG001|Maintenance Phase|Change of treatment|4
931275|NCT00929240|1915783|FG002|Maintenance Phase|Change of treatment|0
931276|NCT00929240|1915781|FG000|Maintenance Phase|Treatment ongoing at study closure|0
931277|NCT00929240|1915782|FG001|Maintenance Phase|Treatment ongoing at study closure|0
931278|NCT00929240|1915783|FG002|Maintenance Phase|Treatment ongoing at study closure|10
931279|NCT00929240|1915781|FG000|Maintenance Phase|Participant not treated|0
931280|NCT00929240|1915782|FG001|Maintenance Phase|Participant not treated|2
931281|NCT00929240|1915783|FG002|Maintenance Phase|Participant not treated|0
931282|NCT00929526|1915848|FG000|Overall Study|Withdrawal by Subject|1
931283|NCT00929526|1915849|FG001|Overall Study|Withdrawal by Subject|11
931284|NCT00929526|1915848|FG000|Overall Study|Lost to Follow-up|8
931285|NCT00929526|1915849|FG001|Overall Study|Lost to Follow-up|12
931286|NCT00929526|1915848|FG000|Overall Study|Other|8
931287|NCT00929526|1915849|FG001|Overall Study|Other|6
931288|NCT00929643|1915864|FG000|Overall Study|Protocol Violation|2
931289|NCT00929656|1915870|FG000|Overall Study|Lost to Follow-up|0
931290|NCT00929656|1915871|FG001|Overall Study|Lost to Follow-up|1
931291|NCT00929669|1915877|FG000|Overall Study|elevated glucose levels|1
931292|NCT00929695|1915883|FG000|Overall Study|Death|2
931293|NCT00929695|1915884|FG001|Overall Study|Death|1
931294|NCT00929695|1915883|FG000|Overall Study|Withdrawal by Subject|0
931295|NCT00929695|1915884|FG001|Overall Study|Withdrawal by Subject|2
931296|NCT00929695|1915883|FG000|Overall Study|discharge home|4
931297|NCT00929695|1915884|FG001|Overall Study|discharge home|3
931298|NCT00929695|1915883|FG000|Overall Study|incorrect stratification|2
931299|NCT00929695|1915884|FG001|Overall Study|incorrect stratification|0
931300|NCT00929708|1915900|FG000|Overall Study|Protocol Violation|2
931301|NCT00929708|1915901|FG001|Overall Study|Protocol Violation|1
931302|NCT00929708|1915902|FG002|Overall Study|Protocol Violation|1
931303|NCT00929708|1915903|FG003|Overall Study|Protocol Violation|1
931304|NCT00929708|1915904|FG004|Overall Study|Protocol Violation|1
931305|NCT00929708|1915900|FG000|Overall Study|Withdrawal by Subject|2
931306|NCT00929708|1915901|FG001|Overall Study|Withdrawal by Subject|0
931307|NCT00929708|1915902|FG002|Overall Study|Withdrawal by Subject|0
931308|NCT00929708|1915903|FG003|Overall Study|Withdrawal by Subject|2
931309|NCT00929708|1915904|FG004|Overall Study|Withdrawal by Subject|1
931310|NCT00929708|1915900|FG000|Overall Study|Adverse Event|0
931311|NCT00929708|1915901|FG001|Overall Study|Adverse Event|0
931312|NCT00929708|1915902|FG002|Overall Study|Adverse Event|0
931313|NCT00929708|1915903|FG003|Overall Study|Adverse Event|0
931314|NCT00929708|1915904|FG004|Overall Study|Adverse Event|3
931315|NCT00929708|1915900|FG000|Overall Study|Physician Decision|0
931316|NCT00929708|1915901|FG001|Overall Study|Physician Decision|2
931317|NCT00929708|1915902|FG002|Overall Study|Physician Decision|2
931318|NCT00929708|1915903|FG003|Overall Study|Physician Decision|2
931319|NCT00929708|1915904|FG004|Overall Study|Physician Decision|1
931320|NCT00929708|1915900|FG000|Overall Study|Lost to Follow-up|0
931321|NCT00929708|1915901|FG001|Overall Study|Lost to Follow-up|0
931322|NCT00929708|1915902|FG002|Overall Study|Lost to Follow-up|0
931323|NCT00929708|1915903|FG003|Overall Study|Lost to Follow-up|1
931324|NCT00929708|1915904|FG004|Overall Study|Lost to Follow-up|0
931325|NCT00929734|1915918|FG000|Overall Study|Lost to Follow-up|2
931326|NCT00929734|1915919|FG001|Overall Study|Lost to Follow-up|1
931327|NCT00929734|1915918|FG000|Overall Study|Withdrawal by Subject|0
931328|NCT00929734|1915919|FG001|Overall Study|Withdrawal by Subject|2
931329|NCT00929864|1915954|FG000|Overall Study|Death|1
931330|NCT00929864|1915955|FG001|Overall Study|Death|1
931331|NCT00929864|1915954|FG000|Overall Study|Adverse Event|11
931332|NCT00929864|1915955|FG001|Overall Study|Adverse Event|30
931333|NCT00929864|1915954|FG000|Overall Study|Lack of Efficacy|19
931334|NCT00929864|1915955|FG001|Overall Study|Lack of Efficacy|16
931335|NCT00929864|1915954|FG000|Overall Study|Lost to Follow-up|7
931336|NCT00929864|1915955|FG001|Overall Study|Lost to Follow-up|12
931337|NCT00929864|1915954|FG000|Overall Study|Withdrawal by Subject|20
931338|NCT00929864|1915955|FG001|Overall Study|Withdrawal by Subject|9
931339|NCT00929864|1915954|FG000|Overall Study|No longer met criteria|2
931340|NCT00929864|1915955|FG001|Overall Study|No longer met criteria|1
931341|NCT00929864|1915954|FG000|Overall Study|Poor or non-compliance|3
931342|NCT00929864|1915955|FG001|Overall Study|Poor or non-compliance|3
931343|NCT00929864|1915954|FG000|Overall Study|Pregnancy|0
931344|NCT00929864|1915955|FG001|Overall Study|Pregnancy|3
931345|NCT00929864|1915954|FG000|Overall Study|Administrative reason by Sponsor|1
931346|NCT00929864|1915955|FG001|Overall Study|Administrative reason by Sponsor|1
931347|NCT00929864|1915954|FG000|Overall Study|Non-specified|2
931348|NCT00929864|1915955|FG001|Overall Study|Non-specified|7
931349|NCT00929994|1915965|FG000|Overall Study|Withdrawal by Subject|1
931350|NCT00929994|1915965|FG000|Overall Study|medical issue unrelated to intervention|4
931351|NCT00929994|1915965|FG000|Overall Study|employment|1
931352|NCT00930046|1915974|FG000|Overall Study|Wound catheter malfunctioned|1
931353|NCT00930046|1915975|FG001|Overall Study|Wound catheter malfunctioned|2
931354|NCT00930059|1915983|FG000|Overall Study|Death|1
931355|NCT00930059|1915984|FG001|Overall Study|Death|0
931356|NCT00930059|1915983|FG000|Overall Study|Did not meet entrance criteria|1
931357|NCT00930059|1915984|FG001|Overall Study|Did not meet entrance criteria|1
931358|NCT00930059|1915983|FG000|Overall Study|Withdrawal by Subject|3
931359|NCT00930059|1915984|FG001|Overall Study|Withdrawal by Subject|4
931360|NCT00930059|1915983|FG000|Overall Study|Other|1
931361|NCT00930059|1915984|FG001|Overall Study|Other|0
931362|NCT00930059|1915983|FG000|Overall Study|1 site terminated by sponsor|1
931363|NCT00930059|1915984|FG001|Overall Study|1 site terminated by sponsor|1
931364|NCT00930059|1915983|FG000|Overall Study|Adverse Event|1
931365|NCT00930059|1915984|FG001|Overall Study|Adverse Event|6
931366|NCT00930176|1915990|FG000|Overall Study|Death|1
931367|NCT00930553|1916003|FG000|Overall Study|Adverse Event|1
931368|NCT00930553|1916003|FG000|Overall Study|Lack of Efficacy|7
931369|NCT00930553|1916003|FG000|Overall Study|Physician Decision|39
931370|NCT00930553|1916003|FG000|Overall Study|Protocol Violation|1
931371|NCT00930553|1916003|FG000|Overall Study|Pregnancy|1
931372|NCT00930553|1916003|FG000|Overall Study|Withdrawal by Subject|88
931373|NCT00930553|1916003|FG000|Overall Study|Lost to Follow-up|25
931374|NCT00930553|1916003|FG000|Overall Study|Death|9
931375|NCT00930553|1916003|FG000|Overall Study|Study terminated by sponsor|24
931376|NCT00930553|1916003|FG000|Overall Study|Other than specified above|28
931377|NCT00930644|1916025|FG000|Overall Study|Withdrawal by Subject|4
931378|NCT00930644|1916025|FG000|Overall Study|Physician Decision|2
931379|NCT00930644|1916025|FG000|Overall Study|Death|1
931380|NCT00930644|1916025|FG000|Overall Study|Adverse Event|16
931381|NCT00930761|1916038|FG000|Overall Study|3 newborns died; 1 mother quit the study|4
931382|NCT00930761|1916039|FG001|Overall Study|3 newborns died; 1 mother quit the study|0
931383|NCT00930761|1916038|FG000|Overall Study|less than 3 music therapy sessions|0
931384|NCT00930761|1916039|FG001|Overall Study|less than 3 music therapy sessions|3
931385|NCT00930774|1916049|FG000|Overall Study|Withdrawal by Subject|1
931386|NCT00930774|1916050|FG001|Overall Study|Withdrawal by Subject|9
931387|NCT00930774|1916051|FG002|Overall Study|Withdrawal by Subject|2
931388|NCT00930774|1916052|FG003|Overall Study|Withdrawal by Subject|0
931389|NCT00930813|1916065|FG000|Overall Study|Death|4
931390|NCT00930813|1916066|FG001|Overall Study|Death|5
931391|NCT00930813|1916065|FG000|Overall Study|Withdrawal by Subject|2
931392|NCT00930813|1916066|FG001|Overall Study|Withdrawal by Subject|5
931393|NCT00930813|1916065|FG000|Overall Study|Lost to Follow-up|2
931394|NCT00930813|1916066|FG001|Overall Study|Lost to Follow-up|4
931395|NCT00930930|1916076|FG000|Overall Study|Death|1
931396|NCT00930930|1916077|FG001|Overall Study|Death|0
931397|NCT00930930|1916076|FG000|Overall Study|Physician Decision|1
931398|NCT00930930|1916077|FG001|Overall Study|Physician Decision|0
931399|NCT00930930|1916076|FG000|Overall Study|Adverse Event|13
931400|NCT00930930|1916077|FG001|Overall Study|Adverse Event|3
931401|NCT00930930|1916076|FG000|Overall Study|Withdrawal by Subject|3
931402|NCT00930930|1916077|FG001|Overall Study|Withdrawal by Subject|1
931403|NCT00930930|1916076|FG000|Overall Study|Disease progression|2
931404|NCT00930930|1916077|FG001|Overall Study|Disease progression|3
931405|NCT00930930|1916076|FG000|Overall Study|excessive lapse btw txs, not eligible|0
931406|NCT00930930|1916077|FG001|Overall Study|excessive lapse btw txs, not eligible|1
931407|NCT00930930|1916076|FG000|Overall Study|patients not compliant|1
931408|NCT00930930|1916077|FG001|Overall Study|patients not compliant|1
931409|NCT00930969|1916083|FG000|Overall Study|Death|5
931410|NCT00930969|1916083|FG000|Overall Study|Lost to Follow-up|1
931411|NCT00930969|1916083|FG000|Overall Study|Physician Decision|13
931412|NCT00930969|1916083|FG000|Overall Study|Withdrawal by Subject|19
931413|NCT00930982|1916089|FG000|Overall Study|Adverse Event|19
931414|NCT00930982|1916090|FG001|Overall Study|Adverse Event|23
931415|NCT00930982|1916089|FG000|Overall Study|Protocol Violation|1
931416|NCT00930982|1916090|FG001|Overall Study|Protocol Violation|5
931417|NCT00930982|1916089|FG000|Overall Study|Withdrawal by Subject|1
931418|NCT00930982|1916090|FG001|Overall Study|Withdrawal by Subject|1
931419|NCT00931255|1916109|FG000|Overall Study|Follow up biopsy not done|2
931420|NCT00931255|1916110|FG001|Overall Study|Follow up biopsy not done|3
931421|NCT00931268|1916116|FG000|Overall Study|Lost to Follow-up|6
931422|NCT00931307|1916120|FG000|Overall Study|Lack of Efficacy|12
931423|NCT00931307|1916120|FG000|Overall Study|Biomicroscopy|1
931424|NCT00931385|1916133|FG000|Overall Study|Adverse Event|2
931425|NCT00931385|1916134|FG001|Overall Study|Adverse Event|1
931426|NCT00931385|1916135|FG002|Overall Study|Adverse Event|0
931427|NCT00931385|1916136|FG003|Overall Study|Adverse Event|3
931428|NCT00931385|1916133|FG000|Overall Study|Protocol Violation|0
931429|NCT00931385|1916134|FG001|Overall Study|Protocol Violation|0
931430|NCT00931385|1916135|FG002|Overall Study|Protocol Violation|1
931431|NCT00931385|1916136|FG003|Overall Study|Protocol Violation|0
931432|NCT00931385|1916133|FG000|Overall Study|Withdrawal by Subject|0
931433|NCT00931385|1916134|FG001|Overall Study|Withdrawal by Subject|1
931434|NCT00931385|1916135|FG002|Overall Study|Withdrawal by Subject|0
931435|NCT00931385|1916136|FG003|Overall Study|Withdrawal by Subject|1
931436|NCT00931385|1916133|FG000|Overall Study|Lost to Follow-up|0
931437|NCT00931385|1916134|FG001|Overall Study|Lost to Follow-up|0
931438|NCT00931385|1916135|FG002|Overall Study|Lost to Follow-up|0
931439|NCT00931385|1916136|FG003|Overall Study|Lost to Follow-up|1
931440|NCT00931411|1916152|FG000|First Intervention - 42 Days|Adverse Event|2
931441|NCT00931411|1916153|FG001|First Intervention - 42 Days|Adverse Event|3
931442|NCT00931411|1916152|FG000|First Intervention - 42 Days|Lost to Follow-up|2
931443|NCT00931411|1916153|FG001|First Intervention - 42 Days|Lost to Follow-up|0
931444|NCT00931411|1916152|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
931445|NCT00931411|1916153|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
931446|NCT00931463|1916165|FG000|Overall Study|Death|8
931447|NCT00931463|1916166|FG001|Overall Study|Death|4
931448|NCT00931463|1916165|FG000|Overall Study|Withdrawal by Subject|5
931449|NCT00931463|1916166|FG001|Overall Study|Withdrawal by Subject|0
931450|NCT00931463|1916165|FG000|Overall Study|Lost to Follow-up|4
931451|NCT00931463|1916166|FG001|Overall Study|Lost to Follow-up|1
931452|NCT00931515|1916194|FG000|Overall Study|Lost to Follow-up|2
931453|NCT00931515|1916195|FG001|Overall Study|Lost to Follow-up|5
931454|NCT00931528|1916203|FG000|Overall Study|Protocol Violation|9
931455|NCT00931528|1916204|FG001|Overall Study|Protocol Violation|12
931456|NCT00931528|1916203|FG000|Overall Study|Withdrawal by Subject|4
931457|NCT00931528|1916204|FG001|Overall Study|Withdrawal by Subject|12
931458|NCT00931528|1916203|FG000|Overall Study|Lost to Follow-up|6
931459|NCT00931528|1916204|FG001|Overall Study|Lost to Follow-up|13
931460|NCT00931528|1916203|FG000|Overall Study|Assessment outside of Time Frame|22
931461|NCT00931528|1916204|FG001|Overall Study|Assessment outside of Time Frame|23
931462|NCT00931632|1916213|FG000|Overall Study|Withdrawal by Subject|2
931463|NCT00931632|1916214|FG001|Overall Study|Withdrawal by Subject|3
931464|NCT00931632|1916213|FG000|Overall Study|Adverse Event|19
931465|NCT00931632|1916214|FG001|Overall Study|Adverse Event|15
931466|NCT00931710|1916222|FG000|Overall Study|Adverse Event|16
931467|NCT00931710|1916223|FG001|Overall Study|Adverse Event|10
931468|NCT00931710|1916222|FG000|Overall Study|Abnormal test procedure results|2
931469|NCT00931710|1916223|FG001|Overall Study|Abnormal test procedure results|0
931470|NCT00931710|1916222|FG000|Overall Study|Unsatisfactory therapeutic effects|5
931471|NCT00931710|1916223|FG001|Overall Study|Unsatisfactory therapeutic effects|12
931472|NCT00931710|1916222|FG000|Overall Study|Patient withdrew consent|4
931473|NCT00931710|1916223|FG001|Overall Study|Patient withdrew consent|9
931474|NCT00931710|1916222|FG000|Overall Study|Lost to Follow-up|6
931475|NCT00931710|1916223|FG001|Overall Study|Lost to Follow-up|5
931476|NCT00931710|1916222|FG000|Overall Study|Protocol deviation|1
931477|NCT00931710|1916223|FG001|Overall Study|Protocol deviation|2
931478|NCT00931723|1916231|FG000|Overall Study|Withdrawal by Subject|11
931479|NCT00931723|1916232|FG001|Overall Study|Withdrawal by Subject|13
931480|NCT00931723|1916231|FG000|Overall Study|Adverse Event|6
931481|NCT00931723|1916232|FG001|Overall Study|Adverse Event|13
931482|NCT00931723|1916231|FG000|Overall Study|Lithium found in blood|0
931483|NCT00931723|1916232|FG001|Overall Study|Lithium found in blood|1
931484|NCT00931723|1916231|FG000|Overall Study|Condition under investigation worsened|1
931485|NCT00931723|1916232|FG001|Overall Study|Condition under investigation worsened|2
931486|NCT00931723|1916231|FG000|Overall Study|Lost to Follow-up|1
931487|NCT00931723|1916232|FG001|Overall Study|Lost to Follow-up|2
931488|NCT00931723|1916231|FG000|Overall Study|Study-specific discontinuation criteria|1
931489|NCT00931723|1916232|FG001|Overall Study|Study-specific discontinuation criteria|1
931490|NCT00931723|1916231|FG000|Overall Study|Severe non-compliance to protocol|2
931491|NCT00931723|1916232|FG001|Overall Study|Severe non-compliance to protocol|0
931492|NCT00931723|1916231|FG000|Overall Study|Safety reasons|0
931493|NCT00931723|1916232|FG001|Overall Study|Safety reasons|1
931494|NCT00931723|1916231|FG000|Overall Study|Took prohibited concomitant medication|0
931495|NCT00931723|1916232|FG001|Overall Study|Took prohibited concomitant medication|1
931496|NCT00931723|1916231|FG000|Overall Study|Lack or insufficient theraputic response|2
931497|NCT00931723|1916232|FG001|Overall Study|Lack or insufficient theraputic response|5
931498|NCT00931723|1916231|FG000|Overall Study|Sponsor decision|1
931499|NCT00931723|1916232|FG001|Overall Study|Sponsor decision|0
931500|NCT00931723|1916231|FG000|Overall Study|Late hospital discharge|1
931501|NCT00931723|1916232|FG001|Overall Study|Late hospital discharge|0
931502|NCT00931762|1916238|FG000|Overall Study|Abnormal Laboratory Value (s)|2
931503|NCT00931762|1916238|FG000|Overall Study|Administrative Problems|5
931504|NCT00931762|1916238|FG000|Overall Study|Death|1
931505|NCT00931762|1916238|FG000|Overall Study|Disease Progression|3
931506|NCT00931762|1916238|FG000|Overall Study|Adverse Event (s)|11
931507|NCT00931762|1916238|FG000|Overall Study|Subject withdrew consent|13
931508|NCT00931801|1916245|FG000|Overall Study|Adverse Event|0
931509|NCT00931801|1916246|FG001|Overall Study|Adverse Event|0
931510|NCT00931801|1916247|FG002|Overall Study|Adverse Event|1
931511|NCT00931801|1916245|FG000|Overall Study|Lost to Follow-up|0
931512|NCT00931801|1916246|FG001|Overall Study|Lost to Follow-up|1
931513|NCT00931801|1916247|FG002|Overall Study|Lost to Follow-up|0
931514|NCT00931801|1916245|FG000|Overall Study|Withdrawal by Subject|1
931515|NCT00931801|1916246|FG001|Overall Study|Withdrawal by Subject|0
931516|NCT00931801|1916247|FG002|Overall Study|Withdrawal by Subject|0
931517|NCT00931801|1916245|FG000|Overall Study|Confirmed Virologic Failure|0
931518|NCT00931801|1916246|FG001|Overall Study|Confirmed Virologic Failure|0
931519|NCT00931801|1916247|FG002|Overall Study|Confirmed Virologic Failure|3
931520|NCT00931892|1916271|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0
931521|NCT00931892|1916272|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1
931522|NCT00931918|1916320|FG000|Overall Study|Adverse Event|4
931523|NCT00931918|1916321|FG001|Overall Study|Adverse Event|6
931524|NCT00931918|1916320|FG000|Overall Study|Progressive Disease|2
931525|NCT00931918|1916321|FG001|Overall Study|Progressive Disease|1
931526|NCT00931918|1916320|FG000|Overall Study|Symptomatic Deterioration|1
931527|NCT00931918|1916321|FG001|Overall Study|Symptomatic Deterioration|0
931528|NCT00931918|1916320|FG000|Overall Study|Withdrawal by Patient|3
931529|NCT00931918|1916321|FG001|Overall Study|Withdrawal by Patient|4
931530|NCT00931918|1916320|FG000|Overall Study|Other Reason not Specified|4
931531|NCT00931918|1916321|FG001|Overall Study|Other Reason not Specified|4
931532|NCT00931918|1916320|FG000|Overall Study|Did not receive study drug|3
931533|NCT00931918|1916321|FG001|Overall Study|Did not receive study drug|2
931534|NCT00931944|1916327|FG000|Overall Study|Adverse Event|4
931535|NCT00931944|1916327|FG000|Overall Study|W/D Consent (due to ALS progression))|19
931536|NCT00931944|1916327|FG000|Overall Study|Withdrawal Consent (due to other)|2
931537|NCT00931944|1916327|FG000|Overall Study|Death|28
931538|NCT00931944|1916327|FG000|Overall Study|Other|2
931539|NCT00932113|1916355|FG000|Overall Study|Lost to Follow-up|1
931540|NCT00932113|1916356|FG001|Overall Study|Lost to Follow-up|0
931541|NCT00932126|1916362|FG000|Overall Study|Adverse Event|0
931542|NCT00932126|1916363|FG001|Overall Study|Adverse Event|0
931543|NCT00932126|1916364|FG002|Overall Study|Adverse Event|0
931544|NCT00932126|1916365|FG003|Overall Study|Adverse Event|0
931545|NCT00932126|1916366|FG004|Overall Study|Adverse Event|0
931546|NCT00932126|1916367|FG005|Overall Study|Adverse Event|0
931547|NCT00932126|1916368|FG006|Overall Study|Adverse Event|1
931548|NCT00932126|1916369|FG007|Overall Study|Adverse Event|2
931549|NCT00932126|1916362|FG000|Overall Study|Protocol Violation|0
931550|NCT00932126|1916363|FG001|Overall Study|Protocol Violation|0
931551|NCT00932126|1916364|FG002|Overall Study|Protocol Violation|0
931552|NCT00932126|1916365|FG003|Overall Study|Protocol Violation|0
931553|NCT00932126|1916366|FG004|Overall Study|Protocol Violation|1
931554|NCT00932126|1916367|FG005|Overall Study|Protocol Violation|0
931555|NCT00932126|1916368|FG006|Overall Study|Protocol Violation|0
931556|NCT00932126|1916369|FG007|Overall Study|Protocol Violation|0
931557|NCT00932126|1916362|FG000|Overall Study|Withdrawal by Subject|0
931558|NCT00932126|1916363|FG001|Overall Study|Withdrawal by Subject|0
931559|NCT00932126|1916364|FG002|Overall Study|Withdrawal by Subject|1
931560|NCT00932126|1916365|FG003|Overall Study|Withdrawal by Subject|0
931561|NCT00932126|1916366|FG004|Overall Study|Withdrawal by Subject|0
931562|NCT00932126|1916367|FG005|Overall Study|Withdrawal by Subject|0
931563|NCT00932126|1916368|FG006|Overall Study|Withdrawal by Subject|0
931564|NCT00932126|1916369|FG007|Overall Study|Withdrawal by Subject|1
931565|NCT00932126|1916362|FG000|Overall Study|Objective progression or relapse|3
931566|NCT00932126|1916363|FG001|Overall Study|Objective progression or relapse|3
931567|NCT00932126|1916364|FG002|Overall Study|Objective progression or relapse|2
931568|NCT00932126|1916365|FG003|Overall Study|Objective progression or relapse|3
931569|NCT00932126|1916366|FG004|Overall Study|Objective progression or relapse|3
931570|NCT00932126|1916367|FG005|Overall Study|Objective progression or relapse|3
931571|NCT00932126|1916368|FG006|Overall Study|Objective progression or relapse|3
931572|NCT00932126|1916369|FG007|Overall Study|Objective progression or relapse|5
931573|NCT00932126|1916362|FG000|Overall Study|Other|0
931574|NCT00932126|1916363|FG001|Overall Study|Other|0
931575|NCT00932126|1916364|FG002|Overall Study|Other|0
931576|NCT00932126|1916365|FG003|Overall Study|Other|0
931577|NCT00932126|1916366|FG004|Overall Study|Other|1
931578|NCT00932126|1916367|FG005|Overall Study|Other|0
931579|NCT00932126|1916368|FG006|Overall Study|Other|1
931580|NCT00932126|1916369|FG007|Overall Study|Other|2
931581|NCT00932165|1916389|FG000|Overall Study|Lost to Follow-up|1
931582|NCT00932360|1916412|FG000|Washout (One Week)|Withdrawal by Subject|0
931583|NCT00932360|1916413|FG001|Washout (One Week)|Withdrawal by Subject|0
931584|NCT00932360|1916414|FG002|Washout (One Week)|Withdrawal by Subject|0
931585|NCT00932360|1916415|FG003|Washout (One Week)|Withdrawal by Subject|0
931586|NCT00932360|1916416|FG004|Washout (One Week)|Withdrawal by Subject|2
931587|NCT00932360|1916417|FG005|Washout (One Week)|Withdrawal by Subject|0
931588|NCT00932373|1916442|FG000|Overall Study|Progressive disease|3
931589|NCT00932373|1916443|FG001|Overall Study|Progressive disease|1
931590|NCT00932373|1916444|FG002|Overall Study|Progressive disease|0
931591|NCT00932373|1916445|FG003|Overall Study|Progressive disease|0
931592|NCT00932373|1916446|FG004|Overall Study|Progressive disease|10
931593|NCT00932373|1916447|FG005|Overall Study|Progressive disease|1
931594|NCT00932373|1916448|FG006|Overall Study|Progressive disease|0
931595|NCT00932373|1916449|FG007|Overall Study|Progressive disease|2
931596|NCT00932373|1916450|FG008|Overall Study|Progressive disease|1
931597|NCT00932373|1916451|FG009|Overall Study|Progressive disease|9
931598|NCT00932373|1916452|FG010|Overall Study|Progressive disease|2
931599|NCT00932373|1916442|FG000|Overall Study|Adverse Event|0
931600|NCT00932373|1916443|FG001|Overall Study|Adverse Event|0
931601|NCT00932373|1916444|FG002|Overall Study|Adverse Event|0
931602|NCT00932373|1916445|FG003|Overall Study|Adverse Event|0
931603|NCT00932373|1916446|FG004|Overall Study|Adverse Event|2
931604|NCT00932373|1916447|FG005|Overall Study|Adverse Event|1
931605|NCT00932373|1916448|FG006|Overall Study|Adverse Event|0
931606|NCT00932373|1916449|FG007|Overall Study|Adverse Event|1
931607|NCT00932373|1916450|FG008|Overall Study|Adverse Event|0
931608|NCT00932373|1916451|FG009|Overall Study|Adverse Event|2
931609|NCT00932373|1916452|FG010|Overall Study|Adverse Event|1
931610|NCT00932373|1916442|FG000|Overall Study|Physician Decision|0
931611|NCT00932373|1916443|FG001|Overall Study|Physician Decision|0
931612|NCT00932373|1916444|FG002|Overall Study|Physician Decision|1
931613|NCT00932373|1916445|FG003|Overall Study|Physician Decision|0
931614|NCT00932373|1916446|FG004|Overall Study|Physician Decision|2
931615|NCT00932373|1916447|FG005|Overall Study|Physician Decision|0
931616|NCT00932373|1916448|FG006|Overall Study|Physician Decision|0
931617|NCT00932373|1916449|FG007|Overall Study|Physician Decision|0
931618|NCT00932373|1916450|FG008|Overall Study|Physician Decision|0
931619|NCT00932373|1916451|FG009|Overall Study|Physician Decision|1
931620|NCT00932373|1916452|FG010|Overall Study|Physician Decision|0
931621|NCT00932373|1916442|FG000|Overall Study|Dose limiting toxicity|0
931622|NCT00932373|1916443|FG001|Overall Study|Dose limiting toxicity|0
931623|NCT00932373|1916444|FG002|Overall Study|Dose limiting toxicity|0
931624|NCT00932373|1916445|FG003|Overall Study|Dose limiting toxicity|0
931625|NCT00932373|1916446|FG004|Overall Study|Dose limiting toxicity|0
931626|NCT00932373|1916447|FG005|Overall Study|Dose limiting toxicity|1
931627|NCT00932373|1916448|FG006|Overall Study|Dose limiting toxicity|0
931628|NCT00932373|1916449|FG007|Overall Study|Dose limiting toxicity|0
931629|NCT00932373|1916450|FG008|Overall Study|Dose limiting toxicity|0
931630|NCT00932373|1916451|FG009|Overall Study|Dose limiting toxicity|0
931631|NCT00932373|1916452|FG010|Overall Study|Dose limiting toxicity|0
931632|NCT00932373|1916442|FG000|Overall Study|Withdrawal by Subject|0
931633|NCT00932373|1916443|FG001|Overall Study|Withdrawal by Subject|0
931634|NCT00932373|1916444|FG002|Overall Study|Withdrawal by Subject|0
931635|NCT00932373|1916445|FG003|Overall Study|Withdrawal by Subject|0
931636|NCT00932373|1916446|FG004|Overall Study|Withdrawal by Subject|0
931637|NCT00932373|1916447|FG005|Overall Study|Withdrawal by Subject|0
931638|NCT00932373|1916448|FG006|Overall Study|Withdrawal by Subject|0
931639|NCT00932373|1916449|FG007|Overall Study|Withdrawal by Subject|0
931640|NCT00932373|1916450|FG008|Overall Study|Withdrawal by Subject|1
931641|NCT00932373|1916451|FG009|Overall Study|Withdrawal by Subject|0
931642|NCT00932373|1916452|FG010|Overall Study|Withdrawal by Subject|0
931643|NCT00932373|1916442|FG000|Overall Study|Clinical progression|0
931644|NCT00932373|1916443|FG001|Overall Study|Clinical progression|0
931645|NCT00932373|1916444|FG002|Overall Study|Clinical progression|0
931646|NCT00932373|1916445|FG003|Overall Study|Clinical progression|0
931647|NCT00932373|1916446|FG004|Overall Study|Clinical progression|0
931648|NCT00932373|1916447|FG005|Overall Study|Clinical progression|0
931649|NCT00932373|1916448|FG006|Overall Study|Clinical progression|1
931650|NCT00932373|1916449|FG007|Overall Study|Clinical progression|0
931651|NCT00932373|1916450|FG008|Overall Study|Clinical progression|0
931652|NCT00932373|1916451|FG009|Overall Study|Clinical progression|0
931653|NCT00932373|1916452|FG010|Overall Study|Clinical progression|0
931654|NCT00932373|1916442|FG000|Overall Study|Lack of Efficacy|0
931655|NCT00932373|1916443|FG001|Overall Study|Lack of Efficacy|0
931656|NCT00932373|1916444|FG002|Overall Study|Lack of Efficacy|0
931657|NCT00932373|1916445|FG003|Overall Study|Lack of Efficacy|0
931658|NCT00932373|1916446|FG004|Overall Study|Lack of Efficacy|0
931659|NCT00932373|1916447|FG005|Overall Study|Lack of Efficacy|0
931660|NCT00932373|1916448|FG006|Overall Study|Lack of Efficacy|0
931661|NCT00932373|1916449|FG007|Overall Study|Lack of Efficacy|0
931662|NCT00932373|1916450|FG008|Overall Study|Lack of Efficacy|0
931663|NCT00932373|1916451|FG009|Overall Study|Lack of Efficacy|1
931664|NCT00932373|1916452|FG010|Overall Study|Lack of Efficacy|0
931665|NCT00932425|1916495|FG000|Overall Study|Lost to Follow-up|0
931666|NCT00932425|1916496|FG001|Overall Study|Lost to Follow-up|1
931667|NCT00932425|1916495|FG000|Overall Study|Withdrawal by Subject|0
931668|NCT00932425|1916496|FG001|Overall Study|Withdrawal by Subject|1
931669|NCT00932451|1916513|FG000|Overall Study|Withdrawal by Subject|69
931670|NCT00932451|1916513|FG000|Overall Study|Lost to Follow-up|22
931671|NCT00932451|1916513|FG000|Overall Study|Death|726
931672|NCT00932451|1916513|FG000|Overall Study|Other reasons|5
931673|NCT00932646|1916545|FG000|Overall Study|Adverse Event|2
931674|NCT00932646|1916546|FG001|Overall Study|Adverse Event|1
931675|NCT00932646|1916547|FG002|Overall Study|Adverse Event|1
931676|NCT00932646|1916548|FG003|Overall Study|Adverse Event|1
931677|NCT00932646|1916545|FG000|Overall Study|Lost to Follow-up|2
931678|NCT00932646|1916546|FG001|Overall Study|Lost to Follow-up|1
931679|NCT00932646|1916547|FG002|Overall Study|Lost to Follow-up|0
931680|NCT00932646|1916548|FG003|Overall Study|Lost to Follow-up|0
931681|NCT00932646|1916545|FG000|Overall Study|Withdrawal by Subject|1
931682|NCT00932646|1916546|FG001|Overall Study|Withdrawal by Subject|1
931683|NCT00932646|1916547|FG002|Overall Study|Withdrawal by Subject|3
931684|NCT00932646|1916548|FG003|Overall Study|Withdrawal by Subject|0
931685|NCT00932698|1916577|FG000|Part 1 (Dose Escalation)|Progressive Disease|3
931686|NCT00932698|1916578|FG001|Part 1 (Dose Escalation)|Progressive Disease|2
931687|NCT00932698|1916579|FG002|Part 1 (Dose Escalation)|Progressive Disease|2
931688|NCT00932698|1916580|FG003|Part 1 (Dose Escalation)|Progressive Disease|2
931689|NCT00932698|1916581|FG004|Part 1 (Dose Escalation)|Progressive Disease|3
931690|NCT00932698|1916582|FG005|Part 1 (Dose Escalation)|Progressive Disease|5
931691|NCT00932698|1916583|FG006|Part 1 (Dose Escalation)|Progressive Disease|2
931692|NCT00932698|1916584|FG007|Part 1 (Dose Escalation)|Progressive Disease|0
931693|NCT00932698|1916585|FG008|Part 1 (Dose Escalation)|Progressive Disease|0
931694|NCT00932698|1916586|FG009|Part 1 (Dose Escalation)|Progressive Disease|0
931695|NCT00932698|1916587|FG010|Part 1 (Dose Escalation)|Progressive Disease|0
931696|NCT00932698|1916577|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0
931697|NCT00932698|1916578|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1
931698|NCT00932698|1916579|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0
931699|NCT00932698|1916580|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1
931700|NCT00932698|1916581|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0
931701|NCT00932698|1916582|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1
931702|NCT00932698|1916583|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1
931703|NCT00932698|1916584|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0
931704|NCT00932698|1916585|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0
931705|NCT00932698|1916586|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0
931706|NCT00932698|1916587|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0
931707|NCT00932698|1916577|FG000|Part 1 (Dose Escalation)|Adverse Event|0
931708|NCT00932698|1916578|FG001|Part 1 (Dose Escalation)|Adverse Event|0
931709|NCT00932698|1916579|FG002|Part 1 (Dose Escalation)|Adverse Event|0
931710|NCT00932698|1916580|FG003|Part 1 (Dose Escalation)|Adverse Event|0
931711|NCT00932698|1916581|FG004|Part 1 (Dose Escalation)|Adverse Event|0
931712|NCT00932698|1916582|FG005|Part 1 (Dose Escalation)|Adverse Event|1
931713|NCT00932698|1916583|FG006|Part 1 (Dose Escalation)|Adverse Event|0
931714|NCT00932698|1916584|FG007|Part 1 (Dose Escalation)|Adverse Event|0
931715|NCT00932698|1916585|FG008|Part 1 (Dose Escalation)|Adverse Event|0
931716|NCT00932698|1916586|FG009|Part 1 (Dose Escalation)|Adverse Event|0
931717|NCT00932698|1916587|FG010|Part 1 (Dose Escalation)|Adverse Event|0
931718|NCT00932698|1916577|FG000|Part 1 (Dose Escalation)|Other|0
931719|NCT00932698|1916578|FG001|Part 1 (Dose Escalation)|Other|0
931720|NCT00932698|1916579|FG002|Part 1 (Dose Escalation)|Other|1
931721|NCT00932698|1916580|FG003|Part 1 (Dose Escalation)|Other|0
931722|NCT00932698|1916581|FG004|Part 1 (Dose Escalation)|Other|0
931723|NCT00932698|1916582|FG005|Part 1 (Dose Escalation)|Other|0
931724|NCT00932698|1916583|FG006|Part 1 (Dose Escalation)|Other|1
931725|NCT00932698|1916584|FG007|Part 1 (Dose Escalation)|Other|0
931726|NCT00932698|1916585|FG008|Part 1 (Dose Escalation)|Other|0
931727|NCT00932698|1916586|FG009|Part 1 (Dose Escalation)|Other|0
931728|NCT00932698|1916587|FG010|Part 1 (Dose Escalation)|Other|0
931729|NCT00932698|1916577|FG000|Part 2 (Dose Expansion)|Progressive Disease|0
931730|NCT00932698|1916578|FG001|Part 2 (Dose Expansion)|Progressive Disease|0
931731|NCT00932698|1916579|FG002|Part 2 (Dose Expansion)|Progressive Disease|0
931732|NCT00932698|1916580|FG003|Part 2 (Dose Expansion)|Progressive Disease|0
931733|NCT00932698|1916581|FG004|Part 2 (Dose Expansion)|Progressive Disease|0
931734|NCT00932698|1916582|FG005|Part 2 (Dose Expansion)|Progressive Disease|0
931735|NCT00932698|1916583|FG006|Part 2 (Dose Expansion)|Progressive Disease|0
931736|NCT00932698|1916584|FG007|Part 2 (Dose Expansion)|Progressive Disease|14
931737|NCT00932698|1916585|FG008|Part 2 (Dose Expansion)|Progressive Disease|8
931738|NCT00932698|1916586|FG009|Part 2 (Dose Expansion)|Progressive Disease|3
931739|NCT00932698|1916587|FG010|Part 2 (Dose Expansion)|Progressive Disease|2
931740|NCT00932698|1916577|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0
931741|NCT00932698|1916578|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0
931742|NCT00932698|1916579|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0
931743|NCT00932698|1916580|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0
931744|NCT00932698|1916581|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0
931745|NCT00932698|1916582|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0
931746|NCT00932698|1916583|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0
931747|NCT00932698|1916584|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1
931748|NCT00932698|1916585|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3
931749|NCT00932698|1916586|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2
931750|NCT00932698|1916587|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0
931751|NCT00932698|1916577|FG000|Part 2 (Dose Expansion)|Adverse Event|0
931752|NCT00932698|1916578|FG001|Part 2 (Dose Expansion)|Adverse Event|0
931753|NCT00932698|1916579|FG002|Part 2 (Dose Expansion)|Adverse Event|0
931754|NCT00932698|1916580|FG003|Part 2 (Dose Expansion)|Adverse Event|0
931755|NCT00932698|1916581|FG004|Part 2 (Dose Expansion)|Adverse Event|0
931756|NCT00932698|1916582|FG005|Part 2 (Dose Expansion)|Adverse Event|0
931757|NCT00932698|1916583|FG006|Part 2 (Dose Expansion)|Adverse Event|0
931758|NCT00932698|1916584|FG007|Part 2 (Dose Expansion)|Adverse Event|5
931759|NCT00932698|1916585|FG008|Part 2 (Dose Expansion)|Adverse Event|1
931760|NCT00932698|1916586|FG009|Part 2 (Dose Expansion)|Adverse Event|1
931761|NCT00932698|1916587|FG010|Part 2 (Dose Expansion)|Adverse Event|0
931762|NCT00932893|1916619|FG000|Overall Study|Death|115
931763|NCT00932893|1916620|FG001|Overall Study|Death|24
931764|NCT00932893|1916619|FG000|Overall Study|Lost to Follow-up|8
931765|NCT00932893|1916620|FG001|Overall Study|Lost to Follow-up|0
931766|NCT00932893|1916619|FG000|Overall Study|Withdrawal by Subject|5
931767|NCT00932893|1916620|FG001|Overall Study|Withdrawal by Subject|2
931768|NCT00932893|1916619|FG000|Overall Study|Other|5
931769|NCT00932893|1916620|FG001|Overall Study|Other|144
931770|NCT00933166|1916627|FG000|Overall Study|Lost to Follow-up|4
931771|NCT00933166|1916627|FG000|Overall Study|Lack of Efficacy|9
931772|NCT00933166|1916627|FG000|Overall Study|Unavailable|4
931773|NCT00933166|1916627|FG000|Overall Study|Withdrawal by Subject|1
931774|NCT00933244|1916634|FG000|Overall Study|Withdrawal by Subject|5
931775|NCT00933244|1916635|FG001|Overall Study|Withdrawal by Subject|1
931776|NCT00933244|1916636|FG002|Overall Study|Withdrawal by Subject|3
931777|NCT00933270|1916644|FG000|Overall Study|Withdrawal by Subject|26
931778|NCT00933270|1916644|FG000|Overall Study|Insufficient Follow-up|10
931779|NCT00933270|1916644|FG000|Overall Study|Lost to Follow-up|14
931780|NCT00933270|1916644|FG000|Overall Study|Adverse Event|1
931781|NCT00933270|1916644|FG000|Overall Study|Missed Visit|2
931782|NCT00933270|1916644|FG000|Overall Study|Death|24
931783|NCT00933270|1916644|FG000|Overall Study|Moved or would not return|10
931784|NCT00933335|1916651|FG000|Overall Study|Lost to Follow-up|1
931785|NCT00933335|1916652|FG001|Overall Study|Lost to Follow-up|3
931786|NCT00933335|1916651|FG000|Overall Study|Withdrawal by Subject|0
931787|NCT00933335|1916652|FG001|Overall Study|Withdrawal by Subject|1
931788|NCT00933335|1916651|FG000|Overall Study|Progressive Disease|0
931789|NCT00933335|1916652|FG001|Overall Study|Progressive Disease|11
931790|NCT00933335|1916651|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
931791|NCT00933335|1916652|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
931792|NCT00933335|1916651|FG000|Overall Study|Co-morbid Illness|1
931793|NCT00933335|1916652|FG001|Overall Study|Co-morbid Illness|0
931794|NCT00933543|1916675|FG000|Overall Study|Adverse Event|2
931795|NCT00933543|1916676|FG001|Overall Study|Adverse Event|1
931796|NCT00933543|1916675|FG000|Overall Study|Lost to Follow-up|0
931797|NCT00933543|1916676|FG001|Overall Study|Lost to Follow-up|1
931798|NCT00933543|1916675|FG000|Overall Study|Withdrawal by Subject|0
931799|NCT00933543|1916676|FG001|Overall Study|Withdrawal by Subject|1
931800|NCT00933543|1916675|FG000|Overall Study|Lack of Efficacy|0
931801|NCT00933543|1916676|FG001|Overall Study|Lack of Efficacy|3
931802|NCT00933543|1916675|FG000|Overall Study|Other|1
931803|NCT00933543|1916676|FG001|Overall Study|Other|1
931804|NCT00933608|1916684|FG000|Overall Study|Adverse Event|4
931805|NCT00933608|1916685|FG001|Overall Study|Adverse Event|2
931806|NCT00933608|1916684|FG000|Overall Study|Physician Decision|1
931807|NCT00933608|1916685|FG001|Overall Study|Physician Decision|0
931808|NCT00933686|1916693|FG000|Overall Study|Protocol Violation|0
931809|NCT00933686|1916694|FG001|Overall Study|Protocol Violation|1
931810|NCT00933686|1916693|FG000|Overall Study|Lost to Follow-up|2
931811|NCT00933686|1916694|FG001|Overall Study|Lost to Follow-up|2
931812|NCT00933686|1916693|FG000|Overall Study|Withdrawal by Subject|6
931813|NCT00933686|1916694|FG001|Overall Study|Withdrawal by Subject|5
931814|NCT00933686|1916693|FG000|Overall Study|Adverse Event|1
931815|NCT00933686|1916694|FG001|Overall Study|Adverse Event|1
931816|NCT00933686|1916693|FG000|Overall Study|Physician Decision|1
931817|NCT00933686|1916694|FG001|Overall Study|Physician Decision|0
931818|NCT00933686|1916693|FG000|Overall Study|Failure to show up at endpoint visits|0
931819|NCT00933686|1916694|FG001|Overall Study|Failure to show up at endpoint visits|2
931820|NCT00933933|1916705|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
931821|NCT00933933|1916706|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
931822|NCT00933933|1916707|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
931823|NCT00933933|1916705|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
931824|NCT00933933|1916706|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
931825|NCT00933933|1916707|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
931826|NCT00934050|1916737|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1
931827|NCT00934050|1916738|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0
931828|NCT00934050|1916739|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0
931829|NCT00934050|1916740|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1
931830|NCT00934050|1916741|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0
931831|NCT00934050|1916742|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0
931832|NCT00934050|1916737|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
931833|NCT00934050|1916738|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
931834|NCT00934050|1916739|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
931835|NCT00934050|1916740|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
931836|NCT00934050|1916741|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
931837|NCT00934050|1916742|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
931838|NCT00934050|1916737|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
931839|NCT00934050|1916738|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
931840|NCT00934050|1916739|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
931841|NCT00934050|1916740|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
931842|NCT00934050|1916741|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
931843|NCT00934050|1916742|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
931844|NCT00934050|1916737|FG000|Enrolled After 15 Dec 2009|Adverse Event|0
931845|NCT00934050|1916738|FG001|Enrolled After 15 Dec 2009|Adverse Event|0
931846|NCT00934050|1916739|FG002|Enrolled After 15 Dec 2009|Adverse Event|0
931847|NCT00934050|1916740|FG003|Enrolled After 15 Dec 2009|Adverse Event|0
931848|NCT00934050|1916741|FG004|Enrolled After 15 Dec 2009|Adverse Event|3
931849|NCT00934050|1916742|FG005|Enrolled After 15 Dec 2009|Adverse Event|0
931850|NCT00934050|1916737|FG000|Enrolled After 15 Dec 2009|Death|0
931851|NCT00934050|1916738|FG001|Enrolled After 15 Dec 2009|Death|0
931852|NCT00934050|1916739|FG002|Enrolled After 15 Dec 2009|Death|0
931853|NCT00934050|1916740|FG003|Enrolled After 15 Dec 2009|Death|0
931854|NCT00934050|1916741|FG004|Enrolled After 15 Dec 2009|Death|0
931855|NCT00934050|1916742|FG005|Enrolled After 15 Dec 2009|Death|1
931856|NCT00934050|1916737|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0
931857|NCT00934050|1916738|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0
931858|NCT00934050|1916739|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0
931859|NCT00934050|1916740|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0
931860|NCT00934050|1916741|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0
931861|NCT00934050|1916742|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1
931862|NCT00934050|1916737|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
931863|NCT00934050|1916738|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
931864|NCT00934050|1916739|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
931865|NCT00934050|1916740|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
931866|NCT00934050|1916741|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
931867|NCT00934050|1916742|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
931868|NCT00934089|1916754|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1
931869|NCT00934089|1916755|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0
931870|NCT00934089|1916754|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1
931871|NCT00934089|1916755|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0
931872|NCT00934102|1916761|FG000|Period 1, One Night of Wear|Personal Reasons|1
931873|NCT00934102|1916762|FG001|Period 1, One Night of Wear|Personal Reasons|0
931874|NCT00934102|1916763|FG002|Period 1, One Night of Wear|Personal Reasons|0
931875|NCT00934128|1916773|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0
931876|NCT00934128|1916774|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1
931877|NCT00934128|1916773|FG000|First Intervention (2 Hours)|Adverse Event|4
931878|NCT00934128|1916774|FG001|First Intervention (2 Hours)|Adverse Event|1
931879|NCT00934128|1916773|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
931880|NCT00934128|1916774|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
931881|NCT00934128|1916773|FG000|Washout Period (1 Hour)|Patient preference|1
931882|NCT00934128|1916774|FG001|Washout Period (1 Hour)|Patient preference|3
931883|NCT00934128|1916773|FG000|Washout Period (1 Hour)|Pain|1
931884|NCT00934128|1916774|FG001|Washout Period (1 Hour)|Pain|0
931885|NCT00934128|1916773|FG000|Washout Period (1 Hour)|Too tired|1
931886|NCT00934128|1916774|FG001|Washout Period (1 Hour)|Too tired|0
931887|NCT00934128|1916773|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4
931888|NCT00934128|1916774|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2
931889|NCT00934128|1916773|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
931890|NCT00934128|1916774|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
931891|NCT00934362|1916808|FG000|Overall Study|Adverse Event|1
931892|NCT00934362|1916809|FG001|Overall Study|Adverse Event|0
931893|NCT00934440|1916824|FG000|Overall Study|Lost to Follow-up|1
931894|NCT00934544|1916831|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12
931895|NCT00934544|1916832|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4
931896|NCT00934544|1916833|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0
931897|NCT00934544|1916831|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
931898|NCT00934544|1916832|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
931899|NCT00934544|1916833|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
931900|NCT00934544|1916831|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2
931901|NCT00934544|1916832|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0
931902|NCT00934544|1916833|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0
931903|NCT00934544|1916831|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1
931904|NCT00934544|1916832|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3
931905|NCT00934544|1916833|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0
931906|NCT00934544|1916831|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
931907|NCT00934544|1916832|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
931908|NCT00934544|1916833|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
931909|NCT00934544|1916831|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
931910|NCT00934544|1916832|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
931911|NCT00934544|1916833|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
931912|NCT00934544|1916831|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7
931913|NCT00934544|1916832|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7
931914|NCT00934544|1916833|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0
931915|NCT00934544|1916831|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29
931916|NCT00934544|1916832|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18
931917|NCT00934544|1916833|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0
931918|NCT00934544|1916831|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
931919|NCT00934544|1916832|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
931920|NCT00934544|1916833|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
931921|NCT00934544|1916831|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35
931922|NCT00934544|1916832|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5
931923|NCT00934544|1916833|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10
931924|NCT00934544|1916831|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
931925|NCT00934544|1916832|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
931926|NCT00934544|1916833|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
931927|NCT00934544|1916831|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
931928|NCT00934544|1916832|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
931929|NCT00934544|1916833|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
931930|NCT00934544|1916831|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32
931931|NCT00934544|1916832|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4
931932|NCT00934544|1916833|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7
931933|NCT00934544|1916831|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
931934|NCT00934544|1916832|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
931935|NCT00934544|1916833|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
931936|NCT00934544|1916831|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
931937|NCT00934544|1916832|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
931938|NCT00934544|1916833|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
931939|NCT00934544|1916831|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
931940|NCT00934544|1916832|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
931941|NCT00934544|1916833|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
931942|NCT00934622|1916863|FG000|Overall Study|Lost to Follow-up|7
931943|NCT00934622|1916863|FG000|Overall Study|2nd Intraoperative exclusion criteria|1
931944|NCT00934648|1916904|FG000|Overall Study|Failure to return|8
931945|NCT00934648|1916904|FG000|Overall Study|Withdrawal by Subject|1
931946|NCT00934661|1916910|FG000|Overall Study|Failure of Combined/Spinal Epidural|1
931947|NCT00934661|1916911|FG001|Overall Study|Failure of Combined/Spinal Epidural|0
931948|NCT00934843|1916919|FG000|Overall Study|Protocol Violation|0
931949|NCT00934843|1916920|FG001|Overall Study|Protocol Violation|1
931950|NCT00934856|1916932|FG000|Feasibility Part|Progressive disease|4
931951|NCT00934856|1916933|FG001|Feasibility Part|Progressive disease|4
931952|NCT00934856|1916934|FG002|Feasibility Part|Progressive disease|2
931953|NCT00934856|1916935|FG003|Feasibility Part|Progressive disease|3
931954|NCT00934856|1916936|FG004|Feasibility Part|Progressive disease|0
931955|NCT00934856|1916937|FG005|Feasibility Part|Progressive disease|0
931956|NCT00934856|1916932|FG000|Feasibility Part|Physician Decision|0
931957|NCT00934856|1916933|FG001|Feasibility Part|Physician Decision|0
931958|NCT00934856|1916934|FG002|Feasibility Part|Physician Decision|1
931959|NCT00934856|1916935|FG003|Feasibility Part|Physician Decision|0
931960|NCT00934856|1916936|FG004|Feasibility Part|Physician Decision|0
931961|NCT00934856|1916937|FG005|Feasibility Part|Physician Decision|0
931962|NCT00934856|1916932|FG000|Feasibility Part|Adverse Event|1
931963|NCT00934856|1916933|FG001|Feasibility Part|Adverse Event|1
931964|NCT00934856|1916934|FG002|Feasibility Part|Adverse Event|0
931965|NCT00934856|1916935|FG003|Feasibility Part|Adverse Event|1
931966|NCT00934856|1916936|FG004|Feasibility Part|Adverse Event|0
931967|NCT00934856|1916937|FG005|Feasibility Part|Adverse Event|2
931968|NCT00934856|1916932|FG000|Feasibility Part|Withdrawal by Subject|0
931969|NCT00934856|1916933|FG001|Feasibility Part|Withdrawal by Subject|0
931970|NCT00934856|1916934|FG002|Feasibility Part|Withdrawal by Subject|0
931971|NCT00934856|1916935|FG003|Feasibility Part|Withdrawal by Subject|1
931972|NCT00934856|1916936|FG004|Feasibility Part|Withdrawal by Subject|0
931973|NCT00934856|1916937|FG005|Feasibility Part|Withdrawal by Subject|1
931974|NCT00934856|1916932|FG000|Extension Part|Adverse Event|0
931975|NCT00934856|1916933|FG001|Extension Part|Adverse Event|0
931976|NCT00934856|1916934|FG002|Extension Part|Adverse Event|0
931977|NCT00934856|1916935|FG003|Extension Part|Adverse Event|1
931978|NCT00934856|1916936|FG004|Extension Part|Adverse Event|4
931979|NCT00934856|1916937|FG005|Extension Part|Adverse Event|4
931980|NCT00934856|1916932|FG000|Extension Part|Progressive disease|0
931981|NCT00934856|1916933|FG001|Extension Part|Progressive disease|0
931982|NCT00934856|1916934|FG002|Extension Part|Progressive disease|0
931983|NCT00934856|1916935|FG003|Extension Part|Progressive disease|1
931984|NCT00934856|1916936|FG004|Extension Part|Progressive disease|0
931985|NCT00934856|1916937|FG005|Extension Part|Progressive disease|0
931986|NCT00934856|1916932|FG000|Extension Part|Non-compliance with drug|0
931987|NCT00934856|1916933|FG001|Extension Part|Non-compliance with drug|0
931988|NCT00934856|1916934|FG002|Extension Part|Non-compliance with drug|0
931989|NCT00934856|1916935|FG003|Extension Part|Non-compliance with drug|0
931990|NCT00934856|1916936|FG004|Extension Part|Non-compliance with drug|0
931991|NCT00934856|1916937|FG005|Extension Part|Non-compliance with drug|1
931992|NCT00934947|1916990|FG000|Overall Study|Adverse Event|0
931993|NCT00934947|1916991|FG001|Overall Study|Adverse Event|2
931994|NCT00935012|1916999|FG000|Overall Study|Death|19
931995|NCT00935012|1916999|FG000|Overall Study|Withdrawal by Subject|3
931996|NCT00935012|1916999|FG000|Overall Study|Other|5
931997|NCT00935012|1916999|FG000|Overall Study|Adverse Event|2
931998|NCT00935220|1917012|FG000|Overall Study|Adverse Event|1
931999|NCT00935220|1917012|FG000|Overall Study|Other reason (not specified)|1
932000|NCT00935259|1917016|FG000|Period 1|Administrative (scheduling conflict)|1
932001|NCT00935259|1917017|FG001|Period 1|Administrative (scheduling conflict)|1
932002|NCT00935272|1917027|FG000|Overall Study|Lost to Follow-up|10
932003|NCT00935272|1917028|FG001|Overall Study|Lost to Follow-up|3
932004|NCT00935272|1917027|FG000|Overall Study|Withdrawal by Subject|8
932005|NCT00935272|1917028|FG001|Overall Study|Withdrawal by Subject|2
932006|NCT00935272|1917027|FG000|Overall Study|Physician Decision|1
932007|NCT00935272|1917028|FG001|Overall Study|Physician Decision|0
932008|NCT00935272|1917027|FG000|Overall Study|Protocol Violation|0
932009|NCT00935272|1917028|FG001|Overall Study|Protocol Violation|1
932010|NCT00935493|1917061|FG000|Overall Study|Lost to Follow-up|1
932011|NCT00935493|1917062|FG001|Overall Study|Lost to Follow-up|1
932012|NCT00935493|1917063|FG002|Overall Study|Lost to Follow-up|1
932013|NCT00935493|1917061|FG000|Overall Study|Treatment Discontinued|0
932014|NCT00935493|1917062|FG001|Overall Study|Treatment Discontinued|1
932015|NCT00935493|1917063|FG002|Overall Study|Treatment Discontinued|0
932016|NCT00935532|1917073|FG000|Overall Study|Adverse Event|11
932017|NCT00935532|1917074|FG001|Overall Study|Adverse Event|6
932018|NCT00935532|1917073|FG000|Overall Study|Death|1
932019|NCT00935532|1917074|FG001|Overall Study|Death|0
932020|NCT00935532|1917073|FG000|Overall Study|Lost to Follow-up|1
932021|NCT00935532|1917074|FG001|Overall Study|Lost to Follow-up|0
932022|NCT00935532|1917073|FG000|Overall Study|Physician Decision|1
932023|NCT00935532|1917074|FG001|Overall Study|Physician Decision|2
932024|NCT00935532|1917073|FG000|Overall Study|Protocol Violation|2
932025|NCT00935532|1917074|FG001|Overall Study|Protocol Violation|1
932026|NCT00935532|1917073|FG000|Overall Study|Subject Decision|2
932027|NCT00935532|1917074|FG001|Overall Study|Subject Decision|1
932028|NCT00935532|1917073|FG000|Overall Study|Sponsor Decision|0
932029|NCT00935532|1917074|FG001|Overall Study|Sponsor Decision|1
932030|NCT00935532|1917073|FG000|Overall Study|Loss Glucose Control|4
932031|NCT00935532|1917074|FG001|Overall Study|Loss Glucose Control|0
932032|NCT00935584|1917082|FG000|Overall Study|Withdrawal by Subject|9
932033|NCT00935584|1917083|FG001|Overall Study|Withdrawal by Subject|0
932034|NCT00935584|1917082|FG000|Overall Study|Death|3
932035|NCT00935584|1917083|FG001|Overall Study|Death|0
932036|NCT00935584|1917082|FG000|Overall Study|Lost to Follow-up|8
932037|NCT00935584|1917083|FG001|Overall Study|Lost to Follow-up|0
932038|NCT00935584|1917082|FG000|Overall Study|No show|9
932039|NCT00935584|1917083|FG001|Overall Study|No show|0
932040|NCT00935584|1917082|FG000|Overall Study|Relocated|3
932041|NCT00935584|1917083|FG001|Overall Study|Relocated|0
932042|NCT00935584|1917082|FG000|Overall Study|Patient changed provider|3
932043|NCT00935584|1917083|FG001|Overall Study|Patient changed provider|0
932044|NCT00935584|1917082|FG000|Overall Study|Provider dropped out of study|14
932045|NCT00935584|1917083|FG001|Overall Study|Provider dropped out of study|4
932046|NCT00935701|1917087|FG000|Overall Study|Failure to Transition to Acupuncture|1
932047|NCT00935818|1917118|FG000|Overall Study|Withdrawal by Subject|45
932048|NCT00935818|1917119|FG001|Overall Study|Withdrawal by Subject|50
932049|NCT00935818|1917118|FG000|Overall Study|Lost to Follow-up|40
932050|NCT00935818|1917119|FG001|Overall Study|Lost to Follow-up|42
932051|NCT00935818|1917118|FG000|Overall Study|Adverse Event|6
932052|NCT00935818|1917119|FG001|Overall Study|Adverse Event|7
932053|NCT00935818|1917118|FG000|Overall Study|Physician Decision|0
932054|NCT00935818|1917119|FG001|Overall Study|Physician Decision|1
932055|NCT00935883|1917136|FG000|Treatment Period|Physician Decision|1
932056|NCT00935883|1917137|FG001|Treatment Period|Physician Decision|0
932057|NCT00935883|1917136|FG000|Treatment Period|Withdrawal by Subject|0
932058|NCT00935883|1917137|FG001|Treatment Period|Withdrawal by Subject|2
932059|NCT00936065|1917146|FG000|Overall Study|Adverse Event|1
932060|NCT00936065|1917147|FG001|Overall Study|Adverse Event|0
932061|NCT00936065|1917148|FG002|Overall Study|Adverse Event|1
932062|NCT00936065|1917146|FG000|Overall Study|Lack of Efficacy|1
932063|NCT00936065|1917147|FG001|Overall Study|Lack of Efficacy|0
932064|NCT00936065|1917148|FG002|Overall Study|Lack of Efficacy|1
932065|NCT00936065|1917146|FG000|Overall Study|Lost to Follow-up|1
932066|NCT00936065|1917147|FG001|Overall Study|Lost to Follow-up|0
932067|NCT00936065|1917148|FG002|Overall Study|Lost to Follow-up|0
932068|NCT00936065|1917146|FG000|Overall Study|Protocol Violation|1
932069|NCT00936065|1917147|FG001|Overall Study|Protocol Violation|2
932070|NCT00936065|1917148|FG002|Overall Study|Protocol Violation|1
932071|NCT00936065|1917146|FG000|Overall Study|Withdrawal by Subject|0
932072|NCT00936065|1917147|FG001|Overall Study|Withdrawal by Subject|2
932073|NCT00936065|1917148|FG002|Overall Study|Withdrawal by Subject|4
932074|NCT00936117|1917156|FG000|Overall Study|Adverse Event|7
932075|NCT00936117|1917156|FG000|Overall Study|Unable to continue oral medication|3
932076|NCT00936208|1917163|FG000|Overall Study|Protocol Violation|37
932077|NCT00936208|1917164|FG001|Overall Study|Protocol Violation|22
932078|NCT00936221|1917172|FG000|Overall Study|Withdrawal by Subject|1
932079|NCT00936221|1917173|FG001|Overall Study|Withdrawal by Subject|1
932080|NCT00936611|1917236|FG000|Overall Study|Progressive Disease|3
932081|NCT00936611|1917236|FG000|Overall Study|New Systemic Therapy|22
932082|NCT00936611|1917236|FG000|Overall Study|Lost to Follow-up|1
932083|NCT00936611|1917236|FG000|Overall Study|Withdrawal by Subject|2
932084|NCT00936611|1917236|FG000|Overall Study|Still on Follow-up|1
932085|NCT00936611|1917236|FG000|Overall Study|Still on Active Therapy|7
932086|NCT00936611|1917236|FG000|Overall Study|Ineligible for Study Drug|3
932087|NCT00936702|1917249|FG000|Overall Study|Disease progression|34
932088|NCT00936702|1917249|FG000|Overall Study|Adverse Event|8
932089|NCT00936702|1917249|FG000|Overall Study|Withdrawal by Subject|2
932090|NCT00936702|1917249|FG000|Overall Study|Alternative Treatment|1
932091|NCT00936702|1917249|FG000|Overall Study|Other|1
932092|NCT00936715|1917253|FG000|Overall Study|Investigators Discretion|1
932093|NCT00936715|1917253|FG000|Overall Study|Protocol Violation|1
932094|NCT00936715|1917253|FG000|Overall Study|Safety or Tolerability Reasons|4
932095|NCT00936858|1917261|FG000|Overall Study|Death|3
932096|NCT00936858|1917261|FG000|Overall Study|Progression|29
932097|NCT00936858|1917261|FG000|Overall Study|Withdrawal by Subject|5
932098|NCT00936858|1917261|FG000|Overall Study|Adverse Event|1
932099|NCT00936858|1917261|FG000|Overall Study|Physician Decision|7
932100|NCT00936858|1917261|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4
932101|NCT00936858|1917261|FG000|Overall Study|Lost to Follow-up|1
932102|NCT00936884|1917268|FG000|Double-blind|Withdrawal by Subject|6
932103|NCT00936884|1917269|FG001|Double-blind|Withdrawal by Subject|4
932104|NCT00936884|1917270|FG002|Double-blind|Withdrawal by Subject|0
932105|NCT00936884|1917268|FG000|Double-blind|Death|2
932106|NCT00936884|1917269|FG001|Double-blind|Death|1
932107|NCT00936884|1917270|FG002|Double-blind|Death|0
932108|NCT00936884|1917268|FG000|Double-blind|Lack of Efficacy|1
932109|NCT00936884|1917269|FG001|Double-blind|Lack of Efficacy|1
932110|NCT00936884|1917270|FG002|Double-blind|Lack of Efficacy|0
932111|NCT00936884|1917268|FG000|Double-blind|Adverse Event|1
932112|NCT00936884|1917269|FG001|Double-blind|Adverse Event|0
932113|NCT00936884|1917270|FG002|Double-blind|Adverse Event|0
932114|NCT00936884|1917268|FG000|Double-blind|Physician Decision|1
932115|NCT00936884|1917269|FG001|Double-blind|Physician Decision|0
932116|NCT00936884|1917270|FG002|Double-blind|Physician Decision|0
932117|NCT00936884|1917268|FG000|Double-blind|No post baseline diary entry|1
932118|NCT00936884|1917269|FG001|Double-blind|No post baseline diary entry|0
932119|NCT00936884|1917270|FG002|Double-blind|No post baseline diary entry|0
932120|NCT00936884|1917268|FG000|Double-blind|Did not receive study drug|0
932121|NCT00936884|1917269|FG001|Double-blind|Did not receive study drug|1
932122|NCT00936884|1917270|FG002|Double-blind|Did not receive study drug|0
932123|NCT00936897|1917279|FG000|Overall Study|Withdrawal by Subject|9
932124|NCT00936897|1917280|FG001|Overall Study|Withdrawal by Subject|19
932125|NCT00936897|1917279|FG000|Overall Study|Adverse Event|4
932126|NCT00936897|1917280|FG001|Overall Study|Adverse Event|13
932127|NCT00936897|1917279|FG000|Overall Study|Other|3
932128|NCT00936897|1917280|FG001|Overall Study|Other|9
932129|NCT00936897|1917279|FG000|Overall Study|Lost to Follow-up|1
932130|NCT00936897|1917280|FG001|Overall Study|Lost to Follow-up|10
932131|NCT00936897|1917279|FG000|Overall Study|Administrative Decision|1
932132|NCT00936897|1917280|FG001|Overall Study|Administrative Decision|2
932133|NCT00936897|1917279|FG000|Overall Study|Protocol Violation|1
932134|NCT00936897|1917280|FG001|Overall Study|Protocol Violation|1
932135|NCT00936897|1917279|FG000|Overall Study|Ineligibility Determined|0
932136|NCT00936897|1917280|FG001|Overall Study|Ineligibility Determined|3
932137|NCT00936897|1917279|FG000|Overall Study|Noncompliance|0
932138|NCT00936897|1917280|FG001|Overall Study|Noncompliance|2
932139|NCT00936897|1917279|FG000|Overall Study|Death|0
932140|NCT00936897|1917280|FG001|Overall Study|Death|1
932141|NCT00936910|1917286|FG000|Overall Study|Lack of Efficacy|3
932142|NCT00936975|1917291|FG000|Overall Study|Withdrawal by Subject|1
932143|NCT00936975|1917291|FG000|Overall Study|Disease progression|3
932144|NCT00936975|1917291|FG000|Overall Study|Post-Tx scan uninterpretable|2
932145|NCT00937040|1917298|FG000|Overall Study|Adverse Event|5
932146|NCT00937040|1917299|FG001|Overall Study|Adverse Event|8
932147|NCT00937040|1917298|FG000|Overall Study|Lost to Follow-up|12
932148|NCT00937040|1917299|FG001|Overall Study|Lost to Follow-up|12
932149|NCT00937040|1917298|FG000|Overall Study|Protocol Violation|3
932150|NCT00937040|1917299|FG001|Overall Study|Protocol Violation|0
932151|NCT00937040|1917298|FG000|Overall Study|Withdrawal by Subject|13
932152|NCT00937040|1917299|FG001|Overall Study|Withdrawal by Subject|7
932153|NCT00937040|1917298|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
932154|NCT00937040|1917299|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
932155|NCT00937040|1917298|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
932156|NCT00937040|1917299|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
932157|NCT00937157|1917330|FG000|Overall Study|Pregnancy|1
932158|NCT00937157|1917330|FG000|Overall Study|Lost to Follow-up|3
932159|NCT00937326|1917348|FG000|Overall Study|Adverse Event|0
932160|NCT00937326|1917349|FG001|Overall Study|Adverse Event|3
932161|NCT00937326|1917350|FG002|Overall Study|Adverse Event|1
932162|NCT00937326|1917351|FG003|Overall Study|Adverse Event|1
932163|NCT00937326|1917352|FG004|Overall Study|Adverse Event|2
932164|NCT00937326|1917348|FG000|Overall Study|Death|0
932165|NCT00937326|1917349|FG001|Overall Study|Death|0
932166|NCT00937326|1917350|FG002|Overall Study|Death|1
932167|NCT00937326|1917351|FG003|Overall Study|Death|0
932168|NCT00937326|1917352|FG004|Overall Study|Death|0
932169|NCT00937326|1917348|FG000|Overall Study|Withdrawal by Subject|3
932170|NCT00937326|1917349|FG001|Overall Study|Withdrawal by Subject|4
932171|NCT00937326|1917350|FG002|Overall Study|Withdrawal by Subject|1
932172|NCT00937326|1917351|FG003|Overall Study|Withdrawal by Subject|4
932173|NCT00937326|1917352|FG004|Overall Study|Withdrawal by Subject|3
932174|NCT00937326|1917348|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0
932175|NCT00937326|1917349|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0
932176|NCT00937326|1917350|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1
932177|NCT00937326|1917351|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0
932178|NCT00937326|1917352|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0
932179|NCT00937391|1917380|FG000|Stage 2|Withdrawal by Subject|1
932180|NCT00937404|1917397|FG000|Overall Study|Protocol Violation|1
932181|NCT00937404|1917397|FG000|Overall Study|Withdrawal by Subject|1
932182|NCT00937495|1917401|FG000|Overall Study|Protocol Violation|2
932183|NCT00937521|1917413|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0
932184|NCT00937521|1917414|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0
932185|NCT00937521|1917415|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2
932186|NCT00937521|1917416|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0
932187|NCT00937521|1917417|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0
932188|NCT00937521|1917418|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0
932189|NCT00937521|1917419|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1
932190|NCT00937521|1917420|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0
932191|NCT00937521|1917413|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
932192|NCT00937521|1917414|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
932193|NCT00937521|1917415|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
932194|NCT00937521|1917416|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
932195|NCT00937521|1917417|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
932196|NCT00937521|1917418|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
932197|NCT00937521|1917419|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
932198|NCT00937521|1917420|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
932199|NCT00937521|1917413|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
932200|NCT00937521|1917414|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
932201|NCT00937521|1917415|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
932202|NCT00937521|1917416|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
932203|NCT00937521|1917417|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
932204|NCT00937521|1917418|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
932205|NCT00937521|1917419|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
932206|NCT00937521|1917420|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
932207|NCT00937521|1917413|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
932208|NCT00937521|1917414|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
932209|NCT00937521|1917415|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
932210|NCT00937521|1917416|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
932211|NCT00937521|1917417|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
932212|NCT00937521|1917418|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
932213|NCT00937521|1917419|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
932214|NCT00937521|1917420|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
932215|NCT00937521|1917413|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1
932216|NCT00937521|1917414|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0
932217|NCT00937521|1917415|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0
932218|NCT00937521|1917416|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0
932219|NCT00937521|1917417|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0
932220|NCT00937521|1917418|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0
932221|NCT00937521|1917419|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1
932222|NCT00937521|1917420|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0
932223|NCT00937521|1917413|FG000|Booster Phase|Adverse Event|0
932224|NCT00937521|1917414|FG001|Booster Phase|Adverse Event|0
932225|NCT00937521|1917415|FG002|Booster Phase|Adverse Event|0
932226|NCT00937521|1917416|FG003|Booster Phase|Adverse Event|0
932227|NCT00937521|1917417|FG004|Booster Phase|Adverse Event|0
932228|NCT00937521|1917418|FG005|Booster Phase|Adverse Event|0
932229|NCT00937521|1917419|FG006|Booster Phase|Adverse Event|1
932230|NCT00937521|1917420|FG007|Booster Phase|Adverse Event|0
932231|NCT00937521|1917413|FG000|Booster Phase|Withdrawal by Subject|1
932232|NCT00937521|1917414|FG001|Booster Phase|Withdrawal by Subject|0
932233|NCT00937521|1917415|FG002|Booster Phase|Withdrawal by Subject|0
932234|NCT00937521|1917416|FG003|Booster Phase|Withdrawal by Subject|1
932235|NCT00937521|1917417|FG004|Booster Phase|Withdrawal by Subject|0
932236|NCT00937521|1917418|FG005|Booster Phase|Withdrawal by Subject|0
932237|NCT00937521|1917419|FG006|Booster Phase|Withdrawal by Subject|0
932238|NCT00937521|1917420|FG007|Booster Phase|Withdrawal by Subject|2
932239|NCT00937521|1917413|FG000|Booster Phase|Lost to Follow-up|2
932240|NCT00937521|1917414|FG001|Booster Phase|Lost to Follow-up|2
932241|NCT00937521|1917415|FG002|Booster Phase|Lost to Follow-up|4
932242|NCT00937521|1917416|FG003|Booster Phase|Lost to Follow-up|2
932243|NCT00937521|1917417|FG004|Booster Phase|Lost to Follow-up|4
932244|NCT00937521|1917418|FG005|Booster Phase|Lost to Follow-up|4
932245|NCT00937521|1917419|FG006|Booster Phase|Lost to Follow-up|3
932246|NCT00937521|1917420|FG007|Booster Phase|Lost to Follow-up|0
932247|NCT00937521|1917413|FG000|Booster Phase|Administrative Reason|0
932248|NCT00937521|1917414|FG001|Booster Phase|Administrative Reason|0
932249|NCT00937521|1917415|FG002|Booster Phase|Administrative Reason|1
932250|NCT00937521|1917416|FG003|Booster Phase|Administrative Reason|0
932251|NCT00937521|1917417|FG004|Booster Phase|Administrative Reason|1
932252|NCT00937521|1917418|FG005|Booster Phase|Administrative Reason|1
932253|NCT00937521|1917419|FG006|Booster Phase|Administrative Reason|0
932254|NCT00937521|1917420|FG007|Booster Phase|Administrative Reason|0
932255|NCT00937521|1917413|FG000|Booster Phase|Protocol Deviation|0
932256|NCT00937521|1917414|FG001|Booster Phase|Protocol Deviation|0
932257|NCT00937521|1917415|FG002|Booster Phase|Protocol Deviation|0
932258|NCT00937521|1917416|FG003|Booster Phase|Protocol Deviation|0
932259|NCT00937521|1917417|FG004|Booster Phase|Protocol Deviation|0
932260|NCT00937521|1917418|FG005|Booster Phase|Protocol Deviation|0
932261|NCT00937521|1917419|FG006|Booster Phase|Protocol Deviation|1
932262|NCT00937521|1917420|FG007|Booster Phase|Protocol Deviation|0
932263|NCT00937547|1917456|FG000|Overall Study|misdiagnosis|1
932264|NCT00937547|1917457|FG001|Overall Study|misdiagnosis|6
932265|NCT00937547|1917458|FG002|Overall Study|misdiagnosis|7
932266|NCT00937560|1917466|FG000|Initial Treatment|Death|6
932267|NCT00937560|1917466|FG000|Initial Treatment|Withdraw consent|3
932268|NCT00937560|1917466|FG000|Initial Treatment|Adverse Event|1
932269|NCT00937560|1917466|FG000|Initial Treatment|Lost to Follow-up|1
932270|NCT00937560|1917466|FG000|Initial Treatment|No end of study page|10
932271|NCT00937560|1917466|FG000|Maintenance Treatment|Death|12
932272|NCT00937560|1917466|FG000|Maintenance Treatment|Withdraw consent|5
932273|NCT00937560|1917466|FG000|Maintenance Treatment|According to protocol|1
932274|NCT00937768|1917472|FG000|Overall Study|Refused Further Treatment|3
932275|NCT00937768|1917473|FG001|Overall Study|Refused Further Treatment|2
932276|NCT00937768|1917472|FG000|Overall Study|Disease Progression|1
932277|NCT00937768|1917473|FG001|Overall Study|Disease Progression|1
932278|NCT00937768|1917472|FG000|Overall Study|Alternate Treatment|0
932279|NCT00937768|1917473|FG001|Overall Study|Alternate Treatment|1
932280|NCT00937768|1917472|FG000|Overall Study|No Further Funding|4
932281|NCT00937768|1917473|FG001|Overall Study|No Further Funding|4
932282|NCT00937833|1917485|FG000|Overall Study|Protocol Violation|1
932283|NCT00937833|1917486|FG001|Overall Study|Protocol Violation|2
932284|NCT00937833|1917485|FG000|Overall Study|Procedure delayed; enrollment closed|0
932285|NCT00937833|1917486|FG001|Overall Study|Procedure delayed; enrollment closed|1
932286|NCT00937833|1917485|FG000|Overall Study|Lost to Follow-up|10
932287|NCT00937833|1917486|FG001|Overall Study|Lost to Follow-up|8
932288|NCT00937833|1917485|FG000|Overall Study|Withdrawal by Subject|4
932289|NCT00937833|1917486|FG001|Overall Study|Withdrawal by Subject|6
932290|NCT00937950|1917501|FG000|Overall Study|Withdrawal by Subject|23
932291|NCT00937950|1917501|FG000|Overall Study|Migrated/moved from study area|27
932292|NCT00937950|1917501|FG000|Overall Study|Lost to Follow-up|144
932293|NCT00937950|1917501|FG000|Overall Study|Missing confirmed|4
932294|NCT00937950|1917501|FG000|Overall Study|Other|18
932295|NCT00938015|1917505|FG000|Overall Study|Death|2
932296|NCT00938015|1917505|FG000|Overall Study|Lost to Follow-up|32
932297|NCT00938015|1917505|FG000|Overall Study|Adverse Event|32
932298|NCT00938015|1917505|FG000|Overall Study|Non-responder|52
932299|NCT00938015|1917505|FG000|Overall Study|Reason not related to Etanercept|29
932300|NCT00938041|1917509|FG000|Overall Study|Lost to Follow-up|6
932301|NCT00938041|1917509|FG000|Overall Study|Received Alternative Therapy|1
932302|NCT00938041|1917509|FG000|Overall Study|Progressive Disease|5
932303|NCT00938041|1917509|FG000|Overall Study|Death|12
932304|NCT00938041|1917509|FG000|Overall Study|Adrenal Insufficiency|3
932305|NCT00938327|1917530|FG000|Overall Study|Adverse Event|2
932306|NCT00938327|1917530|FG000|Overall Study|Protocol Violation|1
932307|NCT00938327|1917530|FG000|Overall Study|Withdrawal by Subject|4
932308|NCT00938327|1917530|FG000|Overall Study|Lost to Follow-up|37
932309|NCT00938327|1917530|FG000|Overall Study|2nd dose received outside of the study|7
932310|NCT00938327|1917530|FG000|Overall Study|Vaccine not received as out of stock|9
932311|NCT00938340|1917534|FG000|Overall Study|Withdrawal by Subject|3
932312|NCT00938340|1917534|FG000|Overall Study|Protocol Violation|1
932313|NCT00938340|1917534|FG000|Overall Study|Adverse Event|1
932314|NCT00938366|1917582|FG000|Overall Study|Withdrawal by Subject|1
932315|NCT00938366|1917583|FG001|Overall Study|Withdrawal by Subject|0
932316|NCT00938392|1917591|FG000|Overall Study|Adverse Event|0
932317|NCT00938392|1917592|FG001|Overall Study|Adverse Event|1
932318|NCT00938392|1917591|FG000|Overall Study|Withdrawal by Subject|0
932319|NCT00938392|1917592|FG001|Overall Study|Withdrawal by Subject|1
932320|NCT00938392|1917591|FG000|Overall Study|Lost to Follow-up|2
932321|NCT00938392|1917592|FG001|Overall Study|Lost to Follow-up|2
932322|NCT00938431|1917601|FG000|Overall Study|Adverse Event|5
932323|NCT00938431|1917602|FG001|Overall Study|Adverse Event|8
932324|NCT00938431|1917603|FG002|Overall Study|Adverse Event|6
932325|NCT00938431|1917601|FG000|Overall Study|Lack of Efficacy|0
932326|NCT00938431|1917602|FG001|Overall Study|Lack of Efficacy|1
932327|NCT00938431|1917603|FG002|Overall Study|Lack of Efficacy|0
932328|NCT00938431|1917601|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1
932329|NCT00938431|1917602|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0
932330|NCT00938431|1917603|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0
932331|NCT00938431|1917601|FG000|Overall Study|Dosing compliance issue|0
932332|NCT00938431|1917602|FG001|Overall Study|Dosing compliance issue|0
932333|NCT00938431|1917603|FG002|Overall Study|Dosing compliance issue|1
932334|NCT00938431|1917601|FG000|Overall Study|Reached maximum dose early|0
932335|NCT00938431|1917602|FG001|Overall Study|Reached maximum dose early|0
932336|NCT00938431|1917603|FG002|Overall Study|Reached maximum dose early|1
932337|NCT00938470|1917621|FG000|Overall Study|Disease Progression|3
932338|NCT00938470|1917622|FG001|Overall Study|Disease Progression|0
932339|NCT00938470|1917621|FG000|Overall Study|Alternate Treatment|1
932340|NCT00938470|1917622|FG001|Overall Study|Alternate Treatment|0
932341|NCT00938470|1917621|FG000|Overall Study|Death|3
932342|NCT00938470|1917622|FG001|Overall Study|Death|2
932343|NCT00938470|1917621|FG000|Overall Study|Other Reason|0
932344|NCT00938470|1917622|FG001|Overall Study|Other Reason|1
932345|NCT00938639|1917639|FG000|Overall Study|Moved away from study area|0
932346|NCT00938639|1917640|FG001|Overall Study|Moved away from study area|1
932347|NCT00938639|1917639|FG000|Overall Study|Lost to Follow-up|1
932348|NCT00938639|1917640|FG001|Overall Study|Lost to Follow-up|2
932349|NCT00938639|1917639|FG000|Overall Study|Family issues|1
932350|NCT00938639|1917640|FG001|Overall Study|Family issues|1
932351|NCT00938639|1917639|FG000|Overall Study|Participant noncompliance|1
932352|NCT00938639|1917640|FG001|Overall Study|Participant noncompliance|0
932353|NCT00938717|1917661|FG000|Overall Study|Adverse Event|10
932354|NCT00938717|1917662|FG001|Overall Study|Adverse Event|41
932355|NCT00938717|1917661|FG000|Overall Study|Protocol Violation|11
932356|NCT00938717|1917662|FG001|Overall Study|Protocol Violation|8
932357|NCT00938717|1917661|FG000|Overall Study|Withdrawal by Subject|26
932358|NCT00938717|1917662|FG001|Overall Study|Withdrawal by Subject|24
932359|NCT00938717|1917661|FG000|Overall Study|Lost to Follow-up|13
932360|NCT00938717|1917662|FG001|Overall Study|Lost to Follow-up|18
932361|NCT00938717|1917661|FG000|Overall Study|Lack of Efficacy|33
932362|NCT00938717|1917662|FG001|Overall Study|Lack of Efficacy|15
932363|NCT00938717|1917661|FG000|Overall Study|Other reason|5
932364|NCT00938717|1917662|FG001|Overall Study|Other reason|2
932365|NCT00938860|1917679|FG000|Overall Study|Adverse Event|2
932366|NCT00938860|1917680|FG001|Overall Study|Adverse Event|1
932367|NCT00938860|1917679|FG000|Overall Study|Abnormal laboratory values|2
932368|NCT00938860|1917680|FG001|Overall Study|Abnormal laboratory values|2
932369|NCT00938860|1917679|FG000|Overall Study|Withdrawal by Subject|11
932370|NCT00938860|1917680|FG001|Overall Study|Withdrawal by Subject|8
932371|NCT00938860|1917679|FG000|Overall Study|Lost to Follow-up|4
932372|NCT00938860|1917680|FG001|Overall Study|Lost to Follow-up|4
932373|NCT00938860|1917679|FG000|Overall Study|Administration problems|2
932374|NCT00938860|1917680|FG001|Overall Study|Administration problems|0
932375|NCT00938860|1917679|FG000|Overall Study|Death|1
932376|NCT00938860|1917680|FG001|Overall Study|Death|1
932377|NCT00938860|1917679|FG000|Overall Study|Protocol Violation|3
932378|NCT00938860|1917680|FG001|Overall Study|Protocol Violation|1
932379|NCT00938886|1917688|FG000|Overall Study|Death|0
932380|NCT00938886|1917689|FG001|Overall Study|Death|1
932381|NCT00938886|1917688|FG000|Overall Study|Withdrawal by Subject|4
932382|NCT00938886|1917689|FG001|Overall Study|Withdrawal by Subject|7
932383|NCT00938886|1917688|FG000|Overall Study|Lost to Follow-up|3
932384|NCT00938886|1917689|FG001|Overall Study|Lost to Follow-up|2
932385|NCT00938964|1917697|FG000|Overall Study|Death|3
932386|NCT00938964|1917698|FG001|Overall Study|Death|3
932387|NCT00938964|1917697|FG000|Overall Study|Lost to Follow-up|2
932388|NCT00938964|1917698|FG001|Overall Study|Lost to Follow-up|3
932389|NCT00938964|1917697|FG000|Overall Study|Withdrawal by Subject|22
932390|NCT00938964|1917698|FG001|Overall Study|Withdrawal by Subject|18
932391|NCT00938964|1917697|FG000|Overall Study|Found to Meet Exclusion Criteria|3
932392|NCT00938964|1917698|FG001|Overall Study|Found to Meet Exclusion Criteria|4
932393|NCT00939003|1917706|FG000|Double-blind Treatment Period|Adverse Event|1
932394|NCT00939003|1917707|FG001|Double-blind Treatment Period|Adverse Event|1
932395|NCT00939003|1917706|FG000|Double-blind Treatment Period|Lack of Efficacy|0
932396|NCT00939003|1917707|FG001|Double-blind Treatment Period|Lack of Efficacy|1
932397|NCT00939003|1917706|FG000|Double-blind Treatment Period|Pregnancy|0
932398|NCT00939003|1917707|FG001|Double-blind Treatment Period|Pregnancy|1
932399|NCT00939003|1917706|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1
932400|NCT00939003|1917707|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1
932401|NCT00939003|1917706|FG000|Open-label Treatment Period|Adverse Event|4
932402|NCT00939003|1917707|FG001|Open-label Treatment Period|Adverse Event|8
932403|NCT00939003|1917706|FG000|Open-label Treatment Period|Withdrawal by Subject|14
932404|NCT00939003|1917707|FG001|Open-label Treatment Period|Withdrawal by Subject|7
932405|NCT00939003|1917706|FG000|Open-label Treatment Period|Lack of Efficacy|6
932406|NCT00939003|1917707|FG001|Open-label Treatment Period|Lack of Efficacy|9
932407|NCT00939003|1917706|FG000|Open-label Treatment Period|Pregnancy|1
932408|NCT00939003|1917707|FG001|Open-label Treatment Period|Pregnancy|1
932409|NCT00939003|1917706|FG000|Open-label Treatment Period|Exclusion Criteria|1
932410|NCT00939003|1917707|FG001|Open-label Treatment Period|Exclusion Criteria|0
932411|NCT00939003|1917706|FG000|Open-label Treatment Period|Site Closure|3
932412|NCT00939003|1917707|FG001|Open-label Treatment Period|Site Closure|4
932413|NCT00939029|1917718|FG000|Overall Study|Withdrawal by Subject|3
932414|NCT00939029|1917719|FG001|Overall Study|Withdrawal by Subject|7
932415|NCT00939029|1917718|FG000|Overall Study|Lost to Follow-up|3
932416|NCT00939029|1917719|FG001|Overall Study|Lost to Follow-up|4
932417|NCT00939029|1917718|FG000|Overall Study|Adverse Event|0
932418|NCT00939029|1917719|FG001|Overall Study|Adverse Event|1
932419|NCT00939055|1917727|FG000|Overall Study|Discontinuation prior to procedure|4
932420|NCT00939055|1917728|FG001|Overall Study|Discontinuation prior to procedure|0
932421|NCT00939094|1917737|FG000|Overall Study|Adverse Event|9
932422|NCT00939094|1917738|FG001|Overall Study|Adverse Event|0
932423|NCT00939094|1917737|FG000|Overall Study|Withdrawal by Subject|1
932424|NCT00939094|1917738|FG001|Overall Study|Withdrawal by Subject|6
932425|NCT00939094|1917737|FG000|Overall Study|Lost to Follow-up|1
932426|NCT00939094|1917738|FG001|Overall Study|Lost to Follow-up|1
932427|NCT00939094|1917737|FG000|Overall Study|Eligibility criteria not fulfilled|2
932428|NCT00939094|1917738|FG001|Overall Study|Eligibility criteria not fulfilled|0
932429|NCT00939094|1917737|FG000|Overall Study|Severe non-compliance to protocol|0
932430|NCT00939094|1917738|FG001|Overall Study|Severe non-compliance to protocol|1
932431|NCT00939094|1917737|FG000|Overall Study|Study stopped by sponsor|0
932432|NCT00939094|1917738|FG001|Overall Study|Study stopped by sponsor|2
932433|NCT00939094|1917737|FG000|Overall Study|Abnormal ECG findings|1
932434|NCT00939094|1917738|FG001|Overall Study|Abnormal ECG findings|0
932435|NCT00939107|1917746|FG000|Overall Study|Lost to Follow-up|14
932436|NCT00939107|1917747|FG001|Overall Study|Lost to Follow-up|12
932437|NCT00939185|1917766|FG000|Overall Study|Adverse Event|3
932438|NCT00939185|1917766|FG000|Overall Study|Lack of Efficacy|1
932439|NCT00939185|1917766|FG000|Overall Study|Lost to Follow-up|6
932440|NCT00939185|1917766|FG000|Overall Study|Other|3
932441|NCT00939185|1917766|FG000|Overall Study|Withdrawal by Subject|2
932442|NCT00939185|1917766|FG000|Overall Study|Randomized But Did Not Receive Treatment|10
932443|NCT00939341|1917787|FG000|Overall Study|Adverse Event|15
932444|NCT00939341|1917787|FG000|Overall Study|Pregnancy|1
932445|NCT00939341|1917787|FG000|Overall Study|Lost to Follow-up|23
932446|NCT00939341|1917787|FG000|Overall Study|Withdrawal by Subject|13
932447|NCT00939341|1917787|FG000|Overall Study|Protocol Violation|6
932448|NCT00939341|1917787|FG000|Overall Study|Incorrect enrolment|8
932449|NCT00939393|1917800|FG000|Overall Study|Withdrawal by Subject|1
932450|NCT00939393|1917801|FG001|Overall Study|Withdrawal by Subject|0
932451|NCT00939393|1917800|FG000|Overall Study|Lost to Follow-up|3
932452|NCT00939393|1917801|FG001|Overall Study|Lost to Follow-up|0
932453|NCT00939484|1917816|FG000|Overall Study|Progression/Relapse|8
932454|NCT00939484|1917817|FG001|Overall Study|Progression/Relapse|20
932455|NCT00939484|1917818|FG002|Overall Study|Progression/Relapse|3
932456|NCT00939510|1917828|FG000|Overall Study|Withdrawal by Subject|1
932457|NCT00939523|1917832|FG000|Overall Study|Lack of Efficacy|1
932458|NCT00939523|1917832|FG000|Overall Study|Physician Decision|2
932459|NCT00939627|1917854|FG000|Overall Study|Disease Progression|16
932460|NCT00939627|1917855|FG001|Overall Study|Disease Progression|12
932461|NCT00939627|1917856|FG002|Overall Study|Disease Progression|0
932462|NCT00939627|1917854|FG000|Overall Study|Adverse Event|6
932463|NCT00939627|1917855|FG001|Overall Study|Adverse Event|7
932464|NCT00939627|1917856|FG002|Overall Study|Adverse Event|0
932465|NCT00939627|1917854|FG000|Overall Study|Death|0
932466|NCT00939627|1917855|FG001|Overall Study|Death|2
932467|NCT00939627|1917856|FG002|Overall Study|Death|0
932468|NCT00939627|1917854|FG000|Overall Study|Withdrawal by Subject|2
932469|NCT00939627|1917855|FG001|Overall Study|Withdrawal by Subject|4
932470|NCT00939627|1917856|FG002|Overall Study|Withdrawal by Subject|0
932471|NCT00939627|1917854|FG000|Overall Study|Other complicating disease|1
932472|NCT00939627|1917855|FG001|Overall Study|Other complicating disease|1
932473|NCT00939627|1917856|FG002|Overall Study|Other complicating disease|0
932474|NCT00939627|1917854|FG000|Overall Study|Not compliant|2
932475|NCT00939627|1917855|FG001|Overall Study|Not compliant|0
932476|NCT00939627|1917856|FG002|Overall Study|Not compliant|0
932477|NCT00939627|1917854|FG000|Overall Study|No off-tx reason given|0
932478|NCT00939627|1917855|FG001|Overall Study|No off-tx reason given|2
932479|NCT00939627|1917856|FG002|Overall Study|No off-tx reason given|0
932480|NCT00939640|1917862|FG000|Overall Study|Physician Decision|1
932481|NCT00939692|1917878|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
932482|NCT00939692|1917879|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
932483|NCT00939692|1917878|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
932484|NCT00939692|1917879|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
932485|NCT00939770|1917909|FG000|Overall Study|Adverse Event|1
932486|NCT00939770|1917910|FG001|Overall Study|Adverse Event|1
932487|NCT00939770|1917911|FG002|Overall Study|Adverse Event|0
932488|NCT00939770|1917912|FG003|Overall Study|Adverse Event|0
932489|NCT00939770|1917913|FG004|Overall Study|Adverse Event|6
932490|NCT00939770|1917914|FG005|Overall Study|Adverse Event|2
932491|NCT00939770|1917915|FG006|Overall Study|Adverse Event|1
932492|NCT00939770|1917916|FG007|Overall Study|Adverse Event|1
932493|NCT00939770|1917909|FG000|Overall Study|Lack of Efficacy|4
932494|NCT00939770|1917910|FG001|Overall Study|Lack of Efficacy|6
932495|NCT00939770|1917911|FG002|Overall Study|Lack of Efficacy|13
932496|NCT00939770|1917912|FG003|Overall Study|Lack of Efficacy|9
932497|NCT00939770|1917913|FG004|Overall Study|Lack of Efficacy|16
932498|NCT00939770|1917914|FG005|Overall Study|Lack of Efficacy|8
932499|NCT00939770|1917915|FG006|Overall Study|Lack of Efficacy|11
932500|NCT00939770|1917916|FG007|Overall Study|Lack of Efficacy|1
932501|NCT00939770|1917909|FG000|Overall Study|Lost to Follow-up|0
932502|NCT00939770|1917910|FG001|Overall Study|Lost to Follow-up|0
932503|NCT00939770|1917911|FG002|Overall Study|Lost to Follow-up|0
932504|NCT00939770|1917912|FG003|Overall Study|Lost to Follow-up|0
932505|NCT00939770|1917913|FG004|Overall Study|Lost to Follow-up|1
932506|NCT00939770|1917914|FG005|Overall Study|Lost to Follow-up|0
932507|NCT00939770|1917915|FG006|Overall Study|Lost to Follow-up|0
932508|NCT00939770|1917916|FG007|Overall Study|Lost to Follow-up|0
932509|NCT00939770|1917909|FG000|Overall Study|Physician Decision|0
932510|NCT00939770|1917910|FG001|Overall Study|Physician Decision|0
932511|NCT00939770|1917911|FG002|Overall Study|Physician Decision|2
932512|NCT00939770|1917912|FG003|Overall Study|Physician Decision|0
932513|NCT00939770|1917913|FG004|Overall Study|Physician Decision|7
932514|NCT00939770|1917914|FG005|Overall Study|Physician Decision|1
932515|NCT00939770|1917915|FG006|Overall Study|Physician Decision|0
932516|NCT00939770|1917916|FG007|Overall Study|Physician Decision|6
932517|NCT00939770|1917909|FG000|Overall Study|Protocol Violation|0
932518|NCT00939770|1917910|FG001|Overall Study|Protocol Violation|0
932519|NCT00939770|1917911|FG002|Overall Study|Protocol Violation|0
932520|NCT00939770|1917912|FG003|Overall Study|Protocol Violation|0
932521|NCT00939770|1917913|FG004|Overall Study|Protocol Violation|1
932522|NCT00939770|1917914|FG005|Overall Study|Protocol Violation|0
932523|NCT00939770|1917915|FG006|Overall Study|Protocol Violation|0
932524|NCT00939770|1917916|FG007|Overall Study|Protocol Violation|0
932525|NCT00939770|1917909|FG000|Overall Study|Withdrawal by Subject|0
932526|NCT00939770|1917910|FG001|Overall Study|Withdrawal by Subject|1
932527|NCT00939770|1917911|FG002|Overall Study|Withdrawal by Subject|5
932528|NCT00939770|1917912|FG003|Overall Study|Withdrawal by Subject|2
932529|NCT00939770|1917913|FG004|Overall Study|Withdrawal by Subject|6
932530|NCT00939770|1917914|FG005|Overall Study|Withdrawal by Subject|0
932531|NCT00939770|1917915|FG006|Overall Study|Withdrawal by Subject|2
932532|NCT00939770|1917916|FG007|Overall Study|Withdrawal by Subject|2
932533|NCT00939783|1917947|FG000|Overall Study|Death|6
932534|NCT00939783|1917947|FG000|Overall Study|Adverse Event|39
932535|NCT00939783|1917947|FG000|Overall Study|Study Terminated by Sponsor|498
932536|NCT00939783|1917947|FG000|Overall Study|Withdrawal by Subject|78
932537|NCT00939783|1917947|FG000|Overall Study|Other|16
932538|NCT00939783|1917947|FG000|Overall Study|Lost to Follow-up|8
932539|NCT00939783|1917947|FG000|Overall Study|Protocol Violation|3
932540|NCT00939783|1917947|FG000|Overall Study|Enrolled but not treated|1
932541|NCT00939809|1917955|FG000|Overall Study|Adverse Event|2
932542|NCT00939809|1917955|FG000|Overall Study|Death|1
932543|NCT00939822|1917961|FG000|Overall Study|Lost to Follow-up|1
932544|NCT00939822|1917962|FG001|Overall Study|Lost to Follow-up|0
932545|NCT00939822|1917961|FG000|Overall Study|withdrew from study due to busy schedule|1
932546|NCT00939822|1917962|FG001|Overall Study|withdrew from study due to busy schedule|1
932547|NCT00939822|1917961|FG000|Overall Study|Mental health issues|0
932548|NCT00939822|1917962|FG001|Overall Study|Mental health issues|2
932549|NCT00940017|1917994|FG000|Overall Study|did not meet entrance criteria|3
932550|NCT00940017|1917994|FG000|Overall Study|Adverse Event|1
932551|NCT00940108|1918002|FG000|Overall Study|Adverse Event|2
932552|NCT00940108|1918003|FG001|Overall Study|Adverse Event|4
932553|NCT00940108|1918004|FG002|Overall Study|Adverse Event|0
932554|NCT00940108|1918005|FG003|Overall Study|Adverse Event|2
932555|NCT00940108|1918002|FG000|Overall Study|Withdrew Consent|2
932556|NCT00940108|1918003|FG001|Overall Study|Withdrew Consent|1
932557|NCT00940108|1918004|FG002|Overall Study|Withdrew Consent|0
932558|NCT00940108|1918005|FG003|Overall Study|Withdrew Consent|1
932559|NCT00940108|1918002|FG000|Overall Study|Dose 2 contraindicated|1
932560|NCT00940108|1918003|FG001|Overall Study|Dose 2 contraindicated|1
932561|NCT00940108|1918004|FG002|Overall Study|Dose 2 contraindicated|0
932562|NCT00940108|1918005|FG003|Overall Study|Dose 2 contraindicated|1
932563|NCT00940108|1918002|FG000|Overall Study|Declined further vaccination|0
932564|NCT00940108|1918003|FG001|Overall Study|Declined further vaccination|1
932565|NCT00940108|1918004|FG002|Overall Study|Declined further vaccination|3
932566|NCT00940108|1918005|FG003|Overall Study|Declined further vaccination|0
932567|NCT00940108|1918002|FG000|Overall Study|Refused - pyrexia after Dose 1|0
932568|NCT00940108|1918003|FG001|Overall Study|Refused - pyrexia after Dose 1|1
932569|NCT00940108|1918004|FG002|Overall Study|Refused - pyrexia after Dose 1|0
932570|NCT00940108|1918005|FG003|Overall Study|Refused - pyrexia after Dose 1|0
932571|NCT00940108|1918002|FG000|Overall Study|Viral illness after Dose 1|0
932572|NCT00940108|1918003|FG001|Overall Study|Viral illness after Dose 1|1
932573|NCT00940108|1918004|FG002|Overall Study|Viral illness after Dose 1|0
932574|NCT00940108|1918005|FG003|Overall Study|Viral illness after Dose 1|0
932575|NCT00940108|1918002|FG000|Overall Study|Diagnosed with H1N1|0
932576|NCT00940108|1918003|FG001|Overall Study|Diagnosed with H1N1|0
932577|NCT00940108|1918004|FG002|Overall Study|Diagnosed with H1N1|0
932578|NCT00940108|1918005|FG003|Overall Study|Diagnosed with H1N1|1
932579|NCT00940316|1918035|FG000|Reached First Response at 8 Weeks|Adverse Event|2
932580|NCT00940316|1918036|FG001|Reached First Response at 8 Weeks|Adverse Event|1
932581|NCT00940316|1918037|FG002|Reached First Response at 8 Weeks|Adverse Event|0
932582|NCT00940316|1918035|FG000|Reached First Response at 8 Weeks|Progressive disease|1
932583|NCT00940316|1918036|FG001|Reached First Response at 8 Weeks|Progressive disease|3
932584|NCT00940316|1918037|FG002|Reached First Response at 8 Weeks|Progressive disease|0
932585|NCT00940316|1918035|FG000|Moved on to be Treated Cycle 5|Adverse Event|2
932586|NCT00940316|1918036|FG001|Moved on to be Treated Cycle 5|Adverse Event|0
932587|NCT00940316|1918037|FG002|Moved on to be Treated Cycle 5|Adverse Event|0
932588|NCT00940316|1918035|FG000|Treated After Cycle 5|Adverse Event|0
932589|NCT00940316|1918036|FG001|Treated After Cycle 5|Adverse Event|0
932590|NCT00940316|1918037|FG002|Treated After Cycle 5|Adverse Event|1
932591|NCT00940316|1918035|FG000|Treated After Cycle 5|Progressive disease|0
932592|NCT00940316|1918036|FG001|Treated After Cycle 5|Progressive disease|1
932593|NCT00940316|1918037|FG002|Treated After Cycle 5|Progressive disease|0
932594|NCT00940342|1918056|FG000|Overall Study|Adverse Event|0
932595|NCT00940342|1918057|FG001|Overall Study|Adverse Event|2
932596|NCT00940342|1918058|FG002|Overall Study|Adverse Event|1
932597|NCT00940485|1918079|FG000|Overall Study|HBeAb positive at Baseline|3
932598|NCT00940485|1918080|FG001|Overall Study|HBeAb positive at Baseline|2
932599|NCT00940485|1918079|FG000|Overall Study|Lost to Follow-up|2
932600|NCT00940485|1918080|FG001|Overall Study|Lost to Follow-up|3
932601|NCT00940485|1918079|FG000|Overall Study|Adverse Event|8
932602|NCT00940485|1918080|FG001|Overall Study|Adverse Event|0
932603|NCT00940485|1918079|FG000|Overall Study|Withdrawal by Subject|1
932604|NCT00940485|1918080|FG001|Overall Study|Withdrawal by Subject|1
932605|NCT00940485|1918079|FG000|Overall Study|Others|1
932606|NCT00940485|1918080|FG001|Overall Study|Others|1
932607|NCT00940602|1918154|FG000|Overall Study|Administrative problems|1
932608|NCT00940602|1918155|FG001|Overall Study|Administrative problems|1
932609|NCT00940602|1918154|FG000|Overall Study|Patient/guardian decision|13
932610|NCT00940602|1918155|FG001|Overall Study|Patient/guardian decision|28
932611|NCT00940602|1918154|FG000|Overall Study|Physician Decision|8
932612|NCT00940602|1918155|FG001|Overall Study|Physician Decision|5
932613|NCT00940602|1918154|FG000|Overall Study|Pregnancy|1
932614|NCT00940602|1918155|FG001|Overall Study|Pregnancy|0
932615|NCT00940602|1918154|FG000|Overall Study|Protocol Deviation (untreated)|1
932616|NCT00940602|1918155|FG001|Overall Study|Protocol Deviation (untreated)|0
932617|NCT00940602|1918154|FG000|Overall Study|Disease progression|8
932618|NCT00940602|1918155|FG001|Overall Study|Disease progression|2
932619|NCT00940602|1918154|FG000|Overall Study|Death|38
932620|NCT00940602|1918155|FG001|Overall Study|Death|19
932621|NCT00940602|1918154|FG000|Overall Study|Lost to Follow-up|3
932622|NCT00940602|1918155|FG001|Overall Study|Lost to Follow-up|1
932623|NCT00940602|1918154|FG000|Overall Study|Patient withdrew consent|26
932624|NCT00940602|1918155|FG001|Overall Study|Patient withdrew consent|13
932625|NCT00940602|1918154|FG000|Overall Study|Adverse Event|7
932626|NCT00940602|1918155|FG001|Overall Study|Adverse Event|2
932627|NCT00940602|1918154|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43
932628|NCT00940602|1918155|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5
932629|NCT00940823|1918168|FG000|Overall Study|Death|8
932630|NCT00940823|1918169|FG001|Overall Study|Death|12
932631|NCT00940823|1918168|FG000|Overall Study|Lost to Follow-up|27
932632|NCT00940823|1918169|FG001|Overall Study|Lost to Follow-up|20
932633|NCT00940875|1918179|FG000|Treatment Phase|Adverse Event|9
932634|NCT00940875|1918180|FG001|Treatment Phase|Adverse Event|3
932635|NCT00940875|1918179|FG000|Treatment Phase|Death|3
932636|NCT00940875|1918180|FG001|Treatment Phase|Death|5
932637|NCT00940875|1918179|FG000|Treatment Phase|Lack of Efficacy|1
932638|NCT00940875|1918180|FG001|Treatment Phase|Lack of Efficacy|0
932639|NCT00940875|1918179|FG000|Treatment Phase|Withdrawal by Subject|3
932640|NCT00940875|1918180|FG001|Treatment Phase|Withdrawal by Subject|0
932641|NCT00940875|1918179|FG000|Treatment Phase|Disease progression|9
932642|NCT00940875|1918180|FG001|Treatment Phase|Disease progression|11
932643|NCT00940875|1918179|FG000|Treatment Phase|Physician Decision|1
932644|NCT00940875|1918180|FG001|Treatment Phase|Physician Decision|0
932645|NCT00940875|1918179|FG000|Post-Study Treatment|Death|0
932646|NCT00940875|1918180|FG001|Post-Study Treatment|Death|1
932647|NCT00940875|1918179|FG000|Post-Study Treatment|Disease Progression|0
932648|NCT00940875|1918180|FG001|Post-Study Treatment|Disease Progression|2
932649|NCT00940888|1918187|FG000|Overall Study|Unsuccessful Implant|4
932650|NCT00940888|1918187|FG000|Overall Study|Death|461
932651|NCT00940888|1918187|FG000|Overall Study|Withdrawn - Non-Death|364
932652|NCT00940888|1918187|FG000|Overall Study|Lost to Follow-up|6
932653|NCT00940992|1918209|FG000|Overall Study|Adverse Event|2
932654|NCT00940992|1918210|FG001|Overall Study|Adverse Event|0
932655|NCT00940992|1918211|FG002|Overall Study|Adverse Event|1
932656|NCT00940992|1918209|FG000|Overall Study|subject request|2
932657|NCT00940992|1918210|FG001|Overall Study|subject request|1
932658|NCT00940992|1918211|FG002|Overall Study|subject request|0
932659|NCT00940992|1918209|FG000|Overall Study|Lost to Follow-up|0
932660|NCT00940992|1918210|FG001|Overall Study|Lost to Follow-up|1
932661|NCT00940992|1918211|FG002|Overall Study|Lost to Follow-up|1
932662|NCT00941031|1918234|FG000|Induction Period|Lack of Efficacy|2
932663|NCT00941031|1918235|FG001|Induction Period|Lack of Efficacy|1
932664|NCT00941031|1918236|FG002|Induction Period|Lack of Efficacy|0
932665|NCT00941031|1918237|FG003|Induction Period|Lack of Efficacy|5
932666|NCT00941031|1918238|FG004|Induction Period|Lack of Efficacy|0
932667|NCT00941031|1918239|FG005|Induction Period|Lack of Efficacy|0
932668|NCT00941031|1918240|FG006|Induction Period|Lack of Efficacy|0
932669|NCT00941031|1918234|FG000|Induction Period|Withdrawal by Subject|1
932670|NCT00941031|1918235|FG001|Induction Period|Withdrawal by Subject|2
932671|NCT00941031|1918236|FG002|Induction Period|Withdrawal by Subject|2
932672|NCT00941031|1918237|FG003|Induction Period|Withdrawal by Subject|2
932673|NCT00941031|1918238|FG004|Induction Period|Withdrawal by Subject|0
932674|NCT00941031|1918239|FG005|Induction Period|Withdrawal by Subject|0
932675|NCT00941031|1918240|FG006|Induction Period|Withdrawal by Subject|0
932676|NCT00941031|1918234|FG000|Induction Period|Adminstative Problems|1
932677|NCT00941031|1918235|FG001|Induction Period|Adminstative Problems|1
932678|NCT00941031|1918236|FG002|Induction Period|Adminstative Problems|1
932679|NCT00941031|1918237|FG003|Induction Period|Adminstative Problems|0
932680|NCT00941031|1918238|FG004|Induction Period|Adminstative Problems|0
932681|NCT00941031|1918239|FG005|Induction Period|Adminstative Problems|0
932682|NCT00941031|1918240|FG006|Induction Period|Adminstative Problems|0
932683|NCT00941031|1918234|FG000|Induction Period|Adverse Event|1
932684|NCT00941031|1918235|FG001|Induction Period|Adverse Event|0
932685|NCT00941031|1918236|FG002|Induction Period|Adverse Event|3
932686|NCT00941031|1918237|FG003|Induction Period|Adverse Event|2
932687|NCT00941031|1918238|FG004|Induction Period|Adverse Event|0
932688|NCT00941031|1918239|FG005|Induction Period|Adverse Event|0
932689|NCT00941031|1918240|FG006|Induction Period|Adverse Event|0
932690|NCT00941031|1918234|FG000|Maintenance Period|Withdrawal by Subject|0
932691|NCT00941031|1918235|FG001|Maintenance Period|Withdrawal by Subject|0
932692|NCT00941031|1918236|FG002|Maintenance Period|Withdrawal by Subject|0
932693|NCT00941031|1918237|FG003|Maintenance Period|Withdrawal by Subject|0
932694|NCT00941031|1918238|FG004|Maintenance Period|Withdrawal by Subject|6
932695|NCT00941031|1918239|FG005|Maintenance Period|Withdrawal by Subject|2
932696|NCT00941031|1918240|FG006|Maintenance Period|Withdrawal by Subject|13
932697|NCT00941031|1918234|FG000|Maintenance Period|Administrative Problems|0
932698|NCT00941031|1918235|FG001|Maintenance Period|Administrative Problems|0
932699|NCT00941031|1918236|FG002|Maintenance Period|Administrative Problems|0
932700|NCT00941031|1918237|FG003|Maintenance Period|Administrative Problems|0
932701|NCT00941031|1918238|FG004|Maintenance Period|Administrative Problems|1
932702|NCT00941031|1918239|FG005|Maintenance Period|Administrative Problems|0
932703|NCT00941031|1918240|FG006|Maintenance Period|Administrative Problems|1
932704|NCT00941031|1918234|FG000|Maintenance Period|Protocol Violation|0
932705|NCT00941031|1918235|FG001|Maintenance Period|Protocol Violation|0
932706|NCT00941031|1918236|FG002|Maintenance Period|Protocol Violation|0
932707|NCT00941031|1918237|FG003|Maintenance Period|Protocol Violation|0
932708|NCT00941031|1918238|FG004|Maintenance Period|Protocol Violation|0
932709|NCT00941031|1918239|FG005|Maintenance Period|Protocol Violation|0
932710|NCT00941031|1918240|FG006|Maintenance Period|Protocol Violation|1
932711|NCT00941031|1918234|FG000|Maintenance Period|Adverse Event|0
932712|NCT00941031|1918235|FG001|Maintenance Period|Adverse Event|0
932713|NCT00941031|1918236|FG002|Maintenance Period|Adverse Event|0
932714|NCT00941031|1918237|FG003|Maintenance Period|Adverse Event|0
932715|NCT00941031|1918238|FG004|Maintenance Period|Adverse Event|0
932716|NCT00941031|1918239|FG005|Maintenance Period|Adverse Event|2
932717|NCT00941031|1918240|FG006|Maintenance Period|Adverse Event|8
932718|NCT00941031|1918234|FG000|Maintenance Period|Lost to Follow-up|0
932719|NCT00941031|1918235|FG001|Maintenance Period|Lost to Follow-up|0
932720|NCT00941031|1918236|FG002|Maintenance Period|Lost to Follow-up|0
932721|NCT00941031|1918237|FG003|Maintenance Period|Lost to Follow-up|0
932722|NCT00941031|1918238|FG004|Maintenance Period|Lost to Follow-up|2
932723|NCT00941031|1918239|FG005|Maintenance Period|Lost to Follow-up|2
932724|NCT00941031|1918240|FG006|Maintenance Period|Lost to Follow-up|7
932725|NCT00941031|1918234|FG000|Maintenance Period|Lack of Efficacy|0
932726|NCT00941031|1918235|FG001|Maintenance Period|Lack of Efficacy|0
932727|NCT00941031|1918236|FG002|Maintenance Period|Lack of Efficacy|0
932728|NCT00941031|1918237|FG003|Maintenance Period|Lack of Efficacy|0
932729|NCT00941031|1918238|FG004|Maintenance Period|Lack of Efficacy|0
932730|NCT00941031|1918239|FG005|Maintenance Period|Lack of Efficacy|0
932731|NCT00941031|1918240|FG006|Maintenance Period|Lack of Efficacy|13
932732|NCT00941070|1918259|FG000|Overall Study|Patient non-compliant|1
932733|NCT00941304|1918270|FG000|Overall Study|Lost to Follow-up|1
932734|NCT00941304|1918271|FG001|Overall Study|Lost to Follow-up|0
932735|NCT00941304|1918272|FG002|Overall Study|Lost to Follow-up|0
932736|NCT00941304|1918273|FG003|Overall Study|Lost to Follow-up|0
932737|NCT00941304|1918274|FG004|Overall Study|Lost to Follow-up|0
932738|NCT00941330|1918288|FG000|Overall Study|Other|1
932739|NCT00941330|1918289|FG001|Overall Study|Other|0
932740|NCT00941330|1918288|FG000|Overall Study|Physician Decision|0
932741|NCT00941330|1918289|FG001|Overall Study|Physician Decision|2
932742|NCT00941603|1918301|FG000|Overall Study|Adverse Event|10
932743|NCT00941603|1918302|FG001|Overall Study|Adverse Event|15
932744|NCT00941603|1918303|FG002|Overall Study|Adverse Event|5
932745|NCT00941603|1918304|FG003|Overall Study|Adverse Event|1
932746|NCT00941603|1918305|FG004|Overall Study|Adverse Event|4
932747|NCT00941603|1918306|FG005|Overall Study|Adverse Event|0
932748|NCT00941603|1918301|FG000|Overall Study|Lost to Follow-up|0
932749|NCT00941603|1918302|FG001|Overall Study|Lost to Follow-up|0
932750|NCT00941603|1918303|FG002|Overall Study|Lost to Follow-up|0
932751|NCT00941603|1918304|FG003|Overall Study|Lost to Follow-up|1
932752|NCT00941603|1918305|FG004|Overall Study|Lost to Follow-up|0
932753|NCT00941603|1918306|FG005|Overall Study|Lost to Follow-up|2
932754|NCT00941603|1918301|FG000|Overall Study|Withdrawal by Subject|0
932755|NCT00941603|1918302|FG001|Overall Study|Withdrawal by Subject|0
932756|NCT00941603|1918303|FG002|Overall Study|Withdrawal by Subject|0
932757|NCT00941603|1918304|FG003|Overall Study|Withdrawal by Subject|2
932758|NCT00941603|1918305|FG004|Overall Study|Withdrawal by Subject|0
932759|NCT00941603|1918306|FG005|Overall Study|Withdrawal by Subject|1
932760|NCT00941603|1918301|FG000|Overall Study|Protocol Violation|0
932761|NCT00941603|1918302|FG001|Overall Study|Protocol Violation|1
932762|NCT00941603|1918303|FG002|Overall Study|Protocol Violation|0
932763|NCT00941603|1918304|FG003|Overall Study|Protocol Violation|0
932764|NCT00941603|1918305|FG004|Overall Study|Protocol Violation|0
932765|NCT00941603|1918306|FG005|Overall Study|Protocol Violation|0
932766|NCT00941603|1918301|FG000|Overall Study|Did not meet protocol eligibility|1
932767|NCT00941603|1918302|FG001|Overall Study|Did not meet protocol eligibility|0
932768|NCT00941603|1918303|FG002|Overall Study|Did not meet protocol eligibility|0
932769|NCT00941603|1918304|FG003|Overall Study|Did not meet protocol eligibility|0
932770|NCT00941603|1918305|FG004|Overall Study|Did not meet protocol eligibility|0
932771|NCT00941603|1918306|FG005|Overall Study|Did not meet protocol eligibility|0
932772|NCT00941655|1918322|FG000|Overall Study|received some chemo, 4 and 9 cycles|1
932773|NCT00941655|1918323|FG001|Overall Study|received some chemo, 4 and 9 cycles|0
932774|NCT00941655|1918322|FG000|Overall Study|not meet criteria for chemo foll surgery|4
932775|NCT00941655|1918323|FG001|Overall Study|not meet criteria for chemo foll surgery|0
932776|NCT00941655|1918322|FG000|Overall Study|progressed while on chemo|0
932777|NCT00941655|1918323|FG001|Overall Study|progressed while on chemo|2
932778|NCT00941655|1918322|FG000|Overall Study|refused further treatment|0
932779|NCT00941655|1918323|FG001|Overall Study|refused further treatment|1
932780|NCT00941655|1918322|FG000|Overall Study|withdrew consent|0
932781|NCT00941655|1918323|FG001|Overall Study|withdrew consent|1
932782|NCT00941655|1918322|FG000|Overall Study|non-compliant|0
932783|NCT00941655|1918323|FG001|Overall Study|non-compliant|1
932784|NCT00941720|1918352|FG000|Overall Study|Withdrawal by Subject|1
932785|NCT00941720|1918352|FG000|Overall Study|Insurance denied participation|11
932786|NCT00941720|1918352|FG000|Overall Study|ineligible|2
932787|NCT00941733|1918358|FG000|Overall Study|Death|24
932788|NCT00941733|1918359|FG001|Overall Study|Death|10
932789|NCT00941733|1918358|FG000|Overall Study|Withdrawal by Subject|14
932790|NCT00941733|1918359|FG001|Overall Study|Withdrawal by Subject|6
932791|NCT00941733|1918358|FG000|Overall Study|Adverse Event|20
932792|NCT00941733|1918359|FG001|Overall Study|Adverse Event|4
932793|NCT00941733|1918358|FG000|Overall Study|Lost to Follow-up|1
932794|NCT00941733|1918359|FG001|Overall Study|Lost to Follow-up|2
932795|NCT00941733|1918358|FG000|Overall Study|Protocol Violation|15
932796|NCT00941733|1918359|FG001|Overall Study|Protocol Violation|6
932797|NCT00941798|1918367|FG000|Overall Study|Withdrawal by Subject|72
932798|NCT00941798|1918368|FG001|Overall Study|Withdrawal by Subject|74
932799|NCT00941798|1918367|FG000|Overall Study|Adverse Event|43
932800|NCT00941798|1918368|FG001|Overall Study|Adverse Event|23
932801|NCT00941798|1918367|FG000|Overall Study|Lost to Follow-up|29
932802|NCT00941798|1918368|FG001|Overall Study|Lost to Follow-up|23
932803|NCT00941798|1918367|FG000|Overall Study|Protocol Violation|17
932804|NCT00941798|1918368|FG001|Overall Study|Protocol Violation|20
932805|NCT00941798|1918367|FG000|Overall Study|Administrative problems|13
932806|NCT00941798|1918368|FG001|Overall Study|Administrative problems|23
932807|NCT00941798|1918367|FG000|Overall Study|Lack of Efficacy|10
932808|NCT00941798|1918368|FG001|Overall Study|Lack of Efficacy|17
932809|NCT00941798|1918367|FG000|Overall Study|Patient's inability to use device|6
932810|NCT00941798|1918368|FG001|Overall Study|Patient's inability to use device|1
932811|NCT00941798|1918367|FG000|Overall Study|Abnormal test procedure results|3
932812|NCT00941798|1918368|FG001|Overall Study|Abnormal test procedure results|1
932813|NCT00941798|1918367|FG000|Overall Study|Abnormal laboratory values|1
932814|NCT00941798|1918368|FG001|Overall Study|Abnormal laboratory values|2
932815|NCT00941798|1918367|FG000|Overall Study|Death|0
932816|NCT00941798|1918368|FG001|Overall Study|Death|1
932817|NCT00941863|1918379|FG000|Until Primary Completion Date (PCD)|Adverse Event|1
932818|NCT00941863|1918380|FG001|Until Primary Completion Date (PCD)|Adverse Event|2
932819|NCT00941863|1918381|FG002|Until Primary Completion Date (PCD)|Adverse Event|2
932820|NCT00941863|1918382|FG003|Until Primary Completion Date (PCD)|Adverse Event|1
932821|NCT00941863|1918383|FG004|Until Primary Completion Date (PCD)|Adverse Event|5
932822|NCT00941863|1918379|FG000|Until Primary Completion Date (PCD)|Physician Decision|0
932823|NCT00941863|1918380|FG001|Until Primary Completion Date (PCD)|Physician Decision|0
932824|NCT00941863|1918381|FG002|Until Primary Completion Date (PCD)|Physician Decision|0
932825|NCT00941863|1918382|FG003|Until Primary Completion Date (PCD)|Physician Decision|0
932826|NCT00941863|1918383|FG004|Until Primary Completion Date (PCD)|Physician Decision|1
932827|NCT00941863|1918379|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
932828|NCT00941863|1918380|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
932829|NCT00941863|1918381|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
932830|NCT00941863|1918382|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
932831|NCT00941863|1918383|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
932832|NCT00941863|1918379|FG000|Until Primary Completion Date (PCD)|Death|0
932833|NCT00941863|1918380|FG001|Until Primary Completion Date (PCD)|Death|0
932834|NCT00941863|1918381|FG002|Until Primary Completion Date (PCD)|Death|1
932835|NCT00941863|1918382|FG003|Until Primary Completion Date (PCD)|Death|2
932836|NCT00941863|1918383|FG004|Until Primary Completion Date (PCD)|Death|7
932837|NCT00941863|1918379|FG000|Until Primary Completion Date (PCD)|Disease progression|6
932838|NCT00941863|1918380|FG001|Until Primary Completion Date (PCD)|Disease progression|1
932839|NCT00941863|1918381|FG002|Until Primary Completion Date (PCD)|Disease progression|8
932840|NCT00941863|1918382|FG003|Until Primary Completion Date (PCD)|Disease progression|14
932841|NCT00941863|1918383|FG004|Until Primary Completion Date (PCD)|Disease progression|73
932842|NCT00941863|1918379|FG000|Continued After PCD|Withdrawal by Subject|0
932843|NCT00941863|1918380|FG001|Continued After PCD|Withdrawal by Subject|0
932844|NCT00941863|1918381|FG002|Continued After PCD|Withdrawal by Subject|0
932845|NCT00941863|1918382|FG003|Continued After PCD|Withdrawal by Subject|0
932846|NCT00941863|1918383|FG004|Continued After PCD|Withdrawal by Subject|1
932847|NCT00941863|1918379|FG000|Continued After PCD|Disease progression, recurrence, relapse|0
932848|NCT00941863|1918380|FG001|Continued After PCD|Disease progression, recurrence, relapse|0
932849|NCT00941863|1918381|FG002|Continued After PCD|Disease progression, recurrence, relapse|0
932850|NCT00941863|1918382|FG003|Continued After PCD|Disease progression, recurrence, relapse|0
932851|NCT00941863|1918383|FG004|Continued After PCD|Disease progression, recurrence, relapse|18
932852|NCT00942084|1918413|FG000|Overall Study|Death|2
932853|NCT00942162|1918424|FG000|Overall Study|Death|45
932854|NCT00942162|1918425|FG001|Overall Study|Death|35
932855|NCT00942162|1918426|FG002|Overall Study|Death|0
932856|NCT00942162|1918424|FG000|Overall Study|Withdrawal by Subject|7
932857|NCT00942162|1918425|FG001|Overall Study|Withdrawal by Subject|2
932858|NCT00942162|1918426|FG002|Overall Study|Withdrawal by Subject|0
932859|NCT00942162|1918424|FG000|Overall Study|Lost to Follow-up|4
932860|NCT00942162|1918425|FG001|Overall Study|Lost to Follow-up|0
932861|NCT00942162|1918426|FG002|Overall Study|Lost to Follow-up|0
932862|NCT00942162|1918424|FG000|Overall Study|Other|14
932863|NCT00942162|1918425|FG001|Overall Study|Other|13
932864|NCT00942162|1918426|FG002|Overall Study|Other|2
932865|NCT00942175|1918440|FG000|Overall Study|Adverse Event|2
932866|NCT00942175|1918441|FG001|Overall Study|Adverse Event|1
932867|NCT00942175|1918442|FG002|Overall Study|Adverse Event|0
932868|NCT00942175|1918443|FG003|Overall Study|Adverse Event|0
932869|NCT00942175|1918440|FG000|Overall Study|Protocol Violation|0
932870|NCT00942175|1918441|FG001|Overall Study|Protocol Violation|1
932871|NCT00942175|1918442|FG002|Overall Study|Protocol Violation|2
932872|NCT00942175|1918443|FG003|Overall Study|Protocol Violation|0
932873|NCT00942175|1918440|FG000|Overall Study|Pregnancy|0
932874|NCT00942175|1918441|FG001|Overall Study|Pregnancy|0
932875|NCT00942175|1918442|FG002|Overall Study|Pregnancy|0
932876|NCT00942175|1918443|FG003|Overall Study|Pregnancy|1
932877|NCT00942175|1918440|FG000|Overall Study|Elevated Alanine Amino Transferase|0
932878|NCT00942175|1918441|FG001|Overall Study|Elevated Alanine Amino Transferase|0
932879|NCT00942175|1918442|FG002|Overall Study|Elevated Alanine Amino Transferase|0
932880|NCT00942175|1918443|FG003|Overall Study|Elevated Alanine Amino Transferase|1
932881|NCT00942175|1918440|FG000|Overall Study|Low Platelet Count|0
932882|NCT00942175|1918441|FG001|Overall Study|Low Platelet Count|2
932883|NCT00942175|1918442|FG002|Overall Study|Low Platelet Count|0
932884|NCT00942175|1918443|FG003|Overall Study|Low Platelet Count|0
932885|NCT00942188|1918465|FG000|Overall Study|Adverse Event|0
932886|NCT00942188|1918466|FG001|Overall Study|Adverse Event|3
932887|NCT00942188|1918467|FG002|Overall Study|Adverse Event|2
932888|NCT00942188|1918468|FG003|Overall Study|Adverse Event|0
932889|NCT00942188|1918465|FG000|Overall Study|Lack of Efficacy|0
932890|NCT00942188|1918466|FG001|Overall Study|Lack of Efficacy|0
932891|NCT00942188|1918467|FG002|Overall Study|Lack of Efficacy|0
932892|NCT00942188|1918468|FG003|Overall Study|Lack of Efficacy|1
932893|NCT00942188|1918465|FG000|Overall Study|Protocol Violation|1
932894|NCT00942188|1918466|FG001|Overall Study|Protocol Violation|1
932895|NCT00942188|1918467|FG002|Overall Study|Protocol Violation|0
932896|NCT00942188|1918468|FG003|Overall Study|Protocol Violation|0
932897|NCT00942188|1918465|FG000|Overall Study|Lost to Follow-up|2
932898|NCT00942188|1918466|FG001|Overall Study|Lost to Follow-up|1
932899|NCT00942188|1918467|FG002|Overall Study|Lost to Follow-up|2
932900|NCT00942188|1918468|FG003|Overall Study|Lost to Follow-up|0
932901|NCT00942188|1918465|FG000|Overall Study|Withdrawal by Subject|1
932902|NCT00942188|1918466|FG001|Overall Study|Withdrawal by Subject|3
932903|NCT00942188|1918467|FG002|Overall Study|Withdrawal by Subject|4
932904|NCT00942188|1918468|FG003|Overall Study|Withdrawal by Subject|2
932905|NCT00942188|1918465|FG000|Overall Study|Physician Decision|0
932906|NCT00942188|1918466|FG001|Overall Study|Physician Decision|0
932907|NCT00942188|1918467|FG002|Overall Study|Physician Decision|1
932908|NCT00942188|1918468|FG003|Overall Study|Physician Decision|0
932909|NCT00942188|1918465|FG000|Overall Study|Sponsor Decision|0
932910|NCT00942188|1918466|FG001|Overall Study|Sponsor Decision|2
932911|NCT00942188|1918467|FG002|Overall Study|Sponsor Decision|0
932912|NCT00942188|1918468|FG003|Overall Study|Sponsor Decision|1
932913|NCT00942266|1918480|FG000|Overall Study|Withdrawal by Subject|1
932914|NCT00942266|1918481|FG001|Overall Study|Withdrawal by Subject|0
932915|NCT00942266|1918480|FG000|Overall Study|Adverse Event|2
932916|NCT00942266|1918481|FG001|Overall Study|Adverse Event|1
932917|NCT00942266|1918480|FG000|Overall Study|Disease Progression|38
932918|NCT00942266|1918481|FG001|Overall Study|Disease Progression|11
932919|NCT00942266|1918480|FG000|Overall Study|Failure to thrive and pt withdrawal|0
932920|NCT00942266|1918481|FG001|Overall Study|Failure to thrive and pt withdrawal|1
932921|NCT00942266|1918480|FG000|Overall Study|Intercurrent illness|0
932922|NCT00942266|1918481|FG001|Overall Study|Intercurrent illness|1
932923|NCT00942266|1918480|FG000|Overall Study|Physician Decision|2
932924|NCT00942266|1918481|FG001|Overall Study|Physician Decision|0
932925|NCT00942266|1918480|FG000|Overall Study|medical deterioration (pneumonia)|0
932926|NCT00942266|1918481|FG001|Overall Study|medical deterioration (pneumonia)|1
932927|NCT00942331|1918530|FG000|Overall Study|Did not start treatment|15
932928|NCT00942331|1918531|FG001|Overall Study|Did not start treatment|22
932929|NCT00942357|1918539|FG000|Overall Study|Ineligible|37
932930|NCT00942357|1918540|FG001|Overall Study|Ineligible|40
932931|NCT00942422|1918546|FG000|Overall Study|Withdrawal by Subject|1
932932|NCT00942422|1918546|FG000|Overall Study|Death|1
932933|NCT00942422|1918546|FG000|Overall Study|Progressive diease|1
932934|NCT00942604|1918591|FG000|Overall Study|Protocol Violation|1
932935|NCT00942604|1918592|FG001|Overall Study|Protocol Violation|1
932936|NCT00942604|1918591|FG000|Overall Study|Adverse Event|0
932937|NCT00942604|1918592|FG001|Overall Study|Adverse Event|1
932938|NCT00942604|1918591|FG000|Overall Study|Withdrawal by Subject|0
932939|NCT00942604|1918592|FG001|Overall Study|Withdrawal by Subject|1
932940|NCT00942604|1918591|FG000|Overall Study|Patient relocation|1
932941|NCT00942604|1918592|FG001|Overall Study|Patient relocation|1
932942|NCT00942708|1918598|FG000|Overall Study|Withdrawal by Subject|1
932943|NCT00942734|1918603|FG000|Overall Study|Adverse Event|2
932944|NCT00942734|1918603|FG000|Overall Study|Protocol Violation|3
932945|NCT00942734|1918603|FG000|Overall Study|Disease Progression|2
932946|NCT00942734|1918603|FG000|Overall Study|Physician Decision|1
932947|NCT00942877|1918638|FG000|Overall Study|Refused further treatment|1
932948|NCT00942877|1918639|FG001|Overall Study|Refused further treatment|1
932949|NCT00942877|1918638|FG000|Overall Study|Patient was not treated|1
932950|NCT00942877|1918639|FG001|Overall Study|Patient was not treated|0
932951|NCT00942877|1918638|FG000|Overall Study|Adverse Event|1
932952|NCT00942877|1918639|FG001|Overall Study|Adverse Event|0
932953|NCT00942877|1918638|FG000|Overall Study|Progressive disease|42
932954|NCT00942877|1918639|FG001|Overall Study|Progressive disease|3
932955|NCT00942968|1918660|FG000|Overall Study|Adverse Event|60
932956|NCT00942968|1918660|FG000|Overall Study|Death|76
932957|NCT00942968|1918660|FG000|Overall Study|Protocol Violation|9
932958|NCT00942968|1918660|FG000|Overall Study|Lost to Follow-up|4
932959|NCT00942968|1918660|FG000|Overall Study|Withdrawal by Subject|44
932960|NCT00942968|1918660|FG000|Overall Study|Sponsor request|5
932961|NCT00942968|1918660|FG000|Overall Study|Physician Decision|11
932962|NCT00942968|1918660|FG000|Overall Study|Progression of disease|12
932963|NCT00942968|1918660|FG000|Overall Study|Inferior vena cava filter placement|4
932964|NCT00942968|1918660|FG000|Overall Study|Pulmonary embolism (PE)|1
932965|NCT00942968|1918660|FG000|Overall Study|Participant required pancreatic biopsy|1
932966|NCT00942968|1918660|FG000|Overall Study|Deep vein thrombosis (DVT)|2
932967|NCT00942994|1918666|FG000|Overall Study|Adverse Event|7
932968|NCT00942994|1918667|FG001|Overall Study|Adverse Event|4
932969|NCT00942994|1918666|FG000|Overall Study|Abnormal laboratory value(s)|1
932970|NCT00942994|1918667|FG001|Overall Study|Abnormal laboratory value(s)|0
932971|NCT00942994|1918666|FG000|Overall Study|Unsatisfactory therapeutic effect|1
932972|NCT00942994|1918667|FG001|Overall Study|Unsatisfactory therapeutic effect|1
932973|NCT00942994|1918666|FG000|Overall Study|Patient withdrew consent|5
932974|NCT00942994|1918667|FG001|Overall Study|Patient withdrew consent|8
932975|NCT00942994|1918666|FG000|Overall Study|Lost to Follow-up|1
932976|NCT00942994|1918667|FG001|Overall Study|Lost to Follow-up|4
932977|NCT00942994|1918666|FG000|Overall Study|Protocol deviation|1
932978|NCT00942994|1918667|FG001|Overall Study|Protocol deviation|2
932979|NCT00943072|1918675|FG000|Overall Study|Adverse Event|0
932980|NCT00943072|1918676|FG001|Overall Study|Adverse Event|3
932981|NCT00943072|1918675|FG000|Overall Study|Death|0
932982|NCT00943072|1918676|FG001|Overall Study|Death|2
932983|NCT00943072|1918675|FG000|Overall Study|Withdrawal by Subject|3
932984|NCT00943072|1918676|FG001|Overall Study|Withdrawal by Subject|1
932985|NCT00943072|1918675|FG000|Overall Study|Protocol Violation|0
932986|NCT00943072|1918676|FG001|Overall Study|Protocol Violation|1
932987|NCT00943072|1918675|FG000|Overall Study|Lost to Follow-up|1
932988|NCT00943072|1918676|FG001|Overall Study|Lost to Follow-up|2
932989|NCT00943072|1918675|FG000|Overall Study|Lack of Efficacy|0
932990|NCT00943072|1918676|FG001|Overall Study|Lack of Efficacy|4
932991|NCT00943072|1918675|FG000|Overall Study|Other|1
932992|NCT00943072|1918676|FG001|Overall Study|Other|1
932993|NCT00943111|1918695|FG000|52-Weeks Primary Analysis Period|Adverse Event|2
932994|NCT00943111|1918696|FG001|52-Weeks Primary Analysis Period|Adverse Event|1
932995|NCT00943111|1918697|FG002|52-Weeks Primary Analysis Period|Adverse Event|0
932996|NCT00943111|1918695|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
932997|NCT00943111|1918696|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
932998|NCT00943111|1918697|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
932999|NCT00943111|1918695|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
933000|NCT00943111|1918696|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
933001|NCT00943111|1918697|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
933002|NCT00943111|1918695|FG000|5 Years Long-term Treatment Period|Adverse Event|0
933003|NCT00943111|1918696|FG001|5 Years Long-term Treatment Period|Adverse Event|0
933004|NCT00943111|1918697|FG002|5 Years Long-term Treatment Period|Adverse Event|9
933005|NCT00943111|1918695|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0
933006|NCT00943111|1918696|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0
933007|NCT00943111|1918697|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8
933008|NCT00943111|1918695|FG000|5 Years Long-term Treatment Period|Pregnancy|0
933009|NCT00943111|1918696|FG001|5 Years Long-term Treatment Period|Pregnancy|0
933010|NCT00943111|1918697|FG002|5 Years Long-term Treatment Period|Pregnancy|4
933011|NCT00943111|1918695|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0
933012|NCT00943111|1918696|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0
933013|NCT00943111|1918697|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1
933014|NCT00943111|1918695|FG000|5 Years Long-term Treatment Period|Other than specified above|0
933015|NCT00943111|1918696|FG001|5 Years Long-term Treatment Period|Other than specified above|0
933016|NCT00943111|1918697|FG002|5 Years Long-term Treatment Period|Other than specified above|2
933017|NCT00943124|1918704|FG000|Period 1|Withdrawal by Subject|1
933018|NCT00943124|1918705|FG001|Period 1|Withdrawal by Subject|1
933019|NCT00943124|1918704|FG000|Period 1|Did Not Follow Study Procedures|1
933020|NCT00943124|1918705|FG001|Period 1|Did Not Follow Study Procedures|0
933021|NCT00943124|1918704|FG000|Period 1|Personal Reasons|0
933022|NCT00943124|1918705|FG001|Period 1|Personal Reasons|1
933023|NCT00943306|1918742|FG000|Overall Study|Physician Decision|1
933024|NCT00943306|1918742|FG000|Overall Study|Death|1
933025|NCT00943306|1918742|FG000|Overall Study|Sponsor decision due to non-compliance|1
933026|NCT00943319|1918746|FG000|Overall Study|Death|1
933027|NCT00943384|1918750|FG000|Overall Study|Dispositioned prior to treatment|23
933028|NCT00943384|1918750|FG000|Overall Study|Treated off protocol-protocol violation|5
933029|NCT00943384|1918750|FG000|Overall Study|Lost to Follow-up|16
933030|NCT00943384|1918750|FG000|Overall Study|Withdrawal by Subject|5
933031|NCT00943397|1918756|FG000|Overall Study|Adverse Event|0
933032|NCT00943397|1918757|FG001|Overall Study|Adverse Event|6
933033|NCT00943397|1918756|FG000|Overall Study|Lost to Follow-up|0
933034|NCT00943397|1918757|FG001|Overall Study|Lost to Follow-up|4
933035|NCT00943397|1918756|FG000|Overall Study|Protocol Violation|2
933036|NCT00943397|1918757|FG001|Overall Study|Protocol Violation|5
933037|NCT00943397|1918756|FG000|Overall Study|Withdrawal by Subject|1
933038|NCT00943397|1918757|FG001|Overall Study|Withdrawal by Subject|1
933039|NCT00943397|1918756|FG000|Overall Study|Site terminated and other|12
933040|NCT00943397|1918757|FG001|Overall Study|Site terminated and other|56
933041|NCT00943579|1918783|FG000|Overall Study|Adverse Event|4
933042|NCT00943579|1918784|FG001|Overall Study|Adverse Event|3
933043|NCT00943579|1918783|FG000|Overall Study|Lack of Efficacy|2
933044|NCT00943579|1918784|FG001|Overall Study|Lack of Efficacy|2
933045|NCT00943592|1918793|FG000|Overall Study|Death|3
933052|NCT00943670|1918819|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2
933053|NCT00943670|1918819|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
933054|NCT00943670|1918819|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15
933055|NCT00943670|1918819|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2
933056|NCT00943670|1918819|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20
933057|NCT00943670|1918819|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
933058|NCT00943670|1918819|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
933059|NCT00943670|1918819|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
933060|NCT00943670|1918819|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
933061|NCT00943670|1918819|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
933062|NCT00943683|1918836|FG000|Overall Study|Adverse Event|3
933063|NCT00943683|1918837|FG001|Overall Study|Adverse Event|3
933064|NCT00943683|1918836|FG000|Overall Study|Lost to Follow-up|1
933065|NCT00943683|1918837|FG001|Overall Study|Lost to Follow-up|1
933066|NCT00943683|1918836|FG000|Overall Study|Protocol Violation|1
933067|NCT00943683|1918837|FG001|Overall Study|Protocol Violation|2
933068|NCT00943683|1918836|FG000|Overall Study|Withdrawal by Subject|1
933069|NCT00943683|1918837|FG001|Overall Study|Withdrawal by Subject|0
933070|NCT00943683|1918836|FG000|Overall Study|Patient Moved|1
933071|NCT00943683|1918837|FG001|Overall Study|Patient Moved|0
933072|NCT00943722|1918848|FG000|Overall Study|Adverse Event|0
933073|NCT00943722|1918849|FG001|Overall Study|Adverse Event|0
933074|NCT00943722|1918850|FG002|Overall Study|Adverse Event|0
933075|NCT00943722|1918851|FG003|Overall Study|Adverse Event|1
933076|NCT00943722|1918852|FG004|Overall Study|Adverse Event|0
933077|NCT00943722|1918848|FG000|Overall Study|Lost to Follow-up|12
933078|NCT00943722|1918849|FG001|Overall Study|Lost to Follow-up|8
933079|NCT00943722|1918850|FG002|Overall Study|Lost to Follow-up|10
933080|NCT00943722|1918851|FG003|Overall Study|Lost to Follow-up|8
933081|NCT00943722|1918852|FG004|Overall Study|Lost to Follow-up|11
933082|NCT00943722|1918848|FG000|Overall Study|Physician Decision|1
933083|NCT00943722|1918849|FG001|Overall Study|Physician Decision|0
933084|NCT00943722|1918850|FG002|Overall Study|Physician Decision|0
933085|NCT00943722|1918851|FG003|Overall Study|Physician Decision|0
933086|NCT00943722|1918852|FG004|Overall Study|Physician Decision|1
933087|NCT00943722|1918848|FG000|Overall Study|Pregnancy|0
933088|NCT00943722|1918849|FG001|Overall Study|Pregnancy|0
933089|NCT00943722|1918850|FG002|Overall Study|Pregnancy|1
933090|NCT00943722|1918851|FG003|Overall Study|Pregnancy|0
933091|NCT00943722|1918852|FG004|Overall Study|Pregnancy|0
933092|NCT00943722|1918848|FG000|Overall Study|Protocol Violation|0
933093|NCT00943722|1918849|FG001|Overall Study|Protocol Violation|1
933094|NCT00943722|1918850|FG002|Overall Study|Protocol Violation|0
933095|NCT00943722|1918851|FG003|Overall Study|Protocol Violation|0
933096|NCT00943722|1918852|FG004|Overall Study|Protocol Violation|2
933097|NCT00943722|1918848|FG000|Overall Study|Withdrawal by Subject|12
933098|NCT00943722|1918849|FG001|Overall Study|Withdrawal by Subject|13
933099|NCT00943722|1918850|FG002|Overall Study|Withdrawal by Subject|2
933100|NCT00943722|1918851|FG003|Overall Study|Withdrawal by Subject|13
933101|NCT00943722|1918852|FG004|Overall Study|Withdrawal by Subject|8
933102|NCT00943735|1918866|FG000|Overall Study|Adverse Event|12
933103|NCT00943735|1918866|FG000|Overall Study|Withdrawal by Subject|8
933104|NCT00943735|1918866|FG000|Overall Study|Death|1
933105|NCT00943735|1918866|FG000|Overall Study|Other|8
933106|NCT00943735|1918866|FG000|Overall Study|Other|3
933107|NCT00943761|1918872|FG000|Overall Study|Lost to Follow-up|2
933108|NCT00943761|1918873|FG001|Overall Study|Lost to Follow-up|0
933109|NCT00943761|1918872|FG000|Overall Study|Withdrawal by Subject|2
933110|NCT00943761|1918873|FG001|Overall Study|Withdrawal by Subject|1
933111|NCT00943787|1918879|FG000|Overall Study|Physician Decision|4
933112|NCT00943787|1918879|FG000|Overall Study|Withdrawal by Subject|3
933113|NCT00943826|1918889|FG000|Concurrent Phase|Adverse Event|50
933114|NCT00943826|1918890|FG001|Concurrent Phase|Adverse Event|27
933115|NCT00943826|1918889|FG000|Concurrent Phase|Withdrew consent|3
933116|NCT00943826|1918890|FG001|Concurrent Phase|Withdrew consent|7
933117|NCT00943826|1918889|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5
933118|NCT00943826|1918890|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7
933119|NCT00943826|1918889|FG000|Concurrent Phase|Administrative reasons|2
933120|NCT00943826|1918890|FG001|Concurrent Phase|Administrative reasons|1
933121|NCT00943826|1918889|FG000|Concurrent Phase|Protocol Violation|1
933122|NCT00943826|1918890|FG001|Concurrent Phase|Protocol Violation|0
933123|NCT00943826|1918889|FG000|Maintenance Phase|Adverse Event|31
933124|NCT00943826|1918890|FG001|Maintenance Phase|Adverse Event|30
933125|NCT00943826|1918889|FG000|Maintenance Phase|Withdrew consent|2
933126|NCT00943826|1918890|FG001|Maintenance Phase|Withdrew consent|4
933127|NCT00943826|1918889|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6
933128|NCT00943826|1918890|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3
933129|NCT00943826|1918889|FG000|Maintenance Phase|Administrative reasons|4
933130|NCT00943826|1918890|FG001|Maintenance Phase|Administrative reasons|1
933131|NCT00943826|1918889|FG000|Maintenance Phase|Failure to return|0
933132|NCT00943826|1918890|FG001|Maintenance Phase|Failure to return|1
933133|NCT00943826|1918889|FG000|Monotherapy Phase|Adverse Event|42
933134|NCT00943826|1918890|FG001|Monotherapy Phase|Adverse Event|5
933135|NCT00943826|1918889|FG000|Monotherapy Phase|Administrative reasons|11
933136|NCT00943826|1918890|FG001|Monotherapy Phase|Administrative reasons|5
933137|NCT00943826|1918889|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8
933138|NCT00943826|1918890|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2
933139|NCT00943826|1918889|FG000|Monotherapy Phase|Withdrew Consent|2
933140|NCT00943826|1918890|FG001|Monotherapy Phase|Withdrew Consent|3
933141|NCT00943826|1918889|FG000|Monotherapy Phase|Failure to return|2
933142|NCT00943826|1918890|FG001|Monotherapy Phase|Failure to return|1
933143|NCT00943826|1918889|FG000|After Primary Overall Survival Analysis|Adverse Event|11
933144|NCT00943826|1918890|FG001|After Primary Overall Survival Analysis|Adverse Event|0
933145|NCT00943826|1918889|FG000|After Primary Overall Survival Analysis|Administrative reasons|10
933146|NCT00943826|1918890|FG001|After Primary Overall Survival Analysis|Administrative reasons|16
933147|NCT00943826|1918889|FG000|After Primary Overall Survival Analysis|Progression of Disease|2
933148|NCT00943826|1918890|FG001|After Primary Overall Survival Analysis|Progression of Disease|4
933149|NCT00943826|1918889|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4
933150|NCT00943826|1918890|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0
933151|NCT00943852|1918897|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
933152|NCT00943852|1918898|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
933153|NCT00943852|1918899|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
933154|NCT00943852|1918900|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
933155|NCT00943852|1918901|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
933156|NCT00943852|1918902|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
933157|NCT00943852|1918903|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
933158|NCT00943852|1918904|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
933159|NCT00943852|1918905|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
933160|NCT00943852|1918906|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
933161|NCT00943852|1918897|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0
933162|NCT00943852|1918898|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0
933163|NCT00943852|1918899|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0
933164|NCT00943852|1918900|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0
933165|NCT00943852|1918901|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0
933166|NCT00943852|1918902|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1
933167|NCT00943852|1918903|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0
933168|NCT00943852|1918904|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0
933169|NCT00943852|1918905|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0
933170|NCT00943852|1918906|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0
933171|NCT00943852|1918897|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
933172|NCT00943852|1918898|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
933173|NCT00943852|1918899|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
933174|NCT00943852|1918900|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
933175|NCT00943852|1918901|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
933176|NCT00943852|1918902|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
933177|NCT00943852|1918903|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
933178|NCT00943852|1918904|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
933179|NCT00943852|1918905|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
933180|NCT00943852|1918906|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
933181|NCT00943852|1918897|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
933182|NCT00943852|1918898|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
933183|NCT00943852|1918899|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
933184|NCT00943852|1918900|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
933185|NCT00943852|1918901|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
933186|NCT00943852|1918902|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
933187|NCT00943852|1918903|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
933188|NCT00943852|1918904|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
933189|NCT00943852|1918905|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
933190|NCT00943852|1918906|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
933191|NCT00943852|1918897|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1
933192|NCT00943852|1918898|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0
933193|NCT00943852|1918899|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1
933194|NCT00943852|1918900|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1
933195|NCT00943852|1918901|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0
933196|NCT00943852|1918902|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0
933197|NCT00943852|1918903|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1
933198|NCT00943852|1918904|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0
933199|NCT00943852|1918905|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0
933200|NCT00943852|1918906|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0
933201|NCT00943917|1918952|FG000|Stage I|Adverse Event|1
933202|NCT00943917|1918953|FG001|Stage I|Adverse Event|2
933203|NCT00943917|1918954|FG002|Stage I|Adverse Event|2
933204|NCT00943917|1918955|FG003|Stage I|Adverse Event|0
933205|NCT00943917|1918956|FG004|Stage I|Adverse Event|0
933206|NCT00943917|1918957|FG005|Stage I|Adverse Event|0
933207|NCT00943917|1918958|FG006|Stage I|Adverse Event|0
933208|NCT00943917|1918959|FG007|Stage I|Adverse Event|0
933209|NCT00943917|1918960|FG008|Stage I|Adverse Event|0
933210|NCT00943917|1918961|FG009|Stage I|Adverse Event|0
933211|NCT00943917|1918962|FG010|Stage I|Adverse Event|0
933212|NCT00943917|1918963|FG011|Stage I|Adverse Event|0
933213|NCT00943917|1918964|FG012|Stage I|Adverse Event|0
933214|NCT00943917|1918965|FG013|Stage I|Adverse Event|0
933215|NCT00943917|1918966|FG014|Stage I|Adverse Event|0
933216|NCT00943917|1918952|FG000|Stage I|Lost to Follow-up|0
933217|NCT00943917|1918953|FG001|Stage I|Lost to Follow-up|0
933218|NCT00943917|1918954|FG002|Stage I|Lost to Follow-up|1
933219|NCT00943917|1918955|FG003|Stage I|Lost to Follow-up|0
933220|NCT00943917|1918956|FG004|Stage I|Lost to Follow-up|0
933221|NCT00943917|1918957|FG005|Stage I|Lost to Follow-up|0
933222|NCT00943917|1918958|FG006|Stage I|Lost to Follow-up|0
933223|NCT00943917|1918959|FG007|Stage I|Lost to Follow-up|0
933224|NCT00943917|1918960|FG008|Stage I|Lost to Follow-up|0
933225|NCT00943917|1918961|FG009|Stage I|Lost to Follow-up|0
933226|NCT00943917|1918962|FG010|Stage I|Lost to Follow-up|0
933227|NCT00943917|1918963|FG011|Stage I|Lost to Follow-up|0
933228|NCT00943917|1918964|FG012|Stage I|Lost to Follow-up|0
933229|NCT00943917|1918965|FG013|Stage I|Lost to Follow-up|0
933230|NCT00943917|1918966|FG014|Stage I|Lost to Follow-up|0
933231|NCT00943917|1918952|FG000|Stage I|hyperglycemia|0
933232|NCT00943917|1918953|FG001|Stage I|hyperglycemia|0
933233|NCT00943917|1918954|FG002|Stage I|hyperglycemia|1
933234|NCT00943917|1918955|FG003|Stage I|hyperglycemia|0
933235|NCT00943917|1918956|FG004|Stage I|hyperglycemia|0
933236|NCT00943917|1918957|FG005|Stage I|hyperglycemia|0
933237|NCT00943917|1918958|FG006|Stage I|hyperglycemia|0
933238|NCT00943917|1918959|FG007|Stage I|hyperglycemia|0
933239|NCT00943917|1918960|FG008|Stage I|hyperglycemia|0
933240|NCT00943917|1918961|FG009|Stage I|hyperglycemia|0
933241|NCT00943917|1918962|FG010|Stage I|hyperglycemia|0
933242|NCT00943917|1918963|FG011|Stage I|hyperglycemia|0
933243|NCT00943917|1918964|FG012|Stage I|hyperglycemia|0
933244|NCT00943917|1918965|FG013|Stage I|hyperglycemia|0
933245|NCT00943917|1918966|FG014|Stage I|hyperglycemia|0
933246|NCT00943917|1918952|FG000|Stage I|A1C elevation|1
933247|NCT00943917|1918953|FG001|Stage I|A1C elevation|0
933248|NCT00943917|1918954|FG002|Stage I|A1C elevation|0
933249|NCT00943917|1918955|FG003|Stage I|A1C elevation|0
933250|NCT00943917|1918956|FG004|Stage I|A1C elevation|0
933251|NCT00943917|1918957|FG005|Stage I|A1C elevation|0
933252|NCT00943917|1918958|FG006|Stage I|A1C elevation|0
933253|NCT00943917|1918959|FG007|Stage I|A1C elevation|0
933254|NCT00943917|1918960|FG008|Stage I|A1C elevation|0
933255|NCT00943917|1918961|FG009|Stage I|A1C elevation|0
933256|NCT00943917|1918962|FG010|Stage I|A1C elevation|0
933257|NCT00943917|1918963|FG011|Stage I|A1C elevation|0
933258|NCT00943917|1918964|FG012|Stage I|A1C elevation|0
933259|NCT00943917|1918965|FG013|Stage I|A1C elevation|0
933260|NCT00943917|1918966|FG014|Stage I|A1C elevation|0
933261|NCT00943917|1918952|FG000|Stage I|Withdrawal by Subject|2
933262|NCT00943917|1918953|FG001|Stage I|Withdrawal by Subject|1
933263|NCT00943917|1918954|FG002|Stage I|Withdrawal by Subject|2
933264|NCT00943917|1918955|FG003|Stage I|Withdrawal by Subject|0
933265|NCT00943917|1918956|FG004|Stage I|Withdrawal by Subject|0
933266|NCT00943917|1918957|FG005|Stage I|Withdrawal by Subject|0
933267|NCT00943917|1918958|FG006|Stage I|Withdrawal by Subject|0
933268|NCT00943917|1918959|FG007|Stage I|Withdrawal by Subject|0
933269|NCT00943917|1918960|FG008|Stage I|Withdrawal by Subject|0
933270|NCT00943917|1918961|FG009|Stage I|Withdrawal by Subject|0
933271|NCT00943917|1918962|FG010|Stage I|Withdrawal by Subject|0
933272|NCT00943917|1918963|FG011|Stage I|Withdrawal by Subject|0
933273|NCT00943917|1918964|FG012|Stage I|Withdrawal by Subject|0
933274|NCT00943917|1918965|FG013|Stage I|Withdrawal by Subject|0
933275|NCT00943917|1918966|FG014|Stage I|Withdrawal by Subject|0
933276|NCT00943917|1918952|FG000|Stage II|Adverse Event|0
933277|NCT00943917|1918953|FG001|Stage II|Adverse Event|0
933278|NCT00943917|1918954|FG002|Stage II|Adverse Event|0
933279|NCT00943917|1918955|FG003|Stage II|Adverse Event|0
933280|NCT00943917|1918956|FG004|Stage II|Adverse Event|0
933281|NCT00943917|1918957|FG005|Stage II|Adverse Event|1
933282|NCT00943917|1918958|FG006|Stage II|Adverse Event|3
933283|NCT00943917|1918959|FG007|Stage II|Adverse Event|0
933284|NCT00943917|1918960|FG008|Stage II|Adverse Event|1
933285|NCT00943917|1918961|FG009|Stage II|Adverse Event|0
933286|NCT00943917|1918962|FG010|Stage II|Adverse Event|0
933287|NCT00943917|1918963|FG011|Stage II|Adverse Event|0
933288|NCT00943917|1918964|FG012|Stage II|Adverse Event|0
933289|NCT00943917|1918965|FG013|Stage II|Adverse Event|0
933290|NCT00943917|1918966|FG014|Stage II|Adverse Event|0
933291|NCT00943917|1918952|FG000|Stage II|Withdrawal by Subject|0
933292|NCT00943917|1918953|FG001|Stage II|Withdrawal by Subject|0
933293|NCT00943917|1918954|FG002|Stage II|Withdrawal by Subject|0
933294|NCT00943917|1918955|FG003|Stage II|Withdrawal by Subject|0
933295|NCT00943917|1918956|FG004|Stage II|Withdrawal by Subject|0
933296|NCT00943917|1918957|FG005|Stage II|Withdrawal by Subject|1
933297|NCT00943917|1918958|FG006|Stage II|Withdrawal by Subject|0
933298|NCT00943917|1918959|FG007|Stage II|Withdrawal by Subject|0
933299|NCT00943917|1918960|FG008|Stage II|Withdrawal by Subject|0
933300|NCT00943917|1918961|FG009|Stage II|Withdrawal by Subject|0
933301|NCT00943917|1918962|FG010|Stage II|Withdrawal by Subject|0
933302|NCT00943917|1918963|FG011|Stage II|Withdrawal by Subject|0
933303|NCT00943917|1918964|FG012|Stage II|Withdrawal by Subject|0
933304|NCT00943917|1918965|FG013|Stage II|Withdrawal by Subject|0
933305|NCT00943917|1918966|FG014|Stage II|Withdrawal by Subject|0
933306|NCT00943917|1918952|FG000|Stage II|Pregnancy|0
933307|NCT00943917|1918953|FG001|Stage II|Pregnancy|0
933308|NCT00943917|1918954|FG002|Stage II|Pregnancy|0
933309|NCT00943917|1918955|FG003|Stage II|Pregnancy|0
933310|NCT00943917|1918956|FG004|Stage II|Pregnancy|0
933311|NCT00943917|1918957|FG005|Stage II|Pregnancy|1
933312|NCT00943917|1918958|FG006|Stage II|Pregnancy|0
933313|NCT00943917|1918959|FG007|Stage II|Pregnancy|0
933314|NCT00943917|1918960|FG008|Stage II|Pregnancy|0
933315|NCT00943917|1918961|FG009|Stage II|Pregnancy|0
933316|NCT00943917|1918962|FG010|Stage II|Pregnancy|0
933317|NCT00943917|1918963|FG011|Stage II|Pregnancy|0
933318|NCT00943917|1918964|FG012|Stage II|Pregnancy|0
933319|NCT00943917|1918965|FG013|Stage II|Pregnancy|0
933320|NCT00943917|1918966|FG014|Stage II|Pregnancy|0
933321|NCT00943917|1918952|FG000|Stage II Continuation|Adverse Event|0
933322|NCT00943917|1918953|FG001|Stage II Continuation|Adverse Event|0
933323|NCT00943917|1918954|FG002|Stage II Continuation|Adverse Event|0
933324|NCT00943917|1918955|FG003|Stage II Continuation|Adverse Event|0
933325|NCT00943917|1918956|FG004|Stage II Continuation|Adverse Event|0
933326|NCT00943917|1918957|FG005|Stage II Continuation|Adverse Event|0
933327|NCT00943917|1918958|FG006|Stage II Continuation|Adverse Event|0
933328|NCT00943917|1918959|FG007|Stage II Continuation|Adverse Event|0
933329|NCT00943917|1918960|FG008|Stage II Continuation|Adverse Event|0
933330|NCT00943917|1918961|FG009|Stage II Continuation|Adverse Event|0
933331|NCT00943917|1918962|FG010|Stage II Continuation|Adverse Event|0
933332|NCT00943917|1918963|FG011|Stage II Continuation|Adverse Event|1
933333|NCT00943917|1918964|FG012|Stage II Continuation|Adverse Event|2
933334|NCT00943917|1918965|FG013|Stage II Continuation|Adverse Event|1
933335|NCT00943917|1918966|FG014|Stage II Continuation|Adverse Event|1
933336|NCT00943917|1918952|FG000|Stage II Continuation|Withdrawal by Subject|0
933337|NCT00943917|1918953|FG001|Stage II Continuation|Withdrawal by Subject|0
933338|NCT00943917|1918954|FG002|Stage II Continuation|Withdrawal by Subject|0
933339|NCT00943917|1918955|FG003|Stage II Continuation|Withdrawal by Subject|0
933340|NCT00943917|1918956|FG004|Stage II Continuation|Withdrawal by Subject|0
933341|NCT00943917|1918957|FG005|Stage II Continuation|Withdrawal by Subject|0
933342|NCT00943917|1918958|FG006|Stage II Continuation|Withdrawal by Subject|0
933343|NCT00943917|1918959|FG007|Stage II Continuation|Withdrawal by Subject|0
933344|NCT00943917|1918960|FG008|Stage II Continuation|Withdrawal by Subject|0
933345|NCT00943917|1918961|FG009|Stage II Continuation|Withdrawal by Subject|0
933346|NCT00943917|1918962|FG010|Stage II Continuation|Withdrawal by Subject|0
933347|NCT00943917|1918963|FG011|Stage II Continuation|Withdrawal by Subject|0
933348|NCT00943917|1918964|FG012|Stage II Continuation|Withdrawal by Subject|0
933349|NCT00943917|1918965|FG013|Stage II Continuation|Withdrawal by Subject|1
933350|NCT00943917|1918966|FG014|Stage II Continuation|Withdrawal by Subject|3
933351|NCT00943917|1918952|FG000|Stage II Continuation|Protocol Violation|0
933352|NCT00943917|1918953|FG001|Stage II Continuation|Protocol Violation|0
933353|NCT00943917|1918954|FG002|Stage II Continuation|Protocol Violation|0
933354|NCT00943917|1918955|FG003|Stage II Continuation|Protocol Violation|0
933355|NCT00943917|1918956|FG004|Stage II Continuation|Protocol Violation|0
933356|NCT00943917|1918957|FG005|Stage II Continuation|Protocol Violation|0
933357|NCT00943917|1918958|FG006|Stage II Continuation|Protocol Violation|0
933358|NCT00943917|1918959|FG007|Stage II Continuation|Protocol Violation|0
933359|NCT00943917|1918960|FG008|Stage II Continuation|Protocol Violation|0
933360|NCT00943917|1918961|FG009|Stage II Continuation|Protocol Violation|1
933361|NCT00943917|1918962|FG010|Stage II Continuation|Protocol Violation|0
933362|NCT00943917|1918963|FG011|Stage II Continuation|Protocol Violation|1
933363|NCT00943917|1918964|FG012|Stage II Continuation|Protocol Violation|0
933364|NCT00943917|1918965|FG013|Stage II Continuation|Protocol Violation|0
933365|NCT00943917|1918966|FG014|Stage II Continuation|Protocol Violation|0
933366|NCT00943917|1918952|FG000|Stage II Continuation|hypoglycemia|0
933367|NCT00943917|1918953|FG001|Stage II Continuation|hypoglycemia|0
933368|NCT00943917|1918954|FG002|Stage II Continuation|hypoglycemia|0
933369|NCT00943917|1918955|FG003|Stage II Continuation|hypoglycemia|0
933370|NCT00943917|1918956|FG004|Stage II Continuation|hypoglycemia|0
933371|NCT00943917|1918957|FG005|Stage II Continuation|hypoglycemia|0
933372|NCT00943917|1918958|FG006|Stage II Continuation|hypoglycemia|0
933373|NCT00943917|1918959|FG007|Stage II Continuation|hypoglycemia|0
933374|NCT00943917|1918960|FG008|Stage II Continuation|hypoglycemia|0
933375|NCT00943917|1918961|FG009|Stage II Continuation|hypoglycemia|0
933376|NCT00943917|1918962|FG010|Stage II Continuation|hypoglycemia|0
933377|NCT00943917|1918963|FG011|Stage II Continuation|hypoglycemia|0
933378|NCT00943917|1918964|FG012|Stage II Continuation|hypoglycemia|1
933379|NCT00943917|1918965|FG013|Stage II Continuation|hypoglycemia|0
933380|NCT00943917|1918966|FG014|Stage II Continuation|hypoglycemia|0
933381|NCT00943917|1918952|FG000|Stage II Continuation|A1C elevation|0
933382|NCT00943917|1918953|FG001|Stage II Continuation|A1C elevation|0
933383|NCT00943917|1918954|FG002|Stage II Continuation|A1C elevation|0
933384|NCT00943917|1918955|FG003|Stage II Continuation|A1C elevation|0
933385|NCT00943917|1918956|FG004|Stage II Continuation|A1C elevation|0
933386|NCT00943917|1918957|FG005|Stage II Continuation|A1C elevation|0
933387|NCT00943917|1918958|FG006|Stage II Continuation|A1C elevation|0
933388|NCT00943917|1918959|FG007|Stage II Continuation|A1C elevation|0
933389|NCT00943917|1918960|FG008|Stage II Continuation|A1C elevation|0
933390|NCT00943917|1918961|FG009|Stage II Continuation|A1C elevation|0
933391|NCT00943917|1918962|FG010|Stage II Continuation|A1C elevation|0
933392|NCT00943917|1918963|FG011|Stage II Continuation|A1C elevation|0
933393|NCT00943917|1918964|FG012|Stage II Continuation|A1C elevation|0
933394|NCT00943917|1918965|FG013|Stage II Continuation|A1C elevation|1
933395|NCT00943917|1918966|FG014|Stage II Continuation|A1C elevation|0
933396|NCT00944034|1919032|FG000|Overall Study|Inappropriate enrollment|0
933397|NCT00944034|1919033|FG001|Overall Study|Inappropriate enrollment|1
933398|NCT00944034|1919034|FG002|Overall Study|Inappropriate enrollment|0
933399|NCT00944034|1919035|FG003|Overall Study|Inappropriate enrollment|1
933400|NCT00944034|1919036|FG004|Overall Study|Inappropriate enrollment|2
933401|NCT00944034|1919037|FG005|Overall Study|Inappropriate enrollment|1
933402|NCT00944034|1919038|FG006|Overall Study|Inappropriate enrollment|0
933403|NCT00944034|1919039|FG007|Overall Study|Inappropriate enrollment|0
933404|NCT00944034|1919040|FG008|Overall Study|Inappropriate enrollment|1
933405|NCT00944034|1919041|FG009|Overall Study|Inappropriate enrollment|1
933406|NCT00944034|1919042|FG010|Overall Study|Inappropriate enrollment|0
933407|NCT00944034|1919043|FG011|Overall Study|Inappropriate enrollment|0
933408|NCT00944034|1919032|FG000|Overall Study|Withdrawal by Subject|3
933409|NCT00944034|1919033|FG001|Overall Study|Withdrawal by Subject|2
933410|NCT00944034|1919034|FG002|Overall Study|Withdrawal by Subject|6
933411|NCT00944034|1919035|FG003|Overall Study|Withdrawal by Subject|2
933412|NCT00944034|1919036|FG004|Overall Study|Withdrawal by Subject|5
933413|NCT00944034|1919037|FG005|Overall Study|Withdrawal by Subject|8
933414|NCT00944034|1919038|FG006|Overall Study|Withdrawal by Subject|2
933415|NCT00944034|1919039|FG007|Overall Study|Withdrawal by Subject|2
933416|NCT00944034|1919040|FG008|Overall Study|Withdrawal by Subject|3
933417|NCT00944034|1919041|FG009|Overall Study|Withdrawal by Subject|4
933418|NCT00944034|1919042|FG010|Overall Study|Withdrawal by Subject|0
933419|NCT00944034|1919043|FG011|Overall Study|Withdrawal by Subject|4
933420|NCT00944034|1919032|FG000|Overall Study|Lost to Follow-up|0
933421|NCT00944034|1919033|FG001|Overall Study|Lost to Follow-up|4
933422|NCT00944034|1919034|FG002|Overall Study|Lost to Follow-up|2
933423|NCT00944034|1919035|FG003|Overall Study|Lost to Follow-up|0
933424|NCT00944034|1919036|FG004|Overall Study|Lost to Follow-up|5
933425|NCT00944034|1919037|FG005|Overall Study|Lost to Follow-up|7
933426|NCT00944034|1919038|FG006|Overall Study|Lost to Follow-up|0
933427|NCT00944034|1919039|FG007|Overall Study|Lost to Follow-up|1
933428|NCT00944034|1919040|FG008|Overall Study|Lost to Follow-up|5
933429|NCT00944034|1919041|FG009|Overall Study|Lost to Follow-up|1
933430|NCT00944034|1919042|FG010|Overall Study|Lost to Follow-up|1
933431|NCT00944034|1919043|FG011|Overall Study|Lost to Follow-up|0
933432|NCT00944034|1919032|FG000|Overall Study|Death|0
933433|NCT00944034|1919033|FG001|Overall Study|Death|0
933434|NCT00944034|1919034|FG002|Overall Study|Death|1
933435|NCT00944034|1919035|FG003|Overall Study|Death|0
933436|NCT00944034|1919036|FG004|Overall Study|Death|0
933437|NCT00944034|1919037|FG005|Overall Study|Death|0
933438|NCT00944034|1919038|FG006|Overall Study|Death|0
933439|NCT00944034|1919039|FG007|Overall Study|Death|0
933440|NCT00944034|1919040|FG008|Overall Study|Death|0
933441|NCT00944034|1919041|FG009|Overall Study|Death|0
933442|NCT00944034|1919042|FG010|Overall Study|Death|0
933443|NCT00944034|1919043|FG011|Overall Study|Death|0
933444|NCT00944034|1919032|FG000|Overall Study|Protocol Violation|2
933445|NCT00944034|1919033|FG001|Overall Study|Protocol Violation|0
933446|NCT00944034|1919034|FG002|Overall Study|Protocol Violation|0
933447|NCT00944034|1919035|FG003|Overall Study|Protocol Violation|1
933448|NCT00944034|1919036|FG004|Overall Study|Protocol Violation|2
933449|NCT00944034|1919037|FG005|Overall Study|Protocol Violation|3
933450|NCT00944034|1919038|FG006|Overall Study|Protocol Violation|0
933451|NCT00944034|1919039|FG007|Overall Study|Protocol Violation|1
933452|NCT00944034|1919040|FG008|Overall Study|Protocol Violation|1
933453|NCT00944034|1919041|FG009|Overall Study|Protocol Violation|4
933454|NCT00944034|1919042|FG010|Overall Study|Protocol Violation|0
933455|NCT00944034|1919043|FG011|Overall Study|Protocol Violation|0
933456|NCT00944034|1919032|FG000|Overall Study|Unable to classify|0
933457|NCT00944034|1919033|FG001|Overall Study|Unable to classify|0
933458|NCT00944034|1919034|FG002|Overall Study|Unable to classify|0
933459|NCT00944034|1919035|FG003|Overall Study|Unable to classify|0
933460|NCT00944034|1919036|FG004|Overall Study|Unable to classify|0
933461|NCT00944034|1919037|FG005|Overall Study|Unable to classify|1
933462|NCT00944034|1919038|FG006|Overall Study|Unable to classify|1
933463|NCT00944034|1919039|FG007|Overall Study|Unable to classify|1
933464|NCT00944034|1919040|FG008|Overall Study|Unable to classify|0
933465|NCT00944034|1919041|FG009|Overall Study|Unable to classify|0
933466|NCT00944034|1919042|FG010|Overall Study|Unable to classify|0
933467|NCT00944034|1919043|FG011|Overall Study|Unable to classify|0
933468|NCT00944034|1919032|FG000|Overall Study|Administrative reason|0
933469|NCT00944034|1919033|FG001|Overall Study|Administrative reason|0
933470|NCT00944034|1919034|FG002|Overall Study|Administrative reason|0
933471|NCT00944034|1919035|FG003|Overall Study|Administrative reason|0
933472|NCT00944034|1919036|FG004|Overall Study|Administrative reason|0
933473|NCT00944034|1919037|FG005|Overall Study|Administrative reason|0
933474|NCT00944034|1919038|FG006|Overall Study|Administrative reason|1
933475|NCT00944034|1919039|FG007|Overall Study|Administrative reason|0
933476|NCT00944034|1919040|FG008|Overall Study|Administrative reason|0
933477|NCT00944034|1919041|FG009|Overall Study|Administrative reason|0
933478|NCT00944034|1919042|FG010|Overall Study|Administrative reason|0
933479|NCT00944034|1919043|FG011|Overall Study|Administrative reason|0
933480|NCT00944125|1919099|FG000|3 to 6 Months|Withdrawal by Subject|0
933481|NCT00944125|1919100|FG001|3 to 6 Months|Withdrawal by Subject|2
933482|NCT00944125|1919099|FG000|6 Months to Study Completion|Withdrawal by Subject|0
933483|NCT00944125|1919100|FG001|6 Months to Study Completion|Withdrawal by Subject|2
933484|NCT00944645|1919136|FG000|Period 2|Adverse Event|1
933485|NCT00944645|1919137|FG001|Period 2|Adverse Event|0
933486|NCT00944645|1919136|FG000|Period 2|Lost to Follow-up|0
933487|NCT00944645|1919137|FG001|Period 2|Lost to Follow-up|3
933488|NCT00944645|1919136|FG000|Period 2|Withdrawal by Subject|7
933489|NCT00944645|1919137|FG001|Period 2|Withdrawal by Subject|6
933490|NCT00944658|1919145|FG000|Treatment 12 Weeks|Adverse Event|0
933491|NCT00944658|1919146|FG001|Treatment 12 Weeks|Adverse Event|2
933492|NCT00944697|1919173|FG000|Overall Study|Withdrawal by Subject|1
933493|NCT00944697|1919174|FG001|Overall Study|Withdrawal by Subject|1
933494|NCT00944697|1919173|FG000|Overall Study|Adverse Event|0
933495|NCT00944697|1919174|FG001|Overall Study|Adverse Event|3
933496|NCT00944697|1919173|FG000|Overall Study|Administrative|1
933497|NCT00944697|1919174|FG001|Overall Study|Administrative|1
933498|NCT00945009|1919196|FG000|Overall Study|Lack of Efficacy|10
933499|NCT00945009|1919197|FG001|Overall Study|Lack of Efficacy|0
933500|NCT00945009|1919198|FG002|Overall Study|Lack of Efficacy|0
933501|NCT00945009|1919196|FG000|Overall Study|Physician Decision|21
933502|NCT00945009|1919197|FG001|Overall Study|Physician Decision|4
933503|NCT00945009|1919198|FG002|Overall Study|Physician Decision|3
933504|NCT00945009|1919196|FG000|Overall Study|Protocol Violation|6
933505|NCT00945009|1919197|FG001|Overall Study|Protocol Violation|1
933506|NCT00945009|1919198|FG002|Overall Study|Protocol Violation|0
933507|NCT00945009|1919196|FG000|Overall Study|Withdrawal by Subject|1
933508|NCT00945009|1919197|FG001|Overall Study|Withdrawal by Subject|0
933509|NCT00945009|1919198|FG002|Overall Study|Withdrawal by Subject|0
933510|NCT00945009|1919196|FG000|Overall Study|Ineligible|6
933511|NCT00945009|1919197|FG001|Overall Study|Ineligible|1
933512|NCT00945009|1919198|FG002|Overall Study|Ineligible|0
933513|NCT00945009|1919196|FG000|Overall Study|Inevaluable|0
933514|NCT00945009|1919197|FG001|Overall Study|Inevaluable|1
933515|NCT00945009|1919198|FG002|Overall Study|Inevaluable|0
933516|NCT00945009|1919196|FG000|Overall Study|Refusal of further protocol|1
933517|NCT00945009|1919197|FG001|Overall Study|Refusal of further protocol|0
933518|NCT00945009|1919198|FG002|Overall Study|Refusal of further protocol|0
933519|NCT00945191|1919245|FG000|Overall Study|Did not achieve a complete response|18
933520|NCT00945191|1919245|FG000|Overall Study|Participant relocated to another state|1
933521|NCT00945191|1919245|FG000|Overall Study|Disease progression|3
933522|NCT00945191|1919245|FG000|Overall Study|Serious adverse event or adverse event|1
933523|NCT00945191|1919245|FG000|Overall Study|Investigator's discretion|1
933524|NCT00945243|1919249|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3
933525|NCT00945321|1919300|FG000|Period 1|Adverse Event|0
933526|NCT00945321|1919301|FG001|Period 1|Adverse Event|0
933527|NCT00945321|1919302|FG002|Period 1|Adverse Event|0
933528|NCT00945321|1919303|FG003|Period 1|Adverse Event|0
933529|NCT00945321|1919304|FG004|Period 1|Adverse Event|1
933530|NCT00945321|1919305|FG005|Period 1|Adverse Event|0
933531|NCT00945321|1919300|FG000|Period 4|Lost to Follow-up|0
933532|NCT00945321|1919301|FG001|Period 4|Lost to Follow-up|0
933533|NCT00945321|1919302|FG002|Period 4|Lost to Follow-up|0
933534|NCT00945321|1919303|FG003|Period 4|Lost to Follow-up|0
933535|NCT00945321|1919304|FG004|Period 4|Lost to Follow-up|0
933536|NCT00945321|1919305|FG005|Period 4|Lost to Follow-up|1
933537|NCT00945477|1919332|FG000|Overall Study|Adverse Event|3
933538|NCT00945477|1919332|FG000|Overall Study|Lack of Efficacy|2
933539|NCT00945477|1919332|FG000|Overall Study|Withdrawal by Subject|1
933540|NCT00945555|1919337|FG000|Overall Study|Referred to another hospital|5
933541|NCT00945555|1919337|FG000|Overall Study|Worsening condition, intensive care unit|1
933542|NCT00945555|1919337|FG000|Overall Study|Withdrawal by Subject|2
933543|NCT00945555|1919337|FG000|Overall Study|Participant continued treatment at home|1
933544|NCT00945555|1919337|FG000|Overall Study|Death|18
933545|NCT00945555|1919337|FG000|Overall Study|Other|1
933546|NCT00945659|1919355|FG000|Overall Study|Lost to Follow-up|7
933547|NCT00945659|1919356|FG001|Overall Study|Lost to Follow-up|20
933548|NCT00945659|1919357|FG002|Overall Study|Lost to Follow-up|17
933549|NCT00945815|1919384|FG000|Overall Study|Death|3
933550|NCT00945815|1919384|FG000|Overall Study|Not protocol specified|1
933551|NCT00945815|1919384|FG000|Overall Study|Ineligible|3
933552|NCT00945815|1919384|FG000|Overall Study|Did not begin protocol therapy|1
933553|NCT00945893|1919399|FG000|Overall Study|Lost to Follow-up|2
933554|NCT00945893|1919400|FG001|Overall Study|Lost to Follow-up|8
933555|NCT00945893|1919399|FG000|Overall Study|Withdrawal of consent|1
933556|NCT00945893|1919400|FG001|Overall Study|Withdrawal of consent|2
933557|NCT00945906|1919410|FG000|Overall Study|Withdrawal by Subject|1
933558|NCT00945906|1919410|FG000|Overall Study|Did not want to return for last visit|2
933559|NCT00945906|1919410|FG000|Overall Study|Unable to return for last visit|2
933560|NCT00945906|1919410|FG000|Overall Study|Moved to another country|2
933561|NCT00945945|1919416|FG000|Overall Study|Adverse Event|15
933562|NCT00945945|1919417|FG001|Overall Study|Adverse Event|35
933563|NCT00945945|1919416|FG000|Overall Study|Withdrawal by Subject|7
933564|NCT00945945|1919417|FG001|Overall Study|Withdrawal by Subject|10
933565|NCT00945945|1919416|FG000|Overall Study|Lost to Follow-up|4
933566|NCT00945945|1919417|FG001|Overall Study|Lost to Follow-up|5
933567|NCT00945945|1919416|FG000|Overall Study|Lack of Efficacy|6
933568|NCT00945945|1919417|FG001|Overall Study|Lack of Efficacy|2
933569|NCT00945945|1919416|FG000|Overall Study|Protocol Violation|4
933570|NCT00945945|1919417|FG001|Overall Study|Protocol Violation|2
933571|NCT00945945|1919416|FG000|Overall Study|Entry Criteria Not Met|0
933572|NCT00945945|1919417|FG001|Overall Study|Entry Criteria Not Met|1
933573|NCT00946088|1919434|FG000|Overall Study|Withdrawal by Subject|0
933574|NCT00946088|1919435|FG001|Overall Study|Withdrawal by Subject|1
933575|NCT00946101|1919445|FG000|Overall Study|Lost to Follow-up|2
933576|NCT00946101|1919446|FG001|Overall Study|Lost to Follow-up|1
933577|NCT00946101|1919445|FG000|Overall Study|Withdrawal of consent|2
933578|NCT00946101|1919446|FG001|Overall Study|Withdrawal of consent|0
933579|NCT00946101|1919445|FG000|Overall Study|Physician Decision|0
933580|NCT00946101|1919446|FG001|Overall Study|Physician Decision|1
933581|NCT00946114|1919458|FG000|Overall Study|Death|5
933582|NCT00946114|1919459|FG001|Overall Study|Death|2
933583|NCT00946114|1919458|FG000|Overall Study|Other|1
933584|NCT00946114|1919459|FG001|Overall Study|Other|0
933585|NCT00946114|1919458|FG000|Overall Study|Withdrawal by Subject|2
933586|NCT00946114|1919459|FG001|Overall Study|Withdrawal by Subject|0
933587|NCT00946153|1919470|FG000|Phase 2|Adverse Event|0
933588|NCT00946153|1919471|FG001|Phase 2|Adverse Event|0
933589|NCT00946153|1919472|FG002|Phase 2|Adverse Event|0
933590|NCT00946153|1919473|FG003|Phase 2|Adverse Event|0
933591|NCT00946153|1919474|FG004|Phase 2|Adverse Event|6
933592|NCT00946153|1919470|FG000|Phase 2|Need more reduction of dose|0
933593|NCT00946153|1919471|FG001|Phase 2|Need more reduction of dose|0
933594|NCT00946153|1919472|FG002|Phase 2|Need more reduction of dose|0
933595|NCT00946153|1919473|FG003|Phase 2|Need more reduction of dose|0
933596|NCT00946153|1919474|FG004|Phase 2|Need more reduction of dose|2
933597|NCT00946153|1919470|FG000|Phase 2|Physician Decision|0
933598|NCT00946153|1919471|FG001|Phase 2|Physician Decision|0
933599|NCT00946153|1919472|FG002|Phase 2|Physician Decision|0
933600|NCT00946153|1919473|FG003|Phase 2|Physician Decision|0
933601|NCT00946153|1919474|FG004|Phase 2|Physician Decision|1
933602|NCT00946153|1919470|FG000|Phase 2|14 days washout for recovery due to AE|0
933603|NCT00946153|1919471|FG001|Phase 2|14 days washout for recovery due to AE|0
933604|NCT00946153|1919472|FG002|Phase 2|14 days washout for recovery due to AE|0
933605|NCT00946153|1919473|FG003|Phase 2|14 days washout for recovery due to AE|0
933606|NCT00946153|1919474|FG004|Phase 2|14 days washout for recovery due to AE|4
933607|NCT00946192|1919494|FG000|Overall Study|Lost to Follow-up|6
933608|NCT00946192|1919495|FG001|Overall Study|Lost to Follow-up|11
933609|NCT00946192|1919496|FG002|Overall Study|Lost to Follow-up|9
933610|NCT00946192|1919494|FG000|Overall Study|Withdrawal by Subject|10
933611|NCT00946192|1919495|FG001|Overall Study|Withdrawal by Subject|7
933612|NCT00946192|1919496|FG002|Overall Study|Withdrawal by Subject|3
933613|NCT00946192|1919494|FG000|Overall Study|Did not start medication|2
933614|NCT00946192|1919495|FG001|Overall Study|Did not start medication|0
933615|NCT00946192|1919496|FG002|Overall Study|Did not start medication|0
933616|NCT00946296|1919519|FG000|Overall Study|Physician Decision|3
933617|NCT00946296|1919520|FG001|Overall Study|Physician Decision|0
933618|NCT00946309|1919528|FG000|Overall Study|Protocol Violation|1
933619|NCT00946309|1919529|FG001|Overall Study|Protocol Violation|0
933620|NCT00946309|1919528|FG000|Overall Study|Lost to Follow-up|0
933621|NCT00946309|1919529|FG001|Overall Study|Lost to Follow-up|1
933622|NCT00946309|1919528|FG000|Overall Study|Procedure cancelled/discontinued|0
933623|NCT00946309|1919529|FG001|Overall Study|Procedure cancelled/discontinued|3
933624|NCT00946322|1919536|FG000|Pre-treatment|participant failure to follow up|1
933625|NCT00946322|1919536|FG000|Post-treatment|participant failure to follow up|2
933626|NCT00946530|1919562|FG000|Overall Study|Withdrawal by Subject|0
933627|NCT00946530|1919563|FG001|Overall Study|Withdrawal by Subject|3
933628|NCT00946530|1919564|FG002|Overall Study|Withdrawal by Subject|0
933629|NCT00946530|1919565|FG003|Overall Study|Withdrawal by Subject|3
933630|NCT00946530|1919562|FG000|Overall Study|Physician Decision|1
933631|NCT00946530|1919563|FG001|Overall Study|Physician Decision|1
933632|NCT00946530|1919564|FG002|Overall Study|Physician Decision|1
933633|NCT00946530|1919565|FG003|Overall Study|Physician Decision|1
933634|NCT00946647|1919584|FG000|Phase 1 Part|Adverse Event|2
933635|NCT00946647|1919585|FG001|Phase 1 Part|Adverse Event|5
933636|NCT00946647|1919586|FG002|Phase 1 Part|Adverse Event|3
933637|NCT00946647|1919587|FG003|Phase 1 Part|Adverse Event|0
933638|NCT00946647|1919588|FG004|Phase 1 Part|Adverse Event|0
933639|NCT00946647|1919584|FG000|Phase 1 Part|Disease progression|3
933640|NCT00946647|1919585|FG001|Phase 1 Part|Disease progression|6
933641|NCT00946647|1919586|FG002|Phase 1 Part|Disease progression|1
933642|NCT00946647|1919587|FG003|Phase 1 Part|Disease progression|0
933643|NCT00946647|1919588|FG004|Phase 1 Part|Disease progression|0
933644|NCT00946647|1919584|FG000|Phase 1 Part|Withdrawal by Subject|1
933645|NCT00946647|1919585|FG001|Phase 1 Part|Withdrawal by Subject|4
933646|NCT00946647|1919586|FG002|Phase 1 Part|Withdrawal by Subject|3
933647|NCT00946647|1919587|FG003|Phase 1 Part|Withdrawal by Subject|0
933648|NCT00946647|1919588|FG004|Phase 1 Part|Withdrawal by Subject|0
933649|NCT00946647|1919584|FG000|Phase 1 Part|Abnormal values|0
933650|NCT00946647|1919585|FG001|Phase 1 Part|Abnormal values|2
933651|NCT00946647|1919586|FG002|Phase 1 Part|Abnormal values|0
933652|NCT00946647|1919587|FG003|Phase 1 Part|Abnormal values|0
933653|NCT00946647|1919588|FG004|Phase 1 Part|Abnormal values|0
933654|NCT00946647|1919584|FG000|Phase 1 Part|Reason missing|0
933655|NCT00946647|1919585|FG001|Phase 1 Part|Reason missing|1
933656|NCT00946647|1919586|FG002|Phase 1 Part|Reason missing|0
933657|NCT00946647|1919587|FG003|Phase 1 Part|Reason missing|0
933658|NCT00946647|1919588|FG004|Phase 1 Part|Reason missing|0
933659|NCT00946647|1919584|FG000|Phase ll Part|Untreated|0
933660|NCT00946647|1919585|FG001|Phase ll Part|Untreated|0
933661|NCT00946647|1919586|FG002|Phase ll Part|Untreated|0
933662|NCT00946647|1919587|FG003|Phase ll Part|Untreated|0
933663|NCT00946647|1919588|FG004|Phase ll Part|Untreated|2
933664|NCT00946647|1919584|FG000|Phase ll Part|Adverse Event|0
933665|NCT00946647|1919585|FG001|Phase ll Part|Adverse Event|0
933666|NCT00946647|1919586|FG002|Phase ll Part|Adverse Event|0
933667|NCT00946647|1919587|FG003|Phase ll Part|Adverse Event|10
933668|NCT00946647|1919588|FG004|Phase ll Part|Adverse Event|6
933669|NCT00946647|1919584|FG000|Phase ll Part|Withdrawal by Subject|0
933670|NCT00946647|1919585|FG001|Phase ll Part|Withdrawal by Subject|0
933671|NCT00946647|1919586|FG002|Phase ll Part|Withdrawal by Subject|0
933672|NCT00946647|1919587|FG003|Phase ll Part|Withdrawal by Subject|8
933673|NCT00946647|1919588|FG004|Phase ll Part|Withdrawal by Subject|6
933674|NCT00946647|1919584|FG000|Phase ll Part|Administrative problems|0
933675|NCT00946647|1919585|FG001|Phase ll Part|Administrative problems|0
933676|NCT00946647|1919586|FG002|Phase ll Part|Administrative problems|0
933677|NCT00946647|1919587|FG003|Phase ll Part|Administrative problems|3
933678|NCT00946647|1919588|FG004|Phase ll Part|Administrative problems|8
933679|NCT00946647|1919584|FG000|Phase ll Part|Death|0
933680|NCT00946647|1919585|FG001|Phase ll Part|Death|0
933681|NCT00946647|1919586|FG002|Phase ll Part|Death|0
933682|NCT00946647|1919587|FG003|Phase ll Part|Death|7
933683|NCT00946647|1919588|FG004|Phase ll Part|Death|4
933684|NCT00946647|1919584|FG000|Phase ll Part|Disease progression|0
933685|NCT00946647|1919585|FG001|Phase ll Part|Disease progression|0
933686|NCT00946647|1919586|FG002|Phase ll Part|Disease progression|0
933687|NCT00946647|1919587|FG003|Phase ll Part|Disease progression|6
933688|NCT00946647|1919588|FG004|Phase ll Part|Disease progression|14
933689|NCT00946647|1919584|FG000|Phase ll Part|Protocol Violation|0
933690|NCT00946647|1919585|FG001|Phase ll Part|Protocol Violation|0
933691|NCT00946647|1919586|FG002|Phase ll Part|Protocol Violation|0
933692|NCT00946647|1919587|FG003|Phase ll Part|Protocol Violation|4
933693|NCT00946647|1919588|FG004|Phase ll Part|Protocol Violation|2
933694|NCT00946647|1919584|FG000|Phase ll Part|Subj cond no longer required study drug|0
933695|NCT00946647|1919585|FG001|Phase ll Part|Subj cond no longer required study drug|0
933696|NCT00946647|1919586|FG002|Phase ll Part|Subj cond no longer required study drug|0
933697|NCT00946647|1919587|FG003|Phase ll Part|Subj cond no longer required study drug|2
933698|NCT00946647|1919588|FG004|Phase ll Part|Subj cond no longer required study drug|0
933699|NCT00946712|1919603|FG000|Overall Study|Adverse Event|118
933700|NCT00946712|1919604|FG001|Overall Study|Adverse Event|124
933701|NCT00946712|1919603|FG000|Overall Study|Disease progression|308
933702|NCT00946712|1919604|FG001|Overall Study|Disease progression|404
933703|NCT00946712|1919603|FG000|Overall Study|Death|21
933704|NCT00946712|1919604|FG001|Overall Study|Death|22
933705|NCT00946712|1919603|FG000|Overall Study|No treatment given|25
933706|NCT00946712|1919604|FG001|Overall Study|No treatment given|29
933707|NCT00946712|1919603|FG000|Overall Study|Other reasons|61
933708|NCT00946712|1919604|FG001|Overall Study|Other reasons|73
933709|NCT00946712|1919603|FG000|Overall Study|On Treatment|0
933710|NCT00946712|1919604|FG001|Overall Study|On Treatment|4
933711|NCT00946712|1919603|FG000|Overall Study|Ineligible|14
933712|NCT00946712|1919604|FG001|Overall Study|Ineligible|6
933713|NCT00946881|1919611|FG000|First Treatment|Withdrawal by Subject|1
933714|NCT00946881|1919611|FG000|First Treatment|Patient relocated to another state|1
933715|NCT00946881|1919611|FG000|Retreatment|Withdrawal by Subject|1
933716|NCT00946920|1919638|FG000|Overall Study|Withdrawal by Subject|28
933717|NCT00946920|1919639|FG001|Overall Study|Withdrawal by Subject|15
933718|NCT00946920|1919638|FG000|Overall Study|Lost to Follow-up|2
933719|NCT00946920|1919639|FG001|Overall Study|Lost to Follow-up|2
933720|NCT00946920|1919638|FG000|Overall Study|Physician Decision|5
933721|NCT00946920|1919639|FG001|Overall Study|Physician Decision|2
933722|NCT00946920|1919638|FG000|Overall Study|Adverse Event|41
933723|NCT00946920|1919639|FG001|Overall Study|Adverse Event|14
933724|NCT00946920|1919638|FG000|Overall Study|Protocol Violation|16
933725|NCT00946920|1919639|FG001|Overall Study|Protocol Violation|8
933726|NCT00946920|1919638|FG000|Overall Study|Miscellaneous reasons|18
933727|NCT00946920|1919639|FG001|Overall Study|Miscellaneous reasons|3
933728|NCT00946998|1919647|FG000|Overall Study|Exited prior to first outcome assessment|5
933729|NCT00946998|1919648|FG001|Overall Study|Exited prior to first outcome assessment|3
933730|NCT00947115|1919657|FG000|Overall Study|Missed reporting interval|3
933731|NCT00947115|1919658|FG001|Overall Study|Missed reporting interval|4
933732|NCT00947115|1919659|FG002|Overall Study|Missed reporting interval|2
933733|NCT00947115|1919657|FG000|Overall Study|Physician Decision|0
933734|NCT00947115|1919658|FG001|Overall Study|Physician Decision|2
933735|NCT00947115|1919659|FG002|Overall Study|Physician Decision|0
933736|NCT00947115|1919657|FG000|Overall Study|Death|0
933737|NCT00947115|1919658|FG001|Overall Study|Death|1
933738|NCT00947115|1919659|FG002|Overall Study|Death|1
933739|NCT00947115|1919657|FG000|Overall Study|Migrated from study area|2
933740|NCT00947115|1919658|FG001|Overall Study|Migrated from study area|0
933741|NCT00947115|1919659|FG002|Overall Study|Migrated from study area|0
933742|NCT00947115|1919657|FG000|Overall Study|Withdrawal by Subject|1
933743|NCT00947115|1919658|FG001|Overall Study|Withdrawal by Subject|3
933744|NCT00947115|1919659|FG002|Overall Study|Withdrawal by Subject|4
933745|NCT00947115|1919657|FG000|Overall Study|Lost to Follow-up|11
933746|NCT00947115|1919658|FG001|Overall Study|Lost to Follow-up|12
933747|NCT00947115|1919659|FG002|Overall Study|Lost to Follow-up|8
933748|NCT00947154|1919667|FG000|Overall Study|Lost to Follow-up|1
933749|NCT00947193|1919676|FG000|Overall Study|Lost to Follow-up|1
933750|NCT00947193|1919677|FG001|Overall Study|Lost to Follow-up|0
933751|NCT00947193|1919676|FG000|Overall Study|Withdrawal by Subject|1
933752|NCT00947193|1919677|FG001|Overall Study|Withdrawal by Subject|0
933753|NCT00947193|1919676|FG000|Overall Study|Factor VIII >1%|1
933754|NCT00947193|1919677|FG001|Overall Study|Factor VIII >1%|0
933755|NCT00947349|1919734|FG000|Triple Treatment Combination Period|Adverse Event|0
933756|NCT00947349|1919735|FG001|Triple Treatment Combination Period|Adverse Event|1
933757|NCT00947349|1919736|FG002|Triple Treatment Combination Period|Adverse Event|0
933758|NCT00947349|1919737|FG003|Triple Treatment Combination Period|Adverse Event|0
933759|NCT00947349|1919734|FG000|Overall Study Standard of Care|Lack of Efficacy|0
933760|NCT00947349|1919735|FG001|Overall Study Standard of Care|Lack of Efficacy|0
933761|NCT00947349|1919736|FG002|Overall Study Standard of Care|Lack of Efficacy|1
933762|NCT00947349|1919737|FG003|Overall Study Standard of Care|Lack of Efficacy|1
933763|NCT00947349|1919734|FG000|Overall Study Standard of Care|Withdrawal by Subject|0
933764|NCT00947349|1919735|FG001|Overall Study Standard of Care|Withdrawal by Subject|0
933765|NCT00947349|1919736|FG002|Overall Study Standard of Care|Withdrawal by Subject|1
933766|NCT00947349|1919737|FG003|Overall Study Standard of Care|Withdrawal by Subject|0
933767|NCT00947349|1919734|FG000|Overall Study Standard of Care|Other|0
933768|NCT00947349|1919735|FG001|Overall Study Standard of Care|Other|0
933769|NCT00947349|1919736|FG002|Overall Study Standard of Care|Other|0
933770|NCT00947349|1919737|FG003|Overall Study Standard of Care|Other|1
933771|NCT00947427|1919767|FG000|Overall Study|Withdrawal by Subject|1
933772|NCT00947427|1919768|FG001|Overall Study|Withdrawal by Subject|3
933773|NCT00947427|1919767|FG000|Overall Study|Protocol Violation|0
933774|NCT00947427|1919768|FG001|Overall Study|Protocol Violation|1
933775|NCT00947531|1919795|FG000|Overall Study|Withdrawal by Subject|10
933776|NCT00947531|1919796|FG001|Overall Study|Withdrawal by Subject|7
933777|NCT00947531|1919795|FG000|Overall Study|Administrative Reason|0
933778|NCT00947531|1919796|FG001|Overall Study|Administrative Reason|1
933779|NCT00947531|1919795|FG000|Overall Study|Adverse Event|2
933780|NCT00947531|1919796|FG001|Overall Study|Adverse Event|2
933781|NCT00947531|1919795|FG000|Overall Study|Lack of Efficacy|1
933782|NCT00947531|1919796|FG001|Overall Study|Lack of Efficacy|0
933783|NCT00947531|1919795|FG000|Overall Study|Other|1
933784|NCT00947531|1919796|FG001|Overall Study|Other|1
933785|NCT00947544|1919802|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
933786|NCT00947544|1919803|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
933787|NCT00947856|1919842|FG000|Treatment Period|Progressive Disease|33
933788|NCT00947856|1919843|FG001|Treatment Period|Progressive Disease|12
933789|NCT00947856|1919842|FG000|Treatment Period|Adverse Event|15
933790|NCT00947856|1919843|FG001|Treatment Period|Adverse Event|9
933791|NCT00947856|1919842|FG000|Treatment Period|Physician Decision|14
933792|NCT00947856|1919843|FG001|Treatment Period|Physician Decision|6
933793|NCT00947856|1919842|FG000|Treatment Period|Study Stopped by Sponsor|4
933794|NCT00947856|1919843|FG001|Treatment Period|Study Stopped by Sponsor|4
933795|NCT00947856|1919842|FG000|Treatment Period|Withdrawal by Subject|12
933796|NCT00947856|1919843|FG001|Treatment Period|Withdrawal by Subject|1
933797|NCT00947856|1919842|FG000|Follow-up Period|Study Stopped by Sponsor|40
933798|NCT00947856|1919843|FG001|Follow-up Period|Study Stopped by Sponsor|20
933799|NCT00947856|1919842|FG000|Follow-up Period|Re-enrolled for Retreatment|2
933800|NCT00947856|1919843|FG001|Follow-up Period|Re-enrolled for Retreatment|3
933801|NCT00947856|1919842|FG000|Follow-up Period|Lost to Follow-up|7
933802|NCT00947856|1919843|FG001|Follow-up Period|Lost to Follow-up|0
933803|NCT00947856|1919842|FG000|Follow-up Period|Patient unavailable for site visits|1
933804|NCT00947856|1919843|FG001|Follow-up Period|Patient unavailable for site visits|0
933805|NCT00947856|1919842|FG000|Follow-up Period|Withdrawal by Subject|1
933806|NCT00947856|1919843|FG001|Follow-up Period|Withdrawal by Subject|0
933807|NCT00947882|1919862|FG000|Overall Study|Adverse Event|0
933808|NCT00947882|1919863|FG001|Overall Study|Adverse Event|1
933809|NCT00947882|1919864|FG002|Overall Study|Adverse Event|4
933810|NCT00947882|1919865|FG003|Overall Study|Adverse Event|4
933811|NCT00947882|1919862|FG000|Overall Study|Withdrawal by Subject|2
933812|NCT00947882|1919863|FG001|Overall Study|Withdrawal by Subject|0
933813|NCT00947882|1919864|FG002|Overall Study|Withdrawal by Subject|8
933814|NCT00947882|1919865|FG003|Overall Study|Withdrawal by Subject|2
933815|NCT00947882|1919862|FG000|Overall Study|Protocol Violation|0
933816|NCT00947882|1919863|FG001|Overall Study|Protocol Violation|0
933817|NCT00947882|1919864|FG002|Overall Study|Protocol Violation|1
933818|NCT00947882|1919865|FG003|Overall Study|Protocol Violation|0
933819|NCT00947882|1919862|FG000|Overall Study|Lost to Follow-up|0
933820|NCT00947882|1919863|FG001|Overall Study|Lost to Follow-up|2
933821|NCT00947882|1919864|FG002|Overall Study|Lost to Follow-up|1
933822|NCT00947882|1919865|FG003|Overall Study|Lost to Follow-up|0
933823|NCT00947882|1919862|FG000|Overall Study|Other/Unknown|10
933824|NCT00947882|1919863|FG001|Overall Study|Other/Unknown|13
933825|NCT00947882|1919864|FG002|Overall Study|Other/Unknown|3
933826|NCT00947882|1919865|FG003|Overall Study|Other/Unknown|6
933827|NCT00947882|1919862|FG000|Overall Study|Trial Terminated by Sponsor|62
933828|NCT00947882|1919863|FG001|Overall Study|Trial Terminated by Sponsor|61
933829|NCT00947882|1919864|FG002|Overall Study|Trial Terminated by Sponsor|62
933830|NCT00947882|1919865|FG003|Overall Study|Trial Terminated by Sponsor|70
933831|NCT00948025|1919878|FG000|Phase 1 (Pilot Phase)|Adverse Event|1
933832|NCT00948025|1919879|FG001|Phase 1 (Pilot Phase)|Adverse Event|1
933833|NCT00948025|1919878|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7
933834|NCT00948025|1919879|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1
933835|NCT00948025|1919878|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
933836|NCT00948025|1919879|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
933837|NCT00948064|1919889|FG000|Phase I|No treatment received|1
933838|NCT00948064|1919890|FG001|Phase I|No treatment received|0
933839|NCT00948064|1919891|FG002|Phase I|No treatment received|0
933840|NCT00948064|1919889|FG000|Phase II|Physician Decision|0
933841|NCT00948064|1919890|FG001|Phase II|Physician Decision|0
933842|NCT00948064|1919891|FG002|Phase II|Physician Decision|1
933843|NCT00948064|1919889|FG000|Phase II|Withdrawal by Subject|0
933844|NCT00948064|1919890|FG001|Phase II|Withdrawal by Subject|1
933845|NCT00948064|1919891|FG002|Phase II|Withdrawal by Subject|0
933846|NCT00948155|1919915|FG000|First Intervention 21 Days|Lost to Follow-up|2
933847|NCT00948155|1919916|FG001|First Intervention 21 Days|Lost to Follow-up|2
933848|NCT00948155|1919915|FG000|Washout 14 Days|Lost to Follow-up|1
933849|NCT00948155|1919916|FG001|Washout 14 Days|Lost to Follow-up|2
933850|NCT00948246|1919924|FG000|Overall Study|Lost to Follow-up|11
933851|NCT00948246|1919924|FG000|Overall Study|Adverse Event|11
933852|NCT00948246|1919924|FG000|Overall Study|Death|1
933853|NCT00948246|1919924|FG000|Overall Study|Withdrawal by Subject|1
933854|NCT00948389|1919942|FG000|Overall Study|Disease Progression/Relapse/Death|3
933855|NCT00948389|1919943|FG001|Overall Study|Disease Progression/Relapse/Death|3
933856|NCT00948389|1919944|FG002|Overall Study|Disease Progression/Relapse/Death|7
933857|NCT00948389|1919945|FG003|Overall Study|Disease Progression/Relapse/Death|8
933858|NCT00948389|1919946|FG004|Overall Study|Disease Progression/Relapse/Death|1
933859|NCT00948389|1919942|FG000|Overall Study|Thrombocytopenia, Grade 4|2
933860|NCT00948389|1919943|FG001|Overall Study|Thrombocytopenia, Grade 4|0
933861|NCT00948389|1919944|FG002|Overall Study|Thrombocytopenia, Grade 4|0
933862|NCT00948389|1919945|FG003|Overall Study|Thrombocytopenia, Grade 4|1
933863|NCT00948389|1919946|FG004|Overall Study|Thrombocytopenia, Grade 4|0
933864|NCT00948389|1919942|FG000|Overall Study|Both Progression and Toxicity|1
933865|NCT00948389|1919943|FG001|Overall Study|Both Progression and Toxicity|0
933866|NCT00948389|1919944|FG002|Overall Study|Both Progression and Toxicity|0
933867|NCT00948389|1919945|FG003|Overall Study|Both Progression and Toxicity|0
933868|NCT00948389|1919946|FG004|Overall Study|Both Progression and Toxicity|0
933869|NCT00948428|1919963|FG000|Overall Study|Withdrawal by Subject|6
933870|NCT00948428|1919964|FG001|Overall Study|Withdrawal by Subject|12
933871|NCT00948428|1919965|FG002|Overall Study|Withdrawal by Subject|7
933872|NCT00948428|1919963|FG000|Overall Study|Adverse Event|6
933873|NCT00948428|1919964|FG001|Overall Study|Adverse Event|3
933874|NCT00948428|1919965|FG002|Overall Study|Adverse Event|0
933875|NCT00948428|1919963|FG000|Overall Study|Lost to Follow-up|2
933876|NCT00948428|1919964|FG001|Overall Study|Lost to Follow-up|1
933877|NCT00948428|1919965|FG002|Overall Study|Lost to Follow-up|1
933878|NCT00948428|1919963|FG000|Overall Study|Death|2
933879|NCT00948428|1919964|FG001|Overall Study|Death|0
933880|NCT00948428|1919965|FG002|Overall Study|Death|0
933881|NCT00948428|1919963|FG000|Overall Study|Intercurrent Illness|1
933882|NCT00948428|1919964|FG001|Overall Study|Intercurrent Illness|0
933883|NCT00948428|1919965|FG002|Overall Study|Intercurrent Illness|0
933884|NCT00948428|1919963|FG000|Overall Study|Non-compliance|1
933885|NCT00948428|1919964|FG001|Overall Study|Non-compliance|2
933886|NCT00948428|1919965|FG002|Overall Study|Non-compliance|0
933887|NCT00948441|1919975|FG000|Overall Study|no longer meet inclusion criteria|1
933888|NCT00948441|1919976|FG001|Overall Study|no longer meet inclusion criteria|4
933889|NCT00948506|1919986|FG000|Overall Study|Withdrawal by Subject|3
933890|NCT00948506|1919987|FG001|Overall Study|Withdrawal by Subject|1
933891|NCT00948675|1920007|FG000|Overall Study|Lost to Follow-up|1
933892|NCT00948675|1920008|FG001|Overall Study|Lost to Follow-up|0
933893|NCT00948688|1920014|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1
933894|NCT00948688|1920015|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0
933895|NCT00948688|1920014|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1
933896|NCT00948688|1920015|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0
933897|NCT00948688|1920014|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0
933898|NCT00948688|1920015|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1
933899|NCT00948766|1920024|FG000|Core Study|Adverse Event|73
933900|NCT00948766|1920025|FG001|Core Study|Adverse Event|51
933901|NCT00948766|1920024|FG000|Core Study|Unsatisfactory Therapeutic Effect|13
933902|NCT00948766|1920025|FG001|Core Study|Unsatisfactory Therapeutic Effect|14
933903|NCT00948766|1920024|FG000|Core Study|Patient Withdrew Consent|27
933904|NCT00948766|1920025|FG001|Core Study|Patient Withdrew Consent|46
933905|NCT00948766|1920024|FG000|Core Study|Lost to Follow-up|3
933906|NCT00948766|1920025|FG001|Core Study|Lost to Follow-up|2
933907|NCT00948766|1920024|FG000|Core Study|Administrative Problems|2
933908|NCT00948766|1920025|FG001|Core Study|Administrative Problems|2
933909|NCT00948766|1920024|FG000|Core Study|Death|1
933910|NCT00948766|1920025|FG001|Core Study|Death|1
933911|NCT00948766|1920024|FG000|Core Study|Protocol Deviation|8
933912|NCT00948766|1920025|FG001|Core Study|Protocol Deviation|10
933913|NCT00948766|1920024|FG000|Extension Study|Adverse Event|43
933914|NCT00948766|1920025|FG001|Extension Study|Adverse Event|0
933915|NCT00948766|1920024|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2
933916|NCT00948766|1920025|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0
933917|NCT00948766|1920024|FG000|Extension Study|Study Drug No Longer Required|1
933918|NCT00948766|1920025|FG001|Extension Study|Study Drug No Longer Required|0
933919|NCT00948766|1920024|FG000|Extension Study|Patient Withdrew Consent|32
933920|NCT00948766|1920025|FG001|Extension Study|Patient Withdrew Consent|0
933921|NCT00948766|1920024|FG000|Extension Study|Lost to Follow-up|8
933922|NCT00948766|1920025|FG001|Extension Study|Lost to Follow-up|0
933923|NCT00948766|1920024|FG000|Extension Study|Administrative Problems|1
933924|NCT00948766|1920025|FG001|Extension Study|Administrative Problems|0
933925|NCT00948766|1920024|FG000|Extension Study|Death|4
933926|NCT00948766|1920025|FG001|Extension Study|Death|0
933927|NCT00948818|1920040|FG000|Overall Study|Adverse Event|10
933928|NCT00948818|1920041|FG001|Overall Study|Adverse Event|32
933929|NCT00948818|1920040|FG000|Overall Study|Protocol Violation|9
933930|NCT00948818|1920041|FG001|Overall Study|Protocol Violation|10
933931|NCT00948818|1920040|FG000|Overall Study|Withdrawal by Subject|25
933932|NCT00948818|1920041|FG001|Overall Study|Withdrawal by Subject|25
933933|NCT00948818|1920040|FG000|Overall Study|Lost to Follow-up|10
933934|NCT00948818|1920041|FG001|Overall Study|Lost to Follow-up|17
933935|NCT00948818|1920040|FG000|Overall Study|Lack of Efficacy|4
933936|NCT00948818|1920041|FG001|Overall Study|Lack of Efficacy|5
933937|NCT00948818|1920040|FG000|Overall Study|Other Reason|4
933938|NCT00948818|1920041|FG001|Overall Study|Other Reason|5
933939|NCT00948857|1920052|FG000|Overall Study|Lost to Follow-up|1
933940|NCT00948857|1920053|FG001|Overall Study|Lost to Follow-up|0
933941|NCT00948896|1920067|FG000|Randomization to 24 Months of Age|Death|1
933942|NCT00948896|1920068|FG001|Randomization to 24 Months of Age|Death|0
933943|NCT00948896|1920069|FG002|Randomization to 24 Months of Age|Death|0
933944|NCT00948896|1920070|FG003|Randomization to 24 Months of Age|Death|0
933945|NCT00948896|1920071|FG004|Randomization to 24 Months of Age|Death|2
933946|NCT00948896|1920072|FG005|Randomization to 24 Months of Age|Death|1
933947|NCT00948896|1920073|FG006|Randomization to 24 Months of Age|Death|2
933948|NCT00948896|1920074|FG007|Randomization to 24 Months of Age|Death|1
933949|NCT00948896|1920067|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3
933950|NCT00948896|1920068|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5
933951|NCT00948896|1920069|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4
933952|NCT00948896|1920070|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4
933953|NCT00948896|1920071|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0
933954|NCT00948896|1920072|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1
933955|NCT00948896|1920073|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0
933956|NCT00948896|1920074|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0
933957|NCT00948896|1920067|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4
933958|NCT00948896|1920068|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4
933959|NCT00948896|1920069|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2
933960|NCT00948896|1920070|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5
933961|NCT00948896|1920071|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0
933962|NCT00948896|1920072|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0
933963|NCT00948896|1920073|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1
933964|NCT00948896|1920074|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0
933965|NCT00948896|1920067|FG000|Randomization to 24 Months of Age|Protocol Violation|0
933966|NCT00948896|1920068|FG001|Randomization to 24 Months of Age|Protocol Violation|1
933967|NCT00948896|1920069|FG002|Randomization to 24 Months of Age|Protocol Violation|0
933968|NCT00948896|1920070|FG003|Randomization to 24 Months of Age|Protocol Violation|1
933969|NCT00948896|1920071|FG004|Randomization to 24 Months of Age|Protocol Violation|0
933970|NCT00948896|1920072|FG005|Randomization to 24 Months of Age|Protocol Violation|0
933971|NCT00948896|1920073|FG006|Randomization to 24 Months of Age|Protocol Violation|1
933972|NCT00948896|1920074|FG007|Randomization to 24 Months of Age|Protocol Violation|1
933973|NCT00948896|1920067|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0
933974|NCT00948896|1920068|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3
933975|NCT00948896|1920069|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3
933976|NCT00948896|1920070|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1
933977|NCT00948896|1920071|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0
933978|NCT00948896|1920072|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2
933979|NCT00948896|1920073|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0
933980|NCT00948896|1920074|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0
933981|NCT00948896|1920067|FG000|24 Months of Age to 36 Months of Age|Death|0
933982|NCT00948896|1920068|FG001|24 Months of Age to 36 Months of Age|Death|2
933983|NCT00948896|1920069|FG002|24 Months of Age to 36 Months of Age|Death|2
933984|NCT00948896|1920070|FG003|24 Months of Age to 36 Months of Age|Death|0
933985|NCT00948896|1920071|FG004|24 Months of Age to 36 Months of Age|Death|0
933986|NCT00948896|1920072|FG005|24 Months of Age to 36 Months of Age|Death|1
933987|NCT00948896|1920073|FG006|24 Months of Age to 36 Months of Age|Death|0
933988|NCT00948896|1920074|FG007|24 Months of Age to 36 Months of Age|Death|0
933989|NCT00948896|1920067|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
933990|NCT00948896|1920068|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
933991|NCT00948896|1920069|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
933992|NCT00948896|1920070|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
933993|NCT00948896|1920071|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
933994|NCT00948896|1920072|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
933995|NCT00948896|1920073|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
933996|NCT00948896|1920074|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
933997|NCT00948896|1920067|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
933998|NCT00948896|1920068|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
933999|NCT00948896|1920069|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
934000|NCT00948896|1920070|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
934001|NCT00948896|1920071|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
934002|NCT00948896|1920072|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
934003|NCT00948896|1920073|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
934004|NCT00948896|1920074|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
934005|NCT00948896|1920067|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0
934006|NCT00948896|1920068|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0
934007|NCT00948896|1920069|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1
934008|NCT00948896|1920070|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0
934009|NCT00948896|1920071|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0
934010|NCT00948896|1920072|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1
934011|NCT00948896|1920073|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0
934012|NCT00948896|1920074|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0
934013|NCT00948896|1920067|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
934014|NCT00948896|1920068|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
934015|NCT00948896|1920069|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
934016|NCT00948896|1920070|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
934017|NCT00948896|1920071|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
934018|NCT00948896|1920072|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
934019|NCT00948896|1920073|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
934020|NCT00948896|1920074|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
934021|NCT00948922|1920099|FG000|Overall Study|Did not start study treatment|2
934022|NCT00948922|1920100|FG001|Overall Study|Did not start study treatment|5
934023|NCT00948922|1920101|FG002|Overall Study|Did not start study treatment|0
934024|NCT00948922|1920099|FG000|Overall Study|Withdrawal by Subject|0
934025|NCT00948922|1920100|FG001|Overall Study|Withdrawal by Subject|2
934026|NCT00948922|1920101|FG002|Overall Study|Withdrawal by Subject|1
934027|NCT00948922|1920099|FG000|Overall Study|Death|3
934028|NCT00948922|1920100|FG001|Overall Study|Death|0
934029|NCT00948922|1920101|FG002|Overall Study|Death|0
934030|NCT00948922|1920099|FG000|Overall Study|Disease progression|0
934031|NCT00948922|1920100|FG001|Overall Study|Disease progression|1
934032|NCT00948922|1920101|FG002|Overall Study|Disease progression|0
934033|NCT00948922|1920099|FG000|Overall Study|Insurance issues|1
934034|NCT00948922|1920100|FG001|Overall Study|Insurance issues|0
934035|NCT00948922|1920101|FG002|Overall Study|Insurance issues|0
934036|NCT00948922|1920099|FG000|Overall Study|Transplant eligibility issues|2
934037|NCT00948922|1920100|FG001|Overall Study|Transplant eligibility issues|3
934038|NCT00948922|1920101|FG002|Overall Study|Transplant eligibility issues|0
934039|NCT00948922|1920099|FG000|Overall Study|Not evaluable at time of analysis|0
934040|NCT00948922|1920100|FG001|Overall Study|Not evaluable at time of analysis|3
934041|NCT00948922|1920101|FG002|Overall Study|Not evaluable at time of analysis|0
934042|NCT00948974|1920119|FG000|Overall Study|Lost to Follow-up|23
934043|NCT00948974|1920120|FG001|Overall Study|Lost to Follow-up|20
934044|NCT00949117|1920137|FG000|Overall Study|Lack of Efficacy|2
934045|NCT00949117|1920138|FG001|Overall Study|Lack of Efficacy|3
934046|NCT00949117|1920137|FG000|Overall Study|Protocol Violation|1
934047|NCT00949117|1920138|FG001|Overall Study|Protocol Violation|1
934048|NCT00949117|1920137|FG000|Overall Study|Adverse Event|0
934049|NCT00949117|1920138|FG001|Overall Study|Adverse Event|1
934050|NCT00949325|1920150|FG000|Overall Study|Adverse Event|0
934051|NCT00949325|1920151|FG001|Overall Study|Adverse Event|2
934052|NCT00949325|1920152|FG002|Overall Study|Adverse Event|0
934053|NCT00949533|1920170|FG000|Overall Study|Lost to Follow-up|0
934054|NCT00949533|1920171|FG001|Overall Study|Lost to Follow-up|1
934055|NCT00949650|1920179|FG000|Overall Study|Progressive disease|188
934056|NCT00949650|1920180|FG001|Overall Study|Progressive disease|19
934057|NCT00949650|1920179|FG000|Overall Study|Completed 6 courses of chemotherapy|0
934058|NCT00949650|1920180|FG001|Overall Study|Completed 6 courses of chemotherapy|60
934059|NCT00949650|1920179|FG000|Overall Study|Other Adverse Event (AE)|28
934060|NCT00949650|1920180|FG001|Overall Study|Other Adverse Event (AE)|17
934061|NCT00949650|1920179|FG000|Overall Study|Protocol Violation|1
934062|NCT00949650|1920180|FG001|Overall Study|Protocol Violation|4
934063|NCT00949650|1920179|FG000|Overall Study|Refusal to continue medication|7
934064|NCT00949650|1920180|FG001|Overall Study|Refusal to continue medication|11
934065|NCT00949650|1920179|FG000|Overall Study|Not treated|1
934066|NCT00949650|1920180|FG001|Overall Study|Not treated|4
934067|NCT00949650|1920179|FG000|Overall Study|Other not specified above|5
934068|NCT00949650|1920180|FG001|Overall Study|Other not specified above|0
934069|NCT00949702|1920190|FG000|Overall Study|Death|40
934070|NCT00949702|1920190|FG000|Overall Study|Disease progression|7
934071|NCT00949702|1920190|FG000|Overall Study|Withdrawal of consent|1
934072|NCT00949715|1920196|FG000|Overall Study|Physician Decision|1
934073|NCT00949715|1920197|FG001|Overall Study|Physician Decision|0
934074|NCT00949715|1920196|FG000|Overall Study|Lost to Follow-up|1
934075|NCT00949715|1920197|FG001|Overall Study|Lost to Follow-up|0
934076|NCT00949715|1920196|FG000|Overall Study|Missing 24 month LVEF measurement|2
934077|NCT00949715|1920197|FG001|Overall Study|Missing 24 month LVEF measurement|0
934078|NCT00949884|1920205|FG000|Overall Study|Adverse Event|14
934079|NCT00949884|1920206|FG001|Overall Study|Adverse Event|3
934080|NCT00949884|1920207|FG002|Overall Study|Adverse Event|12
934081|NCT00949884|1920205|FG000|Overall Study|Did not meet inclusion/exclusion|2
934082|NCT00949884|1920206|FG001|Overall Study|Did not meet inclusion/exclusion|1
934083|NCT00949884|1920207|FG002|Overall Study|Did not meet inclusion/exclusion|3
934084|NCT00949884|1920205|FG000|Overall Study|Lost to Follow-up|7
934085|NCT00949884|1920206|FG001|Overall Study|Lost to Follow-up|5
934086|NCT00949884|1920207|FG002|Overall Study|Lost to Follow-up|5
934087|NCT00949884|1920205|FG000|Overall Study|Physician Decision|5
934088|NCT00949884|1920206|FG001|Overall Study|Physician Decision|0
934089|NCT00949884|1920207|FG002|Overall Study|Physician Decision|6
934090|NCT00949884|1920205|FG000|Overall Study|Treatment non-compliance|5
934091|NCT00949884|1920206|FG001|Overall Study|Treatment non-compliance|0
934092|NCT00949884|1920207|FG002|Overall Study|Treatment non-compliance|8
934093|NCT00949884|1920205|FG000|Overall Study|Withdrawal by Subject|13
934094|NCT00949884|1920206|FG001|Overall Study|Withdrawal by Subject|4
934095|NCT00949884|1920207|FG002|Overall Study|Withdrawal by Subject|16
934096|NCT00949884|1920205|FG000|Overall Study|Lack of Efficacy|4
934097|NCT00949884|1920206|FG001|Overall Study|Lack of Efficacy|2
934098|NCT00949884|1920207|FG002|Overall Study|Lack of Efficacy|7
934099|NCT00949884|1920205|FG000|Overall Study|Study terminated by sponsor|0
934100|NCT00949884|1920206|FG001|Overall Study|Study terminated by sponsor|0
934101|NCT00949884|1920207|FG002|Overall Study|Study terminated by sponsor|1
934102|NCT00949910|1920216|FG000|Overall Study|Progressive Disease|3750
934103|NCT00949910|1920216|FG000|Overall Study|Symptomatic Deterioration|1088
934104|NCT00949910|1920216|FG000|Overall Study|Lost to Follow-up|100
934105|NCT00949910|1920216|FG000|Overall Study|Study Drug-Related Adverse Event|315
934106|NCT00949910|1920216|FG000|Overall Study|Participant Refusal|390
934107|NCT00949910|1920216|FG000|Overall Study|Death Due to Malignant Disease|456
934108|NCT00949910|1920216|FG000|Overall Study|Death Due to Progression/Deterioration|4
934109|NCT00949910|1920216|FG000|Overall Study|Death Due to Adverse Event|115
934110|NCT00949910|1920216|FG000|Overall Study|Death Due to Toxicity|3
934111|NCT00949910|1920216|FG000|Overall Study|Death from Unknown Cause|5
934112|NCT00949910|1920216|FG000|Overall Study|Unspecified Progression/Deterioration|13
934113|NCT00949910|1920216|FG000|Overall Study|Switched to Compassionate/Other Use|174
934114|NCT00949910|1920216|FG000|Overall Study|Switched to Commercial Treatment|4
934115|NCT00949910|1920216|FG000|Overall Study|Violation of Eligibility|23
934116|NCT00949910|1920216|FG000|Overall Study|Logistical Reasons|13
934117|NCT00949910|1920216|FG000|Overall Study|Non-Compliance|10
934118|NCT00949910|1920216|FG000|Overall Study|Prolonged Dosing Interruption|4
934119|NCT00949910|1920216|FG000|Overall Study|Adverse Event|83
934120|NCT00949910|1920216|FG000|Overall Study|Serious Adverse Event|6
934121|NCT00949910|1920216|FG000|Overall Study|Physician/Participant Decision|7
934122|NCT00949910|1920216|FG000|Overall Study|Other|4
934123|NCT00949910|1920216|FG000|Overall Study|No Data|9
934124|NCT00949975|1920224|FG000|Overall Study|Voluntary discontinuation|6
934125|NCT00949975|1920225|FG001|Overall Study|Voluntary discontinuation|5
934126|NCT00949975|1920226|FG002|Overall Study|Voluntary discontinuation|3
934127|NCT00949975|1920227|FG003|Overall Study|Voluntary discontinuation|6
934128|NCT00949975|1920224|FG000|Overall Study|Adverse Event|11
934129|NCT00949975|1920225|FG001|Overall Study|Adverse Event|11
934130|NCT00949975|1920226|FG002|Overall Study|Adverse Event|10
934131|NCT00949975|1920227|FG003|Overall Study|Adverse Event|10
934132|NCT00949975|1920224|FG000|Overall Study|Safety reason|0
934133|NCT00949975|1920225|FG001|Overall Study|Safety reason|1
934134|NCT00949975|1920226|FG002|Overall Study|Safety reason|0
934135|NCT00949975|1920227|FG003|Overall Study|Safety reason|0
934136|NCT00949975|1920224|FG000|Overall Study|Study-specific criteria|0
934137|NCT00949975|1920225|FG001|Overall Study|Study-specific criteria|1
934138|NCT00949975|1920226|FG002|Overall Study|Study-specific criteria|1
934139|NCT00949975|1920227|FG003|Overall Study|Study-specific criteria|0
934140|NCT00949975|1920224|FG000|Overall Study|Incorrect enrolment|5
934141|NCT00949975|1920225|FG001|Overall Study|Incorrect enrolment|10
934142|NCT00949975|1920226|FG002|Overall Study|Incorrect enrolment|4
934143|NCT00949975|1920227|FG003|Overall Study|Incorrect enrolment|7
934144|NCT00949975|1920224|FG000|Overall Study|Severe non-compliance|3
934145|NCT00949975|1920225|FG001|Overall Study|Severe non-compliance|1
934146|NCT00949975|1920226|FG002|Overall Study|Severe non-compliance|0
934147|NCT00949975|1920227|FG003|Overall Study|Severe non-compliance|2
934148|NCT00949975|1920224|FG000|Overall Study|Lost to Follow-up|1
934149|NCT00949975|1920225|FG001|Overall Study|Lost to Follow-up|0
934150|NCT00949975|1920226|FG002|Overall Study|Lost to Follow-up|1
934151|NCT00949975|1920227|FG003|Overall Study|Lost to Follow-up|3
934152|NCT00949975|1920224|FG000|Overall Study|Other|1
934153|NCT00949975|1920225|FG001|Overall Study|Other|0
934154|NCT00949975|1920226|FG002|Overall Study|Other|0
934155|NCT00949975|1920227|FG003|Overall Study|Other|0
934156|NCT00950170|1920237|FG000|Overall Study|Parent/Legal Guardian Request|1
934157|NCT00950170|1920237|FG000|Overall Study|Adverse Event|2
934158|NCT00950170|1920237|FG000|Overall Study|Discontinuation of Study by Sponsor|1
934159|NCT00950248|1920270|FG000|Year 1: Baseline|Withdrawal by Subject|6
934160|NCT00950248|1920271|FG001|Year 1: Baseline|Withdrawal by Subject|0
934161|NCT00950248|1920272|FG002|Year 1: Baseline|Withdrawal by Subject|0
934162|NCT00950248|1920270|FG000|Year 1: Baseline|worsening of symptoms|2
934163|NCT00950248|1920271|FG001|Year 1: Baseline|worsening of symptoms|0
934164|NCT00950248|1920272|FG002|Year 1: Baseline|worsening of symptoms|0
934165|NCT00950248|1920270|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0
934166|NCT00950248|1920271|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2
934167|NCT00950248|1920272|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4
934168|NCT00950248|1920270|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
934169|NCT00950248|1920271|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
934170|NCT00950248|1920272|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
934171|NCT00950248|1920270|FG000|Year 2&3 Treatment Randomization|Death|0
934172|NCT00950248|1920271|FG001|Year 2&3 Treatment Randomization|Death|0
934173|NCT00950248|1920272|FG002|Year 2&3 Treatment Randomization|Death|1
934174|NCT00950248|1920270|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0
934175|NCT00950248|1920271|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1
934176|NCT00950248|1920272|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0
934177|NCT00950300|1920281|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
934178|NCT00950300|1920282|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
934179|NCT00950300|1920281|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1
934180|NCT00950300|1920282|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3
934181|NCT00950300|1920281|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
934182|NCT00950300|1920282|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
934183|NCT00950300|1920281|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
934184|NCT00950300|1920282|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
934185|NCT00950300|1920281|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
934186|NCT00950300|1920282|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
934187|NCT00950300|1920281|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
934188|NCT00950300|1920282|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
934189|NCT00950300|1920281|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
934190|NCT00950300|1920282|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
934191|NCT00950300|1920281|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
934192|NCT00950300|1920282|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
934193|NCT00950300|1920281|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
934194|NCT00950300|1920282|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
934195|NCT00950300|1920281|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1
934196|NCT00950300|1920282|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1
934197|NCT00950300|1920281|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3
934198|NCT00950300|1920282|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4
934199|NCT00950300|1920281|FG000|TFFU Period|Death|4
934200|NCT00950300|1920282|FG001|TFFU Period|Death|1
934201|NCT00950300|1920281|FG000|TFFU Period|Refused Treatment|10
934202|NCT00950300|1920282|FG001|TFFU Period|Refused Treatment|11
934203|NCT00950300|1920281|FG000|TFFU Period|Failure to Return|16
934204|NCT00950300|1920282|FG001|TFFU Period|Failure to Return|16
934205|NCT00950300|1920281|FG000|TFFU Period|Recurrence of Disease|63
934206|NCT00950300|1920282|FG001|TFFU Period|Recurrence of Disease|72
934207|NCT00950300|1920281|FG000|TFFU Period|Other|4
934208|NCT00950300|1920282|FG001|TFFU Period|Other|3
934209|NCT00950300|1920281|FG000|SFU Period|Death|44
934210|NCT00950300|1920282|FG001|SFU Period|Death|42
934211|NCT00950300|1920281|FG000|SFU Period|Lost to Follow-up|30
934212|NCT00950300|1920282|FG001|SFU Period|Lost to Follow-up|28
934213|NCT00950300|1920281|FG000|SFU Period|Withdrawal by Subject|4
934214|NCT00950300|1920282|FG001|SFU Period|Withdrawal by Subject|8
934215|NCT00950599|1920315|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0
934216|NCT00950599|1920316|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0
934217|NCT00950599|1920317|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0
934218|NCT00950599|1920318|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1
934219|NCT00950599|1920319|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0
934220|NCT00950599|1920320|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0
934221|NCT00950599|1920321|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0
934222|NCT00950599|1920322|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0
934223|NCT00950599|1920323|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0
934224|NCT00950599|1920324|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0
934225|NCT00950599|1920315|FG000|Double-Blind Treatment Period|Adverse Event|0
934226|NCT00950599|1920316|FG001|Double-Blind Treatment Period|Adverse Event|1
934227|NCT00950599|1920317|FG002|Double-Blind Treatment Period|Adverse Event|1
934228|NCT00950599|1920318|FG003|Double-Blind Treatment Period|Adverse Event|1
934229|NCT00950599|1920319|FG004|Double-Blind Treatment Period|Adverse Event|1
934230|NCT00950599|1920320|FG005|Double-Blind Treatment Period|Adverse Event|1
934231|NCT00950599|1920321|FG006|Double-Blind Treatment Period|Adverse Event|0
934232|NCT00950599|1920322|FG007|Double-Blind Treatment Period|Adverse Event|0
934233|NCT00950599|1920323|FG008|Double-Blind Treatment Period|Adverse Event|0
934234|NCT00950599|1920324|FG009|Double-Blind Treatment Period|Adverse Event|0
934235|NCT00950599|1920315|FG000|Double-Blind Treatment Period|Lack of Efficacy|2
934236|NCT00950599|1920316|FG001|Double-Blind Treatment Period|Lack of Efficacy|5
934237|NCT00950599|1920317|FG002|Double-Blind Treatment Period|Lack of Efficacy|5
934238|NCT00950599|1920318|FG003|Double-Blind Treatment Period|Lack of Efficacy|7
934239|NCT00950599|1920319|FG004|Double-Blind Treatment Period|Lack of Efficacy|3
934240|NCT00950599|1920320|FG005|Double-Blind Treatment Period|Lack of Efficacy|6
934241|NCT00950599|1920321|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
934242|NCT00950599|1920322|FG007|Double-Blind Treatment Period|Lack of Efficacy|1
934243|NCT00950599|1920323|FG008|Double-Blind Treatment Period|Lack of Efficacy|0
934244|NCT00950599|1920324|FG009|Double-Blind Treatment Period|Lack of Efficacy|0
934245|NCT00950599|1920315|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
934246|NCT00950599|1920316|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
934247|NCT00950599|1920317|FG002|Double-Blind Treatment Period|Lost to Follow-up|0
934248|NCT00950599|1920318|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
934249|NCT00950599|1920319|FG004|Double-Blind Treatment Period|Lost to Follow-up|1
934250|NCT00950599|1920320|FG005|Double-Blind Treatment Period|Lost to Follow-up|2
934251|NCT00950599|1920321|FG006|Double-Blind Treatment Period|Lost to Follow-up|0
934252|NCT00950599|1920322|FG007|Double-Blind Treatment Period|Lost to Follow-up|1
934253|NCT00950599|1920323|FG008|Double-Blind Treatment Period|Lost to Follow-up|0
934254|NCT00950599|1920324|FG009|Double-Blind Treatment Period|Lost to Follow-up|0
934255|NCT00950599|1920315|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1
934256|NCT00950599|1920316|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1
934257|NCT00950599|1920317|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0
934258|NCT00950599|1920318|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0
934259|NCT00950599|1920319|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0
934260|NCT00950599|1920320|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0
934261|NCT00950599|1920321|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0
934262|NCT00950599|1920322|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1
934263|NCT00950599|1920323|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0
934264|NCT00950599|1920324|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0
934265|NCT00950599|1920315|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0
934266|NCT00950599|1920316|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0
934267|NCT00950599|1920317|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0
934268|NCT00950599|1920318|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0
934269|NCT00950599|1920319|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1
934270|NCT00950599|1920320|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1
934271|NCT00950599|1920321|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0
934272|NCT00950599|1920322|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0
934273|NCT00950599|1920323|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0
934274|NCT00950599|1920324|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0
934275|NCT00950599|1920315|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4
934276|NCT00950599|1920316|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3
934277|NCT00950599|1920317|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3
934278|NCT00950599|1920318|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1
934279|NCT00950599|1920319|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1
934280|NCT00950599|1920320|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2
934281|NCT00950599|1920321|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0
934282|NCT00950599|1920322|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3
934283|NCT00950599|1920323|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0
934284|NCT00950599|1920324|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0
934285|NCT00950599|1920315|FG000|Follow-Up Period|Adverse Event|0
934286|NCT00950599|1920316|FG001|Follow-Up Period|Adverse Event|0
934287|NCT00950599|1920317|FG002|Follow-Up Period|Adverse Event|0
934288|NCT00950599|1920318|FG003|Follow-Up Period|Adverse Event|0
934289|NCT00950599|1920319|FG004|Follow-Up Period|Adverse Event|0
934290|NCT00950599|1920320|FG005|Follow-Up Period|Adverse Event|0
934291|NCT00950599|1920321|FG006|Follow-Up Period|Adverse Event|0
934292|NCT00950599|1920322|FG007|Follow-Up Period|Adverse Event|0
934293|NCT00950599|1920323|FG008|Follow-Up Period|Adverse Event|1
934294|NCT00950599|1920324|FG009|Follow-Up Period|Adverse Event|0
934295|NCT00950599|1920315|FG000|Follow-Up Period|Lack of Efficacy|0
934296|NCT00950599|1920316|FG001|Follow-Up Period|Lack of Efficacy|0
934297|NCT00950599|1920317|FG002|Follow-Up Period|Lack of Efficacy|0
934298|NCT00950599|1920318|FG003|Follow-Up Period|Lack of Efficacy|0
934299|NCT00950599|1920319|FG004|Follow-Up Period|Lack of Efficacy|0
934300|NCT00950599|1920320|FG005|Follow-Up Period|Lack of Efficacy|0
934301|NCT00950599|1920321|FG006|Follow-Up Period|Lack of Efficacy|0
934302|NCT00950599|1920322|FG007|Follow-Up Period|Lack of Efficacy|0
934303|NCT00950599|1920323|FG008|Follow-Up Period|Lack of Efficacy|3
934304|NCT00950599|1920324|FG009|Follow-Up Period|Lack of Efficacy|0
934305|NCT00950599|1920315|FG000|Follow-Up Period|Lost to Follow-up|0
934306|NCT00950599|1920316|FG001|Follow-Up Period|Lost to Follow-up|0
934307|NCT00950599|1920317|FG002|Follow-Up Period|Lost to Follow-up|0
934308|NCT00950599|1920318|FG003|Follow-Up Period|Lost to Follow-up|0
934309|NCT00950599|1920319|FG004|Follow-Up Period|Lost to Follow-up|0
934310|NCT00950599|1920320|FG005|Follow-Up Period|Lost to Follow-up|0
934311|NCT00950599|1920321|FG006|Follow-Up Period|Lost to Follow-up|0
934312|NCT00950599|1920322|FG007|Follow-Up Period|Lost to Follow-up|0
934313|NCT00950599|1920323|FG008|Follow-Up Period|Lost to Follow-up|5
934314|NCT00950599|1920324|FG009|Follow-Up Period|Lost to Follow-up|1
934315|NCT00950599|1920315|FG000|Follow-Up Period|Physician Decision|0
934316|NCT00950599|1920316|FG001|Follow-Up Period|Physician Decision|0
934317|NCT00950599|1920317|FG002|Follow-Up Period|Physician Decision|0
934318|NCT00950599|1920318|FG003|Follow-Up Period|Physician Decision|0
934319|NCT00950599|1920319|FG004|Follow-Up Period|Physician Decision|0
934320|NCT00950599|1920320|FG005|Follow-Up Period|Physician Decision|0
934321|NCT00950599|1920321|FG006|Follow-Up Period|Physician Decision|0
934322|NCT00950599|1920322|FG007|Follow-Up Period|Physician Decision|0
934323|NCT00950599|1920323|FG008|Follow-Up Period|Physician Decision|1
934324|NCT00950599|1920324|FG009|Follow-Up Period|Physician Decision|0
934325|NCT00950599|1920315|FG000|Follow-Up Period|Poor/Noncompliance|0
934326|NCT00950599|1920316|FG001|Follow-Up Period|Poor/Noncompliance|0
934327|NCT00950599|1920317|FG002|Follow-Up Period|Poor/Noncompliance|0
934328|NCT00950599|1920318|FG003|Follow-Up Period|Poor/Noncompliance|0
934329|NCT00950599|1920319|FG004|Follow-Up Period|Poor/Noncompliance|0
934330|NCT00950599|1920320|FG005|Follow-Up Period|Poor/Noncompliance|0
934331|NCT00950599|1920321|FG006|Follow-Up Period|Poor/Noncompliance|0
934332|NCT00950599|1920322|FG007|Follow-Up Period|Poor/Noncompliance|0
934333|NCT00950599|1920323|FG008|Follow-Up Period|Poor/Noncompliance|1
934334|NCT00950599|1920324|FG009|Follow-Up Period|Poor/Noncompliance|0
934335|NCT00950599|1920315|FG000|Follow-Up Period|Subject withdrew Consent|0
934336|NCT00950599|1920316|FG001|Follow-Up Period|Subject withdrew Consent|0
934337|NCT00950599|1920317|FG002|Follow-Up Period|Subject withdrew Consent|0
934338|NCT00950599|1920318|FG003|Follow-Up Period|Subject withdrew Consent|0
934339|NCT00950599|1920319|FG004|Follow-Up Period|Subject withdrew Consent|0
934340|NCT00950599|1920320|FG005|Follow-Up Period|Subject withdrew Consent|0
934341|NCT00950599|1920321|FG006|Follow-Up Period|Subject withdrew Consent|0
934342|NCT00950599|1920322|FG007|Follow-Up Period|Subject withdrew Consent|0
934343|NCT00950599|1920323|FG008|Follow-Up Period|Subject withdrew Consent|2
934344|NCT00950599|1920324|FG009|Follow-Up Period|Subject withdrew Consent|1
934345|NCT00950651|1920358|FG000|Overall Study|Adverse Event|17
934346|NCT00950651|1920359|FG001|Overall Study|Adverse Event|20
934347|NCT00950651|1920358|FG000|Overall Study|Death|1
934348|NCT00950651|1920359|FG001|Overall Study|Death|0
934349|NCT00950651|1920358|FG000|Overall Study|Lack of Efficacy|2
934350|NCT00950651|1920359|FG001|Overall Study|Lack of Efficacy|2
934351|NCT00950651|1920358|FG000|Overall Study|Protocol Violation|3
934352|NCT00950651|1920359|FG001|Overall Study|Protocol Violation|4
934353|NCT00950651|1920358|FG000|Overall Study|Withdrawal by Subject|8
934354|NCT00950651|1920359|FG001|Overall Study|Withdrawal by Subject|9
934355|NCT00950664|1920367|FG000|First Intervention|Lost to Follow-up|1
934356|NCT00950664|1920368|FG001|First Intervention|Lost to Follow-up|3
934357|NCT00950664|1920367|FG000|First Intervention|Withdrawal by Subject|2
934358|NCT00950664|1920368|FG001|First Intervention|Withdrawal by Subject|2
934359|NCT00950742|1920380|FG000|Overall Study|Other Adverse Event|1
934360|NCT00950742|1920381|FG001|Overall Study|Other Adverse Event|0
934361|NCT00950742|1920380|FG000|Overall Study|Withdrawal by Subject|3
934362|NCT00950742|1920381|FG001|Overall Study|Withdrawal by Subject|0
934363|NCT00950742|1920380|FG000|Overall Study|Progressive Disease|6
934364|NCT00950742|1920381|FG001|Overall Study|Progressive Disease|2
934365|NCT00950742|1920380|FG000|Overall Study|Dose limiting toxicity|6
934366|NCT00950742|1920381|FG001|Overall Study|Dose limiting toxicity|0
934367|NCT00950755|1920391|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
934368|NCT00950755|1920391|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
934369|NCT00950755|1920391|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27
934370|NCT00950755|1920391|FG000|Dosimetric and Therapeutic Treatment|Death|1
934371|NCT00950755|1920391|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
934372|NCT00950755|1920391|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
934373|NCT00950755|1920391|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
934374|NCT00950755|1920391|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
934375|NCT00950755|1920391|FG000|Long-Term Follow-Up|Lost to Follow-up|1
934376|NCT00950755|1920391|FG000|Long-Term Follow-Up|Death|8
934377|NCT00950807|1920395|FG000|Treatment Period 1|Lack of Efficacy|1
934378|NCT00950807|1920396|FG001|Treatment Period 1|Lack of Efficacy|0
934379|NCT00950807|1920397|FG002|Treatment Period 1|Lack of Efficacy|0
934380|NCT00950807|1920398|FG003|Treatment Period 1|Lack of Efficacy|0
934381|NCT00950807|1920399|FG004|Treatment Period 1|Lack of Efficacy|0
934382|NCT00950807|1920400|FG005|Treatment Period 1|Lack of Efficacy|1
934383|NCT00950807|1920401|FG006|Treatment Period 1|Lack of Efficacy|0
934384|NCT00950807|1920402|FG007|Treatment Period 1|Lack of Efficacy|0
934385|NCT00950807|1920403|FG008|Treatment Period 1|Lack of Efficacy|0
934386|NCT00950807|1920404|FG009|Treatment Period 1|Lack of Efficacy|0
934387|NCT00950807|1920395|FG000|Treatment Period 1|Protocol Violation|1
934388|NCT00950807|1920396|FG001|Treatment Period 1|Protocol Violation|0
934389|NCT00950807|1920397|FG002|Treatment Period 1|Protocol Violation|0
934390|NCT00950807|1920398|FG003|Treatment Period 1|Protocol Violation|0
934391|NCT00950807|1920399|FG004|Treatment Period 1|Protocol Violation|0
934392|NCT00950807|1920400|FG005|Treatment Period 1|Protocol Violation|0
934393|NCT00950807|1920401|FG006|Treatment Period 1|Protocol Violation|0
934394|NCT00950807|1920402|FG007|Treatment Period 1|Protocol Violation|0
934395|NCT00950807|1920403|FG008|Treatment Period 1|Protocol Violation|0
934396|NCT00950807|1920404|FG009|Treatment Period 1|Protocol Violation|0
934397|NCT00950807|1920395|FG000|Treatment Period 1|Lost to Follow-up|0
934398|NCT00950807|1920396|FG001|Treatment Period 1|Lost to Follow-up|0
934399|NCT00950807|1920397|FG002|Treatment Period 1|Lost to Follow-up|1
934400|NCT00950807|1920398|FG003|Treatment Period 1|Lost to Follow-up|0
934401|NCT00950807|1920399|FG004|Treatment Period 1|Lost to Follow-up|0
934402|NCT00950807|1920400|FG005|Treatment Period 1|Lost to Follow-up|0
934403|NCT00950807|1920401|FG006|Treatment Period 1|Lost to Follow-up|0
934404|NCT00950807|1920402|FG007|Treatment Period 1|Lost to Follow-up|0
934405|NCT00950807|1920403|FG008|Treatment Period 1|Lost to Follow-up|0
934406|NCT00950807|1920404|FG009|Treatment Period 1|Lost to Follow-up|0
934407|NCT00950807|1920395|FG000|Treatment Period 1|Withdrawal by Subject|1
934408|NCT00950807|1920396|FG001|Treatment Period 1|Withdrawal by Subject|0
934409|NCT00950807|1920397|FG002|Treatment Period 1|Withdrawal by Subject|0
934410|NCT00950807|1920398|FG003|Treatment Period 1|Withdrawal by Subject|0
934411|NCT00950807|1920399|FG004|Treatment Period 1|Withdrawal by Subject|1
934412|NCT00950807|1920400|FG005|Treatment Period 1|Withdrawal by Subject|0
934413|NCT00950807|1920401|FG006|Treatment Period 1|Withdrawal by Subject|0
934414|NCT00950807|1920402|FG007|Treatment Period 1|Withdrawal by Subject|0
934415|NCT00950807|1920403|FG008|Treatment Period 1|Withdrawal by Subject|1
934416|NCT00950807|1920404|FG009|Treatment Period 1|Withdrawal by Subject|0
934417|NCT00950807|1920395|FG000|Treatment Period 1|Adverse Event|0
934418|NCT00950807|1920396|FG001|Treatment Period 1|Adverse Event|0
934419|NCT00950807|1920397|FG002|Treatment Period 1|Adverse Event|0
934420|NCT00950807|1920398|FG003|Treatment Period 1|Adverse Event|0
934421|NCT00950807|1920399|FG004|Treatment Period 1|Adverse Event|0
934422|NCT00950807|1920400|FG005|Treatment Period 1|Adverse Event|1
934423|NCT00950807|1920401|FG006|Treatment Period 1|Adverse Event|0
934424|NCT00950807|1920402|FG007|Treatment Period 1|Adverse Event|0
934425|NCT00950807|1920403|FG008|Treatment Period 1|Adverse Event|0
934426|NCT00950807|1920404|FG009|Treatment Period 1|Adverse Event|0
934427|NCT00950807|1920395|FG000|Washout Period 1|Lack of Efficacy|0
934428|NCT00950807|1920396|FG001|Washout Period 1|Lack of Efficacy|0
934429|NCT00950807|1920397|FG002|Washout Period 1|Lack of Efficacy|0
934430|NCT00950807|1920398|FG003|Washout Period 1|Lack of Efficacy|0
934431|NCT00950807|1920399|FG004|Washout Period 1|Lack of Efficacy|0
934432|NCT00950807|1920400|FG005|Washout Period 1|Lack of Efficacy|0
934433|NCT00950807|1920401|FG006|Washout Period 1|Lack of Efficacy|1
934434|NCT00950807|1920402|FG007|Washout Period 1|Lack of Efficacy|0
934435|NCT00950807|1920403|FG008|Washout Period 1|Lack of Efficacy|0
934436|NCT00950807|1920404|FG009|Washout Period 1|Lack of Efficacy|0
934437|NCT00950807|1920395|FG000|Washout Period 1|Withdrawal by Subject|0
934438|NCT00950807|1920396|FG001|Washout Period 1|Withdrawal by Subject|0
934439|NCT00950807|1920397|FG002|Washout Period 1|Withdrawal by Subject|0
934440|NCT00950807|1920398|FG003|Washout Period 1|Withdrawal by Subject|0
934441|NCT00950807|1920399|FG004|Washout Period 1|Withdrawal by Subject|0
934442|NCT00950807|1920400|FG005|Washout Period 1|Withdrawal by Subject|0
934443|NCT00950807|1920401|FG006|Washout Period 1|Withdrawal by Subject|0
934444|NCT00950807|1920402|FG007|Washout Period 1|Withdrawal by Subject|0
934445|NCT00950807|1920403|FG008|Washout Period 1|Withdrawal by Subject|1
934446|NCT00950807|1920404|FG009|Washout Period 1|Withdrawal by Subject|0
934447|NCT00950807|1920395|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3
934448|NCT00950807|1920396|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0
934449|NCT00950807|1920397|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0
934450|NCT00950807|1920398|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0
934451|NCT00950807|1920399|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0
934452|NCT00950807|1920400|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0
934453|NCT00950807|1920401|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1
934454|NCT00950807|1920402|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1
934455|NCT00950807|1920403|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0
934456|NCT00950807|1920404|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0
934457|NCT00950807|1920395|FG000|Washout Period 1|Adverse Event|2
934458|NCT00950807|1920396|FG001|Washout Period 1|Adverse Event|0
934459|NCT00950807|1920397|FG002|Washout Period 1|Adverse Event|0
934460|NCT00950807|1920398|FG003|Washout Period 1|Adverse Event|1
934461|NCT00950807|1920399|FG004|Washout Period 1|Adverse Event|1
934462|NCT00950807|1920400|FG005|Washout Period 1|Adverse Event|0
934463|NCT00950807|1920401|FG006|Washout Period 1|Adverse Event|0
934464|NCT00950807|1920402|FG007|Washout Period 1|Adverse Event|0
934465|NCT00950807|1920403|FG008|Washout Period 1|Adverse Event|0
934466|NCT00950807|1920404|FG009|Washout Period 1|Adverse Event|0
934467|NCT00950807|1920395|FG000|Treatment Period 2|Lack of Efficacy|1
934468|NCT00950807|1920396|FG001|Treatment Period 2|Lack of Efficacy|0
934469|NCT00950807|1920397|FG002|Treatment Period 2|Lack of Efficacy|0
934470|NCT00950807|1920398|FG003|Treatment Period 2|Lack of Efficacy|0
934471|NCT00950807|1920399|FG004|Treatment Period 2|Lack of Efficacy|0
934472|NCT00950807|1920400|FG005|Treatment Period 2|Lack of Efficacy|0
934473|NCT00950807|1920401|FG006|Treatment Period 2|Lack of Efficacy|0
934474|NCT00950807|1920402|FG007|Treatment Period 2|Lack of Efficacy|0
934475|NCT00950807|1920403|FG008|Treatment Period 2|Lack of Efficacy|0
934476|NCT00950807|1920404|FG009|Treatment Period 2|Lack of Efficacy|0
934477|NCT00950807|1920395|FG000|Treatment Period 2|Withdrawal by Subject|0
934478|NCT00950807|1920396|FG001|Treatment Period 2|Withdrawal by Subject|0
934479|NCT00950807|1920397|FG002|Treatment Period 2|Withdrawal by Subject|0
934480|NCT00950807|1920398|FG003|Treatment Period 2|Withdrawal by Subject|0
934481|NCT00950807|1920399|FG004|Treatment Period 2|Withdrawal by Subject|0
934482|NCT00950807|1920400|FG005|Treatment Period 2|Withdrawal by Subject|0
934483|NCT00950807|1920401|FG006|Treatment Period 2|Withdrawal by Subject|1
934484|NCT00950807|1920402|FG007|Treatment Period 2|Withdrawal by Subject|2
934485|NCT00950807|1920403|FG008|Treatment Period 2|Withdrawal by Subject|0
934486|NCT00950807|1920404|FG009|Treatment Period 2|Withdrawal by Subject|0
934487|NCT00950807|1920395|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
934488|NCT00950807|1920396|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
934489|NCT00950807|1920397|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
934490|NCT00950807|1920398|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
934491|NCT00950807|1920399|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
934492|NCT00950807|1920400|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
934493|NCT00950807|1920401|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
934494|NCT00950807|1920402|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
934495|NCT00950807|1920403|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0
934496|NCT00950807|1920404|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0
934497|NCT00950807|1920395|FG000|Treatment Period 2|Adverse Event|0
934498|NCT00950807|1920396|FG001|Treatment Period 2|Adverse Event|1
934499|NCT00950807|1920397|FG002|Treatment Period 2|Adverse Event|0
934500|NCT00950807|1920398|FG003|Treatment Period 2|Adverse Event|1
934501|NCT00950807|1920399|FG004|Treatment Period 2|Adverse Event|0
934502|NCT00950807|1920400|FG005|Treatment Period 2|Adverse Event|1
934503|NCT00950807|1920401|FG006|Treatment Period 2|Adverse Event|0
934504|NCT00950807|1920402|FG007|Treatment Period 2|Adverse Event|1
934505|NCT00950807|1920403|FG008|Treatment Period 2|Adverse Event|0
934506|NCT00950807|1920404|FG009|Treatment Period 2|Adverse Event|0
934507|NCT00950807|1920395|FG000|Washout Period 2|Lack of Efficacy|1
934508|NCT00950807|1920396|FG001|Washout Period 2|Lack of Efficacy|0
934509|NCT00950807|1920397|FG002|Washout Period 2|Lack of Efficacy|0
934510|NCT00950807|1920398|FG003|Washout Period 2|Lack of Efficacy|0
934511|NCT00950807|1920399|FG004|Washout Period 2|Lack of Efficacy|0
934512|NCT00950807|1920400|FG005|Washout Period 2|Lack of Efficacy|0
934513|NCT00950807|1920401|FG006|Washout Period 2|Lack of Efficacy|0
934514|NCT00950807|1920402|FG007|Washout Period 2|Lack of Efficacy|0
934515|NCT00950807|1920403|FG008|Washout Period 2|Lack of Efficacy|0
934516|NCT00950807|1920404|FG009|Washout Period 2|Lack of Efficacy|0
934517|NCT00950807|1920395|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0
934518|NCT00950807|1920396|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1
934519|NCT00950807|1920397|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0
934520|NCT00950807|1920398|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0
934521|NCT00950807|1920399|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1
934522|NCT00950807|1920400|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0
934523|NCT00950807|1920401|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1
934524|NCT00950807|1920402|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1
934525|NCT00950807|1920403|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0
934526|NCT00950807|1920404|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0
934527|NCT00950807|1920395|FG000|Washout Period 2|Adverse Event|3
934528|NCT00950807|1920396|FG001|Washout Period 2|Adverse Event|0
934529|NCT00950807|1920397|FG002|Washout Period 2|Adverse Event|0
934530|NCT00950807|1920398|FG003|Washout Period 2|Adverse Event|1
934531|NCT00950807|1920399|FG004|Washout Period 2|Adverse Event|0
934532|NCT00950807|1920400|FG005|Washout Period 2|Adverse Event|0
934533|NCT00950807|1920401|FG006|Washout Period 2|Adverse Event|0
934534|NCT00950807|1920402|FG007|Washout Period 2|Adverse Event|0
934535|NCT00950807|1920403|FG008|Washout Period 2|Adverse Event|0
934536|NCT00950807|1920404|FG009|Washout Period 2|Adverse Event|0
934537|NCT00950807|1920395|FG000|Treatment Period 3|Withdrawal by Subject|0
934538|NCT00950807|1920396|FG001|Treatment Period 3|Withdrawal by Subject|0
934539|NCT00950807|1920397|FG002|Treatment Period 3|Withdrawal by Subject|0
934540|NCT00950807|1920398|FG003|Treatment Period 3|Withdrawal by Subject|0
934541|NCT00950807|1920399|FG004|Treatment Period 3|Withdrawal by Subject|0
934542|NCT00950807|1920400|FG005|Treatment Period 3|Withdrawal by Subject|0
934543|NCT00950807|1920401|FG006|Treatment Period 3|Withdrawal by Subject|0
934544|NCT00950807|1920402|FG007|Treatment Period 3|Withdrawal by Subject|0
934545|NCT00950807|1920403|FG008|Treatment Period 3|Withdrawal by Subject|0
934546|NCT00950807|1920404|FG009|Treatment Period 3|Withdrawal by Subject|1
934547|NCT00950807|1920395|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1
934548|NCT00950807|1920396|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
934549|NCT00950807|1920397|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
934550|NCT00950807|1920398|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
934551|NCT00950807|1920399|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
934552|NCT00950807|1920400|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
934553|NCT00950807|1920401|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0
934554|NCT00950807|1920402|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1
934555|NCT00950807|1920403|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0
934556|NCT00950807|1920404|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0
934557|NCT00950807|1920395|FG000|Treatment Period 3|Adverse Event|0
934558|NCT00950807|1920396|FG001|Treatment Period 3|Adverse Event|0
934559|NCT00950807|1920397|FG002|Treatment Period 3|Adverse Event|0
934560|NCT00950807|1920398|FG003|Treatment Period 3|Adverse Event|0
934561|NCT00950807|1920399|FG004|Treatment Period 3|Adverse Event|0
934562|NCT00950807|1920400|FG005|Treatment Period 3|Adverse Event|0
934563|NCT00950807|1920401|FG006|Treatment Period 3|Adverse Event|1
934564|NCT00950807|1920402|FG007|Treatment Period 3|Adverse Event|0
934565|NCT00950807|1920403|FG008|Treatment Period 3|Adverse Event|0
934566|NCT00950807|1920404|FG009|Treatment Period 3|Adverse Event|0
934567|NCT00950859|1920443|FG000|Overall Study|Adverse Event|3
934568|NCT00950859|1920444|FG001|Overall Study|Adverse Event|3
934569|NCT00950859|1920443|FG000|Overall Study|Insufficient Viral Load Response|12
934570|NCT00950859|1920444|FG001|Overall Study|Insufficient Viral Load Response|3
934571|NCT00950859|1920443|FG000|Overall Study|Protocol Violation|1
934572|NCT00950859|1920444|FG001|Overall Study|Protocol Violation|1
934573|NCT00950859|1920443|FG000|Overall Study|Lost to Follow-up|0
934574|NCT00950859|1920444|FG001|Overall Study|Lost to Follow-up|3
934575|NCT00950872|1920450|FG000|Overall Study|Withdrawal by Subject|1
934576|NCT00950872|1920450|FG000|Overall Study|Did not have surgery|2
934577|NCT00950911|1920456|FG000|Overall Study|Adverse Event|0
934578|NCT00950911|1920457|FG001|Overall Study|Adverse Event|2
934579|NCT00950911|1920456|FG000|Overall Study|Death|4
934580|NCT00950911|1920457|FG001|Overall Study|Death|6
934581|NCT00950911|1920456|FG000|Overall Study|Disease progression|2
934582|NCT00950911|1920457|FG001|Overall Study|Disease progression|2
934583|NCT00950911|1920456|FG000|Overall Study|Consent withdrawn|1
934584|NCT00950911|1920457|FG001|Overall Study|Consent withdrawn|3
934585|NCT00950911|1920456|FG000|Overall Study|Administrative decision|3
934586|NCT00950911|1920457|FG001|Overall Study|Administrative decision|1
934587|NCT00950911|1920456|FG000|Overall Study|Ineligibility determined|1
934588|NCT00950911|1920457|FG001|Overall Study|Ineligibility determined|0
934589|NCT00950911|1920456|FG000|Overall Study|Noncompliance|1
934590|NCT00950911|1920457|FG001|Overall Study|Noncompliance|0
934591|NCT00950911|1920456|FG000|Overall Study|Poor performance status|0
934592|NCT00950911|1920457|FG001|Overall Study|Poor performance status|1
934593|NCT00950950|1920472|FG000|Overall Study|Adverse Event|1
934594|NCT00950950|1920473|FG001|Overall Study|Adverse Event|0
934595|NCT00950950|1920472|FG000|Overall Study|Withdrawal by Subject|0
934596|NCT00950950|1920473|FG001|Overall Study|Withdrawal by Subject|1
934597|NCT00950963|1920482|FG000|Overall Study|Lost to Follow-up|29
934598|NCT00950963|1920483|FG001|Overall Study|Lost to Follow-up|24
934599|NCT00951015|1920493|FG000|Randomization Phase 96 Week|Adverse Event|1
934600|NCT00951015|1920494|FG001|Randomization Phase 96 Week|Adverse Event|1
934601|NCT00951015|1920495|FG002|Randomization Phase 96 Week|Adverse Event|2
934602|NCT00951015|1920496|FG003|Randomization Phase 96 Week|Adverse Event|5
934603|NCT00951015|1920497|FG004|Randomization Phase 96 Week|Adverse Event|0
934604|NCT00951015|1920493|FG000|Randomization Phase 96 Week|Lack of Efficacy|1
934605|NCT00951015|1920494|FG001|Randomization Phase 96 Week|Lack of Efficacy|1
934606|NCT00951015|1920495|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
934607|NCT00951015|1920496|FG003|Randomization Phase 96 Week|Lack of Efficacy|0
934608|NCT00951015|1920497|FG004|Randomization Phase 96 Week|Lack of Efficacy|0
934609|NCT00951015|1920493|FG000|Randomization Phase 96 Week|Protocol Violation|1
934610|NCT00951015|1920494|FG001|Randomization Phase 96 Week|Protocol Violation|1
934611|NCT00951015|1920495|FG002|Randomization Phase 96 Week|Protocol Violation|1
934612|NCT00951015|1920496|FG003|Randomization Phase 96 Week|Protocol Violation|0
934613|NCT00951015|1920497|FG004|Randomization Phase 96 Week|Protocol Violation|0
934614|NCT00951015|1920493|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
934615|NCT00951015|1920494|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
934616|NCT00951015|1920495|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
934617|NCT00951015|1920496|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
934618|NCT00951015|1920497|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
934619|NCT00951015|1920493|FG000|Randomization Phase 96 Week|Lost to Follow-up|0
934620|NCT00951015|1920494|FG001|Randomization Phase 96 Week|Lost to Follow-up|3
934621|NCT00951015|1920495|FG002|Randomization Phase 96 Week|Lost to Follow-up|1
934622|NCT00951015|1920496|FG003|Randomization Phase 96 Week|Lost to Follow-up|2
934623|NCT00951015|1920497|FG004|Randomization Phase 96 Week|Lost to Follow-up|0
934624|NCT00951015|1920493|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
934625|NCT00951015|1920494|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1
934626|NCT00951015|1920495|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1
934627|NCT00951015|1920496|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2
934628|NCT00951015|1920497|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0
934629|NCT00951015|1920493|FG000|Open-label Phase|Adverse Event|0
934630|NCT00951015|1920494|FG001|Open-label Phase|Adverse Event|0
934631|NCT00951015|1920495|FG002|Open-label Phase|Adverse Event|0
934632|NCT00951015|1920496|FG003|Open-label Phase|Adverse Event|0
934633|NCT00951015|1920497|FG004|Open-label Phase|Adverse Event|3
934634|NCT00951015|1920493|FG000|Open-label Phase|Lack of Efficacy|0
934635|NCT00951015|1920494|FG001|Open-label Phase|Lack of Efficacy|0
934636|NCT00951015|1920495|FG002|Open-label Phase|Lack of Efficacy|0
934637|NCT00951015|1920496|FG003|Open-label Phase|Lack of Efficacy|0
934638|NCT00951015|1920497|FG004|Open-label Phase|Lack of Efficacy|1
934639|NCT00951015|1920493|FG000|Open-label Phase|Protocol Violation|0
934640|NCT00951015|1920494|FG001|Open-label Phase|Protocol Violation|0
934641|NCT00951015|1920495|FG002|Open-label Phase|Protocol Violation|0
934642|NCT00951015|1920496|FG003|Open-label Phase|Protocol Violation|0
934643|NCT00951015|1920497|FG004|Open-label Phase|Protocol Violation|12
934644|NCT00951015|1920493|FG000|Open-label Phase|Lost to Follow-up|0
934645|NCT00951015|1920494|FG001|Open-label Phase|Lost to Follow-up|0
934646|NCT00951015|1920495|FG002|Open-label Phase|Lost to Follow-up|0
934647|NCT00951015|1920496|FG003|Open-label Phase|Lost to Follow-up|0
934648|NCT00951015|1920497|FG004|Open-label Phase|Lost to Follow-up|12
934649|NCT00951015|1920493|FG000|Open-label Phase|Withdrawal by Subject|0
934650|NCT00951015|1920494|FG001|Open-label Phase|Withdrawal by Subject|0
934651|NCT00951015|1920495|FG002|Open-label Phase|Withdrawal by Subject|0
934652|NCT00951015|1920496|FG003|Open-label Phase|Withdrawal by Subject|0
934653|NCT00951015|1920497|FG004|Open-label Phase|Withdrawal by Subject|14
934654|NCT00951015|1920493|FG000|Open-label Phase|Physician Decision|0
934655|NCT00951015|1920494|FG001|Open-label Phase|Physician Decision|0
934656|NCT00951015|1920495|FG002|Open-label Phase|Physician Decision|0
934657|NCT00951015|1920496|FG003|Open-label Phase|Physician Decision|0
934658|NCT00951015|1920497|FG004|Open-label Phase|Physician Decision|8
934659|NCT00951041|1920522|FG000|Overall Study|Withdrawal by Subject|1
934660|NCT00951041|1920523|FG001|Overall Study|Withdrawal by Subject|1
934661|NCT00951041|1920522|FG000|Overall Study|Lost to Follow-up|1
934662|NCT00951041|1920523|FG001|Overall Study|Lost to Follow-up|0
934663|NCT00951041|1920522|FG000|Overall Study|Other|3
934664|NCT00951041|1920523|FG001|Overall Study|Other|0
934665|NCT00951080|1920532|FG000|Overall Study|Adverse Event|3
934666|NCT00951080|1920533|FG001|Overall Study|Adverse Event|3
934667|NCT00951080|1920532|FG000|Overall Study|Lost to Follow-up|0
934668|NCT00951080|1920533|FG001|Overall Study|Lost to Follow-up|1
934669|NCT00951080|1920532|FG000|Overall Study|Physician Decision|4
934670|NCT00951080|1920533|FG001|Overall Study|Physician Decision|1
934671|NCT00951080|1920532|FG000|Overall Study|Other|19
934672|NCT00951080|1920533|FG001|Overall Study|Other|22
934673|NCT00951171|1920547|FG000|Overall Study|Adverse Event|2
934674|NCT00951171|1920548|FG001|Overall Study|Adverse Event|0
934675|NCT00951275|1920554|FG000|Overall Study|Administrative Reason|1
934676|NCT00951275|1920554|FG000|Overall Study|Adverse Event|7
934677|NCT00951275|1920554|FG000|Overall Study|Withdrawal by Subject|4
934678|NCT00951275|1920554|FG000|Overall Study|Protocol Violation|1
934679|NCT00951379|1920560|FG000|Overall Study|Adverse Event|4
934680|NCT00951379|1920561|FG001|Overall Study|Adverse Event|1
934681|NCT00951379|1920560|FG000|Overall Study|Withdrawal by Subject|1
934682|NCT00951379|1920561|FG001|Overall Study|Withdrawal by Subject|0
934683|NCT00951379|1920560|FG000|Overall Study|Noncompliance|1
934684|NCT00951379|1920561|FG001|Overall Study|Noncompliance|0
934685|NCT00951379|1920560|FG000|Overall Study|Disease Progression|0
934686|NCT00951379|1920561|FG001|Overall Study|Disease Progression|1
934687|NCT00951483|1920577|FG000|Overall Study|Physician Decision|4
934688|NCT00951483|1920578|FG001|Overall Study|Physician Decision|0
934689|NCT00951483|1920577|FG000|Overall Study|Withdrawal by Subject|15
934690|NCT00951483|1920578|FG001|Overall Study|Withdrawal by Subject|0
934691|NCT00951496|1920589|FG000|Overall Study|Did not initiate study treatment|10
934692|NCT00951496|1920590|FG001|Overall Study|Did not initiate study treatment|8
934693|NCT00951496|1920591|FG002|Overall Study|Did not initiate study treatment|13
934694|NCT00951509|1920602|FG000|Overall Study|Withdrawal by Subject|2
934695|NCT00951665|1920624|FG000|Phase 1b|Adverse Event|2
934696|NCT00951665|1920625|FG001|Phase 1b|Adverse Event|1
934697|NCT00951665|1920626|FG002|Phase 1b|Adverse Event|0
934698|NCT00951665|1920627|FG003|Phase 1b|Adverse Event|1
934699|NCT00951665|1920628|FG004|Phase 1b|Adverse Event|0
934700|NCT00951665|1920629|FG005|Phase 1b|Adverse Event|0
934701|NCT00951665|1920624|FG000|Phase 1b|Death|1
934702|NCT00951665|1920625|FG001|Phase 1b|Death|0
934703|NCT00951665|1920626|FG002|Phase 1b|Death|2
934704|NCT00951665|1920627|FG003|Phase 1b|Death|0
934705|NCT00951665|1920628|FG004|Phase 1b|Death|0
934706|NCT00951665|1920629|FG005|Phase 1b|Death|0
934707|NCT00951665|1920624|FG000|Phase 1b|Physician Decision|4
934708|NCT00951665|1920625|FG001|Phase 1b|Physician Decision|0
934709|NCT00951665|1920626|FG002|Phase 1b|Physician Decision|1
934710|NCT00951665|1920627|FG003|Phase 1b|Physician Decision|0
934711|NCT00951665|1920628|FG004|Phase 1b|Physician Decision|0
934712|NCT00951665|1920629|FG005|Phase 1b|Physician Decision|0
934713|NCT00951665|1920624|FG000|Phase 1b|Withdrawal by Subject|0
934714|NCT00951665|1920625|FG001|Phase 1b|Withdrawal by Subject|1
934715|NCT00951665|1920626|FG002|Phase 1b|Withdrawal by Subject|0
934716|NCT00951665|1920627|FG003|Phase 1b|Withdrawal by Subject|0
934717|NCT00951665|1920628|FG004|Phase 1b|Withdrawal by Subject|0
934718|NCT00951665|1920629|FG005|Phase 1b|Withdrawal by Subject|0
934719|NCT00951665|1920624|FG000|Phase 1b|Disease Progression|13
934720|NCT00951665|1920625|FG001|Phase 1b|Disease Progression|2
934721|NCT00951665|1920626|FG002|Phase 1b|Disease Progression|14
934722|NCT00951665|1920627|FG003|Phase 1b|Disease Progression|0
934723|NCT00951665|1920628|FG004|Phase 1b|Disease Progression|0
934724|NCT00951665|1920629|FG005|Phase 1b|Disease Progression|0
934725|NCT00951665|1920624|FG000|Phase 1b|Protocol Violation|2
934726|NCT00951665|1920625|FG001|Phase 1b|Protocol Violation|0
934727|NCT00951665|1920626|FG002|Phase 1b|Protocol Violation|0
934728|NCT00951665|1920627|FG003|Phase 1b|Protocol Violation|0
934729|NCT00951665|1920628|FG004|Phase 1b|Protocol Violation|0
934730|NCT00951665|1920629|FG005|Phase 1b|Protocol Violation|0
934731|NCT00951665|1920624|FG000|Phase 2a|Adverse Event|0
934732|NCT00951665|1920625|FG001|Phase 2a|Adverse Event|0
934733|NCT00951665|1920626|FG002|Phase 2a|Adverse Event|0
934734|NCT00951665|1920627|FG003|Phase 2a|Adverse Event|0
934735|NCT00951665|1920628|FG004|Phase 2a|Adverse Event|2
934736|NCT00951665|1920629|FG005|Phase 2a|Adverse Event|0
934737|NCT00951665|1920624|FG000|Phase 2a|Death|0
934738|NCT00951665|1920625|FG001|Phase 2a|Death|0
934739|NCT00951665|1920626|FG002|Phase 2a|Death|0
934740|NCT00951665|1920627|FG003|Phase 2a|Death|0
934741|NCT00951665|1920628|FG004|Phase 2a|Death|1
934742|NCT00951665|1920629|FG005|Phase 2a|Death|1
934743|NCT00951665|1920624|FG000|Phase 2a|Lost to Follow-up|0
934744|NCT00951665|1920625|FG001|Phase 2a|Lost to Follow-up|0
934745|NCT00951665|1920626|FG002|Phase 2a|Lost to Follow-up|0
934746|NCT00951665|1920627|FG003|Phase 2a|Lost to Follow-up|0
934747|NCT00951665|1920628|FG004|Phase 2a|Lost to Follow-up|1
934748|NCT00951665|1920629|FG005|Phase 2a|Lost to Follow-up|0
934749|NCT00951665|1920624|FG000|Phase 2a|Physician Decision|0
934750|NCT00951665|1920625|FG001|Phase 2a|Physician Decision|0
934751|NCT00951665|1920626|FG002|Phase 2a|Physician Decision|0
934752|NCT00951665|1920627|FG003|Phase 2a|Physician Decision|0
934753|NCT00951665|1920628|FG004|Phase 2a|Physician Decision|0
934754|NCT00951665|1920629|FG005|Phase 2a|Physician Decision|1
934755|NCT00951665|1920624|FG000|Phase 2a|Withdrawal by Subject|0
934756|NCT00951665|1920625|FG001|Phase 2a|Withdrawal by Subject|0
934757|NCT00951665|1920626|FG002|Phase 2a|Withdrawal by Subject|0
934758|NCT00951665|1920627|FG003|Phase 2a|Withdrawal by Subject|0
934759|NCT00951665|1920628|FG004|Phase 2a|Withdrawal by Subject|2
934760|NCT00951665|1920629|FG005|Phase 2a|Withdrawal by Subject|0
934761|NCT00951665|1920624|FG000|Phase 2a|Disease Progression|0
934762|NCT00951665|1920625|FG001|Phase 2a|Disease Progression|0
934763|NCT00951665|1920626|FG002|Phase 2a|Disease Progression|0
934764|NCT00951665|1920627|FG003|Phase 2a|Disease Progression|0
934765|NCT00951665|1920628|FG004|Phase 2a|Disease Progression|6
934766|NCT00951665|1920629|FG005|Phase 2a|Disease Progression|5
934767|NCT00951912|1920692|FG000|Overall Study|Lack of Efficacy|1
934768|NCT00951912|1920693|FG001|Overall Study|Lack of Efficacy|0
934769|NCT00951912|1920694|FG002|Overall Study|Lack of Efficacy|0
934770|NCT00951912|1920692|FG000|Overall Study|Adverse Event|0
934771|NCT00951912|1920693|FG001|Overall Study|Adverse Event|1
934772|NCT00951912|1920694|FG002|Overall Study|Adverse Event|1
934773|NCT00951912|1920692|FG000|Overall Study|Lost to Follow-up|2
934774|NCT00951912|1920693|FG001|Overall Study|Lost to Follow-up|2
934775|NCT00951912|1920694|FG002|Overall Study|Lost to Follow-up|0
934776|NCT00951912|1920692|FG000|Overall Study|Physician Decision|1
934777|NCT00951912|1920693|FG001|Overall Study|Physician Decision|0
934778|NCT00951912|1920694|FG002|Overall Study|Physician Decision|1
934779|NCT00951912|1920692|FG000|Overall Study|Withdrawal by Subject|1
934780|NCT00951912|1920693|FG001|Overall Study|Withdrawal by Subject|1
934781|NCT00951912|1920694|FG002|Overall Study|Withdrawal by Subject|0
934782|NCT00951912|1920692|FG000|Overall Study|Other:Depression|1
934783|NCT00951912|1920693|FG001|Overall Study|Other:Depression|0
934784|NCT00951912|1920694|FG002|Overall Study|Other:Depression|0
934785|NCT00951912|1920692|FG000|Overall Study|Other: Colon cancer|1
934786|NCT00951912|1920693|FG001|Overall Study|Other: Colon cancer|0
934787|NCT00951912|1920694|FG002|Overall Study|Other: Colon cancer|0
934788|NCT00951912|1920692|FG000|Overall Study|Other: Stroke|0
934789|NCT00951912|1920693|FG001|Overall Study|Other: Stroke|1
934790|NCT00951912|1920694|FG002|Overall Study|Other: Stroke|0
934791|NCT00952068|1920702|FG000|Overall Study|Adverse Event|3
934792|NCT00952068|1920702|FG000|Overall Study|Withdrawal by Subject|4
934793|NCT00952276|1920746|FG000|Overall Study|Withdrawal by Subject|1
934794|NCT00952276|1920747|FG001|Overall Study|Withdrawal by Subject|0
934795|NCT00952276|1920748|FG002|Overall Study|Withdrawal by Subject|0
934796|NCT00952276|1920749|FG003|Overall Study|Withdrawal by Subject|1
934797|NCT00952276|1920750|FG004|Overall Study|Withdrawal by Subject|0
934798|NCT00952289|1920764|FG000|All Participants|Death|9
934799|NCT00952289|1920765|FG001|All Participants|Death|9
934800|NCT00952289|1920764|FG000|All Participants|Adverse Event|8
934801|NCT00952289|1920765|FG001|All Participants|Adverse Event|8
934802|NCT00952289|1920764|FG000|All Participants|Disease progression|3
934803|NCT00952289|1920765|FG001|All Participants|Disease progression|12
934804|NCT00952289|1920764|FG000|All Participants|Withdrawal by Subject|1
934805|NCT00952289|1920765|FG001|All Participants|Withdrawal by Subject|10
934806|NCT00952289|1920764|FG000|All Participants|Data lost during site relocation|0
934807|NCT00952289|1920765|FG001|All Participants|Data lost during site relocation|1
934808|NCT00952289|1920764|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
934809|NCT00952289|1920765|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
934810|NCT00952289|1920764|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
934811|NCT00952289|1920765|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
934812|NCT00952289|1920764|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
934813|NCT00952289|1920765|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
934814|NCT00952289|1920764|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
934815|NCT00952289|1920765|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
934816|NCT00952289|1920764|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
934817|NCT00952289|1920765|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
934818|NCT00952341|1920789|FG000|Cycle 1|Adverse Event|4
934819|NCT00952341|1920790|FG001|Cycle 1|Adverse Event|1
934820|NCT00952341|1920789|FG000|Cycle 1|Withdrawal by Subject|3
934821|NCT00952341|1920790|FG001|Cycle 1|Withdrawal by Subject|8
934822|NCT00952341|1920789|FG000|Cycle 1|Protocol Violation|2
934823|NCT00952341|1920790|FG001|Cycle 1|Protocol Violation|1
934824|NCT00952341|1920789|FG000|Cycle 1|Lost to Follow-up|11
934825|NCT00952341|1920790|FG001|Cycle 1|Lost to Follow-up|2
934826|NCT00952341|1920789|FG000|Cycle 1|Physician Decision|0
934827|NCT00952341|1920790|FG001|Cycle 1|Physician Decision|1
934828|NCT00952341|1920789|FG000|Cycle 2|Withdrawal by Subject|1
934829|NCT00952341|1920790|FG001|Cycle 2|Withdrawal by Subject|1
934830|NCT00952341|1920789|FG000|Cycle 2|Protocol Violation|1
934831|NCT00952341|1920790|FG001|Cycle 2|Protocol Violation|0
934832|NCT00952341|1920789|FG000|Cycle 2|Lost to Follow-up|6
934833|NCT00952341|1920790|FG001|Cycle 2|Lost to Follow-up|9
934834|NCT00952341|1920789|FG000|Cycle 2|Physician Decision|1
934835|NCT00952341|1920790|FG001|Cycle 2|Physician Decision|1
934836|NCT00952341|1920789|FG000|Cycle 2|Progressive Disease|0
934837|NCT00952341|1920790|FG001|Cycle 2|Progressive Disease|1
934838|NCT00952367|1920796|FG000|Overall Study|Withdrawal by Subject|2
934839|NCT00952367|1920796|FG000|Overall Study|Noncoordination|1
934840|NCT00952367|1920796|FG000|Overall Study|Protocol Violation|3
934841|NCT00952380|1920805|FG000|Overall Study|Other|0
934842|NCT00952380|1920806|FG001|Overall Study|Other|0
934843|NCT00952380|1920807|FG002|Overall Study|Other|0
934844|NCT00952380|1920808|FG003|Overall Study|Other|0
934845|NCT00952380|1920809|FG004|Overall Study|Other|1
934846|NCT00952380|1920805|FG000|Overall Study|Withdrawal by Subject|0
934847|NCT00952380|1920806|FG001|Overall Study|Withdrawal by Subject|0
934848|NCT00952380|1920807|FG002|Overall Study|Withdrawal by Subject|1
934849|NCT00952380|1920808|FG003|Overall Study|Withdrawal by Subject|0
934850|NCT00952380|1920809|FG004|Overall Study|Withdrawal by Subject|2
934851|NCT00952380|1920805|FG000|Overall Study|Adverse Event|0
934852|NCT00952380|1920806|FG001|Overall Study|Adverse Event|1
934853|NCT00952380|1920807|FG002|Overall Study|Adverse Event|0
934854|NCT00952380|1920808|FG003|Overall Study|Adverse Event|0
934855|NCT00952380|1920809|FG004|Overall Study|Adverse Event|3
934856|NCT00952380|1920805|FG000|Overall Study|Physician Decision|0
934857|NCT00952380|1920806|FG001|Overall Study|Physician Decision|0
934858|NCT00952380|1920807|FG002|Overall Study|Physician Decision|1
934859|NCT00952380|1920808|FG003|Overall Study|Physician Decision|2
934860|NCT00952380|1920809|FG004|Overall Study|Physician Decision|0
934861|NCT00952380|1920805|FG000|Overall Study|Non-compliant to protocol|0
934862|NCT00952380|1920806|FG001|Overall Study|Non-compliant to protocol|0
934863|NCT00952380|1920807|FG002|Overall Study|Non-compliant to protocol|0
934864|NCT00952380|1920808|FG003|Overall Study|Non-compliant to protocol|1
934865|NCT00952380|1920809|FG004|Overall Study|Non-compliant to protocol|0
934866|NCT00952419|1920833|FG000|Overall Study|Adverse Event|2
934867|NCT00952419|1920834|FG001|Overall Study|Adverse Event|0
934868|NCT00952419|1920835|FG002|Overall Study|Adverse Event|0
934869|NCT00952419|1920833|FG000|Overall Study|Protocol Violation|3
934870|NCT00952419|1920834|FG001|Overall Study|Protocol Violation|7
934871|NCT00952419|1920835|FG002|Overall Study|Protocol Violation|0
934872|NCT00952419|1920833|FG000|Overall Study|Withdrawal by Subject|1
934873|NCT00952419|1920834|FG001|Overall Study|Withdrawal by Subject|3
934874|NCT00952419|1920835|FG002|Overall Study|Withdrawal by Subject|0
934875|NCT00952484|1920846|FG000|Overall Study|Withdrawal by Subject|0
934876|NCT00952484|1920847|FG001|Overall Study|Withdrawal by Subject|1
934877|NCT00952484|1920848|FG002|Overall Study|Withdrawal by Subject|0
934878|NCT00952523|1920857|FG000|Overall Study|Withdrawal by Subject|7
934879|NCT00952588|1920865|FG000|Overall Study|Death|28
934880|NCT00952588|1920866|FG001|Overall Study|Death|13
934881|NCT00952588|1920865|FG000|Overall Study|Withdrawal by Subject|2
934882|NCT00952588|1920866|FG001|Overall Study|Withdrawal by Subject|5
934883|NCT00952588|1920865|FG000|Overall Study|Adverse Event|2
934884|NCT00952588|1920866|FG001|Overall Study|Adverse Event|3
934885|NCT00952588|1920865|FG000|Overall Study|Lost to Follow-up|2
934886|NCT00952588|1920866|FG001|Overall Study|Lost to Follow-up|0
934887|NCT00952588|1920865|FG000|Overall Study|Physician Decision|0
934888|NCT00952588|1920866|FG001|Overall Study|Physician Decision|1
934889|NCT00952588|1920865|FG000|Overall Study|Lack of Efficacy|2
934890|NCT00952588|1920866|FG001|Overall Study|Lack of Efficacy|2
934891|NCT00952614|1920872|FG000|Overall Study|Death|3
934892|NCT00952614|1920872|FG000|Overall Study|Lost to Follow-up|3
934893|NCT00952614|1920872|FG000|Overall Study|other reason|1
934894|NCT00952705|1920887|FG000|Overall Study|Lost to Follow-up|24
934895|NCT00952705|1920888|FG001|Overall Study|Lost to Follow-up|8
934896|NCT00952705|1920889|FG002|Overall Study|Lost to Follow-up|9
934897|NCT00952705|1920887|FG000|Overall Study|Withdrawal by Subject|2
934898|NCT00952705|1920888|FG001|Overall Study|Withdrawal by Subject|1
934899|NCT00952705|1920889|FG002|Overall Study|Withdrawal by Subject|1
934900|NCT00952705|1920887|FG000|Overall Study|Death|2
934901|NCT00952705|1920888|FG001|Overall Study|Death|0
934902|NCT00952705|1920889|FG002|Overall Study|Death|0
934903|NCT00952705|1920887|FG000|Overall Study|Incarcerated post dose|5
934904|NCT00952705|1920888|FG001|Overall Study|Incarcerated post dose|0
934905|NCT00952705|1920889|FG002|Overall Study|Incarcerated post dose|0
934906|NCT00952705|1920887|FG000|Overall Study|Exclusion criteria not met pre dose|0
934907|NCT00952705|1920888|FG001|Overall Study|Exclusion criteria not met pre dose|1
934908|NCT00952705|1920889|FG002|Overall Study|Exclusion criteria not met pre dose|0
934909|NCT00952731|1920914|FG000|Overall Study|Drug supply expired|1
934910|NCT00952731|1920915|FG001|Overall Study|Drug supply expired|0
934911|NCT00952822|1920921|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
934912|NCT00952822|1920922|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
934913|NCT00952822|1920923|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
934914|NCT00952822|1920924|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
934915|NCT00952822|1920921|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
934916|NCT00952822|1920922|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
934917|NCT00952822|1920923|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
934918|NCT00952822|1920924|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
934919|NCT00952848|1920935|FG000|Overall Study|Withdrawal by Subject|4
934920|NCT00953017|1920943|FG000|Overall Study|DId not show up for colonoscopy|4
934921|NCT00953017|1920944|FG001|Overall Study|DId not show up for colonoscopy|4
934922|NCT00953017|1920945|FG002|Overall Study|DId not show up for colonoscopy|5
934923|NCT00953017|1920946|FG003|Overall Study|DId not show up for colonoscopy|4
934924|NCT00953017|1920943|FG000|Overall Study|Incomplete data|1
934925|NCT00953017|1920944|FG001|Overall Study|Incomplete data|1
934926|NCT00953017|1920945|FG002|Overall Study|Incomplete data|0
934927|NCT00953017|1920946|FG003|Overall Study|Incomplete data|0
934928|NCT00953017|1920943|FG000|Overall Study|Procedure incomplete due to pain/looping|0
934929|NCT00953017|1920944|FG001|Overall Study|Procedure incomplete due to pain/looping|1
934930|NCT00953017|1920945|FG002|Overall Study|Procedure incomplete due to pain/looping|0
934931|NCT00953017|1920946|FG003|Overall Study|Procedure incomplete due to pain/looping|1
934932|NCT00953017|1920943|FG000|Overall Study|Brown stool prior to procedure|0
934933|NCT00953017|1920944|FG001|Overall Study|Brown stool prior to procedure|0
934934|NCT00953017|1920945|FG002|Overall Study|Brown stool prior to procedure|1
934935|NCT00953017|1920946|FG003|Overall Study|Brown stool prior to procedure|0
934936|NCT00953043|1920958|FG000|Overall Study|Withdrawal by Subject|4
934937|NCT00953043|1920959|FG001|Overall Study|Withdrawal by Subject|0
934938|NCT00953043|1920958|FG000|Overall Study|Physician Decision|0
934939|NCT00953043|1920959|FG001|Overall Study|Physician Decision|2
934940|NCT00953056|1920971|FG000|Overall Study|Withdrew Consent|0
934941|NCT00953056|1920972|FG001|Overall Study|Withdrew Consent|0
934942|NCT00953056|1920973|FG002|Overall Study|Withdrew Consent|0
934943|NCT00953056|1920974|FG003|Overall Study|Withdrew Consent|0
934944|NCT00953056|1920975|FG004|Overall Study|Withdrew Consent|2
934945|NCT00953056|1920976|FG005|Overall Study|Withdrew Consent|3
934946|NCT00953056|1920971|FG000|Overall Study|Serious Adverse Event|0
934947|NCT00953056|1920972|FG001|Overall Study|Serious Adverse Event|0
934948|NCT00953056|1920973|FG002|Overall Study|Serious Adverse Event|0
934949|NCT00953056|1920974|FG003|Overall Study|Serious Adverse Event|0
934950|NCT00953056|1920975|FG004|Overall Study|Serious Adverse Event|0
934951|NCT00953056|1920976|FG005|Overall Study|Serious Adverse Event|1
934952|NCT00953147|1921008|FG000|Overall Study|Adverse Event|8
934953|NCT00953147|1921009|FG001|Overall Study|Adverse Event|16
934954|NCT00953147|1921010|FG002|Overall Study|Adverse Event|6
934955|NCT00953147|1921008|FG000|Overall Study|Protocol Violation|2
934956|NCT00953147|1921009|FG001|Overall Study|Protocol Violation|8
934957|NCT00953147|1921010|FG002|Overall Study|Protocol Violation|4
934958|NCT00953147|1921008|FG000|Overall Study|Withdrawal by Subject|13
934959|NCT00953147|1921009|FG001|Overall Study|Withdrawal by Subject|15
934960|NCT00953147|1921010|FG002|Overall Study|Withdrawal by Subject|12
934961|NCT00953147|1921008|FG000|Overall Study|Lost to Follow-up|8
934962|NCT00953147|1921009|FG001|Overall Study|Lost to Follow-up|9
934963|NCT00953147|1921010|FG002|Overall Study|Lost to Follow-up|4
934964|NCT00953147|1921008|FG000|Overall Study|Physician Decision|2
934965|NCT00953147|1921009|FG001|Overall Study|Physician Decision|7
934966|NCT00953147|1921010|FG002|Overall Study|Physician Decision|3
934967|NCT00953147|1921008|FG000|Overall Study|Other|4
934968|NCT00953147|1921009|FG001|Overall Study|Other|11
934969|NCT00953147|1921010|FG002|Overall Study|Other|13
934970|NCT00953160|1921018|FG000|Overall Study|Lost to Follow-up|23
934971|NCT00953160|1921018|FG000|Overall Study|Withdrawal by Subject|4
934972|NCT00953225|1921060|FG000|Overall Study|Withdrawal by Subject|2
934973|NCT00953225|1921061|FG001|Overall Study|Withdrawal by Subject|0
934974|NCT00953407|1921079|FG000|Overall Study|Failed inclusion criteria|1
934975|NCT00953407|1921080|FG001|Overall Study|Failed inclusion criteria|1
934976|NCT00953407|1921081|FG002|Overall Study|Failed inclusion criteria|1
934977|NCT00953407|1921082|FG003|Overall Study|Failed inclusion criteria|1
934978|NCT00953407|1921083|FG004|Overall Study|Failed inclusion criteria|1
934979|NCT00953407|1921079|FG000|Overall Study|Lost to Follow-up|0
934980|NCT00953407|1921080|FG001|Overall Study|Lost to Follow-up|0
934981|NCT00953407|1921081|FG002|Overall Study|Lost to Follow-up|0
934982|NCT00953407|1921082|FG003|Overall Study|Lost to Follow-up|1
934983|NCT00953407|1921083|FG004|Overall Study|Lost to Follow-up|0
934984|NCT00953524|1921099|FG000|Overall Study|Adverse Event|2
934985|NCT00953524|1921100|FG001|Overall Study|Adverse Event|0
934986|NCT00953524|1921101|FG002|Overall Study|Adverse Event|1
934987|NCT00953524|1921102|FG003|Overall Study|Adverse Event|2
934988|NCT00953524|1921099|FG000|Overall Study|Protocol Violation|18
934989|NCT00953524|1921100|FG001|Overall Study|Protocol Violation|10
934990|NCT00953524|1921101|FG002|Overall Study|Protocol Violation|11
934991|NCT00953524|1921102|FG003|Overall Study|Protocol Violation|6
934992|NCT00953524|1921099|FG000|Overall Study|Lost to Follow-up|0
934993|NCT00953524|1921100|FG001|Overall Study|Lost to Follow-up|1
934994|NCT00953524|1921101|FG002|Overall Study|Lost to Follow-up|1
934995|NCT00953524|1921102|FG003|Overall Study|Lost to Follow-up|0
934996|NCT00953524|1921099|FG000|Overall Study|Withdrawal by Subject|2
934997|NCT00953524|1921100|FG001|Overall Study|Withdrawal by Subject|4
934998|NCT00953524|1921101|FG002|Overall Study|Withdrawal by Subject|1
934999|NCT00953524|1921102|FG003|Overall Study|Withdrawal by Subject|0
935000|NCT00953576|1921114|FG000|Overall Study|Adverse Event|0
935001|NCT00953576|1921115|FG001|Overall Study|Adverse Event|1
935002|NCT00953576|1921114|FG000|Overall Study|Ineligible after Consent|2
935003|NCT00953576|1921115|FG001|Overall Study|Ineligible after Consent|0
935004|NCT00953667|1921137|FG000|Overall Study|Lost to Follow-up|11
935005|NCT00953667|1921137|FG000|Overall Study|Physician Decision|35
935006|NCT00953667|1921137|FG000|Overall Study|Withdrawal by Subject|63
935007|NCT00953667|1921137|FG000|Overall Study|Adverse Event|10
935008|NCT00953667|1921137|FG000|Overall Study|poor venous access,unable to draw blood|4
935009|NCT00953680|1921141|FG000|Period 1|Withdrawal by Subject|0
935010|NCT00953680|1921142|FG001|Period 1|Withdrawal by Subject|1
935011|NCT00953706|1921150|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
935012|NCT00953706|1921151|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
935013|NCT00953706|1921152|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
935014|NCT00953706|1921153|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
935015|NCT00953706|1921150|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
935016|NCT00953706|1921151|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
935017|NCT00953706|1921152|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
935018|NCT00953706|1921153|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
935019|NCT00953706|1921150|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
935020|NCT00953706|1921151|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
935021|NCT00953706|1921152|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
935022|NCT00953706|1921153|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
935023|NCT00953706|1921150|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
935024|NCT00953706|1921151|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
935025|NCT00953706|1921152|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
935026|NCT00953706|1921153|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
935027|NCT00953706|1921150|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
935028|NCT00953706|1921151|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
935029|NCT00953706|1921152|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
935030|NCT00953706|1921153|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
935031|NCT00953706|1921150|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0
935032|NCT00953706|1921151|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0
935033|NCT00953706|1921152|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0
935034|NCT00953706|1921153|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2
935035|NCT00953706|1921150|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
935036|NCT00953706|1921151|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
935037|NCT00953706|1921152|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
935038|NCT00953706|1921153|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
935039|NCT00953706|1921150|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
935040|NCT00953706|1921151|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
935041|NCT00953706|1921152|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
935042|NCT00953706|1921153|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
935043|NCT00953706|1921150|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
935044|NCT00953706|1921151|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
935045|NCT00953706|1921152|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
935046|NCT00953706|1921153|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
935047|NCT00953706|1921150|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
935048|NCT00953706|1921151|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
935049|NCT00953706|1921152|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
935050|NCT00953706|1921153|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
935051|NCT00953706|1921150|FG000|Part B (96-Week Open-Label Extension)|Other|0
935052|NCT00953706|1921151|FG001|Part B (96-Week Open-Label Extension)|Other|0
935053|NCT00953706|1921152|FG002|Part B (96-Week Open-Label Extension)|Other|0
935054|NCT00953706|1921153|FG003|Part B (96-Week Open-Label Extension)|Other|2
935055|NCT00953745|1921174|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
935056|NCT00953745|1921175|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
935057|NCT00953745|1921174|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
935058|NCT00953745|1921175|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
935059|NCT00953745|1921174|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
935060|NCT00953745|1921175|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
935061|NCT00953745|1921174|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
935062|NCT00953745|1921175|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
935063|NCT00953745|1921174|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
935064|NCT00953745|1921175|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
935065|NCT00953745|1921174|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
935066|NCT00953745|1921175|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
935067|NCT00953927|1921212|FG000|Overall Study|Lost to Follow-up|61
935068|NCT00953927|1921213|FG001|Overall Study|Lost to Follow-up|65
935069|NCT00953927|1921212|FG000|Overall Study|Withdrawal by Subject|36
935070|NCT00953927|1921213|FG001|Overall Study|Withdrawal by Subject|25
935071|NCT00953927|1921212|FG000|Overall Study|Death|7
935072|NCT00953927|1921213|FG001|Overall Study|Death|4
935073|NCT00953927|1921212|FG000|Overall Study|Other study discontinuation|1
935074|NCT00953927|1921213|FG001|Overall Study|Other study discontinuation|1
935075|NCT00954122|1921223|FG000|Overall Study|Withdrawal by Subject|5
935076|NCT00954122|1921223|FG000|Overall Study|Adverse Event|1
935077|NCT00954122|1921223|FG000|Overall Study|Safety Reason|1
935078|NCT00954174|1921232|FG000|Overall Study|Adverse Event|28
935079|NCT00954174|1921233|FG001|Overall Study|Adverse Event|23
935080|NCT00954174|1921234|FG002|Overall Study|Adverse Event|4
935081|NCT00954174|1921235|FG003|Overall Study|Adverse Event|9
935082|NCT00954174|1921232|FG000|Overall Study|Death|4
935083|NCT00954174|1921233|FG001|Overall Study|Death|2
935084|NCT00954174|1921234|FG002|Overall Study|Death|0
935085|NCT00954174|1921235|FG003|Overall Study|Death|0
935086|NCT00954174|1921232|FG000|Overall Study|Lack of Efficacy|32
935087|NCT00954174|1921233|FG001|Overall Study|Lack of Efficacy|22
935088|NCT00954174|1921234|FG002|Overall Study|Lack of Efficacy|8
935089|NCT00954174|1921235|FG003|Overall Study|Lack of Efficacy|6
935090|NCT00954174|1921232|FG000|Overall Study|Withdrawal by Subject|14
935091|NCT00954174|1921233|FG001|Overall Study|Withdrawal by Subject|10
935092|NCT00954174|1921234|FG002|Overall Study|Withdrawal by Subject|4
935093|NCT00954174|1921235|FG003|Overall Study|Withdrawal by Subject|3
935094|NCT00954174|1921232|FG000|Overall Study|Medical Reason|4
935095|NCT00954174|1921233|FG001|Overall Study|Medical Reason|2
935096|NCT00954174|1921234|FG002|Overall Study|Medical Reason|1
935097|NCT00954174|1921235|FG003|Overall Study|Medical Reason|0
935098|NCT00954174|1921232|FG000|Overall Study|Ineligible|40
935099|NCT00954174|1921233|FG001|Overall Study|Ineligible|47
935100|NCT00954174|1921234|FG002|Overall Study|Ineligible|7
935101|NCT00954174|1921235|FG003|Overall Study|Ineligible|4
935102|NCT00954174|1921232|FG000|Overall Study|Never Treated|4
935103|NCT00954174|1921233|FG001|Overall Study|Never Treated|17
935104|NCT00954174|1921234|FG002|Overall Study|Never Treated|0
935105|NCT00954174|1921235|FG003|Overall Study|Never Treated|3
935106|NCT00954421|1921257|FG000|Screening|screen failures|3
935107|NCT00954421|1921257|FG000|6 Months of DBS|Withdrawal by Subject|1
935108|NCT00954421|1921257|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
935109|NCT00954447|1921265|FG000|Overall Study|Adverse Event|33
935110|NCT00954447|1921266|FG001|Overall Study|Adverse Event|25
935111|NCT00954447|1921265|FG000|Overall Study|Lack of Efficacy|17
935112|NCT00954447|1921266|FG001|Overall Study|Lack of Efficacy|3
935113|NCT00954447|1921265|FG000|Overall Study|Protocol Violation|5
935114|NCT00954447|1921266|FG001|Overall Study|Protocol Violation|7
935115|NCT00954447|1921265|FG000|Overall Study|Lost to Follow-up|8
935116|NCT00954447|1921266|FG001|Overall Study|Lost to Follow-up|14
935117|NCT00954447|1921265|FG000|Overall Study|Withdrawal by Subject|26
935118|NCT00954447|1921266|FG001|Overall Study|Withdrawal by Subject|21
935119|NCT00954447|1921265|FG000|Overall Study|Other|21
935120|NCT00954447|1921266|FG001|Overall Study|Other|18
935121|NCT00954512|1921278|FG000|Overall Study|Withdrawal by Subject|0
935122|NCT00954512|1921279|FG001|Overall Study|Withdrawal by Subject|0
935123|NCT00954512|1921280|FG002|Overall Study|Withdrawal by Subject|0
935124|NCT00954512|1921281|FG003|Overall Study|Withdrawal by Subject|0
935125|NCT00954512|1921282|FG004|Overall Study|Withdrawal by Subject|0
935126|NCT00954512|1921283|FG005|Overall Study|Withdrawal by Subject|1
935127|NCT00954512|1921278|FG000|Overall Study|Adverse Event|0
935128|NCT00954512|1921279|FG001|Overall Study|Adverse Event|0
935129|NCT00954512|1921280|FG002|Overall Study|Adverse Event|0
935130|NCT00954512|1921281|FG003|Overall Study|Adverse Event|0
935131|NCT00954512|1921282|FG004|Overall Study|Adverse Event|1
935132|NCT00954512|1921283|FG005|Overall Study|Adverse Event|2
935133|NCT00954512|1921278|FG000|Overall Study|Physician Decision|0
935134|NCT00954512|1921279|FG001|Overall Study|Physician Decision|1
935135|NCT00954512|1921280|FG002|Overall Study|Physician Decision|0
935136|NCT00954512|1921281|FG003|Overall Study|Physician Decision|1
935137|NCT00954512|1921282|FG004|Overall Study|Physician Decision|0
935138|NCT00954512|1921283|FG005|Overall Study|Physician Decision|0
935139|NCT00954512|1921278|FG000|Overall Study|Symptomatic Deterioration|0
935140|NCT00954512|1921279|FG001|Overall Study|Symptomatic Deterioration|1
935141|NCT00954512|1921280|FG002|Overall Study|Symptomatic Deterioration|0
935142|NCT00954512|1921281|FG003|Overall Study|Symptomatic Deterioration|0
935143|NCT00954512|1921282|FG004|Overall Study|Symptomatic Deterioration|2
935144|NCT00954512|1921283|FG005|Overall Study|Symptomatic Deterioration|0
935145|NCT00954512|1921278|FG000|Overall Study|Progression of Disease|2
935146|NCT00954512|1921279|FG001|Overall Study|Progression of Disease|1
935147|NCT00954512|1921280|FG002|Overall Study|Progression of Disease|0
935148|NCT00954512|1921281|FG003|Overall Study|Progression of Disease|1
935149|NCT00954512|1921282|FG004|Overall Study|Progression of Disease|1
935150|NCT00954512|1921283|FG005|Overall Study|Progression of Disease|1
935151|NCT00954538|1921298|FG000|Part III|Withdrawal by Subject|0
935152|NCT00954538|1921299|FG001|Part III|Withdrawal by Subject|0
935153|NCT00954538|1921300|FG002|Part III|Withdrawal by Subject|0
935154|NCT00954538|1921301|FG003|Part III|Withdrawal by Subject|0
935155|NCT00954538|1921302|FG004|Part III|Withdrawal by Subject|1
935156|NCT00954538|1921303|FG005|Part III|Withdrawal by Subject|0
935157|NCT00954707|1921316|FG000|Overall Study|Death|34
935158|NCT00954707|1921316|FG000|Overall Study|Withdrawal by Subject|100
935159|NCT00954707|1921316|FG000|Overall Study|Lost to Follow-up|33
935160|NCT00954733|1921320|FG000|Overall Study|blood gas machine did not work|1
935161|NCT00954941|1921334|FG000|Overall Study|Received treatment at home|1
935162|NCT00954941|1921335|FG001|Overall Study|Received treatment at home|0
935163|NCT00954941|1921334|FG000|Overall Study|Withdrawal by Subject|1
935164|NCT00954941|1921335|FG001|Overall Study|Withdrawal by Subject|0
935165|NCT00954941|1921334|FG000|Overall Study|Insurance Denial|2
935166|NCT00954941|1921335|FG001|Overall Study|Insurance Denial|2
935167|NCT00954941|1921334|FG000|Overall Study|Physician Decision|2
935168|NCT00954941|1921335|FG001|Overall Study|Physician Decision|2
935169|NCT00954941|1921334|FG000|Overall Study|Ineligible|2
935170|NCT00954941|1921335|FG001|Overall Study|Ineligible|2
935171|NCT00954941|1921334|FG000|Overall Study|Adverse Event|0
935172|NCT00954941|1921335|FG001|Overall Study|Adverse Event|1
935173|NCT00955110|1921365|FG000|Qualification Phase|Did not meet eligibility criteria|24
935174|NCT00955110|1921365|FG000|Treatment Phase|Adverse Event|2
935175|NCT00955110|1921365|FG000|Treatment Phase|Administrative reasons|2
935176|NCT00955110|1921365|FG000|Treatment Phase|Non-compliance with study restrictions|1
935177|NCT00955110|1921365|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1
935178|NCT00955279|1921421|FG000|Overall Study|Other|0
935179|NCT00955279|1921422|FG001|Overall Study|Other|0
935180|NCT00955279|1921423|FG002|Overall Study|Other|3
935181|NCT00955279|1921421|FG000|Overall Study|Death|1
935182|NCT00955279|1921422|FG001|Overall Study|Death|1
935183|NCT00955279|1921423|FG002|Overall Study|Death|1
935184|NCT00955279|1921421|FG000|Overall Study|Lost to Follow-up|0
935185|NCT00955279|1921422|FG001|Overall Study|Lost to Follow-up|3
935186|NCT00955279|1921423|FG002|Overall Study|Lost to Follow-up|1
935187|NCT00955279|1921421|FG000|Overall Study|Withdrawal by Subject|2
935188|NCT00955279|1921422|FG001|Overall Study|Withdrawal by Subject|0
935189|NCT00955279|1921423|FG002|Overall Study|Withdrawal by Subject|3
935190|NCT00955305|1921433|FG000|Overall Study|Disease progression|39
935191|NCT00955305|1921434|FG001|Overall Study|Disease progression|41
935192|NCT00955305|1921433|FG000|Overall Study|Adverse Event|22
935193|NCT00955305|1921434|FG001|Overall Study|Adverse Event|22
935194|NCT00955305|1921433|FG000|Overall Study|Death|2
935195|NCT00955305|1921434|FG001|Overall Study|Death|1
935196|NCT00955305|1921433|FG000|Overall Study|Withdrawal by Subject|5
935197|NCT00955305|1921434|FG001|Overall Study|Withdrawal by Subject|4
935198|NCT00955305|1921433|FG000|Overall Study|Alternative therapy|4
935199|NCT00955305|1921434|FG001|Overall Study|Alternative therapy|0
935200|NCT00955305|1921433|FG000|Overall Study|Other complicating disease|2
935201|NCT00955305|1921434|FG001|Overall Study|Other complicating disease|4
935202|NCT00955305|1921433|FG000|Overall Study|Physician Decision|1
935203|NCT00955305|1921434|FG001|Overall Study|Physician Decision|0
935204|NCT00955305|1921433|FG000|Overall Study|Continued presence of residual disease|0
935205|NCT00955305|1921434|FG001|Overall Study|Continued presence of residual disease|1
935206|NCT00955305|1921433|FG000|Overall Study|Functional decline|2
935207|NCT00955305|1921434|FG001|Overall Study|Functional decline|0
935208|NCT00955305|1921433|FG000|Overall Study|Maximum response achieved|0
935209|NCT00955305|1921434|FG001|Overall Study|Maximum response achieved|1
935210|NCT00955305|1921433|FG000|Overall Study|Lost to Follow-up|0
935211|NCT00955305|1921434|FG001|Overall Study|Lost to Follow-up|1
935212|NCT00955305|1921433|FG000|Overall Study|No off-treatment reason submitted|1
935213|NCT00955305|1921434|FG001|Overall Study|No off-treatment reason submitted|0
935214|NCT00955305|1921433|FG000|Overall Study|Never started protocol treatment|5
935215|NCT00955305|1921434|FG001|Overall Study|Never started protocol treatment|5
935216|NCT00955305|1921433|FG000|Overall Study|Ineligible|5
935217|NCT00955305|1921434|FG001|Overall Study|Ineligible|7
935218|NCT00955357|1921442|FG000|Titration Phase|Adverse Event|9
935219|NCT00955357|1921443|FG001|Titration Phase|Adverse Event|46
935220|NCT00955357|1921442|FG000|Titration Phase|Lack of Efficacy|0
935221|NCT00955357|1921443|FG001|Titration Phase|Lack of Efficacy|2
935222|NCT00955357|1921442|FG000|Titration Phase|Protocol Violation|3
935223|NCT00955357|1921443|FG001|Titration Phase|Protocol Violation|7
935224|NCT00955357|1921442|FG000|Titration Phase|Lost to Follow-up|1
935225|NCT00955357|1921443|FG001|Titration Phase|Lost to Follow-up|3
935226|NCT00955357|1921442|FG000|Titration Phase|Withdrawal by Subject|3
935227|NCT00955357|1921443|FG001|Titration Phase|Withdrawal by Subject|5
935228|NCT00955357|1921442|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0
935229|NCT00955357|1921443|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1
935230|NCT00955357|1921442|FG000|Titration Phase|Study medication not tolerated|0
935231|NCT00955357|1921443|FG001|Titration Phase|Study medication not tolerated|1
935232|NCT00955357|1921442|FG000|Titration Phase|Non compliance to study procedures|0
935233|NCT00955357|1921443|FG001|Titration Phase|Non compliance to study procedures|1
935234|NCT00955357|1921442|FG000|Maintenance Phase|Adverse Event|3
935235|NCT00955357|1921443|FG001|Maintenance Phase|Adverse Event|23
935236|NCT00955357|1921442|FG000|Maintenance Phase|Lack of Efficacy|0
935237|NCT00955357|1921443|FG001|Maintenance Phase|Lack of Efficacy|4
935238|NCT00955357|1921442|FG000|Maintenance Phase|Protocol Violation|2
935239|NCT00955357|1921443|FG001|Maintenance Phase|Protocol Violation|6
935240|NCT00955357|1921442|FG000|Maintenance Phase|Lost to Follow-up|2
935241|NCT00955357|1921443|FG001|Maintenance Phase|Lost to Follow-up|7
935242|NCT00955357|1921442|FG000|Maintenance Phase|Withdrawal by Subject|4
935243|NCT00955357|1921443|FG001|Maintenance Phase|Withdrawal by Subject|4
935244|NCT00955357|1921442|FG000|Maintenance Phase|Patient moving out of area|0
935245|NCT00955357|1921443|FG001|Maintenance Phase|Patient moving out of area|1
935246|NCT00955357|1921442|FG000|Maintenance Phase|Non compliance to study procedures|1
935247|NCT00955357|1921443|FG001|Maintenance Phase|Non compliance to study procedures|0
935248|NCT00955409|1921459|FG000|Overall Study|Lack of Efficacy|1
935249|NCT00955409|1921460|FG001|Overall Study|Lack of Efficacy|0
935250|NCT00955409|1921461|FG002|Overall Study|Lack of Efficacy|0
935251|NCT00955409|1921462|FG003|Overall Study|Lack of Efficacy|0
935252|NCT00955409|1921463|FG004|Overall Study|Lack of Efficacy|0
935253|NCT00955409|1921464|FG005|Overall Study|Lack of Efficacy|0
935254|NCT00955409|1921465|FG006|Overall Study|Lack of Efficacy|0
935255|NCT00955409|1921466|FG007|Overall Study|Lack of Efficacy|0
935256|NCT00955409|1921467|FG008|Overall Study|Lack of Efficacy|0
935257|NCT00955409|1921468|FG009|Overall Study|Lack of Efficacy|0
935258|NCT00955409|1921459|FG000|Overall Study|Withdrawal by Subject|1
935259|NCT00955409|1921460|FG001|Overall Study|Withdrawal by Subject|0
935260|NCT00955409|1921461|FG002|Overall Study|Withdrawal by Subject|5
935261|NCT00955409|1921462|FG003|Overall Study|Withdrawal by Subject|2
935262|NCT00955409|1921463|FG004|Overall Study|Withdrawal by Subject|0
935263|NCT00955409|1921464|FG005|Overall Study|Withdrawal by Subject|0
935264|NCT00955409|1921465|FG006|Overall Study|Withdrawal by Subject|2
935265|NCT00955409|1921466|FG007|Overall Study|Withdrawal by Subject|0
935266|NCT00955409|1921467|FG008|Overall Study|Withdrawal by Subject|1
935267|NCT00955409|1921468|FG009|Overall Study|Withdrawal by Subject|0
935268|NCT00955409|1921459|FG000|Overall Study|Caregiver Request|2
935269|NCT00955409|1921460|FG001|Overall Study|Caregiver Request|0
935270|NCT00955409|1921461|FG002|Overall Study|Caregiver Request|6
935271|NCT00955409|1921462|FG003|Overall Study|Caregiver Request|5
935272|NCT00955409|1921463|FG004|Overall Study|Caregiver Request|0
935273|NCT00955409|1921464|FG005|Overall Study|Caregiver Request|2
935274|NCT00955409|1921465|FG006|Overall Study|Caregiver Request|3
935275|NCT00955409|1921466|FG007|Overall Study|Caregiver Request|1
935276|NCT00955409|1921467|FG008|Overall Study|Caregiver Request|3
935277|NCT00955409|1921468|FG009|Overall Study|Caregiver Request|0
935278|NCT00955409|1921459|FG000|Overall Study|Investigator Request|0
935279|NCT00955409|1921460|FG001|Overall Study|Investigator Request|0
935280|NCT00955409|1921461|FG002|Overall Study|Investigator Request|1
935281|NCT00955409|1921462|FG003|Overall Study|Investigator Request|0
935282|NCT00955409|1921463|FG004|Overall Study|Investigator Request|0
935283|NCT00955409|1921464|FG005|Overall Study|Investigator Request|0
935284|NCT00955409|1921465|FG006|Overall Study|Investigator Request|0
935285|NCT00955409|1921466|FG007|Overall Study|Investigator Request|0
935286|NCT00955409|1921467|FG008|Overall Study|Investigator Request|0
935287|NCT00955409|1921468|FG009|Overall Study|Investigator Request|0
935288|NCT00955409|1921459|FG000|Overall Study|Discontinuation of Study by Sponsor|0
935289|NCT00955409|1921460|FG001|Overall Study|Discontinuation of Study by Sponsor|0
935290|NCT00955409|1921461|FG002|Overall Study|Discontinuation of Study by Sponsor|0
935291|NCT00955409|1921462|FG003|Overall Study|Discontinuation of Study by Sponsor|0
935292|NCT00955409|1921463|FG004|Overall Study|Discontinuation of Study by Sponsor|0
935293|NCT00955409|1921464|FG005|Overall Study|Discontinuation of Study by Sponsor|0
935294|NCT00955409|1921465|FG006|Overall Study|Discontinuation of Study by Sponsor|0
935295|NCT00955409|1921466|FG007|Overall Study|Discontinuation of Study by Sponsor|1
935296|NCT00955409|1921467|FG008|Overall Study|Discontinuation of Study by Sponsor|0
935297|NCT00955409|1921468|FG009|Overall Study|Discontinuation of Study by Sponsor|0
935298|NCT00955409|1921459|FG000|Overall Study|Lost to Follow-up|0
935299|NCT00955409|1921460|FG001|Overall Study|Lost to Follow-up|0
935300|NCT00955409|1921461|FG002|Overall Study|Lost to Follow-up|1
935301|NCT00955409|1921462|FG003|Overall Study|Lost to Follow-up|0
935302|NCT00955409|1921463|FG004|Overall Study|Lost to Follow-up|0
935303|NCT00955409|1921464|FG005|Overall Study|Lost to Follow-up|0
935304|NCT00955409|1921465|FG006|Overall Study|Lost to Follow-up|1
935305|NCT00955409|1921466|FG007|Overall Study|Lost to Follow-up|0
935306|NCT00955409|1921467|FG008|Overall Study|Lost to Follow-up|0
935307|NCT00955409|1921468|FG009|Overall Study|Lost to Follow-up|0
935308|NCT00955409|1921459|FG000|Overall Study|Failed to Return|2
935309|NCT00955409|1921460|FG001|Overall Study|Failed to Return|0
935310|NCT00955409|1921461|FG002|Overall Study|Failed to Return|0
935311|NCT00955409|1921462|FG003|Overall Study|Failed to Return|0
935312|NCT00955409|1921463|FG004|Overall Study|Failed to Return|0
935313|NCT00955409|1921464|FG005|Overall Study|Failed to Return|0
935314|NCT00955409|1921465|FG006|Overall Study|Failed to Return|0
935315|NCT00955409|1921466|FG007|Overall Study|Failed to Return|2
935316|NCT00955409|1921467|FG008|Overall Study|Failed to Return|0
935317|NCT00955409|1921468|FG009|Overall Study|Failed to Return|0
935318|NCT00955409|1921459|FG000|Overall Study|Adverse Event (AE)|2
935319|NCT00955409|1921460|FG001|Overall Study|Adverse Event (AE)|0
935320|NCT00955409|1921461|FG002|Overall Study|Adverse Event (AE)|0
935321|NCT00955409|1921462|FG003|Overall Study|Adverse Event (AE)|0
935322|NCT00955409|1921463|FG004|Overall Study|Adverse Event (AE)|0
935323|NCT00955409|1921464|FG005|Overall Study|Adverse Event (AE)|1
935324|NCT00955409|1921465|FG006|Overall Study|Adverse Event (AE)|2
935325|NCT00955409|1921466|FG007|Overall Study|Adverse Event (AE)|0
935326|NCT00955409|1921467|FG008|Overall Study|Adverse Event (AE)|2
935327|NCT00955409|1921468|FG009|Overall Study|Adverse Event (AE)|0
935328|NCT00955409|1921459|FG000|Overall Study|Reason not Specified|2
935329|NCT00955409|1921460|FG001|Overall Study|Reason not Specified|1
935330|NCT00955409|1921461|FG002|Overall Study|Reason not Specified|13
935331|NCT00955409|1921462|FG003|Overall Study|Reason not Specified|1
935332|NCT00955409|1921463|FG004|Overall Study|Reason not Specified|2
935333|NCT00955409|1921464|FG005|Overall Study|Reason not Specified|0
935334|NCT00955409|1921465|FG006|Overall Study|Reason not Specified|16
935335|NCT00955409|1921466|FG007|Overall Study|Reason not Specified|0
935336|NCT00955409|1921467|FG008|Overall Study|Reason not Specified|8
935337|NCT00955409|1921468|FG009|Overall Study|Reason not Specified|1
935338|NCT00955474|1921496|FG000|Overall Study|Physician Decision|7
935339|NCT00955474|1921497|FG001|Overall Study|Physician Decision|5
935340|NCT00955617|1921537|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
935341|NCT00955617|1921538|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
935342|NCT00955617|1921537|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
935343|NCT00955617|1921538|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
935344|NCT00955617|1921537|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0
935345|NCT00955617|1921538|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1
935346|NCT00955617|1921537|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
935347|NCT00955617|1921538|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
935348|NCT00955682|1921546|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1
935349|NCT00955682|1921547|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1
935350|NCT00955708|1921561|FG000|Overall Study|Death|269
935351|NCT00955708|1921561|FG000|Overall Study|Lost to Follow-up|72
935352|NCT00955708|1921561|FG000|Overall Study|Physician Decision|36
935353|NCT00955708|1921561|FG000|Overall Study|Protocol Violation|134
935354|NCT00955708|1921561|FG000|Overall Study|Registry Conclusion|186
935355|NCT00955708|1921561|FG000|Overall Study|Product removed from service|94
935356|NCT00955708|1921561|FG000|Overall Study|Patient Refused to participate further|116
935357|NCT00955708|1921561|FG000|Overall Study|Closure of study location|60
935358|NCT00955708|1921561|FG000|Overall Study|Patient changed care provider/moved|91
935359|NCT00955721|1921567|FG000|Overall Study|Physician Decision|1
935360|NCT00955721|1921568|FG001|Overall Study|Physician Decision|0
935361|NCT00955721|1921567|FG000|Overall Study|Death|1
935362|NCT00955721|1921568|FG001|Overall Study|Death|0
935363|NCT00955721|1921567|FG000|Overall Study|Withdrawal by Subject|1
935364|NCT00955721|1921568|FG001|Overall Study|Withdrawal by Subject|0
935365|NCT00955825|1921586|FG000|Overall Study|Adverse Event|15
935366|NCT00955825|1921587|FG001|Overall Study|Adverse Event|2
935367|NCT00955825|1921586|FG000|Overall Study|Withdrawal by Subject|4
935368|NCT00955825|1921587|FG001|Overall Study|Withdrawal by Subject|6
935369|NCT00955825|1921586|FG000|Overall Study|Any other reason not above-mentioned|7
935370|NCT00955825|1921587|FG001|Overall Study|Any other reason not above-mentioned|9
935371|NCT00955955|1921626|FG000|Overall Study|Lost to Follow-up|2
935372|NCT00955955|1921627|FG001|Overall Study|Lost to Follow-up|0
935373|NCT00955955|1921628|FG002|Overall Study|Lost to Follow-up|0
935374|NCT00955968|1921644|FG000|Overall Study|Death|2
935375|NCT00955968|1921645|FG001|Overall Study|Death|4
935376|NCT00955968|1921644|FG000|Overall Study|Withdrawal by Subject|35
935377|NCT00955968|1921645|FG001|Overall Study|Withdrawal by Subject|31
935378|NCT00955968|1921644|FG000|Overall Study|Lost to Follow-up|45
935379|NCT00955968|1921645|FG001|Overall Study|Lost to Follow-up|39
935380|NCT00955968|1921644|FG000|Overall Study|Site closed|55
935381|NCT00955968|1921645|FG001|Overall Study|Site closed|52
935382|NCT00956293|1921679|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0
935383|NCT00956293|1921680|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0
935384|NCT00956293|1921681|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1
935385|NCT00956293|1921679|FG000|Main Period (Pre-randomization)|Death|0
935386|NCT00956293|1921680|FG001|Main Period (Pre-randomization)|Death|0
935387|NCT00956293|1921681|FG002|Main Period (Pre-randomization)|Death|1
935388|NCT00956293|1921679|FG000|Main Period (Pre-randomization)|Protocol Violation|0
935389|NCT00956293|1921680|FG001|Main Period (Pre-randomization)|Protocol Violation|0
935390|NCT00956293|1921681|FG002|Main Period (Pre-randomization)|Protocol Violation|1
935391|NCT00956293|1921679|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0
935392|NCT00956293|1921680|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0
935393|NCT00956293|1921681|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2
935394|NCT00956293|1921679|FG000|Main Period (Pre-randomization)|Administrative problems|0
935395|NCT00956293|1921680|FG001|Main Period (Pre-randomization)|Administrative problems|0
935396|NCT00956293|1921681|FG002|Main Period (Pre-randomization)|Administrative problems|6
935397|NCT00956293|1921679|FG000|Main Period (Pre-randomization)|Graft loss|0
935398|NCT00956293|1921680|FG001|Main Period (Pre-randomization)|Graft loss|0
935399|NCT00956293|1921681|FG002|Main Period (Pre-randomization)|Graft loss|7
935400|NCT00956293|1921679|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0
935401|NCT00956293|1921680|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0
935402|NCT00956293|1921681|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12
935403|NCT00956293|1921679|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0
935404|NCT00956293|1921680|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0
935405|NCT00956293|1921681|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20
935406|NCT00956293|1921679|FG000|Main Period (Pre-randomization)|Adverse Event|0
935407|NCT00956293|1921680|FG001|Main Period (Pre-randomization)|Adverse Event|0
935408|NCT00956293|1921681|FG002|Main Period (Pre-randomization)|Adverse Event|36
935409|NCT00956293|1921679|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0
935410|NCT00956293|1921680|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0
935411|NCT00956293|1921681|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44
935412|NCT00956293|1921679|FG000|Main Period (Randomization)|Abnormal laboratory value|0
935413|NCT00956293|1921680|FG001|Main Period (Randomization)|Abnormal laboratory value|2
935414|NCT00956293|1921681|FG002|Main Period (Randomization)|Abnormal laboratory value|0
935415|NCT00956293|1921679|FG000|Main Period (Randomization)|Lack of Efficacy|1
935416|NCT00956293|1921680|FG001|Main Period (Randomization)|Lack of Efficacy|10
935417|NCT00956293|1921681|FG002|Main Period (Randomization)|Lack of Efficacy|0
935418|NCT00956293|1921679|FG000|Main Period (Randomization)|Adverse Event|0
935419|NCT00956293|1921680|FG001|Main Period (Randomization)|Adverse Event|15
935420|NCT00956293|1921681|FG002|Main Period (Randomization)|Adverse Event|0
935421|NCT00956293|1921679|FG000|Follow-up Period|Follow-up period was terminated.|20
935422|NCT00956293|1921680|FG001|Follow-up Period|Follow-up period was terminated.|32
935423|NCT00956293|1921681|FG002|Follow-up Period|Follow-up period was terminated.|0
935424|NCT00956592|1921706|FG000|Overall Study|Protocol Violation|1
935425|NCT00956592|1921707|FG001|Overall Study|Protocol Violation|3
935426|NCT00956813|1921746|FG000|Flaxseed and Placebo|Withdrawal by Subject|5
935427|NCT00956813|1921747|FG001|Flaxseed and Placebo|Withdrawal by Subject|4
935428|NCT00956813|1921746|FG000|Flaxseed and Placebo|Ineligible|3
935429|NCT00956813|1921747|FG001|Flaxseed and Placebo|Ineligible|1
935430|NCT00956839|1921757|FG000|Overall Study|Lost to Follow-up|3
935431|NCT00956839|1921758|FG001|Overall Study|Lost to Follow-up|0
935432|NCT00956839|1921759|FG002|Overall Study|Lost to Follow-up|3
935433|NCT00956943|1921780|FG000|Overall Study|Lost to Follow-up|9
935434|NCT00956943|1921781|FG001|Overall Study|Lost to Follow-up|10
935435|NCT00957008|1921791|FG000|Overall Study|Withdrawal by Subject|13
935436|NCT00957008|1921792|FG001|Overall Study|Withdrawal by Subject|10
935437|NCT00957008|1921793|FG002|Overall Study|Withdrawal by Subject|12
935438|NCT00957008|1921794|FG003|Overall Study|Withdrawal by Subject|16
935439|NCT00957008|1921791|FG000|Overall Study|Lost to Follow-up|3
935440|NCT00957008|1921792|FG001|Overall Study|Lost to Follow-up|1
935441|NCT00957008|1921793|FG002|Overall Study|Lost to Follow-up|3
935442|NCT00957008|1921794|FG003|Overall Study|Lost to Follow-up|4
935443|NCT00957008|1921791|FG000|Overall Study|Physician Decision|1
935444|NCT00957008|1921792|FG001|Overall Study|Physician Decision|0
935445|NCT00957008|1921793|FG002|Overall Study|Physician Decision|1
935446|NCT00957008|1921794|FG003|Overall Study|Physician Decision|1
935447|NCT00957008|1921791|FG000|Overall Study|Relocated; Family conflict|4
935448|NCT00957008|1921792|FG001|Overall Study|Relocated; Family conflict|1
935449|NCT00957008|1921793|FG002|Overall Study|Relocated; Family conflict|1
935450|NCT00957008|1921794|FG003|Overall Study|Relocated; Family conflict|3
935451|NCT00957021|1921808|FG000|Overall Study|Death|5
935452|NCT00957021|1921808|FG000|Overall Study|Lost to Follow-up|8
935453|NCT00957021|1921808|FG000|Overall Study|Withdrawal by Subject|34
935454|NCT00957021|1921808|FG000|Overall Study|No 2 yr ROM data|35
935455|NCT00957021|1921808|FG000|Overall Study|Revised study component by 2 yr visit|8
935456|NCT00957021|1921808|FG000|Overall Study|Site Termination by the 2 yr visit|16
935457|NCT00957021|1921808|FG000|Overall Study|Surgery Cancelled|9
935458|NCT00957021|1921808|FG000|Overall Study|Termination due to language issue|2
935459|NCT00957229|1921841|FG000|Study Start|Adverse Event|0
935460|NCT00957229|1921842|FG001|Study Start|Adverse Event|3
935461|NCT00957229|1921841|FG000|Study Start|Disease Progression|1
935462|NCT00957229|1921842|FG001|Study Start|Disease Progression|0
935463|NCT00957229|1921841|FG000|Reallocated to or Continued Vismodegib|Death|1
935464|NCT00957229|1921842|FG001|Reallocated to or Continued Vismodegib|Death|1
935465|NCT00957229|1921841|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2
935466|NCT00957229|1921842|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1
935467|NCT00957268|1921864|FG000|Overall Study|Voluntary Withdrawal|0
935468|NCT00957268|1921865|FG001|Overall Study|Voluntary Withdrawal|0
935469|NCT00957268|1921866|FG002|Overall Study|Voluntary Withdrawal|1
935470|NCT00957268|1921867|FG003|Overall Study|Voluntary Withdrawal|0
935471|NCT00957268|1921868|FG004|Overall Study|Voluntary Withdrawal|0
935472|NCT00957372|1921896|FG000|PART I|Lost to Follow-up|0
935473|NCT00957372|1921897|FG001|PART I|Lost to Follow-up|0
935474|NCT00957372|1921898|FG002|PART I|Lost to Follow-up|1
935475|NCT00957372|1921899|FG003|PART I|Lost to Follow-up|0
935476|NCT00957372|1921896|FG000|PART II|Withdrawal by Subject|0
935477|NCT00957372|1921897|FG001|PART II|Withdrawal by Subject|0
935478|NCT00957372|1921898|FG002|PART II|Withdrawal by Subject|0
935479|NCT00957372|1921899|FG003|PART II|Withdrawal by Subject|8
935480|NCT00957372|1921896|FG000|PART II|Physician Decision|0
935481|NCT00957372|1921897|FG001|PART II|Physician Decision|0
935482|NCT00957372|1921898|FG002|PART II|Physician Decision|0
935483|NCT00957372|1921899|FG003|PART II|Physician Decision|1
935484|NCT00957372|1921896|FG000|PART II|Pregnancy|0
935485|NCT00957372|1921897|FG001|PART II|Pregnancy|0
935486|NCT00957372|1921898|FG002|PART II|Pregnancy|0
935487|NCT00957372|1921899|FG003|PART II|Pregnancy|1
935488|NCT00957372|1921896|FG000|PART II|Not Know|0
935489|NCT00957372|1921897|FG001|PART II|Not Know|0
935490|NCT00957372|1921898|FG002|PART II|Not Know|0
935491|NCT00957372|1921899|FG003|PART II|Not Know|20
935492|NCT00957372|1921896|FG000|PART II|Adverse Event|0
935493|NCT00957372|1921897|FG001|PART II|Adverse Event|0
935494|NCT00957372|1921898|FG002|PART II|Adverse Event|0
935495|NCT00957372|1921899|FG003|PART II|Adverse Event|10
935496|NCT00957372|1921896|FG000|PART II|Patient non-compliance|0
935497|NCT00957372|1921897|FG001|PART II|Patient non-compliance|0
935498|NCT00957372|1921898|FG002|PART II|Patient non-compliance|0
935499|NCT00957372|1921899|FG003|PART II|Patient non-compliance|4
935500|NCT00957424|1921915|FG000|Overall Study|Lost to Follow-up|19
935501|NCT00957424|1921915|FG000|Overall Study|Protocol Violation|3
935502|NCT00957424|1921915|FG000|Overall Study|Withdrawal by Subject|1
935503|NCT00957528|1921922|FG000|Overall Study|Protocol Violation|0
935504|NCT00957528|1921923|FG001|Overall Study|Protocol Violation|1
935505|NCT00957528|1921924|FG002|Overall Study|Protocol Violation|0
935506|NCT00957528|1921922|FG000|Overall Study|Withdrawal by Subject|0
935507|NCT00957528|1921923|FG001|Overall Study|Withdrawal by Subject|0
935508|NCT00957528|1921924|FG002|Overall Study|Withdrawal by Subject|1
935509|NCT00957580|1921935|FG000|Overall Study|Ongoing at data cut-off|0
935510|NCT00957580|1921936|FG001|Overall Study|Ongoing at data cut-off|1
935511|NCT00957580|1921937|FG002|Overall Study|Ongoing at data cut-off|0
935512|NCT00957580|1921935|FG000|Overall Study|Enrolled but not treated|0
935513|NCT00957580|1921936|FG001|Overall Study|Enrolled but not treated|1
935514|NCT00957580|1921937|FG002|Overall Study|Enrolled but not treated|0
935515|NCT00957658|1921969|FG000|Overall Study|Death|1
935516|NCT00957658|1921969|FG000|Overall Study|Lost to Follow-up|4
935517|NCT00957658|1921969|FG000|Overall Study|Withdrawal by Subject|12
935518|NCT00957658|1921969|FG000|Overall Study|Revision|1
935519|NCT00957658|1921969|FG000|Overall Study|Incomplete 2 yr data|28
935520|NCT00957658|1921969|FG000|Overall Study|Site termination|10
935521|NCT00957658|1921969|FG000|Overall Study|unwilling/unable to return|2
935522|NCT00957658|1921969|FG000|Overall Study|surgery cancelled|2
935523|NCT00957658|1921969|FG000|Overall Study|Protocol Violation|5
935524|NCT00957723|1921998|FG000|Overall Study|Death|3
935525|NCT00957723|1921998|FG000|Overall Study|Revision/ Removal of Study Implant|3
935526|NCT00957723|1921998|FG000|Overall Study|Lost to Follow-up|8
935527|NCT00957723|1921998|FG000|Overall Study|Withdrawal by Subject|24
935528|NCT00957723|1921998|FG000|Overall Study|Investigative Site Terminated|61
935529|NCT00957723|1921998|FG000|Overall Study|Intercurrent Illness|2
935530|NCT00957723|1921998|FG000|Overall Study|2yr ROM Data Not Evaluable|12
935531|NCT00957801|1922008|FG000|Overall Study|Withdrawal by Subject|0
935532|NCT00957801|1922009|FG001|Overall Study|Withdrawal by Subject|0
935533|NCT00957801|1922010|FG002|Overall Study|Withdrawal by Subject|0
935534|NCT00957801|1922011|FG003|Overall Study|Withdrawal by Subject|1
935535|NCT00957853|1922024|FG000|Overall Study|Withdrawal by Subject|1
935536|NCT00957853|1922025|FG001|Overall Study|Withdrawal by Subject|0
935537|NCT00957853|1922026|FG002|Overall Study|Withdrawal by Subject|0
935538|NCT00957905|1922036|FG000|Part B|Not Treated|0
935539|NCT00957905|1922037|FG001|Part B|Not Treated|1
935540|NCT00957905|1922036|FG000|Part B|Physician Decision|0
935541|NCT00957905|1922037|FG001|Part B|Physician Decision|1
935542|NCT00957905|1922036|FG000|Part B|Death|0
935543|NCT00957905|1922037|FG001|Part B|Death|1
935544|NCT00957905|1922036|FG000|Part B|Protocol Violation|0
935545|NCT00957905|1922037|FG001|Part B|Protocol Violation|1
935546|NCT00957931|1922043|FG000|Overall Study|Death|4
935547|NCT00957944|1922049|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0
935548|NCT00957944|1922050|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1
935549|NCT00957996|1922058|FG000|Overall Study|Death|4
935550|NCT00957996|1922059|FG001|Overall Study|Death|10
935551|NCT00957996|1922058|FG000|Overall Study|Lost to Follow-up|4
935552|NCT00957996|1922059|FG001|Overall Study|Lost to Follow-up|7
935553|NCT00957996|1922058|FG000|Overall Study|Withdrawal by Subject|9
935554|NCT00957996|1922059|FG001|Overall Study|Withdrawal by Subject|2
935555|NCT00957996|1922058|FG000|Overall Study|Adverse Event|2
935556|NCT00957996|1922059|FG001|Overall Study|Adverse Event|1
935557|NCT00957996|1922058|FG000|Overall Study|Physician Decision|1
935558|NCT00957996|1922059|FG001|Overall Study|Physician Decision|1
935559|NCT00957996|1922058|FG000|Overall Study|Influenza-related complication|0
935560|NCT00957996|1922059|FG001|Overall Study|Influenza-related complication|1
935561|NCT00957996|1922058|FG000|Overall Study|Missing|1
935562|NCT00957996|1922059|FG001|Overall Study|Missing|0
935563|NCT00957996|1922058|FG000|Overall Study|Noncompliance; Protocol Deviations|5
935564|NCT00957996|1922059|FG001|Overall Study|Noncompliance; Protocol Deviations|6
935565|NCT00958009|1922067|FG000|Overall Study|Adverse Event|1
935566|NCT00958009|1922067|FG000|Overall Study|Subject found device difficult to use|1
935567|NCT00958074|1922082|FG000|Overall Study|Withdrawal by Subject|0
935568|NCT00958074|1922083|FG001|Overall Study|Withdrawal by Subject|1
935569|NCT00958126|1922097|FG000|Overall Study|Serious Adverse Event|0
935570|NCT00958126|1922098|FG001|Overall Study|Serious Adverse Event|2
935571|NCT00958126|1922099|FG002|Overall Study|Serious Adverse Event|0
935572|NCT00958126|1922100|FG003|Overall Study|Serious Adverse Event|0
935573|NCT00958126|1922101|FG004|Overall Study|Serious Adverse Event|0
935574|NCT00958126|1922102|FG005|Overall Study|Serious Adverse Event|0
935575|NCT00958126|1922103|FG006|Overall Study|Serious Adverse Event|1
935576|NCT00958126|1922104|FG007|Overall Study|Serious Adverse Event|0
935577|NCT00958126|1922097|FG000|Overall Study|Withdrawal by Subject|0
935578|NCT00958126|1922098|FG001|Overall Study|Withdrawal by Subject|2
935579|NCT00958126|1922099|FG002|Overall Study|Withdrawal by Subject|0
935580|NCT00958126|1922100|FG003|Overall Study|Withdrawal by Subject|0
935581|NCT00958126|1922101|FG004|Overall Study|Withdrawal by Subject|0
935582|NCT00958126|1922102|FG005|Overall Study|Withdrawal by Subject|0
935583|NCT00958126|1922103|FG006|Overall Study|Withdrawal by Subject|0
935584|NCT00958126|1922104|FG007|Overall Study|Withdrawal by Subject|0
935585|NCT00958126|1922097|FG000|Overall Study|Moved away from study area|0
935586|NCT00958126|1922098|FG001|Overall Study|Moved away from study area|0
935587|NCT00958126|1922099|FG002|Overall Study|Moved away from study area|1
935588|NCT00958126|1922100|FG003|Overall Study|Moved away from study area|1
935589|NCT00958126|1922101|FG004|Overall Study|Moved away from study area|0
935590|NCT00958126|1922102|FG005|Overall Study|Moved away from study area|0
935591|NCT00958126|1922103|FG006|Overall Study|Moved away from study area|0
935592|NCT00958126|1922104|FG007|Overall Study|Moved away from study area|0
935593|NCT00958126|1922097|FG000|Overall Study|Lost to Follow-up|1
935594|NCT00958126|1922098|FG001|Overall Study|Lost to Follow-up|5
935595|NCT00958126|1922099|FG002|Overall Study|Lost to Follow-up|9
935596|NCT00958126|1922100|FG003|Overall Study|Lost to Follow-up|8
935597|NCT00958126|1922101|FG004|Overall Study|Lost to Follow-up|0
935598|NCT00958126|1922102|FG005|Overall Study|Lost to Follow-up|0
935599|NCT00958126|1922103|FG006|Overall Study|Lost to Follow-up|0
935600|NCT00958126|1922104|FG007|Overall Study|Lost to Follow-up|0
935601|NCT00958126|1922097|FG000|Overall Study|Sponsor/Investigator decision|0
935602|NCT00958126|1922098|FG001|Overall Study|Sponsor/Investigator decision|0
935603|NCT00958126|1922099|FG002|Overall Study|Sponsor/Investigator decision|0
935604|NCT00958126|1922100|FG003|Overall Study|Sponsor/Investigator decision|1
935605|NCT00958126|1922101|FG004|Overall Study|Sponsor/Investigator decision|0
935606|NCT00958126|1922102|FG005|Overall Study|Sponsor/Investigator decision|0
935607|NCT00958126|1922103|FG006|Overall Study|Sponsor/Investigator decision|0
935608|NCT00958126|1922104|FG007|Overall Study|Sponsor/Investigator decision|0
935609|NCT00958126|1922097|FG000|Overall Study|Other Reason|0
935610|NCT00958126|1922098|FG001|Overall Study|Other Reason|0
935611|NCT00958126|1922099|FG002|Overall Study|Other Reason|0
935612|NCT00958126|1922100|FG003|Overall Study|Other Reason|1
935613|NCT00958126|1922101|FG004|Overall Study|Other Reason|0
935614|NCT00958126|1922102|FG005|Overall Study|Other Reason|1
935615|NCT00958126|1922103|FG006|Overall Study|Other Reason|0
935616|NCT00958126|1922104|FG007|Overall Study|Other Reason|0
935617|NCT00958165|1922126|FG000|Overall Study|Lost to Follow-up|5
935618|NCT00958165|1922126|FG000|Overall Study|Not eligible|9
935619|NCT00958191|1922130|FG000|Overall Study|Death|4
935620|NCT00958191|1922130|FG000|Overall Study|Lost to Follow-up|5
935621|NCT00958191|1922130|FG000|Overall Study|Inadequate 5 yr x-ray quality|10
935622|NCT00958191|1922130|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21
935623|NCT00958191|1922130|FG000|Overall Study|Revision of study device|4
935624|NCT00958191|1922130|FG000|Overall Study|Site termination|11
935625|NCT00958191|1922130|FG000|Overall Study|No 5 yr x-rays|56
935626|NCT00958217|1922138|FG000|Overall Study|Death|2
935627|NCT00958217|1922139|FG001|Overall Study|Death|1
935628|NCT00958217|1922138|FG000|Overall Study|Withdrawal by Subject|4
935629|NCT00958217|1922139|FG001|Overall Study|Withdrawal by Subject|3
935630|NCT00958217|1922138|FG000|Overall Study|Lost to Follow-up|17
935631|NCT00958217|1922139|FG001|Overall Study|Lost to Follow-up|19
935632|NCT00958217|1922138|FG000|Overall Study|Moved out of area|1
935633|NCT00958217|1922139|FG001|Overall Study|Moved out of area|1
935634|NCT00958217|1922138|FG000|Overall Study|Inpatient hospitalization|0
935635|NCT00958217|1922139|FG001|Overall Study|Inpatient hospitalization|1
935636|NCT00958243|1922152|FG000|Overall Study|Withdrawal by Subject|0
935637|NCT00958243|1922153|FG001|Overall Study|Withdrawal by Subject|1
935638|NCT00958243|1922154|FG002|Overall Study|Withdrawal by Subject|3
935639|NCT00958243|1922155|FG003|Overall Study|Withdrawal by Subject|1
935640|NCT00958243|1922156|FG004|Overall Study|Withdrawal by Subject|1
935641|NCT00958243|1922157|FG005|Overall Study|Withdrawal by Subject|5
935642|NCT00958243|1922152|FG000|Overall Study|Lost to Follow-up|2
935643|NCT00958243|1922153|FG001|Overall Study|Lost to Follow-up|5
935644|NCT00958243|1922154|FG002|Overall Study|Lost to Follow-up|11
935645|NCT00958243|1922155|FG003|Overall Study|Lost to Follow-up|2
935646|NCT00958243|1922156|FG004|Overall Study|Lost to Follow-up|8
935647|NCT00958243|1922157|FG005|Overall Study|Lost to Follow-up|5
935648|NCT00958256|1922177|FG000|Overall Study|Adverse Event|3
935649|NCT00958360|1922218|FG000|Overall Study|Withdrawal by Subject|3
935650|NCT00958360|1922219|FG001|Overall Study|Withdrawal by Subject|1
935651|NCT00958360|1922218|FG000|Overall Study|Death|6
935652|NCT00958360|1922219|FG001|Overall Study|Death|7
935653|NCT00958360|1922218|FG000|Overall Study|Physician Decision|2
935654|NCT00958360|1922219|FG001|Overall Study|Physician Decision|1
935655|NCT00958360|1922218|FG000|Overall Study|Lost to Follow-up|0
935656|NCT00958360|1922219|FG001|Overall Study|Lost to Follow-up|1
935657|NCT00958412|1922225|FG000|Overall Study|Study prematurely terminated|18
935658|NCT00958438|1922232|FG000|Overall Study|Protocol Violation|3
935659|NCT00958438|1922233|FG001|Overall Study|Protocol Violation|2
935660|NCT00958438|1922234|FG002|Overall Study|Protocol Violation|2
935661|NCT00958438|1922232|FG000|Overall Study|Withdrawal by Subject|4
935662|NCT00958438|1922233|FG001|Overall Study|Withdrawal by Subject|2
935663|NCT00958438|1922234|FG002|Overall Study|Withdrawal by Subject|1
935664|NCT00958438|1922232|FG000|Overall Study|Adverse Event|0
935665|NCT00958438|1922233|FG001|Overall Study|Adverse Event|3
935666|NCT00958438|1922234|FG002|Overall Study|Adverse Event|0
935667|NCT00958438|1922232|FG000|Overall Study|Physician Decision|1
935668|NCT00958438|1922233|FG001|Overall Study|Physician Decision|0
935669|NCT00958438|1922234|FG002|Overall Study|Physician Decision|1
935670|NCT00958438|1922232|FG000|Overall Study|Other than specified above|2
935671|NCT00958438|1922233|FG001|Overall Study|Other than specified above|3
935672|NCT00958438|1922234|FG002|Overall Study|Other than specified above|2
935673|NCT00958568|1922265|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
935674|NCT00958568|1922266|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
935675|NCT00958568|1922267|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
935676|NCT00958568|1922268|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
935677|NCT00958568|1922265|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
935678|NCT00958568|1922266|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
935679|NCT00958568|1922267|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
935680|NCT00958568|1922268|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
935681|NCT00958568|1922265|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
935682|NCT00958568|1922266|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
935683|NCT00958568|1922267|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
935684|NCT00958568|1922268|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
935685|NCT00958568|1922265|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
935686|NCT00958568|1922266|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
935687|NCT00958568|1922267|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
935688|NCT00958568|1922268|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
935689|NCT00958568|1922265|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
935690|NCT00958568|1922266|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
935691|NCT00958568|1922267|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
935692|NCT00958568|1922268|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
935693|NCT00958568|1922265|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
935694|NCT00958568|1922266|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
935695|NCT00958568|1922267|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
935696|NCT00958568|1922268|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
935697|NCT00958568|1922265|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
935698|NCT00958568|1922266|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
935699|NCT00958568|1922267|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
935700|NCT00958568|1922268|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
935701|NCT00958568|1922265|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
935702|NCT00958568|1922266|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
935703|NCT00958568|1922267|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
935704|NCT00958568|1922268|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
935705|NCT00958568|1922265|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
935706|NCT00958568|1922266|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
935707|NCT00958568|1922267|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
935708|NCT00958568|1922268|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
935709|NCT00958568|1922265|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
935710|NCT00958568|1922266|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
935711|NCT00958568|1922267|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
935712|NCT00958568|1922268|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
935713|NCT00958568|1922265|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
935714|NCT00958568|1922266|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
935715|NCT00958568|1922267|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
935716|NCT00958568|1922268|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
935717|NCT00958568|1922265|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
935718|NCT00958568|1922266|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
935719|NCT00958568|1922267|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
935720|NCT00958568|1922268|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
935721|NCT00958568|1922265|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
935722|NCT00958568|1922266|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
935723|NCT00958568|1922267|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
935724|NCT00958568|1922268|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
935725|NCT00958568|1922265|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
935726|NCT00958568|1922266|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
935727|NCT00958568|1922267|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
935728|NCT00958568|1922268|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
935729|NCT00958568|1922265|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
935730|NCT00958568|1922266|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
935731|NCT00958568|1922267|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
935732|NCT00958568|1922268|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
935733|NCT00958568|1922265|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
935734|NCT00958568|1922266|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
935735|NCT00958568|1922267|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
935736|NCT00958568|1922268|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
935737|NCT00958568|1922265|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
935738|NCT00958568|1922266|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
935739|NCT00958568|1922267|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
935740|NCT00958568|1922268|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
935741|NCT00958568|1922265|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
935742|NCT00958568|1922266|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
935743|NCT00958568|1922267|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
935744|NCT00958568|1922268|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
935745|NCT00958568|1922265|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
935746|NCT00958568|1922266|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
935747|NCT00958568|1922267|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
935748|NCT00958568|1922268|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
935749|NCT00958568|1922265|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
935750|NCT00958568|1922266|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
935751|NCT00958568|1922267|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
935752|NCT00958568|1922268|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
935753|NCT00958568|1922265|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
935754|NCT00958568|1922266|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
935755|NCT00958568|1922267|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
935756|NCT00958568|1922268|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
935757|NCT00958568|1922265|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
935758|NCT00958568|1922266|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
935759|NCT00958568|1922267|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
935760|NCT00958568|1922268|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
935761|NCT00958568|1922265|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
935762|NCT00958568|1922266|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
935763|NCT00958568|1922267|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
935764|NCT00958568|1922268|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
935765|NCT00958568|1922265|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
935766|NCT00958568|1922266|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
935767|NCT00958568|1922267|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
935768|NCT00958568|1922268|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
935769|NCT00958568|1922265|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
935770|NCT00958568|1922266|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
935771|NCT00958568|1922267|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
935772|NCT00958568|1922268|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
935773|NCT00958568|1922265|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
935774|NCT00958568|1922266|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
935775|NCT00958568|1922267|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
935776|NCT00958568|1922268|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
935777|NCT00958568|1922265|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
935778|NCT00958568|1922266|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
935779|NCT00958568|1922267|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
935780|NCT00958568|1922268|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
935781|NCT00958568|1922265|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
935782|NCT00958568|1922266|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
935783|NCT00958568|1922267|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
935784|NCT00958568|1922268|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
935785|NCT00958568|1922265|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
935786|NCT00958568|1922266|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
935787|NCT00958568|1922267|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
935788|NCT00958568|1922268|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
935789|NCT00958711|1922297|FG000|Overall Study|Withdrawal by Subject|0
935790|NCT00958711|1922298|FG001|Overall Study|Withdrawal by Subject|4
935791|NCT00958711|1922297|FG000|Overall Study|Physician Decision|5
935792|NCT00958711|1922298|FG001|Overall Study|Physician Decision|7
935793|NCT00958711|1922297|FG000|Overall Study|Lost to Follow-up|4
935794|NCT00958711|1922298|FG001|Overall Study|Lost to Follow-up|1
935795|NCT00958711|1922297|FG000|Overall Study|Other|2
935796|NCT00958711|1922298|FG001|Overall Study|Other|5
935797|NCT00958711|1922297|FG000|Overall Study|Death|1
935798|NCT00958711|1922298|FG001|Overall Study|Death|2
935799|NCT00958711|1922297|FG000|Overall Study|Adverse Event|1
935800|NCT00958711|1922298|FG001|Overall Study|Adverse Event|2
935801|NCT00958724|1922304|FG000|Overall Study|Disease Progression|6
935802|NCT00958776|1922310|FG000|Overall Study|Adverse Event|0
935803|NCT00958776|1922311|FG001|Overall Study|Adverse Event|1
935804|NCT00958776|1922310|FG000|Overall Study|Physician Decision|1
935805|NCT00958776|1922311|FG001|Overall Study|Physician Decision|0
935806|NCT00958776|1922310|FG000|Overall Study|Lost to Follow-up|2
935807|NCT00958776|1922311|FG001|Overall Study|Lost to Follow-up|6
935808|NCT00958776|1922310|FG000|Overall Study|Withdrawal by Subject|7
935809|NCT00958776|1922311|FG001|Overall Study|Withdrawal by Subject|16
935810|NCT00958776|1922310|FG000|Overall Study|Protocol Violation|1
935811|NCT00958776|1922311|FG001|Overall Study|Protocol Violation|1
935812|NCT00958776|1922310|FG000|Overall Study|Death|2
935813|NCT00958776|1922311|FG001|Overall Study|Death|1
935814|NCT00958776|1922310|FG000|Overall Study|Noncompliance; Protocol Deviations|2
935815|NCT00958776|1922311|FG001|Overall Study|Noncompliance; Protocol Deviations|3
935816|NCT00958776|1922310|FG000|Overall Study|Missing|1
935817|NCT00958776|1922311|FG001|Overall Study|Missing|1
935818|NCT00958789|1922318|FG000|Overall Study|Death|5
935819|NCT00958789|1922318|FG000|Overall Study|Lost to Follow-up|14
935820|NCT00958789|1922318|FG000|Overall Study|Withdrawal by Subject|17
935821|NCT00958789|1922318|FG000|Overall Study|No 2 yr. Knee Society Score data|4
935822|NCT00958789|1922318|FG000|Overall Study|2 yr. Knee Society Score not calculable|1
935823|NCT00958789|1922318|FG000|Overall Study|Subject terminated|2
935824|NCT00958789|1922318|FG000|Overall Study|Revision|7
935825|NCT00958828|1922327|FG000|Period 1, 1 Week of Wear|Randomization break|0
935826|NCT00958828|1922328|FG001|Period 1, 1 Week of Wear|Randomization break|1
935827|NCT00958828|1922327|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0
935828|NCT00958828|1922328|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1
935829|NCT00958841|1922334|FG000|Overall Study|Abnormal laboratory value(s)|1
935830|NCT00958841|1922334|FG000|Overall Study|Abnormal test procedure result(s)|3
935831|NCT00958841|1922334|FG000|Overall Study|Administrative problems|1
935832|NCT00958841|1922334|FG000|Overall Study|Adverse Event|8
935833|NCT00958841|1922334|FG000|Overall Study|New cancer therapy|5
935834|NCT00958841|1922334|FG000|Overall Study|Withdrawal by Subject|1
935835|NCT00958841|1922334|FG000|Overall Study|Unsatisfactory therapeutic effect|22
935836|NCT00958841|1922334|FG000|Overall Study|Completed M6/did not enter extension|27
935837|NCT00958841|1922334|FG000|Overall Study|Discontinued prior to M*|28
935838|NCT00958880|1922350|FG000|Overall Study|Lost to Follow-up|2
935839|NCT00958880|1922351|FG001|Overall Study|Lost to Follow-up|2
935840|NCT00959049|1922377|FG000|Overall Study|Adverse Event|1
935841|NCT00959049|1922378|FG001|Overall Study|Adverse Event|0
935842|NCT00959049|1922379|FG002|Overall Study|Adverse Event|0
935843|NCT00959049|1922380|FG003|Overall Study|Adverse Event|0
935844|NCT00959049|1922381|FG004|Overall Study|Adverse Event|0
935845|NCT00959049|1922382|FG005|Overall Study|Adverse Event|0
935846|NCT00959049|1922377|FG000|Overall Study|Lost to Follow-up|17
935847|NCT00959049|1922378|FG001|Overall Study|Lost to Follow-up|5
935848|NCT00959049|1922379|FG002|Overall Study|Lost to Follow-up|1
935849|NCT00959049|1922380|FG003|Overall Study|Lost to Follow-up|10
935850|NCT00959049|1922381|FG004|Overall Study|Lost to Follow-up|9
935851|NCT00959049|1922382|FG005|Overall Study|Lost to Follow-up|1
935852|NCT00959049|1922377|FG000|Overall Study|Contraindicated medication|0
935853|NCT00959049|1922378|FG001|Overall Study|Contraindicated medication|0
935854|NCT00959049|1922379|FG002|Overall Study|Contraindicated medication|0
935855|NCT00959049|1922380|FG003|Overall Study|Contraindicated medication|1
935856|NCT00959049|1922381|FG004|Overall Study|Contraindicated medication|0
935857|NCT00959049|1922382|FG005|Overall Study|Contraindicated medication|0
935858|NCT00959049|1922377|FG000|Overall Study|Withdrawal by Subject|0
935859|NCT00959049|1922378|FG001|Overall Study|Withdrawal by Subject|2
935860|NCT00959049|1922379|FG002|Overall Study|Withdrawal by Subject|0
935861|NCT00959049|1922380|FG003|Overall Study|Withdrawal by Subject|0
935862|NCT00959049|1922381|FG004|Overall Study|Withdrawal by Subject|0
935863|NCT00959049|1922382|FG005|Overall Study|Withdrawal by Subject|0
935864|NCT00959192|1922420|FG000|Overall Study|Adverse Event|1
935865|NCT00959192|1922421|FG001|Overall Study|Adverse Event|1
935866|NCT00959192|1922422|FG002|Overall Study|Adverse Event|1
935867|NCT00959192|1922423|FG003|Overall Study|Adverse Event|0
935868|NCT00959192|1922420|FG000|Overall Study|Investigator Request|1
935869|NCT00959192|1922421|FG001|Overall Study|Investigator Request|0
935870|NCT00959192|1922422|FG002|Overall Study|Investigator Request|0
935871|NCT00959192|1922423|FG003|Overall Study|Investigator Request|0
935872|NCT00959192|1922420|FG000|Overall Study|Caregiver Request|0
935873|NCT00959192|1922421|FG001|Overall Study|Caregiver Request|0
935874|NCT00959192|1922422|FG002|Overall Study|Caregiver Request|2
935875|NCT00959192|1922423|FG003|Overall Study|Caregiver Request|1
935876|NCT00959374|1922434|FG000|Overall Study|Withdrawal by Subject|2
935877|NCT00959374|1922434|FG000|Overall Study|Lost to Follow-up|14
935878|NCT00959374|1922434|FG000|Overall Study|Death|1
935879|NCT00959374|1922434|FG000|Overall Study|Protocol Violation|1
935880|NCT00959374|1922434|FG000|Overall Study|Implant Removed/Not Replaced|4
935881|NCT00959374|1922434|FG000|Overall Study|Physician Decision|1
935882|NCT00959647|1922442|FG000|Overall Study|Adverse Event|2
935883|NCT00959647|1922442|FG000|Overall Study|Progressive disease|6
935884|NCT00959647|1922442|FG000|Overall Study|Study terminated by sponsor|4
935885|NCT00959647|1922442|FG000|Overall Study|Withdrawal by Subject|7
935886|NCT00959699|1922465|FG000|Treatment Period|Adverse Event|3
935887|NCT00959699|1922466|FG001|Treatment Period|Adverse Event|13
935888|NCT00959699|1922465|FG000|Treatment Period|Lack of Efficacy|15
935889|NCT00959699|1922466|FG001|Treatment Period|Lack of Efficacy|6
935890|NCT00959699|1922465|FG000|Treatment Period|Lost to Follow-up|0
935891|NCT00959699|1922466|FG001|Treatment Period|Lost to Follow-up|1
935892|NCT00959699|1922465|FG000|Treatment Period|Withdrawal by Subject|1
935893|NCT00959699|1922466|FG001|Treatment Period|Withdrawal by Subject|3
935894|NCT00959699|1922465|FG000|Treatment Period|Non-Compliance with Protocol|0
935895|NCT00959699|1922466|FG001|Treatment Period|Non-Compliance with Protocol|1
935896|NCT00959699|1922465|FG000|Treatment Period|Did not receive treatment|0
935897|NCT00959699|1922466|FG001|Treatment Period|Did not receive treatment|1
935898|NCT00959699|1922465|FG000|Treatment Period|Futility/crossover to boceprevir|4
935899|NCT00959699|1922466|FG001|Treatment Period|Futility/crossover to boceprevir|0
935900|NCT00959699|1922465|FG000|Follow-up Period|Lost to Follow-up|3
935901|NCT00959699|1922466|FG001|Follow-up Period|Lost to Follow-up|2
935902|NCT00959699|1922465|FG000|Follow-up Period|Withdrawal by Subject|3
935903|NCT00959699|1922466|FG001|Follow-up Period|Withdrawal by Subject|4
935904|NCT00959751|1922475|FG000|Overall Study|Lost to Follow-up|2
935905|NCT00959751|1922476|FG001|Overall Study|Lost to Follow-up|3
935906|NCT00959751|1922475|FG000|Overall Study|Consent Withdrawn|0
935907|NCT00959751|1922476|FG001|Overall Study|Consent Withdrawn|1
935908|NCT00959751|1922475|FG000|Overall Study|Non-compliance to Study Procedures|0
935909|NCT00959751|1922476|FG001|Overall Study|Non-compliance to Study Procedures|1
935910|NCT00959751|1922475|FG000|Overall Study|No migraine headache without aura|7
935911|NCT00959751|1922476|FG001|Overall Study|No migraine headache without aura|7
935912|NCT00959894|1922502|FG000|Overall Study|Lost to Follow-up|10
935913|NCT00959894|1922502|FG000|Overall Study|Adverse Event|3
935914|NCT00959894|1922502|FG000|Overall Study|Withdrawal by Subject|1
935915|NCT00959894|1922502|FG000|Overall Study|Need for contraindicated medication|1
935916|NCT00959894|1922502|FG000|Overall Study|Subject moved out of town|1
935917|NCT00959907|1922509|FG000|Overall Study|Protocol Violation|0
935918|NCT00959907|1922510|FG001|Overall Study|Protocol Violation|1
935919|NCT00959907|1922509|FG000|Overall Study|Adverse Event|1
935920|NCT00959907|1922510|FG001|Overall Study|Adverse Event|0
935921|NCT00959907|1922509|FG000|Overall Study|Withdrawal by Subject|2
935922|NCT00959907|1922510|FG001|Overall Study|Withdrawal by Subject|0
935923|NCT00959946|1922535|FG000|Overall Study|Adverse Event|0
935924|NCT00959946|1922536|FG001|Overall Study|Adverse Event|0
935925|NCT00959946|1922537|FG002|Overall Study|Adverse Event|2
935926|NCT00959946|1922538|FG003|Overall Study|Adverse Event|1
935927|NCT00959946|1922539|FG004|Overall Study|Adverse Event|0
935928|NCT00959946|1922540|FG005|Overall Study|Adverse Event|1
935929|NCT00959946|1922541|FG006|Overall Study|Adverse Event|0
935930|NCT00959946|1922542|FG007|Overall Study|Adverse Event|0
935931|NCT00959946|1922535|FG000|Overall Study|Death|0
935932|NCT00959946|1922536|FG001|Overall Study|Death|0
935933|NCT00959946|1922537|FG002|Overall Study|Death|0
935934|NCT00959946|1922538|FG003|Overall Study|Death|0
935935|NCT00959946|1922539|FG004|Overall Study|Death|0
935936|NCT00959946|1922540|FG005|Overall Study|Death|1
935937|NCT00959946|1922541|FG006|Overall Study|Death|0
935938|NCT00959946|1922542|FG007|Overall Study|Death|0
935939|NCT00959946|1922535|FG000|Overall Study|Disease Progression|2
935940|NCT00959946|1922536|FG001|Overall Study|Disease Progression|4
935941|NCT00959946|1922537|FG002|Overall Study|Disease Progression|2
935942|NCT00959946|1922538|FG003|Overall Study|Disease Progression|4
935943|NCT00959946|1922539|FG004|Overall Study|Disease Progression|4
935944|NCT00959946|1922540|FG005|Overall Study|Disease Progression|6
935945|NCT00959946|1922541|FG006|Overall Study|Disease Progression|2
935946|NCT00959946|1922542|FG007|Overall Study|Disease Progression|2
935947|NCT00959946|1922535|FG000|Overall Study|Withdrawal by Subject|0
935948|NCT00959946|1922536|FG001|Overall Study|Withdrawal by Subject|0
935949|NCT00959946|1922537|FG002|Overall Study|Withdrawal by Subject|0
935950|NCT00959946|1922538|FG003|Overall Study|Withdrawal by Subject|0
935951|NCT00959946|1922539|FG004|Overall Study|Withdrawal by Subject|0
935952|NCT00959946|1922540|FG005|Overall Study|Withdrawal by Subject|1
935953|NCT00959946|1922541|FG006|Overall Study|Withdrawal by Subject|0
935954|NCT00959946|1922542|FG007|Overall Study|Withdrawal by Subject|0
935955|NCT00960011|1922584|FG000|Overall Study|Death|5
935956|NCT00960011|1922585|FG001|Overall Study|Death|0
935957|NCT00960011|1922584|FG000|Overall Study|Lost to Follow-up|6
935958|NCT00960011|1922585|FG001|Overall Study|Lost to Follow-up|2
935959|NCT00960063|1922628|FG000|Overall Study|Adverse Event|1
935960|NCT00960063|1922629|FG001|Overall Study|Adverse Event|0
935961|NCT00960063|1922630|FG002|Overall Study|Adverse Event|0
935962|NCT00960063|1922628|FG000|Overall Study|Progression of Disease|0
935963|NCT00960063|1922629|FG001|Overall Study|Progression of Disease|0
935964|NCT00960063|1922630|FG002|Overall Study|Progression of Disease|3
935965|NCT00960076|1922640|FG000|Overall Study|Adverse Event|1
935966|NCT00960076|1922641|FG001|Overall Study|Adverse Event|7
935967|NCT00960076|1922640|FG000|Overall Study|No longer met study criteria|1
935968|NCT00960076|1922641|FG001|Overall Study|No longer met study criteria|5
935969|NCT00960076|1922640|FG000|Overall Study|Withdrawal by Subject|1
935970|NCT00960076|1922641|FG001|Overall Study|Withdrawal by Subject|2
935971|NCT00960076|1922640|FG000|Overall Study|Lost to Follow-up|3
935972|NCT00960076|1922641|FG001|Overall Study|Lost to Follow-up|3
935973|NCT00960076|1922640|FG000|Overall Study|Severe non-compliance to protocol|1
935974|NCT00960076|1922641|FG001|Overall Study|Severe non-compliance to protocol|2
935975|NCT00960076|1922640|FG000|Overall Study|Hyperglycemia|1
935976|NCT00960076|1922641|FG001|Overall Study|Hyperglycemia|5
935977|NCT00960076|1922640|FG000|Overall Study|Did not attend the termination visit|0
935978|NCT00960076|1922641|FG001|Overall Study|Did not attend the termination visit|1
935979|NCT00960115|1922649|FG000|Overall Study|Ongoing treatment at data cut-off date|19
935980|NCT00960115|1922650|FG001|Overall Study|Ongoing treatment at data cut-off date|15
935981|NCT00960141|1922659|FG000|Overall Study|Adverse Event|4
935982|NCT00960141|1922660|FG001|Overall Study|Adverse Event|8
935983|NCT00960141|1922661|FG002|Overall Study|Adverse Event|2
935984|NCT00960141|1922659|FG000|Overall Study|Lack of Efficacy|3
935985|NCT00960141|1922660|FG001|Overall Study|Lack of Efficacy|4
935986|NCT00960141|1922661|FG002|Overall Study|Lack of Efficacy|2
935987|NCT00960141|1922659|FG000|Overall Study|Lost to Follow-up|1
935988|NCT00960141|1922660|FG001|Overall Study|Lost to Follow-up|0
935989|NCT00960141|1922661|FG002|Overall Study|Lost to Follow-up|0
935990|NCT00960141|1922659|FG000|Overall Study|Protocol Violation|1
935991|NCT00960141|1922660|FG001|Overall Study|Protocol Violation|3
935992|NCT00960141|1922661|FG002|Overall Study|Protocol Violation|2
935993|NCT00960141|1922659|FG000|Overall Study|Withdrawal by Subject|1
935994|NCT00960141|1922660|FG001|Overall Study|Withdrawal by Subject|2
935995|NCT00960141|1922661|FG002|Overall Study|Withdrawal by Subject|1
935996|NCT00960193|1922669|FG000|14 Day Washout Period|Withdrawal by Subject|1
935997|NCT00960206|1922679|FG000|Overall Study|Death|7
935998|NCT00960206|1922680|FG001|Overall Study|Death|4
935999|NCT00960206|1922681|FG002|Overall Study|Death|1
936000|NCT00960206|1922679|FG000|Overall Study|Unwilling/Unable to return|1
936001|NCT00960206|1922680|FG001|Overall Study|Unwilling/Unable to return|2
936002|NCT00960206|1922681|FG002|Overall Study|Unwilling/Unable to return|0
936003|NCT00960206|1922679|FG000|Overall Study|Lost to Follow-up|8
936004|NCT00960206|1922680|FG001|Overall Study|Lost to Follow-up|14
936005|NCT00960206|1922681|FG002|Overall Study|Lost to Follow-up|8
936006|NCT00960206|1922679|FG000|Overall Study|Withdrawal by Subject|2
936007|NCT00960206|1922680|FG001|Overall Study|Withdrawal by Subject|4
936008|NCT00960206|1922681|FG002|Overall Study|Withdrawal by Subject|0
936009|NCT00960206|1922679|FG000|Overall Study|Revision of study component|2
936010|NCT00960206|1922680|FG001|Overall Study|Revision of study component|2
936011|NCT00960206|1922681|FG002|Overall Study|Revision of study component|2
936012|NCT00960206|1922679|FG000|Overall Study|Missing 10 year data|20
936013|NCT00960206|1922680|FG001|Overall Study|Missing 10 year data|1
936014|NCT00960206|1922681|FG002|Overall Study|Missing 10 year data|1
936015|NCT00960323|1922690|FG000|Atorvastatin Alone|Withdrawal by Subject|1
936016|NCT00960375|1922700|FG000|Overall Study|Lost to Follow-up|20
936017|NCT00960375|1922701|FG001|Overall Study|Lost to Follow-up|22
936018|NCT00960440|1922711|FG000|Overall Study|Death|0
936019|NCT00960440|1922712|FG001|Overall Study|Death|0
936020|NCT00960440|1922713|FG002|Overall Study|Death|0
936021|NCT00960440|1922714|FG003|Overall Study|Death|1
936022|NCT00960440|1922711|FG000|Overall Study|Adverse Event|12
936023|NCT00960440|1922712|FG001|Overall Study|Adverse Event|12
936024|NCT00960440|1922713|FG002|Overall Study|Adverse Event|4
936025|NCT00960440|1922714|FG003|Overall Study|Adverse Event|4
936026|NCT00960440|1922711|FG000|Overall Study|Lack of Efficacy|2
936027|NCT00960440|1922712|FG001|Overall Study|Lack of Efficacy|5
936028|NCT00960440|1922713|FG002|Overall Study|Lack of Efficacy|3
936029|NCT00960440|1922714|FG003|Overall Study|Lack of Efficacy|8
936030|NCT00960440|1922711|FG000|Overall Study|Protocol Violation|2
936031|NCT00960440|1922712|FG001|Overall Study|Protocol Violation|8
936032|NCT00960440|1922713|FG002|Overall Study|Protocol Violation|3
936033|NCT00960440|1922714|FG003|Overall Study|Protocol Violation|4
936034|NCT00960440|1922711|FG000|Overall Study|Withdrawal by Subject|9
936035|NCT00960440|1922712|FG001|Overall Study|Withdrawal by Subject|5
936036|NCT00960440|1922713|FG002|Overall Study|Withdrawal by Subject|2
936037|NCT00960440|1922714|FG003|Overall Study|Withdrawal by Subject|1
936038|NCT00960440|1922711|FG000|Overall Study|Other|1
936039|NCT00960440|1922712|FG001|Overall Study|Other|1
936040|NCT00960440|1922713|FG002|Overall Study|Other|1
936041|NCT00960440|1922714|FG003|Overall Study|Other|0
936042|NCT00960531|1922749|FG000|Overall Study|Lack of Efficacy|1
936043|NCT00960531|1922750|FG001|Overall Study|Lack of Efficacy|0
936044|NCT00960531|1922751|FG002|Overall Study|Lack of Efficacy|0
936045|NCT00960531|1922752|FG003|Overall Study|Lack of Efficacy|0
936046|NCT00960531|1922753|FG004|Overall Study|Lack of Efficacy|0
936047|NCT00960531|1922754|FG005|Overall Study|Lack of Efficacy|0
936048|NCT00960531|1922755|FG006|Overall Study|Lack of Efficacy|0
936049|NCT00960531|1922756|FG007|Overall Study|Lack of Efficacy|0
936050|NCT00960531|1922757|FG008|Overall Study|Lack of Efficacy|0
936051|NCT00960531|1922758|FG009|Overall Study|Lack of Efficacy|0
936052|NCT00960531|1922749|FG000|Overall Study|Withdrawal by Subject|1
936053|NCT00960531|1922750|FG001|Overall Study|Withdrawal by Subject|0
936054|NCT00960531|1922751|FG002|Overall Study|Withdrawal by Subject|5
936055|NCT00960531|1922752|FG003|Overall Study|Withdrawal by Subject|2
936056|NCT00960531|1922753|FG004|Overall Study|Withdrawal by Subject|0
936057|NCT00960531|1922754|FG005|Overall Study|Withdrawal by Subject|0
936058|NCT00960531|1922755|FG006|Overall Study|Withdrawal by Subject|2
936059|NCT00960531|1922756|FG007|Overall Study|Withdrawal by Subject|0
936060|NCT00960531|1922757|FG008|Overall Study|Withdrawal by Subject|1
936061|NCT00960531|1922758|FG009|Overall Study|Withdrawal by Subject|0
936062|NCT00960531|1922749|FG000|Overall Study|Caregiver Request|2
936063|NCT00960531|1922750|FG001|Overall Study|Caregiver Request|0
936064|NCT00960531|1922751|FG002|Overall Study|Caregiver Request|6
936065|NCT00960531|1922752|FG003|Overall Study|Caregiver Request|5
936066|NCT00960531|1922753|FG004|Overall Study|Caregiver Request|0
936067|NCT00960531|1922754|FG005|Overall Study|Caregiver Request|2
936068|NCT00960531|1922755|FG006|Overall Study|Caregiver Request|3
936069|NCT00960531|1922756|FG007|Overall Study|Caregiver Request|1
936070|NCT00960531|1922757|FG008|Overall Study|Caregiver Request|3
936071|NCT00960531|1922758|FG009|Overall Study|Caregiver Request|0
936072|NCT00960531|1922749|FG000|Overall Study|Investigator Request|0
936073|NCT00960531|1922750|FG001|Overall Study|Investigator Request|0
936074|NCT00960531|1922751|FG002|Overall Study|Investigator Request|1
936075|NCT00960531|1922752|FG003|Overall Study|Investigator Request|0
936076|NCT00960531|1922753|FG004|Overall Study|Investigator Request|0
936077|NCT00960531|1922754|FG005|Overall Study|Investigator Request|0
936078|NCT00960531|1922755|FG006|Overall Study|Investigator Request|0
936079|NCT00960531|1922756|FG007|Overall Study|Investigator Request|0
936080|NCT00960531|1922757|FG008|Overall Study|Investigator Request|0
936081|NCT00960531|1922758|FG009|Overall Study|Investigator Request|0
936082|NCT00960531|1922749|FG000|Overall Study|Discontinuation of Study by Sponsor|0
936083|NCT00960531|1922750|FG001|Overall Study|Discontinuation of Study by Sponsor|0
936084|NCT00960531|1922751|FG002|Overall Study|Discontinuation of Study by Sponsor|0
936085|NCT00960531|1922752|FG003|Overall Study|Discontinuation of Study by Sponsor|0
936086|NCT00960531|1922753|FG004|Overall Study|Discontinuation of Study by Sponsor|0
936087|NCT00960531|1922754|FG005|Overall Study|Discontinuation of Study by Sponsor|0
936088|NCT00960531|1922755|FG006|Overall Study|Discontinuation of Study by Sponsor|0
936089|NCT00960531|1922756|FG007|Overall Study|Discontinuation of Study by Sponsor|1
936090|NCT00960531|1922757|FG008|Overall Study|Discontinuation of Study by Sponsor|0
936091|NCT00960531|1922758|FG009|Overall Study|Discontinuation of Study by Sponsor|0
936092|NCT00960531|1922749|FG000|Overall Study|Lost to Follow-up|0
936093|NCT00960531|1922750|FG001|Overall Study|Lost to Follow-up|0
936094|NCT00960531|1922751|FG002|Overall Study|Lost to Follow-up|1
936095|NCT00960531|1922752|FG003|Overall Study|Lost to Follow-up|0
936096|NCT00960531|1922753|FG004|Overall Study|Lost to Follow-up|0
936097|NCT00960531|1922754|FG005|Overall Study|Lost to Follow-up|0
936098|NCT00960531|1922755|FG006|Overall Study|Lost to Follow-up|1
936099|NCT00960531|1922756|FG007|Overall Study|Lost to Follow-up|0
936100|NCT00960531|1922757|FG008|Overall Study|Lost to Follow-up|0
936101|NCT00960531|1922758|FG009|Overall Study|Lost to Follow-up|0
936102|NCT00960531|1922749|FG000|Overall Study|Failed to Return|2
936103|NCT00960531|1922750|FG001|Overall Study|Failed to Return|0
936104|NCT00960531|1922751|FG002|Overall Study|Failed to Return|0
936105|NCT00960531|1922752|FG003|Overall Study|Failed to Return|0
936106|NCT00960531|1922753|FG004|Overall Study|Failed to Return|0
936107|NCT00960531|1922754|FG005|Overall Study|Failed to Return|0
936108|NCT00960531|1922755|FG006|Overall Study|Failed to Return|0
936109|NCT00960531|1922756|FG007|Overall Study|Failed to Return|2
936110|NCT00960531|1922757|FG008|Overall Study|Failed to Return|0
936111|NCT00960531|1922758|FG009|Overall Study|Failed to Return|0
936112|NCT00960531|1922749|FG000|Overall Study|Adverse Event (AE)|2
936113|NCT00960531|1922750|FG001|Overall Study|Adverse Event (AE)|0
936114|NCT00960531|1922751|FG002|Overall Study|Adverse Event (AE)|0
936115|NCT00960531|1922752|FG003|Overall Study|Adverse Event (AE)|0
936116|NCT00960531|1922753|FG004|Overall Study|Adverse Event (AE)|0
936117|NCT00960531|1922754|FG005|Overall Study|Adverse Event (AE)|1
936118|NCT00960531|1922755|FG006|Overall Study|Adverse Event (AE)|2
936119|NCT00960531|1922756|FG007|Overall Study|Adverse Event (AE)|0
936120|NCT00960531|1922757|FG008|Overall Study|Adverse Event (AE)|2
936121|NCT00960531|1922758|FG009|Overall Study|Adverse Event (AE)|0
936122|NCT00960531|1922749|FG000|Overall Study|Reason not Specified|2
936123|NCT00960531|1922750|FG001|Overall Study|Reason not Specified|1
936124|NCT00960531|1922751|FG002|Overall Study|Reason not Specified|13
936125|NCT00960531|1922752|FG003|Overall Study|Reason not Specified|1
936126|NCT00960531|1922753|FG004|Overall Study|Reason not Specified|2
936127|NCT00960531|1922754|FG005|Overall Study|Reason not Specified|0
936128|NCT00960531|1922755|FG006|Overall Study|Reason not Specified|16
936129|NCT00960531|1922756|FG007|Overall Study|Reason not Specified|0
936130|NCT00960531|1922757|FG008|Overall Study|Reason not Specified|8
936131|NCT00960531|1922758|FG009|Overall Study|Reason not Specified|1
936132|NCT00960570|1922784|FG000|21 Day Washout Period|Adverse Event|1
936133|NCT00960570|1922784|FG000|21 Day Washout Period|Withdrawal by Subject|1
936134|NCT00960570|1922784|FG000|1 Day Period Between Dosing|Adverse Event|2
936135|NCT00960570|1922784|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1
936136|NCT00960661|1922802|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
936137|NCT00960661|1922803|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
936138|NCT00960661|1922804|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
936139|NCT00960661|1922802|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
936140|NCT00960661|1922803|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
936141|NCT00960661|1922804|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
936142|NCT00960661|1922802|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
936143|NCT00960661|1922803|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
936144|NCT00960661|1922804|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
936145|NCT00960661|1922802|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
936146|NCT00960661|1922803|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
936147|NCT00960661|1922804|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
936148|NCT00960661|1922802|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
936149|NCT00960661|1922803|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
936150|NCT00960661|1922804|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
936151|NCT00960661|1922802|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
936152|NCT00960661|1922803|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
936153|NCT00960661|1922804|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
936154|NCT00960661|1922802|FG000|Interventional Phase|Adverse Event|0
936155|NCT00960661|1922803|FG001|Interventional Phase|Adverse Event|17
936156|NCT00960661|1922804|FG002|Interventional Phase|Adverse Event|8
936157|NCT00960661|1922802|FG000|Interventional Phase|Death|0
936158|NCT00960661|1922803|FG001|Interventional Phase|Death|1
936159|NCT00960661|1922804|FG002|Interventional Phase|Death|0
936160|NCT00960661|1922802|FG000|Interventional Phase|Lost to Follow-up|0
936161|NCT00960661|1922803|FG001|Interventional Phase|Lost to Follow-up|0
936162|NCT00960661|1922804|FG002|Interventional Phase|Lost to Follow-up|2
936163|NCT00960661|1922802|FG000|Interventional Phase|entry criteria not met|0
936164|NCT00960661|1922803|FG001|Interventional Phase|entry criteria not met|3
936165|NCT00960661|1922804|FG002|Interventional Phase|entry criteria not met|0
936166|NCT00960661|1922802|FG000|Interventional Phase|Protocol Violation|0
936167|NCT00960661|1922803|FG001|Interventional Phase|Protocol Violation|7
936168|NCT00960661|1922804|FG002|Interventional Phase|Protocol Violation|2
936169|NCT00960661|1922802|FG000|Interventional Phase|Withdrawal by Subject|0
936170|NCT00960661|1922803|FG001|Interventional Phase|Withdrawal by Subject|18
936171|NCT00960661|1922804|FG002|Interventional Phase|Withdrawal by Subject|29
936172|NCT00960661|1922802|FG000|Interventional Phase|Physician Decision|0
936173|NCT00960661|1922803|FG001|Interventional Phase|Physician Decision|3
936174|NCT00960661|1922804|FG002|Interventional Phase|Physician Decision|5
936175|NCT00960661|1922802|FG000|Interventional Phase|sponsor decision|0
936176|NCT00960661|1922803|FG001|Interventional Phase|sponsor decision|1
936177|NCT00960661|1922804|FG002|Interventional Phase|sponsor decision|0
936178|NCT00960661|1922802|FG000|Interventional Phase|Lack of Efficacy|0
936179|NCT00960661|1922803|FG001|Interventional Phase|Lack of Efficacy|2
936180|NCT00960661|1922804|FG002|Interventional Phase|Lack of Efficacy|0
936181|NCT00960687|1922810|FG000|Washout Period of 7 Days|Adverse Event|3
936182|NCT00960687|1922811|FG001|Washout Period of 7 Days|Adverse Event|2
936183|NCT00960687|1922810|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
936184|NCT00960687|1922811|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
936185|NCT00960804|1922829|FG000|Overall Study|Adverse Event|1
936186|NCT00960804|1922830|FG001|Overall Study|Adverse Event|0
936187|NCT00960804|1922831|FG002|Overall Study|Adverse Event|0
936188|NCT00960804|1922829|FG000|Overall Study|Withdrawal by Subject|1
936189|NCT00960804|1922830|FG001|Overall Study|Withdrawal by Subject|0
936190|NCT00960804|1922831|FG002|Overall Study|Withdrawal by Subject|0
936191|NCT00960804|1922829|FG000|Overall Study|Study terminated by the sponsor|5
936192|NCT00960804|1922830|FG001|Overall Study|Study terminated by the sponsor|4
936193|NCT00960804|1922831|FG002|Overall Study|Study terminated by the sponsor|10
936194|NCT00960843|1922841|FG000|Overall Study|Lost to Follow-up|2
936195|NCT00960843|1922842|FG001|Overall Study|Lost to Follow-up|0
936196|NCT00960843|1922841|FG000|Overall Study|Protocol Violation|0
936197|NCT00960843|1922842|FG001|Overall Study|Protocol Violation|4
936198|NCT00960843|1922841|FG000|Overall Study|Repeated needle dislodgment|0
936199|NCT00960843|1922842|FG001|Overall Study|Repeated needle dislodgment|1
936200|NCT00960856|1922848|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
936201|NCT00960856|1922849|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
936202|NCT00960856|1922850|FG002|Washout Period of 7 Days|Withdrawal by Subject|0
936203|NCT00960856|1922851|FG003|Washout Period of 7 Days|Withdrawal by Subject|0
936204|NCT00960856|1922848|FG000|Washout Period of 7 Days|Adverse Event|0
936205|NCT00960856|1922849|FG001|Washout Period of 7 Days|Adverse Event|0
936206|NCT00960856|1922850|FG002|Washout Period of 7 Days|Adverse Event|1
936207|NCT00960856|1922851|FG003|Washout Period of 7 Days|Adverse Event|0
936208|NCT00960869|1922863|FG000|Overall Study|Adverse Event|17
936209|NCT00960869|1922864|FG001|Overall Study|Adverse Event|26
936210|NCT00960869|1922863|FG000|Overall Study|Withdrawal by Subject|16
936211|NCT00960869|1922864|FG001|Overall Study|Withdrawal by Subject|14
936212|NCT00960869|1922863|FG000|Overall Study|Lost to Follow-up|1
936213|NCT00960869|1922864|FG001|Overall Study|Lost to Follow-up|4
936214|NCT00960869|1922863|FG000|Overall Study|Misc|19
936215|NCT00960869|1922864|FG001|Overall Study|Misc|18
936216|NCT00960934|1922876|FG000|Overall Study|Adverse Event|2
936217|NCT00960934|1922877|FG001|Overall Study|Adverse Event|3
936218|NCT00960934|1922878|FG002|Overall Study|Adverse Event|3
936219|NCT00960934|1922879|FG003|Overall Study|Adverse Event|2
936220|NCT00960934|1922880|FG004|Overall Study|Adverse Event|4
936221|NCT00960934|1922881|FG005|Overall Study|Adverse Event|3
936222|NCT00960934|1922876|FG000|Overall Study|Lack of Efficacy|1
936223|NCT00960934|1922877|FG001|Overall Study|Lack of Efficacy|0
936224|NCT00960934|1922878|FG002|Overall Study|Lack of Efficacy|0
936225|NCT00960934|1922879|FG003|Overall Study|Lack of Efficacy|0
936226|NCT00960934|1922880|FG004|Overall Study|Lack of Efficacy|0
936227|NCT00960934|1922881|FG005|Overall Study|Lack of Efficacy|0
936228|NCT00960934|1922876|FG000|Overall Study|Lost to Follow-up|0
936229|NCT00960934|1922877|FG001|Overall Study|Lost to Follow-up|1
936230|NCT00960934|1922878|FG002|Overall Study|Lost to Follow-up|0
936231|NCT00960934|1922879|FG003|Overall Study|Lost to Follow-up|0
936232|NCT00960934|1922880|FG004|Overall Study|Lost to Follow-up|0
936233|NCT00960934|1922881|FG005|Overall Study|Lost to Follow-up|0
936234|NCT00960934|1922876|FG000|Overall Study|Other|2
936235|NCT00960934|1922877|FG001|Overall Study|Other|1
936236|NCT00960934|1922878|FG002|Overall Study|Other|5
936237|NCT00960934|1922879|FG003|Overall Study|Other|4
936238|NCT00960934|1922880|FG004|Overall Study|Other|2
936239|NCT00960934|1922881|FG005|Overall Study|Other|2
936240|NCT00960934|1922876|FG000|Overall Study|Physician Decision|0
936241|NCT00960934|1922877|FG001|Overall Study|Physician Decision|1
936242|NCT00960934|1922878|FG002|Overall Study|Physician Decision|0
936243|NCT00960934|1922879|FG003|Overall Study|Physician Decision|0
936244|NCT00960934|1922880|FG004|Overall Study|Physician Decision|0
936245|NCT00960934|1922881|FG005|Overall Study|Physician Decision|0
936246|NCT00960934|1922876|FG000|Overall Study|Progressive Disease|1
936247|NCT00960934|1922877|FG001|Overall Study|Progressive Disease|1
936248|NCT00960934|1922878|FG002|Overall Study|Progressive Disease|0
936249|NCT00960934|1922879|FG003|Overall Study|Progressive Disease|0
936250|NCT00960934|1922880|FG004|Overall Study|Progressive Disease|1
936251|NCT00960934|1922881|FG005|Overall Study|Progressive Disease|1
936252|NCT00960934|1922876|FG000|Overall Study|Protocol Violation|3
936253|NCT00960934|1922877|FG001|Overall Study|Protocol Violation|4
936254|NCT00960934|1922878|FG002|Overall Study|Protocol Violation|0
936255|NCT00960934|1922879|FG003|Overall Study|Protocol Violation|3
936256|NCT00960934|1922880|FG004|Overall Study|Protocol Violation|3
936257|NCT00960934|1922881|FG005|Overall Study|Protocol Violation|2
936258|NCT00960934|1922876|FG000|Overall Study|Withdrawal by Subject|5
936259|NCT00960934|1922877|FG001|Overall Study|Withdrawal by Subject|6
936260|NCT00960934|1922878|FG002|Overall Study|Withdrawal by Subject|4
936261|NCT00960934|1922879|FG003|Overall Study|Withdrawal by Subject|5
936262|NCT00960934|1922880|FG004|Overall Study|Withdrawal by Subject|5
936263|NCT00960934|1922881|FG005|Overall Study|Withdrawal by Subject|7
936264|NCT00960934|1922876|FG000|Overall Study|Study Terminated by Sponsor|50
936265|NCT00960934|1922877|FG001|Overall Study|Study Terminated by Sponsor|46
936266|NCT00960934|1922878|FG002|Overall Study|Study Terminated by Sponsor|52
936267|NCT00960934|1922879|FG003|Overall Study|Study Terminated by Sponsor|50
936268|NCT00960934|1922880|FG004|Overall Study|Study Terminated by Sponsor|49
936269|NCT00960934|1922881|FG005|Overall Study|Study Terminated by Sponsor|49
936270|NCT00960986|1922899|FG000|Period 1 (Screening and Washout)|Adverse Event|1
936271|NCT00960986|1922900|FG001|Period 1 (Screening and Washout)|Adverse Event|2
936272|NCT00960986|1922901|FG002|Period 1 (Screening and Washout)|Adverse Event|1
936273|NCT00960986|1922902|FG003|Period 1 (Screening and Washout)|Adverse Event|1
936274|NCT00960986|1922899|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0
936275|NCT00960986|1922900|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0
936276|NCT00960986|1922901|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2
936277|NCT00960986|1922902|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1
936278|NCT00960986|1922899|FG000|Period 1 (Screening and Washout)|Protocol Violation|1
936279|NCT00960986|1922900|FG001|Period 1 (Screening and Washout)|Protocol Violation|0
936280|NCT00960986|1922901|FG002|Period 1 (Screening and Washout)|Protocol Violation|0
936281|NCT00960986|1922902|FG003|Period 1 (Screening and Washout)|Protocol Violation|0
936282|NCT00960986|1922899|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1
936283|NCT00960986|1922900|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2
936284|NCT00960986|1922901|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1
936285|NCT00960986|1922902|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1
936286|NCT00960986|1922899|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17
936287|NCT00960986|1922900|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15
936288|NCT00960986|1922901|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10
936289|NCT00960986|1922902|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12
936290|NCT00960986|1922899|FG000|Period 3 (7-week Therapy Period)|Death|0
936291|NCT00960986|1922900|FG001|Period 3 (7-week Therapy Period)|Death|0
936292|NCT00960986|1922901|FG002|Period 3 (7-week Therapy Period)|Death|1
936293|NCT00960986|1922902|FG003|Period 3 (7-week Therapy Period)|Death|0
936294|NCT00960986|1922899|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
936295|NCT00960986|1922900|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
936296|NCT00960986|1922901|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
936297|NCT00960986|1922902|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
936298|NCT00960986|1922899|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10
936299|NCT00960986|1922900|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4
936300|NCT00960986|1922901|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3
936301|NCT00960986|1922902|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11
936302|NCT00960986|1922899|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
936303|NCT00960986|1922900|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
936304|NCT00960986|1922901|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
936305|NCT00960986|1922902|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
936306|NCT00960986|1922899|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
936307|NCT00960986|1922900|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
936308|NCT00960986|1922901|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
936309|NCT00960986|1922902|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
936310|NCT00960999|1922914|FG000|Overall Study|Withdrawal by Subject|1
936311|NCT00960999|1922915|FG001|Overall Study|Withdrawal by Subject|0
936312|NCT00960999|1922914|FG000|Overall Study|Protocol Violation|5
936313|NCT00960999|1922915|FG001|Overall Study|Protocol Violation|2
936314|NCT00960999|1922914|FG000|Overall Study|RT dose constraints not met|2
936315|NCT00960999|1922915|FG001|Overall Study|RT dose constraints not met|0
936316|NCT00961116|1922934|FG000|Washout Period of 7 Days|Adverse Event|1
936317|NCT00961116|1922935|FG001|Washout Period of 7 Days|Adverse Event|1
936318|NCT00961116|1922934|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
936319|NCT00961116|1922935|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
936320|NCT00961116|1922934|FG000|Washout Period of 7 Days|Protocol Violation|0
936321|NCT00961116|1922935|FG001|Washout Period of 7 Days|Protocol Violation|1
936322|NCT00961181|1922942|FG000|Overall Study|Death|2
936323|NCT00961181|1922942|FG000|Overall Study|Withdrawal by Subject|2
936324|NCT00961181|1922942|FG000|Overall Study|Lost to Follow-up|1
936325|NCT00961220|1922946|FG000|Overall Study|Adverse Event|3
936326|NCT00961220|1922946|FG000|Overall Study|Lack of Efficacy|1
936327|NCT00961220|1922946|FG000|Overall Study|No IV access for O6BG|1
936328|NCT00961220|1922946|FG000|Overall Study|O6BG no longer supplied|1
936329|NCT00961220|1922946|FG000|Overall Study|Complete Response prior to 12 courses|1
936330|NCT00961259|1922963|FG000|Washout Period of 7 Days|due to concomitant medication used|0
936331|NCT00961259|1922964|FG001|Washout Period of 7 Days|due to concomitant medication used|1
936332|NCT00961259|1922965|FG002|Washout Period of 7 Days|due to concomitant medication used|0
936333|NCT00961298|1922974|FG000|Two Week Placebo Run in|Withdrawal by Subject|1
936334|NCT00961298|1922974|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
936335|NCT00961298|1922974|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
936336|NCT00961350|1922984|FG000|Overall Study|Adverse Event|18
936337|NCT00961350|1922985|FG001|Overall Study|Adverse Event|33
936338|NCT00961350|1922984|FG000|Overall Study|Withdrawal by Subject|10
936339|NCT00961350|1922985|FG001|Overall Study|Withdrawal by Subject|10
936340|NCT00961350|1922984|FG000|Overall Study|Lost to Follow-up|3
936341|NCT00961350|1922985|FG001|Overall Study|Lost to Follow-up|3
936342|NCT00961350|1922984|FG000|Overall Study|Misc|16
936343|NCT00961350|1922985|FG001|Overall Study|Misc|21
936344|NCT00961415|1923002|FG000|Induction Treatment Phase|Withdrawal by Subject|11
936345|NCT00961415|1923003|FG001|Induction Treatment Phase|Withdrawal by Subject|0
936346|NCT00961415|1923004|FG002|Induction Treatment Phase|Withdrawal by Subject|0
936347|NCT00961415|1923002|FG000|Induction Treatment Phase|Death|77
936348|NCT00961415|1923003|FG001|Induction Treatment Phase|Death|0
936349|NCT00961415|1923004|FG002|Induction Treatment Phase|Death|0
936350|NCT00961415|1923002|FG000|Induction Treatment Phase|Protocol Violation|1
936351|NCT00961415|1923003|FG001|Induction Treatment Phase|Protocol Violation|0
936352|NCT00961415|1923004|FG002|Induction Treatment Phase|Protocol Violation|0
936353|NCT00961415|1923002|FG000|Induction Treatment Phase|Physician Decision|2
936354|NCT00961415|1923003|FG001|Induction Treatment Phase|Physician Decision|0
936355|NCT00961415|1923004|FG002|Induction Treatment Phase|Physician Decision|0
936356|NCT00961415|1923002|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27
936357|NCT00961415|1923003|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
936358|NCT00961415|1923004|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
936359|NCT00961415|1923002|FG000|Induction Treatment Phase|Other Reason|5
936360|NCT00961415|1923003|FG001|Induction Treatment Phase|Other Reason|0
936361|NCT00961415|1923004|FG002|Induction Treatment Phase|Other Reason|0
936362|NCT00961415|1923002|FG000|Maintenance Treatment Phase|Death|0
936363|NCT00961415|1923003|FG001|Maintenance Treatment Phase|Death|42
936364|NCT00961415|1923004|FG002|Maintenance Treatment Phase|Death|34
936365|NCT00961415|1923002|FG000|Maintenance Treatment Phase|Investigators decision|0
936366|NCT00961415|1923003|FG001|Maintenance Treatment Phase|Investigators decision|2
936367|NCT00961415|1923004|FG002|Maintenance Treatment Phase|Investigators decision|0
936368|NCT00961415|1923002|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
936369|NCT00961415|1923003|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3
936370|NCT00961415|1923004|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8
936371|NCT00961415|1923002|FG000|Maintenance Treatment Phase|Other reason|0
936372|NCT00961415|1923003|FG001|Maintenance Treatment Phase|Other reason|1
936373|NCT00961415|1923004|FG002|Maintenance Treatment Phase|Other reason|3
936374|NCT00961571|1923031|FG000|Overall Study|Physician Decision|39
936375|NCT00961636|1923038|FG000|Overall Study|Adverse Event|35
936376|NCT00961636|1923039|FG001|Overall Study|Adverse Event|54
936377|NCT00961636|1923040|FG002|Overall Study|Adverse Event|13
936378|NCT00961636|1923038|FG000|Overall Study|Flushing Symptoms|29
936379|NCT00961636|1923039|FG001|Overall Study|Flushing Symptoms|46
936380|NCT00961636|1923040|FG002|Overall Study|Flushing Symptoms|3
936381|NCT00961636|1923038|FG000|Overall Study|Lost to Follow-up|2
936382|NCT00961636|1923039|FG001|Overall Study|Lost to Follow-up|3
936383|NCT00961636|1923040|FG002|Overall Study|Lost to Follow-up|1
936384|NCT00961636|1923038|FG000|Overall Study|Physician Decision|3
936385|NCT00961636|1923039|FG001|Overall Study|Physician Decision|1
936386|NCT00961636|1923040|FG002|Overall Study|Physician Decision|1
936387|NCT00961636|1923038|FG000|Overall Study|Protocol Violation|9
936388|NCT00961636|1923039|FG001|Overall Study|Protocol Violation|5
936389|NCT00961636|1923040|FG002|Overall Study|Protocol Violation|1
936390|NCT00961636|1923038|FG000|Overall Study|Withdrawal by Subject|29
936391|NCT00961636|1923039|FG001|Overall Study|Withdrawal by Subject|22
936392|NCT00961636|1923040|FG002|Overall Study|Withdrawal by Subject|13
936393|NCT00961649|1923052|FG000|Overall Study|Adverse Event|4
936394|NCT00961649|1923053|FG001|Overall Study|Adverse Event|0
936395|NCT00961649|1923054|FG002|Overall Study|Adverse Event|0
936396|NCT00961649|1923055|FG003|Overall Study|Adverse Event|2
936397|NCT00961649|1923052|FG000|Overall Study|Inadequate control of IOP|0
936398|NCT00961649|1923053|FG001|Overall Study|Inadequate control of IOP|0
936399|NCT00961649|1923054|FG002|Overall Study|Inadequate control of IOP|0
936400|NCT00961649|1923055|FG003|Overall Study|Inadequate control of IOP|1
936401|NCT00961649|1923052|FG000|Overall Study|Patient has travel plans during holidays|0
936402|NCT00961649|1923053|FG001|Overall Study|Patient has travel plans during holidays|0
936403|NCT00961649|1923054|FG002|Overall Study|Patient has travel plans during holidays|1
936404|NCT00961649|1923055|FG003|Overall Study|Patient has travel plans during holidays|0
936405|NCT00961649|1923052|FG000|Overall Study|Patient left to Mexico-family emergency|1
936406|NCT00961649|1923053|FG001|Overall Study|Patient left to Mexico-family emergency|0
936407|NCT00961649|1923054|FG002|Overall Study|Patient left to Mexico-family emergency|0
936408|NCT00961649|1923055|FG003|Overall Study|Patient left to Mexico-family emergency|0
936409|NCT00961649|1923052|FG000|Overall Study|Study terminated by sponsor|4
936410|NCT00961649|1923053|FG001|Overall Study|Study terminated by sponsor|4
936411|NCT00961649|1923054|FG002|Overall Study|Study terminated by sponsor|4
936412|NCT00961649|1923055|FG003|Overall Study|Study terminated by sponsor|1
936413|NCT00961896|1923088|FG000|Overall Study|Abnormal laboratory value|0
936414|NCT00961896|1923089|FG001|Overall Study|Abnormal laboratory value|0
936415|NCT00961896|1923090|FG002|Overall Study|Abnormal laboratory value|1
936416|NCT00961961|1923105|FG000|Phase I|Withdrawal by Subject|7
936417|NCT00961961|1923106|FG001|Phase I|Withdrawal by Subject|0
936418|NCT00961961|1923107|FG002|Phase I|Withdrawal by Subject|0
936419|NCT00961961|1923108|FG003|Phase I|Withdrawal by Subject|0
936420|NCT00961961|1923105|FG000|Phase I|Lost to Follow-up|10
936421|NCT00961961|1923106|FG001|Phase I|Lost to Follow-up|0
936422|NCT00961961|1923107|FG002|Phase I|Lost to Follow-up|0
936423|NCT00961961|1923108|FG003|Phase I|Lost to Follow-up|0
936424|NCT00961961|1923105|FG000|Phase I|Lack of Efficacy|94
936425|NCT00961961|1923106|FG001|Phase I|Lack of Efficacy|0
936426|NCT00961961|1923107|FG002|Phase I|Lack of Efficacy|0
936427|NCT00961961|1923108|FG003|Phase I|Lack of Efficacy|0
936428|NCT00961961|1923105|FG000|Phase I|Adverse Event|7
936429|NCT00961961|1923106|FG001|Phase I|Adverse Event|0
936430|NCT00961961|1923107|FG002|Phase I|Adverse Event|0
936431|NCT00961961|1923108|FG003|Phase I|Adverse Event|0
936432|NCT00961961|1923105|FG000|Phase I|Physician Decision|8
936433|NCT00961961|1923106|FG001|Phase I|Physician Decision|0
936434|NCT00961961|1923107|FG002|Phase I|Physician Decision|0
936435|NCT00961961|1923108|FG003|Phase I|Physician Decision|0
936436|NCT00961961|1923105|FG000|Phase II|Lost to Follow-up|0
936437|NCT00961961|1923106|FG001|Phase II|Lost to Follow-up|0
936438|NCT00961961|1923107|FG002|Phase II|Lost to Follow-up|10
936439|NCT00961961|1923108|FG003|Phase II|Lost to Follow-up|7
936440|NCT00961961|1923105|FG000|Phase II|Adverse Event|0
936441|NCT00961961|1923106|FG001|Phase II|Adverse Event|0
936442|NCT00961961|1923107|FG002|Phase II|Adverse Event|0
936443|NCT00961961|1923108|FG003|Phase II|Adverse Event|1
936444|NCT00961961|1923105|FG000|Phase II|Physician Decision|0
936445|NCT00961961|1923106|FG001|Phase II|Physician Decision|0
936446|NCT00961961|1923107|FG002|Phase II|Physician Decision|1
936447|NCT00961961|1923108|FG003|Phase II|Physician Decision|0
936448|NCT00961961|1923105|FG000|Phase II|Withdrawal by Subject|0
936449|NCT00961961|1923106|FG001|Phase II|Withdrawal by Subject|0
936450|NCT00961961|1923107|FG002|Phase II|Withdrawal by Subject|1
936451|NCT00961961|1923108|FG003|Phase II|Withdrawal by Subject|0
936452|NCT00962013|1923135|FG000|Overall Study|Did not have surgery|1
936453|NCT00962013|1923135|FG000|Overall Study|Death|8
936454|NCT00962013|1923135|FG000|Overall Study|Lost to Follow-up|12
936455|NCT00962013|1923135|FG000|Overall Study|Unable/Unwilling to return|6
936456|NCT00962013|1923135|FG000|Overall Study|Withdrawal by Subject|8
936457|NCT00962013|1923135|FG000|Overall Study|Removal of study device|3
936458|NCT00962013|1923135|FG000|Overall Study|Site Termination|24
936459|NCT00962013|1923135|FG000|Overall Study|No 5 year evaluation|6
936460|NCT00962091|1923177|FG000|Overall Study|Withdrawal by Subject|1
936461|NCT00962091|1923178|FG001|Overall Study|Withdrawal by Subject|2
936462|NCT00962091|1923179|FG002|Overall Study|Withdrawal by Subject|1
936463|NCT00962091|1923180|FG003|Overall Study|Withdrawal by Subject|1
936464|NCT00962091|1923181|FG004|Overall Study|Withdrawal by Subject|0
936465|NCT00962091|1923182|FG005|Overall Study|Withdrawal by Subject|1
936466|NCT00962091|1923183|FG006|Overall Study|Withdrawal by Subject|0
936467|NCT00962091|1923177|FG000|Overall Study|Adverse Event|0
936468|NCT00962091|1923178|FG001|Overall Study|Adverse Event|0
936469|NCT00962091|1923179|FG002|Overall Study|Adverse Event|0
936470|NCT00962091|1923180|FG003|Overall Study|Adverse Event|0
936471|NCT00962091|1923181|FG004|Overall Study|Adverse Event|0
936472|NCT00962091|1923182|FG005|Overall Study|Adverse Event|0
936473|NCT00962091|1923183|FG006|Overall Study|Adverse Event|1
936474|NCT00962104|1923209|FG000|Overall Study|Adverse Event|10
936475|NCT00962104|1923210|FG001|Overall Study|Adverse Event|3
936476|NCT00962104|1923209|FG000|Overall Study|Entry Criteria Not Met|1
936477|NCT00962104|1923210|FG001|Overall Study|Entry Criteria Not Met|2
936478|NCT00962104|1923209|FG000|Overall Study|Lack of Efficacy|0
936479|NCT00962104|1923210|FG001|Overall Study|Lack of Efficacy|1
936480|NCT00962104|1923209|FG000|Overall Study|Lost to Follow-up|10
936481|NCT00962104|1923210|FG001|Overall Study|Lost to Follow-up|4
936482|NCT00962104|1923209|FG000|Overall Study|Physician Decision|1
936483|NCT00962104|1923210|FG001|Overall Study|Physician Decision|0
936484|NCT00962104|1923209|FG000|Overall Study|Protocol Violation|6
936485|NCT00962104|1923210|FG001|Overall Study|Protocol Violation|8
936486|NCT00962104|1923209|FG000|Overall Study|Sponsor Decision|0
936487|NCT00962104|1923210|FG001|Overall Study|Sponsor Decision|1
936488|NCT00962104|1923209|FG000|Overall Study|Withdrawal by Subject|10
936489|NCT00962104|1923210|FG001|Overall Study|Withdrawal by Subject|6
936490|NCT00962104|1923209|FG000|Overall Study|Other|2
936491|NCT00962104|1923210|FG001|Overall Study|Other|0
936492|NCT00962208|1923218|FG000|Overall Study|Could not achieve good vision|9
936493|NCT00962208|1923219|FG001|Overall Study|Could not achieve good vision|0
936494|NCT00962208|1923218|FG000|Overall Study|Contraindicated to continue study|5
936495|NCT00962208|1923219|FG001|Overall Study|Contraindicated to continue study|1
936496|NCT00962208|1923218|FG000|Overall Study|Lost to Follow-up|0
936497|NCT00962208|1923219|FG001|Overall Study|Lost to Follow-up|9
936498|NCT00962247|1923225|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4
936499|NCT00962247|1923225|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
936500|NCT00962390|1923235|FG000|Overall Study|Adverse Event|0
936501|NCT00962390|1923236|FG001|Overall Study|Adverse Event|0
936502|NCT00962390|1923237|FG002|Overall Study|Adverse Event|3
936503|NCT00962390|1923238|FG003|Overall Study|Adverse Event|1
936504|NCT00962390|1923235|FG000|Overall Study|Lost to Follow-up|2
936505|NCT00962390|1923236|FG001|Overall Study|Lost to Follow-up|2
936506|NCT00962390|1923237|FG002|Overall Study|Lost to Follow-up|0
936507|NCT00962390|1923238|FG003|Overall Study|Lost to Follow-up|0
936508|NCT00962390|1923235|FG000|Overall Study|Protocol Violation|1
936509|NCT00962390|1923236|FG001|Overall Study|Protocol Violation|0
936510|NCT00962390|1923237|FG002|Overall Study|Protocol Violation|0
936511|NCT00962390|1923238|FG003|Overall Study|Protocol Violation|0
936512|NCT00962390|1923235|FG000|Overall Study|Withdrawal by Subject|1
936513|NCT00962390|1923236|FG001|Overall Study|Withdrawal by Subject|1
936514|NCT00962390|1923237|FG002|Overall Study|Withdrawal by Subject|1
936515|NCT00962390|1923238|FG003|Overall Study|Withdrawal by Subject|0
936516|NCT00962585|1923252|FG000|Overall Study|Adverse Event|0
936517|NCT00962585|1923253|FG001|Overall Study|Adverse Event|2
936518|NCT00962585|1923254|FG002|Overall Study|Adverse Event|1
936519|NCT00962585|1923255|FG003|Overall Study|Adverse Event|0
936520|NCT00962585|1923252|FG000|Overall Study|Lost to Follow-up|3
936521|NCT00962585|1923253|FG001|Overall Study|Lost to Follow-up|0
936522|NCT00962585|1923254|FG002|Overall Study|Lost to Follow-up|1
936523|NCT00962585|1923255|FG003|Overall Study|Lost to Follow-up|0
936524|NCT00962585|1923252|FG000|Overall Study|Protocol Violation|0
936525|NCT00962585|1923253|FG001|Overall Study|Protocol Violation|0
936526|NCT00962585|1923254|FG002|Overall Study|Protocol Violation|1
936527|NCT00962585|1923255|FG003|Overall Study|Protocol Violation|0
936528|NCT00962585|1923252|FG000|Overall Study|Withdrawal by Subject|1
936529|NCT00962585|1923253|FG001|Overall Study|Withdrawal by Subject|0
936530|NCT00962585|1923254|FG002|Overall Study|Withdrawal by Subject|0
936531|NCT00962585|1923255|FG003|Overall Study|Withdrawal by Subject|0
936532|NCT00962585|1923252|FG000|Overall Study|Withdrew Consent|2
936533|NCT00962585|1923253|FG001|Overall Study|Withdrew Consent|0
936534|NCT00962585|1923254|FG002|Overall Study|Withdrew Consent|0
936535|NCT00962585|1923255|FG003|Overall Study|Withdrew Consent|0
936536|NCT00962650|1923276|FG000|Overall Study|Transgastric DP was not completed|2
936537|NCT00962741|1923280|FG000|Overall Study|Failed to return|3
936538|NCT00962741|1923280|FG000|Overall Study|Lost to Follow-up|2
936539|NCT00962741|1923280|FG000|Overall Study|Withdrawal by Subject|1
936540|NCT00962741|1923280|FG000|Overall Study|Lack of Efficacy|1
936541|NCT00962741|1923280|FG000|Overall Study|drug ineffective+prohibited drug taken|1
936542|NCT00962780|1923299|FG000|Overall Study|Death|0
936543|NCT00962780|1923300|FG001|Overall Study|Death|1
936544|NCT00962780|1923299|FG000|Overall Study|Protocol Violation|9
936545|NCT00962780|1923300|FG001|Overall Study|Protocol Violation|4
936546|NCT00962780|1923299|FG000|Overall Study|Withdrawal by Subject|1
936547|NCT00962780|1923300|FG001|Overall Study|Withdrawal by Subject|8
936548|NCT00962780|1923299|FG000|Overall Study|Other|0
936549|NCT00962780|1923300|FG001|Overall Study|Other|1
936550|NCT00963235|1923372|FG000|Overall Study|Withdrawal by Subject|22
936551|NCT00963235|1923372|FG000|Overall Study|Lost to Follow-up|14
936552|NCT00963235|1923372|FG000|Overall Study|Failed to return|9
936553|NCT00963235|1923372|FG000|Overall Study|Protocol Violation|7
936554|NCT00963235|1923372|FG000|Overall Study|Adverse Event|5
936555|NCT00963235|1923372|FG000|Overall Study|Physician Decision|2
936556|NCT00963235|1923372|FG000|Overall Study|Other|1
936557|NCT00963469|1923391|FG000|Overall Study|Adverse Event|15
936558|NCT00963469|1923392|FG001|Overall Study|Adverse Event|11
936559|NCT00963469|1923393|FG002|Overall Study|Adverse Event|1
936560|NCT00963469|1923391|FG000|Overall Study|Lack of Efficacy|10
936561|NCT00963469|1923392|FG001|Overall Study|Lack of Efficacy|7
936562|NCT00963469|1923393|FG002|Overall Study|Lack of Efficacy|2
936563|NCT00963469|1923391|FG000|Overall Study|Lost to Follow-up|1
936564|NCT00963469|1923392|FG001|Overall Study|Lost to Follow-up|1
936565|NCT00963469|1923393|FG002|Overall Study|Lost to Follow-up|0
936566|NCT00963469|1923391|FG000|Overall Study|Protocol Violation|5
936567|NCT00963469|1923392|FG001|Overall Study|Protocol Violation|5
936568|NCT00963469|1923393|FG002|Overall Study|Protocol Violation|3
936569|NCT00963469|1923391|FG000|Overall Study|Withdrawal by Subject|4
936570|NCT00963469|1923392|FG001|Overall Study|Withdrawal by Subject|1
936571|NCT00963469|1923393|FG002|Overall Study|Withdrawal by Subject|1
936572|NCT00963469|1923391|FG000|Overall Study|Pre-randomization Adverse Event|1
936573|NCT00963469|1923392|FG001|Overall Study|Pre-randomization Adverse Event|2
936574|NCT00963469|1923393|FG002|Overall Study|Pre-randomization Adverse Event|0
936575|NCT00963469|1923391|FG000|Overall Study|Moved|1
936576|NCT00963469|1923392|FG001|Overall Study|Moved|0
936577|NCT00963469|1923393|FG002|Overall Study|Moved|0
936578|NCT00963469|1923391|FG000|Overall Study|Site closed (local pollen Season ended)|4
936579|NCT00963469|1923392|FG001|Overall Study|Site closed (local pollen Season ended)|1
936580|NCT00963469|1923393|FG002|Overall Study|Site closed (local pollen Season ended)|3
936581|NCT00963547|1923423|FG000|Overall Study|Adverse Event|0
936582|NCT00963547|1923424|FG001|Overall Study|Adverse Event|1
936583|NCT00963547|1923425|FG002|Overall Study|Adverse Event|0
936584|NCT00963547|1923426|FG003|Overall Study|Adverse Event|1
936585|NCT00963547|1923427|FG004|Overall Study|Adverse Event|0
936586|NCT00963547|1923428|FG005|Overall Study|Adverse Event|0
936587|NCT00963547|1923429|FG006|Overall Study|Adverse Event|0
936588|NCT00963547|1923423|FG000|Overall Study|Physician Decision|1
936589|NCT00963547|1923424|FG001|Overall Study|Physician Decision|1
936590|NCT00963547|1923425|FG002|Overall Study|Physician Decision|0
936591|NCT00963547|1923426|FG003|Overall Study|Physician Decision|0
936592|NCT00963547|1923427|FG004|Overall Study|Physician Decision|0
936593|NCT00963547|1923428|FG005|Overall Study|Physician Decision|0
936594|NCT00963547|1923429|FG006|Overall Study|Physician Decision|0
936595|NCT00963547|1923423|FG000|Overall Study|Progressive Disease|3
936596|NCT00963547|1923424|FG001|Overall Study|Progressive Disease|8
936597|NCT00963547|1923425|FG002|Overall Study|Progressive Disease|9
936598|NCT00963547|1923426|FG003|Overall Study|Progressive Disease|5
936599|NCT00963547|1923427|FG004|Overall Study|Progressive Disease|0
936600|NCT00963547|1923428|FG005|Overall Study|Progressive Disease|0
936601|NCT00963547|1923429|FG006|Overall Study|Progressive Disease|0
936602|NCT00963547|1923423|FG000|Overall Study|Withdrawal by Subject|0
936603|NCT00963547|1923424|FG001|Overall Study|Withdrawal by Subject|0
936604|NCT00963547|1923425|FG002|Overall Study|Withdrawal by Subject|3
936605|NCT00963547|1923426|FG003|Overall Study|Withdrawal by Subject|0
936606|NCT00963547|1923427|FG004|Overall Study|Withdrawal by Subject|0
936607|NCT00963547|1923428|FG005|Overall Study|Withdrawal by Subject|0
936608|NCT00963547|1923429|FG006|Overall Study|Withdrawal by Subject|0
936609|NCT00963547|1923423|FG000|Overall Study|Reason Unknown|0
936610|NCT00963547|1923424|FG001|Overall Study|Reason Unknown|1
936611|NCT00963547|1923425|FG002|Overall Study|Reason Unknown|0
936612|NCT00963547|1923426|FG003|Overall Study|Reason Unknown|0
936613|NCT00963547|1923427|FG004|Overall Study|Reason Unknown|0
936614|NCT00963547|1923428|FG005|Overall Study|Reason Unknown|0
936615|NCT00963547|1923429|FG006|Overall Study|Reason Unknown|0
936616|NCT00963599|1923459|FG000|Overall Study|Adverse Event|2
936617|NCT00963599|1923460|FG001|Overall Study|Adverse Event|0
936618|NCT00963599|1923461|FG002|Overall Study|Adverse Event|1
936619|NCT00963599|1923462|FG003|Overall Study|Adverse Event|2
936620|NCT00963599|1923459|FG000|Overall Study|Lack of Efficacy|0
936621|NCT00963599|1923460|FG001|Overall Study|Lack of Efficacy|2
936622|NCT00963599|1923461|FG002|Overall Study|Lack of Efficacy|1
936623|NCT00963599|1923462|FG003|Overall Study|Lack of Efficacy|4
936624|NCT00963599|1923459|FG000|Overall Study|Lost to Follow-up|0
936625|NCT00963599|1923460|FG001|Overall Study|Lost to Follow-up|1
936626|NCT00963599|1923461|FG002|Overall Study|Lost to Follow-up|1
936627|NCT00963599|1923462|FG003|Overall Study|Lost to Follow-up|1
936628|NCT00963599|1923459|FG000|Overall Study|Protocol Violation|2
936629|NCT00963599|1923460|FG001|Overall Study|Protocol Violation|2
936630|NCT00963599|1923461|FG002|Overall Study|Protocol Violation|3
936631|NCT00963599|1923462|FG003|Overall Study|Protocol Violation|4
936632|NCT00963599|1923459|FG000|Overall Study|Withdrawal by Subject|2
936633|NCT00963599|1923460|FG001|Overall Study|Withdrawal by Subject|1
936634|NCT00963599|1923461|FG002|Overall Study|Withdrawal by Subject|3
936635|NCT00963599|1923462|FG003|Overall Study|Withdrawal by Subject|3
936636|NCT00963807|1923490|FG000|Overall Study|Physician Decision|2
936637|NCT00963807|1923490|FG000|Overall Study|Reaction to study chemotherapy regimen|1
936638|NCT00963807|1923490|FG000|Overall Study|Disease progression|15
936639|NCT00963820|1923496|FG000|Dose Escalation Phase|Progressive Disease|3
936640|NCT00963820|1923497|FG001|Dose Escalation Phase|Progressive Disease|3
936641|NCT00963820|1923498|FG002|Dose Escalation Phase|Progressive Disease|3
936642|NCT00963820|1923499|FG003|Dose Escalation Phase|Progressive Disease|3
936643|NCT00963820|1923500|FG004|Dose Escalation Phase|Progressive Disease|4
936644|NCT00963820|1923501|FG005|Dose Escalation Phase|Progressive Disease|3
936645|NCT00963820|1923502|FG006|Dose Escalation Phase|Progressive Disease|3
936646|NCT00963820|1923503|FG007|Dose Escalation Phase|Progressive Disease|2
936647|NCT00963820|1923504|FG008|Dose Escalation Phase|Progressive Disease|0
936648|NCT00963820|1923505|FG009|Dose Escalation Phase|Progressive Disease|0
936649|NCT00963820|1923506|FG010|Dose Escalation Phase|Progressive Disease|0
936650|NCT00963820|1923507|FG011|Dose Escalation Phase|Progressive Disease|0
936651|NCT00963820|1923496|FG000|Dose Escalation Phase|Adverse Event|0
936652|NCT00963820|1923497|FG001|Dose Escalation Phase|Adverse Event|0
936653|NCT00963820|1923498|FG002|Dose Escalation Phase|Adverse Event|0
936654|NCT00963820|1923499|FG003|Dose Escalation Phase|Adverse Event|0
936655|NCT00963820|1923500|FG004|Dose Escalation Phase|Adverse Event|0
936656|NCT00963820|1923501|FG005|Dose Escalation Phase|Adverse Event|0
936657|NCT00963820|1923502|FG006|Dose Escalation Phase|Adverse Event|3
936658|NCT00963820|1923503|FG007|Dose Escalation Phase|Adverse Event|1
936659|NCT00963820|1923504|FG008|Dose Escalation Phase|Adverse Event|0
936660|NCT00963820|1923505|FG009|Dose Escalation Phase|Adverse Event|0
936661|NCT00963820|1923506|FG010|Dose Escalation Phase|Adverse Event|0
936662|NCT00963820|1923507|FG011|Dose Escalation Phase|Adverse Event|0
936663|NCT00963820|1923496|FG000|Dose Escalation Phase|Withdrawal by Subject|0
936664|NCT00963820|1923497|FG001|Dose Escalation Phase|Withdrawal by Subject|0
936665|NCT00963820|1923498|FG002|Dose Escalation Phase|Withdrawal by Subject|0
936666|NCT00963820|1923499|FG003|Dose Escalation Phase|Withdrawal by Subject|0
936667|NCT00963820|1923500|FG004|Dose Escalation Phase|Withdrawal by Subject|0
936668|NCT00963820|1923501|FG005|Dose Escalation Phase|Withdrawal by Subject|0
936669|NCT00963820|1923502|FG006|Dose Escalation Phase|Withdrawal by Subject|1
936670|NCT00963820|1923503|FG007|Dose Escalation Phase|Withdrawal by Subject|2
936671|NCT00963820|1923504|FG008|Dose Escalation Phase|Withdrawal by Subject|0
936672|NCT00963820|1923505|FG009|Dose Escalation Phase|Withdrawal by Subject|0
936673|NCT00963820|1923506|FG010|Dose Escalation Phase|Withdrawal by Subject|0
936674|NCT00963820|1923507|FG011|Dose Escalation Phase|Withdrawal by Subject|0
936675|NCT00963820|1923496|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
936676|NCT00963820|1923497|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
936677|NCT00963820|1923498|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
936678|NCT00963820|1923499|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
936679|NCT00963820|1923500|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
936680|NCT00963820|1923501|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
936681|NCT00963820|1923502|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
936682|NCT00963820|1923503|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
936683|NCT00963820|1923504|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
936684|NCT00963820|1923505|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
936685|NCT00963820|1923506|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
936686|NCT00963820|1923507|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
936687|NCT00963820|1923496|FG000|Expansion Phase|Progressive Disease|0
936688|NCT00963820|1923497|FG001|Expansion Phase|Progressive Disease|0
936689|NCT00963820|1923498|FG002|Expansion Phase|Progressive Disease|0
936690|NCT00963820|1923499|FG003|Expansion Phase|Progressive Disease|0
936691|NCT00963820|1923500|FG004|Expansion Phase|Progressive Disease|0
936692|NCT00963820|1923501|FG005|Expansion Phase|Progressive Disease|0
936693|NCT00963820|1923502|FG006|Expansion Phase|Progressive Disease|0
936694|NCT00963820|1923503|FG007|Expansion Phase|Progressive Disease|0
936695|NCT00963820|1923504|FG008|Expansion Phase|Progressive Disease|8
936696|NCT00963820|1923505|FG009|Expansion Phase|Progressive Disease|6
936697|NCT00963820|1923506|FG010|Expansion Phase|Progressive Disease|4
936698|NCT00963820|1923507|FG011|Expansion Phase|Progressive Disease|2
936699|NCT00963820|1923496|FG000|Expansion Phase|Adverse Event|0
936700|NCT00963820|1923497|FG001|Expansion Phase|Adverse Event|0
936701|NCT00963820|1923498|FG002|Expansion Phase|Adverse Event|0
936702|NCT00963820|1923499|FG003|Expansion Phase|Adverse Event|0
936703|NCT00963820|1923500|FG004|Expansion Phase|Adverse Event|0
936704|NCT00963820|1923501|FG005|Expansion Phase|Adverse Event|0
936705|NCT00963820|1923502|FG006|Expansion Phase|Adverse Event|0
936706|NCT00963820|1923503|FG007|Expansion Phase|Adverse Event|0
936707|NCT00963820|1923504|FG008|Expansion Phase|Adverse Event|1
936708|NCT00963820|1923505|FG009|Expansion Phase|Adverse Event|3
936709|NCT00963820|1923506|FG010|Expansion Phase|Adverse Event|0
936710|NCT00963820|1923507|FG011|Expansion Phase|Adverse Event|0
936711|NCT00963820|1923496|FG000|Expansion Phase|Withdrawal by Subject|0
936712|NCT00963820|1923497|FG001|Expansion Phase|Withdrawal by Subject|0
936713|NCT00963820|1923498|FG002|Expansion Phase|Withdrawal by Subject|0
936714|NCT00963820|1923499|FG003|Expansion Phase|Withdrawal by Subject|0
936715|NCT00963820|1923500|FG004|Expansion Phase|Withdrawal by Subject|0
936716|NCT00963820|1923501|FG005|Expansion Phase|Withdrawal by Subject|0
936717|NCT00963820|1923502|FG006|Expansion Phase|Withdrawal by Subject|0
936718|NCT00963820|1923503|FG007|Expansion Phase|Withdrawal by Subject|0
936719|NCT00963820|1923504|FG008|Expansion Phase|Withdrawal by Subject|1
936720|NCT00963820|1923505|FG009|Expansion Phase|Withdrawal by Subject|0
936721|NCT00963820|1923506|FG010|Expansion Phase|Withdrawal by Subject|1
936722|NCT00963820|1923507|FG011|Expansion Phase|Withdrawal by Subject|1
936723|NCT00963820|1923496|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0
936724|NCT00963820|1923497|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0
936725|NCT00963820|1923498|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0
936726|NCT00963820|1923499|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0
936727|NCT00963820|1923500|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0
936728|NCT00963820|1923501|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0
936729|NCT00963820|1923502|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0
936730|NCT00963820|1923503|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0
936731|NCT00963820|1923504|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0
936732|NCT00963820|1923505|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0
936733|NCT00963820|1923506|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0
936734|NCT00963820|1923507|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1
936735|NCT00963924|1923543|FG000|Overall Study|Adverse Event|1
936736|NCT00963924|1923544|FG001|Overall Study|Adverse Event|0
936737|NCT00963924|1923543|FG000|Overall Study|Withdrawal by Subject|0
936738|NCT00963924|1923544|FG001|Overall Study|Withdrawal by Subject|1
936739|NCT00963924|1923543|FG000|Overall Study|Changed antipsychotic|0
936740|NCT00963924|1923544|FG001|Overall Study|Changed antipsychotic|1
936741|NCT00963924|1923543|FG000|Overall Study|Lost to Follow-up|0
936742|NCT00963924|1923544|FG001|Overall Study|Lost to Follow-up|1
936743|NCT00963937|1923555|FG000|Overall Study|Protocol Violation|1
936744|NCT00963937|1923556|FG001|Overall Study|Protocol Violation|1
936745|NCT00963937|1923557|FG002|Overall Study|Protocol Violation|0
936746|NCT00963937|1923555|FG000|Overall Study|Physician Decision|18
936747|NCT00963937|1923556|FG001|Overall Study|Physician Decision|10
936748|NCT00963937|1923557|FG002|Overall Study|Physician Decision|4
936749|NCT00964028|1923574|FG000|Overall Study|Withdrawal by Subject|0
936750|NCT00964028|1923575|FG001|Overall Study|Withdrawal by Subject|1
936751|NCT00964158|1923588|FG000|Overall Study|Lost to Follow-up|0
936752|NCT00964158|1923589|FG001|Overall Study|Lost to Follow-up|1
936753|NCT00964158|1923590|FG002|Overall Study|Lost to Follow-up|2
936754|NCT00964158|1923588|FG000|Overall Study|Withdrawal by Subject|0
936755|NCT00964158|1923589|FG001|Overall Study|Withdrawal by Subject|0
936756|NCT00964158|1923590|FG002|Overall Study|Withdrawal by Subject|6
936757|NCT00964223|1923601|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
936758|NCT00964366|1923617|FG000|Overall Study|Did not qualify at Day 1|1
936759|NCT00964366|1923618|FG001|Overall Study|Did not qualify at Day 1|0
936760|NCT00964366|1923617|FG000|Overall Study|Withdrawal by Subject|0
936761|NCT00964366|1923618|FG001|Overall Study|Withdrawal by Subject|1
936762|NCT00964392|1923626|FG000|Overall Study|Withdrawal by Subject|4
936763|NCT00964392|1923627|FG001|Overall Study|Withdrawal by Subject|6
936764|NCT00964392|1923626|FG000|Overall Study|Lost to Follow-up|4
936765|NCT00964392|1923627|FG001|Overall Study|Lost to Follow-up|10
936766|NCT00964392|1923626|FG000|Overall Study|Early Termination, non-study arrhythmia|1
936767|NCT00964392|1923627|FG001|Overall Study|Early Termination, non-study arrhythmia|6
936768|NCT00964392|1923626|FG000|Overall Study|Not completed|44
936769|NCT00964392|1923627|FG001|Overall Study|Not completed|168
936770|NCT00964678|1923672|FG000|Overall Study|Physician Decision|4
936771|NCT00964743|1923677|FG000|Overall Study|Neither patient completed 8 weeks of tre|2
936772|NCT00964782|1923683|FG000|Overall Study|Lost to Follow-up|1
936773|NCT00964782|1923684|FG001|Overall Study|Lost to Follow-up|0
936774|NCT00964795|1923692|FG000|Overall Study|Withdrawal by Subject|79
936775|NCT00964795|1923692|FG000|Overall Study|Adverse Event|12
936776|NCT00964795|1923692|FG000|Overall Study|Death|14
936777|NCT00964795|1923692|FG000|Overall Study|Lost to Follow-up|7
936778|NCT00964795|1923692|FG000|Overall Study|Termination of Study by Sponsor|169
936779|NCT00964795|1923692|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3
936780|NCT00964795|1923692|FG000|Overall Study|Other|23
936781|NCT00964860|1923699|FG000|Overall Study|Withdrawal by Subject|0
936782|NCT00964860|1923700|FG001|Overall Study|Withdrawal by Subject|1
936783|NCT00964886|1923710|FG000|Overall Study|Lost to Follow-up|2
936784|NCT00964886|1923711|FG001|Overall Study|Lost to Follow-up|2
936785|NCT00964886|1923712|FG002|Overall Study|Lost to Follow-up|6
936786|NCT00964886|1923713|FG003|Overall Study|Lost to Follow-up|4
936787|NCT00964886|1923710|FG000|Overall Study|Withdrawal by Subject|6
936788|NCT00964886|1923711|FG001|Overall Study|Withdrawal by Subject|2
936789|NCT00964886|1923712|FG002|Overall Study|Withdrawal by Subject|5
936790|NCT00964886|1923713|FG003|Overall Study|Withdrawal by Subject|3
936791|NCT00964886|1923710|FG000|Overall Study|Adverse Event|3
936792|NCT00964886|1923711|FG001|Overall Study|Adverse Event|1
936793|NCT00964886|1923712|FG002|Overall Study|Adverse Event|5
936794|NCT00964886|1923713|FG003|Overall Study|Adverse Event|2
936795|NCT00964886|1923710|FG000|Overall Study|Protocol Violation|0
936796|NCT00964886|1923711|FG001|Overall Study|Protocol Violation|2
936797|NCT00964886|1923712|FG002|Overall Study|Protocol Violation|0
936798|NCT00964886|1923713|FG003|Overall Study|Protocol Violation|0
936799|NCT00965081|1923729|FG000|Overall Study|Adverse Event|14
936800|NCT00965081|1923730|FG001|Overall Study|Adverse Event|9
936801|NCT00965081|1923729|FG000|Overall Study|Lack of Efficacy|2
936802|NCT00965081|1923730|FG001|Overall Study|Lack of Efficacy|5
936803|NCT00965081|1923729|FG000|Overall Study|Lost to Follow-up|4
936804|NCT00965081|1923730|FG001|Overall Study|Lost to Follow-up|5
936805|NCT00965081|1923729|FG000|Overall Study|Physician Decision|2
936806|NCT00965081|1923730|FG001|Overall Study|Physician Decision|0
936807|NCT00965081|1923729|FG000|Overall Study|Protocol Violation|2
936808|NCT00965081|1923730|FG001|Overall Study|Protocol Violation|5
936809|NCT00965081|1923729|FG000|Overall Study|Sponsor Decision|1
936810|NCT00965081|1923730|FG001|Overall Study|Sponsor Decision|0
936811|NCT00965081|1923729|FG000|Overall Study|Withdrawal by Subject|4
936812|NCT00965081|1923730|FG001|Overall Study|Withdrawal by Subject|7
936813|NCT00965081|1923729|FG000|Overall Study|Switched to Rescue Arm|5
936814|NCT00965081|1923730|FG001|Overall Study|Switched to Rescue Arm|12
936815|NCT00965094|1923739|FG000|Overall Study|Adverse Event|5
936816|NCT00965094|1923740|FG001|Overall Study|Adverse Event|0
936817|NCT00965094|1923739|FG000|Overall Study|Lost to Follow-up|0
936818|NCT00965094|1923740|FG001|Overall Study|Lost to Follow-up|1
936819|NCT00965185|1923749|FG000|Overall Study|Lost to Follow-up|2
936820|NCT00965185|1923750|FG001|Overall Study|Lost to Follow-up|0
936821|NCT00965185|1923749|FG000|Overall Study|Withdrawal by Subject|0
936822|NCT00965185|1923750|FG001|Overall Study|Withdrawal by Subject|1
936823|NCT00965263|1923776|FG000|Overall Study|Physician Decision|2
936824|NCT00965263|1923777|FG001|Overall Study|Physician Decision|0
936825|NCT00965263|1923776|FG000|Overall Study|Family emergency|0
936826|NCT00965263|1923777|FG001|Overall Study|Family emergency|1
936827|NCT00965263|1923776|FG000|Overall Study|Protocol Violation|0
936828|NCT00965263|1923777|FG001|Overall Study|Protocol Violation|2
936829|NCT00965341|1923803|FG000|Overall Study|Withdrew consent|1
936830|NCT00965341|1923804|FG001|Overall Study|Withdrew consent|5
936831|NCT00965341|1923803|FG000|Overall Study|Lost to Follow-up|1
936832|NCT00965341|1923804|FG001|Overall Study|Lost to Follow-up|0
936833|NCT00965341|1923803|FG000|Overall Study|Transportation issues|4
936834|NCT00965341|1923804|FG001|Overall Study|Transportation issues|3
936835|NCT00965419|1923810|FG000|Open Label Treatment for Responders|Adverse Event|33
936836|NCT00965419|1923810|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1
936837|NCT00965419|1923810|FG000|Open Label Treatment for Responders|Protocol Violation|21
936838|NCT00965419|1923810|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27
936839|NCT00965419|1923810|FG000|Open Label Treatment for Responders|Physician Decision|6
936840|NCT00965419|1923810|FG000|Open Label Treatment for Responders|Sponsor Decision|5
936841|NCT00965419|1923810|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41
936842|NCT00965419|1923810|FG000|Open Label Treatment for Responders|Lack of Efficacy|67
936843|NCT00965419|1923810|FG000|Open Label Treatment for Responders|Lost to Follow-up|46
936844|NCT00965419|1923810|FG000|Follow-up Phase|Adverse Event|9
936845|NCT00965419|1923810|FG000|Follow-up Phase|Protocol Violation|4
936846|NCT00965419|1923810|FG000|Follow-up Phase|Withdrawal by Subject|8
936847|NCT00965419|1923810|FG000|Follow-up Phase|Physician Decision|4
936848|NCT00965419|1923810|FG000|Follow-up Phase|Parent/Caregiver Decision|9
936849|NCT00965419|1923810|FG000|Follow-up Phase|Lack of Efficacy|28
936850|NCT00965458|1923817|FG000|Overall Study|Adverse Event|1
936851|NCT00965458|1923818|FG001|Overall Study|Adverse Event|0
936852|NCT00965458|1923817|FG000|Overall Study|Lost to Follow-up|1
936853|NCT00965458|1923818|FG001|Overall Study|Lost to Follow-up|3
936854|NCT00965458|1923817|FG000|Overall Study|Withdrawal by Subject|0
936855|NCT00965458|1923818|FG001|Overall Study|Withdrawal by Subject|1
936856|NCT00965484|1923826|FG000|Overall Study|Protocol Violation|1
936857|NCT00965484|1923826|FG000|Overall Study|Withdrawal by Subject|1
936858|NCT00965497|1923830|FG000|Overall Study|Physician Decision|1
936859|NCT00965523|1923834|FG000|Study 221|Progressive Disease|4
936860|NCT00965523|1923834|FG000|Study 221|Physician Decision|3
936861|NCT00965523|1923834|FG000|Study 224|Progressive Disease|5
936862|NCT00965523|1923834|FG000|Study 224|Physician Decision|1
936863|NCT00965562|1923841|FG000|Overall Study|Lost to Follow-up|1
936864|NCT00965562|1923842|FG001|Overall Study|Lost to Follow-up|2
936865|NCT00965562|1923843|FG002|Overall Study|Lost to Follow-up|3
936866|NCT00965562|1923841|FG000|Overall Study|Withdrawal by Subject|2
936867|NCT00965562|1923842|FG001|Overall Study|Withdrawal by Subject|2
936868|NCT00965562|1923843|FG002|Overall Study|Withdrawal by Subject|0
936869|NCT00965575|1923854|FG000|Overall Study|subject unwillingness to swallow study c|1
936870|NCT00965575|1923855|FG001|Overall Study|subject unwillingness to swallow study c|0
936871|NCT00965718|1923863|FG000|Overall Study|Withdrawal by Subject|4
936872|NCT00965731|1923869|FG000|Overall Study|Death|0
936873|NCT00965731|1923870|FG001|Overall Study|Death|4
936874|NCT00965731|1923869|FG000|Overall Study|Withdrawal by Subject|0
936875|NCT00965731|1923870|FG001|Overall Study|Withdrawal by Subject|1
936876|NCT00965731|1923869|FG000|Overall Study|Other|7
936877|NCT00965731|1923870|FG001|Overall Study|Other|15
936946|NCT00965848|1923894|FG000|Overall Study|Protocol Violation|3
936947|NCT00965848|1923895|FG001|Overall Study|Protocol Violation|0
936948|NCT00965848|1923896|FG002|Overall Study|Protocol Violation|1
936949|NCT00965848|1923894|FG000|Overall Study|Death|11
936950|NCT00965848|1923895|FG001|Overall Study|Death|1
936951|NCT00965848|1923896|FG002|Overall Study|Death|5
936952|NCT00965848|1923894|FG000|Overall Study|Lost to Follow-up|0
936953|NCT00965848|1923895|FG001|Overall Study|Lost to Follow-up|0
936954|NCT00965848|1923896|FG002|Overall Study|Lost to Follow-up|1
936955|NCT00965848|1923894|FG000|Overall Study|Withdrawal by Subject|1
936956|NCT00965848|1923895|FG001|Overall Study|Withdrawal by Subject|0
936957|NCT00965848|1923896|FG002|Overall Study|Withdrawal by Subject|0
936958|NCT00965848|1923894|FG000|Overall Study|Indeterminate Clinical Outcome|2
936959|NCT00965848|1923895|FG001|Overall Study|Indeterminate Clinical Outcome|0
936960|NCT00965848|1923896|FG002|Overall Study|Indeterminate Clinical Outcome|1
936961|NCT00965848|1923894|FG000|Overall Study|Not Clinically Evaluable|7
936962|NCT00965848|1923895|FG001|Overall Study|Not Clinically Evaluable|1
936963|NCT00965848|1923896|FG002|Overall Study|Not Clinically Evaluable|1
936964|NCT00965848|1923894|FG000|Overall Study|Other|5
936965|NCT00965848|1923895|FG001|Overall Study|Other|0
936966|NCT00965848|1923896|FG002|Overall Study|Other|1
936967|NCT00966264|1923940|FG000|Overall Study|Lost to Follow-up|4
936968|NCT00966264|1923941|FG001|Overall Study|Lost to Follow-up|3
936969|NCT00966277|1923949|FG000|Overall Study|Withdrawal by Subject|3
936970|NCT00966277|1923950|FG001|Overall Study|Withdrawal by Subject|0
936971|NCT00966277|1923949|FG000|Overall Study|Ineligible|1
936972|NCT00966277|1923950|FG001|Overall Study|Ineligible|3
936973|NCT00966277|1923949|FG000|Overall Study|Treatment Plan Changed|0
936974|NCT00966277|1923950|FG001|Overall Study|Treatment Plan Changed|1
936975|NCT00966355|1923959|FG000|Overall Study|non-variceal bleeding on endoscopy|68
936976|NCT00966355|1923960|FG001|Overall Study|non-variceal bleeding on endoscopy|70
936977|NCT00966355|1923961|FG002|Overall Study|non-variceal bleeding on endoscopy|71
936978|NCT00966355|1923959|FG000|Overall Study|newly diagnosed advanced HCC|11
936979|NCT00966355|1923960|FG001|Overall Study|newly diagnosed advanced HCC|12
936980|NCT00966355|1923961|FG002|Overall Study|newly diagnosed advanced HCC|10
936981|NCT00966355|1923959|FG000|Overall Study|Lost to Follow-up|5
936982|NCT00966355|1923960|FG001|Overall Study|Lost to Follow-up|4
936983|NCT00966355|1923961|FG002|Overall Study|Lost to Follow-up|3
936984|NCT00966693|1924017|FG000|Overall Study|Adverse Event|0
936985|NCT00966693|1924018|FG001|Overall Study|Adverse Event|0
936986|NCT00966693|1924019|FG002|Overall Study|Adverse Event|1
936987|NCT00966693|1924020|FG003|Overall Study|Adverse Event|2
936988|NCT00966693|1924017|FG000|Overall Study|Death|0
936989|NCT00966693|1924018|FG001|Overall Study|Death|0
936990|NCT00966693|1924019|FG002|Overall Study|Death|1
936991|NCT00966693|1924020|FG003|Overall Study|Death|0
936992|NCT00966693|1924017|FG000|Overall Study|Withdrawal by Subject|1
936993|NCT00966693|1924018|FG001|Overall Study|Withdrawal by Subject|0
936994|NCT00966693|1924019|FG002|Overall Study|Withdrawal by Subject|0
936995|NCT00966693|1924020|FG003|Overall Study|Withdrawal by Subject|5
936996|NCT00966693|1924017|FG000|Overall Study|Disease Progression|0
936997|NCT00966693|1924018|FG001|Overall Study|Disease Progression|0
936998|NCT00966693|1924019|FG002|Overall Study|Disease Progression|1
936999|NCT00966693|1924020|FG003|Overall Study|Disease Progression|16
937000|NCT00966719|1924032|FG000|Overall Study|Lost to Follow-up|6
937001|NCT00966719|1924033|FG001|Overall Study|Lost to Follow-up|11
937002|NCT00966875|1924065|FG000|Part A|Adverse Event|2
937003|NCT00966875|1924066|FG001|Part A|Adverse Event|1
937004|NCT00966875|1924067|FG002|Part A|Adverse Event|0
937005|NCT00966875|1924068|FG003|Part A|Adverse Event|1
937006|NCT00966875|1924069|FG004|Part A|Adverse Event|0
937007|NCT00966875|1924070|FG005|Part A|Adverse Event|1
937008|NCT00966875|1924071|FG006|Part A|Adverse Event|0
937009|NCT00966875|1924072|FG007|Part A|Adverse Event|3
937010|NCT00966875|1924073|FG008|Part A|Adverse Event|3
937011|NCT00966875|1924065|FG000|Part A|Entry Criteria|0
937012|NCT00966875|1924066|FG001|Part A|Entry Criteria|0
937013|NCT00966875|1924067|FG002|Part A|Entry Criteria|0
937014|NCT00966875|1924068|FG003|Part A|Entry Criteria|0
937015|NCT00966875|1924069|FG004|Part A|Entry Criteria|0
937016|NCT00966875|1924070|FG005|Part A|Entry Criteria|2
937017|NCT00966875|1924071|FG006|Part A|Entry Criteria|0
937018|NCT00966875|1924072|FG007|Part A|Entry Criteria|0
937019|NCT00966875|1924073|FG008|Part A|Entry Criteria|0
937020|NCT00966875|1924065|FG000|Part A|Lack of Efficacy|0
937021|NCT00966875|1924066|FG001|Part A|Lack of Efficacy|1
937022|NCT00966875|1924067|FG002|Part A|Lack of Efficacy|0
937023|NCT00966875|1924068|FG003|Part A|Lack of Efficacy|0
937024|NCT00966875|1924069|FG004|Part A|Lack of Efficacy|0
937025|NCT00966875|1924070|FG005|Part A|Lack of Efficacy|0
937026|NCT00966875|1924071|FG006|Part A|Lack of Efficacy|4
937027|NCT00966875|1924072|FG007|Part A|Lack of Efficacy|0
937028|NCT00966875|1924073|FG008|Part A|Lack of Efficacy|0
937029|NCT00966875|1924065|FG000|Part A|Lost to Follow-up|2
937030|NCT00966875|1924066|FG001|Part A|Lost to Follow-up|0
937031|NCT00966875|1924067|FG002|Part A|Lost to Follow-up|0
937032|NCT00966875|1924068|FG003|Part A|Lost to Follow-up|0
937033|NCT00966875|1924069|FG004|Part A|Lost to Follow-up|0
937034|NCT00966875|1924070|FG005|Part A|Lost to Follow-up|1
937035|NCT00966875|1924071|FG006|Part A|Lost to Follow-up|0
937036|NCT00966875|1924072|FG007|Part A|Lost to Follow-up|0
937037|NCT00966875|1924073|FG008|Part A|Lost to Follow-up|0
937038|NCT00966875|1924065|FG000|Part A|Parent/Caregiver Decision|0
937039|NCT00966875|1924066|FG001|Part A|Parent/Caregiver Decision|0
937040|NCT00966875|1924067|FG002|Part A|Parent/Caregiver Decision|0
937041|NCT00966875|1924068|FG003|Part A|Parent/Caregiver Decision|1
937042|NCT00966875|1924069|FG004|Part A|Parent/Caregiver Decision|0
937043|NCT00966875|1924070|FG005|Part A|Parent/Caregiver Decision|0
937044|NCT00966875|1924071|FG006|Part A|Parent/Caregiver Decision|0
937045|NCT00966875|1924072|FG007|Part A|Parent/Caregiver Decision|0
937046|NCT00966875|1924073|FG008|Part A|Parent/Caregiver Decision|0
937047|NCT00966875|1924065|FG000|Part A|Physician Decision|0
937048|NCT00966875|1924066|FG001|Part A|Physician Decision|0
937049|NCT00966875|1924067|FG002|Part A|Physician Decision|0
937050|NCT00966875|1924068|FG003|Part A|Physician Decision|0
937051|NCT00966875|1924069|FG004|Part A|Physician Decision|1
937052|NCT00966875|1924070|FG005|Part A|Physician Decision|0
937053|NCT00966875|1924071|FG006|Part A|Physician Decision|1
937054|NCT00966875|1924072|FG007|Part A|Physician Decision|0
937055|NCT00966875|1924073|FG008|Part A|Physician Decision|2
937056|NCT00966875|1924065|FG000|Part A|Sponsor Decision|0
937057|NCT00966875|1924066|FG001|Part A|Sponsor Decision|0
937058|NCT00966875|1924067|FG002|Part A|Sponsor Decision|1
937059|NCT00966875|1924068|FG003|Part A|Sponsor Decision|0
937060|NCT00966875|1924069|FG004|Part A|Sponsor Decision|1
937061|NCT00966875|1924070|FG005|Part A|Sponsor Decision|0
937062|NCT00966875|1924071|FG006|Part A|Sponsor Decision|0
937063|NCT00966875|1924072|FG007|Part A|Sponsor Decision|2
937064|NCT00966875|1924073|FG008|Part A|Sponsor Decision|1
937065|NCT00966875|1924065|FG000|Part A|Withdrawal by Subject|2
937066|NCT00966875|1924066|FG001|Part A|Withdrawal by Subject|2
937067|NCT00966875|1924067|FG002|Part A|Withdrawal by Subject|1
937068|NCT00966875|1924068|FG003|Part A|Withdrawal by Subject|1
937069|NCT00966875|1924069|FG004|Part A|Withdrawal by Subject|3
937070|NCT00966875|1924070|FG005|Part A|Withdrawal by Subject|0
937071|NCT00966875|1924071|FG006|Part A|Withdrawal by Subject|5
937072|NCT00966875|1924072|FG007|Part A|Withdrawal by Subject|1
937073|NCT00966875|1924073|FG008|Part A|Withdrawal by Subject|1
937074|NCT00966875|1924065|FG000|Part A|Protocol Violation|0
937075|NCT00966875|1924066|FG001|Part A|Protocol Violation|0
937076|NCT00966875|1924067|FG002|Part A|Protocol Violation|0
937077|NCT00966875|1924068|FG003|Part A|Protocol Violation|0
937078|NCT00966875|1924069|FG004|Part A|Protocol Violation|0
937079|NCT00966875|1924070|FG005|Part A|Protocol Violation|0
937080|NCT00966875|1924071|FG006|Part A|Protocol Violation|2
937081|NCT00966875|1924072|FG007|Part A|Protocol Violation|1
937082|NCT00966875|1924073|FG008|Part A|Protocol Violation|1
937083|NCT00966875|1924065|FG000|Part B|Adverse Event|0
937084|NCT00966875|1924066|FG001|Part B|Adverse Event|1
937085|NCT00966875|1924067|FG002|Part B|Adverse Event|1
937086|NCT00966875|1924068|FG003|Part B|Adverse Event|0
937087|NCT00966875|1924069|FG004|Part B|Adverse Event|1
937088|NCT00966875|1924070|FG005|Part B|Adverse Event|0
937089|NCT00966875|1924071|FG006|Part B|Adverse Event|5
937090|NCT00966875|1924072|FG007|Part B|Adverse Event|2
937091|NCT00966875|1924073|FG008|Part B|Adverse Event|2
937092|NCT00966875|1924065|FG000|Part B|Death|0
937093|NCT00966875|1924066|FG001|Part B|Death|0
937094|NCT00966875|1924067|FG002|Part B|Death|1
937095|NCT00966875|1924068|FG003|Part B|Death|0
937096|NCT00966875|1924069|FG004|Part B|Death|0
937097|NCT00966875|1924070|FG005|Part B|Death|0
937098|NCT00966875|1924071|FG006|Part B|Death|0
937099|NCT00966875|1924072|FG007|Part B|Death|1
937100|NCT00966875|1924073|FG008|Part B|Death|0
937101|NCT00966875|1924065|FG000|Part B|Lack of Efficacy|2
937102|NCT00966875|1924066|FG001|Part B|Lack of Efficacy|1
937103|NCT00966875|1924067|FG002|Part B|Lack of Efficacy|1
937104|NCT00966875|1924068|FG003|Part B|Lack of Efficacy|1
937105|NCT00966875|1924069|FG004|Part B|Lack of Efficacy|2
937106|NCT00966875|1924070|FG005|Part B|Lack of Efficacy|3
937107|NCT00966875|1924071|FG006|Part B|Lack of Efficacy|12
937108|NCT00966875|1924072|FG007|Part B|Lack of Efficacy|9
937109|NCT00966875|1924073|FG008|Part B|Lack of Efficacy|6
937110|NCT00966875|1924065|FG000|Part B|Lost to Follow-up|0
937111|NCT00966875|1924066|FG001|Part B|Lost to Follow-up|0
937112|NCT00966875|1924067|FG002|Part B|Lost to Follow-up|0
937113|NCT00966875|1924068|FG003|Part B|Lost to Follow-up|1
937114|NCT00966875|1924069|FG004|Part B|Lost to Follow-up|0
937115|NCT00966875|1924070|FG005|Part B|Lost to Follow-up|0
937116|NCT00966875|1924071|FG006|Part B|Lost to Follow-up|0
937117|NCT00966875|1924072|FG007|Part B|Lost to Follow-up|0
937118|NCT00966875|1924073|FG008|Part B|Lost to Follow-up|1
937119|NCT00966875|1924065|FG000|Part B|Physician Decision|0
937120|NCT00966875|1924066|FG001|Part B|Physician Decision|0
937121|NCT00966875|1924067|FG002|Part B|Physician Decision|1
937122|NCT00966875|1924068|FG003|Part B|Physician Decision|0
937123|NCT00966875|1924069|FG004|Part B|Physician Decision|2
937124|NCT00966875|1924070|FG005|Part B|Physician Decision|1
937125|NCT00966875|1924071|FG006|Part B|Physician Decision|0
937126|NCT00966875|1924072|FG007|Part B|Physician Decision|0
937127|NCT00966875|1924073|FG008|Part B|Physician Decision|2
937128|NCT00966875|1924065|FG000|Part B|Sponsor Decision|1
937129|NCT00966875|1924066|FG001|Part B|Sponsor Decision|0
937130|NCT00966875|1924067|FG002|Part B|Sponsor Decision|0
937131|NCT00966875|1924068|FG003|Part B|Sponsor Decision|0
937132|NCT00966875|1924069|FG004|Part B|Sponsor Decision|0
937133|NCT00966875|1924070|FG005|Part B|Sponsor Decision|1
937134|NCT00966875|1924071|FG006|Part B|Sponsor Decision|0
937135|NCT00966875|1924072|FG007|Part B|Sponsor Decision|2
937136|NCT00966875|1924073|FG008|Part B|Sponsor Decision|1
937137|NCT00966875|1924065|FG000|Part B|Withdrawal by Subject|2
937138|NCT00966875|1924066|FG001|Part B|Withdrawal by Subject|1
937139|NCT00966875|1924067|FG002|Part B|Withdrawal by Subject|2
937140|NCT00966875|1924068|FG003|Part B|Withdrawal by Subject|1
937141|NCT00966875|1924069|FG004|Part B|Withdrawal by Subject|2
937142|NCT00966875|1924070|FG005|Part B|Withdrawal by Subject|1
937143|NCT00966875|1924071|FG006|Part B|Withdrawal by Subject|4
937144|NCT00966875|1924072|FG007|Part B|Withdrawal by Subject|5
937145|NCT00966875|1924073|FG008|Part B|Withdrawal by Subject|5
937146|NCT00966875|1924065|FG000|Part B|Entry Criteria|0
937147|NCT00966875|1924066|FG001|Part B|Entry Criteria|0
937148|NCT00966875|1924067|FG002|Part B|Entry Criteria|0
937149|NCT00966875|1924068|FG003|Part B|Entry Criteria|0
937150|NCT00966875|1924069|FG004|Part B|Entry Criteria|0
937151|NCT00966875|1924070|FG005|Part B|Entry Criteria|0
937152|NCT00966875|1924071|FG006|Part B|Entry Criteria|1
937153|NCT00966875|1924072|FG007|Part B|Entry Criteria|0
937154|NCT00966875|1924073|FG008|Part B|Entry Criteria|1
937155|NCT00966940|1924148|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2
937156|NCT00966940|1924149|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0
937157|NCT00966940|1924148|FG000|Period 1, First 6 Weeks|Protocol Violation|1
937158|NCT00966940|1924149|FG001|Period 1, First 6 Weeks|Protocol Violation|0
937159|NCT00967005|1924170|FG000|Overall Study|Lost to Follow-up|7
937160|NCT00967005|1924171|FG001|Overall Study|Lost to Follow-up|10
937161|NCT00967018|1924177|FG000|Overall Study|Adverse Event|2
937162|NCT00967018|1924177|FG000|Overall Study|Physician Decision|7
937163|NCT00967018|1924177|FG000|Overall Study|Lost to Follow-up|2
937164|NCT00967018|1924177|FG000|Overall Study|Withdrawal by Subject|1
937165|NCT00967018|1924177|FG000|Overall Study|Miscellaneous Reasons|9
937166|NCT00967226|1924187|FG000|Overall Study|Adverse Event|0
937167|NCT00967226|1924188|FG001|Overall Study|Adverse Event|5
937168|NCT00967226|1924187|FG000|Overall Study|Protocol Violation|2
937169|NCT00967226|1924188|FG001|Overall Study|Protocol Violation|0
937170|NCT00967226|1924187|FG000|Overall Study|Physician Decision|0
937171|NCT00967226|1924188|FG001|Overall Study|Physician Decision|1
937172|NCT00967330|1924220|FG000|Overall Study|Protocol Violation|3
937173|NCT00967330|1924221|FG001|Overall Study|Protocol Violation|4
937174|NCT00967330|1924220|FG000|Overall Study|Regular|10
937175|NCT00967330|1924221|FG001|Overall Study|Regular|3
937176|NCT00967330|1924220|FG000|Overall Study|Withdrawal by Subject|6
937177|NCT00967330|1924221|FG001|Overall Study|Withdrawal by Subject|0
937178|NCT00967330|1924220|FG000|Overall Study|Lost to Follow-up|1
937179|NCT00967330|1924221|FG001|Overall Study|Lost to Follow-up|1
937180|NCT00967330|1924220|FG000|Overall Study|Death|102
937181|NCT00967330|1924221|FG001|Overall Study|Death|51
937182|NCT00967330|1924220|FG000|Overall Study|Severe protocol deviation|0
937183|NCT00967330|1924221|FG001|Overall Study|Severe protocol deviation|1
937184|NCT00967343|1924227|FG000|Overall Study|Study termination by sponsor|12
937185|NCT00967343|1924227|FG000|Overall Study|Death|24
937186|NCT00967343|1924227|FG000|Overall Study|Relapse|1
937187|NCT00967343|1924227|FG000|Overall Study|Lost to Follow-up|1
937188|NCT00967499|1924255|FG000|Overall Study|Adverse Event|0
937189|NCT00967499|1924256|FG001|Overall Study|Adverse Event|1
937190|NCT00967499|1924255|FG000|Overall Study|Protocol Violation|1
937191|NCT00967499|1924256|FG001|Overall Study|Protocol Violation|0
937192|NCT00967499|1924255|FG000|Overall Study|Sponsor Decision|1
937193|NCT00967499|1924256|FG001|Overall Study|Sponsor Decision|0
937194|NCT00967499|1924255|FG000|Overall Study|Randomized but not treated|63
937195|NCT00967499|1924256|FG001|Overall Study|Randomized but not treated|59
937196|NCT00967616|1924273|FG000|Overall Study|Adverse Event or Serious Adverse Event|2
937197|NCT00967616|1924274|FG001|Overall Study|Adverse Event or Serious Adverse Event|17
937198|NCT00967616|1924273|FG000|Overall Study|Death|0
937199|NCT00967616|1924274|FG001|Overall Study|Death|3
937200|NCT00967616|1924273|FG000|Overall Study|Withdrawal by Subject|8
937201|NCT00967616|1924274|FG001|Overall Study|Withdrawal by Subject|4
937202|NCT00967616|1924273|FG000|Overall Study|Progressive Disease|31
937203|NCT00967616|1924274|FG001|Overall Study|Progressive Disease|18
937204|NCT00967616|1924273|FG000|Overall Study|Other|8
937205|NCT00967616|1924274|FG001|Overall Study|Other|8
937206|NCT00967616|1924273|FG000|Overall Study|Protocol Violation|1
937207|NCT00967616|1924274|FG001|Overall Study|Protocol Violation|0
937208|NCT00967668|1924283|FG000|Overall Study|Withdrawal by Subject|13
937209|NCT00967668|1924284|FG001|Overall Study|Withdrawal by Subject|8
937210|NCT00967668|1924285|FG002|Overall Study|Withdrawal by Subject|8
937211|NCT00967668|1924283|FG000|Overall Study|Death|0
937212|NCT00967668|1924284|FG001|Overall Study|Death|2
937213|NCT00967668|1924285|FG002|Overall Study|Death|4
937214|NCT00967668|1924283|FG000|Overall Study|Removed due to behavior|1
937215|NCT00967668|1924284|FG001|Overall Study|Removed due to behavior|1
937216|NCT00967668|1924285|FG002|Overall Study|Removed due to behavior|2
937217|NCT00967668|1924283|FG000|Overall Study|Refused Year 2|11
937218|NCT00967668|1924284|FG001|Overall Study|Refused Year 2|6
937219|NCT00967668|1924285|FG002|Overall Study|Refused Year 2|4
937220|NCT00967668|1924283|FG000|Overall Study|Lost to follow-up at 12-mo|27
937221|NCT00967668|1924284|FG001|Overall Study|Lost to follow-up at 12-mo|29
937222|NCT00967668|1924285|FG002|Overall Study|Lost to follow-up at 12-mo|26
937223|NCT00967668|1924283|FG000|Overall Study|Lost to Follow-up|15
937224|NCT00967668|1924284|FG001|Overall Study|Lost to Follow-up|9
937225|NCT00967668|1924285|FG002|Overall Study|Lost to Follow-up|16
937226|NCT00967668|1924283|FG000|Overall Study|Refused 12-mo assessment|3
937227|NCT00967668|1924284|FG001|Overall Study|Refused 12-mo assessment|1
937228|NCT00967668|1924285|FG002|Overall Study|Refused 12-mo assessment|9
937229|NCT00967668|1924283|FG000|Overall Study|Pregnancy|1
937230|NCT00967668|1924284|FG001|Overall Study|Pregnancy|0
937231|NCT00967668|1924285|FG002|Overall Study|Pregnancy|0
937232|NCT00967694|1924296|FG000|Overall Study|Withdrawal by Subject|6
937233|NCT00967798|1924302|FG000|Overall Study|Withdrawal by Subject|5
937234|NCT00967798|1924303|FG001|Overall Study|Withdrawal by Subject|2
937235|NCT00967798|1924302|FG000|Overall Study|Lost to Follow-up|4
937236|NCT00967798|1924303|FG001|Overall Study|Lost to Follow-up|1
937237|NCT00968149|1924340|FG000|Overall Study|Adverse Event|5
937238|NCT00968149|1924341|FG001|Overall Study|Adverse Event|1
937239|NCT00968149|1924340|FG000|Overall Study|Lack of Efficacy|0
937240|NCT00968149|1924341|FG001|Overall Study|Lack of Efficacy|4
937241|NCT00968149|1924340|FG000|Overall Study|Lost to Follow-up|0
937242|NCT00968149|1924341|FG001|Overall Study|Lost to Follow-up|1
937243|NCT00968149|1924340|FG000|Overall Study|Protocol Violation|4
937244|NCT00968149|1924341|FG001|Overall Study|Protocol Violation|0
937245|NCT00968149|1924340|FG000|Overall Study|Withdrawal by Subject|2
937246|NCT00968149|1924341|FG001|Overall Study|Withdrawal by Subject|0
937247|NCT00968201|1924349|FG000|Base Study - (Period II)|Adverse Event|8
937248|NCT00968201|1924350|FG001|Base Study - (Period II)|Adverse Event|0
937249|NCT00968201|1924351|FG002|Base Study - (Period II)|Adverse Event|16
937250|NCT00968201|1924349|FG000|Base Study - (Period II)|Lack of Efficacy|0
937251|NCT00968201|1924350|FG001|Base Study - (Period II)|Lack of Efficacy|0
937252|NCT00968201|1924351|FG002|Base Study - (Period II)|Lack of Efficacy|1
937253|NCT00968201|1924349|FG000|Base Study - (Period II)|Lost to Follow-up|2
937254|NCT00968201|1924350|FG001|Base Study - (Period II)|Lost to Follow-up|0
937255|NCT00968201|1924351|FG002|Base Study - (Period II)|Lost to Follow-up|7
937256|NCT00968201|1924349|FG000|Base Study - (Period II)|Protocol Violation|12
937257|NCT00968201|1924350|FG001|Base Study - (Period II)|Protocol Violation|0
937258|NCT00968201|1924351|FG002|Base Study - (Period II)|Protocol Violation|12
937259|NCT00968201|1924349|FG000|Base Study - (Period II)|Withdrawal by Subject|4
937260|NCT00968201|1924350|FG001|Base Study - (Period II)|Withdrawal by Subject|0
937261|NCT00968201|1924351|FG002|Base Study - (Period II)|Withdrawal by Subject|8
937262|NCT00968201|1924349|FG000|Base Study - (Period II)|Site Error|0
937263|NCT00968201|1924350|FG001|Base Study - (Period II)|Site Error|0
937264|NCT00968201|1924351|FG002|Base Study - (Period II)|Site Error|1
937265|NCT00968201|1924349|FG000|Extension Study - (Period III)|Adverse Event|0
937266|NCT00968201|1924350|FG001|Extension Study - (Period III)|Adverse Event|5
937267|NCT00968201|1924351|FG002|Extension Study - (Period III)|Adverse Event|22
937268|NCT00968201|1924349|FG000|Extension Study - (Period III)|Lost to Follow-up|0
937269|NCT00968201|1924350|FG001|Extension Study - (Period III)|Lost to Follow-up|7
937270|NCT00968201|1924351|FG002|Extension Study - (Period III)|Lost to Follow-up|13
937271|NCT00968201|1924349|FG000|Extension Study - (Period III)|Protocol Violation|0
937272|NCT00968201|1924350|FG001|Extension Study - (Period III)|Protocol Violation|17
937273|NCT00968201|1924351|FG002|Extension Study - (Period III)|Protocol Violation|14
937274|NCT00968201|1924349|FG000|Extension Study - (Period III)|Withdrawal by Subject|0
937275|NCT00968201|1924350|FG001|Extension Study - (Period III)|Withdrawal by Subject|20
937276|NCT00968201|1924351|FG002|Extension Study - (Period III)|Withdrawal by Subject|40
937277|NCT00968201|1924349|FG000|Extension Study - (Period III)|Patient Relocated|0
937278|NCT00968201|1924350|FG001|Extension Study - (Period III)|Patient Relocated|1
937279|NCT00968201|1924351|FG002|Extension Study - (Period III)|Patient Relocated|1
937280|NCT00968201|1924349|FG000|Extension Study - (Period III)|Noncompliance|0
937281|NCT00968201|1924350|FG001|Extension Study - (Period III)|Noncompliance|0
937282|NCT00968201|1924351|FG002|Extension Study - (Period III)|Noncompliance|3
937283|NCT00968201|1924349|FG000|Extension Study - (Period III)|Other|0
937284|NCT00968201|1924350|FG001|Extension Study - (Period III)|Other|0
937285|NCT00968201|1924351|FG002|Extension Study - (Period III)|Other|2
937286|NCT00968201|1924349|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
937287|NCT00968201|1924350|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
937288|NCT00968201|1924351|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
937289|NCT00968253|1924367|FG000|Overall Study|Death|0
937290|NCT00968253|1924368|FG001|Overall Study|Death|0
937291|NCT00968253|1924369|FG002|Overall Study|Death|2
937292|NCT00968253|1924367|FG000|Overall Study|Withdrawal by Subject|0
937293|NCT00968253|1924368|FG001|Overall Study|Withdrawal by Subject|0
937294|NCT00968253|1924369|FG002|Overall Study|Withdrawal by Subject|1
937295|NCT00968253|1924367|FG000|Overall Study|Disease Progression|0
937296|NCT00968253|1924368|FG001|Overall Study|Disease Progression|3
937297|NCT00968253|1924369|FG002|Overall Study|Disease Progression|3
937298|NCT00968253|1924367|FG000|Overall Study|Adverse Event|0
937299|NCT00968253|1924368|FG001|Overall Study|Adverse Event|0
937300|NCT00968253|1924369|FG002|Overall Study|Adverse Event|1
937301|NCT00968526|1924389|FG000|Overall Study|Adverse Event|2
937302|NCT00968526|1924390|FG001|Overall Study|Adverse Event|0
937303|NCT00968526|1924389|FG000|Overall Study|Migrated/moved from study area|1
937304|NCT00968526|1924390|FG001|Overall Study|Migrated/moved from study area|0
937305|NCT00968539|1924407|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1
937306|NCT00968539|1924408|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
937307|NCT00968617|1924415|FG000|Overall Study|Study terminated by sponsor|6
937308|NCT00968669|1924423|FG000|Overall Study|Lost to Follow-up|5
937309|NCT00968669|1924424|FG001|Overall Study|Lost to Follow-up|2
937310|NCT00968669|1924425|FG002|Overall Study|Lost to Follow-up|1
937311|NCT00968669|1924426|FG003|Overall Study|Lost to Follow-up|4
937312|NCT00968669|1924423|FG000|Overall Study|Withdrawal by Subject|9
937313|NCT00968669|1924424|FG001|Overall Study|Withdrawal by Subject|7
937314|NCT00968669|1924425|FG002|Overall Study|Withdrawal by Subject|5
937315|NCT00968669|1924426|FG003|Overall Study|Withdrawal by Subject|3
937316|NCT00968669|1924423|FG000|Overall Study|Pregnancy|0
937317|NCT00968669|1924424|FG001|Overall Study|Pregnancy|0
937318|NCT00968669|1924425|FG002|Overall Study|Pregnancy|2
937319|NCT00968669|1924426|FG003|Overall Study|Pregnancy|0
937320|NCT00968669|1924423|FG000|Overall Study|AE|1
937321|NCT00968669|1924424|FG001|Overall Study|AE|0
937322|NCT00968669|1924425|FG002|Overall Study|AE|0
937323|NCT00968669|1924426|FG003|Overall Study|AE|0
937324|NCT00968669|1924423|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
937325|NCT00968669|1924424|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
937326|NCT00968669|1924425|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
937327|NCT00968669|1924426|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
937328|NCT00968669|1924423|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
937329|NCT00968669|1924424|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
937330|NCT00968669|1924425|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
937331|NCT00968669|1924426|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
937332|NCT00968669|1924423|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
937333|NCT00968669|1924424|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
937334|NCT00968669|1924425|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
937335|NCT00968669|1924426|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
937336|NCT00968669|1924423|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
937337|NCT00968669|1924424|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
937338|NCT00968669|1924425|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
937339|NCT00968669|1924426|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
937340|NCT00968669|1924423|FG000|Overall Study|EARLY WITHDRAWAL|0
937341|NCT00968669|1924424|FG001|Overall Study|EARLY WITHDRAWAL|1
937342|NCT00968669|1924425|FG002|Overall Study|EARLY WITHDRAWAL|0
937343|NCT00968669|1924426|FG003|Overall Study|EARLY WITHDRAWAL|0
937344|NCT00968669|1924423|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0
937345|NCT00968669|1924424|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0
937346|NCT00968669|1924425|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1
937347|NCT00968669|1924426|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0
937348|NCT00968669|1924423|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1
937349|NCT00968669|1924424|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0
937350|NCT00968669|1924425|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0
937351|NCT00968669|1924426|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0
937352|NCT00968669|1924423|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
937353|NCT00968669|1924424|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
937354|NCT00968669|1924425|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
937355|NCT00968669|1924426|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
937356|NCT00968669|1924423|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
937357|NCT00968669|1924424|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
937358|NCT00968669|1924425|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
937359|NCT00968669|1924426|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
937360|NCT00968669|1924423|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
937361|NCT00968669|1924424|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
937362|NCT00968669|1924425|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
937363|NCT00968669|1924426|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
937364|NCT00968669|1924423|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0
937365|NCT00968669|1924424|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1
937366|NCT00968669|1924425|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0
937367|NCT00968669|1924426|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0
937368|NCT00968669|1924423|FG000|Overall Study|SPONSOR DECISION|0
937369|NCT00968669|1924424|FG001|Overall Study|SPONSOR DECISION|1
937370|NCT00968669|1924425|FG002|Overall Study|SPONSOR DECISION|0
937371|NCT00968669|1924426|FG003|Overall Study|SPONSOR DECISION|0
937372|NCT00968669|1924423|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
937373|NCT00968669|1924424|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
937374|NCT00968669|1924425|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
937375|NCT00968669|1924426|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
937376|NCT00968669|1924423|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
937377|NCT00968669|1924424|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
937378|NCT00968669|1924425|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
937379|NCT00968669|1924426|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
937380|NCT00968669|1924423|FG000|Overall Study|SUBJECT INCARCERATED|0
937381|NCT00968669|1924424|FG001|Overall Study|SUBJECT INCARCERATED|1
937382|NCT00968669|1924425|FG002|Overall Study|SUBJECT INCARCERATED|0
937383|NCT00968669|1924426|FG003|Overall Study|SUBJECT INCARCERATED|0
937384|NCT00968669|1924423|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
937385|NCT00968669|1924424|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
937386|NCT00968669|1924425|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
937387|NCT00968669|1924426|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
937388|NCT00968669|1924423|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
937389|NCT00968669|1924424|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
937390|NCT00968669|1924425|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
937391|NCT00968669|1924426|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
937392|NCT00968708|1924438|FG000|Overall Study|Adverse Event|169
937393|NCT00968708|1924439|FG001|Overall Study|Adverse Event|150
937394|NCT00968708|1924438|FG000|Overall Study|Major Protocol Deviation|0
937395|NCT00968708|1924439|FG001|Overall Study|Major Protocol Deviation|1
937396|NCT00968708|1924438|FG000|Overall Study|Lost to Follow-up|19
937397|NCT00968708|1924439|FG001|Overall Study|Lost to Follow-up|11
937398|NCT00968708|1924438|FG000|Overall Study|Voluntary Withdrawal|104
937399|NCT00968708|1924439|FG001|Overall Study|Voluntary Withdrawal|101
937400|NCT00968708|1924438|FG000|Overall Study|Investigator Discretion|0
937401|NCT00968708|1924439|FG001|Overall Study|Investigator Discretion|1
937402|NCT00968708|1924438|FG000|Overall Study|Other|26
937403|NCT00968708|1924439|FG001|Overall Study|Other|34
937404|NCT00968799|1924445|FG000|Overall Study|Advanced disease, HIPEC not applicable|2
937405|NCT00968812|1924452|FG000|Overall Study|Adverse Event|30
937406|NCT00968812|1924453|FG001|Overall Study|Adverse Event|46
937407|NCT00968812|1924454|FG002|Overall Study|Adverse Event|33
937408|NCT00968812|1924452|FG000|Overall Study|Death|2
937409|NCT00968812|1924453|FG001|Overall Study|Death|2
937410|NCT00968812|1924454|FG002|Overall Study|Death|1
937411|NCT00968812|1924452|FG000|Overall Study|Lack of Efficacy|9
937412|NCT00968812|1924453|FG001|Overall Study|Lack of Efficacy|7
937413|NCT00968812|1924454|FG002|Overall Study|Lack of Efficacy|16
937414|NCT00968812|1924452|FG000|Overall Study|Lost to Follow-up|17
937415|NCT00968812|1924453|FG001|Overall Study|Lost to Follow-up|12
937416|NCT00968812|1924454|FG002|Overall Study|Lost to Follow-up|11
937417|NCT00968812|1924452|FG000|Overall Study|Physician Decision|8
937418|NCT00968812|1924453|FG001|Overall Study|Physician Decision|5
937419|NCT00968812|1924454|FG002|Overall Study|Physician Decision|9
937420|NCT00968812|1924452|FG000|Overall Study|Protocol Violation|7
937421|NCT00968812|1924453|FG001|Overall Study|Protocol Violation|4
937422|NCT00968812|1924454|FG002|Overall Study|Protocol Violation|3
937423|NCT00968812|1924452|FG000|Overall Study|Withdrawal by Subject|17
937424|NCT00968812|1924453|FG001|Overall Study|Withdrawal by Subject|23
937425|NCT00968812|1924454|FG002|Overall Study|Withdrawal by Subject|25
937426|NCT00968812|1924452|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9
937427|NCT00968812|1924453|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13
937428|NCT00968812|1924454|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7
937429|NCT00968812|1924452|FG000|Overall Study|Noncompliance with study drug|4
937430|NCT00968812|1924453|FG001|Overall Study|Noncompliance with study drug|1
937431|NCT00968812|1924454|FG002|Overall Study|Noncompliance with study drug|6
937432|NCT00968812|1924452|FG000|Overall Study|Unable to take rescue therapy|12
937433|NCT00968812|1924453|FG001|Overall Study|Unable to take rescue therapy|12
937434|NCT00968812|1924454|FG002|Overall Study|Unable to take rescue therapy|17
937435|NCT00968812|1924452|FG000|Overall Study|Other|25
937436|NCT00968812|1924453|FG001|Overall Study|Other|37
937437|NCT00968812|1924454|FG002|Overall Study|Other|40
937438|NCT00968864|1924474|FG000|Overall Study|Protocol exception/ not evaluable|1
937439|NCT00968968|1924494|FG000|Overall Study|Study closed/terminated|10
937440|NCT00968968|1924495|FG001|Overall Study|Study closed/terminated|10
937441|NCT00968968|1924494|FG000|Overall Study|Protocol defined stopping criteria|3
937442|NCT00968968|1924495|FG001|Overall Study|Protocol defined stopping criteria|1
937443|NCT00968968|1924494|FG000|Overall Study|Withdrawal by Subject|2
937444|NCT00968968|1924495|FG001|Overall Study|Withdrawal by Subject|0
937445|NCT00968968|1924494|FG000|Overall Study|Physician Decision|1
937446|NCT00968968|1924495|FG001|Overall Study|Physician Decision|2
937447|NCT00968968|1924494|FG000|Overall Study|Lost to Follow-up|0
937448|NCT00968968|1924495|FG001|Overall Study|Lost to Follow-up|1
937449|NCT00968981|1924505|FG000|Overall Study|Adverse Event|2
937450|NCT00968981|1924506|FG001|Overall Study|Adverse Event|0
937451|NCT00968981|1924507|FG002|Overall Study|Adverse Event|0
937452|NCT00968981|1924505|FG000|Overall Study|Disease Progression|14
937453|NCT00968981|1924506|FG001|Overall Study|Disease Progression|16
937454|NCT00968981|1924507|FG002|Overall Study|Disease Progression|13
937455|NCT00968981|1924505|FG000|Overall Study|Lost to Follow-up|0
937456|NCT00968981|1924506|FG001|Overall Study|Lost to Follow-up|0
937457|NCT00968981|1924507|FG002|Overall Study|Lost to Follow-up|1
937458|NCT00968981|1924505|FG000|Overall Study|Physician Decision|5
937459|NCT00968981|1924506|FG001|Overall Study|Physician Decision|3
937460|NCT00968981|1924507|FG002|Overall Study|Physician Decision|5
937461|NCT00968981|1924505|FG000|Overall Study|Withdrawal by Subject|1
937462|NCT00968981|1924506|FG001|Overall Study|Withdrawal by Subject|3
937463|NCT00968981|1924507|FG002|Overall Study|Withdrawal by Subject|3
937464|NCT00969124|1924516|FG000|Overall Study|Protocol Violation|2
937465|NCT00969124|1924516|FG000|Overall Study|Inadequate bowel preparation|15
937466|NCT00969124|1924516|FG000|Overall Study|Inability to reach cecum|9
937467|NCT00969124|1924516|FG000|Overall Study|Previously unrecognized disease|3
937468|NCT00969124|1924516|FG000|Overall Study|Technical error|1
937469|NCT00969150|1924523|FG000|Overall Study|Adverse Event|4
937470|NCT00969150|1924524|FG001|Overall Study|Adverse Event|14
937471|NCT00969150|1924523|FG000|Overall Study|Lack of Efficacy|1
937472|NCT00969150|1924524|FG001|Overall Study|Lack of Efficacy|1
937473|NCT00969150|1924523|FG000|Overall Study|Protocol Violation|9
937474|NCT00969150|1924524|FG001|Overall Study|Protocol Violation|12
937475|NCT00969150|1924523|FG000|Overall Study|Withdrawal by Subject|13
937476|NCT00969150|1924524|FG001|Overall Study|Withdrawal by Subject|9
937477|NCT00969150|1924523|FG000|Overall Study|Lost to Follow-up|5
937478|NCT00969150|1924524|FG001|Overall Study|Lost to Follow-up|4
937479|NCT00969150|1924523|FG000|Overall Study|Other reasons|1
937480|NCT00969150|1924524|FG001|Overall Study|Other reasons|0
937481|NCT00969228|1924532|FG000|Overall Study|Adverse Event|1
937482|NCT00969228|1924533|FG001|Overall Study|Adverse Event|0
937483|NCT00969228|1924532|FG000|Overall Study|Withdrawal by Subject|4
937484|NCT00969228|1924533|FG001|Overall Study|Withdrawal by Subject|0
937485|NCT00969228|1924532|FG000|Overall Study|Porcine circovirus detection in vaccine|38
937486|NCT00969228|1924533|FG001|Overall Study|Porcine circovirus detection in vaccine|14
937487|NCT00969280|1924541|FG000|Overall Study|Protocol Violation|2
937488|NCT00969280|1924542|FG001|Overall Study|Protocol Violation|1
937489|NCT00969280|1924541|FG000|Overall Study|Withdrawal by Subject|0
937490|NCT00969280|1924542|FG001|Overall Study|Withdrawal by Subject|1
937491|NCT00969280|1924541|FG000|Overall Study|infection of influenza A(H1N1)|0
937492|NCT00969280|1924542|FG001|Overall Study|infection of influenza A(H1N1)|1
937493|NCT00969332|1924548|FG000|Overall Study|Physician Decision|8
937494|NCT00969332|1924548|FG000|Overall Study|Withdrawal by Subject|3
937495|NCT00969436|1924556|FG000|Overall Study|Protocol Violation|1
937496|NCT00969436|1924557|FG001|Overall Study|Protocol Violation|3
937497|NCT00969436|1924558|FG002|Overall Study|Protocol Violation|0
937498|NCT00969436|1924556|FG000|Overall Study|Migrated/moved from study area|12
937499|NCT00969436|1924557|FG001|Overall Study|Migrated/moved from study area|10
937500|NCT00969436|1924558|FG002|Overall Study|Migrated/moved from study area|2
937501|NCT00969436|1924556|FG000|Overall Study|Father - serious health problem|0
937502|NCT00969436|1924557|FG001|Overall Study|Father - serious health problem|0
937503|NCT00969436|1924558|FG002|Overall Study|Father - serious health problem|1
937504|NCT00969436|1924556|FG000|Overall Study|Parents personal problem|0
937505|NCT00969436|1924557|FG001|Overall Study|Parents personal problem|0
937506|NCT00969436|1924558|FG002|Overall Study|Parents personal problem|1
937507|NCT00969436|1924556|FG000|Overall Study|Subject eliminated (other vaccine)|1
937508|NCT00969436|1924557|FG001|Overall Study|Subject eliminated (other vaccine)|0
937509|NCT00969436|1924558|FG002|Overall Study|Subject eliminated (other vaccine)|0
937510|NCT00969436|1924556|FG000|Overall Study|Withdrawal by Subject|3
937511|NCT00969436|1924557|FG001|Overall Study|Withdrawal by Subject|0
937512|NCT00969436|1924558|FG002|Overall Study|Withdrawal by Subject|2
937513|NCT00969436|1924556|FG000|Overall Study|Lost to Follow-up|8
937514|NCT00969436|1924557|FG001|Overall Study|Lost to Follow-up|8
937515|NCT00969436|1924558|FG002|Overall Study|Lost to Follow-up|5
937516|NCT00969540|1924572|FG000|Overall Study|Lost to Follow-up|1
937517|NCT00969540|1924573|FG001|Overall Study|Lost to Follow-up|1
937518|NCT00969553|1924600|FG000|Overall Study|Progressive disease (PD)|2
937519|NCT00969553|1924601|FG001|Overall Study|Progressive disease (PD)|2
937520|NCT00969553|1924602|FG002|Overall Study|Progressive disease (PD)|6
937521|NCT00969553|1924603|FG003|Overall Study|Progressive disease (PD)|9
937522|NCT00969553|1924604|FG004|Overall Study|Progressive disease (PD)|2
937523|NCT00969553|1924605|FG005|Overall Study|Progressive disease (PD)|4
937524|NCT00969553|1924606|FG006|Overall Study|Progressive disease (PD)|2
937525|NCT00969553|1924607|FG007|Overall Study|Progressive disease (PD)|12
937526|NCT00969553|1924608|FG008|Overall Study|Progressive disease (PD)|3
937527|NCT00969553|1924600|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
937528|NCT00969553|1924601|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
937529|NCT00969553|1924602|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
937530|NCT00969553|1924603|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
937531|NCT00969553|1924604|FG004|Overall Study|Dose limiting Toxicity (DLT)|1
937532|NCT00969553|1924605|FG005|Overall Study|Dose limiting Toxicity (DLT)|0
937533|NCT00969553|1924606|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
937534|NCT00969553|1924607|FG007|Overall Study|Dose limiting Toxicity (DLT)|0
937535|NCT00969553|1924608|FG008|Overall Study|Dose limiting Toxicity (DLT)|0
937536|NCT00969553|1924600|FG000|Overall Study|Other Adverse Event|0
937537|NCT00969553|1924601|FG001|Overall Study|Other Adverse Event|0
937538|NCT00969553|1924602|FG002|Overall Study|Other Adverse Event|0
937539|NCT00969553|1924603|FG003|Overall Study|Other Adverse Event|1
937540|NCT00969553|1924604|FG004|Overall Study|Other Adverse Event|0
937541|NCT00969553|1924605|FG005|Overall Study|Other Adverse Event|0
937542|NCT00969553|1924606|FG006|Overall Study|Other Adverse Event|1
937543|NCT00969553|1924607|FG007|Overall Study|Other Adverse Event|0
937544|NCT00969553|1924608|FG008|Overall Study|Other Adverse Event|0
937545|NCT00969553|1924600|FG000|Overall Study|Refused cont. medication|1
937546|NCT00969553|1924601|FG001|Overall Study|Refused cont. medication|1
937547|NCT00969553|1924602|FG002|Overall Study|Refused cont. medication|0
937548|NCT00969553|1924603|FG003|Overall Study|Refused cont. medication|2
937549|NCT00969553|1924604|FG004|Overall Study|Refused cont. medication|0
937550|NCT00969553|1924605|FG005|Overall Study|Refused cont. medication|0
937551|NCT00969553|1924606|FG006|Overall Study|Refused cont. medication|0
937552|NCT00969553|1924607|FG007|Overall Study|Refused cont. medication|1
937553|NCT00969553|1924608|FG008|Overall Study|Refused cont. medication|0
937554|NCT00969553|1924600|FG000|Overall Study|Not specified above|0
937555|NCT00969553|1924601|FG001|Overall Study|Not specified above|0
937556|NCT00969553|1924602|FG002|Overall Study|Not specified above|0
937557|NCT00969553|1924603|FG003|Overall Study|Not specified above|4
937558|NCT00969553|1924604|FG004|Overall Study|Not specified above|0
937559|NCT00969553|1924605|FG005|Overall Study|Not specified above|0
937560|NCT00969553|1924606|FG006|Overall Study|Not specified above|1
937561|NCT00969553|1924607|FG007|Overall Study|Not specified above|1
937562|NCT00969553|1924608|FG008|Overall Study|Not specified above|0
937563|NCT00969618|1924636|FG000|Overall Study|Adverse Event|29
937564|NCT00969618|1924636|FG000|Overall Study|Entry Criteria Not Met|3
937565|NCT00969618|1924636|FG000|Overall Study|Lack of Efficacy|2
937566|NCT00969618|1924636|FG000|Overall Study|Lost to Follow-up|7
937567|NCT00969618|1924636|FG000|Overall Study|Physician Decision|1
937568|NCT00969618|1924636|FG000|Overall Study|Protocol Violation|9
937569|NCT00969618|1924636|FG000|Overall Study|Withdrawal by Subject|27
937570|NCT00969709|1924644|FG000|Overall Study|Adverse Event|3
937571|NCT00969709|1924645|FG001|Overall Study|Adverse Event|13
937572|NCT00969709|1924646|FG002|Overall Study|Adverse Event|26
937573|NCT00969709|1924647|FG003|Overall Study|Adverse Event|12
937574|NCT00969709|1924644|FG000|Overall Study|Lack of Efficacy|7
937575|NCT00969709|1924645|FG001|Overall Study|Lack of Efficacy|4
937576|NCT00969709|1924646|FG002|Overall Study|Lack of Efficacy|1
937577|NCT00969709|1924647|FG003|Overall Study|Lack of Efficacy|3
937578|NCT00969709|1924644|FG000|Overall Study|Protocol Violation|9
937579|NCT00969709|1924645|FG001|Overall Study|Protocol Violation|5
937580|NCT00969709|1924646|FG002|Overall Study|Protocol Violation|9
937581|NCT00969709|1924647|FG003|Overall Study|Protocol Violation|10
937582|NCT00969709|1924644|FG000|Overall Study|Withdrawal by Subject|9
937583|NCT00969709|1924645|FG001|Overall Study|Withdrawal by Subject|12
937584|NCT00969709|1924646|FG002|Overall Study|Withdrawal by Subject|11
937585|NCT00969709|1924647|FG003|Overall Study|Withdrawal by Subject|23
937586|NCT00969709|1924644|FG000|Overall Study|Lost to Follow-up|10
937587|NCT00969709|1924645|FG001|Overall Study|Lost to Follow-up|14
937588|NCT00969709|1924646|FG002|Overall Study|Lost to Follow-up|8
937589|NCT00969709|1924647|FG003|Overall Study|Lost to Follow-up|15
937590|NCT00969709|1924644|FG000|Overall Study|Other reasons|0
937591|NCT00969709|1924645|FG001|Overall Study|Other reasons|0
937592|NCT00969709|1924646|FG002|Overall Study|Other reasons|3
937593|NCT00969709|1924647|FG003|Overall Study|Other reasons|0
937594|NCT00969761|1924673|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
937595|NCT00969761|1924674|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
937596|NCT00969761|1924675|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
937597|NCT00969761|1924676|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
937598|NCT00969761|1924677|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
937599|NCT00969761|1924678|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
937600|NCT00969761|1924679|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
937601|NCT00969761|1924680|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
937602|NCT00969761|1924681|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
937603|NCT00969761|1924682|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
937604|NCT00969761|1924683|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
937605|NCT00969761|1924684|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
937606|NCT00969761|1924673|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
937607|NCT00969761|1924674|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
937608|NCT00969761|1924675|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
937609|NCT00969761|1924676|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
937610|NCT00969761|1924677|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
937611|NCT00969761|1924678|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
937612|NCT00969761|1924679|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
937613|NCT00969761|1924680|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
937614|NCT00969761|1924681|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
937615|NCT00969761|1924682|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
937616|NCT00969761|1924683|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
937617|NCT00969761|1924684|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
937618|NCT00969761|1924673|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
937619|NCT00969761|1924674|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
937620|NCT00969761|1924675|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
937621|NCT00969761|1924676|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
937622|NCT00969761|1924677|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
937623|NCT00969761|1924678|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
937624|NCT00969761|1924679|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
937625|NCT00969761|1924680|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
937626|NCT00969761|1924681|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
937627|NCT00969761|1924682|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
937628|NCT00969761|1924683|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
937629|NCT00969761|1924684|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
937630|NCT00969761|1924673|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
937631|NCT00969761|1924674|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
937632|NCT00969761|1924675|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
937633|NCT00969761|1924676|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
937634|NCT00969761|1924677|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
937635|NCT00969761|1924678|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
937636|NCT00969761|1924679|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
937637|NCT00969761|1924680|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
937638|NCT00969761|1924681|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
937639|NCT00969761|1924682|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
937640|NCT00969761|1924683|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
937641|NCT00969761|1924684|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
937642|NCT00969761|1924673|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
937643|NCT00969761|1924674|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
937644|NCT00969761|1924675|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
937645|NCT00969761|1924676|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
937646|NCT00969761|1924677|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
937647|NCT00969761|1924678|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
937648|NCT00969761|1924679|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
937649|NCT00969761|1924680|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
937650|NCT00969761|1924681|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
937651|NCT00969761|1924682|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
937652|NCT00969761|1924683|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
937653|NCT00969761|1924684|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
937654|NCT00969761|1924673|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
937655|NCT00969761|1924674|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
937656|NCT00969761|1924675|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
937657|NCT00969761|1924676|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
937658|NCT00969761|1924677|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
937659|NCT00969761|1924678|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
937660|NCT00969761|1924679|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
937661|NCT00969761|1924680|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
937662|NCT00969761|1924681|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
937663|NCT00969761|1924682|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
937664|NCT00969761|1924683|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
937665|NCT00969761|1924684|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
937666|NCT00970268|1924749|FG000|Overall Study|Withdrawal by Subject|12
937667|NCT00970268|1924750|FG001|Overall Study|Withdrawal by Subject|19
937668|NCT00970268|1924749|FG000|Overall Study|Adverse Event|15
937669|NCT00970268|1924750|FG001|Overall Study|Adverse Event|12
937670|NCT00970268|1924749|FG000|Overall Study|Lack of Efficacy|3
937671|NCT00970268|1924750|FG001|Overall Study|Lack of Efficacy|6
937672|NCT00970268|1924749|FG000|Overall Study|Protocol Violation|4
937673|NCT00970268|1924750|FG001|Overall Study|Protocol Violation|7
937674|NCT00970268|1924749|FG000|Overall Study|Other Reason|3
937675|NCT00970268|1924750|FG001|Overall Study|Other Reason|1
937676|NCT00970268|1924749|FG000|Overall Study|COPD Exacerbation|4
937677|NCT00970268|1924750|FG001|Overall Study|COPD Exacerbation|2
937678|NCT00970268|1924749|FG000|Overall Study|Lost to Follow-up|1
937679|NCT00970268|1924750|FG001|Overall Study|Lost to Follow-up|2
937680|NCT00970268|1924749|FG000|Overall Study|Inclusion/Exclusion Criteria|1
937681|NCT00970268|1924750|FG001|Overall Study|Inclusion/Exclusion Criteria|0
937682|NCT00970281|1924764|FG000|Overall Study|Lack of Efficacy|1
937683|NCT00970281|1924765|FG001|Overall Study|Lack of Efficacy|14
937684|NCT00970281|1924764|FG000|Overall Study|Withdrawal by Subject|0
937685|NCT00970281|1924765|FG001|Overall Study|Withdrawal by Subject|1
937686|NCT00970281|1924764|FG000|Overall Study|Physician Decision|1
937687|NCT00970281|1924765|FG001|Overall Study|Physician Decision|1
937688|NCT00970294|1924771|FG000|Overall Study|Physician Decision|4
937689|NCT00970294|1924771|FG000|Overall Study|Withdrawal by Subject|1
937690|NCT00970307|1924778|FG000|Overall Study|Serious Adverse Event|1
937691|NCT00970307|1924779|FG001|Overall Study|Serious Adverse Event|0
937692|NCT00970307|1924780|FG002|Overall Study|Serious Adverse Event|0
937693|NCT00970307|1924778|FG000|Overall Study|Withdrawal by Subject|2
937694|NCT00970307|1924779|FG001|Overall Study|Withdrawal by Subject|3
937695|NCT00970307|1924780|FG002|Overall Study|Withdrawal by Subject|2
937696|NCT00970359|1924809|FG000|Overall Study|Not Treated|4
937697|NCT00970489|1924815|FG000|Overall Study|Death/Withdrew/Criteria Violation|54
937698|NCT00970489|1924816|FG001|Overall Study|Death/Withdrew/Criteria Violation|41
937699|NCT00970502|1924822|FG000|Overall Study|Withdrawal by Subject|1
937700|NCT00970593|1924837|FG000|Overall Study|Adverse Event|1
937701|NCT00970593|1924838|FG001|Overall Study|Adverse Event|1
937702|NCT00970593|1924839|FG002|Overall Study|Adverse Event|0
937703|NCT00970593|1924840|FG003|Overall Study|Adverse Event|0
937704|NCT00970593|1924841|FG004|Overall Study|Adverse Event|0
937705|NCT00970593|1924842|FG005|Overall Study|Adverse Event|0
937706|NCT00970593|1924843|FG006|Overall Study|Adverse Event|0
937707|NCT00970593|1924837|FG000|Overall Study|Discontinuation of study by sponsor|0
937708|NCT00970593|1924838|FG001|Overall Study|Discontinuation of study by sponsor|0
937709|NCT00970593|1924839|FG002|Overall Study|Discontinuation of study by sponsor|5
937710|NCT00970593|1924840|FG003|Overall Study|Discontinuation of study by sponsor|0
937711|NCT00970593|1924841|FG004|Overall Study|Discontinuation of study by sponsor|0
937712|NCT00970593|1924842|FG005|Overall Study|Discontinuation of study by sponsor|0
937713|NCT00970593|1924843|FG006|Overall Study|Discontinuation of study by sponsor|2
937714|NCT00970593|1924837|FG000|Overall Study|Withdrawal by Subject|0
937715|NCT00970593|1924838|FG001|Overall Study|Withdrawal by Subject|0
937716|NCT00970593|1924839|FG002|Overall Study|Withdrawal by Subject|1
937717|NCT00970593|1924840|FG003|Overall Study|Withdrawal by Subject|0
937718|NCT00970593|1924841|FG004|Overall Study|Withdrawal by Subject|0
937719|NCT00970593|1924842|FG005|Overall Study|Withdrawal by Subject|0
937720|NCT00970593|1924843|FG006|Overall Study|Withdrawal by Subject|0
937721|NCT00970632|1924866|FG000|Overall Study|Adverse Event|2
937722|NCT00970632|1924867|FG001|Overall Study|Adverse Event|2
937723|NCT00970632|1924868|FG002|Overall Study|Adverse Event|1
937724|NCT00970632|1924866|FG000|Overall Study|Lack of Efficacy|3
937725|NCT00970632|1924867|FG001|Overall Study|Lack of Efficacy|0
937726|NCT00970632|1924868|FG002|Overall Study|Lack of Efficacy|0
937727|NCT00970632|1924866|FG000|Overall Study|Lost to Follow-up|3
937728|NCT00970632|1924867|FG001|Overall Study|Lost to Follow-up|0
937729|NCT00970632|1924868|FG002|Overall Study|Lost to Follow-up|2
937730|NCT00970632|1924866|FG000|Overall Study|Protocol Violation|8
937731|NCT00970632|1924867|FG001|Overall Study|Protocol Violation|5
937732|NCT00970632|1924868|FG002|Overall Study|Protocol Violation|8
937733|NCT00970632|1924866|FG000|Overall Study|Withdrawal by Subject|7
937734|NCT00970632|1924867|FG001|Overall Study|Withdrawal by Subject|6
937735|NCT00970632|1924868|FG002|Overall Study|Withdrawal by Subject|4
937736|NCT00970632|1924866|FG000|Overall Study|Entry criteria not met|0
937737|NCT00970632|1924867|FG001|Overall Study|Entry criteria not met|2
937738|NCT00970632|1924868|FG002|Overall Study|Entry criteria not met|2
937739|NCT00970632|1924866|FG000|Overall Study|Sponsor decision|1
937740|NCT00970632|1924867|FG001|Overall Study|Sponsor decision|0
937741|NCT00970632|1924868|FG002|Overall Study|Sponsor decision|1
937742|NCT00970684|1924876|FG000|Overall Study|Lack of Efficacy|5
937743|NCT00970684|1924876|FG000|Overall Study|Adverse Event|4
937744|NCT00970684|1924876|FG000|Overall Study|Withdrawal by Subject|1
937745|NCT00970944|1924900|FG000|Overall Study|Death|1
937746|NCT00970944|1924901|FG001|Overall Study|Death|0
937747|NCT00970944|1924900|FG000|Overall Study|Physician Decision|0
937748|NCT00970944|1924901|FG001|Overall Study|Physician Decision|2
937749|NCT00971048|1924912|FG000|Overall Study|Protocol Violation|1
937750|NCT00971048|1924913|FG001|Overall Study|Protocol Violation|2
937751|NCT00971048|1924914|FG002|Overall Study|Protocol Violation|0
937752|NCT00971048|1924915|FG003|Overall Study|Protocol Violation|1
937753|NCT00971048|1924912|FG000|Overall Study|Adverse Event|0
937754|NCT00971048|1924913|FG001|Overall Study|Adverse Event|0
937755|NCT00971048|1924914|FG002|Overall Study|Adverse Event|1
937756|NCT00971048|1924915|FG003|Overall Study|Adverse Event|0
937757|NCT00971048|1924912|FG000|Overall Study|Physician Decision|0
937758|NCT00971048|1924913|FG001|Overall Study|Physician Decision|0
937759|NCT00971048|1924914|FG002|Overall Study|Physician Decision|0
937760|NCT00971048|1924915|FG003|Overall Study|Physician Decision|1
937761|NCT00971178|1924930|FG000|Overall Study|Lost to Follow-up|2
937762|NCT00971178|1924931|FG001|Overall Study|Lost to Follow-up|2
937763|NCT00971178|1924932|FG002|Overall Study|Lost to Follow-up|2
937764|NCT00971204|1924940|FG000|Overall Study|Did not meet all criteria-not treated|14
937765|NCT00971204|1924940|FG000|Overall Study|Lost to Follow-up|10
937766|NCT00971243|1924949|FG000|Double Blind Period|Adverse Event|2
937767|NCT00971243|1924950|FG001|Double Blind Period|Adverse Event|3
937768|NCT00971243|1924951|FG002|Double Blind Period|Adverse Event|2
937769|NCT00971243|1924952|FG003|Double Blind Period|Adverse Event|2
937770|NCT00971243|1924953|FG004|Double Blind Period|Adverse Event|3
937771|NCT00971243|1924949|FG000|Double Blind Period|Lost to Follow-up|0
937772|NCT00971243|1924950|FG001|Double Blind Period|Lost to Follow-up|1
937773|NCT00971243|1924951|FG002|Double Blind Period|Lost to Follow-up|1
937774|NCT00971243|1924952|FG003|Double Blind Period|Lost to Follow-up|0
937775|NCT00971243|1924953|FG004|Double Blind Period|Lost to Follow-up|1
937776|NCT00971243|1924949|FG000|Double Blind Period|Physician Decision|10
937777|NCT00971243|1924950|FG001|Double Blind Period|Physician Decision|6
937778|NCT00971243|1924951|FG002|Double Blind Period|Physician Decision|7
937779|NCT00971243|1924952|FG003|Double Blind Period|Physician Decision|6
937780|NCT00971243|1924953|FG004|Double Blind Period|Physician Decision|7
937781|NCT00971243|1924949|FG000|Double Blind Period|Protocol Violation|2
937782|NCT00971243|1924950|FG001|Double Blind Period|Protocol Violation|0
937783|NCT00971243|1924951|FG002|Double Blind Period|Protocol Violation|3
937784|NCT00971243|1924952|FG003|Double Blind Period|Protocol Violation|2
937785|NCT00971243|1924953|FG004|Double Blind Period|Protocol Violation|2
937786|NCT00971243|1924949|FG000|Double Blind Period|Withdrawal by Subject|4
937787|NCT00971243|1924950|FG001|Double Blind Period|Withdrawal by Subject|1
937788|NCT00971243|1924951|FG002|Double Blind Period|Withdrawal by Subject|4
937789|NCT00971243|1924952|FG003|Double Blind Period|Withdrawal by Subject|4
937790|NCT00971243|1924953|FG004|Double Blind Period|Withdrawal by Subject|4
937791|NCT00971243|1924949|FG000|Double Blind Period|Other reasons|1
937792|NCT00971243|1924950|FG001|Double Blind Period|Other reasons|0
937793|NCT00971243|1924951|FG002|Double Blind Period|Other reasons|2
937794|NCT00971243|1924952|FG003|Double Blind Period|Other reasons|0
937795|NCT00971243|1924953|FG004|Double Blind Period|Other reasons|1
937796|NCT00971243|1924949|FG000|Open-label Period|Adverse Event|1
937797|NCT00971243|1924950|FG001|Open-label Period|Adverse Event|0
937798|NCT00971243|1924951|FG002|Open-label Period|Adverse Event|1
937799|NCT00971243|1924952|FG003|Open-label Period|Adverse Event|1
937800|NCT00971243|1924953|FG004|Open-label Period|Adverse Event|0
937801|NCT00971243|1924949|FG000|Open-label Period|Physician Decision|5
937802|NCT00971243|1924950|FG001|Open-label Period|Physician Decision|9
937803|NCT00971243|1924951|FG002|Open-label Period|Physician Decision|3
937804|NCT00971243|1924952|FG003|Open-label Period|Physician Decision|7
937805|NCT00971243|1924953|FG004|Open-label Period|Physician Decision|2
937806|NCT00971243|1924949|FG000|Open-label Period|Protocol Violation|1
937807|NCT00971243|1924950|FG001|Open-label Period|Protocol Violation|1
937808|NCT00971243|1924951|FG002|Open-label Period|Protocol Violation|1
937809|NCT00971243|1924952|FG003|Open-label Period|Protocol Violation|0
937810|NCT00971243|1924953|FG004|Open-label Period|Protocol Violation|1
937811|NCT00971243|1924949|FG000|Open-label Period|Withdrawal by Subject|1
937812|NCT00971243|1924950|FG001|Open-label Period|Withdrawal by Subject|0
937813|NCT00971243|1924951|FG002|Open-label Period|Withdrawal by Subject|0
937814|NCT00971243|1924952|FG003|Open-label Period|Withdrawal by Subject|2
937815|NCT00971243|1924953|FG004|Open-label Period|Withdrawal by Subject|1
937816|NCT00971243|1924949|FG000|Open-label Period|Other reason|0
937817|NCT00971243|1924950|FG001|Open-label Period|Other reason|0
937818|NCT00971243|1924951|FG002|Open-label Period|Other reason|0
937819|NCT00971243|1924952|FG003|Open-label Period|Other reason|0
937820|NCT00971243|1924953|FG004|Open-label Period|Other reason|2
937821|NCT00971321|1924980|FG000|Up to Month 7|Withdrawal by Subject|1
937822|NCT00971321|1924981|FG001|Up to Month 7|Withdrawal by Subject|0
937823|NCT00971321|1924980|FG000|Up to Month 7|Migrated/moved from study area|3
937824|NCT00971321|1924981|FG001|Up to Month 7|Migrated/moved from study area|2
937825|NCT00971321|1924980|FG000|Up to Month 11-12|Withdrawal by Subject|2
937826|NCT00971321|1924981|FG001|Up to Month 11-12|Withdrawal by Subject|1
937827|NCT00971321|1924980|FG000|Up to Month 11-12|Migrated/moved from study area|2
937828|NCT00971321|1924981|FG001|Up to Month 11-12|Migrated/moved from study area|2
937829|NCT00971321|1924980|FG000|Up to Month 11-12|Lost to Follow-up|1
937830|NCT00971321|1924981|FG001|Up to Month 11-12|Lost to Follow-up|0
937831|NCT00971425|1924989|FG000|Overall Study|Adverse Event|1
937832|NCT00971425|1924990|FG001|Overall Study|Adverse Event|1
937833|NCT00971425|1924989|FG000|Overall Study|Withdrawal by Subject|0
937834|NCT00971425|1924990|FG001|Overall Study|Withdrawal by Subject|1
937835|NCT00971932|1925041|FG000|Overall Study|Withdrawal by Subject|1
937836|NCT00971932|1925041|FG000|Overall Study|Investigator's decision|2
937837|NCT00971932|1925041|FG000|Overall Study|Ongoing|4
937838|NCT00971945|1925045|FG000|Overall Study|Progressive Disease|3
937839|NCT00971945|1925045|FG000|Overall Study|Change in treatment policy|1
937840|NCT00971945|1925045|FG000|Overall Study|Other reasons|2
937841|NCT00971997|1925049|FG000|Overall Study|Adverse Event|2
937842|NCT00971997|1925049|FG000|Overall Study|Death|1
937843|NCT00971997|1925049|FG000|Overall Study|Protocol Violation|4
937844|NCT00971997|1925049|FG000|Overall Study|Withdrawal by Subject|5
937845|NCT00971997|1925049|FG000|Overall Study|Physician Decision|7
937846|NCT00972153|1925063|FG000|Overall Study|Equipment malfunction during case|0
937847|NCT00972153|1925064|FG001|Overall Study|Equipment malfunction during case|1
937848|NCT00972153|1925065|FG002|Overall Study|Equipment malfunction during case|0
937849|NCT00972244|1925082|FG000|Overall Study|Incorrect Enrolment|1
937850|NCT00972244|1925083|FG001|Overall Study|Incorrect Enrolment|0
937851|NCT00972244|1925084|FG002|Overall Study|Incorrect Enrolment|0
937852|NCT00972244|1925085|FG003|Overall Study|Incorrect Enrolment|0
937853|NCT00972244|1925086|FG004|Overall Study|Incorrect Enrolment|0
937854|NCT00972244|1925082|FG000|Overall Study|Adverse Event|0
937855|NCT00972244|1925083|FG001|Overall Study|Adverse Event|1
937856|NCT00972244|1925084|FG002|Overall Study|Adverse Event|1
937857|NCT00972244|1925085|FG003|Overall Study|Adverse Event|0
937858|NCT00972244|1925086|FG004|Overall Study|Adverse Event|0
937859|NCT00972244|1925082|FG000|Overall Study|Subject No Longer Meets Study Criteria|2
937860|NCT00972244|1925083|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
937861|NCT00972244|1925084|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
937862|NCT00972244|1925085|FG003|Overall Study|Subject No Longer Meets Study Criteria|0
937863|NCT00972244|1925086|FG004|Overall Study|Subject No Longer Meets Study Criteria|5
937864|NCT00972244|1925082|FG000|Overall Study|Withdrawal by Subject|1
937865|NCT00972244|1925083|FG001|Overall Study|Withdrawal by Subject|2
937866|NCT00972244|1925084|FG002|Overall Study|Withdrawal by Subject|1
937867|NCT00972244|1925085|FG003|Overall Study|Withdrawal by Subject|0
937868|NCT00972244|1925086|FG004|Overall Study|Withdrawal by Subject|1
937869|NCT00972244|1925082|FG000|Overall Study|Safety|0
937870|NCT00972244|1925083|FG001|Overall Study|Safety|0
937871|NCT00972244|1925084|FG002|Overall Study|Safety|0
937872|NCT00972244|1925085|FG003|Overall Study|Safety|0
937873|NCT00972244|1925086|FG004|Overall Study|Safety|1
937874|NCT00972244|1925082|FG000|Overall Study|Death|1
937875|NCT00972244|1925083|FG001|Overall Study|Death|0
937876|NCT00972244|1925084|FG002|Overall Study|Death|0
937877|NCT00972244|1925085|FG003|Overall Study|Death|0
937878|NCT00972244|1925086|FG004|Overall Study|Death|0
937879|NCT00972244|1925082|FG000|Overall Study|Various|0
937880|NCT00972244|1925083|FG001|Overall Study|Various|0
937881|NCT00972244|1925084|FG002|Overall Study|Various|0
937882|NCT00972244|1925085|FG003|Overall Study|Various|0
937883|NCT00972244|1925086|FG004|Overall Study|Various|2
937884|NCT00972283|1925100|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
937885|NCT00972283|1925101|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
937886|NCT00972283|1925100|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
937887|NCT00972283|1925101|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
937888|NCT00972283|1925100|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
937889|NCT00972283|1925101|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
937890|NCT00972283|1925100|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
937891|NCT00972283|1925101|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
937892|NCT00972283|1925100|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
937893|NCT00972283|1925101|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
937894|NCT00972283|1925100|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
937895|NCT00972283|1925101|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
937896|NCT00972283|1925100|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
937897|NCT00972283|1925101|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
937898|NCT00972283|1925100|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
937899|NCT00972283|1925101|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
937900|NCT00972283|1925100|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
937901|NCT00972283|1925101|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
937902|NCT00972283|1925100|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
937903|NCT00972283|1925101|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
937904|NCT00972322|1925109|FG000|Overall Study|Adverse Event|2
937905|NCT00972322|1925110|FG001|Overall Study|Adverse Event|1
937906|NCT00972322|1925109|FG000|Overall Study|Positive drug screen|0
937907|NCT00972322|1925110|FG001|Overall Study|Positive drug screen|1
937908|NCT00972322|1925109|FG000|Overall Study|Lost to Follow-up|0
937909|NCT00972322|1925110|FG001|Overall Study|Lost to Follow-up|1
937910|NCT00972322|1925109|FG000|Overall Study|Consistently high glucose values|1
937911|NCT00972322|1925110|FG001|Overall Study|Consistently high glucose values|0
937912|NCT00972478|1925144|FG000|Overall Study|Adverse Event|3
937913|NCT00972478|1925145|FG001|Overall Study|Adverse Event|16
937914|NCT00972478|1925144|FG000|Overall Study|Withdrawal by Subject|1
937915|NCT00972478|1925145|FG001|Overall Study|Withdrawal by Subject|8
937916|NCT00972478|1925144|FG000|Overall Study|Progression/Relapse|0
937917|NCT00972478|1925145|FG001|Overall Study|Progression/Relapse|2
937918|NCT00972478|1925144|FG000|Overall Study|Death|0
937919|NCT00972478|1925145|FG001|Overall Study|Death|2
937920|NCT00972478|1925144|FG000|Overall Study|Not protocol specified|1
937921|NCT00972478|1925145|FG001|Overall Study|Not protocol specified|1
937922|NCT00972478|1925144|FG000|Overall Study|Ineligible|1
937923|NCT00972478|1925145|FG001|Overall Study|Ineligible|7
937924|NCT00972478|1925144|FG000|Overall Study|Not start protocol treatment|1
937925|NCT00972478|1925145|FG001|Overall Study|Not start protocol treatment|2
937926|NCT00972504|1925152|FG000|Overall Study|Adverse Event|2
937927|NCT00972504|1925152|FG000|Overall Study|Investigator discretion|1
937928|NCT00972517|1925162|FG000|Overall Study|Adverse Event|0
937929|NCT00972517|1925163|FG001|Overall Study|Adverse Event|0
937930|NCT00972517|1925164|FG002|Overall Study|Adverse Event|0
937931|NCT00972517|1925165|FG003|Overall Study|Adverse Event|1
937932|NCT00972517|1925166|FG004|Overall Study|Adverse Event|0
937933|NCT00972517|1925167|FG005|Overall Study|Adverse Event|0
937934|NCT00972517|1925162|FG000|Overall Study|Withdrawal by Subject|0
937935|NCT00972517|1925163|FG001|Overall Study|Withdrawal by Subject|1
937936|NCT00972517|1925164|FG002|Overall Study|Withdrawal by Subject|0
937937|NCT00972517|1925165|FG003|Overall Study|Withdrawal by Subject|2
937938|NCT00972517|1925166|FG004|Overall Study|Withdrawal by Subject|1
937939|NCT00972517|1925167|FG005|Overall Study|Withdrawal by Subject|0
937940|NCT00972543|1925198|FG000|Overall Study|Adverse Event|1
937941|NCT00972543|1925199|FG001|Overall Study|Adverse Event|0
937942|NCT00972543|1925198|FG000|Overall Study|Early study termination by sponsor|4
937943|NCT00972543|1925199|FG001|Overall Study|Early study termination by sponsor|1
937944|NCT00972595|1925205|FG000|Period 1|Adverse Event|1
937945|NCT00972595|1925206|FG001|Period 1|Adverse Event|0
937946|NCT00972738|1925233|FG000|Overall Study|Adverse Event|7
937947|NCT00972738|1925234|FG001|Overall Study|Adverse Event|1
937948|NCT00972738|1925235|FG002|Overall Study|Adverse Event|8
937949|NCT00972738|1925233|FG000|Overall Study|Protocol Violation|2
937950|NCT00972738|1925234|FG001|Overall Study|Protocol Violation|1
937951|NCT00972738|1925235|FG002|Overall Study|Protocol Violation|3
937952|NCT00972738|1925233|FG000|Overall Study|Lost to Follow-up|1
937953|NCT00972738|1925234|FG001|Overall Study|Lost to Follow-up|0
937954|NCT00972738|1925235|FG002|Overall Study|Lost to Follow-up|1
937955|NCT00972738|1925233|FG000|Overall Study|Lack of Efficacy|5
937956|NCT00972738|1925234|FG001|Overall Study|Lack of Efficacy|1
937957|NCT00972738|1925235|FG002|Overall Study|Lack of Efficacy|11
937958|NCT00972738|1925233|FG000|Overall Study|Withdrawal by Subject|5
937959|NCT00972738|1925234|FG001|Overall Study|Withdrawal by Subject|1
937960|NCT00972738|1925235|FG002|Overall Study|Withdrawal by Subject|4
937961|NCT00972738|1925233|FG000|Overall Study|Moved|0
937962|NCT00972738|1925234|FG001|Overall Study|Moved|0
937963|NCT00972738|1925235|FG002|Overall Study|Moved|1
937964|NCT00972738|1925233|FG000|Overall Study|Other|1
937965|NCT00972738|1925234|FG001|Overall Study|Other|2
937966|NCT00972738|1925235|FG002|Overall Study|Other|1
937967|NCT00972777|1925245|FG000|Overall Study|Adverse Event|3
937968|NCT00972777|1925246|FG001|Overall Study|Adverse Event|2
937969|NCT00972777|1925245|FG000|Overall Study|Lost to Follow-up|0
937970|NCT00972777|1925246|FG001|Overall Study|Lost to Follow-up|4
937971|NCT00972777|1925245|FG000|Overall Study|Withdrawal by Subject|4
937972|NCT00972777|1925246|FG001|Overall Study|Withdrawal by Subject|5
937973|NCT00972777|1925245|FG000|Overall Study|Physician Decision|4
937974|NCT00972777|1925246|FG001|Overall Study|Physician Decision|0
937975|NCT00972777|1925245|FG000|Overall Study|Protocol Violation|0
937976|NCT00972777|1925246|FG001|Overall Study|Protocol Violation|2
937977|NCT00972777|1925245|FG000|Overall Study|Screening Failure|2
937978|NCT00972777|1925246|FG001|Overall Study|Screening Failure|1
937979|NCT00972777|1925245|FG000|Overall Study|Missed visit|1
937980|NCT00972777|1925246|FG001|Overall Study|Missed visit|0
937981|NCT00972816|1925260|FG000|Overall Study|Adverse Event|0
937982|NCT00972816|1925261|FG001|Overall Study|Adverse Event|0
937983|NCT00972816|1925262|FG002|Overall Study|Adverse Event|1
937984|NCT00972816|1925263|FG003|Overall Study|Adverse Event|0
937985|NCT00972816|1925264|FG004|Overall Study|Adverse Event|0
937986|NCT00972816|1925265|FG005|Overall Study|Adverse Event|0
937987|NCT00972816|1925266|FG006|Overall Study|Adverse Event|0
937988|NCT00972816|1925267|FG007|Overall Study|Adverse Event|0
937989|NCT00972816|1925260|FG000|Overall Study|Withdrawal by Subject|4
937990|NCT00972816|1925261|FG001|Overall Study|Withdrawal by Subject|2
937991|NCT00972816|1925262|FG002|Overall Study|Withdrawal by Subject|1
937992|NCT00972816|1925263|FG003|Overall Study|Withdrawal by Subject|3
937993|NCT00972816|1925264|FG004|Overall Study|Withdrawal by Subject|0
937994|NCT00972816|1925265|FG005|Overall Study|Withdrawal by Subject|1
937995|NCT00972816|1925266|FG006|Overall Study|Withdrawal by Subject|1
937996|NCT00972816|1925267|FG007|Overall Study|Withdrawal by Subject|2
937997|NCT00972816|1925260|FG000|Overall Study|Lost to Follow-up|11
937998|NCT00972816|1925261|FG001|Overall Study|Lost to Follow-up|9
937999|NCT00972816|1925262|FG002|Overall Study|Lost to Follow-up|7
938000|NCT00972816|1925263|FG003|Overall Study|Lost to Follow-up|5
938001|NCT00972816|1925264|FG004|Overall Study|Lost to Follow-up|11
938002|NCT00972816|1925265|FG005|Overall Study|Lost to Follow-up|10
938003|NCT00972816|1925266|FG006|Overall Study|Lost to Follow-up|7
938004|NCT00972816|1925267|FG007|Overall Study|Lost to Follow-up|7
938005|NCT00972816|1925260|FG000|Overall Study|Inappropriate enrolment|0
938006|NCT00972816|1925261|FG001|Overall Study|Inappropriate enrolment|0
938007|NCT00972816|1925262|FG002|Overall Study|Inappropriate enrolment|0
938008|NCT00972816|1925263|FG003|Overall Study|Inappropriate enrolment|0
938009|NCT00972816|1925264|FG004|Overall Study|Inappropriate enrolment|0
938010|NCT00972816|1925265|FG005|Overall Study|Inappropriate enrolment|0
938011|NCT00972816|1925266|FG006|Overall Study|Inappropriate enrolment|2
938012|NCT00972816|1925267|FG007|Overall Study|Inappropriate enrolment|0
938013|NCT00972816|1925260|FG000|Overall Study|Unable to classify|2
938014|NCT00972816|1925261|FG001|Overall Study|Unable to classify|0
938015|NCT00972816|1925262|FG002|Overall Study|Unable to classify|0
938016|NCT00972816|1925263|FG003|Overall Study|Unable to classify|0
938017|NCT00972816|1925264|FG004|Overall Study|Unable to classify|1
938018|NCT00972816|1925265|FG005|Overall Study|Unable to classify|0
938019|NCT00972816|1925266|FG006|Overall Study|Unable to classify|0
938020|NCT00972816|1925267|FG007|Overall Study|Unable to classify|0
938021|NCT00973102|1925291|FG000|Overall Study|Protocol Violation|1
938022|NCT00973102|1925292|FG001|Overall Study|Protocol Violation|0
938023|NCT00973102|1925291|FG000|Overall Study|Prisoner|0
938024|NCT00973102|1925292|FG001|Overall Study|Prisoner|1
938025|NCT00973349|1925314|FG000|Overall Study|Adverse Event|0
938026|NCT00973349|1925315|FG001|Overall Study|Adverse Event|0
938027|NCT00973349|1925316|FG002|Overall Study|Adverse Event|0
938028|NCT00973349|1925317|FG003|Overall Study|Adverse Event|0
938029|NCT00973349|1925318|FG004|Overall Study|Adverse Event|1
938030|NCT00973349|1925319|FG005|Overall Study|Adverse Event|0
938031|NCT00973349|1925320|FG006|Overall Study|Adverse Event|0
938032|NCT00973349|1925321|FG007|Overall Study|Adverse Event|0
938033|NCT00973349|1925322|FG008|Overall Study|Adverse Event|1
938034|NCT00973349|1925323|FG009|Overall Study|Adverse Event|0
938035|NCT00973349|1925324|FG010|Overall Study|Adverse Event|0
938036|NCT00973349|1925325|FG011|Overall Study|Adverse Event|0
938037|NCT00973349|1925326|FG012|Overall Study|Adverse Event|0
938038|NCT00973349|1925327|FG013|Overall Study|Adverse Event|0
938039|NCT00973349|1925328|FG014|Overall Study|Adverse Event|1
938040|NCT00973349|1925329|FG015|Overall Study|Adverse Event|0
938041|NCT00973349|1925314|FG000|Overall Study|Withdrawal by Subject|1
938042|NCT00973349|1925315|FG001|Overall Study|Withdrawal by Subject|2
938043|NCT00973349|1925316|FG002|Overall Study|Withdrawal by Subject|2
938044|NCT00973349|1925317|FG003|Overall Study|Withdrawal by Subject|3
938045|NCT00973349|1925318|FG004|Overall Study|Withdrawal by Subject|2
938046|NCT00973349|1925319|FG005|Overall Study|Withdrawal by Subject|0
938047|NCT00973349|1925320|FG006|Overall Study|Withdrawal by Subject|2
938048|NCT00973349|1925321|FG007|Overall Study|Withdrawal by Subject|2
938049|NCT00973349|1925322|FG008|Overall Study|Withdrawal by Subject|0
938050|NCT00973349|1925323|FG009|Overall Study|Withdrawal by Subject|2
938051|NCT00973349|1925324|FG010|Overall Study|Withdrawal by Subject|0
938052|NCT00973349|1925325|FG011|Overall Study|Withdrawal by Subject|1
938053|NCT00973349|1925326|FG012|Overall Study|Withdrawal by Subject|0
938054|NCT00973349|1925327|FG013|Overall Study|Withdrawal by Subject|0
938055|NCT00973349|1925328|FG014|Overall Study|Withdrawal by Subject|0
938056|NCT00973349|1925329|FG015|Overall Study|Withdrawal by Subject|0
938057|NCT00973349|1925314|FG000|Overall Study|Lost to Follow-up|3
938058|NCT00973349|1925315|FG001|Overall Study|Lost to Follow-up|1
938059|NCT00973349|1925316|FG002|Overall Study|Lost to Follow-up|2
938060|NCT00973349|1925317|FG003|Overall Study|Lost to Follow-up|2
938061|NCT00973349|1925318|FG004|Overall Study|Lost to Follow-up|1
938062|NCT00973349|1925319|FG005|Overall Study|Lost to Follow-up|3
938063|NCT00973349|1925320|FG006|Overall Study|Lost to Follow-up|0
938064|NCT00973349|1925321|FG007|Overall Study|Lost to Follow-up|1
938065|NCT00973349|1925322|FG008|Overall Study|Lost to Follow-up|2
938066|NCT00973349|1925323|FG009|Overall Study|Lost to Follow-up|1
938067|NCT00973349|1925324|FG010|Overall Study|Lost to Follow-up|0
938068|NCT00973349|1925325|FG011|Overall Study|Lost to Follow-up|1
938069|NCT00973349|1925326|FG012|Overall Study|Lost to Follow-up|0
938070|NCT00973349|1925327|FG013|Overall Study|Lost to Follow-up|0
938071|NCT00973349|1925328|FG014|Overall Study|Lost to Follow-up|0
938072|NCT00973349|1925329|FG015|Overall Study|Lost to Follow-up|1
938073|NCT00973349|1925314|FG000|Overall Study|Inappropriate enrolment|0
938074|NCT00973349|1925315|FG001|Overall Study|Inappropriate enrolment|0
938075|NCT00973349|1925316|FG002|Overall Study|Inappropriate enrolment|1
938076|NCT00973349|1925317|FG003|Overall Study|Inappropriate enrolment|0
938077|NCT00973349|1925318|FG004|Overall Study|Inappropriate enrolment|0
938078|NCT00973349|1925319|FG005|Overall Study|Inappropriate enrolment|0
938079|NCT00973349|1925320|FG006|Overall Study|Inappropriate enrolment|0
938080|NCT00973349|1925321|FG007|Overall Study|Inappropriate enrolment|0
938081|NCT00973349|1925322|FG008|Overall Study|Inappropriate enrolment|0
938082|NCT00973349|1925323|FG009|Overall Study|Inappropriate enrolment|2
938083|NCT00973349|1925324|FG010|Overall Study|Inappropriate enrolment|0
938084|NCT00973349|1925325|FG011|Overall Study|Inappropriate enrolment|0
938085|NCT00973349|1925326|FG012|Overall Study|Inappropriate enrolment|1
938086|NCT00973349|1925327|FG013|Overall Study|Inappropriate enrolment|0
938087|NCT00973349|1925328|FG014|Overall Study|Inappropriate enrolment|1
938088|NCT00973349|1925329|FG015|Overall Study|Inappropriate enrolment|1
938089|NCT00973349|1925314|FG000|Overall Study|Protocol Violation|0
938090|NCT00973349|1925315|FG001|Overall Study|Protocol Violation|0
938091|NCT00973349|1925316|FG002|Overall Study|Protocol Violation|0
938092|NCT00973349|1925317|FG003|Overall Study|Protocol Violation|0
938093|NCT00973349|1925318|FG004|Overall Study|Protocol Violation|0
938094|NCT00973349|1925319|FG005|Overall Study|Protocol Violation|0
938095|NCT00973349|1925320|FG006|Overall Study|Protocol Violation|0
938096|NCT00973349|1925321|FG007|Overall Study|Protocol Violation|0
938097|NCT00973349|1925322|FG008|Overall Study|Protocol Violation|1
938098|NCT00973349|1925323|FG009|Overall Study|Protocol Violation|0
938099|NCT00973349|1925324|FG010|Overall Study|Protocol Violation|0
938100|NCT00973349|1925325|FG011|Overall Study|Protocol Violation|0
938101|NCT00973349|1925326|FG012|Overall Study|Protocol Violation|0
938102|NCT00973349|1925327|FG013|Overall Study|Protocol Violation|0
938103|NCT00973349|1925328|FG014|Overall Study|Protocol Violation|0
938104|NCT00973349|1925329|FG015|Overall Study|Protocol Violation|0
938105|NCT00973349|1925314|FG000|Overall Study|Unable to classify|0
938106|NCT00973349|1925315|FG001|Overall Study|Unable to classify|0
938107|NCT00973349|1925316|FG002|Overall Study|Unable to classify|0
938108|NCT00973349|1925317|FG003|Overall Study|Unable to classify|0
938109|NCT00973349|1925318|FG004|Overall Study|Unable to classify|1
938110|NCT00973349|1925319|FG005|Overall Study|Unable to classify|1
938111|NCT00973349|1925320|FG006|Overall Study|Unable to classify|0
938112|NCT00973349|1925321|FG007|Overall Study|Unable to classify|0
938113|NCT00973349|1925322|FG008|Overall Study|Unable to classify|0
938114|NCT00973349|1925323|FG009|Overall Study|Unable to classify|1
938115|NCT00973349|1925324|FG010|Overall Study|Unable to classify|0
938116|NCT00973349|1925325|FG011|Overall Study|Unable to classify|0
938117|NCT00973349|1925326|FG012|Overall Study|Unable to classify|0
938118|NCT00973349|1925327|FG013|Overall Study|Unable to classify|0
938119|NCT00973349|1925328|FG014|Overall Study|Unable to classify|0
938120|NCT00973349|1925329|FG015|Overall Study|Unable to classify|0
938121|NCT00973362|1925357|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25
938122|NCT00973362|1925358|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0
938123|NCT00973362|1925357|FG000|Baseline Evaluation|No colposcopy visit|62
938124|NCT00973362|1925358|FG001|Baseline Evaluation|No colposcopy visit|0
938125|NCT00973362|1925357|FG000|Baseline Evaluation|Inevaluable|686
938126|NCT00973362|1925358|FG001|Baseline Evaluation|Inevaluable|223
938127|NCT00973362|1925357|FG000|3-Year Follow-up|Lost to Follow-up|17
938128|NCT00973362|1925358|FG001|3-Year Follow-up|Lost to Follow-up|0
938129|NCT00973479|1925369|FG000|Overall Study|Lost to Follow-up|0
938130|NCT00973479|1925370|FG001|Overall Study|Lost to Follow-up|3
938131|NCT00973479|1925369|FG000|Overall Study|Death|2
938132|NCT00973479|1925370|FG001|Overall Study|Death|2
938133|NCT00973479|1925369|FG000|Overall Study|Withdrawal by Subject|15
938134|NCT00973479|1925370|FG001|Overall Study|Withdrawal by Subject|16
938135|NCT00973479|1925369|FG000|Overall Study|Lack of Efficacy|5
938136|NCT00973479|1925370|FG001|Overall Study|Lack of Efficacy|7
938137|NCT00973479|1925369|FG000|Overall Study|Adverse Event|12
938138|NCT00973479|1925370|FG001|Overall Study|Adverse Event|32
938139|NCT00973479|1925369|FG000|Overall Study|Protocol Violation|2
938140|NCT00973479|1925370|FG001|Overall Study|Protocol Violation|2
938141|NCT00973479|1925369|FG000|Overall Study|Other|1
938142|NCT00973479|1925370|FG001|Overall Study|Other|7
938143|NCT00973622|1925380|FG000|Overall Study|did not attend MRI|14
938144|NCT00973622|1925381|FG001|Overall Study|did not attend MRI|3
938145|NCT00973622|1925380|FG000|Overall Study|did not pass MRI screen|6
938146|NCT00973622|1925381|FG001|Overall Study|did not pass MRI screen|0
938147|NCT00973622|1925380|FG000|Overall Study|did not complete rTMS sessions|11
938148|NCT00973622|1925381|FG001|Overall Study|did not complete rTMS sessions|2
938149|NCT00973674|1925389|FG000|Overall Study|Protocol Violation|2
938150|NCT00973674|1925390|FG001|Overall Study|Protocol Violation|0
938151|NCT00973700|1925402|FG000|Overall Study|Withdrawal by Subject|2
938152|NCT00973700|1925403|FG001|Overall Study|Withdrawal by Subject|2
938153|NCT00973700|1925404|FG002|Overall Study|Withdrawal by Subject|8
938154|NCT00973700|1925405|FG003|Overall Study|Withdrawal by Subject|4
938155|NCT00973700|1925406|FG004|Overall Study|Withdrawal by Subject|4
938156|NCT00973700|1925402|FG000|Overall Study|Lost to Follow-up|5
938157|NCT00973700|1925403|FG001|Overall Study|Lost to Follow-up|0
938158|NCT00973700|1925404|FG002|Overall Study|Lost to Follow-up|1
938159|NCT00973700|1925405|FG003|Overall Study|Lost to Follow-up|8
938160|NCT00973700|1925406|FG004|Overall Study|Lost to Follow-up|5
938161|NCT00973700|1925402|FG000|Overall Study|Inappropriate enrolment|0
938162|NCT00973700|1925403|FG001|Overall Study|Inappropriate enrolment|0
938163|NCT00973700|1925404|FG002|Overall Study|Inappropriate enrolment|0
938164|NCT00973700|1925405|FG003|Overall Study|Inappropriate enrolment|4
938165|NCT00973700|1925406|FG004|Overall Study|Inappropriate enrolment|0
938166|NCT00973700|1925402|FG000|Overall Study|Unable to Classify|0
938167|NCT00973700|1925403|FG001|Overall Study|Unable to Classify|0
938168|NCT00973700|1925404|FG002|Overall Study|Unable to Classify|1
938169|NCT00973700|1925405|FG003|Overall Study|Unable to Classify|2
938170|NCT00973700|1925406|FG004|Overall Study|Unable to Classify|1
938171|NCT00973765|1925443|FG000|Overall Study|Lost to Follow-up|8
938172|NCT00973765|1925444|FG001|Overall Study|Lost to Follow-up|14
938173|NCT00973921|1925450|FG000|Overall Study|IVUS results were not available|9
938174|NCT00973973|1925456|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
938175|NCT00973973|1925457|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
938176|NCT00973973|1925456|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
938177|NCT00973973|1925457|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
938178|NCT00973973|1925456|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
938179|NCT00973973|1925457|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
938180|NCT00973973|1925456|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
938181|NCT00973973|1925457|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
938182|NCT00973973|1925456|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
938183|NCT00973973|1925457|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
938184|NCT00973973|1925456|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
938185|NCT00973973|1925457|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
938186|NCT00973973|1925456|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
938187|NCT00973973|1925457|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
938188|NCT00973973|1925456|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
938189|NCT00973973|1925457|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
938190|NCT00973973|1925456|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
938191|NCT00973973|1925457|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
938192|NCT00973973|1925456|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
938193|NCT00973973|1925457|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
938194|NCT00973973|1925456|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
938195|NCT00973973|1925457|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
938196|NCT00973973|1925456|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
938197|NCT00973973|1925457|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
938198|NCT00974090|1925476|FG000|Period 1: Double Blind Period|Adverse Event|2
938199|NCT00974090|1925477|FG001|Period 1: Double Blind Period|Adverse Event|1
938200|NCT00974090|1925476|FG000|Period 1: Double Blind Period|Physician Decision|1
938201|NCT00974090|1925477|FG001|Period 1: Double Blind Period|Physician Decision|0
938202|NCT00974090|1925476|FG000|Period 2: Open-label Period|Adverse Event|4
938203|NCT00974090|1925477|FG001|Period 2: Open-label Period|Adverse Event|6
938204|NCT00974090|1925476|FG000|Period 2: Open-label Period|Lack of Efficacy|3
938205|NCT00974090|1925477|FG001|Period 2: Open-label Period|Lack of Efficacy|1
938206|NCT00974090|1925476|FG000|Period 2: Open-label Period|Physician Decision|0
938207|NCT00974090|1925477|FG001|Period 2: Open-label Period|Physician Decision|3
938208|NCT00974090|1925476|FG000|Period 2: Open-label Period|Withdrawal by Subject|1
938209|NCT00974090|1925477|FG001|Period 2: Open-label Period|Withdrawal by Subject|0
938210|NCT00974220|1925496|FG000|Treatment Period 1|Adverse Event|2
938211|NCT00974220|1925497|FG001|Treatment Period 1|Adverse Event|1
938212|NCT00974220|1925496|FG000|Treatment Period 1|noncompliant subjects|0
938213|NCT00974220|1925497|FG001|Treatment Period 1|noncompliant subjects|1
938214|NCT00974233|1925503|FG000|Induction Chemoimmunotherapy|Death|2
938215|NCT00974233|1925503|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5
938216|NCT00974233|1925503|FG000|Induction Chemoimmunotherapy|Adverse Event|7
938217|NCT00974233|1925503|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1
938218|NCT00974233|1925503|FG000|Maintenance Lenalidomide|Lack of Efficacy|5
938219|NCT00974233|1925503|FG000|Maintenance Lenalidomide|Adverse Event|8
938220|NCT00974259|1925522|FG000|Overall Study|Technically inadequate PbtO2 recordings|2
938221|NCT00974259|1925523|FG001|Overall Study|Technically inadequate PbtO2 recordings|1
938222|NCT00974311|1925531|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5
938223|NCT00974311|1925532|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2
938224|NCT00974311|1925531|FG000|DB Phase (up to 24 Months)|Death|561
938225|NCT00974311|1925532|FG001|DB Phase (up to 24 Months)|Death|298
938226|NCT00974311|1925531|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16
938227|NCT00974311|1925532|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7
938228|NCT00974311|1925531|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
938229|NCT00974311|1925532|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
938230|NCT00974311|1925531|FG000|DB Phase (up to 24 Months)|Other|1
938231|NCT00974311|1925532|FG001|DB Phase (up to 24 Months)|Other|0
938232|NCT00974311|1925531|FG000|OLE Phase (up to 77 Months)|Death|14
938233|NCT00974311|1925532|FG001|OLE Phase (up to 77 Months)|Death|21
938234|NCT00974311|1925531|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
938235|NCT00974311|1925532|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
938236|NCT00974311|1925531|FG000|OLE Phase (up to 77 Months)|Other|15
938237|NCT00974311|1925532|FG001|OLE Phase (up to 77 Months)|Other|2
938238|NCT00974311|1925531|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
938239|NCT00974311|1925532|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
938240|NCT00974571|1925604|FG000|Overall Study|Adverse Event|31
938241|NCT00974571|1925605|FG001|Overall Study|Adverse Event|4
938242|NCT00974571|1925606|FG002|Overall Study|Adverse Event|27
938243|NCT00974571|1925604|FG000|Overall Study|Lack of Efficacy|3
938244|NCT00974571|1925605|FG001|Overall Study|Lack of Efficacy|2
938245|NCT00974571|1925606|FG002|Overall Study|Lack of Efficacy|9
938246|NCT00974571|1925604|FG000|Overall Study|Lost to Follow-up|2
938247|NCT00974571|1925605|FG001|Overall Study|Lost to Follow-up|1
938248|NCT00974571|1925606|FG002|Overall Study|Lost to Follow-up|2
938249|NCT00974571|1925604|FG000|Overall Study|Protocol Violation|13
938250|NCT00974571|1925605|FG001|Overall Study|Protocol Violation|4
938251|NCT00974571|1925606|FG002|Overall Study|Protocol Violation|18
938252|NCT00974571|1925604|FG000|Overall Study|Withdrawal by Subject|14
938253|NCT00974571|1925605|FG001|Overall Study|Withdrawal by Subject|5
938254|NCT00974571|1925606|FG002|Overall Study|Withdrawal by Subject|16
938255|NCT00974571|1925604|FG000|Overall Study|Patient Moved|1
938256|NCT00974571|1925605|FG001|Overall Study|Patient Moved|0
938257|NCT00974571|1925606|FG002|Overall Study|Patient Moved|1
938258|NCT00974571|1925604|FG000|Overall Study|Other|4
938259|NCT00974571|1925605|FG001|Overall Study|Other|0
938260|NCT00974571|1925606|FG002|Overall Study|Other|10
938261|NCT00974675|1925618|FG000|Overall Study|Adverse Event|2
938262|NCT00974675|1925619|FG001|Overall Study|Adverse Event|1
938263|NCT00974675|1925620|FG002|Overall Study|Adverse Event|1
938264|NCT00974675|1925621|FG003|Overall Study|Adverse Event|1
938265|NCT00974675|1925618|FG000|Overall Study|Physician Decision|0
938266|NCT00974675|1925619|FG001|Overall Study|Physician Decision|0
938267|NCT00974675|1925620|FG002|Overall Study|Physician Decision|1
938268|NCT00974675|1925621|FG003|Overall Study|Physician Decision|0
938269|NCT00974675|1925618|FG000|Overall Study|Participant on holiday; unable to attend|0
938270|NCT00974675|1925619|FG001|Overall Study|Participant on holiday; unable to attend|0
938271|NCT00974675|1925620|FG002|Overall Study|Participant on holiday; unable to attend|0
938272|NCT00974675|1925621|FG003|Overall Study|Participant on holiday; unable to attend|1
938273|NCT00974974|1925642|FG000|IR CD-LD Dose Adjustment|Adverse Event|0
938274|NCT00974974|1925643|FG001|IR CD-LD Dose Adjustment|Adverse Event|3
938275|NCT00974974|1925642|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0
938276|NCT00974974|1925643|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1
938277|NCT00974974|1925642|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
938278|NCT00974974|1925643|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
938279|NCT00974974|1925642|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
938280|NCT00974974|1925643|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
938281|NCT00974974|1925642|FG000|IR CD-LD Dose Adjustment|Various|0
938282|NCT00974974|1925643|FG001|IR CD-LD Dose Adjustment|Various|9
938283|NCT00974974|1925642|FG000|IPX066 Dose Conversion|Adverse Event|23
938284|NCT00974974|1925643|FG001|IPX066 Dose Conversion|Adverse Event|0
938285|NCT00974974|1925642|FG000|IPX066 Dose Conversion|Death|2
938286|NCT00974974|1925643|FG001|IPX066 Dose Conversion|Death|0
938287|NCT00974974|1925642|FG000|IPX066 Dose Conversion|Lack of Efficacy|13
938288|NCT00974974|1925643|FG001|IPX066 Dose Conversion|Lack of Efficacy|0
938289|NCT00974974|1925642|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12
938290|NCT00974974|1925643|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0
938291|NCT00974974|1925642|FG000|IPX066 Dose Conversion|Various|3
938292|NCT00974974|1925643|FG001|IPX066 Dose Conversion|Various|0
938293|NCT00974974|1925642|FG000|IPX066 Dose Conversion|Protocol Violation|4
938294|NCT00974974|1925643|FG001|IPX066 Dose Conversion|Protocol Violation|0
938295|NCT00974974|1925642|FG000|Maintenance - Double Blind Treatment|Adverse Event|3
938296|NCT00974974|1925643|FG001|Maintenance - Double Blind Treatment|Adverse Event|3
938297|NCT00974974|1925642|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1
938298|NCT00974974|1925643|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1
938299|NCT00974974|1925642|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
938300|NCT00974974|1925643|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
938301|NCT00974974|1925642|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2
938302|NCT00974974|1925643|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2
938303|NCT00974974|1925642|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0
938304|NCT00974974|1925643|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1
938305|NCT00974974|1925642|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
938306|NCT00974974|1925643|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
938307|NCT00974974|1925642|FG000|Maintenance - Double Blind Treatment|Various|4
938308|NCT00974974|1925643|FG001|Maintenance - Double Blind Treatment|Various|0
938309|NCT00975000|1925651|FG000|Overall Study|Other|1
938310|NCT00975000|1925652|FG001|Overall Study|Other|0
938311|NCT00975000|1925651|FG000|Overall Study|Adverse Event|1
938312|NCT00975000|1925652|FG001|Overall Study|Adverse Event|1
938313|NCT00975000|1925651|FG000|Overall Study|Withdrawal by Subject|2
938314|NCT00975000|1925652|FG001|Overall Study|Withdrawal by Subject|2
938315|NCT00975000|1925651|FG000|Overall Study|Lost to Follow-up|0
938316|NCT00975000|1925652|FG001|Overall Study|Lost to Follow-up|1
938317|NCT00975000|1925651|FG000|Overall Study|Protocol-specified Criteria|1
938318|NCT00975000|1925652|FG001|Overall Study|Protocol-specified Criteria|0
938319|NCT00975000|1925651|FG000|Overall Study|Non-compliance|0
938320|NCT00975000|1925652|FG001|Overall Study|Non-compliance|1
938321|NCT00975130|1925658|FG000|Study Part 1|Adverse Event|150
938322|NCT00975130|1925659|FG001|Study Part 1|Adverse Event|0
938323|NCT00975130|1925660|FG002|Study Part 1|Adverse Event|0
938324|NCT00975130|1925658|FG000|Study Part 1|Lost to Follow-up|19
938325|NCT00975130|1925659|FG001|Study Part 1|Lost to Follow-up|0
938326|NCT00975130|1925660|FG002|Study Part 1|Lost to Follow-up|0
938327|NCT00975130|1925658|FG000|Study Part 1|Withdrawal by Subject|61
938328|NCT00975130|1925659|FG001|Study Part 1|Withdrawal by Subject|0
938329|NCT00975130|1925660|FG002|Study Part 1|Withdrawal by Subject|0
938330|NCT00975130|1925658|FG000|Study Part 1|Protocol Violation|13
938331|NCT00975130|1925659|FG001|Study Part 1|Protocol Violation|0
938332|NCT00975130|1925660|FG002|Study Part 1|Protocol Violation|0
938333|NCT00975130|1925658|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9
938334|NCT00975130|1925659|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0
938335|NCT00975130|1925660|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0
938336|NCT00975130|1925658|FG000|Study Part 1|Administrative|4
938337|NCT00975130|1925659|FG001|Study Part 1|Administrative|0
938338|NCT00975130|1925660|FG002|Study Part 1|Administrative|0
938339|NCT00975130|1925658|FG000|Study Part 1|Withdrew Consent|24
938340|NCT00975130|1925659|FG001|Study Part 1|Withdrew Consent|0
938341|NCT00975130|1925660|FG002|Study Part 1|Withdrew Consent|0
938342|NCT00975130|1925658|FG000|Study Part 2|Adverse Event|0
938343|NCT00975130|1925659|FG001|Study Part 2|Adverse Event|14
938344|NCT00975130|1925660|FG002|Study Part 2|Adverse Event|7
938345|NCT00975130|1925658|FG000|Study Part 2|Lost to Follow-up|0
938346|NCT00975130|1925659|FG001|Study Part 2|Lost to Follow-up|0
938347|NCT00975130|1925660|FG002|Study Part 2|Lost to Follow-up|1
938348|NCT00975130|1925658|FG000|Study Part 2|Withdrawal by Subject|0
938349|NCT00975130|1925659|FG001|Study Part 2|Withdrawal by Subject|13
938350|NCT00975130|1925660|FG002|Study Part 2|Withdrawal by Subject|5
938351|NCT00975130|1925658|FG000|Study Part 2|Withdrew Consent|0
938352|NCT00975130|1925659|FG001|Study Part 2|Withdrew Consent|6
938353|NCT00975130|1925660|FG002|Study Part 2|Withdrew Consent|2
938354|NCT00975130|1925658|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0
938355|NCT00975130|1925659|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4
938356|NCT00975130|1925660|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1
938357|NCT00975130|1925658|FG000|Study Part 2|Administrative|0
938358|NCT00975130|1925659|FG001|Study Part 2|Administrative|1
938359|NCT00975130|1925660|FG002|Study Part 2|Administrative|0
938360|NCT00975130|1925658|FG000|Study Part 2|Protocol Violation|0
938361|NCT00975130|1925659|FG001|Study Part 2|Protocol Violation|0
938362|NCT00975130|1925660|FG002|Study Part 2|Protocol Violation|1
938363|NCT00975143|1925675|FG000|Overall Study|Adverse Event|19
938364|NCT00975143|1925676|FG001|Overall Study|Adverse Event|15
938365|NCT00975143|1925675|FG000|Overall Study|Withdrawal by Subject|15
938366|NCT00975143|1925676|FG001|Overall Study|Withdrawal by Subject|15
938367|NCT00975143|1925675|FG000|Overall Study|Lost to Follow-up|20
938368|NCT00975143|1925676|FG001|Overall Study|Lost to Follow-up|16
938369|NCT00975143|1925675|FG000|Overall Study|Non-compliance|5
938370|NCT00975143|1925676|FG001|Overall Study|Non-compliance|8
938371|NCT00975143|1925675|FG000|Overall Study|Physician Decision|1
938372|NCT00975143|1925676|FG001|Overall Study|Physician Decision|2
938373|NCT00975143|1925675|FG000|Overall Study|Details not available|10
938374|NCT00975143|1925676|FG001|Overall Study|Details not available|4
938375|NCT00975156|1925684|FG000|Overall Study|Protocol Violation|0
938376|NCT00975156|1925685|FG001|Overall Study|Protocol Violation|1
938377|NCT00975195|1925697|FG000|Overall Study|Adverse Event|108
938378|NCT00975195|1925698|FG001|Overall Study|Adverse Event|101
938379|NCT00975195|1925697|FG000|Overall Study|Lack of Efficacy|6
938380|NCT00975195|1925698|FG001|Overall Study|Lack of Efficacy|6
938381|NCT00975195|1925697|FG000|Overall Study|Protocol Violation|27
938382|NCT00975195|1925698|FG001|Overall Study|Protocol Violation|23
938383|NCT00975195|1925697|FG000|Overall Study|Lost to Follow-up|9
938384|NCT00975195|1925698|FG001|Overall Study|Lost to Follow-up|7
938385|NCT00975195|1925697|FG000|Overall Study|Withdrawal by Subject|48
938386|NCT00975195|1925698|FG001|Overall Study|Withdrawal by Subject|61
938387|NCT00975195|1925697|FG000|Overall Study|Other reason not defined above|29
938388|NCT00975195|1925698|FG001|Overall Study|Other reason not defined above|33
938389|NCT00975195|1925697|FG000|Overall Study|Not treated|1
938390|NCT00975195|1925698|FG001|Overall Study|Not treated|2
938391|NCT00975221|1925706|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
938392|NCT00975221|1925707|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
938393|NCT00975221|1925706|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
938394|NCT00975221|1925707|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
938395|NCT00975221|1925706|FG000|Titration Phase (Weeks 1-12)|Other|0
938396|NCT00975221|1925707|FG001|Titration Phase (Weeks 1-12)|Other|1
938397|NCT00975221|1925706|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
938398|NCT00975221|1925707|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
938399|NCT00975221|1925706|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
938400|NCT00975221|1925707|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
938401|NCT00975221|1925706|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
938402|NCT00975221|1925707|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
938403|NCT00975286|1925717|FG000|Overall Study|Adverse Event|9
938404|NCT00975286|1925718|FG001|Overall Study|Adverse Event|19
938405|NCT00975286|1925717|FG000|Overall Study|Protocol Violation|1
938406|NCT00975286|1925718|FG001|Overall Study|Protocol Violation|2
938407|NCT00975286|1925717|FG000|Overall Study|Withdrawal by Subject|0
938408|NCT00975286|1925718|FG001|Overall Study|Withdrawal by Subject|2
938409|NCT00975286|1925717|FG000|Overall Study|Familial and Personal Reasons|2
938410|NCT00975286|1925718|FG001|Overall Study|Familial and Personal Reasons|2
938411|NCT00975286|1925717|FG000|Overall Study|Poor Compliance to Protocol|0
938412|NCT00975286|1925718|FG001|Overall Study|Poor Compliance to Protocol|2
938413|NCT00975286|1925717|FG000|Overall Study|Sponsor Decision|0
938414|NCT00975286|1925718|FG001|Overall Study|Sponsor Decision|2
938415|NCT00975416|1925726|FG000|Overall Study|early discharge from tx|3
938416|NCT00975416|1925727|FG001|Overall Study|early discharge from tx|5
938417|NCT00975481|1925734|FG000|Second Intervention Period|Adverse Event|2
938418|NCT00975481|1925735|FG001|Second Intervention Period|Adverse Event|1
938419|NCT00975481|1925736|FG002|Second Intervention Period|Adverse Event|0
938420|NCT00975481|1925737|FG003|Second Intervention Period|Adverse Event|0
938421|NCT00975481|1925738|FG004|Second Intervention Period|Adverse Event|0
938422|NCT00975481|1925739|FG005|Second Intervention Period|Adverse Event|0
938423|NCT00975481|1925734|FG000|Second Intervention Period|Withdrawal by Subject|0
938424|NCT00975481|1925735|FG001|Second Intervention Period|Withdrawal by Subject|0
938425|NCT00975481|1925736|FG002|Second Intervention Period|Withdrawal by Subject|1
938426|NCT00975481|1925737|FG003|Second Intervention Period|Withdrawal by Subject|0
938427|NCT00975481|1925738|FG004|Second Intervention Period|Withdrawal by Subject|0
938428|NCT00975481|1925739|FG005|Second Intervention Period|Withdrawal by Subject|0
938429|NCT00975481|1925734|FG000|Fourth Intervention Period|Withdrawal by Subject|0
938430|NCT00975481|1925735|FG001|Fourth Intervention Period|Withdrawal by Subject|0
938431|NCT00975481|1925736|FG002|Fourth Intervention Period|Withdrawal by Subject|1
938432|NCT00975481|1925737|FG003|Fourth Intervention Period|Withdrawal by Subject|1
938433|NCT00975481|1925738|FG004|Fourth Intervention Period|Withdrawal by Subject|0
938434|NCT00975481|1925739|FG005|Fourth Intervention Period|Withdrawal by Subject|0
938435|NCT00975481|1925734|FG000|Fifth Intervention Period|Withdrawal by Subject|0
938436|NCT00975481|1925735|FG001|Fifth Intervention Period|Withdrawal by Subject|0
938437|NCT00975481|1925736|FG002|Fifth Intervention Period|Withdrawal by Subject|0
938438|NCT00975481|1925737|FG003|Fifth Intervention Period|Withdrawal by Subject|0
938439|NCT00975481|1925738|FG004|Fifth Intervention Period|Withdrawal by Subject|1
938440|NCT00975481|1925739|FG005|Fifth Intervention Period|Withdrawal by Subject|0
938441|NCT00975507|1925759|FG000|Overall Study|Adverse Event|1
938442|NCT00975507|1925760|FG001|Overall Study|Adverse Event|0
938443|NCT00975507|1925759|FG000|Overall Study|Lost to Follow-up|7
938444|NCT00975507|1925760|FG001|Overall Study|Lost to Follow-up|1
938445|NCT00975507|1925759|FG000|Overall Study|Protocol Violation|2
938446|NCT00975507|1925760|FG001|Overall Study|Protocol Violation|0
938447|NCT00975507|1925759|FG000|Overall Study|Withdrawal by Subject|10
938448|NCT00975507|1925760|FG001|Overall Study|Withdrawal by Subject|3
938449|NCT00975585|1925770|FG000|Overall Study|Adverse Event|0
938450|NCT00975585|1925771|FG001|Overall Study|Adverse Event|4
938451|NCT00975585|1925770|FG000|Overall Study|Lost to Follow-up|3
938452|NCT00975585|1925771|FG001|Overall Study|Lost to Follow-up|5
938453|NCT00975585|1925770|FG000|Overall Study|Withdrawal by Subject|2
938454|NCT00975585|1925771|FG001|Overall Study|Withdrawal by Subject|1
938455|NCT00975585|1925770|FG000|Overall Study|Lens issue|2
938456|NCT00975585|1925771|FG001|Overall Study|Lens issue|2
938457|NCT00975676|1925815|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6
938458|NCT00975676|1925816|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8
938459|NCT00975689|1925829|FG000|Overall Study|Adverse Event|0
938460|NCT00975689|1925830|FG001|Overall Study|Adverse Event|3
938461|NCT00975689|1925829|FG000|Overall Study|Withdrawal by Subject|1
938462|NCT00975689|1925830|FG001|Overall Study|Withdrawal by Subject|0
938463|NCT00975689|1925829|FG000|Overall Study|Physician Decision|1
938464|NCT00975689|1925830|FG001|Overall Study|Physician Decision|0
938465|NCT00975715|1925838|FG000|Titration Period|Adverse Event|6
938466|NCT00975715|1925839|FG001|Titration Period|Adverse Event|0
938467|NCT00975715|1925838|FG000|Titration Period|Protocol Violation|1
938468|NCT00975715|1925839|FG001|Titration Period|Protocol Violation|0
938469|NCT00975715|1925838|FG000|Maintenance Period|Adverse Event|2
938470|NCT00975715|1925839|FG001|Maintenance Period|Adverse Event|1
938471|NCT00975780|1925847|FG000|Follow Up|Death|88
938472|NCT00975780|1925848|FG001|Follow Up|Death|122
938473|NCT00975780|1925847|FG000|Follow Up|Facility Withdrawal|7
938474|NCT00975780|1925848|FG001|Follow Up|Facility Withdrawal|23
938475|NCT00975780|1925847|FG000|Follow Up|Discharged from Facility|7
938476|NCT00975780|1925848|FG001|Follow Up|Discharged from Facility|12
938477|NCT00975806|1925857|FG000|Overall Study|Adverse Event|2
938478|NCT00975806|1925858|FG001|Overall Study|Adverse Event|1
938479|NCT00975806|1925859|FG002|Overall Study|Adverse Event|2
938480|NCT00975806|1925857|FG000|Overall Study|Disease Progression|1
938481|NCT00975806|1925858|FG001|Overall Study|Disease Progression|5
938482|NCT00975806|1925859|FG002|Overall Study|Disease Progression|1
938483|NCT00975806|1925857|FG000|Overall Study|Withdrawal by Subject|1
938484|NCT00975806|1925858|FG001|Overall Study|Withdrawal by Subject|0
938485|NCT00975806|1925859|FG002|Overall Study|Withdrawal by Subject|0
938486|NCT00975806|1925857|FG000|Overall Study|Death|0
938487|NCT00975806|1925858|FG001|Overall Study|Death|1
938488|NCT00975806|1925859|FG002|Overall Study|Death|0
938489|NCT00975806|1925857|FG000|Overall Study|Physician decision and disease related|1
938490|NCT00975806|1925858|FG001|Overall Study|Physician decision and disease related|0
938491|NCT00975806|1925859|FG002|Overall Study|Physician decision and disease related|1
938492|NCT00975884|1925871|FG000|Overall Study|Adverse Event|1
938493|NCT00975884|1925872|FG001|Overall Study|Adverse Event|0
938494|NCT00975884|1925871|FG000|Overall Study|Lost to Follow-up|5
938495|NCT00975884|1925872|FG001|Overall Study|Lost to Follow-up|3
938496|NCT00975884|1925871|FG000|Overall Study|Withdrawal by Subject|9
938497|NCT00975884|1925872|FG001|Overall Study|Withdrawal by Subject|9
938498|NCT00975884|1925871|FG000|Overall Study|Other|1
938499|NCT00975884|1925872|FG001|Overall Study|Other|3
938500|NCT00975923|1925890|FG000|Overall Study|Withdrawal by Subject|0
938501|NCT00975923|1925891|FG001|Overall Study|Withdrawal by Subject|1
938502|NCT00975975|1925898|FG000|Overall Study|Death|6
938503|NCT00976027|1925904|FG000|Overall Study|Serious Adverse Event|36
938504|NCT00976027|1925905|FG001|Overall Study|Serious Adverse Event|17
938505|NCT00976027|1925904|FG000|Overall Study|Adverse Event|0
938506|NCT00976027|1925905|FG001|Overall Study|Adverse Event|2
938507|NCT00976027|1925904|FG000|Overall Study|Protocol Violation|60
938508|NCT00976027|1925905|FG001|Overall Study|Protocol Violation|27
938509|NCT00976027|1925904|FG000|Overall Study|Lost to Follow-up|208
938510|NCT00976027|1925905|FG001|Overall Study|Lost to Follow-up|103
938511|NCT00976027|1925904|FG000|Overall Study|Withdrawal by Subject|107
938512|NCT00976027|1925905|FG001|Overall Study|Withdrawal by Subject|66
938513|NCT00976209|1925917|FG000|Treatment Period 1|Protocol Violation|1
938514|NCT00976209|1925918|FG001|Treatment Period 1|Protocol Violation|0
938515|NCT00976209|1925917|FG000|Treatment Period 1|Lost to Follow-up|2
938516|NCT00976209|1925918|FG001|Treatment Period 1|Lost to Follow-up|0
938517|NCT00976209|1925917|FG000|Treatment Period 1|Other|0
938518|NCT00976209|1925918|FG001|Treatment Period 1|Other|1
938519|NCT00976209|1925917|FG000|Wash-out Period|Adverse Event|1
938520|NCT00976209|1925918|FG001|Wash-out Period|Adverse Event|2
938521|NCT00976209|1925917|FG000|Wash-out Period|Lost to Follow-up|1
938522|NCT00976209|1925918|FG001|Wash-out Period|Lost to Follow-up|0
938523|NCT00976209|1925917|FG000|Wash-out Period|Protocol Violation|1
938524|NCT00976209|1925918|FG001|Wash-out Period|Protocol Violation|0
938525|NCT00976209|1925917|FG000|Wash-out Period|Other|1
938526|NCT00976209|1925918|FG001|Wash-out Period|Other|0
938527|NCT00976209|1925917|FG000|Treatment Period 2|Withdrawal by Subject|0
938528|NCT00976209|1925918|FG001|Treatment Period 2|Withdrawal by Subject|1
938529|NCT00976209|1925917|FG000|Treatment Period 2|Lost to Follow-up|0
938530|NCT00976209|1925918|FG001|Treatment Period 2|Lost to Follow-up|1
938531|NCT00976274|1925930|FG000|Overall Study|Lost to Follow-up|5
938532|NCT00976274|1925931|FG001|Overall Study|Lost to Follow-up|5
938533|NCT00976274|1925930|FG000|Overall Study|Withdrawal by Subject|1
938534|NCT00976274|1925931|FG001|Overall Study|Withdrawal by Subject|1
938535|NCT00976274|1925930|FG000|Overall Study|Physician Decision|1
938536|NCT00976274|1925931|FG001|Overall Study|Physician Decision|2
938537|NCT00976391|1925952|FG000|Treatment Period (52 Weeks)|Adverse Event|16
938538|NCT00976391|1925953|FG001|Treatment Period (52 Weeks)|Adverse Event|2
938539|NCT00976391|1925952|FG000|Treatment Period (52 Weeks)|Protocol Violation|1
938540|NCT00976391|1925953|FG001|Treatment Period (52 Weeks)|Protocol Violation|1
938541|NCT00976391|1925952|FG000|Treatment Period (52 Weeks)|Noncompliance|4
938542|NCT00976391|1925953|FG001|Treatment Period (52 Weeks)|Noncompliance|4
938543|NCT00976391|1925952|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10
938544|NCT00976391|1925953|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8
938545|NCT00976391|1925952|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9
938546|NCT00976391|1925953|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19
938547|NCT00976391|1925952|FG000|Treatment Period (52 Weeks)|Physician Decision|1
938548|NCT00976391|1925953|FG001|Treatment Period (52 Weeks)|Physician Decision|1
938549|NCT00976391|1925952|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
938550|NCT00976391|1925953|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
938551|NCT00976391|1925952|FG000|Treatment Period (52 Weeks)|Pregnancy|1
938552|NCT00976391|1925953|FG001|Treatment Period (52 Weeks)|Pregnancy|0
938553|NCT00976391|1925952|FG000|Follow-up Period (8 Weeks)|Adverse Event|3
938554|NCT00976391|1925953|FG001|Follow-up Period (8 Weeks)|Adverse Event|1
938555|NCT00976391|1925952|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
938556|NCT00976391|1925953|FG001|Follow-up Period (8 Weeks)|Noncompliance|2
938557|NCT00976391|1925952|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14
938558|NCT00976391|1925953|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
938559|NCT00976391|1925952|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
938560|NCT00976391|1925953|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
938561|NCT00976391|1925952|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
938562|NCT00976391|1925953|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
938563|NCT00976391|1925952|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
938564|NCT00976391|1925953|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
938565|NCT00976456|1925972|FG000|Overall Study|Adverse Event|17
938566|NCT00976456|1925973|FG001|Overall Study|Adverse Event|22
938567|NCT00976456|1925972|FG000|Overall Study|Death|7
938568|NCT00976456|1925973|FG001|Overall Study|Death|9
938569|NCT00976456|1925972|FG000|Overall Study|Lack of Efficacy|5
938570|NCT00976456|1925973|FG001|Overall Study|Lack of Efficacy|2
938571|NCT00976456|1925972|FG000|Overall Study|Withdrawal by Subject|3
938572|NCT00976456|1925973|FG001|Overall Study|Withdrawal by Subject|1
938573|NCT00976456|1925972|FG000|Overall Study|screening failure, unknown|11
938574|NCT00976456|1925973|FG001|Overall Study|screening failure, unknown|4
938575|NCT00976482|1925979|FG000|Overall Study|Death|208
938576|NCT00976482|1925979|FG000|Overall Study|Withdrawal by Subject|45
938577|NCT00976482|1925979|FG000|Overall Study|Center terminated|1
938578|NCT00976482|1925979|FG000|Overall Study|Protocol Violation|5
938579|NCT00976495|1925986|FG000|Overall Study|Withdrawal by Subject|0
938580|NCT00976495|1925987|FG001|Overall Study|Withdrawal by Subject|1
938581|NCT00976495|1925988|FG002|Overall Study|Withdrawal by Subject|0
938582|NCT00976508|1925998|FG000|Overall Study|Death|7
938583|NCT00976508|1925999|FG001|Overall Study|Death|1
938584|NCT00976508|1925998|FG000|Overall Study|Lost to Follow-up|1
938585|NCT00976508|1925999|FG001|Overall Study|Lost to Follow-up|0
938586|NCT00976508|1925998|FG000|Overall Study|Withdrawal by Subject|1
938587|NCT00976508|1925999|FG001|Overall Study|Withdrawal by Subject|0
938588|NCT00976508|1925998|FG000|Overall Study|Disease Progression|4
938589|NCT00976508|1925999|FG001|Overall Study|Disease Progression|4
938590|NCT00976508|1925998|FG000|Overall Study|Subject Enrolled in Hospice|1
938591|NCT00976508|1925999|FG001|Overall Study|Subject Enrolled in Hospice|0
938592|NCT00976508|1925998|FG000|Overall Study|Terminated by the Sponsor|0
938593|NCT00976508|1925999|FG001|Overall Study|Terminated by the Sponsor|1
938594|NCT00976560|1926028|FG000|Overall Study|Adverse Event|5
938595|NCT00976560|1926029|FG001|Overall Study|Adverse Event|5
938596|NCT00976560|1926028|FG000|Overall Study|Lack of Efficacy|3
938597|NCT00976560|1926029|FG001|Overall Study|Lack of Efficacy|5
938598|NCT00976560|1926028|FG000|Overall Study|Protocol Violation|1
938599|NCT00976560|1926029|FG001|Overall Study|Protocol Violation|0
938600|NCT00976560|1926028|FG000|Overall Study|Lost to Follow-up|1
938601|NCT00976560|1926029|FG001|Overall Study|Lost to Follow-up|0
938602|NCT00976560|1926028|FG000|Overall Study|Physician Decision|2
938603|NCT00976560|1926029|FG001|Overall Study|Physician Decision|0
938604|NCT00976560|1926028|FG000|Overall Study|Withdrawal by Subject|2
938605|NCT00976560|1926029|FG001|Overall Study|Withdrawal by Subject|3
938606|NCT00976573|1926037|FG000|Overall Study|Ineligible|0
938607|NCT00976573|1926038|FG001|Overall Study|Ineligible|1
938608|NCT00976573|1926037|FG000|Overall Study|Cancel prior to receiving treatment|4
938609|NCT00976573|1926038|FG001|Overall Study|Cancel prior to receiving treatment|2
938610|NCT00976677|1926064|FG000|Overall Study|Adverse Event|1
938611|NCT00976677|1926065|FG001|Overall Study|Adverse Event|0
938612|NCT00976677|1926064|FG000|Overall Study|Withdrawal by Subject|0
938613|NCT00976677|1926065|FG001|Overall Study|Withdrawal by Subject|2
938614|NCT00976677|1926064|FG000|Overall Study|Disease progression|1
938615|NCT00976677|1926065|FG001|Overall Study|Disease progression|1
938616|NCT00976677|1926064|FG000|Overall Study|Trial unblinded|2
938617|NCT00976677|1926065|FG001|Overall Study|Trial unblinded|2
938618|NCT00976677|1926064|FG000|Overall Study|Unknown/Missing|1
938619|NCT00976677|1926065|FG001|Overall Study|Unknown/Missing|0
938620|NCT00976703|1926073|FG000|Overall Study|Physician Decision|1
938621|NCT00976703|1926074|FG001|Overall Study|Physician Decision|1
938622|NCT00976703|1926073|FG000|Overall Study|ineligible for study|2
938623|NCT00976703|1926074|FG001|Overall Study|ineligible for study|2
938624|NCT00976716|1926080|FG000|Overall Study|Adverse Event|1
938625|NCT00976820|1926089|FG000|Overall Study|Lost to Follow-up|5
938626|NCT00976820|1926090|FG001|Overall Study|Lost to Follow-up|16
938627|NCT00976820|1926091|FG002|Overall Study|Lost to Follow-up|2
938628|NCT00976820|1926092|FG003|Overall Study|Lost to Follow-up|3
938629|NCT00976820|1926089|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1
938630|NCT00976820|1926090|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0
938631|NCT00976820|1926091|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1
938632|NCT00976820|1926092|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0
938633|NCT00976820|1926089|FG000|Overall Study|Withdrawal by Subject|2
938634|NCT00976820|1926090|FG001|Overall Study|Withdrawal by Subject|4
938635|NCT00976820|1926091|FG002|Overall Study|Withdrawal by Subject|1
938636|NCT00976820|1926092|FG003|Overall Study|Withdrawal by Subject|4
938637|NCT00976898|1926143|FG000|Overall Study|Protocol Violation|1
938638|NCT00976898|1926143|FG000|Overall Study|Adverse Event|1
938639|NCT00976898|1926143|FG000|Overall Study|Physician Decision|1
938640|NCT00976898|1926143|FG000|Overall Study|Liver Transplant|1
938641|NCT00976898|1926143|FG000|Overall Study|Progressive Disease|1
938642|NCT00976911|1926149|FG000|Overall Study|Withdrawal by Subject|4
938643|NCT00976911|1926150|FG001|Overall Study|Withdrawal by Subject|6
938644|NCT00976911|1926149|FG000|Overall Study|Death|138
938645|NCT00976911|1926150|FG001|Overall Study|Death|126
938646|NCT00976911|1926149|FG000|Overall Study|Adverse Event|0
938647|NCT00976911|1926150|FG001|Overall Study|Adverse Event|1
938648|NCT00976911|1926149|FG000|Overall Study|Protocol Violation|2
938649|NCT00976911|1926150|FG001|Overall Study|Protocol Violation|0
938650|NCT00976911|1926149|FG000|Overall Study|Other|8
938651|NCT00976911|1926150|FG001|Overall Study|Other|9
938652|NCT00976911|1926149|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30
938653|NCT00976911|1926150|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37
938654|NCT00976937|1926158|FG000|Overall Study|Adverse Event|4
938655|NCT00976937|1926159|FG001|Overall Study|Adverse Event|5
938656|NCT00976937|1926158|FG000|Overall Study|Lost to Follow-up|2
938657|NCT00976937|1926159|FG001|Overall Study|Lost to Follow-up|1
938658|NCT00976937|1926158|FG000|Overall Study|Withdrawal by Subject|5
938659|NCT00976937|1926159|FG001|Overall Study|Withdrawal by Subject|3
938660|NCT00976937|1926158|FG000|Overall Study|Poor compliance to protocol|3
938661|NCT00976937|1926159|FG001|Overall Study|Poor compliance to protocol|0
938662|NCT00976937|1926158|FG000|Overall Study|Personal and Familial Reason|2
938663|NCT00976937|1926159|FG001|Overall Study|Personal and Familial Reason|2
938664|NCT00976950|1926165|FG000|Overall Study|Adverse Event|3
938665|NCT00976950|1926165|FG000|Overall Study|Events with no relationship to Aptivus|3
938666|NCT00976989|1926172|FG000|Overall Study|Violation of Selection Criteria at Entry|1
938667|NCT00976989|1926173|FG001|Overall Study|Violation of Selection Criteria at Entry|0
938668|NCT00976989|1926174|FG002|Overall Study|Violation of Selection Criteria at Entry|1
938669|NCT00976989|1926172|FG000|Overall Study|Death|5
938670|NCT00976989|1926173|FG001|Overall Study|Death|7
938671|NCT00976989|1926174|FG002|Overall Study|Death|10
938672|NCT00976989|1926172|FG000|Overall Study|Refused Treatment|4
938673|NCT00976989|1926173|FG001|Overall Study|Refused Treatment|3
938674|NCT00976989|1926174|FG002|Overall Study|Refused Treatment|5
938675|NCT00976989|1926172|FG000|Overall Study|Failure to Return|2
938676|NCT00976989|1926173|FG001|Overall Study|Failure to Return|1
938677|NCT00976989|1926174|FG002|Overall Study|Failure to Return|0
938678|NCT00976989|1926172|FG000|Overall Study|Recurrence of Disease|0
938679|NCT00976989|1926173|FG001|Overall Study|Recurrence of Disease|1
938680|NCT00976989|1926174|FG002|Overall Study|Recurrence of Disease|0
938681|NCT00976989|1926172|FG000|Overall Study|Other|1
938682|NCT00976989|1926173|FG001|Overall Study|Other|0
938683|NCT00976989|1926174|FG002|Overall Study|Other|1
938684|NCT00977080|1926186|FG000|Overall Study|Adverse Event|2
938685|NCT00977080|1926187|FG001|Overall Study|Adverse Event|7
938686|NCT00977080|1926188|FG002|Overall Study|Adverse Event|7
938687|NCT00977080|1926189|FG003|Overall Study|Adverse Event|7
938688|NCT00977080|1926186|FG000|Overall Study|Withdrawal by Subject|1
938689|NCT00977080|1926187|FG001|Overall Study|Withdrawal by Subject|5
938690|NCT00977080|1926188|FG002|Overall Study|Withdrawal by Subject|1
938691|NCT00977080|1926189|FG003|Overall Study|Withdrawal by Subject|5
938692|NCT00977080|1926186|FG000|Overall Study|Protocol Violation|7
938693|NCT00977080|1926187|FG001|Overall Study|Protocol Violation|3
938694|NCT00977080|1926188|FG002|Overall Study|Protocol Violation|4
938695|NCT00977080|1926189|FG003|Overall Study|Protocol Violation|3
938696|NCT00977080|1926186|FG000|Overall Study|Noncompliance|0
938697|NCT00977080|1926187|FG001|Overall Study|Noncompliance|2
938698|NCT00977080|1926188|FG002|Overall Study|Noncompliance|1
938699|NCT00977080|1926189|FG003|Overall Study|Noncompliance|0
938700|NCT00977080|1926186|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
938701|NCT00977080|1926187|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
938702|NCT00977080|1926188|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
938703|NCT00977080|1926189|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
938704|NCT00977080|1926186|FG000|Overall Study|Required kidney transplantation|1
938705|NCT00977080|1926187|FG001|Overall Study|Required kidney transplantation|3
938706|NCT00977080|1926188|FG002|Overall Study|Required kidney transplantation|3
938707|NCT00977080|1926189|FG003|Overall Study|Required kidney transplantation|1
938708|NCT00977080|1926186|FG000|Overall Study|Travel for family reasons|1
938709|NCT00977080|1926187|FG001|Overall Study|Travel for family reasons|0
938710|NCT00977080|1926188|FG002|Overall Study|Travel for family reasons|0
938711|NCT00977080|1926189|FG003|Overall Study|Travel for family reasons|0
938712|NCT00977106|1926201|FG000|Overall Study|Adverse Event|5
938713|NCT00977106|1926202|FG001|Overall Study|Adverse Event|6
938714|NCT00977106|1926201|FG000|Overall Study|Withdrawal by Subject|2
938715|NCT00977106|1926202|FG001|Overall Study|Withdrawal by Subject|2
938716|NCT00977106|1926201|FG000|Overall Study|Lack of Efficacy|2
938717|NCT00977106|1926202|FG001|Overall Study|Lack of Efficacy|2
938718|NCT00977106|1926201|FG000|Overall Study|Protocol Violation|0
938719|NCT00977106|1926202|FG001|Overall Study|Protocol Violation|1
938720|NCT00977106|1926201|FG000|Overall Study|Other|1
938721|NCT00977106|1926202|FG001|Overall Study|Other|0
938722|NCT00977197|1926232|FG000|Overall Study|Withdrawal by Subject|3
938723|NCT00977197|1926233|FG001|Overall Study|Withdrawal by Subject|4
938724|NCT00977197|1926232|FG000|Overall Study|Adverse Event|3
938725|NCT00977197|1926233|FG001|Overall Study|Adverse Event|1
938726|NCT00977197|1926232|FG000|Overall Study|Lack of Efficacy|1
938727|NCT00977197|1926233|FG001|Overall Study|Lack of Efficacy|0
938728|NCT00977197|1926232|FG000|Overall Study|Lost to Follow-up|1
938729|NCT00977197|1926233|FG001|Overall Study|Lost to Follow-up|3
938730|NCT00977197|1926232|FG000|Overall Study|Nonadherence|1
938731|NCT00977197|1926233|FG001|Overall Study|Nonadherence|1
938732|NCT00977314|1926241|FG000|Overall Study|Withdrawal by Subject|1
938733|NCT00977314|1926242|FG001|Overall Study|Withdrawal by Subject|0
938734|NCT00977314|1926241|FG000|Overall Study|Physician Decision|1
938735|NCT00977314|1926242|FG001|Overall Study|Physician Decision|0
938736|NCT00977379|1926250|FG000|Overall Study|Withdrawal by Subject|1
938737|NCT00977379|1926251|FG001|Overall Study|Withdrawal by Subject|1
938738|NCT00977379|1926250|FG000|Overall Study|Death|7
938739|NCT00977379|1926251|FG001|Overall Study|Death|9
938740|NCT00977379|1926250|FG000|Overall Study|Premature Study Termination|4
938741|NCT00977379|1926251|FG001|Overall Study|Premature Study Termination|0
938742|NCT00977379|1926250|FG000|Overall Study|Participant Moving House|0
938743|NCT00977379|1926251|FG001|Overall Study|Participant Moving House|1
938744|NCT00977379|1926250|FG000|Overall Study|Randomization Error|0
938745|NCT00977379|1926251|FG001|Overall Study|Randomization Error|1
938746|NCT00977431|1926262|FG000|Overall Study|Other than listed|1
938747|NCT00977431|1926263|FG001|Overall Study|Other than listed|0
938748|NCT00977431|1926264|FG002|Overall Study|Other than listed|0
938749|NCT00977431|1926265|FG003|Overall Study|Other than listed|0
938750|NCT00977431|1926266|FG004|Overall Study|Other than listed|2
938751|NCT00977431|1926262|FG000|Overall Study|Protocol Violation|0
938752|NCT00977431|1926263|FG001|Overall Study|Protocol Violation|0
938753|NCT00977431|1926264|FG002|Overall Study|Protocol Violation|1
938754|NCT00977431|1926265|FG003|Overall Study|Protocol Violation|0
938755|NCT00977431|1926266|FG004|Overall Study|Protocol Violation|0
938756|NCT00977431|1926262|FG000|Overall Study|Adverse Event|3
938757|NCT00977431|1926263|FG001|Overall Study|Adverse Event|0
938758|NCT00977431|1926264|FG002|Overall Study|Adverse Event|4
938759|NCT00977431|1926265|FG003|Overall Study|Adverse Event|0
938760|NCT00977431|1926266|FG004|Overall Study|Adverse Event|6
938761|NCT00977431|1926262|FG000|Overall Study|Dose-limiting toxicity (DLT)|1
938762|NCT00977431|1926263|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
938763|NCT00977431|1926264|FG002|Overall Study|Dose-limiting toxicity (DLT)|1
938764|NCT00977431|1926265|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
938765|NCT00977431|1926266|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
938766|NCT00977431|1926262|FG000|Overall Study|Progressive disease|2
938767|NCT00977431|1926263|FG001|Overall Study|Progressive disease|6
938768|NCT00977431|1926264|FG002|Overall Study|Progressive disease|1
938769|NCT00977431|1926265|FG003|Overall Study|Progressive disease|3
938770|NCT00977431|1926266|FG004|Overall Study|Progressive disease|5
938771|NCT00977470|1926284|FG000|Overall Study|Lack of Efficacy|32
938772|NCT00977470|1926285|FG001|Overall Study|Lack of Efficacy|30
938773|NCT00977470|1926284|FG000|Overall Study|Physician Decision|2
938774|NCT00977470|1926285|FG001|Overall Study|Physician Decision|0
938775|NCT00977470|1926284|FG000|Overall Study|Adverse Event|1
938776|NCT00977470|1926285|FG001|Overall Study|Adverse Event|2
938777|NCT00977470|1926284|FG000|Overall Study|Protocol Violation|1
938778|NCT00977470|1926285|FG001|Overall Study|Protocol Violation|0
938779|NCT00977470|1926284|FG000|Overall Study|Withdrawal by Subject|0
938780|NCT00977470|1926285|FG001|Overall Study|Withdrawal by Subject|2
938781|NCT00977470|1926284|FG000|Overall Study|Death|0
938782|NCT00977470|1926285|FG001|Overall Study|Death|2
938783|NCT00977470|1926284|FG000|Overall Study|clinical decline|0
938784|NCT00977470|1926285|FG001|Overall Study|clinical decline|1
938785|NCT00977470|1926284|FG000|Overall Study|prolonged recovery post-surgery|0
938786|NCT00977470|1926285|FG001|Overall Study|prolonged recovery post-surgery|1
938787|NCT00977470|1926284|FG000|Overall Study|Still on-study|2
938788|NCT00977470|1926285|FG001|Overall Study|Still on-study|0
938789|NCT00977548|1926291|FG000|Overall Study|Ineligible|4
938790|NCT00977548|1926291|FG000|Overall Study|Adverse Event|8
938791|NCT00977548|1926291|FG000|Overall Study|Withdrawal by Subject|1
938792|NCT00977561|1926297|FG000|Overall Study|Death|3
938793|NCT00977561|1926298|FG001|Overall Study|Death|2
938794|NCT00977561|1926297|FG000|Overall Study|Study terminated|0
938795|NCT00977561|1926298|FG001|Overall Study|Study terminated|2
938796|NCT00977561|1926297|FG000|Overall Study|Other|2
938797|NCT00977561|1926298|FG001|Overall Study|Other|0
938798|NCT00977613|1926306|FG000|Overall Study|Lost to Follow-up|16
938799|NCT00977665|1926312|FG000|Overall Study|Withdrawal by Subject|1
938800|NCT00977665|1926313|FG001|Overall Study|Withdrawal by Subject|3
938801|NCT00977665|1926312|FG000|Overall Study|Physician Decision|2
938802|NCT00977665|1926313|FG001|Overall Study|Physician Decision|1
938803|NCT00977665|1926312|FG000|Overall Study|Sponsor requested withdrawal|0
938804|NCT00977665|1926313|FG001|Overall Study|Sponsor requested withdrawal|1
938805|NCT00977665|1926312|FG000|Overall Study|Lost to Follow-up|1
938806|NCT00977665|1926313|FG001|Overall Study|Lost to Follow-up|0
938807|NCT00977665|1926312|FG000|Overall Study|Death|3
938808|NCT00977665|1926313|FG001|Overall Study|Death|2
938809|NCT00977665|1926312|FG000|Overall Study|Adverse Event|14
938810|NCT00977665|1926313|FG001|Overall Study|Adverse Event|7
938811|NCT00977665|1926312|FG000|Overall Study|Treatment failure|0
938812|NCT00977665|1926313|FG001|Overall Study|Treatment failure|1
938813|NCT00977938|1926358|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
938814|NCT00977938|1926359|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
938815|NCT00977938|1926360|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
938816|NCT00977938|1926361|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
938817|NCT00977938|1926358|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
938818|NCT00977938|1926359|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
938819|NCT00977938|1926360|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
938820|NCT00977938|1926361|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
938821|NCT00977938|1926358|FG000|Treatment (12-30 mo. Post Procedure)|Other|17
938822|NCT00977938|1926359|FG001|Treatment (12-30 mo. Post Procedure)|Other|18
938823|NCT00977938|1926360|FG002|Treatment (12-30 mo. Post Procedure)|Other|3
938824|NCT00977938|1926361|FG003|Treatment (12-30 mo. Post Procedure)|Other|4
938825|NCT00977938|1926358|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
938826|NCT00977938|1926359|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
938827|NCT00977938|1926360|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
938828|NCT00977938|1926361|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
938829|NCT00977938|1926358|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
938830|NCT00977938|1926359|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
938831|NCT00977938|1926360|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
938832|NCT00977938|1926361|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
938833|NCT00977938|1926358|FG000|Observation (30-33 mo. Post Procedure)|Other|8
938834|NCT00977938|1926359|FG001|Observation (30-33 mo. Post Procedure)|Other|4
938835|NCT00977938|1926360|FG002|Observation (30-33 mo. Post Procedure)|Other|0
938836|NCT00977938|1926361|FG003|Observation (30-33 mo. Post Procedure)|Other|0
938837|NCT00978029|1926376|FG000|Overall Study|Adverse Event|1
938838|NCT00978029|1926377|FG001|Overall Study|Adverse Event|2
938839|NCT00978029|1926378|FG002|Overall Study|Adverse Event|5
938840|NCT00978029|1926376|FG000|Overall Study|Withdrawal by Subject|0
938841|NCT00978029|1926377|FG001|Overall Study|Withdrawal by Subject|0
938842|NCT00978029|1926378|FG002|Overall Study|Withdrawal by Subject|1
938843|NCT00978029|1926376|FG000|Overall Study|Protocol Violation|0
938844|NCT00978029|1926377|FG001|Overall Study|Protocol Violation|1
938845|NCT00978029|1926378|FG002|Overall Study|Protocol Violation|0
938846|NCT00978042|1926388|FG000|Initial Treatment Period|Treated in Error|0
938847|NCT00978042|1926389|FG001|Initial Treatment Period|Treated in Error|3
938848|NCT00978042|1926388|FG000|Initial Treatment Period|Ineligibility|1
938849|NCT00978042|1926389|FG001|Initial Treatment Period|Ineligibility|0
938850|NCT00978042|1926388|FG000|Initial Treatment Period|Lost to Follow-up|21
938851|NCT00978042|1926389|FG001|Initial Treatment Period|Lost to Follow-up|3
938852|NCT00978042|1926388|FG000|Initial Treatment Period|Adverse Event|2
938853|NCT00978042|1926389|FG001|Initial Treatment Period|Adverse Event|0
938854|NCT00978042|1926388|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
938855|NCT00978042|1926389|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
938856|NCT00978042|1926388|FG000|Initial Treatment Period|Consent withdrawn|22
938857|NCT00978042|1926389|FG001|Initial Treatment Period|Consent withdrawn|9
938858|NCT00978042|1926388|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13
938859|NCT00978042|1926389|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0
938860|NCT00978068|1926397|FG000|Overall Study|Were Awaiting Initiation of ART|2
938861|NCT00978068|1926398|FG001|Overall Study|Were Awaiting Initiation of ART|2
938862|NCT00978068|1926397|FG000|Overall Study|Death|1
938863|NCT00978068|1926398|FG001|Overall Study|Death|2
938864|NCT00978068|1926397|FG000|Overall Study|Lost to Follow-up|1
938865|NCT00978068|1926398|FG001|Overall Study|Lost to Follow-up|2
938866|NCT00978068|1926397|FG000|Overall Study|Physician Decision|0
938867|NCT00978068|1926398|FG001|Overall Study|Physician Decision|1
938868|NCT00978068|1926397|FG000|Overall Study|Unable to Comply with Study|0
938869|NCT00978068|1926398|FG001|Overall Study|Unable to Comply with Study|2
938870|NCT00978120|1926412|FG000|Overall Study|Death|0
938871|NCT00978120|1926413|FG001|Overall Study|Death|0
938872|NCT00978120|1926414|FG002|Overall Study|Death|0
938873|NCT00978120|1926415|FG003|Overall Study|Death|1
938874|NCT00978120|1926412|FG000|Overall Study|Lost to Follow-up|0
938875|NCT00978120|1926413|FG001|Overall Study|Lost to Follow-up|0
938876|NCT00978120|1926414|FG002|Overall Study|Lost to Follow-up|3
938877|NCT00978120|1926415|FG003|Overall Study|Lost to Follow-up|0
938878|NCT00978120|1926412|FG000|Overall Study|Withdrawal by Subject|2
938879|NCT00978120|1926413|FG001|Overall Study|Withdrawal by Subject|0
938880|NCT00978120|1926414|FG002|Overall Study|Withdrawal by Subject|0
938881|NCT00978120|1926415|FG003|Overall Study|Withdrawal by Subject|0
938882|NCT00978120|1926412|FG000|Overall Study|Moved out of state|0
938883|NCT00978120|1926413|FG001|Overall Study|Moved out of state|0
938884|NCT00978120|1926414|FG002|Overall Study|Moved out of state|0
938885|NCT00978120|1926415|FG003|Overall Study|Moved out of state|1
938886|NCT00978250|1926433|FG000|Overall Study|Late determination of ineligibility|0
938887|NCT00978250|1926434|FG001|Overall Study|Late determination of ineligibility|1
938888|NCT00978250|1926435|FG002|Overall Study|Late determination of ineligibility|0
938889|NCT00978250|1926436|FG003|Overall Study|Late determination of ineligibility|1
938890|NCT00978341|1926448|FG000|Washout Period of 2 Weeks|Adverse Event|1
938891|NCT00978341|1926449|FG001|Washout Period of 2 Weeks|Adverse Event|0
938892|NCT00978380|1926456|FG000|Overall Study|Protocol Violation|2
938893|NCT00978380|1926456|FG000|Overall Study|Withdrawal criteria|9
938894|NCT00978380|1926456|FG000|Overall Study|Unclassified|8
938895|NCT00978432|1926464|FG000|Overall Study|Withdrawal by Subject|0
938896|NCT00978432|1926465|FG001|Overall Study|Withdrawal by Subject|0
938897|NCT00978432|1926466|FG002|Overall Study|Withdrawal by Subject|1
938898|NCT00978432|1926464|FG000|Overall Study|Lack of Efficacy|1
938899|NCT00978432|1926465|FG001|Overall Study|Lack of Efficacy|1
938900|NCT00978432|1926466|FG002|Overall Study|Lack of Efficacy|3
938901|NCT00978432|1926464|FG000|Overall Study|Adverse Event|2
938902|NCT00978432|1926465|FG001|Overall Study|Adverse Event|0
938903|NCT00978432|1926466|FG002|Overall Study|Adverse Event|1
938904|NCT00978627|1926489|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
938905|NCT00978627|1926490|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
938906|NCT00978627|1926489|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
938907|NCT00978627|1926490|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
938908|NCT00978627|1926489|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
938909|NCT00978627|1926490|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
938910|NCT00978627|1926489|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
938911|NCT00978627|1926490|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
938912|NCT00978627|1926489|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
938913|NCT00978627|1926490|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
938914|NCT00978627|1926489|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
938915|NCT00978627|1926490|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
938916|NCT00978627|1926489|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
938917|NCT00978627|1926490|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
938918|NCT00978627|1926489|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
938919|NCT00978627|1926490|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
938920|NCT00978627|1926489|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
938921|NCT00978627|1926490|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
938922|NCT00978731|1926500|FG000|Overall Study|Death|4
938923|NCT00978731|1926501|FG001|Overall Study|Death|1
938924|NCT00978731|1926502|FG002|Overall Study|Death|1
938925|NCT00978731|1926503|FG003|Overall Study|Death|0
938926|NCT00978731|1926500|FG000|Overall Study|Lost to Follow-up|0
938927|NCT00978731|1926501|FG001|Overall Study|Lost to Follow-up|0
938928|NCT00978731|1926502|FG002|Overall Study|Lost to Follow-up|0
938929|NCT00978731|1926503|FG003|Overall Study|Lost to Follow-up|1
938930|NCT00978731|1926500|FG000|Overall Study|Adverse Event|5
938931|NCT00978731|1926501|FG001|Overall Study|Adverse Event|2
938932|NCT00978731|1926502|FG002|Overall Study|Adverse Event|0
938933|NCT00978731|1926503|FG003|Overall Study|Adverse Event|0
938934|NCT00978731|1926500|FG000|Overall Study|Participant's request|1
938935|NCT00978731|1926501|FG001|Overall Study|Participant's request|0
938936|NCT00978731|1926502|FG002|Overall Study|Participant's request|0
938937|NCT00978731|1926503|FG003|Overall Study|Participant's request|0
938938|NCT00978731|1926500|FG000|Overall Study|Administrative reason|3
938939|NCT00978731|1926501|FG001|Overall Study|Administrative reason|3
938940|NCT00978731|1926502|FG002|Overall Study|Administrative reason|1
938941|NCT00978731|1926503|FG003|Overall Study|Administrative reason|0
938942|NCT00978731|1926500|FG000|Overall Study|Deterioration without progression|0
938943|NCT00978731|1926501|FG001|Overall Study|Deterioration without progression|1
938944|NCT00978731|1926502|FG002|Overall Study|Deterioration without progression|0
938945|NCT00978731|1926503|FG003|Overall Study|Deterioration without progression|0
938946|NCT00978731|1926500|FG000|Overall Study|Disease progression/relapse|5
938947|NCT00978731|1926501|FG001|Overall Study|Disease progression/relapse|4
938948|NCT00978731|1926502|FG002|Overall Study|Disease progression/relapse|2
938949|NCT00978731|1926503|FG003|Overall Study|Disease progression/relapse|2
938950|NCT00978731|1926500|FG000|Overall Study|Study closure|3
938951|NCT00978731|1926501|FG001|Overall Study|Study closure|4
938952|NCT00978731|1926502|FG002|Overall Study|Study closure|1
938953|NCT00978731|1926503|FG003|Overall Study|Study closure|1
938954|NCT00978731|1926500|FG000|Overall Study|No response|1
938955|NCT00978731|1926501|FG001|Overall Study|No response|0
938956|NCT00978731|1926502|FG002|Overall Study|No response|0
938957|NCT00978731|1926503|FG003|Overall Study|No response|0
938958|NCT00978757|1926519|FG000|Overall Study|Physician Decision|1
938959|NCT00978757|1926520|FG001|Overall Study|Physician Decision|3
938960|NCT00979134|1926557|FG000|Overall Study|Disease progression|18
938961|NCT00979134|1926558|FG001|Overall Study|Disease progression|2
938962|NCT00979134|1926559|FG002|Overall Study|Disease progression|5
938963|NCT00979134|1926557|FG000|Overall Study|Adverse Event|0
938964|NCT00979134|1926558|FG001|Overall Study|Adverse Event|0
938965|NCT00979134|1926559|FG002|Overall Study|Adverse Event|2
938966|NCT00979134|1926557|FG000|Overall Study|Withdrawal by Subject|1
938967|NCT00979134|1926558|FG001|Overall Study|Withdrawal by Subject|1
938968|NCT00979134|1926559|FG002|Overall Study|Withdrawal by Subject|2
938969|NCT00979134|1926557|FG000|Overall Study|Lost to Follow-up|2
938970|NCT00979134|1926558|FG001|Overall Study|Lost to Follow-up|2
938971|NCT00979134|1926559|FG002|Overall Study|Lost to Follow-up|0
938972|NCT00979134|1926557|FG000|Overall Study|Death|4
938973|NCT00979134|1926558|FG001|Overall Study|Death|0
938974|NCT00979134|1926559|FG002|Overall Study|Death|26
938975|NCT00979134|1926557|FG000|Overall Study|Other|8
938976|NCT00979134|1926558|FG001|Overall Study|Other|1
938977|NCT00979134|1926559|FG002|Overall Study|Other|5
938978|NCT00979212|1926578|FG000|Overall Study|Protocol Violation|1
938979|NCT00979212|1926579|FG001|Overall Study|Protocol Violation|8
938980|NCT00979212|1926578|FG000|Overall Study|No protocol therapy received|1
938981|NCT00979212|1926579|FG001|Overall Study|No protocol therapy received|0
938982|NCT00979407|1926596|FG000|Overall Study|Withdrawal by Subject|3
938983|NCT00979407|1926597|FG001|Overall Study|Withdrawal by Subject|4
938984|NCT00979407|1926596|FG000|Overall Study|Lost to Follow-up|3
938985|NCT00979407|1926597|FG001|Overall Study|Lost to Follow-up|3
938986|NCT00979420|1926609|FG000|Overall Study|Adverse Event|1
938987|NCT00979420|1926610|FG001|Overall Study|Adverse Event|0
938988|NCT00979420|1926611|FG002|Overall Study|Adverse Event|0
938989|NCT00979420|1926612|FG003|Overall Study|Adverse Event|0
938990|NCT00979420|1926609|FG000|Overall Study|Lack of Efficacy|3
938991|NCT00979420|1926610|FG001|Overall Study|Lack of Efficacy|0
938992|NCT00979420|1926611|FG002|Overall Study|Lack of Efficacy|1
938993|NCT00979420|1926612|FG003|Overall Study|Lack of Efficacy|1
938994|NCT00979420|1926609|FG000|Overall Study|Other reasons not related to Viramune|3
938995|NCT00979420|1926610|FG001|Overall Study|Other reasons not related to Viramune|0
938996|NCT00979420|1926611|FG002|Overall Study|Other reasons not related to Viramune|0
938997|NCT00979420|1926612|FG003|Overall Study|Other reasons not related to Viramune|1
938998|NCT00979576|1926632|FG000|Combination Treatment Phase|Progressive disease|3
938999|NCT00979576|1926633|FG001|Combination Treatment Phase|Progressive disease|1
939000|NCT00979576|1926634|FG002|Combination Treatment Phase|Progressive disease|5
939001|NCT00979576|1926632|FG000|Combination Treatment Phase|Dose limiting toxicity|0
939002|NCT00979576|1926633|FG001|Combination Treatment Phase|Dose limiting toxicity|3
939003|NCT00979576|1926634|FG002|Combination Treatment Phase|Dose limiting toxicity|2
939004|NCT00979576|1926632|FG000|Combination Treatment Phase|Adverse Event|0
939005|NCT00979576|1926633|FG001|Combination Treatment Phase|Adverse Event|2
939006|NCT00979576|1926634|FG002|Combination Treatment Phase|Adverse Event|2
939007|NCT00979576|1926632|FG000|Combination Followed by Monotherapy|Progressive Disease|0
939008|NCT00979576|1926633|FG001|Combination Followed by Monotherapy|Progressive Disease|2
939009|NCT00979576|1926634|FG002|Combination Followed by Monotherapy|Progressive Disease|1
939010|NCT00979602|1926645|FG000|Overall Study|Serious Adverse Event|5
939011|NCT00979602|1926646|FG001|Overall Study|Serious Adverse Event|3
939012|NCT00979602|1926645|FG000|Overall Study|Protocol Violation|3
939013|NCT00979602|1926646|FG001|Overall Study|Protocol Violation|0
939014|NCT00979602|1926645|FG000|Overall Study|Withdrawal by Subject|31
939015|NCT00979602|1926646|FG001|Overall Study|Withdrawal by Subject|25
939016|NCT00979602|1926645|FG000|Overall Study|Lost to Follow-up|100
939017|NCT00979602|1926646|FG001|Overall Study|Lost to Follow-up|96
939018|NCT00979602|1926645|FG000|Overall Study|Migrated/moved from study area|3
939019|NCT00979602|1926646|FG001|Overall Study|Migrated/moved from study area|6
939020|NCT00979602|1926645|FG000|Overall Study|Others|3
939021|NCT00979602|1926646|FG001|Overall Study|Others|3
939022|NCT00979628|1926676|FG000|Overall Study|received regimen < 24 hours|7
939023|NCT00979628|1926677|FG001|Overall Study|received regimen < 24 hours|6
939024|NCT00979628|1926678|FG002|Overall Study|received regimen < 24 hours|5
939025|NCT00979628|1926676|FG000|Overall Study|received steroids|1
939026|NCT00979628|1926677|FG001|Overall Study|received steroids|1
939027|NCT00979628|1926678|FG002|Overall Study|received steroids|0
939028|NCT00979628|1926676|FG000|Overall Study|transferred to ICU|1
939029|NCT00979628|1926677|FG001|Overall Study|transferred to ICU|2
939030|NCT00979628|1926678|FG002|Overall Study|transferred to ICU|1
939031|NCT00979654|1926689|FG000|Overall Study|Lost to Follow-up|1
939032|NCT00979654|1926689|FG000|Overall Study|Withdrawal by Subject|22
939033|NCT00979654|1926689|FG000|Overall Study|Death|1
939034|NCT00979654|1926689|FG000|Overall Study|Lack of Efficacy|6
939035|NCT00979654|1926689|FG000|Overall Study|Adverse Event|1
939036|NCT00979654|1926689|FG000|Overall Study|Adverse Event of Diverticulitis|1
939037|NCT00979654|1926689|FG000|Overall Study|Per Principal Investigator's Discretion|1
939038|NCT00979654|1926689|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1
939039|NCT00979654|1926689|FG000|Overall Study|Serious Adverse Event|1
939040|NCT00979654|1926689|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1
939041|NCT00979901|1926734|FG000|Overall Study|Adverse Event|1
939042|NCT00979901|1926735|FG001|Overall Study|Adverse Event|3
939043|NCT00979901|1926736|FG002|Overall Study|Adverse Event|9
939044|NCT00979901|1926737|FG003|Overall Study|Adverse Event|2
939045|NCT00979901|1926734|FG000|Overall Study|Lack of Efficacy|8
939046|NCT00979901|1926735|FG001|Overall Study|Lack of Efficacy|4
939047|NCT00979901|1926736|FG002|Overall Study|Lack of Efficacy|9
939048|NCT00979901|1926737|FG003|Overall Study|Lack of Efficacy|0
939049|NCT00979901|1926734|FG000|Overall Study|Lost to Follow-up|1
939050|NCT00979901|1926735|FG001|Overall Study|Lost to Follow-up|1
939051|NCT00979901|1926736|FG002|Overall Study|Lost to Follow-up|2
939052|NCT00979901|1926737|FG003|Overall Study|Lost to Follow-up|0
939053|NCT00979901|1926734|FG000|Overall Study|Protocol Violation|2
939054|NCT00979901|1926735|FG001|Overall Study|Protocol Violation|2
939055|NCT00979901|1926736|FG002|Overall Study|Protocol Violation|7
939056|NCT00979901|1926737|FG003|Overall Study|Protocol Violation|1
939057|NCT00979901|1926734|FG000|Overall Study|Withdrawal by Subject|2
939058|NCT00979901|1926735|FG001|Overall Study|Withdrawal by Subject|1
939059|NCT00979901|1926736|FG002|Overall Study|Withdrawal by Subject|1
939060|NCT00979901|1926737|FG003|Overall Study|Withdrawal by Subject|1
939061|NCT00979901|1926734|FG000|Overall Study|Noncompliance|1
939062|NCT00979901|1926735|FG001|Overall Study|Noncompliance|0
939063|NCT00979901|1926736|FG002|Overall Study|Noncompliance|0
939064|NCT00979901|1926737|FG003|Overall Study|Noncompliance|0
939065|NCT00979901|1926734|FG000|Overall Study|out-of-state|1
939066|NCT00979901|1926735|FG001|Overall Study|out-of-state|0
939067|NCT00979901|1926736|FG002|Overall Study|out-of-state|0
939068|NCT00979901|1926737|FG003|Overall Study|out-of-state|0
939069|NCT00979901|1926734|FG000|Overall Study|vacation|1
939070|NCT00979901|1926735|FG001|Overall Study|vacation|0
939071|NCT00979901|1926736|FG002|Overall Study|vacation|0
939072|NCT00979901|1926737|FG003|Overall Study|vacation|0
939073|NCT00979901|1926734|FG000|Overall Study|elevated lab values pre-randomization|1
939074|NCT00979901|1926735|FG001|Overall Study|elevated lab values pre-randomization|0
939075|NCT00979901|1926736|FG002|Overall Study|elevated lab values pre-randomization|0
939076|NCT00979901|1926737|FG003|Overall Study|elevated lab values pre-randomization|0
939077|NCT00979901|1926734|FG000|Overall Study|Discontinued in Error|0
939078|NCT00979901|1926735|FG001|Overall Study|Discontinued in Error|1
939079|NCT00979901|1926736|FG002|Overall Study|Discontinued in Error|0
939080|NCT00979901|1926737|FG003|Overall Study|Discontinued in Error|0
939081|NCT00979901|1926734|FG000|Overall Study|Left Country|0
939082|NCT00979901|1926735|FG001|Overall Study|Left Country|0
939083|NCT00979901|1926736|FG002|Overall Study|Left Country|1
939084|NCT00979901|1926737|FG003|Overall Study|Left Country|0
939085|NCT00979901|1926734|FG000|Overall Study|Treatment Group Terminated by Sponsor|0
939086|NCT00979901|1926735|FG001|Overall Study|Treatment Group Terminated by Sponsor|0
939087|NCT00979901|1926736|FG002|Overall Study|Treatment Group Terminated by Sponsor|0
939088|NCT00979901|1926737|FG003|Overall Study|Treatment Group Terminated by Sponsor|112
939089|NCT00979953|1926759|FG000|Overall Study|Adverse Event|5
939090|NCT00979953|1926760|FG001|Overall Study|Adverse Event|2
939091|NCT00979953|1926761|FG002|Overall Study|Adverse Event|17
939092|NCT00979953|1926762|FG003|Overall Study|Adverse Event|4
939093|NCT00979953|1926759|FG000|Overall Study|Lack of Efficacy|1
939094|NCT00979953|1926760|FG001|Overall Study|Lack of Efficacy|2
939095|NCT00979953|1926761|FG002|Overall Study|Lack of Efficacy|0
939096|NCT00979953|1926762|FG003|Overall Study|Lack of Efficacy|0
939097|NCT00979953|1926759|FG000|Overall Study|Lost to Follow-up|1
939098|NCT00979953|1926760|FG001|Overall Study|Lost to Follow-up|1
939099|NCT00979953|1926761|FG002|Overall Study|Lost to Follow-up|1
939100|NCT00979953|1926762|FG003|Overall Study|Lost to Follow-up|0
939101|NCT00979953|1926759|FG000|Overall Study|Withdrawal by Subject|0
939102|NCT00979953|1926760|FG001|Overall Study|Withdrawal by Subject|0
939103|NCT00979953|1926761|FG002|Overall Study|Withdrawal by Subject|2
939104|NCT00979953|1926762|FG003|Overall Study|Withdrawal by Subject|1
939105|NCT00979953|1926759|FG000|Overall Study|Protocol Violation|1
939106|NCT00979953|1926760|FG001|Overall Study|Protocol Violation|0
939107|NCT00979953|1926761|FG002|Overall Study|Protocol Violation|2
939108|NCT00979953|1926762|FG003|Overall Study|Protocol Violation|2
939109|NCT00979992|1926772|FG000|Overall Study|Ineligible - inadequate pathology|1
939110|NCT00979992|1926772|FG000|Overall Study|Ineligible - wrong cell type|2
939111|NCT00979992|1926772|FG000|Overall Study|Refused - Never Treated|2
939112|NCT00980005|1926778|FG000|Overall Study|Withdrawal by Subject|6
939113|NCT00980005|1926779|FG001|Overall Study|Withdrawal by Subject|17
939114|NCT00980005|1926778|FG000|Overall Study|Lost to Follow-up|37
939115|NCT00980005|1926779|FG001|Overall Study|Lost to Follow-up|43
939116|NCT00980005|1926778|FG000|Overall Study|Other|4
939117|NCT00980005|1926779|FG001|Overall Study|Other|3
939118|NCT00980018|1926789|FG000|Overall Study|Adverse Event|8
939119|NCT00980018|1926789|FG000|Overall Study|Patient withdrew consent|3
939120|NCT00980018|1926789|FG000|Overall Study|Lost to Follow-up|1
939121|NCT00980044|1926796|FG000|Overall Study|Withdrawal by Subject|5
939122|NCT00980044|1926797|FG001|Overall Study|Withdrawal by Subject|7
939123|NCT00980044|1926798|FG002|Overall Study|Withdrawal by Subject|3
939124|NCT00980044|1926796|FG000|Overall Study|Protocol Violation|0
939125|NCT00980044|1926797|FG001|Overall Study|Protocol Violation|0
939126|NCT00980044|1926798|FG002|Overall Study|Protocol Violation|2
939127|NCT00980057|1926811|FG000|Overall Study|Death|13
939128|NCT00980057|1926812|FG001|Overall Study|Death|3
939129|NCT00980057|1926811|FG000|Overall Study|Adverse Event|0
939130|NCT00980057|1926812|FG001|Overall Study|Adverse Event|1
939131|NCT00980057|1926811|FG000|Overall Study|Physician Decision|4
939132|NCT00980057|1926812|FG001|Overall Study|Physician Decision|0
939133|NCT00980057|1926811|FG000|Overall Study|Lost to Follow-up|1
939134|NCT00980057|1926812|FG001|Overall Study|Lost to Follow-up|0
939135|NCT00980057|1926811|FG000|Overall Study|Withdrawal by Subject|1
939136|NCT00980057|1926812|FG001|Overall Study|Withdrawal by Subject|1
939137|NCT00980148|1926821|FG000|Overall Study|Discharged from facility|89
939138|NCT00980148|1926822|FG001|Overall Study|Discharged from facility|96
939139|NCT00980148|1926821|FG000|Overall Study|Received other antichlamydia treatment|20
939140|NCT00980148|1926822|FG001|Overall Study|Received other antichlamydia treatment|14
939141|NCT00980148|1926821|FG000|Overall Study|Negative for chlamydia at enrollment|12
939142|NCT00980148|1926822|FG001|Overall Study|Negative for chlamydia at enrollment|9
939143|NCT00980148|1926821|FG000|Overall Study|Various other reasons|8
939144|NCT00980148|1926822|FG001|Overall Study|Various other reasons|9
939145|NCT00980174|1926830|FG000|Overall Study|Withdrawal by Subject|1
939146|NCT00980174|1926831|FG001|Overall Study|Withdrawal by Subject|4
939147|NCT00980174|1926830|FG000|Overall Study|Adverse Event|0
939148|NCT00980174|1926831|FG001|Overall Study|Adverse Event|3
939149|NCT00980174|1926830|FG000|Overall Study|Ineligibility determined|2
939150|NCT00980174|1926831|FG001|Overall Study|Ineligibility determined|1
939151|NCT00980174|1926830|FG000|Overall Study|Death|1
939152|NCT00980174|1926831|FG001|Overall Study|Death|1
939153|NCT00980174|1926830|FG000|Overall Study|Other|0
939154|NCT00980174|1926831|FG001|Overall Study|Other|1
939155|NCT00980200|1926837|FG000|7-day Treatment Period 1|Withdrawal by Subject|0
939156|NCT00980200|1926838|FG001|7-day Treatment Period 1|Withdrawal by Subject|1
939157|NCT00980200|1926839|FG002|7-day Treatment Period 1|Withdrawal by Subject|0
939158|NCT00980200|1926840|FG003|7-day Treatment Period 1|Withdrawal by Subject|0
939159|NCT00980200|1926841|FG004|7-day Treatment Period 1|Withdrawal by Subject|0
939160|NCT00980200|1926837|FG000|7-day Treatment Period 3|Lack of Efficacy|0
939161|NCT00980200|1926838|FG001|7-day Treatment Period 3|Lack of Efficacy|1
939162|NCT00980200|1926839|FG002|7-day Treatment Period 3|Lack of Efficacy|0
939163|NCT00980200|1926840|FG003|7-day Treatment Period 3|Lack of Efficacy|0
939164|NCT00980200|1926841|FG004|7-day Treatment Period 3|Lack of Efficacy|1
939165|NCT00980330|1926869|FG000|Overall Study|Adverse Event|0
939166|NCT00980330|1926870|FG001|Overall Study|Adverse Event|0
939167|NCT00980330|1926871|FG002|Overall Study|Adverse Event|0
939168|NCT00980330|1926872|FG003|Overall Study|Adverse Event|1
939169|NCT00980330|1926873|FG004|Overall Study|Adverse Event|0
939170|NCT00980330|1926874|FG005|Overall Study|Adverse Event|0
939171|NCT00980330|1926875|FG006|Overall Study|Adverse Event|0
939172|NCT00980330|1926869|FG000|Overall Study|Lost to Follow-up|1
939173|NCT00980330|1926870|FG001|Overall Study|Lost to Follow-up|1
939174|NCT00980330|1926871|FG002|Overall Study|Lost to Follow-up|4
939175|NCT00980330|1926872|FG003|Overall Study|Lost to Follow-up|2
939176|NCT00980330|1926873|FG004|Overall Study|Lost to Follow-up|1
939177|NCT00980330|1926874|FG005|Overall Study|Lost to Follow-up|1
939178|NCT00980330|1926875|FG006|Overall Study|Lost to Follow-up|2
939179|NCT00980330|1926869|FG000|Overall Study|Withdrawal by Subject|2
939180|NCT00980330|1926870|FG001|Overall Study|Withdrawal by Subject|4
939181|NCT00980330|1926871|FG002|Overall Study|Withdrawal by Subject|4
939182|NCT00980330|1926872|FG003|Overall Study|Withdrawal by Subject|1
939183|NCT00980330|1926873|FG004|Overall Study|Withdrawal by Subject|3
939184|NCT00980330|1926874|FG005|Overall Study|Withdrawal by Subject|2
939185|NCT00980330|1926875|FG006|Overall Study|Withdrawal by Subject|5
939186|NCT00980330|1926869|FG000|Overall Study|(not specified)|2
939187|NCT00980330|1926870|FG001|Overall Study|(not specified)|0
939188|NCT00980330|1926871|FG002|Overall Study|(not specified)|0
939189|NCT00980330|1926872|FG003|Overall Study|(not specified)|1
939190|NCT00980330|1926873|FG004|Overall Study|(not specified)|1
939191|NCT00980330|1926874|FG005|Overall Study|(not specified)|1
939192|NCT00980330|1926875|FG006|Overall Study|(not specified)|0
939193|NCT00980343|1926894|FG000|Overall Study|no tumor at surgery - treatment effect|1
939194|NCT00980343|1926895|FG001|Overall Study|no tumor at surgery - treatment effect|3
939195|NCT00980655|1926927|FG000|Overall Study|Adverse Event|13
939196|NCT00980655|1926928|FG001|Overall Study|Adverse Event|31
939197|NCT00980655|1926927|FG000|Overall Study|Death|0
939198|NCT00980655|1926928|FG001|Overall Study|Death|7
939199|NCT00980655|1926927|FG000|Overall Study|Protocol Violation|2
939200|NCT00980655|1926928|FG001|Overall Study|Protocol Violation|7
939201|NCT00980655|1926927|FG000|Overall Study|Withdrawal by Subject|0
939202|NCT00980655|1926928|FG001|Overall Study|Withdrawal by Subject|4
939203|NCT00980655|1926927|FG000|Overall Study|Lost to Follow-up|0
939204|NCT00980655|1926928|FG001|Overall Study|Lost to Follow-up|1
939205|NCT00980655|1926927|FG000|Overall Study|Parent/legal guardian request|1
939206|NCT00980655|1926928|FG001|Overall Study|Parent/legal guardian request|0
939207|NCT00980655|1926927|FG000|Overall Study|Other|0
939208|NCT00980655|1926928|FG001|Overall Study|Other|1
939209|NCT00980798|1926981|FG000|Overall Study|Adverse Event|7
939210|NCT00980798|1926982|FG001|Overall Study|Adverse Event|36
939211|NCT00980798|1926981|FG000|Overall Study|Lack of Efficacy|16
939212|NCT00980798|1926982|FG001|Overall Study|Lack of Efficacy|5
939213|NCT00980798|1926981|FG000|Overall Study|Lost to Follow-up|0
939214|NCT00980798|1926982|FG001|Overall Study|Lost to Follow-up|1
939215|NCT00980798|1926981|FG000|Overall Study|Physician Decision|2
939216|NCT00980798|1926982|FG001|Overall Study|Physician Decision|1
939217|NCT00980798|1926981|FG000|Overall Study|Withdrawal by Subject|8
939218|NCT00980798|1926982|FG001|Overall Study|Withdrawal by Subject|11
939219|NCT00980798|1926981|FG000|Overall Study|Other|0
939220|NCT00980798|1926982|FG001|Overall Study|Other|1
939221|NCT00980980|1926991|FG000|Overall Study|Withdrawal by Hospital|0
939222|NCT00980980|1926992|FG001|Overall Study|Withdrawal by Hospital|1
939223|NCT00980980|1926993|FG002|Overall Study|Withdrawal by Hospital|0
939224|NCT00981019|1927004|FG000|Overall Study|Did not respond|65
939225|NCT00981019|1927004|FG000|Overall Study|Did not match target population|94
939226|NCT00981019|1927004|FG000|Overall Study|Inadvertent exclusion|239
939227|NCT00981019|1927004|FG000|Overall Study|Hit the survey after closure|79
939228|NCT00981058|1927019|FG000|Overall Study|Adverse Event|1
939229|NCT00981058|1927020|FG001|Overall Study|Adverse Event|1
939230|NCT00981058|1927019|FG000|Overall Study|Progressive Disease|61
939231|NCT00981058|1927020|FG001|Overall Study|Progressive Disease|49
939232|NCT00981058|1927019|FG000|Overall Study|Lost to Follow-up|16
939233|NCT00981058|1927020|FG001|Overall Study|Lost to Follow-up|15
939234|NCT00981058|1927019|FG000|Overall Study|New Anticancer Therapy|6
939235|NCT00981058|1927020|FG001|Overall Study|New Anticancer Therapy|6
939236|NCT00981058|1927019|FG000|Overall Study|Noncompliance|1
939237|NCT00981058|1927020|FG001|Overall Study|Noncompliance|0
939238|NCT00981058|1927019|FG000|Overall Study|Radiologist Error|0
939239|NCT00981058|1927020|FG001|Overall Study|Radiologist Error|1
939240|NCT00981058|1927019|FG000|Overall Study|Randomization Error|1
939241|NCT00981058|1927020|FG001|Overall Study|Randomization Error|2
939242|NCT00981058|1927019|FG000|Overall Study|Withdrawal by Subject|25
939243|NCT00981058|1927020|FG001|Overall Study|Withdrawal by Subject|23
939244|NCT00981058|1927019|FG000|Overall Study|On study treatment at conclusion|9
939245|NCT00981058|1927020|FG001|Overall Study|On study treatment at conclusion|0
939246|NCT00981084|1927028|FG000|Post Intervention (Data Analysis)|poor effort|1
939247|NCT00981084|1927029|FG001|Post Intervention (Data Analysis)|poor effort|1
939248|NCT00981084|1927028|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1
939249|NCT00981084|1927029|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0
939250|NCT00981149|1927039|FG000|Overall Study|Lost to Follow-up|1
939251|NCT00981149|1927040|FG001|Overall Study|Lost to Follow-up|2
939252|NCT00981149|1927039|FG000|Overall Study|Withdrawal by Subject|1
939253|NCT00981149|1927040|FG001|Overall Study|Withdrawal by Subject|1
939254|NCT00981175|1927049|FG000|Primary Dose Vaccination|Adverse Event|1
939255|NCT00981175|1927050|FG001|Primary Dose Vaccination|Adverse Event|0
939256|NCT00981175|1927049|FG000|Primary Dose Vaccination|Protocol Violation|0
939257|NCT00981175|1927050|FG001|Primary Dose Vaccination|Protocol Violation|1
939258|NCT00981175|1927049|FG000|Primary Dose Vaccination|Lost to Follow-up|2
939259|NCT00981175|1927050|FG001|Primary Dose Vaccination|Lost to Follow-up|1
939260|NCT00981175|1927049|FG000|Booster Dose Vaccination|Lost to Follow-up|2
939261|NCT00981175|1927050|FG001|Booster Dose Vaccination|Lost to Follow-up|3
939262|NCT00981292|1927112|FG000|Day 1|Protocol Violation|1
939263|NCT00981292|1927113|FG001|Day 1|Protocol Violation|0
939264|NCT00981292|1927114|FG002|Day 1|Protocol Violation|0
939265|NCT00981292|1927115|FG003|Day 1|Protocol Violation|0
939266|NCT00981292|1927116|FG004|Day 1|Protocol Violation|0
939267|NCT00981292|1927117|FG005|Day 1|Protocol Violation|2
939268|NCT00981292|1927112|FG000|Day 2|Protocol Violation|2
939269|NCT00981292|1927113|FG001|Day 2|Protocol Violation|0
939270|NCT00981292|1927114|FG002|Day 2|Protocol Violation|0
939271|NCT00981292|1927115|FG003|Day 2|Protocol Violation|0
939272|NCT00981292|1927116|FG004|Day 2|Protocol Violation|0
939273|NCT00981292|1927117|FG005|Day 2|Protocol Violation|0
939274|NCT00981292|1927112|FG000|Day 3|Protocol Violation|0
939275|NCT00981292|1927113|FG001|Day 3|Protocol Violation|0
939276|NCT00981292|1927114|FG002|Day 3|Protocol Violation|0
939277|NCT00981292|1927115|FG003|Day 3|Protocol Violation|0
939278|NCT00981292|1927116|FG004|Day 3|Protocol Violation|0
939279|NCT00981292|1927117|FG005|Day 3|Protocol Violation|1
939280|NCT00981409|1927140|FG000|Overall Study|Adverse Event|4
939281|NCT00981409|1927141|FG001|Overall Study|Adverse Event|0
939282|NCT00981409|1927140|FG000|Overall Study|Protocol Violation|0
939283|NCT00981409|1927141|FG001|Overall Study|Protocol Violation|1
939284|NCT00981409|1927140|FG000|Overall Study|Prostate Cancer Treatment before Trial|2
939285|NCT00981409|1927141|FG001|Overall Study|Prostate Cancer Treatment before Trial|0
939286|NCT00981461|1927162|FG000|Overall Study|Lost to Follow-up|5
939287|NCT00981461|1927163|FG001|Overall Study|Lost to Follow-up|2
939288|NCT00981526|1927182|FG000|Overall Study|Withdrawal by Subject|0
939289|NCT00981526|1927183|FG001|Overall Study|Withdrawal by Subject|2
939290|NCT00981526|1927182|FG000|Overall Study|Physician Decision|4
939291|NCT00981526|1927183|FG001|Overall Study|Physician Decision|4
939292|NCT00981578|1927191|FG000|Overall Study|Death|1
939293|NCT00981578|1927191|FG000|Overall Study|Withdrawal by Subject|2
939294|NCT00981682|1927221|FG000|Overall Study|Adverse Event|48
939295|NCT00981682|1927221|FG000|Overall Study|Withdrawal by Subject|52
939296|NCT00981682|1927221|FG000|Overall Study|Lost to Follow-up|14
939297|NCT00981682|1927221|FG000|Overall Study|Lack of Efficacy|13
939298|NCT00981682|1927221|FG000|Overall Study|Protocol Violation|6
939299|NCT00981682|1927221|FG000|Overall Study|administrative|9
939300|NCT00981747|1927225|FG000|Losartan|Withdrawal by Subject|1
939301|NCT00981747|1927225|FG000|Losartan|Death|1
939302|NCT00981747|1927225|FG000|Placebo Oral Tablet|Withdrawal by Subject|1
939303|NCT00981799|1927239|FG000|Overall Study|Adverse Event|1
939304|NCT00981799|1927240|FG001|Overall Study|Adverse Event|1
939305|NCT00981799|1927241|FG002|Overall Study|Adverse Event|0
939306|NCT00981799|1927242|FG003|Overall Study|Adverse Event|0
939307|NCT00982020|1927285|FG000|Overall Study|Adverse Event|19
939308|NCT00982020|1927286|FG001|Overall Study|Adverse Event|15
939309|NCT00982020|1927285|FG000|Overall Study|Withdrawal by Subject|11
939310|NCT00982020|1927286|FG001|Overall Study|Withdrawal by Subject|14
939311|NCT00982020|1927285|FG000|Overall Study|Lost to Follow-up|5
939312|NCT00982020|1927286|FG001|Overall Study|Lost to Follow-up|11
939313|NCT00982020|1927285|FG000|Overall Study|Lack of Efficacy|10
939314|NCT00982020|1927286|FG001|Overall Study|Lack of Efficacy|4
939315|NCT00982020|1927285|FG000|Overall Study|Parent/Caregiver Decision|5
939316|NCT00982020|1927286|FG001|Overall Study|Parent/Caregiver Decision|5
939317|NCT00982020|1927285|FG000|Overall Study|Treatment Non-compliance|3
939318|NCT00982020|1927286|FG001|Overall Study|Treatment Non-compliance|6
939319|NCT00982020|1927285|FG000|Overall Study|Physician Decision|2
939320|NCT00982020|1927286|FG001|Overall Study|Physician Decision|5
939321|NCT00982020|1927285|FG000|Overall Study|Entry Criteria Not Met|2
939322|NCT00982020|1927286|FG001|Overall Study|Entry Criteria Not Met|1
939323|NCT00982020|1927285|FG000|Overall Study|Protocol Violation|0
939324|NCT00982020|1927286|FG001|Overall Study|Protocol Violation|2
939325|NCT00982020|1927285|FG000|Overall Study|Clinical Relapse|0
939326|NCT00982020|1927286|FG001|Overall Study|Clinical Relapse|1
939339|NCT00982137|1927329|FG000|Overall Study|Lost to Follow-up|0
939340|NCT00982137|1927330|FG001|Overall Study|Lost to Follow-up|0
939341|NCT00982137|1927331|FG002|Overall Study|Lost to Follow-up|0
939342|NCT00982137|1927332|FG003|Overall Study|Lost to Follow-up|1
939343|NCT00982137|1927329|FG000|Overall Study|Withdrawal by Subject|0
939344|NCT00982137|1927330|FG001|Overall Study|Withdrawal by Subject|1
939345|NCT00982137|1927331|FG002|Overall Study|Withdrawal by Subject|0
939346|NCT00982137|1927332|FG003|Overall Study|Withdrawal by Subject|0
939347|NCT00982228|1927370|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
939348|NCT00982228|1927371|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
939349|NCT00982228|1927370|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
939350|NCT00982228|1927371|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
939351|NCT00982228|1927370|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
939352|NCT00982228|1927371|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
939353|NCT00982228|1927370|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
939354|NCT00982228|1927371|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
939355|NCT00982228|1927370|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
939356|NCT00982228|1927371|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
939357|NCT00982228|1927370|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
939358|NCT00982228|1927371|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
939359|NCT00982228|1927370|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
939360|NCT00982228|1927371|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
939361|NCT00982228|1927370|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
939362|NCT00982228|1927371|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
939363|NCT00982228|1927370|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
939364|NCT00982228|1927371|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
939365|NCT00982228|1927370|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
939366|NCT00982228|1927371|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
939367|NCT00982280|1927377|FG000|Observation Period|Not eligible to be dosed|19
939368|NCT00982280|1927377|FG000|Titration and Optimal Dose Period|Adverse Event|5
939369|NCT00982280|1927377|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2
939370|NCT00982280|1927377|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1
939371|NCT00982280|1927377|FG000|Maintenance Period|Adverse Event|1
939372|NCT00982319|1927384|FG000|Overall Study|Surgery date change|1
939373|NCT00982319|1927385|FG001|Overall Study|Surgery date change|0
939374|NCT00982319|1927384|FG000|Overall Study|Preop values out of acceptable range|1
939375|NCT00982319|1927385|FG001|Overall Study|Preop values out of acceptable range|1
939376|NCT00982319|1927384|FG000|Overall Study|Pregnancy|0
939377|NCT00982319|1927385|FG001|Overall Study|Pregnancy|1
939378|NCT00982410|1927409|FG000|3-month Follow-up Assessment|Could not reach to schedule|8
939379|NCT00982410|1927410|FG001|3-month Follow-up Assessment|Could not reach to schedule|9
939380|NCT00982410|1927409|FG000|3-month Follow-up Assessment|Scheduled, no-show|1
939381|NCT00982410|1927410|FG001|3-month Follow-up Assessment|Scheduled, no-show|2
939382|NCT00982410|1927409|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0
939383|NCT00982410|1927410|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2
939384|NCT00982410|1927409|FG000|6-month Follow-up Assessment|Could not reach to schedule|5
939385|NCT00982410|1927410|FG001|6-month Follow-up Assessment|Could not reach to schedule|7
939386|NCT00982410|1927409|FG000|6-month Follow-up Assessment|participant no transportation|1
939387|NCT00982410|1927410|FG001|6-month Follow-up Assessment|participant no transportation|0
939388|NCT00982410|1927409|FG000|6-month Follow-up Assessment|incarceration|0
939389|NCT00982410|1927410|FG001|6-month Follow-up Assessment|incarceration|2
939390|NCT00982410|1927409|FG000|6-month Follow-up Assessment|patent surgery|0
939391|NCT00982410|1927410|FG001|6-month Follow-up Assessment|patent surgery|1
939392|NCT00982410|1927409|FG000|6-month Follow-up Assessment|scheduled, no-show|0
939393|NCT00982410|1927410|FG001|6-month Follow-up Assessment|scheduled, no-show|1
939394|NCT00982410|1927409|FG000|12-month Follow-up Assessment|Death|0
939395|NCT00982410|1927410|FG001|12-month Follow-up Assessment|Death|2
939396|NCT00982410|1927409|FG000|12-month Follow-up Assessment|could not reach to schedule|6
939397|NCT00982410|1927410|FG001|12-month Follow-up Assessment|could not reach to schedule|5
939398|NCT00982410|1927409|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0
939399|NCT00982410|1927410|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1
939400|NCT00982410|1927409|FG000|12-month Follow-up Assessment|incarceration|2
939401|NCT00982410|1927410|FG001|12-month Follow-up Assessment|incarceration|1
939402|NCT00982410|1927409|FG000|12-month Follow-up Assessment|scheduled, no-show|1
939403|NCT00982410|1927410|FG001|12-month Follow-up Assessment|scheduled, no-show|0
939404|NCT00982488|1927432|FG000|Overall Study|Administrative reason by sponsor|81
939405|NCT00982488|1927433|FG001|Overall Study|Administrative reason by sponsor|3
939406|NCT00982488|1927434|FG002|Overall Study|Administrative reason by sponsor|11
939407|NCT00982488|1927435|FG003|Overall Study|Administrative reason by sponsor|0
939408|NCT00982488|1927436|FG004|Overall Study|Administrative reason by sponsor|0
939409|NCT00982488|1927432|FG000|Overall Study|Adverse event unrelated to study drug|5
939410|NCT00982488|1927433|FG001|Overall Study|Adverse event unrelated to study drug|1
939411|NCT00982488|1927434|FG002|Overall Study|Adverse event unrelated to study drug|0
939412|NCT00982488|1927435|FG003|Overall Study|Adverse event unrelated to study drug|0
939413|NCT00982488|1927436|FG004|Overall Study|Adverse event unrelated to study drug|0
939414|NCT00982488|1927432|FG000|Overall Study|Death|11
939415|NCT00982488|1927433|FG001|Overall Study|Death|0
939416|NCT00982488|1927434|FG002|Overall Study|Death|2
939417|NCT00982488|1927435|FG003|Overall Study|Death|0
939418|NCT00982488|1927436|FG004|Overall Study|Death|0
939419|NCT00982488|1927432|FG000|Overall Study|Disease progression|30
939420|NCT00982488|1927433|FG001|Overall Study|Disease progression|5
939421|NCT00982488|1927434|FG002|Overall Study|Disease progression|10
939422|NCT00982488|1927435|FG003|Overall Study|Disease progression|1
939423|NCT00982488|1927436|FG004|Overall Study|Disease progression|1
939424|NCT00982488|1927432|FG000|Overall Study|Lost to Follow-up|1
939425|NCT00982488|1927433|FG001|Overall Study|Lost to Follow-up|0
939426|NCT00982488|1927434|FG002|Overall Study|Lost to Follow-up|0
939427|NCT00982488|1927435|FG003|Overall Study|Lost to Follow-up|0
939428|NCT00982488|1927436|FG004|Overall Study|Lost to Follow-up|0
939429|NCT00982488|1927432|FG000|Overall Study|Maximum clinical benefit|1
939430|NCT00982488|1927433|FG001|Overall Study|Maximum clinical benefit|1
939431|NCT00982488|1927434|FG002|Overall Study|Maximum clinical benefit|1
939432|NCT00982488|1927435|FG003|Overall Study|Maximum clinical benefit|0
939433|NCT00982488|1927436|FG004|Overall Study|Maximum clinical benefit|0
939434|NCT00982488|1927432|FG000|Overall Study|Other|15
939435|NCT00982488|1927433|FG001|Overall Study|Other|1
939436|NCT00982488|1927434|FG002|Overall Study|Other|3
939437|NCT00982488|1927435|FG003|Overall Study|Other|1
939438|NCT00982488|1927436|FG004|Overall Study|Other|0
939439|NCT00982488|1927432|FG000|Overall Study|Poor compliance/noncompliance|0
939440|NCT00982488|1927433|FG001|Overall Study|Poor compliance/noncompliance|1
939441|NCT00982488|1927434|FG002|Overall Study|Poor compliance/noncompliance|0
939442|NCT00982488|1927435|FG003|Overall Study|Poor compliance/noncompliance|0
939443|NCT00982488|1927436|FG004|Overall Study|Poor compliance/noncompliance|0
939444|NCT00982488|1927432|FG000|Overall Study|Stem cell transplant|2
939445|NCT00982488|1927433|FG001|Overall Study|Stem cell transplant|0
939446|NCT00982488|1927434|FG002|Overall Study|Stem cell transplant|0
939447|NCT00982488|1927435|FG003|Overall Study|Stem cell transplant|1
939448|NCT00982488|1927436|FG004|Overall Study|Stem cell transplant|0
939449|NCT00982488|1927432|FG000|Overall Study|Study drug toxicity|34
939450|NCT00982488|1927433|FG001|Overall Study|Study drug toxicity|1
939451|NCT00982488|1927434|FG002|Overall Study|Study drug toxicity|6
939452|NCT00982488|1927435|FG003|Overall Study|Study drug toxicity|0
939453|NCT00982488|1927436|FG004|Overall Study|Study drug toxicity|0
939454|NCT00982488|1927432|FG000|Overall Study|Withdrawal by Subject|5
939455|NCT00982488|1927433|FG001|Overall Study|Withdrawal by Subject|1
939456|NCT00982488|1927434|FG002|Overall Study|Withdrawal by Subject|1
939457|NCT00982488|1927435|FG003|Overall Study|Withdrawal by Subject|0
939458|NCT00982488|1927436|FG004|Overall Study|Withdrawal by Subject|0
939459|NCT00982644|1927468|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
939460|NCT00982644|1927469|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
939461|NCT00982644|1927468|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
939462|NCT00982644|1927469|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
939463|NCT00982644|1927468|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
939464|NCT00982644|1927469|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
939465|NCT00982644|1927468|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
939466|NCT00982644|1927469|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
939467|NCT00982644|1927468|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
939468|NCT00982644|1927469|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
939469|NCT00982644|1927468|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
939470|NCT00982644|1927469|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
939471|NCT00982644|1927468|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
939472|NCT00982644|1927469|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
939473|NCT00982644|1927468|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
939474|NCT00982644|1927469|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
939475|NCT00982644|1927468|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
939476|NCT00982644|1927469|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
939477|NCT00982644|1927468|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
939478|NCT00982644|1927469|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
939479|NCT00982657|1927479|FG000|Overall Study|Death|1
939480|NCT00982657|1927480|FG001|Overall Study|Death|0
939481|NCT00982657|1927481|FG002|Overall Study|Death|1
939482|NCT00982657|1927482|FG003|Overall Study|Death|1
939483|NCT00982657|1927479|FG000|Overall Study|Withdrawal by Subject|0
939484|NCT00982657|1927480|FG001|Overall Study|Withdrawal by Subject|0
939485|NCT00982657|1927481|FG002|Overall Study|Withdrawal by Subject|1
939486|NCT00982657|1927482|FG003|Overall Study|Withdrawal by Subject|3
939487|NCT00982657|1927479|FG000|Overall Study|Other|0
939488|NCT00982657|1927480|FG001|Overall Study|Other|0
939489|NCT00982657|1927481|FG002|Overall Study|Other|0
939490|NCT00982657|1927482|FG003|Overall Study|Other|4
939491|NCT00982657|1927479|FG000|Overall Study|On going at date of cut-off|0
939492|NCT00982657|1927480|FG001|Overall Study|On going at date of cut-off|0
939493|NCT00982657|1927481|FG002|Overall Study|On going at date of cut-off|0
939494|NCT00982657|1927482|FG003|Overall Study|On going at date of cut-off|1
939495|NCT00982735|1927502|FG000|Overall Study|Lost to Follow-up|6
939496|NCT00982735|1927502|FG000|Overall Study|Patient ineligible for trial|224
939497|NCT00982878|1927560|FG000|Overall Study|Physician Decision|1
939498|NCT00982930|1927564|FG000|Overall Study|Adverse Event|1
939499|NCT00982930|1927564|FG000|Overall Study|Withdrawal by Subject|1
939500|NCT00982930|1927564|FG000|Overall Study|Administrative Problems|2
939501|NCT00983073|1927568|FG000|Titration and Optimal Dose Period|Adverse Event|19
939502|NCT00983073|1927568|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11
939503|NCT00983073|1927568|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5
939504|NCT00983073|1927568|FG000|Titration and Optimal Dose Period|Non-Compliance|1
939505|NCT00983073|1927568|FG000|Titration and Optimal Dose Period|Other reason|4
939506|NCT00983073|1927568|FG000|Maintenance Period|Adverse Event|5
939507|NCT00983073|1927568|FG000|Maintenance Period|Withdrawal by Subject|2
939508|NCT00983073|1927568|FG000|Maintenance Period|Lack of Efficacy|2
939509|NCT00983073|1927568|FG000|Maintenance Period|Other Reason|7
939510|NCT00983294|1927596|FG000|14 Day Washout Period|Withdrawal by Subject|2
939511|NCT00983294|1927596|FG000|Colchicine With Azithromycin|Adverse Event|1
939512|NCT00983372|1927615|FG000|14 Day Washout Period|Withdrawal by Subject|1
939513|NCT00983372|1927615|FG000|Diltiazem ER Alone|missed diltiazem dose|2
939514|NCT00983372|1927615|FG000|Diltiazem ER Alone|Adverse Event|1
939515|NCT00983385|1927622|FG000|Observation Period|Not eligible to be dosed|20
939516|NCT00983385|1927622|FG000|Observation Period|Not Evaluable due to Non Compliance|12
939523|NCT00983476|1927648|FG000|Overall Study|Did not receive intervention|17
939524|NCT00983476|1927649|FG001|Overall Study|Did not receive intervention|22
939525|NCT00983476|1927650|FG002|Overall Study|Did not receive intervention|0
939526|NCT00983515|1927677|FG000|Ritonavir Alone|liver panel out of range|6
939527|NCT00983515|1927677|FG000|Colchicine With Ritonavir|Lost to Follow-up|1
939528|NCT00983528|1927684|FG000|Overall Study|Death|4
939529|NCT00983528|1927684|FG000|Overall Study|Lost to Follow-up|1
939530|NCT00983528|1927684|FG000|Overall Study|Study Terminated|1
939531|NCT00983580|1927694|FG000|Overall Study|Cancel Prior to treatment|1
939532|NCT00983580|1927695|FG001|Overall Study|Cancel Prior to treatment|3
939533|NCT00983580|1927694|FG000|Overall Study|Protocol Violation|1
939534|NCT00983580|1927695|FG001|Overall Study|Protocol Violation|1
939535|NCT00983580|1927694|FG000|Overall Study|Ineligible|3
939536|NCT00983580|1927695|FG001|Overall Study|Ineligible|0
939537|NCT00983619|1927714|FG000|Overall Study|Lost to Follow-up|0
939538|NCT00983619|1927715|FG001|Overall Study|Lost to Follow-up|1
939539|NCT00983619|1927716|FG002|Overall Study|Lost to Follow-up|0
939540|NCT00983619|1927717|FG003|Overall Study|Lost to Follow-up|0
939541|NCT00983619|1927718|FG004|Overall Study|Lost to Follow-up|0
939542|NCT00983619|1927719|FG005|Overall Study|Lost to Follow-up|2
939543|NCT00983619|1927720|FG006|Overall Study|Lost to Follow-up|0
939544|NCT00983619|1927721|FG007|Overall Study|Lost to Follow-up|0
939545|NCT00983619|1927722|FG008|Overall Study|Lost to Follow-up|0
939546|NCT00983619|1927723|FG009|Overall Study|Lost to Follow-up|0
939547|NCT00983619|1927724|FG010|Overall Study|Lost to Follow-up|0
939548|NCT00983619|1927725|FG011|Overall Study|Lost to Follow-up|2
939549|NCT00983619|1927714|FG000|Overall Study|Withdrawal by Subject|2
939550|NCT00983619|1927715|FG001|Overall Study|Withdrawal by Subject|1
939551|NCT00983619|1927716|FG002|Overall Study|Withdrawal by Subject|1
939552|NCT00983619|1927717|FG003|Overall Study|Withdrawal by Subject|3
939553|NCT00983619|1927718|FG004|Overall Study|Withdrawal by Subject|1
939554|NCT00983619|1927719|FG005|Overall Study|Withdrawal by Subject|23
939555|NCT00983619|1927720|FG006|Overall Study|Withdrawal by Subject|0
939556|NCT00983619|1927721|FG007|Overall Study|Withdrawal by Subject|0
939557|NCT00983619|1927722|FG008|Overall Study|Withdrawal by Subject|0
939558|NCT00983619|1927723|FG009|Overall Study|Withdrawal by Subject|0
939559|NCT00983619|1927724|FG010|Overall Study|Withdrawal by Subject|1
939560|NCT00983619|1927725|FG011|Overall Study|Withdrawal by Subject|1
939561|NCT00983619|1927714|FG000|Overall Study|Death|0
939562|NCT00983619|1927715|FG001|Overall Study|Death|2
939563|NCT00983619|1927716|FG002|Overall Study|Death|2
939564|NCT00983619|1927717|FG003|Overall Study|Death|1
939565|NCT00983619|1927718|FG004|Overall Study|Death|2
939566|NCT00983619|1927719|FG005|Overall Study|Death|30
939567|NCT00983619|1927720|FG006|Overall Study|Death|1
939568|NCT00983619|1927721|FG007|Overall Study|Death|0
939569|NCT00983619|1927722|FG008|Overall Study|Death|1
939570|NCT00983619|1927723|FG009|Overall Study|Death|2
939571|NCT00983619|1927724|FG010|Overall Study|Death|9
939572|NCT00983619|1927725|FG011|Overall Study|Death|8
939573|NCT00983619|1927714|FG000|Overall Study|Other|1
939574|NCT00983619|1927715|FG001|Overall Study|Other|0
939575|NCT00983619|1927716|FG002|Overall Study|Other|0
939576|NCT00983619|1927717|FG003|Overall Study|Other|1
939577|NCT00983619|1927718|FG004|Overall Study|Other|0
939578|NCT00983619|1927719|FG005|Overall Study|Other|12
939579|NCT00983619|1927720|FG006|Overall Study|Other|2
939580|NCT00983619|1927721|FG007|Overall Study|Other|2
939581|NCT00983619|1927722|FG008|Overall Study|Other|0
939582|NCT00983619|1927723|FG009|Overall Study|Other|1
939583|NCT00983619|1927724|FG010|Overall Study|Other|1
939584|NCT00983619|1927725|FG011|Overall Study|Other|0
939585|NCT00983749|1927773|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
939586|NCT00983749|1927774|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
939587|NCT00983827|1927784|FG000|Overall Study|Withdrawal by Subject|1
939588|NCT00983853|1927794|FG000|Overall Study|Lost to Follow-up|1
939589|NCT00983853|1927795|FG001|Overall Study|Lost to Follow-up|1
939590|NCT00983853|1927796|FG002|Overall Study|Lost to Follow-up|2
939591|NCT00983853|1927797|FG003|Overall Study|Lost to Follow-up|2
939592|NCT00983853|1927798|FG004|Overall Study|Lost to Follow-up|2
939593|NCT00983853|1927799|FG005|Overall Study|Lost to Follow-up|1
939594|NCT00983853|1927794|FG000|Overall Study|Withdrawal by Subject|0
939595|NCT00983853|1927795|FG001|Overall Study|Withdrawal by Subject|0
939596|NCT00983853|1927796|FG002|Overall Study|Withdrawal by Subject|1
939597|NCT00983853|1927797|FG003|Overall Study|Withdrawal by Subject|0
939598|NCT00983853|1927798|FG004|Overall Study|Withdrawal by Subject|1
939599|NCT00983853|1927799|FG005|Overall Study|Withdrawal by Subject|0
939600|NCT00983853|1927794|FG000|Overall Study|Unable to come to study follow-up visits|0
939601|NCT00983853|1927795|FG001|Overall Study|Unable to come to study follow-up visits|1
939602|NCT00983853|1927796|FG002|Overall Study|Unable to come to study follow-up visits|0
939603|NCT00983853|1927797|FG003|Overall Study|Unable to come to study follow-up visits|0
939604|NCT00983853|1927798|FG004|Overall Study|Unable to come to study follow-up visits|0
939605|NCT00983853|1927799|FG005|Overall Study|Unable to come to study follow-up visits|0
939606|NCT00983892|1927817|FG000|Overall Study|Withdrawal by Subject|10
939607|NCT00983892|1927818|FG001|Overall Study|Withdrawal by Subject|12
939608|NCT00983905|1927824|FG000|Theophylline Alone|Adverse Event|1
939609|NCT00983905|1927824|FG000|Colchicine Alone|Adverse Event|2
939610|NCT00983918|1927835|FG000|Overall Study|conversion to open cholecystectomy|0
939611|NCT00983918|1927836|FG001|Overall Study|conversion to open cholecystectomy|2
939612|NCT00983918|1927837|FG002|Overall Study|conversion to open cholecystectomy|2
939613|NCT00983918|1927838|FG003|Overall Study|conversion to open cholecystectomy|2
939614|NCT00983931|1927848|FG000|14 Day Washout Period|Physician Decision|1
939615|NCT00983957|1927854|FG000|Overall Study|Adverse Event|1
939616|NCT00983957|1927854|FG000|Overall Study|Personal Reasons|1
939617|NCT00984009|1927878|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1
939618|NCT00984022|1927887|FG000|Overall Study|Lost to Follow-up|10
939619|NCT00984022|1927888|FG001|Overall Study|Lost to Follow-up|14
939620|NCT00984061|1927894|FG000|Clarithromycin Alone|Protocol Violation|1
939621|NCT00984126|1927905|FG000|Overall Study|Protocol Violation|0
939622|NCT00984126|1927906|FG001|Overall Study|Protocol Violation|0
939623|NCT00984126|1927907|FG002|Overall Study|Protocol Violation|1
939624|NCT00984126|1927908|FG003|Overall Study|Protocol Violation|2
939625|NCT00984126|1927905|FG000|Overall Study|Adverse Event|0
939626|NCT00984126|1927906|FG001|Overall Study|Adverse Event|0
939627|NCT00984126|1927907|FG002|Overall Study|Adverse Event|0
939628|NCT00984126|1927908|FG003|Overall Study|Adverse Event|2
939629|NCT00984126|1927905|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7
939630|NCT00984126|1927906|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7
939631|NCT00984126|1927907|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3
939632|NCT00984126|1927908|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46
939633|NCT00984126|1927905|FG000|Overall Study|Withdrawal criteria|0
939634|NCT00984126|1927906|FG001|Overall Study|Withdrawal criteria|1
939635|NCT00984126|1927907|FG002|Overall Study|Withdrawal criteria|3
939636|NCT00984126|1927908|FG003|Overall Study|Withdrawal criteria|9
939637|NCT00984165|1927935|FG000|Overall Study|Death on study|2
939638|NCT00984165|1927936|FG001|Overall Study|Death on study|0
939639|NCT00984165|1927937|FG002|Overall Study|Death on study|0
939640|NCT00984165|1927938|FG003|Overall Study|Death on study|0
939641|NCT00984165|1927935|FG000|Overall Study|Disease progression on study|5
939642|NCT00984165|1927936|FG001|Overall Study|Disease progression on study|1
939643|NCT00984165|1927937|FG002|Overall Study|Disease progression on study|0
939644|NCT00984165|1927938|FG003|Overall Study|Disease progression on study|0
939645|NCT00984165|1927935|FG000|Overall Study|Death of recipient|0
939646|NCT00984165|1927936|FG001|Overall Study|Death of recipient|0
939647|NCT00984165|1927937|FG002|Overall Study|Death of recipient|0
939648|NCT00984165|1927938|FG003|Overall Study|Death of recipient|1
939649|NCT00984165|1927935|FG000|Overall Study|New protocol|0
939650|NCT00984165|1927936|FG001|Overall Study|New protocol|0
939651|NCT00984165|1927937|FG002|Overall Study|New protocol|0
939652|NCT00984165|1927938|FG003|Overall Study|New protocol|1
939653|NCT00984165|1927935|FG000|Overall Study|P+/donor pair removed from protocol|0
939654|NCT00984165|1927936|FG001|Overall Study|P+/donor pair removed from protocol|0
939655|NCT00984165|1927937|FG002|Overall Study|P+/donor pair removed from protocol|0
939656|NCT00984165|1927938|FG003|Overall Study|P+/donor pair removed from protocol|1
939657|NCT00984165|1927935|FG000|Overall Study|removed with a pair recipient|0
939658|NCT00984165|1927936|FG001|Overall Study|removed with a pair recipient|0
939659|NCT00984165|1927937|FG002|Overall Study|removed with a pair recipient|0
939660|NCT00984165|1927938|FG003|Overall Study|removed with a pair recipient|1
939661|NCT00984204|1927949|FG000|Overall Study|Death|1
939662|NCT00984204|1927949|FG000|Overall Study|Lost to Follow-up|4
939663|NCT00984204|1927949|FG000|Overall Study|Lack of Efficacy|10
939664|NCT00984256|1927955|FG000|Overall Study|Withdrawal by Subject|0
939665|NCT00984256|1927956|FG001|Overall Study|Withdrawal by Subject|1
939666|NCT00984282|1927973|FG000|Double Blind Treatment|Adverse Event|40
939667|NCT00984282|1927974|FG001|Double Blind Treatment|Adverse Event|6
939668|NCT00984282|1927973|FG000|Double Blind Treatment|Progression, recurrence or relapse|25
939669|NCT00984282|1927974|FG001|Double Blind Treatment|Progression, recurrence or relapse|3
939670|NCT00984282|1927973|FG000|Double Blind Treatment|Physician Decision|1
939671|NCT00984282|1927974|FG001|Double Blind Treatment|Physician Decision|2
939672|NCT00984282|1927973|FG000|Double Blind Treatment|Noncompliance with study medication|3
939673|NCT00984282|1927974|FG001|Double Blind Treatment|Noncompliance with study medication|0
939674|NCT00984282|1927973|FG000|Double Blind Treatment|Progression by clinical judgment|2
939675|NCT00984282|1927974|FG001|Double Blind Treatment|Progression by clinical judgment|0
939676|NCT00984282|1927973|FG000|Double Blind Treatment|Withdrawal by Subject|13
939677|NCT00984282|1927974|FG001|Double Blind Treatment|Withdrawal by Subject|18
939678|NCT00984282|1927973|FG000|Double Blind Treatment|Lost to Follow-up|3
939679|NCT00984282|1927974|FG001|Double Blind Treatment|Lost to Follow-up|0
939680|NCT00984282|1927973|FG000|Double Blind Treatment|Death|8
939681|NCT00984282|1927974|FG001|Double Blind Treatment|Death|4
939682|NCT00984282|1927973|FG000|Double Blind Treatment|Not treated|0
939683|NCT00984282|1927974|FG001|Double Blind Treatment|Not treated|1
939684|NCT00984282|1927973|FG000|Double Blind Treatment|Switched to commercial drug|6
939685|NCT00984282|1927974|FG001|Double Blind Treatment|Switched to commercial drug|1
939686|NCT00984282|1927973|FG000|Double Blind Treatment|protocol driven decision point|1
939687|NCT00984282|1927974|FG001|Double Blind Treatment|protocol driven decision point|1
939688|NCT00984282|1927973|FG000|Double Blind Treatment|Radiological and clinical progression|0
939689|NCT00984282|1927974|FG001|Double Blind Treatment|Radiological and clinical progression|1
939690|NCT00984282|1927973|FG000|Double Blind Treatment|Transferred to treat. continuation study|2
939691|NCT00984282|1927974|FG001|Double Blind Treatment|Transferred to treat. continuation study|1
939692|NCT00984282|1927973|FG000|Open-label Treatment|Adverse Event|20
939693|NCT00984282|1927974|FG001|Open-label Treatment|Adverse Event|30
939694|NCT00984282|1927973|FG000|Open-label Treatment|Withdrawal by Subject|6
939695|NCT00984282|1927974|FG001|Open-label Treatment|Withdrawal by Subject|21
939696|NCT00984282|1927973|FG000|Open-label Treatment|Death|7
939697|NCT00984282|1927974|FG001|Open-label Treatment|Death|15
939698|NCT00984282|1927973|FG000|Open-label Treatment|Progression, recurrence or relapse|40
939699|NCT00984282|1927974|FG001|Open-label Treatment|Progression, recurrence or relapse|82
939700|NCT00984282|1927973|FG000|Open-label Treatment|Lost to Follow-up|1
939701|NCT00984282|1927974|FG001|Open-label Treatment|Lost to Follow-up|1
939702|NCT00984282|1927973|FG000|Open-label Treatment|Patient convenience|1
939703|NCT00984282|1927974|FG001|Open-label Treatment|Patient convenience|0
939704|NCT00984282|1927973|FG000|Open-label Treatment|Non-compliant with study medication|1
939705|NCT00984282|1927974|FG001|Open-label Treatment|Non-compliant with study medication|0
939706|NCT00984282|1927973|FG000|Open-label Treatment|Target lesion removed|0
939707|NCT00984282|1927974|FG001|Open-label Treatment|Target lesion removed|1
939708|NCT00984282|1927973|FG000|Open-label Treatment|Protocol driven decision point|1
939709|NCT00984282|1927974|FG001|Open-label Treatment|Protocol driven decision point|1
939710|NCT00984282|1927973|FG000|Open-label Treatment|Transferred to treat. continuation study|2
939711|NCT00984282|1927974|FG001|Open-label Treatment|Transferred to treat. continuation study|3
939712|NCT00984282|1927973|FG000|Open-label Treatment|Switched to commercial drug|6
939713|NCT00984282|1927974|FG001|Open-label Treatment|Switched to commercial drug|7
939714|NCT00984282|1927973|FG000|Open-label Treatment|Physician Decision|1
939715|NCT00984282|1927974|FG001|Open-label Treatment|Physician Decision|0
939716|NCT00984282|1927973|FG000|Long Term Follow-up|Withdrawal by Subject|8
939717|NCT00984282|1927974|FG001|Long Term Follow-up|Withdrawal by Subject|14
939718|NCT00984282|1927973|FG000|Long Term Follow-up|Death|27
939719|NCT00984282|1927974|FG001|Long Term Follow-up|Death|68
939720|NCT00984282|1927973|FG000|Long Term Follow-up|Lost to Follow-up|3
939721|NCT00984282|1927974|FG001|Long Term Follow-up|Lost to Follow-up|6
939722|NCT00984282|1927973|FG000|Long Term Follow-up|Protocol driven decision point|25
939723|NCT00984282|1927974|FG001|Long Term Follow-up|Protocol driven decision point|26
939724|NCT00984282|1927973|FG000|Long Term Follow-up|Transferred to treat. continuation study|2
939725|NCT00984282|1927974|FG001|Long Term Follow-up|Transferred to treat. continuation study|3
939726|NCT00984282|1927973|FG000|Long Term Follow-up|Switched to commercial drug|4
939727|NCT00984282|1927974|FG001|Long Term Follow-up|Switched to commercial drug|2
939728|NCT00984282|1927973|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0
939729|NCT00984282|1927974|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1
939730|NCT00984295|1927985|FG000|Overall Study|Lost to Follow-up|31
939731|NCT00984295|1927986|FG001|Overall Study|Lost to Follow-up|12
939732|NCT00984295|1927987|FG002|Overall Study|Lost to Follow-up|13
939733|NCT00984295|1927985|FG000|Overall Study|Protocol Violation|2
939734|NCT00984295|1927986|FG001|Overall Study|Protocol Violation|1
939735|NCT00984295|1927987|FG002|Overall Study|Protocol Violation|4
939736|NCT00984295|1927985|FG000|Overall Study|Withdrawal by Subject|18
939737|NCT00984295|1927986|FG001|Overall Study|Withdrawal by Subject|9
939738|NCT00984295|1927987|FG002|Overall Study|Withdrawal by Subject|12
939739|NCT00984295|1927985|FG000|Overall Study|CAE - discontinued test vaccine|0
939740|NCT00984295|1927986|FG001|Overall Study|CAE - discontinued test vaccine|1
939741|NCT00984295|1927987|FG002|Overall Study|CAE - discontinued test vaccine|3
939742|NCT00984295|1927985|FG000|Overall Study|Missed one or more blood samplings|3
939743|NCT00984295|1927986|FG001|Overall Study|Missed one or more blood samplings|7
939744|NCT00984295|1927987|FG002|Overall Study|Missed one or more blood samplings|2
939745|NCT00984295|1927985|FG000|Overall Study|Incomplete safety follow-up|11
939746|NCT00984295|1927986|FG001|Overall Study|Incomplete safety follow-up|2
939747|NCT00984295|1927987|FG002|Overall Study|Incomplete safety follow-up|3
939748|NCT00984542|1928025|FG000|Overall Study|disease progression|19
939749|NCT00984542|1928025|FG000|Overall Study|toxicity|7
939750|NCT00984542|1928025|FG000|Overall Study|Death|7
939751|NCT00984542|1928025|FG000|Overall Study|complicating disease|3
939752|NCT00984542|1928025|FG000|Overall Study|Withdrawal by Subject|3
939753|NCT00984542|1928025|FG000|Overall Study|clinical deterioration|2
939754|NCT00984568|1928032|FG000|Overall Study|Withdrawal by Subject|1
939755|NCT00984568|1928033|FG001|Overall Study|Withdrawal by Subject|2
939756|NCT00984568|1928032|FG000|Overall Study|Lack of Efficacy|2
939757|NCT00984568|1928033|FG001|Overall Study|Lack of Efficacy|0
939758|NCT00984568|1928032|FG000|Overall Study|Adverse Event|2
939759|NCT00984568|1928033|FG001|Overall Study|Adverse Event|0
939760|NCT00984568|1928032|FG000|Overall Study|Did Not Meet Randomization Criteria|1
939761|NCT00984568|1928033|FG001|Overall Study|Did Not Meet Randomization Criteria|0
939762|NCT00984568|1928032|FG000|Overall Study|Lost to Follow-up|0
939763|NCT00984568|1928033|FG001|Overall Study|Lost to Follow-up|1
939764|NCT00984568|1928032|FG000|Overall Study|Opportunistic Infection|1
939765|NCT00984568|1928033|FG001|Overall Study|Opportunistic Infection|0
939766|NCT00984568|1928032|FG000|Overall Study|Unknown Reason|1
939767|NCT00984568|1928033|FG001|Overall Study|Unknown Reason|3
939768|NCT00984594|1928041|FG000|Overall Study|Lost to Follow-up|1
939769|NCT00984594|1928042|FG001|Overall Study|Lost to Follow-up|0
939770|NCT00984594|1928041|FG000|Overall Study|Withdrawal by Subject|0
939771|NCT00984594|1928042|FG001|Overall Study|Withdrawal by Subject|1
939772|NCT00984620|1928052|FG000|Overall Study|Adverse Event|5
939773|NCT00984620|1928053|FG001|Overall Study|Adverse Event|5
939774|NCT00984620|1928052|FG000|Overall Study|Lost to Follow-up|1
939775|NCT00984620|1928053|FG001|Overall Study|Lost to Follow-up|1
939776|NCT00984620|1928052|FG000|Overall Study|Withdrawal by Subject|0
939777|NCT00984620|1928053|FG001|Overall Study|Withdrawal by Subject|2
939778|NCT00984620|1928052|FG000|Overall Study|reason other than listed above|0
939779|NCT00984620|1928053|FG001|Overall Study|reason other than listed above|4
939780|NCT00984659|1928065|FG000|2-week Run-in Period|Adverse Event|8
939781|NCT00984659|1928066|FG001|2-week Run-in Period|Adverse Event|0
939782|NCT00984659|1928067|FG002|2-week Run-in Period|Adverse Event|0
939783|NCT00984659|1928068|FG003|2-week Run-in Period|Adverse Event|0
939784|NCT00984659|1928065|FG000|2-week Run-in Period|Protocol Violation|5
939785|NCT00984659|1928066|FG001|2-week Run-in Period|Protocol Violation|0
939786|NCT00984659|1928067|FG002|2-week Run-in Period|Protocol Violation|0
939787|NCT00984659|1928068|FG003|2-week Run-in Period|Protocol Violation|0
939788|NCT00984659|1928065|FG000|2-week Run-in Period|Study Closed/Terminated|2
939789|NCT00984659|1928066|FG001|2-week Run-in Period|Study Closed/Terminated|0
939790|NCT00984659|1928067|FG002|2-week Run-in Period|Study Closed/Terminated|0
939791|NCT00984659|1928068|FG003|2-week Run-in Period|Study Closed/Terminated|0
939792|NCT00984659|1928065|FG000|2-week Run-in Period|Lost to Follow-up|3
939793|NCT00984659|1928066|FG001|2-week Run-in Period|Lost to Follow-up|0
939794|NCT00984659|1928067|FG002|2-week Run-in Period|Lost to Follow-up|0
939795|NCT00984659|1928068|FG003|2-week Run-in Period|Lost to Follow-up|0
939796|NCT00984659|1928065|FG000|2-week Run-in Period|Physician Decision|10
939797|NCT00984659|1928066|FG001|2-week Run-in Period|Physician Decision|0
939798|NCT00984659|1928067|FG002|2-week Run-in Period|Physician Decision|0
939799|NCT00984659|1928068|FG003|2-week Run-in Period|Physician Decision|0
939800|NCT00984659|1928065|FG000|2-week Run-in Period|Withdrawal by Subject|10
939801|NCT00984659|1928066|FG001|2-week Run-in Period|Withdrawal by Subject|0
939802|NCT00984659|1928067|FG002|2-week Run-in Period|Withdrawal by Subject|0
939803|NCT00984659|1928068|FG003|2-week Run-in Period|Withdrawal by Subject|0
939804|NCT00984659|1928065|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14
939805|NCT00984659|1928066|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
939806|NCT00984659|1928067|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
939807|NCT00984659|1928068|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
939808|NCT00984659|1928065|FG000|6-week Double-blind Treatment Period|Adverse Event|0
939809|NCT00984659|1928066|FG001|6-week Double-blind Treatment Period|Adverse Event|3
939810|NCT00984659|1928067|FG002|6-week Double-blind Treatment Period|Adverse Event|3
939811|NCT00984659|1928068|FG003|6-week Double-blind Treatment Period|Adverse Event|7
939812|NCT00984659|1928065|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0
939813|NCT00984659|1928066|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2
939814|NCT00984659|1928067|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0
939815|NCT00984659|1928068|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1
939816|NCT00984659|1928065|FG000|6-week Double-blind Treatment Period|Protocol Violation|0
939817|NCT00984659|1928066|FG001|6-week Double-blind Treatment Period|Protocol Violation|0
939818|NCT00984659|1928067|FG002|6-week Double-blind Treatment Period|Protocol Violation|0
939819|NCT00984659|1928068|FG003|6-week Double-blind Treatment Period|Protocol Violation|4
939820|NCT00984659|1928065|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0
939821|NCT00984659|1928066|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0
939822|NCT00984659|1928067|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1
939823|NCT00984659|1928068|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0
939824|NCT00984659|1928065|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0
939825|NCT00984659|1928066|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1
939826|NCT00984659|1928067|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7
939827|NCT00984659|1928068|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1
939828|NCT00984867|1928090|FG000|Overall Study|Adverse Event|3
939829|NCT00984867|1928091|FG001|Overall Study|Adverse Event|7
939830|NCT00984867|1928090|FG000|Overall Study|Death|1
939831|NCT00984867|1928091|FG001|Overall Study|Death|0
939832|NCT00984867|1928090|FG000|Overall Study|Withdrawal by Subject|13
939833|NCT00984867|1928091|FG001|Overall Study|Withdrawal by Subject|4
939834|NCT00984867|1928090|FG000|Overall Study|Lost to Follow-up|3
939835|NCT00984867|1928091|FG001|Overall Study|Lost to Follow-up|4
939836|NCT00984867|1928090|FG000|Overall Study|Poor/non-compliance|0
939837|NCT00984867|1928091|FG001|Overall Study|Poor/non-compliance|1
939838|NCT00984867|1928090|FG000|Overall Study|Subject no longer meets study criteria|1
939839|NCT00984867|1928091|FG001|Overall Study|Subject no longer meets study criteria|1
939840|NCT00984867|1928090|FG000|Overall Study|site closing|1
939841|NCT00984867|1928091|FG001|Overall Study|site closing|0
939842|NCT00984867|1928090|FG000|Overall Study|lack of efficacy and subject compliance|1
939843|NCT00984867|1928091|FG001|Overall Study|lack of efficacy and subject compliance|0
939844|NCT00985088|1928116|FG000|Overall Study|Serious Adverse Event|1
939845|NCT00985088|1928117|FG001|Overall Study|Serious Adverse Event|1
939846|NCT00985088|1928118|FG002|Overall Study|Serious Adverse Event|0
939847|NCT00985088|1928119|FG003|Overall Study|Serious Adverse Event|0
939848|NCT00985088|1928120|FG004|Overall Study|Serious Adverse Event|0
939849|NCT00985088|1928121|FG005|Overall Study|Serious Adverse Event|0
939850|NCT00985088|1928122|FG006|Overall Study|Serious Adverse Event|0
939851|NCT00985088|1928123|FG007|Overall Study|Serious Adverse Event|1
939852|NCT00985088|1928116|FG000|Overall Study|Adverse Event|0
939853|NCT00985088|1928117|FG001|Overall Study|Adverse Event|0
939854|NCT00985088|1928118|FG002|Overall Study|Adverse Event|1
939855|NCT00985088|1928119|FG003|Overall Study|Adverse Event|0
939856|NCT00985088|1928120|FG004|Overall Study|Adverse Event|0
939857|NCT00985088|1928121|FG005|Overall Study|Adverse Event|0
939858|NCT00985088|1928122|FG006|Overall Study|Adverse Event|0
939859|NCT00985088|1928123|FG007|Overall Study|Adverse Event|0
939860|NCT00985088|1928116|FG000|Overall Study|Withdrawal by Subject|4
939861|NCT00985088|1928117|FG001|Overall Study|Withdrawal by Subject|0
939862|NCT00985088|1928118|FG002|Overall Study|Withdrawal by Subject|0
939863|NCT00985088|1928119|FG003|Overall Study|Withdrawal by Subject|1
939864|NCT00985088|1928120|FG004|Overall Study|Withdrawal by Subject|3
939865|NCT00985088|1928121|FG005|Overall Study|Withdrawal by Subject|2
939866|NCT00985088|1928122|FG006|Overall Study|Withdrawal by Subject|1
939867|NCT00985088|1928123|FG007|Overall Study|Withdrawal by Subject|2
939868|NCT00985088|1928116|FG000|Overall Study|Migrated/moved from study area|0
939869|NCT00985088|1928117|FG001|Overall Study|Migrated/moved from study area|0
939870|NCT00985088|1928118|FG002|Overall Study|Migrated/moved from study area|1
939871|NCT00985088|1928119|FG003|Overall Study|Migrated/moved from study area|0
939872|NCT00985088|1928120|FG004|Overall Study|Migrated/moved from study area|0
939873|NCT00985088|1928121|FG005|Overall Study|Migrated/moved from study area|0
939874|NCT00985088|1928122|FG006|Overall Study|Migrated/moved from study area|0
939875|NCT00985088|1928123|FG007|Overall Study|Migrated/moved from study area|1
939876|NCT00985088|1928116|FG000|Overall Study|Lost to Follow-up|6
939877|NCT00985088|1928117|FG001|Overall Study|Lost to Follow-up|1
939878|NCT00985088|1928118|FG002|Overall Study|Lost to Follow-up|2
939879|NCT00985088|1928119|FG003|Overall Study|Lost to Follow-up|6
939880|NCT00985088|1928120|FG004|Overall Study|Lost to Follow-up|6
939881|NCT00985088|1928121|FG005|Overall Study|Lost to Follow-up|5
939882|NCT00985088|1928122|FG006|Overall Study|Lost to Follow-up|3
939883|NCT00985088|1928123|FG007|Overall Study|Lost to Follow-up|2
939884|NCT00985114|1928153|FG000|Overall Study|Adverse Event|1
939885|NCT00985114|1928154|FG001|Overall Study|Adverse Event|0
939886|NCT00985114|1928153|FG000|Overall Study|Withdrawal by Subject|0
939887|NCT00985114|1928154|FG001|Overall Study|Withdrawal by Subject|2
939888|NCT00985153|1928168|FG000|Overall Study|Lost to Follow-up|16
939889|NCT00985153|1928169|FG001|Overall Study|Lost to Follow-up|19
939890|NCT00985153|1928170|FG002|Overall Study|Lost to Follow-up|17
939891|NCT00985153|1928171|FG003|Overall Study|Lost to Follow-up|20
939892|NCT00985153|1928168|FG000|Overall Study|Protocol Violation|3
939893|NCT00985153|1928169|FG001|Overall Study|Protocol Violation|2
939894|NCT00985153|1928170|FG002|Overall Study|Protocol Violation|4
939895|NCT00985153|1928171|FG003|Overall Study|Protocol Violation|3
939896|NCT00985153|1928168|FG000|Overall Study|Withdrawal by Subject|6
939897|NCT00985153|1928169|FG001|Overall Study|Withdrawal by Subject|11
939898|NCT00985153|1928170|FG002|Overall Study|Withdrawal by Subject|11
939899|NCT00985153|1928171|FG003|Overall Study|Withdrawal by Subject|10
939900|NCT00985153|1928168|FG000|Overall Study|Missed One or More Bleeds|7
939901|NCT00985153|1928169|FG001|Overall Study|Missed One or More Bleeds|7
939902|NCT00985153|1928170|FG002|Overall Study|Missed One or More Bleeds|8
939903|NCT00985153|1928171|FG003|Overall Study|Missed One or More Bleeds|10
939904|NCT00985153|1928168|FG000|Overall Study|Incomplete Safety Follow-up|3
939905|NCT00985153|1928169|FG001|Overall Study|Incomplete Safety Follow-up|5
939906|NCT00985153|1928170|FG002|Overall Study|Incomplete Safety Follow-up|4
939907|NCT00985153|1928171|FG003|Overall Study|Incomplete Safety Follow-up|4
939908|NCT00985166|1928184|FG000|Overall Study|Lost to Follow-up|3
939909|NCT00985166|1928185|FG001|Overall Study|Lost to Follow-up|2
939910|NCT00985166|1928186|FG002|Overall Study|Lost to Follow-up|2
939911|NCT00985166|1928184|FG000|Overall Study|Withdrawal by Subject|3
939912|NCT00985166|1928185|FG001|Overall Study|Withdrawal by Subject|2
939913|NCT00985166|1928186|FG002|Overall Study|Withdrawal by Subject|0
939914|NCT00985166|1928184|FG000|Overall Study|Test not done|2
939915|NCT00985166|1928185|FG001|Overall Study|Test not done|0
939916|NCT00985166|1928186|FG002|Overall Study|Test not done|4
939917|NCT00985166|1928184|FG000|Overall Study|Other|1
939918|NCT00985166|1928185|FG001|Overall Study|Other|0
939919|NCT00985166|1928186|FG002|Overall Study|Other|1
939920|NCT00985192|1928196|FG000|Overall Study|Withdrawal by Subject|1
939921|NCT00985192|1928196|FG000|Overall Study|Disease Progression|1
939922|NCT00985192|1928196|FG000|Overall Study|Determined to be Ineligible During Trial|2
939923|NCT00985231|1928202|FG000|Overall Study|ineligible|1
939924|NCT00985231|1928203|FG001|Overall Study|ineligible|0
939925|NCT00985231|1928202|FG000|Overall Study|Protocol Violation|1
939926|NCT00985231|1928203|FG001|Overall Study|Protocol Violation|0
939927|NCT00985231|1928202|FG000|Overall Study|Withdrawal by Subject|1
939928|NCT00985231|1928203|FG001|Overall Study|Withdrawal by Subject|0
939929|NCT00985231|1928202|FG000|Overall Study|Lost to Follow-up|0
939930|NCT00985231|1928203|FG001|Overall Study|Lost to Follow-up|1
939931|NCT00985231|1928202|FG000|Overall Study|Study related symptoms & complaints|0
939932|NCT00985231|1928203|FG001|Overall Study|Study related symptoms & complaints|2
939933|NCT00985426|1928215|FG000|Overall Study|Adverse Event|0
939934|NCT00985426|1928216|FG001|Overall Study|Adverse Event|1
939935|NCT00985426|1928215|FG000|Overall Study|Subject Non-Compliance|3
939936|NCT00985426|1928216|FG001|Overall Study|Subject Non-Compliance|3
939937|NCT00985426|1928215|FG000|Overall Study|Withdrawal by Subject|12
939938|NCT00985426|1928216|FG001|Overall Study|Withdrawal by Subject|16
939939|NCT00985426|1928215|FG000|Overall Study|Lost to Follow-up|8
939940|NCT00985426|1928216|FG001|Overall Study|Lost to Follow-up|10
939941|NCT00985426|1928215|FG000|Overall Study|Death|7
939942|NCT00985426|1928216|FG001|Overall Study|Death|3
939943|NCT00985426|1928215|FG000|Overall Study|Protocol Violation|2
939944|NCT00985426|1928216|FG001|Overall Study|Protocol Violation|0
939945|NCT00985426|1928215|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
939946|NCT00985426|1928216|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
939947|NCT00985439|1928226|FG000|Overall Study|Adverse Event|0
939948|NCT00985439|1928227|FG001|Overall Study|Adverse Event|0
939949|NCT00985439|1928228|FG002|Overall Study|Adverse Event|1
939950|NCT00985439|1928229|FG003|Overall Study|Adverse Event|0
939951|NCT00985465|1928241|FG000|Overall Study|Withdrawal by Subject|1
939952|NCT00985465|1928242|FG001|Overall Study|Withdrawal by Subject|2
939953|NCT00985465|1928241|FG000|Overall Study|Considered to be part of the other group|0
939954|NCT00985465|1928242|FG001|Overall Study|Considered to be part of the other group|1
939955|NCT00985491|1928249|FG000|Overall Study|Adverse Event|8
939956|NCT00985491|1928249|FG000|Overall Study|device migration|7
939957|NCT00985491|1928249|FG000|Overall Study|Withdrawal by Subject|1
939958|NCT00985491|1928249|FG000|Overall Study|implant failure|3
939959|NCT00985504|1928256|FG000|Acute Treatment Period|Adverse Event|3
939960|NCT00985504|1928257|FG001|Acute Treatment Period|Adverse Event|4
939961|NCT00985504|1928256|FG000|Acute Treatment Period|Entry Criteria Not Met|1
939962|NCT00985504|1928257|FG001|Acute Treatment Period|Entry Criteria Not Met|2
939963|NCT00985504|1928256|FG000|Acute Treatment Period|Protocol Violation|2
939964|NCT00985504|1928257|FG001|Acute Treatment Period|Protocol Violation|0
939965|NCT00985504|1928256|FG000|Acute Treatment Period|Sponsor Decision|0
939966|NCT00985504|1928257|FG001|Acute Treatment Period|Sponsor Decision|1
939967|NCT00985504|1928256|FG000|Acute Treatment Period|Withdrawal by Subject|9
939968|NCT00985504|1928257|FG001|Acute Treatment Period|Withdrawal by Subject|5
939969|NCT00985504|1928256|FG000|Optimization Period|Adverse Event|7
939970|NCT00985504|1928257|FG001|Optimization Period|Adverse Event|9
939971|NCT00985504|1928256|FG000|Optimization Period|Death|0
939972|NCT00985504|1928257|FG001|Optimization Period|Death|1
939973|NCT00985504|1928256|FG000|Optimization Period|Lack of Efficacy|5
939974|NCT00985504|1928257|FG001|Optimization Period|Lack of Efficacy|3
939975|NCT00985504|1928256|FG000|Optimization Period|Lost to Follow-up|0
939976|NCT00985504|1928257|FG001|Optimization Period|Lost to Follow-up|1
939977|NCT00985504|1928256|FG000|Optimization Period|Physician Decision|1
939978|NCT00985504|1928257|FG001|Optimization Period|Physician Decision|0
939979|NCT00985504|1928256|FG000|Optimization Period|Protocol Violation|3
939980|NCT00985504|1928257|FG001|Optimization Period|Protocol Violation|1
939981|NCT00985504|1928256|FG000|Optimization Period|Withdrawal by Subject|10
939982|NCT00985504|1928257|FG001|Optimization Period|Withdrawal by Subject|8
939983|NCT00985621|1928291|FG000|Overall Study|Adverse Event|2
939984|NCT00985621|1928292|FG001|Overall Study|Adverse Event|3
939985|NCT00985621|1928293|FG002|Overall Study|Adverse Event|4
939986|NCT00985621|1928294|FG003|Overall Study|Adverse Event|16
939987|NCT00985621|1928291|FG000|Overall Study|Lack of Efficacy|10
939988|NCT00985621|1928292|FG001|Overall Study|Lack of Efficacy|6
939989|NCT00985621|1928293|FG002|Overall Study|Lack of Efficacy|5
939990|NCT00985621|1928294|FG003|Overall Study|Lack of Efficacy|12
939991|NCT00985621|1928291|FG000|Overall Study|Lost to Follow-up|2
939992|NCT00985621|1928292|FG001|Overall Study|Lost to Follow-up|3
939993|NCT00985621|1928293|FG002|Overall Study|Lost to Follow-up|4
939994|NCT00985621|1928294|FG003|Overall Study|Lost to Follow-up|4
939995|NCT00985621|1928291|FG000|Overall Study|Study Terminated by Sponsor|89
939996|NCT00985621|1928292|FG001|Overall Study|Study Terminated by Sponsor|108
939997|NCT00985621|1928293|FG002|Overall Study|Study Terminated by Sponsor|99
939998|NCT00985621|1928294|FG003|Overall Study|Study Terminated by Sponsor|92
939999|NCT00985621|1928291|FG000|Overall Study|Protocol Violation|1
940000|NCT00985621|1928292|FG001|Overall Study|Protocol Violation|1
940001|NCT00985621|1928293|FG002|Overall Study|Protocol Violation|1
940002|NCT00985621|1928294|FG003|Overall Study|Protocol Violation|0
940003|NCT00985621|1928291|FG000|Overall Study|Withdrawal by Subject|8
940004|NCT00985621|1928292|FG001|Overall Study|Withdrawal by Subject|10
940005|NCT00985621|1928293|FG002|Overall Study|Withdrawal by Subject|8
940006|NCT00985621|1928294|FG003|Overall Study|Withdrawal by Subject|12
940007|NCT00985621|1928291|FG000|Overall Study|Other|1
940008|NCT00985621|1928292|FG001|Overall Study|Other|0
940009|NCT00985621|1928293|FG002|Overall Study|Other|0
940010|NCT00985621|1928294|FG003|Overall Study|Other|0
940011|NCT00985621|1928291|FG000|Overall Study|Randomized but not Treated|1
940012|NCT00985621|1928292|FG001|Overall Study|Randomized but not Treated|0
940013|NCT00985621|1928293|FG002|Overall Study|Randomized but not Treated|2
940014|NCT00985621|1928294|FG003|Overall Study|Randomized but not Treated|1
940015|NCT00985673|1928312|FG000|Overall Study|Lost to Follow-up|6
940016|NCT00985673|1928313|FG001|Overall Study|Lost to Follow-up|7
940017|NCT00985673|1928314|FG002|Overall Study|Lost to Follow-up|6
940018|NCT00985673|1928315|FG003|Overall Study|Lost to Follow-up|10
940019|NCT00985673|1928316|FG004|Overall Study|Lost to Follow-up|5
940020|NCT00985673|1928317|FG005|Overall Study|Lost to Follow-up|3
940021|NCT00985673|1928312|FG000|Overall Study|Withdrawal by Subject|0
940022|NCT00985673|1928313|FG001|Overall Study|Withdrawal by Subject|4
940023|NCT00985673|1928314|FG002|Overall Study|Withdrawal by Subject|5
940024|NCT00985673|1928315|FG003|Overall Study|Withdrawal by Subject|2
940025|NCT00985673|1928316|FG004|Overall Study|Withdrawal by Subject|2
940026|NCT00985673|1928317|FG005|Overall Study|Withdrawal by Subject|3
940027|NCT00985673|1928312|FG000|Overall Study|Other|1
940028|NCT00985673|1928313|FG001|Overall Study|Other|0
940029|NCT00985673|1928314|FG002|Overall Study|Other|1
940030|NCT00985673|1928315|FG003|Overall Study|Other|0
940031|NCT00985673|1928316|FG004|Overall Study|Other|1
940032|NCT00985673|1928317|FG005|Overall Study|Other|0
940033|NCT00985686|1928336|FG000|Overall Study|Lost to Follow-up|1
940034|NCT00985686|1928337|FG001|Overall Study|Lost to Follow-up|1
940035|NCT00985686|1928338|FG002|Overall Study|Lost to Follow-up|0
940036|NCT00985686|1928339|FG003|Overall Study|Lost to Follow-up|2
940037|NCT00985712|1928349|FG000|Overall Study|Adverse Event|0
940038|NCT00985712|1928350|FG001|Overall Study|Adverse Event|1
940039|NCT00985712|1928349|FG000|Overall Study|Lost to Follow-up|2
940040|NCT00985712|1928350|FG001|Overall Study|Lost to Follow-up|2
940041|NCT00985712|1928349|FG000|Overall Study|Protocol Violation|0
940042|NCT00985712|1928350|FG001|Overall Study|Protocol Violation|1
940043|NCT00985712|1928349|FG000|Overall Study|Withdrawal by Subject|4
940044|NCT00985712|1928350|FG001|Overall Study|Withdrawal by Subject|1
940045|NCT00985712|1928349|FG000|Overall Study|Sponsor decision|0
940046|NCT00985712|1928350|FG001|Overall Study|Sponsor decision|2
940047|NCT00985725|1928358|FG000|Overall Study|Adverse Event|4
940048|NCT00985725|1928359|FG001|Overall Study|Adverse Event|1
940049|NCT00985725|1928358|FG000|Overall Study|Protocol Violation|1
940050|NCT00985725|1928359|FG001|Overall Study|Protocol Violation|3
940051|NCT00985725|1928358|FG000|Overall Study|Withdrawal by Subject|4
940052|NCT00985725|1928359|FG001|Overall Study|Withdrawal by Subject|4
940053|NCT00985725|1928358|FG000|Overall Study|Lost to Follow-up|1
940054|NCT00985725|1928359|FG001|Overall Study|Lost to Follow-up|1
940055|NCT00985725|1928358|FG000|Overall Study|Lack of Efficacy|0
940056|NCT00985725|1928359|FG001|Overall Study|Lack of Efficacy|1
940057|NCT00985725|1928358|FG000|Overall Study|Non-compliance|1
940058|NCT00985725|1928359|FG001|Overall Study|Non-compliance|2
940059|NCT00985725|1928358|FG000|Overall Study|Out-of-window visits|0
940060|NCT00985725|1928359|FG001|Overall Study|Out-of-window visits|1
940061|NCT00985751|1928370|FG000|Overall Study|Adverse Event|0
940062|NCT00985751|1928371|FG001|Overall Study|Adverse Event|0
940063|NCT00985751|1928372|FG002|Overall Study|Adverse Event|0
940064|NCT00985751|1928373|FG003|Overall Study|Adverse Event|0
940065|NCT00985751|1928374|FG004|Overall Study|Adverse Event|1
940066|NCT00985790|1928391|FG000|Overall Study|Withdrawal by Subject|1
940067|NCT00985790|1928392|FG001|Overall Study|Withdrawal by Subject|1
940068|NCT00985790|1928391|FG000|Overall Study|Lost to Follow-up|6
940069|NCT00985790|1928392|FG001|Overall Study|Lost to Follow-up|7
940070|NCT00985946|1928412|FG000|Overall Study|Lost to Follow-up|6
940071|NCT00985946|1928412|FG000|Overall Study|Withdrawal by Subject|1
940072|NCT00985959|1928419|FG000|Overall Study|Adverse Event|0
940073|NCT00985959|1928420|FG001|Overall Study|Adverse Event|0
940074|NCT00985959|1928421|FG002|Overall Study|Adverse Event|19
940075|NCT00985959|1928419|FG000|Overall Study|Withdrawal by Subject|0
940076|NCT00985959|1928420|FG001|Overall Study|Withdrawal by Subject|0
940077|NCT00985959|1928421|FG002|Overall Study|Withdrawal by Subject|8
940078|NCT00985959|1928419|FG000|Overall Study|Progressive disease|1
940079|NCT00985959|1928420|FG001|Overall Study|Progressive disease|2
940080|NCT00985959|1928421|FG002|Overall Study|Progressive disease|8
940081|NCT00985959|1928419|FG000|Overall Study|Unrecovered toxicity|0
940082|NCT00985959|1928420|FG001|Overall Study|Unrecovered toxicity|0
940083|NCT00985959|1928421|FG002|Overall Study|Unrecovered toxicity|7
940084|NCT00985959|1928419|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2
940085|NCT00985959|1928420|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0
940086|NCT00985959|1928421|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2
940087|NCT00985959|1928419|FG000|Overall Study|Complete response observed over 2 cycles|0
940088|NCT00985959|1928420|FG001|Overall Study|Complete response observed over 2 cycles|1
940089|NCT00985959|1928421|FG002|Overall Study|Complete response observed over 2 cycles|4
940090|NCT00985959|1928419|FG000|Overall Study|Other|0
940091|NCT00985959|1928420|FG001|Overall Study|Other|0
940092|NCT00985959|1928421|FG002|Overall Study|Other|11
940093|NCT00985985|1928439|FG000|Overall Study|Adverse Event|4
940094|NCT00985985|1928440|FG001|Overall Study|Adverse Event|2
940095|NCT00985985|1928441|FG002|Overall Study|Adverse Event|2
940096|NCT00985985|1928442|FG003|Overall Study|Adverse Event|2
940097|NCT00985985|1928439|FG000|Overall Study|Lost to Follow-up|4
940098|NCT00985985|1928440|FG001|Overall Study|Lost to Follow-up|11
940099|NCT00985985|1928441|FG002|Overall Study|Lost to Follow-up|2
940100|NCT00985985|1928442|FG003|Overall Study|Lost to Follow-up|3
940101|NCT00985985|1928439|FG000|Overall Study|Protocol Violation|1
940102|NCT00985985|1928440|FG001|Overall Study|Protocol Violation|2
940103|NCT00985985|1928441|FG002|Overall Study|Protocol Violation|0
940104|NCT00985985|1928442|FG003|Overall Study|Protocol Violation|1
940105|NCT00985985|1928439|FG000|Overall Study|Lack of Efficacy|5
940106|NCT00985985|1928440|FG001|Overall Study|Lack of Efficacy|6
940107|NCT00985985|1928441|FG002|Overall Study|Lack of Efficacy|1
940108|NCT00985985|1928442|FG003|Overall Study|Lack of Efficacy|3
940109|NCT00985985|1928439|FG000|Overall Study|Withdrawal by Subject|4
940110|NCT00985985|1928440|FG001|Overall Study|Withdrawal by Subject|2
940111|NCT00985985|1928441|FG002|Overall Study|Withdrawal by Subject|2
940112|NCT00985985|1928442|FG003|Overall Study|Withdrawal by Subject|2
940113|NCT00985985|1928439|FG000|Overall Study|Other Reason|6
940114|NCT00985985|1928440|FG001|Overall Study|Other Reason|1
940115|NCT00985985|1928441|FG002|Overall Study|Other Reason|4
940116|NCT00985985|1928442|FG003|Overall Study|Other Reason|2
940117|NCT00986102|1928461|FG000|Overall Study|Lost to Follow-up|0
940118|NCT00986102|1928462|FG001|Overall Study|Lost to Follow-up|1
940119|NCT00986102|1928463|FG002|Overall Study|Lost to Follow-up|0
940120|NCT00986102|1928464|FG003|Overall Study|Lost to Follow-up|1
940121|NCT00986102|1928461|FG000|Overall Study|Withdrawal by Subject|1
940122|NCT00986102|1928462|FG001|Overall Study|Withdrawal by Subject|1
940123|NCT00986102|1928463|FG002|Overall Study|Withdrawal by Subject|0
940124|NCT00986102|1928464|FG003|Overall Study|Withdrawal by Subject|0
940125|NCT00986154|1928476|FG000|Overall Study|Death|136
940126|NCT00986154|1928477|FG001|Overall Study|Death|127
940127|NCT00986154|1928476|FG000|Overall Study|Lost to Follow-up|7
940128|NCT00986154|1928477|FG001|Overall Study|Lost to Follow-up|4
940129|NCT00986154|1928476|FG000|Overall Study|Withdrawal by Subject|32
940130|NCT00986154|1928477|FG001|Overall Study|Withdrawal by Subject|33
940131|NCT00986154|1928476|FG000|Overall Study|investigator/subject decide not continue|6
940132|NCT00986154|1928477|FG001|Overall Study|investigator/subject decide not continue|3
940133|NCT00986154|1928476|FG000|Overall Study|never received study drug|25
940134|NCT00986154|1928477|FG001|Overall Study|never received study drug|27
940135|NCT00986180|1928485|FG000|Overall Study|Adverse Event|21
940136|NCT00986180|1928486|FG001|Overall Study|Adverse Event|23
940137|NCT00986180|1928485|FG000|Overall Study|Lack of Efficacy|4
940138|NCT00986180|1928486|FG001|Overall Study|Lack of Efficacy|3
940139|NCT00986180|1928485|FG000|Overall Study|Lost to Follow-up|5
940140|NCT00986180|1928486|FG001|Overall Study|Lost to Follow-up|7
940141|NCT00986180|1928485|FG000|Overall Study|Physician Decision|1
940142|NCT00986180|1928486|FG001|Overall Study|Physician Decision|3
940143|NCT00986180|1928485|FG000|Overall Study|Protocol Violation|2
940144|NCT00986180|1928486|FG001|Overall Study|Protocol Violation|0
940145|NCT00986180|1928485|FG000|Overall Study|Withdrawal by Subject|1
940146|NCT00986180|1928486|FG001|Overall Study|Withdrawal by Subject|9
940147|NCT00986180|1928485|FG000|Overall Study|Miscellanies|10
940148|NCT00986180|1928486|FG001|Overall Study|Miscellanies|11
940149|NCT00986232|1928496|FG000|Overall Study|Adverse Event|1
940150|NCT00986232|1928497|FG001|Overall Study|Adverse Event|2
940151|NCT00986232|1928498|FG002|Overall Study|Adverse Event|3
940152|NCT00986232|1928499|FG003|Overall Study|Adverse Event|0
940153|NCT00986232|1928496|FG000|Overall Study|Lost to Follow-up|19
940154|NCT00986232|1928497|FG001|Overall Study|Lost to Follow-up|12
940155|NCT00986232|1928498|FG002|Overall Study|Lost to Follow-up|12
940156|NCT00986232|1928499|FG003|Overall Study|Lost to Follow-up|7
940157|NCT00986232|1928496|FG000|Overall Study|Protocol Violation|2
940158|NCT00986232|1928497|FG001|Overall Study|Protocol Violation|3
940159|NCT00986232|1928498|FG002|Overall Study|Protocol Violation|0
940160|NCT00986232|1928499|FG003|Overall Study|Protocol Violation|1
940161|NCT00986232|1928496|FG000|Overall Study|Withdrawal by Subject|13
940162|NCT00986232|1928497|FG001|Overall Study|Withdrawal by Subject|16
940163|NCT00986232|1928498|FG002|Overall Study|Withdrawal by Subject|12
940164|NCT00986232|1928499|FG003|Overall Study|Withdrawal by Subject|3
940165|NCT00986232|1928496|FG000|Overall Study|Missed one or more bleeds|13
940166|NCT00986232|1928497|FG001|Overall Study|Missed one or more bleeds|10
940167|NCT00986232|1928498|FG002|Overall Study|Missed one or more bleeds|6
940168|NCT00986232|1928499|FG003|Overall Study|Missed one or more bleeds|7
940169|NCT00986232|1928496|FG000|Overall Study|Incomplete safety follow-up|3
940170|NCT00986232|1928497|FG001|Overall Study|Incomplete safety follow-up|7
940171|NCT00986232|1928498|FG002|Overall Study|Incomplete safety follow-up|2
940172|NCT00986232|1928499|FG003|Overall Study|Incomplete safety follow-up|2
940173|NCT00986245|1928515|FG000|First Intervention|Poor compliance|8
940174|NCT00986245|1928516|FG001|First Intervention|Poor compliance|4
940175|NCT00986245|1928515|FG000|First Intervention|Lack of Efficacy|1
940176|NCT00986245|1928516|FG001|First Intervention|Lack of Efficacy|2
940177|NCT00986245|1928515|FG000|First Intervention|Withdrawal by Subject|0
940178|NCT00986245|1928516|FG001|First Intervention|Withdrawal by Subject|1
940179|NCT00986245|1928515|FG000|First Intervention|Protocol Violation|0
940180|NCT00986245|1928516|FG001|First Intervention|Protocol Violation|1
940181|NCT00986245|1928515|FG000|First Intervention|Out of indication|1
940182|NCT00986245|1928516|FG001|First Intervention|Out of indication|0
940183|NCT00986245|1928515|FG000|Second Intervention|Poor compliance|1
940184|NCT00986245|1928516|FG001|Second Intervention|Poor compliance|0
940185|NCT00986245|1928515|FG000|Second Intervention|Lost to Follow-up|1
940186|NCT00986245|1928516|FG001|Second Intervention|Lost to Follow-up|0
940187|NCT00986245|1928515|FG000|Second Intervention|Protocol Violation|0
940188|NCT00986245|1928516|FG001|Second Intervention|Protocol Violation|1
940189|NCT00986258|1928527|FG000|Observation Period|Not eligible to be dosed|11
940190|NCT00986258|1928527|FG000|Titration and Optimal Dose Period|Adverse Event|15
940191|NCT00986258|1928527|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3
940192|NCT00986258|1928527|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3
940193|NCT00986258|1928527|FG000|Titration and Optimal Dose Period|Non-Compliance|1
940194|NCT00986258|1928527|FG000|Titration and Optimal Dose Period|Other|1
940195|NCT00986258|1928527|FG000|Maintenance Period|Adverse Event|5
940196|NCT00986258|1928527|FG000|Maintenance Period|Lack of Efficacy|2
940197|NCT00986258|1928527|FG000|Maintenance Period|Withdrawal by Subject|2
940198|NCT00986349|1928541|FG000|Overall Study|Unsuccessful implant procedure|3
940199|NCT00986349|1928541|FG000|Overall Study|Adverse Event|2
940200|NCT00986349|1928541|FG000|Overall Study|Physician Decision|1
940201|NCT00986349|1928541|FG000|Overall Study|device migration|1
940202|NCT00986362|1928556|FG000|Overall Study|Death|2
940203|NCT00986362|1928557|FG001|Overall Study|Death|0
940204|NCT00986362|1928556|FG000|Overall Study|Lost to Follow-up|0
940205|NCT00986362|1928557|FG001|Overall Study|Lost to Follow-up|1
940206|NCT00986427|1928577|FG000|Overall Study|Lost to Follow-up|2
940207|NCT00986427|1928578|FG001|Overall Study|Lost to Follow-up|0
940208|NCT00986427|1928577|FG000|Overall Study|Lack of Efficacy|1
940209|NCT00986427|1928578|FG001|Overall Study|Lack of Efficacy|0
940210|NCT00986427|1928577|FG000|Overall Study|Withdrawal by Subject|1
940211|NCT00986427|1928578|FG001|Overall Study|Withdrawal by Subject|0
940212|NCT00986440|1928590|FG000|Overall Study|Progressive disease|27
940213|NCT00986440|1928591|FG001|Overall Study|Progressive disease|37
940214|NCT00986440|1928590|FG000|Overall Study|Serious adverse event or adverse event|9
940215|NCT00986440|1928591|FG001|Overall Study|Serious adverse event or adverse event|2
940216|NCT00986440|1928590|FG000|Overall Study|Withdrawal by Subject|1
940217|NCT00986440|1928591|FG001|Overall Study|Withdrawal by Subject|2
940218|NCT00986440|1928590|FG000|Overall Study|Screen failure (not dosed)|4
940219|NCT00986440|1928591|FG001|Overall Study|Screen failure (not dosed)|2
940220|NCT00986479|1928605|FG000|Period 1|Improved mood|1
940221|NCT00986479|1928606|FG001|Period 1|Improved mood|0
940222|NCT00986479|1928605|FG000|Period 1|Administrative reasons|1
940223|NCT00986479|1928606|FG001|Period 1|Administrative reasons|0
940224|NCT00986570|1928622|FG000|Overall Study|Lost to Follow-up|6
940225|NCT00986570|1928622|FG000|Overall Study|Potential bias for objective assessment|1
940226|NCT00986674|1928639|FG000|Overall Study|Lack of Efficacy|28
940227|NCT00986674|1928640|FG001|Overall Study|Lack of Efficacy|25
940228|NCT00986674|1928641|FG002|Overall Study|Lack of Efficacy|23
940229|NCT00986674|1928639|FG000|Overall Study|Adverse Event|4
940230|NCT00986674|1928640|FG001|Overall Study|Adverse Event|8
940231|NCT00986674|1928641|FG002|Overall Study|Adverse Event|9
940232|NCT00986674|1928639|FG000|Overall Study|Death|5
940233|NCT00986674|1928640|FG001|Overall Study|Death|0
940234|NCT00986674|1928641|FG002|Overall Study|Death|4
940235|NCT00986674|1928639|FG000|Overall Study|Withdrawal by Subject|6
940236|NCT00986674|1928640|FG001|Overall Study|Withdrawal by Subject|2
940237|NCT00986674|1928641|FG002|Overall Study|Withdrawal by Subject|1
940238|NCT00986674|1928639|FG000|Overall Study|alternative therapy|0
940239|NCT00986674|1928640|FG001|Overall Study|alternative therapy|0
940240|NCT00986674|1928641|FG002|Overall Study|alternative therapy|1
940241|NCT00986674|1928639|FG000|Overall Study|not start protocol therapy|4
940242|NCT00986674|1928640|FG001|Overall Study|not start protocol therapy|3
940243|NCT00986674|1928641|FG002|Overall Study|not start protocol therapy|1
940244|NCT00986674|1928639|FG000|Overall Study|unknown/not specify|0
940245|NCT00986674|1928640|FG001|Overall Study|unknown/not specify|7
940246|NCT00986674|1928641|FG002|Overall Study|unknown/not specify|9
940247|NCT00986830|1928649|FG000|Overall Study|Death|1
940248|NCT00986830|1928649|FG000|Overall Study|Lost to Follow-up|1
940249|NCT00986830|1928649|FG000|Overall Study|Lack of Efficacy|1
940250|NCT00986830|1928649|FG000|Overall Study|Unable to access sinus with device|5
940251|NCT00986921|1928664|FG000|Overall Study|Physician Decision|1
940252|NCT00986921|1928665|FG001|Overall Study|Physician Decision|0
940253|NCT00986973|1928674|FG000|Overall Study|Withdrawn by study team|1
940254|NCT00986986|1928681|FG000|Overall Study|Lost to Follow-up|0
940255|NCT00986986|1928682|FG001|Overall Study|Lost to Follow-up|1
940256|NCT00987337|1928692|FG000|Overall Study|Adverse Event|10
940257|NCT00987337|1928693|FG001|Overall Study|Adverse Event|9
940258|NCT00987337|1928694|FG002|Overall Study|Adverse Event|8
940259|NCT00987337|1928692|FG000|Overall Study|Insufficient Virologic Response|10
940260|NCT00987337|1928693|FG001|Overall Study|Insufficient Virologic Response|7
940261|NCT00987337|1928694|FG002|Overall Study|Insufficient Virologic Response|12
940262|NCT00987337|1928692|FG000|Overall Study|Virologic Breakthrough|2
940263|NCT00987337|1928693|FG001|Overall Study|Virologic Breakthrough|2
940264|NCT00987337|1928694|FG002|Overall Study|Virologic Breakthrough|8
940265|NCT00987337|1928692|FG000|Overall Study|Lost to Follow-up|10
940266|NCT00987337|1928693|FG001|Overall Study|Lost to Follow-up|6
940267|NCT00987337|1928694|FG002|Overall Study|Lost to Follow-up|2
940268|NCT00987337|1928692|FG000|Overall Study|Withdrawal by Subject|6
940269|NCT00987337|1928693|FG001|Overall Study|Withdrawal by Subject|9
940270|NCT00987337|1928694|FG002|Overall Study|Withdrawal by Subject|9
940271|NCT00987337|1928692|FG000|Overall Study|Other|0
940272|NCT00987337|1928693|FG001|Overall Study|Other|2
940273|NCT00987337|1928694|FG002|Overall Study|Other|5
940274|NCT00987337|1928692|FG000|Overall Study|Protocol Violation|1
940275|NCT00987337|1928693|FG001|Overall Study|Protocol Violation|0
940276|NCT00987337|1928694|FG002|Overall Study|Protocol Violation|2
940277|NCT00987337|1928692|FG000|Overall Study|Participant Relapsed|18
940278|NCT00987337|1928693|FG001|Overall Study|Participant Relapsed|20
940279|NCT00987337|1928694|FG002|Overall Study|Participant Relapsed|5
940280|NCT00987389|1928706|FG000|Overall Study|Ineligible|0
940281|NCT00987389|1928707|FG001|Overall Study|Ineligible|3
940282|NCT00987389|1928708|FG002|Overall Study|Ineligible|0
940283|NCT00987389|1928709|FG003|Overall Study|Ineligible|0
940284|NCT00987389|1928706|FG000|Overall Study|Lost to Follow-up|4
940285|NCT00987389|1928707|FG001|Overall Study|Lost to Follow-up|1
940286|NCT00987389|1928708|FG002|Overall Study|Lost to Follow-up|3
940287|NCT00987389|1928709|FG003|Overall Study|Lost to Follow-up|1
940288|NCT00987389|1928706|FG000|Overall Study|Withdrawal by Subject|4
940289|NCT00987389|1928707|FG001|Overall Study|Withdrawal by Subject|3
940290|NCT00987389|1928708|FG002|Overall Study|Withdrawal by Subject|2
940291|NCT00987389|1928709|FG003|Overall Study|Withdrawal by Subject|1
940292|NCT00987389|1928706|FG000|Overall Study|Withdrawn from Treatment|0
940293|NCT00987389|1928707|FG001|Overall Study|Withdrawn from Treatment|1
940294|NCT00987389|1928708|FG002|Overall Study|Withdrawn from Treatment|0
940295|NCT00987389|1928709|FG003|Overall Study|Withdrawn from Treatment|0
940296|NCT00987389|1928706|FG000|Overall Study|Multiple different reasons|1
940297|NCT00987389|1928707|FG001|Overall Study|Multiple different reasons|0
940298|NCT00987389|1928708|FG002|Overall Study|Multiple different reasons|3
940299|NCT00987389|1928709|FG003|Overall Study|Multiple different reasons|1
940300|NCT00987402|1928719|FG000|Overall Study|Insufficient data entry|86
940301|NCT00987402|1928720|FG001|Overall Study|Insufficient data entry|98
940302|NCT00987467|1928735|FG000|Overall Study|Lost to Follow-up|2
940303|NCT00987623|1928754|FG000|Overall Study|Lost to Follow-up|2
940304|NCT00987623|1928755|FG001|Overall Study|Lost to Follow-up|1
940305|NCT00987623|1928754|FG000|Overall Study|Time/job conflict|2
940306|NCT00987623|1928755|FG001|Overall Study|Time/job conflict|0
940307|NCT00987623|1928754|FG000|Overall Study|Discomfort|1
940308|NCT00987623|1928755|FG001|Overall Study|Discomfort|0
940309|NCT00987623|1928754|FG000|Overall Study|Biomicroscopy|0
940310|NCT00987623|1928755|FG001|Overall Study|Biomicroscopy|1
940311|NCT00987623|1928754|FG000|Overall Study|Influenza|0
940312|NCT00987623|1928755|FG001|Overall Study|Influenza|1
940313|NCT00987831|1928773|FG000|Overall Study|Never flared in 12 months|1
940314|NCT00987831|1928774|FG001|Overall Study|Never flared in 12 months|0
940315|NCT00987831|1928775|FG002|Overall Study|Never flared in 12 months|0
940316|NCT00987831|1928773|FG000|Overall Study|Lost to Follow-up|0
940317|NCT00987831|1928774|FG001|Overall Study|Lost to Follow-up|3
940318|NCT00987831|1928775|FG002|Overall Study|Lost to Follow-up|0
940319|NCT00987935|1928793|FG000|Overall Study|Progressive disease|3
940320|NCT00987935|1928794|FG001|Overall Study|Progressive disease|2
940321|NCT00987935|1928795|FG002|Overall Study|Progressive disease|3
940322|NCT00987935|1928796|FG003|Overall Study|Progressive disease|2
940323|NCT00987935|1928797|FG004|Overall Study|Progressive disease|5
940324|NCT00987935|1928798|FG005|Overall Study|Progressive disease|3
940325|NCT00987935|1928799|FG006|Overall Study|Progressive disease|9
940326|NCT00987935|1928800|FG007|Overall Study|Progressive disease|48
940327|NCT00987935|1928801|FG008|Overall Study|Progressive disease|23
940328|NCT00987935|1928793|FG000|Overall Study|Adverse Event|0
940329|NCT00987935|1928794|FG001|Overall Study|Adverse Event|1
940330|NCT00987935|1928795|FG002|Overall Study|Adverse Event|0
940331|NCT00987935|1928796|FG003|Overall Study|Adverse Event|1
940332|NCT00987935|1928797|FG004|Overall Study|Adverse Event|1
940333|NCT00987935|1928798|FG005|Overall Study|Adverse Event|0
940334|NCT00987935|1928799|FG006|Overall Study|Adverse Event|2
940335|NCT00987935|1928800|FG007|Overall Study|Adverse Event|10
940336|NCT00987935|1928801|FG008|Overall Study|Adverse Event|6
940337|NCT00987935|1928793|FG000|Overall Study|Refused to continue taking trial med.|1
940338|NCT00987935|1928794|FG001|Overall Study|Refused to continue taking trial med.|0
940339|NCT00987935|1928795|FG002|Overall Study|Refused to continue taking trial med.|0
940340|NCT00987935|1928796|FG003|Overall Study|Refused to continue taking trial med.|0
940341|NCT00987935|1928797|FG004|Overall Study|Refused to continue taking trial med.|1
940342|NCT00987935|1928798|FG005|Overall Study|Refused to continue taking trial med.|0
940343|NCT00987935|1928799|FG006|Overall Study|Refused to continue taking trial med.|4
940344|NCT00987935|1928800|FG007|Overall Study|Refused to continue taking trial med.|4
940345|NCT00987935|1928801|FG008|Overall Study|Refused to continue taking trial med.|2
940346|NCT00987935|1928793|FG000|Overall Study|Reason other than those specified above|0
940347|NCT00987935|1928794|FG001|Overall Study|Reason other than those specified above|0
940348|NCT00987935|1928795|FG002|Overall Study|Reason other than those specified above|0
940349|NCT00987935|1928796|FG003|Overall Study|Reason other than those specified above|0
940350|NCT00987935|1928797|FG004|Overall Study|Reason other than those specified above|0
940351|NCT00987935|1928798|FG005|Overall Study|Reason other than those specified above|0
940352|NCT00987935|1928799|FG006|Overall Study|Reason other than those specified above|0
940353|NCT00987935|1928800|FG007|Overall Study|Reason other than those specified above|0
940354|NCT00987935|1928801|FG008|Overall Study|Reason other than those specified above|1
940377|NCT00988065|1928877|FG000|Overall Study|Adverse Event|4
940378|NCT00988065|1928878|FG001|Overall Study|Adverse Event|10
940379|NCT00988065|1928879|FG002|Overall Study|Adverse Event|2
940380|NCT00988065|1928877|FG000|Overall Study|Lost to Follow-up|1
940381|NCT00988065|1928878|FG001|Overall Study|Lost to Follow-up|2
940382|NCT00988065|1928879|FG002|Overall Study|Lost to Follow-up|2
940383|NCT00988065|1928877|FG000|Overall Study|Subject withdrew consent|3
940384|NCT00988065|1928878|FG001|Overall Study|Subject withdrew consent|5
940385|NCT00988065|1928879|FG002|Overall Study|Subject withdrew consent|2
940386|NCT00988065|1928877|FG000|Overall Study|Noncompliance with protocol|5
940387|NCT00988065|1928878|FG001|Overall Study|Noncompliance with protocol|6
940388|NCT00988065|1928879|FG002|Overall Study|Noncompliance with protocol|9
940389|NCT00988091|1928889|FG000|Double-blind Period|Withdrawal by Subject|15
940390|NCT00988091|1928890|FG001|Double-blind Period|Withdrawal by Subject|13
940391|NCT00988091|1928889|FG000|Double-blind Period|Lost to Follow-up|12
940392|NCT00988091|1928890|FG001|Double-blind Period|Lost to Follow-up|14
940393|NCT00988091|1928889|FG000|Double-blind Period|Other|8
940394|NCT00988091|1928890|FG001|Double-blind Period|Other|8
940395|NCT00988091|1928889|FG000|Double-blind Period|Adverse Event|6
940396|NCT00988091|1928890|FG001|Double-blind Period|Adverse Event|9
940397|NCT00988091|1928889|FG000|Double-blind Period|Use of exclusionary medication|2
940398|NCT00988091|1928890|FG001|Double-blind Period|Use of exclusionary medication|3
940399|NCT00988091|1928889|FG000|Open-label Period|Adverse Event|4
940400|NCT00988091|1928890|FG001|Open-label Period|Adverse Event|7
940401|NCT00988091|1928889|FG000|Open-label Period|Use of exclusionary medication|1
940402|NCT00988091|1928890|FG001|Open-label Period|Use of exclusionary medication|1
940403|NCT00988091|1928889|FG000|Open-label Period|Protocol Violation|1
940404|NCT00988091|1928890|FG001|Open-label Period|Protocol Violation|1
940405|NCT00988091|1928889|FG000|Open-label Period|Withdrawal by Subject|10
940406|NCT00988091|1928890|FG001|Open-label Period|Withdrawal by Subject|16
940407|NCT00988091|1928889|FG000|Open-label Period|Lost to Follow-up|3
940408|NCT00988091|1928890|FG001|Open-label Period|Lost to Follow-up|5
940409|NCT00988091|1928889|FG000|Open-label Period|Other|2
940410|NCT00988091|1928890|FG001|Open-label Period|Other|3
940411|NCT00988117|1928897|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
940412|NCT00988117|1928897|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
940413|NCT00988169|1928924|FG000|Overall Study|Withdrawal by Subject|1
940414|NCT00988208|1928930|FG000|Overall Study|Adverse Event|71
940415|NCT00988208|1928931|FG001|Overall Study|Adverse Event|122
940416|NCT00988208|1928930|FG000|Overall Study|Disease Progression|103
940417|NCT00988208|1928931|FG001|Overall Study|Disease Progression|89
940418|NCT00988208|1928930|FG000|Overall Study|Withdrawal by Subject|50
940419|NCT00988208|1928931|FG001|Overall Study|Withdrawal by Subject|57
940420|NCT00988208|1928930|FG000|Overall Study|Death|9
940421|NCT00988208|1928931|FG001|Overall Study|Death|15
940422|NCT00988208|1928930|FG000|Overall Study|Lost to Follow-up|2
940423|NCT00988208|1928931|FG001|Overall Study|Lost to Follow-up|3
940424|NCT00988208|1928930|FG000|Overall Study|Protocol Violation|9
940425|NCT00988208|1928931|FG001|Overall Study|Protocol Violation|2
940426|NCT00988208|1928930|FG000|Overall Study|Sponsor Decision|102
940427|NCT00988208|1928931|FG001|Overall Study|Sponsor Decision|78
940428|NCT00988208|1928930|FG000|Overall Study|Clinical Progression|17
940429|NCT00988208|1928931|FG001|Overall Study|Clinical Progression|16
940430|NCT00988208|1928930|FG000|Overall Study|Biochemical Progression|21
940431|NCT00988208|1928931|FG001|Overall Study|Biochemical Progression|7
940432|NCT00988208|1928930|FG000|Overall Study|Clinical Deterioration|7
940433|NCT00988208|1928931|FG001|Overall Study|Clinical Deterioration|14
940434|NCT00988208|1928930|FG000|Overall Study|Subject Decision/Investigator Discretion|32
940435|NCT00988208|1928931|FG001|Overall Study|Subject Decision/Investigator Discretion|32
940436|NCT00988208|1928930|FG000|Overall Study|Other|8
940437|NCT00988208|1928931|FG001|Overall Study|Other|3
940438|NCT00988221|1928940|FG000|Part I|Adverse Event|0
940439|NCT00988221|1928941|FG001|Part I|Adverse Event|1
940440|NCT00988221|1928942|FG002|Part I|Adverse Event|2
940441|NCT00988221|1928943|FG003|Part I|Adverse Event|0
940442|NCT00988221|1928940|FG000|Part I|Insufficient Therapeutic Response|4
940443|NCT00988221|1928941|FG001|Part I|Insufficient Therapeutic Response|6
940444|NCT00988221|1928942|FG002|Part I|Insufficient Therapeutic Response|5
940445|NCT00988221|1928943|FG003|Part I|Insufficient Therapeutic Response|0
940446|NCT00988221|1928940|FG000|Part I|Refused Treatment|0
940447|NCT00988221|1928941|FG001|Part I|Refused Treatment|2
940448|NCT00988221|1928942|FG002|Part I|Refused Treatment|1
940449|NCT00988221|1928943|FG003|Part I|Refused Treatment|0
940450|NCT00988221|1928940|FG000|Part I|Lost to Follow-up|0
940451|NCT00988221|1928941|FG001|Part I|Lost to Follow-up|1
940452|NCT00988221|1928942|FG002|Part I|Lost to Follow-up|0
940453|NCT00988221|1928943|FG003|Part I|Lost to Follow-up|0
940454|NCT00988221|1928940|FG000|Part II|Adverse Event|1
940455|NCT00988221|1928941|FG001|Part II|Adverse Event|0
940456|NCT00988221|1928942|FG002|Part II|Adverse Event|0
940457|NCT00988221|1928943|FG003|Part II|Adverse Event|1
940458|NCT00988221|1928940|FG000|Part II|Withdrawal by Subject|0
940459|NCT00988221|1928941|FG001|Part II|Withdrawal by Subject|0
940460|NCT00988221|1928942|FG002|Part II|Withdrawal by Subject|2
940461|NCT00988221|1928943|FG003|Part II|Withdrawal by Subject|2
940462|NCT00988221|1928940|FG000|Part II|Reason not Specified|0
940463|NCT00988221|1928941|FG001|Part II|Reason not Specified|0
940464|NCT00988221|1928942|FG002|Part II|Reason not Specified|1
940465|NCT00988221|1928943|FG003|Part II|Reason not Specified|0
940466|NCT00988221|1928940|FG000|Part III|Adverse Event|1
940467|NCT00988221|1928941|FG001|Part III|Adverse Event|0
940468|NCT00988221|1928942|FG002|Part III|Adverse Event|1
940469|NCT00988221|1928943|FG003|Part III|Adverse Event|0
940470|NCT00988221|1928940|FG000|Part III|Insufficient Therapeutic Response|0
940471|NCT00988221|1928941|FG001|Part III|Insufficient Therapeutic Response|1
940472|NCT00988221|1928942|FG002|Part III|Insufficient Therapeutic Response|1
940473|NCT00988221|1928943|FG003|Part III|Insufficient Therapeutic Response|0
940474|NCT00988221|1928940|FG000|Part III|Refused Treatment|0
940475|NCT00988221|1928941|FG001|Part III|Refused Treatment|0
940476|NCT00988221|1928942|FG002|Part III|Refused Treatment|1
940477|NCT00988221|1928943|FG003|Part III|Refused Treatment|0
940492|NCT00988351|1928990|FG000|Overall Study|Withdrawal by Subject|8
940493|NCT00988351|1928991|FG001|Overall Study|Withdrawal by Subject|0
940494|NCT00988351|1928990|FG000|Overall Study|Lost to Follow-up|6
940495|NCT00988351|1928991|FG001|Overall Study|Lost to Follow-up|9
940496|NCT00988351|1928990|FG000|Overall Study|not using CPAP|5
940497|NCT00988351|1928991|FG001|Overall Study|not using CPAP|3
940498|NCT00988429|1929000|FG000|Overall Study|Adverse Event|9
940499|NCT00988429|1929001|FG001|Overall Study|Adverse Event|21
940500|NCT00988429|1929002|FG002|Overall Study|Adverse Event|45
940501|NCT00988429|1929000|FG000|Overall Study|Lack of Efficacy|0
940502|NCT00988429|1929001|FG001|Overall Study|Lack of Efficacy|0
940503|NCT00988429|1929002|FG002|Overall Study|Lack of Efficacy|1
940504|NCT00988429|1929000|FG000|Overall Study|Non-Compliance with Study Drug|5
940505|NCT00988429|1929001|FG001|Overall Study|Non-Compliance with Study Drug|1
940506|NCT00988429|1929002|FG002|Overall Study|Non-Compliance with Study Drug|3
940507|NCT00988429|1929000|FG000|Overall Study|Physician Decision|1
940508|NCT00988429|1929001|FG001|Overall Study|Physician Decision|0
940509|NCT00988429|1929002|FG002|Overall Study|Physician Decision|3
940510|NCT00988429|1929000|FG000|Overall Study|Pregnancy|2
940511|NCT00988429|1929001|FG001|Overall Study|Pregnancy|1
940512|NCT00988429|1929002|FG002|Overall Study|Pregnancy|0
940513|NCT00988429|1929000|FG000|Overall Study|Protocol Violation|4
940514|NCT00988429|1929001|FG001|Overall Study|Protocol Violation|3
940515|NCT00988429|1929002|FG002|Overall Study|Protocol Violation|3
940516|NCT00988429|1929000|FG000|Overall Study|Withdrawal by Subject|7
940517|NCT00988429|1929001|FG001|Overall Study|Withdrawal by Subject|7
940518|NCT00988429|1929002|FG002|Overall Study|Withdrawal by Subject|12
940519|NCT00988429|1929000|FG000|Overall Study|Administrative Reasons|1
940520|NCT00988429|1929001|FG001|Overall Study|Administrative Reasons|2
940521|NCT00988429|1929002|FG002|Overall Study|Administrative Reasons|1
940522|NCT00988429|1929000|FG000|Overall Study|other reasons|8
940523|NCT00988429|1929001|FG001|Overall Study|other reasons|8
940524|NCT00988429|1929002|FG002|Overall Study|other reasons|1
940525|NCT00988442|1929013|FG000|Overall Study|Death|1
940526|NCT00988442|1929014|FG001|Overall Study|Death|2
940527|NCT00988442|1929013|FG000|Overall Study|Lost to Follow-up|0
940528|NCT00988442|1929014|FG001|Overall Study|Lost to Follow-up|1
940529|NCT00988442|1929013|FG000|Overall Study|Early Study Closure|29
940530|NCT00988442|1929014|FG001|Overall Study|Early Study Closure|25
940531|NCT00988533|1929023|FG000|Overall Study|Lost to Follow-up|3
940532|NCT00988559|1929031|FG000|Overall Study|Withdrawal by Subject|1
940533|NCT00988559|1929032|FG001|Overall Study|Withdrawal by Subject|1
940534|NCT00988559|1929033|FG002|Overall Study|Withdrawal by Subject|0
940535|NCT00988559|1929034|FG003|Overall Study|Withdrawal by Subject|1
940536|NCT00988559|1929031|FG000|Overall Study|Pregnancy|0
940537|NCT00988559|1929032|FG001|Overall Study|Pregnancy|1
940538|NCT00988559|1929033|FG002|Overall Study|Pregnancy|1
940539|NCT00988559|1929034|FG003|Overall Study|Pregnancy|0
940540|NCT00988559|1929031|FG000|Overall Study|Lost to Follow-up|0
940541|NCT00988559|1929032|FG001|Overall Study|Lost to Follow-up|0
940542|NCT00988559|1929033|FG002|Overall Study|Lost to Follow-up|1
940543|NCT00988559|1929034|FG003|Overall Study|Lost to Follow-up|0
940544|NCT00988598|1929046|FG000|Overall Study|Withdrawal by Subject|2
940545|NCT00988598|1929047|FG001|Overall Study|Withdrawal by Subject|0
940546|NCT00988637|1929055|FG000|Overall Study|Lost to Follow-up|2
940547|NCT00988637|1929056|FG001|Overall Study|Lost to Follow-up|1
940548|NCT00988637|1929055|FG000|Overall Study|Withdrawal by Subject|1
940549|NCT00988637|1929056|FG001|Overall Study|Withdrawal by Subject|1
940550|NCT00988637|1929055|FG000|Overall Study|non-compliance with study drug|0
940551|NCT00988637|1929056|FG001|Overall Study|non-compliance with study drug|1
940552|NCT00988858|1929069|FG000|Overall Study|Adverse Event|7
940553|NCT00988858|1929069|FG000|Overall Study|Death|1
940554|NCT00988858|1929069|FG000|Overall Study|Physician Decision|1
940555|NCT00988858|1929069|FG000|Overall Study|Sponsor Decision|1
940556|NCT00988884|1929075|FG000|Overall Study|Adverse Event|0
940557|NCT00988884|1929076|FG001|Overall Study|Adverse Event|1
940558|NCT00988884|1929075|FG000|Overall Study|Lost to Follow-up|20
940559|NCT00988884|1929076|FG001|Overall Study|Lost to Follow-up|16
940560|NCT00988884|1929075|FG000|Overall Study|Protocol Violation|0
940561|NCT00988884|1929076|FG001|Overall Study|Protocol Violation|1
940562|NCT00988884|1929075|FG000|Overall Study|Withdrawal by Subject|15
940563|NCT00988884|1929076|FG001|Overall Study|Withdrawal by Subject|18
940564|NCT00989092|1929101|FG000|Overall Study|Physician Decision|9
940565|NCT00989092|1929102|FG001|Overall Study|Physician Decision|6
940566|NCT00989092|1929101|FG000|Overall Study|Adverse Event|20
940567|NCT00989092|1929102|FG001|Overall Study|Adverse Event|1
940568|NCT00989092|1929101|FG000|Overall Study|Chemotherapy initiated|12
940569|NCT00989092|1929102|FG001|Overall Study|Chemotherapy initiated|4
940570|NCT00989092|1929101|FG000|Overall Study|Withdrawal by Subject|17
940571|NCT00989092|1929102|FG001|Overall Study|Withdrawal by Subject|9
940572|NCT00989092|1929101|FG000|Overall Study|Death|14
940573|NCT00989092|1929102|FG001|Overall Study|Death|2
940574|NCT00989092|1929101|FG000|Overall Study|Ineligibility determined|3
940575|NCT00989092|1929102|FG001|Overall Study|Ineligibility determined|3
940576|NCT00989092|1929101|FG000|Overall Study|Lost to Follow-up|6
940577|NCT00989092|1929102|FG001|Overall Study|Lost to Follow-up|2
940578|NCT00989092|1929101|FG000|Overall Study|Other|3
940579|NCT00989092|1929102|FG001|Overall Study|Other|1
940580|NCT00989092|1929101|FG000|Overall Study|Protocol deviation|2
940581|NCT00989092|1929102|FG001|Overall Study|Protocol deviation|0
940582|NCT00989092|1929101|FG000|Overall Study|Erythropoietin therapy initiated|2
940583|NCT00989092|1929102|FG001|Overall Study|Erythropoietin therapy initiated|0
940584|NCT00989092|1929101|FG000|Overall Study|Did not receive study drug|2
940585|NCT00989092|1929102|FG001|Overall Study|Did not receive study drug|0
940586|NCT00989196|1929120|FG000|Treatment Period|Lost to Follow-up|1
940587|NCT00989196|1929121|FG001|Treatment Period|Lost to Follow-up|0
940588|NCT00989235|1929129|FG000|Overall Study|Death|0
940589|NCT00989235|1929130|FG001|Overall Study|Death|1
940590|NCT00989235|1929129|FG000|Overall Study|Adverse Event|0
940591|NCT00989235|1929130|FG001|Overall Study|Adverse Event|1
940592|NCT00989235|1929129|FG000|Overall Study|Lack of Efficacy|1
940593|NCT00989235|1929130|FG001|Overall Study|Lack of Efficacy|0
940594|NCT00989235|1929129|FG000|Overall Study|Withdrawal of Consent|1
940595|NCT00989235|1929130|FG001|Overall Study|Withdrawal of Consent|1
940596|NCT00989235|1929129|FG000|Overall Study|Desire to Become Pregnant|1
940597|NCT00989235|1929130|FG001|Overall Study|Desire to Become Pregnant|0
940598|NCT00989235|1929129|FG000|Overall Study|Randomized by Mistake|0
940599|NCT00989235|1929130|FG001|Overall Study|Randomized by Mistake|2
940600|NCT00989235|1929129|FG000|Overall Study|Lost to Follow-up|0
940601|NCT00989235|1929130|FG001|Overall Study|Lost to Follow-up|1
940602|NCT00989261|1929141|FG000|Overall Study|Still in follow up|12
940603|NCT00989261|1929142|FG001|Overall Study|Still in follow up|21
940604|NCT00989261|1929141|FG000|Overall Study|Withdrawal by Subject|0
940605|NCT00989261|1929142|FG001|Overall Study|Withdrawal by Subject|1
940606|NCT00989261|1929141|FG000|Overall Study|Lost to Follow-up|3
940607|NCT00989261|1929142|FG001|Overall Study|Lost to Follow-up|0
940608|NCT00989287|1929150|FG000|Overall Study|Adverse Event|1
940609|NCT00989287|1929151|FG001|Overall Study|Adverse Event|0
940610|NCT00989287|1929150|FG000|Overall Study|Lost to Follow-up|0
940611|NCT00989287|1929151|FG001|Overall Study|Lost to Follow-up|1
940612|NCT00989573|1929173|FG000|Overall Study|Adverse Event|8
940613|NCT00989573|1929174|FG001|Overall Study|Adverse Event|12
940614|NCT00989573|1929175|FG002|Overall Study|Adverse Event|4
940615|NCT00989573|1929173|FG000|Overall Study|Physician Decision|0
940616|NCT00989573|1929174|FG001|Overall Study|Physician Decision|2
940617|NCT00989573|1929175|FG002|Overall Study|Physician Decision|0
940618|NCT00989573|1929173|FG000|Overall Study|Protocol Violation|1
940619|NCT00989573|1929174|FG001|Overall Study|Protocol Violation|1
940620|NCT00989573|1929175|FG002|Overall Study|Protocol Violation|1
940621|NCT00989573|1929173|FG000|Overall Study|Withdrawal by Subject|4
940622|NCT00989573|1929174|FG001|Overall Study|Withdrawal by Subject|7
940623|NCT00989573|1929175|FG002|Overall Study|Withdrawal by Subject|3
940624|NCT00989664|1929199|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
940625|NCT00989664|1929199|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
940626|NCT00989664|1929199|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49
940627|NCT00989664|1929199|FG000|Dosimetric and Therapeutic Treatment|Death|1
940628|NCT00989664|1929199|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
940629|NCT00989664|1929199|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
940630|NCT00989664|1929199|FG000|Long-Term Follow-Up|Death|3
940631|NCT00989781|1929215|FG000|Ovarian Response to hCG|Lost to Follow-up|3
940632|NCT00989781|1929216|FG001|Ovarian Response to hCG|Lost to Follow-up|2
940633|NCT00989833|1929226|FG000|Overall Study|Lost to Follow-up|0
940634|NCT00989833|1929227|FG001|Overall Study|Lost to Follow-up|1
940635|NCT00989833|1929228|FG002|Overall Study|Lost to Follow-up|0
940636|NCT00989833|1929226|FG000|Overall Study|Protocol Violation|1
940637|NCT00989833|1929227|FG001|Overall Study|Protocol Violation|2
940638|NCT00989833|1929228|FG002|Overall Study|Protocol Violation|1
940639|NCT00989833|1929226|FG000|Overall Study|Withdrawal by Subject|0
940640|NCT00989833|1929227|FG001|Overall Study|Withdrawal by Subject|0
940641|NCT00989833|1929228|FG002|Overall Study|Withdrawal by Subject|1
940642|NCT00989833|1929226|FG000|Overall Study|Incorrectly randomized|1
940643|NCT00989833|1929227|FG001|Overall Study|Incorrectly randomized|0
940644|NCT00989833|1929228|FG002|Overall Study|Incorrectly randomized|0
940645|NCT00989950|1929244|FG000|Randomized Phase|Protocol Violation|1
940646|NCT00989950|1929245|FG001|Randomized Phase|Protocol Violation|0
940647|NCT00989950|1929246|FG002|Randomized Phase|Protocol Violation|0
940648|NCT00989950|1929247|FG003|Randomized Phase|Protocol Violation|0
940649|NCT00989950|1929244|FG000|Randomized Phase|Adverse Event|0
940650|NCT00989950|1929245|FG001|Randomized Phase|Adverse Event|1
940651|NCT00989950|1929246|FG002|Randomized Phase|Adverse Event|0
940652|NCT00989950|1929247|FG003|Randomized Phase|Adverse Event|0
940653|NCT00989963|1929260|FG000|Overall Study|Adverse Event|1
940654|NCT00989963|1929261|FG001|Overall Study|Adverse Event|1
940655|NCT00989963|1929262|FG002|Overall Study|Adverse Event|1
940656|NCT00990093|1929283|FG000|Test Period 1 (1-14 Days)|Adverse Event|1
940657|NCT00990093|1929284|FG001|Test Period 1 (1-14 Days)|Adverse Event|0
940658|NCT00990093|1929283|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
940659|NCT00990093|1929284|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
940660|NCT00990093|1929283|FG000|Test Period 1 (1-14 Days)|Other|1
940661|NCT00990093|1929284|FG001|Test Period 1 (1-14 Days)|Other|0
940662|NCT00990093|1929283|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0
940663|NCT00990093|1929284|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2
940664|NCT00990093|1929283|FG000|Test Period 2 (15-28 Days)|Adverse Event|1
940665|NCT00990093|1929284|FG001|Test Period 2 (15-28 Days)|Adverse Event|0
940666|NCT00990093|1929283|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1
940667|NCT00990093|1929284|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0
940668|NCT00990093|1929283|FG000|Test Period 2 (15-28 Days)|Other|0
940669|NCT00990093|1929284|FG001|Test Period 2 (15-28 Days)|Other|1
940670|NCT00990106|1929292|FG000|Overall Study|"too busy to continue"|1
940671|NCT00990106|1929293|FG001|Overall Study|"too busy to continue"|2
940672|NCT00990106|1929292|FG000|Overall Study|Lost to Follow-up|1
940673|NCT00990106|1929293|FG001|Overall Study|Lost to Follow-up|3
940674|NCT00990106|1929292|FG000|Overall Study|Withdrawal by Subject|2
940675|NCT00990106|1929293|FG001|Overall Study|Withdrawal by Subject|1
940676|NCT00990106|1929292|FG000|Overall Study|opted for open label prazosin|1
940677|NCT00990106|1929293|FG001|Overall Study|opted for open label prazosin|1
940678|NCT00990106|1929292|FG000|Overall Study|relocation/deployment|4
940679|NCT00990106|1929293|FG001|Overall Study|relocation/deployment|1
940680|NCT00990106|1929292|FG000|Overall Study|started exclusionary medication|0
940681|NCT00990106|1929293|FG001|Overall Study|started exclusionary medication|1
940682|NCT00990106|1929292|FG000|Overall Study|planned major surgery|0
940683|NCT00990106|1929293|FG001|Overall Study|planned major surgery|1
940684|NCT00990106|1929292|FG000|Overall Study|scheduling conflicts|0
940685|NCT00990106|1929293|FG001|Overall Study|scheduling conflicts|2
940686|NCT00990184|1929299|FG000|Overall Study|Physician Decision|1
940687|NCT00990249|1929314|FG000|Overall Study|Disease Progression|8
940688|NCT00990249|1929314|FG000|Overall Study|Non-Compliance|1
940689|NCT00990249|1929314|FG000|Overall Study|Death|2
940690|NCT00990249|1929314|FG000|Overall Study|Not treated|2
940691|NCT00990314|1929327|FG000|Overall Study|Death|2
940692|NCT00990314|1929327|FG000|Overall Study|Adverse Event|2
940693|NCT00990314|1929327|FG000|Overall Study|Withdrawal by Subject|3
940694|NCT00990314|1929327|FG000|Overall Study|Non-Compliance|1
940695|NCT00990314|1929327|FG000|Overall Study|Physician Decision|3
940696|NCT00990314|1929327|FG000|Overall Study|Lack of Efficacy|1
940697|NCT00990340|1929333|FG000|First 14-day Treatment|Not Compliant|2
940698|NCT00990340|1929334|FG001|First 14-day Treatment|Not Compliant|1
940699|NCT00990340|1929333|FG000|First 14-day Treatment|Lost to Follow-up|2
940700|NCT00990340|1929334|FG001|First 14-day Treatment|Lost to Follow-up|1
940701|NCT00990340|1929333|FG000|First 14-day Treatment|Protocol Violation|2
940702|NCT00990340|1929334|FG001|First 14-day Treatment|Protocol Violation|2
940703|NCT00990652|1929362|FG000|Pre-surgical Bortezomib|Adverse Event|1
940704|NCT00990652|1929362|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
940705|NCT00990665|1929367|FG000|Overall Study|Unsuccessful Implant|8
940706|NCT00990665|1929367|FG000|Overall Study|Death|29
940707|NCT00990665|1929367|FG000|Overall Study|Heart Transplant|1
940708|NCT00990665|1929367|FG000|Overall Study|Withdrawal by Subject|6
940709|NCT00990665|1929367|FG000|Overall Study|Lost to Follow-up|1
940710|NCT00990665|1929367|FG000|Overall Study|System Explant|3
940711|NCT00990704|1929375|FG000|Overall Study|Adverse Event|1
940712|NCT00990704|1929376|FG001|Overall Study|Adverse Event|1
940713|NCT00990704|1929375|FG000|Overall Study|Physician Decision|0
940714|NCT00990704|1929376|FG001|Overall Study|Physician Decision|1
940715|NCT00990821|1929409|FG000|Overall Study|Withdrawal by Subject|0
940716|NCT00990821|1929410|FG001|Overall Study|Withdrawal by Subject|2
940717|NCT00990821|1929411|FG002|Overall Study|Withdrawal by Subject|0
940718|NCT00990821|1929412|FG003|Overall Study|Withdrawal by Subject|0
940719|NCT00990821|1929413|FG004|Overall Study|Withdrawal by Subject|3
940720|NCT00990821|1929414|FG005|Overall Study|Withdrawal by Subject|3
940721|NCT00990821|1929415|FG006|Overall Study|Withdrawal by Subject|1
940722|NCT00990821|1929416|FG007|Overall Study|Withdrawal by Subject|0
940723|NCT00990821|1929417|FG008|Overall Study|Withdrawal by Subject|0
940724|NCT00990821|1929418|FG009|Overall Study|Withdrawal by Subject|1
940725|NCT00990821|1929419|FG010|Overall Study|Withdrawal by Subject|3
940726|NCT00990821|1929420|FG011|Overall Study|Withdrawal by Subject|5
940727|NCT00990821|1929421|FG012|Overall Study|Withdrawal by Subject|2
940728|NCT00990821|1929422|FG013|Overall Study|Withdrawal by Subject|1
940729|NCT00991276|1929498|FG000|First Intervention Period|Adverse Event|0
940730|NCT00991276|1929499|FG001|First Intervention Period|Adverse Event|1
940731|NCT00991276|1929500|FG002|First Intervention Period|Adverse Event|0
940732|NCT00991276|1929501|FG003|First Intervention Period|Adverse Event|1
940733|NCT00991276|1929502|FG004|First Intervention Period|Adverse Event|0
940734|NCT00991276|1929503|FG005|First Intervention Period|Adverse Event|0
940735|NCT00991276|1929498|FG000|First Intervention Period|Protocol Violation|0
940736|NCT00991276|1929499|FG001|First Intervention Period|Protocol Violation|0
940737|NCT00991276|1929500|FG002|First Intervention Period|Protocol Violation|0
940738|NCT00991276|1929501|FG003|First Intervention Period|Protocol Violation|0
940739|NCT00991276|1929502|FG004|First Intervention Period|Protocol Violation|2
940740|NCT00991276|1929503|FG005|First Intervention Period|Protocol Violation|0
940741|NCT00991276|1929498|FG000|First Intervention Period|Insufficient clinical response|0
940742|NCT00991276|1929499|FG001|First Intervention Period|Insufficient clinical response|0
940743|NCT00991276|1929500|FG002|First Intervention Period|Insufficient clinical response|0
940744|NCT00991276|1929501|FG003|First Intervention Period|Insufficient clinical response|0
940745|NCT00991276|1929502|FG004|First Intervention Period|Insufficient clinical response|1
940746|NCT00991276|1929503|FG005|First Intervention Period|Insufficient clinical response|0
940747|NCT00991276|1929498|FG000|First Intervention Period|Other|0
940748|NCT00991276|1929499|FG001|First Intervention Period|Other|0
940749|NCT00991276|1929500|FG002|First Intervention Period|Other|0
940750|NCT00991276|1929501|FG003|First Intervention Period|Other|1
940751|NCT00991276|1929502|FG004|First Intervention Period|Other|1
940752|NCT00991276|1929503|FG005|First Intervention Period|Other|0
940753|NCT00991276|1929498|FG000|First Intervention Period|Withdrawal by Subject|0
940754|NCT00991276|1929499|FG001|First Intervention Period|Withdrawal by Subject|1
940755|NCT00991276|1929500|FG002|First Intervention Period|Withdrawal by Subject|0
940756|NCT00991276|1929501|FG003|First Intervention Period|Withdrawal by Subject|1
940757|NCT00991276|1929502|FG004|First Intervention Period|Withdrawal by Subject|0
940758|NCT00991276|1929503|FG005|First Intervention Period|Withdrawal by Subject|1
940759|NCT00991276|1929498|FG000|First Intervention Period|Lost to Follow-up|0
940760|NCT00991276|1929499|FG001|First Intervention Period|Lost to Follow-up|1
940761|NCT00991276|1929500|FG002|First Intervention Period|Lost to Follow-up|0
940762|NCT00991276|1929501|FG003|First Intervention Period|Lost to Follow-up|1
940763|NCT00991276|1929502|FG004|First Intervention Period|Lost to Follow-up|0
940764|NCT00991276|1929503|FG005|First Intervention Period|Lost to Follow-up|0
940765|NCT00991276|1929498|FG000|Second Intervention Period|Adverse Event|0
940766|NCT00991276|1929499|FG001|Second Intervention Period|Adverse Event|2
940767|NCT00991276|1929500|FG002|Second Intervention Period|Adverse Event|0
940768|NCT00991276|1929501|FG003|Second Intervention Period|Adverse Event|1
940769|NCT00991276|1929502|FG004|Second Intervention Period|Adverse Event|1
940770|NCT00991276|1929503|FG005|Second Intervention Period|Adverse Event|0
940771|NCT00991276|1929498|FG000|Second Intervention Period|Protocol Violation|1
940772|NCT00991276|1929499|FG001|Second Intervention Period|Protocol Violation|0
940773|NCT00991276|1929500|FG002|Second Intervention Period|Protocol Violation|0
940774|NCT00991276|1929501|FG003|Second Intervention Period|Protocol Violation|0
940775|NCT00991276|1929502|FG004|Second Intervention Period|Protocol Violation|0
940776|NCT00991276|1929503|FG005|Second Intervention Period|Protocol Violation|0
940777|NCT00991276|1929498|FG000|Second Intervention Period|Other|0
940778|NCT00991276|1929499|FG001|Second Intervention Period|Other|0
940779|NCT00991276|1929500|FG002|Second Intervention Period|Other|0
940780|NCT00991276|1929501|FG003|Second Intervention Period|Other|1
940781|NCT00991276|1929502|FG004|Second Intervention Period|Other|0
940782|NCT00991276|1929503|FG005|Second Intervention Period|Other|1
940783|NCT00991276|1929498|FG000|Third Intervention Period|Protocol Violation|1
940784|NCT00991276|1929499|FG001|Third Intervention Period|Protocol Violation|0
940785|NCT00991276|1929500|FG002|Third Intervention Period|Protocol Violation|0
940786|NCT00991276|1929501|FG003|Third Intervention Period|Protocol Violation|0
940787|NCT00991276|1929502|FG004|Third Intervention Period|Protocol Violation|0
940788|NCT00991276|1929503|FG005|Third Intervention Period|Protocol Violation|0
940789|NCT00991276|1929498|FG000|Third Intervention Period|Other|0
940790|NCT00991276|1929499|FG001|Third Intervention Period|Other|0
940791|NCT00991276|1929500|FG002|Third Intervention Period|Other|0
940792|NCT00991276|1929501|FG003|Third Intervention Period|Other|0
940793|NCT00991276|1929502|FG004|Third Intervention Period|Other|0
940794|NCT00991276|1929503|FG005|Third Intervention Period|Other|1
940795|NCT00991276|1929498|FG000|Third Intervention Period|Adverse Event|0
940796|NCT00991276|1929499|FG001|Third Intervention Period|Adverse Event|0
940797|NCT00991276|1929500|FG002|Third Intervention Period|Adverse Event|1
940798|NCT00991276|1929501|FG003|Third Intervention Period|Adverse Event|0
940799|NCT00991276|1929502|FG004|Third Intervention Period|Adverse Event|0
940800|NCT00991276|1929503|FG005|Third Intervention Period|Adverse Event|0
940801|NCT00991276|1929498|FG000|Third Intervention Period|Withdrawal by Subject|0
940802|NCT00991276|1929499|FG001|Third Intervention Period|Withdrawal by Subject|0
940803|NCT00991276|1929500|FG002|Third Intervention Period|Withdrawal by Subject|0
940804|NCT00991276|1929501|FG003|Third Intervention Period|Withdrawal by Subject|1
940805|NCT00991276|1929502|FG004|Third Intervention Period|Withdrawal by Subject|0
940806|NCT00991276|1929503|FG005|Third Intervention Period|Withdrawal by Subject|0
940807|NCT00991289|1929512|FG000|Overall Study|Adverse Event|1
940808|NCT00991289|1929512|FG000|Overall Study|Physician Decision|2
940809|NCT00991289|1929512|FG000|Overall Study|Withdrawal by Subject|3
940810|NCT00991289|1929512|FG000|Overall Study|Lost to Follow-up|4
940811|NCT00991289|1929512|FG000|Overall Study|Protocol Violation|2
940812|NCT00991302|1929518|FG000|Overall Study|Death|0
940813|NCT00991302|1929519|FG001|Overall Study|Death|1
940814|NCT00991302|1929518|FG000|Overall Study|Lost to Follow-up|14
940815|NCT00991302|1929519|FG001|Overall Study|Lost to Follow-up|12
940816|NCT00991341|1929527|FG000|Overall Study|no surgery w/in 30 days of randomization|11
940817|NCT00991341|1929528|FG001|Overall Study|no surgery w/in 30 days of randomization|18
940818|NCT00991341|1929527|FG000|Overall Study|Death|3
940819|NCT00991341|1929528|FG001|Overall Study|Death|0
940820|NCT00991341|1929527|FG000|Overall Study|no RBCs received 96hrs after randomized|186
940821|NCT00991341|1929528|FG001|Overall Study|no RBCs received 96hrs after randomized|155
940822|NCT00991341|1929527|FG000|Overall Study|Physician Decision|1
940823|NCT00991341|1929528|FG001|Overall Study|Physician Decision|2
940824|NCT00991341|1929527|FG000|Overall Study|Withdrawal by Subject|3
940825|NCT00991341|1929528|FG001|Overall Study|Withdrawal by Subject|4
940826|NCT00991406|1929534|FG000|Overall Study|One participant did not respond to FES.|1
940827|NCT00991510|1929553|FG000|Period I (Days 1-14)|Adverse Event|1
940828|NCT00991510|1929554|FG001|Period I (Days 1-14)|Adverse Event|0
940829|NCT00991510|1929553|FG000|Period III (Days 29-112)|Adverse Event|1
940830|NCT00991510|1929554|FG001|Period III (Days 29-112)|Adverse Event|1
940831|NCT00991887|1929577|FG000|Overall Study|Lost to Follow-up|2
940832|NCT00991887|1929578|FG001|Overall Study|Lost to Follow-up|1
940833|NCT00991939|1929586|FG000|Overall Study|Lost to Follow-up|0
940834|NCT00991939|1929587|FG001|Overall Study|Lost to Follow-up|1
940835|NCT00991939|1929586|FG000|Overall Study|Withdrawal by Subject|1
940836|NCT00991939|1929587|FG001|Overall Study|Withdrawal by Subject|0
940837|NCT00991939|1929586|FG000|Overall Study|Entire study terminated|4
940838|NCT00991939|1929587|FG001|Overall Study|Entire study terminated|1
940839|NCT00991952|1929597|FG000|Overall Study|Adverse Event|0
940840|NCT00991952|1929598|FG001|Overall Study|Adverse Event|1
940841|NCT00992017|1929604|FG000|Overall Study|Lost to Follow-up|2
940842|NCT00992017|1929604|FG000|Overall Study|Withdrawal by Subject|2
940843|NCT00992017|1929604|FG000|Overall Study|Unable to get to clinic|5
940844|NCT00992017|1929604|FG000|Overall Study|Not adhere to study requirements|1
940845|NCT00992056|1929615|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
940846|NCT00992056|1929616|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
940847|NCT00992056|1929615|FG000|Washout Period (2 Weeks)|Physician Decision|1
940848|NCT00992056|1929616|FG001|Washout Period (2 Weeks)|Physician Decision|0
940849|NCT00992108|1929624|FG000|Overall Study|Lost to Follow-up|0
940850|NCT00992108|1929625|FG001|Overall Study|Lost to Follow-up|1
940851|NCT00992186|1929631|FG000|Overall Study|Withdrawal by Subject|2
940852|NCT00992186|1929631|FG000|Overall Study|Protocol Violation|1
940853|NCT00992186|1929631|FG000|Overall Study|Physician Decision|1
940854|NCT00992186|1929631|FG000|Overall Study|Adverse Event|9
940855|NCT00992186|1929631|FG000|Overall Study|Progressive Disease|30
940856|NCT00992186|1929631|FG000|Overall Study|Refusal To Receive Study Agent|3
940857|NCT00992225|1929636|FG000|Overall Study|Entry Criteria Not Met|8
940858|NCT00992225|1929636|FG000|Overall Study|Adverse Event|2
940859|NCT00992394|1929684|FG000|Overall Study|Lack of Efficacy|6
940860|NCT00992394|1929685|FG001|Overall Study|Lack of Efficacy|3
940861|NCT00992394|1929684|FG000|Overall Study|Adverse Event|4
940862|NCT00992394|1929685|FG001|Overall Study|Adverse Event|5
940863|NCT00992394|1929684|FG000|Overall Study|Withdrawal by Subject|8
940864|NCT00992394|1929685|FG001|Overall Study|Withdrawal by Subject|2
940865|NCT00992394|1929684|FG000|Overall Study|Physician Decision|1
940866|NCT00992394|1929685|FG001|Overall Study|Physician Decision|0
940867|NCT00992394|1929684|FG000|Overall Study|Protocol Violation|2
940868|NCT00992394|1929685|FG001|Overall Study|Protocol Violation|4
940869|NCT00992394|1929684|FG000|Overall Study|Lost to Follow-up|2
940870|NCT00992394|1929685|FG001|Overall Study|Lost to Follow-up|0
940871|NCT00992394|1929684|FG000|Overall Study|Other event|1
940872|NCT00992394|1929685|FG001|Overall Study|Other event|0
940873|NCT00992407|1929693|FG000|Overall Study|Protocol Violation|2
940874|NCT00992407|1929694|FG001|Overall Study|Protocol Violation|1
940875|NCT00992407|1929693|FG000|Overall Study|Lost to Follow-up|3
940876|NCT00992407|1929694|FG001|Overall Study|Lost to Follow-up|3
940877|NCT00992407|1929693|FG000|Overall Study|Adverse Event|3
940878|NCT00992407|1929694|FG001|Overall Study|Adverse Event|2
940879|NCT00992407|1929693|FG000|Overall Study|protocol Violation & Adverse events|2
940880|NCT00992407|1929694|FG001|Overall Study|protocol Violation & Adverse events|4
940881|NCT00992407|1929693|FG000|Overall Study|Other|2
940882|NCT00992407|1929694|FG001|Overall Study|Other|0
940883|NCT00992407|1929693|FG000|Overall Study|Loss of follow-up & Adverse events|2
940884|NCT00992407|1929694|FG001|Overall Study|Loss of follow-up & Adverse events|1
940885|NCT00992407|1929693|FG000|Overall Study|Study medication not administered|17
940886|NCT00992407|1929694|FG001|Overall Study|Study medication not administered|13
940887|NCT00992446|1929712|FG000|Overall Study|Disease Progression|1
940888|NCT00992446|1929712|FG000|Overall Study|Withdrawal by Subject|2
940889|NCT00992446|1929712|FG000|Overall Study|Maintenance Therapy Screen Fail|5
940890|NCT00992459|1929718|FG000|Overall Study|Withdrawal by Subject|0
940891|NCT00992459|1929719|FG001|Overall Study|Withdrawal by Subject|1
940892|NCT00992459|1929718|FG000|Overall Study|Adverse Event|1
940893|NCT00992459|1929719|FG001|Overall Study|Adverse Event|0
940894|NCT00992511|1929729|FG000|Overall Study|Migrated/moved from study area|1
940895|NCT00992511|1929730|FG001|Overall Study|Migrated/moved from study area|0
940896|NCT00992511|1929731|FG002|Overall Study|Migrated/moved from study area|1
940897|NCT00992511|1929732|FG003|Overall Study|Migrated/moved from study area|2
940898|NCT00992511|1929729|FG000|Overall Study|Lost to Follow-up|1
940899|NCT00992511|1929730|FG001|Overall Study|Lost to Follow-up|0
940900|NCT00992511|1929731|FG002|Overall Study|Lost to Follow-up|0
940901|NCT00992511|1929732|FG003|Overall Study|Lost to Follow-up|2
940902|NCT00992511|1929729|FG000|Overall Study|Withdrawal by Subject|0
940903|NCT00992511|1929730|FG001|Overall Study|Withdrawal by Subject|0
940904|NCT00992511|1929731|FG002|Overall Study|Withdrawal by Subject|1
940905|NCT00992511|1929732|FG003|Overall Study|Withdrawal by Subject|1
940906|NCT00992589|1929742|FG000|Open-Label Phase|Adverse Event|4
940907|NCT00992589|1929743|FG001|Open-Label Phase|Adverse Event|0
940908|NCT00992589|1929744|FG002|Open-Label Phase|Adverse Event|0
940909|NCT00992589|1929745|FG003|Open-Label Phase|Adverse Event|0
940910|NCT00992589|1929742|FG000|Open-Label Phase|Withdrawal by Subject|20
940911|NCT00992589|1929743|FG001|Open-Label Phase|Withdrawal by Subject|0
940912|NCT00992589|1929744|FG002|Open-Label Phase|Withdrawal by Subject|0
940913|NCT00992589|1929745|FG003|Open-Label Phase|Withdrawal by Subject|0
940914|NCT00992589|1929742|FG000|Open-Label Phase|Lost to Follow-up|1
940915|NCT00992589|1929743|FG001|Open-Label Phase|Lost to Follow-up|0
940916|NCT00992589|1929744|FG002|Open-Label Phase|Lost to Follow-up|0
940917|NCT00992589|1929745|FG003|Open-Label Phase|Lost to Follow-up|0
940918|NCT00992589|1929742|FG000|Open-Label Phase|Protocol Violation|3
940919|NCT00992589|1929743|FG001|Open-Label Phase|Protocol Violation|0
940920|NCT00992589|1929744|FG002|Open-Label Phase|Protocol Violation|0
940921|NCT00992589|1929745|FG003|Open-Label Phase|Protocol Violation|0
940922|NCT00992589|1929742|FG000|Open-Label Phase|Physician Decision|4
940923|NCT00992589|1929743|FG001|Open-Label Phase|Physician Decision|0
940924|NCT00992589|1929744|FG002|Open-Label Phase|Physician Decision|0
940925|NCT00992589|1929745|FG003|Open-Label Phase|Physician Decision|0
940926|NCT00992589|1929742|FG000|Open-Label Phase|Other|45
940927|NCT00992589|1929743|FG001|Open-Label Phase|Other|0
940928|NCT00992589|1929744|FG002|Open-Label Phase|Other|0
940929|NCT00992589|1929745|FG003|Open-Label Phase|Other|0
940930|NCT00992589|1929742|FG000|Double-Blind Phase|Adverse Event|0
940931|NCT00992589|1929743|FG001|Double-Blind Phase|Adverse Event|6
940932|NCT00992589|1929744|FG002|Double-Blind Phase|Adverse Event|2
940933|NCT00992589|1929745|FG003|Double-Blind Phase|Adverse Event|3
940934|NCT00992589|1929742|FG000|Double-Blind Phase|Withdrawal by Subject|0
940935|NCT00992589|1929743|FG001|Double-Blind Phase|Withdrawal by Subject|6
940936|NCT00992589|1929744|FG002|Double-Blind Phase|Withdrawal by Subject|5
940937|NCT00992589|1929745|FG003|Double-Blind Phase|Withdrawal by Subject|2
940938|NCT00992589|1929742|FG000|Double-Blind Phase|Lost to Follow-up|0
940939|NCT00992589|1929743|FG001|Double-Blind Phase|Lost to Follow-up|0
940940|NCT00992589|1929744|FG002|Double-Blind Phase|Lost to Follow-up|0
940941|NCT00992589|1929745|FG003|Double-Blind Phase|Lost to Follow-up|2
940942|NCT00992589|1929742|FG000|Double-Blind Phase|Other|0
940943|NCT00992589|1929743|FG001|Double-Blind Phase|Other|1
940944|NCT00992589|1929744|FG002|Double-Blind Phase|Other|6
940945|NCT00992589|1929745|FG003|Double-Blind Phase|Other|3
940946|NCT00992784|1929783|FG000|Overall Study|Adverse Event|2
940947|NCT00992784|1929784|FG001|Overall Study|Adverse Event|1
940948|NCT00992784|1929785|FG002|Overall Study|Adverse Event|0
940949|NCT00992784|1929783|FG000|Overall Study|Withdrawal by Subject|1
940950|NCT00992784|1929784|FG001|Overall Study|Withdrawal by Subject|1
940951|NCT00992784|1929785|FG002|Overall Study|Withdrawal by Subject|1
940952|NCT00992836|1929793|FG000|Overall Study|Lost to Follow-up|1
940953|NCT00992836|1929793|FG000|Overall Study|Withdrawal by Subject|2
940954|NCT00992836|1929793|FG000|Overall Study|Protocol Violation|2
940955|NCT00992992|1929812|FG000|Overall Study|Lost to Follow-up|3
940956|NCT00992992|1929812|FG000|Overall Study|Death|16
940957|NCT00992992|1929812|FG000|Overall Study|GlaxoSmithKline Closed the Study|2
940958|NCT00992992|1929812|FG000|Overall Study|Sponsor Closed the Study|4
940959|NCT00993031|1929818|FG000|Overall Study|Death|0
940960|NCT00993031|1929819|FG001|Overall Study|Death|1
940961|NCT00993031|1929818|FG000|Overall Study|Physician Decision|0
940962|NCT00993031|1929819|FG001|Overall Study|Physician Decision|2
940963|NCT00993031|1929818|FG000|Overall Study|Withdrawal by Subject|3
940964|NCT00993031|1929819|FG001|Overall Study|Withdrawal by Subject|3
940965|NCT00993031|1929818|FG000|Overall Study|Lost to Follow-up|19
940966|NCT00993031|1929819|FG001|Overall Study|Lost to Follow-up|13
940967|NCT00993044|1929829|FG000|Irinotecan 50 mg|Physician Decision|1
940968|NCT00993148|1929834|FG000|Overall Study|Lost to Follow-up|2
940969|NCT00993148|1929834|FG000|Overall Study|never initiated treatment|1
940970|NCT00993265|1929873|FG000|Overall Study|Adverse Event|1
940971|NCT00993265|1929874|FG001|Overall Study|Adverse Event|0
940972|NCT00993265|1929873|FG000|Overall Study|Changed dose of concomitant drug|2
940973|NCT00993265|1929874|FG001|Overall Study|Changed dose of concomitant drug|0
940974|NCT00993265|1929873|FG000|Overall Study|Non-compliant with study medication|1
940975|NCT00993265|1929874|FG001|Overall Study|Non-compliant with study medication|0
940976|NCT00993291|1929880|FG000|Overall Study|Withdrawal by Subject|1
940977|NCT00993317|1929886|FG000|Overall Study|Adverse Event|2
940978|NCT00993317|1929887|FG001|Overall Study|Adverse Event|4
940979|NCT00993317|1929886|FG000|Overall Study|Lack of Efficacy|18
940980|NCT00993317|1929887|FG001|Overall Study|Lack of Efficacy|18
940981|NCT00993317|1929886|FG000|Overall Study|Withdrawal by Subject|0
940982|NCT00993317|1929887|FG001|Overall Study|Withdrawal by Subject|2
940983|NCT00993317|1929886|FG000|Overall Study|Investigator's opinion|0
940984|NCT00993317|1929887|FG001|Overall Study|Investigator's opinion|1
940985|NCT00993317|1929886|FG000|Overall Study|Early study termination at the site|1
940986|NCT00993317|1929887|FG001|Overall Study|Early study termination at the site|0
940987|NCT00993421|1929900|FG000|Overall Study|Adverse Event|2
940988|NCT00993421|1929901|FG001|Overall Study|Adverse Event|7
940989|NCT00993421|1929902|FG002|Overall Study|Adverse Event|6
940990|NCT00993421|1929903|FG003|Overall Study|Adverse Event|9
940991|NCT00993421|1929904|FG004|Overall Study|Adverse Event|5
940992|NCT00993421|1929905|FG005|Overall Study|Adverse Event|7
940993|NCT00993421|1929906|FG006|Overall Study|Adverse Event|1
940994|NCT00993421|1929900|FG000|Overall Study|Sponsor Decision|36
940995|NCT00993421|1929901|FG001|Overall Study|Sponsor Decision|31
940996|NCT00993421|1929902|FG002|Overall Study|Sponsor Decision|28
940997|NCT00993421|1929903|FG003|Overall Study|Sponsor Decision|30
940998|NCT00993421|1929904|FG004|Overall Study|Sponsor Decision|38
940999|NCT00993421|1929905|FG005|Overall Study|Sponsor Decision|30
941000|NCT00993421|1929906|FG006|Overall Study|Sponsor Decision|29
941001|NCT00993421|1929900|FG000|Overall Study|Lost to Follow-up|3
941002|NCT00993421|1929901|FG001|Overall Study|Lost to Follow-up|5
941003|NCT00993421|1929902|FG002|Overall Study|Lost to Follow-up|5
941004|NCT00993421|1929903|FG003|Overall Study|Lost to Follow-up|0
941005|NCT00993421|1929904|FG004|Overall Study|Lost to Follow-up|0
941006|NCT00993421|1929905|FG005|Overall Study|Lost to Follow-up|0
941007|NCT00993421|1929906|FG006|Overall Study|Lost to Follow-up|6
941008|NCT00993421|1929900|FG000|Overall Study|Withdrawal by Subject|3
941009|NCT00993421|1929901|FG001|Overall Study|Withdrawal by Subject|2
941010|NCT00993421|1929902|FG002|Overall Study|Withdrawal by Subject|3
941011|NCT00993421|1929903|FG003|Overall Study|Withdrawal by Subject|3
941012|NCT00993421|1929904|FG004|Overall Study|Withdrawal by Subject|3
941013|NCT00993421|1929905|FG005|Overall Study|Withdrawal by Subject|5
941014|NCT00993421|1929906|FG006|Overall Study|Withdrawal by Subject|3
941015|NCT00993421|1929900|FG000|Overall Study|Death|0
941016|NCT00993421|1929901|FG001|Overall Study|Death|0
941017|NCT00993421|1929902|FG002|Overall Study|Death|0
941018|NCT00993421|1929903|FG003|Overall Study|Death|0
941019|NCT00993421|1929904|FG004|Overall Study|Death|0
941020|NCT00993421|1929905|FG005|Overall Study|Death|0
941021|NCT00993421|1929906|FG006|Overall Study|Death|1
941022|NCT00993421|1929900|FG000|Overall Study|Entry Criteria Exclusion|0
941023|NCT00993421|1929901|FG001|Overall Study|Entry Criteria Exclusion|0
941024|NCT00993421|1929902|FG002|Overall Study|Entry Criteria Exclusion|1
941025|NCT00993421|1929903|FG003|Overall Study|Entry Criteria Exclusion|3
941026|NCT00993421|1929904|FG004|Overall Study|Entry Criteria Exclusion|0
941027|NCT00993421|1929905|FG005|Overall Study|Entry Criteria Exclusion|1
941028|NCT00993421|1929906|FG006|Overall Study|Entry Criteria Exclusion|0
941029|NCT00993421|1929900|FG000|Overall Study|Physician Decision|0
941030|NCT00993421|1929901|FG001|Overall Study|Physician Decision|0
941031|NCT00993421|1929902|FG002|Overall Study|Physician Decision|0
941032|NCT00993421|1929903|FG003|Overall Study|Physician Decision|0
941033|NCT00993421|1929904|FG004|Overall Study|Physician Decision|0
941034|NCT00993421|1929905|FG005|Overall Study|Physician Decision|1
941035|NCT00993421|1929906|FG006|Overall Study|Physician Decision|1
941036|NCT00993421|1929900|FG000|Overall Study|Protocol Violation|0
941037|NCT00993421|1929901|FG001|Overall Study|Protocol Violation|0
941038|NCT00993421|1929902|FG002|Overall Study|Protocol Violation|0
941039|NCT00993421|1929903|FG003|Overall Study|Protocol Violation|0
941040|NCT00993421|1929904|FG004|Overall Study|Protocol Violation|0
941041|NCT00993421|1929905|FG005|Overall Study|Protocol Violation|2
941042|NCT00993421|1929906|FG006|Overall Study|Protocol Violation|1
941043|NCT00993447|1929924|FG000|Overall Study|Withdrawal by Subject|23
941044|NCT00993447|1929925|FG001|Overall Study|Withdrawal by Subject|8
941045|NCT00993447|1929924|FG000|Overall Study|Protocol Violation|12
941046|NCT00993447|1929925|FG001|Overall Study|Protocol Violation|8
941047|NCT00993447|1929924|FG000|Overall Study|Lost to Follow-up|1
941048|NCT00993447|1929925|FG001|Overall Study|Lost to Follow-up|3
941049|NCT00993447|1929924|FG000|Overall Study|Adverse Event|1
941050|NCT00993447|1929925|FG001|Overall Study|Adverse Event|0
941051|NCT00993473|1929933|FG000|Overall Study|Adverse Event|0
941052|NCT00993473|1929934|FG001|Overall Study|Adverse Event|2
941053|NCT00993473|1929933|FG000|Overall Study|Protocol Violation|1
941054|NCT00993473|1929934|FG001|Overall Study|Protocol Violation|2
941055|NCT00993473|1929933|FG000|Overall Study|Lost to Follow-up|1
941056|NCT00993473|1929934|FG001|Overall Study|Lost to Follow-up|0
941057|NCT00993473|1929933|FG000|Overall Study|Withdrawal by Subject|1
941058|NCT00993473|1929934|FG001|Overall Study|Withdrawal by Subject|5
941059|NCT00993473|1929933|FG000|Overall Study|Technical problem with CGM device|0
941060|NCT00993473|1929934|FG001|Overall Study|Technical problem with CGM device|1
941061|NCT00993473|1929933|FG000|Overall Study|Family event|1
941062|NCT00993473|1929934|FG001|Overall Study|Family event|0
941063|NCT00993499|1929946|FG000|Run-in Period (8 Days)|Adverse Event|0
941064|NCT00993499|1929947|FG001|Run-in Period (8 Days)|Adverse Event|1
941065|NCT00993499|1929948|FG002|Run-in Period (8 Days)|Adverse Event|0
941066|NCT00993499|1929949|FG003|Run-in Period (8 Days)|Adverse Event|0
941067|NCT00993499|1929950|FG004|Run-in Period (8 Days)|Adverse Event|0
941068|NCT00993499|1929951|FG005|Run-in Period (8 Days)|Adverse Event|0
941069|NCT00993499|1929946|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
941070|NCT00993499|1929947|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
941071|NCT00993499|1929948|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
941072|NCT00993499|1929949|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
941073|NCT00993499|1929950|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
941074|NCT00993499|1929951|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
941075|NCT00993499|1929946|FG000|Run-in Period (8 Days)|Consent withdrawn|0
941076|NCT00993499|1929947|FG001|Run-in Period (8 Days)|Consent withdrawn|1
941077|NCT00993499|1929948|FG002|Run-in Period (8 Days)|Consent withdrawn|0
941078|NCT00993499|1929949|FG003|Run-in Period (8 Days)|Consent withdrawn|0
941079|NCT00993499|1929950|FG004|Run-in Period (8 Days)|Consent withdrawn|0
941080|NCT00993499|1929951|FG005|Run-in Period (8 Days)|Consent withdrawn|0
941081|NCT00993499|1929946|FG000|Run-in Period (8 Days)|Progressive disease|0
941082|NCT00993499|1929947|FG001|Run-in Period (8 Days)|Progressive disease|1
941083|NCT00993499|1929948|FG002|Run-in Period (8 Days)|Progressive disease|1
941084|NCT00993499|1929949|FG003|Run-in Period (8 Days)|Progressive disease|0
941085|NCT00993499|1929950|FG004|Run-in Period (8 Days)|Progressive disease|0
941086|NCT00993499|1929951|FG005|Run-in Period (8 Days)|Progressive disease|0
941087|NCT00993499|1929946|FG000|Discontinued Before Starting Course 3|Progressive Disease|2
941088|NCT00993499|1929947|FG001|Discontinued Before Starting Course 3|Progressive Disease|2
941089|NCT00993499|1929948|FG002|Discontinued Before Starting Course 3|Progressive Disease|0
941090|NCT00993499|1929949|FG003|Discontinued Before Starting Course 3|Progressive Disease|0
941091|NCT00993499|1929950|FG004|Discontinued Before Starting Course 3|Progressive Disease|0
941092|NCT00993499|1929951|FG005|Discontinued Before Starting Course 3|Progressive Disease|0
941093|NCT00993499|1929946|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2
941094|NCT00993499|1929947|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2
941095|NCT00993499|1929948|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0
941096|NCT00993499|1929949|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0
941097|NCT00993499|1929950|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0
941098|NCT00993499|1929951|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0
941099|NCT00993499|1929946|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
941100|NCT00993499|1929947|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
941101|NCT00993499|1929948|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
941102|NCT00993499|1929949|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
941103|NCT00993499|1929950|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
941104|NCT00993499|1929951|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
941105|NCT00993499|1929946|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0
941106|NCT00993499|1929947|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0
941107|NCT00993499|1929948|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2
941108|NCT00993499|1929949|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0
941109|NCT00993499|1929950|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0
941110|NCT00993499|1929951|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0
941111|NCT00993499|1929946|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0
941112|NCT00993499|1929947|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1
941113|NCT00993499|1929948|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0
941114|NCT00993499|1929949|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0
941115|NCT00993499|1929950|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0
941116|NCT00993499|1929951|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0
941117|NCT00993499|1929946|FG000|Discontinued After Starting Course 3|Progressive Disease|6
941118|NCT00993499|1929947|FG001|Discontinued After Starting Course 3|Progressive Disease|4
941119|NCT00993499|1929948|FG002|Discontinued After Starting Course 3|Progressive Disease|3
941120|NCT00993499|1929949|FG003|Discontinued After Starting Course 3|Progressive Disease|1
941121|NCT00993499|1929950|FG004|Discontinued After Starting Course 3|Progressive Disease|3
941122|NCT00993499|1929951|FG005|Discontinued After Starting Course 3|Progressive Disease|3
941123|NCT00993499|1929946|FG000|Discontinued After Starting Course 3|DLT|1
941124|NCT00993499|1929947|FG001|Discontinued After Starting Course 3|DLT|0
941125|NCT00993499|1929948|FG002|Discontinued After Starting Course 3|DLT|2
941126|NCT00993499|1929949|FG003|Discontinued After Starting Course 3|DLT|1
941127|NCT00993499|1929950|FG004|Discontinued After Starting Course 3|DLT|0
941128|NCT00993499|1929951|FG005|Discontinued After Starting Course 3|DLT|0
941129|NCT00993499|1929946|FG000|Discontinued After Starting Course 3|Other adverse event|1
941130|NCT00993499|1929947|FG001|Discontinued After Starting Course 3|Other adverse event|0
941131|NCT00993499|1929948|FG002|Discontinued After Starting Course 3|Other adverse event|1
941132|NCT00993499|1929949|FG003|Discontinued After Starting Course 3|Other adverse event|0
941133|NCT00993499|1929950|FG004|Discontinued After Starting Course 3|Other adverse event|0
941134|NCT00993499|1929951|FG005|Discontinued After Starting Course 3|Other adverse event|0
941135|NCT00993616|1929965|FG000|Overall Study|No tumor at entry|1
941136|NCT00993616|1929965|FG000|Overall Study|Never treated|1
941137|NCT00993668|1929993|FG000|Single-Blind Period|Adverse Event|1
941138|NCT00993668|1929994|FG001|Single-Blind Period|Adverse Event|1
941139|NCT00993668|1929993|FG000|Single-Blind Period|Lack of Efficacy|0
941140|NCT00993668|1929994|FG001|Single-Blind Period|Lack of Efficacy|1
941141|NCT00993668|1929993|FG000|Single-Blind Period|Lost to Follow-up|3
941142|NCT00993668|1929994|FG001|Single-Blind Period|Lost to Follow-up|1
941143|NCT00993668|1929993|FG000|Open-Label Period|Adverse Event|9
941144|NCT00993668|1929994|FG001|Open-Label Period|Adverse Event|8
941145|NCT00993668|1929993|FG000|Open-Label Period|Lack of Efficacy|4
941146|NCT00993668|1929994|FG001|Open-Label Period|Lack of Efficacy|3
941147|NCT00993668|1929993|FG000|Open-Label Period|Withdrawal by Subject|4
941148|NCT00993668|1929994|FG001|Open-Label Period|Withdrawal by Subject|3
941149|NCT00993668|1929993|FG000|Open-Label Period|Lost to Follow-up|6
941150|NCT00993668|1929994|FG001|Open-Label Period|Lost to Follow-up|1
941151|NCT00993915|1930027|FG000|Overall Study|Insufficient clinical response|3
941152|NCT00993915|1930027|FG000|Overall Study|Withdrawal by Subject|2
941153|NCT00993915|1930027|FG000|Overall Study|Other|1
941154|NCT00993915|1930027|FG000|Overall Study|Ongoing|3
941155|NCT00993928|1930033|FG000|Overall Study|Withdrawal by Subject|4
941156|NCT00993928|1930034|FG001|Overall Study|Withdrawal by Subject|7
941157|NCT00993928|1930033|FG000|Overall Study|ineligible|1
941158|NCT00993928|1930034|FG001|Overall Study|ineligible|0
941159|NCT00993954|1930046|FG000|Overall Study|Protocol Violation|21
941160|NCT00993954|1930047|FG001|Overall Study|Protocol Violation|2
941161|NCT00993967|1930053|FG000|Overall Study|Adverse Event|8
941162|NCT00993967|1930053|FG000|Overall Study|Death|1
941163|NCT00993967|1930053|FG000|Overall Study|Lost to Follow-up|14
941164|NCT00993967|1930053|FG000|Overall Study|Withdrawal by Subject|36
941165|NCT00993967|1930053|FG000|Overall Study|Protocol Violation|2
941166|NCT00994110|1930059|FG000|Overall Study|Withdrawal by Subject|9
941167|NCT00994110|1930060|FG001|Overall Study|Withdrawal by Subject|9
941168|NCT00994110|1930059|FG000|Overall Study|Not Treated|4
941169|NCT00994110|1930060|FG001|Overall Study|Not Treated|8
941170|NCT00994110|1930059|FG000|Overall Study|Adverse Event|1
941171|NCT00994110|1930060|FG001|Overall Study|Adverse Event|0
941172|NCT00994110|1930059|FG000|Overall Study|Patient not resected|41
941173|NCT00994110|1930060|FG001|Overall Study|Patient not resected|52
941174|NCT00994110|1930059|FG000|Overall Study|Pt not eligible|10
941175|NCT00994110|1930060|FG001|Overall Study|Pt not eligible|5
941176|NCT00994214|1930101|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0
941177|NCT00994214|1930102|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1
941178|NCT00994214|1930103|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0
941179|NCT00994214|1930104|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0
941180|NCT00994214|1930101|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
941181|NCT00994214|1930102|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
941182|NCT00994214|1930103|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
941183|NCT00994214|1930104|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
941184|NCT00994214|1930101|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
941185|NCT00994214|1930102|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
941186|NCT00994214|1930103|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
941187|NCT00994214|1930104|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
941188|NCT00994214|1930101|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
941189|NCT00994214|1930102|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
941190|NCT00994214|1930103|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
941191|NCT00994214|1930104|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
941192|NCT00994214|1930101|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
941193|NCT00994214|1930102|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
941194|NCT00994214|1930103|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
941195|NCT00994214|1930104|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
941196|NCT00994214|1930101|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
941197|NCT00994214|1930102|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
941198|NCT00994214|1930103|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
941199|NCT00994214|1930104|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
941200|NCT00994240|1930134|FG000|Overall Study|Lost to Follow-up|3
941201|NCT00994240|1930135|FG001|Overall Study|Lost to Follow-up|2
941202|NCT00994240|1930134|FG000|Overall Study|Withdrawal by Subject|1
941203|NCT00994240|1930135|FG001|Overall Study|Withdrawal by Subject|0
941204|NCT00994240|1930134|FG000|Overall Study|study termination|2
941205|NCT00994240|1930135|FG001|Overall Study|study termination|3
941206|NCT00994279|1930143|FG000|Overall Study|Withdrawal by Subject|2
941207|NCT00994279|1930144|FG001|Overall Study|Withdrawal by Subject|2
941208|NCT00994279|1930143|FG000|Overall Study|Toxicity|1
941209|NCT00994279|1930144|FG001|Overall Study|Toxicity|0
941210|NCT00994279|1930143|FG000|Overall Study|Multiple reasons|1
941211|NCT00994279|1930144|FG001|Overall Study|Multiple reasons|3
941212|NCT00994422|1930165|FG000|Overall Study|Lost to Follow-up|7
941213|NCT00994422|1930166|FG001|Overall Study|Lost to Follow-up|1
941214|NCT00994448|1930176|FG000|Overall Study|Adverse Event|1
941215|NCT00994448|1930177|FG001|Overall Study|Adverse Event|0
941216|NCT00994448|1930176|FG000|Overall Study|Lost to Follow-up|5
941217|NCT00994448|1930177|FG001|Overall Study|Lost to Follow-up|1
941218|NCT00994448|1930176|FG000|Overall Study|Withdrawal by Subject|1
941219|NCT00994448|1930177|FG001|Overall Study|Withdrawal by Subject|1
941220|NCT00994448|1930176|FG000|Overall Study|Physician Decision|1
941221|NCT00994448|1930177|FG001|Overall Study|Physician Decision|0
941222|NCT00994461|1930186|FG000|Overall Study|Adverse Event|2
941223|NCT00994461|1930187|FG001|Overall Study|Adverse Event|1
941224|NCT00994461|1930188|FG002|Overall Study|Adverse Event|0
941225|NCT00994643|1930203|FG000|Overall Study|Withdrawal by Subject|1
941226|NCT00994682|1930209|FG000|Double Bilnd|Withdrawal by Subject|5
941227|NCT00994682|1930210|FG001|Double Bilnd|Withdrawal by Subject|6
941228|NCT00994682|1930209|FG000|Double Bilnd|Lost to Follow-up|3
941229|NCT00994682|1930210|FG001|Double Bilnd|Lost to Follow-up|3
941230|NCT00994682|1930209|FG000|Double Bilnd|Adverse Event|1
941231|NCT00994682|1930210|FG001|Double Bilnd|Adverse Event|0
941232|NCT00994682|1930209|FG000|Pioglitazone Open Label|Withdrawal by Subject|4
941233|NCT00994682|1930210|FG001|Pioglitazone Open Label|Withdrawal by Subject|4
941234|NCT00994682|1930209|FG000|Pioglitazone Open Label|Lost to Follow-up|3
941235|NCT00994682|1930210|FG001|Pioglitazone Open Label|Lost to Follow-up|2
941236|NCT00994682|1930209|FG000|Pioglitazone Open Label|Physician Decision|6
941237|NCT00994682|1930210|FG001|Pioglitazone Open Label|Physician Decision|1
941238|NCT00994890|1930241|FG000|Overall Study|Adverse Event|13
941239|NCT00994890|1930242|FG001|Overall Study|Adverse Event|9
941240|NCT00994890|1930243|FG002|Overall Study|Adverse Event|11
941241|NCT00994890|1930241|FG000|Overall Study|Lack of Efficacy|0
941242|NCT00994890|1930242|FG001|Overall Study|Lack of Efficacy|0
941243|NCT00994890|1930243|FG002|Overall Study|Lack of Efficacy|1
941244|NCT00994890|1930241|FG000|Overall Study|Lost to Follow-up|6
941245|NCT00994890|1930242|FG001|Overall Study|Lost to Follow-up|1
941246|NCT00994890|1930243|FG002|Overall Study|Lost to Follow-up|3
941247|NCT00994890|1930241|FG000|Overall Study|No longer willing to participate|8
941248|NCT00994890|1930242|FG001|Overall Study|No longer willing to participate|5
941249|NCT00994890|1930243|FG002|Overall Study|No longer willing to participate|13
941250|NCT00994890|1930241|FG000|Overall Study|Protocol Violation|2
941251|NCT00994890|1930242|FG001|Overall Study|Protocol Violation|4
941252|NCT00994890|1930243|FG002|Overall Study|Protocol Violation|0
941253|NCT00994890|1930241|FG000|Overall Study|Study terminated by sponsor|199
941254|NCT00994890|1930242|FG001|Overall Study|Study terminated by sponsor|201
941255|NCT00994890|1930243|FG002|Overall Study|Study terminated by sponsor|197
941256|NCT00994890|1930241|FG000|Overall Study|Randomized, but not treated|1
941257|NCT00994890|1930242|FG001|Overall Study|Randomized, but not treated|0
941258|NCT00994890|1930243|FG002|Overall Study|Randomized, but not treated|0
941259|NCT00994890|1930241|FG000|Overall Study|Other|2
941260|NCT00994890|1930242|FG001|Overall Study|Other|2
941261|NCT00994890|1930243|FG002|Overall Study|Other|1
941262|NCT00995007|1930258|FG000|Overall Study|Withdrew consent|1
941263|NCT00995007|1930259|FG001|Overall Study|Withdrew consent|0
941264|NCT00995007|1930258|FG000|Overall Study|Refused further treatment|8
941265|NCT00995007|1930259|FG001|Overall Study|Refused further treatment|2
941266|NCT00995007|1930258|FG000|Overall Study|Toxicity|8
941267|NCT00995007|1930259|FG001|Overall Study|Toxicity|0
941268|NCT00995020|1930276|FG000|Overall Study|margin analysis not performed|2
941269|NCT00995020|1930277|FG001|Overall Study|margin analysis not performed|5
941270|NCT00995020|1930276|FG000|Overall Study|specimen fragmentation, thermal damage|1
941271|NCT00995020|1930277|FG001|Overall Study|specimen fragmentation, thermal damage|2
941272|NCT00995085|1930294|FG000|Overall Study|Withdrawal by Subject|5
941273|NCT00995345|1930308|FG000|Overall Study|Withdrawal by Subject|4
941274|NCT00995345|1930309|FG001|Overall Study|Withdrawal by Subject|2
941275|NCT00995345|1930310|FG002|Overall Study|Withdrawal by Subject|1
941276|NCT00995345|1930311|FG003|Overall Study|Withdrawal by Subject|3
941277|NCT00995345|1930312|FG004|Overall Study|Withdrawal by Subject|1
941278|NCT00995345|1930308|FG000|Overall Study|Adverse Event|3
941279|NCT00995345|1930309|FG001|Overall Study|Adverse Event|1
941280|NCT00995345|1930310|FG002|Overall Study|Adverse Event|2
941281|NCT00995345|1930311|FG003|Overall Study|Adverse Event|0
941282|NCT00995345|1930312|FG004|Overall Study|Adverse Event|1
941283|NCT00995345|1930308|FG000|Overall Study|Lost to Follow-up|2
941284|NCT00995345|1930309|FG001|Overall Study|Lost to Follow-up|2
941285|NCT00995345|1930310|FG002|Overall Study|Lost to Follow-up|2
941286|NCT00995345|1930311|FG003|Overall Study|Lost to Follow-up|1
941287|NCT00995345|1930312|FG004|Overall Study|Lost to Follow-up|0
941288|NCT00995345|1930308|FG000|Overall Study|all other reasons combined|2
941289|NCT00995345|1930309|FG001|Overall Study|all other reasons combined|2
941290|NCT00995345|1930310|FG002|Overall Study|all other reasons combined|2
941291|NCT00995345|1930311|FG003|Overall Study|all other reasons combined|1
941292|NCT00995345|1930312|FG004|Overall Study|all other reasons combined|3
941293|NCT00995371|1930326|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
941294|NCT00995371|1930327|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
941295|NCT00995410|1930335|FG000|Overall Study|Adverse Event|51
941296|NCT00995410|1930335|FG000|Overall Study|Withdrawal by Subject|7
941297|NCT00995410|1930335|FG000|Overall Study|Lost to Follow-up|2
941298|NCT00995410|1930335|FG000|Overall Study|Misc|28
941299|NCT00995436|1930342|FG000|Overall Study|Withdrawal by Subject|2
941300|NCT00995436|1930343|FG001|Overall Study|Withdrawal by Subject|5
941301|NCT00995436|1930344|FG002|Overall Study|Withdrawal by Subject|0
941302|NCT00995488|1930374|FG000|Overall Study|Withdrawal by Subject|1
941303|NCT00995553|1930413|FG000|Overall Study|Withdrawal by Subject|2
941304|NCT00995553|1930414|FG001|Overall Study|Withdrawal by Subject|6
941305|NCT00995566|1930420|FG000|Overall Study|Adverse Event|2
941306|NCT00995566|1930420|FG000|Overall Study|Early study termination|52
941307|NCT00995670|1930427|FG000|Overall Study|Failed arterial cannulation|1
941308|NCT00995670|1930428|FG001|Overall Study|Failed arterial cannulation|0
941309|NCT00995670|1930429|FG002|Overall Study|Failed arterial cannulation|3
941310|NCT00995709|1930440|FG000|Overall Study|Adverse Event|4
941311|NCT00995709|1930441|FG001|Overall Study|Adverse Event|2
941312|NCT00995709|1930442|FG002|Overall Study|Adverse Event|0
941313|NCT00995709|1930440|FG000|Overall Study|Lack of Efficacy|0
941314|NCT00995709|1930441|FG001|Overall Study|Lack of Efficacy|1
941315|NCT00995709|1930442|FG002|Overall Study|Lack of Efficacy|4
941316|NCT00995709|1930440|FG000|Overall Study|Withdrawal by Subject|0
941317|NCT00995709|1930441|FG001|Overall Study|Withdrawal by Subject|4
941318|NCT00995709|1930442|FG002|Overall Study|Withdrawal by Subject|1
941319|NCT00995709|1930440|FG000|Overall Study|Lost to Follow-up|1
941320|NCT00995709|1930441|FG001|Overall Study|Lost to Follow-up|0
941321|NCT00995709|1930442|FG002|Overall Study|Lost to Follow-up|0
941322|NCT00995709|1930440|FG000|Overall Study|Death|0
941323|NCT00995709|1930441|FG001|Overall Study|Death|1
941324|NCT00995709|1930442|FG002|Overall Study|Death|0
941325|NCT00995709|1930440|FG000|Overall Study|Protocol Violation|2
941326|NCT00995709|1930441|FG001|Overall Study|Protocol Violation|1
941327|NCT00995709|1930442|FG002|Overall Study|Protocol Violation|0
941328|NCT00995774|1930465|FG000|Training Period 2|Withdrawal by Subject|2
941329|NCT00995774|1930466|FG001|Training Period 2|Withdrawal by Subject|0
941330|NCT00995865|1930475|FG000|Overall Study|Protocol Violation|2
941331|NCT00995865|1930476|FG001|Overall Study|Protocol Violation|0
941332|NCT00995865|1930477|FG002|Overall Study|Protocol Violation|0
941333|NCT00995865|1930475|FG000|Overall Study|Lost to Follow-up|0
941334|NCT00995865|1930476|FG001|Overall Study|Lost to Follow-up|0
941335|NCT00995865|1930477|FG002|Overall Study|Lost to Follow-up|1
941336|NCT00995930|1930508|FG000|Overall Study|Protocol deviation|2
941337|NCT00995930|1930509|FG001|Overall Study|Protocol deviation|5
941338|NCT00995930|1930508|FG000|Overall Study|Death|0
941339|NCT00995930|1930509|FG001|Overall Study|Death|1
941340|NCT00995930|1930508|FG000|Overall Study|Administrative problems|4
941341|NCT00995930|1930509|FG001|Overall Study|Administrative problems|2
941342|NCT00995930|1930508|FG000|Overall Study|Lost to Follow-up|1
941343|NCT00995930|1930509|FG001|Overall Study|Lost to Follow-up|2
941344|NCT00995930|1930508|FG000|Overall Study|Withdrawal by Subject|3
941345|NCT00995930|1930509|FG001|Overall Study|Withdrawal by Subject|4
941346|NCT00995930|1930508|FG000|Overall Study|Adverse Event|11
941347|NCT00995930|1930509|FG001|Overall Study|Adverse Event|14
941348|NCT00996034|1930516|FG000|Overall Study|Lost to Follow-up|2
941349|NCT00996034|1930516|FG000|Overall Study|withdrawn by PI|1
941350|NCT00996125|1930522|FG000|Overall Study|Adverse Event|0
941351|NCT00996125|1930523|FG001|Overall Study|Adverse Event|2
941352|NCT00996125|1930522|FG000|Overall Study|Lost to Follow-up|1
941353|NCT00996125|1930523|FG001|Overall Study|Lost to Follow-up|6
941354|NCT00996125|1930522|FG000|Overall Study|Withdrawal by Subject|4
941355|NCT00996125|1930523|FG001|Overall Study|Withdrawal by Subject|3
941356|NCT00996203|1930538|FG000|Overall Study|Adverse Event|3
941357|NCT00996203|1930538|FG000|Overall Study|Lost to Follow-up|1
941358|NCT00996203|1930538|FG000|Overall Study|Lack of Efficacy|1
941359|NCT00996203|1930538|FG000|Overall Study|Protocol Violation|2
941360|NCT00996216|1930543|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
941361|NCT00996216|1930543|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
941362|NCT00996216|1930543|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
941363|NCT00996281|1930550|FG000|Overall Study|Adverse Event|75
941364|NCT00996281|1930551|FG001|Overall Study|Adverse Event|37
941365|NCT00996281|1930550|FG000|Overall Study|Major Protocol Deviation|6
941366|NCT00996281|1930551|FG001|Overall Study|Major Protocol Deviation|7
941367|NCT00996281|1930550|FG000|Overall Study|Lost to Follow-up|14
941368|NCT00996281|1930551|FG001|Overall Study|Lost to Follow-up|16
941369|NCT00996281|1930550|FG000|Overall Study|Withdrawal by Subject|31
941370|NCT00996281|1930551|FG001|Overall Study|Withdrawal by Subject|20
941371|NCT00996281|1930550|FG000|Overall Study|Lack of Efficacy|0
941372|NCT00996281|1930551|FG001|Overall Study|Lack of Efficacy|2
941373|NCT00996281|1930550|FG000|Overall Study|Other|5
941374|NCT00996281|1930551|FG001|Overall Study|Other|7
941375|NCT00996307|1930561|FG000|Overall Study|Adverse Event|0
941376|NCT00996307|1930562|FG001|Overall Study|Adverse Event|1
941377|NCT00996307|1930563|FG002|Overall Study|Adverse Event|0
941378|NCT00996307|1930564|FG003|Overall Study|Adverse Event|0
941379|NCT00996307|1930561|FG000|Overall Study|Withdrawal by Subject|3
941380|NCT00996307|1930562|FG001|Overall Study|Withdrawal by Subject|2
941381|NCT00996307|1930563|FG002|Overall Study|Withdrawal by Subject|5
941382|NCT00996307|1930564|FG003|Overall Study|Withdrawal by Subject|5
941383|NCT00996307|1930561|FG000|Overall Study|Lost to Follow-up|13
941384|NCT00996307|1930562|FG001|Overall Study|Lost to Follow-up|13
941385|NCT00996307|1930563|FG002|Overall Study|Lost to Follow-up|7
941386|NCT00996307|1930564|FG003|Overall Study|Lost to Follow-up|15
941387|NCT00996307|1930561|FG000|Overall Study|Administrative reason|0
941388|NCT00996307|1930562|FG001|Overall Study|Administrative reason|1
941389|NCT00996307|1930563|FG002|Overall Study|Administrative reason|0
941390|NCT00996307|1930564|FG003|Overall Study|Administrative reason|0
941391|NCT00996307|1930561|FG000|Overall Study|Unable to classify|4
941392|NCT00996307|1930562|FG001|Overall Study|Unable to classify|0
941393|NCT00996307|1930563|FG002|Overall Study|Unable to classify|2
941394|NCT00996307|1930564|FG003|Overall Study|Unable to classify|1
1014800|NCT01534962|2036807|FG000|Overall Study|Randomized but did not start treatment|2
1014801|NCT01534962|2036808|FG001|Overall Study|Randomized but did not start treatment|0
1014802|NCT01534962|2036809|FG002|Overall Study|Randomized but did not start treatment|0
1014803|NCT01534962|2036810|FG003|Overall Study|Randomized but did not start treatment|1
1014804|NCT01534962|2036807|FG000|Overall Study|Discontinued at AF recurrence|35
1014805|NCT01534962|2036808|FG001|Overall Study|Discontinued at AF recurrence|26
1014806|NCT01534962|2036809|FG002|Overall Study|Discontinued at AF recurrence|24
1014807|NCT01534962|2036810|FG003|Overall Study|Discontinued at AF recurrence|31
1014808|NCT01535040|2036863|FG000|Overall Study|Physician Decision|0
1014809|NCT01535040|2036864|FG001|Overall Study|Physician Decision|1
1014810|NCT01535040|2036863|FG000|Overall Study|Withdrawal by Subject|13
1014811|NCT01535040|2036864|FG001|Overall Study|Withdrawal by Subject|10
1014812|NCT01535040|2036863|FG000|Overall Study|Never Started|9
1014813|NCT01535040|2036864|FG001|Overall Study|Never Started|4
1014814|NCT01535040|2036863|FG000|Overall Study|Toxicity|7
1014815|NCT01535040|2036864|FG001|Overall Study|Toxicity|5
1014816|NCT01535040|2036863|FG000|Overall Study|Multiple Reasons|1
1014817|NCT01535040|2036864|FG001|Overall Study|Multiple Reasons|1
1014818|NCT01535053|2036872|FG000|Overall Study|Ineligible|1
1014819|NCT01535053|2036873|FG001|Overall Study|Ineligible|2
1014820|NCT01535222|2036889|FG000|Overall Study|Inclusion/exclusion|0
1014821|NCT01535222|2036890|FG001|Overall Study|Inclusion/exclusion|0
1014822|NCT01535222|2036891|FG002|Overall Study|Inclusion/exclusion|1
1014823|NCT01535222|2036892|FG003|Overall Study|Inclusion/exclusion|0
1014824|NCT01535222|2036893|FG004|Overall Study|Inclusion/exclusion|0
1014825|NCT01535222|2036894|FG005|Overall Study|Inclusion/exclusion|0
1014826|NCT01535235|2036910|FG000|Overall Study|Adverse Event|1
1014827|NCT01535235|2036911|FG001|Overall Study|Adverse Event|0
1014828|NCT01535261|2036917|FG000|Overall Study|Physician Decision|8
1014829|NCT01535261|2036917|FG000|Overall Study|Protocol Violation|3
1014830|NCT01535261|2036917|FG000|Overall Study|Death|5
1014831|NCT01535261|2036917|FG000|Overall Study|Lost to Follow-up|8
1014832|NCT01535261|2036917|FG000|Overall Study|Withdrawal by Subject|14
1014833|NCT01535261|2036917|FG000|Overall Study|Adverse Event|12
1014834|NCT01535287|2036923|FG000|Overall Study|drug not prepared in time|5
1014835|NCT01535287|2036924|FG001|Overall Study|drug not prepared in time|6
1014836|NCT01535443|2036957|FG000|Overall Study|Physician Decision|3
1014837|NCT01535560|2036964|FG000|Overall Study|Adverse Event|12
1014838|NCT01535560|2036965|FG001|Overall Study|Adverse Event|7
1014839|NCT01535560|2036964|FG000|Overall Study|Lost to Follow-up|1
1014840|NCT01535560|2036965|FG001|Overall Study|Lost to Follow-up|3
1014841|NCT01535560|2036964|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3
1014842|NCT01535560|2036965|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1
1014843|NCT01535560|2036964|FG000|Overall Study|Treatment Failure|21
1014844|NCT01535560|2036965|FG001|Overall Study|Treatment Failure|83
1014845|NCT01535560|2036964|FG000|Overall Study|Other|0
1014846|NCT01535560|2036965|FG001|Overall Study|Other|1
1014847|NCT01535560|2036964|FG000|Overall Study|Randomized in Error|0
1014848|NCT01535560|2036965|FG001|Overall Study|Randomized in Error|1
1014849|NCT01535599|2036986|FG000|Overall Study|Adverse Event|6
1014850|NCT01535599|2036987|FG001|Overall Study|Adverse Event|15
1014851|NCT01535599|2036986|FG000|Overall Study|Lost to Follow-up|3
1014852|NCT01535599|2036987|FG001|Overall Study|Lost to Follow-up|4
1014853|NCT01535599|2036986|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4
1014854|NCT01535599|2036987|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3
1014855|NCT01535599|2036986|FG000|Overall Study|Treatment Failure|33
1014856|NCT01535599|2036987|FG001|Overall Study|Treatment Failure|66
1014857|NCT01535599|2036986|FG000|Overall Study|BL Culture + for Group A Strep|0
1014858|NCT01535599|2036987|FG001|Overall Study|BL Culture + for Group A Strep|1
1014859|NCT01535599|2036986|FG000|Overall Study|BL Culture + for Yeast//Fungi|0
1014860|NCT01535599|2036987|FG001|Overall Study|BL Culture + for Yeast//Fungi|1
1014861|NCT01535599|2036986|FG000|Overall Study|Randomized in Error|2
1014862|NCT01535599|2036987|FG001|Overall Study|Randomized in Error|4
1014863|NCT01535599|2036986|FG000|Overall Study|Did not use product|1
1014864|NCT01535599|2036987|FG001|Overall Study|Did not use product|0
1014865|NCT01535599|2036986|FG000|Overall Study|Other|1
941395|NCT00996437|1930616|FG000|Overall Study|Death|1
941396|NCT00996437|1930617|FG001|Overall Study|Death|0
941397|NCT00996437|1930616|FG000|Overall Study|Dropped|2
941398|NCT00996437|1930617|FG001|Overall Study|Dropped|2
941399|NCT00996437|1930616|FG000|Overall Study|Missed|2
941400|NCT00996437|1930617|FG001|Overall Study|Missed|5
941401|NCT00996476|1930628|FG000|Overall Study|Withdrawal by Subject|1
941402|NCT00996476|1930629|FG001|Overall Study|Withdrawal by Subject|2
941403|NCT00996476|1930630|FG002|Overall Study|Withdrawal by Subject|1
941404|NCT00996476|1930631|FG003|Overall Study|Withdrawal by Subject|0
941405|NCT00996476|1930632|FG004|Overall Study|Withdrawal by Subject|1
941406|NCT00996476|1930628|FG000|Overall Study|Adverse Event|0
941407|NCT00996476|1930629|FG001|Overall Study|Adverse Event|1
941408|NCT00996476|1930630|FG002|Overall Study|Adverse Event|0
941409|NCT00996476|1930631|FG003|Overall Study|Adverse Event|0
941410|NCT00996476|1930632|FG004|Overall Study|Adverse Event|1
941411|NCT00996489|1930649|FG000|Overall Study|Device failure|45
941412|NCT00996489|1930649|FG000|Overall Study|Discontinued|116
941413|NCT00996580|1930653|FG000|Overall Study|Adverse Event|466
941414|NCT00996580|1930653|FG000|Overall Study|Lost to Follow-up|480
941415|NCT00996580|1930653|FG000|Overall Study|Noncompliance with the protocol|137
941416|NCT00996580|1930653|FG000|Overall Study|Physician Decision|5
941417|NCT00996580|1930653|FG000|Overall Study|Pregnancy|68
941418|NCT00996580|1930653|FG000|Overall Study|Protocol Violation|16
941419|NCT00996580|1930653|FG000|Overall Study|Sponsor requested participant withdrawal|35
941420|NCT00996580|1930653|FG000|Overall Study|Withdrawal by Subject|217
941421|NCT00996580|1930653|FG000|Overall Study|Other|29
941422|NCT00996593|1930660|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
941423|NCT00996593|1930660|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
941424|NCT00996593|1930660|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22
941425|NCT00996593|1930660|FG000|Dosimetric and Therapeutic Treatment|Death|1
941426|NCT00996593|1930660|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
941427|NCT00996593|1930660|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
941428|NCT00996593|1930660|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1
941429|NCT00996593|1930660|FG000|Long-Term Follow-Up|Withdrawal by Subject|2
941430|NCT00996593|1930660|FG000|Long-Term Follow-Up|Site Closed|1
941431|NCT00996606|1930664|FG000|Overall Study|Adverse Event or Intercurrent Illness|2
941432|NCT00996606|1930664|FG000|Overall Study|Insufficient Therapeutic Response|2
941433|NCT00996606|1930664|FG000|Overall Study|Protocol Violation|1
941434|NCT00996606|1930664|FG000|Overall Study|Withdrawal by Subject|3
941435|NCT00996632|1930670|FG000|Overall Study|Physician Decision|0
941436|NCT00996632|1930671|FG001|Overall Study|Physician Decision|0
941437|NCT00996658|1930679|FG000|Overall Study|Adverse Event|2
941438|NCT00996658|1930680|FG001|Overall Study|Adverse Event|5
941439|NCT00996658|1930679|FG000|Overall Study|Protocol Violation|0
941440|NCT00996658|1930680|FG001|Overall Study|Protocol Violation|1
941441|NCT00996658|1930679|FG000|Overall Study|Lost to Follow-up|2
941442|NCT00996658|1930680|FG001|Overall Study|Lost to Follow-up|5
941443|NCT00996658|1930679|FG000|Overall Study|Non-compliance issues|3
941444|NCT00996658|1930680|FG001|Overall Study|Non-compliance issues|3
941445|NCT00996658|1930679|FG000|Overall Study|Other|9
941446|NCT00996658|1930680|FG001|Overall Study|Other|7
941447|NCT00996736|1930688|FG000|Overall Study|Death|1
941448|NCT00996736|1930689|FG001|Overall Study|Death|1
941449|NCT00996736|1930688|FG000|Overall Study|Lost to Follow-up|15
941450|NCT00996736|1930689|FG001|Overall Study|Lost to Follow-up|14
941451|NCT00996736|1930688|FG000|Overall Study|Visit not within 3-month window|5
941452|NCT00996736|1930689|FG001|Overall Study|Visit not within 3-month window|3
941453|NCT00996801|1930710|FG000|Overall Study|Adverse Event|6
941454|NCT00996801|1930711|FG001|Overall Study|Adverse Event|4
941455|NCT00996801|1930712|FG002|Overall Study|Adverse Event|12
941456|NCT00996801|1930713|FG003|Overall Study|Adverse Event|17
941457|NCT00996801|1930714|FG004|Overall Study|Adverse Event|31
941458|NCT00996801|1930715|FG005|Overall Study|Adverse Event|3
941459|NCT00996801|1930710|FG000|Overall Study|Lack of Efficacy|3
941460|NCT00996801|1930711|FG001|Overall Study|Lack of Efficacy|0
941461|NCT00996801|1930712|FG002|Overall Study|Lack of Efficacy|1
941462|NCT00996801|1930713|FG003|Overall Study|Lack of Efficacy|3
941463|NCT00996801|1930714|FG004|Overall Study|Lack of Efficacy|0
941464|NCT00996801|1930715|FG005|Overall Study|Lack of Efficacy|1
941465|NCT00996801|1930710|FG000|Overall Study|Lost to Follow-up|0
941466|NCT00996801|1930711|FG001|Overall Study|Lost to Follow-up|0
941467|NCT00996801|1930712|FG002|Overall Study|Lost to Follow-up|0
941468|NCT00996801|1930713|FG003|Overall Study|Lost to Follow-up|3
941469|NCT00996801|1930714|FG004|Overall Study|Lost to Follow-up|3
941470|NCT00996801|1930715|FG005|Overall Study|Lost to Follow-up|2
941471|NCT00996801|1930710|FG000|Overall Study|Physician Decision|0
941472|NCT00996801|1930711|FG001|Overall Study|Physician Decision|0
941473|NCT00996801|1930712|FG002|Overall Study|Physician Decision|0
941474|NCT00996801|1930713|FG003|Overall Study|Physician Decision|1
941475|NCT00996801|1930714|FG004|Overall Study|Physician Decision|0
941476|NCT00996801|1930715|FG005|Overall Study|Physician Decision|0
941477|NCT00996801|1930710|FG000|Overall Study|Progressive Disease|0
941478|NCT00996801|1930711|FG001|Overall Study|Progressive Disease|1
941479|NCT00996801|1930712|FG002|Overall Study|Progressive Disease|0
941480|NCT00996801|1930713|FG003|Overall Study|Progressive Disease|0
941481|NCT00996801|1930714|FG004|Overall Study|Progressive Disease|0
941482|NCT00996801|1930715|FG005|Overall Study|Progressive Disease|0
941483|NCT00996801|1930710|FG000|Overall Study|Protocol Violation|3
941484|NCT00996801|1930711|FG001|Overall Study|Protocol Violation|4
941485|NCT00996801|1930712|FG002|Overall Study|Protocol Violation|1
941486|NCT00996801|1930713|FG003|Overall Study|Protocol Violation|2
941487|NCT00996801|1930714|FG004|Overall Study|Protocol Violation|3
941488|NCT00996801|1930715|FG005|Overall Study|Protocol Violation|4
941489|NCT00996801|1930710|FG000|Overall Study|Study Terminated by Sponsor|0
941490|NCT00996801|1930711|FG001|Overall Study|Study Terminated by Sponsor|1
941491|NCT00996801|1930712|FG002|Overall Study|Study Terminated by Sponsor|0
941492|NCT00996801|1930713|FG003|Overall Study|Study Terminated by Sponsor|0
941493|NCT00996801|1930714|FG004|Overall Study|Study Terminated by Sponsor|46
941494|NCT00996801|1930715|FG005|Overall Study|Study Terminated by Sponsor|0
941495|NCT00996801|1930710|FG000|Overall Study|Withdrawal by Subject|8
941496|NCT00996801|1930711|FG001|Overall Study|Withdrawal by Subject|6
941497|NCT00996801|1930712|FG002|Overall Study|Withdrawal by Subject|9
941498|NCT00996801|1930713|FG003|Overall Study|Withdrawal by Subject|5
941499|NCT00996801|1930714|FG004|Overall Study|Withdrawal by Subject|5
941500|NCT00996801|1930715|FG005|Overall Study|Withdrawal by Subject|9
941501|NCT00996840|1930736|FG000|Overall Study|Adverse Event|0
941502|NCT00996840|1930737|FG001|Overall Study|Adverse Event|1
941503|NCT00996840|1930738|FG002|Overall Study|Adverse Event|0
941504|NCT00996840|1930739|FG003|Overall Study|Adverse Event|0
941505|NCT00996840|1930740|FG004|Overall Study|Adverse Event|0
941506|NCT00996840|1930736|FG000|Overall Study|Physician Decision|0
941507|NCT00996840|1930737|FG001|Overall Study|Physician Decision|0
941508|NCT00996840|1930738|FG002|Overall Study|Physician Decision|1
941509|NCT00996840|1930739|FG003|Overall Study|Physician Decision|1
941510|NCT00996840|1930740|FG004|Overall Study|Physician Decision|2
941511|NCT00996840|1930736|FG000|Overall Study|Withdrawal by Subject|1
941512|NCT00996840|1930737|FG001|Overall Study|Withdrawal by Subject|1
941513|NCT00996840|1930738|FG002|Overall Study|Withdrawal by Subject|0
941514|NCT00996840|1930739|FG003|Overall Study|Withdrawal by Subject|0
941515|NCT00996840|1930740|FG004|Overall Study|Withdrawal by Subject|0
941516|NCT00996892|1930756|FG000|Dose-Escalation Stage 1|Adverse Event|0
941517|NCT00996892|1930757|FG001|Dose-Escalation Stage 1|Adverse Event|0
941518|NCT00996892|1930758|FG002|Dose-Escalation Stage 1|Adverse Event|0
941519|NCT00996892|1930759|FG003|Dose-Escalation Stage 1|Adverse Event|2
941520|NCT00996892|1930760|FG004|Dose-Escalation Stage 1|Adverse Event|0
941521|NCT00996892|1930761|FG005|Dose-Escalation Stage 1|Adverse Event|0
941522|NCT00996892|1930762|FG006|Dose-Escalation Stage 1|Adverse Event|1
941523|NCT00996892|1930763|FG007|Dose-Escalation Stage 1|Adverse Event|0
941524|NCT00996892|1930764|FG008|Dose-Escalation Stage 1|Adverse Event|0
941525|NCT00996892|1930765|FG009|Dose-Escalation Stage 1|Adverse Event|0
941526|NCT00996892|1930766|FG010|Dose-Escalation Stage 1|Adverse Event|0
941527|NCT00996892|1930767|FG011|Dose-Escalation Stage 1|Adverse Event|0
941528|NCT00996892|1930768|FG012|Dose-Escalation Stage 1|Adverse Event|0
941529|NCT00996892|1930769|FG013|Dose-Escalation Stage 1|Adverse Event|0
941530|NCT00996892|1930770|FG014|Dose-Escalation Stage 1|Adverse Event|0
941531|NCT00996892|1930771|FG015|Dose-Escalation Stage 1|Adverse Event|0
941532|NCT00996892|1930772|FG016|Dose-Escalation Stage 1|Adverse Event|0
941533|NCT00996892|1930773|FG017|Dose-Escalation Stage 1|Adverse Event|0
941534|NCT00996892|1930774|FG018|Dose-Escalation Stage 1|Adverse Event|0
941535|NCT00996892|1930775|FG019|Dose-Escalation Stage 1|Adverse Event|0
941536|NCT00996892|1930756|FG000|Dose-Escalation Stage 1|Death|1
941537|NCT00996892|1930757|FG001|Dose-Escalation Stage 1|Death|0
941538|NCT00996892|1930758|FG002|Dose-Escalation Stage 1|Death|0
941539|NCT00996892|1930759|FG003|Dose-Escalation Stage 1|Death|0
941540|NCT00996892|1930760|FG004|Dose-Escalation Stage 1|Death|0
941541|NCT00996892|1930761|FG005|Dose-Escalation Stage 1|Death|1
941542|NCT00996892|1930762|FG006|Dose-Escalation Stage 1|Death|0
941543|NCT00996892|1930763|FG007|Dose-Escalation Stage 1|Death|0
941544|NCT00996892|1930764|FG008|Dose-Escalation Stage 1|Death|0
941545|NCT00996892|1930765|FG009|Dose-Escalation Stage 1|Death|0
941546|NCT00996892|1930766|FG010|Dose-Escalation Stage 1|Death|0
941547|NCT00996892|1930767|FG011|Dose-Escalation Stage 1|Death|0
941548|NCT00996892|1930768|FG012|Dose-Escalation Stage 1|Death|0
941549|NCT00996892|1930769|FG013|Dose-Escalation Stage 1|Death|0
941550|NCT00996892|1930770|FG014|Dose-Escalation Stage 1|Death|0
941551|NCT00996892|1930771|FG015|Dose-Escalation Stage 1|Death|0
941552|NCT00996892|1930772|FG016|Dose-Escalation Stage 1|Death|0
941553|NCT00996892|1930773|FG017|Dose-Escalation Stage 1|Death|0
941554|NCT00996892|1930774|FG018|Dose-Escalation Stage 1|Death|0
941555|NCT00996892|1930775|FG019|Dose-Escalation Stage 1|Death|0
941556|NCT00996892|1930756|FG000|Dose-Escalation Stage 1|Physician Decision|1
941557|NCT00996892|1930757|FG001|Dose-Escalation Stage 1|Physician Decision|0
941558|NCT00996892|1930758|FG002|Dose-Escalation Stage 1|Physician Decision|0
941559|NCT00996892|1930759|FG003|Dose-Escalation Stage 1|Physician Decision|1
941560|NCT00996892|1930760|FG004|Dose-Escalation Stage 1|Physician Decision|0
941561|NCT00996892|1930761|FG005|Dose-Escalation Stage 1|Physician Decision|1
941562|NCT00996892|1930762|FG006|Dose-Escalation Stage 1|Physician Decision|2
941563|NCT00996892|1930763|FG007|Dose-Escalation Stage 1|Physician Decision|0
941564|NCT00996892|1930764|FG008|Dose-Escalation Stage 1|Physician Decision|0
941565|NCT00996892|1930765|FG009|Dose-Escalation Stage 1|Physician Decision|0
941566|NCT00996892|1930766|FG010|Dose-Escalation Stage 1|Physician Decision|0
941567|NCT00996892|1930767|FG011|Dose-Escalation Stage 1|Physician Decision|0
941568|NCT00996892|1930768|FG012|Dose-Escalation Stage 1|Physician Decision|0
941569|NCT00996892|1930769|FG013|Dose-Escalation Stage 1|Physician Decision|0
941570|NCT00996892|1930770|FG014|Dose-Escalation Stage 1|Physician Decision|0
941571|NCT00996892|1930771|FG015|Dose-Escalation Stage 1|Physician Decision|0
941572|NCT00996892|1930772|FG016|Dose-Escalation Stage 1|Physician Decision|0
941573|NCT00996892|1930773|FG017|Dose-Escalation Stage 1|Physician Decision|0
941574|NCT00996892|1930774|FG018|Dose-Escalation Stage 1|Physician Decision|0
941575|NCT00996892|1930775|FG019|Dose-Escalation Stage 1|Physician Decision|0
941576|NCT00996892|1930756|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0
941577|NCT00996892|1930757|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1
941578|NCT00996892|1930758|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0
941579|NCT00996892|1930759|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2
941580|NCT00996892|1930760|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1
941581|NCT00996892|1930761|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1
941582|NCT00996892|1930762|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1
941583|NCT00996892|1930763|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0
941584|NCT00996892|1930764|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0
941585|NCT00996892|1930765|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0
941586|NCT00996892|1930766|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0
941587|NCT00996892|1930767|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0
941588|NCT00996892|1930768|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0
941589|NCT00996892|1930769|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0
941590|NCT00996892|1930770|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0
941591|NCT00996892|1930771|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0
941592|NCT00996892|1930772|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0
941593|NCT00996892|1930773|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0
941594|NCT00996892|1930774|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0
941595|NCT00996892|1930775|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0
941596|NCT00996892|1930756|FG000|Dose-Escalation Stage 1|Disease Progression|2
941597|NCT00996892|1930757|FG001|Dose-Escalation Stage 1|Disease Progression|2
941598|NCT00996892|1930758|FG002|Dose-Escalation Stage 1|Disease Progression|3
941599|NCT00996892|1930759|FG003|Dose-Escalation Stage 1|Disease Progression|4
941600|NCT00996892|1930760|FG004|Dose-Escalation Stage 1|Disease Progression|10
941601|NCT00996892|1930761|FG005|Dose-Escalation Stage 1|Disease Progression|7
941602|NCT00996892|1930762|FG006|Dose-Escalation Stage 1|Disease Progression|0
941603|NCT00996892|1930763|FG007|Dose-Escalation Stage 1|Disease Progression|0
941604|NCT00996892|1930764|FG008|Dose-Escalation Stage 1|Disease Progression|0
941605|NCT00996892|1930765|FG009|Dose-Escalation Stage 1|Disease Progression|0
941606|NCT00996892|1930766|FG010|Dose-Escalation Stage 1|Disease Progression|0
941607|NCT00996892|1930767|FG011|Dose-Escalation Stage 1|Disease Progression|0
941608|NCT00996892|1930768|FG012|Dose-Escalation Stage 1|Disease Progression|0
941609|NCT00996892|1930769|FG013|Dose-Escalation Stage 1|Disease Progression|0
941610|NCT00996892|1930770|FG014|Dose-Escalation Stage 1|Disease Progression|0
941611|NCT00996892|1930771|FG015|Dose-Escalation Stage 1|Disease Progression|0
941612|NCT00996892|1930772|FG016|Dose-Escalation Stage 1|Disease Progression|0
941613|NCT00996892|1930773|FG017|Dose-Escalation Stage 1|Disease Progression|0
941614|NCT00996892|1930774|FG018|Dose-Escalation Stage 1|Disease Progression|0
941615|NCT00996892|1930775|FG019|Dose-Escalation Stage 1|Disease Progression|0
941616|NCT00996892|1930756|FG000|Dose-Escalation Stage 1A|Adverse Event|0
941617|NCT00996892|1930757|FG001|Dose-Escalation Stage 1A|Adverse Event|0
941618|NCT00996892|1930758|FG002|Dose-Escalation Stage 1A|Adverse Event|0
941619|NCT00996892|1930759|FG003|Dose-Escalation Stage 1A|Adverse Event|0
941620|NCT00996892|1930760|FG004|Dose-Escalation Stage 1A|Adverse Event|0
941621|NCT00996892|1930761|FG005|Dose-Escalation Stage 1A|Adverse Event|0
941622|NCT00996892|1930762|FG006|Dose-Escalation Stage 1A|Adverse Event|0
941623|NCT00996892|1930763|FG007|Dose-Escalation Stage 1A|Adverse Event|0
941624|NCT00996892|1930764|FG008|Dose-Escalation Stage 1A|Adverse Event|0
941625|NCT00996892|1930765|FG009|Dose-Escalation Stage 1A|Adverse Event|0
941626|NCT00996892|1930766|FG010|Dose-Escalation Stage 1A|Adverse Event|1
941627|NCT00996892|1930767|FG011|Dose-Escalation Stage 1A|Adverse Event|0
941628|NCT00996892|1930768|FG012|Dose-Escalation Stage 1A|Adverse Event|0
941629|NCT00996892|1930769|FG013|Dose-Escalation Stage 1A|Adverse Event|1
941630|NCT00996892|1930770|FG014|Dose-Escalation Stage 1A|Adverse Event|0
941631|NCT00996892|1930771|FG015|Dose-Escalation Stage 1A|Adverse Event|0
941632|NCT00996892|1930772|FG016|Dose-Escalation Stage 1A|Adverse Event|0
941633|NCT00996892|1930773|FG017|Dose-Escalation Stage 1A|Adverse Event|0
941634|NCT00996892|1930774|FG018|Dose-Escalation Stage 1A|Adverse Event|0
941635|NCT00996892|1930775|FG019|Dose-Escalation Stage 1A|Adverse Event|0
941636|NCT00996892|1930756|FG000|Dose-Escalation Stage 1A|Death|0
941637|NCT00996892|1930757|FG001|Dose-Escalation Stage 1A|Death|0
941638|NCT00996892|1930758|FG002|Dose-Escalation Stage 1A|Death|0
941639|NCT00996892|1930759|FG003|Dose-Escalation Stage 1A|Death|0
941640|NCT00996892|1930760|FG004|Dose-Escalation Stage 1A|Death|0
941641|NCT00996892|1930761|FG005|Dose-Escalation Stage 1A|Death|0
941642|NCT00996892|1930762|FG006|Dose-Escalation Stage 1A|Death|0
941643|NCT00996892|1930763|FG007|Dose-Escalation Stage 1A|Death|0
941644|NCT00996892|1930764|FG008|Dose-Escalation Stage 1A|Death|0
941645|NCT00996892|1930765|FG009|Dose-Escalation Stage 1A|Death|2
941646|NCT00996892|1930766|FG010|Dose-Escalation Stage 1A|Death|0
941647|NCT00996892|1930767|FG011|Dose-Escalation Stage 1A|Death|1
941648|NCT00996892|1930768|FG012|Dose-Escalation Stage 1A|Death|1
941649|NCT00996892|1930769|FG013|Dose-Escalation Stage 1A|Death|0
941650|NCT00996892|1930770|FG014|Dose-Escalation Stage 1A|Death|0
941651|NCT00996892|1930771|FG015|Dose-Escalation Stage 1A|Death|0
941652|NCT00996892|1930772|FG016|Dose-Escalation Stage 1A|Death|0
941653|NCT00996892|1930773|FG017|Dose-Escalation Stage 1A|Death|0
941654|NCT00996892|1930774|FG018|Dose-Escalation Stage 1A|Death|0
941655|NCT00996892|1930775|FG019|Dose-Escalation Stage 1A|Death|0
941656|NCT00996892|1930756|FG000|Dose-Escalation Stage 1A|Physician Decision|0
941657|NCT00996892|1930757|FG001|Dose-Escalation Stage 1A|Physician Decision|0
941658|NCT00996892|1930758|FG002|Dose-Escalation Stage 1A|Physician Decision|0
941659|NCT00996892|1930759|FG003|Dose-Escalation Stage 1A|Physician Decision|0
941660|NCT00996892|1930760|FG004|Dose-Escalation Stage 1A|Physician Decision|0
941661|NCT00996892|1930761|FG005|Dose-Escalation Stage 1A|Physician Decision|0
941662|NCT00996892|1930762|FG006|Dose-Escalation Stage 1A|Physician Decision|0
941663|NCT00996892|1930763|FG007|Dose-Escalation Stage 1A|Physician Decision|1
941664|NCT00996892|1930764|FG008|Dose-Escalation Stage 1A|Physician Decision|0
941665|NCT00996892|1930765|FG009|Dose-Escalation Stage 1A|Physician Decision|0
941666|NCT00996892|1930766|FG010|Dose-Escalation Stage 1A|Physician Decision|0
941667|NCT00996892|1930767|FG011|Dose-Escalation Stage 1A|Physician Decision|0
941668|NCT00996892|1930768|FG012|Dose-Escalation Stage 1A|Physician Decision|0
941669|NCT00996892|1930769|FG013|Dose-Escalation Stage 1A|Physician Decision|0
941670|NCT00996892|1930770|FG014|Dose-Escalation Stage 1A|Physician Decision|0
941671|NCT00996892|1930771|FG015|Dose-Escalation Stage 1A|Physician Decision|0
941672|NCT00996892|1930772|FG016|Dose-Escalation Stage 1A|Physician Decision|0
941673|NCT00996892|1930773|FG017|Dose-Escalation Stage 1A|Physician Decision|0
941674|NCT00996892|1930774|FG018|Dose-Escalation Stage 1A|Physician Decision|0
941675|NCT00996892|1930775|FG019|Dose-Escalation Stage 1A|Physician Decision|0
941676|NCT00996892|1930756|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941677|NCT00996892|1930757|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941678|NCT00996892|1930758|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941679|NCT00996892|1930759|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941680|NCT00996892|1930760|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941681|NCT00996892|1930761|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941682|NCT00996892|1930762|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941683|NCT00996892|1930763|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941684|NCT00996892|1930764|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941685|NCT00996892|1930765|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1
941686|NCT00996892|1930766|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1
941687|NCT00996892|1930767|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1
941688|NCT00996892|1930768|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1
941689|NCT00996892|1930769|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941690|NCT00996892|1930770|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941691|NCT00996892|1930771|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941692|NCT00996892|1930772|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941693|NCT00996892|1930773|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941694|NCT00996892|1930774|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941695|NCT00996892|1930775|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0
941696|NCT00996892|1930756|FG000|Dose-Escalation Stage 1A|Disease Progression|0
941697|NCT00996892|1930757|FG001|Dose-Escalation Stage 1A|Disease Progression|0
941698|NCT00996892|1930758|FG002|Dose-Escalation Stage 1A|Disease Progression|0
941699|NCT00996892|1930759|FG003|Dose-Escalation Stage 1A|Disease Progression|0
941700|NCT00996892|1930760|FG004|Dose-Escalation Stage 1A|Disease Progression|0
941701|NCT00996892|1930761|FG005|Dose-Escalation Stage 1A|Disease Progression|0
941702|NCT00996892|1930762|FG006|Dose-Escalation Stage 1A|Disease Progression|0
941703|NCT00996892|1930763|FG007|Dose-Escalation Stage 1A|Disease Progression|2
941704|NCT00996892|1930764|FG008|Dose-Escalation Stage 1A|Disease Progression|3
941705|NCT00996892|1930765|FG009|Dose-Escalation Stage 1A|Disease Progression|1
941706|NCT00996892|1930766|FG010|Dose-Escalation Stage 1A|Disease Progression|5
941707|NCT00996892|1930767|FG011|Dose-Escalation Stage 1A|Disease Progression|7
941708|NCT00996892|1930768|FG012|Dose-Escalation Stage 1A|Disease Progression|6
941709|NCT00996892|1930769|FG013|Dose-Escalation Stage 1A|Disease Progression|4
941710|NCT00996892|1930770|FG014|Dose-Escalation Stage 1A|Disease Progression|0
941711|NCT00996892|1930771|FG015|Dose-Escalation Stage 1A|Disease Progression|0
941712|NCT00996892|1930772|FG016|Dose-Escalation Stage 1A|Disease Progression|0
941713|NCT00996892|1930773|FG017|Dose-Escalation Stage 1A|Disease Progression|0
941714|NCT00996892|1930774|FG018|Dose-Escalation Stage 1A|Disease Progression|0
941715|NCT00996892|1930775|FG019|Dose-Escalation Stage 1A|Disease Progression|0
941716|NCT00996892|1930756|FG000|Dose-Escalation Stage 1B|Physician Decision|0
941717|NCT00996892|1930757|FG001|Dose-Escalation Stage 1B|Physician Decision|0
941718|NCT00996892|1930758|FG002|Dose-Escalation Stage 1B|Physician Decision|0
941719|NCT00996892|1930759|FG003|Dose-Escalation Stage 1B|Physician Decision|0
941720|NCT00996892|1930760|FG004|Dose-Escalation Stage 1B|Physician Decision|0
941721|NCT00996892|1930761|FG005|Dose-Escalation Stage 1B|Physician Decision|0
941722|NCT00996892|1930762|FG006|Dose-Escalation Stage 1B|Physician Decision|0
941723|NCT00996892|1930763|FG007|Dose-Escalation Stage 1B|Physician Decision|0
941724|NCT00996892|1930764|FG008|Dose-Escalation Stage 1B|Physician Decision|0
941725|NCT00996892|1930765|FG009|Dose-Escalation Stage 1B|Physician Decision|0
941726|NCT00996892|1930766|FG010|Dose-Escalation Stage 1B|Physician Decision|0
941727|NCT00996892|1930767|FG011|Dose-Escalation Stage 1B|Physician Decision|0
941728|NCT00996892|1930768|FG012|Dose-Escalation Stage 1B|Physician Decision|0
941729|NCT00996892|1930769|FG013|Dose-Escalation Stage 1B|Physician Decision|0
941730|NCT00996892|1930770|FG014|Dose-Escalation Stage 1B|Physician Decision|0
941731|NCT00996892|1930771|FG015|Dose-Escalation Stage 1B|Physician Decision|0
941732|NCT00996892|1930772|FG016|Dose-Escalation Stage 1B|Physician Decision|0
941733|NCT00996892|1930773|FG017|Dose-Escalation Stage 1B|Physician Decision|2
941734|NCT00996892|1930774|FG018|Dose-Escalation Stage 1B|Physician Decision|0
941735|NCT00996892|1930775|FG019|Dose-Escalation Stage 1B|Physician Decision|0
941736|NCT00996892|1930756|FG000|Dose-Escalation Stage 1B|Disease Progression|0
941737|NCT00996892|1930757|FG001|Dose-Escalation Stage 1B|Disease Progression|0
941738|NCT00996892|1930758|FG002|Dose-Escalation Stage 1B|Disease Progression|0
941739|NCT00996892|1930759|FG003|Dose-Escalation Stage 1B|Disease Progression|0
941740|NCT00996892|1930760|FG004|Dose-Escalation Stage 1B|Disease Progression|0
941741|NCT00996892|1930761|FG005|Dose-Escalation Stage 1B|Disease Progression|0
941742|NCT00996892|1930762|FG006|Dose-Escalation Stage 1B|Disease Progression|0
941743|NCT00996892|1930763|FG007|Dose-Escalation Stage 1B|Disease Progression|0
941744|NCT00996892|1930764|FG008|Dose-Escalation Stage 1B|Disease Progression|0
941745|NCT00996892|1930765|FG009|Dose-Escalation Stage 1B|Disease Progression|0
941746|NCT00996892|1930766|FG010|Dose-Escalation Stage 1B|Disease Progression|0
941747|NCT00996892|1930767|FG011|Dose-Escalation Stage 1B|Disease Progression|0
941748|NCT00996892|1930768|FG012|Dose-Escalation Stage 1B|Disease Progression|0
941749|NCT00996892|1930769|FG013|Dose-Escalation Stage 1B|Disease Progression|0
941750|NCT00996892|1930770|FG014|Dose-Escalation Stage 1B|Disease Progression|4
941751|NCT00996892|1930771|FG015|Dose-Escalation Stage 1B|Disease Progression|3
941752|NCT00996892|1930772|FG016|Dose-Escalation Stage 1B|Disease Progression|3
941753|NCT00996892|1930773|FG017|Dose-Escalation Stage 1B|Disease Progression|3
941754|NCT00996892|1930774|FG018|Dose-Escalation Stage 1B|Disease Progression|0
941755|NCT00996892|1930775|FG019|Dose-Escalation Stage 1B|Disease Progression|0
941756|NCT00996892|1930756|FG000|Expansion Stage 2|Adverse Event|0
941757|NCT00996892|1930757|FG001|Expansion Stage 2|Adverse Event|0
941758|NCT00996892|1930758|FG002|Expansion Stage 2|Adverse Event|0
941759|NCT00996892|1930759|FG003|Expansion Stage 2|Adverse Event|0
941760|NCT00996892|1930760|FG004|Expansion Stage 2|Adverse Event|0
941761|NCT00996892|1930761|FG005|Expansion Stage 2|Adverse Event|0
941762|NCT00996892|1930762|FG006|Expansion Stage 2|Adverse Event|0
941763|NCT00996892|1930763|FG007|Expansion Stage 2|Adverse Event|0
941764|NCT00996892|1930764|FG008|Expansion Stage 2|Adverse Event|0
941765|NCT00996892|1930765|FG009|Expansion Stage 2|Adverse Event|0
941766|NCT00996892|1930766|FG010|Expansion Stage 2|Adverse Event|0
941767|NCT00996892|1930767|FG011|Expansion Stage 2|Adverse Event|0
941768|NCT00996892|1930768|FG012|Expansion Stage 2|Adverse Event|0
941769|NCT00996892|1930769|FG013|Expansion Stage 2|Adverse Event|0
941770|NCT00996892|1930770|FG014|Expansion Stage 2|Adverse Event|0
941771|NCT00996892|1930771|FG015|Expansion Stage 2|Adverse Event|0
941772|NCT00996892|1930772|FG016|Expansion Stage 2|Adverse Event|0
941773|NCT00996892|1930773|FG017|Expansion Stage 2|Adverse Event|0
941774|NCT00996892|1930774|FG018|Expansion Stage 2|Adverse Event|3
941775|NCT00996892|1930775|FG019|Expansion Stage 2|Adverse Event|0
941776|NCT00996892|1930756|FG000|Expansion Stage 2|Death|0
941777|NCT00996892|1930757|FG001|Expansion Stage 2|Death|0
941778|NCT00996892|1930758|FG002|Expansion Stage 2|Death|0
941779|NCT00996892|1930759|FG003|Expansion Stage 2|Death|0
941780|NCT00996892|1930760|FG004|Expansion Stage 2|Death|0
941781|NCT00996892|1930761|FG005|Expansion Stage 2|Death|0
941782|NCT00996892|1930762|FG006|Expansion Stage 2|Death|0
941783|NCT00996892|1930763|FG007|Expansion Stage 2|Death|0
941784|NCT00996892|1930764|FG008|Expansion Stage 2|Death|0
941785|NCT00996892|1930765|FG009|Expansion Stage 2|Death|0
941786|NCT00996892|1930766|FG010|Expansion Stage 2|Death|0
941787|NCT00996892|1930767|FG011|Expansion Stage 2|Death|0
941788|NCT00996892|1930768|FG012|Expansion Stage 2|Death|0
941789|NCT00996892|1930769|FG013|Expansion Stage 2|Death|0
941790|NCT00996892|1930770|FG014|Expansion Stage 2|Death|0
941791|NCT00996892|1930771|FG015|Expansion Stage 2|Death|0
941792|NCT00996892|1930772|FG016|Expansion Stage 2|Death|0
941793|NCT00996892|1930773|FG017|Expansion Stage 2|Death|0
941794|NCT00996892|1930774|FG018|Expansion Stage 2|Death|2
941795|NCT00996892|1930775|FG019|Expansion Stage 2|Death|0
941796|NCT00996892|1930756|FG000|Expansion Stage 2|Physician Decision|0
941797|NCT00996892|1930757|FG001|Expansion Stage 2|Physician Decision|0
941798|NCT00996892|1930758|FG002|Expansion Stage 2|Physician Decision|0
941799|NCT00996892|1930759|FG003|Expansion Stage 2|Physician Decision|0
941800|NCT00996892|1930760|FG004|Expansion Stage 2|Physician Decision|0
941801|NCT00996892|1930761|FG005|Expansion Stage 2|Physician Decision|0
941802|NCT00996892|1930762|FG006|Expansion Stage 2|Physician Decision|0
941803|NCT00996892|1930763|FG007|Expansion Stage 2|Physician Decision|0
941804|NCT00996892|1930764|FG008|Expansion Stage 2|Physician Decision|0
941805|NCT00996892|1930765|FG009|Expansion Stage 2|Physician Decision|0
941806|NCT00996892|1930766|FG010|Expansion Stage 2|Physician Decision|0
941807|NCT00996892|1930767|FG011|Expansion Stage 2|Physician Decision|0
941808|NCT00996892|1930768|FG012|Expansion Stage 2|Physician Decision|0
941809|NCT00996892|1930769|FG013|Expansion Stage 2|Physician Decision|0
941810|NCT00996892|1930770|FG014|Expansion Stage 2|Physician Decision|0
941811|NCT00996892|1930771|FG015|Expansion Stage 2|Physician Decision|0
941812|NCT00996892|1930772|FG016|Expansion Stage 2|Physician Decision|0
941813|NCT00996892|1930773|FG017|Expansion Stage 2|Physician Decision|0
941814|NCT00996892|1930774|FG018|Expansion Stage 2|Physician Decision|1
941815|NCT00996892|1930775|FG019|Expansion Stage 2|Physician Decision|0
941816|NCT00996892|1930756|FG000|Expansion Stage 2|Withdrawal by Subject|0
941817|NCT00996892|1930757|FG001|Expansion Stage 2|Withdrawal by Subject|0
941818|NCT00996892|1930758|FG002|Expansion Stage 2|Withdrawal by Subject|0
941819|NCT00996892|1930759|FG003|Expansion Stage 2|Withdrawal by Subject|0
941820|NCT00996892|1930760|FG004|Expansion Stage 2|Withdrawal by Subject|0
941821|NCT00996892|1930761|FG005|Expansion Stage 2|Withdrawal by Subject|0
941822|NCT00996892|1930762|FG006|Expansion Stage 2|Withdrawal by Subject|0
941823|NCT00996892|1930763|FG007|Expansion Stage 2|Withdrawal by Subject|0
941824|NCT00996892|1930764|FG008|Expansion Stage 2|Withdrawal by Subject|0
941825|NCT00996892|1930765|FG009|Expansion Stage 2|Withdrawal by Subject|0
941826|NCT00996892|1930766|FG010|Expansion Stage 2|Withdrawal by Subject|0
941827|NCT00996892|1930767|FG011|Expansion Stage 2|Withdrawal by Subject|0
941828|NCT00996892|1930768|FG012|Expansion Stage 2|Withdrawal by Subject|0
941829|NCT00996892|1930769|FG013|Expansion Stage 2|Withdrawal by Subject|0
941830|NCT00996892|1930770|FG014|Expansion Stage 2|Withdrawal by Subject|0
941831|NCT00996892|1930771|FG015|Expansion Stage 2|Withdrawal by Subject|0
941832|NCT00996892|1930772|FG016|Expansion Stage 2|Withdrawal by Subject|0
941833|NCT00996892|1930773|FG017|Expansion Stage 2|Withdrawal by Subject|0
941834|NCT00996892|1930774|FG018|Expansion Stage 2|Withdrawal by Subject|1
941835|NCT00996892|1930775|FG019|Expansion Stage 2|Withdrawal by Subject|0
941836|NCT00996892|1930756|FG000|Expansion Stage 2|Disease Progression|0
941837|NCT00996892|1930757|FG001|Expansion Stage 2|Disease Progression|0
941838|NCT00996892|1930758|FG002|Expansion Stage 2|Disease Progression|0
941839|NCT00996892|1930759|FG003|Expansion Stage 2|Disease Progression|0
941840|NCT00996892|1930760|FG004|Expansion Stage 2|Disease Progression|0
941841|NCT00996892|1930761|FG005|Expansion Stage 2|Disease Progression|0
941842|NCT00996892|1930762|FG006|Expansion Stage 2|Disease Progression|0
941843|NCT00996892|1930763|FG007|Expansion Stage 2|Disease Progression|0
941844|NCT00996892|1930764|FG008|Expansion Stage 2|Disease Progression|0
941845|NCT00996892|1930765|FG009|Expansion Stage 2|Disease Progression|0
941846|NCT00996892|1930766|FG010|Expansion Stage 2|Disease Progression|0
941847|NCT00996892|1930767|FG011|Expansion Stage 2|Disease Progression|0
941848|NCT00996892|1930768|FG012|Expansion Stage 2|Disease Progression|0
941849|NCT00996892|1930769|FG013|Expansion Stage 2|Disease Progression|0
941850|NCT00996892|1930770|FG014|Expansion Stage 2|Disease Progression|0
941851|NCT00996892|1930771|FG015|Expansion Stage 2|Disease Progression|0
941852|NCT00996892|1930772|FG016|Expansion Stage 2|Disease Progression|0
941853|NCT00996892|1930773|FG017|Expansion Stage 2|Disease Progression|0
941854|NCT00996892|1930774|FG018|Expansion Stage 2|Disease Progression|28
941855|NCT00996892|1930775|FG019|Expansion Stage 2|Disease Progression|0
941856|NCT00996892|1930756|FG000|Expansion Stage 2A|Adverse Event|0
941857|NCT00996892|1930757|FG001|Expansion Stage 2A|Adverse Event|0
941858|NCT00996892|1930758|FG002|Expansion Stage 2A|Adverse Event|0
941859|NCT00996892|1930759|FG003|Expansion Stage 2A|Adverse Event|0
941860|NCT00996892|1930760|FG004|Expansion Stage 2A|Adverse Event|0
941861|NCT00996892|1930761|FG005|Expansion Stage 2A|Adverse Event|0
941862|NCT00996892|1930762|FG006|Expansion Stage 2A|Adverse Event|0
941863|NCT00996892|1930763|FG007|Expansion Stage 2A|Adverse Event|0
941864|NCT00996892|1930764|FG008|Expansion Stage 2A|Adverse Event|0
941865|NCT00996892|1930765|FG009|Expansion Stage 2A|Adverse Event|0
941866|NCT00996892|1930766|FG010|Expansion Stage 2A|Adverse Event|0
941867|NCT00996892|1930767|FG011|Expansion Stage 2A|Adverse Event|0
941868|NCT00996892|1930768|FG012|Expansion Stage 2A|Adverse Event|0
941869|NCT00996892|1930769|FG013|Expansion Stage 2A|Adverse Event|0
941870|NCT00996892|1930770|FG014|Expansion Stage 2A|Adverse Event|0
941871|NCT00996892|1930771|FG015|Expansion Stage 2A|Adverse Event|0
941872|NCT00996892|1930772|FG016|Expansion Stage 2A|Adverse Event|0
941873|NCT00996892|1930773|FG017|Expansion Stage 2A|Adverse Event|0
941874|NCT00996892|1930774|FG018|Expansion Stage 2A|Adverse Event|0
941875|NCT00996892|1930775|FG019|Expansion Stage 2A|Adverse Event|8
941876|NCT00996892|1930756|FG000|Expansion Stage 2A|Physician Decision|0
941877|NCT00996892|1930757|FG001|Expansion Stage 2A|Physician Decision|0
941878|NCT00996892|1930758|FG002|Expansion Stage 2A|Physician Decision|0
941879|NCT00996892|1930759|FG003|Expansion Stage 2A|Physician Decision|0
941880|NCT00996892|1930760|FG004|Expansion Stage 2A|Physician Decision|0
941881|NCT00996892|1930761|FG005|Expansion Stage 2A|Physician Decision|0
941882|NCT00996892|1930762|FG006|Expansion Stage 2A|Physician Decision|0
941883|NCT00996892|1930763|FG007|Expansion Stage 2A|Physician Decision|0
941884|NCT00996892|1930764|FG008|Expansion Stage 2A|Physician Decision|0
941885|NCT00996892|1930765|FG009|Expansion Stage 2A|Physician Decision|0
941886|NCT00996892|1930766|FG010|Expansion Stage 2A|Physician Decision|0
941887|NCT00996892|1930767|FG011|Expansion Stage 2A|Physician Decision|0
941888|NCT00996892|1930768|FG012|Expansion Stage 2A|Physician Decision|0
941889|NCT00996892|1930769|FG013|Expansion Stage 2A|Physician Decision|0
941890|NCT00996892|1930770|FG014|Expansion Stage 2A|Physician Decision|0
941891|NCT00996892|1930771|FG015|Expansion Stage 2A|Physician Decision|0
941892|NCT00996892|1930772|FG016|Expansion Stage 2A|Physician Decision|0
941893|NCT00996892|1930773|FG017|Expansion Stage 2A|Physician Decision|0
941894|NCT00996892|1930774|FG018|Expansion Stage 2A|Physician Decision|0
941895|NCT00996892|1930775|FG019|Expansion Stage 2A|Physician Decision|2
941896|NCT00996892|1930756|FG000|Expansion Stage 2A|Withdrawal by Subject|0
941897|NCT00996892|1930757|FG001|Expansion Stage 2A|Withdrawal by Subject|0
941898|NCT00996892|1930758|FG002|Expansion Stage 2A|Withdrawal by Subject|0
941899|NCT00996892|1930759|FG003|Expansion Stage 2A|Withdrawal by Subject|0
941900|NCT00996892|1930760|FG004|Expansion Stage 2A|Withdrawal by Subject|0
941901|NCT00996892|1930761|FG005|Expansion Stage 2A|Withdrawal by Subject|0
941902|NCT00996892|1930762|FG006|Expansion Stage 2A|Withdrawal by Subject|0
941903|NCT00996892|1930763|FG007|Expansion Stage 2A|Withdrawal by Subject|0
941904|NCT00996892|1930764|FG008|Expansion Stage 2A|Withdrawal by Subject|0
941905|NCT00996892|1930765|FG009|Expansion Stage 2A|Withdrawal by Subject|0
941906|NCT00996892|1930766|FG010|Expansion Stage 2A|Withdrawal by Subject|0
941907|NCT00996892|1930767|FG011|Expansion Stage 2A|Withdrawal by Subject|0
941908|NCT00996892|1930768|FG012|Expansion Stage 2A|Withdrawal by Subject|0
941909|NCT00996892|1930769|FG013|Expansion Stage 2A|Withdrawal by Subject|0
941910|NCT00996892|1930770|FG014|Expansion Stage 2A|Withdrawal by Subject|0
941911|NCT00996892|1930771|FG015|Expansion Stage 2A|Withdrawal by Subject|0
941912|NCT00996892|1930772|FG016|Expansion Stage 2A|Withdrawal by Subject|0
941913|NCT00996892|1930773|FG017|Expansion Stage 2A|Withdrawal by Subject|0
941914|NCT00996892|1930774|FG018|Expansion Stage 2A|Withdrawal by Subject|0
941915|NCT00996892|1930775|FG019|Expansion Stage 2A|Withdrawal by Subject|4
941916|NCT00996892|1930756|FG000|Expansion Stage 2A|Disease Progression|0
941917|NCT00996892|1930757|FG001|Expansion Stage 2A|Disease Progression|0
941918|NCT00996892|1930758|FG002|Expansion Stage 2A|Disease Progression|0
941919|NCT00996892|1930759|FG003|Expansion Stage 2A|Disease Progression|0
941920|NCT00996892|1930760|FG004|Expansion Stage 2A|Disease Progression|0
941921|NCT00996892|1930761|FG005|Expansion Stage 2A|Disease Progression|0
941922|NCT00996892|1930762|FG006|Expansion Stage 2A|Disease Progression|0
941923|NCT00996892|1930763|FG007|Expansion Stage 2A|Disease Progression|0
941924|NCT00996892|1930764|FG008|Expansion Stage 2A|Disease Progression|0
941925|NCT00996892|1930765|FG009|Expansion Stage 2A|Disease Progression|0
941926|NCT00996892|1930766|FG010|Expansion Stage 2A|Disease Progression|0
941927|NCT00996892|1930767|FG011|Expansion Stage 2A|Disease Progression|0
941928|NCT00996892|1930768|FG012|Expansion Stage 2A|Disease Progression|0
941929|NCT00996892|1930769|FG013|Expansion Stage 2A|Disease Progression|0
941930|NCT00996892|1930770|FG014|Expansion Stage 2A|Disease Progression|0
941931|NCT00996892|1930771|FG015|Expansion Stage 2A|Disease Progression|0
941932|NCT00996892|1930772|FG016|Expansion Stage 2A|Disease Progression|0
941933|NCT00996892|1930773|FG017|Expansion Stage 2A|Disease Progression|0
941934|NCT00996892|1930774|FG018|Expansion Stage 2A|Disease Progression|0
941935|NCT00996892|1930775|FG019|Expansion Stage 2A|Disease Progression|31
941936|NCT00996918|1930841|FG000|Overall Study|Lack of Efficacy|1
941937|NCT00996918|1930842|FG001|Overall Study|Lack of Efficacy|1
941938|NCT00996918|1930843|FG002|Overall Study|Lack of Efficacy|2
941939|NCT00996918|1930844|FG003|Overall Study|Lack of Efficacy|2
941940|NCT00996918|1930845|FG004|Overall Study|Lack of Efficacy|0
941941|NCT00996918|1930841|FG000|Overall Study|Adverse Event|2
941942|NCT00996918|1930842|FG001|Overall Study|Adverse Event|5
941943|NCT00996918|1930843|FG002|Overall Study|Adverse Event|2
941944|NCT00996918|1930844|FG003|Overall Study|Adverse Event|6
941945|NCT00996918|1930845|FG004|Overall Study|Adverse Event|0
941946|NCT00996918|1930841|FG000|Overall Study|Withdrawal by Subject|1
941947|NCT00996918|1930842|FG001|Overall Study|Withdrawal by Subject|4
941948|NCT00996918|1930843|FG002|Overall Study|Withdrawal by Subject|3
941949|NCT00996918|1930844|FG003|Overall Study|Withdrawal by Subject|3
941950|NCT00996918|1930845|FG004|Overall Study|Withdrawal by Subject|2
941951|NCT00996918|1930841|FG000|Overall Study|Physician Decision|1
941952|NCT00996918|1930842|FG001|Overall Study|Physician Decision|0
941953|NCT00996918|1930843|FG002|Overall Study|Physician Decision|0
941954|NCT00996918|1930844|FG003|Overall Study|Physician Decision|0
941955|NCT00996918|1930845|FG004|Overall Study|Physician Decision|0
941956|NCT00996918|1930841|FG000|Overall Study|Discontinuation of Study by Sponsor|31
941957|NCT00996918|1930842|FG001|Overall Study|Discontinuation of Study by Sponsor|54
941958|NCT00996918|1930843|FG002|Overall Study|Discontinuation of Study by Sponsor|30
941959|NCT00996918|1930844|FG003|Overall Study|Discontinuation of Study by Sponsor|45
941960|NCT00996918|1930845|FG004|Overall Study|Discontinuation of Study by Sponsor|2
941961|NCT00996918|1930841|FG000|Overall Study|Loss of Caregiver|0
941962|NCT00996918|1930842|FG001|Overall Study|Loss of Caregiver|1
941963|NCT00996918|1930843|FG002|Overall Study|Loss of Caregiver|0
941964|NCT00996918|1930844|FG003|Overall Study|Loss of Caregiver|0
941965|NCT00996918|1930845|FG004|Overall Study|Loss of Caregiver|0
941966|NCT00996918|1930841|FG000|Overall Study|Other|3
941967|NCT00996918|1930842|FG001|Overall Study|Other|1
941968|NCT00996918|1930843|FG002|Overall Study|Other|0
941969|NCT00996918|1930844|FG003|Overall Study|Other|0
941970|NCT00996918|1930845|FG004|Overall Study|Other|0
941971|NCT00996944|1930864|FG000|Double-blind Treatment Period|Adverse Event|2
941972|NCT00996944|1930865|FG001|Double-blind Treatment Period|Adverse Event|1
941973|NCT00996944|1930864|FG000|Double-blind Treatment Period|Protocol Violation|1
941974|NCT00996944|1930865|FG001|Double-blind Treatment Period|Protocol Violation|0
941975|NCT00996944|1930864|FG000|Double-blind Treatment Period|Study Closed/Terminated|6
941976|NCT00996944|1930865|FG001|Double-blind Treatment Period|Study Closed/Terminated|5
941977|NCT00996944|1930864|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
941978|NCT00996944|1930865|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
941979|NCT00996944|1930864|FG000|Long-term Treatment Period|Study Closed/Terminated|12
941980|NCT00996944|1930865|FG001|Long-term Treatment Period|Study Closed/Terminated|5
941981|NCT00996996|1930873|FG000|Overall Study|Progressive Disease|10
941982|NCT00996996|1930873|FG000|Overall Study|Non-compliance|8
941983|NCT00996996|1930873|FG000|Overall Study|Lost to Follow-up|9
941984|NCT00996996|1930873|FG000|Overall Study|Death|5
941985|NCT00996996|1930873|FG000|Overall Study|Did Not Receive Study Medications|1
941986|NCT00997035|1930879|FG000|3-week Followup Visit|Lost to Follow-up|9
941987|NCT00997035|1930880|FG001|3-week Followup Visit|Lost to Follow-up|6
941988|NCT00997035|1930879|FG000|3-month Follow-up Visit|Lost to Follow-up|12
941989|NCT00997035|1930880|FG001|3-month Follow-up Visit|Lost to Follow-up|6
941990|NCT00997126|1930907|FG000|Overall Study|Physician Decision|7
941991|NCT00997126|1930908|FG001|Overall Study|Physician Decision|11
941992|NCT00997243|1930933|FG000|Overall Study|Early termination of study by sponsor|7
941993|NCT00997321|1930939|FG000|Overall Study|did not undergo sedation after enrollmen|0
941994|NCT00997321|1930940|FG001|Overall Study|did not undergo sedation after enrollmen|3
941995|NCT00997334|1930952|FG000|Overall Study|still on therapy|12
941996|NCT00997334|1930952|FG000|Overall Study|Adverse Event|3
941997|NCT00997334|1930952|FG000|Overall Study|Patient non-compliance|1
941998|NCT00997334|1930952|FG000|Overall Study|Withdrawal by Subject|3
941999|NCT00997334|1930952|FG000|Overall Study|Death|2
942000|NCT00997334|1930952|FG000|Overall Study|Urgent Palliative Care|2
942001|NCT00997334|1930952|FG000|Overall Study|No lesion amenable|1
942002|NCT00997334|1930952|FG000|Overall Study|Ineligible|1
942003|NCT00997373|1930958|FG000|Overall Study|Withdrawal by Subject|5
942004|NCT00997373|1930959|FG001|Overall Study|Withdrawal by Subject|0
942005|NCT00997373|1930958|FG000|Overall Study|wrong tumor type|4
942006|NCT00997373|1930959|FG001|Overall Study|wrong tumor type|0
942007|NCT00997373|1930958|FG000|Overall Study|could not have hysterectomy|6
942008|NCT00997373|1930959|FG001|Overall Study|could not have hysterectomy|0
942009|NCT00997438|1930973|FG000|Overall Study|Blood draw difficulty|2
942010|NCT00997438|1930974|FG001|Overall Study|Blood draw difficulty|0
942011|NCT00997438|1930975|FG002|Overall Study|Blood draw difficulty|1
942012|NCT00997438|1930973|FG000|Overall Study|Withdrawal by Subject|1
942013|NCT00997438|1930974|FG001|Overall Study|Withdrawal by Subject|1
942014|NCT00997438|1930975|FG002|Overall Study|Withdrawal by Subject|0
942015|NCT00997438|1930973|FG000|Overall Study|Exclusion criteria at visit 1|2
942016|NCT00997438|1930974|FG001|Overall Study|Exclusion criteria at visit 1|2
942017|NCT00997438|1930975|FG002|Overall Study|Exclusion criteria at visit 1|3
942018|NCT00997503|1930984|FG000|Overall Study|Death|53
942019|NCT00997503|1930984|FG000|Overall Study|Withdrawal by Subject|76
942020|NCT00997503|1930984|FG000|Overall Study|Lost to Follow-up|33
942021|NCT00997503|1930984|FG000|Overall Study|Adverse Event|3
942022|NCT00997503|1930984|FG000|Overall Study|Physician Decision|10
942023|NCT00997503|1930984|FG000|Overall Study|Missed 12-month follow-up|85
942024|NCT00997503|1930984|FG000|Overall Study|Other reason|13
942025|NCT00997893|1931042|FG000|Overall Study|Adverse Event|1
942026|NCT00997893|1931043|FG001|Overall Study|Adverse Event|0
942027|NCT00997893|1931044|FG002|Overall Study|Adverse Event|0
942028|NCT00997893|1931042|FG000|Overall Study|Unable to meet study timelines|1
942029|NCT00997893|1931043|FG001|Overall Study|Unable to meet study timelines|0
942030|NCT00997893|1931044|FG002|Overall Study|Unable to meet study timelines|0
942031|NCT00997893|1931042|FG000|Overall Study|Pain/pain meds during Visit 4|0
942032|NCT00997893|1931043|FG001|Overall Study|Pain/pain meds during Visit 4|1
942033|NCT00997893|1931044|FG002|Overall Study|Pain/pain meds during Visit 4|0
942034|NCT00997984|1931060|FG000|Overall Study|Adverse Event|1
942035|NCT00997984|1931061|FG001|Overall Study|Adverse Event|8
942036|NCT00997984|1931062|FG002|Overall Study|Adverse Event|8
942037|NCT00997984|1931060|FG000|Overall Study|Protocol Violation|1
942038|NCT00997984|1931061|FG001|Overall Study|Protocol Violation|3
942039|NCT00997984|1931062|FG002|Overall Study|Protocol Violation|0
942040|NCT00997984|1931060|FG000|Overall Study|Withdrawal by Subject|6
942041|NCT00997984|1931061|FG001|Overall Study|Withdrawal by Subject|9
942042|NCT00997984|1931062|FG002|Overall Study|Withdrawal by Subject|5
942043|NCT00997984|1931060|FG000|Overall Study|Lost to Follow-up|8
942044|NCT00997984|1931061|FG001|Overall Study|Lost to Follow-up|5
942045|NCT00997984|1931062|FG002|Overall Study|Lost to Follow-up|4
942046|NCT00997984|1931060|FG000|Overall Study|Lack of Efficacy|20
942047|NCT00997984|1931061|FG001|Overall Study|Lack of Efficacy|6
942048|NCT00997984|1931062|FG002|Overall Study|Lack of Efficacy|3
942049|NCT00997984|1931060|FG000|Overall Study|Met exclusion criteria|1
942050|NCT00997984|1931061|FG001|Overall Study|Met exclusion criteria|0
942051|NCT00997984|1931062|FG002|Overall Study|Met exclusion criteria|0
942052|NCT00997984|1931060|FG000|Overall Study|non-compliance|0
942053|NCT00997984|1931061|FG001|Overall Study|non-compliance|2
942054|NCT00997984|1931062|FG002|Overall Study|non-compliance|3
942055|NCT00997984|1931060|FG000|Overall Study|Wrong medication dispensed|0
942056|NCT00997984|1931061|FG001|Overall Study|Wrong medication dispensed|1
942057|NCT00997984|1931062|FG002|Overall Study|Wrong medication dispensed|0
942058|NCT00997984|1931060|FG000|Overall Study|Suicidal ideation|0
942059|NCT00997984|1931061|FG001|Overall Study|Suicidal ideation|0
942060|NCT00997984|1931062|FG002|Overall Study|Suicidal ideation|1
942061|NCT00997984|1931060|FG000|Overall Study|Work schedule|0
942062|NCT00997984|1931061|FG001|Overall Study|Work schedule|0
942063|NCT00997984|1931062|FG002|Overall Study|Work schedule|2
942064|NCT00998296|1931105|FG000|Overall Study|Progressive disease|0
942065|NCT00998296|1931106|FG001|Overall Study|Progressive disease|1
942066|NCT00998296|1931107|FG002|Overall Study|Progressive disease|0
942067|NCT00998296|1931108|FG003|Overall Study|Progressive disease|0
942068|NCT00998296|1931109|FG004|Overall Study|Progressive disease|0
942069|NCT00998296|1931110|FG005|Overall Study|Progressive disease|0
942070|NCT00998296|1931111|FG006|Overall Study|Progressive disease|1
942071|NCT00998296|1931112|FG007|Overall Study|Progressive disease|0
942072|NCT00998296|1931113|FG008|Overall Study|Progressive disease|0
942073|NCT00998296|1931114|FG009|Overall Study|Progressive disease|14
942074|NCT00998296|1931115|FG010|Overall Study|Progressive disease|5
942075|NCT00998296|1931105|FG000|Overall Study|Dose limiting or dose reducing toxicity|0
942076|NCT00998296|1931106|FG001|Overall Study|Dose limiting or dose reducing toxicity|0
942077|NCT00998296|1931107|FG002|Overall Study|Dose limiting or dose reducing toxicity|0
942078|NCT00998296|1931108|FG003|Overall Study|Dose limiting or dose reducing toxicity|0
942079|NCT00998296|1931109|FG004|Overall Study|Dose limiting or dose reducing toxicity|1
942080|NCT00998296|1931110|FG005|Overall Study|Dose limiting or dose reducing toxicity|0
942081|NCT00998296|1931111|FG006|Overall Study|Dose limiting or dose reducing toxicity|0
942082|NCT00998296|1931112|FG007|Overall Study|Dose limiting or dose reducing toxicity|2
942083|NCT00998296|1931113|FG008|Overall Study|Dose limiting or dose reducing toxicity|2
942084|NCT00998296|1931114|FG009|Overall Study|Dose limiting or dose reducing toxicity|0
942085|NCT00998296|1931115|FG010|Overall Study|Dose limiting or dose reducing toxicity|0
942086|NCT00998296|1931105|FG000|Overall Study|Other adverse event|0
942087|NCT00998296|1931106|FG001|Overall Study|Other adverse event|0
942088|NCT00998296|1931107|FG002|Overall Study|Other adverse event|0
942089|NCT00998296|1931108|FG003|Overall Study|Other adverse event|0
942090|NCT00998296|1931109|FG004|Overall Study|Other adverse event|1
942091|NCT00998296|1931110|FG005|Overall Study|Other adverse event|0
942092|NCT00998296|1931111|FG006|Overall Study|Other adverse event|0
942093|NCT00998296|1931112|FG007|Overall Study|Other adverse event|0
942094|NCT00998296|1931113|FG008|Overall Study|Other adverse event|0
942095|NCT00998296|1931114|FG009|Overall Study|Other adverse event|1
942096|NCT00998296|1931115|FG010|Overall Study|Other adverse event|2
942097|NCT00998296|1931105|FG000|Overall Study|Refused to continue taking trial med.|0
942098|NCT00998296|1931106|FG001|Overall Study|Refused to continue taking trial med.|0
942099|NCT00998296|1931107|FG002|Overall Study|Refused to continue taking trial med.|0
942100|NCT00998296|1931108|FG003|Overall Study|Refused to continue taking trial med.|0
942101|NCT00998296|1931109|FG004|Overall Study|Refused to continue taking trial med.|0
942102|NCT00998296|1931110|FG005|Overall Study|Refused to continue taking trial med.|0
942103|NCT00998296|1931111|FG006|Overall Study|Refused to continue taking trial med.|0
942104|NCT00998296|1931112|FG007|Overall Study|Refused to continue taking trial med.|0
942105|NCT00998296|1931113|FG008|Overall Study|Refused to continue taking trial med.|0
942106|NCT00998296|1931114|FG009|Overall Study|Refused to continue taking trial med.|2
942107|NCT00998296|1931115|FG010|Overall Study|Refused to continue taking trial med.|0
942108|NCT00998296|1931105|FG000|Overall Study|Reason other than those specified above|0
942109|NCT00998296|1931106|FG001|Overall Study|Reason other than those specified above|0
942110|NCT00998296|1931107|FG002|Overall Study|Reason other than those specified above|0
942111|NCT00998296|1931108|FG003|Overall Study|Reason other than those specified above|0
942112|NCT00998296|1931109|FG004|Overall Study|Reason other than those specified above|0
942113|NCT00998296|1931110|FG005|Overall Study|Reason other than those specified above|0
942114|NCT00998296|1931111|FG006|Overall Study|Reason other than those specified above|0
942115|NCT00998296|1931112|FG007|Overall Study|Reason other than those specified above|0
942116|NCT00998296|1931113|FG008|Overall Study|Reason other than those specified above|0
942117|NCT00998296|1931114|FG009|Overall Study|Reason other than those specified above|1
942118|NCT00998296|1931115|FG010|Overall Study|Reason other than those specified above|0
942119|NCT00998309|1931144|FG000|Overall Study|Protocol Violation|4
942120|NCT00998335|1931198|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
942121|NCT00998335|1931199|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
942122|NCT00998400|1931224|FG000|Overall Study|Lack of interest/motivation|1
942123|NCT00998400|1931225|FG001|Overall Study|Lack of interest/motivation|2
942124|NCT00998400|1931224|FG000|Overall Study|Logistical problems|1
942125|NCT00998400|1931225|FG001|Overall Study|Logistical problems|0
942126|NCT00998764|1931268|FG000|Overall Study|Lack of Efficacy|3
942127|NCT00998764|1931269|FG001|Overall Study|Lack of Efficacy|6
942128|NCT00998764|1931268|FG000|Overall Study|Adverse Event|17
942129|NCT00998764|1931269|FG001|Overall Study|Adverse Event|12
942130|NCT00998764|1931268|FG000|Overall Study|Withdrawal by Subject|19
942131|NCT00998764|1931269|FG001|Overall Study|Withdrawal by Subject|25
942132|NCT00998764|1931268|FG000|Overall Study|Physician Decision|3
942133|NCT00998764|1931269|FG001|Overall Study|Physician Decision|3
942134|NCT00998764|1931268|FG000|Overall Study|Death|3
942135|NCT00998764|1931269|FG001|Overall Study|Death|1
942136|NCT00998764|1931268|FG000|Overall Study|Discontinuation of Study by Sponsor|164
942137|NCT00998764|1931269|FG001|Overall Study|Discontinuation of Study by Sponsor|217
942138|NCT00998764|1931268|FG000|Overall Study|Protocol Violation|0
942139|NCT00998764|1931269|FG001|Overall Study|Protocol Violation|1
942140|NCT00998764|1931268|FG000|Overall Study|Failed to Return|1
942141|NCT00998764|1931269|FG001|Overall Study|Failed to Return|1
942142|NCT00998764|1931268|FG000|Overall Study|Lost to Follow-up|1
942143|NCT00998764|1931269|FG001|Overall Study|Lost to Follow-up|1
942144|NCT00998764|1931268|FG000|Overall Study|Loss of Caregiver|0
942145|NCT00998764|1931269|FG001|Overall Study|Loss of Caregiver|3
942146|NCT00998764|1931268|FG000|Overall Study|Other|4
942147|NCT00998764|1931269|FG001|Overall Study|Other|4
942148|NCT00998764|1931268|FG000|Overall Study|Recurrent Episode of vasogenic edema|1
942149|NCT00998764|1931269|FG001|Overall Study|Recurrent Episode of vasogenic edema|0
942150|NCT00998790|1931277|FG000|Overall Study|Withdrawal by Subject|21
942151|NCT00998881|1931287|FG000|Overall Study|Adverse Event|2
942152|NCT00998881|1931288|FG001|Overall Study|Adverse Event|2
942153|NCT00998881|1931287|FG000|Overall Study|Lack of Efficacy|1
942154|NCT00998881|1931288|FG001|Overall Study|Lack of Efficacy|0
942155|NCT00998881|1931287|FG000|Overall Study|Physician Decision|3
942156|NCT00998881|1931288|FG001|Overall Study|Physician Decision|0
942157|NCT00998881|1931287|FG000|Overall Study|Withdrawal by Subject|1
942158|NCT00998881|1931288|FG001|Overall Study|Withdrawal by Subject|0
942159|NCT00998881|1931287|FG000|Overall Study|Personal matter|1
942160|NCT00998881|1931288|FG001|Overall Study|Personal matter|0
942161|NCT00998946|1931294|FG000|Overall Study|Lost to Follow-up|1
942162|NCT00998946|1931294|FG000|Overall Study|Withdrawal by Subject|1
942163|NCT00998946|1931294|FG000|Overall Study|Death|2
942164|NCT00998946|1931294|FG000|Overall Study|Reason Unspecified|3
942165|NCT00998946|1931294|FG000|Overall Study|Enrolled but not Dosed|2
942166|NCT00998985|1931312|FG000|Overall Study|Withdrawal by Subject|0
942167|NCT00998985|1931313|FG001|Overall Study|Withdrawal by Subject|0
942168|NCT00998985|1931314|FG002|Overall Study|Withdrawal by Subject|0
942169|NCT00998985|1931315|FG003|Overall Study|Withdrawal by Subject|0
942170|NCT00998985|1931316|FG004|Overall Study|Withdrawal by Subject|0
942171|NCT00998985|1931317|FG005|Overall Study|Withdrawal by Subject|0
942172|NCT00998985|1931318|FG006|Overall Study|Withdrawal by Subject|0
942173|NCT00998985|1931319|FG007|Overall Study|Withdrawal by Subject|0
942174|NCT00998985|1931320|FG008|Overall Study|Withdrawal by Subject|1
942175|NCT00998985|1931321|FG009|Overall Study|Withdrawal by Subject|0
942176|NCT00998985|1931322|FG010|Overall Study|Withdrawal by Subject|0
942177|NCT00998985|1931323|FG011|Overall Study|Withdrawal by Subject|0
942178|NCT00998985|1931324|FG012|Overall Study|Withdrawal by Subject|0
942179|NCT00998985|1931325|FG013|Overall Study|Withdrawal by Subject|0
942180|NCT00998985|1931312|FG000|Overall Study|Protocol Violation|0
942181|NCT00998985|1931313|FG001|Overall Study|Protocol Violation|0
942182|NCT00998985|1931314|FG002|Overall Study|Protocol Violation|0
942183|NCT00998985|1931315|FG003|Overall Study|Protocol Violation|0
942184|NCT00998985|1931316|FG004|Overall Study|Protocol Violation|0
942185|NCT00998985|1931317|FG005|Overall Study|Protocol Violation|1
942186|NCT00998985|1931318|FG006|Overall Study|Protocol Violation|0
942187|NCT00998985|1931319|FG007|Overall Study|Protocol Violation|0
942188|NCT00998985|1931320|FG008|Overall Study|Protocol Violation|0
942189|NCT00998985|1931321|FG009|Overall Study|Protocol Violation|0
942190|NCT00998985|1931322|FG010|Overall Study|Protocol Violation|0
942191|NCT00998985|1931323|FG011|Overall Study|Protocol Violation|0
942192|NCT00998985|1931324|FG012|Overall Study|Protocol Violation|0
942193|NCT00998985|1931325|FG013|Overall Study|Protocol Violation|0
942194|NCT00999167|1931450|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
942195|NCT00999167|1931451|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
942196|NCT00999167|1931452|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
942197|NCT00999167|1931450|FG000|Part A: Open Label Safety run-in|Adverse Event|3
942198|NCT00999167|1931451|FG001|Part A: Open Label Safety run-in|Adverse Event|0
942199|NCT00999167|1931452|FG002|Part A: Open Label Safety run-in|Adverse Event|0
942200|NCT00999167|1931450|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
942201|NCT00999167|1931451|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
942202|NCT00999167|1931452|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
942203|NCT00999167|1931450|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
942204|NCT00999167|1931451|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
942205|NCT00999167|1931452|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
942206|NCT00999167|1931450|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0
942207|NCT00999167|1931451|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6
942208|NCT00999167|1931452|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1
942209|NCT00999167|1931450|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0
942210|NCT00999167|1931451|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1
942211|NCT00999167|1931452|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0
942212|NCT00999167|1931450|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0
942213|NCT00999167|1931451|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1
942214|NCT00999167|1931452|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0
942215|NCT00999167|1931450|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
942216|NCT00999167|1931451|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
942217|NCT00999167|1931452|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
942218|NCT00999466|1931465|FG000|Main Part|Withdrawal by Subject|0
942219|NCT00999466|1931466|FG001|Main Part|Withdrawal by Subject|0
942220|NCT00999466|1931467|FG002|Main Part|Withdrawal by Subject|2
942221|NCT00999466|1931465|FG000|Main Part|Adverse Event|0
942222|NCT00999466|1931466|FG001|Main Part|Adverse Event|4
942223|NCT00999466|1931467|FG002|Main Part|Adverse Event|2
942224|NCT00999518|1931480|FG000|Overall Study|Adverse Event|1
942225|NCT00999518|1931481|FG001|Overall Study|Adverse Event|6
942226|NCT00999518|1931482|FG002|Overall Study|Adverse Event|3
942227|NCT00999518|1931483|FG003|Overall Study|Adverse Event|1
942228|NCT00999518|1931484|FG004|Overall Study|Adverse Event|2
942229|NCT00999518|1931480|FG000|Overall Study|Lack of Efficacy|2
942230|NCT00999518|1931481|FG001|Overall Study|Lack of Efficacy|0
942231|NCT00999518|1931482|FG002|Overall Study|Lack of Efficacy|0
942232|NCT00999518|1931483|FG003|Overall Study|Lack of Efficacy|2
942233|NCT00999518|1931484|FG004|Overall Study|Lack of Efficacy|2
942234|NCT00999518|1931480|FG000|Overall Study|Lost to Follow-up|0
942235|NCT00999518|1931481|FG001|Overall Study|Lost to Follow-up|0
942236|NCT00999518|1931482|FG002|Overall Study|Lost to Follow-up|0
942237|NCT00999518|1931483|FG003|Overall Study|Lost to Follow-up|4
942238|NCT00999518|1931484|FG004|Overall Study|Lost to Follow-up|1
942239|NCT00999518|1931480|FG000|Overall Study|Did not meet entrance criteria|0
942240|NCT00999518|1931481|FG001|Overall Study|Did not meet entrance criteria|0
942241|NCT00999518|1931482|FG002|Overall Study|Did not meet entrance criteria|0
942242|NCT00999518|1931483|FG003|Overall Study|Did not meet entrance criteria|0
942243|NCT00999518|1931484|FG004|Overall Study|Did not meet entrance criteria|1
942244|NCT00999518|1931480|FG000|Overall Study|Study terminated by sponsor|10
942245|NCT00999518|1931481|FG001|Overall Study|Study terminated by sponsor|6
942246|NCT00999518|1931482|FG002|Overall Study|Study terminated by sponsor|5
942247|NCT00999518|1931483|FG003|Overall Study|Study terminated by sponsor|5
942248|NCT00999518|1931484|FG004|Overall Study|Study terminated by sponsor|9
942249|NCT00999518|1931480|FG000|Overall Study|Pregnancy|0
942250|NCT00999518|1931481|FG001|Overall Study|Pregnancy|0
942251|NCT00999518|1931482|FG002|Overall Study|Pregnancy|1
942252|NCT00999518|1931483|FG003|Overall Study|Pregnancy|0
942253|NCT00999518|1931484|FG004|Overall Study|Pregnancy|0
942254|NCT00999518|1931480|FG000|Overall Study|Protocol Violation|0
942255|NCT00999518|1931481|FG001|Overall Study|Protocol Violation|1
942256|NCT00999518|1931482|FG002|Overall Study|Protocol Violation|0
942257|NCT00999518|1931483|FG003|Overall Study|Protocol Violation|0
942258|NCT00999518|1931484|FG004|Overall Study|Protocol Violation|2
942259|NCT00999518|1931480|FG000|Overall Study|Withdrawal by Subject|5
942260|NCT00999518|1931481|FG001|Overall Study|Withdrawal by Subject|4
942261|NCT00999518|1931482|FG002|Overall Study|Withdrawal by Subject|10
942262|NCT00999518|1931483|FG003|Overall Study|Withdrawal by Subject|6
942263|NCT00999518|1931484|FG004|Overall Study|Withdrawal by Subject|1
942264|NCT00999518|1931480|FG000|Overall Study|Other|5
942265|NCT00999518|1931481|FG001|Overall Study|Other|7
942266|NCT00999518|1931482|FG002|Overall Study|Other|1
942267|NCT00999518|1931483|FG003|Overall Study|Other|4
942268|NCT00999518|1931484|FG004|Overall Study|Other|5
942269|NCT00999518|1931480|FG000|Overall Study|Randomized but not Treated|1
942270|NCT00999518|1931481|FG001|Overall Study|Randomized but not Treated|1
942271|NCT00999518|1931482|FG002|Overall Study|Randomized but not Treated|2
942272|NCT00999518|1931483|FG003|Overall Study|Randomized but not Treated|0
942273|NCT00999518|1931484|FG004|Overall Study|Randomized but not Treated|1
942274|NCT00999544|1931500|FG000|Overall Study|Withdrawal by Subject|1
942275|NCT00999596|1931533|FG000|Overall Study|Statistical population not required|101
942276|NCT00999661|1931547|FG000|Overall Study|Lost to Follow-up|59
942277|NCT00999661|1931547|FG000|Overall Study|Adverse Event|1
942278|NCT00999661|1931547|FG000|Overall Study|Withdrawal by Subject|1
942279|NCT00999661|1931547|FG000|Overall Study|Not meeting eligibility criteria|9
942280|NCT00999687|1931551|FG000|First Intervention|Withdrawal by Subject|1
942281|NCT00999687|1931551|FG000|Second Intervention|Withdrawal by Subject|2
942282|NCT00999687|1931551|FG000|Second Intervention|Lack of Efficacy|1
942283|NCT00999713|1931559|FG000|Overall Study|Physician Decision|2
942284|NCT00999713|1931560|FG001|Overall Study|Physician Decision|0
942285|NCT00999804|1931568|FG000|Overall Study|Lack of Efficacy|9
942286|NCT00999804|1931569|FG001|Overall Study|Lack of Efficacy|2
942287|NCT00999804|1931568|FG000|Overall Study|Adverse Event|4
942288|NCT00999804|1931569|FG001|Overall Study|Adverse Event|3
942289|NCT00999804|1931568|FG000|Overall Study|Withdrawal by Subject|4
942290|NCT00999804|1931569|FG001|Overall Study|Withdrawal by Subject|0
942291|NCT00999804|1931568|FG000|Overall Study|Death|1
942292|NCT00999804|1931569|FG001|Overall Study|Death|0
942293|NCT00999804|1931568|FG000|Overall Study|Ineligible|3
942294|NCT00999804|1931569|FG001|Overall Study|Ineligible|0
942295|NCT00999908|1931584|FG000|Treatment Period 1|Subject withdrew consent|2
942296|NCT00999908|1931585|FG001|Treatment Period 1|Subject withdrew consent|0
942297|NCT00999908|1931586|FG002|Treatment Period 1|Subject withdrew consent|0
942298|NCT00999908|1931584|FG000|Treatment Period 2|Protocol Violation|1
942299|NCT00999908|1931585|FG001|Treatment Period 2|Protocol Violation|0
942300|NCT00999908|1931586|FG002|Treatment Period 2|Protocol Violation|0
942301|NCT00999921|1931596|FG000|Overall Study|Lost to Follow-up|10
942302|NCT00999921|1931597|FG001|Overall Study|Lost to Follow-up|19
942303|NCT01000025|1931608|FG000|Overall Study|Adverse Event|43
942304|NCT01000025|1931609|FG001|Overall Study|Adverse Event|2
942305|NCT01000025|1931608|FG000|Overall Study|Withdrawal by Subject|13
942306|NCT01000025|1931609|FG001|Overall Study|Withdrawal by Subject|8
942307|NCT01000025|1931608|FG000|Overall Study|Death|23
942308|NCT01000025|1931609|FG001|Overall Study|Death|13
942309|NCT01000025|1931608|FG000|Overall Study|Lack of Efficacy|363
942310|NCT01000025|1931609|FG001|Overall Study|Lack of Efficacy|208
942311|NCT01000025|1931608|FG000|Overall Study|Intercurrent Illness|26
942312|NCT01000025|1931609|FG001|Overall Study|Intercurrent Illness|7
942313|NCT01000051|1931617|FG000|Overall Study|Withdrawal by Subject|1
942314|NCT01000051|1931618|FG001|Overall Study|Withdrawal by Subject|1
942315|NCT01000051|1931617|FG000|Overall Study|Disease Progression|1
942316|NCT01000051|1931618|FG001|Overall Study|Disease Progression|0
942317|NCT01000051|1931617|FG000|Overall Study|Serious noncompliance|1
942318|NCT01000051|1931618|FG001|Overall Study|Serious noncompliance|0
942319|NCT01000064|1931624|FG000|Overall Study|Withdrawal by Subject|1
942320|NCT01000064|1931625|FG001|Overall Study|Withdrawal by Subject|1
942321|NCT01000155|1931634|FG000|Overall Study|Withdrawal by Subject|1
942322|NCT01000155|1931634|FG000|Overall Study|Adverse Event|1
942323|NCT01000311|1931656|FG000|Overall Study|Adverse Event|2
942324|NCT01000311|1931657|FG001|Overall Study|Adverse Event|5
942325|NCT01000311|1931656|FG000|Overall Study|Withdrawal by Subject|16
942326|NCT01000311|1931657|FG001|Overall Study|Withdrawal by Subject|24
942327|NCT01000311|1931656|FG000|Overall Study|Lost to Follow-up|15
942328|NCT01000311|1931657|FG001|Overall Study|Lost to Follow-up|24
942329|NCT01000311|1931656|FG000|Overall Study|Protocol Violation|1
942330|NCT01000311|1931657|FG001|Overall Study|Protocol Violation|2
942331|NCT01000311|1931656|FG000|Overall Study|Inappropriate enrollment|2
942332|NCT01000311|1931657|FG001|Overall Study|Inappropriate enrollment|0
942333|NCT01000311|1931656|FG000|Overall Study|Administrative reason|9
942334|NCT01000311|1931657|FG001|Overall Study|Administrative reason|15
942335|NCT01000337|1931670|FG000|Overall Study|Lost to Follow-up|4
942336|NCT01000337|1931671|FG001|Overall Study|Lost to Follow-up|3
942337|NCT01000376|1931679|FG000|Cycle 1 Day 1|Adverse Event|1
942338|NCT01000376|1931680|FG001|Cycle 1 Day 1|Adverse Event|0
942339|NCT01000376|1931679|FG000|Cycle 1 Day 1|Progressive Disease|1
942340|NCT01000376|1931680|FG001|Cycle 1 Day 1|Progressive Disease|0
942341|NCT01000480|1931686|FG000|Induction Phase|Adverse Event|2
942342|NCT01000480|1931686|FG000|Induction Phase|Lost to Follow-up|1
942343|NCT01000480|1931686|FG000|Induction Phase|Physician Decision|1
942344|NCT01000480|1931686|FG000|Induction Phase|Entry Criteria Not Met|3
942345|NCT01000480|1931686|FG000|Concurrent Therapy Phase|Adverse Event|4
942346|NCT01000480|1931686|FG000|Concurrent Therapy Phase|Protocol Violation|2
942347|NCT01000480|1931686|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3
942348|NCT01000480|1931686|FG000|Concurrent Therapy Phase|Physician Decision|1
942349|NCT01000493|1931692|FG000|Overall Study|Adverse Event|3
942350|NCT01000493|1931693|FG001|Overall Study|Adverse Event|6
942351|NCT01000493|1931692|FG000|Overall Study|Lack of Efficacy|1
942352|NCT01000493|1931693|FG001|Overall Study|Lack of Efficacy|1
942353|NCT01000493|1931692|FG000|Overall Study|Protocol Violation|1
942354|NCT01000493|1931693|FG001|Overall Study|Protocol Violation|8
942355|NCT01000493|1931692|FG000|Overall Study|Study closed/terminated|25
942356|NCT01000493|1931693|FG001|Overall Study|Study closed/terminated|23
942357|NCT01000493|1931692|FG000|Overall Study|Lost to Follow-up|5
942358|NCT01000493|1931693|FG001|Overall Study|Lost to Follow-up|9
942359|NCT01000493|1931692|FG000|Overall Study|Physician Decision|1
942360|NCT01000493|1931693|FG001|Overall Study|Physician Decision|1
942361|NCT01000493|1931692|FG000|Overall Study|Withdrawal by Subject|3
942362|NCT01000493|1931693|FG001|Overall Study|Withdrawal by Subject|7
942363|NCT01000506|1931703|FG000|Overall Study|Adverse Event|6
942364|NCT01000506|1931704|FG001|Overall Study|Adverse Event|5
942365|NCT01000506|1931705|FG002|Overall Study|Adverse Event|8
942366|NCT01000506|1931706|FG003|Overall Study|Adverse Event|9
942367|NCT01000506|1931703|FG000|Overall Study|Lack of Efficacy|8
942368|NCT01000506|1931704|FG001|Overall Study|Lack of Efficacy|6
942369|NCT01000506|1931705|FG002|Overall Study|Lack of Efficacy|4
942370|NCT01000506|1931706|FG003|Overall Study|Lack of Efficacy|4
942371|NCT01000506|1931703|FG000|Overall Study|Protocol Violation|1
942372|NCT01000506|1931704|FG001|Overall Study|Protocol Violation|1
942373|NCT01000506|1931705|FG002|Overall Study|Protocol Violation|0
942374|NCT01000506|1931706|FG003|Overall Study|Protocol Violation|0
942375|NCT01000506|1931703|FG000|Overall Study|Lost to Follow-up|1
942376|NCT01000506|1931704|FG001|Overall Study|Lost to Follow-up|1
942377|NCT01000506|1931705|FG002|Overall Study|Lost to Follow-up|4
942378|NCT01000506|1931706|FG003|Overall Study|Lost to Follow-up|0
942379|NCT01000506|1931703|FG000|Overall Study|Physician Decision|1
942380|NCT01000506|1931704|FG001|Overall Study|Physician Decision|3
942381|NCT01000506|1931705|FG002|Overall Study|Physician Decision|3
942382|NCT01000506|1931706|FG003|Overall Study|Physician Decision|3
942383|NCT01000506|1931703|FG000|Overall Study|Withdrawal by Subject|11
942384|NCT01000506|1931704|FG001|Overall Study|Withdrawal by Subject|8
942385|NCT01000506|1931705|FG002|Overall Study|Withdrawal by Subject|2
942386|NCT01000506|1931706|FG003|Overall Study|Withdrawal by Subject|7
942387|NCT01000610|1931716|FG000|Overall Study|Adverse Event|1
942388|NCT01000610|1931716|FG000|Overall Study|Lost to Follow-up|4
942389|NCT01000610|1931716|FG000|Overall Study|Treatment failure|1
942390|NCT01000636|1931720|FG000|Overall Study|Withdrawal by Subject|1
942391|NCT01000636|1931720|FG000|Overall Study|Adverse Event|1
942392|NCT01000649|1931728|FG000|Overall Study|Adverse Event|5
942393|NCT01000649|1931729|FG001|Overall Study|Adverse Event|1
942394|NCT01000649|1931730|FG002|Overall Study|Adverse Event|2
942395|NCT01000649|1931731|FG003|Overall Study|Adverse Event|4
942396|NCT01000649|1931728|FG000|Overall Study|Lost to Follow-up|0
942397|NCT01000649|1931729|FG001|Overall Study|Lost to Follow-up|2
942398|NCT01000649|1931730|FG002|Overall Study|Lost to Follow-up|0
942399|NCT01000649|1931731|FG003|Overall Study|Lost to Follow-up|2
942400|NCT01000727|1931753|FG000|Overall Study|Lost to Follow-up|41
942401|NCT01000727|1931754|FG001|Overall Study|Lost to Follow-up|43
942402|NCT01000727|1931753|FG000|Overall Study|Withdrawal by Subject|111
942403|NCT01000727|1931754|FG001|Overall Study|Withdrawal by Subject|109
942404|NCT01000727|1931753|FG000|Overall Study|Study closed/terminated|23
942405|NCT01000727|1931754|FG001|Overall Study|Study closed/terminated|24
942406|NCT01000805|1931764|FG000|Overall Study|Adverse Event|21
942407|NCT01000805|1931765|FG001|Overall Study|Adverse Event|9
942408|NCT01000805|1931764|FG000|Overall Study|Lack of Efficacy|5
942409|NCT01000805|1931765|FG001|Overall Study|Lack of Efficacy|16
942410|NCT01000805|1931764|FG000|Overall Study|Lost to Follow-up|16
942411|NCT01000805|1931765|FG001|Overall Study|Lost to Follow-up|21
942412|NCT01000805|1931764|FG000|Overall Study|Physician Decision|0
942413|NCT01000805|1931765|FG001|Overall Study|Physician Decision|1
942414|NCT01000805|1931764|FG000|Overall Study|Protocol Violation|12
942415|NCT01000805|1931765|FG001|Overall Study|Protocol Violation|8
942416|NCT01000805|1931764|FG000|Overall Study|Withdrawal by Subject|16
942417|NCT01000805|1931765|FG001|Overall Study|Withdrawal by Subject|6
942418|NCT01000805|1931764|FG000|Overall Study|Sponsor Decision|0
942419|NCT01000805|1931765|FG001|Overall Study|Sponsor Decision|1
942420|NCT01000961|1931781|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
942421|NCT01000961|1931782|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
942422|NCT01000961|1931781|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
942423|NCT01000961|1931782|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
942424|NCT01000974|1931793|FG000|Primary Vaccination Phase|Withdrawal by Subject|109
942425|NCT01000974|1931794|FG001|Primary Vaccination Phase|Withdrawal by Subject|17
942426|NCT01000974|1931795|FG002|Primary Vaccination Phase|Withdrawal by Subject|21
942427|NCT01000974|1931793|FG000|Primary Vaccination Phase|Lost to Follow-up|171
942428|NCT01000974|1931794|FG001|Primary Vaccination Phase|Lost to Follow-up|19
942429|NCT01000974|1931795|FG002|Primary Vaccination Phase|Lost to Follow-up|26
942430|NCT01000974|1931793|FG000|Primary Vaccination Phase|Protocol Violation|40
942431|NCT01000974|1931794|FG001|Primary Vaccination Phase|Protocol Violation|3
942432|NCT01000974|1931795|FG002|Primary Vaccination Phase|Protocol Violation|2
942433|NCT01000974|1931793|FG000|Primary Vaccination Phase|Adverse Event|14
942434|NCT01000974|1931794|FG001|Primary Vaccination Phase|Adverse Event|2
942435|NCT01000974|1931795|FG002|Primary Vaccination Phase|Adverse Event|2
942436|NCT01000974|1931793|FG000|Primary Vaccination Phase|Other|4
942437|NCT01000974|1931794|FG001|Primary Vaccination Phase|Other|9
942438|NCT01000974|1931795|FG002|Primary Vaccination Phase|Other|12
942439|NCT01000974|1931793|FG000|Booster Vaccination Phase|Protocol Violation|0
942440|NCT01000974|1931794|FG001|Booster Vaccination Phase|Protocol Violation|0
942441|NCT01000974|1931795|FG002|Booster Vaccination Phase|Protocol Violation|2
942442|NCT01000974|1931793|FG000|Booster Vaccination Phase|Withdrawal by Subject|3
942443|NCT01000974|1931794|FG001|Booster Vaccination Phase|Withdrawal by Subject|1
942444|NCT01000974|1931795|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
942445|NCT01000974|1931793|FG000|Booster Vaccination Phase|Lost to Follow-up|40
942446|NCT01000974|1931794|FG001|Booster Vaccination Phase|Lost to Follow-up|5
942447|NCT01000974|1931795|FG002|Booster Vaccination Phase|Lost to Follow-up|7
942448|NCT01000974|1931793|FG000|Booster Vaccination Phase|Other|24
942449|NCT01000974|1931794|FG001|Booster Vaccination Phase|Other|6
942450|NCT01000974|1931795|FG002|Booster Vaccination Phase|Other|4
942451|NCT01001104|1931841|FG000|Overall Study|Adverse Event|2
942452|NCT01001104|1931842|FG001|Overall Study|Adverse Event|1
942453|NCT01001104|1931843|FG002|Overall Study|Adverse Event|0
942454|NCT01001104|1931844|FG003|Overall Study|Adverse Event|0
942455|NCT01001104|1931841|FG000|Overall Study|Lost to Follow-up|0
942456|NCT01001104|1931842|FG001|Overall Study|Lost to Follow-up|0
942457|NCT01001104|1931843|FG002|Overall Study|Lost to Follow-up|1
942458|NCT01001104|1931844|FG003|Overall Study|Lost to Follow-up|0
942459|NCT01001104|1931841|FG000|Overall Study|Entry Criteria Not Met|0
942460|NCT01001104|1931842|FG001|Overall Study|Entry Criteria Not Met|0
942461|NCT01001104|1931843|FG002|Overall Study|Entry Criteria Not Met|0
942462|NCT01001104|1931844|FG003|Overall Study|Entry Criteria Not Met|1
942463|NCT01001104|1931841|FG000|Overall Study|Withdrawal by Subject|0
942464|NCT01001104|1931842|FG001|Overall Study|Withdrawal by Subject|0
942465|NCT01001104|1931843|FG002|Overall Study|Withdrawal by Subject|0
942466|NCT01001104|1931844|FG003|Overall Study|Withdrawal by Subject|2
942467|NCT01001169|1931859|FG000|Overall Study|Withdrawal by Subject|2
942468|NCT01001169|1931860|FG001|Overall Study|Withdrawal by Subject|1
942469|NCT01001208|1931893|FG000|Overall Study|Adverse Event|10
942470|NCT01001208|1931894|FG001|Overall Study|Adverse Event|5
942471|NCT01001208|1931893|FG000|Overall Study|Lost to Follow-up|5
942472|NCT01001208|1931894|FG001|Overall Study|Lost to Follow-up|9
942473|NCT01001208|1931893|FG000|Overall Study|Physician Decision|1
942474|NCT01001208|1931894|FG001|Overall Study|Physician Decision|0
942475|NCT01001208|1931893|FG000|Overall Study|Withdrawal by Subject|4
942476|NCT01001208|1931894|FG001|Overall Study|Withdrawal by Subject|5
942477|NCT01001208|1931893|FG000|Overall Study|Ineligibility Determined|4
942478|NCT01001208|1931894|FG001|Overall Study|Ineligibility Determined|2
942479|NCT01001208|1931893|FG000|Overall Study|Noncompliance|4
942480|NCT01001208|1931894|FG001|Overall Study|Noncompliance|7
942481|NCT01001208|1931893|FG000|Overall Study|Disease Progression|0
942482|NCT01001208|1931894|FG001|Overall Study|Disease Progression|3
942483|NCT01001208|1931893|FG000|Overall Study|Other|0
942484|NCT01001208|1931894|FG001|Overall Study|Other|2
942485|NCT01001221|1931904|FG000|Overall Study|Adverse Event|1
942486|NCT01001221|1931905|FG001|Overall Study|Adverse Event|2
942487|NCT01001221|1931906|FG002|Overall Study|Adverse Event|0
942488|NCT01001221|1931907|FG003|Overall Study|Adverse Event|2
942489|NCT01001221|1931908|FG004|Overall Study|Adverse Event|0
942490|NCT01001221|1931904|FG000|Overall Study|Disease progression|3
942491|NCT01001221|1931905|FG001|Overall Study|Disease progression|2
942492|NCT01001221|1931906|FG002|Overall Study|Disease progression|2
942493|NCT01001221|1931907|FG003|Overall Study|Disease progression|4
942494|NCT01001221|1931908|FG004|Overall Study|Disease progression|0
942495|NCT01001221|1931904|FG000|Overall Study|Other|1
942496|NCT01001221|1931905|FG001|Overall Study|Other|1
942497|NCT01001221|1931906|FG002|Overall Study|Other|0
942498|NCT01001221|1931907|FG003|Overall Study|Other|0
942499|NCT01001221|1931908|FG004|Overall Study|Other|0
942500|NCT01001221|1931904|FG000|Overall Study|Not treated; protocol exclusion|0
942501|NCT01001221|1931905|FG001|Overall Study|Not treated; protocol exclusion|0
942502|NCT01001221|1931906|FG002|Overall Study|Not treated; protocol exclusion|1
942503|NCT01001221|1931907|FG003|Overall Study|Not treated; protocol exclusion|0
942504|NCT01001221|1931908|FG004|Overall Study|Not treated; protocol exclusion|0
942505|NCT01001234|1931924|FG000|Overall Study|Withdrawal by Subject|2
942506|NCT01001234|1931925|FG001|Overall Study|Withdrawal by Subject|0
942507|NCT01001234|1931926|FG002|Overall Study|Withdrawal by Subject|3
942508|NCT01001234|1931927|FG003|Overall Study|Withdrawal by Subject|0
942509|NCT01001234|1931928|FG004|Overall Study|Withdrawal by Subject|0
942510|NCT01001234|1931924|FG000|Overall Study|Protocol Violation|34
942511|NCT01001234|1931925|FG001|Overall Study|Protocol Violation|3
942512|NCT01001234|1931926|FG002|Overall Study|Protocol Violation|19
942513|NCT01001234|1931927|FG003|Overall Study|Protocol Violation|18
942514|NCT01001234|1931928|FG004|Overall Study|Protocol Violation|0
942515|NCT01001234|1931924|FG000|Overall Study|Lost to Follow-up|0
942516|NCT01001234|1931925|FG001|Overall Study|Lost to Follow-up|0
942517|NCT01001234|1931926|FG002|Overall Study|Lost to Follow-up|1
942518|NCT01001234|1931927|FG003|Overall Study|Lost to Follow-up|2
942519|NCT01001234|1931928|FG004|Overall Study|Lost to Follow-up|0
942520|NCT01001234|1931924|FG000|Overall Study|Physician Decision|1
942521|NCT01001234|1931925|FG001|Overall Study|Physician Decision|0
942522|NCT01001234|1931926|FG002|Overall Study|Physician Decision|0
942523|NCT01001234|1931927|FG003|Overall Study|Physician Decision|0
942524|NCT01001234|1931928|FG004|Overall Study|Physician Decision|0
942525|NCT01001234|1931924|FG000|Overall Study|Not Treated: Adverse Event|1
942526|NCT01001234|1931925|FG001|Overall Study|Not Treated: Adverse Event|0
942527|NCT01001234|1931926|FG002|Overall Study|Not Treated: Adverse Event|0
942528|NCT01001234|1931927|FG003|Overall Study|Not Treated: Adverse Event|0
942529|NCT01001234|1931928|FG004|Overall Study|Not Treated: Adverse Event|0
942530|NCT01001234|1931924|FG000|Overall Study|Not Treated: Withdrawal by Subject|23
942531|NCT01001234|1931925|FG001|Overall Study|Not Treated: Withdrawal by Subject|2
942532|NCT01001234|1931926|FG002|Overall Study|Not Treated: Withdrawal by Subject|2
942533|NCT01001234|1931927|FG003|Overall Study|Not Treated: Withdrawal by Subject|0
942534|NCT01001234|1931928|FG004|Overall Study|Not Treated: Withdrawal by Subject|0
942535|NCT01001234|1931924|FG000|Overall Study|Not Treated: Protocol Violation|3
942536|NCT01001234|1931925|FG001|Overall Study|Not Treated: Protocol Violation|0
942537|NCT01001234|1931926|FG002|Overall Study|Not Treated: Protocol Violation|0
942538|NCT01001234|1931927|FG003|Overall Study|Not Treated: Protocol Violation|0
942539|NCT01001234|1931928|FG004|Overall Study|Not Treated: Protocol Violation|0
942540|NCT01001234|1931924|FG000|Overall Study|Not Treated: Lost to Follow-up|53
942541|NCT01001234|1931925|FG001|Overall Study|Not Treated: Lost to Follow-up|4
942542|NCT01001234|1931926|FG002|Overall Study|Not Treated: Lost to Follow-up|7
942543|NCT01001234|1931927|FG003|Overall Study|Not Treated: Lost to Follow-up|5
942544|NCT01001234|1931928|FG004|Overall Study|Not Treated: Lost to Follow-up|0
942545|NCT01001234|1931924|FG000|Overall Study|Not Treated: Pregnancy|3
942546|NCT01001234|1931925|FG001|Overall Study|Not Treated: Pregnancy|0
942547|NCT01001234|1931926|FG002|Overall Study|Not Treated: Pregnancy|0
942548|NCT01001234|1931927|FG003|Overall Study|Not Treated: Pregnancy|0
942549|NCT01001234|1931928|FG004|Overall Study|Not Treated: Pregnancy|0
942550|NCT01001234|1931924|FG000|Overall Study|Not Treated: Physician Decision|37
942551|NCT01001234|1931925|FG001|Overall Study|Not Treated: Physician Decision|4
942552|NCT01001234|1931926|FG002|Overall Study|Not Treated: Physician Decision|0
942553|NCT01001234|1931927|FG003|Overall Study|Not Treated: Physician Decision|0
942554|NCT01001234|1931928|FG004|Overall Study|Not Treated: Physician Decision|0
942555|NCT01001234|1931924|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248
942556|NCT01001234|1931925|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13
942557|NCT01001234|1931926|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0
942558|NCT01001234|1931927|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0
942559|NCT01001234|1931928|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0
942560|NCT01001299|1931934|FG000|Overall Study|Insufficient Therapeutic Response|20
942561|NCT01001299|1931934|FG000|Overall Study|Adverse event or Intercurrent Illness|1
942562|NCT01001299|1931934|FG000|Overall Study|Death|1
942563|NCT01001299|1931934|FG000|Overall Study|Began Taking Commercially Available Drug|2
942564|NCT01001299|1931934|FG000|Overall Study|Withdrew Consent|1
942565|NCT01001325|1931940|FG000|Overall Study|Lost to Follow-up|16
942566|NCT01001325|1931941|FG001|Overall Study|Lost to Follow-up|10
942567|NCT01001325|1931940|FG000|Overall Study|Protocol Violation|2
942568|NCT01001325|1931941|FG001|Overall Study|Protocol Violation|0
942569|NCT01001377|1931949|FG000|Overall Study|Ineligibility determined|2
942570|NCT01001377|1931950|FG001|Overall Study|Ineligibility determined|0
942571|NCT01001377|1931949|FG000|Overall Study|Withdrawal by Subject|19
942572|NCT01001377|1931950|FG001|Overall Study|Withdrawal by Subject|20
942573|NCT01001377|1931949|FG000|Overall Study|Lost to Follow-up|14
942574|NCT01001377|1931950|FG001|Overall Study|Lost to Follow-up|17
942575|NCT01001377|1931949|FG000|Overall Study|Death|391
942576|NCT01001377|1931950|FG001|Overall Study|Death|384
942577|NCT01001429|1931967|FG000|Overall Study|surgery cancelled|0
942578|NCT01001429|1931968|FG001|Overall Study|surgery cancelled|1
942579|NCT01001494|1932038|FG000|Overall Study|Adverse Event|8
942580|NCT01001494|1932039|FG001|Overall Study|Adverse Event|4
942581|NCT01001494|1932040|FG002|Overall Study|Adverse Event|6
942582|NCT01001494|1932038|FG000|Overall Study|Protocol Violation|0
942583|NCT01001494|1932039|FG001|Overall Study|Protocol Violation|1
942584|NCT01001494|1932040|FG002|Overall Study|Protocol Violation|1
942585|NCT01001494|1932038|FG000|Overall Study|Lost to Follow-up|2
942586|NCT01001494|1932039|FG001|Overall Study|Lost to Follow-up|0
942587|NCT01001494|1932040|FG002|Overall Study|Lost to Follow-up|1
942588|NCT01001494|1932038|FG000|Overall Study|Withdrawal by Subject|9
942589|NCT01001494|1932039|FG001|Overall Study|Withdrawal by Subject|7
942590|NCT01001494|1932040|FG002|Overall Study|Withdrawal by Subject|17
942591|NCT01001494|1932038|FG000|Overall Study|COPD exacerbation|3
942592|NCT01001494|1932039|FG001|Overall Study|COPD exacerbation|4
942593|NCT01001494|1932040|FG002|Overall Study|COPD exacerbation|5
942594|NCT01001494|1932038|FG000|Overall Study|Lack of Efficacy|2
942595|NCT01001494|1932039|FG001|Overall Study|Lack of Efficacy|0
942596|NCT01001494|1932040|FG002|Overall Study|Lack of Efficacy|8
942597|NCT01001494|1932038|FG000|Overall Study|Other|0
942598|NCT01001494|1932039|FG001|Overall Study|Other|1
942599|NCT01001494|1932040|FG002|Overall Study|Other|3
942600|NCT01001520|1932048|FG000|Medication Period 1|Withdrawal by Subject|2
942601|NCT01001520|1932049|FG001|Medication Period 1|Withdrawal by Subject|2
942602|NCT01001520|1932048|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
942603|NCT01001520|1932049|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
942604|NCT01001520|1932048|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0
942605|NCT01001520|1932049|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2
942606|NCT01001520|1932048|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
942607|NCT01001520|1932049|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
942608|NCT01001520|1932048|FG000|Washout Period|Withdrawal by Subject|2
942609|NCT01001520|1932049|FG001|Washout Period|Withdrawal by Subject|1
942610|NCT01001520|1932048|FG000|Medication Period 2|Withdrawal by Subject|0
942611|NCT01001520|1932049|FG001|Medication Period 2|Withdrawal by Subject|3
942612|NCT01001572|1932078|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
942613|NCT01001572|1932079|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
942614|NCT01001572|1932080|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
942615|NCT01001572|1932078|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11
942616|NCT01001572|1932079|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0
942617|NCT01001572|1932080|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0
942618|NCT01001572|1932078|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
942619|NCT01001572|1932079|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
942620|NCT01001572|1932080|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
942621|NCT01001572|1932078|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
942622|NCT01001572|1932079|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
942623|NCT01001572|1932080|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
942624|NCT01001572|1932078|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
942625|NCT01001572|1932079|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
942626|NCT01001572|1932080|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
942627|NCT01001572|1932078|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
942628|NCT01001572|1932079|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
942629|NCT01001572|1932080|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
942630|NCT01001572|1932078|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82
942631|NCT01001572|1932079|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0
942632|NCT01001572|1932080|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0
942633|NCT01001572|1932078|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
942634|NCT01001572|1932079|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
942635|NCT01001572|1932080|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
942636|NCT01001572|1932078|FG000|Double-Blind Treatment Phase|Adverse Event|0
942637|NCT01001572|1932079|FG001|Double-Blind Treatment Phase|Adverse Event|2
942638|NCT01001572|1932080|FG002|Double-Blind Treatment Phase|Adverse Event|2
942639|NCT01001572|1932078|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
942640|NCT01001572|1932079|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8
942641|NCT01001572|1932080|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13
942642|NCT01001572|1932078|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
942643|NCT01001572|1932079|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
942644|NCT01001572|1932080|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
942645|NCT01001572|1932078|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
942646|NCT01001572|1932079|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
942647|NCT01001572|1932080|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
942648|NCT01001572|1932078|FG000|Double-Blind Treatment Phase|Protocol deviation|0
942649|NCT01001572|1932079|FG001|Double-Blind Treatment Phase|Protocol deviation|0
942650|NCT01001572|1932080|FG002|Double-Blind Treatment Phase|Protocol deviation|1
942651|NCT01001572|1932078|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
942652|NCT01001572|1932079|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
942653|NCT01001572|1932080|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
942654|NCT01001598|1932086|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1
942655|NCT01001598|1932086|FG000|Overall Study|Adverse Event|1
942656|NCT01001702|1932090|FG000|Overall Study|Lost to Follow-up|7
942657|NCT01001702|1932090|FG000|Overall Study|Adverse Event|7
942658|NCT01001702|1932090|FG000|Overall Study|Sponsor Discontinued Study|4
942659|NCT01001702|1932090|FG000|Overall Study|Subject met Withdrawal Criteria|22
942660|NCT01001702|1932090|FG000|Overall Study|Investigator withdrew Subject|10
942661|NCT01001702|1932090|FG000|Overall Study|Withdrawal by Subject|19
942662|NCT01001702|1932090|FG000|Overall Study|Lack of Efficacy per Investigator|3
942663|NCT01001767|1932096|FG000|Overall Study|no baseline study performed|1
942664|NCT01001767|1932097|FG001|Overall Study|no baseline study performed|0
942665|NCT01001767|1932096|FG000|Overall Study|Protocol Violation|1
942666|NCT01001767|1932097|FG001|Overall Study|Protocol Violation|0
942667|NCT01001767|1932096|FG000|Overall Study|Lost to Follow-up|1
942668|NCT01001767|1932097|FG001|Overall Study|Lost to Follow-up|0
942669|NCT01001767|1932096|FG000|Overall Study|Physician Decision|1
942670|NCT01001767|1932097|FG001|Overall Study|Physician Decision|0
942671|NCT01001832|1932118|FG000|Short-term Period|Adverse Event|2
942672|NCT01001832|1932119|FG001|Short-term Period|Adverse Event|3
942673|NCT01001832|1932118|FG000|Long-term Period|Adverse Event|2
942674|NCT01001832|1932119|FG001|Long-term Period|Adverse Event|1
942675|NCT01001832|1932118|FG000|Long-term Period|Withdrawal by Subject|1
942676|NCT01001832|1932119|FG001|Long-term Period|Withdrawal by Subject|0
942677|NCT01001832|1932118|FG000|Long-term Period|Lack of Efficacy|0
942678|NCT01001832|1932119|FG001|Long-term Period|Lack of Efficacy|2
942679|NCT01001832|1932118|FG000|Long-term Period|Other|1
942680|NCT01001832|1932119|FG001|Long-term Period|Other|2
942681|NCT01001832|1932118|FG000|Follow-up Period|Withdrawal by Subject|1
942682|NCT01001832|1932119|FG001|Follow-up Period|Withdrawal by Subject|0
942683|NCT01001832|1932118|FG000|Follow-up Period|Follow-up no longer required /protocol|15
942684|NCT01001832|1932119|FG001|Follow-up Period|Follow-up no longer required /protocol|20
942685|NCT01001832|1932118|FG000|Follow-up Period|Other|2
942686|NCT01001832|1932119|FG001|Follow-up Period|Other|1
942687|NCT01001910|1932128|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6
942688|NCT01001988|1932141|FG000|Overall Study|Protocol Violation|84
942689|NCT01001988|1932141|FG000|Overall Study|Withdrawal by Subject|18
942690|NCT01001988|1932141|FG000|Overall Study|Lost to Follow-up|15
942691|NCT01002105|1932147|FG000|Overall Study|Lost to Follow-up|10
942692|NCT01002105|1932148|FG001|Overall Study|Lost to Follow-up|16
942693|NCT01002105|1932147|FG000|Overall Study|non compliance|5
942694|NCT01002105|1932148|FG001|Overall Study|non compliance|3
942695|NCT01002105|1932147|FG000|Overall Study|condition worsened|4
942696|NCT01002105|1932148|FG001|Overall Study|condition worsened|2
942697|NCT01002339|1932173|FG000|Overall Study|Withdrawal by Subject|0
942698|NCT01002339|1932174|FG001|Overall Study|Withdrawal by Subject|1
942699|NCT01002339|1932175|FG002|Overall Study|Withdrawal by Subject|0
942700|NCT01002339|1932173|FG000|Overall Study|Incorrect treatment assignment|0
942701|NCT01002339|1932174|FG001|Overall Study|Incorrect treatment assignment|0
942702|NCT01002339|1932175|FG002|Overall Study|Incorrect treatment assignment|1
942703|NCT01002339|1932173|FG000|Overall Study|Protocol Violation|0
942704|NCT01002339|1932174|FG001|Overall Study|Protocol Violation|0
942705|NCT01002339|1932175|FG002|Overall Study|Protocol Violation|2
942706|NCT01002339|1932173|FG000|Overall Study|Lung cancer detected before transplant|0
942707|NCT01002339|1932174|FG001|Overall Study|Lung cancer detected before transplant|0
942708|NCT01002339|1932175|FG002|Overall Study|Lung cancer detected before transplant|1
942709|NCT01002339|1932173|FG000|Overall Study|Randomized. Not transplanted|0
942710|NCT01002339|1932174|FG001|Overall Study|Randomized. Not transplanted|0
942711|NCT01002339|1932175|FG002|Overall Study|Randomized. Not transplanted|1
942712|NCT01002482|1932196|FG000|Overall Study|Withdrawal by Subject|14
942713|NCT01002482|1932197|FG001|Overall Study|Withdrawal by Subject|21
942714|NCT01002482|1932196|FG000|Overall Study|Included twice|1
942715|NCT01002482|1932197|FG001|Overall Study|Included twice|0
942716|NCT01002547|1932206|FG000|Overall Study|Withdrawal by Subject|4
942717|NCT01002547|1932207|FG001|Overall Study|Withdrawal by Subject|0
942718|NCT01002547|1932208|FG002|Overall Study|Withdrawal by Subject|5
942719|NCT01002547|1932206|FG000|Overall Study|Lost to Follow-up|2
942720|NCT01002547|1932207|FG001|Overall Study|Lost to Follow-up|1
942721|NCT01002547|1932208|FG002|Overall Study|Lost to Follow-up|1
942722|NCT01002547|1932206|FG000|Overall Study|Physician Decision|1
942723|NCT01002547|1932207|FG001|Overall Study|Physician Decision|0
942724|NCT01002547|1932208|FG002|Overall Study|Physician Decision|0
942725|NCT01002547|1932206|FG000|Overall Study|Death|0
942726|NCT01002547|1932207|FG001|Overall Study|Death|2
942727|NCT01002547|1932208|FG002|Overall Study|Death|2
942728|NCT01002547|1932206|FG000|Overall Study|Adverse Event|1
942729|NCT01002547|1932207|FG001|Overall Study|Adverse Event|0
942730|NCT01002547|1932208|FG002|Overall Study|Adverse Event|0
942731|NCT01002573|1932218|FG000|Overall Study|Subject did not receive at least 1 dose|11
942732|NCT01002573|1932219|FG001|Overall Study|Subject did not receive at least 1 dose|7
942733|NCT01002742|1932227|FG000|Overall Study|Determined to be ineligible|0
942734|NCT01002742|1932228|FG001|Overall Study|Determined to be ineligible|1
942735|NCT01002989|1932238|FG000|Overall Study|exclusion criteria, no consent|5
942736|NCT01003184|1932287|FG000|Overall Study|Adverse Event|12
942737|NCT01003184|1932288|FG001|Overall Study|Adverse Event|5
942738|NCT01003184|1932287|FG000|Overall Study|Lost to Follow-up|1
942739|NCT01003184|1932288|FG001|Overall Study|Lost to Follow-up|0
942740|NCT01003184|1932287|FG000|Overall Study|Loss of glucose control|1
942741|NCT01003184|1932288|FG001|Overall Study|Loss of glucose control|1
942742|NCT01003184|1932287|FG000|Overall Study|Protocol Violation|3
942743|NCT01003184|1932288|FG001|Overall Study|Protocol Violation|0
942744|NCT01003184|1932287|FG000|Overall Study|Withdrawal by Subject|1
942745|NCT01003184|1932288|FG001|Overall Study|Withdrawal by Subject|6
942746|NCT01003184|1932287|FG000|Overall Study|Physician Decision|1
942747|NCT01003184|1932288|FG001|Overall Study|Physician Decision|0
942748|NCT01003210|1932296|FG000|Overall Study|Lost to Follow-up|1
942749|NCT01003210|1932297|FG001|Overall Study|Lost to Follow-up|3
942750|NCT01003249|1932303|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1
942751|NCT01003249|1932304|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
942752|NCT01003249|1932303|FG000|First Intervention (4 Weeks)|Non-Serious Event|1
942753|NCT01003249|1932304|FG001|First Intervention (4 Weeks)|Non-Serious Event|1
942754|NCT01003249|1932303|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0
942755|NCT01003249|1932304|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
942756|NCT01003249|1932303|FG000|Second Intervention (4 Weeks)|Adverse Event|1
942757|NCT01003249|1932304|FG001|Second Intervention (4 Weeks)|Adverse Event|0
942758|NCT01003639|1932350|FG000|Overall Study|Lost to Follow-up|6
942759|NCT01003639|1932351|FG001|Overall Study|Lost to Follow-up|9
942760|NCT01003639|1932350|FG000|Overall Study|Withdrawal by Subject|9
942761|NCT01003639|1932351|FG001|Overall Study|Withdrawal by Subject|5
942762|NCT01003639|1932350|FG000|Overall Study|Lack of Efficacy|1
942763|NCT01003639|1932351|FG001|Overall Study|Lack of Efficacy|6
942764|NCT01003639|1932350|FG000|Overall Study|Adverse Event|0
942765|NCT01003639|1932351|FG001|Overall Study|Adverse Event|1
942766|NCT01003639|1932350|FG000|Overall Study|Protocol Violation|0
942767|NCT01003639|1932351|FG001|Overall Study|Protocol Violation|1
942768|NCT01003639|1932350|FG000|Overall Study|Physician Decision|1
942769|NCT01003639|1932351|FG001|Overall Study|Physician Decision|0
942770|NCT01003886|1932361|FG000|Overall Study|Lack of Efficacy|5
942771|NCT01003886|1932361|FG000|Overall Study|Lost to Follow-up|169
942772|NCT01003886|1932361|FG000|Overall Study|Withdrawal by Subject|39
942773|NCT01003886|1932361|FG000|Overall Study|Other|14
942774|NCT01003886|1932361|FG000|Overall Study|Adverse Event|3
942775|NCT01003899|1932365|FG000|Overall Study|Other Adverse Event|8
942776|NCT01003899|1932365|FG000|Overall Study|Not entered|4
942777|NCT01003899|1932365|FG000|Overall Study|Not treated|1
942778|NCT01003899|1932365|FG000|Overall Study|Progressive disease|34
942779|NCT01003990|1932376|FG000|Overall Study|Adverse Event|8
942780|NCT01003990|1932377|FG001|Overall Study|Adverse Event|5
942781|NCT01003990|1932378|FG002|Overall Study|Adverse Event|11
942782|NCT01003990|1932376|FG000|Overall Study|Death|0
942783|NCT01003990|1932377|FG001|Overall Study|Death|8
942784|NCT01003990|1932378|FG002|Overall Study|Death|1
942785|NCT01003990|1932376|FG000|Overall Study|Lack of Efficacy|10
942786|NCT01003990|1932377|FG001|Overall Study|Lack of Efficacy|2
942787|NCT01003990|1932378|FG002|Overall Study|Lack of Efficacy|3
942788|NCT01003990|1932376|FG000|Overall Study|Lost to Follow-up|30
942789|NCT01003990|1932377|FG001|Overall Study|Lost to Follow-up|12
942790|NCT01003990|1932378|FG002|Overall Study|Lost to Follow-up|7
942791|NCT01003990|1932376|FG000|Overall Study|Reasons Not Identified|14
942792|NCT01003990|1932377|FG001|Overall Study|Reasons Not Identified|13
942793|NCT01003990|1932378|FG002|Overall Study|Reasons Not Identified|8
942794|NCT01003990|1932376|FG000|Overall Study|Poor/Non-compliance|4
942795|NCT01003990|1932377|FG001|Overall Study|Poor/Non-compliance|3
942796|NCT01003990|1932378|FG002|Overall Study|Poor/Non-compliance|2
942797|NCT01003990|1932376|FG000|Overall Study|Pregnancy|10
942798|NCT01003990|1932377|FG001|Overall Study|Pregnancy|2
942799|NCT01003990|1932378|FG002|Overall Study|Pregnancy|4
942800|NCT01003990|1932376|FG000|Overall Study|No Longer Met Study Criteria|4
942801|NCT01003990|1932377|FG001|Overall Study|No Longer Met Study Criteria|1
942802|NCT01003990|1932378|FG002|Overall Study|No Longer Met Study Criteria|0
942803|NCT01003990|1932376|FG000|Overall Study|Subject Withdrew Consent|12
942804|NCT01003990|1932377|FG001|Overall Study|Subject Withdrew Consent|5
942805|NCT01003990|1932378|FG002|Overall Study|Subject Withdrew Consent|7
942806|NCT01004003|1932395|FG000|Overall Study|Progressive disease|2
942807|NCT01004003|1932396|FG001|Overall Study|Progressive disease|1
942808|NCT01004003|1932397|FG002|Overall Study|Progressive disease|1
942809|NCT01004003|1932398|FG003|Overall Study|Progressive disease|0
942810|NCT01004003|1932399|FG004|Overall Study|Progressive disease|2
942811|NCT01004003|1932400|FG005|Overall Study|Progressive disease|1
942812|NCT01004003|1932401|FG006|Overall Study|Progressive disease|1
942813|NCT01004003|1932402|FG007|Overall Study|Progressive disease|39
942814|NCT01004003|1932403|FG008|Overall Study|Progressive disease|22
942815|NCT01004003|1932395|FG000|Overall Study|Adverse Event|4
942816|NCT01004003|1932396|FG001|Overall Study|Adverse Event|2
942817|NCT01004003|1932397|FG002|Overall Study|Adverse Event|3
942818|NCT01004003|1932398|FG003|Overall Study|Adverse Event|3
942819|NCT01004003|1932399|FG004|Overall Study|Adverse Event|2
942820|NCT01004003|1932400|FG005|Overall Study|Adverse Event|2
942821|NCT01004003|1932401|FG006|Overall Study|Adverse Event|7
942822|NCT01004003|1932402|FG007|Overall Study|Adverse Event|21
942823|NCT01004003|1932403|FG008|Overall Study|Adverse Event|6
942824|NCT01004003|1932395|FG000|Overall Study|Refused to continue taking trial med.|0
942825|NCT01004003|1932396|FG001|Overall Study|Refused to continue taking trial med.|0
942826|NCT01004003|1932397|FG002|Overall Study|Refused to continue taking trial med.|0
942827|NCT01004003|1932398|FG003|Overall Study|Refused to continue taking trial med.|0
942828|NCT01004003|1932399|FG004|Overall Study|Refused to continue taking trial med.|0
942829|NCT01004003|1932400|FG005|Overall Study|Refused to continue taking trial med.|0
942830|NCT01004003|1932401|FG006|Overall Study|Refused to continue taking trial med.|0
942831|NCT01004003|1932402|FG007|Overall Study|Refused to continue taking trial med.|0
942832|NCT01004003|1932403|FG008|Overall Study|Refused to continue taking trial med.|2
942833|NCT01004003|1932395|FG000|Overall Study|Other|0
942834|NCT01004003|1932396|FG001|Overall Study|Other|0
942835|NCT01004003|1932397|FG002|Overall Study|Other|0
942836|NCT01004003|1932398|FG003|Overall Study|Other|0
942837|NCT01004003|1932399|FG004|Overall Study|Other|0
942838|NCT01004003|1932400|FG005|Overall Study|Other|1
942839|NCT01004003|1932401|FG006|Overall Study|Other|0
942840|NCT01004003|1932402|FG007|Overall Study|Other|0
942841|NCT01004003|1932403|FG008|Overall Study|Other|0
942842|NCT01004146|1932474|FG000|Overall Study|Withdrawal by Subject|4
942843|NCT01004146|1932475|FG001|Overall Study|Withdrawal by Subject|5
942844|NCT01004159|1932481|FG000|Overall Study|Adverse Event|2
942845|NCT01004159|1932481|FG000|Overall Study|Disease Progression|18
942846|NCT01004172|1932485|FG000|Overall Study|Progressive Disease in CNS Only|16
942847|NCT01004172|1932485|FG000|Overall Study|Progressive Disease in Non-CNS Only|16
942848|NCT01004172|1932485|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2
942849|NCT01004172|1932485|FG000|Overall Study|Adverse Event|1
942850|NCT01004172|1932485|FG000|Overall Study|Physician Decision|1
942851|NCT01004172|1932485|FG000|Overall Study|Symptomatic Deterioration|2
942852|NCT01004185|1932492|FG000|Overall Study|Adverse Event|1
942853|NCT01004185|1932493|FG001|Overall Study|Adverse Event|1
942854|NCT01004185|1932492|FG000|Overall Study|Lost to Follow-up|0
942855|NCT01004185|1932493|FG001|Overall Study|Lost to Follow-up|1
942856|NCT01004185|1932492|FG000|Overall Study|Lack of Efficacy|2
942857|NCT01004185|1932493|FG001|Overall Study|Lack of Efficacy|1
942858|NCT01004185|1932492|FG000|Overall Study|Sponsor Terminated Study|4
942859|NCT01004185|1932493|FG001|Overall Study|Sponsor Terminated Study|5
942860|NCT01004185|1932492|FG000|Overall Study|Withdrawal by Subject|2
942861|NCT01004185|1932493|FG001|Overall Study|Withdrawal by Subject|1
942862|NCT01004250|1932499|FG000|Induction Therapy Period|Adverse Event|10
942863|NCT01004250|1932499|FG000|Induction Therapy Period|Entry Criteria Not Met|1
942864|NCT01004250|1932499|FG000|Induction Therapy Period|Withdrawal by Subject|2
942865|NCT01004250|1932499|FG000|Induction Therapy Period|Physician Decision|2
942866|NCT01004250|1932499|FG000|Maintenance Therapy Period|Adverse Event|15
942867|NCT01004250|1932499|FG000|Maintenance Therapy Period|Lost to Follow-up|1
942868|NCT01004250|1932499|FG000|Maintenance Therapy Period|Protocol Violation|1
942869|NCT01004250|1932499|FG000|Maintenance Therapy Period|Withdrawal by Subject|5
942870|NCT01004250|1932499|FG000|Maintenance Therapy Period|Physician Decision|4
942871|NCT01004250|1932499|FG000|Follow-Up (FU) Period|Lost to Follow-up|1
942872|NCT01004263|1932507|FG000|Overall Study|Adverse Event|15
942873|NCT01004263|1932507|FG000|Overall Study|Withdrawal by Subject|58
942874|NCT01004263|1932507|FG000|Overall Study|Protocol Violation|10
942875|NCT01004263|1932507|FG000|Overall Study|Lost to Follow-up|64
942876|NCT01004263|1932507|FG000|Overall Study|Lack of Efficacy|13
942877|NCT01004263|1932507|FG000|Overall Study|Pregnancy|2
942878|NCT01004263|1932507|FG000|Overall Study|Physician Decision|15
942879|NCT01004263|1932507|FG000|Overall Study|Lack of Qualifying Event|2
942880|NCT01004406|1932521|FG000|Overall Study|Withdrawal by Subject|2
942881|NCT01004406|1932522|FG001|Overall Study|Withdrawal by Subject|0
942882|NCT01004406|1932521|FG000|Overall Study|Lost to Follow-up|1
942883|NCT01004406|1932522|FG001|Overall Study|Lost to Follow-up|0
942884|NCT01004432|1932528|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20
942885|NCT01004432|1932529|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
942886|NCT01004432|1932530|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
942887|NCT01004432|1932531|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
942888|NCT01004432|1932532|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
942889|NCT01004432|1932528|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29
942890|NCT01004432|1932529|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
942891|NCT01004432|1932530|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
942892|NCT01004432|1932531|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
942893|NCT01004432|1932532|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
942894|NCT01004432|1932528|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17
942895|NCT01004432|1932529|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
942896|NCT01004432|1932530|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
942897|NCT01004432|1932531|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
942898|NCT01004432|1932532|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
942899|NCT01004432|1932528|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15
942900|NCT01004432|1932529|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
942901|NCT01004432|1932530|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
942902|NCT01004432|1932531|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
942903|NCT01004432|1932532|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
942904|NCT01004432|1932528|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2
942905|NCT01004432|1932529|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
942906|NCT01004432|1932530|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
942907|NCT01004432|1932531|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
942908|NCT01004432|1932532|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
942909|NCT01004432|1932528|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
942910|NCT01004432|1932529|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
942911|NCT01004432|1932530|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
942912|NCT01004432|1932531|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
942913|NCT01004432|1932532|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
942914|NCT01004432|1932528|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
942915|NCT01004432|1932529|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
942916|NCT01004432|1932530|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
942917|NCT01004432|1932531|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
942918|NCT01004432|1932532|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
942919|NCT01004432|1932528|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
942920|NCT01004432|1932529|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
942921|NCT01004432|1932530|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
942922|NCT01004432|1932531|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
942923|NCT01004432|1932532|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
942924|NCT01004432|1932528|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
942925|NCT01004432|1932529|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
942926|NCT01004432|1932530|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
942927|NCT01004432|1932531|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
942928|NCT01004432|1932532|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
942929|NCT01004432|1932528|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
942930|NCT01004432|1932529|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
942931|NCT01004432|1932530|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
942932|NCT01004432|1932531|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
942933|NCT01004432|1932532|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
942934|NCT01004432|1932528|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
942935|NCT01004432|1932529|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
942936|NCT01004432|1932530|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
942937|NCT01004432|1932531|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
942938|NCT01004432|1932532|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
942939|NCT01004432|1932528|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0
942940|NCT01004432|1932529|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0
942941|NCT01004432|1932530|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0
942942|NCT01004432|1932531|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0
942943|NCT01004432|1932532|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2
942944|NCT01004432|1932528|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0
942945|NCT01004432|1932529|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0
942946|NCT01004432|1932530|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0
942947|NCT01004432|1932531|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0
942948|NCT01004432|1932532|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4
942949|NCT01004432|1932528|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
942950|NCT01004432|1932529|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
942951|NCT01004432|1932530|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
942952|NCT01004432|1932531|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
942953|NCT01004432|1932532|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
942954|NCT01004432|1932528|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
942955|NCT01004432|1932529|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
942956|NCT01004432|1932530|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
942957|NCT01004432|1932531|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
942958|NCT01004432|1932532|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
1014866|NCT01535599|2036987|FG001|Overall Study|Other|0
1014867|NCT01535599|2036986|FG000|Overall Study|Stopped medication|0
1014868|NCT01535599|2036987|FG001|Overall Study|Stopped medication|1
1014869|NCT01535599|2036986|FG000|Overall Study|Noncompliance|0
1014870|NCT01535599|2036987|FG001|Overall Study|Noncompliance|1
1014871|NCT01535638|2036993|FG000|Treatment 1 (Single Dose)|Protocol Violation|0
1014872|NCT01535638|2036994|FG001|Treatment 1 (Single Dose)|Protocol Violation|0
1014873|NCT01535638|2036995|FG002|Treatment 1 (Single Dose)|Protocol Violation|0
1014874|NCT01535638|2036996|FG003|Treatment 1 (Single Dose)|Protocol Violation|0
1014875|NCT01535638|2036997|FG004|Treatment 1 (Single Dose)|Protocol Violation|0
1014876|NCT01535638|2036998|FG005|Treatment 1 (Single Dose)|Protocol Violation|1
1014877|NCT01535638|2036993|FG000|Treatment 3 (Single Dose)|Protocol Violation|0
1014878|NCT01535638|2036994|FG001|Treatment 3 (Single Dose)|Protocol Violation|0
1014879|NCT01535638|2036995|FG002|Treatment 3 (Single Dose)|Protocol Violation|0
1014880|NCT01535638|2036996|FG003|Treatment 3 (Single Dose)|Protocol Violation|1
1014881|NCT01535638|2036997|FG004|Treatment 3 (Single Dose)|Protocol Violation|0
1014882|NCT01535638|2036998|FG005|Treatment 3 (Single Dose)|Protocol Violation|0
1014883|NCT01535729|2037015|FG000|Overall Study|Withdrawal by Subject|2
1014884|NCT01535729|2037015|FG000|Overall Study|Disease progression|230
1014885|NCT01535729|2037015|FG000|Overall Study|Discontinued treatment|25
1014886|NCT01535729|2037015|FG000|Overall Study|Lost to Follow-up|8
1014887|NCT01535729|2037015|FG000|Overall Study|Death|52
1014888|NCT01535729|2037015|FG000|Overall Study|Other|19
1014889|NCT01535729|2037015|FG000|Overall Study|Did not sign informed consent|1
1014890|NCT01535729|2037015|FG000|Overall Study|No previous chemotherapy|33
1014891|NCT01535729|2037015|FG000|Overall Study|NSCLC grade IV histology not confirmed|20
1014892|NCT01535729|2037015|FG000|Overall Study|Protocol Violation|11
1014893|NCT01535729|2037015|FG000|Overall Study|Screening failure|1
1014894|NCT01535729|2037015|FG000|Overall Study|Not treated|9
1014895|NCT01535729|2037015|FG000|Overall Study|No participant record available|5
1014900|NCT01536067|2037072|FG000|Overall Study|Disease Progression|1
1014901|NCT01536093|2037078|FG000|Overall Study|Death|1
1014902|NCT01536093|2037079|FG001|Overall Study|Death|2
1014903|NCT01536093|2037078|FG000|Overall Study|absence of maternal colostrum|2
1014904|NCT01536093|2037079|FG001|Overall Study|absence of maternal colostrum|0
1014905|NCT01536093|2037078|FG000|Overall Study|Withdrawal by Subject|0
1014906|NCT01536093|2037079|FG001|Overall Study|Withdrawal by Subject|1
1014907|NCT01536119|2037087|FG000|Overall Study|Lost to Follow-up|17
1014908|NCT01536119|2037088|FG001|Overall Study|Lost to Follow-up|14
1014909|NCT01536145|2037094|FG000|Overall Study|Progressive disease|3
1014910|NCT01536145|2037095|FG001|Overall Study|Progressive disease|4
1014911|NCT01536145|2037096|FG002|Overall Study|Progressive disease|1
1014912|NCT01536145|2037097|FG003|Overall Study|Progressive disease|2
1014913|NCT01536145|2037098|FG004|Overall Study|Progressive disease|1
1014914|NCT01536145|2037099|FG005|Overall Study|Progressive disease|2
1014915|NCT01536145|2037100|FG006|Overall Study|Progressive disease|1
1014916|NCT01536145|2037101|FG007|Overall Study|Progressive disease|2
1014917|NCT01536145|2037102|FG008|Overall Study|Progressive disease|1
1014918|NCT01536145|2037103|FG009|Overall Study|Progressive disease|3
1014919|NCT01536145|2037104|FG010|Overall Study|Progressive disease|3
1014920|NCT01536145|2037094|FG000|Overall Study|Withdrawal by Subject|0
1014921|NCT01536145|2037095|FG001|Overall Study|Withdrawal by Subject|0
1014922|NCT01536145|2037096|FG002|Overall Study|Withdrawal by Subject|1
1014923|NCT01536145|2037097|FG003|Overall Study|Withdrawal by Subject|0
1014924|NCT01536145|2037098|FG004|Overall Study|Withdrawal by Subject|0
1014925|NCT01536145|2037099|FG005|Overall Study|Withdrawal by Subject|1
1014926|NCT01536145|2037100|FG006|Overall Study|Withdrawal by Subject|0
1014927|NCT01536145|2037101|FG007|Overall Study|Withdrawal by Subject|0
1014928|NCT01536145|2037102|FG008|Overall Study|Withdrawal by Subject|2
1014929|NCT01536145|2037103|FG009|Overall Study|Withdrawal by Subject|0
1014930|NCT01536145|2037104|FG010|Overall Study|Withdrawal by Subject|2
1014931|NCT01536145|2037094|FG000|Overall Study|Other|0
1014932|NCT01536145|2037095|FG001|Overall Study|Other|0
1014933|NCT01536145|2037096|FG002|Overall Study|Other|0
1014934|NCT01536145|2037097|FG003|Overall Study|Other|0
1014935|NCT01536145|2037098|FG004|Overall Study|Other|1
1014936|NCT01536145|2037099|FG005|Overall Study|Other|0
1014937|NCT01536145|2037100|FG006|Overall Study|Other|0
1014938|NCT01536145|2037101|FG007|Overall Study|Other|0
1014939|NCT01536145|2037102|FG008|Overall Study|Other|0
1014940|NCT01536145|2037103|FG009|Overall Study|Other|3
1014941|NCT01536145|2037104|FG010|Overall Study|Other|2
1014942|NCT01536145|2037094|FG000|Overall Study|Death|0
1014943|NCT01536145|2037095|FG001|Overall Study|Death|0
1014944|NCT01536145|2037096|FG002|Overall Study|Death|0
1014945|NCT01536145|2037097|FG003|Overall Study|Death|0
1014946|NCT01536145|2037098|FG004|Overall Study|Death|0
1014947|NCT01536145|2037099|FG005|Overall Study|Death|0
1014948|NCT01536145|2037100|FG006|Overall Study|Death|1
1014949|NCT01536145|2037101|FG007|Overall Study|Death|0
1014950|NCT01536145|2037102|FG008|Overall Study|Death|0
1014951|NCT01536145|2037103|FG009|Overall Study|Death|0
1014952|NCT01536145|2037104|FG010|Overall Study|Death|0
1014953|NCT01536145|2037094|FG000|Overall Study|Adverse Event|0
1014954|NCT01536145|2037095|FG001|Overall Study|Adverse Event|0
1014955|NCT01536145|2037096|FG002|Overall Study|Adverse Event|0
1014956|NCT01536145|2037097|FG003|Overall Study|Adverse Event|0
1014957|NCT01536145|2037098|FG004|Overall Study|Adverse Event|0
1014958|NCT01536145|2037099|FG005|Overall Study|Adverse Event|0
1014959|NCT01536145|2037100|FG006|Overall Study|Adverse Event|0
1014960|NCT01536145|2037101|FG007|Overall Study|Adverse Event|2
1014961|NCT01536145|2037102|FG008|Overall Study|Adverse Event|0
1014962|NCT01536145|2037103|FG009|Overall Study|Adverse Event|0
1014963|NCT01536145|2037104|FG010|Overall Study|Adverse Event|3
1014964|NCT01536171|2037135|FG000|Overall Study|Withdrawal by Subject|1
1014965|NCT01536262|2037161|FG000|Overall Study|Adverse Event|6
1014966|NCT01536262|2037162|FG001|Overall Study|Adverse Event|1
1014967|NCT01536262|2037163|FG002|Overall Study|Adverse Event|2
1014968|NCT01536262|2037161|FG000|Overall Study|Withdrawal by Subject|1
1014969|NCT01536262|2037162|FG001|Overall Study|Withdrawal by Subject|1
1014970|NCT01536262|2037163|FG002|Overall Study|Withdrawal by Subject|0
1014971|NCT01536262|2037161|FG000|Overall Study|Other than stated above|1
1014972|NCT01536262|2037162|FG001|Overall Study|Other than stated above|0
1014973|NCT01536262|2037163|FG002|Overall Study|Other than stated above|0
1014974|NCT01536379|2037183|FG000|Overall Study|Adverse Event|1
1014975|NCT01536379|2037184|FG001|Overall Study|Adverse Event|2
1014976|NCT01536379|2037183|FG000|Overall Study|Withdrawal by Subject|1
1014977|NCT01536379|2037184|FG001|Overall Study|Withdrawal by Subject|1
1014978|NCT01536392|2037192|FG000|Overall Study|Adverse Event|2
1014979|NCT01536392|2037193|FG001|Overall Study|Adverse Event|2
1014980|NCT01536392|2037192|FG000|Overall Study|Physician Decision|2
1014981|NCT01536392|2037193|FG001|Overall Study|Physician Decision|3
1014982|NCT01536392|2037192|FG000|Overall Study|Withdrawal by Subject|3
1014983|NCT01536392|2037193|FG001|Overall Study|Withdrawal by Subject|6
1014984|NCT01536392|2037192|FG000|Overall Study|Non Compliance|3
1014985|NCT01536392|2037193|FG001|Overall Study|Non Compliance|4
1014986|NCT01536392|2037192|FG000|Overall Study|Completed therapy early|3
1014987|NCT01536392|2037193|FG001|Overall Study|Completed therapy early|0
1014988|NCT01536405|2037201|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
1014989|NCT01536405|2037202|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
1014990|NCT01536405|2037201|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
1014991|NCT01536405|2037202|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
1014992|NCT01536405|2037201|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
1014993|NCT01536405|2037202|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
1014994|NCT01536405|2037201|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
1014995|NCT01536405|2037202|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
1014996|NCT01536405|2037201|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
1014997|NCT01536405|2037202|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
1014998|NCT01536405|2037201|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
1014999|NCT01536405|2037202|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
1015000|NCT01536405|2037201|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
1015001|NCT01536405|2037202|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
1015002|NCT01536405|2037201|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
1015003|NCT01536405|2037202|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
1015004|NCT01536405|2037201|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
1015005|NCT01536405|2037202|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
1015006|NCT01536405|2037201|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
1015007|NCT01536405|2037202|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
1015008|NCT01536405|2037201|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
1015009|NCT01536405|2037202|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
1015010|NCT01536405|2037201|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0
1015011|NCT01536405|2037202|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1
1015012|NCT01536405|2037201|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
1015013|NCT01536405|2037202|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
1015014|NCT01536418|2037210|FG000|Overall Study|Protocol Violation|2
1015015|NCT01536418|2037211|FG001|Overall Study|Protocol Violation|3
1015016|NCT01536418|2037210|FG000|Overall Study|Physician Decision|1
1015017|NCT01536418|2037211|FG001|Overall Study|Physician Decision|3
1015018|NCT01536418|2037210|FG000|Overall Study|Study closed/terminated|41
1015019|NCT01536418|2037211|FG001|Overall Study|Study closed/terminated|37
1015020|NCT01536418|2037210|FG000|Overall Study|Lack of Efficacy|10
1015021|NCT01536418|2037211|FG001|Overall Study|Lack of Efficacy|16
1015022|NCT01536418|2037210|FG000|Overall Study|Adverse Event|9
1015023|NCT01536418|2037211|FG001|Overall Study|Adverse Event|4
1015024|NCT01536418|2037210|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1
1015025|NCT01536418|2037211|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0
1015026|NCT01536418|2037210|FG000|Overall Study|Withdrawal by Subject|5
1015027|NCT01536418|2037211|FG001|Overall Study|Withdrawal by Subject|3
1015028|NCT01536535|2037231|FG000|Overall Study|Withdrawal by Subject|10
1015029|NCT01536535|2037232|FG001|Overall Study|Withdrawal by Subject|5
1015030|NCT01536535|2037231|FG000|Overall Study|Lost to Follow-up|4
1015031|NCT01536535|2037232|FG001|Overall Study|Lost to Follow-up|6
1015032|NCT01536535|2037231|FG000|Overall Study|Physician Decision|1
1015033|NCT01536535|2037232|FG001|Overall Study|Physician Decision|1
1015034|NCT01536535|2037231|FG000|Overall Study|Participant moved|0
1015035|NCT01536535|2037232|FG001|Overall Study|Participant moved|1
1015036|NCT01536561|2037239|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40
1015037|NCT01536561|2037239|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
1015038|NCT01536561|2037239|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
1015039|NCT01536561|2037239|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
1015040|NCT01536561|2037239|FG000|Dosimetric and Therapeutic Treatment|Death|2
1015041|NCT01536561|2037239|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
1015042|NCT01536574|2037248|FG000|Overall Study|Adverse Event|4
1015043|NCT01536574|2037249|FG001|Overall Study|Adverse Event|5
1015044|NCT01536574|2037248|FG000|Overall Study|Withdrawal by Subject|1
1015045|NCT01536574|2037249|FG001|Overall Study|Withdrawal by Subject|2
1015046|NCT01536574|2037248|FG000|Overall Study|Lack of Efficacy|1
1015047|NCT01536574|2037249|FG001|Overall Study|Lack of Efficacy|0
1015048|NCT01536587|2037255|FG000|Overall Study|Adverse Event|2
1015049|NCT01536704|2037259|FG000|Washout Period 1|Withdrawal by Subject|1
1015050|NCT01536704|2037260|FG001|Washout Period 1|Withdrawal by Subject|2
1015051|NCT01536704|2037261|FG002|Washout Period 1|Withdrawal by Subject|0
1015052|NCT01536704|2037262|FG003|Washout Period 1|Withdrawal by Subject|0
1015053|NCT01536704|2037259|FG000|Washout Period 2|Adverse Event|1
1015054|NCT01536704|2037260|FG001|Washout Period 2|Adverse Event|0
1015055|NCT01536704|2037261|FG002|Washout Period 2|Adverse Event|0
1015056|NCT01536704|2037262|FG003|Washout Period 2|Adverse Event|0
1015057|NCT01536704|2037259|FG000|Washout Period 2|Withdrawal by Subject|0
1015058|NCT01536704|2037260|FG001|Washout Period 2|Withdrawal by Subject|0
1015059|NCT01536704|2037261|FG002|Washout Period 2|Withdrawal by Subject|0
1015060|NCT01536704|2037262|FG003|Washout Period 2|Withdrawal by Subject|1
1015061|NCT01536704|2037259|FG000|Period 3|Adverse Event|0
1015062|NCT01536704|2037260|FG001|Period 3|Adverse Event|0
1015063|NCT01536704|2037261|FG002|Period 3|Adverse Event|0
1015064|NCT01536704|2037262|FG003|Period 3|Adverse Event|1
1015065|NCT01536704|2037259|FG000|Washout Period 3|Adverse Event|0
1015066|NCT01536704|2037260|FG001|Washout Period 3|Adverse Event|0
1015067|NCT01536704|2037261|FG002|Washout Period 3|Adverse Event|1
1015068|NCT01536704|2037262|FG003|Washout Period 3|Adverse Event|0
1015069|NCT01536795|2037278|FG000|Overall Study|Lost to Follow-up|0
1015070|NCT01536795|2037279|FG001|Overall Study|Lost to Follow-up|2
1015071|NCT01536795|2037278|FG000|Overall Study|Lack of Efficacy|1
1015072|NCT01536795|2037279|FG001|Overall Study|Lack of Efficacy|0
1015073|NCT01536860|2037285|FG000|Washout Period (3 Days)|Lost to Follow-up|1
1015074|NCT01536860|2037286|FG001|Washout Period (3 Days)|Lost to Follow-up|0
1015075|NCT01536860|2037287|FG002|Washout Period (3 Days)|Lost to Follow-up|0
1015076|NCT01536951|2037327|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0
1015077|NCT01536951|2037328|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0
1015078|NCT01536951|2037329|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1
1015079|NCT01536951|2037330|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0
1015080|NCT01536951|2037331|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0
1015081|NCT01536951|2037332|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0
1015082|NCT01536951|2037333|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0
1015083|NCT01536951|2037334|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0
1015084|NCT01536951|2037335|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0
1015085|NCT01536951|2037327|FG000|Second Intervention and Washout Period 2|Adverse Event|0
1015086|NCT01536951|2037328|FG001|Second Intervention and Washout Period 2|Adverse Event|0
1015087|NCT01536951|2037329|FG002|Second Intervention and Washout Period 2|Adverse Event|0
1015088|NCT01536951|2037330|FG003|Second Intervention and Washout Period 2|Adverse Event|0
1015089|NCT01536951|2037331|FG004|Second Intervention and Washout Period 2|Adverse Event|0
1015090|NCT01536951|2037332|FG005|Second Intervention and Washout Period 2|Adverse Event|0
1015091|NCT01536951|2037333|FG006|Second Intervention and Washout Period 2|Adverse Event|0
1015092|NCT01536951|2037334|FG007|Second Intervention and Washout Period 2|Adverse Event|1
1015093|NCT01536951|2037335|FG008|Second Intervention and Washout Period 2|Adverse Event|0
1015094|NCT01537042|2037364|FG000|Overall Study|Adverse Event|0
1015095|NCT01537042|2037365|FG001|Overall Study|Adverse Event|2
1015096|NCT01537042|2037364|FG000|Overall Study|Lack of Efficacy|0
1015097|NCT01537042|2037365|FG001|Overall Study|Lack of Efficacy|1
1015098|NCT01537042|2037364|FG000|Overall Study|Protocol Violation|0
1015099|NCT01537042|2037365|FG001|Overall Study|Protocol Violation|1
1015100|NCT01537042|2037364|FG000|Overall Study|Other|0
1015101|NCT01537042|2037365|FG001|Overall Study|Other|1
1015102|NCT01537068|2037377|FG000|Overall Study|Lost to Follow-up|2
1015103|NCT01537068|2037378|FG001|Overall Study|Lost to Follow-up|1
1015104|NCT01537068|2037377|FG000|Overall Study|Adverse Event|0
1015105|NCT01537068|2037378|FG001|Overall Study|Adverse Event|1
1015106|NCT01537068|2037377|FG000|Overall Study|Withdrawal by Subject|1
1015107|NCT01537068|2037378|FG001|Overall Study|Withdrawal by Subject|1
1015108|NCT01537068|2037377|FG000|Overall Study|Lack of Efficacy|1
1015109|NCT01537068|2037378|FG001|Overall Study|Lack of Efficacy|0
1015110|NCT01537081|2037387|FG000|Overall Study|Adverse Event|5
1015111|NCT01537081|2037388|FG001|Overall Study|Adverse Event|2
1015112|NCT01537081|2037389|FG002|Overall Study|Adverse Event|2
1015113|NCT01537081|2037387|FG000|Overall Study|Lack of Efficacy|2
1015114|NCT01537081|2037388|FG001|Overall Study|Lack of Efficacy|1
1015115|NCT01537081|2037389|FG002|Overall Study|Lack of Efficacy|0
1015116|NCT01537081|2037387|FG000|Overall Study|Lost to Follow-up|17
1015117|NCT01537081|2037388|FG001|Overall Study|Lost to Follow-up|15
1015118|NCT01537081|2037389|FG002|Overall Study|Lost to Follow-up|9
1015119|NCT01537081|2037387|FG000|Overall Study|Protocol Violation|3
1015120|NCT01537081|2037388|FG001|Overall Study|Protocol Violation|2
1015121|NCT01537081|2037389|FG002|Overall Study|Protocol Violation|2
1015122|NCT01537081|2037387|FG000|Overall Study|Withdrawal by Subject|6
1015123|NCT01537081|2037388|FG001|Overall Study|Withdrawal by Subject|11
1015124|NCT01537081|2037389|FG002|Overall Study|Withdrawal by Subject|3
1015125|NCT01537081|2037387|FG000|Overall Study|Physician Decision|5
1015126|NCT01537081|2037388|FG001|Overall Study|Physician Decision|6
1015127|NCT01537081|2037389|FG002|Overall Study|Physician Decision|0
1015128|NCT01537081|2037387|FG000|Overall Study|Sponsor decision|0
1015129|NCT01537081|2037388|FG001|Overall Study|Sponsor decision|1
1015130|NCT01537081|2037389|FG002|Overall Study|Sponsor decision|0
1015131|NCT01537081|2037387|FG000|Overall Study|Assigned but never dosed|1
1015132|NCT01537081|2037388|FG001|Overall Study|Assigned but never dosed|0
1015133|NCT01537081|2037389|FG002|Overall Study|Assigned but never dosed|0
1015134|NCT01537120|2037398|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1
1015135|NCT01537120|2037398|FG000|3 Weeks Placebo|Withdrawal by Subject|1
1015136|NCT01537133|2037408|FG000|Overall Study|Withdrawal by Subject|2
1015137|NCT01537133|2037409|FG001|Overall Study|Withdrawal by Subject|0
1015138|NCT01537133|2037410|FG002|Overall Study|Withdrawal by Subject|0
1015139|NCT01537133|2037411|FG003|Overall Study|Withdrawal by Subject|0
1015140|NCT01537133|2037408|FG000|Overall Study|Lost to Follow-up|1
1015141|NCT01537133|2037409|FG001|Overall Study|Lost to Follow-up|0
1015142|NCT01537133|2037410|FG002|Overall Study|Lost to Follow-up|0
1015143|NCT01537133|2037411|FG003|Overall Study|Lost to Follow-up|0
1015144|NCT01537198|2037438|FG000|Overall Study|RSV infection|2
1015145|NCT01537198|2037438|FG000|Overall Study|Adverse Event|4
1015146|NCT01537198|2037438|FG000|Overall Study|No Further Visits to the Clinic|37
1015147|NCT01537198|2037438|FG000|Overall Study|Other|111
1015148|NCT01537211|2037444|FG000|Overall Study|Lost to Follow-up|0
1015149|NCT01537211|2037445|FG001|Overall Study|Lost to Follow-up|1
1015150|NCT01537393|2037483|FG000|Overall Study|Exclude prior to study|32
1015151|NCT01537393|2037484|FG001|Overall Study|Exclude prior to study|44
1015152|NCT01537393|2037483|FG000|Overall Study|Death|20
1015153|NCT01537393|2037484|FG001|Overall Study|Death|32
1015154|NCT01537393|2037483|FG000|Overall Study|Withdrawal by Subject|18
1015155|NCT01537393|2037484|FG001|Overall Study|Withdrawal by Subject|17
1015156|NCT01537393|2037483|FG000|Overall Study|Lost to Follow-up|53
1015157|NCT01537393|2037484|FG001|Overall Study|Lost to Follow-up|48
1015158|NCT01537393|2037483|FG000|Overall Study|Failure - Regrafted|28
1015159|NCT01537393|2037484|FG001|Overall Study|Failure - Regrafted|43
1015160|NCT01537393|2037483|FG000|Overall Study|Failure - Not regrafted|2
1015161|NCT01537393|2037484|FG001|Overall Study|Failure - Not regrafted|6
1015162|NCT01537393|2037483|FG000|Overall Study|Censored (severe event unrelated to PT)|1
1015163|NCT01537393|2037484|FG001|Overall Study|Censored (severe event unrelated to PT)|1
1015164|NCT01537432|2037501|FG000|Overall Study|Lost to Follow-up|3
1015165|NCT01537432|2037502|FG001|Overall Study|Lost to Follow-up|1
1015166|NCT01537432|2037501|FG000|Overall Study|Withdrawal by Subject|0
1015167|NCT01537432|2037502|FG001|Overall Study|Withdrawal by Subject|1
1015168|NCT01537432|2037501|FG000|Overall Study|Administrative problems|1
1015169|NCT01537432|2037502|FG001|Overall Study|Administrative problems|0
1015170|NCT01537432|2037501|FG000|Overall Study|Adverse Event|1
1015171|NCT01537432|2037502|FG001|Overall Study|Adverse Event|0
1015172|NCT01537432|2037501|FG000|Overall Study|Unsatisfactory therapeutic effect|1
1015173|NCT01537432|2037502|FG001|Overall Study|Unsatisfactory therapeutic effect|0
1015174|NCT01537549|2037508|FG000|Overall Study|Lost to Follow-up|1
1015175|NCT01537549|2037508|FG000|Overall Study|Withdrawal by Subject|2
1015176|NCT01537783|2037543|FG000|Overall Study|Lost to Follow-up|11
1015177|NCT01537783|2037544|FG001|Overall Study|Lost to Follow-up|2
1015178|NCT01537887|2037563|FG000|Period 1|Physician Decision|0
1015179|NCT01537887|2037564|FG001|Period 1|Physician Decision|0
1015180|NCT01537887|2037565|FG002|Period 1|Physician Decision|0
1015181|NCT01537887|2037566|FG003|Period 1|Physician Decision|0
1015182|NCT01537887|2037567|FG004|Period 1|Physician Decision|1
1015183|NCT01537887|2037568|FG005|Period 1|Physician Decision|1
1015184|NCT01537887|2037563|FG000|Period 1|Did not receive treatment|0
1015185|NCT01537887|2037564|FG001|Period 1|Did not receive treatment|0
1015186|NCT01537887|2037565|FG002|Period 1|Did not receive treatment|1
1015187|NCT01537887|2037566|FG003|Period 1|Did not receive treatment|0
1015188|NCT01537887|2037567|FG004|Period 1|Did not receive treatment|0
1015189|NCT01537887|2037568|FG005|Period 1|Did not receive treatment|0
1015190|NCT01537887|2037563|FG000|Period 2|Withdrawal by Subject|0
1015191|NCT01537887|2037564|FG001|Period 2|Withdrawal by Subject|1
1015192|NCT01537887|2037565|FG002|Period 2|Withdrawal by Subject|0
1015193|NCT01537887|2037566|FG003|Period 2|Withdrawal by Subject|0
1015194|NCT01537887|2037567|FG004|Period 2|Withdrawal by Subject|0
1015195|NCT01537887|2037568|FG005|Period 2|Withdrawal by Subject|0
1015196|NCT01537887|2037563|FG000|Period 3|Adverse Event|0
1015197|NCT01537887|2037564|FG001|Period 3|Adverse Event|0
1015198|NCT01537887|2037565|FG002|Period 3|Adverse Event|1
1015199|NCT01537887|2037566|FG003|Period 3|Adverse Event|0
1015200|NCT01537887|2037567|FG004|Period 3|Adverse Event|0
1015201|NCT01537887|2037568|FG005|Period 3|Adverse Event|0
1015202|NCT01537887|2037563|FG000|Period 3|Withdrawal by Subject|0
1015203|NCT01537887|2037564|FG001|Period 3|Withdrawal by Subject|1
1015204|NCT01537887|2037565|FG002|Period 3|Withdrawal by Subject|0
1015205|NCT01537887|2037566|FG003|Period 3|Withdrawal by Subject|0
1015206|NCT01537887|2037567|FG004|Period 3|Withdrawal by Subject|0
1015207|NCT01537887|2037568|FG005|Period 3|Withdrawal by Subject|0
1015208|NCT01538199|2037596|FG000|Overall Study|Lost to Follow-up|1
1015209|NCT01538199|2037597|FG001|Overall Study|Lost to Follow-up|2
1015210|NCT01538199|2037598|FG002|Overall Study|Lost to Follow-up|1
1015211|NCT01538199|2037599|FG003|Overall Study|Lost to Follow-up|0
1015212|NCT01538199|2037596|FG000|Overall Study|participant did not have time|1
1015213|NCT01538199|2037597|FG001|Overall Study|participant did not have time|0
1015214|NCT01538199|2037598|FG002|Overall Study|participant did not have time|0
1015215|NCT01538199|2037599|FG003|Overall Study|participant did not have time|2
1015216|NCT01538199|2037596|FG000|Overall Study|Lack of Efficacy|0
1015217|NCT01538199|2037597|FG001|Overall Study|Lack of Efficacy|1
1015218|NCT01538199|2037598|FG002|Overall Study|Lack of Efficacy|0
1015219|NCT01538199|2037599|FG003|Overall Study|Lack of Efficacy|0
1015220|NCT01538472|2037616|FG000|Overall Study|Disease Progression|3
1015221|NCT01538472|2037616|FG000|Overall Study|Death|1
1015222|NCT01538628|2037631|FG000|Overall Study|Withdrawal by Subject|1
1015223|NCT01538628|2037632|FG001|Overall Study|Withdrawal by Subject|1
1015224|NCT01538628|2037631|FG000|Overall Study|Lost to Follow-up|0
1015225|NCT01538628|2037632|FG001|Overall Study|Lost to Follow-up|1
1015226|NCT01538719|2037641|FG000|Overall Study|Lost to Follow-up|2
1015227|NCT01538719|2037642|FG001|Overall Study|Lost to Follow-up|0
1015228|NCT01539083|2037671|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4
1015229|NCT01539083|2037672|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0
1015230|NCT01539083|2037673|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0
1015231|NCT01539083|2037671|FG000|Before Randomization (VCD Induction)|Adverse Event|14
1015232|NCT01539083|2037672|FG001|Before Randomization (VCD Induction)|Adverse Event|0
1015233|NCT01539083|2037673|FG002|Before Randomization (VCD Induction)|Adverse Event|0
1015234|NCT01539083|2037671|FG000|Before Randomization (VCD Induction)|Death|6
1015235|NCT01539083|2037672|FG001|Before Randomization (VCD Induction)|Death|0
1015236|NCT01539083|2037673|FG002|Before Randomization (VCD Induction)|Death|0
1015237|NCT01539083|2037671|FG000|Before Randomization (VCD Induction)|Protocol Violation|2
1015238|NCT01539083|2037672|FG001|Before Randomization (VCD Induction)|Protocol Violation|0
1015239|NCT01539083|2037673|FG002|Before Randomization (VCD Induction)|Protocol Violation|0
1015240|NCT01539083|2037671|FG000|Before Randomization (VCD Induction)|Physician Decision|14
1015241|NCT01539083|2037672|FG001|Before Randomization (VCD Induction)|Physician Decision|0
1015242|NCT01539083|2037673|FG002|Before Randomization (VCD Induction)|Physician Decision|0
1015243|NCT01539083|2037671|FG000|Before Randomization (VCD Induction)|Progressive Disease|8
1015244|NCT01539083|2037672|FG001|Before Randomization (VCD Induction)|Progressive Disease|0
1015245|NCT01539083|2037673|FG002|Before Randomization (VCD Induction)|Progressive Disease|0
1015246|NCT01539083|2037671|FG000|Before Randomization (VCD Induction)|Other|5
1015247|NCT01539083|2037672|FG001|Before Randomization (VCD Induction)|Other|0
1015248|NCT01539083|2037673|FG002|Before Randomization (VCD Induction)|Other|0
1015249|NCT01539083|2037671|FG000|After Randomization (TP and VTP)|Physician Decision|0
1015250|NCT01539083|2037672|FG001|After Randomization (TP and VTP)|Physician Decision|0
1015251|NCT01539083|2037673|FG002|After Randomization (TP and VTP)|Physician Decision|1
1015252|NCT01539083|2037671|FG000|After Randomization (TP and VTP)|Other|0
1015253|NCT01539083|2037672|FG001|After Randomization (TP and VTP)|Other|1
1015254|NCT01539083|2037673|FG002|After Randomization (TP and VTP)|Other|1
1015255|NCT01539083|2037671|FG000|After Randomization (TP and VTP)|Adverse Event|0
1015256|NCT01539083|2037672|FG001|After Randomization (TP and VTP)|Adverse Event|1
1015257|NCT01539083|2037673|FG002|After Randomization (TP and VTP)|Adverse Event|1
1015258|NCT01539083|2037671|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0
1015259|NCT01539083|2037672|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2
1015260|NCT01539083|2037673|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2
1015261|NCT01539083|2037671|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0
1015262|NCT01539083|2037672|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5
1015263|NCT01539083|2037673|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4
1015264|NCT01539083|2037671|FG000|After Randomization (TP and VTP)|Progressive Disease|0
1015265|NCT01539083|2037672|FG001|After Randomization (TP and VTP)|Progressive Disease|6
1015266|NCT01539083|2037673|FG002|After Randomization (TP and VTP)|Progressive Disease|3
1015267|NCT01539083|2037671|FG000|After Randomization (TP and VTP)|Death|0
1015268|NCT01539083|2037672|FG001|After Randomization (TP and VTP)|Death|6
1015269|NCT01539083|2037673|FG002|After Randomization (TP and VTP)|Death|11
1015270|NCT01539239|2037691|FG000|Overall Study|Death|5
1015271|NCT01539239|2037692|FG001|Overall Study|Death|5
1015272|NCT01539239|2037691|FG000|Overall Study|Lost to Follow-up|7
1015273|NCT01539239|2037692|FG001|Overall Study|Lost to Follow-up|12
1015274|NCT01539291|2037701|FG000|Study GS-US-312-0116|Adverse Event|9
1015275|NCT01539291|2037702|FG001|Study GS-US-312-0116|Adverse Event|0
1015276|NCT01539291|2037703|FG002|Study GS-US-312-0116|Adverse Event|0
1015277|NCT01539291|2037704|FG003|Study GS-US-312-0116|Adverse Event|0
1015278|NCT01539291|2037701|FG000|Study GS-US-312-0116|Physician Decision|1
1015279|NCT01539291|2037702|FG001|Study GS-US-312-0116|Physician Decision|0
1015280|NCT01539291|2037703|FG002|Study GS-US-312-0116|Physician Decision|0
1015281|NCT01539291|2037704|FG003|Study GS-US-312-0116|Physician Decision|0
1015282|NCT01539291|2037701|FG000|Study GS-US-312-0116|Withdrawal by Subject|12
1015283|NCT01539291|2037702|FG001|Study GS-US-312-0116|Withdrawal by Subject|0
1015284|NCT01539291|2037703|FG002|Study GS-US-312-0116|Withdrawal by Subject|0
1015285|NCT01539291|2037704|FG003|Study GS-US-312-0116|Withdrawal by Subject|0
1015286|NCT01539291|2037701|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2
1015287|NCT01539291|2037702|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0
1015288|NCT01539291|2037703|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0
1015289|NCT01539291|2037704|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0
1015290|NCT01539291|2037701|FG000|Study GS-US-312-0116|Other|1
1015291|NCT01539291|2037702|FG001|Study GS-US-312-0116|Other|0
1015292|NCT01539291|2037703|FG002|Study GS-US-312-0116|Other|0
1015293|NCT01539291|2037704|FG003|Study GS-US-312-0116|Other|0
1015294|NCT01539291|2037701|FG000|Study GS-US-312-0117|Adverse Event|22
1015295|NCT01539291|2037702|FG001|Study GS-US-312-0117|Adverse Event|1
1015296|NCT01539291|2037703|FG002|Study GS-US-312-0117|Adverse Event|9
1015297|NCT01539291|2037704|FG003|Study GS-US-312-0117|Adverse Event|12
1015298|NCT01539291|2037701|FG000|Study GS-US-312-0117|Physician Decision|9
1015299|NCT01539291|2037702|FG001|Study GS-US-312-0117|Physician Decision|0
1015300|NCT01539291|2037703|FG002|Study GS-US-312-0117|Physician Decision|6
1015301|NCT01539291|2037704|FG003|Study GS-US-312-0117|Physician Decision|4
1015302|NCT01539291|2037701|FG000|Study GS-US-312-0117|Withdrawal by Subject|5
1015303|NCT01539291|2037702|FG001|Study GS-US-312-0117|Withdrawal by Subject|0
1015304|NCT01539291|2037703|FG002|Study GS-US-312-0117|Withdrawal by Subject|6
1015305|NCT01539291|2037704|FG003|Study GS-US-312-0117|Withdrawal by Subject|4
1015306|NCT01539291|2037701|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3
1015307|NCT01539291|2037702|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0
1015308|NCT01539291|2037703|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0
1015309|NCT01539291|2037704|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5
1015310|NCT01539291|2037701|FG000|Study GS-US-312-0117|Other|2
1015311|NCT01539291|2037702|FG001|Study GS-US-312-0117|Other|1
1015312|NCT01539291|2037703|FG002|Study GS-US-312-0117|Other|1
1015313|NCT01539291|2037704|FG003|Study GS-US-312-0117|Other|1
1015314|NCT01539317|2037723|FG000|Overall Study|Screening Error. Deleted from analysis.|1
1015315|NCT01539317|2037724|FG001|Overall Study|Screening Error. Deleted from analysis.|0
1015316|NCT01539512|2037735|FG000|Overall Study|Adverse Event|9
1015317|NCT01539512|2037736|FG001|Overall Study|Adverse Event|7
1015318|NCT01539512|2037735|FG000|Overall Study|Physician Decision|1
1015319|NCT01539512|2037736|FG001|Overall Study|Physician Decision|1
1015320|NCT01539512|2037735|FG000|Overall Study|Withdrawal by Subject|12
1015321|NCT01539512|2037736|FG001|Overall Study|Withdrawal by Subject|5
1015322|NCT01539512|2037735|FG000|Overall Study|Richter's Transformation|1
1015323|NCT01539512|2037736|FG001|Overall Study|Richter's Transformation|0
1015324|NCT01539525|2037745|FG000|Overall Study|Lost to Follow-up|19
1015325|NCT01539525|2037746|FG001|Overall Study|Lost to Follow-up|12
1015326|NCT01539525|2037747|FG002|Overall Study|Lost to Follow-up|11
1015327|NCT01539525|2037745|FG000|Overall Study|Withdrawal by Subject|0
1015328|NCT01539525|2037746|FG001|Overall Study|Withdrawal by Subject|3
1015329|NCT01539525|2037747|FG002|Overall Study|Withdrawal by Subject|2
1015330|NCT01539525|2037745|FG000|Overall Study|Protocol Violation|1
1015331|NCT01539525|2037746|FG001|Overall Study|Protocol Violation|1
1015332|NCT01539525|2037747|FG002|Overall Study|Protocol Violation|4
1015333|NCT01539538|2037760|FG000|Overall Study|Adverse Event|13
1015334|NCT01539538|2037761|FG001|Overall Study|Adverse Event|18
1015335|NCT01539538|2037760|FG000|Overall Study|Lack of Efficacy|13
1015336|NCT01539538|2037761|FG001|Overall Study|Lack of Efficacy|16
1015337|NCT01539538|2037760|FG000|Overall Study|Withdrawal by Subject|2
1015338|NCT01539538|2037761|FG001|Overall Study|Withdrawal by Subject|3
1015339|NCT01539538|2037760|FG000|Overall Study|PCA no longer required or PCA problem|3
1015340|NCT01539538|2037761|FG001|Overall Study|PCA no longer required or PCA problem|7
1015341|NCT01539642|2037769|FG000|Overall Study|Lack of Efficacy|20
1015342|NCT01539642|2037770|FG001|Overall Study|Lack of Efficacy|18
1015343|NCT01539642|2037769|FG000|Overall Study|Patient ready for early discharge|8
1015344|NCT01539642|2037770|FG001|Overall Study|Patient ready for early discharge|7
1015345|NCT01539642|2037769|FG000|Overall Study|Adverse Event|6
1015346|NCT01539642|2037770|FG001|Overall Study|Adverse Event|4
1015347|NCT01539642|2037769|FG000|Overall Study|Withdrawal by Subject|2
1015348|NCT01539642|2037770|FG001|Overall Study|Withdrawal by Subject|2
1015349|NCT01539759|2037785|FG000|Overall Study|Lost to Follow-up|6
1015350|NCT01539759|2037786|FG001|Overall Study|Lost to Follow-up|8
1015351|NCT01539837|2037795|FG000|Overall Study|reduce neutrophil level|0
1015352|NCT01539837|2037796|FG001|Overall Study|reduce neutrophil level|1
1015353|NCT01539837|2037797|FG002|Overall Study|reduce neutrophil level|1
1015354|NCT01539837|2037795|FG000|Overall Study|bad compliance|0
1015355|NCT01539837|2037796|FG001|Overall Study|bad compliance|0
1015356|NCT01539837|2037797|FG002|Overall Study|bad compliance|1
1015357|NCT01539863|2037807|FG000|Overall Study|Lost to Follow-up|5
1015358|NCT01539863|2037808|FG001|Overall Study|Lost to Follow-up|4
1015359|NCT01540474|2037902|FG000|Vaccination Period|Lost to Follow-up|0
1015360|NCT01540474|2037903|FG001|Vaccination Period|Lost to Follow-up|1
1015361|NCT01540474|2037904|FG002|Vaccination Period|Lost to Follow-up|0
1015362|NCT01540474|2037905|FG003|Vaccination Period|Lost to Follow-up|0
1015363|NCT01540487|2037918|FG000|Overall Study|Protocol Violation|1
1015364|NCT01540487|2037919|FG001|Overall Study|Protocol Violation|0
1015365|NCT01540565|2037933|FG000|Overall Study|Ineligible|2
1015366|NCT01540838|2038003|FG000|Overall Study|Open nasogastric tube|9
1015367|NCT01540838|2038004|FG001|Overall Study|Open nasogastric tube|7
1015368|NCT01540838|2038003|FG000|Overall Study|Treatment doses missing|8
1015369|NCT01540838|2038004|FG001|Overall Study|Treatment doses missing|12
1015370|NCT01540838|2038003|FG000|Overall Study|Additional antibiotic treatment|1
1015371|NCT01540838|2038004|FG001|Overall Study|Additional antibiotic treatment|2
1015372|NCT01540838|2038003|FG000|Overall Study|Died before treatment initiation|1
1015373|NCT01540838|2038004|FG001|Overall Study|Died before treatment initiation|1
1015374|NCT01540838|2038003|FG000|Overall Study|Not BM. Other treatment|3
1015375|NCT01540838|2038004|FG001|Overall Study|Not BM. Other treatment|1
1015376|NCT01540851|2038012|FG000|Overall Study|Lost to Follow-up|14
1015377|NCT01540851|2038013|FG001|Overall Study|Lost to Follow-up|15
1015378|NCT01540851|2038012|FG000|Overall Study|Withdrawal by Subject|7
1015379|NCT01540851|2038013|FG001|Overall Study|Withdrawal by Subject|3
1015380|NCT01540981|2038023|FG000|Overall Study|Withdrawal by Subject|1
1015381|NCT01540981|2038024|FG001|Overall Study|Withdrawal by Subject|0
1015382|NCT01541215|2038032|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6
1015383|NCT01541215|2038033|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8
1015384|NCT01541215|2038032|FG000|Treatment Period (52 Weeks)|Non-compliance|4
1015385|NCT01541215|2038033|FG001|Treatment Period (52 Weeks)|Non-compliance|4
1015386|NCT01541215|2038032|FG000|Treatment Period (52 Weeks)|Adverse Event|0
1015387|NCT01541215|2038033|FG001|Treatment Period (52 Weeks)|Adverse Event|1
1015388|NCT01541215|2038032|FG000|Treatment Period (52 Weeks)|Unclassified|0
1015389|NCT01541215|2038033|FG001|Treatment Period (52 Weeks)|Unclassified|3
1015390|NCT01541215|2038032|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1
1015391|NCT01541215|2038033|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0
1015392|NCT01541215|2038032|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1
1015393|NCT01541215|2038033|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0
1015394|NCT01541254|2038043|FG000|Overall Study|Withdrawal by Subject|1
1015395|NCT01541254|2038043|FG000|Overall Study|excluded - metal allergy|1
1015396|NCT01541254|2038043|FG000|Overall Study|enrolled after study closed|1
1015397|NCT01541254|2038043|FG000|Overall Study|GI bleed prior to procedure|1
1015398|NCT01541254|2038043|FG000|Overall Study|stent not required|1
1015399|NCT01541254|2038043|FG000|Overall Study|alternate stent used|1
1015400|NCT01541371|2038052|FG000|Overall Study|Withdrawal by Subject|14
1015401|NCT01541371|2038052|FG000|Overall Study|Lost to Follow-up|21
1015402|NCT01541371|2038052|FG000|Overall Study|Adverse Event|15
1015403|NCT01541371|2038052|FG000|Overall Study|Lack of Efficacy|12
1015404|NCT01541371|2038052|FG000|Overall Study|Protocol Violation|6
1015405|NCT01541371|2038052|FG000|Overall Study|Study medication non-compliance|3
1015406|NCT01541371|2038052|FG000|Overall Study|Other|6
1015407|NCT01541644|2038082|FG000|Overall Study|Withdrawal by Subject|3
1015408|NCT01541748|2038095|FG000|Overall Study|Lost to Follow-up|17
1015409|NCT01541748|2038095|FG000|Overall Study|Moved out of state|1
1015410|NCT01541748|2038095|FG000|Overall Study|Withdrawal by Subject|7
1015411|NCT01541748|2038095|FG000|Overall Study|Screen failure|5
1015412|NCT01541748|2038095|FG000|Overall Study|Did not receive study device|1
1015413|NCT01541826|2038111|FG000|Overall Study|Lost to Follow-up|2
1015414|NCT01541826|2038112|FG001|Overall Study|Lost to Follow-up|3
1015415|NCT01541826|2038113|FG002|Overall Study|Lost to Follow-up|0
1015416|NCT01541826|2038111|FG000|Overall Study|Withdrawal by Subject|2
1015417|NCT01541826|2038112|FG001|Overall Study|Withdrawal by Subject|0
1015418|NCT01541826|2038113|FG002|Overall Study|Withdrawal by Subject|0
1015419|NCT01541865|2038121|FG000|Overall Study|Lost to Follow-up|11
1015420|NCT01541865|2038121|FG000|Overall Study|Withdrawal by Subject|9
1015421|NCT01541865|2038121|FG000|Overall Study|Adverse Event|1
1015422|NCT01541865|2038121|FG000|Overall Study|Protocol Violation|1
1015423|NCT01541917|2038139|FG000|Overall Study|Lost to Follow-up|2
1015424|NCT01541917|2038140|FG001|Overall Study|Lost to Follow-up|2
1015425|NCT01541917|2038139|FG000|Overall Study|Withdrawal by Subject|13
1015426|NCT01541917|2038140|FG001|Overall Study|Withdrawal by Subject|7
1015427|NCT01541930|2038149|FG000|Overall Study|Withdrawal by Subject|1
1015428|NCT01541969|2038166|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
1015429|NCT01541969|2038167|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
1015430|NCT01541969|2038166|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
1015431|NCT01541969|2038167|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
1015432|NCT01541969|2038166|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
1015433|NCT01541969|2038167|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
1015434|NCT01541969|2038166|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1
1015435|NCT01541969|2038167|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0
1015436|NCT01541969|2038166|FG000|Double-blind (0-12 Weeks)|Adverse Event|2
1015437|NCT01541969|2038167|FG001|Double-blind (0-12 Weeks)|Adverse Event|0
1015438|NCT01541969|2038166|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
1015439|NCT01541969|2038167|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
1015440|NCT01541969|2038166|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
1015441|NCT01541969|2038167|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
1015442|NCT01541969|2038166|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
1015443|NCT01541969|2038167|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
1015444|NCT01541969|2038166|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
1015445|NCT01541969|2038167|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
1015446|NCT01541969|2038166|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2
1015447|NCT01541969|2038167|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3
1015448|NCT01542034|2038178|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20
1015449|NCT01542034|2038179|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12
1015450|NCT01542034|2038178|FG000|Overall Study|Administrative decision|0
1015451|NCT01542034|2038179|FG001|Overall Study|Administrative decision|3
1015452|NCT01542034|2038178|FG000|Overall Study|Subject Noncompliance|1
1015453|NCT01542034|2038179|FG001|Overall Study|Subject Noncompliance|0
1015454|NCT01542034|2038178|FG000|Overall Study|Adverse Event|2
1015455|NCT01542034|2038179|FG001|Overall Study|Adverse Event|2
1015456|NCT01542034|2038178|FG000|Overall Study|Lost to Follow-up|7
1015457|NCT01542034|2038179|FG001|Overall Study|Lost to Follow-up|6
1015458|NCT01542528|2038243|FG000|Overall Study|Lost to Follow-up|2
1015459|NCT01542528|2038244|FG001|Overall Study|Lost to Follow-up|1
1015460|NCT01542528|2038243|FG000|Overall Study|Physician Decision|1
1015461|NCT01542528|2038244|FG001|Overall Study|Physician Decision|0
1015462|NCT01542528|2038243|FG000|Overall Study|Withdrawal by Subject|9
1015463|NCT01542528|2038244|FG001|Overall Study|Withdrawal by Subject|6
1015464|NCT01542632|2038265|FG000|Overall Study|Withdrawal of Consent|0
1015465|NCT01542632|2038266|FG001|Overall Study|Withdrawal of Consent|0
1015466|NCT01542632|2038267|FG002|Overall Study|Withdrawal of Consent|0
1015467|NCT01542632|2038268|FG003|Overall Study|Withdrawal of Consent|2
1015468|NCT01542632|2038269|FG004|Overall Study|Withdrawal of Consent|3
1015469|NCT01542632|2038270|FG005|Overall Study|Withdrawal of Consent|0
1015470|NCT01542632|2038265|FG000|Overall Study|Adverse Event|0
1015471|NCT01542632|2038266|FG001|Overall Study|Adverse Event|0
1015472|NCT01542632|2038267|FG002|Overall Study|Adverse Event|1
1015473|NCT01542632|2038268|FG003|Overall Study|Adverse Event|0
1015474|NCT01542632|2038269|FG004|Overall Study|Adverse Event|0
1015475|NCT01542632|2038270|FG005|Overall Study|Adverse Event|0
1015476|NCT01542632|2038265|FG000|Overall Study|Lost to Follow-up|0
1015477|NCT01542632|2038266|FG001|Overall Study|Lost to Follow-up|1
1015478|NCT01542632|2038267|FG002|Overall Study|Lost to Follow-up|0
1015479|NCT01542632|2038268|FG003|Overall Study|Lost to Follow-up|0
1015480|NCT01542632|2038269|FG004|Overall Study|Lost to Follow-up|0
1015481|NCT01542632|2038270|FG005|Overall Study|Lost to Follow-up|0
1015482|NCT01542632|2038265|FG000|Overall Study|Sponsor/Investigator Decision|0
1015483|NCT01542632|2038266|FG001|Overall Study|Sponsor/Investigator Decision|0
1015484|NCT01542632|2038267|FG002|Overall Study|Sponsor/Investigator Decision|0
1015485|NCT01542632|2038268|FG003|Overall Study|Sponsor/Investigator Decision|0
1015486|NCT01542632|2038269|FG004|Overall Study|Sponsor/Investigator Decision|1
1015487|NCT01542632|2038270|FG005|Overall Study|Sponsor/Investigator Decision|0
1015488|NCT01542788|2038308|FG000|Overall Study|Randomized but Not Treated|2
1015489|NCT01542788|2038309|FG001|Overall Study|Randomized but Not Treated|0
1015490|NCT01542788|2038308|FG000|Overall Study|Lack of Efficacy|41
1015491|NCT01542788|2038309|FG001|Overall Study|Lack of Efficacy|71
1015492|NCT01542788|2038308|FG000|Overall Study|Lost to Follow-up|5
1015493|NCT01542788|2038309|FG001|Overall Study|Lost to Follow-up|0
1015494|NCT01542788|2038308|FG000|Overall Study|Death|3
1015495|NCT01542788|2038309|FG001|Overall Study|Death|0
1015496|NCT01542788|2038308|FG000|Overall Study|Protocol Violation|2
1015497|NCT01542788|2038309|FG001|Overall Study|Protocol Violation|0
1015498|NCT01542788|2038308|FG000|Overall Study|Physician Decision|1
1015499|NCT01542788|2038309|FG001|Overall Study|Physician Decision|0
1015500|NCT01542788|2038308|FG000|Overall Study|Withdrawal by Subject|1
1015501|NCT01542788|2038309|FG001|Overall Study|Withdrawal by Subject|0
1015502|NCT01543087|2038351|FG000|Stage 1 (48 Months)|Lost to Follow-up|3
1015503|NCT01543087|2038352|FG001|Stage 1 (48 Months)|Lost to Follow-up|4
1015504|NCT01543087|2038353|FG002|Stage 1 (48 Months)|Lost to Follow-up|12
1015505|NCT01543087|2038354|FG003|Stage 1 (48 Months)|Lost to Follow-up|0
1015506|NCT01543087|2038355|FG004|Stage 1 (48 Months)|Lost to Follow-up|0
1015507|NCT01543087|2038356|FG005|Stage 1 (48 Months)|Lost to Follow-up|0
1015508|NCT01543087|2038351|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1
1015509|NCT01543087|2038352|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0
1015510|NCT01543087|2038353|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1
1015511|NCT01543087|2038354|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2
1015512|NCT01543087|2038355|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0
1015513|NCT01543087|2038356|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0
1015514|NCT01543087|2038351|FG000|Stage 1 (48 Months)|No longer willing to participate|5
1015515|NCT01543087|2038352|FG001|Stage 1 (48 Months)|No longer willing to participate|3
1015516|NCT01543087|2038353|FG002|Stage 1 (48 Months)|No longer willing to participate|18
1015517|NCT01543087|2038354|FG003|Stage 1 (48 Months)|No longer willing to participate|6
1015518|NCT01543087|2038355|FG004|Stage 1 (48 Months)|No longer willing to participate|3
1015519|NCT01543087|2038356|FG005|Stage 1 (48 Months)|No longer willing to participate|0
1015520|NCT01543087|2038351|FG000|Stage 1 (48 Months)|Other than specified|5
1015521|NCT01543087|2038352|FG001|Stage 1 (48 Months)|Other than specified|0
1015522|NCT01543087|2038353|FG002|Stage 1 (48 Months)|Other than specified|9
1015523|NCT01543087|2038354|FG003|Stage 1 (48 Months)|Other than specified|0
1015524|NCT01543087|2038355|FG004|Stage 1 (48 Months)|Other than specified|0
1015525|NCT01543087|2038356|FG005|Stage 1 (48 Months)|Other than specified|0
1015526|NCT01543087|2038351|FG000|Stage 1 (48 Months)|Protocol Violation|0
1015527|NCT01543087|2038352|FG001|Stage 1 (48 Months)|Protocol Violation|3
1015528|NCT01543087|2038353|FG002|Stage 1 (48 Months)|Protocol Violation|0
1015529|NCT01543087|2038354|FG003|Stage 1 (48 Months)|Protocol Violation|0
1015530|NCT01543087|2038355|FG004|Stage 1 (48 Months)|Protocol Violation|0
1015531|NCT01543087|2038356|FG005|Stage 1 (48 Months)|Protocol Violation|0
1015532|NCT01543087|2038351|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
1015533|NCT01543087|2038352|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
1015534|NCT01543087|2038353|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
1015535|NCT01543087|2038354|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
1015536|NCT01543087|2038355|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
1015537|NCT01543087|2038356|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
1015538|NCT01543087|2038351|FG000|Booster Stage (26 Months)|Lost to Follow-up|0
1015539|NCT01543087|2038352|FG001|Booster Stage (26 Months)|Lost to Follow-up|0
1015540|NCT01543087|2038353|FG002|Booster Stage (26 Months)|Lost to Follow-up|1
1015541|NCT01543087|2038354|FG003|Booster Stage (26 Months)|Lost to Follow-up|0
1015542|NCT01543087|2038355|FG004|Booster Stage (26 Months)|Lost to Follow-up|0
1015543|NCT01543087|2038356|FG005|Booster Stage (26 Months)|Lost to Follow-up|0
1015544|NCT01543152|2038397|FG000|Overall Study|Withdrawal by Subject|0
1015545|NCT01543152|2038398|FG001|Overall Study|Withdrawal by Subject|2
1015546|NCT01543152|2038399|FG002|Overall Study|Withdrawal by Subject|0
1015547|NCT01543152|2038400|FG003|Overall Study|Withdrawal by Subject|0
1015548|NCT01543152|2038401|FG004|Overall Study|Withdrawal by Subject|0
1015549|NCT01543204|2038425|FG000|Overall Study|Non-compliance|1
1015550|NCT01543204|2038425|FG000|Overall Study|Adverse Event|1
1015551|NCT01543204|2038425|FG000|Overall Study|Withdrawal by Subject|4
1015552|NCT01543204|2038425|FG000|Overall Study|Requirement for Alternative Therapy|1
1015553|NCT01543204|2038425|FG000|Overall Study|Lost to Follow-up|1
1015554|NCT01543490|2038435|FG000|Overall Study|Adverse Event|4
1015555|NCT01543490|2038436|FG001|Overall Study|Adverse Event|0
1015556|NCT01543490|2038435|FG000|Overall Study|Physician Decision|1
1015557|NCT01543490|2038436|FG001|Overall Study|Physician Decision|0
1015558|NCT01543490|2038435|FG000|Overall Study|Lack of Efficacy|3
1015559|NCT01543490|2038436|FG001|Overall Study|Lack of Efficacy|3
1015560|NCT01543490|2038435|FG000|Overall Study|Lost to Follow-up|5
1015561|NCT01543490|2038436|FG001|Overall Study|Lost to Follow-up|0
1015562|NCT01543490|2038435|FG000|Overall Study|Withdrawal by Subject|2
1015563|NCT01543490|2038436|FG001|Overall Study|Withdrawal by Subject|0
1015564|NCT01543490|2038435|FG000|Overall Study|Other-Various Administrative Reasons|1
1015565|NCT01543490|2038436|FG001|Overall Study|Other-Various Administrative Reasons|2
1015566|NCT01543503|2038444|FG000|Overall Study|Lost to Follow-up|32
1015567|NCT01543503|2038445|FG001|Overall Study|Lost to Follow-up|36
1015568|NCT01543503|2038444|FG000|Overall Study|Adverse Event|9
1015569|NCT01543503|2038445|FG001|Overall Study|Adverse Event|13
1015570|NCT01543503|2038444|FG000|Overall Study|Lack of Efficacy|4
1015571|NCT01543503|2038445|FG001|Overall Study|Lack of Efficacy|16
1015572|NCT01543503|2038444|FG000|Overall Study|Participant withdrew informed consent|8
1015573|NCT01543503|2038445|FG001|Overall Study|Participant withdrew informed consent|10
1015574|NCT01543503|2038444|FG000|Overall Study|Change of jobs|0
1015575|NCT01543503|2038445|FG001|Overall Study|Change of jobs|1
1015576|NCT01543503|2038444|FG000|Overall Study|Intolerance to the biologic treatment|0
1015577|NCT01543503|2038445|FG001|Overall Study|Intolerance to the biologic treatment|1
1015578|NCT01543503|2038444|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1
1015579|NCT01543503|2038445|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0
1015580|NCT01543503|2038444|FG000|Overall Study|Participant did not complete last visit|0
1015581|NCT01543503|2038445|FG001|Overall Study|Participant did not complete last visit|2
1015582|NCT01543503|2038444|FG000|Overall Study|Refused to continue treatment|7
1015583|NCT01543503|2038445|FG001|Overall Study|Refused to continue treatment|0
1015584|NCT01543503|2038444|FG000|Overall Study|Incorrect medication received|1
1015585|NCT01543503|2038445|FG001|Overall Study|Incorrect medication received|0
1015586|NCT01543503|2038444|FG000|Overall Study|Participant moved to another city|2
1015587|NCT01543503|2038445|FG001|Overall Study|Participant moved to another city|0
1015588|NCT01543503|2038444|FG000|Overall Study|Participant will not return for visits|0
1015589|NCT01543503|2038445|FG001|Overall Study|Participant will not return for visits|2
1015590|NCT01543503|2038444|FG000|Overall Study|Participant transferred to another city|1
1015591|NCT01543503|2038445|FG001|Overall Study|Participant transferred to another city|0
1015592|NCT01543503|2038444|FG000|Overall Study|Participant moved to Scotland|1
1015593|NCT01543503|2038445|FG001|Overall Study|Participant moved to Scotland|0
1015594|NCT01543503|2038444|FG000|Overall Study|Participant decision to stop treatment|1
1015595|NCT01543503|2038445|FG001|Overall Study|Participant decision to stop treatment|0
1015596|NCT01543503|2038444|FG000|Overall Study|Investigator did not wish to participate|1
1015597|NCT01543503|2038445|FG001|Overall Study|Investigator did not wish to participate|1
1015598|NCT01543503|2038444|FG000|Overall Study|Participant recruited after closing date|0
1015599|NCT01543503|2038445|FG001|Overall Study|Participant recruited after closing date|1
1015600|NCT01543503|2038444|FG000|Overall Study|Site stopped participation|5
1015601|NCT01543503|2038445|FG001|Overall Study|Site stopped participation|1
1015602|NCT01543503|2038444|FG000|Overall Study|Participant did not attend a visit|1
1015603|NCT01543503|2038445|FG001|Overall Study|Participant did not attend a visit|0
1015604|NCT01543503|2038444|FG000|Overall Study|Moved to other rheumatologic site|0
1015605|NCT01543503|2038445|FG001|Overall Study|Moved to other rheumatologic site|1
1015606|NCT01543503|2038444|FG000|Overall Study|Participant consented to another study|0
1015607|NCT01543503|2038445|FG001|Overall Study|Participant consented to another study|2
1015608|NCT01543503|2038444|FG000|Overall Study|Participant went to United States|1
1015609|NCT01543503|2038445|FG001|Overall Study|Participant went to United States|0
1015610|NCT01543503|2038444|FG000|Overall Study|Screen failure|1
1015611|NCT01543503|2038445|FG001|Overall Study|Screen failure|0
1015612|NCT01543685|2038471|FG000|Overall Study|Lack of Efficacy|1
1015613|NCT01543685|2038472|FG001|Overall Study|Lack of Efficacy|2
1015614|NCT01543685|2038473|FG002|Overall Study|Lack of Efficacy|2
1015615|NCT01543685|2038474|FG003|Overall Study|Lack of Efficacy|0
1015616|NCT01543685|2038475|FG004|Overall Study|Lack of Efficacy|2
1015617|NCT01543685|2038471|FG000|Overall Study|Adverse Event|2
1015618|NCT01543685|2038472|FG001|Overall Study|Adverse Event|1
1015619|NCT01543685|2038473|FG002|Overall Study|Adverse Event|0
1015620|NCT01543685|2038474|FG003|Overall Study|Adverse Event|0
1015621|NCT01543685|2038475|FG004|Overall Study|Adverse Event|2
1015622|NCT01543776|2038489|FG000|Overall Study|Withdrawal by Subject|2
1015623|NCT01543776|2038490|FG001|Overall Study|Withdrawal by Subject|2
1015624|NCT01543828|2038498|FG000|Treatment 2|Lost to Follow-up|1
1015625|NCT01543828|2038499|FG001|Treatment 2|Lost to Follow-up|0
1015626|NCT01543958|2038507|FG000|Overall Study|Loss to follow-up|3
1015627|NCT01543958|2038507|FG000|Overall Study|ART initiation|1
1015628|NCT01544114|2038537|FG000|Overall Study|Withdrawal by Subject|0
1015629|NCT01544114|2038538|FG001|Overall Study|Withdrawal by Subject|0
1015630|NCT01544114|2038539|FG002|Overall Study|Withdrawal by Subject|3
1015631|NCT01544114|2038537|FG000|Overall Study|Lost to Follow-up|0
1015632|NCT01544114|2038538|FG001|Overall Study|Lost to Follow-up|2
1015633|NCT01544114|2038539|FG002|Overall Study|Lost to Follow-up|0
1015634|NCT01544114|2038537|FG000|Overall Study|Adverse Event|1
1015635|NCT01544114|2038538|FG001|Overall Study|Adverse Event|1
1015636|NCT01544114|2038539|FG002|Overall Study|Adverse Event|2
1015637|NCT01544114|2038537|FG000|Overall Study|Protocol Violation|0
1015638|NCT01544114|2038538|FG001|Overall Study|Protocol Violation|1
1015639|NCT01544114|2038539|FG002|Overall Study|Protocol Violation|0
1015640|NCT01544127|2038552|FG000|Overall Study|Lost to Follow-up|4
1015641|NCT01544127|2038553|FG001|Overall Study|Lost to Follow-up|2
1015642|NCT01544127|2038554|FG002|Overall Study|Lost to Follow-up|9
1015643|NCT01544127|2038552|FG000|Overall Study|Withdrawal by Subject|2
1015644|NCT01544127|2038553|FG001|Overall Study|Withdrawal by Subject|2
1015645|NCT01544127|2038554|FG002|Overall Study|Withdrawal by Subject|1
1015646|NCT01544127|2038552|FG000|Overall Study|Discharged out of catchment area|1
1015647|NCT01544127|2038553|FG001|Overall Study|Discharged out of catchment area|1
1015648|NCT01544127|2038554|FG002|Overall Study|Discharged out of catchment area|1
1015649|NCT01544127|2038552|FG000|Overall Study|Death|1
1015650|NCT01544127|2038553|FG001|Overall Study|Death|0
1015651|NCT01544127|2038554|FG002|Overall Study|Death|0
1015652|NCT01544127|2038552|FG000|Overall Study|Jail or Prison|1
1015653|NCT01544127|2038553|FG001|Overall Study|Jail or Prison|1
1015654|NCT01544127|2038554|FG002|Overall Study|Jail or Prison|2
1015655|NCT01544127|2038552|FG000|Overall Study|Became Psychotic|1
1015656|NCT01544127|2038553|FG001|Overall Study|Became Psychotic|0
1015657|NCT01544127|2038554|FG002|Overall Study|Became Psychotic|0
1015658|NCT01544127|2038552|FG000|Overall Study|Researcher withdrew|1
1015659|NCT01544127|2038553|FG001|Overall Study|Researcher withdrew|0
1015660|NCT01544127|2038554|FG002|Overall Study|Researcher withdrew|0
1015661|NCT01544127|2038552|FG000|Overall Study|Went active duty|0
1015662|NCT01544127|2038553|FG001|Overall Study|Went active duty|0
1015663|NCT01544127|2038554|FG002|Overall Study|Went active duty|1
1015664|NCT01544153|2038567|FG000|Overall Study|Under 18|0
1015665|NCT01544153|2038568|FG001|Overall Study|Under 18|1
1015666|NCT01544153|2038569|FG002|Overall Study|Under 18|0
1015667|NCT01544153|2038570|FG003|Overall Study|Under 18|0
1015668|NCT01544153|2038567|FG000|Overall Study|Non-smoker|0
1015669|NCT01544153|2038568|FG001|Overall Study|Non-smoker|0
1015670|NCT01544153|2038569|FG002|Overall Study|Non-smoker|1
1015671|NCT01544153|2038570|FG003|Overall Study|Non-smoker|0
1015672|NCT01544179|2038589|FG000|Overall Study|Death|50
1015673|NCT01544179|2038590|FG001|Overall Study|Death|37
1015674|NCT01544179|2038589|FG000|Overall Study|Lost to Follow-up|0
1015675|NCT01544179|2038590|FG001|Overall Study|Lost to Follow-up|1
1015676|NCT01544179|2038589|FG000|Overall Study|Adverse Event|0
1015677|NCT01544179|2038590|FG001|Overall Study|Adverse Event|1
1015678|NCT01544179|2038589|FG000|Overall Study|Withdrawal by Subject|12
1015679|NCT01544179|2038590|FG001|Overall Study|Withdrawal by Subject|7
1015680|NCT01544179|2038589|FG000|Overall Study|Eligibility criteria not fulfilled|1
1015681|NCT01544179|2038590|FG001|Overall Study|Eligibility criteria not fulfilled|0
1015682|NCT01544309|2038598|FG000|Overall Study|Withdrawal by Subject|12
1015683|NCT01544309|2038599|FG001|Overall Study|Withdrawal by Subject|7
1015684|NCT01544309|2038598|FG000|Overall Study|Protocol Violation|2
1015685|NCT01544309|2038599|FG001|Overall Study|Protocol Violation|1
1015686|NCT01544309|2038598|FG000|Overall Study|Physician Decision|4
1015687|NCT01544309|2038599|FG001|Overall Study|Physician Decision|1
1015688|NCT01544309|2038598|FG000|Overall Study|Not performed pre-dose examination|1
1015689|NCT01544309|2038599|FG001|Overall Study|Not performed pre-dose examination|2
1015690|NCT01544309|2038598|FG000|Overall Study|Administered prohibit prior medication|1
1015691|NCT01544309|2038599|FG001|Overall Study|Administered prohibit prior medication|0
1015692|NCT01544335|2038607|FG000|Overall Study|Lost to Follow-up|27
1015693|NCT01544335|2038607|FG000|Overall Study|Death|4
1015694|NCT01544335|2038607|FG000|Overall Study|Disease progression|3
1015695|NCT01544335|2038607|FG000|Overall Study|Baseline Measurements not Available|19
1015696|NCT01544348|2038619|FG000|Overall Study|Lost to Follow-up|1
1015697|NCT01544348|2038620|FG001|Overall Study|Lost to Follow-up|0
1015698|NCT01544348|2038621|FG002|Overall Study|Lost to Follow-up|0
1015699|NCT01544348|2038622|FG003|Overall Study|Lost to Follow-up|0
1015700|NCT01544348|2038623|FG004|Overall Study|Lost to Follow-up|0
1015701|NCT01544348|2038624|FG005|Overall Study|Lost to Follow-up|0
1015702|NCT01544348|2038625|FG006|Overall Study|Lost to Follow-up|1
1015703|NCT01544348|2038626|FG007|Overall Study|Lost to Follow-up|0
1015704|NCT01544348|2038619|FG000|Overall Study|Withdrawal by Subject|1
1015705|NCT01544348|2038620|FG001|Overall Study|Withdrawal by Subject|0
1015706|NCT01544348|2038621|FG002|Overall Study|Withdrawal by Subject|0
1015707|NCT01544348|2038622|FG003|Overall Study|Withdrawal by Subject|0
1015708|NCT01544348|2038623|FG004|Overall Study|Withdrawal by Subject|1
1015709|NCT01544348|2038624|FG005|Overall Study|Withdrawal by Subject|2
1015710|NCT01544348|2038625|FG006|Overall Study|Withdrawal by Subject|1
1015711|NCT01544348|2038626|FG007|Overall Study|Withdrawal by Subject|0
1015712|NCT01544348|2038619|FG000|Overall Study|Physician Decision|0
1015713|NCT01544348|2038620|FG001|Overall Study|Physician Decision|0
1015714|NCT01544348|2038621|FG002|Overall Study|Physician Decision|0
1015715|NCT01544348|2038622|FG003|Overall Study|Physician Decision|0
1015716|NCT01544348|2038623|FG004|Overall Study|Physician Decision|0
1015717|NCT01544348|2038624|FG005|Overall Study|Physician Decision|1
1015718|NCT01544348|2038625|FG006|Overall Study|Physician Decision|0
1015719|NCT01544348|2038626|FG007|Overall Study|Physician Decision|0
1015720|NCT01544478|2038672|FG000|Overall Study|Adverse Event|1
1015721|NCT01544478|2038672|FG000|Overall Study|Death|1
1015722|NCT01544478|2038672|FG000|Overall Study|Lost to Follow-up|48
1015723|NCT01544478|2038672|FG000|Overall Study|Physician Decision|15
1015724|NCT01544478|2038672|FG000|Overall Study|Pregnancy|1
1015725|NCT01544478|2038672|FG000|Overall Study|Withdrawal by Subject|52
1015726|NCT01544491|2038678|FG000|Overall Study|Withdrawal by Subject|3
1015727|NCT01544491|2038679|FG001|Overall Study|Withdrawal by Subject|2
1015728|NCT01544491|2038678|FG000|Overall Study|Lost to Follow-up|0
1015729|NCT01544491|2038679|FG001|Overall Study|Lost to Follow-up|1
1015730|NCT01544491|2038678|FG000|Overall Study|administrative problems|2
1015731|NCT01544491|2038679|FG001|Overall Study|administrative problems|0
1015732|NCT01544582|2038688|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1
1015733|NCT01544582|2038689|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0
1015734|NCT01544582|2038690|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0
1015735|NCT01544582|2038691|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0
1015736|NCT01544582|2038688|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33
1015737|NCT01544582|2038689|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0
1015738|NCT01544582|2038690|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0
1015739|NCT01544582|2038691|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0
1015740|NCT01544582|2038688|FG000|Analysis Population|Participant Refuses to Continue Study|0
1015741|NCT01544582|2038689|FG001|Analysis Population|Participant Refuses to Continue Study|15
1015742|NCT01544582|2038690|FG002|Analysis Population|Participant Refuses to Continue Study|17
1015743|NCT01544582|2038691|FG003|Analysis Population|Participant Refuses to Continue Study|4
1015744|NCT01544582|2038688|FG000|Analysis Population|Physician Decision|0
1015745|NCT01544582|2038689|FG001|Analysis Population|Physician Decision|13
1015746|NCT01544582|2038690|FG002|Analysis Population|Physician Decision|10
1015747|NCT01544582|2038691|FG003|Analysis Population|Physician Decision|9
1015748|NCT01544582|2038688|FG000|Analysis Population|Safety Reason|0
1015749|NCT01544582|2038689|FG001|Analysis Population|Safety Reason|33
1015750|NCT01544582|2038690|FG002|Analysis Population|Safety Reason|31
1015751|NCT01544582|2038691|FG003|Analysis Population|Safety Reason|8
1015752|NCT01544582|2038688|FG000|Analysis Population|Effectiveness Reason|0
1015753|NCT01544582|2038689|FG001|Analysis Population|Effectiveness Reason|48
1015754|NCT01544582|2038690|FG002|Analysis Population|Effectiveness Reason|29
1015755|NCT01544582|2038691|FG003|Analysis Population|Effectiveness Reason|12
1015756|NCT01544582|2038688|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0
1015757|NCT01544582|2038689|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0
1015758|NCT01544582|2038690|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0
1015759|NCT01544582|2038691|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1
1015760|NCT01544582|2038688|FG000|Analysis Population|Lost to Follow-up|0
1015761|NCT01544582|2038689|FG001|Analysis Population|Lost to Follow-up|6
1015762|NCT01544582|2038690|FG002|Analysis Population|Lost to Follow-up|6
1015763|NCT01544582|2038691|FG003|Analysis Population|Lost to Follow-up|5
1015764|NCT01544582|2038688|FG000|Analysis Population|Bad Tolerance to Treatment|0
1015765|NCT01544582|2038689|FG001|Analysis Population|Bad Tolerance to Treatment|0
1015766|NCT01544582|2038690|FG002|Analysis Population|Bad Tolerance to Treatment|2
1015767|NCT01544582|2038691|FG003|Analysis Population|Bad Tolerance to Treatment|0
1015768|NCT01544582|2038688|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0
1015769|NCT01544582|2038689|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0
1015770|NCT01544582|2038690|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3
1015771|NCT01544582|2038691|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0
1015772|NCT01544582|2038688|FG000|Analysis Population|Intolerance|0
1015773|NCT01544582|2038689|FG001|Analysis Population|Intolerance|1
1015774|NCT01544582|2038690|FG002|Analysis Population|Intolerance|0
1015775|NCT01544582|2038691|FG003|Analysis Population|Intolerance|0
1015776|NCT01544582|2038688|FG000|Analysis Population|Liver Transplantation|0
1015777|NCT01544582|2038689|FG001|Analysis Population|Liver Transplantation|0
1015778|NCT01544582|2038690|FG002|Analysis Population|Liver Transplantation|1
1015779|NCT01544582|2038691|FG003|Analysis Population|Liver Transplantation|0
1015780|NCT01544582|2038688|FG000|Analysis Population|No Social Insurance|0
1015781|NCT01544582|2038689|FG001|Analysis Population|No Social Insurance|0
1015782|NCT01544582|2038690|FG002|Analysis Population|No Social Insurance|1
1015783|NCT01544582|2038691|FG003|Analysis Population|No Social Insurance|0
1015784|NCT01544582|2038688|FG000|Analysis Population|Poor Adherence|0
1015785|NCT01544582|2038689|FG001|Analysis Population|Poor Adherence|0
1015786|NCT01544582|2038690|FG002|Analysis Population|Poor Adherence|1
1015787|NCT01544582|2038691|FG003|Analysis Population|Poor Adherence|0
1015788|NCT01544582|2038688|FG000|Analysis Population|Poor Participant Compliance|0
1015789|NCT01544582|2038689|FG001|Analysis Population|Poor Participant Compliance|1
1015790|NCT01544582|2038690|FG002|Analysis Population|Poor Participant Compliance|0
1015791|NCT01544582|2038691|FG003|Analysis Population|Poor Participant Compliance|0
1015792|NCT01544582|2038688|FG000|Analysis Population|Programmed Surgery|0
1015793|NCT01544582|2038689|FG001|Analysis Population|Programmed Surgery|1
1015794|NCT01544582|2038690|FG002|Analysis Population|Programmed Surgery|0
1015795|NCT01544582|2038691|FG003|Analysis Population|Programmed Surgery|0
1015796|NCT01544582|2038688|FG000|Analysis Population|Participant in Jail|0
1015797|NCT01544582|2038689|FG001|Analysis Population|Participant in Jail|0
1015798|NCT01544582|2038690|FG002|Analysis Population|Participant in Jail|1
1015799|NCT01544582|2038691|FG003|Analysis Population|Participant in Jail|0
1015800|NCT01544595|2038710|FG000|Status at Week 68|Adverse Event|3
1015801|NCT01544595|2038711|FG001|Status at Week 68|Adverse Event|2
1015802|NCT01544595|2038712|FG002|Status at Week 68|Adverse Event|1
1015803|NCT01544595|2038713|FG003|Status at Week 68|Adverse Event|0
1015804|NCT01544595|2038714|FG004|Status at Week 68|Adverse Event|0
1015805|NCT01544595|2038715|FG005|Status at Week 68|Adverse Event|0
1015806|NCT01544595|2038710|FG000|Status at Week 68|Lack of Efficacy|1
1015807|NCT01544595|2038711|FG001|Status at Week 68|Lack of Efficacy|0
1015808|NCT01544595|2038712|FG002|Status at Week 68|Lack of Efficacy|0
1015809|NCT01544595|2038713|FG003|Status at Week 68|Lack of Efficacy|0
1015810|NCT01544595|2038714|FG004|Status at Week 68|Lack of Efficacy|0
1015811|NCT01544595|2038715|FG005|Status at Week 68|Lack of Efficacy|0
1015812|NCT01544595|2038710|FG000|Status at Week 68|Lost to Follow-up|1
1015813|NCT01544595|2038711|FG001|Status at Week 68|Lost to Follow-up|1
1015814|NCT01544595|2038712|FG002|Status at Week 68|Lost to Follow-up|0
1015815|NCT01544595|2038713|FG003|Status at Week 68|Lost to Follow-up|0
1015816|NCT01544595|2038714|FG004|Status at Week 68|Lost to Follow-up|0
1015817|NCT01544595|2038715|FG005|Status at Week 68|Lost to Follow-up|0
1015818|NCT01544595|2038710|FG000|Status at Week 68|Non-compliance with study treatment|1
1015819|NCT01544595|2038711|FG001|Status at Week 68|Non-compliance with study treatment|0
1015820|NCT01544595|2038712|FG002|Status at Week 68|Non-compliance with study treatment|0
1015821|NCT01544595|2038713|FG003|Status at Week 68|Non-compliance with study treatment|1
1015822|NCT01544595|2038714|FG004|Status at Week 68|Non-compliance with study treatment|0
1015823|NCT01544595|2038715|FG005|Status at Week 68|Non-compliance with study treatment|0
1015824|NCT01544595|2038710|FG000|Status at Week 68|Protocol Violation|2
1015825|NCT01544595|2038711|FG001|Status at Week 68|Protocol Violation|0
1015826|NCT01544595|2038712|FG002|Status at Week 68|Protocol Violation|1
1015827|NCT01544595|2038713|FG003|Status at Week 68|Protocol Violation|1
1015828|NCT01544595|2038714|FG004|Status at Week 68|Protocol Violation|0
1015829|NCT01544595|2038715|FG005|Status at Week 68|Protocol Violation|0
1015830|NCT01544595|2038710|FG000|Status at Week 68|Technical problems|1
1015831|NCT01544595|2038711|FG001|Status at Week 68|Technical problems|0
1015832|NCT01544595|2038712|FG002|Status at Week 68|Technical problems|0
1015833|NCT01544595|2038713|FG003|Status at Week 68|Technical problems|1
1015834|NCT01544595|2038714|FG004|Status at Week 68|Technical problems|0
1015835|NCT01544595|2038715|FG005|Status at Week 68|Technical problems|0
1015836|NCT01544595|2038710|FG000|Status at Week 68|Withdrawal by Subject|0
1015837|NCT01544595|2038711|FG001|Status at Week 68|Withdrawal by Subject|1
1015838|NCT01544595|2038712|FG002|Status at Week 68|Withdrawal by Subject|1
1015839|NCT01544595|2038713|FG003|Status at Week 68|Withdrawal by Subject|2
1015840|NCT01544595|2038714|FG004|Status at Week 68|Withdrawal by Subject|0
1015841|NCT01544595|2038715|FG005|Status at Week 68|Withdrawal by Subject|0
1015842|NCT01544595|2038710|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30
1015843|NCT01544595|2038711|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13
1015844|NCT01544595|2038712|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60
1015845|NCT01544595|2038713|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46
1015846|NCT01544595|2038714|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0
1015847|NCT01544595|2038715|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0
1015848|NCT01544595|2038710|FG000|Status at Week 156|Withdrawal by Subject|9
1015849|NCT01544595|2038711|FG001|Status at Week 156|Withdrawal by Subject|10
1015850|NCT01544595|2038712|FG002|Status at Week 156|Withdrawal by Subject|4
1015851|NCT01544595|2038713|FG003|Status at Week 156|Withdrawal by Subject|9
1015852|NCT01544595|2038714|FG004|Status at Week 156|Withdrawal by Subject|20
1015853|NCT01544595|2038715|FG005|Status at Week 156|Withdrawal by Subject|6
1015854|NCT01544595|2038710|FG000|Status at Week 156|Adverse Event|9
1015855|NCT01544595|2038711|FG001|Status at Week 156|Adverse Event|11
1015856|NCT01544595|2038712|FG002|Status at Week 156|Adverse Event|1
1015857|NCT01544595|2038713|FG003|Status at Week 156|Adverse Event|3
1015858|NCT01544595|2038714|FG004|Status at Week 156|Adverse Event|4
1015859|NCT01544595|2038715|FG005|Status at Week 156|Adverse Event|2
1015860|NCT01544595|2038710|FG000|Status at Week 156|Lost to Follow-up|4
1015861|NCT01544595|2038711|FG001|Status at Week 156|Lost to Follow-up|4
1015862|NCT01544595|2038712|FG002|Status at Week 156|Lost to Follow-up|0
1015863|NCT01544595|2038713|FG003|Status at Week 156|Lost to Follow-up|1
1015864|NCT01544595|2038714|FG004|Status at Week 156|Lost to Follow-up|4
1015865|NCT01544595|2038715|FG005|Status at Week 156|Lost to Follow-up|1
1015866|NCT01544595|2038710|FG000|Status at Week 156|Non-compliance with study treatement|0
1015867|NCT01544595|2038711|FG001|Status at Week 156|Non-compliance with study treatement|1
1015868|NCT01544595|2038712|FG002|Status at Week 156|Non-compliance with study treatement|0
1015869|NCT01544595|2038713|FG003|Status at Week 156|Non-compliance with study treatement|1
1015870|NCT01544595|2038714|FG004|Status at Week 156|Non-compliance with study treatement|0
1015871|NCT01544595|2038715|FG005|Status at Week 156|Non-compliance with study treatement|1
1015872|NCT01544595|2038710|FG000|Status at Week 156|Physician Decision|0
1015873|NCT01544595|2038711|FG001|Status at Week 156|Physician Decision|3
1015874|NCT01544595|2038712|FG002|Status at Week 156|Physician Decision|1
1015875|NCT01544595|2038713|FG003|Status at Week 156|Physician Decision|0
1015876|NCT01544595|2038714|FG004|Status at Week 156|Physician Decision|0
1015877|NCT01544595|2038715|FG005|Status at Week 156|Physician Decision|0
1015878|NCT01544595|2038710|FG000|Status at Week 156|Pregnancy|2
1015879|NCT01544595|2038711|FG001|Status at Week 156|Pregnancy|3
1015880|NCT01544595|2038712|FG002|Status at Week 156|Pregnancy|0
1015881|NCT01544595|2038713|FG003|Status at Week 156|Pregnancy|0
1015882|NCT01544595|2038714|FG004|Status at Week 156|Pregnancy|0
1015883|NCT01544595|2038715|FG005|Status at Week 156|Pregnancy|0
1015884|NCT01544595|2038710|FG000|Status at Week 156|Protocol Violation|3
1015885|NCT01544595|2038711|FG001|Status at Week 156|Protocol Violation|1
1015886|NCT01544595|2038712|FG002|Status at Week 156|Protocol Violation|2
1015887|NCT01544595|2038713|FG003|Status at Week 156|Protocol Violation|2
1015888|NCT01544595|2038714|FG004|Status at Week 156|Protocol Violation|0
1015889|NCT01544595|2038715|FG005|Status at Week 156|Protocol Violation|0
1015890|NCT01544595|2038710|FG000|Status at Week 156|Technical problems|3
1015891|NCT01544595|2038711|FG001|Status at Week 156|Technical problems|1
1015892|NCT01544595|2038712|FG002|Status at Week 156|Technical problems|0
1015893|NCT01544595|2038713|FG003|Status at Week 156|Technical problems|1
1015894|NCT01544595|2038714|FG004|Status at Week 156|Technical problems|0
1015895|NCT01544595|2038715|FG005|Status at Week 156|Technical problems|0
1015896|NCT01544595|2038710|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86
1015897|NCT01544595|2038711|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44
1015898|NCT01544595|2038712|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131
1015899|NCT01544595|2038713|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145
1015900|NCT01544595|2038714|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0
1015901|NCT01544595|2038715|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0
1015902|NCT01544595|2038710|FG000|Status at Week 156|Lack of Efficacy|1
1015903|NCT01544595|2038711|FG001|Status at Week 156|Lack of Efficacy|0
1015904|NCT01544595|2038712|FG002|Status at Week 156|Lack of Efficacy|1
1015905|NCT01544595|2038713|FG003|Status at Week 156|Lack of Efficacy|4
1015906|NCT01544595|2038714|FG004|Status at Week 156|Lack of Efficacy|10
1015907|NCT01544595|2038715|FG005|Status at Week 156|Lack of Efficacy|5
1015908|NCT01544920|2038735|FG000|Overall Study|Adverse Event|0
1015909|NCT01544920|2038736|FG001|Overall Study|Adverse Event|3
1015910|NCT01544920|2038735|FG000|Overall Study|Death|0
1015911|NCT01544920|2038736|FG001|Overall Study|Death|1
1015912|NCT01544920|2038735|FG000|Overall Study|Lost to Follow-up|11
1015913|NCT01544920|2038736|FG001|Overall Study|Lost to Follow-up|12
1015914|NCT01544920|2038735|FG000|Overall Study|Protocol Violation|0
1015915|NCT01544920|2038736|FG001|Overall Study|Protocol Violation|2
1015916|NCT01544920|2038735|FG000|Overall Study|Physician Decision|4
1015917|NCT01544920|2038736|FG001|Overall Study|Physician Decision|1
1015918|NCT01544920|2038735|FG000|Overall Study|Withdrawal by Subject|4
1015919|NCT01544920|2038736|FG001|Overall Study|Withdrawal by Subject|4
1015920|NCT01545076|2038753|FG000|IgPro10 Restabilization Period|Adverse Event|4
1015921|NCT01545076|2038754|FG001|IgPro10 Restabilization Period|Adverse Event|0
1015922|NCT01545076|2038755|FG002|IgPro10 Restabilization Period|Adverse Event|0
1015923|NCT01545076|2038756|FG003|IgPro10 Restabilization Period|Adverse Event|0
1015924|NCT01545076|2038757|FG004|IgPro10 Restabilization Period|Adverse Event|0
1015925|NCT01545076|2038753|FG000|IgPro10 Restabilization Period|Physician Decision|2
1015926|NCT01545076|2038754|FG001|IgPro10 Restabilization Period|Physician Decision|0
1015927|NCT01545076|2038755|FG002|IgPro10 Restabilization Period|Physician Decision|0
1015928|NCT01545076|2038756|FG003|IgPro10 Restabilization Period|Physician Decision|0
1015929|NCT01545076|2038757|FG004|IgPro10 Restabilization Period|Physician Decision|0
1015930|NCT01545076|2038753|FG000|IgPro10 Restabilization Period|Protocol Violation|1
1015931|NCT01545076|2038754|FG001|IgPro10 Restabilization Period|Protocol Violation|0
1015932|NCT01545076|2038755|FG002|IgPro10 Restabilization Period|Protocol Violation|0
1015933|NCT01545076|2038756|FG003|IgPro10 Restabilization Period|Protocol Violation|0
1015934|NCT01545076|2038757|FG004|IgPro10 Restabilization Period|Protocol Violation|0
1015935|NCT01545076|2038753|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
1015936|NCT01545076|2038754|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1015937|NCT01545076|2038755|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1015938|NCT01545076|2038756|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1015939|NCT01545076|2038757|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1015940|NCT01545076|2038753|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7
1015941|NCT01545076|2038754|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0
1015942|NCT01545076|2038755|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0
1015943|NCT01545076|2038756|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0
1015944|NCT01545076|2038757|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0
1015945|NCT01545076|2038753|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1015946|NCT01545076|2038754|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1015947|NCT01545076|2038755|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1015948|NCT01545076|2038756|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
1015949|NCT01545076|2038757|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1015950|NCT01545076|2038753|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
1015951|NCT01545076|2038754|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
1015952|NCT01545076|2038755|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
1015953|NCT01545076|2038756|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
1015954|NCT01545076|2038757|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
1015955|NCT01545076|2038753|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1015956|NCT01545076|2038754|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
1015957|NCT01545076|2038755|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
1015958|NCT01545076|2038756|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1015959|NCT01545076|2038757|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1015960|NCT01545076|2038753|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
1015961|NCT01545076|2038754|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
1015962|NCT01545076|2038755|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
1015963|NCT01545076|2038756|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
1015964|NCT01545076|2038757|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
1015965|NCT01545375|2038819|FG000|Overall Study|Adverse Event|2
1015966|NCT01545375|2038820|FG001|Overall Study|Adverse Event|1
1015967|NCT01545375|2038819|FG000|Overall Study|Lost to Follow-up|34
1015968|NCT01545375|2038820|FG001|Overall Study|Lost to Follow-up|31
1015969|NCT01545375|2038819|FG000|Overall Study|Protocol Violation|3
1015970|NCT01545375|2038820|FG001|Overall Study|Protocol Violation|3
1015971|NCT01545375|2038819|FG000|Overall Study|Withdrawal by Subject|58
1015972|NCT01545375|2038820|FG001|Overall Study|Withdrawal by Subject|55
1015973|NCT01545388|2038829|FG000|Overall Study|Adverse Event|2
1015974|NCT01545388|2038830|FG001|Overall Study|Adverse Event|4
1015975|NCT01545388|2038831|FG002|Overall Study|Adverse Event|1
1015976|NCT01545388|2038829|FG000|Overall Study|Lack of Efficacy|3
1015977|NCT01545388|2038830|FG001|Overall Study|Lack of Efficacy|2
1015978|NCT01545388|2038831|FG002|Overall Study|Lack of Efficacy|5
1015979|NCT01545388|2038829|FG000|Overall Study|Participant moved or relocated|1
1015980|NCT01545388|2038830|FG001|Overall Study|Participant moved or relocated|0
1015981|NCT01545388|2038831|FG002|Overall Study|Participant moved or relocated|0
1015982|NCT01545388|2038829|FG000|Overall Study|Withdrawal by Subject|1
1015983|NCT01545388|2038830|FG001|Overall Study|Withdrawal by Subject|4
1015984|NCT01545388|2038831|FG002|Overall Study|Withdrawal by Subject|2
1015985|NCT01545388|2038829|FG000|Overall Study|Other|1
1015986|NCT01545388|2038830|FG001|Overall Study|Other|1
1015987|NCT01545388|2038831|FG002|Overall Study|Other|0
1015988|NCT01545817|2038935|FG000|Pazopanib|Disease progression|51
1015989|NCT01545817|2038936|FG001|Pazopanib|Disease progression|0
1015990|NCT01545817|2038935|FG000|Pazopanib|Adverse Event|19
1015991|NCT01545817|2038936|FG001|Pazopanib|Adverse Event|0
1015992|NCT01545817|2038935|FG000|Pazopanib|Other reason|4
1015993|NCT01545817|2038936|FG001|Pazopanib|Other reason|0
1015994|NCT01545817|2038935|FG000|Everolimus|Other reason|0
1015995|NCT01545817|2038936|FG001|Everolimus|Other reason|7
1015996|NCT01545817|2038935|FG000|Everolimus|Disease progression|0
1015997|NCT01545817|2038936|FG001|Everolimus|Disease progression|25
1015998|NCT01545817|2038935|FG000|Everolimus|Adverse Event|0
1015999|NCT01545817|2038936|FG001|Everolimus|Adverse Event|6
1016000|NCT01545934|2038962|FG000|Overall Study|Withdrawal by Subject|4
1016001|NCT01545934|2038963|FG001|Overall Study|Withdrawal by Subject|3
1016002|NCT01545934|2038962|FG000|Overall Study|Lost to Follow-up|1
1016003|NCT01545934|2038963|FG001|Overall Study|Lost to Follow-up|0
1016004|NCT01546038|2038976|FG000|Overall Study|Death|15
1016005|NCT01546038|2038977|FG001|Overall Study|Death|6
1016006|NCT01546038|2038978|FG002|Overall Study|Death|4
1016007|NCT01546038|2038979|FG003|Overall Study|Death|2
1016008|NCT01546038|2038980|FG004|Overall Study|Death|9
1016009|NCT01546038|2038981|FG005|Overall Study|Death|3
1016010|NCT01546038|2038982|FG006|Overall Study|Death|46
1016011|NCT01546038|2038983|FG007|Overall Study|Death|76
1016012|NCT01546038|2038984|FG008|Overall Study|Death|39
1016013|NCT01546038|2038976|FG000|Overall Study|Lost to Follow-up|0
1016014|NCT01546038|2038977|FG001|Overall Study|Lost to Follow-up|0
1016015|NCT01546038|2038978|FG002|Overall Study|Lost to Follow-up|0
1016016|NCT01546038|2038979|FG003|Overall Study|Lost to Follow-up|0
1016017|NCT01546038|2038980|FG004|Overall Study|Lost to Follow-up|1
1016018|NCT01546038|2038981|FG005|Overall Study|Lost to Follow-up|0
1016019|NCT01546038|2038982|FG006|Overall Study|Lost to Follow-up|2
1016020|NCT01546038|2038983|FG007|Overall Study|Lost to Follow-up|1
1016021|NCT01546038|2038984|FG008|Overall Study|Lost to Follow-up|0
1016022|NCT01546038|2038976|FG000|Overall Study|Withdrawal by Subject|1
1016023|NCT01546038|2038977|FG001|Overall Study|Withdrawal by Subject|0
1016024|NCT01546038|2038978|FG002|Overall Study|Withdrawal by Subject|0
1016025|NCT01546038|2038979|FG003|Overall Study|Withdrawal by Subject|1
1016026|NCT01546038|2038980|FG004|Overall Study|Withdrawal by Subject|0
1016027|NCT01546038|2038981|FG005|Overall Study|Withdrawal by Subject|1
1016028|NCT01546038|2038982|FG006|Overall Study|Withdrawal by Subject|3
1016029|NCT01546038|2038983|FG007|Overall Study|Withdrawal by Subject|3
1016030|NCT01546038|2038984|FG008|Overall Study|Withdrawal by Subject|1
1016031|NCT01546038|2038976|FG000|Overall Study|: Randomized, not treated|0
1016032|NCT01546038|2038977|FG001|Overall Study|: Randomized, not treated|0
1016033|NCT01546038|2038978|FG002|Overall Study|: Randomized, not treated|0
1016034|NCT01546038|2038979|FG003|Overall Study|: Randomized, not treated|0
1016035|NCT01546038|2038980|FG004|Overall Study|: Randomized, not treated|0
1016036|NCT01546038|2038981|FG005|Overall Study|: Randomized, not treated|0
1016037|NCT01546038|2038982|FG006|Overall Study|: Randomized, not treated|2
1016038|NCT01546038|2038983|FG007|Overall Study|: Randomized, not treated|4
1016039|NCT01546038|2038984|FG008|Overall Study|: Randomized, not treated|3
1016040|NCT01546142|2039036|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15
1016041|NCT01546142|2039037|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15
1016042|NCT01546142|2039036|FG000|Overall Study|Subject Noncompliance|1
1016043|NCT01546142|2039037|FG001|Overall Study|Subject Noncompliance|1
1016044|NCT01546142|2039036|FG000|Overall Study|Adverse Event|6
1016045|NCT01546142|2039037|FG001|Overall Study|Adverse Event|3
1016046|NCT01546142|2039036|FG000|Overall Study|Lost to Follow-up|20
1016047|NCT01546142|2039037|FG001|Overall Study|Lost to Follow-up|15
1016048|NCT01546142|2039036|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1
1016049|NCT01546142|2039037|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0
1016050|NCT01546142|2039036|FG000|Overall Study|Subject Randomized but Not Treated|1
1016051|NCT01546142|2039037|FG001|Overall Study|Subject Randomized but Not Treated|0
1016052|NCT01546155|2039043|FG000|Overall Study|could not tolerate long scan duration|3
1016053|NCT01546168|2039049|FG000|Overall Study|Lost to Follow-up|1
1016054|NCT01546168|2039050|FG001|Overall Study|Lost to Follow-up|0
1016055|NCT01546168|2039049|FG000|Overall Study|Withdrawal by Subject|1
1016056|NCT01546168|2039050|FG001|Overall Study|Withdrawal by Subject|0
1016057|NCT01546168|2039049|FG000|Overall Study|ineligible after signing consent|2
1016058|NCT01546168|2039050|FG001|Overall Study|ineligible after signing consent|0
1016059|NCT01546519|2039090|FG000|Overall Study|Adverse Event|0
1016060|NCT01546519|2039091|FG001|Overall Study|Adverse Event|0
1016061|NCT01546519|2039092|FG002|Overall Study|Adverse Event|1
1016062|NCT01546519|2039093|FG003|Overall Study|Adverse Event|1
1016063|NCT01546519|2039090|FG000|Overall Study|Death|0
1016064|NCT01546519|2039091|FG001|Overall Study|Death|1
1016065|NCT01546519|2039092|FG002|Overall Study|Death|3
1016066|NCT01546519|2039093|FG003|Overall Study|Death|1
1016067|NCT01546519|2039090|FG000|Overall Study|related to disease progression|2
1016068|NCT01546519|2039091|FG001|Overall Study|related to disease progression|2
1016069|NCT01546519|2039092|FG002|Overall Study|related to disease progression|2
1016070|NCT01546519|2039093|FG003|Overall Study|related to disease progression|1
1016071|NCT01546519|2039090|FG000|Overall Study|Physician Decision|6
1016072|NCT01546519|2039091|FG001|Overall Study|Physician Decision|5
1016073|NCT01546519|2039092|FG002|Overall Study|Physician Decision|2
1016074|NCT01546519|2039093|FG003|Overall Study|Physician Decision|3
1016075|NCT01546519|2039090|FG000|Overall Study|Withdrawal by Subject|1
1016076|NCT01546519|2039091|FG001|Overall Study|Withdrawal by Subject|0
1016077|NCT01546519|2039092|FG002|Overall Study|Withdrawal by Subject|0
1016078|NCT01546519|2039093|FG003|Overall Study|Withdrawal by Subject|0
1016079|NCT01546623|2039109|FG000|Overall Study|Adverse Event|2
1016080|NCT01546623|2039110|FG001|Overall Study|Adverse Event|3
1016081|NCT01546623|2039109|FG000|Overall Study|Major Protocol Deviation|1
1016082|NCT01546623|2039110|FG001|Overall Study|Major Protocol Deviation|1
1016083|NCT01546623|2039109|FG000|Overall Study|High Prostate specific antigen|2
1016084|NCT01546623|2039110|FG001|Overall Study|High Prostate specific antigen|1
1016085|NCT01546623|2039109|FG000|Overall Study|Did Not Receive Study Drug|1
1016086|NCT01546623|2039110|FG001|Overall Study|Did Not Receive Study Drug|1
1016087|NCT01546649|2039127|FG000|Overall Study|Adverse Event|4
1016088|NCT01546649|2039128|FG001|Overall Study|Adverse Event|5
1016089|NCT01546649|2039127|FG000|Overall Study|Protocol Violation|1
1016090|NCT01546649|2039128|FG001|Overall Study|Protocol Violation|0
1016091|NCT01546649|2039127|FG000|Overall Study|Lack of Efficacy|1
1016092|NCT01546649|2039128|FG001|Overall Study|Lack of Efficacy|0
1016093|NCT01546649|2039127|FG000|Overall Study|Recurrence|1
1016094|NCT01546649|2039128|FG001|Overall Study|Recurrence|1
1016095|NCT01546649|2039127|FG000|Overall Study|Discovery of secondary cancer|0
1016096|NCT01546649|2039128|FG001|Overall Study|Discovery of secondary cancer|1
1016097|NCT01546649|2039127|FG000|Overall Study|Withdrawal by Subject|1
1016098|NCT01546649|2039128|FG001|Overall Study|Withdrawal by Subject|2
1016099|NCT01546688|2039145|FG000|Overall Study|Adverse Event|0
1016100|NCT01546688|2039146|FG001|Overall Study|Adverse Event|4
1016101|NCT01546688|2039145|FG000|Overall Study|Withdrawal by Subject|2
1016102|NCT01546688|2039146|FG001|Overall Study|Withdrawal by Subject|1
1016103|NCT01546688|2039145|FG000|Overall Study|Lack of Efficacy|1
1016104|NCT01546688|2039146|FG001|Overall Study|Lack of Efficacy|0
1016105|NCT01546857|2039154|FG000|Overall Study|Withdrawal by Subject|2
1016106|NCT01546857|2039155|FG001|Overall Study|Withdrawal by Subject|3
1016107|NCT01546922|2039162|FG000|First Period of 10 Weeks|Protocol Violation|3
1016108|NCT01546922|2039163|FG001|First Period of 10 Weeks|Protocol Violation|1
1016109|NCT01546922|2039162|FG000|First Period of 10 Weeks|Withdrawal by Subject|1
1016110|NCT01546922|2039163|FG001|First Period of 10 Weeks|Withdrawal by Subject|1
1016111|NCT01546922|2039162|FG000|First Period of 10 Weeks|Investigator's judgment|1
1016112|NCT01546922|2039163|FG001|First Period of 10 Weeks|Investigator's judgment|0
1016113|NCT01546922|2039162|FG000|Second Period of 10 Weeks|Protocol Violation|3
1016114|NCT01546922|2039163|FG001|Second Period of 10 Weeks|Protocol Violation|1
1016115|NCT01546922|2039162|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0
1016116|NCT01546922|2039163|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2
1016117|NCT01547130|2039180|FG000|Overall Study|Lost to Follow-up|9
1016118|NCT01547130|2039181|FG001|Overall Study|Lost to Follow-up|5
1016119|NCT01547286|2039204|FG000|Overall Study|Did not meet all eligibility criteria|1
1016120|NCT01547286|2039204|FG000|Overall Study|Physician Decision|1
1016121|NCT01547299|2039211|FG000|Overall Study|Withdrawal by Subject|2
1016122|NCT01547299|2039212|FG001|Overall Study|Withdrawal by Subject|2
1016123|NCT01547390|2039220|FG000|Overall Study|Withdrawal by Subject|10
1016124|NCT01547390|2039221|FG001|Overall Study|Withdrawal by Subject|7
1016125|NCT01547390|2039220|FG000|Overall Study|termination of pregnancy|0
1016126|NCT01547390|2039221|FG001|Overall Study|termination of pregnancy|1
1016127|NCT01547390|2039220|FG000|Overall Study|Lost to Follow-up|0
1016128|NCT01547390|2039221|FG001|Overall Study|Lost to Follow-up|2
1016129|NCT01547390|2039220|FG000|Overall Study|Adverse Event|3
1016130|NCT01547390|2039221|FG001|Overall Study|Adverse Event|0
1016131|NCT01547598|2039229|FG000|Overall Study|Withdrew consent|1
1016132|NCT01547598|2039230|FG001|Overall Study|Withdrew consent|1
1016133|NCT01547598|2039229|FG000|Overall Study|Lost to Follow-up|1
1016134|NCT01547598|2039230|FG001|Overall Study|Lost to Follow-up|1
1016135|NCT01547598|2039229|FG000|Overall Study|Adverse Event|1
1016136|NCT01547598|2039230|FG001|Overall Study|Adverse Event|1
1016137|NCT01547598|2039229|FG000|Overall Study|Protocol Violation|1
1016138|NCT01547598|2039230|FG001|Overall Study|Protocol Violation|1
1016139|NCT01547598|2039229|FG000|Overall Study|Other Miscellaneous Reasons|2
1016140|NCT01547598|2039230|FG001|Overall Study|Other Miscellaneous Reasons|1
1016141|NCT01547780|2039255|FG000|Baseline PET Scan|Physician Decision|1
1016142|NCT01547780|2039256|FG001|Baseline PET Scan|Physician Decision|0
1016143|NCT01547780|2039257|FG002|Baseline PET Scan|Physician Decision|1
1016144|NCT01547780|2039258|FG003|Baseline PET Scan|Physician Decision|0
1016145|NCT01547780|2039255|FG000|Baseline PET Scan|Withdrawal by Subject|2
1016146|NCT01547780|2039256|FG001|Baseline PET Scan|Withdrawal by Subject|0
1016147|NCT01547780|2039257|FG002|Baseline PET Scan|Withdrawal by Subject|1
1016148|NCT01547780|2039258|FG003|Baseline PET Scan|Withdrawal by Subject|0
1016149|NCT01548287|2039286|FG000|Screening|No reason provided|0
1016150|NCT01548287|2039287|FG001|Screening|No reason provided|0
1016151|NCT01548287|2039288|FG002|Screening|No reason provided|0
1016152|NCT01548287|2039289|FG003|Screening|No reason provided|0
1016153|NCT01548287|2039290|FG004|Screening|No reason provided|9
1016154|NCT01548287|2039286|FG000|Screening|Did not meet eligibility criteria|0
1016155|NCT01548287|2039287|FG001|Screening|Did not meet eligibility criteria|0
1016156|NCT01548287|2039288|FG002|Screening|Did not meet eligibility criteria|0
1016157|NCT01548287|2039289|FG003|Screening|Did not meet eligibility criteria|0
1016158|NCT01548287|2039290|FG004|Screening|Did not meet eligibility criteria|74
1016159|NCT01548287|2039286|FG000|Randomized Period|Did not meet inclusion criteria|0
1016160|NCT01548287|2039287|FG001|Randomized Period|Did not meet inclusion criteria|0
1016161|NCT01548287|2039288|FG002|Randomized Period|Did not meet inclusion criteria|2
1016162|NCT01548287|2039289|FG003|Randomized Period|Did not meet inclusion criteria|0
1016163|NCT01548287|2039290|FG004|Randomized Period|Did not meet inclusion criteria|0
1016164|NCT01548287|2039286|FG000|Randomized Period|Adverse Event|0
1016165|NCT01548287|2039287|FG001|Randomized Period|Adverse Event|2
1016166|NCT01548287|2039288|FG002|Randomized Period|Adverse Event|5
1016167|NCT01548287|2039289|FG003|Randomized Period|Adverse Event|0
1016168|NCT01548287|2039290|FG004|Randomized Period|Adverse Event|0
1016169|NCT01548404|2039311|FG000|Overall Study|Adverse Event|3
1016170|NCT01548404|2039312|FG001|Overall Study|Adverse Event|1
1016171|NCT01548404|2039311|FG000|Overall Study|Physician Decision|2
1016172|NCT01548404|2039312|FG001|Overall Study|Physician Decision|1
1016173|NCT01548404|2039311|FG000|Overall Study|Inadequate response to study treatment|23
1016174|NCT01548404|2039312|FG001|Overall Study|Inadequate response to study treatment|7
1016175|NCT01548404|2039311|FG000|Overall Study|Lost to Follow-up|2
1016176|NCT01548404|2039312|FG001|Overall Study|Lost to Follow-up|0
1016177|NCT01548404|2039311|FG000|Overall Study|Withdrawal by Subject|0
1016178|NCT01548404|2039312|FG001|Overall Study|Withdrawal by Subject|3
1016179|NCT01548404|2039311|FG000|Overall Study|Other than specified above|0
1016180|NCT01548404|2039312|FG001|Overall Study|Other than specified above|2
1016181|NCT01548417|2039321|FG000|Overall Study|Withdrawal by Subject|0
1016182|NCT01548417|2039322|FG001|Overall Study|Withdrawal by Subject|2
1016183|NCT01548573|2039328|FG000|Overall Study|Death|3
1016184|NCT01548573|2039328|FG000|Overall Study|Withdrawal by Subject|2
1016185|NCT01548599|2039335|FG000|Overall Study|Lost to Follow-up|0
1016186|NCT01548599|2039336|FG001|Overall Study|Lost to Follow-up|1
1016187|NCT01548599|2039335|FG000|Overall Study|Withdrawal by Subject|4
1016188|NCT01548599|2039336|FG001|Overall Study|Withdrawal by Subject|0
1016189|NCT01548599|2039335|FG000|Overall Study|Death|2
1016190|NCT01548599|2039336|FG001|Overall Study|Death|1
1016191|NCT01548638|2039345|FG000|Overall Study|Protocol Violation|3
1016192|NCT01548638|2039345|FG000|Overall Study|Withdrawal by Subject|1
1016193|NCT01548768|2039385|FG000|Overall Study|Withdrawal by Subject|0
1016194|NCT01548768|2039386|FG001|Overall Study|Withdrawal by Subject|2
1016195|NCT01548768|2039387|FG002|Overall Study|Withdrawal by Subject|1
1016196|NCT01548768|2039388|FG003|Overall Study|Withdrawal by Subject|0
1016197|NCT01548768|2039385|FG000|Overall Study|Physician Decision|1
1016198|NCT01548768|2039386|FG001|Overall Study|Physician Decision|0
1016199|NCT01548768|2039387|FG002|Overall Study|Physician Decision|0
1016200|NCT01548768|2039388|FG003|Overall Study|Physician Decision|0
1016201|NCT01548768|2039385|FG000|Overall Study|Adverse Event|0
1016202|NCT01548768|2039386|FG001|Overall Study|Adverse Event|0
1016203|NCT01548768|2039387|FG002|Overall Study|Adverse Event|0
1016204|NCT01548768|2039388|FG003|Overall Study|Adverse Event|1
1016205|NCT01548768|2039385|FG000|Overall Study|Non-Compliance|0
1016206|NCT01548768|2039386|FG001|Overall Study|Non-Compliance|0
1016207|NCT01548768|2039387|FG002|Overall Study|Non-Compliance|0
1016208|NCT01548768|2039388|FG003|Overall Study|Non-Compliance|3
1016209|NCT01549002|2039414|FG000|Overall Study|Excessive pain|0
1016210|NCT01549002|2039415|FG001|Overall Study|Excessive pain|2
1016211|NCT01549002|2039414|FG000|Overall Study|Moderate sedation required|0
1016212|NCT01549002|2039415|FG001|Overall Study|Moderate sedation required|2
1016213|NCT01549041|2039423|FG000|Overall Study|Lack of Efficacy|2
1016214|NCT01549041|2039424|FG001|Overall Study|Lack of Efficacy|4
1016215|NCT01549041|2039423|FG000|Overall Study|Adverse Event|0
1016216|NCT01549041|2039424|FG001|Overall Study|Adverse Event|4
1016217|NCT01549275|2039441|FG000|Overall Study|Lost to Follow-up|1
1016218|NCT01549275|2039442|FG001|Overall Study|Lost to Follow-up|0
1016219|NCT01549392|2039476|FG000|Overall Study|Withdrawal by Subject|1
1016220|NCT01549392|2039477|FG001|Overall Study|Withdrawal by Subject|0
1016221|NCT01549613|2039505|FG000|Overall Study|Lost to Follow-up|11
1016222|NCT01549613|2039506|FG001|Overall Study|Lost to Follow-up|11
1016223|NCT01549652|2039515|FG000|Overall Study|Did Not Receive Allocated Intervention|0
1016224|NCT01549652|2039516|FG001|Overall Study|Did Not Receive Allocated Intervention|0
1016225|NCT01549652|2039517|FG002|Overall Study|Did Not Receive Allocated Intervention|2
1016226|NCT01549652|2039518|FG003|Overall Study|Did Not Receive Allocated Intervention|0
1016227|NCT01549652|2039515|FG000|Overall Study|Study Drug Titration Failure|5
1016228|NCT01549652|2039516|FG001|Overall Study|Study Drug Titration Failure|6
1016229|NCT01549652|2039517|FG002|Overall Study|Study Drug Titration Failure|0
1016230|NCT01549652|2039518|FG003|Overall Study|Study Drug Titration Failure|0
1016231|NCT01549652|2039515|FG000|Overall Study|Withdrawal Effect|0
1016232|NCT01549652|2039516|FG001|Overall Study|Withdrawal Effect|2
1016233|NCT01549652|2039517|FG002|Overall Study|Withdrawal Effect|0
1016234|NCT01549652|2039518|FG003|Overall Study|Withdrawal Effect|0
1016235|NCT01549652|2039515|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5
1016236|NCT01549652|2039516|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1
1016237|NCT01549652|2039517|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0
1016238|NCT01549652|2039518|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0
1016239|NCT01549652|2039515|FG000|Overall Study|Problem with Infusion|1
1016240|NCT01549652|2039516|FG001|Overall Study|Problem with Infusion|0
1016241|NCT01549652|2039517|FG002|Overall Study|Problem with Infusion|0
1016242|NCT01549652|2039518|FG003|Overall Study|Problem with Infusion|0
1016243|NCT01549652|2039515|FG000|Overall Study|Titration Non-Compliance|1
1016244|NCT01549652|2039516|FG001|Overall Study|Titration Non-Compliance|3
1016245|NCT01549652|2039517|FG002|Overall Study|Titration Non-Compliance|4
1016246|NCT01549652|2039518|FG003|Overall Study|Titration Non-Compliance|5
1016247|NCT01549652|2039515|FG000|Overall Study|Titration Side Effects|0
1016248|NCT01549652|2039516|FG001|Overall Study|Titration Side Effects|0
1016249|NCT01549652|2039517|FG002|Overall Study|Titration Side Effects|6
1016250|NCT01549652|2039518|FG003|Overall Study|Titration Side Effects|3
1016251|NCT01549652|2039515|FG000|Overall Study|Withdrawal by Subject|0
1016252|NCT01549652|2039516|FG001|Overall Study|Withdrawal by Subject|0
1016253|NCT01549652|2039517|FG002|Overall Study|Withdrawal by Subject|5
1016254|NCT01549652|2039518|FG003|Overall Study|Withdrawal by Subject|3
1016255|NCT01549860|2039526|FG000|Overall Study|Withdrawal by Subject|1
1016256|NCT01549860|2039527|FG001|Overall Study|Withdrawal by Subject|0
1016257|NCT01549860|2039526|FG000|Overall Study|Physician Decision|1
1016258|NCT01549860|2039527|FG001|Overall Study|Physician Decision|1
1016259|NCT01549873|2039535|FG000|Overall Study|Physician Decision|0
1016260|NCT01549873|2039536|FG001|Overall Study|Physician Decision|1
1016261|NCT01549886|2039544|FG000|Overall Study|Sponsor's decision|2
1016262|NCT01549886|2039545|FG001|Overall Study|Sponsor's decision|3
1016263|NCT01549951|2039562|FG000|Overall Study|Adverse Event|15
1016264|NCT01549951|2039562|FG000|Overall Study|Withdrawal by Subject|2
1016265|NCT01549951|2039562|FG000|Overall Study|Unsatisfactory therapeutic response|1
1016266|NCT01549951|2039562|FG000|Overall Study|Progressive disease|29
1016267|NCT01549951|2039562|FG000|Overall Study|Symptomatic deterioration|1
1016268|NCT01549951|2039562|FG000|Overall Study|Other|2
1016269|NCT01549964|2039570|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50
1016270|NCT01549964|2039571|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104
1016271|NCT01549964|2039572|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104
1016272|NCT01549964|2039573|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105
1016273|NCT01549964|2039570|FG000|24-Week Treatment Period|Voluntary Withdrawal|6
1016274|NCT01549964|2039571|FG001|24-Week Treatment Period|Voluntary Withdrawal|3
1016275|NCT01549964|2039572|FG002|24-Week Treatment Period|Voluntary Withdrawal|3
1016276|NCT01549964|2039573|FG003|24-Week Treatment Period|Voluntary Withdrawal|8
1016277|NCT01549964|2039570|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
1016278|NCT01549964|2039571|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1016279|NCT01549964|2039572|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1016280|NCT01549964|2039573|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1016281|NCT01549964|2039570|FG000|24-Week Treatment Period|Lost to Follow-up|1
1016282|NCT01549964|2039571|FG001|24-Week Treatment Period|Lost to Follow-up|0
1016283|NCT01549964|2039572|FG002|24-Week Treatment Period|Lost to Follow-up|1
1016284|NCT01549964|2039573|FG003|24-Week Treatment Period|Lost to Follow-up|2
1016285|NCT01549964|2039570|FG000|24-Week Treatment Period|Lack of Efficacy|1
1016286|NCT01549964|2039571|FG001|24-Week Treatment Period|Lack of Efficacy|0
1016287|NCT01549964|2039572|FG002|24-Week Treatment Period|Lack of Efficacy|1
1016288|NCT01549964|2039573|FG003|24-Week Treatment Period|Lack of Efficacy|1
1016289|NCT01549964|2039570|FG000|24-Week Treatment Period|Other|1
1016290|NCT01549964|2039571|FG001|24-Week Treatment Period|Other|0
1016291|NCT01549964|2039572|FG002|24-Week Treatment Period|Other|1
1016292|NCT01549964|2039573|FG003|24-Week Treatment Period|Other|0
1016293|NCT01549964|2039570|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1016294|NCT01549964|2039571|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1016295|NCT01549964|2039572|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
1016296|NCT01549964|2039573|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1016297|NCT01549964|2039570|FG000|24-Week Treatment Period|Randomized but Not Treated|0
1016298|NCT01549964|2039571|FG001|24-Week Treatment Period|Randomized but Not Treated|0
1016299|NCT01549964|2039572|FG002|24-Week Treatment Period|Randomized but Not Treated|0
1016300|NCT01549964|2039573|FG003|24-Week Treatment Period|Randomized but Not Treated|1
1016301|NCT01549964|2039570|FG000|24-Week Treatment Period|Completion Status Unknown|1
1016302|NCT01549964|2039571|FG001|24-Week Treatment Period|Completion Status Unknown|0
1016303|NCT01549964|2039572|FG002|24-Week Treatment Period|Completion Status Unknown|1
1016304|NCT01549964|2039573|FG003|24-Week Treatment Period|Completion Status Unknown|0
1016305|NCT01549964|2039570|FG000|80-Week Extension Period|Pregnancy|0
1016306|NCT01549964|2039571|FG001|80-Week Extension Period|Pregnancy|0
1016307|NCT01549964|2039572|FG002|80-Week Extension Period|Pregnancy|1
1016308|NCT01549964|2039573|FG003|80-Week Extension Period|Pregnancy|0
1016309|NCT01549964|2039570|FG000|80-Week Extension Period|Study Terminated by Sponsor|65
1016310|NCT01549964|2039571|FG001|80-Week Extension Period|Study Terminated by Sponsor|137
1016311|NCT01549964|2039572|FG002|80-Week Extension Period|Study Terminated by Sponsor|132
1016312|NCT01549964|2039573|FG003|80-Week Extension Period|Study Terminated by Sponsor|132
1016313|NCT01549964|2039570|FG000|80-Week Extension Period|Voluntary Withdrawal|0
1016314|NCT01549964|2039571|FG001|80-Week Extension Period|Voluntary Withdrawal|1
1016315|NCT01549964|2039572|FG002|80-Week Extension Period|Voluntary Withdrawal|4
1016316|NCT01549964|2039573|FG003|80-Week Extension Period|Voluntary Withdrawal|2
1016317|NCT01549964|2039570|FG000|80-Week Extension Period|Lost to Follow-up|1
1016318|NCT01549964|2039571|FG001|80-Week Extension Period|Lost to Follow-up|0
1016319|NCT01549964|2039572|FG002|80-Week Extension Period|Lost to Follow-up|2
1016320|NCT01549964|2039573|FG003|80-Week Extension Period|Lost to Follow-up|1
1016321|NCT01549964|2039570|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0
1016322|NCT01549964|2039571|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0
1016323|NCT01549964|2039572|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1
1016324|NCT01549964|2039573|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2
1016325|NCT01550289|2039594|FG000|Overall Study|Protocol Violation|1
1016326|NCT01550289|2039595|FG001|Overall Study|Protocol Violation|0
1016327|NCT01550289|2039594|FG000|Overall Study|Lost to Follow-up|1
1016328|NCT01550289|2039595|FG001|Overall Study|Lost to Follow-up|1
1016329|NCT01550289|2039594|FG000|Overall Study|Withdrawal by Subject|11
1016330|NCT01550289|2039595|FG001|Overall Study|Withdrawal by Subject|3
1016331|NCT01550744|2039667|FG000|Open-Label|Lost to Follow-up|7
1016332|NCT01550744|2039668|FG001|Open-Label|Lost to Follow-up|0
1016333|NCT01550744|2039669|FG002|Open-Label|Lost to Follow-up|0
1016334|NCT01550744|2039667|FG000|Open-Label|Withdrawal by Subject|13
1016335|NCT01550744|2039668|FG001|Open-Label|Withdrawal by Subject|0
1016336|NCT01550744|2039669|FG002|Open-Label|Withdrawal by Subject|0
1016337|NCT01550744|2039667|FG000|Open-Label|Adverse Event|11
1016338|NCT01550744|2039668|FG001|Open-Label|Adverse Event|0
1016339|NCT01550744|2039669|FG002|Open-Label|Adverse Event|0
1016340|NCT01550744|2039667|FG000|Open-Label|Lack of Efficacy|4
1016341|NCT01550744|2039668|FG001|Open-Label|Lack of Efficacy|0
1016342|NCT01550744|2039669|FG002|Open-Label|Lack of Efficacy|0
1016343|NCT01550744|2039667|FG000|Open-Label|Protocol Violation|4
1016344|NCT01550744|2039668|FG001|Open-Label|Protocol Violation|0
1016345|NCT01550744|2039669|FG002|Open-Label|Protocol Violation|0
1016346|NCT01550744|2039667|FG000|Open-Label|Not all 3 study drug injections received|2
1016347|NCT01550744|2039668|FG001|Open-Label|Not all 3 study drug injections received|0
1016348|NCT01550744|2039669|FG002|Open-Label|Not all 3 study drug injections received|0
1016349|NCT01550744|2039667|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58
1016350|NCT01550744|2039668|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0
1016351|NCT01550744|2039669|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0
1016352|NCT01550744|2039667|FG000|Open-Label|Other|1
1016353|NCT01550744|2039668|FG001|Open-Label|Other|0
1016354|NCT01550744|2039669|FG002|Open-Label|Other|0
1016355|NCT01550744|2039667|FG000|Double-Blind|Lost to Follow-up|0
1016356|NCT01550744|2039668|FG001|Double-Blind|Lost to Follow-up|6
1016357|NCT01550744|2039669|FG002|Double-Blind|Lost to Follow-up|12
1016358|NCT01550744|2039667|FG000|Double-Blind|Withdrawal by Subject|0
1016359|NCT01550744|2039668|FG001|Double-Blind|Withdrawal by Subject|2
1016360|NCT01550744|2039669|FG002|Double-Blind|Withdrawal by Subject|15
1016361|NCT01550744|2039667|FG000|Double-Blind|Adverse Event|0
1016362|NCT01550744|2039668|FG001|Double-Blind|Adverse Event|4
1016363|NCT01550744|2039669|FG002|Double-Blind|Adverse Event|15
1016364|NCT01550744|2039667|FG000|Double-Blind|Death|0
1016365|NCT01550744|2039668|FG001|Double-Blind|Death|1
1016366|NCT01550744|2039669|FG002|Double-Blind|Death|0
1016367|NCT01550744|2039667|FG000|Double-Blind|Lack of Efficacy|0
1016368|NCT01550744|2039668|FG001|Double-Blind|Lack of Efficacy|2
1016369|NCT01550744|2039669|FG002|Double-Blind|Lack of Efficacy|8
1016370|NCT01550744|2039667|FG000|Double-Blind|Protocol Violation|0
1016371|NCT01550744|2039668|FG001|Double-Blind|Protocol Violation|0
1016372|NCT01550744|2039669|FG002|Double-Blind|Protocol Violation|4
1016373|NCT01550744|2039667|FG000|Double-Blind|Pregnancy|0
1016374|NCT01550744|2039668|FG001|Double-Blind|Pregnancy|0
1016375|NCT01550744|2039669|FG002|Double-Blind|Pregnancy|3
1016376|NCT01550744|2039667|FG000|Double-Blind|Other|0
1016377|NCT01550744|2039668|FG001|Double-Blind|Other|2
1016378|NCT01550744|2039669|FG002|Double-Blind|Other|10
1016379|NCT01550757|2039680|FG000|Overall Study|Lost to Follow-up|21
1016380|NCT01550757|2039681|FG001|Overall Study|Lost to Follow-up|14
1016381|NCT01550757|2039682|FG002|Overall Study|Lost to Follow-up|42
1016382|NCT01550757|2039683|FG003|Overall Study|Lost to Follow-up|53
1016383|NCT01550757|2039680|FG000|Overall Study|Withdrawal by Subject|2
1016384|NCT01550757|2039681|FG001|Overall Study|Withdrawal by Subject|0
1016385|NCT01550757|2039682|FG002|Overall Study|Withdrawal by Subject|3
1016386|NCT01550757|2039683|FG003|Overall Study|Withdrawal by Subject|1
1016387|NCT01550965|2039706|FG000|Overall Study|Adverse Event|26
1016388|NCT01550965|2039706|FG000|Overall Study|Withdrawal by Subject|10
1016389|NCT01550965|2039706|FG000|Overall Study|Lost to Follow-up|2
1016390|NCT01550965|2039706|FG000|Overall Study|Lack of Efficacy|59
1016391|NCT01550965|2039706|FG000|Overall Study|Other|13
1016392|NCT01551173|2039730|FG000|Overall Study|Withdrawal by Subject|11
1016393|NCT01551173|2039731|FG001|Overall Study|Withdrawal by Subject|16
1016394|NCT01551173|2039730|FG000|Overall Study|Adverse Event|7
1016395|NCT01551173|2039731|FG001|Overall Study|Adverse Event|6
1016396|NCT01551173|2039730|FG000|Overall Study|Lost to Follow-up|5
1016397|NCT01551173|2039731|FG001|Overall Study|Lost to Follow-up|7
1016398|NCT01551173|2039730|FG000|Overall Study|Other|5
1016399|NCT01551173|2039731|FG001|Overall Study|Other|3
1016400|NCT01551212|2039753|FG000|Overall Study|Graft loss/Retransplantation|0
1016401|NCT01551212|2039754|FG001|Overall Study|Graft loss/Retransplantation|1
1016402|NCT01551212|2039753|FG000|Overall Study|Administrative problems|1
1016403|NCT01551212|2039754|FG001|Overall Study|Administrative problems|2
1016404|NCT01551212|2039753|FG000|Overall Study|Lost to Follow-up|0
1016405|NCT01551212|2039754|FG001|Overall Study|Lost to Follow-up|1
1016406|NCT01551212|2039753|FG000|Overall Study|Protocol Violation|0
1016407|NCT01551212|2039754|FG001|Overall Study|Protocol Violation|1
1016408|NCT01551212|2039753|FG000|Overall Study|Withdrawal by Subject|0
1016409|NCT01551212|2039754|FG001|Overall Study|Withdrawal by Subject|7
1016410|NCT01551212|2039753|FG000|Overall Study|Death|2
1016411|NCT01551212|2039754|FG001|Overall Study|Death|4
1016412|NCT01551212|2039753|FG000|Overall Study|Never Received Study Treatment|2
1016413|NCT01551212|2039754|FG001|Overall Study|Never Received Study Treatment|4
1016414|NCT01551303|2039771|FG000|Overall Study|failed awareness check on vision test|4
1016415|NCT01551303|2039772|FG001|Overall Study|failed awareness check on vision test|7
1016416|NCT01551355|2039784|FG000|Overall Study|Lost to Follow-up|51
1016417|NCT01551355|2039785|FG001|Overall Study|Lost to Follow-up|49
1016418|NCT01551355|2039786|FG002|Overall Study|Lost to Follow-up|34
1016419|NCT01551355|2039787|FG003|Overall Study|Lost to Follow-up|24
1016420|NCT01551355|2039788|FG004|Overall Study|Lost to Follow-up|9
1016421|NCT01551355|2039789|FG005|Overall Study|Lost to Follow-up|6
1016422|NCT01551420|2039799|FG000|In-laboratory (Part A)|Lost to Follow-up|2
1016423|NCT01551420|2039800|FG001|In-laboratory (Part A)|Lost to Follow-up|1
1016424|NCT01551420|2039799|FG000|In-laboratory (Part A)|Withdrawal by Subject|2
1016425|NCT01551420|2039800|FG001|In-laboratory (Part A)|Withdrawal by Subject|0
1016426|NCT01551420|2039799|FG000|In-laboratory (Part A)|Scheduling conflict|2
1016427|NCT01551420|2039800|FG001|In-laboratory (Part A)|Scheduling conflict|1
1016428|NCT01551420|2039799|FG000|Screened for Part B Eligibility|Declined participation|8
1016429|NCT01551420|2039800|FG001|Screened for Part B Eligibility|Declined participation|1
1016430|NCT01551420|2039799|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1
1016431|NCT01551420|2039800|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2
1016432|NCT01551420|2039799|FG000|Home Use (Part B)|Withdrawal by Subject|6
1016433|NCT01551420|2039800|FG001|Home Use (Part B)|Withdrawal by Subject|0
1016434|NCT01551420|2039799|FG000|Home Use (Part B)|Withdrawal by staff|0
1016435|NCT01551420|2039800|FG001|Home Use (Part B)|Withdrawal by staff|1
1016436|NCT01551693|2039817|FG000|Overall Study|Disease Progression|1
1016437|NCT01551693|2039818|FG001|Overall Study|Disease Progression|0
1016438|NCT01551693|2039817|FG000|Overall Study|Adverse Event|0
1016439|NCT01551693|2039818|FG001|Overall Study|Adverse Event|1
1016440|NCT01551693|2039817|FG000|Overall Study|Withdrawal by Subject|0
1016441|NCT01551693|2039818|FG001|Overall Study|Withdrawal by Subject|1
1016442|NCT01551745|2039824|FG000|Overall Study|Withdrawal by Subject|1
1016443|NCT01551745|2039824|FG000|Overall Study|Disease Progression|2
1016444|NCT01551758|2039830|FG000|Overall Study|Adverse Event|29
1016445|NCT01551758|2039831|FG001|Overall Study|Adverse Event|43
1016446|NCT01551758|2039830|FG000|Overall Study|Lack of Efficacy|0
1016447|NCT01551758|2039831|FG001|Overall Study|Lack of Efficacy|1
1016448|NCT01551758|2039830|FG000|Overall Study|Protocol Violation|5
1016449|NCT01551758|2039831|FG001|Overall Study|Protocol Violation|6
1016450|NCT01551758|2039830|FG000|Overall Study|Met Protocol-defined stopping criteria|8
1016451|NCT01551758|2039831|FG001|Overall Study|Met Protocol-defined stopping criteria|10
1016452|NCT01551758|2039830|FG000|Overall Study|Lost to Follow-up|29
1016453|NCT01551758|2039831|FG001|Overall Study|Lost to Follow-up|25
1016454|NCT01551758|2039830|FG000|Overall Study|Physician Decision|9
1016455|NCT01551758|2039831|FG001|Overall Study|Physician Decision|3
1016456|NCT01551758|2039830|FG000|Overall Study|Withdrawal by Subject|14
1016457|NCT01551758|2039831|FG001|Overall Study|Withdrawal by Subject|17
1016458|NCT01552057|2039859|FG000|Overall Study|Adverse Event|14
1016459|NCT01552057|2039860|FG001|Overall Study|Adverse Event|15
1016460|NCT01552057|2039859|FG000|Overall Study|Lack of Efficacy|8
1016461|NCT01552057|2039860|FG001|Overall Study|Lack of Efficacy|23
1016462|NCT01552057|2039859|FG000|Overall Study|Withdrawal by Subject|5
1016463|NCT01552057|2039860|FG001|Overall Study|Withdrawal by Subject|8
1016464|NCT01552057|2039859|FG000|Overall Study|Entry Criteria Not Met|2
1016465|NCT01552057|2039860|FG001|Overall Study|Entry Criteria Not Met|2
1016466|NCT01552057|2039859|FG000|Overall Study|Physician Decision|1
1016467|NCT01552057|2039860|FG001|Overall Study|Physician Decision|0
1016468|NCT01552369|2039895|FG000|Overall Study|Did not consent to extended follow up|8
1016469|NCT01552369|2039896|FG001|Overall Study|Did not consent to extended follow up|9
1016470|NCT01552408|2039906|FG000|Overall Study|Lost to Follow-up|2
1016471|NCT01552408|2039907|FG001|Overall Study|Lost to Follow-up|0
1016472|NCT01552408|2039906|FG000|Overall Study|Relocation|0
1016473|NCT01552408|2039907|FG001|Overall Study|Relocation|1
1016474|NCT01552408|2039906|FG000|Overall Study|Withdrawal by Subject|2
1016475|NCT01552408|2039907|FG001|Overall Study|Withdrawal by Subject|1
1016476|NCT01552603|2039914|FG000|Overall Study|Physician Decision|1
1016477|NCT01552681|2039920|FG000|Overall Study|Withdrawal by Subject|4
1016478|NCT01552681|2039921|FG001|Overall Study|Withdrawal by Subject|0
1016479|NCT01552681|2039920|FG000|Overall Study|Physician Decision|1
1016480|NCT01552681|2039921|FG001|Overall Study|Physician Decision|0
1016481|NCT01552681|2039920|FG000|Overall Study|Subject moved away|0
1016482|NCT01552681|2039921|FG001|Overall Study|Subject moved away|1
1016483|NCT01552694|2039929|FG000|Overall Study|Lost to Follow-up|0
1016484|NCT01552694|2039930|FG001|Overall Study|Lost to Follow-up|1
1016485|NCT01552694|2039929|FG000|Overall Study|Protocol Violation|0
1016486|NCT01552694|2039930|FG001|Overall Study|Protocol Violation|1
1016487|NCT01552772|2039936|FG000|Overall Study|Lost to Follow-up|2
1016488|NCT01552772|2039936|FG000|Overall Study|Adverse Event|1
1016489|NCT01552772|2039936|FG000|Overall Study|Protocol Deviation|1
1016490|NCT01552902|2039968|FG000|Overall Study|Adverse Event|1
1016491|NCT01552902|2039969|FG001|Overall Study|Adverse Event|15
1016492|NCT01552902|2039970|FG002|Overall Study|Adverse Event|14
1016493|NCT01552902|2039968|FG000|Overall Study|Protocol Violation|3
1016494|NCT01552902|2039969|FG001|Overall Study|Protocol Violation|3
1016495|NCT01552902|2039970|FG002|Overall Study|Protocol Violation|3
1016496|NCT01552902|2039968|FG000|Overall Study|Lack of Efficacy|4
1016497|NCT01552902|2039969|FG001|Overall Study|Lack of Efficacy|3
1016498|NCT01552902|2039970|FG002|Overall Study|Lack of Efficacy|1
1016499|NCT01552902|2039968|FG000|Overall Study|Withdrawal by Subject|1
1016500|NCT01552902|2039969|FG001|Overall Study|Withdrawal by Subject|9
1016501|NCT01552902|2039970|FG002|Overall Study|Withdrawal by Subject|6
1016502|NCT01552902|2039968|FG000|Overall Study|Lost to Follow-up|1
1016503|NCT01552902|2039969|FG001|Overall Study|Lost to Follow-up|3
1016504|NCT01552902|2039970|FG002|Overall Study|Lost to Follow-up|6
1016505|NCT01552902|2039968|FG000|Overall Study|Other|3
1016506|NCT01552902|2039969|FG001|Overall Study|Other|4
1016507|NCT01552902|2039970|FG002|Overall Study|Other|3
1016508|NCT01552915|2039981|FG000|Overall Study|Adverse Event|3
1016509|NCT01552915|2039982|FG001|Overall Study|Adverse Event|14
1016510|NCT01552915|2039983|FG002|Overall Study|Adverse Event|3
1016511|NCT01552915|2039981|FG000|Overall Study|Lost to Follow-up|4
1016512|NCT01552915|2039982|FG001|Overall Study|Lost to Follow-up|6
1016513|NCT01552915|2039983|FG002|Overall Study|Lost to Follow-up|5
1016514|NCT01552915|2039981|FG000|Overall Study|Withdrawal by Subject|6
1016515|NCT01552915|2039982|FG001|Overall Study|Withdrawal by Subject|4
1016516|NCT01552915|2039983|FG002|Overall Study|Withdrawal by Subject|5
1016517|NCT01552915|2039981|FG000|Overall Study|Protocol Violation|0
1016518|NCT01552915|2039982|FG001|Overall Study|Protocol Violation|4
1016519|NCT01552915|2039983|FG002|Overall Study|Protocol Violation|4
1016520|NCT01552915|2039981|FG000|Overall Study|Lack of Efficacy|8
1016521|NCT01552915|2039982|FG001|Overall Study|Lack of Efficacy|1
1016522|NCT01552915|2039983|FG002|Overall Study|Lack of Efficacy|4
1016523|NCT01552915|2039981|FG000|Overall Study|Other|2
1016524|NCT01552915|2039982|FG001|Overall Study|Other|0
1016525|NCT01552915|2039983|FG002|Overall Study|Other|6
1016526|NCT01552928|2039995|FG000|Period 3|Adverse Event|0
1016527|NCT01552928|2039996|FG001|Period 3|Adverse Event|0
1016528|NCT01552928|2039997|FG002|Period 3|Adverse Event|1
1016529|NCT01552928|2039998|FG003|Period 3|Adverse Event|0
1016530|NCT01552954|2040017|FG000|Overall Study|Adverse Event|1
1016531|NCT01552954|2040018|FG001|Overall Study|Adverse Event|2
1016532|NCT01552954|2040017|FG000|Overall Study|Lost to Follow-up|1
1016533|NCT01552954|2040018|FG001|Overall Study|Lost to Follow-up|1
1016534|NCT01552954|2040017|FG000|Overall Study|Withdrawal by Subject|1
1016535|NCT01552954|2040018|FG001|Overall Study|Withdrawal by Subject|1
1016536|NCT01552954|2040017|FG000|Overall Study|Protocol Violation|1
1016537|NCT01552954|2040018|FG001|Overall Study|Protocol Violation|2
1016538|NCT01552954|2040017|FG000|Overall Study|diagnosed DM|1
1016539|NCT01552954|2040018|FG001|Overall Study|diagnosed DM|0
1016540|NCT01553084|2040044|FG000|Overall Study|Withdrawal by Subject|15
1016541|NCT01553084|2040045|FG001|Overall Study|Withdrawal by Subject|13
1016542|NCT01553084|2040046|FG002|Overall Study|Withdrawal by Subject|35
1016543|NCT01553136|2040058|FG000|Overall Study|Adverse Event|3
1016544|NCT01553136|2040059|FG001|Overall Study|Adverse Event|2
1016545|NCT01553136|2040058|FG000|Overall Study|Withdrawal by Subject|2
1016546|NCT01553136|2040059|FG001|Overall Study|Withdrawal by Subject|3
1016547|NCT01553136|2040058|FG000|Overall Study|Lost to Follow-up|4
1016548|NCT01553136|2040059|FG001|Overall Study|Lost to Follow-up|10
1016549|NCT01553136|2040058|FG000|Overall Study|Physician Decision|2
1016550|NCT01553136|2040059|FG001|Overall Study|Physician Decision|3
1016551|NCT01553136|2040058|FG000|Overall Study|Scheduling Difficulties|5
1016552|NCT01553136|2040059|FG001|Overall Study|Scheduling Difficulties|4
1016553|NCT01553149|2040067|FG000|Overall Study|Adverse Event|0
1016554|NCT01553149|2040068|FG001|Overall Study|Adverse Event|9
1016555|NCT01553149|2040067|FG000|Overall Study|Physician Decision|5
1016556|NCT01553149|2040068|FG001|Overall Study|Physician Decision|10
1016557|NCT01553149|2040067|FG000|Overall Study|Ineligible|0
1016558|NCT01553149|2040068|FG001|Overall Study|Ineligible|1
1016559|NCT01553188|2040078|FG000|Overall Study|Patient choice|1
1016560|NCT01553188|2040079|FG001|Overall Study|Patient choice|0
1016561|NCT01553188|2040080|FG002|Overall Study|Patient choice|0
1016562|NCT01553188|2040081|FG003|Overall Study|Patient choice|0
1016563|NCT01553188|2040078|FG000|Overall Study|Intercurrent illness and adverse event|0
1016564|NCT01553188|2040079|FG001|Overall Study|Intercurrent illness and adverse event|1
1016565|NCT01553188|2040080|FG002|Overall Study|Intercurrent illness and adverse event|2
1016566|NCT01553188|2040081|FG003|Overall Study|Intercurrent illness and adverse event|0
1016567|NCT01553279|2040105|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
1016568|NCT01553279|2040106|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
1016569|NCT01553279|2040105|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
1016570|NCT01553279|2040106|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
1016571|NCT01553279|2040105|FG000|Interim Period|Withdrawal by Subject|2
1016572|NCT01553279|2040106|FG001|Interim Period|Withdrawal by Subject|2
1016573|NCT01553279|2040105|FG000|Interim Period|Lost to Follow-up|1
1016574|NCT01553279|2040106|FG001|Interim Period|Lost to Follow-up|0
1016575|NCT01553279|2040105|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
1016576|NCT01553279|2040106|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
1016577|NCT01553279|2040105|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3
1016578|NCT01553279|2040106|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2
1016579|NCT01553318|2040121|FG000|Overall Study|Protocol Violation|3
1016580|NCT01553318|2040122|FG001|Overall Study|Protocol Violation|2
1016581|NCT01553591|2040137|FG000|Overall Study|Voluntarily withdrew|94
1016582|NCT01553591|2040138|FG001|Overall Study|Voluntarily withdrew|79
1016583|NCT01553591|2040139|FG002|Overall Study|Voluntarily withdrew|96
1016584|NCT01553591|2040137|FG000|Overall Study|Adverse Event|36
1016585|NCT01553591|2040138|FG001|Overall Study|Adverse Event|45
1016586|NCT01553591|2040139|FG002|Overall Study|Adverse Event|16
1016587|NCT01553591|2040137|FG000|Overall Study|Lost to Follow-up|25
1016588|NCT01553591|2040138|FG001|Overall Study|Lost to Follow-up|23
1016589|NCT01553591|2040139|FG002|Overall Study|Lost to Follow-up|16
1016590|NCT01553591|2040137|FG000|Overall Study|Physician decision: other|11
1016591|NCT01553591|2040138|FG001|Overall Study|Physician decision: other|14
1016592|NCT01553591|2040139|FG002|Overall Study|Physician decision: other|16
1016593|NCT01553591|2040137|FG000|Overall Study|Physician decision: lack of efficacy|2
1016594|NCT01553591|2040138|FG001|Overall Study|Physician decision: lack of efficacy|3
1016595|NCT01553591|2040139|FG002|Overall Study|Physician decision: lack of efficacy|7
1016596|NCT01553591|2040137|FG000|Overall Study|Protocol Violation|3
1016597|NCT01553591|2040138|FG001|Overall Study|Protocol Violation|4
1016598|NCT01553591|2040139|FG002|Overall Study|Protocol Violation|4
1016599|NCT01553591|2040137|FG000|Overall Study|Sponsor decision|1
1016600|NCT01553591|2040138|FG001|Overall Study|Sponsor decision|0
1016601|NCT01553591|2040139|FG002|Overall Study|Sponsor decision|3
1016602|NCT01553591|2040137|FG000|Overall Study|Randomized and never dispensed drug|0
1016603|NCT01553591|2040138|FG001|Overall Study|Randomized and never dispensed drug|1
1016604|NCT01553591|2040139|FG002|Overall Study|Randomized and never dispensed drug|0
1016605|NCT01553747|2040159|FG000|Overall Study|Protocol Violation|0
1016606|NCT01553747|2040160|FG001|Overall Study|Protocol Violation|2
1016607|NCT01553747|2040161|FG002|Overall Study|Protocol Violation|0
1016608|NCT01553747|2040159|FG000|Overall Study|Voluntarily withdrew|70
1016609|NCT01553747|2040160|FG001|Overall Study|Voluntarily withdrew|66
1016610|NCT01553747|2040161|FG002|Overall Study|Voluntarily withdrew|74
1016611|NCT01553747|2040159|FG000|Overall Study|Adverse event or SAE|32
1016612|NCT01553747|2040160|FG001|Overall Study|Adverse event or SAE|28
1016613|NCT01553747|2040161|FG002|Overall Study|Adverse event or SAE|19
1016614|NCT01553747|2040159|FG000|Overall Study|Physician decision: other|10
1016615|NCT01553747|2040160|FG001|Overall Study|Physician decision: other|8
1016616|NCT01553747|2040161|FG002|Overall Study|Physician decision: other|7
1016617|NCT01553747|2040159|FG000|Overall Study|Lost to Follow-up|11
1016618|NCT01553747|2040160|FG001|Overall Study|Lost to Follow-up|5
1016619|NCT01553747|2040161|FG002|Overall Study|Lost to Follow-up|6
1016620|NCT01553747|2040159|FG000|Overall Study|Sponsor decision, specify|7
1016621|NCT01553747|2040160|FG001|Overall Study|Sponsor decision, specify|5
1016622|NCT01553747|2040161|FG002|Overall Study|Sponsor decision, specify|0
1016623|NCT01553747|2040159|FG000|Overall Study|Physician decision: lack of efficacy|1
1016624|NCT01553747|2040160|FG001|Overall Study|Physician decision: lack of efficacy|5
1016625|NCT01553747|2040161|FG002|Overall Study|Physician decision: lack of efficacy|3
1016626|NCT01553851|2040172|FG000|Overall Study|Adverse Event|2
1016627|NCT01553851|2040172|FG000|Overall Study|constipation|1
1016628|NCT01553916|2040176|FG000|Overall Study|Withdrawal by Subject|2
1016629|NCT01553916|2040176|FG000|Overall Study|Pre-treatment MRI metastatic disease|1
1016630|NCT01554163|2040182|FG000|Overall Study|Adverse Event|3
1016631|NCT01554163|2040183|FG001|Overall Study|Adverse Event|0
1016632|NCT01554163|2040182|FG000|Overall Study|Lack of Efficacy|1
1016633|NCT01554163|2040183|FG001|Overall Study|Lack of Efficacy|0
1016634|NCT01554163|2040182|FG000|Overall Study|Lost to Follow-up|1
1016635|NCT01554163|2040183|FG001|Overall Study|Lost to Follow-up|0
1016636|NCT01554163|2040182|FG000|Overall Study|Non-Compliance With Study Drug|1
1016637|NCT01554163|2040183|FG001|Overall Study|Non-Compliance With Study Drug|1
1016638|NCT01554163|2040182|FG000|Overall Study|Protocol Violation|0
1016639|NCT01554163|2040183|FG001|Overall Study|Protocol Violation|4
1016640|NCT01554163|2040182|FG000|Overall Study|Withdrawal by Subject|1
1016641|NCT01554163|2040183|FG001|Overall Study|Withdrawal by Subject|5
1016642|NCT01554163|2040182|FG000|Overall Study|Not Treated|1
1016643|NCT01554163|2040183|FG001|Overall Study|Not Treated|0
1016644|NCT01554176|2040191|FG000|Treatment Phase|Protocol Violation|1
1016645|NCT01554176|2040192|FG001|Treatment Phase|Protocol Violation|2
1016646|NCT01554176|2040193|FG002|Treatment Phase|Protocol Violation|0
1016647|NCT01554176|2040194|FG003|Treatment Phase|Protocol Violation|0
1016648|NCT01554176|2040195|FG004|Treatment Phase|Protocol Violation|0
1016649|NCT01554176|2040191|FG000|Treatment Phase|Physician Decision|1
1016650|NCT01554176|2040192|FG001|Treatment Phase|Physician Decision|1
1016651|NCT01554176|2040193|FG002|Treatment Phase|Physician Decision|0
1016652|NCT01554176|2040194|FG003|Treatment Phase|Physician Decision|0
1016653|NCT01554176|2040195|FG004|Treatment Phase|Physician Decision|0
1016654|NCT01554176|2040191|FG000|Treatment Phase|Lack of Efficacy|0
1016655|NCT01554176|2040192|FG001|Treatment Phase|Lack of Efficacy|1
1016656|NCT01554176|2040193|FG002|Treatment Phase|Lack of Efficacy|0
1016657|NCT01554176|2040194|FG003|Treatment Phase|Lack of Efficacy|0
1016658|NCT01554176|2040195|FG004|Treatment Phase|Lack of Efficacy|0
1016659|NCT01554176|2040191|FG000|Treatment Phase|Adverse event, non-fatal|1
1016660|NCT01554176|2040192|FG001|Treatment Phase|Adverse event, non-fatal|1
1016661|NCT01554176|2040193|FG002|Treatment Phase|Adverse event, non-fatal|0
1016662|NCT01554176|2040194|FG003|Treatment Phase|Adverse event, non-fatal|0
1016663|NCT01554176|2040195|FG004|Treatment Phase|Adverse event, non-fatal|0
1016664|NCT01554176|2040191|FG000|Treatment Phase|Non-compliance with study drug|1
1016665|NCT01554176|2040192|FG001|Treatment Phase|Non-compliance with study drug|0
1016666|NCT01554176|2040193|FG002|Treatment Phase|Non-compliance with study drug|0
1016667|NCT01554176|2040194|FG003|Treatment Phase|Non-compliance with study drug|0
1016668|NCT01554176|2040195|FG004|Treatment Phase|Non-compliance with study drug|0
1016669|NCT01554176|2040191|FG000|Treatment Phase|Withdrawal by Subject|1
1016670|NCT01554176|2040192|FG001|Treatment Phase|Withdrawal by Subject|0
1016671|NCT01554176|2040193|FG002|Treatment Phase|Withdrawal by Subject|0
1016672|NCT01554176|2040194|FG003|Treatment Phase|Withdrawal by Subject|0
1016673|NCT01554176|2040195|FG004|Treatment Phase|Withdrawal by Subject|0
1016674|NCT01554176|2040191|FG000|Treatment Phase|Lost to Follow-up|3
1016675|NCT01554176|2040192|FG001|Treatment Phase|Lost to Follow-up|0
1016676|NCT01554176|2040193|FG002|Treatment Phase|Lost to Follow-up|0
1016677|NCT01554176|2040194|FG003|Treatment Phase|Lost to Follow-up|0
1016678|NCT01554176|2040195|FG004|Treatment Phase|Lost to Follow-up|0
1016679|NCT01554176|2040191|FG000|Run-out Phase|Protocol Violation|0
1016680|NCT01554176|2040192|FG001|Run-out Phase|Protocol Violation|0
1016681|NCT01554176|2040193|FG002|Run-out Phase|Protocol Violation|0
1016682|NCT01554176|2040194|FG003|Run-out Phase|Protocol Violation|1
1016683|NCT01554176|2040195|FG004|Run-out Phase|Protocol Violation|0
1016684|NCT01554241|2040211|FG000|Overall Study|Death|3
1016685|NCT01554241|2040212|FG001|Overall Study|Death|1
1016686|NCT01554241|2040213|FG002|Overall Study|Death|1
1016687|NCT01554241|2040214|FG003|Overall Study|Death|0
1016688|NCT01554241|2040211|FG000|Overall Study|protocol specified renal stone|0
1016689|NCT01554241|2040212|FG001|Overall Study|protocol specified renal stone|0
1016690|NCT01554241|2040213|FG002|Overall Study|protocol specified renal stone|0
1016691|NCT01554241|2040214|FG003|Overall Study|protocol specified renal stone|1
1016692|NCT01554241|2040211|FG000|Overall Study|protocol specified change in eGFR|0
1016693|NCT01554241|2040212|FG001|Overall Study|protocol specified change in eGFR|0
1016694|NCT01554241|2040213|FG002|Overall Study|protocol specified change in eGFR|1
1016695|NCT01554241|2040214|FG003|Overall Study|protocol specified change in eGFR|0
1016696|NCT01554241|2040211|FG000|Overall Study|Withdrawal by Subject|0
1016697|NCT01554241|2040212|FG001|Overall Study|Withdrawal by Subject|0
1016698|NCT01554241|2040213|FG002|Overall Study|Withdrawal by Subject|2
1016699|NCT01554241|2040214|FG003|Overall Study|Withdrawal by Subject|0
1016700|NCT01554514|2040249|FG000|Overall Study|1 patient ineligible with congenital TTP|1
1016701|NCT01554514|2040249|FG000|Overall Study|Physician Decision|1
1016702|NCT01554527|2040256|FG000|Overall Study|Withdrawal by Subject|1
1016703|NCT01554527|2040257|FG001|Overall Study|Withdrawal by Subject|0
1016704|NCT01554527|2040258|FG002|Overall Study|Withdrawal by Subject|3
1016705|NCT01554527|2040256|FG000|Overall Study|Lost to Follow-up|0
1016706|NCT01554527|2040257|FG001|Overall Study|Lost to Follow-up|0
1016707|NCT01554527|2040258|FG002|Overall Study|Lost to Follow-up|4
1016708|NCT01554527|2040256|FG000|Overall Study|Physician Decision|0
1016709|NCT01554527|2040257|FG001|Overall Study|Physician Decision|0
1016710|NCT01554527|2040258|FG002|Overall Study|Physician Decision|1
1016711|NCT01554579|2040269|FG000|Overall Study|Adverse Event|6
1016712|NCT01554579|2040270|FG001|Overall Study|Adverse Event|25
1016713|NCT01554579|2040269|FG000|Overall Study|Lack of Efficacy|2
1016714|NCT01554579|2040270|FG001|Overall Study|Lack of Efficacy|1
1016715|NCT01554579|2040269|FG000|Overall Study|Withdrawal by Subject|2
1016716|NCT01554579|2040270|FG001|Overall Study|Withdrawal by Subject|1
1016717|NCT01554618|2040279|FG000|Randomized Through Start of Treatment|Adverse Event|1
1016718|NCT01554618|2040280|FG001|Randomized Through Start of Treatment|Adverse Event|0
1016719|NCT01554618|2040279|FG000|Controlled Assessment Period|Lost to Follow-up|2
1016720|NCT01554618|2040280|FG001|Controlled Assessment Period|Lost to Follow-up|1
1016721|NCT01554618|2040279|FG000|Controlled Assessment Period|Withdrawal by Subject|6
1016722|NCT01554618|2040280|FG001|Controlled Assessment Period|Withdrawal by Subject|0
1016723|NCT01554618|2040279|FG000|Open-Label Extension Period|Withdrawal by Subject|2
1016724|NCT01554618|2040280|FG001|Open-Label Extension Period|Withdrawal by Subject|3
1016725|NCT01554618|2040279|FG000|Open-Label Extension Period|Physician Decision|0
1016726|NCT01554618|2040280|FG001|Open-Label Extension Period|Physician Decision|1
1016727|NCT01554618|2040279|FG000|Open-Label Extension Period|Lost to Follow-up|1
1016728|NCT01554618|2040280|FG001|Open-Label Extension Period|Lost to Follow-up|1
1016729|NCT01554904|2040316|FG000|Overall Study|Withdrawal by Subject|3
1016730|NCT01554904|2040316|FG000|Overall Study|Had sleep apnea on Home Study 1|1
1016731|NCT01555125|2040342|FG000|Induction Period|Lost to Follow-up|0
1016732|NCT01555125|2040343|FG001|Induction Period|Lost to Follow-up|2
1016733|NCT01555125|2040344|FG002|Induction Period|Lost to Follow-up|0
1016734|NCT01555125|2040345|FG003|Induction Period|Lost to Follow-up|0
1016735|NCT01555125|2040346|FG004|Induction Period|Lost to Follow-up|0
1016736|NCT01555125|2040342|FG000|Induction Period|Adverse Event|0
1016737|NCT01555125|2040343|FG001|Induction Period|Adverse Event|1
1016738|NCT01555125|2040344|FG002|Induction Period|Adverse Event|0
1016739|NCT01555125|2040345|FG003|Induction Period|Adverse Event|0
1016740|NCT01555125|2040346|FG004|Induction Period|Adverse Event|1
1016741|NCT01555125|2040342|FG000|Induction Period|Subject / guardian decision|0
1016742|NCT01555125|2040343|FG001|Induction Period|Subject / guardian decision|0
1016743|NCT01555125|2040344|FG002|Induction Period|Subject / guardian decision|0
1016744|NCT01555125|2040345|FG003|Induction Period|Subject / guardian decision|0
1016745|NCT01555125|2040346|FG004|Induction Period|Subject / guardian decision|2
1016746|NCT01555125|2040342|FG000|Induction Period|Death|1
1016747|NCT01555125|2040343|FG001|Induction Period|Death|0
1016748|NCT01555125|2040344|FG002|Induction Period|Death|0
1016749|NCT01555125|2040345|FG003|Induction Period|Death|0
1016750|NCT01555125|2040346|FG004|Induction Period|Death|0
1016751|NCT01555125|2040342|FG000|Maintenance Period|Adverse Event|1
1016752|NCT01555125|2040343|FG001|Maintenance Period|Adverse Event|1
1016753|NCT01555125|2040344|FG002|Maintenance Period|Adverse Event|0
1016754|NCT01555125|2040345|FG003|Maintenance Period|Adverse Event|0
1016755|NCT01555125|2040346|FG004|Maintenance Period|Adverse Event|0
1016756|NCT01555125|2040342|FG000|Maintenance Period|Subject / guardian decision|1
1016757|NCT01555125|2040343|FG001|Maintenance Period|Subject / guardian decision|2
1016758|NCT01555125|2040344|FG002|Maintenance Period|Subject / guardian decision|0
1016759|NCT01555125|2040345|FG003|Maintenance Period|Subject / guardian decision|0
1016760|NCT01555125|2040346|FG004|Maintenance Period|Subject / guardian decision|0
1016761|NCT01555125|2040342|FG000|Maintenance Period|Lost to Follow-up|2
1016762|NCT01555125|2040343|FG001|Maintenance Period|Lost to Follow-up|0
1016763|NCT01555125|2040344|FG002|Maintenance Period|Lost to Follow-up|0
1016764|NCT01555125|2040345|FG003|Maintenance Period|Lost to Follow-up|1
1016765|NCT01555125|2040346|FG004|Maintenance Period|Lost to Follow-up|0
1016766|NCT01555125|2040342|FG000|Maintenance Period|Lack of Efficacy|6
1016767|NCT01555125|2040343|FG001|Maintenance Period|Lack of Efficacy|1
1016768|NCT01555125|2040344|FG002|Maintenance Period|Lack of Efficacy|3
1016769|NCT01555125|2040345|FG003|Maintenance Period|Lack of Efficacy|0
1016770|NCT01555125|2040346|FG004|Maintenance Period|Lack of Efficacy|0
1016771|NCT01555125|2040342|FG000|Maintenance Period|Physician Decision|0
1016772|NCT01555125|2040343|FG001|Maintenance Period|Physician Decision|0
1016773|NCT01555125|2040344|FG002|Maintenance Period|Physician Decision|1
1016774|NCT01555125|2040345|FG003|Maintenance Period|Physician Decision|0
1016775|NCT01555125|2040346|FG004|Maintenance Period|Physician Decision|0
1016776|NCT01555125|2040342|FG000|Maintenance Period|Death|0
1016777|NCT01555125|2040343|FG001|Maintenance Period|Death|0
1016778|NCT01555125|2040344|FG002|Maintenance Period|Death|0
1016779|NCT01555125|2040345|FG003|Maintenance Period|Death|1
1016780|NCT01555125|2040346|FG004|Maintenance Period|Death|0
1016781|NCT01555125|2040342|FG000|Extension|Adverse Event|1
1016782|NCT01555125|2040343|FG001|Extension|Adverse Event|2
1016783|NCT01555125|2040344|FG002|Extension|Adverse Event|1
1016784|NCT01555125|2040345|FG003|Extension|Adverse Event|1
1016785|NCT01555125|2040346|FG004|Extension|Adverse Event|0
1016786|NCT01555125|2040342|FG000|Extension|Protocol deviation|1
1016787|NCT01555125|2040343|FG001|Extension|Protocol deviation|0
1016788|NCT01555125|2040344|FG002|Extension|Protocol deviation|0
1016789|NCT01555125|2040345|FG003|Extension|Protocol deviation|0
1016790|NCT01555125|2040346|FG004|Extension|Protocol deviation|0
1016791|NCT01555125|2040342|FG000|Extension|Lack of Efficacy|7
1016792|NCT01555125|2040343|FG001|Extension|Lack of Efficacy|6
1016793|NCT01555125|2040344|FG002|Extension|Lack of Efficacy|3
1016794|NCT01555125|2040345|FG003|Extension|Lack of Efficacy|0
1016795|NCT01555125|2040346|FG004|Extension|Lack of Efficacy|0
1016796|NCT01555125|2040342|FG000|Extension|Lost to Follow-up|2
1016797|NCT01555125|2040343|FG001|Extension|Lost to Follow-up|1
1016798|NCT01555125|2040344|FG002|Extension|Lost to Follow-up|2
1016799|NCT01555125|2040345|FG003|Extension|Lost to Follow-up|0
1016800|NCT01555125|2040346|FG004|Extension|Lost to Follow-up|0
1016801|NCT01555125|2040342|FG000|Extension|Study terminated by sponsor|32
1016802|NCT01555125|2040343|FG001|Extension|Study terminated by sponsor|33
1016803|NCT01555125|2040344|FG002|Extension|Study terminated by sponsor|16
1016804|NCT01555125|2040345|FG003|Extension|Study terminated by sponsor|20
1016805|NCT01555125|2040346|FG004|Extension|Study terminated by sponsor|0
1016806|NCT01555125|2040342|FG000|Extension|Subject/guardian decision|1
1016807|NCT01555125|2040343|FG001|Extension|Subject/guardian decision|9
1016808|NCT01555125|2040344|FG002|Extension|Subject/guardian decision|1
1016809|NCT01555125|2040345|FG003|Extension|Subject/guardian decision|0
1016810|NCT01555125|2040346|FG004|Extension|Subject/guardian decision|0
1016811|NCT01555125|2040342|FG000|Extension|Technical Problems|1
1016812|NCT01555125|2040343|FG001|Extension|Technical Problems|0
1016813|NCT01555125|2040344|FG002|Extension|Technical Problems|0
1016814|NCT01555125|2040345|FG003|Extension|Technical Problems|1
1016815|NCT01555125|2040346|FG004|Extension|Technical Problems|0
1016816|NCT01555125|2040342|FG000|Follow-Up Period|Lost to Follow-up|1
1016817|NCT01555125|2040343|FG001|Follow-Up Period|Lost to Follow-up|0
1016818|NCT01555125|2040344|FG002|Follow-Up Period|Lost to Follow-up|0
1016819|NCT01555125|2040345|FG003|Follow-Up Period|Lost to Follow-up|0
1016820|NCT01555125|2040346|FG004|Follow-Up Period|Lost to Follow-up|0
1016821|NCT01555125|2040342|FG000|Follow-Up Period|Subject / guardian decision|3
1016822|NCT01555125|2040343|FG001|Follow-Up Period|Subject / guardian decision|1
1016823|NCT01555125|2040344|FG002|Follow-Up Period|Subject / guardian decision|1
1016824|NCT01555125|2040345|FG003|Follow-Up Period|Subject / guardian decision|1
1016825|NCT01555125|2040346|FG004|Follow-Up Period|Subject / guardian decision|0
1016826|NCT01555138|2040363|FG000|Overall Study|Death|0
1016827|NCT01555138|2040364|FG001|Overall Study|Death|1
1016828|NCT01555138|2040363|FG000|Overall Study|Lost to Follow-up|1
1016829|NCT01555138|2040364|FG001|Overall Study|Lost to Follow-up|0
1016830|NCT01555138|2040363|FG000|Overall Study|Abnormal Lab reults|1
1016831|NCT01555138|2040364|FG001|Overall Study|Abnormal Lab reults|3
1016832|NCT01555138|2040363|FG000|Overall Study|Lack of Efficacy|2
1016833|NCT01555138|2040364|FG001|Overall Study|Lack of Efficacy|2
1016834|NCT01555138|2040363|FG000|Overall Study|Protocol Violation|5
1016835|NCT01555138|2040364|FG001|Overall Study|Protocol Violation|3
1016836|NCT01555138|2040363|FG000|Overall Study|Administrative problems|8
1016837|NCT01555138|2040364|FG001|Overall Study|Administrative problems|0
1016838|NCT01555138|2040363|FG000|Overall Study|Withdrawal by Subject|16
1016839|NCT01555138|2040364|FG001|Overall Study|Withdrawal by Subject|15
1016840|NCT01555138|2040363|FG000|Overall Study|Adverse Event|14
1016841|NCT01555138|2040364|FG001|Overall Study|Adverse Event|14
1016842|NCT01555151|2040374|FG000|Overall Study|Withdrawal by Subject|6
1016843|NCT01555151|2040375|FG001|Overall Study|Withdrawal by Subject|2
1016844|NCT01555151|2040376|FG002|Overall Study|Withdrawal by Subject|0
1016845|NCT01555151|2040377|FG003|Overall Study|Withdrawal by Subject|2
1016846|NCT01555151|2040374|FG000|Overall Study|Administrative|3
1016847|NCT01555151|2040375|FG001|Overall Study|Administrative|1
1016848|NCT01555151|2040376|FG002|Overall Study|Administrative|2
1016849|NCT01555151|2040377|FG003|Overall Study|Administrative|0
1016850|NCT01555151|2040374|FG000|Overall Study|Protocol Violation|3
1016851|NCT01555151|2040375|FG001|Overall Study|Protocol Violation|3
1016852|NCT01555151|2040376|FG002|Overall Study|Protocol Violation|3
1016853|NCT01555151|2040377|FG003|Overall Study|Protocol Violation|5
1016854|NCT01555151|2040374|FG000|Overall Study|Adverse Event|1
1016855|NCT01555151|2040375|FG001|Overall Study|Adverse Event|2
1016856|NCT01555151|2040376|FG002|Overall Study|Adverse Event|1
1016857|NCT01555151|2040377|FG003|Overall Study|Adverse Event|2
1016858|NCT01555151|2040374|FG000|Overall Study|Lost to Follow-up|0
1016859|NCT01555151|2040375|FG001|Overall Study|Lost to Follow-up|0
1016860|NCT01555151|2040376|FG002|Overall Study|Lost to Follow-up|0
1016861|NCT01555151|2040377|FG003|Overall Study|Lost to Follow-up|1
1016862|NCT01555164|2040390|FG000|Overall Study|Adverse Event|5
1016863|NCT01555164|2040391|FG001|Overall Study|Adverse Event|7
1016864|NCT01555164|2040390|FG000|Overall Study|Hyperglycemia|0
1016865|NCT01555164|2040391|FG001|Overall Study|Hyperglycemia|1
1016866|NCT01555164|2040390|FG000|Overall Study|Investigator's Discretion|2
1016867|NCT01555164|2040391|FG001|Overall Study|Investigator's Discretion|2
1016868|NCT01555164|2040390|FG000|Overall Study|Lost to Follow-up|4
1016869|NCT01555164|2040391|FG001|Overall Study|Lost to Follow-up|3
1016870|NCT01555164|2040390|FG000|Overall Study|Protocol Violation|9
1016871|NCT01555164|2040391|FG001|Overall Study|Protocol Violation|5
1016872|NCT01555164|2040390|FG000|Overall Study|Subject Non-compliance|14
1016873|NCT01555164|2040391|FG001|Overall Study|Subject Non-compliance|6
1016874|NCT01555164|2040390|FG000|Overall Study|Subject Withdrew Consent|6
1016875|NCT01555164|2040391|FG001|Overall Study|Subject Withdrew Consent|11
1016876|NCT01555463|2040399|FG000|Treatment|Adverse Event|6
1016877|NCT01555463|2040400|FG001|Treatment|Adverse Event|12
1016878|NCT01555463|2040399|FG000|Treatment|Withdrawal by Subject|24
1016879|NCT01555463|2040400|FG001|Treatment|Withdrawal by Subject|36
1016880|NCT01555463|2040399|FG000|Treatment|Lost to Follow-up|28
1016881|NCT01555463|2040400|FG001|Treatment|Lost to Follow-up|23
1016882|NCT01555463|2040399|FG000|Treatment|Protocol Violation|4
1016883|NCT01555463|2040400|FG001|Treatment|Protocol Violation|5
1016884|NCT01555463|2040399|FG000|Treatment|Other reason|2
1016885|NCT01555463|2040400|FG001|Treatment|Other reason|3
1016886|NCT01555463|2040399|FG000|Follow up|Adverse Event|2
1016887|NCT01555463|2040400|FG001|Follow up|Adverse Event|5
1016888|NCT01555463|2040399|FG000|Follow up|Death|0
1016889|NCT01555463|2040400|FG001|Follow up|Death|1
1016890|NCT01555463|2040399|FG000|Follow up|Withdrawal by Subject|22
1016891|NCT01555463|2040400|FG001|Follow up|Withdrawal by Subject|22
1016892|NCT01555463|2040399|FG000|Follow up|Lost to Follow-up|9
1016893|NCT01555463|2040400|FG001|Follow up|Lost to Follow-up|10
1016894|NCT01555463|2040399|FG000|Follow up|Protocol Violation|2
1016895|NCT01555463|2040400|FG001|Follow up|Protocol Violation|4
1016896|NCT01555463|2040399|FG000|Follow up|Other reason|3
1016897|NCT01555463|2040400|FG001|Follow up|Other reason|3
1016898|NCT01555671|2040430|FG000|Overall Study|Physician Decision|20
1016899|NCT01555671|2040431|FG001|Overall Study|Physician Decision|25
1016900|NCT01555762|2040466|FG000|Overall Study|No information on Bevacizumab intake|11
1016901|NCT01555762|2040466|FG000|Overall Study|Missing start date of infusion|8
1016902|NCT01555762|2040466|FG000|Overall Study|75 years old or more ticked No|1
1016903|NCT01555762|2040466|FG000|Overall Study|Treatment with Bevacizumab ticked No|24
1016904|NCT01555762|2040466|FG000|Overall Study|Death linked to progression of disease|165
1016905|NCT01555762|2040466|FG000|Overall Study|Lost follow-up/moved house/changed team|35
1016906|NCT01555762|2040466|FG000|Overall Study|Investigator's decision|10
1016907|NCT01555762|2040466|FG000|Overall Study|Participant not wishing to continue|5
1016908|NCT01555762|2040466|FG000|Overall Study|Missing data|1
1016909|NCT01555762|2040466|FG000|Overall Study|Death linked to an adverse event|14
1016910|NCT01555931|2040472|FG000|Overall Study|Lost to Follow-up|2
1016911|NCT01555931|2040473|FG001|Overall Study|Lost to Follow-up|5
1016912|NCT01555983|2040488|FG000|Overall Study|Withdrawal by Subject|1
1016913|NCT01555983|2040489|FG001|Overall Study|Withdrawal by Subject|0
1016914|NCT01555983|2040490|FG002|Overall Study|Withdrawal by Subject|0
1016915|NCT01555983|2040491|FG003|Overall Study|Withdrawal by Subject|0
1016916|NCT01555983|2040492|FG004|Overall Study|Withdrawal by Subject|1
1016917|NCT01555983|2040493|FG005|Overall Study|Withdrawal by Subject|1
1016918|NCT01556165|2040518|FG000|Overall Study|Adverse Event|5
1016919|NCT01556165|2040519|FG001|Overall Study|Adverse Event|3
1016920|NCT01556165|2040518|FG000|Overall Study|Protocol Violation|0
1016921|NCT01556165|2040519|FG001|Overall Study|Protocol Violation|3
1016922|NCT01556165|2040518|FG000|Overall Study|Withdrawal of Consent|7
1016923|NCT01556165|2040519|FG001|Overall Study|Withdrawal of Consent|1
1016924|NCT01556438|2040581|FG000|Overall Study|Adverse Event|4
1016925|NCT01556438|2040582|FG001|Overall Study|Adverse Event|2
1016926|NCT01556438|2040581|FG000|Overall Study|Sponsor Decision|0
1016927|NCT01556438|2040582|FG001|Overall Study|Sponsor Decision|2
1016928|NCT01556438|2040581|FG000|Overall Study|Progressive Disease|0
1016929|NCT01556438|2040582|FG001|Overall Study|Progressive Disease|6
1016930|NCT01556438|2040581|FG000|Overall Study|Death|0
1016931|NCT01556438|2040582|FG001|Overall Study|Death|1
1016932|NCT01556763|2040651|FG000|Overall Study|Withdrawal by Subject|0
1016933|NCT01556763|2040652|FG001|Overall Study|Withdrawal by Subject|1
1016934|NCT01556763|2040653|FG002|Overall Study|Withdrawal by Subject|0
1016935|NCT01556932|2040667|FG000|Time Point 60 Minutes|Withdrawal by Subject|1
1016936|NCT01556932|2040668|FG001|Time Point 60 Minutes|Withdrawal by Subject|1
1016937|NCT01556997|2040676|FG000|Overall Study|Adverse Event|10
1016938|NCT01556997|2040677|FG001|Overall Study|Adverse Event|12
1016939|NCT01556997|2040678|FG002|Overall Study|Adverse Event|12
1016940|NCT01556997|2040676|FG000|Overall Study|Lost to Follow-up|6
1016941|NCT01556997|2040677|FG001|Overall Study|Lost to Follow-up|6
1016942|NCT01556997|2040678|FG002|Overall Study|Lost to Follow-up|4
1016943|NCT01556997|2040676|FG000|Overall Study|Physician Decision|1
1016944|NCT01556997|2040677|FG001|Overall Study|Physician Decision|1
1016945|NCT01556997|2040678|FG002|Overall Study|Physician Decision|1
1016946|NCT01556997|2040676|FG000|Overall Study|Withdrawal by Subject|7
1016947|NCT01556997|2040677|FG001|Overall Study|Withdrawal by Subject|6
1016948|NCT01556997|2040678|FG002|Overall Study|Withdrawal by Subject|8
1016949|NCT01556997|2040676|FG000|Overall Study|Other|2
1016950|NCT01556997|2040677|FG001|Overall Study|Other|3
1016951|NCT01556997|2040678|FG002|Overall Study|Other|7
1016952|NCT01557166|2040688|FG000|Overall Study|Adverse Event|20
1016953|NCT01557166|2040689|FG001|Overall Study|Adverse Event|6
1016954|NCT01557166|2040688|FG000|Overall Study|Lack of Efficacy|2
1016955|NCT01557166|2040689|FG001|Overall Study|Lack of Efficacy|1
1016956|NCT01557166|2040688|FG000|Overall Study|Protocol Violation|8
1016957|NCT01557166|2040689|FG001|Overall Study|Protocol Violation|5
1016958|NCT01557166|2040688|FG000|Overall Study|Withdrawn consent|12
1016959|NCT01557166|2040689|FG001|Overall Study|Withdrawn consent|20
1016960|NCT01557166|2040688|FG000|Overall Study|Target dose not tolerated|1
1016961|NCT01557166|2040689|FG001|Overall Study|Target dose not tolerated|0
1016962|NCT01557166|2040688|FG000|Overall Study|Psychiatric disorder|1
1016963|NCT01557166|2040689|FG001|Overall Study|Psychiatric disorder|0
1016964|NCT01557166|2040688|FG000|Overall Study|Unclassified|2
1016965|NCT01557166|2040689|FG001|Overall Study|Unclassified|5
1016966|NCT01557244|2040700|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
1016967|NCT01557244|2040701|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
1016968|NCT01557244|2040702|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
1016969|NCT01557244|2040703|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
1016970|NCT01557244|2040704|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
1016971|NCT01557244|2040705|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
1016972|NCT01557244|2040706|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
1016973|NCT01557244|2040700|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2
1016974|NCT01557244|2040701|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
1016975|NCT01557244|2040702|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1
1016976|NCT01557244|2040703|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
1016977|NCT01557244|2040704|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
1016978|NCT01557244|2040705|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
1016979|NCT01557244|2040706|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
1016980|NCT01557244|2040700|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1
1016981|NCT01557244|2040701|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
1016982|NCT01557244|2040702|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
1016983|NCT01557244|2040703|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
1016984|NCT01557244|2040704|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
1016985|NCT01557244|2040705|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
1016986|NCT01557244|2040706|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
1016987|NCT01557244|2040700|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2
1016988|NCT01557244|2040701|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
1016989|NCT01557244|2040702|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
1016990|NCT01557244|2040703|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
1016991|NCT01557244|2040704|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
1016992|NCT01557244|2040705|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3
1016993|NCT01557244|2040706|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
1016994|NCT01557244|2040700|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
1016995|NCT01557244|2040701|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1
1016996|NCT01557244|2040702|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
1016997|NCT01557244|2040703|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
1016998|NCT01557244|2040704|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
1016999|NCT01557244|2040705|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
1017000|NCT01557244|2040706|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
1017001|NCT01557244|2040700|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
1017002|NCT01557244|2040701|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
1017003|NCT01557244|2040702|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
1017004|NCT01557244|2040703|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
1017005|NCT01557244|2040704|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
1017006|NCT01557244|2040705|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
1017007|NCT01557244|2040706|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
1017008|NCT01557244|2040700|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
1017009|NCT01557244|2040701|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
1017010|NCT01557244|2040702|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
1017011|NCT01557244|2040703|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
1017012|NCT01557244|2040704|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
1017013|NCT01557244|2040705|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
1017014|NCT01557244|2040706|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
1017015|NCT01557244|2040700|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2
1017016|NCT01557244|2040701|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0
1017017|NCT01557244|2040702|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2
1017018|NCT01557244|2040703|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0
1017019|NCT01557244|2040704|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0
1017020|NCT01557244|2040705|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0
1017021|NCT01557244|2040706|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0
1017022|NCT01557244|2040700|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1
1017023|NCT01557244|2040701|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1
1017024|NCT01557244|2040702|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0
1017025|NCT01557244|2040703|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0
1017026|NCT01557244|2040704|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0
1017027|NCT01557244|2040705|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1
1017028|NCT01557244|2040706|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0
1017029|NCT01557244|2040700|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
1017030|NCT01557244|2040701|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
1017031|NCT01557244|2040702|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
1017032|NCT01557244|2040703|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
1017033|NCT01557244|2040704|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
1017034|NCT01557244|2040705|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
1017035|NCT01557244|2040706|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
1017036|NCT01557244|2040700|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
1017037|NCT01557244|2040701|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
1017038|NCT01557244|2040702|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
1017039|NCT01557244|2040703|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1
1017040|NCT01557244|2040704|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
1017041|NCT01557244|2040705|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
1017042|NCT01557244|2040706|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
1017043|NCT01557244|2040700|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1
1017044|NCT01557244|2040701|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2
1017045|NCT01557244|2040702|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
1017046|NCT01557244|2040703|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
1017047|NCT01557244|2040704|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
1017048|NCT01557244|2040705|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
1017049|NCT01557244|2040706|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
1017050|NCT01557283|2040734|FG000|Overall Study|Lost to Follow-up|7
1017051|NCT01557283|2040734|FG000|Overall Study|Non-responder|19
1017052|NCT01557283|2040734|FG000|Overall Study|Adverse Event|7
1017053|NCT01557283|2040734|FG000|Overall Study|Lack of Efficacy|1
1017054|NCT01557283|2040734|FG000|Overall Study|Non-compliance|1
1017055|NCT01557283|2040734|FG000|Overall Study|Withdrawal by Subject|1
1017056|NCT01557283|2040734|FG000|Overall Study|Participant's weight too high for dose|1
1017057|NCT01557283|2040734|FG000|Overall Study|Worsening of psoriasis|1
1017058|NCT01557283|2040734|FG000|Overall Study|Other|6
1017059|NCT01557348|2040749|FG000|Overall Study|Adverse Event|6
1017060|NCT01557348|2040750|FG001|Overall Study|Adverse Event|16
1017061|NCT01557348|2040749|FG000|Overall Study|Infusion reaction event|5
1017062|NCT01557348|2040750|FG001|Overall Study|Infusion reaction event|5
1017063|NCT01557348|2040749|FG000|Overall Study|Death|7
1017064|NCT01557348|2040750|FG001|Overall Study|Death|4
1017065|NCT01557348|2040749|FG000|Overall Study|Insufficient Therapeutic Response|13
1017066|NCT01557348|2040750|FG001|Overall Study|Insufficient Therapeutic Response|28
1017067|NCT01557348|2040749|FG000|Overall Study|Withdrawal by Subject|5
1017068|NCT01557348|2040750|FG001|Overall Study|Withdrawal by Subject|4
1017069|NCT01557348|2040749|FG000|Overall Study|Lost to Follow-up|26
1017070|NCT01557348|2040750|FG001|Overall Study|Lost to Follow-up|22
1017071|NCT01557348|2040749|FG000|Overall Study|Administrative|18
1017072|NCT01557348|2040750|FG001|Overall Study|Administrative|11
1017073|NCT01557400|2040757|FG000|Overall Study|Transitioned to Commercial Drug Product|40
1017074|NCT01557400|2040757|FG000|Overall Study|Adverse Event|3
1017075|NCT01557400|2040757|FG000|Overall Study|Lost to Follow-up|5
1017076|NCT01557400|2040757|FG000|Overall Study|Withdrawal by Subject|9
1017077|NCT01557504|2040768|FG000|Overall Study|Physician Decision|1
1017078|NCT01557504|2040769|FG001|Overall Study|Physician Decision|0
1017079|NCT01557517|2040783|FG000|Overall Study|Death|1
1017080|NCT01557517|2040784|FG001|Overall Study|Death|0
1017081|NCT01557517|2040783|FG000|Overall Study|Refused further treatment|0
1017082|NCT01557517|2040784|FG001|Overall Study|Refused further treatment|2
1017083|NCT01557517|2040783|FG000|Overall Study|Adverse Event|0
1017084|NCT01557517|2040784|FG001|Overall Study|Adverse Event|2
1017085|NCT01557517|2040783|FG000|Overall Study|Pt declined before treatment started|1
1017086|NCT01557517|2040784|FG001|Overall Study|Pt declined before treatment started|0
1017087|NCT01557569|2040799|FG000|Overall Study|Adverse Event|2
1017088|NCT01557569|2040800|FG001|Overall Study|Adverse Event|0
1017089|NCT01557569|2040799|FG000|Overall Study|high blood pressure|0
1017090|NCT01557569|2040800|FG001|Overall Study|high blood pressure|1
1017091|NCT01557569|2040799|FG000|Overall Study|Withdrawal by Subject|3
1017092|NCT01557569|2040800|FG001|Overall Study|Withdrawal by Subject|5
1017093|NCT01557569|2040799|FG000|Overall Study|noncompliance with rules of residential|0
1017094|NCT01557569|2040800|FG001|Overall Study|noncompliance with rules of residential|1
1017095|NCT01557582|2040806|FG000|Overall Study|Protocol Violation|4
1017096|NCT01557582|2040806|FG000|Overall Study|Operator error|2
1017097|NCT01557751|2040830|FG000|Overall Study|Physician Decision|3
1017098|NCT01557842|2040840|FG000|Overall Study|Lost to Follow-up|0
1017099|NCT01557842|2040841|FG001|Overall Study|Lost to Follow-up|1
1017100|NCT01557842|2040840|FG000|Overall Study|Death|1
1017101|NCT01557842|2040841|FG001|Overall Study|Death|0
1017102|NCT01557842|2040840|FG000|Overall Study|Lack of Efficacy|0
1017103|NCT01557842|2040841|FG001|Overall Study|Lack of Efficacy|1
1017104|NCT01557842|2040840|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
1017105|NCT01557842|2040841|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
1017106|NCT01557842|2040840|FG000|Overall Study|Study Terminated by Sponsor|3
1017107|NCT01557842|2040841|FG001|Overall Study|Study Terminated by Sponsor|4
1017108|NCT01557842|2040840|FG000|Overall Study|Not Ablated|2
1017109|NCT01557842|2040841|FG001|Overall Study|Not Ablated|0
1017110|NCT01557920|2040866|FG000|Overall Study|Withdrawal by Subject|2
1017111|NCT01557920|2040867|FG001|Overall Study|Withdrawal by Subject|3
1017112|NCT01557920|2040866|FG000|Overall Study|Lack of Efficacy|1
1017113|NCT01557920|2040867|FG001|Overall Study|Lack of Efficacy|0
1017114|NCT01557946|2040902|FG000|Overall Study|Adverse Event|3
1017115|NCT01557946|2040903|FG001|Overall Study|Adverse Event|0
1017116|NCT01558089|2040934|FG000|Overall Study|Adverse Event|1
1017117|NCT01558089|2040934|FG000|Overall Study|Lack of Efficacy|1
1017118|NCT01558089|2040934|FG000|Overall Study|Lost to Follow-up|5
1017119|NCT01558089|2040934|FG000|Overall Study|Withdrawal by Subject|6
1017120|NCT01558271|2040945|FG000|Overall Study|Adverse Event|6
1017121|NCT01558271|2040946|FG001|Overall Study|Adverse Event|3
1017122|NCT01558271|2040947|FG002|Overall Study|Adverse Event|4
1017123|NCT01558271|2040945|FG000|Overall Study|Lost to Follow-up|1
1017124|NCT01558271|2040946|FG001|Overall Study|Lost to Follow-up|0
1017125|NCT01558271|2040947|FG002|Overall Study|Lost to Follow-up|0
1017126|NCT01558271|2040945|FG000|Overall Study|Protocol Violation|1
1017127|NCT01558271|2040946|FG001|Overall Study|Protocol Violation|0
1017128|NCT01558271|2040947|FG002|Overall Study|Protocol Violation|0
1017129|NCT01558271|2040945|FG000|Overall Study|Withdrawal by Subject|10
1017130|NCT01558271|2040946|FG001|Overall Study|Withdrawal by Subject|6
1017131|NCT01558271|2040947|FG002|Overall Study|Withdrawal by Subject|12
1017132|NCT01558271|2040945|FG000|Overall Study|Physician Decision|0
1017133|NCT01558271|2040946|FG001|Overall Study|Physician Decision|2
1017134|NCT01558271|2040947|FG002|Overall Study|Physician Decision|1
1017135|NCT01558297|2040962|FG000|Overall Study|Withdrawal by Subject|2
1017136|NCT01558297|2040963|FG001|Overall Study|Withdrawal by Subject|2
1017137|NCT01558297|2040964|FG002|Overall Study|Withdrawal by Subject|1
1017138|NCT01558596|2040974|FG000|Overall Study|Withdrawal by Subject|1
1017139|NCT01558596|2040975|FG001|Overall Study|Withdrawal by Subject|0
1017140|NCT01558596|2040974|FG000|Overall Study|surgery elsewhere or cancelled|1
1017141|NCT01558596|2040975|FG001|Overall Study|surgery elsewhere or cancelled|1
1017142|NCT01558596|2040974|FG000|Overall Study|Protocol Violation|1
1017143|NCT01558596|2040975|FG001|Overall Study|Protocol Violation|0
1017144|NCT01558635|2040981|FG000|Overall Study|Death|1
1017145|NCT01558635|2040981|FG000|Overall Study|Withdrawal by Subject|2
1017146|NCT01558635|2040981|FG000|Overall Study|Physician Decision|1
1017147|NCT01558635|2040981|FG000|Overall Study|Subject received other treatment|1
1017148|NCT01558635|2040981|FG000|Overall Study|Reveal XT was explanted|1
1017149|NCT01558674|2040998|FG000|Part 1|Study Terminated by Sponsor|10
1017150|NCT01558674|2040999|FG001|Part 1|Study Terminated by Sponsor|0
1017151|NCT01558674|2040998|FG000|Part 1|Withdrawal by Subject|1
1017152|NCT01558674|2040999|FG001|Part 1|Withdrawal by Subject|0
1017153|NCT01558739|2041027|FG000|Overall Study|Adverse Event|7
1017154|NCT01558739|2041027|FG000|Overall Study|Withdrawal by Subject|2
1017155|NCT01558739|2041027|FG000|Overall Study|Death|3
1017156|NCT01558739|2041027|FG000|Overall Study|Disease Progression|4
1017157|NCT01558739|2041027|FG000|Overall Study|Protocol Violation|1
1017158|NCT01558752|2041033|FG000|Overall Study|Physician Decision|2
1017159|NCT01558752|2041034|FG001|Overall Study|Physician Decision|0
1017160|NCT01559012|2041053|FG000|Overall Study|Withdrawal by Subject|0
1017161|NCT01559012|2041054|FG001|Overall Study|Withdrawal by Subject|1
1017162|NCT01559090|2041091|FG000|Stage I|Withdrawal by Subject|2
1017163|NCT01559090|2041092|FG001|Stage I|Withdrawal by Subject|2
1017164|NCT01559090|2041093|FG002|Stage I|Withdrawal by Subject|3
1017165|NCT01559090|2041091|FG000|Stage II|Withdrawal by Subject|1
1017166|NCT01559090|2041092|FG001|Stage II|Withdrawal by Subject|0
1017167|NCT01559090|2041093|FG002|Stage II|Withdrawal by Subject|0
1017168|NCT01559116|2041101|FG000|Overall Study|Adverse Event|10
1017169|NCT01559116|2041101|FG000|Overall Study|Lack of Efficacy|1
1017170|NCT01559116|2041101|FG000|Overall Study|Lost to Follow-up|1
1017171|NCT01559116|2041101|FG000|Overall Study|Protocol Violation|1
1017172|NCT01559116|2041101|FG000|Overall Study|Withdrawal by Subject|4
1017173|NCT01559116|2041101|FG000|Overall Study|other than stated above|9
1017174|NCT01559129|2041120|FG000|Treatment Phase|Adverse Event|0
1017175|NCT01559129|2041121|FG001|Treatment Phase|Adverse Event|2
1017176|NCT01559129|2041120|FG000|Treatment Phase|Progressive Disease|1
1017177|NCT01559129|2041121|FG001|Treatment Phase|Progressive Disease|1
1017178|NCT01559129|2041120|FG000|Treatment Phase|Lack of Efficacy|0
1017179|NCT01559129|2041121|FG001|Treatment Phase|Lack of Efficacy|1
1017180|NCT01559129|2041120|FG000|Treatment Phase|Study Terminated by Sponsor|3
1017181|NCT01559129|2041121|FG001|Treatment Phase|Study Terminated by Sponsor|2
1017182|NCT01559129|2041120|FG000|Treatment Phase|Protocol Exclusion Criteria|1
1017183|NCT01559129|2041121|FG001|Treatment Phase|Protocol Exclusion Criteria|0
1017184|NCT01559129|2041120|FG000|Treatment Phase|Did Not Receive Study Drug|0
1017185|NCT01559129|2041121|FG001|Treatment Phase|Did Not Receive Study Drug|1
1017186|NCT01559129|2041120|FG000|Open-label Extension Period|Adverse Event|1
1017187|NCT01559129|2041121|FG001|Open-label Extension Period|Adverse Event|0
1017188|NCT01559129|2041120|FG000|Open-label Extension Period|Study Terminated by Sponsor|5
1017189|NCT01559129|2041121|FG001|Open-label Extension Period|Study Terminated by Sponsor|2
1017190|NCT01559259|2041138|FG000|Overall Study|Withdrawal by Subject|0
1017191|NCT01559259|2041139|FG001|Overall Study|Withdrawal by Subject|0
1017192|NCT01559259|2041140|FG002|Overall Study|Withdrawal by Subject|0
1017193|NCT01559259|2041141|FG003|Overall Study|Withdrawal by Subject|1
1017194|NCT01559259|2041142|FG004|Overall Study|Withdrawal by Subject|0
1017195|NCT01559259|2041138|FG000|Overall Study|Adverse Event|0
1017196|NCT01559259|2041139|FG001|Overall Study|Adverse Event|1
1017197|NCT01559259|2041140|FG002|Overall Study|Adverse Event|1
1017198|NCT01559259|2041141|FG003|Overall Study|Adverse Event|0
1017199|NCT01559259|2041142|FG004|Overall Study|Adverse Event|0
1017200|NCT01559311|2041157|FG000|Overall Study|Protocol Violation|0
1017201|NCT01559311|2041158|FG001|Overall Study|Protocol Violation|0
1017202|NCT01559311|2041159|FG002|Overall Study|Protocol Violation|2
1017203|NCT01559311|2041157|FG000|Overall Study|Difficulty in cannulating the lateral ve|1
1017204|NCT01559311|2041158|FG001|Overall Study|Difficulty in cannulating the lateral ve|0
1017205|NCT01559311|2041159|FG002|Overall Study|Difficulty in cannulating the lateral ve|0
1017206|NCT01559311|2041157|FG000|Overall Study|Withdrawal by Subject|2
1017207|NCT01559311|2041158|FG001|Overall Study|Withdrawal by Subject|1
1017208|NCT01559311|2041159|FG002|Overall Study|Withdrawal by Subject|0
1017209|NCT01559311|2041157|FG000|Overall Study|Death|0
1017210|NCT01559311|2041158|FG001|Overall Study|Death|2
1017211|NCT01559311|2041159|FG002|Overall Study|Death|3
1017212|NCT01559311|2041157|FG000|Overall Study|Lost to Follow-up|0
1017213|NCT01559311|2041158|FG001|Overall Study|Lost to Follow-up|3
1017214|NCT01559311|2041159|FG002|Overall Study|Lost to Follow-up|2
1017215|NCT01559311|2041157|FG000|Overall Study|Adverse Event|0
1017216|NCT01559311|2041158|FG001|Overall Study|Adverse Event|0
1017217|NCT01559311|2041159|FG002|Overall Study|Adverse Event|1
1017218|NCT01559389|2041169|FG000|Overall Study|Withdrawal by Subject|20
1017219|NCT01559389|2041170|FG001|Overall Study|Withdrawal by Subject|20
1017220|NCT01559454|2041182|FG000|Overall Study|Lost to Follow-up|3
1017221|NCT01559454|2041183|FG001|Overall Study|Lost to Follow-up|2
1017222|NCT01559454|2041182|FG000|Overall Study|Withdrawal by Subject|0
1017223|NCT01559454|2041183|FG001|Overall Study|Withdrawal by Subject|1
1017224|NCT01559454|2041182|FG000|Overall Study|Physician Decision|0
1017225|NCT01559454|2041183|FG001|Overall Study|Physician Decision|1
1017226|NCT01559454|2041182|FG000|Overall Study|Protocol Violation|0
1017227|NCT01559454|2041183|FG001|Overall Study|Protocol Violation|1
1017228|NCT01559454|2041182|FG000|Overall Study|Lack of Efficacy|0
1017229|NCT01559454|2041183|FG001|Overall Study|Lack of Efficacy|1
1017230|NCT01559675|2041210|FG000|Overall Study|Protocol Violation|1
1017231|NCT01559675|2041211|FG001|Overall Study|Protocol Violation|2
1017232|NCT01559675|2041210|FG000|Overall Study|2nd operation on same patient excluded|14
1017233|NCT01559675|2041211|FG001|Overall Study|2nd operation on same patient excluded|12
1017234|NCT01559844|2041217|FG000|Overall Study|Consent Withdrawn|7
1017235|NCT01559844|2041217|FG000|Overall Study|Death|5
1017236|NCT01559844|2041217|FG000|Overall Study|Efficacy Failure|10
1017237|NCT01559844|2041217|FG000|Overall Study|No Longer A Transplant Candidate|3
1017238|NCT01559935|2041241|FG000|Car Phase|Toxicity|4
1017239|NCT01559935|2041241|FG000|Car Phase|Death|1
1017240|NCT01559935|2041241|FG000|Car Phase|Lack of Efficacy|2
1017241|NCT01559935|2041241|FG000|Car Phase|Lost to Follow-up|1
1017242|NCT01559935|2041241|FG000|Car Phase|Physician Decision|1
1017243|NCT01559935|2041241|FG000|Car Phase|Withdrawal by Subject|2
1017244|NCT01559935|2041241|FG000|Car Phase|Per protocol|1
1017245|NCT01559935|2041241|FG000|Car Phase|Insurance|1
1017246|NCT01559935|2041241|FG000|Car Phase|non-compliance|1
1017247|NCT01559935|2041241|FG000|BiRD Phase|Toxicity|1
1017248|NCT01559935|2041241|FG000|BiRD Phase|Lack of Efficacy|1
1017249|NCT01559935|2041241|FG000|BiRD Phase|Withdrawal by Subject|2
1017250|NCT01559935|2041241|FG000|Maintenance Phase|Remains on study|28
1017251|NCT01559935|2041241|FG000|Maintenance Phase|Toxicity|1
1017252|NCT01559935|2041241|FG000|Maintenance Phase|Lack of Efficacy|18
1017253|NCT01559935|2041241|FG000|Maintenance Phase|Withdrawal by Subject|5
1017254|NCT01559935|2041241|FG000|Maintenance Phase|Non-compliance|2
1017255|NCT01560234|2041270|FG000|Overall Study|Lost to Follow-up|3
1017256|NCT01560234|2041271|FG001|Overall Study|Lost to Follow-up|0
1017257|NCT01560234|2041272|FG002|Overall Study|Lost to Follow-up|1
1017258|NCT01560234|2041273|FG003|Overall Study|Lost to Follow-up|0
1017259|NCT01560234|2041274|FG004|Overall Study|Lost to Follow-up|0
1017260|NCT01560234|2041275|FG005|Overall Study|Lost to Follow-up|2
1017261|NCT01560234|2041276|FG006|Overall Study|Lost to Follow-up|0
1017262|NCT01560234|2041277|FG007|Overall Study|Lost to Follow-up|2
1017263|NCT01560403|2041311|FG000|Overall Study|Lost to Follow-up|0
1017264|NCT01560403|2041312|FG001|Overall Study|Lost to Follow-up|1
1017265|NCT01560416|2041320|FG000|Randomized Phase|Crossover Participants|7
1017266|NCT01560416|2041321|FG001|Randomized Phase|Crossover Participants|0
1017267|NCT01560429|2041331|FG000|Overall Study|Protocol Violation|3
1017268|NCT01560429|2041332|FG001|Overall Study|Protocol Violation|6
1017269|NCT01560780|2041351|FG000|Overall Study|Death|2
1017270|NCT01560780|2041352|FG001|Overall Study|Death|1
1017271|NCT01560780|2041351|FG000|Overall Study|Patient Preference|11
1017272|NCT01560780|2041352|FG001|Overall Study|Patient Preference|11
1017273|NCT01560819|2041360|FG000|Overall Study|Physician Decision|1
1017274|NCT01560819|2041361|FG001|Overall Study|Physician Decision|0
1017275|NCT01560871|2041367|FG000|Overall Study|transportation issues|2
1017276|NCT01560871|2041368|FG001|Overall Study|transportation issues|1
1017277|NCT01560871|2041367|FG000|Overall Study|relocation|1
1017278|NCT01560871|2041368|FG001|Overall Study|relocation|0
1017279|NCT01560871|2041367|FG000|Overall Study|readmission to a hospital|2
1017280|NCT01560871|2041368|FG001|Overall Study|readmission to a hospital|1
1017281|NCT01560871|2041367|FG000|Overall Study|Lost to Follow-up|1
1017282|NCT01560871|2041368|FG001|Overall Study|Lost to Follow-up|0
1017283|NCT01560949|2041384|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6
1017284|NCT01560949|2041384|FG000|Surgery Phase|Physician Decision|3
1017285|NCT01560988|2041400|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7
1017286|NCT01560988|2041401|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4
1017287|NCT01560988|2041400|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3
1017288|NCT01560988|2041401|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0
1017289|NCT01560988|2041400|FG000|Washout (Six Weeks)|Lost to Follow-up|2
1017290|NCT01560988|2041401|FG001|Washout (Six Weeks)|Lost to Follow-up|2
1017291|NCT01561079|2041430|FG000|Overall Study|Physician Decision|17
1017292|NCT01561079|2041430|FG000|Overall Study|Withdrawal by Subject|59
1017293|NCT01561079|2041430|FG000|Overall Study|Protocol Violation|2
1017294|NCT01561300|2041473|FG000|Run in on Placebo|Adverse Event|1
1017295|NCT01561300|2041474|FG001|Run in on Placebo|Adverse Event|0
1017296|NCT01561313|2041483|FG000|Overall Study|Withdrawal by Subject|1
1017297|NCT01561313|2041484|FG001|Overall Study|Withdrawal by Subject|0
1017298|NCT01561313|2041483|FG000|Overall Study|Adverse event and withdrawal by subject|1
1017299|NCT01561313|2041484|FG001|Overall Study|Adverse event and withdrawal by subject|0
1017300|NCT01561560|2041517|FG000|First Two Weeks of Wear|Time/job conflict|0
1017301|NCT01561560|2041518|FG001|First Two Weeks of Wear|Time/job conflict|1
1017302|NCT01561560|2041517|FG000|First Two Weeks of Wear|Adverse Event|0
1017303|NCT01561560|2041518|FG001|First Two Weeks of Wear|Adverse Event|1
1017304|NCT01561560|2041517|FG000|Second Two Weeks of Wear|Adverse Event|0
1017305|NCT01561560|2041518|FG001|Second Two Weeks of Wear|Adverse Event|1
1017306|NCT01561755|2041560|FG000|Overall Study|Lost to Follow-up|0
1017307|NCT01561755|2041561|FG001|Overall Study|Lost to Follow-up|1
1017308|NCT01561898|2041575|FG000|Overall Study|Withdrawal by Subject|0
1017309|NCT01561898|2041576|FG001|Overall Study|Withdrawal by Subject|8
1017310|NCT01561898|2041577|FG002|Overall Study|Withdrawal by Subject|12
1017311|NCT01561898|2041578|FG003|Overall Study|Withdrawal by Subject|5
1017312|NCT01561898|2041575|FG000|Overall Study|Lack of Efficacy|0
1017313|NCT01561898|2041576|FG001|Overall Study|Lack of Efficacy|8
1017314|NCT01561898|2041577|FG002|Overall Study|Lack of Efficacy|10
1017315|NCT01561898|2041578|FG003|Overall Study|Lack of Efficacy|5
1017316|NCT01561898|2041575|FG000|Overall Study|Worsening of complications|0
1017317|NCT01561898|2041576|FG001|Overall Study|Worsening of complications|1
1017318|NCT01561898|2041577|FG002|Overall Study|Worsening of complications|0
1017319|NCT01561898|2041578|FG003|Overall Study|Worsening of complications|0
1017320|NCT01561898|2041575|FG000|Overall Study|Lost to Follow-up|0
1017321|NCT01561898|2041576|FG001|Overall Study|Lost to Follow-up|0
1017322|NCT01561898|2041577|FG002|Overall Study|Lost to Follow-up|1
1017323|NCT01561898|2041578|FG003|Overall Study|Lost to Follow-up|0
1017324|NCT01561898|2041575|FG000|Overall Study|Adverse Event|1
1017325|NCT01561898|2041576|FG001|Overall Study|Adverse Event|19
1017326|NCT01561898|2041577|FG002|Overall Study|Adverse Event|14
1017327|NCT01561898|2041578|FG003|Overall Study|Adverse Event|9
1017328|NCT01561898|2041575|FG000|Overall Study|Physician Decision|1
1017329|NCT01561898|2041576|FG001|Overall Study|Physician Decision|5
1017330|NCT01561898|2041577|FG002|Overall Study|Physician Decision|7
1017331|NCT01561898|2041578|FG003|Overall Study|Physician Decision|1
1017332|NCT01561963|2041586|FG000|Overall Study|Adverse Event|1
1017333|NCT01561976|2041601|FG000|Period 1|Adverse Event|0
1017334|NCT01561976|2041602|FG001|Period 1|Adverse Event|0
1017335|NCT01561976|2041603|FG002|Period 1|Adverse Event|1
1017336|NCT01561976|2041604|FG003|Period 1|Adverse Event|0
1017337|NCT01561976|2041605|FG004|Period 1|Adverse Event|0
1017338|NCT01561976|2041606|FG005|Period 1|Adverse Event|0
1017339|NCT01561976|2041601|FG000|Washout Period 1 (7 Days)|Adverse Event|0
1017340|NCT01561976|2041602|FG001|Washout Period 1 (7 Days)|Adverse Event|0
1017341|NCT01561976|2041603|FG002|Washout Period 1 (7 Days)|Adverse Event|0
1017342|NCT01561976|2041604|FG003|Washout Period 1 (7 Days)|Adverse Event|1
1017343|NCT01561976|2041605|FG004|Washout Period 1 (7 Days)|Adverse Event|0
1017344|NCT01561976|2041606|FG005|Washout Period 1 (7 Days)|Adverse Event|0
1017345|NCT01561976|2041601|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1017346|NCT01561976|2041602|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1017347|NCT01561976|2041603|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1017348|NCT01561976|2041604|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1017349|NCT01561976|2041605|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1017350|NCT01561976|2041606|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1017351|NCT01561976|2041601|FG000|Washout Period 2 (7 Days)|Non-compliance|1
1017352|NCT01561976|2041602|FG001|Washout Period 2 (7 Days)|Non-compliance|0
1017353|NCT01561976|2041603|FG002|Washout Period 2 (7 Days)|Non-compliance|1
1017354|NCT01561976|2041604|FG003|Washout Period 2 (7 Days)|Non-compliance|0
1017355|NCT01561976|2041605|FG004|Washout Period 2 (7 Days)|Non-compliance|0
1017356|NCT01561976|2041606|FG005|Washout Period 2 (7 Days)|Non-compliance|0
1017357|NCT01562028|2041616|FG000|Overall Study|Withdrawal by Subject|1
1017358|NCT01562028|2041617|FG001|Overall Study|Withdrawal by Subject|1
1017359|NCT01562028|2041616|FG000|Overall Study|Lost to Follow-up|2
1017360|NCT01562028|2041617|FG001|Overall Study|Lost to Follow-up|1
1017361|NCT01562275|2041649|FG000|Stage 1|Adverse Event|0
1017362|NCT01562275|2041650|FG001|Stage 1|Adverse Event|0
1017363|NCT01562275|2041651|FG002|Stage 1|Adverse Event|0
1017364|NCT01562275|2041652|FG003|Stage 1|Adverse Event|1
1017365|NCT01562275|2041653|FG004|Stage 1|Adverse Event|1
1017366|NCT01562275|2041654|FG005|Stage 1|Adverse Event|0
1017367|NCT01562275|2041655|FG006|Stage 1|Adverse Event|0
1017368|NCT01562275|2041656|FG007|Stage 1|Adverse Event|0
1017369|NCT01562275|2041657|FG008|Stage 1|Adverse Event|0
1017370|NCT01562275|2041658|FG009|Stage 1|Adverse Event|1
1017371|NCT01562275|2041659|FG010|Stage 1|Adverse Event|0
1017372|NCT01562275|2041660|FG011|Stage 1|Adverse Event|0
1017373|NCT01562275|2041661|FG012|Stage 1|Adverse Event|0
1017374|NCT01562275|2041649|FG000|Stage 1|Death|1
1017375|NCT01562275|2041650|FG001|Stage 1|Death|0
1017376|NCT01562275|2041651|FG002|Stage 1|Death|0
1017377|NCT01562275|2041652|FG003|Stage 1|Death|0
1017378|NCT01562275|2041653|FG004|Stage 1|Death|0
1017379|NCT01562275|2041654|FG005|Stage 1|Death|0
1017380|NCT01562275|2041655|FG006|Stage 1|Death|0
1017381|NCT01562275|2041656|FG007|Stage 1|Death|0
1017382|NCT01562275|2041657|FG008|Stage 1|Death|0
1017383|NCT01562275|2041658|FG009|Stage 1|Death|0
1017384|NCT01562275|2041659|FG010|Stage 1|Death|0
1017385|NCT01562275|2041660|FG011|Stage 1|Death|0
1017386|NCT01562275|2041661|FG012|Stage 1|Death|0
1017387|NCT01562275|2041649|FG000|Stage 1|Non Compliance|0
1017388|NCT01562275|2041650|FG001|Stage 1|Non Compliance|0
1017389|NCT01562275|2041651|FG002|Stage 1|Non Compliance|1
1017390|NCT01562275|2041652|FG003|Stage 1|Non Compliance|0
1017391|NCT01562275|2041653|FG004|Stage 1|Non Compliance|0
1017392|NCT01562275|2041654|FG005|Stage 1|Non Compliance|0
1017393|NCT01562275|2041655|FG006|Stage 1|Non Compliance|0
1017394|NCT01562275|2041656|FG007|Stage 1|Non Compliance|0
1017395|NCT01562275|2041657|FG008|Stage 1|Non Compliance|0
1017396|NCT01562275|2041658|FG009|Stage 1|Non Compliance|0
1017397|NCT01562275|2041659|FG010|Stage 1|Non Compliance|0
1017398|NCT01562275|2041660|FG011|Stage 1|Non Compliance|0
1017399|NCT01562275|2041661|FG012|Stage 1|Non Compliance|0
1017400|NCT01562275|2041649|FG000|Stage 1|Physician Decision|0
1017401|NCT01562275|2041650|FG001|Stage 1|Physician Decision|0
1017402|NCT01562275|2041651|FG002|Stage 1|Physician Decision|0
1017403|NCT01562275|2041652|FG003|Stage 1|Physician Decision|0
1017404|NCT01562275|2041653|FG004|Stage 1|Physician Decision|1
1017405|NCT01562275|2041654|FG005|Stage 1|Physician Decision|0
1017406|NCT01562275|2041655|FG006|Stage 1|Physician Decision|1
1017407|NCT01562275|2041656|FG007|Stage 1|Physician Decision|0
1017408|NCT01562275|2041657|FG008|Stage 1|Physician Decision|1
1017409|NCT01562275|2041658|FG009|Stage 1|Physician Decision|0
1017410|NCT01562275|2041659|FG010|Stage 1|Physician Decision|0
1017411|NCT01562275|2041660|FG011|Stage 1|Physician Decision|0
1017412|NCT01562275|2041661|FG012|Stage 1|Physician Decision|0
1017413|NCT01562275|2041649|FG000|Stage 1|Progression of Disease|2
1017414|NCT01562275|2041650|FG001|Stage 1|Progression of Disease|6
1017415|NCT01562275|2041651|FG002|Stage 1|Progression of Disease|2
1017416|NCT01562275|2041652|FG003|Stage 1|Progression of Disease|1
1017417|NCT01562275|2041653|FG004|Stage 1|Progression of Disease|2
1017418|NCT01562275|2041654|FG005|Stage 1|Progression of Disease|4
1017419|NCT01562275|2041655|FG006|Stage 1|Progression of Disease|1
1017420|NCT01562275|2041656|FG007|Stage 1|Progression of Disease|7
1017421|NCT01562275|2041657|FG008|Stage 1|Progression of Disease|2
1017422|NCT01562275|2041658|FG009|Stage 1|Progression of Disease|5
1017423|NCT01562275|2041659|FG010|Stage 1|Progression of Disease|3
1017424|NCT01562275|2041660|FG011|Stage 1|Progression of Disease|0
1017425|NCT01562275|2041661|FG012|Stage 1|Progression of Disease|0
1017426|NCT01562275|2041649|FG000|Stage 1|Withdrawal by Subject|0
1017427|NCT01562275|2041650|FG001|Stage 1|Withdrawal by Subject|1
1017428|NCT01562275|2041651|FG002|Stage 1|Withdrawal by Subject|0
1017429|NCT01562275|2041652|FG003|Stage 1|Withdrawal by Subject|2
1017430|NCT01562275|2041653|FG004|Stage 1|Withdrawal by Subject|0
1017431|NCT01562275|2041654|FG005|Stage 1|Withdrawal by Subject|0
1017432|NCT01562275|2041655|FG006|Stage 1|Withdrawal by Subject|1
1017433|NCT01562275|2041656|FG007|Stage 1|Withdrawal by Subject|0
1017434|NCT01562275|2041657|FG008|Stage 1|Withdrawal by Subject|0
1017435|NCT01562275|2041658|FG009|Stage 1|Withdrawal by Subject|1
1017436|NCT01562275|2041659|FG010|Stage 1|Withdrawal by Subject|0
1017437|NCT01562275|2041660|FG011|Stage 1|Withdrawal by Subject|0
1017438|NCT01562275|2041661|FG012|Stage 1|Withdrawal by Subject|0
1017439|NCT01562275|2041649|FG000|Stage 2|Death|0
1017440|NCT01562275|2041650|FG001|Stage 2|Death|0
1017441|NCT01562275|2041651|FG002|Stage 2|Death|0
1017442|NCT01562275|2041652|FG003|Stage 2|Death|0
1017443|NCT01562275|2041653|FG004|Stage 2|Death|0
1017444|NCT01562275|2041654|FG005|Stage 2|Death|0
1017445|NCT01562275|2041655|FG006|Stage 2|Death|0
1017446|NCT01562275|2041656|FG007|Stage 2|Death|0
1017447|NCT01562275|2041657|FG008|Stage 2|Death|0
1017448|NCT01562275|2041658|FG009|Stage 2|Death|0
1017449|NCT01562275|2041659|FG010|Stage 2|Death|0
1017450|NCT01562275|2041660|FG011|Stage 2|Death|2
1017451|NCT01562275|2041661|FG012|Stage 2|Death|1
1017452|NCT01562275|2041649|FG000|Stage 2|Progression of Disease|0
1017453|NCT01562275|2041650|FG001|Stage 2|Progression of Disease|0
1017454|NCT01562275|2041651|FG002|Stage 2|Progression of Disease|0
1017455|NCT01562275|2041652|FG003|Stage 2|Progression of Disease|0
1017456|NCT01562275|2041653|FG004|Stage 2|Progression of Disease|0
1017457|NCT01562275|2041654|FG005|Stage 2|Progression of Disease|0
1017458|NCT01562275|2041655|FG006|Stage 2|Progression of Disease|0
1017459|NCT01562275|2041656|FG007|Stage 2|Progression of Disease|0
1017460|NCT01562275|2041657|FG008|Stage 2|Progression of Disease|0
1017461|NCT01562275|2041658|FG009|Stage 2|Progression of Disease|0
1017462|NCT01562275|2041659|FG010|Stage 2|Progression of Disease|0
1017463|NCT01562275|2041660|FG011|Stage 2|Progression of Disease|12
1017464|NCT01562275|2041661|FG012|Stage 2|Progression of Disease|4
1017465|NCT01562314|2041693|FG000|Overall Study|Adverse Event|10
1017466|NCT01562314|2041694|FG001|Overall Study|Adverse Event|5
1017467|NCT01562314|2041693|FG000|Overall Study|Met Withdrawal Criteria|3
1017468|NCT01562314|2041694|FG001|Overall Study|Met Withdrawal Criteria|2
1017469|NCT01562314|2041693|FG000|Overall Study|Withdrawal by Subject|0
1017470|NCT01562314|2041694|FG001|Overall Study|Withdrawal by Subject|1
1017471|NCT01562327|2041700|FG000|Overall Study|Adverse Event|2
1017472|NCT01562327|2041700|FG000|Overall Study|Lack of Efficacy|1
1017473|NCT01562327|2041700|FG000|Overall Study|Participant drop-out|1
1017474|NCT01562327|2041700|FG000|Overall Study|Infusion not received at 6 month window|4
1017475|NCT01562444|2041729|FG000|Overall Study|Did not meet entry criteria|2
1017476|NCT01562444|2041730|FG001|Overall Study|Did not meet entry criteria|0
1017477|NCT01562444|2041731|FG002|Overall Study|Did not meet entry criteria|3
1017478|NCT01562444|2041729|FG000|Overall Study|Did not comply with blood draw schedule|1
1017479|NCT01562444|2041730|FG001|Overall Study|Did not comply with blood draw schedule|0
1017480|NCT01562444|2041731|FG002|Overall Study|Did not comply with blood draw schedule|1
1017481|NCT01562444|2041729|FG000|Overall Study|Unavailable serological results|0
1017482|NCT01562444|2041730|FG001|Overall Study|Unavailable serological results|2
1017483|NCT01562444|2041731|FG002|Overall Study|Unavailable serological results|2
1017484|NCT01562444|2041729|FG000|Overall Study|Protocol forbidden concomitant vaccine|1
1017485|NCT01562444|2041730|FG001|Overall Study|Protocol forbidden concomitant vaccine|0
1017486|NCT01562444|2041731|FG002|Overall Study|Protocol forbidden concomitant vaccine|1
1017487|NCT01562444|2041729|FG000|Overall Study|Protocol forbidden medication|1
1017488|NCT01562444|2041730|FG001|Overall Study|Protocol forbidden medication|0
1017489|NCT01562444|2041731|FG002|Overall Study|Protocol forbidden medication|0
1017490|NCT01562548|2041743|FG000|Overall Study|Lost to Follow-up|0
1017491|NCT01562548|2041744|FG001|Overall Study|Lost to Follow-up|0
1017492|NCT01562548|2041745|FG002|Overall Study|Lost to Follow-up|1
1017493|NCT01562548|2041746|FG003|Overall Study|Lost to Follow-up|0
1017494|NCT01562613|2041758|FG000|Overall Study|Lost to Follow-up|2
1017495|NCT01562613|2041758|FG000|Overall Study|Withdrawal by Subject|2
1017496|NCT01562743|2041771|FG000|Overall Study|Adverse Event|29
1017497|NCT01562743|2041771|FG000|Overall Study|Lack of Efficacy|3
1017498|NCT01562743|2041771|FG000|Overall Study|Withdrawal by Subject|13
1017499|NCT01562743|2041771|FG000|Overall Study|Protocol Violation|1
1017500|NCT01562743|2041771|FG000|Overall Study|Discontinuation criteria|2
1017501|NCT01562743|2041771|FG000|Overall Study|Lost to Follow-up|2
1017502|NCT01562743|2041771|FG000|Overall Study|Physician Decision|2
1017503|NCT01562782|2041781|FG000|Overall Study|Withdrawal by Subject|3
1017504|NCT01562782|2041782|FG001|Overall Study|Withdrawal by Subject|3
1017505|NCT01562782|2041781|FG000|Overall Study|screen failure|1
1017506|NCT01562782|2041782|FG001|Overall Study|screen failure|2
1017507|NCT01562873|2041788|FG000|Overall Study|Disease Progression per RECIST|10
1017508|NCT01562873|2041789|FG001|Overall Study|Disease Progression per RECIST|0
1017509|NCT01562873|2041788|FG000|Overall Study|Adverse Event|1
1017510|NCT01562873|2041789|FG001|Overall Study|Adverse Event|0
1017511|NCT01562873|2041788|FG000|Overall Study|Clinical Disease Progression|9
1017512|NCT01562873|2041789|FG001|Overall Study|Clinical Disease Progression|0
1017513|NCT01562873|2041788|FG000|Overall Study|Clinical PD and adverse event|1
1017514|NCT01562873|2041789|FG001|Overall Study|Clinical PD and adverse event|0
1017515|NCT01563029|2041811|FG000|Overall Study|Adverse Event|1
1017516|NCT01563029|2041812|FG001|Overall Study|Adverse Event|0
1017517|NCT01563029|2041813|FG002|Overall Study|Adverse Event|1
1017518|NCT01563029|2041814|FG003|Overall Study|Adverse Event|2
1017519|NCT01563029|2041815|FG004|Overall Study|Adverse Event|1
1017520|NCT01563029|2041811|FG000|Overall Study|Lack of Efficacy|42
1017521|NCT01563029|2041812|FG001|Overall Study|Lack of Efficacy|16
1017522|NCT01563029|2041813|FG002|Overall Study|Lack of Efficacy|23
1017523|NCT01563029|2041814|FG003|Overall Study|Lack of Efficacy|21
1017524|NCT01563029|2041815|FG004|Overall Study|Lack of Efficacy|19
1017525|NCT01563029|2041811|FG000|Overall Study|Protocol Violation|1
1017526|NCT01563029|2041812|FG001|Overall Study|Protocol Violation|2
1017527|NCT01563029|2041813|FG002|Overall Study|Protocol Violation|3
1017528|NCT01563029|2041814|FG003|Overall Study|Protocol Violation|1
1017529|NCT01563029|2041815|FG004|Overall Study|Protocol Violation|3
1017530|NCT01563029|2041811|FG000|Overall Study|Protocol defined stopping criteria|1
1017531|NCT01563029|2041812|FG001|Overall Study|Protocol defined stopping criteria|0
1017532|NCT01563029|2041813|FG002|Overall Study|Protocol defined stopping criteria|0
1017533|NCT01563029|2041814|FG003|Overall Study|Protocol defined stopping criteria|0
1017534|NCT01563029|2041815|FG004|Overall Study|Protocol defined stopping criteria|0
1017535|NCT01563029|2041811|FG000|Overall Study|Lost to Follow-up|1
1017536|NCT01563029|2041812|FG001|Overall Study|Lost to Follow-up|0
1017537|NCT01563029|2041813|FG002|Overall Study|Lost to Follow-up|1
1017538|NCT01563029|2041814|FG003|Overall Study|Lost to Follow-up|1
1017539|NCT01563029|2041815|FG004|Overall Study|Lost to Follow-up|1
1017540|NCT01563029|2041811|FG000|Overall Study|Physician Decision|3
1017541|NCT01563029|2041812|FG001|Overall Study|Physician Decision|5
1017542|NCT01563029|2041813|FG002|Overall Study|Physician Decision|2
1017543|NCT01563029|2041814|FG003|Overall Study|Physician Decision|4
1017544|NCT01563029|2041815|FG004|Overall Study|Physician Decision|2
1017545|NCT01563029|2041811|FG000|Overall Study|Withdrawal by Subject|4
1017546|NCT01563029|2041812|FG001|Overall Study|Withdrawal by Subject|1
1017547|NCT01563029|2041813|FG002|Overall Study|Withdrawal by Subject|3
1017548|NCT01563029|2041814|FG003|Overall Study|Withdrawal by Subject|4
1017549|NCT01563029|2041815|FG004|Overall Study|Withdrawal by Subject|3
1017550|NCT01563172|2041848|FG000|Overall Study|Adverse Event|5
1017551|NCT01563172|2041848|FG000|Overall Study|Lost to Follow-up|2
1017552|NCT01563172|2041848|FG000|Overall Study|Other (Protocol deviation)|5
1017553|NCT01563172|2041848|FG000|Overall Study|Other (Not specified)|1
1017554|NCT01563185|2041863|FG000|Overall Study|Withdrawal by Subject|1
1017555|NCT01563185|2041863|FG000|Overall Study|Non-Compliance with study drug|1
1017556|NCT01563237|2041871|FG000|Overall Study|Lost to Follow-up|6
1017557|NCT01563237|2041872|FG001|Overall Study|Lost to Follow-up|0
1017558|NCT01563237|2041871|FG000|Overall Study|Withdrawal by Subject|1
1017559|NCT01563237|2041872|FG001|Overall Study|Withdrawal by Subject|0
1017560|NCT01563237|2041871|FG000|Overall Study|Adverse Event|1
1017561|NCT01563237|2041872|FG001|Overall Study|Adverse Event|0
1017562|NCT01563237|2041871|FG000|Overall Study|Medical Reasons|1
1017563|NCT01563237|2041872|FG001|Overall Study|Medical Reasons|0
1017564|NCT01563237|2041871|FG000|Overall Study|Death|1
1017565|NCT01563237|2041872|FG001|Overall Study|Death|0
1017566|NCT01563354|2041880|FG000|Core Phase|Adverse Event|5
1017567|NCT01563354|2041881|FG001|Core Phase|Adverse Event|15
1017568|NCT01563354|2041882|FG002|Core Phase|Adverse Event|13
1017569|NCT01563354|2041880|FG000|Core Phase|Withdrawal by Subject|1
1017570|NCT01563354|2041881|FG001|Core Phase|Withdrawal by Subject|0
1017571|NCT01563354|2041882|FG002|Core Phase|Withdrawal by Subject|3
1017572|NCT01563354|2041880|FG000|Core Phase|Lost to Follow-up|1
1017573|NCT01563354|2041881|FG001|Core Phase|Lost to Follow-up|0
1017574|NCT01563354|2041882|FG002|Core Phase|Lost to Follow-up|0
1017575|NCT01563354|2041880|FG000|Core Phase|Death|1
1017576|NCT01563354|2041881|FG001|Core Phase|Death|5
1017577|NCT01563354|2041882|FG002|Core Phase|Death|2
1017578|NCT01563354|2041880|FG000|Core Phase|Diseasse progression|18
1017579|NCT01563354|2041881|FG001|Core Phase|Diseasse progression|7
1017580|NCT01563354|2041882|FG002|Core Phase|Diseasse progression|8
1017581|NCT01563354|2041880|FG000|Core Phase|Protocol deviation|2
1017582|NCT01563354|2041881|FG001|Core Phase|Protocol deviation|0
1017583|NCT01563354|2041882|FG002|Core Phase|Protocol deviation|0
1017584|NCT01563354|2041880|FG000|Core Phase|PI decision - did not enter extension|0
1017585|NCT01563354|2041881|FG001|Core Phase|PI decision - did not enter extension|1
1017586|NCT01563354|2041882|FG002|Core Phase|PI decision - did not enter extension|0
1017587|NCT01563354|2041880|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1
1017588|NCT01563354|2041881|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0
1017589|NCT01563354|2041882|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0
1017590|NCT01563354|2041880|FG000|Extension Phase|Adverse Event|0
1017591|NCT01563354|2041881|FG001|Extension Phase|Adverse Event|3
1017592|NCT01563354|2041882|FG002|Extension Phase|Adverse Event|2
1017593|NCT01563354|2041880|FG000|Extension Phase|Withdrawal by Subject|0
1017594|NCT01563354|2041881|FG001|Extension Phase|Withdrawal by Subject|1
1017595|NCT01563354|2041882|FG002|Extension Phase|Withdrawal by Subject|0
1017596|NCT01563354|2041880|FG000|Extension Phase|Administration problems|3
1017597|NCT01563354|2041881|FG001|Extension Phase|Administration problems|2
1017598|NCT01563354|2041882|FG002|Extension Phase|Administration problems|3
1017599|NCT01563354|2041880|FG000|Extension Phase|Disease progression|9
1017600|NCT01563354|2041881|FG001|Extension Phase|Disease progression|8
1017601|NCT01563354|2041882|FG002|Extension Phase|Disease progression|10
1017602|NCT01563536|2041913|FG000|Overall Study|Withdrawal by Subject|0
1017603|NCT01563536|2041914|FG001|Overall Study|Withdrawal by Subject|2
1017604|NCT01563536|2041913|FG000|Overall Study|Lost to Follow-up|1
1017605|NCT01563536|2041914|FG001|Overall Study|Lost to Follow-up|0
1017606|NCT01563913|2041922|FG000|Overall Study|Physician Decision|1
1017607|NCT01563913|2041923|FG001|Overall Study|Physician Decision|0
1017608|NCT01563913|2041922|FG000|Overall Study|Spouse Passed Away|1
1017609|NCT01563913|2041923|FG001|Overall Study|Spouse Passed Away|0
1017610|NCT01563978|2041931|FG000|Overall Study|Physician Decision|1
1017611|NCT01563978|2041932|FG001|Overall Study|Physician Decision|0
1017612|NCT01563978|2041931|FG000|Overall Study|Lost to Follow-up|1
1017613|NCT01563978|2041932|FG001|Overall Study|Lost to Follow-up|0
1017614|NCT01563978|2041931|FG000|Overall Study|Dev. of study specific discont. criteria|1
1017615|NCT01563978|2041932|FG001|Overall Study|Dev. of study specific discont. criteria|0
1017616|NCT01563978|2041931|FG000|Overall Study|Adverse Event|1
1017617|NCT01563978|2041932|FG001|Overall Study|Adverse Event|2
1017618|NCT01564277|2041940|FG000|Overall Study|Protocol Violation|0
1017619|NCT01564277|2041941|FG001|Overall Study|Protocol Violation|1
1017620|NCT01564277|2041940|FG000|Overall Study|Physician Decision|1
1017621|NCT01564277|2041941|FG001|Overall Study|Physician Decision|0
1017622|NCT01564394|2041949|FG000|Overall Study|Withdrawal by Subject|6
1017623|NCT01564394|2041950|FG001|Overall Study|Withdrawal by Subject|10
1017624|NCT01564407|2041961|FG000|Overall Study|Lost to Follow-up|0
1017625|NCT01564407|2041962|FG001|Overall Study|Lost to Follow-up|1
1017626|NCT01564407|2041963|FG002|Overall Study|Lost to Follow-up|0
1017627|NCT01564407|2041964|FG003|Overall Study|Lost to Follow-up|0
1017628|NCT01564407|2041965|FG004|Overall Study|Lost to Follow-up|0
1017629|NCT01564407|2041961|FG000|Overall Study|Withdrawal by Subject|0
1017630|NCT01564407|2041962|FG001|Overall Study|Withdrawal by Subject|1
1017631|NCT01564407|2041963|FG002|Overall Study|Withdrawal by Subject|0
1017632|NCT01564407|2041964|FG003|Overall Study|Withdrawal by Subject|0
1017633|NCT01564407|2041965|FG004|Overall Study|Withdrawal by Subject|0
1017634|NCT01564407|2041961|FG000|Overall Study|funding lost, study ended|0
1017635|NCT01564407|2041962|FG001|Overall Study|funding lost, study ended|0
1017636|NCT01564407|2041963|FG002|Overall Study|funding lost, study ended|0
1017637|NCT01564407|2041964|FG003|Overall Study|funding lost, study ended|1
1017638|NCT01564407|2041965|FG004|Overall Study|funding lost, study ended|0
1017639|NCT01564459|2041989|FG000|Run-In|Adverse Event|7
1017640|NCT01564459|2041990|FG001|Run-In|Adverse Event|0
1017641|NCT01564459|2041991|FG002|Run-In|Adverse Event|0
1017642|NCT01564459|2041989|FG000|Run-In|Lost to Follow-up|1
1017643|NCT01564459|2041990|FG001|Run-In|Lost to Follow-up|0
1017644|NCT01564459|2041991|FG002|Run-In|Lost to Follow-up|0
1017645|NCT01564459|2041989|FG000|Run-In|Non-compliance with study drug|2
1017646|NCT01564459|2041990|FG001|Run-In|Non-compliance with study drug|0
1017647|NCT01564459|2041991|FG002|Run-In|Non-compliance with study drug|0
1017648|NCT01564459|2041989|FG000|Run-In|Protocol Violation|1
1017649|NCT01564459|2041990|FG001|Run-In|Protocol Violation|0
1017650|NCT01564459|2041991|FG002|Run-In|Protocol Violation|0
1017651|NCT01564459|2041989|FG000|Run-In|Withdrawal by Subject|1
1017652|NCT01564459|2041990|FG001|Run-In|Withdrawal by Subject|0
1017653|NCT01564459|2041991|FG002|Run-In|Withdrawal by Subject|0
1017654|NCT01564459|2041989|FG000|Double-blind Treatment|Adverse Event|0
1017655|NCT01564459|2041990|FG001|Double-blind Treatment|Adverse Event|0
1017656|NCT01564459|2041991|FG002|Double-blind Treatment|Adverse Event|1
1017663|NCT01564758|2042048|FG000|Overall Study|Death|8
1017664|NCT01564758|2042048|FG000|Overall Study|Adverse Event|3
1017665|NCT01564758|2042048|FG000|Overall Study|Other|3
1017666|NCT01564784|2042054|FG000|Overall Study|Other|1
1017667|NCT01564784|2042055|FG001|Overall Study|Other|0
1017668|NCT01564784|2042054|FG000|Overall Study|Subject refused further follow-up|1
1017669|NCT01564784|2042055|FG001|Overall Study|Subject refused further follow-up|6
1017670|NCT01564784|2042054|FG000|Overall Study|Lost to Follow-up|1
1017671|NCT01564784|2042055|FG001|Overall Study|Lost to Follow-up|1
1017672|NCT01564784|2042054|FG000|Overall Study|Death|131
1017673|NCT01564784|2042055|FG001|Overall Study|Death|126
1017674|NCT01564862|2042064|FG000|Overall Study|Pretreatment Event or Adverse Event|6
1017675|NCT01564862|2042065|FG001|Overall Study|Pretreatment Event or Adverse Event|12
1017676|NCT01564862|2042066|FG002|Overall Study|Pretreatment Event or Adverse Event|6
1017677|NCT01564862|2042064|FG000|Overall Study|Major Protocol Deviation|3
1017678|NCT01564862|2042065|FG001|Overall Study|Major Protocol Deviation|3
1017679|NCT01564862|2042066|FG002|Overall Study|Major Protocol Deviation|4
1017680|NCT01564862|2042064|FG000|Overall Study|Lost to Follow-up|10
1017681|NCT01564862|2042065|FG001|Overall Study|Lost to Follow-up|8
1017682|NCT01564862|2042066|FG002|Overall Study|Lost to Follow-up|6
1017683|NCT01564862|2042064|FG000|Overall Study|Voluntary Withdrawal|9
1017684|NCT01564862|2042065|FG001|Overall Study|Voluntary Withdrawal|6
1017685|NCT01564862|2042066|FG002|Overall Study|Voluntary Withdrawal|8
1017686|NCT01564862|2042064|FG000|Overall Study|Lack of Efficacy|1
1017687|NCT01564862|2042065|FG001|Overall Study|Lack of Efficacy|5
1017688|NCT01564862|2042066|FG002|Overall Study|Lack of Efficacy|6
1017689|NCT01564862|2042064|FG000|Overall Study|Other reason(s)|1
1017690|NCT01564862|2042065|FG001|Overall Study|Other reason(s)|0
1017691|NCT01564862|2042066|FG002|Overall Study|Other reason(s)|0
1017692|NCT01565083|2042096|FG000|Overall Study|Withdrawal by Subject|6
1017693|NCT01565083|2042097|FG001|Overall Study|Withdrawal by Subject|4
1017694|NCT01565083|2042096|FG000|Overall Study|Lost to Follow-up|2
1017695|NCT01565083|2042097|FG001|Overall Study|Lost to Follow-up|7
1017696|NCT01565083|2042096|FG000|Overall Study|Death|22
1017697|NCT01565083|2042097|FG001|Overall Study|Death|23
1017698|NCT01565083|2042096|FG000|Overall Study|Other|3
1017699|NCT01565083|2042097|FG001|Overall Study|Other|5
1017700|NCT01565148|2042107|FG000|Overall Study|Withdrawal by Subject|1
1017701|NCT01565148|2042108|FG001|Overall Study|Withdrawal by Subject|1
1017702|NCT01565148|2042109|FG002|Overall Study|Withdrawal by Subject|1
1017703|NCT01565148|2042110|FG003|Overall Study|Withdrawal by Subject|2
1017704|NCT01565148|2042107|FG000|Overall Study|Lost to Follow-up|4
1017705|NCT01565148|2042108|FG001|Overall Study|Lost to Follow-up|4
1017706|NCT01565148|2042109|FG002|Overall Study|Lost to Follow-up|0
1017707|NCT01565148|2042110|FG003|Overall Study|Lost to Follow-up|3
1017708|NCT01565148|2042107|FG000|Overall Study|Rescue Therapy|8
1017709|NCT01565148|2042108|FG001|Overall Study|Rescue Therapy|5
1017710|NCT01565148|2042109|FG002|Overall Study|Rescue Therapy|5
1017711|NCT01565148|2042110|FG003|Overall Study|Rescue Therapy|8
1017712|NCT01565148|2042107|FG000|Overall Study|Death|0
1017713|NCT01565148|2042108|FG001|Overall Study|Death|0
1017714|NCT01565148|2042109|FG002|Overall Study|Death|1
1017715|NCT01565148|2042110|FG003|Overall Study|Death|0
1017716|NCT01565148|2042107|FG000|Overall Study|Physician Decision|2
1017717|NCT01565148|2042108|FG001|Overall Study|Physician Decision|5
1017718|NCT01565148|2042109|FG002|Overall Study|Physician Decision|0
1017719|NCT01565148|2042110|FG003|Overall Study|Physician Decision|0
1017720|NCT01565291|2042126|FG000|Overall Study|Withdrawal by Subject|1
1017721|NCT01565291|2042127|FG001|Overall Study|Withdrawal by Subject|0
1017722|NCT01565343|2042154|FG000|Overall Study|Administrative decision/technical issues|1
1017723|NCT01565343|2042155|FG001|Overall Study|Administrative decision/technical issues|0
1017724|NCT01565343|2042156|FG002|Overall Study|Administrative decision/technical issues|0
1017725|NCT01565499|2042178|FG000|Overall Study|Physician Decision|1
1017726|NCT01565499|2042178|FG000|Overall Study|Adverse Event|5
1017727|NCT01565499|2042178|FG000|Overall Study|Withdrawal by Subject|2
1017728|NCT01565564|2042202|FG000|Overall Study|Lost to Follow-up|5
1017729|NCT01565564|2042203|FG001|Overall Study|Lost to Follow-up|1
1017730|NCT01565642|2042215|FG000|Overall Study|Withdrawal by Subject|2
1017731|NCT01565642|2042216|FG001|Overall Study|Withdrawal by Subject|1
1017732|NCT01565668|2042224|FG000|Overall Study|Death|2
1017733|NCT01565668|2042225|FG001|Overall Study|Death|1
1017734|NCT01565668|2042224|FG000|Overall Study|Lack of Efficacy|4
1017735|NCT01565668|2042225|FG001|Overall Study|Lack of Efficacy|2
1017736|NCT01565668|2042224|FG000|Overall Study|Participant went on Hospice Care|1
1017737|NCT01565668|2042225|FG001|Overall Study|Participant went on Hospice Care|0
1017738|NCT01565668|2042224|FG000|Overall Study|Adverse Event|6
1017739|NCT01565668|2042225|FG001|Overall Study|Adverse Event|1
1017740|NCT01565668|2042224|FG000|Overall Study|Randomized, but never received drug|0
1017741|NCT01565668|2042225|FG001|Overall Study|Randomized, but never received drug|2
1017742|NCT01565668|2042224|FG000|Overall Study|Progressive disease|13
1017743|NCT01565668|2042225|FG001|Overall Study|Progressive disease|14
1017744|NCT01565668|2042224|FG000|Overall Study|Withdrawal by Subject|1
1017745|NCT01565668|2042225|FG001|Overall Study|Withdrawal by Subject|3
1017746|NCT01565668|2042224|FG000|Overall Study|HSCT Transplant|11
1017747|NCT01565668|2042225|FG001|Overall Study|HSCT Transplant|15
1017748|NCT01565694|2042231|FG000|Dose-Titration Period|Adverse Event|4
1017749|NCT01565694|2042231|FG000|Dose-Titration Period|Protocol Violation|10
1017750|NCT01565694|2042231|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4
1017751|NCT01565707|2042239|FG000|Overall Study|Adverse Event|1
1017752|NCT01565707|2042240|FG001|Overall Study|Adverse Event|6
1017753|NCT01565707|2042241|FG002|Overall Study|Adverse Event|2
1017754|NCT01565707|2042242|FG003|Overall Study|Adverse Event|1
1017755|NCT01565707|2042239|FG000|Overall Study|Lost to Follow-up|1
1017756|NCT01565707|2042240|FG001|Overall Study|Lost to Follow-up|0
1017757|NCT01565707|2042241|FG002|Overall Study|Lost to Follow-up|0
1017758|NCT01565707|2042242|FG003|Overall Study|Lost to Follow-up|0
1017759|NCT01565707|2042239|FG000|Overall Study|Protocol Violation|1
1017760|NCT01565707|2042240|FG001|Overall Study|Protocol Violation|0
1017761|NCT01565707|2042241|FG002|Overall Study|Protocol Violation|0
1017762|NCT01565707|2042242|FG003|Overall Study|Protocol Violation|1
1017763|NCT01565707|2042239|FG000|Overall Study|Withdrawal by Subject|3
1017764|NCT01565707|2042240|FG001|Overall Study|Withdrawal by Subject|1
1017765|NCT01565707|2042241|FG002|Overall Study|Withdrawal by Subject|1
1017766|NCT01565707|2042242|FG003|Overall Study|Withdrawal by Subject|1
1017767|NCT01565707|2042239|FG000|Overall Study|Randomized but not evaluable|2
1017768|NCT01565707|2042240|FG001|Overall Study|Randomized but not evaluable|0
1017769|NCT01565707|2042241|FG002|Overall Study|Randomized but not evaluable|0
1017770|NCT01565707|2042242|FG003|Overall Study|Randomized but not evaluable|0
1017771|NCT01565707|2042239|FG000|Overall Study|Miscellaneous|1
1017772|NCT01565707|2042240|FG001|Overall Study|Miscellaneous|1
1017773|NCT01565707|2042241|FG002|Overall Study|Miscellaneous|0
1017774|NCT01565707|2042242|FG003|Overall Study|Miscellaneous|2
1017775|NCT01565850|2042261|FG000|Overall Study|Adverse Event|0
1017776|NCT01565850|2042262|FG001|Overall Study|Adverse Event|1
1017777|NCT01565850|2042261|FG000|Overall Study|Lost to Follow-up|12
1017778|NCT01565850|2042262|FG001|Overall Study|Lost to Follow-up|4
1017779|NCT01565850|2042261|FG000|Overall Study|Investigator's Discretion|2
1017780|NCT01565850|2042262|FG001|Overall Study|Investigator's Discretion|1
1017781|NCT01565850|2042261|FG000|Overall Study|Participant noncompliance|2
1017782|NCT01565850|2042262|FG001|Overall Study|Participant noncompliance|0
1017783|NCT01565850|2042261|FG000|Overall Study|Withdrew Consent|4
1017784|NCT01565850|2042262|FG001|Overall Study|Withdrew Consent|2
1017785|NCT01565889|2042274|FG000|Part A|Withdrawal by Subject|1
1017786|NCT01565889|2042275|FG001|Part A|Withdrawal by Subject|0
1017787|NCT01565889|2042276|FG002|Part A|Withdrawal by Subject|0
1017788|NCT01565889|2042277|FG003|Part A|Withdrawal by Subject|0
1017789|NCT01565889|2042278|FG004|Part A|Withdrawal by Subject|0
1017790|NCT01565889|2042279|FG005|Part A|Withdrawal by Subject|0
1017791|NCT01565889|2042274|FG000|Part B|Withdrawal by Subject|0
1017792|NCT01565889|2042275|FG001|Part B|Withdrawal by Subject|0
1017793|NCT01565889|2042276|FG002|Part B|Withdrawal by Subject|0
1017794|NCT01565889|2042277|FG003|Part B|Withdrawal by Subject|0
1017795|NCT01565889|2042278|FG004|Part B|Withdrawal by Subject|0
1017796|NCT01565889|2042279|FG005|Part B|Withdrawal by Subject|1
1017797|NCT01565889|2042274|FG000|Part B|Lack of Efficacy|0
1017798|NCT01565889|2042275|FG001|Part B|Lack of Efficacy|0
1017799|NCT01565889|2042276|FG002|Part B|Lack of Efficacy|0
1017800|NCT01565889|2042277|FG003|Part B|Lack of Efficacy|0
1017801|NCT01565889|2042278|FG004|Part B|Lack of Efficacy|0
1017802|NCT01565889|2042279|FG005|Part B|Lack of Efficacy|2
1017803|NCT01565889|2042274|FG000|Part B|Lost to Follow-up|0
1017804|NCT01565889|2042275|FG001|Part B|Lost to Follow-up|0
1017805|NCT01565889|2042276|FG002|Part B|Lost to Follow-up|0
1017806|NCT01565889|2042277|FG003|Part B|Lost to Follow-up|0
1017807|NCT01565889|2042278|FG004|Part B|Lost to Follow-up|0
1017808|NCT01565889|2042279|FG005|Part B|Lost to Follow-up|1
1017809|NCT01565928|2042314|FG000|Overall Study|Adverse Event|3
1017810|NCT01565928|2042314|FG000|Overall Study|Other|3
1017811|NCT01565928|2042314|FG000|Overall Study|Progressive Disease|13
1017812|NCT01565928|2042314|FG000|Overall Study|Withdrawal by Subject|1
1017813|NCT01565928|2042314|FG000|Overall Study|Death|2
1017814|NCT01565941|2042323|FG000|Overall Study|Withdrawn by parent/guardian|3
1017815|NCT01565941|2042324|FG001|Overall Study|Withdrawn by parent/guardian|2
1017816|NCT01565941|2042323|FG000|Overall Study|Randomized; did not receive intevention|8
1017817|NCT01565941|2042324|FG001|Overall Study|Randomized; did not receive intevention|2
1017818|NCT01565980|2042334|FG000|Overall Study|Death|1
1017819|NCT01565980|2042335|FG001|Overall Study|Death|0
1017820|NCT01565980|2042334|FG000|Overall Study|Lost to Follow-up|1
1017821|NCT01565980|2042335|FG001|Overall Study|Lost to Follow-up|0
1017822|NCT01565980|2042334|FG000|Overall Study|health complications|1
1017823|NCT01565980|2042335|FG001|Overall Study|health complications|1
1017824|NCT01565980|2042334|FG000|Overall Study|stopped medical treatment|1
1017825|NCT01565980|2042335|FG001|Overall Study|stopped medical treatment|0
1017826|NCT01565980|2042334|FG000|Overall Study|Withdrawal by Subject|0
1017827|NCT01565980|2042335|FG001|Overall Study|Withdrawal by Subject|3
1017828|NCT01565993|2042347|FG000|Overall Study|Physician Decision|0
1017829|NCT01565993|2042348|FG001|Overall Study|Physician Decision|3
1017830|NCT01566149|2042373|FG000|Overall Study|Adverse Event|0
1017831|NCT01566149|2042374|FG001|Overall Study|Adverse Event|1
1017832|NCT01566149|2042373|FG000|Overall Study|Non-compliance with study medication|2
1017833|NCT01566149|2042374|FG001|Overall Study|Non-compliance with study medication|0
1017834|NCT01566149|2042373|FG000|Overall Study|Protocol Violation|0
1017835|NCT01566149|2042374|FG001|Overall Study|Protocol Violation|1
1017836|NCT01566149|2042373|FG000|Overall Study|Withdrawal by Subject|1
1017837|NCT01566149|2042374|FG001|Overall Study|Withdrawal by Subject|0
1017838|NCT01566214|2042386|FG000|Overall Study|Lost to Follow-up|3
1017839|NCT01566214|2042387|FG001|Overall Study|Lost to Follow-up|0
1017840|NCT01566435|2042411|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
1017841|NCT01566604|2042480|FG000|Overall Study|Patient's inability to use the device|1
1017842|NCT01566604|2042481|FG001|Overall Study|Patient's inability to use the device|0
1017843|NCT01566604|2042480|FG000|Overall Study|Administrative problems|1
1017844|NCT01566604|2042481|FG001|Overall Study|Administrative problems|0
1017845|NCT01566604|2042480|FG000|Overall Study|Lack of Efficacy|1
1017846|NCT01566604|2042481|FG001|Overall Study|Lack of Efficacy|2
1017847|NCT01566604|2042480|FG000|Overall Study|Protocol deviation|2
1017848|NCT01566604|2042481|FG001|Overall Study|Protocol deviation|0
1017849|NCT01566604|2042480|FG000|Overall Study|Abnormal laboratory value|2
1017850|NCT01566604|2042481|FG001|Overall Study|Abnormal laboratory value|0
1017851|NCT01566604|2042480|FG000|Overall Study|Death|4
1017852|NCT01566604|2042481|FG001|Overall Study|Death|1
1017853|NCT01566604|2042480|FG000|Overall Study|Adverse Event|4
1017854|NCT01566604|2042481|FG001|Overall Study|Adverse Event|2
1017855|NCT01566604|2042480|FG000|Overall Study|Withdrawal by Subject|9
1017856|NCT01566604|2042481|FG001|Overall Study|Withdrawal by Subject|6
1017869|NCT01566721|2042517|FG000|Treatment Period|Withdrawal by Subject|35
1017870|NCT01566721|2042518|FG001|Treatment Period|Withdrawal by Subject|9
1017871|NCT01566721|2042517|FG000|Treatment Period|Disease Progression/Recurrence|37
1017872|NCT01566721|2042518|FG001|Treatment Period|Disease Progression/Recurrence|13
1017873|NCT01566721|2042517|FG000|Treatment Period|Investigator/Sponsor Decision|6
1017874|NCT01566721|2042518|FG001|Treatment Period|Investigator/Sponsor Decision|3
1017875|NCT01566721|2042517|FG000|Treatment Period|Other|13
1017876|NCT01566721|2042518|FG001|Treatment Period|Other|2
1017877|NCT01566721|2042517|FG000|Treatment Period|Lack of Compliance|5
1017878|NCT01566721|2042518|FG001|Treatment Period|Lack of Compliance|1
1017879|NCT01566721|2042517|FG000|Treatment Period|Adverse Event|100
1017880|NCT01566721|2042518|FG001|Treatment Period|Adverse Event|30
1017881|NCT01566721|2042517|FG000|Treatment Period|Pregnancy|1
1017882|NCT01566721|2042518|FG001|Treatment Period|Pregnancy|0
1017883|NCT01566721|2042517|FG000|Safety Follow-up|Physician Decision|6
1017884|NCT01566721|2042518|FG001|Safety Follow-up|Physician Decision|4
1017885|NCT01566721|2042517|FG000|Safety Follow-up|Lost to Follow-up|101
1017886|NCT01566721|2042518|FG001|Safety Follow-up|Lost to Follow-up|48
1017887|NCT01566721|2042517|FG000|Safety Follow-up|Withdrawal by Subject|155
1017888|NCT01566721|2042518|FG001|Safety Follow-up|Withdrawal by Subject|49
1017889|NCT01566721|2042517|FG000|Safety Follow-up|Death|28
1017890|NCT01566721|2042518|FG001|Safety Follow-up|Death|4
1017891|NCT01566721|2042517|FG000|Safety Follow-up|Non-compliance|7
1017892|NCT01566721|2042518|FG001|Safety Follow-up|Non-compliance|3
1017893|NCT01566721|2042517|FG000|Safety Follow-up|Protocol Violation|7
1017894|NCT01566721|2042518|FG001|Safety Follow-up|Protocol Violation|0
1017895|NCT01566721|2042517|FG000|Safety Follow-up|Site closure|2
1017896|NCT01566721|2042518|FG001|Safety Follow-up|Site closure|3
1017897|NCT01566721|2042517|FG000|Safety Follow-up|Erroneous reporting or late reporting|2
1017898|NCT01566721|2042518|FG001|Safety Follow-up|Erroneous reporting or late reporting|0
1017899|NCT01566721|2042517|FG000|Safety Follow-up|Missing|7
1017900|NCT01566721|2042518|FG001|Safety Follow-up|Missing|2
1017901|NCT01566721|2042517|FG000|Safety Follow-up|Disease progression /disease recurrence|223
1017902|NCT01566721|2042518|FG001|Safety Follow-up|Disease progression /disease recurrence|90
1017903|NCT01566721|2042517|FG000|Safety Follow-up|Sponsor decision|1
1017904|NCT01566721|2042518|FG001|Safety Follow-up|Sponsor decision|0
1017905|NCT01566721|2042517|FG000|Safety Follow-up|Adverse Event|8
1017906|NCT01566721|2042518|FG001|Safety Follow-up|Adverse Event|4
1017907|NCT01566773|2042531|FG000|Overall Study|Protocol specified criteria|4
1017908|NCT01566773|2042531|FG000|Overall Study|Protocol Violation|4
1017909|NCT01566773|2042531|FG000|Overall Study|Withdrawal by Subject|9
1017910|NCT01566773|2042531|FG000|Overall Study|Administrative reason|1
1017911|NCT01566773|2042531|FG000|Overall Study|Adverse Event|10
1017912|NCT01566773|2042531|FG000|Overall Study|Physician Decision|2
1017913|NCT01566981|2042562|FG000|Overall Study|Lost to Follow-up|5
1017914|NCT01566981|2042563|FG001|Overall Study|Lost to Follow-up|8
1017915|NCT01567085|2042588|FG000|Overall Study|Death|6
1017916|NCT01567085|2042588|FG000|Overall Study|Adverse Event|6
1017917|NCT01567085|2042588|FG000|Overall Study|Lost to Follow-up|3
1017918|NCT01567085|2042588|FG000|Overall Study|Graft loss|2
1017919|NCT01567085|2042588|FG000|Overall Study|Renal transplantectomy|1
1017920|NCT01567085|2042588|FG000|Overall Study|Returned to chronic dialysis|1
1017921|NCT01567085|2042588|FG000|Overall Study|Terminal chronic kidney dysfunction|1
1017922|NCT01567163|2042601|FG000|Overall Study|Progressive Disease|2
1017923|NCT01567163|2042601|FG000|Overall Study|Lost to Follow-up|2
1017924|NCT01567306|2042616|FG000|Overall Study|Protocol Violation|2
1017925|NCT01567306|2042617|FG001|Overall Study|Protocol Violation|2
1017926|NCT01567306|2042618|FG002|Overall Study|Protocol Violation|0
1017927|NCT01567306|2042619|FG003|Overall Study|Protocol Violation|3
1017928|NCT01567306|2042620|FG004|Overall Study|Protocol Violation|1
1017929|NCT01567306|2042621|FG005|Overall Study|Protocol Violation|1
1017930|NCT01567306|2042616|FG000|Overall Study|Change site living|1
1017931|NCT01567306|2042617|FG001|Overall Study|Change site living|0
1017932|NCT01567306|2042618|FG002|Overall Study|Change site living|0
1017933|NCT01567306|2042619|FG003|Overall Study|Change site living|0
1017934|NCT01567306|2042620|FG004|Overall Study|Change site living|0
1017935|NCT01567306|2042621|FG005|Overall Study|Change site living|0
1017936|NCT01567306|2042616|FG000|Overall Study|Adverse Event|0
1017937|NCT01567306|2042617|FG001|Overall Study|Adverse Event|0
1017938|NCT01567306|2042618|FG002|Overall Study|Adverse Event|0
1017939|NCT01567306|2042619|FG003|Overall Study|Adverse Event|2
1017940|NCT01567306|2042620|FG004|Overall Study|Adverse Event|4
1017941|NCT01567306|2042621|FG005|Overall Study|Adverse Event|1
1017942|NCT01567306|2042616|FG000|Overall Study|Lost to Follow-up|0
1017943|NCT01567306|2042617|FG001|Overall Study|Lost to Follow-up|0
1017944|NCT01567306|2042618|FG002|Overall Study|Lost to Follow-up|0
1017945|NCT01567306|2042619|FG003|Overall Study|Lost to Follow-up|0
1017946|NCT01567306|2042620|FG004|Overall Study|Lost to Follow-up|2
1017947|NCT01567306|2042621|FG005|Overall Study|Lost to Follow-up|0
1017948|NCT01567306|2042616|FG000|Overall Study|Withdrawal by Subject|0
1017949|NCT01567306|2042617|FG001|Overall Study|Withdrawal by Subject|0
1017950|NCT01567306|2042618|FG002|Overall Study|Withdrawal by Subject|0
1017951|NCT01567306|2042619|FG003|Overall Study|Withdrawal by Subject|0
1017952|NCT01567306|2042620|FG004|Overall Study|Withdrawal by Subject|0
1017953|NCT01567306|2042621|FG005|Overall Study|Withdrawal by Subject|1
1017954|NCT01567462|2042641|FG000|Overall Study|Withdrawal by Subject|4
1017955|NCT01567462|2042642|FG001|Overall Study|Withdrawal by Subject|7
1017956|NCT01567527|2042650|FG000|Conversion Phase.|Protocol deviation|3
1017957|NCT01567527|2042651|FG001|Conversion Phase.|Protocol deviation|0
1017958|NCT01567527|2042652|FG002|Conversion Phase.|Protocol deviation|0
1017959|NCT01567527|2042653|FG003|Conversion Phase.|Protocol deviation|0
1017960|NCT01567527|2042654|FG004|Conversion Phase.|Protocol deviation|0
1017961|NCT01567527|2042650|FG000|Conversion Phase.|Met withdrawal criteria|10
1017962|NCT01567527|2042651|FG001|Conversion Phase.|Met withdrawal criteria|0
1017963|NCT01567527|2042652|FG002|Conversion Phase.|Met withdrawal criteria|0
1017964|NCT01567527|2042653|FG003|Conversion Phase.|Met withdrawal criteria|0
1017965|NCT01567527|2042654|FG004|Conversion Phase.|Met withdrawal criteria|0
1017966|NCT01567527|2042650|FG000|Conversion Phase.|Withdrawal by Subject|32
1017967|NCT01567527|2042651|FG001|Conversion Phase.|Withdrawal by Subject|0
1017968|NCT01567527|2042652|FG002|Conversion Phase.|Withdrawal by Subject|0
1017969|NCT01567527|2042653|FG003|Conversion Phase.|Withdrawal by Subject|0
1017970|NCT01567527|2042654|FG004|Conversion Phase.|Withdrawal by Subject|0
1017971|NCT01567527|2042650|FG000|Conversion Phase.|Lost to Follow-up|16
1017972|NCT01567527|2042651|FG001|Conversion Phase.|Lost to Follow-up|0
1017973|NCT01567527|2042652|FG002|Conversion Phase.|Lost to Follow-up|0
1017974|NCT01567527|2042653|FG003|Conversion Phase.|Lost to Follow-up|0
1017975|NCT01567527|2042654|FG004|Conversion Phase.|Lost to Follow-up|0
1017976|NCT01567527|2042650|FG000|Conversion Phase.|Lack of Efficacy|2
1017977|NCT01567527|2042651|FG001|Conversion Phase.|Lack of Efficacy|0
1017978|NCT01567527|2042652|FG002|Conversion Phase.|Lack of Efficacy|0
1017979|NCT01567527|2042653|FG003|Conversion Phase.|Lack of Efficacy|0
1017980|NCT01567527|2042654|FG004|Conversion Phase.|Lack of Efficacy|0
1017981|NCT01567527|2042650|FG000|Conversion Phase.|Adverse Event|33
1017982|NCT01567527|2042651|FG001|Conversion Phase.|Adverse Event|0
1017983|NCT01567527|2042652|FG002|Conversion Phase.|Adverse Event|0
1017984|NCT01567527|2042653|FG003|Conversion Phase.|Adverse Event|0
1017985|NCT01567527|2042654|FG004|Conversion Phase.|Adverse Event|0
1017986|NCT01567527|2042650|FG000|Conversion Phase.|Withdrawn by the investigator|3
1017987|NCT01567527|2042651|FG001|Conversion Phase.|Withdrawn by the investigator|0
1017988|NCT01567527|2042652|FG002|Conversion Phase.|Withdrawn by the investigator|0
1017989|NCT01567527|2042653|FG003|Conversion Phase.|Withdrawn by the investigator|0
1017990|NCT01567527|2042654|FG004|Conversion Phase.|Withdrawn by the investigator|0
1017991|NCT01567527|2042650|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1017992|NCT01567527|2042651|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
1017993|NCT01567527|2042652|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1017994|NCT01567527|2042653|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1017995|NCT01567527|2042654|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1017996|NCT01567527|2042650|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1017997|NCT01567527|2042651|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
1017998|NCT01567527|2042652|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1017999|NCT01567527|2042653|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1018000|NCT01567527|2042654|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1018001|NCT01567527|2042650|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1018002|NCT01567527|2042651|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
1018003|NCT01567527|2042652|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1018004|NCT01567527|2042653|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1018005|NCT01567527|2042654|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1018006|NCT01567527|2042650|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1018007|NCT01567527|2042651|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
1018008|NCT01567527|2042652|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1018009|NCT01567527|2042653|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1018010|NCT01567527|2042654|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1018011|NCT01567527|2042650|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1018012|NCT01567527|2042651|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
1018013|NCT01567527|2042652|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1018014|NCT01567527|2042653|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1018015|NCT01567527|2042654|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1018016|NCT01567527|2042650|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1018017|NCT01567527|2042651|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
1018018|NCT01567527|2042652|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1018019|NCT01567527|2042653|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1018020|NCT01567527|2042654|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1018021|NCT01567527|2042650|FG000|IM Depot Stabilization.|Protocol deviation|0
1018022|NCT01567527|2042651|FG001|IM Depot Stabilization.|Protocol deviation|0
1018023|NCT01567527|2042652|FG002|IM Depot Stabilization.|Protocol deviation|5
1018024|NCT01567527|2042653|FG003|IM Depot Stabilization.|Protocol deviation|0
1018025|NCT01567527|2042654|FG004|IM Depot Stabilization.|Protocol deviation|0
1018026|NCT01567527|2042650|FG000|IM Depot Stabilization.|Met withdrawal criteria|0
1018027|NCT01567527|2042651|FG001|IM Depot Stabilization.|Met withdrawal criteria|0
1018028|NCT01567527|2042652|FG002|IM Depot Stabilization.|Met withdrawal criteria|26
1018029|NCT01567527|2042653|FG003|IM Depot Stabilization.|Met withdrawal criteria|0
1018030|NCT01567527|2042654|FG004|IM Depot Stabilization.|Met withdrawal criteria|0
1018031|NCT01567527|2042650|FG000|IM Depot Stabilization.|Withdrawal by Subject|0
1018032|NCT01567527|2042651|FG001|IM Depot Stabilization.|Withdrawal by Subject|0
1018033|NCT01567527|2042652|FG002|IM Depot Stabilization.|Withdrawal by Subject|56
1018034|NCT01567527|2042653|FG003|IM Depot Stabilization.|Withdrawal by Subject|0
1018035|NCT01567527|2042654|FG004|IM Depot Stabilization.|Withdrawal by Subject|0
1018036|NCT01567527|2042650|FG000|IM Depot Stabilization.|Sponsor discontinued study|0
1018037|NCT01567527|2042651|FG001|IM Depot Stabilization.|Sponsor discontinued study|0
1018038|NCT01567527|2042652|FG002|IM Depot Stabilization.|Sponsor discontinued study|1
1018039|NCT01567527|2042653|FG003|IM Depot Stabilization.|Sponsor discontinued study|0
1018040|NCT01567527|2042654|FG004|IM Depot Stabilization.|Sponsor discontinued study|0
1018041|NCT01567527|2042650|FG000|IM Depot Stabilization.|Lost to Follow-up|0
1018042|NCT01567527|2042651|FG001|IM Depot Stabilization.|Lost to Follow-up|0
1018043|NCT01567527|2042652|FG002|IM Depot Stabilization.|Lost to Follow-up|21
1018044|NCT01567527|2042653|FG003|IM Depot Stabilization.|Lost to Follow-up|0
1018045|NCT01567527|2042654|FG004|IM Depot Stabilization.|Lost to Follow-up|0
1018046|NCT01567527|2042650|FG000|IM Depot Stabilization.|Lack of Efficacy|0
1018047|NCT01567527|2042651|FG001|IM Depot Stabilization.|Lack of Efficacy|0
1018048|NCT01567527|2042652|FG002|IM Depot Stabilization.|Lack of Efficacy|7
1018049|NCT01567527|2042653|FG003|IM Depot Stabilization.|Lack of Efficacy|0
1018050|NCT01567527|2042654|FG004|IM Depot Stabilization.|Lack of Efficacy|0
1018051|NCT01567527|2042650|FG000|IM Depot Stabilization.|Adverse Event|0
1018052|NCT01567527|2042651|FG001|IM Depot Stabilization.|Adverse Event|0
1018053|NCT01567527|2042652|FG002|IM Depot Stabilization.|Adverse Event|37
1018054|NCT01567527|2042653|FG003|IM Depot Stabilization.|Adverse Event|0
1018055|NCT01567527|2042654|FG004|IM Depot Stabilization.|Adverse Event|0
1018056|NCT01567527|2042650|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0
1018057|NCT01567527|2042651|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0
1018058|NCT01567527|2042652|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6
1018059|NCT01567527|2042653|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0
1018060|NCT01567527|2042654|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0
1018061|NCT01567527|2042650|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1018062|NCT01567527|2042651|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1018063|NCT01567527|2042652|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1018064|NCT01567527|2042653|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1
1018065|NCT01567527|2042654|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1
1018066|NCT01567527|2042650|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1018067|NCT01567527|2042651|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1018068|NCT01567527|2042652|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1018069|NCT01567527|2042653|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
1018070|NCT01567527|2042654|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
1018071|NCT01567527|2042650|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1018072|NCT01567527|2042651|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1018073|NCT01567527|2042652|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1018074|NCT01567527|2042653|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
1018075|NCT01567527|2042654|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
1018076|NCT01567527|2042650|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1018077|NCT01567527|2042651|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1018078|NCT01567527|2042652|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1018079|NCT01567527|2042653|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
1018080|NCT01567527|2042654|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
1018081|NCT01567527|2042650|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1018082|NCT01567527|2042651|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1018083|NCT01567527|2042652|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1018084|NCT01567527|2042653|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
1018085|NCT01567527|2042654|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
1018086|NCT01567527|2042650|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1018087|NCT01567527|2042651|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1018088|NCT01567527|2042652|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1018089|NCT01567527|2042653|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
1018090|NCT01567527|2042654|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
1018091|NCT01567527|2042650|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1018092|NCT01567527|2042651|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1018093|NCT01567527|2042652|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1018094|NCT01567527|2042653|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
1018095|NCT01567527|2042654|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
1018096|NCT01567527|2042650|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1018097|NCT01567527|2042651|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1018098|NCT01567527|2042652|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1018099|NCT01567527|2042653|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
1018100|NCT01567527|2042654|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
1018101|NCT01567826|2042665|FG000|Overall Study|Lost to Follow-up|3
1018102|NCT01567826|2042666|FG001|Overall Study|Lost to Follow-up|2
1018103|NCT01567852|2042684|FG000|Overall Study|Withdrawal by Subject|3
1018104|NCT01567852|2042685|FG001|Overall Study|Withdrawal by Subject|6
1018105|NCT01567852|2042684|FG000|Overall Study|ECT discontinued|1
1018106|NCT01567852|2042685|FG001|Overall Study|ECT discontinued|1
1018107|NCT01567865|2042695|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
1018108|NCT01567865|2042696|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
1018109|NCT01567865|2042697|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
1018110|NCT01567865|2042698|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
1018111|NCT01567865|2042695|FG000|Evaluated for Immunogenicity|Missing blood sample|17
1018112|NCT01567865|2042696|FG001|Evaluated for Immunogenicity|Missing blood sample|24
1018113|NCT01567865|2042697|FG002|Evaluated for Immunogenicity|Missing blood sample|16
1018114|NCT01567865|2042698|FG003|Evaluated for Immunogenicity|Missing blood sample|28
1018115|NCT01568034|2042740|FG000|Overall Study|Withdrawal by Subject|1
1018116|NCT01568034|2042741|FG001|Overall Study|Withdrawal by Subject|0
1018117|NCT01568034|2042742|FG002|Overall Study|Withdrawal by Subject|0
1018118|NCT01568034|2042743|FG003|Overall Study|Withdrawal by Subject|0
1018119|NCT01568047|2042757|FG000|Overall Study|Ineligibility|1
1018120|NCT01568047|2042758|FG001|Overall Study|Ineligibility|0
1018121|NCT01568047|2042759|FG002|Overall Study|Ineligibility|0
1018122|NCT01568047|2042760|FG003|Overall Study|Ineligibility|0
1018123|NCT01568047|2042757|FG000|Overall Study|Withdrawal by Subject|0
1018124|NCT01568047|2042758|FG001|Overall Study|Withdrawal by Subject|1
1018125|NCT01568047|2042759|FG002|Overall Study|Withdrawal by Subject|0
1018126|NCT01568047|2042760|FG003|Overall Study|Withdrawal by Subject|0
1018127|NCT01568047|2042757|FG000|Overall Study|Adverse Event|0
1018128|NCT01568047|2042758|FG001|Overall Study|Adverse Event|0
1018129|NCT01568047|2042759|FG002|Overall Study|Adverse Event|1
1018130|NCT01568047|2042760|FG003|Overall Study|Adverse Event|1
1018131|NCT01568112|2042795|FG000|Overall Study|Randomized But Not Treated|0
1018132|NCT01568112|2042796|FG001|Overall Study|Randomized But Not Treated|1
1018133|NCT01568112|2042797|FG002|Overall Study|Randomized But Not Treated|0
1018134|NCT01568112|2042798|FG003|Overall Study|Randomized But Not Treated|0
1018135|NCT01568112|2042795|FG000|Overall Study|Withdrew due to Adverse Event|2
1018136|NCT01568112|2042796|FG001|Overall Study|Withdrew due to Adverse Event|4
1018137|NCT01568112|2042797|FG002|Overall Study|Withdrew due to Adverse Event|6
1018138|NCT01568112|2042798|FG003|Overall Study|Withdrew due to Adverse Event|3
1018139|NCT01568112|2042795|FG000|Overall Study|Lost to Follow-up|0
1018140|NCT01568112|2042796|FG001|Overall Study|Lost to Follow-up|0
1018141|NCT01568112|2042797|FG002|Overall Study|Lost to Follow-up|0
1018142|NCT01568112|2042798|FG003|Overall Study|Lost to Follow-up|1
1018143|NCT01568112|2042795|FG000|Overall Study|Withdrawal by Subject|2
1018144|NCT01568112|2042796|FG001|Overall Study|Withdrawal by Subject|3
1018145|NCT01568112|2042797|FG002|Overall Study|Withdrawal by Subject|0
1018146|NCT01568112|2042798|FG003|Overall Study|Withdrawal by Subject|7
1018147|NCT01568112|2042795|FG000|Overall Study|Withdrawal by Physician|1
1018148|NCT01568112|2042796|FG001|Overall Study|Withdrawal by Physician|0
1018149|NCT01568112|2042797|FG002|Overall Study|Withdrawal by Physician|1
1018150|NCT01568112|2042798|FG003|Overall Study|Withdrawal by Physician|1
1018151|NCT01568320|2042818|FG000|Overall Study|Death|20
1018152|NCT01568320|2042818|FG000|Overall Study|Lost to Follow-up|9
1018153|NCT01568320|2042818|FG000|Overall Study|Withdrawal by Subject|10
1018154|NCT01568320|2042818|FG000|Overall Study|Conversion to open repair|1
1018155|NCT01568320|2042818|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1
1018156|NCT01568593|2042841|FG000|Overall Study|Lack of Efficacy|4
1018157|NCT01568593|2042842|FG001|Overall Study|Lack of Efficacy|1
1018158|NCT01568593|2042841|FG000|Overall Study|Adverse Event|3
1018159|NCT01568593|2042842|FG001|Overall Study|Adverse Event|2
1018160|NCT01568866|2042863|FG000|Overall Study|Disease Progression|208
1018161|NCT01568866|2042864|FG001|Overall Study|Disease Progression|183
1018162|NCT01568866|2042863|FG000|Overall Study|Adverse Event|94
1018163|NCT01568866|2042864|FG001|Overall Study|Adverse Event|96
1018164|NCT01568866|2042863|FG000|Overall Study|Patient Request|55
1018165|NCT01568866|2042864|FG001|Overall Study|Patient Request|71
1018166|NCT01568866|2042863|FG000|Overall Study|Physician Decision|40
1018167|NCT01568866|2042864|FG001|Overall Study|Physician Decision|32
1018168|NCT01568866|2042863|FG000|Overall Study|Withdrawal by Subject|19
1018169|NCT01568866|2042864|FG001|Overall Study|Withdrawal by Subject|11
1018170|NCT01568866|2042863|FG000|Overall Study|Death|10
1018171|NCT01568866|2042864|FG001|Overall Study|Death|18
1018172|NCT01568866|2042863|FG000|Overall Study|Protocol Non-compliance|2
1018173|NCT01568866|2042864|FG001|Overall Study|Protocol Non-compliance|4
1018174|NCT01568866|2042863|FG000|Overall Study|Lost to Follow-up|1
1018175|NCT01568866|2042864|FG001|Overall Study|Lost to Follow-up|0
1018176|NCT01568866|2042863|FG000|Overall Study|Randomized but Not Dosed|9
1018177|NCT01568866|2042864|FG001|Overall Study|Randomized but Not Dosed|1
1018178|NCT01568892|2042872|FG000|Open-label Phase|Adverse Event|2
1018179|NCT01568892|2042873|FG001|Open-label Phase|Adverse Event|0
1018180|NCT01568892|2042872|FG000|Open-label Phase|Lack of Efficacy|4
1018181|NCT01568892|2042873|FG001|Open-label Phase|Lack of Efficacy|2
1018182|NCT01568892|2042872|FG000|Open-label Phase|Lost to Follow-up|0
1018183|NCT01568892|2042873|FG001|Open-label Phase|Lost to Follow-up|1
1018184|NCT01569022|2042902|FG000|First Intervention|Lost to Follow-up|2
1018185|NCT01569022|2042903|FG001|First Intervention|Lost to Follow-up|1
1018186|NCT01569022|2042902|FG000|Second Intervention|Lost to Follow-up|2
1018187|NCT01569022|2042903|FG001|Second Intervention|Lost to Follow-up|2
1018188|NCT01569074|2042916|FG000|Overall Study|Study stopped|6
1018189|NCT01569074|2042917|FG001|Overall Study|Study stopped|6
1018190|NCT01569074|2042918|FG002|Overall Study|Study stopped|8
1018191|NCT01569074|2042919|FG003|Overall Study|Study stopped|7
1018192|NCT01569074|2042920|FG004|Overall Study|Study stopped|7
1018193|NCT01569074|2042916|FG000|Overall Study|Study-specific discontinuation criteria|0
1018194|NCT01569074|2042917|FG001|Overall Study|Study-specific discontinuation criteria|1
1018195|NCT01569074|2042918|FG002|Overall Study|Study-specific discontinuation criteria|0
1018196|NCT01569074|2042919|FG003|Overall Study|Study-specific discontinuation criteria|0
1018197|NCT01569074|2042920|FG004|Overall Study|Study-specific discontinuation criteria|0
1018198|NCT01569074|2042916|FG000|Overall Study|Severe non-compliance to protocol|0
1018199|NCT01569074|2042917|FG001|Overall Study|Severe non-compliance to protocol|0
1018200|NCT01569074|2042918|FG002|Overall Study|Severe non-compliance to protocol|1
1018201|NCT01569074|2042919|FG003|Overall Study|Severe non-compliance to protocol|0
1018202|NCT01569074|2042920|FG004|Overall Study|Severe non-compliance to protocol|0
1018203|NCT01569074|2042916|FG000|Overall Study|eg change in circumstances|0
1018204|NCT01569074|2042917|FG001|Overall Study|eg change in circumstances|2
1018205|NCT01569074|2042918|FG002|Overall Study|eg change in circumstances|0
1018206|NCT01569074|2042919|FG003|Overall Study|eg change in circumstances|1
1018207|NCT01569074|2042920|FG004|Overall Study|eg change in circumstances|1
1018208|NCT01569074|2042916|FG000|Overall Study|Adverse Event|1
1018209|NCT01569074|2042917|FG001|Overall Study|Adverse Event|0
1018210|NCT01569074|2042918|FG002|Overall Study|Adverse Event|3
1018211|NCT01569074|2042919|FG003|Overall Study|Adverse Event|0
1018212|NCT01569074|2042920|FG004|Overall Study|Adverse Event|0
1018213|NCT01569152|2042981|FG000|Phase IIa, Period 1|Early Escape|5
1018214|NCT01569152|2042982|FG001|Phase IIa, Period 1|Early Escape|22
1018215|NCT01569152|2042983|FG002|Phase IIa, Period 1|Early Escape|0
1018216|NCT01569152|2042981|FG000|Phase IIa, Period 1|Adverse Event|4
1018217|NCT01569152|2042982|FG001|Phase IIa, Period 1|Adverse Event|0
1018218|NCT01569152|2042983|FG002|Phase IIa, Period 1|Adverse Event|0
1018219|NCT01569152|2042981|FG000|Phase IIa, Period 1|Lost to Follow-up|1
1018220|NCT01569152|2042982|FG001|Phase IIa, Period 1|Lost to Follow-up|0
1018221|NCT01569152|2042983|FG002|Phase IIa, Period 1|Lost to Follow-up|0
1018222|NCT01569152|2042981|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9
1018223|NCT01569152|2042982|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8
1018224|NCT01569152|2042983|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0
1018225|NCT01569152|2042981|FG000|Phase IIa, Period 1|Protocol Violation|0
1018226|NCT01569152|2042982|FG001|Phase IIa, Period 1|Protocol Violation|1
1018227|NCT01569152|2042983|FG002|Phase IIa, Period 1|Protocol Violation|0
1018228|NCT01569152|2042981|FG000|Phase IIa, Period 1|Withdrawal by Subject|2
1018229|NCT01569152|2042982|FG001|Phase IIa, Period 1|Withdrawal by Subject|1
1018230|NCT01569152|2042983|FG002|Phase IIa, Period 1|Withdrawal by Subject|0
1018231|NCT01569152|2042981|FG000|Safety Extension, Period 3|Adverse Event|0
1018232|NCT01569152|2042982|FG001|Safety Extension, Period 3|Adverse Event|0
1018233|NCT01569152|2042983|FG002|Safety Extension, Period 3|Adverse Event|4
1018234|NCT01569152|2042981|FG000|Safety Extension, Period 3|Withdrawal by Subject|0
1018235|NCT01569152|2042982|FG001|Safety Extension, Period 3|Withdrawal by Subject|0
1018236|NCT01569152|2042983|FG002|Safety Extension, Period 3|Withdrawal by Subject|2
1018237|NCT01569152|2042981|FG000|Safety Extension, Period 3|Physician Decision|0
1018238|NCT01569152|2042982|FG001|Safety Extension, Period 3|Physician Decision|0
1018239|NCT01569152|2042983|FG002|Safety Extension, Period 3|Physician Decision|2
1018240|NCT01569152|2042981|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0
1018241|NCT01569152|2042982|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0
1018242|NCT01569152|2042983|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47
1018243|NCT01569295|2043005|FG000|Overall Study|Progressive Disease|75
1018244|NCT01569295|2043006|FG001|Overall Study|Progressive Disease|139
1018245|NCT01569295|2043005|FG000|Overall Study|Adverse Event|39
1018246|NCT01569295|2043006|FG001|Overall Study|Adverse Event|14
1018247|NCT01569295|2043005|FG000|Overall Study|Withdrawal by Subject|25
1018248|NCT01569295|2043006|FG001|Overall Study|Withdrawal by Subject|12
1018249|NCT01569295|2043005|FG000|Overall Study|Death|19
1018250|NCT01569295|2043006|FG001|Overall Study|Death|15
1018251|NCT01569295|2043005|FG000|Overall Study|Physician Decision|13
1018252|NCT01569295|2043006|FG001|Overall Study|Physician Decision|18
1018253|NCT01569295|2043005|FG000|Overall Study|Study Terminated by Sponsor|24
1018254|NCT01569295|2043006|FG001|Overall Study|Study Terminated by Sponsor|2
1018255|NCT01569295|2043005|FG000|Overall Study|Other Reason not Specified|3
1018256|NCT01569295|2043006|FG001|Overall Study|Other Reason not Specified|5
1018257|NCT01569295|2043005|FG000|Overall Study|Non-Compliance with Study Drug|6
1018258|NCT01569295|2043006|FG001|Overall Study|Non-Compliance with Study Drug|1
1018259|NCT01569295|2043005|FG000|Overall Study|Other Anticancer/Experimental Therapy|2
1018260|NCT01569295|2043006|FG001|Overall Study|Other Anticancer/Experimental Therapy|2
1018261|NCT01569295|2043005|FG000|Overall Study|Lost to Follow-up|1
1018262|NCT01569295|2043006|FG001|Overall Study|Lost to Follow-up|1
1018263|NCT01569438|2043015|FG000|Overall Study|Lack of Efficacy|1
1018264|NCT01569438|2043016|FG001|Overall Study|Lack of Efficacy|2
1018265|NCT01569438|2043015|FG000|Overall Study|Withdrawal by Subject|0
1018266|NCT01569438|2043016|FG001|Overall Study|Withdrawal by Subject|3
1018267|NCT01569438|2043015|FG000|Overall Study|Adverse Event|2
1018268|NCT01569438|2043016|FG001|Overall Study|Adverse Event|15
1018269|NCT01569438|2043015|FG000|Overall Study|Protocol Violation|2
1018270|NCT01569438|2043016|FG001|Overall Study|Protocol Violation|0
1018271|NCT01569438|2043015|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1
1018272|NCT01569438|2043016|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0
1018273|NCT01569438|2043015|FG000|Overall Study|Sponsor/Physician decision|1
1018274|NCT01569438|2043016|FG001|Overall Study|Sponsor/Physician decision|1
1018275|NCT01569438|2043015|FG000|Overall Study|Unable to adhere to study schedule|0
1018276|NCT01569438|2043016|FG001|Overall Study|Unable to adhere to study schedule|1
1018277|NCT01569464|2043035|FG000|Overall Study|Adverse Event|4
1018278|NCT01569464|2043036|FG001|Overall Study|Adverse Event|0
1018279|NCT01569464|2043035|FG000|Overall Study|Lack of Efficacy|1
1018280|NCT01569464|2043036|FG001|Overall Study|Lack of Efficacy|0
1018281|NCT01569464|2043035|FG000|Overall Study|Protocol Violation|1
1018282|NCT01569464|2043036|FG001|Overall Study|Protocol Violation|0
1018283|NCT01569464|2043035|FG000|Overall Study|Lost to Follow-up|2
1018284|NCT01569464|2043036|FG001|Overall Study|Lost to Follow-up|3
1018285|NCT01569464|2043035|FG000|Overall Study|Withdrawal by Subject|1
1018286|NCT01569464|2043036|FG001|Overall Study|Withdrawal by Subject|1
1018287|NCT01569464|2043035|FG000|Overall Study|Other|1
1018288|NCT01569464|2043036|FG001|Overall Study|Other|1
1018289|NCT01569568|2043055|FG000|Overall Study|Physician Decision|0
1018290|NCT01569568|2043056|FG001|Overall Study|Physician Decision|2
1018291|NCT01569594|2043062|FG000|Overall Study|Physician Decision|4
1018292|NCT01569594|2043062|FG000|Overall Study|Death|13
1018293|NCT01569594|2043062|FG000|Overall Study|Lost to Follow-up|22
1018294|NCT01569594|2043062|FG000|Overall Study|Adverse Event|2
1018295|NCT01569594|2043062|FG000|Overall Study|Withdrawal by Subject|13
1018296|NCT01569594|2043062|FG000|Overall Study|Other|4
1018297|NCT01569594|2043062|FG000|Overall Study|No ECM used|9
1018298|NCT01569763|2043081|FG000|Overall Study|Lack of Efficacy|2
1018299|NCT01569763|2043082|FG001|Overall Study|Lack of Efficacy|7
1018300|NCT01569763|2043081|FG000|Overall Study|Adverse Event|1
1018301|NCT01569763|2043082|FG001|Overall Study|Adverse Event|0
1018302|NCT01569841|2043116|FG000|Period A (6 Weeks)|Withdrawal by Subject|0
1018303|NCT01569841|2043117|FG001|Period A (6 Weeks)|Withdrawal by Subject|1
1018304|NCT01570192|2043136|FG000|Overall Study|no qualifying organism|6
1018305|NCT01570192|2043137|FG001|Overall Study|no qualifying organism|12
1018306|NCT01570192|2043136|FG000|Overall Study|changed to palliative care|1
1018307|NCT01570192|2043137|FG001|Overall Study|changed to palliative care|0
1018308|NCT01570192|2043136|FG000|Overall Study|Physician Decision|0
1018309|NCT01570192|2043137|FG001|Overall Study|Physician Decision|1
1090961|NCT02250651|2158803|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2
1090962|NCT02250651|2158804|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
1090963|NCT02250651|2158805|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
1090964|NCT02251275|2158844|FG000|Overall Study|Adverse Event|23
1090965|NCT02251275|2158845|FG001|Overall Study|Adverse Event|60
1090966|NCT02251275|2158846|FG002|Overall Study|Adverse Event|28
1090967|NCT02251275|2158847|FG003|Overall Study|Adverse Event|0
1090968|NCT02251275|2158848|FG004|Overall Study|Adverse Event|0
1090969|NCT02251275|2158844|FG000|Overall Study|Lost to Follow-up|5
1090970|NCT02251275|2158845|FG001|Overall Study|Lost to Follow-up|6
1090971|NCT02251275|2158846|FG002|Overall Study|Lost to Follow-up|4
1090972|NCT02251275|2158847|FG003|Overall Study|Lost to Follow-up|0
1090973|NCT02251275|2158848|FG004|Overall Study|Lost to Follow-up|0
1090974|NCT02251275|2158844|FG000|Overall Study|Physician Decision|19
1090975|NCT02251275|2158845|FG001|Overall Study|Physician Decision|30
1090976|NCT02251275|2158846|FG002|Overall Study|Physician Decision|26
1090977|NCT02251275|2158847|FG003|Overall Study|Physician Decision|0
1090978|NCT02251275|2158848|FG004|Overall Study|Physician Decision|1
1090979|NCT02251275|2158844|FG000|Overall Study|Protocol Deviation|0
1090980|NCT02251275|2158845|FG001|Overall Study|Protocol Deviation|0
1090981|NCT02251275|2158846|FG002|Overall Study|Protocol Deviation|1
1090982|NCT02251275|2158847|FG003|Overall Study|Protocol Deviation|0
1090983|NCT02251275|2158848|FG004|Overall Study|Protocol Deviation|0
1090984|NCT02251275|2158844|FG000|Overall Study|Withdrawal by Subject|25
1090985|NCT02251275|2158845|FG001|Overall Study|Withdrawal by Subject|51
1090986|NCT02251275|2158846|FG002|Overall Study|Withdrawal by Subject|35
1090987|NCT02251275|2158847|FG003|Overall Study|Withdrawal by Subject|1
1090988|NCT02251275|2158848|FG004|Overall Study|Withdrawal by Subject|0
1090989|NCT02251652|2158895|FG000|Overall Study|Withdrawal by Subject|1
1090990|NCT02251717|2158903|FG000|Overall Study|Adverse Event|0
1090991|NCT02251717|2158904|FG001|Overall Study|Adverse Event|1
1090992|NCT02251717|2158903|FG000|Overall Study|Withdrew Consent|1
1090993|NCT02251717|2158904|FG001|Overall Study|Withdrew Consent|0
1090994|NCT02251743|2158912|FG000|Overall Study|Withdrawal by Subject|1
1090995|NCT02251743|2158913|FG001|Overall Study|Withdrawal by Subject|1
1090996|NCT02251912|2158938|FG000|Overall Study|Withdrawal by Subject|2
1090997|NCT02251912|2158939|FG001|Overall Study|Withdrawal by Subject|3
1090998|NCT02251912|2158938|FG000|Overall Study|Adverse Event|0
1090999|NCT02251912|2158939|FG001|Overall Study|Adverse Event|2
1091000|NCT02251990|2158951|FG000|Period 1 (Double-blind [DB])|Adverse Event|1
1091001|NCT02251990|2158952|FG001|Period 1 (Double-blind [DB])|Adverse Event|1
1091002|NCT02251990|2158951|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5
1091003|NCT02251990|2158952|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0
1091004|NCT02251990|2158951|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
1091005|NCT02251990|2158952|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
1091006|NCT02251990|2158951|FG000|Period 1 (Double-blind [DB])|Not Treated|1
1091007|NCT02251990|2158952|FG001|Period 1 (Double-blind [DB])|Not Treated|0
1091008|NCT02251990|2158951|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
1091009|NCT02251990|2158952|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
1091010|NCT02251990|2158951|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
1091011|NCT02251990|2158952|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
1091012|NCT02252016|2158961|FG000|Overall Study|Lost to Follow-up|2
1091013|NCT02252016|2158962|FG001|Overall Study|Lost to Follow-up|1
1091014|NCT02252016|2158961|FG000|Overall Study|Physician Decision|1
1091015|NCT02252016|2158962|FG001|Overall Study|Physician Decision|0
1091016|NCT02252016|2158961|FG000|Overall Study|Withdrawal by Subject|0
1091017|NCT02252016|2158962|FG001|Overall Study|Withdrawal by Subject|2
1091018|NCT02252042|2158970|FG000|Overall Study|Death|170
1091019|NCT02252042|2158971|FG001|Overall Study|Death|192
1091020|NCT02252042|2158970|FG000|Overall Study|Physician Decision|0
1091021|NCT02252042|2158971|FG001|Overall Study|Physician Decision|1
1091022|NCT02252042|2158970|FG000|Overall Study|Withdrawal by Subject|13
1091023|NCT02252042|2158971|FG001|Overall Study|Withdrawal by Subject|20
1091024|NCT02252042|2158970|FG000|Overall Study|Ongoing in study|64
1091025|NCT02252042|2158971|FG001|Overall Study|Ongoing in study|35
1091026|NCT02252081|2158992|FG000|Overall Study|Withdrawal by Subject|2
1091027|NCT02252081|2158993|FG001|Overall Study|Withdrawal by Subject|1
1091028|NCT02252081|2158992|FG000|Overall Study|Adverse Event|4
1091029|NCT02252081|2158993|FG001|Overall Study|Adverse Event|1
1091030|NCT02252081|2158992|FG000|Overall Study|non compliance & others|0
1091031|NCT02252081|2158993|FG001|Overall Study|non compliance & others|2
1091032|NCT02252146|2159011|FG000|Overall Study|Lack of Efficacy|4
1091033|NCT02252146|2159011|FG000|Overall Study|Entered hospice care|1
1091034|NCT02252146|2159011|FG000|Overall Study|Inability to travel to study site|1
1091039|NCT02252211|2159026|FG000|Overall Study|Adverse Event|0
1091040|NCT02252211|2159027|FG001|Overall Study|Adverse Event|1
1091041|NCT02252211|2159028|FG002|Overall Study|Adverse Event|0
1091042|NCT02252211|2159026|FG000|Overall Study|Progressive disease|3
1091043|NCT02252211|2159027|FG001|Overall Study|Progressive disease|2
1091044|NCT02252211|2159028|FG002|Overall Study|Progressive disease|0
1091045|NCT02252211|2159026|FG000|Overall Study|Withdrawal by Subject|1
1091046|NCT02252211|2159027|FG001|Overall Study|Withdrawal by Subject|0
1091047|NCT02252211|2159028|FG002|Overall Study|Withdrawal by Subject|0
1091048|NCT02252211|2159026|FG000|Overall Study|Serious Adverse Event During Screening|1
1091049|NCT02252211|2159027|FG001|Overall Study|Serious Adverse Event During Screening|0
1091050|NCT02252211|2159028|FG002|Overall Study|Serious Adverse Event During Screening|1
1091051|NCT02252406|2159046|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
1091052|NCT02252406|2159047|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
1091053|NCT02252406|2159046|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
1091054|NCT02252406|2159047|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
1091055|NCT02252406|2159046|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
1091056|NCT02252406|2159047|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
1091057|NCT02252406|2159046|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
1091058|NCT02252406|2159047|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
1091059|NCT02252406|2159046|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2
1091060|NCT02252406|2159047|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0
1091061|NCT02252536|2159064|FG000|Overall Study|Lost to Follow-up|5
1091062|NCT02252536|2159065|FG001|Overall Study|Lost to Follow-up|3
1091063|NCT02252588|2159083|FG000|Overall Study|Withdrawal by Subject|4
1091064|NCT02252588|2159084|FG001|Overall Study|Withdrawal by Subject|0
1091065|NCT02252939|2159102|FG000|Overall Study|Lost to Follow-up|3
1091066|NCT02252965|2159113|FG000|Overall Study|Adverse Event|9
1091067|NCT02252965|2159114|FG001|Overall Study|Adverse Event|14
1091068|NCT02252965|2159113|FG000|Overall Study|Lost to Follow-up|16
1091069|NCT02252965|2159114|FG001|Overall Study|Lost to Follow-up|8
1091070|NCT02252965|2159113|FG000|Overall Study|Protocol Violation|4
1091071|NCT02252965|2159114|FG001|Overall Study|Protocol Violation|5
1091072|NCT02252965|2159113|FG000|Overall Study|Lack of Efficacy|0
1091073|NCT02252965|2159114|FG001|Overall Study|Lack of Efficacy|2
1091074|NCT02252965|2159113|FG000|Overall Study|Withdrawal by Subject|7
1091075|NCT02252965|2159114|FG001|Overall Study|Withdrawal by Subject|9
1091076|NCT02252965|2159113|FG000|Overall Study|Other|4
1091077|NCT02252965|2159114|FG001|Overall Study|Other|5
1091078|NCT02253147|2159122|FG000|Overall Study|Protocol Violation|30
1091079|NCT02253147|2159122|FG000|Overall Study|Did not consent to study extension|9
1091080|NCT02253147|2159122|FG000|Overall Study|Conditional re-treatment at W52|5
1091081|NCT02253147|2159122|FG000|Overall Study|Lost to Follow-up|2
1091082|NCT02253147|2159122|FG000|Overall Study|Withdrawal by Subject|1
1091083|NCT02253316|2159164|FG000|Consolidation|Progression|5
1091084|NCT02253316|2159165|FG001|Consolidation|Progression|0
1091085|NCT02253316|2159166|FG002|Consolidation|Progression|0
1091086|NCT02253316|2159164|FG000|Consolidation|Non-Compliance|1
1091087|NCT02253316|2159165|FG001|Consolidation|Non-Compliance|0
1091088|NCT02253316|2159166|FG002|Consolidation|Non-Compliance|0
1091089|NCT02253316|2159164|FG000|Consolidation|Patient Withdrew Logistical Concerns|2
1091090|NCT02253316|2159165|FG001|Consolidation|Patient Withdrew Logistical Concerns|0
1091091|NCT02253316|2159166|FG002|Consolidation|Patient Withdrew Logistical Concerns|0
1091092|NCT02253316|2159164|FG000|Consolidation|Secondary Malignancy|2
1091093|NCT02253316|2159165|FG001|Consolidation|Secondary Malignancy|0
1091094|NCT02253316|2159166|FG002|Consolidation|Secondary Malignancy|0
1091095|NCT02253316|2159164|FG000|Consolidation|Adverse Event|7
1091096|NCT02253316|2159165|FG001|Consolidation|Adverse Event|0
1091097|NCT02253316|2159166|FG002|Consolidation|Adverse Event|0
1091098|NCT02253316|2159164|FG000|Maintenance|Ineligible|0
1091099|NCT02253316|2159165|FG001|Maintenance|Ineligible|1
1091100|NCT02253316|2159166|FG002|Maintenance|Ineligible|0
1091101|NCT02253316|2159164|FG000|Maintenance|Patient Withdrew Logistical Concerns|0
1091102|NCT02253316|2159165|FG001|Maintenance|Patient Withdrew Logistical Concerns|4
1091103|NCT02253316|2159166|FG002|Maintenance|Patient Withdrew Logistical Concerns|5
1091104|NCT02253316|2159164|FG000|Maintenance|Physician Decision|0
1091105|NCT02253316|2159165|FG001|Maintenance|Physician Decision|2
1091106|NCT02253316|2159166|FG002|Maintenance|Physician Decision|1
1091107|NCT02253316|2159164|FG000|Maintenance|Non-Compliance|0
1091108|NCT02253316|2159165|FG001|Maintenance|Non-Compliance|1
1091109|NCT02253316|2159166|FG002|Maintenance|Non-Compliance|0
1091110|NCT02253316|2159164|FG000|Maintenance|Secondary Malignancy|0
1091111|NCT02253316|2159165|FG001|Maintenance|Secondary Malignancy|1
1091112|NCT02253316|2159166|FG002|Maintenance|Secondary Malignancy|5
1091113|NCT02253316|2159164|FG000|Maintenance|Adverse Event|0
1091114|NCT02253316|2159165|FG001|Maintenance|Adverse Event|7
1091115|NCT02253316|2159166|FG002|Maintenance|Adverse Event|11
1091116|NCT02253316|2159164|FG000|Maintenance|Still receiving active treatment|0
1091117|NCT02253316|2159165|FG001|Maintenance|Still receiving active treatment|37
1091118|NCT02253316|2159166|FG002|Maintenance|Still receiving active treatment|59
1091119|NCT02253433|2159176|FG000|Overall Study|Unable to Contact|9
1091120|NCT02253433|2159177|FG001|Overall Study|Unable to Contact|16
1091121|NCT02253433|2159176|FG000|Overall Study|Death|1
1091122|NCT02253433|2159177|FG001|Overall Study|Death|1
1091123|NCT02253433|2159176|FG000|Overall Study|No Longer Interested|3
1091124|NCT02253433|2159177|FG001|Overall Study|No Longer Interested|15
1091125|NCT02253433|2159176|FG000|Overall Study|Out of Study Area|2
1091126|NCT02253433|2159177|FG001|Overall Study|Out of Study Area|7
1091127|NCT02253433|2159176|FG000|Overall Study|Uncomfortable with home visitors|0
1091128|NCT02253433|2159177|FG001|Overall Study|Uncomfortable with home visitors|3
1091129|NCT02253433|2159176|FG000|Overall Study|Unstable Housing/Homeless|0
1091130|NCT02253433|2159177|FG001|Overall Study|Unstable Housing/Homeless|7
1091131|NCT02253433|2159176|FG000|Overall Study|Too Busy|0
1091132|NCT02253433|2159177|FG001|Overall Study|Too Busy|4
1091133|NCT02253433|2159176|FG000|Overall Study|Medical or Other Concerns|1
1091134|NCT02253433|2159177|FG001|Overall Study|Medical or Other Concerns|2
1091135|NCT02253654|2159190|FG000|Overall Study|Withdrawal by Subject|12
1091136|NCT02253654|2159191|FG001|Overall Study|Withdrawal by Subject|4
1091137|NCT02253654|2159190|FG000|Overall Study|Decision by Sponsor|1
1091138|NCT02253654|2159191|FG001|Overall Study|Decision by Sponsor|1
1091139|NCT02253654|2159190|FG000|Overall Study|Lost to Follow-up|2
1091140|NCT02253654|2159191|FG001|Overall Study|Lost to Follow-up|5
1091141|NCT02253654|2159190|FG000|Overall Study|Death|4
1091142|NCT02253654|2159191|FG001|Overall Study|Death|7
1091143|NCT02253654|2159190|FG000|Overall Study|Did Not Receive Study Treatment|4
1091144|NCT02253654|2159191|FG001|Overall Study|Did Not Receive Study Treatment|1
1091145|NCT02253992|2159200|FG000|Overall Study|Study drug toxicity|1
1091146|NCT02253992|2159201|FG001|Overall Study|Study drug toxicity|0
1091147|NCT02253992|2159202|FG002|Overall Study|Study drug toxicity|10
1091148|NCT02253992|2159200|FG000|Overall Study|Disease progression|4
1091149|NCT02253992|2159201|FG001|Overall Study|Disease progression|3
1091150|NCT02253992|2159202|FG002|Overall Study|Disease progression|98
1091151|NCT02253992|2159200|FG000|Overall Study|Withdrawal by Subject|0
1091152|NCT02253992|2159201|FG001|Overall Study|Withdrawal by Subject|0
1091153|NCT02253992|2159202|FG002|Overall Study|Withdrawal by Subject|3
1091154|NCT02253992|2159200|FG000|Overall Study|Adverse Event|0
1091155|NCT02253992|2159201|FG001|Overall Study|Adverse Event|0
1091156|NCT02253992|2159202|FG002|Overall Study|Adverse Event|8
1091157|NCT02253992|2159200|FG000|Overall Study|Death|0
1091158|NCT02253992|2159201|FG001|Overall Study|Death|0
1091159|NCT02253992|2159202|FG002|Overall Study|Death|1
1091160|NCT02253992|2159200|FG000|Overall Study|Subject discontinued study drug|1
1091161|NCT02253992|2159201|FG001|Overall Study|Subject discontinued study drug|0
1091162|NCT02253992|2159202|FG002|Overall Study|Subject discontinued study drug|1
1091163|NCT02253992|2159200|FG000|Overall Study|Completed treatment as per protocol|0
1091164|NCT02253992|2159201|FG001|Overall Study|Completed treatment as per protocol|1
1091165|NCT02253992|2159202|FG002|Overall Study|Completed treatment as per protocol|22
1091166|NCT02253992|2159200|FG000|Overall Study|Other|0
1091167|NCT02253992|2159201|FG001|Overall Study|Other|0
1091168|NCT02253992|2159202|FG002|Overall Study|Other|1
1091169|NCT02254278|2159248|FG000|Overall Study|Protocol Violation|1
1091170|NCT02254278|2159249|FG001|Overall Study|Protocol Violation|1
1091171|NCT02254291|2159261|FG000|Overall Study|Withdrawal by Subject|0
1091172|NCT02254291|2159262|FG001|Overall Study|Withdrawal by Subject|3
1091173|NCT02254291|2159263|FG002|Overall Study|Withdrawal by Subject|1
1091174|NCT02254291|2159261|FG000|Overall Study|Missing follow-up information|0
1091175|NCT02254291|2159262|FG001|Overall Study|Missing follow-up information|0
1091176|NCT02254291|2159263|FG002|Overall Study|Missing follow-up information|1
1091177|NCT02254304|2159273|FG000|Overall Study|Adverse Event|2
1091178|NCT02254304|2159274|FG001|Overall Study|Adverse Event|1
1091179|NCT02254304|2159273|FG000|Overall Study|Lost to Follow-up|2
1091180|NCT02254304|2159274|FG001|Overall Study|Lost to Follow-up|2
1091181|NCT02254304|2159273|FG000|Overall Study|Protocol Violation|1
1091182|NCT02254304|2159274|FG001|Overall Study|Protocol Violation|0
1091183|NCT02254304|2159273|FG000|Overall Study|Withdrawal by Subject|3
1091184|NCT02254304|2159274|FG001|Overall Study|Withdrawal by Subject|0
1091185|NCT02254304|2159273|FG000|Overall Study|Injection site pain and Injection fear|1
1091186|NCT02254304|2159274|FG001|Overall Study|Injection site pain and Injection fear|0
1091187|NCT02254304|2159273|FG000|Overall Study|Personal causes|4
1091188|NCT02254304|2159274|FG001|Overall Study|Personal causes|1
1091189|NCT02254304|2159273|FG000|Overall Study|Personal decision|1
1091190|NCT02254304|2159274|FG001|Overall Study|Personal decision|0
1091191|NCT02254408|2159284|FG000|Overall Study|Randomized But Not Treated|1
1091192|NCT02254408|2159285|FG001|Overall Study|Randomized But Not Treated|3
1091193|NCT02254408|2159284|FG000|Overall Study|Adverse Event|1
1091194|NCT02254408|2159285|FG001|Overall Study|Adverse Event|0
1091195|NCT02254408|2159284|FG000|Overall Study|Death|2
1091196|NCT02254408|2159285|FG001|Overall Study|Death|3
1091197|NCT02254408|2159284|FG000|Overall Study|Investigator's Discretion|0
1091198|NCT02254408|2159285|FG001|Overall Study|Investigator's Discretion|1
1091199|NCT02254408|2159284|FG000|Overall Study|Withdrawal by Subject|3
1091200|NCT02254408|2159285|FG001|Overall Study|Withdrawal by Subject|3
1091201|NCT02254408|2159284|FG000|Overall Study|Lost to Follow-up|1
1091202|NCT02254408|2159285|FG001|Overall Study|Lost to Follow-up|0
1091203|NCT02254421|2159293|FG000|Overall Study|Randomized but Not Treated|1
1091204|NCT02254421|2159294|FG001|Overall Study|Randomized but Not Treated|0
1091205|NCT02254421|2159293|FG000|Overall Study|Death|0
1091206|NCT02254421|2159294|FG001|Overall Study|Death|2
1091207|NCT02254421|2159293|FG000|Overall Study|Withdrew Consent|1
1091208|NCT02254421|2159294|FG001|Overall Study|Withdrew Consent|1
1091209|NCT02254460|2159300|FG000|Overall Study|Adverse Event|1
1091210|NCT02254460|2159301|FG001|Overall Study|Adverse Event|0
1091211|NCT02254486|2159318|FG000|Overall Study|Adverse Event|1
1091212|NCT02254486|2159319|FG001|Overall Study|Adverse Event|1
1091213|NCT02254486|2159318|FG000|Overall Study|Lack of Efficacy|1
1091214|NCT02254486|2159319|FG001|Overall Study|Lack of Efficacy|0
1091215|NCT02254486|2159318|FG000|Overall Study|Lost to Follow-up|2
1091216|NCT02254486|2159319|FG001|Overall Study|Lost to Follow-up|4
1091217|NCT02254486|2159318|FG000|Overall Study|Protocol Violation|1
1091218|NCT02254486|2159319|FG001|Overall Study|Protocol Violation|2
1091219|NCT02254486|2159318|FG000|Overall Study|Withdrawal by Subject|17
1091220|NCT02254486|2159319|FG001|Overall Study|Withdrawal by Subject|15
1091221|NCT02254486|2159318|FG000|Overall Study|GFR<60mL/min|16
1091222|NCT02254486|2159319|FG001|Overall Study|GFR<60mL/min|21
1091223|NCT02254486|2159318|FG000|Overall Study|Various|12
1091224|NCT02254486|2159319|FG001|Overall Study|Various|12
1091225|NCT02254551|2159325|FG000|Dose Escalation|Physician Decision|1
1091226|NCT02254551|2159325|FG000|Dose Escalation|Dose-limiting toxicity|2
1091227|NCT02254681|2159332|FG000|Overall Study|Lack of Efficacy|6
1091228|NCT02254772|2159337|FG000|Overall Study|Ineligible|1
1091229|NCT02254772|2159337|FG000|Overall Study|Withdrawal by Subject|1
1091230|NCT02255097|2159350|FG000|Overall Study|Adverse Event|24
1091231|NCT02255097|2159350|FG000|Overall Study|Clinical Progression|23
1091232|NCT02255097|2159350|FG000|Overall Study|Complete Response|1
1091233|NCT02255097|2159350|FG000|Overall Study|Excluded Medication|1
1091234|NCT02255097|2159350|FG000|Overall Study|Death|2
1091235|NCT02255097|2159350|FG000|Overall Study|Lost to Follow-up|1
1091236|NCT02255097|2159350|FG000|Overall Study|Physician Decision|1
1091237|NCT02255097|2159350|FG000|Overall Study|Progressive Disease|80
1091238|NCT02255097|2159350|FG000|Overall Study|Withdrawal by Subject|2
1091239|NCT02255097|2159350|FG000|Overall Study|Allocated but not treated|1
1091240|NCT02255097|2159350|FG000|Overall Study|Treatment Ongoing|36
1091241|NCT02255149|2159358|FG000|Overall Study|Lost to Follow-up|2
1091242|NCT02255149|2159358|FG000|Overall Study|Withdrawal by Subject|1
1091243|NCT02255149|2159358|FG000|Overall Study|Withdrawal by PI|1
1091244|NCT02255149|2159358|FG000|Overall Study|Implant Failure|1
1091245|NCT02255279|2159377|FG000|Overall Study|Lost to Follow-up|2
1091246|NCT02255279|2159378|FG001|Overall Study|Lost to Follow-up|2
1091247|NCT02255279|2159377|FG000|Overall Study|Protocol Violation|0
1091248|NCT02255279|2159378|FG001|Overall Study|Protocol Violation|1
1091249|NCT02255279|2159377|FG000|Overall Study|Withdrawal by Subject|3
1091250|NCT02255279|2159378|FG001|Overall Study|Withdrawal by Subject|6
1091251|NCT02255422|2159414|FG000|Overall Study|Withdrawal by Subject|0
1091252|NCT02255422|2159415|FG001|Overall Study|Withdrawal by Subject|0
1091253|NCT02255422|2159416|FG002|Overall Study|Withdrawal by Subject|0
1091254|NCT02255422|2159417|FG003|Overall Study|Withdrawal by Subject|0
1091255|NCT02255422|2159418|FG004|Overall Study|Withdrawal by Subject|0
1091256|NCT02255422|2159419|FG005|Overall Study|Withdrawal by Subject|0
1091257|NCT02255422|2159420|FG006|Overall Study|Withdrawal by Subject|2
1091258|NCT02255422|2159414|FG000|Overall Study|Lost to Follow-up|0
1091259|NCT02255422|2159415|FG001|Overall Study|Lost to Follow-up|0
1091260|NCT02255422|2159416|FG002|Overall Study|Lost to Follow-up|1
1091261|NCT02255422|2159417|FG003|Overall Study|Lost to Follow-up|0
1091262|NCT02255422|2159418|FG004|Overall Study|Lost to Follow-up|0
1091263|NCT02255422|2159419|FG005|Overall Study|Lost to Follow-up|0
1091264|NCT02255422|2159420|FG006|Overall Study|Lost to Follow-up|0
1091265|NCT02255461|2159441|FG000|Overall Study|Adverse Event|0
1091266|NCT02255461|2159442|FG001|Overall Study|Adverse Event|1
1091267|NCT02255461|2159443|FG002|Overall Study|Adverse Event|0
1091268|NCT02255461|2159444|FG003|Overall Study|Adverse Event|0
1091269|NCT02255461|2159445|FG004|Overall Study|Adverse Event|1
1091270|NCT02255461|2159441|FG000|Overall Study|Withdrawal by Subject|0
1091271|NCT02255461|2159442|FG001|Overall Study|Withdrawal by Subject|0
1091272|NCT02255461|2159443|FG002|Overall Study|Withdrawal by Subject|1
1091273|NCT02255461|2159444|FG003|Overall Study|Withdrawal by Subject|0
1091274|NCT02255461|2159445|FG004|Overall Study|Withdrawal by Subject|1
1091275|NCT02255461|2159441|FG000|Overall Study|Not meet dose reduction BSA requirement|0
1091276|NCT02255461|2159442|FG001|Overall Study|Not meet dose reduction BSA requirement|1
1091277|NCT02255461|2159443|FG002|Overall Study|Not meet dose reduction BSA requirement|0
1091278|NCT02255461|2159444|FG003|Overall Study|Not meet dose reduction BSA requirement|0
1091279|NCT02255461|2159445|FG004|Overall Study|Not meet dose reduction BSA requirement|0
1091280|NCT02255474|2159465|FG000|Overall Study|Lost to Follow-up|1
1091281|NCT02255474|2159466|FG001|Overall Study|Lost to Follow-up|1
1091282|NCT02255474|2159467|FG002|Overall Study|Lost to Follow-up|3
1091283|NCT02255474|2159465|FG000|Overall Study|Withdrawal by Subject|1
1091284|NCT02255474|2159466|FG001|Overall Study|Withdrawal by Subject|1
1091285|NCT02255474|2159467|FG002|Overall Study|Withdrawal by Subject|0
1091286|NCT02255500|2159478|FG000|Overall Study|Withdrawal by Subject|1
1091287|NCT02255500|2159479|FG001|Overall Study|Withdrawal by Subject|0
1091288|NCT02255552|2159496|FG000|Overall Study|Participants enrolled into another study|0
1091289|NCT02255552|2159497|FG001|Overall Study|Participants enrolled into another study|11
1091290|NCT02255552|2159496|FG000|Overall Study|Withdrawal by Subject|1
1091291|NCT02255552|2159497|FG001|Overall Study|Withdrawal by Subject|4
1091292|NCT02255565|2159506|FG000|Overall Study|Withdrawal by Subject|0
1091293|NCT02255565|2159507|FG001|Overall Study|Withdrawal by Subject|1
1091294|NCT02255565|2159508|FG002|Overall Study|Withdrawal by Subject|0
1091295|NCT02255656|2159562|FG000|Overall Study|Adverse Event|11
1091296|NCT02255656|2159562|FG000|Overall Study|Poor compliance to protocol|3
1091297|NCT02255656|2159562|FG000|Overall Study|Lost to Follow-up|30
1091298|NCT02255656|2159562|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300
1091299|NCT02255656|2159562|FG000|Overall Study|Other|126
1091300|NCT02255760|2159578|FG000|Overall Study|Lost to Follow-up|0
1091301|NCT02255760|2159579|FG001|Overall Study|Lost to Follow-up|1
1091302|NCT02255760|2159580|FG002|Overall Study|Lost to Follow-up|0
1091303|NCT02255760|2159581|FG003|Overall Study|Lost to Follow-up|0
1091304|NCT02255760|2159582|FG004|Overall Study|Lost to Follow-up|0
1091305|NCT02255981|2159598|FG000|Overall Study|Lost to Follow-up|3
1091306|NCT02255981|2159598|FG000|Overall Study|Withdrawal by Subject|1
1091307|NCT02256267|2159639|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
1091308|NCT02256267|2159639|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1
1091309|NCT02256384|2159664|FG000|Overall Study|Withdrawal by Subject|12
1091310|NCT02256384|2159664|FG000|Overall Study|Equipment not capturing data|2
1091311|NCT02256436|2159674|FG000|Overall Study|Adverse Event|9
1091312|NCT02256436|2159675|FG001|Overall Study|Adverse Event|14
1091313|NCT02256436|2159674|FG000|Overall Study|Death|216
1091314|NCT02256436|2159675|FG001|Overall Study|Death|208
1091315|NCT02256436|2159674|FG000|Overall Study|Lost to Follow-up|1
1091316|NCT02256436|2159675|FG001|Overall Study|Lost to Follow-up|2
1091317|NCT02256436|2159674|FG000|Overall Study|Physician Decision|1
1091318|NCT02256436|2159675|FG001|Overall Study|Physician Decision|0
1091319|NCT02256436|2159674|FG000|Overall Study|Protocol Violation|0
1091320|NCT02256436|2159675|FG001|Overall Study|Protocol Violation|1
1091321|NCT02256436|2159674|FG000|Overall Study|Withdrawal by Subject|26
1091322|NCT02256436|2159675|FG001|Overall Study|Withdrawal by Subject|10
1091323|NCT02256436|2159674|FG000|Overall Study|Transferred to Extension Study|11
1091324|NCT02256436|2159675|FG001|Overall Study|Transferred to Extension Study|23
1091325|NCT02256436|2159674|FG000|Overall Study|Did Not Continue on Extension Study|8
1091326|NCT02256436|2159675|FG001|Overall Study|Did Not Continue on Extension Study|12
1091327|NCT02256488|2159686|FG000|Overall Study|Lost to Follow-up|6
1091328|NCT02256488|2159687|FG001|Overall Study|Lost to Follow-up|6
1091329|NCT02256488|2159688|FG002|Overall Study|Lost to Follow-up|9
1091330|NCT02256488|2159689|FG003|Overall Study|Lost to Follow-up|3
1091331|NCT02256488|2159686|FG000|Overall Study|OTHER|1
1091332|NCT02256488|2159687|FG001|Overall Study|OTHER|0
1091333|NCT02256488|2159688|FG002|Overall Study|OTHER|1
1091334|NCT02256488|2159689|FG003|Overall Study|OTHER|1
1091335|NCT02256488|2159686|FG000|Overall Study|Withdrawal by Subject|1
1091336|NCT02256488|2159687|FG001|Overall Study|Withdrawal by Subject|0
1091337|NCT02256488|2159688|FG002|Overall Study|Withdrawal by Subject|0
1091338|NCT02256488|2159689|FG003|Overall Study|Withdrawal by Subject|2
1091339|NCT02256540|2159700|FG000|Overall Study|Withdrawal by Subject|0
1091340|NCT02256540|2159701|FG001|Overall Study|Withdrawal by Subject|1
1091341|NCT02256540|2159702|FG002|Overall Study|Withdrawal by Subject|1
1091342|NCT02256540|2159700|FG000|Overall Study|Back pain preventing exercise|0
1091343|NCT02256540|2159701|FG001|Overall Study|Back pain preventing exercise|0
1091344|NCT02256540|2159702|FG002|Overall Study|Back pain preventing exercise|1
1091345|NCT02256553|2159710|FG000|Period I|Adverse Event|5
1091346|NCT02256553|2159710|FG000|Period I|Protocol Violation|1
1091347|NCT02256553|2159710|FG000|Period II|Adverse Event|1
1091348|NCT02256553|2159710|FG000|Period II|Subject Moved|1
1091349|NCT02256553|2159710|FG000|Period III|Adverse Event|3
1091371|NCT02256839|2159747|FG000|Overall Study|Did not meet Eligibility Criteria|2
1091372|NCT02256839|2159748|FG001|Overall Study|Did not meet Eligibility Criteria|3
1091373|NCT02256891|2159756|FG000|Overall Study|Death|0
1091374|NCT02256891|2159757|FG001|Overall Study|Death|2
1091375|NCT02256891|2159756|FG000|Overall Study|Lost to Follow-up|0
1091376|NCT02256891|2159757|FG001|Overall Study|Lost to Follow-up|3
1091377|NCT02256891|2159756|FG000|Overall Study|Physician Decision|7
1091378|NCT02256891|2159757|FG001|Overall Study|Physician Decision|3
1091379|NCT02256891|2159756|FG000|Overall Study|Screen Fail|5
1091380|NCT02256891|2159757|FG001|Overall Study|Screen Fail|4
1091381|NCT02256891|2159756|FG000|Overall Study|Equipment Malfunction|0
1091382|NCT02256891|2159757|FG001|Overall Study|Equipment Malfunction|1
1091383|NCT02256917|2159765|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1
1091384|NCT02256917|2159765|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1
1091385|NCT02256917|2159765|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1
1091386|NCT02256917|2159765|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1
1091387|NCT02256917|2159765|FG000|Prophylactic Treatment Phase II|Discontinued medication|1
1091388|NCT02256969|2159779|FG000|Overall Study|Screenfailed or withdrew|2
1091389|NCT02256969|2159780|FG001|Overall Study|Screenfailed or withdrew|1
1091390|NCT02256969|2159781|FG002|Overall Study|Screenfailed or withdrew|1
1091391|NCT02256982|2159791|FG000|Overall Study|Disease Progression|0
1091392|NCT02256982|2159792|FG001|Overall Study|Disease Progression|1
1091393|NCT02257372|2159851|FG000|Overall Study|Adverse Event|3
1091394|NCT02257372|2159852|FG001|Overall Study|Adverse Event|7
1091395|NCT02257372|2159851|FG000|Overall Study|Lack of Efficacy|2
1091396|NCT02257372|2159852|FG001|Overall Study|Lack of Efficacy|1
1091397|NCT02257372|2159851|FG000|Overall Study|Protocol Violation|1
1091398|NCT02257372|2159852|FG001|Overall Study|Protocol Violation|1
1091399|NCT02257372|2159851|FG000|Overall Study|Lost to Follow-up|0
1091400|NCT02257372|2159852|FG001|Overall Study|Lost to Follow-up|1
1091401|NCT02257372|2159851|FG000|Overall Study|Withdrew consent|1
1091402|NCT02257372|2159852|FG001|Overall Study|Withdrew consent|0
1091403|NCT02257385|2159860|FG000|Overall Study|Adverse Event|12
1091404|NCT02257385|2159861|FG001|Overall Study|Adverse Event|8
1091405|NCT02257385|2159860|FG000|Overall Study|Lack of Efficacy|1
1091406|NCT02257385|2159861|FG001|Overall Study|Lack of Efficacy|2
1091407|NCT02257385|2159860|FG000|Overall Study|Protocol Violation|5
1091408|NCT02257385|2159861|FG001|Overall Study|Protocol Violation|7
1091409|NCT02257385|2159860|FG000|Overall Study|Lost to Follow-up|0
1091410|NCT02257385|2159861|FG001|Overall Study|Lost to Follow-up|1
1091411|NCT02257385|2159860|FG000|Overall Study|Withdrawal by Subject|4
1091412|NCT02257385|2159861|FG001|Overall Study|Withdrawal by Subject|4
1091413|NCT02257489|2159876|FG000|Overall Study|Withdrawal by Subject|0
1091414|NCT02257489|2159877|FG001|Overall Study|Withdrawal by Subject|0
1091415|NCT02257489|2159878|FG002|Overall Study|Withdrawal by Subject|0
1091416|NCT02257489|2159879|FG003|Overall Study|Withdrawal by Subject|1
1091417|NCT02257489|2159880|FG004|Overall Study|Withdrawal by Subject|0
1091418|NCT02257489|2159881|FG005|Overall Study|Withdrawal by Subject|0
1091419|NCT02257489|2159882|FG006|Overall Study|Withdrawal by Subject|0
1091420|NCT02257489|2159883|FG007|Overall Study|Withdrawal by Subject|0
1091421|NCT02257489|2159884|FG008|Overall Study|Withdrawal by Subject|0
1091423|NCT02257632|2159930|FG000|Overall Study|Withdrawal by Subject|0
1091424|NCT02257632|2159931|FG001|Overall Study|Withdrawal by Subject|1
1091425|NCT02257632|2159930|FG000|Overall Study|Adverse Event|1
1091426|NCT02257632|2159931|FG001|Overall Study|Adverse Event|2
1091427|NCT02257684|2159939|FG000|Overall Study|Adverse Event|2
1091428|NCT02257684|2159939|FG000|Overall Study|Lack of Efficacy|1
1091429|NCT02257684|2159939|FG000|Overall Study|Sponsor's Decision|1
1091448|NCT02258074|2160004|FG000|Overall Study|Withdrawal by Subject|1
1091449|NCT02258074|2160005|FG001|Overall Study|Withdrawal by Subject|0
1091450|NCT02258074|2160006|FG002|Overall Study|Withdrawal by Subject|0
1091451|NCT02258074|2160007|FG003|Overall Study|Withdrawal by Subject|0
1091452|NCT02258334|2160044|FG000|Overall Study|Adverse Event|1
1091453|NCT02258334|2160045|FG001|Overall Study|Adverse Event|0
1091454|NCT02258334|2160046|FG002|Overall Study|Adverse Event|0
1091455|NCT02258334|2160047|FG003|Overall Study|Adverse Event|0
1091456|NCT02258464|2160082|FG000|Overall Study|Progressive disease (PD)|9
1091457|NCT02258464|2160083|FG001|Overall Study|Progressive disease (PD)|17
1091458|NCT02258464|2160082|FG000|Overall Study|Study drug never administered|1
1091459|NCT02258464|2160083|FG001|Overall Study|Study drug never administered|1
1091460|NCT02258464|2160082|FG000|Overall Study|AE not related to clinical PD|1
1091461|NCT02258464|2160083|FG001|Overall Study|AE not related to clinical PD|3
1091462|NCT02258464|2160082|FG000|Overall Study|Withdrawal by Subject|5
1091463|NCT02258464|2160083|FG001|Overall Study|Withdrawal by Subject|4
1091464|NCT02258464|2160082|FG000|Overall Study|AE related to clinical PD|1
1091465|NCT02258464|2160083|FG001|Overall Study|AE related to clinical PD|0
1091466|NCT02258529|2160101|FG000|Overall Study|Study Terminated by Sponsor|9
1091467|NCT02258529|2160101|FG000|Overall Study|Adverse Event|1
1091468|NCT02258659|2160140|FG000|Overall Study|Withdrawal by Subject|1
1091469|NCT02259010|2160144|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5
1091470|NCT02259088|2160152|FG000|Overall Study|Adverse Event|6
1091471|NCT02259088|2160153|FG001|Overall Study|Adverse Event|4
1091472|NCT02259088|2160152|FG000|Overall Study|Lost to Follow-up|2
1091473|NCT02259088|2160153|FG001|Overall Study|Lost to Follow-up|0
1091474|NCT02259088|2160152|FG000|Overall Study|Death|2
1091475|NCT02259088|2160153|FG001|Overall Study|Death|0
1091476|NCT02259088|2160152|FG000|Overall Study|Physician Decision|5
1091477|NCT02259088|2160153|FG001|Overall Study|Physician Decision|2
1091478|NCT02259088|2160152|FG000|Overall Study|Protocol deviation|5
1091479|NCT02259088|2160153|FG001|Overall Study|Protocol deviation|0
1091480|NCT02259088|2160152|FG000|Overall Study|Subject/guardian decision|8
1091481|NCT02259088|2160153|FG001|Overall Study|Subject/guardian decision|8
1091482|NCT02259114|2160164|FG000|Overall Study|Progressive Disease|14
1091483|NCT02259114|2160165|FG001|Overall Study|Progressive Disease|2
1091484|NCT02259114|2160166|FG002|Overall Study|Progressive Disease|10
1091485|NCT02259114|2160167|FG003|Overall Study|Progressive Disease|2
1091486|NCT02259114|2160168|FG004|Overall Study|Progressive Disease|5
1091487|NCT02259114|2160164|FG000|Overall Study|Adverse Event|2
1091488|NCT02259114|2160165|FG001|Overall Study|Adverse Event|1
1091489|NCT02259114|2160166|FG002|Overall Study|Adverse Event|0
1091490|NCT02259114|2160167|FG003|Overall Study|Adverse Event|0
1091491|NCT02259114|2160168|FG004|Overall Study|Adverse Event|1
1091492|NCT02259114|2160164|FG000|Overall Study|Death|3
1091493|NCT02259114|2160165|FG001|Overall Study|Death|0
1091494|NCT02259114|2160166|FG002|Overall Study|Death|1
1091495|NCT02259114|2160167|FG003|Overall Study|Death|0
1091496|NCT02259114|2160168|FG004|Overall Study|Death|0
1091497|NCT02259114|2160164|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1091498|NCT02259114|2160165|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1091499|NCT02259114|2160166|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1
1091500|NCT02259114|2160167|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1091501|NCT02259114|2160168|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1091502|NCT02259114|2160164|FG000|Overall Study|Withdrawal by Subject|0
1091503|NCT02259114|2160165|FG001|Overall Study|Withdrawal by Subject|0
1091504|NCT02259114|2160166|FG002|Overall Study|Withdrawal by Subject|1
1091505|NCT02259114|2160167|FG003|Overall Study|Withdrawal by Subject|1
1091506|NCT02259114|2160168|FG004|Overall Study|Withdrawal by Subject|0
1091507|NCT02259114|2160164|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1
1091508|NCT02259114|2160165|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1
1091509|NCT02259114|2160166|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0
1091510|NCT02259114|2160167|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0
1091511|NCT02259114|2160168|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0
1091512|NCT02259114|2160164|FG000|Overall Study|Not Treated|1
1091513|NCT02259114|2160165|FG001|Overall Study|Not Treated|0
1091514|NCT02259114|2160166|FG002|Overall Study|Not Treated|0
1091515|NCT02259114|2160167|FG003|Overall Study|Not Treated|0
1091516|NCT02259114|2160168|FG004|Overall Study|Not Treated|0
1091517|NCT02259231|2160187|FG000|Overall Study|Adverse Event|1
1091518|NCT02259231|2160188|FG001|Overall Study|Adverse Event|1
1091519|NCT02259231|2160189|FG002|Overall Study|Adverse Event|2
1091520|NCT02259231|2160190|FG003|Overall Study|Adverse Event|0
1091521|NCT02259231|2160191|FG004|Overall Study|Adverse Event|0
1091522|NCT02259231|2160192|FG005|Overall Study|Adverse Event|0
1091523|NCT02259231|2160193|FG006|Overall Study|Adverse Event|0
1091524|NCT02259231|2160187|FG000|Overall Study|Progressive Disease|4
1091525|NCT02259231|2160188|FG001|Overall Study|Progressive Disease|5
1091526|NCT02259231|2160189|FG002|Overall Study|Progressive Disease|4
1091527|NCT02259231|2160190|FG003|Overall Study|Progressive Disease|5
1091528|NCT02259231|2160191|FG004|Overall Study|Progressive Disease|4
1091529|NCT02259231|2160192|FG005|Overall Study|Progressive Disease|5
1091530|NCT02259231|2160193|FG006|Overall Study|Progressive Disease|4
1091531|NCT02259231|2160187|FG000|Overall Study|Sponsor termination of study|1
1091532|NCT02259231|2160188|FG001|Overall Study|Sponsor termination of study|0
1091533|NCT02259231|2160189|FG002|Overall Study|Sponsor termination of study|0
1091534|NCT02259231|2160190|FG003|Overall Study|Sponsor termination of study|1
1091535|NCT02259231|2160191|FG004|Overall Study|Sponsor termination of study|2
1091536|NCT02259231|2160192|FG005|Overall Study|Sponsor termination of study|1
1091537|NCT02259231|2160193|FG006|Overall Study|Sponsor termination of study|1
1091538|NCT02259348|2160209|FG000|Overall Study|Donors|6
1091539|NCT02259348|2160209|FG000|Overall Study|Death|4
1091540|NCT02259400|2160215|FG000|Overall Study|Death|0
1091541|NCT02259400|2160216|FG001|Overall Study|Death|2
1091542|NCT02259582|2160225|FG000|Overall Study|Physician Decision|0
1091543|NCT02259582|2160226|FG001|Overall Study|Physician Decision|1
1091544|NCT02259582|2160227|FG002|Overall Study|Physician Decision|0
1091545|NCT02259582|2160225|FG000|Overall Study|Death|0
1091546|NCT02259582|2160226|FG001|Overall Study|Death|0
1091547|NCT02259582|2160227|FG002|Overall Study|Death|1
1091548|NCT02259582|2160225|FG000|Overall Study|Adverse Event|1
1091549|NCT02259582|2160226|FG001|Overall Study|Adverse Event|0
1091550|NCT02259582|2160227|FG002|Overall Study|Adverse Event|1
1091551|NCT02259582|2160225|FG000|Overall Study|Withdrawal by Subject|0
1091552|NCT02259582|2160226|FG001|Overall Study|Withdrawal by Subject|0
1091553|NCT02259582|2160227|FG002|Overall Study|Withdrawal by Subject|1
1091554|NCT02259582|2160225|FG000|Overall Study|Disease progression|14
1091555|NCT02259582|2160226|FG001|Overall Study|Disease progression|15
1091556|NCT02259582|2160227|FG002|Overall Study|Disease progression|17
1091557|NCT02259582|2160225|FG000|Overall Study|Lack of Subject Adherence to Protocol|1
1091558|NCT02259582|2160226|FG001|Overall Study|Lack of Subject Adherence to Protocol|1
1091559|NCT02259582|2160227|FG002|Overall Study|Lack of Subject Adherence to Protocol|1
1091560|NCT02260154|2160248|FG000|Overall Study|Screening failure|2
1091561|NCT02260180|2160256|FG000|Overall Study|Adverse Event|2
1091562|NCT02260180|2160257|FG001|Overall Study|Adverse Event|0
1091563|NCT02260180|2160258|FG002|Overall Study|Adverse Event|1
1091564|NCT02260258|2160268|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2
1091565|NCT02260258|2160269|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1
1091566|NCT02260388|2160280|FG000|Overall Study|Lost to Follow-up|2
1091567|NCT02260388|2160281|FG001|Overall Study|Lost to Follow-up|8
1091568|NCT02260388|2160282|FG002|Overall Study|Lost to Follow-up|3
1091569|NCT02260388|2160283|FG003|Overall Study|Lost to Follow-up|4
1091570|NCT02260492|2160309|FG000|Overall Study|Adverse Event|6
1091571|NCT02260492|2160310|FG001|Overall Study|Adverse Event|1
1091572|NCT02260492|2160311|FG002|Overall Study|Adverse Event|2
1091573|NCT02260492|2160309|FG000|Overall Study|Death|0
1091574|NCT02260492|2160310|FG001|Overall Study|Death|1
1091575|NCT02260492|2160311|FG002|Overall Study|Death|0
1091576|NCT02260492|2160309|FG000|Overall Study|Lost to Follow-up|12
1091577|NCT02260492|2160310|FG001|Overall Study|Lost to Follow-up|9
1091578|NCT02260492|2160311|FG002|Overall Study|Lost to Follow-up|0
1091579|NCT02260492|2160309|FG000|Overall Study|Physician Decision|2
1091580|NCT02260492|2160310|FG001|Overall Study|Physician Decision|0
1091581|NCT02260492|2160311|FG002|Overall Study|Physician Decision|1
1091582|NCT02260492|2160309|FG000|Overall Study|Withdrawal by Subject|3
1091583|NCT02260492|2160310|FG001|Overall Study|Withdrawal by Subject|2
1091584|NCT02260492|2160311|FG002|Overall Study|Withdrawal by Subject|2
1091585|NCT02260635|2160350|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
1091586|NCT02260635|2160351|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
1091587|NCT02260635|2160350|FG000|Open-Label Extension|Study Termination|25
1091588|NCT02260635|2160351|FG001|Open-Label Extension|Study Termination|25
1091589|NCT02260635|2160350|FG000|Open-Label Extension|Withdrawal by Subject|1
1091590|NCT02260635|2160351|FG001|Open-Label Extension|Withdrawal by Subject|0
1091591|NCT02260648|2160362|FG000|Overall Study|Adverse Event|3
1091592|NCT02260648|2160363|FG001|Overall Study|Adverse Event|0
1091593|NCT02260648|2160364|FG002|Overall Study|Adverse Event|1
1091594|NCT02260648|2160362|FG000|Overall Study|Withdrawal by Subject|1
1091595|NCT02260648|2160363|FG001|Overall Study|Withdrawal by Subject|1
1091596|NCT02260648|2160364|FG002|Overall Study|Withdrawal by Subject|0
1091597|NCT02260648|2160362|FG000|Overall Study|Protocol Violation|1
1091598|NCT02260648|2160363|FG001|Overall Study|Protocol Violation|0
1091599|NCT02260648|2160364|FG002|Overall Study|Protocol Violation|0
1091600|NCT02260648|2160362|FG000|Overall Study|Discontinue Due to Study Termination|13
1091601|NCT02260648|2160363|FG001|Overall Study|Discontinue Due to Study Termination|12
1091602|NCT02260648|2160364|FG002|Overall Study|Discontinue Due to Study Termination|7
1091603|NCT02260791|2160374|FG000|Overall Study|Lost to Follow-up|4
1091604|NCT02260791|2160375|FG001|Overall Study|Lost to Follow-up|4
1091605|NCT02260791|2160374|FG000|Overall Study|Lack of Efficacy|2
1091606|NCT02260791|2160375|FG001|Overall Study|Lack of Efficacy|1
1091607|NCT02260791|2160374|FG000|Overall Study|Adverse Event|13
1091608|NCT02260791|2160375|FG001|Overall Study|Adverse Event|9
1091609|NCT02260791|2160374|FG000|Overall Study|Death|1
1091610|NCT02260791|2160375|FG001|Overall Study|Death|0
1091611|NCT02260791|2160374|FG000|Overall Study|Withdrawal by Subject|11
1091612|NCT02260791|2160375|FG001|Overall Study|Withdrawal by Subject|16
1091613|NCT02260791|2160374|FG000|Overall Study|Screen failure|0
1091614|NCT02260791|2160375|FG001|Overall Study|Screen failure|1
1091615|NCT02260791|2160374|FG000|Overall Study|Protocol deviation|2
1091616|NCT02260791|2160375|FG001|Overall Study|Protocol deviation|3
1091617|NCT02260804|2160383|FG000|Induction Study Period|Protocol Violation|2
1091618|NCT02260804|2160384|FG001|Induction Study Period|Protocol Violation|0
1091619|NCT02260804|2160383|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6
1091620|NCT02260804|2160384|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9
1091621|NCT02260804|2160383|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3
1091622|NCT02260804|2160384|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1
1091623|NCT02260804|2160383|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1
1091624|NCT02260804|2160384|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3
1091625|NCT02260804|2160383|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1
1091626|NCT02260804|2160384|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0
1091627|NCT02260804|2160383|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1
1091628|NCT02260804|2160384|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0
1091629|NCT02260804|2160383|FG000|1st Year of the Maintenance Period (MP1)|Death|0
1091630|NCT02260804|2160384|FG001|1st Year of the Maintenance Period (MP1)|Death|1
1091631|NCT02260804|2160383|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0
1091632|NCT02260804|2160384|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1
1091633|NCT02260804|2160383|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6
1091634|NCT02260804|2160384|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5
1091635|NCT02260804|2160383|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3
1091636|NCT02260804|2160384|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0
1091637|NCT02260804|2160383|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0
1091638|NCT02260804|2160384|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1
1091639|NCT02260817|2160392|FG000|Overall Study|Lost to Follow-up|0
1091640|NCT02260817|2160393|FG001|Overall Study|Lost to Follow-up|14
1091641|NCT02260817|2160392|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0
1091642|NCT02260817|2160393|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7
1091643|NCT02260817|2160392|FG000|Overall Study|Observation, no biopsy|0
1091644|NCT02260817|2160393|FG001|Overall Study|Observation, no biopsy|1
1091645|NCT02260817|2160392|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
1091646|NCT02260817|2160393|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
1091647|NCT02260817|2160392|FG000|Overall Study|Protocol Violation|0
1091648|NCT02260817|2160393|FG001|Overall Study|Protocol Violation|14
1091649|NCT02260882|2160401|FG000|Overall Study|Protocol Violation|0
1091650|NCT02260882|2160402|FG001|Overall Study|Protocol Violation|1
1091651|NCT02260921|2160411|FG000|Overall Study|Adverse Event|1
1091652|NCT02260921|2160412|FG001|Overall Study|Adverse Event|0
1091653|NCT02260921|2160411|FG000|Overall Study|Lost to Follow-up|4
1091654|NCT02260921|2160412|FG001|Overall Study|Lost to Follow-up|3
1091655|NCT02260921|2160411|FG000|Overall Study|Withdraw Consent|4
1091656|NCT02260921|2160412|FG001|Overall Study|Withdraw Consent|1
1091657|NCT02260921|2160411|FG000|Overall Study|Death|1
1091658|NCT02260921|2160412|FG001|Overall Study|Death|0
1091659|NCT02260921|2160411|FG000|Overall Study|Prohibited Treatment for Knee Pain|4
1091660|NCT02260921|2160412|FG001|Overall Study|Prohibited Treatment for Knee Pain|0
1091661|NCT02260934|2160420|FG000|Overall Study|Lost to Follow-up|2
1091662|NCT02260934|2160421|FG001|Overall Study|Lost to Follow-up|1
1091663|NCT02260934|2160420|FG000|Overall Study|Withdrawal by Subject|0
1091664|NCT02260934|2160421|FG001|Overall Study|Withdrawal by Subject|2
1091665|NCT02260934|2160420|FG000|Overall Study|Participant Relocated|1
1091666|NCT02260934|2160421|FG001|Overall Study|Participant Relocated|0
1091667|NCT02260934|2160420|FG000|Overall Study|Site error|0
1091668|NCT02260934|2160421|FG001|Overall Study|Site error|1
1091669|NCT02260986|2160437|FG000|Overall Study|Adverse Event|24
1091670|NCT02260986|2160438|FG001|Overall Study|Adverse Event|0
1091671|NCT02260986|2160439|FG002|Overall Study|Adverse Event|11
1091672|NCT02260986|2160437|FG000|Overall Study|Lack of Efficacy|27
1091673|NCT02260986|2160438|FG001|Overall Study|Lack of Efficacy|3
1091674|NCT02260986|2160439|FG002|Overall Study|Lack of Efficacy|0
1091675|NCT02260986|2160437|FG000|Overall Study|Protocol Violation|14
1091676|NCT02260986|2160438|FG001|Overall Study|Protocol Violation|5
1091677|NCT02260986|2160439|FG002|Overall Study|Protocol Violation|16
1091678|NCT02260986|2160437|FG000|Overall Study|Car accident|0
1091679|NCT02260986|2160438|FG001|Overall Study|Car accident|0
1091680|NCT02260986|2160439|FG002|Overall Study|Car accident|1
1091681|NCT02260986|2160437|FG000|Overall Study|Withdrawal by Subject|17
1091682|NCT02260986|2160438|FG001|Overall Study|Withdrawal by Subject|4
1091683|NCT02260986|2160439|FG002|Overall Study|Withdrawal by Subject|9
1091684|NCT02260986|2160437|FG000|Overall Study|Incorrect randomization|0
1091685|NCT02260986|2160438|FG001|Overall Study|Incorrect randomization|1
1091686|NCT02260986|2160439|FG002|Overall Study|Incorrect randomization|0
1091687|NCT02260986|2160437|FG000|Overall Study|Lack of investigation product supply|2
1091688|NCT02260986|2160438|FG001|Overall Study|Lack of investigation product supply|0
1091689|NCT02260986|2160439|FG002|Overall Study|Lack of investigation product supply|1
1091690|NCT02260986|2160437|FG000|Overall Study|Lost to Follow-up|4
1091691|NCT02260986|2160438|FG001|Overall Study|Lost to Follow-up|0
1091692|NCT02260986|2160439|FG002|Overall Study|Lost to Follow-up|3
1091693|NCT02260986|2160437|FG000|Overall Study|Pregnancy|2
1091694|NCT02260986|2160438|FG001|Overall Study|Pregnancy|0
1091695|NCT02260986|2160439|FG002|Overall Study|Pregnancy|0
1091696|NCT02261467|2160475|FG000|Overall Study|Enrolled in Error|1
1091697|NCT02261467|2160476|FG001|Overall Study|Enrolled in Error|0
1091698|NCT02261467|2160475|FG000|Overall Study|Protocol Violation|0
1091699|NCT02261467|2160476|FG001|Overall Study|Protocol Violation|1
1091700|NCT02261467|2160475|FG000|Overall Study|Personal Reasons|17
1091701|NCT02261467|2160476|FG001|Overall Study|Personal Reasons|22
1091702|NCT02261467|2160475|FG000|Overall Study|Lost to Follow-up|2
1091703|NCT02261467|2160476|FG001|Overall Study|Lost to Follow-up|13
1091704|NCT02261467|2160475|FG000|Overall Study|Adverse Event|1
1091705|NCT02261467|2160476|FG001|Overall Study|Adverse Event|1
1091706|NCT02261493|2160485|FG000|Overall Study|Noncompliance|0
1091707|NCT02261493|2160486|FG001|Overall Study|Noncompliance|0
1091708|NCT02261493|2160487|FG002|Overall Study|Noncompliance|2
1091709|NCT02261493|2160485|FG000|Overall Study|Physician Decision|0
1091710|NCT02261493|2160486|FG001|Overall Study|Physician Decision|1
1091711|NCT02261493|2160487|FG002|Overall Study|Physician Decision|0
1091712|NCT02261493|2160485|FG000|Overall Study|Undisclosed alcohol abuse|0
1091713|NCT02261493|2160486|FG001|Overall Study|Undisclosed alcohol abuse|1
1091714|NCT02261493|2160487|FG002|Overall Study|Undisclosed alcohol abuse|0
1091715|NCT02261493|2160485|FG000|Overall Study|Protocol Violation|1
1091716|NCT02261493|2160486|FG001|Overall Study|Protocol Violation|0
1091717|NCT02261493|2160487|FG002|Overall Study|Protocol Violation|0
1091718|NCT02261493|2160485|FG000|Overall Study|Personal Reasons|14
1091719|NCT02261493|2160486|FG001|Overall Study|Personal Reasons|14
1091720|NCT02261493|2160487|FG002|Overall Study|Personal Reasons|16
1091721|NCT02261493|2160485|FG000|Overall Study|Lost to Follow-up|14
1091722|NCT02261493|2160486|FG001|Overall Study|Lost to Follow-up|27
1091723|NCT02261493|2160487|FG002|Overall Study|Lost to Follow-up|8
1091724|NCT02261493|2160485|FG000|Overall Study|Pregnancy|1
1091725|NCT02261493|2160486|FG001|Overall Study|Pregnancy|2
1091726|NCT02261493|2160487|FG002|Overall Study|Pregnancy|0
1091727|NCT02261493|2160485|FG000|Overall Study|Lack of Efficacy|0
1091728|NCT02261493|2160486|FG001|Overall Study|Lack of Efficacy|1
1091729|NCT02261493|2160487|FG002|Overall Study|Lack of Efficacy|0
1091730|NCT02261493|2160485|FG000|Overall Study|Adverse Event|0
1091731|NCT02261493|2160486|FG001|Overall Study|Adverse Event|1
1091732|NCT02261493|2160487|FG002|Overall Study|Adverse Event|0
1091733|NCT02261974|2160565|FG000|Overall Study|Withdrawal by Subject|3
1091734|NCT02261974|2160566|FG001|Overall Study|Withdrawal by Subject|2
1091735|NCT02261974|2160565|FG000|Overall Study|Pregnancy|0
1091736|NCT02261974|2160566|FG001|Overall Study|Pregnancy|1
1091737|NCT02261974|2160565|FG000|Overall Study|Missed treatment cut-off date|6
1091738|NCT02261974|2160566|FG001|Overall Study|Missed treatment cut-off date|3
1091739|NCT02261974|2160565|FG000|Overall Study|Received partial treatment; FU to 1 mo|3
1091740|NCT02261974|2160566|FG001|Overall Study|Received partial treatment; FU to 1 mo|1
1091741|NCT02261974|2160565|FG000|Overall Study|Lost to Follow-up|2
1091742|NCT02261974|2160566|FG001|Overall Study|Lost to Follow-up|0
1091743|NCT02261974|2160565|FG000|Overall Study|Adverse Event|1
1091744|NCT02261974|2160566|FG001|Overall Study|Adverse Event|0
1091745|NCT02262260|2160596|FG000|Overall Study|Adverse Event|4
1091746|NCT02262260|2160597|FG001|Overall Study|Adverse Event|1
1091747|NCT02262260|2160596|FG000|Overall Study|Withdrawal of consent|4
1091748|NCT02262260|2160597|FG001|Overall Study|Withdrawal of consent|2
1091749|NCT02262260|2160596|FG000|Overall Study|Lost to Follow-up|1
1091750|NCT02262260|2160597|FG001|Overall Study|Lost to Follow-up|2
1091751|NCT02262260|2160596|FG000|Overall Study|Protocol deviation|2
1091752|NCT02262260|2160597|FG001|Overall Study|Protocol deviation|5
1091753|NCT02262364|2160603|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1
1091754|NCT02262377|2160609|FG000|Overall Study|Lost to Follow-up|5
1091755|NCT02262377|2160610|FG001|Overall Study|Lost to Follow-up|6
1091756|NCT02262377|2160609|FG000|Overall Study|Found ineligible after enrollment|3
1091757|NCT02262377|2160610|FG001|Overall Study|Found ineligible after enrollment|0
1091758|NCT02262377|2160609|FG000|Overall Study|Withdrawal by Subject|4
1091759|NCT02262377|2160610|FG001|Overall Study|Withdrawal by Subject|0
1091760|NCT02262728|2160624|FG000|Follow-up Phase (3 Years)|Death|0
1091761|NCT02262728|2160625|FG001|Follow-up Phase (3 Years)|Death|1
1091762|NCT02262728|2160624|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4
1091763|NCT02262728|2160625|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1
1091764|NCT02262728|2160624|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0
1091765|NCT02262728|2160625|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1
1091766|NCT02262754|2160634|FG000|Overall Study|Adverse Event|3
1091767|NCT02262754|2160635|FG001|Overall Study|Adverse Event|4
1091768|NCT02262754|2160636|FG002|Overall Study|Adverse Event|0
1091769|NCT02262754|2160634|FG000|Overall Study|Lack of Efficacy|2
1091770|NCT02262754|2160635|FG001|Overall Study|Lack of Efficacy|0
1091771|NCT02262754|2160636|FG002|Overall Study|Lack of Efficacy|1
1091772|NCT02262754|2160634|FG000|Overall Study|Lost to Follow-up|0
1091773|NCT02262754|2160635|FG001|Overall Study|Lost to Follow-up|0
1091774|NCT02262754|2160636|FG002|Overall Study|Lost to Follow-up|1
1091775|NCT02262754|2160634|FG000|Overall Study|No longer meets eligibility criteria|0
1091776|NCT02262754|2160635|FG001|Overall Study|No longer meets eligibility criteria|1
1091777|NCT02262754|2160636|FG002|Overall Study|No longer meets eligibility criteria|0
1091778|NCT02262754|2160634|FG000|Overall Study|Study terminated by sponsor|5
1091779|NCT02262754|2160635|FG001|Overall Study|Study terminated by sponsor|4
1091780|NCT02262754|2160636|FG002|Overall Study|Study terminated by sponsor|4
1091781|NCT02262754|2160634|FG000|Overall Study|Protocol Violation|1
1091782|NCT02262754|2160635|FG001|Overall Study|Protocol Violation|0
1091783|NCT02262754|2160636|FG002|Overall Study|Protocol Violation|0
1091784|NCT02262754|2160634|FG000|Overall Study|Withdrawal by Subject|1
1091785|NCT02262754|2160635|FG001|Overall Study|Withdrawal by Subject|0
1091786|NCT02262754|2160636|FG002|Overall Study|Withdrawal by Subject|1
1091787|NCT02262754|2160634|FG000|Overall Study|Other|4
1091788|NCT02262754|2160635|FG001|Overall Study|Other|0
1091789|NCT02262754|2160636|FG002|Overall Study|Other|2
1091790|NCT02263079|2160673|FG000|Overall Study|Physician Decision|1
1091791|NCT02263079|2160674|FG001|Overall Study|Physician Decision|0
1091792|NCT02263079|2160675|FG002|Overall Study|Physician Decision|0
1091793|NCT02263079|2160673|FG000|Overall Study|Withdrawal by Subject|2
1091794|NCT02263079|2160674|FG001|Overall Study|Withdrawal by Subject|8
1091795|NCT02263079|2160675|FG002|Overall Study|Withdrawal by Subject|0
1091796|NCT02263326|2160713|FG000|Overall Study|Lost to Follow-up|1
1091797|NCT02263326|2160714|FG001|Overall Study|Lost to Follow-up|1
1091798|NCT02263547|2160720|FG000|Overall Study|Adverse Event|1
1091799|NCT02263547|2160720|FG000|Overall Study|Lost to Follow-up|2
1091800|NCT02264574|2160767|FG000|Overall Study|Death|21
1091801|NCT02264574|2160768|FG001|Overall Study|Death|21
1091802|NCT02264574|2160767|FG000|Overall Study|Withdrawal by Subject|8
1091803|NCT02264574|2160768|FG001|Overall Study|Withdrawal by Subject|6
1091804|NCT02264574|2160767|FG000|Overall Study|Other, Not Specified|0
1091805|NCT02264574|2160768|FG001|Overall Study|Other, Not Specified|3
1091806|NCT02264639|2160779|FG000|Overall Study|Death (after completing single-dose phase)|1
1091807|NCT02264639|2160780|FG001|Overall Study|Death (after completing single-dose phase)|0
1091808|NCT02264639|2160781|FG002|Overall Study|Death (after completing single-dose phase)|0
1091809|NCT02264639|2160782|FG003|Overall Study|Death (after completing single-dose phase)|0
1091810|NCT02264639|2160783|FG004|Overall Study|Death (after completing single-dose phase)|0
1091811|NCT02264639|2160779|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1
1091812|NCT02264639|2160780|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
1091813|NCT02264639|2160781|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
1091814|NCT02264639|2160782|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
1091815|NCT02264639|2160783|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
1091816|NCT02264639|2160779|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0
1091817|NCT02264639|2160780|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0
1091818|NCT02264639|2160781|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1
1091819|NCT02264639|2160782|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0
1091820|NCT02264639|2160783|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0
1091821|NCT02264639|2160779|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
1091822|NCT02264639|2160780|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
1091823|NCT02264639|2160781|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
1091824|NCT02264639|2160782|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
1091825|NCT02264639|2160783|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1
1091826|NCT02264821|2160801|FG000|Overall Study|Protocol Violation|1
1091827|NCT02264821|2160802|FG001|Overall Study|Protocol Violation|3
1091828|NCT02264821|2160803|FG002|Overall Study|Protocol Violation|6
1091829|NCT02264977|2160811|FG000|Overall Study|Death|3
1091830|NCT02264977|2160811|FG000|Overall Study|Withdrawal by Subject|1
1091831|NCT02264977|2160811|FG000|Overall Study|Physician Decision|1
1091832|NCT02264990|2160817|FG000|Overall Study|Death|255
1091833|NCT02264990|2160818|FG001|Overall Study|Death|250
1091834|NCT02264990|2160817|FG000|Overall Study|Withdrawal by Subject|4
1091835|NCT02264990|2160818|FG001|Overall Study|Withdrawal by Subject|5
1091836|NCT02264990|2160817|FG000|Overall Study|Lost to Follow-up|1
1091837|NCT02264990|2160818|FG001|Overall Study|Lost to Follow-up|3
1091838|NCT02264990|2160817|FG000|Overall Study|Other|0
1091839|NCT02264990|2160818|FG001|Overall Study|Other|1
1091840|NCT02265237|2160836|FG000|As Treated (Overall Study)|Adverse Event|1
1091841|NCT02265237|2160837|FG001|As Treated (Overall Study)|Adverse Event|1
1091842|NCT02265237|2160838|FG002|As Treated (Overall Study)|Adverse Event|0
1091843|NCT02265237|2160839|FG003|As Treated (Overall Study)|Adverse Event|0
1091844|NCT02265237|2160836|FG000|As Treated (Overall Study)|Withdrawal by Subject|1
1091845|NCT02265237|2160837|FG001|As Treated (Overall Study)|Withdrawal by Subject|0
1091846|NCT02265237|2160838|FG002|As Treated (Overall Study)|Withdrawal by Subject|1
1091847|NCT02265237|2160839|FG003|As Treated (Overall Study)|Withdrawal by Subject|0
1091848|NCT02265237|2160836|FG000|As Treated (Overall Study)|Lost to Follow-up|1
1091849|NCT02265237|2160837|FG001|As Treated (Overall Study)|Lost to Follow-up|2
1091850|NCT02265237|2160838|FG002|As Treated (Overall Study)|Lost to Follow-up|6
1091851|NCT02265237|2160839|FG003|As Treated (Overall Study)|Lost to Follow-up|0
1091852|NCT02265237|2160836|FG000|As Treated (Overall Study)|Other|2
1091853|NCT02265237|2160837|FG001|As Treated (Overall Study)|Other|0
1091854|NCT02265237|2160838|FG002|As Treated (Overall Study)|Other|3
1091855|NCT02265237|2160839|FG003|As Treated (Overall Study)|Other|1
1091856|NCT02265510|2160868|FG000|Overall Study|Withdrawal by Subject|1
1091857|NCT02265510|2160869|FG001|Overall Study|Withdrawal by Subject|1
1091858|NCT02265510|2160870|FG002|Overall Study|Withdrawal by Subject|2
1091859|NCT02265510|2160871|FG003|Overall Study|Withdrawal by Subject|1
1091860|NCT02265510|2160872|FG004|Overall Study|Withdrawal by Subject|0
1091861|NCT02265510|2160873|FG005|Overall Study|Withdrawal by Subject|2
1091862|NCT02265510|2160874|FG006|Overall Study|Withdrawal by Subject|0
1091863|NCT02265510|2160875|FG007|Overall Study|Withdrawal by Subject|2
1091864|NCT02265510|2160876|FG008|Overall Study|Withdrawal by Subject|0
1091865|NCT02265510|2160877|FG009|Overall Study|Withdrawal by Subject|0
1091866|NCT02265510|2160878|FG010|Overall Study|Withdrawal by Subject|0
1091867|NCT02265510|2160879|FG011|Overall Study|Withdrawal by Subject|0
1091868|NCT02265510|2160880|FG012|Overall Study|Withdrawal by Subject|1
1091869|NCT02265510|2160881|FG013|Overall Study|Withdrawal by Subject|0
1091870|NCT02265510|2160868|FG000|Overall Study|Disease Progression|0
1091871|NCT02265510|2160869|FG001|Overall Study|Disease Progression|1
1091872|NCT02265510|2160870|FG002|Overall Study|Disease Progression|2
1091873|NCT02265510|2160871|FG003|Overall Study|Disease Progression|1
1091874|NCT02265510|2160872|FG004|Overall Study|Disease Progression|1
1091875|NCT02265510|2160873|FG005|Overall Study|Disease Progression|0
1091876|NCT02265510|2160874|FG006|Overall Study|Disease Progression|0
1091877|NCT02265510|2160875|FG007|Overall Study|Disease Progression|0
1091878|NCT02265510|2160876|FG008|Overall Study|Disease Progression|0
1091879|NCT02265510|2160877|FG009|Overall Study|Disease Progression|0
1091880|NCT02265510|2160878|FG010|Overall Study|Disease Progression|0
1091881|NCT02265510|2160879|FG011|Overall Study|Disease Progression|0
1091882|NCT02265510|2160880|FG012|Overall Study|Disease Progression|0
1091883|NCT02265510|2160881|FG013|Overall Study|Disease Progression|0
1091884|NCT02265510|2160868|FG000|Overall Study|Death|2
1091885|NCT02265510|2160869|FG001|Overall Study|Death|0
1091886|NCT02265510|2160870|FG002|Overall Study|Death|2
1091887|NCT02265510|2160871|FG003|Overall Study|Death|2
1091888|NCT02265510|2160872|FG004|Overall Study|Death|1
1091889|NCT02265510|2160873|FG005|Overall Study|Death|3
1091890|NCT02265510|2160874|FG006|Overall Study|Death|2
1091891|NCT02265510|2160875|FG007|Overall Study|Death|1
1091892|NCT02265510|2160876|FG008|Overall Study|Death|3
1091893|NCT02265510|2160877|FG009|Overall Study|Death|3
1091894|NCT02265510|2160878|FG010|Overall Study|Death|4
1091895|NCT02265510|2160879|FG011|Overall Study|Death|12
1091896|NCT02265510|2160880|FG012|Overall Study|Death|7
1091897|NCT02265510|2160881|FG013|Overall Study|Death|6
1091898|NCT02265510|2160868|FG000|Overall Study|Lost to Follow-up|0
1091899|NCT02265510|2160869|FG001|Overall Study|Lost to Follow-up|0
1091900|NCT02265510|2160870|FG002|Overall Study|Lost to Follow-up|0
1091901|NCT02265510|2160871|FG003|Overall Study|Lost to Follow-up|0
1091902|NCT02265510|2160872|FG004|Overall Study|Lost to Follow-up|1
1091903|NCT02265510|2160873|FG005|Overall Study|Lost to Follow-up|0
1091904|NCT02265510|2160874|FG006|Overall Study|Lost to Follow-up|0
1091905|NCT02265510|2160875|FG007|Overall Study|Lost to Follow-up|0
1091906|NCT02265510|2160876|FG008|Overall Study|Lost to Follow-up|0
1091907|NCT02265510|2160877|FG009|Overall Study|Lost to Follow-up|2
1091908|NCT02265510|2160878|FG010|Overall Study|Lost to Follow-up|0
1091909|NCT02265510|2160879|FG011|Overall Study|Lost to Follow-up|0
1091910|NCT02265510|2160880|FG012|Overall Study|Lost to Follow-up|0
1091911|NCT02265510|2160881|FG013|Overall Study|Lost to Follow-up|2
1091912|NCT02265510|2160868|FG000|Overall Study|Other|0
1091913|NCT02265510|2160869|FG001|Overall Study|Other|1
1091914|NCT02265510|2160870|FG002|Overall Study|Other|0
1091915|NCT02265510|2160871|FG003|Overall Study|Other|0
1091916|NCT02265510|2160872|FG004|Overall Study|Other|0
1091917|NCT02265510|2160873|FG005|Overall Study|Other|0
1091918|NCT02265510|2160874|FG006|Overall Study|Other|0
1091919|NCT02265510|2160875|FG007|Overall Study|Other|0
1091920|NCT02265510|2160876|FG008|Overall Study|Other|0
1091921|NCT02265510|2160877|FG009|Overall Study|Other|0
1091922|NCT02265510|2160878|FG010|Overall Study|Other|0
1091923|NCT02265510|2160879|FG011|Overall Study|Other|0
1091924|NCT02265510|2160880|FG012|Overall Study|Other|0
1091925|NCT02265510|2160881|FG013|Overall Study|Other|0
1091926|NCT02265510|2160868|FG000|Overall Study|Study Terminated by Sponsor|0
1091927|NCT02265510|2160869|FG001|Overall Study|Study Terminated by Sponsor|0
1091928|NCT02265510|2160870|FG002|Overall Study|Study Terminated by Sponsor|0
1091929|NCT02265510|2160871|FG003|Overall Study|Study Terminated by Sponsor|0
1091930|NCT02265510|2160872|FG004|Overall Study|Study Terminated by Sponsor|0
1091931|NCT02265510|2160873|FG005|Overall Study|Study Terminated by Sponsor|1
1091932|NCT02265510|2160874|FG006|Overall Study|Study Terminated by Sponsor|1
1091933|NCT02265510|2160875|FG007|Overall Study|Study Terminated by Sponsor|1
1091934|NCT02265510|2160876|FG008|Overall Study|Study Terminated by Sponsor|1
1091935|NCT02265510|2160877|FG009|Overall Study|Study Terminated by Sponsor|2
1091936|NCT02265510|2160878|FG010|Overall Study|Study Terminated by Sponsor|1
1091937|NCT02265510|2160879|FG011|Overall Study|Study Terminated by Sponsor|4
1091938|NCT02265510|2160880|FG012|Overall Study|Study Terminated by Sponsor|1
1091939|NCT02265510|2160881|FG013|Overall Study|Study Terminated by Sponsor|2
1091940|NCT02265705|2160939|FG000|Treatment Period Week 0-24|Adverse Event|3
1091941|NCT02265705|2160940|FG001|Treatment Period Week 0-24|Adverse Event|2
1091942|NCT02265705|2160941|FG002|Treatment Period Week 0-24|Adverse Event|0
1091943|NCT02265705|2160942|FG003|Treatment Period Week 0-24|Adverse Event|0
1091944|NCT02265705|2160943|FG004|Treatment Period Week 0-24|Adverse Event|0
1091945|NCT02265705|2160944|FG005|Treatment Period Week 0-24|Adverse Event|0
1091946|NCT02265705|2160945|FG006|Treatment Period Week 0-24|Adverse Event|0
1091947|NCT02265705|2160939|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1
1091948|NCT02265705|2160940|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1
1091949|NCT02265705|2160941|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0
1091950|NCT02265705|2160942|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0
1091951|NCT02265705|2160943|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0
1091952|NCT02265705|2160944|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0
1091953|NCT02265705|2160945|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0
1091954|NCT02265705|2160939|FG000|Treatment Period Week 0-24|Physician Decision|1
1091955|NCT02265705|2160940|FG001|Treatment Period Week 0-24|Physician Decision|0
1091956|NCT02265705|2160941|FG002|Treatment Period Week 0-24|Physician Decision|0
1091957|NCT02265705|2160942|FG003|Treatment Period Week 0-24|Physician Decision|0
1091958|NCT02265705|2160943|FG004|Treatment Period Week 0-24|Physician Decision|0
1091959|NCT02265705|2160944|FG005|Treatment Period Week 0-24|Physician Decision|0
1091960|NCT02265705|2160945|FG006|Treatment Period Week 0-24|Physician Decision|0
1091961|NCT02265705|2160939|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7
1091962|NCT02265705|2160940|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5
1091963|NCT02265705|2160941|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0
1091964|NCT02265705|2160942|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0
1091965|NCT02265705|2160943|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0
1091966|NCT02265705|2160944|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0
1091967|NCT02265705|2160945|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0
1091968|NCT02265705|2160939|FG000|Treatment Period Week 0-24|Lack of Efficacy|0
1091969|NCT02265705|2160940|FG001|Treatment Period Week 0-24|Lack of Efficacy|1
1091970|NCT02265705|2160941|FG002|Treatment Period Week 0-24|Lack of Efficacy|0
1091971|NCT02265705|2160942|FG003|Treatment Period Week 0-24|Lack of Efficacy|0
1091972|NCT02265705|2160943|FG004|Treatment Period Week 0-24|Lack of Efficacy|0
1091973|NCT02265705|2160944|FG005|Treatment Period Week 0-24|Lack of Efficacy|0
1091974|NCT02265705|2160945|FG006|Treatment Period Week 0-24|Lack of Efficacy|0
1091975|NCT02265705|2160939|FG000|Rescue Period|Withdrawal by Subject|0
1091976|NCT02265705|2160940|FG001|Rescue Period|Withdrawal by Subject|0
1091977|NCT02265705|2160941|FG002|Rescue Period|Withdrawal by Subject|1
1091978|NCT02265705|2160942|FG003|Rescue Period|Withdrawal by Subject|0
1091979|NCT02265705|2160943|FG004|Rescue Period|Withdrawal by Subject|0
1091980|NCT02265705|2160944|FG005|Rescue Period|Withdrawal by Subject|0
1091981|NCT02265705|2160945|FG006|Rescue Period|Withdrawal by Subject|0
1091982|NCT02265705|2160939|FG000|Rescue Period|Death|0
1091983|NCT02265705|2160940|FG001|Rescue Period|Death|0
1091984|NCT02265705|2160941|FG002|Rescue Period|Death|1
1091985|NCT02265705|2160942|FG003|Rescue Period|Death|0
1091986|NCT02265705|2160943|FG004|Rescue Period|Death|0
1091987|NCT02265705|2160944|FG005|Rescue Period|Death|0
1091988|NCT02265705|2160945|FG006|Rescue Period|Death|0
1091989|NCT02265705|2160939|FG000|Rescue Period|Lack of Efficacy|0
1091990|NCT02265705|2160940|FG001|Rescue Period|Lack of Efficacy|0
1091991|NCT02265705|2160941|FG002|Rescue Period|Lack of Efficacy|1
1091992|NCT02265705|2160942|FG003|Rescue Period|Lack of Efficacy|0
1091993|NCT02265705|2160943|FG004|Rescue Period|Lack of Efficacy|0
1091994|NCT02265705|2160944|FG005|Rescue Period|Lack of Efficacy|0
1091995|NCT02265705|2160945|FG006|Rescue Period|Lack of Efficacy|0
1091996|NCT02265705|2160939|FG000|Open Label Period|Adverse Event|0
1091997|NCT02265705|2160940|FG001|Open Label Period|Adverse Event|0
1091998|NCT02265705|2160941|FG002|Open Label Period|Adverse Event|0
1091999|NCT02265705|2160942|FG003|Open Label Period|Adverse Event|2
1092000|NCT02265705|2160943|FG004|Open Label Period|Adverse Event|2
1092001|NCT02265705|2160944|FG005|Open Label Period|Adverse Event|0
1092002|NCT02265705|2160945|FG006|Open Label Period|Adverse Event|0
1092003|NCT02265705|2160939|FG000|Open Label Period|Physician Decision|0
1092004|NCT02265705|2160940|FG001|Open Label Period|Physician Decision|0
1092005|NCT02265705|2160941|FG002|Open Label Period|Physician Decision|0
1092006|NCT02265705|2160942|FG003|Open Label Period|Physician Decision|0
1092007|NCT02265705|2160943|FG004|Open Label Period|Physician Decision|1
1092008|NCT02265705|2160944|FG005|Open Label Period|Physician Decision|0
1092009|NCT02265705|2160945|FG006|Open Label Period|Physician Decision|0
1092010|NCT02265705|2160939|FG000|Open Label Period|Withdrawal by Subject|0
1092011|NCT02265705|2160940|FG001|Open Label Period|Withdrawal by Subject|0
1092012|NCT02265705|2160941|FG002|Open Label Period|Withdrawal by Subject|0
1092013|NCT02265705|2160942|FG003|Open Label Period|Withdrawal by Subject|0
1092014|NCT02265705|2160943|FG004|Open Label Period|Withdrawal by Subject|2
1092015|NCT02265705|2160944|FG005|Open Label Period|Withdrawal by Subject|0
1092016|NCT02265705|2160945|FG006|Open Label Period|Withdrawal by Subject|0
1092017|NCT02265705|2160939|FG000|Follow-up Period|Sponsor Decision|0
1092018|NCT02265705|2160940|FG001|Follow-up Period|Sponsor Decision|0
1092019|NCT02265705|2160941|FG002|Follow-up Period|Sponsor Decision|0
1092020|NCT02265705|2160942|FG003|Follow-up Period|Sponsor Decision|0
1092021|NCT02265705|2160943|FG004|Follow-up Period|Sponsor Decision|0
1092022|NCT02265705|2160944|FG005|Follow-up Period|Sponsor Decision|1
1092023|NCT02265705|2160945|FG006|Follow-up Period|Sponsor Decision|6
1092024|NCT02265705|2160939|FG000|Follow-up Period|Adverse Event|0
1092025|NCT02265705|2160940|FG001|Follow-up Period|Adverse Event|0
1092026|NCT02265705|2160941|FG002|Follow-up Period|Adverse Event|0
1092027|NCT02265705|2160942|FG003|Follow-up Period|Adverse Event|0
1092028|NCT02265705|2160943|FG004|Follow-up Period|Adverse Event|0
1092029|NCT02265705|2160944|FG005|Follow-up Period|Adverse Event|0
1092030|NCT02265705|2160945|FG006|Follow-up Period|Adverse Event|3
1092031|NCT02265705|2160939|FG000|Follow-up Period|Physician Decision|0
1092032|NCT02265705|2160940|FG001|Follow-up Period|Physician Decision|0
1092033|NCT02265705|2160941|FG002|Follow-up Period|Physician Decision|0
1092034|NCT02265705|2160942|FG003|Follow-up Period|Physician Decision|0
1092035|NCT02265705|2160943|FG004|Follow-up Period|Physician Decision|0
1092036|NCT02265705|2160944|FG005|Follow-up Period|Physician Decision|0
1092037|NCT02265705|2160945|FG006|Follow-up Period|Physician Decision|1
1092038|NCT02265705|2160939|FG000|Follow-up Period|Withdrawal by Subject|0
1092039|NCT02265705|2160940|FG001|Follow-up Period|Withdrawal by Subject|0
1092040|NCT02265705|2160941|FG002|Follow-up Period|Withdrawal by Subject|0
1092041|NCT02265705|2160942|FG003|Follow-up Period|Withdrawal by Subject|0
1092042|NCT02265705|2160943|FG004|Follow-up Period|Withdrawal by Subject|0
1092043|NCT02265705|2160944|FG005|Follow-up Period|Withdrawal by Subject|0
1092044|NCT02265705|2160945|FG006|Follow-up Period|Withdrawal by Subject|1
1092045|NCT02265744|2160961|FG000|Overall Study|Poor/Non-compliance|1
1092046|NCT02265744|2160962|FG001|Overall Study|Poor/Non-compliance|1
1092047|NCT02265744|2160963|FG002|Overall Study|Poor/Non-compliance|0
1092048|NCT02265744|2160964|FG003|Overall Study|Poor/Non-compliance|0
1092049|NCT02265744|2160965|FG004|Overall Study|Poor/Non-compliance|2
1092050|NCT02265744|2160961|FG000|Overall Study|Lost to Follow-up|0
1092051|NCT02265744|2160962|FG001|Overall Study|Lost to Follow-up|0
1092052|NCT02265744|2160963|FG002|Overall Study|Lost to Follow-up|0
1092053|NCT02265744|2160964|FG003|Overall Study|Lost to Follow-up|1
1092054|NCT02265744|2160965|FG004|Overall Study|Lost to Follow-up|0
1092055|NCT02265744|2160961|FG000|Overall Study|Death|0
1092056|NCT02265744|2160962|FG001|Overall Study|Death|0
1092057|NCT02265744|2160963|FG002|Overall Study|Death|0
1092058|NCT02265744|2160964|FG003|Overall Study|Death|2
1092059|NCT02265744|2160965|FG004|Overall Study|Death|0
1092060|NCT02265744|2160961|FG000|Overall Study|Withdrawal by Subject|2
1092061|NCT02265744|2160962|FG001|Overall Study|Withdrawal by Subject|0
1092062|NCT02265744|2160963|FG002|Overall Study|Withdrawal by Subject|0
1092063|NCT02265744|2160964|FG003|Overall Study|Withdrawal by Subject|2
1092064|NCT02265744|2160965|FG004|Overall Study|Withdrawal by Subject|0
1092065|NCT02265744|2160961|FG000|Overall Study|Participant request to discontinue|2
1092066|NCT02265744|2160962|FG001|Overall Study|Participant request to discontinue|2
1092067|NCT02265744|2160963|FG002|Overall Study|Participant request to discontinue|2
1092068|NCT02265744|2160964|FG003|Overall Study|Participant request to discontinue|0
1092069|NCT02265744|2160965|FG004|Overall Study|Participant request to discontinue|0
1092070|NCT02265744|2160961|FG000|Overall Study|Adverse Event|8
1092071|NCT02265744|2160962|FG001|Overall Study|Adverse Event|4
1092072|NCT02265744|2160963|FG002|Overall Study|Adverse Event|9
1092073|NCT02265744|2160964|FG003|Overall Study|Adverse Event|8
1092074|NCT02265744|2160965|FG004|Overall Study|Adverse Event|2
1092075|NCT02265744|2160961|FG000|Overall Study|Lack of Efficacy|2
1092076|NCT02265744|2160962|FG001|Overall Study|Lack of Efficacy|4
1092077|NCT02265744|2160963|FG002|Overall Study|Lack of Efficacy|3
1092078|NCT02265744|2160964|FG003|Overall Study|Lack of Efficacy|4
1092079|NCT02265744|2160965|FG004|Overall Study|Lack of Efficacy|5
1092080|NCT02265744|2160961|FG000|Overall Study|Reason not provided by Investigator|1
1092081|NCT02265744|2160962|FG001|Overall Study|Reason not provided by Investigator|0
1092082|NCT02265744|2160963|FG002|Overall Study|Reason not provided by Investigator|0
1092083|NCT02265744|2160964|FG003|Overall Study|Reason not provided by Investigator|2
1092084|NCT02265744|2160965|FG004|Overall Study|Reason not provided by Investigator|0
1092085|NCT02265744|2160961|FG000|Overall Study|Administrative reason by sponsor|3
1092086|NCT02265744|2160962|FG001|Overall Study|Administrative reason by sponsor|2
1092087|NCT02265744|2160963|FG002|Overall Study|Administrative reason by sponsor|2
1092088|NCT02265744|2160964|FG003|Overall Study|Administrative reason by sponsor|3
1092089|NCT02265744|2160965|FG004|Overall Study|Administrative reason by sponsor|3
1092090|NCT02265744|2160961|FG000|Overall Study|Subject no longer meets study criteria|0
1092091|NCT02265744|2160962|FG001|Overall Study|Subject no longer meets study criteria|0
1092092|NCT02265744|2160963|FG002|Overall Study|Subject no longer meets study criteria|0
1092093|NCT02265744|2160964|FG003|Overall Study|Subject no longer meets study criteria|0
1092094|NCT02265744|2160965|FG004|Overall Study|Subject no longer meets study criteria|1
1092095|NCT02265744|2160961|FG000|Overall Study|Pregnancy|1
1092096|NCT02265744|2160962|FG001|Overall Study|Pregnancy|2
1092097|NCT02265744|2160963|FG002|Overall Study|Pregnancy|1
1092098|NCT02265744|2160964|FG003|Overall Study|Pregnancy|1
1092099|NCT02265744|2160965|FG004|Overall Study|Pregnancy|0
1092100|NCT02265796|2160983|FG000|Overall Study|Death|1
1092101|NCT02265796|2160984|FG001|Overall Study|Death|0
1092102|NCT02265796|2160983|FG000|Overall Study|started on excluded medication|1
1092103|NCT02265796|2160984|FG001|Overall Study|started on excluded medication|0
1092104|NCT02265796|2160983|FG000|Overall Study|Withdrawal by Subject|1
1092105|NCT02265796|2160984|FG001|Overall Study|Withdrawal by Subject|1
1092106|NCT02265952|2161012|FG000|Open Label Extension (OLE) Period|Physician Decision|0
1092107|NCT02265952|2161013|FG001|Open Label Extension (OLE) Period|Physician Decision|7
1092108|NCT02265952|2161012|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
1092109|NCT02265952|2161013|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1
1092110|NCT02266004|2161028|FG000|Overall Study|unrelated adverse event|1
1092111|NCT02266004|2161028|FG000|Overall Study|Physician Decision|1
1092112|NCT02266147|2161045|FG000|PART 1: Dose Escalation|Physician Decision|0
1092113|NCT02266147|2161046|FG001|PART 1: Dose Escalation|Physician Decision|0
1092114|NCT02266147|2161047|FG002|PART 1: Dose Escalation|Physician Decision|1
1092115|NCT02266147|2161048|FG003|PART 1: Dose Escalation|Physician Decision|0
1092116|NCT02266147|2161045|FG000|PART 1: Dose Escalation|Lack of Efficacy|0
1092117|NCT02266147|2161046|FG001|PART 1: Dose Escalation|Lack of Efficacy|2
1092118|NCT02266147|2161047|FG002|PART 1: Dose Escalation|Lack of Efficacy|1
1092119|NCT02266147|2161048|FG003|PART 1: Dose Escalation|Lack of Efficacy|1
1092120|NCT02266147|2161045|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0
1092121|NCT02266147|2161046|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0
1092122|NCT02266147|2161047|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1
1092123|NCT02266147|2161048|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3
1092124|NCT02266147|2161045|FG000|PART 1: Dose Escalation|Other|1
1092125|NCT02266147|2161046|FG001|PART 1: Dose Escalation|Other|1
1092126|NCT02266147|2161047|FG002|PART 1: Dose Escalation|Other|0
1092127|NCT02266147|2161048|FG003|PART 1: Dose Escalation|Other|0
1092128|NCT02266147|2161045|FG000|PART 2: Dose Expansion|Lack of Efficacy|1
1092129|NCT02266147|2161046|FG001|PART 2: Dose Expansion|Lack of Efficacy|0
1092130|NCT02266147|2161047|FG002|PART 2: Dose Expansion|Lack of Efficacy|0
1092131|NCT02266147|2161048|FG003|PART 2: Dose Expansion|Lack of Efficacy|1
1092132|NCT02266147|2161045|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6
1092133|NCT02266147|2161046|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0
1092134|NCT02266147|2161047|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0
1092135|NCT02266147|2161048|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8
1092136|NCT02266225|2161060|FG000|Overall Study|Lost to Follow-up|2
1092137|NCT02266225|2161060|FG000|Overall Study|Death|1
1092138|NCT02266225|2161060|FG000|Overall Study|Withdrawal by Subject|13
1092139|NCT02266381|2161095|FG000|Overall Study|Physician Decision|3
1092140|NCT02266381|2161096|FG001|Overall Study|Physician Decision|5
1092141|NCT02266381|2161097|FG002|Overall Study|Physician Decision|4
1092142|NCT02266433|2161109|FG000|Overall Study|Lost to Follow-up|54
1092143|NCT02266433|2161110|FG001|Overall Study|Lost to Follow-up|46
1092144|NCT02266433|2161109|FG000|Overall Study|Withdrawal by Subject|5
1092145|NCT02266433|2161110|FG001|Overall Study|Withdrawal by Subject|7
1092146|NCT02266706|2161144|FG000|Overall Study|Withdrawal by Subject|0
1092147|NCT02266706|2161145|FG001|Overall Study|Withdrawal by Subject|1
1092148|NCT02266706|2161146|FG002|Overall Study|Withdrawal by Subject|1
1092149|NCT02266706|2161147|FG003|Overall Study|Withdrawal by Subject|0
1092150|NCT02266706|2161148|FG004|Overall Study|Withdrawal by Subject|0
1092151|NCT02266706|2161149|FG005|Overall Study|Withdrawal by Subject|1
1092152|NCT02266706|2161150|FG006|Overall Study|Withdrawal by Subject|0
1092153|NCT02266706|2161151|FG007|Overall Study|Withdrawal by Subject|0
1092154|NCT02266706|2161152|FG008|Overall Study|Withdrawal by Subject|0
1092155|NCT02266706|2161144|FG000|Overall Study|Screen failure|0
1092156|NCT02266706|2161145|FG001|Overall Study|Screen failure|0
1092157|NCT02266706|2161146|FG002|Overall Study|Screen failure|0
1092158|NCT02266706|2161147|FG003|Overall Study|Screen failure|0
1092159|NCT02266706|2161148|FG004|Overall Study|Screen failure|0
1092160|NCT02266706|2161149|FG005|Overall Study|Screen failure|1
1092161|NCT02266706|2161150|FG006|Overall Study|Screen failure|1
1092162|NCT02266706|2161151|FG007|Overall Study|Screen failure|0
1092163|NCT02266706|2161152|FG008|Overall Study|Screen failure|0
1092164|NCT02266706|2161144|FG000|Overall Study|Enrollment in another study|0
1092165|NCT02266706|2161145|FG001|Overall Study|Enrollment in another study|0
1092166|NCT02266706|2161146|FG002|Overall Study|Enrollment in another study|0
1092167|NCT02266706|2161147|FG003|Overall Study|Enrollment in another study|1
1092168|NCT02266706|2161148|FG004|Overall Study|Enrollment in another study|0
1092169|NCT02266706|2161149|FG005|Overall Study|Enrollment in another study|0
1092170|NCT02266706|2161150|FG006|Overall Study|Enrollment in another study|0
1092171|NCT02266706|2161151|FG007|Overall Study|Enrollment in another study|0
1092172|NCT02266706|2161152|FG008|Overall Study|Enrollment in another study|0
1092173|NCT02266875|2161192|FG000|Overall Study|Withdrawal by Subject|9
1092174|NCT02266875|2161193|FG001|Overall Study|Withdrawal by Subject|0
1092175|NCT02266875|2161192|FG000|Overall Study|Lost to Follow-up|2
1092176|NCT02266875|2161193|FG001|Overall Study|Lost to Follow-up|0
1092177|NCT02266888|2161201|FG000|Overall Study|Death|2
1092178|NCT02266888|2161202|FG001|Overall Study|Death|2
1092179|NCT02266888|2161203|FG002|Overall Study|Death|4
1092180|NCT02266888|2161204|FG003|Overall Study|Death|2
1092181|NCT02266888|2161201|FG000|Overall Study|Physician Decision|0
1092182|NCT02266888|2161202|FG001|Overall Study|Physician Decision|1
1092183|NCT02266888|2161203|FG002|Overall Study|Physician Decision|2
1092184|NCT02266888|2161204|FG003|Overall Study|Physician Decision|2
1092185|NCT02266888|2161201|FG000|Overall Study|Study Terminated|5
1092186|NCT02266888|2161202|FG001|Overall Study|Study Terminated|1
1092187|NCT02266888|2161203|FG002|Overall Study|Study Terminated|0
1092188|NCT02266888|2161204|FG003|Overall Study|Study Terminated|0
1092189|NCT02266888|2161201|FG000|Overall Study|No Longer Eligible|0
1092190|NCT02266888|2161202|FG001|Overall Study|No Longer Eligible|0
1092191|NCT02266888|2161203|FG002|Overall Study|No Longer Eligible|0
1092192|NCT02266888|2161204|FG003|Overall Study|No Longer Eligible|2
1092193|NCT02266888|2161201|FG000|Overall Study|Randomization Closed|0
1092194|NCT02266888|2161202|FG001|Overall Study|Randomization Closed|0
1092195|NCT02266888|2161203|FG002|Overall Study|Randomization Closed|4
1092196|NCT02266888|2161204|FG003|Overall Study|Randomization Closed|0
1092197|NCT02266888|2161201|FG000|Overall Study|Personnel unavailable at transplant|0
1092198|NCT02266888|2161202|FG001|Overall Study|Personnel unavailable at transplant|0
1092199|NCT02266888|2161203|FG002|Overall Study|Personnel unavailable at transplant|0
1092200|NCT02266888|2161204|FG003|Overall Study|Personnel unavailable at transplant|1
1092201|NCT02266888|2161201|FG000|Overall Study|Transfer of care|0
1092202|NCT02266888|2161202|FG001|Overall Study|Transfer of care|0
1092203|NCT02266888|2161203|FG002|Overall Study|Transfer of care|1
1092204|NCT02266888|2161204|FG003|Overall Study|Transfer of care|0
1092205|NCT02267135|2161218|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1
1092206|NCT02267135|2161219|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3
1092207|NCT02267135|2161218|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0
1092208|NCT02267135|2161219|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1
1092209|NCT02267135|2161218|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1
1092210|NCT02267135|2161219|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1
1092211|NCT02267135|2161218|FG000|Period 2 (Randomized Set)|Adverse Event|2
1092212|NCT02267135|2161219|FG001|Period 2 (Randomized Set)|Adverse Event|0
1092213|NCT02267135|2161218|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1
1092214|NCT02267135|2161219|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0
1092215|NCT02267187|2161228|FG000|Overall Study|Physician Decision|2
1092216|NCT02267187|2161228|FG000|Overall Study|Screen fail|3
1092217|NCT02267278|2161251|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1
1092218|NCT02267278|2161251|FG000|Overall Study|transformation to acute leukemia (AML)|1
1092219|NCT02267278|2161251|FG000|Overall Study|Developed new cancer diagnoses|2
1092220|NCT02267278|2161251|FG000|Overall Study|prescribed prohibited medication|1
1092221|NCT02267317|2161258|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
1092222|NCT02267317|2161259|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
1092223|NCT02267317|2161260|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
1092224|NCT02267317|2161261|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
1092225|NCT02267317|2161262|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
1092226|NCT02267317|2161263|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
1092227|NCT02267317|2161258|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
1092228|NCT02267317|2161259|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
1092229|NCT02267317|2161260|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
1092230|NCT02267317|2161261|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
1092231|NCT02267317|2161262|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
1092232|NCT02267317|2161263|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
1092233|NCT02267746|2161354|FG000|Overall Study|Adverse Event|0
1092234|NCT02267746|2161355|FG001|Overall Study|Adverse Event|2
1092235|NCT02267746|2161356|FG002|Overall Study|Adverse Event|1
1092236|NCT02267746|2161354|FG000|Overall Study|Protocol Violation|8
1092237|NCT02267746|2161355|FG001|Overall Study|Protocol Violation|7
1092238|NCT02267746|2161356|FG002|Overall Study|Protocol Violation|3
1092239|NCT02267746|2161354|FG000|Overall Study|Lack of Efficacy|11
1092240|NCT02267746|2161355|FG001|Overall Study|Lack of Efficacy|11
1092241|NCT02267746|2161356|FG002|Overall Study|Lack of Efficacy|15
1092242|NCT02267746|2161354|FG000|Overall Study|Protocol Violation|1
1092243|NCT02267746|2161355|FG001|Overall Study|Protocol Violation|2
1092244|NCT02267746|2161356|FG002|Overall Study|Protocol Violation|1
1092245|NCT02267746|2161354|FG000|Overall Study|Miscellaneous|1
1092246|NCT02267746|2161355|FG001|Overall Study|Miscellaneous|0
1092247|NCT02267746|2161356|FG002|Overall Study|Miscellaneous|1
1092248|NCT02267824|2161388|FG000|Overall Study|Pregnancy|1
1092249|NCT02267824|2161389|FG001|Overall Study|Pregnancy|1
1092250|NCT02267824|2161388|FG000|Overall Study|Lost to Follow-up|4
1092251|NCT02267824|2161389|FG001|Overall Study|Lost to Follow-up|0
1092252|NCT02267824|2161388|FG000|Overall Study|Protocol Violation|3
1092253|NCT02267824|2161389|FG001|Overall Study|Protocol Violation|0
1092254|NCT02267824|2161388|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2
1092255|NCT02267824|2161389|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0
1092256|NCT02268045|2161415|FG000|Overall Study|Death|4
1092257|NCT02268045|2161416|FG001|Overall Study|Death|4
1092258|NCT02268045|2161415|FG000|Overall Study|Disease Progression|2
1092259|NCT02268045|2161416|FG001|Overall Study|Disease Progression|1
1092260|NCT02268045|2161415|FG000|Overall Study|Adverse Event|7
1092261|NCT02268045|2161416|FG001|Overall Study|Adverse Event|7
1092262|NCT02268045|2161415|FG000|Overall Study|Withdrawal by Subject|2
1092263|NCT02268045|2161416|FG001|Overall Study|Withdrawal by Subject|6
1092264|NCT02268045|2161415|FG000|Overall Study|Physician Decision|0
1092265|NCT02268045|2161416|FG001|Overall Study|Physician Decision|1
1092266|NCT02268045|2161415|FG000|Overall Study|Protocol Violation|1
1092267|NCT02268045|2161416|FG001|Overall Study|Protocol Violation|1
1092268|NCT02268058|2161428|FG000|Overall Study|Protocol Violation|1
1092269|NCT02268058|2161429|FG001|Overall Study|Protocol Violation|0
1092270|NCT02268058|2161430|FG002|Overall Study|Protocol Violation|0
1092271|NCT02268058|2161431|FG003|Overall Study|Protocol Violation|0
1092272|NCT02268084|2161443|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0
1092273|NCT02268084|2161444|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3
1092274|NCT02268084|2161443|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9
1092275|NCT02268084|2161444|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4
1092276|NCT02268214|2161468|FG000|Overall Study|Subject no longer meets study criteria|0
1092277|NCT02268214|2161469|FG001|Overall Study|Subject no longer meets study criteria|2
1092278|NCT02268214|2161470|FG002|Overall Study|Subject no longer meets study criteria|0
1092279|NCT02268214|2161468|FG000|Overall Study|Pregnancy|2
1092280|NCT02268214|2161469|FG001|Overall Study|Pregnancy|2
1092281|NCT02268214|2161470|FG002|Overall Study|Pregnancy|1
1092282|NCT02268214|2161468|FG000|Overall Study|Lost to Follow-up|3
1092283|NCT02268214|2161469|FG001|Overall Study|Lost to Follow-up|3
1092284|NCT02268214|2161470|FG002|Overall Study|Lost to Follow-up|4
1092285|NCT02268214|2161468|FG000|Overall Study|Lack of Efficacy|1
1092286|NCT02268214|2161469|FG001|Overall Study|Lack of Efficacy|0
1092287|NCT02268214|2161470|FG002|Overall Study|Lack of Efficacy|2
1092288|NCT02268214|2161468|FG000|Overall Study|Adverse Event|11
1092289|NCT02268214|2161469|FG001|Overall Study|Adverse Event|14
1092290|NCT02268214|2161470|FG002|Overall Study|Adverse Event|9
1092291|NCT02268214|2161468|FG000|Overall Study|Withdrawal by Subject|4
1092292|NCT02268214|2161469|FG001|Overall Study|Withdrawal by Subject|5
1092293|NCT02268214|2161470|FG002|Overall Study|Withdrawal by Subject|10
1092294|NCT02268214|2161468|FG000|Overall Study|Subject request to discontinue treatment|10
1092295|NCT02268214|2161469|FG001|Overall Study|Subject request to discontinue treatment|8
1092296|NCT02268214|2161470|FG002|Overall Study|Subject request to discontinue treatment|6
1092297|NCT02268214|2161468|FG000|Overall Study|Poor/non-compliance|2
1092298|NCT02268214|2161469|FG001|Overall Study|Poor/non-compliance|1
1092299|NCT02268214|2161470|FG002|Overall Study|Poor/non-compliance|2
1092300|NCT02268214|2161468|FG000|Overall Study|Other reasons|7
1092301|NCT02268214|2161469|FG001|Overall Study|Other reasons|3
1092302|NCT02268214|2161470|FG002|Overall Study|Other reasons|3
1092303|NCT02268214|2161468|FG000|Overall Study|Not entering long-term period|2
1092304|NCT02268214|2161469|FG001|Overall Study|Not entering long-term period|3
1092305|NCT02268214|2161470|FG002|Overall Study|Not entering long-term period|5
1092306|NCT02268396|2161478|FG000|Overall Study|Adverse Event|3
1092307|NCT02268396|2161478|FG000|Overall Study|Administrative|2
1092308|NCT02268396|2161478|FG000|Overall Study|Withdrawal by Subject|1
1092309|NCT02268396|2161478|FG000|Overall Study|Lost to Follow-up|2
1092310|NCT02268396|2161478|FG000|Overall Study|Protocol-Specified Criteria|2
1092311|NCT02268396|2161478|FG000|Overall Study|2 Subjects no Day 29 Assessment|2
1092312|NCT02268526|2161494|FG000|Overall Study|Adverse Event|0
1092313|NCT02268526|2161495|FG001|Overall Study|Adverse Event|2
1092314|NCT02268526|2161496|FG002|Overall Study|Adverse Event|1
1092315|NCT02268526|2161494|FG000|Overall Study|Death|1
1092316|NCT02268526|2161495|FG001|Overall Study|Death|11
1092317|NCT02268526|2161496|FG002|Overall Study|Death|0
1092318|NCT02268526|2161494|FG000|Overall Study|protocol deviation|0
1092319|NCT02268526|2161495|FG001|Overall Study|protocol deviation|1
1092320|NCT02268526|2161496|FG002|Overall Study|protocol deviation|0
1092321|NCT02268526|2161494|FG000|Overall Study|Physician Decision|0
1092322|NCT02268526|2161495|FG001|Overall Study|Physician Decision|0
1092323|NCT02268526|2161496|FG002|Overall Study|Physician Decision|1
1092324|NCT02268526|2161494|FG000|Overall Study|Subject/guardian decision|0
1092325|NCT02268526|2161495|FG001|Overall Study|Subject/guardian decision|7
1092326|NCT02268526|2161496|FG002|Overall Study|Subject/guardian decision|3
1092327|NCT02268786|2161508|FG000|Overall Study|No Euploid Embryos available|42
1092328|NCT02268786|2161509|FG001|Overall Study|No Euploid Embryos available|0
1092329|NCT02268786|2161508|FG000|Overall Study|Withdrawal by Subject|7
1092330|NCT02268786|2161509|FG001|Overall Study|Withdrawal by Subject|14
1092331|NCT02268786|2161508|FG000|Overall Study|Thaw Failure|6
1092332|NCT02268786|2161509|FG001|Overall Study|Thaw Failure|4
1092333|NCT02268786|2161508|FG000|Overall Study|Protocol Violation|1
1092334|NCT02268786|2161509|FG001|Overall Study|Protocol Violation|0
1092335|NCT02268812|2161519|FG000|Overall Study|Adverse Event|8
1092336|NCT02268812|2161520|FG001|Overall Study|Adverse Event|26
1092337|NCT02268812|2161521|FG002|Overall Study|Adverse Event|7
1092338|NCT02268812|2161522|FG003|Overall Study|Adverse Event|10
1092339|NCT02268812|2161519|FG000|Overall Study|Protocol deviation|0
1092340|NCT02268812|2161520|FG001|Overall Study|Protocol deviation|0
1092341|NCT02268812|2161521|FG002|Overall Study|Protocol deviation|1
1092342|NCT02268812|2161522|FG003|Overall Study|Protocol deviation|0
1092343|NCT02268812|2161519|FG000|Overall Study|Withdrawal by Subject|0
1092344|NCT02268812|2161520|FG001|Overall Study|Withdrawal by Subject|1
1092345|NCT02268812|2161521|FG002|Overall Study|Withdrawal by Subject|0
1092346|NCT02268812|2161522|FG003|Overall Study|Withdrawal by Subject|0
1092347|NCT02268812|2161519|FG000|Overall Study|Physician Decision|3
1092348|NCT02268812|2161520|FG001|Overall Study|Physician Decision|1
1092349|NCT02268812|2161521|FG002|Overall Study|Physician Decision|0
1092350|NCT02268812|2161522|FG003|Overall Study|Physician Decision|1
1092351|NCT02268812|2161519|FG000|Overall Study|Other|5
1092352|NCT02268812|2161520|FG001|Overall Study|Other|4
1092353|NCT02268812|2161521|FG002|Overall Study|Other|1
1092354|NCT02268812|2161522|FG003|Overall Study|Other|3
1092355|NCT02268851|2161538|FG000|Overall Study|Death|0
1092356|NCT02268851|2161539|FG001|Overall Study|Death|0
1092357|NCT02268851|2161540|FG002|Overall Study|Death|0
1092358|NCT02268851|2161541|FG003|Overall Study|Death|1
1092359|NCT02268851|2161542|FG004|Overall Study|Death|2
1092360|NCT02268851|2161543|FG005|Overall Study|Death|1
1092361|NCT02268851|2161538|FG000|Overall Study|Adverse Event|0
1092362|NCT02268851|2161539|FG001|Overall Study|Adverse Event|0
1092363|NCT02268851|2161540|FG002|Overall Study|Adverse Event|0
1092364|NCT02268851|2161541|FG003|Overall Study|Adverse Event|0
1092365|NCT02268851|2161542|FG004|Overall Study|Adverse Event|2
1092366|NCT02268851|2161543|FG005|Overall Study|Adverse Event|2
1092367|NCT02268851|2161538|FG000|Overall Study|Withdrawal by Subject|0
1092368|NCT02268851|2161539|FG001|Overall Study|Withdrawal by Subject|0
1092369|NCT02268851|2161540|FG002|Overall Study|Withdrawal by Subject|0
1092370|NCT02268851|2161541|FG003|Overall Study|Withdrawal by Subject|2
1092371|NCT02268851|2161542|FG004|Overall Study|Withdrawal by Subject|0
1092372|NCT02268851|2161543|FG005|Overall Study|Withdrawal by Subject|1
1092373|NCT02268851|2161538|FG000|Overall Study|Progressive Disease|1
1092374|NCT02268851|2161539|FG001|Overall Study|Progressive Disease|3
1092375|NCT02268851|2161540|FG002|Overall Study|Progressive Disease|0
1092376|NCT02268851|2161541|FG003|Overall Study|Progressive Disease|0
1092377|NCT02268851|2161542|FG004|Overall Study|Progressive Disease|1
1092378|NCT02268851|2161543|FG005|Overall Study|Progressive Disease|4
1092379|NCT02268851|2161538|FG000|Overall Study|Physician Decision|0
1092380|NCT02268851|2161539|FG001|Overall Study|Physician Decision|0
1092381|NCT02268851|2161540|FG002|Overall Study|Physician Decision|1
1092382|NCT02268851|2161541|FG003|Overall Study|Physician Decision|0
1092383|NCT02268851|2161542|FG004|Overall Study|Physician Decision|0
1092384|NCT02268851|2161543|FG005|Overall Study|Physician Decision|1
1092385|NCT02268851|2161538|FG000|Overall Study|Patient Compliance|0
1092386|NCT02268851|2161539|FG001|Overall Study|Patient Compliance|0
1092387|NCT02268851|2161540|FG002|Overall Study|Patient Compliance|0
1092388|NCT02268851|2161541|FG003|Overall Study|Patient Compliance|0
1092389|NCT02268851|2161542|FG004|Overall Study|Patient Compliance|1
1092390|NCT02268851|2161543|FG005|Overall Study|Patient Compliance|1
1092391|NCT02268851|2161538|FG000|Overall Study|Co-Morbid Condition|0
1092392|NCT02268851|2161539|FG001|Overall Study|Co-Morbid Condition|0
1092393|NCT02268851|2161540|FG002|Overall Study|Co-Morbid Condition|0
1092394|NCT02268851|2161541|FG003|Overall Study|Co-Morbid Condition|0
1092395|NCT02268851|2161542|FG004|Overall Study|Co-Morbid Condition|1
1092396|NCT02268851|2161543|FG005|Overall Study|Co-Morbid Condition|1
1092397|NCT02268864|2161560|FG000|Overall Study|Withdrawal by Subject|2
1092398|NCT02268864|2161561|FG001|Overall Study|Withdrawal by Subject|0
1092399|NCT02268864|2161562|FG002|Overall Study|Withdrawal by Subject|0
1092400|NCT02268864|2161560|FG000|Overall Study|Death|0
1092401|NCT02268864|2161561|FG001|Overall Study|Death|1
1092402|NCT02268864|2161562|FG002|Overall Study|Death|0
1092403|NCT02269098|2161608|FG000|Overall Study|Lost to Follow-up|14
1092404|NCT02269098|2161609|FG001|Overall Study|Lost to Follow-up|9
1092405|NCT02269124|2161618|FG000|Overall Study|Lost to Follow-up|1
1092406|NCT02269124|2161619|FG001|Overall Study|Lost to Follow-up|0
1092407|NCT02269124|2161618|FG000|Overall Study|Withdrawal by Subject|0
1092408|NCT02269124|2161619|FG001|Overall Study|Withdrawal by Subject|2
1092409|NCT02269163|2161628|FG000|Overall Study|Lost to Follow-up|1
1092410|NCT02269163|2161629|FG001|Overall Study|Lost to Follow-up|0
1092411|NCT02269163|2161628|FG000|Overall Study|Major protocol violation|0
1092412|NCT02269163|2161629|FG001|Overall Study|Major protocol violation|1
1092413|NCT02269163|2161628|FG000|Overall Study|Other|2
1092414|NCT02269163|2161629|FG001|Overall Study|Other|2
1092415|NCT02269163|2161628|FG000|Overall Study|Withdrawal by Subject|0
1092416|NCT02269163|2161629|FG001|Overall Study|Withdrawal by Subject|3
1092417|NCT02269163|2161628|FG000|Overall Study|Physician Decision|0
1092418|NCT02269163|2161629|FG001|Overall Study|Physician Decision|1
1092419|NCT02269241|2161637|FG000|Overall Study|Lost to Follow-up|269
1092420|NCT02269241|2161637|FG000|Overall Study|Withdrawal by Subject|155
1092421|NCT02269241|2161637|FG000|Overall Study|Protocol Violation|1
1092422|NCT02269241|2161637|FG000|Overall Study|Physician Decision|7
1092423|NCT02269241|2161637|FG000|Overall Study|Pregnancy|15
1092424|NCT02269241|2161637|FG000|Overall Study|Wish for pregnancy|5
1092425|NCT02269241|2161637|FG000|Overall Study|Development of an exclusion criteria|16
1092426|NCT02269241|2161637|FG000|Overall Study|Adverse Event|113
1092427|NCT02269241|2161637|FG000|Overall Study|At the specific request of the sponsor|20
1092428|NCT02269241|2161637|FG000|Overall Study|Several reasons not classified|53
1092429|NCT02269241|2161637|FG000|Overall Study|Screening failures|546
1092430|NCT02269423|2161646|FG000|Overall Study|Discontinued due to change in residence|0
1092431|NCT02269423|2161647|FG001|Overall Study|Discontinued due to change in residence|1
1092432|NCT02269423|2161648|FG002|Overall Study|Discontinued due to change in residence|0
1092433|NCT02269423|2161649|FG003|Overall Study|Discontinued due to change in residence|1
1092434|NCT02269475|2161661|FG000|Overall Study|Meet Exclusion Criteria No. 17|3
1092435|NCT02269475|2161662|FG001|Overall Study|Meet Exclusion Criteria No. 17|0
1092436|NCT02269475|2161661|FG000|Overall Study|Withdrawal by Subject|0
1092437|NCT02269475|2161662|FG001|Overall Study|Withdrawal by Subject|1
1092438|NCT02269657|2161682|FG000|Overall Study|Protocol Violation|3
1092439|NCT02269709|2161688|FG000|Time of Enrollment|Withdrawal by Subject|3
1092440|NCT02269709|2161688|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
1092441|NCT02269709|2161688|FG000|Six Month Follow-up|Lost to Follow-up|12
1092442|NCT02269787|2161695|FG000|Overall Study|Lost to Follow-up|20
1092443|NCT02269787|2161696|FG001|Overall Study|Lost to Follow-up|6
1092444|NCT02269787|2161695|FG000|Overall Study|Death|2
1092445|NCT02269787|2161696|FG001|Overall Study|Death|3
1092446|NCT02269787|2161695|FG000|Overall Study|Incapacitated|0
1092447|NCT02269787|2161696|FG001|Overall Study|Incapacitated|1
1092462|NCT02269943|2161713|FG000|Treatment Period|Death|0
1092463|NCT02269943|2161714|FG001|Treatment Period|Death|1
1092464|NCT02269943|2161713|FG000|Treatment Period|Adverse Event|1
1092465|NCT02269943|2161714|FG001|Treatment Period|Adverse Event|10
1092466|NCT02269943|2161713|FG000|Treatment Period|Progressive Disease|5
1092467|NCT02269943|2161714|FG001|Treatment Period|Progressive Disease|17
1092468|NCT02269943|2161713|FG000|Treatment Period|Symptomatic Deterioration|0
1092469|NCT02269943|2161714|FG001|Treatment Period|Symptomatic Deterioration|2
1092470|NCT02269943|2161713|FG000|Follow-Up Survival Period|Death|3
1092471|NCT02269943|2161714|FG001|Follow-Up Survival Period|Death|16
1092472|NCT02269943|2161713|FG000|Follow-Up Survival Period|Lost to Follow-up|0
1092473|NCT02269943|2161714|FG001|Follow-Up Survival Period|Lost to Follow-up|2
1092474|NCT02269943|2161713|FG000|Follow-Up Survival Period|Alive|2
1092475|NCT02269943|2161714|FG001|Follow-Up Survival Period|Alive|8
1092476|NCT02270242|2161735|FG000|Overall Study|Withdrawal by Subject|18
1092477|NCT02270242|2161736|FG001|Overall Study|Withdrawal by Subject|25
1092478|NCT02270242|2161735|FG000|Overall Study|Lost to Follow-up|41
1092479|NCT02270242|2161736|FG001|Overall Study|Lost to Follow-up|27
1092480|NCT02270242|2161735|FG000|Overall Study|Physician Decision|0
1092481|NCT02270242|2161736|FG001|Overall Study|Physician Decision|1
1092482|NCT02270515|2161751|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
1092483|NCT02270515|2161751|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5
1092484|NCT02270515|2161751|FG000|Intervention Period 1: 0-6 Months|Received transplant|3
1092485|NCT02270515|2161751|FG000|Intervention Period 1: 0-6 Months|Death|7
1092486|NCT02270515|2161751|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
1092487|NCT02270515|2161751|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7
1092488|NCT02270515|2161751|FG000|Intervention Period 2: 6-12 Months|Received transplant|1
1092489|NCT02270515|2161751|FG000|Intervention Period 2: 6-12 Months|Death|5
1092490|NCT02270515|2161751|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
1092491|NCT02270515|2161751|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
1092492|NCT02270515|2161751|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2
1092493|NCT02270515|2161751|FG000|Intervention Period 3: 12-18 Months|Received transplant|2
1092494|NCT02270515|2161751|FG000|Intervention Period 3: 12-18 Months|Death|3
1092495|NCT02270515|2161751|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
1092496|NCT02270671|2161773|FG000|Overall Study|Withdrawal by Subject|1
1092497|NCT02270671|2161774|FG001|Overall Study|Withdrawal by Subject|1
1092498|NCT02270671|2161773|FG000|Overall Study|Protocol Violation|0
1092499|NCT02270671|2161774|FG001|Overall Study|Protocol Violation|1
1092500|NCT02270671|2161773|FG000|Overall Study|Missed Post-intervention Data Collection|2
1092501|NCT02270671|2161774|FG001|Overall Study|Missed Post-intervention Data Collection|2
1092502|NCT02270671|2161773|FG000|Overall Study|Lost to Follow-up|2
1092503|NCT02270671|2161774|FG001|Overall Study|Lost to Follow-up|1
1092504|NCT02270736|2161783|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
1092505|NCT02270736|2161784|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1
1092506|NCT02270736|2161785|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
1092507|NCT02270736|2161786|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
1092508|NCT02270736|2161787|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
1092509|NCT02270736|2161783|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2
1092510|NCT02270736|2161784|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
1092511|NCT02270736|2161785|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1
1092512|NCT02270736|2161786|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
1092513|NCT02270736|2161787|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
1092514|NCT02270736|2161783|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
1092515|NCT02270736|2161784|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1
1092516|NCT02270736|2161785|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
1092517|NCT02270736|2161786|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
1092518|NCT02270736|2161787|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
1092519|NCT02270736|2161783|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
1092520|NCT02270736|2161784|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
1092521|NCT02270736|2161785|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1
1092522|NCT02270736|2161786|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
1092523|NCT02270736|2161787|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
1092524|NCT02270736|2161783|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0
1092525|NCT02270736|2161784|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0
1092526|NCT02270736|2161785|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0
1092527|NCT02270736|2161786|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1
1092528|NCT02270736|2161787|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0
1092529|NCT02270736|2161783|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
1092530|NCT02270736|2161784|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
1092531|NCT02270736|2161785|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
1092532|NCT02270736|2161786|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2
1092533|NCT02270736|2161787|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
1092534|NCT02270736|2161783|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0
1092535|NCT02270736|2161784|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0
1092536|NCT02270736|2161785|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0
1092537|NCT02270736|2161786|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4
1092538|NCT02270736|2161787|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0
1092539|NCT02270736|2161783|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
1092540|NCT02270736|2161784|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
1092541|NCT02270736|2161785|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
1092542|NCT02270736|2161786|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16
1092543|NCT02270736|2161787|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
1092544|NCT02270736|2161783|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
1092545|NCT02270736|2161784|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
1092546|NCT02270736|2161785|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
1092547|NCT02270736|2161786|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2
1092548|NCT02270736|2161787|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
1092549|NCT02270944|2161802|FG000|Overall Study|Lost to Follow-up|9
1092550|NCT02270944|2161803|FG001|Overall Study|Lost to Follow-up|4
1092551|NCT02270944|2161802|FG000|Overall Study|Withdrawal by Subject|2
1092552|NCT02270944|2161803|FG001|Overall Study|Withdrawal by Subject|1
1092557|NCT02270983|2161823|FG000|Overall Study|Adverse Event|3
1092558|NCT02270983|2161824|FG001|Overall Study|Adverse Event|2
1092559|NCT02270983|2161825|FG002|Overall Study|Adverse Event|6
1092560|NCT02270983|2161823|FG000|Overall Study|Lack of Efficacy|2
1092561|NCT02270983|2161824|FG001|Overall Study|Lack of Efficacy|1
1092562|NCT02270983|2161825|FG002|Overall Study|Lack of Efficacy|1
1092563|NCT02270983|2161823|FG000|Overall Study|Withdrawal by Subject|1
1092564|NCT02270983|2161824|FG001|Overall Study|Withdrawal by Subject|0
1092565|NCT02270983|2161825|FG002|Overall Study|Withdrawal by Subject|2
1092566|NCT02270983|2161823|FG000|Overall Study|Lost to Follow-up|1
1092567|NCT02270983|2161824|FG001|Overall Study|Lost to Follow-up|1
1092568|NCT02270983|2161825|FG002|Overall Study|Lost to Follow-up|2
1092569|NCT02270983|2161823|FG000|Overall Study|Protocol Violation|1
1092570|NCT02270983|2161824|FG001|Overall Study|Protocol Violation|1
1092571|NCT02270983|2161825|FG002|Overall Study|Protocol Violation|1
1092572|NCT02270983|2161823|FG000|Overall Study|family emergency|0
1092573|NCT02270983|2161824|FG001|Overall Study|family emergency|1
1092574|NCT02270983|2161825|FG002|Overall Study|family emergency|0
1092575|NCT02270983|2161823|FG000|Overall Study|study procedure non-compliance|1
1092576|NCT02270983|2161824|FG001|Overall Study|study procedure non-compliance|0
1092577|NCT02270983|2161825|FG002|Overall Study|study procedure non-compliance|0
1092578|NCT02270983|2161823|FG000|Overall Study|moved away from study site|0
1092579|NCT02270983|2161824|FG001|Overall Study|moved away from study site|1
1092580|NCT02270983|2161825|FG002|Overall Study|moved away from study site|0
1092581|NCT02271529|2161891|FG000|Overall Study|Withdrawal by Subject|1
1092582|NCT02271854|2161912|FG000|Overall Study|Withdrawal by Subject|2
1092583|NCT02271854|2161912|FG000|Overall Study|Unable or unwilling to cooperate with st|1
1092584|NCT02271854|2161912|FG000|Overall Study|Lost to Follow-up|1
1092585|NCT02271880|2161919|FG000|Overall Study|Premature discontinuation of study|3
1092586|NCT02271880|2161920|FG001|Overall Study|Premature discontinuation of study|4
1092587|NCT02271945|2161934|FG000|Overall Study|Death|3
1092588|NCT02271945|2161935|FG001|Overall Study|Death|3
1092589|NCT02271945|2161934|FG000|Overall Study|Withdrawal by Subject|1
1092590|NCT02271945|2161935|FG001|Overall Study|Withdrawal by Subject|1
1092591|NCT02271945|2161934|FG000|Overall Study|Other|1
1092592|NCT02271945|2161935|FG001|Overall Study|Other|1
1092593|NCT02271984|2161941|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1092594|NCT02271984|2161942|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1092595|NCT02271984|2161943|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1092596|NCT02271984|2161944|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1092597|NCT02271984|2161945|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1092598|NCT02271984|2161946|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1
1092599|NCT02271984|2161947|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1092600|NCT02271984|2161948|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1
1092601|NCT02271984|2161949|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1092602|NCT02271984|2161950|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1092603|NCT02271984|2161951|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1092604|NCT02271984|2161952|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1092605|NCT02272413|2161978|FG000|Randomized Through Treatment Start|Not treated|3
1092606|NCT02272413|2161979|FG001|Randomized Through Treatment Start|Not treated|5
1092607|NCT02272413|2161978|FG000|Pre-switch Period|Adverse Event|38
1092608|NCT02272413|2161979|FG001|Pre-switch Period|Adverse Event|37
1092609|NCT02272413|2161978|FG000|Pre-switch Period|Death|26
1092610|NCT02272413|2161979|FG001|Pre-switch Period|Death|26
1092611|NCT02272413|2161978|FG000|Pre-switch Period|Withdrawal by Subject|27
1092612|NCT02272413|2161979|FG001|Pre-switch Period|Withdrawal by Subject|15
1092613|NCT02272413|2161978|FG000|Pre-switch Period|Physician Decision|6
1092614|NCT02272413|2161979|FG001|Pre-switch Period|Physician Decision|18
1092615|NCT02272413|2161978|FG000|Pre-switch Period|Progressive disease|185
1092616|NCT02272413|2161979|FG001|Pre-switch Period|Progressive disease|173
1092617|NCT02272413|2161978|FG000|Pre-switch Period|Lost to Follow-up|0
1092618|NCT02272413|2161979|FG001|Pre-switch Period|Lost to Follow-up|2
1092619|NCT02272413|2161978|FG000|Pre-switch Period|Protocol Violation|1
1092620|NCT02272413|2161979|FG001|Pre-switch Period|Protocol Violation|0
1092621|NCT02272413|2161978|FG000|Pre-switch Period|Other than listed|10
1092622|NCT02272413|2161979|FG001|Pre-switch Period|Other than listed|11
1092623|NCT02272413|2161978|FG000|Post-switch Period|Adverse Event|4
1092624|NCT02272413|2161979|FG001|Post-switch Period|Adverse Event|4
1092625|NCT02272413|2161978|FG000|Post-switch Period|Death|3
1092626|NCT02272413|2161979|FG001|Post-switch Period|Death|2
1092627|NCT02272413|2161978|FG000|Post-switch Period|Withdrawal by Subject|1
1092628|NCT02272413|2161979|FG001|Post-switch Period|Withdrawal by Subject|2
1092629|NCT02272413|2161978|FG000|Post-switch Period|Physician Decision|1
1092630|NCT02272413|2161979|FG001|Post-switch Period|Physician Decision|1
1092631|NCT02272413|2161978|FG000|Post-switch Period|Progressive disease|21
1092632|NCT02272413|2161979|FG001|Post-switch Period|Progressive disease|21
1092633|NCT02272413|2161978|FG000|Post-switch Period|Study terminated by sponsor|8
1092634|NCT02272413|2161979|FG001|Post-switch Period|Study terminated by sponsor|11
1092635|NCT02272413|2161978|FG000|Post-switch Period|Other than listed|4
1092636|NCT02272413|2161979|FG001|Post-switch Period|Other than listed|5
1092637|NCT02272634|2161990|FG000|Overall Study|Adverse Event|1
1092638|NCT02272634|2161991|FG001|Overall Study|Adverse Event|0
1092639|NCT02272634|2161992|FG002|Overall Study|Adverse Event|0
1092640|NCT02272634|2161990|FG000|Overall Study|Protocol Violation|0
1092641|NCT02272634|2161991|FG001|Overall Study|Protocol Violation|0
1092642|NCT02272634|2161992|FG002|Overall Study|Protocol Violation|1
1092643|NCT02272634|2161990|FG000|Overall Study|Withdrawal by Subject|0
1092644|NCT02272634|2161991|FG001|Overall Study|Withdrawal by Subject|1
1092645|NCT02272634|2161992|FG002|Overall Study|Withdrawal by Subject|0
1092646|NCT02272725|2162009|FG000|Overall Study|equipment malfunction|2
1092647|NCT02272725|2162010|FG001|Overall Study|equipment malfunction|0
1092648|NCT02272777|2162018|FG000|Overall Study|Adverse Event|0
1092649|NCT02272777|2162019|FG001|Overall Study|Adverse Event|1
1092650|NCT02272777|2162018|FG000|Overall Study|Withdrawal by Subject|0
1092651|NCT02272777|2162019|FG001|Overall Study|Withdrawal by Subject|3
1092652|NCT02272777|2162018|FG000|Overall Study|Lost to Follow-up|2
1092653|NCT02272777|2162019|FG001|Overall Study|Lost to Follow-up|0
1092654|NCT02272777|2162018|FG000|Overall Study|Other|2
1092655|NCT02272777|2162019|FG001|Overall Study|Other|0
1092656|NCT02272790|2162031|FG000|Overall Study|Physician Decision|0
1092657|NCT02272790|2162032|FG001|Overall Study|Physician Decision|1
1092658|NCT02272790|2162033|FG002|Overall Study|Physician Decision|0
1092659|NCT02272790|2162034|FG003|Overall Study|Physician Decision|0
1092660|NCT02272790|2162035|FG004|Overall Study|Physician Decision|0
1092661|NCT02272790|2162036|FG005|Overall Study|Physician Decision|0
1092678|NCT02272816|2162065|FG000|Overall Study|Adverse Event|1
1092679|NCT02272842|2162071|FG000|Overall Study|Lost to Follow-up|8
1092680|NCT02272842|2162072|FG001|Overall Study|Lost to Follow-up|8
1092681|NCT02272842|2162071|FG000|Overall Study|Withdrawal by Subject|8
1092682|NCT02272842|2162072|FG001|Overall Study|Withdrawal by Subject|2
1092683|NCT02272985|2162079|FG000|Overall Study|Withdrawal by Subject|1
1092684|NCT02272985|2162079|FG000|Overall Study|hip fracture|1
1092685|NCT02272985|2162079|FG000|Overall Study|kidney transplantation|1
1092686|NCT02273037|2162086|FG000|Overall Study|Lost to Follow-up|1
1092687|NCT02273037|2162087|FG001|Overall Study|Lost to Follow-up|0
1092688|NCT02273037|2162086|FG000|Overall Study|Delivered before monitoring initiated|1
1092689|NCT02273037|2162087|FG001|Overall Study|Delivered before monitoring initiated|3
1092690|NCT02273037|2162086|FG000|Overall Study|Breech delivery|2
1092691|NCT02273037|2162087|FG001|Overall Study|Breech delivery|3
1092692|NCT02273037|2162086|FG000|Overall Study|Multiple delivery|2
1092693|NCT02273037|2162087|FG001|Overall Study|Multiple delivery|2
1092694|NCT02273037|2162086|FG000|Overall Study|Other complication|2
1092695|NCT02273037|2162087|FG001|Overall Study|Other complication|0
1092696|NCT02273050|2162098|FG000|Overall Study|Adverse Event|4
1092697|NCT02273050|2162099|FG001|Overall Study|Adverse Event|3
1092698|NCT02273050|2162100|FG002|Overall Study|Adverse Event|3
1092699|NCT02273050|2162098|FG000|Overall Study|Death|0
1092700|NCT02273050|2162099|FG001|Overall Study|Death|0
1092701|NCT02273050|2162100|FG002|Overall Study|Death|1
1092702|NCT02273050|2162098|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0
1092703|NCT02273050|2162099|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1
1092704|NCT02273050|2162100|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1
1092705|NCT02273050|2162098|FG000|Overall Study|Lack of Efficacy|0
1092706|NCT02273050|2162099|FG001|Overall Study|Lack of Efficacy|1
1092707|NCT02273050|2162100|FG002|Overall Study|Lack of Efficacy|1
1092708|NCT02273050|2162098|FG000|Overall Study|Withdrawal by Subject|17
1092709|NCT02273050|2162099|FG001|Overall Study|Withdrawal by Subject|14
1092710|NCT02273050|2162100|FG002|Overall Study|Withdrawal by Subject|16
1092711|NCT02273050|2162098|FG000|Overall Study|Lost to Follow-up|0
1092712|NCT02273050|2162099|FG001|Overall Study|Lost to Follow-up|2
1092713|NCT02273050|2162100|FG002|Overall Study|Lost to Follow-up|3
1092714|NCT02273050|2162098|FG000|Overall Study|Protocol Violation|3
1092715|NCT02273050|2162099|FG001|Overall Study|Protocol Violation|1
1092716|NCT02273050|2162100|FG002|Overall Study|Protocol Violation|4
1092717|NCT02273141|2162132|FG000|Overall Study|Adverse Event|0
1092718|NCT02273141|2162133|FG001|Overall Study|Adverse Event|1
1092719|NCT02273141|2162132|FG000|Overall Study|Lost to Follow-up|1
1092720|NCT02273141|2162133|FG001|Overall Study|Lost to Follow-up|3
1092721|NCT02273141|2162132|FG000|Overall Study|Withdrawal by Subject|10
1092722|NCT02273141|2162133|FG001|Overall Study|Withdrawal by Subject|15
1092723|NCT02273141|2162132|FG000|Overall Study|Various|6
1092724|NCT02273141|2162133|FG001|Overall Study|Various|6
1092725|NCT02273167|2162142|FG000|Overall Study|Adverse Event|1
1092726|NCT02273167|2162143|FG001|Overall Study|Adverse Event|0
1092727|NCT02273167|2162144|FG002|Overall Study|Adverse Event|0
1092728|NCT02273167|2162142|FG000|Overall Study|Protocol Violation|3
1092729|NCT02273167|2162143|FG001|Overall Study|Protocol Violation|1
1092730|NCT02273167|2162144|FG002|Overall Study|Protocol Violation|1
1092731|NCT02273167|2162142|FG000|Overall Study|Lost to Follow-up|0
1092732|NCT02273167|2162143|FG001|Overall Study|Lost to Follow-up|1
1092733|NCT02273167|2162144|FG002|Overall Study|Lost to Follow-up|1
1092734|NCT02273167|2162142|FG000|Overall Study|Withdrawal by Subject|10
1092735|NCT02273167|2162143|FG001|Overall Study|Withdrawal by Subject|12
1092736|NCT02273167|2162144|FG002|Overall Study|Withdrawal by Subject|11
1092737|NCT02273167|2162142|FG000|Overall Study|Various|10
1092738|NCT02273167|2162143|FG001|Overall Study|Various|9
1092739|NCT02273167|2162144|FG002|Overall Study|Various|8
1092740|NCT02273180|2162155|FG000|Overall Study|Adverse Event|2
1092741|NCT02273180|2162156|FG001|Overall Study|Adverse Event|2
1092742|NCT02273180|2162155|FG000|Overall Study|Lack of Efficacy|1
1092743|NCT02273180|2162156|FG001|Overall Study|Lack of Efficacy|0
1092744|NCT02273180|2162155|FG000|Overall Study|Protocol Violation|1
1092745|NCT02273180|2162156|FG001|Overall Study|Protocol Violation|7
1092746|NCT02273180|2162155|FG000|Overall Study|Randomized but not treated|1
1092747|NCT02273180|2162156|FG001|Overall Study|Randomized but not treated|0
1092748|NCT02273180|2162155|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1
1092749|NCT02273180|2162156|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0
1092750|NCT02273180|2162155|FG000|Overall Study|Other than specified above|21
1092751|NCT02273180|2162156|FG001|Overall Study|Other than specified above|10
1092752|NCT02273596|2162188|FG000|24-Week Treatment Period|Adverse Event|3
1092753|NCT02273596|2162188|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1
1092754|NCT02273596|2162188|FG000|24-Week Treatment Period|Participant was unable to Come|1
1092755|NCT02273596|2162188|FG000|24-Week Treatment Period|Physician Decision|1
1092756|NCT02273596|2162188|FG000|24-Week Treatment Period|Protocol Deviation|1
1092757|NCT02273596|2162188|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19
1092758|NCT02273596|2162188|FG000|Extension Period|Participant Withdrew for Personal Reasons|1
1092759|NCT02273596|2162188|FG000|Extension Period|Lost to Follow-up|1
1092760|NCT02273596|2162188|FG000|Extension Period|Protocol Deviation|1
1092761|NCT02273726|2162200|FG000|Overall Study|Death|70
1092762|NCT02273726|2162201|FG001|Overall Study|Death|62
1092763|NCT02273726|2162200|FG000|Overall Study|Withdrawal by Subject|41
1092764|NCT02273726|2162201|FG001|Overall Study|Withdrawal by Subject|29
1092765|NCT02273726|2162200|FG000|Overall Study|Kidney transplant|31
1092766|NCT02273726|2162201|FG001|Overall Study|Kidney transplant|39
1092767|NCT02273726|2162200|FG000|Overall Study|Physician Decision|30
1092768|NCT02273726|2162201|FG001|Overall Study|Physician Decision|15
1092769|NCT02273726|2162200|FG000|Overall Study|Adverse Event|27
1092770|NCT02273726|2162201|FG001|Overall Study|Adverse Event|9
1092771|NCT02273726|2162200|FG000|Overall Study|Lost to Follow-up|6
1092772|NCT02273726|2162201|FG001|Overall Study|Lost to Follow-up|3
1092773|NCT02273726|2162200|FG000|Overall Study|Lack of Efficacy|6
1092774|NCT02273726|2162201|FG001|Overall Study|Lack of Efficacy|1
1092775|NCT02273726|2162200|FG000|Overall Study|Protocol Violation|4
1092776|NCT02273726|2162201|FG001|Overall Study|Protocol Violation|0
1092777|NCT02273726|2162200|FG000|Overall Study|Other than specified|28
1092778|NCT02273726|2162201|FG001|Overall Study|Other than specified|30
1092779|NCT02273739|2162211|FG000|Overall Study|Progression of Disease|3
1092780|NCT02273739|2162212|FG001|Overall Study|Progression of Disease|4
1092781|NCT02273739|2162213|FG002|Overall Study|Progression of Disease|5
1092782|NCT02273739|2162214|FG003|Overall Study|Progression of Disease|2
1092783|NCT02273739|2162211|FG000|Overall Study|Death|0
1092784|NCT02273739|2162212|FG001|Overall Study|Death|0
1092785|NCT02273739|2162213|FG002|Overall Study|Death|0
1092786|NCT02273739|2162214|FG003|Overall Study|Death|2
1092787|NCT02273739|2162211|FG000|Overall Study|Adverse Event|0
1092788|NCT02273739|2162212|FG001|Overall Study|Adverse Event|0
1092789|NCT02273739|2162213|FG002|Overall Study|Adverse Event|0
1092790|NCT02273739|2162214|FG003|Overall Study|Adverse Event|1
1092791|NCT02273739|2162211|FG000|Overall Study|Withdrawal by Subject|0
1092792|NCT02273739|2162212|FG001|Overall Study|Withdrawal by Subject|0
1092793|NCT02273739|2162213|FG002|Overall Study|Withdrawal by Subject|2
1092794|NCT02273739|2162214|FG003|Overall Study|Withdrawal by Subject|1
1092795|NCT02273739|2162211|FG000|Overall Study|Physician Decision|0
1092796|NCT02273739|2162212|FG001|Overall Study|Physician Decision|0
1092797|NCT02273739|2162213|FG002|Overall Study|Physician Decision|0
1092798|NCT02273739|2162214|FG003|Overall Study|Physician Decision|1
1092799|NCT02273908|2162231|FG000|Overall Study|Adverse Event|16
1092800|NCT02273908|2162232|FG001|Overall Study|Adverse Event|0
1092801|NCT02273908|2162231|FG000|Overall Study|Lost to Follow-up|10
1092802|NCT02273908|2162232|FG001|Overall Study|Lost to Follow-up|1
1092803|NCT02273908|2162231|FG000|Overall Study|Did not meet entrance criteria|3
1092804|NCT02273908|2162232|FG001|Overall Study|Did not meet entrance criteria|2
1092805|NCT02273908|2162231|FG000|Overall Study|Withdrawal by Subject|4
1092806|NCT02273908|2162232|FG001|Overall Study|Withdrawal by Subject|2
1092807|NCT02273960|2162246|FG000|Short Term Period|Lost to Follow-up|1
1092808|NCT02273960|2162247|FG001|Short Term Period|Lost to Follow-up|0
1092809|NCT02273960|2162248|FG002|Short Term Period|Lost to Follow-up|0
1092810|NCT02273960|2162249|FG003|Short Term Period|Lost to Follow-up|0
1092811|NCT02273960|2162246|FG000|Short Term Period|Lack of Efficacy|0
1092812|NCT02273960|2162247|FG001|Short Term Period|Lack of Efficacy|0
1092813|NCT02273960|2162248|FG002|Short Term Period|Lack of Efficacy|0
1092814|NCT02273960|2162249|FG003|Short Term Period|Lack of Efficacy|1
1092815|NCT02273960|2162246|FG000|Short Term Period|ST complete, not entering LTE|4
1092816|NCT02273960|2162247|FG001|Short Term Period|ST complete, not entering LTE|6
1092817|NCT02273960|2162248|FG002|Short Term Period|ST complete, not entering LTE|4
1092818|NCT02273960|2162249|FG003|Short Term Period|ST complete, not entering LTE|5
1092819|NCT02273960|2162246|FG000|Long Term Extension|Death|0
1092820|NCT02273960|2162247|FG001|Long Term Extension|Death|0
1092821|NCT02273960|2162248|FG002|Long Term Extension|Death|0
1092822|NCT02273960|2162249|FG003|Long Term Extension|Death|1
1092823|NCT02273973|2162261|FG000|Overall Study|Adverse Event|4
1092824|NCT02273973|2162262|FG001|Overall Study|Adverse Event|0
1092825|NCT02273973|2162261|FG000|Overall Study|Withdrawal by Subject|2
1092826|NCT02273973|2162262|FG001|Overall Study|Withdrawal by Subject|3
1092827|NCT02273973|2162261|FG000|Overall Study|Death|1
1092828|NCT02273973|2162262|FG001|Overall Study|Death|0
1092829|NCT02273973|2162261|FG000|Overall Study|Non-compliance|1
1092830|NCT02273973|2162262|FG001|Overall Study|Non-compliance|0
1092831|NCT02273973|2162261|FG000|Overall Study|Protocol Violation|1
1092832|NCT02273973|2162262|FG001|Overall Study|Protocol Violation|0
1092833|NCT02273973|2162261|FG000|Overall Study|Progression of disease|0
1092834|NCT02273973|2162262|FG001|Overall Study|Progression of disease|2
1092835|NCT02273973|2162261|FG000|Overall Study|Lost to Follow-up|0
1092836|NCT02273973|2162262|FG001|Overall Study|Lost to Follow-up|1
1092837|NCT02273973|2162261|FG000|Overall Study|Physician Decision|0
1092838|NCT02273973|2162262|FG001|Overall Study|Physician Decision|1
1092839|NCT02273973|2162261|FG000|Overall Study|Reason not specified|0
1092840|NCT02273973|2162262|FG001|Overall Study|Reason not specified|1
1092841|NCT02274038|2162268|FG000|Overall Study|Death|1
1092842|NCT02274311|2162274|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
1092843|NCT02274493|2162280|FG000|Overall Study|Withdrawal by Subject|1
1092844|NCT02274558|2162287|FG000|Overall Study|Adverse Event|2
1092845|NCT02274558|2162288|FG001|Overall Study|Adverse Event|4
1092846|NCT02274558|2162289|FG002|Overall Study|Adverse Event|2
1092847|NCT02274558|2162287|FG000|Overall Study|Non-compliance|2
1092848|NCT02274558|2162288|FG001|Overall Study|Non-compliance|1
1092849|NCT02274558|2162289|FG002|Overall Study|Non-compliance|0
1092850|NCT02274558|2162287|FG000|Overall Study|Withdrawal by Subject|1
1092851|NCT02274558|2162288|FG001|Overall Study|Withdrawal by Subject|5
1092852|NCT02274558|2162289|FG002|Overall Study|Withdrawal by Subject|4
1092853|NCT02274558|2162287|FG000|Overall Study|Death|0
1092854|NCT02274558|2162288|FG001|Overall Study|Death|0
1092855|NCT02274558|2162289|FG002|Overall Study|Death|1
1092856|NCT02274558|2162287|FG000|Overall Study|Lost to Follow-up|2
1092857|NCT02274558|2162288|FG001|Overall Study|Lost to Follow-up|1
1092858|NCT02274558|2162289|FG002|Overall Study|Lost to Follow-up|1
1092859|NCT02274558|2162287|FG000|Overall Study|Physician Decision|0
1092860|NCT02274558|2162288|FG001|Overall Study|Physician Decision|2
1092861|NCT02274558|2162289|FG002|Overall Study|Physician Decision|1
1092862|NCT02274766|2162324|FG000|Overall Study|Withdrawal by Subject|3
1092863|NCT02274766|2162325|FG001|Overall Study|Withdrawal by Subject|6
1092864|NCT02274766|2162324|FG000|Overall Study|Did Not Receive Study Drug|1
1092865|NCT02274766|2162325|FG001|Overall Study|Did Not Receive Study Drug|1
1092866|NCT02274766|2162324|FG000|Overall Study|Subject Unwilling to Proceed|0
1092867|NCT02274766|2162325|FG001|Overall Study|Subject Unwilling to Proceed|1
1092868|NCT02274766|2162324|FG000|Overall Study|Adverse Event|0
1092869|NCT02274766|2162325|FG001|Overall Study|Adverse Event|1
1092870|NCT02274792|2162331|FG000|Overall Study|Withdrawal by Subject|13
1092871|NCT02274792|2162331|FG000|Overall Study|Lost to Follow-up|8
1092872|NCT02274792|2162331|FG000|Overall Study|Protocol Specified Criteria|2
1092873|NCT02274792|2162331|FG000|Overall Study|Sponsor Decision|2
1092874|NCT02274857|2162346|FG000|Overall Study|Adverse Event|1
1092875|NCT02274857|2162347|FG001|Overall Study|Adverse Event|0
1092876|NCT02274857|2162346|FG000|Overall Study|Death|1
1092877|NCT02274857|2162347|FG001|Overall Study|Death|2
1092878|NCT02274857|2162346|FG000|Overall Study|Lost to Follow-up|3
1092879|NCT02274857|2162347|FG001|Overall Study|Lost to Follow-up|0
1092880|NCT02274857|2162346|FG000|Overall Study|Physician Decision|2
1092881|NCT02274857|2162347|FG001|Overall Study|Physician Decision|0
1092882|NCT02274857|2162346|FG000|Overall Study|Trial screen failure|0
1092883|NCT02274857|2162347|FG001|Overall Study|Trial screen failure|2
1092884|NCT02274857|2162346|FG000|Overall Study|Withdrawal by Subject|11
1092885|NCT02274857|2162347|FG001|Overall Study|Withdrawal by Subject|2
1092886|NCT02274857|2162346|FG000|Overall Study|Other|2
1092887|NCT02274857|2162347|FG001|Overall Study|Other|0
1092888|NCT02274948|2162368|FG000|Overall Study|Lost to Follow-up|28
1092889|NCT02274948|2162369|FG001|Overall Study|Lost to Follow-up|25
1092890|NCT02274948|2162368|FG000|Overall Study|Withdrawal by Subject|64
1092891|NCT02274948|2162369|FG001|Overall Study|Withdrawal by Subject|58
1092892|NCT02274948|2162368|FG000|Overall Study|Stopped on family Practitioner advice|2
1092893|NCT02274948|2162369|FG001|Overall Study|Stopped on family Practitioner advice|5
1092894|NCT02274948|2162368|FG000|Overall Study|Left the area|4
1092895|NCT02274948|2162369|FG001|Overall Study|Left the area|3
1092896|NCT02275026|2162376|FG000|Overall Study|Ineligible after cognitive baseline testing|11
1092897|NCT02275026|2162376|FG000|Overall Study|Withdrawal by Subject|4
1092898|NCT02275026|2162376|FG000|Overall Study|Ineligible due to medical history|13
1092899|NCT02275026|2162376|FG000|Overall Study|MRI malfunction precluded testing|1
1092900|NCT02275026|2162376|FG000|Overall Study|Ineligible after MRI findings|1
1092901|NCT02275026|2162376|FG000|Overall Study|Lost to Follow-up|2
1092902|NCT02275026|2162376|FG000|Overall Study|Scanner failure|1
1092903|NCT02275052|2162383|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1092904|NCT02275052|2162384|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1092905|NCT02275052|2162385|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1092906|NCT02275052|2162386|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1092907|NCT02275052|2162383|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1092908|NCT02275052|2162384|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
1092909|NCT02275052|2162385|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1092910|NCT02275052|2162386|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1092911|NCT02275052|2162383|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
1092912|NCT02275052|2162384|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
1092913|NCT02275052|2162385|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1092914|NCT02275052|2162386|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1092915|NCT02275052|2162383|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
1092916|NCT02275052|2162384|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1092917|NCT02275052|2162385|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1092918|NCT02275052|2162386|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1092919|NCT02275052|2162383|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
1092920|NCT02275052|2162384|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1092921|NCT02275052|2162385|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1092922|NCT02275052|2162386|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1092923|NCT02275052|2162383|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3
1092924|NCT02275052|2162384|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0
1092925|NCT02275052|2162385|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0
1092926|NCT02275052|2162386|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0
1092927|NCT02275052|2162383|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1
1092928|NCT02275052|2162384|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0
1092929|NCT02275052|2162385|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0
1092930|NCT02275052|2162386|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0
1092931|NCT02275052|2162383|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
1092932|NCT02275052|2162384|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
1092933|NCT02275052|2162385|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
1092934|NCT02275052|2162386|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
1092935|NCT02275052|2162383|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1092936|NCT02275052|2162384|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1092937|NCT02275052|2162385|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1092938|NCT02275052|2162386|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
1092939|NCT02275052|2162383|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
1092940|NCT02275052|2162384|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
1092941|NCT02275052|2162385|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1092942|NCT02275052|2162386|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
1092943|NCT02275052|2162383|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1092944|NCT02275052|2162384|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1092945|NCT02275052|2162385|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1092946|NCT02275052|2162386|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
1092947|NCT02275065|2162397|FG000|Overall Study|Randomized but not treated|1
1092948|NCT02275065|2162398|FG001|Overall Study|Randomized but not treated|0
1092949|NCT02275065|2162399|FG002|Overall Study|Randomized but not treated|1
1092950|NCT02275065|2162400|FG003|Overall Study|Randomized but not treated|1
1092951|NCT02275065|2162401|FG004|Overall Study|Randomized but not treated|0
1092952|NCT02275117|2162418|FG000|Overall Study|Adverse Event|0
1092953|NCT02275117|2162419|FG001|Overall Study|Adverse Event|0
1092954|NCT02275117|2162420|FG002|Overall Study|Adverse Event|0
1092955|NCT02275117|2162421|FG003|Overall Study|Adverse Event|0
1092956|NCT02275117|2162422|FG004|Overall Study|Adverse Event|1
1092957|NCT02275117|2162418|FG000|Overall Study|Lack of Efficacy|6
1092958|NCT02275117|2162419|FG001|Overall Study|Lack of Efficacy|7
1092959|NCT02275117|2162420|FG002|Overall Study|Lack of Efficacy|5
1092960|NCT02275117|2162421|FG003|Overall Study|Lack of Efficacy|2
1092961|NCT02275117|2162422|FG004|Overall Study|Lack of Efficacy|10
1092962|NCT02275117|2162418|FG000|Overall Study|Lost to Follow-up|11
1092963|NCT02275117|2162419|FG001|Overall Study|Lost to Follow-up|16
1092964|NCT02275117|2162420|FG002|Overall Study|Lost to Follow-up|15
1092965|NCT02275117|2162421|FG003|Overall Study|Lost to Follow-up|16
1092966|NCT02275117|2162422|FG004|Overall Study|Lost to Follow-up|8
1092967|NCT02275117|2162418|FG000|Overall Study|Physician Decision|0
1092968|NCT02275117|2162419|FG001|Overall Study|Physician Decision|1
1092969|NCT02275117|2162420|FG002|Overall Study|Physician Decision|1
1092970|NCT02275117|2162421|FG003|Overall Study|Physician Decision|0
1092971|NCT02275117|2162422|FG004|Overall Study|Physician Decision|1
1092972|NCT02275117|2162418|FG000|Overall Study|Protocol Violation|1
1092973|NCT02275117|2162419|FG001|Overall Study|Protocol Violation|0
1092974|NCT02275117|2162420|FG002|Overall Study|Protocol Violation|1
1092975|NCT02275117|2162421|FG003|Overall Study|Protocol Violation|1
1092976|NCT02275117|2162422|FG004|Overall Study|Protocol Violation|0
1092977|NCT02275117|2162418|FG000|Overall Study|Withdrawal by Subject|6
1092978|NCT02275117|2162419|FG001|Overall Study|Withdrawal by Subject|4
1092979|NCT02275117|2162420|FG002|Overall Study|Withdrawal by Subject|7
1092980|NCT02275117|2162421|FG003|Overall Study|Withdrawal by Subject|3
1092981|NCT02275117|2162422|FG004|Overall Study|Withdrawal by Subject|3
1092982|NCT02275117|2162418|FG000|Overall Study|Terminated by Sponsor|4
1092983|NCT02275117|2162419|FG001|Overall Study|Terminated by Sponsor|4
1092984|NCT02275117|2162420|FG002|Overall Study|Terminated by Sponsor|4
1092985|NCT02275117|2162421|FG003|Overall Study|Terminated by Sponsor|6
1092986|NCT02275117|2162422|FG004|Overall Study|Terminated by Sponsor|4
1092987|NCT02275117|2162418|FG000|Overall Study|Worsening of Study Indication|0
1092988|NCT02275117|2162419|FG001|Overall Study|Worsening of Study Indication|1
1092989|NCT02275117|2162420|FG002|Overall Study|Worsening of Study Indication|2
1092990|NCT02275117|2162421|FG003|Overall Study|Worsening of Study Indication|0
1092991|NCT02275117|2162422|FG004|Overall Study|Worsening of Study Indication|0
1092992|NCT02275117|2162418|FG000|Overall Study|Study Burden|5
1092993|NCT02275117|2162419|FG001|Overall Study|Study Burden|4
1092994|NCT02275117|2162420|FG002|Overall Study|Study Burden|7
1092995|NCT02275117|2162421|FG003|Overall Study|Study Burden|5
1092996|NCT02275117|2162422|FG004|Overall Study|Study Burden|7
1092997|NCT02275117|2162418|FG000|Overall Study|Other|1
1092998|NCT02275117|2162419|FG001|Overall Study|Other|0
1092999|NCT02275117|2162420|FG002|Overall Study|Other|0
1093000|NCT02275117|2162421|FG003|Overall Study|Other|0
1093001|NCT02275117|2162422|FG004|Overall Study|Other|2
1093002|NCT02275338|2162448|FG000|Overall Study|Adverse Event|15
1093003|NCT02275338|2162448|FG000|Overall Study|Lack of Efficacy|3
1093004|NCT02275338|2162448|FG000|Overall Study|Withdrawal by Subject|4
1093005|NCT02275338|2162448|FG000|Overall Study|Disease progression (death)|1
1093006|NCT02275338|2162448|FG000|Overall Study|Ineligible to start Phase 2|4
1093007|NCT02275338|2162448|FG000|Overall Study|Reason not specified|5
1093008|NCT02275338|2162448|FG000|Overall Study|Does not meet entry criteria|1
1093009|NCT02275364|2162453|FG000|Period 1|Withdrawal by Subject|1
1093010|NCT02275364|2162454|FG001|Period 1|Withdrawal by Subject|0
1093011|NCT02275364|2162453|FG000|Period 1|Other reason|1
1093012|NCT02275364|2162454|FG001|Period 1|Other reason|0
1093013|NCT02275546|2162471|FG000|Treatment Period 2|Withdrawal by Subject|2
1093014|NCT02275546|2162472|FG001|Treatment Period 2|Withdrawal by Subject|1
1093015|NCT02275546|2162471|FG000|Treatment Period 2|Protocol Violation|0
1093016|NCT02275546|2162472|FG001|Treatment Period 2|Protocol Violation|1
1093017|NCT02275611|2162482|FG000|Inpatient Withdrawal|Withdrawal by Subject|1
1093018|NCT02275611|2162483|FG001|Inpatient Withdrawal|Withdrawal by Subject|0
1093019|NCT02275611|2162484|FG002|Inpatient Withdrawal|Withdrawal by Subject|0
1093020|NCT02275611|2162485|FG003|Inpatient Withdrawal|Withdrawal by Subject|0
1093021|NCT02275780|2162512|FG000|Base Study: 96 Weeks|Adverse Event|6
1093022|NCT02275780|2162513|FG001|Base Study: 96 Weeks|Adverse Event|14
1093023|NCT02275780|2162512|FG000|Base Study: 96 Weeks|Death|3
1093024|NCT02275780|2162513|FG001|Base Study: 96 Weeks|Death|1
1093025|NCT02275780|2162512|FG000|Base Study: 96 Weeks|Lack of Efficacy|21
1093026|NCT02275780|2162513|FG001|Base Study: 96 Weeks|Lack of Efficacy|32
1093027|NCT02275780|2162512|FG000|Base Study: 96 Weeks|Lost to Follow-up|28
1093028|NCT02275780|2162513|FG001|Base Study: 96 Weeks|Lost to Follow-up|24
1093029|NCT02275780|2162512|FG000|Base Study: 96 Weeks|Protocol Violation|1
1093030|NCT02275780|2162513|FG001|Base Study: 96 Weeks|Protocol Violation|6
1093031|NCT02275780|2162512|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19
1093032|NCT02275780|2162513|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22
1093033|NCT02275780|2162512|FG000|Base Study: 96 Weeks|Noncompliance with drug|9
1093034|NCT02275780|2162513|FG001|Base Study: 96 Weeks|Noncompliance with drug|6
1093035|NCT02275780|2162512|FG000|Base Study: 96 Weeks|Physician Decision|2
1093036|NCT02275780|2162513|FG001|Base Study: 96 Weeks|Physician Decision|4
1093037|NCT02275780|2162512|FG000|Base Study: 96 Weeks|Pregnancy|2
1093038|NCT02275780|2162513|FG001|Base Study: 96 Weeks|Pregnancy|1
1093039|NCT02275780|2162512|FG000|Base Study: 96 Weeks|Randomized not treated|2
1093040|NCT02275780|2162513|FG001|Base Study: 96 Weeks|Randomized not treated|1
1093041|NCT02275780|2162512|FG000|Extension Study: up to 192 Weeks|Ongoing|260
1093042|NCT02275780|2162513|FG001|Extension Study: up to 192 Weeks|Ongoing|233
1093043|NCT02275819|2162521|FG000|Overall Study|Adverse Event|0
1093044|NCT02275819|2162522|FG001|Overall Study|Adverse Event|1
1093045|NCT02276027|2162536|FG000|Overall Study|Death|1
1093046|NCT02276027|2162537|FG001|Overall Study|Death|0
1093047|NCT02276027|2162538|FG002|Overall Study|Death|0
1093048|NCT02276027|2162539|FG003|Overall Study|Death|2
1093049|NCT02276027|2162536|FG000|Overall Study|Physician Decision|0
1093050|NCT02276027|2162537|FG001|Overall Study|Physician Decision|0
1093051|NCT02276027|2162538|FG002|Overall Study|Physician Decision|0
1093052|NCT02276027|2162539|FG003|Overall Study|Physician Decision|1
1093053|NCT02276027|2162536|FG000|Overall Study|Progressive disease|1
1093054|NCT02276027|2162537|FG001|Overall Study|Progressive disease|13
1093055|NCT02276027|2162538|FG002|Overall Study|Progressive disease|12
1093056|NCT02276027|2162539|FG003|Overall Study|Progressive disease|14
1093057|NCT02276027|2162536|FG000|Overall Study|Subject/guardian decision|0
1093058|NCT02276027|2162537|FG001|Overall Study|Subject/guardian decision|1
1093059|NCT02276027|2162538|FG002|Overall Study|Subject/guardian decision|0
1093060|NCT02276027|2162539|FG003|Overall Study|Subject/guardian decision|3
1093061|NCT02276027|2162536|FG000|Overall Study|Adverse Event|0
1093062|NCT02276027|2162537|FG001|Overall Study|Adverse Event|2
1093063|NCT02276027|2162538|FG002|Overall Study|Adverse Event|8
1093064|NCT02276027|2162539|FG003|Overall Study|Adverse Event|2
1093065|NCT02276040|2162549|FG000|Overall Study|Physician Decision|15
1093066|NCT02276053|2162553|FG000|Overall Study|Death|2
1093067|NCT02276053|2162553|FG000|Overall Study|Adverse Event|5
1093068|NCT02276053|2162553|FG000|Overall Study|Lack of Efficacy|2
1093069|NCT02276053|2162553|FG000|Overall Study|Withdrawal by Subject|1
1093070|NCT02276053|2162553|FG000|Overall Study|Patient does not meet selection criteria|3
1093071|NCT02276053|2162553|FG000|Overall Study|Patient needs to increase baseline AED|1
1093072|NCT02276222|2162560|FG000|Overall Study|Adverse Event|62
1093073|NCT02276222|2162561|FG001|Overall Study|Adverse Event|11
1093074|NCT02276222|2162560|FG000|Overall Study|Death|3
1093075|NCT02276222|2162561|FG001|Overall Study|Death|4
1093076|NCT02276222|2162560|FG000|Overall Study|Lack of Efficacy|13
1093077|NCT02276222|2162561|FG001|Overall Study|Lack of Efficacy|3
1093078|NCT02276222|2162560|FG000|Overall Study|Protocol Violation|3
1093079|NCT02276222|2162561|FG001|Overall Study|Protocol Violation|2
1093080|NCT02276222|2162560|FG000|Overall Study|Withdrawal by Subject|79
1093081|NCT02276222|2162561|FG001|Overall Study|Withdrawal by Subject|33
1093082|NCT02276222|2162560|FG000|Overall Study|non compliance with study medication|6
1093083|NCT02276222|2162561|FG001|Overall Study|non compliance with study medication|2
1093084|NCT02276222|2162560|FG000|Overall Study|sponsor decision|0
1093085|NCT02276222|2162561|FG001|Overall Study|sponsor decision|3
1093086|NCT02276222|2162560|FG000|Overall Study|Lost to Follow-up|15
1093087|NCT02276222|2162561|FG001|Overall Study|Lost to Follow-up|5
1093088|NCT02276222|2162560|FG000|Overall Study|Physician Decision|2
1093089|NCT02276222|2162561|FG001|Overall Study|Physician Decision|1
1093090|NCT02276222|2162560|FG000|Overall Study|sheduling conflict|1
1093091|NCT02276222|2162561|FG001|Overall Study|sheduling conflict|0
1093092|NCT02276222|2162560|FG000|Overall Study|subject withdrew after randomization|1
1093093|NCT02276222|2162561|FG001|Overall Study|subject withdrew after randomization|0
1093094|NCT02276482|2162578|FG000|Overall Study|Adverse Event|1
1093095|NCT02276482|2162579|FG001|Overall Study|Adverse Event|0
1093096|NCT02276482|2162578|FG000|Overall Study|Withdrawal by Subject|1
1093097|NCT02276482|2162579|FG001|Overall Study|Withdrawal by Subject|0
1093098|NCT02276482|2162578|FG000|Overall Study|Gram-negative infection|1
1093099|NCT02276482|2162579|FG001|Overall Study|Gram-negative infection|0
1093100|NCT02276482|2162578|FG000|Overall Study|Reason not specified|0
1093101|NCT02276482|2162579|FG001|Overall Study|Reason not specified|1
1093104|NCT02276612|2162591|FG000|Overall Study|Death|1
1093105|NCT02276612|2162592|FG001|Overall Study|Death|0
1093106|NCT02276612|2162591|FG000|Overall Study|Pregnancy|1
1093107|NCT02276612|2162592|FG001|Overall Study|Pregnancy|0
1093108|NCT02276612|2162591|FG000|Overall Study|Withdrew Consent|1
1093109|NCT02276612|2162592|FG001|Overall Study|Withdrew Consent|0
1093110|NCT02276612|2162591|FG000|Overall Study|Lost to Follow-up|1
1093111|NCT02276612|2162592|FG001|Overall Study|Lost to Follow-up|0
1093112|NCT02276807|2162613|FG000|Overall Study|Withdrawal by Subject|8
1093113|NCT02276807|2162614|FG001|Overall Study|Withdrawal by Subject|7
1093114|NCT02276807|2162613|FG000|Overall Study|Lost to Follow-up|10
1093115|NCT02276807|2162614|FG001|Overall Study|Lost to Follow-up|10
1093116|NCT02276872|2162623|FG000|Overall Study|Adverse Event|1
1093117|NCT02276872|2162624|FG001|Overall Study|Adverse Event|0
1093118|NCT02276872|2162625|FG002|Overall Study|Adverse Event|0
1093130|NCT02277691|2162718|FG000|Overall Study|Pretreatment Event/Adverse Event|33
1093131|NCT02277691|2162718|FG000|Overall Study|Voluntary Withdrawal|7
1093132|NCT02277691|2162718|FG000|Overall Study|Lack of Efficacy|5
1093133|NCT02277691|2162718|FG000|Overall Study|Used Other Antihypertensive Drug|1
1093134|NCT02277743|2162725|FG000|Overall Study|Protocol Violation|1
1093135|NCT02277743|2162726|FG001|Overall Study|Protocol Violation|1
1093136|NCT02277743|2162727|FG002|Overall Study|Protocol Violation|1
1093137|NCT02277743|2162725|FG000|Overall Study|Adverse Event|10
1093138|NCT02277743|2162726|FG001|Overall Study|Adverse Event|6
1093139|NCT02277743|2162727|FG002|Overall Study|Adverse Event|6
1093140|NCT02277743|2162725|FG000|Overall Study|Lack of Efficacy|11
1093141|NCT02277743|2162726|FG001|Overall Study|Lack of Efficacy|4
1093142|NCT02277743|2162727|FG002|Overall Study|Lack of Efficacy|3
1093143|NCT02277743|2162725|FG000|Overall Study|Other than specified above|18
1093144|NCT02277743|2162726|FG001|Overall Study|Other than specified above|5
1093145|NCT02277743|2162727|FG002|Overall Study|Other than specified above|16
1093146|NCT02277769|2162738|FG000|Overall Study|Protocol Violation|3
1093147|NCT02277769|2162739|FG001|Overall Study|Protocol Violation|3
1093148|NCT02277769|2162740|FG002|Overall Study|Protocol Violation|5
1093149|NCT02277769|2162738|FG000|Overall Study|Lack of Efficacy|17
1093150|NCT02277769|2162739|FG001|Overall Study|Lack of Efficacy|0
1093151|NCT02277769|2162740|FG002|Overall Study|Lack of Efficacy|4
1093152|NCT02277769|2162738|FG000|Overall Study|Adverse Event|14
1093153|NCT02277769|2162739|FG001|Overall Study|Adverse Event|2
1093154|NCT02277769|2162740|FG002|Overall Study|Adverse Event|4
1093155|NCT02277769|2162738|FG000|Overall Study|Other than specified above|12
1093156|NCT02277769|2162739|FG001|Overall Study|Other than specified above|8
1093157|NCT02277769|2162740|FG002|Overall Study|Other than specified above|5
1093158|NCT02277990|2162761|FG000|Overall Study|Death|170
1093159|NCT02277990|2162762|FG001|Overall Study|Death|188
1093160|NCT02277990|2162761|FG000|Overall Study|Withdrawal by Subject|64
1093161|NCT02277990|2162762|FG001|Overall Study|Withdrawal by Subject|53
1093162|NCT02277990|2162761|FG000|Overall Study|Physician Decision|40
1093163|NCT02277990|2162762|FG001|Overall Study|Physician Decision|34
1093164|NCT02277990|2162761|FG000|Overall Study|Lost to Follow-up|66
1093165|NCT02277990|2162762|FG001|Overall Study|Lost to Follow-up|69
1093166|NCT02277990|2162761|FG000|Overall Study|Had other reason|26
1093167|NCT02277990|2162762|FG001|Overall Study|Had other reason|32
1093168|NCT02278003|2162770|FG000|Overall Study|Withdrawal by Subject|11
1093169|NCT02278003|2162771|FG001|Overall Study|Withdrawal by Subject|0
1093170|NCT02278003|2162770|FG000|Overall Study|Not Treated|1
1093171|NCT02278003|2162771|FG001|Overall Study|Not Treated|0
1093172|NCT02278003|2162770|FG000|Overall Study|Recognition task improperly completed|7
1093173|NCT02278003|2162771|FG001|Overall Study|Recognition task improperly completed|0
1093188|NCT02278263|2162802|FG000|Overall Study|Protocol Violation|7
1093189|NCT02278263|2162803|FG001|Overall Study|Protocol Violation|0
1093190|NCT02278263|2162804|FG002|Overall Study|Protocol Violation|9
1093191|NCT02278328|2162824|FG000|Neuropsych Screening|found ineligible on neuropsych|1
1093192|NCT02278328|2162825|FG001|Neuropsych Screening|found ineligible on neuropsych|0
1093193|NCT02278328|2162826|FG002|Neuropsych Screening|found ineligible on neuropsych|0
1093194|NCT02278328|2162824|FG000|Neuropsych Screening|Withdrawal by Subject|0
1093195|NCT02278328|2162825|FG001|Neuropsych Screening|Withdrawal by Subject|1
1093196|NCT02278328|2162826|FG002|Neuropsych Screening|Withdrawal by Subject|0
1093197|NCT02278328|2162824|FG000|Neuropsych Screening|incomplete consent|0
1093198|NCT02278328|2162825|FG001|Neuropsych Screening|incomplete consent|0
1093199|NCT02278328|2162826|FG002|Neuropsych Screening|incomplete consent|2
1093200|NCT02278341|2162834|FG000|Overall Study|Randomized but never received study drug|1
1093201|NCT02278341|2162835|FG001|Overall Study|Randomized but never received study drug|1
1093202|NCT02278341|2162834|FG000|Overall Study|Adverse Event|3
1093203|NCT02278341|2162835|FG001|Overall Study|Adverse Event|0
1093204|NCT02278341|2162834|FG000|Overall Study|Death|68
1093205|NCT02278341|2162835|FG001|Overall Study|Death|56
1093206|NCT02278341|2162834|FG000|Overall Study|Withdrawal by Subject|30
1093207|NCT02278341|2162835|FG001|Overall Study|Withdrawal by Subject|19
1093208|NCT02278341|2162834|FG000|Overall Study|Lost to Follow-up|0
1093209|NCT02278341|2162835|FG001|Overall Study|Lost to Follow-up|1
1093210|NCT02278341|2162834|FG000|Overall Study|Physician Decision|1
1093211|NCT02278341|2162835|FG001|Overall Study|Physician Decision|1
1093212|NCT02278341|2162834|FG000|Overall Study|Miscellaneous|15
1093213|NCT02278341|2162835|FG001|Overall Study|Miscellaneous|14
1093214|NCT02278354|2162844|FG000|Overall Study|Lost to Follow-up|2
1093215|NCT02278354|2162845|FG001|Overall Study|Lost to Follow-up|2
1093216|NCT02278354|2162844|FG000|Overall Study|Withdrawal by Subject|0
1093217|NCT02278354|2162845|FG001|Overall Study|Withdrawal by Subject|1
1093218|NCT02278354|2162844|FG000|Overall Study|<10 professional fights|2
1093219|NCT02278354|2162845|FG001|Overall Study|<10 professional fights|0
1093220|NCT02278367|2162855|FG000|Overall Study|Physician Decision|5
1093221|NCT02278367|2162856|FG001|Overall Study|Physician Decision|0
1093222|NCT02278367|2162855|FG000|Overall Study|Withdrawal by Subject|5
1093223|NCT02278367|2162856|FG001|Overall Study|Withdrawal by Subject|0
1093224|NCT02278471|2162864|FG000|Overall Study|Lost to Follow-up|6
1093225|NCT02278471|2162865|FG001|Overall Study|Lost to Follow-up|15
1093226|NCT02278471|2162864|FG000|Overall Study|Death|2
1093227|NCT02278471|2162865|FG001|Overall Study|Death|2
1093228|NCT02278471|2162864|FG000|Overall Study|Withdrawal by Subject|0
1093229|NCT02278471|2162865|FG001|Overall Study|Withdrawal by Subject|3
1093230|NCT02278614|2162892|FG000|Overall Study|Withdrawal by Subject|3
1093231|NCT02278614|2162893|FG001|Overall Study|Withdrawal by Subject|5
1093232|NCT02278614|2162892|FG000|Overall Study|Adverse Event|1
1093233|NCT02278614|2162893|FG001|Overall Study|Adverse Event|0
1093234|NCT02278614|2162892|FG000|Overall Study|left eye was not eligible|1
1093235|NCT02278614|2162893|FG001|Overall Study|left eye was not eligible|0
1093236|NCT02278939|2162909|FG000|Overall Study|lack of time|1
1093237|NCT02278939|2162910|FG001|Overall Study|lack of time|0
1093238|NCT02278939|2162909|FG000|Overall Study|Lost to Follow-up|1
1093239|NCT02278939|2162910|FG001|Overall Study|Lost to Follow-up|1
1093240|NCT02278939|2162909|FG000|Overall Study|death in family|1
1093241|NCT02278939|2162910|FG001|Overall Study|death in family|0
1093242|NCT02278939|2162909|FG000|Overall Study|family emergency unable to commit|2
1093243|NCT02278939|2162910|FG001|Overall Study|family emergency unable to commit|0
1093244|NCT02278952|2162916|FG000|Overall Study|Insufficient Sample|6
1093245|NCT02279043|2162929|FG000|Overall Study|Post-rand. exclusion - not eligible|1
1093246|NCT02279043|2162930|FG001|Overall Study|Post-rand. exclusion - not eligible|1
1093247|NCT02279043|2162931|FG002|Overall Study|Post-rand. exclusion - not eligible|0
1093248|NCT02279043|2162929|FG000|Overall Study|Lost to Follow-up|46
1093249|NCT02279043|2162930|FG001|Overall Study|Lost to Follow-up|88
1093250|NCT02279043|2162931|FG002|Overall Study|Lost to Follow-up|0
1093251|NCT02279173|2162959|FG000|Overall Study|Protocol-specified Criteria|67
1093252|NCT02279173|2162959|FG000|Overall Study|Withdrawal by Subject|20
1093253|NCT02279173|2162959|FG000|Overall Study|Decision by Sponsor|4
1093254|NCT02279173|2162959|FG000|Overall Study|Lost to Follow-up|3
1093255|NCT02279407|2162969|FG000|Overall Study|Couldn't swallow IP; noncompliance|0
1093256|NCT02279407|2162970|FG001|Overall Study|Couldn't swallow IP; noncompliance|0
1093257|NCT02279407|2162971|FG002|Overall Study|Couldn't swallow IP; noncompliance|2
1093258|NCT02279407|2162972|FG003|Overall Study|Couldn't swallow IP; noncompliance|0
1093259|NCT02279407|2162969|FG000|Overall Study|Withdrawal by Subject|1
1093260|NCT02279407|2162970|FG001|Overall Study|Withdrawal by Subject|0
1093261|NCT02279407|2162971|FG002|Overall Study|Withdrawal by Subject|1
1093262|NCT02279407|2162972|FG003|Overall Study|Withdrawal by Subject|1
1093263|NCT02279407|2162969|FG000|Overall Study|Adverse Event|1
1093264|NCT02279407|2162970|FG001|Overall Study|Adverse Event|1
1093265|NCT02279407|2162971|FG002|Overall Study|Adverse Event|2
1093266|NCT02279407|2162972|FG003|Overall Study|Adverse Event|0
1093267|NCT02279420|2162982|FG000|Overall Study|Lost to Follow-up|23
1093268|NCT02279498|2162988|FG000|Overall Study|Adverse Event|3
1093269|NCT02279498|2162989|FG001|Overall Study|Adverse Event|0
1093270|NCT02279498|2162988|FG000|Overall Study|Lack of Efficacy|4
1093271|NCT02279498|2162989|FG001|Overall Study|Lack of Efficacy|0
1093272|NCT02279498|2162988|FG000|Overall Study|Lost to Follow-up|0
1093273|NCT02279498|2162989|FG001|Overall Study|Lost to Follow-up|1
1093274|NCT02279498|2162988|FG000|Overall Study|Withdrawal by Subject|9
1093275|NCT02279498|2162989|FG001|Overall Study|Withdrawal by Subject|2
1093276|NCT02279498|2162988|FG000|Overall Study|Undefined|2
1093277|NCT02279498|2162989|FG001|Overall Study|Undefined|1
1093278|NCT02279524|2162999|FG000|Overall Study|Withdrawal by Subject|3
1093279|NCT02279524|2163000|FG001|Overall Study|Withdrawal by Subject|6
1093280|NCT02279524|2163001|FG002|Overall Study|Withdrawal by Subject|3
1093281|NCT02279524|2162999|FG000|Overall Study|Adverse Event|4
1093282|NCT02279524|2163000|FG001|Overall Study|Adverse Event|3
1093283|NCT02279524|2163001|FG002|Overall Study|Adverse Event|2
1093284|NCT02279524|2162999|FG000|Overall Study|Lost to Follow-up|1
1093285|NCT02279524|2163000|FG001|Overall Study|Lost to Follow-up|1
1093286|NCT02279524|2163001|FG002|Overall Study|Lost to Follow-up|0
1093287|NCT02279524|2162999|FG000|Overall Study|Disallowed medication|1
1093288|NCT02279524|2163000|FG001|Overall Study|Disallowed medication|1
1093289|NCT02279524|2163001|FG002|Overall Study|Disallowed medication|2
1093290|NCT02279524|2162999|FG000|Overall Study|Bariatric surgery|1
1093291|NCT02279524|2163000|FG001|Overall Study|Bariatric surgery|0
1093292|NCT02279524|2163001|FG002|Overall Study|Bariatric surgery|0
1093293|NCT02279719|2163049|FG000|Overall Study|Patients randomized but never treated|0
1093294|NCT02279719|2163050|FG001|Overall Study|Patients randomized but never treated|0
1093295|NCT02279719|2163051|FG002|Overall Study|Patients randomized but never treated|0
1093296|NCT02279719|2163052|FG003|Overall Study|Patients randomized but never treated|0
1093297|NCT02279719|2163053|FG004|Overall Study|Patients randomized but never treated|3
1093298|NCT02279719|2163054|FG005|Overall Study|Patients randomized but never treated|0
1093299|NCT02279719|2163055|FG006|Overall Study|Patients randomized but never treated|3
1093300|NCT02279732|2163090|FG000|Overall Study|Death|23
1093301|NCT02279732|2163091|FG001|Overall Study|Death|20
1093302|NCT02279732|2163090|FG000|Overall Study|Disease Progression|13
1093303|NCT02279732|2163091|FG001|Overall Study|Disease Progression|3
1093304|NCT02279732|2163090|FG000|Overall Study|Withdrawal by Subject|2
1093305|NCT02279732|2163091|FG001|Overall Study|Withdrawal by Subject|7
1093306|NCT02279732|2163090|FG000|Overall Study|Adverse Event|1
1093307|NCT02279732|2163091|FG001|Overall Study|Adverse Event|2
1093308|NCT02279732|2163090|FG000|Overall Study|Administrative Reason By Sponsor|0
1093309|NCT02279732|2163091|FG001|Overall Study|Administrative Reason By Sponsor|2
1093310|NCT02279732|2163090|FG000|Overall Study|Study Drug Toxicity|2
1093311|NCT02279732|2163091|FG001|Overall Study|Study Drug Toxicity|0
1093312|NCT02279732|2163090|FG000|Overall Study|Lost to Follow-up|0
1093313|NCT02279732|2163091|FG001|Overall Study|Lost to Follow-up|1
1093314|NCT02279732|2163090|FG000|Overall Study|Maximum Clinical Benefit|1
1093315|NCT02279732|2163091|FG001|Overall Study|Maximum Clinical Benefit|0
1093316|NCT02279732|2163090|FG000|Overall Study|Subject Requested to Discontinue|0
1093317|NCT02279732|2163091|FG001|Overall Study|Subject Requested to Discontinue|1
1093318|NCT02279732|2163090|FG000|Overall Study|Other|53
1093319|NCT02279732|2163091|FG001|Overall Study|Other|67
1093320|NCT02279732|2163090|FG000|Overall Study|Other|3
1093321|NCT02279732|2163091|FG001|Overall Study|Other|3
1093322|NCT02279862|2163099|FG000|Overall Study|Study drug toxicity|3
1093323|NCT02279862|2163100|FG001|Overall Study|Study drug toxicity|6
1093324|NCT02279862|2163099|FG000|Overall Study|No longer meets criteria|0
1093325|NCT02279862|2163100|FG001|Overall Study|No longer meets criteria|1
1093326|NCT02279862|2163099|FG000|Overall Study|Administrative reason by sponsor|0
1093327|NCT02279862|2163100|FG001|Overall Study|Administrative reason by sponsor|1
1093328|NCT02279862|2163099|FG000|Overall Study|Disease progression|5
1093329|NCT02279862|2163100|FG001|Overall Study|Disease progression|2
1093330|NCT02279862|2163099|FG000|Overall Study|Study closed by sponsor|16
1093331|NCT02279862|2163100|FG001|Overall Study|Study closed by sponsor|13
1093332|NCT02279862|2163099|FG000|Overall Study|Other|1
1093333|NCT02279862|2163100|FG001|Overall Study|Other|2
1093334|NCT02279862|2163099|FG000|Overall Study|Withdrawal by Subject|1
1093335|NCT02279862|2163100|FG001|Overall Study|Withdrawal by Subject|0
1093336|NCT02280044|2163108|FG000|Overall Study|Planned alternate|0
1093337|NCT02280044|2163109|FG001|Overall Study|Planned alternate|2
1093338|NCT02280096|2163117|FG000|Overall Study|Pregnancy|1
1093339|NCT02280096|2163118|FG001|Overall Study|Pregnancy|0
1093340|NCT02280096|2163117|FG000|Overall Study|Functional neurological disorder|1
1093341|NCT02280096|2163118|FG001|Overall Study|Functional neurological disorder|0
1093342|NCT02280096|2163117|FG000|Overall Study|Lack of attachment|0
1093343|NCT02280096|2163118|FG001|Overall Study|Lack of attachment|1
1093344|NCT02280187|2163143|FG000|Overall Study|Lost to Follow-up|218
1093345|NCT02280291|2163164|FG000|Overall Study|Lost to Follow-up|2
1093346|NCT02280291|2163165|FG001|Overall Study|Lost to Follow-up|1
1093347|NCT02280291|2163166|FG002|Overall Study|Lost to Follow-up|3
1093348|NCT02280291|2163167|FG003|Overall Study|Lost to Follow-up|8
1093349|NCT02280291|2163164|FG000|Overall Study|Protocol Violation|1
1093350|NCT02280291|2163165|FG001|Overall Study|Protocol Violation|0
1093351|NCT02280291|2163166|FG002|Overall Study|Protocol Violation|0
1093352|NCT02280291|2163167|FG003|Overall Study|Protocol Violation|0
1093353|NCT02280291|2163164|FG000|Overall Study|Other|1
1093354|NCT02280291|2163165|FG001|Overall Study|Other|1
1093355|NCT02280291|2163166|FG002|Overall Study|Other|0
1093356|NCT02280291|2163167|FG003|Overall Study|Other|0
1093357|NCT02280304|2163181|FG000|Overall Study|Lost to Follow-up|7
1093358|NCT02280304|2163182|FG001|Overall Study|Lost to Follow-up|8
1093359|NCT02280408|2163231|FG000|Overall Study|Lost to Follow-up|0
1093360|NCT02280408|2163232|FG001|Overall Study|Lost to Follow-up|2
1093361|NCT02280408|2163233|FG002|Overall Study|Lost to Follow-up|0
1093362|NCT02280408|2163234|FG003|Overall Study|Lost to Follow-up|0
1093363|NCT02280421|2163246|FG000|Washout (2 Weeks)|Adverse Event|0
1093364|NCT02280421|2163247|FG001|Washout (2 Weeks)|Adverse Event|1
1093365|NCT02280421|2163246|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
1093366|NCT02280421|2163247|FG001|Washout (2 Weeks)|Withdrawal by Subject|0
1093367|NCT02280473|2163267|FG000|Overall Study|Adverse Event|1
1093368|NCT02280473|2163268|FG001|Overall Study|Adverse Event|1
1093369|NCT02280473|2163267|FG000|Overall Study|Lack of Efficacy|0
1093370|NCT02280473|2163268|FG001|Overall Study|Lack of Efficacy|1
1093371|NCT02280473|2163267|FG000|Overall Study|Lost to Follow-up|0
1093372|NCT02280473|2163268|FG001|Overall Study|Lost to Follow-up|1
1093373|NCT02280499|2163274|FG000|Overall Study|Death|14
1093374|NCT02280499|2163274|FG000|Overall Study|Lost to Follow-up|42
1093375|NCT02280499|2163274|FG000|Overall Study|Adverse Event|5
1093376|NCT02280863|2163312|FG000|Integrated Platform|Met stopping criteria|0
1093377|NCT02280863|2163313|FG001|Integrated Platform|Met stopping criteria|1
1093394|NCT02281318|2163346|FG000|Overall Study|Adverse Event|2
1093395|NCT02281318|2163347|FG001|Overall Study|Adverse Event|2
1093396|NCT02281318|2163346|FG000|Overall Study|Lack of Efficacy|2
1093397|NCT02281318|2163347|FG001|Overall Study|Lack of Efficacy|0
1093398|NCT02281318|2163346|FG000|Overall Study|Lost to Follow-up|2
1093399|NCT02281318|2163347|FG001|Overall Study|Lost to Follow-up|1
1093400|NCT02281318|2163346|FG000|Overall Study|Physician Decision|2
1093401|NCT02281318|2163347|FG001|Overall Study|Physician Decision|0
1093402|NCT02281318|2163346|FG000|Overall Study|Withdrawal by Subject|6
1093403|NCT02281318|2163347|FG001|Overall Study|Withdrawal by Subject|2
1093404|NCT02281357|2163359|FG000|Overall Study|Adverse Event|2
1093405|NCT02281357|2163360|FG001|Overall Study|Adverse Event|1
1093406|NCT02281357|2163359|FG000|Overall Study|Lost to Follow-up|1
1093407|NCT02281357|2163360|FG001|Overall Study|Lost to Follow-up|0
1093408|NCT02281357|2163359|FG000|Overall Study|Withdrawal by Subject|4
1093409|NCT02281357|2163360|FG001|Overall Study|Withdrawal by Subject|3
1093410|NCT02281552|2163429|FG000|Overall Study|Medication error|1
1093411|NCT02281552|2163430|FG001|Overall Study|Medication error|0
1093412|NCT02281552|2163429|FG000|Overall Study|Insufficient clinical response|0
1093413|NCT02281552|2163430|FG001|Overall Study|Insufficient clinical response|1
1093414|NCT02281552|2163429|FG000|Overall Study|Adverse Event|3
1093415|NCT02281552|2163430|FG001|Overall Study|Adverse Event|9
1093416|NCT02281760|2163453|FG000|Overall Study|Withdrawal by Subject|1
1093417|NCT02281773|2163462|FG000|Overall Study|Adverse Event|6
1093418|NCT02281773|2163463|FG001|Overall Study|Adverse Event|1
1093419|NCT02281773|2163464|FG002|Overall Study|Adverse Event|4
1093420|NCT02281773|2163465|FG003|Overall Study|Adverse Event|8
1093421|NCT02281773|2163466|FG004|Overall Study|Adverse Event|9
1093422|NCT02281773|2163462|FG000|Overall Study|Protocol Violation|1
1093423|NCT02281773|2163463|FG001|Overall Study|Protocol Violation|0
1093424|NCT02281773|2163464|FG002|Overall Study|Protocol Violation|0
1093425|NCT02281773|2163465|FG003|Overall Study|Protocol Violation|2
1093426|NCT02281773|2163466|FG004|Overall Study|Protocol Violation|2
1093427|NCT02281773|2163462|FG000|Overall Study|Lost to Follow-up|2
1093428|NCT02281773|2163463|FG001|Overall Study|Lost to Follow-up|2
1093429|NCT02281773|2163464|FG002|Overall Study|Lost to Follow-up|6
1093430|NCT02281773|2163465|FG003|Overall Study|Lost to Follow-up|2
1093431|NCT02281773|2163466|FG004|Overall Study|Lost to Follow-up|10
1093432|NCT02281773|2163462|FG000|Overall Study|Withdrawal by Subject|2
1093433|NCT02281773|2163463|FG001|Overall Study|Withdrawal by Subject|8
1093434|NCT02281773|2163464|FG002|Overall Study|Withdrawal by Subject|6
1093435|NCT02281773|2163465|FG003|Overall Study|Withdrawal by Subject|6
1093436|NCT02281773|2163466|FG004|Overall Study|Withdrawal by Subject|8
1093437|NCT02281773|2163462|FG000|Overall Study|Other Reason|0
1093438|NCT02281773|2163463|FG001|Overall Study|Other Reason|4
1093439|NCT02281773|2163464|FG002|Overall Study|Other Reason|2
1093440|NCT02281773|2163465|FG003|Overall Study|Other Reason|3
1093441|NCT02281773|2163466|FG004|Overall Study|Other Reason|1
1093443|NCT02282163|2163500|FG000|Overall Study|Protocol Violation|1
1093444|NCT02282293|2163515|FG000|Overall Study|Lost to Follow-up|2
1093445|NCT02282293|2163516|FG001|Overall Study|Lost to Follow-up|2
1093446|NCT02282293|2163515|FG000|Overall Study|Unable to comply with study procedures|1
1093447|NCT02282293|2163516|FG001|Overall Study|Unable to comply with study procedures|0
1093448|NCT02282293|2163515|FG000|Overall Study|Moved out of study area|0
1093449|NCT02282293|2163516|FG001|Overall Study|Moved out of study area|1
1093450|NCT02282527|2163528|FG000|Overall Study|Lost to Follow-up|0
1093451|NCT02282527|2163529|FG001|Overall Study|Lost to Follow-up|1
1093452|NCT02282527|2163528|FG000|Overall Study|Lack of home health aid|1
1093453|NCT02282527|2163529|FG001|Overall Study|Lack of home health aid|0
1093454|NCT02282605|2163541|FG000|Overall Study|negative SA result on Day -1|3
1093455|NCT02282605|2163542|FG001|Overall Study|negative SA result on Day -1|0
1093456|NCT02282605|2163543|FG002|Overall Study|negative SA result on Day -1|0
1093457|NCT02282631|2163553|FG000|Overall Study|Lost to Follow-up|2
1093458|NCT02282631|2163554|FG001|Overall Study|Lost to Follow-up|0
1162158|NCT03384745|2284283|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
1162159|NCT03384745|2284284|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1
1162160|NCT03384745|2284285|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
1162161|NCT03384745|2284280|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
1162162|NCT03384745|2284281|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
1162163|NCT03384745|2284282|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
1162164|NCT03384745|2284283|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
1162165|NCT03384745|2284284|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
1162166|NCT03384745|2284285|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
1162167|NCT03384745|2284280|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
1162168|NCT03384745|2284281|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
1162169|NCT03384745|2284282|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3
1162170|NCT03384745|2284283|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
1162171|NCT03384745|2284284|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
1162172|NCT03384745|2284285|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
1162173|NCT03384745|2284280|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
1162174|NCT03384745|2284281|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
1162175|NCT03384745|2284282|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
1162176|NCT03384745|2284283|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
1162177|NCT03384745|2284284|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
1162178|NCT03384745|2284285|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
1162179|NCT03384745|2284280|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
1162180|NCT03384745|2284281|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
1162181|NCT03384745|2284282|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
1162182|NCT03384745|2284283|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2
1162183|NCT03384745|2284284|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
1162184|NCT03384745|2284285|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
1162185|NCT03384745|2284280|FG000|Response Assess/Dose Hold (W24-W48)|Death|0
1162186|NCT03384745|2284281|FG001|Response Assess/Dose Hold (W24-W48)|Death|1
1162187|NCT03384745|2284282|FG002|Response Assess/Dose Hold (W24-W48)|Death|0
1162188|NCT03384745|2284283|FG003|Response Assess/Dose Hold (W24-W48)|Death|0
1162189|NCT03384745|2284284|FG004|Response Assess/Dose Hold (W24-W48)|Death|0
1162190|NCT03384745|2284285|FG005|Response Assess/Dose Hold (W24-W48)|Death|0
1162191|NCT03384940|2284308|FG000|Overall Study|Progressive disease|36
1162192|NCT03384940|2284309|FG001|Overall Study|Progressive disease|11
1162193|NCT03384940|2284310|FG002|Overall Study|Progressive disease|13
1162194|NCT03384940|2284308|FG000|Overall Study|Clinical progression|4
1162195|NCT03384940|2284309|FG001|Overall Study|Clinical progression|0
1162196|NCT03384940|2284310|FG002|Overall Study|Clinical progression|3
1162197|NCT03384940|2284308|FG000|Overall Study|Adverse Event|7
1162198|NCT03384940|2284309|FG001|Overall Study|Adverse Event|1
1162199|NCT03384940|2284310|FG002|Overall Study|Adverse Event|1
1162200|NCT03384940|2284308|FG000|Overall Study|Withdrawal by Subject|3
1162201|NCT03384940|2284309|FG001|Overall Study|Withdrawal by Subject|1
1162202|NCT03384940|2284310|FG002|Overall Study|Withdrawal by Subject|0
1162203|NCT03384940|2284308|FG000|Overall Study|Physician Decision|1
1162204|NCT03384940|2284309|FG001|Overall Study|Physician Decision|1
1162205|NCT03384940|2284310|FG002|Overall Study|Physician Decision|0
1162206|NCT03384940|2284308|FG000|Overall Study|Death|2
1162207|NCT03384940|2284309|FG001|Overall Study|Death|1
1162208|NCT03384940|2284310|FG002|Overall Study|Death|0
1162209|NCT03384940|2284308|FG000|Overall Study|Other|0
1162210|NCT03384940|2284309|FG001|Overall Study|Other|0
1162211|NCT03384940|2284310|FG002|Overall Study|Other|1
1162212|NCT03384966|2284330|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1
1162213|NCT03384966|2284331|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0
1162214|NCT03384966|2284332|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0
1162215|NCT03384966|2284330|FG000|Follow-up Period|Adverse Event|1
1162216|NCT03384966|2284331|FG001|Follow-up Period|Adverse Event|0
1162217|NCT03384966|2284332|FG002|Follow-up Period|Adverse Event|0
1162218|NCT03386032|2284352|FG000|Overall Study|Lack of Efficacy|6
1162219|NCT03386032|2284353|FG001|Overall Study|Lack of Efficacy|2
1162220|NCT03386032|2284354|FG002|Overall Study|Lack of Efficacy|0
1162221|NCT03386032|2284352|FG000|Overall Study|Adverse Event|2
1162222|NCT03386032|2284353|FG001|Overall Study|Adverse Event|2
1162223|NCT03386032|2284354|FG002|Overall Study|Adverse Event|0
1162224|NCT03386032|2284352|FG000|Overall Study|Withdrawal by Subject|1
1162225|NCT03386032|2284353|FG001|Overall Study|Withdrawal by Subject|0
1162226|NCT03386032|2284354|FG002|Overall Study|Withdrawal by Subject|0
1162227|NCT03386032|2284352|FG000|Overall Study|Lost to Follow-up|9
1162228|NCT03386032|2284353|FG001|Overall Study|Lost to Follow-up|3
1162229|NCT03386032|2284354|FG002|Overall Study|Lost to Follow-up|0
1162230|NCT03386344|2284374|FG000|Overall Study|Adverse Event|6
1162231|NCT03386344|2284375|FG001|Overall Study|Adverse Event|3
1162232|NCT03386344|2284376|FG002|Overall Study|Adverse Event|1
1162233|NCT03386344|2284374|FG000|Overall Study|Poor Compliance to Protocol|0
1162234|NCT03386344|2284375|FG001|Overall Study|Poor Compliance to Protocol|1
1162235|NCT03386344|2284376|FG002|Overall Study|Poor Compliance to Protocol|0
1162236|NCT03386344|2284374|FG000|Overall Study|Study Terminated by Sponsor|101
1162237|NCT03386344|2284375|FG001|Overall Study|Study Terminated by Sponsor|102
1162238|NCT03386344|2284376|FG002|Overall Study|Study Terminated by Sponsor|106
1162239|NCT03386344|2284374|FG000|Overall Study|Lost to Follow-up|3
1162240|NCT03386344|2284375|FG001|Overall Study|Lost to Follow-up|2
1162241|NCT03386344|2284376|FG002|Overall Study|Lost to Follow-up|1
1162242|NCT03386344|2284374|FG000|Overall Study|At the Participant's own Request|7
1162243|NCT03386344|2284375|FG001|Overall Study|At the Participant's own Request|7
1162244|NCT03386344|2284376|FG002|Overall Study|At the Participant's own Request|8
1162245|NCT03386344|2284374|FG000|Overall Study|Reason not Specified|0
1162246|NCT03386344|2284375|FG001|Overall Study|Reason not Specified|1
1162247|NCT03386344|2284376|FG002|Overall Study|Reason not Specified|0
1162248|NCT03386435|2284386|FG000|Overall Study|Protocol Violation|5
1162249|NCT03386435|2284387|FG001|Overall Study|Protocol Violation|7
1162250|NCT03386448|2284395|FG000|Overall Study|Adverse Event|0
1162251|NCT03386448|2284396|FG001|Overall Study|Adverse Event|2
1162252|NCT03386474|2284404|FG000|Overall Study|Death|1
1162253|NCT03386474|2284405|FG001|Overall Study|Death|0
1162254|NCT03386474|2284404|FG000|Overall Study|Adverse Event|0
1162255|NCT03386474|2284405|FG001|Overall Study|Adverse Event|1
1162256|NCT03386994|2284419|FG000|Overall Study|Lung transplant|1
1162257|NCT03386994|2284419|FG000|Overall Study|Adverse Event|14
1162258|NCT03386994|2284419|FG000|Overall Study|Lost to Follow-up|4
1162259|NCT03386994|2284419|FG000|Overall Study|Withdrawal by Subject|3
1162260|NCT03386994|2284419|FG000|Overall Study|Death|16
1162261|NCT03387020|2284437|FG000|Overall Study|Adverse Event|0
1162262|NCT03387020|2284438|FG001|Overall Study|Adverse Event|2
1162263|NCT03387020|2284439|FG002|Overall Study|Adverse Event|0
1162264|NCT03387020|2284437|FG000|Overall Study|Withdrawal by Subject|2
1162265|NCT03387020|2284438|FG001|Overall Study|Withdrawal by Subject|0
1162266|NCT03387020|2284439|FG002|Overall Study|Withdrawal by Subject|0
1162267|NCT03387046|2284463|FG000|Overall Study|Adverse Event|1
1162268|NCT03387046|2284464|FG001|Overall Study|Adverse Event|1
1162269|NCT03387462|2284484|FG000|Overall Study|Lost to Follow-up|1
1162270|NCT03387683|2284490|FG000|Overall Study|In receipt of disallowed medication|1
1162271|NCT03387683|2284491|FG001|Overall Study|In receipt of disallowed medication|0
1162272|NCT03387683|2284490|FG000|Overall Study|Did not receive treatment|1
1162273|NCT03387683|2284491|FG001|Overall Study|Did not receive treatment|0
1162274|NCT03388164|2284508|FG000|Overall Study|Withdrawal by Subject|3
1162275|NCT03388164|2284509|FG001|Overall Study|Withdrawal by Subject|1
1162276|NCT03389308|2284542|FG000|Overall Study|Withdrawal by Subject|5
1162277|NCT03389308|2284542|FG000|Overall Study|Lost to Follow-up|3
1162278|NCT03389308|2284542|FG000|Overall Study|Adverse Event|2
1162279|NCT03389308|2284542|FG000|Overall Study|Sponsor Request|2
1162280|NCT03389555|2284548|FG000|Overall Study|Protocol Violation|1
1162281|NCT03389555|2284549|FG001|Overall Study|Protocol Violation|3
1162282|NCT03389555|2284548|FG000|Overall Study|Death|1
1162283|NCT03389555|2284549|FG001|Overall Study|Death|0
1162284|NCT03389893|2284578|FG000|Randomized Double Blind Period|Withdrawal by Subject|1
1162285|NCT03389893|2284579|FG001|Randomized Double Blind Period|Withdrawal by Subject|0
1162286|NCT03389893|2284580|FG002|Randomized Double Blind Period|Withdrawal by Subject|0
1162287|NCT03389893|2284581|FG003|Randomized Double Blind Period|Withdrawal by Subject|0
1162288|NCT03389893|2284578|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0
1162289|NCT03389893|2284579|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0
1162290|NCT03389893|2284580|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2
1162291|NCT03389893|2284581|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1
1162292|NCT03389893|2284578|FG000|Open Label Extension and Follow-Up|Physician Decision|0
1162293|NCT03389893|2284579|FG001|Open Label Extension and Follow-Up|Physician Decision|0
1162294|NCT03389893|2284580|FG002|Open Label Extension and Follow-Up|Physician Decision|1
1162295|NCT03389893|2284581|FG003|Open Label Extension and Follow-Up|Physician Decision|0
1162296|NCT03389893|2284578|FG000|Open Label Extension and Follow-Up|Participant Moved|0
1162297|NCT03389893|2284579|FG001|Open Label Extension and Follow-Up|Participant Moved|0
1162298|NCT03389893|2284580|FG002|Open Label Extension and Follow-Up|Participant Moved|1
1162299|NCT03389893|2284581|FG003|Open Label Extension and Follow-Up|Participant Moved|0
1162300|NCT03390101|2284590|FG000|Weeks 0-12|Withdrawal by Subject|0
1162301|NCT03390101|2284591|FG001|Weeks 0-12|Withdrawal by Subject|1
1162302|NCT03390101|2284592|FG002|Weeks 0-12|Withdrawal by Subject|1
1162303|NCT03390101|2284590|FG000|Weeks 0-12|Lost to Follow-up|0
1162304|NCT03390101|2284591|FG001|Weeks 0-12|Lost to Follow-up|1
1162305|NCT03390101|2284592|FG002|Weeks 0-12|Lost to Follow-up|0
1162306|NCT03390101|2284590|FG000|Weeks 12-54|Withdrawal by Subject|0
1162307|NCT03390101|2284591|FG001|Weeks 12-54|Withdrawal by Subject|3
1162308|NCT03390101|2284592|FG002|Weeks 12-54|Withdrawal by Subject|1
1162309|NCT03390101|2284590|FG000|Weeks 12-54|Pregnancy|1
1162310|NCT03390101|2284591|FG001|Weeks 12-54|Pregnancy|0
1162311|NCT03390101|2284592|FG002|Weeks 12-54|Pregnancy|0
1162312|NCT03390101|2284590|FG000|Weeks 12-54|Adverse Event|2
1162313|NCT03390101|2284591|FG001|Weeks 12-54|Adverse Event|1
1162314|NCT03390101|2284592|FG002|Weeks 12-54|Adverse Event|1
1162315|NCT03390166|2284611|FG000|Overall Study|Death|0
1162316|NCT03390166|2284612|FG001|Overall Study|Death|1
1162317|NCT03390166|2284611|FG000|Overall Study|Lost to Follow-up|6
1162318|NCT03390166|2284612|FG001|Overall Study|Lost to Follow-up|4
1162319|NCT03390166|2284611|FG000|Overall Study|Physician Decision|2
1162320|NCT03390166|2284612|FG001|Overall Study|Physician Decision|1
1162321|NCT03390166|2284611|FG000|Overall Study|Move from study area|3
1162322|NCT03390166|2284612|FG001|Overall Study|Move from study area|2
1162323|NCT03390166|2284611|FG000|Overall Study|To militarycamp for conscript|1
1162324|NCT03390166|2284612|FG001|Overall Study|To militarycamp for conscript|0
1162325|NCT03390166|2284611|FG000|Overall Study|To drug therapy course|0
1162326|NCT03390166|2284612|FG001|Overall Study|To drug therapy course|1
1162327|NCT03390166|2284611|FG000|Overall Study|Move to work oversea|0
1162328|NCT03390166|2284612|FG001|Overall Study|Move to work oversea|1
1162329|NCT03390426|2284626|FG000|Overall Study|Protocol Violation|0
1162330|NCT03390426|2284627|FG001|Overall Study|Protocol Violation|1
1162331|NCT03391765|2284660|FG000|Overall Study|Adverse Event|2
1162332|NCT03391765|2284661|FG001|Overall Study|Adverse Event|0
1162333|NCT03391765|2284662|FG002|Overall Study|Adverse Event|0
1162334|NCT03391765|2284663|FG003|Overall Study|Adverse Event|2
1162335|NCT03391765|2284660|FG000|Overall Study|Withdrew consent|5
1162336|NCT03391765|2284661|FG001|Overall Study|Withdrew consent|7
1162337|NCT03391765|2284662|FG002|Overall Study|Withdrew consent|2
1162338|NCT03391765|2284663|FG003|Overall Study|Withdrew consent|5
1162339|NCT03391765|2284660|FG000|Overall Study|Other, not specified|44
1162340|NCT03391765|2284661|FG001|Overall Study|Other, not specified|38
1162341|NCT03391765|2284662|FG002|Overall Study|Other, not specified|21
1162342|NCT03391765|2284663|FG003|Overall Study|Other, not specified|16
1162343|NCT03392168|2284690|FG000|Period 2: Cohort 2|Lost to Follow-up|0
1162344|NCT03392168|2284691|FG001|Period 2: Cohort 2|Lost to Follow-up|1
1162345|NCT03392168|2284692|FG002|Period 2: Cohort 2|Lost to Follow-up|1
1162346|NCT03392168|2284693|FG003|Period 2: Cohort 2|Lost to Follow-up|1
1162347|NCT03392168|2284690|FG000|Period 2: Cohort 2|Other|0
1162348|NCT03392168|2284691|FG001|Period 2: Cohort 2|Other|1
1162349|NCT03392168|2284692|FG002|Period 2: Cohort 2|Other|0
1162350|NCT03392168|2284693|FG003|Period 2: Cohort 2|Other|0
1162351|NCT03392194|2284704|FG000|Overall Study|Withdrawal by Subject|1
1162352|NCT03392194|2284705|FG001|Overall Study|Withdrawal by Subject|2
1162353|NCT03392194|2284704|FG000|Overall Study|Conflicts with personal schedule|1
1162354|NCT03392194|2284705|FG001|Overall Study|Conflicts with personal schedule|0
1162355|NCT03393000|2284727|FG000|Overall Study|Death|11
1162356|NCT03393000|2284727|FG000|Overall Study|Withdrawal by Subject|2
1162357|NCT03393000|2284727|FG000|Overall Study|Physician Decision|1
1162358|NCT03393806|2284774|FG000|Overall Study|Physician Decision|1
1162359|NCT03393806|2284775|FG001|Overall Study|Physician Decision|0
1162360|NCT03394391|2284784|FG000|Overall Study|Lost to Follow-up|1
1162361|NCT03394391|2284785|FG001|Overall Study|Lost to Follow-up|2
1162362|NCT03394508|2284793|FG000|Overall Study|Protocol Violation|0
1162363|NCT03394508|2284794|FG001|Overall Study|Protocol Violation|3
1162364|NCT03394508|2284793|FG000|Overall Study|Lost to Follow-up|1
1162365|NCT03394508|2284794|FG001|Overall Study|Lost to Follow-up|0
1162366|NCT03394885|2284808|FG000|Overall Study|Adverse Event|4
1162367|NCT03394885|2284808|FG000|Overall Study|Lack of Efficacy|1
1162368|NCT03394885|2284808|FG000|Overall Study|Physician Decision|1
1162369|NCT03394885|2284808|FG000|Overall Study|Withdrawal by Subject|8
1162370|NCT03394885|2284808|FG000|Overall Study|Alternative Therapy|1
1162371|NCT03394924|2284815|FG000|Overall Study|Adverse Event|0
1162372|NCT03394924|2284816|FG001|Overall Study|Adverse Event|5
1162373|NCT03394924|2284817|FG002|Overall Study|Adverse Event|0
1162374|NCT03394924|2284815|FG000|Overall Study|Withdrawal by Subject|2
1162375|NCT03394924|2284816|FG001|Overall Study|Withdrawal by Subject|0
1162376|NCT03394924|2284817|FG002|Overall Study|Withdrawal by Subject|0
1162377|NCT03394924|2284815|FG000|Overall Study|Lost to Follow-up|0
1162378|NCT03394924|2284816|FG001|Overall Study|Lost to Follow-up|1
1162379|NCT03394924|2284817|FG002|Overall Study|Lost to Follow-up|0
1162380|NCT03394924|2284815|FG000|Overall Study|Did not meet all inclusion criteria|1
1162381|NCT03394924|2284816|FG001|Overall Study|Did not meet all inclusion criteria|0
1162382|NCT03394924|2284817|FG002|Overall Study|Did not meet all inclusion criteria|0
1162383|NCT03395353|2284827|FG000|Overall Study|Adverse Event|20
1162384|NCT03395353|2284827|FG000|Overall Study|Protocol Violation|1
1162385|NCT03395353|2284827|FG000|Overall Study|Lack of Efficacy|3
1162386|NCT03395353|2284827|FG000|Overall Study|Withdrawal by Subject|24
1162387|NCT03395353|2284827|FG000|Overall Study|Discontinued visit|1
1162388|NCT03395353|2284827|FG000|Overall Study|Refrain from visit due to COVID-19|1
1162389|NCT03395353|2284827|FG000|Overall Study|Physician Decision|4
1162390|NCT03395353|2284827|FG000|Overall Study|Early termination of overall study|33
1162391|NCT03396835|2284868|FG000|Overall Study|Withdrawn prior to completion|1
1162392|NCT03396835|2284868|FG000|Overall Study|Did not meet criteria for data analysis|1
1162393|NCT03396913|2284874|FG000|Overall Study|Lost to Follow-up|0
1162394|NCT03396913|2284875|FG001|Overall Study|Lost to Follow-up|6
1162395|NCT03397771|2284912|FG000|Overall Study|2 erroneously randomized, never treated|3
1162396|NCT03397771|2284913|FG001|Overall Study|2 erroneously randomized, never treated|1
1162397|NCT03397771|2284912|FG000|Overall Study|Withdrawal by Subject|1
1162398|NCT03397771|2284913|FG001|Overall Study|Withdrawal by Subject|3
1162399|NCT03397771|2284912|FG000|Overall Study|Protocol Violation|2
1162400|NCT03397771|2284913|FG001|Overall Study|Protocol Violation|2
1162401|NCT03397771|2284912|FG000|Overall Study|Adverse Event|2
1162402|NCT03397771|2284913|FG001|Overall Study|Adverse Event|1
1162403|NCT03398356|2284991|FG000|Before Treatment|Lost to Follow-up|1
1162404|NCT03398356|2284992|FG001|Before Treatment|Lost to Follow-up|2
1162405|NCT03398356|2284993|FG002|Before Treatment|Lost to Follow-up|0
1162406|NCT03398356|2284991|FG000|Before Treatment|drug intolerance|2
1162407|NCT03398356|2284992|FG001|Before Treatment|drug intolerance|1
1162408|NCT03398356|2284993|FG002|Before Treatment|drug intolerance|0
1162409|NCT03398356|2284991|FG000|Before Treatment|Withdrawal by Subject|0
1162410|NCT03398356|2284992|FG001|Before Treatment|Withdrawal by Subject|5
1162411|NCT03398356|2284993|FG002|Before Treatment|Withdrawal by Subject|0
1162412|NCT03398356|2284991|FG000|Before Treatment|Physician Decision|0
1162413|NCT03398356|2284992|FG001|Before Treatment|Physician Decision|0
1162414|NCT03398356|2284993|FG002|Before Treatment|Physician Decision|11
1162415|NCT03398356|2284991|FG000|After 6 Weeks of Treatment|Physician Decision|0
1162416|NCT03398356|2284992|FG001|After 6 Weeks of Treatment|Physician Decision|2
1162417|NCT03398356|2284993|FG002|After 6 Weeks of Treatment|Physician Decision|0
1162418|NCT03399786|2285048|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1
1162419|NCT03399786|2285049|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
1162420|NCT03399786|2285050|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
1162421|NCT03399786|2285051|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
1162422|NCT03399786|2285048|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
1162423|NCT03399786|2285049|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
1162424|NCT03399786|2285050|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1
1162425|NCT03399786|2285051|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
1162426|NCT03399786|2285048|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0
1162427|NCT03399786|2285049|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0
1162428|NCT03399786|2285050|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0
1162429|NCT03399786|2285051|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1
1162430|NCT03400033|2285061|FG000|Overall Study|Withdrawal by Subject|1
1162431|NCT03400033|2285062|FG001|Overall Study|Withdrawal by Subject|2
1162432|NCT03400787|2285117|FG000|Overall Study|Lost to Follow-up|1
1162433|NCT03400787|2285118|FG001|Overall Study|Lost to Follow-up|0
1162434|NCT03400787|2285117|FG000|Overall Study|Death|1
1162435|NCT03400787|2285118|FG001|Overall Study|Death|0
1162436|NCT03400787|2285117|FG000|Overall Study|Protocol Violation|0
1162437|NCT03400787|2285118|FG001|Overall Study|Protocol Violation|2
1162438|NCT03400787|2285117|FG000|Overall Study|Unblinded before 3-month follow-upa-|0
1162439|NCT03400787|2285118|FG001|Overall Study|Unblinded before 3-month follow-upa-|6
1162440|NCT03400852|2285135|FG000|Blinded Treatment Period|Physician Decision|0
1162441|NCT03400852|2285136|FG001|Blinded Treatment Period|Physician Decision|1
1162442|NCT03400852|2285137|FG002|Blinded Treatment Period|Physician Decision|0
1162443|NCT03400852|2285135|FG000|Blinded Treatment Period|Adverse Event|1
1162444|NCT03400852|2285136|FG001|Blinded Treatment Period|Adverse Event|1
1162445|NCT03400852|2285137|FG002|Blinded Treatment Period|Adverse Event|0
1162446|NCT03400852|2285135|FG000|Blinded Treatment Period|Study terminated by sponsor|8
1162447|NCT03400852|2285136|FG001|Blinded Treatment Period|Study terminated by sponsor|4
1162448|NCT03400852|2285137|FG002|Blinded Treatment Period|Study terminated by sponsor|0
1162449|NCT03400852|2285135|FG000|Open Label Period|Physician Decision|0
1162450|NCT03400852|2285136|FG001|Open Label Period|Physician Decision|0
1162451|NCT03400852|2285137|FG002|Open Label Period|Physician Decision|1
1162452|NCT03400852|2285135|FG000|Open Label Period|Study terminated by sponsor|0
1162453|NCT03400852|2285136|FG001|Open Label Period|Study terminated by sponsor|0
1162454|NCT03400852|2285137|FG002|Open Label Period|Study terminated by sponsor|21
1162515|NCT03400956|2285167|FG000|Treatment Period 1|Adverse Event|0
1162516|NCT03400956|2285168|FG001|Treatment Period 1|Adverse Event|1
1162517|NCT03400956|2285169|FG002|Treatment Period 1|Adverse Event|0
1162518|NCT03400956|2285167|FG000|Treatment Period 1|Lost to Follow-up|0
1162519|NCT03400956|2285168|FG001|Treatment Period 1|Lost to Follow-up|0
1162520|NCT03400956|2285169|FG002|Treatment Period 1|Lost to Follow-up|1
1162521|NCT03400956|2285167|FG000|Treatment Period 1|Protocol Violation|0
1162522|NCT03400956|2285168|FG001|Treatment Period 1|Protocol Violation|2
1162523|NCT03400956|2285169|FG002|Treatment Period 1|Protocol Violation|0
1162524|NCT03400956|2285167|FG000|Treatment Period 1|Study terminated by sponsor|3
1162525|NCT03400956|2285168|FG001|Treatment Period 1|Study terminated by sponsor|1
1162526|NCT03400956|2285169|FG002|Treatment Period 1|Study terminated by sponsor|1
1162527|NCT03400956|2285167|FG000|Treatment Period 1|Withdrawal by Subject|0
1162528|NCT03400956|2285168|FG001|Treatment Period 1|Withdrawal by Subject|2
1162529|NCT03400956|2285169|FG002|Treatment Period 1|Withdrawal by Subject|4
1162530|NCT03400956|2285167|FG000|Treatment Period 1|Other|1
1162531|NCT03400956|2285168|FG001|Treatment Period 1|Other|2
1162532|NCT03400956|2285169|FG002|Treatment Period 1|Other|3
1162533|NCT03400956|2285167|FG000|Post-treatment Period 1|Adverse Event|0
1162534|NCT03400956|2285168|FG001|Post-treatment Period 1|Adverse Event|0
1162535|NCT03400956|2285169|FG002|Post-treatment Period 1|Adverse Event|1
1162536|NCT03400956|2285167|FG000|Post-treatment Period 1|Physician Decision|2
1162537|NCT03400956|2285168|FG001|Post-treatment Period 1|Physician Decision|3
1162538|NCT03400956|2285169|FG002|Post-treatment Period 1|Physician Decision|0
1162539|NCT03400956|2285167|FG000|Post-treatment Period 1|Study terminated by sponsor|11
1162540|NCT03400956|2285168|FG001|Post-treatment Period 1|Study terminated by sponsor|10
1162541|NCT03400956|2285169|FG002|Post-treatment Period 1|Study terminated by sponsor|11
1162542|NCT03400956|2285167|FG000|Post-treatment Period 1|Withdrawal by Subject|5
1162543|NCT03400956|2285168|FG001|Post-treatment Period 1|Withdrawal by Subject|0
1162544|NCT03400956|2285169|FG002|Post-treatment Period 1|Withdrawal by Subject|0
1162545|NCT03400956|2285167|FG000|Post-treatment Period 1|Other|4
1162546|NCT03400956|2285168|FG001|Post-treatment Period 1|Other|3
1162547|NCT03400956|2285169|FG002|Post-treatment Period 1|Other|4
1162548|NCT03400956|2285167|FG000|Treatment Period 2|Adverse Event|2
1162549|NCT03400956|2285168|FG001|Treatment Period 2|Adverse Event|1
1162550|NCT03400956|2285169|FG002|Treatment Period 2|Adverse Event|1
1162551|NCT03400956|2285167|FG000|Treatment Period 2|Lost to Follow-up|1
1162552|NCT03400956|2285168|FG001|Treatment Period 2|Lost to Follow-up|1
1162553|NCT03400956|2285169|FG002|Treatment Period 2|Lost to Follow-up|0
1162554|NCT03400956|2285167|FG000|Treatment Period 2|Withdrawal by Subject|0
1162555|NCT03400956|2285168|FG001|Treatment Period 2|Withdrawal by Subject|0
1162556|NCT03400956|2285169|FG002|Treatment Period 2|Withdrawal by Subject|3
1162557|NCT03400956|2285167|FG000|Treatment Period 2|Other|1
1162558|NCT03400956|2285168|FG001|Treatment Period 2|Other|1
1162559|NCT03400956|2285169|FG002|Treatment Period 2|Other|0
1162560|NCT03400956|2285167|FG000|Follow-up Period|Withdrawal by Subject|0
1162561|NCT03400956|2285168|FG001|Follow-up Period|Withdrawal by Subject|0
1162562|NCT03400956|2285169|FG002|Follow-up Period|Withdrawal by Subject|1
1162563|NCT03400956|2285167|FG000|Follow-up Period|Other|0
1162564|NCT03400956|2285168|FG001|Follow-up Period|Other|0
1162565|NCT03400956|2285169|FG002|Follow-up Period|Other|1
1162566|NCT03401229|2285182|FG000|Overall Study|Lost to Follow-up|2
1162567|NCT03401229|2285183|FG001|Overall Study|Lost to Follow-up|1
1162568|NCT03401229|2285182|FG000|Overall Study|Other|1
1162569|NCT03401229|2285183|FG001|Overall Study|Other|3
1162570|NCT03401229|2285182|FG000|Overall Study|Adverse Event|8
1162571|NCT03401229|2285183|FG001|Overall Study|Adverse Event|6
1162572|NCT03401229|2285182|FG000|Overall Study|Withdrawal by Subject|29
1162573|NCT03401229|2285183|FG001|Overall Study|Withdrawal by Subject|26
1162574|NCT03401229|2285182|FG000|Overall Study|COVID-19|0
1162575|NCT03401229|2285183|FG001|Overall Study|COVID-19|1
1162576|NCT03401450|2285191|FG000|Overall Study|Lost to Follow-up|4
1162577|NCT03401450|2285192|FG001|Overall Study|Lost to Follow-up|6
1162578|NCT03401450|2285191|FG000|Overall Study|Anesthesia plan changed|2
1162579|NCT03401450|2285192|FG001|Overall Study|Anesthesia plan changed|2
1162580|NCT03401450|2285191|FG000|Overall Study|Did not complete medication diary|4
1162581|NCT03401450|2285192|FG001|Overall Study|Did not complete medication diary|2
1162582|NCT03401450|2285191|FG000|Overall Study|post surgery medication change|2
1162583|NCT03401450|2285192|FG001|Overall Study|post surgery medication change|1
1162584|NCT03401450|2285191|FG000|Overall Study|Cancelled surgery|0
1162585|NCT03401450|2285192|FG001|Overall Study|Cancelled surgery|2
1162586|NCT03402126|2285207|FG000|Overall Study|Lost to Follow-up|6
1162587|NCT03402126|2285207|FG000|Overall Study|Protocol Violation|10
1162588|NCT03402126|2285207|FG000|Overall Study|Sponsor request/Study termination|29
1162589|NCT03402126|2285207|FG000|Overall Study|Study product no longer in use|1
1162590|NCT03402126|2285207|FG000|Overall Study|Technical problems|1
1162591|NCT03402126|2285207|FG000|Overall Study|Withdrawal by Subject|6
1162592|NCT03402126|2285207|FG000|Overall Study|Physician Decision|2
1162593|NCT03402126|2285207|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3
1162594|NCT03402126|2285207|FG000|Overall Study|Death|4
1162595|NCT03402386|2285230|FG000|Overall Study|Adverse Event|3
1162596|NCT03402386|2285230|FG000|Overall Study|Physician Decision|1
1162597|NCT03402386|2285230|FG000|Overall Study|Difficult to control Hb|2
1162598|NCT03402750|2285249|FG000|Overall Study|Lost to Follow-up|2
1162599|NCT03402750|2285250|FG001|Overall Study|Lost to Follow-up|1
1162600|NCT03402893|2285256|FG000|Overall Study|Withdrawal by Subject|1
1162601|NCT03403036|2285282|FG000|Overall Study|Lack of Efficacy|5
1162602|NCT03403192|2285290|FG000|Overall Study|Lost to Follow-up|1
1162603|NCT03403192|2285291|FG001|Overall Study|Lost to Follow-up|2
1162604|NCT03403192|2285292|FG002|Overall Study|Lost to Follow-up|0
1162605|NCT03403192|2285293|FG003|Overall Study|Lost to Follow-up|0
1162606|NCT03403192|2285290|FG000|Overall Study|Unable to respond|0
1162607|NCT03403192|2285291|FG001|Overall Study|Unable to respond|1
1162608|NCT03403192|2285292|FG002|Overall Study|Unable to respond|0
1162609|NCT03403192|2285293|FG003|Overall Study|Unable to respond|0
1162610|NCT03403192|2285290|FG000|Overall Study|Incomplete|3
1162611|NCT03403192|2285291|FG001|Overall Study|Incomplete|1
1162612|NCT03403192|2285292|FG002|Overall Study|Incomplete|3
1162613|NCT03403192|2285293|FG003|Overall Study|Incomplete|6
1162614|NCT03403374|2285368|FG000|Overall Study|Lost to Follow-up|1
1162615|NCT03403400|2285375|FG000|Overall Study|Lost to Follow-up|1
1162616|NCT03403400|2285376|FG001|Overall Study|Lost to Follow-up|0
1162617|NCT03403400|2285377|FG002|Overall Study|Lost to Follow-up|1
1162618|NCT03403400|2285375|FG000|Overall Study|Hospitalization|1
1162619|NCT03403400|2285376|FG001|Overall Study|Hospitalization|0
1162620|NCT03403400|2285377|FG002|Overall Study|Hospitalization|0
1162621|NCT03403400|2285375|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0
1162622|NCT03403400|2285376|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0
1162623|NCT03403400|2285377|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1
1162624|NCT03403413|2285400|FG000|Overall Study|Lack of Efficacy|2
1162625|NCT03403426|2285406|FG000|Overall Study|Death|1
1162626|NCT03403426|2285406|FG000|Overall Study|Lost to Follow-up|2
1162627|NCT03403751|2285508|FG000|Overall Study|Death|5
1162628|NCT03403751|2285509|FG001|Overall Study|Death|6
1162629|NCT03403751|2285508|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2
1162630|NCT03403751|2285509|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2
1162631|NCT03404206|2285526|FG000|Overall Study|Withdrawal by Subject|1
1162632|NCT03404206|2285527|FG001|Overall Study|Withdrawal by Subject|1
1162633|NCT03404206|2285528|FG002|Overall Study|Withdrawal by Subject|0
1162634|NCT03404206|2285526|FG000|Overall Study|Lost to Follow-up|3
1162635|NCT03404206|2285527|FG001|Overall Study|Lost to Follow-up|1
1162636|NCT03404206|2285528|FG002|Overall Study|Lost to Follow-up|0
1162637|NCT03404674|2285573|FG000|Overall Study|Inability to Attend Future Visits|0
1162638|NCT03404674|2285574|FG001|Overall Study|Inability to Attend Future Visits|1
1162639|NCT03404674|2285575|FG002|Overall Study|Inability to Attend Future Visits|1
1162640|NCT03404674|2285576|FG003|Overall Study|Inability to Attend Future Visits|0
1162641|NCT03404674|2285577|FG004|Overall Study|Inability to Attend Future Visits|0
1162642|NCT03404674|2285578|FG005|Overall Study|Inability to Attend Future Visits|0
1162643|NCT03404674|2285573|FG000|Overall Study|Behavioral Problems|0
1162644|NCT03404674|2285574|FG001|Overall Study|Behavioral Problems|0
1162645|NCT03404674|2285575|FG002|Overall Study|Behavioral Problems|1
1162646|NCT03404674|2285576|FG003|Overall Study|Behavioral Problems|0
1162647|NCT03404674|2285577|FG004|Overall Study|Behavioral Problems|0
1162648|NCT03404674|2285578|FG005|Overall Study|Behavioral Problems|0
1162649|NCT03404674|2285573|FG000|Overall Study|Started a Medication that Precluded Eligibility|0
1162650|NCT03404674|2285574|FG001|Overall Study|Started a Medication that Precluded Eligibility|0
1162651|NCT03404674|2285575|FG002|Overall Study|Started a Medication that Precluded Eligibility|0
1162652|NCT03404674|2285576|FG003|Overall Study|Started a Medication that Precluded Eligibility|1
1162653|NCT03404674|2285577|FG004|Overall Study|Started a Medication that Precluded Eligibility|0
1162654|NCT03404674|2285578|FG005|Overall Study|Started a Medication that Precluded Eligibility|1
1162655|NCT03404843|2285595|FG000|Overall Study|Study difficulties unrelated to Tx|4
1162656|NCT03404843|2285596|FG001|Overall Study|Study difficulties unrelated to Tx|1
1162657|NCT03405818|2285647|FG000|Overall Study|Withdrawal by Subject|4
1162658|NCT03405818|2285647|FG000|Overall Study|Lost to Follow-up|4
1162659|NCT03405935|2285651|FG000|Overall Study|Adverse Event|3
1162660|NCT03405935|2285651|FG000|Overall Study|Death|2
1162661|NCT03405935|2285651|FG000|Overall Study|Withdrawal by Subject|1
1162662|NCT03405935|2285651|FG000|Overall Study|Lost to Follow-up|2
1162663|NCT03406260|2285661|FG000|Period 1|Adverse Event|0
1162664|NCT03406260|2285662|FG001|Period 1|Adverse Event|0
1162665|NCT03406260|2285663|FG002|Period 1|Adverse Event|0
1162666|NCT03406260|2285664|FG003|Period 1|Adverse Event|0
1162667|NCT03406260|2285665|FG004|Period 1|Adverse Event|1
1162668|NCT03406260|2285666|FG005|Period 1|Adverse Event|0
1162669|NCT03406962|2285732|FG000|Overall Study|Death|2
1162670|NCT03406962|2285732|FG000|Overall Study|Adverse Event|1
1162671|NCT03407118|2285746|FG000|Period 2|Withdrawal by Subject|1
1162672|NCT03407118|2285747|FG001|Period 2|Withdrawal by Subject|0
1162673|NCT03407170|2285753|FG000|Overall Study|Adverse Event|1
1162674|NCT03407430|2285763|FG000|Washout|Protocol Violation|1
1162675|NCT03407430|2285764|FG001|Washout|Protocol Violation|0
1162676|NCT03407482|2285777|FG000|Overall Study|Adverse Event|12
1162677|NCT03407482|2285777|FG000|Overall Study|Disease Relapse|1
1162678|NCT03407482|2285777|FG000|Overall Study|Lost to Follow-up|1
1162679|NCT03407482|2285777|FG000|Overall Study|Non-Compliance With Study Drug|1
1162680|NCT03407482|2285777|FG000|Overall Study|Pregnancy|2
1162681|NCT03407482|2285777|FG000|Overall Study|Protocol Violation|1
1162682|NCT03407482|2285777|FG000|Overall Study|Study Terminated By Sponsor|106
1162683|NCT03407482|2285777|FG000|Overall Study|Withdrawal by Subject|6
1162684|NCT03407482|2285777|FG000|Overall Study|Data Entry Error|1
1162685|NCT03408483|2285837|FG000|Overall Study|Physician Decision|3
1162686|NCT03408483|2285838|FG001|Overall Study|Physician Decision|3
1162687|NCT03408483|2285837|FG000|Overall Study|Lost to Follow-up|3
1162688|NCT03408483|2285838|FG001|Overall Study|Lost to Follow-up|0
1162689|NCT03408639|2285846|FG000|Overall Study|Death|5
1162690|NCT03408639|2285847|FG001|Overall Study|Death|5
1162691|NCT03408639|2285846|FG000|Overall Study|Lost to Follow-up|1
1162692|NCT03408639|2285847|FG001|Overall Study|Lost to Follow-up|4
1162693|NCT03408639|2285846|FG000|Overall Study|Withdrawal by Subject|2
1162694|NCT03408639|2285847|FG001|Overall Study|Withdrawal by Subject|7
1162695|NCT03408639|2285846|FG000|Overall Study|Physician Decision|3
1162696|NCT03408639|2285847|FG001|Overall Study|Physician Decision|6
1162697|NCT03409107|2285885|FG000|Overall Study|Withdrawal by Subject|4
1162698|NCT03409107|2285886|FG001|Overall Study|Withdrawal by Subject|2
1162699|NCT03409107|2285885|FG000|Overall Study|Physician Decision|1
1162700|NCT03409107|2285886|FG001|Overall Study|Physician Decision|0
1162701|NCT03409107|2285885|FG000|Overall Study|Lost to Follow-up|7
1162702|NCT03409107|2285886|FG001|Overall Study|Lost to Follow-up|2
1162703|NCT03409107|2285885|FG000|Overall Study|Adverse Event|5
1162704|NCT03409107|2285886|FG001|Overall Study|Adverse Event|3
1162705|NCT03409731|2285892|FG000|Overall Study|Withdrawal by Subject|1
1162706|NCT03409731|2285892|FG000|Overall Study|Death|2
1162707|NCT03409796|2285898|FG000|Overall Study|Adverse Event|2
1162708|NCT03409796|2285899|FG001|Overall Study|Adverse Event|0
1162709|NCT03409796|2285898|FG000|Overall Study|Other|0
1162710|NCT03409796|2285899|FG001|Overall Study|Other|1
1162711|NCT03411902|2285959|FG000|Overall Study|Lost to Follow-up|3
1162712|NCT03411902|2285960|FG001|Overall Study|Lost to Follow-up|0
1162713|NCT03412019|2285968|FG000|Overall Study|Withdrawal by Subject|1
1162714|NCT03412019|2285969|FG001|Overall Study|Withdrawal by Subject|1
1162715|NCT03412084|2285977|FG000|Overall Study|Withdrawal by Subject|2
1162716|NCT03412084|2285978|FG001|Overall Study|Withdrawal by Subject|0
1162717|NCT03412084|2285977|FG000|Overall Study|Participant moved|1
1162718|NCT03412084|2285978|FG001|Overall Study|Participant moved|0
1162719|NCT03412084|2285977|FG000|Overall Study|Lost to Follow-up|1
1162720|NCT03412084|2285978|FG001|Overall Study|Lost to Follow-up|1
1162721|NCT03412604|2285984|FG000|Overall Study|Withdrawal by Subject|1
1162722|NCT03412734|2285990|FG000|Overall Study|Incorrect labeling of samples|2
1162723|NCT03412734|2285991|FG001|Overall Study|Incorrect labeling of samples|0
1162724|NCT03412734|2285990|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1
1162725|NCT03412734|2285991|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0
1162726|NCT03412929|2285997|FG000|Overall Study|Protocol Violation|3
1162727|NCT03414047|2286014|FG000|Overall Study|Adverse Event|0
1162728|NCT03414047|2286015|FG001|Overall Study|Adverse Event|0
1162729|NCT03414047|2286016|FG002|Overall Study|Adverse Event|1
1162730|NCT03414047|2286017|FG003|Overall Study|Adverse Event|1
1162731|NCT03414047|2286014|FG000|Overall Study|Physician Decision|1
1162732|NCT03414047|2286015|FG001|Overall Study|Physician Decision|0
1162733|NCT03414047|2286016|FG002|Overall Study|Physician Decision|0
1162734|NCT03414047|2286017|FG003|Overall Study|Physician Decision|1
1162735|NCT03414047|2286014|FG000|Overall Study|Withdrawal by Subject|1
1162736|NCT03414047|2286015|FG001|Overall Study|Withdrawal by Subject|0
1162737|NCT03414047|2286016|FG002|Overall Study|Withdrawal by Subject|2
1162738|NCT03414047|2286017|FG003|Overall Study|Withdrawal by Subject|0
1162739|NCT03414359|2286030|FG000|Overall Study|Lack of Efficacy|1
1162740|NCT03414359|2286031|FG001|Overall Study|Lack of Efficacy|1
1162741|NCT03414359|2286030|FG000|Overall Study|Protocol Violation|0
1162742|NCT03414359|2286031|FG001|Overall Study|Protocol Violation|1
1162743|NCT03415022|2286039|FG000|Overall Study|Withdrawal by Subject|1
1162744|NCT03415022|2286040|FG001|Overall Study|Withdrawal by Subject|2
1162745|NCT03415022|2286039|FG000|Overall Study|COVID-19 Suspension|2
1162746|NCT03415022|2286040|FG001|Overall Study|COVID-19 Suspension|3
1162747|NCT03415022|2286039|FG000|Overall Study|Lost to Follow-up|2
1162748|NCT03415022|2286040|FG001|Overall Study|Lost to Follow-up|0
1162749|NCT03415178|2286055|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
1162750|NCT03415178|2286056|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
1162751|NCT03415178|2286055|FG000|Single Arm Period (up to Week 16)|Adverse Event|0
1162752|NCT03415178|2286056|FG001|Single Arm Period (up to Week 16)|Adverse Event|1
1162753|NCT03416127|2286089|FG000|Overall Study|Withdrawal by Subject|0
1162754|NCT03416127|2286090|FG001|Overall Study|Withdrawal by Subject|1
1162755|NCT03416127|2286091|FG002|Overall Study|Withdrawal by Subject|1
1162776|NCT03417024|2286157|FG000|Overall Study|Study Termination prior to follow-up|11
1162777|NCT03417024|2286157|FG000|Overall Study|Physician Decision|2
1162778|NCT03417141|2286161|FG000|Overall Study|Withdrawal by Subject|1
1162779|NCT03417141|2286161|FG000|Overall Study|Protocol Violation|3
1162780|NCT03417219|2286167|FG000|Overall Study|Lost to Follow-up|0
1162781|NCT03417219|2286168|FG001|Overall Study|Lost to Follow-up|3
1162782|NCT03417505|2286178|FG000|First Lens Type (30 Days)|Lost to Follow-up|1
1162783|NCT03417505|2286179|FG001|First Lens Type (30 Days)|Lost to Follow-up|1
1162784|NCT03418324|2286267|FG000|Overall Study|Death|0
1162785|NCT03418324|2286268|FG001|Overall Study|Death|1
1162786|NCT03418324|2286267|FG000|Overall Study|Physician Decision|1
1162787|NCT03418324|2286268|FG001|Overall Study|Physician Decision|1
1162788|NCT03418376|2286278|FG000|Overall Study|Musculoskeletal injury|1
1162789|NCT03418376|2286279|FG001|Overall Study|Musculoskeletal injury|2
1162790|NCT03418376|2286280|FG002|Overall Study|Musculoskeletal injury|1
1162791|NCT03418376|2286281|FG003|Overall Study|Musculoskeletal injury|0
1162792|NCT03418376|2286278|FG000|Overall Study|Personal reasons|0
1162793|NCT03418376|2286279|FG001|Overall Study|Personal reasons|2
1162794|NCT03418376|2286280|FG002|Overall Study|Personal reasons|2
1162795|NCT03418376|2286281|FG003|Overall Study|Personal reasons|1
1162796|NCT03418376|2286278|FG000|Overall Study|Exacerbation|0
1162797|NCT03418376|2286279|FG001|Overall Study|Exacerbation|1
1162798|NCT03418376|2286280|FG002|Overall Study|Exacerbation|0
1162799|NCT03418376|2286281|FG003|Overall Study|Exacerbation|0
1162800|NCT03418545|2286293|FG000|Overall Study|Withdrawal by Participant|2
1162801|NCT03418545|2286294|FG001|Overall Study|Withdrawal by Participant|4
1162802|NCT03418545|2286293|FG000|Overall Study|Lost to Follow-up|3
1162803|NCT03418545|2286294|FG001|Overall Study|Lost to Follow-up|5
1162804|NCT03418545|2286293|FG000|Overall Study|Reason Not Specified|0
1162805|NCT03418545|2286294|FG001|Overall Study|Reason Not Specified|1
1162806|NCT03418545|2286293|FG000|Overall Study|Missing Completion Status|0
1162807|NCT03418545|2286294|FG001|Overall Study|Missing Completion Status|1
1162808|NCT03418571|2286305|FG000|Overall Study|Consent withdrawn by legal guardian|1
1162809|NCT03418571|2286306|FG001|Overall Study|Consent withdrawn by legal guardian|0
1162810|NCT03419403|2286341|FG000|Overall Study|Withdrawal by Subject|5
1162811|NCT03419403|2286342|FG001|Overall Study|Withdrawal by Subject|2
1162812|NCT03419403|2286343|FG002|Overall Study|Withdrawal by Subject|5
1162813|NCT03419403|2286344|FG003|Overall Study|Withdrawal by Subject|1
1162814|NCT03419403|2286341|FG000|Overall Study|Progressive disease (per protocol)|0
1162815|NCT03419403|2286342|FG001|Overall Study|Progressive disease (per protocol)|2
1162816|NCT03419403|2286343|FG002|Overall Study|Progressive disease (per protocol)|2
1162817|NCT03419403|2286344|FG003|Overall Study|Progressive disease (per protocol)|0
1162818|NCT03419403|2286341|FG000|Overall Study|Other, not specified|6
1162819|NCT03419403|2286342|FG001|Overall Study|Other, not specified|4
1162820|NCT03419403|2286343|FG002|Overall Study|Other, not specified|5
1162821|NCT03419403|2286344|FG003|Overall Study|Other, not specified|1
1162822|NCT03419403|2286341|FG000|Overall Study|Left study due to COVID-19 restrictions|1
1162823|NCT03419403|2286342|FG001|Overall Study|Left study due to COVID-19 restrictions|1
1162824|NCT03419403|2286343|FG002|Overall Study|Left study due to COVID-19 restrictions|0
1162825|NCT03419403|2286344|FG003|Overall Study|Left study due to COVID-19 restrictions|0
1162826|NCT03419598|2286369|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2
1162827|NCT03419962|2286384|FG000|Overall Study|Change to other medication|1
1162828|NCT03419962|2286384|FG000|Overall Study|Refusal of continuing with trial drug|1
1162829|NCT03419962|2286384|FG000|Overall Study|Lost to Follow-up|3
1162830|NCT03419962|2286384|FG000|Overall Study|Difficulty in inhaling the doses|1
1162831|NCT03419962|2286384|FG000|Overall Study|Missing completion data|31
1162832|NCT03420300|2286388|FG000|Overall Study|Death|2
1162833|NCT03421379|2286431|FG000|Period 1|Withdrawal by Subject|0
1162834|NCT03421379|2286432|FG001|Period 1|Withdrawal by Subject|1
1162835|NCT03421379|2286431|FG000|Period 1|Physician Decision|1
1162836|NCT03421379|2286432|FG001|Period 1|Physician Decision|1
1162837|NCT03421379|2286431|FG000|Period 1|Did not receive treatment|1
1162838|NCT03421379|2286432|FG001|Period 1|Did not receive treatment|2
1162839|NCT03421431|2286441|FG000|Overall Study|Adverse Event|2
1162840|NCT03421431|2286442|FG001|Overall Study|Adverse Event|1
1162841|NCT03421431|2286443|FG002|Overall Study|Adverse Event|12
1162842|NCT03421431|2286441|FG000|Overall Study|Lost to Follow-up|1
1162843|NCT03421431|2286442|FG001|Overall Study|Lost to Follow-up|1
1162844|NCT03421431|2286443|FG002|Overall Study|Lost to Follow-up|1
1162845|NCT03421431|2286441|FG000|Overall Study|Withdrawal by Subject|3
1162846|NCT03421431|2286442|FG001|Overall Study|Withdrawal by Subject|2
1162847|NCT03421431|2286443|FG002|Overall Study|Withdrawal by Subject|1
1162848|NCT03421431|2286441|FG000|Overall Study|Protocol Violation|0
1162849|NCT03421431|2286442|FG001|Overall Study|Protocol Violation|1
1162850|NCT03421431|2286443|FG002|Overall Study|Protocol Violation|0
1162851|NCT03421431|2286441|FG000|Overall Study|Participant met Stopping Rules|0
1162852|NCT03421431|2286442|FG001|Overall Study|Participant met Stopping Rules|1
1162853|NCT03421431|2286443|FG002|Overall Study|Participant met Stopping Rules|0
1162854|NCT03421730|2286453|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1162855|NCT03421730|2286454|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
1162856|NCT03421730|2286455|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1162857|NCT03421730|2286456|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1162858|NCT03421730|2286457|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1162859|NCT03421730|2286458|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1162860|NCT03421730|2286459|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1162861|NCT03421730|2286460|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1162862|NCT03421730|2286461|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1162863|NCT03421730|2286462|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1162864|NCT03421730|2286463|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1162865|NCT03421730|2286464|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1162866|NCT03421730|2286453|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1162867|NCT03421730|2286454|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1162868|NCT03421730|2286455|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1162869|NCT03421730|2286456|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1162870|NCT03421730|2286457|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
1162871|NCT03421730|2286458|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1162872|NCT03421730|2286459|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1162873|NCT03421730|2286460|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1162874|NCT03421730|2286461|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1162875|NCT03421730|2286462|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1162876|NCT03421730|2286463|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1162877|NCT03421730|2286464|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1162878|NCT03422159|2286489|FG000|Overall Study|Exclusion due to terminal disease|2
1162879|NCT03422159|2286490|FG001|Overall Study|Exclusion due to terminal disease|1
1162880|NCT03422172|2286498|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1
1162881|NCT03422172|2286498|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1
1162882|NCT03422172|2286498|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3
1162883|NCT03422250|2286511|FG000|Intervention|Adverse Event|0
1162884|NCT03422250|2286512|FG001|Intervention|Adverse Event|1
1162885|NCT03422250|2286513|FG002|Intervention|Adverse Event|0
1162886|NCT03422250|2286514|FG003|Intervention|Adverse Event|1
1162887|NCT03422250|2286511|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1
1162888|NCT03422250|2286512|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
1162889|NCT03422250|2286513|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2
1162890|NCT03422250|2286514|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
1162891|NCT03422250|2286511|FG000|Follow-up|Withdrawal by Subject|0
1162892|NCT03422250|2286512|FG001|Follow-up|Withdrawal by Subject|0
1162893|NCT03422250|2286513|FG002|Follow-up|Withdrawal by Subject|0
1162894|NCT03422250|2286514|FG003|Follow-up|Withdrawal by Subject|1
1162895|NCT03422250|2286511|FG000|Follow-up|Adverse Event|0
1162896|NCT03422250|2286512|FG001|Follow-up|Adverse Event|0
1162897|NCT03422250|2286513|FG002|Follow-up|Adverse Event|0
1162898|NCT03422250|2286514|FG003|Follow-up|Adverse Event|1
1162899|NCT03423173|2286534|FG000|Overall Study|Randomized but not vaccinated|1
1162900|NCT03423173|2286535|FG001|Overall Study|Randomized but not vaccinated|0
1162901|NCT03423173|2286536|FG002|Overall Study|Randomized but not vaccinated|2
1162902|NCT03423173|2286537|FG003|Overall Study|Randomized but not vaccinated|1
1162903|NCT03423173|2286534|FG000|Overall Study|Adverse Event|1
1162904|NCT03423173|2286535|FG001|Overall Study|Adverse Event|1
1162905|NCT03423173|2286536|FG002|Overall Study|Adverse Event|1
1162906|NCT03423173|2286537|FG003|Overall Study|Adverse Event|1
1162907|NCT03423173|2286534|FG000|Overall Study|Lost to Follow-up|10
1162908|NCT03423173|2286535|FG001|Overall Study|Lost to Follow-up|19
1162909|NCT03423173|2286536|FG002|Overall Study|Lost to Follow-up|17
1162910|NCT03423173|2286537|FG003|Overall Study|Lost to Follow-up|22
1162911|NCT03423173|2286534|FG000|Overall Study|Withdrawal of consent|4
1162912|NCT03423173|2286535|FG001|Overall Study|Withdrawal of consent|10
1162913|NCT03423173|2286536|FG002|Overall Study|Withdrawal of consent|4
1162914|NCT03423173|2286537|FG003|Overall Study|Withdrawal of consent|5
1162915|NCT03423173|2286534|FG000|Overall Study|Death|1
1162916|NCT03423173|2286535|FG001|Overall Study|Death|0
1162917|NCT03423173|2286536|FG002|Overall Study|Death|0
1162918|NCT03423173|2286537|FG003|Overall Study|Death|0
1162919|NCT03423173|2286534|FG000|Overall Study|Reason not Specified|2
1162920|NCT03423173|2286535|FG001|Overall Study|Reason not Specified|5
1162921|NCT03423173|2286536|FG002|Overall Study|Reason not Specified|3
1162922|NCT03423173|2286537|FG003|Overall Study|Reason not Specified|1
1162923|NCT03423238|2286558|FG000|Overall Study|Lost to Follow-up|1
1162924|NCT03423238|2286559|FG001|Overall Study|Lost to Follow-up|0
1162925|NCT03423238|2286558|FG000|Overall Study|Withdrawal by Subject|1
1162926|NCT03423238|2286559|FG001|Overall Study|Withdrawal by Subject|0
1162927|NCT03424044|2286575|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
1162928|NCT03424044|2286576|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
1162929|NCT03424044|2286577|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
1162930|NCT03424044|2286578|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
1162931|NCT03424044|2286579|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
1162932|NCT03424044|2286580|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
1162933|NCT03424044|2286581|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
1162934|NCT03424044|2286582|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
1162935|NCT03424044|2286583|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
1162936|NCT03424044|2286575|FG000|First Intervention (76 Hours)|Adverse Event|0
1162937|NCT03424044|2286576|FG001|First Intervention (76 Hours)|Adverse Event|0
1162938|NCT03424044|2286577|FG002|First Intervention (76 Hours)|Adverse Event|0
1162939|NCT03424044|2286578|FG003|First Intervention (76 Hours)|Adverse Event|0
1162940|NCT03424044|2286579|FG004|First Intervention (76 Hours)|Adverse Event|1
1162941|NCT03424044|2286580|FG005|First Intervention (76 Hours)|Adverse Event|0
1162942|NCT03424044|2286581|FG006|First Intervention (76 Hours)|Adverse Event|0
1162943|NCT03424044|2286582|FG007|First Intervention (76 Hours)|Adverse Event|0
1162944|NCT03424044|2286583|FG008|First Intervention (76 Hours)|Adverse Event|0
1162945|NCT03424044|2286575|FG000|First Intervention (76 Hours)|device issues|0
1162946|NCT03424044|2286576|FG001|First Intervention (76 Hours)|device issues|0
1162947|NCT03424044|2286577|FG002|First Intervention (76 Hours)|device issues|0
1162948|NCT03424044|2286578|FG003|First Intervention (76 Hours)|device issues|0
1162949|NCT03424044|2286579|FG004|First Intervention (76 Hours)|device issues|0
1162950|NCT03424044|2286580|FG005|First Intervention (76 Hours)|device issues|0
1162951|NCT03424044|2286581|FG006|First Intervention (76 Hours)|device issues|1
1162952|NCT03424044|2286582|FG007|First Intervention (76 Hours)|device issues|1
1162953|NCT03424044|2286583|FG008|First Intervention (76 Hours)|device issues|1
1162954|NCT03424044|2286575|FG000|Third Intervention (76 Hours)|Adverse Event|1
1162955|NCT03424044|2286576|FG001|Third Intervention (76 Hours)|Adverse Event|0
1162956|NCT03424044|2286577|FG002|Third Intervention (76 Hours)|Adverse Event|0
1162957|NCT03424044|2286578|FG003|Third Intervention (76 Hours)|Adverse Event|0
1162958|NCT03424044|2286579|FG004|Third Intervention (76 Hours)|Adverse Event|0
1162959|NCT03424044|2286580|FG005|Third Intervention (76 Hours)|Adverse Event|0
1162960|NCT03424044|2286581|FG006|Third Intervention (76 Hours)|Adverse Event|1
1162961|NCT03424044|2286582|FG007|Third Intervention (76 Hours)|Adverse Event|0
1162962|NCT03424044|2286583|FG008|Third Intervention (76 Hours)|Adverse Event|0
1162963|NCT03424044|2286575|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0
1162964|NCT03424044|2286576|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0
1162965|NCT03424044|2286577|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0
1162966|NCT03424044|2286578|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1
1162967|NCT03424044|2286579|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0
1162968|NCT03424044|2286580|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0
1162969|NCT03424044|2286581|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0
1162970|NCT03424044|2286582|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0
1162971|NCT03424044|2286583|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0
1162972|NCT03424239|2286617|FG000|Overall Study|Withdrawal by Subject|2
1162973|NCT03424265|2286623|FG000|Overall Study|screening failure|1
1162974|NCT03424265|2286624|FG001|Overall Study|screening failure|0
1162975|NCT03424265|2286623|FG000|Overall Study|Withdrawal by Subject|0
1162976|NCT03424265|2286624|FG001|Overall Study|Withdrawal by Subject|2
1162977|NCT03425188|2286654|FG000|Overall Study|Withdrawal by Subject|1
1162978|NCT03425253|2286659|FG000|Overall Study|Adverse Event|2
1162979|NCT03425253|2286659|FG000|Overall Study|Lost to Follow-up|3
1162980|NCT03425253|2286659|FG000|Overall Study|Withdrew Consent|6
1162981|NCT03425253|2286659|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5
1162982|NCT03425396|2286669|FG000|Overall Study|Lost to Follow-up|2
1162983|NCT03425396|2286670|FG001|Overall Study|Lost to Follow-up|5
1162984|NCT03425396|2286671|FG002|Overall Study|Lost to Follow-up|2
1162985|NCT03425396|2286672|FG003|Overall Study|Lost to Follow-up|0
1162986|NCT03425396|2286673|FG004|Overall Study|Lost to Follow-up|0
1162987|NCT03425396|2286669|FG000|Overall Study|Withdrawal by Subject|0
1162988|NCT03425396|2286670|FG001|Overall Study|Withdrawal by Subject|1
1162989|NCT03425396|2286671|FG002|Overall Study|Withdrawal by Subject|0
1162990|NCT03425396|2286672|FG003|Overall Study|Withdrawal by Subject|1
1162991|NCT03425396|2286673|FG004|Overall Study|Withdrawal by Subject|0
1162992|NCT03425396|2286669|FG000|Overall Study|Other|0
1162993|NCT03425396|2286670|FG001|Overall Study|Other|1
1162994|NCT03425396|2286671|FG002|Overall Study|Other|1
1162995|NCT03425396|2286672|FG003|Overall Study|Other|0
1162996|NCT03425396|2286673|FG004|Overall Study|Other|1
1162997|NCT03426267|2286698|FG000|Overall Study|Physician Decision|1
1162998|NCT03426267|2286699|FG001|Overall Study|Physician Decision|4
1162999|NCT03426267|2286698|FG000|Overall Study|Lost to Follow-up|1
1163000|NCT03426267|2286699|FG001|Overall Study|Lost to Follow-up|0
1163001|NCT03426267|2286698|FG000|Overall Study|Withdrawal by Subject|4
1163002|NCT03426267|2286699|FG001|Overall Study|Withdrawal by Subject|10
1163003|NCT03426267|2286698|FG000|Overall Study|Protocol Violation|1
1163004|NCT03426267|2286699|FG001|Overall Study|Protocol Violation|3
1163005|NCT03426267|2286698|FG000|Overall Study|Adverse Event|9
1163006|NCT03426267|2286699|FG001|Overall Study|Adverse Event|27
1163007|NCT03426267|2286698|FG000|Overall Study|Prohibited Treatment Intake|2
1163008|NCT03426267|2286699|FG001|Overall Study|Prohibited Treatment Intake|3
1163009|NCT03426267|2286698|FG000|Overall Study|Lack of Efficacy|0
1163010|NCT03426267|2286699|FG001|Overall Study|Lack of Efficacy|25
1163011|NCT03426267|2286698|FG000|Overall Study|other|3
1163012|NCT03426267|2286699|FG001|Overall Study|other|0
1163013|NCT03426345|2286707|FG000|Overall Study|Adverse Event|4
1163014|NCT03426345|2286708|FG001|Overall Study|Adverse Event|4
1163015|NCT03426345|2286707|FG000|Overall Study|Lack of Efficacy|1
1163016|NCT03426345|2286708|FG001|Overall Study|Lack of Efficacy|0
1163017|NCT03426345|2286707|FG000|Overall Study|Withdrawal by Subject|5
1163018|NCT03426345|2286708|FG001|Overall Study|Withdrawal by Subject|6
1163019|NCT03426345|2286707|FG000|Overall Study|Lost to Follow-up|3
1163020|NCT03426345|2286708|FG001|Overall Study|Lost to Follow-up|1
1163021|NCT03426345|2286707|FG000|Overall Study|Protocol Deviation|3
1163022|NCT03426345|2286708|FG001|Overall Study|Protocol Deviation|4
1163023|NCT03426345|2286707|FG000|Overall Study|Reason Not Specified|1
1163024|NCT03426345|2286708|FG001|Overall Study|Reason Not Specified|2
1163025|NCT03426345|2286707|FG000|Overall Study|Missing Completion Status|1
1163026|NCT03426345|2286708|FG001|Overall Study|Missing Completion Status|0
1163027|NCT03426436|2286715|FG000|Overall Study|Incorrect lead placement|12
1163028|NCT03426436|2286715|FG000|Overall Study|Withdrawal by Subject|2
1163029|NCT03426436|2286715|FG000|Overall Study|Consent issue|1
1163030|NCT03426436|2286715|FG000|Overall Study|ECGs not saved|4
1163031|NCT03426631|2286725|FG000|Overall Study|Lost to Follow-up|0
1163032|NCT03426631|2286726|FG001|Overall Study|Lost to Follow-up|1
1163033|NCT03426787|2286732|FG000|Overall Study|Withdrawal by Subject|6
1163034|NCT03426787|2286732|FG000|Overall Study|Lost to Follow-up|7
1163035|NCT03426787|2286732|FG000|Overall Study|Unrelated to intervention death|1
1163036|NCT03427073|2286834|FG000|Overall Study|Disease Progression|1
1163037|NCT03427073|2286835|FG001|Overall Study|Disease Progression|1
1163038|NCT03427073|2286836|FG002|Overall Study|Disease Progression|1
1163039|NCT03427073|2286837|FG003|Overall Study|Disease Progression|3
1163040|NCT03427073|2286838|FG004|Overall Study|Disease Progression|3
1163041|NCT03427073|2286839|FG005|Overall Study|Disease Progression|4
1163042|NCT03427073|2286840|FG006|Overall Study|Disease Progression|2
1163043|NCT03427073|2286841|FG007|Overall Study|Disease Progression|3
1163044|NCT03427073|2286834|FG000|Overall Study|Physician Decision|0
1163045|NCT03427073|2286835|FG001|Overall Study|Physician Decision|0
1163046|NCT03427073|2286836|FG002|Overall Study|Physician Decision|0
1163047|NCT03427073|2286837|FG003|Overall Study|Physician Decision|0
1163048|NCT03427073|2286838|FG004|Overall Study|Physician Decision|0
1163049|NCT03427073|2286839|FG005|Overall Study|Physician Decision|0
1163050|NCT03427073|2286840|FG006|Overall Study|Physician Decision|1
1163051|NCT03427073|2286841|FG007|Overall Study|Physician Decision|1
1163052|NCT03427268|2286868|FG000|Overall Study|Progressive disease|25
1163053|NCT03427268|2286868|FG000|Overall Study|Never treated|2
1163054|NCT03427268|2286868|FG000|Overall Study|Compassionate use|1
1163055|NCT03427268|2286868|FG000|Overall Study|Withdrawal by Subject|1
1163056|NCT03427268|2286868|FG000|Overall Study|Adverse Event|3
1163057|NCT03427619|2286872|FG000|Overall Study|Physician Decision|3
1163058|NCT03427619|2286872|FG000|Overall Study|Withdrawal by Subject|4
1163059|NCT03427619|2286872|FG000|Overall Study|Lost to Follow-up|5
1163060|NCT03427619|2286872|FG000|Overall Study|Administrative|4
1163061|NCT03427619|2286872|FG000|Overall Study|Other|2
1163062|NCT03427619|2286872|FG000|Overall Study|Unknown or Missing Completion Status|48
1163063|NCT03427892|2286876|FG000|Overall Study|Lost to Follow-up|2
1163064|NCT03428100|2286888|FG000|Overall Study|Adverse Event|1
1163065|NCT03428100|2286889|FG001|Overall Study|Adverse Event|0
1163066|NCT03428100|2286890|FG002|Overall Study|Adverse Event|3
1163067|NCT03428100|2286891|FG003|Overall Study|Adverse Event|1
1163068|NCT03428100|2286888|FG000|Overall Study|Lack of Efficacy|16
1163069|NCT03428100|2286889|FG001|Overall Study|Lack of Efficacy|10
1163070|NCT03428100|2286890|FG002|Overall Study|Lack of Efficacy|7
1163071|NCT03428100|2286891|FG003|Overall Study|Lack of Efficacy|6
1163072|NCT03428100|2286888|FG000|Overall Study|Protocol Deviation|0
1163073|NCT03428100|2286889|FG001|Overall Study|Protocol Deviation|2
1163074|NCT03428100|2286890|FG002|Overall Study|Protocol Deviation|2
1163075|NCT03428100|2286891|FG003|Overall Study|Protocol Deviation|0
1163076|NCT03428100|2286888|FG000|Overall Study|Withdrawal by Subject|4
1163077|NCT03428100|2286889|FG001|Overall Study|Withdrawal by Subject|0
1163078|NCT03428100|2286890|FG002|Overall Study|Withdrawal by Subject|0
1163079|NCT03428100|2286891|FG003|Overall Study|Withdrawal by Subject|0
1163080|NCT03428100|2286888|FG000|Overall Study|Physician Decision|0
1163081|NCT03428100|2286889|FG001|Overall Study|Physician Decision|1
1163082|NCT03428100|2286890|FG002|Overall Study|Physician Decision|0
1163083|NCT03428100|2286891|FG003|Overall Study|Physician Decision|0
1163084|NCT03428152|2286913|FG000|Overall Study|Physician Decision|4
1163085|NCT03428152|2286914|FG001|Overall Study|Physician Decision|2
1163086|NCT03428152|2286913|FG000|Overall Study|Protocol Violation|3
1163087|NCT03428152|2286914|FG001|Overall Study|Protocol Violation|5
1163088|NCT03428152|2286913|FG000|Overall Study|Lack of Efficacy|0
1163089|NCT03428152|2286914|FG001|Overall Study|Lack of Efficacy|4
1163090|NCT03428360|2286937|FG000|Overall Study|Informed consent withdrawn|5
1163091|NCT03428360|2286937|FG000|Overall Study|Withdrawal by Subject|4
1163092|NCT03428360|2286937|FG000|Overall Study|Lost to Follow-up|5
1163093|NCT03428360|2286937|FG000|Overall Study|Physician Decision|2
1163094|NCT03428360|2286937|FG000|Overall Study|Informed consent withdrawn|5
1163095|NCT03428360|2286937|FG000|Overall Study|Study terminated by sponsor|10
1163096|NCT03428360|2286937|FG000|Overall Study|Non-compliant with study|1
1163097|NCT03428360|2286937|FG000|Overall Study|Non-compliant with study drug|3
1163098|NCT03428360|2286937|FG000|Overall Study|Death|3
1163099|NCT03428360|2286937|FG000|Overall Study|Adverse Event|1
1163100|NCT03428360|2286937|FG000|Overall Study|Not on antiepileptic drug|1
1163101|NCT03428750|2286947|FG000|Overall Study|Withdrawal by Subject|11
1163102|NCT03428750|2286948|FG001|Overall Study|Withdrawal by Subject|10
1163103|NCT03428750|2286947|FG000|Overall Study|Lost to Follow-up|3
1163104|NCT03428750|2286948|FG001|Overall Study|Lost to Follow-up|9
1163105|NCT03428750|2286947|FG000|Overall Study|Adverse Event|9
1163106|NCT03428750|2286948|FG001|Overall Study|Adverse Event|1
1163107|NCT03428750|2286947|FG000|Overall Study|Protocol Violation|1
1163108|NCT03428750|2286948|FG001|Overall Study|Protocol Violation|0
1163109|NCT03428750|2286947|FG000|Overall Study|Administrative|0
1163110|NCT03428750|2286948|FG001|Overall Study|Administrative|1
1163111|NCT03428815|2286979|FG000|Overall Study|Lost to Follow-up|2
1163112|NCT03428815|2286980|FG001|Overall Study|Lost to Follow-up|2
1163113|NCT03428815|2286979|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5
1163114|NCT03428815|2286980|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2
1163115|NCT03428815|2286979|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3
1163116|NCT03428815|2286980|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1
1163117|NCT03428997|2286986|FG000|Overall Study|Sponsor decision.|1
1163118|NCT03428997|2286986|FG000|Overall Study|Withdrawal by Subject|3
1163119|NCT03428997|2286986|FG000|Overall Study|Lost to Follow-up|4
1163120|NCT03429556|2287011|FG000|Overall Study|Lost to Follow-up|0
1163121|NCT03429556|2287012|FG001|Overall Study|Lost to Follow-up|1
1163122|NCT03429556|2287013|FG002|Overall Study|Lost to Follow-up|0
1163123|NCT03429556|2287014|FG003|Overall Study|Lost to Follow-up|0
1163124|NCT03430245|2287042|FG000|Overall Study|Withdrawal by Subject|6
1163125|NCT03430245|2287042|FG000|Overall Study|Lost to Follow-up|1
1163126|NCT03430856|2287059|FG000|Overall Study|Adverse Event|0
1163127|NCT03430856|2287060|FG001|Overall Study|Adverse Event|1
1163128|NCT03430856|2287061|FG002|Overall Study|Adverse Event|0
1163129|NCT03430856|2287059|FG000|Overall Study|Rescue criteria|1
1163130|NCT03430856|2287060|FG001|Overall Study|Rescue criteria|1
1163131|NCT03430856|2287061|FG002|Overall Study|Rescue criteria|0
1163132|NCT03430856|2287059|FG000|Overall Study|Voluntary withdrawal of consent|1
1163133|NCT03430856|2287060|FG001|Overall Study|Voluntary withdrawal of consent|1
1163134|NCT03430856|2287061|FG002|Overall Study|Voluntary withdrawal of consent|1
1163135|NCT03430986|2287074|FG000|24-week Control Period|Adverse Event|1
1163136|NCT03430986|2287075|FG001|24-week Control Period|Adverse Event|0
1163137|NCT03430986|2287074|FG000|24-week Control Period|Lost to Follow-up|2
1163138|NCT03430986|2287075|FG001|24-week Control Period|Lost to Follow-up|2
1163139|NCT03430986|2287074|FG000|24-week Control Period|Withdrawal by Participant|5
1163140|NCT03430986|2287075|FG001|24-week Control Period|Withdrawal by Participant|0
1163141|NCT03430986|2287074|FG000|24-week Control Period|Protocol Deviation|0
1163142|NCT03430986|2287075|FG001|24-week Control Period|Protocol Deviation|2
1163143|NCT03430986|2287074|FG000|24-week Post-Control Period|Lost to Follow-up|1
1163144|NCT03430986|2287075|FG001|24-week Post-Control Period|Lost to Follow-up|1
1163145|NCT03430986|2287074|FG000|24-week Post-Control Period|Withdrawal by Participant|0
1163146|NCT03430986|2287075|FG001|24-week Post-Control Period|Withdrawal by Participant|1
1163147|NCT03431337|2287107|FG000|Overall Study|Lost to Follow-up|21
1163148|NCT03431337|2287108|FG001|Overall Study|Lost to Follow-up|19
1163149|NCT03431337|2287107|FG000|Overall Study|Withdrawal by Subject|8
1163150|NCT03431337|2287108|FG001|Overall Study|Withdrawal by Subject|3
1163151|NCT03431441|2287118|FG000|Overall Study|Withdrawal by Subject|2
1163152|NCT03431441|2287118|FG000|Overall Study|Adverse Event|2
1163153|NCT03431441|2287118|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1
1163154|NCT03431857|2287122|FG000|Overall Study|Death|6
1163155|NCT03431857|2287122|FG000|Overall Study|Lost to Follow-up|41
1163156|NCT03431857|2287122|FG000|Overall Study|Adverse Event|6
1163157|NCT03431857|2287122|FG000|Overall Study|Withdrawal by Subject|1
1163158|NCT03432390|2287128|FG000|Apnea Period|Protocol Violation|2
1163159|NCT03432390|2287129|FG001|Apnea Period|Protocol Violation|2
1163160|NCT03432533|2287137|FG000|Overall Study|Lost to Follow-up|1
1163161|NCT03432533|2287138|FG001|Overall Study|Lost to Follow-up|2
1163162|NCT03432533|2287137|FG000|Overall Study|Withdrawal by Subject|14
1163163|NCT03432533|2287138|FG001|Overall Study|Withdrawal by Subject|9
1163168|NCT03432858|2287156|FG000|Overall Study|Protocol Violation|2
1163169|NCT03432858|2287157|FG001|Overall Study|Protocol Violation|1
1163170|NCT03432858|2287158|FG002|Overall Study|Protocol Violation|9
1163171|NCT03432858|2287156|FG000|Overall Study|Withdrawal by Subject|0
1163172|NCT03432858|2287157|FG001|Overall Study|Withdrawal by Subject|1
1163173|NCT03432858|2287158|FG002|Overall Study|Withdrawal by Subject|1
1163174|NCT03432858|2287156|FG000|Overall Study|Procedure canceled/rescheduled|0
1163175|NCT03432858|2287157|FG001|Overall Study|Procedure canceled/rescheduled|9
1163176|NCT03432858|2287158|FG002|Overall Study|Procedure canceled/rescheduled|6
1163177|NCT03432858|2287156|FG000|Overall Study|Required postop mobilization with splinting|0
1163178|NCT03432858|2287157|FG001|Overall Study|Required postop mobilization with splinting|0
1163179|NCT03432858|2287158|FG002|Overall Study|Required postop mobilization with splinting|1
1163180|NCT03433482|2287170|FG000|Overall Study|Lost to Follow-up|1
1163181|NCT03433482|2287171|FG001|Overall Study|Lost to Follow-up|0
1163182|NCT03433482|2287172|FG002|Overall Study|Lost to Follow-up|1
1163183|NCT03433482|2287173|FG003|Overall Study|Lost to Follow-up|1
1163184|NCT03433482|2287170|FG000|Overall Study|Withdrawal by Subject|0
1163185|NCT03433482|2287171|FG001|Overall Study|Withdrawal by Subject|0
1163186|NCT03433482|2287172|FG002|Overall Study|Withdrawal by Subject|1
1163187|NCT03433482|2287173|FG003|Overall Study|Withdrawal by Subject|0
1163188|NCT03433482|2287170|FG000|Overall Study|Unknown reason|0
1163189|NCT03433482|2287171|FG001|Overall Study|Unknown reason|0
1163190|NCT03433482|2287172|FG002|Overall Study|Unknown reason|2
1163191|NCT03433482|2287173|FG003|Overall Study|Unknown reason|0
1163192|NCT03433677|2287185|FG000|Period 1|Protocol Violation|1
1163193|NCT03433677|2287186|FG001|Period 1|Protocol Violation|0
1163194|NCT03433677|2287185|FG000|Period 2|Withdrawal by Subject|1
1163195|NCT03433677|2287186|FG001|Period 2|Withdrawal by Subject|1
1163196|NCT03433703|2287193|FG000|Overall Study|Study terminated by Sponsor|2
1163197|NCT03433755|2287201|FG000|Overall Study|Lost to Follow-up|1
1163198|NCT03433755|2287202|FG001|Overall Study|Lost to Follow-up|0
1163199|NCT03433755|2287203|FG002|Overall Study|Lost to Follow-up|0
1163200|NCT03433755|2287204|FG003|Overall Study|Lost to Follow-up|0
1163201|NCT03433755|2287201|FG000|Overall Study|Decision by Sponsor|1
1163202|NCT03433755|2287202|FG001|Overall Study|Decision by Sponsor|0
1163203|NCT03433755|2287203|FG002|Overall Study|Decision by Sponsor|0
1163204|NCT03433755|2287204|FG003|Overall Study|Decision by Sponsor|0
1163205|NCT03434119|2287231|FG000|Overall Study|Randomized but not treated|1
1163206|NCT03434119|2287232|FG001|Overall Study|Randomized but not treated|0
1163207|NCT03434119|2287231|FG000|Overall Study|Adverse Event|1
1163208|NCT03434119|2287232|FG001|Overall Study|Adverse Event|0
1163209|NCT03434119|2287231|FG000|Overall Study|Poor Compliance to Protocol|0
1163210|NCT03434119|2287232|FG001|Overall Study|Poor Compliance to Protocol|1
1163211|NCT03434119|2287231|FG000|Overall Study|Study Terminated by Sponsor|91
1163212|NCT03434119|2287232|FG001|Overall Study|Study Terminated by Sponsor|102
1163213|NCT03434119|2287231|FG000|Overall Study|Withdrawal by Subject|7
1163214|NCT03434119|2287232|FG001|Overall Study|Withdrawal by Subject|5
1163215|NCT03434119|2287231|FG000|Overall Study|Other than specified|7
1163216|NCT03434119|2287232|FG001|Overall Study|Other than specified|5
1163217|NCT03434249|2287240|FG000|Overall Study|Adverse Event|1
1163218|NCT03434249|2287241|FG001|Overall Study|Adverse Event|0
1163219|NCT03434249|2287240|FG000|Overall Study|Lost to Follow-up|0
1163220|NCT03434249|2287241|FG001|Overall Study|Lost to Follow-up|1
1163221|NCT03434249|2287240|FG000|Overall Study|Non-compliance of family|2
1163222|NCT03434249|2287241|FG001|Overall Study|Non-compliance of family|1
1163223|NCT03434249|2287240|FG000|Overall Study|Difficulties in completing daily diary|2
1163224|NCT03434249|2287241|FG001|Overall Study|Difficulties in completing daily diary|1
1163257|NCT03434834|2287268|FG000|Overall Study|unable to swallow OCT probe|16
1163258|NCT03434977|2287274|FG000|Washout Period (at Least 6 Days)|Adverse Event|0
1163259|NCT03434977|2287275|FG001|Washout Period (at Least 6 Days)|Adverse Event|1
1163260|NCT03435055|2287281|FG000|Screening|Physician Decision|2
1163261|NCT03435055|2287281|FG000|Received Intervention|Did not complete nitrous administration|3
1163262|NCT03435081|2287295|FG000|Overall Study|Lack of Efficacy|6
1163263|NCT03435081|2287296|FG001|Overall Study|Lack of Efficacy|5
1163264|NCT03435081|2287297|FG002|Overall Study|Lack of Efficacy|0
1163265|NCT03435081|2287295|FG000|Overall Study|Adverse Event|2
1163266|NCT03435081|2287296|FG001|Overall Study|Adverse Event|2
1163267|NCT03435081|2287297|FG002|Overall Study|Adverse Event|2
1163268|NCT03435081|2287295|FG000|Overall Study|Withdrawal by Subject|8
1163269|NCT03435081|2287296|FG001|Overall Study|Withdrawal by Subject|7
1163270|NCT03435081|2287297|FG002|Overall Study|Withdrawal by Subject|10
1163271|NCT03435081|2287295|FG000|Overall Study|Lost to Follow-up|3
1163272|NCT03435081|2287296|FG001|Overall Study|Lost to Follow-up|1
1163273|NCT03435081|2287297|FG002|Overall Study|Lost to Follow-up|4
1163274|NCT03435081|2287295|FG000|Overall Study|Pregnancy|1
1163275|NCT03435081|2287296|FG001|Overall Study|Pregnancy|0
1163276|NCT03435081|2287297|FG002|Overall Study|Pregnancy|0
1163277|NCT03435081|2287295|FG000|Overall Study|Non-compliance|1
1163278|NCT03435081|2287296|FG001|Overall Study|Non-compliance|0
1163279|NCT03435081|2287297|FG002|Overall Study|Non-compliance|2
1163280|NCT03435081|2287295|FG000|Overall Study|Inadequate Response|0
1163281|NCT03435081|2287296|FG001|Overall Study|Inadequate Response|1
1163282|NCT03435081|2287297|FG002|Overall Study|Inadequate Response|0
1163283|NCT03435081|2287295|FG000|Overall Study|Withdrawal Due to Caregiver Circumstance|0
1163284|NCT03435081|2287296|FG001|Overall Study|Withdrawal Due to Caregiver Circumstance|0
1163285|NCT03435081|2287297|FG002|Overall Study|Withdrawal Due to Caregiver Circumstance|1
1163286|NCT03435211|2287315|FG000|Overall Study|Unable to achieve minimum desaturation level|1
1163287|NCT03435224|2287319|FG000|Overall Study|Unable to achieve a minimum desaturation level|4
1163288|NCT03435497|2287325|FG000|Overall Study|Lost to Follow-up|1
1163289|NCT03435497|2287326|FG001|Overall Study|Lost to Follow-up|0
1163290|NCT03435497|2287325|FG000|Overall Study|Death|1
1163291|NCT03435497|2287326|FG001|Overall Study|Death|0
1163292|NCT03435497|2287325|FG000|Overall Study|Withdrawal by Subject|0
1163293|NCT03435497|2287326|FG001|Overall Study|Withdrawal by Subject|4
1163294|NCT03435497|2287325|FG000|Overall Study|Wrong survey administered|0
1163295|NCT03435497|2287326|FG001|Overall Study|Wrong survey administered|2
1163296|NCT03435692|2287356|FG000|Overall Study|Lack of Efficacy|2
1163297|NCT03435692|2287357|FG001|Overall Study|Lack of Efficacy|2
1163298|NCT03435692|2287358|FG002|Overall Study|Lack of Efficacy|0
1163299|NCT03436082|2287381|FG000|Overall Study|Did not undergo procedure|1
1163300|NCT03436082|2287382|FG001|Overall Study|Did not undergo procedure|0
1163301|NCT03436420|2287399|FG000|Overall Study|Lack of Efficacy|3
1163302|NCT03436732|2287405|FG000|Overall Study|Not treated-enrolled in different study|1
1163303|NCT03436732|2287406|FG001|Overall Study|Not treated-enrolled in different study|0
1163304|NCT03436732|2287405|FG000|Overall Study|Off study after cycle 1|1
1163305|NCT03436732|2287406|FG001|Overall Study|Off study after cycle 1|0
1163306|NCT03436732|2287405|FG000|Overall Study|Adverse Event|2
1163307|NCT03436732|2287406|FG001|Overall Study|Adverse Event|0
1163308|NCT03436732|2287405|FG000|Overall Study|Death|0
1163309|NCT03436732|2287406|FG001|Overall Study|Death|1
1163310|NCT03437265|2287442|FG000|Overall Study|Protocol Violation|6
1163311|NCT03437278|2287449|FG000|Overall Study|Adverse Event|0
1163312|NCT03437278|2287450|FG001|Overall Study|Adverse Event|0
1163313|NCT03437278|2287451|FG002|Overall Study|Adverse Event|1
1163314|NCT03437278|2287449|FG000|Overall Study|Progressive disease|1
1163315|NCT03437278|2287450|FG001|Overall Study|Progressive disease|0
1163316|NCT03437278|2287451|FG002|Overall Study|Progressive disease|0
1163317|NCT03437278|2287449|FG000|Overall Study|Physician Decision|1
1163318|NCT03437278|2287450|FG001|Overall Study|Physician Decision|0
1163319|NCT03437278|2287451|FG002|Overall Study|Physician Decision|1
1163320|NCT03437447|2287464|FG000|Treatment Period 1|Withdrawal by Subject|0
1163321|NCT03437447|2287465|FG001|Treatment Period 1|Withdrawal by Subject|0
1163322|NCT03437447|2287466|FG002|Treatment Period 1|Withdrawal by Subject|1
1163323|NCT03437512|2287476|FG000|Randomized|Withdrawal by Subject|0
1163324|NCT03437512|2287477|FG001|Randomized|Withdrawal by Subject|2
1163325|NCT03437512|2287476|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2
1163326|NCT03437512|2287477|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1
1163327|NCT03437577|2287495|FG000|Pre-Randomization|Withdrawal by Subject|0
1163328|NCT03437577|2287496|FG001|Pre-Randomization|Withdrawal by Subject|0
1163329|NCT03437577|2287497|FG002|Pre-Randomization|Withdrawal by Subject|10
1163330|NCT03437577|2287495|FG000|Post-Randomization|Physician Decision|0
1163331|NCT03437577|2287496|FG001|Post-Randomization|Physician Decision|2
1163332|NCT03437577|2287497|FG002|Post-Randomization|Physician Decision|0
1163333|NCT03437733|2287505|FG000|Overall Study|Eligibility criteria not met|0
1163334|NCT03437733|2287506|FG001|Overall Study|Eligibility criteria not met|3
1163335|NCT03438006|2287515|FG000|Overall Study|Adverse Event|1
1163336|NCT03438006|2287515|FG000|Overall Study|Lost to Follow-up|67
1163337|NCT03438006|2287515|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47
1163338|NCT03438006|2287515|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3
1163339|NCT03438383|2287531|FG000|Overall Study|Protocol Violation|9
1163340|NCT03438383|2287532|FG001|Overall Study|Protocol Violation|3
1163341|NCT03438396|2287538|FG000|Overall Study|Ongoing on study treatment|4
1163342|NCT03438396|2287538|FG000|Overall Study|Ongoing in survival follow-up|33
1163343|NCT03438396|2287538|FG000|Overall Study|Withdrawal by Subject|4
1163344|NCT03438396|2287538|FG000|Overall Study|Lost to Follow-up|2
1163345|NCT03438396|2287538|FG000|Overall Study|Death|58
1163346|NCT03438396|2287538|FG000|Overall Study|Not treated|1
1163347|NCT03438539|2287548|FG000|Overall Study|Lost to Follow-up|8
1163348|NCT03438539|2287549|FG001|Overall Study|Lost to Follow-up|4
1163349|NCT03438539|2287550|FG002|Overall Study|Lost to Follow-up|10
1163350|NCT03438539|2287551|FG003|Overall Study|Lost to Follow-up|9
1163351|NCT03438539|2287552|FG004|Overall Study|Lost to Follow-up|3
1163352|NCT03438539|2287553|FG005|Overall Study|Lost to Follow-up|8
1163353|NCT03439072|2287576|FG000|Overall Study|Withdrawal by Subject|2
1163354|NCT03439072|2287577|FG001|Overall Study|Withdrawal by Subject|3
1163355|NCT03439072|2287576|FG000|Overall Study|Physician Decision|0
1163356|NCT03439072|2287577|FG001|Overall Study|Physician Decision|1
1163357|NCT03439124|2287585|FG000|Overall Study|Adverse Event|2
1163358|NCT03439124|2287586|FG001|Overall Study|Adverse Event|0
1163359|NCT03439124|2287585|FG000|Overall Study|Lost to Follow-up|1
1163360|NCT03439124|2287586|FG001|Overall Study|Lost to Follow-up|0
1163361|NCT03439124|2287585|FG000|Overall Study|Other reasons|1
1163362|NCT03439124|2287586|FG001|Overall Study|Other reasons|0
1163363|NCT03439137|2287594|FG000|Overall Study|Adverse Event|16
1163364|NCT03439137|2287595|FG001|Overall Study|Adverse Event|12
1163365|NCT03439137|2287594|FG000|Overall Study|Physician Decision|0
1163366|NCT03439137|2287595|FG001|Overall Study|Physician Decision|5
1163367|NCT03439137|2287594|FG000|Overall Study|Withdrawal by Subject|14
1163368|NCT03439137|2287595|FG001|Overall Study|Withdrawal by Subject|4
1163369|NCT03439137|2287594|FG000|Overall Study|Conducting rescue therapy|2
1163370|NCT03439137|2287595|FG001|Overall Study|Conducting rescue therapy|1
1163371|NCT03439137|2287594|FG000|Overall Study|Difficult to control Hb|10
1163372|NCT03439137|2287595|FG001|Overall Study|Difficult to control Hb|2
1163373|NCT03439137|2287594|FG000|Overall Study|Initiation of a renal transplant|0
1163374|NCT03439137|2287595|FG001|Overall Study|Initiation of a renal transplant|2
1163375|NCT03439189|2287601|FG000|Overall Study|Protocol Violation|19
1163376|NCT03439189|2287601|FG000|Overall Study|Lack of Efficacy|63
1163385|NCT03440320|2287630|FG000|Overall Study|Withdrawal by Subject|0
1163386|NCT03440320|2287631|FG001|Overall Study|Withdrawal by Subject|1
1163387|NCT03440411|2287643|FG000|Overall Study|Adverse Event|0
1163388|NCT03440411|2287644|FG001|Overall Study|Adverse Event|0
1163389|NCT03440411|2287645|FG002|Overall Study|Adverse Event|1
1163390|NCT03440411|2287646|FG003|Overall Study|Adverse Event|0
1163391|NCT03440411|2287643|FG000|Overall Study|PD|2
1163392|NCT03440411|2287644|FG001|Overall Study|PD|1
1163393|NCT03440411|2287645|FG002|Overall Study|PD|1
1163394|NCT03440411|2287646|FG003|Overall Study|PD|1
1163395|NCT03440411|2287643|FG000|Overall Study|Withdrawal by Subject|1
1163396|NCT03440411|2287644|FG001|Overall Study|Withdrawal by Subject|0
1163397|NCT03440411|2287645|FG002|Overall Study|Withdrawal by Subject|0
1163398|NCT03440411|2287646|FG003|Overall Study|Withdrawal by Subject|0
1163399|NCT03440411|2287643|FG000|Overall Study|Closed study by sponsor|0
1163400|NCT03440411|2287644|FG001|Overall Study|Closed study by sponsor|0
1163401|NCT03440411|2287645|FG002|Overall Study|Closed study by sponsor|0
1163402|NCT03440411|2287646|FG003|Overall Study|Closed study by sponsor|1
1163403|NCT03440918|2287690|FG000|Overall Study|Protocol Violation|0
1163404|NCT03440918|2287691|FG001|Overall Study|Protocol Violation|16
1163405|NCT03440944|2287699|FG000|Overall Study|Physician Decision|1
1163406|NCT03440944|2287700|FG001|Overall Study|Physician Decision|0
1163407|NCT03440944|2287699|FG000|Overall Study|No Acceptable Vasculature|0
1163408|NCT03440944|2287700|FG001|Overall Study|No Acceptable Vasculature|1
1163409|NCT03441789|2287792|FG000|Overall Study|Withdrawal by Subject|1
1163410|NCT03441789|2287793|FG001|Overall Study|Withdrawal by Subject|1
1163411|NCT03441789|2287792|FG000|Overall Study|Adverse Event|0
1163412|NCT03441789|2287793|FG001|Overall Study|Adverse Event|1
1163413|NCT03441789|2287792|FG000|Overall Study|Protocol Violation|0
1163414|NCT03441789|2287793|FG001|Overall Study|Protocol Violation|1
1163415|NCT03441789|2287792|FG000|Overall Study|Lost to Follow-up|0
1163416|NCT03441789|2287793|FG001|Overall Study|Lost to Follow-up|1
1163417|NCT03441984|2287801|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1163418|NCT03441984|2287802|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1163419|NCT03441984|2287803|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
1163420|NCT03441984|2287804|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1163421|NCT03441984|2287805|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1163422|NCT03441984|2287806|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1163423|NCT03441984|2287807|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1163424|NCT03441984|2287808|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1163425|NCT03441984|2287809|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1163426|NCT03441984|2287810|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1163427|NCT03441984|2287811|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1163428|NCT03441984|2287812|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1163429|NCT03442296|2287840|FG000|3 Month Follow-up|Death|3
1163430|NCT03442296|2287841|FG001|3 Month Follow-up|Death|1
1163431|NCT03442296|2287840|FG000|3 Month Follow-up|Lost to Follow-up|1
1163432|NCT03442296|2287841|FG001|3 Month Follow-up|Lost to Follow-up|1
1163433|NCT03442296|2287840|FG000|3 Month Follow-up|Withdrawal by Subject|1
1163434|NCT03442296|2287841|FG001|3 Month Follow-up|Withdrawal by Subject|0
1163435|NCT03442296|2287840|FG000|3 Month Follow-up|Obtained Hearing Aids|0
1163436|NCT03442296|2287841|FG001|3 Month Follow-up|Obtained Hearing Aids|1
1163437|NCT03442296|2287840|FG000|12 Month Follow-up|Incomplete measurement|1
1163438|NCT03442296|2287841|FG001|12 Month Follow-up|Incomplete measurement|1
1163439|NCT03442569|2287847|FG000|Overall Study|Subject was ineligible after enrollment|1
1163440|NCT03442595|2287853|FG000|Overall Study|Lost to Follow-up|94
1163441|NCT03442595|2287854|FG001|Overall Study|Lost to Follow-up|0
1163442|NCT03442777|2287877|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8
1163443|NCT03442777|2287878|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13
1163444|NCT03442777|2287879|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7
1163445|NCT03442829|2287887|FG000|Overall Study|Scheduling clash|3
1163446|NCT03442829|2287888|FG001|Overall Study|Scheduling clash|1
1163447|NCT03442829|2287887|FG000|Overall Study|Illness unrelated to study|1
1163448|NCT03442829|2287888|FG001|Overall Study|Illness unrelated to study|1
1163449|NCT03443024|2287912|FG000|Overall Study|Adverse Event|2
1163450|NCT03443024|2287913|FG001|Overall Study|Adverse Event|4
1163451|NCT03443024|2287914|FG002|Overall Study|Adverse Event|3
1163452|NCT03443024|2287915|FG003|Overall Study|Adverse Event|1
1163453|NCT03443024|2287912|FG000|Overall Study|Lost to Follow-up|9
1163454|NCT03443024|2287913|FG001|Overall Study|Lost to Follow-up|9
1163455|NCT03443024|2287914|FG002|Overall Study|Lost to Follow-up|7
1163456|NCT03443024|2287915|FG003|Overall Study|Lost to Follow-up|5
1163457|NCT03443024|2287912|FG000|Overall Study|Withdrawal by Subject|8
1163458|NCT03443024|2287913|FG001|Overall Study|Withdrawal by Subject|15
1163459|NCT03443024|2287914|FG002|Overall Study|Withdrawal by Subject|9
1163460|NCT03443024|2287915|FG003|Overall Study|Withdrawal by Subject|23
1163461|NCT03443024|2287912|FG000|Overall Study|Physician Decision|1
1163462|NCT03443024|2287913|FG001|Overall Study|Physician Decision|2
1163463|NCT03443024|2287914|FG002|Overall Study|Physician Decision|0
1163464|NCT03443024|2287915|FG003|Overall Study|Physician Decision|1
1163465|NCT03443024|2287912|FG000|Overall Study|Sponsor Decision|1
1163466|NCT03443024|2287913|FG001|Overall Study|Sponsor Decision|1
1163467|NCT03443024|2287914|FG002|Overall Study|Sponsor Decision|0
1163468|NCT03443024|2287915|FG003|Overall Study|Sponsor Decision|0
1163469|NCT03443024|2287912|FG000|Overall Study|Protocol Deviation|0
1163470|NCT03443024|2287913|FG001|Overall Study|Protocol Deviation|0
1163471|NCT03443024|2287914|FG002|Overall Study|Protocol Deviation|0
1163472|NCT03443024|2287915|FG003|Overall Study|Protocol Deviation|2
1163473|NCT03443414|2287941|FG000|Overall Study|Adverse Event|6
1163474|NCT03443414|2287942|FG001|Overall Study|Adverse Event|0
1163475|NCT03443414|2287943|FG002|Overall Study|Adverse Event|4
1163476|NCT03443414|2287944|FG003|Overall Study|Adverse Event|2
1163477|NCT03443414|2287945|FG004|Overall Study|Adverse Event|3
1163478|NCT03443414|2287941|FG000|Overall Study|Withdrawal by Subject|3
1163479|NCT03443414|2287942|FG001|Overall Study|Withdrawal by Subject|2
1163480|NCT03443414|2287943|FG002|Overall Study|Withdrawal by Subject|2
1163481|NCT03443414|2287944|FG003|Overall Study|Withdrawal by Subject|2
1163482|NCT03443414|2287945|FG004|Overall Study|Withdrawal by Subject|1
1163483|NCT03443414|2287941|FG000|Overall Study|Death|0
1163484|NCT03443414|2287942|FG001|Overall Study|Death|1
1163485|NCT03443414|2287943|FG002|Overall Study|Death|0
1163486|NCT03443414|2287944|FG003|Overall Study|Death|1
1163487|NCT03443414|2287945|FG004|Overall Study|Death|0
1163488|NCT03443414|2287941|FG000|Overall Study|Reason not specified|2
1163489|NCT03443414|2287942|FG001|Overall Study|Reason not specified|0
1163490|NCT03443414|2287943|FG002|Overall Study|Reason not specified|0
1163491|NCT03443414|2287944|FG003|Overall Study|Reason not specified|0
1163492|NCT03443414|2287945|FG004|Overall Study|Reason not specified|1
1163493|NCT03443427|2287959|FG000|Overall Study|Adverse Event|2
1163494|NCT03443427|2287960|FG001|Overall Study|Adverse Event|3
1163495|NCT03443427|2287959|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
1163496|NCT03443427|2287960|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
1163497|NCT03443427|2287959|FG000|Overall Study|Other|4
1163498|NCT03443427|2287960|FG001|Overall Study|Other|6
1163499|NCT03443713|2287969|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0
1163500|NCT03443713|2287970|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0
1163501|NCT03443713|2287971|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1
1163502|NCT03444155|2287994|FG000|First Intervention (6 Weeks)|Adverse Event|1
1163503|NCT03444155|2287995|FG001|First Intervention (6 Weeks)|Adverse Event|0
1163504|NCT03444584|2288003|FG000|Overall Study|Withdrawal by Subject|0
1163505|NCT03444584|2288004|FG001|Overall Study|Withdrawal by Subject|1
1163506|NCT03444584|2288003|FG000|Overall Study|Other|0
1163507|NCT03444584|2288004|FG001|Overall Study|Other|1
1163508|NCT03444766|2288011|FG000|Overall Study|Other Reasons|2
1163509|NCT03444766|2288011|FG000|Overall Study|Participant Withdrew Consent|5
1163510|NCT03444766|2288011|FG000|Overall Study|Lost to Follow-up|2
1163511|NCT03444766|2288011|FG000|Overall Study|Death|2
1163512|NCT03444766|2288011|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6
1163513|NCT03444766|2288011|FG000|Overall Study|Disease Progression|49
1163514|NCT03445065|2288027|FG000|Overall Study|Withdrawal by Subject|3
1163515|NCT03445065|2288028|FG001|Overall Study|Withdrawal by Subject|6
1163516|NCT03445065|2288029|FG002|Overall Study|Withdrawal by Subject|2
1163517|NCT03445065|2288030|FG003|Overall Study|Withdrawal by Subject|2
1163518|NCT03445065|2288027|FG000|Overall Study|Other|4
1163519|NCT03445065|2288028|FG001|Overall Study|Other|3
1163520|NCT03445065|2288029|FG002|Overall Study|Other|3
1163521|NCT03445065|2288030|FG003|Overall Study|Other|1
1163524|NCT03446781|2288160|FG000|Overall Study|Lost to Follow-up|11
1163525|NCT03446781|2288161|FG001|Overall Study|Lost to Follow-up|5
1163526|NCT03446781|2288160|FG000|Overall Study|Withdrawal by Subject|9
1163527|NCT03446781|2288161|FG001|Overall Study|Withdrawal by Subject|7
1163528|NCT03446781|2288160|FG000|Overall Study|Adverse Event|8
1163529|NCT03446781|2288161|FG001|Overall Study|Adverse Event|2
1163530|NCT03446781|2288160|FG000|Overall Study|Protocol Violation|0
1163531|NCT03446781|2288161|FG001|Overall Study|Protocol Violation|3
1163532|NCT03446885|2288202|FG000|Overall Study|Lost to Follow-up|1
1163533|NCT03446885|2288203|FG001|Overall Study|Lost to Follow-up|0
1163534|NCT03446885|2288202|FG000|Overall Study|Did not complete entire visit|1
1163535|NCT03446885|2288203|FG001|Overall Study|Did not complete entire visit|0
1163536|NCT03447249|2288222|FG000|Overall Study|Adverse Event|1
1163537|NCT03447249|2288223|FG001|Overall Study|Adverse Event|0
1163538|NCT03447249|2288222|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
1163539|NCT03447249|2288223|FG001|Overall Study|Withdrawal of consent (not due to AE)|0
1163540|NCT03447249|2288222|FG000|Overall Study|Other|3
1163541|NCT03447249|2288223|FG001|Overall Study|Other|0
1163542|NCT03447353|2288307|FG000|Overall Study|Failure at Screening Visit|2
1163543|NCT03447353|2288307|FG000|Overall Study|Lost to Follow-up|4
1163544|NCT03447353|2288307|FG000|Overall Study|Scheduling Conflicts|3
1163545|NCT03447353|2288307|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
1163546|NCT03447730|2288320|FG000|Overall Study|Adverse Event|0
1163547|NCT03447730|2288321|FG001|Overall Study|Adverse Event|2
1163548|NCT03447730|2288322|FG002|Overall Study|Adverse Event|0
1163549|NCT03447821|2288333|FG000|Overall Study|Withdrawal by Subject|1
1163550|NCT03447821|2288334|FG001|Overall Study|Withdrawal by Subject|1
1163551|NCT03447821|2288335|FG002|Overall Study|Withdrawal by Subject|0
1163552|NCT03447821|2288333|FG000|Overall Study|Lost to Follow-up|0
1163553|NCT03447821|2288334|FG001|Overall Study|Lost to Follow-up|0
1163554|NCT03447821|2288335|FG002|Overall Study|Lost to Follow-up|1
1163555|NCT03448224|2288354|FG000|Overall Study|Provided same answer to every question|1
1163556|NCT03448224|2288355|FG001|Overall Study|Provided same answer to every question|0
1163557|NCT03448406|2288363|FG000|Overall Study|Noncompliance of scheduled visits|1
1163558|NCT03448406|2288364|FG001|Overall Study|Noncompliance of scheduled visits|2
1163559|NCT03448406|2288363|FG000|Overall Study|Withdrawal by Subject|1
1163560|NCT03448406|2288364|FG001|Overall Study|Withdrawal by Subject|2
1163561|NCT03448406|2288363|FG000|Overall Study|Protocol Violation|1
1163562|NCT03448406|2288364|FG001|Overall Study|Protocol Violation|0
1163563|NCT03448406|2288363|FG000|Overall Study|Adverse Event|8
1163564|NCT03448406|2288364|FG001|Overall Study|Adverse Event|9
1163565|NCT03448419|2288372|FG000|Overall Study|Adverse Event|10
1163566|NCT03448419|2288373|FG001|Overall Study|Adverse Event|9
1163567|NCT03448419|2288372|FG000|Overall Study|Lost to Follow-up|0
1163568|NCT03448419|2288373|FG001|Overall Study|Lost to Follow-up|2
1163569|NCT03448419|2288372|FG000|Overall Study|Withdrawal by Subject|3
1163570|NCT03448419|2288373|FG001|Overall Study|Withdrawal by Subject|1
1163571|NCT03448419|2288372|FG000|Overall Study|Not treated|0
1163572|NCT03448419|2288373|FG001|Overall Study|Not treated|1
1163573|NCT03448419|2288372|FG000|Overall Study|Patient did not attend all visits|0
1163574|NCT03448419|2288373|FG001|Overall Study|Patient did not attend all visits|2
1163575|NCT03448419|2288372|FG000|Overall Study|Withdrawn by Sponsor|0
1163576|NCT03448419|2288373|FG001|Overall Study|Withdrawn by Sponsor|1
1163577|NCT03448536|2288383|FG000|Overall Study|Protocol Violation|2
1163578|NCT03448536|2288384|FG001|Overall Study|Protocol Violation|0
1163579|NCT03448536|2288383|FG000|Overall Study|Pregnancy|1
1163580|NCT03448536|2288384|FG001|Overall Study|Pregnancy|0
1163581|NCT03448536|2288383|FG000|Overall Study|Withdrawal by Subject|1
1163582|NCT03448536|2288384|FG001|Overall Study|Withdrawal by Subject|2
1163583|NCT03448536|2288383|FG000|Overall Study|Lost to Follow-up|3
1163584|NCT03448536|2288384|FG001|Overall Study|Lost to Follow-up|2
1163585|NCT03448536|2288383|FG000|Overall Study|Inadequate pain reporter|1
1163586|NCT03448536|2288384|FG001|Overall Study|Inadequate pain reporter|0
1163587|NCT03448536|2288383|FG000|Overall Study|Other|3
1163588|NCT03448536|2288384|FG001|Overall Study|Other|0
1163589|NCT03448536|2288383|FG000|Overall Study|Physician Decision|1
1163590|NCT03448536|2288384|FG001|Overall Study|Physician Decision|0
1163591|NCT03449030|2288400|FG000|Overall Study|Withdrawal by Subject|0
1163592|NCT03449030|2288401|FG001|Overall Study|Withdrawal by Subject|0
1163593|NCT03449030|2288402|FG002|Overall Study|Withdrawal by Subject|0
1163594|NCT03449030|2288403|FG003|Overall Study|Withdrawal by Subject|1
1163595|NCT03449030|2288404|FG004|Overall Study|Withdrawal by Subject|1
1163596|NCT03449030|2288405|FG005|Overall Study|Withdrawal by Subject|1
1163597|NCT03449030|2288406|FG006|Overall Study|Withdrawal by Subject|1
1163598|NCT03449030|2288407|FG007|Overall Study|Withdrawal by Subject|2
1163599|NCT03449030|2288408|FG008|Overall Study|Withdrawal by Subject|0
1163600|NCT03449030|2288409|FG009|Overall Study|Withdrawal by Subject|0
1163601|NCT03449030|2288400|FG000|Overall Study|Symptomatic Deterioration|0
1163602|NCT03449030|2288401|FG001|Overall Study|Symptomatic Deterioration|1
1163603|NCT03449030|2288402|FG002|Overall Study|Symptomatic Deterioration|0
1163604|NCT03449030|2288403|FG003|Overall Study|Symptomatic Deterioration|0
1163605|NCT03449030|2288404|FG004|Overall Study|Symptomatic Deterioration|0
1163606|NCT03449030|2288405|FG005|Overall Study|Symptomatic Deterioration|1
1163607|NCT03449030|2288406|FG006|Overall Study|Symptomatic Deterioration|1
1163608|NCT03449030|2288407|FG007|Overall Study|Symptomatic Deterioration|0
1163609|NCT03449030|2288408|FG008|Overall Study|Symptomatic Deterioration|2
1163610|NCT03449030|2288409|FG009|Overall Study|Symptomatic Deterioration|0
1163611|NCT03449030|2288400|FG000|Overall Study|Progressive Disease|1
1163612|NCT03449030|2288401|FG001|Overall Study|Progressive Disease|0
1163613|NCT03449030|2288402|FG002|Overall Study|Progressive Disease|1
1163614|NCT03449030|2288403|FG003|Overall Study|Progressive Disease|4
1163615|NCT03449030|2288404|FG004|Overall Study|Progressive Disease|5
1163616|NCT03449030|2288405|FG005|Overall Study|Progressive Disease|3
1163617|NCT03449030|2288406|FG006|Overall Study|Progressive Disease|0
1163618|NCT03449030|2288407|FG007|Overall Study|Progressive Disease|1
1163619|NCT03449030|2288408|FG008|Overall Study|Progressive Disease|1
1163620|NCT03449030|2288409|FG009|Overall Study|Progressive Disease|1
1163621|NCT03449030|2288400|FG000|Overall Study|Adverse Event|0
1163622|NCT03449030|2288401|FG001|Overall Study|Adverse Event|0
1163623|NCT03449030|2288402|FG002|Overall Study|Adverse Event|0
1163624|NCT03449030|2288403|FG003|Overall Study|Adverse Event|0
1163625|NCT03449030|2288404|FG004|Overall Study|Adverse Event|0
1163626|NCT03449030|2288405|FG005|Overall Study|Adverse Event|2
1163627|NCT03449030|2288406|FG006|Overall Study|Adverse Event|0
1163628|NCT03449030|2288407|FG007|Overall Study|Adverse Event|0
1163629|NCT03449030|2288408|FG008|Overall Study|Adverse Event|0
1163630|NCT03449030|2288409|FG009|Overall Study|Adverse Event|0
1163631|NCT03449030|2288400|FG000|Overall Study|Death|0
1163632|NCT03449030|2288401|FG001|Overall Study|Death|0
1163633|NCT03449030|2288402|FG002|Overall Study|Death|0
1163634|NCT03449030|2288403|FG003|Overall Study|Death|0
1163635|NCT03449030|2288404|FG004|Overall Study|Death|1
1163636|NCT03449030|2288405|FG005|Overall Study|Death|0
1163637|NCT03449030|2288406|FG006|Overall Study|Death|0
1163638|NCT03449030|2288407|FG007|Overall Study|Death|0
1163639|NCT03449030|2288408|FG008|Overall Study|Death|0
1163640|NCT03449030|2288409|FG009|Overall Study|Death|0
1163641|NCT03449134|2288435|FG000|52-Week Treatment Period|Death|2
1163642|NCT03449134|2288436|FG001|52-Week Treatment Period|Death|1
1163643|NCT03449134|2288437|FG002|52-Week Treatment Period|Death|0
1163644|NCT03449134|2288435|FG000|52-Week Treatment Period|Lost to Follow-up|2
1163645|NCT03449134|2288436|FG001|52-Week Treatment Period|Lost to Follow-up|1
1163646|NCT03449134|2288437|FG002|52-Week Treatment Period|Lost to Follow-up|1
1163647|NCT03449134|2288435|FG000|52-Week Treatment Period|Physician Decision|2
1163648|NCT03449134|2288436|FG001|52-Week Treatment Period|Physician Decision|3
1163649|NCT03449134|2288437|FG002|52-Week Treatment Period|Physician Decision|3
1163650|NCT03449134|2288435|FG000|52-Week Treatment Period|Screen Failure|1
1163651|NCT03449134|2288436|FG001|52-Week Treatment Period|Screen Failure|0
1163652|NCT03449134|2288437|FG002|52-Week Treatment Period|Screen Failure|1
1163653|NCT03449134|2288435|FG000|52-Week Treatment Period|Withdrawal by Subject|37
1163654|NCT03449134|2288436|FG001|52-Week Treatment Period|Withdrawal by Subject|39
1163655|NCT03449134|2288437|FG002|52-Week Treatment Period|Withdrawal by Subject|55
1163656|NCT03449134|2288435|FG000|52-Week Treatment Period|Site Closure|1
1163657|NCT03449134|2288436|FG001|52-Week Treatment Period|Site Closure|0
1163658|NCT03449134|2288437|FG002|52-Week Treatment Period|Site Closure|0
1163659|NCT03449147|2288451|FG000|52-week Treatment Period|Death|0
1163660|NCT03449147|2288452|FG001|52-week Treatment Period|Death|1
1163661|NCT03449147|2288453|FG002|52-week Treatment Period|Death|0
1163662|NCT03449147|2288451|FG000|52-week Treatment Period|Lost to Follow-up|6
1163663|NCT03449147|2288452|FG001|52-week Treatment Period|Lost to Follow-up|2
1163664|NCT03449147|2288453|FG002|52-week Treatment Period|Lost to Follow-up|5
1163665|NCT03449147|2288451|FG000|52-week Treatment Period|Other|0
1163666|NCT03449147|2288452|FG001|52-week Treatment Period|Other|1
1163667|NCT03449147|2288453|FG002|52-week Treatment Period|Other|2
1163668|NCT03449147|2288451|FG000|52-week Treatment Period|Physician Decision|1
1163669|NCT03449147|2288452|FG001|52-week Treatment Period|Physician Decision|0
1163670|NCT03449147|2288453|FG002|52-week Treatment Period|Physician Decision|3
1163671|NCT03449147|2288451|FG000|52-week Treatment Period|Screen Failure|1
1163672|NCT03449147|2288452|FG001|52-week Treatment Period|Screen Failure|2
1163673|NCT03449147|2288453|FG002|52-week Treatment Period|Screen Failure|0
1163674|NCT03449147|2288451|FG000|52-week Treatment Period|Withdrawal by Subject|46
1163675|NCT03449147|2288452|FG001|52-week Treatment Period|Withdrawal by Subject|68
1163676|NCT03449147|2288453|FG002|52-week Treatment Period|Withdrawal by Subject|74
1163677|NCT03449147|2288451|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1
1163678|NCT03449147|2288452|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
1163679|NCT03449147|2288453|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
1163680|NCT03449147|2288451|FG000|12-Week Off-Treatment Durability Period|Other|0
1163681|NCT03449147|2288452|FG001|12-Week Off-Treatment Durability Period|Other|1
1163682|NCT03449147|2288453|FG002|12-Week Off-Treatment Durability Period|Other|0
1163683|NCT03449446|2288501|FG000|Overall Study|Randomized but Never Treated|0
1163684|NCT03449446|2288502|FG001|Overall Study|Randomized but Never Treated|0
1163685|NCT03449446|2288503|FG002|Overall Study|Randomized but Never Treated|1
1163686|NCT03449446|2288504|FG003|Overall Study|Randomized but Never Treated|1
1163687|NCT03449446|2288505|FG004|Overall Study|Randomized but Never Treated|1
1163688|NCT03449446|2288506|FG005|Overall Study|Randomized but Never Treated|0
1163689|NCT03449446|2288507|FG006|Overall Study|Randomized but Never Treated|0
1163690|NCT03449446|2288501|FG000|Overall Study|Unknown Reason|33
1163691|NCT03449446|2288502|FG001|Overall Study|Unknown Reason|1
1163692|NCT03449446|2288503|FG002|Overall Study|Unknown Reason|1
1163693|NCT03449446|2288504|FG003|Overall Study|Unknown Reason|1
1163694|NCT03449446|2288505|FG004|Overall Study|Unknown Reason|2
1163695|NCT03449446|2288506|FG005|Overall Study|Unknown Reason|2
1163696|NCT03449446|2288507|FG006|Overall Study|Unknown Reason|0
1163697|NCT03449446|2288501|FG000|Overall Study|Withdrew Consent|1
1163698|NCT03449446|2288502|FG001|Overall Study|Withdrew Consent|3
1163699|NCT03449446|2288503|FG002|Overall Study|Withdrew Consent|1
1163700|NCT03449446|2288504|FG003|Overall Study|Withdrew Consent|4
1163701|NCT03449446|2288505|FG004|Overall Study|Withdrew Consent|4
1163702|NCT03449446|2288506|FG005|Overall Study|Withdrew Consent|4
1163703|NCT03449446|2288507|FG006|Overall Study|Withdrew Consent|1
1163704|NCT03449446|2288501|FG000|Overall Study|Adverse Event|1
1163705|NCT03449446|2288502|FG001|Overall Study|Adverse Event|2
1163706|NCT03449446|2288503|FG002|Overall Study|Adverse Event|1
1163707|NCT03449446|2288504|FG003|Overall Study|Adverse Event|0
1163708|NCT03449446|2288505|FG004|Overall Study|Adverse Event|0
1163709|NCT03449446|2288506|FG005|Overall Study|Adverse Event|2
1163710|NCT03449446|2288507|FG006|Overall Study|Adverse Event|0
1163711|NCT03449446|2288501|FG000|Overall Study|Lost to Follow-up|0
1163712|NCT03449446|2288502|FG001|Overall Study|Lost to Follow-up|0
1163713|NCT03449446|2288503|FG002|Overall Study|Lost to Follow-up|2
1163714|NCT03449446|2288504|FG003|Overall Study|Lost to Follow-up|1
1163715|NCT03449446|2288505|FG004|Overall Study|Lost to Follow-up|3
1163716|NCT03449446|2288506|FG005|Overall Study|Lost to Follow-up|0
1163717|NCT03449446|2288507|FG006|Overall Study|Lost to Follow-up|0
1163718|NCT03449446|2288501|FG000|Overall Study|Investigator's Discretion|0
1163719|NCT03449446|2288502|FG001|Overall Study|Investigator's Discretion|1
1163720|NCT03449446|2288503|FG002|Overall Study|Investigator's Discretion|1
1163721|NCT03449446|2288504|FG003|Overall Study|Investigator's Discretion|2
1163722|NCT03449446|2288505|FG004|Overall Study|Investigator's Discretion|0
1163723|NCT03449446|2288506|FG005|Overall Study|Investigator's Discretion|0
1163724|NCT03449446|2288507|FG006|Overall Study|Investigator's Discretion|0
1163725|NCT03449446|2288501|FG000|Overall Study|Non Compliance with Study Drug|1
1163726|NCT03449446|2288502|FG001|Overall Study|Non Compliance with Study Drug|0
1163727|NCT03449446|2288503|FG002|Overall Study|Non Compliance with Study Drug|0
1163728|NCT03449446|2288504|FG003|Overall Study|Non Compliance with Study Drug|0
1163729|NCT03449446|2288505|FG004|Overall Study|Non Compliance with Study Drug|0
1163730|NCT03449446|2288506|FG005|Overall Study|Non Compliance with Study Drug|0
1163731|NCT03449446|2288507|FG006|Overall Study|Non Compliance with Study Drug|0
1163732|NCT03449446|2288501|FG000|Overall Study|Protocol Violation|0
1163733|NCT03449446|2288502|FG001|Overall Study|Protocol Violation|0
1163734|NCT03449446|2288503|FG002|Overall Study|Protocol Violation|0
1163735|NCT03449446|2288504|FG003|Overall Study|Protocol Violation|0
1163736|NCT03449446|2288505|FG004|Overall Study|Protocol Violation|1
1163737|NCT03449446|2288506|FG005|Overall Study|Protocol Violation|1
1163738|NCT03449446|2288507|FG006|Overall Study|Protocol Violation|0
1163739|NCT03449446|2288501|FG000|Overall Study|Death|0
1163740|NCT03449446|2288502|FG001|Overall Study|Death|0
1163741|NCT03449446|2288503|FG002|Overall Study|Death|0
1163742|NCT03449446|2288504|FG003|Overall Study|Death|0
1163743|NCT03449446|2288505|FG004|Overall Study|Death|1
1163744|NCT03449446|2288506|FG005|Overall Study|Death|0
1163745|NCT03449446|2288507|FG006|Overall Study|Death|0
1163746|NCT03449758|2288523|FG000|Overall Study|Major protocol deviation|1
1163747|NCT03449758|2288523|FG000|Overall Study|Treatment inefficacy|5
1163748|NCT03449758|2288523|FG000|Overall Study|Adverse Event|9
1163749|NCT03449758|2288523|FG000|Overall Study|Consent withdrawal|1
1163750|NCT03449758|2288523|FG000|Overall Study|Other unspecified reason|3
1163751|NCT03449979|2288532|FG000|Overall Study|Technical difficulty|0
1163752|NCT03449979|2288533|FG001|Overall Study|Technical difficulty|0
1163753|NCT03449979|2288534|FG002|Overall Study|Technical difficulty|0
1163754|NCT03449979|2288535|FG003|Overall Study|Technical difficulty|1
1163755|NCT03450070|2288545|FG000|Overall Study|Withdrawal by Subject|8
1163756|NCT03451071|2288576|FG000|First Vaccine|Withdrawal by Subject|1
1163757|NCT03451071|2288576|FG000|Second Vaccine|Lost to Follow-up|19
1163758|NCT03451071|2288576|FG000|Third Vaccine|Lost to Follow-up|22
1163759|NCT03451071|2288576|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4
1163760|NCT03451084|2288584|FG000|Overall Study|Withdrawal by Subject|2
1163761|NCT03451084|2288585|FG001|Overall Study|Withdrawal by Subject|1
1163762|NCT03451084|2288586|FG002|Overall Study|Withdrawal by Subject|2
1163763|NCT03451084|2288587|FG003|Overall Study|Withdrawal by Subject|1
1163764|NCT03451084|2288584|FG000|Overall Study|Disease recurrence|0
1163765|NCT03451084|2288585|FG001|Overall Study|Disease recurrence|2
1163766|NCT03451084|2288586|FG002|Overall Study|Disease recurrence|0
1163767|NCT03451084|2288587|FG003|Overall Study|Disease recurrence|0
1163768|NCT03451084|2288584|FG000|Overall Study|Lack of Efficacy|0
1163769|NCT03451084|2288585|FG001|Overall Study|Lack of Efficacy|3
1163770|NCT03451084|2288586|FG002|Overall Study|Lack of Efficacy|0
1163771|NCT03451084|2288587|FG003|Overall Study|Lack of Efficacy|1
1163772|NCT03451084|2288584|FG000|Overall Study|Death|1
1163773|NCT03451084|2288585|FG001|Overall Study|Death|0
1163774|NCT03451084|2288586|FG002|Overall Study|Death|2
1163775|NCT03451084|2288587|FG003|Overall Study|Death|0
1163776|NCT03451084|2288584|FG000|Overall Study|Physician Decision|0
1163777|NCT03451084|2288585|FG001|Overall Study|Physician Decision|0
1163778|NCT03451084|2288586|FG002|Overall Study|Physician Decision|2
1163779|NCT03451084|2288587|FG003|Overall Study|Physician Decision|2
1163780|NCT03451084|2288584|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3
1163781|NCT03451084|2288585|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
1163782|NCT03451084|2288586|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
1163783|NCT03451084|2288587|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2
1163784|NCT03451721|2288597|FG000|Overall Study|Death|1
1163785|NCT03452189|2288648|FG000|First Intervention (3 Months)|Adverse Event|1
1163786|NCT03452189|2288649|FG001|First Intervention (3 Months)|Adverse Event|0
1163787|NCT03452189|2288648|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4
1163788|NCT03452189|2288649|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0
1163789|NCT03452527|2288666|FG000|Overall Study|Withdrawal by Subject|1
1163790|NCT03452527|2288667|FG001|Overall Study|Withdrawal by Subject|1
1163791|NCT03452527|2288666|FG000|Overall Study|Study Terminated|2
1163792|NCT03452527|2288667|FG001|Overall Study|Study Terminated|3
1163793|NCT03452943|2288675|FG000|Titration Period (7 Weeks)|Adverse Event|1
1163794|NCT03452943|2288676|FG001|Titration Period (7 Weeks)|Adverse Event|1
1163795|NCT03452943|2288675|FG000|Titration Period (7 Weeks)|Protocol Violation|0
1163796|NCT03452943|2288676|FG001|Titration Period (7 Weeks)|Protocol Violation|1
1163797|NCT03452943|2288675|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3
1163798|NCT03452943|2288676|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2
1163799|NCT03452943|2288675|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1
1163800|NCT03452943|2288676|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0
1163801|NCT03452943|2288675|FG000|Maintenance Period (5 Weeks)|Adverse Event|1
1163802|NCT03452943|2288676|FG001|Maintenance Period (5 Weeks)|Adverse Event|0
1163803|NCT03452943|2288675|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2
1163804|NCT03452943|2288676|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0
1163805|NCT03453151|2288703|FG000|Overall Study|Withdrawal by Subject|1
1163806|NCT03453151|2288703|FG000|Overall Study|Physician Decision|3
1163807|NCT03454412|2288735|FG000|Baseline Assesment|Physician Decision|12
1163808|NCT03455543|2288777|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2
1163809|NCT03455543|2288778|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5
1163810|NCT03455543|2288779|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0
1163811|NCT03455543|2288777|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7
1163812|NCT03455543|2288778|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2
1163813|NCT03455543|2288779|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0
1163814|NCT03455543|2288777|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2
1163815|NCT03455543|2288778|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
1163816|NCT03455543|2288779|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
1163817|NCT03455543|2288777|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
1163818|NCT03455543|2288778|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
1163819|NCT03455543|2288779|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3
1163820|NCT03455543|2288777|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
1163821|NCT03455543|2288778|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
1163822|NCT03455543|2288779|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20
1163823|NCT03455543|2288777|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
1163824|NCT03455543|2288778|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
1163825|NCT03455543|2288779|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7
1163826|NCT03455543|2288777|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
1163827|NCT03455543|2288778|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
1163828|NCT03455543|2288779|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4
1163829|NCT03455543|2288777|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
1163830|NCT03455543|2288778|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
1163831|NCT03455543|2288779|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2
1163832|NCT03455543|2288777|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
1163833|NCT03455543|2288778|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
1163834|NCT03455543|2288779|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1
1163835|NCT03456700|2288796|FG000|Overall Study|Withdrawal by Subject|1
1163836|NCT03456856|2288800|FG000|Overall Study|Lost to Follow-up|2
1163837|NCT03456856|2288800|FG000|Overall Study|Withdrawal by Subject|1
1163838|NCT03456960|2288810|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1163839|NCT03456960|2288811|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1163840|NCT03456960|2288812|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
1163841|NCT03456960|2288813|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
1163842|NCT03456960|2288814|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1163843|NCT03456960|2288815|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1163844|NCT03456960|2288810|FG000|Period 2 (1 Day)|Adverse Event|1
1163845|NCT03456960|2288811|FG001|Period 2 (1 Day)|Adverse Event|0
1163846|NCT03456960|2288812|FG002|Period 2 (1 Day)|Adverse Event|0
1163847|NCT03456960|2288813|FG003|Period 2 (1 Day)|Adverse Event|1
1163848|NCT03456960|2288814|FG004|Period 2 (1 Day)|Adverse Event|0
1163849|NCT03456960|2288815|FG005|Period 2 (1 Day)|Adverse Event|0
1163850|NCT03457103|2288833|FG000|Overall Study|illness/hospitalization|4
1163851|NCT03457103|2288834|FG001|Overall Study|illness/hospitalization|2
1163852|NCT03457103|2288833|FG000|Overall Study|Lost to Follow-up|2
1163853|NCT03457103|2288834|FG001|Overall Study|Lost to Follow-up|1
1163854|NCT03457103|2288833|FG000|Overall Study|Withdrawal by Subject|1
1163855|NCT03457103|2288834|FG001|Overall Study|Withdrawal by Subject|2
1163856|NCT03457103|2288833|FG000|Overall Study|financial/ insurance issues|1
1163857|NCT03457103|2288834|FG001|Overall Study|financial/ insurance issues|1
1163858|NCT03457636|2288849|FG000|Overall Study|Lost to Follow-up|2
1163859|NCT03457727|2288857|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
1163860|NCT03457727|2288858|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
1163861|NCT03457727|2288859|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
1163862|NCT03457727|2288860|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
1163863|NCT03458702|2288896|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
1163864|NCT03458702|2288897|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
1163865|NCT03458702|2288896|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
1163866|NCT03458702|2288897|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
1163867|NCT03459040|2288907|FG000|Overall Study|Death|8
1163868|NCT03459040|2288907|FG000|Overall Study|Withdrawal by Subject|1
1163869|NCT03459196|2288919|FG000|Overall Study|Subject didn't receive study catheter|2
1163870|NCT03461146|2288980|FG000|Overall Study|Adverse Event|2
1163871|NCT03461146|2288980|FG000|Overall Study|Physician Decision|1
1163876|NCT03461289|2288995|FG000|Overall Study|Death|1
1163877|NCT03461757|2289001|FG000|Overall Study|Adverse Event|1
1163878|NCT03461757|2289002|FG001|Overall Study|Adverse Event|0
1163879|NCT03461757|2289001|FG000|Overall Study|Lost to Follow-up|13
1163880|NCT03461757|2289002|FG001|Overall Study|Lost to Follow-up|7
1163881|NCT03461757|2289001|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28
1163882|NCT03461757|2289002|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25
1163883|NCT03461757|2289001|FG000|Overall Study|Non-compliance with study treatment|0
1163884|NCT03461757|2289002|FG001|Overall Study|Non-compliance with study treatment|1
1163885|NCT03461757|2289001|FG000|Overall Study|Pregnancy|2
1163886|NCT03461757|2289002|FG001|Overall Study|Pregnancy|0
1163887|NCT03461757|2289001|FG000|Overall Study|Protocol Violation|1
1163888|NCT03461757|2289002|FG001|Overall Study|Protocol Violation|1
1163889|NCT03461757|2289001|FG000|Overall Study|Withdrawal by Subject|7
1163890|NCT03461757|2289002|FG001|Overall Study|Withdrawal by Subject|7
1163891|NCT03461757|2289001|FG000|Overall Study|Other Reasons|1
1163892|NCT03461757|2289002|FG001|Overall Study|Other Reasons|4
1163893|NCT03462082|2289017|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0
1163894|NCT03462082|2289018|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0
1163895|NCT03462082|2289019|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0
1163896|NCT03462082|2289020|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0
1163897|NCT03462082|2289021|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0
1163898|NCT03462082|2289022|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0
1163899|NCT03462082|2289023|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1
1163900|NCT03462082|2289024|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2
1163901|NCT03462576|2289037|FG000|Overall Study|Protocol Violation|5
1163902|NCT03462576|2289038|FG001|Overall Study|Protocol Violation|11
1163903|NCT03462576|2289039|FG002|Overall Study|Protocol Violation|7
1163904|NCT03462576|2289037|FG000|Overall Study|Device Malfunction|0
1163905|NCT03462576|2289038|FG001|Overall Study|Device Malfunction|0
1163906|NCT03462576|2289039|FG002|Overall Study|Device Malfunction|1
1163907|NCT03462680|2289049|FG000|Overall Study|Withdrawal by Subject|3
1163908|NCT03462680|2289050|FG001|Overall Study|Withdrawal by Subject|5
1163909|NCT03463031|2289078|FG000|Overall Study|Withdrawal by Subject|4
1163910|NCT03463031|2289079|FG001|Overall Study|Withdrawal by Subject|2
1163911|NCT03463031|2289078|FG000|Overall Study|Investigator/Sponsor Decision|0
1163912|NCT03463031|2289079|FG001|Overall Study|Investigator/Sponsor Decision|1
1163913|NCT03463031|2289078|FG000|Overall Study|Lost to Follow-up|1
1163914|NCT03463031|2289079|FG001|Overall Study|Lost to Follow-up|1
1163915|NCT03463031|2289078|FG000|Overall Study|Adverse Event|4
1163916|NCT03463031|2289079|FG001|Overall Study|Adverse Event|1
1163917|NCT03463031|2289078|FG000|Overall Study|Use of prohibited medication by subject|1
1163918|NCT03463031|2289079|FG001|Overall Study|Use of prohibited medication by subject|0
1163919|NCT03464383|2289121|FG000|Overall Study|Lost to Follow-up|1
1163920|NCT03464383|2289122|FG001|Overall Study|Lost to Follow-up|0
1163921|NCT03464383|2289123|FG002|Overall Study|Lost to Follow-up|0
1163922|NCT03464383|2289121|FG000|Overall Study|Withdrawal by Subject|0
1163923|NCT03464383|2289122|FG001|Overall Study|Withdrawal by Subject|1
1163924|NCT03464383|2289123|FG002|Overall Study|Withdrawal by Subject|0
1163925|NCT03464422|2289132|FG000|Overall Study|Lost to Follow-up|2
1163926|NCT03464422|2289132|FG000|Overall Study|Withdrawal by Subject|2
1163927|NCT03465436|2289142|FG000|Period 1|Protocol Violation|0
1163928|NCT03465436|2289143|FG001|Period 1|Protocol Violation|0
1163929|NCT03465436|2289144|FG002|Period 1|Protocol Violation|1
1163930|NCT03465436|2289145|FG003|Period 1|Protocol Violation|0
1163931|NCT03465436|2289142|FG000|Period 2|Protocol Violation|0
1163932|NCT03465436|2289143|FG001|Period 2|Protocol Violation|1
1163933|NCT03465436|2289144|FG002|Period 2|Protocol Violation|0
1163934|NCT03465436|2289145|FG003|Period 2|Protocol Violation|0
1163935|NCT03465436|2289142|FG000|Period 3|Protocol Violation|1
1163936|NCT03465436|2289143|FG001|Period 3|Protocol Violation|1
1163937|NCT03465436|2289144|FG002|Period 3|Protocol Violation|0
1163938|NCT03465436|2289145|FG003|Period 3|Protocol Violation|0
1163939|NCT03465436|2289142|FG000|Period 4|Protocol Violation|0
1163940|NCT03465436|2289143|FG001|Period 4|Protocol Violation|0
1163941|NCT03465436|2289144|FG002|Period 4|Protocol Violation|1
1163942|NCT03465436|2289145|FG003|Period 4|Protocol Violation|0
1163943|NCT03465709|2289157|FG000|Overall Study|Study/Site Terminated by Sponsor|14
1163944|NCT03465709|2289157|FG000|Overall Study|Withdrawal by Subject|3
1163945|NCT03465722|2289165|FG000|End of Treatment|Patient Refused Treatment|3
1163946|NCT03465722|2289166|FG001|End of Treatment|Patient Refused Treatment|1
1163947|NCT03465722|2289165|FG000|End of Treatment|Withdrawal by Subject|6
1163948|NCT03465722|2289166|FG001|End of Treatment|Withdrawal by Subject|1
1163949|NCT03465722|2289165|FG000|End of Treatment|Adverse Event|30
1163950|NCT03465722|2289166|FG001|End of Treatment|Adverse Event|23
1163951|NCT03465722|2289165|FG000|End of Treatment|Disease Progression (Confirmed by Central Review)|102
1163952|NCT03465722|2289166|FG001|End of Treatment|Disease Progression (Confirmed by Central Review)|101
1163953|NCT03465722|2289165|FG000|End of Treatment|Clinical Progression|17
1163954|NCT03465722|2289166|FG001|End of Treatment|Clinical Progression|5
1163955|NCT03465722|2289165|FG000|End of Treatment|Physician Decision|4
1163956|NCT03465722|2289166|FG001|End of Treatment|Physician Decision|5
1163957|NCT03465722|2289165|FG000|End of Treatment|Lost to Follow-up|3
1163958|NCT03465722|2289166|FG001|End of Treatment|Lost to Follow-up|1
1163959|NCT03465722|2289165|FG000|End of Treatment|Administrative/Other|6
1163960|NCT03465722|2289166|FG001|End of Treatment|Administrative/Other|3
1163961|NCT03465722|2289165|FG000|End of Treatment|Treatment Ongoing|68
1163962|NCT03465722|2289166|FG001|End of Treatment|Treatment Ongoing|94
1163963|NCT03465722|2289165|FG000|End of Treatment|Randomized But Not Treated|1
1163964|NCT03465722|2289166|FG001|End of Treatment|Randomized But Not Treated|2
1163965|NCT03465722|2289165|FG000|End of Study|Withdrawal by Subject|17
1163966|NCT03465722|2289166|FG001|End of Study|Withdrawal by Subject|7
1163967|NCT03465722|2289165|FG000|End of Study|Death|57
1163968|NCT03465722|2289166|FG001|End of Study|Death|57
1163969|NCT03465722|2289165|FG000|End of Study|Lost to Follow-up|5
1163970|NCT03465722|2289166|FG001|End of Study|Lost to Follow-up|2
1163971|NCT03465722|2289165|FG000|End of Study|Administrative/Other|4
1163972|NCT03465722|2289166|FG001|End of Study|Administrative/Other|2
1163973|NCT03465722|2289165|FG000|End of Study|On Treatment or in Follow Up|157
1163974|NCT03465722|2289166|FG001|End of Study|On Treatment or in Follow Up|168
1163975|NCT03465878|2289174|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
1163976|NCT03465878|2289175|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1
1163977|NCT03465878|2289176|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
1163978|NCT03465878|2289177|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
1163979|NCT03465878|2289174|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
1163980|NCT03465878|2289175|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
1163981|NCT03465878|2289176|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
1163982|NCT03465878|2289177|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1
1163983|NCT03465878|2289174|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0
1163984|NCT03465878|2289175|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0
1163985|NCT03465878|2289176|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0
1163986|NCT03465878|2289177|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1
1163987|NCT03465904|2289205|FG000|Overall Study|Withdrawal by Subject|9
1163988|NCT03465904|2289206|FG001|Overall Study|Withdrawal by Subject|5
1163989|NCT03465904|2289205|FG000|Overall Study|Lost to Follow-up|10
1163990|NCT03465904|2289206|FG001|Overall Study|Lost to Follow-up|9
1163991|NCT03465904|2289205|FG000|Overall Study|Protocol Violation|8
1163992|NCT03465904|2289206|FG001|Overall Study|Protocol Violation|5
1163993|NCT03465904|2289205|FG000|Overall Study|Ineligible for mITT analysis|62
1163994|NCT03465904|2289206|FG001|Overall Study|Ineligible for mITT analysis|47
1163995|NCT03466060|2289241|FG000|Period 1|Test Lens Damage|0
1163996|NCT03466060|2289242|FG001|Period 1|Test Lens Damage|2
1163997|NCT03466060|2289243|FG002|Period 1|Test Lens Damage|0
1163998|NCT03466060|2289244|FG003|Period 1|Test Lens Damage|0
1163999|NCT03466060|2289245|FG004|Period 1|Test Lens Damage|0
1164000|NCT03466060|2289246|FG005|Period 1|Test Lens Damage|0
1164001|NCT03466060|2289241|FG000|Period 1|Withdrawal by Subject|0
1164002|NCT03466060|2289242|FG001|Period 1|Withdrawal by Subject|0
1164003|NCT03466060|2289243|FG002|Period 1|Withdrawal by Subject|2
1164004|NCT03466060|2289244|FG003|Period 1|Withdrawal by Subject|0
1164005|NCT03466060|2289245|FG004|Period 1|Withdrawal by Subject|0
1164006|NCT03466060|2289246|FG005|Period 1|Withdrawal by Subject|0
1164007|NCT03466060|2289241|FG000|Period 1|Lost to Follow-up|0
1164008|NCT03466060|2289242|FG001|Period 1|Lost to Follow-up|0
1164009|NCT03466060|2289243|FG002|Period 1|Lost to Follow-up|0
1164010|NCT03466060|2289244|FG003|Period 1|Lost to Follow-up|1
1164011|NCT03466060|2289245|FG004|Period 1|Lost to Follow-up|0
1164012|NCT03466060|2289246|FG005|Period 1|Lost to Follow-up|0
1164013|NCT03466060|2289241|FG000|Period 1|Grade 2 Conjunctivitis|0
1164014|NCT03466060|2289242|FG001|Period 1|Grade 2 Conjunctivitis|0
1164015|NCT03466060|2289243|FG002|Period 1|Grade 2 Conjunctivitis|1
1164016|NCT03466060|2289244|FG003|Period 1|Grade 2 Conjunctivitis|0
1164017|NCT03466060|2289245|FG004|Period 1|Grade 2 Conjunctivitis|0
1164018|NCT03466060|2289246|FG005|Period 1|Grade 2 Conjunctivitis|0
1164019|NCT03466060|2289241|FG000|Period 2|Lens Handling Difficulties|0
1164020|NCT03466060|2289242|FG001|Period 2|Lens Handling Difficulties|0
1164021|NCT03466060|2289243|FG002|Period 2|Lens Handling Difficulties|1
1164022|NCT03466060|2289244|FG003|Period 2|Lens Handling Difficulties|0
1164023|NCT03466060|2289245|FG004|Period 2|Lens Handling Difficulties|0
1164024|NCT03466060|2289246|FG005|Period 2|Lens Handling Difficulties|0
1164025|NCT03466073|2289266|FG000|Overall Study|Death|1
1164026|NCT03466073|2289267|FG001|Overall Study|Death|0
1164027|NCT03466073|2289268|FG002|Overall Study|Death|0
1164028|NCT03466073|2289269|FG003|Overall Study|Death|0
1164029|NCT03466073|2289270|FG004|Overall Study|Death|0
1164030|NCT03466073|2289271|FG005|Overall Study|Death|1
1164031|NCT03466086|2289292|FG000|Period 1|Sponsor decision due to study timeline|1
1164032|NCT03466086|2289293|FG001|Period 1|Sponsor decision due to study timeline|0
1164033|NCT03466086|2289292|FG000|Period 1|Withdrawal by Subject|1
1164034|NCT03466086|2289293|FG001|Period 1|Withdrawal by Subject|0
1164035|NCT03466099|2289302|FG000|Overall Study|Adverse Event|1
1164036|NCT03466099|2289303|FG001|Overall Study|Adverse Event|1
1164037|NCT03466099|2289304|FG002|Overall Study|Adverse Event|1
1164038|NCT03466099|2289302|FG000|Overall Study|Withdrawal by Subject|2
1164039|NCT03466099|2289303|FG001|Overall Study|Withdrawal by Subject|3
1164040|NCT03466099|2289304|FG002|Overall Study|Withdrawal by Subject|1
1164041|NCT03466099|2289302|FG000|Overall Study|Use of rescue medication|8
1164042|NCT03466099|2289303|FG001|Overall Study|Use of rescue medication|9
1164043|NCT03466099|2289304|FG002|Overall Study|Use of rescue medication|13
1164044|NCT03466099|2289302|FG000|Overall Study|Rescued without meeting criteria|4
1164045|NCT03466099|2289303|FG001|Overall Study|Rescued without meeting criteria|1
1164046|NCT03466099|2289304|FG002|Overall Study|Rescued without meeting criteria|1
1164047|NCT03466099|2289302|FG000|Overall Study|Subject compliance|2
1164048|NCT03466099|2289303|FG001|Overall Study|Subject compliance|0
1164049|NCT03466099|2289304|FG002|Overall Study|Subject compliance|0
1164050|NCT03466099|2289302|FG000|Overall Study|Worsening disease|0
1164051|NCT03466099|2289303|FG001|Overall Study|Worsening disease|0
1164052|NCT03466099|2289304|FG002|Overall Study|Worsening disease|1
1164053|NCT03467217|2289328|FG000|Overall Study|Trial stopped early|5
1164054|NCT03467217|2289329|FG001|Overall Study|Trial stopped early|2
1164055|NCT03467217|2289328|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5
1164056|NCT03467217|2289329|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2
1164057|NCT03467217|2289328|FG000|Overall Study|Lost to Follow-up|0
1164058|NCT03467217|2289329|FG001|Overall Study|Lost to Follow-up|2
1164059|NCT03467425|2289360|FG000|Overall Study|Adverse Event|9
1164060|NCT03467425|2289361|FG001|Overall Study|Adverse Event|9
1164061|NCT03467425|2289360|FG000|Overall Study|Lack of Efficacy|3
1164062|NCT03467425|2289361|FG001|Overall Study|Lack of Efficacy|1
1164063|NCT03467425|2289360|FG000|Overall Study|Protocol Violation|0
1164064|NCT03467425|2289361|FG001|Overall Study|Protocol Violation|1
1164065|NCT03467425|2289360|FG000|Overall Study|Lost to Follow-up|18
1164066|NCT03467425|2289361|FG001|Overall Study|Lost to Follow-up|25
1164067|NCT03467425|2289360|FG000|Overall Study|Physician Decision|2
1164068|NCT03467425|2289361|FG001|Overall Study|Physician Decision|1
1164069|NCT03467425|2289360|FG000|Overall Study|Withdrawal by Subject|15
1164070|NCT03467425|2289361|FG001|Overall Study|Withdrawal by Subject|17
1164071|NCT03467763|2289383|FG000|Overall Study|Lost to Follow-up|1
1164072|NCT03467763|2289383|FG000|Overall Study|Protocol Violation|2
1164073|NCT03467945|2289393|FG000|Treatment Period 2|Withdrawal by Subject|0
1164074|NCT03467945|2289394|FG001|Treatment Period 2|Withdrawal by Subject|1
1164075|NCT03467945|2289395|FG002|Treatment Period 2|Withdrawal by Subject|0
1164076|NCT03467945|2289396|FG003|Treatment Period 2|Withdrawal by Subject|0
1164077|NCT03467945|2289393|FG000|Treatment Period 3|Withdrawal by Subject|1
1164078|NCT03467945|2289394|FG001|Treatment Period 3|Withdrawal by Subject|0
1164079|NCT03467945|2289395|FG002|Treatment Period 3|Withdrawal by Subject|2
1164080|NCT03467945|2289396|FG003|Treatment Period 3|Withdrawal by Subject|1
1164081|NCT03467971|2289409|FG000|Treatment Period 2|Withdrawal by Subject|0
1164082|NCT03467971|2289410|FG001|Treatment Period 2|Withdrawal by Subject|1
1164083|NCT03468543|2289428|FG000|Overall Study|Protocol stopping rules met|3
1164084|NCT03468855|2289443|FG000|Overall Study|Adverse Event|2
1164085|NCT03468855|2289443|FG000|Overall Study|Lost to Follow-up|5
1164086|NCT03468855|2289443|FG000|Overall Study|Withdrawal by Subject|3
1164087|NCT03468855|2289443|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1
1164088|NCT03469336|2289465|FG000|Overall Study|Adverse Event|1
1164089|NCT03469349|2289477|FG000|Overall Study|Withdrawal by Subject|1
1164090|NCT03469349|2289478|FG001|Overall Study|Withdrawal by Subject|3
1164091|NCT03469349|2289477|FG000|Overall Study|Progressive Disease|0
1164092|NCT03469349|2289478|FG001|Overall Study|Progressive Disease|1
1164093|NCT03469349|2289477|FG000|Overall Study|Lost to Follow-up|2
1164094|NCT03469349|2289478|FG001|Overall Study|Lost to Follow-up|2
1164095|NCT03469349|2289477|FG000|Overall Study|Adverse Event|2
1164096|NCT03469349|2289478|FG001|Overall Study|Adverse Event|4
1164097|NCT03470194|2289490|FG000|Overall Study|Lost to Follow-up|11
1164098|NCT03470194|2289491|FG001|Overall Study|Lost to Follow-up|17
1164099|NCT03470545|2289503|FG000|Overall Study|Death|0
1164100|NCT03470545|2289504|FG001|Overall Study|Death|1
1164101|NCT03470545|2289503|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1
1164102|NCT03470545|2289504|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0
1164103|NCT03470545|2289503|FG000|Overall Study|Adverse Event|2
1164104|NCT03470545|2289504|FG001|Overall Study|Adverse Event|0
1164105|NCT03470545|2289503|FG000|Overall Study|Withdrawal by Subject|1
1164106|NCT03470545|2289504|FG001|Overall Study|Withdrawal by Subject|1
1164107|NCT03470545|2289503|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0
1164108|NCT03470545|2289504|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1
1164109|NCT03471078|2289527|FG000|Overall Study|Withdrawal by Subject|9
1164110|NCT03471078|2289528|FG001|Overall Study|Withdrawal by Subject|1
1164111|NCT03471078|2289527|FG000|Overall Study|Adverse Event|4
1164112|NCT03471078|2289528|FG001|Overall Study|Adverse Event|1
1164113|NCT03471078|2289527|FG000|Overall Study|Physician Decision|3
1164114|NCT03471078|2289528|FG001|Overall Study|Physician Decision|2
1164115|NCT03471078|2289527|FG000|Overall Study|Death|2
1164116|NCT03471078|2289528|FG001|Overall Study|Death|0
1164117|NCT03471078|2289527|FG000|Overall Study|Other|3
1164118|NCT03471078|2289528|FG001|Overall Study|Other|2
1164119|NCT03471871|2289545|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
1164120|NCT03471871|2289546|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
1164121|NCT03471871|2289547|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
1164122|NCT03471871|2289548|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
1164123|NCT03471871|2289549|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
1164124|NCT03471871|2289545|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
1164125|NCT03471871|2289546|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
1164126|NCT03471871|2289547|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
1164127|NCT03471871|2289548|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
1164128|NCT03471871|2289549|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
1164129|NCT03471871|2289545|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
1164130|NCT03471871|2289546|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
1164131|NCT03471871|2289547|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
1164132|NCT03471871|2289548|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
1164133|NCT03471871|2289549|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
1164134|NCT03471871|2289545|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
1164135|NCT03471871|2289546|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
1164136|NCT03471871|2289547|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
1164137|NCT03471871|2289548|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
1164138|NCT03471871|2289549|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
1164139|NCT03471871|2289545|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
1164140|NCT03471871|2289546|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
1164141|NCT03471871|2289547|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
1164142|NCT03471871|2289548|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
1164143|NCT03471871|2289549|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
1164144|NCT03472014|2289570|FG000|Overall Study|Lost to Follow-up|4
1164145|NCT03472326|2289585|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0
1164146|NCT03472326|2289586|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0
1164147|NCT03472326|2289587|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1
1164148|NCT03472326|2289588|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2
1164149|NCT03472326|2289585|FG000|Part 2: Combination Therapy|Pregnancy|0
1164150|NCT03472326|2289586|FG001|Part 2: Combination Therapy|Pregnancy|0
1164151|NCT03472326|2289587|FG002|Part 2: Combination Therapy|Pregnancy|0
1164152|NCT03472326|2289588|FG003|Part 2: Combination Therapy|Pregnancy|1
1164153|NCT03472521|2289608|FG000|Overall Study|Lost to Follow-up|3
1164154|NCT03472521|2289609|FG001|Overall Study|Lost to Follow-up|2
1164155|NCT03472521|2289608|FG000|Overall Study|Discontinued intervention|3
1164156|NCT03472521|2289609|FG001|Overall Study|Discontinued intervention|1
1164157|NCT03472534|2289615|FG000|Overall Study|Withdrawal by Subject|9
1164158|NCT03472534|2289615|FG000|Overall Study|Adverse Event|2
1164159|NCT03472547|2289619|FG000|Overall Study|Withdrawal by Subject|30
1164160|NCT03472885|2289623|FG000|Overall Study|Adverse Event|1
1164161|NCT03473197|2289635|FG000|Overall Study|Adverse Event|4
1164162|NCT03473197|2289635|FG000|Overall Study|Lost to Follow-up|1
1164163|NCT03473197|2289635|FG000|Overall Study|Withdrawal by Subject|5
1164164|NCT03473236|2289649|FG000|Overall Study|Withdrawal by Subject|0
1164165|NCT03473236|2289650|FG001|Overall Study|Withdrawal by Subject|0
1164166|NCT03473236|2289651|FG002|Overall Study|Withdrawal by Subject|0
1164167|NCT03473236|2289652|FG003|Overall Study|Withdrawal by Subject|0
1164168|NCT03473236|2289653|FG004|Overall Study|Withdrawal by Subject|0
1164169|NCT03473236|2289654|FG005|Overall Study|Withdrawal by Subject|1
1164170|NCT03473236|2289655|FG006|Overall Study|Withdrawal by Subject|0
1164171|NCT03473236|2289656|FG007|Overall Study|Withdrawal by Subject|0
1164172|NCT03473236|2289657|FG008|Overall Study|Withdrawal by Subject|1
1164173|NCT03473236|2289658|FG009|Overall Study|Withdrawal by Subject|0
1164174|NCT03473301|2289691|FG000|Overall Study|Protocol Violation|4
1164175|NCT03473301|2289692|FG001|Overall Study|Protocol Violation|0
1164176|NCT03473301|2289693|FG002|Overall Study|Protocol Violation|0
1164177|NCT03473301|2289691|FG000|Overall Study|Withdrawal by Subject|0
1164178|NCT03473301|2289692|FG001|Overall Study|Withdrawal by Subject|1
1164179|NCT03473301|2289693|FG002|Overall Study|Withdrawal by Subject|0
1164180|NCT03473301|2289691|FG000|Overall Study|Missed study visit due to pandemic restrictions|7
1164181|NCT03473301|2289692|FG001|Overall Study|Missed study visit due to pandemic restrictions|5
1164182|NCT03473301|2289693|FG002|Overall Study|Missed study visit due to pandemic restrictions|6
1164183|NCT03473808|2289712|FG000|Overall Study|Withdrawal by Subject|1
1164184|NCT03474081|2289731|FG000|Overall Study|Adverse Event|6
1164185|NCT03474081|2289732|FG001|Overall Study|Adverse Event|3
1164186|NCT03474081|2289731|FG000|Overall Study|Lost to Follow-up|2
1164187|NCT03474081|2289732|FG001|Overall Study|Lost to Follow-up|1
1164188|NCT03474081|2289731|FG000|Overall Study|Physician Decision|3
1164189|NCT03474081|2289732|FG001|Overall Study|Physician Decision|2
1164190|NCT03474081|2289731|FG000|Overall Study|Withdrawal by Subject|5
1164191|NCT03474081|2289732|FG001|Overall Study|Withdrawal by Subject|7
1164192|NCT03474081|2289731|FG000|Overall Study|Investigator site closed|1
1164193|NCT03474081|2289732|FG001|Overall Study|Investigator site closed|0
1164210|NCT03475056|2289771|FG000|Overall Study|Lost to Follow-up|0
1164211|NCT03475056|2289772|FG001|Overall Study|Lost to Follow-up|1
1164212|NCT03475056|2289771|FG000|Overall Study|Moved from Area|0
1164213|NCT03475056|2289772|FG001|Overall Study|Moved from Area|2
1164214|NCT03475316|2289781|FG000|6 Month Intervention|Adverse Event|2
1164215|NCT03475316|2289782|FG001|6 Month Intervention|Adverse Event|1
1164216|NCT03475316|2289781|FG000|6 Month Intervention|Withdrawal by Subject|2
1164217|NCT03475316|2289782|FG001|6 Month Intervention|Withdrawal by Subject|0
1164218|NCT03475316|2289781|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1
1164219|NCT03475316|2289782|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3
1164220|NCT03475316|2289781|FG000|9 Months|Study stopped due to COVID pandemic|3
1164221|NCT03475316|2289782|FG001|9 Months|Study stopped due to COVID pandemic|4
1164222|NCT03475875|2289788|FG000|Period 1|Lost to Follow-up|1
1164223|NCT03475875|2289789|FG001|Period 1|Lost to Follow-up|0
1164224|NCT03475875|2289788|FG000|Period 1|Adverse Event|2
1164225|NCT03475875|2289789|FG001|Period 1|Adverse Event|1
1164226|NCT03475875|2289788|FG000|Period 2|Adverse Event|3
1164227|NCT03475875|2289789|FG001|Period 2|Adverse Event|0
1164228|NCT03475875|2289788|FG000|Period 2|Protocol Violation|0
1164229|NCT03475875|2289789|FG001|Period 2|Protocol Violation|1
1164236|NCT03476798|2289835|FG000|Overall Study|Death|1
1164237|NCT03476798|2289835|FG000|Overall Study|Withdrawal by Subject|2
1164238|NCT03476798|2289835|FG000|Overall Study|Protocol Violation|2
1164239|NCT03477838|2289879|FG000|Overall Study|Lost to Follow-up|14
1164240|NCT03478371|2289897|FG000|Overall Study|non-compliance|1
1164241|NCT03478371|2289897|FG000|Overall Study|Lost to Follow-up|4
1164242|NCT03478644|2289909|FG000|Phase 2|Withdrawal by Subject|2
1164243|NCT03478644|2289910|FG001|Phase 2|Withdrawal by Subject|1
1164244|NCT03478644|2289909|FG000|Phase 2|Lost to Follow-up|1
1164245|NCT03478644|2289910|FG001|Phase 2|Lost to Follow-up|0
1164246|NCT03478657|2289918|FG000|Overall Study|Withdrawal by Subject|0
1164247|NCT03478657|2289919|FG001|Overall Study|Withdrawal by Subject|1
1164248|NCT03478683|2289927|FG000|Overall Study|Adverse Event|5
1164249|NCT03478683|2289928|FG001|Overall Study|Adverse Event|3
1164250|NCT03478683|2289927|FG000|Overall Study|Lost to Follow-up|0
1164251|NCT03478683|2289928|FG001|Overall Study|Lost to Follow-up|5
1164252|NCT03478683|2289927|FG000|Overall Study|Physician Decision|1
1164253|NCT03478683|2289928|FG001|Overall Study|Physician Decision|3
1164254|NCT03478683|2289927|FG000|Overall Study|Withdrawal by Subject|7
1164255|NCT03478683|2289928|FG001|Overall Study|Withdrawal by Subject|7
1164256|NCT03478696|2289936|FG000|Overall Study|Adverse Event|1
1164257|NCT03478696|2289937|FG001|Overall Study|Adverse Event|5
1164258|NCT03478696|2289936|FG000|Overall Study|Lost to Follow-up|1
1164259|NCT03478696|2289937|FG001|Overall Study|Lost to Follow-up|0
1164260|NCT03478696|2289936|FG000|Overall Study|Physician Decision|6
1164261|NCT03478696|2289937|FG001|Overall Study|Physician Decision|3
1164262|NCT03478696|2289936|FG000|Overall Study|Withdrawal by Subject|9
1164263|NCT03478696|2289937|FG001|Overall Study|Withdrawal by Subject|4
1164264|NCT03478787|2289945|FG000|Overall Study|Adverse Event|5
1164265|NCT03478787|2289946|FG001|Overall Study|Adverse Event|1
1164266|NCT03478787|2289945|FG000|Overall Study|Protocol Violation|3
1164267|NCT03478787|2289946|FG001|Overall Study|Protocol Violation|0
1164268|NCT03478787|2289945|FG000|Overall Study|Lack of Efficacy|7
1164269|NCT03478787|2289946|FG001|Overall Study|Lack of Efficacy|1
1164270|NCT03478787|2289945|FG000|Overall Study|Lost to Follow-up|9
1164271|NCT03478787|2289946|FG001|Overall Study|Lost to Follow-up|5
1164272|NCT03478787|2289945|FG000|Overall Study|Withdrawal by Subject|2
1164273|NCT03478787|2289946|FG001|Overall Study|Withdrawal by Subject|6
1164274|NCT03478787|2289945|FG000|Overall Study|Other, Not Specified|3
1164275|NCT03478787|2289946|FG001|Overall Study|Other, Not Specified|0
1164276|NCT03478891|2289955|FG000|Overall Study|Enrolled, but product never administered|0
1164277|NCT03478891|2289956|FG001|Overall Study|Enrolled, but product never administered|0
1164278|NCT03478891|2289957|FG002|Overall Study|Enrolled, but product never administered|1
1164279|NCT03478891|2289955|FG000|Overall Study|Moved from area|0
1164280|NCT03478891|2289956|FG001|Overall Study|Moved from area|0
1164281|NCT03478891|2289957|FG002|Overall Study|Moved from area|1
1164282|NCT03478891|2289955|FG000|Overall Study|Lost to Follow-up|1
1164283|NCT03478891|2289956|FG001|Overall Study|Lost to Follow-up|0
1164284|NCT03478891|2289957|FG002|Overall Study|Lost to Follow-up|1
1164285|NCT03478930|2289982|FG000|Overall Study|Adverse Event|0
1164286|NCT03478930|2289983|FG001|Overall Study|Adverse Event|1
1164287|NCT03478930|2289982|FG000|Overall Study|Lack of Efficacy|3
1164288|NCT03478930|2289983|FG001|Overall Study|Lack of Efficacy|3
1164289|NCT03478930|2289982|FG000|Overall Study|Withdrawal by Subject|6
1164290|NCT03478930|2289983|FG001|Overall Study|Withdrawal by Subject|5
1164297|NCT03478969|2290001|FG000|Overall Study|Withdrawal by Subject|4
1164298|NCT03478969|2290002|FG001|Overall Study|Withdrawal by Subject|7
1164299|NCT03478969|2290003|FG002|Overall Study|Withdrawal by Subject|6
1164300|NCT03478969|2290001|FG000|Overall Study|Adverse Event|2
1164301|NCT03478969|2290002|FG001|Overall Study|Adverse Event|0
1164302|NCT03478969|2290003|FG002|Overall Study|Adverse Event|1
1164303|NCT03478969|2290001|FG000|Overall Study|Pregnancy|1
1164304|NCT03478969|2290002|FG001|Overall Study|Pregnancy|0
1164305|NCT03478969|2290003|FG002|Overall Study|Pregnancy|0
1164306|NCT03478969|2290001|FG000|Overall Study|Personal Reasons|1
1164307|NCT03478969|2290002|FG001|Overall Study|Personal Reasons|0
1164308|NCT03478969|2290003|FG002|Overall Study|Personal Reasons|1
1164309|NCT03478969|2290001|FG000|Overall Study|Covid-19|1
1164310|NCT03478969|2290002|FG001|Overall Study|Covid-19|4
1164311|NCT03478969|2290003|FG002|Overall Study|Covid-19|3
1164312|NCT03478969|2290001|FG000|Overall Study|Multiple Reasons|0
1164313|NCT03478969|2290002|FG001|Overall Study|Multiple Reasons|1
1164314|NCT03478969|2290003|FG002|Overall Study|Multiple Reasons|1
1164315|NCT03478969|2290001|FG000|Overall Study|Eligibility Criteria|0
1164316|NCT03478969|2290002|FG001|Overall Study|Eligibility Criteria|0
1164317|NCT03478969|2290003|FG002|Overall Study|Eligibility Criteria|5
1164318|NCT03478969|2290001|FG000|Overall Study|Lost to Follow-up|0
1164319|NCT03478969|2290002|FG001|Overall Study|Lost to Follow-up|0
1164320|NCT03478969|2290003|FG002|Overall Study|Lost to Follow-up|1
1164321|NCT03479216|2290032|FG000|Overall Study|Withdrawal by Subject|3
1164322|NCT03479216|2290033|FG001|Overall Study|Withdrawal by Subject|2
1164323|NCT03479216|2290032|FG000|Overall Study|Physician Decision|2
1164324|NCT03479216|2290033|FG001|Overall Study|Physician Decision|3
1164325|NCT03480009|2290051|FG000|Overall Study|Lost to Follow-up|4
1164326|NCT03480009|2290052|FG001|Overall Study|Lost to Follow-up|5
1164327|NCT03480009|2290053|FG002|Overall Study|Lost to Follow-up|4
1164328|NCT03480009|2290054|FG003|Overall Study|Lost to Follow-up|0
1164329|NCT03480022|2290069|FG000|Overall Study|Pregnancy|2
1164330|NCT03480022|2290070|FG001|Overall Study|Pregnancy|0
1164331|NCT03480022|2290069|FG000|Overall Study|Adverse Event|6
1164332|NCT03480022|2290070|FG001|Overall Study|Adverse Event|0
1164333|NCT03480022|2290069|FG000|Overall Study|Lack of Efficacy|0
1164334|NCT03480022|2290070|FG001|Overall Study|Lack of Efficacy|2
1164335|NCT03480022|2290069|FG000|Overall Study|Physician Decision|0
1164336|NCT03480022|2290070|FG001|Overall Study|Physician Decision|1
1164337|NCT03480022|2290069|FG000|Overall Study|Withdrawal by Subject|2
1164338|NCT03480022|2290070|FG001|Overall Study|Withdrawal by Subject|0
1164339|NCT03480022|2290069|FG000|Overall Study|Medication concerns|1
1164340|NCT03480022|2290070|FG001|Overall Study|Medication concerns|0
1164341|NCT03480022|2290069|FG000|Overall Study|Family member COVID exposure|0
1164342|NCT03480022|2290070|FG001|Overall Study|Family member COVID exposure|1
1164343|NCT03480152|2290087|FG000|Phase I|Signed consent. Died before treatment.|1
1164344|NCT03480152|2290088|FG001|Phase I|Signed consent. Died before treatment.|0
1164345|NCT03480152|2290089|FG002|Phase I|Signed consent. Died before treatment.|0
1164346|NCT03480243|2290097|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1
1164347|NCT03480243|2290097|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1
1164348|NCT03480425|2290110|FG000|Overall Study|Force transducer technical failure|1
1164349|NCT03480750|2290126|FG000|Overall Study|Withdrawal by Subject|0
1164350|NCT03480750|2290127|FG001|Overall Study|Withdrawal by Subject|1
1164351|NCT03480750|2290128|FG002|Overall Study|Withdrawal by Subject|0
1164352|NCT03480750|2290129|FG003|Overall Study|Withdrawal by Subject|0
1164353|NCT03480750|2290130|FG004|Overall Study|Withdrawal by Subject|0
1164354|NCT03480750|2290131|FG005|Overall Study|Withdrawal by Subject|0
1164355|NCT03480750|2290126|FG000|Overall Study|The interruption in Trientine shippment|0
1164356|NCT03480750|2290127|FG001|Overall Study|The interruption in Trientine shippment|0
1164357|NCT03480750|2290128|FG002|Overall Study|The interruption in Trientine shippment|0
1164358|NCT03480750|2290129|FG003|Overall Study|The interruption in Trientine shippment|0
1164359|NCT03480750|2290130|FG004|Overall Study|The interruption in Trientine shippment|0
1164360|NCT03480750|2290131|FG005|Overall Study|The interruption in Trientine shippment|1
1164361|NCT03480763|2290156|FG000|Overall Study|Withdrawal by Subject|18
1164362|NCT03480763|2290157|FG001|Overall Study|Withdrawal by Subject|10
1164363|NCT03480763|2290156|FG000|Overall Study|Lost to Follow-up|4
1164364|NCT03480763|2290157|FG001|Overall Study|Lost to Follow-up|7
1164365|NCT03480763|2290156|FG000|Overall Study|non-study pneumococcal vaccine|1
1164366|NCT03480763|2290157|FG001|Overall Study|non-study pneumococcal vaccine|0
1164367|NCT03480763|2290156|FG000|Overall Study|oncological treatment|0
1164368|NCT03480763|2290157|FG001|Overall Study|oncological treatment|2
1164369|NCT03480763|2290156|FG000|Overall Study|pain with vaccination|1
1164370|NCT03480763|2290157|FG001|Overall Study|pain with vaccination|0
1164371|NCT03480802|2290171|FG000|Overall Study|Lost to Follow-up|5
1164372|NCT03480802|2290172|FG001|Overall Study|Lost to Follow-up|1
1164373|NCT03480802|2290171|FG000|Overall Study|Withdrawal by Subject|2
1164374|NCT03480802|2290172|FG001|Overall Study|Withdrawal by Subject|1
1164375|NCT03480802|2290171|FG000|Overall Study|Relocated|0
1164376|NCT03480802|2290172|FG001|Overall Study|Relocated|1
1164377|NCT03480841|2290180|FG000|Overall Study|Lost to Follow-up|2
1164378|NCT03480932|2290200|FG000|Overall Study|Death|1
1164379|NCT03480932|2290201|FG001|Overall Study|Death|1
1164380|NCT03480932|2290202|FG002|Overall Study|Death|0
1164381|NCT03480932|2290200|FG000|Overall Study|Lost to Follow-up|0
1164382|NCT03480932|2290201|FG001|Overall Study|Lost to Follow-up|2
1164383|NCT03480932|2290202|FG002|Overall Study|Lost to Follow-up|3
1164384|NCT03480932|2290200|FG000|Overall Study|Incarcerated|2
1164385|NCT03480932|2290201|FG001|Overall Study|Incarcerated|2
1164386|NCT03480932|2290202|FG002|Overall Study|Incarcerated|2
1164387|NCT03481309|2290225|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1
1164388|NCT03481309|2290226|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0
1164389|NCT03481309|2290227|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0
1164390|NCT03481309|2290228|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0
1164391|NCT03481309|2290229|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0
1164392|NCT03481309|2290230|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0
1164393|NCT03481725|2290249|FG000|Overall Study|Withdrawal by Subject|1
1164394|NCT03481725|2290250|FG001|Overall Study|Withdrawal by Subject|0
1164395|NCT03481816|2290260|FG000|Starting Dose|Refused further vaccines after 1 dose|1
1164396|NCT03481816|2290261|FG001|Starting Dose|Refused further vaccines after 1 dose|0
1164397|NCT03481816|2290260|FG000|Dose Expansion|Off treatment due to progressive disease|0
1164398|NCT03481816|2290261|FG001|Dose Expansion|Off treatment due to progressive disease|5
1164399|NCT03481816|2290260|FG000|Dose Expansion|Withdrawal by Subject|0
1164400|NCT03481816|2290261|FG001|Dose Expansion|Withdrawal by Subject|2
1164401|NCT03481816|2290260|FG000|Dose Expansion|Physician Decision|0
1164402|NCT03481816|2290261|FG001|Dose Expansion|Physician Decision|5
1164403|NCT03482011|2290271|FG000|Induction Period (16 Weeks)|Adverse Event|1
1164404|NCT03482011|2290272|FG001|Induction Period (16 Weeks)|Adverse Event|3
1164405|NCT03482011|2290273|FG002|Induction Period (16 Weeks)|Adverse Event|0
1164406|NCT03482011|2290274|FG003|Induction Period (16 Weeks)|Adverse Event|0
1164407|NCT03482011|2290275|FG004|Induction Period (16 Weeks)|Adverse Event|0
1164408|NCT03482011|2290276|FG005|Induction Period (16 Weeks)|Adverse Event|0
1164409|NCT03482011|2290277|FG006|Induction Period (16 Weeks)|Adverse Event|0
1164410|NCT03482011|2290278|FG007|Induction Period (16 Weeks)|Adverse Event|0
1164411|NCT03482011|2290271|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3
1164412|NCT03482011|2290272|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1
1164413|NCT03482011|2290273|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
1164414|NCT03482011|2290274|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
1164415|NCT03482011|2290275|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
1164416|NCT03482011|2290276|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
1164417|NCT03482011|2290277|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
1164418|NCT03482011|2290278|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
1164419|NCT03482011|2290271|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0
1164420|NCT03482011|2290272|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1
1164421|NCT03482011|2290273|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0
1164422|NCT03482011|2290274|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0
1164423|NCT03482011|2290275|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0
1164424|NCT03482011|2290276|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0
1164425|NCT03482011|2290277|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0
1164426|NCT03482011|2290278|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0
1164427|NCT03482011|2290271|FG000|Induction Period (16 Weeks)|Screen Failure|0
1164428|NCT03482011|2290272|FG001|Induction Period (16 Weeks)|Screen Failure|1
1164429|NCT03482011|2290273|FG002|Induction Period (16 Weeks)|Screen Failure|0
1164430|NCT03482011|2290274|FG003|Induction Period (16 Weeks)|Screen Failure|0
1164431|NCT03482011|2290275|FG004|Induction Period (16 Weeks)|Screen Failure|0
1164432|NCT03482011|2290276|FG005|Induction Period (16 Weeks)|Screen Failure|0
1164433|NCT03482011|2290277|FG006|Induction Period (16 Weeks)|Screen Failure|0
1164434|NCT03482011|2290278|FG007|Induction Period (16 Weeks)|Screen Failure|0
1164435|NCT03482011|2290271|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
1164436|NCT03482011|2290272|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5
1164437|NCT03482011|2290273|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
1164438|NCT03482011|2290274|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
1164439|NCT03482011|2290275|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
1164440|NCT03482011|2290276|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
1164441|NCT03482011|2290277|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
1164442|NCT03482011|2290278|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
1164443|NCT03482011|2290271|FG000|Maintenance Period (36 Weeks)|Adverse Event|0
1164444|NCT03482011|2290272|FG001|Maintenance Period (36 Weeks)|Adverse Event|0
1164445|NCT03482011|2290273|FG002|Maintenance Period (36 Weeks)|Adverse Event|0
1164446|NCT03482011|2290274|FG003|Maintenance Period (36 Weeks)|Adverse Event|0
1164447|NCT03482011|2290275|FG004|Maintenance Period (36 Weeks)|Adverse Event|0
1164448|NCT03482011|2290276|FG005|Maintenance Period (36 Weeks)|Adverse Event|1
1164449|NCT03482011|2290277|FG006|Maintenance Period (36 Weeks)|Adverse Event|1
1164450|NCT03482011|2290278|FG007|Maintenance Period (36 Weeks)|Adverse Event|4
1164451|NCT03482011|2290271|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0
1164452|NCT03482011|2290272|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0
1164453|NCT03482011|2290273|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1
1164454|NCT03482011|2290274|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2
1164455|NCT03482011|2290275|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1
1164456|NCT03482011|2290276|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1
1164457|NCT03482011|2290277|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0
1164458|NCT03482011|2290278|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9
1164459|NCT03482011|2290271|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1164460|NCT03482011|2290272|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1164461|NCT03482011|2290273|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1164462|NCT03482011|2290274|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1164463|NCT03482011|2290275|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2
1164464|NCT03482011|2290276|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1164465|NCT03482011|2290277|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
1164466|NCT03482011|2290278|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1
1164467|NCT03482011|2290271|FG000|Maintenance Period (36 Weeks)|Physician Decision|0
1164468|NCT03482011|2290272|FG001|Maintenance Period (36 Weeks)|Physician Decision|0
1164469|NCT03482011|2290273|FG002|Maintenance Period (36 Weeks)|Physician Decision|0
1164470|NCT03482011|2290274|FG003|Maintenance Period (36 Weeks)|Physician Decision|1
1164471|NCT03482011|2290275|FG004|Maintenance Period (36 Weeks)|Physician Decision|0
1164472|NCT03482011|2290276|FG005|Maintenance Period (36 Weeks)|Physician Decision|1
1164473|NCT03482011|2290277|FG006|Maintenance Period (36 Weeks)|Physician Decision|1
1164474|NCT03482011|2290278|FG007|Maintenance Period (36 Weeks)|Physician Decision|1
1164475|NCT03482011|2290271|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1164476|NCT03482011|2290272|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1164477|NCT03482011|2290273|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
1164478|NCT03482011|2290274|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
1164479|NCT03482011|2290275|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
1164480|NCT03482011|2290276|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
1164481|NCT03482011|2290277|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
1164482|NCT03482011|2290278|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
1164483|NCT03482011|2290271|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
1164484|NCT03482011|2290272|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
1164485|NCT03482011|2290273|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
1164486|NCT03482011|2290274|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2
1164487|NCT03482011|2290275|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
1164488|NCT03482011|2290276|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
1164489|NCT03482011|2290277|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
1164490|NCT03482011|2290278|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5
1164491|NCT03482011|2290271|FG000|Follow-up Period (12 Weeks)|Adverse Event|0
1164492|NCT03482011|2290272|FG001|Follow-up Period (12 Weeks)|Adverse Event|0
1164493|NCT03482011|2290273|FG002|Follow-up Period (12 Weeks)|Adverse Event|0
1164494|NCT03482011|2290274|FG003|Follow-up Period (12 Weeks)|Adverse Event|0
1164495|NCT03482011|2290275|FG004|Follow-up Period (12 Weeks)|Adverse Event|0
1164496|NCT03482011|2290276|FG005|Follow-up Period (12 Weeks)|Adverse Event|0
1164497|NCT03482011|2290277|FG006|Follow-up Period (12 Weeks)|Adverse Event|1
1164498|NCT03482011|2290278|FG007|Follow-up Period (12 Weeks)|Adverse Event|4
1164499|NCT03482011|2290271|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0
1164500|NCT03482011|2290272|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0
1164501|NCT03482011|2290273|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1
1164502|NCT03482011|2290274|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3
1164503|NCT03482011|2290275|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0
1164504|NCT03482011|2290276|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0
1164505|NCT03482011|2290277|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0
1164506|NCT03482011|2290278|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6
1164507|NCT03482011|2290271|FG000|Follow-up Period (12 Weeks)|Physician Decision|0
1164508|NCT03482011|2290272|FG001|Follow-up Period (12 Weeks)|Physician Decision|0
1164509|NCT03482011|2290273|FG002|Follow-up Period (12 Weeks)|Physician Decision|0
1164510|NCT03482011|2290274|FG003|Follow-up Period (12 Weeks)|Physician Decision|0
1164511|NCT03482011|2290275|FG004|Follow-up Period (12 Weeks)|Physician Decision|0
1164512|NCT03482011|2290276|FG005|Follow-up Period (12 Weeks)|Physician Decision|0
1164513|NCT03482011|2290277|FG006|Follow-up Period (12 Weeks)|Physician Decision|0
1164514|NCT03482011|2290278|FG007|Follow-up Period (12 Weeks)|Physician Decision|1
1164515|NCT03482011|2290271|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0
1164516|NCT03482011|2290272|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0
1164517|NCT03482011|2290273|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0
1164518|NCT03482011|2290274|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0
1164519|NCT03482011|2290275|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0
1164520|NCT03482011|2290276|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0
1164521|NCT03482011|2290277|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0
1164522|NCT03482011|2290278|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1
1164523|NCT03482453|2290315|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1164524|NCT03482453|2290316|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1164525|NCT03482453|2290317|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1164526|NCT03482453|2290318|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1164527|NCT03482453|2290319|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1164528|NCT03482453|2290320|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1164529|NCT03482453|2290321|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1164530|NCT03482453|2290322|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1164531|NCT03482453|2290323|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1164532|NCT03482453|2290324|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1164533|NCT03482453|2290325|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
1164534|NCT03482453|2290326|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1164535|NCT03482635|2290380|FG000|Overall Study|Lack of Efficacy|0
1164536|NCT03482635|2290381|FG001|Overall Study|Lack of Efficacy|0
1164537|NCT03482635|2290382|FG002|Overall Study|Lack of Efficacy|1
1164538|NCT03482635|2290383|FG003|Overall Study|Lack of Efficacy|3
1164539|NCT03482635|2290380|FG000|Overall Study|Adverse Event|2
1164540|NCT03482635|2290381|FG001|Overall Study|Adverse Event|2
1164541|NCT03482635|2290382|FG002|Overall Study|Adverse Event|0
1164542|NCT03482635|2290383|FG003|Overall Study|Adverse Event|3
1164543|NCT03482635|2290380|FG000|Overall Study|Withdrawal by Subject|2
1164544|NCT03482635|2290381|FG001|Overall Study|Withdrawal by Subject|1
1164545|NCT03482635|2290382|FG002|Overall Study|Withdrawal by Subject|0
1164546|NCT03482635|2290383|FG003|Overall Study|Withdrawal by Subject|1
1164547|NCT03482635|2290380|FG000|Overall Study|Withdrawn by Principle Investigator|1
1164548|NCT03482635|2290381|FG001|Overall Study|Withdrawn by Principle Investigator|0
1164549|NCT03482635|2290382|FG002|Overall Study|Withdrawn by Principle Investigator|0
1164550|NCT03482635|2290383|FG003|Overall Study|Withdrawn by Principle Investigator|0
1164551|NCT03482635|2290380|FG000|Overall Study|Not treated|0
1164552|NCT03482635|2290381|FG001|Overall Study|Not treated|0
1164553|NCT03482635|2290382|FG002|Overall Study|Not treated|0
1164554|NCT03482635|2290383|FG003|Overall Study|Not treated|1
1164555|NCT03482882|2290402|FG000|Overall Study|Adverse Event|3
1164556|NCT03482882|2290402|FG000|Overall Study|Lost to Follow-up|1
1164557|NCT03482882|2290402|FG000|Overall Study|Protocol Violation|2
1164558|NCT03482882|2290402|FG000|Overall Study|Not further specified|1
1164559|NCT03483623|2290421|FG000|Overall Study|43 complete sets achieved|1
1164560|NCT03483961|2290464|FG000|Overall Study|Lost to Follow-up|7
1164561|NCT03483961|2290465|FG001|Overall Study|Lost to Follow-up|6
1164562|NCT03483961|2290466|FG002|Overall Study|Lost to Follow-up|6
1164563|NCT03483961|2290467|FG003|Overall Study|Lost to Follow-up|6
1164564|NCT03483961|2290468|FG004|Overall Study|Lost to Follow-up|6
1164565|NCT03483961|2290469|FG005|Overall Study|Lost to Follow-up|4
1164566|NCT03483961|2290470|FG006|Overall Study|Lost to Follow-up|4
1164567|NCT03483961|2290471|FG007|Overall Study|Lost to Follow-up|11
1164568|NCT03483961|2290472|FG008|Overall Study|Lost to Follow-up|1
1164569|NCT03483961|2290473|FG009|Overall Study|Lost to Follow-up|0
1164570|NCT03483961|2290464|FG000|Overall Study|Withdrawal by Subject|3
1164571|NCT03483961|2290465|FG001|Overall Study|Withdrawal by Subject|4
1164572|NCT03483961|2290466|FG002|Overall Study|Withdrawal by Subject|5
1164573|NCT03483961|2290467|FG003|Overall Study|Withdrawal by Subject|3
1164574|NCT03483961|2290468|FG004|Overall Study|Withdrawal by Subject|4
1164575|NCT03483961|2290469|FG005|Overall Study|Withdrawal by Subject|2
1164576|NCT03483961|2290470|FG006|Overall Study|Withdrawal by Subject|1
1164577|NCT03483961|2290471|FG007|Overall Study|Withdrawal by Subject|2
1164578|NCT03483961|2290472|FG008|Overall Study|Withdrawal by Subject|1
1164579|NCT03483961|2290473|FG009|Overall Study|Withdrawal by Subject|0
1164580|NCT03483961|2290464|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1
1164581|NCT03483961|2290465|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
1164582|NCT03483961|2290466|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
1164583|NCT03483961|2290467|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
1164584|NCT03483961|2290468|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
1164585|NCT03483961|2290469|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
1164586|NCT03483961|2290470|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
1164587|NCT03483961|2290471|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
1164588|NCT03483961|2290472|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
1164589|NCT03483961|2290473|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
1164590|NCT03483961|2290464|FG000|Overall Study|Adverse Event|0
1164591|NCT03483961|2290465|FG001|Overall Study|Adverse Event|0
1164592|NCT03483961|2290466|FG002|Overall Study|Adverse Event|1
1164593|NCT03483961|2290467|FG003|Overall Study|Adverse Event|0
1164594|NCT03483961|2290468|FG004|Overall Study|Adverse Event|0
1164595|NCT03483961|2290469|FG005|Overall Study|Adverse Event|0
1164596|NCT03483961|2290470|FG006|Overall Study|Adverse Event|0
1164597|NCT03483961|2290471|FG007|Overall Study|Adverse Event|0
1164598|NCT03483961|2290472|FG008|Overall Study|Adverse Event|0
1164599|NCT03483961|2290473|FG009|Overall Study|Adverse Event|0
1164600|NCT03484273|2290494|FG000|Overall Study|Equipment Malfunction|1
1164601|NCT03484273|2290494|FG000|Overall Study|Data excluded from analysis|1
1164602|NCT03484429|2290508|FG000|Overall Study|Withdrawal by Subject|1
1164603|NCT03484429|2290509|FG001|Overall Study|Withdrawal by Subject|0
1164604|NCT03484429|2290508|FG000|Overall Study|Adverse Event|2
1164605|NCT03484429|2290509|FG001|Overall Study|Adverse Event|0
1164606|NCT03485222|2290517|FG000|Overall Study|Death|0
1164607|NCT03485222|2290518|FG001|Overall Study|Death|1
1164608|NCT03485222|2290517|FG000|Overall Study|Lost to Follow-up|2
1164609|NCT03485222|2290518|FG001|Overall Study|Lost to Follow-up|1
1164610|NCT03485495|2290530|FG000|Overall Study|Non-compliance with inclusion criteria|1
1164611|NCT03485495|2290531|FG001|Overall Study|Non-compliance with inclusion criteria|0
1164612|NCT03485911|2290540|FG000|Overall Study|Withdrawal by Subject|0
1164613|NCT03485911|2290541|FG001|Overall Study|Withdrawal by Subject|2
1164614|NCT03485911|2290542|FG002|Overall Study|Withdrawal by Subject|2
1164615|NCT03485911|2290540|FG000|Overall Study|Adverse Event|1
1164616|NCT03485911|2290541|FG001|Overall Study|Adverse Event|0
1164617|NCT03485911|2290542|FG002|Overall Study|Adverse Event|1
1164618|NCT03485911|2290540|FG000|Overall Study|High frequency of HAE attacks|0
1164619|NCT03485911|2290541|FG001|Overall Study|High frequency of HAE attacks|0
1164620|NCT03485911|2290542|FG002|Overall Study|High frequency of HAE attacks|1
1164621|NCT03485950|2290552|FG000|Overall Study|Adverse Event|1
1164622|NCT03485950|2290553|FG001|Overall Study|Adverse Event|0
1164623|NCT03485950|2290552|FG000|Overall Study|Death|3
1164624|NCT03485950|2290553|FG001|Overall Study|Death|2
1164625|NCT03485950|2290552|FG000|Overall Study|Withdrawal by Subject|3
1164626|NCT03485950|2290553|FG001|Overall Study|Withdrawal by Subject|0
1164627|NCT03486392|2290568|FG000|Overall Study|Lost to Follow-up|0
1164628|NCT03486392|2290569|FG001|Overall Study|Lost to Follow-up|0
1164629|NCT03486392|2290570|FG002|Overall Study|Lost to Follow-up|8
1164630|NCT03486392|2290571|FG003|Overall Study|Lost to Follow-up|5
1164631|NCT03486392|2290572|FG004|Overall Study|Lost to Follow-up|2
1164632|NCT03486392|2290568|FG000|Overall Study|Withdrawal by Subject|3
1164633|NCT03486392|2290569|FG001|Overall Study|Withdrawal by Subject|0
1164634|NCT03486392|2290570|FG002|Overall Study|Withdrawal by Subject|6
1164635|NCT03486392|2290571|FG003|Overall Study|Withdrawal by Subject|4
1164636|NCT03486392|2290572|FG004|Overall Study|Withdrawal by Subject|1
1164637|NCT03486392|2290568|FG000|Overall Study|Death|0
1164638|NCT03486392|2290569|FG001|Overall Study|Death|0
1164639|NCT03486392|2290570|FG002|Overall Study|Death|0
1164640|NCT03486392|2290571|FG003|Overall Study|Death|0
1164641|NCT03486392|2290572|FG004|Overall Study|Death|1
1164642|NCT03486834|2290587|FG000|Overall Study|Withdrawal by Subject|46
1164643|NCT03486834|2290588|FG001|Overall Study|Withdrawal by Subject|46
1164644|NCT03486834|2290589|FG002|Overall Study|Withdrawal by Subject|52
1164645|NCT03486834|2290587|FG000|Overall Study|Adverse Event|8
1164646|NCT03486834|2290588|FG001|Overall Study|Adverse Event|7
1164647|NCT03486834|2290589|FG002|Overall Study|Adverse Event|0
1164648|NCT03486834|2290587|FG000|Overall Study|Lost to Follow-up|41
1164649|NCT03486834|2290588|FG001|Overall Study|Lost to Follow-up|24
1164650|NCT03486834|2290589|FG002|Overall Study|Lost to Follow-up|39
1164651|NCT03486834|2290587|FG000|Overall Study|Non-compliance with Study Drug|2
1164652|NCT03486834|2290588|FG001|Overall Study|Non-compliance with Study Drug|2
1164653|NCT03486834|2290589|FG002|Overall Study|Non-compliance with Study Drug|0
1164654|NCT03486834|2290587|FG000|Overall Study|Physician Decision|5
1164655|NCT03486834|2290588|FG001|Overall Study|Physician Decision|2
1164656|NCT03486834|2290589|FG002|Overall Study|Physician Decision|3
1164657|NCT03486834|2290587|FG000|Overall Study|Pregnancy|10
1164658|NCT03486834|2290588|FG001|Overall Study|Pregnancy|12
1164659|NCT03486834|2290589|FG002|Overall Study|Pregnancy|12
1164660|NCT03486834|2290587|FG000|Overall Study|Protocol Deviation|2
1164661|NCT03486834|2290588|FG001|Overall Study|Protocol Deviation|3
1164662|NCT03486834|2290589|FG002|Overall Study|Protocol Deviation|3
1164663|NCT03486834|2290587|FG000|Overall Study|Withdrawal by Parent/Guardian|1
1164664|NCT03486834|2290588|FG001|Overall Study|Withdrawal by Parent/Guardian|2
1164665|NCT03486834|2290589|FG002|Overall Study|Withdrawal by Parent/Guardian|2
1164666|NCT03486834|2290587|FG000|Overall Study|Randomized but not treated|4
1164667|NCT03486834|2290588|FG001|Overall Study|Randomized but not treated|4
1164668|NCT03486834|2290589|FG002|Overall Study|Randomized but not treated|1
1164669|NCT03487445|2290684|FG000|Randomization|Not treated for administrative reasons|1
1164670|NCT03487445|2290685|FG001|Randomization|Not treated for administrative reasons|0
1164671|NCT03487549|2290693|FG000|Overall Study|Protocol Violation|0
1164672|NCT03487549|2290694|FG001|Overall Study|Protocol Violation|1
1164673|NCT03487549|2290693|FG000|Overall Study|Lost to Follow-up|2
1164674|NCT03487549|2290694|FG001|Overall Study|Lost to Follow-up|1
1164675|NCT03487549|2290693|FG000|Overall Study|Withdrawal by Subject|2
1164676|NCT03487549|2290694|FG001|Overall Study|Withdrawal by Subject|0
1164677|NCT03487848|2290713|FG000|Overall Study|Lost to Follow-up|1
1164678|NCT03488108|2290733|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0
1164679|NCT03488108|2290734|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
1164680|NCT03488108|2290733|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
1164681|NCT03488108|2290734|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
1164682|NCT03488225|2290742|FG000|Overall Study|Off Protocol Therapy|2
1164683|NCT03488225|2290742|FG000|Overall Study|Stem Cell Transplant|2
1164684|NCT03488238|2290746|FG000|Overall Study|Equipment malfunction|1
1164685|NCT03488238|2290746|FG000|Overall Study|Adverse Event|1
1164686|NCT03488927|2290766|FG000|Overall Study|Withdrawal by Subject|44
1164687|NCT03488927|2290767|FG001|Overall Study|Withdrawal by Subject|118
1164688|NCT03488927|2290768|FG002|Overall Study|Withdrawal by Subject|217
1164689|NCT03489304|2290776|FG000|Overall Study|Lost to Follow-up|4
1164690|NCT03489343|2290787|FG000|Overall Study|Documented progressive disease|1
1164691|NCT03489343|2290788|FG001|Overall Study|Documented progressive disease|0
1164692|NCT03489343|2290789|FG002|Overall Study|Documented progressive disease|3
1164693|NCT03489343|2290790|FG003|Overall Study|Documented progressive disease|1
1164694|NCT03489343|2290791|FG004|Overall Study|Documented progressive disease|3
1164695|NCT03489343|2290792|FG005|Overall Study|Documented progressive disease|5
1164696|NCT03489343|2290793|FG006|Overall Study|Documented progressive disease|4
1164697|NCT03489343|2290787|FG000|Overall Study|Adverse Event|0
1164698|NCT03489343|2290788|FG001|Overall Study|Adverse Event|1
1164699|NCT03489343|2290789|FG002|Overall Study|Adverse Event|0
1164700|NCT03489343|2290790|FG003|Overall Study|Adverse Event|0
1164701|NCT03489343|2290791|FG004|Overall Study|Adverse Event|0
1164702|NCT03489343|2290792|FG005|Overall Study|Adverse Event|1
1164703|NCT03489343|2290793|FG006|Overall Study|Adverse Event|0
1164704|NCT03489343|2290787|FG000|Overall Study|Withdrawal by Subject|0
1164705|NCT03489343|2290788|FG001|Overall Study|Withdrawal by Subject|0
1164706|NCT03489343|2290789|FG002|Overall Study|Withdrawal by Subject|0
1164707|NCT03489343|2290790|FG003|Overall Study|Withdrawal by Subject|1
1164708|NCT03489343|2290791|FG004|Overall Study|Withdrawal by Subject|0
1164709|NCT03489343|2290792|FG005|Overall Study|Withdrawal by Subject|1
1164710|NCT03489343|2290793|FG006|Overall Study|Withdrawal by Subject|1
1164711|NCT03489343|2290787|FG000|Overall Study|Clinical progression|0
1164712|NCT03489343|2290788|FG001|Overall Study|Clinical progression|0
1164713|NCT03489343|2290789|FG002|Overall Study|Clinical progression|0
1164714|NCT03489343|2290790|FG003|Overall Study|Clinical progression|1
1164715|NCT03489343|2290791|FG004|Overall Study|Clinical progression|0
1164716|NCT03489343|2290792|FG005|Overall Study|Clinical progression|0
1164717|NCT03489343|2290793|FG006|Overall Study|Clinical progression|1
1164718|NCT03489369|2290813|FG000|Overall Study|Documented Progressive Disease|3
1164719|NCT03489369|2290814|FG001|Overall Study|Documented Progressive Disease|2
1164720|NCT03489369|2290815|FG002|Overall Study|Documented Progressive Disease|3
1164721|NCT03489369|2290816|FG003|Overall Study|Documented Progressive Disease|6
1164722|NCT03489369|2290813|FG000|Overall Study|Clinical Progression (Worsening of Clini|0
1164723|NCT03489369|2290814|FG001|Overall Study|Clinical Progression (Worsening of Clini|1
1164724|NCT03489369|2290815|FG002|Overall Study|Clinical Progression (Worsening of Clini|0
1164725|NCT03489369|2290816|FG003|Overall Study|Clinical Progression (Worsening of Clini|0
1164726|NCT03489551|2290826|FG000|Overall Study|Withdrawal by Subject|2
1164727|NCT03489720|2290832|FG000|Overall Study|Withdrawal by Subject|2
1164728|NCT03489720|2290833|FG001|Overall Study|Withdrawal by Subject|0
1164729|NCT03489863|2290854|FG000|Overall Study|Withdrawal by Subject|0
1164730|NCT03489863|2290855|FG001|Overall Study|Withdrawal by Subject|1
1164731|NCT03490032|2290872|FG000|Overall Study|family issue (child custody)|1
1164732|NCT03490032|2290873|FG001|Overall Study|family issue (child custody)|0
1164733|NCT03490032|2290874|FG002|Overall Study|family issue (child custody)|0
1164734|NCT03490981|2290911|FG000|Overall Study|Lost to Follow-up|1
1164735|NCT03490981|2290912|FG001|Overall Study|Lost to Follow-up|2
1164736|NCT03491150|2290920|FG000|Overall Study|Adverse Event|1
1164737|NCT03491150|2290921|FG001|Overall Study|Adverse Event|0
1164738|NCT03491150|2290920|FG000|Overall Study|Study Terminated by Sponsor|74
1164739|NCT03491150|2290921|FG001|Overall Study|Study Terminated by Sponsor|70
1164740|NCT03491150|2290920|FG000|Overall Study|Other|0
1164741|NCT03491150|2290921|FG001|Overall Study|Other|1
1164742|NCT03491150|2290920|FG000|Overall Study|Withdrawal by Subject|1
1164743|NCT03491150|2290921|FG001|Overall Study|Withdrawal by Subject|2
1164744|NCT03491553|2290937|FG000|Main Study (Up to Week 48)|Adverse Event|0
1164745|NCT03491553|2290938|FG001|Main Study (Up to Week 48)|Adverse Event|0
1164746|NCT03491553|2290939|FG002|Main Study (Up to Week 48)|Adverse Event|0
1164747|NCT03491553|2290940|FG003|Main Study (Up to Week 48)|Adverse Event|1
1164748|NCT03491553|2290941|FG004|Main Study (Up to Week 48)|Adverse Event|0
1164749|NCT03491553|2290942|FG005|Main Study (Up to Week 48)|Adverse Event|0
1164750|NCT03491553|2290937|FG000|Main Study (Up to Week 48)|Withdrew Consent|1
1164751|NCT03491553|2290938|FG001|Main Study (Up to Week 48)|Withdrew Consent|1
1164752|NCT03491553|2290939|FG002|Main Study (Up to Week 48)|Withdrew Consent|0
1164753|NCT03491553|2290940|FG003|Main Study (Up to Week 48)|Withdrew Consent|0
1164754|NCT03491553|2290941|FG004|Main Study (Up to Week 48)|Withdrew Consent|0
1164755|NCT03491553|2290942|FG005|Main Study (Up to Week 48)|Withdrew Consent|0
1164756|NCT03492281|2290995|FG000|Overall Study|Withdrawal by Subject|21
1164757|NCT03492281|2290996|FG001|Overall Study|Withdrawal by Subject|14
1164758|NCT03492281|2290997|FG002|Overall Study|Withdrawal by Subject|13
1164759|NCT03492281|2290995|FG000|Overall Study|Lost to Follow-up|14
1164760|NCT03492281|2290996|FG001|Overall Study|Lost to Follow-up|15
1164761|NCT03492281|2290997|FG002|Overall Study|Lost to Follow-up|10
1164762|NCT03492281|2290995|FG000|Overall Study|Adverse Event|6
1164763|NCT03492281|2290996|FG001|Overall Study|Adverse Event|8
1164764|NCT03492281|2290997|FG002|Overall Study|Adverse Event|13
1164765|NCT03492281|2290995|FG000|Overall Study|Lack of Efficacy|3
1164766|NCT03492281|2290996|FG001|Overall Study|Lack of Efficacy|0
1164767|NCT03492281|2290997|FG002|Overall Study|Lack of Efficacy|1
1164768|NCT03492281|2290995|FG000|Overall Study|Physician Decision|1
1164769|NCT03492281|2290996|FG001|Overall Study|Physician Decision|0
1164770|NCT03492281|2290997|FG002|Overall Study|Physician Decision|3
1164771|NCT03492281|2290995|FG000|Overall Study|Protocol Violation|0
1164772|NCT03492281|2290996|FG001|Overall Study|Protocol Violation|2
1164773|NCT03492281|2290997|FG002|Overall Study|Protocol Violation|1
1164774|NCT03492281|2290995|FG000|Overall Study|Withdrawn Due to Sponsor|1
1164775|NCT03492281|2290996|FG001|Overall Study|Withdrawn Due to Sponsor|0
1164776|NCT03492281|2290997|FG002|Overall Study|Withdrawn Due to Sponsor|1
1164777|NCT03492281|2290995|FG000|Overall Study|Death|0
1164778|NCT03492281|2290996|FG001|Overall Study|Death|0
1164779|NCT03492281|2290997|FG002|Overall Study|Death|1
1164780|NCT03492281|2290995|FG000|Overall Study|Captured as Other in Database|8
1164781|NCT03492281|2290996|FG001|Overall Study|Captured as Other in Database|6
1164782|NCT03492281|2290997|FG002|Overall Study|Captured as Other in Database|3
1164783|NCT03492554|2291047|FG000|Overall Study|Protocol Violation|0
1164784|NCT03492554|2291048|FG001|Overall Study|Protocol Violation|14
1164785|NCT03493386|2291057|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1164786|NCT03493386|2291058|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
1164787|NCT03493386|2291059|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1164788|NCT03493386|2291060|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1164789|NCT03493542|2291079|FG000|Overall Study|Ongoing|2
1164790|NCT03493542|2291080|FG001|Overall Study|Ongoing|3
1164791|NCT03493542|2291079|FG000|Overall Study|Withdrawal by parent or guardian|3
1164792|NCT03493542|2291080|FG001|Overall Study|Withdrawal by parent or guardian|0
1164793|NCT03493542|2291079|FG000|Overall Study|Withdrawal by Subject|2
1164794|NCT03493542|2291080|FG001|Overall Study|Withdrawal by Subject|6
1164795|NCT03493698|2291090|FG000|Treatment Period C|Adverse Event|1
1164796|NCT03493698|2291090|FG000|Treatment Period C|Withdrawal by Subject|1
1164797|NCT03493854|2291128|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3
1164798|NCT03493854|2291129|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5
1164799|NCT03493854|2291128|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
1164800|NCT03493854|2291129|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
1164801|NCT03493854|2291128|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0
1164802|NCT03493854|2291129|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1
1164803|NCT03493854|2291128|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1
1164804|NCT03493854|2291129|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2
1164805|NCT03493854|2291128|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
1164806|NCT03493854|2291129|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
1164807|NCT03493854|2291128|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
1164808|NCT03493854|2291129|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2
1164809|NCT03493854|2291128|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
1164810|NCT03493854|2291129|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0
1164811|NCT03493854|2291128|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229
1164812|NCT03493854|2291129|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228
1164813|NCT03493854|2291128|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
1164814|NCT03493854|2291129|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
1164815|NCT03493854|2291128|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0
1164816|NCT03493854|2291129|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1
1164817|NCT03493854|2291128|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3
1164818|NCT03493854|2291129|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0
1164819|NCT03493854|2291128|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1
1164820|NCT03493854|2291129|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0
1164821|NCT03493854|2291128|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2
1164822|NCT03493854|2291129|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0
1164823|NCT03493854|2291128|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5
1164824|NCT03493854|2291129|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3
1164825|NCT03493854|2291128|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
1164826|NCT03493854|2291129|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
1164827|NCT03493854|2291128|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18
1164828|NCT03493854|2291129|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16
1164829|NCT03494725|2291137|FG000|Overall Study|Withdrawal by Subject|0
1164830|NCT03494725|2291138|FG001|Overall Study|Withdrawal by Subject|2
1164831|NCT03494725|2291137|FG000|Overall Study|Antibiotic use|1
1164832|NCT03494725|2291138|FG001|Overall Study|Antibiotic use|0
1164833|NCT03494816|2291150|FG000|Overall Study|Protocol Violation|2
1164834|NCT03494816|2291150|FG000|Overall Study|Physician Decision|2
1164835|NCT03494816|2291150|FG000|Overall Study|Did not start trial treatment|1
1164836|NCT03494816|2291150|FG000|Overall Study|Adverse Event|1
1164837|NCT03494985|2291162|FG000|Overall Study|Adverse Event|3
1164838|NCT03494985|2291163|FG001|Overall Study|Adverse Event|2
1164839|NCT03494985|2291164|FG002|Overall Study|Adverse Event|3
1164840|NCT03494985|2291165|FG003|Overall Study|Adverse Event|0
1164841|NCT03494985|2291162|FG000|Overall Study|Other (Withdrawal of consent)|2
1164842|NCT03494985|2291163|FG001|Overall Study|Other (Withdrawal of consent)|3
1164843|NCT03494985|2291164|FG002|Overall Study|Other (Withdrawal of consent)|2
1164844|NCT03494985|2291165|FG003|Overall Study|Other (Withdrawal of consent)|5
1164845|NCT03494985|2291162|FG000|Overall Study|Other (Not specified)|0
1164846|NCT03494985|2291163|FG001|Overall Study|Other (Not specified)|1
1164847|NCT03494985|2291164|FG002|Overall Study|Other (Not specified)|1
1164848|NCT03494985|2291165|FG003|Overall Study|Other (Not specified)|0
1164849|NCT03495102|2291178|FG000|Overall Study|Adverse Event|5
1164850|NCT03495102|2291179|FG001|Overall Study|Adverse Event|7
1164851|NCT03495102|2291180|FG002|Overall Study|Adverse Event|10
1164852|NCT03495102|2291178|FG000|Overall Study|Death|3
1164853|NCT03495102|2291179|FG001|Overall Study|Death|4
1164854|NCT03495102|2291180|FG002|Overall Study|Death|4
1164855|NCT03495102|2291178|FG000|Overall Study|Lost to Follow-up|15
1164856|NCT03495102|2291179|FG001|Overall Study|Lost to Follow-up|16
1164857|NCT03495102|2291180|FG002|Overall Study|Lost to Follow-up|17
1164858|NCT03495102|2291178|FG000|Overall Study|Physician Decision|2
1164859|NCT03495102|2291179|FG001|Overall Study|Physician Decision|0
1164860|NCT03495102|2291180|FG002|Overall Study|Physician Decision|2
1164861|NCT03495102|2291178|FG000|Overall Study|Withdrawal by Subject|25
1164862|NCT03495102|2291179|FG001|Overall Study|Withdrawal by Subject|36
1164863|NCT03495102|2291180|FG002|Overall Study|Withdrawal by Subject|18
1164864|NCT03495102|2291178|FG000|Overall Study|Protocol Violation|1
1164865|NCT03495102|2291179|FG001|Overall Study|Protocol Violation|1
1164866|NCT03495102|2291180|FG002|Overall Study|Protocol Violation|0
1164867|NCT03495102|2291178|FG000|Overall Study|Site Closure|3
1164868|NCT03495102|2291179|FG001|Overall Study|Site Closure|1
1164869|NCT03495102|2291180|FG002|Overall Study|Site Closure|2
1164870|NCT03495102|2291178|FG000|Overall Study|Non-compliance|1
1164871|NCT03495102|2291179|FG001|Overall Study|Non-compliance|0
1164872|NCT03495102|2291180|FG002|Overall Study|Non-compliance|0
1164873|NCT03495102|2291178|FG000|Overall Study|Participant Duplicated at Another Site|0
1164874|NCT03495102|2291179|FG001|Overall Study|Participant Duplicated at Another Site|0
1164875|NCT03495102|2291180|FG002|Overall Study|Participant Duplicated at Another Site|1
1164876|NCT03495102|2291178|FG000|Overall Study|Primary Care Physician Recommendation|0
1164877|NCT03495102|2291179|FG001|Overall Study|Primary Care Physician Recommendation|1
1164878|NCT03495102|2291180|FG002|Overall Study|Primary Care Physician Recommendation|0
1164879|NCT03495102|2291178|FG000|Overall Study|Relocated to Another Country|0
1164880|NCT03495102|2291179|FG001|Overall Study|Relocated to Another Country|1
1164881|NCT03495102|2291180|FG002|Overall Study|Relocated to Another Country|0
1164882|NCT03495102|2291178|FG000|Overall Study|Participant was in Rehabilitation|1
1164883|NCT03495102|2291179|FG001|Overall Study|Participant was in Rehabilitation|0
1164884|NCT03495102|2291180|FG002|Overall Study|Participant was in Rehabilitation|0
1164885|NCT03495817|2291197|FG000|26 Week Open Label|Adverse Event|3
1164886|NCT03495817|2291197|FG000|26 Week Open Label|Withdrawal by Subject|4
1164887|NCT03495817|2291197|FG000|26 Week Open Label|Lost to Follow-up|1
1164888|NCT03495817|2291197|FG000|26 Week Extension|Lost to Follow-up|2
1164889|NCT03495869|2291209|FG000|Overall Study|Lost to Follow-up|4
1164890|NCT03495869|2291210|FG001|Overall Study|Lost to Follow-up|17
1164891|NCT03495869|2291211|FG002|Overall Study|Lost to Follow-up|8
1164892|NCT03495869|2291212|FG003|Overall Study|Lost to Follow-up|14
1164893|NCT03495869|2291209|FG000|Overall Study|Withdrawal by Subject|0
1164894|NCT03495869|2291210|FG001|Overall Study|Withdrawal by Subject|3
1164895|NCT03495869|2291211|FG002|Overall Study|Withdrawal by Subject|0
1164896|NCT03495869|2291212|FG003|Overall Study|Withdrawal by Subject|3
1164897|NCT03495869|2291209|FG000|Overall Study|Dropped from study|0
1164898|NCT03495869|2291210|FG001|Overall Study|Dropped from study|7
1164899|NCT03495869|2291211|FG002|Overall Study|Dropped from study|2
1164900|NCT03495869|2291212|FG003|Overall Study|Dropped from study|4
1164901|NCT03495908|2291224|FG000|Overall Study|Withdrawal by Subject|3
1164902|NCT03495908|2291225|FG001|Overall Study|Withdrawal by Subject|1
1164903|NCT03495908|2291224|FG000|Overall Study|Lost to Follow-up|1
1164904|NCT03495908|2291225|FG001|Overall Study|Lost to Follow-up|4
1164905|NCT03495908|2291224|FG000|Overall Study|Adverse Event|0
1164906|NCT03495908|2291225|FG001|Overall Study|Adverse Event|2
1164907|NCT03495908|2291224|FG000|Overall Study|Death|1
1164908|NCT03495908|2291225|FG001|Overall Study|Death|0
1164909|NCT03495908|2291224|FG000|Overall Study|Physician Decision|5
1164910|NCT03495908|2291225|FG001|Overall Study|Physician Decision|4
1164911|NCT03495908|2291224|FG000|Overall Study|No documented reason|0
1164912|NCT03495908|2291225|FG001|Overall Study|No documented reason|2
1164913|NCT03496298|2291244|FG000|Overall Study|Adverse Event|49
1164914|NCT03496298|2291245|FG001|Overall Study|Adverse Event|68
1164915|NCT03496298|2291246|FG002|Overall Study|Adverse Event|79
1164916|NCT03496298|2291244|FG000|Overall Study|Study terminated by Sponsor|1050
1164917|NCT03496298|2291245|FG001|Overall Study|Study terminated by Sponsor|1063
1164918|NCT03496298|2291246|FG002|Overall Study|Study terminated by Sponsor|1071
1164919|NCT03496298|2291244|FG000|Overall Study|Physician decision (other than Adverse event)|12
1164920|NCT03496298|2291245|FG001|Overall Study|Physician decision (other than Adverse event)|17
1164921|NCT03496298|2291246|FG002|Overall Study|Physician decision (other than Adverse event)|10
1164922|NCT03496298|2291244|FG000|Overall Study|Withdrawal by Subject|176
1164923|NCT03496298|2291245|FG001|Overall Study|Withdrawal by Subject|154
1164924|NCT03496298|2291246|FG002|Overall Study|Withdrawal by Subject|151
1164925|NCT03496298|2291244|FG000|Overall Study|Other|29
1164926|NCT03496298|2291245|FG001|Overall Study|Other|20
1164927|NCT03496298|2291246|FG002|Overall Study|Other|23
1164928|NCT03496298|2291244|FG000|Overall Study|Randomized and not treated|1
1164929|NCT03496298|2291245|FG001|Overall Study|Randomized and not treated|1
1164930|NCT03496298|2291246|FG002|Overall Study|Randomized and not treated|1
1164931|NCT03497039|2291318|FG000|Overall Study|Withdrawal by Subject|1
1164932|NCT03497039|2291319|FG001|Overall Study|Withdrawal by Subject|0
1164933|NCT03497039|2291318|FG000|Overall Study|Protocol Violation|0
1164934|NCT03497039|2291319|FG001|Overall Study|Protocol Violation|1
1164935|NCT03497130|2291327|FG000|Overall Study|Lost to Follow-up|1
1164936|NCT03497130|2291328|FG001|Overall Study|Lost to Follow-up|1
1164937|NCT03497429|2291336|FG000|Overall Study|Progressive disease|3
1164938|NCT03497429|2291337|FG001|Overall Study|Progressive disease|4
1164939|NCT03497429|2291336|FG000|Overall Study|Adverse Event|0
1164940|NCT03497429|2291337|FG001|Overall Study|Adverse Event|2
1164941|NCT03498287|2291408|FG000|Overall Study|Withdrawal by Subject|3
1164942|NCT03498287|2291409|FG001|Overall Study|Withdrawal by Subject|0
1164943|NCT03498287|2291408|FG000|Overall Study|Protocol Violation|0
1164944|NCT03498287|2291409|FG001|Overall Study|Protocol Violation|4
1164945|NCT03498287|2291408|FG000|Overall Study|Adverse Event|0
1164946|NCT03498287|2291409|FG001|Overall Study|Adverse Event|1
1164947|NCT03498560|2291425|FG000|Overall Study|Found Ineligible|2
1164948|NCT03498560|2291425|FG000|Overall Study|Withdrawal by Subject|14
1164949|NCT03498560|2291425|FG000|Overall Study|Lost to Follow-up|4
1164950|NCT03498560|2291425|FG000|Overall Study|Death|1
1164951|NCT03499028|2291432|FG000|Overall Study|Lost to Follow-up|12
1164952|NCT03499028|2291433|FG001|Overall Study|Lost to Follow-up|9
1164953|NCT03499028|2291432|FG000|Overall Study|Withdrawal by Subject|5
1164954|NCT03499028|2291433|FG001|Overall Study|Withdrawal by Subject|8
1164955|NCT03499028|2291432|FG000|Overall Study|Unplanned SNF discharge|5
1164956|NCT03499028|2291433|FG001|Overall Study|Unplanned SNF discharge|8
1164957|NCT03499067|2291441|FG000|First Intervention|Physician Decision|2
1164958|NCT03499067|2291442|FG001|First Intervention|Physician Decision|1
1164959|NCT03499067|2291441|FG000|First Intervention|Withdrawal by Subject|3
1164960|NCT03499067|2291442|FG001|First Intervention|Withdrawal by Subject|6
1164961|NCT03499873|2291455|FG000|Overall Study|Withdrawal by Subject|4
1164962|NCT03499873|2291456|FG001|Overall Study|Withdrawal by Subject|6
1164963|NCT03499873|2291457|FG002|Overall Study|Withdrawal by Subject|1
1164964|NCT03499873|2291455|FG000|Overall Study|Subjects condition worsened|0
1164965|NCT03499873|2291456|FG001|Overall Study|Subjects condition worsened|3
1164966|NCT03499873|2291457|FG002|Overall Study|Subjects condition worsened|11
1164967|NCT03499873|2291455|FG000|Overall Study|Adverse Event|8
1164968|NCT03499873|2291456|FG001|Overall Study|Adverse Event|3
1164969|NCT03499873|2291457|FG002|Overall Study|Adverse Event|6
1164970|NCT03499873|2291455|FG000|Overall Study|Physician Decision|1
1164971|NCT03499873|2291456|FG001|Overall Study|Physician Decision|0
1164972|NCT03499873|2291457|FG002|Overall Study|Physician Decision|0
1164973|NCT03499873|2291455|FG000|Overall Study|Administrative reasons|0
1164974|NCT03499873|2291456|FG001|Overall Study|Administrative reasons|1
1164975|NCT03499873|2291457|FG002|Overall Study|Administrative reasons|0
1164976|NCT03499873|2291455|FG000|Overall Study|Concomitant therapy|5
1164977|NCT03499873|2291456|FG001|Overall Study|Concomitant therapy|4
1164978|NCT03499873|2291457|FG002|Overall Study|Concomitant therapy|7
1164979|NCT03499873|2291455|FG000|Overall Study|Miscellaneous|1
1164980|NCT03499873|2291456|FG001|Overall Study|Miscellaneous|2
1164981|NCT03499873|2291457|FG002|Overall Study|Miscellaneous|2
1164982|NCT03499873|2291455|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1
1164983|NCT03499873|2291456|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1
1164984|NCT03499873|2291457|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0
1164985|NCT03500094|2291465|FG000|Overall Study|Withdrawal by Subject|1
1164986|NCT03500094|2291465|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1
1164987|NCT03500094|2291465|FG000|Overall Study|Lost to Follow-up|1
1164988|NCT03500198|2291473|FG000|Overall Study|Lost to Follow-up|0
1164989|NCT03500198|2291474|FG001|Overall Study|Lost to Follow-up|1
1164990|NCT03500211|2291484|FG000|Overall Study|Withdrawal by Subject|1
1164991|NCT03500211|2291485|FG001|Overall Study|Withdrawal by Subject|1
1164992|NCT03500224|2291491|FG000|Overall Study|Withdrawal by Subject|2
1164993|NCT03500419|2291510|FG000|Overall Study|Withdrawal by Subject|2
1164994|NCT03500419|2291511|FG001|Overall Study|Withdrawal by Subject|25
1164995|NCT03500679|2291519|FG000|Overall Study|Lost to Follow-up|6
1164996|NCT03500679|2291520|FG001|Overall Study|Lost to Follow-up|3
1164997|NCT03500679|2291519|FG000|Overall Study|Withdrawal by Subject|3
1164998|NCT03500679|2291520|FG001|Overall Study|Withdrawal by Subject|0
1164999|NCT03500692|2291526|FG000|Overall Study|Death|76
1165000|NCT03500692|2291526|FG000|Overall Study|Missed visit|30
1165001|NCT03500692|2291526|FG000|Overall Study|Termination Reasons|3
1165002|NCT03501277|2291603|FG000|Intervention Period 1 (4 Days)|Other|0
1165003|NCT03501277|2291604|FG001|Intervention Period 1 (4 Days)|Other|0
1165004|NCT03501277|2291605|FG002|Intervention Period 1 (4 Days)|Other|1
1165005|NCT03501277|2291606|FG003|Intervention Period 1 (4 Days)|Other|0
1165006|NCT03501277|2291603|FG000|Intervention Period 1 (4 Days)|Adverse Event|0
1165007|NCT03501277|2291604|FG001|Intervention Period 1 (4 Days)|Adverse Event|0
1165008|NCT03501277|2291605|FG002|Intervention Period 1 (4 Days)|Adverse Event|0
1165009|NCT03501277|2291606|FG003|Intervention Period 1 (4 Days)|Adverse Event|1
1165010|NCT03501277|2291603|FG000|Intervention Period 2 (4 Days)|Adverse Event|0
1165011|NCT03501277|2291604|FG001|Intervention Period 2 (4 Days)|Adverse Event|0
1165012|NCT03501277|2291605|FG002|Intervention Period 2 (4 Days)|Adverse Event|0
1165013|NCT03501277|2291606|FG003|Intervention Period 2 (4 Days)|Adverse Event|1
1165014|NCT03501277|2291603|FG000|Intervention Period 3 (4 Days)|Adverse Event|0
1165015|NCT03501277|2291604|FG001|Intervention Period 3 (4 Days)|Adverse Event|0
1165016|NCT03501277|2291605|FG002|Intervention Period 3 (4 Days)|Adverse Event|0
1165017|NCT03501277|2291606|FG003|Intervention Period 3 (4 Days)|Adverse Event|1
1165018|NCT03502070|2291627|FG000|Overall Study|Withdrawal by Subject|1
1165019|NCT03502070|2291627|FG000|Overall Study|Screen Failure|1
1165020|NCT03502616|2291637|FG000|Up to Week 16|Withdrawal by Subject|1
1165021|NCT03502616|2291638|FG001|Up to Week 16|Withdrawal by Subject|2
1165022|NCT03502616|2291637|FG000|Up to Week 16|Lost to Follow-up|0
1165023|NCT03502616|2291638|FG001|Up to Week 16|Lost to Follow-up|1
1165024|NCT03502616|2291637|FG000|Up to Week 16|Randomized, but not treated|1
1165025|NCT03502616|2291638|FG001|Up to Week 16|Randomized, but not treated|0
1165026|NCT03502616|2291637|FG000|Week 16 to Week 48|Withdrawal by Subject|6
1165027|NCT03502616|2291638|FG001|Week 16 to Week 48|Withdrawal by Subject|6
1165028|NCT03502616|2291637|FG000|Week 16 to Week 48|Lost to Follow-up|1
1165029|NCT03502616|2291638|FG001|Week 16 to Week 48|Lost to Follow-up|0
1165030|NCT03502681|2291648|FG000|Overall Study|Adverse Event|1
1165031|NCT03502681|2291649|FG001|Overall Study|Adverse Event|1
1165032|NCT03502681|2291648|FG000|Overall Study|Disease Progression|2
1165033|NCT03502681|2291649|FG001|Overall Study|Disease Progression|1
1165034|NCT03502798|2291656|FG000|Overall Study|equipment failure|0
1165035|NCT03502798|2291657|FG001|Overall Study|equipment failure|7
1165036|NCT03503162|2291685|FG000|Overall Study|did not meet eligibility|1
1165037|NCT03503188|2291691|FG000|Overall Study|Non eligible in the sub study|0
1165038|NCT03503188|2291692|FG001|Overall Study|Non eligible in the sub study|1
1165039|NCT03504189|2291720|FG000|Overall Study|Withdrawal by Subject|1
1165040|NCT03504189|2291720|FG000|Overall Study|Screening Failure|1
1165041|NCT03504189|2291720|FG000|Overall Study|Device Failure|2
1165042|NCT03504852|2291736|FG000|Overall Study|Withdrawal of informed consent|2
1165043|NCT03504852|2291737|FG001|Overall Study|Withdrawal of informed consent|1
1165044|NCT03504852|2291738|FG002|Overall Study|Withdrawal of informed consent|0
1165045|NCT03504852|2291736|FG000|Overall Study|Withdrawal by Subject|5
1165046|NCT03504852|2291737|FG001|Overall Study|Withdrawal by Subject|5
1165047|NCT03504852|2291738|FG002|Overall Study|Withdrawal by Subject|1
1165048|NCT03504852|2291736|FG000|Overall Study|Lost to Follow-up|4
1165049|NCT03504852|2291737|FG001|Overall Study|Lost to Follow-up|1
1165050|NCT03504852|2291738|FG002|Overall Study|Lost to Follow-up|0
1165051|NCT03504852|2291736|FG000|Overall Study|New therapy for study indication|1
1165052|NCT03504852|2291737|FG001|Overall Study|New therapy for study indication|0
1165053|NCT03504852|2291738|FG002|Overall Study|New therapy for study indication|0
1165054|NCT03504852|2291736|FG000|Overall Study|Lack of Efficacy|1
1165055|NCT03504852|2291737|FG001|Overall Study|Lack of Efficacy|2
1165056|NCT03504852|2291738|FG002|Overall Study|Lack of Efficacy|0
1165057|NCT03504852|2291736|FG000|Overall Study|Death|0
1165058|NCT03504852|2291737|FG001|Overall Study|Death|1
1165059|NCT03504852|2291738|FG002|Overall Study|Death|0
1165060|NCT03504852|2291736|FG000|Overall Study|Adverse Event|4
1165061|NCT03504852|2291737|FG001|Overall Study|Adverse Event|8
1165062|NCT03504852|2291738|FG002|Overall Study|Adverse Event|2
1165063|NCT03504917|2291750|FG000|Blinded Treatment Period|Protocol Violation|1
1165064|NCT03504917|2291751|FG001|Blinded Treatment Period|Protocol Violation|0
1165065|NCT03504917|2291750|FG000|Blinded Treatment Period|Withdrawal by Subject|12
1165066|NCT03504917|2291751|FG001|Blinded Treatment Period|Withdrawal by Subject|9
1165067|NCT03504917|2291750|FG000|Blinded Treatment Period|Lack of Efficacy|1
1165068|NCT03504917|2291751|FG001|Blinded Treatment Period|Lack of Efficacy|1
1165069|NCT03504917|2291750|FG000|Blinded Treatment Period|Lost to Follow-up|1
1165070|NCT03504917|2291751|FG001|Blinded Treatment Period|Lost to Follow-up|4
1165071|NCT03504917|2291750|FG000|Blinded Treatment Period|Adverse Event|4
1165072|NCT03504917|2291751|FG001|Blinded Treatment Period|Adverse Event|4
1165073|NCT03504917|2291750|FG000|Blinded Treatment Period|Physician Decision|1
1165074|NCT03504917|2291751|FG001|Blinded Treatment Period|Physician Decision|0
1165075|NCT03504917|2291750|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1
1165076|NCT03504917|2291751|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3
1165077|NCT03504917|2291750|FG000|Blinded Treatment Period|Study terminated by sponsor|39
1165078|NCT03504917|2291751|FG001|Blinded Treatment Period|Study terminated by sponsor|34
1165079|NCT03504917|2291750|FG000|Blinded Treatment Period|Non-compliance with study drug|0
1165080|NCT03504917|2291751|FG001|Blinded Treatment Period|Non-compliance with study drug|1
1165081|NCT03504917|2291750|FG000|Open Label Extension Treatment Period|The participant left the study site|0
1165082|NCT03504917|2291751|FG001|Open Label Extension Treatment Period|The participant left the study site|1
1165083|NCT03504917|2291750|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8
1165084|NCT03504917|2291751|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2
1165085|NCT03504917|2291750|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1
1165086|NCT03504917|2291751|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4
1165087|NCT03504917|2291750|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3
1165088|NCT03504917|2291751|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1
1165089|NCT03504917|2291750|FG000|Open Label Extension Treatment Period|Adverse Event|7
1165090|NCT03504917|2291751|FG001|Open Label Extension Treatment Period|Adverse Event|0
1165091|NCT03504917|2291750|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0
1165092|NCT03504917|2291751|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1
1165093|NCT03504917|2291750|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81
1165094|NCT03504917|2291751|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88
1165095|NCT03505021|2291765|FG000|Overall Study|Protocol Violation|1
1165096|NCT03505021|2291766|FG001|Overall Study|Protocol Violation|0
1165097|NCT03505021|2291765|FG000|Overall Study|Death|9
1165098|NCT03505021|2291766|FG001|Overall Study|Death|8
1165099|NCT03505021|2291765|FG000|Overall Study|Consent withdrawn by subject|6
1165100|NCT03505021|2291766|FG001|Overall Study|Consent withdrawn by subject|1
1165101|NCT03505021|2291765|FG000|Overall Study|Lost to Follow-up|5
1165102|NCT03505021|2291766|FG001|Overall Study|Lost to Follow-up|3
1165103|NCT03505021|2291765|FG000|Overall Study|Adverse Event|26
1165104|NCT03505021|2291766|FG001|Overall Study|Adverse Event|9
1165105|NCT03505021|2291765|FG000|Overall Study|Disease progression|33
1165106|NCT03505021|2291766|FG001|Overall Study|Disease progression|17
1165107|NCT03505021|2291765|FG000|Overall Study|Other|11
1165108|NCT03505021|2291766|FG001|Overall Study|Other|5
1165109|NCT03505021|2291765|FG000|Overall Study|Personal reason|21
1165110|NCT03505021|2291766|FG001|Overall Study|Personal reason|12
1165111|NCT03505593|2291793|FG000|Overall Study|Withdrawal by Subject|1
1165112|NCT03505593|2291793|FG000|Overall Study|Died before procedure|1
1165113|NCT03505593|2291793|FG000|Overall Study|Anatomical abnormality|1
1165114|NCT03505593|2291793|FG000|Overall Study|Unable to pass through esophagus|1
1165115|NCT03505593|2291793|FG000|Overall Study|Obstruction by Endotracheal tube|1
1165116|NCT03505749|2291799|FG000|Overall Study|Lost to Follow-up|7
1165117|NCT03505749|2291800|FG001|Overall Study|Lost to Follow-up|11
1165118|NCT03505749|2291799|FG000|Overall Study|Withdrawal by Subject|6
1165119|NCT03505749|2291800|FG001|Overall Study|Withdrawal by Subject|0
1165120|NCT03505749|2291799|FG000|Overall Study|Discharged from treatment|3
1165121|NCT03505749|2291800|FG001|Overall Study|Discharged from treatment|6
1165122|NCT03506425|2291830|FG000|Overall Study|Adverse Event|1
1165123|NCT03506425|2291831|FG001|Overall Study|Adverse Event|3
1165124|NCT03506425|2291832|FG002|Overall Study|Adverse Event|0
1165125|NCT03506425|2291830|FG000|Overall Study|Death|1
1165126|NCT03506425|2291831|FG001|Overall Study|Death|0
1165127|NCT03506425|2291832|FG002|Overall Study|Death|0
1165128|NCT03506425|2291830|FG000|Overall Study|Withdrawal by Subject|0
1165129|NCT03506425|2291831|FG001|Overall Study|Withdrawal by Subject|0
1165130|NCT03506425|2291832|FG002|Overall Study|Withdrawal by Subject|1
1165131|NCT03506477|2291843|FG000|Overall Study|Withdrawal by Subject|1
1165132|NCT03506477|2291844|FG001|Overall Study|Withdrawal by Subject|0
1165133|NCT03508050|2291885|FG000|Overall Study|Pleural adhesions|1
1165134|NCT03508050|2291886|FG001|Overall Study|Pleural adhesions|0
1165135|NCT03508050|2291885|FG000|Overall Study|Mucus plug|1
1165136|NCT03508050|2291886|FG001|Overall Study|Mucus plug|0
1165137|NCT03508050|2291885|FG000|Overall Study|Negative biopsy, surgery cancelled|3
1165138|NCT03508050|2291886|FG001|Overall Study|Negative biopsy, surgery cancelled|1
1165139|NCT03508050|2291885|FG000|Overall Study|Sustained desaturation|0
1165140|NCT03508050|2291886|FG001|Overall Study|Sustained desaturation|1
1165141|NCT03508609|2291893|FG000|Overall Study|Withdrawal by Subject|1
1165142|NCT03508830|2291914|FG000|Overall Study|Withdrawal by Subject|3
1165143|NCT03508830|2291915|FG001|Overall Study|Withdrawal by Subject|4
1165144|NCT03508830|2291914|FG000|Overall Study|Physician Decision|2
1165145|NCT03508830|2291915|FG001|Overall Study|Physician Decision|2
1165146|NCT03508843|2291921|FG000|Overall Study|Withdrawal by Subject|1
1165147|NCT03508843|2291921|FG000|Overall Study|technical difficulties|2
1165148|NCT03509350|2291927|FG000|Overall Study|Withdrawal by Subject|0
1165149|NCT03509350|2291928|FG001|Overall Study|Withdrawal by Subject|2
1165150|NCT03509675|2291936|FG000|First Intervention (7 Days)|Lost to Follow-up|3
1165151|NCT03509675|2291937|FG001|First Intervention (7 Days)|Lost to Follow-up|3
1165152|NCT03509675|2291936|FG000|First Intervention (7 Days)|Lack of Efficacy|2
1165153|NCT03509675|2291937|FG001|First Intervention (7 Days)|Lack of Efficacy|1
1165154|NCT03509675|2291936|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1
1165155|NCT03509675|2291937|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0
1165156|NCT03509675|2291936|FG000|Second Intervention )7 Days)|Lost Rinse B|1
1165157|NCT03509675|2291937|FG001|Second Intervention )7 Days)|Lost Rinse B|0
1165158|NCT03509948|2291958|FG000|Overall Study|Protocol Violation|0
1165159|NCT03509948|2291959|FG001|Overall Study|Protocol Violation|1
1165160|NCT03510182|2291969|FG000|Overall Study|Withdrawal by Subject|2
1165161|NCT03510273|2291987|FG000|Overall Study|Withdrawal by Subject|2
1165162|NCT03510273|2291987|FG000|Overall Study|Care outside study, ineligible to cont.|3
1165163|NCT03510273|2291987|FG000|Overall Study|Moved away from study area|4
1165164|NCT03510455|2291995|FG000|Overall Study|Physician Decision|1
1165165|NCT03510663|2292028|FG000|Overall Study|Withdrawal by Subject|0
1165166|NCT03510663|2292029|FG001|Overall Study|Withdrawal by Subject|1
1165167|NCT03510663|2292030|FG002|Overall Study|Withdrawal by Subject|0
1165168|NCT03510663|2292031|FG003|Overall Study|Withdrawal by Subject|0
1165169|NCT03510663|2292032|FG004|Overall Study|Withdrawal by Subject|0
1165170|NCT03510663|2292033|FG005|Overall Study|Withdrawal by Subject|0
1165171|NCT03510663|2292034|FG006|Overall Study|Withdrawal by Subject|0
1165172|NCT03510663|2292035|FG007|Overall Study|Withdrawal by Subject|0
1165173|NCT03510715|2292047|FG000|Overall Study|Adverse Event|1
1165174|NCT03510715|2292048|FG001|Overall Study|Adverse Event|0
1165175|NCT03510910|2292057|FG000|Overall Study|Incomplete Survey|2
1165176|NCT03510910|2292058|FG001|Overall Study|Incomplete Survey|3
1165177|NCT03511053|2292073|FG000|Overall Study|Withdrawal by Subject|1
1165178|NCT03511105|2292079|FG000|Overall Study|Adverse Event|1
1165179|NCT03511105|2292080|FG001|Overall Study|Adverse Event|0
1165180|NCT03511105|2292079|FG000|Overall Study|Withdrew consent|1
1165181|NCT03511105|2292080|FG001|Overall Study|Withdrew consent|0
1165182|NCT03511326|2292087|FG000|Overall Study|Withdrawal by Subject|1
1165183|NCT03511378|2292093|FG000|Overall Study|Withdrawal by Subject|2
1165184|NCT03511378|2292094|FG001|Overall Study|Withdrawal by Subject|2
1165185|NCT03511378|2292093|FG000|Overall Study|Patient not coming or schedule visit|1
1165186|NCT03511378|2292094|FG001|Overall Study|Patient not coming or schedule visit|0
1165187|NCT03512028|2292131|FG000|Overall Study|Withdrawal by Subject|2
1165188|NCT03512028|2292132|FG001|Overall Study|Withdrawal by Subject|0
1165189|NCT03512028|2292131|FG000|Overall Study|Protocol Violation|2
1165190|NCT03512028|2292132|FG001|Overall Study|Protocol Violation|0
1165191|NCT03512210|2292159|FG000|Overall Study|Lost to Follow-up|3
1165192|NCT03512210|2292159|FG000|Overall Study|Protocol Violation|1
1165193|NCT03512288|2292165|FG000|Overall Study|Adverse Event|1
1165194|NCT03512288|2292166|FG001|Overall Study|Adverse Event|0
1165195|NCT03512288|2292165|FG000|Overall Study|Lost to Follow-up|12
1165196|NCT03512288|2292166|FG001|Overall Study|Lost to Follow-up|15
1165197|NCT03512288|2292165|FG000|Overall Study|Physician Decision|0
1165198|NCT03512288|2292166|FG001|Overall Study|Physician Decision|2
1165199|NCT03512288|2292165|FG000|Overall Study|Protocol Violation|6
1165200|NCT03512288|2292166|FG001|Overall Study|Protocol Violation|4
1165201|NCT03512288|2292165|FG000|Overall Study|Medication error without associated adverse event|1
1165202|NCT03512288|2292166|FG001|Overall Study|Medication error without associated adverse event|0
1165203|NCT03512288|2292165|FG000|Overall Study|No longer met eligibility criteria|5
1165204|NCT03512288|2292166|FG001|Overall Study|No longer met eligibility criteria|2
1165205|NCT03512288|2292165|FG000|Overall Study|Withdrawal by parent/guardian|14
1165206|NCT03512288|2292166|FG001|Overall Study|Withdrawal by parent/guardian|18
1165207|NCT03512288|2292165|FG000|Overall Study|Other|1
1165208|NCT03512288|2292166|FG001|Overall Study|Other|1
1165209|NCT03512288|2292165|FG000|Overall Study|Randomized but not treated|1
1165210|NCT03512288|2292166|FG001|Overall Study|Randomized but not treated|1
1165211|NCT03512353|2292172|FG000|Overall Study|Sponsor Decision|3
1165212|NCT03512353|2292172|FG000|Overall Study|Death|1
1165213|NCT03513588|2292192|FG000|Overall Study|Lost to Follow-up|0
1165214|NCT03513588|2292193|FG001|Overall Study|Lost to Follow-up|1
1165215|NCT03513588|2292194|FG002|Overall Study|Lost to Follow-up|1
1165216|NCT03513588|2292192|FG000|Overall Study|Study dosing paused by sponsor|1
1165217|NCT03513588|2292193|FG001|Overall Study|Study dosing paused by sponsor|1
1165218|NCT03513588|2292194|FG002|Overall Study|Study dosing paused by sponsor|0
1165219|NCT03513588|2292192|FG000|Overall Study|Death|0
1165220|NCT03513588|2292193|FG001|Overall Study|Death|0
1165221|NCT03513588|2292194|FG002|Overall Study|Death|1
1165222|NCT03514641|2292246|FG000|603A: 0-12 Week Study Period|Protocol Violation|3
1165223|NCT03514641|2292247|FG001|603A: 0-12 Week Study Period|Protocol Violation|3
1165224|NCT03514641|2292248|FG002|603A: 0-12 Week Study Period|Protocol Violation|0
1165225|NCT03514641|2292249|FG003|603A: 0-12 Week Study Period|Protocol Violation|0
1165226|NCT03514641|2292246|FG000|603A: 0-12 Week Study Period|Adverse Event|5
1165227|NCT03514641|2292247|FG001|603A: 0-12 Week Study Period|Adverse Event|2
1165228|NCT03514641|2292248|FG002|603A: 0-12 Week Study Period|Adverse Event|0
1165229|NCT03514641|2292249|FG003|603A: 0-12 Week Study Period|Adverse Event|0
1165230|NCT03514641|2292246|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7
1165231|NCT03514641|2292247|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5
1165232|NCT03514641|2292248|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0
1165233|NCT03514641|2292249|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0
1165234|NCT03514641|2292246|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10
1165235|NCT03514641|2292247|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9
1165236|NCT03514641|2292248|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0
1165237|NCT03514641|2292249|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0
1165238|NCT03514641|2292246|FG000|603A: 0-12 Week Study Period|Physician Decision|1
1165239|NCT03514641|2292247|FG001|603A: 0-12 Week Study Period|Physician Decision|0
1165240|NCT03514641|2292248|FG002|603A: 0-12 Week Study Period|Physician Decision|0
1165241|NCT03514641|2292249|FG003|603A: 0-12 Week Study Period|Physician Decision|0
1165242|NCT03514641|2292246|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1
1165243|NCT03514641|2292247|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0
1165244|NCT03514641|2292248|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0
1165245|NCT03514641|2292249|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0
1165246|NCT03514641|2292246|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
1165247|NCT03514641|2292247|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1
1165248|NCT03514641|2292248|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
1165249|NCT03514641|2292249|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
1165250|NCT03514641|2292246|FG000|603B: 24-36 Week Study Period|Protocol Violation|0
1165251|NCT03514641|2292247|FG001|603B: 24-36 Week Study Period|Protocol Violation|0
1165252|NCT03514641|2292248|FG002|603B: 24-36 Week Study Period|Protocol Violation|0
1165253|NCT03514641|2292249|FG003|603B: 24-36 Week Study Period|Protocol Violation|2
1165254|NCT03514641|2292246|FG000|603B: 24-36 Week Study Period|Adverse Event|0
1165255|NCT03514641|2292247|FG001|603B: 24-36 Week Study Period|Adverse Event|0
1165256|NCT03514641|2292248|FG002|603B: 24-36 Week Study Period|Adverse Event|3
1165257|NCT03514641|2292249|FG003|603B: 24-36 Week Study Period|Adverse Event|1
1165258|NCT03514641|2292246|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0
1165259|NCT03514641|2292247|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0
1165260|NCT03514641|2292248|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2
1165261|NCT03514641|2292249|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3
1165262|NCT03514641|2292246|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0
1165263|NCT03514641|2292247|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0
1165264|NCT03514641|2292248|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6
1165265|NCT03514641|2292249|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6
1165266|NCT03514641|2292246|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
1165267|NCT03514641|2292247|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
1165268|NCT03514641|2292248|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
1165269|NCT03514641|2292249|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
1165270|NCT03515824|2292282|FG000|Overall Study|Death|3
1165271|NCT03515824|2292283|FG001|Overall Study|Death|2
1165272|NCT03515824|2292284|FG002|Overall Study|Death|6
1165273|NCT03515824|2292285|FG003|Overall Study|Death|0
1165274|NCT03515824|2292282|FG000|Overall Study|Lost to Follow-up|0
1165275|NCT03515824|2292283|FG001|Overall Study|Lost to Follow-up|1
1165276|NCT03515824|2292284|FG002|Overall Study|Lost to Follow-up|1
1165277|NCT03515824|2292285|FG003|Overall Study|Lost to Follow-up|0
1165278|NCT03515824|2292282|FG000|Overall Study|Study terminated by sponsor|0
1165279|NCT03515824|2292283|FG001|Overall Study|Study terminated by sponsor|1
1165280|NCT03515824|2292284|FG002|Overall Study|Study terminated by sponsor|6
1165281|NCT03515824|2292285|FG003|Overall Study|Study terminated by sponsor|0
1165282|NCT03515824|2292282|FG000|Overall Study|Status not recorded|0
1165283|NCT03515824|2292283|FG001|Overall Study|Status not recorded|0
1165284|NCT03515824|2292284|FG002|Overall Study|Status not recorded|2
1165285|NCT03515824|2292285|FG003|Overall Study|Status not recorded|0
1165286|NCT03515941|2292295|FG000|Overall Study|Adverse Event|1
1165287|NCT03515941|2292296|FG001|Overall Study|Adverse Event|0
1165288|NCT03517436|2292312|FG000|Overall Study|Death|3
1165289|NCT03517436|2292312|FG000|Overall Study|Withdrawal by Subject|4
1165290|NCT03517436|2292312|FG000|Overall Study|Did not receive study valve.|1
1165311|NCT03517566|2292347|FG000|Overall Study|Adverse Event|5
1165312|NCT03517566|2292348|FG001|Overall Study|Adverse Event|2
1165313|NCT03517566|2292349|FG002|Overall Study|Adverse Event|2
1165314|NCT03517566|2292350|FG003|Overall Study|Adverse Event|8
1165315|NCT03517566|2292351|FG004|Overall Study|Adverse Event|7
1165316|NCT03517566|2292347|FG000|Overall Study|Lack of Efficacy|3
1165317|NCT03517566|2292348|FG001|Overall Study|Lack of Efficacy|2
1165318|NCT03517566|2292349|FG002|Overall Study|Lack of Efficacy|1
1165319|NCT03517566|2292350|FG003|Overall Study|Lack of Efficacy|1
1165320|NCT03517566|2292351|FG004|Overall Study|Lack of Efficacy|4
1165321|NCT03517566|2292347|FG000|Overall Study|Lost to Follow-up|3
1165322|NCT03517566|2292348|FG001|Overall Study|Lost to Follow-up|1
1165323|NCT03517566|2292349|FG002|Overall Study|Lost to Follow-up|1
1165324|NCT03517566|2292350|FG003|Overall Study|Lost to Follow-up|1
1165325|NCT03517566|2292351|FG004|Overall Study|Lost to Follow-up|0
1165326|NCT03517566|2292347|FG000|Overall Study|Physician Decision|1
1165327|NCT03517566|2292348|FG001|Overall Study|Physician Decision|1
1165328|NCT03517566|2292349|FG002|Overall Study|Physician Decision|0
1165329|NCT03517566|2292350|FG003|Overall Study|Physician Decision|1
1165330|NCT03517566|2292351|FG004|Overall Study|Physician Decision|0
1165331|NCT03517566|2292347|FG000|Overall Study|Pregnancy|0
1165332|NCT03517566|2292348|FG001|Overall Study|Pregnancy|1
1165333|NCT03517566|2292349|FG002|Overall Study|Pregnancy|0
1165334|NCT03517566|2292350|FG003|Overall Study|Pregnancy|0
1165335|NCT03517566|2292351|FG004|Overall Study|Pregnancy|0
1165336|NCT03517566|2292347|FG000|Overall Study|Protocol Deviation|0
1165337|NCT03517566|2292348|FG001|Overall Study|Protocol Deviation|1
1165338|NCT03517566|2292349|FG002|Overall Study|Protocol Deviation|0
1165339|NCT03517566|2292350|FG003|Overall Study|Protocol Deviation|1
1165340|NCT03517566|2292351|FG004|Overall Study|Protocol Deviation|1
1165341|NCT03517566|2292347|FG000|Overall Study|Study terminated by Sponsor|11
1165342|NCT03517566|2292348|FG001|Overall Study|Study terminated by Sponsor|5
1165343|NCT03517566|2292349|FG002|Overall Study|Study terminated by Sponsor|6
1165344|NCT03517566|2292350|FG003|Overall Study|Study terminated by Sponsor|14
1165345|NCT03517566|2292351|FG004|Overall Study|Study terminated by Sponsor|12
1165346|NCT03517566|2292347|FG000|Overall Study|Subject Decision /Guardian Decision|9
1165347|NCT03517566|2292348|FG001|Overall Study|Subject Decision /Guardian Decision|8
1165348|NCT03517566|2292349|FG002|Overall Study|Subject Decision /Guardian Decision|5
1165349|NCT03517566|2292350|FG003|Overall Study|Subject Decision /Guardian Decision|8
1165350|NCT03517566|2292351|FG004|Overall Study|Subject Decision /Guardian Decision|8
1165351|NCT03518008|2292364|FG000|Period 2, Second Week of Wear|Family emergency|0
1165352|NCT03518008|2292365|FG001|Period 2, Second Week of Wear|Family emergency|1
1165353|NCT03518125|2292377|FG000|Overall Study|Lost to Follow-up|0
1165354|NCT03518125|2292378|FG001|Overall Study|Lost to Follow-up|2
1165355|NCT03518125|2292379|FG002|Overall Study|Lost to Follow-up|0
1165356|NCT03518125|2292380|FG003|Overall Study|Lost to Follow-up|0
1165357|NCT03518125|2292381|FG004|Overall Study|Lost to Follow-up|3
1165358|NCT03518125|2292382|FG005|Overall Study|Lost to Follow-up|5
1165359|NCT03518125|2292377|FG000|Overall Study|Physician Decision|0
1165360|NCT03518125|2292378|FG001|Overall Study|Physician Decision|1
1165361|NCT03518125|2292379|FG002|Overall Study|Physician Decision|0
1165362|NCT03518125|2292380|FG003|Overall Study|Physician Decision|0
1165363|NCT03518125|2292381|FG004|Overall Study|Physician Decision|0
1165364|NCT03518125|2292382|FG005|Overall Study|Physician Decision|0
1165365|NCT03518125|2292377|FG000|Overall Study|Withdrawal by Subject|1
1165366|NCT03518125|2292378|FG001|Overall Study|Withdrawal by Subject|1
1165367|NCT03518125|2292379|FG002|Overall Study|Withdrawal by Subject|0
1165368|NCT03518125|2292380|FG003|Overall Study|Withdrawal by Subject|1
1165369|NCT03518125|2292381|FG004|Overall Study|Withdrawal by Subject|1
1165370|NCT03518125|2292382|FG005|Overall Study|Withdrawal by Subject|3
1165371|NCT03518125|2292377|FG000|Overall Study|Missed Day 394 Visit|1
1165372|NCT03518125|2292378|FG001|Overall Study|Missed Day 394 Visit|0
1165373|NCT03518125|2292379|FG002|Overall Study|Missed Day 394 Visit|0
1165374|NCT03518125|2292380|FG003|Overall Study|Missed Day 394 Visit|0
1165375|NCT03518125|2292381|FG004|Overall Study|Missed Day 394 Visit|0
1165376|NCT03518125|2292382|FG005|Overall Study|Missed Day 394 Visit|0
1165377|NCT03518658|2292399|FG000|Overall Study|Other|51
1165378|NCT03518658|2292400|FG001|Overall Study|Other|0
1165379|NCT03518840|2292408|FG000|Overall Study|Lost to Follow-up|6
1165380|NCT03519087|2292417|FG000|Clinic Evaluation|Physician Decision|15
1165381|NCT03519087|2292418|FG001|Clinic Evaluation|Physician Decision|18
1165382|NCT03519087|2292419|FG002|Clinic Evaluation|Physician Decision|0
1165383|NCT03519087|2292420|FG003|Clinic Evaluation|Physician Decision|0
1165384|NCT03519087|2292421|FG004|Clinic Evaluation|Physician Decision|0
1165385|NCT03519087|2292417|FG000|Clinic Evaluation|Protocol Violation|1
1165386|NCT03519087|2292418|FG001|Clinic Evaluation|Protocol Violation|0
1165387|NCT03519087|2292419|FG002|Clinic Evaluation|Protocol Violation|0
1165388|NCT03519087|2292420|FG003|Clinic Evaluation|Protocol Violation|0
1165389|NCT03519087|2292421|FG004|Clinic Evaluation|Protocol Violation|0
1165390|NCT03519087|2292417|FG000|Re-randomization for Treatment|Withdrawal by Subject|25
1165391|NCT03519087|2292418|FG001|Re-randomization for Treatment|Withdrawal by Subject|29
1165392|NCT03519087|2292419|FG002|Re-randomization for Treatment|Withdrawal by Subject|0
1165393|NCT03519087|2292420|FG003|Re-randomization for Treatment|Withdrawal by Subject|0
1165394|NCT03519087|2292421|FG004|Re-randomization for Treatment|Withdrawal by Subject|0
1165395|NCT03519087|2292417|FG000|Re-randomization for Treatment|Not appropriate|2
1165396|NCT03519087|2292418|FG001|Re-randomization for Treatment|Not appropriate|3
1165397|NCT03519087|2292419|FG002|Re-randomization for Treatment|Not appropriate|0
1165398|NCT03519087|2292420|FG003|Re-randomization for Treatment|Not appropriate|0
1165399|NCT03519087|2292421|FG004|Re-randomization for Treatment|Not appropriate|0
1165400|NCT03519087|2292417|FG000|Laboratory Testing|Lost to Follow-up|0
1165401|NCT03519087|2292418|FG001|Laboratory Testing|Lost to Follow-up|0
1165402|NCT03519087|2292419|FG002|Laboratory Testing|Lost to Follow-up|2
1165403|NCT03519087|2292420|FG003|Laboratory Testing|Lost to Follow-up|3
1165404|NCT03519087|2292421|FG004|Laboratory Testing|Lost to Follow-up|6
1165405|NCT03519087|2292417|FG000|Laboratory Testing|Protocol Violation|0
1165406|NCT03519087|2292418|FG001|Laboratory Testing|Protocol Violation|0
1165407|NCT03519087|2292419|FG002|Laboratory Testing|Protocol Violation|0
1165408|NCT03519087|2292420|FG003|Laboratory Testing|Protocol Violation|1
1165409|NCT03519087|2292421|FG004|Laboratory Testing|Protocol Violation|0
1165410|NCT03519204|2292439|FG000|Overall Study|Lost to Follow-up|3
1165411|NCT03519204|2292440|FG001|Overall Study|Lost to Follow-up|8
1165412|NCT03519204|2292439|FG000|Overall Study|Withdrawal by Subject|9
1165413|NCT03519204|2292440|FG001|Overall Study|Withdrawal by Subject|7
1165414|NCT03519204|2292439|FG000|Overall Study|Other Miscellaneous Reasons|1
1165415|NCT03519204|2292440|FG001|Overall Study|Other Miscellaneous Reasons|0
1165416|NCT03519516|2292473|FG000|Overall Study|Adverse Event|0
1165417|NCT03519516|2292474|FG001|Overall Study|Adverse Event|1
1165418|NCT03519854|2292498|FG000|Overall Study|Technical Error|0
1165419|NCT03519854|2292499|FG001|Overall Study|Technical Error|0
1165420|NCT03519854|2292500|FG002|Overall Study|Technical Error|1
1165421|NCT03519854|2292501|FG003|Overall Study|Technical Error|0
1165422|NCT03519854|2292502|FG004|Overall Study|Technical Error|0
1165423|NCT03519854|2292503|FG005|Overall Study|Technical Error|0
1165424|NCT03519854|2292504|FG006|Overall Study|Technical Error|0
1165425|NCT03519854|2292505|FG007|Overall Study|Technical Error|0
1165426|NCT03519854|2292506|FG008|Overall Study|Technical Error|0
1165427|NCT03519854|2292507|FG009|Overall Study|Technical Error|0
1165428|NCT03519854|2292508|FG010|Overall Study|Technical Error|0
1165429|NCT03519854|2292509|FG011|Overall Study|Technical Error|0
1165430|NCT03519854|2292510|FG012|Overall Study|Technical Error|0
1165431|NCT03519854|2292511|FG013|Overall Study|Technical Error|0
1165432|NCT03519854|2292512|FG014|Overall Study|Technical Error|0
1165433|NCT03519854|2292513|FG015|Overall Study|Technical Error|0
1165434|NCT03519854|2292514|FG016|Overall Study|Technical Error|0
1165435|NCT03519854|2292515|FG017|Overall Study|Technical Error|0
1165436|NCT03519867|2292563|FG000|Overall Study|Adverse Event|1
1165437|NCT03519867|2292564|FG001|Overall Study|Adverse Event|1
1165438|NCT03519867|2292565|FG002|Overall Study|Adverse Event|0
1165439|NCT03519867|2292566|FG003|Overall Study|Adverse Event|0
1165440|NCT03519867|2292567|FG004|Overall Study|Adverse Event|0
1165441|NCT03519867|2292568|FG005|Overall Study|Adverse Event|0
1165442|NCT03519867|2292569|FG006|Overall Study|Adverse Event|0
1165443|NCT03519867|2292570|FG007|Overall Study|Adverse Event|0
1165444|NCT03519867|2292571|FG008|Overall Study|Adverse Event|0
1165445|NCT03519867|2292572|FG009|Overall Study|Adverse Event|0
1165446|NCT03519867|2292563|FG000|Overall Study|Protocol Violation|0
1165447|NCT03519867|2292564|FG001|Overall Study|Protocol Violation|0
1165448|NCT03519867|2292565|FG002|Overall Study|Protocol Violation|0
1165449|NCT03519867|2292566|FG003|Overall Study|Protocol Violation|0
1165450|NCT03519867|2292567|FG004|Overall Study|Protocol Violation|0
1165451|NCT03519867|2292568|FG005|Overall Study|Protocol Violation|1
1165452|NCT03519867|2292569|FG006|Overall Study|Protocol Violation|0
1165453|NCT03519867|2292570|FG007|Overall Study|Protocol Violation|0
1165454|NCT03519867|2292571|FG008|Overall Study|Protocol Violation|0
1165455|NCT03519867|2292572|FG009|Overall Study|Protocol Violation|0
1165456|NCT03519867|2292563|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0
1165457|NCT03519867|2292564|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0
1165458|NCT03519867|2292565|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0
1165459|NCT03519867|2292566|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0
1165460|NCT03519867|2292567|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0
1165461|NCT03519867|2292568|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0
1165462|NCT03519867|2292569|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1
1165463|NCT03519867|2292570|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0
1165464|NCT03519867|2292571|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0
1165465|NCT03519867|2292572|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0
1165466|NCT03519867|2292563|FG000|Overall Study|Admin. of other reversal agent|1
1165467|NCT03519867|2292564|FG001|Overall Study|Admin. of other reversal agent|1
1165468|NCT03519867|2292565|FG002|Overall Study|Admin. of other reversal agent|0
1165469|NCT03519867|2292566|FG003|Overall Study|Admin. of other reversal agent|0
1165470|NCT03519867|2292567|FG004|Overall Study|Admin. of other reversal agent|0
1165471|NCT03519867|2292568|FG005|Overall Study|Admin. of other reversal agent|1
1165472|NCT03519867|2292569|FG006|Overall Study|Admin. of other reversal agent|0
1165473|NCT03519867|2292570|FG007|Overall Study|Admin. of other reversal agent|0
1165474|NCT03519867|2292571|FG008|Overall Study|Admin. of other reversal agent|0
1165475|NCT03519867|2292572|FG009|Overall Study|Admin. of other reversal agent|0
1165476|NCT03519867|2292563|FG000|Overall Study|Reason not provided|1
1165477|NCT03519867|2292564|FG001|Overall Study|Reason not provided|1
1165478|NCT03519867|2292565|FG002|Overall Study|Reason not provided|1
1165479|NCT03519867|2292566|FG003|Overall Study|Reason not provided|1
1165480|NCT03519867|2292567|FG004|Overall Study|Reason not provided|0
1165481|NCT03519867|2292568|FG005|Overall Study|Reason not provided|1
1165482|NCT03519867|2292569|FG006|Overall Study|Reason not provided|0
1165483|NCT03519867|2292570|FG007|Overall Study|Reason not provided|1
1165484|NCT03519867|2292571|FG008|Overall Study|Reason not provided|1
1165485|NCT03519867|2292572|FG009|Overall Study|Reason not provided|0
1165486|NCT03519919|2292594|FG000|Overall Study|Withdrawal by Subject|1
1165487|NCT03519919|2292594|FG000|Overall Study|Lack of Efficacy|1
1165488|NCT03519919|2292594|FG000|Overall Study|Screen Failure|1
1165489|NCT03519932|2292624|FG000|First Intervention|Adverse Event|1
1165490|NCT03519932|2292625|FG001|First Intervention|Adverse Event|3
1165491|NCT03520387|2292668|FG000|Pre-Randomization|Withdrawal by Subject|1
1165492|NCT03520387|2292669|FG001|Pre-Randomization|Withdrawal by Subject|0
1165493|NCT03520387|2292670|FG002|Pre-Randomization|Withdrawal by Subject|0
1165494|NCT03520387|2292671|FG003|Pre-Randomization|Withdrawal by Subject|0
1165495|NCT03520387|2292672|FG004|Pre-Randomization|Withdrawal by Subject|0
1165496|NCT03520387|2292668|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2
1165497|NCT03520387|2292669|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
1165498|NCT03520387|2292670|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
1165499|NCT03520387|2292671|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
1165500|NCT03520387|2292672|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
1165501|NCT03520400|2292685|FG000|Overall Study|Physician Decision|15
1165502|NCT03520400|2292686|FG001|Overall Study|Physician Decision|7
1165503|NCT03520920|2292695|FG000|Overall Study|Death|13
1165504|NCT03520920|2292696|FG001|Overall Study|Death|1
1165505|NCT03520920|2292697|FG002|Overall Study|Death|0
1165506|NCT03520920|2292695|FG000|Overall Study|Withdrawal by Subject|2
1165507|NCT03520920|2292696|FG001|Overall Study|Withdrawal by Subject|1
1165508|NCT03520920|2292697|FG002|Overall Study|Withdrawal by Subject|0
1165509|NCT03520920|2292695|FG000|Overall Study|Study Terminated by the Sponsor|5
1165510|NCT03520920|2292696|FG001|Overall Study|Study Terminated by the Sponsor|14
1165511|NCT03520920|2292697|FG002|Overall Study|Study Terminated by the Sponsor|5
1165512|NCT03520959|2292713|FG000|Overall Study|Study terminated by Sponsor|0
1165513|NCT03520959|2292714|FG001|Overall Study|Study terminated by Sponsor|1
1165514|NCT03521115|2292740|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56
1165515|NCT03521115|2292741|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40
1165516|NCT03521115|2292740|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3
1165517|NCT03521115|2292741|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1
1165518|NCT03521141|2292756|FG000|Overall Study|Death|1
1165519|NCT03521141|2292757|FG001|Overall Study|Death|0
1165520|NCT03521141|2292758|FG002|Overall Study|Death|1
1165521|NCT03521193|2292768|FG000|Overall Study|Withdrawal by Subject|8
1165522|NCT03521193|2292769|FG001|Overall Study|Withdrawal by Subject|0
1165523|NCT03521193|2292768|FG000|Overall Study|non compliant to ASA treatment|8
1165524|NCT03521193|2292769|FG001|Overall Study|non compliant to ASA treatment|0
1165525|NCT03521635|2292804|FG000|Overall Study|Adverse Event|1
1165526|NCT03521635|2292805|FG001|Overall Study|Adverse Event|1
1165527|NCT03521635|2292804|FG000|Overall Study|Refused to complete study visit|1
1165528|NCT03521635|2292805|FG001|Overall Study|Refused to complete study visit|0
1165529|NCT03521635|2292804|FG000|Overall Study|Refused to continue trial medication|2
1165530|NCT03521635|2292805|FG001|Overall Study|Refused to continue trial medication|2
1165531|NCT03521635|2292804|FG000|Overall Study|Lost to Follow-up|0
1165532|NCT03521635|2292805|FG001|Overall Study|Lost to Follow-up|1
1165533|NCT03521635|2292804|FG000|Overall Study|Meet exclusion criteria|0
1165534|NCT03521635|2292805|FG001|Overall Study|Meet exclusion criteria|1
1165535|NCT03521635|2292804|FG000|Overall Study|Patient not taken study medicine|0
1165536|NCT03521635|2292805|FG001|Overall Study|Patient not taken study medicine|1
1165537|NCT03521791|2292813|FG000|Overall Study|Protocol Violation|7
1165538|NCT03521791|2292814|FG001|Overall Study|Protocol Violation|17
1165539|NCT03521817|2292822|FG000|Overall Study|Protocol Violation|0
1165540|NCT03521817|2292823|FG001|Overall Study|Protocol Violation|1
1165541|NCT03522506|2292852|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1165542|NCT03522506|2292853|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1165543|NCT03522506|2292854|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1165544|NCT03522506|2292855|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1165545|NCT03522506|2292852|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0
1165546|NCT03522506|2292853|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0
1165547|NCT03522506|2292854|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0
1165548|NCT03522506|2292855|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1
1165549|NCT03522675|2292869|FG000|Overall Study|Screen fail|1
1165550|NCT03522675|2292869|FG000|Overall Study|Non-reactive to histamine|1
1165551|NCT03522948|2292877|FG000|Overall Study|Lost to Follow-up|1
1165552|NCT03523715|2292883|FG000|Overall Study|Lost to Follow-up|11
1165553|NCT03523715|2292884|FG001|Overall Study|Lost to Follow-up|14
1165554|NCT03523715|2292883|FG000|Overall Study|Did not meet inclusion criteria|1
1165555|NCT03523715|2292884|FG001|Overall Study|Did not meet inclusion criteria|0
1165556|NCT03523715|2292883|FG000|Overall Study|Internally inconsistent reporting|0
1165557|NCT03523715|2292884|FG001|Overall Study|Internally inconsistent reporting|2
1165558|NCT03523871|2292890|FG000|Overall Study|Death|1
1165559|NCT03524157|2292910|FG000|Overall Study|cytology not readable|0
1165560|NCT03524157|2292911|FG001|Overall Study|cytology not readable|0
1165561|NCT03524157|2292912|FG002|Overall Study|cytology not readable|1
1165562|NCT03525119|2292932|FG000|Overall Study|Adverse Event|0
1165563|NCT03525119|2292933|FG001|Overall Study|Adverse Event|1
1165564|NCT03525119|2292934|FG002|Overall Study|Adverse Event|0
1165565|NCT03525119|2292932|FG000|Overall Study|Lost to Follow-up|32
1165566|NCT03525119|2292933|FG001|Overall Study|Lost to Follow-up|33
1165567|NCT03525119|2292934|FG002|Overall Study|Lost to Follow-up|37
1165568|NCT03525119|2292932|FG000|Overall Study|Withdrawal by Subject|5
1165569|NCT03525119|2292933|FG001|Overall Study|Withdrawal by Subject|4
1165570|NCT03525119|2292934|FG002|Overall Study|Withdrawal by Subject|2
1165571|NCT03525119|2292932|FG000|Overall Study|Reason not Specified|2
1165572|NCT03525119|2292933|FG001|Overall Study|Reason not Specified|1
1165573|NCT03525119|2292934|FG002|Overall Study|Reason not Specified|2
1165574|NCT03525119|2292932|FG000|Overall Study|Randomized but not Vaccinated|1
1165575|NCT03525119|2292933|FG001|Overall Study|Randomized but not Vaccinated|0
1165576|NCT03525119|2292934|FG002|Overall Study|Randomized but not Vaccinated|2
1165577|NCT03525444|2292955|FG000|Overall Study|Adverse Event|0
1165578|NCT03525444|2292956|FG001|Overall Study|Adverse Event|1
1165579|NCT03525444|2292955|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
1165580|NCT03525444|2292956|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
1165581|NCT03525444|2292955|FG000|Overall Study|Other|0
1165582|NCT03525444|2292956|FG001|Overall Study|Other|1
1165583|NCT03525678|2292975|FG000|Overall Study|Ongoing at the time of interim analysis|60
1165584|NCT03525678|2292976|FG001|Overall Study|Ongoing at the time of interim analysis|65
1165585|NCT03525678|2292977|FG002|Overall Study|Ongoing at the time of interim analysis|21
1165586|NCT03525678|2292975|FG000|Overall Study|Withdrawal by Subject|3
1165587|NCT03525678|2292976|FG001|Overall Study|Withdrawal by Subject|1
1165588|NCT03525678|2292977|FG002|Overall Study|Withdrawal by Subject|0
1165589|NCT03525678|2292975|FG000|Overall Study|Physician Decision|1
1165590|NCT03525678|2292976|FG001|Overall Study|Physician Decision|2
1165591|NCT03525678|2292977|FG002|Overall Study|Physician Decision|0
1165592|NCT03525678|2292975|FG000|Overall Study|Lost to Follow-up|1
1165593|NCT03525678|2292976|FG001|Overall Study|Lost to Follow-up|0
1165594|NCT03525678|2292977|FG002|Overall Study|Lost to Follow-up|0
1165595|NCT03525678|2292975|FG000|Overall Study|Death|32
1165596|NCT03525678|2292976|FG001|Overall Study|Death|31
1165597|NCT03525678|2292977|FG002|Overall Study|Death|4
1165598|NCT03525834|2292985|FG000|Overall Study|Progressive disease|1
1165599|NCT03526458|2292999|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
1165600|NCT03526458|2293000|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
1165601|NCT03526458|2292999|FG000|Overall Study|Stone passed, surgery cancelled|2
1165602|NCT03526458|2293000|FG001|Overall Study|Stone passed, surgery cancelled|1
1165603|NCT03526458|2292999|FG000|Overall Study|Withdrawal by Subject|1
1165604|NCT03526458|2293000|FG001|Overall Study|Withdrawal by Subject|0
1165605|NCT03526458|2292999|FG000|Overall Study|Physician Decision|2
1165606|NCT03526458|2293000|FG001|Overall Study|Physician Decision|1
1165607|NCT03526458|2292999|FG000|Overall Study|Lack of equipment|1
1165608|NCT03526458|2293000|FG001|Overall Study|Lack of equipment|1
1165609|NCT03526861|2293009|FG000|Initial Treatment Period|Not dosed|1
1165610|NCT03526861|2293010|FG001|Initial Treatment Period|Not dosed|1
1165611|NCT03526861|2293011|FG002|Initial Treatment Period|Not dosed|1
1165612|NCT03526861|2293012|FG003|Initial Treatment Period|Not dosed|0
1165613|NCT03526861|2293013|FG004|Initial Treatment Period|Not dosed|0
1165614|NCT03526861|2293014|FG005|Initial Treatment Period|Not dosed|0
1165615|NCT03526861|2293015|FG006|Initial Treatment Period|Not dosed|0
1165616|NCT03526861|2293016|FG007|Initial Treatment Period|Not dosed|0
1165617|NCT03526861|2293017|FG008|Initial Treatment Period|Not dosed|0
1165618|NCT03526861|2293009|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3
1165619|NCT03526861|2293010|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
1165620|NCT03526861|2293011|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5
1165621|NCT03526861|2293012|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165622|NCT03526861|2293013|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165623|NCT03526861|2293014|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165624|NCT03526861|2293015|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165625|NCT03526861|2293016|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165626|NCT03526861|2293017|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165627|NCT03526861|2293009|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3
1165628|NCT03526861|2293010|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5
1165629|NCT03526861|2293011|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8
1165630|NCT03526861|2293012|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0
1165631|NCT03526861|2293013|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0
1165632|NCT03526861|2293014|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0
1165633|NCT03526861|2293015|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0
1165634|NCT03526861|2293016|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0
1165635|NCT03526861|2293017|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0
1165636|NCT03526861|2293009|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165637|NCT03526861|2293010|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165638|NCT03526861|2293011|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165639|NCT03526861|2293012|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
1165640|NCT03526861|2293013|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
1165641|NCT03526861|2293014|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165642|NCT03526861|2293015|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
1165643|NCT03526861|2293016|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165644|NCT03526861|2293017|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165645|NCT03526861|2293009|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0
1165646|NCT03526861|2293010|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0
1165647|NCT03526861|2293011|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0
1165648|NCT03526861|2293012|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6
1165649|NCT03526861|2293013|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5
1165650|NCT03526861|2293014|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4
1165651|NCT03526861|2293015|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5
1165652|NCT03526861|2293016|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2
1165653|NCT03526861|2293017|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0
1165654|NCT03526861|2293009|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165655|NCT03526861|2293010|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165656|NCT03526861|2293011|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165657|NCT03526861|2293012|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
1165658|NCT03526861|2293013|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165659|NCT03526861|2293014|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165660|NCT03526861|2293015|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165661|NCT03526861|2293016|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165662|NCT03526861|2293017|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165663|NCT03526861|2293009|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165664|NCT03526861|2293010|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165665|NCT03526861|2293011|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165666|NCT03526861|2293012|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165667|NCT03526861|2293013|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165668|NCT03526861|2293014|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165669|NCT03526861|2293015|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165670|NCT03526861|2293016|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
1165671|NCT03526861|2293017|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19
1165672|NCT03526861|2293009|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
1165673|NCT03526861|2293010|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
1165674|NCT03526861|2293011|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
1165675|NCT03526861|2293012|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
1165676|NCT03526861|2293013|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
1165677|NCT03526861|2293014|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
1165678|NCT03526861|2293015|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
1165679|NCT03526861|2293016|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
1165680|NCT03526861|2293017|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1
1165681|NCT03526861|2293009|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165682|NCT03526861|2293010|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165683|NCT03526861|2293011|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165684|NCT03526861|2293012|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165685|NCT03526861|2293013|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165686|NCT03526861|2293014|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165687|NCT03526861|2293015|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165688|NCT03526861|2293016|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
1165689|NCT03526861|2293017|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8
1165690|NCT03527160|2293039|FG000|Overall Study|No urine collected|13
1165691|NCT03527160|2293039|FG000|Overall Study|No clinical serum creatinine collected|6
1165692|NCT03527160|2293039|FG000|Overall Study|Did not meet inclusion|2
1165693|NCT03527173|2293048|FG000|Overall Study|Lost to Follow-up|4
1165694|NCT03527173|2293049|FG001|Overall Study|Lost to Follow-up|2
1165695|NCT03527173|2293048|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
1165696|NCT03527173|2293049|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
1165697|NCT03527173|2293048|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
1165698|NCT03527173|2293049|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
1165699|NCT03527173|2293048|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
1165700|NCT03527173|2293049|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
1165701|NCT03527550|2293057|FG000|Overall Study|Lost to Follow-up|4
1165702|NCT03527550|2293058|FG001|Overall Study|Lost to Follow-up|2
1165703|NCT03527550|2293057|FG000|Overall Study|Withdrawal by Subject|4
1165704|NCT03527550|2293058|FG001|Overall Study|Withdrawal by Subject|1
1165705|NCT03527550|2293057|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1
1165706|NCT03527550|2293058|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0
1165707|NCT03527745|2293092|FG000|Overall Study|Lost to Follow-up|3
1165708|NCT03527745|2293093|FG001|Overall Study|Lost to Follow-up|6
1165709|NCT03527745|2293094|FG002|Overall Study|Lost to Follow-up|7
1165710|NCT03527745|2293095|FG003|Overall Study|Lost to Follow-up|9
1165711|NCT03527745|2293096|FG004|Overall Study|Lost to Follow-up|0
1165712|NCT03527745|2293097|FG005|Overall Study|Lost to Follow-up|2
1165713|NCT03527745|2293098|FG006|Overall Study|Lost to Follow-up|3
1165714|NCT03527745|2293099|FG007|Overall Study|Lost to Follow-up|2
1165715|NCT03527745|2293100|FG008|Overall Study|Lost to Follow-up|3
1165716|NCT03527745|2293101|FG009|Overall Study|Lost to Follow-up|2
1165717|NCT03527745|2293102|FG010|Overall Study|Lost to Follow-up|1
1165718|NCT03527745|2293103|FG011|Overall Study|Lost to Follow-up|1
1165719|NCT03527745|2293104|FG012|Overall Study|Lost to Follow-up|0
1165720|NCT03527745|2293105|FG013|Overall Study|Lost to Follow-up|0
1165721|NCT03527745|2293106|FG014|Overall Study|Lost to Follow-up|0
1165722|NCT03527745|2293107|FG015|Overall Study|Lost to Follow-up|0
1165723|NCT03527745|2293108|FG016|Overall Study|Lost to Follow-up|1
1165724|NCT03527745|2293109|FG017|Overall Study|Lost to Follow-up|0
1165725|NCT03527745|2293110|FG018|Overall Study|Lost to Follow-up|0
1165726|NCT03527745|2293111|FG019|Overall Study|Lost to Follow-up|1
1165727|NCT03527745|2293112|FG020|Overall Study|Lost to Follow-up|1
1165728|NCT03527745|2293113|FG021|Overall Study|Lost to Follow-up|5
1165729|NCT03527745|2293114|FG022|Overall Study|Lost to Follow-up|6
1165730|NCT03527745|2293115|FG023|Overall Study|Lost to Follow-up|8
1165731|NCT03527745|2293116|FG024|Overall Study|Lost to Follow-up|1
1165732|NCT03527745|2293117|FG025|Overall Study|Lost to Follow-up|3
1165733|NCT03528174|2293182|FG000|Overall Study|Adverse Event|1
1165734|NCT03528174|2293182|FG000|Overall Study|sensors dislodged|1
1165735|NCT03528369|2293189|FG000|Overall Study|Withdrawal by Subject|2
1165736|NCT03528369|2293190|FG001|Overall Study|Withdrawal by Subject|0
1165737|NCT03528369|2293191|FG002|Overall Study|Withdrawal by Subject|0
1165738|NCT03528369|2293189|FG000|Overall Study|Lost to Follow-up|1
1165739|NCT03528369|2293190|FG001|Overall Study|Lost to Follow-up|0
1165740|NCT03528369|2293191|FG002|Overall Study|Lost to Follow-up|0
1165741|NCT03528369|2293189|FG000|Overall Study|Adverse Event|0
1165742|NCT03528369|2293190|FG001|Overall Study|Adverse Event|1
1165743|NCT03528369|2293191|FG002|Overall Study|Adverse Event|0
1165744|NCT03528551|2293211|FG000|Overall Study|Lost to Follow-up|0
1165745|NCT03528551|2293212|FG001|Overall Study|Lost to Follow-up|1
1165746|NCT03528551|2293213|FG002|Overall Study|Lost to Follow-up|0
1165747|NCT03528551|2293211|FG000|Overall Study|Transferred to other arm/group|2
1165748|NCT03528551|2293212|FG001|Overall Study|Transferred to other arm/group|3
1165749|NCT03528551|2293213|FG002|Overall Study|Transferred to other arm/group|0
1165750|NCT03528551|2293211|FG000|Overall Study|Withdrawal by parent/guardian|0
1165751|NCT03528551|2293212|FG001|Overall Study|Withdrawal by parent/guardian|5
1165752|NCT03528551|2293213|FG002|Overall Study|Withdrawal by parent/guardian|0
1165753|NCT03528551|2293211|FG000|Overall Study|Protocol Violation|0
1165754|NCT03528551|2293212|FG001|Overall Study|Protocol Violation|3
1165755|NCT03528551|2293213|FG002|Overall Study|Protocol Violation|0
1165756|NCT03528551|2293211|FG000|Overall Study|Withdrawal by Subject|0
1165757|NCT03528551|2293212|FG001|Overall Study|Withdrawal by Subject|7
1165758|NCT03528551|2293213|FG002|Overall Study|Withdrawal by Subject|0
1165759|NCT03528577|2293222|FG000|Sequence 1|Failed Spirometry|1
1165760|NCT03528577|2293222|FG000|Sequence 1|Restricted medication|1
1165761|NCT03528577|2293222|FG000|Sequence 2|Adverse Event|1
1165762|NCT03528577|2293222|FG000|Sequence 2|Withdrawal by Subject|1
1165763|NCT03528577|2293222|FG000|Sequence 2|Failed Spirometry|1
1165764|NCT03528577|2293222|FG000|Sequence 3|Failed Spirometry|1
1165765|NCT03528577|2293222|FG000|Sequence 4|Failed Spirometry|2
1165766|NCT03528577|2293222|FG000|Sequence 4|Adverse Event|1
1165767|NCT03529162|2293231|FG000|Overall Study|Lost to Follow-up|2
1165768|NCT03529162|2293232|FG001|Overall Study|Lost to Follow-up|2
1165769|NCT03529409|2293243|FG000|Randomized|Lost to Follow-up|0
1165770|NCT03529409|2293244|FG001|Randomized|Lost to Follow-up|0
1165771|NCT03529409|2293245|FG002|Randomized|Lost to Follow-up|4
1165772|NCT03529409|2293243|FG000|Randomized|Excluded|0
1165773|NCT03529409|2293244|FG001|Randomized|Excluded|0
1165774|NCT03529409|2293245|FG002|Randomized|Excluded|1
1165775|NCT03529409|2293243|FG000|Post-treatment Assessment|Death|1
1165776|NCT03529409|2293244|FG001|Post-treatment Assessment|Death|0
1165777|NCT03529409|2293245|FG002|Post-treatment Assessment|Death|0
1165778|NCT03529409|2293243|FG000|Post-treatment Assessment|Lost to Follow-up|1
1165779|NCT03529409|2293244|FG001|Post-treatment Assessment|Lost to Follow-up|1
1165780|NCT03529409|2293245|FG002|Post-treatment Assessment|Lost to Follow-up|0
1165781|NCT03529409|2293243|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2
1165782|NCT03529409|2293244|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4
1165783|NCT03529409|2293245|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0
1165784|NCT03529409|2293243|FG000|Follow-up Assessment|Death|1
1165785|NCT03529409|2293244|FG001|Follow-up Assessment|Death|0
1165786|NCT03529409|2293245|FG002|Follow-up Assessment|Death|0
1165787|NCT03529409|2293243|FG000|Follow-up Assessment|Withdrawal by Subject|0
1165788|NCT03529409|2293244|FG001|Follow-up Assessment|Withdrawal by Subject|1
1165789|NCT03529409|2293245|FG002|Follow-up Assessment|Withdrawal by Subject|0
1165790|NCT03529773|2293302|FG000|Overall Study|Adverse Event|0
1165791|NCT03529773|2293303|FG001|Overall Study|Adverse Event|0
1165792|NCT03529773|2293304|FG002|Overall Study|Adverse Event|0
1165793|NCT03529773|2293305|FG003|Overall Study|Adverse Event|0
1165794|NCT03529773|2293306|FG004|Overall Study|Adverse Event|0
1165795|NCT03529773|2293307|FG005|Overall Study|Adverse Event|0
1165796|NCT03529773|2293308|FG006|Overall Study|Adverse Event|0
1165797|NCT03529773|2293309|FG007|Overall Study|Adverse Event|0
1165798|NCT03529773|2293310|FG008|Overall Study|Adverse Event|0
1165799|NCT03529773|2293311|FG009|Overall Study|Adverse Event|0
1165800|NCT03529773|2293312|FG010|Overall Study|Adverse Event|0
1165801|NCT03529773|2293313|FG011|Overall Study|Adverse Event|0
1165802|NCT03529773|2293314|FG012|Overall Study|Adverse Event|0
1165803|NCT03529773|2293315|FG013|Overall Study|Adverse Event|0
1165804|NCT03529773|2293316|FG014|Overall Study|Adverse Event|0
1165805|NCT03529773|2293317|FG015|Overall Study|Adverse Event|0
1165806|NCT03529773|2293318|FG016|Overall Study|Adverse Event|0
1165807|NCT03529773|2293319|FG017|Overall Study|Adverse Event|0
1165808|NCT03529773|2293320|FG018|Overall Study|Adverse Event|0
1165809|NCT03529773|2293321|FG019|Overall Study|Adverse Event|0
1165810|NCT03529773|2293322|FG020|Overall Study|Adverse Event|0
1165811|NCT03529773|2293323|FG021|Overall Study|Adverse Event|0
1165812|NCT03529773|2293324|FG022|Overall Study|Adverse Event|0
1165813|NCT03529773|2293325|FG023|Overall Study|Adverse Event|0
1165814|NCT03529773|2293326|FG024|Overall Study|Adverse Event|0
1165815|NCT03529773|2293327|FG025|Overall Study|Adverse Event|0
1165816|NCT03529773|2293328|FG026|Overall Study|Adverse Event|0
1165817|NCT03529773|2293329|FG027|Overall Study|Adverse Event|0
1165818|NCT03529773|2293330|FG028|Overall Study|Adverse Event|0
1165819|NCT03529773|2293331|FG029|Overall Study|Adverse Event|0
1165820|NCT03529773|2293332|FG030|Overall Study|Adverse Event|1
1165821|NCT03529773|2293333|FG031|Overall Study|Adverse Event|0
1165822|NCT03529773|2293334|FG032|Overall Study|Adverse Event|0
1165823|NCT03529773|2293335|FG033|Overall Study|Adverse Event|0
1165824|NCT03529773|2293336|FG034|Overall Study|Adverse Event|0
1165825|NCT03529773|2293337|FG035|Overall Study|Adverse Event|1
1165826|NCT03529773|2293338|FG036|Overall Study|Adverse Event|0
1165827|NCT03529773|2293339|FG037|Overall Study|Adverse Event|0
1165828|NCT03529773|2293340|FG038|Overall Study|Adverse Event|0
1165829|NCT03529773|2293341|FG039|Overall Study|Adverse Event|1
1165830|NCT03529773|2293302|FG000|Overall Study|Death|0
1165831|NCT03529773|2293303|FG001|Overall Study|Death|0
1165832|NCT03529773|2293304|FG002|Overall Study|Death|0
1165833|NCT03529773|2293305|FG003|Overall Study|Death|0
1165834|NCT03529773|2293306|FG004|Overall Study|Death|0
1165835|NCT03529773|2293307|FG005|Overall Study|Death|0
1165836|NCT03529773|2293308|FG006|Overall Study|Death|0
1165837|NCT03529773|2293309|FG007|Overall Study|Death|0
1165838|NCT03529773|2293310|FG008|Overall Study|Death|0
1165839|NCT03529773|2293311|FG009|Overall Study|Death|0
1165840|NCT03529773|2293312|FG010|Overall Study|Death|0
1165841|NCT03529773|2293313|FG011|Overall Study|Death|0
1165842|NCT03529773|2293314|FG012|Overall Study|Death|1
1165843|NCT03529773|2293315|FG013|Overall Study|Death|0
1165844|NCT03529773|2293316|FG014|Overall Study|Death|0
1165845|NCT03529773|2293317|FG015|Overall Study|Death|0
1165846|NCT03529773|2293318|FG016|Overall Study|Death|0
1165847|NCT03529773|2293319|FG017|Overall Study|Death|0
1165848|NCT03529773|2293320|FG018|Overall Study|Death|0
1165849|NCT03529773|2293321|FG019|Overall Study|Death|1
1165850|NCT03529773|2293322|FG020|Overall Study|Death|0
1165851|NCT03529773|2293323|FG021|Overall Study|Death|0
1165852|NCT03529773|2293324|FG022|Overall Study|Death|1
1165853|NCT03529773|2293325|FG023|Overall Study|Death|0
1165854|NCT03529773|2293326|FG024|Overall Study|Death|0
1165855|NCT03529773|2293327|FG025|Overall Study|Death|0
1165856|NCT03529773|2293328|FG026|Overall Study|Death|0
1165857|NCT03529773|2293329|FG027|Overall Study|Death|0
1165858|NCT03529773|2293330|FG028|Overall Study|Death|0
1165859|NCT03529773|2293331|FG029|Overall Study|Death|0
1165860|NCT03529773|2293332|FG030|Overall Study|Death|0
1165861|NCT03529773|2293333|FG031|Overall Study|Death|0
1165862|NCT03529773|2293334|FG032|Overall Study|Death|0
1165863|NCT03529773|2293335|FG033|Overall Study|Death|1
1165864|NCT03529773|2293336|FG034|Overall Study|Death|1
1165865|NCT03529773|2293337|FG035|Overall Study|Death|0
1165866|NCT03529773|2293338|FG036|Overall Study|Death|1
1165867|NCT03529773|2293339|FG037|Overall Study|Death|0
1165868|NCT03529773|2293340|FG038|Overall Study|Death|0
1165869|NCT03529773|2293341|FG039|Overall Study|Death|0
1165870|NCT03529773|2293302|FG000|Overall Study|Lost to Follow-up|0
1165871|NCT03529773|2293303|FG001|Overall Study|Lost to Follow-up|0
1165872|NCT03529773|2293304|FG002|Overall Study|Lost to Follow-up|1
1165873|NCT03529773|2293305|FG003|Overall Study|Lost to Follow-up|0
1165874|NCT03529773|2293306|FG004|Overall Study|Lost to Follow-up|1
1165875|NCT03529773|2293307|FG005|Overall Study|Lost to Follow-up|1
1165876|NCT03529773|2293308|FG006|Overall Study|Lost to Follow-up|0
1165877|NCT03529773|2293309|FG007|Overall Study|Lost to Follow-up|0
1165878|NCT03529773|2293310|FG008|Overall Study|Lost to Follow-up|0
1165879|NCT03529773|2293311|FG009|Overall Study|Lost to Follow-up|0
1165880|NCT03529773|2293312|FG010|Overall Study|Lost to Follow-up|0
1165881|NCT03529773|2293313|FG011|Overall Study|Lost to Follow-up|0
1165882|NCT03529773|2293314|FG012|Overall Study|Lost to Follow-up|0
1165883|NCT03529773|2293315|FG013|Overall Study|Lost to Follow-up|1
1165884|NCT03529773|2293316|FG014|Overall Study|Lost to Follow-up|4
1165885|NCT03529773|2293317|FG015|Overall Study|Lost to Follow-up|1
1165886|NCT03529773|2293318|FG016|Overall Study|Lost to Follow-up|1
1165887|NCT03529773|2293319|FG017|Overall Study|Lost to Follow-up|0
1165888|NCT03529773|2293320|FG018|Overall Study|Lost to Follow-up|1
1165889|NCT03529773|2293321|FG019|Overall Study|Lost to Follow-up|1
1165890|NCT03529773|2293322|FG020|Overall Study|Lost to Follow-up|2
1165891|NCT03529773|2293323|FG021|Overall Study|Lost to Follow-up|4
1165892|NCT03529773|2293324|FG022|Overall Study|Lost to Follow-up|1
1165893|NCT03529773|2293325|FG023|Overall Study|Lost to Follow-up|4
1165894|NCT03529773|2293326|FG024|Overall Study|Lost to Follow-up|3
1165895|NCT03529773|2293327|FG025|Overall Study|Lost to Follow-up|4
1165896|NCT03529773|2293328|FG026|Overall Study|Lost to Follow-up|5
1165897|NCT03529773|2293329|FG027|Overall Study|Lost to Follow-up|0
1165898|NCT03529773|2293330|FG028|Overall Study|Lost to Follow-up|0
1165899|NCT03529773|2293331|FG029|Overall Study|Lost to Follow-up|0
1165900|NCT03529773|2293332|FG030|Overall Study|Lost to Follow-up|1
1165901|NCT03529773|2293333|FG031|Overall Study|Lost to Follow-up|0
1165902|NCT03529773|2293334|FG032|Overall Study|Lost to Follow-up|0
1165903|NCT03529773|2293335|FG033|Overall Study|Lost to Follow-up|1
1165904|NCT03529773|2293336|FG034|Overall Study|Lost to Follow-up|1
1165905|NCT03529773|2293337|FG035|Overall Study|Lost to Follow-up|0
1165906|NCT03529773|2293338|FG036|Overall Study|Lost to Follow-up|0
1165907|NCT03529773|2293339|FG037|Overall Study|Lost to Follow-up|0
1165908|NCT03529773|2293340|FG038|Overall Study|Lost to Follow-up|0
1165909|NCT03529773|2293341|FG039|Overall Study|Lost to Follow-up|1
1165910|NCT03529773|2293302|FG000|Overall Study|No longer meets eligibility criteria|0
1165911|NCT03529773|2293303|FG001|Overall Study|No longer meets eligibility criteria|0
1165912|NCT03529773|2293304|FG002|Overall Study|No longer meets eligibility criteria|0
1165913|NCT03529773|2293305|FG003|Overall Study|No longer meets eligibility criteria|0
1165914|NCT03529773|2293306|FG004|Overall Study|No longer meets eligibility criteria|0
1165915|NCT03529773|2293307|FG005|Overall Study|No longer meets eligibility criteria|0
1165916|NCT03529773|2293308|FG006|Overall Study|No longer meets eligibility criteria|0
1165917|NCT03529773|2293309|FG007|Overall Study|No longer meets eligibility criteria|0
1165918|NCT03529773|2293310|FG008|Overall Study|No longer meets eligibility criteria|0
1165919|NCT03529773|2293311|FG009|Overall Study|No longer meets eligibility criteria|0
1165920|NCT03529773|2293312|FG010|Overall Study|No longer meets eligibility criteria|0
1165921|NCT03529773|2293313|FG011|Overall Study|No longer meets eligibility criteria|0
1165922|NCT03529773|2293314|FG012|Overall Study|No longer meets eligibility criteria|0
1165923|NCT03529773|2293315|FG013|Overall Study|No longer meets eligibility criteria|0
1165924|NCT03529773|2293316|FG014|Overall Study|No longer meets eligibility criteria|0
1165925|NCT03529773|2293317|FG015|Overall Study|No longer meets eligibility criteria|0
1165926|NCT03529773|2293318|FG016|Overall Study|No longer meets eligibility criteria|0
1165927|NCT03529773|2293319|FG017|Overall Study|No longer meets eligibility criteria|0
1165928|NCT03529773|2293320|FG018|Overall Study|No longer meets eligibility criteria|0
1165929|NCT03529773|2293321|FG019|Overall Study|No longer meets eligibility criteria|0
1165930|NCT03529773|2293322|FG020|Overall Study|No longer meets eligibility criteria|0
1165931|NCT03529773|2293323|FG021|Overall Study|No longer meets eligibility criteria|0
1165932|NCT03529773|2293324|FG022|Overall Study|No longer meets eligibility criteria|1
1165933|NCT03529773|2293325|FG023|Overall Study|No longer meets eligibility criteria|0
1165934|NCT03529773|2293326|FG024|Overall Study|No longer meets eligibility criteria|0
1165935|NCT03529773|2293327|FG025|Overall Study|No longer meets eligibility criteria|0
1165936|NCT03529773|2293328|FG026|Overall Study|No longer meets eligibility criteria|0
1165937|NCT03529773|2293329|FG027|Overall Study|No longer meets eligibility criteria|0
1165938|NCT03529773|2293330|FG028|Overall Study|No longer meets eligibility criteria|0
1165939|NCT03529773|2293331|FG029|Overall Study|No longer meets eligibility criteria|0
1165940|NCT03529773|2293332|FG030|Overall Study|No longer meets eligibility criteria|0
1165941|NCT03529773|2293333|FG031|Overall Study|No longer meets eligibility criteria|0
1165942|NCT03529773|2293334|FG032|Overall Study|No longer meets eligibility criteria|0
1165943|NCT03529773|2293335|FG033|Overall Study|No longer meets eligibility criteria|0
1165944|NCT03529773|2293336|FG034|Overall Study|No longer meets eligibility criteria|0
1165945|NCT03529773|2293337|FG035|Overall Study|No longer meets eligibility criteria|0
1165946|NCT03529773|2293338|FG036|Overall Study|No longer meets eligibility criteria|0
1165947|NCT03529773|2293339|FG037|Overall Study|No longer meets eligibility criteria|0
1165948|NCT03529773|2293340|FG038|Overall Study|No longer meets eligibility criteria|0
1165949|NCT03529773|2293341|FG039|Overall Study|No longer meets eligibility criteria|0
1165950|NCT03529773|2293302|FG000|Overall Study|Other|0
1165951|NCT03529773|2293303|FG001|Overall Study|Other|0
1165952|NCT03529773|2293304|FG002|Overall Study|Other|0
1165953|NCT03529773|2293305|FG003|Overall Study|Other|0
1165954|NCT03529773|2293306|FG004|Overall Study|Other|0
1165955|NCT03529773|2293307|FG005|Overall Study|Other|0
1165956|NCT03529773|2293308|FG006|Overall Study|Other|0
1165957|NCT03529773|2293309|FG007|Overall Study|Other|0
1165958|NCT03529773|2293310|FG008|Overall Study|Other|0
1165959|NCT03529773|2293311|FG009|Overall Study|Other|0
1165960|NCT03529773|2293312|FG010|Overall Study|Other|0
1165961|NCT03529773|2293313|FG011|Overall Study|Other|0
1165962|NCT03529773|2293314|FG012|Overall Study|Other|1
1165963|NCT03529773|2293315|FG013|Overall Study|Other|0
1165964|NCT03529773|2293316|FG014|Overall Study|Other|2
1165965|NCT03529773|2293317|FG015|Overall Study|Other|0
1165966|NCT03529773|2293318|FG016|Overall Study|Other|0
1165967|NCT03529773|2293319|FG017|Overall Study|Other|2
1165968|NCT03529773|2293320|FG018|Overall Study|Other|0
1165969|NCT03529773|2293321|FG019|Overall Study|Other|0
1165970|NCT03529773|2293322|FG020|Overall Study|Other|1
1165971|NCT03529773|2293323|FG021|Overall Study|Other|0
1165972|NCT03529773|2293324|FG022|Overall Study|Other|1
1165973|NCT03529773|2293325|FG023|Overall Study|Other|0
1165974|NCT03529773|2293326|FG024|Overall Study|Other|2
1165975|NCT03529773|2293327|FG025|Overall Study|Other|2
1165976|NCT03529773|2293328|FG026|Overall Study|Other|1
1165977|NCT03529773|2293329|FG027|Overall Study|Other|0
1165978|NCT03529773|2293330|FG028|Overall Study|Other|0
1165979|NCT03529773|2293331|FG029|Overall Study|Other|0
1165980|NCT03529773|2293332|FG030|Overall Study|Other|0
1165981|NCT03529773|2293333|FG031|Overall Study|Other|0
1165982|NCT03529773|2293334|FG032|Overall Study|Other|0
1165983|NCT03529773|2293335|FG033|Overall Study|Other|0
1165984|NCT03529773|2293336|FG034|Overall Study|Other|1
1165985|NCT03529773|2293337|FG035|Overall Study|Other|1
1165986|NCT03529773|2293338|FG036|Overall Study|Other|0
1165987|NCT03529773|2293339|FG037|Overall Study|Other|0
1165988|NCT03529773|2293340|FG038|Overall Study|Other|0
1165989|NCT03529773|2293341|FG039|Overall Study|Other|0
1165990|NCT03529773|2293302|FG000|Overall Study|Physician Decision|0
1165991|NCT03529773|2293303|FG001|Overall Study|Physician Decision|0
1165992|NCT03529773|2293304|FG002|Overall Study|Physician Decision|0
1165993|NCT03529773|2293305|FG003|Overall Study|Physician Decision|0
1165994|NCT03529773|2293306|FG004|Overall Study|Physician Decision|0
1165995|NCT03529773|2293307|FG005|Overall Study|Physician Decision|0
1165996|NCT03529773|2293308|FG006|Overall Study|Physician Decision|0
1165997|NCT03529773|2293309|FG007|Overall Study|Physician Decision|0
1165998|NCT03529773|2293310|FG008|Overall Study|Physician Decision|0
1165999|NCT03529773|2293311|FG009|Overall Study|Physician Decision|0
1166000|NCT03529773|2293312|FG010|Overall Study|Physician Decision|0
1166001|NCT03529773|2293313|FG011|Overall Study|Physician Decision|0
1166002|NCT03529773|2293314|FG012|Overall Study|Physician Decision|0
1166003|NCT03529773|2293315|FG013|Overall Study|Physician Decision|0
1166004|NCT03529773|2293316|FG014|Overall Study|Physician Decision|0
1166005|NCT03529773|2293317|FG015|Overall Study|Physician Decision|0
1166006|NCT03529773|2293318|FG016|Overall Study|Physician Decision|0
1166007|NCT03529773|2293319|FG017|Overall Study|Physician Decision|0
1166008|NCT03529773|2293320|FG018|Overall Study|Physician Decision|0
1166009|NCT03529773|2293321|FG019|Overall Study|Physician Decision|1
1166010|NCT03529773|2293322|FG020|Overall Study|Physician Decision|1
1166011|NCT03529773|2293323|FG021|Overall Study|Physician Decision|0
1166012|NCT03529773|2293324|FG022|Overall Study|Physician Decision|0
1166013|NCT03529773|2293325|FG023|Overall Study|Physician Decision|0
1166014|NCT03529773|2293326|FG024|Overall Study|Physician Decision|0
1166015|NCT03529773|2293327|FG025|Overall Study|Physician Decision|0
1166016|NCT03529773|2293328|FG026|Overall Study|Physician Decision|0
1166017|NCT03529773|2293329|FG027|Overall Study|Physician Decision|0
1166018|NCT03529773|2293330|FG028|Overall Study|Physician Decision|0
1166019|NCT03529773|2293331|FG029|Overall Study|Physician Decision|0
1166020|NCT03529773|2293332|FG030|Overall Study|Physician Decision|0
1166021|NCT03529773|2293333|FG031|Overall Study|Physician Decision|0
1166022|NCT03529773|2293334|FG032|Overall Study|Physician Decision|0
1166023|NCT03529773|2293335|FG033|Overall Study|Physician Decision|0
1166024|NCT03529773|2293336|FG034|Overall Study|Physician Decision|0
1166025|NCT03529773|2293337|FG035|Overall Study|Physician Decision|0
1166026|NCT03529773|2293338|FG036|Overall Study|Physician Decision|0
1166027|NCT03529773|2293339|FG037|Overall Study|Physician Decision|0
1166028|NCT03529773|2293340|FG038|Overall Study|Physician Decision|0
1166029|NCT03529773|2293341|FG039|Overall Study|Physician Decision|0
1166030|NCT03529773|2293302|FG000|Overall Study|Protocol Violation|0
1166031|NCT03529773|2293303|FG001|Overall Study|Protocol Violation|0
1166032|NCT03529773|2293304|FG002|Overall Study|Protocol Violation|0
1166033|NCT03529773|2293305|FG003|Overall Study|Protocol Violation|0
1166034|NCT03529773|2293306|FG004|Overall Study|Protocol Violation|0
1166035|NCT03529773|2293307|FG005|Overall Study|Protocol Violation|0
1166036|NCT03529773|2293308|FG006|Overall Study|Protocol Violation|0
1166037|NCT03529773|2293309|FG007|Overall Study|Protocol Violation|0
1166038|NCT03529773|2293310|FG008|Overall Study|Protocol Violation|0
1166039|NCT03529773|2293311|FG009|Overall Study|Protocol Violation|0
1166040|NCT03529773|2293312|FG010|Overall Study|Protocol Violation|0
1166041|NCT03529773|2293313|FG011|Overall Study|Protocol Violation|0
1166042|NCT03529773|2293314|FG012|Overall Study|Protocol Violation|0
1166043|NCT03529773|2293315|FG013|Overall Study|Protocol Violation|0
1166044|NCT03529773|2293316|FG014|Overall Study|Protocol Violation|0
1166045|NCT03529773|2293317|FG015|Overall Study|Protocol Violation|0
1166046|NCT03529773|2293318|FG016|Overall Study|Protocol Violation|0
1166047|NCT03529773|2293319|FG017|Overall Study|Protocol Violation|0
1166048|NCT03529773|2293320|FG018|Overall Study|Protocol Violation|0
1166049|NCT03529773|2293321|FG019|Overall Study|Protocol Violation|0
1166050|NCT03529773|2293322|FG020|Overall Study|Protocol Violation|0
1166051|NCT03529773|2293323|FG021|Overall Study|Protocol Violation|0
1166052|NCT03529773|2293324|FG022|Overall Study|Protocol Violation|0
1166053|NCT03529773|2293325|FG023|Overall Study|Protocol Violation|0
1166054|NCT03529773|2293326|FG024|Overall Study|Protocol Violation|0
1166055|NCT03529773|2293327|FG025|Overall Study|Protocol Violation|0
1166056|NCT03529773|2293328|FG026|Overall Study|Protocol Violation|0
1166057|NCT03529773|2293329|FG027|Overall Study|Protocol Violation|0
1166058|NCT03529773|2293330|FG028|Overall Study|Protocol Violation|0
1166059|NCT03529773|2293331|FG029|Overall Study|Protocol Violation|0
1166060|NCT03529773|2293332|FG030|Overall Study|Protocol Violation|1
1166061|NCT03529773|2293333|FG031|Overall Study|Protocol Violation|0
1166062|NCT03529773|2293334|FG032|Overall Study|Protocol Violation|0
1166063|NCT03529773|2293335|FG033|Overall Study|Protocol Violation|0
1166064|NCT03529773|2293336|FG034|Overall Study|Protocol Violation|0
1166065|NCT03529773|2293337|FG035|Overall Study|Protocol Violation|0
1166066|NCT03529773|2293338|FG036|Overall Study|Protocol Violation|0
1166067|NCT03529773|2293339|FG037|Overall Study|Protocol Violation|0
1166068|NCT03529773|2293340|FG038|Overall Study|Protocol Violation|0
1166069|NCT03529773|2293341|FG039|Overall Study|Protocol Violation|0
1166070|NCT03529773|2293302|FG000|Overall Study|Withdrawal by Subject|0
1166071|NCT03529773|2293303|FG001|Overall Study|Withdrawal by Subject|0
1166072|NCT03529773|2293304|FG002|Overall Study|Withdrawal by Subject|0
1166073|NCT03529773|2293305|FG003|Overall Study|Withdrawal by Subject|0
1166074|NCT03529773|2293306|FG004|Overall Study|Withdrawal by Subject|0
1166075|NCT03529773|2293307|FG005|Overall Study|Withdrawal by Subject|0
1166076|NCT03529773|2293308|FG006|Overall Study|Withdrawal by Subject|0
1166077|NCT03529773|2293309|FG007|Overall Study|Withdrawal by Subject|1
1166078|NCT03529773|2293310|FG008|Overall Study|Withdrawal by Subject|0
1166079|NCT03529773|2293311|FG009|Overall Study|Withdrawal by Subject|1
1166080|NCT03529773|2293312|FG010|Overall Study|Withdrawal by Subject|1
1166081|NCT03529773|2293313|FG011|Overall Study|Withdrawal by Subject|0
1166082|NCT03529773|2293314|FG012|Overall Study|Withdrawal by Subject|0
1166083|NCT03529773|2293315|FG013|Overall Study|Withdrawal by Subject|0
1166084|NCT03529773|2293316|FG014|Overall Study|Withdrawal by Subject|0
1166085|NCT03529773|2293317|FG015|Overall Study|Withdrawal by Subject|3
1166086|NCT03529773|2293318|FG016|Overall Study|Withdrawal by Subject|0
1166087|NCT03529773|2293319|FG017|Overall Study|Withdrawal by Subject|3
1166088|NCT03529773|2293320|FG018|Overall Study|Withdrawal by Subject|3
1166089|NCT03529773|2293321|FG019|Overall Study|Withdrawal by Subject|1
1166090|NCT03529773|2293322|FG020|Overall Study|Withdrawal by Subject|3
1166091|NCT03529773|2293323|FG021|Overall Study|Withdrawal by Subject|1
1166092|NCT03529773|2293324|FG022|Overall Study|Withdrawal by Subject|1
1166093|NCT03529773|2293325|FG023|Overall Study|Withdrawal by Subject|1
1166094|NCT03529773|2293326|FG024|Overall Study|Withdrawal by Subject|2
1166095|NCT03529773|2293327|FG025|Overall Study|Withdrawal by Subject|4
1166096|NCT03529773|2293328|FG026|Overall Study|Withdrawal by Subject|2
1166097|NCT03529773|2293329|FG027|Overall Study|Withdrawal by Subject|1
1166098|NCT03529773|2293330|FG028|Overall Study|Withdrawal by Subject|1
1166099|NCT03529773|2293331|FG029|Overall Study|Withdrawal by Subject|0
1166100|NCT03529773|2293332|FG030|Overall Study|Withdrawal by Subject|0
1166101|NCT03529773|2293333|FG031|Overall Study|Withdrawal by Subject|0
1166102|NCT03529773|2293334|FG032|Overall Study|Withdrawal by Subject|0
1166103|NCT03529773|2293335|FG033|Overall Study|Withdrawal by Subject|0
1166104|NCT03529773|2293336|FG034|Overall Study|Withdrawal by Subject|1
1166105|NCT03529773|2293337|FG035|Overall Study|Withdrawal by Subject|1
1166106|NCT03529773|2293338|FG036|Overall Study|Withdrawal by Subject|0
1166107|NCT03529773|2293339|FG037|Overall Study|Withdrawal by Subject|1
1166108|NCT03529773|2293340|FG038|Overall Study|Withdrawal by Subject|0
1166109|NCT03529773|2293341|FG039|Overall Study|Withdrawal by Subject|0
1166115|NCT03530345|2293445|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
1166116|NCT03530345|2293446|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0
1166117|NCT03530345|2293445|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
1166118|NCT03530345|2293446|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
1166119|NCT03530345|2293445|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17
1166120|NCT03530345|2293446|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21
1166121|NCT03530345|2293445|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5
1166122|NCT03530345|2293446|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7
1166123|NCT03530995|2293509|FG000|Part 1 Period 3|Withdrawal by Subject|2
1166124|NCT03530995|2293510|FG001|Part 1 Period 3|Withdrawal by Subject|0
1166125|NCT03530995|2293509|FG000|Part 1 Period 3|Protocol Violation|1
1166126|NCT03530995|2293510|FG001|Part 1 Period 3|Protocol Violation|0
1166127|NCT03530995|2293509|FG000|Part 1 Period 4|Physician Decision|1
1166128|NCT03530995|2293510|FG001|Part 1 Period 4|Physician Decision|0
1166129|NCT03530995|2293509|FG000|Part 1 Period 4|Withdrawal by Subject|1
1166130|NCT03530995|2293510|FG001|Part 1 Period 4|Withdrawal by Subject|0
1166131|NCT03531632|2293535|FG000|Overall Study|Adverse Event|0
1166132|NCT03531632|2293536|FG001|Overall Study|Adverse Event|0
1166133|NCT03531632|2293537|FG002|Overall Study|Adverse Event|1
1166134|NCT03531632|2293535|FG000|Overall Study|Death|4
1166135|NCT03531632|2293536|FG001|Overall Study|Death|0
1166136|NCT03531632|2293537|FG002|Overall Study|Death|14
1166137|NCT03531632|2293535|FG000|Overall Study|Study Terminated|1
1166138|NCT03531632|2293536|FG001|Overall Study|Study Terminated|3
1166139|NCT03531632|2293537|FG002|Overall Study|Study Terminated|11
1166140|NCT03531840|2293575|FG000|Overall Study|Death on study|3
1166141|NCT03531840|2293576|FG001|Overall Study|Death on study|2
1166142|NCT03531840|2293577|FG002|Overall Study|Death on study|1
1166143|NCT03531840|2293578|FG003|Overall Study|Death on study|2
1166144|NCT03531840|2293575|FG000|Overall Study|Death during follow up|2
1166145|NCT03531840|2293576|FG001|Overall Study|Death during follow up|3
1166146|NCT03531840|2293577|FG002|Overall Study|Death during follow up|4
1166147|NCT03531840|2293578|FG003|Overall Study|Death during follow up|1
1166148|NCT03531905|2293596|FG000|Overall Study|Withdrawal by Subject|3
1166149|NCT03531905|2293597|FG001|Overall Study|Withdrawal by Subject|3
1166150|NCT03531905|2293598|FG002|Overall Study|Withdrawal by Subject|2
1166151|NCT03531905|2293596|FG000|Overall Study|Lost to Follow-up|2
1166152|NCT03531905|2293597|FG001|Overall Study|Lost to Follow-up|2
1166153|NCT03531905|2293598|FG002|Overall Study|Lost to Follow-up|1
1166154|NCT03531905|2293596|FG000|Overall Study|Participant was out of town|1
1166155|NCT03531905|2293597|FG001|Overall Study|Participant was out of town|0
1166156|NCT03531905|2293598|FG002|Overall Study|Participant was out of town|0
1166157|NCT03531905|2293596|FG000|Overall Study|Could not speak with the participant|1
1166158|NCT03531905|2293597|FG001|Overall Study|Could not speak with the participant|0
1166159|NCT03531905|2293598|FG002|Overall Study|Could not speak with the participant|0
1166160|NCT03532009|2293610|FG000|Overall Study|Other|1
1166161|NCT03532009|2293611|FG001|Overall Study|Other|1
1166162|NCT03532009|2293610|FG000|Overall Study|Death|1
1166163|NCT03532009|2293611|FG001|Overall Study|Death|1
1166164|NCT03532009|2293610|FG000|Overall Study|Withdrawal by Patient|0
1166165|NCT03532009|2293611|FG001|Overall Study|Withdrawal by Patient|2
1166166|NCT03532048|2293619|FG000|Overall Study|Lost to Follow-up|12
1166167|NCT03532048|2293620|FG001|Overall Study|Lost to Follow-up|17
1166168|NCT03532048|2293619|FG000|Overall Study|Withdrawal by Subject|7
1166169|NCT03532048|2293620|FG001|Overall Study|Withdrawal by Subject|0
1166174|NCT03533114|2293669|FG000|Overall|Adverse Event|16
1166175|NCT03533114|2293670|FG001|Overall|Adverse Event|11
1166176|NCT03533114|2293669|FG000|Overall|Consent Withdrawal by Participant|7
1166177|NCT03533114|2293670|FG001|Overall|Consent Withdrawal by Participant|6
1166178|NCT03533114|2293669|FG000|Overall|Lack of Efficacy|5
1166179|NCT03533114|2293670|FG001|Overall|Lack of Efficacy|3
1166180|NCT03533114|2293669|FG000|Overall|Lost to Follow-up|1
1166181|NCT03533114|2293670|FG001|Overall|Lost to Follow-up|1
1166182|NCT03533114|2293669|FG000|Overall|Physician Decision|0
1166183|NCT03533114|2293670|FG001|Overall|Physician Decision|2
1166184|NCT03533114|2293669|FG000|Overall|Protocol deviation|1
1166185|NCT03533114|2293670|FG001|Overall|Protocol deviation|1
1166186|NCT03533114|2293669|FG000|Overall|Failure to meet randomization criteria|1
1166187|NCT03533114|2293670|FG001|Overall|Failure to meet randomization criteria|2
1166188|NCT03533114|2293669|FG000|Overall|Non-Compliance with study drug|0
1166189|NCT03533114|2293670|FG001|Overall|Non-Compliance with study drug|1
1166190|NCT03533114|2293669|FG000|Overall|Other|0
1166191|NCT03533114|2293670|FG001|Overall|Other|1
1166192|NCT03533114|2293669|FG000|Open Label Titration and Optimization|Adverse Event|11
1166193|NCT03533114|2293670|FG001|Open Label Titration and Optimization|Adverse Event|8
1166194|NCT03533114|2293669|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2
1166195|NCT03533114|2293670|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1
1166196|NCT03533114|2293669|FG000|Open Label Titration and Optimization|Lack of Efficacy|3
1166197|NCT03533114|2293670|FG001|Open Label Titration and Optimization|Lack of Efficacy|1
1166198|NCT03533114|2293669|FG000|Open Label Titration and Optimization|Lost to Follow-up|0
1166199|NCT03533114|2293670|FG001|Open Label Titration and Optimization|Lost to Follow-up|1
1166200|NCT03533114|2293669|FG000|Open Label Titration and Optimization|Protocol Deviation|0
1166201|NCT03533114|2293670|FG001|Open Label Titration and Optimization|Protocol Deviation|1
1166202|NCT03533114|2293669|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0
1166203|NCT03533114|2293670|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1
1166204|NCT03533114|2293669|FG000|Stable Dose|Adverse Event|0
1166205|NCT03533114|2293670|FG001|Stable Dose|Adverse Event|2
1166206|NCT03533114|2293669|FG000|Stable Dose|Consent Withdrawal by Participant|1
1166207|NCT03533114|2293670|FG001|Stable Dose|Consent Withdrawal by Participant|0
1166208|NCT03533114|2293669|FG000|Stable Dose|Lack of Efficacy|1
1166209|NCT03533114|2293670|FG001|Stable Dose|Lack of Efficacy|0
1166210|NCT03533114|2293669|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1
1166211|NCT03533114|2293670|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1
1166212|NCT03533114|2293669|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1
1166213|NCT03533114|2293670|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0
1166214|NCT03533114|2293669|FG000|Open-Label Safety Extension|Adverse Event|3
1166215|NCT03533114|2293670|FG001|Open-Label Safety Extension|Adverse Event|0
1166216|NCT03533114|2293669|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2
1166217|NCT03533114|2293670|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3
1166218|NCT03533114|2293669|FG000|Open-Label Safety Extension|Lack of Efficacy|1
1166219|NCT03533114|2293670|FG001|Open-Label Safety Extension|Lack of Efficacy|0
1166220|NCT03533114|2293669|FG000|Open-Label Safety Extension|Lost to Follow-up|1
1166221|NCT03533114|2293670|FG001|Open-Label Safety Extension|Lost to Follow-up|0
1166222|NCT03533114|2293669|FG000|Open-Label Safety Extension|Protocol Deviation|1
1166223|NCT03533114|2293670|FG001|Open-Label Safety Extension|Protocol Deviation|0
1166224|NCT03533608|2293700|FG000|Overall Study|Withdrawal by Subject|3
1166225|NCT03533608|2293700|FG000|Overall Study|Physician Decision|2
1166226|NCT03535194|2293745|FG000|Induction Period|Adverse Event|2
1166227|NCT03535194|2293746|FG001|Induction Period|Adverse Event|2
1166228|NCT03535194|2293747|FG002|Induction Period|Adverse Event|1
1166229|NCT03535194|2293748|FG003|Induction Period|Adverse Event|3
1166230|NCT03535194|2293749|FG004|Induction Period|Adverse Event|0
1166231|NCT03535194|2293745|FG000|Induction Period|Death|0
1166232|NCT03535194|2293746|FG001|Induction Period|Death|1
1166233|NCT03535194|2293747|FG002|Induction Period|Death|0
1166234|NCT03535194|2293748|FG003|Induction Period|Death|0
1166235|NCT03535194|2293749|FG004|Induction Period|Death|0
1166236|NCT03535194|2293745|FG000|Induction Period|Lack of Efficacy|1
1166237|NCT03535194|2293746|FG001|Induction Period|Lack of Efficacy|3
1166238|NCT03535194|2293747|FG002|Induction Period|Lack of Efficacy|2
1166239|NCT03535194|2293748|FG003|Induction Period|Lack of Efficacy|2
1166240|NCT03535194|2293749|FG004|Induction Period|Lack of Efficacy|0
1166241|NCT03535194|2293745|FG000|Induction Period|Lost to Follow-up|3
1166242|NCT03535194|2293746|FG001|Induction Period|Lost to Follow-up|5
1166243|NCT03535194|2293747|FG002|Induction Period|Lost to Follow-up|2
1166244|NCT03535194|2293748|FG003|Induction Period|Lost to Follow-up|3
1166245|NCT03535194|2293749|FG004|Induction Period|Lost to Follow-up|0
1166246|NCT03535194|2293745|FG000|Induction Period|Physician Decision|1
1166247|NCT03535194|2293746|FG001|Induction Period|Physician Decision|1
1166248|NCT03535194|2293747|FG002|Induction Period|Physician Decision|0
1166249|NCT03535194|2293748|FG003|Induction Period|Physician Decision|0
1166250|NCT03535194|2293749|FG004|Induction Period|Physician Decision|0
1166251|NCT03535194|2293745|FG000|Induction Period|Protocol Violation|1
1166252|NCT03535194|2293746|FG001|Induction Period|Protocol Violation|0
1166253|NCT03535194|2293747|FG002|Induction Period|Protocol Violation|0
1166254|NCT03535194|2293748|FG003|Induction Period|Protocol Violation|1
1166255|NCT03535194|2293749|FG004|Induction Period|Protocol Violation|0
1166256|NCT03535194|2293745|FG000|Induction Period|Screen Failure|0
1166257|NCT03535194|2293746|FG001|Induction Period|Screen Failure|1
1166258|NCT03535194|2293747|FG002|Induction Period|Screen Failure|0
1166259|NCT03535194|2293748|FG003|Induction Period|Screen Failure|0
1166260|NCT03535194|2293749|FG004|Induction Period|Screen Failure|0
1166261|NCT03535194|2293745|FG000|Induction Period|Withdrawal by Subject|3
1166262|NCT03535194|2293746|FG001|Induction Period|Withdrawal by Subject|4
1166263|NCT03535194|2293747|FG002|Induction Period|Withdrawal by Subject|3
1166264|NCT03535194|2293748|FG003|Induction Period|Withdrawal by Subject|2
1166265|NCT03535194|2293749|FG004|Induction Period|Withdrawal by Subject|0
1166266|NCT03535194|2293745|FG000|Maintenance Period|Adverse Event|6
1166267|NCT03535194|2293746|FG001|Maintenance Period|Adverse Event|5
1166268|NCT03535194|2293747|FG002|Maintenance Period|Adverse Event|1
1166269|NCT03535194|2293748|FG003|Maintenance Period|Adverse Event|11
1166270|NCT03535194|2293749|FG004|Maintenance Period|Adverse Event|4
1166271|NCT03535194|2293745|FG000|Maintenance Period|Lack of Efficacy|3
1166272|NCT03535194|2293746|FG001|Maintenance Period|Lack of Efficacy|2
1166273|NCT03535194|2293747|FG002|Maintenance Period|Lack of Efficacy|5
1166274|NCT03535194|2293748|FG003|Maintenance Period|Lack of Efficacy|9
1166275|NCT03535194|2293749|FG004|Maintenance Period|Lack of Efficacy|0
1166276|NCT03535194|2293745|FG000|Maintenance Period|Lost to Follow-up|4
1166277|NCT03535194|2293746|FG001|Maintenance Period|Lost to Follow-up|2
1166278|NCT03535194|2293747|FG002|Maintenance Period|Lost to Follow-up|1
1166279|NCT03535194|2293748|FG003|Maintenance Period|Lost to Follow-up|5
1166280|NCT03535194|2293749|FG004|Maintenance Period|Lost to Follow-up|2
1166281|NCT03535194|2293745|FG000|Maintenance Period|Other|1
1166282|NCT03535194|2293746|FG001|Maintenance Period|Other|2
1166283|NCT03535194|2293747|FG002|Maintenance Period|Other|0
1166284|NCT03535194|2293748|FG003|Maintenance Period|Other|0
1166285|NCT03535194|2293749|FG004|Maintenance Period|Other|0
1166286|NCT03535194|2293745|FG000|Maintenance Period|Physician Decision|1
1166287|NCT03535194|2293746|FG001|Maintenance Period|Physician Decision|2
1166288|NCT03535194|2293747|FG002|Maintenance Period|Physician Decision|0
1166289|NCT03535194|2293748|FG003|Maintenance Period|Physician Decision|2
1166290|NCT03535194|2293749|FG004|Maintenance Period|Physician Decision|0
1166291|NCT03535194|2293745|FG000|Maintenance Period|Pregnancy|0
1166292|NCT03535194|2293746|FG001|Maintenance Period|Pregnancy|0
1166293|NCT03535194|2293747|FG002|Maintenance Period|Pregnancy|0
1166294|NCT03535194|2293748|FG003|Maintenance Period|Pregnancy|2
1166295|NCT03535194|2293749|FG004|Maintenance Period|Pregnancy|0
1166296|NCT03535194|2293745|FG000|Maintenance Period|Protocol Violation|0
1166297|NCT03535194|2293746|FG001|Maintenance Period|Protocol Violation|1
1166298|NCT03535194|2293747|FG002|Maintenance Period|Protocol Violation|0
1166299|NCT03535194|2293748|FG003|Maintenance Period|Protocol Violation|0
1166300|NCT03535194|2293749|FG004|Maintenance Period|Protocol Violation|0
1166301|NCT03535194|2293745|FG000|Maintenance Period|Withdrawal by Subject|7
1166302|NCT03535194|2293746|FG001|Maintenance Period|Withdrawal by Subject|2
1166303|NCT03535194|2293747|FG002|Maintenance Period|Withdrawal by Subject|1
1166304|NCT03535194|2293748|FG003|Maintenance Period|Withdrawal by Subject|8
1166305|NCT03535194|2293749|FG004|Maintenance Period|Withdrawal by Subject|0
1166306|NCT03535194|2293745|FG000|Post-Treatment Followup Period|Adverse Event|4
1166307|NCT03535194|2293746|FG001|Post-Treatment Followup Period|Adverse Event|5
1166308|NCT03535194|2293747|FG002|Post-Treatment Followup Period|Adverse Event|1
1166309|NCT03535194|2293748|FG003|Post-Treatment Followup Period|Adverse Event|8
1166310|NCT03535194|2293749|FG004|Post-Treatment Followup Period|Adverse Event|0
1166311|NCT03535194|2293745|FG000|Post-Treatment Followup Period|Lack of Efficacy|3
1166312|NCT03535194|2293746|FG001|Post-Treatment Followup Period|Lack of Efficacy|4
1166313|NCT03535194|2293747|FG002|Post-Treatment Followup Period|Lack of Efficacy|5
1166314|NCT03535194|2293748|FG003|Post-Treatment Followup Period|Lack of Efficacy|4
1166315|NCT03535194|2293749|FG004|Post-Treatment Followup Period|Lack of Efficacy|0
1166316|NCT03535194|2293745|FG000|Post-Treatment Followup Period|Lost to Follow-up|1
1166317|NCT03535194|2293746|FG001|Post-Treatment Followup Period|Lost to Follow-up|1
1166318|NCT03535194|2293747|FG002|Post-Treatment Followup Period|Lost to Follow-up|1
1166319|NCT03535194|2293748|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
1166320|NCT03535194|2293749|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
1166321|NCT03535194|2293745|FG000|Post-Treatment Followup Period|Other|1
1166322|NCT03535194|2293746|FG001|Post-Treatment Followup Period|Other|0
1166323|NCT03535194|2293747|FG002|Post-Treatment Followup Period|Other|0
1166324|NCT03535194|2293748|FG003|Post-Treatment Followup Period|Other|5
1166325|NCT03535194|2293749|FG004|Post-Treatment Followup Period|Other|0
1166326|NCT03535194|2293745|FG000|Post-Treatment Followup Period|Physician Decision|0
1166327|NCT03535194|2293746|FG001|Post-Treatment Followup Period|Physician Decision|2
1166328|NCT03535194|2293747|FG002|Post-Treatment Followup Period|Physician Decision|1
1166329|NCT03535194|2293748|FG003|Post-Treatment Followup Period|Physician Decision|1
1166330|NCT03535194|2293749|FG004|Post-Treatment Followup Period|Physician Decision|0
1166331|NCT03535194|2293745|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2
1166332|NCT03535194|2293746|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2
1166333|NCT03535194|2293747|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3
1166334|NCT03535194|2293748|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6
1166335|NCT03535194|2293749|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
1166340|NCT03535844|2293790|FG000|Overall Study|Withdrawal by Subject|0
1166341|NCT03535844|2293791|FG001|Overall Study|Withdrawal by Subject|1
1166342|NCT03535974|2293800|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
1166343|NCT03535974|2293801|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
1166344|NCT03535974|2293802|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
1166345|NCT03535974|2293800|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
1166346|NCT03535974|2293801|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
1166347|NCT03535974|2293802|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
1166348|NCT03536663|2293810|FG000|Endexo|Protocol Violation|1
1166349|NCT03536949|2293838|FG000|Overall Study|Adverse Event|4
1166350|NCT03536949|2293839|FG001|Overall Study|Adverse Event|0
1166351|NCT03536949|2293838|FG000|Overall Study|Lost to Follow-up|2
1166352|NCT03536949|2293839|FG001|Overall Study|Lost to Follow-up|1
1166353|NCT03536949|2293838|FG000|Overall Study|Withdrawal by Subject|6
1166354|NCT03536949|2293839|FG001|Overall Study|Withdrawal by Subject|0
1166355|NCT03536949|2293838|FG000|Overall Study|Non-compliance|2
1166356|NCT03536949|2293839|FG001|Overall Study|Non-compliance|1
1166357|NCT03537261|2293860|FG000|Overall Study|Lost to Follow-up|4
1166358|NCT03537261|2293861|FG001|Overall Study|Lost to Follow-up|5
1166359|NCT03537261|2293860|FG000|Overall Study|Withdrawal by Subject|4
1166360|NCT03537261|2293861|FG001|Overall Study|Withdrawal by Subject|6
1166361|NCT03537261|2293860|FG000|Overall Study|Did not return study questionnaires|0
1166362|NCT03537261|2293861|FG001|Overall Study|Did not return study questionnaires|1
1166363|NCT03537651|2293912|FG000|Overall Study|Adverse Event|2
1166364|NCT03537651|2293912|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
1166365|NCT03537651|2293912|FG000|Overall Study|Commercial Drug is Available for Participant|56
1166366|NCT03537651|2293912|FG000|Overall Study|Other|1
1166367|NCT03538431|2293931|FG000|Overall Study|Physician Decision|0
1166368|NCT03538431|2293932|FG001|Overall Study|Physician Decision|1
1166369|NCT03538431|2293931|FG000|Overall Study|Withdrawal by Subject|1
1166370|NCT03538431|2293932|FG001|Overall Study|Withdrawal by Subject|0
1166371|NCT03538743|2293964|FG000|Overall Study|Adverse Event|0
1166372|NCT03538743|2293965|FG001|Overall Study|Adverse Event|0
1166373|NCT03538743|2293966|FG002|Overall Study|Adverse Event|1
1166374|NCT03538743|2293967|FG003|Overall Study|Adverse Event|1
1166375|NCT03538743|2293968|FG004|Overall Study|Adverse Event|0
1166376|NCT03538743|2293969|FG005|Overall Study|Adverse Event|0
1166377|NCT03538743|2293970|FG006|Overall Study|Adverse Event|0
1166378|NCT03538743|2293971|FG007|Overall Study|Adverse Event|0
1166379|NCT03538743|2293972|FG008|Overall Study|Adverse Event|0
1166380|NCT03538743|2293964|FG000|Overall Study|Non-Treatment-Related Reasons|0
1166381|NCT03538743|2293965|FG001|Overall Study|Non-Treatment-Related Reasons|0
1166382|NCT03538743|2293966|FG002|Overall Study|Non-Treatment-Related Reasons|0
1166383|NCT03538743|2293967|FG003|Overall Study|Non-Treatment-Related Reasons|0
1166384|NCT03538743|2293968|FG004|Overall Study|Non-Treatment-Related Reasons|0
1166385|NCT03538743|2293969|FG005|Overall Study|Non-Treatment-Related Reasons|0
1166386|NCT03538743|2293970|FG006|Overall Study|Non-Treatment-Related Reasons|0
1166387|NCT03538743|2293971|FG007|Overall Study|Non-Treatment-Related Reasons|0
1166388|NCT03538743|2293972|FG008|Overall Study|Non-Treatment-Related Reasons|3
1166389|NCT03538743|2293964|FG000|Overall Study|Withdrawal by Subject|0
1166390|NCT03538743|2293965|FG001|Overall Study|Withdrawal by Subject|0
1166391|NCT03538743|2293966|FG002|Overall Study|Withdrawal by Subject|0
1166392|NCT03538743|2293967|FG003|Overall Study|Withdrawal by Subject|1
1166393|NCT03538743|2293968|FG004|Overall Study|Withdrawal by Subject|0
1166394|NCT03538743|2293969|FG005|Overall Study|Withdrawal by Subject|0
1166395|NCT03538743|2293970|FG006|Overall Study|Withdrawal by Subject|0
1166396|NCT03538743|2293971|FG007|Overall Study|Withdrawal by Subject|0
1166397|NCT03538743|2293972|FG008|Overall Study|Withdrawal by Subject|0
1166398|NCT03539432|2294032|FG000|Overall Study|Lost to Follow-up|0
1166399|NCT03539432|2294033|FG001|Overall Study|Lost to Follow-up|1
799645|NCT04993339|1750744|FG000|Overall Study|Lost to Follow-up|0
799646|NCT04993339|1750745|FG001|Overall Study|Lost to Follow-up|1
799647|NCT04993339|1750744|FG000|Overall Study|no MRI scan|3
799648|NCT04993339|1750745|FG001|Overall Study|no MRI scan|1
799649|NCT04919161|1750787|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1
799650|NCT04919161|1750788|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0
799651|NCT04919161|1750787|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0
799652|NCT04919161|1750788|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1
799653|NCT04919161|1750787|FG000|Overall Study|Acute ankle sprain after session 1|0
799654|NCT04919161|1750788|FG001|Overall Study|Acute ankle sprain after session 1|1
799655|NCT04883541|1750870|FG000|Overall Study|Not attending regular yoga class|16
799656|NCT04883541|1750871|FG001|Overall Study|Not attending regular yoga class|0
799657|NCT04883541|1750870|FG000|Overall Study|Not attending the pregnancy school|0
799658|NCT04883541|1750871|FG001|Overall Study|Not attending the pregnancy school|9
799659|NCT04851314|1750891|FG000|Overall Study|Unable to complete research set-up procedures|0
799660|NCT04851314|1750892|FG001|Overall Study|Unable to complete research set-up procedures|2
799661|NCT04851314|1750891|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3
799662|NCT04851314|1750892|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2
799663|NCT04821245|1750917|FG000|Overall Study|Withdrawal by Subject|3
799664|NCT04821245|1750917|FG000|Overall Study|Physician Decision|1
799665|NCT04821245|1750917|FG000|Overall Study|Protocol Violation|5
799666|NCT04799782|1750932|FG000|Washout|Physician Decision|2
799667|NCT04799782|1750933|FG001|Washout|Physician Decision|0
799668|NCT04799782|1750932|FG000|Washout|Withdrawal by Subject|0
799669|NCT04799782|1750933|FG001|Washout|Withdrawal by Subject|2
799670|NCT04799782|1750932|FG000|Washout|Lost to Follow-up|0
799671|NCT04799782|1750933|FG001|Washout|Lost to Follow-up|1
799672|NCT04755595|1750968|FG000|Overall Study|Lost to Follow-up|1
799673|NCT04749745|1750973|FG000|Overall Study|Withdrawal by Subject|1
799674|NCT04749745|1750974|FG001|Overall Study|Withdrawal by Subject|0
799675|NCT04748341|1750982|FG000|Overall Study|Lost to Follow-up|1
799676|NCT04748341|1750983|FG001|Overall Study|Lost to Follow-up|1
799677|NCT04737278|1750991|FG000|Overall Study|Lost to Follow-up|1
799678|NCT04737278|1750992|FG001|Overall Study|Lost to Follow-up|1
799679|NCT04737278|1750991|FG000|Overall Study|Withdrawal by Subject|1
799680|NCT04737278|1750992|FG001|Overall Study|Withdrawal by Subject|0
799681|NCT04737278|1750991|FG000|Overall Study|Protocol Violation|1
799682|NCT04737278|1750992|FG001|Overall Study|Protocol Violation|1
799683|NCT04737278|1750991|FG000|Overall Study|failure to complete questionnaire|1
799684|NCT04737278|1750992|FG001|Overall Study|failure to complete questionnaire|1
799685|NCT04732338|1751024|FG000|Overall Study|Lost to Follow-up|3
799686|NCT04732338|1751025|FG001|Overall Study|Lost to Follow-up|3
799687|NCT04728802|1751033|FG000|Overall Study|Withdrawal by Subject|4
799688|NCT04728802|1751034|FG001|Overall Study|Withdrawal by Subject|20
799689|NCT04728802|1751033|FG000|Overall Study|Physician Decision|7
799690|NCT04728802|1751034|FG001|Overall Study|Physician Decision|7
799691|NCT04728802|1751033|FG000|Overall Study|Protocol Violation|10
799692|NCT04728802|1751034|FG001|Overall Study|Protocol Violation|4
799693|NCT04728802|1751033|FG000|Overall Study|Transfer|1
799694|NCT04728802|1751034|FG001|Overall Study|Transfer|0
799695|NCT04728802|1751033|FG000|Overall Study|Death|4
799696|NCT04728802|1751034|FG001|Overall Study|Death|5
799697|NCT04728802|1751033|FG000|Overall Study|Other|3
799698|NCT04728802|1751034|FG001|Overall Study|Other|0
799699|NCT04725500|1751055|FG000|Screening|Screen Failure|26
799700|NCT04725500|1751055|FG000|Screening|Withdrawal by Subject|1
799701|NCT04725500|1751055|FG000|2 Week Take Home|Screen Fail|5
799702|NCT04716426|1751070|FG000|Overall Study|Vaccination|1
799703|NCT04716426|1751071|FG001|Overall Study|Vaccination|1
799704|NCT04716426|1751070|FG000|Overall Study|Contamination|1
799705|NCT04716426|1751071|FG001|Overall Study|Contamination|0
799706|NCT04698993|1751103|FG000|Overall Study|PCR results not accessible|2
799707|NCT04698993|1751104|FG001|Overall Study|PCR results not accessible|7
799708|NCT04698993|1751103|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1
799709|NCT04698993|1751104|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0
799710|NCT04674644|1751131|FG000|Overall Study|with missing data|37
799711|NCT04668989|1751149|FG000|First Intervention|Covid-19 related self-isolation|0
799712|NCT04668989|1751150|FG001|First Intervention|Covid-19 related self-isolation|1
799713|NCT04668989|1751149|FG000|Second Intervention|Adverse Event|0
799714|NCT04668989|1751150|FG001|Second Intervention|Adverse Event|1
799715|NCT04646109|1751216|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0
799716|NCT04646109|1751217|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6
799717|NCT04633642|1751252|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1
799718|NCT04633642|1751253|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2
799719|NCT04633564|1751261|FG000|Period 1|Adverse Event|28
799720|NCT04633564|1751262|FG001|Period 1|Adverse Event|19
799721|NCT04633564|1751261|FG000|Period 1|Death|8
799722|NCT04633564|1751262|FG001|Period 1|Death|7
799723|NCT04633564|1751261|FG000|Period 1|Lost to Follow-up|3
799724|NCT04633564|1751262|FG001|Period 1|Lost to Follow-up|5
799725|NCT04633564|1751261|FG000|Period 1|Physician Decision|4
799726|NCT04633564|1751262|FG001|Period 1|Physician Decision|12
799727|NCT04633564|1751261|FG000|Period 1|Protocol Violation|0
799728|NCT04633564|1751262|FG001|Period 1|Protocol Violation|1
799729|NCT04633564|1751261|FG000|Period 1|Withdrawal by Subject|10
799730|NCT04633564|1751262|FG001|Period 1|Withdrawal by Subject|8
799731|NCT04633564|1751261|FG000|Period 1|Progressive disease|47
799732|NCT04633564|1751262|FG001|Period 1|Progressive disease|51
799733|NCT04633564|1751261|FG000|Period 1|Terminated by Sponsor|8
799734|NCT04633564|1751262|FG001|Period 1|Terminated by Sponsor|6
799735|NCT04633564|1751261|FG000|Period 2|Adverse Event|3
799736|NCT04633564|1751262|FG001|Period 2|Adverse Event|4
799737|NCT04633564|1751261|FG000|Period 2|Death|0
799738|NCT04633564|1751262|FG001|Period 2|Death|2
799739|NCT04633564|1751261|FG000|Period 2|Lost to Follow-up|0
799740|NCT04633564|1751262|FG001|Period 2|Lost to Follow-up|1
799741|NCT04633564|1751261|FG000|Period 2|Physician Decision|2
799742|NCT04633564|1751262|FG001|Period 2|Physician Decision|4
799743|NCT04633564|1751261|FG000|Period 2|Withdrawal by Subject|5
799744|NCT04633564|1751262|FG001|Period 2|Withdrawal by Subject|1
799745|NCT04633564|1751261|FG000|Period 2|Progressive Disease|74
799746|NCT04633564|1751262|FG001|Period 2|Progressive Disease|82
799747|NCT04633564|1751261|FG000|Period 2|Terminated by Sponsor|9
799748|NCT04633564|1751262|FG001|Period 2|Terminated by Sponsor|3
799749|NCT04608500|1751322|FG000|Overall Study|Adverse Event|2
799750|NCT04608500|1751323|FG001|Overall Study|Adverse Event|0
799751|NCT04608500|1751322|FG000|Overall Study|Lost to Follow-up|15
799752|NCT04608500|1751323|FG001|Overall Study|Lost to Follow-up|9
799753|NCT04608500|1751322|FG000|Overall Study|Participant request|11
799754|NCT04608500|1751323|FG001|Overall Study|Participant request|7
799755|NCT04608500|1751322|FG000|Overall Study|Protocol Violation|1
799756|NCT04608500|1751323|FG001|Overall Study|Protocol Violation|0
799757|NCT04608500|1751322|FG000|Overall Study|Other|6
799758|NCT04608500|1751323|FG001|Overall Study|Other|2
799759|NCT04590027|1751352|FG000|Overall Study|Lost to Follow-up|17
799760|NCT04590027|1751353|FG001|Overall Study|Lost to Follow-up|14
799761|NCT04590027|1751352|FG000|Overall Study|Protocol Violation|0
799762|NCT04590027|1751353|FG001|Overall Study|Protocol Violation|3
799763|NCT04578457|1751363|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2
799764|NCT04578457|1751363|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2
799765|NCT04578457|1751363|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2
799766|NCT04578457|1751363|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2
799767|NCT04577183|1751375|FG000|Overall Study|Death|1
799768|NCT04577183|1751375|FG000|Overall Study|Withdrawal by Subject|3
799769|NCT04577183|1751375|FG000|Overall Study|Early termination|2
799770|NCT04574999|1751381|FG000|Overall Study|Adverse Event|1
799771|NCT04574999|1751382|FG001|Overall Study|Adverse Event|0
799772|NCT04574999|1751381|FG000|Overall Study|Lack of Efficacy|2
799773|NCT04574999|1751382|FG001|Overall Study|Lack of Efficacy|3
799774|NCT04574999|1751381|FG000|Overall Study|Protocol Violation|1
799775|NCT04574999|1751382|FG001|Overall Study|Protocol Violation|0
799776|NCT04574999|1751381|FG000|Overall Study|Withdrawal by Subject|2
799777|NCT04574999|1751382|FG001|Overall Study|Withdrawal by Subject|2
799778|NCT04574999|1751381|FG000|Overall Study|Lost to Follow-up|1
799779|NCT04574999|1751382|FG001|Overall Study|Lost to Follow-up|0
799780|NCT04574999|1751381|FG000|Overall Study|Personal problems|1
799781|NCT04574999|1751382|FG001|Overall Study|Personal problems|0
799782|NCT04574999|1751381|FG000|Overall Study|Previous planned surgery|1
799783|NCT04574999|1751382|FG001|Overall Study|Previous planned surgery|0
799784|NCT04572997|1751388|FG000|Overall Study|Adverse Event|1
799785|NCT04570670|1751398|FG000|Overall Study|Withdrawal by Subject|1
799786|NCT04570670|1751399|FG001|Overall Study|Withdrawal by Subject|0
799787|NCT04542694|1751582|FG000|Overall Study|The need for prohibited therapy|2
799788|NCT04542694|1751583|FG001|Overall Study|The need for prohibited therapy|0
799789|NCT04542694|1751582|FG000|Overall Study|Adverse Event|1
799790|NCT04542694|1751583|FG001|Overall Study|Adverse Event|0
799791|NCT04542694|1751582|FG000|Overall Study|Protocol Violation|1
799792|NCT04542694|1751583|FG001|Overall Study|Protocol Violation|0
799793|NCT04534491|1751625|FG000|Overall Study|Not completed end-of-study interview|24
799794|NCT04534491|1751625|FG000|Overall Study|Non-users|70
799795|NCT04534491|1751625|FG000|Overall Study|Non-verifiable users|58
799796|NCT04533204|1751647|FG000|Overall Study|Unable to understand training instructions|1
799797|NCT04533204|1751648|FG001|Overall Study|Unable to understand training instructions|1
799798|NCT04532164|1751654|FG000|Overall Study|Adverse Event|1
799799|NCT04532164|1751654|FG000|Overall Study|Protocol Violation|5
799800|NCT04532164|1751654|FG000|Overall Study|Lost to Follow-up|1
799801|NCT04532164|1751654|FG000|Overall Study|Found to be Ineligible|3
799802|NCT04532164|1751654|FG000|Overall Study|Withdrawal by Subject|14
799803|NCT04531813|1751659|FG000|Overall Study|Protocol Violation|1
799804|NCT04531813|1751659|FG000|Overall Study|Withdrawal by Subject|1
799805|NCT04531527|1751663|FG000|Overall Study|Found to be Ineligible|3
799806|NCT04531540|1751667|FG000|Overall Study|Adverse Event|1
799807|NCT04531540|1751667|FG000|Overall Study|Protocol Violation|3
799808|NCT04531540|1751667|FG000|Overall Study|Withdrawal by Subject|4
799809|NCT04531540|1751667|FG000|Overall Study|Found to be Ineligible|1
799810|NCT04093258|1751698|FG000|Period 2|Subject no longer meets the eligibility criteria|1
799811|NCT04093258|1751699|FG001|Period 2|Subject no longer meets the eligibility criteria|0
799812|NCT03993379|1751713|FG000|Overall Study|The study was terminated early due to business decision.|0
799813|NCT03993379|1751714|FG001|Overall Study|The study was terminated early due to business decision.|2
799814|NCT03993379|1751715|FG002|Overall Study|The study was terminated early due to business decision.|0
799815|NCT03993379|1751716|FG003|Overall Study|The study was terminated early due to business decision.|0
799816|NCT03993379|1751713|FG000|Overall Study|Withdrawal by Subject|0
799817|NCT03993379|1751714|FG001|Overall Study|Withdrawal by Subject|1
799818|NCT03993379|1751715|FG002|Overall Study|Withdrawal by Subject|0
799819|NCT03993379|1751716|FG003|Overall Study|Withdrawal by Subject|0
799820|NCT03956615|1751726|FG000|Overall Study|No multiple myeloma confirmed|2
799821|NCT03956615|1751726|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1
799822|NCT03956615|1751726|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2
799823|NCT03956615|1751726|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2
799824|NCT03803059|1751730|FG000|Overall Study|Protocol Violation|2
799825|NCT03803059|1751730|FG000|Overall Study|Lost to Follow-up|1
799856|NCT03723590|1751753|FG000|Overall Study|Withdrawal by Subject|3
799858|NCT03430895|1751780|FG000|Overall Study|Not Treated|2
799859|NCT03402841|1751784|FG000|Overall Study|Withdrawal by Subject|4
799860|NCT03402841|1751784|FG000|Overall Study|Lost to Follow-up|3
799861|NCT03402841|1751784|FG000|Overall Study|Death|85
799862|NCT03388138|1751790|FG000|Overall Study|Protocol Violation|1
799863|NCT03388138|1751791|FG001|Overall Study|Protocol Violation|0
799864|NCT03230838|1751816|FG000|Overall Study|Withdrawal by Subject|3
799865|NCT03230838|1751817|FG001|Overall Study|Withdrawal by Subject|0
799866|NCT03230838|1751816|FG000|Overall Study|Temperature excursion|1
799867|NCT03230838|1751817|FG001|Overall Study|Temperature excursion|0
799868|NCT03183778|1751823|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1
799869|NCT03170349|1751827|FG000|At 30 Days Follow-up|Death|1
799870|NCT03170349|1751827|FG000|At 6 Months Follow-up|Death|3
799871|NCT03170349|1751827|FG000|At 6 Months Follow-up|Withdrawal by Subject|1
799872|NCT03170349|1751827|FG000|At 6 Months Follow-up|Exited for Other Reasons|5
799873|NCT03029234|1751835|FG000|Overall Study|Sponsor Decision|1
799874|NCT03029234|1751835|FG000|Overall Study|Withdrawal by Subject|5
799875|NCT03029234|1751835|FG000|Overall Study|Death|61
799876|NCT02937818|1751859|FG000|Overall Study|Participants decision|1
799877|NCT02937818|1751860|FG001|Overall Study|Participants decision|0
799878|NCT02937818|1751861|FG002|Overall Study|Participants decision|1
799879|NCT02937818|1751862|FG003|Overall Study|Participants decision|1
799880|NCT02937818|1751859|FG000|Overall Study|Adverse Event|2
799881|NCT02937818|1751860|FG001|Overall Study|Adverse Event|4
799882|NCT02937818|1751861|FG002|Overall Study|Adverse Event|1
799883|NCT02937818|1751862|FG003|Overall Study|Adverse Event|1
799884|NCT02937818|1751859|FG000|Overall Study|Disease progression|17
799885|NCT02937818|1751860|FG001|Overall Study|Disease progression|14
799886|NCT02937818|1751861|FG002|Overall Study|Disease progression|7
799887|NCT02937818|1751862|FG003|Overall Study|Disease progression|18
799888|NCT02937818|1751859|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1
799889|NCT02937818|1751860|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2
799890|NCT02937818|1751861|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
799891|NCT02937818|1751862|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
799892|NCT02937818|1751859|FG000|Overall Study|Condition under investigation worsened|0
799893|NCT02937818|1751860|FG001|Overall Study|Condition under investigation worsened|0
799894|NCT02937818|1751861|FG002|Overall Study|Condition under investigation worsened|1
799895|NCT02937818|1751862|FG003|Overall Study|Condition under investigation worsened|0
799896|NCT02937818|1751859|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
799897|NCT02937818|1751860|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
799898|NCT02937818|1751861|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
799899|NCT02937818|1751862|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1
799900|NCT02926833|1751879|FG000|Overall Study|Full Consent Withdrawal|0
799901|NCT02926833|1751880|FG001|Overall Study|Full Consent Withdrawal|0
799902|NCT02926833|1751881|FG002|Overall Study|Full Consent Withdrawal|0
799903|NCT02926833|1751882|FG003|Overall Study|Full Consent Withdrawal|2
799904|NCT02926833|1751879|FG000|Overall Study|Death|1
799905|NCT02926833|1751880|FG001|Overall Study|Death|1
799906|NCT02926833|1751881|FG002|Overall Study|Death|1
799907|NCT02926833|1751882|FG003|Overall Study|Death|7
799908|NCT02926833|1751879|FG000|Overall Study|Still on study|2
799909|NCT02926833|1751880|FG001|Overall Study|Still on study|3
799910|NCT02926833|1751881|FG002|Overall Study|Still on study|5
799911|NCT02926833|1751882|FG003|Overall Study|Still on study|14
799912|NCT02926833|1751879|FG000|Overall Study|Adverse Event|0
799913|NCT02926833|1751880|FG001|Overall Study|Adverse Event|0
799914|NCT02926833|1751881|FG002|Overall Study|Adverse Event|1
799915|NCT02926833|1751882|FG003|Overall Study|Adverse Event|0
799916|NCT02700698|1751895|FG000|Overall Study|Withdrawal by Subject|1
799917|NCT02700698|1751896|FG001|Overall Study|Withdrawal by Subject|0
799918|NCT02698865|1751913|FG000|Overall Study|Other|11
799919|NCT02698865|1751914|FG001|Overall Study|Other|11
799920|NCT02698865|1751913|FG000|Overall Study|Withdrawal by Subject|20
799921|NCT02698865|1751914|FG001|Overall Study|Withdrawal by Subject|16
799922|NCT02698865|1751913|FG000|Overall Study|Physician Decision|0
799923|NCT02698865|1751914|FG001|Overall Study|Physician Decision|4
799924|NCT02698865|1751913|FG000|Overall Study|Lost to Follow-up|4
799925|NCT02698865|1751914|FG001|Overall Study|Lost to Follow-up|2
799926|NCT02660086|1751922|FG000|Overall Study- 12-month|Withdrawal by Subject|5
799927|NCT02660086|1751923|FG001|Overall Study- 12-month|Withdrawal by Subject|5
799928|NCT02660086|1751922|FG000|Overall Study- 12-month|Left full-time employment|12
799929|NCT02660086|1751923|FG001|Overall Study- 12-month|Left full-time employment|20
799930|NCT02660086|1751922|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8
799931|NCT02660086|1751923|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4
799932|NCT02660086|1751922|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1
799933|NCT02660086|1751923|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0
799934|NCT02660086|1751922|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17
799935|NCT02660086|1751923|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8
799936|NCT02660086|1751922|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9
799937|NCT02660086|1751923|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16
799938|NCT02653482|1751931|FG000|Overall Study|Death|1
799939|NCT02653482|1751932|FG001|Overall Study|Death|1
799992|NCT02454933|1751969|FG000|Overall Study|Progressive disease|7
799993|NCT02454933|1751970|FG001|Overall Study|Progressive disease|5
799994|NCT02454933|1751969|FG000|Overall Study|Adverse Event|1
799995|NCT02454933|1751970|FG001|Overall Study|Adverse Event|1
799996|NCT02454933|1751969|FG000|Overall Study|Withdrawal by Subject|0
799997|NCT02454933|1751970|FG001|Overall Study|Withdrawal by Subject|2
799998|NCT02282020|1751981|FG000|Overall Study|Objective Disease Progression|111
799999|NCT02282020|1751982|FG001|Overall Study|Objective Disease Progression|30
800000|NCT02282020|1751981|FG000|Overall Study|Adverse Event|13
800001|NCT02282020|1751982|FG001|Overall Study|Adverse Event|15
800002|NCT02282020|1751981|FG000|Overall Study|Withdrawal by Subject|5
800003|NCT02282020|1751982|FG001|Overall Study|Withdrawal by Subject|10
800004|NCT02282020|1751981|FG000|Overall Study|Miscellaneous|4
800005|NCT02282020|1751982|FG001|Overall Study|Miscellaneous|17
800006|NCT02282020|1751981|FG000|Overall Study|Severe Non-compliance to Protocol|1
800007|NCT02282020|1751982|FG001|Overall Study|Severe Non-compliance to Protocol|0
800008|NCT02282020|1751981|FG000|Overall Study|Developed Discontinuation Criteria|1
800009|NCT02282020|1751982|FG001|Overall Study|Developed Discontinuation Criteria|3
800010|NCT02282020|1751981|FG000|Overall Study|Withdrew Consent Prior to Dosing|0
800011|NCT02282020|1751982|FG001|Overall Study|Withdrew Consent Prior to Dosing|12
800012|NCT02129647|1751988|FG000|Overall Study|Adverse Event|2
800013|NCT02129647|1751988|FG000|Overall Study|surgical intervention for clinically progressive disease|1
800014|NCT01959139|1752000|FG000|Phase II|Disease progression|0
800015|NCT01959139|1752001|FG001|Phase II|Disease progression|0
800016|NCT01959139|1752002|FG002|Phase II|Disease progression|26
800017|NCT01959139|1752003|FG003|Phase II|Disease progression|34
800018|NCT01959139|1752000|FG000|Phase II|Adverse Event|0
800019|NCT01959139|1752001|FG001|Phase II|Adverse Event|0
800020|NCT01959139|1752002|FG002|Phase II|Adverse Event|10
800021|NCT01959139|1752003|FG003|Phase II|Adverse Event|11
800022|NCT01959139|1752000|FG000|Phase II|Patient Refusal|0
800023|NCT01959139|1752001|FG001|Phase II|Patient Refusal|0
800024|NCT01959139|1752002|FG002|Phase II|Patient Refusal|5
800025|NCT01959139|1752003|FG003|Phase II|Patient Refusal|4
800026|NCT01959139|1752000|FG000|Phase II|Death|0
800027|NCT01959139|1752001|FG001|Phase II|Death|0
800028|NCT01959139|1752002|FG002|Phase II|Death|3
800029|NCT01959139|1752003|FG003|Phase II|Death|1
800030|NCT01959139|1752000|FG000|Phase II|Other/Unknown|0
800031|NCT01959139|1752001|FG001|Phase II|Other/Unknown|0
800032|NCT01959139|1752002|FG002|Phase II|Other/Unknown|8
800033|NCT01959139|1752003|FG003|Phase II|Other/Unknown|5
800034|NCT01959139|1752000|FG000|Phase II|On treatment|0
800035|NCT01959139|1752001|FG001|Phase II|On treatment|0
800036|NCT01959139|1752002|FG002|Phase II|On treatment|4
800037|NCT01959139|1752003|FG003|Phase II|On treatment|0
800038|NCT01874353|1752020|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2
800039|NCT01874353|1752021|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0
800040|NCT01874353|1752022|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0
800041|NCT01874353|1752023|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0
800042|NCT01874353|1752020|FG000|Overall Study|Lost to Follow-up|2
800043|NCT01874353|1752021|FG001|Overall Study|Lost to Follow-up|2
800044|NCT01874353|1752022|FG002|Overall Study|Lost to Follow-up|2
800045|NCT01874353|1752023|FG003|Overall Study|Lost to Follow-up|0
800046|NCT01874353|1752020|FG000|Overall Study|Death|110
800047|NCT01874353|1752021|FG001|Overall Study|Death|60
800048|NCT01874353|1752022|FG002|Overall Study|Death|13
800049|NCT01874353|1752023|FG003|Overall Study|Death|7
800050|NCT01874353|1752020|FG000|Overall Study|Withdrawal by Subject|13
800051|NCT01874353|1752021|FG001|Overall Study|Withdrawal by Subject|11
800052|NCT01874353|1752022|FG002|Overall Study|Withdrawal by Subject|0
800053|NCT01874353|1752023|FG003|Overall Study|Withdrawal by Subject|0
800059|NCT01597778|1752051|FG000|Overall Study|Death|7
800060|NCT01597778|1752052|FG001|Overall Study|Death|10
800061|NCT01597778|1752051|FG000|Overall Study|Withdrawal by Subject|3
800062|NCT01597778|1752052|FG001|Overall Study|Withdrawal by Subject|4
800063|NCT01597778|1752051|FG000|Overall Study|Adverse Event|1
800064|NCT01597778|1752052|FG001|Overall Study|Adverse Event|1
800065|NCT01597778|1752051|FG000|Overall Study|Protocol Violation|1
800066|NCT01597778|1752052|FG001|Overall Study|Protocol Violation|11
800067|NCT01597778|1752051|FG000|Overall Study|Transplanted off protocol|2
800068|NCT01597778|1752052|FG001|Overall Study|Transplanted off protocol|3
800069|NCT01522976|1752061|FG000|Overall Study|Ineligible|4
800070|NCT01522976|1752062|FG001|Overall Study|Ineligible|0
800071|NCT01522976|1752063|FG002|Overall Study|Ineligible|1
800072|NCT01522976|1752061|FG000|Overall Study|Death|7
800073|NCT01522976|1752062|FG001|Overall Study|Death|6
800074|NCT01522976|1752063|FG002|Overall Study|Death|2
800075|NCT01522976|1752061|FG000|Overall Study|Still on treatment|9
800076|NCT01522976|1752062|FG001|Overall Study|Still on treatment|9
800077|NCT01522976|1752063|FG002|Overall Study|Still on treatment|6
800078|NCT01522976|1752061|FG000|Overall Study|Disease progression|28
800079|NCT01522976|1752062|FG001|Overall Study|Disease progression|30
800080|NCT01522976|1752063|FG002|Overall Study|Disease progression|25
800081|NCT01522976|1752061|FG000|Overall Study|Adverse Event|17
800082|NCT01522976|1752062|FG001|Overall Study|Adverse Event|7
800083|NCT01522976|1752063|FG002|Overall Study|Adverse Event|18
800084|NCT01522976|1752061|FG000|Overall Study|Refusal unrelated to adverse event|10
800085|NCT01522976|1752062|FG001|Overall Study|Refusal unrelated to adverse event|13
800086|NCT01522976|1752063|FG002|Overall Study|Refusal unrelated to adverse event|14
800087|NCT01522976|1752061|FG000|Overall Study|Not protocol specified|22
800088|NCT01522976|1752062|FG001|Overall Study|Not protocol specified|27
800089|NCT01522976|1752063|FG002|Overall Study|Not protocol specified|27
800090|NCT01286272|1752076|FG000|Overall Study|Ineligible after beginning treatment|1
800091|NCT01286272|1752077|FG001|Overall Study|Ineligible after beginning treatment|3
800092|NCT01145495|1752083|FG000|Overall Study|Adverse Event|6
800093|NCT01145495|1752083|FG000|Overall Study|Withdrawal by Subject|5
800094|NCT01145495|1752083|FG000|Overall Study|Disease progression after respone|1
800095|NCT00977574|1752099|FG000|Overall Study|Never Treated|4
800096|NCT00977574|1752100|FG001|Overall Study|Never Treated|2
800097|NCT00977574|1752101|FG002|Overall Study|Never Treated|4
800098|NCT00937937|1752109|FG000|Overall Study|Adverse Event|6
800099|NCT00937937|1752109|FG000|Overall Study|Withdrawal by Subject|2
800100|NCT00937937|1752109|FG000|Overall Study|Progression/relapse|61
800101|NCT00937937|1752109|FG000|Overall Study|Death|1
800102|NCT00937937|1752109|FG000|Overall Study|Other|2
800103|NCT00879086|1752116|FG000|Overall Study|Adverse Event|3
800104|NCT00879086|1752117|FG001|Overall Study|Adverse Event|15
800105|NCT00879086|1752116|FG000|Overall Study|Participant choice|2
800106|NCT00879086|1752117|FG001|Overall Study|Participant choice|2
800107|NCT00879086|1752116|FG000|Overall Study|Progression of disease|40
800108|NCT00879086|1752117|FG001|Overall Study|Progression of disease|26
800109|NCT00879086|1752116|FG000|Overall Study|Withdrawal of consent|2
800110|NCT00879086|1752117|FG001|Overall Study|Withdrawal of consent|1
800111|NCT00879086|1752116|FG000|Overall Study|Other|4
800112|NCT00879086|1752117|FG001|Overall Study|Other|6
800113|NCT00879086|1752116|FG000|Overall Study|Death|1
800114|NCT00879086|1752117|FG001|Overall Study|Death|2
800115|NCT00864227|1752123|FG000|Overall Study|Withdrawal by Subject|1
800116|NCT00864227|1752123|FG000|Overall Study|Disease Relapse/Progression|3
800117|NCT00731731|1752130|FG000|Overall Study|Protocol Violation|0
800118|NCT00731731|1752131|FG001|Overall Study|Protocol Violation|0
800119|NCT00731731|1752132|FG002|Overall Study|Protocol Violation|1
800120|NCT00731731|1752130|FG000|Overall Study|Cancel prior to treatment|0
800121|NCT00731731|1752131|FG001|Overall Study|Cancel prior to treatment|0
800122|NCT00731731|1752132|FG002|Overall Study|Cancel prior to treatment|2
800123|NCT00685360|1752148|FG000|Overall Study|Lost to Follow-up|0
800124|NCT00685360|1752149|FG001|Overall Study|Lost to Follow-up|1
800125|NCT00685360|1752150|FG002|Overall Study|Lost to Follow-up|2
800126|NCT00685360|1752148|FG000|Overall Study|Adverse Event|4
800127|NCT00685360|1752149|FG001|Overall Study|Adverse Event|6
800128|NCT00685360|1752150|FG002|Overall Study|Adverse Event|4
800129|NCT00685360|1752148|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1
800130|NCT00685360|1752149|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0
800131|NCT00685360|1752150|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2
800132|NCT00685360|1752148|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0
800133|NCT00685360|1752149|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4
800134|NCT00685360|1752150|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1
800135|NCT00685360|1752148|FG000|Overall Study|Subject Withdrew Consent to Participate|13
800136|NCT00685360|1752149|FG001|Overall Study|Subject Withdrew Consent to Participate|2
800137|NCT00685360|1752150|FG002|Overall Study|Subject Withdrew Consent to Participate|5
800138|NCT00685360|1752148|FG000|Overall Study|Protocol Deviation|0
800139|NCT00685360|1752149|FG001|Overall Study|Protocol Deviation|1
800140|NCT00685360|1752150|FG002|Overall Study|Protocol Deviation|1
800141|NCT00299728|1752160|FG000|Overall Study|Lost to Follow-up|0
800142|NCT00299728|1752161|FG001|Overall Study|Lost to Follow-up|1
800143|NCT00299728|1752160|FG000|Overall Study|Withdrawal by Subject|0
800144|NCT00299728|1752161|FG001|Overall Study|Withdrawal by Subject|1
800145|NCT00299728|1752160|FG000|Overall Study|Progressive disease|0
800146|NCT00299728|1752161|FG001|Overall Study|Progressive disease|1
800147|NCT00159588|1752170|FG000|5 Month Follow-up|Withdrawal by Subject|2
800148|NCT00159588|1752171|FG001|5 Month Follow-up|Withdrawal by Subject|4
800149|NCT00159588|1752172|FG002|5 Month Follow-up|Withdrawal by Subject|2
800150|NCT00070499|1752189|FG000|Overall Study|Adverse Event|6
800151|NCT00070499|1752190|FG001|Overall Study|Adverse Event|6
800152|NCT00070499|1752191|FG002|Overall Study|Adverse Event|19
800153|NCT00070499|1752192|FG003|Overall Study|Adverse Event|15
800154|NCT00070499|1752189|FG000|Overall Study|Refusal unrelated to adverse effects|7
800155|NCT00070499|1752190|FG001|Overall Study|Refusal unrelated to adverse effects|5
800156|NCT00070499|1752191|FG002|Overall Study|Refusal unrelated to adverse effects|5
800157|NCT00070499|1752192|FG003|Overall Study|Refusal unrelated to adverse effects|8
800158|NCT00070499|1752189|FG000|Overall Study|Progression/relapse|4
800159|NCT00070499|1752190|FG001|Overall Study|Progression/relapse|2
800160|NCT00070499|1752191|FG002|Overall Study|Progression/relapse|1
800161|NCT00070499|1752192|FG003|Overall Study|Progression/relapse|4
800162|NCT00070499|1752189|FG000|Overall Study|Death|1
800163|NCT00070499|1752190|FG001|Overall Study|Death|1
800164|NCT00070499|1752191|FG002|Overall Study|Death|1
800165|NCT00070499|1752192|FG003|Overall Study|Death|2
800166|NCT00070499|1752189|FG000|Overall Study|Other - not protocol specified|7
800167|NCT00070499|1752190|FG001|Overall Study|Other - not protocol specified|3
800168|NCT00070499|1752191|FG002|Overall Study|Other - not protocol specified|12
800169|NCT00070499|1752192|FG003|Overall Study|Other - not protocol specified|20
800170|NCT00070499|1752189|FG000|Overall Study|Still on protocol treatment|10
800171|NCT00070499|1752190|FG001|Overall Study|Still on protocol treatment|4
800172|NCT00070499|1752191|FG002|Overall Study|Still on protocol treatment|79
800173|NCT00070499|1752192|FG003|Overall Study|Still on protocol treatment|57
800174|NCT00070499|1752189|FG000|Overall Study|Did not start treatment|1
800175|NCT00070499|1752190|FG001|Overall Study|Did not start treatment|0
800176|NCT00070499|1752191|FG002|Overall Study|Did not start treatment|0
800177|NCT00070499|1752192|FG003|Overall Study|Did not start treatment|2
800178|NCT00070499|1752189|FG000|Overall Study|Not eligible|2
800179|NCT00070499|1752190|FG001|Overall Study|Not eligible|5
800180|NCT00070499|1752191|FG002|Overall Study|Not eligible|3
800181|NCT00070499|1752192|FG003|Overall Study|Not eligible|2
800182|NCT04330157|1752227|FG000|Overall Study|Protocol Violation|4
800183|NCT04330157|1752227|FG000|Overall Study|Not extubated within 24 h postoperatively|3
800184|NCT04160988|1752248|FG000|Overall Study|poor image quality|28
800185|NCT04079114|1752294|FG000|Overall Study|Study prematuely terminated.|166
800186|NCT03790917|1752441|FG000|Overall Study|Death|1
800187|NCT05017493|1752457|FG000|Overall Study|Withdrawal by Subject|26
800188|NCT05017493|1752458|FG001|Overall Study|Withdrawal by Subject|0
800189|NCT05017493|1752457|FG000|Overall Study|Physician Decision|15
800190|NCT05017493|1752458|FG001|Overall Study|Physician Decision|0
800191|NCT05017493|1752457|FG000|Overall Study|Protocol Violation|81
800192|NCT05017493|1752458|FG001|Overall Study|Protocol Violation|0
800193|NCT04348500|1752491|FG000|Overall Study|Death|2
800194|NCT04348500|1752492|FG001|Overall Study|Death|2
800195|NCT04348500|1752491|FG000|Overall Study|Withdrawn by subject due to dementia|0
800196|NCT04348500|1752492|FG001|Overall Study|Withdrawn by subject due to dementia|1
800199|NCT03799198|1752699|FG000|Overall Study|Lost to Follow-up|4
800200|NCT03799198|1752700|FG001|Overall Study|Lost to Follow-up|8
800201|NCT03799198|1752699|FG000|Overall Study|Death|0
800202|NCT03799198|1752700|FG001|Overall Study|Death|1
800203|NCT03770728|1752710|FG000|Overall Study|Adverse Event|1
800204|NCT03770728|1752711|FG001|Overall Study|Adverse Event|0
800205|NCT03770728|1752712|FG002|Overall Study|Adverse Event|1
800206|NCT03770728|1752713|FG003|Overall Study|Adverse Event|0
800207|NCT03770728|1752710|FG000|Overall Study|Poor compliance to protocol|0
800208|NCT03770728|1752711|FG001|Overall Study|Poor compliance to protocol|0
800209|NCT03770728|1752712|FG002|Overall Study|Poor compliance to protocol|1
800210|NCT03770728|1752713|FG003|Overall Study|Poor compliance to protocol|0
800211|NCT03770728|1752710|FG000|Overall Study|Withdrawal by Subject|13
800212|NCT03770728|1752711|FG001|Overall Study|Withdrawal by Subject|8
800213|NCT03770728|1752712|FG002|Overall Study|Withdrawal by Subject|9
800214|NCT03770728|1752713|FG003|Overall Study|Withdrawal by Subject|13
800215|NCT03770728|1752710|FG000|Overall Study|Other than specified|24
800216|NCT03770728|1752711|FG001|Overall Study|Other than specified|23
800217|NCT03770728|1752712|FG002|Overall Study|Other than specified|21
800218|NCT03770728|1752713|FG003|Overall Study|Other than specified|22
800219|NCT03760146|1752754|FG000|Overall Study|Adverse Event|11
800220|NCT03760146|1752755|FG001|Overall Study|Adverse Event|8
800221|NCT03760146|1752756|FG002|Overall Study|Adverse Event|0
800222|NCT03760146|1752757|FG003|Overall Study|Adverse Event|0
800223|NCT03760146|1752758|FG004|Overall Study|Adverse Event|0
800224|NCT03760146|1752759|FG005|Overall Study|Adverse Event|0
800225|NCT03760146|1752754|FG000|Overall Study|Death|1
800226|NCT03760146|1752755|FG001|Overall Study|Death|0
800227|NCT03760146|1752756|FG002|Overall Study|Death|0
800228|NCT03760146|1752757|FG003|Overall Study|Death|0
800229|NCT03760146|1752758|FG004|Overall Study|Death|0
800230|NCT03760146|1752759|FG005|Overall Study|Death|0
800231|NCT03760146|1752754|FG000|Overall Study|Lost to Follow-up|41
800232|NCT03760146|1752755|FG001|Overall Study|Lost to Follow-up|28
800233|NCT03760146|1752756|FG002|Overall Study|Lost to Follow-up|9
800234|NCT03760146|1752757|FG003|Overall Study|Lost to Follow-up|2
800235|NCT03760146|1752758|FG004|Overall Study|Lost to Follow-up|14
800236|NCT03760146|1752759|FG005|Overall Study|Lost to Follow-up|8
800237|NCT03760146|1752754|FG000|Overall Study|No longer met eligibility criteria|3
800238|NCT03760146|1752755|FG001|Overall Study|No longer met eligibility criteria|9
800239|NCT03760146|1752756|FG002|Overall Study|No longer met eligibility criteria|0
800240|NCT03760146|1752757|FG003|Overall Study|No longer met eligibility criteria|0
800241|NCT03760146|1752758|FG004|Overall Study|No longer met eligibility criteria|1
800242|NCT03760146|1752759|FG005|Overall Study|No longer met eligibility criteria|0
800243|NCT03760146|1752754|FG000|Overall Study|Protocol Violation|21
800244|NCT03760146|1752755|FG001|Overall Study|Protocol Violation|13
800245|NCT03760146|1752756|FG002|Overall Study|Protocol Violation|1
800246|NCT03760146|1752757|FG003|Overall Study|Protocol Violation|0
800247|NCT03760146|1752758|FG004|Overall Study|Protocol Violation|1
800248|NCT03760146|1752759|FG005|Overall Study|Protocol Violation|0
800249|NCT03760146|1752754|FG000|Overall Study|Withdrawal by Subject|19
800250|NCT03760146|1752755|FG001|Overall Study|Withdrawal by Subject|20
800251|NCT03760146|1752756|FG002|Overall Study|Withdrawal by Subject|1
800252|NCT03760146|1752757|FG003|Overall Study|Withdrawal by Subject|0
800253|NCT03760146|1752758|FG004|Overall Study|Withdrawal by Subject|1
800254|NCT03760146|1752759|FG005|Overall Study|Withdrawal by Subject|0
800255|NCT03737110|1752790|FG000|Run-in (RI) Period|Lack of Efficacy|3
800256|NCT03737110|1752791|FG001|Run-in (RI) Period|Lack of Efficacy|0
800257|NCT03737110|1752792|FG002|Run-in (RI) Period|Lack of Efficacy|0
800258|NCT03737110|1752790|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3
800259|NCT03737110|1752791|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
800260|NCT03737110|1752792|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
800261|NCT03737110|1752790|FG000|Run-in (RI) Period|Adverse Event|4
800262|NCT03737110|1752791|FG001|Run-in (RI) Period|Adverse Event|0
800263|NCT03737110|1752792|FG002|Run-in (RI) Period|Adverse Event|0
800264|NCT03737110|1752790|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
800265|NCT03737110|1752791|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1
800266|NCT03737110|1752792|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
800267|NCT03737110|1752790|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
800268|NCT03737110|1752791|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
800269|NCT03737110|1752792|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
800270|NCT03713684|1752814|FG000|Overall Study|Adverse Event|1
800271|NCT03713684|1752815|FG001|Overall Study|Adverse Event|3
800272|NCT03713684|1752816|FG002|Overall Study|Adverse Event|1
800273|NCT03713684|1752817|FG003|Overall Study|Adverse Event|0
800274|NCT03713684|1752814|FG000|Overall Study|Poor compliance to protocol|2
800275|NCT03713684|1752815|FG001|Overall Study|Poor compliance to protocol|1
800276|NCT03713684|1752816|FG002|Overall Study|Poor compliance to protocol|0
800277|NCT03713684|1752817|FG003|Overall Study|Poor compliance to protocol|1
800278|NCT03713684|1752814|FG000|Overall Study|Withdrawal by Subject|14
800279|NCT03713684|1752815|FG001|Overall Study|Withdrawal by Subject|6
800280|NCT03713684|1752816|FG002|Overall Study|Withdrawal by Subject|14
800281|NCT03713684|1752817|FG003|Overall Study|Withdrawal by Subject|16
800282|NCT03713684|1752814|FG000|Overall Study|Other than specified|69
800283|NCT03713684|1752815|FG001|Overall Study|Other than specified|77
800284|NCT03713684|1752816|FG002|Overall Study|Other than specified|73
800285|NCT03713684|1752817|FG003|Overall Study|Other than specified|70
800286|NCT03644550|1752827|FG000|Overall Study|Withdrawal by Subject|3
800287|NCT03644550|1752827|FG000|Overall Study|Progressive disease|15
800288|NCT03557970|1752834|FG000|Overall Study|Study closure|1
800289|NCT03557970|1752835|FG001|Overall Study|Study closure|0
800290|NCT03557970|1752834|FG000|Overall Study|Physician Decision|0
800291|NCT03557970|1752835|FG001|Overall Study|Physician Decision|1
800292|NCT03557970|1752834|FG000|Overall Study|Death|0
800293|NCT03557970|1752835|FG001|Overall Study|Death|1
800294|NCT03332095|1752856|FG000|Overall Study|Lost to Follow-up|1
800295|NCT03332095|1752857|FG001|Overall Study|Lost to Follow-up|0
800296|NCT03332095|1752856|FG000|Overall Study|Pregnancy|0
800297|NCT03332095|1752857|FG001|Overall Study|Pregnancy|1
800298|NCT03022461|1752863|FG000|Overall Study|Death|3
800299|NCT02964039|1752879|FG000|Overall Study|Medical reason unrelated to study participation|1
800300|NCT02964039|1752880|FG001|Overall Study|Medical reason unrelated to study participation|0
800301|NCT02964039|1752881|FG002|Overall Study|Medical reason unrelated to study participation|3
800302|NCT02964039|1752879|FG000|Overall Study|Research shutdown due to pandemic|2
800303|NCT02964039|1752880|FG001|Overall Study|Research shutdown due to pandemic|0
800304|NCT02964039|1752881|FG002|Overall Study|Research shutdown due to pandemic|1
800305|NCT02964039|1752879|FG000|Overall Study|Withdrawal by Subject|0
800306|NCT02964039|1752880|FG001|Overall Study|Withdrawal by Subject|1
800307|NCT02964039|1752881|FG002|Overall Study|Withdrawal by Subject|0
800308|NCT02964039|1752879|FG000|Overall Study|Lost to Follow-up|1
800309|NCT02964039|1752880|FG001|Overall Study|Lost to Follow-up|0
800310|NCT02964039|1752881|FG002|Overall Study|Lost to Follow-up|1
800311|NCT02930889|1752889|FG000|Overall Study|Lost to Follow-up|2
800312|NCT02930889|1752889|FG000|Overall Study|Withdrawal by Subject|6
800313|NCT02930889|1752889|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8
800314|NCT02919618|1752893|FG000|Overall Study|Death|1
800315|NCT02844946|1752910|FG000|Overall Study|Lost to Follow-up|7
800316|NCT02844946|1752911|FG001|Overall Study|Lost to Follow-up|0
800317|NCT02564796|1752928|FG000|Overall Study|Physician Decision|2
800318|NCT02564796|1752929|FG001|Overall Study|Physician Decision|2
800319|NCT02562716|1752937|FG000|Overall Study|Adverse Event|7
800320|NCT02562716|1752938|FG001|Overall Study|Adverse Event|14
800321|NCT02562716|1752937|FG000|Overall Study|Withdrawal unrelated to AE|7
800322|NCT02562716|1752938|FG001|Overall Study|Withdrawal unrelated to AE|1
800323|NCT02562716|1752937|FG000|Overall Study|Progression|8
800324|NCT02562716|1752938|FG001|Overall Study|Progression|10
800325|NCT02562716|1752937|FG000|Overall Study|Death|2
800326|NCT02562716|1752938|FG001|Overall Study|Death|1
800327|NCT02562716|1752937|FG000|Overall Study|Not protocol specified|4
800328|NCT02562716|1752938|FG001|Overall Study|Not protocol specified|2
800329|NCT02442349|1752946|FG000|Overall Study|Death|14
800330|NCT02442349|1752946|FG000|Overall Study|Withdrawal by Subject|8
800331|NCT02442349|1752946|FG000|Overall Study|On-going Study at Data Cut-off|149
800332|NCT02211131|1752956|FG000|Overall Study|Death|20
800333|NCT02211131|1752957|FG001|Overall Study|Death|11
800334|NCT02211131|1752956|FG000|Overall Study|Lost to Follow-up|1
800335|NCT02211131|1752957|FG001|Overall Study|Lost to Follow-up|0
800336|NCT02211131|1752956|FG000|Overall Study|Decision by Sponsor|1
800337|NCT02211131|1752957|FG001|Overall Study|Decision by Sponsor|1
800338|NCT02211131|1752956|FG000|Overall Study|Withdrawal by Subject|3
800339|NCT02211131|1752957|FG001|Overall Study|Withdrawal by Subject|4
800340|NCT02211131|1752956|FG000|Overall Study|Continuing on Study|49
800341|NCT02211131|1752957|FG001|Overall Study|Continuing on Study|60
800342|NCT02163733|1752972|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0
800343|NCT02163733|1752973|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0
800344|NCT02163733|1752974|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5
800345|NCT02163733|1752972|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
800346|NCT02163733|1752973|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
800347|NCT02163733|1752974|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
800356|NCT02094261|1752990|FG000|Overall Study|Death|24
800357|NCT02094261|1752990|FG000|Overall Study|Lost to Follow-up|1
800358|NCT02094261|1752990|FG000|Overall Study|Withdrawal by Subject|4
800359|NCT02094261|1752990|FG000|Overall Study|Ongoing Study at Data Cut-off|181
800360|NCT01496976|1752999|FG000|Overall Study|Withdrew - received stem cell transplant|1
800361|NCT01472081|1753009|FG000|Overall Study|Continuing treatment at time of analysis|1
800362|NCT01472081|1753010|FG001|Overall Study|Continuing treatment at time of analysis|4
800363|NCT01472081|1753011|FG002|Overall Study|Continuing treatment at time of analysis|1
800364|NCT01472081|1753012|FG003|Overall Study|Continuing treatment at time of analysis|8
800365|NCT01472081|1753013|FG004|Overall Study|Continuing treatment at time of analysis|9
800366|NCT01472081|1753014|FG005|Overall Study|Continuing treatment at time of analysis|0
800367|NCT01472081|1753009|FG000|Overall Study|Disease Progression|4
800368|NCT01472081|1753010|FG001|Overall Study|Disease Progression|10
800369|NCT01472081|1753011|FG002|Overall Study|Disease Progression|12
800370|NCT01472081|1753012|FG003|Overall Study|Disease Progression|31
800371|NCT01472081|1753013|FG004|Overall Study|Disease Progression|22
800372|NCT01472081|1753014|FG005|Overall Study|Disease Progression|3
800373|NCT01472081|1753009|FG000|Overall Study|Study drug toxicity|2
800374|NCT01472081|1753010|FG001|Overall Study|Study drug toxicity|9
800375|NCT01472081|1753011|FG002|Overall Study|Study drug toxicity|4
800376|NCT01472081|1753012|FG003|Overall Study|Study drug toxicity|6
800377|NCT01472081|1753013|FG004|Overall Study|Study drug toxicity|13
800378|NCT01472081|1753014|FG005|Overall Study|Study drug toxicity|2
800379|NCT01472081|1753009|FG000|Overall Study|Death|0
800380|NCT01472081|1753010|FG001|Overall Study|Death|0
800381|NCT01472081|1753011|FG002|Overall Study|Death|0
800382|NCT01472081|1753012|FG003|Overall Study|Death|0
800383|NCT01472081|1753013|FG004|Overall Study|Death|1
800384|NCT01472081|1753014|FG005|Overall Study|Death|0
800385|NCT01472081|1753009|FG000|Overall Study|Adverse Event unrelated to study drug|0
800386|NCT01472081|1753010|FG001|Overall Study|Adverse Event unrelated to study drug|0
800387|NCT01472081|1753011|FG002|Overall Study|Adverse Event unrelated to study drug|0
800388|NCT01472081|1753012|FG003|Overall Study|Adverse Event unrelated to study drug|0
800389|NCT01472081|1753013|FG004|Overall Study|Adverse Event unrelated to study drug|1
800390|NCT01472081|1753014|FG005|Overall Study|Adverse Event unrelated to study drug|0
800391|NCT01472081|1753009|FG000|Overall Study|Withdrawal by Subject|0
800392|NCT01472081|1753010|FG001|Overall Study|Withdrawal by Subject|0
800393|NCT01472081|1753011|FG002|Overall Study|Withdrawal by Subject|0
800394|NCT01472081|1753012|FG003|Overall Study|Withdrawal by Subject|0
800395|NCT01472081|1753013|FG004|Overall Study|Withdrawal by Subject|0
800396|NCT01472081|1753014|FG005|Overall Study|Withdrawal by Subject|1
800397|NCT01472081|1753009|FG000|Overall Study|Poor/non-compliance|0
800398|NCT01472081|1753010|FG001|Overall Study|Poor/non-compliance|0
800399|NCT01472081|1753011|FG002|Overall Study|Poor/non-compliance|1
800400|NCT01472081|1753012|FG003|Overall Study|Poor/non-compliance|0
800401|NCT01472081|1753013|FG004|Overall Study|Poor/non-compliance|1
800402|NCT01472081|1753014|FG005|Overall Study|Poor/non-compliance|0
800403|NCT01472081|1753009|FG000|Overall Study|No longer meets study criteria|0
800404|NCT01472081|1753010|FG001|Overall Study|No longer meets study criteria|0
800405|NCT01472081|1753011|FG002|Overall Study|No longer meets study criteria|1
800406|NCT01472081|1753012|FG003|Overall Study|No longer meets study criteria|0
800407|NCT01472081|1753013|FG004|Overall Study|No longer meets study criteria|0
800408|NCT01472081|1753014|FG005|Overall Study|No longer meets study criteria|0
800409|NCT01472081|1753009|FG000|Overall Study|Subject request to discontinue treatment|0
800410|NCT01472081|1753010|FG001|Overall Study|Subject request to discontinue treatment|3
800411|NCT01472081|1753011|FG002|Overall Study|Subject request to discontinue treatment|1
800412|NCT01472081|1753012|FG003|Overall Study|Subject request to discontinue treatment|1
800413|NCT01472081|1753013|FG004|Overall Study|Subject request to discontinue treatment|0
800414|NCT01472081|1753014|FG005|Overall Study|Subject request to discontinue treatment|0
800415|NCT01309672|1753027|FG000|Overall Study|Lack of Efficacy|20
800416|NCT01309672|1753027|FG000|Overall Study|Other|9
800417|NCT01309672|1753027|FG000|Overall Study|Adverse Event|5
800418|NCT01309672|1753027|FG000|Overall Study|Withdrawal by Subject|3
800419|NCT00774345|1753044|FG000|Pre-treatment|Other reasons|2
800420|NCT00774345|1753045|FG001|Pre-treatment|Other reasons|0
800421|NCT00774345|1753044|FG000|Treatment|Adverse Event|61
800422|NCT00774345|1753045|FG001|Treatment|Adverse Event|15
800423|NCT00774345|1753044|FG000|Treatment|Progressive Disease without histologic transformation|51
800424|NCT00774345|1753045|FG001|Treatment|Progressive Disease without histologic transformation|111
800425|NCT00774345|1753044|FG000|Treatment|Progressive Disease with histologic transformation|4
800426|NCT00774345|1753045|FG001|Treatment|Progressive Disease with histologic transformation|2
800427|NCT00774345|1753044|FG000|Treatment|Withdrawal by Subject|5
800428|NCT00774345|1753045|FG001|Treatment|Withdrawal by Subject|2
800429|NCT00774345|1753044|FG000|Treatment|Lost to Follow-up|1
800430|NCT00774345|1753045|FG001|Treatment|Lost to Follow-up|1
800431|NCT00774345|1753044|FG000|Treatment|Death|4
800432|NCT00774345|1753045|FG001|Treatment|Death|0
800433|NCT00774345|1753044|FG000|Treatment|Other Reasons|32
800434|NCT00774345|1753045|FG001|Treatment|Other Reasons|26
800435|NCT00000135|1753129|FG000|Overall Study|Death|27
800436|NCT00000135|1753130|FG001|Overall Study|Death|14
800437|NCT00000378|1753178|FG000|Overall Study|Lack of Efficacy|16
800438|NCT00000378|1753179|FG001|Overall Study|Lack of Efficacy|14
800439|NCT00000620|1753226|FG000|Overall Study|Death|86
800440|NCT00000620|1753227|FG001|Overall Study|Death|67
800441|NCT00000620|1753228|FG002|Overall Study|Death|112
800442|NCT00000620|1753229|FG003|Overall Study|Death|126
800443|NCT00000620|1753230|FG004|Overall Study|Death|64
800444|NCT00000620|1753231|FG005|Overall Study|Death|77
800445|NCT00000620|1753232|FG006|Overall Study|Death|91
800446|NCT00000620|1753233|FG007|Overall Study|Death|95
800447|NCT00000620|1753226|FG000|Overall Study|Lost to Follow-up|14
800448|NCT00000620|1753227|FG001|Overall Study|Lost to Follow-up|14
800449|NCT00000620|1753228|FG002|Overall Study|Lost to Follow-up|14
800450|NCT00000620|1753229|FG003|Overall Study|Lost to Follow-up|14
800451|NCT00000620|1753230|FG004|Overall Study|Lost to Follow-up|15
800452|NCT00000620|1753231|FG005|Overall Study|Lost to Follow-up|15
800453|NCT00000620|1753232|FG006|Overall Study|Lost to Follow-up|13
800454|NCT00000620|1753233|FG007|Overall Study|Lost to Follow-up|14
800455|NCT00000620|1753226|FG000|Overall Study|Withdrawal by Subject|40
800456|NCT00000620|1753227|FG001|Overall Study|Withdrawal by Subject|27
800457|NCT00000620|1753228|FG002|Overall Study|Withdrawal by Subject|28
800458|NCT00000620|1753229|FG003|Overall Study|Withdrawal by Subject|27
800459|NCT00000620|1753230|FG004|Overall Study|Withdrawal by Subject|30
800460|NCT00000620|1753231|FG005|Overall Study|Withdrawal by Subject|32
800461|NCT00000620|1753232|FG006|Overall Study|Withdrawal by Subject|32
800462|NCT00000620|1753233|FG007|Overall Study|Withdrawal by Subject|21
800463|NCT00000620|1753226|FG000|Overall Study|missed closeout visit|22
800464|NCT00000620|1753227|FG001|Overall Study|missed closeout visit|28
800465|NCT00000620|1753228|FG002|Overall Study|missed closeout visit|16
800466|NCT00000620|1753229|FG003|Overall Study|missed closeout visit|11
800467|NCT00000620|1753230|FG004|Overall Study|missed closeout visit|26
800468|NCT00000620|1753231|FG005|Overall Study|missed closeout visit|28
800469|NCT00000620|1753232|FG006|Overall Study|missed closeout visit|13
800470|NCT00000620|1753233|FG007|Overall Study|missed closeout visit|16
800471|NCT00001213|1753249|FG000|Overall Study|Death|18
800472|NCT00001262|1753256|FG000|Overall Study|Death|10
800473|NCT00001262|1753257|FG001|Overall Study|Death|11
800474|NCT00001262|1753258|FG002|Overall Study|Death|0
800475|NCT00001262|1753256|FG000|Overall Study|Withdrawal by Subject|0
800476|NCT00001262|1753257|FG001|Overall Study|Withdrawal by Subject|3
800477|NCT00001262|1753258|FG002|Overall Study|Withdrawal by Subject|0
800478|NCT00001566|1753279|FG000|Overall Study|patients' choice to discontinue protocol|3
800479|NCT00001566|1753279|FG000|Overall Study|stopped after C3 due to symptomatic PD|1
800480|NCT00001566|1753279|FG000|Overall Study|Death|13
800481|NCT00001566|1753279|FG000|Overall Study|Lost to Follow-up|1
800482|NCT00001566|1753279|FG000|Overall Study|unable to complete initial apheresis|1
800483|NCT00001575|1753283|FG000|Overall Study|Screening failures-Ph I portion|22
800484|NCT00001575|1753283|FG000|Overall Study|Withdrawn/deaths|23
800485|NCT00001596|1753298|FG000|Overall Study|Death|1
800486|NCT00001596|1753299|FG001|Overall Study|Death|0
800487|NCT00001596|1753298|FG000|Overall Study|Withdrawal by Subject|3
800488|NCT00001596|1753299|FG001|Overall Study|Withdrawal by Subject|1
800489|NCT00001596|1753298|FG000|Overall Study|Study Termination|12
800490|NCT00001596|1753299|FG001|Overall Study|Study Termination|9
800491|NCT00001596|1753298|FG000|Overall Study|Adverse Event|1
800492|NCT00001596|1753299|FG001|Overall Study|Adverse Event|0
800493|NCT00001703|1753314|FG000|Overall Study|progressed disease|2
800494|NCT00001703|1753314|FG000|Overall Study|No evidence of disease|1
800495|NCT00001703|1753314|FG000|Overall Study|recurrent disease|2
800496|NCT00001723|1753320|FG000|Overall Study|Lack of Efficacy|6
800497|NCT00001723|1753321|FG001|Overall Study|Lack of Efficacy|7
800498|NCT00001723|1753320|FG000|Overall Study|Lack of family interest|4
800499|NCT00001723|1753321|FG001|Overall Study|Lack of family interest|5
800500|NCT00001723|1753320|FG000|Overall Study|Lost to Follow-up|2
800501|NCT00001723|1753321|FG001|Overall Study|Lost to Follow-up|2
800502|NCT00001723|1753320|FG000|Overall Study|medication intolerance|1
800503|NCT00001723|1753321|FG001|Overall Study|medication intolerance|2
800504|NCT00001832|1753345|FG000|Apheresis Period|not able to manufacture treatment cells|60
800505|NCT00001832|1753346|FG001|Apheresis Period|not able to manufacture treatment cells|0
800506|NCT00001832|1753347|FG002|Apheresis Period|not able to manufacture treatment cells|0
800507|NCT00001832|1753348|FG003|Apheresis Period|not able to manufacture treatment cells|0
800508|NCT00001832|1753349|FG004|Apheresis Period|not able to manufacture treatment cells|0
800509|NCT00001832|1753350|FG005|Apheresis Period|not able to manufacture treatment cells|0
800510|NCT00001832|1753351|FG006|Apheresis Period|not able to manufacture treatment cells|0
800511|NCT00001832|1753352|FG007|Apheresis Period|not able to manufacture treatment cells|0
800512|NCT00001832|1753353|FG008|Apheresis Period|not able to manufacture treatment cells|0
800513|NCT00001832|1753354|FG009|Apheresis Period|not able to manufacture treatment cells|0
800514|NCT00001832|1753355|FG010|Apheresis Period|not able to manufacture treatment cells|0
800515|NCT00001832|1753356|FG011|Apheresis Period|not able to manufacture treatment cells|0
800516|NCT00001832|1753357|FG012|Apheresis Period|not able to manufacture treatment cells|0
800517|NCT00001832|1753358|FG013|Apheresis Period|not able to manufacture treatment cells|0
800518|NCT00001832|1753359|FG014|Apheresis Period|not able to manufacture treatment cells|0
800519|NCT00001832|1753345|FG000|Treatment Period|Death during treatment|0
800520|NCT00001832|1753346|FG001|Treatment Period|Death during treatment|0
800521|NCT00001832|1753347|FG002|Treatment Period|Death during treatment|0
800522|NCT00001832|1753348|FG003|Treatment Period|Death during treatment|0
800523|NCT00001832|1753349|FG004|Treatment Period|Death during treatment|0
800524|NCT00001832|1753350|FG005|Treatment Period|Death during treatment|1
800525|NCT00001832|1753351|FG006|Treatment Period|Death during treatment|0
800526|NCT00001832|1753352|FG007|Treatment Period|Death during treatment|0
800527|NCT00001832|1753353|FG008|Treatment Period|Death during treatment|0
800528|NCT00001832|1753354|FG009|Treatment Period|Death during treatment|0
800529|NCT00001832|1753355|FG010|Treatment Period|Death during treatment|0
800530|NCT00001832|1753356|FG011|Treatment Period|Death during treatment|0
800531|NCT00001832|1753357|FG012|Treatment Period|Death during treatment|0
800532|NCT00001832|1753358|FG013|Treatment Period|Death during treatment|0
800533|NCT00001832|1753359|FG014|Treatment Period|Death during treatment|0
800534|NCT00001832|1753345|FG000|Treatment Period|Not treated|0
800535|NCT00001832|1753346|FG001|Treatment Period|Not treated|0
800536|NCT00001832|1753347|FG002|Treatment Period|Not treated|0
800537|NCT00001832|1753348|FG003|Treatment Period|Not treated|0
800538|NCT00001832|1753349|FG004|Treatment Period|Not treated|0
800539|NCT00001832|1753350|FG005|Treatment Period|Not treated|0
800540|NCT00001832|1753351|FG006|Treatment Period|Not treated|0
800541|NCT00001832|1753352|FG007|Treatment Period|Not treated|1
800542|NCT00001832|1753353|FG008|Treatment Period|Not treated|0
800543|NCT00001832|1753354|FG009|Treatment Period|Not treated|0
800544|NCT00001832|1753355|FG010|Treatment Period|Not treated|0
800545|NCT00001832|1753356|FG011|Treatment Period|Not treated|0
800546|NCT00001832|1753357|FG012|Treatment Period|Not treated|0
800547|NCT00001832|1753358|FG013|Treatment Period|Not treated|0
800548|NCT00001832|1753359|FG014|Treatment Period|Not treated|0
800549|NCT00001849|1753389|FG000|Overall Study|Death|4
800550|NCT00001849|1753389|FG000|Overall Study|Lost to Follow-up|2
800551|NCT00001849|1753389|FG000|Overall Study|Withdrawal by Subject|2
800552|NCT00001849|1753389|FG000|Overall Study|tumor remained occult|6
800553|NCT00001880|1753402|FG000|Overall Study|Death|14
800554|NCT00001941|1753406|FG000|Overall Study|not treated- rapidly progressing disease|0
800555|NCT00001941|1753407|FG001|Overall Study|not treated- rapidly progressing disease|0
800556|NCT00001941|1753408|FG002|Overall Study|not treated- rapidly progressing disease|0
800557|NCT00001941|1753409|FG003|Overall Study|not treated- rapidly progressing disease|0
800558|NCT00001941|1753410|FG004|Overall Study|not treated- rapidly progressing disease|1
800559|NCT00001959|1753415|FG000|Overall Study|newly diagnosed colon cancer|1
800560|NCT00001959|1753415|FG000|Overall Study|disabling sedation|1
800561|NCT00001959|1753415|FG000|Overall Study|non-compliance|1
800562|NCT00001962|1753419|FG000|Overall Study|Lack of Efficacy|18
800563|NCT00001962|1753419|FG000|Overall Study|Lack of Accrual|6
800564|NCT00001962|1753419|FG000|Overall Study|Death|1
800565|NCT00001962|1753419|FG000|Overall Study|Lost to Follow-up|2
800566|NCT00001962|1753419|FG000|Overall Study|Adverse Event|1
800567|NCT00002525|1753429|FG000|Overall Study|Adverse Event|36
800568|NCT00002525|1753430|FG001|Overall Study|Adverse Event|0
800569|NCT00002525|1753429|FG000|Overall Study|Death|5
800570|NCT00002525|1753430|FG001|Overall Study|Death|0
800571|NCT00002525|1753429|FG000|Overall Study|Withdrawal by Subject|11
800572|NCT00002525|1753430|FG001|Overall Study|Withdrawal by Subject|0
800573|NCT00002525|1753429|FG000|Overall Study|Start non-protocol therapy|1
800574|NCT00002525|1753430|FG001|Overall Study|Start non-protocol therapy|0
800575|NCT00002525|1753429|FG000|Overall Study|Other complicating disease|1
800576|NCT00002525|1753430|FG001|Overall Study|Other complicating disease|0
800577|NCT00002525|1753429|FG000|Overall Study|Duke's A, B1, D disease|92
800578|NCT00002525|1753430|FG001|Overall Study|Duke's A, B1, D disease|0
800579|NCT00002525|1753429|FG000|Overall Study|Error|6
800580|NCT00002525|1753430|FG001|Overall Study|Error|0
800581|NCT00002525|1753429|FG000|Overall Study|Other|26
800582|NCT00002525|1753430|FG001|Overall Study|Other|0
800583|NCT00002525|1753429|FG000|Overall Study|Never start protocol therapy|8
800584|NCT00002525|1753430|FG001|Overall Study|Never start protocol therapy|0
800585|NCT00002540|1753440|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0
800586|NCT00002540|1753441|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25
800587|NCT00002540|1753440|FG000|Overall Study|Died Before Randomization|2
800588|NCT00002540|1753441|FG001|Overall Study|Died Before Randomization|6
800589|NCT00002540|1753440|FG000|Overall Study|Died Before ASU (Control)|202
800590|NCT00002540|1753441|FG001|Overall Study|Died Before ASU (Control)|0
800591|NCT00002540|1753440|FG000|Overall Study|Refused ASU (Control)|597
800592|NCT00002540|1753441|FG001|Overall Study|Refused ASU (Control)|0
800593|NCT00002540|1753440|FG000|Overall Study|Refused Screen (Prostate Screening)|0
800594|NCT00002540|1753441|FG001|Overall Study|Refused Screen (Prostate Screening)|2433
800595|NCT00002558|1753449|FG000|Overall Study|Withdrawal by Subject|0
800596|NCT00002558|1753450|FG001|Overall Study|Withdrawal by Subject|1
800597|NCT00002597|1753458|FG000|Overall Study|Protocol Violation|19
800598|NCT00002597|1753459|FG001|Overall Study|Protocol Violation|17
800599|NCT00002597|1753458|FG000|Overall Study|Withdrawal by Subject|7
800600|NCT00002597|1753459|FG001|Overall Study|Withdrawal by Subject|6
800601|NCT00002651|1753473|FG000|Induction|Adverse Event|44
800602|NCT00002651|1753474|FG001|Induction|Adverse Event|0
800603|NCT00002651|1753475|FG002|Induction|Adverse Event|0
800604|NCT00002651|1753473|FG000|Induction|Refusal unrelated to adverse event|50
800605|NCT00002651|1753474|FG001|Induction|Refusal unrelated to adverse event|0
800606|NCT00002651|1753475|FG002|Induction|Refusal unrelated to adverse event|0
800607|NCT00002651|1753473|FG000|Induction|Progression/relapse|274
800608|NCT00002651|1753474|FG001|Induction|Progression/relapse|0
800609|NCT00002651|1753475|FG002|Induction|Progression/relapse|0
800610|NCT00002651|1753473|FG000|Induction|Death|62
800611|NCT00002651|1753474|FG001|Induction|Death|0
800612|NCT00002651|1753475|FG002|Induction|Death|0
800613|NCT00002651|1753473|FG000|Induction|Other|823
800614|NCT00002651|1753474|FG001|Induction|Other|0
800615|NCT00002651|1753475|FG002|Induction|Other|0
800616|NCT00002651|1753473|FG000|Induction|not eligible|90
800617|NCT00002651|1753474|FG001|Induction|not eligible|0
800618|NCT00002651|1753475|FG002|Induction|not eligible|0
800619|NCT00002651|1753473|FG000|Consolidation and Randomization|Adverse Event|0
800620|NCT00002651|1753474|FG001|Consolidation and Randomization|Adverse Event|36
800621|NCT00002651|1753475|FG002|Consolidation and Randomization|Adverse Event|14
800622|NCT00002651|1753473|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0
800623|NCT00002651|1753474|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53
800624|NCT00002651|1753475|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75
800625|NCT00002651|1753473|FG000|Consolidation and Randomization|Progression/relapse|0
800626|NCT00002651|1753474|FG001|Consolidation and Randomization|Progression/relapse|295
800627|NCT00002651|1753475|FG002|Consolidation and Randomization|Progression/relapse|298
800628|NCT00002651|1753473|FG000|Consolidation and Randomization|Death|0
800629|NCT00002651|1753474|FG001|Consolidation and Randomization|Death|38
800630|NCT00002651|1753475|FG002|Consolidation and Randomization|Death|48
800631|NCT00002651|1753473|FG000|Consolidation and Randomization|Other|0
800632|NCT00002651|1753474|FG001|Consolidation and Randomization|Other|314
800633|NCT00002651|1753475|FG002|Consolidation and Randomization|Other|313
800634|NCT00002651|1753473|FG000|Consolidation and Randomization|not eligible|0
800635|NCT00002651|1753474|FG001|Consolidation and Randomization|not eligible|102
800636|NCT00002651|1753475|FG002|Consolidation and Randomization|not eligible|112
800637|NCT00002766|1753485|FG000|Overall Study|Withdrawal by Subject|0
800638|NCT00002766|1753486|FG001|Overall Study|Withdrawal by Subject|1
800639|NCT00002766|1753485|FG000|Overall Study|Patient Not Treated|1
800640|NCT00002766|1753486|FG001|Overall Study|Patient Not Treated|2
800641|NCT00002766|1753485|FG000|Overall Study|Adverse Event|1
800642|NCT00002766|1753486|FG001|Overall Study|Adverse Event|1
800643|NCT00002766|1753485|FG000|Overall Study|Protocol Violation|1
800644|NCT00002766|1753486|FG001|Overall Study|Protocol Violation|0
800645|NCT00002842|1753492|FG000|Overall Study|ineligible for surgical resection|27
800646|NCT00002850|1753499|FG000|Overall Study|Death|4
800647|NCT00002850|1753500|FG001|Overall Study|Death|1
800648|NCT00002850|1753501|FG002|Overall Study|Death|3
800649|NCT00002850|1753499|FG000|Overall Study|Protocol Violation|1
800650|NCT00002850|1753500|FG001|Overall Study|Protocol Violation|0
800651|NCT00002850|1753501|FG002|Overall Study|Protocol Violation|1
800652|NCT00002850|1753499|FG000|Overall Study|Withdrawal by Subject|0
800653|NCT00002850|1753500|FG001|Overall Study|Withdrawal by Subject|1
800654|NCT00002850|1753501|FG002|Overall Study|Withdrawal by Subject|0
800655|NCT00002874|1753511|FG000|Overall Study|Withdrawal by Subject|1
800656|NCT00002874|1753512|FG001|Overall Study|Withdrawal by Subject|1
800657|NCT00002874|1753511|FG000|Overall Study|Protocol Violation|44
800658|NCT00002874|1753512|FG001|Overall Study|Protocol Violation|34
800659|NCT00002931|1753518|FG000|Overall Study|rapidly progressing disease during|2
800660|NCT00003138|1753533|FG000|Step 1|Reasons off treatment not documented|60
800661|NCT00003138|1753534|FG001|Step 1|Reasons off treatment not documented|57
800662|NCT00003138|1753533|FG000|Step 1|Never started treatment|1
800663|NCT00003138|1753534|FG001|Step 1|Never started treatment|0
800664|NCT00003138|1753533|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26
800665|NCT00003138|1753534|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0
800666|NCT00003138|1753533|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
800667|NCT00003138|1753534|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
800668|NCT00003138|1753533|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
800669|NCT00003138|1753534|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
800670|NCT00003138|1753533|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
800671|NCT00003138|1753534|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
800672|NCT00003199|1753543|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5
800673|NCT00003199|1753543|FG000|Overall Study|Lack of insurance clearance|2
800674|NCT00003199|1753543|FG000|Overall Study|Screen fail|15
800675|NCT00003222|1753549|FG000|Overall Study|Physician Decision|0
800676|NCT00003222|1753550|FG001|Overall Study|Physician Decision|1
800677|NCT00003298|1753583|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
800678|NCT00003298|1753583|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
800679|NCT00003298|1753583|FG000|Surgery|Unresectable at surgery|3
800680|NCT00003298|1753583|FG000|Surgery|Progression before surgery|2
800681|NCT00003298|1753583|FG000|Surgery|Unevaluable and off study|2
800682|NCT00003298|1753583|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
800683|NCT00003298|1753583|FG000|Re-register to Step 2 After Surgery|Positive margins|5
800684|NCT00003298|1753583|FG000|Re-register to Step 2 After Surgery|Other complications|2
800685|NCT00003298|1753583|FG000|Re-register to Step 2 After Surgery|Reason unknown|1
800686|NCT00003298|1753583|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
800687|NCT00003298|1753583|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1
800688|NCT00003298|1753583|FG000|Step 2 (Adjuvant Therapy)|Death|1
800689|NCT00003298|1753583|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
800690|NCT00003298|1753583|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1
800691|NCT00003298|1753583|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
800692|NCT00003377|1753593|FG000|Period I|Dose Limiting Toxicity(DLT)|0
800693|NCT00003377|1753594|FG001|Period I|Dose Limiting Toxicity(DLT)|0
800694|NCT00003377|1753595|FG002|Period I|Dose Limiting Toxicity(DLT)|1
800695|NCT00003377|1753596|FG003|Period I|Dose Limiting Toxicity(DLT)|1
800696|NCT00003377|1753597|FG004|Period I|Dose Limiting Toxicity(DLT)|0
800697|NCT00003377|1753593|FG000|Period II|Ureteral stent complications|0
800698|NCT00003377|1753594|FG001|Period II|Ureteral stent complications|0
800699|NCT00003377|1753595|FG002|Period II|Ureteral stent complications|0
800700|NCT00003377|1753596|FG003|Period II|Ureteral stent complications|0
800701|NCT00003377|1753597|FG004|Period II|Ureteral stent complications|1
800702|NCT00003389|1753612|FG000|Overall Study|Disease progression|6
800703|NCT00003389|1753613|FG001|Overall Study|Disease progression|1
800704|NCT00003389|1753612|FG000|Overall Study|Adverse Event|13
800705|NCT00003389|1753613|FG001|Overall Study|Adverse Event|2
800706|NCT00003389|1753612|FG000|Overall Study|Death|0
800707|NCT00003389|1753613|FG001|Overall Study|Death|3
800708|NCT00003389|1753612|FG000|Overall Study|Withdrawal by Subject|12
800709|NCT00003389|1753613|FG001|Overall Study|Withdrawal by Subject|5
800710|NCT00003389|1753612|FG000|Overall Study|Alternative therapy|2
800711|NCT00003389|1753613|FG001|Overall Study|Alternative therapy|1
800712|NCT00003389|1753612|FG000|Overall Study|Complicating disease|1
800713|NCT00003389|1753613|FG001|Overall Study|Complicating disease|0
800714|NCT00003389|1753612|FG000|Overall Study|Off-treatment reason missing|31
800715|NCT00003389|1753613|FG001|Overall Study|Off-treatment reason missing|21
800716|NCT00003389|1753612|FG000|Overall Study|Ineligible|33
800717|NCT00003389|1753613|FG001|Overall Study|Ineligible|27
800718|NCT00003456|1753628|FG000|Overall Study|Not evaluable|8
800719|NCT00003457|1753632|FG000|Overall Study|Not evaluable|9
800720|NCT00003458|1753636|FG000|Overall Study|Not evaluable|4
800721|NCT00003470|1753657|FG000|Overall Study|Not evaluable|6
800722|NCT00003471|1753661|FG000|Overall Study|Not evaluable|4
800723|NCT00003472|1753665|FG000|Overall Study|Not evaluable|3
800724|NCT00003473|1753669|FG000|Overall Study|Three patients were not evaluable.|3
800725|NCT00003474|1753673|FG000|Overall Study|Not Evaluable|14
800726|NCT00003475|1753677|FG000|Overall Study|Not evaluable|13
800727|NCT00003476|1753682|FG000|Overall Study|Not evaluable|1
800728|NCT00003477|1753686|FG000|Overall Study|Not evalauable|4
800729|NCT00003479|1753690|FG000|Overall Study|Not evaluable|3
800730|NCT00003483|1753694|FG000|Overall Study|Not evaluable|1
800731|NCT00003487|1753698|FG000|Overall Study|Not evaluable|2
800732|NCT00003492|1753702|FG000|Overall Study|Not evaluable|6
800733|NCT00003498|1753706|FG000|Overall Study|Not evaluable.|4
800734|NCT00003499|1753710|FG000|Overall Study|Not evaluable|8
800735|NCT00003508|1753714|FG000|Overall Study|Not evaluable|5
800736|NCT00003509|1753718|FG000|Overall Study|Not evaluable|5
800737|NCT00003511|1753722|FG000|Overall Study|Not evaluable|4
800738|NCT00003526|1753726|FG000|Overall Study|Not evaluable|6
800739|NCT00003531|1753730|FG000|Overall Study|Not evaluable|10
800740|NCT00003535|1753734|FG000|Overall Study|Not evaluable|5
800741|NCT00003537|1753738|FG000|Overall Study|Not evalauable|1
800742|NCT00003590|1753742|FG000|Overall Study|Ineligible Patient|1
800743|NCT00003590|1753742|FG000|Overall Study|Adverse Event|7
800744|NCT00003590|1753742|FG000|Overall Study|Withdrawal by Subject|1
800745|NCT00003590|1753742|FG000|Overall Study|Lack of Efficacy|11
800746|NCT00003590|1753742|FG000|Overall Study|Death|1
800747|NCT00003590|1753742|FG000|Overall Study|Physician Decision|1
800748|NCT00003631|1753749|FG000|Overall Study|Patient not treated|1
800749|NCT00003631|1753750|FG001|Overall Study|Patient not treated|0
800750|NCT00003631|1753751|FG002|Overall Study|Patient not treated|1
800751|NCT00003631|1753749|FG000|Overall Study|Protocol Violation|1
800752|NCT00003631|1753750|FG001|Overall Study|Protocol Violation|0
800753|NCT00003631|1753751|FG002|Overall Study|Protocol Violation|0
800754|NCT00003631|1753749|FG000|Overall Study|Adverse Event|1
800755|NCT00003631|1753750|FG001|Overall Study|Adverse Event|1
800756|NCT00003631|1753751|FG002|Overall Study|Adverse Event|5
800757|NCT00003631|1753749|FG000|Overall Study|Death|0
800758|NCT00003631|1753750|FG001|Overall Study|Death|0
800759|NCT00003631|1753751|FG002|Overall Study|Death|1
800760|NCT00003631|1753749|FG000|Overall Study|Evaluable for toxicity only|0
800761|NCT00003631|1753750|FG001|Overall Study|Evaluable for toxicity only|0
800762|NCT00003631|1753751|FG002|Overall Study|Evaluable for toxicity only|2
800763|NCT00003641|1753761|FG000|Overall Study|Withdrawal by Subject|0
800764|NCT00003641|1753762|FG001|Overall Study|Withdrawal by Subject|100
800765|NCT00003641|1753761|FG000|Overall Study|Adverse Event|0
800766|NCT00003641|1753762|FG001|Overall Study|Adverse Event|38
800767|NCT00003641|1753761|FG000|Overall Study|Disease progression|0
800768|NCT00003641|1753762|FG001|Overall Study|Disease progression|2
800769|NCT00003641|1753761|FG000|Overall Study|Unknown/missing|0
800770|NCT00003641|1753762|FG001|Overall Study|Unknown/missing|22
800771|NCT00003641|1753761|FG000|Overall Study|Should not receive interferon therapy|2
800772|NCT00003641|1753762|FG001|Overall Study|Should not receive interferon therapy|0
800773|NCT00003641|1753761|FG000|Overall Study|Never started interferon|567
800774|NCT00003641|1753762|FG001|Overall Study|Never started interferon|12
800775|NCT00003645|1753781|FG000|Overall Study|Death|4
800776|NCT00003645|1753782|FG001|Overall Study|Death|1
800777|NCT00003645|1753781|FG000|Overall Study|Lost to Follow-up|7
800778|NCT00003645|1753782|FG001|Overall Study|Lost to Follow-up|8
800779|NCT00003645|1753781|FG000|Overall Study|Withdrawal by Subject|1
800780|NCT00003645|1753782|FG001|Overall Study|Withdrawal by Subject|3
800781|NCT00003659|1753790|FG000|Overall Study|Withdrawal by Subject|3
800782|NCT00003702|1753796|FG000|Overall Study|Ineligible cell types|2
800783|NCT00003702|1753797|FG001|Overall Study|Ineligible cell types|2
800784|NCT00003702|1753796|FG000|Overall Study|Did not meet criteria for persistence|8
800785|NCT00003702|1753797|FG001|Overall Study|Did not meet criteria for persistence|5
800786|NCT00003702|1753796|FG000|Overall Study|WHO score > 6|2
800787|NCT00003702|1753797|FG001|Overall Study|WHO score > 6|1
800788|NCT00003702|1753796|FG000|Overall Study|Inadequate documentation of disease|1
800789|NCT00003702|1753797|FG001|Overall Study|Inadequate documentation of disease|3
800790|NCT00003782|1753807|FG000|Overall Study|No follow up data|30
800791|NCT00003782|1753808|FG001|Overall Study|No follow up data|31
800792|NCT00003782|1753809|FG002|Overall Study|No follow up data|26
800793|NCT00003830|1753847|FG000|Overall Study|No follow up data|3
800794|NCT00003830|1753848|FG001|Overall Study|No follow up data|0
800795|NCT00003830|1753847|FG000|Overall Study|Sentinel node positive patients|829
800796|NCT00003830|1753848|FG001|Overall Study|Sentinel node positive patients|793
800797|NCT00003869|1753858|FG000|Overall Study|Adverse Event|14
800798|NCT00003869|1753859|FG001|Overall Study|Adverse Event|3
800799|NCT00003869|1753858|FG000|Overall Study|Withdrawal by Subject|21
800800|NCT00003869|1753859|FG001|Overall Study|Withdrawal by Subject|3
800801|NCT00003869|1753858|FG000|Overall Study|Death|1
800802|NCT00003869|1753859|FG001|Overall Study|Death|2
800803|NCT00003869|1753858|FG000|Overall Study|Alternative treatmnt, medical problems|5
800804|NCT00003869|1753859|FG001|Overall Study|Alternative treatmnt, medical problems|4
800805|NCT00003875|1753865|FG000|Overall Study|Screen Failed|1
800806|NCT00003895|1753871|FG000|Overall Study|Adverse Event|4
800807|NCT00003895|1753872|FG001|Overall Study|Adverse Event|0
800808|NCT00003895|1753871|FG000|Overall Study|Lack of Efficacy|1
800809|NCT00003895|1753872|FG001|Overall Study|Lack of Efficacy|1
800810|NCT00003895|1753871|FG000|Overall Study|Patient Vacation|2
800811|NCT00003895|1753872|FG001|Overall Study|Patient Vacation|0
800812|NCT00003895|1753871|FG000|Overall Study|Withdrawal by Subject|0
800813|NCT00003895|1753872|FG001|Overall Study|Withdrawal by Subject|3
800814|NCT00003896|1753878|FG000|Overall Study|Adverse Event|16
800815|NCT00003896|1753878|FG000|Overall Study|Withdrawal by Subject|1
800816|NCT00003896|1753878|FG000|Overall Study|Lack of Efficacy|1
800817|NCT00003896|1753878|FG000|Overall Study|Death|3
800818|NCT00003896|1753878|FG000|Overall Study|not protocol specified|3
800819|NCT00003896|1753878|FG000|Overall Study|ineligible|5
800820|NCT00003901|1753883|FG000|Overall Study|Adverse Event|1
800821|NCT00003901|1753883|FG000|Overall Study|Withdrawal by Subject|1
800822|NCT00003901|1753883|FG000|Overall Study|Ineligible|6
800823|NCT00003901|1753883|FG000|Overall Study|CT Scan not within protocol requirement|2
800824|NCT00003901|1753883|FG000|Overall Study|Chest X-Ray not done prior registration|1
800825|NCT00003901|1753883|FG000|Overall Study|Medical problems|6
800826|NCT00003907|1753892|FG000|Overall Study|Adverse Event|2
800827|NCT00003907|1753893|FG001|Overall Study|Adverse Event|11
800828|NCT00003907|1753892|FG000|Overall Study|Death|2
800829|NCT00003907|1753893|FG001|Overall Study|Death|0
800830|NCT00003907|1753892|FG000|Overall Study|Withdrawal by Subject|1
800831|NCT00003907|1753893|FG001|Overall Study|Withdrawal by Subject|3
800832|NCT00003907|1753892|FG000|Overall Study|Progressive disease|4
800833|NCT00003907|1753893|FG001|Overall Study|Progressive disease|4
800834|NCT00003907|1753892|FG000|Overall Study|Complicating disease|1
800835|NCT00003907|1753893|FG001|Overall Study|Complicating disease|0
800836|NCT00003907|1753892|FG000|Overall Study|Other|1
800837|NCT00003907|1753893|FG001|Overall Study|Other|3
800838|NCT00003907|1753892|FG000|Overall Study|ineligible or not treated|2
800839|NCT00003907|1753893|FG001|Overall Study|ineligible or not treated|2
800840|NCT00004031|1753908|FG000|Overall Study|Adverse Event|5
800841|NCT00004031|1753909|FG001|Overall Study|Adverse Event|0
800842|NCT00004031|1753908|FG000|Overall Study|Refusal unrelated to adverse events|2
800843|NCT00004031|1753909|FG001|Overall Study|Refusal unrelated to adverse events|11
800844|NCT00004031|1753908|FG000|Overall Study|Progression/relapse|9
800845|NCT00004031|1753909|FG001|Overall Study|Progression/relapse|4
800846|NCT00004031|1753908|FG000|Overall Study|Death|3
800847|NCT00004031|1753909|FG001|Overall Study|Death|1
800848|NCT00004031|1753908|FG000|Overall Study|Other- not protocol specified|3
800849|NCT00004031|1753909|FG001|Overall Study|Other- not protocol specified|3
800850|NCT00004031|1753908|FG000|Overall Study|Reason under review|3
800851|NCT00004031|1753909|FG001|Overall Study|Reason under review|2
800852|NCT00004088|1753926|FG000|Overall Study|No C2 given due to study on hold by IRB|4
800853|NCT00004088|1753926|FG000|Overall Study|Withdrawal by Subject|1
800854|NCT00004088|1753926|FG000|Overall Study|Protocol Violation|3
800855|NCT00004088|1753926|FG000|Overall Study|Physician Decision|1
800856|NCT00004124|1753941|FG000|Overall Study|Received no protocol therapy|12
800857|NCT00004124|1753942|FG001|Overall Study|Received no protocol therapy|20
800858|NCT00004228|1753965|FG000|Overall Study|Adverse Event|0
800859|NCT00004228|1753966|FG001|Overall Study|Adverse Event|1
800860|NCT00004228|1753967|FG002|Overall Study|Adverse Event|0
800861|NCT00004228|1753968|FG003|Overall Study|Adverse Event|0
800862|NCT00004228|1753969|FG004|Overall Study|Adverse Event|1
800863|NCT00004228|1753970|FG005|Overall Study|Adverse Event|0
800864|NCT00004228|1753971|FG006|Overall Study|Adverse Event|0
800865|NCT00004228|1753965|FG000|Overall Study|Death|0
800866|NCT00004228|1753966|FG001|Overall Study|Death|1
800867|NCT00004228|1753967|FG002|Overall Study|Death|2
800868|NCT00004228|1753968|FG003|Overall Study|Death|0
800869|NCT00004228|1753969|FG004|Overall Study|Death|1
800870|NCT00004228|1753970|FG005|Overall Study|Death|0
800871|NCT00004228|1753971|FG006|Overall Study|Death|0
800872|NCT00004228|1753965|FG000|Overall Study|Lack of Efficacy|1
800873|NCT00004228|1753966|FG001|Overall Study|Lack of Efficacy|6
800874|NCT00004228|1753967|FG002|Overall Study|Lack of Efficacy|5
800875|NCT00004228|1753968|FG003|Overall Study|Lack of Efficacy|3
800876|NCT00004228|1753969|FG004|Overall Study|Lack of Efficacy|9
800877|NCT00004228|1753970|FG005|Overall Study|Lack of Efficacy|8
800878|NCT00004228|1753971|FG006|Overall Study|Lack of Efficacy|4
800879|NCT00004228|1753965|FG000|Overall Study|Lost to Follow-up|0
800880|NCT00004228|1753966|FG001|Overall Study|Lost to Follow-up|0
800881|NCT00004228|1753967|FG002|Overall Study|Lost to Follow-up|1
800882|NCT00004228|1753968|FG003|Overall Study|Lost to Follow-up|0
800883|NCT00004228|1753969|FG004|Overall Study|Lost to Follow-up|0
800884|NCT00004228|1753970|FG005|Overall Study|Lost to Follow-up|0
800885|NCT00004228|1753971|FG006|Overall Study|Lost to Follow-up|0
800886|NCT00004228|1753965|FG000|Overall Study|Physician Decision|1
800887|NCT00004228|1753966|FG001|Overall Study|Physician Decision|0
800888|NCT00004228|1753967|FG002|Overall Study|Physician Decision|3
800889|NCT00004228|1753968|FG003|Overall Study|Physician Decision|2
800890|NCT00004228|1753969|FG004|Overall Study|Physician Decision|1
800891|NCT00004228|1753970|FG005|Overall Study|Physician Decision|1
800892|NCT00004228|1753971|FG006|Overall Study|Physician Decision|1
800893|NCT00004228|1753965|FG000|Overall Study|Protocol Violation|0
800894|NCT00004228|1753966|FG001|Overall Study|Protocol Violation|5
800895|NCT00004228|1753967|FG002|Overall Study|Protocol Violation|2
800896|NCT00004228|1753968|FG003|Overall Study|Protocol Violation|1
800897|NCT00004228|1753969|FG004|Overall Study|Protocol Violation|1
800898|NCT00004228|1753970|FG005|Overall Study|Protocol Violation|2
800899|NCT00004228|1753971|FG006|Overall Study|Protocol Violation|0
800900|NCT00004228|1753965|FG000|Overall Study|Withdrawal by Subject|3
800901|NCT00004228|1753966|FG001|Overall Study|Withdrawal by Subject|0
800902|NCT00004228|1753967|FG002|Overall Study|Withdrawal by Subject|1
800903|NCT00004228|1753968|FG003|Overall Study|Withdrawal by Subject|0
800904|NCT00004228|1753969|FG004|Overall Study|Withdrawal by Subject|2
800905|NCT00004228|1753970|FG005|Overall Study|Withdrawal by Subject|1
800906|NCT00004228|1753971|FG006|Overall Study|Withdrawal by Subject|2
800907|NCT00004228|1753965|FG000|Overall Study|Other|0
800908|NCT00004228|1753966|FG001|Overall Study|Other|0
800909|NCT00004228|1753967|FG002|Overall Study|Other|1
800910|NCT00004228|1753968|FG003|Overall Study|Other|0
800911|NCT00004228|1753969|FG004|Overall Study|Other|0
800912|NCT00004228|1753970|FG005|Overall Study|Other|0
800913|NCT00004228|1753971|FG006|Overall Study|Other|0
800914|NCT00004228|1753965|FG000|Overall Study|ineligible|4
800915|NCT00004228|1753966|FG001|Overall Study|ineligible|2
800916|NCT00004228|1753967|FG002|Overall Study|ineligible|4
800917|NCT00004228|1753968|FG003|Overall Study|ineligible|1
800918|NCT00004228|1753969|FG004|Overall Study|ineligible|1
800919|NCT00004228|1753970|FG005|Overall Study|ineligible|2
800920|NCT00004228|1753971|FG006|Overall Study|ineligible|5
800921|NCT00004259|1753992|FG000|Overall Study|Protocol Violation|1
800922|NCT00004259|1753993|FG001|Overall Study|Protocol Violation|2
800923|NCT00004259|1753994|FG002|Overall Study|Protocol Violation|0
800924|NCT00004259|1753995|FG003|Overall Study|Protocol Violation|0
800925|NCT00004259|1753992|FG000|Overall Study|Withdrawal by Subject|0
800926|NCT00004259|1753993|FG001|Overall Study|Withdrawal by Subject|2
800927|NCT00004259|1753994|FG002|Overall Study|Withdrawal by Subject|0
800928|NCT00004259|1753995|FG003|Overall Study|Withdrawal by Subject|0
800929|NCT00004412|1754011|FG000|Randomized Period|Moved to Crossover Period|3
800930|NCT00004412|1754012|FG001|Randomized Period|Moved to Crossover Period|0
800931|NCT00004412|1754013|FG002|Randomized Period|Moved to Crossover Period|0
800932|NCT00004445|1754023|FG000|Overall Study|Physician Decision|2
800933|NCT00004445|1754023|FG000|Overall Study|Withdrawal by Subject|1
800934|NCT00004562|1754052|FG000|Overall Study|Lost to Follow-up|102
800935|NCT00004562|1754053|FG001|Overall Study|Lost to Follow-up|91
800936|NCT00004563|1754061|FG000|Overall Study|Withdrawal by Subject|20
800937|NCT00004563|1754062|FG001|Overall Study|Withdrawal by Subject|16
800938|NCT00004563|1754061|FG000|Overall Study|Lack of Efficacy|3
800939|NCT00004563|1754062|FG001|Overall Study|Lack of Efficacy|5
800940|NCT00004563|1754061|FG000|Overall Study|Death|2
800941|NCT00004563|1754062|FG001|Overall Study|Death|3
800942|NCT00004635|1754070|FG000|Period One|refused|2
800943|NCT00004635|1754071|FG001|Period One|refused|1
800944|NCT00004635|1754070|FG000|Period One|Withdrawal by Subject|1
800945|NCT00004635|1754071|FG001|Period One|Withdrawal by Subject|1
800946|NCT00004635|1754070|FG000|Period One|Protocol Violation|1
800947|NCT00004635|1754071|FG001|Period One|Protocol Violation|0
800948|NCT00004635|1754070|FG000|Period One|PSA did not go <5 ng/mL|1
800949|NCT00004635|1754071|FG001|Period One|PSA did not go <5 ng/mL|0
800950|NCT00004635|1754070|FG000|Period One|second malignancy|1
800951|NCT00004635|1754071|FG001|Period One|second malignancy|0
800952|NCT00004635|1754070|FG000|Period One|progressed|0
800953|NCT00004635|1754071|FG001|Period One|progressed|2
800954|NCT00004635|1754070|FG000|Period One|health problem|0
800955|NCT00004635|1754071|FG001|Period One|health problem|1
800956|NCT00004635|1754070|FG000|Period One|discrepancy in data entry|0
800957|NCT00004635|1754071|FG001|Period One|discrepancy in data entry|1
800958|NCT00004635|1754070|FG000|Period Two|progression|2
800959|NCT00004635|1754071|FG001|Period Two|progression|3
800960|NCT00004635|1754070|FG000|Period Two|Adverse Event|1
800961|NCT00004635|1754071|FG001|Period Two|Adverse Event|0
800962|NCT00004635|1754070|FG000|Period Two|refused|0
800963|NCT00004635|1754071|FG001|Period Two|refused|2
800964|NCT00004635|1754070|FG000|Period Two|health problem|1
800965|NCT00004635|1754071|FG001|Period Two|health problem|1
800966|NCT00004635|1754070|FG000|Period Two|travel issues|0
800967|NCT00004635|1754071|FG001|Period Two|travel issues|1
800968|NCT00004635|1754070|FG000|Period Two|secondary malignancy|1
800969|NCT00004635|1754071|FG001|Period Two|secondary malignancy|1
800970|NCT00004635|1754070|FG000|Period Two|Lost to Follow-up|1
800971|NCT00004635|1754071|FG001|Period Two|Lost to Follow-up|0
800972|NCT00004635|1754070|FG000|Period Two|discrepancy in data entry|0
800973|NCT00004635|1754071|FG001|Period Two|discrepancy in data entry|1
800974|NCT00004732|1754082|FG000|Overall Study|Withdrawal by Subject|36
800975|NCT00004732|1754083|FG001|Overall Study|Withdrawal by Subject|64
800976|NCT00004732|1754082|FG000|Overall Study|Lost to Follow-up|33
800977|NCT00004732|1754083|FG001|Overall Study|Lost to Follow-up|47
800978|NCT00004859|1754093|FG000|Overall Study|Lack of Efficacy|43
800979|NCT00004859|1754094|FG001|Overall Study|Lack of Efficacy|113
800980|NCT00004859|1754093|FG000|Overall Study|Adverse Event|31
800981|NCT00004859|1754094|FG001|Overall Study|Adverse Event|93
800982|NCT00004859|1754093|FG000|Overall Study|Death|5
800983|NCT00004859|1754094|FG001|Overall Study|Death|5
800984|NCT00004859|1754093|FG000|Overall Study|Withdrawal by Subject|7
800985|NCT00004859|1754094|FG001|Overall Study|Withdrawal by Subject|33
800986|NCT00004859|1754093|FG000|Overall Study|Protocol Violation|2
800987|NCT00004859|1754094|FG001|Overall Study|Protocol Violation|2
800988|NCT00004859|1754093|FG000|Overall Study|other disease|0
800989|NCT00004859|1754094|FG001|Overall Study|other disease|3
800990|NCT00004859|1754093|FG000|Overall Study|error|3
800991|NCT00004859|1754094|FG001|Overall Study|error|1
800992|NCT00004859|1754093|FG000|Overall Study|missing data|14
800993|NCT00004859|1754094|FG001|Overall Study|missing data|11
800994|NCT00004859|1754093|FG000|Overall Study|Other|13
800995|NCT00004859|1754094|FG001|Overall Study|Other|21
800996|NCT00004888|1754104|FG000|Overall Study|Adverse Event|5
800997|NCT00004888|1754105|FG001|Overall Study|Adverse Event|10
800998|NCT00004888|1754104|FG000|Overall Study|Withdrawal by Subject|0
800999|NCT00004888|1754105|FG001|Overall Study|Withdrawal by Subject|3
801000|NCT00004888|1754104|FG000|Overall Study|Physician Decision|1
801001|NCT00004888|1754105|FG001|Overall Study|Physician Decision|1
801002|NCT00004888|1754104|FG000|Overall Study|Progressive Disease|4
801003|NCT00004888|1754105|FG001|Overall Study|Progressive Disease|9
801004|NCT00004888|1754104|FG000|Overall Study|Death without progressive disease|0
801005|NCT00004888|1754105|FG001|Overall Study|Death without progressive disease|1
801006|NCT00004888|1754104|FG000|Overall Study|Toxic death|1
801007|NCT00004888|1754105|FG001|Overall Study|Toxic death|0
801008|NCT00004978|1754113|FG000|Overall Study|Death|107
801009|NCT00004978|1754114|FG001|Overall Study|Death|116
801010|NCT00004978|1754113|FG000|Overall Study|Lost to Follow-up|101
801011|NCT00004978|1754114|FG001|Overall Study|Lost to Follow-up|108
801012|NCT00004978|1754113|FG000|Overall Study|Withdrawal by Subject|17
801013|NCT00004978|1754114|FG001|Overall Study|Withdrawal by Subject|26
801014|NCT00004978|1754113|FG000|Overall Study|site closure - not in analysis cohort|19
801015|NCT00004978|1754114|FG001|Overall Study|site closure - not in analysis cohort|20
801016|NCT00004980|1754122|FG000|Overall Study|Withdrawal by Subject|1
801017|NCT00004980|1754123|FG001|Overall Study|Withdrawal by Subject|0
801018|NCT00004980|1754122|FG000|Overall Study|memory difficulties|1
801019|NCT00004980|1754123|FG001|Overall Study|memory difficulties|1
801020|NCT00004980|1754122|FG000|Overall Study|Physician Decision|0
801021|NCT00004980|1754123|FG001|Overall Study|Physician Decision|1
801022|NCT00005044|1754131|FG000|Overall Study|Protocol Violation|37
801023|NCT00005044|1754132|FG001|Overall Study|Protocol Violation|46
801024|NCT00005044|1754131|FG000|Overall Study|Withdrawal by Subject|1
801025|NCT00005044|1754132|FG001|Overall Study|Withdrawal by Subject|5
801026|NCT00005044|1754131|FG000|Overall Study|No protocol treatment|0
801027|NCT00005044|1754132|FG001|Overall Study|No protocol treatment|1
801028|NCT00005047|1754142|FG000|Overall Study|Withdrawal by Subject|12
801029|NCT00005047|1754143|FG001|Overall Study|Withdrawal by Subject|0
801030|NCT00005047|1754144|FG002|Overall Study|Withdrawal by Subject|0
801031|NCT00005047|1754145|FG003|Overall Study|Withdrawal by Subject|0
801032|NCT00005047|1754142|FG000|Overall Study|Adverse Event|5
801033|NCT00005047|1754143|FG001|Overall Study|Adverse Event|0
801034|NCT00005047|1754144|FG002|Overall Study|Adverse Event|0
801035|NCT00005047|1754145|FG003|Overall Study|Adverse Event|0
801036|NCT00005047|1754142|FG000|Overall Study|Lost to Follow-up|1
801037|NCT00005047|1754143|FG001|Overall Study|Lost to Follow-up|0
801038|NCT00005047|1754144|FG002|Overall Study|Lost to Follow-up|0
801039|NCT00005047|1754145|FG003|Overall Study|Lost to Follow-up|0
801040|NCT00005047|1754142|FG000|Overall Study|Lack of Efficacy|1
801041|NCT00005047|1754143|FG001|Overall Study|Lack of Efficacy|0
801042|NCT00005047|1754144|FG002|Overall Study|Lack of Efficacy|0
801043|NCT00005047|1754145|FG003|Overall Study|Lack of Efficacy|0
801044|NCT00005879|1754173|FG000|Overall Study|Withdrawal by Subject|8
801045|NCT00005879|1754174|FG001|Overall Study|Withdrawal by Subject|10
801046|NCT00005906|1754189|FG000|Overall Study|Lack of Efficacy|3
801047|NCT00005908|1754193|FG000|Overall Study|Withdrawal by Subject|1
801048|NCT00005908|1754194|FG001|Overall Study|Withdrawal by Subject|0
801049|NCT00005937|1754203|FG000|Overall Study|Lack of Efficacy|5
801050|NCT00005947|1754209|FG000|Overall Study|Death|54
801051|NCT00005947|1754210|FG001|Overall Study|Death|40
801052|NCT00005947|1754209|FG000|Overall Study|Patient Refused to Continue|2
801053|NCT00005947|1754210|FG001|Overall Study|Patient Refused to Continue|1
801054|NCT00005947|1754209|FG000|Overall Study|Site Closure|1
801055|NCT00005947|1754210|FG001|Overall Study|Site Closure|0
801056|NCT00005957|1754220|FG000|Overall Study|No treated|3
801057|NCT00005957|1754221|FG001|Overall Study|No treated|9
801058|NCT00005957|1754220|FG000|Overall Study|Crossover to the other arm|5
801059|NCT00005957|1754221|FG001|Overall Study|Crossover to the other arm|19
801060|NCT00006011|1754230|FG000|Overall Study|Disease progression|13
801061|NCT00006011|1754231|FG001|Overall Study|Disease progression|6
801062|NCT00006011|1754232|FG002|Overall Study|Disease progression|26
801063|NCT00006011|1754230|FG000|Overall Study|Refused further treatment|15
801064|NCT00006011|1754231|FG001|Overall Study|Refused further treatment|13
801065|NCT00006011|1754232|FG002|Overall Study|Refused further treatment|26
801066|NCT00006011|1754230|FG000|Overall Study|Adverse Event|15
801067|NCT00006011|1754231|FG001|Overall Study|Adverse Event|39
801068|NCT00006011|1754232|FG002|Overall Study|Adverse Event|5
801069|NCT00006011|1754230|FG000|Overall Study|Death|0
801070|NCT00006011|1754231|FG001|Overall Study|Death|1
801071|NCT00006011|1754232|FG002|Overall Study|Death|2
801072|NCT00006011|1754230|FG000|Overall Study|Other|4
801073|NCT00006011|1754231|FG001|Overall Study|Other|2
801074|NCT00006011|1754232|FG002|Overall Study|Other|5
801075|NCT00006011|1754230|FG000|Overall Study|Ineligible|18
801076|NCT00006011|1754231|FG001|Overall Study|Ineligible|16
801077|NCT00006011|1754232|FG002|Overall Study|Ineligible|9
801078|NCT00006046|1754243|FG000|Overall Study|Adverse Event|3
801079|NCT00006046|1754244|FG001|Overall Study|Adverse Event|0
801080|NCT00006046|1754245|FG002|Overall Study|Adverse Event|0
801081|NCT00006046|1754246|FG003|Overall Study|Adverse Event|0
801082|NCT00006046|1754247|FG004|Overall Study|Adverse Event|0
801083|NCT00006046|1754243|FG000|Overall Study|Disease Progression|2
801084|NCT00006046|1754244|FG001|Overall Study|Disease Progression|0
801085|NCT00006046|1754245|FG002|Overall Study|Disease Progression|0
801086|NCT00006046|1754246|FG003|Overall Study|Disease Progression|0
801087|NCT00006046|1754247|FG004|Overall Study|Disease Progression|0
801088|NCT00006164|1754311|FG000|Overall Study|Withdrew or lost to follow-up|70
801089|NCT00006164|1754312|FG001|Overall Study|Withdrew or lost to follow-up|81
801090|NCT00006184|1754341|FG000|Overall Study|Death|1
801091|NCT00006184|1754342|FG001|Overall Study|Death|0
801092|NCT00006237|1754354|FG000|Overall Study|Adverse Event|39
801093|NCT00006237|1754355|FG001|Overall Study|Adverse Event|29
801094|NCT00006237|1754354|FG000|Overall Study|Death|1
801095|NCT00006237|1754355|FG001|Overall Study|Death|0
801096|NCT00006237|1754354|FG000|Overall Study|Refusal unrelated to adverse effects|8
801097|NCT00006237|1754355|FG001|Overall Study|Refusal unrelated to adverse effects|4
801098|NCT00006237|1754354|FG000|Overall Study|Progression/relapse|54
801099|NCT00006237|1754355|FG001|Overall Study|Progression/relapse|2
801100|NCT00006237|1754354|FG000|Overall Study|Not eligible|9
801101|NCT00006237|1754355|FG001|Overall Study|Not eligible|20
801102|NCT00006237|1754354|FG000|Overall Study|Withdrawal by Subject|0
801103|NCT00006237|1754355|FG001|Overall Study|Withdrawal by Subject|1
801104|NCT00006237|1754354|FG000|Overall Study|Not protocol specified|14
801105|NCT00006237|1754355|FG001|Overall Study|Not protocol specified|5
801106|NCT00006289|1754370|FG000|First Intervention (5 Weeks)|Adverse Event|1
801107|NCT00006289|1754371|FG001|First Intervention (5 Weeks)|Adverse Event|0
801108|NCT00006289|1754370|FG000|Second Intervention (5 Weeks)|Protocol Violation|1
801109|NCT00006289|1754371|FG001|Second Intervention (5 Weeks)|Protocol Violation|1
801110|NCT00006305|1754391|FG000|Overall Study|Withdrawal by Subject|17
801111|NCT00006305|1754392|FG001|Overall Study|Withdrawal by Subject|10
801112|NCT00006305|1754393|FG002|Overall Study|Withdrawal by Subject|15
801113|NCT00006305|1754394|FG003|Overall Study|Withdrawal by Subject|14
801114|NCT00006389|1754404|FG000|Overall Study|Adverse Event|1
801115|NCT00006392|1754413|FG000|Overall Study|Ineligible|11
801116|NCT00006392|1754414|FG001|Overall Study|Ineligible|3
801117|NCT00006392|1754415|FG002|Overall Study|Ineligible|5
801118|NCT00006392|1754416|FG003|Overall Study|Ineligible|5
801119|NCT00006392|1754413|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156
801120|NCT00006392|1754414|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155
801121|NCT00006392|1754415|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155
801122|NCT00006392|1754416|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155
801123|NCT00006409|1754441|FG000|Baseline|Protocol Violation|48
801124|NCT00006409|1754442|FG001|Baseline|Protocol Violation|70
801125|NCT00006409|1754443|FG002|Baseline|Protocol Violation|0
801126|NCT00006409|1754444|FG003|Baseline|Protocol Violation|0
801127|NCT00006409|1754445|FG004|Baseline|Protocol Violation|0
801128|NCT00006409|1754446|FG005|Baseline|Protocol Violation|0
801129|NCT00006409|1754441|FG000|Post-2 Year Intervention|Protocol Violation|0
801130|NCT00006409|1754442|FG001|Post-2 Year Intervention|Protocol Violation|0
801131|NCT00006409|1754443|FG002|Post-2 Year Intervention|Protocol Violation|251
801132|NCT00006409|1754444|FG003|Post-2 Year Intervention|Protocol Violation|168
801133|NCT00006409|1754445|FG004|Post-2 Year Intervention|Protocol Violation|0
801134|NCT00006409|1754446|FG005|Post-2 Year Intervention|Protocol Violation|0
801135|NCT00006409|1754441|FG000|Post-3 Year Intervention|Protocol Violation|0
801136|NCT00006409|1754442|FG001|Post-3 Year Intervention|Protocol Violation|0
801137|NCT00006409|1754443|FG002|Post-3 Year Intervention|Protocol Violation|0
801138|NCT00006409|1754444|FG003|Post-3 Year Intervention|Protocol Violation|0
801139|NCT00006409|1754445|FG004|Post-3 Year Intervention|Protocol Violation|62
801140|NCT00006409|1754446|FG005|Post-3 Year Intervention|Protocol Violation|62
801141|NCT00006489|1754473|FG000|Overall Study|Adverse Event|3
801142|NCT00006489|1754474|FG001|Overall Study|Adverse Event|2
801143|NCT00006489|1754475|FG002|Overall Study|Adverse Event|4
801144|NCT00006489|1754476|FG003|Overall Study|Adverse Event|3
801145|NCT00006489|1754473|FG000|Overall Study|Withdrawal by Subject|10
801146|NCT00006489|1754474|FG001|Overall Study|Withdrawal by Subject|9
801147|NCT00006489|1754475|FG002|Overall Study|Withdrawal by Subject|9
801148|NCT00006489|1754476|FG003|Overall Study|Withdrawal by Subject|6
801149|NCT00006489|1754473|FG000|Overall Study|Scheduling Conflict|0
801150|NCT00006489|1754474|FG001|Overall Study|Scheduling Conflict|3
801151|NCT00006489|1754475|FG002|Overall Study|Scheduling Conflict|2
801152|NCT00006489|1754476|FG003|Overall Study|Scheduling Conflict|1
801153|NCT00006489|1754473|FG000|Overall Study|Death|0
801154|NCT00006489|1754474|FG001|Overall Study|Death|0
801155|NCT00006489|1754475|FG002|Overall Study|Death|0
801156|NCT00006489|1754476|FG003|Overall Study|Death|1
801157|NCT00006604|1754493|FG000|Overall Study|Met study objective - no further FU|1
801158|NCT00006604|1754494|FG001|Overall Study|Met study objective - no further FU|0
801159|NCT00006604|1754495|FG002|Overall Study|Met study objective - no further FU|0
801160|NCT00006604|1754496|FG003|Overall Study|Met study objective - no further FU|0
801161|NCT00006604|1754497|FG004|Overall Study|Met study objective - no further FU|0
801162|NCT00006604|1754498|FG005|Overall Study|Met study objective - no further FU|0
801163|NCT00006604|1754499|FG006|Overall Study|Met study objective - no further FU|0
801164|NCT00006604|1754500|FG007|Overall Study|Met study objective - no further FU|0
801165|NCT00006604|1754501|FG008|Overall Study|Met study objective - no further FU|0
801166|NCT00006604|1754502|FG009|Overall Study|Met study objective - no further FU|0
801167|NCT00006604|1754503|FG010|Overall Study|Met study objective - no further FU|0
801168|NCT00006604|1754504|FG011|Overall Study|Met study objective - no further FU|0
801169|NCT00006604|1754505|FG012|Overall Study|Met study objective - no further FU|0
801170|NCT00006604|1754506|FG013|Overall Study|Met study objective - no further FU|0
801171|NCT00006604|1754507|FG014|Overall Study|Met study objective - no further FU|1
801172|NCT00006604|1754508|FG015|Overall Study|Met study objective - no further FU|1
801173|NCT00006604|1754509|FG016|Overall Study|Met study objective - no further FU|0
801174|NCT00006604|1754493|FG000|Overall Study|Randomization entry error-no RX, no FU|0
801175|NCT00006604|1754494|FG001|Overall Study|Randomization entry error-no RX, no FU|0
801176|NCT00006604|1754495|FG002|Overall Study|Randomization entry error-no RX, no FU|0
801177|NCT00006604|1754496|FG003|Overall Study|Randomization entry error-no RX, no FU|0
801178|NCT00006604|1754497|FG004|Overall Study|Randomization entry error-no RX, no FU|0
801179|NCT00006604|1754498|FG005|Overall Study|Randomization entry error-no RX, no FU|0
801180|NCT00006604|1754499|FG006|Overall Study|Randomization entry error-no RX, no FU|0
801181|NCT00006604|1754500|FG007|Overall Study|Randomization entry error-no RX, no FU|0
801182|NCT00006604|1754501|FG008|Overall Study|Randomization entry error-no RX, no FU|0
801183|NCT00006604|1754502|FG009|Overall Study|Randomization entry error-no RX, no FU|0
801184|NCT00006604|1754503|FG010|Overall Study|Randomization entry error-no RX, no FU|0
801185|NCT00006604|1754504|FG011|Overall Study|Randomization entry error-no RX, no FU|1
801186|NCT00006604|1754505|FG012|Overall Study|Randomization entry error-no RX, no FU|0
801187|NCT00006604|1754506|FG013|Overall Study|Randomization entry error-no RX, no FU|0
801188|NCT00006604|1754507|FG014|Overall Study|Randomization entry error-no RX, no FU|0
801189|NCT00006604|1754508|FG015|Overall Study|Randomization entry error-no RX, no FU|0
801190|NCT00006604|1754509|FG016|Overall Study|Randomization entry error-no RX, no FU|0
801191|NCT00006604|1754493|FG000|Overall Study|Death|0
801192|NCT00006604|1754494|FG001|Overall Study|Death|0
801193|NCT00006604|1754495|FG002|Overall Study|Death|0
801194|NCT00006604|1754496|FG003|Overall Study|Death|0
801195|NCT00006604|1754497|FG004|Overall Study|Death|0
801196|NCT00006604|1754498|FG005|Overall Study|Death|0
801197|NCT00006604|1754499|FG006|Overall Study|Death|0
801198|NCT00006604|1754500|FG007|Overall Study|Death|0
801199|NCT00006604|1754501|FG008|Overall Study|Death|0
801200|NCT00006604|1754502|FG009|Overall Study|Death|1
801201|NCT00006604|1754503|FG010|Overall Study|Death|1
801202|NCT00006604|1754504|FG011|Overall Study|Death|1
801203|NCT00006604|1754505|FG012|Overall Study|Death|0
801204|NCT00006604|1754506|FG013|Overall Study|Death|0
801205|NCT00006604|1754507|FG014|Overall Study|Death|0
801206|NCT00006604|1754508|FG015|Overall Study|Death|0
801207|NCT00006604|1754509|FG016|Overall Study|Death|0
801208|NCT00006604|1754493|FG000|Overall Study|Severe debilitation, unable to continue|0
801209|NCT00006604|1754494|FG001|Overall Study|Severe debilitation, unable to continue|0
801210|NCT00006604|1754495|FG002|Overall Study|Severe debilitation, unable to continue|0
801211|NCT00006604|1754496|FG003|Overall Study|Severe debilitation, unable to continue|0
801212|NCT00006604|1754497|FG004|Overall Study|Severe debilitation, unable to continue|0
801213|NCT00006604|1754498|FG005|Overall Study|Severe debilitation, unable to continue|0
801214|NCT00006604|1754499|FG006|Overall Study|Severe debilitation, unable to continue|3
801215|NCT00006604|1754500|FG007|Overall Study|Severe debilitation, unable to continue|0
801216|NCT00006604|1754501|FG008|Overall Study|Severe debilitation, unable to continue|0
801217|NCT00006604|1754502|FG009|Overall Study|Severe debilitation, unable to continue|5
801218|NCT00006604|1754503|FG010|Overall Study|Severe debilitation, unable to continue|0
801219|NCT00006604|1754504|FG011|Overall Study|Severe debilitation, unable to continue|2
801220|NCT00006604|1754505|FG012|Overall Study|Severe debilitation, unable to continue|1
801221|NCT00006604|1754506|FG013|Overall Study|Severe debilitation, unable to continue|0
801222|NCT00006604|1754507|FG014|Overall Study|Severe debilitation, unable to continue|2
801223|NCT00006604|1754508|FG015|Overall Study|Severe debilitation, unable to continue|0
801224|NCT00006604|1754509|FG016|Overall Study|Severe debilitation, unable to continue|0
801225|NCT00006604|1754493|FG000|Overall Study|Subj/Parent not able to get to clinic|0
801226|NCT00006604|1754494|FG001|Overall Study|Subj/Parent not able to get to clinic|0
801227|NCT00006604|1754495|FG002|Overall Study|Subj/Parent not able to get to clinic|0
801228|NCT00006604|1754496|FG003|Overall Study|Subj/Parent not able to get to clinic|1
801229|NCT00006604|1754497|FG004|Overall Study|Subj/Parent not able to get to clinic|1
801230|NCT00006604|1754498|FG005|Overall Study|Subj/Parent not able to get to clinic|0
801231|NCT00006604|1754499|FG006|Overall Study|Subj/Parent not able to get to clinic|1
801232|NCT00006604|1754500|FG007|Overall Study|Subj/Parent not able to get to clinic|0
801233|NCT00006604|1754501|FG008|Overall Study|Subj/Parent not able to get to clinic|0
801234|NCT00006604|1754502|FG009|Overall Study|Subj/Parent not able to get to clinic|1
801235|NCT00006604|1754503|FG010|Overall Study|Subj/Parent not able to get to clinic|2
801236|NCT00006604|1754504|FG011|Overall Study|Subj/Parent not able to get to clinic|1
801237|NCT00006604|1754505|FG012|Overall Study|Subj/Parent not able to get to clinic|1
801238|NCT00006604|1754506|FG013|Overall Study|Subj/Parent not able to get to clinic|1
801239|NCT00006604|1754507|FG014|Overall Study|Subj/Parent not able to get to clinic|3
801240|NCT00006604|1754508|FG015|Overall Study|Subj/Parent not able to get to clinic|0
801241|NCT00006604|1754509|FG016|Overall Study|Subj/Parent not able to get to clinic|0
801242|NCT00006604|1754493|FG000|Overall Study|Site closing|0
801243|NCT00006604|1754494|FG001|Overall Study|Site closing|0
801244|NCT00006604|1754495|FG002|Overall Study|Site closing|1
801245|NCT00006604|1754496|FG003|Overall Study|Site closing|1
801246|NCT00006604|1754497|FG004|Overall Study|Site closing|0
801247|NCT00006604|1754498|FG005|Overall Study|Site closing|0
801248|NCT00006604|1754499|FG006|Overall Study|Site closing|0
801249|NCT00006604|1754500|FG007|Overall Study|Site closing|1
801250|NCT00006604|1754501|FG008|Overall Study|Site closing|0
801251|NCT00006604|1754502|FG009|Overall Study|Site closing|0
801252|NCT00006604|1754503|FG010|Overall Study|Site closing|0
801253|NCT00006604|1754504|FG011|Overall Study|Site closing|1
801254|NCT00006604|1754505|FG012|Overall Study|Site closing|1
801255|NCT00006604|1754506|FG013|Overall Study|Site closing|1
801256|NCT00006604|1754507|FG014|Overall Study|Site closing|0
801257|NCT00006604|1754508|FG015|Overall Study|Site closing|0
801258|NCT00006604|1754509|FG016|Overall Study|Site closing|1
801259|NCT00006604|1754493|FG000|Overall Study|Withdrawal by Subject|1
801260|NCT00006604|1754494|FG001|Overall Study|Withdrawal by Subject|0
801261|NCT00006604|1754495|FG002|Overall Study|Withdrawal by Subject|2
801262|NCT00006604|1754496|FG003|Overall Study|Withdrawal by Subject|0
801263|NCT00006604|1754497|FG004|Overall Study|Withdrawal by Subject|1
801264|NCT00006604|1754498|FG005|Overall Study|Withdrawal by Subject|2
801265|NCT00006604|1754499|FG006|Overall Study|Withdrawal by Subject|2
801266|NCT00006604|1754500|FG007|Overall Study|Withdrawal by Subject|0
801267|NCT00006604|1754501|FG008|Overall Study|Withdrawal by Subject|1
801268|NCT00006604|1754502|FG009|Overall Study|Withdrawal by Subject|3
801269|NCT00006604|1754503|FG010|Overall Study|Withdrawal by Subject|2
801270|NCT00006604|1754504|FG011|Overall Study|Withdrawal by Subject|0
801271|NCT00006604|1754505|FG012|Overall Study|Withdrawal by Subject|1
801272|NCT00006604|1754506|FG013|Overall Study|Withdrawal by Subject|2
801273|NCT00006604|1754507|FG014|Overall Study|Withdrawal by Subject|1
801274|NCT00006604|1754508|FG015|Overall Study|Withdrawal by Subject|0
801275|NCT00006604|1754509|FG016|Overall Study|Withdrawal by Subject|1
801276|NCT00006604|1754493|FG000|Overall Study|Subj/parent not willing to adhere to req|0
801277|NCT00006604|1754494|FG001|Overall Study|Subj/parent not willing to adhere to req|0
801278|NCT00006604|1754495|FG002|Overall Study|Subj/parent not willing to adhere to req|1
801279|NCT00006604|1754496|FG003|Overall Study|Subj/parent not willing to adhere to req|3
801280|NCT00006604|1754497|FG004|Overall Study|Subj/parent not willing to adhere to req|0
801281|NCT00006604|1754498|FG005|Overall Study|Subj/parent not willing to adhere to req|0
801282|NCT00006604|1754499|FG006|Overall Study|Subj/parent not willing to adhere to req|3
801283|NCT00006604|1754500|FG007|Overall Study|Subj/parent not willing to adhere to req|1
801284|NCT00006604|1754501|FG008|Overall Study|Subj/parent not willing to adhere to req|0
801285|NCT00006604|1754502|FG009|Overall Study|Subj/parent not willing to adhere to req|6
801286|NCT00006604|1754503|FG010|Overall Study|Subj/parent not willing to adhere to req|3
801287|NCT00006604|1754504|FG011|Overall Study|Subj/parent not willing to adhere to req|0
801288|NCT00006604|1754505|FG012|Overall Study|Subj/parent not willing to adhere to req|0
801289|NCT00006604|1754506|FG013|Overall Study|Subj/parent not willing to adhere to req|2
801290|NCT00006604|1754507|FG014|Overall Study|Subj/parent not willing to adhere to req|3
801291|NCT00006604|1754508|FG015|Overall Study|Subj/parent not willing to adhere to req|3
801292|NCT00006604|1754509|FG016|Overall Study|Subj/parent not willing to adhere to req|4
801293|NCT00006604|1754493|FG000|Overall Study|Lost to Follow-up|0
801294|NCT00006604|1754494|FG001|Overall Study|Lost to Follow-up|0
801295|NCT00006604|1754495|FG002|Overall Study|Lost to Follow-up|0
801296|NCT00006604|1754496|FG003|Overall Study|Lost to Follow-up|0
801297|NCT00006604|1754497|FG004|Overall Study|Lost to Follow-up|0
801298|NCT00006604|1754498|FG005|Overall Study|Lost to Follow-up|0
801299|NCT00006604|1754499|FG006|Overall Study|Lost to Follow-up|0
801300|NCT00006604|1754500|FG007|Overall Study|Lost to Follow-up|1
801301|NCT00006604|1754501|FG008|Overall Study|Lost to Follow-up|0
801302|NCT00006604|1754502|FG009|Overall Study|Lost to Follow-up|2
801303|NCT00006604|1754503|FG010|Overall Study|Lost to Follow-up|0
801304|NCT00006604|1754504|FG011|Overall Study|Lost to Follow-up|0
801305|NCT00006604|1754505|FG012|Overall Study|Lost to Follow-up|0
801306|NCT00006604|1754506|FG013|Overall Study|Lost to Follow-up|0
801307|NCT00006604|1754507|FG014|Overall Study|Lost to Follow-up|0
801308|NCT00006604|1754508|FG015|Overall Study|Lost to Follow-up|1
801309|NCT00006604|1754509|FG016|Overall Study|Lost to Follow-up|3
801310|NCT00006604|1754493|FG000|Overall Study|Other Reason|0
801311|NCT00006604|1754494|FG001|Overall Study|Other Reason|0
801312|NCT00006604|1754495|FG002|Overall Study|Other Reason|0
801313|NCT00006604|1754496|FG003|Overall Study|Other Reason|0
801314|NCT00006604|1754497|FG004|Overall Study|Other Reason|0
801315|NCT00006604|1754498|FG005|Overall Study|Other Reason|1
801316|NCT00006604|1754499|FG006|Overall Study|Other Reason|0
801317|NCT00006604|1754500|FG007|Overall Study|Other Reason|0
801318|NCT00006604|1754501|FG008|Overall Study|Other Reason|0
801319|NCT00006604|1754502|FG009|Overall Study|Other Reason|1
801320|NCT00006604|1754503|FG010|Overall Study|Other Reason|0
801321|NCT00006604|1754504|FG011|Overall Study|Other Reason|0
801322|NCT00006604|1754505|FG012|Overall Study|Other Reason|0
801323|NCT00006604|1754506|FG013|Overall Study|Other Reason|0
801324|NCT00006604|1754507|FG014|Overall Study|Other Reason|0
801325|NCT00006604|1754508|FG015|Overall Study|Other Reason|0
801326|NCT00006604|1754509|FG016|Overall Study|Other Reason|0
801327|NCT00006721|1754535|FG000|Overall Study|Adverse Event|0
801328|NCT00006721|1754536|FG001|Overall Study|Adverse Event|4
801329|NCT00006721|1754537|FG002|Overall Study|Adverse Event|4
801330|NCT00006721|1754535|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
801331|NCT00006721|1754536|FG001|Overall Study|Refusal Unrelated to Adverse Event|0
801332|NCT00006721|1754537|FG002|Overall Study|Refusal Unrelated to Adverse Event|8
801333|NCT00006721|1754535|FG000|Overall Study|Progression/Relapse|0
801334|NCT00006721|1754536|FG001|Overall Study|Progression/Relapse|1
801335|NCT00006721|1754537|FG002|Overall Study|Progression/Relapse|2
801336|NCT00006721|1754535|FG000|Overall Study|Death|0
801337|NCT00006721|1754536|FG001|Overall Study|Death|1
801338|NCT00006721|1754537|FG002|Overall Study|Death|2
801339|NCT00006721|1754535|FG000|Overall Study|Other - Not Protocol Specified|0
801340|NCT00006721|1754536|FG001|Overall Study|Other - Not Protocol Specified|7
801341|NCT00006721|1754537|FG002|Overall Study|Other - Not Protocol Specified|7
801342|NCT00006721|1754535|FG000|Overall Study|Ineligible|2
801343|NCT00006721|1754536|FG001|Overall Study|Ineligible|12
801344|NCT00006721|1754537|FG002|Overall Study|Ineligible|10
801345|NCT00006721|1754535|FG000|Overall Study|Eligible but no Treatment Received|1
801346|NCT00006721|1754536|FG001|Overall Study|Eligible but no Treatment Received|0
801347|NCT00006721|1754537|FG002|Overall Study|Eligible but no Treatment Received|0
801348|NCT00006903|1754549|FG000|Overall Study|Still receiving treatment|0
801349|NCT00006903|1754550|FG001|Overall Study|Still receiving treatment|0
801350|NCT00006903|1754551|FG002|Overall Study|Still receiving treatment|1
801351|NCT00006903|1754549|FG000|Overall Study|Refused further treatment|0
801352|NCT00006903|1754550|FG001|Overall Study|Refused further treatment|2
801353|NCT00006903|1754551|FG002|Overall Study|Refused further treatment|1
801354|NCT00006903|1754549|FG000|Overall Study|Adverse Event|0
801355|NCT00006903|1754550|FG001|Overall Study|Adverse Event|0
801356|NCT00006903|1754551|FG002|Overall Study|Adverse Event|1
801357|NCT00006903|1754549|FG000|Overall Study|Death|0
801358|NCT00006903|1754550|FG001|Overall Study|Death|1
801359|NCT00006903|1754551|FG002|Overall Study|Death|0
801360|NCT00006903|1754549|FG000|Overall Study|Patient never treated|0
801361|NCT00006903|1754550|FG001|Overall Study|Patient never treated|0
801362|NCT00006903|1754551|FG002|Overall Study|Patient never treated|1
801363|NCT00006903|1754549|FG000|Overall Study|Ineligible|10
801364|NCT00006903|1754550|FG001|Overall Study|Ineligible|1
801365|NCT00006903|1754551|FG002|Overall Study|Ineligible|2
801366|NCT00007020|1754559|FG000|Overall Study|Death|16
801367|NCT00007020|1754559|FG000|Overall Study|Lost to Follow-up|13
801368|NCT00007020|1754559|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1
801369|NCT00007020|1754559|FG000|Overall Study|Pt withdrawn (liver transplant)|4
801370|NCT00007020|1754559|FG000|Overall Study|Pt cared for by outside physician|4
801371|NCT00007020|1754559|FG000|Overall Study|No evidence of treatment|6
801372|NCT00007345|1754567|FG000|Overall Study|Refused further treatment|0
801373|NCT00007345|1754568|FG001|Overall Study|Refused further treatment|7
801374|NCT00007345|1754567|FG000|Overall Study|Switched to alternative treatment|0
801375|NCT00007345|1754568|FG001|Overall Study|Switched to alternative treatment|3
801376|NCT00007345|1754567|FG000|Overall Study|Intercurrent illness|1
801377|NCT00007345|1754568|FG001|Overall Study|Intercurrent illness|0
801378|NCT00007345|1754567|FG000|Overall Study|Death on study|1
801379|NCT00007345|1754568|FG001|Overall Study|Death on study|1
801380|NCT00007475|1754577|FG000|Overall Study|Withdrawal by Subject|1
801381|NCT00007475|1754578|FG001|Overall Study|Withdrawal by Subject|0
801382|NCT00007475|1754579|FG002|Overall Study|Withdrawal by Subject|0
801383|NCT00007475|1754580|FG003|Overall Study|Withdrawal by Subject|0
801384|NCT00007475|1754577|FG000|Overall Study|Adverse Event|3
801385|NCT00007475|1754578|FG001|Overall Study|Adverse Event|0
801386|NCT00007475|1754579|FG002|Overall Study|Adverse Event|0
801387|NCT00007475|1754580|FG003|Overall Study|Adverse Event|0
801388|NCT00008138|1754599|FG000|Neoadjuvant Chemotherapy|Adverse Event|3
801389|NCT00008138|1754599|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
801390|NCT00008138|1754599|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6
801391|NCT00008138|1754599|FG000|Neoadjuvant Chemotherapy|not protocol specified|8
801392|NCT00008138|1754599|FG000|Interval Debulking|Withdrawal by Subject|2
801393|NCT00008138|1754599|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6
801394|NCT00008138|1754599|FG000|Post-Cytoreduction Chemotherapy|Progression|1
801395|NCT00008138|1754599|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1
801396|NCT00008385|1754606|FG000|Overall Study|Off treatment reasons not reported|79
801397|NCT00008385|1754607|FG001|Overall Study|Off treatment reasons not reported|70
801398|NCT00008385|1754606|FG000|Overall Study|Progressive disease|52
801399|NCT00008385|1754607|FG001|Overall Study|Progressive disease|117
801400|NCT00008385|1754606|FG000|Overall Study|Adverse Event|8
801401|NCT00008385|1754607|FG001|Overall Study|Adverse Event|20
801402|NCT00008385|1754606|FG000|Overall Study|Death|12
801403|NCT00008385|1754607|FG001|Overall Study|Death|18
801404|NCT00008385|1754606|FG000|Overall Study|Withdrawal by Subject|67
801405|NCT00008385|1754607|FG001|Overall Study|Withdrawal by Subject|157
801406|NCT00008385|1754606|FG000|Overall Study|Start non-protocol therapy|3
801407|NCT00008385|1754607|FG001|Overall Study|Start non-protocol therapy|1
801408|NCT00008385|1754606|FG000|Overall Study|Other complicating disease|17
801409|NCT00008385|1754607|FG001|Overall Study|Other complicating disease|30
801410|NCT00008385|1754606|FG000|Overall Study|Maximum dose reached|0
801411|NCT00008385|1754607|FG001|Overall Study|Maximum dose reached|2
801412|NCT00008385|1754606|FG000|Overall Study|Other|105
801413|NCT00008385|1754607|FG001|Overall Study|Other|212
801414|NCT00008385|1754606|FG000|Overall Study|Not start protocol therapy|44
801415|NCT00008385|1754607|FG001|Overall Study|Not start protocol therapy|175
801416|NCT00009737|1754615|FG000|Overall Study|Adverse Event|112
801417|NCT00009737|1754616|FG001|Overall Study|Adverse Event|75
801418|NCT00009737|1754615|FG000|Overall Study|Death|4
801419|NCT00009737|1754616|FG001|Overall Study|Death|6
801420|NCT00009737|1754615|FG000|Overall Study|Lack of Efficacy|17
801421|NCT00009737|1754616|FG001|Overall Study|Lack of Efficacy|15
801422|NCT00009737|1754615|FG000|Overall Study|Violation of Selection Criteria at Entry|13
801423|NCT00009737|1754616|FG001|Overall Study|Violation of Selection Criteria at Entry|9
801424|NCT00009737|1754615|FG000|Overall Study|Other Protocol Violation|1
801425|NCT00009737|1754616|FG001|Overall Study|Other Protocol Violation|0
801426|NCT00009737|1754615|FG000|Overall Study|Refused Treatment|15
801427|NCT00009737|1754616|FG001|Overall Study|Refused Treatment|16
801428|NCT00009737|1754615|FG000|Overall Study|Lost to Follow-up|1
801429|NCT00009737|1754616|FG001|Overall Study|Lost to Follow-up|1
801430|NCT00009737|1754615|FG000|Overall Study|Administrative/Other Reasons|7
801431|NCT00009737|1754616|FG001|Overall Study|Administrative/Other Reasons|1
801432|NCT00009945|1754624|FG000|Overall Study|no follow up data|7
801433|NCT00009945|1754625|FG001|Overall Study|no follow up data|5
801434|NCT00010257|1754633|FG000|Overall Study|Withdrawal by Subject|1
801435|NCT00010257|1754634|FG001|Overall Study|Withdrawal by Subject|0
801436|NCT00010374|1754640|FG000|Overall Study|False positive phrenic nerve test|1
801437|NCT00010803|1754651|FG000|Overall Study|Withdrawal by Subject|97
801438|NCT00010803|1754652|FG001|Overall Study|Withdrawal by Subject|98
801439|NCT00012012|1754686|FG000|Overall Study|Protocol Violation|1
801440|NCT00012012|1754687|FG001|Overall Study|Protocol Violation|1
801441|NCT00012012|1754686|FG000|Overall Study|Withdrawal by Subject|0
801442|NCT00012012|1754687|FG001|Overall Study|Withdrawal by Subject|2
801443|NCT00013611|1754726|FG000|Overall Study|Lost to Follow-up|91
801444|NCT00013611|1754727|FG001|Overall Study|Lost to Follow-up|100
801445|NCT00014495|1754750|FG000|Overall Study|Death|0
801446|NCT00014495|1754751|FG001|Overall Study|Death|0
801447|NCT00014495|1754752|FG002|Overall Study|Death|1
801448|NCT00014495|1754753|FG003|Overall Study|Death|0
801449|NCT00014495|1754750|FG000|Overall Study|Clinical deterioration|0
801450|NCT00014495|1754751|FG001|Overall Study|Clinical deterioration|0
801451|NCT00014495|1754752|FG002|Overall Study|Clinical deterioration|0
801452|NCT00014495|1754753|FG003|Overall Study|Clinical deterioration|1
801453|NCT00014911|1754760|FG000|Overall Study|Adverse Event|1
801454|NCT00014911|1754760|FG000|Overall Study|Lost to Follow-up|1
801455|NCT00014911|1754760|FG000|Overall Study|Withdrawal by Subject|6
801456|NCT00014911|1754760|FG000|Overall Study|Unknown Reasons|2
801457|NCT00014911|1754760|FG000|Overall Study|Immunosuppression-related Side Effects|1
801458|NCT00015457|1754764|FG000|First Intervention|Adverse Event|0
801459|NCT00015457|1754765|FG001|First Intervention|Adverse Event|2
801460|NCT00015457|1754764|FG000|First Intervention|Lack of Efficacy|0
801461|NCT00015457|1754765|FG001|First Intervention|Lack of Efficacy|1
801462|NCT00015457|1754764|FG000|Second Intervention|Withdrawal by Subject|1
801463|NCT00015457|1754765|FG001|Second Intervention|Withdrawal by Subject|0
801464|NCT00016354|1754775|FG000|Overall Study|Lack of Efficacy|0
801465|NCT00016354|1754776|FG001|Overall Study|Lack of Efficacy|0
801466|NCT00016354|1754777|FG002|Overall Study|Lack of Efficacy|0
801467|NCT00016354|1754778|FG003|Overall Study|Lack of Efficacy|0
801468|NCT00016354|1754779|FG004|Overall Study|Lack of Efficacy|0
801469|NCT00016354|1754780|FG005|Overall Study|Lack of Efficacy|0
801470|NCT00016354|1754781|FG006|Overall Study|Lack of Efficacy|0
801471|NCT00016354|1754782|FG007|Overall Study|Lack of Efficacy|1
801472|NCT00019604|1754811|FG000|Overall Study|Death|1
801473|NCT00019604|1754811|FG000|Overall Study|Progressive disease|23
801474|NCT00019604|1754811|FG000|Overall Study|Refused treatment|1
801475|NCT00019604|1754811|FG000|Overall Study|Carcinoid tumor, not treatable|1
801476|NCT00019604|1754811|FG000|Overall Study|Going to have liver transplant|1
801477|NCT00019604|1754811|FG000|Overall Study|Move to a different study|1
801478|NCT00019604|1754811|FG000|Overall Study|Non compliant on systemic CH|1
801479|NCT00019604|1754811|FG000|Overall Study|Non compliant|1
801480|NCT00019604|1754811|FG000|Overall Study|Resectable disease|1
801481|NCT00019604|1754811|FG000|Overall Study|Started new chemo regimen|1
801482|NCT00019604|1754811|FG000|Overall Study|Pt going to immunotherapy study|1
801483|NCT00019604|1754811|FG000|Overall Study|Too much disease|1
801484|NCT00019604|1754811|FG000|Overall Study|Unable to evaluate|1
801485|NCT00019604|1754811|FG000|Overall Study|Details for other not available|4
801486|NCT00021229|1754827|FG000|Overall Study|Adverse Event|10
801487|NCT00021229|1754828|FG001|Overall Study|Adverse Event|5
801488|NCT00021229|1754829|FG002|Overall Study|Adverse Event|2
801489|NCT00021229|1754827|FG000|Overall Study|Death|0
801490|NCT00021229|1754828|FG001|Overall Study|Death|1
801491|NCT00021229|1754829|FG002|Overall Study|Death|0
801492|NCT00021229|1754827|FG000|Overall Study|Withdrawal by Subject|7
801493|NCT00021229|1754828|FG001|Overall Study|Withdrawal by Subject|7
801494|NCT00021229|1754829|FG002|Overall Study|Withdrawal by Subject|1
801495|NCT00021229|1754827|FG000|Overall Study|Progressive Disease|15
801496|NCT00021229|1754828|FG001|Overall Study|Progressive Disease|19
801497|NCT00021229|1754829|FG002|Overall Study|Progressive Disease|12
801498|NCT00021229|1754827|FG000|Overall Study|Protocol Violation|1
801499|NCT00021229|1754828|FG001|Overall Study|Protocol Violation|1
801500|NCT00021229|1754829|FG002|Overall Study|Protocol Violation|0
801501|NCT00021229|1754827|FG000|Overall Study|Physician Decision|0
801502|NCT00021229|1754828|FG001|Overall Study|Physician Decision|0
801503|NCT00021229|1754829|FG002|Overall Study|Physician Decision|1
801504|NCT00021229|1754827|FG000|Overall Study|Punctate hemmorrhage post RT|2
801505|NCT00021229|1754828|FG001|Overall Study|Punctate hemmorrhage post RT|0
801506|NCT00021229|1754829|FG002|Overall Study|Punctate hemmorrhage post RT|0
801507|NCT00021255|1754842|FG000|Overall Study|Death|1
801508|NCT00021255|1754843|FG001|Overall Study|Death|0
801509|NCT00021255|1754844|FG002|Overall Study|Death|2
801510|NCT00021255|1754842|FG000|Overall Study|Breast cancer relapse|5
801511|NCT00021255|1754843|FG001|Overall Study|Breast cancer relapse|18
801512|NCT00021255|1754844|FG002|Overall Study|Breast cancer relapse|11
801513|NCT00021255|1754842|FG000|Overall Study|Second primary malignancy|0
801514|NCT00021255|1754843|FG001|Overall Study|Second primary malignancy|4
801515|NCT00021255|1754844|FG002|Overall Study|Second primary malignancy|1
801516|NCT00021255|1754842|FG000|Overall Study|Withdrawal by Subject|41
801517|NCT00021255|1754843|FG001|Overall Study|Withdrawal by Subject|64
801518|NCT00021255|1754844|FG002|Overall Study|Withdrawal by Subject|26
801519|NCT00021255|1754842|FG000|Overall Study|Lost to Follow-up|0
801520|NCT00021255|1754843|FG001|Overall Study|Lost to Follow-up|2
801521|NCT00021255|1754844|FG002|Overall Study|Lost to Follow-up|3
801522|NCT00021255|1754842|FG000|Overall Study|Cardiac toxicity|0
801523|NCT00021255|1754843|FG001|Overall Study|Cardiac toxicity|61
801524|NCT00021255|1754844|FG002|Overall Study|Cardiac toxicity|32
801525|NCT00021255|1754842|FG000|Overall Study|Herceptin toxicity|0
801526|NCT00021255|1754843|FG001|Overall Study|Herceptin toxicity|22
801527|NCT00021255|1754844|FG002|Overall Study|Herceptin toxicity|6
801528|NCT00021255|1754842|FG000|Overall Study|Adverse Event|46
801529|NCT00021255|1754843|FG001|Overall Study|Adverse Event|30
801530|NCT00021255|1754844|FG002|Overall Study|Adverse Event|18
801531|NCT00021255|1754842|FG000|Overall Study|Protocol Violation|0
801532|NCT00021255|1754843|FG001|Overall Study|Protocol Violation|2
801533|NCT00021255|1754844|FG002|Overall Study|Protocol Violation|0
801534|NCT00021255|1754842|FG000|Overall Study|Other than specified above|0
801535|NCT00021255|1754843|FG001|Overall Study|Other than specified above|38
801536|NCT00021255|1754844|FG002|Overall Study|Other than specified above|19
801537|NCT00021255|1754842|FG000|Overall Study|Missing|0
801538|NCT00021255|1754843|FG001|Overall Study|Missing|27
801539|NCT00021255|1754844|FG002|Overall Study|Missing|13
801540|NCT00021255|1754842|FG000|Overall Study|Randomized but not treated|28
801541|NCT00021255|1754843|FG001|Overall Study|Randomized but not treated|2
801542|NCT00021255|1754844|FG002|Overall Study|Randomized but not treated|18
801543|NCT00021541|1754854|FG000|Period 1-First Treatment|Withdrawal by Subject|3
801544|NCT00021541|1754855|FG001|Period 1-First Treatment|Withdrawal by Subject|3
801545|NCT00021541|1754854|FG000|Period 1-First Treatment|Adverse Event|2
801546|NCT00021541|1754855|FG001|Period 1-First Treatment|Adverse Event|1
801547|NCT00021541|1754854|FG000|Period 1-First Treatment|non-adherence|3
801548|NCT00021541|1754855|FG001|Period 1-First Treatment|non-adherence|0
801549|NCT00021541|1754854|FG000|Period 1-First Treatment|Death|1
801550|NCT00021541|1754855|FG001|Period 1-First Treatment|Death|0
801551|NCT00021541|1754854|FG000|Period 1-First Treatment|Pts that did not progress|2
801552|NCT00021541|1754855|FG001|Period 1-First Treatment|Pts that did not progress|2
801553|NCT00021541|1754854|FG000|Period 1-First Treatment|Ineligible|0
801554|NCT00021541|1754855|FG001|Period 1-First Treatment|Ineligible|2
801555|NCT00021541|1754854|FG000|Period 2-crossover|refused phase B|2
801556|NCT00021541|1754855|FG001|Period 2-crossover|refused phase B|2
801557|NCT00021541|1754854|FG000|Period 2-crossover|Withdrawal by Subject|3
801558|NCT00021541|1754855|FG001|Period 2-crossover|Withdrawal by Subject|4
801559|NCT00021541|1754854|FG000|Period 2-crossover|Adverse Event|2
801560|NCT00021541|1754855|FG001|Period 2-crossover|Adverse Event|2
801561|NCT00021541|1754854|FG000|Period 2-crossover|non-adherence|1
801562|NCT00021541|1754855|FG001|Period 2-crossover|non-adherence|0
801563|NCT00021541|1754854|FG000|Period 2-crossover|Pts that did not progress|2
801564|NCT00021541|1754855|FG001|Period 2-crossover|Pts that did not progress|3
801565|NCT00022516|1754869|FG000|Overall Study|Adverse Event|0
801566|NCT00022516|1754870|FG001|Overall Study|Adverse Event|59
801567|NCT00022516|1754869|FG000|Overall Study|Lack of Efficacy|0
801568|NCT00022516|1754870|FG001|Overall Study|Lack of Efficacy|27
801569|NCT00022516|1754869|FG000|Overall Study|Physician Decision|0
801570|NCT00022516|1754870|FG001|Overall Study|Physician Decision|1
801571|NCT00022516|1754869|FG000|Overall Study|Protocol Violation|1
801572|NCT00022516|1754870|FG001|Overall Study|Protocol Violation|3
801573|NCT00022516|1754869|FG000|Overall Study|Withdrawal by Subject|2
801574|NCT00022516|1754870|FG001|Overall Study|Withdrawal by Subject|113
801575|NCT00022516|1754869|FG000|Overall Study|Incomplete documentation|0
801576|NCT00022516|1754870|FG001|Overall Study|Incomplete documentation|27
801577|NCT00022633|1754878|FG000|Overall Study|Adverse Event|11
801578|NCT00022633|1754879|FG001|Overall Study|Adverse Event|1
801579|NCT00022633|1754878|FG000|Overall Study|Refusal unrelated to adverse event|1
801580|NCT00022633|1754879|FG001|Overall Study|Refusal unrelated to adverse event|0
801581|NCT00022633|1754878|FG000|Overall Study|Progression/relapse|9
801582|NCT00022633|1754879|FG001|Overall Study|Progression/relapse|2
801583|NCT00022633|1754878|FG000|Overall Study|Death|4
801584|NCT00022633|1754879|FG001|Overall Study|Death|0
801585|NCT00022633|1754878|FG000|Overall Study|Other - not protocol specified|3
801586|NCT00022633|1754879|FG001|Overall Study|Other - not protocol specified|2
801587|NCT00022633|1754878|FG000|Overall Study|Ineligible|4
801588|NCT00022633|1754879|FG001|Overall Study|Ineligible|0
801589|NCT00022659|1754884|FG000|Overall Study|Ineligible: wrong primary|1
801590|NCT00022659|1754884|FG000|Overall Study|Never treated|1
801591|NCT00022672|1754894|FG000|Main Phase: 24 Months|Adverse Event|6
801592|NCT00022672|1754895|FG001|Main Phase: 24 Months|Adverse Event|0
801593|NCT00022672|1754894|FG000|Main Phase: 24 Months|Death|0
801594|NCT00022672|1754895|FG001|Main Phase: 24 Months|Death|3
801595|NCT00022672|1754894|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75
801596|NCT00022672|1754895|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91
801597|NCT00022672|1754894|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
801598|NCT00022672|1754895|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
801599|NCT00022672|1754894|FG000|Main Phase: 24 Months|Other Protocol Violation|1
801600|NCT00022672|1754895|FG001|Main Phase: 24 Months|Other Protocol Violation|0
801601|NCT00022672|1754894|FG000|Main Phase: 24 Months|Refused Treatment|3
801602|NCT00022672|1754895|FG001|Main Phase: 24 Months|Refused Treatment|4
801603|NCT00022672|1754894|FG000|Main Phase: 24 Months|Failure to Return|1
801604|NCT00022672|1754895|FG001|Main Phase: 24 Months|Failure to Return|1
801605|NCT00022672|1754894|FG000|Main Phase: 24 Months|Other|1
801606|NCT00022672|1754895|FG001|Main Phase: 24 Months|Other|0
801607|NCT00022672|1754894|FG000|Extension Phase|Adverse Event|1
801608|NCT00022672|1754895|FG001|Extension Phase|Adverse Event|3
801609|NCT00022672|1754894|FG000|Extension Phase|Death|0
801610|NCT00022672|1754895|FG001|Extension Phase|Death|1
801611|NCT00022672|1754894|FG000|Extension Phase|Insufficient Therapeutic Response|1
801612|NCT00022672|1754895|FG001|Extension Phase|Insufficient Therapeutic Response|44
801613|NCT00022672|1754894|FG000|Extension Phase|Refused Treatment|0
801614|NCT00022672|1754895|FG001|Extension Phase|Refused Treatment|2
801615|NCT00022672|1754894|FG000|Extension Phase|Other|1
801616|NCT00022672|1754895|FG001|Extension Phase|Other|1
801617|NCT00022698|1754904|FG000|Overall Study|Adverse Event|5
801618|NCT00022698|1754905|FG001|Overall Study|Adverse Event|9
801619|NCT00022698|1754904|FG000|Overall Study|Death|0
801620|NCT00022698|1754905|FG001|Overall Study|Death|2
801621|NCT00022698|1754904|FG000|Overall Study|Failure to return|0
801622|NCT00022698|1754905|FG001|Overall Study|Failure to return|1
801623|NCT00022698|1754904|FG000|Overall Study|Refused treatment|0
801624|NCT00022698|1754905|FG001|Overall Study|Refused treatment|2
801625|NCT00022698|1754904|FG000|Overall Study|Insufficient therapeutic response|2
801626|NCT00022698|1754905|FG001|Overall Study|Insufficient therapeutic response|14
801627|NCT00022698|1754904|FG000|Overall Study|Administrative /other|1
801628|NCT00022698|1754905|FG001|Overall Study|Administrative /other|7
801629|NCT00022763|1754915|FG000|Overall Study|Adverse Event|1
801630|NCT00022763|1754916|FG001|Overall Study|Adverse Event|2
801631|NCT00022763|1754915|FG000|Overall Study|Injection Site Reactions|0
801632|NCT00022763|1754916|FG001|Overall Study|Injection Site Reactions|2
801633|NCT00022763|1754915|FG000|Overall Study|Death|0
801634|NCT00022763|1754916|FG001|Overall Study|Death|1
801635|NCT00022763|1754915|FG000|Overall Study|Lost to Follow-up|0
801636|NCT00022763|1754916|FG001|Overall Study|Lost to Follow-up|3
801637|NCT00022763|1754915|FG000|Overall Study|Withdrawal by Subject|4
801638|NCT00022763|1754916|FG001|Overall Study|Withdrawal by Subject|7
801639|NCT00022763|1754915|FG000|Overall Study|Insufficient Therapy|1
801640|NCT00022763|1754916|FG001|Overall Study|Insufficient Therapy|0
801641|NCT00022763|1754915|FG000|Overall Study|Admin|3
801642|NCT00022763|1754916|FG001|Overall Study|Admin|2
801643|NCT00023322|1754930|FG000|Overall Study|Lost to Follow-up|1
801644|NCT00023452|1754936|FG000|Overall Study|Ineligible for Study|163
801645|NCT00023452|1754937|FG001|Overall Study|Ineligible for Study|159
801646|NCT00023452|1754936|FG000|Overall Study|Out of Window|129
801647|NCT00023452|1754937|FG001|Overall Study|Out of Window|69
801648|NCT00023452|1754936|FG000|Overall Study|Death|2
801649|NCT00023452|1754937|FG001|Overall Study|Death|0
801650|NCT00023452|1754936|FG000|Overall Study|Withdrawal by Subject|66
801651|NCT00023452|1754937|FG001|Overall Study|Withdrawal by Subject|54
801652|NCT00023452|1754936|FG000|Overall Study|Adverse Event|139
801653|NCT00023452|1754937|FG001|Overall Study|Adverse Event|196
801654|NCT00023452|1754936|FG000|Overall Study|Lost to Follow-up|293
801655|NCT00023452|1754937|FG001|Overall Study|Lost to Follow-up|60
801656|NCT00023452|1754936|FG000|Overall Study|Physician Decision|49
801657|NCT00023452|1754937|FG001|Overall Study|Physician Decision|21
801658|NCT00023452|1754936|FG000|Overall Study|Refused Treatment (continued follow-up)|225
801659|NCT00023452|1754937|FG001|Overall Study|Refused Treatment (continued follow-up)|224
801660|NCT00023452|1754936|FG000|Overall Study|Pregnant|53
801661|NCT00023452|1754937|FG001|Overall Study|Pregnant|20
801662|NCT00023452|1754936|FG000|Overall Study|Other|204
801663|NCT00023452|1754937|FG001|Overall Study|Other|69
801664|NCT00023595|1754952|FG000|5 Year Follow up|Lost to Follow-up|2
801665|NCT00023595|1754953|FG001|5 Year Follow up|Lost to Follow-up|2
801666|NCT00023595|1754954|FG002|5 Year Follow up|Lost to Follow-up|1
801667|NCT00023595|1754955|FG003|5 Year Follow up|Lost to Follow-up|7
801668|NCT00023595|1754956|FG004|5 Year Follow up|Lost to Follow-up|3
801669|NCT00023595|1754952|FG000|10 Year Follow up|Lost to Follow-up|12
801670|NCT00023595|1754953|FG001|10 Year Follow up|Lost to Follow-up|10
801671|NCT00023595|1754954|FG002|10 Year Follow up|Lost to Follow-up|3
801672|NCT00023595|1754955|FG003|10 Year Follow up|Lost to Follow-up|0
801673|NCT00023595|1754956|FG004|10 Year Follow up|Lost to Follow-up|0
801674|NCT00023673|1754982|FG000|Overall Study|Ineligible / no protocol treatment|0
801675|NCT00023673|1754983|FG001|Overall Study|Ineligible / no protocol treatment|0
801676|NCT00023673|1754984|FG002|Overall Study|Ineligible / no protocol treatment|0
801677|NCT00023673|1754985|FG003|Overall Study|Ineligible / no protocol treatment|1
801678|NCT00023673|1754982|FG000|Overall Study|Patient withdrew consent|0
801679|NCT00023673|1754983|FG001|Overall Study|Patient withdrew consent|0
801680|NCT00023673|1754984|FG002|Overall Study|Patient withdrew consent|0
801681|NCT00023673|1754985|FG003|Overall Study|Patient withdrew consent|1
801682|NCT00023712|1754997|FG000|Overall Study|Not platinum sensitive|1
801683|NCT00023712|1754998|FG001|Overall Study|Not platinum sensitive|0
801684|NCT00023712|1754997|FG000|Overall Study|Never treated|1
801685|NCT00023712|1754998|FG001|Overall Study|Never treated|1
801686|NCT00023764|1755014|FG000|Overall Study|Other|1
801687|NCT00023764|1755014|FG000|Overall Study|Adverse Event|4
801688|NCT00023764|1755014|FG000|Overall Study|Withdrawal by Subject|1
801689|NCT00023764|1755014|FG000|Overall Study|Progression of disease|6
801690|NCT00023764|1755014|FG000|Overall Study|patient received other treatment|1
801691|NCT00023764|1755014|FG000|Overall Study|delay in obtaining staging images|1
801692|NCT00024167|1755035|FG000|Overall Study|Death|53
801693|NCT00024167|1755036|FG001|Overall Study|Death|47
801694|NCT00024258|1755043|FG000|Overall Study|Withdrawal by Subject|1
801695|NCT00024258|1755043|FG000|Overall Study|Disease Progression|8
801696|NCT00025155|1755047|FG000|Overall Study|Ineligible: Wrong primary cancer site|1
801697|NCT00025155|1755047|FG000|Overall Study|Ineligible: Second primary cancer site|1
801698|NCT00025233|1755056|FG000|Overall Study|Ineligible: wrong cell type|1
801699|NCT00025233|1755056|FG000|Overall Study|Ineligible: wrong primary|1
801700|NCT00025233|1755056|FG000|Overall Study|Ineligible: improper prior treatment|1
801701|NCT00025233|1755056|FG000|Overall Study|Never treated|1
801702|NCT00025259|1755073|FG000|Overall Study|Death|1
801703|NCT00025259|1755074|FG001|Overall Study|Death|3
801704|NCT00025259|1755075|FG002|Overall Study|Death|0
801705|NCT00025259|1755076|FG003|Overall Study|Death|3
801706|NCT00025259|1755077|FG004|Overall Study|Death|0
801707|NCT00025259|1755078|FG005|Overall Study|Death|1
801708|NCT00025259|1755079|FG006|Overall Study|Death|2
801709|NCT00025259|1755073|FG000|Overall Study|Lack of Efficacy|2
801710|NCT00025259|1755074|FG001|Overall Study|Lack of Efficacy|46
801711|NCT00025259|1755075|FG002|Overall Study|Lack of Efficacy|60
801712|NCT00025259|1755076|FG003|Overall Study|Lack of Efficacy|78
801713|NCT00025259|1755077|FG004|Overall Study|Lack of Efficacy|11
801714|NCT00025259|1755078|FG005|Overall Study|Lack of Efficacy|30
801715|NCT00025259|1755079|FG006|Overall Study|Lack of Efficacy|38
801716|NCT00025259|1755073|FG000|Overall Study|Lost to Follow-up|2
801717|NCT00025259|1755074|FG001|Overall Study|Lost to Follow-up|9
801718|NCT00025259|1755075|FG002|Overall Study|Lost to Follow-up|13
801719|NCT00025259|1755076|FG003|Overall Study|Lost to Follow-up|13
801720|NCT00025259|1755077|FG004|Overall Study|Lost to Follow-up|1
801721|NCT00025259|1755078|FG005|Overall Study|Lost to Follow-up|3
801722|NCT00025259|1755079|FG006|Overall Study|Lost to Follow-up|1
801723|NCT00025259|1755073|FG000|Overall Study|Physician Decision|12
801724|NCT00025259|1755074|FG001|Overall Study|Physician Decision|1
801725|NCT00025259|1755075|FG002|Overall Study|Physician Decision|0
801726|NCT00025259|1755076|FG003|Overall Study|Physician Decision|5
801727|NCT00025259|1755077|FG004|Overall Study|Physician Decision|4
801728|NCT00025259|1755078|FG005|Overall Study|Physician Decision|2
801729|NCT00025259|1755079|FG006|Overall Study|Physician Decision|1
801730|NCT00025259|1755073|FG000|Overall Study|Protocol Violation|3
801731|NCT00025259|1755074|FG001|Overall Study|Protocol Violation|2
801732|NCT00025259|1755075|FG002|Overall Study|Protocol Violation|2
801733|NCT00025259|1755076|FG003|Overall Study|Protocol Violation|1
801734|NCT00025259|1755077|FG004|Overall Study|Protocol Violation|2
801735|NCT00025259|1755078|FG005|Overall Study|Protocol Violation|1
801736|NCT00025259|1755079|FG006|Overall Study|Protocol Violation|3
801737|NCT00025259|1755073|FG000|Overall Study|Withdrawal by Subject|9
801738|NCT00025259|1755074|FG001|Overall Study|Withdrawal by Subject|27
801739|NCT00025259|1755075|FG002|Overall Study|Withdrawal by Subject|6
801740|NCT00025259|1755076|FG003|Overall Study|Withdrawal by Subject|14
801741|NCT00025259|1755077|FG004|Overall Study|Withdrawal by Subject|11
801742|NCT00025259|1755078|FG005|Overall Study|Withdrawal by Subject|8
801743|NCT00025259|1755079|FG006|Overall Study|Withdrawal by Subject|3
801744|NCT00025259|1755073|FG000|Overall Study|Ineligible|14
801745|NCT00025259|1755074|FG001|Overall Study|Ineligible|1
801746|NCT00025259|1755075|FG002|Overall Study|Ineligible|0
801747|NCT00025259|1755076|FG003|Overall Study|Ineligible|0
801748|NCT00025259|1755077|FG004|Overall Study|Ineligible|6
801749|NCT00025259|1755078|FG005|Overall Study|Ineligible|0
801750|NCT00025259|1755079|FG006|Overall Study|Ineligible|1
801751|NCT00025259|1755073|FG000|Overall Study|Randomization error|1
801752|NCT00025259|1755074|FG001|Overall Study|Randomization error|0
801753|NCT00025259|1755075|FG002|Overall Study|Randomization error|0
801754|NCT00025259|1755076|FG003|Overall Study|Randomization error|0
801755|NCT00025259|1755077|FG004|Overall Study|Randomization error|1
801756|NCT00025259|1755078|FG005|Overall Study|Randomization error|7
801757|NCT00025259|1755079|FG006|Overall Study|Randomization error|2
801758|NCT00025259|1755073|FG000|Overall Study|Adverse Event|1
801759|NCT00025259|1755074|FG001|Overall Study|Adverse Event|0
801760|NCT00025259|1755075|FG002|Overall Study|Adverse Event|0
801761|NCT00025259|1755076|FG003|Overall Study|Adverse Event|0
801762|NCT00025259|1755077|FG004|Overall Study|Adverse Event|0
801763|NCT00025259|1755078|FG005|Overall Study|Adverse Event|0
801764|NCT00025259|1755079|FG006|Overall Study|Adverse Event|0
801765|NCT00025506|1755098|FG000|Overall Study|Ineligible: clerical error|1
801766|NCT00025506|1755098|FG000|Overall Study|Ineligible: wrong cell type|5
801767|NCT00025506|1755098|FG000|Overall Study|Ineligible: inadequate pathology|2
801768|NCT00025506|1755098|FG000|Overall Study|Never Treated|2
801769|NCT00025662|1755107|FG000|Overall Study|Withdrawal by Subject|2
801770|NCT00025662|1755107|FG000|Overall Study|Technical failure of manipulation|1
801771|NCT00025883|1755113|FG000|Overall Study|had atypical progeriod lipodystrophy|4
801772|NCT00025883|1755113|FG000|Overall Study|no baseline data|1
801773|NCT00025883|1755113|FG000|Overall Study|Death|1
801774|NCT00025883|1755113|FG000|Overall Study|Adverse Event|1
801775|NCT00025883|1755113|FG000|Overall Study|didn't reach 6 months of Metreleptin|10
801776|NCT00026208|1755120|FG000|Overall Study|Complications of auto accident|1
801777|NCT00026208|1755121|FG001|Overall Study|Complications of auto accident|0
801778|NCT00026312|1755142|FG000|Overall Study|Adverse Event|0
801779|NCT00026312|1755143|FG001|Overall Study|Adverse Event|32
801780|NCT00026312|1755142|FG000|Overall Study|Death|1
801781|NCT00026312|1755143|FG001|Overall Study|Death|7
801782|NCT00026312|1755142|FG000|Overall Study|Lack of Efficacy|19
801783|NCT00026312|1755143|FG001|Overall Study|Lack of Efficacy|114
801784|NCT00026312|1755142|FG000|Overall Study|Lost to Follow-up|0
801785|NCT00026312|1755143|FG001|Overall Study|Lost to Follow-up|5
801786|NCT00026312|1755142|FG000|Overall Study|Physician Decision|1
801787|NCT00026312|1755143|FG001|Overall Study|Physician Decision|37
801788|NCT00026312|1755142|FG000|Overall Study|Protocol Violation|0
801789|NCT00026312|1755143|FG001|Overall Study|Protocol Violation|3
801790|NCT00026312|1755142|FG000|Overall Study|Withdrawal by Subject|1
801791|NCT00026312|1755143|FG001|Overall Study|Withdrawal by Subject|6
801792|NCT00026312|1755142|FG000|Overall Study|Ineligible|4
801793|NCT00026312|1755143|FG001|Overall Study|Ineligible|5
801794|NCT00026312|1755142|FG000|Overall Study|Entry onto another COG study|0
801795|NCT00026312|1755143|FG001|Overall Study|Entry onto another COG study|1
801796|NCT00026312|1755142|FG000|Overall Study|Refusal by patient/parent/guardian|8
801797|NCT00026312|1755143|FG001|Overall Study|Refusal by patient/parent/guardian|59
801798|NCT00026494|1755157|FG000|Overall Study|Withdrawal by Subject|1
801799|NCT00026494|1755158|FG001|Overall Study|Withdrawal by Subject|0
801800|NCT00026494|1755159|FG002|Overall Study|Withdrawal by Subject|1
801801|NCT00026494|1755160|FG003|Overall Study|Withdrawal by Subject|0
801802|NCT00026494|1755157|FG000|Overall Study|Patient non-compliance|1
801803|NCT00026494|1755158|FG001|Overall Study|Patient non-compliance|0
801804|NCT00026494|1755159|FG002|Overall Study|Patient non-compliance|0
801805|NCT00026494|1755160|FG003|Overall Study|Patient non-compliance|0
801806|NCT00026494|1755157|FG000|Overall Study|Patient not treated|0
801807|NCT00026494|1755158|FG001|Overall Study|Patient not treated|0
801808|NCT00026494|1755159|FG002|Overall Study|Patient not treated|2
801809|NCT00026494|1755160|FG003|Overall Study|Patient not treated|0
801810|NCT00026494|1755157|FG000|Overall Study|Clinical progression|0
801811|NCT00026494|1755158|FG001|Overall Study|Clinical progression|0
801812|NCT00026494|1755159|FG002|Overall Study|Clinical progression|3
801813|NCT00026494|1755160|FG003|Overall Study|Clinical progression|0
801814|NCT00026793|1755170|FG000|Overall Study|Death on study due to underlying disease|4
801815|NCT00026793|1755170|FG000|Overall Study|Physician Decision|2
801816|NCT00026793|1755170|FG000|Overall Study|Off study|2
801817|NCT00027027|1755179|FG000|Overall Study|Adverse Event|0
801818|NCT00027027|1755180|FG001|Overall Study|Adverse Event|0
801819|NCT00027027|1755181|FG002|Overall Study|Adverse Event|1
801820|NCT00027027|1755182|FG003|Overall Study|Adverse Event|0
801821|NCT00027027|1755183|FG004|Overall Study|Adverse Event|1
801822|NCT00027027|1755179|FG000|Overall Study|Admitted for Signs of PD|0
801823|NCT00027027|1755180|FG001|Overall Study|Admitted for Signs of PD|0
801824|NCT00027027|1755181|FG002|Overall Study|Admitted for Signs of PD|0
801825|NCT00027027|1755182|FG003|Overall Study|Admitted for Signs of PD|0
801826|NCT00027027|1755183|FG004|Overall Study|Admitted for Signs of PD|1
801827|NCT00027027|1755179|FG000|Overall Study|Clinical Symptoms Progression not PD|1
801828|NCT00027027|1755180|FG001|Overall Study|Clinical Symptoms Progression not PD|0
801829|NCT00027027|1755181|FG002|Overall Study|Clinical Symptoms Progression not PD|0
801830|NCT00027027|1755182|FG003|Overall Study|Clinical Symptoms Progression not PD|0
801831|NCT00027027|1755183|FG004|Overall Study|Clinical Symptoms Progression not PD|0
801832|NCT00027027|1755179|FG000|Overall Study|PD Requiring Surgery|0
801833|NCT00027027|1755180|FG001|Overall Study|PD Requiring Surgery|0
801834|NCT00027027|1755181|FG002|Overall Study|PD Requiring Surgery|1
801835|NCT00027027|1755182|FG003|Overall Study|PD Requiring Surgery|0
801836|NCT00027027|1755183|FG004|Overall Study|PD Requiring Surgery|0
801837|NCT00027027|1755179|FG000|Overall Study|Physician Decision Due To PD|2
801838|NCT00027027|1755180|FG001|Overall Study|Physician Decision Due To PD|3
801839|NCT00027027|1755181|FG002|Overall Study|Physician Decision Due To PD|2
801840|NCT00027027|1755182|FG003|Overall Study|Physician Decision Due To PD|3
801841|NCT00027027|1755183|FG004|Overall Study|Physician Decision Due To PD|5
801842|NCT00027027|1755179|FG000|Overall Study|Withdrawal by Subject|0
801843|NCT00027027|1755180|FG001|Overall Study|Withdrawal by Subject|0
801844|NCT00027027|1755181|FG002|Overall Study|Withdrawal by Subject|0
801845|NCT00027027|1755182|FG003|Overall Study|Withdrawal by Subject|0
801846|NCT00027027|1755183|FG004|Overall Study|Withdrawal by Subject|1
801847|NCT00027378|1755201|FG000|Overall Study|Physician Decision|0
801848|NCT00027378|1755202|FG001|Overall Study|Physician Decision|3
801849|NCT00027560|1755208|FG000|Overall Study|Withdrawal by Subject|1
801850|NCT00027846|1755217|FG000|Overall Study|Lost to Follow-up|0
801851|NCT00027846|1755218|FG001|Overall Study|Lost to Follow-up|41
801852|NCT00027846|1755219|FG002|Overall Study|Lost to Follow-up|9
801853|NCT00027846|1755217|FG000|Overall Study|Withdrawal by Subject|0
801854|NCT00027846|1755218|FG001|Overall Study|Withdrawal by Subject|14
801855|NCT00027846|1755219|FG002|Overall Study|Withdrawal by Subject|7
801856|NCT00027846|1755217|FG000|Overall Study|Ineligible for study|2
801857|NCT00027846|1755218|FG001|Overall Study|Ineligible for study|6
801858|NCT00027846|1755219|FG002|Overall Study|Ineligible for study|14
801859|NCT00027846|1755217|FG000|Overall Study|Entry into another COG therapeutic study|0
801860|NCT00027846|1755218|FG001|Overall Study|Entry into another COG therapeutic study|5
801861|NCT00027846|1755219|FG002|Overall Study|Entry into another COG therapeutic study|2
801862|NCT00027846|1755217|FG000|Overall Study|Neuraxis dissemination during/after ther|0
801863|NCT00027846|1755218|FG001|Overall Study|Neuraxis dissemination during/after ther|2
801864|NCT00027846|1755219|FG002|Overall Study|Neuraxis dissemination during/after ther|5
801865|NCT00028002|1755229|FG000|Overall Study|Withdrawal by Subject|3
801866|NCT00028002|1755229|FG000|Overall Study|Ineligible|8
801867|NCT00028769|1755247|FG000|Overall Study|Adverse Event|2
801868|NCT00028769|1755247|FG000|Overall Study|Refusal Unrelated to Adverse Events|1
801869|NCT00028769|1755247|FG000|Overall Study|Progression or Death|31
801870|NCT00028769|1755247|FG000|Overall Study|Other - Not Protocol Specified|1
801871|NCT00028769|1755247|FG000|Overall Study|Ineligible|5
801872|NCT00028769|1755247|FG000|Overall Study|Not Analyzable|1
801873|NCT00029146|1755262|FG000|Overall Study|Lost to Follow-up|2
801874|NCT00029146|1755263|FG001|Overall Study|Lost to Follow-up|1
801875|NCT00030823|1755313|FG000|Overall Study|Withdrawal by Subject|1
801876|NCT00030901|1755319|FG000|Initial Registration|Ineligible|167
801877|NCT00030901|1755320|FG001|Initial Registration|Ineligible|0
801878|NCT00030901|1755321|FG002|Initial Registration|Ineligible|0
801879|NCT00030901|1755319|FG000|Randomization|Adverse Event|0
801880|NCT00030901|1755320|FG001|Randomization|Adverse Event|11
801881|NCT00030901|1755321|FG002|Randomization|Adverse Event|7
801882|NCT00030901|1755319|FG000|Randomization|Refusal Unrelated to Adverse Event|0
801883|NCT00030901|1755320|FG001|Randomization|Refusal Unrelated to Adverse Event|16
801884|NCT00030901|1755321|FG002|Randomization|Refusal Unrelated to Adverse Event|10
801885|NCT00030901|1755319|FG000|Randomization|Progression/Relapse|0
801886|NCT00030901|1755320|FG001|Randomization|Progression/Relapse|22
801887|NCT00030901|1755321|FG002|Randomization|Progression/Relapse|21
801888|NCT00030901|1755319|FG000|Randomization|Death|0
801889|NCT00030901|1755320|FG001|Randomization|Death|1
801890|NCT00030901|1755321|FG002|Randomization|Death|3
801891|NCT00030901|1755319|FG000|Randomization|Other|0
801892|NCT00030901|1755320|FG001|Randomization|Other|36
801893|NCT00030901|1755321|FG002|Randomization|Other|33
801894|NCT00030901|1755319|FG000|Randomization|Ineligible|0
801895|NCT00030901|1755320|FG001|Randomization|Ineligible|15
801896|NCT00030901|1755321|FG002|Randomization|Ineligible|14
801897|NCT00031447|1755333|FG000|Overall Study|Lost to Follow-up|0
801898|NCT00031447|1755334|FG001|Overall Study|Lost to Follow-up|1
801899|NCT00031447|1755333|FG000|Overall Study|Non-compliant|1
801900|NCT00031447|1755334|FG001|Overall Study|Non-compliant|1
801901|NCT00031447|1755333|FG000|Overall Study|Re-activation of Disease|2
801902|NCT00031447|1755334|FG001|Overall Study|Re-activation of Disease|1
801903|NCT00031447|1755333|FG000|Overall Study|Disruption of blinded study drug supply|7
801904|NCT00031447|1755334|FG001|Overall Study|Disruption of blinded study drug supply|4
801905|NCT00031460|1755342|FG000|Overall Study|Lost to Follow-up|0
801906|NCT00031460|1755343|FG001|Overall Study|Lost to Follow-up|1
801907|NCT00031460|1755342|FG000|Overall Study|Withdrawal by Subject|1
801908|NCT00031460|1755343|FG001|Overall Study|Withdrawal by Subject|1
801909|NCT00031460|1755342|FG000|Overall Study|Non-Compliant|1
801910|NCT00031460|1755343|FG001|Overall Study|Non-Compliant|1
801911|NCT00031460|1755342|FG000|Overall Study|Death|0
801912|NCT00031460|1755343|FG001|Overall Study|Death|1
801913|NCT00031460|1755342|FG000|Overall Study|Reactivation of Disease|5
801914|NCT00031460|1755343|FG001|Overall Study|Reactivation of Disease|9
801915|NCT00031460|1755342|FG000|Overall Study|Disruption of blinded drug supply|2
801916|NCT00031460|1755343|FG001|Overall Study|Disruption of blinded drug supply|0
801917|NCT00031460|1755342|FG000|Overall Study|Confirmed unevaluable|0
801918|NCT00031460|1755343|FG001|Overall Study|Confirmed unevaluable|1
801919|NCT00031486|1755351|FG000|Overall Study|Adverse Event|1
801920|NCT00031486|1755352|FG001|Overall Study|Adverse Event|0
801921|NCT00031486|1755351|FG000|Overall Study|Lost to Follow-up|0
801922|NCT00031486|1755352|FG001|Overall Study|Lost to Follow-up|1
801923|NCT00031486|1755351|FG000|Overall Study|Withdrawal by Subject|3
801924|NCT00031486|1755352|FG001|Overall Study|Withdrawal by Subject|2
801925|NCT00031486|1755351|FG000|Overall Study|Death|0
801926|NCT00031486|1755352|FG001|Overall Study|Death|3
801927|NCT00031486|1755351|FG000|Overall Study|Non-compliant|0
801928|NCT00031486|1755352|FG001|Overall Study|Non-compliant|4
801929|NCT00031486|1755351|FG000|Overall Study|Did not meet eligibility requirement|2
801930|NCT00031486|1755352|FG001|Overall Study|Did not meet eligibility requirement|1
801931|NCT00031486|1755351|FG000|Overall Study|Other|1
801932|NCT00031486|1755352|FG001|Overall Study|Other|1
801933|NCT00031551|1755362|FG000|Overall Study|Withdrew due to chemotherapy effects|2
801934|NCT00031551|1755363|FG001|Overall Study|Withdrew due to chemotherapy effects|0
801935|NCT00031590|1755373|FG000|Overall Study|Adverse Event|1
801936|NCT00031590|1755373|FG000|Overall Study|Withdrawal by parents|2
801937|NCT00031694|1755378|FG000|Overall Study|Adverse Event|12
801938|NCT00031694|1755378|FG000|Overall Study|Death|2
801939|NCT00031694|1755378|FG000|Overall Study|Withdrawal by Subject|5
801940|NCT00032487|1755385|FG000|Overall Study|Withdrawal by Subject|67
801941|NCT00032487|1755386|FG001|Overall Study|Withdrawal by Subject|43
801942|NCT00032487|1755385|FG000|Overall Study|Adverse Event|3
801943|NCT00032487|1755386|FG001|Overall Study|Adverse Event|7
801944|NCT00032487|1755385|FG000|Overall Study|Lost to Follow-up|57
801945|NCT00032487|1755386|FG001|Overall Study|Lost to Follow-up|58
801946|NCT00032487|1755385|FG000|Overall Study|Had other reason|12
801947|NCT00032487|1755386|FG001|Overall Study|Had other reason|12
801962|NCT00033371|1755423|FG000|Overall Study|Adverse Event|1
801963|NCT00033371|1755424|FG001|Overall Study|Adverse Event|5
801964|NCT00033371|1755423|FG000|Overall Study|Lost to Follow-up|2
801965|NCT00033371|1755424|FG001|Overall Study|Lost to Follow-up|1
801966|NCT00033371|1755423|FG000|Overall Study|Withdrawal by Subject|3
801967|NCT00033371|1755424|FG001|Overall Study|Withdrawal by Subject|3
801968|NCT00033371|1755423|FG000|Overall Study|Disease Progression|0
801969|NCT00033371|1755424|FG001|Overall Study|Disease Progression|1
801970|NCT00033514|1755436|FG000|Overall Study|Lost to Follow-up|1
801971|NCT00033514|1755437|FG001|Overall Study|Lost to Follow-up|1
801972|NCT00033514|1755436|FG000|Overall Study|Withdrawal by Subject|0
801973|NCT00033514|1755437|FG001|Overall Study|Withdrawal by Subject|3
801974|NCT00033540|1755444|FG000|Overall Study|Adverse Event|14
801975|NCT00033540|1755444|FG000|Overall Study|Death|1
801976|NCT00033540|1755444|FG000|Overall Study|Progression|26
801977|NCT00033540|1755444|FG000|Overall Study|Withdrawal by Subject|6
801978|NCT00033540|1755444|FG000|Overall Study|Other|5
801979|NCT00033540|1755444|FG000|Overall Study|Ineligible|3
801980|NCT00033540|1755444|FG000|Overall Study|Never received treatment|2
801981|NCT00033631|1755451|FG000|Overall Study|Protocol Violation|14
801982|NCT00033631|1755452|FG001|Overall Study|Protocol Violation|11
801983|NCT00033631|1755451|FG000|Overall Study|Withdrawal by Subject|4
801984|NCT00033631|1755452|FG001|Overall Study|Withdrawal by Subject|4
801985|NCT00033657|1755461|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1
801986|NCT00033657|1755462|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2
801987|NCT00033657|1755461|FG000|Neoadjuvant Chemotherapy|Adverse Event|0
801988|NCT00033657|1755462|FG001|Neoadjuvant Chemotherapy|Adverse Event|2
801989|NCT00033657|1755461|FG000|Neoadjuvant Chemotherapy|Death|1
801990|NCT00033657|1755462|FG001|Neoadjuvant Chemotherapy|Death|1
801991|NCT00033657|1755461|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
801992|NCT00033657|1755462|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
801993|NCT00033657|1755461|FG000|Neoadjuvant Chemotherapy|other complicating disease|0
801994|NCT00033657|1755462|FG001|Neoadjuvant Chemotherapy|other complicating disease|1
801995|NCT00033657|1755461|FG000|Neoadjuvant Chemotherapy|Ineligible|8
801996|NCT00033657|1755462|FG001|Neoadjuvant Chemotherapy|Ineligible|4
801997|NCT00033657|1755461|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3
801998|NCT00033657|1755462|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1
801999|NCT00033657|1755461|FG000|Surgical Resection|not complete resection|0
802000|NCT00033657|1755462|FG001|Surgical Resection|not complete resection|3
802001|NCT00033657|1755461|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3
802002|NCT00033657|1755462|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1
802003|NCT00033657|1755461|FG000|Adjuvant Chemotherapy|Adverse Event|7
802004|NCT00033657|1755462|FG001|Adjuvant Chemotherapy|Adverse Event|10
802005|NCT00033657|1755461|FG000|Adjuvant Chemotherapy|Death|2
802006|NCT00033657|1755462|FG001|Adjuvant Chemotherapy|Death|1
802007|NCT00033657|1755461|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5
802008|NCT00033657|1755462|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3
802009|NCT00033657|1755461|FG000|Adjuvant Chemotherapy|alternative therapy|1
802010|NCT00033657|1755462|FG001|Adjuvant Chemotherapy|alternative therapy|0
802011|NCT00033657|1755461|FG000|Adjuvant Chemotherapy|Other|0
802012|NCT00033657|1755462|FG001|Adjuvant Chemotherapy|Other|2
802013|NCT00035555|1755486|FG000|Overall Study|Adverse Event|5
802014|NCT00035555|1755487|FG001|Overall Study|Adverse Event|8
802015|NCT00035555|1755488|FG002|Overall Study|Adverse Event|9
802016|NCT00035555|1755486|FG000|Overall Study|Allograft loss|1
802017|NCT00035555|1755487|FG001|Overall Study|Allograft loss|1
802018|NCT00035555|1755488|FG002|Overall Study|Allograft loss|2
802019|NCT00035555|1755486|FG000|Overall Study|Death|0
802020|NCT00035555|1755487|FG001|Overall Study|Death|0
802021|NCT00035555|1755488|FG002|Overall Study|Death|2
802022|NCT00035555|1755486|FG000|Overall Study|Lost to Follow-up|0
802023|NCT00035555|1755487|FG001|Overall Study|Lost to Follow-up|0
802024|NCT00035555|1755488|FG002|Overall Study|Lost to Follow-up|1
802025|NCT00035555|1755486|FG000|Overall Study|Noncompliance|0
802026|NCT00035555|1755487|FG001|Overall Study|Noncompliance|1
802027|NCT00035555|1755488|FG002|Overall Study|Noncompliance|1
802028|NCT00035555|1755486|FG000|Overall Study|Prohibited medication|1
802029|NCT00035555|1755487|FG001|Overall Study|Prohibited medication|1
802030|NCT00035555|1755488|FG002|Overall Study|Prohibited medication|0
802031|NCT00035555|1755486|FG000|Overall Study|Treatment failure/lack of efficacy|7
802032|NCT00035555|1755487|FG001|Overall Study|Treatment failure/lack of efficacy|5
802033|NCT00035555|1755488|FG002|Overall Study|Treatment failure/lack of efficacy|3
802034|NCT00035555|1755486|FG000|Overall Study|Withdrawal by Subject|2
802035|NCT00035555|1755487|FG001|Overall Study|Withdrawal by Subject|0
802036|NCT00035555|1755488|FG002|Overall Study|Withdrawal by Subject|2
802037|NCT00035555|1755486|FG000|Overall Study|Investigator deemed not a good candidate|0
802038|NCT00035555|1755487|FG001|Overall Study|Investigator deemed not a good candidate|0
802039|NCT00035555|1755488|FG002|Overall Study|Investigator deemed not a good candidate|1
802040|NCT00035555|1755486|FG000|Overall Study|Received cyclosporin in error|0
802041|NCT00035555|1755487|FG001|Overall Study|Received cyclosporin in error|0
802042|NCT00035555|1755488|FG002|Overall Study|Received cyclosporin in error|1
802043|NCT00035815|1755499|FG000|Overall Study|Withdrawal by Subject|17
802044|NCT00035815|1755500|FG001|Overall Study|Withdrawal by Subject|11
802045|NCT00035932|1755509|FG000|Overall Study|Adverse Event|10
802046|NCT00035932|1755510|FG001|Overall Study|Adverse Event|9
802047|NCT00035932|1755511|FG002|Overall Study|Adverse Event|9
802048|NCT00035932|1755509|FG000|Overall Study|Death|0
802049|NCT00035932|1755510|FG001|Overall Study|Death|0
802050|NCT00035932|1755511|FG002|Overall Study|Death|1
802051|NCT00035932|1755509|FG000|Overall Study|Disease Progression / Relapse|1
802052|NCT00035932|1755510|FG001|Overall Study|Disease Progression / Relapse|1
802053|NCT00035932|1755511|FG002|Overall Study|Disease Progression / Relapse|0
802054|NCT00035932|1755509|FG000|Overall Study|Lost to Follow-up|4
802055|NCT00035932|1755510|FG001|Overall Study|Lost to Follow-up|4
802056|NCT00035932|1755511|FG002|Overall Study|Lost to Follow-up|3
802057|NCT00035932|1755509|FG000|Overall Study|Noncompliance|6
802058|NCT00035932|1755510|FG001|Overall Study|Noncompliance|7
802059|NCT00035932|1755511|FG002|Overall Study|Noncompliance|6
802060|NCT00035932|1755509|FG000|Overall Study|Protocol Violation While on Study|0
802061|NCT00035932|1755510|FG001|Overall Study|Protocol Violation While on Study|1
802062|NCT00035932|1755511|FG002|Overall Study|Protocol Violation While on Study|2
802063|NCT00035932|1755509|FG000|Overall Study|Withdrawal by Subject|1
802064|NCT00035932|1755510|FG001|Overall Study|Withdrawal by Subject|5
802065|NCT00035932|1755511|FG002|Overall Study|Withdrawal by Subject|0
802066|NCT00035932|1755509|FG000|Overall Study|Study Termination by Sponsor|1
802067|NCT00035932|1755510|FG001|Overall Study|Study Termination by Sponsor|0
802068|NCT00035932|1755511|FG002|Overall Study|Study Termination by Sponsor|0
802069|NCT00035932|1755509|FG000|Overall Study|Lack of Efficacy|33
802070|NCT00035932|1755510|FG001|Overall Study|Lack of Efficacy|33
802071|NCT00035932|1755511|FG002|Overall Study|Lack of Efficacy|28
802072|NCT00036270|1755526|FG000|Randomized to Study Treatment|Withdrawal by Subject|6
802073|NCT00036270|1755527|FG001|Randomized to Study Treatment|Withdrawal by Subject|7
802074|NCT00036270|1755526|FG000|Study Treatment to 5 Year Report|Ongoing|1081
802075|NCT00036270|1755527|FG001|Study Treatment to 5 Year Report|Ongoing|736
802076|NCT00036270|1755526|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
802077|NCT00036270|1755527|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
802078|NCT00036270|1755526|FG000|Study Treatment to 5 Year Report|Adverse Event|501
802079|NCT00036270|1755527|FG001|Study Treatment to 5 Year Report|Adverse Event|782
802080|NCT00036270|1755526|FG000|Study Treatment to 5 Year Report|Other|277
802081|NCT00036270|1755527|FG001|Study Treatment to 5 Year Report|Other|288
802082|NCT00036270|1755526|FG000|Study Treatment to 5 Year Report|Treatment refusal|113
802083|NCT00036270|1755527|FG001|Study Treatment to 5 Year Report|Treatment refusal|208
802084|NCT00036270|1755526|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46
802085|NCT00036270|1755527|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54
802086|NCT00036270|1755526|FG000|Study Treatment to 5 Year Report|Protocol Violation|23
802087|NCT00036270|1755527|FG001|Study Treatment to 5 Year Report|Protocol Violation|91
802088|NCT00036270|1755526|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17
802089|NCT00036270|1755527|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29
802090|NCT00036270|1755526|FG000|Study Treatment to 5 Year Report|Too early switch|0
802091|NCT00036270|1755527|FG001|Study Treatment to 5 Year Report|Too early switch|103
802092|NCT00036270|1755526|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
802093|NCT00036270|1755527|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
802094|NCT00037830|1755546|FG000|Overall Study|Adverse Event|2
802095|NCT00037830|1755547|FG001|Overall Study|Adverse Event|0
802096|NCT00037830|1755548|FG002|Overall Study|Adverse Event|0
802097|NCT00037830|1755546|FG000|Overall Study|Withdrawal by Subject|4
802098|NCT00037830|1755547|FG001|Overall Study|Withdrawal by Subject|5
802099|NCT00037830|1755548|FG002|Overall Study|Withdrawal by Subject|1
802100|NCT00037830|1755546|FG000|Overall Study|Protocol Violation|2
802101|NCT00037830|1755547|FG001|Overall Study|Protocol Violation|2
802102|NCT00037830|1755548|FG002|Overall Study|Protocol Violation|0
802103|NCT00037830|1755546|FG000|Overall Study|Unrelated Medical Problem|2
802104|NCT00037830|1755547|FG001|Overall Study|Unrelated Medical Problem|0
802105|NCT00037830|1755548|FG002|Overall Study|Unrelated Medical Problem|0
802106|NCT00038103|1755558|FG000|Overall Study|Adverse Event|5
802107|NCT00038103|1755559|FG001|Overall Study|Adverse Event|6
802108|NCT00038103|1755558|FG000|Overall Study|Lack of Efficacy|48
802109|NCT00038103|1755559|FG001|Overall Study|Lack of Efficacy|41
802110|NCT00038103|1755558|FG000|Overall Study|Withdrawal by Subject|0
802111|NCT00038103|1755559|FG001|Overall Study|Withdrawal by Subject|3
802112|NCT00038103|1755558|FG000|Overall Study|Lost to Follow-up|0
802113|NCT00038103|1755559|FG001|Overall Study|Lost to Follow-up|3
802114|NCT00038103|1755558|FG000|Overall Study|Protocol Violation|0
802115|NCT00038103|1755559|FG001|Overall Study|Protocol Violation|2
802116|NCT00038103|1755558|FG000|Overall Study|Sponsor Decision|0
802117|NCT00038103|1755559|FG001|Overall Study|Sponsor Decision|1
802118|NCT00038103|1755558|FG000|Overall Study|Randomized/never treated|2
802119|NCT00038103|1755559|FG001|Overall Study|Randomized/never treated|0
802120|NCT00038467|1755567|FG000|Overall Study|Adverse Event|170
802121|NCT00038467|1755568|FG001|Overall Study|Adverse Event|145
802122|NCT00038467|1755567|FG000|Overall Study|Withdrawal by Subject|150
802123|NCT00038467|1755568|FG001|Overall Study|Withdrawal by Subject|107
802124|NCT00038467|1755567|FG000|Overall Study|Protocol Violation|19
802125|NCT00038467|1755568|FG001|Overall Study|Protocol Violation|22
802126|NCT00038467|1755567|FG000|Overall Study|Death|22
802127|NCT00038467|1755568|FG001|Overall Study|Death|16
802128|NCT00038467|1755567|FG000|Overall Study|Lost to Follow-up|15
802129|NCT00038467|1755568|FG001|Overall Study|Lost to Follow-up|10
802130|NCT00038467|1755567|FG000|Overall Study|Recurrence|109
802131|NCT00038467|1755568|FG001|Overall Study|Recurrence|179
802132|NCT00038467|1755567|FG000|Overall Study|Randomized, but not treated|31
802133|NCT00038467|1755568|FG001|Overall Study|Randomized, but not treated|35
802134|NCT00038467|1755567|FG000|Overall Study|Other|26
802135|NCT00038467|1755568|FG001|Overall Study|Other|28
802136|NCT00038649|1755578|FG000|Overall Study|Adverse Event|9
802137|NCT00038948|1755604|FG000|Overall Study|Adverse Event|131
802138|NCT00038948|1755605|FG001|Overall Study|Adverse Event|43
802139|NCT00038948|1755604|FG000|Overall Study|Lost to Follow-up|4
802140|NCT00038948|1755605|FG001|Overall Study|Lost to Follow-up|4
802141|NCT00038948|1755604|FG000|Overall Study|Nonmedical event|5
802142|NCT00038948|1755605|FG001|Overall Study|Nonmedical event|7
802143|NCT00038948|1755604|FG000|Overall Study|Withdrawal by Subject|23
802144|NCT00038948|1755605|FG001|Overall Study|Withdrawal by Subject|10
802145|NCT00038948|1755604|FG000|Overall Study|Protocol Violation|3
802146|NCT00038948|1755605|FG001|Overall Study|Protocol Violation|7
802147|NCT00038948|1755604|FG000|Overall Study|Lack of Efficacy|3
802148|NCT00038948|1755605|FG001|Overall Study|Lack of Efficacy|6
802149|NCT00039130|1755617|FG000|Overall Study|Adverse Event|11
802150|NCT00039130|1755617|FG000|Overall Study|Death|9
802151|NCT00039130|1755617|FG000|Overall Study|Withdrawal by Subject|3
802152|NCT00039130|1755617|FG000|Overall Study|Progression|2
802153|NCT00039130|1755617|FG000|Overall Study|Subsequent treatment|2
802154|NCT00039130|1755617|FG000|Overall Study|Physician Decision|3
802155|NCT00039377|1755625|FG000|Initial Registration|Adverse Event|2
802156|NCT00039377|1755626|FG001|Initial Registration|Adverse Event|0
802157|NCT00039377|1755627|FG002|Initial Registration|Adverse Event|0
802158|NCT00039377|1755628|FG003|Initial Registration|Adverse Event|0
802159|NCT00039377|1755625|FG000|Initial Registration|Relapsed|6
802160|NCT00039377|1755626|FG001|Initial Registration|Relapsed|0
802161|NCT00039377|1755627|FG002|Initial Registration|Relapsed|0
802162|NCT00039377|1755628|FG003|Initial Registration|Relapsed|0
802163|NCT00039377|1755625|FG000|Initial Registration|Received non-protocol therapy|11
802164|NCT00039377|1755626|FG001|Initial Registration|Received non-protocol therapy|0
802165|NCT00039377|1755627|FG002|Initial Registration|Received non-protocol therapy|0
802166|NCT00039377|1755628|FG003|Initial Registration|Received non-protocol therapy|0
802167|NCT00039377|1755625|FG000|Initial Registration|Withdrawal by Subject|3
802168|NCT00039377|1755626|FG001|Initial Registration|Withdrawal by Subject|0
802169|NCT00039377|1755627|FG002|Initial Registration|Withdrawal by Subject|0
802170|NCT00039377|1755628|FG003|Initial Registration|Withdrawal by Subject|0
802171|NCT00039741|1755640|FG000|Overall Study|Death|0
802172|NCT00039741|1755641|FG001|Overall Study|Death|1
802173|NCT00039741|1755642|FG002|Overall Study|Death|0
802174|NCT00039741|1755643|FG003|Overall Study|Death|0
802175|NCT00039741|1755640|FG000|Overall Study|Lost to Follow-up|3
802176|NCT00039741|1755641|FG001|Overall Study|Lost to Follow-up|1
802177|NCT00039741|1755642|FG002|Overall Study|Lost to Follow-up|5
802178|NCT00039741|1755643|FG003|Overall Study|Lost to Follow-up|2
802179|NCT00039741|1755640|FG000|Overall Study|Confounding medical condition|1
802180|NCT00039741|1755641|FG001|Overall Study|Confounding medical condition|0
802181|NCT00039741|1755642|FG002|Overall Study|Confounding medical condition|0
802182|NCT00039741|1755643|FG003|Overall Study|Confounding medical condition|0
802183|NCT00039741|1755640|FG000|Overall Study|Not able to get to clinic|5
802184|NCT00039741|1755641|FG001|Overall Study|Not able to get to clinic|2
802185|NCT00039741|1755642|FG002|Overall Study|Not able to get to clinic|0
802186|NCT00039741|1755643|FG003|Overall Study|Not able to get to clinic|3
802187|NCT00039741|1755640|FG000|Overall Study|Moved|3
802188|NCT00039741|1755641|FG001|Overall Study|Moved|2
802189|NCT00039741|1755642|FG002|Overall Study|Moved|3
802190|NCT00039741|1755643|FG003|Overall Study|Moved|6
802191|NCT00039741|1755640|FG000|Overall Study|Non-compliance with protocol|1
802192|NCT00039741|1755641|FG001|Overall Study|Non-compliance with protocol|0
802193|NCT00039741|1755642|FG002|Overall Study|Non-compliance with protocol|1
802194|NCT00039741|1755643|FG003|Overall Study|Non-compliance with protocol|0
802195|NCT00039741|1755640|FG000|Overall Study|Withdrew consent|0
802196|NCT00039741|1755641|FG001|Overall Study|Withdrew consent|5
802197|NCT00039741|1755642|FG002|Overall Study|Withdrew consent|0
802198|NCT00039741|1755643|FG003|Overall Study|Withdrew consent|1
802199|NCT00039741|1755640|FG000|Overall Study|Missed final visit|2
802200|NCT00039741|1755641|FG001|Overall Study|Missed final visit|1
802201|NCT00039741|1755642|FG002|Overall Study|Missed final visit|2
802202|NCT00039741|1755643|FG003|Overall Study|Missed final visit|2
802203|NCT00039871|1755653|FG000|Overall Study|Adverse Event|165
802204|NCT00039871|1755653|FG000|Overall Study|Lost to Follow-up|18
802205|NCT00039871|1755653|FG000|Overall Study|Protocol Violation|24
802206|NCT00039871|1755653|FG000|Overall Study|Withdrawal by Subject|97
802207|NCT00039871|1755653|FG000|Overall Study|Did not meet eligibility criteria|11
802208|NCT00039871|1755653|FG000|Overall Study|Administrative|1
802209|NCT00039871|1755653|FG000|Overall Study|Discontinued at Week 12 per protocol|1061
802210|NCT00039871|1755653|FG000|Overall Study|Never entered follow-up|7
802211|NCT00040365|1755657|FG000|Overall Study|Death|1
802212|NCT00040365|1755657|FG000|Overall Study|Progressive disease|7
802213|NCT00040365|1755657|FG000|Overall Study|Lost to Follow-up|3
802214|NCT00040664|1755670|FG000|Overall Study|Adverse Event|12
802215|NCT00040664|1755671|FG001|Overall Study|Adverse Event|3
802216|NCT00040664|1755672|FG002|Overall Study|Adverse Event|2
802217|NCT00040664|1755673|FG003|Overall Study|Adverse Event|7
802218|NCT00040664|1755670|FG000|Overall Study|Lack of Efficacy|9
802219|NCT00040664|1755671|FG001|Overall Study|Lack of Efficacy|2
802220|NCT00040664|1755672|FG002|Overall Study|Lack of Efficacy|3
802221|NCT00040664|1755673|FG003|Overall Study|Lack of Efficacy|4
802222|NCT00040664|1755670|FG000|Overall Study|Insufficient CD4 response|1
802223|NCT00040664|1755671|FG001|Overall Study|Insufficient CD4 response|0
802224|NCT00040664|1755672|FG002|Overall Study|Insufficient CD4 response|1
802225|NCT00040664|1755673|FG003|Overall Study|Insufficient CD4 response|0
802226|NCT00040664|1755670|FG000|Overall Study|Lost to Follow-up|4
802227|NCT00040664|1755671|FG001|Overall Study|Lost to Follow-up|2
802228|NCT00040664|1755672|FG002|Overall Study|Lost to Follow-up|0
802229|NCT00040664|1755673|FG003|Overall Study|Lost to Follow-up|2
802230|NCT00040664|1755670|FG000|Overall Study|Protocol Violation|2
802231|NCT00040664|1755671|FG001|Overall Study|Protocol Violation|1
802232|NCT00040664|1755672|FG002|Overall Study|Protocol Violation|0
802233|NCT00040664|1755673|FG003|Overall Study|Protocol Violation|1
802234|NCT00040664|1755670|FG000|Overall Study|Withdrawal by Subject|7
802235|NCT00040664|1755671|FG001|Overall Study|Withdrawal by Subject|0
802236|NCT00040664|1755672|FG002|Overall Study|Withdrawal by Subject|3
802237|NCT00040664|1755673|FG003|Overall Study|Withdrawal by Subject|4
802238|NCT00040664|1755670|FG000|Overall Study|Pregnancy|3
802239|NCT00040664|1755671|FG001|Overall Study|Pregnancy|0
802240|NCT00040664|1755672|FG002|Overall Study|Pregnancy|0
802241|NCT00040664|1755673|FG003|Overall Study|Pregnancy|3
802242|NCT00040664|1755670|FG000|Overall Study|Medication adherence/compliance problems|8
802243|NCT00040664|1755671|FG001|Overall Study|Medication adherence/compliance problems|2
802244|NCT00040664|1755672|FG002|Overall Study|Medication adherence/compliance problems|1
802245|NCT00040664|1755673|FG003|Overall Study|Medication adherence/compliance problems|5
802246|NCT00040664|1755670|FG000|Overall Study|Poor taste|2
802247|NCT00040664|1755671|FG001|Overall Study|Poor taste|0
802248|NCT00040664|1755672|FG002|Overall Study|Poor taste|2
802249|NCT00040664|1755673|FG003|Overall Study|Poor taste|0
802250|NCT00040664|1755670|FG000|Overall Study|Pharmacokinetic target not achieved|2
802251|NCT00040664|1755671|FG001|Overall Study|Pharmacokinetic target not achieved|1
802252|NCT00040664|1755672|FG002|Overall Study|Pharmacokinetic target not achieved|0
802253|NCT00040664|1755673|FG003|Overall Study|Pharmacokinetic target not achieved|1
802254|NCT00040664|1755670|FG000|Overall Study|Change of formulation|2
802255|NCT00040664|1755671|FG001|Overall Study|Change of formulation|2
802256|NCT00040664|1755672|FG002|Overall Study|Change of formulation|0
802257|NCT00040664|1755673|FG003|Overall Study|Change of formulation|0
802258|NCT00040664|1755670|FG000|Overall Study|Non-viability of oral suspension|1
802259|NCT00040664|1755671|FG001|Overall Study|Non-viability of oral suspension|0
802260|NCT00040664|1755672|FG002|Overall Study|Non-viability of oral suspension|1
802261|NCT00040664|1755673|FG003|Overall Study|Non-viability of oral suspension|0
802262|NCT00040742|1755695|FG000|Overall Study|Death|0
802263|NCT00040742|1755696|FG001|Overall Study|Death|0
802264|NCT00040742|1755697|FG002|Overall Study|Death|1
802265|NCT00040742|1755698|FG003|Overall Study|Death|0
802266|NCT00040742|1755695|FG000|Overall Study|Adverse Event|15
802267|NCT00040742|1755696|FG001|Overall Study|Adverse Event|16
802268|NCT00040742|1755697|FG002|Overall Study|Adverse Event|21
802269|NCT00040742|1755698|FG003|Overall Study|Adverse Event|9
802270|NCT00040742|1755695|FG000|Overall Study|Withdrawal by Subject|7
802271|NCT00040742|1755696|FG001|Overall Study|Withdrawal by Subject|15
802272|NCT00040742|1755697|FG002|Overall Study|Withdrawal by Subject|10
802273|NCT00040742|1755698|FG003|Overall Study|Withdrawal by Subject|13
802274|NCT00040742|1755695|FG000|Overall Study|Chemotoxicity|4
802275|NCT00040742|1755696|FG001|Overall Study|Chemotoxicity|3
802276|NCT00040742|1755697|FG002|Overall Study|Chemotoxicity|5
802277|NCT00040742|1755698|FG003|Overall Study|Chemotoxicity|2
802278|NCT00040742|1755695|FG000|Overall Study|Incomplete Forms|6
802279|NCT00040742|1755696|FG001|Overall Study|Incomplete Forms|10
802280|NCT00040742|1755697|FG002|Overall Study|Incomplete Forms|4
802281|NCT00040742|1755698|FG003|Overall Study|Incomplete Forms|5
802282|NCT00040742|1755695|FG000|Overall Study|Other medical|7
802283|NCT00040742|1755696|FG001|Overall Study|Other medical|5
802284|NCT00040742|1755697|FG002|Overall Study|Other medical|5
802285|NCT00040742|1755698|FG003|Overall Study|Other medical|5
802286|NCT00041067|1755740|FG000|Overall Study|Adverse Event|20
802287|NCT00041067|1755740|FG000|Overall Study|Progression|19
802288|NCT00041067|1755740|FG000|Overall Study|Patient refusal|12
802289|NCT00041067|1755740|FG000|Overall Study|Other reasons|23
802290|NCT00041067|1755740|FG000|Overall Study|Ineligible|2
802291|NCT00041080|1755747|FG000|Overall Study|Adverse Event|21
802292|NCT00041080|1755748|FG001|Overall Study|Adverse Event|1
802293|NCT00041080|1755747|FG000|Overall Study|Withdrawal by Subject|6
802294|NCT00041080|1755748|FG001|Overall Study|Withdrawal by Subject|6
802295|NCT00041080|1755747|FG000|Overall Study|Concommitant Illness/Other|1
802296|NCT00041080|1755748|FG001|Overall Study|Concommitant Illness/Other|2
802297|NCT00041080|1755747|FG000|Overall Study|Did not start therapy|1
802298|NCT00041080|1755748|FG001|Overall Study|Did not start therapy|1
802299|NCT00041080|1755747|FG000|Overall Study|Ineligible|1
802300|NCT00041080|1755748|FG001|Overall Study|Ineligible|0
802301|NCT00041132|1755775|FG000|Overall Study|Adverse Event|19
802302|NCT00041132|1755775|FG000|Overall Study|Death|1
802303|NCT00041132|1755775|FG000|Overall Study|Not Eligible|7
802304|NCT00041132|1755775|FG000|Overall Study|Withdrawal by Subject|1
802305|NCT00041132|1755775|FG000|Overall Study|Physician Decision|2
802306|NCT00041470|1755788|FG000|Overall Study|Loss of Funding|38
802307|NCT00041756|1755806|FG000|Overall Study|Adverse Event|4
802308|NCT00041756|1755807|FG001|Overall Study|Adverse Event|10
802309|NCT00041756|1755808|FG002|Overall Study|Adverse Event|6
802310|NCT00041756|1755809|FG003|Overall Study|Adverse Event|11
802311|NCT00041756|1755810|FG004|Overall Study|Adverse Event|34
802312|NCT00041756|1755806|FG000|Overall Study|Protocol Violation|1
802313|NCT00041756|1755807|FG001|Overall Study|Protocol Violation|1
802314|NCT00041756|1755808|FG002|Overall Study|Protocol Violation|2
802315|NCT00041756|1755809|FG003|Overall Study|Protocol Violation|2
802316|NCT00041756|1755810|FG004|Overall Study|Protocol Violation|1
802317|NCT00041756|1755806|FG000|Overall Study|Withdrawal by Subject|3
802318|NCT00041756|1755807|FG001|Overall Study|Withdrawal by Subject|3
802319|NCT00041756|1755808|FG002|Overall Study|Withdrawal by Subject|4
802320|NCT00041756|1755809|FG003|Overall Study|Withdrawal by Subject|2
802321|NCT00041756|1755810|FG004|Overall Study|Withdrawal by Subject|3
802322|NCT00041756|1755806|FG000|Overall Study|Lost to Follow-up|0
802323|NCT00041756|1755807|FG001|Overall Study|Lost to Follow-up|1
802324|NCT00041756|1755808|FG002|Overall Study|Lost to Follow-up|0
802325|NCT00041756|1755809|FG003|Overall Study|Lost to Follow-up|1
802326|NCT00041756|1755810|FG004|Overall Study|Lost to Follow-up|0
802327|NCT00041756|1755806|FG000|Overall Study|Unable to meet protocol criteria|0
802328|NCT00041756|1755807|FG001|Overall Study|Unable to meet protocol criteria|0
802329|NCT00041756|1755808|FG002|Overall Study|Unable to meet protocol criteria|1
802330|NCT00041756|1755809|FG003|Overall Study|Unable to meet protocol criteria|0
802331|NCT00041756|1755810|FG004|Overall Study|Unable to meet protocol criteria|1
802332|NCT00041756|1755806|FG000|Overall Study|Data Monitoring Committee Recommendation|0
802333|NCT00041756|1755807|FG001|Overall Study|Data Monitoring Committee Recommendation|0
802334|NCT00041756|1755808|FG002|Overall Study|Data Monitoring Committee Recommendation|0
802335|NCT00041756|1755809|FG003|Overall Study|Data Monitoring Committee Recommendation|0
802336|NCT00041756|1755810|FG004|Overall Study|Data Monitoring Committee Recommendation|21
802337|NCT00042432|1755842|FG000|Overall Study|Adverse Event|4
802338|NCT00042432|1755843|FG001|Overall Study|Adverse Event|1
802339|NCT00042432|1755842|FG000|Overall Study|Withdrawal by Subject|1
802340|NCT00042432|1755843|FG001|Overall Study|Withdrawal by Subject|3
802341|NCT00042432|1755842|FG000|Overall Study|Death|0
802342|NCT00042432|1755843|FG001|Overall Study|Death|2
802343|NCT00042432|1755842|FG000|Overall Study|Ineligibility determined|1
802344|NCT00042432|1755843|FG001|Overall Study|Ineligibility determined|0
802345|NCT00042432|1755842|FG000|Overall Study|Initiation of maintenance dialysis|1
802346|NCT00042432|1755843|FG001|Overall Study|Initiation of maintenance dialysis|1
802347|NCT00042432|1755842|FG000|Overall Study|Other|2
802348|NCT00042432|1755843|FG001|Overall Study|Other|0
802349|NCT00042666|1755849|FG000|Overall Study|Adverse Event|2
802350|NCT00042666|1755849|FG000|Overall Study|Death|4
802351|NCT00042666|1755849|FG000|Overall Study|Protocol Violation|1
802352|NCT00042666|1755849|FG000|Overall Study|Participant/Physician Perception|1
802353|NCT00042666|1755849|FG000|Overall Study|Progressive Disease|41
802354|NCT00042666|1755849|FG000|Overall Study|Other|1
802355|NCT00042666|1755849|FG000|Overall Study|Other|4
802356|NCT00042939|1755856|FG000|Overall Study|Adverse Event|6
802357|NCT00042939|1755857|FG001|Overall Study|Adverse Event|7
802358|NCT00042939|1755856|FG000|Overall Study|Death|3
802359|NCT00042939|1755857|FG001|Overall Study|Death|2
802360|NCT00042939|1755856|FG000|Overall Study|Withdrawal by Subject|3
802361|NCT00042939|1755857|FG001|Overall Study|Withdrawal by Subject|4
802362|NCT00042939|1755856|FG000|Overall Study|Other disease|1
802363|NCT00042939|1755857|FG001|Overall Study|Other disease|0
802364|NCT00042939|1755856|FG000|Overall Study|Ineligible|2
802365|NCT00042939|1755857|FG001|Overall Study|Ineligible|2
802366|NCT00042939|1755856|FG000|Overall Study|Deterioration of health|3
802367|NCT00042939|1755857|FG001|Overall Study|Deterioration of health|4
802368|NCT00042939|1755856|FG000|Overall Study|QOL diminished|1
802369|NCT00042939|1755857|FG001|Overall Study|QOL diminished|0
802370|NCT00042939|1755856|FG000|Overall Study|Rising ca 19-9|1
802371|NCT00042939|1755857|FG001|Overall Study|Rising ca 19-9|0
802372|NCT00042939|1755856|FG000|Overall Study|Patient non-compliance|1
802373|NCT00042939|1755857|FG001|Overall Study|Patient non-compliance|0
802374|NCT00042939|1755856|FG000|Overall Study|Still on treatment|1
802375|NCT00042939|1755857|FG001|Overall Study|Still on treatment|0
802376|NCT00042939|1755856|FG000|Overall Study|Treatment break > 4 weeks|0
802377|NCT00042939|1755857|FG001|Overall Study|Treatment break > 4 weeks|1
802378|NCT00042939|1755856|FG000|Overall Study|Did not start treatment|2
802379|NCT00042939|1755857|FG001|Overall Study|Did not start treatment|1
802380|NCT00042991|1755870|FG000|Overall Study|Adverse Event|1
802381|NCT00042991|1755871|FG001|Overall Study|Adverse Event|4
802382|NCT00042991|1755872|FG002|Overall Study|Adverse Event|2
802383|NCT00042991|1755873|FG003|Overall Study|Adverse Event|0
802384|NCT00042991|1755874|FG004|Overall Study|Adverse Event|0
802385|NCT00042991|1755875|FG005|Overall Study|Adverse Event|1
802386|NCT00042991|1755876|FG006|Overall Study|Adverse Event|0
802387|NCT00042991|1755870|FG000|Overall Study|Withdrawal by Subject|0
802388|NCT00042991|1755871|FG001|Overall Study|Withdrawal by Subject|7
802389|NCT00042991|1755872|FG002|Overall Study|Withdrawal by Subject|2
802390|NCT00042991|1755873|FG003|Overall Study|Withdrawal by Subject|0
802391|NCT00042991|1755874|FG004|Overall Study|Withdrawal by Subject|1
802392|NCT00042991|1755875|FG005|Overall Study|Withdrawal by Subject|0
802393|NCT00042991|1755876|FG006|Overall Study|Withdrawal by Subject|0
802394|NCT00042991|1755870|FG000|Overall Study|Disease Progression|5
802395|NCT00042991|1755871|FG001|Overall Study|Disease Progression|29
802396|NCT00042991|1755872|FG002|Overall Study|Disease Progression|2
802397|NCT00042991|1755873|FG003|Overall Study|Disease Progression|2
802398|NCT00042991|1755874|FG004|Overall Study|Disease Progression|1
802399|NCT00042991|1755875|FG005|Overall Study|Disease Progression|4
802400|NCT00042991|1755876|FG006|Overall Study|Disease Progression|2
802401|NCT00042991|1755870|FG000|Overall Study|Alternative Therapy|0
802402|NCT00042991|1755871|FG001|Overall Study|Alternative Therapy|0
802403|NCT00042991|1755872|FG002|Overall Study|Alternative Therapy|0
802404|NCT00042991|1755873|FG003|Overall Study|Alternative Therapy|0
802405|NCT00042991|1755874|FG004|Overall Study|Alternative Therapy|1
802406|NCT00042991|1755875|FG005|Overall Study|Alternative Therapy|0
802407|NCT00042991|1755876|FG006|Overall Study|Alternative Therapy|0
802408|NCT00043186|1755903|FG000|Overall Study|Physician Decision|0
802409|NCT00043186|1755904|FG001|Overall Study|Physician Decision|0
802410|NCT00043186|1755905|FG002|Overall Study|Physician Decision|3
802411|NCT00043186|1755906|FG003|Overall Study|Physician Decision|0
802412|NCT00043186|1755907|FG004|Overall Study|Physician Decision|1
802413|NCT00043186|1755908|FG005|Overall Study|Physician Decision|0
802414|NCT00043186|1755909|FG006|Overall Study|Physician Decision|0
802415|NCT00043186|1755910|FG007|Overall Study|Physician Decision|1
802416|NCT00043186|1755911|FG008|Overall Study|Physician Decision|1
802417|NCT00043186|1755903|FG000|Overall Study|Adverse Event|2
802418|NCT00043186|1755904|FG001|Overall Study|Adverse Event|2
802419|NCT00043186|1755905|FG002|Overall Study|Adverse Event|2
802420|NCT00043186|1755906|FG003|Overall Study|Adverse Event|3
802421|NCT00043186|1755907|FG004|Overall Study|Adverse Event|2
802422|NCT00043186|1755908|FG005|Overall Study|Adverse Event|1
802423|NCT00043186|1755909|FG006|Overall Study|Adverse Event|2
802424|NCT00043186|1755910|FG007|Overall Study|Adverse Event|1
802425|NCT00043186|1755911|FG008|Overall Study|Adverse Event|3
802426|NCT00043186|1755903|FG000|Overall Study|Withdrawal by Subject|11
802427|NCT00043186|1755904|FG001|Overall Study|Withdrawal by Subject|8
802428|NCT00043186|1755905|FG002|Overall Study|Withdrawal by Subject|11
802429|NCT00043186|1755906|FG003|Overall Study|Withdrawal by Subject|13
802430|NCT00043186|1755907|FG004|Overall Study|Withdrawal by Subject|14
802431|NCT00043186|1755908|FG005|Overall Study|Withdrawal by Subject|6
802432|NCT00043186|1755909|FG006|Overall Study|Withdrawal by Subject|12
802433|NCT00043186|1755910|FG007|Overall Study|Withdrawal by Subject|9
802434|NCT00043186|1755911|FG008|Overall Study|Withdrawal by Subject|10
802435|NCT00043186|1755903|FG000|Overall Study|Death|0
802436|NCT00043186|1755904|FG001|Overall Study|Death|0
802437|NCT00043186|1755905|FG002|Overall Study|Death|1
802438|NCT00043186|1755906|FG003|Overall Study|Death|0
802439|NCT00043186|1755907|FG004|Overall Study|Death|0
802440|NCT00043186|1755908|FG005|Overall Study|Death|0
802441|NCT00043186|1755909|FG006|Overall Study|Death|2
802442|NCT00043186|1755910|FG007|Overall Study|Death|0
802443|NCT00043186|1755911|FG008|Overall Study|Death|0
802444|NCT00043186|1755903|FG000|Overall Study|Disease progression|1
802445|NCT00043186|1755904|FG001|Overall Study|Disease progression|0
802446|NCT00043186|1755905|FG002|Overall Study|Disease progression|0
802447|NCT00043186|1755906|FG003|Overall Study|Disease progression|3
802448|NCT00043186|1755907|FG004|Overall Study|Disease progression|0
802449|NCT00043186|1755908|FG005|Overall Study|Disease progression|0
802450|NCT00043186|1755909|FG006|Overall Study|Disease progression|0
802451|NCT00043186|1755910|FG007|Overall Study|Disease progression|4
802452|NCT00043186|1755911|FG008|Overall Study|Disease progression|0
802453|NCT00043186|1755903|FG000|Overall Study|Ineligibility determined|0
802454|NCT00043186|1755904|FG001|Overall Study|Ineligibility determined|0
802455|NCT00043186|1755905|FG002|Overall Study|Ineligibility determined|0
802456|NCT00043186|1755906|FG003|Overall Study|Ineligibility determined|0
802457|NCT00043186|1755907|FG004|Overall Study|Ineligibility determined|0
802458|NCT00043186|1755908|FG005|Overall Study|Ineligibility determined|0
802459|NCT00043186|1755909|FG006|Overall Study|Ineligibility determined|0
802460|NCT00043186|1755910|FG007|Overall Study|Ineligibility determined|0
802461|NCT00043186|1755911|FG008|Overall Study|Ineligibility determined|1
802462|NCT00043186|1755903|FG000|Overall Study|Lost to Follow-up|3
802463|NCT00043186|1755904|FG001|Overall Study|Lost to Follow-up|5
802464|NCT00043186|1755905|FG002|Overall Study|Lost to Follow-up|1
802465|NCT00043186|1755906|FG003|Overall Study|Lost to Follow-up|1
802466|NCT00043186|1755907|FG004|Overall Study|Lost to Follow-up|1
802467|NCT00043186|1755908|FG005|Overall Study|Lost to Follow-up|1
802468|NCT00043186|1755909|FG006|Overall Study|Lost to Follow-up|1
802469|NCT00043186|1755910|FG007|Overall Study|Lost to Follow-up|1
802470|NCT00043186|1755911|FG008|Overall Study|Lost to Follow-up|2
802471|NCT00043186|1755903|FG000|Overall Study|Noncompliance|0
802472|NCT00043186|1755904|FG001|Overall Study|Noncompliance|0
802473|NCT00043186|1755905|FG002|Overall Study|Noncompliance|1
802474|NCT00043186|1755906|FG003|Overall Study|Noncompliance|1
802475|NCT00043186|1755907|FG004|Overall Study|Noncompliance|0
802476|NCT00043186|1755908|FG005|Overall Study|Noncompliance|0
802477|NCT00043186|1755909|FG006|Overall Study|Noncompliance|0
802478|NCT00043186|1755910|FG007|Overall Study|Noncompliance|0
802479|NCT00043186|1755911|FG008|Overall Study|Noncompliance|0
802480|NCT00043186|1755903|FG000|Overall Study|Other|0
802481|NCT00043186|1755904|FG001|Overall Study|Other|0
802482|NCT00043186|1755905|FG002|Overall Study|Other|1
802483|NCT00043186|1755906|FG003|Overall Study|Other|1
802484|NCT00043186|1755907|FG004|Overall Study|Other|0
802485|NCT00043186|1755908|FG005|Overall Study|Other|0
802486|NCT00043186|1755909|FG006|Overall Study|Other|0
802487|NCT00043186|1755910|FG007|Overall Study|Other|0
802488|NCT00043186|1755911|FG008|Overall Study|Other|0
802489|NCT00043550|1755935|FG000|Overall Study|Withdrawal by Subject|22
802490|NCT00043550|1755936|FG001|Overall Study|Withdrawal by Subject|12
802491|NCT00043550|1755937|FG002|Overall Study|Withdrawal by Subject|20
802492|NCT00043979|1755947|FG000|Period 1|recipient with progressive disease|7
802493|NCT00043979|1755948|FG001|Period 1|recipient with progressive disease|4
802494|NCT00043979|1755949|FG002|Period 1|recipient with progressive disease|3
802495|NCT00044083|1755991|FG000|First Intervention (One Week)- HV's|Adverse Event|1
802496|NCT00044083|1755992|FG001|First Intervention (One Week)- HV's|Adverse Event|0
802497|NCT00044083|1755991|FG000|First Intervention (One Week)- HV's|Not follow directions|2
802498|NCT00044083|1755992|FG001|First Intervention (One Week)- HV's|Not follow directions|2
802499|NCT00044083|1755991|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5
802500|NCT00044083|1755992|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3
802501|NCT00044083|1755991|FG000|First Intervention (One Week)- HV's|Pregnancy|1
802502|NCT00044083|1755992|FG001|First Intervention (One Week)- HV's|Pregnancy|0
802503|NCT00044083|1755991|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1
802504|NCT00044083|1755992|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0
802505|NCT00044083|1755991|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0
802506|NCT00044083|1755992|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1
802507|NCT00044083|1755991|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0
802508|NCT00044083|1755992|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1
802509|NCT00044083|1755991|FG000|First Intervention (One Week) Patients|Not follow directions|0
802510|NCT00044083|1755992|FG001|First Intervention (One Week) Patients|Not follow directions|2
802511|NCT00044083|1755991|FG000|First Intervention (One Week) Patients|Used illegal drug|1
802512|NCT00044083|1755992|FG001|First Intervention (One Week) Patients|Used illegal drug|0
802513|NCT00044083|1755991|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0
802514|NCT00044083|1755992|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1
802515|NCT00044213|1756029|FG000|Overall Study|Withdrawal by Subject|50
802516|NCT00044213|1756030|FG001|Overall Study|Withdrawal by Subject|65
802517|NCT00044213|1756031|FG002|Overall Study|Withdrawal by Subject|91
802518|NCT00044213|1756032|FG003|Overall Study|Withdrawal by Subject|83
802519|NCT00044213|1756029|FG000|Overall Study|Death|42
802520|NCT00044213|1756030|FG001|Overall Study|Death|42
802521|NCT00044213|1756031|FG002|Overall Study|Death|42
802522|NCT00044213|1756032|FG003|Overall Study|Death|49
802523|NCT00044213|1756029|FG000|Overall Study|Lost to Follow-up|8
802524|NCT00044213|1756030|FG001|Overall Study|Lost to Follow-up|5
802525|NCT00044213|1756031|FG002|Overall Study|Lost to Follow-up|5
802526|NCT00044213|1756032|FG003|Overall Study|Lost to Follow-up|4
802527|NCT00044512|1756042|FG000|Follow Up|Lost to Follow-up|2
802528|NCT00045032|1756058|FG000|Overall Study|Adverse Event/Intercurrent Illness|2
802529|NCT00045032|1756059|FG001|Overall Study|Adverse Event/Intercurrent Illness|2
802530|NCT00045032|1756060|FG002|Overall Study|Adverse Event/Intercurrent Illness|7
802531|NCT00045032|1756058|FG000|Overall Study|Death|22
802532|NCT00045032|1756059|FG001|Overall Study|Death|24
802533|NCT00045032|1756060|FG002|Overall Study|Death|17
802534|NCT00045032|1756058|FG000|Overall Study|Insufficient Therapeutic Response|542
802535|NCT00045032|1756059|FG001|Overall Study|Insufficient Therapeutic Response|437
802536|NCT00045032|1756060|FG002|Overall Study|Insufficient Therapeutic Response|445
802537|NCT00045032|1756058|FG000|Overall Study|Violation of Selection Criteria at Entry|3
802538|NCT00045032|1756059|FG001|Overall Study|Violation of Selection Criteria at Entry|6
802539|NCT00045032|1756060|FG002|Overall Study|Violation of Selection Criteria at Entry|6
802540|NCT00045032|1756058|FG000|Overall Study|Other Protocol Violation|2
802541|NCT00045032|1756059|FG001|Overall Study|Other Protocol Violation|0
802542|NCT00045032|1756060|FG002|Overall Study|Other Protocol Violation|1
802543|NCT00045032|1756058|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142
802544|NCT00045032|1756059|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93
802545|NCT00045032|1756060|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84
802546|NCT00045032|1756058|FG000|Overall Study|Failure to Return|57
802547|NCT00045032|1756059|FG001|Overall Study|Failure to Return|62
802548|NCT00045032|1756060|FG002|Overall Study|Failure to Return|61
802549|NCT00045032|1756058|FG000|Overall Study|Other|93
802550|NCT00045032|1756059|FG001|Overall Study|Other|84
802551|NCT00045032|1756060|FG002|Overall Study|Other|105
802552|NCT00045110|1756073|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
802553|NCT00045110|1756074|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
802554|NCT00045110|1756075|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
802555|NCT00045110|1756073|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0
802556|NCT00045110|1756074|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4
802557|NCT00045110|1756075|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0
802558|NCT00045110|1756073|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0
802559|NCT00045110|1756074|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0
802560|NCT00045110|1756075|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1
802561|NCT00045162|1756094|FG000|Overall Study|Ineligible|12
802562|NCT00045162|1756095|FG001|Overall Study|Ineligible|8
802563|NCT00045162|1756094|FG000|Overall Study|Not treated|7
802564|NCT00045162|1756095|FG001|Overall Study|Not treated|2
802565|NCT00045162|1756094|FG000|Overall Study|Adverse Event|55
802566|NCT00045162|1756095|FG001|Overall Study|Adverse Event|50
802567|NCT00045162|1756094|FG000|Overall Study|Lack of Efficacy|32
802568|NCT00045162|1756095|FG001|Overall Study|Lack of Efficacy|29
802569|NCT00045162|1756094|FG000|Overall Study|Death|10
802570|NCT00045162|1756095|FG001|Overall Study|Death|10
802571|NCT00045162|1756094|FG000|Overall Study|Withdrawal by Subject|5
802572|NCT00045162|1756095|FG001|Overall Study|Withdrawal by Subject|3
802573|NCT00045162|1756094|FG000|Overall Study|Other|21
802574|NCT00045162|1756095|FG001|Overall Study|Other|16
802575|NCT00045305|1756101|FG000|Overall Study|Lack of Efficacy|6
802576|NCT00045305|1756101|FG000|Overall Study|Adverse Event|3
802577|NCT00045305|1756101|FG000|Overall Study|Death|3
802578|NCT00045305|1756101|FG000|Overall Study|site error|2
802579|NCT00045630|1756113|FG000|Overall Study|Adverse Event|1
802580|NCT00045630|1756113|FG000|Overall Study|Refusal unrelated to adverse event|1
802581|NCT00045630|1756113|FG000|Overall Study|Progression/relapse|1
802582|NCT00045630|1756113|FG000|Overall Study|Death|1
802583|NCT00045630|1756113|FG000|Overall Study|Ineligible|2
802584|NCT00045708|1756120|FG000|Phase 1|early progressive disease|0
802585|NCT00045708|1756121|FG001|Phase 1|early progressive disease|1
802586|NCT00045708|1756122|FG002|Phase 1|early progressive disease|0
802587|NCT00045734|1756139|FG000|Overall Study|Protocol Violation|1
802588|NCT00045942|1756152|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1
802589|NCT00045942|1756153|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0
802590|NCT00045942|1756154|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0
802591|NCT00045942|1756155|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0
802592|NCT00045942|1756156|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0
802593|NCT00045942|1756157|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0
802594|NCT00045942|1756158|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0
802595|NCT00045942|1756159|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0
802596|NCT00045942|1756160|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0
802597|NCT00045942|1756152|FG000|PKC412A2104 (Core)|Adverse Event|5
802598|NCT00045942|1756153|FG001|PKC412A2104 (Core)|Adverse Event|0
802599|NCT00045942|1756154|FG002|PKC412A2104 (Core)|Adverse Event|0
802600|NCT00045942|1756155|FG003|PKC412A2104 (Core)|Adverse Event|0
802601|NCT00045942|1756156|FG004|PKC412A2104 (Core)|Adverse Event|0
802602|NCT00045942|1756157|FG005|PKC412A2104 (Core)|Adverse Event|0
802603|NCT00045942|1756158|FG006|PKC412A2104 (Core)|Adverse Event|0
802604|NCT00045942|1756159|FG007|PKC412A2104 (Core)|Adverse Event|0
802605|NCT00045942|1756160|FG008|PKC412A2104 (Core)|Adverse Event|0
802606|NCT00045942|1756152|FG000|PKC412A2104 (Core)|Lack of Efficacy|13
802607|NCT00045942|1756153|FG001|PKC412A2104 (Core)|Lack of Efficacy|0
802608|NCT00045942|1756154|FG002|PKC412A2104 (Core)|Lack of Efficacy|0
802609|NCT00045942|1756155|FG003|PKC412A2104 (Core)|Lack of Efficacy|0
802610|NCT00045942|1756156|FG004|PKC412A2104 (Core)|Lack of Efficacy|0
802611|NCT00045942|1756157|FG005|PKC412A2104 (Core)|Lack of Efficacy|0
802612|NCT00045942|1756158|FG006|PKC412A2104 (Core)|Lack of Efficacy|0
802613|NCT00045942|1756159|FG007|PKC412A2104 (Core)|Lack of Efficacy|0
802614|NCT00045942|1756160|FG008|PKC412A2104 (Core)|Lack of Efficacy|0
802615|NCT00045942|1756152|FG000|PKC412A2104 (Core)|Death|1
802616|NCT00045942|1756153|FG001|PKC412A2104 (Core)|Death|0
802617|NCT00045942|1756154|FG002|PKC412A2104 (Core)|Death|0
802618|NCT00045942|1756155|FG003|PKC412A2104 (Core)|Death|0
802619|NCT00045942|1756156|FG004|PKC412A2104 (Core)|Death|0
802620|NCT00045942|1756157|FG005|PKC412A2104 (Core)|Death|0
802621|NCT00045942|1756158|FG006|PKC412A2104 (Core)|Death|0
802622|NCT00045942|1756159|FG007|PKC412A2104 (Core)|Death|0
802623|NCT00045942|1756160|FG008|PKC412A2104 (Core)|Death|0
802624|NCT00045942|1756152|FG000|PKC412A2104E1|Withdrawal by Subject|0
802625|NCT00045942|1756153|FG001|PKC412A2104E1|Withdrawal by Subject|0
802626|NCT00045942|1756154|FG002|PKC412A2104E1|Withdrawal by Subject|2
802627|NCT00045942|1756155|FG003|PKC412A2104E1|Withdrawal by Subject|5
802628|NCT00045942|1756156|FG004|PKC412A2104E1|Withdrawal by Subject|2
802629|NCT00045942|1756157|FG005|PKC412A2104E1|Withdrawal by Subject|0
802630|NCT00045942|1756158|FG006|PKC412A2104E1|Withdrawal by Subject|0
802631|NCT00045942|1756159|FG007|PKC412A2104E1|Withdrawal by Subject|0
802632|NCT00045942|1756160|FG008|PKC412A2104E1|Withdrawal by Subject|0
802633|NCT00045942|1756152|FG000|PKC412A2104E1|Condition no longer requires study drug|0
802634|NCT00045942|1756153|FG001|PKC412A2104E1|Condition no longer requires study drug|1
802635|NCT00045942|1756154|FG002|PKC412A2104E1|Condition no longer requires study drug|1
802636|NCT00045942|1756155|FG003|PKC412A2104E1|Condition no longer requires study drug|0
802637|NCT00045942|1756156|FG004|PKC412A2104E1|Condition no longer requires study drug|1
802638|NCT00045942|1756157|FG005|PKC412A2104E1|Condition no longer requires study drug|0
802639|NCT00045942|1756158|FG006|PKC412A2104E1|Condition no longer requires study drug|0
802640|NCT00045942|1756159|FG007|PKC412A2104E1|Condition no longer requires study drug|0
802641|NCT00045942|1756160|FG008|PKC412A2104E1|Condition no longer requires study drug|0
802642|NCT00045942|1756152|FG000|PKC412A2104E1|Lack of Efficacy|0
802643|NCT00045942|1756153|FG001|PKC412A2104E1|Lack of Efficacy|11
802644|NCT00045942|1756154|FG002|PKC412A2104E1|Lack of Efficacy|11
802645|NCT00045942|1756155|FG003|PKC412A2104E1|Lack of Efficacy|23
802646|NCT00045942|1756156|FG004|PKC412A2104E1|Lack of Efficacy|17
802647|NCT00045942|1756157|FG005|PKC412A2104E1|Lack of Efficacy|0
802648|NCT00045942|1756158|FG006|PKC412A2104E1|Lack of Efficacy|0
802649|NCT00045942|1756159|FG007|PKC412A2104E1|Lack of Efficacy|0
802650|NCT00045942|1756160|FG008|PKC412A2104E1|Lack of Efficacy|0
802651|NCT00045942|1756152|FG000|PKC412A2104E1|Abnormal laboratory value|0
802652|NCT00045942|1756153|FG001|PKC412A2104E1|Abnormal laboratory value|1
802653|NCT00045942|1756154|FG002|PKC412A2104E1|Abnormal laboratory value|0
802654|NCT00045942|1756155|FG003|PKC412A2104E1|Abnormal laboratory value|0
802655|NCT00045942|1756156|FG004|PKC412A2104E1|Abnormal laboratory value|0
802656|NCT00045942|1756157|FG005|PKC412A2104E1|Abnormal laboratory value|0
802657|NCT00045942|1756158|FG006|PKC412A2104E1|Abnormal laboratory value|0
802658|NCT00045942|1756159|FG007|PKC412A2104E1|Abnormal laboratory value|0
802659|NCT00045942|1756160|FG008|PKC412A2104E1|Abnormal laboratory value|0
802660|NCT00045942|1756152|FG000|PKC412A2104E1|Adverse Event|0
802661|NCT00045942|1756153|FG001|PKC412A2104E1|Adverse Event|1
802662|NCT00045942|1756154|FG002|PKC412A2104E1|Adverse Event|1
802663|NCT00045942|1756155|FG003|PKC412A2104E1|Adverse Event|3
802664|NCT00045942|1756156|FG004|PKC412A2104E1|Adverse Event|6
802665|NCT00045942|1756157|FG005|PKC412A2104E1|Adverse Event|0
802666|NCT00045942|1756158|FG006|PKC412A2104E1|Adverse Event|0
802667|NCT00045942|1756159|FG007|PKC412A2104E1|Adverse Event|0
802668|NCT00045942|1756160|FG008|PKC412A2104E1|Adverse Event|0
802669|NCT00045942|1756152|FG000|PKC412A2104E1|Death|0
802670|NCT00045942|1756153|FG001|PKC412A2104E1|Death|4
802671|NCT00045942|1756154|FG002|PKC412A2104E1|Death|1
802672|NCT00045942|1756155|FG003|PKC412A2104E1|Death|1
802673|NCT00045942|1756156|FG004|PKC412A2104E1|Death|1
802674|NCT00045942|1756157|FG005|PKC412A2104E1|Death|0
802675|NCT00045942|1756158|FG006|PKC412A2104E1|Death|0
802676|NCT00045942|1756159|FG007|PKC412A2104E1|Death|0
802677|NCT00045942|1756160|FG008|PKC412A2104E1|Death|0
802678|NCT00045942|1756152|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0
802679|NCT00045942|1756153|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0
802680|NCT00045942|1756154|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1
802681|NCT00045942|1756155|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1
802682|NCT00045942|1756156|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0
802683|NCT00045942|1756157|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0
802684|NCT00045942|1756158|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0
802685|NCT00045942|1756159|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0
802686|NCT00045942|1756160|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0
802687|NCT00045942|1756152|FG000|PKC412A2104E2|Lost to Follow-up|0
802688|NCT00045942|1756153|FG001|PKC412A2104E2|Lost to Follow-up|0
802689|NCT00045942|1756154|FG002|PKC412A2104E2|Lost to Follow-up|0
802690|NCT00045942|1756155|FG003|PKC412A2104E2|Lost to Follow-up|0
802691|NCT00045942|1756156|FG004|PKC412A2104E2|Lost to Follow-up|0
802692|NCT00045942|1756157|FG005|PKC412A2104E2|Lost to Follow-up|0
802693|NCT00045942|1756158|FG006|PKC412A2104E2|Lost to Follow-up|0
802694|NCT00045942|1756159|FG007|PKC412A2104E2|Lost to Follow-up|3
802695|NCT00045942|1756160|FG008|PKC412A2104E2|Lost to Follow-up|0
802696|NCT00045942|1756152|FG000|PKC412A2104E2|Withdrawal by Subject|0
802697|NCT00045942|1756153|FG001|PKC412A2104E2|Withdrawal by Subject|0
802698|NCT00045942|1756154|FG002|PKC412A2104E2|Withdrawal by Subject|0
802699|NCT00045942|1756155|FG003|PKC412A2104E2|Withdrawal by Subject|0
802700|NCT00045942|1756156|FG004|PKC412A2104E2|Withdrawal by Subject|0
802701|NCT00045942|1756157|FG005|PKC412A2104E2|Withdrawal by Subject|1
802702|NCT00045942|1756158|FG006|PKC412A2104E2|Withdrawal by Subject|0
802703|NCT00045942|1756159|FG007|PKC412A2104E2|Withdrawal by Subject|1
802704|NCT00045942|1756160|FG008|PKC412A2104E2|Withdrawal by Subject|0
802705|NCT00045942|1756152|FG000|PKC412A2104E2|Lack of Efficacy|0
802706|NCT00045942|1756153|FG001|PKC412A2104E2|Lack of Efficacy|0
802707|NCT00045942|1756154|FG002|PKC412A2104E2|Lack of Efficacy|0
802708|NCT00045942|1756155|FG003|PKC412A2104E2|Lack of Efficacy|0
802709|NCT00045942|1756156|FG004|PKC412A2104E2|Lack of Efficacy|0
802710|NCT00045942|1756157|FG005|PKC412A2104E2|Lack of Efficacy|3
802711|NCT00045942|1756158|FG006|PKC412A2104E2|Lack of Efficacy|2
802712|NCT00045942|1756159|FG007|PKC412A2104E2|Lack of Efficacy|2
802713|NCT00045942|1756160|FG008|PKC412A2104E2|Lack of Efficacy|6
802714|NCT00045942|1756152|FG000|PKC412A2104E2|Adverse Event|0
802715|NCT00045942|1756153|FG001|PKC412A2104E2|Adverse Event|0
802716|NCT00045942|1756154|FG002|PKC412A2104E2|Adverse Event|0
802717|NCT00045942|1756155|FG003|PKC412A2104E2|Adverse Event|0
802718|NCT00045942|1756156|FG004|PKC412A2104E2|Adverse Event|0
802719|NCT00045942|1756157|FG005|PKC412A2104E2|Adverse Event|4
802720|NCT00045942|1756158|FG006|PKC412A2104E2|Adverse Event|3
802721|NCT00045942|1756159|FG007|PKC412A2104E2|Adverse Event|1
802722|NCT00045942|1756160|FG008|PKC412A2104E2|Adverse Event|0
802723|NCT00045942|1756152|FG000|PKC412A2104E2|Death|0
802724|NCT00045942|1756153|FG001|PKC412A2104E2|Death|0
802725|NCT00045942|1756154|FG002|PKC412A2104E2|Death|0
802726|NCT00045942|1756155|FG003|PKC412A2104E2|Death|0
802727|NCT00045942|1756156|FG004|PKC412A2104E2|Death|0
802728|NCT00045942|1756157|FG005|PKC412A2104E2|Death|1
802729|NCT00045942|1756158|FG006|PKC412A2104E2|Death|2
802730|NCT00045942|1756159|FG007|PKC412A2104E2|Death|0
802731|NCT00045942|1756160|FG008|PKC412A2104E2|Death|0
802732|NCT00046839|1756227|FG000|Overall Study|Ineligible / No protocol treatment|0
802733|NCT00046839|1756228|FG001|Overall Study|Ineligible / No protocol treatment|2
802734|NCT00046839|1756227|FG000|Overall Study|Withdrawal of consent|1
802735|NCT00046839|1756228|FG001|Overall Study|Withdrawal of consent|0
802736|NCT00046891|1756237|FG000|Overall Study|Cancels|5
802737|NCT00046891|1756238|FG001|Overall Study|Cancels|9
802738|NCT00046891|1756237|FG000|Overall Study|Ineligible|1
802739|NCT00046891|1756238|FG001|Overall Study|Ineligible|1
802740|NCT00046891|1756237|FG000|Overall Study|Withdrawal by Subject|18
802741|NCT00046891|1756238|FG001|Overall Study|Withdrawal by Subject|15
802742|NCT00046891|1756237|FG000|Overall Study|Adverse Event|5
802743|NCT00046891|1756238|FG001|Overall Study|Adverse Event|5
802744|NCT00046930|1756254|FG000|Overall Study|Ineligible|12
802745|NCT00046930|1756255|FG001|Overall Study|Ineligible|4
802746|NCT00047008|1756266|FG000|Overall Study|Withdrawn consent|2
802747|NCT00047008|1756267|FG001|Overall Study|Withdrawn consent|3
802748|NCT00047008|1756266|FG000|Overall Study|Ineligible|9
802749|NCT00047008|1756267|FG001|Overall Study|Ineligible|8
802750|NCT00047320|1756277|FG000|Overall Study|Lack of Efficacy|8
802751|NCT00047320|1756277|FG000|Overall Study|Lost to Follow-up|1
802752|NCT00047320|1756277|FG000|Overall Study|Physician Decision|8
802753|NCT00047320|1756277|FG000|Overall Study|Withdrawal by Subject|9
802754|NCT00047320|1756277|FG000|Overall Study|Ineligible|2
802755|NCT00047385|1756283|FG000|Overall Study|Death before any screening|2
802756|NCT00047385|1756284|FG001|Overall Study|Death before any screening|5
802757|NCT00047385|1756283|FG000|Overall Study|Lung Cancer diagnosed before screening|5
802758|NCT00047385|1756284|FG001|Overall Study|Lung Cancer diagnosed before screening|3
802759|NCT00047385|1756283|FG000|Overall Study|Eligible for screening but had no screen|260
802760|NCT00047385|1756284|FG001|Overall Study|Eligible for screening but had no screen|492
802761|NCT00047463|1756292|FG000|Overall Study|Withdrawal by Subject|0
802762|NCT00047463|1756293|FG001|Overall Study|Withdrawal by Subject|3
802763|NCT00047879|1756323|FG000|Overall Study|Progressive disease|4
802764|NCT00047879|1756324|FG001|Overall Study|Progressive disease|3
802765|NCT00048035|1756336|FG000|Core Period|Early Withdrawals|4
802766|NCT00048035|1756337|FG001|Core Period|Early Withdrawals|2
802767|NCT00048035|1756338|FG002|Core Period|Early Withdrawals|1
802768|NCT00048035|1756339|FG003|Core Period|Early Withdrawals|1
802769|NCT00048035|1756340|FG004|Core Period|Early Withdrawals|1
802770|NCT00048035|1756341|FG005|Core Period|Early Withdrawals|1
802771|NCT00048035|1756342|FG006|Core Period|Early Withdrawals|0
802772|NCT00048035|1756343|FG007|Core Period|Early Withdrawals|0
802773|NCT00048035|1756336|FG000|Extension Year 1|Early Withdrawals|0
802774|NCT00048035|1756337|FG001|Extension Year 1|Early Withdrawals|0
802775|NCT00048035|1756338|FG002|Extension Year 1|Early Withdrawals|0
802776|NCT00048035|1756339|FG003|Extension Year 1|Early Withdrawals|0
802777|NCT00048035|1756340|FG004|Extension Year 1|Early Withdrawals|0
802778|NCT00048035|1756341|FG005|Extension Year 1|Early Withdrawals|0
802779|NCT00048035|1756342|FG006|Extension Year 1|Early Withdrawals|11
802780|NCT00048035|1756343|FG007|Extension Year 1|Early Withdrawals|11
802781|NCT00048035|1756336|FG000|Extension Year 2|Early Withdrawals|0
802782|NCT00048035|1756337|FG001|Extension Year 2|Early Withdrawals|0
802783|NCT00048035|1756338|FG002|Extension Year 2|Early Withdrawals|0
802784|NCT00048035|1756339|FG003|Extension Year 2|Early Withdrawals|0
802785|NCT00048035|1756340|FG004|Extension Year 2|Early Withdrawals|0
802786|NCT00048035|1756341|FG005|Extension Year 2|Early Withdrawals|0
802787|NCT00048035|1756342|FG006|Extension Year 2|Early Withdrawals|3
802788|NCT00048035|1756343|FG007|Extension Year 2|Early Withdrawals|3
802789|NCT00048048|1756367|FG000|Core Treatment|Withdrawal by Subject|0
802790|NCT00048048|1756368|FG001|Core Treatment|Withdrawal by Subject|0
802791|NCT00048048|1756369|FG002|Core Treatment|Withdrawal by Subject|1
802792|NCT00048048|1756370|FG003|Core Treatment|Withdrawal by Subject|0
802793|NCT00048048|1756371|FG004|Core Treatment|Withdrawal by Subject|0
802794|NCT00048048|1756372|FG005|Core Treatment|Withdrawal by Subject|0
802795|NCT00048048|1756373|FG006|Core Treatment|Withdrawal by Subject|0
802796|NCT00048048|1756374|FG007|Core Treatment|Withdrawal by Subject|0
802797|NCT00048048|1756375|FG008|Core Treatment|Withdrawal by Subject|0
802798|NCT00048048|1756376|FG009|Core Treatment|Withdrawal by Subject|0
802799|NCT00048048|1756377|FG010|Core Treatment|Withdrawal by Subject|0
802800|NCT00048048|1756378|FG011|Core Treatment|Withdrawal by Subject|0
802801|NCT00048048|1756367|FG000|Core Treatment|Adverse Event|0
802802|NCT00048048|1756368|FG001|Core Treatment|Adverse Event|0
802803|NCT00048048|1756369|FG002|Core Treatment|Adverse Event|0
802804|NCT00048048|1756370|FG003|Core Treatment|Adverse Event|0
802805|NCT00048048|1756371|FG004|Core Treatment|Adverse Event|0
802806|NCT00048048|1756372|FG005|Core Treatment|Adverse Event|0
802807|NCT00048048|1756373|FG006|Core Treatment|Adverse Event|0
802808|NCT00048048|1756374|FG007|Core Treatment|Adverse Event|1
802809|NCT00048048|1756375|FG008|Core Treatment|Adverse Event|0
802810|NCT00048048|1756376|FG009|Core Treatment|Adverse Event|0
802811|NCT00048048|1756377|FG010|Core Treatment|Adverse Event|0
802812|NCT00048048|1756378|FG011|Core Treatment|Adverse Event|0
802813|NCT00048048|1756367|FG000|Extension Year 1|Early withdrawals|0
802814|NCT00048048|1756368|FG001|Extension Year 1|Early withdrawals|0
802815|NCT00048048|1756369|FG002|Extension Year 1|Early withdrawals|0
802816|NCT00048048|1756370|FG003|Extension Year 1|Early withdrawals|0
802817|NCT00048048|1756371|FG004|Extension Year 1|Early withdrawals|0
802818|NCT00048048|1756372|FG005|Extension Year 1|Early withdrawals|0
802819|NCT00048048|1756373|FG006|Extension Year 1|Early withdrawals|0
802820|NCT00048048|1756374|FG007|Extension Year 1|Early withdrawals|0
802821|NCT00048048|1756375|FG008|Extension Year 1|Early withdrawals|0
802822|NCT00048048|1756376|FG009|Extension Year 1|Early withdrawals|2
802823|NCT00048048|1756377|FG010|Extension Year 1|Early withdrawals|2
802824|NCT00048048|1756378|FG011|Extension Year 1|Early withdrawals|4
802825|NCT00048048|1756367|FG000|Extension Year 2|Early withdrawals|0
802826|NCT00048048|1756368|FG001|Extension Year 2|Early withdrawals|0
802827|NCT00048048|1756369|FG002|Extension Year 2|Early withdrawals|0
802828|NCT00048048|1756370|FG003|Extension Year 2|Early withdrawals|0
802829|NCT00048048|1756371|FG004|Extension Year 2|Early withdrawals|0
802830|NCT00048048|1756372|FG005|Extension Year 2|Early withdrawals|0
802831|NCT00048048|1756373|FG006|Extension Year 2|Early withdrawals|0
802832|NCT00048048|1756374|FG007|Extension Year 2|Early withdrawals|0
802833|NCT00048048|1756375|FG008|Extension Year 2|Early withdrawals|0
802834|NCT00048048|1756376|FG009|Extension Year 2|Early withdrawals|0
802835|NCT00048048|1756377|FG010|Extension Year 2|Early withdrawals|4
802836|NCT00048048|1756378|FG011|Extension Year 2|Early withdrawals|2
802837|NCT00048061|1756409|FG000|Overall Study|Adverse Event|41
802838|NCT00048061|1756410|FG001|Overall Study|Adverse Event|32
802839|NCT00048061|1756411|FG002|Overall Study|Adverse Event|44
802840|NCT00048061|1756412|FG003|Overall Study|Adverse Event|37
802841|NCT00048061|1756409|FG000|Overall Study|Lost to Follow-up|3
802842|NCT00048061|1756410|FG001|Overall Study|Lost to Follow-up|2
802843|NCT00048061|1756411|FG002|Overall Study|Lost to Follow-up|4
802844|NCT00048061|1756412|FG003|Overall Study|Lost to Follow-up|5
802845|NCT00048061|1756409|FG000|Overall Study|Withdrawal by Subject|20
802846|NCT00048061|1756410|FG001|Overall Study|Withdrawal by Subject|29
802847|NCT00048061|1756411|FG002|Overall Study|Withdrawal by Subject|29
802848|NCT00048061|1756412|FG003|Overall Study|Withdrawal by Subject|32
802849|NCT00048061|1756409|FG000|Overall Study|Did not follow-up|5
802850|NCT00048061|1756410|FG001|Overall Study|Did not follow-up|5
802851|NCT00048061|1756411|FG002|Overall Study|Did not follow-up|4
802852|NCT00048061|1756412|FG003|Overall Study|Did not follow-up|5
802853|NCT00048061|1756409|FG000|Overall Study|Early improvement|6
802854|NCT00048061|1756410|FG001|Overall Study|Early improvement|5
802855|NCT00048061|1756411|FG002|Overall Study|Early improvement|3
802856|NCT00048061|1756412|FG003|Overall Study|Early improvement|0
802857|NCT00048074|1756425|FG000|Overall Study|Adverse Event|46
802858|NCT00048074|1756426|FG001|Overall Study|Adverse Event|41
802859|NCT00048074|1756427|FG002|Overall Study|Adverse Event|53
802860|NCT00048074|1756425|FG000|Overall Study|Death|3
802861|NCT00048074|1756426|FG001|Overall Study|Death|3
802862|NCT00048074|1756427|FG002|Overall Study|Death|2
802863|NCT00048074|1756425|FG000|Overall Study|Lost to Follow-up|2
802864|NCT00048074|1756426|FG001|Overall Study|Lost to Follow-up|6
802865|NCT00048074|1756427|FG002|Overall Study|Lost to Follow-up|6
802866|NCT00048074|1756425|FG000|Overall Study|Withdrawal by Subject|28
802867|NCT00048074|1756426|FG001|Overall Study|Withdrawal by Subject|30
802868|NCT00048074|1756427|FG002|Overall Study|Withdrawal by Subject|35
802869|NCT00048074|1756425|FG000|Overall Study|Protocol Violation|1
802870|NCT00048074|1756426|FG001|Overall Study|Protocol Violation|3
802871|NCT00048074|1756427|FG002|Overall Study|Protocol Violation|0
802872|NCT00048074|1756425|FG000|Overall Study|Study participation was terminated|0
802873|NCT00048074|1756426|FG001|Overall Study|Study participation was terminated|1
802874|NCT00048074|1756427|FG002|Overall Study|Study participation was terminated|0
802875|NCT00048074|1756425|FG000|Overall Study|Husband ill|0
802876|NCT00048074|1756426|FG001|Overall Study|Husband ill|1
802877|NCT00048074|1756427|FG002|Overall Study|Husband ill|0
802878|NCT00048074|1756425|FG000|Overall Study|Poor compliance|0
802879|NCT00048074|1756426|FG001|Overall Study|Poor compliance|1
802880|NCT00048074|1756427|FG002|Overall Study|Poor compliance|0
802881|NCT00048074|1756425|FG000|Overall Study|Out of station|0
802882|NCT00048074|1756426|FG001|Overall Study|Out of station|1
802883|NCT00048074|1756427|FG002|Overall Study|Out of station|1
802884|NCT00048074|1756425|FG000|Overall Study|Social reasons|1
802885|NCT00048074|1756426|FG001|Overall Study|Social reasons|0
802886|NCT00048074|1756427|FG002|Overall Study|Social reasons|0
802887|NCT00048165|1756437|FG000|Completed 6 Months Study|Administration/Other|8
802888|NCT00048165|1756438|FG001|Completed 6 Months Study|Administration/Other|8
802889|NCT00048165|1756437|FG000|Completed 6 Months Study|Abnormality of laboratory test|1
802890|NCT00048165|1756438|FG001|Completed 6 Months Study|Abnormality of laboratory test|0
802891|NCT00048165|1756437|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14
802892|NCT00048165|1756438|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11
802893|NCT00048165|1756437|FG000|Completed 6 Months Study|Death|12
802894|NCT00048165|1756438|FG001|Completed 6 Months Study|Death|6
802895|NCT00048165|1756437|FG000|Completed 6 Months Study|Insufficient therapy|1
802896|NCT00048165|1756438|FG001|Completed 6 Months Study|Insufficient therapy|4
802897|NCT00048165|1756437|FG000|Completed 6 Months Study|Other violation|4
802898|NCT00048165|1756438|FG001|Completed 6 Months Study|Other violation|6
802899|NCT00048165|1756437|FG000|Completed 6 Months Study|Refused treatment|5
802900|NCT00048165|1756438|FG001|Completed 6 Months Study|Refused treatment|5
802901|NCT00048165|1756437|FG000|Completed 6 Months Study|Violation criteria|0
802902|NCT00048165|1756438|FG001|Completed 6 Months Study|Violation criteria|2
802903|NCT00048165|1756437|FG000|Completed 6 Months Study|Did not receive study drug|6
802904|NCT00048165|1756438|FG001|Completed 6 Months Study|Did not receive study drug|6
802905|NCT00048165|1756437|FG000|Completed 12 Months Study|Administration/Other|0
802906|NCT00048165|1756438|FG001|Completed 12 Months Study|Administration/Other|2
802907|NCT00048165|1756437|FG000|Completed 12 Months Study|Death|2
802908|NCT00048165|1756438|FG001|Completed 12 Months Study|Death|1
802909|NCT00048165|1756437|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1
802910|NCT00048165|1756438|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0
802911|NCT00048347|1756446|FG000|Overall Study|Screen failure|2
802912|NCT00048542|1756454|FG000|Double-Blind Phase|Withdrawal by Subject|0
802913|NCT00048542|1756455|FG001|Double-Blind Phase|Withdrawal by Subject|1
802914|NCT00048542|1756456|FG002|Double-Blind Phase|Withdrawal by Subject|0
802915|NCT00048542|1756457|FG003|Double-Blind Phase|Withdrawal by Subject|0
802916|NCT00048542|1756458|FG004|Double-Blind Phase|Withdrawal by Subject|0
802917|NCT00048542|1756459|FG005|Double-Blind Phase|Withdrawal by Subject|0
802918|NCT00048542|1756460|FG006|Double-Blind Phase|Withdrawal by Subject|0
802919|NCT00048542|1756461|FG007|Double-Blind Phase|Withdrawal by Subject|0
802920|NCT00048542|1756454|FG000|Double-Blind Phase|Protocol Violation|0
802921|NCT00048542|1756455|FG001|Double-Blind Phase|Protocol Violation|0
802922|NCT00048542|1756456|FG002|Double-Blind Phase|Protocol Violation|1
802923|NCT00048542|1756457|FG003|Double-Blind Phase|Protocol Violation|0
802924|NCT00048542|1756458|FG004|Double-Blind Phase|Protocol Violation|0
802925|NCT00048542|1756459|FG005|Double-Blind Phase|Protocol Violation|0
802926|NCT00048542|1756460|FG006|Double-Blind Phase|Protocol Violation|0
802927|NCT00048542|1756461|FG007|Double-Blind Phase|Protocol Violation|0
802928|NCT00048542|1756454|FG000|Double-Blind Phase|Sponsor request or decision|2
802929|NCT00048542|1756455|FG001|Double-Blind Phase|Sponsor request or decision|0
802930|NCT00048542|1756456|FG002|Double-Blind Phase|Sponsor request or decision|0
802931|NCT00048542|1756457|FG003|Double-Blind Phase|Sponsor request or decision|0
802932|NCT00048542|1756458|FG004|Double-Blind Phase|Sponsor request or decision|0
802933|NCT00048542|1756459|FG005|Double-Blind Phase|Sponsor request or decision|0
802934|NCT00048542|1756460|FG006|Double-Blind Phase|Sponsor request or decision|0
802935|NCT00048542|1756461|FG007|Double-Blind Phase|Sponsor request or decision|0
802936|NCT00048542|1756454|FG000|Double-Blind Phase|Randomized in error|1
802937|NCT00048542|1756455|FG001|Double-Blind Phase|Randomized in error|0
802938|NCT00048542|1756456|FG002|Double-Blind Phase|Randomized in error|0
802939|NCT00048542|1756457|FG003|Double-Blind Phase|Randomized in error|0
802940|NCT00048542|1756458|FG004|Double-Blind Phase|Randomized in error|0
802941|NCT00048542|1756459|FG005|Double-Blind Phase|Randomized in error|0
802942|NCT00048542|1756460|FG006|Double-Blind Phase|Randomized in error|0
802943|NCT00048542|1756461|FG007|Double-Blind Phase|Randomized in error|0
802944|NCT00048542|1756454|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0
802945|NCT00048542|1756455|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0
802946|NCT00048542|1756456|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0
802947|NCT00048542|1756457|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0
802948|NCT00048542|1756458|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3
802949|NCT00048542|1756459|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6
802950|NCT00048542|1756460|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0
802951|NCT00048542|1756461|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0
802952|NCT00048542|1756454|FG000|Open-Label Extension BSA Phase|Protocol Violation|0
802953|NCT00048542|1756455|FG001|Open-Label Extension BSA Phase|Protocol Violation|0
802954|NCT00048542|1756456|FG002|Open-Label Extension BSA Phase|Protocol Violation|0
802955|NCT00048542|1756457|FG003|Open-Label Extension BSA Phase|Protocol Violation|0
802956|NCT00048542|1756458|FG004|Open-Label Extension BSA Phase|Protocol Violation|0
802957|NCT00048542|1756459|FG005|Open-Label Extension BSA Phase|Protocol Violation|1
802958|NCT00048542|1756460|FG006|Open-Label Extension BSA Phase|Protocol Violation|0
802959|NCT00048542|1756461|FG007|Open-Label Extension BSA Phase|Protocol Violation|0
802960|NCT00048542|1756454|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0
802961|NCT00048542|1756455|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0
802962|NCT00048542|1756456|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0
802963|NCT00048542|1756457|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0
802964|NCT00048542|1756458|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5
802965|NCT00048542|1756459|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1
802966|NCT00048542|1756460|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0
802967|NCT00048542|1756461|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0
802968|NCT00048542|1756454|FG000|Open-Label Extension BSA Phase|Adverse Event|0
802969|NCT00048542|1756455|FG001|Open-Label Extension BSA Phase|Adverse Event|0
802970|NCT00048542|1756456|FG002|Open-Label Extension BSA Phase|Adverse Event|0
802971|NCT00048542|1756457|FG003|Open-Label Extension BSA Phase|Adverse Event|0
802972|NCT00048542|1756458|FG004|Open-Label Extension BSA Phase|Adverse Event|1
802973|NCT00048542|1756459|FG005|Open-Label Extension BSA Phase|Adverse Event|1
802974|NCT00048542|1756460|FG006|Open-Label Extension BSA Phase|Adverse Event|0
802975|NCT00048542|1756461|FG007|Open-Label Extension BSA Phase|Adverse Event|0
802976|NCT00048542|1756454|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0
802977|NCT00048542|1756455|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0
802978|NCT00048542|1756456|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0
802979|NCT00048542|1756457|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0
802980|NCT00048542|1756458|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3
802981|NCT00048542|1756459|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1
802982|NCT00048542|1756460|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0
802983|NCT00048542|1756461|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0
802984|NCT00048542|1756454|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
802985|NCT00048542|1756455|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
802986|NCT00048542|1756456|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
802987|NCT00048542|1756457|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
802988|NCT00048542|1756458|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
802989|NCT00048542|1756459|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
802990|NCT00048542|1756460|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
802991|NCT00048542|1756461|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
802992|NCT00048542|1756454|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
802993|NCT00048542|1756455|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
802994|NCT00048542|1756456|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
802995|NCT00048542|1756457|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
802996|NCT00048542|1756458|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
802997|NCT00048542|1756459|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
802998|NCT00048542|1756460|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
802999|NCT00048542|1756461|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
803000|NCT00048542|1756454|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
803001|NCT00048542|1756455|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
803002|NCT00048542|1756456|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
803003|NCT00048542|1756457|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
803004|NCT00048542|1756458|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
803005|NCT00048542|1756459|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
803006|NCT00048542|1756460|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
803007|NCT00048542|1756461|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
803008|NCT00048542|1756454|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0
803009|NCT00048542|1756455|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0
803010|NCT00048542|1756456|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0
803011|NCT00048542|1756457|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0
803012|NCT00048542|1756458|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0
803013|NCT00048542|1756459|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0
803014|NCT00048542|1756460|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2
803015|NCT00048542|1756461|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2
803016|NCT00048542|1756454|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
803017|NCT00048542|1756455|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
803018|NCT00048542|1756456|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
803019|NCT00048542|1756457|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
803020|NCT00048542|1756458|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
803021|NCT00048542|1756459|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
803022|NCT00048542|1756460|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
803023|NCT00048542|1756461|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
803024|NCT00048542|1756454|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
803025|NCT00048542|1756455|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
803026|NCT00048542|1756456|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
803027|NCT00048542|1756457|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
803028|NCT00048542|1756458|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
803029|NCT00048542|1756459|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
803030|NCT00048542|1756460|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
803031|NCT00048542|1756461|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
803032|NCT00048568|1756492|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11
803033|NCT00048568|1756493|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3
803034|NCT00048568|1756494|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0
803035|NCT00048568|1756492|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
803036|NCT00048568|1756493|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
803037|NCT00048568|1756494|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
803038|NCT00048568|1756492|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
803039|NCT00048568|1756493|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
803040|NCT00048568|1756494|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
803041|NCT00048568|1756492|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
803042|NCT00048568|1756493|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
803043|NCT00048568|1756494|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
803044|NCT00048568|1756492|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2
803045|NCT00048568|1756493|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4
803046|NCT00048568|1756494|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0
803047|NCT00048568|1756492|FG000|Double-Blind Period Days 170 to 365|Death|1
803048|NCT00048568|1756493|FG001|Double-Blind Period Days 170 to 365|Death|1
803049|NCT00048568|1756494|FG002|Double-Blind Period Days 170 to 365|Death|0
803050|NCT00048568|1756492|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7
803051|NCT00048568|1756493|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1
803052|NCT00048568|1756494|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0
803053|NCT00048568|1756492|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
803054|NCT00048568|1756493|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
803055|NCT00048568|1756494|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
803056|NCT00048568|1756492|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
803057|NCT00048568|1756493|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
803058|NCT00048568|1756494|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
803059|NCT00048568|1756492|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
803060|NCT00048568|1756493|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
803061|NCT00048568|1756494|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
803062|NCT00048568|1756492|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2
803063|NCT00048568|1756493|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0
803064|NCT00048568|1756494|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0
803065|NCT00048568|1756492|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
803066|NCT00048568|1756493|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
803067|NCT00048568|1756494|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
803068|NCT00048568|1756492|FG000|Open-Label Period|Death|0
803069|NCT00048568|1756493|FG001|Open-Label Period|Death|0
803070|NCT00048568|1756494|FG002|Open-Label Period|Death|13
803071|NCT00048568|1756492|FG000|Open-Label Period|Adverse Event|0
803072|NCT00048568|1756493|FG001|Open-Label Period|Adverse Event|0
803073|NCT00048568|1756494|FG002|Open-Label Period|Adverse Event|49
803074|NCT00048568|1756492|FG000|Open-Label Period|Lack of Efficacy|0
803075|NCT00048568|1756493|FG001|Open-Label Period|Lack of Efficacy|0
803076|NCT00048568|1756494|FG002|Open-Label Period|Lack of Efficacy|32
803077|NCT00048568|1756492|FG000|Open-Label Period|Withdrawal by Subject|0
803078|NCT00048568|1756493|FG001|Open-Label Period|Withdrawal by Subject|0
803079|NCT00048568|1756494|FG002|Open-Label Period|Withdrawal by Subject|26
803080|NCT00048568|1756492|FG000|Open-Label Period|Pregnancy|0
803081|NCT00048568|1756493|FG001|Open-Label Period|Pregnancy|0
803082|NCT00048568|1756494|FG002|Open-Label Period|Pregnancy|5
803083|NCT00048568|1756492|FG000|Open-Label Period|No Longer Met Study Criteria|0
803084|NCT00048568|1756493|FG001|Open-Label Period|No Longer Met Study Criteria|0
803085|NCT00048568|1756494|FG002|Open-Label Period|No Longer Met Study Criteria|2
803086|NCT00048568|1756492|FG000|Open-Label Period|Administrative Decision By Sponsor|0
803087|NCT00048568|1756493|FG001|Open-Label Period|Administrative Decision By Sponsor|0
803088|NCT00048568|1756494|FG002|Open-Label Period|Administrative Decision By Sponsor|1
803089|NCT00048568|1756492|FG000|Open-Label Period|Unknown Reasons|0
803090|NCT00048568|1756493|FG001|Open-Label Period|Unknown Reasons|0
803091|NCT00048568|1756494|FG002|Open-Label Period|Unknown Reasons|25
803092|NCT00048568|1756492|FG000|Open-Label Period|Lost to Follow-up|0
803093|NCT00048568|1756493|FG001|Open-Label Period|Lost to Follow-up|0
803094|NCT00048568|1756494|FG002|Open-Label Period|Lost to Follow-up|7
803095|NCT00048581|1756517|FG000|Double-Blind Period|Adverse Event|9
803096|NCT00048581|1756518|FG001|Double-Blind Period|Adverse Event|5
803097|NCT00048581|1756519|FG002|Double-Blind Period|Adverse Event|0
803098|NCT00048581|1756517|FG000|Double-Blind Period|Lack of Efficacy|14
803099|NCT00048581|1756518|FG001|Double-Blind Period|Lack of Efficacy|27
803100|NCT00048581|1756519|FG002|Double-Blind Period|Lack of Efficacy|0
803101|NCT00048581|1756517|FG000|Double-Blind Period|Lost to Follow-up|5
803102|NCT00048581|1756518|FG001|Double-Blind Period|Lost to Follow-up|0
803103|NCT00048581|1756519|FG002|Double-Blind Period|Lost to Follow-up|0
803104|NCT00048581|1756517|FG000|Double-Blind Period|Withdrawal by Subject|5
803105|NCT00048581|1756518|FG001|Double-Blind Period|Withdrawal by Subject|2
803106|NCT00048581|1756519|FG002|Double-Blind Period|Withdrawal by Subject|0
803107|NCT00048581|1756517|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1
803108|NCT00048581|1756518|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0
803109|NCT00048581|1756519|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0
803110|NCT00048581|1756517|FG000|Double-Blind Period|Investigator Decision|1
803111|NCT00048581|1756518|FG001|Double-Blind Period|Investigator Decision|0
803112|NCT00048581|1756519|FG002|Double-Blind Period|Investigator Decision|0
803113|NCT00048581|1756517|FG000|Open-Label Period|Death|0
803114|NCT00048581|1756518|FG001|Open-Label Period|Death|0
803115|NCT00048581|1756519|FG002|Open-Label Period|Death|4
803116|NCT00048581|1756517|FG000|Open-Label Period|Adverse Event|0
803117|NCT00048581|1756518|FG001|Open-Label Period|Adverse Event|0
803118|NCT00048581|1756519|FG002|Open-Label Period|Adverse Event|37
803119|NCT00048581|1756517|FG000|Open-Label Period|Lack of Efficacy|0
803120|NCT00048581|1756518|FG001|Open-Label Period|Lack of Efficacy|0
803121|NCT00048581|1756519|FG002|Open-Label Period|Lack of Efficacy|69
803122|NCT00048581|1756517|FG000|Open-Label Period|Lost to Follow-up|0
803123|NCT00048581|1756518|FG001|Open-Label Period|Lost to Follow-up|0
803124|NCT00048581|1756519|FG002|Open-Label Period|Lost to Follow-up|14
803125|NCT00048581|1756517|FG000|Open-Label Period|Withdrawal by Subject|0
803126|NCT00048581|1756518|FG001|Open-Label Period|Withdrawal by Subject|0
803127|NCT00048581|1756519|FG002|Open-Label Period|Withdrawal by Subject|20
803128|NCT00048581|1756517|FG000|Open-Label Period|No Longer Meets Study Criteria|0
803129|NCT00048581|1756518|FG001|Open-Label Period|No Longer Meets Study Criteria|0
803130|NCT00048581|1756519|FG002|Open-Label Period|No Longer Meets Study Criteria|2
803131|NCT00048581|1756517|FG000|Open-Label Period|Poor/Non-compliance|0
803132|NCT00048581|1756518|FG001|Open-Label Period|Poor/Non-compliance|0
803133|NCT00048581|1756519|FG002|Open-Label Period|Poor/Non-compliance|5
803134|NCT00048581|1756517|FG000|Open-Label Period|Pregnancy|0
803135|NCT00048581|1756518|FG001|Open-Label Period|Pregnancy|0
803136|NCT00048581|1756519|FG002|Open-Label Period|Pregnancy|7
803137|NCT00048581|1756517|FG000|Open-Label Period|Study Site Closure|0
803138|NCT00048581|1756518|FG001|Open-Label Period|Study Site Closure|0
803139|NCT00048581|1756519|FG002|Open-Label Period|Study Site Closure|2
803140|NCT00048581|1756517|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0
803141|NCT00048581|1756518|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0
803142|NCT00048581|1756519|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3
803143|NCT00048581|1756517|FG000|Open-Label Period|Problem With Transportation To Site|0
803144|NCT00048581|1756518|FG001|Open-Label Period|Problem With Transportation To Site|0
803145|NCT00048581|1756519|FG002|Open-Label Period|Problem With Transportation To Site|1
803146|NCT00048581|1756517|FG000|Open-Label Period|Primary Investigator Retired|0
803147|NCT00048581|1756518|FG001|Open-Label Period|Primary Investigator Retired|0
803148|NCT00048581|1756519|FG002|Open-Label Period|Primary Investigator Retired|2
803149|NCT00048581|1756517|FG000|Open-Label Period|Study Ended By Sponsor|0
803150|NCT00048581|1756518|FG001|Open-Label Period|Study Ended By Sponsor|0
803151|NCT00048581|1756519|FG002|Open-Label Period|Study Ended By Sponsor|1
803152|NCT00048724|1756534|FG000|Overall Study|Adverse Event|53
803153|NCT00048724|1756535|FG001|Overall Study|Adverse Event|12
803154|NCT00048724|1756534|FG000|Overall Study|Withdrawal by Subject|34
803155|NCT00048724|1756535|FG001|Overall Study|Withdrawal by Subject|54
803156|NCT00048724|1756534|FG000|Overall Study|Lost to Follow-up|5
803157|NCT00048724|1756535|FG001|Overall Study|Lost to Follow-up|5
803158|NCT00048724|1756534|FG000|Overall Study|Protocol-defined Clinical Event|17
803159|NCT00048724|1756535|FG001|Overall Study|Protocol-defined Clinical Event|32
803160|NCT00048724|1756534|FG000|Overall Study|Noncompliance With Protocol|4
803161|NCT00048724|1756535|FG001|Overall Study|Noncompliance With Protocol|12
803162|NCT00048724|1756534|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
803163|NCT00048724|1756535|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
803164|NCT00048724|1756534|FG000|Overall Study|Administrative|1
803165|NCT00048724|1756535|FG001|Overall Study|Administrative|1
803166|NCT00048932|1756564|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1
803167|NCT00048932|1756565|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0
803168|NCT00048932|1756566|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0
803169|NCT00048932|1756564|FG000|Double Blind Period (DB)|Adverse Event|51
803170|NCT00048932|1756565|FG001|Double Blind Period (DB)|Adverse Event|19
803171|NCT00048932|1756566|FG002|Double Blind Period (DB)|Adverse Event|0
803172|NCT00048932|1756564|FG000|Double Blind Period (DB)|Death|5
803173|NCT00048932|1756565|FG001|Double Blind Period (DB)|Death|3
803174|NCT00048932|1756566|FG002|Double Blind Period (DB)|Death|0
803175|NCT00048932|1756564|FG000|Double Blind Period (DB)|Lack of Efficacy|26
803176|NCT00048932|1756565|FG001|Double Blind Period (DB)|Lack of Efficacy|44
803177|NCT00048932|1756566|FG002|Double Blind Period (DB)|Lack of Efficacy|0
803178|NCT00048932|1756564|FG000|Double Blind Period (DB)|Lost to Follow-up|3
803179|NCT00048932|1756565|FG001|Double Blind Period (DB)|Lost to Follow-up|4
803180|NCT00048932|1756566|FG002|Double Blind Period (DB)|Lost to Follow-up|0
803181|NCT00048932|1756564|FG000|Double Blind Period (DB)|Relocation|1
803182|NCT00048932|1756565|FG001|Double Blind Period (DB)|Relocation|0
803183|NCT00048932|1756566|FG002|Double Blind Period (DB)|Relocation|0
803184|NCT00048932|1756564|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0
803185|NCT00048932|1756565|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1
803186|NCT00048932|1756566|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0
803187|NCT00048932|1756564|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
803188|NCT00048932|1756565|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
803189|NCT00048932|1756566|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
803190|NCT00048932|1756564|FG000|Double Blind Period (DB)|Pregnancy|1
803191|NCT00048932|1756565|FG001|Double Blind Period (DB)|Pregnancy|0
803192|NCT00048932|1756566|FG002|Double Blind Period (DB)|Pregnancy|0
803193|NCT00048932|1756564|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8
803194|NCT00048932|1756565|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2
803195|NCT00048932|1756566|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0
803196|NCT00048932|1756564|FG000|Double Blind Period (DB)|Withdrawal by Subject|24
803197|NCT00048932|1756565|FG001|Double Blind Period (DB)|Withdrawal by Subject|10
803198|NCT00048932|1756566|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
803199|NCT00048932|1756564|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2
803200|NCT00048932|1756565|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4
803201|NCT00048932|1756566|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0
803202|NCT00048932|1756564|FG000|Open Label Period (OL)|Death|0
803203|NCT00048932|1756565|FG001|Open Label Period (OL)|Death|0
803204|NCT00048932|1756566|FG002|Open Label Period (OL)|Death|25
803205|NCT00048932|1756564|FG000|Open Label Period (OL)|Adverse Event|0
803206|NCT00048932|1756565|FG001|Open Label Period (OL)|Adverse Event|0
803207|NCT00048932|1756566|FG002|Open Label Period (OL)|Adverse Event|103
803208|NCT00048932|1756564|FG000|Open Label Period (OL)|Lack of Efficacy|0
803209|NCT00048932|1756565|FG001|Open Label Period (OL)|Lack of Efficacy|0
803210|NCT00048932|1756566|FG002|Open Label Period (OL)|Lack of Efficacy|81
803211|NCT00048932|1756564|FG000|Open Label Period (OL)|Lost to Follow-up|0
803212|NCT00048932|1756565|FG001|Open Label Period (OL)|Lost to Follow-up|0
803213|NCT00048932|1756566|FG002|Open Label Period (OL)|Lost to Follow-up|27
803214|NCT00048932|1756564|FG000|Open Label Period (OL)|Withdrawal by Subject|0
803215|NCT00048932|1756565|FG001|Open Label Period (OL)|Withdrawal by Subject|0
803216|NCT00048932|1756566|FG002|Open Label Period (OL)|Withdrawal by Subject|117
803217|NCT00048932|1756564|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0
803218|NCT00048932|1756565|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0
803219|NCT00048932|1756566|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5
803220|NCT00048932|1756564|FG000|Open Label Period (OL)|Poor/Non-Compliance|0
803221|NCT00048932|1756565|FG001|Open Label Period (OL)|Poor/Non-Compliance|0
803222|NCT00048932|1756566|FG002|Open Label Period (OL)|Poor/Non-Compliance|13
803223|NCT00048932|1756564|FG000|Open Label Period (OL)|Pregnancy|0
803224|NCT00048932|1756565|FG001|Open Label Period (OL)|Pregnancy|0
803225|NCT00048932|1756566|FG002|Open Label Period (OL)|Pregnancy|6
803226|NCT00048932|1756564|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0
803227|NCT00048932|1756565|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0
803228|NCT00048932|1756566|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20
803229|NCT00048932|1756564|FG000|Open Label Period (OL)|Investigator Retiring|0
803230|NCT00048932|1756565|FG001|Open Label Period (OL)|Investigator Retiring|0
803231|NCT00048932|1756566|FG002|Open Label Period (OL)|Investigator Retiring|2
803232|NCT00048932|1756564|FG000|Open Label Period (OL)|Participant Transportation Issues|0
803233|NCT00048932|1756565|FG001|Open Label Period (OL)|Participant Transportation Issues|0
803234|NCT00048932|1756566|FG002|Open Label Period (OL)|Participant Transportation Issues|1
803235|NCT00048932|1756564|FG000|Open Label Period (OL)|Participant Relocated|0
803236|NCT00048932|1756565|FG001|Open Label Period (OL)|Participant Relocated|0
803237|NCT00048932|1756566|FG002|Open Label Period (OL)|Participant Relocated|6
803238|NCT00048932|1756564|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0
803239|NCT00048932|1756565|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0
803240|NCT00048932|1756566|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1
803241|NCT00048932|1756564|FG000|Open Label Period (OL)|Site Closure|0
803242|NCT00048932|1756565|FG001|Open Label Period (OL)|Site Closure|0
803243|NCT00048932|1756566|FG002|Open Label Period (OL)|Site Closure|3
803244|NCT00048932|1756564|FG000|Open Label Period (OL)|Trial Terminated|0
803245|NCT00048932|1756565|FG001|Open Label Period (OL)|Trial Terminated|0
803246|NCT00048932|1756566|FG002|Open Label Period (OL)|Trial Terminated|1
803247|NCT00048932|1756564|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0
803248|NCT00048932|1756565|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0
803249|NCT00048932|1756566|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1
803250|NCT00048932|1756564|FG000|Open Label Period (OL)|Patient Decision|0
803251|NCT00048932|1756565|FG001|Open Label Period (OL)|Patient Decision|0
803252|NCT00048932|1756566|FG002|Open Label Period (OL)|Patient Decision|4
803253|NCT00048932|1756564|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0
803254|NCT00048932|1756565|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0
803255|NCT00048932|1756566|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1
803256|NCT00048932|1756564|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0
803257|NCT00048932|1756565|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0
803258|NCT00048932|1756566|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2
803259|NCT00048932|1756564|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0
803260|NCT00048932|1756565|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0
803261|NCT00048932|1756566|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5
803262|NCT00048932|1756564|FG000|Open Label Period (OL)|Medication Lost Efficacy|0
803263|NCT00048932|1756565|FG001|Open Label Period (OL)|Medication Lost Efficacy|0
803264|NCT00048932|1756566|FG002|Open Label Period (OL)|Medication Lost Efficacy|1
803265|NCT00048932|1756564|FG000|Open Label Period (OL)|Investigator Decision|0
803266|NCT00048932|1756565|FG001|Open Label Period (OL)|Investigator Decision|0
803267|NCT00048932|1756566|FG002|Open Label Period (OL)|Investigator Decision|4
803268|NCT00048932|1756564|FG000|Open Label Period (OL)|Site Staff Issues|0
803269|NCT00048932|1756565|FG001|Open Label Period (OL)|Site Staff Issues|0
803270|NCT00048932|1756566|FG002|Open Label Period (OL)|Site Staff Issues|2
803271|NCT00048932|1756564|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0
803272|NCT00048932|1756565|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0
803273|NCT00048932|1756566|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9
803274|NCT00048932|1756564|FG000|Open Label Period (OL)|Participant Surgery|0
803275|NCT00048932|1756565|FG001|Open Label Period (OL)|Participant Surgery|0
803276|NCT00048932|1756566|FG002|Open Label Period (OL)|Participant Surgery|1
803277|NCT00048997|1756577|FG000|Overall Study|Protocol Violation|7
803278|NCT00048997|1756578|FG001|Overall Study|Protocol Violation|2
803279|NCT00048997|1756577|FG000|Overall Study|Withdrawal by Subject|6
803280|NCT00048997|1756578|FG001|Overall Study|Withdrawal by Subject|1
803281|NCT00049127|1756597|FG000|Overall Study|Withdrawal by Subject|0
803282|NCT00049127|1756598|FG001|Overall Study|Withdrawal by Subject|0
803283|NCT00049127|1756599|FG002|Overall Study|Withdrawal by Subject|1
803284|NCT00049127|1756600|FG003|Overall Study|Withdrawal by Subject|0
803285|NCT00049127|1756601|FG004|Overall Study|Withdrawal by Subject|0
803286|NCT00049257|1756613|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10
803287|NCT00049257|1756613|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1
803288|NCT00049257|1756613|FG000|Carboplatin, Paclitaxel|Death|2
803289|NCT00049257|1756613|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4
803290|NCT00049322|1756619|FG000|Overall Study|disease burden|0
803291|NCT00049322|1756620|FG001|Overall Study|disease burden|3
803292|NCT00049322|1756619|FG000|Overall Study|Adverse Event|1
803293|NCT00049322|1756620|FG001|Overall Study|Adverse Event|0
803294|NCT00049322|1756619|FG000|Overall Study|refused angio|0
803295|NCT00049322|1756620|FG001|Overall Study|refused angio|3
803296|NCT00049517|1756634|FG000|Induction|Disease progression|0
803297|NCT00049517|1756635|FG001|Induction|Disease progression|0
803298|NCT00049517|1756636|FG002|Induction|Disease progression|0
803299|NCT00049517|1756637|FG003|Induction|Disease progression|0
803300|NCT00049517|1756638|FG004|Induction|Disease progression|18
803301|NCT00049517|1756639|FG005|Induction|Disease progression|11
803302|NCT00049517|1756634|FG000|Induction|Adverse Event|0
803303|NCT00049517|1756635|FG001|Induction|Adverse Event|0
803304|NCT00049517|1756636|FG002|Induction|Adverse Event|0
803305|NCT00049517|1756637|FG003|Induction|Adverse Event|0
803306|NCT00049517|1756638|FG004|Induction|Adverse Event|5
803307|NCT00049517|1756639|FG005|Induction|Adverse Event|7
803308|NCT00049517|1756634|FG000|Induction|Death|0
803309|NCT00049517|1756635|FG001|Induction|Death|0
803310|NCT00049517|1756636|FG002|Induction|Death|0
803311|NCT00049517|1756637|FG003|Induction|Death|0
803312|NCT00049517|1756638|FG004|Induction|Death|9
803313|NCT00049517|1756639|FG005|Induction|Death|6
803314|NCT00049517|1756634|FG000|Induction|Withdrawal by Subject|0
803315|NCT00049517|1756635|FG001|Induction|Withdrawal by Subject|0
803316|NCT00049517|1756636|FG002|Induction|Withdrawal by Subject|0
803317|NCT00049517|1756637|FG003|Induction|Withdrawal by Subject|0
803318|NCT00049517|1756638|FG004|Induction|Withdrawal by Subject|1
803319|NCT00049517|1756639|FG005|Induction|Withdrawal by Subject|3
803320|NCT00049517|1756634|FG000|Induction|Alternative therapy|0
803321|NCT00049517|1756635|FG001|Induction|Alternative therapy|0
803322|NCT00049517|1756636|FG002|Induction|Alternative therapy|0
803323|NCT00049517|1756637|FG003|Induction|Alternative therapy|0
803324|NCT00049517|1756638|FG004|Induction|Alternative therapy|2
803325|NCT00049517|1756639|FG005|Induction|Alternative therapy|2
803326|NCT00049517|1756634|FG000|Induction|Other complicating disease|0
803327|NCT00049517|1756635|FG001|Induction|Other complicating disease|0
803328|NCT00049517|1756636|FG002|Induction|Other complicating disease|0
803329|NCT00049517|1756637|FG003|Induction|Other complicating disease|0
803330|NCT00049517|1756638|FG004|Induction|Other complicating disease|3
803331|NCT00049517|1756639|FG005|Induction|Other complicating disease|0
803332|NCT00049517|1756634|FG000|Induction|Reasons not reported|0
803333|NCT00049517|1756635|FG001|Induction|Reasons not reported|0
803334|NCT00049517|1756636|FG002|Induction|Reasons not reported|0
803335|NCT00049517|1756637|FG003|Induction|Reasons not reported|0
803336|NCT00049517|1756638|FG004|Induction|Reasons not reported|22
803337|NCT00049517|1756639|FG005|Induction|Reasons not reported|25
803338|NCT00049517|1756634|FG000|Conditioning/Transplant|Disease progression|14
803339|NCT00049517|1756635|FG001|Conditioning/Transplant|Disease progression|6
803340|NCT00049517|1756636|FG002|Conditioning/Transplant|Disease progression|10
803341|NCT00049517|1756637|FG003|Conditioning/Transplant|Disease progression|6
803342|NCT00049517|1756638|FG004|Conditioning/Transplant|Disease progression|0
803343|NCT00049517|1756639|FG005|Conditioning/Transplant|Disease progression|0
803344|NCT00049517|1756634|FG000|Conditioning/Transplant|Adverse Event|2
803345|NCT00049517|1756635|FG001|Conditioning/Transplant|Adverse Event|1
803346|NCT00049517|1756636|FG002|Conditioning/Transplant|Adverse Event|4
803347|NCT00049517|1756637|FG003|Conditioning/Transplant|Adverse Event|8
803348|NCT00049517|1756638|FG004|Conditioning/Transplant|Adverse Event|0
803349|NCT00049517|1756639|FG005|Conditioning/Transplant|Adverse Event|0
803350|NCT00049517|1756634|FG000|Conditioning/Transplant|Death|1
803351|NCT00049517|1756635|FG001|Conditioning/Transplant|Death|0
803352|NCT00049517|1756636|FG002|Conditioning/Transplant|Death|0
803353|NCT00049517|1756637|FG003|Conditioning/Transplant|Death|2
803354|NCT00049517|1756638|FG004|Conditioning/Transplant|Death|0
803355|NCT00049517|1756639|FG005|Conditioning/Transplant|Death|0
803356|NCT00049517|1756634|FG000|Conditioning/Transplant|Withdrawal by Subject|4
803357|NCT00049517|1756635|FG001|Conditioning/Transplant|Withdrawal by Subject|8
803358|NCT00049517|1756636|FG002|Conditioning/Transplant|Withdrawal by Subject|4
803359|NCT00049517|1756637|FG003|Conditioning/Transplant|Withdrawal by Subject|7
803360|NCT00049517|1756638|FG004|Conditioning/Transplant|Withdrawal by Subject|0
803361|NCT00049517|1756639|FG005|Conditioning/Transplant|Withdrawal by Subject|0
803362|NCT00049517|1756634|FG000|Conditioning/Transplant|Alternative therapy|4
803363|NCT00049517|1756635|FG001|Conditioning/Transplant|Alternative therapy|4
803364|NCT00049517|1756636|FG002|Conditioning/Transplant|Alternative therapy|2
803365|NCT00049517|1756637|FG003|Conditioning/Transplant|Alternative therapy|1
803366|NCT00049517|1756638|FG004|Conditioning/Transplant|Alternative therapy|1
803367|NCT00049517|1756639|FG005|Conditioning/Transplant|Alternative therapy|0
803368|NCT00049517|1756634|FG000|Conditioning/Transplant|Other complicating disease|2
803369|NCT00049517|1756635|FG001|Conditioning/Transplant|Other complicating disease|0
803370|NCT00049517|1756636|FG002|Conditioning/Transplant|Other complicating disease|0
803371|NCT00049517|1756637|FG003|Conditioning/Transplant|Other complicating disease|4
803372|NCT00049517|1756638|FG004|Conditioning/Transplant|Other complicating disease|0
803373|NCT00049517|1756639|FG005|Conditioning/Transplant|Other complicating disease|1
803374|NCT00049517|1756634|FG000|Conditioning/Transplant|Reasons not reported|25
803375|NCT00049517|1756635|FG001|Conditioning/Transplant|Reasons not reported|31
803376|NCT00049517|1756636|FG002|Conditioning/Transplant|Reasons not reported|18
803377|NCT00049517|1756637|FG003|Conditioning/Transplant|Reasons not reported|15
803378|NCT00049517|1756638|FG004|Conditioning/Transplant|Reasons not reported|5
803379|NCT00049517|1756639|FG005|Conditioning/Transplant|Reasons not reported|5
803380|NCT00049530|1756647|FG000|Overall Study|Lack of Efficacy|25
803381|NCT00049530|1756647|FG000|Overall Study|Adverse Event|2
803382|NCT00049530|1756647|FG000|Overall Study|Death|1
803383|NCT00049530|1756647|FG000|Overall Study|symptomatic deterioration|1
803384|NCT00049530|1756647|FG000|Overall Study|ineligible|3
803385|NCT00049543|1756653|FG000|Overall Study|still on treatment|2
803386|NCT00049543|1756654|FG001|Overall Study|still on treatment|9
803387|NCT00049673|1756662|FG000|Overall Study|No receive treatment/lost to follow-up|1
803388|NCT00049673|1756663|FG001|Overall Study|No receive treatment/lost to follow-up|3
803389|NCT00049842|1756671|FG000|Treatment Phase|Adverse Event|47
803390|NCT00049842|1756672|FG001|Treatment Phase|Adverse Event|12
803391|NCT00049842|1756671|FG000|Treatment Phase|Withdrawal by Subject|35
803392|NCT00049842|1756672|FG001|Treatment Phase|Withdrawal by Subject|46
803393|NCT00049842|1756671|FG000|Treatment Phase|Non-compliance with protocol|7
803394|NCT00049842|1756672|FG001|Treatment Phase|Non-compliance with protocol|8
803395|NCT00049842|1756671|FG000|Treatment Phase|Lost to Follow-up|4
803396|NCT00049842|1756672|FG001|Treatment Phase|Lost to Follow-up|8
803397|NCT00049842|1756671|FG000|Treatment Phase|Administrative|0
803398|NCT00049842|1756672|FG001|Treatment Phase|Administrative|3
803399|NCT00049842|1756671|FG000|Treatment Phase|Did not meet protocol eligibility|0
803400|NCT00049842|1756672|FG001|Treatment Phase|Did not meet protocol eligibility|1
803401|NCT00049842|1756671|FG000|Follow-up Phase|Adverse Event|6
803402|NCT00049842|1756672|FG001|Follow-up Phase|Adverse Event|1
803403|NCT00049842|1756671|FG000|Follow-up Phase|Other|1
803404|NCT00049842|1756672|FG001|Follow-up Phase|Other|4
803405|NCT00050011|1756680|FG000|Overall Study|Adverse Event|41
803406|NCT00050011|1756681|FG001|Overall Study|Adverse Event|46
803407|NCT00050011|1756680|FG000|Overall Study|Abnormal laboratory value(s)|1
803408|NCT00050011|1756681|FG001|Overall Study|Abnormal laboratory value(s)|1
803409|NCT00050011|1756680|FG000|Overall Study|Abnormal test procedure results|0
803410|NCT00050011|1756681|FG001|Overall Study|Abnormal test procedure results|1
803411|NCT00050011|1756680|FG000|Overall Study|Lack of Efficacy|16
803412|NCT00050011|1756681|FG001|Overall Study|Lack of Efficacy|21
803413|NCT00050011|1756680|FG000|Overall Study|Participant condition no longer required|1
803414|NCT00050011|1756681|FG001|Overall Study|Participant condition no longer required|0
803415|NCT00050011|1756680|FG000|Overall Study|Protocol Violation|4
803416|NCT00050011|1756681|FG001|Overall Study|Protocol Violation|10
803417|NCT00050011|1756680|FG000|Overall Study|Withdrawal by Subject|34
803418|NCT00050011|1756681|FG001|Overall Study|Withdrawal by Subject|26
803419|NCT00050011|1756680|FG000|Overall Study|Lost to Follow-up|7
803420|NCT00050011|1756681|FG001|Overall Study|Lost to Follow-up|9
803421|NCT00050011|1756680|FG000|Overall Study|Administrative problems|10
803422|NCT00050011|1756681|FG001|Overall Study|Administrative problems|6
803423|NCT00050011|1756680|FG000|Overall Study|Death|7
803424|NCT00050011|1756681|FG001|Overall Study|Death|4
803425|NCT00050011|1756680|FG000|Overall Study|Unknown - Reason is missing|0
803426|NCT00050011|1756681|FG001|Overall Study|Unknown - Reason is missing|2
803427|NCT00050167|1756711|FG000|Overall Study|not eligible not invasive|1
803428|NCT00050167|1756712|FG001|Overall Study|not eligible not invasive|1
803429|NCT00050622|1756718|FG000|Overall Study|Adverse Event|1
803430|NCT00050778|1756745|FG000|Overall Study|Adverse Event|13
803431|NCT00050778|1756746|FG001|Overall Study|Adverse Event|3
803432|NCT00050778|1756747|FG002|Overall Study|Adverse Event|2
803433|NCT00050778|1756745|FG000|Overall Study|Death|0
803434|NCT00050778|1756746|FG001|Overall Study|Death|1
803435|NCT00050778|1756747|FG002|Overall Study|Death|1
803436|NCT00050778|1756745|FG000|Overall Study|Lack of Efficacy|16
803437|NCT00050778|1756746|FG001|Overall Study|Lack of Efficacy|2
803438|NCT00050778|1756747|FG002|Overall Study|Lack of Efficacy|2
803439|NCT00050778|1756745|FG000|Overall Study|Lost to Follow-up|0
803440|NCT00050778|1756746|FG001|Overall Study|Lost to Follow-up|2
803441|NCT00050778|1756747|FG002|Overall Study|Lost to Follow-up|4
803442|NCT00050778|1756745|FG000|Overall Study|Physician Decision|3
803443|NCT00050778|1756746|FG001|Overall Study|Physician Decision|0
803444|NCT00050778|1756747|FG002|Overall Study|Physician Decision|2
803445|NCT00050778|1756745|FG000|Overall Study|Protocol Violation|2
803446|NCT00050778|1756746|FG001|Overall Study|Protocol Violation|0
803447|NCT00050778|1756747|FG002|Overall Study|Protocol Violation|1
803448|NCT00050778|1756745|FG000|Overall Study|Withdrawal by Subject|6
803449|NCT00050778|1756746|FG001|Overall Study|Withdrawal by Subject|8
803450|NCT00050778|1756747|FG002|Overall Study|Withdrawal by Subject|4
803451|NCT00050778|1756745|FG000|Overall Study|Randomized but not treated|4
803452|NCT00050778|1756746|FG001|Overall Study|Randomized but not treated|5
803453|NCT00050778|1756747|FG002|Overall Study|Randomized but not treated|2
803454|NCT00050778|1756745|FG000|Overall Study|Familial and personal reasons|1
803455|NCT00050778|1756746|FG001|Overall Study|Familial and personal reasons|0
803456|NCT00050778|1756747|FG002|Overall Study|Familial and personal reasons|0
803457|NCT00050960|1756759|FG000|Overall Study|Progressive Disease|137
803458|NCT00050960|1756760|FG001|Overall Study|Progressive Disease|93
803459|NCT00050960|1756759|FG000|Overall Study|Stable Disease|19
803460|NCT00050960|1756760|FG001|Overall Study|Stable Disease|48
803461|NCT00050960|1756759|FG000|Overall Study|Partial Response|14
803462|NCT00050960|1756760|FG001|Overall Study|Partial Response|19
803463|NCT00050960|1756759|FG000|Overall Study|Complete Response|0
803464|NCT00050960|1756760|FG001|Overall Study|Complete Response|2
803465|NCT00050960|1756759|FG000|Overall Study|Adverse Event|62
803466|NCT00050960|1756760|FG001|Overall Study|Adverse Event|61
803467|NCT00050960|1756759|FG000|Overall Study|Lost to Follow-up|0
803468|NCT00050960|1756760|FG001|Overall Study|Lost to Follow-up|1
803469|NCT00050960|1756759|FG000|Overall Study|Withdrawal by Subject|23
803470|NCT00050960|1756760|FG001|Overall Study|Withdrawal by Subject|18
803471|NCT00050960|1756759|FG000|Overall Study|Administrative|31
803472|NCT00050960|1756760|FG001|Overall Study|Administrative|46
803473|NCT00050960|1756759|FG000|Overall Study|Non-compliance|3
803474|NCT00050960|1756760|FG001|Overall Study|Non-compliance|1
803475|NCT00050960|1756759|FG000|Overall Study|Death|13
803476|NCT00050960|1756760|FG001|Overall Study|Death|15
803477|NCT00051025|1756772|FG000|Overall Study|Progressive Disease|1
803478|NCT00051025|1756773|FG001|Overall Study|Progressive Disease|1
803479|NCT00051025|1756772|FG000|Overall Study|Adverse Event|1
803480|NCT00051025|1756773|FG001|Overall Study|Adverse Event|1
803481|NCT00051025|1756772|FG000|Overall Study|Withdrawal by Subject|0
803482|NCT00051025|1756773|FG001|Overall Study|Withdrawal by Subject|1
803483|NCT00051025|1756772|FG000|Overall Study|Death|0
803484|NCT00051025|1756773|FG001|Overall Study|Death|1
803485|NCT00051311|1756785|FG000|Overall Study|Starting new study|0
803486|NCT00051311|1756786|FG001|Overall Study|Starting new study|1
803487|NCT00051311|1756785|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0
803488|NCT00051311|1756786|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1
803489|NCT00051311|1756785|FG000|Overall Study|Death of recipient|8
803490|NCT00051311|1756786|FG001|Overall Study|Death of recipient|8
803491|NCT00051311|1756785|FG000|Overall Study|Recipient taken off study|4
803492|NCT00051311|1756786|FG001|Overall Study|Recipient taken off study|4
803493|NCT00051363|1756792|FG000|Overall Study|Dropped Post-Rand for Any Reason|102
803494|NCT00051363|1756793|FG001|Overall Study|Dropped Post-Rand for Any Reason|126
803495|NCT00051363|1756792|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9
803496|NCT00051363|1756793|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11
803497|NCT00051363|1756792|FG000|Overall Study|Death|2
803498|NCT00051363|1756793|FG001|Overall Study|Death|2
803499|NCT00051363|1756792|FG000|Overall Study|Excluded Pre-Randomization|2
803500|NCT00051363|1756793|FG001|Overall Study|Excluded Pre-Randomization|5
803501|NCT00051558|1756801|FG000|Overall Study|Adverse Event|30
803502|NCT00051558|1756802|FG001|Overall Study|Adverse Event|18
803503|NCT00051558|1756801|FG000|Overall Study|Withdrawal by Subject|29
803504|NCT00051558|1756802|FG001|Overall Study|Withdrawal by Subject|42
803505|NCT00051558|1756801|FG000|Overall Study|Death|9
803506|NCT00051558|1756802|FG001|Overall Study|Death|15
803507|NCT00051558|1756801|FG000|Overall Study|Lost to Follow-up|4
803508|NCT00051558|1756802|FG001|Overall Study|Lost to Follow-up|13
803509|NCT00051558|1756801|FG000|Overall Study|Protocol Violation|3
803510|NCT00051558|1756802|FG001|Overall Study|Protocol Violation|4
803511|NCT00051558|1756801|FG000|Overall Study|Protocol Entry Criteria Unmet|1
803512|NCT00051558|1756802|FG001|Overall Study|Protocol Entry Criteria Unmet|2
803513|NCT00051558|1756801|FG000|Overall Study|Sponsor Decision|6
803514|NCT00051558|1756802|FG001|Overall Study|Sponsor Decision|1
803515|NCT00051558|1756801|FG000|Overall Study|Other|2
803516|NCT00051558|1756802|FG001|Overall Study|Other|1
803517|NCT00051558|1756801|FG000|Overall Study|Significant Lab Value|2
803518|NCT00051558|1756802|FG001|Overall Study|Significant Lab Value|0
803519|NCT00051558|1756801|FG000|Overall Study|Physician Decision|5
803520|NCT00051558|1756802|FG001|Overall Study|Physician Decision|0
803521|NCT00051636|1756810|FG000|Period 1 - Core|Adverse Event|2
803522|NCT00051636|1756811|FG001|Period 1 - Core|Adverse Event|2
803523|NCT00051636|1756810|FG000|Period 1 - Core|Protocol Violation|1
803524|NCT00051636|1756811|FG001|Period 1 - Core|Protocol Violation|0
803525|NCT00051636|1756810|FG000|Period 1 - Core|Withdrawal by Subject|1
803526|NCT00051636|1756811|FG001|Period 1 - Core|Withdrawal by Subject|2
803527|NCT00051636|1756810|FG000|Period 1 - Core|Lost to Follow-up|0
803528|NCT00051636|1756811|FG001|Period 1 - Core|Lost to Follow-up|2
803529|NCT00051636|1756810|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5
803530|NCT00051636|1756811|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4
803531|NCT00051636|1756810|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
803532|NCT00051636|1756811|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
803533|NCT00051636|1756810|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
803534|NCT00051636|1756811|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
803535|NCT00051636|1756810|FG000|Period 2- Extended Observation Period|Death|4
803536|NCT00051636|1756811|FG001|Period 2- Extended Observation Period|Death|5
803537|NCT00051636|1756810|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
803538|NCT00051636|1756811|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
803539|NCT00052715|1756859|FG000|Overall Study|wrong histology|1
803540|NCT00052962|1756874|FG000|Overall Study|Not evaluable|0
803541|NCT00052962|1756875|FG001|Overall Study|Not evaluable|2
803542|NCT00052962|1756874|FG000|Overall Study|Not randomized/not evaluable|1
803543|NCT00052962|1756875|FG001|Overall Study|Not randomized/not evaluable|0
803544|NCT00053352|1756887|FG000|Overall Study|Lost to Follow-up|0
803545|NCT00053352|1756888|FG001|Overall Study|Lost to Follow-up|1
803546|NCT00053352|1756887|FG000|Overall Study|Physician Decision|11
803547|NCT00053352|1756888|FG001|Overall Study|Physician Decision|1
803548|NCT00053352|1756887|FG000|Overall Study|Withdrawal by Subject|1
803549|NCT00053352|1756888|FG001|Overall Study|Withdrawal by Subject|0
803550|NCT00053352|1756887|FG000|Overall Study|Ineligible|8
803551|NCT00053352|1756888|FG001|Overall Study|Ineligible|8
803552|NCT00053352|1756887|FG000|Overall Study|Disease at new site|1
803553|NCT00053352|1756888|FG001|Overall Study|Disease at new site|0
803554|NCT00053365|1756895|FG000|Overall Study|Incorrect cell type|1
803555|NCT00053365|1756895|FG000|Overall Study|Platinum-sensitive interval >12 months|1
803556|NCT00053365|1756895|FG000|Overall Study|Never treated|4
803557|NCT00053417|1756905|FG000|Overall Study|Adverse Event|1
803558|NCT00053417|1756906|FG001|Overall Study|Adverse Event|0
803559|NCT00053417|1756907|FG002|Overall Study|Adverse Event|1
803560|NCT00053417|1756908|FG003|Overall Study|Adverse Event|5
803561|NCT00053417|1756905|FG000|Overall Study|Non-Compliance|0
803562|NCT00053417|1756906|FG001|Overall Study|Non-Compliance|0
803563|NCT00053417|1756907|FG002|Overall Study|Non-Compliance|0
803564|NCT00053417|1756908|FG003|Overall Study|Non-Compliance|1
803565|NCT00053417|1756905|FG000|Overall Study|Withdrawal by Subject|0
803566|NCT00053417|1756906|FG001|Overall Study|Withdrawal by Subject|1
803567|NCT00053417|1756907|FG002|Overall Study|Withdrawal by Subject|0
803568|NCT00053417|1756908|FG003|Overall Study|Withdrawal by Subject|0
803569|NCT00053417|1756905|FG000|Overall Study|Lost to Follow-up|1
803570|NCT00053417|1756906|FG001|Overall Study|Lost to Follow-up|1
803571|NCT00053417|1756907|FG002|Overall Study|Lost to Follow-up|0
803572|NCT00053417|1756908|FG003|Overall Study|Lost to Follow-up|0
803573|NCT00053846|1756984|FG000|Overall Study|Changed mind|8
803574|NCT00053846|1756985|FG001|Overall Study|Changed mind|13
803575|NCT00053846|1756984|FG000|Overall Study|Became too ill|8
803576|NCT00053846|1756985|FG001|Overall Study|Became too ill|7
803577|NCT00053846|1756984|FG000|Overall Study|Expired|5
803578|NCT00053846|1756985|FG001|Overall Study|Expired|0
803579|NCT00053846|1756984|FG000|Overall Study|Became ineligible|3
803580|NCT00053846|1756985|FG001|Overall Study|Became ineligible|1
803581|NCT00053846|1756984|FG000|Overall Study|Did not return data|1
803582|NCT00053846|1756985|FG001|Overall Study|Did not return data|2
803583|NCT00053846|1756984|FG000|Overall Study|Quit due to side effects|1
803584|NCT00053846|1756985|FG001|Overall Study|Quit due to side effects|3
803585|NCT00053846|1756984|FG000|Overall Study|Pills too large|0
803586|NCT00053846|1756985|FG001|Overall Study|Pills too large|1
803587|NCT00053898|1756993|FG000|Overall Study|No follow-up data from any source|9
803588|NCT00053898|1756994|FG001|Overall Study|No follow-up data from any source|12
803589|NCT00053898|1756993|FG000|Overall Study|Follow-up from telephone contact only|5
803590|NCT00053898|1756994|FG001|Overall Study|Follow-up from telephone contact only|1
803591|NCT00054132|1757011|FG000|Overall Study|Not Treated|1
803592|NCT00054275|1757016|FG000|Overall Study|Withdrawal by Subject|4
803593|NCT00054275|1757016|FG000|Overall Study|Adverse Event|5
803594|NCT00054275|1757016|FG000|Overall Study|Progressive disease in cycle 1|1
803595|NCT00054275|1757016|FG000|Overall Study|Physician Decision|1
803596|NCT00054327|1757026|FG000|Overall Study|Engraftment failure|1
803597|NCT00054327|1757027|FG001|Overall Study|Engraftment failure|0
803598|NCT00054327|1757028|FG002|Overall Study|Engraftment failure|0
803599|NCT00054327|1757029|FG003|Overall Study|Engraftment failure|0
803600|NCT00054327|1757030|FG004|Overall Study|Engraftment failure|0
803601|NCT00054327|1757031|FG005|Overall Study|Engraftment failure|0
803602|NCT00054639|1757058|FG000|Overall Study|Lack of Efficacy|1
803603|NCT00054639|1757058|FG000|Overall Study|Physician Decision|1
803604|NCT00054691|1757071|FG000|Overall Study|Unmeasurable Disease|2
803605|NCT00054691|1757071|FG000|Overall Study|Noncompliant|1
803606|NCT00054704|1757077|FG000|Overall Study|Lack of Efficacy|2
803607|NCT00054704|1757078|FG001|Overall Study|Lack of Efficacy|3
803608|NCT00054704|1757077|FG000|Overall Study|Adverse Event|3
803609|NCT00054704|1757078|FG001|Overall Study|Adverse Event|1
803610|NCT00054704|1757077|FG000|Overall Study|Lost to Follow-up|0
803611|NCT00054704|1757078|FG001|Overall Study|Lost to Follow-up|1
803612|NCT00054717|1757086|FG000|Overall Study|Randomized but not treated|2
803613|NCT00054717|1757087|FG001|Overall Study|Randomized but not treated|8
803614|NCT00054717|1757086|FG000|Overall Study|Adverse Event|70
803615|NCT00054717|1757087|FG001|Overall Study|Adverse Event|22
803616|NCT00054717|1757086|FG000|Overall Study|Protocol Violation|18
803617|NCT00054717|1757087|FG001|Overall Study|Protocol Violation|19
803618|NCT00054717|1757086|FG000|Overall Study|Lost to Follow-up|23
803619|NCT00054717|1757087|FG001|Overall Study|Lost to Follow-up|13
803620|NCT00054717|1757086|FG000|Overall Study|Withdrawal by Subject|32
803621|NCT00054717|1757087|FG001|Overall Study|Withdrawal by Subject|20
803622|NCT00054717|1757086|FG000|Overall Study|Other reason not defined above|117
803623|NCT00054717|1757087|FG001|Overall Study|Other reason not defined above|217
803624|NCT00055471|1757121|FG000|Period 1: Dose Escalation Period|Adverse Event|0
803625|NCT00055471|1757122|FG001|Period 1: Dose Escalation Period|Adverse Event|1
803626|NCT00055471|1757123|FG002|Period 1: Dose Escalation Period|Adverse Event|2
803627|NCT00055471|1757121|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
803628|NCT00055471|1757122|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
803629|NCT00055471|1757123|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
803630|NCT00055471|1757121|FG000|Period 1: Dose Escalation Period|Disease progression|0
803631|NCT00055471|1757122|FG001|Period 1: Dose Escalation Period|Disease progression|1
803632|NCT00055471|1757123|FG002|Period 1: Dose Escalation Period|Disease progression|0
803633|NCT00055497|1757135|FG000|Overall Study|Adverse Event|1
803634|NCT00055497|1757136|FG001|Overall Study|Adverse Event|1
803635|NCT00055497|1757137|FG002|Overall Study|Adverse Event|1
803636|NCT00055497|1757138|FG003|Overall Study|Adverse Event|28
803637|NCT00055497|1757135|FG000|Overall Study|Withdrawal by Subject|3
803638|NCT00055497|1757136|FG001|Overall Study|Withdrawal by Subject|1
803639|NCT00055497|1757137|FG002|Overall Study|Withdrawal by Subject|1
803640|NCT00055497|1757138|FG003|Overall Study|Withdrawal by Subject|15
803641|NCT00055497|1757135|FG000|Overall Study|Lost to Follow-up|0
803642|NCT00055497|1757136|FG001|Overall Study|Lost to Follow-up|1
803643|NCT00055497|1757137|FG002|Overall Study|Lost to Follow-up|0
803644|NCT00055497|1757138|FG003|Overall Study|Lost to Follow-up|5
803645|NCT00055497|1757135|FG000|Overall Study|Protocol Violation|0
803646|NCT00055497|1757136|FG001|Overall Study|Protocol Violation|0
803647|NCT00055497|1757137|FG002|Overall Study|Protocol Violation|0
803648|NCT00055497|1757138|FG003|Overall Study|Protocol Violation|3
803649|NCT00055497|1757135|FG000|Overall Study|Lack of Efficacy|1
803650|NCT00055497|1757136|FG001|Overall Study|Lack of Efficacy|0
803651|NCT00055497|1757137|FG002|Overall Study|Lack of Efficacy|0
803652|NCT00055497|1757138|FG003|Overall Study|Lack of Efficacy|27
803653|NCT00055497|1757135|FG000|Overall Study|Administrative Reasons|0
803654|NCT00055497|1757136|FG001|Overall Study|Administrative Reasons|0
803655|NCT00055497|1757137|FG002|Overall Study|Administrative Reasons|0
803656|NCT00055497|1757138|FG003|Overall Study|Administrative Reasons|1
803657|NCT00055497|1757135|FG000|Overall Study|Other|0
803658|NCT00055497|1757136|FG001|Overall Study|Other|0
803659|NCT00055497|1757137|FG002|Overall Study|Other|0
803660|NCT00055497|1757138|FG003|Overall Study|Other|11
803661|NCT00055601|1757155|FG000|Overall Study|Protocol Violation|1
803662|NCT00055601|1757156|FG001|Overall Study|Protocol Violation|1
803663|NCT00055601|1757155|FG000|Overall Study|No protocol treatment received|1
803664|NCT00055601|1757156|FG001|Overall Study|No protocol treatment received|1
803665|NCT00056160|1757170|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35
803666|NCT00056160|1757171|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18
803667|NCT00056160|1757170|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57
803668|NCT00056160|1757171|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124
803669|NCT00056160|1757170|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
803670|NCT00056160|1757171|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
803671|NCT00056160|1757170|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
803672|NCT00056160|1757171|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
803673|NCT00056160|1757170|FG000|Up to Unblinding (07 Jun 2005)|Death|2
803674|NCT00056160|1757171|FG001|Up to Unblinding (07 Jun 2005)|Death|1
803675|NCT00056160|1757170|FG000|Up to Unblinding (07 Jun 2005)|Other|8
803676|NCT00056160|1757171|FG001|Up to Unblinding (07 Jun 2005)|Other|7
803677|NCT00056160|1757170|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
803678|NCT00056160|1757171|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
803679|NCT00056160|1757170|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
803680|NCT00056160|1757171|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
803681|NCT00056160|1757170|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
803682|NCT00056160|1757171|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
803683|NCT00056160|1757170|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
803684|NCT00056160|1757171|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
803685|NCT00056160|1757170|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
803686|NCT00056160|1757171|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
803687|NCT00056160|1757170|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
803688|NCT00056160|1757171|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
803689|NCT00056160|1757170|FG000|Final Follow-up|Transferred into expanded access study.|3
803690|NCT00056160|1757171|FG001|Final Follow-up|Transferred into expanded access study.|0
803691|NCT00056160|1757170|FG000|Final Follow-up|Transferred into RevAssist Program|2
803692|NCT00056160|1757171|FG001|Final Follow-up|Transferred into RevAssist Program|0
803693|NCT00056160|1757170|FG000|Final Follow-up|Adverse Event|1
803694|NCT00056160|1757171|FG001|Final Follow-up|Adverse Event|0
803695|NCT00056316|1757179|FG000|Overall Study|Withdrawal by Subject|2
803696|NCT00056316|1757180|FG001|Overall Study|Withdrawal by Subject|2
803697|NCT00056316|1757179|FG000|Overall Study|Death/NH placement of pt|1
803698|NCT00056316|1757180|FG001|Overall Study|Death/NH placement of pt|1
803699|NCT00056407|1757188|FG000|Overall Study|Adverse Event|282
803700|NCT00056407|1757189|FG001|Overall Study|Adverse Event|364
803701|NCT00056407|1757188|FG000|Overall Study|Withdrawal by Subject|377
803702|NCT00056407|1757189|FG001|Overall Study|Withdrawal by Subject|361
803703|NCT00056407|1757188|FG000|Overall Study|Lost to Follow-up|123
803704|NCT00056407|1757189|FG001|Overall Study|Lost to Follow-up|113
803705|NCT00056407|1757188|FG000|Overall Study|Protocol Violation|104
803706|NCT00056407|1757189|FG001|Overall Study|Protocol Violation|95
803707|NCT00056407|1757188|FG000|Overall Study|Diagnosed with Prostate Cancer|202
803708|NCT00056407|1757189|FG001|Overall Study|Diagnosed with Prostate Cancer|166
803709|NCT00056407|1757188|FG000|Overall Study|"Listed as Other on Case Report Form"|98
803710|NCT00056407|1757189|FG001|Overall Study|"Listed as Other on Case Report Form"|60
803711|NCT00056407|1757188|FG000|Overall Study|Missing|25
803712|NCT00056407|1757189|FG001|Overall Study|Missing|34
803713|NCT00056862|1757229|FG000|Overall Study|Protocol Violation|1
803714|NCT00056862|1757230|FG001|Overall Study|Protocol Violation|0
803715|NCT00057330|1757238|FG000|Overall Study|Adverse Event|9
803716|NCT00057330|1757239|FG001|Overall Study|Adverse Event|12
803717|NCT00057330|1757238|FG000|Overall Study|Death|1
803718|NCT00057330|1757239|FG001|Overall Study|Death|0
803719|NCT00057330|1757238|FG000|Overall Study|Protocol Violation|1
803720|NCT00057330|1757239|FG001|Overall Study|Protocol Violation|1
803721|NCT00057330|1757238|FG000|Overall Study|Withdrawal by Subject|115
803722|NCT00057330|1757239|FG001|Overall Study|Withdrawal by Subject|84
803723|NCT00057330|1757238|FG000|Overall Study|Lost to Follow-up|745
803724|NCT00057330|1757239|FG001|Overall Study|Lost to Follow-up|617
803725|NCT00057330|1757238|FG000|Overall Study|Physician Decision|1
803726|NCT00057330|1757239|FG001|Overall Study|Physician Decision|0
803727|NCT00057330|1757238|FG000|Overall Study|Other|260
803728|NCT00057330|1757239|FG001|Overall Study|Other|206
803729|NCT00057746|1757288|FG000|Overall Study|Withdrawal by Subject|0
803730|NCT00057746|1757289|FG001|Overall Study|Withdrawal by Subject|0
803731|NCT00057746|1757290|FG002|Overall Study|Withdrawal by Subject|1
803732|NCT00057811|1757304|FG000|Overall Study|Lack of Efficacy|1
803733|NCT00057811|1757305|FG001|Overall Study|Lack of Efficacy|4
803734|NCT00057811|1757304|FG000|Overall Study|Physician Decision|1
803735|NCT00057811|1757305|FG001|Overall Study|Physician Decision|0
803736|NCT00057811|1757304|FG000|Overall Study|Withdrawal by Subject|3
803737|NCT00057811|1757305|FG001|Overall Study|Withdrawal by Subject|4
803738|NCT00057811|1757304|FG000|Overall Study|Ineligible|4
803739|NCT00057811|1757305|FG001|Overall Study|Ineligible|2
803740|NCT00057811|1757304|FG000|Overall Study|Inevaluable|1
803741|NCT00057811|1757305|FG001|Overall Study|Inevaluable|2
803742|NCT00057837|1757313|FG000|Overall Study|Progression/relapse|12
803743|NCT00057837|1757314|FG001|Overall Study|Progression/relapse|14
803744|NCT00057837|1757313|FG000|Overall Study|Adverse Event|2
803745|NCT00057837|1757314|FG001|Overall Study|Adverse Event|12
803746|NCT00057837|1757313|FG000|Overall Study|Death|5
803747|NCT00057837|1757314|FG001|Overall Study|Death|4
803748|NCT00057837|1757313|FG000|Overall Study|Withdrawal by Subject|5
803749|NCT00057837|1757314|FG001|Overall Study|Withdrawal by Subject|3
803750|NCT00057837|1757313|FG000|Overall Study|Alternative therapy|0
803751|NCT00057837|1757314|FG001|Overall Study|Alternative therapy|1
803752|NCT00057837|1757313|FG000|Overall Study|Other complicating disease|2
803753|NCT00057837|1757314|FG001|Overall Study|Other complicating disease|1
803754|NCT00057837|1757313|FG000|Overall Study|Physician Decision|1
803755|NCT00057837|1757314|FG001|Overall Study|Physician Decision|0
803756|NCT00057837|1757313|FG000|Overall Study|Ineligible|3
803757|NCT00057837|1757314|FG001|Overall Study|Ineligible|3
803758|NCT00057837|1757313|FG000|Overall Study|Never started treatment|1
803759|NCT00057837|1757314|FG001|Overall Study|Never started treatment|1
803760|NCT00057863|1757320|FG000|Overall Study|Death|1
803761|NCT00057863|1757320|FG000|Overall Study|Withdrawal by Subject|2
803762|NCT00057876|1757326|FG000|Overall Study|Adverse Event|8
803763|NCT00057876|1757327|FG001|Overall Study|Adverse Event|8
803764|NCT00057876|1757326|FG000|Overall Study|Death|2
803765|NCT00057876|1757327|FG001|Overall Study|Death|1
803766|NCT00057876|1757326|FG000|Overall Study|Withdrawal by Subject|5
803767|NCT00057876|1757327|FG001|Overall Study|Withdrawal by Subject|6
803768|NCT00057876|1757326|FG000|Overall Study|Lack of Efficacy|10
803769|NCT00057876|1757327|FG001|Overall Study|Lack of Efficacy|8
803770|NCT00057876|1757326|FG000|Overall Study|Ineligible|1
803771|NCT00057876|1757327|FG001|Overall Study|Ineligible|2
803772|NCT00057876|1757326|FG000|Overall Study|other reason|2
803773|NCT00057876|1757327|FG001|Overall Study|other reason|2
803774|NCT00057876|1757326|FG000|Overall Study|other complicating disease|1
803775|NCT00057876|1757327|FG001|Overall Study|other complicating disease|0
803776|NCT00057941|1757335|FG000|Overall Study|Death|1
803777|NCT00057941|1757336|FG001|Overall Study|Death|2
803778|NCT00057941|1757335|FG000|Overall Study|Adverse Event|7
803779|NCT00057941|1757336|FG001|Overall Study|Adverse Event|9
803780|NCT00057941|1757335|FG000|Overall Study|Lack of Efficacy|54
803781|NCT00057941|1757336|FG001|Overall Study|Lack of Efficacy|53
803782|NCT00057941|1757335|FG000|Overall Study|Withdrawal by Subject|6
803783|NCT00057941|1757336|FG001|Overall Study|Withdrawal by Subject|1
803784|NCT00057941|1757335|FG000|Overall Study|still on treatment|3
803785|NCT00057941|1757336|FG001|Overall Study|still on treatment|1
803786|NCT00057941|1757335|FG000|Overall Study|insurance, symptomatic deterioration|1
803787|NCT00057941|1757336|FG001|Overall Study|insurance, symptomatic deterioration|3
803788|NCT00057941|1757335|FG000|Overall Study|Ineligible|2
803789|NCT00057941|1757336|FG001|Overall Study|Ineligible|5
803790|NCT00057954|1757342|FG000|Overall Study|Death|1
803791|NCT00057954|1757342|FG000|Overall Study|Disease progression|1
803792|NCT00058058|1757354|FG000|Overall Study|Withdrawal by Subject|4
803793|NCT00058058|1757354|FG000|Overall Study|Ineligible|20
803794|NCT00058058|1757354|FG000|Overall Study|Claustrophobic|5
803795|NCT00058058|1757354|FG000|Overall Study|technical issues|6
803796|NCT00058058|1757354|FG000|Overall Study|Poor positioning, illness,pain|3
803797|NCT00058123|1757359|FG000|Overall Study|Wrong histology|9
803798|NCT00058123|1757359|FG000|Overall Study|Received >3 prior treatments|1
803799|NCT00058214|1757364|FG000|Overall Study|Adverse Event|1
803800|NCT00058422|1757389|FG000|Overall Study|Not treated|2
803801|NCT00058539|1757393|FG000|Overall Study|Disease progression|24
803802|NCT00058539|1757393|FG000|Overall Study|Adverse Event|3
803803|NCT00058539|1757393|FG000|Overall Study|Withdrawal by Subject|5
803804|NCT00058539|1757393|FG000|Overall Study|Physician Decision|9
803805|NCT00058539|1757393|FG000|Overall Study|Death|1
803806|NCT00058552|1757399|FG000|Overall Study|Died prior to receiving treatment|4
803807|NCT00058552|1757400|FG001|Overall Study|Died prior to receiving treatment|2
803808|NCT00058552|1757399|FG000|Overall Study|Disease progression|52
803809|NCT00058552|1757400|FG001|Overall Study|Disease progression|44
803810|NCT00058552|1757399|FG000|Overall Study|Adverse Event|4
803811|NCT00058552|1757400|FG001|Overall Study|Adverse Event|2
803812|NCT00058552|1757399|FG000|Overall Study|Withdrawal by Subject|3
803813|NCT00058552|1757400|FG001|Overall Study|Withdrawal by Subject|5
803814|NCT00058552|1757399|FG000|Overall Study|Physician Decision|2
803815|NCT00058552|1757400|FG001|Overall Study|Physician Decision|5
803816|NCT00058552|1757399|FG000|Overall Study|Clinical disease progression|0
803817|NCT00058552|1757400|FG001|Overall Study|Clinical disease progression|4
803818|NCT00058825|1757408|FG000|Overall Study|Relapse|9
803819|NCT00058825|1757408|FG000|Overall Study|Progressive Disease|5
803820|NCT00058825|1757408|FG000|Overall Study|Graft Failure|5
803821|NCT00058825|1757408|FG000|Overall Study|Death|3
803822|NCT00059202|1757416|FG000|Overall Study|Withdrawal by Subject|5
803823|NCT00059202|1757417|FG001|Overall Study|Withdrawal by Subject|9
803824|NCT00059202|1757416|FG000|Overall Study|Protocol Violation|1
803825|NCT00059202|1757417|FG001|Overall Study|Protocol Violation|3
803826|NCT00059202|1757416|FG000|Overall Study|drug toxicity|0
803827|NCT00059202|1757417|FG001|Overall Study|drug toxicity|3
803828|NCT00059215|1757430|FG000|Overall Study|Adverse Event|5
803829|NCT00059215|1757431|FG001|Overall Study|Adverse Event|5
803830|NCT00059215|1757432|FG002|Overall Study|Adverse Event|9
803831|NCT00059215|1757433|FG003|Overall Study|Adverse Event|9
803832|NCT00059215|1757430|FG000|Overall Study|Death|0
803833|NCT00059215|1757431|FG001|Overall Study|Death|0
803834|NCT00059215|1757432|FG002|Overall Study|Death|3
803835|NCT00059215|1757433|FG003|Overall Study|Death|0
803836|NCT00059215|1757430|FG000|Overall Study|Lost to Follow-up|1
803837|NCT00059215|1757431|FG001|Overall Study|Lost to Follow-up|2
803838|NCT00059215|1757432|FG002|Overall Study|Lost to Follow-up|0
803839|NCT00059215|1757433|FG003|Overall Study|Lost to Follow-up|0
803840|NCT00059215|1757430|FG000|Overall Study|Withdrawal by Subject|4
803841|NCT00059215|1757431|FG001|Overall Study|Withdrawal by Subject|4
803842|NCT00059215|1757432|FG002|Overall Study|Withdrawal by Subject|1
803843|NCT00059215|1757433|FG003|Overall Study|Withdrawal by Subject|3
803844|NCT00059215|1757430|FG000|Overall Study|Protocol Violation|1
803845|NCT00059215|1757431|FG001|Overall Study|Protocol Violation|0
803846|NCT00059215|1757432|FG002|Overall Study|Protocol Violation|1
803847|NCT00059215|1757433|FG003|Overall Study|Protocol Violation|0
803848|NCT00059215|1757430|FG000|Overall Study|Protocol entry criteria not met|1
803849|NCT00059215|1757431|FG001|Overall Study|Protocol entry criteria not met|1
803850|NCT00059215|1757432|FG002|Overall Study|Protocol entry criteria not met|0
803851|NCT00059215|1757433|FG003|Overall Study|Protocol entry criteria not met|2
803852|NCT00059215|1757430|FG000|Overall Study|Physician Decision|1
803853|NCT00059215|1757431|FG001|Overall Study|Physician Decision|2
803854|NCT00059215|1757432|FG002|Overall Study|Physician Decision|1
803855|NCT00059215|1757433|FG003|Overall Study|Physician Decision|1
803856|NCT00059332|1757455|FG000|Overall Study|Withdrawal by Subject|2
803857|NCT00059332|1757456|FG001|Overall Study|Withdrawal by Subject|1
803858|NCT00059332|1757455|FG000|Overall Study|Lost to Follow-up|1
803859|NCT00059332|1757456|FG001|Overall Study|Lost to Follow-up|1
803860|NCT00059787|1757502|FG000|Overall Study|Adverse Event|13
803861|NCT00059787|1757502|FG000|Overall Study|disease progression|2
803862|NCT00059787|1757502|FG000|Overall Study|ineligible|1
803863|NCT00059787|1757502|FG000|Overall Study|Other|4
803864|NCT00059839|1757509|FG000|Overall Study|Death|1
803865|NCT00059839|1757510|FG001|Overall Study|Death|1
803866|NCT00059839|1757509|FG000|Overall Study|Lack of Efficacy|6
803867|NCT00059839|1757510|FG001|Overall Study|Lack of Efficacy|5
803868|NCT00059839|1757509|FG000|Overall Study|Lost to Follow-up|2
803869|NCT00059839|1757510|FG001|Overall Study|Lost to Follow-up|0
803870|NCT00059839|1757509|FG000|Overall Study|Physician Decision|1
803871|NCT00059839|1757510|FG001|Overall Study|Physician Decision|2
803872|NCT00059839|1757509|FG000|Overall Study|Withdrawal by Subject|1
803873|NCT00059839|1757510|FG001|Overall Study|Withdrawal by Subject|6
803874|NCT00059839|1757509|FG000|Overall Study|Ineligible|1
803875|NCT00059839|1757510|FG001|Overall Study|Ineligible|3
803876|NCT00060840|1757563|FG000|Overall Study|Change in surgical plan|2
803877|NCT00060840|1757564|FG001|Overall Study|Change in surgical plan|6
803878|NCT00060840|1757563|FG000|Overall Study|Death|0
803879|NCT00060840|1757564|FG001|Overall Study|Death|1
803880|NCT00060840|1757563|FG000|Overall Study|Withdrawal by Subject|0
803881|NCT00060840|1757564|FG001|Overall Study|Withdrawal by Subject|1
803882|NCT00060840|1757563|FG000|Overall Study|Subinvestigator unavailable|0
803883|NCT00060840|1757564|FG001|Overall Study|Subinvestigator unavailable|1
803884|NCT00060840|1757563|FG000|Overall Study|Physician Decision|1
803885|NCT00060840|1757564|FG001|Overall Study|Physician Decision|0
803886|NCT00060840|1757563|FG000|Overall Study|Other|1
803887|NCT00060840|1757564|FG001|Overall Study|Other|0
803888|NCT00060944|1757572|FG000|Overall Study|Adverse Event|12
803889|NCT00060944|1757573|FG001|Overall Study|Adverse Event|10
803890|NCT00060944|1757572|FG000|Overall Study|Death|2
803891|NCT00060944|1757573|FG001|Overall Study|Death|3
803892|NCT00060944|1757572|FG000|Overall Study|Withdrawal by Subject|18
803893|NCT00060944|1757573|FG001|Overall Study|Withdrawal by Subject|5
803894|NCT00060944|1757572|FG000|Overall Study|Disease Progression|93
803895|NCT00060944|1757573|FG001|Overall Study|Disease Progression|94
803896|NCT00060944|1757572|FG000|Overall Study|Lost to Follow-up|1
803897|NCT00060944|1757573|FG001|Overall Study|Lost to Follow-up|0
803898|NCT00060944|1757572|FG000|Overall Study|Subject Ineligible To Continue|2
803899|NCT00060944|1757573|FG001|Overall Study|Subject Ineligible To Continue|1
803900|NCT00060944|1757572|FG000|Overall Study|Treatment Switch|0
803901|NCT00060944|1757573|FG001|Overall Study|Treatment Switch|13
803902|NCT00060944|1757572|FG000|Overall Study|Other|2
803903|NCT00060944|1757573|FG001|Overall Study|Other|4
803904|NCT00060944|1757572|FG000|Overall Study|randomized but not treated|6
803905|NCT00060944|1757573|FG001|Overall Study|randomized but not treated|4
803906|NCT00061048|1757579|FG000|Overall Study|Adverse Event|2
803907|NCT00061048|1757579|FG000|Overall Study|disease progression|20
803908|NCT00061633|1757594|FG000|Overall Study|Adverse Event|1
803909|NCT00061633|1757595|FG001|Overall Study|Adverse Event|2
803910|NCT00061633|1757594|FG000|Overall Study|Withdrawal by Subject|2
803911|NCT00061633|1757595|FG001|Overall Study|Withdrawal by Subject|2
803912|NCT00061633|1757594|FG000|Overall Study|Lost to Follow-up|1
803913|NCT00061633|1757595|FG001|Overall Study|Lost to Follow-up|4
803914|NCT00061633|1757594|FG000|Overall Study|Other|1
803915|NCT00061633|1757595|FG001|Overall Study|Other|1
803916|NCT00061633|1757594|FG000|Overall Study|Never received study treatment|0
803917|NCT00061633|1757595|FG001|Overall Study|Never received study treatment|2
803918|NCT00061932|1757607|FG000|Overall Study|Withdrawal by Subject|13
803919|NCT00061932|1757608|FG001|Overall Study|Withdrawal by Subject|4
803920|NCT00061945|1757617|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18
803921|NCT00061945|1757618|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25
803922|NCT00061945|1757617|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76
803923|NCT00061945|1757618|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90
803924|NCT00061945|1757617|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1
803925|NCT00061945|1757618|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1
803926|NCT00061945|1757617|FG000|Course IV: Alemtuzumab|Early exits|6
803927|NCT00061945|1757618|FG001|Course IV: Alemtuzumab|Early exits|15
803928|NCT00062010|1757626|FG000|Overall Study|Ineligible|3
803929|NCT00062166|1757630|FG000|Overall Study|Withdrawal by Subject|6
803930|NCT00062374|1757635|FG000|Overall Study|Not treated|12
803931|NCT00062439|1757639|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1
803932|NCT00062439|1757639|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
803933|NCT00062439|1757639|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3
803934|NCT00062439|1757639|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
803935|NCT00062439|1757639|FG000|Post Chemoradiation Assessment|Death|1
803936|NCT00062439|1757639|FG000|Post Chemoradiation Assessment|Disease progression|2
803937|NCT00062439|1757639|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1
803938|NCT00062439|1757639|FG000|Post Chemoradiation Assessment|Physician Decision|1
803939|NCT00062439|1757639|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
803940|NCT00062439|1757639|FG000|Surgery|Physician Decision|4
803941|NCT00062439|1757639|FG000|Surgery|Death|1
803942|NCT00062439|1757639|FG000|Surgery|Adverse Event|2
803943|NCT00062439|1757639|FG000|Consolidation Chemotherapy|Adverse Event|2
803944|NCT00062647|1757650|FG000|Overall Study|Death|2
803945|NCT00062647|1757651|FG001|Overall Study|Death|2
803946|NCT00062647|1757650|FG000|Overall Study|Adverse Event|1
803947|NCT00062647|1757651|FG001|Overall Study|Adverse Event|1
803948|NCT00062647|1757650|FG000|Overall Study|Withdrawal by Subject|2
803949|NCT00062647|1757651|FG001|Overall Study|Withdrawal by Subject|1
803950|NCT00062647|1757650|FG000|Overall Study|Protocol Violation|1
803951|NCT00062647|1757651|FG001|Overall Study|Protocol Violation|0
803952|NCT00062647|1757650|FG000|Overall Study|Lost to Follow-up|1
803953|NCT00062647|1757651|FG001|Overall Study|Lost to Follow-up|2
803954|NCT00062647|1757650|FG000|Overall Study|Failed continuation criteria|4
803955|NCT00062647|1757651|FG001|Overall Study|Failed continuation criteria|2
803956|NCT00062647|1757650|FG000|Overall Study|Other|4
803957|NCT00062647|1757651|FG001|Overall Study|Other|4
803958|NCT00062647|1757650|FG000|Overall Study|Never received study treatment|1
803959|NCT00062647|1757651|FG001|Overall Study|Never received study treatment|1
803960|NCT00062868|1757698|FG000|Dose Level 1|Death|2
803961|NCT00062868|1757699|FG001|Dose Level 1|Death|0
803962|NCT00062868|1757700|FG002|Dose Level 1|Death|0
803963|NCT00062868|1757701|FG003|Dose Level 1|Death|2
803964|NCT00062868|1757702|FG004|Dose Level 1|Death|0
803965|NCT00062868|1757703|FG005|Dose Level 1|Death|0
803966|NCT00062868|1757704|FG006|Dose Level 1|Death|3
803967|NCT00062868|1757705|FG007|Dose Level 1|Death|0
803968|NCT00062868|1757706|FG008|Dose Level 1|Death|0
803969|NCT00062868|1757707|FG009|Dose Level 1|Death|0
803970|NCT00062868|1757708|FG010|Dose Level 1|Death|0
803971|NCT00062868|1757709|FG011|Dose Level 1|Death|0
803972|NCT00062868|1757710|FG012|Dose Level 1|Death|0
803973|NCT00062868|1757711|FG013|Dose Level 1|Death|0
803974|NCT00062868|1757712|FG014|Dose Level 1|Death|0
803975|NCT00062868|1757713|FG015|Dose Level 1|Death|0
803976|NCT00062868|1757714|FG016|Dose Level 1|Death|0
803977|NCT00062868|1757715|FG017|Dose Level 1|Death|0
803978|NCT00062868|1757716|FG018|Dose Level 1|Death|7
803979|NCT00062868|1757717|FG019|Dose Level 1|Death|0
803980|NCT00062868|1757718|FG020|Dose Level 1|Death|1
803981|NCT00062868|1757698|FG000|Dose Level 1|Lost to Follow-up|0
803982|NCT00062868|1757699|FG001|Dose Level 1|Lost to Follow-up|0
803983|NCT00062868|1757700|FG002|Dose Level 1|Lost to Follow-up|0
803984|NCT00062868|1757701|FG003|Dose Level 1|Lost to Follow-up|0
803985|NCT00062868|1757702|FG004|Dose Level 1|Lost to Follow-up|0
803986|NCT00062868|1757703|FG005|Dose Level 1|Lost to Follow-up|0
803987|NCT00062868|1757704|FG006|Dose Level 1|Lost to Follow-up|0
803988|NCT00062868|1757705|FG007|Dose Level 1|Lost to Follow-up|0
803989|NCT00062868|1757706|FG008|Dose Level 1|Lost to Follow-up|0
803990|NCT00062868|1757707|FG009|Dose Level 1|Lost to Follow-up|0
803991|NCT00062868|1757708|FG010|Dose Level 1|Lost to Follow-up|0
803992|NCT00062868|1757709|FG011|Dose Level 1|Lost to Follow-up|0
803993|NCT00062868|1757710|FG012|Dose Level 1|Lost to Follow-up|1
803994|NCT00062868|1757711|FG013|Dose Level 1|Lost to Follow-up|0
803995|NCT00062868|1757712|FG014|Dose Level 1|Lost to Follow-up|0
803996|NCT00062868|1757713|FG015|Dose Level 1|Lost to Follow-up|0
803997|NCT00062868|1757714|FG016|Dose Level 1|Lost to Follow-up|0
803998|NCT00062868|1757715|FG017|Dose Level 1|Lost to Follow-up|0
803999|NCT00062868|1757716|FG018|Dose Level 1|Lost to Follow-up|2
804000|NCT00062868|1757717|FG019|Dose Level 1|Lost to Follow-up|0
804001|NCT00062868|1757718|FG020|Dose Level 1|Lost to Follow-up|1
804002|NCT00062868|1757698|FG000|Dose Level 2|Death|0
804003|NCT00062868|1757699|FG001|Dose Level 2|Death|3
804004|NCT00062868|1757700|FG002|Dose Level 2|Death|0
804005|NCT00062868|1757701|FG003|Dose Level 2|Death|0
804006|NCT00062868|1757702|FG004|Dose Level 2|Death|2
804007|NCT00062868|1757703|FG005|Dose Level 2|Death|0
804008|NCT00062868|1757704|FG006|Dose Level 2|Death|0
804009|NCT00062868|1757705|FG007|Dose Level 2|Death|0
804010|NCT00062868|1757706|FG008|Dose Level 2|Death|0
804011|NCT00062868|1757707|FG009|Dose Level 2|Death|0
804012|NCT00062868|1757708|FG010|Dose Level 2|Death|1
804013|NCT00062868|1757709|FG011|Dose Level 2|Death|0
804014|NCT00062868|1757710|FG012|Dose Level 2|Death|0
804015|NCT00062868|1757711|FG013|Dose Level 2|Death|0
804016|NCT00062868|1757712|FG014|Dose Level 2|Death|0
804017|NCT00062868|1757713|FG015|Dose Level 2|Death|0
804018|NCT00062868|1757714|FG016|Dose Level 2|Death|2
804019|NCT00062868|1757715|FG017|Dose Level 2|Death|0
804020|NCT00062868|1757716|FG018|Dose Level 2|Death|0
804021|NCT00062868|1757717|FG019|Dose Level 2|Death|0
804022|NCT00062868|1757718|FG020|Dose Level 2|Death|0
804023|NCT00062868|1757698|FG000|Dose Level 2|Lost to Follow-up|0
804024|NCT00062868|1757699|FG001|Dose Level 2|Lost to Follow-up|0
804025|NCT00062868|1757700|FG002|Dose Level 2|Lost to Follow-up|0
804026|NCT00062868|1757701|FG003|Dose Level 2|Lost to Follow-up|0
804027|NCT00062868|1757702|FG004|Dose Level 2|Lost to Follow-up|0
804028|NCT00062868|1757703|FG005|Dose Level 2|Lost to Follow-up|0
804029|NCT00062868|1757704|FG006|Dose Level 2|Lost to Follow-up|0
804030|NCT00062868|1757705|FG007|Dose Level 2|Lost to Follow-up|0
804031|NCT00062868|1757706|FG008|Dose Level 2|Lost to Follow-up|0
804032|NCT00062868|1757707|FG009|Dose Level 2|Lost to Follow-up|0
804033|NCT00062868|1757708|FG010|Dose Level 2|Lost to Follow-up|0
804034|NCT00062868|1757709|FG011|Dose Level 2|Lost to Follow-up|0
804035|NCT00062868|1757710|FG012|Dose Level 2|Lost to Follow-up|0
804036|NCT00062868|1757711|FG013|Dose Level 2|Lost to Follow-up|1
804037|NCT00062868|1757712|FG014|Dose Level 2|Lost to Follow-up|0
804038|NCT00062868|1757713|FG015|Dose Level 2|Lost to Follow-up|0
804039|NCT00062868|1757714|FG016|Dose Level 2|Lost to Follow-up|1
804040|NCT00062868|1757715|FG017|Dose Level 2|Lost to Follow-up|0
804041|NCT00062868|1757716|FG018|Dose Level 2|Lost to Follow-up|0
804042|NCT00062868|1757717|FG019|Dose Level 2|Lost to Follow-up|0
804043|NCT00062868|1757718|FG020|Dose Level 2|Lost to Follow-up|0
804044|NCT00062868|1757698|FG000|Dose Level 3|Death|0
804045|NCT00062868|1757699|FG001|Dose Level 3|Death|0
804046|NCT00062868|1757700|FG002|Dose Level 3|Death|0
804047|NCT00062868|1757701|FG003|Dose Level 3|Death|0
804048|NCT00062868|1757702|FG004|Dose Level 3|Death|0
804049|NCT00062868|1757703|FG005|Dose Level 3|Death|0
804050|NCT00062868|1757704|FG006|Dose Level 3|Death|0
804051|NCT00062868|1757705|FG007|Dose Level 3|Death|0
804052|NCT00062868|1757706|FG008|Dose Level 3|Death|0
804053|NCT00062868|1757707|FG009|Dose Level 3|Death|0
804054|NCT00062868|1757708|FG010|Dose Level 3|Death|0
804055|NCT00062868|1757709|FG011|Dose Level 3|Death|1
804056|NCT00062868|1757710|FG012|Dose Level 3|Death|0
804057|NCT00062868|1757711|FG013|Dose Level 3|Death|0
804058|NCT00062868|1757712|FG014|Dose Level 3|Death|0
804059|NCT00062868|1757713|FG015|Dose Level 3|Death|0
804060|NCT00062868|1757714|FG016|Dose Level 3|Death|0
804061|NCT00062868|1757715|FG017|Dose Level 3|Death|1
804062|NCT00062868|1757716|FG018|Dose Level 3|Death|0
804063|NCT00062868|1757717|FG019|Dose Level 3|Death|0
804064|NCT00062868|1757718|FG020|Dose Level 3|Death|0
804065|NCT00062868|1757698|FG000|Dose Level 3|Lost to Follow-up|0
804066|NCT00062868|1757699|FG001|Dose Level 3|Lost to Follow-up|0
804067|NCT00062868|1757700|FG002|Dose Level 3|Lost to Follow-up|0
804068|NCT00062868|1757701|FG003|Dose Level 3|Lost to Follow-up|0
804069|NCT00062868|1757702|FG004|Dose Level 3|Lost to Follow-up|0
804070|NCT00062868|1757703|FG005|Dose Level 3|Lost to Follow-up|0
804071|NCT00062868|1757704|FG006|Dose Level 3|Lost to Follow-up|0
804072|NCT00062868|1757705|FG007|Dose Level 3|Lost to Follow-up|0
804073|NCT00062868|1757706|FG008|Dose Level 3|Lost to Follow-up|0
804074|NCT00062868|1757707|FG009|Dose Level 3|Lost to Follow-up|0
804075|NCT00062868|1757708|FG010|Dose Level 3|Lost to Follow-up|0
804076|NCT00062868|1757709|FG011|Dose Level 3|Lost to Follow-up|0
804077|NCT00062868|1757710|FG012|Dose Level 3|Lost to Follow-up|0
804078|NCT00062868|1757711|FG013|Dose Level 3|Lost to Follow-up|0
804079|NCT00062868|1757712|FG014|Dose Level 3|Lost to Follow-up|1
804080|NCT00062868|1757713|FG015|Dose Level 3|Lost to Follow-up|0
804081|NCT00062868|1757714|FG016|Dose Level 3|Lost to Follow-up|0
804082|NCT00062868|1757715|FG017|Dose Level 3|Lost to Follow-up|0
804083|NCT00062868|1757716|FG018|Dose Level 3|Lost to Follow-up|0
804084|NCT00062868|1757717|FG019|Dose Level 3|Lost to Follow-up|0
804085|NCT00062868|1757718|FG020|Dose Level 3|Lost to Follow-up|0
804086|NCT00062868|1757698|FG000|Dose Level 3|Withdrew|0
804087|NCT00062868|1757699|FG001|Dose Level 3|Withdrew|0
804088|NCT00062868|1757700|FG002|Dose Level 3|Withdrew|2
804089|NCT00062868|1757701|FG003|Dose Level 3|Withdrew|0
804090|NCT00062868|1757702|FG004|Dose Level 3|Withdrew|0
804091|NCT00062868|1757703|FG005|Dose Level 3|Withdrew|0
804092|NCT00062868|1757704|FG006|Dose Level 3|Withdrew|0
804093|NCT00062868|1757705|FG007|Dose Level 3|Withdrew|0
804094|NCT00062868|1757706|FG008|Dose Level 3|Withdrew|0
804095|NCT00062868|1757707|FG009|Dose Level 3|Withdrew|0
804096|NCT00062868|1757708|FG010|Dose Level 3|Withdrew|0
804097|NCT00062868|1757709|FG011|Dose Level 3|Withdrew|0
804098|NCT00062868|1757710|FG012|Dose Level 3|Withdrew|0
804099|NCT00062868|1757711|FG013|Dose Level 3|Withdrew|0
804100|NCT00062868|1757712|FG014|Dose Level 3|Withdrew|0
804101|NCT00062868|1757713|FG015|Dose Level 3|Withdrew|0
804102|NCT00062868|1757714|FG016|Dose Level 3|Withdrew|0
804103|NCT00062868|1757715|FG017|Dose Level 3|Withdrew|0
804104|NCT00062868|1757716|FG018|Dose Level 3|Withdrew|0
804105|NCT00062868|1757717|FG019|Dose Level 3|Withdrew|0
804106|NCT00062868|1757718|FG020|Dose Level 3|Withdrew|0
804107|NCT00063154|1757762|FG000|Overall Study|Disease progression|27
804108|NCT00063154|1757762|FG000|Overall Study|Adverse Event|2
804109|NCT00063154|1757762|FG000|Overall Study|Physician Decision|10
804110|NCT00063154|1757762|FG000|Overall Study|Death|3
804111|NCT00063154|1757762|FG000|Overall Study|Reason unspecified|1
804112|NCT00063154|1757762|FG000|Overall Study|Did not receive treatment|8
804113|NCT00063258|1757772|FG000|Overall Study|Physician Decision|2
804114|NCT00063258|1757773|FG001|Overall Study|Physician Decision|0
804115|NCT00063258|1757772|FG000|Overall Study|Lack of Efficacy|2
804116|NCT00063258|1757773|FG001|Overall Study|Lack of Efficacy|0
804117|NCT00063882|1757825|FG000|Overall Study|Protocol Violation|3
804118|NCT00063882|1757826|FG001|Overall Study|Protocol Violation|3
804119|NCT00063882|1757825|FG000|Overall Study|Withdrawal by Subject|2
804120|NCT00063882|1757826|FG001|Overall Study|Withdrawal by Subject|1
804121|NCT00063934|1757832|FG000|Overall Study|Ineligible|1
804122|NCT00063986|1757836|FG000|Overall Study|Withdrawal by Subject|1
804123|NCT00063986|1757836|FG000|Overall Study|Ineligible|1
804124|NCT00063986|1757836|FG000|Overall Study|Intra-operatively ineligible|4
804125|NCT00063999|1757842|FG000|Overall Study|Withdrawal by Subject|1
804126|NCT00063999|1757843|FG001|Overall Study|Withdrawal by Subject|0
804127|NCT00063999|1757842|FG000|Overall Study|Ineligible|44
804128|NCT00063999|1757843|FG001|Overall Study|Ineligible|24
804129|NCT00064025|1757856|FG000|Overall Study|Ineligible|4
804130|NCT00064025|1757856|FG000|Overall Study|Inevaluable|3
804131|NCT00064077|1757879|FG000|Overall Study|Improper prior treatment|1
804132|NCT00064077|1757880|FG001|Overall Study|Improper prior treatment|0
804133|NCT00064077|1757881|FG002|Overall Study|Improper prior treatment|0
804134|NCT00064077|1757882|FG003|Overall Study|Improper prior treatment|0
804135|NCT00064077|1757879|FG000|Overall Study|Poor risk|2
804136|NCT00064077|1757880|FG001|Overall Study|Poor risk|0
804137|NCT00064077|1757881|FG002|Overall Study|Poor risk|1
804138|NCT00064077|1757882|FG003|Overall Study|Poor risk|1
804139|NCT00064077|1757879|FG000|Overall Study|Pathology|10
804140|NCT00064077|1757880|FG001|Overall Study|Pathology|7
804141|NCT00064077|1757881|FG002|Overall Study|Pathology|3
804142|NCT00064077|1757882|FG003|Overall Study|Pathology|4
804143|NCT00064077|1757879|FG000|Overall Study|No surgery|0
804144|NCT00064077|1757880|FG001|Overall Study|No surgery|0
804145|NCT00064077|1757881|FG002|Overall Study|No surgery|1
804146|NCT00064077|1757882|FG003|Overall Study|No surgery|0
804147|NCT00064077|1757879|FG000|Overall Study|No tumor|0
804148|NCT00064077|1757880|FG001|Overall Study|No tumor|0
804149|NCT00064077|1757881|FG002|Overall Study|No tumor|1
804150|NCT00064077|1757882|FG003|Overall Study|No tumor|0
804151|NCT00064077|1757879|FG000|Overall Study|Other reasons|2
804152|NCT00064077|1757880|FG001|Overall Study|Other reasons|2
804153|NCT00064077|1757881|FG002|Overall Study|Other reasons|1
804154|NCT00064077|1757882|FG003|Overall Study|Other reasons|2
804155|NCT00064259|1757892|FG000|Overall Study|Adverse Event|1
804156|NCT00064259|1757893|FG001|Overall Study|Adverse Event|0
804157|NCT00064259|1757894|FG002|Overall Study|Adverse Event|0
804158|NCT00064259|1757895|FG003|Overall Study|Adverse Event|1
804159|NCT00064298|1757902|FG000|Overall Study|Withdrawal by Subject|2
804160|NCT00064298|1757903|FG001|Overall Study|Withdrawal by Subject|1
804161|NCT00064298|1757902|FG000|Overall Study|Lost to Follow-up|2
804162|NCT00064298|1757903|FG001|Overall Study|Lost to Follow-up|2
804163|NCT00064298|1757902|FG000|Overall Study|Death|0
804164|NCT00064298|1757903|FG001|Overall Study|Death|1
804165|NCT00064298|1757902|FG000|Overall Study|Disease Progression|2
804166|NCT00064298|1757903|FG001|Overall Study|Disease Progression|1
804167|NCT00064337|1757909|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7
804168|NCT00064337|1757909|FG000|PBSCC or Induction/PBSCC|Adverse Event|6
804169|NCT00064337|1757909|FG000|PBSCC or Induction/PBSCC|Progression|3
804170|NCT00064337|1757909|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2
804171|NCT00064337|1757909|FG000|PBSCC or Induction/PBSCC|Death|2
804172|NCT00064337|1757909|FG000|Transplant|Adverse Event|9
804173|NCT00064337|1757909|FG000|Transplant|Not protocol-specified|5
804174|NCT00064337|1757909|FG000|Transplant|Death|3
804175|NCT00064337|1757909|FG000|Transplant|Patient Refusal|2
804176|NCT00064337|1757909|FG000|Transplant|Progression|2
804177|NCT00064337|1757909|FG000|Maintenance|Adverse Event|3
804178|NCT00064337|1757909|FG000|Maintenance|Progression|2
804179|NCT00064337|1757909|FG000|Maintenance|On treatment at time of analysis|2
804180|NCT00064337|1757909|FG000|Maintenance|Not protocol-specified|2
804181|NCT00064337|1757909|FG000|Maintenance|Death|1
804182|NCT00064350|1757919|FG000|Induction Treatment|Disease Progression|5
804183|NCT00064350|1757920|FG001|Induction Treatment|Disease Progression|1
804184|NCT00064350|1757921|FG002|Induction Treatment|Disease Progression|110
804185|NCT00064350|1757919|FG000|Induction Treatment|Adverse Event|0
804186|NCT00064350|1757920|FG001|Induction Treatment|Adverse Event|2
804187|NCT00064350|1757921|FG002|Induction Treatment|Adverse Event|49
804188|NCT00064350|1757919|FG000|Induction Treatment|Death|0
804189|NCT00064350|1757920|FG001|Induction Treatment|Death|0
804190|NCT00064350|1757921|FG002|Induction Treatment|Death|9
804191|NCT00064350|1757919|FG000|Induction Treatment|Withdrawal by Subject|0
804192|NCT00064350|1757920|FG001|Induction Treatment|Withdrawal by Subject|0
804193|NCT00064350|1757921|FG002|Induction Treatment|Withdrawal by Subject|21
804194|NCT00064350|1757919|FG000|Induction Treatment|Ineligible or never started treatment|3
804195|NCT00064350|1757920|FG001|Induction Treatment|Ineligible or never started treatment|6
804196|NCT00064350|1757921|FG002|Induction Treatment|Ineligible or never started treatment|34
804197|NCT00064350|1757919|FG000|Induction Treatment|Other|0
804198|NCT00064350|1757920|FG001|Induction Treatment|Other|0
804199|NCT00064350|1757921|FG002|Induction Treatment|Other|13
804200|NCT00064350|1757919|FG000|Randomization|Adverse Event|8
804201|NCT00064350|1757920|FG001|Randomization|Adverse Event|3
804202|NCT00064350|1757921|FG002|Randomization|Adverse Event|0
804203|NCT00064350|1757919|FG000|Randomization|Death|3
804204|NCT00064350|1757920|FG001|Randomization|Death|0
804205|NCT00064350|1757921|FG002|Randomization|Death|0
804206|NCT00064350|1757919|FG000|Randomization|Withdrawal by Subject|1
804207|NCT00064350|1757920|FG001|Randomization|Withdrawal by Subject|0
804208|NCT00064350|1757921|FG002|Randomization|Withdrawal by Subject|0
804209|NCT00064350|1757919|FG000|Randomization|Ineligible or never started treatment|9
804210|NCT00064350|1757920|FG001|Randomization|Ineligible or never started treatment|15
804211|NCT00064350|1757921|FG002|Randomization|Ineligible or never started treatment|0
804212|NCT00064350|1757919|FG000|Randomization|Other|5
804213|NCT00064350|1757920|FG001|Randomization|Other|0
804214|NCT00064350|1757921|FG002|Randomization|Other|0
804215|NCT00064350|1757919|FG000|Cross-Over|Adverse Event|0
804216|NCT00064350|1757920|FG001|Cross-Over|Adverse Event|1
804217|NCT00064350|1757921|FG002|Cross-Over|Adverse Event|0
804218|NCT00064350|1757919|FG000|Cross-Over|Death|1
804219|NCT00064350|1757920|FG001|Cross-Over|Death|3
804220|NCT00064350|1757921|FG002|Cross-Over|Death|0
804221|NCT00064350|1757919|FG000|Cross-Over|Withdrawal by Subject|2
804222|NCT00064350|1757920|FG001|Cross-Over|Withdrawal by Subject|2
804223|NCT00064350|1757921|FG002|Cross-Over|Withdrawal by Subject|0
804224|NCT00064350|1757919|FG000|Cross-Over|Ineligible or never started treatment|3
804225|NCT00064350|1757920|FG001|Cross-Over|Ineligible or never started treatment|6
804226|NCT00064350|1757921|FG002|Cross-Over|Ineligible or never started treatment|0
804227|NCT00064350|1757919|FG000|Cross-Over|Other|0
804228|NCT00064350|1757920|FG001|Cross-Over|Other|2
804229|NCT00064350|1757921|FG002|Cross-Over|Other|0
804230|NCT00064662|1757932|FG000|Overall Study|Death|1
804231|NCT00064662|1757933|FG001|Overall Study|Death|1
804232|NCT00064662|1757932|FG000|Overall Study|Lost to Follow-up|57
804233|NCT00064662|1757933|FG001|Overall Study|Lost to Follow-up|44
804234|NCT00064662|1757932|FG000|Overall Study|Withdrawal by Subject|14
804235|NCT00064662|1757933|FG001|Overall Study|Withdrawal by Subject|14
804236|NCT00064662|1757932|FG000|Overall Study|Administratively withdrawn|2
804237|NCT00064662|1757933|FG001|Overall Study|Administratively withdrawn|2
804238|NCT00064701|1757942|FG000|One Year Post-transplant|Did not receive study drug|7
804239|NCT00064701|1757943|FG001|One Year Post-transplant|Did not receive study drug|12
804240|NCT00064701|1757944|FG002|One Year Post-transplant|Did not receive study drug|11
804241|NCT00064701|1757942|FG000|One Year Post-transplant|Adverse Event|23
804242|NCT00064701|1757943|FG001|One Year Post-transplant|Adverse Event|19
804243|NCT00064701|1757944|FG002|One Year Post-transplant|Adverse Event|37
804244|NCT00064701|1757942|FG000|One Year Post-transplant|Rejection|0
804245|NCT00064701|1757943|FG001|One Year Post-transplant|Rejection|1
804246|NCT00064701|1757944|FG002|One Year Post-transplant|Rejection|16
804247|NCT00064701|1757942|FG000|One Year Post-transplant|Non-compliance|4
804248|NCT00064701|1757943|FG001|One Year Post-transplant|Non-compliance|2
804249|NCT00064701|1757944|FG002|One Year Post-transplant|Non-compliance|5
804250|NCT00064701|1757942|FG000|One Year Post-transplant|Graft Failure|3
804251|NCT00064701|1757943|FG001|One Year Post-transplant|Graft Failure|2
804252|NCT00064701|1757944|FG002|One Year Post-transplant|Graft Failure|1
804253|NCT00064701|1757942|FG000|One Year Post-transplant|Withdrawal by Subject|0
804254|NCT00064701|1757943|FG001|One Year Post-transplant|Withdrawal by Subject|4
804255|NCT00064701|1757944|FG002|One Year Post-transplant|Withdrawal by Subject|1
804256|NCT00064701|1757942|FG000|One Year Post-transplant|Lost to Follow-up|1
804257|NCT00064701|1757943|FG001|One Year Post-transplant|Lost to Follow-up|0
804258|NCT00064701|1757944|FG002|One Year Post-transplant|Lost to Follow-up|0
804259|NCT00064701|1757942|FG000|One Year Post-transplant|Converted to rapamycin|1
804260|NCT00064701|1757943|FG001|One Year Post-transplant|Converted to rapamycin|0
804261|NCT00064701|1757944|FG002|One Year Post-transplant|Converted to rapamycin|0
804262|NCT00064701|1757942|FG000|One Year Post-transplant|Acute tubular necrosis|1
804263|NCT00064701|1757943|FG001|One Year Post-transplant|Acute tubular necrosis|0
804264|NCT00064701|1757944|FG002|One Year Post-transplant|Acute tubular necrosis|0
804265|NCT00064701|1757942|FG000|One Year Post-transplant|Incorrect study drug dispensed|0
804266|NCT00064701|1757943|FG001|One Year Post-transplant|Incorrect study drug dispensed|1
804267|NCT00064701|1757944|FG002|One Year Post-transplant|Incorrect study drug dispensed|0
804268|NCT00064701|1757942|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0
804269|NCT00064701|1757943|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1
804270|NCT00064701|1757944|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0
804271|NCT00064701|1757942|FG000|One Year Post-transplant|Poor absorption|0
804272|NCT00064701|1757943|FG001|One Year Post-transplant|Poor absorption|1
804273|NCT00064701|1757944|FG002|One Year Post-transplant|Poor absorption|0
804274|NCT00064701|1757942|FG000|One Year Post-transplant|Pancreas transplant|0
804275|NCT00064701|1757943|FG001|One Year Post-transplant|Pancreas transplant|0
804276|NCT00064701|1757944|FG002|One Year Post-transplant|Pancreas transplant|1
804277|NCT00064701|1757942|FG000|Clinical Continuation Phase|Adverse Event|12
804278|NCT00064701|1757943|FG001|Clinical Continuation Phase|Adverse Event|21
804279|NCT00064701|1757944|FG002|Clinical Continuation Phase|Adverse Event|14
804280|NCT00064701|1757942|FG000|Clinical Continuation Phase|Non-compliance|8
804281|NCT00064701|1757943|FG001|Clinical Continuation Phase|Non-compliance|6
804282|NCT00064701|1757944|FG002|Clinical Continuation Phase|Non-compliance|7
804283|NCT00064701|1757942|FG000|Clinical Continuation Phase|Withdrawal by Subject|22
804284|NCT00064701|1757943|FG001|Clinical Continuation Phase|Withdrawal by Subject|3
804285|NCT00064701|1757944|FG002|Clinical Continuation Phase|Withdrawal by Subject|22
804286|NCT00064701|1757942|FG000|Clinical Continuation Phase|Lost to Follow-up|6
804287|NCT00064701|1757943|FG001|Clinical Continuation Phase|Lost to Follow-up|3
804288|NCT00064701|1757944|FG002|Clinical Continuation Phase|Lost to Follow-up|6
804289|NCT00064701|1757942|FG000|Clinical Continuation Phase|Graft Failure|5
804290|NCT00064701|1757943|FG001|Clinical Continuation Phase|Graft Failure|5
804291|NCT00064701|1757944|FG002|Clinical Continuation Phase|Graft Failure|2
804292|NCT00064701|1757942|FG000|Clinical Continuation Phase|Rejection|1
804293|NCT00064701|1757943|FG001|Clinical Continuation Phase|Rejection|2
804294|NCT00064701|1757944|FG002|Clinical Continuation Phase|Rejection|2
804295|NCT00064701|1757942|FG000|Clinical Continuation Phase|Sponsor discontinued study|113
804296|NCT00064701|1757943|FG001|Clinical Continuation Phase|Sponsor discontinued study|129
804297|NCT00064701|1757944|FG002|Clinical Continuation Phase|Sponsor discontinued study|79
804298|NCT00064701|1757942|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
804299|NCT00064701|1757943|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
804300|NCT00064701|1757944|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
804301|NCT00064701|1757942|FG000|Clinical Continuation Phase|Physician Decision|1
804302|NCT00064701|1757943|FG001|Clinical Continuation Phase|Physician Decision|3
804303|NCT00064701|1757944|FG002|Clinical Continuation Phase|Physician Decision|0
804304|NCT00064701|1757942|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1
804305|NCT00064701|1757943|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0
804306|NCT00064701|1757944|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1
804307|NCT00064701|1757942|FG000|Clinical Continuation Phase|Pancreas transplant|1
804308|NCT00064701|1757943|FG001|Clinical Continuation Phase|Pancreas transplant|0
804309|NCT00064701|1757944|FG002|Clinical Continuation Phase|Pancreas transplant|0
804310|NCT00064701|1757942|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
804311|NCT00064701|1757943|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
804312|NCT00064701|1757944|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
804313|NCT00064701|1757942|FG000|Clinical Continuation Phase|Discharged to nursing home|0
804314|NCT00064701|1757943|FG001|Clinical Continuation Phase|Discharged to nursing home|1
804315|NCT00064701|1757944|FG002|Clinical Continuation Phase|Discharged to nursing home|0
804316|NCT00064701|1757942|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0
804317|NCT00064701|1757943|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1
804318|NCT00064701|1757944|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0
804319|NCT00064701|1757942|FG000|Clinical Continuation Phase|Patient opted out|0
804320|NCT00064701|1757943|FG001|Clinical Continuation Phase|Patient opted out|0
804321|NCT00064701|1757944|FG002|Clinical Continuation Phase|Patient opted out|1
804322|NCT00064753|1757954|FG000|Overall Study|Death|251
804323|NCT00064753|1757955|FG001|Overall Study|Death|242
804324|NCT00064753|1757954|FG000|Overall Study|Withdrawal by Subject|198
804325|NCT00064753|1757955|FG001|Overall Study|Withdrawal by Subject|171
804326|NCT00064753|1757954|FG000|Overall Study|Lost to Follow-up|225
804327|NCT00064753|1757955|FG001|Overall Study|Lost to Follow-up|235
804328|NCT00064792|1757963|FG000|Overall Study|Withdrawal by Subject|2
804329|NCT00064792|1757964|FG001|Overall Study|Withdrawal by Subject|0
804330|NCT00064792|1757963|FG000|Overall Study|Adverse Event|3
804331|NCT00064792|1757964|FG001|Overall Study|Adverse Event|0
804332|NCT00064987|1757981|FG000|Overall Study|Physician Decision|3
804333|NCT00064987|1757982|FG001|Overall Study|Physician Decision|0
804334|NCT00065065|1757990|FG000|Overall Study|Adverse Event|3
804335|NCT00065065|1757991|FG001|Overall Study|Adverse Event|2
804336|NCT00065065|1757990|FG000|Overall Study|Withdrawal by Subject|1
804337|NCT00065065|1757991|FG001|Overall Study|Withdrawal by Subject|5
804338|NCT00065065|1757990|FG000|Overall Study|Lack of Efficacy|4
804339|NCT00065065|1757991|FG001|Overall Study|Lack of Efficacy|11
804340|NCT00065065|1757990|FG000|Overall Study|Other|2
804341|NCT00065065|1757991|FG001|Overall Study|Other|2
804342|NCT00065156|1757999|FG000|Overall Study|Adverse Event|37
804343|NCT00065156|1757999|FG000|Overall Study|Lack of Efficacy|52
804344|NCT00065156|1757999|FG000|Overall Study|Withdrawal by Subject|8
804345|NCT00065156|1757999|FG000|Overall Study|Lost to Follow-up|1
804346|NCT00065156|1757999|FG000|Overall Study|Death|11
804347|NCT00065156|1757999|FG000|Overall Study|Study Closed by Sponsor|2
804348|NCT00065156|1757999|FG000|Overall Study|Disease Progression|7
804349|NCT00065156|1757999|FG000|Overall Study|Investigator Decision|2
804350|NCT00065156|1757999|FG000|Overall Study|Non-Compliance|2
804351|NCT00065156|1757999|FG000|Overall Study|Loss of Response|1
804352|NCT00065156|1757999|FG000|Overall Study|Secondary Malign Disease|1
804353|NCT00065182|1758005|FG000|Overall Study|Adverse Event|24
804354|NCT00065182|1758006|FG001|Overall Study|Adverse Event|17
804355|NCT00065182|1758005|FG000|Overall Study|Lost to Follow-up|0
804356|NCT00065182|1758006|FG001|Overall Study|Lost to Follow-up|4
804357|NCT00065182|1758005|FG000|Overall Study|Protocol Violation|3
804358|NCT00065182|1758006|FG001|Overall Study|Protocol Violation|4
804359|NCT00065182|1758005|FG000|Overall Study|Serious adverse events (SAE)|1
804360|NCT00065182|1758006|FG001|Overall Study|Serious adverse events (SAE)|0
804361|NCT00065182|1758005|FG000|Overall Study|Sponsor Decision|11
804362|NCT00065182|1758006|FG001|Overall Study|Sponsor Decision|7
804363|NCT00065182|1758005|FG000|Overall Study|Withdrawal by Subject|8
804364|NCT00065182|1758006|FG001|Overall Study|Withdrawal by Subject|3
804365|NCT00065182|1758005|FG000|Overall Study|No clinical benefit|1
804366|NCT00065182|1758006|FG001|Overall Study|No clinical benefit|0
804367|NCT00065182|1758005|FG000|Overall Study|Death|0
804368|NCT00065182|1758006|FG001|Overall Study|Death|1
804369|NCT00065182|1758005|FG000|Overall Study|Decline in Status|0
804370|NCT00065182|1758006|FG001|Overall Study|Decline in Status|1
804371|NCT00065260|1758014|FG000|Overall Study|Death|0
804372|NCT00065260|1758015|FG001|Overall Study|Death|1
804373|NCT00065429|1758028|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
804374|NCT00065429|1758029|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
804375|NCT00065429|1758030|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
804376|NCT00065429|1758031|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
804377|NCT00065429|1758032|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
804378|NCT00065429|1758033|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
804379|NCT00065429|1758034|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
804380|NCT00065429|1758028|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
804381|NCT00065429|1758029|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
804382|NCT00065429|1758030|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
804383|NCT00065429|1758031|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
804384|NCT00065429|1758032|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
804385|NCT00065429|1758033|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
804386|NCT00065429|1758034|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
804387|NCT00065429|1758028|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1
804388|NCT00065429|1758029|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0
804389|NCT00065429|1758030|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0
804390|NCT00065429|1758031|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0
804391|NCT00065429|1758032|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0
804392|NCT00065429|1758033|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0
804393|NCT00065429|1758034|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0
804394|NCT00065429|1758028|FG000|Phase I - May 2001 - Oct 2002|Death|0
804395|NCT00065429|1758029|FG001|Phase I - May 2001 - Oct 2002|Death|0
804396|NCT00065429|1758030|FG002|Phase I - May 2001 - Oct 2002|Death|0
804397|NCT00065429|1758031|FG003|Phase I - May 2001 - Oct 2002|Death|0
804398|NCT00065429|1758032|FG004|Phase I - May 2001 - Oct 2002|Death|1
804399|NCT00065429|1758033|FG005|Phase I - May 2001 - Oct 2002|Death|0
804400|NCT00065429|1758034|FG006|Phase I - May 2001 - Oct 2002|Death|0
804401|NCT00065429|1758028|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0
804402|NCT00065429|1758029|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0
804403|NCT00065429|1758030|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0
804404|NCT00065429|1758031|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1
804405|NCT00065429|1758032|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0
804406|NCT00065429|1758033|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1
804407|NCT00065429|1758034|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2
804408|NCT00065429|1758028|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
804409|NCT00065429|1758029|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
804410|NCT00065429|1758030|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
804411|NCT00065429|1758031|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
804412|NCT00065429|1758032|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
804413|NCT00065429|1758033|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
804414|NCT00065429|1758034|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
804415|NCT00065429|1758028|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
804416|NCT00065429|1758029|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
804417|NCT00065429|1758030|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
804418|NCT00065429|1758031|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
804419|NCT00065429|1758032|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
804420|NCT00065429|1758033|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
804421|NCT00065429|1758034|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
804422|NCT00065442|1758047|FG000|Overall Study|Lost to Follow-up|1
804423|NCT00065442|1758048|FG001|Overall Study|Lost to Follow-up|1
804424|NCT00065442|1758047|FG000|Overall Study|Death|121
804425|NCT00065442|1758048|FG001|Overall Study|Death|210
804426|NCT00065442|1758047|FG000|Overall Study|Withdrawal by Subject|3
804427|NCT00065442|1758048|FG001|Overall Study|Withdrawal by Subject|9
804428|NCT00065468|1758057|FG000|Overall Study|Death|172
804429|NCT00065468|1758058|FG001|Overall Study|Death|169
804430|NCT00065468|1758059|FG002|Overall Study|Death|171
804431|NCT00065468|1758057|FG000|Overall Study|Withdrawal by Subject|3
804432|NCT00065468|1758058|FG001|Overall Study|Withdrawal by Subject|4
804433|NCT00065468|1758059|FG002|Overall Study|Withdrawal by Subject|5
804434|NCT00065468|1758057|FG000|Overall Study|Lost to Follow-up|5
804435|NCT00065468|1758058|FG001|Overall Study|Lost to Follow-up|3
804436|NCT00065468|1758059|FG002|Overall Study|Lost to Follow-up|2
804437|NCT00065468|1758057|FG000|Overall Study|Discontinuation of study by Sponsor|13
804438|NCT00065468|1758058|FG001|Overall Study|Discontinuation of study by Sponsor|9
804439|NCT00065468|1758059|FG002|Overall Study|Discontinuation of study by Sponsor|13
804440|NCT00065468|1758057|FG000|Overall Study|Disease progression|0
804441|NCT00065468|1758058|FG001|Overall Study|Disease progression|0
804442|NCT00065468|1758059|FG002|Overall Study|Disease progression|1
804443|NCT00065468|1758057|FG000|Overall Study|Other|14
804444|NCT00065468|1758058|FG001|Overall Study|Other|24
804445|NCT00065468|1758059|FG002|Overall Study|Other|18
804446|NCT00065507|1758069|FG000|Overall Study|Death|16
804447|NCT00065507|1758070|FG001|Overall Study|Death|17
804448|NCT00065507|1758069|FG000|Overall Study|Adverse Event|4
804449|NCT00065507|1758070|FG001|Overall Study|Adverse Event|3
804450|NCT00065507|1758069|FG000|Overall Study|Lack of Efficacy|0
804451|NCT00065507|1758070|FG001|Overall Study|Lack of Efficacy|6
804452|NCT00065507|1758069|FG000|Overall Study|Poor/Non-compliance|3
804453|NCT00065507|1758070|FG001|Overall Study|Poor/Non-compliance|2
804454|NCT00065507|1758069|FG000|Overall Study|Lost to Follow-up|3
804455|NCT00065507|1758070|FG001|Overall Study|Lost to Follow-up|0
804456|NCT00065507|1758069|FG000|Overall Study|Subject Withdrew Consent|2
804457|NCT00065507|1758070|FG001|Overall Study|Subject Withdrew Consent|1
804458|NCT00065507|1758069|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
804459|NCT00065507|1758070|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
804460|NCT00066066|1758101|FG000|Overall Study|Lost to Follow-up|6
804461|NCT00066066|1758102|FG001|Overall Study|Lost to Follow-up|4
804462|NCT00066066|1758103|FG002|Overall Study|Lost to Follow-up|7
804463|NCT00066066|1758104|FG003|Overall Study|Lost to Follow-up|4
804464|NCT00066066|1758105|FG004|Overall Study|Lost to Follow-up|3
804465|NCT00066066|1758106|FG005|Overall Study|Lost to Follow-up|5
804466|NCT00066170|1758124|FG000|Overall Study|Adverse Event|2
804467|NCT00066170|1758125|FG001|Overall Study|Adverse Event|4
804468|NCT00066170|1758126|FG002|Overall Study|Adverse Event|1
804469|NCT00066170|1758127|FG003|Overall Study|Adverse Event|7
804470|NCT00066170|1758124|FG000|Overall Study|Serious Adverse Event|0
804471|NCT00066170|1758125|FG001|Overall Study|Serious Adverse Event|0
804472|NCT00066170|1758126|FG002|Overall Study|Serious Adverse Event|1
804473|NCT00066170|1758127|FG003|Overall Study|Serious Adverse Event|1
804474|NCT00066170|1758124|FG000|Overall Study|Lost to Follow-up|0
804475|NCT00066170|1758125|FG001|Overall Study|Lost to Follow-up|1
804476|NCT00066170|1758126|FG002|Overall Study|Lost to Follow-up|0
804477|NCT00066170|1758127|FG003|Overall Study|Lost to Follow-up|0
804478|NCT00066170|1758124|FG000|Overall Study|Non-Compliance with Trial Medicine|1
804479|NCT00066170|1758125|FG001|Overall Study|Non-Compliance with Trial Medicine|0
804480|NCT00066170|1758126|FG002|Overall Study|Non-Compliance with Trial Medicine|0
804481|NCT00066170|1758127|FG003|Overall Study|Non-Compliance with Trial Medicine|1
804482|NCT00066170|1758124|FG000|Overall Study|Protocol Violation|3
804483|NCT00066170|1758125|FG001|Overall Study|Protocol Violation|0
804484|NCT00066170|1758126|FG002|Overall Study|Protocol Violation|0
804485|NCT00066170|1758127|FG003|Overall Study|Protocol Violation|0
804486|NCT00066170|1758124|FG000|Overall Study|Other|1
804487|NCT00066170|1758125|FG001|Overall Study|Other|5
804488|NCT00066170|1758126|FG002|Overall Study|Other|2
804489|NCT00066170|1758127|FG003|Overall Study|Other|0
804490|NCT00066222|1758137|FG000|Overall Study|No protocol treatment received|1
804491|NCT00066365|1758143|FG000|Overall Study|Adverse Event|1
804492|NCT00066365|1758144|FG001|Overall Study|Adverse Event|0
804493|NCT00066365|1758143|FG000|Overall Study|Lack of Efficacy|15
804494|NCT00066365|1758144|FG001|Overall Study|Lack of Efficacy|12
804495|NCT00066365|1758143|FG000|Overall Study|Physician Decision|1
804496|NCT00066365|1758144|FG001|Overall Study|Physician Decision|0
804497|NCT00066365|1758143|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2
804498|NCT00066365|1758144|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0
804499|NCT00066365|1758143|FG000|Overall Study|Ineligible|4
804500|NCT00066365|1758144|FG001|Overall Study|Ineligible|2
804501|NCT00066469|1758152|FG000|Overall Study|Death|3
804502|NCT00066469|1758152|FG000|Overall Study|Lack of Efficacy|9
804503|NCT00066469|1758152|FG000|Overall Study|Lost to Follow-up|1
804504|NCT00066469|1758152|FG000|Overall Study|Physician Decision|1
804505|NCT00066469|1758152|FG000|Overall Study|Withdrawal by Subject|1
804506|NCT00066469|1758152|FG000|Overall Study|ineligible|1
804507|NCT00066573|1758158|FG000|Overall Study|Did not received protocol treatment|28
804508|NCT00066573|1758159|FG001|Overall Study|Did not received protocol treatment|28
804509|NCT00066690|1758177|FG000|Overall Study|Adverse Event|145
804510|NCT00066690|1758178|FG001|Overall Study|Adverse Event|58
804511|NCT00066690|1758179|FG002|Overall Study|Adverse Event|126
804512|NCT00066690|1758177|FG000|Overall Study|Death|3
804513|NCT00066690|1758178|FG001|Overall Study|Death|0
804514|NCT00066690|1758179|FG002|Overall Study|Death|2
804515|NCT00066690|1758177|FG000|Overall Study|Lack of Efficacy|114
804516|NCT00066690|1758178|FG001|Overall Study|Lack of Efficacy|110
804517|NCT00066690|1758179|FG002|Overall Study|Lack of Efficacy|76
804518|NCT00066690|1758177|FG000|Overall Study|Lost to Follow-up|40
804519|NCT00066690|1758178|FG001|Overall Study|Lost to Follow-up|21
804520|NCT00066690|1758179|FG002|Overall Study|Lost to Follow-up|29
804521|NCT00066690|1758177|FG000|Overall Study|Withdrawal by Subject|50
804522|NCT00066690|1758178|FG001|Overall Study|Withdrawal by Subject|55
804523|NCT00066690|1758179|FG002|Overall Study|Withdrawal by Subject|49
804524|NCT00066690|1758177|FG000|Overall Study|Treatment Ongoing|246
804525|NCT00066690|1758178|FG001|Overall Study|Treatment Ongoing|278
804526|NCT00066690|1758179|FG002|Overall Study|Treatment Ongoing|282
804527|NCT00066703|1758192|FG000|Overall Study|Adverse Event|80
804528|NCT00066703|1758193|FG001|Overall Study|Adverse Event|111
804529|NCT00066703|1758192|FG000|Overall Study|Death|3
804530|NCT00066703|1758193|FG001|Overall Study|Death|0
804531|NCT00066703|1758192|FG000|Overall Study|Lack of Efficacy|114
804532|NCT00066703|1758193|FG001|Overall Study|Lack of Efficacy|69
804533|NCT00066703|1758192|FG000|Overall Study|Lost to Follow-up|31
804534|NCT00066703|1758193|FG001|Overall Study|Lost to Follow-up|28
804535|NCT00066703|1758192|FG000|Overall Study|Withdrawal by Subject|38
804536|NCT00066703|1758193|FG001|Overall Study|Withdrawal by Subject|63
804537|NCT00066703|1758192|FG000|Overall Study|Treatment ongoing|346
804538|NCT00066703|1758193|FG001|Overall Study|Treatment ongoing|311
804539|NCT00066729|1758199|FG000|Overall Study|Lost to Follow-up|1
804540|NCT00066729|1758199|FG000|Overall Study|Disease progression|1
804541|NCT00066742|1758203|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
804542|NCT00066742|1758203|FG000|Induction Chemoradiotherapy|Adverse Event|21
804543|NCT00066742|1758203|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2
804544|NCT00066742|1758203|FG000|Induction Chemoradiotherapy|not protocol specified|2
804545|NCT00066742|1758203|FG000|Induction Chemoradiotherapy|Ineligible|3
804546|NCT00066742|1758203|FG000|Consolidation Chemotherapy|not protocol specified|1
804547|NCT00066742|1758203|FG000|Consolidation Chemotherapy|Ineligible|2
804548|NCT00067002|1758250|FG000|Overall Study|Early Death|1
804549|NCT00067002|1758251|FG001|Overall Study|Early Death|2
804550|NCT00067002|1758250|FG000|Overall Study|Delayed|1
804551|NCT00067002|1758251|FG001|Overall Study|Delayed|1
804552|NCT00067002|1758250|FG000|Overall Study|Graft Failure|5
804553|NCT00067002|1758251|FG001|Overall Study|Graft Failure|6
804554|NCT00067470|1758283|FG000|Overall Study|Withdrawal by Subject|0
804555|NCT00067470|1758284|FG001|Overall Study|Withdrawal by Subject|1
804556|NCT00067990|1758305|FG000|Overall Study|Death|5
804557|NCT00067990|1758306|FG001|Overall Study|Death|7
804558|NCT00067990|1758305|FG000|Overall Study|ESRD, Non IF/TA|1
804559|NCT00067990|1758306|FG001|Overall Study|ESRD, Non IF/TA|3
804560|NCT00067990|1758305|FG000|Overall Study|Withdrawal by Subject|4
804561|NCT00067990|1758306|FG001|Overall Study|Withdrawal by Subject|12
804562|NCT00068107|1758312|FG000|Overall Study|end-stage renal disease|6
804563|NCT00068107|1758312|FG000|Overall Study|Death|2
804564|NCT00068107|1758312|FG000|Overall Study|Withdrawal by Subject|1
804565|NCT00068237|1758319|FG000|Overall Study|Ineligible|3
804566|NCT00068237|1758319|FG000|Overall Study|No protocol treatment received|2
804567|NCT00068250|1758326|FG000|Phase I: Dose Level 2|Protocol Violation|0
804568|NCT00068250|1758327|FG001|Phase I: Dose Level 2|Protocol Violation|1
804569|NCT00068250|1758328|FG002|Phase I: Dose Level 2|Protocol Violation|0
804570|NCT00068250|1758329|FG003|Phase I: Dose Level 2|Protocol Violation|0
804571|NCT00068380|1758367|FG000|Overall Study|Withdrawal by Subject|3
804572|NCT00068380|1758367|FG000|Overall Study|Adverse Event|2
804573|NCT00068393|1758371|FG000|Overall Study|Adverse Event|2
804574|NCT00068393|1758371|FG000|Overall Study|Death|3
804575|NCT00068393|1758371|FG000|Overall Study|Withdrawal by Subject|3
804576|NCT00068393|1758371|FG000|Overall Study|Alternative treatment|1
804577|NCT00068393|1758371|FG000|Overall Study|Quality of life worsening|1
804578|NCT00068406|1758375|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1
804579|NCT00068406|1758375|FG000|Overall Study|Ineligible-Inadequate Pathology|2
804580|NCT00068419|1758379|FG000|Overall Study|Adverse Event|3
804581|NCT00068419|1758379|FG000|Overall Study|Lack of Efficacy|24
804582|NCT00068419|1758379|FG000|Overall Study|Lost to Follow-up|1
804583|NCT00068419|1758379|FG000|Overall Study|Physician Decision|7
804584|NCT00068419|1758379|FG000|Overall Study|Withdrawal by Subject|14
804585|NCT00068419|1758379|FG000|Overall Study|Ineligible|11
804586|NCT00068445|1758385|FG000|Randomization|Cancel|1
804587|NCT00068445|1758386|FG001|Randomization|Cancel|3
804588|NCT00068445|1758385|FG000|Randomization|Ineligible|1
804589|NCT00068445|1758386|FG001|Randomization|Ineligible|1
804590|NCT00068445|1758385|FG000|Treatment|Refused Further Treatment|13
804591|NCT00068445|1758386|FG001|Treatment|Refused Further Treatment|10
804592|NCT00068445|1758385|FG000|Treatment|Adverse Event|7
804593|NCT00068445|1758386|FG001|Treatment|Adverse Event|1
804594|NCT00068445|1758385|FG000|Treatment|Other (Specifics not available)|9
804595|NCT00068445|1758386|FG001|Treatment|Other (Specifics not available)|5
804596|NCT00068588|1758399|FG000|Overall Study|Adverse Event|0
804597|NCT00068588|1758400|FG001|Overall Study|Adverse Event|0
804598|NCT00068588|1758401|FG002|Overall Study|Adverse Event|2
804599|NCT00068588|1758399|FG000|Overall Study|Withdrawal by Subject|0
804600|NCT00068588|1758400|FG001|Overall Study|Withdrawal by Subject|0
804601|NCT00068588|1758401|FG002|Overall Study|Withdrawal by Subject|1
804602|NCT00068588|1758399|FG000|Overall Study|Poor KPS|0
804603|NCT00068588|1758400|FG001|Overall Study|Poor KPS|0
804604|NCT00068588|1758401|FG002|Overall Study|Poor KPS|1
804605|NCT00068601|1758410|FG000|Overall Study|Ineligible|11
804606|NCT00068601|1758411|FG001|Overall Study|Ineligible|13
804607|NCT00068601|1758410|FG000|Overall Study|Not evaluable: withdrew consent|5
804608|NCT00068601|1758411|FG001|Overall Study|Not evaluable: withdrew consent|4
804609|NCT00068601|1758410|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
804610|NCT00068601|1758411|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
804611|NCT00068601|1758410|FG000|Overall Study|Death|11
804612|NCT00068601|1758411|FG001|Overall Study|Death|3
804613|NCT00068601|1758410|FG000|Overall Study|Lost to Follow-up|3
804614|NCT00068601|1758411|FG001|Overall Study|Lost to Follow-up|2
804615|NCT00068601|1758410|FG000|Overall Study|Missing primary outcome data|30
804616|NCT00068601|1758411|FG001|Overall Study|Missing primary outcome data|34
804617|NCT00068692|1758420|FG000|Step 1: Registration|Disese progression/relapse|5
804618|NCT00068692|1758421|FG001|Step 1: Registration|Disese progression/relapse|0
804619|NCT00068692|1758422|FG002|Step 1: Registration|Disese progression/relapse|0
804620|NCT00068692|1758423|FG003|Step 1: Registration|Disese progression/relapse|0
804621|NCT00068692|1758424|FG004|Step 1: Registration|Disese progression/relapse|0
804622|NCT00068692|1758425|FG005|Step 1: Registration|Disese progression/relapse|0
804623|NCT00068692|1758426|FG006|Step 1: Registration|Disese progression/relapse|0
804624|NCT00068692|1758427|FG007|Step 1: Registration|Disese progression/relapse|0
804625|NCT00068692|1758420|FG000|Step 1: Registration|Adverse Event|7
804626|NCT00068692|1758421|FG001|Step 1: Registration|Adverse Event|0
804627|NCT00068692|1758422|FG002|Step 1: Registration|Adverse Event|0
804628|NCT00068692|1758423|FG003|Step 1: Registration|Adverse Event|0
804629|NCT00068692|1758424|FG004|Step 1: Registration|Adverse Event|0
804630|NCT00068692|1758425|FG005|Step 1: Registration|Adverse Event|0
804631|NCT00068692|1758426|FG006|Step 1: Registration|Adverse Event|0
804632|NCT00068692|1758427|FG007|Step 1: Registration|Adverse Event|0
804633|NCT00068692|1758420|FG000|Step 1: Registration|Death|1
804634|NCT00068692|1758421|FG001|Step 1: Registration|Death|0
804635|NCT00068692|1758422|FG002|Step 1: Registration|Death|0
804636|NCT00068692|1758423|FG003|Step 1: Registration|Death|0
804637|NCT00068692|1758424|FG004|Step 1: Registration|Death|0
804638|NCT00068692|1758425|FG005|Step 1: Registration|Death|0
804639|NCT00068692|1758426|FG006|Step 1: Registration|Death|0
804640|NCT00068692|1758427|FG007|Step 1: Registration|Death|0
804641|NCT00068692|1758420|FG000|Step 1: Registration|Withdrawal by Subject|11
804642|NCT00068692|1758421|FG001|Step 1: Registration|Withdrawal by Subject|0
804643|NCT00068692|1758422|FG002|Step 1: Registration|Withdrawal by Subject|0
804644|NCT00068692|1758423|FG003|Step 1: Registration|Withdrawal by Subject|0
804645|NCT00068692|1758424|FG004|Step 1: Registration|Withdrawal by Subject|0
804646|NCT00068692|1758425|FG005|Step 1: Registration|Withdrawal by Subject|0
804647|NCT00068692|1758426|FG006|Step 1: Registration|Withdrawal by Subject|0
804648|NCT00068692|1758427|FG007|Step 1: Registration|Withdrawal by Subject|0
804649|NCT00068692|1758420|FG000|Step 1: Registration|Alternative therapy|2
804650|NCT00068692|1758421|FG001|Step 1: Registration|Alternative therapy|0
804651|NCT00068692|1758422|FG002|Step 1: Registration|Alternative therapy|0
804652|NCT00068692|1758423|FG003|Step 1: Registration|Alternative therapy|0
804653|NCT00068692|1758424|FG004|Step 1: Registration|Alternative therapy|0
804654|NCT00068692|1758425|FG005|Step 1: Registration|Alternative therapy|0
804655|NCT00068692|1758426|FG006|Step 1: Registration|Alternative therapy|0
804656|NCT00068692|1758427|FG007|Step 1: Registration|Alternative therapy|0
804657|NCT00068692|1758420|FG000|Step 1: Registration|Complicating disease|2
804658|NCT00068692|1758421|FG001|Step 1: Registration|Complicating disease|0
804659|NCT00068692|1758422|FG002|Step 1: Registration|Complicating disease|0
804660|NCT00068692|1758423|FG003|Step 1: Registration|Complicating disease|0
804661|NCT00068692|1758424|FG004|Step 1: Registration|Complicating disease|0
804662|NCT00068692|1758425|FG005|Step 1: Registration|Complicating disease|0
804663|NCT00068692|1758426|FG006|Step 1: Registration|Complicating disease|0
804664|NCT00068692|1758427|FG007|Step 1: Registration|Complicating disease|0
804665|NCT00068692|1758420|FG000|Step 1: Registration|Protocol Violation|1
804666|NCT00068692|1758421|FG001|Step 1: Registration|Protocol Violation|0
804667|NCT00068692|1758422|FG002|Step 1: Registration|Protocol Violation|0
804668|NCT00068692|1758423|FG003|Step 1: Registration|Protocol Violation|0
804669|NCT00068692|1758424|FG004|Step 1: Registration|Protocol Violation|0
804670|NCT00068692|1758425|FG005|Step 1: Registration|Protocol Violation|0
804671|NCT00068692|1758426|FG006|Step 1: Registration|Protocol Violation|0
804672|NCT00068692|1758427|FG007|Step 1: Registration|Protocol Violation|0
804673|NCT00068692|1758420|FG000|Step 1: Registration|Not eligible|6
804674|NCT00068692|1758421|FG001|Step 1: Registration|Not eligible|0
804675|NCT00068692|1758422|FG002|Step 1: Registration|Not eligible|0
804676|NCT00068692|1758423|FG003|Step 1: Registration|Not eligible|0
804677|NCT00068692|1758424|FG004|Step 1: Registration|Not eligible|0
804678|NCT00068692|1758425|FG005|Step 1: Registration|Not eligible|0
804679|NCT00068692|1758426|FG006|Step 1: Registration|Not eligible|0
804680|NCT00068692|1758427|FG007|Step 1: Registration|Not eligible|0
804681|NCT00068692|1758420|FG000|Step 1: Registration|Other|2
804682|NCT00068692|1758421|FG001|Step 1: Registration|Other|0
804683|NCT00068692|1758422|FG002|Step 1: Registration|Other|0
804684|NCT00068692|1758423|FG003|Step 1: Registration|Other|0
804685|NCT00068692|1758424|FG004|Step 1: Registration|Other|0
804686|NCT00068692|1758425|FG005|Step 1: Registration|Other|0
804687|NCT00068692|1758426|FG006|Step 1: Registration|Other|0
804688|NCT00068692|1758427|FG007|Step 1: Registration|Other|0
804689|NCT00068692|1758420|FG000|Step 1: Registration|Not start protocol therapy|3
804690|NCT00068692|1758421|FG001|Step 1: Registration|Not start protocol therapy|0
804691|NCT00068692|1758422|FG002|Step 1: Registration|Not start protocol therapy|0
804692|NCT00068692|1758423|FG003|Step 1: Registration|Not start protocol therapy|0
804693|NCT00068692|1758424|FG004|Step 1: Registration|Not start protocol therapy|0
804694|NCT00068692|1758425|FG005|Step 1: Registration|Not start protocol therapy|0
804695|NCT00068692|1758426|FG006|Step 1: Registration|Not start protocol therapy|0
804696|NCT00068692|1758427|FG007|Step 1: Registration|Not start protocol therapy|0
804697|NCT00068692|1758420|FG000|Step 1: Registration|Registered but not randomized|0
804698|NCT00068692|1758421|FG001|Step 1: Registration|Registered but not randomized|1
804699|NCT00068692|1758422|FG002|Step 1: Registration|Registered but not randomized|0
804700|NCT00068692|1758423|FG003|Step 1: Registration|Registered but not randomized|0
804701|NCT00068692|1758424|FG004|Step 1: Registration|Registered but not randomized|0
804702|NCT00068692|1758425|FG005|Step 1: Registration|Registered but not randomized|0
804703|NCT00068692|1758426|FG006|Step 1: Registration|Registered but not randomized|0
804704|NCT00068692|1758427|FG007|Step 1: Registration|Registered but not randomized|0
804705|NCT00068692|1758420|FG000|Step 2: Randomization|Disesae progression/replase|0
804706|NCT00068692|1758421|FG001|Step 2: Randomization|Disesae progression/replase|0
804707|NCT00068692|1758422|FG002|Step 2: Randomization|Disesae progression/replase|1
804708|NCT00068692|1758423|FG003|Step 2: Randomization|Disesae progression/replase|1
804709|NCT00068692|1758424|FG004|Step 2: Randomization|Disesae progression/replase|0
804710|NCT00068692|1758425|FG005|Step 2: Randomization|Disesae progression/replase|0
804711|NCT00068692|1758426|FG006|Step 2: Randomization|Disesae progression/replase|0
804712|NCT00068692|1758427|FG007|Step 2: Randomization|Disesae progression/replase|0
804713|NCT00068692|1758420|FG000|Step 2: Randomization|Adverse Event|0
804714|NCT00068692|1758421|FG001|Step 2: Randomization|Adverse Event|0
804715|NCT00068692|1758422|FG002|Step 2: Randomization|Adverse Event|4
804716|NCT00068692|1758423|FG003|Step 2: Randomization|Adverse Event|2
804717|NCT00068692|1758424|FG004|Step 2: Randomization|Adverse Event|2
804718|NCT00068692|1758425|FG005|Step 2: Randomization|Adverse Event|3
804719|NCT00068692|1758426|FG006|Step 2: Randomization|Adverse Event|4
804720|NCT00068692|1758427|FG007|Step 2: Randomization|Adverse Event|4
804721|NCT00068692|1758420|FG000|Step 2: Randomization|Death|0
804722|NCT00068692|1758421|FG001|Step 2: Randomization|Death|0
804723|NCT00068692|1758422|FG002|Step 2: Randomization|Death|0
804724|NCT00068692|1758423|FG003|Step 2: Randomization|Death|0
804725|NCT00068692|1758424|FG004|Step 2: Randomization|Death|1
804726|NCT00068692|1758425|FG005|Step 2: Randomization|Death|0
804727|NCT00068692|1758426|FG006|Step 2: Randomization|Death|0
804728|NCT00068692|1758427|FG007|Step 2: Randomization|Death|1
804729|NCT00068692|1758420|FG000|Step 2: Randomization|Withdrawal by Subject|0
804730|NCT00068692|1758421|FG001|Step 2: Randomization|Withdrawal by Subject|0
804731|NCT00068692|1758422|FG002|Step 2: Randomization|Withdrawal by Subject|4
804732|NCT00068692|1758423|FG003|Step 2: Randomization|Withdrawal by Subject|6
804733|NCT00068692|1758424|FG004|Step 2: Randomization|Withdrawal by Subject|3
804734|NCT00068692|1758425|FG005|Step 2: Randomization|Withdrawal by Subject|2
804735|NCT00068692|1758426|FG006|Step 2: Randomization|Withdrawal by Subject|0
804736|NCT00068692|1758427|FG007|Step 2: Randomization|Withdrawal by Subject|3
804737|NCT00068692|1758420|FG000|Step 2: Randomization|alternative therapy|0
804738|NCT00068692|1758421|FG001|Step 2: Randomization|alternative therapy|0
804739|NCT00068692|1758422|FG002|Step 2: Randomization|alternative therapy|0
804740|NCT00068692|1758423|FG003|Step 2: Randomization|alternative therapy|1
804741|NCT00068692|1758424|FG004|Step 2: Randomization|alternative therapy|1
804742|NCT00068692|1758425|FG005|Step 2: Randomization|alternative therapy|0
804743|NCT00068692|1758426|FG006|Step 2: Randomization|alternative therapy|0
804744|NCT00068692|1758427|FG007|Step 2: Randomization|alternative therapy|0
804745|NCT00068692|1758420|FG000|Step 2: Randomization|Physician Decision|0
804746|NCT00068692|1758421|FG001|Step 2: Randomization|Physician Decision|0
804747|NCT00068692|1758422|FG002|Step 2: Randomization|Physician Decision|0
804748|NCT00068692|1758423|FG003|Step 2: Randomization|Physician Decision|1
804749|NCT00068692|1758424|FG004|Step 2: Randomization|Physician Decision|1
804750|NCT00068692|1758425|FG005|Step 2: Randomization|Physician Decision|0
804751|NCT00068692|1758426|FG006|Step 2: Randomization|Physician Decision|0
804752|NCT00068692|1758427|FG007|Step 2: Randomization|Physician Decision|0
804753|NCT00068692|1758420|FG000|Step 2: Randomization|Other|0
804754|NCT00068692|1758421|FG001|Step 2: Randomization|Other|0
804755|NCT00068692|1758422|FG002|Step 2: Randomization|Other|0
804756|NCT00068692|1758423|FG003|Step 2: Randomization|Other|1
804757|NCT00068692|1758424|FG004|Step 2: Randomization|Other|0
804758|NCT00068692|1758425|FG005|Step 2: Randomization|Other|1
804759|NCT00068692|1758426|FG006|Step 2: Randomization|Other|0
804760|NCT00068692|1758427|FG007|Step 2: Randomization|Other|0
804761|NCT00068692|1758420|FG000|Step 2: Randomization|never start protocol therapy|0
804762|NCT00068692|1758421|FG001|Step 2: Randomization|never start protocol therapy|0
804763|NCT00068692|1758422|FG002|Step 2: Randomization|never start protocol therapy|1
804764|NCT00068692|1758423|FG003|Step 2: Randomization|never start protocol therapy|0
804765|NCT00068692|1758424|FG004|Step 2: Randomization|never start protocol therapy|1
804766|NCT00068692|1758425|FG005|Step 2: Randomization|never start protocol therapy|0
804767|NCT00068692|1758426|FG006|Step 2: Randomization|never start protocol therapy|0
804768|NCT00068692|1758427|FG007|Step 2: Randomization|never start protocol therapy|0
804769|NCT00068822|1758457|FG000|First Randomized Intervention|Lost to Follow-up|1
804770|NCT00068822|1758458|FG001|First Randomized Intervention|Lost to Follow-up|2
804771|NCT00069095|1758470|FG000|Primary Treatment Phase|Ongoing|0
804772|NCT00069095|1758471|FG001|Primary Treatment Phase|Ongoing|0
804773|NCT00069095|1758472|FG002|Primary Treatment Phase|Ongoing|5
804774|NCT00069095|1758473|FG003|Primary Treatment Phase|Ongoing|7
804775|NCT00069095|1758474|FG004|Primary Treatment Phase|Ongoing|7
804776|NCT00069095|1758475|FG005|Primary Treatment Phase|Ongoing|4
804777|NCT00069095|1758470|FG000|Primary Treatment Phase|Admin/Other|29
804778|NCT00069095|1758471|FG001|Primary Treatment Phase|Admin/Other|38
804779|NCT00069095|1758472|FG002|Primary Treatment Phase|Admin/Other|31
804780|NCT00069095|1758473|FG003|Primary Treatment Phase|Admin/Other|45
804781|NCT00069095|1758474|FG004|Primary Treatment Phase|Admin/Other|48
804782|NCT00069095|1758475|FG005|Primary Treatment Phase|Admin/Other|42
804783|NCT00069095|1758470|FG000|Primary Treatment Phase|Adverse Event|99
804784|NCT00069095|1758471|FG001|Primary Treatment Phase|Adverse Event|92
804785|NCT00069095|1758472|FG002|Primary Treatment Phase|Adverse Event|71
804786|NCT00069095|1758473|FG003|Primary Treatment Phase|Adverse Event|72
804787|NCT00069095|1758474|FG004|Primary Treatment Phase|Adverse Event|109
804788|NCT00069095|1758475|FG005|Primary Treatment Phase|Adverse Event|101
804789|NCT00069095|1758470|FG000|Primary Treatment Phase|Death|14
804790|NCT00069095|1758471|FG001|Primary Treatment Phase|Death|8
804791|NCT00069095|1758472|FG002|Primary Treatment Phase|Death|2
804792|NCT00069095|1758473|FG003|Primary Treatment Phase|Death|5
804793|NCT00069095|1758474|FG004|Primary Treatment Phase|Death|8
804794|NCT00069095|1758475|FG005|Primary Treatment Phase|Death|8
804795|NCT00069095|1758470|FG000|Primary Treatment Phase|Failure to return|5
804796|NCT00069095|1758471|FG001|Primary Treatment Phase|Failure to return|5
804797|NCT00069095|1758472|FG002|Primary Treatment Phase|Failure to return|0
804798|NCT00069095|1758473|FG003|Primary Treatment Phase|Failure to return|0
804799|NCT00069095|1758474|FG004|Primary Treatment Phase|Failure to return|0
804800|NCT00069095|1758475|FG005|Primary Treatment Phase|Failure to return|2
804801|NCT00069095|1758470|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131
804802|NCT00069095|1758471|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127
804803|NCT00069095|1758472|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175
804804|NCT00069095|1758473|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154
804805|NCT00069095|1758474|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101
804806|NCT00069095|1758475|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102
804807|NCT00069095|1758470|FG000|Primary Treatment Phase|Refused treatment|15
804808|NCT00069095|1758471|FG001|Primary Treatment Phase|Refused treatment|26
804809|NCT00069095|1758472|FG002|Primary Treatment Phase|Refused treatment|17
804810|NCT00069095|1758473|FG003|Primary Treatment Phase|Refused treatment|31
804811|NCT00069095|1758474|FG004|Primary Treatment Phase|Refused treatment|24
804812|NCT00069095|1758475|FG005|Primary Treatment Phase|Refused treatment|27
804813|NCT00069095|1758470|FG000|Primary Treatment Phase|Withdrew|2
804814|NCT00069095|1758471|FG001|Primary Treatment Phase|Withdrew|3
804815|NCT00069095|1758472|FG002|Primary Treatment Phase|Withdrew|8
804816|NCT00069095|1758473|FG003|Primary Treatment Phase|Withdrew|2
804817|NCT00069095|1758474|FG004|Primary Treatment Phase|Withdrew|4
804818|NCT00069095|1758475|FG005|Primary Treatment Phase|Withdrew|9
804819|NCT00069095|1758470|FG000|Primary Treatment Phase|Other Violation|0
804820|NCT00069095|1758471|FG001|Primary Treatment Phase|Other Violation|1
804821|NCT00069095|1758472|FG002|Primary Treatment Phase|Other Violation|1
804822|NCT00069095|1758473|FG003|Primary Treatment Phase|Other Violation|1
804823|NCT00069095|1758474|FG004|Primary Treatment Phase|Other Violation|0
804824|NCT00069095|1758475|FG005|Primary Treatment Phase|Other Violation|1
804825|NCT00069095|1758470|FG000|Primary Treatment Phase|Violation criteria|0
804826|NCT00069095|1758471|FG001|Primary Treatment Phase|Violation criteria|2
804827|NCT00069095|1758472|FG002|Primary Treatment Phase|Violation criteria|4
804828|NCT00069095|1758473|FG003|Primary Treatment Phase|Violation criteria|3
804829|NCT00069095|1758474|FG004|Primary Treatment Phase|Violation criteria|1
804830|NCT00069095|1758475|FG005|Primary Treatment Phase|Violation criteria|5
804831|NCT00069095|1758470|FG000|Post-study Treatment Phase|Missing reason|1
804832|NCT00069095|1758471|FG001|Post-study Treatment Phase|Missing reason|3
804833|NCT00069095|1758472|FG002|Post-study Treatment Phase|Missing reason|12
804834|NCT00069095|1758473|FG003|Post-study Treatment Phase|Missing reason|8
804835|NCT00069095|1758474|FG004|Post-study Treatment Phase|Missing reason|18
804836|NCT00069095|1758475|FG005|Post-study Treatment Phase|Missing reason|17
804837|NCT00069095|1758470|FG000|Post-study Treatment Phase|Adverse Event|2
804838|NCT00069095|1758471|FG001|Post-study Treatment Phase|Adverse Event|3
804839|NCT00069095|1758472|FG002|Post-study Treatment Phase|Adverse Event|1
804840|NCT00069095|1758473|FG003|Post-study Treatment Phase|Adverse Event|0
804841|NCT00069095|1758474|FG004|Post-study Treatment Phase|Adverse Event|5
804842|NCT00069095|1758475|FG005|Post-study Treatment Phase|Adverse Event|1
804843|NCT00069095|1758470|FG000|Post-study Treatment Phase|Eligible for surgery|2
804844|NCT00069095|1758471|FG001|Post-study Treatment Phase|Eligible for surgery|0
804845|NCT00069095|1758472|FG002|Post-study Treatment Phase|Eligible for surgery|0
804846|NCT00069095|1758473|FG003|Post-study Treatment Phase|Eligible for surgery|0
804847|NCT00069095|1758474|FG004|Post-study Treatment Phase|Eligible for surgery|0
804848|NCT00069095|1758475|FG005|Post-study Treatment Phase|Eligible for surgery|0
804849|NCT00069095|1758470|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1
804850|NCT00069095|1758471|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4
804851|NCT00069095|1758472|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5
804852|NCT00069095|1758473|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6
804853|NCT00069095|1758474|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7
804854|NCT00069095|1758475|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9
804855|NCT00069095|1758470|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1
804856|NCT00069095|1758471|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0
804857|NCT00069095|1758472|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0
804858|NCT00069095|1758473|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0
804859|NCT00069095|1758474|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0
804860|NCT00069095|1758475|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1
804861|NCT00069095|1758470|FG000|Post-study Treatment Phase|Participant had complete response|1
804862|NCT00069095|1758471|FG001|Post-study Treatment Phase|Participant had complete response|1
804863|NCT00069095|1758472|FG002|Post-study Treatment Phase|Participant had complete response|0
804864|NCT00069095|1758473|FG003|Post-study Treatment Phase|Participant had complete response|0
804865|NCT00069095|1758474|FG004|Post-study Treatment Phase|Participant had complete response|0
804866|NCT00069095|1758475|FG005|Post-study Treatment Phase|Participant had complete response|0
804867|NCT00069095|1758470|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0
804868|NCT00069095|1758471|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1
804869|NCT00069095|1758472|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0
804870|NCT00069095|1758473|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0
804871|NCT00069095|1758474|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0
804872|NCT00069095|1758475|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0
804873|NCT00069095|1758470|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0
804874|NCT00069095|1758471|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1
804875|NCT00069095|1758472|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1
804876|NCT00069095|1758473|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0
804877|NCT00069095|1758474|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1
804878|NCT00069095|1758475|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0
804879|NCT00069095|1758470|FG000|Post-study Treatment Phase|Participant withdrew consent|0
804880|NCT00069095|1758471|FG001|Post-study Treatment Phase|Participant withdrew consent|0
804881|NCT00069095|1758472|FG002|Post-study Treatment Phase|Participant withdrew consent|1
804882|NCT00069095|1758473|FG003|Post-study Treatment Phase|Participant withdrew consent|0
804883|NCT00069095|1758474|FG004|Post-study Treatment Phase|Participant withdrew consent|0
804884|NCT00069095|1758475|FG005|Post-study Treatment Phase|Participant withdrew consent|0
804885|NCT00069095|1758470|FG000|Post-study Treatment Phase|Participant will start new treatment|0
804886|NCT00069095|1758471|FG001|Post-study Treatment Phase|Participant will start new treatment|0
804887|NCT00069095|1758472|FG002|Post-study Treatment Phase|Participant will start new treatment|1
804888|NCT00069095|1758473|FG003|Post-study Treatment Phase|Participant will start new treatment|0
804964|NCT00069121|1758500|FG001|Overall Study|Lost to Follow-up|63
804889|NCT00069095|1758474|FG004|Post-study Treatment Phase|Participant will start new treatment|0
804890|NCT00069095|1758475|FG005|Post-study Treatment Phase|Participant will start new treatment|0
804891|NCT00069095|1758470|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0
804892|NCT00069095|1758471|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0
804893|NCT00069095|1758472|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0
804894|NCT00069095|1758473|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1
804895|NCT00069095|1758474|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0
804896|NCT00069095|1758475|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0
804897|NCT00069095|1758470|FG000|Post-study Treatment Phase|Participant completed treatment|0
804898|NCT00069095|1758471|FG001|Post-study Treatment Phase|Participant completed treatment|0
804899|NCT00069095|1758472|FG002|Post-study Treatment Phase|Participant completed treatment|0
804900|NCT00069095|1758473|FG003|Post-study Treatment Phase|Participant completed treatment|1
804901|NCT00069095|1758474|FG004|Post-study Treatment Phase|Participant completed treatment|0
804902|NCT00069095|1758475|FG005|Post-study Treatment Phase|Participant completed treatment|0
804903|NCT00069095|1758470|FG000|Post-study Treatment Phase|Surgery|0
804904|NCT00069095|1758471|FG001|Post-study Treatment Phase|Surgery|0
804905|NCT00069095|1758472|FG002|Post-study Treatment Phase|Surgery|0
804906|NCT00069095|1758473|FG003|Post-study Treatment Phase|Surgery|1
804907|NCT00069095|1758474|FG004|Post-study Treatment Phase|Surgery|1
804908|NCT00069095|1758475|FG005|Post-study Treatment Phase|Surgery|0
804909|NCT00069095|1758470|FG000|Post-study Treatment Phase|Death|0
804910|NCT00069095|1758471|FG001|Post-study Treatment Phase|Death|0
804911|NCT00069095|1758472|FG002|Post-study Treatment Phase|Death|0
804912|NCT00069095|1758473|FG003|Post-study Treatment Phase|Death|0
804913|NCT00069095|1758474|FG004|Post-study Treatment Phase|Death|1
804914|NCT00069095|1758475|FG005|Post-study Treatment Phase|Death|0
804915|NCT00069095|1758470|FG000|Post-study Treatment Phase|Participant had progressive disease|0
804916|NCT00069095|1758471|FG001|Post-study Treatment Phase|Participant had progressive disease|0
804917|NCT00069095|1758472|FG002|Post-study Treatment Phase|Participant had progressive disease|0
804918|NCT00069095|1758473|FG003|Post-study Treatment Phase|Participant had progressive disease|0
804919|NCT00069095|1758474|FG004|Post-study Treatment Phase|Participant had progressive disease|1
804920|NCT00069095|1758475|FG005|Post-study Treatment Phase|Participant had progressive disease|0
804921|NCT00069095|1758470|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0
804922|NCT00069095|1758471|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0
804923|NCT00069095|1758472|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0
804924|NCT00069095|1758473|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0
804925|NCT00069095|1758474|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1
804926|NCT00069095|1758475|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0
804927|NCT00069095|1758470|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
804928|NCT00069095|1758471|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
804929|NCT00069095|1758472|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
804930|NCT00069095|1758473|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
804931|NCT00069095|1758474|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
804932|NCT00069095|1758475|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
804933|NCT00069095|1758470|FG000|Post-study Treatment Phase|Investigator decision|0
804934|NCT00069095|1758471|FG001|Post-study Treatment Phase|Investigator decision|0
804935|NCT00069095|1758472|FG002|Post-study Treatment Phase|Investigator decision|0
804936|NCT00069095|1758473|FG003|Post-study Treatment Phase|Investigator decision|0
804937|NCT00069095|1758474|FG004|Post-study Treatment Phase|Investigator decision|0
804938|NCT00069095|1758475|FG005|Post-study Treatment Phase|Investigator decision|1
804939|NCT00069095|1758470|FG000|Follow-up Phase|Death|174
804940|NCT00069095|1758471|FG001|Follow-up Phase|Death|206
804941|NCT00069095|1758472|FG002|Follow-up Phase|Death|120
804942|NCT00069095|1758473|FG003|Follow-up Phase|Death|112
804943|NCT00069095|1758474|FG004|Follow-up Phase|Death|92
804944|NCT00069095|1758475|FG005|Follow-up Phase|Death|101
804945|NCT00069108|1758489|FG000|Overall Study|Withdrawal by Subject|5
804946|NCT00069108|1758490|FG001|Overall Study|Withdrawal by Subject|9
804947|NCT00069108|1758489|FG000|Overall Study|Adverse Event|64
804948|NCT00069108|1758490|FG001|Overall Study|Adverse Event|42
804949|NCT00069108|1758489|FG000|Overall Study|Death|6
804950|NCT00069108|1758490|FG001|Overall Study|Death|6
804951|NCT00069108|1758489|FG000|Overall Study|Administration|15
804952|NCT00069108|1758490|FG001|Overall Study|Administration|4
804953|NCT00069108|1758489|FG000|Overall Study|Insufficient therapy|117
804954|NCT00069108|1758490|FG001|Overall Study|Insufficient therapy|144
804955|NCT00069108|1758489|FG000|Overall Study|Violation criteria|1
804956|NCT00069108|1758490|FG001|Overall Study|Violation criteria|4
804957|NCT00069108|1758489|FG000|Overall Study|Refused treatment|5
804958|NCT00069108|1758490|FG001|Overall Study|Refused treatment|10
804959|NCT00069121|1758499|FG000|Overall Study|Death|286
804960|NCT00069121|1758500|FG001|Overall Study|Death|242
804961|NCT00069121|1758499|FG000|Overall Study|Withdrawal by Subject|18
804962|NCT00069121|1758500|FG001|Overall Study|Withdrawal by Subject|20
804963|NCT00069121|1758499|FG000|Overall Study|Lost to Follow-up|63
804965|NCT00069238|1758522|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
804966|NCT00069238|1758523|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
804967|NCT00069238|1758524|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
804968|NCT00069238|1758522|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
804969|NCT00069238|1758523|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
804970|NCT00069238|1758524|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
804971|NCT00069238|1758522|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
804972|NCT00069238|1758523|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
804973|NCT00069238|1758524|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
804974|NCT00069264|1758529|FG000|Overall Study|Adverse Event|3
804975|NCT00069264|1758529|FG000|Overall Study|Progressive Disease|23
804976|NCT00069264|1758529|FG000|Overall Study|Withdrawal by Subject|3
804977|NCT00069264|1758529|FG000|Overall Study|Discon Therapy|3
804978|NCT00069277|1758533|FG000|Overall Study|Adverse Event|3
804979|NCT00069277|1758533|FG000|Overall Study|Withdrawal by Subject|1
804980|NCT00069277|1758533|FG000|Overall Study|Progressive Disease|15
804981|NCT00069277|1758533|FG000|Overall Study|Physician Decision|2
804982|NCT00069576|1758543|FG000|Original Trial|Lost to Follow-up|25
804983|NCT00069576|1758544|FG001|Original Trial|Lost to Follow-up|33
804984|NCT00069576|1758543|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
804985|NCT00069576|1758544|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
804986|NCT00069641|1758553|FG000|Overall Study|Death|1
804987|NCT00069641|1758554|FG001|Overall Study|Death|0
804988|NCT00069641|1758555|FG002|Overall Study|Death|1
804989|NCT00069784|1758566|FG000|Overall Study|Adverse Event|105
804990|NCT00069784|1758567|FG001|Overall Study|Adverse Event|0
804991|NCT00069784|1758566|FG000|Overall Study|Withdrawal by Subject|1090
804992|NCT00069784|1758567|FG001|Overall Study|Withdrawal by Subject|0
804993|NCT00069784|1758566|FG000|Overall Study|Other|17
804994|NCT00069784|1758567|FG001|Overall Study|Other|0
804995|NCT00069823|1758575|FG000|Overall Study|Did not have follow-up diary cards|6
804996|NCT00069823|1758576|FG001|Overall Study|Did not have follow-up diary cards|3
804997|NCT00069953|1758582|FG000|Overall Study|Protocol Violation|2
805001|NCT00070109|1758612|FG000|Overall Study|Death|1
805002|NCT00070109|1758613|FG001|Overall Study|Death|1
805003|NCT00070109|1758614|FG002|Overall Study|Death|0
805004|NCT00070109|1758615|FG003|Overall Study|Death|0
805005|NCT00070109|1758616|FG004|Overall Study|Death|1
805006|NCT00070109|1758612|FG000|Overall Study|Lack of Efficacy|6
805007|NCT00070109|1758613|FG001|Overall Study|Lack of Efficacy|4
805008|NCT00070109|1758614|FG002|Overall Study|Lack of Efficacy|5
805009|NCT00070109|1758615|FG003|Overall Study|Lack of Efficacy|15
805010|NCT00070109|1758616|FG004|Overall Study|Lack of Efficacy|5
805011|NCT00070109|1758612|FG000|Overall Study|Physician Decision|1
805012|NCT00070109|1758613|FG001|Overall Study|Physician Decision|0
805013|NCT00070109|1758614|FG002|Overall Study|Physician Decision|0
805014|NCT00070109|1758615|FG003|Overall Study|Physician Decision|0
805015|NCT00070109|1758616|FG004|Overall Study|Physician Decision|0
805016|NCT00070109|1758612|FG000|Overall Study|Withdrawal by Subject|0
805017|NCT00070109|1758613|FG001|Overall Study|Withdrawal by Subject|1
805018|NCT00070109|1758614|FG002|Overall Study|Withdrawal by Subject|1
805019|NCT00070109|1758615|FG003|Overall Study|Withdrawal by Subject|0
805020|NCT00070109|1758616|FG004|Overall Study|Withdrawal by Subject|0
805021|NCT00070109|1758612|FG000|Overall Study|Adverse Event|0
805022|NCT00070109|1758613|FG001|Overall Study|Adverse Event|0
805023|NCT00070109|1758614|FG002|Overall Study|Adverse Event|2
805024|NCT00070109|1758615|FG003|Overall Study|Adverse Event|4
805025|NCT00070109|1758616|FG004|Overall Study|Adverse Event|2
805026|NCT00070109|1758612|FG000|Overall Study|removed from prot thpy prior to chemo|0
805027|NCT00070109|1758613|FG001|Overall Study|removed from prot thpy prior to chemo|0
805028|NCT00070109|1758614|FG002|Overall Study|removed from prot thpy prior to chemo|0
805029|NCT00070109|1758615|FG003|Overall Study|removed from prot thpy prior to chemo|1
805030|NCT00070109|1758616|FG004|Overall Study|removed from prot thpy prior to chemo|0
805031|NCT00070291|1758639|FG000|Step 1|Withdrawal by Subject|1
805032|NCT00070291|1758639|FG000|Step 1|Adverse Event|1
805033|NCT00070291|1758639|FG000|Step 2|Adverse Event|1
805034|NCT00070317|1758643|FG000|Overall Study|Inevaluable (Never Treated)|1
805035|NCT00070317|1758643|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3
805036|NCT00070317|1758643|FG000|Overall Study|Ineligible required test not done|1
805037|NCT00070317|1758643|FG000|Overall Study|Ineligible-Improper prior treatment|2
805038|NCT00070317|1758643|FG000|Overall Study|Ineligible-Inadequate pathology|6
805081|NCT00070707|1758680|FG000|Overall Study|Adverse Event|1
805082|NCT00070707|1758681|FG001|Overall Study|Adverse Event|2
805083|NCT00070707|1758680|FG000|Overall Study|Lack of Efficacy|4
805084|NCT00070707|1758681|FG001|Overall Study|Lack of Efficacy|1
805085|NCT00070707|1758680|FG000|Overall Study|Protocol Violation|8
805086|NCT00070707|1758681|FG001|Overall Study|Protocol Violation|4
805087|NCT00070707|1758680|FG000|Overall Study|Unrelated to Study Medication|1
805088|NCT00070707|1758681|FG001|Overall Study|Unrelated to Study Medication|0
805089|NCT00070941|1758690|FG000|Overall Study|Adverse Event|10
805090|NCT00070941|1758691|FG001|Overall Study|Adverse Event|8
805091|NCT00070941|1758692|FG002|Overall Study|Adverse Event|4
805092|NCT00071006|1758700|FG000|Overall Study|Lack of Efficacy|7
805093|NCT00071006|1758700|FG000|Overall Study|Adverse Event|1
805094|NCT00071006|1758700|FG000|Overall Study|Withdrawal by Subject|1
805095|NCT00071006|1758700|FG000|Overall Study|Other|3
805096|NCT00071032|1758706|FG000|Overall Study|Lost to Follow-up|1
805097|NCT00071032|1758707|FG001|Overall Study|Lost to Follow-up|1
805098|NCT00071032|1758706|FG000|Overall Study|Withdrawal by Subject|8
805099|NCT00071032|1758707|FG001|Overall Study|Withdrawal by Subject|6
805100|NCT00071032|1758706|FG000|Overall Study|Missing Primary Outcome|0
805101|NCT00071032|1758707|FG001|Overall Study|Missing Primary Outcome|1
805102|NCT00071058|1758714|FG000|Overall Study|brain tumor-removed from study|1
805103|NCT00071110|1758721|FG000|Overall Study|Protocol Violation|0
805104|NCT00071110|1758722|FG001|Overall Study|Protocol Violation|4
805105|NCT00071396|1758728|FG000|Overall Study|Withdrawal by Subject|1
805106|NCT00071396|1758728|FG000|Overall Study|Physician Decision|2
805107|NCT00071487|1758736|FG000|52-Week Double-Blind Period|Adverse Event|5
805108|NCT00071487|1758737|FG001|52-Week Double-Blind Period|Adverse Event|8
805109|NCT00071487|1758738|FG002|52-Week Double-Blind Period|Adverse Event|4
805110|NCT00071487|1758739|FG003|52-Week Double-Blind Period|Adverse Event|8
805111|NCT00071487|1758736|FG000|52-Week Double-Blind Period|Lack of Efficacy|1
805112|NCT00071487|1758737|FG001|52-Week Double-Blind Period|Lack of Efficacy|2
805113|NCT00071487|1758738|FG002|52-Week Double-Blind Period|Lack of Efficacy|0
805114|NCT00071487|1758739|FG003|52-Week Double-Blind Period|Lack of Efficacy|1
805115|NCT00071487|1758736|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7
805116|NCT00071487|1758737|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11
805117|NCT00071487|1758738|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7
805118|NCT00071487|1758739|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7
805119|NCT00071487|1758736|FG000|52-Week Double-Blind Period|Physician Decision|1
805120|NCT00071487|1758737|FG001|52-Week Double-Blind Period|Physician Decision|0
805121|NCT00071487|1758738|FG002|52-Week Double-Blind Period|Physician Decision|0
805122|NCT00071487|1758739|FG003|52-Week Double-Blind Period|Physician Decision|0
805123|NCT00071487|1758736|FG000|52-Week Double-Blind Period|Lost to Follow-up|0
805124|NCT00071487|1758737|FG001|52-Week Double-Blind Period|Lost to Follow-up|0
805125|NCT00071487|1758738|FG002|52-Week Double-Blind Period|Lost to Follow-up|2
805126|NCT00071487|1758739|FG003|52-Week Double-Blind Period|Lost to Follow-up|2
805127|NCT00071487|1758736|FG000|52-Week Double-Blind Period|Pregnancy|0
805128|NCT00071487|1758737|FG001|52-Week Double-Blind Period|Pregnancy|1
805129|NCT00071487|1758738|FG002|52-Week Double-Blind Period|Pregnancy|0
805130|NCT00071487|1758739|FG003|52-Week Double-Blind Period|Pregnancy|0
805131|NCT00071487|1758736|FG000|52-Week Double-Blind Period|Protocol Violation|0
805132|NCT00071487|1758737|FG001|52-Week Double-Blind Period|Protocol Violation|1
805133|NCT00071487|1758738|FG002|52-Week Double-Blind Period|Protocol Violation|1
805134|NCT00071487|1758739|FG003|52-Week Double-Blind Period|Protocol Violation|0
805135|NCT00071487|1758736|FG000|52-Week Double-Blind Period|Death|0
805136|NCT00071487|1758737|FG001|52-Week Double-Blind Period|Death|1
805137|NCT00071487|1758738|FG002|52-Week Double-Blind Period|Death|0
805138|NCT00071487|1758739|FG003|52-Week Double-Blind Period|Death|0
805139|NCT00071487|1758736|FG000|52-Week Double-Blind Period|Lack of Compliance|6
805140|NCT00071487|1758737|FG001|52-Week Double-Blind Period|Lack of Compliance|3
805141|NCT00071487|1758738|FG002|52-Week Double-Blind Period|Lack of Compliance|3
805142|NCT00071487|1758739|FG003|52-Week Double-Blind Period|Lack of Compliance|3
805143|NCT00071487|1758736|FG000|24-Week Open-Label Extension Period|Adverse Event|0
805144|NCT00071487|1758737|FG001|24-Week Open-Label Extension Period|Adverse Event|0
805145|NCT00071487|1758738|FG002|24-Week Open-Label Extension Period|Adverse Event|1
805146|NCT00071487|1758739|FG003|24-Week Open-Label Extension Period|Adverse Event|6
805147|NCT00071487|1758736|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
805148|NCT00071487|1758737|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
805149|NCT00071487|1758738|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
805150|NCT00071487|1758739|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3
805151|NCT00071487|1758736|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
805152|NCT00071487|1758737|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
805153|NCT00071487|1758738|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
805154|NCT00071487|1758739|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9
805155|NCT00071487|1758736|FG000|24-Week Open-Label Extension Period|Pregnancy|0
805156|NCT00071487|1758737|FG001|24-Week Open-Label Extension Period|Pregnancy|0
805157|NCT00071487|1758738|FG002|24-Week Open-Label Extension Period|Pregnancy|0
805158|NCT00071487|1758739|FG003|24-Week Open-Label Extension Period|Pregnancy|1
805159|NCT00071487|1758736|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
805160|NCT00071487|1758737|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
805161|NCT00071487|1758738|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
805162|NCT00071487|1758739|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
805163|NCT00071487|1758736|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
805164|NCT00071487|1758737|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
805165|NCT00071487|1758738|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0
805166|NCT00071487|1758739|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
805167|NCT00071513|1758753|FG000|Intervention Component|Withdrawal by Subject|2
805168|NCT00071513|1758754|FG001|Intervention Component|Withdrawal by Subject|3
805169|NCT00071513|1758753|FG000|Follow-up Assessment|Withdrawal by Subject|6
805170|NCT00071513|1758754|FG001|Follow-up Assessment|Withdrawal by Subject|6
805171|NCT00071760|1758771|FG000|Overall Study|Adverse Event|3
805172|NCT00071760|1758771|FG000|Overall Study|Lost to Follow-up|4
805173|NCT00071760|1758771|FG000|Overall Study|Protocol Violation|1
805174|NCT00071760|1758771|FG000|Overall Study|Withdrawal by Subject|3
805175|NCT00071760|1758771|FG000|Overall Study|Insufficient Viral Load Response|3
805176|NCT00071760|1758771|FG000|Overall Study|Pulmonary Tuberculosis|1
805177|NCT00071760|1758771|FG000|Overall Study|Unavailability of RTV|8
805178|NCT00071760|1758771|FG000|Overall Study|Relocation|1
805179|NCT00071760|1758771|FG000|Overall Study|Investigator's Recommendation (Rec.)|4
805180|NCT00071760|1758771|FG000|Overall Study|Study Team Rec./Resistance|1
805181|NCT00071760|1758771|FG000|Overall Study|Ongoing|25
805182|NCT00071799|1758783|FG000|Overall Study|Adverse Event|19
805183|NCT00071799|1758784|FG001|Overall Study|Adverse Event|10
805184|NCT00071799|1758783|FG000|Overall Study|Protocol Violation|1
805185|NCT00071799|1758784|FG001|Overall Study|Protocol Violation|7
805186|NCT00071799|1758783|FG000|Overall Study|Lost to Follow-up|1
805187|NCT00071799|1758784|FG001|Overall Study|Lost to Follow-up|1
805188|NCT00071799|1758783|FG000|Overall Study|Withdrawal by Subject|15
805189|NCT00071799|1758784|FG001|Overall Study|Withdrawal by Subject|37
805190|NCT00071799|1758783|FG000|Overall Study|Physician Decision|0
805191|NCT00071799|1758784|FG001|Overall Study|Physician Decision|2
805192|NCT00071799|1758783|FG000|Overall Study|Lack of Efficacy|11
805193|NCT00071799|1758784|FG001|Overall Study|Lack of Efficacy|18
805194|NCT00071799|1758783|FG000|Overall Study|Disease Progression|23
805195|NCT00071799|1758784|FG001|Overall Study|Disease Progression|20
805196|NCT00071799|1758783|FG000|Overall Study|Different Central+Local Pathology Review|0
805197|NCT00071799|1758784|FG001|Overall Study|Different Central+Local Pathology Review|1
805198|NCT00071799|1758783|FG000|Overall Study|Not Documented|0
805199|NCT00071799|1758784|FG001|Overall Study|Not Documented|2
805200|NCT00071812|1758800|FG000|24-Week Double-Blind Period|Adverse Event|2
805201|NCT00071812|1758801|FG001|24-Week Double-Blind Period|Adverse Event|3
805202|NCT00071812|1758802|FG002|24-Week Double-Blind Period|Adverse Event|4
805203|NCT00071812|1758803|FG003|24-Week Double-Blind Period|Adverse Event|4
805204|NCT00071812|1758800|FG000|24-Week Double-Blind Period|Lack of Efficacy|3
805205|NCT00071812|1758801|FG001|24-Week Double-Blind Period|Lack of Efficacy|1
805206|NCT00071812|1758802|FG002|24-Week Double-Blind Period|Lack of Efficacy|2
805207|NCT00071812|1758803|FG003|24-Week Double-Blind Period|Lack of Efficacy|1
805208|NCT00071812|1758800|FG000|24-Week Double-Blind Period|Lost to Follow-up|0
805209|NCT00071812|1758801|FG001|24-Week Double-Blind Period|Lost to Follow-up|1
805210|NCT00071812|1758802|FG002|24-Week Double-Blind Period|Lost to Follow-up|1
805211|NCT00071812|1758803|FG003|24-Week Double-Blind Period|Lost to Follow-up|0
805212|NCT00071812|1758800|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5
805213|NCT00071812|1758801|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1
805214|NCT00071812|1758802|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1
805215|NCT00071812|1758803|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5
805216|NCT00071812|1758800|FG000|24-Week Double-Blind Period|Protocol Violation|0
805217|NCT00071812|1758801|FG001|24-Week Double-Blind Period|Protocol Violation|0
805218|NCT00071812|1758802|FG002|24-Week Double-Blind Period|Protocol Violation|0
805219|NCT00071812|1758803|FG003|24-Week Double-Blind Period|Protocol Violation|1
805220|NCT00071812|1758800|FG000|24-Week Open-Label Extension Period|Adverse Event|0
805221|NCT00071812|1758801|FG001|24-Week Open-Label Extension Period|Adverse Event|0
805222|NCT00071812|1758802|FG002|24-Week Open-Label Extension Period|Adverse Event|0
805223|NCT00071812|1758803|FG003|24-Week Open-Label Extension Period|Adverse Event|7
805224|NCT00071812|1758800|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
805225|NCT00071812|1758801|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
805226|NCT00071812|1758802|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
805227|NCT00071812|1758803|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17
805228|NCT00071812|1758800|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
805229|NCT00071812|1758801|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
805230|NCT00071812|1758802|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
805231|NCT00071812|1758803|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
805232|NCT00071812|1758800|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
805233|NCT00071812|1758801|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
805234|NCT00071812|1758802|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
805235|NCT00071812|1758803|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12
805236|NCT00071812|1758800|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
805237|NCT00071812|1758801|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
805238|NCT00071812|1758802|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1
805239|NCT00071812|1758803|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
805240|NCT00071981|1758828|FG000|Overall Study|Lack of Efficacy|37
805241|NCT00071981|1758829|FG001|Overall Study|Lack of Efficacy|29
805242|NCT00071981|1758830|FG002|Overall Study|Lack of Efficacy|30
805243|NCT00071981|1758831|FG003|Overall Study|Lack of Efficacy|43
805244|NCT00071981|1758828|FG000|Overall Study|Adverse Event|4
805245|NCT00071981|1758829|FG001|Overall Study|Adverse Event|4
805246|NCT00071981|1758830|FG002|Overall Study|Adverse Event|3
805247|NCT00071981|1758831|FG003|Overall Study|Adverse Event|1
805248|NCT00071981|1758828|FG000|Overall Study|Death|0
805249|NCT00071981|1758829|FG001|Overall Study|Death|0
805250|NCT00071981|1758830|FG002|Overall Study|Death|1
805251|NCT00071981|1758831|FG003|Overall Study|Death|1
805252|NCT00071981|1758828|FG000|Overall Study|Withdrawal by Subject|3
805253|NCT00071981|1758829|FG001|Overall Study|Withdrawal by Subject|1
805254|NCT00071981|1758830|FG002|Overall Study|Withdrawal by Subject|0
805255|NCT00071981|1758831|FG003|Overall Study|Withdrawal by Subject|0
805256|NCT00071981|1758828|FG000|Overall Study|No protocol therapy|2
805257|NCT00071981|1758829|FG001|Overall Study|No protocol therapy|5
805258|NCT00071981|1758830|FG002|Overall Study|No protocol therapy|1
805259|NCT00071981|1758831|FG003|Overall Study|No protocol therapy|0
805260|NCT00071981|1758828|FG000|Overall Study|others (not specified in the study)|0
805261|NCT00071981|1758829|FG001|Overall Study|others (not specified in the study)|2
805262|NCT00071981|1758830|FG002|Overall Study|others (not specified in the study)|2
805263|NCT00071981|1758831|FG003|Overall Study|others (not specified in the study)|0
805264|NCT00072176|1758843|FG000|Overall Study|Withdrawal by Subject|1
805265|NCT00072176|1758844|FG001|Overall Study|Withdrawal by Subject|0
805266|NCT00072176|1758843|FG000|Overall Study|Protocol Violation|0
805267|NCT00072176|1758844|FG001|Overall Study|Protocol Violation|1
805268|NCT00072189|1758850|FG000|Overall Study|Withdrawal by Subject|1
805269|NCT00072280|1758856|FG000|Treatment|Found ineligible|1
805270|NCT00072280|1758857|FG001|Treatment|Found ineligible|2
805271|NCT00072280|1758856|FG000|Follow-up|Early termination of study|2
805272|NCT00072280|1758857|FG001|Follow-up|Early termination of study|2
805273|NCT00072293|1758864|FG000|Overall Study|Lost to Follow-up|1
805274|NCT00072293|1758865|FG001|Overall Study|Lost to Follow-up|1
805275|NCT00072293|1758864|FG000|Overall Study|Withdrawal by Subject|0
805276|NCT00072293|1758865|FG001|Overall Study|Withdrawal by Subject|1
805277|NCT00072384|1758871|FG000|Overall Study|Physician Decision|1
805278|NCT00072384|1758871|FG000|Overall Study|Ineligible|8
805279|NCT00072475|1758881|FG000|Overall Study|Adverse Event|44
805280|NCT00072475|1758881|FG000|Overall Study|Death|3
805281|NCT00072475|1758881|FG000|Overall Study|Withdrawal by Subject|46
805282|NCT00072475|1758881|FG000|Overall Study|Patient/Investigator Decision|4
805283|NCT00073008|1758904|FG000|Overall Study|Missing|6
805284|NCT00073008|1758905|FG001|Overall Study|Missing|6
805285|NCT00073008|1758904|FG000|Overall Study|Withdrawal by Subject|2
805286|NCT00073008|1758905|FG001|Overall Study|Withdrawal by Subject|2
805287|NCT00073008|1758904|FG000|Overall Study|Lost to Follow-up|1
805288|NCT00073008|1758905|FG001|Overall Study|Lost to Follow-up|3
805289|NCT00073008|1758904|FG000|Overall Study|Death|46
805290|NCT00073008|1758905|FG001|Overall Study|Death|47
805447|NCT00074282|1759033|FG000|Step 1|Disease progression|2
805291|NCT00073008|1758904|FG000|Overall Study|"Other selected on Case Report Form"|7
805292|NCT00073008|1758905|FG001|Overall Study|"Other selected on Case Report Form"|5
805293|NCT00073021|1758913|FG000|Overall Study|Protocol Violation|2
805294|NCT00073021|1758914|FG001|Overall Study|Protocol Violation|1
805295|NCT00073021|1758913|FG000|Overall Study|Adverse Event|4
805296|NCT00073021|1758914|FG001|Overall Study|Adverse Event|4
805297|NCT00073021|1758913|FG000|Overall Study|Withdrawal by Subject|6
805298|NCT00073021|1758914|FG001|Overall Study|Withdrawal by Subject|5
805299|NCT00073021|1758913|FG000|Overall Study|Physician Decision|3
805300|NCT00073021|1758914|FG001|Overall Study|Physician Decision|1
805301|NCT00073021|1758913|FG000|Overall Study|Lack of Efficacy|11
805302|NCT00073021|1758914|FG001|Overall Study|Lack of Efficacy|5
805303|NCT00073307|1758926|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
805304|NCT00073307|1758927|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
805305|NCT00073307|1758928|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
805306|NCT00073307|1758926|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
805307|NCT00073307|1758927|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
805308|NCT00073307|1758928|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
805309|NCT00073307|1758926|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
805310|NCT00073307|1758927|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
805311|NCT00073307|1758928|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
805312|NCT00073307|1758926|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
805313|NCT00073307|1758927|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
805314|NCT00073307|1758928|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
805315|NCT00073307|1758926|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
805316|NCT00073307|1758927|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
805317|NCT00073307|1758928|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
805318|NCT00073307|1758926|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
805319|NCT00073307|1758927|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
805320|NCT00073307|1758928|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
805321|NCT00073307|1758926|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
805322|NCT00073307|1758927|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
805323|NCT00073307|1758928|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
805324|NCT00073307|1758926|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
805325|NCT00073307|1758927|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
805326|NCT00073307|1758928|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
805327|NCT00073307|1758926|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
805328|NCT00073307|1758927|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
805329|NCT00073307|1758928|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
805330|NCT00073307|1758926|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
805331|NCT00073307|1758927|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
805332|NCT00073307|1758928|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
805333|NCT00073307|1758926|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
805334|NCT00073307|1758927|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
805335|NCT00073307|1758928|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
805336|NCT00073307|1758926|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
805337|NCT00073307|1758927|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
805338|NCT00073307|1758928|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
805339|NCT00073307|1758926|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
805340|NCT00073307|1758927|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
805341|NCT00073307|1758928|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
805342|NCT00073307|1758926|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
805343|NCT00073307|1758927|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
805344|NCT00073307|1758928|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
805345|NCT00073307|1758926|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
805346|NCT00073307|1758927|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
805347|NCT00073307|1758928|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
805348|NCT00073307|1758926|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
805349|NCT00073307|1758927|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
805350|NCT00073307|1758928|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
805351|NCT00073307|1758926|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3
805352|NCT00073307|1758927|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0
805353|NCT00073307|1758928|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1
805354|NCT00073307|1758926|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
805355|NCT00073307|1758927|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
805356|NCT00073307|1758928|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
805357|NCT00073307|1758926|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
805358|NCT00073307|1758927|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
805359|NCT00073307|1758928|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
805360|NCT00073528|1758952|FG000|Overall Study|Death|488
805361|NCT00073528|1758953|FG001|Overall Study|Death|473
805362|NCT00073528|1758952|FG000|Overall Study|Lost to Follow-up|52
805363|NCT00073528|1758953|FG001|Overall Study|Lost to Follow-up|45
805364|NCT00073528|1758952|FG000|Overall Study|Withdrawal by Subject|50
805365|NCT00073528|1758953|FG001|Overall Study|Withdrawal by Subject|45
805366|NCT00073528|1758952|FG000|Overall Study|Study terminated by Sponsor|10
805367|NCT00073528|1758953|FG001|Overall Study|Study terminated by Sponsor|29
805368|NCT00073528|1758952|FG000|Overall Study|Other|18
805369|NCT00073528|1758953|FG001|Overall Study|Other|19
805370|NCT00073528|1758952|FG000|Overall Study|Other|9
805371|NCT00073528|1758953|FG001|Overall Study|Other|12
805372|NCT00073528|1758952|FG000|Overall Study|Protocol Violation|3
805373|NCT00073528|1758953|FG001|Overall Study|Protocol Violation|5
805374|NCT00073749|1758966|FG000|Overall Study|Disease Progression|2
805375|NCT00073749|1758967|FG001|Overall Study|Disease Progression|0
805376|NCT00073749|1758968|FG002|Overall Study|Disease Progression|3
805377|NCT00073749|1758969|FG003|Overall Study|Disease Progression|2
805378|NCT00073749|1758970|FG004|Overall Study|Disease Progression|3
805379|NCT00073749|1758971|FG005|Overall Study|Disease Progression|1
805380|NCT00073749|1758972|FG006|Overall Study|Disease Progression|3
805381|NCT00073749|1758966|FG000|Overall Study|Death|0
805382|NCT00073749|1758967|FG001|Overall Study|Death|1
805383|NCT00073749|1758968|FG002|Overall Study|Death|1
805384|NCT00073749|1758969|FG003|Overall Study|Death|0
805385|NCT00073749|1758970|FG004|Overall Study|Death|0
805386|NCT00073749|1758971|FG005|Overall Study|Death|0
805387|NCT00073749|1758972|FG006|Overall Study|Death|29
805388|NCT00073749|1758966|FG000|Overall Study|Adverse Event|0
805389|NCT00073749|1758967|FG001|Overall Study|Adverse Event|3
805390|NCT00073749|1758968|FG002|Overall Study|Adverse Event|6
805391|NCT00073749|1758969|FG003|Overall Study|Adverse Event|4
805392|NCT00073749|1758970|FG004|Overall Study|Adverse Event|2
805393|NCT00073749|1758971|FG005|Overall Study|Adverse Event|1
805394|NCT00073749|1758972|FG006|Overall Study|Adverse Event|0
805395|NCT00073749|1758966|FG000|Overall Study|Physician Decision|0
805396|NCT00073749|1758967|FG001|Overall Study|Physician Decision|0
805397|NCT00073749|1758968|FG002|Overall Study|Physician Decision|1
805398|NCT00073749|1758969|FG003|Overall Study|Physician Decision|0
805399|NCT00073749|1758970|FG004|Overall Study|Physician Decision|0
805400|NCT00073749|1758971|FG005|Overall Study|Physician Decision|2
805401|NCT00073749|1758972|FG006|Overall Study|Physician Decision|0
805402|NCT00073749|1758966|FG000|Overall Study|Withdrawal by Subject|0
805403|NCT00073749|1758967|FG001|Overall Study|Withdrawal by Subject|1
805404|NCT00073749|1758968|FG002|Overall Study|Withdrawal by Subject|0
805405|NCT00073749|1758969|FG003|Overall Study|Withdrawal by Subject|0
805406|NCT00073749|1758970|FG004|Overall Study|Withdrawal by Subject|1
805407|NCT00073749|1758971|FG005|Overall Study|Withdrawal by Subject|0
805408|NCT00073749|1758972|FG006|Overall Study|Withdrawal by Subject|2
805409|NCT00073749|1758966|FG000|Overall Study|Discontinuation of Study by Sponsor|0
805410|NCT00073749|1758967|FG001|Overall Study|Discontinuation of Study by Sponsor|0
805411|NCT00073749|1758968|FG002|Overall Study|Discontinuation of Study by Sponsor|0
805412|NCT00073749|1758969|FG003|Overall Study|Discontinuation of Study by Sponsor|0
805413|NCT00073749|1758970|FG004|Overall Study|Discontinuation of Study by Sponsor|0
805414|NCT00073749|1758971|FG005|Overall Study|Discontinuation of Study by Sponsor|0
805415|NCT00073749|1758972|FG006|Overall Study|Discontinuation of Study by Sponsor|4
805416|NCT00073749|1758966|FG000|Overall Study|Lost to Follow-up|0
805417|NCT00073749|1758967|FG001|Overall Study|Lost to Follow-up|0
805418|NCT00073749|1758968|FG002|Overall Study|Lost to Follow-up|0
805419|NCT00073749|1758969|FG003|Overall Study|Lost to Follow-up|0
805420|NCT00073749|1758970|FG004|Overall Study|Lost to Follow-up|0
805421|NCT00073749|1758971|FG005|Overall Study|Lost to Follow-up|0
805422|NCT00073749|1758972|FG006|Overall Study|Lost to Follow-up|2
805423|NCT00073749|1758966|FG000|Overall Study|Other|0
805424|NCT00073749|1758967|FG001|Overall Study|Other|0
805425|NCT00073749|1758968|FG002|Overall Study|Other|0
805426|NCT00073749|1758969|FG003|Overall Study|Other|0
805427|NCT00073749|1758970|FG004|Overall Study|Other|0
805428|NCT00073749|1758971|FG005|Overall Study|Other|2
805429|NCT00073749|1758972|FG006|Overall Study|Other|0
805430|NCT00073918|1758991|FG000|Overall Study|Eligibility requirement not met - HAMA+|1
805431|NCT00073918|1758991|FG000|Overall Study|Rapid disease progression|2
805432|NCT00073918|1758991|FG000|Overall Study|Eligibility requirement not met-low CD20|1
805433|NCT00073983|1759001|FG000|Overall Study|not evaluable|1
805434|NCT00074152|1759013|FG000|Overall Study|Death|21
805435|NCT00074152|1759014|FG001|Overall Study|Death|9
805436|NCT00074152|1759013|FG000|Overall Study|Lack of Efficacy|34
805437|NCT00074152|1759014|FG001|Overall Study|Lack of Efficacy|24
805438|NCT00074282|1759033|FG000|Step 1|Adverse Event|32
805439|NCT00074282|1759034|FG001|Step 1|Adverse Event|0
805440|NCT00074282|1759035|FG002|Step 1|Adverse Event|0
805441|NCT00074282|1759033|FG000|Step 1|Death|6
805442|NCT00074282|1759034|FG001|Step 1|Death|0
805443|NCT00074282|1759035|FG002|Step 1|Death|0
805444|NCT00074282|1759033|FG000|Step 1|Withdrawal by Subject|7
805445|NCT00074282|1759034|FG001|Step 1|Withdrawal by Subject|0
805446|NCT00074282|1759035|FG002|Step 1|Withdrawal by Subject|0
805448|NCT00074282|1759034|FG001|Step 1|Disease progression|0
805449|NCT00074282|1759035|FG002|Step 1|Disease progression|0
805450|NCT00074282|1759033|FG000|Step 1|Alternative therapy|2
805451|NCT00074282|1759034|FG001|Step 1|Alternative therapy|0
805452|NCT00074282|1759035|FG002|Step 1|Alternative therapy|0
805453|NCT00074282|1759033|FG000|Step 1|Other complicating disease|2
805454|NCT00074282|1759034|FG001|Step 1|Other complicating disease|0
805455|NCT00074282|1759035|FG002|Step 1|Other complicating disease|0
805456|NCT00074282|1759033|FG000|Step 1|Physician Decision|1
805457|NCT00074282|1759034|FG001|Step 1|Physician Decision|0
805458|NCT00074282|1759035|FG002|Step 1|Physician Decision|0
805459|NCT00074282|1759033|FG000|Step 1|Ineligible|4
805460|NCT00074282|1759034|FG001|Step 1|Ineligible|0
805461|NCT00074282|1759035|FG002|Step 1|Ineligible|0
805462|NCT00074282|1759033|FG000|Step 1|Never started treatment|2
805463|NCT00074282|1759034|FG001|Step 1|Never started treatment|0
805464|NCT00074282|1759035|FG002|Step 1|Never started treatment|0
805465|NCT00074282|1759033|FG000|Step 2|Adverse Event|0
805466|NCT00074282|1759034|FG001|Step 2|Adverse Event|2
805467|NCT00074282|1759035|FG002|Step 2|Adverse Event|12
805468|NCT00074282|1759033|FG000|Step 2|Disease progression|0
805469|NCT00074282|1759034|FG001|Step 2|Disease progression|0
805470|NCT00074282|1759035|FG002|Step 2|Disease progression|5
805471|NCT00074282|1759033|FG000|Step 2|Death|0
805472|NCT00074282|1759034|FG001|Step 2|Death|0
805473|NCT00074282|1759035|FG002|Step 2|Death|3
805474|NCT00074282|1759033|FG000|Step 2|Withdrawal by Subject|0
805475|NCT00074282|1759034|FG001|Step 2|Withdrawal by Subject|0
805476|NCT00074282|1759035|FG002|Step 2|Withdrawal by Subject|2
805477|NCT00074282|1759033|FG000|Step 2|Physician Decision|0
805478|NCT00074282|1759034|FG001|Step 2|Physician Decision|0
805479|NCT00074282|1759035|FG002|Step 2|Physician Decision|1
805480|NCT00074282|1759033|FG000|Step 2|Ineligible|0
805481|NCT00074282|1759034|FG001|Step 2|Ineligible|0
805482|NCT00074282|1759035|FG002|Step 2|Ineligible|1
805483|NCT00074412|1759061|FG000|Overall Study|Death|30
805484|NCT00074412|1759062|FG001|Overall Study|Death|26
805485|NCT00074412|1759061|FG000|Overall Study|Lost to Follow-up|52
805486|NCT00074412|1759062|FG001|Overall Study|Lost to Follow-up|58
805487|NCT00074490|1759074|FG000|Overall Study|Progressive malignancy|0
805488|NCT00074490|1759075|FG001|Overall Study|Progressive malignancy|7
805489|NCT00074490|1759076|FG002|Overall Study|Progressive malignancy|0
805490|NCT00074490|1759077|FG003|Overall Study|Progressive malignancy|0
805491|NCT00074490|1759078|FG004|Overall Study|Progressive malignancy|3
805492|NCT00074490|1759079|FG005|Overall Study|Progressive malignancy|0
805493|NCT00074581|1759094|FG000|Overall Study|Death|15
805494|NCT00074581|1759095|FG001|Overall Study|Death|16
805495|NCT00074581|1759094|FG000|Overall Study|Withdrawal by Subject|50
805496|NCT00074581|1759095|FG001|Overall Study|Withdrawal by Subject|49
805497|NCT00074581|1759094|FG000|Overall Study|Unable to adhere to visit schedule|13
805498|NCT00074581|1759095|FG001|Overall Study|Unable to adhere to visit schedule|14
805499|NCT00074581|1759094|FG000|Overall Study|Relocated|14
805500|NCT00074581|1759095|FG001|Overall Study|Relocated|9
805501|NCT00074581|1759094|FG000|Overall Study|Were withdrawn by investigator|5
805502|NCT00074581|1759095|FG001|Overall Study|Were withdrawn by investigator|2
805503|NCT00074581|1759094|FG000|Overall Study|Lost to Follow-up|16
805504|NCT00074581|1759095|FG001|Overall Study|Lost to Follow-up|11
805505|NCT00074581|1759094|FG000|Overall Study|Ended relationship w. index participant|117
805506|NCT00074581|1759095|FG001|Overall Study|Ended relationship w. index participant|106
805507|NCT00074581|1759094|FG000|Overall Study|Other|14
805508|NCT00074581|1759095|FG001|Overall Study|Other|19
805509|NCT00074711|1759103|FG000|Overall Study|Withdrawal by Subject|1
805510|NCT00074711|1759104|FG001|Overall Study|Withdrawal by Subject|1
805511|NCT00074711|1759103|FG000|Overall Study|Lost to Follow-up|10
805512|NCT00074711|1759104|FG001|Overall Study|Lost to Follow-up|8
805513|NCT00074711|1759103|FG000|Overall Study|Participant stopped study drug|4
805514|NCT00074711|1759104|FG001|Overall Study|Participant stopped study drug|6
805515|NCT00074958|1759132|FG000|Overall Study|Adverse Event|1
805516|NCT00074984|1759138|FG000|Overall Study|Death|1
805517|NCT00074984|1759139|FG001|Overall Study|Death|2
805518|NCT00074984|1759138|FG000|Overall Study|Withdrawal by Subject|2
805519|NCT00074984|1759139|FG001|Overall Study|Withdrawal by Subject|3
805520|NCT00074984|1759138|FG000|Overall Study|Patient Withdrawn Per Protocol|0
805521|NCT00074984|1759139|FG001|Overall Study|Patient Withdrawn Per Protocol|3
805522|NCT00075023|1759148|FG000|Pilot Study|Physician Decision|1
805523|NCT00075023|1759149|FG001|Pilot Study|Physician Decision|2
805524|NCT00075023|1759148|FG000|Pilot Study|Withdrawal by Subject|1
805525|NCT00075023|1759149|FG001|Pilot Study|Withdrawal by Subject|0
805526|NCT00075218|1759168|FG000|Double-Blind Treatment|Adverse Event|23
805527|NCT00075218|1759169|FG001|Double-Blind Treatment|Adverse Event|4
805528|NCT00075218|1759170|FG002|Double-Blind Treatment|Adverse Event|0
805529|NCT00075218|1759168|FG000|Double-Blind Treatment|Withdrawal by Subject|7
805530|NCT00075218|1759169|FG001|Double-Blind Treatment|Withdrawal by Subject|4
805531|NCT00075218|1759170|FG002|Double-Blind Treatment|Withdrawal by Subject|0
805532|NCT00075218|1759168|FG000|Double-Blind Treatment|Lost to Follow-up|1
805533|NCT00075218|1759169|FG001|Double-Blind Treatment|Lost to Follow-up|0
805534|NCT00075218|1759170|FG002|Double-Blind Treatment|Lost to Follow-up|0
805535|NCT00075218|1759168|FG000|Double-Blind Treatment|Lack of Efficacy|58
805536|NCT00075218|1759169|FG001|Double-Blind Treatment|Lack of Efficacy|6
805537|NCT00075218|1759170|FG002|Double-Blind Treatment|Lack of Efficacy|0
805538|NCT00075218|1759168|FG000|Double-Blind Treatment|Decision of Sponsor|0
805539|NCT00075218|1759169|FG001|Double-Blind Treatment|Decision of Sponsor|1
805540|NCT00075218|1759170|FG002|Double-Blind Treatment|Decision of Sponsor|0
805541|NCT00075218|1759168|FG000|Double-Blind Treatment|No study medication taken|2
805542|NCT00075218|1759169|FG001|Double-Blind Treatment|No study medication taken|0
805543|NCT00075218|1759170|FG002|Double-Blind Treatment|No study medication taken|0
805544|NCT00075218|1759168|FG000|Open-Label Treatment|Lack of Efficacy|0
805545|NCT00075218|1759169|FG001|Open-Label Treatment|Lack of Efficacy|0
805546|NCT00075218|1759170|FG002|Open-Label Treatment|Lack of Efficacy|174
805547|NCT00075218|1759168|FG000|Open-Label Treatment|Adverse Event|0
805548|NCT00075218|1759169|FG001|Open-Label Treatment|Adverse Event|0
805549|NCT00075218|1759170|FG002|Open-Label Treatment|Adverse Event|51
805550|NCT00075218|1759168|FG000|Open-Label Treatment|Withdrawal by Subject|0
805551|NCT00075218|1759169|FG001|Open-Label Treatment|Withdrawal by Subject|0
805552|NCT00075218|1759170|FG002|Open-Label Treatment|Withdrawal by Subject|12
805553|NCT00075218|1759168|FG000|Open-Label Treatment|Decision of Sponsor|0
805554|NCT00075218|1759169|FG001|Open-Label Treatment|Decision of Sponsor|0
805555|NCT00075218|1759170|FG002|Open-Label Treatment|Decision of Sponsor|8
805556|NCT00075218|1759168|FG000|Open-Label Treatment|Protocol Violation|0
805557|NCT00075218|1759169|FG001|Open-Label Treatment|Protocol Violation|0
805558|NCT00075218|1759170|FG002|Open-Label Treatment|Protocol Violation|1
805559|NCT00075218|1759168|FG000|Open-Label Treatment|enrolled in a separate continuation|0
805560|NCT00075218|1759169|FG001|Open-Label Treatment|enrolled in a separate continuation|0
805561|NCT00075218|1759170|FG002|Open-Label Treatment|enrolled in a separate continuation|9
805562|NCT00075270|1759179|FG000|Overall Study|Withdrawal by Subject|28
805563|NCT00075270|1759180|FG001|Overall Study|Withdrawal by Subject|21
805564|NCT00075270|1759179|FG000|Overall Study|Lost to Follow-up|25
805565|NCT00075270|1759180|FG001|Overall Study|Lost to Follow-up|28
805566|NCT00075270|1759179|FG000|Overall Study|Protocol Violation|0
805567|NCT00075270|1759180|FG001|Overall Study|Protocol Violation|2
805568|NCT00075270|1759179|FG000|Overall Study|Death|198
805569|NCT00075270|1759180|FG001|Overall Study|Death|215
805570|NCT00075270|1759179|FG000|Overall Study|Other/Unknown|9
805571|NCT00075270|1759180|FG001|Overall Study|Other/Unknown|5
805572|NCT00075270|1759179|FG000|Overall Study|Missing|26
805573|NCT00075270|1759180|FG001|Overall Study|Missing|13
805574|NCT00075400|1759191|FG000|Overall Study|Ineligible: wrong primary|1
805575|NCT00075400|1759191|FG000|Overall Study|Never treated|2
805576|NCT00075478|1759202|FG000|Overall Study|not eligible|1
805577|NCT00075478|1759203|FG001|Overall Study|not eligible|0
805578|NCT00075478|1759202|FG000|Overall Study|Physician Decision|0
805579|NCT00075478|1759203|FG001|Overall Study|Physician Decision|1
805580|NCT00075504|1759211|FG000|Overall Study|Withdrawal by Subject|9
805581|NCT00075504|1759212|FG001|Overall Study|Withdrawal by Subject|7
805582|NCT00075582|1759220|FG000|Overall Study|Adverse Event|3
805583|NCT00075582|1759221|FG001|Overall Study|Adverse Event|1
805584|NCT00075582|1759220|FG000|Overall Study|Lack of Efficacy|4
805585|NCT00075582|1759221|FG001|Overall Study|Lack of Efficacy|8
805586|NCT00075582|1759220|FG000|Overall Study|Physician Decision|5
805587|NCT00075582|1759221|FG001|Overall Study|Physician Decision|8
805588|NCT00075582|1759220|FG000|Overall Study|Withdrawal by Subject|2
805589|NCT00075582|1759221|FG001|Overall Study|Withdrawal by Subject|2
805590|NCT00075582|1759220|FG000|Overall Study|Ineligible for study|36
805591|NCT00075582|1759221|FG001|Overall Study|Ineligible for study|16
805592|NCT00075725|1759243|FG000|Overall Study|Adverse Event|6
805593|NCT00075725|1759244|FG001|Overall Study|Adverse Event|6
805594|NCT00075725|1759245|FG002|Overall Study|Adverse Event|20
805595|NCT00075725|1759246|FG003|Overall Study|Adverse Event|8
805596|NCT00075725|1759247|FG004|Overall Study|Adverse Event|4
805597|NCT00075725|1759248|FG005|Overall Study|Adverse Event|38
805598|NCT00075725|1759249|FG006|Overall Study|Adverse Event|3
805599|NCT00075725|1759250|FG007|Overall Study|Adverse Event|51
805600|NCT00075725|1759251|FG008|Overall Study|Adverse Event|15
805601|NCT00075725|1759252|FG009|Overall Study|Adverse Event|4
805602|NCT00075725|1759253|FG010|Overall Study|Adverse Event|2
805603|NCT00075725|1759254|FG011|Overall Study|Adverse Event|2
805604|NCT00075725|1759243|FG000|Overall Study|Death|3
805605|NCT00075725|1759244|FG001|Overall Study|Death|5
805606|NCT00075725|1759245|FG002|Overall Study|Death|10
805607|NCT00075725|1759246|FG003|Overall Study|Death|2
805608|NCT00075725|1759247|FG004|Overall Study|Death|3
805609|NCT00075725|1759248|FG005|Overall Study|Death|25
805610|NCT00075725|1759249|FG006|Overall Study|Death|4
805611|NCT00075725|1759250|FG007|Overall Study|Death|22
805612|NCT00075725|1759251|FG008|Overall Study|Death|14
805613|NCT00075725|1759252|FG009|Overall Study|Death|4
805614|NCT00075725|1759253|FG010|Overall Study|Death|3
805615|NCT00075725|1759254|FG011|Overall Study|Death|0
805616|NCT00075725|1759243|FG000|Overall Study|Lost to Follow-up|1
805617|NCT00075725|1759244|FG001|Overall Study|Lost to Follow-up|1
805618|NCT00075725|1759245|FG002|Overall Study|Lost to Follow-up|4
805619|NCT00075725|1759246|FG003|Overall Study|Lost to Follow-up|1
805620|NCT00075725|1759247|FG004|Overall Study|Lost to Follow-up|0
805621|NCT00075725|1759248|FG005|Overall Study|Lost to Follow-up|13
805622|NCT00075725|1759249|FG006|Overall Study|Lost to Follow-up|2
805623|NCT00075725|1759250|FG007|Overall Study|Lost to Follow-up|4
805624|NCT00075725|1759251|FG008|Overall Study|Lost to Follow-up|1
805625|NCT00075725|1759252|FG009|Overall Study|Lost to Follow-up|0
805626|NCT00075725|1759253|FG010|Overall Study|Lost to Follow-up|0
805627|NCT00075725|1759254|FG011|Overall Study|Lost to Follow-up|0
805628|NCT00075725|1759243|FG000|Overall Study|Physician Decision|2
805629|NCT00075725|1759244|FG001|Overall Study|Physician Decision|6
805630|NCT00075725|1759245|FG002|Overall Study|Physician Decision|5
805631|NCT00075725|1759246|FG003|Overall Study|Physician Decision|8
805632|NCT00075725|1759247|FG004|Overall Study|Physician Decision|4
805633|NCT00075725|1759248|FG005|Overall Study|Physician Decision|19
805634|NCT00075725|1759249|FG006|Overall Study|Physician Decision|3
805635|NCT00075725|1759250|FG007|Overall Study|Physician Decision|17
805636|NCT00075725|1759251|FG008|Overall Study|Physician Decision|5
805637|NCT00075725|1759252|FG009|Overall Study|Physician Decision|0
805638|NCT00075725|1759253|FG010|Overall Study|Physician Decision|1
805639|NCT00075725|1759254|FG011|Overall Study|Physician Decision|0
805640|NCT00075725|1759243|FG000|Overall Study|Pregnancy|0
805641|NCT00075725|1759244|FG001|Overall Study|Pregnancy|0
805642|NCT00075725|1759245|FG002|Overall Study|Pregnancy|0
805643|NCT00075725|1759246|FG003|Overall Study|Pregnancy|0
805644|NCT00075725|1759247|FG004|Overall Study|Pregnancy|0
805645|NCT00075725|1759248|FG005|Overall Study|Pregnancy|1
805646|NCT00075725|1759249|FG006|Overall Study|Pregnancy|0
805647|NCT00075725|1759250|FG007|Overall Study|Pregnancy|1
805648|NCT00075725|1759251|FG008|Overall Study|Pregnancy|0
805649|NCT00075725|1759252|FG009|Overall Study|Pregnancy|0
805650|NCT00075725|1759253|FG010|Overall Study|Pregnancy|0
805651|NCT00075725|1759254|FG011|Overall Study|Pregnancy|0
805652|NCT00075725|1759243|FG000|Overall Study|Protocol Violation|1
805653|NCT00075725|1759244|FG001|Overall Study|Protocol Violation|1
805654|NCT00075725|1759245|FG002|Overall Study|Protocol Violation|0
805655|NCT00075725|1759246|FG003|Overall Study|Protocol Violation|3
805656|NCT00075725|1759247|FG004|Overall Study|Protocol Violation|3
805657|NCT00075725|1759248|FG005|Overall Study|Protocol Violation|2
805658|NCT00075725|1759249|FG006|Overall Study|Protocol Violation|1
805659|NCT00075725|1759250|FG007|Overall Study|Protocol Violation|2
805660|NCT00075725|1759251|FG008|Overall Study|Protocol Violation|3
805661|NCT00075725|1759252|FG009|Overall Study|Protocol Violation|0
805662|NCT00075725|1759253|FG010|Overall Study|Protocol Violation|0
805663|NCT00075725|1759254|FG011|Overall Study|Protocol Violation|1
805664|NCT00075725|1759243|FG000|Overall Study|Withdrawal by Subject|12
805665|NCT00075725|1759244|FG001|Overall Study|Withdrawal by Subject|3
805666|NCT00075725|1759245|FG002|Overall Study|Withdrawal by Subject|6
805667|NCT00075725|1759246|FG003|Overall Study|Withdrawal by Subject|10
805668|NCT00075725|1759247|FG004|Overall Study|Withdrawal by Subject|6
805669|NCT00075725|1759248|FG005|Overall Study|Withdrawal by Subject|27
805670|NCT00075725|1759249|FG006|Overall Study|Withdrawal by Subject|7
805671|NCT00075725|1759250|FG007|Overall Study|Withdrawal by Subject|31
805672|NCT00075725|1759251|FG008|Overall Study|Withdrawal by Subject|10
805673|NCT00075725|1759252|FG009|Overall Study|Withdrawal by Subject|2
805674|NCT00075725|1759253|FG010|Overall Study|Withdrawal by Subject|0
805675|NCT00075725|1759254|FG011|Overall Study|Withdrawal by Subject|0
805676|NCT00075725|1759243|FG000|Overall Study|Disease Progression, all other reasons|17
805677|NCT00075725|1759244|FG001|Overall Study|Disease Progression, all other reasons|5
805678|NCT00075725|1759245|FG002|Overall Study|Disease Progression, all other reasons|33
805679|NCT00075725|1759246|FG003|Overall Study|Disease Progression, all other reasons|6
805680|NCT00075725|1759247|FG004|Overall Study|Disease Progression, all other reasons|21
805681|NCT00075725|1759248|FG005|Overall Study|Disease Progression, all other reasons|59
805682|NCT00075725|1759249|FG006|Overall Study|Disease Progression, all other reasons|20
805683|NCT00075725|1759250|FG007|Overall Study|Disease Progression, all other reasons|46
805684|NCT00075725|1759251|FG008|Overall Study|Disease Progression, all other reasons|21
805685|NCT00075725|1759252|FG009|Overall Study|Disease Progression, all other reasons|4
805686|NCT00075725|1759253|FG010|Overall Study|Disease Progression, all other reasons|0
805687|NCT00075725|1759254|FG011|Overall Study|Disease Progression, all other reasons|5
805688|NCT00075725|1759243|FG000|Overall Study|Patient off treatment|0
805689|NCT00075725|1759244|FG001|Overall Study|Patient off treatment|0
805690|NCT00075725|1759245|FG002|Overall Study|Patient off treatment|1
805691|NCT00075725|1759246|FG003|Overall Study|Patient off treatment|2
805692|NCT00075725|1759247|FG004|Overall Study|Patient off treatment|1
805693|NCT00075725|1759248|FG005|Overall Study|Patient off treatment|0
805694|NCT00075725|1759249|FG006|Overall Study|Patient off treatment|0
805695|NCT00075725|1759250|FG007|Overall Study|Patient off treatment|2
805696|NCT00075725|1759251|FG008|Overall Study|Patient off treatment|1
805697|NCT00075725|1759252|FG009|Overall Study|Patient off treatment|0
805698|NCT00075725|1759253|FG010|Overall Study|Patient off treatment|0
805699|NCT00075725|1759254|FG011|Overall Study|Patient off treatment|0
805700|NCT00075725|1759243|FG000|Overall Study|Ineligible or wrong diagnosis|8
805701|NCT00075725|1759244|FG001|Overall Study|Ineligible or wrong diagnosis|3
805702|NCT00075725|1759245|FG002|Overall Study|Ineligible or wrong diagnosis|3
805859|NCT00075725|1759246|FG003|Overall Study|Pt went to transplant|1
805703|NCT00075725|1759246|FG003|Overall Study|Ineligible or wrong diagnosis|10
805704|NCT00075725|1759247|FG004|Overall Study|Ineligible or wrong diagnosis|3
805705|NCT00075725|1759248|FG005|Overall Study|Ineligible or wrong diagnosis|17
805706|NCT00075725|1759249|FG006|Overall Study|Ineligible or wrong diagnosis|6
805707|NCT00075725|1759250|FG007|Overall Study|Ineligible or wrong diagnosis|9
805708|NCT00075725|1759251|FG008|Overall Study|Ineligible or wrong diagnosis|10
805709|NCT00075725|1759252|FG009|Overall Study|Ineligible or wrong diagnosis|1
805710|NCT00075725|1759253|FG010|Overall Study|Ineligible or wrong diagnosis|2
805711|NCT00075725|1759254|FG011|Overall Study|Ineligible or wrong diagnosis|4
805712|NCT00075725|1759243|FG000|Overall Study|Pt/Guardian refused RT therapy|1
805713|NCT00075725|1759244|FG001|Overall Study|Pt/Guardian refused RT therapy|0
805714|NCT00075725|1759245|FG002|Overall Study|Pt/Guardian refused RT therapy|1
805715|NCT00075725|1759246|FG003|Overall Study|Pt/Guardian refused RT therapy|2
805716|NCT00075725|1759247|FG004|Overall Study|Pt/Guardian refused RT therapy|1
805717|NCT00075725|1759248|FG005|Overall Study|Pt/Guardian refused RT therapy|0
805718|NCT00075725|1759249|FG006|Overall Study|Pt/Guardian refused RT therapy|0
805719|NCT00075725|1759250|FG007|Overall Study|Pt/Guardian refused RT therapy|0
805720|NCT00075725|1759251|FG008|Overall Study|Pt/Guardian refused RT therapy|0
805721|NCT00075725|1759252|FG009|Overall Study|Pt/Guardian refused RT therapy|0
805722|NCT00075725|1759253|FG010|Overall Study|Pt/Guardian refused RT therapy|0
805723|NCT00075725|1759254|FG011|Overall Study|Pt/Guardian refused RT therapy|0
805724|NCT00075725|1759243|FG000|Overall Study|Pt non compliant with therapy|2
805725|NCT00075725|1759244|FG001|Overall Study|Pt non compliant with therapy|1
805726|NCT00075725|1759245|FG002|Overall Study|Pt non compliant with therapy|1
805727|NCT00075725|1759246|FG003|Overall Study|Pt non compliant with therapy|0
805728|NCT00075725|1759247|FG004|Overall Study|Pt non compliant with therapy|2
805729|NCT00075725|1759248|FG005|Overall Study|Pt non compliant with therapy|14
805730|NCT00075725|1759249|FG006|Overall Study|Pt non compliant with therapy|2
805731|NCT00075725|1759250|FG007|Overall Study|Pt non compliant with therapy|5
805732|NCT00075725|1759251|FG008|Overall Study|Pt non compliant with therapy|3
805733|NCT00075725|1759252|FG009|Overall Study|Pt non compliant with therapy|0
805734|NCT00075725|1759253|FG010|Overall Study|Pt non compliant with therapy|0
805735|NCT00075725|1759254|FG011|Overall Study|Pt non compliant with therapy|0
805736|NCT00075725|1759243|FG000|Overall Study|Pt age out of range for treatment|0
805737|NCT00075725|1759244|FG001|Overall Study|Pt age out of range for treatment|1
805738|NCT00075725|1759245|FG002|Overall Study|Pt age out of range for treatment|0
805739|NCT00075725|1759246|FG003|Overall Study|Pt age out of range for treatment|0
805740|NCT00075725|1759247|FG004|Overall Study|Pt age out of range for treatment|0
805741|NCT00075725|1759248|FG005|Overall Study|Pt age out of range for treatment|1
805742|NCT00075725|1759249|FG006|Overall Study|Pt age out of range for treatment|0
805743|NCT00075725|1759250|FG007|Overall Study|Pt age out of range for treatment|1
805744|NCT00075725|1759251|FG008|Overall Study|Pt age out of range for treatment|0
805745|NCT00075725|1759252|FG009|Overall Study|Pt age out of range for treatment|0
805746|NCT00075725|1759253|FG010|Overall Study|Pt age out of range for treatment|0
805747|NCT00075725|1759254|FG011|Overall Study|Pt age out of range for treatment|0
805748|NCT00075725|1759243|FG000|Overall Study|Insurance issues|0
805749|NCT00075725|1759244|FG001|Overall Study|Insurance issues|1
805750|NCT00075725|1759245|FG002|Overall Study|Insurance issues|0
805751|NCT00075725|1759246|FG003|Overall Study|Insurance issues|1
805752|NCT00075725|1759247|FG004|Overall Study|Insurance issues|1
805753|NCT00075725|1759248|FG005|Overall Study|Insurance issues|1
805754|NCT00075725|1759249|FG006|Overall Study|Insurance issues|0
805755|NCT00075725|1759250|FG007|Overall Study|Insurance issues|1
805756|NCT00075725|1759251|FG008|Overall Study|Insurance issues|0
805757|NCT00075725|1759252|FG009|Overall Study|Insurance issues|0
805758|NCT00075725|1759253|FG010|Overall Study|Insurance issues|0
805759|NCT00075725|1759254|FG011|Overall Study|Insurance issues|0
805760|NCT00075725|1759243|FG000|Overall Study|MRD positive after extended ind|0
805761|NCT00075725|1759244|FG001|Overall Study|MRD positive after extended ind|1
805762|NCT00075725|1759245|FG002|Overall Study|MRD positive after extended ind|1
805763|NCT00075725|1759246|FG003|Overall Study|MRD positive after extended ind|0
805764|NCT00075725|1759247|FG004|Overall Study|MRD positive after extended ind|1
805765|NCT00075725|1759248|FG005|Overall Study|MRD positive after extended ind|2
805766|NCT00075725|1759249|FG006|Overall Study|MRD positive after extended ind|0
805767|NCT00075725|1759250|FG007|Overall Study|MRD positive after extended ind|1
805768|NCT00075725|1759251|FG008|Overall Study|MRD positive after extended ind|0
805769|NCT00075725|1759252|FG009|Overall Study|MRD positive after extended ind|0
805770|NCT00075725|1759253|FG010|Overall Study|MRD positive after extended ind|0
805771|NCT00075725|1759254|FG011|Overall Study|MRD positive after extended ind|0
805772|NCT00075725|1759243|FG000|Overall Study|Pt has very high risk ALL characteristic|15
805773|NCT00075725|1759244|FG001|Overall Study|Pt has very high risk ALL characteristic|11
805774|NCT00075725|1759245|FG002|Overall Study|Pt has very high risk ALL characteristic|26
805775|NCT00075725|1759246|FG003|Overall Study|Pt has very high risk ALL characteristic|18
805776|NCT00075725|1759247|FG004|Overall Study|Pt has very high risk ALL characteristic|11
805777|NCT00075725|1759248|FG005|Overall Study|Pt has very high risk ALL characteristic|75
805778|NCT00075725|1759249|FG006|Overall Study|Pt has very high risk ALL characteristic|23
805779|NCT00075725|1759250|FG007|Overall Study|Pt has very high risk ALL characteristic|74
805780|NCT00075725|1759251|FG008|Overall Study|Pt has very high risk ALL characteristic|29
805781|NCT00075725|1759252|FG009|Overall Study|Pt has very high risk ALL characteristic|1
805782|NCT00075725|1759253|FG010|Overall Study|Pt has very high risk ALL characteristic|0
805783|NCT00075725|1759254|FG011|Overall Study|Pt has very high risk ALL characteristic|3
805784|NCT00075725|1759243|FG000|Overall Study|Inevaluable|1
805785|NCT00075725|1759244|FG001|Overall Study|Inevaluable|1
805786|NCT00075725|1759245|FG002|Overall Study|Inevaluable|4
805787|NCT00075725|1759246|FG003|Overall Study|Inevaluable|2
805788|NCT00075725|1759247|FG004|Overall Study|Inevaluable|2
805789|NCT00075725|1759248|FG005|Overall Study|Inevaluable|9
805790|NCT00075725|1759249|FG006|Overall Study|Inevaluable|1
805791|NCT00075725|1759250|FG007|Overall Study|Inevaluable|11
805792|NCT00075725|1759251|FG008|Overall Study|Inevaluable|2
805793|NCT00075725|1759252|FG009|Overall Study|Inevaluable|0
805794|NCT00075725|1759253|FG010|Overall Study|Inevaluable|1
805795|NCT00075725|1759254|FG011|Overall Study|Inevaluable|0
805796|NCT00075725|1759243|FG000|Overall Study|Other|4
805797|NCT00075725|1759244|FG001|Overall Study|Other|2
805798|NCT00075725|1759245|FG002|Overall Study|Other|1
805799|NCT00075725|1759246|FG003|Overall Study|Other|1
805800|NCT00075725|1759247|FG004|Overall Study|Other|1
805801|NCT00075725|1759248|FG005|Overall Study|Other|4
805802|NCT00075725|1759249|FG006|Overall Study|Other|2
805803|NCT00075725|1759250|FG007|Overall Study|Other|9
805804|NCT00075725|1759251|FG008|Overall Study|Other|2
805805|NCT00075725|1759252|FG009|Overall Study|Other|1
805806|NCT00075725|1759253|FG010|Overall Study|Other|0
805807|NCT00075725|1759254|FG011|Overall Study|Other|3
805808|NCT00075725|1759243|FG000|Overall Study|Pt trying to find a BM donor|0
805809|NCT00075725|1759244|FG001|Overall Study|Pt trying to find a BM donor|1
805810|NCT00075725|1759245|FG002|Overall Study|Pt trying to find a BM donor|0
805811|NCT00075725|1759246|FG003|Overall Study|Pt trying to find a BM donor|0
805812|NCT00075725|1759247|FG004|Overall Study|Pt trying to find a BM donor|0
805813|NCT00075725|1759248|FG005|Overall Study|Pt trying to find a BM donor|0
805814|NCT00075725|1759249|FG006|Overall Study|Pt trying to find a BM donor|0
805815|NCT00075725|1759250|FG007|Overall Study|Pt trying to find a BM donor|0
805816|NCT00075725|1759251|FG008|Overall Study|Pt trying to find a BM donor|0
805817|NCT00075725|1759252|FG009|Overall Study|Pt trying to find a BM donor|0
805818|NCT00075725|1759253|FG010|Overall Study|Pt trying to find a BM donor|0
805819|NCT00075725|1759254|FG011|Overall Study|Pt trying to find a BM donor|0
805820|NCT00075725|1759243|FG000|Overall Study|Clinic chart lost unable to recreate|0
805821|NCT00075725|1759244|FG001|Overall Study|Clinic chart lost unable to recreate|0
805822|NCT00075725|1759245|FG002|Overall Study|Clinic chart lost unable to recreate|1
805823|NCT00075725|1759246|FG003|Overall Study|Clinic chart lost unable to recreate|0
805824|NCT00075725|1759247|FG004|Overall Study|Clinic chart lost unable to recreate|0
805825|NCT00075725|1759248|FG005|Overall Study|Clinic chart lost unable to recreate|0
805826|NCT00075725|1759249|FG006|Overall Study|Clinic chart lost unable to recreate|0
805827|NCT00075725|1759250|FG007|Overall Study|Clinic chart lost unable to recreate|0
805828|NCT00075725|1759251|FG008|Overall Study|Clinic chart lost unable to recreate|0
805829|NCT00075725|1759252|FG009|Overall Study|Clinic chart lost unable to recreate|0
805830|NCT00075725|1759253|FG010|Overall Study|Clinic chart lost unable to recreate|0
805831|NCT00075725|1759254|FG011|Overall Study|Clinic chart lost unable to recreate|0
805832|NCT00075725|1759243|FG000|Overall Study|Unsuccessful institutional transfer|0
805833|NCT00075725|1759244|FG001|Overall Study|Unsuccessful institutional transfer|0
805834|NCT00075725|1759245|FG002|Overall Study|Unsuccessful institutional transfer|2
805835|NCT00075725|1759246|FG003|Overall Study|Unsuccessful institutional transfer|0
805836|NCT00075725|1759247|FG004|Overall Study|Unsuccessful institutional transfer|0
805837|NCT00075725|1759248|FG005|Overall Study|Unsuccessful institutional transfer|0
805838|NCT00075725|1759249|FG006|Overall Study|Unsuccessful institutional transfer|0
805839|NCT00075725|1759250|FG007|Overall Study|Unsuccessful institutional transfer|0
805840|NCT00075725|1759251|FG008|Overall Study|Unsuccessful institutional transfer|0
805841|NCT00075725|1759252|FG009|Overall Study|Unsuccessful institutional transfer|1
805842|NCT00075725|1759253|FG010|Overall Study|Unsuccessful institutional transfer|0
805843|NCT00075725|1759254|FG011|Overall Study|Unsuccessful institutional transfer|0
805844|NCT00075725|1759243|FG000|Overall Study|specimen(s) not submitted|0
805845|NCT00075725|1759244|FG001|Overall Study|specimen(s) not submitted|0
805846|NCT00075725|1759245|FG002|Overall Study|specimen(s) not submitted|2
805847|NCT00075725|1759246|FG003|Overall Study|specimen(s) not submitted|0
805848|NCT00075725|1759247|FG004|Overall Study|specimen(s) not submitted|0
805849|NCT00075725|1759248|FG005|Overall Study|specimen(s) not submitted|0
805850|NCT00075725|1759249|FG006|Overall Study|specimen(s) not submitted|0
805851|NCT00075725|1759250|FG007|Overall Study|specimen(s) not submitted|0
805852|NCT00075725|1759251|FG008|Overall Study|specimen(s) not submitted|0
805853|NCT00075725|1759252|FG009|Overall Study|specimen(s) not submitted|0
805854|NCT00075725|1759253|FG010|Overall Study|specimen(s) not submitted|0
805855|NCT00075725|1759254|FG011|Overall Study|specimen(s) not submitted|0
805856|NCT00075725|1759243|FG000|Overall Study|Pt went to transplant|0
805857|NCT00075725|1759244|FG001|Overall Study|Pt went to transplant|0
805858|NCT00075725|1759245|FG002|Overall Study|Pt went to transplant|0
805860|NCT00075725|1759247|FG004|Overall Study|Pt went to transplant|0
805861|NCT00075725|1759248|FG005|Overall Study|Pt went to transplant|1
805862|NCT00075725|1759249|FG006|Overall Study|Pt went to transplant|0
805863|NCT00075725|1759250|FG007|Overall Study|Pt went to transplant|0
805864|NCT00075725|1759251|FG008|Overall Study|Pt went to transplant|0
805865|NCT00075725|1759252|FG009|Overall Study|Pt went to transplant|0
805866|NCT00075725|1759253|FG010|Overall Study|Pt went to transplant|0
805867|NCT00075725|1759254|FG011|Overall Study|Pt went to transplant|0
805868|NCT00075725|1759243|FG000|Overall Study|Pt received additional steroids|0
805869|NCT00075725|1759244|FG001|Overall Study|Pt received additional steroids|0
805870|NCT00075725|1759245|FG002|Overall Study|Pt received additional steroids|0
805871|NCT00075725|1759246|FG003|Overall Study|Pt received additional steroids|1
805872|NCT00075725|1759247|FG004|Overall Study|Pt received additional steroids|0
805873|NCT00075725|1759248|FG005|Overall Study|Pt received additional steroids|0
805874|NCT00075725|1759249|FG006|Overall Study|Pt received additional steroids|0
805875|NCT00075725|1759250|FG007|Overall Study|Pt received additional steroids|0
805876|NCT00075725|1759251|FG008|Overall Study|Pt received additional steroids|0
805877|NCT00075725|1759252|FG009|Overall Study|Pt received additional steroids|0
805878|NCT00075725|1759253|FG010|Overall Study|Pt received additional steroids|0
805879|NCT00075725|1759254|FG011|Overall Study|Pt received additional steroids|0
805880|NCT00075725|1759243|FG000|Overall Study|Pt relocated|0
805881|NCT00075725|1759244|FG001|Overall Study|Pt relocated|0
805882|NCT00075725|1759245|FG002|Overall Study|Pt relocated|0
805883|NCT00075725|1759246|FG003|Overall Study|Pt relocated|2
805884|NCT00075725|1759247|FG004|Overall Study|Pt relocated|0
805885|NCT00075725|1759248|FG005|Overall Study|Pt relocated|1
805886|NCT00075725|1759249|FG006|Overall Study|Pt relocated|1
805887|NCT00075725|1759250|FG007|Overall Study|Pt relocated|2
805888|NCT00075725|1759251|FG008|Overall Study|Pt relocated|1
805889|NCT00075725|1759252|FG009|Overall Study|Pt relocated|0
805890|NCT00075725|1759253|FG010|Overall Study|Pt relocated|0
805891|NCT00075725|1759254|FG011|Overall Study|Pt relocated|0
805892|NCT00075725|1759243|FG000|Overall Study|Institution Terminated|0
805893|NCT00075725|1759244|FG001|Overall Study|Institution Terminated|0
805894|NCT00075725|1759245|FG002|Overall Study|Institution Terminated|0
805895|NCT00075725|1759246|FG003|Overall Study|Institution Terminated|0
805896|NCT00075725|1759247|FG004|Overall Study|Institution Terminated|1
805897|NCT00075725|1759248|FG005|Overall Study|Institution Terminated|0
805898|NCT00075725|1759249|FG006|Overall Study|Institution Terminated|0
805899|NCT00075725|1759250|FG007|Overall Study|Institution Terminated|3
805900|NCT00075725|1759251|FG008|Overall Study|Institution Terminated|0
805901|NCT00075725|1759252|FG009|Overall Study|Institution Terminated|0
805902|NCT00075725|1759253|FG010|Overall Study|Institution Terminated|0
805903|NCT00075725|1759254|FG011|Overall Study|Institution Terminated|0
805904|NCT00075725|1759243|FG000|Overall Study|Study Closure|1
805905|NCT00075725|1759244|FG001|Overall Study|Study Closure|0
805906|NCT00075725|1759245|FG002|Overall Study|Study Closure|0
805907|NCT00075725|1759246|FG003|Overall Study|Study Closure|0
805908|NCT00075725|1759247|FG004|Overall Study|Study Closure|1
805909|NCT00075725|1759248|FG005|Overall Study|Study Closure|3
805910|NCT00075725|1759249|FG006|Overall Study|Study Closure|0
805911|NCT00075725|1759250|FG007|Overall Study|Study Closure|1
805912|NCT00075725|1759251|FG008|Overall Study|Study Closure|0
805913|NCT00075725|1759252|FG009|Overall Study|Study Closure|0
805914|NCT00075725|1759253|FG010|Overall Study|Study Closure|0
805915|NCT00075725|1759254|FG011|Overall Study|Study Closure|0
805916|NCT00075725|1759243|FG000|Overall Study|Other complications|0
805917|NCT00075725|1759244|FG001|Overall Study|Other complications|0
805918|NCT00075725|1759245|FG002|Overall Study|Other complications|0
805919|NCT00075725|1759246|FG003|Overall Study|Other complications|0
805920|NCT00075725|1759247|FG004|Overall Study|Other complications|0
805921|NCT00075725|1759248|FG005|Overall Study|Other complications|1
805922|NCT00075725|1759249|FG006|Overall Study|Other complications|0
805923|NCT00075725|1759250|FG007|Overall Study|Other complications|0
805924|NCT00075725|1759251|FG008|Overall Study|Other complications|0
805925|NCT00075725|1759252|FG009|Overall Study|Other complications|0
805926|NCT00075725|1759253|FG010|Overall Study|Other complications|0
805927|NCT00075725|1759254|FG011|Overall Study|Other complications|0
805928|NCT00075725|1759243|FG000|Overall Study|Pt care terminated due to pt behavior|0
805929|NCT00075725|1759244|FG001|Overall Study|Pt care terminated due to pt behavior|0
805930|NCT00075725|1759245|FG002|Overall Study|Pt care terminated due to pt behavior|0
805931|NCT00075725|1759246|FG003|Overall Study|Pt care terminated due to pt behavior|0
805932|NCT00075725|1759247|FG004|Overall Study|Pt care terminated due to pt behavior|0
805933|NCT00075725|1759248|FG005|Overall Study|Pt care terminated due to pt behavior|0
805934|NCT00075725|1759249|FG006|Overall Study|Pt care terminated due to pt behavior|0
805935|NCT00075725|1759250|FG007|Overall Study|Pt care terminated due to pt behavior|1
805936|NCT00075725|1759251|FG008|Overall Study|Pt care terminated due to pt behavior|0
805937|NCT00075725|1759252|FG009|Overall Study|Pt care terminated due to pt behavior|0
805938|NCT00075725|1759253|FG010|Overall Study|Pt care terminated due to pt behavior|0
805939|NCT00075725|1759254|FG011|Overall Study|Pt care terminated due to pt behavior|0
805940|NCT00075725|1759243|FG000|Overall Study|Pt incarcerated|0
805941|NCT00075725|1759244|FG001|Overall Study|Pt incarcerated|0
805942|NCT00075725|1759245|FG002|Overall Study|Pt incarcerated|0
805943|NCT00075725|1759246|FG003|Overall Study|Pt incarcerated|0
805944|NCT00075725|1759247|FG004|Overall Study|Pt incarcerated|0
805945|NCT00075725|1759248|FG005|Overall Study|Pt incarcerated|0
805946|NCT00075725|1759249|FG006|Overall Study|Pt incarcerated|0
805947|NCT00075725|1759250|FG007|Overall Study|Pt incarcerated|1
805948|NCT00075725|1759251|FG008|Overall Study|Pt incarcerated|0
805949|NCT00075725|1759252|FG009|Overall Study|Pt incarcerated|0
805950|NCT00075725|1759253|FG010|Overall Study|Pt incarcerated|0
805951|NCT00075725|1759254|FG011|Overall Study|Pt incarcerated|0
805952|NCT00075764|1759287|FG000|Overall Study|Adverse Event|5
805953|NCT00075764|1759288|FG001|Overall Study|Adverse Event|12
805954|NCT00075764|1759287|FG000|Overall Study|Death|4
805955|NCT00075764|1759288|FG001|Overall Study|Death|8
805956|NCT00075764|1759287|FG000|Overall Study|Withdrawal by Subject|28
805957|NCT00075764|1759288|FG001|Overall Study|Withdrawal by Subject|18
805958|NCT00075764|1759287|FG000|Overall Study|Progression|269
805959|NCT00075764|1759288|FG001|Overall Study|Progression|274
805960|NCT00075764|1759287|FG000|Overall Study|Still on treatment|8
805961|NCT00075764|1759288|FG001|Overall Study|Still on treatment|15
805962|NCT00075764|1759287|FG000|Overall Study|Delinquent|4
805963|NCT00075764|1759288|FG001|Overall Study|Delinquent|2
805964|NCT00075764|1759287|FG000|Overall Study|Not protocol specified|27
805965|NCT00075764|1759288|FG001|Overall Study|Not protocol specified|19
805966|NCT00075764|1759287|FG000|Overall Study|Under review|0
805967|NCT00075764|1759288|FG001|Overall Study|Under review|1
805968|NCT00075816|1759307|FG000|Overall Study|Did not undergo transplantation|14
805969|NCT00075816|1759308|FG001|Overall Study|Did not undergo transplantation|11
805970|NCT00075881|1759336|FG000|Overall Study|Lack of Efficacy|18
805971|NCT00075881|1759336|FG000|Overall Study|Adverse Event|7
805972|NCT00075881|1759336|FG000|Overall Study|Death|1
805973|NCT00075881|1759336|FG000|Overall Study|Withdrawal by Subject|2
805974|NCT00075881|1759336|FG000|Overall Study|Protocol Violation|4
805975|NCT00075881|1759336|FG000|Overall Study|other complicating disease|3
805976|NCT00075881|1759336|FG000|Overall Study|other|4
805977|NCT00075881|1759336|FG000|Overall Study|missing data|2
805978|NCT00075881|1759336|FG000|Overall Study|Ineligible|1
805979|NCT00075881|1759336|FG000|Overall Study|never start protocol therapy|1
805980|NCT00075946|1759346|FG000|Overall Study|Path ineligible: undetermined histology|0
805981|NCT00075946|1759347|FG001|Overall Study|Path ineligible: undetermined histology|0
805982|NCT00075946|1759348|FG002|Overall Study|Path ineligible: undetermined histology|0
805983|NCT00075946|1759349|FG003|Overall Study|Path ineligible: undetermined histology|0
805984|NCT00075946|1759350|FG004|Overall Study|Path ineligible: undetermined histology|6
805985|NCT00075946|1759346|FG000|Overall Study|Did not achieve response after induction|0
805986|NCT00075946|1759347|FG001|Overall Study|Did not achieve response after induction|0
805987|NCT00075946|1759348|FG002|Overall Study|Did not achieve response after induction|0
805988|NCT00075946|1759349|FG003|Overall Study|Did not achieve response after induction|0
805989|NCT00075946|1759350|FG004|Overall Study|Did not achieve response after induction|182
805990|NCT00075946|1759346|FG000|Overall Study|Incorrectly randomized (no response)|5
805991|NCT00075946|1759347|FG001|Overall Study|Incorrectly randomized (no response)|5
805992|NCT00075946|1759348|FG002|Overall Study|Incorrectly randomized (no response)|5
805993|NCT00075946|1759349|FG003|Overall Study|Incorrectly randomized (no response)|1
805994|NCT00075946|1759350|FG004|Overall Study|Incorrectly randomized (no response)|0
805995|NCT00075946|1759346|FG000|Overall Study|Still on treatment at time of analysis|52
805996|NCT00075946|1759347|FG001|Overall Study|Still on treatment at time of analysis|19
805997|NCT00075946|1759348|FG002|Overall Study|Still on treatment at time of analysis|3
805998|NCT00075946|1759349|FG003|Overall Study|Still on treatment at time of analysis|9
805999|NCT00075946|1759350|FG004|Overall Study|Still on treatment at time of analysis|0
806000|NCT00075946|1759346|FG000|Overall Study|Adverse Event|2
806001|NCT00075946|1759347|FG001|Overall Study|Adverse Event|10
806002|NCT00075946|1759348|FG002|Overall Study|Adverse Event|0
806003|NCT00075946|1759349|FG003|Overall Study|Adverse Event|2
806004|NCT00075946|1759350|FG004|Overall Study|Adverse Event|0
806005|NCT00075946|1759346|FG000|Overall Study|Death|0
806006|NCT00075946|1759347|FG001|Overall Study|Death|1
806007|NCT00075946|1759348|FG002|Overall Study|Death|0
806008|NCT00075946|1759349|FG003|Overall Study|Death|0
806009|NCT00075946|1759350|FG004|Overall Study|Death|0
806010|NCT00075946|1759346|FG000|Overall Study|Withdrawal by Subject|23
806011|NCT00075946|1759347|FG001|Overall Study|Withdrawal by Subject|58
806012|NCT00075946|1759348|FG002|Overall Study|Withdrawal by Subject|4
806013|NCT00075946|1759349|FG003|Overall Study|Withdrawal by Subject|9
806014|NCT00075946|1759350|FG004|Overall Study|Withdrawal by Subject|0
806015|NCT00075946|1759346|FG000|Overall Study|Alternative therapy|16
806016|NCT00075946|1759347|FG001|Overall Study|Alternative therapy|2
806017|NCT00075946|1759348|FG002|Overall Study|Alternative therapy|5
806018|NCT00075946|1759349|FG003|Overall Study|Alternative therapy|0
806019|NCT00075946|1759350|FG004|Overall Study|Alternative therapy|0
806020|NCT00075946|1759346|FG000|Overall Study|Other complicating disease|7
806021|NCT00075946|1759347|FG001|Overall Study|Other complicating disease|13
806022|NCT00075946|1759348|FG002|Overall Study|Other complicating disease|1
806023|NCT00075946|1759349|FG003|Overall Study|Other complicating disease|4
806024|NCT00075946|1759350|FG004|Overall Study|Other complicating disease|0
806025|NCT00075946|1759346|FG000|Overall Study|No response to retreatment|23
806026|NCT00075946|1759347|FG001|Overall Study|No response to retreatment|0
806027|NCT00075946|1759348|FG002|Overall Study|No response to retreatment|2
806028|NCT00075946|1759349|FG003|Overall Study|No response to retreatment|0
806029|NCT00075946|1759350|FG004|Overall Study|No response to retreatment|0
806030|NCT00075946|1759346|FG000|Overall Study|Time to progression less than 6 months|15
806031|NCT00075946|1759347|FG001|Overall Study|Time to progression less than 6 months|30
806032|NCT00075946|1759348|FG002|Overall Study|Time to progression less than 6 months|8
806033|NCT00075946|1759349|FG003|Overall Study|Time to progression less than 6 months|3
806034|NCT00075946|1759350|FG004|Overall Study|Time to progression less than 6 months|0
806035|NCT00075946|1759346|FG000|Overall Study|Other|5
806036|NCT00075946|1759347|FG001|Overall Study|Other|13
806037|NCT00075946|1759348|FG002|Overall Study|Other|0
806038|NCT00075946|1759349|FG003|Overall Study|Other|2
806039|NCT00075946|1759350|FG004|Overall Study|Other|0
806040|NCT00076011|1759361|FG000|Overall Study|Death|1
806041|NCT00076011|1759361|FG000|Overall Study|Adverse Event|10
806042|NCT00076011|1759361|FG000|Overall Study|Lack of Efficacy|25
806043|NCT00076011|1759361|FG000|Overall Study|Withdrawal by Subject|1
806044|NCT00076011|1759361|FG000|Overall Study|Study terminated by sponsor|3
806045|NCT00076011|1759361|FG000|Overall Study|Other|11
806046|NCT00076011|1759361|FG000|Overall Study|Ongoing|1
806047|NCT00076024|1759368|FG000|Phase 1, Lead-in|Lack of Efficacy|4
806048|NCT00076024|1759369|FG001|Phase 1, Lead-in|Lack of Efficacy|0
806049|NCT00076024|1759370|FG002|Phase 1, Lead-in|Lack of Efficacy|0
806050|NCT00076024|1759371|FG003|Phase 1, Lead-in|Lack of Efficacy|0
806051|NCT00076024|1759368|FG000|Phase 1, Lead-in|Adverse Event|1
806052|NCT00076024|1759369|FG001|Phase 1, Lead-in|Adverse Event|0
806053|NCT00076024|1759370|FG002|Phase 1, Lead-in|Adverse Event|0
806054|NCT00076024|1759371|FG003|Phase 1, Lead-in|Adverse Event|0
806055|NCT00076024|1759368|FG000|Phase 1, Lead-in|Clinical progression|1
806056|NCT00076024|1759369|FG001|Phase 1, Lead-in|Clinical progression|0
806057|NCT00076024|1759370|FG002|Phase 1, Lead-in|Clinical progression|0
806058|NCT00076024|1759371|FG003|Phase 1, Lead-in|Clinical progression|0
806059|NCT00076024|1759368|FG000|Phase 2, Double-blind|Lack of Efficacy|0
806060|NCT00076024|1759369|FG001|Phase 2, Double-blind|Lack of Efficacy|59
806061|NCT00076024|1759370|FG002|Phase 2, Double-blind|Lack of Efficacy|40
806062|NCT00076024|1759371|FG003|Phase 2, Double-blind|Lack of Efficacy|0
806063|NCT00076024|1759368|FG000|Phase 2, Double-blind|Withdrawal by Subject|0
806064|NCT00076024|1759369|FG001|Phase 2, Double-blind|Withdrawal by Subject|13
806065|NCT00076024|1759370|FG002|Phase 2, Double-blind|Withdrawal by Subject|4
806066|NCT00076024|1759371|FG003|Phase 2, Double-blind|Withdrawal by Subject|0
806067|NCT00076024|1759368|FG000|Phase 2, Double-blind|Adverse Event|0
806068|NCT00076024|1759369|FG001|Phase 2, Double-blind|Adverse Event|25
806069|NCT00076024|1759370|FG002|Phase 2, Double-blind|Adverse Event|6
806070|NCT00076024|1759371|FG003|Phase 2, Double-blind|Adverse Event|0
806071|NCT00076024|1759368|FG000|Phase 2, Double-blind|Un-specified|0
806072|NCT00076024|1759369|FG001|Phase 2, Double-blind|Un-specified|14
806073|NCT00076024|1759370|FG002|Phase 2, Double-blind|Un-specified|6
806074|NCT00076024|1759371|FG003|Phase 2, Double-blind|Un-specified|0
806075|NCT00076024|1759368|FG000|Phase 2, Double-blind|Randomized but not treated|0
806076|NCT00076024|1759369|FG001|Phase 2, Double-blind|Randomized but not treated|1
806077|NCT00076024|1759370|FG002|Phase 2, Double-blind|Randomized but not treated|0
806078|NCT00076024|1759371|FG003|Phase 2, Double-blind|Randomized but not treated|0
806079|NCT00076024|1759368|FG000|Phase 2, Open-label|Adverse Event|0
806080|NCT00076024|1759369|FG001|Phase 2, Open-label|Adverse Event|0
806081|NCT00076024|1759370|FG002|Phase 2, Open-label|Adverse Event|0
806082|NCT00076024|1759371|FG003|Phase 2, Open-label|Adverse Event|2
806083|NCT00076024|1759368|FG000|Phase 2, Open-label|Lack of Efficacy|0
806084|NCT00076024|1759369|FG001|Phase 2, Open-label|Lack of Efficacy|0
806085|NCT00076024|1759370|FG002|Phase 2, Open-label|Lack of Efficacy|0
806086|NCT00076024|1759371|FG003|Phase 2, Open-label|Lack of Efficacy|11
806087|NCT00076024|1759368|FG000|Phase 2, Open-label|Withdrawal by Subject|0
806088|NCT00076024|1759369|FG001|Phase 2, Open-label|Withdrawal by Subject|0
806089|NCT00076024|1759370|FG002|Phase 2, Open-label|Withdrawal by Subject|0
806090|NCT00076024|1759371|FG003|Phase 2, Open-label|Withdrawal by Subject|1
806091|NCT00076024|1759368|FG000|Phase 2, Open-label|Other|0
806092|NCT00076024|1759369|FG001|Phase 2, Open-label|Other|0
806093|NCT00076024|1759370|FG002|Phase 2, Open-label|Other|0
806094|NCT00076024|1759371|FG003|Phase 2, Open-label|Other|2
806095|NCT00076102|1759389|FG000|Overall Study|Clinical progression|1
806096|NCT00076102|1759389|FG000|Overall Study|Progression in pre-existing brain tumor|1
806097|NCT00076102|1759389|FG000|Overall Study|plexiform neurofibroma surgery|1
806098|NCT00076102|1759389|FG000|Overall Study|refusal of further therapy|2
806099|NCT00076336|1759432|FG000|Overall Study|Death|13
806100|NCT00076336|1759433|FG001|Overall Study|Death|17
806101|NCT00076336|1759432|FG000|Overall Study|Adverse Event|4
806102|NCT00076336|1759433|FG001|Overall Study|Adverse Event|4
806103|NCT00076336|1759432|FG000|Overall Study|Lost to Follow-up|4
806104|NCT00076336|1759433|FG001|Overall Study|Lost to Follow-up|4
806105|NCT00076336|1759432|FG000|Overall Study|Non-Compliance|2
806106|NCT00076336|1759433|FG001|Overall Study|Non-Compliance|0
806107|NCT00076336|1759432|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0
806108|NCT00076336|1759433|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1
806109|NCT00076336|1759432|FG000|Overall Study|Patient, Investigator, Sponsor request|8
806110|NCT00076336|1759433|FG001|Overall Study|Patient, Investigator, Sponsor request|6
806111|NCT00076336|1759432|FG000|Overall Study|Liver Transplantation|3
806112|NCT00076336|1759433|FG001|Overall Study|Liver Transplantation|3
806113|NCT00076336|1759432|FG000|Overall Study|Virologic Breakthrough|14
806114|NCT00076336|1759433|FG001|Overall Study|Virologic Breakthrough|16
806115|NCT00076336|1759432|FG000|Overall Study|Treatment failure|4
806116|NCT00076336|1759433|FG001|Overall Study|Treatment failure|5
806117|NCT00076570|1759441|FG000|Overall Study|Drug intolerance|8
806118|NCT00076570|1759442|FG001|Overall Study|Drug intolerance|8
806119|NCT00076752|1759482|FG000|Overall Study|Death|2
806120|NCT00076752|1759482|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1
806121|NCT00076804|1759489|FG000|Overall Study|Death|9
806122|NCT00076804|1759490|FG001|Overall Study|Death|20
806123|NCT00076804|1759489|FG000|Overall Study|Lost to Follow-up|9
806124|NCT00076804|1759490|FG001|Overall Study|Lost to Follow-up|9
806125|NCT00076804|1759489|FG000|Overall Study|Withdrawal by Subject|10
806126|NCT00076804|1759490|FG001|Overall Study|Withdrawal by Subject|8
806127|NCT00076804|1759489|FG000|Overall Study|Early study Closure|32
806128|NCT00076804|1759490|FG001|Overall Study|Early study Closure|32
806129|NCT00076999|1759500|FG000|Overall Study|Adverse Event|2
806130|NCT00076999|1759501|FG001|Overall Study|Adverse Event|8
806131|NCT00076999|1759502|FG002|Overall Study|Adverse Event|6
806132|NCT00076999|1759503|FG003|Overall Study|Adverse Event|0
806133|NCT00076999|1759504|FG004|Overall Study|Adverse Event|2
806134|NCT00076999|1759500|FG000|Overall Study|Protocol Violation|0
806135|NCT00076999|1759501|FG001|Overall Study|Protocol Violation|3
806136|NCT00076999|1759502|FG002|Overall Study|Protocol Violation|4
806137|NCT00076999|1759503|FG003|Overall Study|Protocol Violation|0
806138|NCT00076999|1759504|FG004|Overall Study|Protocol Violation|9
806139|NCT00076999|1759500|FG000|Overall Study|Lost to Follow-up|2
806140|NCT00076999|1759501|FG001|Overall Study|Lost to Follow-up|1
806141|NCT00076999|1759502|FG002|Overall Study|Lost to Follow-up|0
806142|NCT00076999|1759503|FG003|Overall Study|Lost to Follow-up|0
806143|NCT00076999|1759504|FG004|Overall Study|Lost to Follow-up|0
806144|NCT00076999|1759500|FG000|Overall Study|Withdrawal by Subject|0
806145|NCT00076999|1759501|FG001|Overall Study|Withdrawal by Subject|4
806146|NCT00076999|1759502|FG002|Overall Study|Withdrawal by Subject|3
806147|NCT00076999|1759503|FG003|Overall Study|Withdrawal by Subject|0
806148|NCT00076999|1759504|FG004|Overall Study|Withdrawal by Subject|1
806149|NCT00076999|1759500|FG000|Overall Study|Other reason (not specified)|8
806150|NCT00076999|1759501|FG001|Overall Study|Other reason (not specified)|8
806151|NCT00076999|1759502|FG002|Overall Study|Other reason (not specified)|4
806152|NCT00076999|1759503|FG003|Overall Study|Other reason (not specified)|1
806153|NCT00076999|1759504|FG004|Overall Study|Other reason (not specified)|13
806154|NCT00077064|1759519|FG000|Overall Study|Adverse Event|0
806155|NCT00077064|1759520|FG001|Overall Study|Adverse Event|4
806156|NCT00077064|1759519|FG000|Overall Study|Patient refusal|0
806157|NCT00077064|1759520|FG001|Overall Study|Patient refusal|2
806158|NCT00077207|1759527|FG000|Overall Study|Adverse Event|5
806159|NCT00077207|1759527|FG000|Overall Study|Lack of Efficacy|12
806160|NCT00077207|1759527|FG000|Overall Study|Physician Decision|6
806161|NCT00077207|1759527|FG000|Overall Study|Withdrawal by Subject|6
806162|NCT00077207|1759527|FG000|Overall Study|Ineligible|1
806163|NCT00077376|1759532|FG000|Overall Study|Adverse Event|8
806164|NCT00077376|1759532|FG000|Overall Study|Withdrawal by Subject|2
806165|NCT00077376|1759532|FG000|Overall Study|Death|1
806166|NCT00077376|1759532|FG000|Overall Study|Physician Decision|1
806167|NCT00077376|1759532|FG000|Overall Study|Alternative therapy|5
806168|NCT00077376|1759532|FG000|Overall Study|Complicating disease|1
806169|NCT00077376|1759532|FG000|Overall Study|Still on treatment|1
806170|NCT00077376|1759532|FG000|Overall Study|Symptomatic deterioration|1
806171|NCT00077376|1759532|FG000|Overall Study|Surgery|1
806172|NCT00077376|1759532|FG000|Overall Study|Insurance ran out|1
806173|NCT00077610|1759539|FG000|Overall Study|Adverse Event|9
806174|NCT00077610|1759540|FG001|Overall Study|Adverse Event|7
806175|NCT00077610|1759541|FG002|Overall Study|Adverse Event|1
806176|NCT00077610|1759539|FG000|Overall Study|Lost to Follow-up|0
806177|NCT00077610|1759540|FG001|Overall Study|Lost to Follow-up|1
806178|NCT00077610|1759541|FG002|Overall Study|Lost to Follow-up|2
806179|NCT00077610|1759539|FG000|Overall Study|Withdrawal by Subject|4
806180|NCT00077610|1759540|FG001|Overall Study|Withdrawal by Subject|10
806181|NCT00077610|1759541|FG002|Overall Study|Withdrawal by Subject|6
806182|NCT00077610|1759539|FG000|Overall Study|Death|17
806183|NCT00077610|1759540|FG001|Overall Study|Death|13
806184|NCT00077610|1759541|FG002|Overall Study|Death|13
806185|NCT00077610|1759539|FG000|Overall Study|Renal transplant|12
806186|NCT00077610|1759540|FG001|Overall Study|Renal transplant|15
806187|NCT00077610|1759541|FG002|Overall Study|Renal transplant|11
806188|NCT00077610|1759539|FG000|Overall Study|Withdrew from dialysis care|5
806189|NCT00077610|1759540|FG001|Overall Study|Withdrew from dialysis care|0
806190|NCT00077610|1759541|FG002|Overall Study|Withdrew from dialysis care|3
806191|NCT00077610|1759539|FG000|Overall Study|Insufficient Therapeutic Response|1
806192|NCT00077610|1759540|FG001|Overall Study|Insufficient Therapeutic Response|0
806193|NCT00077610|1759541|FG002|Overall Study|Insufficient Therapeutic Response|0
806194|NCT00077610|1759539|FG000|Overall Study|Multiple blood transfusions|0
806195|NCT00077610|1759540|FG001|Overall Study|Multiple blood transfusions|0
806196|NCT00077610|1759541|FG002|Overall Study|Multiple blood transfusions|1
806197|NCT00077610|1759539|FG000|Overall Study|Principal Investigator's decision|1
806198|NCT00077610|1759540|FG001|Overall Study|Principal Investigator's decision|0
806199|NCT00077610|1759541|FG002|Overall Study|Principal Investigator's decision|1
806200|NCT00077610|1759539|FG000|Overall Study|Worsening of health condition|1
806201|NCT00077610|1759540|FG001|Overall Study|Worsening of health condition|1
806202|NCT00077610|1759541|FG002|Overall Study|Worsening of health condition|0
806203|NCT00077610|1759539|FG000|Overall Study|Given Epogen in hospital|1
806204|NCT00077610|1759540|FG001|Overall Study|Given Epogen in hospital|0
806205|NCT00077610|1759541|FG002|Overall Study|Given Epogen in hospital|0
806206|NCT00077610|1759539|FG000|Overall Study|Transferred to other unit|0
806207|NCT00077610|1759540|FG001|Overall Study|Transferred to other unit|0
806208|NCT00077610|1759541|FG002|Overall Study|Transferred to other unit|1
806209|NCT00077610|1759539|FG000|Overall Study|Transferred to nursing home|0
806210|NCT00077610|1759540|FG001|Overall Study|Transferred to nursing home|0
806211|NCT00077610|1759541|FG002|Overall Study|Transferred to nursing home|1
806212|NCT00077610|1759539|FG000|Overall Study|Transfer to satellite unit|1
806213|NCT00077610|1759540|FG001|Overall Study|Transfer to satellite unit|0
806214|NCT00077610|1759541|FG002|Overall Study|Transfer to satellite unit|0
806215|NCT00077610|1759539|FG000|Overall Study|Transfer to other center for surgery|1
806216|NCT00077610|1759540|FG001|Overall Study|Transfer to other center for surgery|0
806217|NCT00077610|1759541|FG002|Overall Study|Transfer to other center for surgery|0
806218|NCT00077610|1759539|FG000|Overall Study|Change in dialysis modality|1
806219|NCT00077610|1759540|FG001|Overall Study|Change in dialysis modality|0
806220|NCT00077610|1759541|FG002|Overall Study|Change in dialysis modality|0
806221|NCT00077610|1759539|FG000|Overall Study|Relocation|0
806222|NCT00077610|1759540|FG001|Overall Study|Relocation|8
806223|NCT00077610|1759541|FG002|Overall Study|Relocation|5
806224|NCT00077610|1759539|FG000|Overall Study|Financial issues|0
806225|NCT00077610|1759540|FG001|Overall Study|Financial issues|1
806226|NCT00077610|1759541|FG002|Overall Study|Financial issues|0
806227|NCT00077610|1759539|FG000|Overall Study|Sponsors decision to withdraw|0
806228|NCT00077610|1759540|FG001|Overall Study|Sponsors decision to withdraw|0
806229|NCT00077610|1759541|FG002|Overall Study|Sponsors decision to withdraw|1
806230|NCT00077623|1759557|FG000|Overall Study|Adverse Event|1
806231|NCT00077623|1759558|FG001|Overall Study|Adverse Event|0
806232|NCT00077623|1759559|FG002|Overall Study|Adverse Event|1
806233|NCT00077623|1759557|FG000|Overall Study|Withdrawal by Subject|2
806234|NCT00077623|1759558|FG001|Overall Study|Withdrawal by Subject|10
806235|NCT00077623|1759559|FG002|Overall Study|Withdrawal by Subject|1
806236|NCT00077623|1759557|FG000|Overall Study|Other-Non safety reason|18
806237|NCT00077623|1759558|FG001|Overall Study|Other-Non safety reason|15
806238|NCT00077623|1759559|FG002|Overall Study|Other-Non safety reason|19
806239|NCT00077623|1759557|FG000|Overall Study|Insufficient therapeutic response|2
806240|NCT00077623|1759558|FG001|Overall Study|Insufficient therapeutic response|0
806241|NCT00077623|1759559|FG002|Overall Study|Insufficient therapeutic response|0
806242|NCT00077623|1759557|FG000|Overall Study|Death|12
806243|NCT00077623|1759558|FG001|Overall Study|Death|18
806244|NCT00077623|1759559|FG002|Overall Study|Death|11
806245|NCT00077623|1759557|FG000|Overall Study|Failure to return|1
806246|NCT00077623|1759558|FG001|Overall Study|Failure to return|0
806247|NCT00077623|1759559|FG002|Overall Study|Failure to return|0
806248|NCT00077636|1759569|FG000|Overall Study|Refused Treatment|9
806249|NCT00077636|1759570|FG001|Overall Study|Refused Treatment|31
806250|NCT00077636|1759569|FG000|Overall Study|Admin|3
806251|NCT00077636|1759570|FG001|Overall Study|Admin|3
806252|NCT00077636|1759569|FG000|Overall Study|Withdrawal by Subject|2
806253|NCT00077636|1759570|FG001|Overall Study|Withdrawal by Subject|2
806254|NCT00077636|1759569|FG000|Overall Study|Adverse Event|17
806255|NCT00077636|1759570|FG001|Overall Study|Adverse Event|34
806256|NCT00077636|1759569|FG000|Overall Study|Protocol Violation|0
806257|NCT00077636|1759570|FG001|Overall Study|Protocol Violation|2
806258|NCT00077636|1759569|FG000|Overall Study|Lost to Follow-up|10
806259|NCT00077636|1759570|FG001|Overall Study|Lost to Follow-up|18
806260|NCT00077636|1759569|FG000|Overall Study|Abnormality Of Laboratory Test|3
806261|NCT00077636|1759570|FG001|Overall Study|Abnormality Of Laboratory Test|2
806262|NCT00077649|1759581|FG000|Overall Study|Adverse Event|5
806263|NCT00077649|1759582|FG001|Overall Study|Adverse Event|1
806264|NCT00077649|1759583|FG002|Overall Study|Adverse Event|7
806265|NCT00077649|1759584|FG003|Overall Study|Adverse Event|9
806266|NCT00077649|1759581|FG000|Overall Study|Lack of Efficacy|5
806267|NCT00077649|1759582|FG001|Overall Study|Lack of Efficacy|3
806268|NCT00077649|1759583|FG002|Overall Study|Lack of Efficacy|3
806269|NCT00077649|1759584|FG003|Overall Study|Lack of Efficacy|2
806270|NCT00077649|1759581|FG000|Overall Study|Withdrawal by Subject|0
806271|NCT00077649|1759582|FG001|Overall Study|Withdrawal by Subject|1
806272|NCT00077649|1759583|FG002|Overall Study|Withdrawal by Subject|1
806273|NCT00077649|1759584|FG003|Overall Study|Withdrawal by Subject|2
806274|NCT00077649|1759581|FG000|Overall Study|Lost to Follow-up|2
806275|NCT00077649|1759582|FG001|Overall Study|Lost to Follow-up|2
806276|NCT00077649|1759583|FG002|Overall Study|Lost to Follow-up|3
806277|NCT00077649|1759584|FG003|Overall Study|Lost to Follow-up|2
806278|NCT00077649|1759581|FG000|Overall Study|Abnormality of Laboratory Test|1
806279|NCT00077649|1759582|FG001|Overall Study|Abnormality of Laboratory Test|2
806280|NCT00077649|1759583|FG002|Overall Study|Abnormality of Laboratory Test|1
806281|NCT00077649|1759584|FG003|Overall Study|Abnormality of Laboratory Test|2
806282|NCT00077649|1759581|FG000|Overall Study|Randomized but never dosed|1
806283|NCT00077649|1759582|FG001|Overall Study|Randomized but never dosed|0
806284|NCT00077649|1759583|FG002|Overall Study|Randomized but never dosed|0
806285|NCT00077649|1759584|FG003|Overall Study|Randomized but never dosed|0
806286|NCT00077675|1759600|FG000|Overall Study|Adverse Event|1
806287|NCT00077675|1759601|FG001|Overall Study|Adverse Event|2
806288|NCT00077675|1759600|FG000|Overall Study|Lost to Follow-up|6
806289|NCT00077675|1759601|FG001|Overall Study|Lost to Follow-up|3
806290|NCT00077675|1759600|FG000|Overall Study|Withdrawal by Subject|1
806291|NCT00077675|1759601|FG001|Overall Study|Withdrawal by Subject|0
806292|NCT00077675|1759600|FG000|Overall Study|Other|0
806293|NCT00077675|1759601|FG001|Overall Study|Other|1
806294|NCT00077675|1759600|FG000|Overall Study|Never received study treatment|3
806295|NCT00077675|1759601|FG001|Overall Study|Never received study treatment|3
806296|NCT00077766|1759609|FG000|Overall Study|Adverse Event|1
806297|NCT00077766|1759610|FG001|Overall Study|Adverse Event|1
806298|NCT00077766|1759609|FG000|Overall Study|Withdrawal by Subject|4
806299|NCT00077766|1759610|FG001|Overall Study|Withdrawal by Subject|3
806300|NCT00077766|1759609|FG000|Overall Study|Death|12
806301|NCT00077766|1759610|FG001|Overall Study|Death|10
806302|NCT00077766|1759609|FG000|Overall Study|Lost to Follow-up|2
806303|NCT00077766|1759610|FG001|Overall Study|Lost to Follow-up|0
806304|NCT00077766|1759609|FG000|Overall Study|Protocol Violation|1
806305|NCT00077766|1759610|FG001|Overall Study|Protocol Violation|0
806306|NCT00077766|1759609|FG000|Overall Study|Kidney Transplantation|9
806307|NCT00077766|1759610|FG001|Overall Study|Kidney Transplantation|5
806308|NCT00077766|1759609|FG000|Overall Study|Transplantation|5
806309|NCT00077766|1759610|FG001|Overall Study|Transplantation|1
806310|NCT00077766|1759609|FG000|Overall Study|Investigators Discretion|1
806311|NCT00077766|1759610|FG001|Overall Study|Investigators Discretion|0
806312|NCT00077766|1759609|FG000|Overall Study|Participant's decision|1
806313|NCT00077766|1759610|FG001|Overall Study|Participant's decision|0
806314|NCT00077766|1759609|FG000|Overall Study|Dialysis Discontinued|1
806315|NCT00077766|1759610|FG001|Overall Study|Dialysis Discontinued|0
806316|NCT00077766|1759609|FG000|Overall Study|Dialysis|0
806317|NCT00077766|1759610|FG001|Overall Study|Dialysis|1
806318|NCT00077766|1759609|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
806319|NCT00077766|1759610|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
806320|NCT00077766|1759609|FG000|Overall Study|Started Nocturnal Dialysis|0
806321|NCT00077766|1759610|FG001|Overall Study|Started Nocturnal Dialysis|1
806322|NCT00077766|1759609|FG000|Overall Study|Stop Dialysis|0
806323|NCT00077766|1759610|FG001|Overall Study|Stop Dialysis|1
806324|NCT00077766|1759609|FG000|Overall Study|Participants Vacation|2
806325|NCT00077766|1759610|FG001|Overall Study|Participants Vacation|1
806326|NCT00077857|1759619|FG000|Overall Study|Adverse Event|30
806327|NCT00077857|1759620|FG001|Overall Study|Adverse Event|32
806328|NCT00077857|1759619|FG000|Overall Study|Death|7
806329|NCT00077857|1759620|FG001|Overall Study|Death|3
806330|NCT00077857|1759619|FG000|Overall Study|Insufficient therapeutic response|112
806331|NCT00077857|1759620|FG001|Overall Study|Insufficient therapeutic response|128
806332|NCT00077857|1759619|FG000|Overall Study|Violation of selection criteria at entry|3
806333|NCT00077857|1759620|FG001|Overall Study|Violation of selection criteria at entry|1
806334|NCT00077857|1759619|FG000|Overall Study|Other protocol violation|0
806335|NCT00077857|1759620|FG001|Overall Study|Other protocol violation|1
806336|NCT00077857|1759619|FG000|Overall Study|Refused treatment|29
806337|NCT00077857|1759620|FG001|Overall Study|Refused treatment|21
806338|NCT00077857|1759619|FG000|Overall Study|Failure to return|5
806339|NCT00077857|1759620|FG001|Overall Study|Failure to return|5
806340|NCT00077857|1759619|FG000|Overall Study|Other|15
806341|NCT00077857|1759620|FG001|Overall Study|Other|13
806342|NCT00077974|1759630|FG000|Overall Study|Adverse Event|22
806343|NCT00077974|1759630|FG000|Overall Study|Protocol Violation|1
806344|NCT00077974|1759630|FG000|Overall Study|Withdrawal by Subject|3
806345|NCT00077974|1759630|FG000|Overall Study|Lack of Efficacy|76
806346|NCT00077974|1759630|FG000|Overall Study|Decision of Sponsor|2
806347|NCT00078312|1759643|FG000|Overall Study|Adverse Event|43
806348|NCT00078312|1759643|FG000|Overall Study|Lack of Efficacy|15
806349|NCT00078312|1759643|FG000|Overall Study|Lost to Follow-up|41
806350|NCT00078312|1759643|FG000|Overall Study|Physician Decision|9
806351|NCT00078312|1759643|FG000|Overall Study|Protocol Violation|3
806352|NCT00078312|1759643|FG000|Overall Study|Withdrawal by Subject|33
806353|NCT00078312|1759643|FG000|Overall Study|Miscellaneous|33
806354|NCT00078325|1759650|FG000|Overall Study|Adverse Event|15
806355|NCT00078325|1759651|FG001|Overall Study|Adverse Event|10
806356|NCT00078325|1759652|FG002|Overall Study|Adverse Event|5
806357|NCT00078325|1759650|FG000|Overall Study|Protocol Violation|2
806358|NCT00078325|1759651|FG001|Overall Study|Protocol Violation|2
806359|NCT00078325|1759652|FG002|Overall Study|Protocol Violation|0
806360|NCT00078325|1759650|FG000|Overall Study|Withdrawal by Subject|1
806361|NCT00078325|1759651|FG001|Overall Study|Withdrawal by Subject|5
806362|NCT00078325|1759652|FG002|Overall Study|Withdrawal by Subject|3
806363|NCT00078325|1759650|FG000|Overall Study|Lost to Follow-up|0
806364|NCT00078325|1759651|FG001|Overall Study|Lost to Follow-up|1
806365|NCT00078325|1759652|FG002|Overall Study|Lost to Follow-up|1
806366|NCT00078325|1759650|FG000|Overall Study|Physician Decision|2
806367|NCT00078325|1759651|FG001|Overall Study|Physician Decision|0
806368|NCT00078325|1759652|FG002|Overall Study|Physician Decision|1
806369|NCT00078325|1759650|FG000|Overall Study|Miscellaneous|1
806370|NCT00078325|1759651|FG001|Overall Study|Miscellaneous|1
806371|NCT00078325|1759652|FG002|Overall Study|Miscellaneous|1
806372|NCT00078338|1759662|FG000|Overall Study|Adverse Event|31
806373|NCT00078338|1759663|FG001|Overall Study|Adverse Event|24
806374|NCT00078338|1759662|FG000|Overall Study|Lost to Follow-up|17
806375|NCT00078338|1759663|FG001|Overall Study|Lost to Follow-up|2
806376|NCT00078338|1759662|FG000|Overall Study|Protocol Violation|2
806377|NCT00078338|1759663|FG001|Overall Study|Protocol Violation|2
806378|NCT00078338|1759662|FG000|Overall Study|Disease Progression|4
806379|NCT00078338|1759663|FG001|Overall Study|Disease Progression|7
806380|NCT00078338|1759662|FG000|Overall Study|Other|28
806381|NCT00078338|1759663|FG001|Overall Study|Other|16
806382|NCT00078338|1759662|FG000|Overall Study|Subjects randomized, but not treated|3
806383|NCT00078338|1759663|FG001|Overall Study|Subjects randomized, but not treated|3
806384|NCT00078377|1759672|FG000|Overall Study|Adverse Event|2
806385|NCT00078377|1759673|FG001|Overall Study|Adverse Event|5
806386|NCT00078377|1759674|FG002|Overall Study|Adverse Event|1
806387|NCT00078377|1759672|FG000|Overall Study|Lack of Efficacy|2
806388|NCT00078377|1759673|FG001|Overall Study|Lack of Efficacy|0
806389|NCT00078377|1759674|FG002|Overall Study|Lack of Efficacy|2
806390|NCT00078377|1759672|FG000|Overall Study|Lost to Follow-up|0
806391|NCT00078377|1759673|FG001|Overall Study|Lost to Follow-up|1
806392|NCT00078377|1759674|FG002|Overall Study|Lost to Follow-up|1
806393|NCT00078377|1759672|FG000|Overall Study|Physician Decision|2
806394|NCT00078377|1759673|FG001|Overall Study|Physician Decision|0
806395|NCT00078377|1759674|FG002|Overall Study|Physician Decision|0
806396|NCT00078377|1759672|FG000|Overall Study|Withdrawal by Subject|3
806397|NCT00078377|1759673|FG001|Overall Study|Withdrawal by Subject|4
806398|NCT00078377|1759674|FG002|Overall Study|Withdrawal by Subject|4
806399|NCT00078377|1759672|FG000|Overall Study|Miscellaneous|2
806400|NCT00078377|1759673|FG001|Overall Study|Miscellaneous|6
806401|NCT00078377|1759674|FG002|Overall Study|Miscellaneous|1
806402|NCT00078767|1759739|FG000|Overall Study|Withdrawal by Subject|1
806403|NCT00078767|1759740|FG001|Overall Study|Withdrawal by Subject|1
806404|NCT00078819|1759766|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0
806405|NCT00078819|1759767|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1
806406|NCT00078819|1759768|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0
806407|NCT00078819|1759769|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0
806408|NCT00078819|1759766|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
806409|NCT00078819|1759767|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
806410|NCT00078819|1759768|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
806411|NCT00078819|1759769|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
806412|NCT00078819|1759766|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
806413|NCT00078819|1759767|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
806414|NCT00078819|1759768|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
806415|NCT00078819|1759769|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
806416|NCT00078819|1759766|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
806417|NCT00078819|1759767|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
806418|NCT00078819|1759768|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
806419|NCT00078819|1759769|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
806420|NCT00078819|1759766|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
806421|NCT00078819|1759767|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
806422|NCT00078819|1759768|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
806423|NCT00078819|1759769|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
806424|NCT00078819|1759766|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
806425|NCT00078819|1759767|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
806426|NCT00078819|1759768|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
806427|NCT00078819|1759769|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
806428|NCT00078819|1759766|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
806429|NCT00078819|1759767|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
806430|NCT00078819|1759768|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
806431|NCT00078819|1759769|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
806432|NCT00078819|1759766|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
806433|NCT00078819|1759767|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
806434|NCT00078819|1759768|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
806435|NCT00078819|1759769|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
806436|NCT00078949|1759799|FG000|Overall Study|No treated|4
806437|NCT00078949|1759800|FG001|Overall Study|No treated|5
806438|NCT00078949|1759801|FG002|Overall Study|No treated|3
806439|NCT00078949|1759802|FG003|Overall Study|No treated|3
806440|NCT00079040|1759823|FG000|Overall Study|Withdrew before treatment|1
806441|NCT00079040|1759823|FG000|Overall Study|Ineligible|1
806442|NCT00079183|1759827|FG000|Overall Study|Withdrawal by Subject|4
806443|NCT00079183|1759827|FG000|Overall Study|Study medication non-compliance|2
806444|NCT00079183|1759827|FG000|Overall Study|Specimen collection non-compliance|1
806445|NCT00079274|1759839|FG000|Overall Study|Withdrawal by Subject|111
806446|NCT00079274|1759840|FG001|Overall Study|Withdrawal by Subject|10
806447|NCT00079274|1759841|FG002|Overall Study|Withdrawal by Subject|12
806448|NCT00079274|1759842|FG003|Overall Study|Withdrawal by Subject|163
806449|NCT00079274|1759843|FG004|Overall Study|Withdrawal by Subject|7
806450|NCT00079274|1759844|FG005|Overall Study|Withdrawal by Subject|8
806451|NCT00079274|1759845|FG006|Overall Study|Withdrawal by Subject|0
806452|NCT00079274|1759839|FG000|Overall Study|Adverse Event|130
806453|NCT00079274|1759840|FG001|Overall Study|Adverse Event|8
806454|NCT00079274|1759841|FG002|Overall Study|Adverse Event|8
806455|NCT00079274|1759842|FG003|Overall Study|Adverse Event|184
806456|NCT00079274|1759843|FG004|Overall Study|Adverse Event|7
806457|NCT00079274|1759844|FG005|Overall Study|Adverse Event|8
806458|NCT00079274|1759845|FG006|Overall Study|Adverse Event|0
806459|NCT00079274|1759839|FG000|Overall Study|Recurrence|21
806460|NCT00079274|1759840|FG001|Overall Study|Recurrence|0
806461|NCT00079274|1759841|FG002|Overall Study|Recurrence|1
806462|NCT00079274|1759842|FG003|Overall Study|Recurrence|15
806463|NCT00079274|1759843|FG004|Overall Study|Recurrence|0
806464|NCT00079274|1759844|FG005|Overall Study|Recurrence|2
806465|NCT00079274|1759845|FG006|Overall Study|Recurrence|0
806466|NCT00079274|1759839|FG000|Overall Study|Alternate Treatment|6
806467|NCT00079274|1759840|FG001|Overall Study|Alternate Treatment|1
806468|NCT00079274|1759841|FG002|Overall Study|Alternate Treatment|0
806469|NCT00079274|1759842|FG003|Overall Study|Alternate Treatment|3
806470|NCT00079274|1759843|FG004|Overall Study|Alternate Treatment|0
806471|NCT00079274|1759844|FG005|Overall Study|Alternate Treatment|0
806472|NCT00079274|1759845|FG006|Overall Study|Alternate Treatment|0
806473|NCT00079274|1759839|FG000|Overall Study|Other Medical Problems|6
806474|NCT00079274|1759840|FG001|Overall Study|Other Medical Problems|1
806475|NCT00079274|1759841|FG002|Overall Study|Other Medical Problems|0
806476|NCT00079274|1759842|FG003|Overall Study|Other Medical Problems|7
806477|NCT00079274|1759843|FG004|Overall Study|Other Medical Problems|0
806478|NCT00079274|1759844|FG005|Overall Study|Other Medical Problems|0
806479|NCT00079274|1759845|FG006|Overall Study|Other Medical Problems|0
806480|NCT00079274|1759839|FG000|Overall Study|Death|4
806481|NCT00079274|1759840|FG001|Overall Study|Death|0
806482|NCT00079274|1759841|FG002|Overall Study|Death|1
806483|NCT00079274|1759842|FG003|Overall Study|Death|15
806484|NCT00079274|1759843|FG004|Overall Study|Death|0
806485|NCT00079274|1759844|FG005|Overall Study|Death|0
806486|NCT00079274|1759845|FG006|Overall Study|Death|0
806487|NCT00079274|1759839|FG000|Overall Study|Cytogenetic resistance|0
806488|NCT00079274|1759840|FG001|Overall Study|Cytogenetic resistance|0
806489|NCT00079274|1759841|FG002|Overall Study|Cytogenetic resistance|0
806490|NCT00079274|1759842|FG003|Overall Study|Cytogenetic resistance|2
806491|NCT00079274|1759843|FG004|Overall Study|Cytogenetic resistance|0
806492|NCT00079274|1759844|FG005|Overall Study|Cytogenetic resistance|0
806493|NCT00079274|1759845|FG006|Overall Study|Cytogenetic resistance|0
806494|NCT00079274|1759839|FG000|Overall Study|Other|43
806495|NCT00079274|1759840|FG001|Overall Study|Other|7
806496|NCT00079274|1759841|FG002|Overall Study|Other|5
806497|NCT00079274|1759842|FG003|Overall Study|Other|55
806498|NCT00079274|1759843|FG004|Overall Study|Other|1
806499|NCT00079274|1759844|FG005|Overall Study|Other|2
806500|NCT00079274|1759845|FG006|Overall Study|Other|0
806501|NCT00079339|1759869|FG000|Overall Study|Adverse Event|1
806502|NCT00079339|1759870|FG001|Overall Study|Adverse Event|7
806503|NCT00079339|1759871|FG002|Overall Study|Adverse Event|2
806504|NCT00079339|1759869|FG000|Overall Study|Death|1
806505|NCT00079339|1759870|FG001|Overall Study|Death|0
806506|NCT00079339|1759871|FG002|Overall Study|Death|0
806507|NCT00079339|1759869|FG000|Overall Study|Non-compliance|0
806508|NCT00079339|1759870|FG001|Overall Study|Non-compliance|0
806509|NCT00079339|1759871|FG002|Overall Study|Non-compliance|1
806510|NCT00079339|1759869|FG000|Overall Study|Withdrawal by Subject|0
806511|NCT00079339|1759870|FG001|Overall Study|Withdrawal by Subject|4
806512|NCT00079339|1759871|FG002|Overall Study|Withdrawal by Subject|1
806513|NCT00079339|1759869|FG000|Overall Study|Disease progression|3
806514|NCT00079339|1759870|FG001|Overall Study|Disease progression|28
806515|NCT00079339|1759871|FG002|Overall Study|Disease progression|2
806516|NCT00079391|1759884|FG000|Overall Study|Withdrawal by Subject|1
806517|NCT00079417|1759890|FG000|Overall Study|Physician Decision|2
806518|NCT00079417|1759890|FG000|Overall Study|Ineligible|7
806519|NCT00079677|1759896|FG000|Overall Study|Adverse Event|5
806520|NCT00079677|1759897|FG001|Overall Study|Adverse Event|6
806521|NCT00079677|1759896|FG000|Overall Study|Lack of Efficacy|1
806522|NCT00079677|1759897|FG001|Overall Study|Lack of Efficacy|0
806523|NCT00079677|1759896|FG000|Overall Study|Lost to Follow-up|2
806524|NCT00079677|1759897|FG001|Overall Study|Lost to Follow-up|2
806525|NCT00079677|1759896|FG000|Overall Study|Physician Decision|3
806526|NCT00079677|1759897|FG001|Overall Study|Physician Decision|0
806527|NCT00079677|1759896|FG000|Overall Study|Protocol Violation|2
806528|NCT00079677|1759897|FG001|Overall Study|Protocol Violation|3
806529|NCT00079677|1759896|FG000|Overall Study|Withdrawal by Subject|5
806530|NCT00079677|1759897|FG001|Overall Study|Withdrawal by Subject|3
806531|NCT00079677|1759896|FG000|Overall Study|Miscellaneous|2
806532|NCT00079677|1759897|FG001|Overall Study|Miscellaneous|0
806533|NCT00079781|1759906|FG000|Pre-implant Period|Withdrawal by Subject|2
806534|NCT00079781|1759907|FG001|Pre-implant Period|Withdrawal by Subject|0
806535|NCT00079781|1759908|FG002|Pre-implant Period|Withdrawal by Subject|0
806536|NCT00079781|1759906|FG000|Pre-implant Period|Did not meet I/E criteria|1
806537|NCT00079781|1759907|FG001|Pre-implant Period|Did not meet I/E criteria|1
806538|NCT00079781|1759908|FG002|Pre-implant Period|Did not meet I/E criteria|1
806539|NCT00079781|1759906|FG000|Follow-up Period|Withdrawal by Subject|3
806540|NCT00079781|1759907|FG001|Follow-up Period|Withdrawal by Subject|0
806541|NCT00079781|1759908|FG002|Follow-up Period|Withdrawal by Subject|1
806542|NCT00079781|1759906|FG000|Follow-up Period|Lost to Follow-up|1
806543|NCT00079781|1759907|FG001|Follow-up Period|Lost to Follow-up|0
806544|NCT00079781|1759908|FG002|Follow-up Period|Lost to Follow-up|0
806545|NCT00079781|1759906|FG000|Follow-up Period|Death|0
806546|NCT00079781|1759907|FG001|Follow-up Period|Death|0
806547|NCT00079781|1759908|FG002|Follow-up Period|Death|1
806548|NCT00079937|1759916|FG000|Overall Study|Adverse Event|2
806549|NCT00079937|1759917|FG001|Overall Study|Adverse Event|1
806550|NCT00079937|1759916|FG000|Overall Study|Unsatisfactory therapeutic effect|1
806551|NCT00079937|1759917|FG001|Overall Study|Unsatisfactory therapeutic effect|2
806552|NCT00079937|1759916|FG000|Overall Study|Subject no longer requires study drug|3
806553|NCT00079937|1759917|FG001|Overall Study|Subject no longer requires study drug|0
806554|NCT00079937|1759916|FG000|Overall Study|Protocol Violation|8
806555|NCT00079937|1759917|FG001|Overall Study|Protocol Violation|6
806556|NCT00079937|1759916|FG000|Overall Study|Withdrawal by Subject|21
806557|NCT00079937|1759917|FG001|Overall Study|Withdrawal by Subject|7
806558|NCT00079937|1759916|FG000|Overall Study|Lost to Follow-up|12
806559|NCT00079937|1759917|FG001|Overall Study|Lost to Follow-up|5
806560|NCT00079937|1759916|FG000|Overall Study|Administrative problems|22
806561|NCT00079937|1759917|FG001|Overall Study|Administrative problems|11
806562|NCT00080119|1759927|FG000|Overall Study|Discontinued because of study closure|0
806563|NCT00080119|1759928|FG001|Overall Study|Discontinued because of study closure|0
806564|NCT00080119|1759929|FG002|Overall Study|Discontinued because of study closure|130
806565|NCT00080119|1759930|FG003|Overall Study|Discontinued because of study closure|141
806566|NCT00080119|1759927|FG000|Overall Study|Unable to get to clinic|24
806567|NCT00080119|1759928|FG001|Overall Study|Unable to get to clinic|24
806568|NCT00080119|1759929|FG002|Overall Study|Unable to get to clinic|7
806569|NCT00080119|1759930|FG003|Overall Study|Unable to get to clinic|1
806570|NCT00080119|1759927|FG000|Overall Study|Consent withdrawn|13
806571|NCT00080119|1759928|FG001|Overall Study|Consent withdrawn|17
806572|NCT00080119|1759929|FG002|Overall Study|Consent withdrawn|4
806573|NCT00080119|1759930|FG003|Overall Study|Consent withdrawn|6
806574|NCT00080119|1759927|FG000|Overall Study|Unwilling to adhere to study requirement|3
806575|NCT00080119|1759928|FG001|Overall Study|Unwilling to adhere to study requirement|2
806576|NCT00080119|1759929|FG002|Overall Study|Unwilling to adhere to study requirement|5
806577|NCT00080119|1759930|FG003|Overall Study|Unwilling to adhere to study requirement|1
806578|NCT00080119|1759927|FG000|Overall Study|Lost to Follow-up|16
806579|NCT00080119|1759928|FG001|Overall Study|Lost to Follow-up|19
806580|NCT00080119|1759929|FG002|Overall Study|Lost to Follow-up|19
806581|NCT00080119|1759930|FG003|Overall Study|Lost to Follow-up|14
806582|NCT00080223|1759942|FG000|Overall Study|Adverse Event|23
806583|NCT00080223|1759942|FG000|Overall Study|Death|21
806584|NCT00080223|1759942|FG000|Overall Study|Withdrawal by Subject|13
806585|NCT00080223|1759942|FG000|Overall Study|Lung Transplantation|9
806586|NCT00080223|1759942|FG000|Overall Study|Non-compliance With Study Treatment|7
806587|NCT00080223|1759942|FG000|Overall Study|Participant unwilling to continue|2
806588|NCT00080223|1759942|FG000|Overall Study|Physician Decision|1
806589|NCT00080288|1759948|FG000|Overall Study|Adverse Event|7
806590|NCT00080288|1759949|FG001|Overall Study|Adverse Event|4
806591|NCT00080288|1759948|FG000|Overall Study|Lost to Follow-up|3
806592|NCT00080288|1759949|FG001|Overall Study|Lost to Follow-up|5
806593|NCT00080288|1759948|FG000|Overall Study|Physician Decision|6
806594|NCT00080288|1759949|FG001|Overall Study|Physician Decision|2
806595|NCT00080288|1759948|FG000|Overall Study|Withdrawal by Subject|3
806596|NCT00080288|1759949|FG001|Overall Study|Withdrawal by Subject|16
806597|NCT00080288|1759948|FG000|Overall Study|Miscellaneous|11
806598|NCT00080288|1759949|FG001|Overall Study|Miscellaneous|11
806599|NCT00080301|1759957|FG000|Overall Study|Randomized but Never Treated|5
806600|NCT00080301|1759958|FG001|Overall Study|Randomized but Never Treated|10
806601|NCT00080301|1759957|FG000|Overall Study|Still on Treatment as of CSR date|0
806602|NCT00080301|1759958|FG001|Overall Study|Still on Treatment as of CSR date|1
806603|NCT00080483|1759978|FG000|Overall Study|Lost to Follow-up|1
806604|NCT00080483|1759979|FG001|Overall Study|Lost to Follow-up|1
806605|NCT00080483|1759978|FG000|Overall Study|Physician Decision|1
806606|NCT00080483|1759979|FG001|Overall Study|Physician Decision|1
806607|NCT00080899|1759989|FG000|Overall Study|Adverse Event|1
806608|NCT00080938|1760002|FG000|Overall Study|Adverse Event|3
806609|NCT00080938|1760002|FG000|Overall Study|Withdrawal by Subject|6
806610|NCT00080938|1760002|FG000|Overall Study|Death|2
806611|NCT00080938|1760002|FG000|Overall Study|Lack of Efficacy|7
806612|NCT00080938|1760002|FG000|Overall Study|other disease|1
806613|NCT00080938|1760002|FG000|Overall Study|Not started protocol therapy|1
806614|NCT00080938|1760002|FG000|Overall Study|Ineligible|4
806615|NCT00081159|1760008|FG000|Overall Study|Withdrawal by Subject|0
806616|NCT00081159|1760009|FG001|Overall Study|Withdrawal by Subject|3
806617|NCT00081159|1760008|FG000|Overall Study|Myelosuppression prior to treatment|0
806618|NCT00081159|1760009|FG001|Overall Study|Myelosuppression prior to treatment|1
806619|NCT00081159|1760008|FG000|Overall Study|Lost to Follow-up|2
806620|NCT00081159|1760009|FG001|Overall Study|Lost to Follow-up|1
806621|NCT00081263|1760017|FG000|Overall Study|clerical error|1
806622|NCT00081263|1760018|FG001|Overall Study|clerical error|0
806623|NCT00081263|1760017|FG000|Overall Study|wrong cell type|7
806624|NCT00081263|1760018|FG001|Overall Study|wrong cell type|5
806625|NCT00081263|1760017|FG000|Overall Study|improper pre-protocol therapy|0
806626|NCT00081263|1760018|FG001|Overall Study|improper pre-protocol therapy|1
806627|NCT00081263|1760017|FG000|Overall Study|Inadequate pathology|0
806628|NCT00081263|1760018|FG001|Overall Study|Inadequate pathology|1
806629|NCT00081263|1760017|FG000|Overall Study|Never treated|4
806630|NCT00081263|1760018|FG001|Overall Study|Never treated|5
806631|NCT00081263|1760017|FG000|Overall Study|Inadequate data|5
806632|NCT00081263|1760018|FG001|Overall Study|Inadequate data|10
806633|NCT00081289|1760026|FG000|Overall Study|Accrued prior to chemotherapy amendment|18
806634|NCT00081289|1760027|FG001|Overall Study|Accrued prior to chemotherapy amendment|17
806635|NCT00081289|1760026|FG000|Overall Study|Ineligible / no protocol treatment|3
806636|NCT00081289|1760027|FG001|Overall Study|Ineligible / no protocol treatment|4
806637|NCT00081458|1760051|FG000|Overall Study|Adverse Event|1
806638|NCT00081458|1760052|FG001|Overall Study|Adverse Event|5
806639|NCT00081458|1760053|FG002|Overall Study|Adverse Event|2
806640|NCT00081458|1760051|FG000|Overall Study|Withdrawal by Subject|0
806641|NCT00081458|1760052|FG001|Overall Study|Withdrawal by Subject|3
806642|NCT00081458|1760053|FG002|Overall Study|Withdrawal by Subject|1
806643|NCT00081458|1760051|FG000|Overall Study|Randomized but not dosed|0
806644|NCT00081458|1760052|FG001|Overall Study|Randomized but not dosed|0
806645|NCT00081458|1760053|FG002|Overall Study|Randomized but not dosed|1
806646|NCT00081497|1760064|FG000|Overall Study|Adverse Event|2
806647|NCT00081497|1760065|FG001|Overall Study|Adverse Event|0
806648|NCT00081497|1760064|FG000|Overall Study|Death|0
806649|NCT00081497|1760065|FG001|Overall Study|Death|1
806650|NCT00081497|1760064|FG000|Overall Study|Withdrawal by Subject|1
806651|NCT00081497|1760065|FG001|Overall Study|Withdrawal by Subject|0
806652|NCT00081497|1760064|FG000|Overall Study|Non-compliance|0
806653|NCT00081497|1760065|FG001|Overall Study|Non-compliance|1
806654|NCT00081653|1760079|FG000|Overall Study|Adverse Event|23
806655|NCT00081653|1760080|FG001|Overall Study|Adverse Event|17
806656|NCT00081653|1760079|FG000|Overall Study|Lost to Follow-up|2
806657|NCT00081653|1760080|FG001|Overall Study|Lost to Follow-up|4
806658|NCT00081653|1760079|FG000|Overall Study|Refused Treatment|18
806659|NCT00081653|1760080|FG001|Overall Study|Refused Treatment|14
806660|NCT00081653|1760079|FG000|Overall Study|Low bone mineral density|1
806661|NCT00081653|1760080|FG001|Overall Study|Low bone mineral density|0
806662|NCT00081653|1760079|FG000|Overall Study|Bone loss|2
806663|NCT00081653|1760080|FG001|Overall Study|Bone loss|0
806664|NCT00081653|1760079|FG000|Overall Study|Participant leaving country|1
806665|NCT00081653|1760080|FG001|Overall Study|Participant leaving country|0
806666|NCT00081653|1760079|FG000|Overall Study|Loss of bone mass|0
806667|NCT00081653|1760080|FG001|Overall Study|Loss of bone mass|2
806668|NCT00081731|1760089|FG000|Overall Study|scientific integrity issue|8
806669|NCT00081731|1760090|FG001|Overall Study|scientific integrity issue|8
806670|NCT00081770|1760099|FG000|Overall Study|Adverse Event|130
806671|NCT00081770|1760100|FG001|Overall Study|Adverse Event|98
806672|NCT00081770|1760101|FG002|Overall Study|Adverse Event|136
806673|NCT00081770|1760099|FG000|Overall Study|Lack of Efficacy|262
806674|NCT00081770|1760100|FG001|Overall Study|Lack of Efficacy|357
806675|NCT00081770|1760101|FG002|Overall Study|Lack of Efficacy|211
806676|NCT00081770|1760099|FG000|Overall Study|Lost to Follow-up|45
806677|NCT00081770|1760100|FG001|Overall Study|Lost to Follow-up|34
806678|NCT00081770|1760101|FG002|Overall Study|Lost to Follow-up|45
806679|NCT00081770|1760099|FG000|Overall Study|Protocol Violation|15
806680|NCT00081770|1760100|FG001|Overall Study|Protocol Violation|10
806681|NCT00081770|1760101|FG002|Overall Study|Protocol Violation|10
806682|NCT00081770|1760099|FG000|Overall Study|Withdrawal by Subject|45
806683|NCT00081770|1760100|FG001|Overall Study|Withdrawal by Subject|40
806684|NCT00081770|1760101|FG002|Overall Study|Withdrawal by Subject|42
806685|NCT00081770|1760099|FG000|Overall Study|Did not meet protocol eligibility|2
806686|NCT00081770|1760100|FG001|Overall Study|Did not meet protocol eligibility|0
806687|NCT00081770|1760101|FG002|Overall Study|Did not meet protocol eligibility|3
806688|NCT00081770|1760099|FG000|Overall Study|Administrative|1
806689|NCT00081770|1760100|FG001|Overall Study|Administrative|0
806690|NCT00081770|1760101|FG002|Overall Study|Administrative|1
806691|NCT00081770|1760099|FG000|Overall Study|Other|2
806692|NCT00081770|1760100|FG001|Overall Study|Other|7
806693|NCT00081770|1760101|FG002|Overall Study|Other|8
806694|NCT00082173|1760126|FG000|Overall Study|Withdrawal by Subject|3
806695|NCT00082173|1760127|FG001|Overall Study|Withdrawal by Subject|5
806696|NCT00082173|1760126|FG000|Overall Study|Lost to Follow-up|1
806697|NCT00082173|1760127|FG001|Overall Study|Lost to Follow-up|0
806698|NCT00082173|1760126|FG000|Overall Study|Adverse Event|1
806699|NCT00082173|1760127|FG001|Overall Study|Adverse Event|0
806700|NCT00082173|1760126|FG000|Overall Study|Culture negative or resistant at baselin|5
806701|NCT00082173|1760127|FG001|Overall Study|Culture negative or resistant at baselin|6
806702|NCT00082355|1760160|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
806703|NCT00082355|1760160|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
806704|NCT00082355|1760160|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
806705|NCT00082368|1760164|FG000|Overall Study|Not treated-pt had poor IV access|1
806706|NCT00082381|1760170|FG000|Overall Study|Adverse Event|27
806707|NCT00082381|1760171|FG001|Overall Study|Adverse Event|2
806708|NCT00082381|1760170|FG000|Overall Study|Lost to Follow-up|5
806709|NCT00082381|1760171|FG001|Overall Study|Lost to Follow-up|7
806710|NCT00082381|1760170|FG000|Overall Study|Patient Decision|8
806711|NCT00082381|1760171|FG001|Overall Study|Patient Decision|4
806712|NCT00082381|1760170|FG000|Overall Study|Physician Decision|1
806713|NCT00082381|1760171|FG001|Overall Study|Physician Decision|2
806714|NCT00082381|1760170|FG000|Overall Study|Protocol Violation|10
806715|NCT00082381|1760171|FG001|Overall Study|Protocol Violation|11
806716|NCT00082381|1760170|FG000|Overall Study|Loss of Glucose Control|4
806717|NCT00082381|1760171|FG001|Overall Study|Loss of Glucose Control|0
806718|NCT00082407|1760179|FG000|Overall Study|Adverse Event|20
806719|NCT00082407|1760180|FG001|Overall Study|Adverse Event|0
806720|NCT00082407|1760179|FG000|Overall Study|Protocol Violation|14
806721|NCT00082407|1760180|FG001|Overall Study|Protocol Violation|12
806722|NCT00082407|1760179|FG000|Overall Study|Patient Decision|13
806723|NCT00082407|1760180|FG001|Overall Study|Patient Decision|6
806724|NCT00082407|1760179|FG000|Overall Study|Physician Decision|5
806725|NCT00082407|1760180|FG001|Overall Study|Physician Decision|3
806726|NCT00082407|1760179|FG000|Overall Study|Loss of Glucose Control|2
806727|NCT00082407|1760180|FG001|Overall Study|Loss of Glucose Control|2
806728|NCT00082407|1760179|FG000|Overall Study|Death|2
806729|NCT00082407|1760180|FG001|Overall Study|Death|1
806730|NCT00082407|1760179|FG000|Overall Study|Lost to Follow-up|0
806731|NCT00082407|1760180|FG001|Overall Study|Lost to Follow-up|3
806732|NCT00082433|1760188|FG000|Overall Study|Adverse Event|12
806733|NCT00082433|1760189|FG001|Overall Study|Adverse Event|17
806734|NCT00082433|1760188|FG000|Overall Study|Death|8
806735|NCT00082433|1760189|FG001|Overall Study|Death|18
806736|NCT00082433|1760188|FG000|Overall Study|Disease Progression/Relapse|270
806737|NCT00082433|1760189|FG001|Overall Study|Disease Progression/Relapse|388
806738|NCT00082433|1760188|FG000|Overall Study|Physician Decision|50
806739|NCT00082433|1760189|FG001|Overall Study|Physician Decision|61
806740|NCT00082433|1760188|FG000|Overall Study|Lost to Follow-up|1
806741|NCT00082433|1760189|FG001|Overall Study|Lost to Follow-up|2
806742|NCT00082433|1760188|FG000|Overall Study|Study Drug Toxicity|179
806743|NCT00082433|1760189|FG001|Overall Study|Study Drug Toxicity|66
806744|NCT00082433|1760188|FG000|Overall Study|Withdrawal by Subject|55
806745|NCT00082433|1760189|FG001|Overall Study|Withdrawal by Subject|30
806746|NCT00082433|1760188|FG000|Overall Study|Still On Treatment|2
806747|NCT00082433|1760189|FG001|Overall Study|Still On Treatment|1
806748|NCT00082433|1760188|FG000|Overall Study|Not Treated|12
806749|NCT00082433|1760189|FG001|Overall Study|Not Treated|11
806750|NCT00082433|1760188|FG000|Overall Study|Ineligible|2
806751|NCT00082433|1760189|FG001|Overall Study|Ineligible|1
806752|NCT00082433|1760188|FG000|Overall Study|Noncompliance|2
806753|NCT00082433|1760189|FG001|Overall Study|Noncompliance|1
806754|NCT00082433|1760188|FG000|Overall Study|New primary cancer|1
806755|NCT00082433|1760189|FG001|Overall Study|New primary cancer|0
806756|NCT00082433|1760188|FG000|Overall Study|Impending surgery|0
806757|NCT00082433|1760189|FG001|Overall Study|Impending surgery|1
806758|NCT00082628|1760197|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
806759|NCT00082628|1760198|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
806760|NCT00082628|1760199|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
806761|NCT00082628|1760200|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
806762|NCT00082628|1760201|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
806763|NCT00082628|1760197|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
806764|NCT00082628|1760198|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
806765|NCT00082628|1760199|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
806766|NCT00082628|1760200|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
806767|NCT00082628|1760201|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
806768|NCT00082628|1760197|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
806769|NCT00082628|1760198|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
806770|NCT00082628|1760199|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
806850|NCT00083889|1760313|FG001|Overall Study|Lack of Efficacy|219
806771|NCT00082628|1760200|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
806772|NCT00082628|1760201|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
806773|NCT00082628|1760197|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
806774|NCT00082628|1760198|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
806775|NCT00082628|1760199|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
806776|NCT00082628|1760200|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
806777|NCT00082628|1760201|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
806778|NCT00082628|1760197|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
806779|NCT00082628|1760198|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
806780|NCT00082628|1760199|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
806781|NCT00082628|1760200|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
806782|NCT00082628|1760201|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
806783|NCT00082628|1760197|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
806784|NCT00082628|1760198|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
806785|NCT00082628|1760199|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
806786|NCT00082628|1760200|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
806787|NCT00082628|1760201|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
806788|NCT00082628|1760197|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
806789|NCT00082628|1760198|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
806790|NCT00082628|1760199|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
806791|NCT00082628|1760200|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
806792|NCT00082628|1760201|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
806793|NCT00082758|1760226|FG000|Overall Study|Adverse Event|0
806794|NCT00082758|1760227|FG001|Overall Study|Adverse Event|2
806795|NCT00082758|1760228|FG002|Overall Study|Adverse Event|0
806796|NCT00082758|1760226|FG000|Overall Study|Lack of Efficacy|12
806797|NCT00082758|1760227|FG001|Overall Study|Lack of Efficacy|13
806798|NCT00082758|1760228|FG002|Overall Study|Lack of Efficacy|0
806799|NCT00082758|1760226|FG000|Overall Study|Physician Decision|0
806800|NCT00082758|1760227|FG001|Overall Study|Physician Decision|1
806801|NCT00082758|1760228|FG002|Overall Study|Physician Decision|0
806802|NCT00082758|1760226|FG000|Overall Study|Withdrawal by Subject|3
806803|NCT00082758|1760227|FG001|Overall Study|Withdrawal by Subject|0
806804|NCT00082758|1760228|FG002|Overall Study|Withdrawal by Subject|0
806805|NCT00082758|1760226|FG000|Overall Study|Protocol Violation|0
806806|NCT00082758|1760227|FG001|Overall Study|Protocol Violation|1
806807|NCT00082758|1760228|FG002|Overall Study|Protocol Violation|0
806808|NCT00082810|1760236|FG000|Overall Study|Adverse Event|3
806809|NCT00082810|1760236|FG000|Overall Study|Progressive disease|24
806810|NCT00082810|1760236|FG000|Overall Study|Withdrawal by Subject|4
806811|NCT00082888|1760244|FG000|Overall Study|Ineligible|1
806812|NCT00082888|1760245|FG001|Overall Study|Ineligible|0
806813|NCT00082888|1760246|FG002|Overall Study|Ineligible|0
806814|NCT00083226|1760278|FG000|Overall Study|Lack of Efficacy|19
806815|NCT00083226|1760278|FG000|Overall Study|Adverse Event|9
806816|NCT00083226|1760278|FG000|Overall Study|Death|4
806817|NCT00083226|1760278|FG000|Overall Study|Withdrawal by Subject|4
806818|NCT00083226|1760278|FG000|Overall Study|Other|2
806819|NCT00083226|1760278|FG000|Overall Study|ineligible or not receiving treatment|4
806820|NCT00083616|1760295|FG000|Overall Study|Disease Progression|16
806821|NCT00083616|1760295|FG000|Overall Study|Lost to Follow-up|1
806822|NCT00083616|1760295|FG000|Overall Study|Physician Decision|2
806823|NCT00083616|1760295|FG000|Overall Study|Withdrawal by Subject|3
806824|NCT00083616|1760295|FG000|Overall Study|Ineligibility determined|2
806825|NCT00083616|1760295|FG000|Overall Study|Non-compliance|1
806826|NCT00083616|1760295|FG000|Overall Study|Other|6
806827|NCT00083759|1760305|FG000|Overall Study|Adverse Event|5
806828|NCT00083759|1760306|FG001|Overall Study|Adverse Event|3
806829|NCT00083759|1760305|FG000|Overall Study|Lost to Follow-up|1
806830|NCT00083759|1760306|FG001|Overall Study|Lost to Follow-up|0
806831|NCT00083759|1760305|FG000|Overall Study|Death|1
806832|NCT00083759|1760306|FG001|Overall Study|Death|1
806833|NCT00083759|1760305|FG000|Overall Study|Inadequate Therapeutic Response|32
806834|NCT00083759|1760306|FG001|Overall Study|Inadequate Therapeutic Response|35
806835|NCT00083759|1760305|FG000|Overall Study|Subject Withdrew Consent|2
806836|NCT00083759|1760306|FG001|Overall Study|Subject Withdrew Consent|2
806837|NCT00083759|1760305|FG000|Overall Study|Non-Compliance|1
806838|NCT00083759|1760306|FG001|Overall Study|Non-Compliance|0
806839|NCT00083759|1760305|FG000|Overall Study|Sponsor's Discretion|28
806840|NCT00083759|1760306|FG001|Overall Study|Sponsor's Discretion|29
806841|NCT00083759|1760305|FG000|Overall Study|Other|14
806842|NCT00083759|1760306|FG001|Overall Study|Other|13
806843|NCT00083889|1760312|FG000|Overall Study|Adverse Event|76
806844|NCT00083889|1760313|FG001|Overall Study|Adverse Event|86
806845|NCT00083889|1760312|FG000|Overall Study|Protocol Violation|2
806846|NCT00083889|1760313|FG001|Overall Study|Protocol Violation|2
806847|NCT00083889|1760312|FG000|Overall Study|Withdrawal by Subject|22
806848|NCT00083889|1760313|FG001|Overall Study|Withdrawal by Subject|24
806849|NCT00083889|1760312|FG000|Overall Study|Lack of Efficacy|240
806851|NCT00083889|1760312|FG000|Overall Study|Decision of sponsor|32
806852|NCT00083889|1760313|FG001|Overall Study|Decision of sponsor|4
806853|NCT00083889|1760312|FG000|Overall Study|Randomized: did not take study drug|0
806854|NCT00083889|1760313|FG001|Overall Study|Randomized: did not take study drug|15
806855|NCT00083889|1760312|FG000|Overall Study|Completed on marketed sunitinub|3
806856|NCT00083889|1760313|FG001|Overall Study|Completed on marketed sunitinub|0
806857|NCT00083889|1760312|FG000|Overall Study|Crossover to SU011248|0
806858|NCT00083889|1760313|FG001|Overall Study|Crossover to SU011248|25
806859|NCT00084084|1760322|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
806860|NCT00084084|1760322|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
806861|NCT00084136|1760330|FG000|PI Comparison|Death|10
806862|NCT00084136|1760331|FG001|PI Comparison|Death|9
806863|NCT00084136|1760332|FG002|PI Comparison|Death|0
806864|NCT00084136|1760330|FG000|PI Comparison|Lost to Follow-up|11
806865|NCT00084136|1760331|FG001|PI Comparison|Lost to Follow-up|8
806866|NCT00084136|1760332|FG002|PI Comparison|Lost to Follow-up|0
806867|NCT00084136|1760330|FG000|PI Comparison|Withdrawal by Subject|33
806868|NCT00084136|1760331|FG001|PI Comparison|Withdrawal by Subject|30
806869|NCT00084136|1760332|FG002|PI Comparison|Withdrawal by Subject|0
806870|NCT00084136|1760330|FG000|PI Comparison|Clinic site closed|1
806871|NCT00084136|1760331|FG001|PI Comparison|Clinic site closed|0
806872|NCT00084136|1760332|FG002|PI Comparison|Clinic site closed|0
806873|NCT00084136|1760330|FG000|NRTI Comparison|Death|20
806874|NCT00084136|1760331|FG001|NRTI Comparison|Death|0
806875|NCT00084136|1760332|FG002|NRTI Comparison|Death|18
806876|NCT00084136|1760330|FG000|NRTI Comparison|Lost to Follow-up|14
806877|NCT00084136|1760331|FG001|NRTI Comparison|Lost to Follow-up|0
806878|NCT00084136|1760332|FG002|NRTI Comparison|Lost to Follow-up|12
806879|NCT00084136|1760330|FG000|NRTI Comparison|Withdrawal by Subject|54
806880|NCT00084136|1760331|FG001|NRTI Comparison|Withdrawal by Subject|0
806881|NCT00084136|1760332|FG002|NRTI Comparison|Withdrawal by Subject|38
806882|NCT00084136|1760330|FG000|NRTI Comparison|Clinic site closed|12
806883|NCT00084136|1760331|FG001|NRTI Comparison|Clinic site closed|0
806884|NCT00084136|1760332|FG002|NRTI Comparison|Clinic site closed|14
806885|NCT00084136|1760330|FG000|NRTI Comparison|Not reason above|1
806886|NCT00084136|1760331|FG001|NRTI Comparison|Not reason above|0
806887|NCT00084136|1760332|FG002|NRTI Comparison|Not reason above|0
806888|NCT00084266|1760356|FG000|Overall Study|Death|42
806889|NCT00084266|1760357|FG001|Overall Study|Death|39
806890|NCT00084266|1760356|FG000|Overall Study|Adverse Event|8
806891|NCT00084266|1760357|FG001|Overall Study|Adverse Event|5
806892|NCT00084266|1760356|FG000|Overall Study|Lack of Efficacy|2
806893|NCT00084266|1760357|FG001|Overall Study|Lack of Efficacy|4
806894|NCT00084266|1760356|FG000|Overall Study|Lost to Follow-up|5
806895|NCT00084266|1760357|FG001|Overall Study|Lost to Follow-up|3
806896|NCT00084266|1760356|FG000|Overall Study|Participant not willing to participate|3
806897|NCT00084266|1760357|FG001|Overall Study|Participant not willing to participate|8
806898|NCT00084266|1760356|FG000|Overall Study|Other|360
806899|NCT00084266|1760357|FG001|Overall Study|Other|344
806900|NCT00084266|1760356|FG000|Overall Study|Randomized not treated|21
806901|NCT00084266|1760357|FG001|Overall Study|Randomized not treated|20
806902|NCT00084318|1760365|FG000|Overall Study|Withdrawal by Subject|5
806903|NCT00084318|1760366|FG001|Overall Study|Withdrawal by Subject|2
806904|NCT00084318|1760365|FG000|Overall Study|Protocol Violation|15
806905|NCT00084318|1760366|FG001|Overall Study|Protocol Violation|11
806906|NCT00084318|1760365|FG000|Overall Study|No protocol treatment|2
806907|NCT00084318|1760366|FG001|Overall Study|No protocol treatment|0
806908|NCT00084487|1760389|FG000|Overall Study|Death|1
806909|NCT00084617|1760402|FG000|Overall Study|Withdrawal by Subject|7
806910|NCT00084617|1760402|FG000|Overall Study|Lack of Efficacy|1
806911|NCT00084617|1760402|FG000|Overall Study|Protocol Violation|1
806912|NCT00084682|1760406|FG000|Overall Study|Withdrawal by Subject|1
806913|NCT00084747|1760411|FG000|Overall Study|Relapsed|8
806914|NCT00084747|1760411|FG000|Overall Study|Death|3
806915|NCT00084747|1760411|FG000|Overall Study|Withdrawal by Subject|2
806916|NCT00084838|1760416|FG000|Overall Study|Death|1
806917|NCT00084838|1760416|FG000|Overall Study|Adverse Event|2
806918|NCT00084838|1760416|FG000|Overall Study|Withdrawal by Subject|1
806919|NCT00084838|1760416|FG000|Overall Study|Progressive Disease|4
806920|NCT00084838|1760416|FG000|Overall Study|Pt Non-Compliance|1
806921|NCT00084838|1760416|FG000|Overall Study|Ineligible|4
806922|NCT00084864|1760426|FG000|Overall Study|Adverse Event|1
806923|NCT00084864|1760427|FG001|Overall Study|Adverse Event|0
806924|NCT00084864|1760428|FG002|Overall Study|Adverse Event|0
806925|NCT00084864|1760429|FG003|Overall Study|Adverse Event|0
806926|NCT00084929|1760439|FG000|Overall Study|ineligible - medical contraindication|1
806927|NCT00084929|1760439|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1
806928|NCT00084929|1760439|FG000|Overall Study|Ineligible - Medical history|6
806929|NCT00084929|1760439|FG000|Overall Study|Withdrawal by Subject|10
806930|NCT00084929|1760439|FG000|Overall Study|Missing/incomplete CTC exam|9
806931|NCT00084929|1760439|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42
806932|NCT00085098|1760449|FG000|Overall Study|Withdrawal by Subject|0
806933|NCT00085098|1760450|FG001|Overall Study|Withdrawal by Subject|1
806934|NCT00085098|1760449|FG000|Overall Study|Ineligible|1
806935|NCT00085098|1760450|FG001|Overall Study|Ineligible|1
806950|NCT00085423|1760509|FG000|Overall Study|Withdrawal by Subject|1
806951|NCT00085423|1760509|FG000|Overall Study|screen failure|1
806952|NCT00085540|1760520|FG000|Overall Study|Withdrawal by Subject|0
806953|NCT00085540|1760521|FG001|Overall Study|Withdrawal by Subject|1
806954|NCT00085540|1760520|FG000|Overall Study|Protocol Violation|0
806955|NCT00085540|1760521|FG001|Overall Study|Protocol Violation|1
806956|NCT00085566|1760530|FG000|Overall Study|Adverse Event|0
806957|NCT00085566|1760531|FG001|Overall Study|Adverse Event|0
806958|NCT00085566|1760532|FG002|Overall Study|Adverse Event|10
806959|NCT00085566|1760530|FG000|Overall Study|Patient Not treated|0
806960|NCT00085566|1760531|FG001|Overall Study|Patient Not treated|0
806961|NCT00085566|1760532|FG002|Overall Study|Patient Not treated|3
806962|NCT00085566|1760530|FG000|Overall Study|Clinical progression|0
806963|NCT00085566|1760531|FG001|Overall Study|Clinical progression|0
806964|NCT00085566|1760532|FG002|Overall Study|Clinical progression|1
806965|NCT00085644|1760542|FG000|Double-Blind Period|Adverse Event|5
806966|NCT00085644|1760543|FG001|Double-Blind Period|Adverse Event|2
806967|NCT00085644|1760544|FG002|Double-Blind Period|Adverse Event|0
806968|NCT00085644|1760542|FG000|Double-Blind Period|Withdrawal by Subject|3
806969|NCT00085644|1760543|FG001|Double-Blind Period|Withdrawal by Subject|0
806970|NCT00085644|1760544|FG002|Double-Blind Period|Withdrawal by Subject|0
806971|NCT00085644|1760542|FG000|Double-Blind Period|Lost to Follow-up|2
806972|NCT00085644|1760543|FG001|Double-Blind Period|Lost to Follow-up|1
806973|NCT00085644|1760544|FG002|Double-Blind Period|Lost to Follow-up|0
806974|NCT00085644|1760542|FG000|Double-Blind Period|Lack/loss of efficacy|2
806975|NCT00085644|1760543|FG001|Double-Blind Period|Lack/loss of efficacy|2
806976|NCT00085644|1760544|FG002|Double-Blind Period|Lack/loss of efficacy|0
806977|NCT00085644|1760542|FG000|Double-Blind Period|Contemplating pregnancy|1
806978|NCT00085644|1760543|FG001|Double-Blind Period|Contemplating pregnancy|0
806979|NCT00085644|1760544|FG002|Double-Blind Period|Contemplating pregnancy|0
806980|NCT00085644|1760542|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0
806981|NCT00085644|1760543|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1
806982|NCT00085644|1760544|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0
806983|NCT00085644|1760542|FG000|Open-Label Period|Adverse Event|0
806984|NCT00085644|1760543|FG001|Open-Label Period|Adverse Event|0
806985|NCT00085644|1760544|FG002|Open-Label Period|Adverse Event|38
806986|NCT00085644|1760542|FG000|Open-Label Period|Withdrawal by Subject|0
806987|NCT00085644|1760543|FG001|Open-Label Period|Withdrawal by Subject|0
806988|NCT00085644|1760544|FG002|Open-Label Period|Withdrawal by Subject|29
806989|NCT00085644|1760542|FG000|Open-Label Period|Lost to Follow-up|0
806990|NCT00085644|1760543|FG001|Open-Label Period|Lost to Follow-up|0
806991|NCT00085644|1760544|FG002|Open-Label Period|Lost to Follow-up|13
806992|NCT00085644|1760542|FG000|Open-Label Period|Lack of Efficacy|0
806993|NCT00085644|1760543|FG001|Open-Label Period|Lack of Efficacy|0
806994|NCT00085644|1760544|FG002|Open-Label Period|Lack of Efficacy|15
806995|NCT00085644|1760542|FG000|Open-Label Period|Pregnancy|0
806996|NCT00085644|1760543|FG001|Open-Label Period|Pregnancy|0
806997|NCT00085644|1760544|FG002|Open-Label Period|Pregnancy|3
806998|NCT00085644|1760542|FG000|Open-Label Period|Contemplating pregnancy|0
806999|NCT00085644|1760543|FG001|Open-Label Period|Contemplating pregnancy|0
807000|NCT00085644|1760544|FG002|Open-Label Period|Contemplating pregnancy|3
807001|NCT00085644|1760542|FG000|Open-Label Period|Protocol Violation|0
807002|NCT00085644|1760543|FG001|Open-Label Period|Protocol Violation|0
807003|NCT00085644|1760544|FG002|Open-Label Period|Protocol Violation|4
807004|NCT00085644|1760542|FG000|Open-Label Period|Personal reason|0
807005|NCT00085644|1760543|FG001|Open-Label Period|Personal reason|0
807006|NCT00085644|1760544|FG002|Open-Label Period|Personal reason|4
807007|NCT00085709|1760553|FG000|Overall Study|Adverse Event|8
807008|NCT00085709|1760554|FG001|Overall Study|Adverse Event|0
807009|NCT00085709|1760553|FG000|Overall Study|Death|8
807010|NCT00085709|1760554|FG001|Overall Study|Death|2
807011|NCT00085709|1760553|FG000|Overall Study|Refusal unrelated to adverse events|1
807012|NCT00085709|1760554|FG001|Overall Study|Refusal unrelated to adverse events|2
807013|NCT00085709|1760553|FG000|Overall Study|Progression|3
807014|NCT00085709|1760554|FG001|Overall Study|Progression|4
807015|NCT00085709|1760553|FG000|Overall Study|Not protocol specified|12
807016|NCT00085709|1760554|FG001|Overall Study|Not protocol specified|22
807017|NCT00085709|1760553|FG000|Overall Study|Not eligible|19
807018|NCT00085709|1760554|FG001|Overall Study|Not eligible|19
807019|NCT00085709|1760553|FG000|Overall Study|Withdrawal by Subject|2
807020|NCT00085709|1760554|FG001|Overall Study|Withdrawal by Subject|1
807021|NCT00085735|1760574|FG000|Overall Study|Adverse Event|1
807022|NCT00085735|1760575|FG001|Overall Study|Adverse Event|0
807023|NCT00085735|1760576|FG002|Overall Study|Adverse Event|0
807024|NCT00085735|1760577|FG003|Overall Study|Adverse Event|0
807025|NCT00085735|1760578|FG004|Overall Study|Adverse Event|0
807026|NCT00085735|1760579|FG005|Overall Study|Adverse Event|0
807027|NCT00085735|1760574|FG000|Overall Study|Lack of Efficacy|2
807028|NCT00085735|1760575|FG001|Overall Study|Lack of Efficacy|4
807029|NCT00085735|1760576|FG002|Overall Study|Lack of Efficacy|6
807030|NCT00085735|1760577|FG003|Overall Study|Lack of Efficacy|3
807031|NCT00085735|1760578|FG004|Overall Study|Lack of Efficacy|4
807032|NCT00085735|1760579|FG005|Overall Study|Lack of Efficacy|3
807033|NCT00085735|1760574|FG000|Overall Study|Lost to Follow-up|0
807034|NCT00085735|1760575|FG001|Overall Study|Lost to Follow-up|1
807035|NCT00085735|1760576|FG002|Overall Study|Lost to Follow-up|0
807036|NCT00085735|1760577|FG003|Overall Study|Lost to Follow-up|0
807037|NCT00085735|1760578|FG004|Overall Study|Lost to Follow-up|1
807038|NCT00085735|1760579|FG005|Overall Study|Lost to Follow-up|0
807039|NCT00085735|1760574|FG000|Overall Study|Physician Decision|2
807040|NCT00085735|1760575|FG001|Overall Study|Physician Decision|3
807041|NCT00085735|1760576|FG002|Overall Study|Physician Decision|2
807042|NCT00085735|1760577|FG003|Overall Study|Physician Decision|3
807043|NCT00085735|1760578|FG004|Overall Study|Physician Decision|11
807044|NCT00085735|1760579|FG005|Overall Study|Physician Decision|8
807045|NCT00085735|1760574|FG000|Overall Study|Protocol Violation|1
807046|NCT00085735|1760575|FG001|Overall Study|Protocol Violation|0
807047|NCT00085735|1760576|FG002|Overall Study|Protocol Violation|0
807048|NCT00085735|1760577|FG003|Overall Study|Protocol Violation|0
807049|NCT00085735|1760578|FG004|Overall Study|Protocol Violation|0
807050|NCT00085735|1760579|FG005|Overall Study|Protocol Violation|0
807051|NCT00085735|1760574|FG000|Overall Study|Withdrawal by Subject|1
807052|NCT00085735|1760575|FG001|Overall Study|Withdrawal by Subject|0
807053|NCT00085735|1760576|FG002|Overall Study|Withdrawal by Subject|4
807054|NCT00085735|1760577|FG003|Overall Study|Withdrawal by Subject|5
807055|NCT00085735|1760578|FG004|Overall Study|Withdrawal by Subject|7
807056|NCT00085735|1760579|FG005|Overall Study|Withdrawal by Subject|8
807057|NCT00085735|1760574|FG000|Overall Study|Patient ineligible|1
807058|NCT00085735|1760575|FG001|Overall Study|Patient ineligible|0
807059|NCT00085735|1760576|FG002|Overall Study|Patient ineligible|3
807060|NCT00085735|1760577|FG003|Overall Study|Patient ineligible|7
807061|NCT00085735|1760578|FG004|Overall Study|Patient ineligible|17
807062|NCT00085735|1760579|FG005|Overall Study|Patient ineligible|8
807063|NCT00085735|1760574|FG000|Overall Study|Excess residual disease|2
807064|NCT00085735|1760575|FG001|Overall Study|Excess residual disease|2
807065|NCT00085735|1760576|FG002|Overall Study|Excess residual disease|1
807066|NCT00085735|1760577|FG003|Overall Study|Excess residual disease|1
807067|NCT00085735|1760578|FG004|Overall Study|Excess residual disease|1
807068|NCT00085735|1760579|FG005|Overall Study|Excess residual disease|4
807069|NCT00085735|1760574|FG000|Overall Study|Reason not documented|1
807070|NCT00085735|1760575|FG001|Overall Study|Reason not documented|0
807071|NCT00085735|1760576|FG002|Overall Study|Reason not documented|1
807072|NCT00085735|1760577|FG003|Overall Study|Reason not documented|0
807073|NCT00085735|1760578|FG004|Overall Study|Reason not documented|1
807074|NCT00085735|1760579|FG005|Overall Study|Reason not documented|0
807075|NCT00085735|1760574|FG000|Overall Study|Pt transferred to inst w/out study open|1
807076|NCT00085735|1760575|FG001|Overall Study|Pt transferred to inst w/out study open|0
807077|NCT00085735|1760576|FG002|Overall Study|Pt transferred to inst w/out study open|0
807078|NCT00085735|1760577|FG003|Overall Study|Pt transferred to inst w/out study open|0
807079|NCT00085735|1760578|FG004|Overall Study|Pt transferred to inst w/out study open|0
807080|NCT00085735|1760579|FG005|Overall Study|Pt transferred to inst w/out study open|0
807081|NCT00085917|1760617|FG000|Overall Study|Adverse Event|4
807082|NCT00085917|1760618|FG001|Overall Study|Adverse Event|3
807083|NCT00086047|1760626|FG000|Overall Study|Lost to Follow-up|7
807084|NCT00086047|1760627|FG001|Overall Study|Lost to Follow-up|6
807085|NCT00086047|1760626|FG000|Overall Study|Physician Decision|0
807086|NCT00086047|1760627|FG001|Overall Study|Physician Decision|1
807087|NCT00086190|1760645|FG000|Overall Study|Adverse Event|6
807088|NCT00086190|1760646|FG001|Overall Study|Adverse Event|2
807089|NCT00086190|1760647|FG002|Overall Study|Adverse Event|2
807090|NCT00086190|1760645|FG000|Overall Study|Withdrawal by Subject|0
807091|NCT00086190|1760646|FG001|Overall Study|Withdrawal by Subject|2
807092|NCT00086190|1760647|FG002|Overall Study|Withdrawal by Subject|2
807093|NCT00086190|1760645|FG000|Overall Study|Protocol Violation|1
807094|NCT00086190|1760646|FG001|Overall Study|Protocol Violation|0
807095|NCT00086190|1760647|FG002|Overall Study|Protocol Violation|0
807096|NCT00086190|1760645|FG000|Overall Study|Moved|1
807097|NCT00086190|1760646|FG001|Overall Study|Moved|0
807098|NCT00086190|1760647|FG002|Overall Study|Moved|0
807099|NCT00086190|1760645|FG000|Overall Study|Worsening depression|0
807100|NCT00086190|1760646|FG001|Overall Study|Worsening depression|0
807101|NCT00086190|1760647|FG002|Overall Study|Worsening depression|2
807102|NCT00086281|1760670|FG000|Phase 1|Adverse Event|0
807103|NCT00086281|1760671|FG001|Phase 1|Adverse Event|0
807104|NCT00086281|1760672|FG002|Phase 1|Adverse Event|0
807105|NCT00086281|1760673|FG003|Phase 1|Adverse Event|0
807106|NCT00086281|1760674|FG004|Phase 1|Adverse Event|0
807107|NCT00086281|1760675|FG005|Phase 1|Adverse Event|0
807108|NCT00086281|1760676|FG006|Phase 1|Adverse Event|0
807109|NCT00086281|1760677|FG007|Phase 1|Adverse Event|0
807110|NCT00086281|1760678|FG008|Phase 1|Adverse Event|0
807111|NCT00086281|1760679|FG009|Phase 1|Adverse Event|1
807112|NCT00086281|1760680|FG010|Phase 1|Adverse Event|2
807113|NCT00086281|1760681|FG011|Phase 1|Adverse Event|1
807114|NCT00086281|1760682|FG012|Phase 1|Adverse Event|1
807115|NCT00086281|1760683|FG013|Phase 1|Adverse Event|1
807116|NCT00086281|1760684|FG014|Phase 1|Adverse Event|2
807117|NCT00086281|1760670|FG000|Phase 1|Protocol Violation|0
807118|NCT00086281|1760671|FG001|Phase 1|Protocol Violation|0
807119|NCT00086281|1760672|FG002|Phase 1|Protocol Violation|0
807120|NCT00086281|1760673|FG003|Phase 1|Protocol Violation|0
807121|NCT00086281|1760674|FG004|Phase 1|Protocol Violation|0
807122|NCT00086281|1760675|FG005|Phase 1|Protocol Violation|0
807123|NCT00086281|1760676|FG006|Phase 1|Protocol Violation|0
807124|NCT00086281|1760677|FG007|Phase 1|Protocol Violation|0
807125|NCT00086281|1760678|FG008|Phase 1|Protocol Violation|0
807126|NCT00086281|1760679|FG009|Phase 1|Protocol Violation|0
807127|NCT00086281|1760680|FG010|Phase 1|Protocol Violation|1
807128|NCT00086281|1760681|FG011|Phase 1|Protocol Violation|0
807129|NCT00086281|1760682|FG012|Phase 1|Protocol Violation|0
807130|NCT00086281|1760683|FG013|Phase 1|Protocol Violation|0
807131|NCT00086281|1760684|FG014|Phase 1|Protocol Violation|0
807132|NCT00086281|1760670|FG000|Phase 1|Serious Adverse Event|0
807133|NCT00086281|1760671|FG001|Phase 1|Serious Adverse Event|0
807134|NCT00086281|1760672|FG002|Phase 1|Serious Adverse Event|0
807135|NCT00086281|1760673|FG003|Phase 1|Serious Adverse Event|0
807136|NCT00086281|1760674|FG004|Phase 1|Serious Adverse Event|0
807137|NCT00086281|1760675|FG005|Phase 1|Serious Adverse Event|0
807138|NCT00086281|1760676|FG006|Phase 1|Serious Adverse Event|0
807139|NCT00086281|1760677|FG007|Phase 1|Serious Adverse Event|0
807140|NCT00086281|1760678|FG008|Phase 1|Serious Adverse Event|0
807141|NCT00086281|1760679|FG009|Phase 1|Serious Adverse Event|0
807142|NCT00086281|1760680|FG010|Phase 1|Serious Adverse Event|0
807143|NCT00086281|1760681|FG011|Phase 1|Serious Adverse Event|0
807144|NCT00086281|1760682|FG012|Phase 1|Serious Adverse Event|0
807145|NCT00086281|1760683|FG013|Phase 1|Serious Adverse Event|0
807146|NCT00086281|1760684|FG014|Phase 1|Serious Adverse Event|1
807147|NCT00086281|1760670|FG000|Phase 2|Adverse Event|0
807148|NCT00086281|1760671|FG001|Phase 2|Adverse Event|0
807149|NCT00086281|1760672|FG002|Phase 2|Adverse Event|0
807150|NCT00086281|1760673|FG003|Phase 2|Adverse Event|0
807151|NCT00086281|1760674|FG004|Phase 2|Adverse Event|0
807152|NCT00086281|1760675|FG005|Phase 2|Adverse Event|0
807153|NCT00086281|1760676|FG006|Phase 2|Adverse Event|0
807154|NCT00086281|1760677|FG007|Phase 2|Adverse Event|0
807155|NCT00086281|1760678|FG008|Phase 2|Adverse Event|0
807156|NCT00086281|1760679|FG009|Phase 2|Adverse Event|0
807157|NCT00086281|1760680|FG010|Phase 2|Adverse Event|0
807158|NCT00086281|1760681|FG011|Phase 2|Adverse Event|0
807159|NCT00086281|1760682|FG012|Phase 2|Adverse Event|1
807160|NCT00086281|1760683|FG013|Phase 2|Adverse Event|1
807161|NCT00086281|1760684|FG014|Phase 2|Adverse Event|0
807162|NCT00086307|1760697|FG000|Overall Study|Lack of Efficacy|1
807163|NCT00086307|1760698|FG001|Overall Study|Lack of Efficacy|1
807164|NCT00086307|1760699|FG002|Overall Study|Lack of Efficacy|2
807165|NCT00086307|1760697|FG000|Overall Study|Shortness of breath and muscle spasms|1
807166|NCT00086307|1760698|FG001|Overall Study|Shortness of breath and muscle spasms|0
807167|NCT00086307|1760699|FG002|Overall Study|Shortness of breath and muscle spasms|0
807168|NCT00086307|1760697|FG000|Overall Study|Nausea and headaches|0
807169|NCT00086307|1760698|FG001|Overall Study|Nausea and headaches|0
807170|NCT00086307|1760699|FG002|Overall Study|Nausea and headaches|1
807171|NCT00086307|1760697|FG000|Overall Study|Constipation and sleepiness|0
807172|NCT00086307|1760698|FG001|Overall Study|Constipation and sleepiness|0
807173|NCT00086307|1760699|FG002|Overall Study|Constipation and sleepiness|1
807174|NCT00086307|1760697|FG000|Overall Study|Suicidal ideation|0
807175|NCT00086307|1760698|FG001|Overall Study|Suicidal ideation|0
807176|NCT00086307|1760699|FG002|Overall Study|Suicidal ideation|1
807177|NCT00086307|1760697|FG000|Overall Study|Fatigue and difficulty falling asleep|0
807178|NCT00086307|1760698|FG001|Overall Study|Fatigue and difficulty falling asleep|0
807179|NCT00086307|1760699|FG002|Overall Study|Fatigue and difficulty falling asleep|1
807180|NCT00086307|1760697|FG000|Overall Study|Withdrawal by Subject|0
807181|NCT00086307|1760698|FG001|Overall Study|Withdrawal by Subject|0
807182|NCT00086307|1760699|FG002|Overall Study|Withdrawal by Subject|2
807183|NCT00086346|1760709|FG000|Randomization|Did not receive test article|4
807184|NCT00086346|1760710|FG001|Randomization|Did not receive test article|4
807185|NCT00086346|1760709|FG000|Patients Dosed With Test Article|Adverse Event|94
807186|NCT00086346|1760710|FG001|Patients Dosed With Test Article|Adverse Event|11
807187|NCT00086346|1760709|FG000|Patients Dosed With Test Article|Lost to Follow-up|1
807188|NCT00086346|1760710|FG001|Patients Dosed With Test Article|Lost to Follow-up|3
807189|NCT00086346|1760709|FG000|Patients Dosed With Test Article|Nonmedical event|7
807190|NCT00086346|1760710|FG001|Patients Dosed With Test Article|Nonmedical event|3
807191|NCT00086346|1760709|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16
807192|NCT00086346|1760710|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3
807193|NCT00086346|1760709|FG000|Patients Dosed With Test Article|Protocol Violation|11
807194|NCT00086346|1760710|FG001|Patients Dosed With Test Article|Protocol Violation|3
807195|NCT00086346|1760709|FG000|Patients Dosed With Test Article|Lack of Efficacy|11
807196|NCT00086346|1760710|FG001|Patients Dosed With Test Article|Lack of Efficacy|0
807197|NCT00086385|1760720|FG000|Overall Study|Death|2
807198|NCT00086385|1760721|FG001|Overall Study|Death|2
807199|NCT00086385|1760722|FG002|Overall Study|Death|1
807200|NCT00086385|1760723|FG003|Overall Study|Death|1
807201|NCT00086411|1760737|FG000|Overall Study|Lost to Follow-up|11
807202|NCT00086411|1760738|FG001|Overall Study|Lost to Follow-up|11
807203|NCT00086411|1760739|FG002|Overall Study|Lost to Follow-up|13
807204|NCT00086411|1760740|FG003|Overall Study|Lost to Follow-up|12
807205|NCT00086502|1760762|FG000|Overall Study|Adverse Event|11
807206|NCT00086502|1760763|FG001|Overall Study|Adverse Event|2
807207|NCT00086502|1760762|FG000|Overall Study|Lack of Efficacy|0
807208|NCT00086502|1760763|FG001|Overall Study|Lack of Efficacy|2
807209|NCT00086502|1760762|FG000|Overall Study|Lost to Follow-up|3
807210|NCT00086502|1760763|FG001|Overall Study|Lost to Follow-up|1
807211|NCT00086502|1760762|FG000|Overall Study|Physician Decision|1
807212|NCT00086502|1760763|FG001|Overall Study|Physician Decision|1
807213|NCT00086502|1760762|FG000|Overall Study|Pregnancy|0
807214|NCT00086502|1760763|FG001|Overall Study|Pregnancy|1
807215|NCT00086502|1760762|FG000|Overall Study|Protocol Violation|3
807216|NCT00086502|1760763|FG001|Overall Study|Protocol Violation|3
807217|NCT00086502|1760762|FG000|Overall Study|Withdrawal by Subject|5
807218|NCT00086502|1760763|FG001|Overall Study|Withdrawal by Subject|6
807219|NCT00086502|1760762|FG000|Overall Study|Patient Moved|1
807220|NCT00086502|1760763|FG001|Overall Study|Patient Moved|1
807221|NCT00086502|1760762|FG000|Overall Study|Protocol Discontinuation Criteria|1
807222|NCT00086502|1760763|FG001|Overall Study|Protocol Discontinuation Criteria|3
807223|NCT00086502|1760762|FG000|Overall Study|Patient Accidentally Unblinded|1
807224|NCT00086502|1760763|FG001|Overall Study|Patient Accidentally Unblinded|0
807225|NCT00086515|1760771|FG000|Phase A (Weeks 0-24)|Adverse Event|17
807226|NCT00086515|1760772|FG001|Phase A (Weeks 0-24)|Adverse Event|9
807227|NCT00086515|1760771|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7
807228|NCT00086515|1760772|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13
807229|NCT00086515|1760771|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4
807230|NCT00086515|1760772|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5
807231|NCT00086515|1760771|FG000|Phase A (Weeks 0-24)|Protocol Violation|3
807232|NCT00086515|1760772|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
807233|NCT00086515|1760771|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10
807234|NCT00086515|1760772|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10
807235|NCT00086515|1760771|FG000|Phase A (Weeks 0-24)|Patient Moved|2
807236|NCT00086515|1760772|FG001|Phase A (Weeks 0-24)|Patient Moved|3
807237|NCT00086515|1760771|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
807238|NCT00086515|1760772|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
807239|NCT00086515|1760771|FG000|Phase A (Weeks 0-24)|Poor compliance|1
807240|NCT00086515|1760772|FG001|Phase A (Weeks 0-24)|Poor compliance|0
807241|NCT00086515|1760771|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
807242|NCT00086515|1760772|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
807243|NCT00086515|1760771|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1
807244|NCT00086515|1760772|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0
807245|NCT00086515|1760771|FG000|Phase A to Phase B Transition Period|Adverse Event|2
807246|NCT00086515|1760772|FG001|Phase A to Phase B Transition Period|Adverse Event|1
807247|NCT00086515|1760771|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2
807248|NCT00086515|1760772|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2
807249|NCT00086515|1760771|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1
807250|NCT00086515|1760772|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0
807251|NCT00086515|1760771|FG000|Phase A to Phase B Transition Period|Protocol Violation|0
807252|NCT00086515|1760772|FG001|Phase A to Phase B Transition Period|Protocol Violation|1
807253|NCT00086515|1760771|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
807254|NCT00086515|1760772|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
807255|NCT00086515|1760771|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
807256|NCT00086515|1760772|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
807257|NCT00086515|1760771|FG000|Phase A to Phase B Transition Period|Poor compliance|1
807258|NCT00086515|1760772|FG001|Phase A to Phase B Transition Period|Poor compliance|0
807259|NCT00086515|1760771|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
807260|NCT00086515|1760772|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
807261|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Adverse Event|16
807262|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Adverse Event|10
807263|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94
807264|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19
807265|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13
807266|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4
807267|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Physician Decision|3
807268|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Physician Decision|0
807269|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Protocol Violation|1
807270|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Protocol Violation|0
807271|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15
807272|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5
807273|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Patient Moved|2
807274|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Patient Moved|2
807275|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
807276|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
807277|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
807278|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
807279|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Patient Died|3
807280|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Patient Died|1
807281|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
807282|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
807283|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1
807284|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0
807285|NCT00086515|1760771|FG000|Phase B (Weeks 24-104)|Discontinued in error|1
807286|NCT00086515|1760772|FG001|Phase B (Weeks 24-104)|Discontinued in error|0
807287|NCT00086580|1760780|FG000|Treatment Period|Disease progression|9
807288|NCT00086580|1760781|FG001|Treatment Period|Disease progression|8
807289|NCT00086580|1760780|FG000|Treatment Period|Unable to comply with protocol|3
807290|NCT00086580|1760781|FG001|Treatment Period|Unable to comply with protocol|1
807291|NCT00086580|1760780|FG000|Treatment Period|Withdrawal by Subject|7
807292|NCT00086580|1760781|FG001|Treatment Period|Withdrawal by Subject|8
807293|NCT00086580|1760780|FG000|Treatment Period|Physician Decision|13
807294|NCT00086580|1760781|FG001|Treatment Period|Physician Decision|7
807295|NCT00086580|1760780|FG000|Treatment Period|AE - not treatment related|7
807296|NCT00086580|1760781|FG001|Treatment Period|AE - not treatment related|7
807297|NCT00086580|1760780|FG000|Treatment Period|Toxicity - treatment related|15
807298|NCT00086580|1760781|FG001|Treatment Period|Toxicity - treatment related|15
807299|NCT00086580|1760780|FG000|Treatment Period|Anemia or thrombocytopenia|1
807300|NCT00086580|1760781|FG001|Treatment Period|Anemia or thrombocytopenia|4
807301|NCT00086580|1760780|FG000|Treatment Period|Death|5
807302|NCT00086580|1760781|FG001|Treatment Period|Death|7
807303|NCT00086580|1760780|FG000|Treatment Period|Other|5
807304|NCT00086580|1760781|FG001|Treatment Period|Other|3
807305|NCT00086580|1760780|FG000|Follow-up Period|Disease progression|72
807306|NCT00086580|1760781|FG001|Follow-up Period|Disease progression|99
807307|NCT00086580|1760780|FG000|Follow-up Period|Unable to comply with protocol|5
807308|NCT00086580|1760781|FG001|Follow-up Period|Unable to comply with protocol|0
807309|NCT00086580|1760780|FG000|Follow-up Period|Withdrawal by Subject|6
807310|NCT00086580|1760781|FG001|Follow-up Period|Withdrawal by Subject|6
807311|NCT00086580|1760780|FG000|Follow-up Period|Physician Decision|0
807312|NCT00086580|1760781|FG001|Follow-up Period|Physician Decision|1
807313|NCT00086580|1760780|FG000|Follow-up Period|AE - not related|1
807314|NCT00086580|1760781|FG001|Follow-up Period|AE - not related|0
807315|NCT00086580|1760780|FG000|Follow-up Period|Death|13
807316|NCT00086580|1760781|FG001|Follow-up Period|Death|7
807317|NCT00086580|1760780|FG000|Follow-up Period|Other|7
807318|NCT00086580|1760781|FG001|Follow-up Period|Other|6
807319|NCT00086580|1760780|FG000|Observation Period|Unable to comply with protocol|1
807320|NCT00086580|1760781|FG001|Observation Period|Unable to comply with protocol|1
807321|NCT00086580|1760780|FG000|Observation Period|Withdrawal by Subject|4
807322|NCT00086580|1760781|FG001|Observation Period|Withdrawal by Subject|2
807323|NCT00086580|1760780|FG000|Observation Period|Death|33
807324|NCT00086580|1760781|FG001|Observation Period|Death|55
807325|NCT00086580|1760780|FG000|Observation Period|Other|8
807326|NCT00086580|1760781|FG001|Observation Period|Other|7
807327|NCT00086619|1760789|FG000|Overall Study|Withdrawal by Subject|6
807328|NCT00086619|1760790|FG001|Overall Study|Withdrawal by Subject|6
807329|NCT00086619|1760789|FG000|Overall Study|Adverse Event|8
807330|NCT00086619|1760790|FG001|Overall Study|Adverse Event|10
807331|NCT00086619|1760789|FG000|Overall Study|Protocol Violation|1
807332|NCT00086619|1760790|FG001|Overall Study|Protocol Violation|1
807333|NCT00086684|1760799|FG000|Overall Study|Adverse Event|12
807334|NCT00086684|1760800|FG001|Overall Study|Adverse Event|17
807335|NCT00086684|1760801|FG002|Overall Study|Adverse Event|14
807336|NCT00086684|1760799|FG000|Overall Study|Lack of Efficacy|6
807337|NCT00086684|1760800|FG001|Overall Study|Lack of Efficacy|6
807338|NCT00086684|1760801|FG002|Overall Study|Lack of Efficacy|5
807339|NCT00086684|1760799|FG000|Overall Study|Lost to Follow-up|15
807340|NCT00086684|1760800|FG001|Overall Study|Lost to Follow-up|8
807341|NCT00086684|1760801|FG002|Overall Study|Lost to Follow-up|10
807342|NCT00086684|1760799|FG000|Overall Study|Protocol Violation|8
807343|NCT00086684|1760800|FG001|Overall Study|Protocol Violation|3
807344|NCT00086684|1760801|FG002|Overall Study|Protocol Violation|0
807345|NCT00086684|1760799|FG000|Overall Study|Withdrawal by Subject|0
807346|NCT00086684|1760800|FG001|Overall Study|Withdrawal by Subject|4
807347|NCT00086684|1760801|FG002|Overall Study|Withdrawal by Subject|10
807348|NCT00086684|1760799|FG000|Overall Study|NONCOMPLIANCE|5
807349|NCT00086684|1760800|FG001|Overall Study|NONCOMPLIANCE|7
807350|NCT00086684|1760801|FG002|Overall Study|NONCOMPLIANCE|6
807351|NCT00086684|1760799|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0
807352|NCT00086684|1760800|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1
807353|NCT00086684|1760801|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0
807354|NCT00086684|1760799|FG000|Overall Study|WITHDRAWAL OF CONSENT|5
807355|NCT00086684|1760800|FG001|Overall Study|WITHDRAWAL OF CONSENT|7
807356|NCT00086684|1760801|FG002|Overall Study|WITHDRAWAL OF CONSENT|5
807357|NCT00086684|1760799|FG000|Overall Study|Other|4
807358|NCT00086684|1760800|FG001|Overall Study|Other|2
807359|NCT00086684|1760801|FG002|Overall Study|Other|3
807360|NCT00086996|1760820|FG000|Overall Study|Adverse Event|29
807361|NCT00086996|1760820|FG000|Overall Study|Death|4
807362|NCT00086996|1760820|FG000|Overall Study|progression/relapse|7
807363|NCT00086996|1760820|FG000|Overall Study|Withdrawal by Subject|13
807364|NCT00086996|1760820|FG000|Overall Study|Other|6
807365|NCT00086996|1760820|FG000|Overall Study|not eligible|5
807366|NCT00087126|1760833|FG000|Overall Study|Ineligible - second primary|1
807367|NCT00087126|1760833|FG000|Overall Study|Never treated|1
807368|NCT00087139|1760845|FG000|Overall Study|Adverse Event|18
807369|NCT00087139|1760846|FG001|Overall Study|Adverse Event|17
807370|NCT00087139|1760847|FG002|Overall Study|Adverse Event|13
807371|NCT00087139|1760845|FG000|Overall Study|Death|2
807372|NCT00087139|1760846|FG001|Overall Study|Death|1
807373|NCT00087139|1760847|FG002|Overall Study|Death|0
807374|NCT00087139|1760845|FG000|Overall Study|Withdrawal by Subject|3
807375|NCT00087139|1760846|FG001|Overall Study|Withdrawal by Subject|2
807376|NCT00087139|1760847|FG002|Overall Study|Withdrawal by Subject|2
807377|NCT00087139|1760845|FG000|Overall Study|Physician Decision|1
807378|NCT00087139|1760846|FG001|Overall Study|Physician Decision|1
807379|NCT00087139|1760847|FG002|Overall Study|Physician Decision|1
807380|NCT00087139|1760845|FG000|Overall Study|Disease progression|9
807381|NCT00087139|1760846|FG001|Overall Study|Disease progression|19
807382|NCT00087139|1760847|FG002|Overall Study|Disease progression|12
807383|NCT00087139|1760845|FG000|Overall Study|Ineligible|4
807384|NCT00087139|1760846|FG001|Overall Study|Ineligible|7
807385|NCT00087139|1760847|FG002|Overall Study|Ineligible|4
807386|NCT00087139|1760845|FG000|Overall Study|Symptomatic deterioration|1
807387|NCT00087139|1760846|FG001|Overall Study|Symptomatic deterioration|1
807388|NCT00087139|1760847|FG002|Overall Study|Symptomatic deterioration|3
807389|NCT00087139|1760845|FG000|Overall Study|Use of coumadin|1
807390|NCT00087139|1760846|FG001|Overall Study|Use of coumadin|0
807391|NCT00087139|1760847|FG002|Overall Study|Use of coumadin|0
807392|NCT00087139|1760845|FG000|Overall Study|Response achieved|0
807393|NCT00087139|1760846|FG001|Overall Study|Response achieved|1
807394|NCT00087139|1760847|FG002|Overall Study|Response achieved|0
807395|NCT00087139|1760845|FG000|Overall Study|Extradural disease|0
807396|NCT00087139|1760846|FG001|Overall Study|Extradural disease|0
807397|NCT00087139|1760847|FG002|Overall Study|Extradural disease|1
807398|NCT00087152|1760853|FG000|Overall Study|Ineligible|6
807399|NCT00087438|1760858|FG000|Overall Study|Ineligible / No protocol treatment|4
807400|NCT00087490|1760866|FG000|Overall Study|Death|6
807401|NCT00087490|1760867|FG001|Overall Study|Death|4
807402|NCT00087490|1760866|FG000|Overall Study|Adverse Event|3
807403|NCT00087490|1760867|FG001|Overall Study|Adverse Event|8
807404|NCT00087490|1760866|FG000|Overall Study|Lack of Efficacy|0
807405|NCT00087490|1760867|FG001|Overall Study|Lack of Efficacy|2
807406|NCT00087490|1760866|FG000|Overall Study|Protocol Violation or (/) Unspecified|214
807407|NCT00087490|1760867|FG001|Overall Study|Protocol Violation or (/) Unspecified|201
807408|NCT00087490|1760866|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28
807409|NCT00087490|1760867|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36
807410|NCT00087490|1760866|FG000|Overall Study|Randomized but not treated|7
807411|NCT00087490|1760867|FG001|Overall Study|Randomized but not treated|18
807412|NCT00087516|1760876|FG000|Overall Study|Adverse Event|10
807413|NCT00087516|1760877|FG001|Overall Study|Adverse Event|10
807414|NCT00087516|1760878|FG002|Overall Study|Adverse Event|3
807415|NCT00087516|1760879|FG003|Overall Study|Adverse Event|6
807416|NCT00087516|1760876|FG000|Overall Study|Lack of Efficacy|82
807417|NCT00087516|1760877|FG001|Overall Study|Lack of Efficacy|80
807418|NCT00087516|1760878|FG002|Overall Study|Lack of Efficacy|39
807419|NCT00087516|1760879|FG003|Overall Study|Lack of Efficacy|29
807420|NCT00087516|1760876|FG000|Overall Study|Lost to Follow-up|8
807421|NCT00087516|1760877|FG001|Overall Study|Lost to Follow-up|6
807422|NCT00087516|1760878|FG002|Overall Study|Lost to Follow-up|5
807423|NCT00087516|1760879|FG003|Overall Study|Lost to Follow-up|5
807424|NCT00087516|1760876|FG000|Overall Study|Protocol Violation|4
807425|NCT00087516|1760877|FG001|Overall Study|Protocol Violation|8
807426|NCT00087516|1760878|FG002|Overall Study|Protocol Violation|3
807427|NCT00087516|1760879|FG003|Overall Study|Protocol Violation|6
807428|NCT00087516|1760876|FG000|Overall Study|Withdrawal by Subject|16
807429|NCT00087516|1760877|FG001|Overall Study|Withdrawal by Subject|27
807430|NCT00087516|1760878|FG002|Overall Study|Withdrawal by Subject|11
807431|NCT00087516|1760879|FG003|Overall Study|Withdrawal by Subject|12
807432|NCT00087516|1760876|FG000|Overall Study|Site terminated|0
807433|NCT00087516|1760877|FG001|Overall Study|Site terminated|2
807434|NCT00087516|1760878|FG002|Overall Study|Site terminated|1
807435|NCT00087516|1760879|FG003|Overall Study|Site terminated|0
807436|NCT00087516|1760876|FG000|Overall Study|Protocol specified discontinuation|35
807437|NCT00087516|1760877|FG001|Overall Study|Protocol specified discontinuation|33
807438|NCT00087516|1760878|FG002|Overall Study|Protocol specified discontinuation|33
807439|NCT00087516|1760879|FG003|Overall Study|Protocol specified discontinuation|26
807440|NCT00087516|1760876|FG000|Overall Study|Patient moved|3
807441|NCT00087516|1760877|FG001|Overall Study|Patient moved|2
807442|NCT00087516|1760878|FG002|Overall Study|Patient moved|1
807443|NCT00087516|1760879|FG003|Overall Study|Patient moved|0
807444|NCT00087516|1760876|FG000|Overall Study|Patient was non-compliant|3
807445|NCT00087516|1760877|FG001|Overall Study|Patient was non-compliant|1
807446|NCT00087516|1760878|FG002|Overall Study|Patient was non-compliant|0
807447|NCT00087516|1760879|FG003|Overall Study|Patient was non-compliant|0
807448|NCT00087516|1760876|FG000|Overall Study|Recommendation of Primary Care Physician|0
807449|NCT00087516|1760877|FG001|Overall Study|Recommendation of Primary Care Physician|0
807450|NCT00087516|1760878|FG002|Overall Study|Recommendation of Primary Care Physician|0
807451|NCT00087516|1760879|FG003|Overall Study|Recommendation of Primary Care Physician|1
807452|NCT00087516|1760876|FG000|Overall Study|Other|0
807453|NCT00087516|1760877|FG001|Overall Study|Other|0
807454|NCT00087516|1760878|FG002|Overall Study|Other|1
807455|NCT00087516|1760879|FG003|Overall Study|Other|0
807456|NCT00087529|1760895|FG000|Overall Study|Death|1
807457|NCT00087529|1760896|FG001|Overall Study|Death|0
807458|NCT00087529|1760895|FG000|Overall Study|Adverse Event|0
807459|NCT00087529|1760896|FG001|Overall Study|Adverse Event|8
807460|NCT00087529|1760895|FG000|Overall Study|Pregnancy|0
807461|NCT00087529|1760896|FG001|Overall Study|Pregnancy|1
807462|NCT00087529|1760895|FG000|Overall Study|Lost to Follow-up|2
807463|NCT00087529|1760896|FG001|Overall Study|Lost to Follow-up|3
807464|NCT00087529|1760895|FG000|Overall Study|Participant Decision|14
807465|NCT00087529|1760896|FG001|Overall Study|Participant Decision|37
807466|NCT00087529|1760895|FG000|Overall Study|Physician Decision|4
807467|NCT00087529|1760896|FG001|Overall Study|Physician Decision|8
807468|NCT00087529|1760895|FG000|Overall Study|Initiation of Excluded Therapy|0
807469|NCT00087529|1760896|FG001|Overall Study|Initiation of Excluded Therapy|1
807470|NCT00087529|1760895|FG000|Overall Study|Participant Noncompliance|0
807471|NCT00087529|1760896|FG001|Overall Study|Participant Noncompliance|1
807472|NCT00087529|1760895|FG000|Overall Study|Disease Progression|5
807473|NCT00087529|1760896|FG001|Overall Study|Disease Progression|4
807474|NCT00087529|1760895|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5
807475|NCT00087529|1760896|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5
807476|NCT00087555|1760905|FG000|Overall Study|Adverse Event|3
807477|NCT00087555|1760906|FG001|Overall Study|Adverse Event|6
807478|NCT00087555|1760907|FG002|Overall Study|Adverse Event|14
807479|NCT00087555|1760905|FG000|Overall Study|Lost to Follow-up|0
807480|NCT00087555|1760906|FG001|Overall Study|Lost to Follow-up|1
807481|NCT00087555|1760907|FG002|Overall Study|Lost to Follow-up|1
807482|NCT00087555|1760905|FG000|Overall Study|Non - Compliance|1
807483|NCT00087555|1760906|FG001|Overall Study|Non - Compliance|0
807484|NCT00087555|1760907|FG002|Overall Study|Non - Compliance|0
807485|NCT00087555|1760905|FG000|Overall Study|Protocol Violation|0
807486|NCT00087555|1760906|FG001|Overall Study|Protocol Violation|0
807487|NCT00087555|1760907|FG002|Overall Study|Protocol Violation|2
807488|NCT00087555|1760905|FG000|Overall Study|Screen Failure|1
807489|NCT00087555|1760906|FG001|Overall Study|Screen Failure|1
807490|NCT00087555|1760907|FG002|Overall Study|Screen Failure|0
807491|NCT00087555|1760905|FG000|Overall Study|Pregnancy|0
807492|NCT00087555|1760906|FG001|Overall Study|Pregnancy|1
807493|NCT00087555|1760907|FG002|Overall Study|Pregnancy|1
807494|NCT00087555|1760905|FG000|Overall Study|Withdrawal by Subject|3
807495|NCT00087555|1760906|FG001|Overall Study|Withdrawal by Subject|2
807496|NCT00087555|1760907|FG002|Overall Study|Withdrawal by Subject|1
807497|NCT00087555|1760905|FG000|Overall Study|Lack of Efficacy|2
807498|NCT00087555|1760906|FG001|Overall Study|Lack of Efficacy|0
807499|NCT00087555|1760907|FG002|Overall Study|Lack of Efficacy|1
807500|NCT00087555|1760905|FG000|Overall Study|Non Compliance|0
807501|NCT00087555|1760906|FG001|Overall Study|Non Compliance|0
807502|NCT00087555|1760907|FG002|Overall Study|Non Compliance|1
807503|NCT00087555|1760905|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1
807504|NCT00087555|1760906|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0
807505|NCT00087555|1760907|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0
807506|NCT00087555|1760905|FG000|Overall Study|Patient wanted to go back on Med|1
807507|NCT00087555|1760906|FG001|Overall Study|Patient wanted to go back on Med|0
807508|NCT00087555|1760907|FG002|Overall Study|Patient wanted to go back on Med|0
807509|NCT00087568|1760917|FG000|Overall Study|Adverse Event|4
807510|NCT00087568|1760918|FG001|Overall Study|Adverse Event|0
807511|NCT00087568|1760917|FG000|Overall Study|Withdrawal by Subject|1
807512|NCT00087568|1760918|FG001|Overall Study|Withdrawal by Subject|1
807513|NCT00087568|1760917|FG000|Overall Study|Lost to Follow-up|1
807514|NCT00087568|1760918|FG001|Overall Study|Lost to Follow-up|0
807515|NCT00087568|1760917|FG000|Overall Study|Lack of Efficacy|24
807516|NCT00087568|1760918|FG001|Overall Study|Lack of Efficacy|1
807517|NCT00087594|1760926|FG000|Overall Study|Adverse Event|2
807518|NCT00087594|1760927|FG001|Overall Study|Adverse Event|3
807519|NCT00087594|1760926|FG000|Overall Study|Lost to Follow-up|0
807520|NCT00087594|1760927|FG001|Overall Study|Lost to Follow-up|2
807521|NCT00087594|1760926|FG000|Overall Study|Withdrawal by Subject|4
807522|NCT00087594|1760927|FG001|Overall Study|Withdrawal by Subject|2
807523|NCT00087594|1760926|FG000|Overall Study|Lack of Efficacy|2
807524|NCT00087594|1760927|FG001|Overall Study|Lack of Efficacy|5
807525|NCT00087607|1760935|FG000|Overall Study|Adverse Event|14
807526|NCT00087607|1760936|FG001|Overall Study|Adverse Event|24
807527|NCT00087607|1760935|FG000|Overall Study|Death|0
807528|NCT00087607|1760936|FG001|Overall Study|Death|1
807529|NCT00087607|1760935|FG000|Overall Study|Insufficient Therapeutic Response|53
807530|NCT00087607|1760936|FG001|Overall Study|Insufficient Therapeutic Response|42
807531|NCT00087607|1760935|FG000|Overall Study|Failure to return|21
807532|NCT00087607|1760936|FG001|Overall Study|Failure to return|17
807533|NCT00087607|1760935|FG000|Overall Study|Withdrew Consent|12
807534|NCT00087607|1760936|FG001|Overall Study|Withdrew Consent|16
807535|NCT00087607|1760935|FG000|Overall Study|Administrative|12
807536|NCT00087607|1760936|FG001|Overall Study|Administrative|12
807537|NCT00087607|1760935|FG000|Overall Study|Refused Treatment|5
807538|NCT00087607|1760936|FG001|Overall Study|Refused Treatment|7
807539|NCT00087607|1760935|FG000|Overall Study|Other Protocol Violation|5
807540|NCT00087607|1760936|FG001|Overall Study|Other Protocol Violation|2
807541|NCT00087607|1760935|FG000|Overall Study|Violation of Selection Criteria at Entry|0
807542|NCT00087607|1760936|FG001|Overall Study|Violation of Selection Criteria at Entry|1
807543|NCT00087646|1760959|FG000|Overall Study|Adverse Event|37
807544|NCT00087646|1760960|FG001|Overall Study|Adverse Event|6
807545|NCT00087646|1760961|FG002|Overall Study|Adverse Event|18
807546|NCT00087646|1760962|FG003|Overall Study|Adverse Event|20
807547|NCT00087646|1760959|FG000|Overall Study|Death|0
807548|NCT00087646|1760960|FG001|Overall Study|Death|1
807549|NCT00087646|1760961|FG002|Overall Study|Death|0
807550|NCT00087646|1760962|FG003|Overall Study|Death|0
807551|NCT00087646|1760959|FG000|Overall Study|Withdrawal by Subject|6
807552|NCT00087646|1760960|FG001|Overall Study|Withdrawal by Subject|1
807553|NCT00087646|1760961|FG002|Overall Study|Withdrawal by Subject|2
807554|NCT00087646|1760962|FG003|Overall Study|Withdrawal by Subject|2
807555|NCT00087646|1760959|FG000|Overall Study|Insufficient therapeutic response|64
807556|NCT00087646|1760960|FG001|Overall Study|Insufficient therapeutic response|24
807557|NCT00087646|1760961|FG002|Overall Study|Insufficient therapeutic response|38
807558|NCT00087646|1760962|FG003|Overall Study|Insufficient therapeutic response|51
807559|NCT00087646|1760959|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13
807560|NCT00087646|1760960|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6
807561|NCT00087646|1760961|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4
807562|NCT00087646|1760962|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5
807563|NCT00087646|1760959|FG000|Overall Study|Failure to Return|5
807564|NCT00087646|1760960|FG001|Overall Study|Failure to Return|2
807565|NCT00087646|1760961|FG002|Overall Study|Failure to Return|2
807566|NCT00087646|1760962|FG003|Overall Study|Failure to Return|3
807567|NCT00087646|1760959|FG000|Overall Study|Administrative/Other|6
807568|NCT00087646|1760960|FG001|Overall Study|Administrative/Other|1
807569|NCT00087646|1760961|FG002|Overall Study|Administrative/Other|1
807570|NCT00087646|1760962|FG003|Overall Study|Administrative/Other|2
807571|NCT00087646|1760959|FG000|Overall Study|Other Protocol Violation|3
807572|NCT00087646|1760960|FG001|Overall Study|Other Protocol Violation|1
807573|NCT00087646|1760961|FG002|Overall Study|Other Protocol Violation|0
807574|NCT00087646|1760962|FG003|Overall Study|Other Protocol Violation|0
807575|NCT00087646|1760959|FG000|Overall Study|Violation of Selection Criteria at Entry|1
807576|NCT00087646|1760960|FG001|Overall Study|Violation of Selection Criteria at Entry|0
807577|NCT00087646|1760961|FG002|Overall Study|Violation of Selection Criteria at Entry|0
807578|NCT00087646|1760962|FG003|Overall Study|Violation of Selection Criteria at Entry|1
807579|NCT00087685|1760981|FG000|Overall Study|Adverse Event|5
807580|NCT00087685|1760981|FG000|Overall Study|Non-Compliance|1
807581|NCT00087685|1760981|FG000|Overall Study|Progressive Disease|5
807582|NCT00087685|1760981|FG000|Overall Study|Withdrawal by Subject|3
807583|NCT00087698|1760985|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14
807584|NCT00087698|1760985|FG000|Overall Study|Death from Other Causes|3
807585|NCT00087698|1760985|FG000|Overall Study|Adverse Event|4
807586|NCT00087698|1760985|FG000|Overall Study|Withdrawal by Subject|4
807587|NCT00087698|1760985|FG000|Overall Study|Lack of Efficacy, Physician Perception|3
807588|NCT00087698|1760985|FG000|Overall Study|Protocol Entry Criteria Not Met|2
807589|NCT00087698|1760985|FG000|Overall Study|Clinical Relapse|1
807590|NCT00087698|1760985|FG000|Overall Study|Death from Study Disease|2
807591|NCT00087698|1760985|FG000|Overall Study|Death from Study Drug Toxicity|2
807592|NCT00087698|1760985|FG000|Overall Study|Protocol Violation|1
807593|NCT00088153|1760991|FG000|Overall Study|Physician Decision|3
807594|NCT00088153|1760992|FG001|Overall Study|Physician Decision|3
807595|NCT00088153|1760991|FG000|Overall Study|Withdrawal by Subject|10
807596|NCT00088153|1760992|FG001|Overall Study|Withdrawal by Subject|10
807597|NCT00088153|1760991|FG000|Overall Study|Lost to Follow-up|11
807598|NCT00088153|1760992|FG001|Overall Study|Lost to Follow-up|12
807599|NCT00088166|1761000|FG000|Overall Study|Adverse Event|11
807600|NCT00088166|1761001|FG001|Overall Study|Adverse Event|9
807601|NCT00088166|1761000|FG000|Overall Study|Death|3
807602|NCT00088166|1761001|FG001|Overall Study|Death|1
807603|NCT00088166|1761000|FG000|Overall Study|Lost to Follow-up|0
807604|NCT00088166|1761001|FG001|Overall Study|Lost to Follow-up|1
807605|NCT00088166|1761000|FG000|Overall Study|Physician Decision|4
807606|NCT00088166|1761001|FG001|Overall Study|Physician Decision|1
807607|NCT00088166|1761000|FG000|Overall Study|Protocol Violation|1
807608|NCT00088166|1761001|FG001|Overall Study|Protocol Violation|5
807609|NCT00088166|1761000|FG000|Overall Study|Patient deterioration|29
807610|NCT00088166|1761001|FG001|Overall Study|Patient deterioration|39
807611|NCT00088166|1761000|FG000|Overall Study|Withdrawal by Subject|5
807612|NCT00088166|1761001|FG001|Overall Study|Withdrawal by Subject|5
807613|NCT00088205|1761007|FG000|Overall Study|Adverse Event|4
807614|NCT00088205|1761007|FG000|Overall Study|Progressive Disease|51
807615|NCT00088205|1761007|FG000|Overall Study|Physician Decision|1
807616|NCT00088205|1761007|FG000|Overall Study|Death Due to Study Disease|4
807617|NCT00088374|1761020|FG000|Overall Study|patient did not receive any 17AAG|1
807618|NCT00088374|1761020|FG000|Overall Study|patient received <1 cycle only of 17AAG|1
807619|NCT00088413|1761028|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
807620|NCT00088413|1761029|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
807621|NCT00088413|1761030|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
807622|NCT00088413|1761031|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
807623|NCT00088413|1761028|FG000|Overall Study|Adverse Events/Side Effects|0
807624|NCT00088413|1761029|FG001|Overall Study|Adverse Events/Side Effects|1
807625|NCT00088413|1761030|FG002|Overall Study|Adverse Events/Side Effects|1
807626|NCT00088413|1761031|FG003|Overall Study|Adverse Events/Side Effects|0
807627|NCT00088413|1761028|FG000|Overall Study|Refused trmt Off-study per pt wishes|0
807628|NCT00088413|1761029|FG001|Overall Study|Refused trmt Off-study per pt wishes|1
807629|NCT00088413|1761030|FG002|Overall Study|Refused trmt Off-study per pt wishes|1
807630|NCT00088413|1761031|FG003|Overall Study|Refused trmt Off-study per pt wishes|0
807631|NCT00088413|1761028|FG000|Overall Study|Off study due to missing a vaccine dose|1
807632|NCT00088413|1761029|FG001|Overall Study|Off study due to missing a vaccine dose|0
807633|NCT00088413|1761030|FG002|Overall Study|Off study due to missing a vaccine dose|0
807634|NCT00088413|1761031|FG003|Overall Study|Off study due to missing a vaccine dose|0
807635|NCT00088413|1761028|FG000|Overall Study|Death|0
807636|NCT00088413|1761029|FG001|Overall Study|Death|1
807637|NCT00088413|1761030|FG002|Overall Study|Death|0
807638|NCT00088413|1761031|FG003|Overall Study|Death|0
807639|NCT00088413|1761028|FG000|Overall Study|Progressive disease|9
807640|NCT00088413|1761029|FG001|Overall Study|Progressive disease|11
807641|NCT00088413|1761030|FG002|Overall Study|Progressive disease|8
807642|NCT00088413|1761031|FG003|Overall Study|Progressive disease|14
807643|NCT00088413|1761028|FG000|Overall Study|Other|0
807644|NCT00088413|1761029|FG001|Overall Study|Other|1
807645|NCT00088413|1761030|FG002|Overall Study|Other|0
807646|NCT00088413|1761031|FG003|Overall Study|Other|0
807647|NCT00088413|1761028|FG000|Overall Study|Patient unevaluable due to adverse event|0
807648|NCT00088413|1761029|FG001|Overall Study|Patient unevaluable due to adverse event|0
807649|NCT00088413|1761030|FG002|Overall Study|Patient unevaluable due to adverse event|1
807650|NCT00088413|1761031|FG003|Overall Study|Patient unevaluable due to adverse event|0
807651|NCT00088452|1761046|FG000|Overall Study|Did not receive intervention|1
807652|NCT00088452|1761047|FG001|Overall Study|Did not receive intervention|0
807653|NCT00088452|1761048|FG002|Overall Study|Did not receive intervention|1
807654|NCT00088465|1761056|FG000|Overall Study|Withdrawal by Subject|290
807655|NCT00088465|1761056|FG000|Overall Study|Adverse Event|77
807656|NCT00088465|1761056|FG000|Overall Study|Lost to Follow-up|57
807657|NCT00088465|1761056|FG000|Overall Study|Physician Decision|45
807658|NCT00088465|1761056|FG000|Overall Study|Sponsor Decision|37
807659|NCT00088465|1761056|FG000|Overall Study|Lack of Efficacy|27
807660|NCT00088465|1761056|FG000|Overall Study|Protocol Violation|17
807661|NCT00088465|1761056|FG000|Overall Study|Death|11
807662|NCT00088530|1761062|FG000|Overall Study|Progressive/Relapsed Disease|28
807663|NCT00088530|1761063|FG001|Overall Study|Progressive/Relapsed Disease|39
807664|NCT00088530|1761062|FG000|Overall Study|Adverse Event|15
807665|NCT00088530|1761063|FG001|Overall Study|Adverse Event|9
807666|NCT00088530|1761062|FG000|Overall Study|Withdrawal by Subject|2
807667|NCT00088530|1761063|FG001|Overall Study|Withdrawal by Subject|5
807668|NCT00088530|1761062|FG000|Overall Study|Lost to Follow-up|2
807669|NCT00088530|1761063|FG001|Overall Study|Lost to Follow-up|0
807670|NCT00088530|1761062|FG000|Overall Study|Physician Decision|2
807671|NCT00088530|1761063|FG001|Overall Study|Physician Decision|0
807672|NCT00088530|1761062|FG000|Overall Study|Sponsor decision|0
807673|NCT00088530|1761063|FG001|Overall Study|Sponsor decision|1
807674|NCT00088530|1761062|FG000|Overall Study|Patient never treated|1
807675|NCT00088530|1761063|FG001|Overall Study|Patient never treated|0
807676|NCT00088595|1761069|FG000|Overall Study|Adverse Event|11
807677|NCT00088595|1761069|FG000|Overall Study|Withdrawal by Subject|8
807678|NCT00088595|1761069|FG000|Overall Study|Ongoing (After Core)|7
807679|NCT00088595|1761069|FG000|Overall Study|New Cancer Therapy|2
807680|NCT00088881|1761111|FG000|Step 1 - R-CHOP|Patient ineligible|9
807681|NCT00088881|1761111|FG000|Step 1 - R-CHOP|Adverse Event|1
807682|NCT00088881|1761111|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2
807683|NCT00088881|1761111|FG000|Step 1 - R-CHOP|Physician Decision|1
807684|NCT00088881|1761111|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1
807850|NCT00089791|1761312|FG000|Overall Study|Noncompliance|17
807685|NCT00088881|1761111|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
807686|NCT00088881|1761111|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
807687|NCT00088907|1761119|FG000|Randomized Study (Step 1)|Lack of Efficacy|55
807688|NCT00088907|1761120|FG001|Randomized Study (Step 1)|Lack of Efficacy|62
807689|NCT00088907|1761119|FG000|Randomized Study (Step 1)|Adverse Event|14
807690|NCT00088907|1761120|FG001|Randomized Study (Step 1)|Adverse Event|19
807691|NCT00088907|1761119|FG000|Randomized Study (Step 1)|Death|11
807692|NCT00088907|1761120|FG001|Randomized Study (Step 1)|Death|12
807693|NCT00088907|1761119|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10
807694|NCT00088907|1761120|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15
807695|NCT00088907|1761119|FG000|Randomized Study (Step 1)|complicating disease|3
807696|NCT00088907|1761120|FG001|Randomized Study (Step 1)|complicating disease|1
807697|NCT00088907|1761119|FG000|Randomized Study (Step 1)|unknown/not specify|24
807698|NCT00088907|1761120|FG001|Randomized Study (Step 1)|unknown/not specify|13
807699|NCT00088907|1761119|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
807700|NCT00088907|1761120|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
807701|NCT00088907|1761119|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
807702|NCT00088907|1761120|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
807703|NCT00088907|1761119|FG000|Single Gefitinib Treatment (Step 2)|Death|1
807704|NCT00088907|1761120|FG001|Single Gefitinib Treatment (Step 2)|Death|0
807705|NCT00088907|1761119|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
807706|NCT00088907|1761120|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
807707|NCT00088907|1761119|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
807708|NCT00088907|1761120|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
807709|NCT00089076|1761144|FG000|Overall Study|Alternate Therapy|1
807710|NCT00089076|1761144|FG000|Overall Study|Withdrawal by Subject|2
807711|NCT00089076|1761144|FG000|Overall Study|Progression|7
807712|NCT00089141|1761154|FG000|Overall Study|Termination of trial|18
807713|NCT00089141|1761155|FG001|Overall Study|Termination of trial|24
807714|NCT00089284|1761164|FG000|Overall Study|Adverse event before starting treatment|0
807715|NCT00089284|1761165|FG001|Overall Study|Adverse event before starting treatment|0
807716|NCT00089284|1761166|FG002|Overall Study|Adverse event before starting treatment|0
807717|NCT00089284|1761167|FG003|Overall Study|Adverse event before starting treatment|0
807718|NCT00089284|1761168|FG004|Overall Study|Adverse event before starting treatment|0
807719|NCT00089284|1761169|FG005|Overall Study|Adverse event before starting treatment|0
807720|NCT00089284|1761170|FG006|Overall Study|Adverse event before starting treatment|1
807721|NCT00089297|1761192|FG000|Overall Study|Adverse Event|9
807722|NCT00089297|1761192|FG000|Overall Study|Death|1
807723|NCT00089297|1761192|FG000|Overall Study|Withdrawal by Subject|12
807724|NCT00089297|1761192|FG000|Overall Study|Disease progression|2
807725|NCT00089297|1761192|FG000|Overall Study|Ineligible|11
807726|NCT00089297|1761192|FG000|Overall Study|Secondary malignancy|1
807727|NCT00089297|1761192|FG000|Overall Study|IRB approval not ready|1
807728|NCT00089297|1761192|FG000|Overall Study|Non-compliance|1
807729|NCT00089479|1761198|FG000|Overall Study|Death|108
807730|NCT00089479|1761199|FG001|Overall Study|Death|75
807731|NCT00089479|1761198|FG000|Overall Study|Withdrawal by Subject|86
807732|NCT00089479|1761199|FG001|Overall Study|Withdrawal by Subject|107
807733|NCT00089479|1761198|FG000|Overall Study|Lost to Follow-up|137
807734|NCT00089479|1761199|FG001|Overall Study|Lost to Follow-up|107
807735|NCT00089505|1761209|FG000|Overall Study|Death|4
807736|NCT00089505|1761210|FG001|Overall Study|Death|1
807737|NCT00089505|1761211|FG002|Overall Study|Death|5
807738|NCT00089505|1761212|FG003|Overall Study|Death|8
807739|NCT00089505|1761209|FG000|Overall Study|Withdrawal by Subject|3
807740|NCT00089505|1761210|FG001|Overall Study|Withdrawal by Subject|0
807741|NCT00089505|1761211|FG002|Overall Study|Withdrawal by Subject|6
807742|NCT00089505|1761212|FG003|Overall Study|Withdrawal by Subject|6
807743|NCT00089505|1761209|FG000|Overall Study|Lost to Follow-up|1
807744|NCT00089505|1761210|FG001|Overall Study|Lost to Follow-up|1
807745|NCT00089505|1761211|FG002|Overall Study|Lost to Follow-up|9
807746|NCT00089505|1761212|FG003|Overall Study|Lost to Follow-up|7
807747|NCT00089505|1761209|FG000|Overall Study|Physician Decision|1
807748|NCT00089505|1761210|FG001|Overall Study|Physician Decision|0
807749|NCT00089505|1761211|FG002|Overall Study|Physician Decision|0
807750|NCT00089505|1761212|FG003|Overall Study|Physician Decision|0
807751|NCT00089505|1761209|FG000|Overall Study|Protocol Violation|0
807752|NCT00089505|1761210|FG001|Overall Study|Protocol Violation|0
807753|NCT00089505|1761211|FG002|Overall Study|Protocol Violation|1
807754|NCT00089505|1761212|FG003|Overall Study|Protocol Violation|0
807755|NCT00089544|1761224|FG000|Overall Study|Ineligible|1
807756|NCT00089544|1761225|FG001|Overall Study|Ineligible|0
807757|NCT00089583|1761233|FG000|Overall Study|Adverse Event|0
807758|NCT00089583|1761234|FG001|Overall Study|Adverse Event|3
807759|NCT00089583|1761233|FG000|Overall Study|Insufficient Viral Load Response|5
807760|NCT00089583|1761234|FG001|Overall Study|Insufficient Viral Load Response|5
807761|NCT00089583|1761233|FG000|Overall Study|Withdrawal by Subject|0
807762|NCT00089583|1761234|FG001|Overall Study|Withdrawal by Subject|4
807763|NCT00089583|1761233|FG000|Overall Study|Participant (Par) Didn't Take Medication|1
807764|NCT00089583|1761234|FG001|Overall Study|Participant (Par) Didn't Take Medication|0
807765|NCT00089583|1761233|FG000|Overall Study|Participant Refused Study Medication|0
807766|NCT00089583|1761234|FG001|Overall Study|Participant Refused Study Medication|2
807767|NCT00089583|1761233|FG000|Overall Study|Non-Compliance|0
807768|NCT00089583|1761234|FG001|Overall Study|Non-Compliance|4
807769|NCT00089583|1761233|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0
807770|NCT00089583|1761234|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3
807771|NCT00089583|1761233|FG000|Overall Study|Participant Management Criteria Met|0
807772|NCT00089583|1761234|FG001|Overall Study|Participant Management Criteria Met|1
807773|NCT00089583|1761233|FG000|Overall Study|Reason Not Provided|0
807774|NCT00089583|1761234|FG001|Overall Study|Reason Not Provided|1
807775|NCT00089583|1761233|FG000|Overall Study|Protocol Violation|0
807776|NCT00089583|1761234|FG001|Overall Study|Protocol Violation|3
807777|NCT00089583|1761233|FG000|Overall Study|Principal Investigator Decision|0
807778|NCT00089583|1761234|FG001|Overall Study|Principal Investigator Decision|10
807779|NCT00089583|1761233|FG000|Overall Study|Start of Disallowed Medication|0
807780|NCT00089583|1761234|FG001|Overall Study|Start of Disallowed Medication|1
807781|NCT00089583|1761233|FG000|Overall Study|Necessity to Use Prohibited Drug|1
807782|NCT00089583|1761234|FG001|Overall Study|Necessity to Use Prohibited Drug|0
807783|NCT00089583|1761233|FG000|Overall Study|Participant Incarcerated|0
807784|NCT00089583|1761234|FG001|Overall Study|Participant Incarcerated|1
807785|NCT00089609|1761248|FG000|Overall Study|Withdrawal by Subject|3
807786|NCT00089609|1761249|FG001|Overall Study|Withdrawal by Subject|1
807787|NCT00089635|1761258|FG000|Overall Study|Adverse Event|2
807788|NCT00089635|1761258|FG000|Overall Study|Death|17
807789|NCT00089635|1761258|FG000|Overall Study|Disease Progression|12
807790|NCT00089635|1761258|FG000|Overall Study|Lost to Follow-up|3
807791|NCT00089635|1761258|FG000|Overall Study|Withdrawal by Subject|6
807792|NCT00089635|1761258|FG000|Overall Study|Ineligibility determined|1
807793|NCT00089635|1761258|FG000|Overall Study|Other|2
807794|NCT00089648|1761262|FG000|Overall Study|Adverse Event|7
807795|NCT00089648|1761262|FG000|Overall Study|Withdrawal by Subject|1
807796|NCT00089648|1761262|FG000|Overall Study|Lack of Efficacy|33
807797|NCT00089661|1761268|FG000|Overall Study|Adverse Event|0
807798|NCT00089661|1761269|FG001|Overall Study|Adverse Event|2
807799|NCT00089661|1761268|FG000|Overall Study|Death|1
807800|NCT00089661|1761269|FG001|Overall Study|Death|0
807801|NCT00089661|1761268|FG000|Overall Study|Lost to Follow-up|0
807802|NCT00089661|1761269|FG001|Overall Study|Lost to Follow-up|3
807803|NCT00089661|1761268|FG000|Overall Study|Withdrawal by Subject|11
807804|NCT00089661|1761269|FG001|Overall Study|Withdrawal by Subject|9
807805|NCT00089661|1761268|FG000|Overall Study|Disease progression|1
807806|NCT00089661|1761269|FG001|Overall Study|Disease progression|3
807807|NCT00089661|1761268|FG000|Overall Study|Ineligibility determined|4
807808|NCT00089661|1761269|FG001|Overall Study|Ineligibility determined|4
807809|NCT00089661|1761268|FG000|Overall Study|Noncompliance|2
807810|NCT00089661|1761269|FG001|Overall Study|Noncompliance|4
807811|NCT00089661|1761268|FG000|Overall Study|Other|2
807812|NCT00089661|1761269|FG001|Overall Study|Other|1
807813|NCT00089674|1761277|FG000|Overall Study|Physician Decision|4
807814|NCT00089674|1761278|FG001|Overall Study|Physician Decision|2
807815|NCT00089674|1761277|FG000|Overall Study|Adverse Event|23
807816|NCT00089674|1761278|FG001|Overall Study|Adverse Event|29
807817|NCT00089674|1761277|FG000|Overall Study|Withdrawal by Subject|143
807818|NCT00089674|1761278|FG001|Overall Study|Withdrawal by Subject|127
807819|NCT00089674|1761277|FG000|Overall Study|Death|43
807820|NCT00089674|1761278|FG001|Overall Study|Death|43
807821|NCT00089674|1761277|FG000|Overall Study|Disease progression|21
807822|NCT00089674|1761278|FG001|Overall Study|Disease progression|23
807823|NCT00089674|1761277|FG000|Overall Study|Ineligibility determined|8
807824|NCT00089674|1761278|FG001|Overall Study|Ineligibility determined|10
807825|NCT00089674|1761277|FG000|Overall Study|Lost to Follow-up|21
807826|NCT00089674|1761278|FG001|Overall Study|Lost to Follow-up|17
807827|NCT00089674|1761277|FG000|Overall Study|Noncompliance|7
807828|NCT00089674|1761278|FG001|Overall Study|Noncompliance|3
807829|NCT00089674|1761277|FG000|Overall Study|Other|5
807830|NCT00089674|1761278|FG001|Overall Study|Other|9
807831|NCT00089674|1761277|FG000|Overall Study|Requirement for alternative therapy|14
807832|NCT00089674|1761278|FG001|Overall Study|Requirement for alternative therapy|4
807833|NCT00089778|1761298|FG000|Overall Study|Protocol Violation|0
807834|NCT00089778|1761299|FG001|Overall Study|Protocol Violation|0
807835|NCT00089778|1761300|FG002|Overall Study|Protocol Violation|1
807836|NCT00089791|1761312|FG000|Overall Study|Physician Decision|6
807837|NCT00089791|1761313|FG001|Overall Study|Physician Decision|3
807838|NCT00089791|1761312|FG000|Overall Study|Adverse Event|81
807839|NCT00089791|1761313|FG001|Overall Study|Adverse Event|93
807840|NCT00089791|1761312|FG000|Overall Study|Withdrawal by Subject|403
807841|NCT00089791|1761313|FG001|Overall Study|Withdrawal by Subject|344
807842|NCT00089791|1761312|FG000|Overall Study|Death|78
807843|NCT00089791|1761313|FG001|Overall Study|Death|62
807844|NCT00089791|1761312|FG000|Overall Study|Disease progression|7
807845|NCT00089791|1761313|FG001|Overall Study|Disease progression|3
807846|NCT00089791|1761312|FG000|Overall Study|Ineligibility determined|12
807847|NCT00089791|1761313|FG001|Overall Study|Ineligibility determined|9
807848|NCT00089791|1761312|FG000|Overall Study|Lost to Follow-up|57
807849|NCT00089791|1761313|FG001|Overall Study|Lost to Follow-up|57
807851|NCT00089791|1761313|FG001|Overall Study|Noncompliance|13
807852|NCT00089791|1761312|FG000|Overall Study|Other|20
807853|NCT00089791|1761313|FG001|Overall Study|Other|32
807854|NCT00089791|1761312|FG000|Overall Study|Protocol deviation|12
807855|NCT00089791|1761313|FG001|Overall Study|Protocol deviation|10
807856|NCT00089791|1761312|FG000|Overall Study|Requirement for alternative therapy|7
807857|NCT00089791|1761313|FG001|Overall Study|Requirement for alternative therapy|4
807858|NCT00089843|1761323|FG000|Overall Study|Withdrawal by Subject|1
807859|NCT00089843|1761324|FG001|Overall Study|Withdrawal by Subject|4
807860|NCT00089843|1761325|FG002|Overall Study|Withdrawal by Subject|5
807861|NCT00089843|1761326|FG003|Overall Study|Withdrawal by Subject|6
807862|NCT00089843|1761323|FG000|Overall Study|Physician Decision|1
807863|NCT00089843|1761324|FG001|Overall Study|Physician Decision|0
807864|NCT00089843|1761325|FG002|Overall Study|Physician Decision|0
807865|NCT00089843|1761326|FG003|Overall Study|Physician Decision|1
807866|NCT00089895|1761338|FG000|Overall Study|Consent Withdrawn|11
807867|NCT00089895|1761339|FG001|Overall Study|Consent Withdrawn|14
807868|NCT00089895|1761338|FG000|Overall Study|Technical reason|7
807869|NCT00089895|1761339|FG001|Overall Study|Technical reason|2
807870|NCT00089895|1761338|FG000|Overall Study|Surgery|0
807871|NCT00089895|1761339|FG001|Overall Study|Surgery|1
807872|NCT00089895|1761338|FG000|Overall Study|Bleeding|0
807873|NCT00089895|1761339|FG001|Overall Study|Bleeding|2
807874|NCT00089895|1761338|FG000|Overall Study|Physician Decision|3
807875|NCT00089895|1761339|FG001|Overall Study|Physician Decision|7
807876|NCT00089895|1761338|FG000|Overall Study|Exclusion criteria met|6
807877|NCT00089895|1761339|FG001|Overall Study|Exclusion criteria met|6
807878|NCT00089895|1761338|FG000|Overall Study|Not otherwise specified|4
807879|NCT00089895|1761339|FG001|Overall Study|Not otherwise specified|8
807880|NCT00089895|1761338|FG000|Overall Study|Missing|4
807881|NCT00089895|1761339|FG001|Overall Study|Missing|2
807882|NCT00089973|1761345|FG000|Overall Study|Adverse Event|3
807883|NCT00089973|1761345|FG000|Overall Study|Withdrawal by Subject|1
807884|NCT00089973|1761345|FG000|Overall Study|Disease progression|45
807885|NCT00089973|1761345|FG000|Overall Study|Death|1
807886|NCT00089986|1761352|FG000|Overall Study|Adverse Event|6
807887|NCT00089986|1761353|FG001|Overall Study|Adverse Event|9
807888|NCT00089986|1761354|FG002|Overall Study|Adverse Event|6
807889|NCT00089986|1761352|FG000|Overall Study|Lost to Follow-up|3
807890|NCT00089986|1761353|FG001|Overall Study|Lost to Follow-up|1
807891|NCT00089986|1761354|FG002|Overall Study|Lost to Follow-up|1
807892|NCT00089986|1761352|FG000|Overall Study|Protocol Violation|0
807893|NCT00089986|1761353|FG001|Overall Study|Protocol Violation|1
807894|NCT00089986|1761354|FG002|Overall Study|Protocol Violation|0
807895|NCT00089986|1761352|FG000|Overall Study|Patient transferred to another hospital|2
807896|NCT00089986|1761353|FG001|Overall Study|Patient transferred to another hospital|1
807897|NCT00089986|1761354|FG002|Overall Study|Patient transferred to another hospital|0
807898|NCT00089986|1761352|FG000|Overall Study|Subject withdrew but agreed follow up|1
807899|NCT00089986|1761353|FG001|Overall Study|Subject withdrew but agreed follow up|2
807900|NCT00089986|1761354|FG002|Overall Study|Subject withdrew but agreed follow up|0
807901|NCT00089986|1761352|FG000|Overall Study|Hemohlobin stopping rule|0
807902|NCT00089986|1761353|FG001|Overall Study|Hemohlobin stopping rule|1
807903|NCT00089986|1761354|FG002|Overall Study|Hemohlobin stopping rule|0
807904|NCT00089986|1761352|FG000|Overall Study|Investigator decision to withdrew|0
807905|NCT00089986|1761353|FG001|Overall Study|Investigator decision to withdrew|1
807906|NCT00089986|1761354|FG002|Overall Study|Investigator decision to withdrew|0
807907|NCT00089986|1761352|FG000|Overall Study|Enrollment in another study|0
807908|NCT00089986|1761353|FG001|Overall Study|Enrollment in another study|1
807909|NCT00089986|1761354|FG002|Overall Study|Enrollment in another study|0
807910|NCT00089986|1761352|FG000|Overall Study|Family decision|0
807911|NCT00089986|1761353|FG001|Overall Study|Family decision|1
807912|NCT00089986|1761354|FG002|Overall Study|Family decision|0
807913|NCT00089986|1761352|FG000|Overall Study|Do not resuscitate (DNR)|0
807914|NCT00089986|1761353|FG001|Overall Study|Do not resuscitate (DNR)|0
807915|NCT00089986|1761354|FG002|Overall Study|Do not resuscitate (DNR)|1
807916|NCT00089986|1761352|FG000|Overall Study|Withdrawal by Subject|3
807917|NCT00089986|1761353|FG001|Overall Study|Withdrawal by Subject|6
807918|NCT00089986|1761354|FG002|Overall Study|Withdrawal by Subject|2
807919|NCT00089999|1761364|FG000|Overall Study|Adverse Event|4
807920|NCT00089999|1761365|FG001|Overall Study|Adverse Event|7
807921|NCT00089999|1761364|FG000|Overall Study|Withdrawal by Subject|0
807922|NCT00089999|1761365|FG001|Overall Study|Withdrawal by Subject|4
807923|NCT00089999|1761364|FG000|Overall Study|Lost to Follow-up|2
807924|NCT00089999|1761365|FG001|Overall Study|Lost to Follow-up|1
807925|NCT00089999|1761364|FG000|Overall Study|Radiological Progression of Cancer|52
807926|NCT00089999|1761365|FG001|Overall Study|Radiological Progression of Cancer|44
807927|NCT00089999|1761364|FG000|Overall Study|Symptomatic Progression of Cancer|2
807928|NCT00089999|1761365|FG001|Overall Study|Symptomatic Progression of Cancer|5
807929|NCT00089999|1761364|FG000|Overall Study|Death|3
807930|NCT00089999|1761365|FG001|Overall Study|Death|3
807931|NCT00089999|1761364|FG000|Overall Study|Poor General Condition|1
807932|NCT00089999|1761365|FG001|Overall Study|Poor General Condition|0
807933|NCT00089999|1761364|FG000|Overall Study|Clinical Progression|1
807934|NCT00089999|1761365|FG001|Overall Study|Clinical Progression|2
807935|NCT00089999|1761364|FG000|Overall Study|Physician Decision|2
807936|NCT00089999|1761365|FG001|Overall Study|Physician Decision|2
807937|NCT00089999|1761364|FG000|Overall Study|Patient Underwent Surgery|2
807938|NCT00089999|1761365|FG001|Overall Study|Patient Underwent Surgery|0
807939|NCT00089999|1761364|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0
807940|NCT00089999|1761365|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1
807941|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211
807942|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185
807943|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210
807944|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
807945|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
807946|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
807947|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
807948|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
807949|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
807950|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29
807951|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29
807952|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34
807953|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
807954|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
807955|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
807956|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7
807957|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2
807958|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8
807959|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
807960|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
807961|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
807962|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
807963|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
807964|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
807965|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
807966|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
807967|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
807968|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
807969|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
807970|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
807971|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
807972|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
807973|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
807974|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
807975|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
807976|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
807977|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2
807978|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0
807979|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0
807980|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
807981|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
807982|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
807983|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1
807984|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0
807985|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0
807986|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1
807987|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0
807988|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0
807989|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
807990|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
807991|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
807992|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1
807993|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0
807994|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0
807995|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1
807996|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0
807997|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0
807998|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
807999|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
808000|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
808222|NCT00090220|1761419|FG004|Extension 1 (EXT1)|Protocol Violation|0
808001|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0
808002|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1
808003|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0
808004|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
808005|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
808006|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
808007|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
808008|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
808009|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
808010|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
808011|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
808012|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
808013|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0
808014|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1
808015|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0
808016|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
808017|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
808018|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
808019|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
808020|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
808021|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
808022|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0
808023|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1
808024|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3
808025|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0
808026|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0
808027|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2
808028|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
808029|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
808030|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
808031|NCT00090103|1761396|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
808032|NCT00090103|1761397|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
808033|NCT00090103|1761398|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
808034|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Adverse Event|34
808035|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Adverse Event|39
808036|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Adverse Event|44
808037|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185
808038|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212
808039|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229
808040|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101
808041|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97
808042|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111
808043|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Protocol Violation|18
808044|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Protocol Violation|18
808045|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Protocol Violation|17
808046|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
808047|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
808048|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
808049|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
808050|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
808051|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
808052|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Loss of Contact|4
808053|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Loss of Contact|0
808054|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Loss of Contact|2
808055|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
808056|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
808057|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
808058|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Participant relocated|2
808059|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Participant relocated|3
808060|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Participant relocated|1
808061|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
808062|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
808063|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
808064|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2
808065|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3
808066|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5
808067|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1
808068|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0
808069|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1
808070|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
808071|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
808072|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
808073|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Loss of Libido|1
808074|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Loss of Libido|0
808075|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Loss of Libido|0
808076|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Enrollment Error|1
808077|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Enrollment Error|0
808078|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Enrollment Error|2
808079|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
808080|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
808081|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
808082|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Death|1
808083|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Death|0
808084|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Death|1
808085|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Gyneomastia|1
808086|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Gyneomastia|0
808087|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Gyneomastia|0
808088|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
808089|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
808090|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
808091|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
808092|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
808093|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
808094|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0
808095|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1
808096|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0
808097|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Back Pain|0
808098|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Back Pain|1
808099|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Back Pain|0
808100|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0
808101|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2
808102|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4
808103|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
808104|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
808105|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
808106|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Depression|0
808107|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Depression|1
808108|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Depression|0
808109|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
808110|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
808111|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
808112|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Jailed|0
808113|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Jailed|1
808114|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Jailed|0
808115|NCT00090103|1761396|FG000|16-Week Safety Follow-up Period|Other|0
808116|NCT00090103|1761397|FG001|16-Week Safety Follow-up Period|Other|1
808117|NCT00090103|1761398|FG002|16-Week Safety Follow-up Period|Other|0
808118|NCT00090142|1761406|FG000|Treatment Period I|Lost to Follow-up|1
808119|NCT00090142|1761407|FG001|Treatment Period I|Lost to Follow-up|2
808120|NCT00090142|1761406|FG000|Treatment Period I|Protocol Violation|2
808121|NCT00090142|1761407|FG001|Treatment Period I|Protocol Violation|0
808122|NCT00090142|1761406|FG000|Treatment Period I|Withdrawal by Subject|2
808123|NCT00090142|1761407|FG001|Treatment Period I|Withdrawal by Subject|0
808124|NCT00090142|1761406|FG000|Treatment Period I|Other|0
808125|NCT00090142|1761407|FG001|Treatment Period I|Other|1
808126|NCT00090142|1761406|FG000|Treatment Period II|Other|1
808127|NCT00090142|1761407|FG001|Treatment Period II|Other|0
808128|NCT00090220|1761415|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1
808129|NCT00090220|1761416|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1
808130|NCT00090220|1761417|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
808131|NCT00090220|1761418|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
808132|NCT00090220|1761419|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
808133|NCT00090220|1761420|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0
808134|NCT00090220|1761415|FG000|Base Study Vaccination Period|Adverse Event|6
808135|NCT00090220|1761416|FG001|Base Study Vaccination Period|Adverse Event|1
808136|NCT00090220|1761417|FG002|Base Study Vaccination Period|Adverse Event|0
808137|NCT00090220|1761418|FG003|Base Study Vaccination Period|Adverse Event|0
808138|NCT00090220|1761419|FG004|Base Study Vaccination Period|Adverse Event|0
808139|NCT00090220|1761420|FG005|Base Study Vaccination Period|Adverse Event|0
808140|NCT00090220|1761415|FG000|Base Study Vaccination Period|Lost to Follow-up|24
808141|NCT00090220|1761416|FG001|Base Study Vaccination Period|Lost to Follow-up|28
808142|NCT00090220|1761417|FG002|Base Study Vaccination Period|Lost to Follow-up|0
808143|NCT00090220|1761418|FG003|Base Study Vaccination Period|Lost to Follow-up|0
808144|NCT00090220|1761419|FG004|Base Study Vaccination Period|Lost to Follow-up|0
808145|NCT00090220|1761420|FG005|Base Study Vaccination Period|Lost to Follow-up|0
808146|NCT00090220|1761415|FG000|Base Study Vaccination Period|Withdrawal by Subject|23
808147|NCT00090220|1761416|FG001|Base Study Vaccination Period|Withdrawal by Subject|27
808148|NCT00090220|1761417|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
808149|NCT00090220|1761418|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
808150|NCT00090220|1761419|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
808151|NCT00090220|1761420|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
808152|NCT00090220|1761415|FG000|Base Study Vaccination Period|Patient Moved|6
808153|NCT00090220|1761416|FG001|Base Study Vaccination Period|Patient Moved|2
808154|NCT00090220|1761417|FG002|Base Study Vaccination Period|Patient Moved|0
808155|NCT00090220|1761418|FG003|Base Study Vaccination Period|Patient Moved|0
808156|NCT00090220|1761419|FG004|Base Study Vaccination Period|Patient Moved|0
808157|NCT00090220|1761420|FG005|Base Study Vaccination Period|Patient Moved|0
808158|NCT00090220|1761415|FG000|Base Study Vaccination Period|Other|4
808159|NCT00090220|1761416|FG001|Base Study Vaccination Period|Other|4
808160|NCT00090220|1761417|FG002|Base Study Vaccination Period|Other|0
808161|NCT00090220|1761418|FG003|Base Study Vaccination Period|Other|0
808162|NCT00090220|1761419|FG004|Base Study Vaccination Period|Other|0
808163|NCT00090220|1761420|FG005|Base Study Vaccination Period|Other|0
808164|NCT00090220|1761415|FG000|Base Study Follow-up Period|Adverse Event|6
808165|NCT00090220|1761416|FG001|Base Study Follow-up Period|Adverse Event|1
808166|NCT00090220|1761417|FG002|Base Study Follow-up Period|Adverse Event|0
808167|NCT00090220|1761418|FG003|Base Study Follow-up Period|Adverse Event|0
808168|NCT00090220|1761419|FG004|Base Study Follow-up Period|Adverse Event|0
808169|NCT00090220|1761420|FG005|Base Study Follow-up Period|Adverse Event|0
808170|NCT00090220|1761415|FG000|Base Study Follow-up Period|Lost to Follow-up|88
808171|NCT00090220|1761416|FG001|Base Study Follow-up Period|Lost to Follow-up|78
808172|NCT00090220|1761417|FG002|Base Study Follow-up Period|Lost to Follow-up|0
808173|NCT00090220|1761418|FG003|Base Study Follow-up Period|Lost to Follow-up|0
808174|NCT00090220|1761419|FG004|Base Study Follow-up Period|Lost to Follow-up|0
808175|NCT00090220|1761420|FG005|Base Study Follow-up Period|Lost to Follow-up|0
808176|NCT00090220|1761415|FG000|Base Study Follow-up Period|Withdrawal by Subject|27
808177|NCT00090220|1761416|FG001|Base Study Follow-up Period|Withdrawal by Subject|36
808178|NCT00090220|1761417|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
808179|NCT00090220|1761418|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
808180|NCT00090220|1761419|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
808181|NCT00090220|1761420|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
808182|NCT00090220|1761415|FG000|Base Study Follow-up Period|Patient Moved|20
808183|NCT00090220|1761416|FG001|Base Study Follow-up Period|Patient Moved|28
808184|NCT00090220|1761417|FG002|Base Study Follow-up Period|Patient Moved|0
808185|NCT00090220|1761418|FG003|Base Study Follow-up Period|Patient Moved|0
808186|NCT00090220|1761419|FG004|Base Study Follow-up Period|Patient Moved|0
808187|NCT00090220|1761420|FG005|Base Study Follow-up Period|Patient Moved|0
808188|NCT00090220|1761415|FG000|Base Study Follow-up Period|Other|19
808189|NCT00090220|1761416|FG001|Base Study Follow-up Period|Other|21
808190|NCT00090220|1761417|FG002|Base Study Follow-up Period|Other|0
808191|NCT00090220|1761418|FG003|Base Study Follow-up Period|Other|0
808192|NCT00090220|1761419|FG004|Base Study Follow-up Period|Other|0
808193|NCT00090220|1761420|FG005|Base Study Follow-up Period|Other|0
808194|NCT00090220|1761415|FG000|Extension 1 (EXT1)|Adverse Event|0
808195|NCT00090220|1761416|FG001|Extension 1 (EXT1)|Adverse Event|0
808196|NCT00090220|1761417|FG002|Extension 1 (EXT1)|Adverse Event|4
808197|NCT00090220|1761418|FG003|Extension 1 (EXT1)|Adverse Event|0
808198|NCT00090220|1761419|FG004|Extension 1 (EXT1)|Adverse Event|0
808199|NCT00090220|1761420|FG005|Extension 1 (EXT1)|Adverse Event|0
808200|NCT00090220|1761415|FG000|Extension 1 (EXT1)|Lost to Follow-up|0
808201|NCT00090220|1761416|FG001|Extension 1 (EXT1)|Lost to Follow-up|0
808202|NCT00090220|1761417|FG002|Extension 1 (EXT1)|Lost to Follow-up|22
808203|NCT00090220|1761418|FG003|Extension 1 (EXT1)|Lost to Follow-up|0
808204|NCT00090220|1761419|FG004|Extension 1 (EXT1)|Lost to Follow-up|0
808205|NCT00090220|1761420|FG005|Extension 1 (EXT1)|Lost to Follow-up|0
808206|NCT00090220|1761415|FG000|Extension 1 (EXT1)|Moved|0
808207|NCT00090220|1761416|FG001|Extension 1 (EXT1)|Moved|0
808208|NCT00090220|1761417|FG002|Extension 1 (EXT1)|Moved|2
808209|NCT00090220|1761418|FG003|Extension 1 (EXT1)|Moved|1
808210|NCT00090220|1761419|FG004|Extension 1 (EXT1)|Moved|0
808211|NCT00090220|1761420|FG005|Extension 1 (EXT1)|Moved|0
808212|NCT00090220|1761415|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0
808213|NCT00090220|1761416|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0
808214|NCT00090220|1761417|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25
808215|NCT00090220|1761418|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0
808216|NCT00090220|1761419|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0
808217|NCT00090220|1761420|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0
808218|NCT00090220|1761415|FG000|Extension 1 (EXT1)|Protocol Violation|0
808219|NCT00090220|1761416|FG001|Extension 1 (EXT1)|Protocol Violation|0
808220|NCT00090220|1761417|FG002|Extension 1 (EXT1)|Protocol Violation|0
808221|NCT00090220|1761418|FG003|Extension 1 (EXT1)|Protocol Violation|1
808223|NCT00090220|1761420|FG005|Extension 1 (EXT1)|Protocol Violation|0
808224|NCT00090220|1761415|FG000|Extension 1 (EXT1)|Other reason|0
808225|NCT00090220|1761416|FG001|Extension 1 (EXT1)|Other reason|0
808226|NCT00090220|1761417|FG002|Extension 1 (EXT1)|Other reason|2
808227|NCT00090220|1761418|FG003|Extension 1 (EXT1)|Other reason|0
808228|NCT00090220|1761419|FG004|Extension 1 (EXT1)|Other reason|0
808229|NCT00090220|1761420|FG005|Extension 1 (EXT1)|Other reason|0
808230|NCT00090220|1761415|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
808231|NCT00090220|1761416|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
808232|NCT00090220|1761417|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
808233|NCT00090220|1761418|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
808234|NCT00090220|1761419|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38
808235|NCT00090220|1761420|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23
808236|NCT00090220|1761415|FG000|Long-term Follow-up (EXT2)|Death|0
808237|NCT00090220|1761416|FG001|Long-term Follow-up (EXT2)|Death|0
808238|NCT00090220|1761417|FG002|Long-term Follow-up (EXT2)|Death|0
808239|NCT00090220|1761418|FG003|Long-term Follow-up (EXT2)|Death|0
808240|NCT00090220|1761419|FG004|Long-term Follow-up (EXT2)|Death|1
808241|NCT00090220|1761420|FG005|Long-term Follow-up (EXT2)|Death|1
808242|NCT00090220|1761415|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
808243|NCT00090220|1761416|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
808244|NCT00090220|1761417|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
808245|NCT00090220|1761418|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
808246|NCT00090220|1761419|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
808247|NCT00090220|1761420|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
808248|NCT00090220|1761415|FG000|Long-term Follow-up (EXT2)|Other|0
808249|NCT00090220|1761416|FG001|Long-term Follow-up (EXT2)|Other|0
808250|NCT00090220|1761417|FG002|Long-term Follow-up (EXT2)|Other|0
808251|NCT00090220|1761418|FG003|Long-term Follow-up (EXT2)|Other|0
808252|NCT00090220|1761419|FG004|Long-term Follow-up (EXT2)|Other|1
808253|NCT00090220|1761420|FG005|Long-term Follow-up (EXT2)|Other|0
808254|NCT00090233|1761439|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609
808255|NCT00090233|1761440|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627
808256|NCT00090233|1761439|FG000|Overall Study|Adverse Event|214
808257|NCT00090233|1761440|FG001|Overall Study|Adverse Event|198
808258|NCT00090233|1761439|FG000|Overall Study|Lost to Follow-up|68
808259|NCT00090233|1761440|FG001|Overall Study|Lost to Follow-up|95
808260|NCT00090233|1761439|FG000|Overall Study|Protocol Violation|960
808261|NCT00090233|1761440|FG001|Overall Study|Protocol Violation|1022
808262|NCT00090233|1761439|FG000|Overall Study|Withdrawal by Subject|182
808263|NCT00090233|1761440|FG001|Overall Study|Withdrawal by Subject|211
808264|NCT00090233|1761439|FG000|Overall Study|Moved|203
808265|NCT00090233|1761440|FG001|Overall Study|Moved|189
808266|NCT00090233|1761439|FG000|Overall Study|Other|1211
808267|NCT00090233|1761440|FG001|Overall Study|Other|1160
808268|NCT00090233|1761439|FG000|Overall Study|Data not available at data cut-off point|1552
808269|NCT00090233|1761440|FG001|Overall Study|Data not available at data cut-off point|1563
808270|NCT00090259|1761452|FG000|Overall Study|Lost to Follow-up|30
808271|NCT00090259|1761453|FG001|Overall Study|Lost to Follow-up|26
808272|NCT00090259|1761452|FG000|Overall Study|Withdrawal by Subject|21
808273|NCT00090259|1761453|FG001|Overall Study|Withdrawal by Subject|15
808274|NCT00090259|1761452|FG000|Overall Study|Investigator site closed|11
808275|NCT00090259|1761453|FG001|Overall Study|Investigator site closed|7
808276|NCT00090285|1761461|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7
808277|NCT00090285|1761462|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3
808278|NCT00090285|1761463|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
808279|NCT00090285|1761464|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0
808280|NCT00090285|1761465|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
808281|NCT00090285|1761466|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0
808282|NCT00090285|1761461|FG000|Base Study Vaccination Period|Adverse Event|2
808283|NCT00090285|1761462|FG001|Base Study Vaccination Period|Adverse Event|4
808284|NCT00090285|1761463|FG002|Base Study Vaccination Period|Adverse Event|0
808285|NCT00090285|1761464|FG003|Base Study Vaccination Period|Adverse Event|0
808286|NCT00090285|1761465|FG004|Base Study Vaccination Period|Adverse Event|0
808287|NCT00090285|1761466|FG005|Base Study Vaccination Period|Adverse Event|0
808288|NCT00090285|1761461|FG000|Base Study Vaccination Period|Lost to Follow-up|111
808289|NCT00090285|1761462|FG001|Base Study Vaccination Period|Lost to Follow-up|112
808290|NCT00090285|1761463|FG002|Base Study Vaccination Period|Lost to Follow-up|0
808291|NCT00090285|1761464|FG003|Base Study Vaccination Period|Lost to Follow-up|0
808292|NCT00090285|1761465|FG004|Base Study Vaccination Period|Lost to Follow-up|0
808293|NCT00090285|1761466|FG005|Base Study Vaccination Period|Lost to Follow-up|0
808294|NCT00090285|1761461|FG000|Base Study Vaccination Period|Protocol Violation|2
808295|NCT00090285|1761462|FG001|Base Study Vaccination Period|Protocol Violation|3
808296|NCT00090285|1761463|FG002|Base Study Vaccination Period|Protocol Violation|0
808297|NCT00090285|1761464|FG003|Base Study Vaccination Period|Protocol Violation|0
808298|NCT00090285|1761465|FG004|Base Study Vaccination Period|Protocol Violation|0
808299|NCT00090285|1761466|FG005|Base Study Vaccination Period|Protocol Violation|0
808300|NCT00090285|1761461|FG000|Base Study Vaccination Period|Withdrawal by Subject|64
808301|NCT00090285|1761462|FG001|Base Study Vaccination Period|Withdrawal by Subject|69
808302|NCT00090285|1761463|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
808303|NCT00090285|1761464|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
808304|NCT00090285|1761465|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
808305|NCT00090285|1761466|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
808306|NCT00090285|1761461|FG000|Base Study Vaccination Period|Uncooperative|2
808307|NCT00090285|1761462|FG001|Base Study Vaccination Period|Uncooperative|2
808308|NCT00090285|1761463|FG002|Base Study Vaccination Period|Uncooperative|0
808309|NCT00090285|1761464|FG003|Base Study Vaccination Period|Uncooperative|0
808310|NCT00090285|1761465|FG004|Base Study Vaccination Period|Uncooperative|0
808311|NCT00090285|1761466|FG005|Base Study Vaccination Period|Uncooperative|0
808312|NCT00090285|1761461|FG000|Base Study Vaccination Period|Moved|20
808313|NCT00090285|1761462|FG001|Base Study Vaccination Period|Moved|21
808314|NCT00090285|1761463|FG002|Base Study Vaccination Period|Moved|0
808315|NCT00090285|1761464|FG003|Base Study Vaccination Period|Moved|0
808316|NCT00090285|1761465|FG004|Base Study Vaccination Period|Moved|0
808317|NCT00090285|1761466|FG005|Base Study Vaccination Period|Moved|0
808318|NCT00090285|1761461|FG000|Base Study Vaccination Period|Site Terminated|1
808319|NCT00090285|1761462|FG001|Base Study Vaccination Period|Site Terminated|0
808320|NCT00090285|1761463|FG002|Base Study Vaccination Period|Site Terminated|0
808321|NCT00090285|1761464|FG003|Base Study Vaccination Period|Site Terminated|0
808322|NCT00090285|1761465|FG004|Base Study Vaccination Period|Site Terminated|0
808323|NCT00090285|1761466|FG005|Base Study Vaccination Period|Site Terminated|0
808324|NCT00090285|1761461|FG000|Base Study Vaccination Period|Other|2
808325|NCT00090285|1761462|FG001|Base Study Vaccination Period|Other|2
808326|NCT00090285|1761463|FG002|Base Study Vaccination Period|Other|0
808327|NCT00090285|1761464|FG003|Base Study Vaccination Period|Other|0
808328|NCT00090285|1761465|FG004|Base Study Vaccination Period|Other|0
808329|NCT00090285|1761466|FG005|Base Study Vaccination Period|Other|0
808330|NCT00090285|1761461|FG000|Base Study Vaccination Period|Subject Incarcerated|2
808331|NCT00090285|1761462|FG001|Base Study Vaccination Period|Subject Incarcerated|2
808332|NCT00090285|1761463|FG002|Base Study Vaccination Period|Subject Incarcerated|0
808333|NCT00090285|1761464|FG003|Base Study Vaccination Period|Subject Incarcerated|0
808334|NCT00090285|1761465|FG004|Base Study Vaccination Period|Subject Incarcerated|0
808335|NCT00090285|1761466|FG005|Base Study Vaccination Period|Subject Incarcerated|0
808336|NCT00090285|1761461|FG000|Base Study Vaccination Period|HIV positive|1
808337|NCT00090285|1761462|FG001|Base Study Vaccination Period|HIV positive|1
808338|NCT00090285|1761463|FG002|Base Study Vaccination Period|HIV positive|0
808339|NCT00090285|1761464|FG003|Base Study Vaccination Period|HIV positive|0
808340|NCT00090285|1761465|FG004|Base Study Vaccination Period|HIV positive|0
808341|NCT00090285|1761466|FG005|Base Study Vaccination Period|HIV positive|0
808342|NCT00090285|1761461|FG000|Base Study Follow-up Period|Adverse Event|3
808343|NCT00090285|1761462|FG001|Base Study Follow-up Period|Adverse Event|10
808344|NCT00090285|1761463|FG002|Base Study Follow-up Period|Adverse Event|0
808345|NCT00090285|1761464|FG003|Base Study Follow-up Period|Adverse Event|0
808346|NCT00090285|1761465|FG004|Base Study Follow-up Period|Adverse Event|0
808347|NCT00090285|1761466|FG005|Base Study Follow-up Period|Adverse Event|0
808348|NCT00090285|1761461|FG000|Base Study Follow-up Period|Lost to Follow-up|232
808349|NCT00090285|1761462|FG001|Base Study Follow-up Period|Lost to Follow-up|226
808350|NCT00090285|1761463|FG002|Base Study Follow-up Period|Lost to Follow-up|0
808351|NCT00090285|1761464|FG003|Base Study Follow-up Period|Lost to Follow-up|0
808352|NCT00090285|1761465|FG004|Base Study Follow-up Period|Lost to Follow-up|0
808353|NCT00090285|1761466|FG005|Base Study Follow-up Period|Lost to Follow-up|0
808354|NCT00090285|1761461|FG000|Base Study Follow-up Period|Withdrawal by Subject|53
808355|NCT00090285|1761462|FG001|Base Study Follow-up Period|Withdrawal by Subject|64
808356|NCT00090285|1761463|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
808357|NCT00090285|1761464|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
808358|NCT00090285|1761465|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
808359|NCT00090285|1761466|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
808360|NCT00090285|1761461|FG000|Base Study Follow-up Period|Moved|41
808361|NCT00090285|1761462|FG001|Base Study Follow-up Period|Moved|36
808362|NCT00090285|1761463|FG002|Base Study Follow-up Period|Moved|0
808363|NCT00090285|1761464|FG003|Base Study Follow-up Period|Moved|0
808364|NCT00090285|1761465|FG004|Base Study Follow-up Period|Moved|0
808365|NCT00090285|1761466|FG005|Base Study Follow-up Period|Moved|0
808366|NCT00090285|1761461|FG000|Base Study Follow-up Period|Other|2
808367|NCT00090285|1761462|FG001|Base Study Follow-up Period|Other|0
808368|NCT00090285|1761463|FG002|Base Study Follow-up Period|Other|0
808369|NCT00090285|1761464|FG003|Base Study Follow-up Period|Other|0
808370|NCT00090285|1761465|FG004|Base Study Follow-up Period|Other|0
808371|NCT00090285|1761466|FG005|Base Study Follow-up Period|Other|0
808372|NCT00090285|1761461|FG000|Base Study Follow-up Period|Protocol Violation|1
808373|NCT00090285|1761462|FG001|Base Study Follow-up Period|Protocol Violation|0
808374|NCT00090285|1761463|FG002|Base Study Follow-up Period|Protocol Violation|0
808375|NCT00090285|1761464|FG003|Base Study Follow-up Period|Protocol Violation|0
808376|NCT00090285|1761465|FG004|Base Study Follow-up Period|Protocol Violation|0
808377|NCT00090285|1761466|FG005|Base Study Follow-up Period|Protocol Violation|0
808378|NCT00090285|1761461|FG000|Base Study Follow-up Period|Uncooperative|3
808379|NCT00090285|1761462|FG001|Base Study Follow-up Period|Uncooperative|4
808380|NCT00090285|1761463|FG002|Base Study Follow-up Period|Uncooperative|0
808381|NCT00090285|1761464|FG003|Base Study Follow-up Period|Uncooperative|0
808382|NCT00090285|1761465|FG004|Base Study Follow-up Period|Uncooperative|0
808383|NCT00090285|1761466|FG005|Base Study Follow-up Period|Uncooperative|0
808384|NCT00090285|1761461|FG000|Base Study Follow-up Period|Subject Incarcerated|0
808385|NCT00090285|1761462|FG001|Base Study Follow-up Period|Subject Incarcerated|2
808386|NCT00090285|1761463|FG002|Base Study Follow-up Period|Subject Incarcerated|0
808387|NCT00090285|1761464|FG003|Base Study Follow-up Period|Subject Incarcerated|0
808388|NCT00090285|1761465|FG004|Base Study Follow-up Period|Subject Incarcerated|0
808389|NCT00090285|1761466|FG005|Base Study Follow-up Period|Subject Incarcerated|0
808390|NCT00090285|1761461|FG000|Extension 1|Adverse Event|0
808391|NCT00090285|1761462|FG001|Extension 1|Adverse Event|0
808392|NCT00090285|1761463|FG002|Extension 1|Adverse Event|2
808393|NCT00090285|1761464|FG003|Extension 1|Adverse Event|0
808394|NCT00090285|1761465|FG004|Extension 1|Adverse Event|0
808395|NCT00090285|1761466|FG005|Extension 1|Adverse Event|0
808396|NCT00090285|1761461|FG000|Extension 1|Lost to Follow-up|0
808397|NCT00090285|1761462|FG001|Extension 1|Lost to Follow-up|0
808398|NCT00090285|1761463|FG002|Extension 1|Lost to Follow-up|35
808399|NCT00090285|1761464|FG003|Extension 1|Lost to Follow-up|0
808400|NCT00090285|1761465|FG004|Extension 1|Lost to Follow-up|0
808401|NCT00090285|1761466|FG005|Extension 1|Lost to Follow-up|0
808402|NCT00090285|1761461|FG000|Extension 1|Withdrawal by Subject|0
808403|NCT00090285|1761462|FG001|Extension 1|Withdrawal by Subject|0
808404|NCT00090285|1761463|FG002|Extension 1|Withdrawal by Subject|13
808405|NCT00090285|1761464|FG003|Extension 1|Withdrawal by Subject|1
808406|NCT00090285|1761465|FG004|Extension 1|Withdrawal by Subject|0
808407|NCT00090285|1761466|FG005|Extension 1|Withdrawal by Subject|0
808408|NCT00090285|1761461|FG000|Extension 1|Other|0
808409|NCT00090285|1761462|FG001|Extension 1|Other|0
808410|NCT00090285|1761463|FG002|Extension 1|Other|4
808411|NCT00090285|1761464|FG003|Extension 1|Other|0
808412|NCT00090285|1761465|FG004|Extension 1|Other|0
808413|NCT00090285|1761466|FG005|Extension 1|Other|0
808414|NCT00090285|1761461|FG000|Extension 1|Moved|0
808415|NCT00090285|1761462|FG001|Extension 1|Moved|0
808416|NCT00090285|1761463|FG002|Extension 1|Moved|3
808417|NCT00090285|1761464|FG003|Extension 1|Moved|0
808418|NCT00090285|1761465|FG004|Extension 1|Moved|0
808419|NCT00090285|1761466|FG005|Extension 1|Moved|0
808420|NCT00090285|1761461|FG000|Long-term Follow-up (EXT2)|Adverse Event|0
808421|NCT00090285|1761462|FG001|Long-term Follow-up (EXT2)|Adverse Event|0
808422|NCT00090285|1761463|FG002|Long-term Follow-up (EXT2)|Adverse Event|0
808423|NCT00090285|1761464|FG003|Long-term Follow-up (EXT2)|Adverse Event|0
808424|NCT00090285|1761465|FG004|Long-term Follow-up (EXT2)|Adverse Event|5
808425|NCT00090285|1761466|FG005|Long-term Follow-up (EXT2)|Adverse Event|2
808426|NCT00090285|1761461|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
808427|NCT00090285|1761462|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
808428|NCT00090285|1761463|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
808429|NCT00090285|1761464|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
808430|NCT00090285|1761465|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156
808431|NCT00090285|1761466|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143
808432|NCT00090285|1761461|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
808433|NCT00090285|1761462|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
808434|NCT00090285|1761463|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
808435|NCT00090285|1761464|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
808436|NCT00090285|1761465|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
808437|NCT00090285|1761466|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
808438|NCT00090285|1761461|FG000|Long-term Follow-up (EXT2)|Physician Decision|0
808439|NCT00090285|1761462|FG001|Long-term Follow-up (EXT2)|Physician Decision|0
808440|NCT00090285|1761463|FG002|Long-term Follow-up (EXT2)|Physician Decision|0
808441|NCT00090285|1761464|FG003|Long-term Follow-up (EXT2)|Physician Decision|0
808442|NCT00090285|1761465|FG004|Long-term Follow-up (EXT2)|Physician Decision|6
808443|NCT00090285|1761466|FG005|Long-term Follow-up (EXT2)|Physician Decision|5
808444|NCT00090363|1761484|FG000|Overall Study|Lost to Follow-up|1
808445|NCT00090363|1761485|FG001|Overall Study|Lost to Follow-up|2
808446|NCT00090363|1761486|FG002|Overall Study|Lost to Follow-up|1
808447|NCT00090363|1761484|FG000|Overall Study|Withdrawal by Subject|7
808448|NCT00090363|1761485|FG001|Overall Study|Withdrawal by Subject|7
808449|NCT00090363|1761486|FG002|Overall Study|Withdrawal by Subject|6
808450|NCT00090363|1761484|FG000|Overall Study|Study-specific discontinuation criteria|75
808451|NCT00090363|1761485|FG001|Overall Study|Study-specific discontinuation criteria|74
808452|NCT00090363|1761486|FG002|Overall Study|Study-specific discontinuation criteria|62
808453|NCT00090363|1761484|FG000|Overall Study|Eligibility criteria not fulfilled|0
808454|NCT00090363|1761485|FG001|Overall Study|Eligibility criteria not fulfilled|0
808455|NCT00090363|1761486|FG002|Overall Study|Eligibility criteria not fulfilled|1
808456|NCT00090363|1761484|FG000|Overall Study|Consent expired|7
808457|NCT00090363|1761485|FG001|Overall Study|Consent expired|10
808458|NCT00090363|1761486|FG002|Overall Study|Consent expired|9
808459|NCT00090363|1761484|FG000|Overall Study|Reasons not specified|2
808460|NCT00090363|1761485|FG001|Overall Study|Reasons not specified|1
808461|NCT00090363|1761486|FG002|Overall Study|Reasons not specified|1
808462|NCT00090363|1761484|FG000|Overall Study|Continuing on study off treatment|14
808463|NCT00090363|1761485|FG001|Overall Study|Continuing on study off treatment|13
808464|NCT00090363|1761486|FG002|Overall Study|Continuing on study off treatment|16
808465|NCT00090402|1761497|FG000|Overall Study|Death|1
808466|NCT00090402|1761498|FG001|Overall Study|Death|1
808467|NCT00090402|1761499|FG002|Overall Study|Death|0
808468|NCT00090402|1761497|FG000|Overall Study|subject moved|0
808469|NCT00090402|1761498|FG001|Overall Study|subject moved|1
808470|NCT00090402|1761499|FG002|Overall Study|subject moved|0
808471|NCT00090402|1761497|FG000|Overall Study|stopped taking study medication|1
808472|NCT00090402|1761498|FG001|Overall Study|stopped taking study medication|0
808473|NCT00090402|1761499|FG002|Overall Study|stopped taking study medication|1
808474|NCT00090493|1761510|FG000|Overall Study|Physician Decision|2
808475|NCT00090519|1761516|FG000|Overall Study|Adverse Event|5
808476|NCT00090519|1761517|FG001|Overall Study|Adverse Event|4
808477|NCT00090519|1761516|FG000|Overall Study|Death|9
808478|NCT00090519|1761517|FG001|Overall Study|Death|9
808479|NCT00090519|1761516|FG000|Overall Study|Lost to Follow-up|26
808480|NCT00090519|1761517|FG001|Overall Study|Lost to Follow-up|29
808481|NCT00090519|1761516|FG000|Overall Study|Withdrawal by Subject|28
808482|NCT00090519|1761517|FG001|Overall Study|Withdrawal by Subject|29
808483|NCT00090519|1761516|FG000|Overall Study|Physician Decision|2
808484|NCT00090519|1761517|FG001|Overall Study|Physician Decision|3
808485|NCT00090519|1761516|FG000|Overall Study|Sponsor Decision|3
808486|NCT00090519|1761517|FG001|Overall Study|Sponsor Decision|1
808487|NCT00090545|1761525|FG000|Overall Study|Disease progression on study|21
808488|NCT00090545|1761526|FG001|Overall Study|Disease progression on study|17
808489|NCT00090545|1761525|FG000|Overall Study|Refused further treatment|1
808490|NCT00090545|1761526|FG001|Overall Study|Refused further treatment|4
808491|NCT00090545|1761525|FG000|Overall Study|Death|0
808492|NCT00090545|1761526|FG001|Overall Study|Death|1
808493|NCT00090545|1761525|FG000|Overall Study|Adverse Event|0
808494|NCT00090545|1761526|FG001|Overall Study|Adverse Event|2
808495|NCT00090584|1761536|FG000|Baseline to 10 Weeks|Lost to Follow-up|15
808496|NCT00090584|1761537|FG001|Baseline to 10 Weeks|Lost to Follow-up|12
808497|NCT00090584|1761536|FG000|Baseline to 8 Months|Lost to Follow-up|44
808498|NCT00090584|1761537|FG001|Baseline to 8 Months|Lost to Follow-up|41
808499|NCT00090610|1761553|FG000|Overall Study|Withdrawal by Subject|1
808500|NCT00090610|1761554|FG001|Overall Study|Withdrawal by Subject|1
808501|NCT00090753|1761562|FG000|First Treatment Period|Adverse Event|20
808502|NCT00090753|1761563|FG001|First Treatment Period|Adverse Event|8
808503|NCT00090753|1761562|FG000|First Treatment Period|Death|88
808504|NCT00090753|1761563|FG001|First Treatment Period|Death|62
808505|NCT00090753|1761562|FG000|First Treatment Period|Lack of Efficacy|2
808506|NCT00090753|1761563|FG001|First Treatment Period|Lack of Efficacy|1
808507|NCT00090753|1761562|FG000|First Treatment Period|Refused Treatment|32
808508|NCT00090753|1761563|FG001|First Treatment Period|Refused Treatment|25
808509|NCT00090753|1761562|FG000|First Treatment Period|Lost to Follow-up|4
808510|NCT00090753|1761563|FG001|First Treatment Period|Lost to Follow-up|4
808511|NCT00090753|1761562|FG000|First Treatment Period|Renal Transplant|70
808512|NCT00090753|1761563|FG001|First Treatment Period|Renal Transplant|50
808513|NCT00090753|1761562|FG000|First Treatment Period|Mircera Commercialization|1
808514|NCT00090753|1761563|FG001|First Treatment Period|Mircera Commercialization|0
808515|NCT00090753|1761562|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39
808516|NCT00090753|1761563|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28
808517|NCT00090753|1761562|FG000|Extended Treatment Period|Adverse Event|11
808518|NCT00090753|1761563|FG001|Extended Treatment Period|Adverse Event|0
808519|NCT00090753|1761562|FG000|Extended Treatment Period|Death|58
808520|NCT00090753|1761563|FG001|Extended Treatment Period|Death|30
808521|NCT00090753|1761562|FG000|Extended Treatment Period|Lack of Efficacy|1
808522|NCT00090753|1761563|FG001|Extended Treatment Period|Lack of Efficacy|0
808523|NCT00090753|1761562|FG000|Extended Treatment Period|Refused Treatment|18
808524|NCT00090753|1761563|FG001|Extended Treatment Period|Refused Treatment|12
808525|NCT00090753|1761562|FG000|Extended Treatment Period|Lost to Follow-up|3
808526|NCT00090753|1761563|FG001|Extended Treatment Period|Lost to Follow-up|1
808527|NCT00090753|1761562|FG000|Extended Treatment Period|Renal Transplant|15
808528|NCT00090753|1761563|FG001|Extended Treatment Period|Renal Transplant|12
808529|NCT00090753|1761562|FG000|Extended Treatment Period|Mircera Commercialization|188
808530|NCT00090753|1761563|FG001|Extended Treatment Period|Mircera Commercialization|93
808531|NCT00090753|1761562|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
808532|NCT00090753|1761563|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
808533|NCT00090766|1761572|FG000|Overall Study|Nephrectomy Planned|0
808534|NCT00090766|1761573|FG001|Overall Study|Nephrectomy Planned|0
808535|NCT00090766|1761574|FG002|Overall Study|Nephrectomy Planned|1
808536|NCT00090766|1761572|FG000|Overall Study|Death|1
808537|NCT00090766|1761573|FG001|Overall Study|Death|0
808538|NCT00090766|1761574|FG002|Overall Study|Death|0
808539|NCT00090766|1761572|FG000|Overall Study|Admin|0
808540|NCT00090766|1761573|FG001|Overall Study|Admin|2
808541|NCT00090766|1761574|FG002|Overall Study|Admin|0
808542|NCT00090766|1761572|FG000|Overall Study|Lost to Follow-up|2
808543|NCT00090766|1761573|FG001|Overall Study|Lost to Follow-up|0
808544|NCT00090766|1761574|FG002|Overall Study|Lost to Follow-up|2
808545|NCT00090779|1761586|FG000|Step 1|Withdrawal by Subject|4
808546|NCT00090779|1761587|FG001|Step 1|Withdrawal by Subject|2
808547|NCT00090779|1761586|FG000|Step 1|Lost to Follow-up|3
808548|NCT00090779|1761587|FG001|Step 1|Lost to Follow-up|2
808549|NCT00090779|1761586|FG000|Step 1|Death|0
808550|NCT00090779|1761587|FG001|Step 1|Death|2
808551|NCT00090779|1761586|FG000|Step 1|Physician Decision|1
808552|NCT00090779|1761587|FG001|Step 1|Physician Decision|0
808553|NCT00090779|1761586|FG000|Step 1|Pregnancy|1
808554|NCT00090779|1761587|FG001|Step 1|Pregnancy|0
808555|NCT00090779|1761586|FG000|Step 1|Non-compliance to study requirements|0
808556|NCT00090779|1761587|FG001|Step 1|Non-compliance to study requirements|1
808557|NCT00090779|1761586|FG000|Step 1|Subject relocated|2
808558|NCT00090779|1761587|FG001|Step 1|Subject relocated|8
808559|NCT00090779|1761586|FG000|Step 2|Off study per study closure|6
808560|NCT00090779|1761587|FG001|Step 2|Off study per study closure|16
808561|NCT00090779|1761586|FG000|Step 2|Subject relocated|0
808562|NCT00090779|1761587|FG001|Step 2|Subject relocated|1
808563|NCT00090779|1761586|FG000|Step 2|Non-compliance to study requirements|0
808564|NCT00090779|1761587|FG001|Step 2|Non-compliance to study requirements|1
808565|NCT00090779|1761586|FG000|Step 3|Initiation of ART and off extended study|3
808566|NCT00090779|1761587|FG001|Step 3|Initiation of ART and off extended study|2
808567|NCT00090779|1761586|FG000|Step 3|Off extended study due to study closure|4
808568|NCT00090779|1761587|FG001|Step 3|Off extended study due to study closure|3
808569|NCT00090857|1761605|FG000|Overall Study|Lost to Follow-up|0
808570|NCT00090857|1761606|FG001|Overall Study|Lost to Follow-up|1
808571|NCT00090857|1761605|FG000|Overall Study|Withdrawal by Subject|2
808572|NCT00090857|1761606|FG001|Overall Study|Withdrawal by Subject|0
808573|NCT00090857|1761605|FG000|Overall Study|Adverse Event|2
808574|NCT00090857|1761606|FG001|Overall Study|Adverse Event|2
808575|NCT00090987|1761612|FG000|Overall Study|Adverse Event|5
808576|NCT00090987|1761612|FG000|Overall Study|Lack of Efficacy|7
808577|NCT00090987|1761612|FG000|Overall Study|Withdrawal by Subject|3
808578|NCT00090987|1761612|FG000|Overall Study|alternative therapy|1
808579|NCT00090987|1761612|FG000|Overall Study|Non-compliance|4
808580|NCT00090987|1761612|FG000|Overall Study|Incarcerated|1
808581|NCT00091026|1761618|FG000|Overall Study|Patient deemed non eligible-never receiv|1
808582|NCT00091026|1761619|FG001|Overall Study|Patient deemed non eligible-never receiv|0
808583|NCT00091026|1761618|FG000|Overall Study|Patient withdrew and never received trea|0
808584|NCT00091026|1761619|FG001|Overall Study|Patient withdrew and never received trea|2
808585|NCT00091026|1761618|FG000|Overall Study|Unknown-never received treatment|0
808586|NCT00091026|1761619|FG001|Overall Study|Unknown-never received treatment|1
808587|NCT00091169|1761627|FG000|Overall Study|Disease progression|3
808588|NCT00091169|1761628|FG001|Overall Study|Disease progression|1
808589|NCT00091169|1761627|FG000|Overall Study|Adverse Event|11
808590|NCT00091169|1761628|FG001|Overall Study|Adverse Event|17
808591|NCT00091169|1761627|FG000|Overall Study|Death|4
808592|NCT00091169|1761628|FG001|Overall Study|Death|1
808593|NCT00091169|1761627|FG000|Overall Study|Withdrawal by Subject|10
808594|NCT00091169|1761628|FG001|Overall Study|Withdrawal by Subject|13
808595|NCT00091169|1761627|FG000|Overall Study|Other|3
808596|NCT00091169|1761628|FG001|Overall Study|Other|4
808597|NCT00091169|1761627|FG000|Overall Study|Not start protocol therapy|26
808598|NCT00091169|1761628|FG001|Overall Study|Not start protocol therapy|17
808599|NCT00091390|1761645|FG000|Overall Study|Protocol Violation|1
808600|NCT00091390|1761645|FG000|Overall Study|No protocol treatment|3
808601|NCT00091442|1761651|FG000|Overall Study|Progressive Disease|220
808602|NCT00091442|1761652|FG001|Overall Study|Progressive Disease|189
808603|NCT00091442|1761651|FG000|Overall Study|Physician Decision|61
808604|NCT00091442|1761652|FG001|Overall Study|Physician Decision|58
808605|NCT00091442|1761651|FG000|Overall Study|Withdrawal by Subject|38
808606|NCT00091442|1761652|FG001|Overall Study|Withdrawal by Subject|46
808607|NCT00091442|1761651|FG000|Overall Study|Adverse Event|29
808608|NCT00091442|1761652|FG001|Overall Study|Adverse Event|48
808609|NCT00091442|1761651|FG000|Overall Study|2cycles therapy beyond Complete response|9
808610|NCT00091442|1761652|FG001|Overall Study|2cycles therapy beyond Complete response|16
808611|NCT00091442|1761651|FG000|Overall Study|Death|9
808612|NCT00091442|1761652|FG001|Overall Study|Death|7
808613|NCT00091442|1761651|FG000|Overall Study|Lost to Follow-up|1
808614|NCT00091442|1761652|FG001|Overall Study|Lost to Follow-up|3
808615|NCT00091442|1761651|FG000|Overall Study|Other|2
808616|NCT00091442|1761652|FG001|Overall Study|Other|6
808617|NCT00091572|1761669|FG000|Overall Study|Lost to Follow-up|1
808618|NCT00091572|1761670|FG001|Overall Study|Lost to Follow-up|1
808619|NCT00091572|1761669|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14
808620|NCT00091572|1761670|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22
808621|NCT00091572|1761669|FG000|Overall Study|Death not due to malignancy/toxicity|1
808622|NCT00091572|1761670|FG001|Overall Study|Death not due to malignancy/toxicity|3
808623|NCT00091572|1761669|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10
808624|NCT00091572|1761670|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22
808625|NCT00091572|1761669|FG000|Overall Study|Other Reason|6
808626|NCT00091572|1761670|FG001|Overall Study|Other Reason|13
808627|NCT00091572|1761669|FG000|Overall Study|Ongoing (still on treatment)|8
808628|NCT00091572|1761670|FG001|Overall Study|Ongoing (still on treatment)|12
808629|NCT00091572|1761669|FG000|Overall Study|Major Protocol Violation|2
808630|NCT00091572|1761670|FG001|Overall Study|Major Protocol Violation|0
808631|NCT00091572|1761669|FG000|Overall Study|Toxicity (Related AE)|53
808632|NCT00091572|1761670|FG001|Overall Study|Toxicity (Related AE)|9
808633|NCT00091793|1761678|FG000|Overall Study|Adverse Event|1
808634|NCT00091793|1761679|FG001|Overall Study|Adverse Event|2
808635|NCT00091793|1761678|FG000|Overall Study|Withdrawal by Subject|10
808636|NCT00091793|1761679|FG001|Overall Study|Withdrawal by Subject|15
808637|NCT00091793|1761678|FG000|Overall Study|Ineligibility determined|2
808638|NCT00091793|1761679|FG001|Overall Study|Ineligibility determined|0
808639|NCT00091793|1761678|FG000|Overall Study|Lost to Follow-up|7
808640|NCT00091793|1761679|FG001|Overall Study|Lost to Follow-up|5
808641|NCT00091793|1761678|FG000|Overall Study|Noncompliance|2
808642|NCT00091793|1761679|FG001|Overall Study|Noncompliance|0
808643|NCT00091793|1761678|FG000|Overall Study|Other|2
808644|NCT00091793|1761679|FG001|Overall Study|Other|0
808645|NCT00091819|1761687|FG000|Overall Study|Adverse Event|1
808646|NCT00091819|1761688|FG001|Overall Study|Adverse Event|1
808647|NCT00091819|1761687|FG000|Overall Study|Death|4
808648|NCT00091819|1761688|FG001|Overall Study|Death|5
808649|NCT00091819|1761687|FG000|Overall Study|Lost to Follow-up|26
808650|NCT00091819|1761688|FG001|Overall Study|Lost to Follow-up|23
808651|NCT00091819|1761687|FG000|Overall Study|Withdrawal by Subject|5
808652|NCT00091819|1761688|FG001|Overall Study|Withdrawal by Subject|8
808653|NCT00091819|1761687|FG000|Overall Study|Protocol Violation|1
808654|NCT00091819|1761688|FG001|Overall Study|Protocol Violation|2
808655|NCT00091819|1761687|FG000|Overall Study|Other|2
808656|NCT00091819|1761688|FG001|Overall Study|Other|3
808657|NCT00091819|1761687|FG000|Overall Study|Never received study treatment|3
808658|NCT00091819|1761688|FG001|Overall Study|Never received study treatment|4
808659|NCT00091832|1761700|FG000|Overall Study|Physician Decision|1
808660|NCT00091832|1761701|FG001|Overall Study|Physician Decision|0
808661|NCT00091832|1761702|FG002|Overall Study|Physician Decision|0
808662|NCT00091832|1761703|FG003|Overall Study|Physician Decision|0
808663|NCT00091832|1761704|FG004|Overall Study|Physician Decision|0
808664|NCT00091832|1761705|FG005|Overall Study|Physician Decision|0
808665|NCT00091832|1761700|FG000|Overall Study|Adverse Event|0
808666|NCT00091832|1761701|FG001|Overall Study|Adverse Event|0
808667|NCT00091832|1761702|FG002|Overall Study|Adverse Event|0
808668|NCT00091832|1761703|FG003|Overall Study|Adverse Event|1
808669|NCT00091832|1761704|FG004|Overall Study|Adverse Event|3
808670|NCT00091832|1761705|FG005|Overall Study|Adverse Event|0
808671|NCT00091832|1761700|FG000|Overall Study|Withdrawal by Subject|4
808672|NCT00091832|1761701|FG001|Overall Study|Withdrawal by Subject|5
808673|NCT00091832|1761702|FG002|Overall Study|Withdrawal by Subject|0
808674|NCT00091832|1761703|FG003|Overall Study|Withdrawal by Subject|1
808675|NCT00091832|1761704|FG004|Overall Study|Withdrawal by Subject|3
808676|NCT00091832|1761705|FG005|Overall Study|Withdrawal by Subject|1
808677|NCT00091832|1761700|FG000|Overall Study|Death|6
808678|NCT00091832|1761701|FG001|Overall Study|Death|4
808679|NCT00091832|1761702|FG002|Overall Study|Death|5
808680|NCT00091832|1761703|FG003|Overall Study|Death|8
808681|NCT00091832|1761704|FG004|Overall Study|Death|5
808682|NCT00091832|1761705|FG005|Overall Study|Death|6
808683|NCT00091832|1761700|FG000|Overall Study|Disease Progression|2
808684|NCT00091832|1761701|FG001|Overall Study|Disease Progression|0
808685|NCT00091832|1761702|FG002|Overall Study|Disease Progression|0
808686|NCT00091832|1761703|FG003|Overall Study|Disease Progression|1
808687|NCT00091832|1761704|FG004|Overall Study|Disease Progression|1
808688|NCT00091832|1761705|FG005|Overall Study|Disease Progression|2
808689|NCT00091832|1761700|FG000|Overall Study|Ineligibility Determined|0
808690|NCT00091832|1761701|FG001|Overall Study|Ineligibility Determined|0
808691|NCT00091832|1761702|FG002|Overall Study|Ineligibility Determined|1
808692|NCT00091832|1761703|FG003|Overall Study|Ineligibility Determined|0
808693|NCT00091832|1761704|FG004|Overall Study|Ineligibility Determined|1
808694|NCT00091832|1761705|FG005|Overall Study|Ineligibility Determined|0
808695|NCT00091832|1761700|FG000|Overall Study|Lost to Follow-up|1
808696|NCT00091832|1761701|FG001|Overall Study|Lost to Follow-up|0
808697|NCT00091832|1761702|FG002|Overall Study|Lost to Follow-up|3
808698|NCT00091832|1761703|FG003|Overall Study|Lost to Follow-up|3
808699|NCT00091832|1761704|FG004|Overall Study|Lost to Follow-up|2
808700|NCT00091832|1761705|FG005|Overall Study|Lost to Follow-up|1
808701|NCT00091832|1761700|FG000|Overall Study|Noncompliance|0
808702|NCT00091832|1761701|FG001|Overall Study|Noncompliance|1
808703|NCT00091832|1761702|FG002|Overall Study|Noncompliance|0
808704|NCT00091832|1761703|FG003|Overall Study|Noncompliance|0
808705|NCT00091832|1761704|FG004|Overall Study|Noncompliance|0
808706|NCT00091832|1761705|FG005|Overall Study|Noncompliance|0
808707|NCT00091832|1761700|FG000|Overall Study|Other|0
808708|NCT00091832|1761701|FG001|Overall Study|Other|1
808709|NCT00091832|1761702|FG002|Overall Study|Other|2
808710|NCT00091832|1761703|FG003|Overall Study|Other|0
808711|NCT00091832|1761704|FG004|Overall Study|Other|0
808712|NCT00091832|1761705|FG005|Overall Study|Other|0
808713|NCT00091832|1761700|FG000|Overall Study|Protocol Violation|0
808714|NCT00091832|1761701|FG001|Overall Study|Protocol Violation|0
808715|NCT00091832|1761702|FG002|Overall Study|Protocol Violation|1
808716|NCT00091832|1761703|FG003|Overall Study|Protocol Violation|0
808717|NCT00091832|1761704|FG004|Overall Study|Protocol Violation|0
808718|NCT00091832|1761705|FG005|Overall Study|Protocol Violation|1
808719|NCT00091949|1761721|FG000|Overall Study|Withdrawal by Subject|117
808720|NCT00091949|1761722|FG001|Overall Study|Withdrawal by Subject|110
808721|NCT00091949|1761721|FG000|Overall Study|Lost to Follow-up|58
808722|NCT00091949|1761722|FG001|Overall Study|Lost to Follow-up|41
808723|NCT00092118|1761746|FG000|Overall Study|Adverse Event|35
808724|NCT00092118|1761747|FG001|Overall Study|Adverse Event|32
808725|NCT00092118|1761746|FG000|Overall Study|Lack of Efficacy|12
808726|NCT00092118|1761747|FG001|Overall Study|Lack of Efficacy|14
808727|NCT00092118|1761746|FG000|Overall Study|Lost to Follow-up|4
808728|NCT00092118|1761747|FG001|Overall Study|Lost to Follow-up|3
808729|NCT00092118|1761746|FG000|Overall Study|Protocol Violation|23
808730|NCT00092118|1761747|FG001|Overall Study|Protocol Violation|25
808731|NCT00092118|1761746|FG000|Overall Study|Withdrawal by Subject|4
808732|NCT00092118|1761747|FG001|Overall Study|Withdrawal by Subject|10
808733|NCT00092118|1761746|FG000|Overall Study|Other|6
808734|NCT00092118|1761747|FG001|Overall Study|Other|5
808735|NCT00092131|1761753|FG000|Treatment Period I|Adverse Event|1
808736|NCT00092131|1761754|FG001|Treatment Period I|Adverse Event|0
808737|NCT00092131|1761753|FG000|Treatment Period II|Adverse Event|0
808738|NCT00092131|1761754|FG001|Treatment Period II|Adverse Event|1
808739|NCT00092417|1761762|FG000|Overall Study|Lost to Follow-up|2
808740|NCT00092417|1761763|FG001|Overall Study|Lost to Follow-up|0
808741|NCT00092417|1761762|FG000|Overall Study|Withdrawal by Subject|2
808742|NCT00092417|1761763|FG001|Overall Study|Withdrawal by Subject|1
808743|NCT00092417|1761762|FG000|Overall Study|Other|1
808744|NCT00092417|1761763|FG001|Overall Study|Other|0
808745|NCT00092443|1761771|FG000|Overall Study|Adverse Event|9
808746|NCT00092443|1761772|FG001|Overall Study|Adverse Event|13
808747|NCT00092443|1761771|FG000|Overall Study|Lost to Follow-up|7
808748|NCT00092443|1761772|FG001|Overall Study|Lost to Follow-up|3
808749|NCT00092443|1761771|FG000|Overall Study|Protocol Violation|11
808750|NCT00092443|1761772|FG001|Overall Study|Protocol Violation|9
808751|NCT00092443|1761771|FG000|Overall Study|Withdrawal by Subject|9
808752|NCT00092443|1761772|FG001|Overall Study|Withdrawal by Subject|11
808753|NCT00092443|1761771|FG000|Overall Study|Moved|5
808754|NCT00092443|1761772|FG001|Overall Study|Moved|5
808755|NCT00092443|1761771|FG000|Overall Study|Other|17
808756|NCT00092443|1761772|FG001|Overall Study|Other|13
808757|NCT00092456|1761792|FG000|Overall Study|Adverse Event|0
808758|NCT00092456|1761793|FG001|Overall Study|Adverse Event|0
808759|NCT00092456|1761794|FG002|Overall Study|Adverse Event|1
808760|NCT00092456|1761795|FG003|Overall Study|Adverse Event|1
808761|NCT00092456|1761792|FG000|Overall Study|Lost to Follow-up|2
808762|NCT00092456|1761793|FG001|Overall Study|Lost to Follow-up|2
808763|NCT00092456|1761794|FG002|Overall Study|Lost to Follow-up|1
808764|NCT00092456|1761795|FG003|Overall Study|Lost to Follow-up|2
808765|NCT00092456|1761792|FG000|Overall Study|Protocol Violation|5
808766|NCT00092456|1761793|FG001|Overall Study|Protocol Violation|7
808767|NCT00092456|1761794|FG002|Overall Study|Protocol Violation|8
808768|NCT00092456|1761795|FG003|Overall Study|Protocol Violation|6
808769|NCT00092456|1761792|FG000|Overall Study|Withdrawal by Subject|13
808770|NCT00092456|1761793|FG001|Overall Study|Withdrawal by Subject|5
808771|NCT00092456|1761794|FG002|Overall Study|Withdrawal by Subject|16
808772|NCT00092456|1761795|FG003|Overall Study|Withdrawal by Subject|6
808773|NCT00092456|1761792|FG000|Overall Study|Moved|1
808774|NCT00092456|1761793|FG001|Overall Study|Moved|1
808775|NCT00092456|1761794|FG002|Overall Study|Moved|0
808776|NCT00092456|1761795|FG003|Overall Study|Moved|1
808777|NCT00092456|1761792|FG000|Overall Study|Other|4
808778|NCT00092456|1761793|FG001|Overall Study|Other|2
808779|NCT00092456|1761794|FG002|Overall Study|Other|3
808780|NCT00092456|1761795|FG003|Overall Study|Other|0
808781|NCT00092495|1761809|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1
808782|NCT00092495|1761810|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1
808783|NCT00092495|1761811|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
808784|NCT00092495|1761812|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4
808785|NCT00092495|1761813|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
808786|NCT00092495|1761809|FG000|Base Study Vaccination Period|Extended|0
808787|NCT00092495|1761810|FG001|Base Study Vaccination Period|Extended|0
808788|NCT00092495|1761811|FG002|Base Study Vaccination Period|Extended|0
808789|NCT00092495|1761812|FG003|Base Study Vaccination Period|Extended|1
808790|NCT00092495|1761813|FG004|Base Study Vaccination Period|Extended|0
808791|NCT00092495|1761809|FG000|Base Study Vaccination Period|*Clinical AE|1
808792|NCT00092495|1761810|FG001|Base Study Vaccination Period|*Clinical AE|0
808793|NCT00092495|1761811|FG002|Base Study Vaccination Period|*Clinical AE|1
808794|NCT00092495|1761812|FG003|Base Study Vaccination Period|*Clinical AE|2
808795|NCT00092495|1761813|FG004|Base Study Vaccination Period|*Clinical AE|0
808796|NCT00092495|1761809|FG000|Base Study Vaccination Period|*Other reasons|1
808797|NCT00092495|1761810|FG001|Base Study Vaccination Period|*Other reasons|0
808798|NCT00092495|1761811|FG002|Base Study Vaccination Period|*Other reasons|0
808799|NCT00092495|1761812|FG003|Base Study Vaccination Period|*Other reasons|1
808800|NCT00092495|1761813|FG004|Base Study Vaccination Period|*Other reasons|0
808801|NCT00092495|1761809|FG000|Base Study Vaccination Period|*Pregnancy|0
808802|NCT00092495|1761810|FG001|Base Study Vaccination Period|*Pregnancy|2
808803|NCT00092495|1761811|FG002|Base Study Vaccination Period|*Pregnancy|5
808804|NCT00092495|1761812|FG003|Base Study Vaccination Period|*Pregnancy|7
808805|NCT00092495|1761813|FG004|Base Study Vaccination Period|*Pregnancy|0
808806|NCT00092495|1761809|FG000|Base Study Vaccination Period|Adverse Event|1
808807|NCT00092495|1761810|FG001|Base Study Vaccination Period|Adverse Event|0
808808|NCT00092495|1761811|FG002|Base Study Vaccination Period|Adverse Event|0
808809|NCT00092495|1761812|FG003|Base Study Vaccination Period|Adverse Event|3
808810|NCT00092495|1761813|FG004|Base Study Vaccination Period|Adverse Event|0
808811|NCT00092495|1761809|FG000|Base Study Vaccination Period|Lost to Follow-up|16
808812|NCT00092495|1761810|FG001|Base Study Vaccination Period|Lost to Follow-up|6
808813|NCT00092495|1761811|FG002|Base Study Vaccination Period|Lost to Follow-up|11
808814|NCT00092495|1761812|FG003|Base Study Vaccination Period|Lost to Follow-up|36
808815|NCT00092495|1761813|FG004|Base Study Vaccination Period|Lost to Follow-up|0
808816|NCT00092495|1761809|FG000|Base Study Vaccination Period|Moved|3
808817|NCT00092495|1761810|FG001|Base Study Vaccination Period|Moved|1
808818|NCT00092495|1761811|FG002|Base Study Vaccination Period|Moved|2
808819|NCT00092495|1761812|FG003|Base Study Vaccination Period|Moved|2
808820|NCT00092495|1761813|FG004|Base Study Vaccination Period|Moved|0
808821|NCT00092495|1761809|FG000|Base Study Vaccination Period|Other|1
808822|NCT00092495|1761810|FG001|Base Study Vaccination Period|Other|1
808823|NCT00092495|1761811|FG002|Base Study Vaccination Period|Other|0
808824|NCT00092495|1761812|FG003|Base Study Vaccination Period|Other|2
808825|NCT00092495|1761813|FG004|Base Study Vaccination Period|Other|0
808826|NCT00092495|1761809|FG000|Base Study Vaccination Period|Pregnancy|2
808827|NCT00092495|1761810|FG001|Base Study Vaccination Period|Pregnancy|0
808828|NCT00092495|1761811|FG002|Base Study Vaccination Period|Pregnancy|0
808829|NCT00092495|1761812|FG003|Base Study Vaccination Period|Pregnancy|0
808830|NCT00092495|1761813|FG004|Base Study Vaccination Period|Pregnancy|0
808831|NCT00092495|1761809|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1
808832|NCT00092495|1761810|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1
808833|NCT00092495|1761811|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1
808834|NCT00092495|1761812|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5
808835|NCT00092495|1761813|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0
808836|NCT00092495|1761809|FG000|Base Study Vaccination Period|Protocol Violation|1
808837|NCT00092495|1761810|FG001|Base Study Vaccination Period|Protocol Violation|0
808838|NCT00092495|1761811|FG002|Base Study Vaccination Period|Protocol Violation|0
808839|NCT00092495|1761812|FG003|Base Study Vaccination Period|Protocol Violation|0
808840|NCT00092495|1761813|FG004|Base Study Vaccination Period|Protocol Violation|0
808841|NCT00092495|1761809|FG000|Base Study Vaccination Period|Withdrawal by Subject|9
808842|NCT00092495|1761810|FG001|Base Study Vaccination Period|Withdrawal by Subject|10
808843|NCT00092495|1761811|FG002|Base Study Vaccination Period|Withdrawal by Subject|14
808844|NCT00092495|1761812|FG003|Base Study Vaccination Period|Withdrawal by Subject|25
808845|NCT00092495|1761813|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
808846|NCT00092495|1761809|FG000|Base Study Follow-up Period|Extended|0
808847|NCT00092495|1761810|FG001|Base Study Follow-up Period|Extended|0
808848|NCT00092495|1761811|FG002|Base Study Follow-up Period|Extended|1
808849|NCT00092495|1761812|FG003|Base Study Follow-up Period|Extended|2
808850|NCT00092495|1761813|FG004|Base Study Follow-up Period|Extended|0
808851|NCT00092495|1761809|FG000|Base Study Follow-up Period|Lost to Follow-up|1
808852|NCT00092495|1761810|FG001|Base Study Follow-up Period|Lost to Follow-up|3
808853|NCT00092495|1761811|FG002|Base Study Follow-up Period|Lost to Follow-up|3
808854|NCT00092495|1761812|FG003|Base Study Follow-up Period|Lost to Follow-up|12
808855|NCT00092495|1761813|FG004|Base Study Follow-up Period|Lost to Follow-up|0
808856|NCT00092495|1761809|FG000|Base Study Follow-up Period|Withdrawal by Subject|2
808857|NCT00092495|1761810|FG001|Base Study Follow-up Period|Withdrawal by Subject|0
808858|NCT00092495|1761811|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
808859|NCT00092495|1761812|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
808860|NCT00092495|1761813|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
808861|NCT00092521|1761829|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
808862|NCT00092521|1761830|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
808863|NCT00092521|1761831|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
808864|NCT00092521|1761832|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
808865|NCT00092521|1761829|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1
808866|NCT00092521|1761830|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0
808867|NCT00092521|1761831|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7
808868|NCT00092521|1761832|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0
808869|NCT00092521|1761829|FG000|Vaccination (Day 1 Through Month 7)|Death|0
808870|NCT00092521|1761830|FG001|Vaccination (Day 1 Through Month 7)|Death|0
808871|NCT00092521|1761831|FG002|Vaccination (Day 1 Through Month 7)|Death|1
808872|NCT00092521|1761832|FG003|Vaccination (Day 1 Through Month 7)|Death|0
808873|NCT00092521|1761829|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
808874|NCT00092521|1761830|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
808875|NCT00092521|1761831|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
808876|NCT00092521|1761832|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
808877|NCT00092521|1761829|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5
808878|NCT00092521|1761830|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0
808879|NCT00092521|1761831|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7
808880|NCT00092521|1761832|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0
808881|NCT00092521|1761829|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
808882|NCT00092521|1761830|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
808883|NCT00092521|1761831|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
808884|NCT00092521|1761832|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
808885|NCT00092521|1761829|FG000|Vaccination (Day 1 Through Month 7)|Moved|14
808886|NCT00092521|1761830|FG001|Vaccination (Day 1 Through Month 7)|Moved|1
808887|NCT00092521|1761831|FG002|Vaccination (Day 1 Through Month 7)|Moved|18
808888|NCT00092521|1761832|FG003|Vaccination (Day 1 Through Month 7)|Moved|0
808889|NCT00092521|1761829|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2
808890|NCT00092521|1761830|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0
808891|NCT00092521|1761831|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0
808892|NCT00092521|1761832|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0
808893|NCT00092521|1761829|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
808894|NCT00092521|1761830|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
808895|NCT00092521|1761831|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
808896|NCT00092521|1761832|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
808897|NCT00092521|1761829|FG000|Follow-Up (After Month 7)|Subjects Continuing|34
808898|NCT00092521|1761830|FG001|Follow-Up (After Month 7)|Subjects Continuing|4
808899|NCT00092521|1761831|FG002|Follow-Up (After Month 7)|Subjects Continuing|35
808900|NCT00092521|1761832|FG003|Follow-Up (After Month 7)|Subjects Continuing|0
808901|NCT00092521|1761829|FG000|Follow-Up (After Month 7)|Subjects in Extension|13
808902|NCT00092521|1761830|FG001|Follow-Up (After Month 7)|Subjects in Extension|109
808903|NCT00092521|1761831|FG002|Follow-Up (After Month 7)|Subjects in Extension|412
808904|NCT00092521|1761832|FG003|Follow-Up (After Month 7)|Subjects in Extension|0
808905|NCT00092521|1761829|FG000|Follow-Up (After Month 7)|Adverse Event|1
808906|NCT00092521|1761830|FG001|Follow-Up (After Month 7)|Adverse Event|0
808907|NCT00092521|1761831|FG002|Follow-Up (After Month 7)|Adverse Event|0
808908|NCT00092521|1761832|FG003|Follow-Up (After Month 7)|Adverse Event|0
808909|NCT00092521|1761829|FG000|Follow-Up (After Month 7)|Death|2
808910|NCT00092521|1761830|FG001|Follow-Up (After Month 7)|Death|0
808911|NCT00092521|1761831|FG002|Follow-Up (After Month 7)|Death|1
808912|NCT00092521|1761832|FG003|Follow-Up (After Month 7)|Death|0
808913|NCT00092521|1761829|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113
808914|NCT00092521|1761830|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14
808915|NCT00092521|1761831|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108
808916|NCT00092521|1761832|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0
808917|NCT00092521|1761829|FG000|Follow-Up (After Month 7)|Protocol Violation|1
808918|NCT00092521|1761830|FG001|Follow-Up (After Month 7)|Protocol Violation|1
808919|NCT00092521|1761831|FG002|Follow-Up (After Month 7)|Protocol Violation|5
808920|NCT00092521|1761832|FG003|Follow-Up (After Month 7)|Protocol Violation|0
808921|NCT00092521|1761829|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40
808922|NCT00092521|1761830|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6
808923|NCT00092521|1761831|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51
808924|NCT00092521|1761832|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0
808925|NCT00092521|1761829|FG000|Follow-Up (After Month 7)|Moved|32
808926|NCT00092521|1761830|FG001|Follow-Up (After Month 7)|Moved|2
808927|NCT00092521|1761831|FG002|Follow-Up (After Month 7)|Moved|28
808928|NCT00092521|1761832|FG003|Follow-Up (After Month 7)|Moved|0
808929|NCT00092521|1761829|FG000|Follow-Up (After Month 7)|Site Terminated|3
808930|NCT00092521|1761830|FG001|Follow-Up (After Month 7)|Site Terminated|0
808931|NCT00092521|1761831|FG002|Follow-Up (After Month 7)|Site Terminated|3
808932|NCT00092521|1761832|FG003|Follow-Up (After Month 7)|Site Terminated|0
808933|NCT00092521|1761829|FG000|Follow-Up (After Month 7)|Travel|2
808934|NCT00092521|1761830|FG001|Follow-Up (After Month 7)|Travel|0
808935|NCT00092521|1761831|FG002|Follow-Up (After Month 7)|Travel|0
808936|NCT00092521|1761832|FG003|Follow-Up (After Month 7)|Travel|0
808937|NCT00092521|1761829|FG000|Follow-Up (After Month 7)|Visits Compressed|5
808938|NCT00092521|1761830|FG001|Follow-Up (After Month 7)|Visits Compressed|0
808939|NCT00092521|1761831|FG002|Follow-Up (After Month 7)|Visits Compressed|5
808940|NCT00092521|1761832|FG003|Follow-Up (After Month 7)|Visits Compressed|0
808941|NCT00092521|1761829|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0
808942|NCT00092521|1761830|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0
808943|NCT00092521|1761831|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0
808944|NCT00092521|1761832|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23
808945|NCT00092521|1761829|FG000|Extension Study (Group 4)|Adverse Event|0
808946|NCT00092521|1761830|FG001|Extension Study (Group 4)|Adverse Event|0
808947|NCT00092521|1761831|FG002|Extension Study (Group 4)|Adverse Event|0
808948|NCT00092521|1761832|FG003|Extension Study (Group 4)|Adverse Event|2
808949|NCT00092521|1761829|FG000|Extension Study (Group 4)|Lost to Follow-up|0
808950|NCT00092521|1761830|FG001|Extension Study (Group 4)|Lost to Follow-up|0
808951|NCT00092521|1761831|FG002|Extension Study (Group 4)|Lost to Follow-up|0
808952|NCT00092521|1761832|FG003|Extension Study (Group 4)|Lost to Follow-up|87
808953|NCT00092521|1761829|FG000|Extension Study (Group 4)|Pregnancy|0
808954|NCT00092521|1761830|FG001|Extension Study (Group 4)|Pregnancy|0
808955|NCT00092521|1761831|FG002|Extension Study (Group 4)|Pregnancy|0
808956|NCT00092521|1761832|FG003|Extension Study (Group 4)|Pregnancy|4
808957|NCT00092521|1761829|FG000|Extension Study (Group 4)|Protocol Violation|0
808958|NCT00092521|1761830|FG001|Extension Study (Group 4)|Protocol Violation|0
808959|NCT00092521|1761831|FG002|Extension Study (Group 4)|Protocol Violation|0
808960|NCT00092521|1761832|FG003|Extension Study (Group 4)|Protocol Violation|2
808961|NCT00092521|1761829|FG000|Extension Study (Group 4)|Withdrawal by Subject|0
808962|NCT00092521|1761830|FG001|Extension Study (Group 4)|Withdrawal by Subject|0
808963|NCT00092521|1761831|FG002|Extension Study (Group 4)|Withdrawal by Subject|0
808964|NCT00092521|1761832|FG003|Extension Study (Group 4)|Withdrawal by Subject|46
808965|NCT00092521|1761829|FG000|Extension Study (Group 4)|Moved|0
808966|NCT00092521|1761830|FG001|Extension Study (Group 4)|Moved|0
808967|NCT00092521|1761831|FG002|Extension Study (Group 4)|Moved|0
808968|NCT00092521|1761832|FG003|Extension Study (Group 4)|Moved|16
808969|NCT00092521|1761829|FG000|Extension Study (Group 4)|Site Terminated|0
808970|NCT00092521|1761830|FG001|Extension Study (Group 4)|Site Terminated|0
808971|NCT00092521|1761831|FG002|Extension Study (Group 4)|Site Terminated|0
808972|NCT00092521|1761832|FG003|Extension Study (Group 4)|Site Terminated|4
808973|NCT00092521|1761829|FG000|Extension Study (Group 4)|Unable/unwilling to return|0
808974|NCT00092521|1761830|FG001|Extension Study (Group 4)|Unable/unwilling to return|0
808975|NCT00092521|1761831|FG002|Extension Study (Group 4)|Unable/unwilling to return|0
808976|NCT00092521|1761832|FG003|Extension Study (Group 4)|Unable/unwilling to return|25
808977|NCT00092534|1761842|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5
808978|NCT00092534|1761843|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5
808979|NCT00092534|1761844|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
808980|NCT00092534|1761845|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
808981|NCT00092534|1761846|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
808982|NCT00092534|1761842|FG000|Base Study Vaccination Period|Adverse Event|3
808983|NCT00092534|1761843|FG001|Base Study Vaccination Period|Adverse Event|1
808984|NCT00092534|1761844|FG002|Base Study Vaccination Period|Adverse Event|0
808985|NCT00092534|1761845|FG003|Base Study Vaccination Period|Adverse Event|0
808986|NCT00092534|1761846|FG004|Base Study Vaccination Period|Adverse Event|0
808987|NCT00092534|1761842|FG000|Base Study Vaccination Period|Death|5
808988|NCT00092534|1761843|FG001|Base Study Vaccination Period|Death|4
808989|NCT00092534|1761844|FG002|Base Study Vaccination Period|Death|0
808990|NCT00092534|1761845|FG003|Base Study Vaccination Period|Death|0
808991|NCT00092534|1761846|FG004|Base Study Vaccination Period|Death|0
808992|NCT00092534|1761842|FG000|Base Study Vaccination Period|Lost to Follow-up|41
808993|NCT00092534|1761843|FG001|Base Study Vaccination Period|Lost to Follow-up|37
808994|NCT00092534|1761844|FG002|Base Study Vaccination Period|Lost to Follow-up|0
808995|NCT00092534|1761845|FG003|Base Study Vaccination Period|Lost to Follow-up|0
808996|NCT00092534|1761846|FG004|Base Study Vaccination Period|Lost to Follow-up|0
808997|NCT00092534|1761842|FG000|Base Study Vaccination Period|Physician Decision|1
808998|NCT00092534|1761843|FG001|Base Study Vaccination Period|Physician Decision|0
808999|NCT00092534|1761844|FG002|Base Study Vaccination Period|Physician Decision|0
809000|NCT00092534|1761845|FG003|Base Study Vaccination Period|Physician Decision|0
809001|NCT00092534|1761846|FG004|Base Study Vaccination Period|Physician Decision|0
809002|NCT00092534|1761842|FG000|Base Study Vaccination Period|Pregnancy|9
809003|NCT00092534|1761843|FG001|Base Study Vaccination Period|Pregnancy|7
809004|NCT00092534|1761844|FG002|Base Study Vaccination Period|Pregnancy|0
809005|NCT00092534|1761845|FG003|Base Study Vaccination Period|Pregnancy|0
809006|NCT00092534|1761846|FG004|Base Study Vaccination Period|Pregnancy|0
809007|NCT00092534|1761842|FG000|Base Study Vaccination Period|Protocol Violation|2
809008|NCT00092534|1761843|FG001|Base Study Vaccination Period|Protocol Violation|1
809009|NCT00092534|1761844|FG002|Base Study Vaccination Period|Protocol Violation|0
809010|NCT00092534|1761845|FG003|Base Study Vaccination Period|Protocol Violation|0
809011|NCT00092534|1761846|FG004|Base Study Vaccination Period|Protocol Violation|0
809012|NCT00092534|1761842|FG000|Base Study Vaccination Period|Withdrawal by Subject|85
809013|NCT00092534|1761843|FG001|Base Study Vaccination Period|Withdrawal by Subject|58
809014|NCT00092534|1761844|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
809015|NCT00092534|1761845|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
809016|NCT00092534|1761846|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
809017|NCT00092534|1761842|FG000|Base Study Vaccination Period|Moved|14
809018|NCT00092534|1761843|FG001|Base Study Vaccination Period|Moved|12
809019|NCT00092534|1761844|FG002|Base Study Vaccination Period|Moved|0
809020|NCT00092534|1761845|FG003|Base Study Vaccination Period|Moved|0
809021|NCT00092534|1761846|FG004|Base Study Vaccination Period|Moved|0
809022|NCT00092534|1761842|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5
809023|NCT00092534|1761843|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0
809024|NCT00092534|1761844|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0
809025|NCT00092534|1761845|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0
809026|NCT00092534|1761846|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0
809027|NCT00092534|1761842|FG000|Base Study Vaccination Period|Travel|1
809028|NCT00092534|1761843|FG001|Base Study Vaccination Period|Travel|0
809029|NCT00092534|1761844|FG002|Base Study Vaccination Period|Travel|0
809030|NCT00092534|1761845|FG003|Base Study Vaccination Period|Travel|0
809031|NCT00092534|1761846|FG004|Base Study Vaccination Period|Travel|0
809032|NCT00092534|1761842|FG000|Base Study Vaccination Period|Site Closed|0
809033|NCT00092534|1761843|FG001|Base Study Vaccination Period|Site Closed|1
809034|NCT00092534|1761844|FG002|Base Study Vaccination Period|Site Closed|0
809035|NCT00092534|1761845|FG003|Base Study Vaccination Period|Site Closed|0
809036|NCT00092534|1761846|FG004|Base Study Vaccination Period|Site Closed|0
809037|NCT00092534|1761842|FG000|Base Study Follow-Up Period|Adverse Event|2
809038|NCT00092534|1761843|FG001|Base Study Follow-Up Period|Adverse Event|4
809039|NCT00092534|1761844|FG002|Base Study Follow-Up Period|Adverse Event|0
809040|NCT00092534|1761845|FG003|Base Study Follow-Up Period|Adverse Event|0
809041|NCT00092534|1761846|FG004|Base Study Follow-Up Period|Adverse Event|0
809042|NCT00092534|1761842|FG000|Base Study Follow-Up Period|Death|2
809043|NCT00092534|1761843|FG001|Base Study Follow-Up Period|Death|1
809044|NCT00092534|1761844|FG002|Base Study Follow-Up Period|Death|0
809045|NCT00092534|1761845|FG003|Base Study Follow-Up Period|Death|0
809046|NCT00092534|1761846|FG004|Base Study Follow-Up Period|Death|0
809047|NCT00092534|1761842|FG000|Base Study Follow-Up Period|Lost to Follow-up|120
809048|NCT00092534|1761843|FG001|Base Study Follow-Up Period|Lost to Follow-up|146
809049|NCT00092534|1761844|FG002|Base Study Follow-Up Period|Lost to Follow-up|0
809050|NCT00092534|1761845|FG003|Base Study Follow-Up Period|Lost to Follow-up|0
809051|NCT00092534|1761846|FG004|Base Study Follow-Up Period|Lost to Follow-up|0
809052|NCT00092534|1761842|FG000|Base Study Follow-Up Period|Pregnancy|6
809053|NCT00092534|1761843|FG001|Base Study Follow-Up Period|Pregnancy|10
809054|NCT00092534|1761844|FG002|Base Study Follow-Up Period|Pregnancy|0
809055|NCT00092534|1761845|FG003|Base Study Follow-Up Period|Pregnancy|0
809056|NCT00092534|1761846|FG004|Base Study Follow-Up Period|Pregnancy|0
809057|NCT00092534|1761842|FG000|Base Study Follow-Up Period|Protocol Violation|1
809058|NCT00092534|1761843|FG001|Base Study Follow-Up Period|Protocol Violation|2
809059|NCT00092534|1761844|FG002|Base Study Follow-Up Period|Protocol Violation|0
809060|NCT00092534|1761845|FG003|Base Study Follow-Up Period|Protocol Violation|0
809061|NCT00092534|1761846|FG004|Base Study Follow-Up Period|Protocol Violation|0
809062|NCT00092534|1761842|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71
809063|NCT00092534|1761843|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62
809064|NCT00092534|1761844|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0
809065|NCT00092534|1761845|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0
809066|NCT00092534|1761846|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0
809067|NCT00092534|1761842|FG000|Base Study Follow-Up Period|Moved|62
809068|NCT00092534|1761843|FG001|Base Study Follow-Up Period|Moved|58
809069|NCT00092534|1761844|FG002|Base Study Follow-Up Period|Moved|0
809070|NCT00092534|1761845|FG003|Base Study Follow-Up Period|Moved|0
809071|NCT00092534|1761846|FG004|Base Study Follow-Up Period|Moved|0
809072|NCT00092534|1761842|FG000|Base Study Follow-Up Period|Travel|10
809073|NCT00092534|1761843|FG001|Base Study Follow-Up Period|Travel|7
809074|NCT00092534|1761844|FG002|Base Study Follow-Up Period|Travel|0
809075|NCT00092534|1761845|FG003|Base Study Follow-Up Period|Travel|0
809076|NCT00092534|1761846|FG004|Base Study Follow-Up Period|Travel|0
809077|NCT00092534|1761842|FG000|Base Study Follow-Up Period|Site Closed|0
809078|NCT00092534|1761843|FG001|Base Study Follow-Up Period|Site Closed|2
809079|NCT00092534|1761844|FG002|Base Study Follow-Up Period|Site Closed|0
809080|NCT00092534|1761845|FG003|Base Study Follow-Up Period|Site Closed|0
809081|NCT00092534|1761846|FG004|Base Study Follow-Up Period|Site Closed|0
809082|NCT00092534|1761842|FG000|Base Study Follow-Up Period|Subjects continuing|27
809083|NCT00092534|1761843|FG001|Base Study Follow-Up Period|Subjects continuing|31
809084|NCT00092534|1761844|FG002|Base Study Follow-Up Period|Subjects continuing|0
809085|NCT00092534|1761845|FG003|Base Study Follow-Up Period|Subjects continuing|0
809086|NCT00092534|1761846|FG004|Base Study Follow-Up Period|Subjects continuing|0
809087|NCT00092534|1761842|FG000|Base Study Follow-Up Period|Subjects in extension|15
809088|NCT00092534|1761843|FG001|Base Study Follow-Up Period|Subjects in extension|371
809089|NCT00092534|1761844|FG002|Base Study Follow-Up Period|Subjects in extension|0
809090|NCT00092534|1761845|FG003|Base Study Follow-Up Period|Subjects in extension|0
809091|NCT00092534|1761846|FG004|Base Study Follow-Up Period|Subjects in extension|0
809092|NCT00092534|1761842|FG000|Base Study EXT|Lost to Follow-up|0
809093|NCT00092534|1761843|FG001|Base Study EXT|Lost to Follow-up|0
809094|NCT00092534|1761844|FG002|Base Study EXT|Lost to Follow-up|41
809095|NCT00092534|1761845|FG003|Base Study EXT|Lost to Follow-up|0
809096|NCT00092534|1761846|FG004|Base Study EXT|Lost to Follow-up|0
809097|NCT00092534|1761842|FG000|Base Study EXT|Physician Decision|0
809098|NCT00092534|1761843|FG001|Base Study EXT|Physician Decision|0
809099|NCT00092534|1761844|FG002|Base Study EXT|Physician Decision|1
809100|NCT00092534|1761845|FG003|Base Study EXT|Physician Decision|0
809101|NCT00092534|1761846|FG004|Base Study EXT|Physician Decision|0
809102|NCT00092534|1761842|FG000|Base Study EXT|Pregnancy|0
809103|NCT00092534|1761843|FG001|Base Study EXT|Pregnancy|0
809104|NCT00092534|1761844|FG002|Base Study EXT|Pregnancy|12
809105|NCT00092534|1761845|FG003|Base Study EXT|Pregnancy|0
809106|NCT00092534|1761846|FG004|Base Study EXT|Pregnancy|0
809107|NCT00092534|1761842|FG000|Base Study EXT|Withdrawal by Subject|0
809108|NCT00092534|1761843|FG001|Base Study EXT|Withdrawal by Subject|0
809109|NCT00092534|1761844|FG002|Base Study EXT|Withdrawal by Subject|18
809110|NCT00092534|1761845|FG003|Base Study EXT|Withdrawal by Subject|0
809111|NCT00092534|1761846|FG004|Base Study EXT|Withdrawal by Subject|0
809112|NCT00092534|1761842|FG000|Base Study EXT|Participant moved|0
809113|NCT00092534|1761843|FG001|Base Study EXT|Participant moved|0
809114|NCT00092534|1761844|FG002|Base Study EXT|Participant moved|6
809115|NCT00092534|1761845|FG003|Base Study EXT|Participant moved|0
809116|NCT00092534|1761846|FG004|Base Study EXT|Participant moved|0
809117|NCT00092534|1761842|FG000|Base Study EXT|Travel|0
809118|NCT00092534|1761843|FG001|Base Study EXT|Travel|0
809119|NCT00092534|1761844|FG002|Base Study EXT|Travel|2
809120|NCT00092534|1761845|FG003|Base Study EXT|Travel|0
809121|NCT00092534|1761846|FG004|Base Study EXT|Travel|0
809122|NCT00092534|1761842|FG000|Base Study EXT|Site closed|0
809123|NCT00092534|1761843|FG001|Base Study EXT|Site closed|0
809124|NCT00092534|1761844|FG002|Base Study EXT|Site closed|21
809125|NCT00092534|1761845|FG003|Base Study EXT|Site closed|0
809126|NCT00092534|1761846|FG004|Base Study EXT|Site closed|0
809127|NCT00092534|1761842|FG000|Base Study EXT|Study ended|0
809128|NCT00092534|1761843|FG001|Base Study EXT|Study ended|0
809129|NCT00092534|1761844|FG002|Base Study EXT|Study ended|29
809130|NCT00092534|1761845|FG003|Base Study EXT|Study ended|0
809131|NCT00092534|1761846|FG004|Base Study EXT|Study ended|0
809132|NCT00092534|1761842|FG000|Base Study EXT|Protocol Violation|0
809133|NCT00092534|1761843|FG001|Base Study EXT|Protocol Violation|0
809134|NCT00092534|1761844|FG002|Base Study EXT|Protocol Violation|15
809135|NCT00092534|1761845|FG003|Base Study EXT|Protocol Violation|0
809136|NCT00092534|1761846|FG004|Base Study EXT|Protocol Violation|0
809137|NCT00092534|1761842|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
809138|NCT00092534|1761843|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
809139|NCT00092534|1761844|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
809140|NCT00092534|1761845|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
809141|NCT00092534|1761846|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
809142|NCT00092547|1761858|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
809143|NCT00092547|1761859|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
809144|NCT00092547|1761860|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
809145|NCT00092547|1761858|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
809146|NCT00092547|1761859|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
809147|NCT00092547|1761860|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
809148|NCT00092547|1761858|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
809149|NCT00092547|1761859|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
809150|NCT00092547|1761860|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
809151|NCT00092547|1761858|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
809152|NCT00092547|1761859|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
809153|NCT00092547|1761860|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
809154|NCT00092547|1761858|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
809155|NCT00092547|1761859|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
809156|NCT00092547|1761860|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
809157|NCT00092547|1761858|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
809158|NCT00092547|1761859|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
809159|NCT00092547|1761860|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
809160|NCT00092547|1761858|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
809161|NCT00092547|1761859|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
809162|NCT00092547|1761860|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
809163|NCT00092547|1761858|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
809164|NCT00092547|1761859|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
809165|NCT00092547|1761860|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
809166|NCT00092547|1761858|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
809167|NCT00092547|1761859|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
809168|NCT00092547|1761860|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
809169|NCT00092547|1761858|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
809170|NCT00092547|1761859|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
809171|NCT00092547|1761860|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
809172|NCT00092547|1761858|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
809173|NCT00092547|1761859|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
809174|NCT00092547|1761860|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
809175|NCT00092547|1761858|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
809176|NCT00092547|1761859|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
809177|NCT00092547|1761860|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
809178|NCT00092547|1761858|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
809179|NCT00092547|1761859|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
809180|NCT00092547|1761860|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
809181|NCT00092547|1761858|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
809182|NCT00092547|1761859|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
809183|NCT00092547|1761860|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
809184|NCT00092547|1761858|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
809185|NCT00092547|1761859|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
809186|NCT00092547|1761860|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
809187|NCT00092547|1761858|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
809188|NCT00092547|1761859|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
809189|NCT00092547|1761860|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
809190|NCT00092547|1761858|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
809191|NCT00092547|1761859|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
809192|NCT00092547|1761860|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
809193|NCT00092547|1761858|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
809194|NCT00092547|1761859|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
809195|NCT00092547|1761860|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
809196|NCT00092547|1761858|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
809197|NCT00092547|1761859|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
809198|NCT00092547|1761860|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
809199|NCT00092547|1761858|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
809200|NCT00092547|1761859|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
809201|NCT00092547|1761860|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
809202|NCT00092547|1761858|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
809203|NCT00092547|1761859|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
809204|NCT00092547|1761860|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
809205|NCT00092677|1761873|FG000|Overall Study|Lost to Follow-up|0
809206|NCT00092677|1761874|FG001|Overall Study|Lost to Follow-up|2
809207|NCT00092677|1761873|FG000|Overall Study|Adminstrative|5
809208|NCT00092677|1761874|FG001|Overall Study|Adminstrative|9
809209|NCT00093015|1761882|FG000|Overall Study|Withdrawal by Subject|194
809210|NCT00093015|1761883|FG001|Overall Study|Withdrawal by Subject|171
809211|NCT00093015|1761882|FG000|Overall Study|Lost to Follow-up|96
809212|NCT00093015|1761883|FG001|Overall Study|Lost to Follow-up|108
809213|NCT00093015|1761882|FG000|Overall Study|Death|375
809214|NCT00093015|1761883|FG001|Overall Study|Death|385
809215|NCT00093145|1761914|FG000|Overall Study|Unacceptable Toxicity Only|2
809216|NCT00093145|1761914|FG000|Overall Study|Physician Decision|5
809217|NCT00093145|1761914|FG000|Overall Study|Withdrawal by Subject|9
809218|NCT00093145|1761914|FG000|Overall Study|Other|1
809219|NCT00093470|1761924|FG000|Overall Study|Disease progression|39
809220|NCT00093470|1761925|FG001|Overall Study|Disease progression|0
809221|NCT00093470|1761924|FG000|Overall Study|Adverse Event|15
809222|NCT00093470|1761925|FG001|Overall Study|Adverse Event|0
809223|NCT00093470|1761924|FG000|Overall Study|Death|2
809224|NCT00093470|1761925|FG001|Overall Study|Death|0
809225|NCT00093470|1761924|FG000|Overall Study|Withdrawal by Subject|8
809226|NCT00093470|1761925|FG001|Overall Study|Withdrawal by Subject|0
809227|NCT00093470|1761924|FG000|Overall Study|Alternative therapy|2
809228|NCT00093470|1761925|FG001|Overall Study|Alternative therapy|0
809229|NCT00093470|1761924|FG000|Overall Study|Other complicating disease|3
809230|NCT00093470|1761925|FG001|Overall Study|Other complicating disease|0
809231|NCT00093470|1761924|FG000|Overall Study|Physician Decision|2
809232|NCT00093470|1761925|FG001|Overall Study|Physician Decision|0
809233|NCT00093470|1761924|FG000|Overall Study|Never started treatment|1
809234|NCT00093470|1761925|FG001|Overall Study|Never started treatment|0
809235|NCT00093470|1761924|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1
809236|NCT00093470|1761925|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0
809237|NCT00093496|1761933|FG000|Overall Study|Protocol Violation|1
809238|NCT00093496|1761934|FG001|Overall Study|Protocol Violation|3
809239|NCT00093795|1761957|FG000|Overall Study|No follow up data|20
809240|NCT00093795|1761958|FG001|Overall Study|No follow up data|16
809241|NCT00093795|1761959|FG002|Overall Study|No follow up data|17
809242|NCT00093808|1761967|FG000|Overall Study|Cancel participation before receiving tx|1
809243|NCT00093808|1761967|FG000|Overall Study|Protocol Violation|1
809244|NCT00094055|1761991|FG000|Overall Study|Adverse Event|11
809245|NCT00094055|1761991|FG000|Overall Study|Death|4
809246|NCT00094055|1761991|FG000|Overall Study|Lack of Efficacy|17
809247|NCT00094055|1761991|FG000|Overall Study|Lost to Follow-up|2
809248|NCT00094055|1761991|FG000|Overall Study|progressive disease|2
809249|NCT00094055|1761991|FG000|Overall Study|clinical progression|1
809250|NCT00094055|1761991|FG000|Overall Study|roll-over to another study|14
809251|NCT00094055|1761991|FG000|Overall Study|Withdrawal by Subject|9
809252|NCT00094094|1761995|FG000|Overall Study|Death|2
809253|NCT00094094|1761995|FG000|Overall Study|Lack of Efficacy|23
809254|NCT00094094|1761995|FG000|Overall Study|Adverse Event|7
809255|NCT00094107|1761999|FG000|Overall Study|Lack of Efficacy|23
809256|NCT00094107|1761999|FG000|Overall Study|Death|5
809257|NCT00094107|1761999|FG000|Overall Study|Adverse Event|3
809258|NCT00094107|1761999|FG000|Overall Study|Withdrawal due to Disease Progression|1
809259|NCT00094172|1762005|FG000|Overall Study|Adverse Event|0
809260|NCT00094172|1762006|FG001|Overall Study|Adverse Event|1
809261|NCT00094172|1762005|FG000|Overall Study|Lost to Follow-up|2
809262|NCT00094172|1762006|FG001|Overall Study|Lost to Follow-up|0
809263|NCT00094172|1762005|FG000|Overall Study|Protocol Violation|0
809264|NCT00094172|1762006|FG001|Overall Study|Protocol Violation|1
809265|NCT00094172|1762005|FG000|Overall Study|Withdrawal by Subject|10
809266|NCT00094172|1762006|FG001|Overall Study|Withdrawal by Subject|5
809267|NCT00094172|1762005|FG000|Overall Study|Primary endpoint met.|1
809268|NCT00094172|1762006|FG001|Overall Study|Primary endpoint met.|0
809269|NCT00094172|1762005|FG000|Overall Study|Started other MS therapy due to disease|1
809347|NCT00094458|1762057|FG004|OLE: Open-Label Extension|Adverse Event|3
809270|NCT00094172|1762006|FG001|Overall Study|Started other MS therapy due to disease|0
809271|NCT00094302|1762035|FG000|Overall Study|Lost to Follow-up|43
809272|NCT00094302|1762036|FG001|Overall Study|Lost to Follow-up|41
809273|NCT00094302|1762035|FG000|Overall Study|Physician Decision|5
809274|NCT00094302|1762036|FG001|Overall Study|Physician Decision|8
809275|NCT00094302|1762035|FG000|Overall Study|Withdrawal by Subject|103
809276|NCT00094302|1762036|FG001|Overall Study|Withdrawal by Subject|111
809277|NCT00094302|1762035|FG000|Overall Study|Death|266
809278|NCT00094302|1762036|FG001|Overall Study|Death|246
809279|NCT00094328|1762042|FG000|Overall Study|Lost to Follow-up|1
809280|NCT00094445|1762046|FG000|Overall Study|Withdrawal by Subject|3
809281|NCT00094445|1762046|FG000|Overall Study|Lost to Follow-up|1
809282|NCT00094445|1762046|FG000|Overall Study|Progressive Disease|2
809283|NCT00094458|1762053|FG000|Main Study: Through Week 30|Eligibility criteria not met|3
809284|NCT00094458|1762054|FG001|Main Study: Through Week 30|Eligibility criteria not met|8
809285|NCT00094458|1762055|FG002|Main Study: Through Week 30|Eligibility criteria not met|2
809286|NCT00094458|1762056|FG003|Main Study: Through Week 30|Eligibility criteria not met|0
809287|NCT00094458|1762057|FG004|Main Study: Through Week 30|Eligibility criteria not met|0
809288|NCT00094458|1762058|FG005|Main Study: Through Week 30|Eligibility criteria not met|0
809289|NCT00094458|1762053|FG000|Main Study: Through Week 30|Lost to Follow-up|5
809290|NCT00094458|1762054|FG001|Main Study: Through Week 30|Lost to Follow-up|5
809291|NCT00094458|1762055|FG002|Main Study: Through Week 30|Lost to Follow-up|2
809292|NCT00094458|1762056|FG003|Main Study: Through Week 30|Lost to Follow-up|0
809293|NCT00094458|1762057|FG004|Main Study: Through Week 30|Lost to Follow-up|0
809294|NCT00094458|1762058|FG005|Main Study: Through Week 30|Lost to Follow-up|0
809295|NCT00094458|1762053|FG000|Main Study: Through Week 30|Withdrawal by Subject|18
809296|NCT00094458|1762054|FG001|Main Study: Through Week 30|Withdrawal by Subject|9
809297|NCT00094458|1762055|FG002|Main Study: Through Week 30|Withdrawal by Subject|7
809298|NCT00094458|1762056|FG003|Main Study: Through Week 30|Withdrawal by Subject|0
809299|NCT00094458|1762057|FG004|Main Study: Through Week 30|Withdrawal by Subject|0
809300|NCT00094458|1762058|FG005|Main Study: Through Week 30|Withdrawal by Subject|0
809301|NCT00094458|1762053|FG000|Main Study: Through Week 30|Adverse Event|38
809302|NCT00094458|1762054|FG001|Main Study: Through Week 30|Adverse Event|20
809303|NCT00094458|1762055|FG002|Main Study: Through Week 30|Adverse Event|28
809304|NCT00094458|1762056|FG003|Main Study: Through Week 30|Adverse Event|0
809305|NCT00094458|1762057|FG004|Main Study: Through Week 30|Adverse Event|0
809306|NCT00094458|1762058|FG005|Main Study: Through Week 30|Adverse Event|0
809307|NCT00094458|1762053|FG000|Main Study: Through Week 30|Death|1
809308|NCT00094458|1762054|FG001|Main Study: Through Week 30|Death|0
809309|NCT00094458|1762055|FG002|Main Study: Through Week 30|Death|0
809310|NCT00094458|1762056|FG003|Main Study: Through Week 30|Death|0
809311|NCT00094458|1762057|FG004|Main Study: Through Week 30|Death|0
809312|NCT00094458|1762058|FG005|Main Study: Through Week 30|Death|0
809313|NCT00094458|1762053|FG000|Main Study: Through Week 30|Other|19
809314|NCT00094458|1762054|FG001|Main Study: Through Week 30|Other|16
809315|NCT00094458|1762055|FG002|Main Study: Through Week 30|Other|9
809316|NCT00094458|1762056|FG003|Main Study: Through Week 30|Other|0
809317|NCT00094458|1762057|FG004|Main Study: Through Week 30|Other|0
809318|NCT00094458|1762058|FG005|Main Study: Through Week 30|Other|0
809319|NCT00094458|1762053|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
809320|NCT00094458|1762054|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
809321|NCT00094458|1762055|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
809322|NCT00094458|1762056|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
809323|NCT00094458|1762057|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
809324|NCT00094458|1762058|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
809325|NCT00094458|1762053|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
809326|NCT00094458|1762054|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
809327|NCT00094458|1762055|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
809328|NCT00094458|1762056|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
809329|NCT00094458|1762057|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
809330|NCT00094458|1762058|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
809331|NCT00094458|1762053|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3
809332|NCT00094458|1762054|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9
809333|NCT00094458|1762055|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7
809334|NCT00094458|1762056|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0
809335|NCT00094458|1762057|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0
809336|NCT00094458|1762058|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0
809337|NCT00094458|1762053|FG000|Study Extension: Week 30 Through Week 50|Other|1
809338|NCT00094458|1762054|FG001|Study Extension: Week 30 Through Week 50|Other|2
809339|NCT00094458|1762055|FG002|Study Extension: Week 30 Through Week 50|Other|3
809340|NCT00094458|1762056|FG003|Study Extension: Week 30 Through Week 50|Other|0
809341|NCT00094458|1762057|FG004|Study Extension: Week 30 Through Week 50|Other|0
809342|NCT00094458|1762058|FG005|Study Extension: Week 30 Through Week 50|Other|0
809343|NCT00094458|1762053|FG000|OLE: Open-Label Extension|Adverse Event|0
809344|NCT00094458|1762054|FG001|OLE: Open-Label Extension|Adverse Event|0
809345|NCT00094458|1762055|FG002|OLE: Open-Label Extension|Adverse Event|0
809346|NCT00094458|1762056|FG003|OLE: Open-Label Extension|Adverse Event|0
809348|NCT00094458|1762058|FG005|OLE: Open-Label Extension|Adverse Event|4
809349|NCT00094458|1762053|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0
809350|NCT00094458|1762054|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0
809351|NCT00094458|1762055|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0
809352|NCT00094458|1762056|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1
809353|NCT00094458|1762057|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1
809354|NCT00094458|1762058|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0
809355|NCT00094458|1762053|FG000|OLE: Open-Label Extension|Patient decision|0
809356|NCT00094458|1762054|FG001|OLE: Open-Label Extension|Patient decision|0
809357|NCT00094458|1762055|FG002|OLE: Open-Label Extension|Patient decision|0
809358|NCT00094458|1762056|FG003|OLE: Open-Label Extension|Patient decision|0
809359|NCT00094458|1762057|FG004|OLE: Open-Label Extension|Patient decision|1
809360|NCT00094458|1762058|FG005|OLE: Open-Label Extension|Patient decision|0
809361|NCT00094536|1762081|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
809362|NCT00094536|1762081|FG000|Treatment and Follow-up|Adverse Event|4
809363|NCT00094536|1762081|FG000|Treatment and Follow-up|Lack of Efficacy|9
809364|NCT00094536|1762081|FG000|Treatment and Follow-up|Lost to Follow-up|7
809365|NCT00094536|1762081|FG000|Treatment and Follow-up|Withdrawal by Subject|1
809366|NCT00094536|1762081|FG000|Treatment and Follow-up|Subject non-compliance|9
809367|NCT00094536|1762081|FG000|Treatment and Follow-up|Unable to attend visits|1
809368|NCT00094575|1762087|FG000|Overall Study|Death|146
809369|NCT00094575|1762088|FG001|Overall Study|Death|146
809370|NCT00094653|1762099|FG000|Overall Study|Death|306
809371|NCT00094653|1762100|FG001|Overall Study|Death|100
809372|NCT00094653|1762101|FG002|Overall Study|Death|119
809373|NCT00094653|1762099|FG000|Overall Study|Subject Withdrew Consent|10
809374|NCT00094653|1762100|FG001|Overall Study|Subject Withdrew Consent|2
809375|NCT00094653|1762101|FG002|Overall Study|Subject Withdrew Consent|3
809376|NCT00094653|1762099|FG000|Overall Study|Other|2
809377|NCT00094653|1762100|FG001|Overall Study|Other|2
809378|NCT00094653|1762101|FG002|Overall Study|Other|2
809379|NCT00094653|1762099|FG000|Overall Study|Lost to Follow-up|3
809380|NCT00094653|1762100|FG001|Overall Study|Lost to Follow-up|2
809381|NCT00094653|1762101|FG002|Overall Study|Lost to Follow-up|1
809382|NCT00094653|1762099|FG000|Overall Study|Protocol Violation|0
809383|NCT00094653|1762100|FG001|Overall Study|Protocol Violation|0
809384|NCT00094653|1762101|FG002|Overall Study|Protocol Violation|1
809385|NCT00094757|1762113|FG000|Overall Study|Adverse Event|11
809386|NCT00094757|1762114|FG001|Overall Study|Adverse Event|9
809387|NCT00094757|1762115|FG002|Overall Study|Adverse Event|6
809388|NCT00094757|1762113|FG000|Overall Study|Lack of Efficacy|11
809389|NCT00094757|1762114|FG001|Overall Study|Lack of Efficacy|15
809390|NCT00094757|1762115|FG002|Overall Study|Lack of Efficacy|8
809391|NCT00094757|1762113|FG000|Overall Study|Lost to Follow-up|3
809392|NCT00094757|1762114|FG001|Overall Study|Lost to Follow-up|5
809393|NCT00094757|1762115|FG002|Overall Study|Lost to Follow-up|6
809394|NCT00094757|1762113|FG000|Overall Study|Patient Moved|2
809395|NCT00094757|1762114|FG001|Overall Study|Patient Moved|1
809396|NCT00094757|1762115|FG002|Overall Study|Patient Moved|1
809397|NCT00094757|1762113|FG000|Overall Study|Protocol Violation|8
809398|NCT00094757|1762114|FG001|Overall Study|Protocol Violation|5
809399|NCT00094757|1762115|FG002|Overall Study|Protocol Violation|3
809400|NCT00094757|1762113|FG000|Overall Study|Withdrawal by Subject|14
809401|NCT00094757|1762114|FG001|Overall Study|Withdrawal by Subject|21
809402|NCT00094757|1762115|FG002|Overall Study|Withdrawal by Subject|5
809403|NCT00094757|1762113|FG000|Overall Study|Other|3
809404|NCT00094757|1762114|FG001|Overall Study|Other|3
809405|NCT00094757|1762115|FG002|Overall Study|Other|1
809406|NCT00094757|1762113|FG000|Overall Study|Protocol specified discontinuation|1
809407|NCT00094757|1762114|FG001|Overall Study|Protocol specified discontinuation|3
809408|NCT00094757|1762115|FG002|Overall Study|Protocol specified discontinuation|0
809409|NCT00094770|1762125|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25
809410|NCT00094770|1762126|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26
809411|NCT00094770|1762125|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
809412|NCT00094770|1762126|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
809413|NCT00094770|1762125|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
809414|NCT00094770|1762126|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
809415|NCT00094770|1762125|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
809416|NCT00094770|1762126|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
809417|NCT00094770|1762125|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
809418|NCT00094770|1762126|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
809419|NCT00094770|1762125|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6
809420|NCT00094770|1762126|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2
809421|NCT00094770|1762125|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
809422|NCT00094770|1762126|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
809423|NCT00094770|1762125|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2
809424|NCT00094770|1762126|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2
809425|NCT00094770|1762125|FG000|Year 1 ( Week 0 to Week 52)|Other|10
809426|NCT00094770|1762126|FG001|Year 1 ( Week 0 to Week 52)|Other|11
809427|NCT00094770|1762125|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35
809428|NCT00094770|1762126|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36
809429|NCT00094770|1762125|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
809430|NCT00094770|1762126|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
809431|NCT00094770|1762125|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
809432|NCT00094770|1762126|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
809433|NCT00094770|1762125|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13
809434|NCT00094770|1762126|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12
809435|NCT00094770|1762125|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
809436|NCT00094770|1762126|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
809437|NCT00094770|1762125|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6
809438|NCT00094770|1762126|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2
809439|NCT00094770|1762125|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
809440|NCT00094770|1762126|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
809441|NCT00094770|1762125|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2
809442|NCT00094770|1762126|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2
809443|NCT00094770|1762125|FG000|Year 2 (Week 0 to Week 104)|Other|15
809444|NCT00094770|1762126|FG001|Year 2 (Week 0 to Week 104)|Other|23
809445|NCT00094809|1762134|FG000|Overall Study|Protocol deviation|2
809446|NCT00094809|1762135|FG001|Overall Study|Protocol deviation|2
809447|NCT00094809|1762134|FG000|Overall Study|Noncompliance|1
809448|NCT00094809|1762135|FG001|Overall Study|Noncompliance|0
809449|NCT00094809|1762134|FG000|Overall Study|Adverse Event|3
809450|NCT00094809|1762135|FG001|Overall Study|Adverse Event|1
809451|NCT00094809|1762134|FG000|Overall Study|Withdrawal by Subject|8
809452|NCT00094809|1762135|FG001|Overall Study|Withdrawal by Subject|9
809453|NCT00094809|1762134|FG000|Overall Study|Disease progression|3
809454|NCT00094809|1762135|FG001|Overall Study|Disease progression|3
809455|NCT00094809|1762134|FG000|Overall Study|Physician Decision|3
809456|NCT00094809|1762135|FG001|Overall Study|Physician Decision|5
809457|NCT00094809|1762134|FG000|Overall Study|Lost to Follow-up|6
809458|NCT00094809|1762135|FG001|Overall Study|Lost to Follow-up|6
809459|NCT00094809|1762134|FG000|Overall Study|Death|19
809460|NCT00094809|1762135|FG001|Overall Study|Death|25
809461|NCT00094809|1762134|FG000|Overall Study|Protocol-specified criteria|1
809462|NCT00094809|1762135|FG001|Overall Study|Protocol-specified criteria|1
809463|NCT00094809|1762134|FG000|Overall Study|Other|2
809464|NCT00094809|1762135|FG001|Overall Study|Other|4
809465|NCT00094809|1762134|FG000|Overall Study|Informed consent signed after treatment|1
809466|NCT00094809|1762135|FG001|Overall Study|Informed consent signed after treatment|0
809467|NCT00094809|1762134|FG000|Overall Study|Study drug not received|2
809468|NCT00094809|1762135|FG001|Overall Study|Study drug not received|8
809469|NCT00094809|1762134|FG000|Overall Study|Other|1
809470|NCT00094809|1762135|FG001|Overall Study|Other|1
809471|NCT00094835|1762148|FG000|Overall Study|Physician Decision|1
809472|NCT00094835|1762149|FG001|Overall Study|Physician Decision|0
809473|NCT00094835|1762150|FG002|Overall Study|Physician Decision|0
809474|NCT00094835|1762151|FG003|Overall Study|Physician Decision|0
809475|NCT00094835|1762152|FG004|Overall Study|Physician Decision|0
809476|NCT00094835|1762153|FG005|Overall Study|Physician Decision|1
809477|NCT00094835|1762154|FG006|Overall Study|Physician Decision|0
809478|NCT00094835|1762148|FG000|Overall Study|Withdrawal by Subject|0
809479|NCT00094835|1762149|FG001|Overall Study|Withdrawal by Subject|0
809480|NCT00094835|1762150|FG002|Overall Study|Withdrawal by Subject|0
809481|NCT00094835|1762151|FG003|Overall Study|Withdrawal by Subject|0
809482|NCT00094835|1762152|FG004|Overall Study|Withdrawal by Subject|0
809483|NCT00094835|1762153|FG005|Overall Study|Withdrawal by Subject|0
809484|NCT00094835|1762154|FG006|Overall Study|Withdrawal by Subject|1
809485|NCT00094835|1762148|FG000|Overall Study|Lost to Follow-up|0
809486|NCT00094835|1762149|FG001|Overall Study|Lost to Follow-up|0
809487|NCT00094835|1762150|FG002|Overall Study|Lost to Follow-up|0
809488|NCT00094835|1762151|FG003|Overall Study|Lost to Follow-up|0
809489|NCT00094835|1762152|FG004|Overall Study|Lost to Follow-up|1
809490|NCT00094835|1762153|FG005|Overall Study|Lost to Follow-up|0
809491|NCT00094835|1762154|FG006|Overall Study|Lost to Follow-up|0
809492|NCT00094835|1762148|FG000|Overall Study|Death|1
809493|NCT00094835|1762149|FG001|Overall Study|Death|0
809494|NCT00094835|1762150|FG002|Overall Study|Death|0
809495|NCT00094835|1762151|FG003|Overall Study|Death|0
809496|NCT00094835|1762152|FG004|Overall Study|Death|1
809497|NCT00094835|1762153|FG005|Overall Study|Death|0
809498|NCT00094835|1762154|FG006|Overall Study|Death|0
809499|NCT00094835|1762148|FG000|Overall Study|Non-compliance|1
809500|NCT00094835|1762149|FG001|Overall Study|Non-compliance|2
809501|NCT00094835|1762150|FG002|Overall Study|Non-compliance|2
809502|NCT00094835|1762151|FG003|Overall Study|Non-compliance|0
809503|NCT00094835|1762152|FG004|Overall Study|Non-compliance|2
809504|NCT00094835|1762153|FG005|Overall Study|Non-compliance|2
809505|NCT00094835|1762154|FG006|Overall Study|Non-compliance|1
809506|NCT00094835|1762148|FG000|Overall Study|Other|1
809507|NCT00094835|1762149|FG001|Overall Study|Other|1
809508|NCT00094835|1762150|FG002|Overall Study|Other|1
809509|NCT00094835|1762151|FG003|Overall Study|Other|1
809510|NCT00094835|1762152|FG004|Overall Study|Other|0
809511|NCT00094835|1762153|FG005|Overall Study|Other|0
809512|NCT00094835|1762154|FG006|Overall Study|Other|0
809513|NCT00094861|1762177|FG000|Overall Study|Adverse Event|5
809514|NCT00094861|1762178|FG001|Overall Study|Adverse Event|2
809515|NCT00094861|1762177|FG000|Overall Study|Withdrawal by Subject|5
809516|NCT00094861|1762178|FG001|Overall Study|Withdrawal by Subject|3
809517|NCT00094861|1762177|FG000|Overall Study|Physician Decision|1
809518|NCT00094861|1762178|FG001|Overall Study|Physician Decision|1
809519|NCT00094861|1762177|FG000|Overall Study|Lost to Follow-up|0
809520|NCT00094861|1762178|FG001|Overall Study|Lost to Follow-up|1
809521|NCT00094861|1762177|FG000|Overall Study|Death|4
809522|NCT00094861|1762178|FG001|Overall Study|Death|2
809523|NCT00094861|1762177|FG000|Overall Study|Other|3
809524|NCT00094861|1762178|FG001|Overall Study|Other|0
809525|NCT00095056|1762199|FG000|Phase A (Weeks 0-12)|Adverse Event|1
809526|NCT00095056|1762200|FG001|Phase A (Weeks 0-12)|Adverse Event|1
809527|NCT00095056|1762199|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3
809528|NCT00095056|1762200|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0
809529|NCT00095056|1762199|FG000|Phase A (Weeks 0-12)|Death|1
809530|NCT00095056|1762200|FG001|Phase A (Weeks 0-12)|Death|0
809531|NCT00095056|1762199|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2
809532|NCT00095056|1762200|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0
809533|NCT00095056|1762199|FG000|Phase B (Weeks 12-54)|Adverse Event|2
809534|NCT00095056|1762200|FG001|Phase B (Weeks 12-54)|Adverse Event|2
809535|NCT00095056|1762199|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1
809536|NCT00095056|1762200|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0
809537|NCT00095056|1762199|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2
809538|NCT00095056|1762200|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1
809539|NCT00095056|1762199|FG000|Phase B (Weeks 12-54)|Patient Moved|1
809540|NCT00095056|1762200|FG001|Phase B (Weeks 12-54)|Patient Moved|0
809541|NCT00095056|1762199|FG000|Phase B (Weeks 12-54)|Death|3
809542|NCT00095056|1762200|FG001|Phase B (Weeks 12-54)|Death|1
809543|NCT00095056|1762199|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1
809544|NCT00095056|1762200|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0
809545|NCT00095056|1762199|FG000|Phase B (Weeks 12-54)|Protocol Violation|0
809546|NCT00095056|1762200|FG001|Phase B (Weeks 12-54)|Protocol Violation|1
809547|NCT00095121|1762208|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
809548|NCT00095121|1762209|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
809549|NCT00095121|1762208|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
809550|NCT00095121|1762209|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
809551|NCT00095147|1762228|FG000|Double-blind Period 1 (Days 1-197)|Death|1
809552|NCT00095147|1762229|FG001|Double-blind Period 1 (Days 1-197)|Death|0
809553|NCT00095147|1762230|FG002|Double-blind Period 1 (Days 1-197)|Death|0
809554|NCT00095147|1762231|FG003|Double-blind Period 1 (Days 1-197)|Death|0
809555|NCT00095147|1762232|FG004|Double-blind Period 1 (Days 1-197)|Death|0
809556|NCT00095147|1762228|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2
809557|NCT00095147|1762229|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8
809558|NCT00095147|1762230|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1
809559|NCT00095147|1762231|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0
809560|NCT00095147|1762232|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0
809561|NCT00095147|1762228|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
809562|NCT00095147|1762229|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
809563|NCT00095147|1762230|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
809564|NCT00095147|1762231|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
809565|NCT00095147|1762232|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
809566|NCT00095147|1762228|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
809567|NCT00095147|1762229|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
809568|NCT00095147|1762230|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
809569|NCT00095147|1762231|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
809570|NCT00095147|1762232|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
809571|NCT00095147|1762228|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
809572|NCT00095147|1762229|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
809573|NCT00095147|1762230|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
809574|NCT00095147|1762231|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
809575|NCT00095147|1762232|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
809576|NCT00095147|1762228|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1
809577|NCT00095147|1762229|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1
809578|NCT00095147|1762230|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0
809579|NCT00095147|1762231|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0
809580|NCT00095147|1762232|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0
809581|NCT00095147|1762228|FG000|Double-blind Period 2 (Days 198-365)|Death|0
809582|NCT00095147|1762229|FG001|Double-blind Period 2 (Days 198-365)|Death|1
809583|NCT00095147|1762230|FG002|Double-blind Period 2 (Days 198-365)|Death|0
809584|NCT00095147|1762231|FG003|Double-blind Period 2 (Days 198-365)|Death|1
809585|NCT00095147|1762232|FG004|Double-blind Period 2 (Days 198-365)|Death|0
809586|NCT00095147|1762228|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2
809587|NCT00095147|1762229|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4
809588|NCT00095147|1762230|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0
809589|NCT00095147|1762231|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0
809590|NCT00095147|1762232|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0
809591|NCT00095147|1762228|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
809592|NCT00095147|1762229|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
809593|NCT00095147|1762230|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
809594|NCT00095147|1762231|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
809595|NCT00095147|1762232|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
809596|NCT00095147|1762228|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
809597|NCT00095147|1762229|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
809598|NCT00095147|1762230|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
809599|NCT00095147|1762231|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
809600|NCT00095147|1762232|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
809601|NCT00095147|1762228|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1
809602|NCT00095147|1762229|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0
809603|NCT00095147|1762230|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0
809604|NCT00095147|1762231|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1
809605|NCT00095147|1762232|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0
809606|NCT00095147|1762228|FG000|Long-term Extension Period|Death|0
809607|NCT00095147|1762229|FG001|Long-term Extension Period|Death|0
809608|NCT00095147|1762230|FG002|Long-term Extension Period|Death|0
809609|NCT00095147|1762231|FG003|Long-term Extension Period|Death|0
809610|NCT00095147|1762232|FG004|Long-term Extension Period|Death|3
809611|NCT00095147|1762228|FG000|Long-term Extension Period|Adverse Event|0
809612|NCT00095147|1762229|FG001|Long-term Extension Period|Adverse Event|0
809613|NCT00095147|1762230|FG002|Long-term Extension Period|Adverse Event|0
809614|NCT00095147|1762231|FG003|Long-term Extension Period|Adverse Event|0
809615|NCT00095147|1762232|FG004|Long-term Extension Period|Adverse Event|11
809616|NCT00095147|1762228|FG000|Long-term Extension Period|Lack of Efficacy|0
809617|NCT00095147|1762229|FG001|Long-term Extension Period|Lack of Efficacy|0
809618|NCT00095147|1762230|FG002|Long-term Extension Period|Lack of Efficacy|0
809619|NCT00095147|1762231|FG003|Long-term Extension Period|Lack of Efficacy|0
809620|NCT00095147|1762232|FG004|Long-term Extension Period|Lack of Efficacy|9
809621|NCT00095147|1762228|FG000|Long-term Extension Period|Lost to Follow-up|0
809622|NCT00095147|1762229|FG001|Long-term Extension Period|Lost to Follow-up|0
809623|NCT00095147|1762230|FG002|Long-term Extension Period|Lost to Follow-up|0
809624|NCT00095147|1762231|FG003|Long-term Extension Period|Lost to Follow-up|0
809625|NCT00095147|1762232|FG004|Long-term Extension Period|Lost to Follow-up|6
809626|NCT00095147|1762228|FG000|Long-term Extension Period|Withdrawal of consent|0
809627|NCT00095147|1762229|FG001|Long-term Extension Period|Withdrawal of consent|0
809628|NCT00095147|1762230|FG002|Long-term Extension Period|Withdrawal of consent|0
809629|NCT00095147|1762231|FG003|Long-term Extension Period|Withdrawal of consent|0
809630|NCT00095147|1762232|FG004|Long-term Extension Period|Withdrawal of consent|12
809631|NCT00095147|1762228|FG000|Long-term Extension Period|Pregnancy|0
809632|NCT00095147|1762229|FG001|Long-term Extension Period|Pregnancy|0
809633|NCT00095147|1762230|FG002|Long-term Extension Period|Pregnancy|0
809634|NCT00095147|1762231|FG003|Long-term Extension Period|Pregnancy|0
809635|NCT00095147|1762232|FG004|Long-term Extension Period|Pregnancy|1
809636|NCT00095147|1762228|FG000|Long-term Extension Period|No longer meets study criteria|0
809637|NCT00095147|1762229|FG001|Long-term Extension Period|No longer meets study criteria|0
809638|NCT00095147|1762230|FG002|Long-term Extension Period|No longer meets study criteria|0
809639|NCT00095147|1762231|FG003|Long-term Extension Period|No longer meets study criteria|0
809640|NCT00095147|1762232|FG004|Long-term Extension Period|No longer meets study criteria|1
809641|NCT00095147|1762228|FG000|Long-term Extension Period|Participant chose to use Revellex|0
809642|NCT00095147|1762229|FG001|Long-term Extension Period|Participant chose to use Revellex|0
809643|NCT00095147|1762230|FG002|Long-term Extension Period|Participant chose to use Revellex|0
809644|NCT00095147|1762231|FG003|Long-term Extension Period|Participant chose to use Revellex|0
809645|NCT00095147|1762232|FG004|Long-term Extension Period|Participant chose to use Revellex|1
809646|NCT00095147|1762228|FG000|Long-term Extension Period|Leaving country|0
809647|NCT00095147|1762229|FG001|Long-term Extension Period|Leaving country|0
809648|NCT00095147|1762230|FG002|Long-term Extension Period|Leaving country|0
809649|NCT00095147|1762231|FG003|Long-term Extension Period|Leaving country|0
809650|NCT00095147|1762232|FG004|Long-term Extension Period|Leaving country|1
809651|NCT00095173|1762250|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1
809652|NCT00095173|1762251|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0
809653|NCT00095173|1762252|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0
809654|NCT00095173|1762253|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0
809655|NCT00095173|1762254|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0
809656|NCT00095173|1762255|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0
809657|NCT00095173|1762250|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
809658|NCT00095173|1762251|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
809659|NCT00095173|1762252|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
809660|NCT00095173|1762253|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
809661|NCT00095173|1762254|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
809662|NCT00095173|1762255|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
809663|NCT00095173|1762250|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
809664|NCT00095173|1762251|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
809665|NCT00095173|1762252|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
809666|NCT00095173|1762253|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
809667|NCT00095173|1762254|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
809668|NCT00095173|1762255|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
809669|NCT00095173|1762250|FG000|Open-Label Lead-In Phase (Period A)|Other|1
809670|NCT00095173|1762251|FG001|Open-Label Lead-In Phase (Period A)|Other|0
809671|NCT00095173|1762252|FG002|Open-Label Lead-In Phase (Period A)|Other|0
809672|NCT00095173|1762253|FG003|Open-Label Lead-In Phase (Period A)|Other|0
809673|NCT00095173|1762254|FG004|Open-Label Lead-In Phase (Period A)|Other|0
809674|NCT00095173|1762255|FG005|Open-Label Lead-In Phase (Period A)|Other|0
809675|NCT00095173|1762250|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0
809676|NCT00095173|1762251|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10
809677|NCT00095173|1762252|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31
809678|NCT00095173|1762253|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0
809679|NCT00095173|1762254|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0
809680|NCT00095173|1762255|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0
809681|NCT00095173|1762250|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0
809682|NCT00095173|1762251|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1
809683|NCT00095173|1762252|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0
809684|NCT00095173|1762253|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0
809685|NCT00095173|1762254|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0
809686|NCT00095173|1762255|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0
809687|NCT00095173|1762250|FG000|Open-Label Extension Phase (Period C)|Death|0
809688|NCT00095173|1762251|FG001|Open-Label Extension Phase (Period C)|Death|0
809689|NCT00095173|1762252|FG002|Open-Label Extension Phase (Period C)|Death|0
809690|NCT00095173|1762253|FG003|Open-Label Extension Phase (Period C)|Death|0
809691|NCT00095173|1762254|FG004|Open-Label Extension Phase (Period C)|Death|0
809692|NCT00095173|1762255|FG005|Open-Label Extension Phase (Period C)|Death|1
809693|NCT00095173|1762250|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0
809694|NCT00095173|1762251|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0
809695|NCT00095173|1762252|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0
809696|NCT00095173|1762253|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1
809697|NCT00095173|1762254|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2
809698|NCT00095173|1762255|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3
809699|NCT00095173|1762250|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
809700|NCT00095173|1762251|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
809701|NCT00095173|1762252|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
809702|NCT00095173|1762253|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
809703|NCT00095173|1762254|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
809704|NCT00095173|1762255|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
809705|NCT00095173|1762250|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
809706|NCT00095173|1762251|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
809707|NCT00095173|1762252|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
809708|NCT00095173|1762253|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
809709|NCT00095173|1762254|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
809710|NCT00095173|1762255|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
809711|NCT00095173|1762250|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
809712|NCT00095173|1762251|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
809713|NCT00095173|1762252|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
809714|NCT00095173|1762253|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
809715|NCT00095173|1762254|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
809716|NCT00095173|1762255|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
809717|NCT00095173|1762250|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
809718|NCT00095173|1762251|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
809719|NCT00095173|1762252|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
809720|NCT00095173|1762253|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
809721|NCT00095173|1762254|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
809722|NCT00095173|1762255|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
809723|NCT00095173|1762250|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
809724|NCT00095173|1762251|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
809725|NCT00095173|1762252|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
809726|NCT00095173|1762253|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
809727|NCT00095173|1762254|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
809728|NCT00095173|1762255|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
809729|NCT00095173|1762250|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0
809730|NCT00095173|1762251|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0
809731|NCT00095173|1762252|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0
809732|NCT00095173|1762253|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1
809733|NCT00095173|1762254|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2
809734|NCT00095173|1762255|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3
809735|NCT00095173|1762250|FG000|Open-Label Extension Phase (Period C)|Other|0
809736|NCT00095173|1762251|FG001|Open-Label Extension Phase (Period C)|Other|0
809737|NCT00095173|1762252|FG002|Open-Label Extension Phase (Period C)|Other|0
809738|NCT00095173|1762253|FG003|Open-Label Extension Phase (Period C)|Other|4
809739|NCT00095173|1762254|FG004|Open-Label Extension Phase (Period C)|Other|6
809740|NCT00095173|1762255|FG005|Open-Label Extension Phase (Period C)|Other|8
809741|NCT00095199|1762273|FG000|Overall Study|Adverse Event|40
809742|NCT00095199|1762274|FG001|Overall Study|Adverse Event|22
809743|NCT00095199|1762275|FG002|Overall Study|Adverse Event|26
809744|NCT00095199|1762276|FG003|Overall Study|Adverse Event|11
809745|NCT00095199|1762273|FG000|Overall Study|Progressive disease|213
809746|NCT00095199|1762274|FG001|Overall Study|Progressive disease|179
809747|NCT00095199|1762275|FG002|Overall Study|Progressive disease|105
809748|NCT00095199|1762276|FG003|Overall Study|Progressive disease|98
809749|NCT00095199|1762273|FG000|Overall Study|Death|10
809750|NCT00095199|1762274|FG001|Overall Study|Death|6
809751|NCT00095199|1762275|FG002|Overall Study|Death|11
809752|NCT00095199|1762276|FG003|Overall Study|Death|9
809753|NCT00095199|1762273|FG000|Overall Study|Withdrawal by Subject|21
809754|NCT00095199|1762274|FG001|Overall Study|Withdrawal by Subject|16
809755|NCT00095199|1762275|FG002|Overall Study|Withdrawal by Subject|13
809756|NCT00095199|1762276|FG003|Overall Study|Withdrawal by Subject|22
809757|NCT00095199|1762273|FG000|Overall Study|Protocol Violation|4
809758|NCT00095199|1762274|FG001|Overall Study|Protocol Violation|4
809759|NCT00095199|1762275|FG002|Overall Study|Protocol Violation|2
809760|NCT00095199|1762276|FG003|Overall Study|Protocol Violation|0
809761|NCT00095199|1762273|FG000|Overall Study|Liver function test results elevated|0
809762|NCT00095199|1762274|FG001|Overall Study|Liver function test results elevated|0
809763|NCT00095199|1762275|FG002|Overall Study|Liver function test results elevated|1
809764|NCT00095199|1762276|FG003|Overall Study|Liver function test results elevated|1
809765|NCT00095199|1762273|FG000|Overall Study|Surgery needed could not start in 7 days|0
809766|NCT00095199|1762274|FG001|Overall Study|Surgery needed could not start in 7 days|0
809767|NCT00095199|1762275|FG002|Overall Study|Surgery needed could not start in 7 days|1
809768|NCT00095199|1762276|FG003|Overall Study|Surgery needed could not start in 7 days|0
809769|NCT00095199|1762273|FG000|Overall Study|Physician Decision|5
809770|NCT00095199|1762274|FG001|Overall Study|Physician Decision|6
809771|NCT00095199|1762275|FG002|Overall Study|Physician Decision|1
809772|NCT00095199|1762276|FG003|Overall Study|Physician Decision|1
809773|NCT00095199|1762273|FG000|Overall Study|Not eligible|1
809774|NCT00095199|1762274|FG001|Overall Study|Not eligible|7
809775|NCT00095199|1762275|FG002|Overall Study|Not eligible|0
809776|NCT00095199|1762276|FG003|Overall Study|Not eligible|1
809777|NCT00095199|1762273|FG000|Overall Study|Started Palliative Radiotherapy|1
809778|NCT00095199|1762274|FG001|Overall Study|Started Palliative Radiotherapy|0
809779|NCT00095199|1762275|FG002|Overall Study|Started Palliative Radiotherapy|0
809780|NCT00095199|1762276|FG003|Overall Study|Started Palliative Radiotherapy|0
809781|NCT00095199|1762273|FG000|Overall Study|Started radiotherapy regimen|0
809782|NCT00095199|1762274|FG001|Overall Study|Started radiotherapy regimen|1
809783|NCT00095199|1762275|FG002|Overall Study|Started radiotherapy regimen|0
809784|NCT00095199|1762276|FG003|Overall Study|Started radiotherapy regimen|0
809785|NCT00095199|1762273|FG000|Overall Study|Primary tumor removed in other surgery|0
809786|NCT00095199|1762274|FG001|Overall Study|Primary tumor removed in other surgery|1
809787|NCT00095199|1762275|FG002|Overall Study|Primary tumor removed in other surgery|0
809788|NCT00095199|1762276|FG003|Overall Study|Primary tumor removed in other surgery|0
809789|NCT00095199|1762273|FG000|Overall Study|Data inadvertently lost by site|1
809790|NCT00095199|1762274|FG001|Overall Study|Data inadvertently lost by site|0
809791|NCT00095199|1762275|FG002|Overall Study|Data inadvertently lost by site|0
809792|NCT00095199|1762276|FG003|Overall Study|Data inadvertently lost by site|0
809793|NCT00095212|1762293|FG000|Overall Study|Withdrawal by Subject|1
809794|NCT00095212|1762294|FG001|Overall Study|Withdrawal by Subject|3
809795|NCT00095238|1762302|FG000|Overall Study|Lack of Efficacy|9
809796|NCT00095238|1762303|FG001|Overall Study|Lack of Efficacy|9
809797|NCT00095238|1762302|FG000|Overall Study|Adverse Event|331
809798|NCT00095238|1762303|FG001|Overall Study|Adverse Event|287
809799|NCT00095238|1762302|FG000|Overall Study|Subject Withdrew Consent|208
809800|NCT00095238|1762303|FG001|Overall Study|Subject Withdrew Consent|223
809801|NCT00095238|1762302|FG000|Overall Study|Death|154
809802|NCT00095238|1762303|FG001|Overall Study|Death|170
809803|NCT00095238|1762302|FG000|Overall Study|Lost to Follow-up|19
809804|NCT00095238|1762303|FG001|Overall Study|Lost to Follow-up|24
809805|NCT00095238|1762302|FG000|Overall Study|Noncompliance|44
809806|NCT00095238|1762303|FG001|Overall Study|Noncompliance|45
809807|NCT00095238|1762302|FG000|Overall Study|No longer met study criteria|4
809808|NCT00095238|1762303|FG001|Overall Study|No longer met study criteria|5
809809|NCT00095238|1762302|FG000|Overall Study|Study terminated by sponsor|0
809810|NCT00095238|1762303|FG001|Overall Study|Study terminated by sponsor|1
809811|NCT00095238|1762302|FG000|Overall Study|Missing|1
809812|NCT00095238|1762303|FG001|Overall Study|Missing|0
809813|NCT00095238|1762302|FG000|Overall Study|Other Reasons|87
809814|NCT00095238|1762303|FG001|Overall Study|Other Reasons|88
809815|NCT00095303|1762343|FG000|Main Study|Lost to Follow-up|91
809816|NCT00095303|1762344|FG001|Main Study|Lost to Follow-up|87
809817|NCT00095303|1762343|FG000|Follow Up Study|Lost to Follow-up|59
809818|NCT00095303|1762344|FG001|Follow Up Study|Lost to Follow-up|58
809819|NCT00095498|1762353|FG000|Overall Study|Physician Decision|9
809820|NCT00095498|1762354|FG001|Overall Study|Physician Decision|10
809821|NCT00095498|1762355|FG002|Overall Study|Physician Decision|8
809822|NCT00095498|1762353|FG000|Overall Study|Adverse Event|1
809823|NCT00095498|1762354|FG001|Overall Study|Adverse Event|0
809824|NCT00095498|1762355|FG002|Overall Study|Adverse Event|1
809825|NCT00095498|1762353|FG000|Overall Study|Withdrawal by Subject|15
809826|NCT00095498|1762354|FG001|Overall Study|Withdrawal by Subject|16
809827|NCT00095498|1762355|FG002|Overall Study|Withdrawal by Subject|15
809828|NCT00095498|1762353|FG000|Overall Study|Disease progression|0
809829|NCT00095498|1762354|FG001|Overall Study|Disease progression|1
809830|NCT00095498|1762355|FG002|Overall Study|Disease progression|1
809831|NCT00095498|1762353|FG000|Overall Study|Ineligibility determined|3
809832|NCT00095498|1762354|FG001|Overall Study|Ineligibility determined|0
809833|NCT00095498|1762355|FG002|Overall Study|Ineligibility determined|2
809834|NCT00095498|1762353|FG000|Overall Study|Lost to Follow-up|1
809835|NCT00095498|1762354|FG001|Overall Study|Lost to Follow-up|1
809836|NCT00095498|1762355|FG002|Overall Study|Lost to Follow-up|2
809837|NCT00095498|1762353|FG000|Overall Study|Noncompliance|1
809838|NCT00095498|1762354|FG001|Overall Study|Noncompliance|0
809839|NCT00095498|1762355|FG002|Overall Study|Noncompliance|1
809840|NCT00095498|1762353|FG000|Overall Study|Other|6
809841|NCT00095498|1762354|FG001|Overall Study|Other|7
809842|NCT00095498|1762355|FG002|Overall Study|Other|6
809843|NCT00095498|1762353|FG000|Overall Study|Protocol Violation|0
809844|NCT00095498|1762354|FG001|Overall Study|Protocol Violation|0
809845|NCT00095498|1762355|FG002|Overall Study|Protocol Violation|1
809846|NCT00095498|1762353|FG000|Overall Study|Requirement for alternative therapy|1
809847|NCT00095498|1762354|FG001|Overall Study|Requirement for alternative therapy|0
809848|NCT00095498|1762355|FG002|Overall Study|Requirement for alternative therapy|2
809849|NCT00095576|1762369|FG000|Overall Study|Adverse Event|5
809850|NCT00095576|1762370|FG001|Overall Study|Adverse Event|3
809851|NCT00095576|1762369|FG000|Overall Study|Lost to Follow-up|233
809852|NCT00095576|1762370|FG001|Overall Study|Lost to Follow-up|229
809853|NCT00095576|1762369|FG000|Overall Study|Protocol Violation|1
809854|NCT00095576|1762370|FG001|Overall Study|Protocol Violation|0
809855|NCT00095576|1762369|FG000|Overall Study|Withdrawal by Subject|34
809856|NCT00095576|1762370|FG001|Overall Study|Withdrawal by Subject|47
809857|NCT00095576|1762369|FG000|Overall Study|Option to switch to a rollover study|1097
809858|NCT00095576|1762370|FG001|Overall Study|Option to switch to a rollover study|1099
809859|NCT00095576|1762369|FG000|Overall Study|Site terminated|75
809860|NCT00095576|1762370|FG001|Overall Study|Site terminated|67
809861|NCT00095576|1762369|FG000|Overall Study|Subject moved|30
809862|NCT00095576|1762370|FG001|Overall Study|Subject moved|36
809863|NCT00095628|1762376|FG000|Overall Study|Disease progression prior to treatment|1
809864|NCT00095836|1762380|FG000|Overall Study|Lost to Follow-up|1
809865|NCT00095836|1762380|FG000|Overall Study|Adverse Event|1
809866|NCT00095836|1762380|FG000|Overall Study|Death|2
809867|NCT00095940|1762400|FG000|Lapatinib Continuation/Phase II|Disease Progression|1
809868|NCT00095940|1762401|FG001|Lapatinib Continuation/Phase II|Disease Progression|1
809869|NCT00095940|1762402|FG002|Lapatinib Continuation/Phase II|Disease Progression|15
809870|NCT00095940|1762403|FG003|Lapatinib Continuation/Phase II|Disease Progression|0
809871|NCT00095940|1762404|FG004|Lapatinib Continuation/Phase II|Disease Progression|0
809872|NCT00095940|1762405|FG005|Lapatinib Continuation/Phase II|Disease Progression|13
809873|NCT00095940|1762406|FG006|Lapatinib Continuation/Phase II|Disease Progression|2
809874|NCT00095940|1762407|FG007|Lapatinib Continuation/Phase II|Disease Progression|1
809875|NCT00095940|1762408|FG008|Lapatinib Continuation/Phase II|Disease Progression|12
809876|NCT00095940|1762400|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
809877|NCT00095940|1762401|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
809878|NCT00095940|1762402|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
809879|NCT00095940|1762403|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
809880|NCT00095940|1762404|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
809881|NCT00095940|1762405|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
809882|NCT00095940|1762406|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
809883|NCT00095940|1762407|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
809884|NCT00095940|1762408|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
809885|NCT00095940|1762400|FG000|Lapatinib Continuation/Phase II|Adverse Event|0
809886|NCT00095940|1762401|FG001|Lapatinib Continuation/Phase II|Adverse Event|0
809887|NCT00095940|1762402|FG002|Lapatinib Continuation/Phase II|Adverse Event|0
809888|NCT00095940|1762403|FG003|Lapatinib Continuation/Phase II|Adverse Event|0
809889|NCT00095940|1762404|FG004|Lapatinib Continuation/Phase II|Adverse Event|0
809890|NCT00095940|1762405|FG005|Lapatinib Continuation/Phase II|Adverse Event|0
809891|NCT00095940|1762406|FG006|Lapatinib Continuation/Phase II|Adverse Event|0
809892|NCT00095940|1762407|FG007|Lapatinib Continuation/Phase II|Adverse Event|1
809893|NCT00095940|1762408|FG008|Lapatinib Continuation/Phase II|Adverse Event|0
809894|NCT00095979|1762426|FG000|Overall Study|Ineligible: Second primary cancer site|2
809895|NCT00096018|1762437|FG000|Overall Study|Became Ineligible (not treated)|0
809896|NCT00096018|1762438|FG001|Overall Study|Became Ineligible (not treated)|3
809897|NCT00096018|1762437|FG000|Overall Study|Miscellaneous (not treated)|0
809898|NCT00096018|1762438|FG001|Overall Study|Miscellaneous (not treated)|2
809899|NCT00096018|1762437|FG000|Overall Study|Adverse Event|0
809900|NCT00096018|1762438|FG001|Overall Study|Adverse Event|5
809901|NCT00096018|1762437|FG000|Overall Study|Death|0
809902|NCT00096018|1762438|FG001|Overall Study|Death|1
809903|NCT00096018|1762437|FG000|Overall Study|Withdrawal by Subject|0
809904|NCT00096018|1762438|FG001|Overall Study|Withdrawal by Subject|2
809905|NCT00096018|1762437|FG000|Overall Study|Miscellaneous|2
809906|NCT00096018|1762438|FG001|Overall Study|Miscellaneous|1
809907|NCT00096031|1762444|FG000|Overall Study|Adverse Event|3
809908|NCT00096031|1762444|FG000|Overall Study|Lack of Efficacy|42
809909|NCT00096031|1762444|FG000|Overall Study|Death|4
809910|NCT00096031|1762444|FG000|Overall Study|Withdrawal by Subject|1
809911|NCT00096031|1762444|FG000|Overall Study|Ineligible|8
809912|NCT00096031|1762444|FG000|Overall Study|Not protocol specified|5
809913|NCT00096044|1762448|FG000|Overall Study|Withdrawal by Subject|9
809914|NCT00096044|1762448|FG000|Overall Study|Adverse Event|21
809915|NCT00096044|1762448|FG000|Overall Study|Disease Progression|4
809916|NCT00096135|1762462|FG000|Overall Study|Physician Decision|20
809917|NCT00096135|1762463|FG001|Overall Study|Physician Decision|4
809918|NCT00096135|1762462|FG000|Overall Study|Refusal of further protocol therapy|4
809919|NCT00096135|1762463|FG001|Overall Study|Refusal of further protocol therapy|1
809920|NCT00096135|1762462|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
809921|NCT00096135|1762463|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
809922|NCT00096135|1762462|FG000|Overall Study|Other, specify|15
809923|NCT00096135|1762463|FG001|Overall Study|Other, specify|3
809924|NCT00096135|1762462|FG000|Overall Study|Ineligible|2
809925|NCT00096135|1762463|FG001|Overall Study|Ineligible|0
809926|NCT00096174|1762486|FG000|Overall Study|Lack of Efficacy|9
809927|NCT00096174|1762486|FG000|Overall Study|Adverse Event|15
809928|NCT00096174|1762486|FG000|Overall Study|Death|6
809929|NCT00096174|1762486|FG000|Overall Study|Withdrawal by Subject|15
809930|NCT00096174|1762486|FG000|Overall Study|Not started protocol therapy|3
809931|NCT00096174|1762486|FG000|Overall Study|Ineligible|6
809932|NCT00096174|1762486|FG000|Overall Study|other reason|8
809933|NCT00096200|1762493|FG000|Overall Study|Adverse Event|0
809934|NCT00096200|1762494|FG001|Overall Study|Adverse Event|4
809935|NCT00096200|1762495|FG002|Overall Study|Adverse Event|0
809936|NCT00096200|1762493|FG000|Overall Study|Withdrawal by Subject|1
809937|NCT00096200|1762494|FG001|Overall Study|Withdrawal by Subject|2
809938|NCT00096200|1762495|FG002|Overall Study|Withdrawal by Subject|0
809939|NCT00096200|1762493|FG000|Overall Study|Ineligible pathology|0
809940|NCT00096200|1762494|FG001|Overall Study|Ineligible pathology|1
809941|NCT00096200|1762495|FG002|Overall Study|Ineligible pathology|0
809942|NCT00096226|1762503|FG000|Overall Study|Ineligible|2
809943|NCT00096226|1762503|FG000|Overall Study|Protocol treatment not started|1
809944|NCT00096265|1762510|FG000|Overall Study|Ineligible|1
809945|NCT00096265|1762511|FG001|Overall Study|Ineligible|0
809946|NCT00096265|1762512|FG002|Overall Study|Ineligible|0
809947|NCT00096278|1762523|FG000|Overall Study|No follow-up data|15
809948|NCT00096278|1762524|FG001|Overall Study|No follow-up data|18
809949|NCT00096278|1762523|FG000|Overall Study|Patient not at risk for primary endpoint|3
809950|NCT00096278|1762524|FG001|Overall Study|Patient not at risk for primary endpoint|2
809951|NCT00096356|1762534|FG000|Overall Study|Adverse Event|11
809952|NCT00096356|1762535|FG001|Overall Study|Adverse Event|9
809953|NCT00096356|1762534|FG000|Overall Study|Physician Decision|5
809954|NCT00096356|1762535|FG001|Overall Study|Physician Decision|3
809955|NCT00096356|1762534|FG000|Overall Study|Withdrawal by Subject|17
809956|NCT00096356|1762535|FG001|Overall Study|Withdrawal by Subject|23
809957|NCT00096356|1762534|FG000|Overall Study|Lack of Efficacy|1
809958|NCT00096356|1762535|FG001|Overall Study|Lack of Efficacy|0
809959|NCT00096356|1762534|FG000|Overall Study|multiple reasons|10
809960|NCT00096356|1762535|FG001|Overall Study|multiple reasons|18
809961|NCT00096382|1762544|FG000|Overall Study|Not treated|1
809962|NCT00096382|1762545|FG001|Overall Study|Not treated|0
809963|NCT00096382|1762544|FG000|Overall Study|Death during treatment|1
809964|NCT00096382|1762545|FG001|Overall Study|Death during treatment|0
809965|NCT00096447|1762551|FG000|Overall Study|Never treated|1
809966|NCT00096486|1762573|FG000|Overall Study|Withdrawal by Subject|0
809967|NCT00096486|1762574|FG001|Overall Study|Withdrawal by Subject|0
809968|NCT00096486|1762575|FG002|Overall Study|Withdrawal by Subject|1
809969|NCT00096486|1762576|FG003|Overall Study|Withdrawal by Subject|1
809970|NCT00096486|1762573|FG000|Overall Study|Not Treated|0
809971|NCT00096486|1762574|FG001|Overall Study|Not Treated|0
809972|NCT00096486|1762575|FG002|Overall Study|Not Treated|1
809973|NCT00096486|1762576|FG003|Overall Study|Not Treated|1
809974|NCT00096538|1762586|FG000|Overall Study|Withdrawal by Subject|1
809975|NCT00096785|1762596|FG000|Overall Study|Lost to Follow-up|1
809976|NCT00096785|1762597|FG001|Overall Study|Lost to Follow-up|0
809977|NCT00096785|1762596|FG000|Overall Study|Withdrawal by Subject|0
809978|NCT00096785|1762597|FG001|Overall Study|Withdrawal by Subject|1
809979|NCT00096785|1762596|FG000|Overall Study|Relocated|1
809980|NCT00096785|1762597|FG001|Overall Study|Relocated|0
809981|NCT00096941|1762603|FG000|Overall Study|disease progression|3
809982|NCT00096954|1762609|FG000|Overall Study|Adverse Event|3
809983|NCT00096954|1762610|FG001|Overall Study|Adverse Event|1
809984|NCT00096954|1762609|FG000|Overall Study|Withdrawal by Subject|9
809985|NCT00096954|1762610|FG001|Overall Study|Withdrawal by Subject|8
809986|NCT00096954|1762609|FG000|Overall Study|Physician Decision|1
809987|NCT00096954|1762610|FG001|Overall Study|Physician Decision|1
809988|NCT00096954|1762609|FG000|Overall Study|Sponsors Decision|1
809989|NCT00096954|1762610|FG001|Overall Study|Sponsors Decision|1
809990|NCT00096954|1762609|FG000|Overall Study|Pregnancy|1
809991|NCT00096954|1762610|FG001|Overall Study|Pregnancy|1
809992|NCT00096954|1762609|FG000|Overall Study|Initiation of immunotherapy|1
809993|NCT00096954|1762610|FG001|Overall Study|Initiation of immunotherapy|0
809994|NCT00096954|1762609|FG000|Overall Study|Non-compliance|0
809995|NCT00096954|1762610|FG001|Overall Study|Non-compliance|3
809996|NCT00096954|1762609|FG000|Overall Study|Lost to Follow-up|8
809997|NCT00096954|1762610|FG001|Overall Study|Lost to Follow-up|5
809998|NCT00096993|1762618|FG000|Overall Study|Death|1
809999|NCT00096993|1762619|FG001|Overall Study|Death|0
810000|NCT00096993|1762618|FG000|Overall Study|Disease progression|56
810001|NCT00096993|1762619|FG001|Overall Study|Disease progression|53
810002|NCT00096993|1762618|FG000|Overall Study|Adverse Event|2
810003|NCT00096993|1762619|FG001|Overall Study|Adverse Event|8
810004|NCT00096993|1762618|FG000|Overall Study|Subject's decision|3
810005|NCT00096993|1762619|FG001|Overall Study|Subject's decision|1
810006|NCT00096993|1762618|FG000|Overall Study|Physician Decision|2
810007|NCT00096993|1762619|FG001|Overall Study|Physician Decision|1
810008|NCT00096993|1762618|FG000|Overall Study|Non-compliance|0
810009|NCT00096993|1762619|FG001|Overall Study|Non-compliance|1
810010|NCT00096993|1762618|FG000|Overall Study|Other unspecified|1
810011|NCT00096993|1762619|FG001|Overall Study|Other unspecified|1
810012|NCT00097370|1762633|FG000|Stage 1|Adverse Event|3
810013|NCT00097370|1762633|FG000|Stage 1|Withdrawal by Subject|1
810014|NCT00097370|1762633|FG000|Stage 1|Lack of Efficacy|2
810015|NCT00097370|1762633|FG000|Stage 2|Adverse Event|5
810016|NCT00097370|1762633|FG000|Stage 2|Withdrawal by Subject|1
810017|NCT00097370|1762633|FG000|Stage 2|Lack of Efficacy|3
810018|NCT00097370|1762633|FG000|Stage 2|Pregnancy|1
810019|NCT00097370|1762633|FG000|Stage 2|Sponsor Terminated Study|2
810020|NCT00097370|1762633|FG000|Stage 2|Lost to Follow-up|1
810021|NCT00097370|1762633|FG000|Stage 3|Adverse Event|2
810022|NCT00097370|1762633|FG000|Stage 3|Withdrawal by Subject|3
810023|NCT00097370|1762633|FG000|Stage 3|Lack of Efficacy|1
810024|NCT00097370|1762633|FG000|Stage 3|Sponsor Terminated Study|52
810025|NCT00097370|1762633|FG000|Stage 3|Lost to Follow-up|1
810026|NCT00097500|1762648|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
810027|NCT00097500|1762649|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
810028|NCT00097500|1762648|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5
810029|NCT00097500|1762649|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0
810030|NCT00097500|1762648|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0
810031|NCT00097500|1762649|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1
810032|NCT00097500|1762648|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
810033|NCT00097500|1762649|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
810034|NCT00097500|1762648|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
810035|NCT00097500|1762649|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
810036|NCT00097500|1762648|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
810037|NCT00097500|1762649|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
810038|NCT00097500|1762648|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
810039|NCT00097500|1762649|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
810040|NCT00097539|1762662|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959
810041|NCT00097539|1762663|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948
810042|NCT00097539|1762664|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646
810043|NCT00097539|1762665|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170
810044|NCT00097539|1762666|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106
810045|NCT00097539|1762667|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546
810046|NCT00097539|1762668|FG006|Overall Study|Status Unknown (Or no final evaluation)|108
810047|NCT00097539|1762662|FG000|Overall Study|Withdrawal by Subject|925
810048|NCT00097539|1762663|FG001|Overall Study|Withdrawal by Subject|323
810049|NCT00097539|1762664|FG002|Overall Study|Withdrawal by Subject|346
810050|NCT00097539|1762665|FG003|Overall Study|Withdrawal by Subject|217
810051|NCT00097539|1762666|FG004|Overall Study|Withdrawal by Subject|68
810052|NCT00097539|1762667|FG005|Overall Study|Withdrawal by Subject|229
810053|NCT00097539|1762668|FG006|Overall Study|Withdrawal by Subject|3
810054|NCT00097539|1762662|FG000|Overall Study|Participant Non-compliant|2140
810055|NCT00097539|1762663|FG001|Overall Study|Participant Non-compliant|567
810056|NCT00097539|1762664|FG002|Overall Study|Participant Non-compliant|1067
810057|NCT00097539|1762665|FG003|Overall Study|Participant Non-compliant|353
810058|NCT00097539|1762666|FG004|Overall Study|Participant Non-compliant|136
810059|NCT00097539|1762667|FG005|Overall Study|Participant Non-compliant|543
810060|NCT00097539|1762668|FG006|Overall Study|Participant Non-compliant|18
810061|NCT00097539|1762662|FG000|Overall Study|Lack of Efficacy|249
810062|NCT00097539|1762663|FG001|Overall Study|Lack of Efficacy|122
810063|NCT00097539|1762664|FG002|Overall Study|Lack of Efficacy|202
810064|NCT00097539|1762665|FG003|Overall Study|Lack of Efficacy|105
810065|NCT00097539|1762666|FG004|Overall Study|Lack of Efficacy|45
810066|NCT00097539|1762667|FG005|Overall Study|Lack of Efficacy|228
810067|NCT00097539|1762668|FG006|Overall Study|Lack of Efficacy|5
810068|NCT00097539|1762662|FG000|Overall Study|Adverse Event|78
810069|NCT00097539|1762663|FG001|Overall Study|Adverse Event|133
810070|NCT00097539|1762664|FG002|Overall Study|Adverse Event|37
810071|NCT00097539|1762665|FG003|Overall Study|Adverse Event|27
810072|NCT00097539|1762666|FG004|Overall Study|Adverse Event|30
810073|NCT00097539|1762667|FG005|Overall Study|Adverse Event|59
810074|NCT00097539|1762668|FG006|Overall Study|Adverse Event|1
810075|NCT00097539|1762662|FG000|Overall Study|Death|2
810076|NCT00097539|1762663|FG001|Overall Study|Death|7
810077|NCT00097539|1762664|FG002|Overall Study|Death|0
810078|NCT00097539|1762665|FG003|Overall Study|Death|0
810079|NCT00097539|1762666|FG004|Overall Study|Death|1
810080|NCT00097539|1762667|FG005|Overall Study|Death|3
810081|NCT00097539|1762668|FG006|Overall Study|Death|0
810082|NCT00097539|1762662|FG000|Overall Study|Reasons Other Than Above|3602
810083|NCT00097539|1762663|FG001|Overall Study|Reasons Other Than Above|1382
810084|NCT00097539|1762664|FG002|Overall Study|Reasons Other Than Above|1757
810085|NCT00097539|1762665|FG003|Overall Study|Reasons Other Than Above|692
810086|NCT00097539|1762666|FG004|Overall Study|Reasons Other Than Above|361
810087|NCT00097539|1762667|FG005|Overall Study|Reasons Other Than Above|1244
810088|NCT00097539|1762668|FG006|Overall Study|Reasons Other Than Above|34
810089|NCT00097539|1762662|FG000|Overall Study|Reason not Specified|111
810090|NCT00097539|1762663|FG001|Overall Study|Reason not Specified|49
810091|NCT00097539|1762664|FG002|Overall Study|Reason not Specified|53
810092|NCT00097539|1762665|FG003|Overall Study|Reason not Specified|21
810093|NCT00097539|1762666|FG004|Overall Study|Reason not Specified|11
810094|NCT00097539|1762667|FG005|Overall Study|Reason not Specified|40
810095|NCT00097539|1762668|FG006|Overall Study|Reason not Specified|2
810096|NCT00097591|1762686|FG000|Overall Study|Withdrawal of consent|342
810097|NCT00097591|1762687|FG001|Overall Study|Withdrawal of consent|323
810098|NCT00097591|1762686|FG000|Overall Study|Less than 6 months on study drug|9
810099|NCT00097591|1762687|FG001|Overall Study|Less than 6 months on study drug|7
810100|NCT00097591|1762686|FG000|Overall Study|Unable to attend termination visit|53
810101|NCT00097591|1762687|FG001|Overall Study|Unable to attend termination visit|51
810102|NCT00097591|1762686|FG000|Overall Study|Lost to follow up|6
810103|NCT00097591|1762687|FG001|Overall Study|Lost to follow up|10
810104|NCT00097591|1762686|FG000|Overall Study|Other|0
810105|NCT00097591|1762687|FG001|Overall Study|Other|3
810106|NCT00097721|1762736|FG000|Overall Study|Adverse Event|8
810107|NCT00097721|1762737|FG001|Overall Study|Adverse Event|1
810108|NCT00097721|1762736|FG000|Overall Study|Withdrawal by Subject|6
810109|NCT00097721|1762737|FG001|Overall Study|Withdrawal by Subject|1
810110|NCT00097721|1762736|FG000|Overall Study|Progressive Disease|55
810111|NCT00097721|1762737|FG001|Overall Study|Progressive Disease|27
810112|NCT00097721|1762736|FG000|Overall Study|Physician Decision|1
810113|NCT00097721|1762737|FG001|Overall Study|Physician Decision|3
810114|NCT00097721|1762736|FG000|Overall Study|Reason not given|1
810115|NCT00097721|1762737|FG001|Overall Study|Reason not given|1
810116|NCT00097773|1762747|FG000|Overall Study|Lost to Follow-up|2
810117|NCT00097773|1762748|FG001|Overall Study|Lost to Follow-up|2
810118|NCT00097773|1762749|FG002|Overall Study|Lost to Follow-up|0
810119|NCT00097773|1762750|FG003|Overall Study|Lost to Follow-up|1
810120|NCT00097773|1762747|FG000|Overall Study|Physician Decision|2
810121|NCT00097773|1762748|FG001|Overall Study|Physician Decision|2
810122|NCT00097773|1762749|FG002|Overall Study|Physician Decision|3
810123|NCT00097773|1762750|FG003|Overall Study|Physician Decision|1
810124|NCT00097773|1762747|FG000|Overall Study|Withdrawal by Subject|3
810125|NCT00097773|1762748|FG001|Overall Study|Withdrawal by Subject|3
810126|NCT00097773|1762749|FG002|Overall Study|Withdrawal by Subject|3
810127|NCT00097773|1762750|FG003|Overall Study|Withdrawal by Subject|1
810128|NCT00097773|1762747|FG000|Overall Study|Adverse Event|0
810129|NCT00097773|1762748|FG001|Overall Study|Adverse Event|1
810130|NCT00097773|1762749|FG002|Overall Study|Adverse Event|0
810131|NCT00097773|1762750|FG003|Overall Study|Adverse Event|0
810132|NCT00097773|1762747|FG000|Overall Study|Other|1
810133|NCT00097773|1762748|FG001|Overall Study|Other|0
810134|NCT00097773|1762749|FG002|Overall Study|Other|2
810135|NCT00097773|1762750|FG003|Overall Study|Other|0
810136|NCT00097786|1762769|FG000|Overall Study|lost to follow-up for all-cause death|296
810137|NCT00097786|1762770|FG001|Overall Study|lost to follow-up for all-cause death|292
810138|NCT00097786|1762771|FG002|Overall Study|lost to follow-up for all-cause death|313
810139|NCT00097786|1762772|FG003|Overall Study|lost to follow-up for all-cause death|310
810140|NCT00097981|1762784|FG000|Overall Study|Adverse Event|31
810141|NCT00097981|1762785|FG001|Overall Study|Adverse Event|44
810142|NCT00097981|1762784|FG000|Overall Study|Withdrawal by Subject|10
810143|NCT00097981|1762785|FG001|Overall Study|Withdrawal by Subject|8
810144|NCT00097981|1762784|FG000|Overall Study|Protocol Violation|1
810145|NCT00097981|1762785|FG001|Overall Study|Protocol Violation|1
810146|NCT00097981|1762784|FG000|Overall Study|Death|2
810147|NCT00097981|1762785|FG001|Overall Study|Death|4
810148|NCT00097981|1762784|FG000|Overall Study|Physician Decision|7
810149|NCT00097981|1762785|FG001|Overall Study|Physician Decision|1
810150|NCT00097981|1762784|FG000|Overall Study|Disease Progression|8
810151|NCT00097981|1762785|FG001|Overall Study|Disease Progression|2
810152|NCT00097981|1762784|FG000|Overall Study|Transplant planned|28
810153|NCT00097981|1762785|FG001|Overall Study|Transplant planned|27
810154|NCT00097981|1762784|FG000|Overall Study|Other|19
810155|NCT00097981|1762785|FG001|Overall Study|Other|13
810156|NCT00098020|1762791|FG000|Overall Study|Adverse Event|2
810157|NCT00098020|1762791|FG000|Overall Study|Lost to Follow-up|1
810158|NCT00098020|1762791|FG000|Overall Study|elevated liver enzymes|1
810159|NCT00098020|1762791|FG000|Overall Study|Low urine PCR|1
810160|NCT00098020|1762791|FG000|Overall Study|Low epidermal growth factor receptor|1
810161|NCT00098254|1762809|FG000|Overall Study|Adverse Event|2
810162|NCT00098254|1762809|FG000|Overall Study|Death|1
810163|NCT00098293|1762816|FG000|Double-blind (DB) Phase|Adverse Event|14
810164|NCT00098293|1762817|FG001|Double-blind (DB) Phase|Adverse Event|27
810165|NCT00098293|1762818|FG002|Double-blind (DB) Phase|Adverse Event|60
810166|NCT00098293|1762819|FG003|Double-blind (DB) Phase|Adverse Event|0
810167|NCT00098293|1762820|FG004|Double-blind (DB) Phase|Adverse Event|0
810168|NCT00098293|1762816|FG000|Double-blind (DB) Phase|Pregnancy|0
810169|NCT00098293|1762817|FG001|Double-blind (DB) Phase|Pregnancy|7
810170|NCT00098293|1762818|FG002|Double-blind (DB) Phase|Pregnancy|9
810171|NCT00098293|1762819|FG003|Double-blind (DB) Phase|Pregnancy|0
810172|NCT00098293|1762820|FG004|Double-blind (DB) Phase|Pregnancy|0
810173|NCT00098293|1762816|FG000|Double-blind (DB) Phase|Participant Defaulted|11
810174|NCT00098293|1762817|FG001|Double-blind (DB) Phase|Participant Defaulted|40
810175|NCT00098293|1762818|FG002|Double-blind (DB) Phase|Participant Defaulted|36
810176|NCT00098293|1762819|FG003|Double-blind (DB) Phase|Participant Defaulted|0
810177|NCT00098293|1762820|FG004|Double-blind (DB) Phase|Participant Defaulted|0
810178|NCT00098293|1762816|FG000|Double-blind (DB) Phase|Lack of Efficacy|11
810179|NCT00098293|1762817|FG001|Double-blind (DB) Phase|Lack of Efficacy|64
810180|NCT00098293|1762818|FG002|Double-blind (DB) Phase|Lack of Efficacy|30
810181|NCT00098293|1762819|FG003|Double-blind (DB) Phase|Lack of Efficacy|0
810182|NCT00098293|1762820|FG004|Double-blind (DB) Phase|Lack of Efficacy|0
810183|NCT00098293|1762816|FG000|Double-blind (DB) Phase|Death|1
810184|NCT00098293|1762817|FG001|Double-blind (DB) Phase|Death|2
810185|NCT00098293|1762818|FG002|Double-blind (DB) Phase|Death|2
810186|NCT00098293|1762819|FG003|Double-blind (DB) Phase|Death|0
810187|NCT00098293|1762820|FG004|Double-blind (DB) Phase|Death|0
810188|NCT00098293|1762816|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3
810189|NCT00098293|1762817|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8
810190|NCT00098293|1762818|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11
810191|NCT00098293|1762819|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0
810192|NCT00098293|1762820|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0
810193|NCT00098293|1762816|FG000|Double-blind (DB) Phase|Protocol Violation|2
810194|NCT00098293|1762817|FG001|Double-blind (DB) Phase|Protocol Violation|18
810195|NCT00098293|1762818|FG002|Double-blind (DB) Phase|Protocol Violation|22
810196|NCT00098293|1762819|FG003|Double-blind (DB) Phase|Protocol Violation|0
810197|NCT00098293|1762820|FG004|Double-blind (DB) Phase|Protocol Violation|0
810198|NCT00098293|1762816|FG000|Double-blind (DB) Phase|Terminated by sponsor|135
810199|NCT00098293|1762817|FG001|Double-blind (DB) Phase|Terminated by sponsor|0
810200|NCT00098293|1762818|FG002|Double-blind (DB) Phase|Terminated by sponsor|0
810201|NCT00098293|1762819|FG003|Double-blind (DB) Phase|Terminated by sponsor|0
810202|NCT00098293|1762820|FG004|Double-blind (DB) Phase|Terminated by sponsor|0
810203|NCT00098293|1762816|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0
810204|NCT00098293|1762817|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0
810205|NCT00098293|1762818|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3
810206|NCT00098293|1762819|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0
810207|NCT00098293|1762820|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0
810208|NCT00098293|1762816|FG000|Open-label (OL) Phase|Adverse Event|0
810209|NCT00098293|1762817|FG001|Open-label (OL) Phase|Adverse Event|3
810210|NCT00098293|1762818|FG002|Open-label (OL) Phase|Adverse Event|7
810211|NCT00098293|1762819|FG003|Open-label (OL) Phase|Adverse Event|6
810212|NCT00098293|1762820|FG004|Open-label (OL) Phase|Adverse Event|0
810213|NCT00098293|1762816|FG000|Open-label (OL) Phase|Lack of Efficacy|0
810214|NCT00098293|1762817|FG001|Open-label (OL) Phase|Lack of Efficacy|7
810215|NCT00098293|1762818|FG002|Open-label (OL) Phase|Lack of Efficacy|2
810216|NCT00098293|1762819|FG003|Open-label (OL) Phase|Lack of Efficacy|20
810217|NCT00098293|1762820|FG004|Open-label (OL) Phase|Lack of Efficacy|0
810218|NCT00098293|1762816|FG000|Open-label (OL) Phase|Pregnancy|0
810219|NCT00098293|1762817|FG001|Open-label (OL) Phase|Pregnancy|1
810220|NCT00098293|1762818|FG002|Open-label (OL) Phase|Pregnancy|0
810221|NCT00098293|1762819|FG003|Open-label (OL) Phase|Pregnancy|3
810222|NCT00098293|1762820|FG004|Open-label (OL) Phase|Pregnancy|0
810223|NCT00098293|1762816|FG000|Open-label (OL) Phase|Protocol Violation|0
810224|NCT00098293|1762817|FG001|Open-label (OL) Phase|Protocol Violation|6
810225|NCT00098293|1762818|FG002|Open-label (OL) Phase|Protocol Violation|13
810226|NCT00098293|1762819|FG003|Open-label (OL) Phase|Protocol Violation|16
810227|NCT00098293|1762820|FG004|Open-label (OL) Phase|Protocol Violation|0
810228|NCT00098293|1762816|FG000|Open-label (OL) Phase|Participant Defaulted|0
810229|NCT00098293|1762817|FG001|Open-label (OL) Phase|Participant Defaulted|6
810230|NCT00098293|1762818|FG002|Open-label (OL) Phase|Participant Defaulted|16
810231|NCT00098293|1762819|FG003|Open-label (OL) Phase|Participant Defaulted|20
810232|NCT00098293|1762820|FG004|Open-label (OL) Phase|Participant Defaulted|0
810233|NCT00098293|1762816|FG000|Open-label (OL) Phase|Death|0
810234|NCT00098293|1762817|FG001|Open-label (OL) Phase|Death|2
810235|NCT00098293|1762818|FG002|Open-label (OL) Phase|Death|3
810236|NCT00098293|1762819|FG003|Open-label (OL) Phase|Death|0
810237|NCT00098293|1762820|FG004|Open-label (OL) Phase|Death|0
810238|NCT00098293|1762816|FG000|Supplemental Phase (SP)|Death|0
810239|NCT00098293|1762817|FG001|Supplemental Phase (SP)|Death|0
810240|NCT00098293|1762818|FG002|Supplemental Phase (SP)|Death|0
810241|NCT00098293|1762819|FG003|Supplemental Phase (SP)|Death|0
810242|NCT00098293|1762820|FG004|Supplemental Phase (SP)|Death|1
810243|NCT00098293|1762816|FG000|Supplemental Phase (SP)|Lost to Follow-up|0
810244|NCT00098293|1762817|FG001|Supplemental Phase (SP)|Lost to Follow-up|0
810245|NCT00098293|1762818|FG002|Supplemental Phase (SP)|Lost to Follow-up|0
810246|NCT00098293|1762819|FG003|Supplemental Phase (SP)|Lost to Follow-up|0
810247|NCT00098293|1762820|FG004|Supplemental Phase (SP)|Lost to Follow-up|2
810248|NCT00098293|1762816|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0
810249|NCT00098293|1762817|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0
810250|NCT00098293|1762818|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0
810251|NCT00098293|1762819|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0
810252|NCT00098293|1762820|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8
810253|NCT00098293|1762816|FG000|Supplemental Phase (SP)|Other|0
810254|NCT00098293|1762817|FG001|Supplemental Phase (SP)|Other|0
810255|NCT00098293|1762818|FG002|Supplemental Phase (SP)|Other|0
810256|NCT00098293|1762819|FG003|Supplemental Phase (SP)|Other|0
810257|NCT00098293|1762820|FG004|Supplemental Phase (SP)|Other|22
810258|NCT00098306|1762834|FG000|Double Blind|Randomized, not treated|9
810259|NCT00098306|1762835|FG001|Double Blind|Randomized, not treated|5
810260|NCT00098306|1762836|FG002|Double Blind|Randomized, not treated|2
810261|NCT00098306|1762837|FG003|Double Blind|Randomized, not treated|0
810262|NCT00098306|1762838|FG004|Double Blind|Randomized, not treated|0
810263|NCT00098306|1762839|FG005|Double Blind|Randomized, not treated|0
810264|NCT00098306|1762840|FG006|Double Blind|Randomized, not treated|0
810265|NCT00098306|1762834|FG000|Double Blind|Ongoing at cut-off date|151
810266|NCT00098306|1762835|FG001|Double Blind|Ongoing at cut-off date|166
810267|NCT00098306|1762836|FG002|Double Blind|Ongoing at cut-off date|72
810268|NCT00098306|1762837|FG003|Double Blind|Ongoing at cut-off date|0
810269|NCT00098306|1762838|FG004|Double Blind|Ongoing at cut-off date|0
810270|NCT00098306|1762839|FG005|Double Blind|Ongoing at cut-off date|0
810271|NCT00098306|1762840|FG006|Double Blind|Ongoing at cut-off date|0
810272|NCT00098306|1762834|FG000|Double Blind|Adverse Event|11
810273|NCT00098306|1762835|FG001|Double Blind|Adverse Event|10
810274|NCT00098306|1762836|FG002|Double Blind|Adverse Event|6
810275|NCT00098306|1762837|FG003|Double Blind|Adverse Event|0
810276|NCT00098306|1762838|FG004|Double Blind|Adverse Event|0
810277|NCT00098306|1762839|FG005|Double Blind|Adverse Event|0
810278|NCT00098306|1762840|FG006|Double Blind|Adverse Event|0
810279|NCT00098306|1762834|FG000|Double Blind|Lack of Efficacy|43
810280|NCT00098306|1762835|FG001|Double Blind|Lack of Efficacy|34
810281|NCT00098306|1762836|FG002|Double Blind|Lack of Efficacy|17
810282|NCT00098306|1762837|FG003|Double Blind|Lack of Efficacy|0
810283|NCT00098306|1762838|FG004|Double Blind|Lack of Efficacy|0
810284|NCT00098306|1762839|FG005|Double Blind|Lack of Efficacy|0
810285|NCT00098306|1762840|FG006|Double Blind|Lack of Efficacy|0
810286|NCT00098306|1762834|FG000|Double Blind|Death|1
810287|NCT00098306|1762835|FG001|Double Blind|Death|4
810288|NCT00098306|1762836|FG002|Double Blind|Death|1
810289|NCT00098306|1762837|FG003|Double Blind|Death|0
810290|NCT00098306|1762838|FG004|Double Blind|Death|0
810291|NCT00098306|1762839|FG005|Double Blind|Death|0
810292|NCT00098306|1762840|FG006|Double Blind|Death|0
810293|NCT00098306|1762834|FG000|Double Blind|Participant defaulted|19
810294|NCT00098306|1762835|FG001|Double Blind|Participant defaulted|18
810295|NCT00098306|1762836|FG002|Double Blind|Participant defaulted|11
810296|NCT00098306|1762837|FG003|Double Blind|Participant defaulted|0
810297|NCT00098306|1762838|FG004|Double Blind|Participant defaulted|0
810298|NCT00098306|1762839|FG005|Double Blind|Participant defaulted|0
810299|NCT00098306|1762840|FG006|Double Blind|Participant defaulted|0
810300|NCT00098306|1762834|FG000|Double Blind|Un-specified|7
810301|NCT00098306|1762835|FG001|Double Blind|Un-specified|3
810302|NCT00098306|1762836|FG002|Double Blind|Un-specified|11
810303|NCT00098306|1762837|FG003|Double Blind|Un-specified|0
810304|NCT00098306|1762838|FG004|Double Blind|Un-specified|0
810305|NCT00098306|1762839|FG005|Double Blind|Un-specified|0
810306|NCT00098306|1762840|FG006|Double Blind|Un-specified|0
810307|NCT00098306|1762834|FG000|Open Label|Lack of Efficacy|0
810308|NCT00098306|1762835|FG001|Open Label|Lack of Efficacy|0
810309|NCT00098306|1762836|FG002|Open Label|Lack of Efficacy|0
810310|NCT00098306|1762837|FG003|Open Label|Lack of Efficacy|13
810311|NCT00098306|1762838|FG004|Open Label|Lack of Efficacy|0
810312|NCT00098306|1762839|FG005|Open Label|Lack of Efficacy|0
810313|NCT00098306|1762840|FG006|Open Label|Lack of Efficacy|0
810314|NCT00098306|1762834|FG000|Open Label|Adverse Event|0
810315|NCT00098306|1762835|FG001|Open Label|Adverse Event|0
810316|NCT00098306|1762836|FG002|Open Label|Adverse Event|0
810317|NCT00098306|1762837|FG003|Open Label|Adverse Event|2
810318|NCT00098306|1762838|FG004|Open Label|Adverse Event|0
810319|NCT00098306|1762839|FG005|Open Label|Adverse Event|0
810320|NCT00098306|1762840|FG006|Open Label|Adverse Event|0
810321|NCT00098306|1762834|FG000|Open Label|Death|0
810322|NCT00098306|1762835|FG001|Open Label|Death|0
810323|NCT00098306|1762836|FG002|Open Label|Death|0
810324|NCT00098306|1762837|FG003|Open Label|Death|4
810325|NCT00098306|1762838|FG004|Open Label|Death|0
810326|NCT00098306|1762839|FG005|Open Label|Death|0
810327|NCT00098306|1762840|FG006|Open Label|Death|0
810328|NCT00098306|1762834|FG000|Open Label|Participant defaulted|0
810329|NCT00098306|1762835|FG001|Open Label|Participant defaulted|0
810330|NCT00098306|1762836|FG002|Open Label|Participant defaulted|0
810331|NCT00098306|1762837|FG003|Open Label|Participant defaulted|24
810332|NCT00098306|1762838|FG004|Open Label|Participant defaulted|0
810333|NCT00098306|1762839|FG005|Open Label|Participant defaulted|0
810334|NCT00098306|1762840|FG006|Open Label|Participant defaulted|0
810335|NCT00098306|1762834|FG000|Open Label|Un-specified|0
810336|NCT00098306|1762835|FG001|Open Label|Un-specified|0
810337|NCT00098306|1762836|FG002|Open Label|Un-specified|0
810338|NCT00098306|1762837|FG003|Open Label|Un-specified|15
810339|NCT00098306|1762838|FG004|Open Label|Un-specified|0
810340|NCT00098306|1762839|FG005|Open Label|Un-specified|0
810341|NCT00098306|1762840|FG006|Open Label|Un-specified|0
810342|NCT00098306|1762834|FG000|Open Label|Ongoing at cut-off date|0
810343|NCT00098306|1762835|FG001|Open Label|Ongoing at cut-off date|0
810344|NCT00098306|1762836|FG002|Open Label|Ongoing at cut-off date|0
810345|NCT00098306|1762837|FG003|Open Label|Ongoing at cut-off date|269
810346|NCT00098306|1762838|FG004|Open Label|Ongoing at cut-off date|62
810347|NCT00098306|1762839|FG005|Open Label|Ongoing at cut-off date|0
810348|NCT00098306|1762840|FG006|Open Label|Ongoing at cut-off date|0
810349|NCT00098306|1762834|FG000|Observational Phase|Death|0
810350|NCT00098306|1762835|FG001|Observational Phase|Death|0
810351|NCT00098306|1762836|FG002|Observational Phase|Death|0
810352|NCT00098306|1762837|FG003|Observational Phase|Death|0
810353|NCT00098306|1762838|FG004|Observational Phase|Death|0
810354|NCT00098306|1762839|FG005|Observational Phase|Death|5
810355|NCT00098306|1762840|FG006|Observational Phase|Death|4
810356|NCT00098306|1762834|FG000|Observational Phase|Participant defaulted|0
810357|NCT00098306|1762835|FG001|Observational Phase|Participant defaulted|0
810358|NCT00098306|1762836|FG002|Observational Phase|Participant defaulted|0
810359|NCT00098306|1762837|FG003|Observational Phase|Participant defaulted|0
810360|NCT00098306|1762838|FG004|Observational Phase|Participant defaulted|0
810361|NCT00098306|1762839|FG005|Observational Phase|Participant defaulted|34
810362|NCT00098306|1762840|FG006|Observational Phase|Participant defaulted|18
810363|NCT00098306|1762834|FG000|Observational Phase|Un-specified|0
810364|NCT00098306|1762835|FG001|Observational Phase|Un-specified|0
810365|NCT00098306|1762836|FG002|Observational Phase|Un-specified|0
810366|NCT00098306|1762837|FG003|Observational Phase|Un-specified|0
810367|NCT00098306|1762838|FG004|Observational Phase|Un-specified|0
810368|NCT00098306|1762839|FG005|Observational Phase|Un-specified|7
810369|NCT00098306|1762840|FG006|Observational Phase|Un-specified|4
810370|NCT00098345|1762853|FG000|Overall Study|Adverse Event|7
810371|NCT00098345|1762853|FG000|Overall Study|Withdrawal by Subject|2
810372|NCT00098345|1762853|FG000|Overall Study|progression|4
810373|NCT00098475|1762874|FG000|Step 1|Progressive disease|33
810374|NCT00098475|1762875|FG001|Step 1|Progressive disease|35
810375|NCT00098475|1762876|FG002|Step 1|Progressive disease|2
810376|NCT00098475|1762877|FG003|Step 1|Progressive disease|1
810377|NCT00098475|1762874|FG000|Step 1|Adverse Event|56
810378|NCT00098475|1762875|FG001|Step 1|Adverse Event|37
810379|NCT00098475|1762876|FG002|Step 1|Adverse Event|0
810380|NCT00098475|1762877|FG003|Step 1|Adverse Event|1
810381|NCT00098475|1762874|FG000|Step 1|Death|8
810382|NCT00098475|1762875|FG001|Step 1|Death|5
810383|NCT00098475|1762876|FG002|Step 1|Death|0
810384|NCT00098475|1762877|FG003|Step 1|Death|1
810385|NCT00098475|1762874|FG000|Step 1|Withdrawal by Subject|14
810386|NCT00098475|1762875|FG001|Step 1|Withdrawal by Subject|11
810387|NCT00098475|1762876|FG002|Step 1|Withdrawal by Subject|0
810388|NCT00098475|1762877|FG003|Step 1|Withdrawal by Subject|0
810389|NCT00098475|1762874|FG000|Step 1|Physician Decision|5
810390|NCT00098475|1762875|FG001|Step 1|Physician Decision|2
810391|NCT00098475|1762876|FG002|Step 1|Physician Decision|0
810392|NCT00098475|1762877|FG003|Step 1|Physician Decision|0
810393|NCT00098475|1762874|FG000|Step 1|Alternative therapy|31
810394|NCT00098475|1762875|FG001|Step 1|Alternative therapy|43
810395|NCT00098475|1762876|FG002|Step 1|Alternative therapy|1
810396|NCT00098475|1762877|FG003|Step 1|Alternative therapy|0
810397|NCT00098475|1762874|FG000|Step 1|Other disease|2
810398|NCT00098475|1762875|FG001|Step 1|Other disease|1
810399|NCT00098475|1762876|FG002|Step 1|Other disease|1
810400|NCT00098475|1762877|FG003|Step 1|Other disease|0
810401|NCT00098475|1762874|FG000|Step 1|Never started treatment|0
810402|NCT00098475|1762875|FG001|Step 1|Never started treatment|2
810403|NCT00098475|1762876|FG002|Step 1|Never started treatment|0
810404|NCT00098475|1762877|FG003|Step 1|Never started treatment|0
810405|NCT00098475|1762874|FG000|Step 1|Still on treatment as of this analysis|14
810406|NCT00098475|1762875|FG001|Step 1|Still on treatment as of this analysis|27
810407|NCT00098475|1762876|FG002|Step 1|Still on treatment as of this analysis|0
810408|NCT00098475|1762877|FG003|Step 1|Still on treatment as of this analysis|0
810409|NCT00098475|1762874|FG000|Step 1|Knee surgery|1
810410|NCT00098475|1762875|FG001|Step 1|Knee surgery|0
810411|NCT00098475|1762876|FG002|Step 1|Knee surgery|0
810412|NCT00098475|1762877|FG003|Step 1|Knee surgery|0
810413|NCT00098475|1762874|FG000|Step 1|Complications|1
810414|NCT00098475|1762875|FG001|Step 1|Complications|0
810415|NCT00098475|1762876|FG002|Step 1|Complications|0
810416|NCT00098475|1762877|FG003|Step 1|Complications|0
810417|NCT00098475|1762874|FG000|Step 1|Cannot comply due to other tx|0
810418|NCT00098475|1762875|FG001|Step 1|Cannot comply due to other tx|1
810419|NCT00098475|1762876|FG002|Step 1|Cannot comply due to other tx|0
810420|NCT00098475|1762877|FG003|Step 1|Cannot comply due to other tx|0
810421|NCT00098475|1762874|FG000|Step 1|Both patient and physician's decision|2
810422|NCT00098475|1762875|FG001|Step 1|Both patient and physician's decision|1
810423|NCT00098475|1762876|FG002|Step 1|Both patient and physician's decision|0
810424|NCT00098475|1762877|FG003|Step 1|Both patient and physician's decision|0
810425|NCT00098475|1762874|FG000|Step 1|Incorrect disease assessment|2
810426|NCT00098475|1762875|FG001|Step 1|Incorrect disease assessment|0
810427|NCT00098475|1762876|FG002|Step 1|Incorrect disease assessment|0
810428|NCT00098475|1762877|FG003|Step 1|Incorrect disease assessment|0
810429|NCT00098475|1762874|FG000|Step 1|Off treatment for > specified timeframe|1
810430|NCT00098475|1762875|FG001|Step 1|Off treatment for > specified timeframe|1
810431|NCT00098475|1762876|FG002|Step 1|Off treatment for > specified timeframe|0
810432|NCT00098475|1762877|FG003|Step 1|Off treatment for > specified timeframe|0
810433|NCT00098475|1762874|FG000|Step 1|Declining performance status|0
810434|NCT00098475|1762875|FG001|Step 1|Declining performance status|1
810435|NCT00098475|1762876|FG002|Step 1|Declining performance status|0
810436|NCT00098475|1762877|FG003|Step 1|Declining performance status|0
810437|NCT00098475|1762874|FG000|Step 1|Insurance issue|0
810438|NCT00098475|1762875|FG001|Step 1|Insurance issue|1
810439|NCT00098475|1762876|FG002|Step 1|Insurance issue|0
810440|NCT00098475|1762877|FG003|Step 1|Insurance issue|0
810441|NCT00098475|1762874|FG000|Step 1|Rising paraprotein|0
810442|NCT00098475|1762875|FG001|Step 1|Rising paraprotein|1
810443|NCT00098475|1762876|FG002|Step 1|Rising paraprotein|0
810444|NCT00098475|1762877|FG003|Step 1|Rising paraprotein|0
810445|NCT00098475|1762874|FG000|Step 1|Referred to other physicians|0
810446|NCT00098475|1762875|FG001|Step 1|Referred to other physicians|1
810447|NCT00098475|1762876|FG002|Step 1|Referred to other physicians|0
810448|NCT00098475|1762877|FG003|Step 1|Referred to other physicians|0
810449|NCT00098475|1762874|FG000|Step 1|Criteria to continue treatment not met|0
810450|NCT00098475|1762875|FG001|Step 1|Criteria to continue treatment not met|1
810451|NCT00098475|1762876|FG002|Step 1|Criteria to continue treatment not met|0
810452|NCT00098475|1762877|FG003|Step 1|Criteria to continue treatment not met|0
810453|NCT00098475|1762874|FG000|Step 1|Misinterpretation of lab data|0
810454|NCT00098475|1762875|FG001|Step 1|Misinterpretation of lab data|1
810455|NCT00098475|1762876|FG002|Step 1|Misinterpretation of lab data|0
810456|NCT00098475|1762877|FG003|Step 1|Misinterpretation of lab data|0
810457|NCT00098475|1762874|FG000|Step 1|Patient fell with fracture|1
810458|NCT00098475|1762875|FG001|Step 1|Patient fell with fracture|0
810459|NCT00098475|1762876|FG002|Step 1|Patient fell with fracture|0
810460|NCT00098475|1762877|FG003|Step 1|Patient fell with fracture|0
810461|NCT00098475|1762874|FG000|Step 1|Not documented|0
810462|NCT00098475|1762875|FG001|Step 1|Not documented|1
810463|NCT00098475|1762876|FG002|Step 1|Not documented|0
810464|NCT00098475|1762877|FG003|Step 1|Not documented|0
810465|NCT00098475|1762874|FG000|Step 2|Disease progression|1
810466|NCT00098475|1762875|FG001|Step 2|Disease progression|4
810467|NCT00098475|1762876|FG002|Step 2|Disease progression|0
810468|NCT00098475|1762877|FG003|Step 2|Disease progression|0
810469|NCT00098475|1762874|FG000|Step 2|Adverse Event|2
810470|NCT00098475|1762875|FG001|Step 2|Adverse Event|0
810471|NCT00098475|1762876|FG002|Step 2|Adverse Event|0
810472|NCT00098475|1762877|FG003|Step 2|Adverse Event|0
810473|NCT00098475|1762874|FG000|Step 2|Withdrawal by Subject|0
810474|NCT00098475|1762875|FG001|Step 2|Withdrawal by Subject|2
810475|NCT00098475|1762876|FG002|Step 2|Withdrawal by Subject|0
810476|NCT00098475|1762877|FG003|Step 2|Withdrawal by Subject|0
810477|NCT00098475|1762874|FG000|Step 2|Physician Decision|0
810478|NCT00098475|1762875|FG001|Step 2|Physician Decision|1
810479|NCT00098475|1762876|FG002|Step 2|Physician Decision|0
810480|NCT00098475|1762877|FG003|Step 2|Physician Decision|0
810481|NCT00098475|1762874|FG000|Step 2|Alternative therapy|1
810482|NCT00098475|1762875|FG001|Step 2|Alternative therapy|2
810483|NCT00098475|1762876|FG002|Step 2|Alternative therapy|0
810484|NCT00098475|1762877|FG003|Step 2|Alternative therapy|0
810485|NCT00098475|1762874|FG000|Step 2|Never started treatment|1
810486|NCT00098475|1762875|FG001|Step 2|Never started treatment|1
810487|NCT00098475|1762876|FG002|Step 2|Never started treatment|0
810488|NCT00098475|1762877|FG003|Step 2|Never started treatment|0
810489|NCT00098722|1762895|FG000|Double Blind Phase|Adverse Event|7
810490|NCT00098722|1762896|FG001|Double Blind Phase|Adverse Event|7
810491|NCT00098722|1762897|FG002|Double Blind Phase|Adverse Event|3
810492|NCT00098722|1762898|FG003|Double Blind Phase|Adverse Event|0
810493|NCT00098722|1762899|FG004|Double Blind Phase|Adverse Event|0
810494|NCT00098722|1762900|FG005|Double Blind Phase|Adverse Event|0
810495|NCT00098722|1762901|FG006|Double Blind Phase|Adverse Event|0
810496|NCT00098722|1762895|FG000|Double Blind Phase|Death|2
810497|NCT00098722|1762896|FG001|Double Blind Phase|Death|5
810498|NCT00098722|1762897|FG002|Double Blind Phase|Death|0
810499|NCT00098722|1762898|FG003|Double Blind Phase|Death|0
810500|NCT00098722|1762899|FG004|Double Blind Phase|Death|0
810501|NCT00098722|1762900|FG005|Double Blind Phase|Death|0
810502|NCT00098722|1762901|FG006|Double Blind Phase|Death|0
810503|NCT00098722|1762895|FG000|Double Blind Phase|Lack of Efficacy|21
810504|NCT00098722|1762896|FG001|Double Blind Phase|Lack of Efficacy|23
810505|NCT00098722|1762897|FG002|Double Blind Phase|Lack of Efficacy|15
810506|NCT00098722|1762898|FG003|Double Blind Phase|Lack of Efficacy|0
810507|NCT00098722|1762899|FG004|Double Blind Phase|Lack of Efficacy|0
810508|NCT00098722|1762900|FG005|Double Blind Phase|Lack of Efficacy|0
810509|NCT00098722|1762901|FG006|Double Blind Phase|Lack of Efficacy|0
810510|NCT00098722|1762895|FG000|Double Blind Phase|Participant defaulted|16
810511|NCT00098722|1762896|FG001|Double Blind Phase|Participant defaulted|11
810512|NCT00098722|1762897|FG002|Double Blind Phase|Participant defaulted|9
810513|NCT00098722|1762898|FG003|Double Blind Phase|Participant defaulted|0
810514|NCT00098722|1762899|FG004|Double Blind Phase|Participant defaulted|0
810515|NCT00098722|1762900|FG005|Double Blind Phase|Participant defaulted|0
810516|NCT00098722|1762901|FG006|Double Blind Phase|Participant defaulted|0
810517|NCT00098722|1762895|FG000|Double Blind Phase|Pregnancy|1
810518|NCT00098722|1762896|FG001|Double Blind Phase|Pregnancy|0
810519|NCT00098722|1762897|FG002|Double Blind Phase|Pregnancy|0
810520|NCT00098722|1762898|FG003|Double Blind Phase|Pregnancy|0
810521|NCT00098722|1762899|FG004|Double Blind Phase|Pregnancy|0
810522|NCT00098722|1762900|FG005|Double Blind Phase|Pregnancy|0
810523|NCT00098722|1762901|FG006|Double Blind Phase|Pregnancy|0
810524|NCT00098722|1762895|FG000|Double Blind Phase|Randomized, not treated|4
810525|NCT00098722|1762896|FG001|Double Blind Phase|Randomized, not treated|3
810526|NCT00098722|1762897|FG002|Double Blind Phase|Randomized, not treated|3
810527|NCT00098722|1762898|FG003|Double Blind Phase|Randomized, not treated|0
810528|NCT00098722|1762899|FG004|Double Blind Phase|Randomized, not treated|0
810529|NCT00098722|1762900|FG005|Double Blind Phase|Randomized, not treated|0
810530|NCT00098722|1762901|FG006|Double Blind Phase|Randomized, not treated|0
810531|NCT00098722|1762895|FG000|Double Blind Phase|Ongoing at cut-off date|128
810532|NCT00098722|1762896|FG001|Double Blind Phase|Ongoing at cut-off date|137
810533|NCT00098722|1762897|FG002|Double Blind Phase|Ongoing at cut-off date|57
810534|NCT00098722|1762898|FG003|Double Blind Phase|Ongoing at cut-off date|0
810535|NCT00098722|1762899|FG004|Double Blind Phase|Ongoing at cut-off date|0
810536|NCT00098722|1762900|FG005|Double Blind Phase|Ongoing at cut-off date|0
810537|NCT00098722|1762901|FG006|Double Blind Phase|Ongoing at cut-off date|0
810538|NCT00098722|1762895|FG000|Double Blind Phase|Other|7
810539|NCT00098722|1762896|FG001|Double Blind Phase|Other|8
810540|NCT00098722|1762897|FG002|Double Blind Phase|Other|7
810541|NCT00098722|1762898|FG003|Double Blind Phase|Other|0
810542|NCT00098722|1762899|FG004|Double Blind Phase|Other|0
810543|NCT00098722|1762900|FG005|Double Blind Phase|Other|0
810544|NCT00098722|1762901|FG006|Double Blind Phase|Other|0
810545|NCT00098722|1762895|FG000|Open Label Phase|Adverse Event|0
810546|NCT00098722|1762896|FG001|Open Label Phase|Adverse Event|0
810547|NCT00098722|1762897|FG002|Open Label Phase|Adverse Event|0
810548|NCT00098722|1762898|FG003|Open Label Phase|Adverse Event|5
810549|NCT00098722|1762899|FG004|Open Label Phase|Adverse Event|0
810550|NCT00098722|1762900|FG005|Open Label Phase|Adverse Event|0
810551|NCT00098722|1762901|FG006|Open Label Phase|Adverse Event|0
810552|NCT00098722|1762895|FG000|Open Label Phase|Death|0
810553|NCT00098722|1762896|FG001|Open Label Phase|Death|0
810554|NCT00098722|1762897|FG002|Open Label Phase|Death|0
810555|NCT00098722|1762898|FG003|Open Label Phase|Death|2
810556|NCT00098722|1762899|FG004|Open Label Phase|Death|0
810557|NCT00098722|1762900|FG005|Open Label Phase|Death|0
810558|NCT00098722|1762901|FG006|Open Label Phase|Death|0
810559|NCT00098722|1762895|FG000|Open Label Phase|Lack of Efficacy|0
810560|NCT00098722|1762896|FG001|Open Label Phase|Lack of Efficacy|0
810561|NCT00098722|1762897|FG002|Open Label Phase|Lack of Efficacy|0
810562|NCT00098722|1762898|FG003|Open Label Phase|Lack of Efficacy|8
810563|NCT00098722|1762899|FG004|Open Label Phase|Lack of Efficacy|0
810564|NCT00098722|1762900|FG005|Open Label Phase|Lack of Efficacy|0
810565|NCT00098722|1762901|FG006|Open Label Phase|Lack of Efficacy|0
810566|NCT00098722|1762895|FG000|Open Label Phase|Pregnancy|0
810567|NCT00098722|1762896|FG001|Open Label Phase|Pregnancy|0
810568|NCT00098722|1762897|FG002|Open Label Phase|Pregnancy|0
810569|NCT00098722|1762898|FG003|Open Label Phase|Pregnancy|1
810570|NCT00098722|1762899|FG004|Open Label Phase|Pregnancy|0
810571|NCT00098722|1762900|FG005|Open Label Phase|Pregnancy|0
810572|NCT00098722|1762901|FG006|Open Label Phase|Pregnancy|0
810573|NCT00098722|1762895|FG000|Open Label Phase|Participant defaulted|0
810574|NCT00098722|1762896|FG001|Open Label Phase|Participant defaulted|0
810575|NCT00098722|1762897|FG002|Open Label Phase|Participant defaulted|0
810576|NCT00098722|1762898|FG003|Open Label Phase|Participant defaulted|18
810577|NCT00098722|1762899|FG004|Open Label Phase|Participant defaulted|0
810578|NCT00098722|1762900|FG005|Open Label Phase|Participant defaulted|0
810579|NCT00098722|1762901|FG006|Open Label Phase|Participant defaulted|0
810580|NCT00098722|1762895|FG000|Open Label Phase|Ongoing at cut-off date|0
810581|NCT00098722|1762896|FG001|Open Label Phase|Ongoing at cut-off date|0
810582|NCT00098722|1762897|FG002|Open Label Phase|Ongoing at cut-off date|0
810583|NCT00098722|1762898|FG003|Open Label Phase|Ongoing at cut-off date|220
810584|NCT00098722|1762899|FG004|Open Label Phase|Ongoing at cut-off date|50
810585|NCT00098722|1762900|FG005|Open Label Phase|Ongoing at cut-off date|0
810586|NCT00098722|1762901|FG006|Open Label Phase|Ongoing at cut-off date|0
810587|NCT00098722|1762895|FG000|Open Label Phase|Other|0
810588|NCT00098722|1762896|FG001|Open Label Phase|Other|0
810589|NCT00098722|1762897|FG002|Open Label Phase|Other|0
810590|NCT00098722|1762898|FG003|Open Label Phase|Other|18
810591|NCT00098722|1762899|FG004|Open Label Phase|Other|0
810592|NCT00098722|1762900|FG005|Open Label Phase|Other|0
810593|NCT00098722|1762901|FG006|Open Label Phase|Other|0
810594|NCT00098722|1762895|FG000|Observation Phase|Death|0
810595|NCT00098722|1762896|FG001|Observation Phase|Death|0
810596|NCT00098722|1762897|FG002|Observation Phase|Death|0
810597|NCT00098722|1762898|FG003|Observation Phase|Death|0
810598|NCT00098722|1762899|FG004|Observation Phase|Death|0
810599|NCT00098722|1762900|FG005|Observation Phase|Death|5
810600|NCT00098722|1762901|FG006|Observation Phase|Death|3
810601|NCT00098722|1762895|FG000|Observation Phase|Lack of Efficacy|0
810602|NCT00098722|1762896|FG001|Observation Phase|Lack of Efficacy|0
810603|NCT00098722|1762897|FG002|Observation Phase|Lack of Efficacy|0
810604|NCT00098722|1762898|FG003|Observation Phase|Lack of Efficacy|0
810605|NCT00098722|1762899|FG004|Observation Phase|Lack of Efficacy|0
810606|NCT00098722|1762900|FG005|Observation Phase|Lack of Efficacy|2
810607|NCT00098722|1762901|FG006|Observation Phase|Lack of Efficacy|0
810608|NCT00098722|1762895|FG000|Observation Phase|Participant defaulted|0
810609|NCT00098722|1762896|FG001|Observation Phase|Participant defaulted|0
810610|NCT00098722|1762897|FG002|Observation Phase|Participant defaulted|0
810611|NCT00098722|1762898|FG003|Observation Phase|Participant defaulted|0
810612|NCT00098722|1762899|FG004|Observation Phase|Participant defaulted|0
810613|NCT00098722|1762900|FG005|Observation Phase|Participant defaulted|17
810614|NCT00098722|1762901|FG006|Observation Phase|Participant defaulted|4
810615|NCT00098722|1762895|FG000|Observation Phase|Other|0
810616|NCT00098722|1762896|FG001|Observation Phase|Other|0
810617|NCT00098722|1762897|FG002|Observation Phase|Other|0
810618|NCT00098722|1762898|FG003|Observation Phase|Other|0
810619|NCT00098722|1762899|FG004|Observation Phase|Other|0
810620|NCT00098722|1762900|FG005|Observation Phase|Other|21
810621|NCT00098722|1762901|FG006|Observation Phase|Other|10
810622|NCT00098748|1762916|FG000|Assigned to Study Treatment|Randomized, but not treated|0
810623|NCT00098748|1762917|FG001|Assigned to Study Treatment|Randomized, but not treated|2
810624|NCT00098748|1762918|FG002|Assigned to Study Treatment|Randomized, but not treated|2
810625|NCT00098748|1762916|FG000|Received Study Treatment|Death|2
810626|NCT00098748|1762917|FG001|Received Study Treatment|Death|1
810627|NCT00098748|1762918|FG002|Received Study Treatment|Death|2
810628|NCT00098748|1762916|FG000|Received Study Treatment|Adverse Event|1
810629|NCT00098748|1762917|FG001|Received Study Treatment|Adverse Event|2
810630|NCT00098748|1762918|FG002|Received Study Treatment|Adverse Event|5
810631|NCT00098748|1762916|FG000|Received Study Treatment|Lack of Efficacy|40
810632|NCT00098748|1762917|FG001|Received Study Treatment|Lack of Efficacy|27
810633|NCT00098748|1762918|FG002|Received Study Treatment|Lack of Efficacy|27
810634|NCT00098748|1762916|FG000|Received Study Treatment|Other|2
810635|NCT00098748|1762917|FG001|Received Study Treatment|Other|2
810636|NCT00098748|1762918|FG002|Received Study Treatment|Other|6
810637|NCT00098748|1762916|FG000|Received Study Treatment|Subject defaulted|3
810638|NCT00098748|1762917|FG001|Received Study Treatment|Subject defaulted|4
810639|NCT00098748|1762918|FG002|Received Study Treatment|Subject defaulted|4
810640|NCT00098748|1762916|FG000|Continued on Open-Label Treatment|Adverse Event|0
810641|NCT00098748|1762917|FG001|Continued on Open-Label Treatment|Adverse Event|1
810642|NCT00098748|1762918|FG002|Continued on Open-Label Treatment|Adverse Event|0
810643|NCT00098748|1762916|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1
810644|NCT00098748|1762917|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2
810645|NCT00098748|1762918|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0
810646|NCT00098748|1762916|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6
810647|NCT00098748|1762917|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7
810648|NCT00098748|1762918|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0
810649|NCT00098748|1762916|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1
810650|NCT00098748|1762917|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1
810651|NCT00098748|1762918|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0
810652|NCT00098748|1762916|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0
810653|NCT00098748|1762917|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4
810654|NCT00098748|1762918|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0
810655|NCT00098774|1762926|FG000|Overall Study|Adverse Event|2
810656|NCT00098774|1762926|FG000|Overall Study|Disease Progression|9
810657|NCT00098774|1762926|FG000|Overall Study|Withdrawal by Subject|1
810658|NCT00098774|1762926|FG000|Overall Study|Failed (to respond) during induction|4
810659|NCT00098774|1762926|FG000|Overall Study|Physician Decision|2
810660|NCT00098787|1762933|FG000|Overall Study|Never started treatment|3
810661|NCT00098787|1762934|FG001|Overall Study|Never started treatment|2
810662|NCT00098787|1762935|FG002|Overall Study|Never started treatment|1
810663|NCT00098787|1762933|FG000|Overall Study|Ineligible|9
810664|NCT00098787|1762934|FG001|Overall Study|Ineligible|7
810665|NCT00098787|1762935|FG002|Overall Study|Ineligible|3
810666|NCT00098787|1762933|FG000|Overall Study|Disease progression|28
810667|NCT00098787|1762934|FG001|Overall Study|Disease progression|17
810668|NCT00098787|1762935|FG002|Overall Study|Disease progression|23
810669|NCT00098787|1762933|FG000|Overall Study|Adverse Event|8
810670|NCT00098787|1762934|FG001|Overall Study|Adverse Event|17
810671|NCT00098787|1762935|FG002|Overall Study|Adverse Event|8
810672|NCT00098787|1762933|FG000|Overall Study|Death|6
810673|NCT00098787|1762934|FG001|Overall Study|Death|1
810674|NCT00098787|1762935|FG002|Overall Study|Death|0
810675|NCT00098787|1762933|FG000|Overall Study|Withdrawal by Subject|4
810676|NCT00098787|1762934|FG001|Overall Study|Withdrawal by Subject|12
810677|NCT00098787|1762935|FG002|Overall Study|Withdrawal by Subject|6
810678|NCT00098787|1762933|FG000|Overall Study|Alternative therapy|8
810679|NCT00098787|1762934|FG001|Overall Study|Alternative therapy|13
810680|NCT00098787|1762935|FG002|Overall Study|Alternative therapy|13
810681|NCT00098787|1762933|FG000|Overall Study|Other|7
810682|NCT00098787|1762934|FG001|Overall Study|Other|6
810683|NCT00098787|1762935|FG002|Overall Study|Other|9
810684|NCT00098813|1762943|FG000|Overall Study|Death|8
810685|NCT00098813|1762943|FG000|Overall Study|Protocol Violation|1
810686|NCT00098813|1762943|FG000|Overall Study|Withdrawal by Subject|7
810687|NCT00098813|1762943|FG000|Overall Study|Progression of Disease|1
810688|NCT00098813|1762943|FG000|Overall Study|Other complicating disease|1
810689|NCT00098813|1762943|FG000|Overall Study|Reversal of RAI resistance|1
810690|NCT00098839|1762949|FG000|Overall Study|Adverse Event|5
810691|NCT00098839|1762950|FG001|Overall Study|Adverse Event|2
810692|NCT00098839|1762949|FG000|Overall Study|Death|1
810693|NCT00098839|1762950|FG001|Overall Study|Death|2
810694|NCT00098839|1762949|FG000|Overall Study|Physician Decision|4
810695|NCT00098839|1762950|FG001|Overall Study|Physician Decision|14
810696|NCT00098839|1762949|FG000|Overall Study|Withdrawal by Subject|1
810697|NCT00098839|1762950|FG001|Overall Study|Withdrawal by Subject|0
810698|NCT00098839|1762949|FG000|Overall Study|Refusal of further protocol therapy|3
810699|NCT00098839|1762950|FG001|Overall Study|Refusal of further protocol therapy|1
810700|NCT00098839|1762949|FG000|Overall Study|Relapse|6
810701|NCT00098839|1762950|FG001|Overall Study|Relapse|3
810702|NCT00098839|1762949|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
810703|NCT00098839|1762950|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
810704|NCT00098839|1762949|FG000|Overall Study|Ineligible|2
810705|NCT00098839|1762950|FG001|Overall Study|Ineligible|0
810706|NCT00098865|1762957|FG000|Overall Study|Progressive Disease|6
810707|NCT00098865|1762957|FG000|Overall Study|Adverse Event|2
810708|NCT00098865|1762957|FG000|Overall Study|Alternative Therapy|1
810709|NCT00099268|1762980|FG000|Overall Study|Withdrawal by Subject|46
810710|NCT00099268|1762981|FG001|Overall Study|Withdrawal by Subject|28
810711|NCT00099268|1762980|FG000|Overall Study|Adverse Event|19
810712|NCT00099268|1762981|FG001|Overall Study|Adverse Event|19
810713|NCT00099268|1762980|FG000|Overall Study|Protocol Violation|9
810714|NCT00099268|1762981|FG001|Overall Study|Protocol Violation|8
810715|NCT00099268|1762980|FG000|Overall Study|Lost to Follow-up|6
810716|NCT00099268|1762981|FG001|Overall Study|Lost to Follow-up|4
810717|NCT00099268|1762980|FG000|Overall Study|Lack of Efficacy|5
810718|NCT00099268|1762981|FG001|Overall Study|Lack of Efficacy|18
810719|NCT00099268|1762980|FG000|Overall Study|Administrative problems|4
810720|NCT00099268|1762981|FG001|Overall Study|Administrative problems|4
810721|NCT00099268|1762980|FG000|Overall Study|Death|3
810722|NCT00099268|1762981|FG001|Overall Study|Death|1
810723|NCT00099359|1762990|FG000|Overall Study|Death|11
810724|NCT00099359|1762991|FG001|Overall Study|Death|15
810725|NCT00099359|1762992|FG002|Overall Study|Death|17
810726|NCT00099359|1762990|FG000|Overall Study|Withdrawal by Subject|19
810727|NCT00099359|1762991|FG001|Overall Study|Withdrawal by Subject|19
810728|NCT00099359|1762992|FG002|Overall Study|Withdrawal by Subject|23
810729|NCT00099359|1762990|FG000|Overall Study|Lost to Follow-up|15
810730|NCT00099359|1762991|FG001|Overall Study|Lost to Follow-up|24
810731|NCT00099359|1762992|FG002|Overall Study|Lost to Follow-up|24
810732|NCT00099359|1762990|FG000|Overall Study|moved out of area|9
810733|NCT00099359|1762991|FG001|Overall Study|moved out of area|7
810734|NCT00099359|1762992|FG002|Overall Study|moved out of area|4
810735|NCT00099437|1763023|FG000|Overall Study|Lost to Follow-up|30
810736|NCT00099437|1763024|FG001|Overall Study|Lost to Follow-up|33
810737|NCT00099437|1763023|FG000|Overall Study|Death|293
810738|NCT00099437|1763024|FG001|Overall Study|Death|261
810739|NCT00099437|1763023|FG000|Overall Study|Withdrawal by Subject|6
810740|NCT00099437|1763024|FG001|Overall Study|Withdrawal by Subject|10
810741|NCT00099437|1763023|FG000|Overall Study|Ongoing in FU but not on treatment|37
810742|NCT00099437|1763024|FG001|Overall Study|Ongoing in FU but not on treatment|45
810743|NCT00099632|1763036|FG000|Overall Study|Lost to Follow-up|1
810744|NCT00099632|1763037|FG001|Overall Study|Lost to Follow-up|0
810745|NCT00099632|1763038|FG002|Overall Study|Lost to Follow-up|3
810746|NCT00099632|1763039|FG003|Overall Study|Lost to Follow-up|1
810747|NCT00099632|1763040|FG004|Overall Study|Lost to Follow-up|1
810748|NCT00099632|1763041|FG005|Overall Study|Lost to Follow-up|0
810749|NCT00099632|1763036|FG000|Overall Study|Withdrawal by Subject|0
810750|NCT00099632|1763037|FG001|Overall Study|Withdrawal by Subject|1
810751|NCT00099632|1763038|FG002|Overall Study|Withdrawal by Subject|0
810752|NCT00099632|1763039|FG003|Overall Study|Withdrawal by Subject|0
810753|NCT00099632|1763040|FG004|Overall Study|Withdrawal by Subject|0
810754|NCT00099632|1763041|FG005|Overall Study|Withdrawal by Subject|1
810755|NCT00099632|1763036|FG000|Overall Study|Protocol Violation|0
810756|NCT00099632|1763037|FG001|Overall Study|Protocol Violation|0
810757|NCT00099632|1763038|FG002|Overall Study|Protocol Violation|0
810758|NCT00099632|1763039|FG003|Overall Study|Protocol Violation|0
810759|NCT00099632|1763040|FG004|Overall Study|Protocol Violation|0
810760|NCT00099632|1763041|FG005|Overall Study|Protocol Violation|1
810761|NCT00099983|1763057|FG000|Overall Study|Lost to Follow-up|2
810762|NCT00099983|1763058|FG001|Overall Study|Lost to Follow-up|3
810763|NCT00099983|1763057|FG000|Overall Study|Missing Source Documents|14
810764|NCT00099983|1763058|FG001|Overall Study|Missing Source Documents|15
810765|NCT00099983|1763057|FG000|Overall Study|Withdrawal by Subject|3
810766|NCT00099983|1763058|FG001|Overall Study|Withdrawal by Subject|2
810767|NCT00099983|1763057|FG000|Overall Study|Adverse Event|1
810768|NCT00099983|1763058|FG001|Overall Study|Adverse Event|1
810769|NCT00099983|1763057|FG000|Overall Study|Lack of Efficacy|0
810770|NCT00099983|1763058|FG001|Overall Study|Lack of Efficacy|1
810771|NCT00099983|1763057|FG000|Overall Study|Unable to return for appointments|1
810772|NCT00099983|1763058|FG001|Overall Study|Unable to return for appointments|1
810773|NCT00099983|1763057|FG000|Overall Study|Moved|1
810774|NCT00099983|1763058|FG001|Overall Study|Moved|0
810775|NCT00099983|1763057|FG000|Overall Study|Other psychiatric problem|1
810776|NCT00099983|1763058|FG001|Overall Study|Other psychiatric problem|0
810777|NCT00099983|1763057|FG000|Overall Study|Incarcerated|0
810778|NCT00099983|1763058|FG001|Overall Study|Incarcerated|1
810779|NCT00099983|1763057|FG000|Overall Study|Intolerant of burden of visits|0
810780|NCT00099983|1763058|FG001|Overall Study|Intolerant of burden of visits|1
810781|NCT00099983|1763057|FG000|Overall Study|Other issue|1
810782|NCT00099983|1763058|FG001|Overall Study|Other issue|0
810783|NCT00100048|1763069|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2
810784|NCT00100048|1763070|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0
810785|NCT00100048|1763071|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0
810786|NCT00100048|1763072|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0
810787|NCT00100048|1763073|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0
810788|NCT00100048|1763074|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1
810789|NCT00100048|1763069|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0
810790|NCT00100048|1763070|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1
810791|NCT00100048|1763071|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2
810792|NCT00100048|1763072|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0
810793|NCT00100048|1763073|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0
810794|NCT00100048|1763074|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1
810795|NCT00100048|1763069|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
810796|NCT00100048|1763070|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
810797|NCT00100048|1763071|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
810798|NCT00100048|1763072|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
810799|NCT00100048|1763073|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
810800|NCT00100048|1763074|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
810801|NCT00100048|1763069|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
810802|NCT00100048|1763070|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
810803|NCT00100048|1763071|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
810804|NCT00100048|1763072|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
810805|NCT00100048|1763073|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
810806|NCT00100048|1763074|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
810807|NCT00100048|1763069|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
810808|NCT00100048|1763070|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
810809|NCT00100048|1763071|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
810810|NCT00100048|1763072|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
810811|NCT00100048|1763073|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
810812|NCT00100048|1763074|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
810813|NCT00100048|1763069|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7
810814|NCT00100048|1763070|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1
810815|NCT00100048|1763071|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4
810816|NCT00100048|1763072|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2
810817|NCT00100048|1763073|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0
810818|NCT00100048|1763074|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0
810819|NCT00100048|1763069|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
810820|NCT00100048|1763070|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
810821|NCT00100048|1763071|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
810822|NCT00100048|1763072|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
810823|NCT00100048|1763073|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
810824|NCT00100048|1763074|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
810825|NCT00100048|1763069|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
810826|NCT00100048|1763070|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
810827|NCT00100048|1763071|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
810828|NCT00100048|1763072|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
810829|NCT00100048|1763073|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
810830|NCT00100048|1763074|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
810831|NCT00100178|1763118|FG000|Overall Study|Lost to Follow-up|0
810832|NCT00100178|1763119|FG001|Overall Study|Lost to Follow-up|6
810833|NCT00100178|1763120|FG002|Overall Study|Lost to Follow-up|5
810834|NCT00100178|1763118|FG000|Overall Study|Adverse Event|2
810835|NCT00100178|1763119|FG001|Overall Study|Adverse Event|2
810836|NCT00100178|1763120|FG002|Overall Study|Adverse Event|1
810837|NCT00100178|1763118|FG000|Overall Study|Withdrawal by Subject|1
810838|NCT00100178|1763119|FG001|Overall Study|Withdrawal by Subject|1
810839|NCT00100178|1763120|FG002|Overall Study|Withdrawal by Subject|1
810840|NCT00100178|1763118|FG000|Overall Study|Physician Decision|6
810841|NCT00100178|1763119|FG001|Overall Study|Physician Decision|1
810842|NCT00100178|1763120|FG002|Overall Study|Physician Decision|3
810843|NCT00100789|1763159|FG000|Overall Study|Adverse Event|10
810844|NCT00100789|1763159|FG000|Overall Study|Withdrawal by Subject|1
810845|NCT00100789|1763159|FG000|Overall Study|Progression/relapse|42
810846|NCT00100789|1763159|FG000|Overall Study|Death|2
810847|NCT00100789|1763159|FG000|Overall Study|Not protocol specified|5
810848|NCT00100789|1763159|FG000|Overall Study|Ineligible|3
810849|NCT00100789|1763159|FG000|Overall Study|Never received treatment|1
810850|NCT00100802|1763164|FG000|Overall Study|Adverse Event|9
810851|NCT00100802|1763164|FG000|Overall Study|Death|1
810852|NCT00100802|1763164|FG000|Overall Study|Lack of Efficacy|47
810853|NCT00100802|1763164|FG000|Overall Study|Physician Decision|5
810854|NCT00100802|1763164|FG000|Overall Study|Protocol Violation|1
810855|NCT00100802|1763164|FG000|Overall Study|Withdrawal by Subject|5
810856|NCT00100802|1763164|FG000|Overall Study|Ineligible|12
810857|NCT00100815|1763168|FG000|Overall Study|Progression|24
810858|NCT00100815|1763168|FG000|Overall Study|Adverse Event|18
810859|NCT00100815|1763168|FG000|Overall Study|Death|4
810860|NCT00100815|1763168|FG000|Overall Study|Other|3
810861|NCT00100932|1763178|FG000|Overall Study|Adverse Event|11
810862|NCT00100932|1763179|FG001|Overall Study|Adverse Event|2
810863|NCT00100932|1763178|FG000|Overall Study|Withdrawal by Subject|6
810864|NCT00100932|1763179|FG001|Overall Study|Withdrawal by Subject|0
810865|NCT00100932|1763178|FG000|Overall Study|Progressive Disease|44
810866|NCT00100932|1763179|FG001|Overall Study|Progressive Disease|18
810867|NCT00100932|1763178|FG000|Overall Study|Physician Decision|7
810868|NCT00100932|1763179|FG001|Overall Study|Physician Decision|5
810869|NCT00100932|1763178|FG000|Overall Study|Other|5
810870|NCT00100932|1763179|FG001|Overall Study|Other|2
810871|NCT00101010|1763185|FG000|Overall Study|Physician Decision|1
810872|NCT00101101|1763198|FG000|Overall Study|never received vaccine|20
810873|NCT00101166|1763202|FG000|Overall Study|progressive disease|10
810874|NCT00101192|1763206|FG000|Overall Study|Ineligible|6
810875|NCT00101192|1763206|FG000|Overall Study|Inevaluable|1
810876|NCT00101283|1763212|FG000|Overall Study|Withdrawal by Subject|0
810877|NCT00101283|1763213|FG001|Overall Study|Withdrawal by Subject|1
810878|NCT00101283|1763212|FG000|Overall Study|Insurance Refusal|0
810879|NCT00101283|1763213|FG001|Overall Study|Insurance Refusal|1
810880|NCT00101283|1763212|FG000|Overall Study|Prostate Cancer Recurrence|0
810881|NCT00101283|1763213|FG001|Overall Study|Prostate Cancer Recurrence|1
810882|NCT00101400|1763228|FG000|Survival Follow-Up|Alive|7
810883|NCT00101439|1763238|FG000|Period 2|Withdrawal by Subject|0
810884|NCT00101439|1763239|FG001|Period 2|Withdrawal by Subject|2
810885|NCT00101452|1763248|FG000|Overall Study|Adverse Event|2
810886|NCT00101452|1763249|FG001|Overall Study|Adverse Event|0
810887|NCT00101452|1763250|FG002|Overall Study|Adverse Event|1
810888|NCT00101452|1763248|FG000|Overall Study|Lost to Follow-up|13
810889|NCT00101452|1763249|FG001|Overall Study|Lost to Follow-up|8
810890|NCT00101452|1763250|FG002|Overall Study|Lost to Follow-up|14
810891|NCT00101452|1763248|FG000|Overall Study|Withdrawal by Subject|10
810892|NCT00101452|1763249|FG001|Overall Study|Withdrawal by Subject|14
810893|NCT00101452|1763250|FG002|Overall Study|Withdrawal by Subject|9
810894|NCT00101452|1763248|FG000|Overall Study|Baseline Fail|2
810895|NCT00101452|1763249|FG001|Overall Study|Baseline Fail|1
810896|NCT00101452|1763250|FG002|Overall Study|Baseline Fail|2
810897|NCT00101452|1763248|FG000|Overall Study|Physician Decision|0
810898|NCT00101452|1763249|FG001|Overall Study|Physician Decision|3
810899|NCT00101452|1763250|FG002|Overall Study|Physician Decision|2
810900|NCT00101452|1763248|FG000|Overall Study|Protocol Violation|2
810901|NCT00101452|1763249|FG001|Overall Study|Protocol Violation|1
810902|NCT00101452|1763250|FG002|Overall Study|Protocol Violation|3
810903|NCT00101452|1763248|FG000|Overall Study|Other|15
810904|NCT00101452|1763249|FG001|Overall Study|Other|16
810905|NCT00101452|1763250|FG002|Overall Study|Other|12
810906|NCT00101582|1763264|FG000|Overall Study|Ineligibility determined|0
810907|NCT00101582|1763265|FG001|Overall Study|Ineligibility determined|1
810908|NCT00101582|1763264|FG000|Overall Study|Adverse Event|1
810909|NCT00101582|1763265|FG001|Overall Study|Adverse Event|4
810910|NCT00101582|1763264|FG000|Overall Study|Withdrawal by Subject|6
810911|NCT00101582|1763265|FG001|Overall Study|Withdrawal by Subject|4
810912|NCT00101582|1763264|FG000|Overall Study|Physician Decision|1
810913|NCT00101582|1763265|FG001|Overall Study|Physician Decision|0
810914|NCT00101582|1763264|FG000|Overall Study|Death|3
810915|NCT00101582|1763265|FG001|Overall Study|Death|5
810916|NCT00101582|1763264|FG000|Overall Study|Other|0
810917|NCT00101582|1763265|FG001|Overall Study|Other|1
810918|NCT00101686|1763315|FG000|Overall Study|Progressive Disease|37
810919|NCT00101686|1763316|FG001|Overall Study|Progressive Disease|28
810920|NCT00101686|1763317|FG002|Overall Study|Progressive Disease|37
810921|NCT00101686|1763318|FG003|Overall Study|Progressive Disease|38
810922|NCT00101686|1763319|FG004|Overall Study|Progressive Disease|28
810923|NCT00101686|1763320|FG005|Overall Study|Progressive Disease|25
810924|NCT00101686|1763321|FG006|Overall Study|Progressive Disease|5
810925|NCT00101686|1763322|FG007|Overall Study|Progressive Disease|7
810926|NCT00101686|1763323|FG008|Overall Study|Progressive Disease|10
810927|NCT00101686|1763324|FG009|Overall Study|Progressive Disease|8
810928|NCT00101686|1763315|FG000|Overall Study|initiation other anti-cancer treatment|4
810929|NCT00101686|1763316|FG001|Overall Study|initiation other anti-cancer treatment|3
810930|NCT00101686|1763317|FG002|Overall Study|initiation other anti-cancer treatment|4
810931|NCT00101686|1763318|FG003|Overall Study|initiation other anti-cancer treatment|3
810932|NCT00101686|1763319|FG004|Overall Study|initiation other anti-cancer treatment|1
810933|NCT00101686|1763320|FG005|Overall Study|initiation other anti-cancer treatment|1
810934|NCT00101686|1763321|FG006|Overall Study|initiation other anti-cancer treatment|2
810935|NCT00101686|1763322|FG007|Overall Study|initiation other anti-cancer treatment|2
810936|NCT00101686|1763323|FG008|Overall Study|initiation other anti-cancer treatment|3
810937|NCT00101686|1763324|FG009|Overall Study|initiation other anti-cancer treatment|3
810938|NCT00101686|1763315|FG000|Overall Study|>3 week delay treatment due toxicity|6
810939|NCT00101686|1763316|FG001|Overall Study|>3 week delay treatment due toxicity|2
810940|NCT00101686|1763317|FG002|Overall Study|>3 week delay treatment due toxicity|1
810941|NCT00101686|1763318|FG003|Overall Study|>3 week delay treatment due toxicity|2
810942|NCT00101686|1763319|FG004|Overall Study|>3 week delay treatment due toxicity|7
810943|NCT00101686|1763320|FG005|Overall Study|>3 week delay treatment due toxicity|3
810944|NCT00101686|1763321|FG006|Overall Study|>3 week delay treatment due toxicity|2
810945|NCT00101686|1763322|FG007|Overall Study|>3 week delay treatment due toxicity|1
810946|NCT00101686|1763323|FG008|Overall Study|>3 week delay treatment due toxicity|3
810947|NCT00101686|1763324|FG009|Overall Study|>3 week delay treatment due toxicity|0
810948|NCT00101686|1763315|FG000|Overall Study|unacceptable toxicity|3
810949|NCT00101686|1763316|FG001|Overall Study|unacceptable toxicity|9
810950|NCT00101686|1763317|FG002|Overall Study|unacceptable toxicity|10
810951|NCT00101686|1763318|FG003|Overall Study|unacceptable toxicity|6
810952|NCT00101686|1763319|FG004|Overall Study|unacceptable toxicity|16
810953|NCT00101686|1763320|FG005|Overall Study|unacceptable toxicity|10
810954|NCT00101686|1763321|FG006|Overall Study|unacceptable toxicity|4
810955|NCT00101686|1763322|FG007|Overall Study|unacceptable toxicity|2
810956|NCT00101686|1763323|FG008|Overall Study|unacceptable toxicity|1
810957|NCT00101686|1763324|FG009|Overall Study|unacceptable toxicity|4
810958|NCT00101686|1763315|FG000|Overall Study|Randomized but did not receive treament|1
810959|NCT00101686|1763316|FG001|Overall Study|Randomized but did not receive treament|6
810960|NCT00101686|1763317|FG002|Overall Study|Randomized but did not receive treament|2
810961|NCT00101686|1763318|FG003|Overall Study|Randomized but did not receive treament|2
810962|NCT00101686|1763319|FG004|Overall Study|Randomized but did not receive treament|2
810963|NCT00101686|1763320|FG005|Overall Study|Randomized but did not receive treament|2
810964|NCT00101686|1763321|FG006|Overall Study|Randomized but did not receive treament|0
810965|NCT00101686|1763322|FG007|Overall Study|Randomized but did not receive treament|1
810966|NCT00101686|1763323|FG008|Overall Study|Randomized but did not receive treament|0
810967|NCT00101686|1763324|FG009|Overall Study|Randomized but did not receive treament|1
810968|NCT00101686|1763315|FG000|Overall Study|intercurrent non-cancer related illness|0
810969|NCT00101686|1763316|FG001|Overall Study|intercurrent non-cancer related illness|0
810970|NCT00101686|1763317|FG002|Overall Study|intercurrent non-cancer related illness|2
810971|NCT00101686|1763318|FG003|Overall Study|intercurrent non-cancer related illness|0
810972|NCT00101686|1763319|FG004|Overall Study|intercurrent non-cancer related illness|1
810973|NCT00101686|1763320|FG005|Overall Study|intercurrent non-cancer related illness|3
810974|NCT00101686|1763321|FG006|Overall Study|intercurrent non-cancer related illness|1
810975|NCT00101686|1763322|FG007|Overall Study|intercurrent non-cancer related illness|0
810976|NCT00101686|1763323|FG008|Overall Study|intercurrent non-cancer related illness|1
810977|NCT00101686|1763324|FG009|Overall Study|intercurrent non-cancer related illness|1
810978|NCT00101686|1763315|FG000|Overall Study|Physician Decision|10
810979|NCT00101686|1763316|FG001|Overall Study|Physician Decision|13
810980|NCT00101686|1763317|FG002|Overall Study|Physician Decision|6
810981|NCT00101686|1763318|FG003|Overall Study|Physician Decision|7
810982|NCT00101686|1763319|FG004|Overall Study|Physician Decision|8
810983|NCT00101686|1763320|FG005|Overall Study|Physician Decision|9
810984|NCT00101686|1763321|FG006|Overall Study|Physician Decision|5
810985|NCT00101686|1763322|FG007|Overall Study|Physician Decision|5
810986|NCT00101686|1763323|FG008|Overall Study|Physician Decision|1
810987|NCT00101686|1763324|FG009|Overall Study|Physician Decision|1
810988|NCT00101686|1763315|FG000|Overall Study|Other|1
810989|NCT00101686|1763316|FG001|Overall Study|Other|4
810990|NCT00101686|1763317|FG002|Overall Study|Other|1
810991|NCT00101686|1763318|FG003|Overall Study|Other|6
810992|NCT00101686|1763319|FG004|Overall Study|Other|2
810993|NCT00101686|1763320|FG005|Overall Study|Other|12
810994|NCT00101686|1763321|FG006|Overall Study|Other|1
810995|NCT00101686|1763322|FG007|Overall Study|Other|5
810996|NCT00101686|1763323|FG008|Overall Study|Other|3
810997|NCT00101686|1763324|FG009|Overall Study|Other|3
810998|NCT00101686|1763315|FG000|Overall Study|Withdrawal by Subject|9
810999|NCT00101686|1763316|FG001|Overall Study|Withdrawal by Subject|8
811000|NCT00101686|1763317|FG002|Overall Study|Withdrawal by Subject|6
811001|NCT00101686|1763318|FG003|Overall Study|Withdrawal by Subject|8
811002|NCT00101686|1763319|FG004|Overall Study|Withdrawal by Subject|8
811003|NCT00101686|1763320|FG005|Overall Study|Withdrawal by Subject|7
811004|NCT00101686|1763321|FG006|Overall Study|Withdrawal by Subject|7
811005|NCT00101686|1763322|FG007|Overall Study|Withdrawal by Subject|7
811006|NCT00101686|1763323|FG008|Overall Study|Withdrawal by Subject|8
811007|NCT00101686|1763324|FG009|Overall Study|Withdrawal by Subject|9
811008|NCT00101868|1763360|FG000|Overall Study|Death|10
811009|NCT00101868|1763361|FG001|Overall Study|Death|10
811010|NCT00101868|1763360|FG000|Overall Study|Withdrawal by Subject|8
811011|NCT00101868|1763361|FG001|Overall Study|Withdrawal by Subject|9
811012|NCT00101868|1763360|FG000|Overall Study|Protocol Violation|3
811013|NCT00101868|1763361|FG001|Overall Study|Protocol Violation|0
811014|NCT00101868|1763360|FG000|Overall Study|Lost to Follow-up|8
811015|NCT00101868|1763361|FG001|Overall Study|Lost to Follow-up|13
811016|NCT00101907|1763375|FG000|Overall Study|Adverse Event|1
811017|NCT00101907|1763376|FG001|Overall Study|Adverse Event|0
811018|NCT00101907|1763377|FG002|Overall Study|Adverse Event|0
811019|NCT00101907|1763378|FG003|Overall Study|Adverse Event|0
811020|NCT00101907|1763379|FG004|Overall Study|Adverse Event|0
811021|NCT00101907|1763380|FG005|Overall Study|Adverse Event|0
811022|NCT00101907|1763375|FG000|Overall Study|Death|0
811023|NCT00101907|1763376|FG001|Overall Study|Death|1
811024|NCT00101907|1763377|FG002|Overall Study|Death|0
811025|NCT00101907|1763378|FG003|Overall Study|Death|0
811026|NCT00101907|1763379|FG004|Overall Study|Death|3
811027|NCT00101907|1763380|FG005|Overall Study|Death|0
811028|NCT00101907|1763375|FG000|Overall Study|Physician Decision|0
811029|NCT00101907|1763376|FG001|Overall Study|Physician Decision|0
811030|NCT00101907|1763377|FG002|Overall Study|Physician Decision|0
811031|NCT00101907|1763378|FG003|Overall Study|Physician Decision|1
811032|NCT00101907|1763379|FG004|Overall Study|Physician Decision|1
811033|NCT00101907|1763380|FG005|Overall Study|Physician Decision|0
811034|NCT00101907|1763375|FG000|Overall Study|Withdrawal by Subject|1
811035|NCT00101907|1763376|FG001|Overall Study|Withdrawal by Subject|0
811036|NCT00101907|1763377|FG002|Overall Study|Withdrawal by Subject|1
811037|NCT00101907|1763378|FG003|Overall Study|Withdrawal by Subject|0
811038|NCT00101907|1763379|FG004|Overall Study|Withdrawal by Subject|1
811039|NCT00101907|1763380|FG005|Overall Study|Withdrawal by Subject|0
811040|NCT00102063|1763414|FG000|Overall Study|Lack of Efficacy|5
811041|NCT00102063|1763415|FG001|Overall Study|Lack of Efficacy|1
811042|NCT00102063|1763416|FG002|Overall Study|Lack of Efficacy|1
811043|NCT00102063|1763414|FG000|Overall Study|Adverse Event|7
811044|NCT00102063|1763415|FG001|Overall Study|Adverse Event|4
811045|NCT00102063|1763416|FG002|Overall Study|Adverse Event|2
811046|NCT00102063|1763414|FG000|Overall Study|Withdrawal by Subject|4
811047|NCT00102063|1763415|FG001|Overall Study|Withdrawal by Subject|12
811048|NCT00102063|1763416|FG002|Overall Study|Withdrawal by Subject|5
811049|NCT00102063|1763414|FG000|Overall Study|Lost to Follow-up|0
811050|NCT00102063|1763415|FG001|Overall Study|Lost to Follow-up|0
811051|NCT00102063|1763416|FG002|Overall Study|Lost to Follow-up|1
811052|NCT00102063|1763414|FG000|Overall Study|Protocol Violation|0
811053|NCT00102063|1763415|FG001|Overall Study|Protocol Violation|1
811054|NCT00102063|1763416|FG002|Overall Study|Protocol Violation|1
811055|NCT00102440|1763427|FG000|Overall Study|Lost to Follow-up|25
811056|NCT00102440|1763428|FG001|Overall Study|Lost to Follow-up|18
811057|NCT00102440|1763429|FG002|Overall Study|Lost to Follow-up|21
811058|NCT00102440|1763427|FG000|Overall Study|Adverse Event|16
811059|NCT00102440|1763428|FG001|Overall Study|Adverse Event|23
811060|NCT00102440|1763429|FG002|Overall Study|Adverse Event|8
811061|NCT00102440|1763427|FG000|Overall Study|Gout Flare|10
811062|NCT00102440|1763428|FG001|Overall Study|Gout Flare|28
811063|NCT00102440|1763429|FG002|Overall Study|Gout Flare|9
811064|NCT00102440|1763427|FG000|Overall Study|Personal Reason(s)|19
811065|NCT00102440|1763428|FG001|Overall Study|Personal Reason(s)|13
811066|NCT00102440|1763429|FG002|Overall Study|Personal Reason(s)|13
811067|NCT00102440|1763427|FG000|Overall Study|Other|11
811068|NCT00102440|1763428|FG001|Overall Study|Other|14
811069|NCT00102440|1763429|FG002|Overall Study|Other|14
811070|NCT00102440|1763427|FG000|Overall Study|Protocol Violation|7
811071|NCT00102440|1763428|FG001|Overall Study|Protocol Violation|2
811072|NCT00102440|1763429|FG002|Overall Study|Protocol Violation|1
811073|NCT00102531|1763443|FG000|Overall Study|Adverse Event|0
811074|NCT00102531|1763444|FG001|Overall Study|Adverse Event|1
811075|NCT00102531|1763443|FG000|Overall Study|Disease Progression|5
811076|NCT00102531|1763444|FG001|Overall Study|Disease Progression|9
811077|NCT00102531|1763443|FG000|Overall Study|Physician Decision|0
811078|NCT00102531|1763444|FG001|Overall Study|Physician Decision|1
811079|NCT00102596|1763450|FG000|Part A|Screen failures|6
811080|NCT00102596|1763451|FG001|Part A|Screen failures|0
811081|NCT00102596|1763450|FG000|Part A|Adverse Event|1
811082|NCT00102596|1763451|FG001|Part A|Adverse Event|0
811083|NCT00102687|1763461|FG000|Initial Period|Withdrawal by Subject|6
811084|NCT00102687|1763462|FG001|Initial Period|Withdrawal by Subject|3
811085|NCT00102687|1763463|FG002|Initial Period|Withdrawal by Subject|5
811086|NCT00102687|1763464|FG003|Initial Period|Withdrawal by Subject|0
811087|NCT00102687|1763465|FG004|Initial Period|Withdrawal by Subject|0
811088|NCT00102687|1763461|FG000|Initial Period|Adverse Event|4
811089|NCT00102687|1763462|FG001|Initial Period|Adverse Event|7
811090|NCT00102687|1763463|FG002|Initial Period|Adverse Event|9
811091|NCT00102687|1763464|FG003|Initial Period|Adverse Event|0
811092|NCT00102687|1763465|FG004|Initial Period|Adverse Event|0
811093|NCT00102687|1763461|FG000|Initial Period|Transformation to AML (blast > 30%)|1
811094|NCT00102687|1763462|FG001|Initial Period|Transformation to AML (blast > 30%)|3
811095|NCT00102687|1763463|FG002|Initial Period|Transformation to AML (blast > 30%)|0
811096|NCT00102687|1763464|FG003|Initial Period|Transformation to AML (blast > 30%)|0
811097|NCT00102687|1763465|FG004|Initial Period|Transformation to AML (blast > 30%)|0
811098|NCT00102687|1763461|FG000|Initial Period|Protocol Violation|0
811099|NCT00102687|1763462|FG001|Initial Period|Protocol Violation|0
811100|NCT00102687|1763463|FG002|Initial Period|Protocol Violation|2
811101|NCT00102687|1763464|FG003|Initial Period|Protocol Violation|0
811102|NCT00102687|1763465|FG004|Initial Period|Protocol Violation|0
811103|NCT00102687|1763461|FG000|Initial Period|Physician Decision|2
811104|NCT00102687|1763462|FG001|Initial Period|Physician Decision|9
811105|NCT00102687|1763463|FG002|Initial Period|Physician Decision|6
811106|NCT00102687|1763464|FG003|Initial Period|Physician Decision|0
811107|NCT00102687|1763465|FG004|Initial Period|Physician Decision|0
811108|NCT00102687|1763461|FG000|Initial Period|Sponsor's decision|0
811109|NCT00102687|1763462|FG001|Initial Period|Sponsor's decision|1
811110|NCT00102687|1763463|FG002|Initial Period|Sponsor's decision|1
811111|NCT00102687|1763464|FG003|Initial Period|Sponsor's decision|0
811112|NCT00102687|1763465|FG004|Initial Period|Sponsor's decision|0
811113|NCT00102687|1763461|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4
811114|NCT00102687|1763462|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4
811115|NCT00102687|1763463|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2
811116|NCT00102687|1763464|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0
811117|NCT00102687|1763465|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0
811118|NCT00102687|1763461|FG000|Initial Period|Death|1
811119|NCT00102687|1763462|FG001|Initial Period|Death|1
811120|NCT00102687|1763463|FG002|Initial Period|Death|1
811121|NCT00102687|1763464|FG003|Initial Period|Death|0
811122|NCT00102687|1763465|FG004|Initial Period|Death|0
811123|NCT00102687|1763461|FG000|Maintenance Period|Withdrawal by Subject|4
811124|NCT00102687|1763462|FG001|Maintenance Period|Withdrawal by Subject|0
811125|NCT00102687|1763463|FG002|Maintenance Period|Withdrawal by Subject|2
811126|NCT00102687|1763464|FG003|Maintenance Period|Withdrawal by Subject|3
811127|NCT00102687|1763465|FG004|Maintenance Period|Withdrawal by Subject|1
811128|NCT00102687|1763461|FG000|Maintenance Period|Adverse Event|1
811129|NCT00102687|1763462|FG001|Maintenance Period|Adverse Event|0
811130|NCT00102687|1763463|FG002|Maintenance Period|Adverse Event|0
811131|NCT00102687|1763464|FG003|Maintenance Period|Adverse Event|1
811132|NCT00102687|1763465|FG004|Maintenance Period|Adverse Event|3
811133|NCT00102687|1763461|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0
811134|NCT00102687|1763462|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1
811135|NCT00102687|1763463|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0
811136|NCT00102687|1763464|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2
811137|NCT00102687|1763465|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0
811138|NCT00102687|1763461|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1
811139|NCT00102687|1763462|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1
811140|NCT00102687|1763463|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1
811141|NCT00102687|1763464|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3
811142|NCT00102687|1763465|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4
811143|NCT00102687|1763461|FG000|Maintenance Period|Death|0
811144|NCT00102687|1763462|FG001|Maintenance Period|Death|0
811145|NCT00102687|1763463|FG002|Maintenance Period|Death|0
811146|NCT00102687|1763464|FG003|Maintenance Period|Death|1
811147|NCT00102687|1763465|FG004|Maintenance Period|Death|1
811148|NCT00102687|1763461|FG000|Maintenance Period|Physician Decision|1
811149|NCT00102687|1763462|FG001|Maintenance Period|Physician Decision|2
811150|NCT00102687|1763463|FG002|Maintenance Period|Physician Decision|3
811151|NCT00102687|1763464|FG003|Maintenance Period|Physician Decision|0
811152|NCT00102687|1763465|FG004|Maintenance Period|Physician Decision|4
811153|NCT00102804|1763483|FG000|Overall Study|Progressive Disease (PD)|307
811154|NCT00102804|1763484|FG001|Overall Study|Progressive Disease (PD)|196
811155|NCT00102804|1763483|FG000|Overall Study|Withdrawal by Subject|46
811156|NCT00102804|1763484|FG001|Overall Study|Withdrawal by Subject|7
811157|NCT00102804|1763483|FG000|Overall Study|Adverse Event|37
811158|NCT00102804|1763484|FG001|Overall Study|Adverse Event|3
811159|NCT00102804|1763483|FG000|Overall Study|Physician Decision|24
811160|NCT00102804|1763484|FG001|Overall Study|Physician Decision|6
811161|NCT00102804|1763483|FG000|Overall Study|Death|5
811162|NCT00102804|1763484|FG001|Overall Study|Death|6
811163|NCT00102804|1763483|FG000|Overall Study|Enrollment Criteria Not Met|6
811164|NCT00102804|1763484|FG001|Overall Study|Enrollment Criteria Not Met|0
811165|NCT00102804|1763483|FG000|Overall Study|Lost to Follow-up|4
811166|NCT00102804|1763484|FG001|Overall Study|Lost to Follow-up|1
811167|NCT00102804|1763483|FG000|Overall Study|Protocol Violation|2
811168|NCT00102804|1763484|FG001|Overall Study|Protocol Violation|1
811169|NCT00102804|1763483|FG000|Overall Study|Satisfactory Response|2
811170|NCT00102804|1763484|FG001|Overall Study|Satisfactory Response|0
811171|NCT00102804|1763483|FG000|Overall Study|Sponsor Decision|1
811172|NCT00102804|1763484|FG001|Overall Study|Sponsor Decision|0
811173|NCT00102804|1763483|FG000|Overall Study|Alive, Receiving Treatment|7
811174|NCT00102804|1763484|FG001|Overall Study|Alive, Receiving Treatment|2
811175|NCT00102960|1763493|FG000|Overall Study|Death|23
811176|NCT00102960|1763494|FG001|Overall Study|Death|11
811177|NCT00102960|1763495|FG002|Overall Study|Death|11
811178|NCT00102960|1763493|FG000|Overall Study|Lost to Follow-up|6
811179|NCT00102960|1763494|FG001|Overall Study|Lost to Follow-up|12
811180|NCT00102960|1763495|FG002|Overall Study|Lost to Follow-up|16
811181|NCT00102960|1763493|FG000|Overall Study|Withdrawal by Subject|1
811182|NCT00102960|1763494|FG001|Overall Study|Withdrawal by Subject|0
811183|NCT00102960|1763495|FG002|Overall Study|Withdrawal by Subject|1
811184|NCT00103012|1763510|FG000|Overall Study|Withdrawal by Subject|2
811185|NCT00103012|1763511|FG001|Overall Study|Withdrawal by Subject|1
811186|NCT00103012|1763512|FG002|Overall Study|Withdrawal by Subject|2
811187|NCT00103012|1763510|FG000|Overall Study|Pregnancy|1
811188|NCT00103012|1763511|FG001|Overall Study|Pregnancy|0
811189|NCT00103012|1763512|FG002|Overall Study|Pregnancy|0
811190|NCT00103012|1763510|FG000|Overall Study|Adverse Event|0
811191|NCT00103012|1763511|FG001|Overall Study|Adverse Event|0
811192|NCT00103012|1763512|FG002|Overall Study|Adverse Event|1
811193|NCT00103012|1763510|FG000|Overall Study|Subject non-compliant with medications|0
811194|NCT00103012|1763511|FG001|Overall Study|Subject non-compliant with medications|0
811195|NCT00103012|1763512|FG002|Overall Study|Subject non-compliant with medications|1
811196|NCT00103142|1763526|FG000|Overall Study|Adverse Event|1
811197|NCT00103142|1763527|FG001|Overall Study|Adverse Event|0
811198|NCT00103142|1763526|FG000|Overall Study|Progression of disease|2
811199|NCT00103142|1763527|FG001|Overall Study|Progression of disease|1
811200|NCT00103207|1763539|FG000|Overall Study|Adverse Event|3
811201|NCT00103207|1763539|FG000|Overall Study|Death|1
811202|NCT00103207|1763539|FG000|Overall Study|Withdrawal by Subject|2
811203|NCT00103207|1763539|FG000|Overall Study|Other complicating disease|1
811204|NCT00103207|1763539|FG000|Overall Study|Ineligible|4
811205|NCT00103207|1763539|FG000|Overall Study|Diagnosis of BAC not confirmed|27
811206|NCT00103259|1763547|FG000|Overall Study|Death|3
811207|NCT00103259|1763548|FG001|Overall Study|Death|2
811208|NCT00103259|1763547|FG000|Overall Study|Withdrawal by Subject|2
811209|NCT00103259|1763548|FG001|Overall Study|Withdrawal by Subject|3
811210|NCT00103259|1763547|FG000|Overall Study|alternative therapy|1
811211|NCT00103259|1763548|FG001|Overall Study|alternative therapy|0
811212|NCT00103259|1763547|FG000|Overall Study|other (reasons were not specified)|2
811213|NCT00103259|1763548|FG001|Overall Study|other (reasons were not specified)|1
811214|NCT00103259|1763547|FG000|Overall Study|ineligible/no protocol therapy|4
811215|NCT00103259|1763548|FG001|Overall Study|ineligible/no protocol therapy|6
811216|NCT00103285|1763556|FG000|Induction|Adverse Event|14
811217|NCT00103285|1763557|FG001|Induction|Adverse Event|0
811218|NCT00103285|1763558|FG002|Induction|Adverse Event|0
811219|NCT00103285|1763559|FG003|Induction|Adverse Event|0
811220|NCT00103285|1763560|FG004|Induction|Adverse Event|0
811221|NCT00103285|1763561|FG005|Induction|Adverse Event|0
811222|NCT00103285|1763562|FG006|Induction|Adverse Event|0
811223|NCT00103285|1763563|FG007|Induction|Adverse Event|0
811224|NCT00103285|1763556|FG000|Induction|Death|24
811225|NCT00103285|1763557|FG001|Induction|Death|0
811226|NCT00103285|1763558|FG002|Induction|Death|0
811227|NCT00103285|1763559|FG003|Induction|Death|0
811228|NCT00103285|1763560|FG004|Induction|Death|0
811229|NCT00103285|1763561|FG005|Induction|Death|0
811230|NCT00103285|1763562|FG006|Induction|Death|0
811231|NCT00103285|1763563|FG007|Induction|Death|0
811232|NCT00103285|1763556|FG000|Induction|Physician Decision|103
811233|NCT00103285|1763557|FG001|Induction|Physician Decision|0
811234|NCT00103285|1763558|FG002|Induction|Physician Decision|0
811235|NCT00103285|1763559|FG003|Induction|Physician Decision|0
811236|NCT00103285|1763560|FG004|Induction|Physician Decision|0
811237|NCT00103285|1763561|FG005|Induction|Physician Decision|0
811238|NCT00103285|1763562|FG006|Induction|Physician Decision|0
811239|NCT00103285|1763563|FG007|Induction|Physician Decision|0
811240|NCT00103285|1763556|FG000|Induction|Withdrawal by Subject|1
811241|NCT00103285|1763557|FG001|Induction|Withdrawal by Subject|0
811242|NCT00103285|1763558|FG002|Induction|Withdrawal by Subject|0
811243|NCT00103285|1763559|FG003|Induction|Withdrawal by Subject|0
811244|NCT00103285|1763560|FG004|Induction|Withdrawal by Subject|0
811245|NCT00103285|1763561|FG005|Induction|Withdrawal by Subject|0
811246|NCT00103285|1763562|FG006|Induction|Withdrawal by Subject|0
811247|NCT00103285|1763563|FG007|Induction|Withdrawal by Subject|0
811248|NCT00103285|1763556|FG000|Induction|Ineligible|43
811249|NCT00103285|1763557|FG001|Induction|Ineligible|0
811250|NCT00103285|1763558|FG002|Induction|Ineligible|0
811251|NCT00103285|1763559|FG003|Induction|Ineligible|0
811252|NCT00103285|1763560|FG004|Induction|Ineligible|0
811253|NCT00103285|1763561|FG005|Induction|Ineligible|0
811254|NCT00103285|1763562|FG006|Induction|Ineligible|0
811255|NCT00103285|1763563|FG007|Induction|Ineligible|0
811256|NCT00103285|1763556|FG000|Induction|Refusal|906
811257|NCT00103285|1763557|FG001|Induction|Refusal|0
811258|NCT00103285|1763558|FG002|Induction|Refusal|0
811259|NCT00103285|1763559|FG003|Induction|Refusal|0
811260|NCT00103285|1763560|FG004|Induction|Refusal|0
811261|NCT00103285|1763561|FG005|Induction|Refusal|0
811262|NCT00103285|1763562|FG006|Induction|Refusal|0
811263|NCT00103285|1763563|FG007|Induction|Refusal|0
811264|NCT00103285|1763556|FG000|Induction|Other|258
811265|NCT00103285|1763557|FG001|Induction|Other|0
811266|NCT00103285|1763558|FG002|Induction|Other|0
811267|NCT00103285|1763559|FG003|Induction|Other|0
811268|NCT00103285|1763560|FG004|Induction|Other|0
811269|NCT00103285|1763561|FG005|Induction|Other|0
811270|NCT00103285|1763562|FG006|Induction|Other|0
811271|NCT00103285|1763563|FG007|Induction|Other|0
811272|NCT00103285|1763556|FG000|Response Assignment|Adverse Event|0
811273|NCT00103285|1763557|FG001|Response Assignment|Adverse Event|8
811274|NCT00103285|1763558|FG002|Response Assignment|Adverse Event|3
811275|NCT00103285|1763559|FG003|Response Assignment|Adverse Event|2
811276|NCT00103285|1763560|FG004|Response Assignment|Adverse Event|3
811277|NCT00103285|1763561|FG005|Response Assignment|Adverse Event|1
811278|NCT00103285|1763562|FG006|Response Assignment|Adverse Event|1
811279|NCT00103285|1763563|FG007|Response Assignment|Adverse Event|2
811280|NCT00103285|1763556|FG000|Response Assignment|Death|0
811281|NCT00103285|1763557|FG001|Response Assignment|Death|5
811282|NCT00103285|1763558|FG002|Response Assignment|Death|2
811283|NCT00103285|1763559|FG003|Response Assignment|Death|2
811284|NCT00103285|1763560|FG004|Response Assignment|Death|3
811285|NCT00103285|1763561|FG005|Response Assignment|Death|1
811286|NCT00103285|1763562|FG006|Response Assignment|Death|0
811287|NCT00103285|1763563|FG007|Response Assignment|Death|8
811288|NCT00103285|1763556|FG000|Response Assignment|Lost to Follow-up|0
811289|NCT00103285|1763557|FG001|Response Assignment|Lost to Follow-up|9
811290|NCT00103285|1763558|FG002|Response Assignment|Lost to Follow-up|5
811291|NCT00103285|1763559|FG003|Response Assignment|Lost to Follow-up|5
811292|NCT00103285|1763560|FG004|Response Assignment|Lost to Follow-up|1
811293|NCT00103285|1763561|FG005|Response Assignment|Lost to Follow-up|2
811294|NCT00103285|1763562|FG006|Response Assignment|Lost to Follow-up|2
811295|NCT00103285|1763563|FG007|Response Assignment|Lost to Follow-up|5
811296|NCT00103285|1763556|FG000|Response Assignment|Physician Decision|0
811297|NCT00103285|1763557|FG001|Response Assignment|Physician Decision|13
811298|NCT00103285|1763558|FG002|Response Assignment|Physician Decision|14
811299|NCT00103285|1763559|FG003|Response Assignment|Physician Decision|9
811300|NCT00103285|1763560|FG004|Response Assignment|Physician Decision|13
811301|NCT00103285|1763561|FG005|Response Assignment|Physician Decision|7
811302|NCT00103285|1763562|FG006|Response Assignment|Physician Decision|4
811303|NCT00103285|1763563|FG007|Response Assignment|Physician Decision|35
811304|NCT00103285|1763556|FG000|Response Assignment|Protocol Violation|0
811305|NCT00103285|1763557|FG001|Response Assignment|Protocol Violation|2
811306|NCT00103285|1763558|FG002|Response Assignment|Protocol Violation|0
811307|NCT00103285|1763559|FG003|Response Assignment|Protocol Violation|0
811308|NCT00103285|1763560|FG004|Response Assignment|Protocol Violation|0
811309|NCT00103285|1763561|FG005|Response Assignment|Protocol Violation|0
811310|NCT00103285|1763562|FG006|Response Assignment|Protocol Violation|0
811311|NCT00103285|1763563|FG007|Response Assignment|Protocol Violation|0
811312|NCT00103285|1763556|FG000|Response Assignment|Withdrawal by Subject|0
811313|NCT00103285|1763557|FG001|Response Assignment|Withdrawal by Subject|4
811314|NCT00103285|1763558|FG002|Response Assignment|Withdrawal by Subject|1
811315|NCT00103285|1763559|FG003|Response Assignment|Withdrawal by Subject|1
811316|NCT00103285|1763560|FG004|Response Assignment|Withdrawal by Subject|2
811317|NCT00103285|1763561|FG005|Response Assignment|Withdrawal by Subject|2
811318|NCT00103285|1763562|FG006|Response Assignment|Withdrawal by Subject|0
811319|NCT00103285|1763563|FG007|Response Assignment|Withdrawal by Subject|2
811320|NCT00103285|1763556|FG000|Response Assignment|Ineligible|0
811321|NCT00103285|1763557|FG001|Response Assignment|Ineligible|8
811322|NCT00103285|1763558|FG002|Response Assignment|Ineligible|6
811323|NCT00103285|1763559|FG003|Response Assignment|Ineligible|2
811324|NCT00103285|1763560|FG004|Response Assignment|Ineligible|0
811325|NCT00103285|1763561|FG005|Response Assignment|Ineligible|3
811326|NCT00103285|1763562|FG006|Response Assignment|Ineligible|1
811327|NCT00103285|1763563|FG007|Response Assignment|Ineligible|5
811328|NCT00103285|1763556|FG000|Response Assignment|Refusal|0
811329|NCT00103285|1763557|FG001|Response Assignment|Refusal|53
811330|NCT00103285|1763558|FG002|Response Assignment|Refusal|5
811331|NCT00103285|1763559|FG003|Response Assignment|Refusal|3
811332|NCT00103285|1763560|FG004|Response Assignment|Refusal|25
811333|NCT00103285|1763561|FG005|Response Assignment|Refusal|15
811334|NCT00103285|1763562|FG006|Response Assignment|Refusal|30
811335|NCT00103285|1763563|FG007|Response Assignment|Refusal|10
811336|NCT00103285|1763556|FG000|Response Assignment|Other|0
811337|NCT00103285|1763557|FG001|Response Assignment|Other|30
811338|NCT00103285|1763558|FG002|Response Assignment|Other|48
811339|NCT00103285|1763559|FG003|Response Assignment|Other|38
811340|NCT00103285|1763560|FG004|Response Assignment|Other|37
811341|NCT00103285|1763561|FG005|Response Assignment|Other|17
811342|NCT00103285|1763562|FG006|Response Assignment|Other|11
811343|NCT00103285|1763563|FG007|Response Assignment|Other|53
811344|NCT00103311|1763590|FG000|Overall Study|Lost to Follow-up|1
811345|NCT00103311|1763591|FG001|Overall Study|Lost to Follow-up|0
811346|NCT00103311|1763590|FG000|Overall Study|Withdrawal by Subject|2
811347|NCT00103311|1763591|FG001|Overall Study|Withdrawal by Subject|1
811348|NCT00103311|1763590|FG000|Overall Study|Adverse Event|1
811349|NCT00103311|1763591|FG001|Overall Study|Adverse Event|0
811350|NCT00103402|1763618|FG000|Overall Study|Adverse Event|3
811351|NCT00103402|1763619|FG001|Overall Study|Adverse Event|4
811352|NCT00103402|1763618|FG000|Overall Study|Lost to Follow-up|8
811353|NCT00103402|1763619|FG001|Overall Study|Lost to Follow-up|7
811354|NCT00103402|1763618|FG000|Overall Study|Dissatisfied/No longer interested|6
811355|NCT00103402|1763619|FG001|Overall Study|Dissatisfied/No longer interested|6
811356|NCT00103402|1763618|FG000|Overall Study|Personal constraints/Other|5
811357|NCT00103402|1763619|FG001|Overall Study|Personal constraints/Other|0
811358|NCT00103506|1763627|FG000|Overall Study|Study closed by sponsor|34
811359|NCT00103506|1763628|FG001|Overall Study|Study closed by sponsor|37
811360|NCT00103506|1763627|FG000|Overall Study|Death|257
811361|NCT00103506|1763628|FG001|Overall Study|Death|253
811362|NCT00103506|1763627|FG000|Overall Study|Lost to Follow-up|13
811363|NCT00103506|1763628|FG001|Overall Study|Lost to Follow-up|13
811364|NCT00103506|1763627|FG000|Overall Study|Withdrawal by Subject|18
811365|NCT00103506|1763628|FG001|Overall Study|Withdrawal by Subject|21
811366|NCT00103610|1763636|FG000|Overall Study|Entered Rescue Procedure|10
811367|NCT00103610|1763637|FG001|Overall Study|Entered Rescue Procedure|52
811368|NCT00103610|1763636|FG000|Overall Study|Death|16
811369|NCT00103610|1763637|FG001|Overall Study|Death|12
811370|NCT00103610|1763636|FG000|Overall Study|Elective Withdrawal|4
811371|NCT00103610|1763637|FG001|Overall Study|Elective Withdrawal|0
811372|NCT00103610|1763636|FG000|Overall Study|Lost to Follow-up|3
811373|NCT00103610|1763637|FG001|Overall Study|Lost to Follow-up|1
811374|NCT00103610|1763636|FG000|Overall Study|Adverse Event|2
811375|NCT00103610|1763637|FG001|Overall Study|Adverse Event|2
811376|NCT00103610|1763636|FG000|Overall Study|Other|2
811377|NCT00103610|1763637|FG001|Overall Study|Other|7
811378|NCT00103610|1763636|FG000|Overall Study|Failed mobilization|1
811379|NCT00103610|1763637|FG001|Overall Study|Failed mobilization|5
811380|NCT00103610|1763636|FG000|Overall Study|Noncompliance|0
811381|NCT00103610|1763637|FG001|Overall Study|Noncompliance|1
811382|NCT00103662|1763646|FG000|Overall Study|Entered Rescue Procedure|0
811383|NCT00103662|1763647|FG001|Overall Study|Entered Rescue Procedure|7
811384|NCT00103662|1763646|FG000|Overall Study|Death|7
811385|NCT00103662|1763647|FG001|Overall Study|Death|7
811386|NCT00103662|1763646|FG000|Overall Study|Elective Withdrawal|5
811387|NCT00103662|1763647|FG001|Overall Study|Elective Withdrawal|5
811388|NCT00103662|1763646|FG000|Overall Study|Lost to Follow-up|0
811389|NCT00103662|1763647|FG001|Overall Study|Lost to Follow-up|1
811390|NCT00103662|1763646|FG000|Overall Study|Other|6
811391|NCT00103662|1763647|FG001|Overall Study|Other|9
811392|NCT00103662|1763646|FG000|Overall Study|Failed mobilization|0
811393|NCT00103662|1763647|FG001|Overall Study|Failed mobilization|4
811394|NCT00103662|1763646|FG000|Overall Study|Intercurrent illness|1
811395|NCT00103662|1763647|FG001|Overall Study|Intercurrent illness|0
811396|NCT00103740|1763655|FG000|Period 1 - Core|Adverse Event|1
811397|NCT00103740|1763656|FG001|Period 1 - Core|Adverse Event|0
811398|NCT00103740|1763655|FG000|Period 1 - Core|Protocol Violation|3
811399|NCT00103740|1763656|FG001|Period 1 - Core|Protocol Violation|2
811400|NCT00103740|1763655|FG000|Period 1 - Core|Patient withdrew consent|3
811401|NCT00103740|1763656|FG001|Period 1 - Core|Patient withdrew consent|2
811402|NCT00103740|1763655|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7
811403|NCT00103740|1763656|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6
811404|NCT00103740|1763655|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
811405|NCT00103740|1763656|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
811406|NCT00103740|1763655|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
811407|NCT00103740|1763656|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
811408|NCT00103740|1763655|FG000|Period 2 - Extended Observation Period|Death|6
811409|NCT00103740|1763656|FG001|Period 2 - Extended Observation Period|Death|2
811410|NCT00103740|1763655|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
811411|NCT00103740|1763656|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
811412|NCT00103857|1763678|FG000|54-Week Base Study|Adverse Event|12
811413|NCT00103857|1763679|FG001|54-Week Base Study|Adverse Event|9
811414|NCT00103857|1763680|FG002|54-Week Base Study|Adverse Event|11
811415|NCT00103857|1763681|FG003|54-Week Base Study|Adverse Event|6
811416|NCT00103857|1763682|FG004|54-Week Base Study|Adverse Event|5
811417|NCT00103857|1763683|FG005|54-Week Base Study|Adverse Event|11
811418|NCT00103857|1763684|FG006|54-Week Base Study|Adverse Event|3
811419|NCT00103857|1763678|FG000|54-Week Base Study|Death|0
811420|NCT00103857|1763679|FG001|54-Week Base Study|Death|0
811421|NCT00103857|1763680|FG002|54-Week Base Study|Death|0
811422|NCT00103857|1763681|FG003|54-Week Base Study|Death|0
811423|NCT00103857|1763682|FG004|54-Week Base Study|Death|1
811424|NCT00103857|1763683|FG005|54-Week Base Study|Death|1
811425|NCT00103857|1763684|FG006|54-Week Base Study|Death|0
811426|NCT00103857|1763678|FG000|54-Week Base Study|Lack of Efficacy|11
811427|NCT00103857|1763679|FG001|54-Week Base Study|Lack of Efficacy|14
811428|NCT00103857|1763680|FG002|54-Week Base Study|Lack of Efficacy|8
811429|NCT00103857|1763681|FG003|54-Week Base Study|Lack of Efficacy|4
811430|NCT00103857|1763682|FG004|54-Week Base Study|Lack of Efficacy|3
811431|NCT00103857|1763683|FG005|54-Week Base Study|Lack of Efficacy|14
811432|NCT00103857|1763684|FG006|54-Week Base Study|Lack of Efficacy|19
811433|NCT00103857|1763678|FG000|54-Week Base Study|Lost to Follow-up|5
811434|NCT00103857|1763679|FG001|54-Week Base Study|Lost to Follow-up|4
811435|NCT00103857|1763680|FG002|54-Week Base Study|Lost to Follow-up|7
811436|NCT00103857|1763681|FG003|54-Week Base Study|Lost to Follow-up|5
811437|NCT00103857|1763682|FG004|54-Week Base Study|Lost to Follow-up|10
811438|NCT00103857|1763683|FG005|54-Week Base Study|Lost to Follow-up|9
811439|NCT00103857|1763684|FG006|54-Week Base Study|Lost to Follow-up|3
811440|NCT00103857|1763678|FG000|54-Week Base Study|Physician Decision|1
811441|NCT00103857|1763679|FG001|54-Week Base Study|Physician Decision|1
811442|NCT00103857|1763680|FG002|54-Week Base Study|Physician Decision|0
811443|NCT00103857|1763681|FG003|54-Week Base Study|Physician Decision|0
811444|NCT00103857|1763682|FG004|54-Week Base Study|Physician Decision|1
811445|NCT00103857|1763683|FG005|54-Week Base Study|Physician Decision|0
811446|NCT00103857|1763684|FG006|54-Week Base Study|Physician Decision|0
811447|NCT00103857|1763678|FG000|54-Week Base Study|Pregnancy|1
811448|NCT00103857|1763679|FG001|54-Week Base Study|Pregnancy|0
811449|NCT00103857|1763680|FG002|54-Week Base Study|Pregnancy|0
811450|NCT00103857|1763681|FG003|54-Week Base Study|Pregnancy|0
811451|NCT00103857|1763682|FG004|54-Week Base Study|Pregnancy|1
811452|NCT00103857|1763683|FG005|54-Week Base Study|Pregnancy|0
811453|NCT00103857|1763684|FG006|54-Week Base Study|Pregnancy|1
811454|NCT00103857|1763678|FG000|54-Week Base Study|Protocol Violation|6
811455|NCT00103857|1763679|FG001|54-Week Base Study|Protocol Violation|4
811456|NCT00103857|1763680|FG002|54-Week Base Study|Protocol Violation|2
811457|NCT00103857|1763681|FG003|54-Week Base Study|Protocol Violation|4
811458|NCT00103857|1763682|FG004|54-Week Base Study|Protocol Violation|0
811459|NCT00103857|1763683|FG005|54-Week Base Study|Protocol Violation|3
811460|NCT00103857|1763684|FG006|54-Week Base Study|Protocol Violation|3
811461|NCT00103857|1763678|FG000|54-Week Base Study|Withdrawal by Subject|17
811462|NCT00103857|1763679|FG001|54-Week Base Study|Withdrawal by Subject|16
811463|NCT00103857|1763680|FG002|54-Week Base Study|Withdrawal by Subject|16
811464|NCT00103857|1763681|FG003|54-Week Base Study|Withdrawal by Subject|15
811465|NCT00103857|1763682|FG004|54-Week Base Study|Withdrawal by Subject|10
811466|NCT00103857|1763683|FG005|54-Week Base Study|Withdrawal by Subject|15
811467|NCT00103857|1763684|FG006|54-Week Base Study|Withdrawal by Subject|4
811468|NCT00103857|1763678|FG000|54-Week Base Study|protocol discontinuation criteria|2
811469|NCT00103857|1763679|FG001|54-Week Base Study|protocol discontinuation criteria|5
811470|NCT00103857|1763680|FG002|54-Week Base Study|protocol discontinuation criteria|2
811471|NCT00103857|1763681|FG003|54-Week Base Study|protocol discontinuation criteria|6
811472|NCT00103857|1763682|FG004|54-Week Base Study|protocol discontinuation criteria|5
811473|NCT00103857|1763683|FG005|54-Week Base Study|protocol discontinuation criteria|3
811474|NCT00103857|1763684|FG006|54-Week Base Study|protocol discontinuation criteria|5
811475|NCT00103857|1763678|FG000|54-Week Base Study|patient moved|0
811476|NCT00103857|1763679|FG001|54-Week Base Study|patient moved|1
811477|NCT00103857|1763680|FG002|54-Week Base Study|patient moved|1
811478|NCT00103857|1763681|FG003|54-Week Base Study|patient moved|2
811479|NCT00103857|1763682|FG004|54-Week Base Study|patient moved|3
811480|NCT00103857|1763683|FG005|54-Week Base Study|patient moved|1
811481|NCT00103857|1763684|FG006|54-Week Base Study|patient moved|0
811482|NCT00103857|1763678|FG000|54-Week Base Study|non-compliance with study procedures|1
811483|NCT00103857|1763679|FG001|54-Week Base Study|non-compliance with study procedures|2
811484|NCT00103857|1763680|FG002|54-Week Base Study|non-compliance with study procedures|0
811485|NCT00103857|1763681|FG003|54-Week Base Study|non-compliance with study procedures|0
811486|NCT00103857|1763682|FG004|54-Week Base Study|non-compliance with study procedures|0
811487|NCT00103857|1763683|FG005|54-Week Base Study|non-compliance with study procedures|2
811488|NCT00103857|1763684|FG006|54-Week Base Study|non-compliance with study procedures|0
811489|NCT00103857|1763678|FG000|54-Week Base Study|patient incarcerated|0
811490|NCT00103857|1763679|FG001|54-Week Base Study|patient incarcerated|0
811491|NCT00103857|1763680|FG002|54-Week Base Study|patient incarcerated|0
811492|NCT00103857|1763681|FG003|54-Week Base Study|patient incarcerated|0
811493|NCT00103857|1763682|FG004|54-Week Base Study|patient incarcerated|1
811494|NCT00103857|1763683|FG005|54-Week Base Study|patient incarcerated|1
811495|NCT00103857|1763684|FG006|54-Week Base Study|patient incarcerated|0
811496|NCT00103857|1763678|FG000|54-Week Base Study|laboratory reporting error|0
811497|NCT00103857|1763679|FG001|54-Week Base Study|laboratory reporting error|0
811498|NCT00103857|1763680|FG002|54-Week Base Study|laboratory reporting error|0
811499|NCT00103857|1763681|FG003|54-Week Base Study|laboratory reporting error|0
811500|NCT00103857|1763682|FG004|54-Week Base Study|laboratory reporting error|1
811501|NCT00103857|1763683|FG005|54-Week Base Study|laboratory reporting error|0
811502|NCT00103857|1763684|FG006|54-Week Base Study|laboratory reporting error|0
811503|NCT00103857|1763678|FG000|54-Week Base Study|site error|0
811504|NCT00103857|1763679|FG001|54-Week Base Study|site error|0
811505|NCT00103857|1763680|FG002|54-Week Base Study|site error|0
811506|NCT00103857|1763681|FG003|54-Week Base Study|site error|0
811507|NCT00103857|1763682|FG004|54-Week Base Study|site error|0
811508|NCT00103857|1763683|FG005|54-Week Base Study|site error|1
811509|NCT00103857|1763684|FG006|54-Week Base Study|site error|0
811510|NCT00103857|1763678|FG000|54-Week Base Study|patient intolerance to rescue therapy|1
811511|NCT00103857|1763679|FG001|54-Week Base Study|patient intolerance to rescue therapy|0
811512|NCT00103857|1763680|FG002|54-Week Base Study|patient intolerance to rescue therapy|0
811513|NCT00103857|1763681|FG003|54-Week Base Study|patient intolerance to rescue therapy|0
811514|NCT00103857|1763682|FG004|54-Week Base Study|patient intolerance to rescue therapy|0
811515|NCT00103857|1763683|FG005|54-Week Base Study|patient intolerance to rescue therapy|0
811516|NCT00103857|1763684|FG006|54-Week Base Study|patient intolerance to rescue therapy|0
811517|NCT00103857|1763678|FG000|50-Week Extension Study|Adverse Event|2
811518|NCT00103857|1763679|FG001|50-Week Extension Study|Adverse Event|3
811519|NCT00103857|1763680|FG002|50-Week Extension Study|Adverse Event|2
811520|NCT00103857|1763681|FG003|50-Week Extension Study|Adverse Event|0
811521|NCT00103857|1763682|FG004|50-Week Extension Study|Adverse Event|1
811522|NCT00103857|1763683|FG005|50-Week Extension Study|Adverse Event|1
811523|NCT00103857|1763684|FG006|50-Week Extension Study|Adverse Event|0
811524|NCT00103857|1763678|FG000|50-Week Extension Study|Death|0
811525|NCT00103857|1763679|FG001|50-Week Extension Study|Death|0
811526|NCT00103857|1763680|FG002|50-Week Extension Study|Death|0
811527|NCT00103857|1763681|FG003|50-Week Extension Study|Death|1
811528|NCT00103857|1763682|FG004|50-Week Extension Study|Death|0
811529|NCT00103857|1763683|FG005|50-Week Extension Study|Death|1
811530|NCT00103857|1763684|FG006|50-Week Extension Study|Death|0
811531|NCT00103857|1763678|FG000|50-Week Extension Study|Lack of Efficacy|26
811532|NCT00103857|1763679|FG001|50-Week Extension Study|Lack of Efficacy|15
811533|NCT00103857|1763680|FG002|50-Week Extension Study|Lack of Efficacy|13
811534|NCT00103857|1763681|FG003|50-Week Extension Study|Lack of Efficacy|16
811535|NCT00103857|1763682|FG004|50-Week Extension Study|Lack of Efficacy|8
811536|NCT00103857|1763683|FG005|50-Week Extension Study|Lack of Efficacy|8
811537|NCT00103857|1763684|FG006|50-Week Extension Study|Lack of Efficacy|0
811538|NCT00103857|1763678|FG000|50-Week Extension Study|Lost to Follow-up|4
811539|NCT00103857|1763679|FG001|50-Week Extension Study|Lost to Follow-up|0
811540|NCT00103857|1763680|FG002|50-Week Extension Study|Lost to Follow-up|1
811541|NCT00103857|1763681|FG003|50-Week Extension Study|Lost to Follow-up|4
811542|NCT00103857|1763682|FG004|50-Week Extension Study|Lost to Follow-up|3
811543|NCT00103857|1763683|FG005|50-Week Extension Study|Lost to Follow-up|3
811544|NCT00103857|1763684|FG006|50-Week Extension Study|Lost to Follow-up|0
811545|NCT00103857|1763678|FG000|50-Week Extension Study|Physician Decision|0
811546|NCT00103857|1763679|FG001|50-Week Extension Study|Physician Decision|1
811547|NCT00103857|1763680|FG002|50-Week Extension Study|Physician Decision|1
811548|NCT00103857|1763681|FG003|50-Week Extension Study|Physician Decision|0
811549|NCT00103857|1763682|FG004|50-Week Extension Study|Physician Decision|0
811550|NCT00103857|1763683|FG005|50-Week Extension Study|Physician Decision|0
811551|NCT00103857|1763684|FG006|50-Week Extension Study|Physician Decision|0
811552|NCT00103857|1763678|FG000|50-Week Extension Study|Pregnancy|0
811553|NCT00103857|1763679|FG001|50-Week Extension Study|Pregnancy|0
811554|NCT00103857|1763680|FG002|50-Week Extension Study|Pregnancy|1
811555|NCT00103857|1763681|FG003|50-Week Extension Study|Pregnancy|0
811556|NCT00103857|1763682|FG004|50-Week Extension Study|Pregnancy|1
811557|NCT00103857|1763683|FG005|50-Week Extension Study|Pregnancy|0
811558|NCT00103857|1763684|FG006|50-Week Extension Study|Pregnancy|0
811559|NCT00103857|1763678|FG000|50-Week Extension Study|Protocol Violation|1
811560|NCT00103857|1763679|FG001|50-Week Extension Study|Protocol Violation|1
811561|NCT00103857|1763680|FG002|50-Week Extension Study|Protocol Violation|1
811562|NCT00103857|1763681|FG003|50-Week Extension Study|Protocol Violation|2
811563|NCT00103857|1763682|FG004|50-Week Extension Study|Protocol Violation|0
811564|NCT00103857|1763683|FG005|50-Week Extension Study|Protocol Violation|1
811565|NCT00103857|1763684|FG006|50-Week Extension Study|Protocol Violation|0
811566|NCT00103857|1763678|FG000|50-Week Extension Study|Withdrawal by Subject|2
811567|NCT00103857|1763679|FG001|50-Week Extension Study|Withdrawal by Subject|5
811568|NCT00103857|1763680|FG002|50-Week Extension Study|Withdrawal by Subject|2
811569|NCT00103857|1763681|FG003|50-Week Extension Study|Withdrawal by Subject|8
811570|NCT00103857|1763682|FG004|50-Week Extension Study|Withdrawal by Subject|3
811571|NCT00103857|1763683|FG005|50-Week Extension Study|Withdrawal by Subject|3
811572|NCT00103857|1763684|FG006|50-Week Extension Study|Withdrawal by Subject|0
811573|NCT00103857|1763678|FG000|50-Week Extension Study|protocol discontinuation criteria|2
811574|NCT00103857|1763679|FG001|50-Week Extension Study|protocol discontinuation criteria|2
811575|NCT00103857|1763680|FG002|50-Week Extension Study|protocol discontinuation criteria|3
811576|NCT00103857|1763681|FG003|50-Week Extension Study|protocol discontinuation criteria|2
811577|NCT00103857|1763682|FG004|50-Week Extension Study|protocol discontinuation criteria|3
811578|NCT00103857|1763683|FG005|50-Week Extension Study|protocol discontinuation criteria|3
811579|NCT00103857|1763684|FG006|50-Week Extension Study|protocol discontinuation criteria|0
811580|NCT00103857|1763678|FG000|50-Week Extension Study|non-compliance with study procedures|1
811581|NCT00103857|1763679|FG001|50-Week Extension Study|non-compliance with study procedures|0
811582|NCT00103857|1763680|FG002|50-Week Extension Study|non-compliance with study procedures|0
811583|NCT00103857|1763681|FG003|50-Week Extension Study|non-compliance with study procedures|1
811584|NCT00103857|1763682|FG004|50-Week Extension Study|non-compliance with study procedures|1
811585|NCT00103857|1763683|FG005|50-Week Extension Study|non-compliance with study procedures|0
811586|NCT00103857|1763684|FG006|50-Week Extension Study|non-compliance with study procedures|0
811587|NCT00103857|1763678|FG000|50-Week Extension Study|patient moved|0
811588|NCT00103857|1763679|FG001|50-Week Extension Study|patient moved|0
811589|NCT00103857|1763680|FG002|50-Week Extension Study|patient moved|1
811590|NCT00103857|1763681|FG003|50-Week Extension Study|patient moved|2
811591|NCT00103857|1763682|FG004|50-Week Extension Study|patient moved|0
811592|NCT00103857|1763683|FG005|50-Week Extension Study|patient moved|0
811593|NCT00103857|1763684|FG006|50-Week Extension Study|patient moved|0
811594|NCT00103857|1763678|FG000|50-Week Extension Study|patient scheduled for elective surgery|0
811595|NCT00103857|1763679|FG001|50-Week Extension Study|patient scheduled for elective surgery|0
811596|NCT00103857|1763680|FG002|50-Week Extension Study|patient scheduled for elective surgery|1
811597|NCT00103857|1763681|FG003|50-Week Extension Study|patient scheduled for elective surgery|0
811598|NCT00103857|1763682|FG004|50-Week Extension Study|patient scheduled for elective surgery|0
811599|NCT00103857|1763683|FG005|50-Week Extension Study|patient scheduled for elective surgery|0
811600|NCT00103857|1763684|FG006|50-Week Extension Study|patient scheduled for elective surgery|0
811601|NCT00103857|1763678|FG000|50-Week Extension Study|reason unspecified|0
811602|NCT00103857|1763679|FG001|50-Week Extension Study|reason unspecified|0
811603|NCT00103857|1763680|FG002|50-Week Extension Study|reason unspecified|0
811604|NCT00103857|1763681|FG003|50-Week Extension Study|reason unspecified|0
811605|NCT00103857|1763682|FG004|50-Week Extension Study|reason unspecified|1
811606|NCT00103857|1763683|FG005|50-Week Extension Study|reason unspecified|0
811607|NCT00103857|1763684|FG006|50-Week Extension Study|reason unspecified|0
811608|NCT00104052|1763699|FG000|Overall Study|Adverse Event|1
811609|NCT00104052|1763699|FG000|Overall Study|Lack of Efficacy|26
811610|NCT00104052|1763699|FG000|Overall Study|Discontinuation unrelated to treatment|2
811611|NCT00104104|1763705|FG000|Overall Study|Adverse Event|8
811612|NCT00104104|1763706|FG001|Overall Study|Adverse Event|8
811613|NCT00104104|1763705|FG000|Overall Study|Abnormal laboratory value(s)|20
811614|NCT00104104|1763706|FG001|Overall Study|Abnormal laboratory value(s)|14
811615|NCT00104104|1763705|FG000|Overall Study|Lack of Efficacy|0
811616|NCT00104104|1763706|FG001|Overall Study|Lack of Efficacy|3
811617|NCT00104104|1763705|FG000|Overall Study|Condition no longer requires study drug|7
811618|NCT00104104|1763706|FG001|Overall Study|Condition no longer requires study drug|4
811619|NCT00104104|1763705|FG000|Overall Study|Protocol Violation|5
811620|NCT00104104|1763706|FG001|Overall Study|Protocol Violation|2
811621|NCT00104104|1763705|FG000|Overall Study|Withdrawal by Subject|11
811622|NCT00104104|1763706|FG001|Overall Study|Withdrawal by Subject|15
811623|NCT00104104|1763705|FG000|Overall Study|Lost to Follow-up|3
811624|NCT00104104|1763706|FG001|Overall Study|Lost to Follow-up|7
811625|NCT00104104|1763705|FG000|Overall Study|Administrative problems|12
811626|NCT00104104|1763706|FG001|Overall Study|Administrative problems|13
811627|NCT00104104|1763705|FG000|Overall Study|Death|9
811628|NCT00104104|1763706|FG001|Overall Study|Death|6
811629|NCT00104247|1763723|FG000|Overall Study|Withdrawal by Subject|1
811630|NCT00104247|1763724|FG001|Overall Study|Withdrawal by Subject|0
811631|NCT00104247|1763723|FG000|Overall Study|Noncompliant with dosing|0
811632|NCT00104247|1763724|FG001|Overall Study|Noncompliant with dosing|1
811633|NCT00104299|1763732|FG000|Overall Study|Adverse Event|3
811634|NCT00104299|1763733|FG001|Overall Study|Adverse Event|1
811635|NCT00104299|1763732|FG000|Overall Study|Death|2
811636|NCT00104299|1763733|FG001|Overall Study|Death|2
811637|NCT00104299|1763732|FG000|Overall Study|Withdrawal by Subject|2
811638|NCT00104299|1763733|FG001|Overall Study|Withdrawal by Subject|6
811639|NCT00104299|1763732|FG000|Overall Study|Physician Decision|1
811640|NCT00104299|1763733|FG001|Overall Study|Physician Decision|1
811641|NCT00104299|1763732|FG000|Overall Study|To have renal transplant|1
811642|NCT00104299|1763733|FG001|Overall Study|To have renal transplant|0
811643|NCT00104416|1763741|FG000|Double-Blind Phase|Adverse Event|2
811644|NCT00104416|1763742|FG001|Double-Blind Phase|Adverse Event|1
811645|NCT00104416|1763743|FG002|Double-Blind Phase|Adverse Event|0
811646|NCT00104416|1763744|FG003|Double-Blind Phase|Adverse Event|0
811647|NCT00104416|1763745|FG004|Double-Blind Phase|Adverse Event|0
811648|NCT00104416|1763741|FG000|Double-Blind Phase|Lost to Follow-up|0
811649|NCT00104416|1763742|FG001|Double-Blind Phase|Lost to Follow-up|1
811650|NCT00104416|1763743|FG002|Double-Blind Phase|Lost to Follow-up|0
811651|NCT00104416|1763744|FG003|Double-Blind Phase|Lost to Follow-up|0
811652|NCT00104416|1763745|FG004|Double-Blind Phase|Lost to Follow-up|0
811653|NCT00104416|1763741|FG000|Double-Blind Phase|Protocol Violation|0
811654|NCT00104416|1763742|FG001|Double-Blind Phase|Protocol Violation|1
811655|NCT00104416|1763743|FG002|Double-Blind Phase|Protocol Violation|0
811656|NCT00104416|1763744|FG003|Double-Blind Phase|Protocol Violation|0
811657|NCT00104416|1763745|FG004|Double-Blind Phase|Protocol Violation|0
811658|NCT00104416|1763741|FG000|Double-Blind Phase|Withdrawal by Subject|2
811659|NCT00104416|1763742|FG001|Double-Blind Phase|Withdrawal by Subject|3
811660|NCT00104416|1763743|FG002|Double-Blind Phase|Withdrawal by Subject|0
811661|NCT00104416|1763744|FG003|Double-Blind Phase|Withdrawal by Subject|0
811662|NCT00104416|1763745|FG004|Double-Blind Phase|Withdrawal by Subject|0
811663|NCT00104416|1763741|FG000|Double-Blind Phase|Pregnancy|1
811664|NCT00104416|1763742|FG001|Double-Blind Phase|Pregnancy|0
811665|NCT00104416|1763743|FG002|Double-Blind Phase|Pregnancy|0
811666|NCT00104416|1763744|FG003|Double-Blind Phase|Pregnancy|0
811667|NCT00104416|1763745|FG004|Double-Blind Phase|Pregnancy|0
811668|NCT00104416|1763741|FG000|Double-Blind Phase|Participant Did Not Take Drug|3
811669|NCT00104416|1763742|FG001|Double-Blind Phase|Participant Did Not Take Drug|4
811670|NCT00104416|1763743|FG002|Double-Blind Phase|Participant Did Not Take Drug|0
811671|NCT00104416|1763744|FG003|Double-Blind Phase|Participant Did Not Take Drug|0
811672|NCT00104416|1763745|FG004|Double-Blind Phase|Participant Did Not Take Drug|0
811673|NCT00104416|1763741|FG000|Continuation Phase|Adverse Event|0
811674|NCT00104416|1763742|FG001|Continuation Phase|Adverse Event|0
811675|NCT00104416|1763743|FG002|Continuation Phase|Adverse Event|2
811676|NCT00104416|1763744|FG003|Continuation Phase|Adverse Event|0
811677|NCT00104416|1763745|FG004|Continuation Phase|Adverse Event|2
811678|NCT00104416|1763741|FG000|Continuation Phase|Lost to Follow-up|0
811679|NCT00104416|1763742|FG001|Continuation Phase|Lost to Follow-up|0
811680|NCT00104416|1763743|FG002|Continuation Phase|Lost to Follow-up|1
811681|NCT00104416|1763744|FG003|Continuation Phase|Lost to Follow-up|0
811682|NCT00104416|1763745|FG004|Continuation Phase|Lost to Follow-up|1
811683|NCT00104416|1763741|FG000|Continuation Phase|Withdrawal by Subject|0
811684|NCT00104416|1763742|FG001|Continuation Phase|Withdrawal by Subject|0
811685|NCT00104416|1763743|FG002|Continuation Phase|Withdrawal by Subject|2
811686|NCT00104416|1763744|FG003|Continuation Phase|Withdrawal by Subject|1
811687|NCT00104416|1763745|FG004|Continuation Phase|Withdrawal by Subject|1
811688|NCT00104416|1763741|FG000|Continuation Phase|Pregnancy|0
811689|NCT00104416|1763742|FG001|Continuation Phase|Pregnancy|0
811690|NCT00104416|1763743|FG002|Continuation Phase|Pregnancy|1
811691|NCT00104416|1763744|FG003|Continuation Phase|Pregnancy|1
811692|NCT00104416|1763745|FG004|Continuation Phase|Pregnancy|0
811693|NCT00104416|1763741|FG000|Continuation Phase|Non-compliance|0
811694|NCT00104416|1763742|FG001|Continuation Phase|Non-compliance|0
811695|NCT00104416|1763743|FG002|Continuation Phase|Non-compliance|0
811696|NCT00104416|1763744|FG003|Continuation Phase|Non-compliance|0
811697|NCT00104416|1763745|FG004|Continuation Phase|Non-compliance|1
811698|NCT00104520|1763759|FG000|Overall Study|Unrelated adverse event|34
811699|NCT00104520|1763760|FG001|Overall Study|Unrelated adverse event|47
811700|NCT00104520|1763759|FG000|Overall Study|Study drug intolerance|0
811701|NCT00104520|1763760|FG001|Overall Study|Study drug intolerance|1
811702|NCT00104520|1763759|FG000|Overall Study|Related adverse event|13
811703|NCT00104520|1763760|FG001|Overall Study|Related adverse event|15
811704|NCT00104520|1763759|FG000|Overall Study|Lost to Follow-up|1
811705|NCT00104520|1763760|FG001|Overall Study|Lost to Follow-up|0
811706|NCT00104520|1763759|FG000|Overall Study|Noncompliance|0
811707|NCT00104520|1763760|FG001|Overall Study|Noncompliance|2
811708|NCT00104520|1763759|FG000|Overall Study|Personal/administrative|1
811709|NCT00104520|1763760|FG001|Overall Study|Personal/administrative|1
811710|NCT00104520|1763759|FG000|Overall Study|Other|1
811711|NCT00104520|1763760|FG001|Overall Study|Other|5
811712|NCT00104572|1763769|FG000|Overall Study|Withdrawal by Subject|3
811713|NCT00104572|1763770|FG001|Overall Study|Withdrawal by Subject|3
811714|NCT00104572|1763771|FG002|Overall Study|Withdrawal by Subject|0
811715|NCT00104637|1763779|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
811716|NCT00104637|1763780|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
811717|NCT00104650|1763792|FG000|Treatment Period (25 Weeks)|Physician Decision|0
811718|NCT00104650|1763793|FG001|Treatment Period (25 Weeks)|Physician Decision|0
811719|NCT00104650|1763794|FG002|Treatment Period (25 Weeks)|Physician Decision|1
811720|NCT00104650|1763792|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2
811721|NCT00104650|1763793|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1
811722|NCT00104650|1763794|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1
811723|NCT00104650|1763792|FG000|Treatment Period (25 Weeks)|Death|7
811724|NCT00104650|1763793|FG001|Treatment Period (25 Weeks)|Death|5
811725|NCT00104650|1763794|FG002|Treatment Period (25 Weeks)|Death|6
811726|NCT00104650|1763792|FG000|Treatment Period (25 Weeks)|Disease progression|2
811727|NCT00104650|1763793|FG001|Treatment Period (25 Weeks)|Disease progression|3
811728|NCT00104650|1763794|FG002|Treatment Period (25 Weeks)|Disease progression|2
811729|NCT00104650|1763792|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0
811730|NCT00104650|1763793|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1
811731|NCT00104650|1763794|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0
811732|NCT00104650|1763792|FG000|Treatment Period (25 Weeks)|Other|1
811733|NCT00104650|1763793|FG001|Treatment Period (25 Weeks)|Other|0
811734|NCT00104650|1763794|FG002|Treatment Period (25 Weeks)|Other|0
811735|NCT00104650|1763792|FG000|Treatment Period (25 Weeks)|Protocol deviation|0
811736|NCT00104650|1763793|FG001|Treatment Period (25 Weeks)|Protocol deviation|1
811737|NCT00104650|1763794|FG002|Treatment Period (25 Weeks)|Protocol deviation|0
811738|NCT00104650|1763792|FG000|Follow-up Period|Physician Decision|1
811739|NCT00104650|1763793|FG001|Follow-up Period|Physician Decision|1
811740|NCT00104650|1763794|FG002|Follow-up Period|Physician Decision|0
811741|NCT00104650|1763792|FG000|Follow-up Period|Adverse Event|1
811742|NCT00104650|1763793|FG001|Follow-up Period|Adverse Event|0
811743|NCT00104650|1763794|FG002|Follow-up Period|Adverse Event|1
811744|NCT00104650|1763792|FG000|Follow-up Period|Withdrawal by Subject|0
811745|NCT00104650|1763793|FG001|Follow-up Period|Withdrawal by Subject|3
811746|NCT00104650|1763794|FG002|Follow-up Period|Withdrawal by Subject|3
811747|NCT00104650|1763792|FG000|Follow-up Period|Death|6
811748|NCT00104650|1763793|FG001|Follow-up Period|Death|6
811749|NCT00104650|1763794|FG002|Follow-up Period|Death|4
811750|NCT00104650|1763792|FG000|Follow-up Period|Disease progression|3
811751|NCT00104650|1763793|FG001|Follow-up Period|Disease progression|1
811752|NCT00104650|1763794|FG002|Follow-up Period|Disease progression|0
811753|NCT00104650|1763792|FG000|Follow-up Period|Lost to Follow-up|0
811754|NCT00104650|1763793|FG001|Follow-up Period|Lost to Follow-up|1
811755|NCT00104650|1763794|FG002|Follow-up Period|Lost to Follow-up|2
811756|NCT00104650|1763792|FG000|Follow-up Period|Other|0
811757|NCT00104650|1763793|FG001|Follow-up Period|Other|1
811758|NCT00104650|1763794|FG002|Follow-up Period|Other|0
811759|NCT00104676|1763804|FG000|Overall Study|Death|3
811760|NCT00104676|1763805|FG001|Overall Study|Death|2
811761|NCT00104676|1763804|FG000|Overall Study|Withdrawal by Subject|0
811762|NCT00104676|1763805|FG001|Overall Study|Withdrawal by Subject|2
811763|NCT00104676|1763804|FG000|Overall Study|treatment interruption|4
811764|NCT00104676|1763805|FG001|Overall Study|treatment interruption|10
811765|NCT00104871|1763817|FG000|Overall Study|Not evaluable|1
811766|NCT00104884|1763821|FG000|Overall Study|Disease progression|4
811767|NCT00105066|1763865|FG000|Overall Study|Adverse Event|2
811768|NCT00105066|1763866|FG001|Overall Study|Adverse Event|5
811769|NCT00105079|1763874|FG000|Overall Study|Adverse Event|5
811770|NCT00105079|1763875|FG001|Overall Study|Adverse Event|12
811771|NCT00105079|1763874|FG000|Overall Study|Death|3
811772|NCT00105079|1763875|FG001|Overall Study|Death|1
811773|NCT00105079|1763874|FG000|Overall Study|Lost to Follow-up|12
811774|NCT00105079|1763875|FG001|Overall Study|Lost to Follow-up|12
811775|NCT00105079|1763874|FG000|Overall Study|Lack of Efficacy|9
811776|NCT00105079|1763875|FG001|Overall Study|Lack of Efficacy|3
811777|NCT00105079|1763874|FG000|Overall Study|Refused treatment|6
811778|NCT00105079|1763875|FG001|Overall Study|Refused treatment|4
811779|NCT00105079|1763874|FG000|Overall Study|Violation of selection criteria at entry|0
811780|NCT00105079|1763875|FG001|Overall Study|Violation of selection criteria at entry|2
811781|NCT00105079|1763874|FG000|Overall Study|Protocol Violation|1
811782|NCT00105079|1763875|FG001|Overall Study|Protocol Violation|0
811783|NCT00105079|1763874|FG000|Overall Study|Other|3
811784|NCT00105079|1763875|FG001|Overall Study|Other|1
811785|NCT00105157|1763885|FG000|Double-Blind (DB)|Never Treated|1
811786|NCT00105157|1763886|FG001|Double-Blind (DB)|Never Treated|0
811787|NCT00105157|1763887|FG002|Double-Blind (DB)|Never Treated|0
811788|NCT00105157|1763888|FG003|Double-Blind (DB)|Never Treated|0
811789|NCT00105157|1763885|FG000|Double-Blind (DB)|Adverse Event|2
811790|NCT00105157|1763886|FG001|Double-Blind (DB)|Adverse Event|0
811791|NCT00105157|1763887|FG002|Double-Blind (DB)|Adverse Event|1
811792|NCT00105157|1763888|FG003|Double-Blind (DB)|Adverse Event|1
811793|NCT00105157|1763885|FG000|Double-Blind (DB)|Lack of Efficacy|11
811794|NCT00105157|1763886|FG001|Double-Blind (DB)|Lack of Efficacy|14
811795|NCT00105157|1763887|FG002|Double-Blind (DB)|Lack of Efficacy|11
811796|NCT00105157|1763888|FG003|Double-Blind (DB)|Lack of Efficacy|38
811797|NCT00105157|1763885|FG000|Open-Label Continuation of DB|Adverse Event|3
811798|NCT00105157|1763886|FG001|Open-Label Continuation of DB|Adverse Event|1
811799|NCT00105157|1763887|FG002|Open-Label Continuation of DB|Adverse Event|0
811800|NCT00105157|1763888|FG003|Open-Label Continuation of DB|Adverse Event|0
811801|NCT00105157|1763885|FG000|Open-Label Continuation of DB|Lack of Efficacy|1
811802|NCT00105157|1763886|FG001|Open-Label Continuation of DB|Lack of Efficacy|4
811803|NCT00105157|1763887|FG002|Open-Label Continuation of DB|Lack of Efficacy|3
811804|NCT00105157|1763888|FG003|Open-Label Continuation of DB|Lack of Efficacy|1
811805|NCT00105157|1763885|FG000|Open-Label Continuation of DB|Lost to Follow-up|1
811806|NCT00105157|1763886|FG001|Open-Label Continuation of DB|Lost to Follow-up|1
811807|NCT00105157|1763887|FG002|Open-Label Continuation of DB|Lost to Follow-up|1
811808|NCT00105157|1763888|FG003|Open-Label Continuation of DB|Lost to Follow-up|0
811809|NCT00105157|1763885|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0
811810|NCT00105157|1763886|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1
811811|NCT00105157|1763887|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3
811812|NCT00105157|1763888|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0
811813|NCT00105157|1763885|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1
811814|NCT00105157|1763886|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0
811815|NCT00105157|1763887|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0
811816|NCT00105157|1763888|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0
811817|NCT00105157|1763885|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1
811818|NCT00105157|1763886|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3
811819|NCT00105157|1763887|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2
811820|NCT00105157|1763888|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0
811821|NCT00105157|1763885|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
811822|NCT00105157|1763886|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
811823|NCT00105157|1763887|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
811824|NCT00105157|1763888|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
811825|NCT00105157|1763885|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
811826|NCT00105157|1763886|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
811827|NCT00105157|1763887|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
811828|NCT00105157|1763888|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
811829|NCT00105157|1763885|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
811830|NCT00105157|1763886|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
811831|NCT00105157|1763887|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
811832|NCT00105157|1763888|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
811833|NCT00105157|1763885|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
811834|NCT00105157|1763886|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
811835|NCT00105157|1763887|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
811836|NCT00105157|1763888|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
811837|NCT00105157|1763885|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
811838|NCT00105157|1763886|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
811839|NCT00105157|1763887|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
811840|NCT00105157|1763888|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
811841|NCT00105183|1763899|FG000|Overall Study|Death|19
811842|NCT00105183|1763900|FG001|Overall Study|Death|13
811843|NCT00105183|1763901|FG002|Overall Study|Death|15
811844|NCT00105183|1763899|FG000|Overall Study|Withdrawal by Subject|1
811845|NCT00105183|1763900|FG001|Overall Study|Withdrawal by Subject|1
811846|NCT00105183|1763901|FG002|Overall Study|Withdrawal by Subject|4
811847|NCT00105183|1763899|FG000|Overall Study|Physician Decision|1
811848|NCT00105183|1763900|FG001|Overall Study|Physician Decision|2
811849|NCT00105183|1763901|FG002|Overall Study|Physician Decision|3
811850|NCT00105183|1763899|FG000|Overall Study|Lost to Follow-up|0
811851|NCT00105183|1763900|FG001|Overall Study|Lost to Follow-up|1
811852|NCT00105183|1763901|FG002|Overall Study|Lost to Follow-up|1
811853|NCT00105183|1763899|FG000|Overall Study|Other reason|1
811854|NCT00105183|1763900|FG001|Overall Study|Other reason|2
811855|NCT00105183|1763901|FG002|Overall Study|Other reason|0
811856|NCT00105196|1763911|FG000|Overall Study|Lack of Efficacy|2
811857|NCT00105196|1763912|FG001|Overall Study|Lack of Efficacy|3
811858|NCT00105196|1763911|FG000|Overall Study|Adverse Event|11
811859|NCT00105196|1763912|FG001|Overall Study|Adverse Event|3
811860|NCT00105196|1763911|FG000|Overall Study|Withdrawal by Subject|6
811861|NCT00105196|1763912|FG001|Overall Study|Withdrawal by Subject|6
811862|NCT00105196|1763911|FG000|Overall Study|Lost to Follow-up|3
811863|NCT00105196|1763912|FG001|Overall Study|Lost to Follow-up|2
811864|NCT00105196|1763911|FG000|Overall Study|Poor/noncompliance|3
811865|NCT00105196|1763912|FG001|Overall Study|Poor/noncompliance|4
811866|NCT00105196|1763911|FG000|Overall Study|Protocol Violation|5
811867|NCT00105196|1763912|FG001|Overall Study|Protocol Violation|2
811868|NCT00105196|1763911|FG000|Overall Study|pending surgery|0
811869|NCT00105196|1763912|FG001|Overall Study|pending surgery|1
811870|NCT00105196|1763911|FG000|Overall Study|marijuana use|0
811871|NCT00105196|1763912|FG001|Overall Study|marijuana use|1
811872|NCT00105196|1763911|FG000|Overall Study|Subject became unblinded|0
811873|NCT00105196|1763912|FG001|Overall Study|Subject became unblinded|1
811874|NCT00105235|1763918|FG000|Overall Study|Death|4
811875|NCT00105235|1763918|FG000|Overall Study|Physician Decision|1
811876|NCT00105235|1763918|FG000|Overall Study|Withdrawal by Subject|2
811877|NCT00105443|1763928|FG000|Double-Blind Treatment|Adverse Event|1
811878|NCT00105443|1763929|FG001|Double-Blind Treatment|Adverse Event|0
811879|NCT00105443|1763930|FG002|Double-Blind Treatment|Adverse Event|0
811880|NCT00105443|1763931|FG003|Double-Blind Treatment|Adverse Event|0
811881|NCT00105443|1763928|FG000|Double-Blind Treatment|Lost to Follow-up|0
811882|NCT00105443|1763929|FG001|Double-Blind Treatment|Lost to Follow-up|0
811883|NCT00105443|1763930|FG002|Double-Blind Treatment|Lost to Follow-up|1
811884|NCT00105443|1763931|FG003|Double-Blind Treatment|Lost to Follow-up|0
811885|NCT00105443|1763928|FG000|Double-Blind Treatment|Withdrawal by Subject|8
811886|NCT00105443|1763929|FG001|Double-Blind Treatment|Withdrawal by Subject|0
811887|NCT00105443|1763930|FG002|Double-Blind Treatment|Withdrawal by Subject|7
811888|NCT00105443|1763931|FG003|Double-Blind Treatment|Withdrawal by Subject|0
811889|NCT00105443|1763928|FG000|Double-Blind Treatment|Physician Decision|1
811890|NCT00105443|1763929|FG001|Double-Blind Treatment|Physician Decision|0
811891|NCT00105443|1763930|FG002|Double-Blind Treatment|Physician Decision|2
811892|NCT00105443|1763931|FG003|Double-Blind Treatment|Physician Decision|0
811893|NCT00105443|1763928|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4
811894|NCT00105443|1763929|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0
811895|NCT00105443|1763930|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1
811896|NCT00105443|1763931|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0
811897|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Death|180
811898|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Death|7
811899|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Death|219
811900|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Death|4
811901|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
811902|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
811903|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
811904|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
811905|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
811906|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
811907|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
811908|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
811909|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0
811910|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14
811911|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0
811912|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16
811913|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1
811914|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0
811915|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1
811916|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0
811917|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0
811918|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2
811919|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0
811920|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0
811921|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
811922|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
811923|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
811924|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
811925|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
811926|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
811927|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
811928|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
811929|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
811930|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
811931|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
811932|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
811933|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
811934|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
811935|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
811936|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
811937|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
811938|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
811939|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
811940|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
811941|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
811942|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
811943|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
811944|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
811945|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
811946|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
811947|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
811948|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
811949|NCT00105443|1763928|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
811950|NCT00105443|1763929|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
811951|NCT00105443|1763930|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
811952|NCT00105443|1763931|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
811953|NCT00105469|1763942|FG000|Overall Study|Adverse Event|9
811954|NCT00105469|1763943|FG001|Overall Study|Adverse Event|8
811955|NCT00105469|1763942|FG000|Overall Study|Protocol Violation|4
811956|NCT00105469|1763943|FG001|Overall Study|Protocol Violation|0
811957|NCT00105469|1763942|FG000|Overall Study|Withdrawal by Subject|2
811958|NCT00105469|1763943|FG001|Overall Study|Withdrawal by Subject|3
811959|NCT00105469|1763942|FG000|Overall Study|Lost to Follow-up|1
811960|NCT00105469|1763943|FG001|Overall Study|Lost to Follow-up|0
811961|NCT00105469|1763942|FG000|Overall Study|Lack of Efficacy|2
811962|NCT00105469|1763943|FG001|Overall Study|Lack of Efficacy|0
811963|NCT00105469|1763942|FG000|Overall Study|Other Reason|4
811964|NCT00105469|1763943|FG001|Overall Study|Other Reason|0
811965|NCT00105482|1763951|FG000|Overall Study|Adverse Event|1
811966|NCT00105482|1763952|FG001|Overall Study|Adverse Event|1
811967|NCT00105482|1763951|FG000|Overall Study|Lost to Follow-up|26
811968|NCT00105482|1763952|FG001|Overall Study|Lost to Follow-up|17
811969|NCT00105482|1763951|FG000|Overall Study|Withdrawal by Subject|0
811970|NCT00105482|1763952|FG001|Overall Study|Withdrawal by Subject|1
811971|NCT00105482|1763951|FG000|Overall Study|Lost Interest|29
811972|NCT00105482|1763952|FG001|Overall Study|Lost Interest|32
811973|NCT00105482|1763951|FG000|Overall Study|Scheduling Conflict|2
811974|NCT00105482|1763952|FG001|Overall Study|Scheduling Conflict|3
811975|NCT00105482|1763951|FG000|Overall Study|Withdrawn by PI|1
811976|NCT00105482|1763952|FG001|Overall Study|Withdrawn by PI|1
811977|NCT00105508|1763960|FG000|Overall Study|Prephase Dropout|1
811978|NCT00105508|1763961|FG001|Overall Study|Prephase Dropout|0
811979|NCT00105508|1763960|FG000|Overall Study|Adverse Event|16
811980|NCT00105508|1763961|FG001|Overall Study|Adverse Event|19
811981|NCT00105508|1763960|FG000|Overall Study|Insufficient Efficacy|1
811982|NCT00105508|1763961|FG001|Overall Study|Insufficient Efficacy|0
811983|NCT00105508|1763960|FG000|Overall Study|Withdrawal by Subject|10
811984|NCT00105508|1763961|FG001|Overall Study|Withdrawal by Subject|6
811985|NCT00105508|1763960|FG000|Overall Study|Lost to Follow-up|3
811986|NCT00105508|1763961|FG001|Overall Study|Lost to Follow-up|0
811987|NCT00105508|1763960|FG000|Overall Study|Protocol Violation|1
811988|NCT00105508|1763961|FG001|Overall Study|Protocol Violation|2
811989|NCT00105508|1763960|FG000|Overall Study|Other|8
811990|NCT00105508|1763961|FG001|Overall Study|Other|9
811991|NCT00105521|1763971|FG000|Overall Study|Other|1
811992|NCT00105521|1763972|FG001|Overall Study|Other|1
811993|NCT00105521|1763973|FG002|Overall Study|Other|2
811994|NCT00105521|1763974|FG003|Overall Study|Other|0
811995|NCT00105521|1763971|FG000|Overall Study|Adverse Event|10
811996|NCT00105521|1763972|FG001|Overall Study|Adverse Event|4
811997|NCT00105521|1763973|FG002|Overall Study|Adverse Event|10
811998|NCT00105521|1763974|FG003|Overall Study|Adverse Event|8
811999|NCT00105521|1763971|FG000|Overall Study|Withdrawal by Subject|1
812000|NCT00105521|1763972|FG001|Overall Study|Withdrawal by Subject|0
812001|NCT00105521|1763973|FG002|Overall Study|Withdrawal by Subject|1
812002|NCT00105521|1763974|FG003|Overall Study|Withdrawal by Subject|4
812003|NCT00105521|1763971|FG000|Overall Study|Lack of Efficacy|0
812004|NCT00105521|1763972|FG001|Overall Study|Lack of Efficacy|0
812005|NCT00105521|1763973|FG002|Overall Study|Lack of Efficacy|0
812006|NCT00105521|1763974|FG003|Overall Study|Lack of Efficacy|1
812007|NCT00105521|1763971|FG000|Overall Study|Protocol Violation|3
812008|NCT00105521|1763972|FG001|Overall Study|Protocol Violation|5
812009|NCT00105521|1763973|FG002|Overall Study|Protocol Violation|4
812010|NCT00105521|1763974|FG003|Overall Study|Protocol Violation|4
812011|NCT00105521|1763971|FG000|Overall Study|Lost to Follow-up|0
812012|NCT00105521|1763972|FG001|Overall Study|Lost to Follow-up|1
812013|NCT00105521|1763973|FG002|Overall Study|Lost to Follow-up|0
812014|NCT00105521|1763974|FG003|Overall Study|Lost to Follow-up|0
812015|NCT00105534|1763986|FG000|Overall Study|Adverse Event|2
812016|NCT00105534|1763987|FG001|Overall Study|Adverse Event|5
812017|NCT00105534|1763986|FG000|Overall Study|Protocol Violation|1
812018|NCT00105534|1763987|FG001|Overall Study|Protocol Violation|4
812019|NCT00105534|1763986|FG000|Overall Study|Withdrawal by Subject|6
812020|NCT00105534|1763987|FG001|Overall Study|Withdrawal by Subject|6
812021|NCT00105534|1763986|FG000|Overall Study|Lost to Follow-up|5
812022|NCT00105534|1763987|FG001|Overall Study|Lost to Follow-up|1
812023|NCT00105534|1763986|FG000|Overall Study|Lack of Efficacy|7
812024|NCT00105534|1763987|FG001|Overall Study|Lack of Efficacy|15
812025|NCT00105534|1763986|FG000|Overall Study|Treatment unmasked|1
812026|NCT00105534|1763987|FG001|Overall Study|Treatment unmasked|0
812027|NCT00105534|1763986|FG000|Overall Study|Other Reason|0
812028|NCT00105534|1763987|FG001|Overall Study|Other Reason|2
812030|NCT00105586|1764008|FG000|Overall Study|Adverse Event|4
812031|NCT00105586|1764009|FG001|Overall Study|Adverse Event|3
812032|NCT00105586|1764008|FG000|Overall Study|Physician Decision|13
812033|NCT00105586|1764009|FG001|Overall Study|Physician Decision|13
812034|NCT00105989|1764017|FG000|Acute - Open Label: Week 0-10|Adverse Event|33
812035|NCT00105989|1764018|FG001|Acute - Open Label: Week 0-10|Adverse Event|0
812036|NCT00105989|1764017|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
812037|NCT00105989|1764018|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
812038|NCT00105989|1764017|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17
812039|NCT00105989|1764018|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0
812040|NCT00105989|1764017|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
812041|NCT00105989|1764018|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
812042|NCT00105989|1764017|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8
812043|NCT00105989|1764018|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0
812044|NCT00105989|1764017|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4
812045|NCT00105989|1764018|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0
812046|NCT00105989|1764017|FG000|Acute - Open Label: Week 0-10|Physician Decision|0
812047|NCT00105989|1764018|FG001|Acute - Open Label: Week 0-10|Physician Decision|0
812048|NCT00105989|1764017|FG000|Acute - Open Label: Week 0-10|Death|1
812049|NCT00105989|1764018|FG001|Acute - Open Label: Week 0-10|Death|0
812050|NCT00105989|1764017|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
812051|NCT00105989|1764018|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
812052|NCT00105989|1764017|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
812053|NCT00105989|1764018|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
812129|NCT00106353|1764101|FG005|Part 1|Symptomatic deterioration|0
812054|NCT00105989|1764017|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25
812055|NCT00105989|1764018|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0
812056|NCT00105989|1764017|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
812057|NCT00105989|1764018|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
812058|NCT00105989|1764017|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
812059|NCT00105989|1764018|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
812060|NCT00105989|1764017|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
812061|NCT00105989|1764018|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
812062|NCT00105989|1764017|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5
812063|NCT00105989|1764018|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0
812064|NCT00105989|1764017|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
812065|NCT00105989|1764018|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
812066|NCT00105989|1764017|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3
812067|NCT00105989|1764018|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0
812068|NCT00105989|1764017|FG000|Continuation - Open Label:Week 10-34|Death|0
812069|NCT00105989|1764018|FG001|Continuation - Open Label:Week 10-34|Death|0
812070|NCT00105989|1764017|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
812071|NCT00105989|1764018|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
812072|NCT00105989|1764017|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
812073|NCT00105989|1764018|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
812074|NCT00105989|1764017|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
812075|NCT00105989|1764018|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
812076|NCT00105989|1764017|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
812077|NCT00105989|1764018|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
812078|NCT00105989|1764017|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
812079|NCT00105989|1764018|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
812080|NCT00105989|1764017|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
812081|NCT00105989|1764018|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
812082|NCT00105989|1764017|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
812083|NCT00105989|1764018|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
812084|NCT00105989|1764017|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
812085|NCT00105989|1764018|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
812086|NCT00105989|1764017|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
812087|NCT00105989|1764018|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
812088|NCT00105989|1764017|FG000|Maintenance - Double-Blind:Week 34-86|Death|0
812089|NCT00105989|1764018|FG001|Maintenance - Double-Blind:Week 34-86|Death|0
812090|NCT00105989|1764017|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
812091|NCT00105989|1764018|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
812092|NCT00105989|1764017|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
812093|NCT00105989|1764018|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
812094|NCT00106002|1764034|FG000|Overall Study|Did not take any study drug|1
812095|NCT00106002|1764034|FG000|Overall Study|Ineligible after Registration|1
812096|NCT00106028|1764040|FG000|Overall Study|Adverse Event|3
812097|NCT00106028|1764041|FG001|Overall Study|Adverse Event|2
812098|NCT00106028|1764040|FG000|Overall Study|Protocol Violation|1
812099|NCT00106028|1764041|FG001|Overall Study|Protocol Violation|1
812100|NCT00106028|1764040|FG000|Overall Study|Withdrawal by Subject|2
812101|NCT00106028|1764041|FG001|Overall Study|Withdrawal by Subject|8
812102|NCT00106028|1764040|FG000|Overall Study|Lost to Follow-up|0
812103|NCT00106028|1764041|FG001|Overall Study|Lost to Follow-up|1
812104|NCT00106080|1764051|FG000|Overall Study|Withdrew/Loss to follow-up|43
812105|NCT00106080|1764052|FG001|Overall Study|Withdrew/Loss to follow-up|27
812106|NCT00106184|1764076|FG000|Overall Study|Withdrawal by Subject|3
812107|NCT00106184|1764077|FG001|Overall Study|Withdrawal by Subject|2
812108|NCT00106249|1764087|FG000|Overall Study|Lost to Follow-up|3
812109|NCT00106249|1764088|FG001|Overall Study|Lost to Follow-up|2
812110|NCT00106353|1764096|FG000|Part 1|Disease progression|3
812111|NCT00106353|1764097|FG001|Part 1|Disease progression|4
812112|NCT00106353|1764098|FG002|Part 1|Disease progression|1
812113|NCT00106353|1764099|FG003|Part 1|Disease progression|3
812114|NCT00106353|1764100|FG004|Part 1|Disease progression|0
812115|NCT00106353|1764101|FG005|Part 1|Disease progression|0
812116|NCT00106353|1764102|FG006|Part 1|Disease progression|0
812117|NCT00106353|1764096|FG000|Part 1|Withdrawal by Subject|0
812118|NCT00106353|1764097|FG001|Part 1|Withdrawal by Subject|0
812119|NCT00106353|1764098|FG002|Part 1|Withdrawal by Subject|1
812120|NCT00106353|1764099|FG003|Part 1|Withdrawal by Subject|2
812121|NCT00106353|1764100|FG004|Part 1|Withdrawal by Subject|0
812122|NCT00106353|1764101|FG005|Part 1|Withdrawal by Subject|0
812123|NCT00106353|1764102|FG006|Part 1|Withdrawal by Subject|0
812124|NCT00106353|1764096|FG000|Part 1|Symptomatic deterioration|0
812125|NCT00106353|1764097|FG001|Part 1|Symptomatic deterioration|0
812126|NCT00106353|1764098|FG002|Part 1|Symptomatic deterioration|1
812127|NCT00106353|1764099|FG003|Part 1|Symptomatic deterioration|0
812128|NCT00106353|1764100|FG004|Part 1|Symptomatic deterioration|0
812130|NCT00106353|1764102|FG006|Part 1|Symptomatic deterioration|0
812131|NCT00106353|1764096|FG000|Part 1|Entered follow-up phase|1
812132|NCT00106353|1764097|FG001|Part 1|Entered follow-up phase|1
812133|NCT00106353|1764098|FG002|Part 1|Entered follow-up phase|0
812134|NCT00106353|1764099|FG003|Part 1|Entered follow-up phase|1
812135|NCT00106353|1764100|FG004|Part 1|Entered follow-up phase|0
812136|NCT00106353|1764101|FG005|Part 1|Entered follow-up phase|0
812137|NCT00106353|1764102|FG006|Part 1|Entered follow-up phase|0
812138|NCT00106353|1764096|FG000|Part 1|Adverse Event|0
812139|NCT00106353|1764097|FG001|Part 1|Adverse Event|0
812140|NCT00106353|1764098|FG002|Part 1|Adverse Event|0
812141|NCT00106353|1764099|FG003|Part 1|Adverse Event|1
812142|NCT00106353|1764100|FG004|Part 1|Adverse Event|0
812143|NCT00106353|1764101|FG005|Part 1|Adverse Event|0
812144|NCT00106353|1764102|FG006|Part 1|Adverse Event|0
812145|NCT00106353|1764096|FG000|Part 2|Disease progression|0
812146|NCT00106353|1764097|FG001|Part 2|Disease progression|0
812147|NCT00106353|1764098|FG002|Part 2|Disease progression|0
812148|NCT00106353|1764099|FG003|Part 2|Disease progression|0
812149|NCT00106353|1764100|FG004|Part 2|Disease progression|8
812150|NCT00106353|1764101|FG005|Part 2|Disease progression|14
812151|NCT00106353|1764102|FG006|Part 2|Disease progression|13
812152|NCT00106353|1764096|FG000|Part 2|Death|0
812153|NCT00106353|1764097|FG001|Part 2|Death|0
812154|NCT00106353|1764098|FG002|Part 2|Death|0
812155|NCT00106353|1764099|FG003|Part 2|Death|0
812156|NCT00106353|1764100|FG004|Part 2|Death|3
812157|NCT00106353|1764101|FG005|Part 2|Death|0
812158|NCT00106353|1764102|FG006|Part 2|Death|1
812159|NCT00106353|1764096|FG000|Part 2|Symptomatic deterioration|0
812160|NCT00106353|1764097|FG001|Part 2|Symptomatic deterioration|0
812161|NCT00106353|1764098|FG002|Part 2|Symptomatic deterioration|0
812162|NCT00106353|1764099|FG003|Part 2|Symptomatic deterioration|0
812163|NCT00106353|1764100|FG004|Part 2|Symptomatic deterioration|3
812164|NCT00106353|1764101|FG005|Part 2|Symptomatic deterioration|0
812165|NCT00106353|1764102|FG006|Part 2|Symptomatic deterioration|0
812166|NCT00106353|1764096|FG000|Part 2|Adverse Event|0
812167|NCT00106353|1764097|FG001|Part 2|Adverse Event|0
812168|NCT00106353|1764098|FG002|Part 2|Adverse Event|0
812169|NCT00106353|1764099|FG003|Part 2|Adverse Event|0
812170|NCT00106353|1764100|FG004|Part 2|Adverse Event|0
812171|NCT00106353|1764101|FG005|Part 2|Adverse Event|2
812172|NCT00106353|1764102|FG006|Part 2|Adverse Event|1
812173|NCT00106353|1764096|FG000|Part 2|Other|0
812174|NCT00106353|1764097|FG001|Part 2|Other|0
812175|NCT00106353|1764098|FG002|Part 2|Other|0
812176|NCT00106353|1764099|FG003|Part 2|Other|0
812177|NCT00106353|1764100|FG004|Part 2|Other|1
812178|NCT00106353|1764101|FG005|Part 2|Other|1
812179|NCT00106353|1764102|FG006|Part 2|Other|1
812180|NCT00106353|1764096|FG000|Part 2|Withdrawal by Subject|0
812181|NCT00106353|1764097|FG001|Part 2|Withdrawal by Subject|0
812182|NCT00106353|1764098|FG002|Part 2|Withdrawal by Subject|0
812183|NCT00106353|1764099|FG003|Part 2|Withdrawal by Subject|0
812184|NCT00106353|1764100|FG004|Part 2|Withdrawal by Subject|1
812185|NCT00106353|1764101|FG005|Part 2|Withdrawal by Subject|0
812186|NCT00106353|1764102|FG006|Part 2|Withdrawal by Subject|0
812187|NCT00106353|1764096|FG000|Part 2|Physician Decision|0
812188|NCT00106353|1764097|FG001|Part 2|Physician Decision|0
812189|NCT00106353|1764098|FG002|Part 2|Physician Decision|0
812190|NCT00106353|1764099|FG003|Part 2|Physician Decision|0
812191|NCT00106353|1764100|FG004|Part 2|Physician Decision|0
812192|NCT00106353|1764101|FG005|Part 2|Physician Decision|1
812193|NCT00106353|1764102|FG006|Part 2|Physician Decision|0
812194|NCT00106626|1764158|FG000|Overall Study|Adverse Event|5
812195|NCT00106626|1764159|FG001|Overall Study|Adverse Event|4
812196|NCT00106626|1764160|FG002|Overall Study|Adverse Event|3
812197|NCT00106626|1764161|FG003|Overall Study|Adverse Event|3
812198|NCT00106626|1764158|FG000|Overall Study|Progressive Disease|4
812199|NCT00106626|1764159|FG001|Overall Study|Progressive Disease|1
812200|NCT00106626|1764160|FG002|Overall Study|Progressive Disease|9
812201|NCT00106626|1764161|FG003|Overall Study|Progressive Disease|10
812202|NCT00106626|1764158|FG000|Overall Study|Received radiation on new therapy|1
812203|NCT00106626|1764159|FG001|Overall Study|Received radiation on new therapy|0
812204|NCT00106626|1764160|FG002|Overall Study|Received radiation on new therapy|0
812205|NCT00106626|1764161|FG003|Overall Study|Received radiation on new therapy|0
812206|NCT00106626|1764158|FG000|Overall Study|> 14 day delay in therapy start|0
812207|NCT00106626|1764159|FG001|Overall Study|> 14 day delay in therapy start|1
812208|NCT00106626|1764160|FG002|Overall Study|> 14 day delay in therapy start|0
812209|NCT00106626|1764161|FG003|Overall Study|> 14 day delay in therapy start|0
812210|NCT00106639|1764179|FG000|Overall Study|Adverse Event|3
812211|NCT00106639|1764180|FG001|Overall Study|Adverse Event|4
812212|NCT00106639|1764181|FG002|Overall Study|Adverse Event|1
812213|NCT00106639|1764179|FG000|Overall Study|Protocol Violation|0
812214|NCT00106639|1764180|FG001|Overall Study|Protocol Violation|1
812215|NCT00106639|1764181|FG002|Overall Study|Protocol Violation|0
812216|NCT00106639|1764179|FG000|Overall Study|Withdrawal by Subject|0
812217|NCT00106639|1764180|FG001|Overall Study|Withdrawal by Subject|1
812218|NCT00106639|1764181|FG002|Overall Study|Withdrawal by Subject|0
812219|NCT00106639|1764179|FG000|Overall Study|Participant defaulted|0
812220|NCT00106639|1764180|FG001|Overall Study|Participant defaulted|1
812221|NCT00106639|1764181|FG002|Overall Study|Participant defaulted|1
812222|NCT00106704|1764192|FG000|Overall Study|Adverse Event|10
812223|NCT00106704|1764193|FG001|Overall Study|Adverse Event|7
812224|NCT00106704|1764192|FG000|Overall Study|Death|2
812225|NCT00106704|1764193|FG001|Overall Study|Death|1
812226|NCT00106704|1764192|FG000|Overall Study|Lack of Efficacy|67
812227|NCT00106704|1764193|FG001|Overall Study|Lack of Efficacy|69
812228|NCT00106704|1764192|FG000|Overall Study|Lost to Follow-up|7
812229|NCT00106704|1764193|FG001|Overall Study|Lost to Follow-up|3
812230|NCT00106704|1764192|FG000|Overall Study|Pregnancy|1
812231|NCT00106704|1764193|FG001|Overall Study|Pregnancy|0
812232|NCT00106704|1764192|FG000|Overall Study|Protocol Violation|4
812233|NCT00106704|1764193|FG001|Overall Study|Protocol Violation|7
812234|NCT00106704|1764192|FG000|Overall Study|Withdrawal by Subject|14
812235|NCT00106704|1764193|FG001|Overall Study|Withdrawal by Subject|21
812236|NCT00106704|1764192|FG000|Overall Study|Patient moved|1
812237|NCT00106704|1764193|FG001|Overall Study|Patient moved|0
812238|NCT00106704|1764192|FG000|Overall Study|Site terminated|0
812239|NCT00106704|1764193|FG001|Overall Study|Site terminated|1
812240|NCT00106704|1764192|FG000|Overall Study|Planned major surgery|1
812241|NCT00106704|1764193|FG001|Overall Study|Planned major surgery|0
812242|NCT00106704|1764192|FG000|Overall Study|Patient Received Glycemic Medication|22
812243|NCT00106704|1764193|FG001|Overall Study|Patient Received Glycemic Medication|41
812244|NCT00106704|1764192|FG000|Overall Study|Unable to re-enter US|1
812245|NCT00106704|1764193|FG001|Overall Study|Unable to re-enter US|0
812246|NCT00106704|1764192|FG000|Overall Study|Laboratory test|1
812247|NCT00106704|1764193|FG001|Overall Study|Laboratory test|1
812248|NCT00106964|1764211|FG000|Overall Study|Lost to Follow-up|8
812249|NCT00106964|1764212|FG001|Overall Study|Lost to Follow-up|6
812250|NCT00106964|1764213|FG002|Overall Study|Lost to Follow-up|2
812251|NCT00106964|1764211|FG000|Overall Study|Pregnancy|2
812252|NCT00106964|1764212|FG001|Overall Study|Pregnancy|3
812253|NCT00106964|1764213|FG002|Overall Study|Pregnancy|2
812254|NCT00106964|1764211|FG000|Overall Study|Death|1
812255|NCT00106964|1764212|FG001|Overall Study|Death|1
812256|NCT00106964|1764213|FG002|Overall Study|Death|0
812257|NCT00106964|1764211|FG000|Overall Study|Incarceration|0
812258|NCT00106964|1764212|FG001|Overall Study|Incarceration|1
812259|NCT00106964|1764213|FG002|Overall Study|Incarceration|0
812260|NCT00106964|1764211|FG000|Overall Study|Site Funding Terminated|0
812261|NCT00106964|1764212|FG001|Overall Study|Site Funding Terminated|1
812262|NCT00106964|1764213|FG002|Overall Study|Site Funding Terminated|1
812263|NCT00106964|1764211|FG000|Overall Study|Failure to adhere|2
812264|NCT00106964|1764212|FG001|Overall Study|Failure to adhere|0
812265|NCT00106964|1764213|FG002|Overall Study|Failure to adhere|0
812266|NCT00106964|1764211|FG000|Overall Study|Did not meet eligibility criteria|0
812267|NCT00106964|1764212|FG001|Overall Study|Did not meet eligibility criteria|2
812268|NCT00106964|1764213|FG002|Overall Study|Did not meet eligibility criteria|2
812269|NCT00106964|1764211|FG000|Overall Study|Required disallowed medication|0
812270|NCT00106964|1764212|FG001|Overall Study|Required disallowed medication|1
812271|NCT00106964|1764213|FG002|Overall Study|Required disallowed medication|0
812272|NCT00107042|1764232|FG000|Overall Study|Lost to Follow-up|9
812273|NCT00107042|1764233|FG001|Overall Study|Lost to Follow-up|7
812274|NCT00107042|1764232|FG000|Overall Study|Withdrawal by Subject|6
812275|NCT00107042|1764233|FG001|Overall Study|Withdrawal by Subject|1
812276|NCT00107042|1764232|FG000|Overall Study|Moved out of area|5
812277|NCT00107042|1764233|FG001|Overall Study|Moved out of area|3
812278|NCT00107042|1764232|FG000|Overall Study|Pregnancy|1
812279|NCT00107042|1764233|FG001|Overall Study|Pregnancy|1
812280|NCT00107042|1764232|FG000|Overall Study|Inadvertent enrollment|0
812281|NCT00107042|1764233|FG001|Overall Study|Inadvertent enrollment|1
812282|NCT00107042|1764232|FG000|Overall Study|vaccinated outside window|1
812283|NCT00107042|1764233|FG001|Overall Study|vaccinated outside window|1
812284|NCT00107042|1764232|FG000|Overall Study|Disallowed medications|0
812285|NCT00107042|1764233|FG001|Overall Study|Disallowed medications|2
812286|NCT00107120|1764283|FG000|Overall Study|Adverse Event|4
812287|NCT00107120|1764284|FG001|Overall Study|Adverse Event|1
812288|NCT00107120|1764283|FG000|Overall Study|Lack of Efficacy|5
812289|NCT00107120|1764284|FG001|Overall Study|Lack of Efficacy|5
812290|NCT00107120|1764283|FG000|Overall Study|Protocol Violation|3
812291|NCT00107120|1764284|FG001|Overall Study|Protocol Violation|0
812292|NCT00107120|1764283|FG000|Overall Study|Withdrawal by Subject|8
812293|NCT00107120|1764284|FG001|Overall Study|Withdrawal by Subject|9
812294|NCT00107120|1764283|FG000|Overall Study|Lost to Follow-up|8
812295|NCT00107120|1764284|FG001|Overall Study|Lost to Follow-up|6
812296|NCT00107120|1764283|FG000|Overall Study|Pregnancy|0
812297|NCT00107120|1764284|FG001|Overall Study|Pregnancy|1
812298|NCT00107120|1764283|FG000|Overall Study|moving away from site|1
812299|NCT00107120|1764284|FG001|Overall Study|moving away from site|1
812300|NCT00107120|1764283|FG000|Overall Study|death of parent|0
812301|NCT00107120|1764284|FG001|Overall Study|death of parent|1
812302|NCT00107172|1764292|FG000|Overall Study|Withdrawal by Subject|1
812303|NCT00107172|1764293|FG001|Overall Study|Withdrawal by Subject|0
812304|NCT00107172|1764292|FG000|Overall Study|Death|0
812305|NCT00107172|1764293|FG001|Overall Study|Death|2
812306|NCT00107172|1764292|FG000|Overall Study|Other Reason|4
812307|NCT00107172|1764293|FG001|Overall Study|Other Reason|3
812308|NCT00107198|1764299|FG000|Overall Study|Lack of Efficacy|28
812309|NCT00107198|1764299|FG000|Overall Study|Lost to Follow-up|12
812310|NCT00107198|1764299|FG000|Overall Study|Protocol Violation|1
812311|NCT00107198|1764299|FG000|Overall Study|Withdrawal by Subject|6
812312|NCT00107198|1764299|FG000|Overall Study|Ineligible|5
812313|NCT00107276|1764303|FG000|Overall Study|Progression|46
812314|NCT00107276|1764303|FG000|Overall Study|Adverse Event|6
812315|NCT00107276|1764303|FG000|Overall Study|M.D. decision|2
812316|NCT00107276|1764303|FG000|Overall Study|Patient refusal|1
812317|NCT00107276|1764303|FG000|Overall Study|Death|1
812318|NCT00107276|1764303|FG000|Overall Study|Ineligible|16
812319|NCT00107380|1764308|FG000|Overall Study|Adverse Event|7
812320|NCT00107380|1764308|FG000|Overall Study|Refusal Unrelated to Adverse Event|7
812321|NCT00107380|1764308|FG000|Overall Study|Progression/relapse|4
812322|NCT00107380|1764308|FG000|Overall Study|Death|3
812323|NCT00107380|1764308|FG000|Overall Study|Other - not protocol specified|7
812324|NCT00107380|1764308|FG000|Overall Study|Ineligible|2
812325|NCT00107653|1764328|FG000|Overall Study|Adverse Event|24
812326|NCT00107653|1764329|FG001|Overall Study|Adverse Event|43
812327|NCT00107653|1764328|FG000|Overall Study|Insufficient Therapeutic Response|25
812328|NCT00107653|1764329|FG001|Overall Study|Insufficient Therapeutic Response|11
812329|NCT00107653|1764328|FG000|Overall Study|Violation of Selection Criteria at Entry|1
812330|NCT00107653|1764329|FG001|Overall Study|Violation of Selection Criteria at Entry|1
812331|NCT00107653|1764328|FG000|Overall Study|Protocol Violation|1
812332|NCT00107653|1764329|FG001|Overall Study|Protocol Violation|0
812333|NCT00107653|1764328|FG000|Overall Study|Withdrawal by Subject|12
812334|NCT00107653|1764329|FG001|Overall Study|Withdrawal by Subject|13
812335|NCT00107653|1764328|FG000|Overall Study|Lost to Follow-up|13
812336|NCT00107653|1764329|FG001|Overall Study|Lost to Follow-up|5
812337|NCT00107653|1764328|FG000|Overall Study|Administrative Reasons|3
812338|NCT00107653|1764329|FG001|Overall Study|Administrative Reasons|3
812339|NCT00107783|1764350|FG000|Overall Study|Adverse Event|0
812340|NCT00107783|1764351|FG001|Overall Study|Adverse Event|2
812341|NCT00107783|1764350|FG000|Overall Study|Death|0
812342|NCT00107783|1764351|FG001|Overall Study|Death|1
812343|NCT00107783|1764350|FG000|Overall Study|Withdrawal by Subject|2
812344|NCT00107783|1764351|FG001|Overall Study|Withdrawal by Subject|0
812345|NCT00107783|1764350|FG000|Overall Study|Second hip replacement|1
812346|NCT00107783|1764351|FG001|Overall Study|Second hip replacement|1
812347|NCT00107900|1764363|FG000|Overall Study|Adverse Event|3
812348|NCT00107900|1764364|FG001|Overall Study|Adverse Event|2
812349|NCT00107900|1764365|FG002|Overall Study|Adverse Event|10
812350|NCT00107900|1764366|FG003|Overall Study|Adverse Event|3
812351|NCT00107900|1764367|FG004|Overall Study|Adverse Event|5
812352|NCT00107900|1764368|FG005|Overall Study|Adverse Event|3
812353|NCT00107900|1764363|FG000|Overall Study|Death|0
812354|NCT00107900|1764364|FG001|Overall Study|Death|0
812355|NCT00107900|1764365|FG002|Overall Study|Death|0
812356|NCT00107900|1764366|FG003|Overall Study|Death|0
812357|NCT00107900|1764367|FG004|Overall Study|Death|1
812358|NCT00107900|1764368|FG005|Overall Study|Death|0
812359|NCT00107900|1764363|FG000|Overall Study|Lost to Follow-up|4
812360|NCT00107900|1764364|FG001|Overall Study|Lost to Follow-up|1
812361|NCT00107900|1764365|FG002|Overall Study|Lost to Follow-up|3
812362|NCT00107900|1764366|FG003|Overall Study|Lost to Follow-up|2
812363|NCT00107900|1764367|FG004|Overall Study|Lost to Follow-up|5
812364|NCT00107900|1764368|FG005|Overall Study|Lost to Follow-up|5
812365|NCT00107900|1764363|FG000|Overall Study|Protocol Violation|1
812366|NCT00107900|1764364|FG001|Overall Study|Protocol Violation|0
812367|NCT00107900|1764365|FG002|Overall Study|Protocol Violation|5
812368|NCT00107900|1764366|FG003|Overall Study|Protocol Violation|5
812369|NCT00107900|1764367|FG004|Overall Study|Protocol Violation|7
812370|NCT00107900|1764368|FG005|Overall Study|Protocol Violation|0
812371|NCT00107900|1764363|FG000|Overall Study|Withdrawal by Subject|1
812372|NCT00107900|1764364|FG001|Overall Study|Withdrawal by Subject|0
812373|NCT00107900|1764365|FG002|Overall Study|Withdrawal by Subject|5
812374|NCT00107900|1764366|FG003|Overall Study|Withdrawal by Subject|0
812375|NCT00107900|1764367|FG004|Overall Study|Withdrawal by Subject|1
812376|NCT00107900|1764368|FG005|Overall Study|Withdrawal by Subject|1
812377|NCT00107900|1764363|FG000|Overall Study|Administrative Reasons|1
812378|NCT00107900|1764364|FG001|Overall Study|Administrative Reasons|0
812379|NCT00107900|1764365|FG002|Overall Study|Administrative Reasons|2
812380|NCT00107900|1764366|FG003|Overall Study|Administrative Reasons|2
812381|NCT00107900|1764367|FG004|Overall Study|Administrative Reasons|2
812382|NCT00107900|1764368|FG005|Overall Study|Administrative Reasons|0
812383|NCT00107952|1764384|FG000|Overall Study|Death|75
812384|NCT00107952|1764385|FG001|Overall Study|Death|61
812385|NCT00107952|1764384|FG000|Overall Study|Lost to Follow-up|0
812386|NCT00107952|1764385|FG001|Overall Study|Lost to Follow-up|3
812387|NCT00107952|1764384|FG000|Overall Study|Withdrawal by Subject|9
812388|NCT00107952|1764385|FG001|Overall Study|Withdrawal by Subject|6
812389|NCT00107952|1764384|FG000|Overall Study|Other|2
812390|NCT00107952|1764385|FG001|Overall Study|Other|5
812391|NCT00107952|1764384|FG000|Overall Study|Never received study treatment|9
812392|NCT00107952|1764385|FG001|Overall Study|Never received study treatment|6
812393|NCT00107978|1764393|FG000|Overall Study|Adverse Event|1
812394|NCT00107978|1764394|FG001|Overall Study|Adverse Event|5
812395|NCT00107978|1764393|FG000|Overall Study|Death|3
812396|NCT00107978|1764394|FG001|Overall Study|Death|3
812397|NCT00107978|1764393|FG000|Overall Study|Lost to Follow-up|20
812398|NCT00107978|1764394|FG001|Overall Study|Lost to Follow-up|28
812399|NCT00107978|1764393|FG000|Overall Study|Withdrawal by Subject|4
812400|NCT00107978|1764394|FG001|Overall Study|Withdrawal by Subject|9
812401|NCT00107978|1764393|FG000|Overall Study|Protocol Violation|0
812402|NCT00107978|1764394|FG001|Overall Study|Protocol Violation|1
812403|NCT00107978|1764393|FG000|Overall Study|Other|5
812404|NCT00107978|1764394|FG001|Overall Study|Other|4
812405|NCT00107991|1764400|FG000|Eligibility Assessment|Disease not severe enough|7
812406|NCT00107991|1764400|FG000|Eligibility Assessment|Unwilling to participate|7
812407|NCT00107991|1764400|FG000|Eligibility Assessment|Positive purified protein derivative|4
812408|NCT00107991|1764400|FG000|Eligibility Assessment|Abnormal labs|2
812409|NCT00107991|1764400|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1
812410|NCT00107991|1764400|FG000|Eligibility Assessment|chronic uncontrolled asthma|1
812411|NCT00107991|1764400|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
812412|NCT00107991|1764400|FG000|12 Week Treatment Period|Lack of Efficacy|2
812413|NCT00107991|1764400|FG000|12 Week Treatment Period|Adverse Event|1
812414|NCT00107991|1764400|FG000|12 Week Treatment Period|Protocol Violation|1
812415|NCT00107991|1764400|FG000|12 Week Treatment Period|Incarcerated|1
812416|NCT00107991|1764400|FG000|18-Week Post Treatment Assessment|Adverse Event|2
812417|NCT00108069|1764406|FG000|Overall Study|Never rec'd study drug|0
812418|NCT00108069|1764407|FG001|Overall Study|Never rec'd study drug|1
812419|NCT00108069|1764406|FG000|Overall Study|Adverse Event|1
812420|NCT00108069|1764407|FG001|Overall Study|Adverse Event|1
812421|NCT00108069|1764406|FG000|Overall Study|Withdrawal by Subject|1
812422|NCT00108069|1764407|FG001|Overall Study|Withdrawal by Subject|0
812423|NCT00108069|1764406|FG000|Overall Study|Death|1
812424|NCT00108069|1764407|FG001|Overall Study|Death|0
812425|NCT00108069|1764406|FG000|Overall Study|Progessive disease|27
812426|NCT00108069|1764407|FG001|Overall Study|Progessive disease|11
812427|NCT00108082|1764422|FG000|Overall Study|Adverse Event|14
812428|NCT00108082|1764423|FG001|Overall Study|Adverse Event|12
812429|NCT00108082|1764424|FG002|Overall Study|Adverse Event|17
812430|NCT00108082|1764422|FG000|Overall Study|Lost to Follow-up|6
812431|NCT00108082|1764423|FG001|Overall Study|Lost to Follow-up|3
812432|NCT00108082|1764424|FG002|Overall Study|Lost to Follow-up|7
812433|NCT00108082|1764422|FG000|Overall Study|Consent Withdrawn|3
812434|NCT00108082|1764423|FG001|Overall Study|Consent Withdrawn|3
812435|NCT00108082|1764424|FG002|Overall Study|Consent Withdrawn|5
812436|NCT00108082|1764422|FG000|Overall Study|Protocol Violation|1
812437|NCT00108082|1764423|FG001|Overall Study|Protocol Violation|2
812438|NCT00108082|1764424|FG002|Overall Study|Protocol Violation|0
812439|NCT00108082|1764422|FG000|Overall Study|Lack of Efficacy|3
812440|NCT00108082|1764423|FG001|Overall Study|Lack of Efficacy|1
812441|NCT00108082|1764424|FG002|Overall Study|Lack of Efficacy|2
812442|NCT00108082|1764422|FG000|Overall Study|Amendment 4: > Month 12|5
812443|NCT00108082|1764423|FG001|Overall Study|Amendment 4: > Month 12|7
812444|NCT00108082|1764424|FG002|Overall Study|Amendment 4: > Month 12|5
812445|NCT00108082|1764422|FG000|Overall Study|Woman of Child-bearing Potential|2
812446|NCT00108082|1764423|FG001|Overall Study|Woman of Child-bearing Potential|0
812447|NCT00108082|1764424|FG002|Overall Study|Woman of Child-bearing Potential|2
812448|NCT00108082|1764422|FG000|Overall Study|Incorrectly Randomized|0
812449|NCT00108082|1764423|FG001|Overall Study|Incorrectly Randomized|0
812450|NCT00108082|1764424|FG002|Overall Study|Incorrectly Randomized|2
812451|NCT00108082|1764422|FG000|Overall Study|Non-compliance|1
812452|NCT00108082|1764423|FG001|Overall Study|Non-compliance|0
812453|NCT00108082|1764424|FG002|Overall Study|Non-compliance|2
812454|NCT00108082|1764422|FG000|Overall Study|Stopped Study Medication|0
812455|NCT00108082|1764423|FG001|Overall Study|Stopped Study Medication|0
812456|NCT00108082|1764424|FG002|Overall Study|Stopped Study Medication|1
812457|NCT00108082|1764422|FG000|Overall Study|Site Closed Study|0
812458|NCT00108082|1764423|FG001|Overall Study|Site Closed Study|2
812459|NCT00108082|1764424|FG002|Overall Study|Site Closed Study|0
812460|NCT00108082|1764422|FG000|Overall Study|Protocol Amendment|0
812461|NCT00108082|1764423|FG001|Overall Study|Protocol Amendment|1
812462|NCT00108082|1764424|FG002|Overall Study|Protocol Amendment|0
812463|NCT00108082|1764422|FG000|Overall Study|Study Medication Not Tapered|0
812464|NCT00108082|1764423|FG001|Overall Study|Study Medication Not Tapered|1
812465|NCT00108082|1764424|FG002|Overall Study|Study Medication Not Tapered|0
812466|NCT00108082|1764422|FG000|Overall Study|Subject Left Site Location|1
812467|NCT00108082|1764423|FG001|Overall Study|Subject Left Site Location|0
812468|NCT00108082|1764424|FG002|Overall Study|Subject Left Site Location|0
812469|NCT00108082|1764422|FG000|Overall Study|Investigator Not at Site|1
812470|NCT00108082|1764423|FG001|Overall Study|Investigator Not at Site|0
812471|NCT00108082|1764424|FG002|Overall Study|Investigator Not at Site|0
812472|NCT00108082|1764422|FG000|Overall Study|Blood Pressure Not Controlled|1
812473|NCT00108082|1764423|FG001|Overall Study|Blood Pressure Not Controlled|0
812474|NCT00108082|1764424|FG002|Overall Study|Blood Pressure Not Controlled|0
812475|NCT00108160|1764434|FG000|Overall Study|Lost to Follow-up|25
812476|NCT00108160|1764435|FG001|Overall Study|Lost to Follow-up|12
812477|NCT00108160|1764434|FG000|Overall Study|Death|1
812478|NCT00108160|1764435|FG001|Overall Study|Death|2
812479|NCT00108160|1764434|FG000|Overall Study|Withdrawal by Subject|4
812480|NCT00108160|1764435|FG001|Overall Study|Withdrawal by Subject|2
812481|NCT00108160|1764434|FG000|Overall Study|Protocol Violation|9
812482|NCT00108160|1764435|FG001|Overall Study|Protocol Violation|5
812483|NCT00108355|1764475|FG000|Overall Study|Peritonitis at index paracentesis|1
812484|NCT00108355|1764476|FG001|Overall Study|Peritonitis at index paracentesis|1
812485|NCT00108355|1764475|FG000|Overall Study|Loculated ascites, limiting paracentesis|1
812486|NCT00108355|1764476|FG001|Overall Study|Loculated ascites, limiting paracentesis|1
812487|NCT00108485|1764484|FG000|Overall Study|Withdrawal by Subject|3
812488|NCT00108485|1764485|FG001|Overall Study|Withdrawal by Subject|0
812489|NCT00108485|1764484|FG000|Overall Study|Lost to Follow-up|0
812490|NCT00108485|1764485|FG001|Overall Study|Lost to Follow-up|2
812491|NCT00108628|1764511|FG000|Overall Study|Withdrawal by Subject|17
812492|NCT00108628|1764512|FG001|Overall Study|Withdrawal by Subject|9
812493|NCT00108628|1764511|FG000|Overall Study|Lack of Efficacy|2
812494|NCT00108628|1764512|FG001|Overall Study|Lack of Efficacy|1
812495|NCT00108628|1764511|FG000|Overall Study|Death|1
812496|NCT00108628|1764512|FG001|Overall Study|Death|0
812497|NCT00108732|1764518|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
812498|NCT00108732|1764518|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
812499|NCT00108732|1764518|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
812500|NCT00108732|1764518|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
812501|NCT00108732|1764518|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
812502|NCT00108732|1764518|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
812503|NCT00108732|1764518|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1
812504|NCT00108745|1764525|FG000|Overall Study|Withdrawal by Subject|19
812505|NCT00108745|1764526|FG001|Overall Study|Withdrawal by Subject|12
812506|NCT00108745|1764527|FG002|Overall Study|Withdrawal by Subject|12
812507|NCT00108745|1764525|FG000|Overall Study|Never Treated|8
812508|NCT00108745|1764526|FG001|Overall Study|Never Treated|10
812509|NCT00108745|1764527|FG002|Overall Study|Never Treated|12
812510|NCT00108745|1764525|FG000|Overall Study|Ineligible|7
812511|NCT00108745|1764526|FG001|Overall Study|Ineligible|13
812512|NCT00108745|1764527|FG002|Overall Study|Ineligible|13
812513|NCT00108862|1764537|FG000|Overall Study|Death|31
812514|NCT00108862|1764538|FG001|Overall Study|Death|37
812515|NCT00108862|1764537|FG000|Overall Study|Withdrawal by Subject|10
812516|NCT00108862|1764538|FG001|Overall Study|Withdrawal by Subject|6
812517|NCT00108862|1764537|FG000|Overall Study|Lost to Follow-up|27
812518|NCT00108862|1764538|FG001|Overall Study|Lost to Follow-up|19
812519|NCT00108953|1764546|FG000|Follow-up|Death|18
812520|NCT00108953|1764547|FG001|Follow-up|Death|26
812521|NCT00108953|1764546|FG000|Follow-up|Lost to Follow-up|1
812522|NCT00108953|1764547|FG001|Follow-up|Lost to Follow-up|1
812523|NCT00108953|1764546|FG000|Follow-up|Study terminated by sponsor|10
812524|NCT00108953|1764547|FG001|Follow-up|Study terminated by sponsor|6
812525|NCT00109031|1764569|FG000|Overall Study|Adverse Event|0
812526|NCT00109031|1764570|FG001|Overall Study|Adverse Event|0
812527|NCT00109031|1764571|FG002|Overall Study|Adverse Event|1
812528|NCT00109031|1764572|FG003|Overall Study|Adverse Event|0
812529|NCT00109031|1764569|FG000|Overall Study|Withdrawal by Subject|0
812530|NCT00109031|1764570|FG001|Overall Study|Withdrawal by Subject|1
812531|NCT00109031|1764571|FG002|Overall Study|Withdrawal by Subject|0
812532|NCT00109031|1764572|FG003|Overall Study|Withdrawal by Subject|0
812533|NCT00109031|1764569|FG000|Overall Study|Physician Decision|0
812534|NCT00109031|1764570|FG001|Overall Study|Physician Decision|1
812535|NCT00109031|1764571|FG002|Overall Study|Physician Decision|0
812536|NCT00109031|1764572|FG003|Overall Study|Physician Decision|0
812537|NCT00109031|1764569|FG000|Overall Study|Protocol Violation|0
812538|NCT00109031|1764570|FG001|Overall Study|Protocol Violation|0
812539|NCT00109031|1764571|FG002|Overall Study|Protocol Violation|1
812540|NCT00109031|1764572|FG003|Overall Study|Protocol Violation|0
812541|NCT00109343|1764585|FG000|Overall Study|Adverse Event|1
812542|NCT00109343|1764586|FG001|Overall Study|Adverse Event|0
812543|NCT00109343|1764587|FG002|Overall Study|Adverse Event|2
812544|NCT00109343|1764585|FG000|Overall Study|Lack of Efficacy|1
812545|NCT00109343|1764586|FG001|Overall Study|Lack of Efficacy|0
812546|NCT00109343|1764587|FG002|Overall Study|Lack of Efficacy|0
812547|NCT00109343|1764585|FG000|Overall Study|Lost to Follow-up|35
812548|NCT00109343|1764586|FG001|Overall Study|Lost to Follow-up|20
812549|NCT00109343|1764587|FG002|Overall Study|Lost to Follow-up|14
812550|NCT00109343|1764585|FG000|Overall Study|Protocol Violation|1
812551|NCT00109343|1764586|FG001|Overall Study|Protocol Violation|2
812552|NCT00109343|1764587|FG002|Overall Study|Protocol Violation|2
812553|NCT00109343|1764585|FG000|Overall Study|Withdrawal by Subject|15
812554|NCT00109343|1764586|FG001|Overall Study|Withdrawal by Subject|11
812555|NCT00109343|1764587|FG002|Overall Study|Withdrawal by Subject|10
812556|NCT00109343|1764585|FG000|Overall Study|Subject Moved|6
812557|NCT00109343|1764586|FG001|Overall Study|Subject Moved|2
812558|NCT00109343|1764587|FG002|Overall Study|Subject Moved|1
812559|NCT00109343|1764585|FG000|Overall Study|Other|5
812560|NCT00109343|1764586|FG001|Overall Study|Other|2
812561|NCT00109343|1764587|FG002|Overall Study|Other|1
812562|NCT00109577|1764609|FG000|Overall Study|Withdrawal by Subject|3
812563|NCT00109577|1764610|FG001|Overall Study|Withdrawal by Subject|3
812564|NCT00109590|1764619|FG000|Overall Study|Lost to Follow-up|1
812565|NCT00109590|1764620|FG001|Overall Study|Lost to Follow-up|0
812566|NCT00109590|1764621|FG002|Overall Study|Lost to Follow-up|1
812567|NCT00109590|1764619|FG000|Overall Study|Never Started Treatment|1
812568|NCT00109590|1764620|FG001|Overall Study|Never Started Treatment|2
812569|NCT00109590|1764621|FG002|Overall Study|Never Started Treatment|3
812570|NCT00109707|1764646|FG000|Overall Study|Discontinued in core study without entering the extension study|215
812571|NCT00109707|1764647|FG001|Overall Study|Discontinued in core study without entering the extension study|122
812572|NCT00109707|1764648|FG002|Overall Study|Discontinued in core study without entering the extension study|34
812573|NCT00109707|1764646|FG000|Overall Study|Abnormal laboratory values|1
812574|NCT00109707|1764647|FG001|Overall Study|Abnormal laboratory values|0
812575|NCT00109707|1764648|FG002|Overall Study|Abnormal laboratory values|0
812576|NCT00109707|1764646|FG000|Overall Study|Administrative problems|2
812577|NCT00109707|1764647|FG001|Overall Study|Administrative problems|0
812578|NCT00109707|1764648|FG002|Overall Study|Administrative problems|1
812579|NCT00109707|1764646|FG000|Overall Study|Adverse Event|10
812580|NCT00109707|1764647|FG001|Overall Study|Adverse Event|2
812581|NCT00109707|1764648|FG002|Overall Study|Adverse Event|3
812582|NCT00109707|1764646|FG000|Overall Study|Death|4
812583|NCT00109707|1764647|FG001|Overall Study|Death|0
812584|NCT00109707|1764648|FG002|Overall Study|Death|0
812585|NCT00109707|1764646|FG000|Overall Study|Disease progression|12
812586|NCT00109707|1764647|FG001|Overall Study|Disease progression|4
812587|NCT00109707|1764648|FG002|Overall Study|Disease progression|3
812588|NCT00109707|1764646|FG000|Overall Study|Lost to Follow-up|3
812589|NCT00109707|1764647|FG001|Overall Study|Lost to Follow-up|0
812590|NCT00109707|1764648|FG002|Overall Study|Lost to Follow-up|0
812591|NCT00109707|1764646|FG000|Overall Study|Protocol Violation|1
812592|NCT00109707|1764647|FG001|Overall Study|Protocol Violation|0
812593|NCT00109707|1764648|FG002|Overall Study|Protocol Violation|0
812594|NCT00109707|1764646|FG000|Overall Study|Patient withdrew consent|6
812595|NCT00109707|1764647|FG001|Overall Study|Patient withdrew consent|1
812596|NCT00109707|1764648|FG002|Overall Study|Patient withdrew consent|0
812597|NCT00109733|1764662|FG000|Overall Study|Protocol Violation|0
812598|NCT00109733|1764663|FG001|Overall Study|Protocol Violation|1
812599|NCT00109733|1764662|FG000|Overall Study|Stopped taking study drug|1
812600|NCT00109733|1764663|FG001|Overall Study|Stopped taking study drug|1
812601|NCT00109733|1764662|FG000|Overall Study|Non-compliant|0
812602|NCT00109733|1764663|FG001|Overall Study|Non-compliant|1
812603|NCT00109733|1764662|FG000|Overall Study|Could not commit time for study|1
812604|NCT00109733|1764663|FG001|Overall Study|Could not commit time for study|1
812605|NCT00109772|1764671|FG000|Double-blind Treatment|Adverse Event|14
812606|NCT00109772|1764672|FG001|Double-blind Treatment|Adverse Event|5
812607|NCT00109772|1764671|FG000|Double-blind Treatment|Lack of Efficacy|1
812608|NCT00109772|1764672|FG001|Double-blind Treatment|Lack of Efficacy|0
812609|NCT00109772|1764671|FG000|Double-blind Treatment|Withdrawal by Subject|2
812610|NCT00109772|1764672|FG001|Double-blind Treatment|Withdrawal by Subject|1
812611|NCT00109772|1764671|FG000|Double-blind Treatment|Lost to Follow-up|2
812612|NCT00109772|1764672|FG001|Double-blind Treatment|Lost to Follow-up|3
812613|NCT00109772|1764671|FG000|Double-blind Treatment|Protocol Violation|0
812614|NCT00109772|1764672|FG001|Double-blind Treatment|Protocol Violation|1
812615|NCT00109772|1764671|FG000|Double-blind Treatment|Other|0
812616|NCT00109772|1764672|FG001|Double-blind Treatment|Other|4
812617|NCT00109772|1764671|FG000|Double-blind Treatment|Withdrew prior to treatment|3
812618|NCT00109772|1764672|FG001|Double-blind Treatment|Withdrew prior to treatment|1
812619|NCT00109772|1764671|FG000|Open-label Extension|Adverse Event|10
812620|NCT00109772|1764672|FG001|Open-label Extension|Adverse Event|19
812621|NCT00109772|1764671|FG000|Open-label Extension|Lack of Efficacy|19
812622|NCT00109772|1764672|FG001|Open-label Extension|Lack of Efficacy|11
812623|NCT00109772|1764671|FG000|Open-label Extension|Withdrawal by Subject|9
812624|NCT00109772|1764672|FG001|Open-label Extension|Withdrawal by Subject|6
812625|NCT00109772|1764671|FG000|Open-label Extension|Lost to Follow-up|1
812626|NCT00109772|1764672|FG001|Open-label Extension|Lost to Follow-up|0
812627|NCT00109772|1764671|FG000|Open-label Extension|Death|0
812628|NCT00109772|1764672|FG001|Open-label Extension|Death|1
812629|NCT00109772|1764671|FG000|Open-label Extension|Protocol Violation|2
812630|NCT00109772|1764672|FG001|Open-label Extension|Protocol Violation|2
812631|NCT00109772|1764671|FG000|Open-label Extension|Other|4
812632|NCT00109772|1764672|FG001|Open-label Extension|Other|10
812633|NCT00109837|1764678|FG000|Overall Study|Adverse Event|2
812634|NCT00109837|1764678|FG000|Overall Study|Refusal unrelated to adverse effects|1
812635|NCT00109837|1764678|FG000|Overall Study|Death|1
812636|NCT00109837|1764678|FG000|Overall Study|BCR/ABL+ or Ph+|17
812637|NCT00109837|1764678|FG000|Overall Study|Not treated|1
812638|NCT00109837|1764678|FG000|Overall Study|Ineligible|1
812639|NCT00109850|1764686|FG000|Overall Study|Adverse Event|1
812640|NCT00109850|1764686|FG000|Overall Study|Death|2
812641|NCT00109850|1764686|FG000|Overall Study|Ineligible|1
812642|NCT00109928|1764694|FG000|Overall Study|Adverse Event|2
812643|NCT00109928|1764694|FG000|Overall Study|Progression|6
812644|NCT00109928|1764694|FG000|Overall Study|Death|2
812645|NCT00109928|1764694|FG000|Overall Study|not protocol specified|2
812646|NCT00109928|1764694|FG000|Overall Study|not eligible|1
812647|NCT00109967|1764701|FG000|Overall Study|Cancel Prior to Treatment|2
812648|NCT00109967|1764702|FG001|Overall Study|Cancel Prior to Treatment|0
812649|NCT00109967|1764701|FG000|Overall Study|Adverse Event|12
812650|NCT00109967|1764702|FG001|Overall Study|Adverse Event|1
812651|NCT00109967|1764701|FG000|Overall Study|Withdrawal by Subject|5
812652|NCT00109967|1764702|FG001|Overall Study|Withdrawal by Subject|0
812653|NCT00109967|1764701|FG000|Overall Study|Physician Decision|1
812654|NCT00109967|1764702|FG001|Overall Study|Physician Decision|3
812655|NCT00109967|1764701|FG000|Overall Study|Death|0
812656|NCT00109967|1764702|FG001|Overall Study|Death|2
812657|NCT00110019|1764710|FG000|Overall Study|Lack of Efficacy|253
812658|NCT00110019|1764711|FG001|Overall Study|Lack of Efficacy|285
812659|NCT00110019|1764710|FG000|Overall Study|Adverse Event|61
812660|NCT00110019|1764711|FG001|Overall Study|Adverse Event|40
812661|NCT00110019|1764710|FG000|Overall Study|Death|13
812662|NCT00110019|1764711|FG001|Overall Study|Death|15
812663|NCT00110019|1764710|FG000|Overall Study|Withdrawal by Subject|21
812664|NCT00110019|1764711|FG001|Overall Study|Withdrawal by Subject|9
812665|NCT00110019|1764710|FG000|Overall Study|alternative therapy|5
812666|NCT00110019|1764711|FG001|Overall Study|alternative therapy|1
812667|NCT00110019|1764710|FG000|Overall Study|complicating disease|1
812668|NCT00110019|1764711|FG001|Overall Study|complicating disease|1
812669|NCT00110019|1764710|FG000|Overall Study|symptom deterioration|13
812670|NCT00110019|1764711|FG001|Overall Study|symptom deterioration|16
812671|NCT00110019|1764710|FG000|Overall Study|Not start protocol therapy|17
812672|NCT00110019|1764711|FG001|Overall Study|Not start protocol therapy|16
812673|NCT00110019|1764710|FG000|Overall Study|other reasons|22
812674|NCT00110019|1764711|FG001|Overall Study|other reasons|30
812675|NCT00110084|1764717|FG000|Overall Study|Adverse Event|9
812676|NCT00110084|1764717|FG000|Overall Study|Death|1
812677|NCT00110084|1764717|FG000|Overall Study|Patient Refusal|10
812678|NCT00110084|1764717|FG000|Overall Study|Alternate Therapy|5
812679|NCT00110084|1764717|FG000|Overall Study|Intercurrent Illness|1
812680|NCT00110084|1764717|FG000|Overall Study|Other|2
812681|NCT00110149|1764726|FG000|Overall Study|Physician Decision|3
812682|NCT00110214|1764733|FG000|Overall Study|Never started treatment|21
812683|NCT00110214|1764734|FG001|Overall Study|Never started treatment|20
812684|NCT00110214|1764733|FG000|Overall Study|Disease progression or death|260
812685|NCT00110214|1764734|FG001|Overall Study|Disease progression or death|151
812686|NCT00110214|1764733|FG000|Overall Study|Adverse Event|115
812687|NCT00110214|1764734|FG001|Overall Study|Adverse Event|192
812688|NCT00110214|1764733|FG000|Overall Study|Refused further treatment|52
812689|NCT00110214|1764734|FG001|Overall Study|Refused further treatment|65
812690|NCT00110214|1764733|FG000|Overall Study|Other (not specified)|61
812691|NCT00110214|1764734|FG001|Overall Study|Other (not specified)|75
812692|NCT00110266|1764740|FG000|Overall Study|Adverse Event|27
812693|NCT00110266|1764740|FG000|Overall Study|Abnormal laboratory value|15
812694|NCT00110266|1764740|FG000|Overall Study|Withdrawal by Subject|16
812695|NCT00110266|1764740|FG000|Overall Study|Death|17
812696|NCT00110266|1764740|FG000|Overall Study|Unsatisfactory therapeutic effect|2
812697|NCT00110266|1764740|FG000|Overall Study|Participant condition no longer requires study drug|1
812698|NCT00110305|1764749|FG000|Overall Study|Adverse Event|46
812699|NCT00110305|1764750|FG001|Overall Study|Adverse Event|13
812700|NCT00110305|1764749|FG000|Overall Study|Sponsors Decision|1
812701|NCT00110305|1764750|FG001|Overall Study|Sponsors Decision|0
812702|NCT00110305|1764749|FG000|Overall Study|Subject Non-Compliant|9
812703|NCT00110305|1764750|FG001|Overall Study|Subject Non-Compliant|2
812704|NCT00110305|1764749|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
812705|NCT00110305|1764750|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
812706|NCT00110305|1764749|FG000|Overall Study|Subject Reached A Virologic Endpoint|21
812707|NCT00110305|1764750|FG001|Overall Study|Subject Reached A Virologic Endpoint|3
812708|NCT00110305|1764749|FG000|Overall Study|Protocol Violation|0
812709|NCT00110305|1764750|FG001|Overall Study|Protocol Violation|1
812710|NCT00110305|1764749|FG000|Overall Study|Withdrawal by Subject|7
812711|NCT00110305|1764750|FG001|Overall Study|Withdrawal by Subject|7
812712|NCT00110305|1764749|FG000|Overall Study|Lost to Follow-up|20
812713|NCT00110305|1764750|FG001|Overall Study|Lost to Follow-up|3
812714|NCT00110305|1764749|FG000|Overall Study|Other|8
812715|NCT00110305|1764750|FG001|Overall Study|Other|2
812716|NCT00110357|1764769|FG000|Overall Study|Deterioration without progression|2
812717|NCT00110357|1764770|FG001|Overall Study|Deterioration without progression|0
812718|NCT00110357|1764769|FG000|Overall Study|Disease progression/relapse|20
812719|NCT00110357|1764770|FG001|Overall Study|Disease progression/relapse|15
812720|NCT00110357|1764769|FG000|Overall Study|Study Closure|1
812721|NCT00110357|1764770|FG001|Overall Study|Study Closure|0
812722|NCT00110357|1764769|FG000|Overall Study|Study Drug Toxicity|1
812723|NCT00110357|1764770|FG001|Overall Study|Study Drug Toxicity|3
812724|NCT00110357|1764769|FG000|Overall Study|Withdrawal by Subject|3
812725|NCT00110357|1764770|FG001|Overall Study|Withdrawal by Subject|1
812726|NCT00110396|1764803|FG000|Overall Study|Adverse Event|15
812727|NCT00110396|1764803|FG000|Overall Study|Lost to Follow-up|1
812728|NCT00110396|1764803|FG000|Overall Study|Administration of plasmapheresis|1
812729|NCT00110396|1764803|FG000|Overall Study|Initiated mitoxantrone therapy|1
812730|NCT00110396|1764803|FG000|Overall Study|Lack of Efficacy|1
812731|NCT00110396|1764803|FG000|Overall Study|Decided not to continue treatment|1
812732|NCT00110396|1764803|FG000|Overall Study|Patient non-compliance|1
812733|NCT00110396|1764803|FG000|Overall Study|Patient refused to continue|1
812734|NCT00110396|1764803|FG000|Overall Study|Patient refused to participate|1
812735|NCT00110396|1764803|FG000|Overall Study|Patient will|1
812736|NCT00110396|1764803|FG000|Overall Study|Patient's decision|1
812737|NCT00110396|1764803|FG000|Overall Study|Participation in MS vaccine study|1
812738|NCT00110396|1764803|FG000|Overall Study|Pregnancy|1
812739|NCT00110396|1764803|FG000|Overall Study|Pregnancy (Protocol violation)|2
812740|NCT00110396|1764803|FG000|Overall Study|Protocol Violation|2
812741|NCT00110396|1764803|FG000|Overall Study|Patient refused to come back|1
812742|NCT00110396|1764803|FG000|Overall Study|The patient has refused|2
812743|NCT00110396|1764803|FG000|Overall Study|The patient has refused to visit site|1
812744|NCT00110396|1764803|FG000|Overall Study|Patient is to be administered copaxone|1
812745|NCT00110617|1764826|FG000|Overall Study|Adverse Event|2
812746|NCT00110617|1764827|FG001|Overall Study|Adverse Event|4
812747|NCT00110617|1764826|FG000|Overall Study|Abnormal Laboratory Value|4
812748|NCT00110617|1764827|FG001|Overall Study|Abnormal Laboratory Value|2
812749|NCT00110617|1764826|FG000|Overall Study|Lack of Efficacy|1
812750|NCT00110617|1764827|FG001|Overall Study|Lack of Efficacy|0
812751|NCT00110617|1764826|FG000|Overall Study|Patient no longer requires study drug|1
812752|NCT00110617|1764827|FG001|Overall Study|Patient no longer requires study drug|0
812753|NCT00110617|1764826|FG000|Overall Study|Protocol Violation|5
812754|NCT00110617|1764827|FG001|Overall Study|Protocol Violation|0
812755|NCT00110617|1764826|FG000|Overall Study|Withdrawal by Subject|10
812756|NCT00110617|1764827|FG001|Overall Study|Withdrawal by Subject|4
812757|NCT00110617|1764826|FG000|Overall Study|Lost to Follow-up|9
812758|NCT00110617|1764827|FG001|Overall Study|Lost to Follow-up|1
812759|NCT00110617|1764826|FG000|Overall Study|Administrative problems|6
812760|NCT00110617|1764827|FG001|Overall Study|Administrative problems|5
812761|NCT00110617|1764826|FG000|Overall Study|Death|1
812762|NCT00110617|1764827|FG001|Overall Study|Death|1
812763|NCT00110617|1764826|FG000|Overall Study|Did not receive study drug|0
812764|NCT00110617|1764827|FG001|Overall Study|Did not receive study drug|12
812765|NCT00110812|1764838|FG000|Main Study|Death|0
812766|NCT00110812|1764839|FG001|Main Study|Death|0
812767|NCT00110812|1764840|FG002|Main Study|Death|2
812768|NCT00110812|1764838|FG000|Main Study|Withdrawal by Subject|0
812769|NCT00110812|1764839|FG001|Main Study|Withdrawal by Subject|0
812770|NCT00110812|1764840|FG002|Main Study|Withdrawal by Subject|1
812771|NCT00110812|1764838|FG000|Main Study|Lost to Follow-up|8
812772|NCT00110812|1764839|FG001|Main Study|Lost to Follow-up|11
812773|NCT00110812|1764840|FG002|Main Study|Lost to Follow-up|10
812774|NCT00110812|1764838|FG000|Extended Follow-up|Death|1
812775|NCT00110812|1764839|FG001|Extended Follow-up|Death|0
812776|NCT00110812|1764840|FG002|Extended Follow-up|Death|3
812777|NCT00110812|1764838|FG000|Extended Follow-up|Withdrawal by Subject|0
812778|NCT00110812|1764839|FG001|Extended Follow-up|Withdrawal by Subject|1
812779|NCT00110812|1764840|FG002|Extended Follow-up|Withdrawal by Subject|0
812780|NCT00110812|1764838|FG000|Extended Follow-up|Lost to Follow-up|1
812781|NCT00110812|1764839|FG001|Extended Follow-up|Lost to Follow-up|3
812782|NCT00110812|1764840|FG002|Extended Follow-up|Lost to Follow-up|1
812783|NCT00110890|1764855|FG000|Overall Study|Adverse Event|30
812784|NCT00110890|1764856|FG001|Overall Study|Adverse Event|7
812785|NCT00110890|1764855|FG000|Overall Study|Death|16
812786|NCT00110890|1764856|FG001|Overall Study|Death|9
812787|NCT00110890|1764855|FG000|Overall Study|Lost to Follow-up|3
812788|NCT00110890|1764856|FG001|Overall Study|Lost to Follow-up|1
812789|NCT00110890|1764855|FG000|Overall Study|Physician Decision|4
812790|NCT00110890|1764856|FG001|Overall Study|Physician Decision|5
812791|NCT00110890|1764855|FG000|Overall Study|Withdrawal by Subject|17
812792|NCT00110890|1764856|FG001|Overall Study|Withdrawal by Subject|5
812793|NCT00110890|1764855|FG000|Overall Study|Protocol Deviation|1
812794|NCT00110890|1764856|FG001|Overall Study|Protocol Deviation|0
812795|NCT00110890|1764855|FG000|Overall Study|Noncompliance|10
812796|NCT00110890|1764856|FG001|Overall Study|Noncompliance|0
812797|NCT00110890|1764855|FG000|Overall Study|Kidney Transplant|16
812798|NCT00110890|1764856|FG001|Overall Study|Kidney Transplant|12
812799|NCT00110890|1764855|FG000|Overall Study|Invest. Product Commercially Available|217
812800|NCT00110890|1764856|FG001|Overall Study|Invest. Product Commercially Available|110
812801|NCT00110890|1764855|FG000|Overall Study|Other|34
812802|NCT00110890|1764856|FG001|Overall Study|Other|23
812803|NCT00110890|1764855|FG000|Overall Study|Ineligibility determined|3
812804|NCT00110890|1764856|FG001|Overall Study|Ineligibility determined|0
812805|NCT00110890|1764855|FG000|Overall Study|Requirement for alternative therapy|0
812806|NCT00110890|1764856|FG001|Overall Study|Requirement for alternative therapy|1
812807|NCT00110890|1764855|FG000|Overall Study|Disease progression|0
812808|NCT00110890|1764856|FG001|Overall Study|Disease progression|1
812809|NCT00110890|1764855|FG000|Overall Study|Parathyroidectomy|0
812810|NCT00110890|1764856|FG001|Overall Study|Parathyroidectomy|1
812811|NCT00110890|1764855|FG000|Overall Study|Did not enter follow-up phase|10
812812|NCT00110890|1764856|FG001|Overall Study|Did not enter follow-up phase|4
812813|NCT00110994|1764864|FG000|Double-blind (DB) Treatment|Adverse Event|3
812814|NCT00110994|1764865|FG001|Double-blind (DB) Treatment|Adverse Event|0
812815|NCT00110994|1764864|FG000|Double-blind (DB) Treatment|Death|1
812816|NCT00110994|1764865|FG001|Double-blind (DB) Treatment|Death|0
812817|NCT00110994|1764864|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0
812818|NCT00110994|1764865|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2
812819|NCT00110994|1764864|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2
812820|NCT00110994|1764865|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1
812821|NCT00110994|1764864|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
812822|NCT00110994|1764865|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
812823|NCT00110994|1764864|FG000|Double-blind (DB) Treatment|other reasons|2
812824|NCT00110994|1764865|FG001|Double-blind (DB) Treatment|other reasons|3
812825|NCT00110994|1764864|FG000|Active Follow-up|Disease progression/recurrence/replace|1
812826|NCT00110994|1764865|FG001|Active Follow-up|Disease progression/recurrence/replace|0
812827|NCT00110994|1764864|FG000|Active Follow-up|Other reasons|0
812828|NCT00110994|1764865|FG001|Active Follow-up|Other reasons|2
812829|NCT00110994|1764864|FG000|Long Term Follow-up|Death|19
812830|NCT00110994|1764865|FG001|Long Term Follow-up|Death|17
812831|NCT00111007|1764873|FG000|Double-blind (DB) Treatment|Adverse Event|12
812832|NCT00111007|1764874|FG001|Double-blind (DB) Treatment|Adverse Event|4
812833|NCT00111007|1764873|FG000|Double-blind (DB) Treatment|Death|5
812834|NCT00111007|1764874|FG001|Double-blind (DB) Treatment|Death|2
812835|NCT00111007|1764873|FG000|Double-blind (DB) Treatment|Protocol Violation|0
812836|NCT00111007|1764874|FG001|Double-blind (DB) Treatment|Protocol Violation|1
812837|NCT00111007|1764873|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6
812838|NCT00111007|1764874|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8
812839|NCT00111007|1764873|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
812840|NCT00111007|1764874|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
812841|NCT00111007|1764873|FG000|Double-blind (DB) Treatment|Relapse|1
812842|NCT00111007|1764874|FG001|Double-blind (DB) Treatment|Relapse|0
812843|NCT00111007|1764873|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0
812844|NCT00111007|1764874|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2
812845|NCT00111007|1764873|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
812846|NCT00111007|1764874|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
812847|NCT00111007|1764873|FG000|Double-blind (DB) Treatment|Primary reason with other category|0
812848|NCT00111007|1764874|FG001|Double-blind (DB) Treatment|Primary reason with other category|1
812849|NCT00111007|1764873|FG000|Active Follow-up|Adverse Event|1
812850|NCT00111007|1764874|FG001|Active Follow-up|Adverse Event|0
812851|NCT00111007|1764873|FG000|Active Follow-up|Death|2
812852|NCT00111007|1764874|FG001|Active Follow-up|Death|0
812853|NCT00111007|1764873|FG000|Active Follow-up|Disease progression/recurrence/relapse|3
812854|NCT00111007|1764874|FG001|Active Follow-up|Disease progression/recurrence/relapse|2
812855|NCT00111007|1764873|FG000|Long Term Follow-up|Death|34
812856|NCT00111007|1764874|FG001|Long Term Follow-up|Death|39
812857|NCT00111007|1764873|FG000|Long Term Follow-up|Lost to Follow-up|1
812858|NCT00111007|1764874|FG001|Long Term Follow-up|Lost to Follow-up|1
812859|NCT00111007|1764873|FG000|Long Term Follow-up|Withdrawal by Subject|0
812860|NCT00111007|1764874|FG001|Long Term Follow-up|Withdrawal by Subject|1
812861|NCT00111007|1764873|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2
812862|NCT00111007|1764874|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1
812863|NCT00111007|1764873|FG000|Long Term Follow-up|Missing|10
812864|NCT00111007|1764874|FG001|Long Term Follow-up|Missing|3
812865|NCT00111228|1764883|FG000|Overall Study|Withdrawal by Subject|5
812866|NCT00111228|1764884|FG001|Overall Study|Withdrawal by Subject|1
812867|NCT00111228|1764885|FG002|Overall Study|Withdrawal by Subject|0
812868|NCT00111241|1764895|FG000|Overall Study|Lost to Follow-up|1
812869|NCT00111241|1764896|FG001|Overall Study|Lost to Follow-up|0
812870|NCT00111241|1764895|FG000|Overall Study|Withdrawal by Subject|4
812871|NCT00111241|1764896|FG001|Overall Study|Withdrawal by Subject|0
812872|NCT00111241|1764895|FG000|Overall Study|Protocol Violation|9
812873|NCT00111241|1764896|FG001|Overall Study|Protocol Violation|8
812874|NCT00111241|1764895|FG000|Overall Study|Adverse Event|1
812875|NCT00111241|1764896|FG001|Overall Study|Adverse Event|0
812876|NCT00111475|1764914|FG000|Overall Study|Lost to Follow-up|0
812877|NCT00111475|1764915|FG001|Overall Study|Lost to Follow-up|0
812878|NCT00111475|1764916|FG002|Overall Study|Lost to Follow-up|0
812879|NCT00111475|1764917|FG003|Overall Study|Lost to Follow-up|0
812880|NCT00111475|1764918|FG004|Overall Study|Lost to Follow-up|0
812881|NCT00111475|1764919|FG005|Overall Study|Lost to Follow-up|1
812882|NCT00111475|1764920|FG006|Overall Study|Lost to Follow-up|0
812883|NCT00111475|1764921|FG007|Overall Study|Lost to Follow-up|0
812884|NCT00111475|1764922|FG008|Overall Study|Lost to Follow-up|0
812885|NCT00111475|1764923|FG009|Overall Study|Lost to Follow-up|0
812886|NCT00111761|1764958|FG000|Part 1|Physician Decision|0
812887|NCT00111761|1764959|FG001|Part 1|Physician Decision|1
812888|NCT00111761|1764958|FG000|Part 1|Death|0
812889|NCT00111761|1764959|FG001|Part 1|Death|2
812890|NCT00111761|1764958|FG000|Part 1|Other|0
812891|NCT00111761|1764959|FG001|Part 1|Other|1
812892|NCT00111761|1764958|FG000|Part 1|Withdrawal by Subject|0
812893|NCT00111761|1764959|FG001|Part 1|Withdrawal by Subject|1
812894|NCT00111761|1764958|FG000|Part 2|Adverse Event|1
812895|NCT00111761|1764959|FG001|Part 2|Adverse Event|0
812896|NCT00111761|1764958|FG000|Part 2|Physician Decision|1
812897|NCT00111761|1764959|FG001|Part 2|Physician Decision|0
812898|NCT00111761|1764958|FG000|Part 2|Death|1
812899|NCT00111761|1764959|FG001|Part 2|Death|0
812900|NCT00111761|1764958|FG000|Part 2|Disease progression|3
812901|NCT00111761|1764959|FG001|Part 2|Disease progression|0
812902|NCT00111761|1764958|FG000|Part 2|Protocol-specified criteria|1
812903|NCT00111761|1764959|FG001|Part 2|Protocol-specified criteria|0
812904|NCT00111761|1764958|FG000|Part 2|Other|1
812905|NCT00111761|1764959|FG001|Part 2|Other|0
812906|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5
812907|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4
812908|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0
812909|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0
812910|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1
812911|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0
812912|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
812913|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
812914|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
812915|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
812916|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
812917|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
812918|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
812919|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
812920|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
812921|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
812922|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
812923|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
812924|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
812925|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
812926|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
812927|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
812928|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
812929|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
812930|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
812931|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
812932|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
812933|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
812934|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
812935|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
812936|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
812937|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
812938|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
812939|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
812940|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
812941|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
812942|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
812943|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
812944|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
812945|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
812946|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
812947|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
812948|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
812949|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
812950|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
812951|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
812952|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
812953|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
812954|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
812955|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
812956|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
812957|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
812958|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
812959|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
812960|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
812961|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
812962|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
812963|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
812964|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
813106|NCT00111839|1765024|FG002|Overall Study|Logistical Constraint|0
812965|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
812966|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
812967|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
812968|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
812969|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
812970|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
812971|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
812972|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
812973|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
812974|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
812975|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
812976|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
812977|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
812978|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
812979|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
812980|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
812981|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
812982|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
812983|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
812984|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
812985|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
812986|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
812987|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
812988|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
812989|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
812990|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
812991|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
812992|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
812993|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
812994|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
812995|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
812996|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
812997|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
812998|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
812999|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
813000|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
813001|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
813002|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
813003|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
813004|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
813005|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
813006|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
813007|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
813008|NCT00111800|1764971|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
813009|NCT00111800|1764972|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
813010|NCT00111800|1764973|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
813011|NCT00111800|1764974|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
813012|NCT00111800|1764975|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
813013|NCT00111800|1764976|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
813014|NCT00111800|1764971|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
813015|NCT00111800|1764972|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
813016|NCT00111800|1764973|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
813017|NCT00111800|1764974|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
813018|NCT00111800|1764975|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
813019|NCT00111800|1764976|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
813020|NCT00111800|1764971|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
813021|NCT00111800|1764972|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
813022|NCT00111800|1764973|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
813023|NCT00111800|1764974|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
813024|NCT00111800|1764975|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
813025|NCT00111800|1764976|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
813026|NCT00111800|1764971|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
813027|NCT00111800|1764972|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
813028|NCT00111800|1764973|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
813029|NCT00111800|1764974|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
813107|NCT00111839|1765022|FG000|Overall Study|Other|6
813030|NCT00111800|1764975|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
813031|NCT00111800|1764976|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
813032|NCT00111800|1764971|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
813033|NCT00111800|1764972|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
813034|NCT00111800|1764973|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
813035|NCT00111800|1764974|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
813036|NCT00111800|1764975|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
813037|NCT00111800|1764976|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
813038|NCT00111800|1764971|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
813039|NCT00111800|1764972|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
813040|NCT00111800|1764973|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
813041|NCT00111800|1764974|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
813042|NCT00111800|1764975|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
813043|NCT00111800|1764976|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
813044|NCT00111800|1764971|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
813045|NCT00111800|1764972|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
813046|NCT00111800|1764973|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
813047|NCT00111800|1764974|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
813048|NCT00111800|1764975|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
813049|NCT00111800|1764976|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
813050|NCT00111800|1764971|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
813051|NCT00111800|1764972|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
813052|NCT00111800|1764973|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
813053|NCT00111800|1764974|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
813054|NCT00111800|1764975|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
813055|NCT00111800|1764976|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
813056|NCT00111800|1764971|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
813057|NCT00111800|1764972|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
813058|NCT00111800|1764973|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
813059|NCT00111800|1764974|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
813060|NCT00111800|1764975|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
813061|NCT00111800|1764976|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
813062|NCT00111813|1764999|FG000|Overall Study|Adverse Event|1
813063|NCT00111813|1765000|FG001|Overall Study|Adverse Event|2
813064|NCT00111813|1765001|FG002|Overall Study|Adverse Event|4
813065|NCT00111813|1765002|FG003|Overall Study|Adverse Event|2
813066|NCT00111813|1765003|FG004|Overall Study|Adverse Event|2
813067|NCT00111813|1765004|FG005|Overall Study|Adverse Event|2
813068|NCT00111813|1764999|FG000|Overall Study|Progressive disease|2
813069|NCT00111813|1765000|FG001|Overall Study|Progressive disease|1
813070|NCT00111813|1765001|FG002|Overall Study|Progressive disease|5
813071|NCT00111813|1765002|FG003|Overall Study|Progressive disease|3
813072|NCT00111813|1765003|FG004|Overall Study|Progressive disease|4
813073|NCT00111813|1765004|FG005|Overall Study|Progressive disease|3
813074|NCT00111813|1764999|FG000|Overall Study|Lack of Efficacy|0
813075|NCT00111813|1765000|FG001|Overall Study|Lack of Efficacy|0
813076|NCT00111813|1765001|FG002|Overall Study|Lack of Efficacy|0
813077|NCT00111813|1765002|FG003|Overall Study|Lack of Efficacy|0
813078|NCT00111813|1765003|FG004|Overall Study|Lack of Efficacy|0
813079|NCT00111813|1765004|FG005|Overall Study|Lack of Efficacy|1
813080|NCT00111813|1764999|FG000|Overall Study|Other|0
813081|NCT00111813|1765000|FG001|Overall Study|Other|0
813082|NCT00111813|1765001|FG002|Overall Study|Other|1
813083|NCT00111813|1765002|FG003|Overall Study|Other|0
813084|NCT00111813|1765003|FG004|Overall Study|Other|0
813085|NCT00111813|1765004|FG005|Overall Study|Other|0
813086|NCT00111839|1765022|FG000|Overall Study|Disease Progression|30
813087|NCT00111839|1765023|FG001|Overall Study|Disease Progression|33
813088|NCT00111839|1765024|FG002|Overall Study|Disease Progression|33
813089|NCT00111839|1765022|FG000|Overall Study|Adverse Event|5
813090|NCT00111839|1765023|FG001|Overall Study|Adverse Event|3
813091|NCT00111839|1765024|FG002|Overall Study|Adverse Event|1
813092|NCT00111839|1765022|FG000|Overall Study|Protocol Violation|2
813093|NCT00111839|1765023|FG001|Overall Study|Protocol Violation|4
813094|NCT00111839|1765024|FG002|Overall Study|Protocol Violation|2
813095|NCT00111839|1765022|FG000|Overall Study|Death|1
813096|NCT00111839|1765023|FG001|Overall Study|Death|1
813097|NCT00111839|1765024|FG002|Overall Study|Death|6
813098|NCT00111839|1765022|FG000|Overall Study|Withdrawal by Subject|2
813099|NCT00111839|1765023|FG001|Overall Study|Withdrawal by Subject|2
813100|NCT00111839|1765024|FG002|Overall Study|Withdrawal by Subject|2
813101|NCT00111839|1765022|FG000|Overall Study|Lost to Follow-up|1
813102|NCT00111839|1765023|FG001|Overall Study|Lost to Follow-up|0
813103|NCT00111839|1765024|FG002|Overall Study|Lost to Follow-up|0
813104|NCT00111839|1765022|FG000|Overall Study|Logistical Constraint|1
813105|NCT00111839|1765023|FG001|Overall Study|Logistical Constraint|0
813108|NCT00111839|1765023|FG001|Overall Study|Other|3
813109|NCT00111839|1765024|FG002|Overall Study|Other|3
813110|NCT00111839|1765022|FG000|Overall Study|Randomized but Not Treated|0
813111|NCT00111839|1765023|FG001|Overall Study|Randomized but Not Treated|0
813112|NCT00111839|1765024|FG002|Overall Study|Randomized but Not Treated|2
813113|NCT00111917|1765034|FG000|Overall Study|Withdrawal by Subject|1
813114|NCT00111917|1765035|FG001|Overall Study|Withdrawal by Subject|1
813115|NCT00112047|1765047|FG000|Randomized Phase|Lost to Follow-up|26
813116|NCT00112047|1765048|FG001|Randomized Phase|Lost to Follow-up|33
813117|NCT00112047|1765047|FG000|Randomized Phase|Adverse Event|10
813118|NCT00112047|1765048|FG001|Randomized Phase|Adverse Event|10
813119|NCT00112047|1765047|FG000|Randomized Phase|Withrawal of consent|10
813120|NCT00112047|1765048|FG001|Randomized Phase|Withrawal of consent|18
813121|NCT00112047|1765047|FG000|Randomized Phase|Sub-optimal virological response|3
813122|NCT00112047|1765048|FG001|Randomized Phase|Sub-optimal virological response|13
813123|NCT00112047|1765047|FG000|Randomized Phase|Noncompliance|8
813124|NCT00112047|1765048|FG001|Randomized Phase|Noncompliance|4
813125|NCT00112047|1765047|FG000|Randomized Phase|Protocol Violation|2
813126|NCT00112047|1765048|FG001|Randomized Phase|Protocol Violation|0
813127|NCT00112047|1765047|FG000|Randomized Phase|Pregnancy|3
813128|NCT00112047|1765048|FG001|Randomized Phase|Pregnancy|1
813129|NCT00112047|1765047|FG000|Randomized Phase|Death|1
813130|NCT00112047|1765048|FG001|Randomized Phase|Death|3
813131|NCT00112047|1765047|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0
813132|NCT00112047|1765048|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1
813133|NCT00112047|1765047|FG000|Randomized Phase|Inability to swallow pills|0
813134|NCT00112047|1765048|FG001|Randomized Phase|Inability to swallow pills|1
813135|NCT00112047|1765047|FG000|Randomized Phase|Incarceration|3
813136|NCT00112047|1765048|FG001|Randomized Phase|Incarceration|2
813137|NCT00112047|1765047|FG000|Randomized Phase|Moved out of State|0
813138|NCT00112047|1765048|FG001|Randomized Phase|Moved out of State|1
813139|NCT00112047|1765047|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4
813140|NCT00112047|1765048|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0
813141|NCT00112047|1765047|FG000|Randomized Phase|High Hepatitis B DNA|0
813142|NCT00112047|1765048|FG001|Randomized Phase|High Hepatitis B DNA|1
813143|NCT00112047|1765047|FG000|Atripla Phase|Adverse Event|2
813144|NCT00112047|1765048|FG001|Atripla Phase|Adverse Event|1
813145|NCT00112047|1765047|FG000|Atripla Phase|Lost to Follow-up|5
813146|NCT00112047|1765048|FG001|Atripla Phase|Lost to Follow-up|7
813147|NCT00112047|1765047|FG000|Atripla Phase|Pregnancy|0
813148|NCT00112047|1765048|FG001|Atripla Phase|Pregnancy|1
813149|NCT00112047|1765047|FG000|Atripla Phase|Death|0
813150|NCT00112047|1765048|FG001|Atripla Phase|Death|2
813151|NCT00112047|1765047|FG000|Atripla Phase|Withdrew consent|7
813152|NCT00112047|1765048|FG001|Atripla Phase|Withdrew consent|7
813153|NCT00112047|1765047|FG000|Atripla Phase|Sub-optimal virological response|0
813154|NCT00112047|1765048|FG001|Atripla Phase|Sub-optimal virological response|1
813155|NCT00112047|1765047|FG000|Atripla Phase|Non-compliance|1
813156|NCT00112047|1765048|FG001|Atripla Phase|Non-compliance|0
813157|NCT00112047|1765047|FG000|Atripla Phase|Other|3
813158|NCT00112047|1765048|FG001|Atripla Phase|Other|1
813159|NCT00112294|1765130|FG000|Overall Study|Still on study|5
813160|NCT00112294|1765131|FG001|Overall Study|Still on study|0
813161|NCT00112359|1765139|FG000|Overall Study|Unrelated adverse event|16
813162|NCT00112359|1765140|FG001|Overall Study|Unrelated adverse event|8
813163|NCT00112359|1765139|FG000|Overall Study|Trial drug intolerance (adverse event)|2
813164|NCT00112359|1765140|FG001|Overall Study|Trial drug intolerance (adverse event)|0
813165|NCT00112359|1765139|FG000|Overall Study|Related adverse event|5
813166|NCT00112359|1765140|FG001|Overall Study|Related adverse event|3
813167|NCT00112359|1765139|FG000|Overall Study|Lost to Follow-up|0
813168|NCT00112359|1765140|FG001|Overall Study|Lost to Follow-up|1
813169|NCT00112359|1765139|FG000|Overall Study|Personal/administrative|1
813170|NCT00112359|1765140|FG001|Overall Study|Personal/administrative|1
813171|NCT00112359|1765139|FG000|Overall Study|Other|3
813172|NCT00112359|1765140|FG001|Overall Study|Other|0
813173|NCT00112385|1765148|FG000|Overall Study|Lost to Follow-up|1
813174|NCT00112385|1765149|FG001|Overall Study|Lost to Follow-up|0
813175|NCT00112385|1765148|FG000|Overall Study|Withdrawal by Subject|0
813176|NCT00112385|1765149|FG001|Overall Study|Withdrawal by Subject|1
813177|NCT00112437|1765160|FG000|Year 1 (12-Month Base Study)|Adverse Event|9
813178|NCT00112437|1765161|FG001|Year 1 (12-Month Base Study)|Adverse Event|10
813179|NCT00112437|1765162|FG002|Year 1 (12-Month Base Study)|Adverse Event|6
813180|NCT00112437|1765163|FG003|Year 1 (12-Month Base Study)|Adverse Event|4
813181|NCT00112437|1765164|FG004|Year 1 (12-Month Base Study)|Adverse Event|3
813182|NCT00112437|1765165|FG005|Year 1 (12-Month Base Study)|Adverse Event|0
813183|NCT00112437|1765166|FG006|Year 1 (12-Month Base Study)|Adverse Event|0
813184|NCT00112437|1765167|FG007|Year 1 (12-Month Base Study)|Adverse Event|0
813185|NCT00112437|1765168|FG008|Year 1 (12-Month Base Study)|Adverse Event|0
813186|NCT00112437|1765169|FG009|Year 1 (12-Month Base Study)|Adverse Event|0
813187|NCT00112437|1765170|FG010|Year 1 (12-Month Base Study)|Adverse Event|0
813188|NCT00112437|1765171|FG011|Year 1 (12-Month Base Study)|Adverse Event|0
813189|NCT00112437|1765172|FG012|Year 1 (12-Month Base Study)|Adverse Event|0
813190|NCT00112437|1765173|FG013|Year 1 (12-Month Base Study)|Adverse Event|0
813191|NCT00112437|1765174|FG014|Year 1 (12-Month Base Study)|Adverse Event|0
813192|NCT00112437|1765175|FG015|Year 1 (12-Month Base Study)|Adverse Event|0
813193|NCT00112437|1765176|FG016|Year 1 (12-Month Base Study)|Adverse Event|0
813194|NCT00112437|1765177|FG017|Year 1 (12-Month Base Study)|Adverse Event|0
813195|NCT00112437|1765178|FG018|Year 1 (12-Month Base Study)|Adverse Event|0
813196|NCT00112437|1765179|FG019|Year 1 (12-Month Base Study)|Adverse Event|0
813197|NCT00112437|1765180|FG020|Year 1 (12-Month Base Study)|Adverse Event|0
813198|NCT00112437|1765181|FG021|Year 1 (12-Month Base Study)|Adverse Event|0
813199|NCT00112437|1765182|FG022|Year 1 (12-Month Base Study)|Adverse Event|0
813200|NCT00112437|1765183|FG023|Year 1 (12-Month Base Study)|Adverse Event|0
813201|NCT00112437|1765184|FG024|Year 1 (12-Month Base Study)|Adverse Event|0
813202|NCT00112437|1765185|FG025|Year 1 (12-Month Base Study)|Adverse Event|0
813203|NCT00112437|1765160|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813204|NCT00112437|1765161|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1
813205|NCT00112437|1765162|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813206|NCT00112437|1765163|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813207|NCT00112437|1765164|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813208|NCT00112437|1765165|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813209|NCT00112437|1765166|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813210|NCT00112437|1765167|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813211|NCT00112437|1765168|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813212|NCT00112437|1765169|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813213|NCT00112437|1765170|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813214|NCT00112437|1765171|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813215|NCT00112437|1765172|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813216|NCT00112437|1765173|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813217|NCT00112437|1765174|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813218|NCT00112437|1765175|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813219|NCT00112437|1765176|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813220|NCT00112437|1765177|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813221|NCT00112437|1765178|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813222|NCT00112437|1765179|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813223|NCT00112437|1765180|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813224|NCT00112437|1765181|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813225|NCT00112437|1765182|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813226|NCT00112437|1765183|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813227|NCT00112437|1765184|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813228|NCT00112437|1765185|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0
813229|NCT00112437|1765160|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813230|NCT00112437|1765161|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1
813231|NCT00112437|1765162|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813232|NCT00112437|1765163|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813233|NCT00112437|1765164|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813234|NCT00112437|1765165|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813235|NCT00112437|1765166|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813236|NCT00112437|1765167|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813237|NCT00112437|1765168|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813238|NCT00112437|1765169|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813239|NCT00112437|1765170|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813240|NCT00112437|1765171|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813241|NCT00112437|1765172|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813242|NCT00112437|1765173|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813243|NCT00112437|1765174|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813244|NCT00112437|1765175|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813245|NCT00112437|1765176|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813246|NCT00112437|1765177|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813247|NCT00112437|1765178|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813248|NCT00112437|1765179|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813249|NCT00112437|1765180|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813250|NCT00112437|1765181|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813251|NCT00112437|1765182|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813252|NCT00112437|1765183|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813253|NCT00112437|1765184|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813254|NCT00112437|1765185|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0
813255|NCT00112437|1765160|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1
813256|NCT00112437|1765161|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0
813257|NCT00112437|1765162|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3
813258|NCT00112437|1765163|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1
813259|NCT00112437|1765164|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1
813260|NCT00112437|1765165|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0
813261|NCT00112437|1765166|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0
813262|NCT00112437|1765167|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0
813263|NCT00112437|1765168|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0
813264|NCT00112437|1765169|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0
813265|NCT00112437|1765170|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0
813266|NCT00112437|1765171|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0
813267|NCT00112437|1765172|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0
813268|NCT00112437|1765173|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0
813269|NCT00112437|1765174|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0
813270|NCT00112437|1765175|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0
813271|NCT00112437|1765176|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0
813272|NCT00112437|1765177|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0
813273|NCT00112437|1765178|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0
813274|NCT00112437|1765179|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0
813275|NCT00112437|1765180|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0
813276|NCT00112437|1765181|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0
813277|NCT00112437|1765182|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0
813278|NCT00112437|1765183|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0
813279|NCT00112437|1765184|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0
813280|NCT00112437|1765185|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0
813281|NCT00112437|1765160|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
813282|NCT00112437|1765161|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
813283|NCT00112437|1765162|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
813284|NCT00112437|1765163|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
813285|NCT00112437|1765164|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
813286|NCT00112437|1765165|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813287|NCT00112437|1765166|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813288|NCT00112437|1765167|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813289|NCT00112437|1765168|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813290|NCT00112437|1765169|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813291|NCT00112437|1765170|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813292|NCT00112437|1765171|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813293|NCT00112437|1765172|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813294|NCT00112437|1765173|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813295|NCT00112437|1765174|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813296|NCT00112437|1765175|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813297|NCT00112437|1765176|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813298|NCT00112437|1765177|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813299|NCT00112437|1765178|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813300|NCT00112437|1765179|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813301|NCT00112437|1765180|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813302|NCT00112437|1765181|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813303|NCT00112437|1765182|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813304|NCT00112437|1765183|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813305|NCT00112437|1765184|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813306|NCT00112437|1765185|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
813307|NCT00112437|1765160|FG000|Year 1 (12-Month Base Study)|moved|0
813308|NCT00112437|1765161|FG001|Year 1 (12-Month Base Study)|moved|1
813309|NCT00112437|1765162|FG002|Year 1 (12-Month Base Study)|moved|1
813310|NCT00112437|1765163|FG003|Year 1 (12-Month Base Study)|moved|0
813311|NCT00112437|1765164|FG004|Year 1 (12-Month Base Study)|moved|0
813312|NCT00112437|1765165|FG005|Year 1 (12-Month Base Study)|moved|0
813313|NCT00112437|1765166|FG006|Year 1 (12-Month Base Study)|moved|0
813314|NCT00112437|1765167|FG007|Year 1 (12-Month Base Study)|moved|0
813315|NCT00112437|1765168|FG008|Year 1 (12-Month Base Study)|moved|0
813316|NCT00112437|1765169|FG009|Year 1 (12-Month Base Study)|moved|0
813317|NCT00112437|1765170|FG010|Year 1 (12-Month Base Study)|moved|0
813318|NCT00112437|1765171|FG011|Year 1 (12-Month Base Study)|moved|0
813319|NCT00112437|1765172|FG012|Year 1 (12-Month Base Study)|moved|0
813320|NCT00112437|1765173|FG013|Year 1 (12-Month Base Study)|moved|0
813321|NCT00112437|1765174|FG014|Year 1 (12-Month Base Study)|moved|0
813322|NCT00112437|1765175|FG015|Year 1 (12-Month Base Study)|moved|0
813323|NCT00112437|1765176|FG016|Year 1 (12-Month Base Study)|moved|0
813324|NCT00112437|1765177|FG017|Year 1 (12-Month Base Study)|moved|0
813325|NCT00112437|1765178|FG018|Year 1 (12-Month Base Study)|moved|0
813326|NCT00112437|1765179|FG019|Year 1 (12-Month Base Study)|moved|0
813327|NCT00112437|1765180|FG020|Year 1 (12-Month Base Study)|moved|0
813328|NCT00112437|1765181|FG021|Year 1 (12-Month Base Study)|moved|0
813329|NCT00112437|1765182|FG022|Year 1 (12-Month Base Study)|moved|0
813330|NCT00112437|1765183|FG023|Year 1 (12-Month Base Study)|moved|0
813331|NCT00112437|1765184|FG024|Year 1 (12-Month Base Study)|moved|0
813332|NCT00112437|1765185|FG025|Year 1 (12-Month Base Study)|moved|0
813333|NCT00112437|1765160|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813334|NCT00112437|1765161|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813335|NCT00112437|1765162|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813336|NCT00112437|1765163|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
813337|NCT00112437|1765164|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813338|NCT00112437|1765165|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813339|NCT00112437|1765166|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813340|NCT00112437|1765167|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813341|NCT00112437|1765168|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813342|NCT00112437|1765169|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813343|NCT00112437|1765170|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813344|NCT00112437|1765171|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813345|NCT00112437|1765172|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813346|NCT00112437|1765173|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813347|NCT00112437|1765174|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813348|NCT00112437|1765175|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813349|NCT00112437|1765176|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813350|NCT00112437|1765177|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813351|NCT00112437|1765178|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813352|NCT00112437|1765179|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813353|NCT00112437|1765180|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813354|NCT00112437|1765181|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813355|NCT00112437|1765182|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813356|NCT00112437|1765183|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813357|NCT00112437|1765184|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813358|NCT00112437|1765185|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
813359|NCT00112437|1765160|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813360|NCT00112437|1765161|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813361|NCT00112437|1765162|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813362|NCT00112437|1765163|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813363|NCT00112437|1765164|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
813364|NCT00112437|1765165|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813365|NCT00112437|1765166|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813366|NCT00112437|1765167|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813367|NCT00112437|1765168|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813368|NCT00112437|1765169|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813369|NCT00112437|1765170|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813370|NCT00112437|1765171|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813371|NCT00112437|1765172|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813372|NCT00112437|1765173|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813373|NCT00112437|1765174|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813374|NCT00112437|1765175|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813375|NCT00112437|1765176|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813376|NCT00112437|1765177|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813377|NCT00112437|1765178|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813378|NCT00112437|1765179|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813379|NCT00112437|1765180|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813380|NCT00112437|1765181|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813381|NCT00112437|1765182|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813382|NCT00112437|1765183|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813383|NCT00112437|1765184|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813384|NCT00112437|1765185|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
813385|NCT00112437|1765160|FG000|Year 2 (12-Month Extension)|Adverse Event|0
813386|NCT00112437|1765161|FG001|Year 2 (12-Month Extension)|Adverse Event|0
813387|NCT00112437|1765162|FG002|Year 2 (12-Month Extension)|Adverse Event|0
813388|NCT00112437|1765163|FG003|Year 2 (12-Month Extension)|Adverse Event|0
813389|NCT00112437|1765164|FG004|Year 2 (12-Month Extension)|Adverse Event|0
813390|NCT00112437|1765165|FG005|Year 2 (12-Month Extension)|Adverse Event|1
813391|NCT00112437|1765166|FG006|Year 2 (12-Month Extension)|Adverse Event|2
813392|NCT00112437|1765167|FG007|Year 2 (12-Month Extension)|Adverse Event|6
813393|NCT00112437|1765168|FG008|Year 2 (12-Month Extension)|Adverse Event|1
813394|NCT00112437|1765169|FG009|Year 2 (12-Month Extension)|Adverse Event|7
813395|NCT00112437|1765170|FG010|Year 2 (12-Month Extension)|Adverse Event|0
813396|NCT00112437|1765171|FG011|Year 2 (12-Month Extension)|Adverse Event|0
813397|NCT00112437|1765172|FG012|Year 2 (12-Month Extension)|Adverse Event|0
813398|NCT00112437|1765173|FG013|Year 2 (12-Month Extension)|Adverse Event|0
813399|NCT00112437|1765174|FG014|Year 2 (12-Month Extension)|Adverse Event|0
813400|NCT00112437|1765175|FG015|Year 2 (12-Month Extension)|Adverse Event|0
813401|NCT00112437|1765176|FG016|Year 2 (12-Month Extension)|Adverse Event|0
813402|NCT00112437|1765177|FG017|Year 2 (12-Month Extension)|Adverse Event|0
813403|NCT00112437|1765178|FG018|Year 2 (12-Month Extension)|Adverse Event|0
813404|NCT00112437|1765179|FG019|Year 2 (12-Month Extension)|Adverse Event|0
813405|NCT00112437|1765180|FG020|Year 2 (12-Month Extension)|Adverse Event|0
813406|NCT00112437|1765181|FG021|Year 2 (12-Month Extension)|Adverse Event|0
813407|NCT00112437|1765182|FG022|Year 2 (12-Month Extension)|Adverse Event|0
813408|NCT00112437|1765183|FG023|Year 2 (12-Month Extension)|Adverse Event|0
813409|NCT00112437|1765184|FG024|Year 2 (12-Month Extension)|Adverse Event|0
813410|NCT00112437|1765185|FG025|Year 2 (12-Month Extension)|Adverse Event|0
813411|NCT00112437|1765160|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0
813412|NCT00112437|1765161|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0
813413|NCT00112437|1765162|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0
813414|NCT00112437|1765163|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0
813415|NCT00112437|1765164|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0
813416|NCT00112437|1765165|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1
813417|NCT00112437|1765166|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6
813418|NCT00112437|1765167|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0
813419|NCT00112437|1765168|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0
813420|NCT00112437|1765169|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2
813421|NCT00112437|1765170|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0
813422|NCT00112437|1765171|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0
813423|NCT00112437|1765172|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0
813424|NCT00112437|1765173|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0
813425|NCT00112437|1765174|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0
813426|NCT00112437|1765175|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0
813427|NCT00112437|1765176|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0
813428|NCT00112437|1765177|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0
813429|NCT00112437|1765178|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0
813430|NCT00112437|1765179|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0
813431|NCT00112437|1765180|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0
813432|NCT00112437|1765181|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0
813433|NCT00112437|1765182|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0
813434|NCT00112437|1765183|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0
813435|NCT00112437|1765184|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0
813436|NCT00112437|1765185|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0
813437|NCT00112437|1765160|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0
813438|NCT00112437|1765161|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0
813439|NCT00112437|1765162|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0
813440|NCT00112437|1765163|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0
813441|NCT00112437|1765164|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0
813442|NCT00112437|1765165|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0
813443|NCT00112437|1765166|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0
813444|NCT00112437|1765167|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0
813445|NCT00112437|1765168|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1
813446|NCT00112437|1765169|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0
813447|NCT00112437|1765170|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0
813448|NCT00112437|1765171|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0
813449|NCT00112437|1765172|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0
813450|NCT00112437|1765173|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0
813451|NCT00112437|1765174|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0
813452|NCT00112437|1765175|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0
813453|NCT00112437|1765176|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0
813454|NCT00112437|1765177|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0
813455|NCT00112437|1765178|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0
813456|NCT00112437|1765179|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0
813457|NCT00112437|1765180|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0
813458|NCT00112437|1765181|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0
813459|NCT00112437|1765182|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0
813460|NCT00112437|1765183|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0
813461|NCT00112437|1765184|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0
813462|NCT00112437|1765185|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0
813463|NCT00112437|1765160|FG000|Year 2 (12-Month Extension)|Protocol Violation|0
813464|NCT00112437|1765161|FG001|Year 2 (12-Month Extension)|Protocol Violation|0
813465|NCT00112437|1765162|FG002|Year 2 (12-Month Extension)|Protocol Violation|0
813466|NCT00112437|1765163|FG003|Year 2 (12-Month Extension)|Protocol Violation|0
813467|NCT00112437|1765164|FG004|Year 2 (12-Month Extension)|Protocol Violation|0
813468|NCT00112437|1765165|FG005|Year 2 (12-Month Extension)|Protocol Violation|0
813469|NCT00112437|1765166|FG006|Year 2 (12-Month Extension)|Protocol Violation|0
813470|NCT00112437|1765167|FG007|Year 2 (12-Month Extension)|Protocol Violation|0
813471|NCT00112437|1765168|FG008|Year 2 (12-Month Extension)|Protocol Violation|1
813472|NCT00112437|1765169|FG009|Year 2 (12-Month Extension)|Protocol Violation|0
813473|NCT00112437|1765170|FG010|Year 2 (12-Month Extension)|Protocol Violation|0
813474|NCT00112437|1765171|FG011|Year 2 (12-Month Extension)|Protocol Violation|0
813475|NCT00112437|1765172|FG012|Year 2 (12-Month Extension)|Protocol Violation|0
813476|NCT00112437|1765173|FG013|Year 2 (12-Month Extension)|Protocol Violation|0
813477|NCT00112437|1765174|FG014|Year 2 (12-Month Extension)|Protocol Violation|0
813478|NCT00112437|1765175|FG015|Year 2 (12-Month Extension)|Protocol Violation|0
813479|NCT00112437|1765176|FG016|Year 2 (12-Month Extension)|Protocol Violation|0
813480|NCT00112437|1765177|FG017|Year 2 (12-Month Extension)|Protocol Violation|0
813481|NCT00112437|1765178|FG018|Year 2 (12-Month Extension)|Protocol Violation|0
813482|NCT00112437|1765179|FG019|Year 2 (12-Month Extension)|Protocol Violation|0
813483|NCT00112437|1765180|FG020|Year 2 (12-Month Extension)|Protocol Violation|0
813484|NCT00112437|1765181|FG021|Year 2 (12-Month Extension)|Protocol Violation|0
813485|NCT00112437|1765182|FG022|Year 2 (12-Month Extension)|Protocol Violation|0
813486|NCT00112437|1765183|FG023|Year 2 (12-Month Extension)|Protocol Violation|0
813487|NCT00112437|1765184|FG024|Year 2 (12-Month Extension)|Protocol Violation|0
813488|NCT00112437|1765185|FG025|Year 2 (12-Month Extension)|Protocol Violation|0
813489|NCT00112437|1765160|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813490|NCT00112437|1765161|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813491|NCT00112437|1765162|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813492|NCT00112437|1765163|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813493|NCT00112437|1765164|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813494|NCT00112437|1765165|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1
813495|NCT00112437|1765166|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1
813496|NCT00112437|1765167|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2
813497|NCT00112437|1765168|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4
813498|NCT00112437|1765169|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1
813499|NCT00112437|1765170|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813500|NCT00112437|1765171|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813501|NCT00112437|1765172|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813502|NCT00112437|1765173|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813503|NCT00112437|1765174|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813504|NCT00112437|1765175|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813505|NCT00112437|1765176|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813506|NCT00112437|1765177|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813507|NCT00112437|1765178|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813508|NCT00112437|1765179|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813509|NCT00112437|1765180|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813510|NCT00112437|1765181|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813511|NCT00112437|1765182|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813512|NCT00112437|1765183|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813513|NCT00112437|1765184|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813514|NCT00112437|1765185|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0
813515|NCT00112437|1765160|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813516|NCT00112437|1765161|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813517|NCT00112437|1765162|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813518|NCT00112437|1765163|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813519|NCT00112437|1765164|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813520|NCT00112437|1765165|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813521|NCT00112437|1765166|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813522|NCT00112437|1765167|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813523|NCT00112437|1765168|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813524|NCT00112437|1765169|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1
813525|NCT00112437|1765170|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813526|NCT00112437|1765171|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813527|NCT00112437|1765172|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813528|NCT00112437|1765173|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813529|NCT00112437|1765174|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813530|NCT00112437|1765175|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813531|NCT00112437|1765176|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813532|NCT00112437|1765177|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813533|NCT00112437|1765178|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813534|NCT00112437|1765179|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813535|NCT00112437|1765180|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813536|NCT00112437|1765181|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813537|NCT00112437|1765182|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813538|NCT00112437|1765183|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813539|NCT00112437|1765184|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813540|NCT00112437|1765185|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0
813541|NCT00112437|1765160|FG000|Year 2 (12-Month Extension)|patient was out of windows|0
813542|NCT00112437|1765161|FG001|Year 2 (12-Month Extension)|patient was out of windows|0
813543|NCT00112437|1765162|FG002|Year 2 (12-Month Extension)|patient was out of windows|0
813544|NCT00112437|1765163|FG003|Year 2 (12-Month Extension)|patient was out of windows|0
813545|NCT00112437|1765164|FG004|Year 2 (12-Month Extension)|patient was out of windows|0
813546|NCT00112437|1765165|FG005|Year 2 (12-Month Extension)|patient was out of windows|0
813547|NCT00112437|1765166|FG006|Year 2 (12-Month Extension)|patient was out of windows|0
813548|NCT00112437|1765167|FG007|Year 2 (12-Month Extension)|patient was out of windows|0
813549|NCT00112437|1765168|FG008|Year 2 (12-Month Extension)|patient was out of windows|0
813550|NCT00112437|1765169|FG009|Year 2 (12-Month Extension)|patient was out of windows|1
813551|NCT00112437|1765170|FG010|Year 2 (12-Month Extension)|patient was out of windows|0
813552|NCT00112437|1765171|FG011|Year 2 (12-Month Extension)|patient was out of windows|0
813553|NCT00112437|1765172|FG012|Year 2 (12-Month Extension)|patient was out of windows|0
813554|NCT00112437|1765173|FG013|Year 2 (12-Month Extension)|patient was out of windows|0
813555|NCT00112437|1765174|FG014|Year 2 (12-Month Extension)|patient was out of windows|0
813556|NCT00112437|1765175|FG015|Year 2 (12-Month Extension)|patient was out of windows|0
813557|NCT00112437|1765176|FG016|Year 2 (12-Month Extension)|patient was out of windows|0
813558|NCT00112437|1765177|FG017|Year 2 (12-Month Extension)|patient was out of windows|0
813559|NCT00112437|1765178|FG018|Year 2 (12-Month Extension)|patient was out of windows|0
813560|NCT00112437|1765179|FG019|Year 2 (12-Month Extension)|patient was out of windows|0
813561|NCT00112437|1765180|FG020|Year 2 (12-Month Extension)|patient was out of windows|0
813562|NCT00112437|1765181|FG021|Year 2 (12-Month Extension)|patient was out of windows|0
813563|NCT00112437|1765182|FG022|Year 2 (12-Month Extension)|patient was out of windows|0
813564|NCT00112437|1765183|FG023|Year 2 (12-Month Extension)|patient was out of windows|0
813565|NCT00112437|1765184|FG024|Year 2 (12-Month Extension)|patient was out of windows|0
813566|NCT00112437|1765185|FG025|Year 2 (12-Month Extension)|patient was out of windows|0
813567|NCT00112437|1765160|FG000|Year 2 (12-Month Extension)|Moved|0
813568|NCT00112437|1765161|FG001|Year 2 (12-Month Extension)|Moved|0
813569|NCT00112437|1765162|FG002|Year 2 (12-Month Extension)|Moved|0
813570|NCT00112437|1765163|FG003|Year 2 (12-Month Extension)|Moved|0
813571|NCT00112437|1765164|FG004|Year 2 (12-Month Extension)|Moved|0
813572|NCT00112437|1765165|FG005|Year 2 (12-Month Extension)|Moved|0
813573|NCT00112437|1765166|FG006|Year 2 (12-Month Extension)|Moved|0
813574|NCT00112437|1765167|FG007|Year 2 (12-Month Extension)|Moved|0
813575|NCT00112437|1765168|FG008|Year 2 (12-Month Extension)|Moved|0
813576|NCT00112437|1765169|FG009|Year 2 (12-Month Extension)|Moved|1
813577|NCT00112437|1765170|FG010|Year 2 (12-Month Extension)|Moved|0
813578|NCT00112437|1765171|FG011|Year 2 (12-Month Extension)|Moved|0
813579|NCT00112437|1765172|FG012|Year 2 (12-Month Extension)|Moved|0
813580|NCT00112437|1765173|FG013|Year 2 (12-Month Extension)|Moved|0
813581|NCT00112437|1765174|FG014|Year 2 (12-Month Extension)|Moved|0
813582|NCT00112437|1765175|FG015|Year 2 (12-Month Extension)|Moved|0
813583|NCT00112437|1765176|FG016|Year 2 (12-Month Extension)|Moved|0
813584|NCT00112437|1765177|FG017|Year 2 (12-Month Extension)|Moved|0
813585|NCT00112437|1765178|FG018|Year 2 (12-Month Extension)|Moved|0
813586|NCT00112437|1765179|FG019|Year 2 (12-Month Extension)|Moved|0
813587|NCT00112437|1765180|FG020|Year 2 (12-Month Extension)|Moved|0
813588|NCT00112437|1765181|FG021|Year 2 (12-Month Extension)|Moved|0
813589|NCT00112437|1765182|FG022|Year 2 (12-Month Extension)|Moved|0
813590|NCT00112437|1765183|FG023|Year 2 (12-Month Extension)|Moved|0
813591|NCT00112437|1765184|FG024|Year 2 (12-Month Extension)|Moved|0
813592|NCT00112437|1765185|FG025|Year 2 (12-Month Extension)|Moved|0
813593|NCT00112437|1765160|FG000|Year 3 (12-Month Extension)|Adverse Event|0
813594|NCT00112437|1765161|FG001|Year 3 (12-Month Extension)|Adverse Event|0
813595|NCT00112437|1765162|FG002|Year 3 (12-Month Extension)|Adverse Event|0
813596|NCT00112437|1765163|FG003|Year 3 (12-Month Extension)|Adverse Event|0
813597|NCT00112437|1765164|FG004|Year 3 (12-Month Extension)|Adverse Event|0
813598|NCT00112437|1765165|FG005|Year 3 (12-Month Extension)|Adverse Event|0
813599|NCT00112437|1765166|FG006|Year 3 (12-Month Extension)|Adverse Event|0
813600|NCT00112437|1765167|FG007|Year 3 (12-Month Extension)|Adverse Event|0
813601|NCT00112437|1765168|FG008|Year 3 (12-Month Extension)|Adverse Event|0
813602|NCT00112437|1765169|FG009|Year 3 (12-Month Extension)|Adverse Event|0
813603|NCT00112437|1765170|FG010|Year 3 (12-Month Extension)|Adverse Event|1
813604|NCT00112437|1765171|FG011|Year 3 (12-Month Extension)|Adverse Event|0
813605|NCT00112437|1765172|FG012|Year 3 (12-Month Extension)|Adverse Event|0
813606|NCT00112437|1765173|FG013|Year 3 (12-Month Extension)|Adverse Event|0
813607|NCT00112437|1765174|FG014|Year 3 (12-Month Extension)|Adverse Event|0
813608|NCT00112437|1765175|FG015|Year 3 (12-Month Extension)|Adverse Event|1
813609|NCT00112437|1765176|FG016|Year 3 (12-Month Extension)|Adverse Event|3
813610|NCT00112437|1765177|FG017|Year 3 (12-Month Extension)|Adverse Event|1
813611|NCT00112437|1765178|FG018|Year 3 (12-Month Extension)|Adverse Event|0
813612|NCT00112437|1765179|FG019|Year 3 (12-Month Extension)|Adverse Event|1
813613|NCT00112437|1765180|FG020|Year 3 (12-Month Extension)|Adverse Event|0
813614|NCT00112437|1765181|FG021|Year 3 (12-Month Extension)|Adverse Event|0
813615|NCT00112437|1765182|FG022|Year 3 (12-Month Extension)|Adverse Event|0
813616|NCT00112437|1765183|FG023|Year 3 (12-Month Extension)|Adverse Event|0
813617|NCT00112437|1765184|FG024|Year 3 (12-Month Extension)|Adverse Event|0
813618|NCT00112437|1765185|FG025|Year 3 (12-Month Extension)|Adverse Event|0
813619|NCT00112437|1765160|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0
813620|NCT00112437|1765161|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0
813621|NCT00112437|1765162|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0
813622|NCT00112437|1765163|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0
813623|NCT00112437|1765164|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0
813624|NCT00112437|1765165|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0
813625|NCT00112437|1765166|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0
813626|NCT00112437|1765167|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0
813627|NCT00112437|1765168|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0
813628|NCT00112437|1765169|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0
813629|NCT00112437|1765170|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0
813630|NCT00112437|1765171|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1
813631|NCT00112437|1765172|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0
813632|NCT00112437|1765173|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1
813633|NCT00112437|1765174|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0
813634|NCT00112437|1765175|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1
813635|NCT00112437|1765176|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0
813636|NCT00112437|1765177|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0
813637|NCT00112437|1765178|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2
813638|NCT00112437|1765179|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0
813639|NCT00112437|1765180|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0
813640|NCT00112437|1765181|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0
813641|NCT00112437|1765182|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0
813642|NCT00112437|1765183|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0
813643|NCT00112437|1765184|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0
813644|NCT00112437|1765185|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0
813645|NCT00112437|1765160|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0
813646|NCT00112437|1765161|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0
813647|NCT00112437|1765162|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0
813648|NCT00112437|1765163|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0
813649|NCT00112437|1765164|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0
813650|NCT00112437|1765165|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0
813651|NCT00112437|1765166|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0
813652|NCT00112437|1765167|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0
813653|NCT00112437|1765168|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0
813654|NCT00112437|1765169|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0
813655|NCT00112437|1765170|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0
813656|NCT00112437|1765171|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0
813657|NCT00112437|1765172|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0
813658|NCT00112437|1765173|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0
813659|NCT00112437|1765174|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0
813660|NCT00112437|1765175|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1
813661|NCT00112437|1765176|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0
813662|NCT00112437|1765177|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0
813663|NCT00112437|1765178|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0
813664|NCT00112437|1765179|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0
813665|NCT00112437|1765180|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0
813666|NCT00112437|1765181|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0
813667|NCT00112437|1765182|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0
813668|NCT00112437|1765183|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0
813669|NCT00112437|1765184|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0
813670|NCT00112437|1765185|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0
813671|NCT00112437|1765160|FG000|Year 3 (12-Month Extension)|Protocol Violation|0
813672|NCT00112437|1765161|FG001|Year 3 (12-Month Extension)|Protocol Violation|0
813673|NCT00112437|1765162|FG002|Year 3 (12-Month Extension)|Protocol Violation|0
813674|NCT00112437|1765163|FG003|Year 3 (12-Month Extension)|Protocol Violation|0
813675|NCT00112437|1765164|FG004|Year 3 (12-Month Extension)|Protocol Violation|0
813676|NCT00112437|1765165|FG005|Year 3 (12-Month Extension)|Protocol Violation|0
813677|NCT00112437|1765166|FG006|Year 3 (12-Month Extension)|Protocol Violation|0
813678|NCT00112437|1765167|FG007|Year 3 (12-Month Extension)|Protocol Violation|0
813679|NCT00112437|1765168|FG008|Year 3 (12-Month Extension)|Protocol Violation|0
813680|NCT00112437|1765169|FG009|Year 3 (12-Month Extension)|Protocol Violation|0
813681|NCT00112437|1765170|FG010|Year 3 (12-Month Extension)|Protocol Violation|0
813682|NCT00112437|1765171|FG011|Year 3 (12-Month Extension)|Protocol Violation|0
813683|NCT00112437|1765172|FG012|Year 3 (12-Month Extension)|Protocol Violation|0
813684|NCT00112437|1765173|FG013|Year 3 (12-Month Extension)|Protocol Violation|0
813685|NCT00112437|1765174|FG014|Year 3 (12-Month Extension)|Protocol Violation|0
813686|NCT00112437|1765175|FG015|Year 3 (12-Month Extension)|Protocol Violation|1
813687|NCT00112437|1765176|FG016|Year 3 (12-Month Extension)|Protocol Violation|0
813688|NCT00112437|1765177|FG017|Year 3 (12-Month Extension)|Protocol Violation|0
813689|NCT00112437|1765178|FG018|Year 3 (12-Month Extension)|Protocol Violation|0
813690|NCT00112437|1765179|FG019|Year 3 (12-Month Extension)|Protocol Violation|0
813691|NCT00112437|1765180|FG020|Year 3 (12-Month Extension)|Protocol Violation|0
813692|NCT00112437|1765181|FG021|Year 3 (12-Month Extension)|Protocol Violation|0
813693|NCT00112437|1765182|FG022|Year 3 (12-Month Extension)|Protocol Violation|0
813694|NCT00112437|1765183|FG023|Year 3 (12-Month Extension)|Protocol Violation|0
813695|NCT00112437|1765184|FG024|Year 3 (12-Month Extension)|Protocol Violation|0
813696|NCT00112437|1765185|FG025|Year 3 (12-Month Extension)|Protocol Violation|0
813697|NCT00112437|1765160|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813698|NCT00112437|1765161|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813699|NCT00112437|1765162|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813700|NCT00112437|1765163|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813701|NCT00112437|1765164|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813702|NCT00112437|1765165|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813703|NCT00112437|1765166|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813704|NCT00112437|1765167|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813705|NCT00112437|1765168|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813706|NCT00112437|1765169|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813707|NCT00112437|1765170|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813708|NCT00112437|1765171|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3
813709|NCT00112437|1765172|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813710|NCT00112437|1765173|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813711|NCT00112437|1765174|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1
813712|NCT00112437|1765175|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813713|NCT00112437|1765176|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813714|NCT00112437|1765177|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813715|NCT00112437|1765178|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813716|NCT00112437|1765179|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813717|NCT00112437|1765180|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813718|NCT00112437|1765181|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813719|NCT00112437|1765182|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813720|NCT00112437|1765183|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813721|NCT00112437|1765184|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813722|NCT00112437|1765185|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0
813723|NCT00112437|1765160|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813724|NCT00112437|1765161|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813725|NCT00112437|1765162|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813726|NCT00112437|1765163|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813727|NCT00112437|1765164|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813728|NCT00112437|1765165|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813729|NCT00112437|1765166|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813730|NCT00112437|1765167|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813731|NCT00112437|1765168|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813732|NCT00112437|1765169|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813733|NCT00112437|1765170|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
813734|NCT00112437|1765171|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
813735|NCT00112437|1765172|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813736|NCT00112437|1765173|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813737|NCT00112437|1765174|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813738|NCT00112437|1765175|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813739|NCT00112437|1765176|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813740|NCT00112437|1765177|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813741|NCT00112437|1765178|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813742|NCT00112437|1765179|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813743|NCT00112437|1765180|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813744|NCT00112437|1765181|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813745|NCT00112437|1765182|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813746|NCT00112437|1765183|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813747|NCT00112437|1765184|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813748|NCT00112437|1765185|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
813749|NCT00112437|1765160|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813750|NCT00112437|1765161|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813751|NCT00112437|1765162|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813752|NCT00112437|1765163|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813753|NCT00112437|1765164|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813754|NCT00112437|1765165|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813755|NCT00112437|1765166|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813756|NCT00112437|1765167|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813757|NCT00112437|1765168|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813758|NCT00112437|1765169|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813759|NCT00112437|1765170|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813760|NCT00112437|1765171|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813761|NCT00112437|1765172|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813762|NCT00112437|1765173|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813763|NCT00112437|1765174|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813764|NCT00112437|1765175|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813765|NCT00112437|1765176|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813766|NCT00112437|1765177|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813767|NCT00112437|1765178|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813768|NCT00112437|1765179|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813769|NCT00112437|1765180|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
813770|NCT00112437|1765181|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
813771|NCT00112437|1765182|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813772|NCT00112437|1765183|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813773|NCT00112437|1765184|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813774|NCT00112437|1765185|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
813775|NCT00112437|1765160|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813776|NCT00112437|1765161|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813777|NCT00112437|1765162|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813778|NCT00112437|1765163|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813779|NCT00112437|1765164|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813780|NCT00112437|1765165|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813781|NCT00112437|1765166|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813782|NCT00112437|1765167|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813783|NCT00112437|1765168|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813784|NCT00112437|1765169|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813785|NCT00112437|1765170|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813786|NCT00112437|1765171|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813787|NCT00112437|1765172|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813788|NCT00112437|1765173|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813789|NCT00112437|1765174|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813790|NCT00112437|1765175|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813791|NCT00112437|1765176|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813792|NCT00112437|1765177|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813793|NCT00112437|1765178|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813794|NCT00112437|1765179|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813795|NCT00112437|1765180|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
813796|NCT00112437|1765181|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813797|NCT00112437|1765182|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813798|NCT00112437|1765183|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813799|NCT00112437|1765184|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813800|NCT00112437|1765185|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
813801|NCT00112437|1765160|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0
813802|NCT00112437|1765161|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0
813803|NCT00112437|1765162|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0
813804|NCT00112437|1765163|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0
813805|NCT00112437|1765164|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0
813806|NCT00112437|1765165|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0
813807|NCT00112437|1765166|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0
813808|NCT00112437|1765167|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0
813809|NCT00112437|1765168|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0
813810|NCT00112437|1765169|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0
813811|NCT00112437|1765170|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0
813812|NCT00112437|1765171|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0
813813|NCT00112437|1765172|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0
813814|NCT00112437|1765173|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0
813815|NCT00112437|1765174|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0
813816|NCT00112437|1765175|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0
813817|NCT00112437|1765176|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0
813818|NCT00112437|1765177|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0
813819|NCT00112437|1765178|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0
813820|NCT00112437|1765179|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0
813821|NCT00112437|1765180|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0
813822|NCT00112437|1765181|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4
813823|NCT00112437|1765182|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0
813824|NCT00112437|1765183|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0
813825|NCT00112437|1765184|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0
813826|NCT00112437|1765185|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0
813827|NCT00112437|1765160|FG000|Years 4-5 (24-Month Extension)|Participant moved|0
813828|NCT00112437|1765161|FG001|Years 4-5 (24-Month Extension)|Participant moved|0
813829|NCT00112437|1765162|FG002|Years 4-5 (24-Month Extension)|Participant moved|0
813830|NCT00112437|1765163|FG003|Years 4-5 (24-Month Extension)|Participant moved|0
813831|NCT00112437|1765164|FG004|Years 4-5 (24-Month Extension)|Participant moved|0
813832|NCT00112437|1765165|FG005|Years 4-5 (24-Month Extension)|Participant moved|0
813833|NCT00112437|1765166|FG006|Years 4-5 (24-Month Extension)|Participant moved|0
813834|NCT00112437|1765167|FG007|Years 4-5 (24-Month Extension)|Participant moved|0
813835|NCT00112437|1765168|FG008|Years 4-5 (24-Month Extension)|Participant moved|0
813836|NCT00112437|1765169|FG009|Years 4-5 (24-Month Extension)|Participant moved|0
813837|NCT00112437|1765170|FG010|Years 4-5 (24-Month Extension)|Participant moved|0
813838|NCT00112437|1765171|FG011|Years 4-5 (24-Month Extension)|Participant moved|0
813839|NCT00112437|1765172|FG012|Years 4-5 (24-Month Extension)|Participant moved|0
813840|NCT00112437|1765173|FG013|Years 4-5 (24-Month Extension)|Participant moved|0
813841|NCT00112437|1765174|FG014|Years 4-5 (24-Month Extension)|Participant moved|0
813842|NCT00112437|1765175|FG015|Years 4-5 (24-Month Extension)|Participant moved|0
813843|NCT00112437|1765176|FG016|Years 4-5 (24-Month Extension)|Participant moved|0
813844|NCT00112437|1765177|FG017|Years 4-5 (24-Month Extension)|Participant moved|0
813845|NCT00112437|1765178|FG018|Years 4-5 (24-Month Extension)|Participant moved|0
813846|NCT00112437|1765179|FG019|Years 4-5 (24-Month Extension)|Participant moved|0
813847|NCT00112437|1765180|FG020|Years 4-5 (24-Month Extension)|Participant moved|0
813848|NCT00112437|1765181|FG021|Years 4-5 (24-Month Extension)|Participant moved|1
813849|NCT00112437|1765182|FG022|Years 4-5 (24-Month Extension)|Participant moved|0
813850|NCT00112437|1765183|FG023|Years 4-5 (24-Month Extension)|Participant moved|0
813851|NCT00112437|1765184|FG024|Years 4-5 (24-Month Extension)|Participant moved|0
813852|NCT00112437|1765185|FG025|Years 4-5 (24-Month Extension)|Participant moved|0
813853|NCT00112437|1765160|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813854|NCT00112437|1765161|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813855|NCT00112437|1765162|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813856|NCT00112437|1765163|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813857|NCT00112437|1765164|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813858|NCT00112437|1765165|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813859|NCT00112437|1765166|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813860|NCT00112437|1765167|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813861|NCT00112437|1765168|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813862|NCT00112437|1765169|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813863|NCT00112437|1765170|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813864|NCT00112437|1765171|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813865|NCT00112437|1765172|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813866|NCT00112437|1765173|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813867|NCT00112437|1765174|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813868|NCT00112437|1765175|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813869|NCT00112437|1765176|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813870|NCT00112437|1765177|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813871|NCT00112437|1765178|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813872|NCT00112437|1765179|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813873|NCT00112437|1765180|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
813874|NCT00112437|1765181|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
813875|NCT00112437|1765182|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813876|NCT00112437|1765183|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813877|NCT00112437|1765184|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813878|NCT00112437|1765185|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
813879|NCT00112437|1765160|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0
813880|NCT00112437|1765161|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0
813881|NCT00112437|1765162|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0
813882|NCT00112437|1765163|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0
813883|NCT00112437|1765164|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0
813884|NCT00112437|1765165|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0
813885|NCT00112437|1765166|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0
813886|NCT00112437|1765167|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0
813887|NCT00112437|1765168|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0
813888|NCT00112437|1765169|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0
813889|NCT00112437|1765170|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0
813890|NCT00112437|1765171|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0
813891|NCT00112437|1765172|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0
813892|NCT00112437|1765173|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0
813893|NCT00112437|1765174|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0
813894|NCT00112437|1765175|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0
813895|NCT00112437|1765176|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0
813896|NCT00112437|1765177|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0
813897|NCT00112437|1765178|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0
813898|NCT00112437|1765179|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0
813899|NCT00112437|1765180|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0
813900|NCT00112437|1765181|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0
813901|NCT00112437|1765182|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1
813902|NCT00112437|1765183|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2
813903|NCT00112437|1765184|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0
813904|NCT00112437|1765185|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1
813905|NCT00112437|1765160|FG000|Years 6-10 (60-Month Extension)|Death|0
813906|NCT00112437|1765161|FG001|Years 6-10 (60-Month Extension)|Death|0
813907|NCT00112437|1765162|FG002|Years 6-10 (60-Month Extension)|Death|0
813908|NCT00112437|1765163|FG003|Years 6-10 (60-Month Extension)|Death|0
813909|NCT00112437|1765164|FG004|Years 6-10 (60-Month Extension)|Death|0
813910|NCT00112437|1765165|FG005|Years 6-10 (60-Month Extension)|Death|0
813911|NCT00112437|1765166|FG006|Years 6-10 (60-Month Extension)|Death|0
813912|NCT00112437|1765167|FG007|Years 6-10 (60-Month Extension)|Death|0
813913|NCT00112437|1765168|FG008|Years 6-10 (60-Month Extension)|Death|0
813914|NCT00112437|1765169|FG009|Years 6-10 (60-Month Extension)|Death|0
813915|NCT00112437|1765170|FG010|Years 6-10 (60-Month Extension)|Death|0
813916|NCT00112437|1765171|FG011|Years 6-10 (60-Month Extension)|Death|0
813917|NCT00112437|1765172|FG012|Years 6-10 (60-Month Extension)|Death|0
813918|NCT00112437|1765173|FG013|Years 6-10 (60-Month Extension)|Death|0
813919|NCT00112437|1765174|FG014|Years 6-10 (60-Month Extension)|Death|0
813920|NCT00112437|1765175|FG015|Years 6-10 (60-Month Extension)|Death|0
813921|NCT00112437|1765176|FG016|Years 6-10 (60-Month Extension)|Death|0
813922|NCT00112437|1765177|FG017|Years 6-10 (60-Month Extension)|Death|0
813923|NCT00112437|1765178|FG018|Years 6-10 (60-Month Extension)|Death|0
813924|NCT00112437|1765179|FG019|Years 6-10 (60-Month Extension)|Death|0
813925|NCT00112437|1765180|FG020|Years 6-10 (60-Month Extension)|Death|0
813926|NCT00112437|1765181|FG021|Years 6-10 (60-Month Extension)|Death|0
813927|NCT00112437|1765182|FG022|Years 6-10 (60-Month Extension)|Death|0
813928|NCT00112437|1765183|FG023|Years 6-10 (60-Month Extension)|Death|2
813929|NCT00112437|1765184|FG024|Years 6-10 (60-Month Extension)|Death|0
813930|NCT00112437|1765185|FG025|Years 6-10 (60-Month Extension)|Death|0
813931|NCT00112437|1765160|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813932|NCT00112437|1765161|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813933|NCT00112437|1765162|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813934|NCT00112437|1765163|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813935|NCT00112437|1765164|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813936|NCT00112437|1765165|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813937|NCT00112437|1765166|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813938|NCT00112437|1765167|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813939|NCT00112437|1765168|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813940|NCT00112437|1765169|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813941|NCT00112437|1765170|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813942|NCT00112437|1765171|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813943|NCT00112437|1765172|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813944|NCT00112437|1765173|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813945|NCT00112437|1765174|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813946|NCT00112437|1765175|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813947|NCT00112437|1765176|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813948|NCT00112437|1765177|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813949|NCT00112437|1765178|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813950|NCT00112437|1765179|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813951|NCT00112437|1765180|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813952|NCT00112437|1765181|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813953|NCT00112437|1765182|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813954|NCT00112437|1765183|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813955|NCT00112437|1765184|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
813956|NCT00112437|1765185|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
813957|NCT00112437|1765160|FG000|Years 6-10 (60-Month Extension)|Other|0
813958|NCT00112437|1765161|FG001|Years 6-10 (60-Month Extension)|Other|0
813959|NCT00112437|1765162|FG002|Years 6-10 (60-Month Extension)|Other|0
813960|NCT00112437|1765163|FG003|Years 6-10 (60-Month Extension)|Other|0
813961|NCT00112437|1765164|FG004|Years 6-10 (60-Month Extension)|Other|0
813962|NCT00112437|1765165|FG005|Years 6-10 (60-Month Extension)|Other|0
813963|NCT00112437|1765166|FG006|Years 6-10 (60-Month Extension)|Other|0
813964|NCT00112437|1765167|FG007|Years 6-10 (60-Month Extension)|Other|0
813965|NCT00112437|1765168|FG008|Years 6-10 (60-Month Extension)|Other|0
813966|NCT00112437|1765169|FG009|Years 6-10 (60-Month Extension)|Other|0
813967|NCT00112437|1765170|FG010|Years 6-10 (60-Month Extension)|Other|0
813968|NCT00112437|1765171|FG011|Years 6-10 (60-Month Extension)|Other|0
813969|NCT00112437|1765172|FG012|Years 6-10 (60-Month Extension)|Other|0
813970|NCT00112437|1765173|FG013|Years 6-10 (60-Month Extension)|Other|0
813971|NCT00112437|1765174|FG014|Years 6-10 (60-Month Extension)|Other|0
813972|NCT00112437|1765175|FG015|Years 6-10 (60-Month Extension)|Other|0
813973|NCT00112437|1765176|FG016|Years 6-10 (60-Month Extension)|Other|0
813974|NCT00112437|1765177|FG017|Years 6-10 (60-Month Extension)|Other|0
813975|NCT00112437|1765178|FG018|Years 6-10 (60-Month Extension)|Other|0
813976|NCT00112437|1765179|FG019|Years 6-10 (60-Month Extension)|Other|0
813977|NCT00112437|1765180|FG020|Years 6-10 (60-Month Extension)|Other|0
813978|NCT00112437|1765181|FG021|Years 6-10 (60-Month Extension)|Other|0
813979|NCT00112437|1765182|FG022|Years 6-10 (60-Month Extension)|Other|0
813980|NCT00112437|1765183|FG023|Years 6-10 (60-Month Extension)|Other|0
813981|NCT00112437|1765184|FG024|Years 6-10 (60-Month Extension)|Other|1
813982|NCT00112437|1765185|FG025|Years 6-10 (60-Month Extension)|Other|0
813983|NCT00112437|1765160|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0
813984|NCT00112437|1765161|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0
813985|NCT00112437|1765162|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0
813986|NCT00112437|1765163|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0
813987|NCT00112437|1765164|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0
813988|NCT00112437|1765165|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0
813989|NCT00112437|1765166|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0
813990|NCT00112437|1765167|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0
813991|NCT00112437|1765168|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0
813992|NCT00112437|1765169|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0
813993|NCT00112437|1765170|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0
813994|NCT00112437|1765171|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0
813995|NCT00112437|1765172|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0
813996|NCT00112437|1765173|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0
813997|NCT00112437|1765174|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0
813998|NCT00112437|1765175|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0
813999|NCT00112437|1765176|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0
814000|NCT00112437|1765177|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0
814001|NCT00112437|1765178|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0
814002|NCT00112437|1765179|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0
814003|NCT00112437|1765180|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0
814004|NCT00112437|1765181|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0
814005|NCT00112437|1765182|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0
814006|NCT00112437|1765183|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2
814007|NCT00112437|1765184|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0
814008|NCT00112437|1765185|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0
814009|NCT00112437|1765160|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814010|NCT00112437|1765161|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814011|NCT00112437|1765162|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814012|NCT00112437|1765163|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814013|NCT00112437|1765164|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814014|NCT00112437|1765165|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814015|NCT00112437|1765166|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814016|NCT00112437|1765167|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814017|NCT00112437|1765168|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814018|NCT00112437|1765169|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814019|NCT00112437|1765170|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814020|NCT00112437|1765171|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814021|NCT00112437|1765172|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814022|NCT00112437|1765173|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814023|NCT00112437|1765174|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814024|NCT00112437|1765175|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814025|NCT00112437|1765176|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814026|NCT00112437|1765177|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814027|NCT00112437|1765178|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814028|NCT00112437|1765179|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814029|NCT00112437|1765180|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814030|NCT00112437|1765181|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814031|NCT00112437|1765182|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
814032|NCT00112437|1765183|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
814033|NCT00112437|1765184|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
814034|NCT00112437|1765185|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
814035|NCT00112463|1765239|FG000|Overall Study|Physician Decision|1
814036|NCT00112463|1765239|FG000|Overall Study|Progression|30
814037|NCT00112463|1765239|FG000|Overall Study|Second Primary|1
814038|NCT00112463|1765239|FG000|Overall Study|Toxicity|3
814039|NCT00112463|1765239|FG000|Overall Study|Withdrawal by Subject|2
814040|NCT00112463|1765239|FG000|Overall Study|Never started treatment|2
814041|NCT00112489|1765244|FG000|Overall Study|Refused further treatment|8
814042|NCT00112489|1765244|FG000|Overall Study|Adverse Event|12
814043|NCT00112489|1765244|FG000|Overall Study|Death|2
814044|NCT00112489|1765244|FG000|Overall Study|Other, Not Specified|9
814045|NCT00112489|1765244|FG000|Overall Study|Patient never treated|2
814046|NCT00112489|1765244|FG000|Overall Study|Ineligible|7
814047|NCT00112502|1765262|FG000|Overall Study|Withdrawal by Subject|0
814048|NCT00112502|1765263|FG001|Overall Study|Withdrawal by Subject|1
814049|NCT00112502|1765264|FG002|Overall Study|Withdrawal by Subject|1
814050|NCT00112502|1765265|FG003|Overall Study|Withdrawal by Subject|4
814051|NCT00112502|1765266|FG004|Overall Study|Withdrawal by Subject|2
814052|NCT00112502|1765267|FG005|Overall Study|Withdrawal by Subject|5
814053|NCT00112502|1765268|FG006|Overall Study|Withdrawal by Subject|3
814054|NCT00112502|1765269|FG007|Overall Study|Withdrawal by Subject|7
814055|NCT00112580|1765299|FG000|Overall Study|Adverse Event|1
814056|NCT00112580|1765300|FG001|Overall Study|Adverse Event|2
814057|NCT00112580|1765299|FG000|Overall Study|Disease progression|5
814058|NCT00112580|1765300|FG001|Overall Study|Disease progression|16
814059|NCT00112580|1765299|FG000|Overall Study|Participant withdrew consent|2
814060|NCT00112580|1765300|FG001|Overall Study|Participant withdrew consent|1
814061|NCT00112736|1765339|FG000|Overall Study|1 pt never had had RX due rapid decline|1
814062|NCT00112736|1765340|FG001|Overall Study|1 pt never had had RX due rapid decline|0
814072|NCT00112866|1765394|FG000|Overall Study|Protocol Violation|1
814073|NCT00112866|1765395|FG001|Overall Study|Protocol Violation|0
814074|NCT00112866|1765394|FG000|Overall Study|did not start treatment post-op|1
814075|NCT00112866|1765395|FG001|Overall Study|did not start treatment post-op|2
814076|NCT00112905|1765409|FG000|Overall Study|Adverse Event|4
814077|NCT00112905|1765409|FG000|Overall Study|Death|1
814078|NCT00112905|1765409|FG000|Overall Study|Ineligibility|5
814079|NCT00112905|1765409|FG000|Overall Study|Alternative treatment|1
814080|NCT00112905|1765409|FG000|Overall Study|performance status was deteiorating|1
814081|NCT00112957|1765426|FG000|Overall Study|Progressive disease|18
814082|NCT00112957|1765426|FG000|Overall Study|Physician Decision|1
814083|NCT00113087|1765441|FG000|Overall Study|Death or Transplant|14
814084|NCT00113087|1765442|FG001|Overall Study|Death or Transplant|16
814085|NCT00113087|1765441|FG000|Overall Study|Family or MD withdrew subject|10
814086|NCT00113087|1765442|FG001|Overall Study|Family or MD withdrew subject|5
814087|NCT00113269|1765460|FG000|Overall Study|Not transplanted, donor issues|4
814088|NCT00113269|1765461|FG001|Overall Study|Not transplanted, donor issues|0
814089|NCT00113269|1765462|FG002|Overall Study|Not transplanted, donor issues|2
814090|NCT00113269|1765463|FG003|Overall Study|Not transplanted, donor issues|2
814091|NCT00113269|1765460|FG000|Overall Study|Not transplanted, recipient issues|2
814092|NCT00113269|1765461|FG001|Overall Study|Not transplanted, recipient issues|1
814093|NCT00113269|1765462|FG002|Overall Study|Not transplanted, recipient issues|7
814094|NCT00113269|1765463|FG003|Overall Study|Not transplanted, recipient issues|4
814095|NCT00113269|1765460|FG000|Overall Study|Early graft loss, technical|0
814096|NCT00113269|1765461|FG001|Overall Study|Early graft loss, technical|0
814097|NCT00113269|1765462|FG002|Overall Study|Early graft loss, technical|2
814098|NCT00113269|1765463|FG003|Overall Study|Early graft loss, technical|0
814099|NCT00113269|1765460|FG000|Overall Study|Death in operating room|0
814100|NCT00113269|1765461|FG001|Overall Study|Death in operating room|0
814101|NCT00113269|1765462|FG002|Overall Study|Death in operating room|0
814102|NCT00113269|1765463|FG003|Overall Study|Death in operating room|1
814103|NCT00113269|1765460|FG000|Overall Study|Did not meet eligibility - pre-treatment|0
814104|NCT00113269|1765461|FG001|Overall Study|Did not meet eligibility - pre-treatment|0
814105|NCT00113269|1765462|FG002|Overall Study|Did not meet eligibility - pre-treatment|0
814106|NCT00113269|1765463|FG003|Overall Study|Did not meet eligibility - pre-treatment|2
814107|NCT00113269|1765460|FG000|Overall Study|Adverse Event|2
814108|NCT00113269|1765461|FG001|Overall Study|Adverse Event|7
814109|NCT00113269|1765462|FG002|Overall Study|Adverse Event|11
814110|NCT00113269|1765463|FG003|Overall Study|Adverse Event|7
814111|NCT00113269|1765460|FG000|Overall Study|Withdrawal by Subject|4
814112|NCT00113269|1765461|FG001|Overall Study|Withdrawal by Subject|3
814113|NCT00113269|1765462|FG002|Overall Study|Withdrawal by Subject|4
814114|NCT00113269|1765463|FG003|Overall Study|Withdrawal by Subject|2
814115|NCT00113269|1765460|FG000|Overall Study|Graft loss|6
814116|NCT00113269|1765461|FG001|Overall Study|Graft loss|6
814117|NCT00113269|1765462|FG002|Overall Study|Graft loss|4
814118|NCT00113269|1765463|FG003|Overall Study|Graft loss|9
814119|NCT00113269|1765460|FG000|Overall Study|Protocol Violation|1
814120|NCT00113269|1765461|FG001|Overall Study|Protocol Violation|0
814121|NCT00113269|1765462|FG002|Overall Study|Protocol Violation|4
814122|NCT00113269|1765463|FG003|Overall Study|Protocol Violation|2
814123|NCT00113269|1765460|FG000|Overall Study|Lost to Follow-up|2
814124|NCT00113269|1765461|FG001|Overall Study|Lost to Follow-up|3
814125|NCT00113269|1765462|FG002|Overall Study|Lost to Follow-up|6
814126|NCT00113269|1765463|FG003|Overall Study|Lost to Follow-up|3
814127|NCT00113269|1765460|FG000|Overall Study|Sponsor elected to discontinue patient|1
814128|NCT00113269|1765461|FG001|Overall Study|Sponsor elected to discontinue patient|0
814129|NCT00113269|1765462|FG002|Overall Study|Sponsor elected to discontinue patient|0
814130|NCT00113269|1765463|FG003|Overall Study|Sponsor elected to discontinue patient|1
814131|NCT00113269|1765460|FG000|Overall Study|Discontinued due to rejection|0
814132|NCT00113269|1765461|FG001|Overall Study|Discontinued due to rejection|0
814133|NCT00113269|1765462|FG002|Overall Study|Discontinued due to rejection|1
814134|NCT00113269|1765463|FG003|Overall Study|Discontinued due to rejection|0
814135|NCT00113269|1765460|FG000|Overall Study|Moved|0
814136|NCT00113269|1765461|FG001|Overall Study|Moved|1
814137|NCT00113269|1765462|FG002|Overall Study|Moved|0
814138|NCT00113269|1765463|FG003|Overall Study|Moved|3
814139|NCT00113269|1765460|FG000|Overall Study|Received pancreas transplant|0
814140|NCT00113269|1765461|FG001|Overall Study|Received pancreas transplant|0
814141|NCT00113269|1765462|FG002|Overall Study|Received pancreas transplant|0
814142|NCT00113269|1765463|FG003|Overall Study|Received pancreas transplant|2
814143|NCT00113269|1765460|FG000|Overall Study|Withdrew consent, Prednisone initiated|0
814144|NCT00113269|1765461|FG001|Overall Study|Withdrew consent, Prednisone initiated|0
814145|NCT00113269|1765462|FG002|Overall Study|Withdrew consent, Prednisone initiated|0
814146|NCT00113269|1765463|FG003|Overall Study|Withdrew consent, Prednisone initiated|1
814147|NCT00113269|1765460|FG000|Overall Study|Did not meet eligibility criteria|1
814148|NCT00113269|1765461|FG001|Overall Study|Did not meet eligibility criteria|0
814149|NCT00113269|1765462|FG002|Overall Study|Did not meet eligibility criteria|0
814150|NCT00113269|1765463|FG003|Overall Study|Did not meet eligibility criteria|1
814151|NCT00113269|1765460|FG000|Overall Study|Unable to return for follow up|2
814152|NCT00113269|1765461|FG001|Overall Study|Unable to return for follow up|1
814153|NCT00113269|1765462|FG002|Overall Study|Unable to return for follow up|0
814154|NCT00113269|1765463|FG003|Overall Study|Unable to return for follow up|0
814155|NCT00113295|1765475|FG000|Overall Study|Adverse Event|4
814156|NCT00113295|1765476|FG001|Overall Study|Adverse Event|1
814157|NCT00113295|1765475|FG000|Overall Study|Unrelated Medical Illness|1
814158|NCT00113295|1765476|FG001|Overall Study|Unrelated Medical Illness|0
814159|NCT00113360|1765492|FG000|Overall Study|Adverse Event|3
814160|NCT00113360|1765492|FG000|Overall Study|Subject required surgery|1
814161|NCT00113360|1765492|FG000|Overall Study|Did not meet eligibility criteria|3
814162|NCT00113373|1765496|FG000|Overall Study|Ineligible: wrong primary|1
814163|NCT00113373|1765496|FG000|Overall Study|Ineligible: second primary|1
814164|NCT00113373|1765496|FG000|Overall Study|Never Treated|1
814165|NCT00113490|1765512|FG000|Overall Study|Withdrawal by Subject|1
814166|NCT00113490|1765513|FG001|Overall Study|Withdrawal by Subject|3
814167|NCT00113490|1765512|FG000|Overall Study|Lost to Follow-up|1
814168|NCT00113490|1765513|FG001|Overall Study|Lost to Follow-up|0
814169|NCT00113516|1765519|FG000|Part 1|Adverse Event|6
814170|NCT00113516|1765520|FG001|Part 1|Adverse Event|0
814171|NCT00113516|1765519|FG000|Part 1|Death|3
814172|NCT00113516|1765520|FG001|Part 1|Death|0
814173|NCT00113516|1765519|FG000|Part 1|Other|3
814174|NCT00113516|1765520|FG001|Part 1|Other|0
814175|NCT00113516|1765519|FG000|Part 1|Withdrawal by Subject|2
814176|NCT00113516|1765520|FG001|Part 1|Withdrawal by Subject|0
814177|NCT00113516|1765519|FG000|Part 1|Lack of Efficacy|2
814178|NCT00113516|1765520|FG001|Part 1|Lack of Efficacy|0
814179|NCT00113516|1765519|FG000|Part 1|Did Not Meet Entrance Criteria|1
814180|NCT00113516|1765520|FG001|Part 1|Did Not Meet Entrance Criteria|0
814181|NCT00113516|1765519|FG000|Part 1|Laboratory Abnormality|1
814182|NCT00113516|1765520|FG001|Part 1|Laboratory Abnormality|0
814183|NCT00113516|1765519|FG000|Part 1|Ongoing|1
814184|NCT00113516|1765520|FG001|Part 1|Ongoing|0
814185|NCT00113516|1765519|FG000|Part 1|Missing|65
814186|NCT00113516|1765520|FG001|Part 1|Missing|0
814187|NCT00113516|1765519|FG000|Part 2|Adverse Event|0
814188|NCT00113516|1765520|FG001|Part 2|Adverse Event|16
814189|NCT00113516|1765519|FG000|Part 2|Death|0
814190|NCT00113516|1765520|FG001|Part 2|Death|5
814191|NCT00113516|1765519|FG000|Part 2|Lack of Efficacy|0
814192|NCT00113516|1765520|FG001|Part 2|Lack of Efficacy|37
814193|NCT00113516|1765519|FG000|Part 2|Withdrawal by Subject|0
814194|NCT00113516|1765520|FG001|Part 2|Withdrawal by Subject|3
814195|NCT00113516|1765519|FG000|Part 2|Other|0
814196|NCT00113516|1765520|FG001|Part 2|Other|3
814197|NCT00113516|1765519|FG000|Part 2|Laboratory Abnormality|0
814198|NCT00113516|1765520|FG001|Part 2|Laboratory Abnormality|1
814199|NCT00113516|1765519|FG000|Part 2|Ongoing|0
814200|NCT00113516|1765520|FG001|Part 2|Ongoing|1
814201|NCT00113529|1765526|FG000|Overall Study|Adverse Event|4
814202|NCT00113529|1765526|FG000|Overall Study|Lack of Efficacy|20
814203|NCT00113529|1765526|FG000|Overall Study|Decision of sponsor|6
814204|NCT00113529|1765526|FG000|Overall Study|Withdrawal by Subject|4
814205|NCT00113555|1765530|FG000|Overall Study|Baseline Failure|59
814206|NCT00113555|1765530|FG000|Overall Study|Permanently Explanted|7
814207|NCT00113555|1765530|FG000|Overall Study|Death|1
814208|NCT00113555|1765530|FG000|Overall Study|Missed Followup|4
814209|NCT00113555|1765530|FG000|Overall Study|Lost to Follow-up|8
814210|NCT00113568|1765535|FG000|Overall Study|Adverse Event|97
814211|NCT00113568|1765535|FG000|Overall Study|Death|1
814212|NCT00113568|1765535|FG000|Overall Study|Lack of Efficacy|30
814213|NCT00113568|1765535|FG000|Overall Study|Lost to Follow-up|156
814214|NCT00113568|1765535|FG000|Overall Study|Protocol Violation|32
814215|NCT00113568|1765535|FG000|Overall Study|Withdrawal by Subject|117
814216|NCT00113568|1765535|FG000|Overall Study|Other|112
814217|NCT00113607|1765541|FG000|Overall Study|Adverse Event|40
814218|NCT00113607|1765542|FG001|Overall Study|Adverse Event|71
814219|NCT00113607|1765541|FG000|Overall Study|Death|8
814220|NCT00113607|1765542|FG001|Overall Study|Death|8
814221|NCT00113607|1765541|FG000|Overall Study|Withdrawal by Subject|50
814222|NCT00113607|1765542|FG001|Overall Study|Withdrawal by Subject|58
814223|NCT00113607|1765541|FG000|Overall Study|Lost to Follow-up|0
814224|NCT00113607|1765542|FG001|Overall Study|Lost to Follow-up|2
814225|NCT00113607|1765541|FG000|Overall Study|Disease Progression|180
814226|NCT00113607|1765542|FG001|Overall Study|Disease Progression|142
814227|NCT00113607|1765541|FG000|Overall Study|Complete Response (Confirmed)|14
814228|NCT00113607|1765542|FG001|Overall Study|Complete Response (Confirmed)|24
814229|NCT00113607|1765541|FG000|Overall Study|Other|43
814230|NCT00113607|1765542|FG001|Overall Study|Other|32
814231|NCT00113763|1765551|FG000|Overall Study|Adverse Event|5
814232|NCT00113763|1765552|FG001|Overall Study|Adverse Event|2
814233|NCT00113763|1765551|FG000|Overall Study|Disease Progression|28
814234|NCT00113763|1765552|FG001|Overall Study|Disease Progression|14
814235|NCT00113763|1765551|FG000|Overall Study|Lost to Follow-up|10
814236|NCT00113763|1765552|FG001|Overall Study|Lost to Follow-up|0
814237|NCT00113763|1765551|FG000|Overall Study|Withdrawal by Subject|1
814238|NCT00113763|1765552|FG001|Overall Study|Withdrawal by Subject|4
814239|NCT00113763|1765551|FG000|Overall Study|Other|27
814240|NCT00113763|1765552|FG001|Overall Study|Other|6
814241|NCT00113763|1765551|FG000|Overall Study|Non-compliance|1
814242|NCT00113763|1765552|FG001|Overall Study|Non-compliance|0
814243|NCT00113763|1765551|FG000|Overall Study|Ongoing|1
814244|NCT00113763|1765552|FG001|Overall Study|Ongoing|0
814245|NCT00113841|1765561|FG000|Overall Study|Disease progression|0
814246|NCT00113841|1765562|FG001|Overall Study|Disease progression|2
814247|NCT00113841|1765561|FG000|Overall Study|Non-compliant|1
814248|NCT00113841|1765562|FG001|Overall Study|Non-compliant|0
814249|NCT00114127|1765628|FG000|Overall Study|Adverse Event|2
814250|NCT00114127|1765629|FG001|Overall Study|Adverse Event|1
814251|NCT00114127|1765628|FG000|Overall Study|Lost to Follow-up|1
814252|NCT00114127|1765629|FG001|Overall Study|Lost to Follow-up|0
814253|NCT00114127|1765628|FG000|Overall Study|Withdrawal by Subject|1
814254|NCT00114127|1765629|FG001|Overall Study|Withdrawal by Subject|3
814255|NCT00114140|1765635|FG000|Overall Study|Protocol Violation|7
814256|NCT00114166|1765648|FG000|Overall Study|Wrong primary|0
814257|NCT00114166|1765649|FG001|Overall Study|Wrong primary|1
814258|NCT00114218|1765657|FG000|Overall Study|Wrong Cell Type|2
814259|NCT00114218|1765657|FG000|Overall Study|Wrong Primary|1
814260|NCT00114218|1765657|FG000|Overall Study|Never Treated|1
814261|NCT00114231|1765663|FG000|Overall Study|No consent|2
814262|NCT00114231|1765664|FG001|Overall Study|No consent|0
814263|NCT00114231|1765663|FG000|Overall Study|QARC requirement not met|1
814264|NCT00114231|1765664|FG001|Overall Study|QARC requirement not met|0
814265|NCT00114231|1765663|FG000|Overall Study|Suspected metastatic disease|1
814266|NCT00114231|1765664|FG001|Overall Study|Suspected metastatic disease|0
814267|NCT00114231|1765663|FG000|Overall Study|No adenocarcinoma|1
814268|NCT00114231|1765664|FG001|Overall Study|No adenocarcinoma|0
814269|NCT00114231|1765663|FG000|Overall Study|Low creatinine clearance|0
814270|NCT00114231|1765664|FG001|Overall Study|Low creatinine clearance|1
814271|NCT00114231|1765663|FG000|Overall Study|Tumor size > 4cm|1
814272|NCT00114231|1765664|FG001|Overall Study|Tumor size > 4cm|0
814273|NCT00114231|1765663|FG000|Overall Study|Tumor fixed on digital exam|0
814274|NCT00114231|1765664|FG001|Overall Study|Tumor fixed on digital exam|1
814275|NCT00114231|1765663|FG000|Overall Study|No Absolute Neutrophil Count|2
814276|NCT00114231|1765664|FG001|Overall Study|No Absolute Neutrophil Count|0
814277|NCT00114231|1765663|FG000|Overall Study|Biopsy done after registration|1
814278|NCT00114231|1765664|FG001|Overall Study|Biopsy done after registration|0
814279|NCT00114244|1765671|FG000|Overall Study|Adverse Event|2
814280|NCT00114244|1765672|FG001|Overall Study|Adverse Event|5
814281|NCT00114244|1765671|FG000|Overall Study|Withdrawal by Subject|0
814282|NCT00114244|1765672|FG001|Overall Study|Withdrawal by Subject|2
814283|NCT00114530|1765706|FG000|Overall Study|Death|3
814284|NCT00114530|1765707|FG001|Overall Study|Death|11
814285|NCT00114530|1765706|FG000|Overall Study|Lost to Follow-up|1
814286|NCT00114530|1765707|FG001|Overall Study|Lost to Follow-up|1
814287|NCT00114530|1765706|FG000|Overall Study|Physician Decision|1
814288|NCT00114530|1765707|FG001|Overall Study|Physician Decision|1
814289|NCT00114530|1765706|FG000|Overall Study|Withdrawal by Subject|2
814290|NCT00114530|1765707|FG001|Overall Study|Withdrawal by Subject|6
814291|NCT00114530|1765706|FG000|Overall Study|Breast Cancer|1
814292|NCT00114530|1765707|FG001|Overall Study|Breast Cancer|0
814293|NCT00114530|1765706|FG000|Overall Study|Subject decision after endpoint failure|0
814294|NCT00114530|1765707|FG001|Overall Study|Subject decision after endpoint failure|1
814295|NCT00114530|1765706|FG000|Overall Study|Ineligible|1
814296|NCT00114530|1765707|FG001|Overall Study|Ineligible|0
814297|NCT00114634|1765717|FG000|Overall Study|failure to return forms|3
814298|NCT00114738|1765723|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
814299|NCT00114738|1765724|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
814300|NCT00114738|1765725|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
814301|NCT00114738|1765723|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
814302|NCT00114738|1765724|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
814303|NCT00114738|1765725|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
814304|NCT00114738|1765723|FG000|Screening for Randomization|Neuropathy|17
814305|NCT00114738|1765724|FG001|Screening for Randomization|Neuropathy|0
814306|NCT00114738|1765725|FG002|Screening for Randomization|Neuropathy|0
814307|NCT00114738|1765723|FG000|Screening for Randomization|Progressive disease|2
814308|NCT00114738|1765724|FG001|Screening for Randomization|Progressive disease|0
814309|NCT00114738|1765725|FG002|Screening for Randomization|Progressive disease|0
814310|NCT00114738|1765723|FG000|Screening for Randomization|CNS Hemorrhage|1
814311|NCT00114738|1765724|FG001|Screening for Randomization|CNS Hemorrhage|0
814312|NCT00114738|1765725|FG002|Screening for Randomization|CNS Hemorrhage|0
814313|NCT00114738|1765723|FG000|Screening for Randomization|Other|1
814314|NCT00114738|1765724|FG001|Screening for Randomization|Other|0
814315|NCT00114738|1765725|FG002|Screening for Randomization|Other|0
814316|NCT00114777|1765735|FG000|Randomization to Month 36|Death|10
814317|NCT00114777|1765736|FG001|Randomization to Month 36|Death|4
814318|NCT00114777|1765737|FG002|Randomization to Month 36|Death|3
814319|NCT00114777|1765735|FG000|Randomization to Month 36|No Longer Met Study Criteria|0
814320|NCT00114777|1765736|FG001|Randomization to Month 36|No Longer Met Study Criteria|0
814321|NCT00114777|1765737|FG002|Randomization to Month 36|No Longer Met Study Criteria|2
814322|NCT00114777|1765735|FG000|Randomization to Month 36|Lack of Efficacy|19
814323|NCT00114777|1765736|FG001|Randomization to Month 36|Lack of Efficacy|15
814324|NCT00114777|1765737|FG002|Randomization to Month 36|Lack of Efficacy|17
814325|NCT00114777|1765735|FG000|Randomization to Month 36|Poor or Non-Compliance|0
814326|NCT00114777|1765736|FG001|Randomization to Month 36|Poor or Non-Compliance|0
814327|NCT00114777|1765737|FG002|Randomization to Month 36|Poor or Non-Compliance|1
814328|NCT00114777|1765735|FG000|Randomization to Month 36|Adverse Event|34
814329|NCT00114777|1765736|FG001|Randomization to Month 36|Adverse Event|35
814330|NCT00114777|1765737|FG002|Randomization to Month 36|Adverse Event|44
814331|NCT00114777|1765735|FG000|Randomization to Month 36|Withdrawal by Subject|3
814332|NCT00114777|1765736|FG001|Randomization to Month 36|Withdrawal by Subject|4
814333|NCT00114777|1765737|FG002|Randomization to Month 36|Withdrawal by Subject|5
814334|NCT00114777|1765735|FG000|Randomization to Month 36|Other|9
814335|NCT00114777|1765736|FG001|Randomization to Month 36|Other|3
814336|NCT00114777|1765737|FG002|Randomization to Month 36|Other|12
814337|NCT00114777|1765735|FG000|Long-Term Extension to Month 84|Death|8
814338|NCT00114777|1765736|FG001|Long-Term Extension to Month 84|Death|13
814339|NCT00114777|1765737|FG002|Long-Term Extension to Month 84|Death|7
814340|NCT00114777|1765735|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
814341|NCT00114777|1765736|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
814342|NCT00114777|1765737|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
814343|NCT00114777|1765735|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1
814344|NCT00114777|1765736|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0
814345|NCT00114777|1765737|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1
814346|NCT00114777|1765735|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1
814347|NCT00114777|1765736|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1
814348|NCT00114777|1765737|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3
814349|NCT00114777|1765735|FG000|Long-Term Extension to Month 84|Adverse Event|15
814350|NCT00114777|1765736|FG001|Long-Term Extension to Month 84|Adverse Event|14
814351|NCT00114777|1765737|FG002|Long-Term Extension to Month 84|Adverse Event|7
814352|NCT00114777|1765735|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2
814353|NCT00114777|1765736|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1
814354|NCT00114777|1765737|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6
814355|NCT00114777|1765735|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0
814356|NCT00114777|1765736|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0
814357|NCT00114777|1765737|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2
814358|NCT00114777|1765735|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
814359|NCT00114777|1765736|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
814360|NCT00114777|1765737|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
814361|NCT00114777|1765735|FG000|Long-Term Extension to Month 84|Other|2
814362|NCT00114777|1765736|FG001|Long-Term Extension to Month 84|Other|0
814363|NCT00114777|1765737|FG002|Long-Term Extension to Month 84|Other|2
814364|NCT00114959|1765746|FG000|Overall Study|Lack of Efficacy|6
814365|NCT00114959|1765746|FG000|Overall Study|Physician Decision|1
814366|NCT00114959|1765746|FG000|Overall Study|Death|1
814367|NCT00114972|1765752|FG000|Overall Study|Withdrawal by Subject|40
814368|NCT00114972|1765753|FG001|Overall Study|Withdrawal by Subject|7
814369|NCT00114972|1765752|FG000|Overall Study|Lost to Follow-up|8
814370|NCT00114972|1765753|FG001|Overall Study|Lost to Follow-up|5
814371|NCT00115037|1765761|FG000|Phase1|Lost to Follow-up|16
814372|NCT00115037|1765762|FG001|Phase1|Lost to Follow-up|23
814373|NCT00115037|1765763|FG002|Phase1|Lost to Follow-up|0
814374|NCT00115037|1765764|FG003|Phase1|Lost to Follow-up|0
814375|NCT00115037|1765765|FG004|Phase1|Lost to Follow-up|0
814376|NCT00115037|1765766|FG005|Phase1|Lost to Follow-up|0
814377|NCT00115037|1765761|FG000|Phase1|Withdrawal by Subject|9
814378|NCT00115037|1765762|FG001|Phase1|Withdrawal by Subject|4
814379|NCT00115037|1765763|FG002|Phase1|Withdrawal by Subject|0
814380|NCT00115037|1765764|FG003|Phase1|Withdrawal by Subject|0
814381|NCT00115037|1765765|FG004|Phase1|Withdrawal by Subject|0
814382|NCT00115037|1765766|FG005|Phase1|Withdrawal by Subject|0
814383|NCT00115037|1765761|FG000|Phase2|Death|0
814384|NCT00115037|1765762|FG001|Phase2|Death|0
814385|NCT00115037|1765763|FG002|Phase2|Death|1
814386|NCT00115037|1765764|FG003|Phase2|Death|0
814387|NCT00115037|1765765|FG004|Phase2|Death|0
814388|NCT00115037|1765766|FG005|Phase2|Death|1
814389|NCT00115037|1765761|FG000|Phase2|Withdrawal by Subject|0
814390|NCT00115037|1765762|FG001|Phase2|Withdrawal by Subject|0
814391|NCT00115037|1765763|FG002|Phase2|Withdrawal by Subject|2
814392|NCT00115037|1765764|FG003|Phase2|Withdrawal by Subject|1
814393|NCT00115037|1765765|FG004|Phase2|Withdrawal by Subject|2
814394|NCT00115037|1765766|FG005|Phase2|Withdrawal by Subject|1
814395|NCT00115037|1765761|FG000|Phase2|Lost to Follow-up|0
814396|NCT00115037|1765762|FG001|Phase2|Lost to Follow-up|0
814397|NCT00115037|1765763|FG002|Phase2|Lost to Follow-up|12
814398|NCT00115037|1765764|FG003|Phase2|Lost to Follow-up|14
814399|NCT00115037|1765765|FG004|Phase2|Lost to Follow-up|4
814400|NCT00115037|1765766|FG005|Phase2|Lost to Follow-up|10
814401|NCT00115063|1765782|FG000|Overall Study|Lost to Follow-up|98
814402|NCT00115063|1765783|FG001|Overall Study|Lost to Follow-up|104
814403|NCT00115063|1765782|FG000|Overall Study|Death|1
814404|NCT00115063|1765783|FG001|Overall Study|Death|0
814405|NCT00115336|1765807|FG000|Overall Study|Hospital discharge before study drug|0
814406|NCT00115336|1765808|FG001|Overall Study|Hospital discharge before study drug|1
814407|NCT00115349|1765818|FG000|Overall Study|Study closed due to low enrollment.|11
814408|NCT00115349|1765819|FG001|Overall Study|Study closed due to low enrollment.|9
814409|NCT00115739|1765825|FG000|Overall Study|Lost to Follow-up|3
814410|NCT00115765|1765835|FG000|Overall Study|Withdrawal by Subject|22
814411|NCT00115765|1765836|FG001|Overall Study|Withdrawal by Subject|53
814412|NCT00115765|1765837|FG002|Overall Study|Withdrawal by Subject|76
814413|NCT00115765|1765838|FG003|Overall Study|Withdrawal by Subject|15
814414|NCT00115765|1765835|FG000|Overall Study|Physician Decision|4
814415|NCT00115765|1765836|FG001|Overall Study|Physician Decision|15
814416|NCT00115765|1765837|FG002|Overall Study|Physician Decision|18
814417|NCT00115765|1765838|FG003|Overall Study|Physician Decision|13
814418|NCT00115765|1765835|FG000|Overall Study|Lost to Follow-up|3
814419|NCT00115765|1765836|FG001|Overall Study|Lost to Follow-up|20
814420|NCT00115765|1765837|FG002|Overall Study|Lost to Follow-up|18
814421|NCT00115765|1765838|FG003|Overall Study|Lost to Follow-up|1
814422|NCT00115765|1765835|FG000|Overall Study|Other|6
814423|NCT00115765|1765836|FG001|Overall Study|Other|12
814424|NCT00115765|1765837|FG002|Overall Study|Other|9
814425|NCT00115765|1765838|FG003|Overall Study|Other|2
814426|NCT00115778|1765846|FG000|Overall Study|Withdrawal by Subject|0
814427|NCT00115778|1765847|FG001|Overall Study|Withdrawal by Subject|1
814428|NCT00115804|1765853|FG000|Overall Study|Adverse Event|2
814429|NCT00115934|1765872|FG000|Overall Study|Lost to Follow-up|1
814430|NCT00115934|1765873|FG001|Overall Study|Lost to Follow-up|0
814431|NCT00115934|1765872|FG000|Overall Study|Did not receive intervention|3
814432|NCT00115934|1765873|FG001|Overall Study|Did not receive intervention|2
814453|NCT00116168|1765895|FG000|Overall Study|Lost to Follow-up|6
814454|NCT00116168|1765896|FG001|Overall Study|Lost to Follow-up|5
814455|NCT00116168|1765897|FG002|Overall Study|Lost to Follow-up|0
814456|NCT00116168|1765898|FG003|Overall Study|Lost to Follow-up|0
814457|NCT00116272|1765919|FG000|Overall Study|Lost to Follow-up|11
814458|NCT00116272|1765920|FG001|Overall Study|Lost to Follow-up|6
814459|NCT00116428|1765941|FG000|Overall Study|Withdrawal by Subject|2
814460|NCT00116428|1765942|FG001|Overall Study|Withdrawal by Subject|5
814461|NCT00116428|1765941|FG000|Overall Study|Did not meet inclusion criteria|1
814462|NCT00116428|1765942|FG001|Overall Study|Did not meet inclusion criteria|0
814463|NCT00116558|1765954|FG000|Overall Study|Death|11
814464|NCT00116558|1765955|FG001|Overall Study|Death|5
814465|NCT00116558|1765956|FG002|Overall Study|Death|3
814466|NCT00116558|1765954|FG000|Overall Study|Withdrawal by Subject|17
814467|NCT00116558|1765955|FG001|Overall Study|Withdrawal by Subject|3
814468|NCT00116558|1765956|FG002|Overall Study|Withdrawal by Subject|12
814469|NCT00116558|1765954|FG000|Overall Study|disease progression|3
814470|NCT00116558|1765955|FG001|Overall Study|disease progression|7
814471|NCT00116558|1765956|FG002|Overall Study|disease progression|18
814472|NCT00116584|1765965|FG000|Overall Study|Withdrawal by Subject|1
814473|NCT00116584|1765966|FG001|Overall Study|Withdrawal by Subject|0
814474|NCT00116584|1765965|FG000|Overall Study|Protocol Violation|1
814475|NCT00116584|1765966|FG001|Overall Study|Protocol Violation|1
814476|NCT00116649|1765972|FG000|Overall Study|Adverse Event|20
814477|NCT00116649|1765972|FG000|Overall Study|Lack of Efficacy|1
814478|NCT00116649|1765972|FG000|Overall Study|Lost to Follow-up|32
814479|NCT00116649|1765972|FG000|Overall Study|Withdrawal by Subject|68
814480|NCT00116649|1765972|FG000|Overall Study|Local Skin Reaction|9
814481|NCT00116649|1765972|FG000|Overall Study|Various Reasons|18
814482|NCT00116649|1765972|FG000|Overall Study|Protocol Specified|7
814483|NCT00116688|1765978|FG000|Overall Study|Protocol deviation|1
814484|NCT00116688|1765979|FG001|Overall Study|Protocol deviation|0
814485|NCT00116688|1765978|FG000|Overall Study|Noncompliance|3
814486|NCT00116688|1765979|FG001|Overall Study|Noncompliance|1
814487|NCT00116688|1765978|FG000|Overall Study|Adverse Event|11
814488|NCT00116688|1765979|FG001|Overall Study|Adverse Event|0
814489|NCT00116688|1765978|FG000|Overall Study|Withdrawal by Subject|26
814490|NCT00116688|1765979|FG001|Overall Study|Withdrawal by Subject|2
814491|NCT00116688|1765978|FG000|Overall Study|Requirement for alternative therapy|11
814492|NCT00116688|1765979|FG001|Overall Study|Requirement for alternative therapy|1
814493|NCT00116688|1765978|FG000|Overall Study|Physician Decision|7
814494|NCT00116688|1765979|FG001|Overall Study|Physician Decision|0
814495|NCT00116688|1765978|FG000|Overall Study|Lost to Follow-up|3
814496|NCT00116688|1765979|FG001|Overall Study|Lost to Follow-up|0
814497|NCT00116688|1765978|FG000|Overall Study|Death|15
814498|NCT00116688|1765979|FG001|Overall Study|Death|0
814499|NCT00116688|1765978|FG000|Overall Study|Protocol-specified criteria|3
814500|NCT00116688|1765979|FG001|Overall Study|Protocol-specified criteria|0
814501|NCT00116688|1765978|FG000|Overall Study|Pregnancy|1
814502|NCT00116688|1765979|FG001|Overall Study|Pregnancy|0
814503|NCT00116688|1765978|FG000|Overall Study|Other|11
814504|NCT00116688|1765979|FG001|Overall Study|Other|0
814505|NCT00116753|1765988|FG000|Overall Study|Adverse Event|16
814506|NCT00116753|1765989|FG001|Overall Study|Adverse Event|10
814507|NCT00116753|1765990|FG002|Overall Study|Adverse Event|7
814508|NCT00116753|1765988|FG000|Overall Study|Withdrawal by Subject|11
814509|NCT00116753|1765989|FG001|Overall Study|Withdrawal by Subject|12
814510|NCT00116753|1765990|FG002|Overall Study|Withdrawal by Subject|8
814511|NCT00116753|1765988|FG000|Overall Study|Lost to Follow-up|0
814512|NCT00116753|1765989|FG001|Overall Study|Lost to Follow-up|2
814513|NCT00116753|1765990|FG002|Overall Study|Lost to Follow-up|1
814514|NCT00116753|1765988|FG000|Overall Study|Protocol Violation|0
814515|NCT00116753|1765989|FG001|Overall Study|Protocol Violation|0
814516|NCT00116753|1765990|FG002|Overall Study|Protocol Violation|1
814517|NCT00116753|1765988|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1
814518|NCT00116753|1765989|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1
814519|NCT00116753|1765990|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3
814520|NCT00116753|1765988|FG000|Overall Study|Disease Progression|3
814521|NCT00116753|1765989|FG001|Overall Study|Disease Progression|4
814522|NCT00116753|1765990|FG002|Overall Study|Disease Progression|3
814523|NCT00116753|1765988|FG000|Overall Study|Abnormal Echocardiogram|0
814524|NCT00116753|1765989|FG001|Overall Study|Abnormal Echocardiogram|0
814525|NCT00116753|1765990|FG002|Overall Study|Abnormal Echocardiogram|1
814526|NCT00116753|1765988|FG000|Overall Study|Progressive Parkinson's Disease|1
814527|NCT00116753|1765989|FG001|Overall Study|Progressive Parkinson's Disease|0
814528|NCT00116753|1765990|FG002|Overall Study|Progressive Parkinson's Disease|0
814529|NCT00116753|1765988|FG000|Overall Study|Dosing Error|0
814530|NCT00116753|1765989|FG001|Overall Study|Dosing Error|1
814531|NCT00116753|1765990|FG002|Overall Study|Dosing Error|0
814532|NCT00116779|1766000|FG000|Overall Study|Adverse Event|4
814533|NCT00116779|1766001|FG001|Overall Study|Adverse Event|2
814534|NCT00116779|1766000|FG000|Overall Study|Protocol Violation|1
814535|NCT00116779|1766001|FG001|Overall Study|Protocol Violation|4
814536|NCT00116779|1766000|FG000|Overall Study|Withdrawal by Subject|4
814537|NCT00116779|1766001|FG001|Overall Study|Withdrawal by Subject|1
814538|NCT00116779|1766000|FG000|Overall Study|Inadequate testosterone suppression|7
814539|NCT00116779|1766001|FG001|Overall Study|Inadequate testosterone suppression|9
814540|NCT00116779|1766000|FG000|Overall Study|Physician Decision|3
814541|NCT00116779|1766001|FG001|Overall Study|Physician Decision|1
814542|NCT00116779|1766000|FG000|Overall Study|Elevated PSA levels|2
814543|NCT00116779|1766001|FG001|Overall Study|Elevated PSA levels|2
814544|NCT00116805|1766009|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6
814545|NCT00116805|1766010|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2
814546|NCT00116805|1766009|FG000|Double-blind Period Through Week 48|Protocol Violation|1
814547|NCT00116805|1766010|FG001|Double-blind Period Through Week 48|Protocol Violation|1
814548|NCT00116805|1766009|FG000|Double-blind Period Through Week 48|Withdrew Consent|4
814549|NCT00116805|1766010|FG001|Double-blind Period Through Week 48|Withdrew Consent|2
814550|NCT00116805|1766009|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
814551|NCT00116805|1766010|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
814552|NCT00116805|1766009|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
814553|NCT00116805|1766010|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
814554|NCT00116805|1766009|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2
814555|NCT00116805|1766010|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0
814556|NCT00116805|1766009|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
814557|NCT00116805|1766010|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
814558|NCT00116805|1766009|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2
814559|NCT00116805|1766010|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0
814560|NCT00116805|1766009|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2
814561|NCT00116805|1766010|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1
814562|NCT00116805|1766009|FG000|Open-label Period Weeks 97 - 144|Completed Study|1
814563|NCT00116805|1766010|FG001|Open-label Period Weeks 97 - 144|Completed Study|0
814564|NCT00116805|1766009|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
814565|NCT00116805|1766010|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
814566|NCT00116805|1766009|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
814567|NCT00116805|1766010|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
814568|NCT00116805|1766009|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0
814569|NCT00116805|1766010|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1
814570|NCT00116805|1766009|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2
814571|NCT00116805|1766010|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3
814572|NCT00116805|1766009|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1
814573|NCT00116805|1766010|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3
814574|NCT00116805|1766009|FG000|Open-label Period Weeks 145 - 192|Completed Study|1
814575|NCT00116805|1766010|FG001|Open-label Period Weeks 145 - 192|Completed Study|1
814576|NCT00116805|1766009|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
814577|NCT00116805|1766010|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
814578|NCT00116805|1766009|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
814579|NCT00116805|1766010|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
814580|NCT00116805|1766009|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1
814581|NCT00116805|1766010|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0
814582|NCT00116805|1766009|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
814583|NCT00116805|1766010|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
814584|NCT00116805|1766009|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0
814585|NCT00116805|1766010|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1
814586|NCT00116805|1766009|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3
814587|NCT00116805|1766010|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2
814588|NCT00116805|1766009|FG000|Open-label Period Weeks 193 - 240|Completed Study|0
814589|NCT00116805|1766010|FG001|Open-label Period Weeks 193 - 240|Completed Study|1
814590|NCT00116805|1766009|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
814591|NCT00116805|1766010|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
814592|NCT00116805|1766009|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
814593|NCT00116805|1766010|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
814594|NCT00116805|1766009|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
814595|NCT00116805|1766010|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
814596|NCT00116805|1766009|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7
814597|NCT00116805|1766010|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1
814598|NCT00116805|1766009|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
814599|NCT00116805|1766010|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
814600|NCT00116805|1766009|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4
814601|NCT00116805|1766010|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0
814602|NCT00116805|1766009|FG000|Open-label Period Weeks 289 - 336|Completed Study|0
814603|NCT00116805|1766010|FG001|Open-label Period Weeks 289 - 336|Completed Study|1
814604|NCT00116805|1766009|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
814605|NCT00116805|1766010|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
814606|NCT00116805|1766009|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
814607|NCT00116805|1766010|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
814608|NCT00116805|1766009|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0
814609|NCT00116805|1766010|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1
814610|NCT00116805|1766009|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
814611|NCT00116805|1766010|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
814612|NCT00116805|1766009|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
814613|NCT00116805|1766010|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
814614|NCT00116805|1766009|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2
814615|NCT00116805|1766010|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0
814616|NCT00116805|1766009|FG000|Open-label Period Weeks 337 - 384|Completed Study|1
814617|NCT00116805|1766010|FG001|Open-label Period Weeks 337 - 384|Completed Study|0
814618|NCT00116805|1766009|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
814619|NCT00116805|1766010|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
814620|NCT00116805|1766009|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
814621|NCT00116805|1766010|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
814622|NCT00116805|1766009|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1
814623|NCT00116805|1766010|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0
814624|NCT00116805|1766009|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3
814625|NCT00116805|1766010|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1
814626|NCT00116805|1766009|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1
814627|NCT00116805|1766010|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0
814628|NCT00116805|1766009|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1
814629|NCT00116805|1766010|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0
814630|NCT00116805|1766009|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1
814631|NCT00116805|1766010|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0
814632|NCT00116805|1766009|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3
814633|NCT00116805|1766010|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0
814634|NCT00116831|1766027|FG000|Overall Study|Adverse Event|14
814635|NCT00116831|1766028|FG001|Overall Study|Adverse Event|16
814636|NCT00116831|1766027|FG000|Overall Study|Baseline IVUS determined unevaluable|12
814637|NCT00116831|1766028|FG001|Overall Study|Baseline IVUS determined unevaluable|11
814638|NCT00116831|1766027|FG000|Overall Study|Lost to Follow-up|8
814639|NCT00116831|1766028|FG001|Overall Study|Lost to Follow-up|6
814640|NCT00116831|1766027|FG000|Overall Study|Protocol Violation|3
814641|NCT00116831|1766028|FG001|Overall Study|Protocol Violation|6
814642|NCT00116831|1766027|FG000|Overall Study|Hypoglycaemic events|1
814643|NCT00116831|1766028|FG001|Overall Study|Hypoglycaemic events|0
814644|NCT00116831|1766027|FG000|Overall Study|Low haemoglobin on screening|1
814645|NCT00116831|1766028|FG001|Overall Study|Low haemoglobin on screening|0
814646|NCT00116831|1766027|FG000|Overall Study|Withdrawn investigational product|1
814647|NCT00116831|1766028|FG001|Overall Study|Withdrawn investigational product|0
814648|NCT00116831|1766027|FG000|Overall Study|Withdrawal by Subject|32
814649|NCT00116831|1766028|FG001|Overall Study|Withdrawal by Subject|32
814650|NCT00116831|1766027|FG000|Overall Study|Insufficient therapeutic effect|0
814651|NCT00116831|1766028|FG001|Overall Study|Insufficient therapeutic effect|1
814652|NCT00116831|1766027|FG000|Overall Study|Missing data for participant|1
814653|NCT00116831|1766028|FG001|Overall Study|Missing data for participant|0
814654|NCT00116844|1766036|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
814655|NCT00116844|1766037|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
814656|NCT00116844|1766036|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
814657|NCT00116844|1766037|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
814658|NCT00116844|1766036|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
814659|NCT00116844|1766037|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
814660|NCT00116844|1766036|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1
814661|NCT00116844|1766037|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1
814662|NCT00116844|1766036|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
814663|NCT00116844|1766037|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
814664|NCT00116844|1766036|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
814665|NCT00116844|1766037|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
814666|NCT00116844|1766036|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0
814667|NCT00116844|1766037|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2
814668|NCT00116844|1766036|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
814669|NCT00116844|1766037|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
814670|NCT00116844|1766036|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
814671|NCT00116844|1766037|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
814672|NCT00117156|1766069|FG000|Overall Study|Adverse Event|9
814673|NCT00117156|1766069|FG000|Overall Study|Physician Decision|1
814674|NCT00117156|1766069|FG000|Overall Study|Trt for Pre-Exist Second Primary|1
814675|NCT00117286|1766075|FG000|Overall Study|Adverse Event|12
814676|NCT00117286|1766076|FG001|Overall Study|Adverse Event|6
814677|NCT00117286|1766075|FG000|Overall Study|Lost to Follow-up|2
814678|NCT00117286|1766076|FG001|Overall Study|Lost to Follow-up|0
814679|NCT00117286|1766075|FG000|Overall Study|Protocol Violation|3
814680|NCT00117286|1766076|FG001|Overall Study|Protocol Violation|3
814681|NCT00117286|1766075|FG000|Overall Study|Withdrawal by Subject|6
814682|NCT00117286|1766076|FG001|Overall Study|Withdrawal by Subject|2
814683|NCT00117286|1766075|FG000|Overall Study|Physician Decision|3
814684|NCT00117286|1766076|FG001|Overall Study|Physician Decision|7
814685|NCT00117286|1766075|FG000|Overall Study|Lack of Efficacy|2
814686|NCT00117286|1766076|FG001|Overall Study|Lack of Efficacy|1
814687|NCT00117286|1766075|FG000|Overall Study|Research site closing|0
814688|NCT00117286|1766076|FG001|Overall Study|Research site closing|2
814689|NCT00117312|1766086|FG000|Overall Study|Testosterone >1.0 ng/mL|9
814690|NCT00117312|1766087|FG001|Overall Study|Testosterone >1.0 ng/mL|9
814691|NCT00117312|1766088|FG002|Overall Study|Testosterone >1.0 ng/mL|5
814692|NCT00117312|1766089|FG003|Overall Study|Testosterone >1.0 ng/mL|9
814693|NCT00117312|1766086|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
814694|NCT00117312|1766087|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
814695|NCT00117312|1766088|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
814696|NCT00117312|1766089|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
814697|NCT00117312|1766086|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
814698|NCT00117312|1766087|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
814699|NCT00117312|1766088|FG002|Overall Study|Prostate-specific antigen increase >=25%|5
814700|NCT00117312|1766089|FG003|Overall Study|Prostate-specific antigen increase >=25%|3
814701|NCT00117312|1766086|FG000|Overall Study|Other|0
814702|NCT00117312|1766087|FG001|Overall Study|Other|1
814703|NCT00117312|1766088|FG002|Overall Study|Other|3
814704|NCT00117312|1766089|FG003|Overall Study|Other|1
814705|NCT00117312|1766086|FG000|Overall Study|Patient choice|0
814706|NCT00117312|1766087|FG001|Overall Study|Patient choice|0
814707|NCT00117312|1766088|FG002|Overall Study|Patient choice|2
814708|NCT00117312|1766089|FG003|Overall Study|Patient choice|1
814709|NCT00117312|1766086|FG000|Overall Study|Adverse Event|0
814710|NCT00117312|1766087|FG001|Overall Study|Adverse Event|2
814711|NCT00117312|1766088|FG002|Overall Study|Adverse Event|0
814712|NCT00117312|1766089|FG003|Overall Study|Adverse Event|0
814713|NCT00117312|1766086|FG000|Overall Study|Protocol Violation|0
814714|NCT00117312|1766087|FG001|Overall Study|Protocol Violation|1
814715|NCT00117312|1766088|FG002|Overall Study|Protocol Violation|3
814716|NCT00117312|1766089|FG003|Overall Study|Protocol Violation|0
814717|NCT00117312|1766086|FG000|Overall Study|PSA decrease <=50%|0
814718|NCT00117312|1766087|FG001|Overall Study|PSA decrease <=50%|2
814719|NCT00117312|1766088|FG002|Overall Study|PSA decrease <=50%|2
814720|NCT00117312|1766089|FG003|Overall Study|PSA decrease <=50%|4
814721|NCT00117312|1766086|FG000|Overall Study|PSA increase >= 10ng/mL|0
814722|NCT00117312|1766087|FG001|Overall Study|PSA increase >= 10ng/mL|1
814723|NCT00117312|1766088|FG002|Overall Study|PSA increase >= 10ng/mL|1
814724|NCT00117312|1766089|FG003|Overall Study|PSA increase >= 10ng/mL|0
814725|NCT00117312|1766086|FG000|Overall Study|Hepatic abnormality|0
814726|NCT00117312|1766087|FG001|Overall Study|Hepatic abnormality|1
814727|NCT00117312|1766088|FG002|Overall Study|Hepatic abnormality|0
814728|NCT00117312|1766089|FG003|Overall Study|Hepatic abnormality|1
814729|NCT00117312|1766086|FG000|Overall Study|Withdrawal by Subject|0
814730|NCT00117312|1766087|FG001|Overall Study|Withdrawal by Subject|2
814731|NCT00117312|1766088|FG002|Overall Study|Withdrawal by Subject|0
814732|NCT00117312|1766089|FG003|Overall Study|Withdrawal by Subject|0
814733|NCT00117325|1766101|FG000|Overall Study|Adverse Event|3
814734|NCT00117325|1766102|FG001|Overall Study|Adverse Event|3
814735|NCT00117325|1766101|FG000|Overall Study|Lost to Follow-up|1
814736|NCT00117325|1766102|FG001|Overall Study|Lost to Follow-up|1
814737|NCT00117325|1766101|FG000|Overall Study|Protocol Violation|2
814738|NCT00117325|1766102|FG001|Overall Study|Protocol Violation|3
814739|NCT00117325|1766101|FG000|Overall Study|Withdrawal by Subject|3
814740|NCT00117325|1766102|FG001|Overall Study|Withdrawal by Subject|2
814741|NCT00117325|1766101|FG000|Overall Study|Lack of Efficacy|1
814742|NCT00117325|1766102|FG001|Overall Study|Lack of Efficacy|0
814743|NCT00117325|1766101|FG000|Overall Study|Use of prohibited medicine|1
814744|NCT00117325|1766102|FG001|Overall Study|Use of prohibited medicine|2
814745|NCT00117325|1766101|FG000|Overall Study|Early termination|1
814746|NCT00117325|1766102|FG001|Overall Study|Early termination|1
814747|NCT00117325|1766101|FG000|Overall Study|Admisnitrative|1
814748|NCT00117325|1766102|FG001|Overall Study|Admisnitrative|0
814749|NCT00117338|1766111|FG000|Overall Study|Adverse Event|0
814750|NCT00117338|1766112|FG001|Overall Study|Adverse Event|1
814751|NCT00117338|1766111|FG000|Overall Study|Protocol Violation|3
814752|NCT00117338|1766112|FG001|Overall Study|Protocol Violation|2
814753|NCT00117338|1766111|FG000|Overall Study|Withdrawal by Subject|1
814754|NCT00117338|1766112|FG001|Overall Study|Withdrawal by Subject|0
814755|NCT00117338|1766111|FG000|Overall Study|Did not meet Inclusion Criteria|1
814756|NCT00117338|1766112|FG001|Overall Study|Did not meet Inclusion Criteria|0
814757|NCT00117338|1766111|FG000|Overall Study|Lack of Efficacy|0
814758|NCT00117338|1766112|FG001|Overall Study|Lack of Efficacy|1
814759|NCT00117507|1766118|FG000|Overall Study|Adverse Event|4
814760|NCT00117507|1766118|FG000|Overall Study|Abnormal laboratory values|3
814761|NCT00117507|1766118|FG000|Overall Study|Unsatisfactory therapeutic effect|1
814762|NCT00117507|1766118|FG000|Overall Study|Patient withdrew consent|4
814763|NCT00117507|1766118|FG000|Overall Study|Death|3
814764|NCT00117572|1766134|FG000|Overall Study|Site withdrew before starting treatment|2
814765|NCT00117572|1766135|FG001|Overall Study|Site withdrew before starting treatment|3
814766|NCT00117572|1766134|FG000|Overall Study|Withdrawal by Subject|3
814767|NCT00117572|1766135|FG001|Overall Study|Withdrawal by Subject|3
814768|NCT00117572|1766134|FG000|Overall Study|Protocol Violation|1
814769|NCT00117572|1766135|FG001|Overall Study|Protocol Violation|0
814770|NCT00117598|1766148|FG000|Prior to Treatment Cross Over|Death|40
814771|NCT00117598|1766149|FG001|Prior to Treatment Cross Over|Death|41
814772|NCT00117598|1766150|FG002|Prior to Treatment Cross Over|Death|37
814773|NCT00117598|1766151|FG003|Prior to Treatment Cross Over|Death|0
814774|NCT00117598|1766152|FG004|Prior to Treatment Cross Over|Death|0
814775|NCT00117598|1766148|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0
814776|NCT00117598|1766149|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2
814777|NCT00117598|1766150|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2
814778|NCT00117598|1766151|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0
814779|NCT00117598|1766152|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0
814780|NCT00117598|1766148|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2
814781|NCT00117598|1766149|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1
814782|NCT00117598|1766150|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4
814783|NCT00117598|1766151|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0
814784|NCT00117598|1766152|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0
814785|NCT00117598|1766148|FG000|Prior to Treatment Cross Over|Other|15
814786|NCT00117598|1766149|FG001|Prior to Treatment Cross Over|Other|9
814787|NCT00117598|1766150|FG002|Prior to Treatment Cross Over|Other|9
814788|NCT00117598|1766151|FG003|Prior to Treatment Cross Over|Other|0
814789|NCT00117598|1766152|FG004|Prior to Treatment Cross Over|Other|0
814790|NCT00117598|1766148|FG000|After Treament Cross Over|Death|0
814791|NCT00117598|1766149|FG001|After Treament Cross Over|Death|0
814792|NCT00117598|1766150|FG002|After Treament Cross Over|Death|0
814793|NCT00117598|1766151|FG003|After Treament Cross Over|Death|1
814794|NCT00117598|1766152|FG004|After Treament Cross Over|Death|2
814795|NCT00117598|1766148|FG000|After Treament Cross Over|Withdrawal by Subject|0
814796|NCT00117598|1766149|FG001|After Treament Cross Over|Withdrawal by Subject|0
814797|NCT00117598|1766150|FG002|After Treament Cross Over|Withdrawal by Subject|0
814798|NCT00117598|1766151|FG003|After Treament Cross Over|Withdrawal by Subject|1
814799|NCT00117598|1766152|FG004|After Treament Cross Over|Withdrawal by Subject|0
814800|NCT00117598|1766148|FG000|After Treament Cross Over|Other|0
814801|NCT00117598|1766149|FG001|After Treament Cross Over|Other|0
814802|NCT00117598|1766150|FG002|After Treament Cross Over|Other|0
814803|NCT00117598|1766151|FG003|After Treament Cross Over|Other|1
814804|NCT00117598|1766152|FG004|After Treament Cross Over|Other|2
814805|NCT00117637|1766164|FG000|First Intervention (Period 1)|Adverse Event|11
814806|NCT00117637|1766165|FG001|First Intervention (Period 1)|Adverse Event|16
814807|NCT00117637|1766164|FG000|First Intervention (Period 1)|Lost to Follow-up|0
814808|NCT00117637|1766165|FG001|First Intervention (Period 1)|Lost to Follow-up|2
814809|NCT00117637|1766164|FG000|First Intervention (Period 1)|Protocol Violation|1
814810|NCT00117637|1766165|FG001|First Intervention (Period 1)|Protocol Violation|0
814811|NCT00117637|1766164|FG000|First Intervention (Period 1)|Withdrawal by Subject|2
814812|NCT00117637|1766165|FG001|First Intervention (Period 1)|Withdrawal by Subject|4
814813|NCT00117637|1766164|FG000|First Intervention (Period 1)|study terminated by the sponsor|3
814814|NCT00117637|1766165|FG001|First Intervention (Period 1)|study terminated by the sponsor|1
814815|NCT00117637|1766164|FG000|First Intervention (Period 1)|protocol driven decision point|1
814816|NCT00117637|1766165|FG001|First Intervention (Period 1)|protocol driven decision point|0
814817|NCT00117637|1766164|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0
814818|NCT00117637|1766165|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1
814819|NCT00117637|1766164|FG000|First Intervention (Period 1)|reason not reported|0
814820|NCT00117637|1766165|FG001|First Intervention (Period 1)|reason not reported|1
814821|NCT00117637|1766164|FG000|Second Intervention (Period 2)|Adverse Event|0
814822|NCT00117637|1766165|FG001|Second Intervention (Period 2)|Adverse Event|9
814823|NCT00117637|1766164|FG000|Second Intervention (Period 2)|Lost to Follow-up|1
814824|NCT00117637|1766165|FG001|Second Intervention (Period 2)|Lost to Follow-up|0
814825|NCT00117637|1766164|FG000|Second Intervention (Period 2)|Protocol Violation|1
814826|NCT00117637|1766165|FG001|Second Intervention (Period 2)|Protocol Violation|0
814827|NCT00117637|1766164|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4
814828|NCT00117637|1766165|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3
814829|NCT00117637|1766164|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2
814830|NCT00117637|1766165|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9
814831|NCT00117637|1766164|FG000|Second Intervention (Period 2)|non compliant with study medication|1
814832|NCT00117637|1766165|FG001|Second Intervention (Period 2)|non compliant with study medication|1
814833|NCT00117637|1766164|FG000|Second Intervention (Period 2)|reason not reported|1
814834|NCT00117637|1766165|FG001|Second Intervention (Period 2)|reason not reported|0
814835|NCT00117676|1766180|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4
814836|NCT00117676|1766181|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3
814837|NCT00117676|1766180|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1
814838|NCT00117676|1766181|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0
814839|NCT00117676|1766180|FG000|Double-blind Period Through Week 48|Protocol Violation|0
814840|NCT00117676|1766181|FG001|Double-blind Period Through Week 48|Protocol Violation|1
814841|NCT00117676|1766180|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
814842|NCT00117676|1766181|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
814843|NCT00117676|1766180|FG000|Double-blind Period Through Week 48|Withdrew Consent|0
814844|NCT00117676|1766181|FG001|Double-blind Period Through Week 48|Withdrew Consent|1
814845|NCT00117676|1766180|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
814846|NCT00117676|1766181|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
814847|NCT00117676|1766180|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
814848|NCT00117676|1766181|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
814849|NCT00117676|1766180|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
814850|NCT00117676|1766181|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
814851|NCT00117676|1766180|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
814852|NCT00117676|1766181|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
814853|NCT00117676|1766180|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
814854|NCT00117676|1766181|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
814855|NCT00117676|1766180|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
814856|NCT00117676|1766181|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
814857|NCT00117676|1766180|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
814858|NCT00117676|1766181|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
814859|NCT00117676|1766180|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
814860|NCT00117676|1766181|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
814861|NCT00117676|1766180|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
814862|NCT00117676|1766181|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
814863|NCT00117676|1766180|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
814864|NCT00117676|1766181|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
814865|NCT00117676|1766180|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
814866|NCT00117676|1766181|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
814867|NCT00117676|1766180|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
814868|NCT00117676|1766181|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
814869|NCT00117676|1766180|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
814870|NCT00117676|1766181|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
814871|NCT00117676|1766180|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
814872|NCT00117676|1766181|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
814873|NCT00117676|1766180|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
814874|NCT00117676|1766181|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
814875|NCT00117676|1766180|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2
814876|NCT00117676|1766181|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0
814877|NCT00117676|1766180|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
814878|NCT00117676|1766181|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
814879|NCT00117676|1766180|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
814880|NCT00117676|1766181|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
814881|NCT00117676|1766180|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
814882|NCT00117676|1766181|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
814883|NCT00117676|1766180|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
814884|NCT00117676|1766181|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
814885|NCT00117676|1766180|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
814886|NCT00117676|1766181|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
814887|NCT00117676|1766180|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
814888|NCT00117676|1766181|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
814889|NCT00117676|1766180|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
814890|NCT00117676|1766181|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
814891|NCT00117676|1766180|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
814892|NCT00117676|1766181|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
814893|NCT00117676|1766180|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
814894|NCT00117676|1766181|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
814895|NCT00117676|1766180|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0
814896|NCT00117676|1766181|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1
814897|NCT00117676|1766180|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
814898|NCT00117676|1766181|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
814899|NCT00117676|1766180|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
814900|NCT00117676|1766181|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
814901|NCT00117676|1766180|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
814902|NCT00117676|1766181|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
814903|NCT00117676|1766180|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
814904|NCT00117676|1766181|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
814905|NCT00117793|1766196|FG000|Overall Study|Withdrawal by Subject|12
814906|NCT00117845|1766213|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1
814907|NCT00117949|1766221|FG000|Overall Study|Testosterone >1.0 ng/mL|10
814908|NCT00117949|1766222|FG001|Overall Study|Testosterone >1.0 ng/mL|18
814909|NCT00117949|1766223|FG002|Overall Study|Testosterone >1.0 ng/mL|17
814910|NCT00117949|1766224|FG003|Overall Study|Testosterone >1.0 ng/mL|15
814911|NCT00117949|1766221|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
814912|NCT00117949|1766222|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
814913|NCT00117949|1766223|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
814914|NCT00117949|1766224|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
814915|NCT00117949|1766221|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
814916|NCT00117949|1766222|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
814917|NCT00117949|1766223|FG002|Overall Study|Prostate-specific antigen increase >=25%|1
814918|NCT00117949|1766224|FG003|Overall Study|Prostate-specific antigen increase >=25%|2
814919|NCT00117949|1766221|FG000|Overall Study|PSA increase >=10ng/mL|0
814920|NCT00117949|1766222|FG001|Overall Study|PSA increase >=10ng/mL|1
814921|NCT00117949|1766223|FG002|Overall Study|PSA increase >=10ng/mL|1
814922|NCT00117949|1766224|FG003|Overall Study|PSA increase >=10ng/mL|0
814923|NCT00117949|1766221|FG000|Overall Study|PSA reduction <=50%|0
814924|NCT00117949|1766222|FG001|Overall Study|PSA reduction <=50%|2
814925|NCT00117949|1766223|FG002|Overall Study|PSA reduction <=50%|2
814926|NCT00117949|1766224|FG003|Overall Study|PSA reduction <=50%|4
814927|NCT00117949|1766221|FG000|Overall Study|Hepatic abnormalities|0
814928|NCT00117949|1766222|FG001|Overall Study|Hepatic abnormalities|1
814929|NCT00117949|1766223|FG002|Overall Study|Hepatic abnormalities|0
814930|NCT00117949|1766224|FG003|Overall Study|Hepatic abnormalities|1
814931|NCT00117988|1766243|FG000|Overall Study|Death|3
814932|NCT00117988|1766243|FG000|Overall Study|Adverse Event|1
814933|NCT00118040|1766250|FG000|Overall Study|Adverse Event|0
814934|NCT00118040|1766251|FG001|Overall Study|Adverse Event|1
814935|NCT00118040|1766252|FG002|Overall Study|Adverse Event|0
814936|NCT00118040|1766250|FG000|Overall Study|Withdrawal by Subject|0
814937|NCT00118040|1766251|FG001|Overall Study|Withdrawal by Subject|0
814938|NCT00118040|1766252|FG002|Overall Study|Withdrawal by Subject|2
814939|NCT00118040|1766250|FG000|Overall Study|Medical Contraindication|0
814940|NCT00118040|1766251|FG001|Overall Study|Medical Contraindication|0
814941|NCT00118040|1766252|FG002|Overall Study|Medical Contraindication|1
814942|NCT00118040|1766250|FG000|Overall Study|Non-Compliant Participant|1
814943|NCT00118040|1766251|FG001|Overall Study|Non-Compliant Participant|1
814944|NCT00118040|1766252|FG002|Overall Study|Non-Compliant Participant|2
814945|NCT00118040|1766250|FG000|Overall Study|Other|0
814946|NCT00118040|1766251|FG001|Overall Study|Other|0
814947|NCT00118040|1766252|FG002|Overall Study|Other|1
814948|NCT00118092|1766265|FG000|Overall Study|Withdrawal by Subject|1
814949|NCT00118092|1766265|FG000|Overall Study|Protocol Violation|1
814950|NCT00118157|1766279|FG000|Overall Study|Adverse Event|2
814951|NCT00118157|1766279|FG000|Overall Study|Death|8
814952|NCT00118157|1766279|FG000|Overall Study|Withdrawal by Subject|2
814953|NCT00118287|1766318|FG000|Overall Study|Intracranial haemorrhage|1
814954|NCT00118287|1766318|FG000|Overall Study|Muscle pain|1
814955|NCT00118417|1766398|FG000|Phase I (Weeks 0 to 6)|Remission|8
814956|NCT00118417|1766399|FG001|Phase I (Weeks 0 to 6)|Remission|0
814957|NCT00118417|1766398|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
814958|NCT00118417|1766399|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
814959|NCT00118417|1766398|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
814960|NCT00118417|1766399|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
814961|NCT00118417|1766398|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
814962|NCT00118417|1766399|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
814963|NCT00118417|1766398|FG000|Phase II (Weeks 6 to 12)|Remission|1
814964|NCT00118417|1766399|FG001|Phase II (Weeks 6 to 12)|Remission|2
814965|NCT00118430|1766412|FG000|Overall Study|Withdrawal by Subject|6
814966|NCT00118430|1766413|FG001|Overall Study|Withdrawal by Subject|2
814967|NCT00118430|1766414|FG002|Overall Study|Withdrawal by Subject|0
814968|NCT00118430|1766412|FG000|Overall Study|Lost to Follow-up|15
814969|NCT00118430|1766413|FG001|Overall Study|Lost to Follow-up|22
814970|NCT00118430|1766414|FG002|Overall Study|Lost to Follow-up|28
814971|NCT00118482|1766423|FG000|Overall Study|Lost to Follow-up|7
814972|NCT00118482|1766424|FG001|Overall Study|Lost to Follow-up|7
814973|NCT00118482|1766423|FG000|Overall Study|Withdrawal by Subject|23
814974|NCT00118482|1766424|FG001|Overall Study|Withdrawal by Subject|22
814975|NCT00118703|1766442|FG000|Overall Study|Protocol Violation|1
814976|NCT00118703|1766443|FG001|Overall Study|Protocol Violation|0
814977|NCT00118703|1766442|FG000|Overall Study|Adverse Event|1
814978|NCT00118703|1766443|FG001|Overall Study|Adverse Event|1
814979|NCT00118703|1766442|FG000|Overall Study|Participant took two different treatment|0
814980|NCT00118703|1766443|FG001|Overall Study|Participant took two different treatment|1
814981|NCT00118703|1766442|FG000|Overall Study|Withdrawal by Subject|2
814982|NCT00118703|1766443|FG001|Overall Study|Withdrawal by Subject|5
814983|NCT00118703|1766442|FG000|Overall Study|Lost to Follow-up|1
814984|NCT00118703|1766443|FG001|Overall Study|Lost to Follow-up|2
814985|NCT00118716|1766451|FG000|Overall Study|Adverse Event|2
814986|NCT00118716|1766452|FG001|Overall Study|Adverse Event|7
814987|NCT00118716|1766451|FG000|Overall Study|Protocol Violation|5
814988|NCT00118716|1766452|FG001|Overall Study|Protocol Violation|4
814989|NCT00118716|1766451|FG000|Overall Study|Withdrawal by Subject|0
814990|NCT00118716|1766452|FG001|Overall Study|Withdrawal by Subject|1
814991|NCT00118716|1766451|FG000|Overall Study|Exacerbation|2
814992|NCT00118716|1766452|FG001|Overall Study|Exacerbation|2
814993|NCT00118716|1766451|FG000|Overall Study|Discontinued by sponsor|1
814994|NCT00118716|1766452|FG001|Overall Study|Discontinued by sponsor|1
814995|NCT00118716|1766451|FG000|Overall Study|Non-compliance|1
814996|NCT00118716|1766452|FG001|Overall Study|Non-compliance|3
814997|NCT00118716|1766451|FG000|Overall Study|misrandomized|1
814998|NCT00118716|1766452|FG001|Overall Study|misrandomized|1
814999|NCT00118716|1766451|FG000|Overall Study|Expired drug use|1
815000|NCT00118716|1766452|FG001|Overall Study|Expired drug use|2
815001|NCT00118716|1766451|FG000|Overall Study|Investigator discretion|0
815002|NCT00118716|1766452|FG001|Overall Study|Investigator discretion|1
815003|NCT00118898|1766480|FG000|Overall Study|Death|6
815004|NCT00118898|1766481|FG001|Overall Study|Death|11
815005|NCT00118898|1766482|FG002|Overall Study|Death|6
815006|NCT00118898|1766483|FG003|Overall Study|Death|8
815007|NCT00118898|1766480|FG000|Overall Study|Lost to Follow-up|26
815008|NCT00118898|1766481|FG001|Overall Study|Lost to Follow-up|34
815009|NCT00118898|1766482|FG002|Overall Study|Lost to Follow-up|33
815010|NCT00118898|1766483|FG003|Overall Study|Lost to Follow-up|33
815011|NCT00118898|1766480|FG000|Overall Study|Withdrawal by Subject|10
815012|NCT00118898|1766481|FG001|Overall Study|Withdrawal by Subject|5
815013|NCT00118898|1766482|FG002|Overall Study|Withdrawal by Subject|8
815014|NCT00118898|1766483|FG003|Overall Study|Withdrawal by Subject|8
815015|NCT00118898|1766480|FG000|Overall Study|Site Closure|33
815016|NCT00118898|1766481|FG001|Overall Study|Site Closure|31
815017|NCT00118898|1766482|FG002|Overall Study|Site Closure|28
815018|NCT00118898|1766483|FG003|Overall Study|Site Closure|37
815019|NCT00118898|1766480|FG000|Overall Study|Severe debilitation|1
815020|NCT00118898|1766481|FG001|Overall Study|Severe debilitation|4
815021|NCT00118898|1766482|FG002|Overall Study|Severe debilitation|6
815022|NCT00118898|1766483|FG003|Overall Study|Severe debilitation|4
815023|NCT00118898|1766480|FG000|Overall Study|Not compliant with requirements|11
815024|NCT00118898|1766481|FG001|Overall Study|Not compliant with requirements|13
815025|NCT00118898|1766482|FG002|Overall Study|Not compliant with requirements|11
815026|NCT00118898|1766483|FG003|Overall Study|Not compliant with requirements|11
815027|NCT00118898|1766480|FG000|Overall Study|Not able to get to clinic|34
815028|NCT00118898|1766481|FG001|Overall Study|Not able to get to clinic|43
815029|NCT00118898|1766482|FG002|Overall Study|Not able to get to clinic|31
815030|NCT00118898|1766483|FG003|Overall Study|Not able to get to clinic|40
815031|NCT00118911|1766495|FG000|Overall Study|Withdrawal by Subject|2
815032|NCT00118911|1766496|FG001|Overall Study|Withdrawal by Subject|5
815033|NCT00119015|1766504|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
815034|NCT00119015|1766505|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
815035|NCT00119015|1766506|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
815036|NCT00119106|1766528|FG000|Overall Study|HIV infected at baseline|179
815037|NCT00119106|1766529|FG001|Overall Study|HIV infected at baseline|178
815038|NCT00119262|1766554|FG000|Overall Study|Lack of Efficacy|0
815039|NCT00119262|1766555|FG001|Overall Study|Lack of Efficacy|3
815040|NCT00119262|1766554|FG000|Overall Study|Withdrawal by Subject|12
815041|NCT00119262|1766555|FG001|Overall Study|Withdrawal by Subject|11
815042|NCT00119262|1766554|FG000|Overall Study|Adverse Event|33
815043|NCT00119262|1766555|FG001|Overall Study|Adverse Event|35
815044|NCT00119262|1766554|FG000|Overall Study|other disease|0
815045|NCT00119262|1766555|FG001|Overall Study|other disease|2
815046|NCT00119262|1766554|FG000|Overall Study|ineligble|1
815047|NCT00119262|1766555|FG001|Overall Study|ineligble|2
815048|NCT00119262|1766554|FG000|Overall Study|others|0
815049|NCT00119262|1766555|FG001|Overall Study|others|5
815050|NCT00119379|1766563|FG000|Overall Study|Adverse Event|4
815051|NCT00119379|1766564|FG001|Overall Study|Adverse Event|1
815052|NCT00119405|1766574|FG000|Overall Study|Withdrawal by Subject|1
815053|NCT00119678|1766580|FG000|Double-blind Treatment Period|Death|1
815054|NCT00119678|1766581|FG001|Double-blind Treatment Period|Death|0
815055|NCT00119678|1766580|FG000|Double-blind Treatment Period|Adverse Event|7
815056|NCT00119678|1766581|FG001|Double-blind Treatment Period|Adverse Event|1
815057|NCT00119678|1766580|FG000|Double-blind Treatment Period|Lack of Efficacy|21
815058|NCT00119678|1766581|FG001|Double-blind Treatment Period|Lack of Efficacy|12
815059|NCT00119678|1766580|FG000|Double-blind Treatment Period|Lost to Follow-up|1
815060|NCT00119678|1766581|FG001|Double-blind Treatment Period|Lost to Follow-up|2
815061|NCT00119678|1766580|FG000|Double-blind Treatment Period|Participant withdrew consent|4
815062|NCT00119678|1766581|FG001|Double-blind Treatment Period|Participant withdrew consent|4
815063|NCT00119678|1766580|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0
815064|NCT00119678|1766581|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1
815065|NCT00119678|1766580|FG000|Double-blind Treatment Period|Poor/Non-compliance|3
815066|NCT00119678|1766581|FG001|Double-blind Treatment Period|Poor/Non-compliance|0
815067|NCT00119678|1766580|FG000|Double-blind Treatment Period|Pregnancy|0
815068|NCT00119678|1766581|FG001|Double-blind Treatment Period|Pregnancy|2
815069|NCT00119678|1766580|FG000|Double-blind Treatment Period|Not treated|1
815070|NCT00119678|1766581|FG001|Double-blind Treatment Period|Not treated|2
815071|NCT00119678|1766580|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3
815072|NCT00119678|1766581|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2
815073|NCT00119678|1766580|FG000|Open-label Treatment Period|Death|1
815074|NCT00119678|1766581|FG001|Open-label Treatment Period|Death|0
815075|NCT00119678|1766580|FG000|Open-label Treatment Period|Adverse Event|3
815076|NCT00119678|1766581|FG001|Open-label Treatment Period|Adverse Event|0
815077|NCT00119678|1766580|FG000|Open-label Treatment Period|Lack of Efficacy|9
815078|NCT00119678|1766581|FG001|Open-label Treatment Period|Lack of Efficacy|0
815079|NCT00119678|1766580|FG000|Open-label Treatment Period|Lost to Follow-up|3
815080|NCT00119678|1766581|FG001|Open-label Treatment Period|Lost to Follow-up|0
815081|NCT00119678|1766580|FG000|Open-label Treatment Period|Participant withdrew consent|4
815082|NCT00119678|1766581|FG001|Open-label Treatment Period|Participant withdrew consent|0
815083|NCT00119678|1766580|FG000|Open-label Treatment Period|Participants not meeting study criteria|2
815084|NCT00119678|1766581|FG001|Open-label Treatment Period|Participants not meeting study criteria|0
815085|NCT00119678|1766580|FG000|Open-label Treatment Period|Pregnancy|1
815086|NCT00119678|1766581|FG001|Open-label Treatment Period|Pregnancy|0
815087|NCT00119678|1766580|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87
815088|NCT00119678|1766581|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0
815089|NCT00120042|1766601|FG000|Overall Study|all completed protocl|0
815090|NCT00120042|1766602|FG001|Overall Study|all completed protocl|0
815091|NCT00120042|1766603|FG002|Overall Study|all completed protocl|0
815092|NCT00120250|1766608|FG000|Overall Study|Lost to Follow-up|1
815093|NCT00120250|1766609|FG001|Overall Study|Lost to Follow-up|1
815094|NCT00120250|1766608|FG000|Overall Study|Protocol Violation|0
815095|NCT00120250|1766609|FG001|Overall Study|Protocol Violation|1
815096|NCT00120289|1766618|FG000|Overall Study|Death|96
815097|NCT00120289|1766619|FG001|Overall Study|Death|82
815098|NCT00120289|1766618|FG000|Overall Study|Lost to Follow-up|11
815099|NCT00120289|1766619|FG001|Overall Study|Lost to Follow-up|14
815100|NCT00120289|1766618|FG000|Overall Study|Withdrawal by Subject|14
815101|NCT00120289|1766619|FG001|Overall Study|Withdrawal by Subject|13
815102|NCT00120406|1766627|FG000|Overall Study|Death|9
815103|NCT00120406|1766628|FG001|Overall Study|Death|4
815104|NCT00120406|1766627|FG000|Overall Study|Withdrawal by Subject|5
815105|NCT00120406|1766628|FG001|Overall Study|Withdrawal by Subject|7
815106|NCT00120406|1766627|FG000|Overall Study|Lost to Follow-up|5
815107|NCT00120406|1766628|FG001|Overall Study|Lost to Follow-up|2
815108|NCT00120406|1766627|FG000|Overall Study|received non-study stent|0
815109|NCT00120406|1766628|FG001|Overall Study|received non-study stent|2
815110|NCT00120406|1766627|FG000|Overall Study|patient moved but has not withdrawn|0
815111|NCT00120406|1766628|FG001|Overall Study|patient moved but has not withdrawn|1
815112|NCT00120627|1766646|FG000|Overall Study|Withdrawal by Subject|5
815113|NCT00120627|1766647|FG001|Overall Study|Withdrawal by Subject|5
815114|NCT00120874|1766664|FG000|Overall Study|Death|0
815115|NCT00120874|1766665|FG001|Overall Study|Death|1
815116|NCT00121134|1766675|FG000|Overall Study|Progression of Disease|5
815117|NCT00121134|1766676|FG001|Overall Study|Progression of Disease|3
815118|NCT00121134|1766677|FG002|Overall Study|Progression of Disease|4
815119|NCT00121134|1766678|FG003|Overall Study|Progression of Disease|2
815120|NCT00121134|1766675|FG000|Overall Study|Toxicity|4
815121|NCT00121134|1766676|FG001|Overall Study|Toxicity|7
815122|NCT00121134|1766677|FG002|Overall Study|Toxicity|13
815123|NCT00121134|1766678|FG003|Overall Study|Toxicity|5
815124|NCT00121134|1766675|FG000|Overall Study|Physician Decision|6
815125|NCT00121134|1766676|FG001|Overall Study|Physician Decision|4
815126|NCT00121134|1766677|FG002|Overall Study|Physician Decision|4
815127|NCT00121134|1766678|FG003|Overall Study|Physician Decision|1
815128|NCT00121134|1766675|FG000|Overall Study|Treatment Delay|1
815129|NCT00121134|1766676|FG001|Overall Study|Treatment Delay|0
815130|NCT00121134|1766677|FG002|Overall Study|Treatment Delay|0
815131|NCT00121134|1766678|FG003|Overall Study|Treatment Delay|0
815132|NCT00121134|1766675|FG000|Overall Study|Intercurrent Illness|0
815133|NCT00121134|1766676|FG001|Overall Study|Intercurrent Illness|0
815134|NCT00121134|1766677|FG002|Overall Study|Intercurrent Illness|0
815135|NCT00121134|1766678|FG003|Overall Study|Intercurrent Illness|1
815136|NCT00121134|1766675|FG000|Overall Study|Patient Personal Reasons|0
815137|NCT00121134|1766676|FG001|Overall Study|Patient Personal Reasons|1
815138|NCT00121134|1766677|FG002|Overall Study|Patient Personal Reasons|0
815139|NCT00121134|1766678|FG003|Overall Study|Patient Personal Reasons|0
815140|NCT00121199|1766708|FG000|Overall Study|Adverse Event|11
815141|NCT00121199|1766708|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
815142|NCT00121199|1766708|FG000|Overall Study|Progression/Relapse|1
815143|NCT00121199|1766708|FG000|Overall Study|Death|3
815144|NCT00121199|1766708|FG000|Overall Study|Other - Not Protocol Specified|3
815145|NCT00121199|1766708|FG000|Overall Study|Ineligible|9
815146|NCT00121238|1766717|FG000|Overall Study|disease progression before intervention|1
815147|NCT00121238|1766717|FG000|Overall Study|Protocol Violation|2
815148|NCT00121485|1766735|FG000|Overall Study|Not implanted|1
815149|NCT00121485|1766736|FG001|Overall Study|Not implanted|5
815150|NCT00121485|1766735|FG000|Overall Study|Crossover|0
815151|NCT00121485|1766736|FG001|Overall Study|Crossover|2
815152|NCT00121641|1766747|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15
815153|NCT00121641|1766748|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21
815154|NCT00121641|1766749|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14
815155|NCT00121641|1766750|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25
815156|NCT00121641|1766751|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30
815157|NCT00121641|1766747|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9
815158|NCT00121641|1766748|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11
815159|NCT00121641|1766749|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5
815160|NCT00121641|1766750|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10
815161|NCT00121641|1766751|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3
815162|NCT00121641|1766747|FG000|24-week Short-term Treatment Period|Adverse Event|3
815163|NCT00121641|1766748|FG001|24-week Short-term Treatment Period|Adverse Event|3
815164|NCT00121641|1766749|FG002|24-week Short-term Treatment Period|Adverse Event|4
815165|NCT00121641|1766750|FG003|24-week Short-term Treatment Period|Adverse Event|0
815166|NCT00121641|1766751|FG004|24-week Short-term Treatment Period|Adverse Event|2
815167|NCT00121641|1766747|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0
815168|NCT00121641|1766748|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2
815169|NCT00121641|1766749|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3
815170|NCT00121641|1766750|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4
815171|NCT00121641|1766751|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4
815172|NCT00121641|1766747|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0
815173|NCT00121641|1766748|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0
815174|NCT00121641|1766749|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3
815175|NCT00121641|1766750|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1
815176|NCT00121641|1766751|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1
815177|NCT00121641|1766747|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
815178|NCT00121641|1766748|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
815179|NCT00121641|1766749|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
815180|NCT00121641|1766750|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
815181|NCT00121641|1766751|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
815182|NCT00121641|1766747|FG000|24-week Short-term Treatment Period|Other Reason|1
815183|NCT00121641|1766748|FG001|24-week Short-term Treatment Period|Other Reason|0
815184|NCT00121641|1766749|FG002|24-week Short-term Treatment Period|Other Reason|0
815185|NCT00121641|1766750|FG003|24-week Short-term Treatment Period|Other Reason|0
815186|NCT00121641|1766751|FG004|24-week Short-term Treatment Period|Other Reason|0
815187|NCT00121641|1766747|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26
815188|NCT00121641|1766748|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27
815189|NCT00121641|1766749|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21
815190|NCT00121641|1766750|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26
815191|NCT00121641|1766751|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25
815192|NCT00121641|1766747|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
815193|NCT00121641|1766748|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
815194|NCT00121641|1766749|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
815195|NCT00121641|1766750|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
815196|NCT00121641|1766751|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
815197|NCT00121641|1766747|FG000|48-month Short Term + Long Term Period|Adverse Event|9
815198|NCT00121641|1766748|FG001|48-month Short Term + Long Term Period|Adverse Event|10
815199|NCT00121641|1766749|FG002|48-month Short Term + Long Term Period|Adverse Event|10
815200|NCT00121641|1766750|FG003|48-month Short Term + Long Term Period|Adverse Event|5
815201|NCT00121641|1766751|FG004|48-month Short Term + Long Term Period|Adverse Event|5
815202|NCT00121641|1766747|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9
815203|NCT00121641|1766748|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7
815204|NCT00121641|1766749|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12
815205|NCT00121641|1766750|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11
815206|NCT00121641|1766751|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12
815207|NCT00121641|1766747|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4
815208|NCT00121641|1766748|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1
815209|NCT00121641|1766749|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4
815210|NCT00121641|1766750|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2
815211|NCT00121641|1766751|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2
815212|NCT00121641|1766747|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
815213|NCT00121641|1766748|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
815214|NCT00121641|1766749|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
815215|NCT00121641|1766750|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
815216|NCT00121641|1766751|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
815217|NCT00121641|1766747|FG000|48-month Short Term + Long Term Period|Pregnancy|0
815218|NCT00121641|1766748|FG001|48-month Short Term + Long Term Period|Pregnancy|1
815219|NCT00121641|1766749|FG002|48-month Short Term + Long Term Period|Pregnancy|0
815220|NCT00121641|1766750|FG003|48-month Short Term + Long Term Period|Pregnancy|1
815221|NCT00121641|1766751|FG004|48-month Short Term + Long Term Period|Pregnancy|0
815222|NCT00121641|1766747|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
815223|NCT00121641|1766748|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
815224|NCT00121641|1766749|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
815225|NCT00121641|1766750|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
815226|NCT00121641|1766751|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
815227|NCT00121641|1766747|FG000|48-month Short Term + Long Term Period|Death|0
815228|NCT00121641|1766748|FG001|48-month Short Term + Long Term Period|Death|0
815229|NCT00121641|1766749|FG002|48-month Short Term + Long Term Period|Death|0
815230|NCT00121641|1766750|FG003|48-month Short Term + Long Term Period|Death|1
815231|NCT00121641|1766751|FG004|48-month Short Term + Long Term Period|Death|0
815232|NCT00121641|1766747|FG000|48-month Short Term + Long Term Period|Missing|0
815233|NCT00121641|1766748|FG001|48-month Short Term + Long Term Period|Missing|0
815234|NCT00121641|1766749|FG002|48-month Short Term + Long Term Period|Missing|1
815235|NCT00121641|1766750|FG003|48-month Short Term + Long Term Period|Missing|0
815236|NCT00121641|1766751|FG004|48-month Short Term + Long Term Period|Missing|0
815237|NCT00121641|1766747|FG000|48-month Short Term + Long Term Period|Other Reason|5
815238|NCT00121641|1766748|FG001|48-month Short Term + Long Term Period|Other Reason|3
815239|NCT00121641|1766749|FG002|48-month Short Term + Long Term Period|Other Reason|2
815240|NCT00121641|1766750|FG003|48-month Short Term + Long Term Period|Other Reason|0
815241|NCT00121641|1766751|FG004|48-month Short Term + Long Term Period|Other Reason|1
815242|NCT00121667|1766769|FG000|Short Term (ST) Period|Lack of Efficacy|25
815243|NCT00121667|1766770|FG001|Short Term (ST) Period|Lack of Efficacy|22
815244|NCT00121667|1766771|FG002|Short Term (ST) Period|Lack of Efficacy|27
815245|NCT00121667|1766772|FG003|Short Term (ST) Period|Lack of Efficacy|44
815246|NCT00121667|1766769|FG000|Short Term (ST) Period|Subject Withdrew Consent|8
815247|NCT00121667|1766770|FG001|Short Term (ST) Period|Subject Withdrew Consent|13
815248|NCT00121667|1766771|FG002|Short Term (ST) Period|Subject Withdrew Consent|4
815249|NCT00121667|1766772|FG003|Short Term (ST) Period|Subject Withdrew Consent|11
815250|NCT00121667|1766769|FG000|Short Term (ST) Period|Adverse Event|5
815251|NCT00121667|1766770|FG001|Short Term (ST) Period|Adverse Event|6
815252|NCT00121667|1766771|FG002|Short Term (ST) Period|Adverse Event|5
815253|NCT00121667|1766772|FG003|Short Term (ST) Period|Adverse Event|3
815254|NCT00121667|1766769|FG000|Short Term (ST) Period|Lost to Follow-up|3
815255|NCT00121667|1766770|FG001|Short Term (ST) Period|Lost to Follow-up|4
815256|NCT00121667|1766771|FG002|Short Term (ST) Period|Lost to Follow-up|4
815257|NCT00121667|1766772|FG003|Short Term (ST) Period|Lost to Follow-up|3
815258|NCT00121667|1766769|FG000|Short Term (ST) Period|Poor / Non-compliance|0
815259|NCT00121667|1766770|FG001|Short Term (ST) Period|Poor / Non-compliance|1
815260|NCT00121667|1766771|FG002|Short Term (ST) Period|Poor / Non-compliance|1
815261|NCT00121667|1766772|FG003|Short Term (ST) Period|Poor / Non-compliance|2
815262|NCT00121667|1766769|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
815263|NCT00121667|1766770|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
815264|NCT00121667|1766771|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
815265|NCT00121667|1766772|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
815266|NCT00121667|1766769|FG000|Short Term (ST) Period|Other Reason|3
815267|NCT00121667|1766770|FG001|Short Term (ST) Period|Other Reason|0
815268|NCT00121667|1766771|FG002|Short Term (ST) Period|Other Reason|0
815269|NCT00121667|1766772|FG003|Short Term (ST) Period|Other Reason|0
815270|NCT00121667|1766769|FG000|Short Term (ST) Period|Death|0
815271|NCT00121667|1766770|FG001|Short Term (ST) Period|Death|0
815272|NCT00121667|1766771|FG002|Short Term (ST) Period|Death|0
815273|NCT00121667|1766772|FG003|Short Term (ST) Period|Death|1
815274|NCT00121667|1766769|FG000|Short Term (ST) Period|Pregnancy|0
815275|NCT00121667|1766770|FG001|Short Term (ST) Period|Pregnancy|0
815276|NCT00121667|1766771|FG002|Short Term (ST) Period|Pregnancy|0
815277|NCT00121667|1766772|FG003|Short Term (ST) Period|Pregnancy|1
815278|NCT00121667|1766769|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
815279|NCT00121667|1766770|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
815280|NCT00121667|1766771|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
815281|NCT00121667|1766772|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
815282|NCT00121667|1766769|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
815283|NCT00121667|1766770|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
815284|NCT00121667|1766771|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
815285|NCT00121667|1766772|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
815286|NCT00121667|1766769|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
815287|NCT00121667|1766770|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
815288|NCT00121667|1766771|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
815289|NCT00121667|1766772|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
815290|NCT00121667|1766769|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
815291|NCT00121667|1766770|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
815292|NCT00121667|1766771|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
815293|NCT00121667|1766772|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
815294|NCT00121667|1766769|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5
815295|NCT00121667|1766770|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7
815296|NCT00121667|1766771|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6
815297|NCT00121667|1766772|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3
815298|NCT00121667|1766769|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
815299|NCT00121667|1766770|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
815300|NCT00121667|1766771|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
815301|NCT00121667|1766772|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
815302|NCT00121667|1766769|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
815303|NCT00121667|1766770|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
815304|NCT00121667|1766771|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
815305|NCT00121667|1766772|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
815306|NCT00121667|1766769|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
815307|NCT00121667|1766770|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
815308|NCT00121667|1766771|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
815309|NCT00121667|1766772|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
815310|NCT00121667|1766769|FG000|Short Term (ST) + Long Term (LT) Period|Death|1
815311|NCT00121667|1766770|FG001|Short Term (ST) + Long Term (LT) Period|Death|0
815312|NCT00121667|1766771|FG002|Short Term (ST) + Long Term (LT) Period|Death|0
815313|NCT00121667|1766772|FG003|Short Term (ST) + Long Term (LT) Period|Death|2
815314|NCT00121992|1766865|FG000|Overall Study|Treatment not received|2
815315|NCT00121992|1766866|FG001|Overall Study|Treatment not received|11
815316|NCT00122109|1766874|FG000|Overall Study|Did not meet criteria|6
815317|NCT00122109|1766875|FG001|Overall Study|Did not meet criteria|7
815318|NCT00122135|1766886|FG000|Overall Study|Withdrawal by Subject|3
815319|NCT00122135|1766887|FG001|Overall Study|Withdrawal by Subject|0
815320|NCT00122187|1766895|FG000|Overall Study|Withdrew because of resource limitations|2
815321|NCT00122187|1766896|FG001|Overall Study|Withdrew because of resource limitations|2
815322|NCT00122278|1766906|FG000|Overall Study|Lost to Follow-up|2
815323|NCT00122278|1766907|FG001|Overall Study|Lost to Follow-up|0
815324|NCT00122317|1766913|FG000|Overall Study|Death|3
815325|NCT00122317|1766913|FG000|Overall Study|Adverse Event|4
815326|NCT00122317|1766913|FG000|Overall Study|Physician Decision|2
815327|NCT00122317|1766913|FG000|Overall Study|patient non-compliance|1
815328|NCT00122317|1766913|FG000|Overall Study|Withdrawal by Subject|1
815329|NCT00122382|1766935|FG000|Double-Blind Study|Adverse Event|9
815330|NCT00122382|1766936|FG001|Double-Blind Study|Adverse Event|11
815331|NCT00122382|1766937|FG002|Double-Blind Study|Adverse Event|0
815332|NCT00122382|1766935|FG000|Double-Blind Study|Death|2
815333|NCT00122382|1766936|FG001|Double-Blind Study|Death|2
815334|NCT00122382|1766937|FG002|Double-Blind Study|Death|0
815335|NCT00122382|1766935|FG000|Double-Blind Study|Lack of Efficacy|0
815336|NCT00122382|1766936|FG001|Double-Blind Study|Lack of Efficacy|8
815337|NCT00122382|1766937|FG002|Double-Blind Study|Lack of Efficacy|0
815338|NCT00122382|1766935|FG000|Double-Blind Study|Lost to Follow-up|2
815339|NCT00122382|1766936|FG001|Double-Blind Study|Lost to Follow-up|1
815340|NCT00122382|1766937|FG002|Double-Blind Study|Lost to Follow-up|0
815341|NCT00122382|1766935|FG000|Double-Blind Study|Pregnancy|2
815342|NCT00122382|1766936|FG001|Double-Blind Study|Pregnancy|0
815343|NCT00122382|1766937|FG002|Double-Blind Study|Pregnancy|0
815344|NCT00122382|1766935|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1
815345|NCT00122382|1766936|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0
815346|NCT00122382|1766937|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0
815347|NCT00122382|1766935|FG000|Double-Blind Study|Withdrawal of Consent|7
815348|NCT00122382|1766936|FG001|Double-Blind Study|Withdrawal of Consent|3
815349|NCT00122382|1766937|FG002|Double-Blind Study|Withdrawal of Consent|0
815350|NCT00122382|1766935|FG000|Double-Blind Study|Protocol Violation|1
815351|NCT00122382|1766936|FG001|Double-Blind Study|Protocol Violation|0
815352|NCT00122382|1766937|FG002|Double-Blind Study|Protocol Violation|0
815353|NCT00122382|1766935|FG000|Double-Blind Study|Methotrexate Discontinued|0
815354|NCT00122382|1766936|FG001|Double-Blind Study|Methotrexate Discontinued|1
815355|NCT00122382|1766937|FG002|Double-Blind Study|Methotrexate Discontinued|0
815356|NCT00122382|1766935|FG000|Double-Blind Study|Randomized but not treated|0
815357|NCT00122382|1766936|FG001|Double-Blind Study|Randomized but not treated|2
815358|NCT00122382|1766937|FG002|Double-Blind Study|Randomized but not treated|0
815359|NCT00122382|1766935|FG000|Open-Label Study|Adverse Event|0
815360|NCT00122382|1766936|FG001|Open-Label Study|Adverse Event|0
815361|NCT00122382|1766937|FG002|Open-Label Study|Adverse Event|11
815362|NCT00122382|1766935|FG000|Open-Label Study|Death|0
815363|NCT00122382|1766936|FG001|Open-Label Study|Death|0
815364|NCT00122382|1766937|FG002|Open-Label Study|Death|2
815365|NCT00122382|1766935|FG000|Open-Label Study|Lack of Efficacy|0
815366|NCT00122382|1766936|FG001|Open-Label Study|Lack of Efficacy|0
815367|NCT00122382|1766937|FG002|Open-Label Study|Lack of Efficacy|3
815368|NCT00122382|1766935|FG000|Open-Label Study|Lost to Follow-up|0
815369|NCT00122382|1766936|FG001|Open-Label Study|Lost to Follow-up|0
815370|NCT00122382|1766937|FG002|Open-Label Study|Lost to Follow-up|3
815371|NCT00122382|1766935|FG000|Open-Label Study|Pregnancy|0
815372|NCT00122382|1766936|FG001|Open-Label Study|Pregnancy|0
815373|NCT00122382|1766937|FG002|Open-Label Study|Pregnancy|2
815374|NCT00122382|1766935|FG000|Open-Label Study|Poor/Non-Compliance|0
815375|NCT00122382|1766936|FG001|Open-Label Study|Poor/Non-Compliance|0
815376|NCT00122382|1766937|FG002|Open-Label Study|Poor/Non-Compliance|1
815377|NCT00122382|1766935|FG000|Open-Label Study|Withdrawal of Consent|0
815378|NCT00122382|1766936|FG001|Open-Label Study|Withdrawal of Consent|0
815379|NCT00122382|1766937|FG002|Open-Label Study|Withdrawal of Consent|4
815380|NCT00122460|1766978|FG000|Overall Study|investigational study phase ongoing|7
815381|NCT00122460|1766979|FG001|Overall Study|investigational study phase ongoing|1
815382|NCT00122681|1766987|FG000|Overall Study|Adverse Event|20
815383|NCT00122681|1766988|FG001|Overall Study|Adverse Event|16
815384|NCT00122681|1766987|FG000|Overall Study|Lost to Follow-up|1080
815385|NCT00122681|1766988|FG001|Overall Study|Lost to Follow-up|1097
815386|NCT00122681|1766987|FG000|Overall Study|Protocol Violation|7
815387|NCT00122681|1766988|FG001|Overall Study|Protocol Violation|10
815388|NCT00122681|1766987|FG000|Overall Study|Withdrawal by Subject|257
815389|NCT00122681|1766988|FG001|Overall Study|Withdrawal by Subject|251
815390|NCT00122681|1766987|FG000|Overall Study|Personal reasons|150
815391|NCT00122681|1766988|FG001|Overall Study|Personal reasons|147
815392|NCT00122954|1767004|FG000|Overall Study|Withdrawal by Subject|2
815393|NCT00122954|1767005|FG001|Overall Study|Withdrawal by Subject|2
815394|NCT00122954|1767004|FG000|Overall Study|Protocol Violation|0
815395|NCT00122954|1767005|FG001|Overall Study|Protocol Violation|1
815396|NCT00122980|1767013|FG000|Overall Study|Death|0
815397|NCT00122980|1767014|FG001|Overall Study|Death|1
815398|NCT00122980|1767013|FG000|Overall Study|Physician Decision|2
815399|NCT00122980|1767014|FG001|Overall Study|Physician Decision|0
815400|NCT00122980|1767013|FG000|Overall Study|Protocol Violation|5
815401|NCT00122980|1767014|FG001|Overall Study|Protocol Violation|1
815402|NCT00122980|1767013|FG000|Overall Study|Withdrawal by Subject|2
815403|NCT00122980|1767014|FG001|Overall Study|Withdrawal by Subject|3
815404|NCT00122980|1767013|FG000|Overall Study|Adjudicated stroke (study endpoint)|7
815405|NCT00122980|1767014|FG001|Overall Study|Adjudicated stroke (study endpoint)|0
815406|NCT00122980|1767013|FG000|Overall Study|Study termination|27
815407|NCT00122980|1767014|FG001|Overall Study|Study termination|35
815408|NCT00123422|1767069|FG000|Overall Study|Physician Decision|2
815409|NCT00123422|1767070|FG001|Overall Study|Physician Decision|2
815410|NCT00123422|1767071|FG002|Overall Study|Physician Decision|6
815411|NCT00123422|1767069|FG000|Overall Study|Withdrawal by Subject|1
815412|NCT00123422|1767070|FG001|Overall Study|Withdrawal by Subject|2
815413|NCT00123422|1767071|FG002|Overall Study|Withdrawal by Subject|2
815414|NCT00123422|1767069|FG000|Overall Study|Lost to Follow-up|1
815415|NCT00123422|1767070|FG001|Overall Study|Lost to Follow-up|2
815416|NCT00123422|1767071|FG002|Overall Study|Lost to Follow-up|2
815417|NCT00123474|1767083|FG000|Randomized to Treatment|Randomized, never treated|1
815418|NCT00123474|1767084|FG001|Randomized to Treatment|Randomized, never treated|4
815419|NCT00123474|1767085|FG002|Randomized to Treatment|Randomized, never treated|2
815420|NCT00123474|1767086|FG003|Randomized to Treatment|Randomized, never treated|1
815421|NCT00123474|1767083|FG000|As Treated at Study Closure|not reported when site closed|1
815422|NCT00123474|1767084|FG001|As Treated at Study Closure|not reported when site closed|0
815423|NCT00123474|1767085|FG002|As Treated at Study Closure|not reported when site closed|1
815424|NCT00123474|1767086|FG003|As Treated at Study Closure|not reported when site closed|0
815425|NCT00123474|1767083|FG000|As Treated at Study Closure|Adverse Event|10
815426|NCT00123474|1767084|FG001|As Treated at Study Closure|Adverse Event|4
815427|NCT00123474|1767085|FG002|As Treated at Study Closure|Adverse Event|10
815428|NCT00123474|1767086|FG003|As Treated at Study Closure|Adverse Event|8
815429|NCT00123474|1767083|FG000|As Treated at Study Closure|Disease Progression|35
815430|NCT00123474|1767084|FG001|As Treated at Study Closure|Disease Progression|42
815431|NCT00123474|1767085|FG002|As Treated at Study Closure|Disease Progression|29
815432|NCT00123474|1767086|FG003|As Treated at Study Closure|Disease Progression|27
815433|NCT00123474|1767083|FG000|As Treated at Study Closure|Investigator Request|12
815434|NCT00123474|1767084|FG001|As Treated at Study Closure|Investigator Request|6
815435|NCT00123474|1767085|FG002|As Treated at Study Closure|Investigator Request|7
815436|NCT00123474|1767086|FG003|As Treated at Study Closure|Investigator Request|5
815437|NCT00123474|1767083|FG000|As Treated at Study Closure|non-specified|54
815438|NCT00123474|1767084|FG001|As Treated at Study Closure|non-specified|47
815439|NCT00123474|1767085|FG002|As Treated at Study Closure|non-specified|57
815440|NCT00123474|1767086|FG003|As Treated at Study Closure|non-specified|60
815441|NCT00123474|1767083|FG000|As Treated at Study Closure|Study Drug Toxicity|39
815442|NCT00123474|1767084|FG001|As Treated at Study Closure|Study Drug Toxicity|45
815443|NCT00123474|1767085|FG002|As Treated at Study Closure|Study Drug Toxicity|45
815444|NCT00123474|1767086|FG003|As Treated at Study Closure|Study Drug Toxicity|51
815445|NCT00123474|1767083|FG000|As Treated at Study Closure|Withdrawal by Subject|14
815446|NCT00123474|1767084|FG001|As Treated at Study Closure|Withdrawal by Subject|19
815447|NCT00123474|1767085|FG002|As Treated at Study Closure|Withdrawal by Subject|18
815448|NCT00123474|1767086|FG003|As Treated at Study Closure|Withdrawal by Subject|16
815449|NCT00123487|1767119|FG000|Randomized|Death prior to starting treatment|0
815450|NCT00123487|1767120|FG001|Randomized|Death prior to starting treatment|1
815451|NCT00123487|1767119|FG000|Randomized|SAE prior to starting treatment|1
815452|NCT00123487|1767120|FG001|Randomized|SAE prior to starting treatment|0
815453|NCT00123487|1767119|FG000|Treated With Study Drug|Adverse Event|23
815454|NCT00123487|1767120|FG001|Treated With Study Drug|Adverse Event|22
815455|NCT00123487|1767119|FG000|Treated With Study Drug|Disease Progression|141
815456|NCT00123487|1767120|FG001|Treated With Study Drug|Disease Progression|122
815457|NCT00123487|1767119|FG000|Treated With Study Drug|Physician Decision|8
815458|NCT00123487|1767120|FG001|Treated With Study Drug|Physician Decision|9
815459|NCT00123487|1767119|FG000|Treated With Study Drug|Other|59
815460|NCT00123487|1767120|FG001|Treated With Study Drug|Other|58
815461|NCT00123487|1767119|FG000|Treated With Study Drug|Study Drug Toxicity|62
815462|NCT00123487|1767120|FG001|Treated With Study Drug|Study Drug Toxicity|80
815463|NCT00123487|1767119|FG000|Treated With Study Drug|Withdrawal by Subject|11
815464|NCT00123487|1767120|FG001|Treated With Study Drug|Withdrawal by Subject|13
815465|NCT00123487|1767119|FG000|Treated With Study Drug|Unknown (case report form lost)|0
815466|NCT00123487|1767120|FG001|Treated With Study Drug|Unknown (case report form lost)|1
815467|NCT00123734|1767175|FG000|Overall Study|Death|3
815468|NCT00123734|1767175|FG000|Overall Study|Lost to Follow-up|3
815469|NCT00123734|1767175|FG000|Overall Study|Dropout|1
815470|NCT00123734|1767175|FG000|Overall Study|Withdrawal by Subject|1
815471|NCT00123955|1767184|FG000|Overall Study|Adverse Event|1
815472|NCT00123955|1767185|FG001|Overall Study|Adverse Event|0
815473|NCT00123955|1767184|FG000|Overall Study|Withdrawal by Subject|4
815474|NCT00123955|1767185|FG001|Overall Study|Withdrawal by Subject|3
815475|NCT00123955|1767184|FG000|Overall Study|Death|0
815476|NCT00123955|1767185|FG001|Overall Study|Death|1
815477|NCT00124020|1767193|FG000|Overall Study|Death|67
815478|NCT00124020|1767194|FG001|Overall Study|Death|71
815479|NCT00124020|1767193|FG000|Overall Study|Withdrawal by Subject|13
815480|NCT00124020|1767194|FG001|Overall Study|Withdrawal by Subject|11
815481|NCT00124020|1767193|FG000|Overall Study|Lost to Follow-up|5
815482|NCT00124020|1767194|FG001|Overall Study|Lost to Follow-up|8
815483|NCT00124020|1767193|FG000|Overall Study|Other|1
815484|NCT00124020|1767194|FG001|Overall Study|Other|1
815485|NCT00124020|1767193|FG000|Overall Study|Transfer to another hospital|2
815486|NCT00124020|1767194|FG001|Overall Study|Transfer to another hospital|0
815487|NCT00124072|1767204|FG000|Overall Study|Lost to Follow-up for Mortality|0
815488|NCT00124072|1767205|FG001|Overall Study|Lost to Follow-up for Mortality|3
815489|NCT00124072|1767206|FG002|Overall Study|Lost to Follow-up for Mortality|2
815490|NCT00124072|1767207|FG003|Overall Study|Lost to Follow-up for Mortality|2
815491|NCT00124072|1767204|FG000|Overall Study|Lost to Follow-up for Morbidity|15
815492|NCT00124072|1767205|FG001|Overall Study|Lost to Follow-up for Morbidity|25
815493|NCT00124072|1767206|FG002|Overall Study|Lost to Follow-up for Morbidity|19
815494|NCT00124072|1767207|FG003|Overall Study|Lost to Follow-up for Morbidity|18
815495|NCT00124072|1767204|FG000|Overall Study|Death|499
815496|NCT00124072|1767205|FG001|Overall Study|Death|484
815497|NCT00124072|1767206|FG002|Overall Study|Death|471
815498|NCT00124072|1767207|FG003|Overall Study|Death|480
815579|NCT00124943|1767358|FG002|Phase II|Adverse Event|0
815499|NCT00124449|1767228|FG000|6-month Double-Blind Treatment Period|Adverse Event|1
815500|NCT00124449|1767229|FG001|6-month Double-Blind Treatment Period|Adverse Event|0
815501|NCT00124449|1767228|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3
815502|NCT00124449|1767229|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8
815503|NCT00124449|1767228|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
815504|NCT00124449|1767229|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
815505|NCT00124449|1767228|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
815506|NCT00124449|1767229|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
815507|NCT00124449|1767228|FG000|6-month Double-Blind Treatment Period|Sponsor request|0
815508|NCT00124449|1767229|FG001|6-month Double-Blind Treatment Period|Sponsor request|1
815509|NCT00124449|1767228|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
815510|NCT00124449|1767229|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
815511|NCT00124449|1767228|FG000|18-Month Untreated Observation Period|Adverse Event|0
815512|NCT00124449|1767229|FG001|18-Month Untreated Observation Period|Adverse Event|1
815513|NCT00124449|1767228|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11
815514|NCT00124449|1767229|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12
815515|NCT00124449|1767228|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1
815516|NCT00124449|1767229|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0
815517|NCT00124449|1767228|FG000|18-Month Untreated Observation Period|Pregnancy|1
815518|NCT00124449|1767229|FG001|18-Month Untreated Observation Period|Pregnancy|0
815519|NCT00124449|1767228|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1
815520|NCT00124449|1767229|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0
815521|NCT00124449|1767228|FG000|18-Month Untreated Observation Period|Relocated|1
815522|NCT00124449|1767229|FG001|18-Month Untreated Observation Period|Relocated|0
815523|NCT00124462|1767238|FG000|Overall Study|Lost to Follow-up|3
815524|NCT00124462|1767239|FG001|Overall Study|Lost to Follow-up|3
815525|NCT00124462|1767238|FG000|Overall Study|Physician Decision|3
815526|NCT00124462|1767239|FG001|Overall Study|Physician Decision|4
815527|NCT00124462|1767238|FG000|Overall Study|Withdrawal by Subject|4
815528|NCT00124462|1767239|FG001|Overall Study|Withdrawal by Subject|5
815529|NCT00124462|1767238|FG000|Overall Study|Device fitting, n=2, other hlth issues|1
815530|NCT00124462|1767239|FG001|Overall Study|Device fitting, n=2, other hlth issues|1
815531|NCT00124618|1767266|FG000|Overall Study|Ineligible|1
815532|NCT00124657|1767273|FG000|Overall Study|Toxicity|0
815533|NCT00124657|1767274|FG001|Overall Study|Toxicity|0
815534|NCT00124657|1767275|FG002|Overall Study|Toxicity|1
815535|NCT00124657|1767273|FG000|Overall Study|Non-compliance|1
815536|NCT00124657|1767274|FG001|Overall Study|Non-compliance|0
815537|NCT00124657|1767275|FG002|Overall Study|Non-compliance|4
815538|NCT00124657|1767273|FG000|Overall Study|Progressive disease|14
815539|NCT00124657|1767274|FG001|Overall Study|Progressive disease|5
815540|NCT00124657|1767275|FG002|Overall Study|Progressive disease|27
815541|NCT00124657|1767273|FG000|Overall Study|Intercurrent illness|1
815542|NCT00124657|1767274|FG001|Overall Study|Intercurrent illness|0
815543|NCT00124657|1767275|FG002|Overall Study|Intercurrent illness|0
815544|NCT00124709|1767298|FG000|Overall Study|Randomized but did not take medication|3
815545|NCT00124709|1767299|FG001|Overall Study|Randomized but did not take medication|1
815546|NCT00124709|1767298|FG000|Overall Study|Adverse Event|3
815547|NCT00124709|1767299|FG001|Overall Study|Adverse Event|0
815548|NCT00124709|1767298|FG000|Overall Study|Lack of Efficacy|5
815549|NCT00124709|1767299|FG001|Overall Study|Lack of Efficacy|10
815550|NCT00124709|1767298|FG000|Overall Study|Protocol Violation|3
815551|NCT00124709|1767299|FG001|Overall Study|Protocol Violation|5
815552|NCT00124709|1767298|FG000|Overall Study|Withdrawal by Subject|127
815553|NCT00124709|1767299|FG001|Overall Study|Withdrawal by Subject|136
815554|NCT00124709|1767298|FG000|Overall Study|Lost to Follow-up|114
815555|NCT00124709|1767299|FG001|Overall Study|Lost to Follow-up|120
815556|NCT00124748|1767340|FG000|Overall Study|Adverse Event|8
815557|NCT00124748|1767341|FG001|Overall Study|Adverse Event|39
815558|NCT00124748|1767340|FG000|Overall Study|Abnormal laboratory Value|2
815559|NCT00124748|1767341|FG001|Overall Study|Abnormal laboratory Value|2
815560|NCT00124748|1767340|FG000|Overall Study|Abnormal Procedure|0
815561|NCT00124748|1767341|FG001|Overall Study|Abnormal Procedure|1
815562|NCT00124748|1767340|FG000|Overall Study|Lack of Efficacy|20
815563|NCT00124748|1767341|FG001|Overall Study|Lack of Efficacy|41
815564|NCT00124748|1767340|FG000|Overall Study|No longer requires study drug|1
815565|NCT00124748|1767341|FG001|Overall Study|No longer requires study drug|1
815566|NCT00124748|1767340|FG000|Overall Study|Protocol Violation|3
815567|NCT00124748|1767341|FG001|Overall Study|Protocol Violation|1
815568|NCT00124748|1767340|FG000|Overall Study|Withdrawal by Subject|5
815569|NCT00124748|1767341|FG001|Overall Study|Withdrawal by Subject|15
815570|NCT00124748|1767340|FG000|Overall Study|Lost to Follow-up|2
815571|NCT00124748|1767341|FG001|Overall Study|Lost to Follow-up|7
815572|NCT00124748|1767340|FG000|Overall Study|Administrative Problem(Study Terminated)|101
815573|NCT00124748|1767341|FG001|Overall Study|Administrative Problem(Study Terminated)|174
815574|NCT00124748|1767340|FG000|Overall Study|Death|1
815575|NCT00124748|1767341|FG001|Overall Study|Death|3
815576|NCT00124917|1767347|FG000|Overall Study|Physician Decision|3
815577|NCT00124943|1767356|FG000|Phase II|Adverse Event|0
815578|NCT00124943|1767357|FG001|Phase II|Adverse Event|2
815580|NCT00124943|1767359|FG003|Phase II|Adverse Event|1
815581|NCT00124943|1767356|FG000|Phase II|Protocol Violation|0
815582|NCT00124943|1767357|FG001|Phase II|Protocol Violation|0
815583|NCT00124943|1767358|FG002|Phase II|Protocol Violation|0
815584|NCT00124943|1767359|FG003|Phase II|Protocol Violation|1
815585|NCT00124943|1767356|FG000|Phase II|Lost to Follow-up|0
815586|NCT00124943|1767357|FG001|Phase II|Lost to Follow-up|0
815587|NCT00124943|1767358|FG002|Phase II|Lost to Follow-up|0
815588|NCT00124943|1767359|FG003|Phase II|Lost to Follow-up|1
815589|NCT00124943|1767356|FG000|Phase II|Withdrawal by Subject|0
815590|NCT00124943|1767357|FG001|Phase II|Withdrawal by Subject|0
815591|NCT00124943|1767358|FG002|Phase II|Withdrawal by Subject|0
815592|NCT00124943|1767359|FG003|Phase II|Withdrawal by Subject|2
815593|NCT00124982|1767371|FG000|Short-term Period|Death|1
815594|NCT00124982|1767372|FG001|Short-term Period|Death|1
815595|NCT00124982|1767373|FG002|Short-term Period|Death|0
815596|NCT00124982|1767371|FG000|Short-term Period|Adverse Event|17
815597|NCT00124982|1767372|FG001|Short-term Period|Adverse Event|22
815598|NCT00124982|1767373|FG002|Short-term Period|Adverse Event|0
815599|NCT00124982|1767371|FG000|Short-term Period|Lack of Efficacy|32
815600|NCT00124982|1767372|FG001|Short-term Period|Lack of Efficacy|73
815601|NCT00124982|1767373|FG002|Short-term Period|Lack of Efficacy|0
815602|NCT00124982|1767371|FG000|Short-term Period|Lost to Follow-up|8
815603|NCT00124982|1767372|FG001|Short-term Period|Lost to Follow-up|5
815604|NCT00124982|1767373|FG002|Short-term Period|Lost to Follow-up|0
815605|NCT00124982|1767371|FG000|Short-term Period|Withdrawal of Consent|7
815606|NCT00124982|1767372|FG001|Short-term Period|Withdrawal of Consent|9
815607|NCT00124982|1767373|FG002|Short-term Period|Withdrawal of Consent|0
815608|NCT00124982|1767371|FG000|Short-term Period|Poor/Non-compliance|3
815609|NCT00124982|1767372|FG001|Short-term Period|Poor/Non-compliance|1
815610|NCT00124982|1767373|FG002|Short-term Period|Poor/Non-compliance|0
815611|NCT00124982|1767371|FG000|Short-term Period|No Longer Meets Study Criteria|1
815612|NCT00124982|1767372|FG001|Short-term Period|No Longer Meets Study Criteria|2
815613|NCT00124982|1767373|FG002|Short-term Period|No Longer Meets Study Criteria|0
815614|NCT00124982|1767371|FG000|Short-term Period|Participant Decision|1
815615|NCT00124982|1767372|FG001|Short-term Period|Participant Decision|0
815616|NCT00124982|1767373|FG002|Short-term Period|Participant Decision|0
815617|NCT00124982|1767371|FG000|Short-term Period|Participant Chose Own Doctor|0
815618|NCT00124982|1767372|FG001|Short-term Period|Participant Chose Own Doctor|1
815619|NCT00124982|1767373|FG002|Short-term Period|Participant Chose Own Doctor|0
815620|NCT00124982|1767371|FG000|Short-term Period|Investigator Decision-No Specific AE|1
815621|NCT00124982|1767372|FG001|Short-term Period|Investigator Decision-No Specific AE|0
815622|NCT00124982|1767373|FG002|Short-term Period|Investigator Decision-No Specific AE|0
815623|NCT00124982|1767371|FG000|Short-term Period|Participant Had Lymphopenia|1
815624|NCT00124982|1767372|FG001|Short-term Period|Participant Had Lymphopenia|0
815625|NCT00124982|1767373|FG002|Short-term Period|Participant Had Lymphopenia|0
815626|NCT00124982|1767371|FG000|Long-term Period|Death|0
815627|NCT00124982|1767372|FG001|Long-term Period|Death|0
815628|NCT00124982|1767373|FG002|Long-term Period|Death|1
815629|NCT00124982|1767371|FG000|Long-term Period|Adverse Event|0
815630|NCT00124982|1767372|FG001|Long-term Period|Adverse Event|0
815631|NCT00124982|1767373|FG002|Long-term Period|Adverse Event|17
815632|NCT00124982|1767371|FG000|Long-term Period|Lack of Efficacy|0
815633|NCT00124982|1767372|FG001|Long-term Period|Lack of Efficacy|0
815634|NCT00124982|1767373|FG002|Long-term Period|Lack of Efficacy|46
815635|NCT00124982|1767371|FG000|Long-term Period|Lost to Follow-up|0
815636|NCT00124982|1767372|FG001|Long-term Period|Lost to Follow-up|0
815637|NCT00124982|1767373|FG002|Long-term Period|Lost to Follow-up|4
815638|NCT00124982|1767371|FG000|Long-term Period|Withdrawal by Subject|0
815639|NCT00124982|1767372|FG001|Long-term Period|Withdrawal by Subject|0
815640|NCT00124982|1767373|FG002|Long-term Period|Withdrawal by Subject|16
815641|NCT00124982|1767371|FG000|Long-term Period|Pregnancy|0
815642|NCT00124982|1767372|FG001|Long-term Period|Pregnancy|0
815643|NCT00124982|1767373|FG002|Long-term Period|Pregnancy|1
815644|NCT00124982|1767371|FG000|Long-term Period|Poor/Non-compliance|0
815645|NCT00124982|1767372|FG001|Long-term Period|Poor/Non-compliance|0
815646|NCT00124982|1767373|FG002|Long-term Period|Poor/Non-compliance|2
815647|NCT00124982|1767371|FG000|Long-term Period|Administrative Reason by Sponsor|0
815648|NCT00124982|1767372|FG001|Long-term Period|Administrative Reason by Sponsor|0
815649|NCT00124982|1767373|FG002|Long-term Period|Administrative Reason by Sponsor|1
815650|NCT00124982|1767371|FG000|Long-term Period|Neurologist Recommendation|0
815651|NCT00124982|1767372|FG001|Long-term Period|Neurologist Recommendation|0
815652|NCT00124982|1767373|FG002|Long-term Period|Neurologist Recommendation|1
815653|NCT00125138|1767395|FG000|Overall Study|Adverse Event|1
815654|NCT00125138|1767396|FG001|Overall Study|Adverse Event|0
815655|NCT00125138|1767397|FG002|Overall Study|Adverse Event|3
815656|NCT00125138|1767398|FG003|Overall Study|Adverse Event|2
815657|NCT00125138|1767395|FG000|Overall Study|Withdrawal by Subject|2
815658|NCT00125138|1767396|FG001|Overall Study|Withdrawal by Subject|3
815659|NCT00125138|1767397|FG002|Overall Study|Withdrawal by Subject|1
815660|NCT00125138|1767398|FG003|Overall Study|Withdrawal by Subject|1
815661|NCT00125138|1767395|FG000|Overall Study|Lack of Efficacy|0
815662|NCT00125138|1767396|FG001|Overall Study|Lack of Efficacy|0
815663|NCT00125138|1767397|FG002|Overall Study|Lack of Efficacy|0
815664|NCT00125138|1767398|FG003|Overall Study|Lack of Efficacy|1
815665|NCT00125138|1767395|FG000|Overall Study|Sponsor decision-pt moved to assist care|0
815666|NCT00125138|1767396|FG001|Overall Study|Sponsor decision-pt moved to assist care|0
815667|NCT00125138|1767397|FG002|Overall Study|Sponsor decision-pt moved to assist care|0
815668|NCT00125138|1767398|FG003|Overall Study|Sponsor decision-pt moved to assist care|1
815669|NCT00125164|1767412|FG000|Overall Study|Adverse Event|0
815670|NCT00125164|1767413|FG001|Overall Study|Adverse Event|0
815671|NCT00125164|1767414|FG002|Overall Study|Adverse Event|2
815672|NCT00125164|1767415|FG003|Overall Study|Adverse Event|4
815673|NCT00125164|1767412|FG000|Overall Study|Lost to Follow-up|0
815674|NCT00125164|1767413|FG001|Overall Study|Lost to Follow-up|0
815675|NCT00125164|1767414|FG002|Overall Study|Lost to Follow-up|1
815676|NCT00125164|1767415|FG003|Overall Study|Lost to Follow-up|1
815677|NCT00125164|1767412|FG000|Overall Study|Withdrawal by Subject|2
815678|NCT00125164|1767413|FG001|Overall Study|Withdrawal by Subject|0
815679|NCT00125164|1767414|FG002|Overall Study|Withdrawal by Subject|1
815680|NCT00125164|1767415|FG003|Overall Study|Withdrawal by Subject|1
815681|NCT00125190|1767425|FG000|Overall Study|Subject/Parent Decision|7
815682|NCT00125190|1767425|FG000|Overall Study|Non-compliance|2
815683|NCT00125190|1767425|FG000|Overall Study|Adverse Event|1
815684|NCT00125190|1767425|FG000|Overall Study|Other|1
815685|NCT00125190|1767425|FG000|Overall Study|Lost to Follow-up|4
815686|NCT00125242|1767432|FG000|Overall Study|did not qualify|7
815687|NCT00125242|1767433|FG001|Overall Study|did not qualify|2
815688|NCT00125359|1767438|FG000|Overall Study|Death|4
815689|NCT00125359|1767438|FG000|Overall Study|Adverse Event|5
815690|NCT00125359|1767438|FG000|Overall Study|Physician Decision|14
815691|NCT00125853|1767511|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3
815692|NCT00125853|1767512|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7
815693|NCT00126126|1767542|FG000|Overall Study|Lost to Follow-up|0
815694|NCT00126126|1767543|FG001|Overall Study|Lost to Follow-up|2
815695|NCT00126191|1767551|FG000|Overall Study|Physician Decision|0
815696|NCT00126191|1767552|FG001|Overall Study|Physician Decision|1
815697|NCT00126191|1767551|FG000|Overall Study|Death|0
815698|NCT00126191|1767552|FG001|Overall Study|Death|1
815699|NCT00126425|1767560|FG000|Overall Study|Withdrawal by Subject|17
815700|NCT00126425|1767561|FG001|Overall Study|Withdrawal by Subject|1
815701|NCT00126425|1767560|FG000|Overall Study|Lost to Follow-up|8
815702|NCT00126425|1767561|FG001|Overall Study|Lost to Follow-up|4
815703|NCT00126425|1767560|FG000|Overall Study|Protocol Violation|9
815704|NCT00126425|1767561|FG001|Overall Study|Protocol Violation|6
815705|NCT00126425|1767560|FG000|Overall Study|Adverse Event|1
815706|NCT00126425|1767561|FG001|Overall Study|Adverse Event|0
815707|NCT00126425|1767560|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1
815708|NCT00126425|1767561|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0
815709|NCT00126425|1767560|FG000|Overall Study|Other|5
815710|NCT00126425|1767561|FG001|Overall Study|Other|0
815711|NCT00126438|1767569|FG000|Overall Study|Withdrawal due to adverse event|1
815712|NCT00126438|1767570|FG001|Overall Study|Withdrawal due to adverse event|0
815713|NCT00126438|1767569|FG000|Overall Study|Lost to Follow-up|22
815714|NCT00126438|1767570|FG001|Overall Study|Lost to Follow-up|0
815715|NCT00126438|1767569|FG000|Overall Study|Protocol Violation|8
815716|NCT00126438|1767570|FG001|Overall Study|Protocol Violation|8
815717|NCT00126438|1767569|FG000|Overall Study|Withdrawal by Subject|3
815718|NCT00126438|1767570|FG001|Overall Study|Withdrawal by Subject|2
815719|NCT00126490|1767576|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1
815720|NCT00126503|1767582|FG000|Overall Study|disease progression|23
815721|NCT00126503|1767583|FG001|Overall Study|disease progression|14
815722|NCT00126503|1767582|FG000|Overall Study|Withdrawal by Subject|0
815723|NCT00126503|1767583|FG001|Overall Study|Withdrawal by Subject|1
815724|NCT00126503|1767582|FG000|Overall Study|alternative therapy|1
815725|NCT00126503|1767583|FG001|Overall Study|alternative therapy|1
815726|NCT00126503|1767582|FG000|Overall Study|other complicating disease|4
815727|NCT00126503|1767583|FG001|Overall Study|other complicating disease|1
815728|NCT00126503|1767582|FG000|Overall Study|Death|3
815729|NCT00126503|1767583|FG001|Overall Study|Death|0
815730|NCT00126503|1767582|FG000|Overall Study|Adverse Event|13
815731|NCT00126503|1767583|FG001|Overall Study|Adverse Event|3
815732|NCT00126503|1767582|FG000|Overall Study|non-compliant|1
815733|NCT00126503|1767583|FG001|Overall Study|non-compliant|0
815734|NCT00126503|1767582|FG000|Overall Study|Physician Decision|2
815735|NCT00126503|1767583|FG001|Overall Study|Physician Decision|1
815736|NCT00126555|1767593|FG000|Overall Study|Withdrawal by Subject|1
815737|NCT00126555|1767593|FG000|Overall Study|Adverse Event|2
815738|NCT00126555|1767593|FG000|Overall Study|Progressive Disease|3
815739|NCT00126568|1767609|FG000|Overall Study|Death|2
815740|NCT00126581|1767616|FG000|Overall Study|Adverse Event|3
815741|NCT00126581|1767617|FG001|Overall Study|Adverse Event|7
815742|NCT00126581|1767616|FG000|Overall Study|Death|3
815743|NCT00126581|1767617|FG001|Overall Study|Death|2
815744|NCT00126581|1767616|FG000|Overall Study|Withdrawal by Subject|1
815745|NCT00126581|1767617|FG001|Overall Study|Withdrawal by Subject|4
815746|NCT00126581|1767616|FG000|Overall Study|Alternative therapy|3
815747|NCT00126581|1767617|FG001|Overall Study|Alternative therapy|3
815748|NCT00126581|1767616|FG000|Overall Study|Other illness/MD discretion|3
815749|NCT00126581|1767617|FG001|Overall Study|Other illness/MD discretion|4
815750|NCT00126594|1767627|FG000|Overall Study|Ineligible|2
815751|NCT00126594|1767628|FG001|Overall Study|Ineligible|0
815752|NCT00126594|1767627|FG000|Overall Study|Withdrawal by Subject|0
815753|NCT00126594|1767628|FG001|Overall Study|Withdrawal by Subject|4
815754|NCT00126594|1767627|FG000|Overall Study|Physician Decision|1
815755|NCT00126594|1767628|FG001|Overall Study|Physician Decision|3
815756|NCT00126594|1767627|FG000|Overall Study|Adverse Event|7
815757|NCT00126594|1767628|FG001|Overall Study|Adverse Event|5
815758|NCT00126594|1767627|FG000|Overall Study|Non-compliance|0
815759|NCT00126594|1767628|FG001|Overall Study|Non-compliance|1
815760|NCT00126594|1767627|FG000|Overall Study|Disease Progression|29
815761|NCT00126594|1767628|FG001|Overall Study|Disease Progression|24
815762|NCT00126776|1767666|FG000|Overall Study|follow up complete on all patients|0
815763|NCT00126776|1767667|FG001|Overall Study|follow up complete on all patients|0
815764|NCT00127036|1767673|FG000|Overall Study|Insufficient Data for Analysis|6
815765|NCT00127036|1767674|FG001|Overall Study|Insufficient Data for Analysis|11
815766|NCT00127036|1767673|FG000|Overall Study|Screen Failure|2
815767|NCT00127036|1767674|FG001|Overall Study|Screen Failure|0
815768|NCT00127101|1767699|FG000|Base Protocol|Adverse Event|0
815769|NCT00127101|1767700|FG001|Base Protocol|Adverse Event|2
815770|NCT00127101|1767701|FG002|Base Protocol|Adverse Event|1
815771|NCT00127101|1767702|FG003|Base Protocol|Adverse Event|0
815772|NCT00127101|1767703|FG004|Base Protocol|Adverse Event|0
815773|NCT00127101|1767704|FG005|Base Protocol|Adverse Event|0
815774|NCT00127101|1767699|FG000|Base Protocol|Lack of Efficacy|1
815775|NCT00127101|1767700|FG001|Base Protocol|Lack of Efficacy|0
815776|NCT00127101|1767701|FG002|Base Protocol|Lack of Efficacy|0
815777|NCT00127101|1767702|FG003|Base Protocol|Lack of Efficacy|0
815778|NCT00127101|1767703|FG004|Base Protocol|Lack of Efficacy|2
815779|NCT00127101|1767704|FG005|Base Protocol|Lack of Efficacy|0
815780|NCT00127101|1767699|FG000|Base Protocol|Withdrawal by Subject|1
815781|NCT00127101|1767700|FG001|Base Protocol|Withdrawal by Subject|2
815782|NCT00127101|1767701|FG002|Base Protocol|Withdrawal by Subject|1
815783|NCT00127101|1767702|FG003|Base Protocol|Withdrawal by Subject|0
815784|NCT00127101|1767703|FG004|Base Protocol|Withdrawal by Subject|0
815785|NCT00127101|1767704|FG005|Base Protocol|Withdrawal by Subject|1
815786|NCT00127101|1767699|FG000|Continuation Phase|Adverse Event|0
815787|NCT00127101|1767700|FG001|Continuation Phase|Adverse Event|0
815788|NCT00127101|1767701|FG002|Continuation Phase|Adverse Event|0
815789|NCT00127101|1767702|FG003|Continuation Phase|Adverse Event|0
815790|NCT00127101|1767703|FG004|Continuation Phase|Adverse Event|1
815791|NCT00127101|1767704|FG005|Continuation Phase|Adverse Event|1
815792|NCT00127101|1767699|FG000|Continuation Phase|Lack of Efficacy|0
815793|NCT00127101|1767700|FG001|Continuation Phase|Lack of Efficacy|0
815794|NCT00127101|1767701|FG002|Continuation Phase|Lack of Efficacy|0
815795|NCT00127101|1767702|FG003|Continuation Phase|Lack of Efficacy|0
815796|NCT00127101|1767703|FG004|Continuation Phase|Lack of Efficacy|0
815797|NCT00127101|1767704|FG005|Continuation Phase|Lack of Efficacy|1
815798|NCT00127101|1767699|FG000|Continuation Phase|Withdrawal by Subject|0
815799|NCT00127101|1767700|FG001|Continuation Phase|Withdrawal by Subject|0
815800|NCT00127101|1767701|FG002|Continuation Phase|Withdrawal by Subject|1
815801|NCT00127101|1767702|FG003|Continuation Phase|Withdrawal by Subject|0
815802|NCT00127101|1767703|FG004|Continuation Phase|Withdrawal by Subject|2
815803|NCT00127101|1767704|FG005|Continuation Phase|Withdrawal by Subject|1
815804|NCT00127166|1767720|FG000|Period I|Protocol Violation|0
815805|NCT00127166|1767721|FG001|Period I|Protocol Violation|2
815806|NCT00127166|1767720|FG000|Period I|Withdrawal by Subject|2
815807|NCT00127166|1767721|FG001|Period I|Withdrawal by Subject|0
815808|NCT00127166|1767720|FG000|Period I|Patient did not meet inclusion criteria|1
815809|NCT00127166|1767721|FG001|Period I|Patient did not meet inclusion criteria|0
815810|NCT00127166|1767720|FG000|Washout Period|Patient did not meet inclusion criteria|0
815811|NCT00127166|1767721|FG001|Washout Period|Patient did not meet inclusion criteria|1
815812|NCT00127166|1767720|FG000|Period II|Withdrawal by Subject|2
815813|NCT00127166|1767721|FG001|Period II|Withdrawal by Subject|0
815814|NCT00127166|1767720|FG000|Period II|Patient did not perform Visit 6 exercise|1
815815|NCT00127166|1767721|FG001|Period II|Patient did not perform Visit 6 exercise|0
815816|NCT00127192|1767732|FG000|Overall Study|Adverse Event|0
815817|NCT00127192|1767733|FG001|Overall Study|Adverse Event|1
815818|NCT00127192|1767734|FG002|Overall Study|Adverse Event|1
815819|NCT00127192|1767735|FG003|Overall Study|Adverse Event|1
815820|NCT00127192|1767736|FG004|Overall Study|Adverse Event|0
815821|NCT00127192|1767732|FG000|Overall Study|Lack of Efficacy|2
815822|NCT00127192|1767733|FG001|Overall Study|Lack of Efficacy|0
815823|NCT00127192|1767734|FG002|Overall Study|Lack of Efficacy|0
815824|NCT00127192|1767735|FG003|Overall Study|Lack of Efficacy|0
815825|NCT00127192|1767736|FG004|Overall Study|Lack of Efficacy|2
815826|NCT00127192|1767732|FG000|Overall Study|Withdrawal by Subject|0
815827|NCT00127192|1767733|FG001|Overall Study|Withdrawal by Subject|0
815828|NCT00127192|1767734|FG002|Overall Study|Withdrawal by Subject|1
815829|NCT00127192|1767735|FG003|Overall Study|Withdrawal by Subject|0
815830|NCT00127192|1767736|FG004|Overall Study|Withdrawal by Subject|3
815831|NCT00127192|1767732|FG000|Overall Study|Adverse event in pre-treatment period|1
815832|NCT00127192|1767733|FG001|Overall Study|Adverse event in pre-treatment period|0
815833|NCT00127192|1767734|FG002|Overall Study|Adverse event in pre-treatment period|0
815834|NCT00127192|1767735|FG003|Overall Study|Adverse event in pre-treatment period|0
815835|NCT00127192|1767736|FG004|Overall Study|Adverse event in pre-treatment period|0
815836|NCT00127205|1767751|FG000|Overall Study|Adverse Event|228
815837|NCT00127205|1767752|FG001|Overall Study|Adverse Event|387
815838|NCT00127205|1767753|FG002|Overall Study|Adverse Event|273
815839|NCT00127205|1767751|FG000|Overall Study|Death|8
815840|NCT00127205|1767752|FG001|Overall Study|Death|6
815841|NCT00127205|1767753|FG002|Overall Study|Death|5
815842|NCT00127205|1767751|FG000|Overall Study|Withdrawal by Subject|318
815843|NCT00127205|1767752|FG001|Overall Study|Withdrawal by Subject|310
815844|NCT00127205|1767753|FG002|Overall Study|Withdrawal by Subject|172
815845|NCT00127205|1767751|FG000|Overall Study|Other-non protocol specified|142
815846|NCT00127205|1767752|FG001|Overall Study|Other-non protocol specified|129
815847|NCT00127205|1767753|FG002|Overall Study|Other-non protocol specified|77
815848|NCT00127205|1767751|FG000|Overall Study|Data not reported|6
815849|NCT00127205|1767752|FG001|Overall Study|Data not reported|10
815850|NCT00127205|1767753|FG002|Overall Study|Data not reported|1
815851|NCT00127205|1767751|FG000|Overall Study|Progression|127
815852|NCT00127205|1767752|FG001|Overall Study|Progression|131
815853|NCT00127205|1767753|FG002|Overall Study|Progression|84
815854|NCT00127413|1767787|FG000|Overall Study|Lost to Follow-up|6
815855|NCT00127413|1767788|FG001|Overall Study|Lost to Follow-up|4
815856|NCT00127413|1767789|FG002|Overall Study|Lost to Follow-up|8
815857|NCT00127413|1767790|FG003|Overall Study|Lost to Follow-up|2
815858|NCT00127608|1767821|FG000|Overall Study|VZV DNA negative|1
815859|NCT00127660|1767829|FG000|Overall Study|Protocol Violation|3
815860|NCT00127660|1767830|FG001|Overall Study|Protocol Violation|3
815861|NCT00127660|1767831|FG002|Overall Study|Protocol Violation|5
815862|NCT00127660|1767832|FG003|Overall Study|Protocol Violation|0
815863|NCT00127712|1767844|FG000|Overall Study|Adverse Event|3
815864|NCT00127712|1767845|FG001|Overall Study|Adverse Event|0
815865|NCT00127712|1767844|FG000|Overall Study|Lack of GI access to continue|2
815866|NCT00127712|1767845|FG001|Overall Study|Lack of GI access to continue|0
815867|NCT00127803|1767872|FG000|Overall Study|Adverse Event|2
815868|NCT00127803|1767873|FG001|Overall Study|Adverse Event|0
815869|NCT00127803|1767874|FG002|Overall Study|Adverse Event|0
815870|NCT00127803|1767875|FG003|Overall Study|Adverse Event|0
815871|NCT00127803|1767872|FG000|Overall Study|Withdrawal by Subject|1
815872|NCT00127803|1767873|FG001|Overall Study|Withdrawal by Subject|0
815873|NCT00127803|1767874|FG002|Overall Study|Withdrawal by Subject|0
815874|NCT00127803|1767875|FG003|Overall Study|Withdrawal by Subject|0
815875|NCT00127803|1767872|FG000|Overall Study|Lost to Follow-up|0
815876|NCT00127803|1767873|FG001|Overall Study|Lost to Follow-up|0
815877|NCT00127803|1767874|FG002|Overall Study|Lost to Follow-up|0
815878|NCT00127803|1767875|FG003|Overall Study|Lost to Follow-up|1
815879|NCT00127842|1767885|FG000|Overall Study|Adverse Event|15
815880|NCT00127842|1767885|FG000|Overall Study|Withdrawal by Subject|3
815881|NCT00127842|1767885|FG000|Overall Study|Lost to Follow-up|1
815882|NCT00127842|1767885|FG000|Overall Study|Lack of Efficacy|12
815883|NCT00127842|1767885|FG000|Overall Study|Noncompliance|2
815884|NCT00127842|1767885|FG000|Overall Study|Protocol Violation|1
815885|NCT00127842|1767885|FG000|Overall Study|Other|5
815886|NCT00127855|1767894|FG000|Primary Vaccination Course|Adverse Event|0
815887|NCT00127855|1767895|FG001|Primary Vaccination Course|Adverse Event|0
815888|NCT00127855|1767896|FG002|Primary Vaccination Course|Adverse Event|1
815889|NCT00127855|1767897|FG003|Primary Vaccination Course|Adverse Event|0
815890|NCT00127855|1767898|FG004|Primary Vaccination Course|Adverse Event|0
815891|NCT00127855|1767894|FG000|Primary Vaccination Course|Withdrawal by Subject|1
815892|NCT00127855|1767895|FG001|Primary Vaccination Course|Withdrawal by Subject|0
815893|NCT00127855|1767896|FG002|Primary Vaccination Course|Withdrawal by Subject|0
815894|NCT00127855|1767897|FG003|Primary Vaccination Course|Withdrawal by Subject|0
815895|NCT00127855|1767898|FG004|Primary Vaccination Course|Withdrawal by Subject|1
815896|NCT00127855|1767894|FG000|Primary Vaccination Course|Lost to Follow-up|1
815897|NCT00127855|1767895|FG001|Primary Vaccination Course|Lost to Follow-up|1
815898|NCT00127855|1767896|FG002|Primary Vaccination Course|Lost to Follow-up|1
815899|NCT00127855|1767897|FG003|Primary Vaccination Course|Lost to Follow-up|0
815900|NCT00127855|1767898|FG004|Primary Vaccination Course|Lost to Follow-up|2
815901|NCT00127855|1767894|FG000|Primary Vaccination Course|Other|0
815902|NCT00127855|1767895|FG001|Primary Vaccination Course|Other|0
815903|NCT00127855|1767896|FG002|Primary Vaccination Course|Other|0
815904|NCT00127855|1767897|FG003|Primary Vaccination Course|Other|0
815905|NCT00127855|1767898|FG004|Primary Vaccination Course|Other|1
815906|NCT00127933|1767912|FG000|Overall Study|Randomized but not dosed|1
815907|NCT00127933|1767913|FG001|Overall Study|Randomized but not dosed|0
815908|NCT00128102|1767921|FG000|Overall Study|Site Discontinued|3
815909|NCT00128102|1767922|FG001|Overall Study|Site Discontinued|6
815910|NCT00128102|1767921|FG000|Overall Study|Other|0
815911|NCT00128102|1767922|FG001|Overall Study|Other|1
815912|NCT00128102|1767921|FG000|Overall Study|Progressive Disease|255
815913|NCT00128102|1767922|FG001|Overall Study|Progressive Disease|285
815914|NCT00128102|1767921|FG000|Overall Study|Adverse Event|34
815915|NCT00128102|1767922|FG001|Overall Study|Adverse Event|11
815916|NCT00128102|1767921|FG000|Overall Study|Death|12
815917|NCT00128102|1767922|FG001|Overall Study|Death|13
815918|NCT00128102|1767921|FG000|Overall Study|Physician Decision|3
815919|NCT00128102|1767922|FG001|Overall Study|Physician Decision|3
815920|NCT00128102|1767921|FG000|Overall Study|Withdrawal by Subject|19
815921|NCT00128102|1767922|FG001|Overall Study|Withdrawal by Subject|11
815922|NCT00128102|1767921|FG000|Overall Study|Protocol Violation|2
815923|NCT00128102|1767922|FG001|Overall Study|Protocol Violation|2
815924|NCT00128206|1768042|FG000|Overall Study|Lost to Follow-up|137
815925|NCT00128206|1768043|FG001|Overall Study|Lost to Follow-up|118
815926|NCT00128206|1768042|FG000|Overall Study|Adverse Event|0
815927|NCT00128206|1768043|FG001|Overall Study|Adverse Event|2
815928|NCT00128492|1768070|FG000|Overall Study|AE unrelated to study|2
815929|NCT00128492|1768071|FG001|Overall Study|AE unrelated to study|9
815930|NCT00128492|1768070|FG000|Overall Study|Study drug intolerance (AE)|2
815931|NCT00128492|1768071|FG001|Overall Study|Study drug intolerance (AE)|8
815932|NCT00128492|1768070|FG000|Overall Study|AE related to study|1
815933|NCT00128492|1768071|FG001|Overall Study|AE related to study|4
815934|NCT00128492|1768070|FG000|Overall Study|Death|1
815935|NCT00128492|1768071|FG001|Overall Study|Death|0
815936|NCT00128492|1768070|FG000|Overall Study|Lost to Follow-up|1
815937|NCT00128492|1768071|FG001|Overall Study|Lost to Follow-up|5
815938|NCT00128492|1768070|FG000|Overall Study|Noncompliance|0
815939|NCT00128492|1768071|FG001|Overall Study|Noncompliance|5
815940|NCT00128492|1768070|FG000|Overall Study|Personal or administrative|10
815941|NCT00128492|1768071|FG001|Overall Study|Personal or administrative|22
815942|NCT00128492|1768070|FG000|Overall Study|Withdrawal by Subject|3
815943|NCT00128492|1768071|FG001|Overall Study|Withdrawal by Subject|5
815944|NCT00128492|1768070|FG000|Overall Study|Pregnancy|0
815945|NCT00128492|1768071|FG001|Overall Study|Pregnancy|1
815946|NCT00128661|1768079|FG000|Overall Study|Adverse Event|14
815947|NCT00128661|1768080|FG001|Overall Study|Adverse Event|11
815948|NCT00128661|1768079|FG000|Overall Study|Lost to Follow-up|10
815949|NCT00128661|1768080|FG001|Overall Study|Lost to Follow-up|7
815950|NCT00128661|1768079|FG000|Overall Study|Withdrawal by Subject|243
815951|NCT00128661|1768080|FG001|Overall Study|Withdrawal by Subject|232
815952|NCT00128661|1768079|FG000|Overall Study|Other|7
815953|NCT00128661|1768080|FG001|Overall Study|Other|8
815954|NCT00128830|1768099|FG000|Overall Study|Adverse Event|10
815955|NCT00128830|1768099|FG000|Overall Study|Withdrawal by Subject|14
815956|NCT00128830|1768099|FG000|Overall Study|Lost to Follow-up|4
815957|NCT00128830|1768099|FG000|Overall Study|Reached a virologic endpoint|29
815958|NCT00128830|1768099|FG000|Overall Study|Non-compliant|4
815959|NCT00128830|1768099|FG000|Overall Study|Discontinued or ineligible for study|2
815960|NCT00128830|1768099|FG000|Overall Study|Other|9
815961|NCT00129116|1768125|FG000|Primary Phase|Lost to Follow-up|1
815962|NCT00129116|1768126|FG001|Primary Phase|Lost to Follow-up|1
815963|NCT00129116|1768127|FG002|Primary Phase|Lost to Follow-up|0
815964|NCT00129116|1768128|FG003|Primary Phase|Lost to Follow-up|1
815965|NCT00129116|1768129|FG004|Primary Phase|Lost to Follow-up|1
815966|NCT00129116|1768125|FG000|Primary Phase|Protocol Violation|0
815967|NCT00129116|1768126|FG001|Primary Phase|Protocol Violation|1
815968|NCT00129116|1768127|FG002|Primary Phase|Protocol Violation|0
815969|NCT00129116|1768128|FG003|Primary Phase|Protocol Violation|0
815970|NCT00129116|1768129|FG004|Primary Phase|Protocol Violation|0
815971|NCT00129116|1768125|FG000|Primary Phase|Adverse Event|1
815972|NCT00129116|1768126|FG001|Primary Phase|Adverse Event|1
815973|NCT00129116|1768127|FG002|Primary Phase|Adverse Event|0
815974|NCT00129116|1768128|FG003|Primary Phase|Adverse Event|0
815975|NCT00129116|1768129|FG004|Primary Phase|Adverse Event|0
815976|NCT00129116|1768125|FG000|Primary Phase|Withdrawal by Subject|0
815977|NCT00129116|1768126|FG001|Primary Phase|Withdrawal by Subject|1
815978|NCT00129116|1768127|FG002|Primary Phase|Withdrawal by Subject|0
815979|NCT00129116|1768128|FG003|Primary Phase|Withdrawal by Subject|0
815980|NCT00129116|1768129|FG004|Primary Phase|Withdrawal by Subject|0
815981|NCT00129116|1768125|FG000|Primary Phase|Other|0
815982|NCT00129116|1768126|FG001|Primary Phase|Other|0
815983|NCT00129116|1768127|FG002|Primary Phase|Other|1
815984|NCT00129116|1768128|FG003|Primary Phase|Other|0
815985|NCT00129116|1768129|FG004|Primary Phase|Other|0
815986|NCT00129116|1768125|FG000|Booster Phase|Lost to Follow-up|2
815987|NCT00129116|1768126|FG001|Booster Phase|Lost to Follow-up|0
815988|NCT00129116|1768127|FG002|Booster Phase|Lost to Follow-up|0
815989|NCT00129116|1768128|FG003|Booster Phase|Lost to Follow-up|0
815990|NCT00129116|1768129|FG004|Booster Phase|Lost to Follow-up|1
815991|NCT00129129|1768144|FG000|Primary Phase|Adverse Event|2
815992|NCT00129129|1768145|FG001|Primary Phase|Adverse Event|1
815993|NCT00129129|1768146|FG002|Primary Phase|Adverse Event|0
815994|NCT00129129|1768147|FG003|Primary Phase|Adverse Event|0
815995|NCT00129129|1768148|FG004|Primary Phase|Adverse Event|0
815996|NCT00129129|1768144|FG000|Primary Phase|Withdrawal by Subject|12
815997|NCT00129129|1768145|FG001|Primary Phase|Withdrawal by Subject|10
815998|NCT00129129|1768146|FG002|Primary Phase|Withdrawal by Subject|0
815999|NCT00129129|1768147|FG003|Primary Phase|Withdrawal by Subject|0
816000|NCT00129129|1768148|FG004|Primary Phase|Withdrawal by Subject|0
816001|NCT00129129|1768144|FG000|Primary Phase|Migration from study area|1
816002|NCT00129129|1768145|FG001|Primary Phase|Migration from study area|3
816003|NCT00129129|1768146|FG002|Primary Phase|Migration from study area|0
816004|NCT00129129|1768147|FG003|Primary Phase|Migration from study area|0
816005|NCT00129129|1768148|FG004|Primary Phase|Migration from study area|0
816006|NCT00129129|1768144|FG000|Primary Phase|Lost to Follow-up|8
816007|NCT00129129|1768145|FG001|Primary Phase|Lost to Follow-up|6
816008|NCT00129129|1768146|FG002|Primary Phase|Lost to Follow-up|0
816009|NCT00129129|1768147|FG003|Primary Phase|Lost to Follow-up|0
816010|NCT00129129|1768148|FG004|Primary Phase|Lost to Follow-up|0
816011|NCT00129129|1768144|FG000|Primary Phase|Other|2
816012|NCT00129129|1768145|FG001|Primary Phase|Other|5
816013|NCT00129129|1768146|FG002|Primary Phase|Other|0
816014|NCT00129129|1768147|FG003|Primary Phase|Other|0
816015|NCT00129129|1768148|FG004|Primary Phase|Other|0
816016|NCT00129129|1768144|FG000|Fourth Dose Phase|Lost to Follow-up|4
816017|NCT00129129|1768145|FG001|Fourth Dose Phase|Lost to Follow-up|0
816018|NCT00129129|1768146|FG002|Fourth Dose Phase|Lost to Follow-up|0
816019|NCT00129129|1768147|FG003|Fourth Dose Phase|Lost to Follow-up|2
816020|NCT00129129|1768148|FG004|Fourth Dose Phase|Lost to Follow-up|2
816021|NCT00129129|1768144|FG000|Fourth Dose Phase|Withdrawal by Subject|0
816022|NCT00129129|1768145|FG001|Fourth Dose Phase|Withdrawal by Subject|0
816023|NCT00129129|1768146|FG002|Fourth Dose Phase|Withdrawal by Subject|0
816024|NCT00129129|1768147|FG003|Fourth Dose Phase|Withdrawal by Subject|0
816025|NCT00129129|1768148|FG004|Fourth Dose Phase|Withdrawal by Subject|1
816026|NCT00129129|1768144|FG000|Fourth Dose Phase|Migration from study area|0
816027|NCT00129129|1768145|FG001|Fourth Dose Phase|Migration from study area|0
816028|NCT00129129|1768146|FG002|Fourth Dose Phase|Migration from study area|0
816029|NCT00129129|1768147|FG003|Fourth Dose Phase|Migration from study area|0
816030|NCT00129129|1768148|FG004|Fourth Dose Phase|Migration from study area|2
816031|NCT00129129|1768144|FG000|Fourth Dose Phase|Other|0
816032|NCT00129129|1768145|FG001|Fourth Dose Phase|Other|0
816033|NCT00129129|1768146|FG002|Fourth Dose Phase|Other|0
816034|NCT00129129|1768147|FG003|Fourth Dose Phase|Other|1
816035|NCT00129129|1768148|FG004|Fourth Dose Phase|Other|1
816036|NCT00129129|1768144|FG000|Fourth Dose Phase|Protocol Violation|0
816037|NCT00129129|1768145|FG001|Fourth Dose Phase|Protocol Violation|0
816038|NCT00129129|1768146|FG002|Fourth Dose Phase|Protocol Violation|0
816039|NCT00129129|1768147|FG003|Fourth Dose Phase|Protocol Violation|1
816040|NCT00129129|1768148|FG004|Fourth Dose Phase|Protocol Violation|0
816041|NCT00129220|1768171|FG000|Study Period II|Adverse Event|9
816042|NCT00129220|1768172|FG001|Study Period II|Adverse Event|5
816043|NCT00129220|1768173|FG002|Study Period II|Adverse Event|7
816044|NCT00129220|1768171|FG000|Study Period II|Lack of Efficacy|15
816045|NCT00129220|1768172|FG001|Study Period II|Lack of Efficacy|1
816046|NCT00129220|1768173|FG002|Study Period II|Lack of Efficacy|28
816047|NCT00129220|1768171|FG000|Study Period II|Entry Criteria Not Met|2
816048|NCT00129220|1768172|FG001|Study Period II|Entry Criteria Not Met|0
816049|NCT00129220|1768173|FG002|Study Period II|Entry Criteria Not Met|2
816050|NCT00129220|1768171|FG000|Study Period II|Protocol Violation|4
816051|NCT00129220|1768172|FG001|Study Period II|Protocol Violation|2
816052|NCT00129220|1768173|FG002|Study Period II|Protocol Violation|1
816053|NCT00129220|1768171|FG000|Study Period II|Physician Decision|0
816054|NCT00129220|1768172|FG001|Study Period II|Physician Decision|1
816055|NCT00129220|1768173|FG002|Study Period II|Physician Decision|0
816056|NCT00129220|1768171|FG000|Study Period II|Withdrawal by Subject|1
816057|NCT00129220|1768172|FG001|Study Period II|Withdrawal by Subject|3
816058|NCT00129220|1768173|FG002|Study Period II|Withdrawal by Subject|4
816059|NCT00129220|1768171|FG000|Study Period II|Reason Not Specified|2
816060|NCT00129220|1768172|FG001|Study Period II|Reason Not Specified|0
816061|NCT00129220|1768173|FG002|Study Period II|Reason Not Specified|5
816062|NCT00129220|1768171|FG000|Study Period III|Adverse Event|1
816063|NCT00129220|1768172|FG001|Study Period III|Adverse Event|0
816064|NCT00129220|1768173|FG002|Study Period III|Adverse Event|3
816065|NCT00129220|1768171|FG000|Study Period III|Protocol Violation|1
816066|NCT00129220|1768172|FG001|Study Period III|Protocol Violation|1
816067|NCT00129220|1768173|FG002|Study Period III|Protocol Violation|2
816068|NCT00129220|1768171|FG000|Study Period III|Withdrawal by Subject|1
816069|NCT00129220|1768172|FG001|Study Period III|Withdrawal by Subject|0
816070|NCT00129220|1768173|FG002|Study Period III|Withdrawal by Subject|3
816071|NCT00129220|1768171|FG000|Study Period III|Sponsor Decision|1
816072|NCT00129220|1768172|FG001|Study Period III|Sponsor Decision|0
816073|NCT00129220|1768173|FG002|Study Period III|Sponsor Decision|0
816074|NCT00129220|1768171|FG000|Study Period III|Reason Not Specified|9
816075|NCT00129220|1768172|FG001|Study Period III|Reason Not Specified|0
816076|NCT00129220|1768173|FG002|Study Period III|Reason Not Specified|2
816077|NCT00129259|1768194|FG000|Overall Study|Lost to Follow-up|1
816078|NCT00129259|1768195|FG001|Overall Study|Lost to Follow-up|1
816079|NCT00129259|1768194|FG000|Overall Study|Withdrawal by Subject|2
816080|NCT00129259|1768195|FG001|Overall Study|Withdrawal by Subject|1
816081|NCT00129259|1768194|FG000|Overall Study|Only available minimal phone assessments|0
816082|NCT00129259|1768195|FG001|Overall Study|Only available minimal phone assessments|1
816083|NCT00129272|1768203|FG000|Overall Study|Lost to Follow-up|12
816084|NCT00129272|1768204|FG001|Overall Study|Lost to Follow-up|11
816085|NCT00129272|1768203|FG000|Overall Study|Withdrawal by Subject|5
816086|NCT00129272|1768204|FG001|Overall Study|Withdrawal by Subject|11
816087|NCT00129311|1768229|FG000|Overall Study|Withdrawal by Subject|12
816088|NCT00129311|1768230|FG001|Overall Study|Withdrawal by Subject|19
816089|NCT00129376|1768236|FG000|Overall Study|Adverse Event|1
816090|NCT00129376|1768236|FG000|Overall Study|Lack of Efficacy|1
816091|NCT00129389|1768242|FG000|Overall Study|Adverse Event|19
816092|NCT00129389|1768243|FG001|Overall Study|Adverse Event|87
816093|NCT00129389|1768242|FG000|Overall Study|Death|0
816094|NCT00129389|1768243|FG001|Overall Study|Death|1
816095|NCT00129389|1768242|FG000|Overall Study|Lost to Follow-up|2
816096|NCT00129389|1768243|FG001|Overall Study|Lost to Follow-up|1
816097|NCT00129389|1768242|FG000|Overall Study|Physician Decision|0
816098|NCT00129389|1768243|FG001|Overall Study|Physician Decision|4
816099|NCT00129389|1768242|FG000|Overall Study|Protocol Violation|0
816100|NCT00129389|1768243|FG001|Overall Study|Protocol Violation|6
816101|NCT00129389|1768242|FG000|Overall Study|Withdrawal by Subject|9
816102|NCT00129389|1768243|FG001|Overall Study|Withdrawal by Subject|23
816103|NCT00129389|1768242|FG000|Overall Study|Relapse|1
816104|NCT00129389|1768243|FG001|Overall Study|Relapse|0
816105|NCT00129389|1768242|FG000|Overall Study|Not eligible|1
816106|NCT00129389|1768243|FG001|Overall Study|Not eligible|2
816107|NCT00129389|1768242|FG000|Overall Study|Crossed to the other arm|1
816108|NCT00129389|1768243|FG001|Overall Study|Crossed to the other arm|16
816109|NCT00129402|1768251|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
816110|NCT00129402|1768252|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
816111|NCT00129402|1768253|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
816112|NCT00129402|1768254|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
816113|NCT00129402|1768255|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
816114|NCT00129402|1768256|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
816115|NCT00129402|1768257|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
816116|NCT00129402|1768251|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
816117|NCT00129402|1768252|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
816118|NCT00129402|1768253|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
816119|NCT00129402|1768254|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
816120|NCT00129402|1768255|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
816121|NCT00129402|1768256|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
816122|NCT00129402|1768257|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
816123|NCT00129402|1768251|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
816124|NCT00129402|1768252|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
816125|NCT00129402|1768253|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
816126|NCT00129402|1768254|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
816127|NCT00129402|1768255|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
816128|NCT00129402|1768256|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
816129|NCT00129402|1768257|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
816130|NCT00129402|1768251|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
816131|NCT00129402|1768252|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
816132|NCT00129402|1768253|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
816133|NCT00129402|1768254|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
816134|NCT00129402|1768255|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
816135|NCT00129402|1768256|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
816136|NCT00129402|1768257|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
816137|NCT00129402|1768251|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
816138|NCT00129402|1768252|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
816139|NCT00129402|1768253|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
816140|NCT00129402|1768254|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
816141|NCT00129402|1768255|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
816142|NCT00129402|1768256|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
816143|NCT00129402|1768257|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
816144|NCT00129402|1768251|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
816145|NCT00129402|1768252|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
816146|NCT00129402|1768253|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
816147|NCT00129402|1768254|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
816148|NCT00129402|1768255|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
816149|NCT00129402|1768256|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
816150|NCT00129402|1768257|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
816151|NCT00129402|1768251|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
816152|NCT00129402|1768252|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
816153|NCT00129402|1768253|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
816154|NCT00129402|1768254|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
816155|NCT00129402|1768255|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
816156|NCT00129402|1768256|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
816157|NCT00129402|1768257|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
816158|NCT00129402|1768251|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
816159|NCT00129402|1768252|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
816160|NCT00129402|1768253|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
816161|NCT00129402|1768254|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
816162|NCT00129402|1768255|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
816163|NCT00129402|1768256|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
816164|NCT00129402|1768257|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
816165|NCT00129402|1768251|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
816166|NCT00129402|1768252|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
816167|NCT00129402|1768253|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
816168|NCT00129402|1768254|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
816169|NCT00129402|1768255|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
816170|NCT00129402|1768256|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
816171|NCT00129402|1768257|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
816172|NCT00129402|1768251|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
816173|NCT00129402|1768252|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
816174|NCT00129402|1768253|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
816175|NCT00129402|1768254|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
816176|NCT00129402|1768255|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
816177|NCT00129402|1768256|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
816178|NCT00129402|1768257|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
816179|NCT00129402|1768251|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
816180|NCT00129402|1768252|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
816181|NCT00129402|1768253|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
816182|NCT00129402|1768254|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
816183|NCT00129402|1768255|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
816184|NCT00129402|1768256|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
816185|NCT00129402|1768257|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
816186|NCT00129402|1768251|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0
816187|NCT00129402|1768252|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0
816188|NCT00129402|1768253|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0
816189|NCT00129402|1768254|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0
816190|NCT00129402|1768255|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0
816191|NCT00129402|1768256|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0
816192|NCT00129402|1768257|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1
816193|NCT00129402|1768251|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
816194|NCT00129402|1768252|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
816195|NCT00129402|1768253|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
816196|NCT00129402|1768254|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
816197|NCT00129402|1768255|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
816198|NCT00129402|1768256|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
816199|NCT00129402|1768257|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
816200|NCT00129467|1768276|FG000|Received Intervention|Death|1
816201|NCT00129467|1768277|FG001|Received Intervention|Death|1
816202|NCT00129467|1768276|FG000|Received Intervention|Cardiac SAE (hypertension)|1
816203|NCT00129467|1768277|FG001|Received Intervention|Cardiac SAE (hypertension)|1
816204|NCT00129467|1768276|FG000|Received Intervention|Delirium|2
816205|NCT00129467|1768277|FG001|Received Intervention|Delirium|0
816206|NCT00129467|1768276|FG000|Received Intervention|Withdrawal by Subject|1
816207|NCT00129467|1768277|FG001|Received Intervention|Withdrawal by Subject|0
816208|NCT00129467|1768276|FG000|Received Intervention|Nausea|1
816209|NCT00129467|1768277|FG001|Received Intervention|Nausea|0
816210|NCT00129467|1768276|FG000|Received Intervention|Intolerance to citalopram|0
816211|NCT00129467|1768277|FG001|Received Intervention|Intolerance to citalopram|1
816212|NCT00129467|1768276|FG000|Received Intervention|Dizzyness, fatigue|0
816213|NCT00129467|1768277|FG001|Received Intervention|Dizzyness, fatigue|1
816214|NCT00129467|1768276|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1
816215|NCT00129467|1768277|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0
816216|NCT00129467|1768276|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1
816217|NCT00129467|1768277|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0
816218|NCT00129545|1768295|FG000|Overall Study|Death|5
816219|NCT00129545|1768296|FG001|Overall Study|Death|60
816220|NCT00129545|1768297|FG002|Overall Study|Death|44
816221|NCT00129545|1768295|FG000|Overall Study|Withdrawal by Subject|3
816222|NCT00129545|1768296|FG001|Overall Study|Withdrawal by Subject|18
816223|NCT00129545|1768297|FG002|Overall Study|Withdrawal by Subject|44
816224|NCT00129545|1768295|FG000|Overall Study|Lost to Follow-up|2
816225|NCT00129545|1768296|FG001|Overall Study|Lost to Follow-up|22
816226|NCT00129545|1768297|FG002|Overall Study|Lost to Follow-up|13
816227|NCT00129545|1768295|FG000|Overall Study|Physician Decision|0
816228|NCT00129545|1768296|FG001|Overall Study|Physician Decision|3
816229|NCT00129545|1768297|FG002|Overall Study|Physician Decision|10
816230|NCT00129545|1768295|FG000|Overall Study|Device not implanted|16
816231|NCT00129545|1768296|FG001|Overall Study|Device not implanted|61
816232|NCT00129545|1768297|FG002|Overall Study|Device not implanted|0
816233|NCT00129623|1768307|FG000|Overall Study|Adverse Event|3
816234|NCT00129623|1768308|FG001|Overall Study|Adverse Event|7
816235|NCT00129623|1768307|FG000|Overall Study|Refused Treatment|5
816236|NCT00129623|1768308|FG001|Overall Study|Refused Treatment|3
816237|NCT00129623|1768307|FG000|Overall Study|Failure to Return|1
816238|NCT00129623|1768308|FG001|Overall Study|Failure to Return|1
816239|NCT00129623|1768307|FG000|Overall Study|Relocated job out of state|1
816240|NCT00129623|1768308|FG001|Overall Study|Relocated job out of state|0
816241|NCT00129623|1768307|FG000|Overall Study|Uncertainty to return|0
816242|NCT00129623|1768308|FG001|Overall Study|Uncertainty to return|1
816243|NCT00129649|1768318|FG000|Overall Study|Withdrawal by Subject|76
816244|NCT00129649|1768319|FG001|Overall Study|Withdrawal by Subject|65
816245|NCT00129701|1768325|FG000|Overall Study|Withdrawal by Subject|33
816246|NCT00129766|1768342|FG000|Overall Study|Death|3
816247|NCT00129766|1768343|FG001|Overall Study|Death|8
816248|NCT00129766|1768342|FG000|Overall Study|Withdrawal of consent|31
816249|NCT00129766|1768343|FG001|Overall Study|Withdrawal of consent|30
816250|NCT00129766|1768342|FG000|Overall Study|Lost to Follow-up|26
816251|NCT00129766|1768343|FG001|Overall Study|Lost to Follow-up|21
816252|NCT00129935|1768352|FG000|Overall Study|Adverse Event|18
816253|NCT00129935|1768353|FG001|Overall Study|Adverse Event|56
816254|NCT00129935|1768352|FG000|Overall Study|Death|1
816255|NCT00129935|1768353|FG001|Overall Study|Death|1
816256|NCT00129935|1768352|FG000|Overall Study|Withdrawal by Subject|7
816257|NCT00129935|1768353|FG001|Overall Study|Withdrawal by Subject|20
816258|NCT00129935|1768352|FG000|Overall Study|Protocol Violation|0
816259|NCT00129935|1768353|FG001|Overall Study|Protocol Violation|4
816260|NCT00129935|1768352|FG000|Overall Study|Physician Decision|3
816261|NCT00129935|1768353|FG001|Overall Study|Physician Decision|4
816262|NCT00129935|1768352|FG000|Overall Study|Recurrence|1
816263|NCT00129935|1768353|FG001|Overall Study|Recurrence|3
816264|NCT00129935|1768352|FG000|Overall Study|Second primary|0
816265|NCT00129935|1768353|FG001|Overall Study|Second primary|1
816266|NCT00129935|1768352|FG000|Overall Study|Other|3
816267|NCT00129935|1768353|FG001|Overall Study|Other|2
816268|NCT00129935|1768352|FG000|Overall Study|Crossed to the other arm|2
816269|NCT00129935|1768353|FG001|Overall Study|Crossed to the other arm|1
816270|NCT00129935|1768352|FG000|Overall Study|Incorrect study treatment|1
816271|NCT00129935|1768353|FG001|Overall Study|Incorrect study treatment|0
816272|NCT00129961|1768361|FG000|Overall Study|Adverse Event|1
816273|NCT00129961|1768362|FG001|Overall Study|Adverse Event|0
816274|NCT00129961|1768361|FG000|Overall Study|Death|1
816275|NCT00129961|1768362|FG001|Overall Study|Death|1
816276|NCT00129961|1768361|FG000|Overall Study|Withdrawal by Sponsor|14
816277|NCT00129961|1768362|FG001|Overall Study|Withdrawal by Sponsor|20
816278|NCT00129961|1768361|FG000|Overall Study|Physician Decision|1
816279|NCT00129961|1768362|FG001|Overall Study|Physician Decision|0
816280|NCT00129961|1768361|FG000|Overall Study|Withdrawal by Subject|2
816281|NCT00129961|1768362|FG001|Overall Study|Withdrawal by Subject|1
816282|NCT00129961|1768361|FG000|Overall Study|Missing Record|0
816283|NCT00129961|1768362|FG001|Overall Study|Missing Record|1
816284|NCT00129987|1768370|FG000|1st Educational Session|Withdrawal by Subject|141
816285|NCT00129987|1768371|FG001|1st Educational Session|Withdrawal by Subject|109
816286|NCT00129987|1768370|FG000|1 Year|Withdrawal by Subject|32
816287|NCT00129987|1768371|FG001|1 Year|Withdrawal by Subject|21
816288|NCT00130039|1768379|FG000|Overall Study|Withdrawal by Subject|15
816289|NCT00130039|1768380|FG001|Overall Study|Withdrawal by Subject|11
816290|NCT00130039|1768379|FG000|Overall Study|Lost to Follow-up|3
816291|NCT00130039|1768380|FG001|Overall Study|Lost to Follow-up|1
816292|NCT00130039|1768379|FG000|Overall Study|Adverse Event|4
816293|NCT00130039|1768380|FG001|Overall Study|Adverse Event|2
816294|NCT00130039|1768379|FG000|Overall Study|Physician Decision|3
816295|NCT00130039|1768380|FG001|Overall Study|Physician Decision|0
816296|NCT00130039|1768379|FG000|Overall Study|clinical events without follow up MRI|5
816297|NCT00130039|1768380|FG001|Overall Study|clinical events without follow up MRI|4
816298|NCT00130208|1768398|FG000|Maintenance Period (26 Weeks)|Adverse Event|10
816299|NCT00130208|1768399|FG001|Maintenance Period (26 Weeks)|Adverse Event|12
816300|NCT00130208|1768398|FG000|Maintenance Period (26 Weeks)|Physician Decision|0
816301|NCT00130208|1768399|FG001|Maintenance Period (26 Weeks)|Physician Decision|2
816302|NCT00130208|1768398|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
816303|NCT00130208|1768399|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
816304|NCT00130208|1768398|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5
816305|NCT00130208|1768399|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4
816306|NCT00130208|1768398|FG000|Maintenance Period (26 Weeks)|Other|1
816307|NCT00130208|1768399|FG001|Maintenance Period (26 Weeks)|Other|1
816308|NCT00130208|1768398|FG000|Washout Period (8 Weeks)|Adverse Event|3
816309|NCT00130208|1768399|FG001|Washout Period (8 Weeks)|Adverse Event|6
816310|NCT00130208|1768398|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2
816311|NCT00130208|1768399|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4
816312|NCT00130208|1768398|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0
816313|NCT00130208|1768399|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1
816314|NCT00130208|1768398|FG000|Washout Period (8 Weeks)|Other|1
816315|NCT00130208|1768399|FG001|Washout Period (8 Weeks)|Other|1
816316|NCT00130247|1768407|FG000|Overall Study|Pregnancy|1
816317|NCT00130247|1768408|FG001|Overall Study|Pregnancy|0
816318|NCT00130247|1768407|FG000|Overall Study|Post-randomization exclusion|1
816319|NCT00130247|1768408|FG001|Overall Study|Post-randomization exclusion|2
816320|NCT00130247|1768407|FG000|Overall Study|Not compliant with DOT|0
816321|NCT00130247|1768408|FG001|Overall Study|Not compliant with DOT|2
816322|NCT00130286|1768418|FG000|Overall Study|Withdrawal by Subject|0
816323|NCT00130286|1768419|FG001|Overall Study|Withdrawal by Subject|1
816324|NCT00130286|1768420|FG002|Overall Study|Withdrawal by Subject|2
816325|NCT00130286|1768421|FG003|Overall Study|Withdrawal by Subject|2
816326|NCT00130286|1768418|FG000|Overall Study|Adverse Event|0
816327|NCT00130286|1768419|FG001|Overall Study|Adverse Event|0
816328|NCT00130286|1768420|FG002|Overall Study|Adverse Event|2
816329|NCT00130286|1768421|FG003|Overall Study|Adverse Event|0
816330|NCT00130286|1768418|FG000|Overall Study|Missing lab specimens|0
816331|NCT00130286|1768419|FG001|Overall Study|Missing lab specimens|2
816332|NCT00130286|1768420|FG002|Overall Study|Missing lab specimens|0
816333|NCT00130286|1768421|FG003|Overall Study|Missing lab specimens|0
816334|NCT00130442|1768433|FG000|Overall Study|Withdrawal by Subject|0
816335|NCT00130442|1768434|FG001|Overall Study|Withdrawal by Subject|1
816336|NCT00130442|1768433|FG000|Overall Study|did not meet criteria|1
816337|NCT00130442|1768434|FG001|Overall Study|did not meet criteria|1
816338|NCT00130520|1768442|FG000|Overall Study|Adverse Event|11
816339|NCT00130520|1768442|FG000|Overall Study|Death|1
816340|NCT00130520|1768442|FG000|Overall Study|Physician Decision|1
816341|NCT00130520|1768442|FG000|Overall Study|Withdrawal by Subject|1
816342|NCT00130520|1768442|FG000|Overall Study|Disease Progression|23
816343|NCT00130520|1768442|FG000|Overall Study|Protocol non-compliance|1
816344|NCT00130520|1768442|FG000|Overall Study|Did not meet re-treatment criteria|1
816345|NCT00130533|1768448|FG000|Overall Study|Withdrawal by Subject|33
816346|NCT00130533|1768449|FG001|Overall Study|Withdrawal by Subject|6
816347|NCT00130533|1768448|FG000|Overall Study|Adverse Event|34
816348|NCT00130533|1768449|FG001|Overall Study|Adverse Event|1
816349|NCT00130533|1768448|FG000|Overall Study|Disease relapse|9
816350|NCT00130533|1768449|FG001|Overall Study|Disease relapse|13
816351|NCT00130533|1768448|FG000|Overall Study|Interruption of treatment > 3 weeks|11
816352|NCT00130533|1768449|FG001|Overall Study|Interruption of treatment > 3 weeks|0
816353|NCT00130533|1768448|FG000|Overall Study|Death|4
816354|NCT00130533|1768449|FG001|Overall Study|Death|2
816355|NCT00130533|1768448|FG000|Overall Study|Protocol Violation|5
816356|NCT00130533|1768449|FG001|Overall Study|Protocol Violation|1
816357|NCT00130533|1768448|FG000|Overall Study|Lost to Follow-up|1
816358|NCT00130533|1768449|FG001|Overall Study|Lost to Follow-up|1
816359|NCT00130533|1768448|FG000|Overall Study|Sponsor´s decision|2
816360|NCT00130533|1768449|FG001|Overall Study|Sponsor´s decision|0
816361|NCT00130533|1768448|FG000|Overall Study|Second Primary Malignancy|0
816362|NCT00130533|1768449|FG001|Overall Study|Second Primary Malignancy|1
816363|NCT00130533|1768448|FG000|Overall Study|Other|12
816364|NCT00130533|1768449|FG001|Overall Study|Other|5
816365|NCT00130637|1768455|FG000|Overall Study|Adverse Event|2
816366|NCT00130637|1768455|FG000|Overall Study|Withdrawal by Subject|1
816367|NCT00130689|1768459|FG000|Overall Study|Progressive Disease|29
816368|NCT00130689|1768459|FG000|Overall Study|Death|1
816369|NCT00130689|1768459|FG000|Overall Study|Clinical Deterioration|4
816370|NCT00130689|1768459|FG000|Overall Study|Withdrawal by Subject|3
816371|NCT00130689|1768459|FG000|Overall Study|Ineligible|6
816372|NCT00130728|1768465|FG000|Overall Study|Death|258
816373|NCT00130728|1768466|FG001|Overall Study|Death|258
816374|NCT00130728|1768465|FG000|Overall Study|Lost to Follow-up|4
816375|NCT00130728|1768466|FG001|Overall Study|Lost to Follow-up|0
816376|NCT00130728|1768465|FG000|Overall Study|Withdrawal by Subject|0
816377|NCT00130728|1768466|FG001|Overall Study|Withdrawal by Subject|2
816378|NCT00130793|1768483|FG000|Overall Study|Lost to Follow-up|1
816379|NCT00130793|1768484|FG001|Overall Study|Lost to Follow-up|4
816380|NCT00130793|1768483|FG000|Overall Study|Withdrew consent|2
816381|NCT00130793|1768484|FG001|Overall Study|Withdrew consent|0
816382|NCT00130832|1768493|FG000|Overall Study|Adverse Event|1
816383|NCT00130832|1768494|FG001|Overall Study|Adverse Event|1
816384|NCT00130832|1768493|FG000|Overall Study|Lost to Follow-up|1
816385|NCT00130832|1768494|FG001|Overall Study|Lost to Follow-up|2
816386|NCT00130832|1768493|FG000|Overall Study|Protocol Violation|6
816387|NCT00130832|1768494|FG001|Overall Study|Protocol Violation|8
816388|NCT00130832|1768493|FG000|Overall Study|Withdrawal by Subject|6
816389|NCT00130832|1768494|FG001|Overall Study|Withdrawal by Subject|1
816390|NCT00130832|1768493|FG000|Overall Study|Moved|2
816391|NCT00130832|1768494|FG001|Overall Study|Moved|2
816392|NCT00130832|1768493|FG000|Overall Study|Other|0
816393|NCT00130832|1768494|FG001|Overall Study|Other|3
816394|NCT00131248|1768510|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1
816395|NCT00131248|1768511|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0
816396|NCT00131352|1768519|FG000|Initial Treatment Period|Adverse Event|1
816397|NCT00131352|1768520|FG001|Initial Treatment Period|Adverse Event|3
816398|NCT00131352|1768519|FG000|Initial Treatment Period|Non-compliant|1
816399|NCT00131352|1768520|FG001|Initial Treatment Period|Non-compliant|2
816400|NCT00131352|1768519|FG000|Initial Treatment Period|Withdrawal by Subject|1
816401|NCT00131352|1768520|FG001|Initial Treatment Period|Withdrawal by Subject|1
816402|NCT00131352|1768519|FG000|Initial Treatment Period|Lack of Efficacy|6
816403|NCT00131352|1768520|FG001|Initial Treatment Period|Lack of Efficacy|4
816404|NCT00131352|1768519|FG000|Initial Treatment Period|Other|0
816405|NCT00131352|1768520|FG001|Initial Treatment Period|Other|2
816406|NCT00131352|1768519|FG000|Repeat Treatment Period|Adverse Event|1
816407|NCT00131352|1768520|FG001|Repeat Treatment Period|Adverse Event|0
816408|NCT00131352|1768519|FG000|Repeat Treatment Period|Other|1
816409|NCT00131352|1768520|FG001|Repeat Treatment Period|Other|0
816410|NCT00131365|1768528|FG000|Overall Study|Withdrawal by Subject|1
816411|NCT00131365|1768528|FG000|Overall Study|Alternative treatment|3
816412|NCT00131469|1768563|FG000|Overall Study|Withdrawal by Subject|3
816413|NCT00131469|1768564|FG001|Overall Study|Withdrawal by Subject|4
816414|NCT00131469|1768563|FG000|Overall Study|Protocol Violation|3
816415|NCT00131469|1768564|FG001|Overall Study|Protocol Violation|1
816416|NCT00131469|1768563|FG000|Overall Study|Death|0
816417|NCT00131469|1768564|FG001|Overall Study|Death|1
816418|NCT00131469|1768563|FG000|Overall Study|Lost to Follow-up|0
816419|NCT00131469|1768564|FG001|Overall Study|Lost to Follow-up|1
816420|NCT00131469|1768563|FG000|Overall Study|scan not analyzable|3
816421|NCT00131469|1768564|FG001|Overall Study|scan not analyzable|6
816422|NCT00131508|1768572|FG000|Overall Study|Disease progression|0
816423|NCT00131508|1768573|FG001|Overall Study|Disease progression|2
816424|NCT00131508|1768572|FG000|Overall Study|Non-Compliance|2
816425|NCT00131508|1768573|FG001|Overall Study|Non-Compliance|4
816426|NCT00131508|1768572|FG000|Overall Study|Withdrawal by Subject|1
816427|NCT00131508|1768573|FG001|Overall Study|Withdrawal by Subject|2
816428|NCT00131664|1768592|FG000|First Period (First 6 Months)|Lost to Follow-up|7
816429|NCT00131664|1768593|FG001|First Period (First 6 Months)|Lost to Follow-up|3
816430|NCT00131664|1768594|FG002|First Period (First 6 Months)|Lost to Follow-up|3
816431|NCT00131664|1768595|FG003|First Period (First 6 Months)|Lost to Follow-up|0
816432|NCT00131664|1768596|FG004|First Period (First 6 Months)|Lost to Follow-up|0
816433|NCT00131664|1768597|FG005|First Period (First 6 Months)|Lost to Follow-up|0
816434|NCT00131664|1768592|FG000|First Period (First 6 Months)|Death|0
816435|NCT00131664|1768593|FG001|First Period (First 6 Months)|Death|1
816436|NCT00131664|1768594|FG002|First Period (First 6 Months)|Death|0
816437|NCT00131664|1768595|FG003|First Period (First 6 Months)|Death|0
816438|NCT00131664|1768596|FG004|First Period (First 6 Months)|Death|0
816439|NCT00131664|1768597|FG005|First Period (First 6 Months)|Death|0
816440|NCT00131664|1768592|FG000|First Period (First 6 Months)|Protocol Violation|2
816441|NCT00131664|1768593|FG001|First Period (First 6 Months)|Protocol Violation|2
816442|NCT00131664|1768594|FG002|First Period (First 6 Months)|Protocol Violation|1
816443|NCT00131664|1768595|FG003|First Period (First 6 Months)|Protocol Violation|0
816444|NCT00131664|1768596|FG004|First Period (First 6 Months)|Protocol Violation|0
816445|NCT00131664|1768597|FG005|First Period (First 6 Months)|Protocol Violation|0
816446|NCT00131664|1768592|FG000|First Period (First 6 Months)|Withdrawal by Subject|4
816447|NCT00131664|1768593|FG001|First Period (First 6 Months)|Withdrawal by Subject|6
816448|NCT00131664|1768594|FG002|First Period (First 6 Months)|Withdrawal by Subject|2
816449|NCT00131664|1768595|FG003|First Period (First 6 Months)|Withdrawal by Subject|0
816450|NCT00131664|1768596|FG004|First Period (First 6 Months)|Withdrawal by Subject|0
816451|NCT00131664|1768597|FG005|First Period (First 6 Months)|Withdrawal by Subject|0
816452|NCT00131664|1768592|FG000|First Period (First 6 Months)|Adverse Event|9
816453|NCT00131664|1768593|FG001|First Period (First 6 Months)|Adverse Event|4
816454|NCT00131664|1768594|FG002|First Period (First 6 Months)|Adverse Event|5
816455|NCT00131664|1768595|FG003|First Period (First 6 Months)|Adverse Event|0
816456|NCT00131664|1768596|FG004|First Period (First 6 Months)|Adverse Event|0
816457|NCT00131664|1768597|FG005|First Period (First 6 Months)|Adverse Event|0
816458|NCT00131664|1768592|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1
816459|NCT00131664|1768593|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2
816460|NCT00131664|1768594|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0
816461|NCT00131664|1768595|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0
816462|NCT00131664|1768596|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0
816463|NCT00131664|1768597|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0
816464|NCT00131664|1768592|FG000|First Period (First 6 Months)|Administrative reasons|2
816465|NCT00131664|1768593|FG001|First Period (First 6 Months)|Administrative reasons|0
816466|NCT00131664|1768594|FG002|First Period (First 6 Months)|Administrative reasons|5
816467|NCT00131664|1768595|FG003|First Period (First 6 Months)|Administrative reasons|0
816468|NCT00131664|1768596|FG004|First Period (First 6 Months)|Administrative reasons|0
816469|NCT00131664|1768597|FG005|First Period (First 6 Months)|Administrative reasons|0
816470|NCT00131664|1768592|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3
816471|NCT00131664|1768593|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0
816472|NCT00131664|1768594|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2
816473|NCT00131664|1768595|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1
816474|NCT00131664|1768596|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0
816475|NCT00131664|1768597|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2
816476|NCT00131664|1768592|FG000|Second Period (Additional Drug Added)|Protocol Violation|0
816477|NCT00131664|1768593|FG001|Second Period (Additional Drug Added)|Protocol Violation|1
816478|NCT00131664|1768594|FG002|Second Period (Additional Drug Added)|Protocol Violation|1
816479|NCT00131664|1768595|FG003|Second Period (Additional Drug Added)|Protocol Violation|0
816480|NCT00131664|1768596|FG004|Second Period (Additional Drug Added)|Protocol Violation|0
816481|NCT00131664|1768597|FG005|Second Period (Additional Drug Added)|Protocol Violation|0
816482|NCT00131664|1768592|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2
816483|NCT00131664|1768593|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0
816484|NCT00131664|1768594|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0
816485|NCT00131664|1768595|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0
816486|NCT00131664|1768596|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0
816487|NCT00131664|1768597|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0
816488|NCT00131664|1768592|FG000|Second Period (Additional Drug Added)|Adverse Event|0
816489|NCT00131664|1768593|FG001|Second Period (Additional Drug Added)|Adverse Event|1
816490|NCT00131664|1768594|FG002|Second Period (Additional Drug Added)|Adverse Event|0
816491|NCT00131664|1768595|FG003|Second Period (Additional Drug Added)|Adverse Event|0
816492|NCT00131664|1768596|FG004|Second Period (Additional Drug Added)|Adverse Event|0
816493|NCT00131664|1768597|FG005|Second Period (Additional Drug Added)|Adverse Event|1
816494|NCT00131664|1768592|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
816495|NCT00131664|1768593|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
816496|NCT00131664|1768594|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
816497|NCT00131664|1768595|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
816498|NCT00131664|1768596|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
816499|NCT00131664|1768597|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
816500|NCT00131664|1768592|FG000|Second Period (Additional Drug Added)|Administrative reasons|4
816501|NCT00131664|1768593|FG001|Second Period (Additional Drug Added)|Administrative reasons|2
816502|NCT00131664|1768594|FG002|Second Period (Additional Drug Added)|Administrative reasons|0
816503|NCT00131664|1768595|FG003|Second Period (Additional Drug Added)|Administrative reasons|0
816504|NCT00131664|1768596|FG004|Second Period (Additional Drug Added)|Administrative reasons|1
816505|NCT00131664|1768597|FG005|Second Period (Additional Drug Added)|Administrative reasons|0
816506|NCT00131911|1768641|FG000|Overall Study|Withdrawal by Subject|1
816507|NCT00131911|1768642|FG001|Overall Study|Withdrawal by Subject|0
816508|NCT00131937|1768647|FG000|Overall Study|Adverse Event|3
816509|NCT00131937|1768647|FG000|Overall Study|Withdrawal by Subject|2
816510|NCT00131937|1768647|FG000|Overall Study|Physician Decision|1
816511|NCT00131937|1768647|FG000|Overall Study|Disease Progression|7
816512|NCT00131937|1768647|FG000|Overall Study|Alternative therapy|1
816513|NCT00132028|1768655|FG000|Overall Study|Adverse Event|7
816514|NCT00132028|1768655|FG000|Overall Study|Death|2
816515|NCT00132028|1768655|FG000|Overall Study|Lack of Efficacy|11
816516|NCT00132028|1768655|FG000|Overall Study|Withdrawal by Subject|2
816517|NCT00132028|1768655|FG000|Overall Study|not eligible|2
816518|NCT00132028|1768655|FG000|Overall Study|Physician Decision|3
816519|NCT00132041|1768659|FG000|Baseline|Ineligible|6
816520|NCT00132041|1768659|FG000|3 Months Post Ablation|Transplant|1
816521|NCT00132041|1768659|FG000|3 Months Post Ablation|Non-Protocol Treatment|2
816522|NCT00132041|1768659|FG000|6 Months Post Ablation|Withdrawal by Subject|2
816523|NCT00132041|1768659|FG000|6 Months Post Ablation|Death|2
816524|NCT00132041|1768659|FG000|6 Months Post Ablation|Transplant|6
816525|NCT00132041|1768659|FG000|9 Months Post Ablation|Death|1
816526|NCT00132041|1768659|FG000|9 Months Post Ablation|Transplant|1
816527|NCT00132041|1768659|FG000|12 Months Post Ablation|Withdrawal by Subject|1
816528|NCT00132041|1768659|FG000|12 Months Post Ablation|Death|1
816529|NCT00132041|1768659|FG000|12 Months Post Ablation|Transplant|1
816530|NCT00132041|1768659|FG000|12 Months Post Ablation|non-protocol Treatment|1
816531|NCT00132041|1768659|FG000|15 Months Post Ablation|Withdrawal by Subject|1
816532|NCT00132041|1768659|FG000|15 Months Post Ablation|Death|1
816533|NCT00132041|1768659|FG000|15 Months Post Ablation|Transplant|5
816534|NCT00132041|1768659|FG000|15 Months Post Ablation|Non-Protocol Treatment|1
816535|NCT00132041|1768659|FG000|18 Months Post Ablation|Withdrawal by Subject|1
816536|NCT00132041|1768659|FG000|18 Months Post Ablation|Transplant|1
816537|NCT00132041|1768659|FG000|18 Months Post Ablation|Non-Protocol Treatment|3
816538|NCT00132041|1768659|FG000|18 Months Post Ablation|ExtraHepatic tumor|1
816539|NCT00132132|1768671|FG000|Overall Study|Lost to Follow-up|7
816540|NCT00132132|1768672|FG001|Overall Study|Lost to Follow-up|2
816541|NCT00132301|1768680|FG000|Overall Study|Death|7
816542|NCT00132301|1768681|FG001|Overall Study|Death|6
816543|NCT00132301|1768680|FG000|Overall Study|Withdrawal by Subject|5
816544|NCT00132301|1768681|FG001|Overall Study|Withdrawal by Subject|2
816545|NCT00132301|1768680|FG000|Overall Study|Physician Decision|1
816546|NCT00132301|1768681|FG001|Overall Study|Physician Decision|1
816547|NCT00132301|1768680|FG000|Overall Study|Lost to Follow-up|5
816548|NCT00132301|1768681|FG001|Overall Study|Lost to Follow-up|3
816549|NCT00132301|1768680|FG000|Overall Study|Other|1
816550|NCT00132301|1768681|FG001|Overall Study|Other|1
816551|NCT00132301|1768680|FG000|Overall Study|Excluded by Data Monitoring Committee|1
816552|NCT00132301|1768681|FG001|Overall Study|Excluded by Data Monitoring Committee|0
816553|NCT00132314|1768689|FG000|Overall Study|Lost to Follow-up|70
816554|NCT00132314|1768690|FG001|Overall Study|Lost to Follow-up|62
816555|NCT00132314|1768689|FG000|Overall Study|Lacked SSN|1
816556|NCT00132314|1768690|FG001|Overall Study|Lacked SSN|3
816557|NCT00132314|1768689|FG000|Overall Study|Refused intervention at baseline|2
816558|NCT00132314|1768690|FG001|Overall Study|Refused intervention at baseline|7
816559|NCT00132496|1768698|FG000|Overall Study|Withdrawal by Subject|1
816560|NCT00132496|1768699|FG001|Overall Study|Withdrawal by Subject|2
816561|NCT00132496|1768698|FG000|Overall Study|Physician Decision|1
816562|NCT00132496|1768699|FG001|Overall Study|Physician Decision|0
816563|NCT00132678|1768707|FG000|Period II (Open-Label Oral Risperidone)|Death|0
816564|NCT00132678|1768708|FG001|Period II (Open-Label Oral Risperidone)|Death|0
816565|NCT00132678|1768709|FG002|Period II (Open-Label Oral Risperidone)|Death|1
816566|NCT00132678|1768707|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0
816567|NCT00132678|1768708|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0
816568|NCT00132678|1768709|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13
816569|NCT00132678|1768707|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0
816570|NCT00132678|1768708|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0
816571|NCT00132678|1768709|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6
816572|NCT00132678|1768707|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
816573|NCT00132678|1768708|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
816574|NCT00132678|1768709|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
816575|NCT00132678|1768707|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
816576|NCT00132678|1768708|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
816577|NCT00132678|1768709|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
816578|NCT00132678|1768707|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
816579|NCT00132678|1768708|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
816580|NCT00132678|1768709|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
816581|NCT00132678|1768707|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0
816582|NCT00132678|1768708|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0
816583|NCT00132678|1768709|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1
816584|NCT00132678|1768707|FG000|Period III (Open-Label Stabilization)|Death|2
816585|NCT00132678|1768708|FG001|Period III (Open-Label Stabilization)|Death|0
816586|NCT00132678|1768709|FG002|Period III (Open-Label Stabilization)|Death|0
816587|NCT00132678|1768707|FG000|Period III (Open-Label Stabilization)|Adverse Event|12
816588|NCT00132678|1768708|FG001|Period III (Open-Label Stabilization)|Adverse Event|0
816589|NCT00132678|1768709|FG002|Period III (Open-Label Stabilization)|Adverse Event|0
816590|NCT00132678|1768707|FG000|Period III (Open-Label Stabilization)|Non responder|107
816591|NCT00132678|1768708|FG001|Period III (Open-Label Stabilization)|Non responder|0
816592|NCT00132678|1768709|FG002|Period III (Open-Label Stabilization)|Non responder|0
816593|NCT00132678|1768707|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
816594|NCT00132678|1768708|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
816595|NCT00132678|1768709|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
816596|NCT00132678|1768707|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19
816597|NCT00132678|1768708|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0
816598|NCT00132678|1768709|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0
816599|NCT00132678|1768707|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
816600|NCT00132678|1768708|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
816601|NCT00132678|1768709|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
816602|NCT00132678|1768707|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1
816603|NCT00132678|1768708|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0
816604|NCT00132678|1768709|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0
816605|NCT00132678|1768707|FG000|Period III (Open-Label Stabilization)|Physician Decision|1
816606|NCT00132678|1768708|FG001|Period III (Open-Label Stabilization)|Physician Decision|0
816607|NCT00132678|1768709|FG002|Period III (Open-Label Stabilization)|Physician Decision|0
816608|NCT00132678|1768707|FG000|Period III (Open-Label Stabilization)|Pregnancy|2
816609|NCT00132678|1768708|FG001|Period III (Open-Label Stabilization)|Pregnancy|0
816610|NCT00132678|1768709|FG002|Period III (Open-Label Stabilization)|Pregnancy|0
816611|NCT00132678|1768707|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1
816612|NCT00132678|1768708|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1
816613|NCT00132678|1768709|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0
816614|NCT00132678|1768707|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
816615|NCT00132678|1768708|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
816616|NCT00132678|1768709|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
816617|NCT00132678|1768707|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
816618|NCT00132678|1768708|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
816619|NCT00132678|1768709|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
816620|NCT00132678|1768707|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
816621|NCT00132678|1768708|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
816622|NCT00132678|1768709|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
816623|NCT00132678|1768707|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10
816624|NCT00132678|1768708|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14
816625|NCT00132678|1768709|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0
816626|NCT00132678|1768707|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
816627|NCT00132678|1768708|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
816628|NCT00132678|1768709|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
816629|NCT00132678|1768707|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0
816630|NCT00132678|1768708|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2
816631|NCT00132678|1768709|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0
816632|NCT00132691|1768719|FG000|Overall Study|Lost to Follow-up|5
816633|NCT00132691|1768720|FG001|Overall Study|Lost to Follow-up|8
816634|NCT00132691|1768719|FG000|Overall Study|Missed 2-year visit|4
816635|NCT00132691|1768720|FG001|Overall Study|Missed 2-year visit|4
816636|NCT00132691|1768719|FG000|Overall Study|Death|2
816637|NCT00132691|1768720|FG001|Overall Study|Death|0
816638|NCT00132730|1768735|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
816639|NCT00132730|1768736|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
816640|NCT00132730|1768737|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
816641|NCT00132730|1768738|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
816642|NCT00132730|1768739|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
816643|NCT00132730|1768740|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
816644|NCT00132730|1768735|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
816645|NCT00132730|1768736|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
816646|NCT00132730|1768737|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
816647|NCT00132730|1768738|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
816648|NCT00132730|1768739|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
816649|NCT00132730|1768740|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
816650|NCT00132730|1768735|FG000|Period II - 12-week Treatment (Base)|Other reasons|11
816651|NCT00132730|1768736|FG001|Period II - 12-week Treatment (Base)|Other reasons|10
816652|NCT00132730|1768737|FG002|Period II - 12-week Treatment (Base)|Other reasons|9
816653|NCT00132730|1768738|FG003|Period II - 12-week Treatment (Base)|Other reasons|13
816654|NCT00132730|1768739|FG004|Period II - 12-week Treatment (Base)|Other reasons|0
816655|NCT00132730|1768740|FG005|Period II - 12-week Treatment (Base)|Other reasons|0
816656|NCT00132730|1768735|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0
816657|NCT00132730|1768736|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0
816658|NCT00132730|1768737|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57
816659|NCT00132730|1768738|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20
816660|NCT00132730|1768739|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0
816661|NCT00132730|1768740|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0
816662|NCT00132730|1768735|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
816663|NCT00132730|1768736|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
816664|NCT00132730|1768737|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
816665|NCT00132730|1768738|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
816666|NCT00132730|1768739|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
816667|NCT00132730|1768740|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
816668|NCT00132730|1768735|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
816669|NCT00132730|1768736|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
816670|NCT00132730|1768737|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
816671|NCT00132730|1768738|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
816672|NCT00132730|1768739|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
816673|NCT00132730|1768740|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
816674|NCT00132730|1768735|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0
816675|NCT00132730|1768736|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0
816676|NCT00132730|1768737|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14
816677|NCT00132730|1768738|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3
816678|NCT00132730|1768739|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0
816679|NCT00132730|1768740|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0
816680|NCT00132730|1768735|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0
816681|NCT00132730|1768736|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0
816682|NCT00132730|1768737|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0
816683|NCT00132730|1768738|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0
816684|NCT00132730|1768739|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169
816685|NCT00132730|1768740|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68
816686|NCT00132730|1768735|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
816687|NCT00132730|1768736|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
816688|NCT00132730|1768737|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
816689|NCT00132730|1768738|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
816690|NCT00132730|1768739|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
816691|NCT00132730|1768740|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
816692|NCT00132730|1768735|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
816693|NCT00132730|1768736|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
816694|NCT00132730|1768737|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
816695|NCT00132730|1768738|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
816696|NCT00132730|1768739|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
816697|NCT00132730|1768740|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
816698|NCT00132730|1768735|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0
816699|NCT00132730|1768736|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0
816700|NCT00132730|1768737|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0
816701|NCT00132730|1768738|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0
816702|NCT00132730|1768739|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6
816703|NCT00132730|1768740|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0
816704|NCT00132730|1768735|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0
816705|NCT00132730|1768736|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0
816706|NCT00132730|1768737|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0
816707|NCT00132730|1768738|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0
816708|NCT00132730|1768739|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7
816709|NCT00132730|1768740|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2
816710|NCT00132769|1768756|FG000|Overall Study|Withdrawal by Subject|1
816711|NCT00132769|1768757|FG001|Overall Study|Withdrawal by Subject|3
816712|NCT00132769|1768756|FG000|Overall Study|Lack of Efficacy|7
816713|NCT00132769|1768757|FG001|Overall Study|Lack of Efficacy|6
816714|NCT00132769|1768756|FG000|Overall Study|Adverse Event|2
816715|NCT00132769|1768757|FG001|Overall Study|Adverse Event|1
816716|NCT00132769|1768756|FG000|Overall Study|Protocol Violation|1
816717|NCT00132769|1768757|FG001|Overall Study|Protocol Violation|1
816718|NCT00132808|1768766|FG000|Stratum I|Adverse Event|2
816719|NCT00132808|1768767|FG001|Stratum I|Adverse Event|1
816720|NCT00132808|1768768|FG002|Stratum I|Adverse Event|0
816721|NCT00132808|1768766|FG000|Stratum I|Lost to Follow-up|3
816722|NCT00132808|1768767|FG001|Stratum I|Lost to Follow-up|4
816723|NCT00132808|1768768|FG002|Stratum I|Lost to Follow-up|1
816724|NCT00132808|1768766|FG000|Stratum I|Withdrawal by Subject|4
816725|NCT00132808|1768767|FG001|Stratum I|Withdrawal by Subject|7
816726|NCT00132808|1768768|FG002|Stratum I|Withdrawal by Subject|3
816727|NCT00132808|1768766|FG000|Stratum I|Abnormal test procedure result (s)|0
816728|NCT00132808|1768767|FG001|Stratum I|Abnormal test procedure result (s)|0
816729|NCT00132808|1768768|FG002|Stratum I|Abnormal test procedure result (s)|1
816730|NCT00132808|1768766|FG000|Stratum II|Adverse Event|1
816731|NCT00132808|1768767|FG001|Stratum II|Adverse Event|2
816732|NCT00132808|1768768|FG002|Stratum II|Adverse Event|1
816733|NCT00132808|1768766|FG000|Stratum II|Death|1
816734|NCT00132808|1768767|FG001|Stratum II|Death|0
816735|NCT00132808|1768768|FG002|Stratum II|Death|0
816736|NCT00132808|1768766|FG000|Stratum II|Lost to Follow-up|2
816737|NCT00132808|1768767|FG001|Stratum II|Lost to Follow-up|2
816738|NCT00132808|1768768|FG002|Stratum II|Lost to Follow-up|1
816739|NCT00132808|1768766|FG000|Stratum II|Protocol Violation|0
816740|NCT00132808|1768767|FG001|Stratum II|Protocol Violation|2
816741|NCT00132808|1768768|FG002|Stratum II|Protocol Violation|1
816742|NCT00132808|1768766|FG000|Stratum II|Withdrawal by Subject|4
816743|NCT00132808|1768767|FG001|Stratum II|Withdrawal by Subject|9
816744|NCT00132808|1768768|FG002|Stratum II|Withdrawal by Subject|6
816745|NCT00132873|1768776|FG000|Overall Study|Adverse Event|3
816746|NCT00132873|1768776|FG000|Overall Study|Lost to Follow-up|1
816747|NCT00132873|1768776|FG000|Overall Study|Lack of Efficacy|1
816748|NCT00132873|1768776|FG000|Overall Study|Withdrawal by Subject|3
816749|NCT00132873|1768776|FG000|Overall Study|Planned Pregnancy|1
816750|NCT00133705|1768820|FG000|Overall Study|Withdrawal by Subject|2
816751|NCT00133705|1768821|FG001|Overall Study|Withdrawal by Subject|3
816752|NCT00133952|1768833|FG000|Overall Study|Adverse Event|1
816753|NCT00133952|1768834|FG001|Overall Study|Adverse Event|2
816754|NCT00133952|1768833|FG000|Overall Study|Death|3
816755|NCT00133952|1768834|FG001|Overall Study|Death|2
816756|NCT00133952|1768833|FG000|Overall Study|Lost to Follow-up|9
816757|NCT00133952|1768834|FG001|Overall Study|Lost to Follow-up|14
816758|NCT00133952|1768833|FG000|Overall Study|Protocol Entry Criteria Exclusion|4
816759|NCT00133952|1768834|FG001|Overall Study|Protocol Entry Criteria Exclusion|1
816760|NCT00133952|1768833|FG000|Overall Study|Protocol Violation|1
816761|NCT00133952|1768834|FG001|Overall Study|Protocol Violation|1
816762|NCT00133952|1768833|FG000|Overall Study|Withdrawal by Subject|20
816763|NCT00133952|1768834|FG001|Overall Study|Withdrawal by Subject|4
816764|NCT00133952|1768833|FG000|Overall Study|Physician Decision|4
816765|NCT00133952|1768834|FG001|Overall Study|Physician Decision|3
816766|NCT00133952|1768833|FG000|Overall Study|Sponsor Decision|0
816767|NCT00133952|1768834|FG001|Overall Study|Sponsor Decision|1
816768|NCT00133991|1768861|FG000|Overall Study|Death|4
816769|NCT00134056|1768883|FG000|Randomization|Not eligible for assigned treatment|22
816770|NCT00134056|1768884|FG001|Randomization|Not eligible for assigned treatment|20
816771|NCT00134056|1768883|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
816772|NCT00134056|1768884|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
816773|NCT00134056|1768883|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81
816856|NCT00135356|1769009|FG001|Overall Study|Surgery for abdominal fat|0
816774|NCT00134056|1768884|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67
816775|NCT00134056|1768883|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
816776|NCT00134056|1768884|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
816777|NCT00134056|1768883|FG000|Eligible for Protocol Assigned Treatment|Other|55
816778|NCT00134056|1768884|FG001|Eligible for Protocol Assigned Treatment|Other|56
816779|NCT00134082|1768893|FG000|Overall Study|Adverse Event|2
816780|NCT00134082|1768893|FG000|Overall Study|Death|1
816781|NCT00134563|1768922|FG000|Overall Study|Not treated due to protocol violation|0
816782|NCT00134563|1768923|FG001|Overall Study|Not treated due to protocol violation|1
816783|NCT00134563|1768924|FG002|Overall Study|Not treated due to protocol violation|1
816784|NCT00134563|1768922|FG000|Overall Study|Adverse Event|29
816785|NCT00134563|1768923|FG001|Overall Study|Adverse Event|37
816786|NCT00134563|1768924|FG002|Overall Study|Adverse Event|38
816787|NCT00134563|1768922|FG000|Overall Study|Lack of Efficacy|24
816788|NCT00134563|1768923|FG001|Overall Study|Lack of Efficacy|14
816789|NCT00134563|1768924|FG002|Overall Study|Lack of Efficacy|17
816790|NCT00134563|1768922|FG000|Overall Study|Protocol Violation|3
816791|NCT00134563|1768923|FG001|Overall Study|Protocol Violation|2
816792|NCT00134563|1768924|FG002|Overall Study|Protocol Violation|5
816793|NCT00134563|1768922|FG000|Overall Study|Lost to Follow-up|4
816794|NCT00134563|1768923|FG001|Overall Study|Lost to Follow-up|0
816795|NCT00134563|1768924|FG002|Overall Study|Lost to Follow-up|2
816796|NCT00134563|1768922|FG000|Overall Study|progressive disease|11
816797|NCT00134563|1768923|FG001|Overall Study|progressive disease|4
816798|NCT00134563|1768924|FG002|Overall Study|progressive disease|2
816799|NCT00134563|1768922|FG000|Overall Study|did not wish to continue|33
816800|NCT00134563|1768923|FG001|Overall Study|did not wish to continue|32
816801|NCT00134563|1768924|FG002|Overall Study|did not wish to continue|26
816802|NCT00134563|1768922|FG000|Overall Study|Reason other than above|0
816803|NCT00134563|1768923|FG001|Overall Study|Reason other than above|2
816804|NCT00134563|1768924|FG002|Overall Study|Reason other than above|5
816805|NCT00134719|1768935|FG000|Primary Vaccination Phase|Adverse Event|4
816806|NCT00134719|1768936|FG001|Primary Vaccination Phase|Adverse Event|0
816807|NCT00134719|1768937|FG002|Primary Vaccination Phase|Adverse Event|0
816808|NCT00134719|1768935|FG000|Primary Vaccination Phase|Protocol Violation|1
816809|NCT00134719|1768936|FG001|Primary Vaccination Phase|Protocol Violation|0
816810|NCT00134719|1768937|FG002|Primary Vaccination Phase|Protocol Violation|0
816811|NCT00134719|1768935|FG000|Primary Vaccination Phase|Withdrawal by Subject|2
816812|NCT00134719|1768936|FG001|Primary Vaccination Phase|Withdrawal by Subject|3
816813|NCT00134719|1768937|FG002|Primary Vaccination Phase|Withdrawal by Subject|2
816814|NCT00134719|1768935|FG000|Primary Vaccination Phase|Lost to Follow-up|7
816815|NCT00134719|1768936|FG001|Primary Vaccination Phase|Lost to Follow-up|3
816816|NCT00134719|1768937|FG002|Primary Vaccination Phase|Lost to Follow-up|3
816817|NCT00134719|1768935|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1
816818|NCT00134719|1768936|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3
816819|NCT00134719|1768937|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1
816820|NCT00134719|1768935|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
816821|NCT00134719|1768936|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
816822|NCT00134719|1768937|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
816823|NCT00134784|1768949|FG000|Overall Study|Withdrawal by Subject|2
816824|NCT00134784|1768950|FG001|Overall Study|Withdrawal by Subject|2
816825|NCT00134784|1768951|FG002|Overall Study|Withdrawal by Subject|2
816826|NCT00134784|1768952|FG003|Overall Study|Withdrawal by Subject|1
816827|NCT00134901|1768961|FG000|Overall Study|Lost to Follow-up|5
816828|NCT00134901|1768962|FG001|Overall Study|Lost to Follow-up|5
816829|NCT00134901|1768961|FG000|Overall Study|discontinued intervention|12
816830|NCT00134901|1768962|FG001|Overall Study|discontinued intervention|10
816831|NCT00135330|1768996|FG000|Overall Study|Adverse Event|2
816832|NCT00135330|1768997|FG001|Overall Study|Adverse Event|5
816833|NCT00135330|1768998|FG002|Overall Study|Adverse Event|1
816834|NCT00135330|1768996|FG000|Overall Study|Lost to Follow-up|0
816835|NCT00135330|1768997|FG001|Overall Study|Lost to Follow-up|2
816836|NCT00135330|1768998|FG002|Overall Study|Lost to Follow-up|3
816837|NCT00135330|1768996|FG000|Overall Study|Physician Decision|1
816838|NCT00135330|1768997|FG001|Overall Study|Physician Decision|1
816839|NCT00135330|1768998|FG002|Overall Study|Physician Decision|0
816840|NCT00135330|1768996|FG000|Overall Study|Protocol Violation|4
816841|NCT00135330|1768997|FG001|Overall Study|Protocol Violation|3
816842|NCT00135330|1768998|FG002|Overall Study|Protocol Violation|3
816843|NCT00135330|1768996|FG000|Overall Study|Patient Decision|5
816844|NCT00135330|1768997|FG001|Overall Study|Patient Decision|1
816845|NCT00135330|1768998|FG002|Overall Study|Patient Decision|4
816846|NCT00135330|1768996|FG000|Overall Study|Sponsor Decision|0
816847|NCT00135330|1768997|FG001|Overall Study|Sponsor Decision|1
816848|NCT00135330|1768998|FG002|Overall Study|Sponsor Decision|0
816849|NCT00135356|1769008|FG000|Overall Study|Adverse Event|6
816850|NCT00135356|1769009|FG001|Overall Study|Adverse Event|2
816851|NCT00135356|1769008|FG000|Overall Study|Lack of Efficacy|2
816852|NCT00135356|1769009|FG001|Overall Study|Lack of Efficacy|0
816853|NCT00135356|1769008|FG000|Overall Study|Lost to Follow-up|3
816854|NCT00135356|1769009|FG001|Overall Study|Lost to Follow-up|1
816855|NCT00135356|1769008|FG000|Overall Study|Surgery for abdominal fat|1
816857|NCT00135356|1769008|FG000|Overall Study|Change in antiviral regimen|0
816858|NCT00135356|1769009|FG001|Overall Study|Change in antiviral regimen|1
816859|NCT00135356|1769008|FG000|Overall Study|Poor/noncompliance|1
816860|NCT00135356|1769009|FG001|Overall Study|Poor/noncompliance|1
816861|NCT00135356|1769008|FG000|Overall Study|No longer meets study criteria|2
816862|NCT00135356|1769009|FG001|Overall Study|No longer meets study criteria|0
816863|NCT00135356|1769008|FG000|Overall Study|Withdrawal by Subject|2
816864|NCT00135356|1769009|FG001|Overall Study|Withdrawal by Subject|4
816865|NCT00135512|1769015|FG000|Overall Study|Adverse Event|56
816866|NCT00135512|1769015|FG000|Overall Study|Lack of Efficacy|25
816867|NCT00135512|1769015|FG000|Overall Study|Other|42
816868|NCT00135694|1769022|FG000|Overall Study|Adverse Event|17
816869|NCT00135694|1769023|FG001|Overall Study|Adverse Event|4
816870|NCT00135694|1769024|FG002|Overall Study|Adverse Event|0
816871|NCT00135694|1769022|FG000|Overall Study|Death|14
816872|NCT00135694|1769023|FG001|Overall Study|Death|1
816873|NCT00135694|1769024|FG002|Overall Study|Death|2
816874|NCT00135694|1769022|FG000|Overall Study|Lost to Follow-up|8
816875|NCT00135694|1769023|FG001|Overall Study|Lost to Follow-up|7
816876|NCT00135694|1769024|FG002|Overall Study|Lost to Follow-up|1
816877|NCT00135694|1769022|FG000|Overall Study|Withdrawal by Subject|41
816878|NCT00135694|1769023|FG001|Overall Study|Withdrawal by Subject|7
816879|NCT00135694|1769024|FG002|Overall Study|Withdrawal by Subject|4
816880|NCT00135694|1769022|FG000|Overall Study|Protocol Violation|19
816881|NCT00135694|1769023|FG001|Overall Study|Protocol Violation|1
816882|NCT00135694|1769024|FG002|Overall Study|Protocol Violation|0
816883|NCT00135694|1769022|FG000|Overall Study|Hepatitis C related reasons|39
816884|NCT00135694|1769023|FG001|Overall Study|Hepatitis C related reasons|1
816885|NCT00135694|1769024|FG002|Overall Study|Hepatitis C related reasons|0
816886|NCT00135694|1769022|FG000|Overall Study|Ineligible for Random assignment|42
816887|NCT00135694|1769023|FG001|Overall Study|Ineligible for Random assignment|0
816888|NCT00135694|1769024|FG002|Overall Study|Ineligible for Random assignment|0
816889|NCT00135707|1769034|FG000|Overall Study|Lost to Follow-up|94
816890|NCT00135707|1769035|FG001|Overall Study|Lost to Follow-up|89
816891|NCT00135707|1769034|FG000|Overall Study|Withdrawal by Subject|0
816892|NCT00135707|1769035|FG001|Overall Study|Withdrawal by Subject|1
816893|NCT00135707|1769034|FG000|Overall Study|Institutional review board request|1
816894|NCT00135707|1769035|FG001|Overall Study|Institutional review board request|0
816895|NCT00136084|1769059|FG000|Overall Study|Death|12
816896|NCT00136084|1769060|FG001|Overall Study|Death|5
816897|NCT00136084|1769059|FG000|Overall Study|Unacceptable toxicity|8
816898|NCT00136084|1769060|FG001|Overall Study|Unacceptable toxicity|11
816899|NCT00136084|1769059|FG000|Overall Study|Relapse|20
816900|NCT00136084|1769060|FG001|Overall Study|Relapse|23
816901|NCT00136084|1769059|FG000|Overall Study|Lost to Follow-up|2
816902|NCT00136084|1769060|FG001|Overall Study|Lost to Follow-up|0
816903|NCT00136084|1769059|FG000|Overall Study|No Response|1
816904|NCT00136084|1769060|FG001|Overall Study|No Response|2
816905|NCT00136084|1769059|FG000|Overall Study|Withdrawal by Subject|5
816906|NCT00136084|1769060|FG001|Overall Study|Withdrawal by Subject|1
816907|NCT00136318|1769085|FG000|Overall Study|Adverse Event|5
816908|NCT00136318|1769086|FG001|Overall Study|Adverse Event|5
816909|NCT00136318|1769085|FG000|Overall Study|Withdrawal by Subject|2
816910|NCT00136318|1769086|FG001|Overall Study|Withdrawal by Subject|2
816911|NCT00136357|1769095|FG000|Overall Study|Withdrawal by Subject|3
816912|NCT00136357|1769096|FG001|Overall Study|Withdrawal by Subject|2
816913|NCT00136604|1769107|FG000|Overall Study|Lost to Follow-up|1
816914|NCT00136604|1769108|FG001|Overall Study|Lost to Follow-up|0
816915|NCT00136604|1769109|FG002|Overall Study|Lost to Follow-up|0
816916|NCT00136604|1769110|FG003|Overall Study|Lost to Follow-up|0
816917|NCT00136604|1769111|FG004|Overall Study|Lost to Follow-up|1
816918|NCT00136604|1769107|FG000|Overall Study|Migrated/moved from study area|0
816919|NCT00136604|1769108|FG001|Overall Study|Migrated/moved from study area|1
816920|NCT00136604|1769109|FG002|Overall Study|Migrated/moved from study area|0
816921|NCT00136604|1769110|FG003|Overall Study|Migrated/moved from study area|0
816922|NCT00136604|1769111|FG004|Overall Study|Migrated/moved from study area|0
816923|NCT00136916|1769173|FG000|Overall Study|Never received study treatment|3
816924|NCT00136916|1769174|FG001|Overall Study|Never received study treatment|5
816925|NCT00136916|1769173|FG000|Overall Study|Death|1
816926|NCT00136916|1769174|FG001|Overall Study|Death|3
816927|NCT00136916|1769173|FG000|Overall Study|Adverse Event|27
816928|NCT00136916|1769174|FG001|Overall Study|Adverse Event|8
816929|NCT00136916|1769173|FG000|Overall Study|Laboratory abnormality|0
816930|NCT00136916|1769174|FG001|Overall Study|Laboratory abnormality|1
816931|NCT00136916|1769173|FG000|Overall Study|Lack of Efficacy|13
816932|NCT00136916|1769174|FG001|Overall Study|Lack of Efficacy|3
816933|NCT00136916|1769173|FG000|Overall Study|Lost to Follow-up|12
816934|NCT00136916|1769174|FG001|Overall Study|Lost to Follow-up|14
816935|NCT00136916|1769173|FG000|Overall Study|Withdrawal by Subject|44
816936|NCT00136916|1769174|FG001|Overall Study|Withdrawal by Subject|46
816937|NCT00136916|1769173|FG000|Overall Study|Other|22
816938|NCT00136916|1769174|FG001|Overall Study|Other|24
816939|NCT00136916|1769173|FG000|Overall Study|Discontinued in follow up period|3
816940|NCT00136916|1769174|FG001|Overall Study|Discontinued in follow up period|0
816941|NCT00136955|1769182|FG000|Overall Study|Adverse Event|8
816942|NCT00136955|1769182|FG000|Overall Study|Lost to Follow-up|1
816943|NCT00136955|1769182|FG000|Overall Study|Withdrawal by Subject|2
816944|NCT00136955|1769182|FG000|Overall Study|Incl. prog. disease, protocol violation|12
816945|NCT00137046|1769188|FG000|Overall Study|Death|2
816946|NCT00137046|1769189|FG001|Overall Study|Death|1
816947|NCT00137046|1769188|FG000|Overall Study|Adverse Event|16
816948|NCT00137046|1769189|FG001|Overall Study|Adverse Event|5
816949|NCT00137046|1769188|FG000|Overall Study|Laboratory Abnormality|2
816950|NCT00137046|1769189|FG001|Overall Study|Laboratory Abnormality|0
816951|NCT00137046|1769188|FG000|Overall Study|Lack of Efficacy|13
816952|NCT00137046|1769189|FG001|Overall Study|Lack of Efficacy|1
816953|NCT00137046|1769188|FG000|Overall Study|Lost to Follow-up|8
816954|NCT00137046|1769189|FG001|Overall Study|Lost to Follow-up|24
816955|NCT00137046|1769188|FG000|Overall Study|Other|23
816956|NCT00137046|1769189|FG001|Overall Study|Other|19
816957|NCT00137046|1769188|FG000|Overall Study|Withdrawal by Subject|33
816958|NCT00137046|1769189|FG001|Overall Study|Withdrawal by Subject|42
816959|NCT00137046|1769188|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1
816960|NCT00137046|1769189|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0
816961|NCT00137046|1769188|FG000|Overall Study|Withdrew prior to study treatment|1
816962|NCT00137046|1769189|FG001|Overall Study|Withdrew prior to study treatment|1
816963|NCT00137111|1769203|FG000|Total Therapy|Death|35
816964|NCT00137111|1769204|FG001|Total Therapy|Death|0
816965|NCT00137111|1769205|FG002|Total Therapy|Death|0
816966|NCT00137111|1769206|FG003|Total Therapy|Death|0
816967|NCT00137111|1769203|FG000|Total Therapy|Non Compliance|5
816968|NCT00137111|1769204|FG001|Total Therapy|Non Compliance|0
816969|NCT00137111|1769205|FG002|Total Therapy|Non Compliance|0
816970|NCT00137111|1769206|FG003|Total Therapy|Non Compliance|0
816971|NCT00137267|1769215|FG000|Overall Study|Lost to Follow-up|15
816972|NCT00137267|1769216|FG001|Overall Study|Lost to Follow-up|21
816973|NCT00137423|1769233|FG000|Overall Study|Adverse Event|7
816974|NCT00137423|1769234|FG001|Overall Study|Adverse Event|9
816975|NCT00137423|1769233|FG000|Overall Study|consent withdrawn|1
816976|NCT00137423|1769234|FG001|Overall Study|consent withdrawn|1
816977|NCT00137423|1769233|FG000|Overall Study|Lack of Efficacy|31
816978|NCT00137423|1769234|FG001|Overall Study|Lack of Efficacy|33
816979|NCT00137423|1769233|FG000|Overall Study|Death|0
816980|NCT00137423|1769234|FG001|Overall Study|Death|1
816981|NCT00137436|1769244|FG000|Overall Study|Adverse Event|13
816982|NCT00137436|1769244|FG000|Overall Study|Death|2
816983|NCT00137436|1769244|FG000|Overall Study|Lack of Efficacy|17
816984|NCT00137436|1769244|FG000|Overall Study|Withdrawal by Subject|6
816985|NCT00137436|1769244|FG000|Overall Study|Other|5
816986|NCT00137449|1769250|FG000|Overall Study|Disease Progression|8
816987|NCT00137449|1769251|FG001|Overall Study|Disease Progression|13
816988|NCT00137449|1769250|FG000|Overall Study|Death|4
816989|NCT00137449|1769251|FG001|Overall Study|Death|3
816990|NCT00137449|1769250|FG000|Overall Study|Adverse Event|3
816991|NCT00137449|1769251|FG001|Overall Study|Adverse Event|1
816992|NCT00137449|1769250|FG000|Overall Study|Withdrawal by Subject|1
816993|NCT00137449|1769251|FG001|Overall Study|Withdrawal by Subject|1
816994|NCT00137631|1769260|FG000|Overall Study|Lost to Follow-up|37
816995|NCT00137631|1769261|FG001|Overall Study|Lost to Follow-up|41
816996|NCT00137839|1769267|FG000|Overall Study|Adverse Event|7
816997|NCT00137839|1769267|FG000|Overall Study|Physician Decision|7
816998|NCT00137839|1769267|FG000|Overall Study|Death|8
816999|NCT00137839|1769267|FG000|Overall Study|Disease Progression|60
817000|NCT00137839|1769267|FG000|Overall Study|Not Start Treatment|1
817001|NCT00137839|1769267|FG000|Overall Study|Prolonged Treatment Delay|1
817002|NCT00138424|1769312|FG000|Overall Study|Physician Decision|0
817003|NCT00138424|1769313|FG001|Overall Study|Physician Decision|1
817004|NCT00138424|1769314|FG002|Overall Study|Physician Decision|0
817005|NCT00138424|1769315|FG003|Overall Study|Physician Decision|0
817006|NCT00138658|1769336|FG000|Overall Study|Adverse Event|23
817007|NCT00138658|1769336|FG000|Overall Study|Death|1
817008|NCT00138658|1769336|FG000|Overall Study|Disease Progression|21
817009|NCT00138658|1769336|FG000|Overall Study|Physician Decision|11
817010|NCT00138658|1769336|FG000|Overall Study|Withdrawal by Subject|5
817011|NCT00138671|1769344|FG000|Overall Study|Death|0
817012|NCT00138671|1769345|FG001|Overall Study|Death|3
817013|NCT00138671|1769344|FG000|Overall Study|Adverse Event|6
817014|NCT00138671|1769345|FG001|Overall Study|Adverse Event|3
817015|NCT00138671|1769344|FG000|Overall Study|Lost to Follow-up|1
817016|NCT00138671|1769345|FG001|Overall Study|Lost to Follow-up|2
817017|NCT00138671|1769344|FG000|Overall Study|Withdrawal by Subject|3
817018|NCT00138671|1769345|FG001|Overall Study|Withdrawal by Subject|5
817019|NCT00138671|1769344|FG000|Overall Study|Other|3
817020|NCT00138671|1769345|FG001|Overall Study|Other|3
817021|NCT00139477|1769364|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6
817022|NCT00139477|1769365|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7
817023|NCT00139477|1769364|FG000|First Intervention -Baseline to 6Months|Relocation|1
817024|NCT00139477|1769365|FG001|First Intervention -Baseline to 6Months|Relocation|2
817025|NCT00139477|1769364|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3
817026|NCT00139477|1769365|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3
817027|NCT00139477|1769364|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
817028|NCT00139477|1769365|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
817029|NCT00139477|1769364|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0
817030|NCT00139477|1769365|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2
817031|NCT00139477|1769364|FG000|Second Intervention -6Months to 12Months|Relocation|1
817032|NCT00139477|1769365|FG001|Second Intervention -6Months to 12Months|Relocation|0
817033|NCT00139477|1769364|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4
817034|NCT00139477|1769365|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3
817035|NCT00139659|1769375|FG000|Overall Study|Adverse Event|12
817036|NCT00139659|1769376|FG001|Overall Study|Adverse Event|1
817037|NCT00139659|1769375|FG000|Overall Study|Lack of Efficacy|1
817038|NCT00139659|1769376|FG001|Overall Study|Lack of Efficacy|1
817039|NCT00139659|1769375|FG000|Overall Study|Lost to Follow-up|7
817040|NCT00139659|1769376|FG001|Overall Study|Lost to Follow-up|3
817041|NCT00139659|1769375|FG000|Overall Study|Reason not Specified|6
817042|NCT00139659|1769376|FG001|Overall Study|Reason not Specified|3
817043|NCT00139659|1769375|FG000|Overall Study|Withdrawal by Subject|14
817044|NCT00139659|1769376|FG001|Overall Study|Withdrawal by Subject|10
817045|NCT00139737|1769386|FG000|Overall Study|Withdrawal by Subject|190
817046|NCT00139737|1769386|FG000|Overall Study|Adverse Event|58
817047|NCT00139737|1769386|FG000|Overall Study|Lack of Efficacy|40
817048|NCT00139737|1769386|FG000|Overall Study|Lost to Follow-up|8
817049|NCT00139737|1769386|FG000|Overall Study|Death|3
817050|NCT00139737|1769386|FG000|Overall Study|Laboratory Abnormality|2
817051|NCT00139737|1769386|FG000|Overall Study|Protocol Violation|18
817052|NCT00139737|1769386|FG000|Overall Study|Withdrew During Screening Phase|8
817053|NCT00139737|1769386|FG000|Overall Study|Did Not Meet Entrance Criteria|1
817054|NCT00139737|1769386|FG000|Overall Study|Screened, Not Treated|13
817055|NCT00139776|1769392|FG000|Period I|Did not enter Period II|575
817056|NCT00139776|1769393|FG001|Period I|Did not enter Period II|0
817057|NCT00139776|1769394|FG002|Period I|Did not enter Period II|0
817058|NCT00139776|1769395|FG003|Period I|Did not enter Period II|0
817059|NCT00139776|1769392|FG000|Period II|Not Randomized into Period III|0
817060|NCT00139776|1769393|FG001|Period II|Not Randomized into Period III|322
817061|NCT00139776|1769394|FG002|Period II|Not Randomized into Period III|0
817062|NCT00139776|1769395|FG003|Period II|Not Randomized into Period III|0
817063|NCT00139776|1769392|FG000|Period III|Adverse Event|0
817064|NCT00139776|1769393|FG001|Period III|Adverse Event|0
817065|NCT00139776|1769394|FG002|Period III|Adverse Event|22
817066|NCT00139776|1769395|FG003|Period III|Adverse Event|23
817067|NCT00139776|1769392|FG000|Period III|Other|0
817068|NCT00139776|1769393|FG001|Period III|Other|0
817069|NCT00139776|1769394|FG002|Period III|Other|23
817070|NCT00139776|1769395|FG003|Period III|Other|34
817071|NCT00139776|1769392|FG000|Period III|Lack of Efficacy|0
817072|NCT00139776|1769393|FG001|Period III|Lack of Efficacy|0
817073|NCT00139776|1769394|FG002|Period III|Lack of Efficacy|10
817074|NCT00139776|1769395|FG003|Period III|Lack of Efficacy|24
817075|NCT00139776|1769392|FG000|Period III|Lost to Follow-up|0
817076|NCT00139776|1769393|FG001|Period III|Lost to Follow-up|0
817077|NCT00139776|1769394|FG002|Period III|Lost to Follow-up|5
817078|NCT00139776|1769395|FG003|Period III|Lost to Follow-up|4
817079|NCT00139776|1769392|FG000|Period III|Withdrawal by Subject|0
817080|NCT00139776|1769393|FG001|Period III|Withdrawal by Subject|0
817081|NCT00139776|1769394|FG002|Period III|Withdrawal by Subject|16
817082|NCT00139776|1769395|FG003|Period III|Withdrawal by Subject|21
817083|NCT00140140|1769414|FG000|Overall Study|Unacceptable toxicity|1
817084|NCT00140140|1769415|FG001|Overall Study|Unacceptable toxicity|1
817085|NCT00140140|1769416|FG002|Overall Study|Unacceptable toxicity|2
817086|NCT00140140|1769414|FG000|Overall Study|Physician Decision|1
817087|NCT00140140|1769415|FG001|Overall Study|Physician Decision|1
817088|NCT00140140|1769416|FG002|Overall Study|Physician Decision|0
817089|NCT00140413|1769477|FG000|Overall Study|Lost to Follow-up|1
817090|NCT00140413|1769478|FG001|Overall Study|Lost to Follow-up|0
817091|NCT00140413|1769477|FG000|Overall Study|Withdrawal by Subject|2
817092|NCT00140413|1769478|FG001|Overall Study|Withdrawal by Subject|0
817093|NCT00140426|1769487|FG000|Overall Study|Withdrawal by Subject|0
817094|NCT00140426|1769488|FG001|Overall Study|Withdrawal by Subject|3
817095|NCT00140855|1769516|FG000|Overall Study|Progressive disease|2
817096|NCT00141037|1769522|FG000|Overall Study|Physician Decision|1
817097|NCT00141037|1769523|FG001|Overall Study|Physician Decision|2
817098|NCT00141037|1769522|FG000|Overall Study|Lost to Follow-up|3
817099|NCT00141037|1769523|FG001|Overall Study|Lost to Follow-up|1
817100|NCT00141037|1769522|FG000|Overall Study|Protocol Violation|0
817101|NCT00141037|1769523|FG001|Overall Study|Protocol Violation|2
817102|NCT00141037|1769522|FG000|Overall Study|Withdrawal by Subject|2
817103|NCT00141037|1769523|FG001|Overall Study|Withdrawal by Subject|1
817104|NCT00141037|1769522|FG000|Overall Study|Other|0
817105|NCT00141037|1769523|FG001|Overall Study|Other|1
817106|NCT00141037|1769522|FG000|Overall Study|Moved from area|1
817107|NCT00141037|1769523|FG001|Overall Study|Moved from area|7
817108|NCT00141037|1769522|FG000|Overall Study|Graft Failure|3
817109|NCT00141037|1769523|FG001|Overall Study|Graft Failure|4
817110|NCT00141102|1769531|FG000|Overall Study|Adverse Event|233
817111|NCT00141102|1769532|FG001|Overall Study|Adverse Event|305
817112|NCT00141102|1769531|FG000|Overall Study|Laboratory Abnormality|9
817113|NCT00141102|1769532|FG001|Overall Study|Laboratory Abnormality|33
817114|NCT00141102|1769531|FG000|Overall Study|Lack of Efficacy|21
817115|NCT00141102|1769532|FG001|Overall Study|Lack of Efficacy|26
817116|NCT00141102|1769531|FG000|Overall Study|Lost to Follow-up|29
817117|NCT00141102|1769532|FG001|Overall Study|Lost to Follow-up|32
817118|NCT00141102|1769531|FG000|Overall Study|Other|87
817119|NCT00141102|1769532|FG001|Overall Study|Other|76
817120|NCT00141102|1769531|FG000|Overall Study|Withdrawal by Subject|112
817121|NCT00141102|1769532|FG001|Overall Study|Withdrawal by Subject|142
817122|NCT00141102|1769531|FG000|Overall Study|Randomized But Did Not Receive Treatment|15
817123|NCT00141102|1769532|FG001|Overall Study|Randomized But Did Not Receive Treatment|9
817124|NCT00141102|1769531|FG000|Overall Study|Death|2
817125|NCT00141102|1769532|FG001|Overall Study|Death|2
817126|NCT00141219|1769546|FG000|Overall Study|Protocol violations|5
817127|NCT00141219|1769547|FG001|Overall Study|Protocol violations|4
817128|NCT00141219|1769546|FG000|Overall Study|Adverse Event|8
817129|NCT00141219|1769547|FG001|Overall Study|Adverse Event|6
817130|NCT00141219|1769546|FG000|Overall Study|Lack of Efficacy|5
817131|NCT00141219|1769547|FG001|Overall Study|Lack of Efficacy|4
817132|NCT00141219|1769546|FG000|Overall Study|Withdrawal by Subject|6
817133|NCT00141219|1769547|FG001|Overall Study|Withdrawal by Subject|2
817134|NCT00141271|1769556|FG000|Overall Study|Adverse Event|31
817135|NCT00141271|1769557|FG001|Overall Study|Adverse Event|19
817136|NCT00141271|1769558|FG002|Overall Study|Adverse Event|17
817137|NCT00141271|1769556|FG000|Overall Study|Laboratory Abnormality|2
817138|NCT00141271|1769557|FG001|Overall Study|Laboratory Abnormality|1
817139|NCT00141271|1769558|FG002|Overall Study|Laboratory Abnormality|1
817140|NCT00141271|1769556|FG000|Overall Study|Lack of Efficacy|7
817141|NCT00141271|1769557|FG001|Overall Study|Lack of Efficacy|7
817142|NCT00141271|1769558|FG002|Overall Study|Lack of Efficacy|3
817143|NCT00141271|1769556|FG000|Overall Study|Lost to Follow-up|15
817144|NCT00141271|1769557|FG001|Overall Study|Lost to Follow-up|15
817145|NCT00141271|1769558|FG002|Overall Study|Lost to Follow-up|21
817146|NCT00141271|1769556|FG000|Overall Study|Withdrawal by Subject|14
817147|NCT00141271|1769557|FG001|Overall Study|Withdrawal by Subject|9
817148|NCT00141271|1769558|FG002|Overall Study|Withdrawal by Subject|10
817149|NCT00141271|1769556|FG000|Overall Study|Other|11
817150|NCT00141271|1769557|FG001|Overall Study|Other|12
817151|NCT00141271|1769558|FG002|Overall Study|Other|5
817152|NCT00141297|1769568|FG000|Overall Study|Adverse Event|0
817153|NCT00141297|1769569|FG001|Overall Study|Adverse Event|0
817154|NCT00141297|1769570|FG002|Overall Study|Adverse Event|1
817155|NCT00141297|1769571|FG003|Overall Study|Adverse Event|0
817156|NCT00141297|1769572|FG004|Overall Study|Adverse Event|1
817157|NCT00141297|1769573|FG005|Overall Study|Adverse Event|1
817158|NCT00141297|1769574|FG006|Overall Study|Adverse Event|0
817159|NCT00141297|1769575|FG007|Overall Study|Adverse Event|1
817160|NCT00141297|1769576|FG008|Overall Study|Adverse Event|1
817161|NCT00141297|1769577|FG009|Overall Study|Adverse Event|0
817162|NCT00141297|1769568|FG000|Overall Study|Death|1
817163|NCT00141297|1769569|FG001|Overall Study|Death|0
817164|NCT00141297|1769570|FG002|Overall Study|Death|0
817165|NCT00141297|1769571|FG003|Overall Study|Death|0
817166|NCT00141297|1769572|FG004|Overall Study|Death|0
817167|NCT00141297|1769573|FG005|Overall Study|Death|0
817168|NCT00141297|1769574|FG006|Overall Study|Death|0
817169|NCT00141297|1769575|FG007|Overall Study|Death|0
817170|NCT00141297|1769576|FG008|Overall Study|Death|1
817171|NCT00141297|1769577|FG009|Overall Study|Death|0
817172|NCT00141297|1769568|FG000|Overall Study|Withdrawal by Subject|0
817173|NCT00141297|1769569|FG001|Overall Study|Withdrawal by Subject|0
817174|NCT00141297|1769570|FG002|Overall Study|Withdrawal by Subject|0
817175|NCT00141297|1769571|FG003|Overall Study|Withdrawal by Subject|0
817176|NCT00141297|1769572|FG004|Overall Study|Withdrawal by Subject|0
817177|NCT00141297|1769573|FG005|Overall Study|Withdrawal by Subject|0
817178|NCT00141297|1769574|FG006|Overall Study|Withdrawal by Subject|0
817179|NCT00141297|1769575|FG007|Overall Study|Withdrawal by Subject|0
817180|NCT00141297|1769576|FG008|Overall Study|Withdrawal by Subject|1
817181|NCT00141297|1769577|FG009|Overall Study|Withdrawal by Subject|0
817182|NCT00141297|1769568|FG000|Overall Study|Other|0
817183|NCT00141297|1769569|FG001|Overall Study|Other|0
817184|NCT00141297|1769570|FG002|Overall Study|Other|0
817185|NCT00141297|1769571|FG003|Overall Study|Other|1
817186|NCT00141297|1769572|FG004|Overall Study|Other|5
817187|NCT00141297|1769573|FG005|Overall Study|Other|0
817188|NCT00141297|1769574|FG006|Overall Study|Other|0
817189|NCT00141297|1769575|FG007|Overall Study|Other|0
817190|NCT00141297|1769576|FG008|Overall Study|Other|2
817191|NCT00141297|1769577|FG009|Overall Study|Other|0
817192|NCT00141297|1769568|FG000|Overall Study|Progressive Disease|2
817193|NCT00141297|1769569|FG001|Overall Study|Progressive Disease|3
817194|NCT00141297|1769570|FG002|Overall Study|Progressive Disease|6
817195|NCT00141297|1769571|FG003|Overall Study|Progressive Disease|2
817196|NCT00141297|1769572|FG004|Overall Study|Progressive Disease|15
817197|NCT00141297|1769573|FG005|Overall Study|Progressive Disease|2
817198|NCT00141297|1769574|FG006|Overall Study|Progressive Disease|3
817199|NCT00141297|1769575|FG007|Overall Study|Progressive Disease|3
817200|NCT00141297|1769576|FG008|Overall Study|Progressive Disease|15
817201|NCT00141297|1769577|FG009|Overall Study|Progressive Disease|6
817202|NCT00141297|1769568|FG000|Overall Study|Transitioned|0
817203|NCT00141297|1769569|FG001|Overall Study|Transitioned|0
817204|NCT00141297|1769570|FG002|Overall Study|Transitioned|0
817205|NCT00141297|1769571|FG003|Overall Study|Transitioned|0
817206|NCT00141297|1769572|FG004|Overall Study|Transitioned|1
817207|NCT00141297|1769573|FG005|Overall Study|Transitioned|0
817208|NCT00141297|1769574|FG006|Overall Study|Transitioned|0
817209|NCT00141297|1769575|FG007|Overall Study|Transitioned|0
817210|NCT00141297|1769576|FG008|Overall Study|Transitioned|0
817211|NCT00141297|1769577|FG009|Overall Study|Transitioned|0
817212|NCT00141453|1769612|FG000|Overall Study|Protocol Violation|6
817213|NCT00141453|1769613|FG001|Overall Study|Protocol Violation|5
817214|NCT00141518|1769622|FG000|Overall Study|Withdrew Consent Prior to Treatment|1
817215|NCT00141518|1769623|FG001|Overall Study|Withdrew Consent Prior to Treatment|0
817216|NCT00141518|1769624|FG002|Overall Study|Withdrew Consent Prior to Treatment|0
817217|NCT00141518|1769622|FG000|Overall Study|Adverse Event|7
817218|NCT00141518|1769623|FG001|Overall Study|Adverse Event|5
817219|NCT00141518|1769624|FG002|Overall Study|Adverse Event|2
817220|NCT00141518|1769622|FG000|Overall Study|Withdrawal by Subject|2
817221|NCT00141518|1769623|FG001|Overall Study|Withdrawal by Subject|0
817222|NCT00141518|1769624|FG002|Overall Study|Withdrawal by Subject|2
817223|NCT00141518|1769622|FG000|Overall Study|Protocol Violation|1
817224|NCT00141518|1769623|FG001|Overall Study|Protocol Violation|1
817225|NCT00141518|1769624|FG002|Overall Study|Protocol Violation|2
817226|NCT00141518|1769622|FG000|Overall Study|Lack of Efficacy|5
817227|NCT00141518|1769623|FG001|Overall Study|Lack of Efficacy|0
817228|NCT00141518|1769624|FG002|Overall Study|Lack of Efficacy|0
817229|NCT00141726|1769634|FG000|Overall Study|Completed <50% Scheduled Dosing|3
817230|NCT00141778|1769651|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5
817231|NCT00141778|1769652|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2
817232|NCT00141778|1769653|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6
817233|NCT00141778|1769651|FG000|Started Study Medication|Met safety criteria for discontinuation|2
817234|NCT00141778|1769652|FG001|Started Study Medication|Met safety criteria for discontinuation|4
817235|NCT00141778|1769653|FG002|Started Study Medication|Met safety criteria for discontinuation|3
817236|NCT00141778|1769651|FG000|Started Study Medication|Withdrawal by Subject|0
817237|NCT00141778|1769652|FG001|Started Study Medication|Withdrawal by Subject|2
817238|NCT00141778|1769653|FG002|Started Study Medication|Withdrawal by Subject|0
817239|NCT00141778|1769651|FG000|Started Study Medication|Difficulty Swallowing|0
817240|NCT00141778|1769652|FG001|Started Study Medication|Difficulty Swallowing|1
817241|NCT00141778|1769653|FG002|Started Study Medication|Difficulty Swallowing|0
817242|NCT00141778|1769651|FG000|Started Study Medication|Chest Discomfort|0
817243|NCT00141778|1769652|FG001|Started Study Medication|Chest Discomfort|0
817244|NCT00141778|1769653|FG002|Started Study Medication|Chest Discomfort|1
817245|NCT00141817|1769665|FG000|Overall Study|Protocol Violation|0
817246|NCT00141817|1769666|FG001|Overall Study|Protocol Violation|0
817247|NCT00141817|1769667|FG002|Overall Study|Protocol Violation|1
817248|NCT00141817|1769668|FG003|Overall Study|Protocol Violation|0
817249|NCT00141817|1769665|FG000|Overall Study|Parent request|1
817250|NCT00141817|1769666|FG001|Overall Study|Parent request|0
817251|NCT00141817|1769667|FG002|Overall Study|Parent request|0
817252|NCT00141817|1769668|FG003|Overall Study|Parent request|0
817253|NCT00141921|1769678|FG000|Overall Study|Remain on Study|28
817254|NCT00141921|1769678|FG000|Overall Study|Withdrawal by Subject|42
817255|NCT00141921|1769678|FG000|Overall Study|Lost to Follow-up|19
817256|NCT00141921|1769678|FG000|Overall Study|Noncompliance|17
817257|NCT00141921|1769678|FG000|Overall Study|Disease Progression|7
817258|NCT00141921|1769678|FG000|Overall Study|Protocol Deviation|7
817259|NCT00141921|1769678|FG000|Overall Study|Adverse Event|5
817260|NCT00141921|1769678|FG000|Overall Study|Administrative Decision|2
817261|NCT00141921|1769678|FG000|Overall Study|Pregnancy|4
817262|NCT00141921|1769678|FG000|Overall Study|Ineligibility Determined|2
817263|NCT00141921|1769678|FG000|Overall Study|Other|8
817264|NCT00142298|1769701|FG000|Overall Study|Adverse Event|10
817265|NCT00142298|1769702|FG001|Overall Study|Adverse Event|10
817266|NCT00142298|1769703|FG002|Overall Study|Adverse Event|1
817267|NCT00142298|1769704|FG003|Overall Study|Adverse Event|5
817268|NCT00142298|1769705|FG004|Overall Study|Adverse Event|2
817269|NCT00142298|1769706|FG005|Overall Study|Adverse Event|2
817270|NCT00142298|1769707|FG006|Overall Study|Adverse Event|0
817271|NCT00142298|1769708|FG007|Overall Study|Adverse Event|0
817272|NCT00142298|1769709|FG008|Overall Study|Adverse Event|0
817273|NCT00142298|1769710|FG009|Overall Study|Adverse Event|0
817274|NCT00142298|1769701|FG000|Overall Study|Clinical disease progression|1
817275|NCT00142298|1769702|FG001|Overall Study|Clinical disease progression|0
817276|NCT00142298|1769703|FG002|Overall Study|Clinical disease progression|0
817277|NCT00142298|1769704|FG003|Overall Study|Clinical disease progression|0
817278|NCT00142298|1769705|FG004|Overall Study|Clinical disease progression|0
817279|NCT00142298|1769706|FG005|Overall Study|Clinical disease progression|0
817280|NCT00142298|1769707|FG006|Overall Study|Clinical disease progression|0
817281|NCT00142298|1769708|FG007|Overall Study|Clinical disease progression|0
817282|NCT00142298|1769709|FG008|Overall Study|Clinical disease progression|0
817283|NCT00142298|1769710|FG009|Overall Study|Clinical disease progression|0
817284|NCT00142298|1769701|FG000|Overall Study|Death|1
817285|NCT00142298|1769702|FG001|Overall Study|Death|1
817286|NCT00142298|1769703|FG002|Overall Study|Death|1
817287|NCT00142298|1769704|FG003|Overall Study|Death|0
817288|NCT00142298|1769705|FG004|Overall Study|Death|0
817289|NCT00142298|1769706|FG005|Overall Study|Death|6
817290|NCT00142298|1769707|FG006|Overall Study|Death|0
817291|NCT00142298|1769708|FG007|Overall Study|Death|0
817292|NCT00142298|1769709|FG008|Overall Study|Death|0
817293|NCT00142298|1769710|FG009|Overall Study|Death|0
817294|NCT00142298|1769701|FG000|Overall Study|Lack of Efficacy|44
817295|NCT00142298|1769702|FG001|Overall Study|Lack of Efficacy|62
817296|NCT00142298|1769703|FG002|Overall Study|Lack of Efficacy|9
817297|NCT00142298|1769704|FG003|Overall Study|Lack of Efficacy|12
817298|NCT00142298|1769705|FG004|Overall Study|Lack of Efficacy|1
817299|NCT00142298|1769706|FG005|Overall Study|Lack of Efficacy|0
817300|NCT00142298|1769707|FG006|Overall Study|Lack of Efficacy|0
817301|NCT00142298|1769708|FG007|Overall Study|Lack of Efficacy|1
817302|NCT00142298|1769709|FG008|Overall Study|Lack of Efficacy|0
817303|NCT00142298|1769710|FG009|Overall Study|Lack of Efficacy|0
817304|NCT00142298|1769701|FG000|Overall Study|Non-compliance|15
817305|NCT00142298|1769702|FG001|Overall Study|Non-compliance|13
817306|NCT00142298|1769703|FG002|Overall Study|Non-compliance|0
817307|NCT00142298|1769704|FG003|Overall Study|Non-compliance|6
817308|NCT00142298|1769705|FG004|Overall Study|Non-compliance|1
817309|NCT00142298|1769706|FG005|Overall Study|Non-compliance|0
817310|NCT00142298|1769707|FG006|Overall Study|Non-compliance|0
817311|NCT00142298|1769708|FG007|Overall Study|Non-compliance|3
817312|NCT00142298|1769709|FG008|Overall Study|Non-compliance|3
817313|NCT00142298|1769710|FG009|Overall Study|Non-compliance|0
817314|NCT00142298|1769701|FG000|Overall Study|Patient, Investigator,or Sponsor request|66
817315|NCT00142298|1769702|FG001|Overall Study|Patient, Investigator,or Sponsor request|60
817316|NCT00142298|1769703|FG002|Overall Study|Patient, Investigator,or Sponsor request|11
817317|NCT00142298|1769704|FG003|Overall Study|Patient, Investigator,or Sponsor request|51
817318|NCT00142298|1769705|FG004|Overall Study|Patient, Investigator,or Sponsor request|4
817319|NCT00142298|1769706|FG005|Overall Study|Patient, Investigator,or Sponsor request|3
817320|NCT00142298|1769707|FG006|Overall Study|Patient, Investigator,or Sponsor request|1
817321|NCT00142298|1769708|FG007|Overall Study|Patient, Investigator,or Sponsor request|4
817322|NCT00142298|1769709|FG008|Overall Study|Patient, Investigator,or Sponsor request|1
817323|NCT00142298|1769710|FG009|Overall Study|Patient, Investigator,or Sponsor request|0
817324|NCT00142298|1769701|FG000|Overall Study|Pregnancy|4
817325|NCT00142298|1769702|FG001|Overall Study|Pregnancy|4
817326|NCT00142298|1769703|FG002|Overall Study|Pregnancy|2
817327|NCT00142298|1769704|FG003|Overall Study|Pregnancy|3
817328|NCT00142298|1769705|FG004|Overall Study|Pregnancy|0
817329|NCT00142298|1769706|FG005|Overall Study|Pregnancy|0
817330|NCT00142298|1769707|FG006|Overall Study|Pregnancy|0
817331|NCT00142298|1769708|FG007|Overall Study|Pregnancy|0
817332|NCT00142298|1769709|FG008|Overall Study|Pregnancy|1
817333|NCT00142298|1769710|FG009|Overall Study|Pregnancy|0
817334|NCT00142298|1769701|FG000|Overall Study|Virologic breakthrough|19
817335|NCT00142298|1769702|FG001|Overall Study|Virologic breakthrough|23
817336|NCT00142298|1769703|FG002|Overall Study|Virologic breakthrough|9
817337|NCT00142298|1769704|FG003|Overall Study|Virologic breakthrough|7
817338|NCT00142298|1769705|FG004|Overall Study|Virologic breakthrough|2
817339|NCT00142298|1769706|FG005|Overall Study|Virologic breakthrough|3
817340|NCT00142298|1769707|FG006|Overall Study|Virologic breakthrough|3
817341|NCT00142298|1769708|FG007|Overall Study|Virologic breakthrough|0
817342|NCT00142298|1769709|FG008|Overall Study|Virologic breakthrough|0
817343|NCT00142298|1769710|FG009|Overall Study|Virologic breakthrough|0
817344|NCT00142298|1769701|FG000|Overall Study|Other- not specified|0
817345|NCT00142298|1769702|FG001|Overall Study|Other- not specified|3
817346|NCT00142298|1769703|FG002|Overall Study|Other- not specified|0
817347|NCT00142298|1769704|FG003|Overall Study|Other- not specified|1
817348|NCT00142298|1769705|FG004|Overall Study|Other- not specified|0
817349|NCT00142298|1769706|FG005|Overall Study|Other- not specified|0
817350|NCT00142298|1769707|FG006|Overall Study|Other- not specified|0
817351|NCT00142298|1769708|FG007|Overall Study|Other- not specified|0
817352|NCT00142298|1769709|FG008|Overall Study|Other- not specified|0
817353|NCT00142298|1769710|FG009|Overall Study|Other- not specified|0
817354|NCT00142298|1769701|FG000|Overall Study|Lost to Follow-up|0
817355|NCT00142298|1769702|FG001|Overall Study|Lost to Follow-up|0
817356|NCT00142298|1769703|FG002|Overall Study|Lost to Follow-up|0
817357|NCT00142298|1769704|FG003|Overall Study|Lost to Follow-up|0
817358|NCT00142298|1769705|FG004|Overall Study|Lost to Follow-up|0
817359|NCT00142298|1769706|FG005|Overall Study|Lost to Follow-up|0
817360|NCT00142298|1769707|FG006|Overall Study|Lost to Follow-up|2
817361|NCT00142298|1769708|FG007|Overall Study|Lost to Follow-up|0
817362|NCT00142298|1769709|FG008|Overall Study|Lost to Follow-up|0
817363|NCT00142298|1769710|FG009|Overall Study|Lost to Follow-up|0
817364|NCT00142298|1769701|FG000|Overall Study|Treatment Failure|0
817365|NCT00142298|1769702|FG001|Overall Study|Treatment Failure|0
817366|NCT00142298|1769703|FG002|Overall Study|Treatment Failure|0
817367|NCT00142298|1769704|FG003|Overall Study|Treatment Failure|0
817368|NCT00142298|1769705|FG004|Overall Study|Treatment Failure|0
817369|NCT00142298|1769706|FG005|Overall Study|Treatment Failure|2
817370|NCT00142298|1769707|FG006|Overall Study|Treatment Failure|2
817371|NCT00142298|1769708|FG007|Overall Study|Treatment Failure|0
817372|NCT00142298|1769709|FG008|Overall Study|Treatment Failure|0
817373|NCT00142298|1769710|FG009|Overall Study|Treatment Failure|0
817374|NCT00142415|1769738|FG000|Overall Study|Physician Decision|0
817375|NCT00142415|1769739|FG001|Overall Study|Physician Decision|0
817376|NCT00142415|1769740|FG002|Overall Study|Physician Decision|0
817377|NCT00142415|1769741|FG003|Overall Study|Physician Decision|0
817378|NCT00142415|1769742|FG004|Overall Study|Physician Decision|1
817379|NCT00142415|1769743|FG005|Overall Study|Physician Decision|2
817380|NCT00142792|1769784|FG000|Overall Study|Death|0
817381|NCT00142792|1769785|FG001|Overall Study|Death|0
817382|NCT00142792|1769786|FG002|Overall Study|Death|1
817383|NCT00142792|1769784|FG000|Overall Study|Withdrawal by Subject|3
817384|NCT00142792|1769785|FG001|Overall Study|Withdrawal by Subject|2
817385|NCT00142792|1769786|FG002|Overall Study|Withdrawal by Subject|3
817386|NCT00142792|1769784|FG000|Overall Study|Lost to Follow-up|8
817387|NCT00142792|1769785|FG001|Overall Study|Lost to Follow-up|11
817388|NCT00142792|1769786|FG002|Overall Study|Lost to Follow-up|7
817389|NCT00142792|1769784|FG000|Overall Study|No category|1
817390|NCT00142792|1769785|FG001|Overall Study|No category|2
817391|NCT00142792|1769786|FG002|Overall Study|No category|1
817392|NCT00142909|1769817|FG000|Randomization|Various Reasons|7
817393|NCT00142909|1769818|FG001|Randomization|Various Reasons|10
817394|NCT00142909|1769817|FG000|Medications Begin|Protocol Violation|2
817395|NCT00142909|1769818|FG001|Medications Begin|Protocol Violation|0
817396|NCT00142909|1769817|FG000|Medications Begin|Withdrawal by Subject|5
817397|NCT00142909|1769818|FG001|Medications Begin|Withdrawal by Subject|3
817398|NCT00142909|1769817|FG000|Medications Begin|Withdrawal by Subject|2
817399|NCT00142909|1769818|FG001|Medications Begin|Withdrawal by Subject|0
817400|NCT00142935|1769827|FG000|Overall Study|Other reason|1
817401|NCT00142935|1769828|FG001|Overall Study|Other reason|1
817402|NCT00142935|1769829|FG002|Overall Study|Other reason|1
817403|NCT00142935|1769827|FG000|Overall Study|Lost to Follow-up|2
817404|NCT00142935|1769828|FG001|Overall Study|Lost to Follow-up|5
817405|NCT00142935|1769829|FG002|Overall Study|Lost to Follow-up|5
817406|NCT00142935|1769827|FG000|Overall Study|Death|0
817407|NCT00142935|1769828|FG001|Overall Study|Death|2
817408|NCT00142935|1769829|FG002|Overall Study|Death|1
817409|NCT00143247|1769841|FG000|Overall Study|Death|8
817410|NCT00143247|1769841|FG000|Overall Study|Adverse Event|19
817411|NCT00143247|1769841|FG000|Overall Study|Lack of Efficacy|3
817412|NCT00143247|1769841|FG000|Overall Study|Withdrawal by Subject|55
817413|NCT00143247|1769841|FG000|Overall Study|Study terminated by sponsor|31
817414|NCT00143247|1769841|FG000|Overall Study|Protocol Violation|15
817415|NCT00143247|1769841|FG000|Overall Study|Lost to Follow-up|12
817416|NCT00143247|1769841|FG000|Overall Study|following inaccurate lab adverse event|1
817417|NCT00143247|1769841|FG000|Overall Study|Other|12
817418|NCT00143312|1769845|FG000|Overall Study|Death|11
817419|NCT00143312|1769845|FG000|Overall Study|Adverse Event|2
817420|NCT00143312|1769845|FG000|Overall Study|Lost to Follow-up|1
817421|NCT00143312|1769845|FG000|Overall Study|Other|1
817422|NCT00143312|1769845|FG000|Overall Study|Withdrawal by Subject|1
817423|NCT00143390|1769851|FG000|Overall Study|Death|2
817424|NCT00143390|1769852|FG001|Overall Study|Death|0
817425|NCT00143390|1769851|FG000|Overall Study|Not meeting entry criteria|2
817426|NCT00143390|1769852|FG001|Overall Study|Not meeting entry criteria|5
817427|NCT00143390|1769851|FG000|Overall Study|Withdrawal by Subject|4
817428|NCT00143390|1769852|FG001|Overall Study|Withdrawal by Subject|4
817429|NCT00143390|1769851|FG000|Overall Study|Progressive disease|119
817430|NCT00143390|1769852|FG001|Overall Study|Progressive disease|115
817431|NCT00143390|1769851|FG000|Overall Study|Protocol Violation|2
817432|NCT00143390|1769852|FG001|Overall Study|Protocol Violation|0
817433|NCT00143390|1769851|FG000|Overall Study|Study termination|10
817434|NCT00143390|1769852|FG001|Overall Study|Study termination|15
817435|NCT00143390|1769851|FG000|Overall Study|Adverse Event|9
817436|NCT00143390|1769852|FG001|Overall Study|Adverse Event|8
817437|NCT00143390|1769851|FG000|Overall Study|Other|1
817438|NCT00143390|1769852|FG001|Overall Study|Other|2
817439|NCT00143403|1769860|FG000|Overall Study|Adverse Event|3
817440|NCT00143403|1769861|FG001|Overall Study|Adverse Event|8
817441|NCT00143403|1769860|FG000|Overall Study|Death|1
817442|NCT00143403|1769861|FG001|Overall Study|Death|0
817443|NCT00143403|1769860|FG000|Overall Study|Withdrawal by Subject|3
817444|NCT00143403|1769861|FG001|Overall Study|Withdrawal by Subject|12
817445|NCT00143403|1769860|FG000|Overall Study|Relapse|15
817446|NCT00143403|1769861|FG001|Overall Study|Relapse|7
817447|NCT00143403|1769860|FG000|Overall Study|Protocol Violation|2
817448|NCT00143403|1769861|FG001|Overall Study|Protocol Violation|2
817449|NCT00143403|1769860|FG000|Overall Study|specified by site|4
817450|NCT00143403|1769861|FG001|Overall Study|specified by site|9
817451|NCT00143403|1769860|FG000|Overall Study|Randomized Not Treated|7
817452|NCT00143403|1769861|FG001|Overall Study|Randomized Not Treated|8
817453|NCT00143455|1769871|FG000|Cohort 1|Adverse Event|8
817454|NCT00143455|1769872|FG001|Cohort 1|Adverse Event|4
817455|NCT00143455|1769873|FG002|Cohort 1|Adverse Event|0
817456|NCT00143455|1769874|FG003|Cohort 1|Adverse Event|0
817457|NCT00143455|1769871|FG000|Cohort 1|Death|5
817458|NCT00143455|1769872|FG001|Cohort 1|Death|2
817459|NCT00143455|1769873|FG002|Cohort 1|Death|0
817460|NCT00143455|1769874|FG003|Cohort 1|Death|0
817461|NCT00143455|1769871|FG000|Cohort 1|Progressive Disease|0
817462|NCT00143455|1769872|FG001|Cohort 1|Progressive Disease|6
817463|NCT00143455|1769873|FG002|Cohort 1|Progressive Disease|0
817464|NCT00143455|1769874|FG003|Cohort 1|Progressive Disease|0
817465|NCT00143455|1769871|FG000|Cohort 1|Withdrawal by Subject|1
817466|NCT00143455|1769872|FG001|Cohort 1|Withdrawal by Subject|4
817467|NCT00143455|1769873|FG002|Cohort 1|Withdrawal by Subject|0
817468|NCT00143455|1769874|FG003|Cohort 1|Withdrawal by Subject|0
817469|NCT00143455|1769871|FG000|Cohort 1|Randomized But Not Treated|0
817470|NCT00143455|1769872|FG001|Cohort 1|Randomized But Not Treated|1
817471|NCT00143455|1769873|FG002|Cohort 1|Randomized But Not Treated|0
817472|NCT00143455|1769874|FG003|Cohort 1|Randomized But Not Treated|0
817473|NCT00143455|1769871|FG000|Cohort 2|Adverse Event|0
817474|NCT00143455|1769872|FG001|Cohort 2|Adverse Event|0
817475|NCT00143455|1769873|FG002|Cohort 2|Adverse Event|42
817476|NCT00143455|1769874|FG003|Cohort 2|Adverse Event|30
817477|NCT00143455|1769871|FG000|Cohort 2|No Longer Required Study Treatment|0
817478|NCT00143455|1769872|FG001|Cohort 2|No Longer Required Study Treatment|0
817479|NCT00143455|1769873|FG002|Cohort 2|No Longer Required Study Treatment|1
817480|NCT00143455|1769874|FG003|Cohort 2|No Longer Required Study Treatment|0
817481|NCT00143455|1769871|FG000|Cohort 2|Protocol Violation|0
817482|NCT00143455|1769872|FG001|Cohort 2|Protocol Violation|0
817483|NCT00143455|1769873|FG002|Cohort 2|Protocol Violation|1
817484|NCT00143455|1769874|FG003|Cohort 2|Protocol Violation|1
817485|NCT00143455|1769871|FG000|Cohort 2|Lost to Follow-up|0
817486|NCT00143455|1769872|FG001|Cohort 2|Lost to Follow-up|0
817487|NCT00143455|1769873|FG002|Cohort 2|Lost to Follow-up|1
817488|NCT00143455|1769874|FG003|Cohort 2|Lost to Follow-up|4
817489|NCT00143455|1769871|FG000|Cohort 2|Death|0
817490|NCT00143455|1769872|FG001|Cohort 2|Death|0
817491|NCT00143455|1769873|FG002|Cohort 2|Death|20
817492|NCT00143455|1769874|FG003|Cohort 2|Death|12
817493|NCT00143455|1769871|FG000|Cohort 2|Progressive Disease|0
817494|NCT00143455|1769872|FG001|Cohort 2|Progressive Disease|0
817495|NCT00143455|1769873|FG002|Cohort 2|Progressive Disease|20
817496|NCT00143455|1769874|FG003|Cohort 2|Progressive Disease|27
817497|NCT00143455|1769871|FG000|Cohort 2|Withdrawal by Subject|0
817498|NCT00143455|1769872|FG001|Cohort 2|Withdrawal by Subject|0
817499|NCT00143455|1769873|FG002|Cohort 2|Withdrawal by Subject|13
817500|NCT00143455|1769874|FG003|Cohort 2|Withdrawal by Subject|12
817501|NCT00143455|1769871|FG000|Cohort 2|Other|0
817502|NCT00143455|1769872|FG001|Cohort 2|Other|0
817503|NCT00143455|1769873|FG002|Cohort 2|Other|7
817504|NCT00143455|1769874|FG003|Cohort 2|Other|6
817505|NCT00143455|1769871|FG000|Cohort 2|Randomized But Not Treated|0
817506|NCT00143455|1769872|FG001|Cohort 2|Randomized But Not Treated|0
817507|NCT00143455|1769873|FG002|Cohort 2|Randomized But Not Treated|1
817508|NCT00143455|1769874|FG003|Cohort 2|Randomized But Not Treated|1
817509|NCT00143507|1769888|FG000|Overall Study|Death|572
817510|NCT00143507|1769889|FG001|Overall Study|Death|547
817511|NCT00143507|1769888|FG000|Overall Study|Withdrawal by Subject|114
817512|NCT00143507|1769889|FG001|Overall Study|Withdrawal by Subject|102
817513|NCT00143507|1769888|FG000|Overall Study|Lost to Follow-up|1
817514|NCT00143507|1769889|FG001|Overall Study|Lost to Follow-up|0
817515|NCT00143507|1769888|FG000|Overall Study|Withdrawn by sponsor's decision|0
817516|NCT00143507|1769889|FG001|Overall Study|Withdrawn by sponsor's decision|3
817517|NCT00143598|1769897|FG000|Overall Study|Lost to Follow-up|23
817518|NCT00143598|1769898|FG001|Overall Study|Lost to Follow-up|21
817519|NCT00143598|1769897|FG000|Overall Study|Withdrawal by Subject|33
817520|NCT00143598|1769898|FG001|Overall Study|Withdrawal by Subject|37
817521|NCT00143598|1769897|FG000|Overall Study|Death|36
817522|NCT00143598|1769898|FG001|Overall Study|Death|36
817523|NCT00144027|1769923|FG000|Overall Study|Lost to Follow-up|1
817524|NCT00144027|1769924|FG001|Overall Study|Lost to Follow-up|3
817525|NCT00144027|1769923|FG000|Overall Study|Withdrawal by Subject|2
817526|NCT00144027|1769924|FG001|Overall Study|Withdrawal by Subject|2
817527|NCT00144027|1769923|FG000|Overall Study|did not complete baseline assessment|0
817528|NCT00144027|1769924|FG001|Overall Study|did not complete baseline assessment|6
817529|NCT00144170|1769932|FG000|Overall Study|Adverse Event|84
817530|NCT00144170|1769933|FG001|Overall Study|Adverse Event|41
817531|NCT00144170|1769932|FG000|Overall Study|Protocol Violation|23
817532|NCT00144170|1769933|FG001|Overall Study|Protocol Violation|16
817533|NCT00144170|1769932|FG000|Overall Study|Lost to Follow-up|5
817534|NCT00144170|1769933|FG001|Overall Study|Lost to Follow-up|10
817535|NCT00144170|1769932|FG000|Overall Study|Withdrawal by Subject|29
817536|NCT00144170|1769933|FG001|Overall Study|Withdrawal by Subject|13
817537|NCT00144170|1769932|FG000|Overall Study|Other reason not defined above|211
817538|NCT00144170|1769933|FG001|Overall Study|Other reason not defined above|316
817539|NCT00144300|1769941|FG000|Overall Study|Adverse Event|18
817540|NCT00144300|1769942|FG001|Overall Study|Adverse Event|16
817541|NCT00144300|1769941|FG000|Overall Study|Protocol Violation|1
817542|NCT00144300|1769942|FG001|Overall Study|Protocol Violation|3
817543|NCT00144300|1769941|FG000|Overall Study|Lost to Follow-up|3
817544|NCT00144300|1769942|FG001|Overall Study|Lost to Follow-up|0
817545|NCT00144300|1769941|FG000|Overall Study|Withdrawal by Subject|6
817546|NCT00144300|1769942|FG001|Overall Study|Withdrawal by Subject|6
817547|NCT00144300|1769941|FG000|Overall Study|Other reason (not specified)|1
817548|NCT00144300|1769942|FG001|Overall Study|Other reason (not specified)|3
817549|NCT00144339|1769950|FG000|Overall Study|Adverse Event|746
817550|NCT00144339|1769951|FG001|Overall Study|Adverse Event|627
817551|NCT00144339|1769950|FG000|Overall Study|Protocol Violation|75
817552|NCT00144339|1769951|FG001|Overall Study|Protocol Violation|48
817553|NCT00144339|1769950|FG000|Overall Study|Withdrawal by Subject|403
817554|NCT00144339|1769951|FG001|Overall Study|Withdrawal by Subject|300
817555|NCT00144339|1769950|FG000|Overall Study|Lost to Follow-up|76
817556|NCT00144339|1769951|FG001|Overall Study|Lost to Follow-up|64
817557|NCT00144339|1769950|FG000|Overall Study|Other|58
817558|NCT00144339|1769951|FG001|Overall Study|Other|60
817559|NCT00144781|1769970|FG000|Overall Study|Adverse Event|0
817560|NCT00144781|1769971|FG001|Overall Study|Adverse Event|1
817561|NCT00144781|1769972|FG002|Overall Study|Adverse Event|0
817562|NCT00144781|1769973|FG003|Overall Study|Adverse Event|0
817563|NCT00144781|1769970|FG000|Overall Study|Non-compliant|0
817564|NCT00144781|1769971|FG001|Overall Study|Non-compliant|1
817565|NCT00144781|1769972|FG002|Overall Study|Non-compliant|0
817566|NCT00144781|1769973|FG003|Overall Study|Non-compliant|0
817567|NCT00145119|1769991|FG000|Overall Study|Death|45
817568|NCT00145327|1770015|FG000|Overall Study|Withdrawal by Subject|77
817569|NCT00145327|1770016|FG001|Overall Study|Withdrawal by Subject|72
817570|NCT00145327|1770017|FG002|Overall Study|Withdrawal by Subject|164
817571|NCT00145327|1770015|FG000|Overall Study|Death|26
817572|NCT00145327|1770016|FG001|Overall Study|Death|18
817573|NCT00145327|1770017|FG002|Overall Study|Death|30
817574|NCT00145327|1770015|FG000|Overall Study|Adverse Event|14
817575|NCT00145327|1770016|FG001|Overall Study|Adverse Event|11
817576|NCT00145327|1770017|FG002|Overall Study|Adverse Event|22
817577|NCT00145327|1770015|FG000|Overall Study|Lost to Follow-up|9
817578|NCT00145327|1770016|FG001|Overall Study|Lost to Follow-up|14
817579|NCT00145327|1770017|FG002|Overall Study|Lost to Follow-up|14
817580|NCT00145327|1770015|FG000|Overall Study|Administrative problems|12
817581|NCT00145327|1770016|FG001|Overall Study|Administrative problems|9
817582|NCT00145327|1770017|FG002|Overall Study|Administrative problems|13
817583|NCT00145327|1770015|FG000|Overall Study|Protocol Violation|2
817584|NCT00145327|1770016|FG001|Overall Study|Protocol Violation|0
817585|NCT00145327|1770017|FG002|Overall Study|Protocol Violation|2
817586|NCT00145327|1770015|FG000|Overall Study|Abnormal laboratory value(s)|1
817587|NCT00145327|1770016|FG001|Overall Study|Abnormal laboratory value(s)|0
817588|NCT00145327|1770017|FG002|Overall Study|Abnormal laboratory value(s)|2
817589|NCT00145327|1770015|FG000|Overall Study|Missing - not stated|1
817590|NCT00145327|1770016|FG001|Overall Study|Missing - not stated|0
817591|NCT00145327|1770017|FG002|Overall Study|Missing - not stated|1
817592|NCT00145470|1770031|FG000|Overall Study|Adverse Event|19
817593|NCT00145470|1770032|FG001|Overall Study|Adverse Event|25
817594|NCT00145470|1770031|FG000|Overall Study|Lack of Efficacy|27
817595|NCT00145470|1770032|FG001|Overall Study|Lack of Efficacy|13
817596|NCT00145470|1770031|FG000|Overall Study|Withdrawal by Subject|36
817597|NCT00145470|1770032|FG001|Overall Study|Withdrawal by Subject|34
817598|NCT00145470|1770031|FG000|Overall Study|Lost to Follow-up|21
817599|NCT00145470|1770032|FG001|Overall Study|Lost to Follow-up|17
817600|NCT00145470|1770031|FG000|Overall Study|Reason Not Reported|9
817601|NCT00145470|1770032|FG001|Overall Study|Reason Not Reported|9
817602|NCT00145496|1770040|FG000|Overall Study|Adverse Event|42
817603|NCT00145496|1770041|FG001|Overall Study|Adverse Event|30
817604|NCT00145496|1770040|FG000|Overall Study|Lack of Efficacy|12
817605|NCT00145496|1770041|FG001|Overall Study|Lack of Efficacy|7
817606|NCT00145496|1770040|FG000|Overall Study|Withdrawal by Subject|32
817607|NCT00145496|1770041|FG001|Overall Study|Withdrawal by Subject|26
817608|NCT00145496|1770040|FG000|Overall Study|Lost to Follow-up|12
817609|NCT00145496|1770041|FG001|Overall Study|Lost to Follow-up|5
817610|NCT00145496|1770040|FG000|Overall Study|Other|25
817611|NCT00145496|1770041|FG001|Overall Study|Other|13
817612|NCT00145509|1770049|FG000|Overall Study|Adverse Event|10
817613|NCT00145509|1770050|FG001|Overall Study|Adverse Event|3
817614|NCT00145509|1770049|FG000|Overall Study|Lack of Efficacy|3
817615|NCT00145509|1770050|FG001|Overall Study|Lack of Efficacy|1
817616|NCT00145509|1770049|FG000|Overall Study|Lost to Follow-up|5
817617|NCT00145509|1770050|FG001|Overall Study|Lost to Follow-up|9
817618|NCT00145509|1770049|FG000|Overall Study|Withdrew Consent|2
817619|NCT00145509|1770050|FG001|Overall Study|Withdrew Consent|7
817620|NCT00145509|1770049|FG000|Overall Study|Reason not provided|2
817621|NCT00145509|1770050|FG001|Overall Study|Reason not provided|1
817622|NCT00145574|1770059|FG000|Double Blind|Adverse Event|0
817623|NCT00145574|1770060|FG001|Double Blind|Adverse Event|3
817624|NCT00145574|1770061|FG002|Double Blind|Adverse Event|1
817625|NCT00145574|1770059|FG000|Double Blind|Withdrawal by Subject|1
817626|NCT00145574|1770060|FG001|Double Blind|Withdrawal by Subject|1
817627|NCT00145574|1770061|FG002|Double Blind|Withdrawal by Subject|1
817628|NCT00145574|1770059|FG000|Double Blind|required restricted medicine|0
817629|NCT00145574|1770060|FG001|Double Blind|required restricted medicine|1
817630|NCT00145574|1770061|FG002|Double Blind|required restricted medicine|0
817631|NCT00145574|1770059|FG000|Open Label Long-term Extension|Adverse Event|0
817632|NCT00145574|1770060|FG001|Open Label Long-term Extension|Adverse Event|0
817633|NCT00145574|1770061|FG002|Open Label Long-term Extension|Adverse Event|5
817634|NCT00145574|1770059|FG000|Open Label Long-term Extension|Lost to Follow-up|0
817635|NCT00145574|1770060|FG001|Open Label Long-term Extension|Lost to Follow-up|0
817636|NCT00145574|1770061|FG002|Open Label Long-term Extension|Lost to Follow-up|1
817637|NCT00145574|1770059|FG000|Open Label Long-term Extension|Withdrawal by Subject|0
817638|NCT00145574|1770060|FG001|Open Label Long-term Extension|Withdrawal by Subject|0
817639|NCT00145574|1770061|FG002|Open Label Long-term Extension|Withdrawal by Subject|4
817640|NCT00145574|1770059|FG000|Open Label Long-term Extension|required restricted medicine|0
817641|NCT00145574|1770060|FG001|Open Label Long-term Extension|required restricted medicine|0
817642|NCT00145574|1770061|FG002|Open Label Long-term Extension|required restricted medicine|1
817643|NCT00145600|1770087|FG000|Overall Study|Death|1
817644|NCT00145600|1770088|FG001|Overall Study|Death|2
817645|NCT00145600|1770089|FG002|Overall Study|Death|2
817646|NCT00145600|1770090|FG003|Overall Study|Death|6
817647|NCT00145600|1770087|FG000|Overall Study|Ineligible|3
817648|NCT00145600|1770088|FG001|Overall Study|Ineligible|0
817649|NCT00145600|1770089|FG002|Overall Study|Ineligible|1
817650|NCT00145600|1770090|FG003|Overall Study|Ineligible|5
817651|NCT00145600|1770087|FG000|Overall Study|Lost to Follow-up|2
817652|NCT00145600|1770088|FG001|Overall Study|Lost to Follow-up|6
817653|NCT00145600|1770089|FG002|Overall Study|Lost to Follow-up|2
817654|NCT00145600|1770090|FG003|Overall Study|Lost to Follow-up|4
817655|NCT00145600|1770087|FG000|Overall Study|Noncompliance|1
817656|NCT00145600|1770088|FG001|Overall Study|Noncompliance|0
817657|NCT00145600|1770089|FG002|Overall Study|Noncompliance|0
817658|NCT00145600|1770090|FG003|Overall Study|Noncompliance|0
817659|NCT00145600|1770087|FG000|Overall Study|Withdrawal by Subject|1
817660|NCT00145600|1770088|FG001|Overall Study|Withdrawal by Subject|2
817661|NCT00145600|1770089|FG002|Overall Study|Withdrawal by Subject|0
817662|NCT00145600|1770090|FG003|Overall Study|Withdrawal by Subject|1
817663|NCT00145626|1770116|FG000|Overall Study|Did not have NK infusions|2
817664|NCT00145626|1770116|FG000|Overall Study|Turned 2 years old before treatment|1
817665|NCT00145626|1770116|FG000|Overall Study|Death|1
817666|NCT00145626|1770116|FG000|Overall Study|Withdrawal by Subject|1
817667|NCT00145795|1770138|FG000|Overall Study|Adverse Event|1
817668|NCT00145795|1770139|FG001|Overall Study|Adverse Event|0
817669|NCT00145977|1770147|FG000|Overall Study|Lack of Efficacy|0
817670|NCT00145977|1770148|FG001|Overall Study|Lack of Efficacy|4
817671|NCT00145977|1770147|FG000|Overall Study|Lost to Follow-up|1
817672|NCT00145977|1770148|FG001|Overall Study|Lost to Follow-up|0
817673|NCT00145977|1770147|FG000|Overall Study|Withdrawal by Subject|1
817674|NCT00145977|1770148|FG001|Overall Study|Withdrawal by Subject|0
817675|NCT00146172|1770162|FG000|Overall Study|Adverse Event|0
817676|NCT00146172|1770163|FG001|Overall Study|Adverse Event|0
817677|NCT00146172|1770164|FG002|Overall Study|Adverse Event|1
817678|NCT00146172|1770165|FG003|Overall Study|Adverse Event|1
817679|NCT00146172|1770166|FG004|Overall Study|Adverse Event|0
817680|NCT00146172|1770167|FG005|Overall Study|Adverse Event|2
817681|NCT00146172|1770168|FG006|Overall Study|Adverse Event|3
817682|NCT00146172|1770169|FG007|Overall Study|Adverse Event|10
817683|NCT00146172|1770162|FG000|Overall Study|Lost to Follow-up|0
817684|NCT00146172|1770163|FG001|Overall Study|Lost to Follow-up|0
817685|NCT00146172|1770164|FG002|Overall Study|Lost to Follow-up|0
817686|NCT00146172|1770165|FG003|Overall Study|Lost to Follow-up|0
817687|NCT00146172|1770166|FG004|Overall Study|Lost to Follow-up|0
817688|NCT00146172|1770167|FG005|Overall Study|Lost to Follow-up|0
817689|NCT00146172|1770168|FG006|Overall Study|Lost to Follow-up|0
817690|NCT00146172|1770169|FG007|Overall Study|Lost to Follow-up|1
817691|NCT00146172|1770162|FG000|Overall Study|Disease Progression|2
817692|NCT00146172|1770163|FG001|Overall Study|Disease Progression|4
817693|NCT00146172|1770164|FG002|Overall Study|Disease Progression|2
817694|NCT00146172|1770165|FG003|Overall Study|Disease Progression|5
817695|NCT00146172|1770166|FG004|Overall Study|Disease Progression|2
817696|NCT00146172|1770167|FG005|Overall Study|Disease Progression|2
817697|NCT00146172|1770168|FG006|Overall Study|Disease Progression|1
817698|NCT00146172|1770169|FG007|Overall Study|Disease Progression|22
817699|NCT00146172|1770162|FG000|Overall Study|Death|0
817700|NCT00146172|1770163|FG001|Overall Study|Death|0
817701|NCT00146172|1770164|FG002|Overall Study|Death|0
817702|NCT00146172|1770165|FG003|Overall Study|Death|0
817703|NCT00146172|1770166|FG004|Overall Study|Death|0
817704|NCT00146172|1770167|FG005|Overall Study|Death|0
817705|NCT00146172|1770168|FG006|Overall Study|Death|1
817706|NCT00146172|1770169|FG007|Overall Study|Death|0
817707|NCT00146172|1770162|FG000|Overall Study|Physician Decision|0
817708|NCT00146172|1770163|FG001|Overall Study|Physician Decision|0
817709|NCT00146172|1770164|FG002|Overall Study|Physician Decision|0
817710|NCT00146172|1770165|FG003|Overall Study|Physician Decision|0
817711|NCT00146172|1770166|FG004|Overall Study|Physician Decision|0
817712|NCT00146172|1770167|FG005|Overall Study|Physician Decision|0
817713|NCT00146172|1770168|FG006|Overall Study|Physician Decision|0
817714|NCT00146172|1770169|FG007|Overall Study|Physician Decision|1
817715|NCT00146172|1770162|FG000|Overall Study|Withdrawal by Subject|0
817716|NCT00146172|1770163|FG001|Overall Study|Withdrawal by Subject|0
817717|NCT00146172|1770164|FG002|Overall Study|Withdrawal by Subject|0
817718|NCT00146172|1770165|FG003|Overall Study|Withdrawal by Subject|0
817719|NCT00146172|1770166|FG004|Overall Study|Withdrawal by Subject|0
817720|NCT00146172|1770167|FG005|Overall Study|Withdrawal by Subject|1
817721|NCT00146172|1770168|FG006|Overall Study|Withdrawal by Subject|1
817722|NCT00146172|1770169|FG007|Overall Study|Withdrawal by Subject|4
817723|NCT00146172|1770162|FG000|Overall Study|Symptomatic Deterioration|1
817724|NCT00146172|1770163|FG001|Overall Study|Symptomatic Deterioration|0
817725|NCT00146172|1770164|FG002|Overall Study|Symptomatic Deterioration|1
817726|NCT00146172|1770165|FG003|Overall Study|Symptomatic Deterioration|0
817727|NCT00146172|1770166|FG004|Overall Study|Symptomatic Deterioration|1
817728|NCT00146172|1770167|FG005|Overall Study|Symptomatic Deterioration|2
817729|NCT00146172|1770168|FG006|Overall Study|Symptomatic Deterioration|0
817730|NCT00146172|1770169|FG007|Overall Study|Symptomatic Deterioration|2
817731|NCT00146328|1770198|FG000|Overall Study|Adverse Event|39
817732|NCT00146328|1770199|FG001|Overall Study|Adverse Event|48
817733|NCT00146328|1770200|FG002|Overall Study|Adverse Event|79
817734|NCT00146328|1770198|FG000|Overall Study|Protocol Violation|11
817735|NCT00146328|1770199|FG001|Overall Study|Protocol Violation|6
817736|NCT00146328|1770200|FG002|Overall Study|Protocol Violation|12
817737|NCT00146328|1770198|FG000|Overall Study|Lost to Follow-up|7
817738|NCT00146328|1770199|FG001|Overall Study|Lost to Follow-up|4
817739|NCT00146328|1770200|FG002|Overall Study|Lost to Follow-up|7
817740|NCT00146328|1770198|FG000|Overall Study|Withdrawal by Subject|16
817741|NCT00146328|1770199|FG001|Overall Study|Withdrawal by Subject|16
817742|NCT00146328|1770200|FG002|Overall Study|Withdrawal by Subject|22
817743|NCT00146328|1770198|FG000|Overall Study|Virologic Failure/lack of efficacy|54
817744|NCT00146328|1770199|FG001|Overall Study|Virologic Failure/lack of efficacy|72
817745|NCT00146328|1770200|FG002|Overall Study|Virologic Failure/lack of efficacy|142
817746|NCT00146328|1770198|FG000|Overall Study|Trial ended/site closed|8
817747|NCT00146328|1770199|FG001|Overall Study|Trial ended/site closed|2
817748|NCT00146328|1770200|FG002|Overall Study|Trial ended/site closed|19
817749|NCT00146328|1770198|FG000|Overall Study|Patient decision to end|0
817750|NCT00146328|1770199|FG001|Overall Study|Patient decision to end|1
817751|NCT00146328|1770200|FG002|Overall Study|Patient decision to end|6
817752|NCT00146328|1770198|FG000|Overall Study|Enroll into other trial|2
817753|NCT00146328|1770199|FG001|Overall Study|Enroll into other trial|4
817754|NCT00146328|1770200|FG002|Overall Study|Enroll into other trial|2
817755|NCT00146328|1770198|FG000|Overall Study|Death|0
817756|NCT00146328|1770199|FG001|Overall Study|Death|1
817757|NCT00146328|1770200|FG002|Overall Study|Death|1
817758|NCT00146328|1770198|FG000|Overall Study|Moved|2
817759|NCT00146328|1770199|FG001|Overall Study|Moved|0
817760|NCT00146328|1770200|FG002|Overall Study|Moved|0
817761|NCT00146328|1770198|FG000|Overall Study|Interaction with other medication|2
817762|NCT00146328|1770199|FG001|Overall Study|Interaction with other medication|0
817763|NCT00146328|1770200|FG002|Overall Study|Interaction with other medication|1
817764|NCT00146640|1770210|FG000|Overall Study|Adverse Event|12
817765|NCT00146640|1770211|FG001|Overall Study|Adverse Event|10
817766|NCT00146640|1770210|FG000|Overall Study|Medical Reasons|3
817767|NCT00146640|1770211|FG001|Overall Study|Medical Reasons|0
817768|NCT00146640|1770210|FG000|Overall Study|Non-Medical Reasons|8
817769|NCT00146640|1770211|FG001|Overall Study|Non-Medical Reasons|4
817770|NCT00146757|1770217|FG000|Overall Study|Death|1
817771|NCT00146757|1770218|FG001|Overall Study|Death|0
817772|NCT00146757|1770217|FG000|Overall Study|Adverse Event|1
817773|NCT00146757|1770218|FG001|Overall Study|Adverse Event|0
817774|NCT00146770|1770226|FG000|Overall Study|Adverse Event|2
817775|NCT00146770|1770227|FG001|Overall Study|Adverse Event|0
817776|NCT00146770|1770226|FG000|Overall Study|Pregnancy|1
817777|NCT00146770|1770227|FG001|Overall Study|Pregnancy|0
817778|NCT00146770|1770226|FG000|Overall Study|Withdrawal by Subject|2
817779|NCT00146770|1770227|FG001|Overall Study|Withdrawal by Subject|0
817780|NCT00146848|1770236|FG000|Pre-randomization|Death|19
817781|NCT00146848|1770237|FG001|Pre-randomization|Death|0
817782|NCT00146848|1770238|FG002|Pre-randomization|Death|0
817783|NCT00146848|1770236|FG000|Pre-randomization|Lost to Follow-up|70
817784|NCT00146848|1770237|FG001|Pre-randomization|Lost to Follow-up|0
817785|NCT00146848|1770238|FG002|Pre-randomization|Lost to Follow-up|0
817786|NCT00146848|1770236|FG000|Pre-randomization|Physician Decision|8
817787|NCT00146848|1770237|FG001|Pre-randomization|Physician Decision|0
817788|NCT00146848|1770238|FG002|Pre-randomization|Physician Decision|0
817789|NCT00146848|1770236|FG000|Pre-randomization|Protocol Violation|172
817790|NCT00146848|1770237|FG001|Pre-randomization|Protocol Violation|0
817791|NCT00146848|1770238|FG002|Pre-randomization|Protocol Violation|0
817792|NCT00146848|1770236|FG000|Pre-randomization|Withdrawal by Subject|40
817793|NCT00146848|1770237|FG001|Pre-randomization|Withdrawal by Subject|0
817794|NCT00146848|1770238|FG002|Pre-randomization|Withdrawal by Subject|0
817795|NCT00146848|1770236|FG000|Post-randomization|Lost to Follow-up|12
817796|NCT00146848|1770237|FG001|Post-randomization|Lost to Follow-up|15
817797|NCT00146848|1770238|FG002|Post-randomization|Lost to Follow-up|12
817798|NCT00146848|1770236|FG000|Post-randomization|Withdrawn|26
817799|NCT00146848|1770237|FG001|Post-randomization|Withdrawn|32
817800|NCT00146848|1770238|FG002|Post-randomization|Withdrawn|27
817801|NCT00147225|1770324|FG000|Overall Study|Withdrawal by Subject|1
817802|NCT00147225|1770325|FG001|Overall Study|Withdrawal by Subject|0
817803|NCT00147225|1770326|FG002|Overall Study|Withdrawal by Subject|1
817804|NCT00147225|1770327|FG003|Overall Study|Withdrawal by Subject|0
817805|NCT00147225|1770328|FG004|Overall Study|Withdrawal by Subject|0
817806|NCT00147225|1770329|FG005|Overall Study|Withdrawal by Subject|1
817807|NCT00147225|1770324|FG000|Overall Study|Adverse Event|0
817808|NCT00147225|1770325|FG001|Overall Study|Adverse Event|0
817809|NCT00147225|1770326|FG002|Overall Study|Adverse Event|1
817810|NCT00147225|1770327|FG003|Overall Study|Adverse Event|1
817811|NCT00147225|1770328|FG004|Overall Study|Adverse Event|0
817812|NCT00147225|1770329|FG005|Overall Study|Adverse Event|0
817813|NCT00147225|1770324|FG000|Overall Study|Screen Failure|0
817814|NCT00147225|1770325|FG001|Overall Study|Screen Failure|0
817815|NCT00147225|1770326|FG002|Overall Study|Screen Failure|0
817816|NCT00147225|1770327|FG003|Overall Study|Screen Failure|0
817817|NCT00147225|1770328|FG004|Overall Study|Screen Failure|1
817818|NCT00147225|1770329|FG005|Overall Study|Screen Failure|0
817819|NCT00147225|1770324|FG000|Overall Study|Chemotherapy Changed|0
817820|NCT00147225|1770325|FG001|Overall Study|Chemotherapy Changed|0
817821|NCT00147225|1770326|FG002|Overall Study|Chemotherapy Changed|0
817822|NCT00147225|1770327|FG003|Overall Study|Chemotherapy Changed|0
817823|NCT00147225|1770328|FG004|Overall Study|Chemotherapy Changed|0
817824|NCT00147225|1770329|FG005|Overall Study|Chemotherapy Changed|1
817825|NCT00147251|1770345|FG000|Recruitment and Enrollment|change in treatment guidelines|24
817826|NCT00147251|1770346|FG001|Recruitment and Enrollment|change in treatment guidelines|25
817827|NCT00147498|1770387|FG000|Overall Study|Adverse Event|1
817828|NCT00147498|1770388|FG001|Overall Study|Adverse Event|6
817829|NCT00147498|1770389|FG002|Overall Study|Adverse Event|7
817830|NCT00147498|1770390|FG003|Overall Study|Adverse Event|3
817831|NCT00147498|1770387|FG000|Overall Study|Lack of Efficacy|1
817832|NCT00147498|1770388|FG001|Overall Study|Lack of Efficacy|1
817833|NCT00147498|1770389|FG002|Overall Study|Lack of Efficacy|1
817834|NCT00147498|1770390|FG003|Overall Study|Lack of Efficacy|8
817835|NCT00147498|1770387|FG000|Overall Study|Laboratory abnormality|0
817836|NCT00147498|1770388|FG001|Overall Study|Laboratory abnormality|0
817837|NCT00147498|1770389|FG002|Overall Study|Laboratory abnormality|2
817838|NCT00147498|1770390|FG003|Overall Study|Laboratory abnormality|0
817839|NCT00147498|1770387|FG000|Overall Study|Participant defaulted|0
817840|NCT00147498|1770388|FG001|Overall Study|Participant defaulted|1
817841|NCT00147498|1770389|FG002|Overall Study|Participant defaulted|4
817842|NCT00147498|1770390|FG003|Overall Study|Participant defaulted|3
817843|NCT00147498|1770387|FG000|Overall Study|Other|1
817844|NCT00147498|1770388|FG001|Overall Study|Other|1
817845|NCT00147498|1770389|FG002|Overall Study|Other|3
817846|NCT00147498|1770390|FG003|Overall Study|Other|3
817847|NCT00147537|1770404|FG000|Phase 1b|Death|0
817848|NCT00147537|1770405|FG001|Phase 1b|Death|1
817849|NCT00147537|1770406|FG002|Phase 1b|Death|2
817850|NCT00147537|1770407|FG003|Phase 1b|Death|1
817851|NCT00147537|1770408|FG004|Phase 1b|Death|2
817852|NCT00147537|1770409|FG005|Phase 1b|Death|2
817853|NCT00147537|1770410|FG006|Phase 1b|Death|1
817854|NCT00147537|1770411|FG007|Phase 1b|Death|3
817855|NCT00147537|1770412|FG008|Phase 1b|Death|9
817856|NCT00147537|1770413|FG009|Phase 1b|Death|0
817857|NCT00147537|1770414|FG010|Phase 1b|Death|0
817858|NCT00147537|1770404|FG000|Phase 1b|Lost to Follow-up|2
817859|NCT00147537|1770405|FG001|Phase 1b|Lost to Follow-up|1
817860|NCT00147537|1770406|FG002|Phase 1b|Lost to Follow-up|0
817861|NCT00147537|1770407|FG003|Phase 1b|Lost to Follow-up|0
817862|NCT00147537|1770408|FG004|Phase 1b|Lost to Follow-up|0
817863|NCT00147537|1770409|FG005|Phase 1b|Lost to Follow-up|0
817864|NCT00147537|1770410|FG006|Phase 1b|Lost to Follow-up|2
817865|NCT00147537|1770411|FG007|Phase 1b|Lost to Follow-up|0
817866|NCT00147537|1770412|FG008|Phase 1b|Lost to Follow-up|1
817867|NCT00147537|1770413|FG009|Phase 1b|Lost to Follow-up|0
817868|NCT00147537|1770414|FG010|Phase 1b|Lost to Follow-up|0
817869|NCT00147537|1770404|FG000|Phase 1b|Other|0
817870|NCT00147537|1770405|FG001|Phase 1b|Other|0
817871|NCT00147537|1770406|FG002|Phase 1b|Other|2
817872|NCT00147537|1770407|FG003|Phase 1b|Other|1
817873|NCT00147537|1770408|FG004|Phase 1b|Other|1
817874|NCT00147537|1770409|FG005|Phase 1b|Other|1
817875|NCT00147537|1770410|FG006|Phase 1b|Other|14
817876|NCT00147537|1770411|FG007|Phase 1b|Other|4
817877|NCT00147537|1770412|FG008|Phase 1b|Other|4
817878|NCT00147537|1770413|FG009|Phase 1b|Other|0
817879|NCT00147537|1770414|FG010|Phase 1b|Other|0
817880|NCT00147537|1770404|FG000|Phase 1b|Withdrawal by Subject|0
817881|NCT00147537|1770405|FG001|Phase 1b|Withdrawal by Subject|0
817882|NCT00147537|1770406|FG002|Phase 1b|Withdrawal by Subject|0
817883|NCT00147537|1770407|FG003|Phase 1b|Withdrawal by Subject|0
817884|NCT00147537|1770408|FG004|Phase 1b|Withdrawal by Subject|0
817885|NCT00147537|1770409|FG005|Phase 1b|Withdrawal by Subject|0
817886|NCT00147537|1770410|FG006|Phase 1b|Withdrawal by Subject|0
817887|NCT00147537|1770411|FG007|Phase 1b|Withdrawal by Subject|0
817888|NCT00147537|1770412|FG008|Phase 1b|Withdrawal by Subject|2
817889|NCT00147537|1770413|FG009|Phase 1b|Withdrawal by Subject|0
817890|NCT00147537|1770414|FG010|Phase 1b|Withdrawal by Subject|0
817891|NCT00147537|1770404|FG000|Phase 1b|Randomized but not treated|0
817892|NCT00147537|1770405|FG001|Phase 1b|Randomized but not treated|0
817893|NCT00147537|1770406|FG002|Phase 1b|Randomized but not treated|0
817894|NCT00147537|1770407|FG003|Phase 1b|Randomized but not treated|0
817895|NCT00147537|1770408|FG004|Phase 1b|Randomized but not treated|0
817896|NCT00147537|1770409|FG005|Phase 1b|Randomized but not treated|0
817897|NCT00147537|1770410|FG006|Phase 1b|Randomized but not treated|1
817898|NCT00147537|1770411|FG007|Phase 1b|Randomized but not treated|0
817899|NCT00147537|1770412|FG008|Phase 1b|Randomized but not treated|1
817900|NCT00147537|1770413|FG009|Phase 1b|Randomized but not treated|0
817901|NCT00147537|1770414|FG010|Phase 1b|Randomized but not treated|0
817902|NCT00147537|1770404|FG000|Phase 2|Death|0
817903|NCT00147537|1770405|FG001|Phase 2|Death|0
817904|NCT00147537|1770406|FG002|Phase 2|Death|0
817905|NCT00147537|1770407|FG003|Phase 2|Death|0
817906|NCT00147537|1770408|FG004|Phase 2|Death|0
817907|NCT00147537|1770409|FG005|Phase 2|Death|0
817908|NCT00147537|1770410|FG006|Phase 2|Death|0
817909|NCT00147537|1770411|FG007|Phase 2|Death|0
817910|NCT00147537|1770412|FG008|Phase 2|Death|0
817911|NCT00147537|1770413|FG009|Phase 2|Death|85
817912|NCT00147537|1770414|FG010|Phase 2|Death|31
817913|NCT00147537|1770404|FG000|Phase 2|Lost to Follow-up|0
817914|NCT00147537|1770405|FG001|Phase 2|Lost to Follow-up|0
817915|NCT00147537|1770406|FG002|Phase 2|Lost to Follow-up|0
817916|NCT00147537|1770407|FG003|Phase 2|Lost to Follow-up|0
817917|NCT00147537|1770408|FG004|Phase 2|Lost to Follow-up|0
817918|NCT00147537|1770409|FG005|Phase 2|Lost to Follow-up|0
817919|NCT00147537|1770410|FG006|Phase 2|Lost to Follow-up|0
817920|NCT00147537|1770411|FG007|Phase 2|Lost to Follow-up|0
817921|NCT00147537|1770412|FG008|Phase 2|Lost to Follow-up|0
817922|NCT00147537|1770413|FG009|Phase 2|Lost to Follow-up|12
817923|NCT00147537|1770414|FG010|Phase 2|Lost to Follow-up|4
817924|NCT00147537|1770404|FG000|Phase 2|Other|0
817925|NCT00147537|1770405|FG001|Phase 2|Other|0
817926|NCT00147537|1770406|FG002|Phase 2|Other|0
817927|NCT00147537|1770407|FG003|Phase 2|Other|0
817928|NCT00147537|1770408|FG004|Phase 2|Other|0
817929|NCT00147537|1770409|FG005|Phase 2|Other|0
817930|NCT00147537|1770410|FG006|Phase 2|Other|0
817931|NCT00147537|1770411|FG007|Phase 2|Other|0
817932|NCT00147537|1770412|FG008|Phase 2|Other|0
817933|NCT00147537|1770413|FG009|Phase 2|Other|47
817934|NCT00147537|1770414|FG010|Phase 2|Other|12
817935|NCT00147537|1770404|FG000|Phase 2|Withdrawal by Subject|0
817936|NCT00147537|1770405|FG001|Phase 2|Withdrawal by Subject|0
817937|NCT00147537|1770406|FG002|Phase 2|Withdrawal by Subject|0
817938|NCT00147537|1770407|FG003|Phase 2|Withdrawal by Subject|0
817939|NCT00147537|1770408|FG004|Phase 2|Withdrawal by Subject|0
817940|NCT00147537|1770409|FG005|Phase 2|Withdrawal by Subject|0
817941|NCT00147537|1770410|FG006|Phase 2|Withdrawal by Subject|0
817942|NCT00147537|1770411|FG007|Phase 2|Withdrawal by Subject|0
817943|NCT00147537|1770412|FG008|Phase 2|Withdrawal by Subject|0
817944|NCT00147537|1770413|FG009|Phase 2|Withdrawal by Subject|16
817945|NCT00147537|1770414|FG010|Phase 2|Withdrawal by Subject|4
817946|NCT00147537|1770404|FG000|Phase 2|Randomized but not treated|0
817947|NCT00147537|1770405|FG001|Phase 2|Randomized but not treated|0
817948|NCT00147537|1770406|FG002|Phase 2|Randomized but not treated|0
817949|NCT00147537|1770407|FG003|Phase 2|Randomized but not treated|0
817950|NCT00147537|1770408|FG004|Phase 2|Randomized but not treated|0
817951|NCT00147537|1770409|FG005|Phase 2|Randomized but not treated|0
817952|NCT00147537|1770410|FG006|Phase 2|Randomized but not treated|0
817953|NCT00147537|1770411|FG007|Phase 2|Randomized but not treated|0
817954|NCT00147537|1770412|FG008|Phase 2|Randomized but not treated|0
817955|NCT00147537|1770413|FG009|Phase 2|Randomized but not treated|1
817956|NCT00147537|1770414|FG010|Phase 2|Randomized but not treated|1
817957|NCT00147745|1770462|FG000|Overall Study|Withdrawal by Subject|1
817958|NCT00147745|1770463|FG001|Overall Study|Withdrawal by Subject|0
817959|NCT00147745|1770464|FG002|Overall Study|Withdrawal by Subject|0
817960|NCT00147823|1770474|FG000|Overall Study|Lost to Follow-up|6
817961|NCT00147823|1770475|FG001|Overall Study|Lost to Follow-up|12
817962|NCT00147823|1770474|FG000|Overall Study|Physician Decision|1
817963|NCT00147823|1770475|FG001|Overall Study|Physician Decision|0
817964|NCT00147823|1770474|FG000|Overall Study|Withdrawal by Subject|0
817965|NCT00147823|1770475|FG001|Overall Study|Withdrawal by Subject|1
817966|NCT00147823|1770474|FG000|Overall Study|Did not receive vitoss due to infection|6
817967|NCT00147823|1770475|FG001|Overall Study|Did not receive vitoss due to infection|2
817968|NCT00148109|1770487|FG000|Overall Study|Lack of Efficacy|10
817969|NCT00148109|1770488|FG001|Overall Study|Lack of Efficacy|18
817970|NCT00148109|1770487|FG000|Overall Study|Adverse Event|0
817971|NCT00148109|1770488|FG001|Overall Study|Adverse Event|2
817972|NCT00148109|1770487|FG000|Overall Study|Withdrawal by Subject|2
817973|NCT00148109|1770488|FG001|Overall Study|Withdrawal by Subject|0
817974|NCT00148122|1770494|FG000|Overall Study|Withdrawal by Subject|2
817975|NCT00148317|1770498|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
817976|NCT00148317|1770498|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
817977|NCT00148317|1770498|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
817978|NCT00148343|1770507|FG000|Overall Study|Withdrawal by Subject|12
817979|NCT00148343|1770508|FG001|Overall Study|Withdrawal by Subject|7
817980|NCT00148343|1770507|FG000|Overall Study|Physician Decision|3
817981|NCT00148343|1770508|FG001|Overall Study|Physician Decision|4
817982|NCT00148759|1770534|FG000|Overall Study|Withdrawal by Subject|1
817983|NCT00148759|1770535|FG001|Overall Study|Withdrawal by Subject|1
817984|NCT00148759|1770534|FG000|Overall Study|Lost to Follow-up|1
817985|NCT00148759|1770535|FG001|Overall Study|Lost to Follow-up|0
817986|NCT00148941|1770556|FG000|Overall Study|Lost to Follow-up|17
817987|NCT00148941|1770557|FG001|Overall Study|Lost to Follow-up|24
817988|NCT00148941|1770558|FG002|Overall Study|Lost to Follow-up|18
817989|NCT00148941|1770559|FG003|Overall Study|Lost to Follow-up|22
817990|NCT00148941|1770556|FG000|Overall Study|Withdrawal by Subject|1
817991|NCT00148941|1770557|FG001|Overall Study|Withdrawal by Subject|0
817992|NCT00148941|1770558|FG002|Overall Study|Withdrawal by Subject|1
817993|NCT00148941|1770559|FG003|Overall Study|Withdrawal by Subject|0
817994|NCT00148941|1770556|FG000|Overall Study|Other|0
817995|NCT00148941|1770557|FG001|Overall Study|Other|0
817996|NCT00148941|1770558|FG002|Overall Study|Other|1
817997|NCT00148941|1770559|FG003|Overall Study|Other|2
817998|NCT00149214|1770580|FG000|Overall Study|Adverse Event|12
817999|NCT00149214|1770581|FG001|Overall Study|Adverse Event|9
818000|NCT00149214|1770580|FG000|Overall Study|Withdrawal by Subject|4
818001|NCT00149214|1770581|FG001|Overall Study|Withdrawal by Subject|1
818002|NCT00149214|1770580|FG000|Overall Study|Physician Decision|3
818003|NCT00149214|1770581|FG001|Overall Study|Physician Decision|3
818004|NCT00149214|1770580|FG000|Overall Study|Sponsor Decision|0
818005|NCT00149214|1770581|FG001|Overall Study|Sponsor Decision|1
818006|NCT00149214|1770580|FG000|Overall Study|Progressive Disease|7
818007|NCT00149214|1770581|FG001|Overall Study|Progressive Disease|3
818008|NCT00149396|1770596|FG000|Overall Study|Death|15
818009|NCT00149396|1770596|FG000|Overall Study|Withdrawal by Subject|1
818010|NCT00149396|1770596|FG000|Overall Study|Subject noncompliance|2
818011|NCT00149396|1770596|FG000|Overall Study|other treatment|5
818012|NCT00149630|1770609|FG000|Overall Study|Incarceration|2
818013|NCT00149630|1770610|FG001|Overall Study|Incarceration|0
818014|NCT00149630|1770609|FG000|Overall Study|Treatment Programs|4
818015|NCT00149630|1770610|FG001|Overall Study|Treatment Programs|5
818016|NCT00149630|1770609|FG000|Overall Study|Adverse Event|2
818017|NCT00149630|1770610|FG001|Overall Study|Adverse Event|0
818018|NCT00149747|1770649|FG000|Overall Study|Death|1
818019|NCT00149747|1770650|FG001|Overall Study|Death|0
818020|NCT00149747|1770649|FG000|Overall Study|Withdrawal by Subject|3
818021|NCT00149747|1770650|FG001|Overall Study|Withdrawal by Subject|3
818022|NCT00149825|1770670|FG000|Overall Study|Intolerance to medication side effects|1
818023|NCT00149825|1770671|FG001|Overall Study|Intolerance to medication side effects|2
818024|NCT00149825|1770670|FG000|Overall Study|Time commitments|2
818025|NCT00149825|1770671|FG001|Overall Study|Time commitments|1
818026|NCT00149825|1770670|FG000|Overall Study|Not liking insomnia therapy|1
818027|NCT00149825|1770671|FG001|Overall Study|Not liking insomnia therapy|0
818028|NCT00149825|1770670|FG000|Overall Study|Other|1
818029|NCT00149825|1770671|FG001|Overall Study|Other|0
818030|NCT00149890|1770694|FG000|Overall Study|Adverse Event|1
818031|NCT00149890|1770695|FG001|Overall Study|Adverse Event|8
818032|NCT00149890|1770694|FG000|Overall Study|Lack of Efficacy|8
818033|NCT00149890|1770695|FG001|Overall Study|Lack of Efficacy|9
818034|NCT00149890|1770694|FG000|Overall Study|Protocol Violation|1
818035|NCT00149890|1770695|FG001|Overall Study|Protocol Violation|0
818036|NCT00149890|1770694|FG000|Overall Study|Lost to Follow-up|1
818037|NCT00149890|1770695|FG001|Overall Study|Lost to Follow-up|0
818038|NCT00149890|1770694|FG000|Overall Study|Graft Loss|2
818039|NCT00149890|1770695|FG001|Overall Study|Graft Loss|1
818040|NCT00149994|1770703|FG000|Overall Study|Administrative problems:|1
818041|NCT00149994|1770704|FG001|Overall Study|Administrative problems:|0
818042|NCT00149994|1770703|FG000|Overall Study|Protocol Violation|0
818043|NCT00149994|1770704|FG001|Overall Study|Protocol Violation|1
818044|NCT00150176|1770712|FG000|Overall Study|Adverse Event|16
818045|NCT00150176|1770713|FG001|Overall Study|Adverse Event|53
818046|NCT00150176|1770712|FG000|Overall Study|Relapse/Impending relapse, non-AE|10
818047|NCT00150176|1770713|FG001|Overall Study|Relapse/Impending relapse, non-AE|39
818048|NCT00150176|1770712|FG000|Overall Study|Withdrawal by Subject|19
818049|NCT00150176|1770713|FG001|Overall Study|Withdrawal by Subject|12
818050|NCT00150176|1770712|FG000|Overall Study|Lost to Follow-up|3
818051|NCT00150176|1770713|FG001|Overall Study|Lost to Follow-up|3
818052|NCT00150176|1770712|FG000|Overall Study|OTHER|11
818053|NCT00150176|1770713|FG001|Overall Study|OTHER|13
818054|NCT00150345|1770722|FG000|Overall Study|Death|5
818055|NCT00150345|1770723|FG001|Overall Study|Death|2
818056|NCT00150345|1770722|FG000|Overall Study|Adverse Event|8
818057|NCT00150345|1770723|FG001|Overall Study|Adverse Event|6
818058|NCT00150345|1770722|FG000|Overall Study|Lack of Efficacy|5
818059|NCT00150345|1770723|FG001|Overall Study|Lack of Efficacy|4
818060|NCT00150345|1770722|FG000|Overall Study|Withdrawal by Subject|3
818061|NCT00150345|1770723|FG001|Overall Study|Withdrawal by Subject|4
818062|NCT00150345|1770722|FG000|Overall Study|Laboratory abnormality|1
818063|NCT00150345|1770723|FG001|Overall Study|Laboratory abnormality|2
818064|NCT00150345|1770722|FG000|Overall Study|Other|12
818065|NCT00150345|1770723|FG001|Overall Study|Other|14
818066|NCT00150462|1770741|FG000|Overall Study|Disease Progression or Relapse|3
818067|NCT00150462|1770742|FG001|Overall Study|Disease Progression or Relapse|1
818155|NCT00150618|1770792|FG000|Overall Study|Protocol Violation|1
818068|NCT00150462|1770743|FG002|Overall Study|Disease Progression or Relapse|2
818069|NCT00150462|1770744|FG003|Overall Study|Disease Progression or Relapse|1
818070|NCT00150462|1770745|FG004|Overall Study|Disease Progression or Relapse|2
818071|NCT00150462|1770746|FG005|Overall Study|Disease Progression or Relapse|2
818072|NCT00150462|1770747|FG006|Overall Study|Disease Progression or Relapse|3
818073|NCT00150462|1770748|FG007|Overall Study|Disease Progression or Relapse|5
818074|NCT00150462|1770749|FG008|Overall Study|Disease Progression or Relapse|5
818075|NCT00150462|1770750|FG009|Overall Study|Disease Progression or Relapse|3
818076|NCT00150462|1770751|FG010|Overall Study|Disease Progression or Relapse|2
818077|NCT00150462|1770741|FG000|Overall Study|Withdrawal by Subject|0
818078|NCT00150462|1770742|FG001|Overall Study|Withdrawal by Subject|1
818079|NCT00150462|1770743|FG002|Overall Study|Withdrawal by Subject|1
818080|NCT00150462|1770744|FG003|Overall Study|Withdrawal by Subject|0
818081|NCT00150462|1770745|FG004|Overall Study|Withdrawal by Subject|1
818082|NCT00150462|1770746|FG005|Overall Study|Withdrawal by Subject|2
818083|NCT00150462|1770747|FG006|Overall Study|Withdrawal by Subject|0
818084|NCT00150462|1770748|FG007|Overall Study|Withdrawal by Subject|1
818085|NCT00150462|1770749|FG008|Overall Study|Withdrawal by Subject|0
818086|NCT00150462|1770750|FG009|Overall Study|Withdrawal by Subject|1
818087|NCT00150462|1770751|FG010|Overall Study|Withdrawal by Subject|0
818088|NCT00150462|1770741|FG000|Overall Study|Death|0
818089|NCT00150462|1770742|FG001|Overall Study|Death|1
818090|NCT00150462|1770743|FG002|Overall Study|Death|0
818091|NCT00150462|1770744|FG003|Overall Study|Death|0
818092|NCT00150462|1770745|FG004|Overall Study|Death|0
818093|NCT00150462|1770746|FG005|Overall Study|Death|0
818094|NCT00150462|1770747|FG006|Overall Study|Death|0
818095|NCT00150462|1770748|FG007|Overall Study|Death|0
818096|NCT00150462|1770749|FG008|Overall Study|Death|1
818097|NCT00150462|1770750|FG009|Overall Study|Death|0
818098|NCT00150462|1770751|FG010|Overall Study|Death|0
818099|NCT00150462|1770741|FG000|Overall Study|Adverse Event|0
818100|NCT00150462|1770742|FG001|Overall Study|Adverse Event|0
818101|NCT00150462|1770743|FG002|Overall Study|Adverse Event|0
818102|NCT00150462|1770744|FG003|Overall Study|Adverse Event|1
818103|NCT00150462|1770745|FG004|Overall Study|Adverse Event|0
818104|NCT00150462|1770746|FG005|Overall Study|Adverse Event|0
818105|NCT00150462|1770747|FG006|Overall Study|Adverse Event|0
818106|NCT00150462|1770748|FG007|Overall Study|Adverse Event|2
818107|NCT00150462|1770749|FG008|Overall Study|Adverse Event|0
818108|NCT00150462|1770750|FG009|Overall Study|Adverse Event|1
818109|NCT00150462|1770751|FG010|Overall Study|Adverse Event|0
818110|NCT00150462|1770741|FG000|Overall Study|Physician Decision|0
818111|NCT00150462|1770742|FG001|Overall Study|Physician Decision|0
818112|NCT00150462|1770743|FG002|Overall Study|Physician Decision|1
818113|NCT00150462|1770744|FG003|Overall Study|Physician Decision|1
818114|NCT00150462|1770745|FG004|Overall Study|Physician Decision|0
818115|NCT00150462|1770746|FG005|Overall Study|Physician Decision|0
818116|NCT00150462|1770747|FG006|Overall Study|Physician Decision|0
818117|NCT00150462|1770748|FG007|Overall Study|Physician Decision|0
818118|NCT00150462|1770749|FG008|Overall Study|Physician Decision|0
818119|NCT00150462|1770750|FG009|Overall Study|Physician Decision|0
818120|NCT00150462|1770751|FG010|Overall Study|Physician Decision|0
818121|NCT00150462|1770741|FG000|Overall Study|Other|0
818122|NCT00150462|1770742|FG001|Overall Study|Other|0
818123|NCT00150462|1770743|FG002|Overall Study|Other|0
818124|NCT00150462|1770744|FG003|Overall Study|Other|0
818125|NCT00150462|1770745|FG004|Overall Study|Other|0
818126|NCT00150462|1770746|FG005|Overall Study|Other|0
818127|NCT00150462|1770747|FG006|Overall Study|Other|0
818128|NCT00150462|1770748|FG007|Overall Study|Other|0
818129|NCT00150462|1770749|FG008|Overall Study|Other|0
818130|NCT00150462|1770750|FG009|Overall Study|Other|1
818131|NCT00150462|1770751|FG010|Overall Study|Other|1
818132|NCT00150592|1770780|FG000|Overall Study|Adverse Event|4
818133|NCT00150592|1770781|FG001|Overall Study|Adverse Event|1
818134|NCT00150592|1770780|FG000|Overall Study|Protocol Violation|1
818135|NCT00150592|1770781|FG001|Overall Study|Protocol Violation|0
818136|NCT00150592|1770780|FG000|Overall Study|Withdrawal by Subject|1
818137|NCT00150592|1770781|FG001|Overall Study|Withdrawal by Subject|2
818138|NCT00150592|1770780|FG000|Overall Study|Non-compliance|1
818139|NCT00150592|1770781|FG001|Overall Study|Non-compliance|0
818140|NCT00150618|1770792|FG000|Overall Study|Adverse Event|2
818141|NCT00150618|1770793|FG001|Overall Study|Adverse Event|2
818142|NCT00150618|1770794|FG002|Overall Study|Adverse Event|6
818143|NCT00150618|1770795|FG003|Overall Study|Adverse Event|9
818144|NCT00150618|1770796|FG004|Overall Study|Adverse Event|5
818145|NCT00150618|1770792|FG000|Overall Study|Withdrawal by Subject|6
818146|NCT00150618|1770793|FG001|Overall Study|Withdrawal by Subject|8
818147|NCT00150618|1770794|FG002|Overall Study|Withdrawal by Subject|8
818148|NCT00150618|1770795|FG003|Overall Study|Withdrawal by Subject|4
818149|NCT00150618|1770796|FG004|Overall Study|Withdrawal by Subject|5
818150|NCT00150618|1770792|FG000|Overall Study|Lost to Follow-up|4
818151|NCT00150618|1770793|FG001|Overall Study|Lost to Follow-up|1
818152|NCT00150618|1770794|FG002|Overall Study|Lost to Follow-up|5
818153|NCT00150618|1770795|FG003|Overall Study|Lost to Follow-up|8
818154|NCT00150618|1770796|FG004|Overall Study|Lost to Follow-up|4
818156|NCT00150618|1770793|FG001|Overall Study|Protocol Violation|0
818157|NCT00150618|1770794|FG002|Overall Study|Protocol Violation|0
818158|NCT00150618|1770795|FG003|Overall Study|Protocol Violation|0
818159|NCT00150618|1770796|FG004|Overall Study|Protocol Violation|1
818160|NCT00150618|1770792|FG000|Overall Study|Lack of Efficacy|1
818161|NCT00150618|1770793|FG001|Overall Study|Lack of Efficacy|4
818162|NCT00150618|1770794|FG002|Overall Study|Lack of Efficacy|7
818163|NCT00150618|1770795|FG003|Overall Study|Lack of Efficacy|4
818164|NCT00150618|1770796|FG004|Overall Study|Lack of Efficacy|6
818165|NCT00150618|1770792|FG000|Overall Study|No study meds|0
818166|NCT00150618|1770793|FG001|Overall Study|No study meds|0
818167|NCT00150618|1770794|FG002|Overall Study|No study meds|0
818168|NCT00150618|1770795|FG003|Overall Study|No study meds|0
818169|NCT00150618|1770796|FG004|Overall Study|No study meds|2
818170|NCT00150618|1770792|FG000|Overall Study|Physician Decision|0
818171|NCT00150618|1770793|FG001|Overall Study|Physician Decision|2
818172|NCT00150618|1770794|FG002|Overall Study|Physician Decision|0
818173|NCT00150618|1770795|FG003|Overall Study|Physician Decision|0
818174|NCT00150618|1770796|FG004|Overall Study|Physician Decision|1
818175|NCT00150618|1770792|FG000|Overall Study|Lack of compliance|2
818176|NCT00150618|1770793|FG001|Overall Study|Lack of compliance|1
818177|NCT00150618|1770794|FG002|Overall Study|Lack of compliance|1
818178|NCT00150618|1770795|FG003|Overall Study|Lack of compliance|0
818179|NCT00150618|1770796|FG004|Overall Study|Lack of compliance|1
818180|NCT00150618|1770792|FG000|Overall Study|Abnormal ECG|1
818181|NCT00150618|1770793|FG001|Overall Study|Abnormal ECG|0
818182|NCT00150618|1770794|FG002|Overall Study|Abnormal ECG|0
818183|NCT00150618|1770795|FG003|Overall Study|Abnormal ECG|0
818184|NCT00150618|1770796|FG004|Overall Study|Abnormal ECG|0
818185|NCT00150618|1770792|FG000|Overall Study|Sponsor's decision|0
818186|NCT00150618|1770793|FG001|Overall Study|Sponsor's decision|0
818187|NCT00150618|1770794|FG002|Overall Study|Sponsor's decision|0
818188|NCT00150618|1770795|FG003|Overall Study|Sponsor's decision|1
818189|NCT00150618|1770796|FG004|Overall Study|Sponsor's decision|0
818190|NCT00150800|1770808|FG000|Overall Study|Adverse Event|89
818191|NCT00150800|1770808|FG000|Overall Study|Death|18
818192|NCT00150800|1770808|FG000|Overall Study|Lack of Efficacy|166
818193|NCT00150800|1770808|FG000|Overall Study|Lost to Follow-up|58
818194|NCT00150800|1770808|FG000|Overall Study|Subject's choice|90
818195|NCT00150800|1770808|FG000|Overall Study|No compliance|18
818196|NCT00150800|1770808|FG000|Overall Study|IP misshandling|1
818197|NCT00150800|1770808|FG000|Overall Study|Site closure|24
818198|NCT00150800|1770808|FG000|Overall Study|Protocol non-adherence|2
818199|NCT00150800|1770808|FG000|Overall Study|Nobody to accompany patient|1
818200|NCT00150800|1770808|FG000|Overall Study|Distance too long for patient|1
818201|NCT00150800|1770808|FG000|Overall Study|Neurosurgery|2
818202|NCT00150800|1770808|FG000|Overall Study|BRV monotherapy|1
818203|NCT00150800|1770808|FG000|Overall Study|Visit refusal|3
818204|NCT00150800|1770808|FG000|Overall Study|Sponsor's request|2
818205|NCT00150800|1770808|FG000|Overall Study|Generalized Epilepsy|1
818206|NCT00150800|1770808|FG000|Overall Study|Moved from area/country|8
818207|NCT00150800|1770808|FG000|Overall Study|PI retiring|2
818208|NCT00150800|1770808|FG000|Overall Study|PI leaving site|2
818209|NCT00150800|1770808|FG000|Overall Study|Patient insurance|1
818210|NCT00150800|1770808|FG000|Overall Study|Surgical intervention|4
818211|NCT00150800|1770808|FG000|Overall Study|Pregnancy planned|1
818212|NCT00150800|1770808|FG000|Overall Study|PI discontinuation request|1
818213|NCT00150813|1770813|FG000|Overall Study|Adverse Event|1
818214|NCT00150813|1770813|FG000|Overall Study|Lack of Efficacy|1
818215|NCT00150813|1770813|FG000|Overall Study|Lost to Follow-up|5
818216|NCT00150813|1770813|FG000|Overall Study|Withdrawal by Subject|5
818217|NCT00150813|1770813|FG000|Overall Study|Remission|3
818218|NCT00150813|1770813|FG000|Overall Study|Planned pregancy|1
818219|NCT00150813|1770813|FG000|Overall Study|Switch to commercially available LEV|2
818220|NCT00150969|1770819|FG000|24 Month Main Study|Adverse Event|3
818221|NCT00150969|1770820|FG001|24 Month Main Study|Adverse Event|4
818222|NCT00150969|1770819|FG000|24 Month Main Study|Death|1
818223|NCT00150969|1770820|FG001|24 Month Main Study|Death|1
818224|NCT00150969|1770819|FG000|24 Month Main Study|Lack of Efficacy|1
818225|NCT00150969|1770820|FG001|24 Month Main Study|Lack of Efficacy|8
818226|NCT00150969|1770819|FG000|24 Month Main Study|Lost to Follow-up|3
818227|NCT00150969|1770820|FG001|24 Month Main Study|Lost to Follow-up|2
818228|NCT00150969|1770819|FG000|24 Month Main Study|Protocol Violation|4
818229|NCT00150969|1770820|FG001|24 Month Main Study|Protocol Violation|2
818230|NCT00150969|1770819|FG000|24 Month Main Study|Withdrawal by Subject|7
818231|NCT00150969|1770820|FG001|24 Month Main Study|Withdrawal by Subject|4
818232|NCT00150969|1770819|FG000|24-48 Month Extension|Withdrawal by Subject|6
818233|NCT00150969|1770820|FG001|24-48 Month Extension|Withdrawal by Subject|5
818234|NCT00150969|1770819|FG000|24-48 Month Extension|Lack of Efficacy|0
818235|NCT00150969|1770820|FG001|24-48 Month Extension|Lack of Efficacy|1
818236|NCT00150969|1770819|FG000|24-48 Month Extension|Adverse Event|1
818237|NCT00150969|1770820|FG001|24-48 Month Extension|Adverse Event|3
818238|NCT00150969|1770819|FG000|24-48 Month Extension|Other Reason|81
818239|NCT00150969|1770820|FG001|24-48 Month Extension|Other Reason|91
818240|NCT00151281|1770827|FG000|Overall Study|Not evaluable|3
818241|NCT00151372|1770841|FG000|Overall Study|Death|12
818242|NCT00151372|1770842|FG001|Overall Study|Death|11
818243|NCT00151372|1770841|FG000|Overall Study|Lost to Follow-up|5
818244|NCT00151372|1770842|FG001|Overall Study|Lost to Follow-up|5
818245|NCT00151372|1770841|FG000|Overall Study|Too sick medically to continue|5
818246|NCT00151372|1770842|FG001|Overall Study|Too sick medically to continue|6
818247|NCT00151372|1770841|FG000|Overall Study|Withdrawal by Subject|7
818248|NCT00151372|1770842|FG001|Overall Study|Withdrawal by Subject|7
818249|NCT00151411|1770850|FG000|Overall Study|Lost to Follow-up|15
818250|NCT00151411|1770851|FG001|Overall Study|Lost to Follow-up|19
818251|NCT00151411|1770850|FG000|Overall Study|Withdrawal by Subject|12
818252|NCT00151411|1770851|FG001|Overall Study|Withdrawal by Subject|20
818253|NCT00151411|1770850|FG000|Overall Study|Adverse Event|6
818254|NCT00151411|1770851|FG001|Overall Study|Adverse Event|0
818255|NCT00151411|1770850|FG000|Overall Study|Pregnancy|0
818256|NCT00151411|1770851|FG001|Overall Study|Pregnancy|4
818257|NCT00151476|1770860|FG000|FAP Identified Subjects|Protocol Violation|0
818258|NCT00151476|1770861|FG001|FAP Identified Subjects|Protocol Violation|1
818259|NCT00151476|1770860|FG000|FAP Analyzed Subjects|Lost to Follow-up|0
818260|NCT00151476|1770861|FG001|FAP Analyzed Subjects|Lost to Follow-up|2
818261|NCT00151476|1770860|FG000|FAP Analyzed Subjects|Other study participation|0
818262|NCT00151476|1770861|FG001|FAP Analyzed Subjects|Other study participation|1
818263|NCT00151775|1770873|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1
818264|NCT00151775|1770874|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2
818265|NCT00151775|1770875|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0
818266|NCT00151775|1770876|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0
818267|NCT00151775|1770877|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0
818268|NCT00151775|1770878|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0
818269|NCT00151775|1770879|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0
818270|NCT00151775|1770880|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0
818271|NCT00151775|1770881|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0
818272|NCT00151775|1770882|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0
818273|NCT00151775|1770883|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0
818274|NCT00151775|1770884|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0
818275|NCT00151775|1770873|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
818276|NCT00151775|1770874|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
818277|NCT00151775|1770875|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
818278|NCT00151775|1770876|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
818279|NCT00151775|1770877|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
818280|NCT00151775|1770878|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
818281|NCT00151775|1770879|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
818282|NCT00151775|1770880|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
818283|NCT00151775|1770881|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
818284|NCT00151775|1770882|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
818285|NCT00151775|1770883|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
818286|NCT00151775|1770884|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
818287|NCT00151775|1770873|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0
818288|NCT00151775|1770874|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4
818289|NCT00151775|1770875|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0
818290|NCT00151775|1770876|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0
818291|NCT00151775|1770877|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0
818292|NCT00151775|1770878|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0
818293|NCT00151775|1770879|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0
818294|NCT00151775|1770880|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0
818295|NCT00151775|1770881|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0
818296|NCT00151775|1770882|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0
818297|NCT00151775|1770883|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0
818298|NCT00151775|1770884|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0
818299|NCT00151775|1770873|FG000|Period 2 - Double-Blind Dose Response|Other|0
818300|NCT00151775|1770874|FG001|Period 2 - Double-Blind Dose Response|Other|0
818301|NCT00151775|1770875|FG002|Period 2 - Double-Blind Dose Response|Other|0
818302|NCT00151775|1770876|FG003|Period 2 - Double-Blind Dose Response|Other|0
818303|NCT00151775|1770877|FG004|Period 2 - Double-Blind Dose Response|Other|0
818304|NCT00151775|1770878|FG005|Period 2 - Double-Blind Dose Response|Other|0
818305|NCT00151775|1770879|FG006|Period 2 - Double-Blind Dose Response|Other|1
818306|NCT00151775|1770880|FG007|Period 2 - Double-Blind Dose Response|Other|0
818307|NCT00151775|1770881|FG008|Period 2 - Double-Blind Dose Response|Other|0
818308|NCT00151775|1770882|FG009|Period 2 - Double-Blind Dose Response|Other|0
818309|NCT00151775|1770883|FG010|Period 2 - Double-Blind Dose Response|Other|0
818310|NCT00151775|1770884|FG011|Period 2 - Double-Blind Dose Response|Other|0
818311|NCT00151775|1770873|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0
818312|NCT00151775|1770874|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0
818313|NCT00151775|1770875|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0
818314|NCT00151775|1770876|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0
818315|NCT00151775|1770877|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0
818316|NCT00151775|1770878|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1
818317|NCT00151775|1770879|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0
818318|NCT00151775|1770880|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0
818319|NCT00151775|1770881|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0
818320|NCT00151775|1770882|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0
818321|NCT00151775|1770883|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0
818322|NCT00151775|1770884|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0
818323|NCT00151775|1770873|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0
818324|NCT00151775|1770874|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0
818325|NCT00151775|1770875|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0
818326|NCT00151775|1770876|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0
818327|NCT00151775|1770877|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0
818328|NCT00151775|1770878|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1
818329|NCT00151775|1770879|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0
818330|NCT00151775|1770880|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0
818331|NCT00151775|1770881|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0
818332|NCT00151775|1770882|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0
818333|NCT00151775|1770883|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0
818334|NCT00151775|1770884|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0
818335|NCT00151775|1770873|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
818336|NCT00151775|1770874|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
818337|NCT00151775|1770875|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
818338|NCT00151775|1770876|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
818339|NCT00151775|1770877|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
818340|NCT00151775|1770878|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
818341|NCT00151775|1770879|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
818342|NCT00151775|1770880|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
818343|NCT00151775|1770881|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
818344|NCT00151775|1770882|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
818345|NCT00151775|1770883|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
818346|NCT00151775|1770884|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
818347|NCT00151775|1770873|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
818348|NCT00151775|1770874|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
818349|NCT00151775|1770875|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
818350|NCT00151775|1770876|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
818351|NCT00151775|1770877|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
818352|NCT00151775|1770878|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
818353|NCT00151775|1770879|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
818354|NCT00151775|1770880|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
818355|NCT00151775|1770881|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
818356|NCT00151775|1770882|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
818357|NCT00151775|1770883|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
818358|NCT00151775|1770884|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
818359|NCT00151775|1770873|FG000|Period 3: Double-blind, Withdrawal|Other|0
818360|NCT00151775|1770874|FG001|Period 3: Double-blind, Withdrawal|Other|0
818361|NCT00151775|1770875|FG002|Period 3: Double-blind, Withdrawal|Other|1
818362|NCT00151775|1770876|FG003|Period 3: Double-blind, Withdrawal|Other|0
818363|NCT00151775|1770877|FG004|Period 3: Double-blind, Withdrawal|Other|0
818364|NCT00151775|1770878|FG005|Period 3: Double-blind, Withdrawal|Other|0
818365|NCT00151775|1770879|FG006|Period 3: Double-blind, Withdrawal|Other|0
818366|NCT00151775|1770880|FG007|Period 3: Double-blind, Withdrawal|Other|1
818367|NCT00151775|1770881|FG008|Period 3: Double-blind, Withdrawal|Other|0
818368|NCT00151775|1770882|FG009|Period 3: Double-blind, Withdrawal|Other|0
818369|NCT00151775|1770883|FG010|Period 3: Double-blind, Withdrawal|Other|0
818370|NCT00151775|1770884|FG011|Period 3: Double-blind, Withdrawal|Other|0
818371|NCT00151775|1770873|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
818372|NCT00151775|1770874|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
818373|NCT00151775|1770875|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
818374|NCT00151775|1770876|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
818375|NCT00151775|1770877|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
818376|NCT00151775|1770878|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
818377|NCT00151775|1770879|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
818378|NCT00151775|1770880|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
818379|NCT00151775|1770881|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
818380|NCT00151775|1770882|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
818381|NCT00151775|1770883|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
818382|NCT00151775|1770884|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
818383|NCT00151775|1770873|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0
818384|NCT00151775|1770874|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0
818385|NCT00151775|1770875|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1
818386|NCT00151775|1770876|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0
818387|NCT00151775|1770877|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0
818388|NCT00151775|1770878|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0
818389|NCT00151775|1770879|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0
818390|NCT00151775|1770880|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0
818391|NCT00151775|1770881|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0
818392|NCT00151775|1770882|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0
818393|NCT00151775|1770883|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0
818394|NCT00151775|1770884|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0
818395|NCT00151775|1770873|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0
818396|NCT00151775|1770874|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0
818397|NCT00151775|1770875|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1
818398|NCT00151775|1770876|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0
818399|NCT00151775|1770877|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0
818400|NCT00151775|1770878|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0
818401|NCT00151775|1770879|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0
818402|NCT00151775|1770880|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0
818403|NCT00151775|1770881|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0
818404|NCT00151775|1770882|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0
818405|NCT00151775|1770883|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0
818406|NCT00151775|1770884|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0
818407|NCT00151775|1770873|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
818408|NCT00151775|1770874|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
818409|NCT00151775|1770875|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
818410|NCT00151775|1770876|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
818411|NCT00151775|1770877|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
818412|NCT00151775|1770878|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
818413|NCT00151775|1770879|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
818414|NCT00151775|1770880|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
818415|NCT00151775|1770881|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
818416|NCT00151775|1770882|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
818417|NCT00151775|1770883|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
818418|NCT00151775|1770884|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
818419|NCT00151775|1770873|FG000|Period 4: Open Label|Increased blood pressure|0
818420|NCT00151775|1770874|FG001|Period 4: Open Label|Increased blood pressure|0
818421|NCT00151775|1770875|FG002|Period 4: Open Label|Increased blood pressure|0
818422|NCT00151775|1770876|FG003|Period 4: Open Label|Increased blood pressure|0
818423|NCT00151775|1770877|FG004|Period 4: Open Label|Increased blood pressure|1
818424|NCT00151775|1770878|FG005|Period 4: Open Label|Increased blood pressure|0
818425|NCT00151775|1770879|FG006|Period 4: Open Label|Increased blood pressure|0
818426|NCT00151775|1770880|FG007|Period 4: Open Label|Increased blood pressure|0
818427|NCT00151775|1770881|FG008|Period 4: Open Label|Increased blood pressure|0
818428|NCT00151775|1770882|FG009|Period 4: Open Label|Increased blood pressure|1
818429|NCT00151775|1770883|FG010|Period 4: Open Label|Increased blood pressure|0
818430|NCT00151775|1770884|FG011|Period 4: Open Label|Increased blood pressure|0
818431|NCT00151775|1770873|FG000|Period 4: Open Label|Withdrawal by Subject|0
818432|NCT00151775|1770874|FG001|Period 4: Open Label|Withdrawal by Subject|0
818433|NCT00151775|1770875|FG002|Period 4: Open Label|Withdrawal by Subject|0
818434|NCT00151775|1770876|FG003|Period 4: Open Label|Withdrawal by Subject|0
818435|NCT00151775|1770877|FG004|Period 4: Open Label|Withdrawal by Subject|5
818436|NCT00151775|1770878|FG005|Period 4: Open Label|Withdrawal by Subject|0
818437|NCT00151775|1770879|FG006|Period 4: Open Label|Withdrawal by Subject|0
818438|NCT00151775|1770880|FG007|Period 4: Open Label|Withdrawal by Subject|0
818439|NCT00151775|1770881|FG008|Period 4: Open Label|Withdrawal by Subject|0
818440|NCT00151775|1770882|FG009|Period 4: Open Label|Withdrawal by Subject|2
818441|NCT00151775|1770883|FG010|Period 4: Open Label|Withdrawal by Subject|0
818442|NCT00151775|1770884|FG011|Period 4: Open Label|Withdrawal by Subject|0
818443|NCT00151775|1770873|FG000|Period 4: Open Label|Adverse Event|0
818444|NCT00151775|1770874|FG001|Period 4: Open Label|Adverse Event|0
818445|NCT00151775|1770875|FG002|Period 4: Open Label|Adverse Event|0
818446|NCT00151775|1770876|FG003|Period 4: Open Label|Adverse Event|0
818447|NCT00151775|1770877|FG004|Period 4: Open Label|Adverse Event|1
818448|NCT00151775|1770878|FG005|Period 4: Open Label|Adverse Event|0
818449|NCT00151775|1770879|FG006|Period 4: Open Label|Adverse Event|0
818450|NCT00151775|1770880|FG007|Period 4: Open Label|Adverse Event|0
818451|NCT00151775|1770881|FG008|Period 4: Open Label|Adverse Event|0
818452|NCT00151775|1770882|FG009|Period 4: Open Label|Adverse Event|2
818453|NCT00151775|1770883|FG010|Period 4: Open Label|Adverse Event|0
818454|NCT00151775|1770884|FG011|Period 4: Open Label|Adverse Event|0
818455|NCT00151775|1770873|FG000|Period 4: Open Label|Lost to Follow-up|0
818456|NCT00151775|1770874|FG001|Period 4: Open Label|Lost to Follow-up|0
818457|NCT00151775|1770875|FG002|Period 4: Open Label|Lost to Follow-up|0
818458|NCT00151775|1770876|FG003|Period 4: Open Label|Lost to Follow-up|0
818459|NCT00151775|1770877|FG004|Period 4: Open Label|Lost to Follow-up|17
818460|NCT00151775|1770878|FG005|Period 4: Open Label|Lost to Follow-up|0
818461|NCT00151775|1770879|FG006|Period 4: Open Label|Lost to Follow-up|0
818462|NCT00151775|1770880|FG007|Period 4: Open Label|Lost to Follow-up|0
818463|NCT00151775|1770881|FG008|Period 4: Open Label|Lost to Follow-up|0
818464|NCT00151775|1770882|FG009|Period 4: Open Label|Lost to Follow-up|7
818465|NCT00151775|1770883|FG010|Period 4: Open Label|Lost to Follow-up|0
818466|NCT00151775|1770884|FG011|Period 4: Open Label|Lost to Follow-up|0
818467|NCT00151775|1770873|FG000|Period 4: Open Label|Non-compliance with protocol|0
818468|NCT00151775|1770874|FG001|Period 4: Open Label|Non-compliance with protocol|0
818469|NCT00151775|1770875|FG002|Period 4: Open Label|Non-compliance with protocol|0
818470|NCT00151775|1770876|FG003|Period 4: Open Label|Non-compliance with protocol|0
818471|NCT00151775|1770877|FG004|Period 4: Open Label|Non-compliance with protocol|4
818472|NCT00151775|1770878|FG005|Period 4: Open Label|Non-compliance with protocol|0
818473|NCT00151775|1770879|FG006|Period 4: Open Label|Non-compliance with protocol|0
818474|NCT00151775|1770880|FG007|Period 4: Open Label|Non-compliance with protocol|0
818475|NCT00151775|1770881|FG008|Period 4: Open Label|Non-compliance with protocol|0
818476|NCT00151775|1770882|FG009|Period 4: Open Label|Non-compliance with protocol|4
818477|NCT00151775|1770883|FG010|Period 4: Open Label|Non-compliance with protocol|0
818478|NCT00151775|1770884|FG011|Period 4: Open Label|Non-compliance with protocol|0
818479|NCT00151775|1770873|FG000|Period 4: Open Label|Other|0
818480|NCT00151775|1770874|FG001|Period 4: Open Label|Other|0
818481|NCT00151775|1770875|FG002|Period 4: Open Label|Other|0
818482|NCT00151775|1770876|FG003|Period 4: Open Label|Other|0
818483|NCT00151775|1770877|FG004|Period 4: Open Label|Other|1
818484|NCT00151775|1770878|FG005|Period 4: Open Label|Other|0
818485|NCT00151775|1770879|FG006|Period 4: Open Label|Other|0
818486|NCT00151775|1770880|FG007|Period 4: Open Label|Other|0
818487|NCT00151775|1770881|FG008|Period 4: Open Label|Other|0
818488|NCT00151775|1770882|FG009|Period 4: Open Label|Other|3
818489|NCT00151775|1770883|FG010|Period 4: Open Label|Other|0
818490|NCT00151775|1770884|FG011|Period 4: Open Label|Other|0
818491|NCT00151775|1770873|FG000|Period 4: Open Label|Physician Decision|0
818492|NCT00151775|1770874|FG001|Period 4: Open Label|Physician Decision|0
818493|NCT00151775|1770875|FG002|Period 4: Open Label|Physician Decision|0
818494|NCT00151775|1770876|FG003|Period 4: Open Label|Physician Decision|0
818495|NCT00151775|1770877|FG004|Period 4: Open Label|Physician Decision|0
818496|NCT00151775|1770878|FG005|Period 4: Open Label|Physician Decision|0
818497|NCT00151775|1770879|FG006|Period 4: Open Label|Physician Decision|0
818498|NCT00151775|1770880|FG007|Period 4: Open Label|Physician Decision|0
818499|NCT00151775|1770881|FG008|Period 4: Open Label|Physician Decision|0
818500|NCT00151775|1770882|FG009|Period 4: Open Label|Physician Decision|2
818501|NCT00151775|1770883|FG010|Period 4: Open Label|Physician Decision|0
818502|NCT00151775|1770884|FG011|Period 4: Open Label|Physician Decision|0
818503|NCT00151775|1770873|FG000|Period 4: Open Label|Protocol Violation|0
818504|NCT00151775|1770874|FG001|Period 4: Open Label|Protocol Violation|0
818505|NCT00151775|1770875|FG002|Period 4: Open Label|Protocol Violation|0
818506|NCT00151775|1770876|FG003|Period 4: Open Label|Protocol Violation|0
818507|NCT00151775|1770877|FG004|Period 4: Open Label|Protocol Violation|1
818508|NCT00151775|1770878|FG005|Period 4: Open Label|Protocol Violation|0
818509|NCT00151775|1770879|FG006|Period 4: Open Label|Protocol Violation|0
818510|NCT00151775|1770880|FG007|Period 4: Open Label|Protocol Violation|0
818511|NCT00151775|1770881|FG008|Period 4: Open Label|Protocol Violation|0
818512|NCT00151775|1770882|FG009|Period 4: Open Label|Protocol Violation|0
818513|NCT00151775|1770883|FG010|Period 4: Open Label|Protocol Violation|0
818514|NCT00151775|1770884|FG011|Period 4: Open Label|Protocol Violation|0
818515|NCT00151892|1770939|FG000|Overall Study|Lack of Efficacy|50
818516|NCT00151892|1770940|FG001|Overall Study|Lack of Efficacy|57
818517|NCT00151892|1770939|FG000|Overall Study|Patient request|10
818518|NCT00151892|1770940|FG001|Overall Study|Patient request|7
818519|NCT00151892|1770939|FG000|Overall Study|Lost to Follow-up|5
818520|NCT00151892|1770940|FG001|Overall Study|Lost to Follow-up|10
818521|NCT00151892|1770939|FG000|Overall Study|Adverse Event|6
818522|NCT00151892|1770940|FG001|Overall Study|Adverse Event|3
818523|NCT00151892|1770939|FG000|Overall Study|Protocol Violation|3
818524|NCT00151892|1770940|FG001|Overall Study|Protocol Violation|3
818525|NCT00151892|1770939|FG000|Overall Study|Non-compliance|0
818526|NCT00151892|1770940|FG001|Overall Study|Non-compliance|1
818527|NCT00151892|1770939|FG000|Overall Study|Pregnancy|0
818528|NCT00151892|1770940|FG001|Overall Study|Pregnancy|1
818529|NCT00151892|1770939|FG000|Overall Study|Did not return for a visit|1
818530|NCT00151892|1770940|FG001|Overall Study|Did not return for a visit|0
818531|NCT00151892|1770939|FG000|Overall Study|Used prohibited corticosteroids|1
818532|NCT00151892|1770940|FG001|Overall Study|Used prohibited corticosteroids|0
818533|NCT00151892|1770939|FG000|Overall Study|Lack of study medication at center|0
818534|NCT00151892|1770940|FG001|Overall Study|Lack of study medication at center|1
818535|NCT00151996|1770948|FG000|Overall Study|Adverse Event|3
818536|NCT00151996|1770949|FG001|Overall Study|Adverse Event|2
818537|NCT00151996|1770948|FG000|Overall Study|Withdrawal by Subject|1
818538|NCT00151996|1770949|FG001|Overall Study|Withdrawal by Subject|1
818539|NCT00151996|1770948|FG000|Overall Study|Protocol Violation|1
818540|NCT00151996|1770949|FG001|Overall Study|Protocol Violation|2
818541|NCT00151996|1770948|FG000|Overall Study|Sponsor's decision|0
818542|NCT00151996|1770949|FG001|Overall Study|Sponsor's decision|2
818543|NCT00152009|1770959|FG000|Overall Study|Adverse Event|9
818544|NCT00152009|1770960|FG001|Overall Study|Adverse Event|13
818545|NCT00152009|1770961|FG002|Overall Study|Adverse Event|20
818546|NCT00152009|1770962|FG003|Overall Study|Adverse Event|1
818547|NCT00152009|1770959|FG000|Overall Study|Protocol Violation|3
818548|NCT00152009|1770960|FG001|Overall Study|Protocol Violation|0
818549|NCT00152009|1770961|FG002|Overall Study|Protocol Violation|0
818550|NCT00152009|1770962|FG003|Overall Study|Protocol Violation|1
818551|NCT00152009|1770959|FG000|Overall Study|Withdrawal by Subject|2
818552|NCT00152009|1770960|FG001|Overall Study|Withdrawal by Subject|3
818553|NCT00152009|1770961|FG002|Overall Study|Withdrawal by Subject|4
818554|NCT00152009|1770962|FG003|Overall Study|Withdrawal by Subject|9
818555|NCT00152009|1770959|FG000|Overall Study|Lost to Follow-up|2
818556|NCT00152009|1770960|FG001|Overall Study|Lost to Follow-up|4
818557|NCT00152009|1770961|FG002|Overall Study|Lost to Follow-up|3
818558|NCT00152009|1770962|FG003|Overall Study|Lost to Follow-up|3
818559|NCT00152009|1770959|FG000|Overall Study|Lack of Efficacy|8
818560|NCT00152009|1770960|FG001|Overall Study|Lack of Efficacy|6
818561|NCT00152009|1770961|FG002|Overall Study|Lack of Efficacy|7
818562|NCT00152009|1770962|FG003|Overall Study|Lack of Efficacy|15
818563|NCT00152009|1770959|FG000|Overall Study|ECG abnormalities|2
818564|NCT00152009|1770960|FG001|Overall Study|ECG abnormalities|2
818565|NCT00152009|1770961|FG002|Overall Study|ECG abnormalities|2
818566|NCT00152009|1770962|FG003|Overall Study|ECG abnormalities|1
818567|NCT00152009|1770959|FG000|Overall Study|Sponsor's decision|3
818568|NCT00152009|1770960|FG001|Overall Study|Sponsor's decision|3
818569|NCT00152009|1770961|FG002|Overall Study|Sponsor's decision|1
818570|NCT00152009|1770962|FG003|Overall Study|Sponsor's decision|3
818571|NCT00152464|1770974|FG000|Overall Study|Adverse Event|3
818572|NCT00152464|1770975|FG001|Overall Study|Adverse Event|6
818573|NCT00152464|1770974|FG000|Overall Study|Lost to Follow-up|8
818574|NCT00152464|1770975|FG001|Overall Study|Lost to Follow-up|4
818575|NCT00152464|1770974|FG000|Overall Study|Protocol Violation|3
818576|NCT00152464|1770975|FG001|Overall Study|Protocol Violation|1
818577|NCT00152464|1770974|FG000|Overall Study|Withdrawal by Subject|21
818578|NCT00152464|1770975|FG001|Overall Study|Withdrawal by Subject|22
818579|NCT00152464|1770974|FG000|Overall Study|Atopic dermatitis poorly controlled|0
818580|NCT00152464|1770975|FG001|Overall Study|Atopic dermatitis poorly controlled|1
818581|NCT00152464|1770974|FG000|Overall Study|Eczema deterioration|0
818582|NCT00152464|1770975|FG001|Overall Study|Eczema deterioration|1
818583|NCT00152464|1770974|FG000|Overall Study|Parent decision|1
818584|NCT00152464|1770975|FG001|Overall Study|Parent decision|1
818585|NCT00152464|1770974|FG000|Overall Study|Investigator decision|1
818586|NCT00152464|1770975|FG001|Overall Study|Investigator decision|0
818587|NCT00152464|1770974|FG000|Overall Study|Lack of Efficacy|1
818588|NCT00152464|1770975|FG001|Overall Study|Lack of Efficacy|0
818589|NCT00152464|1770974|FG000|Overall Study|Eczema poorly controlled|1
818590|NCT00152464|1770975|FG001|Overall Study|Eczema poorly controlled|0
818591|NCT00152464|1770974|FG000|Overall Study|Patient relocated|1
818592|NCT00152464|1770975|FG001|Overall Study|Patient relocated|0
818593|NCT00152516|1770981|FG000|Overall Study|Adverse Event|18
818594|NCT00152516|1770981|FG000|Overall Study|Lack and Loss of Efficacy|30
818595|NCT00152516|1770981|FG000|Overall Study|Lost to Follow-up|5
818596|NCT00152516|1770981|FG000|Overall Study|Withdrawal by Subject|8
818597|NCT00152516|1770981|FG000|Overall Study|Protocol Violation|3
818598|NCT00152516|1770981|FG000|Overall Study|Other: Mother Refused To Cooperate|1
818599|NCT00152516|1770981|FG000|Overall Study|Other: Given Commercial Drug in Error|2
818600|NCT00152516|1770981|FG000|Overall Study|Other: Parents Withdrew Consent|2
818601|NCT00152516|1770981|FG000|Overall Study|Other: Non-Compliance|2
818602|NCT00152516|1770981|FG000|Overall Study|Other: Primary Care Physician's Decision|1
818603|NCT00152516|1770981|FG000|Overall Study|Other: Moved Out Of State|1
818604|NCT00152516|1770981|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1
818605|NCT00152516|1770981|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
818606|NCT00152763|1770989|FG000|Overall Study|Death|4
818607|NCT00152763|1770990|FG001|Overall Study|Death|1
818608|NCT00152763|1770991|FG002|Overall Study|Death|2
818609|NCT00152763|1770992|FG003|Overall Study|Death|1
818610|NCT00152763|1770989|FG000|Overall Study|Lost to Follow-up|6
818611|NCT00152763|1770990|FG001|Overall Study|Lost to Follow-up|4
818612|NCT00152763|1770991|FG002|Overall Study|Lost to Follow-up|2
818613|NCT00152763|1770992|FG003|Overall Study|Lost to Follow-up|13
818614|NCT00152971|1771007|FG000|Overall Study|Adverse Event|12
818615|NCT00152971|1771008|FG001|Overall Study|Adverse Event|10
818616|NCT00152971|1771009|FG002|Overall Study|Adverse Event|9
818617|NCT00152971|1771007|FG000|Overall Study|Protocol Violation|10
818618|NCT00152971|1771008|FG001|Overall Study|Protocol Violation|11
818619|NCT00152971|1771009|FG002|Overall Study|Protocol Violation|8
818620|NCT00152971|1771007|FG000|Overall Study|Lost to Follow-up|17
818621|NCT00152971|1771008|FG001|Overall Study|Lost to Follow-up|14
818622|NCT00152971|1771009|FG002|Overall Study|Lost to Follow-up|13
818623|NCT00152971|1771007|FG000|Overall Study|Withdrawal by Subject|9
818624|NCT00152971|1771008|FG001|Overall Study|Withdrawal by Subject|8
818625|NCT00152971|1771009|FG002|Overall Study|Withdrawal by Subject|14
818626|NCT00152971|1771007|FG000|Overall Study|Other|3
818627|NCT00152971|1771008|FG001|Overall Study|Other|5
818628|NCT00152971|1771009|FG002|Overall Study|Other|5
818629|NCT00152971|1771007|FG000|Treatment|Adverse Event|49
818630|NCT00152971|1771008|FG001|Treatment|Adverse Event|40
818631|NCT00152971|1771009|FG002|Treatment|Adverse Event|54
818632|NCT00152971|1771007|FG000|Treatment|Protocol Violation|8
818633|NCT00152971|1771008|FG001|Treatment|Protocol Violation|6
818634|NCT00152971|1771009|FG002|Treatment|Protocol Violation|10
818635|NCT00152971|1771007|FG000|Treatment|Lost to Follow-up|1
818636|NCT00152971|1771008|FG001|Treatment|Lost to Follow-up|2
818637|NCT00152971|1771009|FG002|Treatment|Lost to Follow-up|1
818638|NCT00152971|1771007|FG000|Treatment|Withdrawal by Subject|4
818639|NCT00152971|1771008|FG001|Treatment|Withdrawal by Subject|4
818640|NCT00152971|1771009|FG002|Treatment|Withdrawal by Subject|5
818641|NCT00152971|1771007|FG000|Treatment|Other|9
818642|NCT00152971|1771008|FG001|Treatment|Other|11
818643|NCT00152971|1771009|FG002|Treatment|Other|10
818644|NCT00153062|1771021|FG000|Overall Study|Death|360
818645|NCT00153062|1771022|FG001|Overall Study|Death|352
818646|NCT00153062|1771023|FG002|Overall Study|Death|369
818647|NCT00153062|1771024|FG003|Overall Study|Death|365
818648|NCT00153062|1771021|FG000|Overall Study|Withdrawal by Subject|14
818649|NCT00153062|1771022|FG001|Overall Study|Withdrawal by Subject|30
818650|NCT00153062|1771023|FG002|Overall Study|Withdrawal by Subject|27
818651|NCT00153062|1771024|FG003|Overall Study|Withdrawal by Subject|28
818652|NCT00153062|1771021|FG000|Overall Study|Lost to Follow-up|12
818653|NCT00153062|1771022|FG001|Overall Study|Lost to Follow-up|20
818654|NCT00153062|1771023|FG002|Overall Study|Lost to Follow-up|15
818655|NCT00153062|1771024|FG003|Overall Study|Lost to Follow-up|16
818656|NCT00153062|1771021|FG000|Overall Study|Adverse Event|0
818657|NCT00153062|1771022|FG001|Overall Study|Adverse Event|1
818658|NCT00153062|1771023|FG002|Overall Study|Adverse Event|1
818659|NCT00153062|1771024|FG003|Overall Study|Adverse Event|0
818660|NCT00153062|1771021|FG000|Overall Study|Protocol Violation|0
818661|NCT00153062|1771022|FG001|Overall Study|Protocol Violation|2
818662|NCT00153062|1771023|FG002|Overall Study|Protocol Violation|1
818663|NCT00153062|1771024|FG003|Overall Study|Protocol Violation|1
818664|NCT00153062|1771021|FG000|Overall Study|No disposition data available|1
818665|NCT00153062|1771022|FG001|Overall Study|No disposition data available|1
818666|NCT00153062|1771023|FG002|Overall Study|No disposition data available|1
818667|NCT00153062|1771024|FG003|Overall Study|No disposition data available|1
818668|NCT00153062|1771021|FG000|Overall Study|Other|0
818669|NCT00153062|1771022|FG001|Overall Study|Other|0
818670|NCT00153062|1771023|FG002|Overall Study|Other|1
818671|NCT00153062|1771024|FG003|Overall Study|Other|0
818672|NCT00153101|1771039|FG000|Overall Study|Lost to Follow-up|14
818673|NCT00153101|1771040|FG001|Overall Study|Lost to Follow-up|14
818674|NCT00153101|1771041|FG002|Overall Study|Lost to Follow-up|12
818675|NCT00153101|1771042|FG003|Overall Study|Lost to Follow-up|5
818676|NCT00153101|1771043|FG004|Overall Study|Lost to Follow-up|5
818677|NCT00153101|1771039|FG000|Overall Study|Withdrawal by Subject|3
818678|NCT00153101|1771040|FG001|Overall Study|Withdrawal by Subject|4
818679|NCT00153101|1771041|FG002|Overall Study|Withdrawal by Subject|3
818680|NCT00153101|1771042|FG003|Overall Study|Withdrawal by Subject|3
818681|NCT00153101|1771043|FG004|Overall Study|Withdrawal by Subject|5
818682|NCT00153179|1771073|FG000|Study Visit Day 2|Withdrawal by Subject|1
818683|NCT00153179|1771074|FG001|Study Visit Day 2|Withdrawal by Subject|0
818684|NCT00153179|1771075|FG002|Study Visit Day 2|Withdrawal by Subject|2
818685|NCT00153179|1771076|FG003|Study Visit Day 2|Withdrawal by Subject|2
818686|NCT00153816|1771102|FG000|Overall Study|Death|6
818687|NCT00153816|1771103|FG001|Overall Study|Death|5
818688|NCT00153816|1771104|FG002|Overall Study|Death|4
818689|NCT00153816|1771105|FG003|Overall Study|Death|6
818690|NCT00153816|1771106|FG004|Overall Study|Death|0
818691|NCT00153816|1771107|FG005|Overall Study|Death|2
818692|NCT00153816|1771102|FG000|Overall Study|Lost to Follow-up|7
818693|NCT00153816|1771103|FG001|Overall Study|Lost to Follow-up|8
818694|NCT00153816|1771104|FG002|Overall Study|Lost to Follow-up|5
818695|NCT00153816|1771105|FG003|Overall Study|Lost to Follow-up|8
818696|NCT00153816|1771106|FG004|Overall Study|Lost to Follow-up|7
818697|NCT00153816|1771107|FG005|Overall Study|Lost to Follow-up|9
818698|NCT00153816|1771102|FG000|Overall Study|Withdrawal by Subject|9
818699|NCT00153816|1771103|FG001|Overall Study|Withdrawal by Subject|9
818700|NCT00153816|1771104|FG002|Overall Study|Withdrawal by Subject|9
818701|NCT00153816|1771105|FG003|Overall Study|Withdrawal by Subject|4
818702|NCT00153816|1771106|FG004|Overall Study|Withdrawal by Subject|1
818703|NCT00153816|1771107|FG005|Overall Study|Withdrawal by Subject|5
818704|NCT00153816|1771102|FG000|Overall Study|Follow-up exam not done|8
818705|NCT00153816|1771103|FG001|Overall Study|Follow-up exam not done|7
818706|NCT00153816|1771104|FG002|Overall Study|Follow-up exam not done|11
818707|NCT00153816|1771105|FG003|Overall Study|Follow-up exam not done|10
818708|NCT00153816|1771106|FG004|Overall Study|Follow-up exam not done|8
818709|NCT00153816|1771107|FG005|Overall Study|Follow-up exam not done|9
818710|NCT00153816|1771102|FG000|Overall Study|Follow-up exam done, histology missing|2
818711|NCT00153816|1771103|FG001|Overall Study|Follow-up exam done, histology missing|3
818712|NCT00153816|1771104|FG002|Overall Study|Follow-up exam done, histology missing|3
818713|NCT00153816|1771105|FG003|Overall Study|Follow-up exam done, histology missing|3
818714|NCT00153816|1771106|FG004|Overall Study|Follow-up exam done, histology missing|1
818715|NCT00153816|1771107|FG005|Overall Study|Follow-up exam done, histology missing|2
818716|NCT00153920|1771132|FG000|Overall Study|Adverse Event|9
818717|NCT00153920|1771132|FG000|Overall Study|Progressive Disease|9
818718|NCT00153920|1771132|FG000|Overall Study|Physician Decision|3
818719|NCT00153920|1771132|FG000|Overall Study|Lack of Response|3
818720|NCT00153920|1771132|FG000|Overall Study|Death|2
818721|NCT00153920|1771132|FG000|Overall Study|Withdrawal by Subject|1
818722|NCT00153920|1771132|FG000|Overall Study|Non-Protocol Therapy|1
818723|NCT00153920|1771132|FG000|Overall Study|Withdrawal of Consent before Trt|1
818724|NCT00153920|1771132|FG000|Overall Study|Progressive Disease before Trt|1
818725|NCT00154063|1771142|FG000|Overall Study|Adverse Event|4
818726|NCT00154063|1771143|FG001|Overall Study|Adverse Event|8
818727|NCT00154063|1771142|FG000|Overall Study|Protocol Violation|1
818728|NCT00154063|1771143|FG001|Overall Study|Protocol Violation|1
818729|NCT00154063|1771142|FG000|Overall Study|Investigator or Sponsor Request|0
818730|NCT00154063|1771143|FG001|Overall Study|Investigator or Sponsor Request|1
818731|NCT00154063|1771142|FG000|Overall Study|Withdrawal by Subject|4
818732|NCT00154063|1771143|FG001|Overall Study|Withdrawal by Subject|9
818733|NCT00154063|1771142|FG000|Overall Study|Other|3
818734|NCT00154063|1771143|FG001|Overall Study|Other|3
818735|NCT00154102|1771155|FG000|Overall Study|investigational study phase ongoing|7
818736|NCT00154102|1771156|FG001|Overall Study|investigational study phase ongoing|2
818737|NCT00154284|1771164|FG000|Overall Study|Adverse Event|6
818738|NCT00154284|1771165|FG001|Overall Study|Adverse Event|9
818739|NCT00154284|1771164|FG000|Overall Study|Abnormal laboratory value(s)|0
818740|NCT00154284|1771165|FG001|Overall Study|Abnormal laboratory value(s)|1
818741|NCT00154284|1771164|FG000|Overall Study|Lack of Efficacy|1
818742|NCT00154284|1771165|FG001|Overall Study|Lack of Efficacy|2
818743|NCT00154284|1771164|FG000|Overall Study|Protocol Violation|0
818744|NCT00154284|1771165|FG001|Overall Study|Protocol Violation|1
818745|NCT00154297|1771175|FG000|Overall Study|Death|5
818746|NCT00154297|1771176|FG001|Overall Study|Death|2
818747|NCT00154297|1771175|FG000|Overall Study|Withdrawal by Subject|0
818748|NCT00154297|1771176|FG001|Overall Study|Withdrawal by Subject|5
818749|NCT00154297|1771175|FG000|Overall Study|Lost to Follow-up|3
818750|NCT00154297|1771176|FG001|Overall Study|Lost to Follow-up|0
818751|NCT00154310|1771184|FG000|Overall Study|Adverse Event|19
818752|NCT00154310|1771185|FG001|Overall Study|Adverse Event|9
818753|NCT00154310|1771184|FG000|Overall Study|Lack of Efficacy|5
818754|NCT00154310|1771185|FG001|Overall Study|Lack of Efficacy|4
818755|NCT00154310|1771184|FG000|Overall Study|Protocol Violation|4
818756|NCT00154310|1771185|FG001|Overall Study|Protocol Violation|2
818757|NCT00154310|1771184|FG000|Overall Study|Withdrawal by Subject|9
818758|NCT00154310|1771185|FG001|Overall Study|Withdrawal by Subject|3
818759|NCT00154310|1771184|FG000|Overall Study|Lost to Follow-up|0
818760|NCT00154310|1771185|FG001|Overall Study|Lost to Follow-up|8
818761|NCT00154310|1771184|FG000|Overall Study|Administrative problems|0
818762|NCT00154310|1771185|FG001|Overall Study|Administrative problems|1
818763|NCT00154310|1771184|FG000|Overall Study|Death|0
818764|NCT00154310|1771185|FG001|Overall Study|Death|1
818765|NCT00154375|1771193|FG000|Overall Study|Unsatisfactory therapeutic effect|25
818766|NCT00154375|1771194|FG001|Overall Study|Unsatisfactory therapeutic effect|26
818767|NCT00154375|1771193|FG000|Overall Study|Adverse Event|18
818768|NCT00154375|1771194|FG001|Overall Study|Adverse Event|20
818769|NCT00154375|1771193|FG000|Overall Study|Withdrawal by Subject|14
818770|NCT00154375|1771194|FG001|Overall Study|Withdrawal by Subject|10
818771|NCT00154375|1771193|FG000|Overall Study|Death|5
818772|NCT00154375|1771194|FG001|Overall Study|Death|13
818773|NCT00154375|1771193|FG000|Overall Study|Study drug no longer required|5
818774|NCT00154375|1771194|FG001|Overall Study|Study drug no longer required|3
818775|NCT00154375|1771193|FG000|Overall Study|Lost to Follow-up|2
818776|NCT00154375|1771194|FG001|Overall Study|Lost to Follow-up|1
818777|NCT00154375|1771193|FG000|Overall Study|Abnormal laboratory value(s)|0
818778|NCT00154375|1771194|FG001|Overall Study|Abnormal laboratory value(s)|2
818779|NCT00154375|1771193|FG000|Overall Study|Protocol Violation|0
818780|NCT00154375|1771194|FG001|Overall Study|Protocol Violation|1
818781|NCT00154375|1771193|FG000|Overall Study|Suspected progression of disease|44
818782|NCT00154375|1771194|FG001|Overall Study|Suspected progression of disease|30
818783|NCT00156065|1771225|FG000|Overall Study|Enrolled But Never Received Treatment|1
818784|NCT00156065|1771226|FG001|Overall Study|Enrolled But Never Received Treatment|1
818785|NCT00156065|1771227|FG002|Overall Study|Enrolled But Never Received Treatment|0
818786|NCT00156065|1771225|FG000|Overall Study|Adverse Event|8
818787|NCT00156065|1771226|FG001|Overall Study|Adverse Event|11
818788|NCT00156065|1771227|FG002|Overall Study|Adverse Event|4
818789|NCT00156065|1771225|FG000|Overall Study|Lack of Efficacy|2
818790|NCT00156065|1771226|FG001|Overall Study|Lack of Efficacy|9
818791|NCT00156065|1771227|FG002|Overall Study|Lack of Efficacy|3
818792|NCT00156065|1771225|FG000|Overall Study|Withdrawal by Subject|13
818793|NCT00156065|1771226|FG001|Overall Study|Withdrawal by Subject|26
818794|NCT00156065|1771227|FG002|Overall Study|Withdrawal by Subject|16
818795|NCT00156065|1771225|FG000|Overall Study|Lost to Follow-up|5
818796|NCT00156065|1771226|FG001|Overall Study|Lost to Follow-up|7
818797|NCT00156065|1771227|FG002|Overall Study|Lost to Follow-up|1
818798|NCT00156065|1771225|FG000|Overall Study|Other|2
818799|NCT00156065|1771226|FG001|Overall Study|Other|9
818800|NCT00156065|1771227|FG002|Overall Study|Other|3
818801|NCT00156533|1771253|FG000|Overall Study|Withdrawn - Medication Expiration|0
818802|NCT00156533|1771254|FG001|Overall Study|Withdrawn - Medication Expiration|2
818803|NCT00156533|1771255|FG002|Overall Study|Withdrawn - Medication Expiration|1
818804|NCT00156533|1771256|FG003|Overall Study|Withdrawn - Medication Expiration|0
818805|NCT00156533|1771253|FG000|Overall Study|Withdrawal by Subject|1
818806|NCT00156533|1771254|FG001|Overall Study|Withdrawal by Subject|0
818807|NCT00156533|1771255|FG002|Overall Study|Withdrawal by Subject|0
818808|NCT00156533|1771256|FG003|Overall Study|Withdrawal by Subject|1
818809|NCT00156533|1771253|FG000|Overall Study|Failed Screening|1
818810|NCT00156533|1771254|FG001|Overall Study|Failed Screening|0
818811|NCT00156533|1771255|FG002|Overall Study|Failed Screening|1
818812|NCT00156533|1771256|FG003|Overall Study|Failed Screening|1
818813|NCT00156819|1771275|FG000|Overall Study|Lost to Follow-up|1
818814|NCT00156819|1771276|FG001|Overall Study|Lost to Follow-up|1
818815|NCT00156819|1771277|FG002|Overall Study|Lost to Follow-up|3
818816|NCT00157014|1771316|FG000|Overall Study|Death|4
818817|NCT00157014|1771317|FG001|Overall Study|Death|2
818818|NCT00157014|1771318|FG002|Overall Study|Death|1
818819|NCT00157014|1771319|FG003|Overall Study|Death|1
818820|NCT00157014|1771316|FG000|Overall Study|Physician Decision|0
818821|NCT00157014|1771317|FG001|Overall Study|Physician Decision|1
818822|NCT00157014|1771318|FG002|Overall Study|Physician Decision|0
818823|NCT00157014|1771319|FG003|Overall Study|Physician Decision|0
818824|NCT00157014|1771316|FG000|Overall Study|Medications withdrawn on family request|0
818825|NCT00157014|1771317|FG001|Overall Study|Medications withdrawn on family request|1
818826|NCT00157014|1771318|FG002|Overall Study|Medications withdrawn on family request|0
818827|NCT00157014|1771319|FG003|Overall Study|Medications withdrawn on family request|0
818828|NCT00157014|1771316|FG000|Overall Study|Patient withdrawn by investigator|1
818829|NCT00157014|1771317|FG001|Overall Study|Patient withdrawn by investigator|0
818830|NCT00157014|1771318|FG002|Overall Study|Patient withdrawn by investigator|0
818831|NCT00157014|1771319|FG003|Overall Study|Patient withdrawn by investigator|0
818832|NCT00157014|1771316|FG000|Overall Study|Patient unable to return in nursing home|1
818833|NCT00157014|1771317|FG001|Overall Study|Patient unable to return in nursing home|0
818834|NCT00157014|1771318|FG002|Overall Study|Patient unable to return in nursing home|0
818835|NCT00157014|1771319|FG003|Overall Study|Patient unable to return in nursing home|0
818836|NCT00157014|1771316|FG000|Overall Study|Patient would not receive transplant|0
818837|NCT00157014|1771317|FG001|Overall Study|Patient would not receive transplant|1
818838|NCT00157014|1771318|FG002|Overall Study|Patient would not receive transplant|0
818839|NCT00157014|1771319|FG003|Overall Study|Patient would not receive transplant|0
818840|NCT00157014|1771316|FG000|Overall Study|Withdrawal by Subject|1
818841|NCT00157014|1771317|FG001|Overall Study|Withdrawal by Subject|0
818842|NCT00157014|1771318|FG002|Overall Study|Withdrawal by Subject|0
818843|NCT00157014|1771319|FG003|Overall Study|Withdrawal by Subject|0
818844|NCT00157157|1771329|FG000|Overall Study|Withdrawal by Subject|6
818845|NCT00157157|1771329|FG000|Overall Study|Physician Decision|1
818846|NCT00157157|1771329|FG000|Overall Study|Lost to Follow-up|1
818847|NCT00157157|1771329|FG000|Overall Study|Enrolled in another study|1
818848|NCT00157157|1771329|FG000|Overall Study|Met exclusion criteria|1
818849|NCT00157157|1771329|FG000|Overall Study|Inclusion not met- baseline FVIII value|1
818850|NCT00157196|1771340|FG000|Overall Study|Ongoing at data cut-off|9
818851|NCT00157209|1771346|FG000|Overall Study|Ongoing at data cut-off|10
818852|NCT00157209|1771347|FG001|Overall Study|Ongoing at data cut-off|0
818853|NCT00157248|1771357|FG000|Overall Study|Adverse Event|36
818854|NCT00157248|1771358|FG001|Overall Study|Adverse Event|25
818855|NCT00157248|1771359|FG002|Overall Study|Adverse Event|13
818856|NCT00157248|1771360|FG003|Overall Study|Adverse Event|33
818857|NCT00157248|1771357|FG000|Overall Study|Protocol Violation|4
818858|NCT00157248|1771358|FG001|Overall Study|Protocol Violation|0
818859|NCT00157248|1771359|FG002|Overall Study|Protocol Violation|2
818860|NCT00157248|1771360|FG003|Overall Study|Protocol Violation|2
818861|NCT00157248|1771357|FG000|Overall Study|Lost to Follow-up|0
818862|NCT00157248|1771358|FG001|Overall Study|Lost to Follow-up|1
818863|NCT00157248|1771359|FG002|Overall Study|Lost to Follow-up|0
818864|NCT00157248|1771360|FG003|Overall Study|Lost to Follow-up|0
818865|NCT00157248|1771357|FG000|Overall Study|Withdrawal by Subject|1
818866|NCT00157248|1771358|FG001|Overall Study|Withdrawal by Subject|4
818867|NCT00157248|1771359|FG002|Overall Study|Withdrawal by Subject|3
818868|NCT00157248|1771360|FG003|Overall Study|Withdrawal by Subject|3
818869|NCT00157248|1771357|FG000|Overall Study|site closures, subject moving|7
818870|NCT00157248|1771358|FG001|Overall Study|site closures, subject moving|7
818871|NCT00157248|1771359|FG002|Overall Study|site closures, subject moving|3
818872|NCT00157248|1771360|FG003|Overall Study|site closures, subject moving|9
818873|NCT00157755|1771382|FG000|Overall Study|Death|2
818874|NCT00157755|1771383|FG001|Overall Study|Death|3
818875|NCT00157755|1771384|FG002|Overall Study|Death|3
818876|NCT00157755|1771385|FG003|Overall Study|Death|2
818877|NCT00157755|1771386|FG004|Overall Study|Death|0
818878|NCT00157755|1771387|FG005|Overall Study|Death|0
818879|NCT00157755|1771382|FG000|Overall Study|Lost to Follow-up|0
818880|NCT00157755|1771383|FG001|Overall Study|Lost to Follow-up|0
818881|NCT00157755|1771384|FG002|Overall Study|Lost to Follow-up|1
818882|NCT00157755|1771385|FG003|Overall Study|Lost to Follow-up|0
818883|NCT00157755|1771386|FG004|Overall Study|Lost to Follow-up|0
818884|NCT00157755|1771387|FG005|Overall Study|Lost to Follow-up|0
818885|NCT00157755|1771382|FG000|Overall Study|Withdrawal by Subject|0
818886|NCT00157755|1771383|FG001|Overall Study|Withdrawal by Subject|0
818887|NCT00157755|1771384|FG002|Overall Study|Withdrawal by Subject|1
818888|NCT00157755|1771385|FG003|Overall Study|Withdrawal by Subject|1
818889|NCT00157755|1771386|FG004|Overall Study|Withdrawal by Subject|1
818890|NCT00157755|1771387|FG005|Overall Study|Withdrawal by Subject|2
818891|NCT00157755|1771382|FG000|Overall Study|Explant due to infection|0
818892|NCT00157755|1771383|FG001|Overall Study|Explant due to infection|0
818893|NCT00157755|1771384|FG002|Overall Study|Explant due to infection|1
818894|NCT00157755|1771385|FG003|Overall Study|Explant due to infection|0
818895|NCT00157755|1771386|FG004|Overall Study|Explant due to infection|0
818896|NCT00157755|1771387|FG005|Overall Study|Explant due to infection|0
818897|NCT00157755|1771382|FG000|Overall Study|Medical reason|0
818898|NCT00157755|1771383|FG001|Overall Study|Medical reason|0
818899|NCT00157755|1771384|FG002|Overall Study|Medical reason|1
818900|NCT00157755|1771385|FG003|Overall Study|Medical reason|1
818901|NCT00157755|1771386|FG004|Overall Study|Medical reason|0
818902|NCT00157755|1771387|FG005|Overall Study|Medical reason|0
818903|NCT00157755|1771382|FG000|Overall Study|Study site closure|0
818904|NCT00157755|1771383|FG001|Overall Study|Study site closure|1
818905|NCT00157755|1771384|FG002|Overall Study|Study site closure|0
818906|NCT00157755|1771385|FG003|Overall Study|Study site closure|0
818907|NCT00157755|1771386|FG004|Overall Study|Study site closure|0
818908|NCT00157755|1771387|FG005|Overall Study|Study site closure|0
818909|NCT00157755|1771382|FG000|Overall Study|Subject non-compliance|0
818910|NCT00157755|1771383|FG001|Overall Study|Subject non-compliance|0
818911|NCT00157755|1771384|FG002|Overall Study|Subject non-compliance|0
818912|NCT00157755|1771385|FG003|Overall Study|Subject non-compliance|0
818913|NCT00157755|1771386|FG004|Overall Study|Subject non-compliance|0
818914|NCT00157755|1771387|FG005|Overall Study|Subject non-compliance|1
818915|NCT00157755|1771382|FG000|Overall Study|Study completion|0
818916|NCT00157755|1771383|FG001|Overall Study|Study completion|0
818917|NCT00157755|1771384|FG002|Overall Study|Study completion|0
818918|NCT00157755|1771385|FG003|Overall Study|Study completion|0
818919|NCT00157755|1771386|FG004|Overall Study|Study completion|1
818920|NCT00157755|1771387|FG005|Overall Study|Study completion|2
818921|NCT00157820|1771396|FG000|Randomized|Physician Decision|4
818922|NCT00157820|1771397|FG001|Randomized|Physician Decision|2
818923|NCT00157820|1771398|FG002|Randomized|Physician Decision|3
818924|NCT00157820|1771396|FG000|Randomized|Withdrawal by Subject|1
818925|NCT00157820|1771397|FG001|Randomized|Withdrawal by Subject|2
818926|NCT00157820|1771398|FG002|Randomized|Withdrawal by Subject|3
818927|NCT00157820|1771396|FG000|Randomized|Protocol Violation|2
818928|NCT00157820|1771397|FG001|Randomized|Protocol Violation|1
818929|NCT00157820|1771398|FG002|Randomized|Protocol Violation|2
818930|NCT00157820|1771396|FG000|1st 8 Month|Death|7
818931|NCT00157820|1771397|FG001|1st 8 Month|Death|8
818932|NCT00157820|1771398|FG002|1st 8 Month|Death|3
818933|NCT00157820|1771396|FG000|1st 8 Month|Lost to Follow-up|1
818934|NCT00157820|1771397|FG001|1st 8 Month|Lost to Follow-up|2
818935|NCT00157820|1771398|FG002|1st 8 Month|Lost to Follow-up|1
818936|NCT00157820|1771396|FG000|1st 8 Month|Premature cross-over|0
818937|NCT00157820|1771397|FG001|1st 8 Month|Premature cross-over|2
818938|NCT00157820|1771398|FG002|1st 8 Month|Premature cross-over|2
818939|NCT00157820|1771396|FG000|2nd 8 Months|Death|3
818940|NCT00157820|1771397|FG001|2nd 8 Months|Death|1
818941|NCT00157820|1771398|FG002|2nd 8 Months|Death|3
818942|NCT00157820|1771396|FG000|2nd 8 Months|Lost to Follow-up|1
818943|NCT00157820|1771397|FG001|2nd 8 Months|Lost to Follow-up|5
818944|NCT00157820|1771398|FG002|2nd 8 Months|Lost to Follow-up|2
818945|NCT00157820|1771396|FG000|2nd 8 Months|Premature cross-over|1
818946|NCT00157820|1771397|FG001|2nd 8 Months|Premature cross-over|7
818947|NCT00157820|1771398|FG002|2nd 8 Months|Premature cross-over|9
818948|NCT00157950|1771409|FG000|Overall Study|Death|1
818949|NCT00157950|1771410|FG001|Overall Study|Death|0
818950|NCT00158054|1771418|FG000|Overall Study|Refused to continue|3
818951|NCT00158054|1771419|FG001|Overall Study|Refused to continue|0
818952|NCT00158054|1771418|FG000|Overall Study|Unavailable for follow up|7
818953|NCT00158054|1771419|FG001|Overall Study|Unavailable for follow up|3
818954|NCT00158184|1771427|FG000|Overall Study|personal issues|3
818955|NCT00158184|1771428|FG001|Overall Study|personal issues|1
818956|NCT00158184|1771427|FG000|Overall Study|failed for follow unit/study rules|2
818957|NCT00158184|1771428|FG001|Overall Study|failed for follow unit/study rules|0
818958|NCT00158184|1771427|FG000|Overall Study|Adverse Event|1
818959|NCT00158184|1771428|FG001|Overall Study|Adverse Event|1
818960|NCT00158262|1771473|FG000|Overall Study|Lost to Follow-up|1
818961|NCT00158262|1771474|FG001|Overall Study|Lost to Follow-up|1
818962|NCT00158600|1771486|FG000|Overall Study|unable to commit time to study|0
818963|NCT00158600|1771487|FG001|Overall Study|unable to commit time to study|1
818964|NCT00158600|1771486|FG000|Overall Study|Adverse Event|2
818965|NCT00158600|1771487|FG001|Overall Study|Adverse Event|1
818966|NCT00158600|1771486|FG000|Overall Study|Death|1
818967|NCT00158600|1771487|FG001|Overall Study|Death|0
818968|NCT00158600|1771486|FG000|Overall Study|Withdrawal by Subject|2
818969|NCT00158600|1771487|FG001|Overall Study|Withdrawal by Subject|2
818970|NCT00158756|1771508|FG000|Overall Study|Withdrawal by Subject|5
818971|NCT00158756|1771509|FG001|Overall Study|Withdrawal by Subject|0
818972|NCT00158756|1771510|FG002|Overall Study|Withdrawal by Subject|6
818973|NCT00158756|1771511|FG003|Overall Study|Withdrawal by Subject|1
818974|NCT00158756|1771512|FG004|Overall Study|Withdrawal by Subject|3
818975|NCT00158756|1771508|FG000|Overall Study|Adverse Event|0
818976|NCT00158756|1771509|FG001|Overall Study|Adverse Event|0
818977|NCT00158756|1771510|FG002|Overall Study|Adverse Event|1
818978|NCT00158756|1771511|FG003|Overall Study|Adverse Event|0
818979|NCT00158756|1771512|FG004|Overall Study|Adverse Event|0
818980|NCT00158756|1771508|FG000|Overall Study|Serious adverse event|0
818981|NCT00158756|1771509|FG001|Overall Study|Serious adverse event|0
818982|NCT00158756|1771510|FG002|Overall Study|Serious adverse event|1
818983|NCT00158756|1771511|FG003|Overall Study|Serious adverse event|0
818984|NCT00158756|1771512|FG004|Overall Study|Serious adverse event|0
818985|NCT00158860|1771526|FG000|Overall Study|Adverse Event|3
818986|NCT00158860|1771527|FG001|Overall Study|Adverse Event|6
818987|NCT00158860|1771526|FG000|Overall Study|Lost to Follow-up|11
818988|NCT00158860|1771527|FG001|Overall Study|Lost to Follow-up|17
818989|NCT00158860|1771526|FG000|Overall Study|Protocol Violation|8
818990|NCT00158860|1771527|FG001|Overall Study|Protocol Violation|23
818991|NCT00158860|1771526|FG000|Overall Study|Withdrawal by Subject|7
818992|NCT00158860|1771527|FG001|Overall Study|Withdrawal by Subject|17
818993|NCT00158860|1771526|FG000|Overall Study|MOVING OUT OF STATE|1
818994|NCT00158860|1771527|FG001|Overall Study|MOVING OUT OF STATE|0
818995|NCT00158860|1771526|FG000|Overall Study|Pregnancy|3
818996|NCT00158860|1771527|FG001|Overall Study|Pregnancy|3
818997|NCT00158860|1771526|FG000|Overall Study|SPONSOR STOPPED STUDY|2
818998|NCT00158860|1771527|FG001|Overall Study|SPONSOR STOPPED STUDY|2
818999|NCT00158860|1771526|FG000|Overall Study|SPONSOR REQUEST|0
819000|NCT00158860|1771527|FG001|Overall Study|SPONSOR REQUEST|1
819001|NCT00158860|1771526|FG000|Overall Study|Lost to Follow up but returned per GSK|0
819002|NCT00158860|1771527|FG001|Overall Study|Lost to Follow up but returned per GSK|1
819003|NCT00158860|1771526|FG000|Overall Study|Closed per sponsor|0
819004|NCT00158860|1771527|FG001|Overall Study|Closed per sponsor|1
819005|NCT00159432|1771575|FG000|Overall Study|Adverse Event|1
819006|NCT00159432|1771575|FG000|Overall Study|Death|1
819007|NCT00159432|1771575|FG000|Overall Study|Lack of Efficacy|8
819008|NCT00159783|1771582|FG000|Overall Study|Adverse Event|5
819009|NCT00159783|1771583|FG001|Overall Study|Adverse Event|7
819010|NCT00159783|1771584|FG002|Overall Study|Adverse Event|9
819011|NCT00159783|1771582|FG000|Overall Study|Lack of Efficacy|1
819012|NCT00159783|1771583|FG001|Overall Study|Lack of Efficacy|2
819013|NCT00159783|1771584|FG002|Overall Study|Lack of Efficacy|3
819014|NCT00159783|1771582|FG000|Overall Study|Withdrawal by Subject|7
819015|NCT00159783|1771583|FG001|Overall Study|Withdrawal by Subject|11
819016|NCT00159783|1771584|FG002|Overall Study|Withdrawal by Subject|12
819017|NCT00159783|1771582|FG000|Overall Study|Lost to Follow-up|6
819018|NCT00159783|1771583|FG001|Overall Study|Lost to Follow-up|5
819019|NCT00159783|1771584|FG002|Overall Study|Lost to Follow-up|11
819020|NCT00159783|1771582|FG000|Overall Study|Other|0
819021|NCT00159783|1771583|FG001|Overall Study|Other|2
819022|NCT00159783|1771584|FG002|Overall Study|Other|4
819023|NCT00159822|1771593|FG000|Voriconazole Treatment Period|Lack of Efficacy|3
819024|NCT00159822|1771593|FG000|Voriconazole Treatment Period|Adverse Event|9
819025|NCT00159822|1771593|FG000|Voriconazole Treatment Period|Death|4
819026|NCT00159822|1771593|FG000|Voriconazole Treatment Period|Protocol Violation|2
819027|NCT00159822|1771593|FG000|Voriconazole Treatment Period|Lost to Follow-up|2
819028|NCT00159822|1771593|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2
819029|NCT00159822|1771593|FG000|Post-treatment Follow-up Period|Death|1
819030|NCT00159822|1771593|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1
819031|NCT00159822|1771593|FG000|Post-treatment Follow-up Period|Reason unspecified|1
819032|NCT00159861|1771599|FG000|Core Study - 16 Weeks|Death|3
819033|NCT00159861|1771600|FG001|Core Study - 16 Weeks|Death|0
819034|NCT00159861|1771599|FG000|Core Study - 16 Weeks|Adverse Event|12
819035|NCT00159861|1771600|FG001|Core Study - 16 Weeks|Adverse Event|6
819036|NCT00159861|1771599|FG000|Core Study - 16 Weeks|Lack of Efficacy|2
819037|NCT00159861|1771600|FG001|Core Study - 16 Weeks|Lack of Efficacy|3
819038|NCT00159861|1771599|FG000|Core Study - 16 Weeks|Reason Unspecified|5
819039|NCT00159861|1771600|FG001|Core Study - 16 Weeks|Reason Unspecified|3
819040|NCT00159861|1771599|FG000|Core Study - 16 Weeks|Subject Defaulted|1
819041|NCT00159861|1771600|FG001|Core Study - 16 Weeks|Subject Defaulted|0
819042|NCT00159861|1771599|FG000|Core Study - 16 Weeks|Randomized but not Treated|2
819043|NCT00159861|1771600|FG001|Core Study - 16 Weeks|Randomized but not Treated|0
819044|NCT00159861|1771599|FG000|Extension Study - up to 3 Years|Death|24
819045|NCT00159861|1771600|FG001|Extension Study - up to 3 Years|Death|28
819046|NCT00159861|1771599|FG000|Extension Study - up to 3 Years|Adverse Event|14
819047|NCT00159861|1771600|FG001|Extension Study - up to 3 Years|Adverse Event|14
819048|NCT00159861|1771599|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5
819049|NCT00159861|1771600|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1
819050|NCT00159861|1771599|FG000|Extension Study - up to 3 Years|Reason Unspecified|12
819051|NCT00159861|1771600|FG001|Extension Study - up to 3 Years|Reason Unspecified|19
819052|NCT00159861|1771599|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7
819053|NCT00159861|1771600|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9
819054|NCT00159874|1771618|FG000|Overall Study|Adverse Event|2
819055|NCT00159874|1771619|FG001|Overall Study|Adverse Event|2
819056|NCT00159874|1771620|FG002|Overall Study|Adverse Event|5
819057|NCT00159874|1771621|FG003|Overall Study|Adverse Event|1
819058|NCT00159874|1771622|FG004|Overall Study|Adverse Event|1
819059|NCT00159874|1771623|FG005|Overall Study|Adverse Event|2
819060|NCT00159874|1771624|FG006|Overall Study|Adverse Event|0
819061|NCT00159874|1771618|FG000|Overall Study|Does Not Meet Entrance Criteria|1
819062|NCT00159874|1771619|FG001|Overall Study|Does Not Meet Entrance Criteria|0
819063|NCT00159874|1771620|FG002|Overall Study|Does Not Meet Entrance Criteria|1
819064|NCT00159874|1771621|FG003|Overall Study|Does Not Meet Entrance Criteria|0
819065|NCT00159874|1771622|FG004|Overall Study|Does Not Meet Entrance Criteria|0
819066|NCT00159874|1771623|FG005|Overall Study|Does Not Meet Entrance Criteria|0
819067|NCT00159874|1771624|FG006|Overall Study|Does Not Meet Entrance Criteria|0
819068|NCT00159874|1771618|FG000|Overall Study|Lack of Efficacy|2
819069|NCT00159874|1771619|FG001|Overall Study|Lack of Efficacy|0
819070|NCT00159874|1771620|FG002|Overall Study|Lack of Efficacy|1
819071|NCT00159874|1771621|FG003|Overall Study|Lack of Efficacy|1
819072|NCT00159874|1771622|FG004|Overall Study|Lack of Efficacy|0
819073|NCT00159874|1771623|FG005|Overall Study|Lack of Efficacy|3
819074|NCT00159874|1771624|FG006|Overall Study|Lack of Efficacy|0
819075|NCT00159874|1771618|FG000|Overall Study|Lost to Follow-up|1
819076|NCT00159874|1771619|FG001|Overall Study|Lost to Follow-up|0
819077|NCT00159874|1771620|FG002|Overall Study|Lost to Follow-up|3
819078|NCT00159874|1771621|FG003|Overall Study|Lost to Follow-up|0
819079|NCT00159874|1771622|FG004|Overall Study|Lost to Follow-up|1
819080|NCT00159874|1771623|FG005|Overall Study|Lost to Follow-up|2
819081|NCT00159874|1771624|FG006|Overall Study|Lost to Follow-up|1
819082|NCT00159874|1771618|FG000|Overall Study|Other|8
819083|NCT00159874|1771619|FG001|Overall Study|Other|8
819084|NCT00159874|1771620|FG002|Overall Study|Other|8
819085|NCT00159874|1771621|FG003|Overall Study|Other|0
819086|NCT00159874|1771622|FG004|Overall Study|Other|2
819087|NCT00159874|1771623|FG005|Overall Study|Other|1
819088|NCT00159874|1771624|FG006|Overall Study|Other|3
819089|NCT00159874|1771618|FG000|Overall Study|Protocol Violation|0
819090|NCT00159874|1771619|FG001|Overall Study|Protocol Violation|5
819091|NCT00159874|1771620|FG002|Overall Study|Protocol Violation|2
819092|NCT00159874|1771621|FG003|Overall Study|Protocol Violation|0
819093|NCT00159874|1771622|FG004|Overall Study|Protocol Violation|0
819094|NCT00159874|1771623|FG005|Overall Study|Protocol Violation|0
819095|NCT00159874|1771624|FG006|Overall Study|Protocol Violation|0
819096|NCT00159874|1771618|FG000|Overall Study|Death|3
819097|NCT00159874|1771619|FG001|Overall Study|Death|8
819098|NCT00159874|1771620|FG002|Overall Study|Death|15
819099|NCT00159874|1771621|FG003|Overall Study|Death|0
819100|NCT00159874|1771622|FG004|Overall Study|Death|1
819101|NCT00159874|1771623|FG005|Overall Study|Death|2
819102|NCT00159874|1771624|FG006|Overall Study|Death|0
819103|NCT00159874|1771618|FG000|Overall Study|Withdrawal by Subject|2
819104|NCT00159874|1771619|FG001|Overall Study|Withdrawal by Subject|6
819105|NCT00159874|1771620|FG002|Overall Study|Withdrawal by Subject|8
819106|NCT00159874|1771621|FG003|Overall Study|Withdrawal by Subject|4
819107|NCT00159874|1771622|FG004|Overall Study|Withdrawal by Subject|3
819108|NCT00159874|1771623|FG005|Overall Study|Withdrawal by Subject|2
819109|NCT00159874|1771624|FG006|Overall Study|Withdrawal by Subject|1
819110|NCT00159874|1771618|FG000|Overall Study|Pregnancy|1
819111|NCT00159874|1771619|FG001|Overall Study|Pregnancy|1
819112|NCT00159874|1771620|FG002|Overall Study|Pregnancy|0
819113|NCT00159874|1771621|FG003|Overall Study|Pregnancy|0
819114|NCT00159874|1771622|FG004|Overall Study|Pregnancy|0
819115|NCT00159874|1771623|FG005|Overall Study|Pregnancy|0
819116|NCT00159874|1771624|FG006|Overall Study|Pregnancy|0
819117|NCT00159913|1771644|FG000|Overall Study|Adverse Event|1
819118|NCT00159913|1771645|FG001|Overall Study|Adverse Event|0
819119|NCT00159913|1771646|FG002|Overall Study|Adverse Event|1
819120|NCT00159913|1771647|FG003|Overall Study|Adverse Event|0
819121|NCT00159913|1771644|FG000|Overall Study|Withdrawal by Subject|0
819122|NCT00159913|1771645|FG001|Overall Study|Withdrawal by Subject|0
819123|NCT00159913|1771646|FG002|Overall Study|Withdrawal by Subject|0
819124|NCT00159913|1771647|FG003|Overall Study|Withdrawal by Subject|1
819125|NCT00159913|1771644|FG000|Overall Study|Lost to Follow-up|0
819126|NCT00159913|1771645|FG001|Overall Study|Lost to Follow-up|0
819127|NCT00159913|1771646|FG002|Overall Study|Lost to Follow-up|0
819128|NCT00159913|1771647|FG003|Overall Study|Lost to Follow-up|1
819129|NCT00159913|1771644|FG000|Overall Study|Protocol Violation|1
819130|NCT00159913|1771645|FG001|Overall Study|Protocol Violation|0
819131|NCT00159913|1771646|FG002|Overall Study|Protocol Violation|1
819132|NCT00159913|1771647|FG003|Overall Study|Protocol Violation|0
819133|NCT00160199|1771670|FG000|Overall Study|Adverse Event|5
819134|NCT00160199|1771671|FG001|Overall Study|Adverse Event|14
819135|NCT00160199|1771670|FG000|Overall Study|Lack of Efficacy|0
819136|NCT00160199|1771671|FG001|Overall Study|Lack of Efficacy|1
819137|NCT00160199|1771670|FG000|Overall Study|Lost to Follow-up|7
819138|NCT00160199|1771671|FG001|Overall Study|Lost to Follow-up|7
819139|NCT00160199|1771670|FG000|Overall Study|Withdrawal by Subject|4
819140|NCT00160199|1771671|FG001|Overall Study|Withdrawal by Subject|6
819141|NCT00160199|1771670|FG000|Overall Study|Administrative|0
819142|NCT00160199|1771671|FG001|Overall Study|Administrative|1
819143|NCT00160199|1771670|FG000|Overall Study|Protocol Violation|8
819144|NCT00160199|1771671|FG001|Overall Study|Protocol Violation|8
819145|NCT00160251|1771683|FG000|Prior to Amendment 2|Adverse Event|2
819146|NCT00160251|1771684|FG001|Prior to Amendment 2|Adverse Event|1
819147|NCT00160251|1771685|FG002|Prior to Amendment 2|Adverse Event|3
819148|NCT00160251|1771686|FG003|Prior to Amendment 2|Adverse Event|1
819149|NCT00160251|1771687|FG004|Prior to Amendment 2|Adverse Event|1
819150|NCT00160251|1771688|FG005|Prior to Amendment 2|Adverse Event|1
819151|NCT00160251|1771689|FG006|Prior to Amendment 2|Adverse Event|1
819152|NCT00160251|1771690|FG007|Prior to Amendment 2|Adverse Event|0
819153|NCT00160251|1771683|FG000|Prior to Amendment 2|Lack of Efficacy|0
819154|NCT00160251|1771684|FG001|Prior to Amendment 2|Lack of Efficacy|4
819155|NCT00160251|1771685|FG002|Prior to Amendment 2|Lack of Efficacy|37
819156|NCT00160251|1771686|FG003|Prior to Amendment 2|Lack of Efficacy|35
819157|NCT00160251|1771687|FG004|Prior to Amendment 2|Lack of Efficacy|24
819158|NCT00160251|1771688|FG005|Prior to Amendment 2|Lack of Efficacy|55
819159|NCT00160251|1771689|FG006|Prior to Amendment 2|Lack of Efficacy|0
819160|NCT00160251|1771690|FG007|Prior to Amendment 2|Lack of Efficacy|0
819161|NCT00160251|1771683|FG000|Prior to Amendment 2|Lost to Follow-up|0
819162|NCT00160251|1771684|FG001|Prior to Amendment 2|Lost to Follow-up|0
819163|NCT00160251|1771685|FG002|Prior to Amendment 2|Lost to Follow-up|1
819164|NCT00160251|1771686|FG003|Prior to Amendment 2|Lost to Follow-up|0
819165|NCT00160251|1771687|FG004|Prior to Amendment 2|Lost to Follow-up|1
819166|NCT00160251|1771688|FG005|Prior to Amendment 2|Lost to Follow-up|1
819167|NCT00160251|1771689|FG006|Prior to Amendment 2|Lost to Follow-up|0
819168|NCT00160251|1771690|FG007|Prior to Amendment 2|Lost to Follow-up|0
819169|NCT00160251|1771683|FG000|Prior to Amendment 2|Withdrawal by Subject|3
819170|NCT00160251|1771684|FG001|Prior to Amendment 2|Withdrawal by Subject|1
819171|NCT00160251|1771685|FG002|Prior to Amendment 2|Withdrawal by Subject|3
819172|NCT00160251|1771686|FG003|Prior to Amendment 2|Withdrawal by Subject|4
819173|NCT00160251|1771687|FG004|Prior to Amendment 2|Withdrawal by Subject|2
819174|NCT00160251|1771688|FG005|Prior to Amendment 2|Withdrawal by Subject|3
819175|NCT00160251|1771689|FG006|Prior to Amendment 2|Withdrawal by Subject|3
819176|NCT00160251|1771690|FG007|Prior to Amendment 2|Withdrawal by Subject|0
819177|NCT00160251|1771683|FG000|Prior to Amendment 2|Noncompliance with protocol|1
819178|NCT00160251|1771684|FG001|Prior to Amendment 2|Noncompliance with protocol|0
819179|NCT00160251|1771685|FG002|Prior to Amendment 2|Noncompliance with protocol|0
819180|NCT00160251|1771686|FG003|Prior to Amendment 2|Noncompliance with protocol|0
819181|NCT00160251|1771687|FG004|Prior to Amendment 2|Noncompliance with protocol|0
819182|NCT00160251|1771688|FG005|Prior to Amendment 2|Noncompliance with protocol|0
819183|NCT00160251|1771689|FG006|Prior to Amendment 2|Noncompliance with protocol|0
819184|NCT00160251|1771690|FG007|Prior to Amendment 2|Noncompliance with protocol|0
819185|NCT00160251|1771683|FG000|Prior to Amendment 2|Completed Treatment Phase|3
819186|NCT00160251|1771684|FG001|Prior to Amendment 2|Completed Treatment Phase|0
819187|NCT00160251|1771685|FG002|Prior to Amendment 2|Completed Treatment Phase|0
819188|NCT00160251|1771686|FG003|Prior to Amendment 2|Completed Treatment Phase|0
819189|NCT00160251|1771687|FG004|Prior to Amendment 2|Completed Treatment Phase|0
819190|NCT00160251|1771688|FG005|Prior to Amendment 2|Completed Treatment Phase|23
819191|NCT00160251|1771689|FG006|Prior to Amendment 2|Completed Treatment Phase|0
819192|NCT00160251|1771690|FG007|Prior to Amendment 2|Completed Treatment Phase|0
819193|NCT00160251|1771683|FG000|Post-amendment 2|Adverse Event|0
819194|NCT00160251|1771684|FG001|Post-amendment 2|Adverse Event|0
819195|NCT00160251|1771685|FG002|Post-amendment 2|Adverse Event|0
819196|NCT00160251|1771686|FG003|Post-amendment 2|Adverse Event|0
819197|NCT00160251|1771687|FG004|Post-amendment 2|Adverse Event|0
819198|NCT00160251|1771688|FG005|Post-amendment 2|Adverse Event|0
819199|NCT00160251|1771689|FG006|Post-amendment 2|Adverse Event|0
819200|NCT00160251|1771690|FG007|Post-amendment 2|Adverse Event|20
819201|NCT00160251|1771683|FG000|Post-amendment 2|Lack of Efficacy|0
819202|NCT00160251|1771684|FG001|Post-amendment 2|Lack of Efficacy|0
819203|NCT00160251|1771685|FG002|Post-amendment 2|Lack of Efficacy|0
819204|NCT00160251|1771686|FG003|Post-amendment 2|Lack of Efficacy|0
819205|NCT00160251|1771687|FG004|Post-amendment 2|Lack of Efficacy|0
819206|NCT00160251|1771688|FG005|Post-amendment 2|Lack of Efficacy|0
819207|NCT00160251|1771689|FG006|Post-amendment 2|Lack of Efficacy|0
819208|NCT00160251|1771690|FG007|Post-amendment 2|Lack of Efficacy|24
819209|NCT00160251|1771683|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
819210|NCT00160251|1771684|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
819211|NCT00160251|1771685|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
819212|NCT00160251|1771686|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
819213|NCT00160251|1771687|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
819214|NCT00160251|1771688|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
819215|NCT00160251|1771689|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
819216|NCT00160251|1771690|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
819217|NCT00160524|1771747|FG000|Overall Study|Adverse Event|119
819218|NCT00160524|1771747|FG000|Overall Study|Adverse Event and Other|94
819219|NCT00160524|1771747|FG000|Overall Study|Protocol Violation|16
819220|NCT00160524|1771747|FG000|Overall Study|Protocol Violation and Other|2
819221|NCT00160524|1771747|FG000|Overall Study|Withdrawal by Subject|141
819222|NCT00160524|1771747|FG000|Overall Study|Withdrawal by Subject and Other|17
819223|NCT00160524|1771747|FG000|Overall Study|Physician Decision|27
819224|NCT00160524|1771747|FG000|Overall Study|Physician Decision and Other|6
819225|NCT00160524|1771747|FG000|Overall Study|Lost to Follow-up|13
819226|NCT00160524|1771747|FG000|Overall Study|Lost to Follow-up and Other|1
819227|NCT00160524|1771747|FG000|Overall Study|Lack of Efficacy|21
819228|NCT00160524|1771747|FG000|Overall Study|Lack of Efficacy and Other|1
819229|NCT00160524|1771747|FG000|Overall Study|Other|20
819230|NCT00160615|1771753|FG000|Overall Study|Adverse Event|5
819231|NCT00160615|1771754|FG001|Overall Study|Adverse Event|12
819232|NCT00160615|1771753|FG000|Overall Study|Withdrawal by Subject|0
819233|NCT00160615|1771754|FG001|Overall Study|Withdrawal by Subject|2
819234|NCT00160615|1771753|FG000|Overall Study|Lack of Efficacy|11
819235|NCT00160615|1771754|FG001|Overall Study|Lack of Efficacy|23
819236|NCT00160615|1771753|FG000|Overall Study|Patient decision|1
819237|NCT00160615|1771754|FG001|Overall Study|Patient decision|2
819238|NCT00160615|1771753|FG000|Overall Study|Investigator decision|1
819239|NCT00160615|1771754|FG001|Overall Study|Investigator decision|1
819240|NCT00160615|1771753|FG000|Overall Study|AE agents had to be discontinued (exam.)|0
819241|NCT00160615|1771754|FG001|Overall Study|AE agents had to be discontinued (exam.)|1
819242|NCT00160615|1771753|FG000|Overall Study|Switch to surgical treatment|0
819243|NCT00160615|1771754|FG001|Overall Study|Switch to surgical treatment|2
819244|NCT00160615|1771753|FG000|Overall Study|Non-compliance was suspected|0
819245|NCT00160615|1771754|FG001|Overall Study|Non-compliance was suspected|1
819246|NCT00160615|1771753|FG000|Overall Study|Poor compliance|0
819247|NCT00160615|1771754|FG001|Overall Study|Poor compliance|1
819248|NCT00160641|1771762|FG000|Overall Study|Adverse Event|102
819249|NCT00160641|1771762|FG000|Overall Study|Withdrawal by Subject|87
819250|NCT00160641|1771762|FG000|Overall Study|Lost to Follow-up|8
819251|NCT00160641|1771762|FG000|Overall Study|Lack of Efficacy|12
819252|NCT00160641|1771762|FG000|Overall Study|Protocol Violation|3
819253|NCT00160641|1771762|FG000|Overall Study|Other|9
819254|NCT00160654|1771766|FG000|Overall Study|Adverse Event|14
819255|NCT00160654|1771766|FG000|Overall Study|Lack of Efficacy|4
819256|NCT00160654|1771766|FG000|Overall Study|Lost to Follow-up|2
819257|NCT00160654|1771766|FG000|Overall Study|Intake of expired drug|7
819258|NCT00160654|1771766|FG000|Overall Study|Psychological trauma|1
819259|NCT00160654|1771766|FG000|Overall Study|Sponsor decision|1
819260|NCT00160654|1771766|FG000|Overall Study|Patient met exclusion criteria|1
819261|NCT00160654|1771766|FG000|Overall Study|Patient decision|1
819262|NCT00160654|1771766|FG000|Overall Study|Poor compliance, dilantin toxicity|1
819263|NCT00160654|1771766|FG000|Overall Study|Met exclusion criteria|1
819264|NCT00160667|1771773|FG000|Overall Study|Adverse Event|3
819265|NCT00160667|1771774|FG001|Overall Study|Adverse Event|1
819266|NCT00160667|1771775|FG002|Overall Study|Adverse Event|4
819267|NCT00160667|1771773|FG000|Overall Study|Withdrawal by Subject|2
819268|NCT00160667|1771774|FG001|Overall Study|Withdrawal by Subject|0
819269|NCT00160667|1771775|FG002|Overall Study|Withdrawal by Subject|1
819270|NCT00160667|1771773|FG000|Overall Study|Lack of Efficacy|0
819271|NCT00160667|1771774|FG001|Overall Study|Lack of Efficacy|1
819272|NCT00160667|1771775|FG002|Overall Study|Lack of Efficacy|0
819273|NCT00160667|1771773|FG000|Overall Study|Protocol Violation|0
819274|NCT00160667|1771774|FG001|Overall Study|Protocol Violation|1
819275|NCT00160667|1771775|FG002|Overall Study|Protocol Violation|0
819276|NCT00160667|1771773|FG000|Overall Study|Patient decision|0
819277|NCT00160667|1771774|FG001|Overall Study|Patient decision|0
819278|NCT00160667|1771775|FG002|Overall Study|Patient decision|1
819279|NCT00160680|1771786|FG000|Overall Study|Adverse Event|0
819280|NCT00160680|1771787|FG001|Overall Study|Adverse Event|1
819281|NCT00160680|1771786|FG000|Overall Study|Lack of Efficacy|2
819282|NCT00160680|1771787|FG001|Overall Study|Lack of Efficacy|1
819283|NCT00160680|1771786|FG000|Overall Study|Lost to Follow-up|3
819284|NCT00160680|1771787|FG001|Overall Study|Lost to Follow-up|2
819285|NCT00160680|1771786|FG000|Overall Study|Withdrawal by Subject|4
819286|NCT00160680|1771787|FG001|Overall Study|Withdrawal by Subject|9
819287|NCT00160693|1771793|FG000|Overall Study|Adverse Event|97
819288|NCT00160693|1771793|FG000|Overall Study|Lack of Efficacy|30
819289|NCT00160693|1771793|FG000|Overall Study|Protocol Violation|24
819290|NCT00160693|1771793|FG000|Overall Study|Lost to Follow-up|15
819291|NCT00160693|1771793|FG000|Overall Study|Withdrawal by Subject|54
819292|NCT00160693|1771793|FG000|Overall Study|Study terminated by sponsor|15
819293|NCT00160706|1771797|FG000|Overall Study|Adverse Event|53
819294|NCT00160706|1771797|FG000|Overall Study|Adverse Event and Other Reason|105
819295|NCT00160706|1771797|FG000|Overall Study|Protocol Violation|3
819296|NCT00160706|1771797|FG000|Overall Study|Withdrawal by Subject|41
819297|NCT00160706|1771797|FG000|Overall Study|Withdrawal by Subject and Other|12
819298|NCT00160706|1771797|FG000|Overall Study|Physician Decision|10
819299|NCT00160706|1771797|FG000|Overall Study|Physician Decision and Other|3
819300|NCT00160706|1771797|FG000|Overall Study|Lost to Follow-up|4
819301|NCT00160706|1771797|FG000|Overall Study|Lost to Follow-up and Other|1
819302|NCT00160706|1771797|FG000|Overall Study|Lack of Efficacy|42
819303|NCT00160706|1771797|FG000|Overall Study|Lack of Efficacy and Other|1
819304|NCT00160706|1771797|FG000|Overall Study|Other Reason|11
819305|NCT00161213|1771801|FG000|Overall Study|Withdrawal by Subject|1
819306|NCT00161213|1771801|FG000|Overall Study|Evaluable for toxicity but not response|1
819307|NCT00161616|1771825|FG000|Overall Study|Withdrawal by Subject|6
819308|NCT00161616|1771826|FG001|Overall Study|Withdrawal by Subject|5
819309|NCT00161616|1771825|FG000|Overall Study|Physician Decision|1
819310|NCT00161616|1771826|FG001|Overall Study|Physician Decision|0
819311|NCT00161616|1771825|FG000|Overall Study|Death|1
819312|NCT00161616|1771826|FG001|Overall Study|Death|1
819313|NCT00161616|1771825|FG000|Overall Study|Lost to Follow-up|17
819314|NCT00161616|1771826|FG001|Overall Study|Lost to Follow-up|13
819315|NCT00161616|1771825|FG000|Overall Study|Protocol deviation|1
819316|NCT00161616|1771826|FG001|Overall Study|Protocol deviation|0
819317|NCT00162032|1771834|FG000|Overall Study|Lost to Follow-up|4
819318|NCT00162032|1771835|FG001|Overall Study|Lost to Follow-up|2
819319|NCT00162032|1771834|FG000|Overall Study|Reason not specified|1
819320|NCT00162032|1771835|FG001|Overall Study|Reason not specified|0
819321|NCT00162097|1771850|FG000|Overall Study|Participant no longer met study criteria|0
819322|NCT00162097|1771851|FG001|Overall Study|Participant no longer met study criteria|0
819323|NCT00162097|1771852|FG002|Overall Study|Participant no longer met study criteria|0
819324|NCT00162097|1771853|FG003|Overall Study|Participant no longer met study criteria|1
819325|NCT00162123|1771877|FG000|Overall Study|Disease progression|27
819326|NCT00162123|1771878|FG001|Overall Study|Disease progression|19
819327|NCT00162123|1771879|FG002|Overall Study|Disease progression|10
819328|NCT00162123|1771880|FG003|Overall Study|Disease progression|4
819329|NCT00162123|1771881|FG004|Overall Study|Disease progression|8
819330|NCT00162123|1771882|FG005|Overall Study|Disease progression|3
819331|NCT00162123|1771883|FG006|Overall Study|Disease progression|1
819332|NCT00162123|1771884|FG007|Overall Study|Disease progression|0
819333|NCT00162123|1771877|FG000|Overall Study|Study drug toxicity|6
819334|NCT00162123|1771878|FG001|Overall Study|Study drug toxicity|1
819335|NCT00162123|1771879|FG002|Overall Study|Study drug toxicity|5
819336|NCT00162123|1771880|FG003|Overall Study|Study drug toxicity|0
819337|NCT00162123|1771881|FG004|Overall Study|Study drug toxicity|4
819338|NCT00162123|1771882|FG005|Overall Study|Study drug toxicity|1
819339|NCT00162123|1771883|FG006|Overall Study|Study drug toxicity|1
819340|NCT00162123|1771884|FG007|Overall Study|Study drug toxicity|0
819341|NCT00162123|1771877|FG000|Overall Study|Death|3
819342|NCT00162123|1771878|FG001|Overall Study|Death|3
819343|NCT00162123|1771879|FG002|Overall Study|Death|1
819344|NCT00162123|1771880|FG003|Overall Study|Death|1
819345|NCT00162123|1771881|FG004|Overall Study|Death|1
819346|NCT00162123|1771882|FG005|Overall Study|Death|1
819347|NCT00162123|1771883|FG006|Overall Study|Death|0
819348|NCT00162123|1771884|FG007|Overall Study|Death|0
819349|NCT00162123|1771877|FG000|Overall Study|Withdrawal by Subject|2
819350|NCT00162123|1771878|FG001|Overall Study|Withdrawal by Subject|0
819351|NCT00162123|1771879|FG002|Overall Study|Withdrawal by Subject|2
819352|NCT00162123|1771880|FG003|Overall Study|Withdrawal by Subject|1
819353|NCT00162123|1771881|FG004|Overall Study|Withdrawal by Subject|1
819354|NCT00162123|1771882|FG005|Overall Study|Withdrawal by Subject|2
819355|NCT00162123|1771883|FG006|Overall Study|Withdrawal by Subject|1
819356|NCT00162123|1771884|FG007|Overall Study|Withdrawal by Subject|0
819357|NCT00162123|1771877|FG000|Overall Study|Deterioration without progression|2
819358|NCT00162123|1771878|FG001|Overall Study|Deterioration without progression|2
819359|NCT00162123|1771879|FG002|Overall Study|Deterioration without progression|3
819360|NCT00162123|1771880|FG003|Overall Study|Deterioration without progression|0
819361|NCT00162123|1771881|FG004|Overall Study|Deterioration without progression|1
819362|NCT00162123|1771882|FG005|Overall Study|Deterioration without progression|0
819363|NCT00162123|1771883|FG006|Overall Study|Deterioration without progression|0
819364|NCT00162123|1771884|FG007|Overall Study|Deterioration without progression|0
819365|NCT00162123|1771877|FG000|Overall Study|Adverse Event|1
819366|NCT00162123|1771878|FG001|Overall Study|Adverse Event|2
819367|NCT00162123|1771879|FG002|Overall Study|Adverse Event|0
819368|NCT00162123|1771880|FG003|Overall Study|Adverse Event|2
819369|NCT00162123|1771881|FG004|Overall Study|Adverse Event|1
819370|NCT00162123|1771882|FG005|Overall Study|Adverse Event|0
819371|NCT00162123|1771883|FG006|Overall Study|Adverse Event|0
819372|NCT00162123|1771884|FG007|Overall Study|Adverse Event|0
819373|NCT00162123|1771877|FG000|Overall Study|Not specified (before treatment)|2
819374|NCT00162123|1771878|FG001|Overall Study|Not specified (before treatment)|0
819375|NCT00162123|1771879|FG002|Overall Study|Not specified (before treatment)|0
819376|NCT00162123|1771880|FG003|Overall Study|Not specified (before treatment)|0
819377|NCT00162123|1771881|FG004|Overall Study|Not specified (before treatment)|12
819378|NCT00162123|1771882|FG005|Overall Study|Not specified (before treatment)|1
819379|NCT00162123|1771883|FG006|Overall Study|Not specified (before treatment)|0
819380|NCT00162123|1771884|FG007|Overall Study|Not specified (before treatment)|0
819381|NCT00162123|1771877|FG000|Overall Study|Not specified (after start of treatment)|0
819382|NCT00162123|1771878|FG001|Overall Study|Not specified (after start of treatment)|0
819383|NCT00162123|1771879|FG002|Overall Study|Not specified (after start of treatment)|0
819384|NCT00162123|1771880|FG003|Overall Study|Not specified (after start of treatment)|0
819385|NCT00162123|1771881|FG004|Overall Study|Not specified (after start of treatment)|3
819386|NCT00162123|1771882|FG005|Overall Study|Not specified (after start of treatment)|0
819387|NCT00162123|1771883|FG006|Overall Study|Not specified (after start of treatment)|0
819388|NCT00162123|1771884|FG007|Overall Study|Not specified (after start of treatment)|0
819389|NCT00162123|1771877|FG000|Overall Study|Physician Decision|1
819390|NCT00162123|1771878|FG001|Overall Study|Physician Decision|2
819391|NCT00162123|1771879|FG002|Overall Study|Physician Decision|0
819392|NCT00162123|1771880|FG003|Overall Study|Physician Decision|0
819393|NCT00162123|1771881|FG004|Overall Study|Physician Decision|0
819394|NCT00162123|1771882|FG005|Overall Study|Physician Decision|1
819395|NCT00162123|1771883|FG006|Overall Study|Physician Decision|1
819396|NCT00162123|1771884|FG007|Overall Study|Physician Decision|0
819397|NCT00162123|1771877|FG000|Overall Study|Tumor assessment only (not treated)|0
819398|NCT00162123|1771878|FG001|Overall Study|Tumor assessment only (not treated)|0
819399|NCT00162123|1771879|FG002|Overall Study|Tumor assessment only (not treated)|0
819400|NCT00162123|1771880|FG003|Overall Study|Tumor assessment only (not treated)|0
819401|NCT00162123|1771881|FG004|Overall Study|Tumor assessment only (not treated)|0
819402|NCT00162123|1771882|FG005|Overall Study|Tumor assessment only (not treated)|0
819403|NCT00162123|1771883|FG006|Overall Study|Tumor assessment only (not treated)|0
819404|NCT00162123|1771884|FG007|Overall Study|Tumor assessment only (not treated)|1
819405|NCT00162123|1771877|FG000|Overall Study|Follow-up only (not treated or assessed)|0
819406|NCT00162123|1771878|FG001|Overall Study|Follow-up only (not treated or assessed)|0
819407|NCT00162123|1771879|FG002|Overall Study|Follow-up only (not treated or assessed)|0
819408|NCT00162123|1771880|FG003|Overall Study|Follow-up only (not treated or assessed)|0
819409|NCT00162123|1771881|FG004|Overall Study|Follow-up only (not treated or assessed)|0
819410|NCT00162123|1771882|FG005|Overall Study|Follow-up only (not treated or assessed)|0
819411|NCT00162123|1771883|FG006|Overall Study|Follow-up only (not treated or assessed)|0
819412|NCT00162123|1771884|FG007|Overall Study|Follow-up only (not treated or assessed)|57
819413|NCT00162136|1771909|FG000|Overall Study|Adverse Event|1
819414|NCT00162136|1771909|FG000|Overall Study|Death|1
819415|NCT00162136|1771909|FG000|Overall Study|Disease Progression/Relapse|23
819416|NCT00162136|1771909|FG000|Overall Study|Investigator Request|5
819417|NCT00162136|1771909|FG000|Overall Study|Study Drug Toxicity|4
819418|NCT00162136|1771909|FG000|Overall Study|Withdrawal by Subject|1
819419|NCT00162266|1771936|FG000|Double-Blind Period|Adverse Event|5
819420|NCT00162266|1771937|FG001|Double-Blind Period|Adverse Event|9
819421|NCT00162266|1771938|FG002|Double-Blind Period|Adverse Event|11
819422|NCT00162266|1771939|FG003|Double-Blind Period|Adverse Event|0
819423|NCT00162266|1771936|FG000|Double-Blind Period|Death|0
819424|NCT00162266|1771937|FG001|Double-Blind Period|Death|1
819425|NCT00162266|1771938|FG002|Double-Blind Period|Death|0
819426|NCT00162266|1771939|FG003|Double-Blind Period|Death|0
819427|NCT00162266|1771936|FG000|Double-Blind Period|Lost to Follow-up|1
819428|NCT00162266|1771937|FG001|Double-Blind Period|Lost to Follow-up|2
819429|NCT00162266|1771938|FG002|Double-Blind Period|Lost to Follow-up|0
819430|NCT00162266|1771939|FG003|Double-Blind Period|Lost to Follow-up|0
819431|NCT00162266|1771936|FG000|Double-Blind Period|Other Reason|1
819432|NCT00162266|1771937|FG001|Double-Blind Period|Other Reason|0
819433|NCT00162266|1771938|FG002|Double-Blind Period|Other Reason|1
819434|NCT00162266|1771939|FG003|Double-Blind Period|Other Reason|0
819435|NCT00162266|1771936|FG000|Double-Blind Period|Lack of Efficacy|13
819436|NCT00162266|1771937|FG001|Double-Blind Period|Lack of Efficacy|17
819437|NCT00162266|1771938|FG002|Double-Blind Period|Lack of Efficacy|30
819438|NCT00162266|1771939|FG003|Double-Blind Period|Lack of Efficacy|0
819439|NCT00162266|1771936|FG000|Double-Blind Period|Withdrawal by Subject|5
819440|NCT00162266|1771937|FG001|Double-Blind Period|Withdrawal by Subject|2
819441|NCT00162266|1771938|FG002|Double-Blind Period|Withdrawal by Subject|6
819442|NCT00162266|1771939|FG003|Double-Blind Period|Withdrawal by Subject|0
819443|NCT00162266|1771936|FG000|Open-Label Period|Death|0
819444|NCT00162266|1771937|FG001|Open-Label Period|Death|0
819445|NCT00162266|1771938|FG002|Open-Label Period|Death|0
819446|NCT00162266|1771939|FG003|Open-Label Period|Death|7
819447|NCT00162266|1771936|FG000|Open-Label Period|Adverse Event|0
819448|NCT00162266|1771937|FG001|Open-Label Period|Adverse Event|0
819449|NCT00162266|1771938|FG002|Open-Label Period|Adverse Event|0
819450|NCT00162266|1771939|FG003|Open-Label Period|Adverse Event|46
819451|NCT00162266|1771936|FG000|Open-Label Period|Lack of Efficacy|0
819452|NCT00162266|1771937|FG001|Open-Label Period|Lack of Efficacy|0
819453|NCT00162266|1771938|FG002|Open-Label Period|Lack of Efficacy|0
819454|NCT00162266|1771939|FG003|Open-Label Period|Lack of Efficacy|26
819455|NCT00162266|1771936|FG000|Open-Label Period|Lost to Follow-up|0
819456|NCT00162266|1771937|FG001|Open-Label Period|Lost to Follow-up|0
819457|NCT00162266|1771938|FG002|Open-Label Period|Lost to Follow-up|0
819458|NCT00162266|1771939|FG003|Open-Label Period|Lost to Follow-up|3
819459|NCT00162266|1771936|FG000|Open-Label Period|Withdrawal by Subject|0
819460|NCT00162266|1771937|FG001|Open-Label Period|Withdrawal by Subject|0
819461|NCT00162266|1771938|FG002|Open-Label Period|Withdrawal by Subject|0
819462|NCT00162266|1771939|FG003|Open-Label Period|Withdrawal by Subject|31
819463|NCT00162266|1771936|FG000|Open-Label Period|Administrative Reason By Sponsor|0
819464|NCT00162266|1771937|FG001|Open-Label Period|Administrative Reason By Sponsor|0
819465|NCT00162266|1771938|FG002|Open-Label Period|Administrative Reason By Sponsor|0
819466|NCT00162266|1771939|FG003|Open-Label Period|Administrative Reason By Sponsor|9
819467|NCT00162266|1771936|FG000|Open-Label Period|Other Reasons|0
819468|NCT00162266|1771937|FG001|Open-Label Period|Other Reasons|0
819469|NCT00162266|1771938|FG002|Open-Label Period|Other Reasons|0
819470|NCT00162266|1771939|FG003|Open-Label Period|Other Reasons|15
819471|NCT00162942|1772000|FG000|Overall Study|Adverse Event|10
819472|NCT00162942|1772001|FG001|Overall Study|Adverse Event|6
819473|NCT00162942|1772000|FG000|Overall Study|Death|1
819474|NCT00162942|1772001|FG001|Overall Study|Death|0
819475|NCT00162942|1772000|FG000|Overall Study|Withdrawal by Subject|3
819476|NCT00162942|1772001|FG001|Overall Study|Withdrawal by Subject|6
819477|NCT00162942|1772000|FG000|Overall Study|Physician Decision|1
819478|NCT00162942|1772001|FG001|Overall Study|Physician Decision|0
819479|NCT00162942|1772000|FG000|Overall Study|Enter Open-Label Study|76
819480|NCT00162942|1772001|FG001|Overall Study|Enter Open-Label Study|35
819481|NCT00162942|1772000|FG000|Overall Study|Alternate Therapy|6
819482|NCT00162942|1772001|FG001|Overall Study|Alternate Therapy|2
819483|NCT00162942|1772000|FG000|Overall Study|Lack of Efficacy|1
819484|NCT00162942|1772001|FG001|Overall Study|Lack of Efficacy|0
819485|NCT00162942|1772000|FG000|Overall Study|Flare During Active Treatment|7
819486|NCT00162942|1772001|FG001|Overall Study|Flare During Active Treatment|3
819487|NCT00162942|1772000|FG000|Overall Study|2 or more consecutive treatments missed|1
819488|NCT00162942|1772001|FG001|Overall Study|2 or more consecutive treatments missed|0
819489|NCT00162981|1772007|FG000|Overall Study|Adverse Event|2
819490|NCT00162981|1772008|FG001|Overall Study|Adverse Event|5
819491|NCT00162981|1772007|FG000|Overall Study|Withdrawal by Subject|1
819492|NCT00162981|1772008|FG001|Overall Study|Withdrawal by Subject|1
819493|NCT00162981|1772007|FG000|Overall Study|Physician Decision|1
819494|NCT00162981|1772008|FG001|Overall Study|Physician Decision|0
819495|NCT00163020|1772016|FG000|Overall Study|Lost to Follow-up|0
819496|NCT00163020|1772017|FG001|Overall Study|Lost to Follow-up|2
819497|NCT00163189|1772025|FG000|Overall Study|Other|6
819498|NCT00163189|1772025|FG000|Overall Study|Lost to Follow-up|1
819499|NCT00163189|1772025|FG000|Overall Study|Protocol Violation|2
819500|NCT00163189|1772025|FG000|Overall Study|Death|3
819501|NCT00163189|1772025|FG000|Overall Study|Adverse Event|6
819502|NCT00163189|1772025|FG000|Overall Study|Lack of Efficacy|7
819503|NCT00163189|1772025|FG000|Overall Study|Study terminated by sponsor|11
819504|NCT00163189|1772025|FG000|Overall Study|Withdrawal by Subject|11
819505|NCT00163189|1772025|FG000|Overall Study|Did not meet continuation criterion|16
819506|NCT00163215|1772029|FG000|Overall Study|Lack of Efficacy|3
819507|NCT00163215|1772029|FG000|Overall Study|Withdrawal by Subject|5
819508|NCT00163215|1772029|FG000|Overall Study|Other|7
819509|NCT00163657|1772049|FG000|Overall Study|Death|12
819510|NCT00163657|1772050|FG001|Overall Study|Death|14
819511|NCT00163657|1772051|FG002|Overall Study|Death|19
819512|NCT00163657|1772049|FG000|Overall Study|graft loss|4
819513|NCT00163657|1772050|FG001|Overall Study|graft loss|1
819514|NCT00163657|1772051|FG002|Overall Study|graft loss|2
819515|NCT00163657|1772049|FG000|Overall Study|Withdrawal by Subject|2
819516|NCT00163657|1772050|FG001|Overall Study|Withdrawal by Subject|3
819517|NCT00163657|1772051|FG002|Overall Study|Withdrawal by Subject|2
819518|NCT00163657|1772049|FG000|Overall Study|Physician Decision|0
819519|NCT00163657|1772050|FG001|Overall Study|Physician Decision|1
819520|NCT00163657|1772051|FG002|Overall Study|Physician Decision|1
819521|NCT00163657|1772049|FG000|Overall Study|Non Compliance|1
819522|NCT00163657|1772050|FG001|Overall Study|Non Compliance|0
819523|NCT00163657|1772051|FG002|Overall Study|Non Compliance|0
819524|NCT00163657|1772049|FG000|Overall Study|Lost to Follow-up|1
819525|NCT00163657|1772050|FG001|Overall Study|Lost to Follow-up|3
819526|NCT00163657|1772051|FG002|Overall Study|Lost to Follow-up|10
819527|NCT00163657|1772049|FG000|Overall Study|Other reason|0
819528|NCT00163657|1772050|FG001|Overall Study|Other reason|1
819529|NCT00163657|1772051|FG002|Overall Study|Other reason|3
819530|NCT00165646|1772062|FG000|Overall Study|Adverse Event|1
819531|NCT00165646|1772063|FG001|Overall Study|Adverse Event|1
819532|NCT00165646|1772064|FG002|Overall Study|Adverse Event|1
819533|NCT00165646|1772062|FG000|Overall Study|Lack of Efficacy|1
819534|NCT00165646|1772063|FG001|Overall Study|Lack of Efficacy|2
819535|NCT00165646|1772064|FG002|Overall Study|Lack of Efficacy|0
819536|NCT00165646|1772062|FG000|Overall Study|Withdrawal by Subject|0
819537|NCT00165646|1772063|FG001|Overall Study|Withdrawal by Subject|2
819538|NCT00165646|1772064|FG002|Overall Study|Withdrawal by Subject|1
819539|NCT00165646|1772062|FG000|Overall Study|Physician Decision|2
819540|NCT00165646|1772063|FG001|Overall Study|Physician Decision|0
819541|NCT00165646|1772064|FG002|Overall Study|Physician Decision|2
819542|NCT00165646|1772062|FG000|Overall Study|Protocol Violation|1
819543|NCT00165646|1772063|FG001|Overall Study|Protocol Violation|0
819544|NCT00165646|1772064|FG002|Overall Study|Protocol Violation|0
819545|NCT00165672|1772074|FG000|Overall Study|Adverse Event|0
819546|NCT00165672|1772075|FG001|Overall Study|Adverse Event|1
819547|NCT00165698|1772083|FG000|Overall Study|Adverse Event|2
819548|NCT00165698|1772084|FG001|Overall Study|Adverse Event|10
819549|NCT00165698|1772083|FG000|Overall Study|Lost to Follow-up|2
819550|NCT00165698|1772084|FG001|Overall Study|Lost to Follow-up|2
819551|NCT00165698|1772083|FG000|Overall Study|Withdrawal by Subject|2
819552|NCT00165698|1772084|FG001|Overall Study|Withdrawal by Subject|1
819553|NCT00165698|1772083|FG000|Overall Study|Protocol Violation|1
819554|NCT00165698|1772084|FG001|Overall Study|Protocol Violation|0
819555|NCT00165698|1772083|FG000|Overall Study|Not Taken/Lost the medicine|1
819556|NCT00165698|1772084|FG001|Overall Study|Not Taken/Lost the medicine|2
819557|NCT00165776|1772094|FG000|Overall Study|Lack of Efficacy|0
819558|NCT00165776|1772095|FG001|Overall Study|Lack of Efficacy|0
819559|NCT00165776|1772096|FG002|Overall Study|Lack of Efficacy|0
819560|NCT00165776|1772097|FG003|Overall Study|Lack of Efficacy|1
819561|NCT00165776|1772094|FG000|Overall Study|Withdrawal by Subject|4
819562|NCT00165776|1772095|FG001|Overall Study|Withdrawal by Subject|1
819563|NCT00165776|1772096|FG002|Overall Study|Withdrawal by Subject|2
819564|NCT00165776|1772097|FG003|Overall Study|Withdrawal by Subject|0
819565|NCT00165776|1772094|FG000|Overall Study|Worsening of Cervical Dystonia|0
819566|NCT00165776|1772095|FG001|Overall Study|Worsening of Cervical Dystonia|0
819567|NCT00165776|1772096|FG002|Overall Study|Worsening of Cervical Dystonia|0
819568|NCT00165776|1772097|FG003|Overall Study|Worsening of Cervical Dystonia|1
819569|NCT00165789|1772111|FG000|Overall Study|Adverse Event|0
819570|NCT00165789|1772112|FG001|Overall Study|Adverse Event|3
819571|NCT00165789|1772113|FG002|Overall Study|Adverse Event|0
819572|NCT00165789|1772114|FG003|Overall Study|Adverse Event|12
819573|NCT00165789|1772111|FG000|Overall Study|Withdrawal by Subject|0
819574|NCT00165789|1772112|FG001|Overall Study|Withdrawal by Subject|1
819575|NCT00165789|1772113|FG002|Overall Study|Withdrawal by Subject|1
819576|NCT00165789|1772114|FG003|Overall Study|Withdrawal by Subject|2
819577|NCT00165841|1772126|FG000|Overall Study|Adverse Event|2
819578|NCT00165841|1772127|FG001|Overall Study|Adverse Event|3
819579|NCT00165841|1772126|FG000|Overall Study|Lack of Efficacy|6
819580|NCT00165841|1772127|FG001|Overall Study|Lack of Efficacy|33
819581|NCT00165841|1772126|FG000|Overall Study|Lost to Follow-up|4
819582|NCT00165841|1772127|FG001|Overall Study|Lost to Follow-up|4
819583|NCT00165841|1772126|FG000|Overall Study|Withdrawal by Subject|7
819584|NCT00165841|1772127|FG001|Overall Study|Withdrawal by Subject|8
819585|NCT00165841|1772126|FG000|Overall Study|Physician Decision|1
819586|NCT00165841|1772127|FG001|Overall Study|Physician Decision|0
819587|NCT00165841|1772126|FG000|Overall Study|Protocol Violation|6
819588|NCT00165841|1772127|FG001|Overall Study|Protocol Violation|8
819589|NCT00165841|1772126|FG000|Overall Study|Other|3
819590|NCT00165841|1772127|FG001|Overall Study|Other|5
819591|NCT00165841|1772126|FG000|Overall Study|Medication Noncompliance|1
819592|NCT00165841|1772127|FG001|Overall Study|Medication Noncompliance|1
819593|NCT00165984|1772142|FG000|Overall Study|Death|15
819594|NCT00166114|1772161|FG000|Overall Study|Protocol Violation|2
819595|NCT00166114|1772162|FG001|Overall Study|Protocol Violation|1
819596|NCT00166114|1772161|FG000|Overall Study|Withdrawal by Subject|10
819597|NCT00166114|1772162|FG001|Overall Study|Withdrawal by Subject|4
819598|NCT00166114|1772161|FG000|Overall Study|Adverse Event|2
819599|NCT00166114|1772162|FG001|Overall Study|Adverse Event|1
819600|NCT00166296|1772196|FG000|Overall Study|Withdrawal by Subject|1
819601|NCT00166296|1772197|FG001|Overall Study|Withdrawal by Subject|3
819602|NCT00166296|1772196|FG000|Overall Study|Adverse Event|2
819603|NCT00166296|1772197|FG001|Overall Study|Adverse Event|4
819604|NCT00166296|1772196|FG000|Overall Study|Lost to Follow-up|4
819605|NCT00166296|1772197|FG001|Overall Study|Lost to Follow-up|2
819606|NCT00166439|1772212|FG000|Overall Study|Ineligible|5
819607|NCT00166504|1772218|FG000|Overall Study|Adverse Event|3
819608|NCT00166504|1772219|FG001|Overall Study|Adverse Event|3
819609|NCT00166504|1772218|FG000|Overall Study|Lost to Follow-up|1
819610|NCT00166504|1772219|FG001|Overall Study|Lost to Follow-up|1
819611|NCT00166504|1772218|FG000|Overall Study|Withdrawal by Subject|1
819612|NCT00166504|1772219|FG001|Overall Study|Withdrawal by Subject|0
819613|NCT00166517|1772227|FG000|Overall Study|Lost to Follow-up|1
819614|NCT00166517|1772228|FG001|Overall Study|Lost to Follow-up|0
819615|NCT00166517|1772227|FG000|Overall Study|Protocol Violation|4
819616|NCT00166517|1772228|FG001|Overall Study|Protocol Violation|1
819617|NCT00166517|1772227|FG000|Overall Study|Withdrawal by Subject|0
819618|NCT00166517|1772228|FG001|Overall Study|Withdrawal by Subject|1
819619|NCT00166712|1772236|FG000|Overall Study|Death|0
819620|NCT00166712|1772237|FG001|Overall Study|Death|1
819621|NCT00166712|1772236|FG000|Overall Study|Adverse Event|1
819622|NCT00166712|1772237|FG001|Overall Study|Adverse Event|0
819623|NCT00166712|1772236|FG000|Overall Study|Withdrawal by Subject|1
819624|NCT00166712|1772237|FG001|Overall Study|Withdrawal by Subject|2
819625|NCT00166712|1772236|FG000|Overall Study|Physician Decision|0
819626|NCT00166712|1772237|FG001|Overall Study|Physician Decision|2
819627|NCT00167245|1772273|FG000|Overall Study|Lost to Follow-up|20
819628|NCT00167245|1772274|FG001|Overall Study|Lost to Follow-up|31
819629|NCT00167245|1772273|FG000|Overall Study|Withdrawal by Subject|5
819630|NCT00167245|1772274|FG001|Overall Study|Withdrawal by Subject|8
819631|NCT00167245|1772273|FG000|Overall Study|Incarcerated|3
819632|NCT00167245|1772274|FG001|Overall Study|Incarcerated|2
819633|NCT00167245|1772273|FG000|Overall Study|Drowsy|1
819634|NCT00167245|1772274|FG001|Overall Study|Drowsy|0
819635|NCT00167310|1772285|FG000|Overall Study|Protocol Violation|5
819636|NCT00167310|1772286|FG001|Overall Study|Protocol Violation|3
819637|NCT00167310|1772285|FG000|Overall Study|Withdrawal by Subject|3
819638|NCT00167310|1772286|FG001|Overall Study|Withdrawal by Subject|7
819639|NCT00167414|1772307|FG000|Overall Study|Death|10
819640|NCT00167778|1772324|FG000|Overall Study|Withdrawal by Subject|1
819641|NCT00168038|1772338|FG000|Overall Study|Adverse Event|1
819642|NCT00168038|1772338|FG000|Overall Study|Therapy failure|1
819643|NCT00168064|1772344|FG000|Overall Study|Adverse Event|26
819644|NCT00168064|1772345|FG001|Overall Study|Adverse Event|22
819645|NCT00168064|1772344|FG000|Overall Study|Withdrawal by Subject|3
819646|NCT00168064|1772345|FG001|Overall Study|Withdrawal by Subject|4
819647|NCT00168064|1772344|FG000|Overall Study|Lack of Efficacy|4
819648|NCT00168064|1772345|FG001|Overall Study|Lack of Efficacy|4
819649|NCT00168064|1772344|FG000|Overall Study|Lost to Follow-up|4
819650|NCT00168064|1772345|FG001|Overall Study|Lost to Follow-up|3
819651|NCT00168064|1772344|FG000|Overall Study|Non-compliance|2
819652|NCT00168064|1772345|FG001|Overall Study|Non-compliance|3
819653|NCT00168064|1772344|FG000|Overall Study|Concurrent Illness|4
819654|NCT00168064|1772345|FG001|Overall Study|Concurrent Illness|3
819655|NCT00168064|1772344|FG000|Overall Study|Subject's Best interest|2
819656|NCT00168064|1772345|FG001|Overall Study|Subject's Best interest|2
819657|NCT00168064|1772344|FG000|Overall Study|Various|4
819658|NCT00168064|1772345|FG001|Overall Study|Various|3
819659|NCT00168103|1772356|FG000|Overall Study|Withdrawal by Subject|1
819660|NCT00168103|1772357|FG001|Overall Study|Withdrawal by Subject|2
819661|NCT00168103|1772358|FG002|Overall Study|Withdrawal by Subject|1
819662|NCT00168103|1772359|FG003|Overall Study|Withdrawal by Subject|0
819663|NCT00168103|1772356|FG000|Overall Study|Lost to Follow-up|1
819664|NCT00168103|1772357|FG001|Overall Study|Lost to Follow-up|3
819665|NCT00168103|1772358|FG002|Overall Study|Lost to Follow-up|0
819666|NCT00168103|1772359|FG003|Overall Study|Lost to Follow-up|0
819667|NCT00168805|1772465|FG000|Overall Study|Adverse Event|7
819668|NCT00168805|1772466|FG001|Overall Study|Adverse Event|11
819669|NCT00168805|1772467|FG002|Overall Study|Adverse Event|16
819670|NCT00168805|1772465|FG000|Overall Study|Protocol Violation|12
819671|NCT00168805|1772466|FG001|Overall Study|Protocol Violation|11
819672|NCT00168805|1772467|FG002|Overall Study|Protocol Violation|8
819673|NCT00168805|1772465|FG000|Overall Study|Lost to Follow-up|12
819674|NCT00168805|1772466|FG001|Overall Study|Lost to Follow-up|17
819675|NCT00168805|1772467|FG002|Overall Study|Lost to Follow-up|11
819676|NCT00168805|1772465|FG000|Overall Study|Withdrawal by Subject|16
819677|NCT00168805|1772466|FG001|Overall Study|Withdrawal by Subject|18
819678|NCT00168805|1772467|FG002|Overall Study|Withdrawal by Subject|21
819679|NCT00168805|1772465|FG000|Overall Study|Other|24
819680|NCT00168805|1772466|FG001|Overall Study|Other|21
819681|NCT00168805|1772467|FG002|Overall Study|Other|22
819682|NCT00168805|1772465|FG000|Treatment|Adverse Event|25
819683|NCT00168805|1772466|FG001|Treatment|Adverse Event|26
819684|NCT00168805|1772467|FG002|Treatment|Adverse Event|32
819685|NCT00168805|1772465|FG000|Treatment|Protocol Violation|3
819686|NCT00168805|1772466|FG001|Treatment|Protocol Violation|5
819687|NCT00168805|1772467|FG002|Treatment|Protocol Violation|5
819688|NCT00168805|1772465|FG000|Treatment|Withdrawal by Subject|3
819689|NCT00168805|1772466|FG001|Treatment|Withdrawal by Subject|7
819690|NCT00168805|1772467|FG002|Treatment|Withdrawal by Subject|8
819691|NCT00168805|1772465|FG000|Treatment|Other|18
819692|NCT00168805|1772466|FG001|Treatment|Other|18
819693|NCT00168805|1772467|FG002|Treatment|Other|17
819694|NCT00168818|1772478|FG000|Overall Study|Adverse Event|23
819695|NCT00168818|1772479|FG001|Overall Study|Adverse Event|29
819696|NCT00168818|1772480|FG002|Overall Study|Adverse Event|31
819697|NCT00168818|1772478|FG000|Overall Study|Protocol Violation|16
819698|NCT00168818|1772479|FG001|Overall Study|Protocol Violation|11
819699|NCT00168818|1772480|FG002|Overall Study|Protocol Violation|11
819700|NCT00168818|1772478|FG000|Overall Study|Lost to Follow-up|13
819701|NCT00168818|1772479|FG001|Overall Study|Lost to Follow-up|4
819702|NCT00168818|1772480|FG002|Overall Study|Lost to Follow-up|15
819703|NCT00168818|1772478|FG000|Overall Study|Withdrawal by Subject|43
819704|NCT00168818|1772479|FG001|Overall Study|Withdrawal by Subject|41
819705|NCT00168818|1772480|FG002|Overall Study|Withdrawal by Subject|37
819706|NCT00168818|1772478|FG000|Overall Study|Other|22
819707|NCT00168818|1772479|FG001|Overall Study|Other|24
819708|NCT00168818|1772480|FG002|Overall Study|Other|30
819709|NCT00168818|1772478|FG000|Treatment|Adverse Event|77
819710|NCT00168818|1772479|FG001|Treatment|Adverse Event|89
819711|NCT00168818|1772480|FG002|Treatment|Adverse Event|68
819712|NCT00168818|1772478|FG000|Treatment|Protocol Violation|8
819713|NCT00168818|1772479|FG001|Treatment|Protocol Violation|11
819714|NCT00168818|1772480|FG002|Treatment|Protocol Violation|11
819715|NCT00168818|1772478|FG000|Treatment|Lost to Follow-up|0
819716|NCT00168818|1772479|FG001|Treatment|Lost to Follow-up|2
819717|NCT00168818|1772480|FG002|Treatment|Lost to Follow-up|1
819718|NCT00168818|1772478|FG000|Treatment|Withdrawal by Subject|25
819719|NCT00168818|1772479|FG001|Treatment|Withdrawal by Subject|20
819720|NCT00168818|1772480|FG002|Treatment|Withdrawal by Subject|22
819721|NCT00168818|1772478|FG000|Treatment|Other|23
819722|NCT00168818|1772479|FG001|Treatment|Other|29
819723|NCT00168818|1772480|FG002|Treatment|Other|31
819724|NCT00168831|1772491|FG000|Overall Study|Adverse Event|36
819725|NCT00168831|1772492|FG001|Overall Study|Adverse Event|47
819726|NCT00168831|1772493|FG002|Overall Study|Adverse Event|74
819727|NCT00168831|1772491|FG000|Overall Study|Lost to Follow-up|5
819728|NCT00168831|1772492|FG001|Overall Study|Lost to Follow-up|6
819729|NCT00168831|1772493|FG002|Overall Study|Lost to Follow-up|4
819730|NCT00168831|1772491|FG000|Overall Study|Withdrawal by Subject|7
819731|NCT00168831|1772492|FG001|Overall Study|Withdrawal by Subject|14
819732|NCT00168831|1772493|FG002|Overall Study|Withdrawal by Subject|19
819733|NCT00168831|1772491|FG000|Overall Study|Protocol Violation|6
819734|NCT00168831|1772492|FG001|Overall Study|Protocol Violation|11
819735|NCT00168831|1772493|FG002|Overall Study|Protocol Violation|11
819736|NCT00168831|1772491|FG000|Overall Study|Other|6
819737|NCT00168831|1772492|FG001|Overall Study|Other|3
819738|NCT00168831|1772493|FG002|Overall Study|Other|6
819739|NCT00168844|1772504|FG000|Overall Study|Adverse Event|31
819740|NCT00168844|1772505|FG001|Overall Study|Adverse Event|32
819741|NCT00168844|1772506|FG002|Overall Study|Adverse Event|48
819742|NCT00168844|1772504|FG000|Overall Study|Lost to Follow-up|4
819743|NCT00168844|1772505|FG001|Overall Study|Lost to Follow-up|5
819744|NCT00168844|1772506|FG002|Overall Study|Lost to Follow-up|11
819745|NCT00168844|1772504|FG000|Overall Study|Withdrawal by Subject|12
819746|NCT00168844|1772505|FG001|Overall Study|Withdrawal by Subject|9
819747|NCT00168844|1772506|FG002|Overall Study|Withdrawal by Subject|19
819748|NCT00168844|1772504|FG000|Overall Study|Protocol Violation|2
819749|NCT00168844|1772505|FG001|Overall Study|Protocol Violation|2
819750|NCT00168844|1772506|FG002|Overall Study|Protocol Violation|4
819751|NCT00168844|1772504|FG000|Overall Study|Other|6
819752|NCT00168844|1772505|FG001|Overall Study|Other|7
819753|NCT00168844|1772506|FG002|Overall Study|Other|9
819754|NCT00169104|1772516|FG000|Overall Study|Withdrawal by Subject|2
819755|NCT00169104|1772517|FG001|Overall Study|Withdrawal by Subject|0
819756|NCT00169104|1772516|FG000|Overall Study|Protocol Violation|0
819757|NCT00169104|1772517|FG001|Overall Study|Protocol Violation|1
819758|NCT00169104|1772516|FG000|Overall Study|Physician Decision|0
819759|NCT00169104|1772517|FG001|Overall Study|Physician Decision|1
819760|NCT00169442|1772530|FG000|Overall Study|Withdrawal by Subject|0
819761|NCT00169442|1772531|FG001|Overall Study|Withdrawal by Subject|0
819762|NCT00169442|1772532|FG002|Overall Study|Withdrawal by Subject|1
819763|NCT00169442|1772533|FG003|Overall Study|Withdrawal by Subject|0
819764|NCT00169442|1772534|FG004|Overall Study|Withdrawal by Subject|0
819765|NCT00169442|1772535|FG005|Overall Study|Withdrawal by Subject|0
819766|NCT00169442|1772530|FG000|Overall Study|Migrated/moved from study area|0
819767|NCT00169442|1772531|FG001|Overall Study|Migrated/moved from study area|0
819768|NCT00169442|1772532|FG002|Overall Study|Migrated/moved from study area|0
819769|NCT00169442|1772533|FG003|Overall Study|Migrated/moved from study area|0
819770|NCT00169442|1772534|FG004|Overall Study|Migrated/moved from study area|0
819771|NCT00169442|1772535|FG005|Overall Study|Migrated/moved from study area|2
819772|NCT00169442|1772530|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0
819773|NCT00169442|1772531|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
819774|NCT00169442|1772532|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0
819775|NCT00169442|1772533|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0
819776|NCT00169442|1772534|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1
819777|NCT00169442|1772535|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0
819778|NCT00169442|1772530|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0
819779|NCT00169442|1772531|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1
819780|NCT00169442|1772532|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0
819781|NCT00169442|1772533|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0
819782|NCT00169442|1772534|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0
819783|NCT00169442|1772535|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0
819784|NCT00170846|1772565|FG000|Overall Study|Subject withdrew Informed Consent|5
819785|NCT00170846|1772566|FG001|Overall Study|Subject withdrew Informed Consent|12
819786|NCT00170846|1772567|FG002|Overall Study|Subject withdrew Informed Consent|8
819787|NCT00170846|1772565|FG000|Overall Study|Lost to Follow-up|6
819788|NCT00170846|1772566|FG001|Overall Study|Lost to Follow-up|3
819789|NCT00170846|1772567|FG002|Overall Study|Lost to Follow-up|2
819790|NCT00170846|1772565|FG000|Overall Study|Death|0
819791|NCT00170846|1772566|FG001|Overall Study|Death|3
819792|NCT00170846|1772567|FG002|Overall Study|Death|3
819793|NCT00170846|1772565|FG000|Overall Study|Reason Missing|0
819794|NCT00170846|1772566|FG001|Overall Study|Reason Missing|1
819795|NCT00170846|1772567|FG002|Overall Study|Reason Missing|0
819796|NCT00170950|1772577|FG000|Overall Study|Death|236
819797|NCT00170950|1772578|FG001|Overall Study|Death|274
819798|NCT00170950|1772577|FG000|Overall Study|Withdrawal by Subject|496
819799|NCT00170950|1772578|FG001|Overall Study|Withdrawal by Subject|498
819800|NCT00170950|1772577|FG000|Overall Study|Lost to Follow-up|134
819801|NCT00170950|1772578|FG001|Overall Study|Lost to Follow-up|115
819802|NCT00170950|1772577|FG000|Overall Study|Missing|2
819803|NCT00170950|1772578|FG001|Overall Study|Missing|1
819804|NCT00170950|1772577|FG000|Overall Study|Termination Data Not Recorded|17
819805|NCT00170950|1772578|FG001|Overall Study|Termination Data Not Recorded|22
819806|NCT00171054|1772586|FG000|Overall Study|Protocol Violation|1
819807|NCT00171054|1772587|FG001|Overall Study|Protocol Violation|2
819808|NCT00171054|1772586|FG000|Overall Study|Patient withdrew consent|1
819809|NCT00171054|1772587|FG001|Overall Study|Patient withdrew consent|0
819810|NCT00171054|1772586|FG000|Overall Study|Lost to Follow-up|0
819811|NCT00171054|1772587|FG001|Overall Study|Lost to Follow-up|1
819812|NCT00171054|1772586|FG000|Overall Study|Adverse Event|8
819813|NCT00171054|1772587|FG001|Overall Study|Adverse Event|8
819814|NCT00171054|1772586|FG000|Overall Study|Condition no longer required study drug|0
819815|NCT00171054|1772587|FG001|Overall Study|Condition no longer required study drug|1
819816|NCT00171158|1772593|FG000|Core Study|Death|27
819817|NCT00171158|1772593|FG000|Core Study|Unsatisfactory therapeutic effect|163
819818|NCT00171158|1772593|FG000|Core Study|Protocol Violation|4
819819|NCT00171158|1772593|FG000|Core Study|Administrative problems|1
819820|NCT00171158|1772593|FG000|Core Study|Adverse event, non-fatal|21
819821|NCT00171158|1772593|FG000|Core Study|Consent withdrawn by subject|6
819822|NCT00171158|1772593|FG000|Core Study|No longer required drug (BMT)|14
819823|NCT00171158|1772593|FG000|Core Study|Abnormal Laboratory Values|2
819824|NCT00171158|1772593|FG000|Core Study|Lost to Follow-up|1
819825|NCT00171158|1772593|FG000|E2 Extension|Other|7
819826|NCT00171210|1772599|FG000|Overall Study|Adverse Event|16
819827|NCT00171210|1772600|FG001|Overall Study|Adverse Event|27
819828|NCT00171210|1772599|FG000|Overall Study|Abnormal laboratory value(s)|6
819829|NCT00171210|1772600|FG001|Overall Study|Abnormal laboratory value(s)|3
819830|NCT00171210|1772599|FG000|Overall Study|Abnormal test procedure result(s)|0
819831|NCT00171210|1772600|FG001|Overall Study|Abnormal test procedure result(s)|1
819832|NCT00171210|1772599|FG000|Overall Study|Unsatisfactory therapeutic effect|11
819833|NCT00171210|1772600|FG001|Overall Study|Unsatisfactory therapeutic effect|15
819834|NCT00171210|1772599|FG000|Overall Study|Protocol Violation|0
819835|NCT00171210|1772600|FG001|Overall Study|Protocol Violation|2
819836|NCT00171210|1772599|FG000|Overall Study|Withdrawal by Subject|32
819837|NCT00171210|1772600|FG001|Overall Study|Withdrawal by Subject|30
819838|NCT00171210|1772599|FG000|Overall Study|Lost to Follow-up|1
819839|NCT00171210|1772600|FG001|Overall Study|Lost to Follow-up|0
819840|NCT00171210|1772599|FG000|Overall Study|Administrative problems|1
819841|NCT00171210|1772600|FG001|Overall Study|Administrative problems|1
819842|NCT00171210|1772599|FG000|Overall Study|Death|2
819843|NCT00171210|1772600|FG001|Overall Study|Death|3
819844|NCT00171210|1772599|FG000|Overall Study|Stopped at end of core|0
819845|NCT00171210|1772600|FG001|Overall Study|Stopped at end of core|32
819846|NCT00171210|1772599|FG000|Overall Study|Stopped at end of extension 1|0
819847|NCT00171210|1772600|FG001|Overall Study|Stopped at end of extension 1|1
819848|NCT00171223|1772609|FG000|Overall Study|Adverse Event (Non-fatal)|6
819849|NCT00171223|1772610|FG001|Overall Study|Adverse Event (Non-fatal)|5
819850|NCT00171223|1772611|FG002|Overall Study|Adverse Event (Non-fatal)|19
819851|NCT00171223|1772609|FG000|Overall Study|Abnormal Laboratory Value (s)|4
819852|NCT00171223|1772610|FG001|Overall Study|Abnormal Laboratory Value (s)|2
819853|NCT00171223|1772611|FG002|Overall Study|Abnormal Laboratory Value (s)|3
819854|NCT00171223|1772609|FG000|Overall Study|Abnormal Procedure|1
819855|NCT00171223|1772610|FG001|Overall Study|Abnormal Procedure|0
819856|NCT00171223|1772611|FG002|Overall Study|Abnormal Procedure|0
819857|NCT00171223|1772609|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57
819858|NCT00171223|1772610|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43
819859|NCT00171223|1772611|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52
819860|NCT00171223|1772609|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
819861|NCT00171223|1772610|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4
819862|NCT00171223|1772611|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
819863|NCT00171223|1772609|FG000|Overall Study|Protocol Violation|2
819864|NCT00171223|1772610|FG001|Overall Study|Protocol Violation|2
819865|NCT00171223|1772611|FG002|Overall Study|Protocol Violation|3
819866|NCT00171223|1772609|FG000|Overall Study|Participant Withdrew Consent|12
819867|NCT00171223|1772610|FG001|Overall Study|Participant Withdrew Consent|21
819868|NCT00171223|1772611|FG002|Overall Study|Participant Withdrew Consent|15
819869|NCT00171223|1772609|FG000|Overall Study|Lost to Follow-up|5
819870|NCT00171223|1772610|FG001|Overall Study|Lost to Follow-up|2
819871|NCT00171223|1772611|FG002|Overall Study|Lost to Follow-up|3
819872|NCT00171223|1772609|FG000|Overall Study|Administrative Problems|4
819873|NCT00171223|1772610|FG001|Overall Study|Administrative Problems|7
819874|NCT00171223|1772611|FG002|Overall Study|Administrative Problems|6
819875|NCT00171223|1772609|FG000|Overall Study|Adverse Event (Serious Fatal)|6
819876|NCT00171223|1772610|FG001|Overall Study|Adverse Event (Serious Fatal)|8
819877|NCT00171223|1772611|FG002|Overall Study|Adverse Event (Serious Fatal)|9
819878|NCT00171223|1772609|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41
819879|NCT00171223|1772610|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47
819880|NCT00171223|1772611|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58
819881|NCT00171249|1772617|FG000|Overall Study|Withdrawal by Subject|2
819882|NCT00171249|1772618|FG001|Overall Study|Withdrawal by Subject|0
819883|NCT00171249|1772619|FG002|Overall Study|Withdrawal by Subject|0
819884|NCT00171249|1772620|FG003|Overall Study|Withdrawal by Subject|6
819885|NCT00171249|1772621|FG004|Overall Study|Withdrawal by Subject|0
819886|NCT00171249|1772622|FG005|Overall Study|Withdrawal by Subject|0
819887|NCT00171249|1772623|FG006|Overall Study|Withdrawal by Subject|0
819888|NCT00171249|1772617|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44
819889|NCT00171249|1772618|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
819890|NCT00171249|1772619|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5
819891|NCT00171249|1772620|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70
819892|NCT00171249|1772621|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3
819893|NCT00171249|1772622|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31
819894|NCT00171249|1772623|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1
819895|NCT00171249|1772617|FG000|Overall Study|Death|7
819896|NCT00171249|1772618|FG001|Overall Study|Death|1
819897|NCT00171249|1772619|FG002|Overall Study|Death|0
819898|NCT00171249|1772620|FG003|Overall Study|Death|4
819899|NCT00171249|1772621|FG004|Overall Study|Death|0
819900|NCT00171249|1772622|FG005|Overall Study|Death|3
819901|NCT00171249|1772623|FG006|Overall Study|Death|1
819902|NCT00171249|1772617|FG000|Overall Study|Other|10
819903|NCT00171249|1772618|FG001|Overall Study|Other|0
819904|NCT00171249|1772619|FG002|Overall Study|Other|0
819905|NCT00171249|1772620|FG003|Overall Study|Other|43
819906|NCT00171249|1772621|FG004|Overall Study|Other|0
819907|NCT00171249|1772622|FG005|Overall Study|Other|2
819908|NCT00171249|1772623|FG006|Overall Study|Other|0
819909|NCT00171249|1772617|FG000|Overall Study|No Longer Requires Study Drug|4
819910|NCT00171249|1772618|FG001|Overall Study|No Longer Requires Study Drug|0
819911|NCT00171249|1772619|FG002|Overall Study|No Longer Requires Study Drug|0
819912|NCT00171249|1772620|FG003|Overall Study|No Longer Requires Study Drug|3
819913|NCT00171249|1772621|FG004|Overall Study|No Longer Requires Study Drug|0
819914|NCT00171249|1772622|FG005|Overall Study|No Longer Requires Study Drug|5
819915|NCT00171249|1772623|FG006|Overall Study|No Longer Requires Study Drug|0
819916|NCT00171249|1772617|FG000|Overall Study|Administrative Problems|1
819917|NCT00171249|1772618|FG001|Overall Study|Administrative Problems|0
819918|NCT00171249|1772619|FG002|Overall Study|Administrative Problems|0
819919|NCT00171249|1772620|FG003|Overall Study|Administrative Problems|2
819920|NCT00171249|1772621|FG004|Overall Study|Administrative Problems|0
819921|NCT00171249|1772622|FG005|Overall Study|Administrative Problems|0
819922|NCT00171249|1772623|FG006|Overall Study|Administrative Problems|0
819923|NCT00171249|1772617|FG000|Overall Study|Adverse Event|3
819924|NCT00171249|1772618|FG001|Overall Study|Adverse Event|1
819925|NCT00171249|1772619|FG002|Overall Study|Adverse Event|0
819926|NCT00171249|1772620|FG003|Overall Study|Adverse Event|15
819927|NCT00171249|1772621|FG004|Overall Study|Adverse Event|0
819928|NCT00171249|1772622|FG005|Overall Study|Adverse Event|2
819929|NCT00171249|1772623|FG006|Overall Study|Adverse Event|0
819930|NCT00171249|1772617|FG000|Overall Study|Lost to Follow-up|5
819931|NCT00171249|1772618|FG001|Overall Study|Lost to Follow-up|0
819932|NCT00171249|1772619|FG002|Overall Study|Lost to Follow-up|0
819933|NCT00171249|1772620|FG003|Overall Study|Lost to Follow-up|9
819934|NCT00171249|1772621|FG004|Overall Study|Lost to Follow-up|0
819935|NCT00171249|1772622|FG005|Overall Study|Lost to Follow-up|0
819936|NCT00171249|1772623|FG006|Overall Study|Lost to Follow-up|0
819937|NCT00171301|1772634|FG000|Overall Study|Death|1
819938|NCT00171301|1772635|FG001|Overall Study|Death|2
819939|NCT00171301|1772634|FG000|Overall Study|Adverse Event|1
819940|NCT00171301|1772635|FG001|Overall Study|Adverse Event|2
819941|NCT00171301|1772634|FG000|Overall Study|Lost to Follow-up|6
819942|NCT00171301|1772635|FG001|Overall Study|Lost to Follow-up|2
819943|NCT00171301|1772634|FG000|Overall Study|Protocol Violation|0
819944|NCT00171301|1772635|FG001|Overall Study|Protocol Violation|2
819945|NCT00171301|1772634|FG000|Overall Study|Withdrawal by Subject|0
819946|NCT00171301|1772635|FG001|Overall Study|Withdrawal by Subject|1
819947|NCT00171314|1772644|FG000|Overall Study|Adverse Event|44
819948|NCT00171314|1772645|FG001|Overall Study|Adverse Event|41
819949|NCT00171314|1772644|FG000|Overall Study|Lack of Efficacy|19
819950|NCT00171314|1772645|FG001|Overall Study|Lack of Efficacy|14
819951|NCT00171314|1772644|FG000|Overall Study|Withdrawal by Subject|9
819952|NCT00171314|1772645|FG001|Overall Study|Withdrawal by Subject|6
819953|NCT00171314|1772644|FG000|Overall Study|Abnormal Test Procedure Results|9
819954|NCT00171314|1772645|FG001|Overall Study|Abnormal Test Procedure Results|3
819955|NCT00171314|1772644|FG000|Overall Study|Protocol Violation|3
819956|NCT00171314|1772645|FG001|Overall Study|Protocol Violation|7
819957|NCT00171314|1772644|FG000|Overall Study|Administrative Problems|4
819958|NCT00171314|1772645|FG001|Overall Study|Administrative Problems|3
819959|NCT00171314|1772644|FG000|Overall Study|Lost to Follow-up|1
819960|NCT00171314|1772645|FG001|Overall Study|Lost to Follow-up|3
819961|NCT00171314|1772644|FG000|Overall Study|Death|2
819962|NCT00171314|1772645|FG001|Overall Study|Death|1
819963|NCT00171340|1772653|FG000|Overall Study|Adverse Event|46
819964|NCT00171340|1772654|FG001|Overall Study|Adverse Event|42
819965|NCT00171340|1772653|FG000|Overall Study|Lack of Efficacy|29
819966|NCT00171340|1772654|FG001|Overall Study|Lack of Efficacy|41
819967|NCT00171340|1772653|FG000|Overall Study|Protocol Violation|7
819968|NCT00171340|1772654|FG001|Overall Study|Protocol Violation|8
819969|NCT00171340|1772653|FG000|Overall Study|Withdrawal by Subject|22
819970|NCT00171340|1772654|FG001|Overall Study|Withdrawal by Subject|19
819971|NCT00171340|1772653|FG000|Overall Study|Lost to Follow-up|0
819972|NCT00171340|1772654|FG001|Overall Study|Lost to Follow-up|5
819973|NCT00171340|1772653|FG000|Overall Study|Abnormal Laboratory Results|2
819974|NCT00171340|1772654|FG001|Overall Study|Abnormal Laboratory Results|0
819975|NCT00171340|1772653|FG000|Overall Study|Abnormal Test Procedure Results|6
819976|NCT00171340|1772654|FG001|Overall Study|Abnormal Test Procedure Results|11
819977|NCT00171340|1772653|FG000|Overall Study|No Longer Required Study Drug|1
819978|NCT00171340|1772654|FG001|Overall Study|No Longer Required Study Drug|1
819979|NCT00171340|1772653|FG000|Overall Study|Administrative Problems|5
819980|NCT00171340|1772654|FG001|Overall Study|Administrative Problems|2
819981|NCT00171340|1772653|FG000|Overall Study|Death|6
819982|NCT00171340|1772654|FG001|Overall Study|Death|6
819983|NCT00171704|1772664|FG000|Overall Study|Adverse Event|24
819984|NCT00171704|1772665|FG001|Overall Study|Adverse Event|33
819985|NCT00171704|1772664|FG000|Overall Study|Disease Progression|14
819986|NCT00171704|1772665|FG001|Overall Study|Disease Progression|9
819987|NCT00171704|1772664|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1
819988|NCT00171704|1772665|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0
819989|NCT00171704|1772664|FG000|Overall Study|Administrative Problems|2
819990|NCT00171704|1772665|FG001|Overall Study|Administrative Problems|1
819991|NCT00171704|1772664|FG000|Overall Study|Death|2
819992|NCT00171704|1772665|FG001|Overall Study|Death|2
819993|NCT00171704|1772664|FG000|Overall Study|Withdrawal by Subject|1
819994|NCT00171704|1772665|FG001|Overall Study|Withdrawal by Subject|3
819995|NCT00171704|1772664|FG000|Overall Study|Protocol Violation|0
819996|NCT00171704|1772665|FG001|Overall Study|Protocol Violation|1
819997|NCT00171730|1772671|FG000|Overall Study|Adverse Event|3
819998|NCT00171730|1772671|FG000|Overall Study|Abnormal Laboratory Value(s)|1
819999|NCT00171730|1772671|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8
820000|NCT00171730|1772671|FG000|Overall Study|Withdrawal by Subject|3
820001|NCT00171834|1772688|FG000|Overall Study|Adverse Event|2
820002|NCT00171834|1772689|FG001|Overall Study|Adverse Event|1
820003|NCT00171834|1772690|FG002|Overall Study|Adverse Event|3
820004|NCT00171834|1772691|FG003|Overall Study|Adverse Event|2
820005|NCT00171834|1772692|FG004|Overall Study|Adverse Event|2
820006|NCT00171834|1772693|FG005|Overall Study|Adverse Event|15
820007|NCT00171834|1772694|FG006|Overall Study|Adverse Event|1
820008|NCT00171834|1772688|FG000|Overall Study|Withdrawal by Subject|0
820009|NCT00171834|1772689|FG001|Overall Study|Withdrawal by Subject|2
820010|NCT00171834|1772690|FG002|Overall Study|Withdrawal by Subject|0
820011|NCT00171834|1772691|FG003|Overall Study|Withdrawal by Subject|1
820012|NCT00171834|1772692|FG004|Overall Study|Withdrawal by Subject|1
820013|NCT00171834|1772693|FG005|Overall Study|Withdrawal by Subject|1
820014|NCT00171834|1772694|FG006|Overall Study|Withdrawal by Subject|0
820015|NCT00171834|1772688|FG000|Overall Study|Death from study indication|0
820016|NCT00171834|1772689|FG001|Overall Study|Death from study indication|1
820017|NCT00171834|1772690|FG002|Overall Study|Death from study indication|0
820018|NCT00171834|1772691|FG003|Overall Study|Death from study indication|0
820019|NCT00171834|1772692|FG004|Overall Study|Death from study indication|1
820020|NCT00171834|1772693|FG005|Overall Study|Death from study indication|0
820021|NCT00171834|1772694|FG006|Overall Study|Death from study indication|0
820022|NCT00171834|1772688|FG000|Overall Study|Disease Progression|4
820023|NCT00171834|1772689|FG001|Overall Study|Disease Progression|8
820024|NCT00171834|1772690|FG002|Overall Study|Disease Progression|8
820025|NCT00171834|1772691|FG003|Overall Study|Disease Progression|9
820026|NCT00171834|1772692|FG004|Overall Study|Disease Progression|2
820027|NCT00171834|1772693|FG005|Overall Study|Disease Progression|18
820028|NCT00171834|1772694|FG006|Overall Study|Disease Progression|3
820029|NCT00171834|1772688|FG000|Overall Study|Treatment Duration Completed|0
820030|NCT00171834|1772689|FG001|Overall Study|Treatment Duration Completed|0
820031|NCT00171834|1772690|FG002|Overall Study|Treatment Duration Completed|1
820032|NCT00171834|1772691|FG003|Overall Study|Treatment Duration Completed|0
820033|NCT00171834|1772692|FG004|Overall Study|Treatment Duration Completed|2
820034|NCT00171834|1772693|FG005|Overall Study|Treatment Duration Completed|1
820035|NCT00171834|1772694|FG006|Overall Study|Treatment Duration Completed|0
820036|NCT00171873|1772726|FG000|Overall Study|Withdrawal by Subject|4
820037|NCT00171873|1772727|FG001|Overall Study|Withdrawal by Subject|2
820038|NCT00171873|1772726|FG000|Overall Study|Adverse Event|5
820039|NCT00171873|1772727|FG001|Overall Study|Adverse Event|0
820040|NCT00171873|1772726|FG000|Overall Study|Switched to Octreotide|0
820041|NCT00171873|1772727|FG001|Overall Study|Switched to Octreotide|1
820042|NCT00171925|1772735|FG000|Overall Study|Adverse Event|10
820043|NCT00171925|1772736|FG001|Overall Study|Adverse Event|6
820044|NCT00171925|1772735|FG000|Overall Study|Protocol Violation|1
820045|NCT00171925|1772736|FG001|Overall Study|Protocol Violation|1
820046|NCT00171925|1772735|FG000|Overall Study|Withdrawal by Subject|6
820047|NCT00171925|1772736|FG001|Overall Study|Withdrawal by Subject|9
820048|NCT00171925|1772735|FG000|Overall Study|Lost to Follow-up|2
820049|NCT00171925|1772736|FG001|Overall Study|Lost to Follow-up|2
820050|NCT00171925|1772735|FG000|Overall Study|Administrative problems|10
820051|NCT00171925|1772736|FG001|Overall Study|Administrative problems|11
820052|NCT00171925|1772735|FG000|Overall Study|Death|1
820053|NCT00171925|1772736|FG001|Overall Study|Death|2
820054|NCT00171951|1772742|FG000|Overall Study|Adverse Event|1
820055|NCT00171951|1772742|FG000|Overall Study|Abnormal Laboratory Values|2
820056|NCT00171951|1772742|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
820057|NCT00171951|1772742|FG000|Overall Study|Participants Withdrew Consent|3
820058|NCT00171951|1772742|FG000|Overall Study|New Cancer Therapy|5
820059|NCT00171951|1772742|FG000|Overall Study|Reason not Specified|2
820060|NCT00172042|1772751|FG000|Overall Study|Adverse Event|27
820061|NCT00172042|1772752|FG001|Overall Study|Adverse Event|13
820062|NCT00172042|1772751|FG000|Overall Study|Abnormal laboratory value(s)|5
820063|NCT00172042|1772752|FG001|Overall Study|Abnormal laboratory value(s)|1
820064|NCT00172042|1772751|FG000|Overall Study|Abnormal test procedure(s)|0
820065|NCT00172042|1772752|FG001|Overall Study|Abnormal test procedure(s)|3
820066|NCT00172042|1772751|FG000|Overall Study|Unsatisfactory therapeutic effect|13
820067|NCT00172042|1772752|FG001|Overall Study|Unsatisfactory therapeutic effect|11
820068|NCT00172042|1772751|FG000|Overall Study|Patient no longer requires study drug|10
820069|NCT00172042|1772752|FG001|Overall Study|Patient no longer requires study drug|8
820070|NCT00172042|1772751|FG000|Overall Study|Protocol Violation|8
820071|NCT00172042|1772752|FG001|Overall Study|Protocol Violation|7
820072|NCT00172042|1772751|FG000|Overall Study|Withdrawal by Subject|37
820073|NCT00172042|1772752|FG001|Overall Study|Withdrawal by Subject|25
820074|NCT00172042|1772751|FG000|Overall Study|Lost to Follow-up|3
820075|NCT00172042|1772752|FG001|Overall Study|Lost to Follow-up|5
820076|NCT00172042|1772751|FG000|Overall Study|Administrative problems|13
820077|NCT00172042|1772752|FG001|Overall Study|Administrative problems|10
820078|NCT00172042|1772751|FG000|Overall Study|Death|42
820079|NCT00172042|1772752|FG001|Overall Study|Death|42
820080|NCT00172185|1772762|FG000|Overall Study|Adverse Event|0
820081|NCT00172185|1772763|FG001|Overall Study|Adverse Event|1
820082|NCT00172185|1772764|FG002|Overall Study|Adverse Event|3
820083|NCT00172185|1772765|FG003|Overall Study|Adverse Event|4
820084|NCT00172185|1772762|FG000|Overall Study|Physician Decision|0
820085|NCT00172185|1772763|FG001|Overall Study|Physician Decision|0
820086|NCT00172185|1772764|FG002|Overall Study|Physician Decision|1
820087|NCT00172185|1772765|FG003|Overall Study|Physician Decision|0
820088|NCT00172185|1772762|FG000|Overall Study|SPONSOR Decision|0
820089|NCT00172185|1772763|FG001|Overall Study|SPONSOR Decision|1
820090|NCT00172185|1772764|FG002|Overall Study|SPONSOR Decision|0
820091|NCT00172185|1772765|FG003|Overall Study|SPONSOR Decision|0
820092|NCT00172185|1772762|FG000|Overall Study|Withdrawal by Subject|0
820093|NCT00172185|1772763|FG001|Overall Study|Withdrawal by Subject|0
820094|NCT00172185|1772764|FG002|Overall Study|Withdrawal by Subject|1
820095|NCT00172185|1772765|FG003|Overall Study|Withdrawal by Subject|0
820096|NCT00174187|1772781|FG000|Period 1 (up to 3 Years)|Serious adverse event|0
820097|NCT00174187|1772782|FG001|Period 1 (up to 3 Years)|Serious adverse event|1
820098|NCT00174187|1772783|FG002|Period 1 (up to 3 Years)|Serious adverse event|0
820099|NCT00174187|1772781|FG000|Period 1 (up to 3 Years)|Non compliance|0
820100|NCT00174187|1772782|FG001|Period 1 (up to 3 Years)|Non compliance|1
820101|NCT00174187|1772783|FG002|Period 1 (up to 3 Years)|Non compliance|0
820102|NCT00174187|1772781|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0
820103|NCT00174187|1772782|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1
820104|NCT00174187|1772783|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0
820105|NCT00174187|1772781|FG000|Period 1 (up to 3 Years)|Other|0
820106|NCT00174187|1772782|FG001|Period 1 (up to 3 Years)|Other|1
820107|NCT00174187|1772783|FG002|Period 1 (up to 3 Years)|Other|0
820108|NCT00174187|1772781|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0
820109|NCT00174187|1772782|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0
820110|NCT00174187|1772783|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2
820111|NCT00174187|1772781|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0
820112|NCT00174187|1772782|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0
820113|NCT00174187|1772783|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3
820114|NCT00174187|1772781|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0
820115|NCT00174187|1772782|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0
820116|NCT00174187|1772783|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2
820117|NCT00174187|1772781|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0
820118|NCT00174187|1772782|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0
820119|NCT00174187|1772783|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1
820120|NCT00174187|1772781|FG000|Period 2 (After 3 Years)|Other|0
820121|NCT00174187|1772782|FG001|Period 2 (After 3 Years)|Other|0
820122|NCT00174187|1772783|FG002|Period 2 (After 3 Years)|Other|5
820123|NCT00174252|1772791|FG000|Overall Study|Protocol Violation|2
820124|NCT00174265|1772799|FG000|Overall Study|Adverse Event|7
820125|NCT00174265|1772800|FG001|Overall Study|Adverse Event|4
820126|NCT00174265|1772799|FG000|Overall Study|Lack of Efficacy|2
820127|NCT00174265|1772800|FG001|Overall Study|Lack of Efficacy|2
820128|NCT00174265|1772799|FG000|Overall Study|Withdrawal by Subject|3
820129|NCT00174265|1772800|FG001|Overall Study|Withdrawal by Subject|5
820130|NCT00174265|1772799|FG000|Overall Study|Lost to Follow-up|1
820131|NCT00174265|1772800|FG001|Overall Study|Lost to Follow-up|0
820132|NCT00174265|1772799|FG000|Overall Study|Other (Not specified)|16
820133|NCT00174265|1772800|FG001|Overall Study|Other (Not specified)|10
820134|NCT00174291|1772808|FG000|Overall Study|Lost to Follow-up|1
820135|NCT00174291|1772809|FG001|Overall Study|Lost to Follow-up|1
820136|NCT00174291|1772808|FG000|Overall Study|Protocol Violation|0
820137|NCT00174291|1772809|FG001|Overall Study|Protocol Violation|2
820138|NCT00174291|1772808|FG000|Overall Study|Study terminated by sponsor|1
820139|NCT00174291|1772809|FG001|Overall Study|Study terminated by sponsor|0
820140|NCT00174291|1772808|FG000|Overall Study|Withdrawal by Subject|3
820141|NCT00174291|1772809|FG001|Overall Study|Withdrawal by Subject|3
820142|NCT00174382|1772815|FG000|Overall Study|Death|2
820143|NCT00174382|1772815|FG000|Overall Study|Adverse Event|19
820144|NCT00174382|1772815|FG000|Overall Study|Withdrawal by Subject|6
820145|NCT00174382|1772815|FG000|Overall Study|Protocol Violation|3
820146|NCT00174382|1772815|FG000|Overall Study|Arrived early for last visit in error|1
820147|NCT00174382|1772815|FG000|Overall Study|Subject felt pill not effective enough|1
820148|NCT00174382|1772815|FG000|Overall Study|Lost to Follow-up|1
820149|NCT00174447|1772819|FG000|Overall Study|Adverse Event|19
820150|NCT00174447|1772819|FG000|Overall Study|Withdrawal by Subject|15
820151|NCT00174447|1772819|FG000|Overall Study|Protocol Violation|1
820152|NCT00174447|1772819|FG000|Overall Study|Lack of Efficacy|1
820153|NCT00174447|1772819|FG000|Overall Study|Administrative reason/Other|2
820154|NCT00174460|1772825|FG000|Overall Study|Withdrawal by Subject|0
820155|NCT00174460|1772826|FG001|Overall Study|Withdrawal by Subject|1
820156|NCT00174785|1772835|FG000|Overall Study|Adverse Event|293
820157|NCT00174785|1772836|FG001|Overall Study|Adverse Event|191
820158|NCT00174785|1772835|FG000|Overall Study|Protocol Violation|14
820159|NCT00174785|1772836|FG001|Overall Study|Protocol Violation|14
820160|NCT00174785|1772835|FG000|Overall Study|Withdrawal by Subject|173
820161|NCT00174785|1772836|FG001|Overall Study|Withdrawal by Subject|175
820162|NCT00174785|1772835|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110
820163|NCT00174785|1772836|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167
820164|NCT00174785|1772835|FG000|Overall Study|Prohibited antiarrhythmic medication|39
820165|NCT00174785|1772836|FG001|Overall Study|Prohibited antiarrhythmic medication|88
820166|NCT00174785|1772835|FG000|Overall Study|Other prohibited medication|5
820167|NCT00174785|1772836|FG001|Overall Study|Other prohibited medication|3
820168|NCT00174785|1772835|FG000|Overall Study|Family request|6
820169|NCT00174785|1772836|FG001|Overall Study|Family request|8
820170|NCT00174785|1772835|FG000|Overall Study|Not pre-specified/Not coded|56
820171|NCT00174785|1772836|FG001|Overall Study|Not pre-specified/Not coded|70
820172|NCT00174915|1772847|FG000|Overall Study|Lost to Follow-up|19
820173|NCT00174915|1772848|FG001|Overall Study|Lost to Follow-up|17
820174|NCT00174915|1772849|FG002|Overall Study|Lost to Follow-up|9
820175|NCT00174915|1772850|FG003|Overall Study|Lost to Follow-up|17
820176|NCT00174915|1772851|FG004|Overall Study|Lost to Follow-up|10
820177|NCT00174915|1772847|FG000|Overall Study|Adverse Event|18
820178|NCT00174915|1772848|FG001|Overall Study|Adverse Event|16
820179|NCT00174915|1772849|FG002|Overall Study|Adverse Event|11
820180|NCT00174915|1772850|FG003|Overall Study|Adverse Event|18
820181|NCT00174915|1772851|FG004|Overall Study|Adverse Event|5
820182|NCT00174915|1772847|FG000|Overall Study|Personal Reason(s)|16
820183|NCT00174915|1772848|FG001|Overall Study|Personal Reason(s)|16
820184|NCT00174915|1772849|FG002|Overall Study|Personal Reason(s)|9
820185|NCT00174915|1772850|FG003|Overall Study|Personal Reason(s)|9
820186|NCT00174915|1772851|FG004|Overall Study|Personal Reason(s)|9
820187|NCT00174915|1772847|FG000|Overall Study|Other|15
820188|NCT00174915|1772848|FG001|Overall Study|Other|8
820189|NCT00174915|1772849|FG002|Overall Study|Other|6
820190|NCT00174915|1772850|FG003|Overall Study|Other|5
820191|NCT00174915|1772851|FG004|Overall Study|Other|3
820192|NCT00174915|1772847|FG000|Overall Study|Gout Flare|13
820193|NCT00174915|1772848|FG001|Overall Study|Gout Flare|6
820194|NCT00174915|1772849|FG002|Overall Study|Gout Flare|8
820195|NCT00174915|1772850|FG003|Overall Study|Gout Flare|1
820196|NCT00174915|1772851|FG004|Overall Study|Gout Flare|0
820197|NCT00174915|1772847|FG000|Overall Study|Protocol Violation|6
820198|NCT00174915|1772848|FG001|Overall Study|Protocol Violation|3
820199|NCT00174915|1772849|FG002|Overall Study|Protocol Violation|3
820200|NCT00174915|1772850|FG003|Overall Study|Protocol Violation|6
820201|NCT00174915|1772851|FG004|Overall Study|Protocol Violation|3
820202|NCT00174915|1772847|FG000|Overall Study|Therapeutic Failure|6
820203|NCT00174915|1772848|FG001|Overall Study|Therapeutic Failure|3
820204|NCT00174915|1772849|FG002|Overall Study|Therapeutic Failure|2
820205|NCT00174915|1772850|FG003|Overall Study|Therapeutic Failure|1
820206|NCT00174915|1772851|FG004|Overall Study|Therapeutic Failure|3
820207|NCT00174941|1772866|FG000|Overall Study|Adverse Event|1
820208|NCT00174941|1772867|FG001|Overall Study|Adverse Event|10
820209|NCT00174941|1772868|FG002|Overall Study|Adverse Event|2
820210|NCT00174941|1772869|FG003|Overall Study|Adverse Event|13
820211|NCT00174941|1772866|FG000|Overall Study|Protocol Violation|0
820212|NCT00174941|1772867|FG001|Overall Study|Protocol Violation|1
820213|NCT00174941|1772868|FG002|Overall Study|Protocol Violation|0
820214|NCT00174941|1772869|FG003|Overall Study|Protocol Violation|1
820215|NCT00174941|1772866|FG000|Overall Study|Lost to Follow-up|0
820216|NCT00174941|1772867|FG001|Overall Study|Lost to Follow-up|3
820217|NCT00174941|1772868|FG002|Overall Study|Lost to Follow-up|2
820218|NCT00174941|1772869|FG003|Overall Study|Lost to Follow-up|5
820219|NCT00174941|1772866|FG000|Overall Study|Personal Reason(s)|0
820220|NCT00174941|1772867|FG001|Overall Study|Personal Reason(s)|14
820221|NCT00174941|1772868|FG002|Overall Study|Personal Reason(s)|8
820222|NCT00174941|1772869|FG003|Overall Study|Personal Reason(s)|22
820223|NCT00174941|1772866|FG000|Overall Study|Gout Flare|0
820224|NCT00174941|1772867|FG001|Overall Study|Gout Flare|4
820225|NCT00174941|1772868|FG002|Overall Study|Gout Flare|4
820226|NCT00174941|1772869|FG003|Overall Study|Gout Flare|8
820227|NCT00174941|1772866|FG000|Overall Study|Reason Not Specified|1
820228|NCT00174941|1772867|FG001|Overall Study|Reason Not Specified|6
820229|NCT00174941|1772868|FG002|Overall Study|Reason Not Specified|2
820230|NCT00174941|1772869|FG003|Overall Study|Reason Not Specified|9
820231|NCT00174954|1772879|FG000|Overall Study|Adverse Event|2
820232|NCT00174954|1772879|FG000|Overall Study|No tophi found in MRI|1
820233|NCT00174954|1772879|FG000|Overall Study|Physician Decision|1
820234|NCT00174967|1772887|FG000|Overall Study|Adverse Event|1
820235|NCT00174967|1772888|FG001|Overall Study|Adverse Event|2
820236|NCT00174967|1772889|FG002|Overall Study|Adverse Event|2
820237|NCT00174967|1772890|FG003|Overall Study|Adverse Event|1
820238|NCT00174967|1772887|FG000|Overall Study|Gout Flare|0
820239|NCT00174967|1772888|FG001|Overall Study|Gout Flare|0
820240|NCT00174967|1772889|FG002|Overall Study|Gout Flare|0
820241|NCT00174967|1772890|FG003|Overall Study|Gout Flare|1
820242|NCT00174967|1772887|FG000|Overall Study|Other|0
820243|NCT00174967|1772888|FG001|Overall Study|Other|1
820244|NCT00174967|1772889|FG002|Overall Study|Other|0
820245|NCT00174967|1772890|FG003|Overall Study|Other|0
820246|NCT00175019|1772907|FG000|Overall Study|Adverse Event|54
820247|NCT00175019|1772908|FG001|Overall Study|Adverse Event|22
820248|NCT00175019|1772909|FG002|Overall Study|Adverse Event|2
820249|NCT00175019|1772907|FG000|Overall Study|Protocol Violation|6
820250|NCT00175019|1772908|FG001|Overall Study|Protocol Violation|3
820251|NCT00175019|1772909|FG002|Overall Study|Protocol Violation|3
820252|NCT00175019|1772907|FG000|Overall Study|Lost to Follow-up|42
820253|NCT00175019|1772908|FG001|Overall Study|Lost to Follow-up|39
820254|NCT00175019|1772909|FG002|Overall Study|Lost to Follow-up|9
820255|NCT00175019|1772907|FG000|Overall Study|Did not continue under Amendment 4|1
820256|NCT00175019|1772908|FG001|Overall Study|Did not continue under Amendment 4|1
820257|NCT00175019|1772909|FG002|Overall Study|Did not continue under Amendment 4|2
820258|NCT00175019|1772907|FG000|Overall Study|Personal Reason(s)|39
820259|NCT00175019|1772908|FG001|Overall Study|Personal Reason(s)|31
820260|NCT00175019|1772909|FG002|Overall Study|Personal Reason(s)|8
820261|NCT00175019|1772907|FG000|Overall Study|Therapeutic Failure|10
820262|NCT00175019|1772908|FG001|Overall Study|Therapeutic Failure|38
820263|NCT00175019|1772909|FG002|Overall Study|Therapeutic Failure|22
820264|NCT00175019|1772907|FG000|Overall Study|Gout Flare|2
820265|NCT00175019|1772908|FG001|Overall Study|Gout Flare|3
820266|NCT00175019|1772909|FG002|Overall Study|Gout Flare|0
820267|NCT00175019|1772907|FG000|Overall Study|Reason Not Specified|40
820268|NCT00175019|1772908|FG001|Overall Study|Reason Not Specified|34
820269|NCT00175019|1772909|FG002|Overall Study|Reason Not Specified|11
820270|NCT00175825|1772921|FG000|Overall Study|Adverse Event|3
820271|NCT00175825|1772922|FG001|Overall Study|Adverse Event|2
820272|NCT00175825|1772923|FG002|Overall Study|Adverse Event|1
820273|NCT00175825|1772924|FG003|Overall Study|Adverse Event|1
820274|NCT00175825|1772921|FG000|Overall Study|Lost to Follow-up|1
820275|NCT00175825|1772922|FG001|Overall Study|Lost to Follow-up|2
820276|NCT00175825|1772923|FG002|Overall Study|Lost to Follow-up|0
820277|NCT00175825|1772924|FG003|Overall Study|Lost to Follow-up|0
820278|NCT00175825|1772921|FG000|Overall Study|Withdrawal by Subject|1
820279|NCT00175825|1772922|FG001|Overall Study|Withdrawal by Subject|0
820280|NCT00175825|1772923|FG002|Overall Study|Withdrawal by Subject|0
820281|NCT00175825|1772924|FG003|Overall Study|Withdrawal by Subject|0
820282|NCT00175877|1772934|FG000|Overall Study|Adverse Event|136
820283|NCT00175877|1772934|FG000|Overall Study|Withdrawal by Subject|141
820284|NCT00175877|1772934|FG000|Overall Study|Lost to Follow-up|9
820285|NCT00175877|1772934|FG000|Overall Study|Lack of Efficacy|26
820286|NCT00175877|1772934|FG000|Overall Study|Protocol Violation|15
820287|NCT00175877|1772934|FG000|Overall Study|Other Reason|20
820288|NCT00175877|1772934|FG000|Overall Study|AE & Other|1
820289|NCT00175877|1772934|FG000|Overall Study|Withdrawal by subject & Other|1
820290|NCT00175916|1772938|FG000|Overall Study|Death|19
820291|NCT00175916|1772938|FG000|Overall Study|Adverse Event|81
820292|NCT00175916|1772938|FG000|Overall Study|Lack of Efficacy|354
820293|NCT00175916|1772938|FG000|Overall Study|Lost to Follow-up|17
820294|NCT00175916|1772938|FG000|Overall Study|Subject Choice|98
820295|NCT00175916|1772938|FG000|Overall Study|Lack of compliance|8
820296|NCT00175916|1772938|FG000|Overall Study|Patient cannot record seizures|1
820297|NCT00175916|1772938|FG000|Overall Study|Sponsor decision|17
820298|NCT00175916|1772938|FG000|Overall Study|Vigabatrin intake|1
820299|NCT00175916|1772938|FG000|Overall Study|Suicidal behaviour|1
820300|NCT00175916|1772938|FG000|Overall Study|Withdrawal by Subject|1
820301|NCT00175916|1772938|FG000|Overall Study|Seizure - free|4
820302|NCT00175916|1772938|FG000|Overall Study|Administrative reason|1
820303|NCT00175916|1772938|FG000|Overall Study|Pregnancy|1
820304|NCT00175916|1772938|FG000|Overall Study|Patient's request|2
820305|NCT00175916|1772938|FG000|Overall Study|Treating physiciant's choice|1
820306|NCT00175916|1772938|FG000|Overall Study|Moved overseas|1
820307|NCT00175916|1772938|FG000|Overall Study|Loss of job and economic burden|1
820308|NCT00175916|1772938|FG000|Overall Study|Site was closed|9
820309|NCT00175916|1772938|FG000|Overall Study|Patient went to prison|1
820310|NCT00176254|1772959|FG000|Overall Study|Lost to Follow-up|1
820311|NCT00176462|1772987|FG000|Induction (4 Weeks)|Withdrawal by Subject|0
820312|NCT00176462|1772988|FG001|Induction (4 Weeks)|Withdrawal by Subject|2
820313|NCT00176462|1772987|FG000|Induction (4 Weeks)|Death|1
820314|NCT00176462|1772988|FG001|Induction (4 Weeks)|Death|2
820315|NCT00176462|1772987|FG000|Induction (4 Weeks)|Lack of Efficacy|0
820316|NCT00176462|1772988|FG001|Induction (4 Weeks)|Lack of Efficacy|1
820317|NCT00176462|1772987|FG000|Consolidation (12 Weeks)|Patient moved to another state|0
820318|NCT00176462|1772988|FG001|Consolidation (12 Weeks)|Patient moved to another state|1
820319|NCT00176462|1772987|FG000|Consolidation (12 Weeks)|Adverse Event|0
820320|NCT00176462|1772988|FG001|Consolidation (12 Weeks)|Adverse Event|1
820321|NCT00176462|1772987|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0
820322|NCT00176462|1772988|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2
820323|NCT00176462|1772987|FG000|Consolidation (12 Weeks)|Not documented|0
820324|NCT00176462|1772988|FG001|Consolidation (12 Weeks)|Not documented|1
820325|NCT00176462|1772987|FG000|Intensive Continuation (8X8-week Cycles)|Death|1
820326|NCT00176462|1772988|FG001|Intensive Continuation (8X8-week Cycles)|Death|0
820327|NCT00176462|1772987|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
820328|NCT00176462|1772988|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
820329|NCT00176605|1773004|FG000|Overall Study|Withdrawal by Subject|2
820330|NCT00176644|1773008|FG000|Overall Study|Withdrawal by Subject|1
820331|NCT00177164|1773105|FG000|Overall Study|Protocol Violation|0
820332|NCT00177164|1773106|FG001|Overall Study|Protocol Violation|7
820333|NCT00177164|1773105|FG000|Overall Study|Lost to Follow-up|4
820334|NCT00177164|1773106|FG001|Overall Study|Lost to Follow-up|5
820335|NCT00177164|1773105|FG000|Overall Study|increase in alcohol and drug use|1
820336|NCT00177164|1773106|FG001|Overall Study|increase in alcohol and drug use|2
820337|NCT00177164|1773105|FG000|Overall Study|Adverse Event|1
820338|NCT00177164|1773106|FG001|Overall Study|Adverse Event|0
820339|NCT00177164|1773105|FG000|Overall Study|discharge from hospital|1
820340|NCT00177164|1773106|FG001|Overall Study|discharge from hospital|0
820341|NCT00177164|1773105|FG000|Overall Study|Lack of Efficacy|2
820342|NCT00177164|1773106|FG001|Overall Study|Lack of Efficacy|1
820343|NCT00177164|1773105|FG000|Overall Study|Pregnancy|0
820344|NCT00177164|1773106|FG001|Overall Study|Pregnancy|1
820345|NCT00177216|1773115|FG000|Overall Study|Withdrawal by Subject|6
820346|NCT00177216|1773116|FG001|Overall Study|Withdrawal by Subject|3
820347|NCT00177216|1773117|FG002|Overall Study|Withdrawal by Subject|1
820348|NCT00177294|1773135|FG000|Overall Study|Withdrawal by Subject|7
820349|NCT00177294|1773136|FG001|Overall Study|Withdrawal by Subject|5
820350|NCT00177307|1773142|FG000|Overall Study|Withdrawal by Subject|1
820351|NCT00177671|1773148|FG000|Overall Study|Withdrawal by Subject|5
820352|NCT00177671|1773149|FG001|Overall Study|Withdrawal by Subject|6
820353|NCT00177671|1773148|FG000|Overall Study|medical complications|2
820354|NCT00177671|1773149|FG001|Overall Study|medical complications|0
820355|NCT00177671|1773148|FG000|Overall Study|Adverse Event|6
820356|NCT00177671|1773149|FG001|Overall Study|Adverse Event|0
820357|NCT00177671|1773148|FG000|Overall Study|Physician Decision|12
820358|NCT00177671|1773149|FG001|Overall Study|Physician Decision|8
820359|NCT00178126|1773157|FG000|Overall Study|Lost to Follow-up|21
820360|NCT00178126|1773158|FG001|Overall Study|Lost to Follow-up|21
820361|NCT00178126|1773157|FG000|Overall Study|did not receive intervention|4
820362|NCT00178126|1773158|FG001|Overall Study|did not receive intervention|6
820363|NCT00178256|1773194|FG000|Overall Study|Adverse Event|2
820364|NCT00178256|1773195|FG001|Overall Study|Adverse Event|0
820365|NCT00178256|1773196|FG002|Overall Study|Adverse Event|0
820366|NCT00178256|1773197|FG003|Overall Study|Adverse Event|0
820367|NCT00178256|1773194|FG000|Overall Study|Death|0
820368|NCT00178256|1773195|FG001|Overall Study|Death|1
820369|NCT00178256|1773196|FG002|Overall Study|Death|0
820370|NCT00178256|1773197|FG003|Overall Study|Death|1
820371|NCT00178256|1773194|FG000|Overall Study|Cancer progression|2
820372|NCT00178256|1773195|FG001|Overall Study|Cancer progression|0
820373|NCT00178256|1773196|FG002|Overall Study|Cancer progression|0
820374|NCT00178256|1773197|FG003|Overall Study|Cancer progression|1
820375|NCT00178399|1773204|FG000|Overall Study|Physician Decision|4
820376|NCT00178399|1773204|FG000|Overall Study|Withdrawal by Subject|8
820377|NCT00178399|1773204|FG000|Overall Study|Lost to Follow-up|1
820378|NCT00178464|1773209|FG000|Overall Study|Withdrawal by Subject|1
820379|NCT00178464|1773209|FG000|Overall Study|Physician Decision|1
820380|NCT00178633|1773228|FG000|Overall Study|Lost to Follow-up|6
820381|NCT00178685|1773252|FG000|Overall Study|Death|3
820382|NCT00178685|1773253|FG001|Overall Study|Death|3
820383|NCT00178685|1773254|FG002|Overall Study|Death|6
820384|NCT00178685|1773252|FG000|Overall Study|Lost to Follow-up|100
820385|NCT00178685|1773253|FG001|Overall Study|Lost to Follow-up|187
820386|NCT00178685|1773254|FG002|Overall Study|Lost to Follow-up|183
820387|NCT00178685|1773252|FG000|Overall Study|Withdrawal by Subject|8
820388|NCT00178685|1773253|FG001|Overall Study|Withdrawal by Subject|14
820389|NCT00178685|1773254|FG002|Overall Study|Withdrawal by Subject|7
820390|NCT00179010|1773289|FG000|Overall Study|Muscle probe defective|1
820391|NCT00179010|1773290|FG001|Overall Study|Muscle probe defective|1
820392|NCT00179010|1773289|FG000|Overall Study|Failure to place arterial line|0
820393|NCT00179010|1773290|FG001|Overall Study|Failure to place arterial line|1
820394|NCT00179309|1773299|FG000|Treatment|Toxicity|2
820395|NCT00179309|1773300|FG001|Treatment|Toxicity|3
820396|NCT00179309|1773299|FG000|Treatment|Withdrawal by Subject|1
820397|NCT00179309|1773300|FG001|Treatment|Withdrawal by Subject|2
820398|NCT00179309|1773299|FG000|Treatment|Allergy|1
820399|NCT00179309|1773300|FG001|Treatment|Allergy|0
820400|NCT00179413|1773308|FG000|Overall Study|Adverse Event|38
820401|NCT00179413|1773309|FG001|Overall Study|Adverse Event|20
820402|NCT00179413|1773308|FG000|Overall Study|Withdrawal by Subject|87
820403|NCT00179413|1773309|FG001|Overall Study|Withdrawal by Subject|95
820404|NCT00179517|1773325|FG000|Overall Study|Withdrawal by Subject|2
820405|NCT00179517|1773326|FG001|Overall Study|Withdrawal by Subject|1
820406|NCT00179621|1773335|FG000|Double-Blind Period|Lack of Therapeutic Effect|59
820407|NCT00179621|1773336|FG001|Double-Blind Period|Lack of Therapeutic Effect|35
820408|NCT00179621|1773337|FG002|Double-Blind Period|Lack of Therapeutic Effect|19
820409|NCT00179621|1773338|FG003|Double-Blind Period|Lack of Therapeutic Effect|0
820410|NCT00179621|1773335|FG000|Double-Blind Period|Adverse Event|2
820411|NCT00179621|1773336|FG001|Double-Blind Period|Adverse Event|7
820412|NCT00179621|1773337|FG002|Double-Blind Period|Adverse Event|4
820413|NCT00179621|1773338|FG003|Double-Blind Period|Adverse Event|0
820414|NCT00179621|1773335|FG000|Double-Blind Period|Withdrawal by Subject|2
820415|NCT00179621|1773336|FG001|Double-Blind Period|Withdrawal by Subject|1
820416|NCT00179621|1773337|FG002|Double-Blind Period|Withdrawal by Subject|3
820417|NCT00179621|1773338|FG003|Double-Blind Period|Withdrawal by Subject|0
820418|NCT00179621|1773335|FG000|Double-Blind Period|Death|0
820419|NCT00179621|1773336|FG001|Double-Blind Period|Death|1
820420|NCT00179621|1773337|FG002|Double-Blind Period|Death|2
820421|NCT00179621|1773338|FG003|Double-Blind Period|Death|0
820422|NCT00179621|1773335|FG000|Double-Blind Period|Protocol Violation|1
820423|NCT00179621|1773336|FG001|Double-Blind Period|Protocol Violation|0
820424|NCT00179621|1773337|FG002|Double-Blind Period|Protocol Violation|0
820425|NCT00179621|1773338|FG003|Double-Blind Period|Protocol Violation|0
820426|NCT00179621|1773335|FG000|Double-Blind Period|Other|0
820427|NCT00179621|1773336|FG001|Double-Blind Period|Other|2
820428|NCT00179621|1773337|FG002|Double-Blind Period|Other|2
820429|NCT00179621|1773338|FG003|Double-Blind Period|Other|0
820430|NCT00179621|1773335|FG000|Open-Label Period|Lack of Therapeutic Effect|0
820431|NCT00179621|1773336|FG001|Open-Label Period|Lack of Therapeutic Effect|19
820432|NCT00179621|1773337|FG002|Open-Label Period|Lack of Therapeutic Effect|19
820433|NCT00179621|1773338|FG003|Open-Label Period|Lack of Therapeutic Effect|31
820434|NCT00179621|1773335|FG000|Open-Label Period|Adverse Event|0
820435|NCT00179621|1773336|FG001|Open-Label Period|Adverse Event|6
820436|NCT00179621|1773337|FG002|Open-Label Period|Adverse Event|5
820437|NCT00179621|1773338|FG003|Open-Label Period|Adverse Event|6
820438|NCT00179621|1773335|FG000|Open-Label Period|Withdrawal by Subject|0
820439|NCT00179621|1773336|FG001|Open-Label Period|Withdrawal by Subject|2
820440|NCT00179621|1773337|FG002|Open-Label Period|Withdrawal by Subject|2
820441|NCT00179621|1773338|FG003|Open-Label Period|Withdrawal by Subject|2
820442|NCT00179621|1773335|FG000|Open-Label Period|Death|0
820443|NCT00179621|1773336|FG001|Open-Label Period|Death|0
820444|NCT00179621|1773337|FG002|Open-Label Period|Death|1
820445|NCT00179621|1773338|FG003|Open-Label Period|Death|2
820446|NCT00179621|1773335|FG000|Open-Label Period|Other|0
820447|NCT00179621|1773336|FG001|Open-Label Period|Other|1
820448|NCT00179621|1773337|FG002|Open-Label Period|Other|1
820449|NCT00179621|1773338|FG003|Open-Label Period|Other|2
820450|NCT00179647|1773347|FG000|Overall Study|Adverse Event|294
820451|NCT00179647|1773347|FG000|Overall Study|Lack of Efficacy|478
820452|NCT00179647|1773347|FG000|Overall Study|Withdrawal by Subject|83
820453|NCT00179647|1773347|FG000|Overall Study|Lost to Follow-up|4
820454|NCT00179647|1773347|FG000|Overall Study|Death|94
820455|NCT00179647|1773347|FG000|Overall Study|Other|960
820456|NCT00179660|1773351|FG000|Overall Study|Adverse Event|7
820457|NCT00179660|1773351|FG000|Overall Study|Lack of therapeutic effect|28
820458|NCT00179660|1773351|FG000|Overall Study|Withdrawal by Subject|2
820459|NCT00179660|1773351|FG000|Overall Study|Lost to Follow-up|1
820460|NCT00179660|1773351|FG000|Overall Study|Death|3
820461|NCT00179660|1773351|FG000|Overall Study|Other - Unspecified|9
820462|NCT00179673|1773355|FG000|Overall Study|Adverse Event|7
820463|NCT00179673|1773355|FG000|Overall Study|Lack of Efficacy|15
820464|NCT00179673|1773355|FG000|Overall Study|Withdrawal by Subject|3
820465|NCT00179673|1773355|FG000|Overall Study|Death|4
820466|NCT00179673|1773355|FG000|Overall Study|Other Observations and options|14
820467|NCT00179959|1773372|FG000|Overall Study|Lost to Follow-up|3
820468|NCT00179959|1773373|FG001|Overall Study|Lost to Follow-up|1
820469|NCT00179959|1773372|FG000|Overall Study|Withdrawal by Subject|3
820470|NCT00179959|1773373|FG001|Overall Study|Withdrawal by Subject|2
820471|NCT00180479|1773420|FG000|Overall Study|Death|4
820472|NCT00180479|1773421|FG001|Overall Study|Death|2
820473|NCT00180479|1773420|FG000|Overall Study|Lost to Follow-up|9
820474|NCT00180479|1773421|FG001|Overall Study|Lost to Follow-up|7
820475|NCT00180479|1773420|FG000|Overall Study|Withdrawal by Subject|3
820476|NCT00180479|1773421|FG001|Overall Study|Withdrawal by Subject|3
820477|NCT00180479|1773420|FG000|Overall Study|Informed consent not signed|0
820478|NCT00180479|1773421|FG001|Overall Study|Informed consent not signed|1
820479|NCT00180674|1773436|FG000|Phase 1, Observation Period|Withdrawal by Subject|4
820480|NCT00180674|1773436|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1
820481|NCT00180713|1773463|FG000|Overall Study|Withdrawal by Subject|2
820482|NCT00180713|1773464|FG001|Overall Study|Withdrawal by Subject|0
820483|NCT00180713|1773463|FG000|Overall Study|Adverse Event|3
820484|NCT00180713|1773464|FG001|Overall Study|Adverse Event|3
820485|NCT00181155|1773470|FG000|Overall Study|Physician Decision|1
820486|NCT00181155|1773471|FG001|Overall Study|Physician Decision|0
820487|NCT00181155|1773470|FG000|Overall Study|Withdrawal by Subject|1
820488|NCT00181155|1773471|FG001|Overall Study|Withdrawal by Subject|0
820489|NCT00181766|1773535|FG000|Overall Study|Lost to Follow-up|6
820490|NCT00181766|1773535|FG000|Overall Study|Adverse Event|4
820491|NCT00181766|1773535|FG000|Overall Study|non-compliance|2
820492|NCT00181844|1773539|FG000|Signed Consent|Withdrawal by Subject|5
820493|NCT00181844|1773539|FG000|Signed Consent|Did not meet entrance criteria|7
820494|NCT00181844|1773539|FG000|Exposed to Study Medication|Adverse Event|10
820495|NCT00181844|1773539|FG000|Exposed to Study Medication|Lack of Efficacy|2
820496|NCT00181844|1773539|FG000|Exposed to Study Medication|Non-compliance|2
820497|NCT00181844|1773539|FG000|Exposed to Study Medication|Withdrawal by Subject|1
820498|NCT00181844|1773539|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2
820499|NCT00181883|1773543|FG000|Overall Study|Lack of Efficacy|2
820500|NCT00181883|1773543|FG000|Overall Study|Treatment Limiting AEs|3
820501|NCT00181883|1773543|FG000|Overall Study|Withdrawal by Subject|4
820502|NCT00181883|1773543|FG000|Overall Study|Lost to Follow-up|1
820503|NCT00182078|1773567|FG000|Overall Study|Withdrawal by Subject|1
820504|NCT00182078|1773568|FG001|Overall Study|Withdrawal by Subject|0
820505|NCT00182091|1773578|FG000|Overall Study|Withdrawal by Subject|1
820506|NCT00182091|1773579|FG001|Overall Study|Withdrawal by Subject|0
820507|NCT00182091|1773580|FG002|Overall Study|Withdrawal by Subject|0
820508|NCT00182091|1773581|FG003|Overall Study|Withdrawal by Subject|0
820509|NCT00182325|1773591|FG000|Overall Study|Lost to Follow-up|7
820510|NCT00182325|1773592|FG001|Overall Study|Lost to Follow-up|7
820511|NCT00182325|1773591|FG000|Overall Study|Miscarriage|5
820512|NCT00182325|1773592|FG001|Overall Study|Miscarriage|3
820513|NCT00182325|1773591|FG000|Overall Study|Did not complete survey|22
820514|NCT00182325|1773592|FG001|Overall Study|Did not complete survey|43
820515|NCT00182689|1773600|FG000|Overall Study|Adverse Event|8
820516|NCT00182689|1773601|FG001|Overall Study|Adverse Event|11
820517|NCT00182689|1773600|FG000|Overall Study|Withdrawal by Subject|2
820518|NCT00182689|1773601|FG001|Overall Study|Withdrawal by Subject|2
820519|NCT00182689|1773600|FG000|Overall Study|Progression|27
820520|NCT00182689|1773601|FG001|Overall Study|Progression|29
820521|NCT00182689|1773600|FG000|Overall Study|Death|1
820522|NCT00182689|1773601|FG001|Overall Study|Death|0
820523|NCT00182689|1773600|FG000|Overall Study|not protocol specified|0
820524|NCT00182689|1773601|FG001|Overall Study|not protocol specified|3
820525|NCT00182689|1773600|FG000|Overall Study|Ineligible|1
820526|NCT00182689|1773601|FG001|Overall Study|Ineligible|4
820527|NCT00182689|1773600|FG000|Overall Study|Never received treatment|1
820528|NCT00182689|1773601|FG001|Overall Study|Never received treatment|0
820529|NCT00183170|1773660|FG000|First Intervention|Did not complete study|1
820530|NCT00183170|1773661|FG001|First Intervention|Did not complete study|0
820531|NCT00183170|1773660|FG000|First Intervention|Did not meet targeted BrAC|1
820532|NCT00183170|1773661|FG001|First Intervention|Did not meet targeted BrAC|0
820533|NCT00183170|1773660|FG000|Washout 1 Week|Did not complete study|6
820534|NCT00183170|1773661|FG001|Washout 1 Week|Did not complete study|8
820535|NCT00183170|1773660|FG000|Second Intervention|Did not complete study|1
820536|NCT00183170|1773661|FG001|Second Intervention|Did not complete study|0
820537|NCT00183170|1773660|FG000|Second Intervention|Did not meet targeted BrAC|0
820538|NCT00183170|1773661|FG001|Second Intervention|Did not meet targeted BrAC|2
820539|NCT00183196|1773670|FG000|Overall Study|Withdrawal by Subject|18
820540|NCT00183196|1773671|FG001|Overall Study|Withdrawal by Subject|11
820541|NCT00183196|1773672|FG002|Overall Study|Withdrawal by Subject|13
820542|NCT00183196|1773670|FG000|Overall Study|Adverse Event|1
820543|NCT00183196|1773671|FG001|Overall Study|Adverse Event|2
820544|NCT00183196|1773672|FG002|Overall Study|Adverse Event|2
820545|NCT00183196|1773670|FG000|Overall Study|Legal event|1
820546|NCT00183196|1773671|FG001|Overall Study|Legal event|1
820547|NCT00183196|1773672|FG002|Overall Study|Legal event|1
820548|NCT00183196|1773670|FG000|Overall Study|Required more intensive care|0
820549|NCT00183196|1773671|FG001|Overall Study|Required more intensive care|1
820550|NCT00183196|1773672|FG002|Overall Study|Required more intensive care|2
820551|NCT00183248|1773682|FG000|Overall Study|Lost to Follow-up|0
820552|NCT00183248|1773683|FG001|Overall Study|Lost to Follow-up|1
820553|NCT00183248|1773682|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1
820554|NCT00183248|1773683|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0
820555|NCT00183274|1773689|FG000|Phase 1: Open-Label|Adverse Event|31
820556|NCT00183274|1773690|FG001|Phase 1: Open-Label|Adverse Event|0
820557|NCT00183274|1773691|FG002|Phase 1: Open-Label|Adverse Event|0
820558|NCT00183274|1773692|FG003|Phase 1: Open-Label|Adverse Event|0
820559|NCT00183274|1773693|FG004|Phase 1: Open-Label|Adverse Event|0
820560|NCT00183274|1773694|FG005|Phase 1: Open-Label|Adverse Event|0
820561|NCT00183274|1773689|FG000|Phase 1: Open-Label|Lack of Efficacy|13
820562|NCT00183274|1773690|FG001|Phase 1: Open-Label|Lack of Efficacy|0
820563|NCT00183274|1773691|FG002|Phase 1: Open-Label|Lack of Efficacy|0
820564|NCT00183274|1773692|FG003|Phase 1: Open-Label|Lack of Efficacy|0
820565|NCT00183274|1773693|FG004|Phase 1: Open-Label|Lack of Efficacy|0
820566|NCT00183274|1773694|FG005|Phase 1: Open-Label|Lack of Efficacy|0
820567|NCT00183274|1773689|FG000|Phase 1: Open-Label|Protocol Violation|11
820568|NCT00183274|1773690|FG001|Phase 1: Open-Label|Protocol Violation|0
820569|NCT00183274|1773691|FG002|Phase 1: Open-Label|Protocol Violation|0
820570|NCT00183274|1773692|FG003|Phase 1: Open-Label|Protocol Violation|0
820571|NCT00183274|1773693|FG004|Phase 1: Open-Label|Protocol Violation|0
820572|NCT00183274|1773694|FG005|Phase 1: Open-Label|Protocol Violation|0
820573|NCT00183274|1773689|FG000|Phase 1: Open-Label|Withdrawal by Subject|13
820574|NCT00183274|1773690|FG001|Phase 1: Open-Label|Withdrawal by Subject|0
820575|NCT00183274|1773691|FG002|Phase 1: Open-Label|Withdrawal by Subject|0
820576|NCT00183274|1773692|FG003|Phase 1: Open-Label|Withdrawal by Subject|0
820577|NCT00183274|1773693|FG004|Phase 1: Open-Label|Withdrawal by Subject|0
820578|NCT00183274|1773694|FG005|Phase 1: Open-Label|Withdrawal by Subject|0
820579|NCT00183274|1773689|FG000|Phase 1: Open-Label|Lost to Follow-up|33
820580|NCT00183274|1773690|FG001|Phase 1: Open-Label|Lost to Follow-up|0
820581|NCT00183274|1773691|FG002|Phase 1: Open-Label|Lost to Follow-up|0
820582|NCT00183274|1773692|FG003|Phase 1: Open-Label|Lost to Follow-up|0
820583|NCT00183274|1773693|FG004|Phase 1: Open-Label|Lost to Follow-up|0
820584|NCT00183274|1773694|FG005|Phase 1: Open-Label|Lost to Follow-up|0
820585|NCT00183274|1773689|FG000|Phase 1: Open-Label|Other|9
820586|NCT00183274|1773690|FG001|Phase 1: Open-Label|Other|0
820587|NCT00183274|1773691|FG002|Phase 1: Open-Label|Other|0
820588|NCT00183274|1773692|FG003|Phase 1: Open-Label|Other|0
820589|NCT00183274|1773693|FG004|Phase 1: Open-Label|Other|0
820590|NCT00183274|1773694|FG005|Phase 1: Open-Label|Other|0
820591|NCT00183274|1773689|FG000|Phase 2: Double-Blind|Relapsed|0
820592|NCT00183274|1773690|FG001|Phase 2: Double-Blind|Relapsed|8
820593|NCT00183274|1773691|FG002|Phase 2: Double-Blind|Relapsed|29
820594|NCT00183274|1773692|FG003|Phase 2: Double-Blind|Relapsed|0
820595|NCT00183274|1773693|FG004|Phase 2: Double-Blind|Relapsed|0
820596|NCT00183274|1773694|FG005|Phase 2: Double-Blind|Relapsed|0
820597|NCT00183274|1773689|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0
820598|NCT00183274|1773690|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18
820599|NCT00183274|1773691|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14
820600|NCT00183274|1773692|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0
820601|NCT00183274|1773693|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0
820602|NCT00183274|1773694|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0
820603|NCT00183274|1773689|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0
820604|NCT00183274|1773690|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0
820605|NCT00183274|1773691|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0
820606|NCT00183274|1773692|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1
820607|NCT00183274|1773693|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9
820608|NCT00183274|1773694|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2
820609|NCT00183274|1773689|FG000|Phase 3: Double-Blind|Relapsed|0
820610|NCT00183274|1773690|FG001|Phase 3: Double-Blind|Relapsed|0
820611|NCT00183274|1773691|FG002|Phase 3: Double-Blind|Relapsed|0
820612|NCT00183274|1773692|FG003|Phase 3: Double-Blind|Relapsed|1
820613|NCT00183274|1773693|FG004|Phase 3: Double-Blind|Relapsed|11
820614|NCT00183274|1773694|FG005|Phase 3: Double-Blind|Relapsed|2
820615|NCT00183391|1773723|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13
820616|NCT00183391|1773724|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14
820617|NCT00183391|1773723|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4
820618|NCT00183391|1773724|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2
820619|NCT00183430|1773734|FG000|Overall Study|Adverse Event|1
820620|NCT00183430|1773735|FG001|Overall Study|Adverse Event|0
820621|NCT00183430|1773734|FG000|Overall Study|Lost to Follow-up|3
820622|NCT00183430|1773735|FG001|Overall Study|Lost to Follow-up|0
820623|NCT00183430|1773734|FG000|Overall Study|did not meet inclusion criteria|1
820624|NCT00183430|1773735|FG001|Overall Study|did not meet inclusion criteria|0
820625|NCT00183430|1773734|FG000|Overall Study|Withdrawal by Subject|1
820626|NCT00183430|1773735|FG001|Overall Study|Withdrawal by Subject|0
820627|NCT00183625|1773782|FG000|Overall Study|Withdrawal by Subject|18
820628|NCT00183625|1773783|FG001|Overall Study|Withdrawal by Subject|18
820629|NCT00183625|1773784|FG002|Overall Study|Withdrawal by Subject|19
820630|NCT00183625|1773785|FG003|Overall Study|Withdrawal by Subject|14
820631|NCT00183872|1773810|FG000|Overall Study|Death|3
820632|NCT00183872|1773810|FG000|Overall Study|Adverse Event|9
820633|NCT00183872|1773810|FG000|Overall Study|Withdrawal by Subject|2
820634|NCT00183872|1773810|FG000|Overall Study|Drug delayed more than 28 days|2
820635|NCT00184002|1773814|FG000|Overall Study|Adverse Event|9
820636|NCT00184002|1773814|FG000|Overall Study|Death|3
820637|NCT00184002|1773814|FG000|Overall Study|Physician Decision|1
820638|NCT00184002|1773814|FG000|Overall Study|Withdrawal by Subject|4
820639|NCT00184028|1773818|FG000|Overall Study|Death|1
820640|NCT00184028|1773818|FG000|Overall Study|Lack of Efficacy|4
820641|NCT00184028|1773818|FG000|Overall Study|Adverse Event|2
820642|NCT00184028|1773818|FG000|Overall Study|Withdrawal by Subject|1
820643|NCT00184028|1773818|FG000|Overall Study|Non-compliance|2
820644|NCT00184054|1773823|FG000|Overall Study|Adverse Event|1
820645|NCT00184093|1773827|FG000|Overall Study|Adverse Event|3
820646|NCT00184093|1773827|FG000|Overall Study|Lost to Follow-up|3
820647|NCT00184093|1773827|FG000|Overall Study|Physician Decision|1
820648|NCT00184093|1773827|FG000|Overall Study|Withdrawal by Subject|2
820649|NCT00184600|1773851|FG000|Overall Study|Adverse Event|9
820650|NCT00184600|1773852|FG001|Overall Study|Adverse Event|0
820651|NCT00184600|1773853|FG002|Overall Study|Adverse Event|5
820652|NCT00184600|1773851|FG000|Overall Study|Death|3
820653|NCT00184600|1773852|FG001|Overall Study|Death|9
820654|NCT00184600|1773853|FG002|Overall Study|Death|7
820655|NCT00184600|1773851|FG000|Overall Study|Lack of Efficacy|3
820656|NCT00184600|1773852|FG001|Overall Study|Lack of Efficacy|1
820657|NCT00184600|1773853|FG002|Overall Study|Lack of Efficacy|3
820658|NCT00184600|1773851|FG000|Overall Study|Lost to Follow-up|4
820659|NCT00184600|1773852|FG001|Overall Study|Lost to Follow-up|6
820660|NCT00184600|1773853|FG002|Overall Study|Lost to Follow-up|1
820661|NCT00184600|1773851|FG000|Overall Study|Protocol Violation|2
820662|NCT00184600|1773852|FG001|Overall Study|Protocol Violation|2
820663|NCT00184600|1773853|FG002|Overall Study|Protocol Violation|3
820664|NCT00184600|1773851|FG000|Overall Study|Withdrawal by Subject|20
820665|NCT00184600|1773852|FG001|Overall Study|Withdrawal by Subject|28
820666|NCT00184600|1773853|FG002|Overall Study|Withdrawal by Subject|12
820667|NCT00184600|1773851|FG000|Overall Study|Unclassified|4
820668|NCT00184600|1773852|FG001|Overall Study|Unclassified|5
820669|NCT00184600|1773853|FG002|Overall Study|Unclassified|3
820670|NCT00185211|1773880|FG000|Placebo-controlled Study (92012)|Adverse Event|8
820671|NCT00185211|1773881|FG001|Placebo-controlled Study (92012)|Adverse Event|0
820672|NCT00185211|1773880|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3
820673|NCT00185211|1773881|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2
820674|NCT00185211|1773880|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9
820675|NCT00185211|1773881|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7
820676|NCT00185211|1773880|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
820677|NCT00185211|1773881|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
820678|NCT00185211|1773880|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
820679|NCT00185211|1773881|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
820680|NCT00185211|1773880|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5
820681|NCT00185211|1773881|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6
820682|NCT00185211|1773880|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
820683|NCT00185211|1773881|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
820684|NCT00185211|1773880|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
820685|NCT00185211|1773881|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
820686|NCT00185211|1773880|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1
820687|NCT00185211|1773881|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0
820688|NCT00185211|1773880|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0
820689|NCT00185211|1773881|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1
820690|NCT00185211|1773880|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
820691|NCT00185211|1773881|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
820692|NCT00185211|1773880|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
820693|NCT00185211|1773881|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
820694|NCT00185380|1773891|FG000|Overall Study|Adverse Event|41
820695|NCT00185380|1773892|FG001|Overall Study|Adverse Event|43
820696|NCT00185380|1773893|FG002|Overall Study|Adverse Event|48
820697|NCT00185380|1773891|FG000|Overall Study|Lost to Follow-up|0
820698|NCT00185380|1773892|FG001|Overall Study|Lost to Follow-up|4
820699|NCT00185380|1773893|FG002|Overall Study|Lost to Follow-up|3
820700|NCT00185380|1773891|FG000|Overall Study|Pregnancy|1
820701|NCT00185380|1773892|FG001|Overall Study|Pregnancy|4
820702|NCT00185380|1773893|FG002|Overall Study|Pregnancy|0
820703|NCT00185380|1773891|FG000|Overall Study|Protocol Violation|2
820704|NCT00185380|1773892|FG001|Overall Study|Protocol Violation|2
820705|NCT00185380|1773893|FG002|Overall Study|Protocol Violation|1
820706|NCT00185380|1773891|FG000|Overall Study|Withdrawal by Subject|1
820707|NCT00185380|1773892|FG001|Overall Study|Withdrawal by Subject|2
820708|NCT00185380|1773893|FG002|Overall Study|Withdrawal by Subject|0
820709|NCT00185380|1773891|FG000|Overall Study|Failed insertion|1
820710|NCT00185380|1773892|FG001|Overall Study|Failed insertion|1
820711|NCT00185380|1773893|FG002|Overall Study|Failed insertion|2
820712|NCT00185380|1773891|FG000|Overall Study|Planned pregnancy|9
820713|NCT00185380|1773892|FG001|Overall Study|Planned pregnancy|12
820714|NCT00185380|1773893|FG002|Overall Study|Planned pregnancy|12
820715|NCT00185380|1773891|FG000|Overall Study|No need for contraception|3
820716|NCT00185380|1773892|FG001|Overall Study|No need for contraception|3
820717|NCT00185380|1773893|FG002|Overall Study|No need for contraception|3
820718|NCT00185380|1773891|FG000|Overall Study|Could not attend visits|2
820719|NCT00185380|1773892|FG001|Overall Study|Could not attend visits|0
820720|NCT00185380|1773893|FG002|Overall Study|Could not attend visits|4
820721|NCT00185380|1773891|FG000|Overall Study|personal reason|6
820722|NCT00185380|1773892|FG001|Overall Study|personal reason|1
820723|NCT00185380|1773893|FG002|Overall Study|personal reason|1
820724|NCT00185458|1773901|FG000|Contraception Phase|Adverse Event|37
820725|NCT00185458|1773901|FG000|Contraception Phase|Lost to Follow-up|10
820726|NCT00185458|1773901|FG000|Contraception Phase|Protocol Violation|2
820727|NCT00185458|1773901|FG000|Contraception Phase|Physician Decision|2
820728|NCT00185458|1773901|FG000|Contraception Phase|Withdrawal by Subject|7
820729|NCT00185458|1773901|FG000|HRT Phase|Adverse Event|18
820730|NCT00185458|1773901|FG000|HRT Phase|Lost to Follow-up|4
820731|NCT00185458|1773901|FG000|HRT Phase|Protocol Violation|2
820732|NCT00185458|1773901|FG000|HRT Phase|Withdrawal by Subject|3
820733|NCT00185588|1773917|FG000|Overall Study|Adverse Event|3
820734|NCT00185588|1773918|FG001|Overall Study|Adverse Event|1
820735|NCT00185588|1773919|FG002|Overall Study|Adverse Event|4
820736|NCT00185588|1773920|FG003|Overall Study|Adverse Event|2
820737|NCT00185588|1773917|FG000|Overall Study|Lost to Follow-up|0
820738|NCT00185588|1773918|FG001|Overall Study|Lost to Follow-up|0
820739|NCT00185588|1773919|FG002|Overall Study|Lost to Follow-up|1
820740|NCT00185588|1773920|FG003|Overall Study|Lost to Follow-up|2
820741|NCT00185588|1773917|FG000|Overall Study|Withdrawal by Subject|0
820742|NCT00185588|1773918|FG001|Overall Study|Withdrawal by Subject|1
820743|NCT00185588|1773919|FG002|Overall Study|Withdrawal by Subject|0
820744|NCT00185588|1773920|FG003|Overall Study|Withdrawal by Subject|0
820745|NCT00185588|1773917|FG000|Overall Study|Physician Decision|0
820746|NCT00185588|1773918|FG001|Overall Study|Physician Decision|0
820747|NCT00185588|1773919|FG002|Overall Study|Physician Decision|1
820748|NCT00185588|1773920|FG003|Overall Study|Physician Decision|0
820749|NCT00185614|1773930|FG000|Inter-treatment Period|Physician Decision|1
820750|NCT00185614|1773930|FG000|Inter-treatment Period|Relapse|2
820751|NCT00185614|1773930|FG000|Inter-treatment Period|Lack of allogenic donor|1
820752|NCT00185640|1773934|FG000|Overall Study|Not Eligible|4
820753|NCT00185640|1773934|FG000|Overall Study|Withdrawal by Subject|3
820754|NCT00185640|1773934|FG000|Overall Study|Death|138
820755|NCT00185731|1773946|FG000|Overall Study|Withdrawal by Subject|1
820756|NCT00185731|1773946|FG000|Overall Study|Not Eligible|1
820757|NCT00185965|1773963|FG000|Overall Study|Adverse Event|0
820758|NCT00185965|1773964|FG001|Overall Study|Adverse Event|1
820759|NCT00186043|1773982|FG000|Overall Study|Lack of Efficacy|1
820760|NCT00186043|1773983|FG001|Overall Study|Lack of Efficacy|3
820761|NCT00186043|1773982|FG000|Overall Study|Lost to Follow-up|4
820762|NCT00186043|1773983|FG001|Overall Study|Lost to Follow-up|6
820763|NCT00186043|1773982|FG000|Overall Study|Withdrawal by Subject|1
820764|NCT00186043|1773983|FG001|Overall Study|Withdrawal by Subject|0
820765|NCT00186043|1773982|FG000|Overall Study|Adverse Event|7
820766|NCT00186043|1773983|FG001|Overall Study|Adverse Event|3
820767|NCT00186043|1773982|FG000|Overall Study|Protocol Violation|2
820768|NCT00186043|1773983|FG001|Overall Study|Protocol Violation|1
820769|NCT00186121|1774007|FG000|Overall Study|Subject withdrawal (no treatment)|1
820770|NCT00186121|1774007|FG000|Overall Study|Underwent oophorectomy (no treatment)|1
820771|NCT00186121|1774007|FG000|Overall Study|Not eligible (no treatment)|1
820772|NCT00186186|1774011|FG000|Overall Study|Lack of Efficacy|3
820773|NCT00186186|1774011|FG000|Overall Study|Withdrawal by Subject|3
820774|NCT00186186|1774011|FG000|Overall Study|Not reported as to reason|2
820775|NCT00186485|1774022|FG000|Overall Study|Lost to Follow-up|3
820776|NCT00186537|1774038|FG000|Overall Study|Withdrawal by Subject|4
820777|NCT00186537|1774039|FG001|Overall Study|Withdrawal by Subject|0
820778|NCT00186537|1774040|FG002|Overall Study|Withdrawal by Subject|3
820779|NCT00186537|1774038|FG000|Overall Study|ALT > 1.5 x ULN|3
820780|NCT00186537|1774039|FG001|Overall Study|ALT > 1.5 x ULN|0
820781|NCT00186537|1774040|FG002|Overall Study|ALT > 1.5 x ULN|0
820782|NCT00186628|1774048|FG000|Overall Study|Death|2
820783|NCT00186628|1774048|FG000|Overall Study|Withdrawal by subject (before treatment)|1
820790|NCT00186901|1774107|FG000|Overall Study|Pregnancy|6
820791|NCT00186901|1774108|FG001|Overall Study|Pregnancy|3
820792|NCT00186901|1774109|FG002|Overall Study|Pregnancy|0
820793|NCT00186901|1774107|FG000|Overall Study|Lost to Follow-up|6
820794|NCT00186901|1774108|FG001|Overall Study|Lost to Follow-up|3
820795|NCT00186901|1774109|FG002|Overall Study|Lost to Follow-up|0
820796|NCT00186901|1774107|FG000|Overall Study|Bone Mineral Density dropped > 5%|9
820797|NCT00186901|1774108|FG001|Overall Study|Bone Mineral Density dropped > 5%|7
820798|NCT00186901|1774109|FG002|Overall Study|Bone Mineral Density dropped > 5%|0
820799|NCT00186901|1774107|FG000|Overall Study|ALL relapse or second malignancy|1
820800|NCT00186901|1774108|FG001|Overall Study|ALL relapse or second malignancy|2
820801|NCT00186901|1774109|FG002|Overall Study|ALL relapse or second malignancy|0
820802|NCT00186901|1774107|FG000|Overall Study|Withdrawal by Subject|4
820803|NCT00186901|1774108|FG001|Overall Study|Withdrawal by Subject|5
820804|NCT00186901|1774109|FG002|Overall Study|Withdrawal by Subject|0
820805|NCT00186901|1774107|FG000|Overall Study|Open label|3
820806|NCT00186901|1774108|FG001|Overall Study|Open label|2
820807|NCT00186901|1774109|FG002|Overall Study|Open label|0
820808|NCT00186901|1774107|FG000|Overall Study|Limited adherence to study requirements|20
820809|NCT00186901|1774108|FG001|Overall Study|Limited adherence to study requirements|23
820810|NCT00186901|1774109|FG002|Overall Study|Limited adherence to study requirements|0
820811|NCT00186901|1774107|FG000|Overall Study|Bone Mineral Density > 0|0
820812|NCT00186901|1774108|FG001|Overall Study|Bone Mineral Density > 0|0
820813|NCT00186901|1774109|FG002|Overall Study|Bone Mineral Density > 0|149
820814|NCT00187096|1774149|FG000|Overall Study|unacceptable toxicity|0
820815|NCT00187096|1774150|FG001|Overall Study|unacceptable toxicity|0
820816|NCT00187096|1774151|FG002|Overall Study|unacceptable toxicity|1
820817|NCT00187135|1774165|FG000|Visit One|Withdrawal by Subject|1
820818|NCT00187135|1774166|FG001|Visit One|Withdrawal by Subject|0
820819|NCT00187135|1774167|FG002|Visit One|Withdrawal by Subject|0
820820|NCT00187135|1774168|FG003|Visit One|Withdrawal by Subject|0
820821|NCT00187135|1774169|FG004|Visit One|Withdrawal by Subject|0
820822|NCT00187135|1774170|FG005|Visit One|Withdrawal by Subject|1
820823|NCT00187135|1774165|FG000|Visit One|Physician Decision|3
820824|NCT00187135|1774166|FG001|Visit One|Physician Decision|1
820825|NCT00187135|1774167|FG002|Visit One|Physician Decision|0
820826|NCT00187135|1774168|FG003|Visit One|Physician Decision|0
820827|NCT00187135|1774169|FG004|Visit One|Physician Decision|0
820828|NCT00187135|1774170|FG005|Visit One|Physician Decision|1
820829|NCT00187135|1774165|FG000|Visit Two|Death|0
820830|NCT00187135|1774166|FG001|Visit Two|Death|0
820831|NCT00187135|1774167|FG002|Visit Two|Death|0
820832|NCT00187135|1774168|FG003|Visit Two|Death|1
820833|NCT00187135|1774169|FG004|Visit Two|Death|0
820834|NCT00187135|1774170|FG005|Visit Two|Death|1
820835|NCT00187135|1774165|FG000|Visit Two|Physician Decision|1
820836|NCT00187135|1774166|FG001|Visit Two|Physician Decision|0
820837|NCT00187135|1774167|FG002|Visit Two|Physician Decision|0
820838|NCT00187135|1774168|FG003|Visit Two|Physician Decision|0
820839|NCT00187135|1774169|FG004|Visit Two|Physician Decision|0
820840|NCT00187135|1774170|FG005|Visit Two|Physician Decision|0
820841|NCT00187135|1774165|FG000|Visit Two|Withdrawal by Subject|1
820842|NCT00187135|1774166|FG001|Visit Two|Withdrawal by Subject|1
820843|NCT00187135|1774167|FG002|Visit Two|Withdrawal by Subject|1
820844|NCT00187135|1774168|FG003|Visit Two|Withdrawal by Subject|0
820845|NCT00187135|1774169|FG004|Visit Two|Withdrawal by Subject|1
820846|NCT00187135|1774170|FG005|Visit Two|Withdrawal by Subject|1
820847|NCT00187135|1774165|FG000|Visit Two|Study Discontinued|3
820848|NCT00187135|1774166|FG001|Visit Two|Study Discontinued|2
820849|NCT00187135|1774167|FG002|Visit Two|Study Discontinued|1
820850|NCT00187135|1774168|FG003|Visit Two|Study Discontinued|7
820851|NCT00187135|1774169|FG004|Visit Two|Study Discontinued|5
820852|NCT00187135|1774170|FG005|Visit Two|Study Discontinued|6
820853|NCT00187135|1774165|FG000|Visit Three|Death|0
820854|NCT00187135|1774166|FG001|Visit Three|Death|0
820855|NCT00187135|1774167|FG002|Visit Three|Death|1
820856|NCT00187135|1774168|FG003|Visit Three|Death|0
820857|NCT00187135|1774169|FG004|Visit Three|Death|1
820858|NCT00187135|1774170|FG005|Visit Three|Death|0
820859|NCT00187135|1774165|FG000|Visit Three|Withdrawal by Subject|0
820860|NCT00187135|1774166|FG001|Visit Three|Withdrawal by Subject|1
820861|NCT00187135|1774167|FG002|Visit Three|Withdrawal by Subject|1
820862|NCT00187135|1774168|FG003|Visit Three|Withdrawal by Subject|2
820863|NCT00187135|1774169|FG004|Visit Three|Withdrawal by Subject|0
820864|NCT00187135|1774170|FG005|Visit Three|Withdrawal by Subject|0
820865|NCT00187135|1774165|FG000|Visit Three|Study Discontinued|7
820866|NCT00187135|1774166|FG001|Visit Three|Study Discontinued|6
820867|NCT00187135|1774167|FG002|Visit Three|Study Discontinued|7
820868|NCT00187135|1774168|FG003|Visit Three|Study Discontinued|7
820869|NCT00187135|1774169|FG004|Visit Three|Study Discontinued|7
820870|NCT00187135|1774170|FG005|Visit Three|Study Discontinued|6
820871|NCT00187278|1774220|FG000|Overall Study|Protocol Violation|10
820872|NCT00187278|1774221|FG001|Overall Study|Protocol Violation|13
820873|NCT00187486|1774244|FG000|Overall Study|Protocol Violation|1
820874|NCT00187889|1774284|FG000|Overall Study|Withdrawal by Subject|6
820875|NCT00187889|1774285|FG001|Overall Study|Withdrawal by Subject|4
820876|NCT00189202|1774312|FG000|Overall Study|Physician Decision|5
820877|NCT00189306|1774320|FG000|Treatment Period|Withdrawal by Subject|2
820878|NCT00189306|1774320|FG000|Treatment Period|Adverse Event|2
820879|NCT00189306|1774320|FG000|Treatment Period|Protocol Violation|1
820880|NCT00189306|1774320|FG000|Posttreatment Period|Death|1
820881|NCT00189306|1774320|FG000|Posttreatment Period|Withdrawal by Subject|2
820882|NCT00189306|1774320|FG000|Posttreatment Period|Noncompliance|1
820883|NCT00189306|1774320|FG000|Posttreatment Period|Target lesion excised|1
820884|NCT00189306|1774320|FG000|Posttreatment Period|Protocol Violation|1
820885|NCT00189306|1774320|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
820886|NCT00189306|1774320|FG000|Posttreatment Period|Local skin reaction/sign|1
820887|NCT00189306|1774320|FG000|Long-Term Follow-up|Adverse Event|2
820888|NCT00189306|1774320|FG000|Long-Term Follow-up|Death|4
820889|NCT00189306|1774320|FG000|Long-Term Follow-up|Withdrawal by Subject|1
820890|NCT00189306|1774320|FG000|Long-Term Follow-up|Intercurrent disease|2
820891|NCT00189306|1774320|FG000|Long-Term Follow-up|Lost to Follow-up|9
820892|NCT00189306|1774320|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
820893|NCT00189423|1774326|FG000|Overall Study|Death|746
820894|NCT00189423|1774327|FG001|Overall Study|Death|747
820895|NCT00189423|1774326|FG000|Overall Study|Withdrawal by Subject|9
820896|NCT00189423|1774327|FG001|Overall Study|Withdrawal by Subject|9
820897|NCT00189423|1774326|FG000|Overall Study|Lost to Follow-up|10
820898|NCT00189423|1774327|FG001|Overall Study|Lost to Follow-up|10
820899|NCT00189462|1774344|FG000|Overall Study|Lack of Efficacy|5
820900|NCT00189462|1774345|FG001|Overall Study|Lack of Efficacy|1
820901|NCT00189462|1774344|FG000|Overall Study|Lost to Follow-up|18
820902|NCT00189462|1774345|FG001|Overall Study|Lost to Follow-up|20
820903|NCT00189488|1774362|FG000|Overall Study|Ineligibility determined|1
820904|NCT00189488|1774363|FG001|Overall Study|Ineligibility determined|0
820905|NCT00189488|1774362|FG000|Overall Study|Protocol deviation|2
820906|NCT00189488|1774363|FG001|Overall Study|Protocol deviation|1
820907|NCT00189488|1774362|FG000|Overall Study|Adverse Event|2
820908|NCT00189488|1774363|FG001|Overall Study|Adverse Event|1
820909|NCT00189488|1774362|FG000|Overall Study|Withdrawal by Subject|2
820910|NCT00189488|1774363|FG001|Overall Study|Withdrawal by Subject|6
820911|NCT00189488|1774362|FG000|Overall Study|Disease progression|2
820912|NCT00189488|1774363|FG001|Overall Study|Disease progression|4
820913|NCT00189488|1774362|FG000|Overall Study|Administrative Decision|0
820914|NCT00189488|1774363|FG001|Overall Study|Administrative Decision|2
820915|NCT00189488|1774362|FG000|Overall Study|Death|5
820916|NCT00189488|1774363|FG001|Overall Study|Death|8
820917|NCT00189488|1774362|FG000|Overall Study|Other|1
820918|NCT00189488|1774363|FG001|Overall Study|Other|0
820919|NCT00189540|1774372|FG000|Overall Study|Withdrawal by Subject|3
820920|NCT00189540|1774373|FG001|Overall Study|Withdrawal by Subject|0
820921|NCT00189540|1774372|FG000|Overall Study|Death|4
820922|NCT00189540|1774373|FG001|Overall Study|Death|1
820923|NCT00190671|1774381|FG000|Overall Study|Satisfactory Response|4
820924|NCT00190671|1774382|FG001|Overall Study|Satisfactory Response|7
820925|NCT00190671|1774381|FG000|Overall Study|Lack of Efficacy|19
820926|NCT00190671|1774382|FG001|Overall Study|Lack of Efficacy|24
820927|NCT00190671|1774381|FG000|Overall Study|Death from Study Disease|1
820928|NCT00190671|1774382|FG001|Overall Study|Death from Study Disease|1
820929|NCT00190671|1774381|FG000|Overall Study|Adverse Event|3
820930|NCT00190671|1774382|FG001|Overall Study|Adverse Event|2
820931|NCT00190671|1774381|FG000|Overall Study|Clinical Relapse|0
820932|NCT00190671|1774382|FG001|Overall Study|Clinical Relapse|1
820933|NCT00190671|1774381|FG000|Overall Study|Death from Study-Drug Toxicity|0
820934|NCT00190671|1774382|FG001|Overall Study|Death from Study-Drug Toxicity|2
820935|NCT00190671|1774381|FG000|Overall Study|Death from Other Causes|0
820936|NCT00190671|1774382|FG001|Overall Study|Death from Other Causes|2
820937|NCT00190671|1774381|FG000|Overall Study|Protocol Violation|0
820938|NCT00190671|1774382|FG001|Overall Study|Protocol Violation|1
820939|NCT00190671|1774381|FG000|Overall Study|Withdrawal by Subject|0
820940|NCT00190671|1774382|FG001|Overall Study|Withdrawal by Subject|2
820941|NCT00190684|1774389|FG000|Overall Study|Adverse Event|86
820942|NCT00190684|1774389|FG000|Overall Study|Satisfactory response|80
820943|NCT00190684|1774389|FG000|Overall Study|Lack of efficacy|204
820944|NCT00190684|1774389|FG000|Overall Study|Lost to Follow-up|232
820945|NCT00190684|1774389|FG000|Overall Study|Patient moved|60
820946|NCT00190684|1774389|FG000|Overall Study|Patient Decision|432
820947|NCT00190684|1774389|FG000|Overall Study|Clinical relapse|67
820948|NCT00190684|1774389|FG000|Overall Study|Sponsor's decision|17
820949|NCT00190684|1774389|FG000|Overall Study|Physician Decision|84
820950|NCT00190684|1774389|FG000|Overall Study|Protocol Violation|123
820951|NCT00190684|1774389|FG000|Overall Study|Study Period III Completed|103
820952|NCT00190684|1774389|FG000|Overall Study|Study Period V Completed|1
820953|NCT00190749|1774395|FG000|Overall Study|Lost to Follow-up|8
820954|NCT00190749|1774396|FG001|Overall Study|Lost to Follow-up|11
820955|NCT00190749|1774395|FG000|Overall Study|Withdrawal by Subject|10
820956|NCT00190749|1774396|FG001|Overall Study|Withdrawal by Subject|6
820957|NCT00190749|1774395|FG000|Overall Study|Protocol Violation|5
820958|NCT00190749|1774396|FG001|Overall Study|Protocol Violation|4
820959|NCT00190749|1774395|FG000|Overall Study|Adverse Event|0
820960|NCT00190749|1774396|FG001|Overall Study|Adverse Event|5
820961|NCT00190749|1774395|FG000|Overall Study|Lack of Efficacy|2
820962|NCT00190749|1774396|FG001|Overall Study|Lack of Efficacy|3
820963|NCT00190749|1774395|FG000|Overall Study|Reason Not Specified|0
820964|NCT00190749|1774396|FG001|Overall Study|Reason Not Specified|2
820965|NCT00190749|1774395|FG000|Overall Study|Sponsor Decision|1
820966|NCT00190749|1774396|FG001|Overall Study|Sponsor Decision|0
820967|NCT00190775|1774404|FG000|Overall Study|Adverse Event|57
820968|NCT00190775|1774405|FG001|Overall Study|Adverse Event|22
820969|NCT00190775|1774404|FG000|Overall Study|Satisfactory Response|1
820970|NCT00190775|1774405|FG001|Overall Study|Satisfactory Response|0
820971|NCT00190775|1774404|FG000|Overall Study|Lack of Efficacy|28
820972|NCT00190775|1774405|FG001|Overall Study|Lack of Efficacy|32
820973|NCT00190775|1774404|FG000|Overall Study|Lost to Follow-up|31
820974|NCT00190775|1774405|FG001|Overall Study|Lost to Follow-up|23
820975|NCT00190775|1774404|FG000|Overall Study|Participant Moved|0
820976|NCT00190775|1774405|FG001|Overall Study|Participant Moved|1
820977|NCT00190775|1774404|FG000|Overall Study|Withdrawal by Subject|24
820978|NCT00190775|1774405|FG001|Overall Study|Withdrawal by Subject|13
820979|NCT00190775|1774404|FG000|Overall Study|Sponsor Decision|1
820980|NCT00190775|1774405|FG001|Overall Study|Sponsor Decision|0
820981|NCT00190775|1774404|FG000|Overall Study|Physician Decision|3
820982|NCT00190775|1774405|FG001|Overall Study|Physician Decision|0
820983|NCT00190775|1774404|FG000|Overall Study|Noncompliance|3
820984|NCT00190775|1774405|FG001|Overall Study|Noncompliance|5
820985|NCT00190775|1774404|FG000|Overall Study|Protocol Violation|0
820986|NCT00190775|1774405|FG001|Overall Study|Protocol Violation|1
820987|NCT00190775|1774404|FG000|Overall Study|Exclusion Criteria Met|1
820988|NCT00190775|1774405|FG001|Overall Study|Exclusion Criteria Met|3
820989|NCT00190983|1774418|FG000|Overall Study|Inevaluable (never treated)|2
820990|NCT00191100|1774424|FG000|Overall Study|Adverse Event|18
820991|NCT00191100|1774425|FG001|Overall Study|Adverse Event|1
820992|NCT00191100|1774424|FG000|Overall Study|Lost to Follow-up|2
820993|NCT00191100|1774425|FG001|Overall Study|Lost to Follow-up|0
820994|NCT00191100|1774424|FG000|Overall Study|Patient Moved|0
820995|NCT00191100|1774425|FG001|Overall Study|Patient Moved|1
820996|NCT00191100|1774424|FG000|Overall Study|Withdrawal by Subject|9
820997|NCT00191100|1774425|FG001|Overall Study|Withdrawal by Subject|3
820998|NCT00191100|1774424|FG000|Overall Study|Protocol Entry Criteria Not Met|2
820999|NCT00191100|1774425|FG001|Overall Study|Protocol Entry Criteria Not Met|1
821000|NCT00191100|1774424|FG000|Overall Study|Clinical Relapse|2
821001|NCT00191100|1774425|FG001|Overall Study|Clinical Relapse|1
821002|NCT00191100|1774424|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1
821003|NCT00191100|1774425|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2
821004|NCT00191100|1774424|FG000|Overall Study|Lack of Efficacy, Stable Disease|1
821005|NCT00191100|1774425|FG001|Overall Study|Lack of Efficacy, Stable Disease|0
821006|NCT00191100|1774424|FG000|Overall Study|Physician Decision|3
821007|NCT00191100|1774425|FG001|Overall Study|Physician Decision|1
821008|NCT00191100|1774424|FG000|Overall Study|Death from Study Drug Toxicity|2
821009|NCT00191100|1774425|FG001|Overall Study|Death from Study Drug Toxicity|0
821010|NCT00191100|1774424|FG000|Overall Study|Protocol Violation|1
821011|NCT00191100|1774425|FG001|Overall Study|Protocol Violation|1
821012|NCT00191100|1774424|FG000|Overall Study|Death from Other Cause|1
821013|NCT00191100|1774425|FG001|Overall Study|Death from Other Cause|0
821014|NCT00191100|1774424|FG000|Overall Study|Reason Not Specified|0
821015|NCT00191100|1774425|FG001|Overall Study|Reason Not Specified|1
821016|NCT00191113|1774433|FG000|Core Study|Withdrawal by Subject|25
821017|NCT00191113|1774434|FG001|Core Study|Withdrawal by Subject|9
821018|NCT00191113|1774433|FG000|Core Study|Protocol Violation|6
821019|NCT00191113|1774434|FG001|Core Study|Protocol Violation|2
821020|NCT00191113|1774433|FG000|Core Study|Lost to Follow-up|3
821021|NCT00191113|1774434|FG001|Core Study|Lost to Follow-up|0
821022|NCT00191113|1774433|FG000|Core Study|Adverse Event|0
821023|NCT00191113|1774434|FG001|Core Study|Adverse Event|2
821024|NCT00191113|1774433|FG000|Core Study|Lack of Efficacy|0
821025|NCT00191113|1774434|FG001|Core Study|Lack of Efficacy|2
821026|NCT00191113|1774433|FG000|Core Study|Death|1
821027|NCT00191113|1774434|FG001|Core Study|Death|0
821028|NCT00191139|1774448|FG000|Overall Study|Adverse Event|2
821029|NCT00191139|1774449|FG001|Overall Study|Adverse Event|6
821030|NCT00191139|1774448|FG000|Overall Study|Death|2
821031|NCT00191139|1774449|FG001|Overall Study|Death|0
821032|NCT00191139|1774448|FG000|Overall Study|Withdrawal by Subject|0
821033|NCT00191139|1774449|FG001|Overall Study|Withdrawal by Subject|3
821034|NCT00191139|1774448|FG000|Overall Study|Disease Progression|0
821035|NCT00191139|1774449|FG001|Overall Study|Disease Progression|1
821036|NCT00191139|1774448|FG000|Overall Study|Other|1
821037|NCT00191139|1774449|FG001|Overall Study|Other|2
821038|NCT00191152|1774457|FG000|Initial Treatment|Adverse Event|43
821039|NCT00191152|1774458|FG001|Initial Treatment|Adverse Event|67
821040|NCT00191152|1774457|FG000|Initial Treatment|Physician Decision|40
821041|NCT00191152|1774458|FG001|Initial Treatment|Physician Decision|31
821042|NCT00191152|1774457|FG000|Initial Treatment|Withdrawal by Subject|40
821043|NCT00191152|1774458|FG001|Initial Treatment|Withdrawal by Subject|28
821044|NCT00191152|1774457|FG000|Initial Treatment|Lost to Follow-up|0
821045|NCT00191152|1774458|FG001|Initial Treatment|Lost to Follow-up|6
821046|NCT00191152|1774457|FG000|Initial Treatment|Other|18
821047|NCT00191152|1774458|FG001|Initial Treatment|Other|21
821048|NCT00191152|1774457|FG000|Crossover Treatment|Adverse Event|8
821049|NCT00191152|1774458|FG001|Crossover Treatment|Adverse Event|8
821050|NCT00191152|1774457|FG000|Crossover Treatment|Physician Decision|7
821051|NCT00191152|1774458|FG001|Crossover Treatment|Physician Decision|7
821052|NCT00191152|1774457|FG000|Crossover Treatment|Withdrawal by Subject|6
821053|NCT00191152|1774458|FG001|Crossover Treatment|Withdrawal by Subject|9
821054|NCT00191152|1774457|FG000|Crossover Treatment|Lost to Follow-up|2
821055|NCT00191152|1774458|FG001|Crossover Treatment|Lost to Follow-up|1
821056|NCT00191152|1774457|FG000|Crossover Treatment|Other|4
821057|NCT00191152|1774458|FG001|Crossover Treatment|Other|3
821058|NCT00191165|1774478|FG000|Overall Study|Adverse Event|2
821059|NCT00191165|1774479|FG001|Overall Study|Adverse Event|0
821060|NCT00191165|1774478|FG000|Overall Study|Protocol Violation|0
821061|NCT00191165|1774479|FG001|Overall Study|Protocol Violation|1
821062|NCT00191165|1774478|FG000|Overall Study|Participant Moved Away|0
821063|NCT00191165|1774479|FG001|Overall Study|Participant Moved Away|1
821064|NCT00191191|1774487|FG000|Overall Study|Entry Criteria Exclusion|2
821065|NCT00191191|1774488|FG001|Overall Study|Entry Criteria Exclusion|0
821066|NCT00191191|1774487|FG000|Overall Study|Treated with Another Systemic Agent|1
821067|NCT00191191|1774488|FG001|Overall Study|Treated with Another Systemic Agent|1
821068|NCT00191191|1774487|FG000|Overall Study|Adverse Event|11
821069|NCT00191191|1774488|FG001|Overall Study|Adverse Event|21
821070|NCT00191191|1774487|FG000|Overall Study|Progressive Disease|84
821071|NCT00191191|1774488|FG001|Overall Study|Progressive Disease|72
821072|NCT00191191|1774487|FG000|Overall Study|Toxicity After Dose Reduction|7
821073|NCT00191191|1774488|FG001|Overall Study|Toxicity After Dose Reduction|8
821074|NCT00191191|1774487|FG000|Overall Study|Family/Caregiver Decision|5
821075|NCT00191191|1774488|FG001|Overall Study|Family/Caregiver Decision|7
821076|NCT00191191|1774487|FG000|Overall Study|Lost to Follow-up|1
821077|NCT00191191|1774488|FG001|Overall Study|Lost to Follow-up|0
821078|NCT00191191|1774487|FG000|Overall Study|Physician Decision|3
821079|NCT00191191|1774488|FG001|Overall Study|Physician Decision|2
821080|NCT00191191|1774487|FG000|Overall Study|Good Clinical Practice Violation|0
821081|NCT00191191|1774488|FG001|Overall Study|Good Clinical Practice Violation|1
821082|NCT00191269|1774496|FG000|Overall Study|Protocol Violation|0
821083|NCT00191269|1774497|FG001|Overall Study|Protocol Violation|2
821084|NCT00191269|1774496|FG000|Overall Study|Adverse Event|1
821085|NCT00191269|1774497|FG001|Overall Study|Adverse Event|4
821086|NCT00191269|1774496|FG000|Overall Study|Progression of Disease|4
821087|NCT00191269|1774497|FG001|Overall Study|Progression of Disease|42
821088|NCT00191269|1774496|FG000|Overall Study|Lack of Efficacy|1
821089|NCT00191269|1774497|FG001|Overall Study|Lack of Efficacy|5
821090|NCT00191269|1774496|FG000|Overall Study|Withdrawal by Subject|0
821091|NCT00191269|1774497|FG001|Overall Study|Withdrawal by Subject|1
821092|NCT00191269|1774496|FG000|Overall Study|Pathologic Aggrevation|0
821093|NCT00191269|1774497|FG001|Overall Study|Pathologic Aggrevation|1
821094|NCT00191269|1774496|FG000|Overall Study|Physician Decision|0
821095|NCT00191269|1774497|FG001|Overall Study|Physician Decision|3
821096|NCT00191282|1774506|FG000|Overall Study|Adverse Event|5
821097|NCT00191282|1774507|FG001|Overall Study|Adverse Event|6
821098|NCT00191282|1774506|FG000|Overall Study|Death|51
821099|NCT00191282|1774507|FG001|Overall Study|Death|51
821100|NCT00191282|1774506|FG000|Overall Study|Lack of Efficacy|11
821101|NCT00191282|1774507|FG001|Overall Study|Lack of Efficacy|6
821102|NCT00191282|1774506|FG000|Overall Study|Noncompliance|14
821103|NCT00191282|1774507|FG001|Overall Study|Noncompliance|17
821104|NCT00191282|1774506|FG000|Overall Study|Patient moved|11
821105|NCT00191282|1774507|FG001|Overall Study|Patient moved|14
821106|NCT00191282|1774506|FG000|Overall Study|Withdrawal by Subject|59
821107|NCT00191282|1774507|FG001|Overall Study|Withdrawal by Subject|44
821108|NCT00191282|1774506|FG000|Overall Study|Physician Decision|18
821109|NCT00191282|1774507|FG001|Overall Study|Physician Decision|15
821110|NCT00191282|1774506|FG000|Overall Study|Protocol entry criteria not met|14
821111|NCT00191282|1774507|FG001|Overall Study|Protocol entry criteria not met|9
821112|NCT00191282|1774506|FG000|Overall Study|Protocol Violation|9
821113|NCT00191282|1774507|FG001|Overall Study|Protocol Violation|12
821114|NCT00191282|1774506|FG000|Overall Study|Severity of outcome|2
821115|NCT00191282|1774507|FG001|Overall Study|Severity of outcome|5
821116|NCT00191282|1774506|FG000|Overall Study|Sponsor's decision|2
821117|NCT00191282|1774507|FG001|Overall Study|Sponsor's decision|2
821118|NCT00191282|1774506|FG000|Overall Study|Lost to Follow-up|24
821119|NCT00191282|1774507|FG001|Overall Study|Lost to Follow-up|31
821120|NCT00191308|1774513|FG000|Overall Study|Adverse Event|1
821121|NCT00191334|1774517|FG000|Overall Study|Adverse Event|4
821122|NCT00191334|1774517|FG000|Overall Study|Disease Progression or Relapse|8
821123|NCT00191334|1774517|FG000|Overall Study|Physician Decision|1
821124|NCT00191334|1774517|FG000|Overall Study|Withdrawal by Subject|4
821125|NCT00191386|1774521|FG000|Overall Study|Adverse Event|16
821126|NCT00191386|1774521|FG000|Overall Study|Lost to Follow-up|1
821127|NCT00191386|1774521|FG000|Overall Study|Entry Criteria Exclusion|3
821128|NCT00191386|1774521|FG000|Overall Study|Protocol Violation|18
821129|NCT00191386|1774521|FG000|Overall Study|Withdrawal by Subject|96
821130|NCT00191386|1774521|FG000|Overall Study|Physician Decision|11
821131|NCT00191386|1774521|FG000|Overall Study|Lack of Efficacy|15
821132|NCT00191451|1774528|FG000|Overall Study|Withdrawal by Subject|2
821133|NCT00191451|1774529|FG001|Overall Study|Withdrawal by Subject|3
821134|NCT00191451|1774530|FG002|Overall Study|Withdrawal by Subject|5
821135|NCT00191451|1774528|FG000|Overall Study|Physician Decision|2
821136|NCT00191451|1774529|FG001|Overall Study|Physician Decision|9
821137|NCT00191451|1774530|FG002|Overall Study|Physician Decision|6
821138|NCT00191451|1774528|FG000|Overall Study|Sponsor Decision|1
821139|NCT00191451|1774529|FG001|Overall Study|Sponsor Decision|0
821140|NCT00191451|1774530|FG002|Overall Study|Sponsor Decision|0
821141|NCT00191451|1774528|FG000|Overall Study|Ineligible|0
821142|NCT00191451|1774529|FG001|Overall Study|Ineligible|1
821143|NCT00191451|1774530|FG002|Overall Study|Ineligible|0
821144|NCT00191451|1774528|FG000|Overall Study|Reason Not Specified|2
821145|NCT00191451|1774529|FG001|Overall Study|Reason Not Specified|1
821146|NCT00191451|1774530|FG002|Overall Study|Reason Not Specified|3
821147|NCT00191477|1774540|FG000|Overall Study|Tumor Recurrence|49
821148|NCT00191477|1774541|FG001|Overall Study|Tumor Recurrence|48
821149|NCT00191477|1774540|FG000|Overall Study|Death, Study Disease|1
821150|NCT00191477|1774541|FG001|Overall Study|Death, Study Disease|1
821151|NCT00191477|1774540|FG000|Overall Study|Death, Other Cause|3
821152|NCT00191477|1774541|FG001|Overall Study|Death, Other Cause|6
821153|NCT00191477|1774540|FG000|Overall Study|Lost to Follow-up|23
821154|NCT00191477|1774541|FG001|Overall Study|Lost to Follow-up|21
821155|NCT00191477|1774540|FG000|Overall Study|Protocol Violation|1
821156|NCT00191477|1774541|FG001|Overall Study|Protocol Violation|1
821157|NCT00191477|1774540|FG000|Overall Study|Treatment Change|2
821158|NCT00191477|1774541|FG001|Overall Study|Treatment Change|0
821159|NCT00191477|1774540|FG000|Overall Study|Withdrawal by Subject|2
821160|NCT00191477|1774541|FG001|Overall Study|Withdrawal by Subject|0
821161|NCT00191477|1774540|FG000|Overall Study|Other|2
821162|NCT00191477|1774541|FG001|Overall Study|Other|0
821163|NCT00191477|1774540|FG000|Overall Study|Not Eligible|41
821164|NCT00191477|1774541|FG001|Overall Study|Not Eligible|38
821165|NCT00191477|1774540|FG000|Overall Study|Pathological Specimen Lost|1
821166|NCT00191477|1774541|FG001|Overall Study|Pathological Specimen Lost|0
821167|NCT00191477|1774540|FG000|Overall Study|Discontinued Prior to Instillation|13
821168|NCT00191477|1774541|FG001|Overall Study|Discontinued Prior to Instillation|14
821169|NCT00191646|1774549|FG000|Overall Study|Toxicity|26
821170|NCT00191646|1774550|FG001|Overall Study|Toxicity|37
821171|NCT00191646|1774549|FG000|Overall Study|Disease Progression|5
821172|NCT00191646|1774550|FG001|Overall Study|Disease Progression|6
821173|NCT00191646|1774549|FG000|Overall Study|Physician Decision|20
821174|NCT00191646|1774550|FG001|Overall Study|Physician Decision|11
821175|NCT00191646|1774549|FG000|Overall Study|Withdrawal by Subject|58
821176|NCT00191646|1774550|FG001|Overall Study|Withdrawal by Subject|39
821177|NCT00191646|1774549|FG000|Overall Study|Protocol Violation|5
821178|NCT00191646|1774550|FG001|Overall Study|Protocol Violation|7
821179|NCT00191646|1774549|FG000|Overall Study|Death|6
821180|NCT00191646|1774550|FG001|Overall Study|Death|8
821181|NCT00191646|1774549|FG000|Overall Study|Other|33
821182|NCT00191646|1774550|FG001|Overall Study|Other|34
821183|NCT00191646|1774549|FG000|Overall Study|Missing Data|18
821184|NCT00191646|1774550|FG001|Overall Study|Missing Data|11
821185|NCT00191724|1774569|FG000|Overall Study|Adverse Event|0
821186|NCT00191724|1774570|FG001|Overall Study|Adverse Event|0
821187|NCT00191724|1774571|FG002|Overall Study|Adverse Event|1
821188|NCT00191724|1774572|FG003|Overall Study|Adverse Event|0
821189|NCT00191724|1774573|FG004|Overall Study|Adverse Event|0
821190|NCT00191724|1774569|FG000|Overall Study|Lost to Follow-up|1
821191|NCT00191724|1774570|FG001|Overall Study|Lost to Follow-up|1
821192|NCT00191724|1774571|FG002|Overall Study|Lost to Follow-up|0
821193|NCT00191724|1774572|FG003|Overall Study|Lost to Follow-up|2
821194|NCT00191724|1774573|FG004|Overall Study|Lost to Follow-up|3
821195|NCT00191724|1774569|FG000|Overall Study|Withdrawal by Subject|0
821196|NCT00191724|1774570|FG001|Overall Study|Withdrawal by Subject|0
821197|NCT00191724|1774571|FG002|Overall Study|Withdrawal by Subject|0
821198|NCT00191724|1774572|FG003|Overall Study|Withdrawal by Subject|1
821199|NCT00191724|1774573|FG004|Overall Study|Withdrawal by Subject|0
821200|NCT00191789|1774585|FG000|Overall Study|Adverse Event|5
821201|NCT00191789|1774585|FG000|Overall Study|Patient: Satisfactory Response|5
821202|NCT00191789|1774585|FG000|Overall Study|Patient/Physician: Satisfactory Response|4
821203|NCT00191789|1774585|FG000|Overall Study|Withdrawal by Subject|4
821204|NCT00191789|1774585|FG000|Overall Study|Death - Possibly Study Drug Related|4
821205|NCT00191789|1774585|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2
821206|NCT00191789|1774585|FG000|Overall Study|Death - Not Study-Drug Related|1
821207|NCT00191815|1774589|FG000|Overall Study|Adverse Event|2
821208|NCT00191815|1774589|FG000|Overall Study|Disease progression or relapse|24
821209|NCT00191815|1774589|FG000|Overall Study|Death|2
821210|NCT00191815|1774589|FG000|Overall Study|Protocol Violation|3
821211|NCT00191815|1774589|FG000|Overall Study|Physician Decision|2
821212|NCT00191815|1774589|FG000|Overall Study|Withdrawal by Subject|7
821213|NCT00191854|1774596|FG000|Overall Study|Death|26
821214|NCT00191854|1774597|FG001|Overall Study|Death|23
821215|NCT00191854|1774598|FG002|Overall Study|Death|29
821216|NCT00191854|1774596|FG000|Overall Study|Lost to Follow-up|7
821217|NCT00191854|1774597|FG001|Overall Study|Lost to Follow-up|5
821218|NCT00191854|1774598|FG002|Overall Study|Lost to Follow-up|5
821219|NCT00191854|1774596|FG000|Overall Study|Withdrawal by Subject|4
821220|NCT00191854|1774597|FG001|Overall Study|Withdrawal by Subject|2
821221|NCT00191854|1774598|FG002|Overall Study|Withdrawal by Subject|3
821222|NCT00191854|1774596|FG000|Overall Study|Sponsor Decision|0
821223|NCT00191854|1774597|FG001|Overall Study|Sponsor Decision|0
821224|NCT00191854|1774598|FG002|Overall Study|Sponsor Decision|1
821225|NCT00191854|1774596|FG000|Overall Study|Screen Failure|0
821226|NCT00191854|1774597|FG001|Overall Study|Screen Failure|0
821227|NCT00191854|1774598|FG002|Overall Study|Screen Failure|1
821228|NCT00191906|1774610|FG000|Study Period II|Adverse Event|0
821229|NCT00191906|1774611|FG001|Study Period II|Adverse Event|1
821230|NCT00191906|1774612|FG002|Study Period II|Adverse Event|0
821231|NCT00191906|1774613|FG003|Study Period II|Adverse Event|0
821232|NCT00191906|1774610|FG000|Study Period II|Withdrawal by Subject|0
821233|NCT00191906|1774611|FG001|Study Period II|Withdrawal by Subject|3
821234|NCT00191906|1774612|FG002|Study Period II|Withdrawal by Subject|0
821235|NCT00191906|1774613|FG003|Study Period II|Withdrawal by Subject|0
821236|NCT00191906|1774610|FG000|Study Period II|Parent/Caregiver Decision|0
821237|NCT00191906|1774611|FG001|Study Period II|Parent/Caregiver Decision|1
821238|NCT00191906|1774612|FG002|Study Period II|Parent/Caregiver Decision|0
821239|NCT00191906|1774613|FG003|Study Period II|Parent/Caregiver Decision|0
821240|NCT00191906|1774610|FG000|Study Period II|Entry Criteria Exclusion|0
821241|NCT00191906|1774611|FG001|Study Period II|Entry Criteria Exclusion|0
821242|NCT00191906|1774612|FG002|Study Period II|Entry Criteria Exclusion|1
821243|NCT00191906|1774613|FG003|Study Period II|Entry Criteria Exclusion|0
821244|NCT00191906|1774610|FG000|Study Period III|Adverse Event|1
821245|NCT00191906|1774611|FG001|Study Period III|Adverse Event|0
821246|NCT00191906|1774612|FG002|Study Period III|Adverse Event|0
821247|NCT00191906|1774613|FG003|Study Period III|Adverse Event|0
821248|NCT00191906|1774610|FG000|Study Period III|Lost to Follow-up|0
821249|NCT00191906|1774611|FG001|Study Period III|Lost to Follow-up|1
821250|NCT00191906|1774612|FG002|Study Period III|Lost to Follow-up|0
821251|NCT00191906|1774613|FG003|Study Period III|Lost to Follow-up|0
821252|NCT00191906|1774610|FG000|Study Period III|Parent/Caregiver Decision|1
821253|NCT00191906|1774611|FG001|Study Period III|Parent/Caregiver Decision|0
821254|NCT00191906|1774612|FG002|Study Period III|Parent/Caregiver Decision|0
821255|NCT00191906|1774613|FG003|Study Period III|Parent/Caregiver Decision|0
821256|NCT00191906|1774610|FG000|Study Period III|Lack of Efficacy|3
821257|NCT00191906|1774611|FG001|Study Period III|Lack of Efficacy|3
821258|NCT00191906|1774612|FG002|Study Period III|Lack of Efficacy|0
821259|NCT00191906|1774613|FG003|Study Period III|Lack of Efficacy|0
821260|NCT00191945|1774631|FG000|Double-Blind Acute Treatment|Parent's Decision|3
821261|NCT00191945|1774632|FG001|Double-Blind Acute Treatment|Parent's Decision|0
821262|NCT00191945|1774631|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0
821263|NCT00191945|1774632|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1
821264|NCT00191945|1774631|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3
821265|NCT00191945|1774632|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0
821266|NCT00191945|1774631|FG000|Double-Blind Acute Treatment|Physician Decision|0
821267|NCT00191945|1774632|FG001|Double-Blind Acute Treatment|Physician Decision|2
821268|NCT00191984|1774639|FG000|Overall Study|Disease Progression|21
821269|NCT00191984|1774639|FG000|Overall Study|Adverse Event|4
821270|NCT00191984|1774639|FG000|Overall Study|Death|2
821271|NCT00191984|1774639|FG000|Overall Study|Entry Criteria Exclusion|1
821272|NCT00191984|1774639|FG000|Overall Study|Withdrawal by Subject|7
821273|NCT00191984|1774639|FG000|Overall Study|Physician Decision|4
821274|NCT00192023|1774645|FG000|Period III - Double-Blind|Adverse Event|3
821275|NCT00192023|1774646|FG001|Period III - Double-Blind|Adverse Event|0
821276|NCT00192023|1774645|FG000|Period III - Double-Blind|Physician Decision|2
821277|NCT00192023|1774646|FG001|Period III - Double-Blind|Physician Decision|0
821278|NCT00192023|1774645|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2
821279|NCT00192023|1774646|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0
821280|NCT00192023|1774645|FG000|Period IV - Optional Open-Label|Adverse Event|6
821281|NCT00192023|1774646|FG001|Period IV - Optional Open-Label|Adverse Event|0
821282|NCT00192023|1774645|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7
821283|NCT00192023|1774646|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0
821284|NCT00192023|1774645|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
821285|NCT00192023|1774646|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
821286|NCT00192023|1774645|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2
821287|NCT00192023|1774646|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0
821288|NCT00192023|1774645|FG000|Period IV - Optional Open-Label|Protocol Violation|1
821289|NCT00192023|1774646|FG001|Period IV - Optional Open-Label|Protocol Violation|0
821290|NCT00192023|1774645|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4
821291|NCT00192023|1774646|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0
821292|NCT00192023|1774645|FG000|Period IV - Optional Open-Label|Physician Decision|9
821293|NCT00192023|1774646|FG001|Period IV - Optional Open-Label|Physician Decision|0
821294|NCT00192036|1774652|FG000|Overall Study|Protocol Violation|3
821295|NCT00192036|1774652|FG000|Overall Study|Adverse Event|6
821296|NCT00192036|1774652|FG000|Overall Study|Patient/Physician Perception|1
821297|NCT00192036|1774652|FG000|Overall Study|Objective Tumor Progression|4
821298|NCT00192036|1774652|FG000|Overall Study|Clinical Disease Progression|1
821299|NCT00192036|1774652|FG000|Overall Study|Death|1
821300|NCT00192036|1774652|FG000|Overall Study|Unknown or Not Specified|5
821301|NCT00192075|1774658|FG000|Overall Study|Disease Progression|23
821302|NCT00192075|1774659|FG001|Overall Study|Disease Progression|6
821303|NCT00192075|1774658|FG000|Overall Study|Adverse Event|1
821304|NCT00192075|1774659|FG001|Overall Study|Adverse Event|3
821305|NCT00192075|1774658|FG000|Overall Study|Death|0
821306|NCT00192075|1774659|FG001|Overall Study|Death|1
821307|NCT00192075|1774658|FG000|Overall Study|Lack of Efficacy|0
821308|NCT00192075|1774659|FG001|Overall Study|Lack of Efficacy|0
821309|NCT00192075|1774658|FG000|Overall Study|Physician Decision|3
821310|NCT00192075|1774659|FG001|Overall Study|Physician Decision|0
821311|NCT00192075|1774658|FG000|Overall Study|Withdrawal by Subject|5
821312|NCT00192075|1774659|FG001|Overall Study|Withdrawal by Subject|5
821313|NCT00192075|1774658|FG000|Overall Study|Patient Non-Compliance|0
821314|NCT00192075|1774659|FG001|Overall Study|Patient Non-Compliance|1
821315|NCT00192075|1774658|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
821316|NCT00192075|1774659|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
821317|NCT00192075|1774658|FG000|Overall Study|Other|5
821318|NCT00192075|1774659|FG001|Overall Study|Other|2
821319|NCT00192114|1774670|FG000|Overall Study|Objective Tumor Progression|19
821320|NCT00192114|1774670|FG000|Overall Study|Adverse Event|2
821321|NCT00192114|1774670|FG000|Overall Study|Clinical Progression|2
821322|NCT00192114|1774670|FG000|Overall Study|Death|1
821323|NCT00192296|1774678|FG000|Overall Study|Withdrawal by Subject|0
821324|NCT00192296|1774679|FG001|Overall Study|Withdrawal by Subject|1
821325|NCT00192296|1774680|FG002|Overall Study|Withdrawal by Subject|0
821326|NCT00192296|1774681|FG003|Overall Study|Withdrawal by Subject|0
821327|NCT00192504|1774695|FG000|Overall Study|Lost to Follow-up|1
821328|NCT00192504|1774696|FG001|Overall Study|Lost to Follow-up|0
821329|NCT00192504|1774697|FG002|Overall Study|Lost to Follow-up|0
821330|NCT00192504|1774698|FG003|Overall Study|Lost to Follow-up|0
821331|NCT00192504|1774695|FG000|Overall Study|Dosing window missed|0
821332|NCT00192504|1774696|FG001|Overall Study|Dosing window missed|0
821333|NCT00192504|1774697|FG002|Overall Study|Dosing window missed|1
821334|NCT00192504|1774698|FG003|Overall Study|Dosing window missed|0
821335|NCT00192647|1774710|FG000|Overall Study|Death|1
821336|NCT00192647|1774711|FG001|Overall Study|Death|1
821337|NCT00192647|1774710|FG000|Overall Study|Adverse Event|35
821338|NCT00192647|1774711|FG001|Overall Study|Adverse Event|29
821339|NCT00192647|1774710|FG000|Overall Study|Laboratory Test Abnormality|4
821340|NCT00192647|1774711|FG001|Overall Study|Laboratory Test Abnormality|2
821341|NCT00192647|1774710|FG000|Overall Study|Insufficient Therapeutic Response|53
821342|NCT00192647|1774711|FG001|Overall Study|Insufficient Therapeutic Response|83
821343|NCT00192647|1774710|FG000|Overall Study|Entry Criteria Violation|6
821344|NCT00192647|1774711|FG001|Overall Study|Entry Criteria Violation|6
821345|NCT00192647|1774710|FG000|Overall Study|Protocol Violation|3
821346|NCT00192647|1774711|FG001|Overall Study|Protocol Violation|1
821347|NCT00192647|1774710|FG000|Overall Study|Refused Treatment/Did not Cooperate|10
821348|NCT00192647|1774711|FG001|Overall Study|Refused Treatment/Did not Cooperate|8
821349|NCT00192647|1774710|FG000|Overall Study|Failure to Return|11
821350|NCT00192647|1774711|FG001|Overall Study|Failure to Return|13
821351|NCT00192647|1774710|FG000|Overall Study|Other/Administrative|5
821352|NCT00192647|1774711|FG001|Overall Study|Other/Administrative|3
821353|NCT00193050|1774726|FG000|Neoadjuvant Treatment|Lack of Efficacy|2
821354|NCT00193050|1774726|FG000|Neoadjuvant Treatment|Intercurrent Illness|3
821355|NCT00193050|1774726|FG000|Neoadjuvant Treatment|Physician Decision|2
821356|NCT00193050|1774726|FG000|Neoadjuvant Treatment|Adverse Event|2
821357|NCT00193050|1774726|FG000|Adjuvant|Physician Decision|5
821358|NCT00193050|1774726|FG000|Adjuvant|Intercurrent Hospitalization|3
821359|NCT00193050|1774726|FG000|Adjuvant|Lack of Efficacy|2
821360|NCT00193063|1774731|FG000|Overall Study|Lack of Efficacy|3
821361|NCT00193063|1774731|FG000|Overall Study|Adverse Event|1
821362|NCT00193180|1774746|FG000|Overall Study|Lack of Efficacy|1
821363|NCT00193180|1774746|FG000|Overall Study|Adverse Event|8
821364|NCT00193180|1774746|FG000|Overall Study|Protocol Violation|1
821365|NCT00193206|1774751|FG000|Preoperative Therapy|Lack of Efficacy|2
821366|NCT00193206|1774751|FG000|Preoperative Therapy|Adverse Event|2
821367|NCT00193206|1774751|FG000|Preoperative Therapy|Withdrawal by Subject|2
821368|NCT00193206|1774751|FG000|Preoperative Therapy|False Positive Pregnancy Test|1
821369|NCT00193206|1774751|FG000|Postoperative Therapy|Withdrawal by Subject|7
821370|NCT00193206|1774751|FG000|Postoperative Therapy|Physician Decision|3
821371|NCT00193206|1774751|FG000|Postoperative Therapy|Intercurrent Illness|2
821372|NCT00193206|1774751|FG000|Postoperative Therapy|Lack of Efficacy|1
821373|NCT00193206|1774751|FG000|Postoperative Therapy|Protocol Violation|1
821374|NCT00193479|1774780|FG000|Induction Chemotherapy|Adverse Event|2
821375|NCT00193479|1774780|FG000|Induction Chemotherapy|Disease Progression|1
821376|NCT00193609|1774802|FG000|Overall Study|Lack of Efficacy|2
821377|NCT00193609|1774802|FG000|Overall Study|Adverse Event|2
821378|NCT00194012|1774808|FG000|Randomized Phase|Lack of Efficacy|8
821379|NCT00194012|1774809|FG001|Randomized Phase|Lack of Efficacy|18
821380|NCT00194012|1774808|FG000|Randomized Phase|Study nonadherence|2
821381|NCT00194012|1774809|FG001|Randomized Phase|Study nonadherence|1
821382|NCT00194012|1774808|FG000|Randomized Phase|Withdrawal by Subject|3
821383|NCT00194012|1774809|FG001|Randomized Phase|Withdrawal by Subject|3
821384|NCT00194012|1774808|FG000|Randomized Phase|Adverse Event|2
821385|NCT00194012|1774809|FG001|Randomized Phase|Adverse Event|1
821386|NCT00194012|1774808|FG000|Randomized Phase|Participant reported having a rash|1
821387|NCT00194012|1774809|FG001|Randomized Phase|Participant reported having a rash|0
821388|NCT00194012|1774808|FG000|Randomized Phase|Emesis and enuresis|0
821389|NCT00194012|1774809|FG001|Randomized Phase|Emesis and enuresis|1
821390|NCT00194012|1774808|FG000|Randomized Phase|Oral/nasal twitching|0
821391|NCT00194012|1774809|FG001|Randomized Phase|Oral/nasal twitching|1
821392|NCT00194012|1774808|FG000|Open Label Extension (OLE)|Weight Gain|1
821393|NCT00194012|1774809|FG001|Open Label Extension (OLE)|Weight Gain|0
821394|NCT00194012|1774808|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0
821395|NCT00194012|1774809|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1
821396|NCT00194012|1774808|FG000|Open Label Extension (OLE)|Lost to Follow-up|3
821397|NCT00194012|1774809|FG001|Open Label Extension (OLE)|Lost to Follow-up|5
821398|NCT00194012|1774808|FG000|Open Label Extension (OLE)|Lack of Efficacy|1
821399|NCT00194012|1774809|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
821400|NCT00194025|1774821|FG000|Overall Study|Adverse Event|1
821401|NCT00194025|1774821|FG000|Overall Study|non-adherence with study medication|4
821402|NCT00194077|1774827|FG000|Overall Study|Lack of Efficacy|22
821403|NCT00194077|1774828|FG001|Overall Study|Lack of Efficacy|29
821404|NCT00194077|1774827|FG000|Overall Study|Study nonadherence|1
821405|NCT00194077|1774828|FG001|Overall Study|Study nonadherence|0
821406|NCT00194077|1774827|FG000|Overall Study|Withdrawal by Subject|1
821407|NCT00194077|1774828|FG001|Overall Study|Withdrawal by Subject|1
821408|NCT00194675|1774879|FG000|Overall Study|Lost to Follow-up|1
821409|NCT00194675|1774880|FG001|Overall Study|Lost to Follow-up|1
821410|NCT00194675|1774879|FG000|Overall Study|lack of interest|1
821411|NCT00194675|1774880|FG001|Overall Study|lack of interest|1
821412|NCT00194675|1774879|FG000|Overall Study|"withdrew due to edgy feeling"|1
821413|NCT00194675|1774880|FG001|Overall Study|"withdrew due to edgy feeling"|0
821414|NCT00194675|1774879|FG000|Overall Study|Protocol Violation|1
821415|NCT00194675|1774880|FG001|Overall Study|Protocol Violation|0
821416|NCT00194675|1774879|FG000|Overall Study|Death|1
821417|NCT00194675|1774880|FG001|Overall Study|Death|0
821418|NCT00194792|1774892|FG000|Overall Study|Withdrawal by Subject|1
821419|NCT00194987|1774915|FG000|Overall Study|Withdrawal by Subject|0
821420|NCT00194987|1774916|FG001|Overall Study|Withdrawal by Subject|3
821421|NCT00195260|1774939|FG000|Part 1: Dose Escalation|Adverse Event|0
821422|NCT00195260|1774940|FG001|Part 1: Dose Escalation|Adverse Event|1
821423|NCT00195260|1774941|FG002|Part 1: Dose Escalation|Adverse Event|0
821424|NCT00195260|1774942|FG003|Part 1: Dose Escalation|Adverse Event|1
821425|NCT00195260|1774943|FG004|Part 1: Dose Escalation|Adverse Event|1
821426|NCT00195260|1774944|FG005|Part 1: Dose Escalation|Adverse Event|0
821427|NCT00195260|1774945|FG006|Part 1: Dose Escalation|Adverse Event|3
821428|NCT00195260|1774946|FG007|Part 1: Dose Escalation|Adverse Event|0
821429|NCT00195260|1774947|FG008|Part 1: Dose Escalation|Adverse Event|0
821430|NCT00195260|1774948|FG009|Part 1: Dose Escalation|Adverse Event|0
821431|NCT00195260|1774949|FG010|Part 1: Dose Escalation|Adverse Event|0
821432|NCT00195260|1774939|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
821433|NCT00195260|1774940|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
821434|NCT00195260|1774941|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
821435|NCT00195260|1774942|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0
821436|NCT00195260|1774943|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2
821437|NCT00195260|1774944|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
821438|NCT00195260|1774945|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
821439|NCT00195260|1774946|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1
821440|NCT00195260|1774947|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0
821441|NCT00195260|1774948|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0
821442|NCT00195260|1774949|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0
821443|NCT00195260|1774939|FG000|Part 1: Dose Escalation|Death|0
821444|NCT00195260|1774940|FG001|Part 1: Dose Escalation|Death|0
821445|NCT00195260|1774941|FG002|Part 1: Dose Escalation|Death|0
821446|NCT00195260|1774942|FG003|Part 1: Dose Escalation|Death|0
821447|NCT00195260|1774943|FG004|Part 1: Dose Escalation|Death|0
821448|NCT00195260|1774944|FG005|Part 1: Dose Escalation|Death|0
821449|NCT00195260|1774945|FG006|Part 1: Dose Escalation|Death|0
821450|NCT00195260|1774946|FG007|Part 1: Dose Escalation|Death|1
821451|NCT00195260|1774947|FG008|Part 1: Dose Escalation|Death|0
821452|NCT00195260|1774948|FG009|Part 1: Dose Escalation|Death|0
821453|NCT00195260|1774949|FG010|Part 1: Dose Escalation|Death|0
821454|NCT00195260|1774939|FG000|Part 1: Dose Escalation|Disease Progression|3
821455|NCT00195260|1774940|FG001|Part 1: Dose Escalation|Disease Progression|2
821456|NCT00195260|1774941|FG002|Part 1: Dose Escalation|Disease Progression|5
821457|NCT00195260|1774942|FG003|Part 1: Dose Escalation|Disease Progression|6
821458|NCT00195260|1774943|FG004|Part 1: Dose Escalation|Disease Progression|4
821459|NCT00195260|1774944|FG005|Part 1: Dose Escalation|Disease Progression|6
821460|NCT00195260|1774945|FG006|Part 1: Dose Escalation|Disease Progression|7
821461|NCT00195260|1774946|FG007|Part 1: Dose Escalation|Disease Progression|4
821462|NCT00195260|1774947|FG008|Part 1: Dose Escalation|Disease Progression|0
821463|NCT00195260|1774948|FG009|Part 1: Dose Escalation|Disease Progression|0
821464|NCT00195260|1774949|FG010|Part 1: Dose Escalation|Disease Progression|0
821465|NCT00195260|1774939|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1
821466|NCT00195260|1774940|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1
821467|NCT00195260|1774941|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1
821468|NCT00195260|1774942|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0
821469|NCT00195260|1774943|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0
821470|NCT00195260|1774944|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1
821471|NCT00195260|1774945|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0
821472|NCT00195260|1774946|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0
821473|NCT00195260|1774947|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0
821474|NCT00195260|1774948|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0
821475|NCT00195260|1774949|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0
821476|NCT00195260|1774939|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
821477|NCT00195260|1774940|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
821478|NCT00195260|1774941|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
821479|NCT00195260|1774942|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
821480|NCT00195260|1774943|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
821481|NCT00195260|1774944|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
821482|NCT00195260|1774945|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
821483|NCT00195260|1774946|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
821484|NCT00195260|1774947|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
821485|NCT00195260|1774948|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
821486|NCT00195260|1774949|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
821487|NCT00195260|1774939|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
821488|NCT00195260|1774940|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
821489|NCT00195260|1774941|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
821490|NCT00195260|1774942|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
821491|NCT00195260|1774943|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
821492|NCT00195260|1774944|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
821493|NCT00195260|1774945|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
821494|NCT00195260|1774946|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
821495|NCT00195260|1774947|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
821496|NCT00195260|1774948|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
821497|NCT00195260|1774949|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
821498|NCT00195260|1774939|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
821499|NCT00195260|1774940|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
821500|NCT00195260|1774941|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
821501|NCT00195260|1774942|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
821502|NCT00195260|1774943|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
821503|NCT00195260|1774944|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
821504|NCT00195260|1774945|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
821505|NCT00195260|1774946|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
821506|NCT00195260|1774947|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
821507|NCT00195260|1774948|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
821508|NCT00195260|1774949|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
821509|NCT00195260|1774939|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
821510|NCT00195260|1774940|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
821511|NCT00195260|1774941|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
821512|NCT00195260|1774942|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
821513|NCT00195260|1774943|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
821514|NCT00195260|1774944|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
821515|NCT00195260|1774945|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
821516|NCT00195260|1774946|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
821517|NCT00195260|1774947|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
821518|NCT00195260|1774948|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
821519|NCT00195260|1774949|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
821520|NCT00195273|1774979|FG000|Overall Study|Adverse Event|9
821521|NCT00195273|1774980|FG001|Overall Study|Adverse Event|9
821522|NCT00195273|1774979|FG000|Overall Study|Protocol deviation|0
821523|NCT00195273|1774980|FG001|Overall Study|Protocol deviation|1
821524|NCT00195273|1774979|FG000|Overall Study|Lack of Efficacy|3
821525|NCT00195273|1774980|FG001|Overall Study|Lack of Efficacy|1
821526|NCT00195273|1774979|FG000|Overall Study|Procedural complications|9
821527|NCT00195273|1774980|FG001|Overall Study|Procedural complications|3
821528|NCT00195338|1774986|FG000|Overall Study|Lost to Follow-up|2
821529|NCT00195338|1774986|FG000|Overall Study|Adverse Event|5
821530|NCT00195338|1774986|FG000|Overall Study|Lack of Efficacy|1
821531|NCT00195338|1774986|FG000|Overall Study|Early closure of the site|4
821532|NCT00195351|1774992|FG000|Overall Study|Lost to Follow-up|9
821533|NCT00195351|1774993|FG001|Overall Study|Lost to Follow-up|9
821534|NCT00195351|1774992|FG000|Overall Study|Withdrawal by Subject|6
821535|NCT00195351|1774993|FG001|Overall Study|Withdrawal by Subject|3
821536|NCT00195351|1774992|FG000|Overall Study|Protocol Deviation|3
821537|NCT00195351|1774993|FG001|Overall Study|Protocol Deviation|2
821538|NCT00195351|1774992|FG000|Overall Study|Death|3
821539|NCT00195351|1774993|FG001|Overall Study|Death|1
821540|NCT00195351|1774992|FG000|Overall Study|Lack of Efficacy|0
821541|NCT00195351|1774993|FG001|Overall Study|Lack of Efficacy|1
821542|NCT00195429|1775005|FG000|Overall Study|Adverse Event|2
821543|NCT00195429|1775006|FG001|Overall Study|Adverse Event|4
821544|NCT00195429|1775005|FG000|Overall Study|Lack of Efficacy|2
821545|NCT00195429|1775006|FG001|Overall Study|Lack of Efficacy|1
821546|NCT00195429|1775005|FG000|Overall Study|Lost to Follow-up|1
821547|NCT00195429|1775006|FG001|Overall Study|Lost to Follow-up|0
821548|NCT00195442|1775012|FG000|Overall Study|Less than expected therapeutic effect|38
821549|NCT00195442|1775012|FG000|Overall Study|Lost to Follow-up|27
821550|NCT00195442|1775012|FG000|Overall Study|Switch to other Factor VIII preparation|23
821551|NCT00195442|1775012|FG000|Overall Study|Intermittent product shortage|21
821552|NCT00195442|1775012|FG000|Overall Study|Death|7
821553|NCT00195442|1775012|FG000|Overall Study|No reason specified|4
821554|NCT00195442|1775012|FG000|Overall Study|Poor cooperation|2
821555|NCT00195442|1775012|FG000|Overall Study|Other|14
821556|NCT00195494|1775018|FG000|Year 1|Adverse Event|0
821557|NCT00195494|1775019|FG001|Year 1|Adverse Event|0
821558|NCT00195494|1775020|FG002|Year 1|Adverse Event|0
821559|NCT00195494|1775021|FG003|Year 1|Adverse Event|0
821560|NCT00195494|1775022|FG004|Year 1|Adverse Event|34
821561|NCT00195494|1775023|FG005|Year 1|Adverse Event|27
821562|NCT00195494|1775018|FG000|Year 1|System Toxicity|0
821563|NCT00195494|1775019|FG001|Year 1|System Toxicity|0
821564|NCT00195494|1775020|FG002|Year 1|System Toxicity|0
821565|NCT00195494|1775021|FG003|Year 1|System Toxicity|0
821566|NCT00195494|1775022|FG004|Year 1|System Toxicity|0
821567|NCT00195494|1775023|FG005|Year 1|System Toxicity|1
821568|NCT00195494|1775018|FG000|Year 1|Lack of Efficacy|0
821569|NCT00195494|1775019|FG001|Year 1|Lack of Efficacy|0
821570|NCT00195494|1775020|FG002|Year 1|Lack of Efficacy|0
821571|NCT00195494|1775021|FG003|Year 1|Lack of Efficacy|0
821572|NCT00195494|1775022|FG004|Year 1|Lack of Efficacy|24
821573|NCT00195494|1775023|FG005|Year 1|Lack of Efficacy|9
821574|NCT00195494|1775018|FG000|Year 1|Compliance|0
821575|NCT00195494|1775019|FG001|Year 1|Compliance|0
821576|NCT00195494|1775020|FG002|Year 1|Compliance|0
821577|NCT00195494|1775021|FG003|Year 1|Compliance|0
821578|NCT00195494|1775022|FG004|Year 1|Compliance|5
821579|NCT00195494|1775023|FG005|Year 1|Compliance|1
821580|NCT00195494|1775018|FG000|Year 1|Lost to Follow-up|0
821581|NCT00195494|1775019|FG001|Year 1|Lost to Follow-up|0
821582|NCT00195494|1775020|FG002|Year 1|Lost to Follow-up|0
821583|NCT00195494|1775021|FG003|Year 1|Lost to Follow-up|0
821584|NCT00195494|1775022|FG004|Year 1|Lost to Follow-up|1
821585|NCT00195494|1775023|FG005|Year 1|Lost to Follow-up|0
821586|NCT00195494|1775018|FG000|Year 1|Missed >4 consecutive doses|0
821587|NCT00195494|1775019|FG001|Year 1|Missed >4 consecutive doses|0
821588|NCT00195494|1775020|FG002|Year 1|Missed >4 consecutive doses|0
821589|NCT00195494|1775021|FG003|Year 1|Missed >4 consecutive doses|0
821590|NCT00195494|1775022|FG004|Year 1|Missed >4 consecutive doses|3
821591|NCT00195494|1775023|FG005|Year 1|Missed >4 consecutive doses|2
821592|NCT00195494|1775018|FG000|Year 1|Protocol deviation|0
821593|NCT00195494|1775019|FG001|Year 1|Protocol deviation|0
821594|NCT00195494|1775020|FG002|Year 1|Protocol deviation|0
821595|NCT00195494|1775021|FG003|Year 1|Protocol deviation|0
821596|NCT00195494|1775022|FG004|Year 1|Protocol deviation|2
821597|NCT00195494|1775023|FG005|Year 1|Protocol deviation|3
821598|NCT00195494|1775018|FG000|Year 1|Physician Decision|0
821599|NCT00195494|1775019|FG001|Year 1|Physician Decision|0
821600|NCT00195494|1775020|FG002|Year 1|Physician Decision|0
821601|NCT00195494|1775021|FG003|Year 1|Physician Decision|0
821602|NCT00195494|1775022|FG004|Year 1|Physician Decision|1
821603|NCT00195494|1775023|FG005|Year 1|Physician Decision|0
821604|NCT00195494|1775018|FG000|Year 1|Withdrawal by Subject|0
821605|NCT00195494|1775019|FG001|Year 1|Withdrawal by Subject|0
821606|NCT00195494|1775020|FG002|Year 1|Withdrawal by Subject|0
821607|NCT00195494|1775021|FG003|Year 1|Withdrawal by Subject|0
821608|NCT00195494|1775022|FG004|Year 1|Withdrawal by Subject|8
821609|NCT00195494|1775023|FG005|Year 1|Withdrawal by Subject|9
821610|NCT00195494|1775018|FG000|Year 1|Protocol Violation|0
821611|NCT00195494|1775019|FG001|Year 1|Protocol Violation|0
821612|NCT00195494|1775020|FG002|Year 1|Protocol Violation|0
821613|NCT00195494|1775021|FG003|Year 1|Protocol Violation|0
821614|NCT00195494|1775022|FG004|Year 1|Protocol Violation|1
821615|NCT00195494|1775023|FG005|Year 1|Protocol Violation|1
821616|NCT00195494|1775018|FG000|Year 2|Adverse Event|3
821617|NCT00195494|1775019|FG001|Year 2|Adverse Event|7
821618|NCT00195494|1775020|FG002|Year 2|Adverse Event|5
821619|NCT00195494|1775021|FG003|Year 2|Adverse Event|9
821620|NCT00195494|1775022|FG004|Year 2|Adverse Event|0
821621|NCT00195494|1775023|FG005|Year 2|Adverse Event|0
821622|NCT00195494|1775018|FG000|Year 2|Lack of Efficacy|0
821623|NCT00195494|1775019|FG001|Year 2|Lack of Efficacy|1
821624|NCT00195494|1775020|FG002|Year 2|Lack of Efficacy|7
821625|NCT00195494|1775021|FG003|Year 2|Lack of Efficacy|7
821626|NCT00195494|1775022|FG004|Year 2|Lack of Efficacy|0
821627|NCT00195494|1775023|FG005|Year 2|Lack of Efficacy|0
821628|NCT00195494|1775018|FG000|Year 2|Compliance|1
821629|NCT00195494|1775019|FG001|Year 2|Compliance|0
821630|NCT00195494|1775020|FG002|Year 2|Compliance|0
821631|NCT00195494|1775021|FG003|Year 2|Compliance|2
821632|NCT00195494|1775022|FG004|Year 2|Compliance|0
821633|NCT00195494|1775023|FG005|Year 2|Compliance|0
821634|NCT00195494|1775018|FG000|Year 2|Lost to Follow-up|0
821635|NCT00195494|1775019|FG001|Year 2|Lost to Follow-up|0
821636|NCT00195494|1775020|FG002|Year 2|Lost to Follow-up|1
821637|NCT00195494|1775021|FG003|Year 2|Lost to Follow-up|1
821638|NCT00195494|1775022|FG004|Year 2|Lost to Follow-up|0
821639|NCT00195494|1775023|FG005|Year 2|Lost to Follow-up|0
821640|NCT00195494|1775018|FG000|Year 2|Missed >4 consecutive doses|1
821641|NCT00195494|1775019|FG001|Year 2|Missed >4 consecutive doses|1
821642|NCT00195494|1775020|FG002|Year 2|Missed >4 consecutive doses|1
821643|NCT00195494|1775021|FG003|Year 2|Missed >4 consecutive doses|0
821644|NCT00195494|1775022|FG004|Year 2|Missed >4 consecutive doses|0
821645|NCT00195494|1775023|FG005|Year 2|Missed >4 consecutive doses|0
821646|NCT00195494|1775018|FG000|Year 2|Protocol deviation|0
821647|NCT00195494|1775019|FG001|Year 2|Protocol deviation|1
821648|NCT00195494|1775020|FG002|Year 2|Protocol deviation|0
821649|NCT00195494|1775021|FG003|Year 2|Protocol deviation|0
821650|NCT00195494|1775022|FG004|Year 2|Protocol deviation|0
821651|NCT00195494|1775023|FG005|Year 2|Protocol deviation|0
821652|NCT00195494|1775018|FG000|Year 2|Physician Decision|1
821653|NCT00195494|1775019|FG001|Year 2|Physician Decision|1
821654|NCT00195494|1775020|FG002|Year 2|Physician Decision|0
821655|NCT00195494|1775021|FG003|Year 2|Physician Decision|0
821656|NCT00195494|1775022|FG004|Year 2|Physician Decision|0
821657|NCT00195494|1775023|FG005|Year 2|Physician Decision|0
821658|NCT00195494|1775018|FG000|Year 2|Withdrawal by Subject|1
821659|NCT00195494|1775019|FG001|Year 2|Withdrawal by Subject|5
821660|NCT00195494|1775020|FG002|Year 2|Withdrawal by Subject|4
821661|NCT00195494|1775021|FG003|Year 2|Withdrawal by Subject|3
821662|NCT00195494|1775022|FG004|Year 2|Withdrawal by Subject|0
821663|NCT00195494|1775023|FG005|Year 2|Withdrawal by Subject|0
821664|NCT00195494|1775018|FG000|Year 2|System toxicity|0
821665|NCT00195494|1775019|FG001|Year 2|System toxicity|0
821666|NCT00195494|1775020|FG002|Year 2|System toxicity|0
821667|NCT00195494|1775021|FG003|Year 2|System toxicity|1
821668|NCT00195494|1775022|FG004|Year 2|System toxicity|0
821669|NCT00195494|1775023|FG005|Year 2|System toxicity|0
821670|NCT00195507|1775041|FG000|Overall Study|Adverse Event|24
821671|NCT00195507|1775042|FG001|Overall Study|Adverse Event|13
821672|NCT00195507|1775041|FG000|Overall Study|Death|0
821673|NCT00195507|1775042|FG001|Overall Study|Death|1
821674|NCT00195507|1775041|FG000|Overall Study|Failed to Return|4
821675|NCT00195507|1775042|FG001|Overall Study|Failed to Return|3
821676|NCT00195507|1775041|FG000|Overall Study|Physician Decision|1
821677|NCT00195507|1775042|FG001|Overall Study|Physician Decision|2
821678|NCT00195507|1775041|FG000|Overall Study|Lost to Follow-up|3
821679|NCT00195507|1775042|FG001|Overall Study|Lost to Follow-up|2
821680|NCT00195507|1775041|FG000|Overall Study|Protocol Violation|5
821681|NCT00195507|1775042|FG001|Overall Study|Protocol Violation|4
821682|NCT00195507|1775041|FG000|Overall Study|Lack of Efficacy|40
821683|NCT00195507|1775042|FG001|Overall Study|Lack of Efficacy|67
821684|NCT00195507|1775041|FG000|Overall Study|Withdrawal by Subject|16
821685|NCT00195507|1775042|FG001|Overall Study|Withdrawal by Subject|23
821686|NCT00195507|1775041|FG000|Overall Study|Protocol Deviation|6
821687|NCT00195507|1775042|FG001|Overall Study|Protocol Deviation|3
821688|NCT00195650|1775057|FG000|Overall Study|Adverse Event|194
821689|NCT00195650|1775057|FG000|Overall Study|Lack of Efficacy|99
821690|NCT00195650|1775057|FG000|Overall Study|Withdrawal by Subject|67
821691|NCT00195650|1775057|FG000|Overall Study|Lost to Follow-up|44
821692|NCT00195650|1775057|FG000|Overall Study|Death|23
821693|NCT00195650|1775057|FG000|Overall Study|Protocol Violation|15
821694|NCT00195650|1775057|FG000|Overall Study|Administrative reasons|83
821695|NCT00195663|1775064|FG000|2-year Double-blind Treatment Period|Adverse Event|21
821696|NCT00195663|1775065|FG001|2-year Double-blind Treatment Period|Adverse Event|27
821697|NCT00195663|1775066|FG002|2-year Double-blind Treatment Period|Adverse Event|32
821698|NCT00195663|1775064|FG000|2-year Double-blind Treatment Period|Death|0
821699|NCT00195663|1775065|FG001|2-year Double-blind Treatment Period|Death|2
821700|NCT00195663|1775066|FG002|2-year Double-blind Treatment Period|Death|0
821701|NCT00195663|1775064|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0
821702|NCT00195663|1775065|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0
821703|NCT00195663|1775066|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1
821704|NCT00195663|1775064|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15
821705|NCT00195663|1775065|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18
821706|NCT00195663|1775066|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12
821707|NCT00195663|1775064|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47
821708|NCT00195663|1775065|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52
821709|NCT00195663|1775066|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13
821710|NCT00195663|1775064|FG000|2-year Double-blind Treatment Period|Protocol Violation|6
821711|NCT00195663|1775065|FG001|2-year Double-blind Treatment Period|Protocol Violation|6
821712|NCT00195663|1775066|FG002|2-year Double-blind Treatment Period|Protocol Violation|4
821713|NCT00195663|1775064|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0
821714|NCT00195663|1775065|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1
821715|NCT00195663|1775066|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0
821716|NCT00195663|1775064|FG000|2-year Double-blind Treatment Period|Recovery|1
821717|NCT00195663|1775065|FG001|2-year Double-blind Treatment Period|Recovery|0
821718|NCT00195663|1775066|FG002|2-year Double-blind Treatment Period|Recovery|1
821719|NCT00195663|1775064|FG000|2-year Double-blind Treatment Period|Administrative reasons|3
821720|NCT00195663|1775065|FG001|2-year Double-blind Treatment Period|Administrative reasons|2
821721|NCT00195663|1775066|FG002|2-year Double-blind Treatment Period|Administrative reasons|9
821722|NCT00195663|1775064|FG000|Open-Label Extension Period|Adverse Event|21
821723|NCT00195663|1775065|FG001|Open-Label Extension Period|Adverse Event|32
821724|NCT00195663|1775066|FG002|Open-Label Extension Period|Adverse Event|36
821725|NCT00195663|1775064|FG000|Open-Label Extension Period|Lost to Follow-up|9
821726|NCT00195663|1775065|FG001|Open-Label Extension Period|Lost to Follow-up|2
821727|NCT00195663|1775066|FG002|Open-Label Extension Period|Lost to Follow-up|6
821728|NCT00195663|1775064|FG000|Open-Label Extension Period|Recovery|0
821729|NCT00195663|1775065|FG001|Open-Label Extension Period|Recovery|2
821730|NCT00195663|1775066|FG002|Open-Label Extension Period|Recovery|2
821731|NCT00195663|1775064|FG000|Open-Label Extension Period|Protocol Violation|3
821732|NCT00195663|1775065|FG001|Open-Label Extension Period|Protocol Violation|4
821733|NCT00195663|1775066|FG002|Open-Label Extension Period|Protocol Violation|4
821734|NCT00195663|1775064|FG000|Open-Label Extension Period|Death|2
821735|NCT00195663|1775065|FG001|Open-Label Extension Period|Death|2
821736|NCT00195663|1775066|FG002|Open-Label Extension Period|Death|2
821737|NCT00195663|1775064|FG000|Open-Label Extension Period|Withdrawal by Subject|16
821738|NCT00195663|1775065|FG001|Open-Label Extension Period|Withdrawal by Subject|15
821739|NCT00195663|1775066|FG002|Open-Label Extension Period|Withdrawal by Subject|22
821740|NCT00195663|1775064|FG000|Open-Label Extension Period|Lack of Efficacy|14
821741|NCT00195663|1775065|FG001|Open-Label Extension Period|Lack of Efficacy|6
821742|NCT00195663|1775066|FG002|Open-Label Extension Period|Lack of Efficacy|12
821743|NCT00195663|1775064|FG000|Open-Label Extension Period|Administrative reasons|11
821744|NCT00195663|1775065|FG001|Open-Label Extension Period|Administrative reasons|11
821745|NCT00195663|1775066|FG002|Open-Label Extension Period|Administrative reasons|13
821746|NCT00195676|1775084|FG000|Period O - Open-label Treatment|Adverse Event|82
821747|NCT00195676|1775084|FG000|Period O - Open-label Treatment|Death|6
821748|NCT00195676|1775084|FG000|Period O - Open-label Treatment|Lack of Efficacy|198
821749|NCT00195676|1775084|FG000|Period O - Open-label Treatment|Lost to Follow-up|91
821750|NCT00195676|1775084|FG000|Period O - Open-label Treatment|Protocol Violation|12
821751|NCT00195676|1775084|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147
821752|NCT00195676|1775084|FG000|Period O - Open-label Treatment|Administrative reasons|2
821753|NCT00195676|1775084|FG000|Period O - Open-label Treatment|Other reasons|68
821754|NCT00195676|1775084|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4
821755|NCT00195676|1775084|FG000|Period W (Withdrawal) - No Treatment|Death|2
821756|NCT00195676|1775084|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
821757|NCT00195676|1775084|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
821758|NCT00195676|1775084|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
821759|NCT00195676|1775084|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129
821760|NCT00195676|1775084|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1
821761|NCT00195676|1775084|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18
821762|NCT00195676|1775084|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4
821763|NCT00195676|1775084|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
821764|NCT00195676|1775084|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
821765|NCT00195676|1775084|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
821766|NCT00195676|1775084|FG000|Period R - Retreatment 16 Weeks|Other reasons|6
821767|NCT00195715|1775113|FG000|Overall Study|Adverse Event|122
821768|NCT00195715|1775113|FG000|Overall Study|Withdrawal by Subject|58
821769|NCT00195715|1775113|FG000|Overall Study|Lost to Follow-up|27
821770|NCT00195715|1775113|FG000|Overall Study|Protocol Violation|13
821771|NCT00195715|1775113|FG000|Overall Study|Lack of Efficacy|93
821772|NCT00195715|1775113|FG000|Overall Study|Pregnancy|14
821773|NCT00195715|1775113|FG000|Overall Study|Investigative site closure|8
821774|NCT00195715|1775113|FG000|Overall Study|Subject moved/relocated|7
821775|NCT00195715|1775113|FG000|Overall Study|Subject non-compliance|6
821776|NCT00195715|1775113|FG000|Overall Study|Subject started commercial Humira|5
821777|NCT00195715|1775113|FG000|Overall Study|Subject choice|3
821778|NCT00195715|1775113|FG000|Overall Study|Loss of response/no improvement|3
821779|NCT00195715|1775113|FG000|Overall Study|Sponsor stopped study|1
821780|NCT00195715|1775113|FG000|Overall Study|Administrative reasons|2
821781|NCT00195715|1775113|FG000|Overall Study|Investigator's decision|2
821782|NCT00195715|1775113|FG000|Overall Study|Subject wants to get pregnant|4
821783|NCT00195715|1775113|FG000|Overall Study|Use of prohibited medication|2
821784|NCT00195715|1775113|FG000|Overall Study|Planned surgery|2
821785|NCT00195715|1775113|FG000|Overall Study|Increased infection rate|1
821786|NCT00195715|1775113|FG000|Overall Study|Ineligible|1
821787|NCT00195715|1775113|FG000|Overall Study|Colonic stricture|1
821788|NCT00195715|1775113|FG000|Overall Study|Sponsor discontinued trial|1
821789|NCT00195715|1775113|FG000|Overall Study|Sponsor discretion - trial ended early|1
821790|NCT00195819|1775117|FG000|Double-Blind|Withdrawal by Subject|1
821791|NCT00195819|1775118|FG001|Double-Blind|Withdrawal by Subject|0
821792|NCT00195819|1775117|FG000|Double-Blind|Moved|1
821793|NCT00195819|1775118|FG001|Double-Blind|Moved|0
821794|NCT00195819|1775117|FG000|Open-label|Adverse Event|0
821795|NCT00195819|1775118|FG001|Open-label|Adverse Event|9
821796|NCT00195819|1775117|FG000|Open-label|Lack of Efficacy|0
821797|NCT00195819|1775118|FG001|Open-label|Lack of Efficacy|2
821798|NCT00195819|1775117|FG000|Open-label|Pregnancy|0
821799|NCT00195819|1775118|FG001|Open-label|Pregnancy|1
821800|NCT00195819|1775117|FG000|Open-label|Protocol Violation|0
821801|NCT00195819|1775118|FG001|Open-label|Protocol Violation|2
821802|NCT00195819|1775117|FG000|Open-label|Moved|0
821803|NCT00195819|1775118|FG001|Open-label|Moved|1
821804|NCT00195819|1775117|FG000|Open-label|Withdrawal by Subject|0
821805|NCT00195819|1775118|FG001|Open-label|Withdrawal by Subject|5
821806|NCT00196105|1775133|FG000|Overall Study|Lost to Follow-up|4
821807|NCT00196105|1775134|FG001|Overall Study|Lost to Follow-up|5
821808|NCT00196105|1775135|FG002|Overall Study|Lost to Follow-up|7
821809|NCT00196196|1775143|FG000|Overall Study|Withdrawal by Subject|2
821810|NCT00196196|1775143|FG000|Overall Study|Did not have required condition (hydroce|5
821811|NCT00196313|1775149|FG000|Overall Study|Protocol Violation|2
821812|NCT00196313|1775150|FG001|Overall Study|Protocol Violation|3
821813|NCT00196313|1775149|FG000|Overall Study|Withdrawal by Subject|3
821814|NCT00196313|1775150|FG001|Overall Study|Withdrawal by Subject|1
821815|NCT00196313|1775149|FG000|Overall Study|Adverse Event|3
821816|NCT00196313|1775150|FG001|Overall Study|Adverse Event|1
821817|NCT00196313|1775149|FG000|Overall Study|Subject Pregnant|1
821818|NCT00196313|1775150|FG001|Overall Study|Subject Pregnant|1
821819|NCT00196313|1775149|FG000|Overall Study|Lost to Follow-up|2
821820|NCT00196313|1775150|FG001|Overall Study|Lost to Follow-up|2
821821|NCT00196326|1775157|FG000|Overall Study|Did not meet protocol requirements|64
821822|NCT00196326|1775157|FG000|Overall Study|Non-compliance with the protocol|81
821823|NCT00196326|1775157|FG000|Overall Study|Physician Decision|3
821824|NCT00196326|1775157|FG000|Overall Study|Withdrawal by Subject|225
821825|NCT00196326|1775157|FG000|Overall Study|Adverse Event|253
821826|NCT00196326|1775157|FG000|Overall Study|Pregnancy|34
821827|NCT00196326|1775157|FG000|Overall Study|Lost to Follow-up|304
821828|NCT00196326|1775157|FG000|Overall Study|Other|22
821829|NCT00196937|1775170|FG000|Overall Study|Serious Adverse Event|1
821830|NCT00196937|1775171|FG001|Overall Study|Serious Adverse Event|0
821831|NCT00196937|1775172|FG002|Overall Study|Serious Adverse Event|0
821832|NCT00196937|1775170|FG000|Overall Study|Non-serious adverse event|1
821833|NCT00196937|1775171|FG001|Overall Study|Non-serious adverse event|1
821834|NCT00196937|1775172|FG002|Overall Study|Non-serious adverse event|1
821835|NCT00196937|1775170|FG000|Overall Study|Withdrawal by Subject|0
821836|NCT00196937|1775171|FG001|Overall Study|Withdrawal by Subject|0
821837|NCT00196937|1775172|FG002|Overall Study|Withdrawal by Subject|2
821838|NCT00196937|1775170|FG000|Overall Study|Lost to Follow-up|4
821839|NCT00196937|1775171|FG001|Overall Study|Lost to Follow-up|3
821840|NCT00196937|1775172|FG002|Overall Study|Lost to Follow-up|3
821841|NCT00196937|1775170|FG000|Overall Study|Other|3
821842|NCT00196937|1775171|FG001|Overall Study|Other|1
821843|NCT00196937|1775172|FG002|Overall Study|Other|1
821844|NCT00196976|1775195|FG000|Primary Study|Migrated from study area|0
821845|NCT00196976|1775196|FG001|Primary Study|Migrated from study area|0
821846|NCT00196976|1775197|FG002|Primary Study|Migrated from study area|0
821847|NCT00196976|1775198|FG003|Primary Study|Migrated from study area|0
821848|NCT00196976|1775199|FG004|Primary Study|Migrated from study area|0
821849|NCT00196976|1775200|FG005|Primary Study|Migrated from study area|0
821850|NCT00196976|1775201|FG006|Primary Study|Migrated from study area|0
821851|NCT00196976|1775202|FG007|Primary Study|Migrated from study area|1
821852|NCT00196976|1775203|FG008|Primary Study|Migrated from study area|0
821853|NCT00196976|1775204|FG009|Primary Study|Migrated from study area|0
821854|NCT00196976|1775205|FG010|Primary Study|Migrated from study area|0
821855|NCT00196976|1775206|FG011|Primary Study|Migrated from study area|0
821856|NCT00196976|1775207|FG012|Primary Study|Migrated from study area|0
821857|NCT00196976|1775208|FG013|Primary Study|Migrated from study area|0
821858|NCT00196976|1775195|FG000|Primary Study|Protocol Violation|0
821859|NCT00196976|1775196|FG001|Primary Study|Protocol Violation|1
821860|NCT00196976|1775197|FG002|Primary Study|Protocol Violation|1
821861|NCT00196976|1775198|FG003|Primary Study|Protocol Violation|0
821862|NCT00196976|1775199|FG004|Primary Study|Protocol Violation|0
821863|NCT00196976|1775200|FG005|Primary Study|Protocol Violation|0
821864|NCT00196976|1775201|FG006|Primary Study|Protocol Violation|0
821865|NCT00196976|1775202|FG007|Primary Study|Protocol Violation|0
821866|NCT00196976|1775203|FG008|Primary Study|Protocol Violation|0
821867|NCT00196976|1775204|FG009|Primary Study|Protocol Violation|0
821868|NCT00196976|1775205|FG010|Primary Study|Protocol Violation|0
821869|NCT00196976|1775206|FG011|Primary Study|Protocol Violation|0
821870|NCT00196976|1775207|FG012|Primary Study|Protocol Violation|0
821871|NCT00196976|1775208|FG013|Primary Study|Protocol Violation|0
821872|NCT00196976|1775195|FG000|Primary Study|Withdrawal by Subject|1
821873|NCT00196976|1775196|FG001|Primary Study|Withdrawal by Subject|0
821874|NCT00196976|1775197|FG002|Primary Study|Withdrawal by Subject|1
821875|NCT00196976|1775198|FG003|Primary Study|Withdrawal by Subject|1
821876|NCT00196976|1775199|FG004|Primary Study|Withdrawal by Subject|2
821877|NCT00196976|1775200|FG005|Primary Study|Withdrawal by Subject|1
821878|NCT00196976|1775201|FG006|Primary Study|Withdrawal by Subject|0
821879|NCT00196976|1775202|FG007|Primary Study|Withdrawal by Subject|0
821880|NCT00196976|1775203|FG008|Primary Study|Withdrawal by Subject|0
821881|NCT00196976|1775204|FG009|Primary Study|Withdrawal by Subject|1
821882|NCT00196976|1775205|FG010|Primary Study|Withdrawal by Subject|0
821883|NCT00196976|1775206|FG011|Primary Study|Withdrawal by Subject|0
821884|NCT00196976|1775207|FG012|Primary Study|Withdrawal by Subject|0
821885|NCT00196976|1775208|FG013|Primary Study|Withdrawal by Subject|0
821886|NCT00196976|1775195|FG000|Primary Study|Lost to Follow-up|0
821887|NCT00196976|1775196|FG001|Primary Study|Lost to Follow-up|0
821888|NCT00196976|1775197|FG002|Primary Study|Lost to Follow-up|0
821889|NCT00196976|1775198|FG003|Primary Study|Lost to Follow-up|0
821890|NCT00196976|1775199|FG004|Primary Study|Lost to Follow-up|1
821891|NCT00196976|1775200|FG005|Primary Study|Lost to Follow-up|1
821892|NCT00196976|1775201|FG006|Primary Study|Lost to Follow-up|0
821893|NCT00196976|1775202|FG007|Primary Study|Lost to Follow-up|2
821894|NCT00196976|1775203|FG008|Primary Study|Lost to Follow-up|0
821895|NCT00196976|1775204|FG009|Primary Study|Lost to Follow-up|0
821896|NCT00196976|1775205|FG010|Primary Study|Lost to Follow-up|0
821897|NCT00196976|1775206|FG011|Primary Study|Lost to Follow-up|0
821898|NCT00196976|1775207|FG012|Primary Study|Lost to Follow-up|0
821899|NCT00196976|1775208|FG013|Primary Study|Lost to Follow-up|0
821900|NCT00196976|1775195|FG000|Primary Study|Other|0
821901|NCT00196976|1775196|FG001|Primary Study|Other|0
821902|NCT00196976|1775197|FG002|Primary Study|Other|2
821903|NCT00196976|1775198|FG003|Primary Study|Other|0
821904|NCT00196976|1775199|FG004|Primary Study|Other|0
821905|NCT00196976|1775200|FG005|Primary Study|Other|0
821906|NCT00196976|1775201|FG006|Primary Study|Other|0
821907|NCT00196976|1775202|FG007|Primary Study|Other|0
821908|NCT00196976|1775203|FG008|Primary Study|Other|0
821909|NCT00196976|1775204|FG009|Primary Study|Other|0
821910|NCT00196976|1775205|FG010|Primary Study|Other|0
821911|NCT00196976|1775206|FG011|Primary Study|Other|0
821912|NCT00196976|1775207|FG012|Primary Study|Other|0
821913|NCT00196976|1775208|FG013|Primary Study|Other|0
821914|NCT00196976|1775195|FG000|Booster Study|Withdrawal by Subject|0
821915|NCT00196976|1775196|FG001|Booster Study|Withdrawal by Subject|0
821916|NCT00196976|1775197|FG002|Booster Study|Withdrawal by Subject|0
821917|NCT00196976|1775198|FG003|Booster Study|Withdrawal by Subject|0
821918|NCT00196976|1775199|FG004|Booster Study|Withdrawal by Subject|0
821919|NCT00196976|1775200|FG005|Booster Study|Withdrawal by Subject|0
821920|NCT00196976|1775201|FG006|Booster Study|Withdrawal by Subject|0
821921|NCT00196976|1775202|FG007|Booster Study|Withdrawal by Subject|0
821922|NCT00196976|1775203|FG008|Booster Study|Withdrawal by Subject|0
821923|NCT00196976|1775204|FG009|Booster Study|Withdrawal by Subject|0
821924|NCT00196976|1775205|FG010|Booster Study|Withdrawal by Subject|1
821925|NCT00196976|1775206|FG011|Booster Study|Withdrawal by Subject|0
821926|NCT00196976|1775207|FG012|Booster Study|Withdrawal by Subject|0
821927|NCT00196976|1775208|FG013|Booster Study|Withdrawal by Subject|0
821928|NCT00196976|1775195|FG000|Booster Study|Lost to Follow-up|0
821929|NCT00196976|1775196|FG001|Booster Study|Lost to Follow-up|0
821930|NCT00196976|1775197|FG002|Booster Study|Lost to Follow-up|0
821931|NCT00196976|1775198|FG003|Booster Study|Lost to Follow-up|0
821932|NCT00196976|1775199|FG004|Booster Study|Lost to Follow-up|0
821933|NCT00196976|1775200|FG005|Booster Study|Lost to Follow-up|0
821934|NCT00196976|1775201|FG006|Booster Study|Lost to Follow-up|0
821935|NCT00196976|1775202|FG007|Booster Study|Lost to Follow-up|0
821936|NCT00196976|1775203|FG008|Booster Study|Lost to Follow-up|0
821937|NCT00196976|1775204|FG009|Booster Study|Lost to Follow-up|0
821938|NCT00196976|1775205|FG010|Booster Study|Lost to Follow-up|1
821939|NCT00196976|1775206|FG011|Booster Study|Lost to Follow-up|2
821940|NCT00196976|1775207|FG012|Booster Study|Lost to Follow-up|0
821941|NCT00196976|1775208|FG013|Booster Study|Lost to Follow-up|0
821942|NCT00197002|1775251|FG000|Overall Study|Adverse Event|0
821943|NCT00197002|1775252|FG001|Overall Study|Adverse Event|1
821944|NCT00197002|1775253|FG002|Overall Study|Adverse Event|0
821945|NCT00197002|1775251|FG000|Overall Study|Protocol Violation|1
821946|NCT00197002|1775252|FG001|Overall Study|Protocol Violation|0
821947|NCT00197002|1775253|FG002|Overall Study|Protocol Violation|2
821948|NCT00197002|1775251|FG000|Overall Study|Withdrawal by Subject|9
821949|NCT00197002|1775252|FG001|Overall Study|Withdrawal by Subject|5
821950|NCT00197002|1775253|FG002|Overall Study|Withdrawal by Subject|7
821951|NCT00197002|1775251|FG000|Overall Study|Migrated/moved from study area|3
821952|NCT00197002|1775252|FG001|Overall Study|Migrated/moved from study area|5
821953|NCT00197002|1775253|FG002|Overall Study|Migrated/moved from study area|1
821954|NCT00197002|1775251|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4
821955|NCT00197002|1775252|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4
821956|NCT00197002|1775253|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5
821957|NCT00197002|1775251|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2
821958|NCT00197002|1775252|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2
821959|NCT00197002|1775253|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1
821960|NCT00197002|1775251|FG000|Overall Study|Others|3
821961|NCT00197002|1775252|FG001|Overall Study|Others|1
821962|NCT00197002|1775253|FG002|Overall Study|Others|1
821963|NCT00197015|1775267|FG000|Overall Study|Adverse Event|3
821964|NCT00197015|1775268|FG001|Overall Study|Adverse Event|0
821965|NCT00197015|1775269|FG002|Overall Study|Adverse Event|1
821966|NCT00197015|1775267|FG000|Overall Study|Protocol Violation|0
821967|NCT00197015|1775268|FG001|Overall Study|Protocol Violation|3
821968|NCT00197015|1775269|FG002|Overall Study|Protocol Violation|3
821969|NCT00197015|1775267|FG000|Overall Study|Withdrawal by Subject|17
821970|NCT00197015|1775268|FG001|Overall Study|Withdrawal by Subject|37
821971|NCT00197015|1775269|FG002|Overall Study|Withdrawal by Subject|34
821972|NCT00197015|1775267|FG000|Overall Study|Lost to Follow-up|28
821973|NCT00197015|1775268|FG001|Overall Study|Lost to Follow-up|46
821974|NCT00197015|1775269|FG002|Overall Study|Lost to Follow-up|37
821975|NCT00197015|1775267|FG000|Overall Study|Other|2
821976|NCT00197015|1775268|FG001|Overall Study|Other|3
821977|NCT00197015|1775269|FG002|Overall Study|Other|2
821978|NCT00197028|1775279|FG000|Overall Study|Adverse Event|2
821979|NCT00197028|1775280|FG001|Overall Study|Adverse Event|2
821980|NCT00197028|1775279|FG000|Overall Study|Protocol Violation|2
821981|NCT00197028|1775280|FG001|Overall Study|Protocol Violation|1
821982|NCT00197028|1775279|FG000|Overall Study|Withdrawal by Subject|8
821983|NCT00197028|1775280|FG001|Overall Study|Withdrawal by Subject|12
821984|NCT00197028|1775279|FG000|Overall Study|Lost to Follow-up|1
821985|NCT00197028|1775280|FG001|Overall Study|Lost to Follow-up|0
821986|NCT00197028|1775279|FG000|Overall Study|Other|3
821987|NCT00197028|1775280|FG001|Overall Study|Other|6
821988|NCT00197054|1775289|FG000|Overall Study|Withdrawal by Subject|9
821989|NCT00197054|1775290|FG001|Overall Study|Withdrawal by Subject|3
821990|NCT00197054|1775291|FG002|Overall Study|Withdrawal by Subject|3
821991|NCT00197054|1775289|FG000|Overall Study|Moved from area|7
821992|NCT00197054|1775290|FG001|Overall Study|Moved from area|14
821993|NCT00197054|1775291|FG002|Overall Study|Moved from area|9
821994|NCT00197054|1775289|FG000|Overall Study|Lost to Follow-up|1
821995|NCT00197054|1775290|FG001|Overall Study|Lost to Follow-up|4
821996|NCT00197054|1775291|FG002|Overall Study|Lost to Follow-up|0
821997|NCT00197106|1775311|FG000|4-Week Run-In Period|Did not meet entry criteria|99
821998|NCT00197106|1775312|FG001|4-Week Run-In Period|Did not meet entry criteria|0
821999|NCT00197106|1775313|FG002|4-Week Run-In Period|Did not meet entry criteria|0
822000|NCT00197106|1775311|FG000|Overall Treatment Period|Lack of Efficacy|0
822001|NCT00197106|1775312|FG001|Overall Treatment Period|Lack of Efficacy|1
822002|NCT00197106|1775313|FG002|Overall Treatment Period|Lack of Efficacy|0
822003|NCT00197106|1775311|FG000|Overall Treatment Period|Lost to Follow-up|0
822004|NCT00197106|1775312|FG001|Overall Treatment Period|Lost to Follow-up|0
822005|NCT00197106|1775313|FG002|Overall Treatment Period|Lost to Follow-up|2
822006|NCT00197106|1775311|FG000|Overall Treatment Period|Protocol Violation|0
822007|NCT00197106|1775312|FG001|Overall Treatment Period|Protocol Violation|0
822008|NCT00197106|1775313|FG002|Overall Treatment Period|Protocol Violation|2
822009|NCT00197106|1775311|FG000|Overall Treatment Period|Withdrawal by Subject|0
822010|NCT00197106|1775312|FG001|Overall Treatment Period|Withdrawal by Subject|0
822011|NCT00197106|1775313|FG002|Overall Treatment Period|Withdrawal by Subject|2
822012|NCT00197145|1775330|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
822013|NCT00197145|1775331|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
822014|NCT00197145|1775330|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
822015|NCT00197145|1775331|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
822016|NCT00197145|1775330|FG000|Period 1: Randomized Treatment Phase|Other|2
822017|NCT00197145|1775331|FG001|Period 1: Randomized Treatment Phase|Other|2
822018|NCT00197145|1775330|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1
822019|NCT00197145|1775331|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0
822020|NCT00197145|1775330|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3
822021|NCT00197145|1775331|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0
822022|NCT00197145|1775330|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2
822023|NCT00197145|1775331|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0
822024|NCT00197145|1775330|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3
822025|NCT00197145|1775331|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0
822026|NCT00197145|1775330|FG000|Period 2 : Open Label Phase|Other|1
822027|NCT00197145|1775331|FG001|Period 2 : Open Label Phase|Other|0
822028|NCT00197236|1775350|FG000|Overall Study|Adverse Event|1
822029|NCT00197236|1775351|FG001|Overall Study|Adverse Event|0
822030|NCT00197236|1775352|FG002|Overall Study|Adverse Event|1
822031|NCT00197236|1775350|FG000|Overall Study|Lost to Follow-up|5
822032|NCT00197236|1775351|FG001|Overall Study|Lost to Follow-up|14
822033|NCT00197236|1775352|FG002|Overall Study|Lost to Follow-up|6
822034|NCT00197236|1775350|FG000|Overall Study|Protocol Violation|0
822035|NCT00197236|1775351|FG001|Overall Study|Protocol Violation|0
822036|NCT00197236|1775352|FG002|Overall Study|Protocol Violation|1
822037|NCT00197236|1775350|FG000|Overall Study|Withdrawal by Subject|7
822038|NCT00197236|1775351|FG001|Overall Study|Withdrawal by Subject|3
822039|NCT00197236|1775352|FG002|Overall Study|Withdrawal by Subject|11
822040|NCT00197236|1775350|FG000|Overall Study|Study drug/medication expiration|1
822041|NCT00197236|1775351|FG001|Overall Study|Study drug/medication expiration|0
822042|NCT00197236|1775352|FG002|Overall Study|Study drug/medication expiration|3
822043|NCT00197236|1775350|FG000|Overall Study|Returned out of specified time window|0
822044|NCT00197236|1775351|FG001|Overall Study|Returned out of specified time window|0
822045|NCT00197236|1775352|FG002|Overall Study|Returned out of specified time window|1
822046|NCT00197496|1775390|FG000|Baseline to Discharge|not interested|1
822047|NCT00197496|1775391|FG001|Baseline to Discharge|not interested|0
822048|NCT00197496|1775390|FG000|Baseline to Discharge|MRSA|1
822049|NCT00197496|1775391|FG001|Baseline to Discharge|MRSA|0
822050|NCT00197496|1775390|FG000|Baseline to Discharge|Physician Decision|0
822051|NCT00197496|1775391|FG001|Baseline to Discharge|Physician Decision|1
822052|NCT00197496|1775390|FG000|Baseline to Discharge|Protocol Violation|0
822053|NCT00197496|1775391|FG001|Baseline to Discharge|Protocol Violation|1
822054|NCT00197496|1775390|FG000|Follow-up|Lost to Follow-up|2
822055|NCT00197496|1775391|FG001|Follow-up|Lost to Follow-up|1
822056|NCT00198029|1775397|FG000|Overall Study|Withdrawal by Subject|4
822057|NCT00198107|1775421|FG000|Double-Blind Period|Adverse Event|1
822058|NCT00198107|1775422|FG001|Double-Blind Period|Adverse Event|1
822059|NCT00198107|1775423|FG002|Double-Blind Period|Adverse Event|0
822060|NCT00198107|1775421|FG000|Double-Blind Period|Lack of Efficacy|2
822061|NCT00198107|1775422|FG001|Double-Blind Period|Lack of Efficacy|0
822062|NCT00198107|1775423|FG002|Double-Blind Period|Lack of Efficacy|0
822063|NCT00198107|1775421|FG000|Double-Blind Period|Lost to Follow-up|2
822064|NCT00198107|1775422|FG001|Double-Blind Period|Lost to Follow-up|1
822065|NCT00198107|1775423|FG002|Double-Blind Period|Lost to Follow-up|0
822066|NCT00198107|1775421|FG000|Double-Blind Period|Physician Decision|1
822067|NCT00198107|1775422|FG001|Double-Blind Period|Physician Decision|0
822068|NCT00198107|1775423|FG002|Double-Blind Period|Physician Decision|0
822069|NCT00198107|1775421|FG000|Double-Blind Period|Withdrawal by Subject|0
822070|NCT00198107|1775422|FG001|Double-Blind Period|Withdrawal by Subject|1
822071|NCT00198107|1775423|FG002|Double-Blind Period|Withdrawal by Subject|0
822072|NCT00198107|1775421|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
822073|NCT00198107|1775422|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
822074|NCT00198107|1775423|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
822075|NCT00198133|1775433|FG000|Overall Study|Disease progression|2
822076|NCT00198133|1775434|FG001|Overall Study|Disease progression|5
822077|NCT00198133|1775433|FG000|Overall Study|Adverse Event|1
822078|NCT00198133|1775434|FG001|Overall Study|Adverse Event|3
822079|NCT00198133|1775433|FG000|Overall Study|Withdrawal by Subject|1
822080|NCT00198133|1775434|FG001|Overall Study|Withdrawal by Subject|0
822081|NCT00198133|1775433|FG000|Overall Study|Physician Decision|1
822082|NCT00198133|1775434|FG001|Overall Study|Physician Decision|0
822083|NCT00198822|1775443|FG000|Overall Study|Lost to Follow-up|14
822084|NCT00198822|1775444|FG001|Overall Study|Lost to Follow-up|20
822085|NCT00198822|1775445|FG002|Overall Study|Lost to Follow-up|21
822086|NCT00199381|1775453|FG000|Overall Study|Withdrawal by Subject|38
822087|NCT00199381|1775453|FG000|Overall Study|Adverse Event|73
822088|NCT00199381|1775453|FG000|Overall Study|Protocol Violation|6
822089|NCT00199381|1775453|FG000|Overall Study|Lack of Efficacy|27
822090|NCT00199381|1775453|FG000|Overall Study|Not including due to early termination|37
822091|NCT00199381|1775453|FG000|Overall Study|Study termination by Sponsor|323
822092|NCT00199797|1775457|FG000|Overall Study|Progressive Disease|1
822093|NCT00199797|1775457|FG000|Overall Study|Adverse Event|1
822094|NCT00199797|1775457|FG000|Overall Study|Physician Decision|1
822095|NCT00199836|1775462|FG000|Overall Study|Progressive Disease|5
822096|NCT00199836|1775462|FG000|Overall Study|Death|1
822097|NCT00199849|1775470|FG000|Overall Study|Unrelated illness or complication|0
822098|NCT00199849|1775471|FG001|Overall Study|Unrelated illness or complication|1
822099|NCT00199849|1775472|FG002|Overall Study|Unrelated illness or complication|0
822100|NCT00199849|1775470|FG000|Overall Study|Progressive disease requiring intervention|0
822101|NCT00199849|1775471|FG001|Overall Study|Progressive disease requiring intervention|0
822102|NCT00199849|1775472|FG002|Overall Study|Progressive disease requiring intervention|1
822103|NCT00199849|1775470|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0
822104|NCT00199849|1775471|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0
822105|NCT00199849|1775472|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1
822106|NCT00199875|1775485|FG000|Overall Study|Withdrawal by Subject|0
822107|NCT00199875|1775486|FG001|Overall Study|Withdrawal by Subject|0
822108|NCT00199875|1775487|FG002|Overall Study|Withdrawal by Subject|0
822109|NCT00199875|1775488|FG003|Overall Study|Withdrawal by Subject|0
822110|NCT00199875|1775489|FG004|Overall Study|Withdrawal by Subject|1
822111|NCT00199888|1775501|FG000|Overall Study|Lost to Follow-up|1
822112|NCT00199901|1775507|FG000|Overall Study|Protocol Violation|2
822113|NCT00199901|1775508|FG001|Overall Study|Protocol Violation|0
822114|NCT00199901|1775507|FG000|Overall Study|Withdrawal by Subject|1
822115|NCT00199901|1775508|FG001|Overall Study|Withdrawal by Subject|0
822116|NCT00199901|1775507|FG000|Overall Study|Progressive Disease|24
822117|NCT00199901|1775508|FG001|Overall Study|Progressive Disease|24
822118|NCT00200057|1775525|FG000|Overall Study|Lack of Efficacy|3
822119|NCT00200057|1775525|FG000|Overall Study|Exited due to terminal illness of PI|2
822120|NCT00200057|1775525|FG000|Overall Study|Withdrawal by Subject|1
822121|NCT00200057|1775525|FG000|Overall Study|Change in medical condition|1
822122|NCT00200057|1775525|FG000|Overall Study|Infection|1
822123|NCT00200057|1775525|FG000|Overall Study|Death|1
822124|NCT00200356|1775553|FG000|Overall Study|Lack of Efficacy|3
822125|NCT00200356|1775554|FG001|Overall Study|Lack of Efficacy|3
822126|NCT00200356|1775553|FG000|Overall Study|Protocol Violation|4
822127|NCT00200356|1775554|FG001|Overall Study|Protocol Violation|4
822128|NCT00200356|1775553|FG000|Overall Study|Nontreatment|1
822129|NCT00200356|1775554|FG001|Overall Study|Nontreatment|0
822130|NCT00200850|1775572|FG000|Overall Study|relocation|1
822131|NCT00200850|1775573|FG001|Overall Study|relocation|0
822132|NCT00200850|1775574|FG002|Overall Study|relocation|1
822133|NCT00200850|1775572|FG000|Overall Study|too busy|1
822134|NCT00200850|1775573|FG001|Overall Study|too busy|0
822135|NCT00200850|1775574|FG002|Overall Study|too busy|0
822136|NCT00200850|1775572|FG000|Overall Study|Pregnancy|0
822137|NCT00200850|1775573|FG001|Overall Study|Pregnancy|0
822138|NCT00200850|1775574|FG002|Overall Study|Pregnancy|1
822139|NCT00200850|1775572|FG000|Overall Study|Poor adherence|0
822140|NCT00200850|1775573|FG001|Overall Study|Poor adherence|0
822141|NCT00200850|1775574|FG002|Overall Study|Poor adherence|1
822142|NCT00200850|1775572|FG000|Overall Study|optic neuritis|0
822143|NCT00200850|1775573|FG001|Overall Study|optic neuritis|0
822144|NCT00200850|1775574|FG002|Overall Study|optic neuritis|1
822145|NCT00200850|1775572|FG000|Overall Study|Adverse Event|1
822146|NCT00200850|1775573|FG001|Overall Study|Adverse Event|1
822147|NCT00200850|1775574|FG002|Overall Study|Adverse Event|2
822148|NCT00200967|1775603|FG000|First Treatment Period|Withdrawal by Subject|5
822149|NCT00200967|1775604|FG001|First Treatment Period|Withdrawal by Subject|1
822150|NCT00200967|1775603|FG000|First Treatment Period|Pregnancy|1
822151|NCT00200967|1775604|FG001|First Treatment Period|Pregnancy|0
822152|NCT00200967|1775603|FG000|Wash-out Period|Lost to Follow-up|0
822153|NCT00200967|1775604|FG001|Wash-out Period|Lost to Follow-up|1
822154|NCT00200967|1775603|FG000|Second Treatment Period|Withdrawal by Subject|1
822155|NCT00200967|1775604|FG001|Second Treatment Period|Withdrawal by Subject|2
822156|NCT00200967|1775603|FG000|Run-out Period|Lost to Follow-up|1
822157|NCT00200967|1775604|FG001|Run-out Period|Lost to Follow-up|0
822158|NCT00201006|1775613|FG000|Overall Study|Withdrawal by Subject|7
822159|NCT00201006|1775614|FG001|Overall Study|Withdrawal by Subject|2
822160|NCT00201006|1775615|FG002|Overall Study|Withdrawal by Subject|3
822161|NCT00201006|1775613|FG000|Overall Study|Adverse Event|1
822162|NCT00201006|1775614|FG001|Overall Study|Adverse Event|0
822163|NCT00201006|1775615|FG002|Overall Study|Adverse Event|1
822164|NCT00201201|1775642|FG000|Overall Study|Death|0
822165|NCT00201201|1775643|FG001|Overall Study|Death|2
822166|NCT00201201|1775642|FG000|Overall Study|Withdrawal by Subject|5
822167|NCT00201201|1775643|FG001|Overall Study|Withdrawal by Subject|5
822168|NCT00201643|1775676|FG000|Overall Study|Withdrawal by Subject|5
822169|NCT00201643|1775677|FG001|Overall Study|Withdrawal by Subject|4
822170|NCT00201851|1775731|FG000|Overall Study|Lost to Follow-up|2
822171|NCT00201851|1775732|FG001|Overall Study|Lost to Follow-up|1
822172|NCT00201851|1775733|FG002|Overall Study|Lost to Follow-up|0
822173|NCT00201851|1775731|FG000|Overall Study|Ineligible post enrollment|6
822174|NCT00201851|1775732|FG001|Overall Study|Ineligible post enrollment|1
822175|NCT00201851|1775733|FG002|Overall Study|Ineligible post enrollment|1
822176|NCT00202644|1775767|FG000|Overall Study|Adverse Event|12
822177|NCT00202644|1775768|FG001|Overall Study|Adverse Event|13
822178|NCT00202644|1775767|FG000|Overall Study|Withdrawal by Subject|8
822179|NCT00202644|1775768|FG001|Overall Study|Withdrawal by Subject|6
822180|NCT00202644|1775767|FG000|Overall Study|Lack of Efficacy|6
822181|NCT00202644|1775768|FG001|Overall Study|Lack of Efficacy|6
822182|NCT00202644|1775767|FG000|Overall Study|Lost to Follow-up|0
822183|NCT00202644|1775768|FG001|Overall Study|Lost to Follow-up|1
822184|NCT00202644|1775767|FG000|Overall Study|Other|9
822185|NCT00202644|1775768|FG001|Overall Study|Other|1
822186|NCT00202839|1775781|FG000|Overall Study|Adverse Event|1
822187|NCT00202839|1775782|FG001|Overall Study|Adverse Event|5
822188|NCT00202839|1775781|FG000|Overall Study|Physician Decision|12
822189|NCT00202839|1775782|FG001|Overall Study|Physician Decision|0
822190|NCT00202839|1775781|FG000|Overall Study|Withdrawal by Subject|6
822191|NCT00202839|1775782|FG001|Overall Study|Withdrawal by Subject|2
822192|NCT00202839|1775781|FG000|Overall Study|Protocol Violation|2
822193|NCT00202839|1775782|FG001|Overall Study|Protocol Violation|1
822194|NCT00202839|1775781|FG000|Overall Study|Lost to Follow-up|3
822195|NCT00202839|1775782|FG001|Overall Study|Lost to Follow-up|2
822196|NCT00202878|1775790|FG000|Overall Study|Death|964
822197|NCT00202878|1775791|FG001|Overall Study|Death|968
822198|NCT00202878|1775790|FG000|Overall Study|Only Vital Status Known|357
822199|NCT00202878|1775791|FG001|Overall Study|Only Vital Status Known|356
822200|NCT00202878|1775790|FG000|Overall Study|Lost to Follow-up|44
822201|NCT00202878|1775791|FG001|Overall Study|Lost to Follow-up|49
822202|NCT00202878|1775790|FG000|Overall Study|Site Closure|39
822203|NCT00202878|1775791|FG001|Overall Study|Site Closure|36
822204|NCT00202878|1775790|FG000|Overall Study|Withdrawal by Subject|795
822205|NCT00202878|1775791|FG001|Overall Study|Withdrawal by Subject|808
822206|NCT00203021|1775803|FG000|Overall Study|Death|4
822207|NCT00203021|1775804|FG001|Overall Study|Death|1
822208|NCT00203021|1775803|FG000|Overall Study|Adverse Event|10
822209|NCT00203021|1775804|FG001|Overall Study|Adverse Event|5
822210|NCT00203021|1775803|FG000|Overall Study|Withdrawal by Subject|45
822211|NCT00203021|1775804|FG001|Overall Study|Withdrawal by Subject|48
822212|NCT00203021|1775803|FG000|Overall Study|Lost to Follow-up|9
822213|NCT00203021|1775804|FG001|Overall Study|Lost to Follow-up|7
822214|NCT00203021|1775803|FG000|Overall Study|Other than specified|11
822215|NCT00203021|1775804|FG001|Overall Study|Other than specified|16
822216|NCT00203047|1775812|FG000|Overall Study|Ongoing: in database - January 29, 2009|131
822217|NCT00203047|1775813|FG001|Overall Study|Ongoing: in database - January 29, 2009|109
822218|NCT00203047|1775812|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5
822219|NCT00203047|1775813|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1
822220|NCT00203047|1775812|FG000|Overall Study|Withdrawal by Subject|13
822221|NCT00203047|1775813|FG001|Overall Study|Withdrawal by Subject|47
822222|NCT00203047|1775812|FG000|Overall Study|Teva requested participant withdrawal|1
822223|NCT00203047|1775813|FG001|Overall Study|Teva requested participant withdrawal|1
822224|NCT00203047|1775812|FG000|Overall Study|Physician Decision|8
822225|NCT00203047|1775813|FG001|Overall Study|Physician Decision|7
822226|NCT00203047|1775812|FG000|Overall Study|Non-compliance|4
822227|NCT00203047|1775813|FG001|Overall Study|Non-compliance|8
822228|NCT00203047|1775812|FG000|Overall Study|Protocol Violation|1
822229|NCT00203047|1775813|FG001|Overall Study|Protocol Violation|0
822230|NCT00203047|1775812|FG000|Overall Study|Lost to Follow-up|11
822231|NCT00203047|1775813|FG001|Overall Study|Lost to Follow-up|5
822232|NCT00203047|1775812|FG000|Overall Study|Adverse Event|8
822233|NCT00203047|1775813|FG001|Overall Study|Adverse Event|18
822234|NCT00203047|1775812|FG000|Overall Study|Death|1
822235|NCT00203047|1775813|FG001|Overall Study|Death|2
822236|NCT00203047|1775812|FG000|Overall Study|Pregnancy|3
822237|NCT00203047|1775813|FG001|Overall Study|Pregnancy|0
822238|NCT00203047|1775812|FG000|Overall Study|Other|5
822239|NCT00203047|1775813|FG001|Overall Study|Other|5
822240|NCT00203242|1775841|FG000|Overall Study|Lost to Follow-up|1
822241|NCT00203268|1775845|FG000|Early Treatment|only treated one headache|2
822242|NCT00203268|1775845|FG000|Early Treatment|Lost to Follow-up|1
822243|NCT00203268|1775845|FG000|Early Treatment|Withdrawal by Subject|1
822244|NCT00203294|1775853|FG000|Overall Study|Withdrawal by Subject|8
822245|NCT00203294|1775854|FG001|Overall Study|Withdrawal by Subject|13
822246|NCT00203307|1775862|FG000|First Intervention|Adverse Event|2
822247|NCT00203307|1775863|FG001|First Intervention|Adverse Event|0
822248|NCT00203411|1775869|FG000|Follow-up|Progressive Disease|4
822249|NCT00203424|1775874|FG000|Treatment Period|Withdrawal by Subject|4
822250|NCT00203424|1775874|FG000|Treatment Period|Adverse Event|5
822251|NCT00203424|1775874|FG000|Treatment Period|progressive disease|2
822252|NCT00203424|1775874|FG000|Follow-up Period|Withdrawal by Subject|1
822253|NCT00203424|1775874|FG000|Follow-up Period|progressive disease|4
822254|NCT00203424|1775874|FG000|Follow-up Period|Lost to Follow-up|1
822255|NCT00203476|1775881|FG000|Overall Study|Lost to Follow-up|1
822256|NCT00203476|1775882|FG001|Overall Study|Lost to Follow-up|0
822257|NCT00203476|1775883|FG002|Overall Study|Lost to Follow-up|0
822258|NCT00203476|1775881|FG000|Overall Study|Withdrawal by Subject|0
822259|NCT00203476|1775882|FG001|Overall Study|Withdrawal by Subject|1
822260|NCT00203476|1775883|FG002|Overall Study|Withdrawal by Subject|0
822261|NCT00203502|1775891|FG000|Overall Study|Death|1
822262|NCT00203892|1775898|FG000|Overall Study|Physician Decision|1
822263|NCT00203892|1775899|FG001|Overall Study|Physician Decision|2
822264|NCT00203892|1775900|FG002|Overall Study|Physician Decision|0
822265|NCT00203892|1775898|FG000|Overall Study|Death|1
822266|NCT00203892|1775899|FG001|Overall Study|Death|0
822267|NCT00203892|1775900|FG002|Overall Study|Death|0
822268|NCT00203996|1775927|FG000|Overall Study|Lost to Follow-up|0
822269|NCT00203996|1775928|FG001|Overall Study|Lost to Follow-up|0
822270|NCT00203996|1775929|FG002|Overall Study|Lost to Follow-up|0
822271|NCT00203996|1775930|FG003|Overall Study|Lost to Follow-up|1
822272|NCT00203996|1775931|FG004|Overall Study|Lost to Follow-up|0
822273|NCT00203996|1775932|FG005|Overall Study|Lost to Follow-up|0
822274|NCT00203996|1775933|FG006|Overall Study|Lost to Follow-up|0
822275|NCT00203996|1775934|FG007|Overall Study|Lost to Follow-up|0
822276|NCT00203996|1775935|FG008|Overall Study|Lost to Follow-up|0
822277|NCT00203996|1775936|FG009|Overall Study|Lost to Follow-up|0
822278|NCT00203996|1775927|FG000|Overall Study|Protocol Violation|0
822279|NCT00203996|1775928|FG001|Overall Study|Protocol Violation|0
822280|NCT00203996|1775929|FG002|Overall Study|Protocol Violation|0
822281|NCT00203996|1775930|FG003|Overall Study|Protocol Violation|6
822282|NCT00203996|1775931|FG004|Overall Study|Protocol Violation|1
822283|NCT00203996|1775932|FG005|Overall Study|Protocol Violation|0
822284|NCT00203996|1775933|FG006|Overall Study|Protocol Violation|0
822285|NCT00203996|1775934|FG007|Overall Study|Protocol Violation|0
822286|NCT00203996|1775935|FG008|Overall Study|Protocol Violation|0
822287|NCT00203996|1775936|FG009|Overall Study|Protocol Violation|0
822288|NCT00203996|1775927|FG000|Overall Study|Physician Decision|0
822289|NCT00203996|1775928|FG001|Overall Study|Physician Decision|0
822290|NCT00203996|1775929|FG002|Overall Study|Physician Decision|0
822291|NCT00203996|1775930|FG003|Overall Study|Physician Decision|2
822292|NCT00203996|1775931|FG004|Overall Study|Physician Decision|0
822293|NCT00203996|1775932|FG005|Overall Study|Physician Decision|0
822294|NCT00203996|1775933|FG006|Overall Study|Physician Decision|0
822295|NCT00203996|1775934|FG007|Overall Study|Physician Decision|0
822296|NCT00203996|1775935|FG008|Overall Study|Physician Decision|0
822297|NCT00203996|1775936|FG009|Overall Study|Physician Decision|1
822298|NCT00203996|1775927|FG000|Overall Study|CPAP machine malfunction|0
822299|NCT00203996|1775928|FG001|Overall Study|CPAP machine malfunction|0
822300|NCT00203996|1775929|FG002|Overall Study|CPAP machine malfunction|0
822301|NCT00203996|1775930|FG003|Overall Study|CPAP machine malfunction|1
822302|NCT00203996|1775931|FG004|Overall Study|CPAP machine malfunction|0
822303|NCT00203996|1775932|FG005|Overall Study|CPAP machine malfunction|0
822304|NCT00203996|1775933|FG006|Overall Study|CPAP machine malfunction|0
822305|NCT00203996|1775934|FG007|Overall Study|CPAP machine malfunction|0
822306|NCT00203996|1775935|FG008|Overall Study|CPAP machine malfunction|0
822307|NCT00203996|1775936|FG009|Overall Study|CPAP machine malfunction|0
822308|NCT00203996|1775927|FG000|Overall Study|Scheduling issue|0
822309|NCT00203996|1775928|FG001|Overall Study|Scheduling issue|0
822310|NCT00203996|1775929|FG002|Overall Study|Scheduling issue|0
822311|NCT00203996|1775930|FG003|Overall Study|Scheduling issue|0
822312|NCT00203996|1775931|FG004|Overall Study|Scheduling issue|0
822313|NCT00203996|1775932|FG005|Overall Study|Scheduling issue|0
822314|NCT00203996|1775933|FG006|Overall Study|Scheduling issue|0
822315|NCT00203996|1775934|FG007|Overall Study|Scheduling issue|2
822316|NCT00203996|1775935|FG008|Overall Study|Scheduling issue|0
822317|NCT00203996|1775936|FG009|Overall Study|Scheduling issue|0
822318|NCT00205179|1775976|FG000|Overall Study|Death|0
822319|NCT00205179|1775977|FG001|Overall Study|Death|2
822320|NCT00205179|1775976|FG000|Overall Study|Physician Decision|1
822321|NCT00205179|1775977|FG001|Overall Study|Physician Decision|1
822322|NCT00205179|1775976|FG000|Overall Study|Adverse Event|1
822323|NCT00205179|1775977|FG001|Overall Study|Adverse Event|1
822324|NCT00205699|1776023|FG000|Overall Study|Lost to Follow-up|1
822325|NCT00205699|1776024|FG001|Overall Study|Lost to Follow-up|3
822326|NCT00205699|1776025|FG002|Overall Study|Lost to Follow-up|5
822327|NCT00205699|1776023|FG000|Overall Study|Adverse Event|1
822328|NCT00205699|1776024|FG001|Overall Study|Adverse Event|0
822329|NCT00205699|1776025|FG002|Overall Study|Adverse Event|0
822330|NCT00205699|1776023|FG000|Overall Study|Withdrawal by Subject|1
822331|NCT00205699|1776024|FG001|Overall Study|Withdrawal by Subject|2
822332|NCT00205699|1776025|FG002|Overall Study|Withdrawal by Subject|1
822333|NCT00205699|1776023|FG000|Overall Study|Lack of Efficacy|0
822334|NCT00205699|1776024|FG001|Overall Study|Lack of Efficacy|1
822335|NCT00205699|1776025|FG002|Overall Study|Lack of Efficacy|0
822336|NCT00205712|1776038|FG000|Overall Study|Lost to Follow-up|0
822337|NCT00205712|1776039|FG001|Overall Study|Lost to Follow-up|1
822338|NCT00205777|1776051|FG000|Core Study (Up to 3 Years)|Adverse Event|260
822339|NCT00205777|1776052|FG001|Core Study (Up to 3 Years)|Adverse Event|267
822340|NCT00205777|1776053|FG002|Core Study (Up to 3 Years)|Adverse Event|252
822341|NCT00205777|1776054|FG003|Core Study (Up to 3 Years)|Adverse Event|232
822342|NCT00205777|1776055|FG004|Core Study (Up to 3 Years)|Adverse Event|0
822343|NCT00205777|1776056|FG005|Core Study (Up to 3 Years)|Adverse Event|0
822344|NCT00205777|1776051|FG000|Core Study (Up to 3 Years)|Death|9
822345|NCT00205777|1776052|FG001|Core Study (Up to 3 Years)|Death|7
822346|NCT00205777|1776053|FG002|Core Study (Up to 3 Years)|Death|14
822347|NCT00205777|1776054|FG003|Core Study (Up to 3 Years)|Death|7
822348|NCT00205777|1776055|FG004|Core Study (Up to 3 Years)|Death|0
822349|NCT00205777|1776056|FG005|Core Study (Up to 3 Years)|Death|0
822350|NCT00205777|1776051|FG000|Core Study (Up to 3 Years)|Failed to return|40
822351|NCT00205777|1776052|FG001|Core Study (Up to 3 Years)|Failed to return|25
822352|NCT00205777|1776053|FG002|Core Study (Up to 3 Years)|Failed to return|27
822353|NCT00205777|1776054|FG003|Core Study (Up to 3 Years)|Failed to return|27
822354|NCT00205777|1776055|FG004|Core Study (Up to 3 Years)|Failed to return|0
822355|NCT00205777|1776056|FG005|Core Study (Up to 3 Years)|Failed to return|0
822356|NCT00205777|1776051|FG000|Core Study (Up to 3 Years)|Other Event|49
822357|NCT00205777|1776052|FG001|Core Study (Up to 3 Years)|Other Event|52
822358|NCT00205777|1776053|FG002|Core Study (Up to 3 Years)|Other Event|41
822359|NCT00205777|1776054|FG003|Core Study (Up to 3 Years)|Other Event|58
822360|NCT00205777|1776055|FG004|Core Study (Up to 3 Years)|Other Event|0
822361|NCT00205777|1776056|FG005|Core Study (Up to 3 Years)|Other Event|0
822362|NCT00205777|1776051|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144
822363|NCT00205777|1776052|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169
822364|NCT00205777|1776053|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149
822365|NCT00205777|1776054|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162
822366|NCT00205777|1776055|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0
822367|NCT00205777|1776056|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0
822368|NCT00205777|1776051|FG000|Core Study (Up to 3 Years)|Protocol Violation|53
822369|NCT00205777|1776052|FG001|Core Study (Up to 3 Years)|Protocol Violation|55
822370|NCT00205777|1776053|FG002|Core Study (Up to 3 Years)|Protocol Violation|50
822371|NCT00205777|1776054|FG003|Core Study (Up to 3 Years)|Protocol Violation|42
822372|NCT00205777|1776055|FG004|Core Study (Up to 3 Years)|Protocol Violation|0
822373|NCT00205777|1776056|FG005|Core Study (Up to 3 Years)|Protocol Violation|0
822374|NCT00205777|1776051|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52
822375|NCT00205777|1776052|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52
822376|NCT00205777|1776053|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39
822377|NCT00205777|1776054|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75
822378|NCT00205777|1776055|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0
822379|NCT00205777|1776056|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0
822380|NCT00205777|1776051|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21
822381|NCT00205777|1776052|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32
822382|NCT00205777|1776053|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35
822383|NCT00205777|1776054|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29
822384|NCT00205777|1776055|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0
822385|NCT00205777|1776056|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0
822386|NCT00205777|1776051|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180
822387|NCT00205777|1776052|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158
822388|NCT00205777|1776053|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160
822389|NCT00205777|1776054|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174
822390|NCT00205777|1776055|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0
822391|NCT00205777|1776056|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0
822392|NCT00205777|1776051|FG000|Completed Core Study, Entered SE I|Other Event|52
822393|NCT00205777|1776052|FG001|Completed Core Study, Entered SE I|Other Event|46
822394|NCT00205777|1776053|FG002|Completed Core Study, Entered SE I|Other Event|47
822395|NCT00205777|1776054|FG003|Completed Core Study, Entered SE I|Other Event|50
822396|NCT00205777|1776055|FG004|Completed Core Study, Entered SE I|Other Event|0
822397|NCT00205777|1776056|FG005|Completed Core Study, Entered SE I|Other Event|0
822398|NCT00205777|1776051|FG000|Study Extension I|Adverse Event|57
822399|NCT00205777|1776052|FG001|Study Extension I|Adverse Event|0
822400|NCT00205777|1776053|FG002|Study Extension I|Adverse Event|0
822401|NCT00205777|1776054|FG003|Study Extension I|Adverse Event|61
822402|NCT00205777|1776055|FG004|Study Extension I|Adverse Event|58
822403|NCT00205777|1776056|FG005|Study Extension I|Adverse Event|0
822404|NCT00205777|1776051|FG000|Study Extension I|Death|5
822405|NCT00205777|1776052|FG001|Study Extension I|Death|0
822406|NCT00205777|1776053|FG002|Study Extension I|Death|0
822407|NCT00205777|1776054|FG003|Study Extension I|Death|1
822408|NCT00205777|1776055|FG004|Study Extension I|Death|2
822409|NCT00205777|1776056|FG005|Study Extension I|Death|0
822410|NCT00205777|1776051|FG000|Study Extension I|Withdrawal by Subject|99
822411|NCT00205777|1776052|FG001|Study Extension I|Withdrawal by Subject|0
822412|NCT00205777|1776053|FG002|Study Extension I|Withdrawal by Subject|0
822413|NCT00205777|1776054|FG003|Study Extension I|Withdrawal by Subject|106
822414|NCT00205777|1776055|FG004|Study Extension I|Withdrawal by Subject|89
822415|NCT00205777|1776056|FG005|Study Extension I|Withdrawal by Subject|0
822416|NCT00205777|1776051|FG000|Study Extension I|Protocol Violation|4
822417|NCT00205777|1776052|FG001|Study Extension I|Protocol Violation|0
822418|NCT00205777|1776053|FG002|Study Extension I|Protocol Violation|0
822419|NCT00205777|1776054|FG003|Study Extension I|Protocol Violation|8
822420|NCT00205777|1776055|FG004|Study Extension I|Protocol Violation|8
822421|NCT00205777|1776056|FG005|Study Extension I|Protocol Violation|0
822422|NCT00205777|1776051|FG000|Study Extension I|Lack of Efficacy|0
822423|NCT00205777|1776052|FG001|Study Extension I|Lack of Efficacy|0
822424|NCT00205777|1776053|FG002|Study Extension I|Lack of Efficacy|0
822425|NCT00205777|1776054|FG003|Study Extension I|Lack of Efficacy|1
822426|NCT00205777|1776055|FG004|Study Extension I|Lack of Efficacy|2
822427|NCT00205777|1776056|FG005|Study Extension I|Lack of Efficacy|0
822428|NCT00205777|1776051|FG000|Study Extension I|Failed to return|15
822429|NCT00205777|1776052|FG001|Study Extension I|Failed to return|0
822430|NCT00205777|1776053|FG002|Study Extension I|Failed to return|0
822431|NCT00205777|1776054|FG003|Study Extension I|Failed to return|17
822432|NCT00205777|1776055|FG004|Study Extension I|Failed to return|13
822433|NCT00205777|1776056|FG005|Study Extension I|Failed to return|0
822434|NCT00205777|1776051|FG000|Study Extension I|Other Event|34
822435|NCT00205777|1776052|FG001|Study Extension I|Other Event|0
822436|NCT00205777|1776053|FG002|Study Extension I|Other Event|0
822437|NCT00205777|1776054|FG003|Study Extension I|Other Event|34
822438|NCT00205777|1776055|FG004|Study Extension I|Other Event|29
822439|NCT00205777|1776056|FG005|Study Extension I|Other Event|0
822440|NCT00205777|1776051|FG000|Study Extension I|Withdrawn as per protocol|0
822441|NCT00205777|1776052|FG001|Study Extension I|Withdrawn as per protocol|0
822442|NCT00205777|1776053|FG002|Study Extension I|Withdrawn as per protocol|1070
822443|NCT00205777|1776054|FG003|Study Extension I|Withdrawn as per protocol|0
822444|NCT00205777|1776055|FG004|Study Extension I|Withdrawn as per protocol|0
822445|NCT00205777|1776056|FG005|Study Extension I|Withdrawn as per protocol|0
822446|NCT00205777|1776051|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
822447|NCT00205777|1776052|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
822448|NCT00205777|1776053|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
822449|NCT00205777|1776054|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
822450|NCT00205777|1776055|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
822451|NCT00205777|1776056|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
822452|NCT00205777|1776051|FG000|Study Extension II|Adverse Event|0
822453|NCT00205777|1776052|FG001|Study Extension II|Adverse Event|0
822454|NCT00205777|1776053|FG002|Study Extension II|Adverse Event|0
822455|NCT00205777|1776054|FG003|Study Extension II|Adverse Event|14
822456|NCT00205777|1776055|FG004|Study Extension II|Adverse Event|0
822457|NCT00205777|1776056|FG005|Study Extension II|Adverse Event|30
822458|NCT00205777|1776051|FG000|Study Extension II|Death|0
822459|NCT00205777|1776052|FG001|Study Extension II|Death|0
822460|NCT00205777|1776053|FG002|Study Extension II|Death|0
822461|NCT00205777|1776054|FG003|Study Extension II|Death|2
822462|NCT00205777|1776055|FG004|Study Extension II|Death|0
822463|NCT00205777|1776056|FG005|Study Extension II|Death|5
822464|NCT00205777|1776051|FG000|Study Extension II|Withdrawal by Subject|0
822465|NCT00205777|1776052|FG001|Study Extension II|Withdrawal by Subject|0
822466|NCT00205777|1776053|FG002|Study Extension II|Withdrawal by Subject|0
822467|NCT00205777|1776054|FG003|Study Extension II|Withdrawal by Subject|35
822468|NCT00205777|1776055|FG004|Study Extension II|Withdrawal by Subject|0
822469|NCT00205777|1776056|FG005|Study Extension II|Withdrawal by Subject|59
822470|NCT00205777|1776051|FG000|Study Extension II|Protocol Violation|0
822471|NCT00205777|1776052|FG001|Study Extension II|Protocol Violation|0
822472|NCT00205777|1776053|FG002|Study Extension II|Protocol Violation|0
822473|NCT00205777|1776054|FG003|Study Extension II|Protocol Violation|1
822474|NCT00205777|1776055|FG004|Study Extension II|Protocol Violation|0
822475|NCT00205777|1776056|FG005|Study Extension II|Protocol Violation|10
822476|NCT00205777|1776051|FG000|Study Extension II|Lack of Efficacy|0
822477|NCT00205777|1776052|FG001|Study Extension II|Lack of Efficacy|0
822478|NCT00205777|1776053|FG002|Study Extension II|Lack of Efficacy|0
822479|NCT00205777|1776054|FG003|Study Extension II|Lack of Efficacy|0
822480|NCT00205777|1776055|FG004|Study Extension II|Lack of Efficacy|0
822481|NCT00205777|1776056|FG005|Study Extension II|Lack of Efficacy|1
822482|NCT00205777|1776051|FG000|Study Extension II|Failed to return|0
822483|NCT00205777|1776052|FG001|Study Extension II|Failed to return|0
822484|NCT00205777|1776053|FG002|Study Extension II|Failed to return|0
822485|NCT00205777|1776054|FG003|Study Extension II|Failed to return|14
822486|NCT00205777|1776055|FG004|Study Extension II|Failed to return|0
822487|NCT00205777|1776056|FG005|Study Extension II|Failed to return|26
822488|NCT00205777|1776051|FG000|Study Extension II|Other Event|0
822489|NCT00205777|1776052|FG001|Study Extension II|Other Event|0
822490|NCT00205777|1776053|FG002|Study Extension II|Other Event|0
822491|NCT00205777|1776054|FG003|Study Extension II|Other Event|12
822492|NCT00205777|1776055|FG004|Study Extension II|Other Event|0
822493|NCT00205777|1776056|FG005|Study Extension II|Other Event|20
822494|NCT00205777|1776051|FG000|Study Extension II|Enrolled but not treated|0
822495|NCT00205777|1776052|FG001|Study Extension II|Enrolled but not treated|0
822496|NCT00205777|1776053|FG002|Study Extension II|Enrolled but not treated|0
822497|NCT00205777|1776054|FG003|Study Extension II|Enrolled but not treated|71
822498|NCT00205777|1776055|FG004|Study Extension II|Enrolled but not treated|0
822499|NCT00205777|1776056|FG005|Study Extension II|Enrolled but not treated|131
822500|NCT00205803|1776073|FG000|Infant Series|Lost to Follow-up|10
822501|NCT00205803|1776074|FG001|Infant Series|Lost to Follow-up|4
822502|NCT00205803|1776073|FG000|Infant Series|Withdrawal by Subject|2
822503|NCT00205803|1776074|FG001|Infant Series|Withdrawal by Subject|5
822504|NCT00205803|1776073|FG000|Infant Series|Physician Decision|3
822505|NCT00205803|1776074|FG001|Infant Series|Physician Decision|1
822506|NCT00205803|1776073|FG000|Infant Series|Protocol Violation|1
822507|NCT00205803|1776074|FG001|Infant Series|Protocol Violation|0
822508|NCT00205803|1776073|FG000|Infant Series|Lost Kaiser coverage|0
822509|NCT00205803|1776074|FG001|Infant Series|Lost Kaiser coverage|1
822510|NCT00205803|1776073|FG000|Infant Series|Non-compliant|1
822511|NCT00205803|1776074|FG001|Infant Series|Non-compliant|0
822512|NCT00205803|1776073|FG000|Infant Series|Sponsor request|1
822513|NCT00205803|1776074|FG001|Infant Series|Sponsor request|0
822514|NCT00205803|1776073|FG000|After Infant Series|Adverse Event|1
822515|NCT00205803|1776074|FG001|After Infant Series|Adverse Event|1
822516|NCT00205803|1776073|FG000|After Infant Series|Protocol Violation|1
822517|NCT00205803|1776074|FG001|After Infant Series|Protocol Violation|1
822518|NCT00205803|1776073|FG000|After Infant Series|Lost to Follow-up|2
822519|NCT00205803|1776074|FG001|After Infant Series|Lost to Follow-up|1
822520|NCT00205803|1776073|FG000|After Infant Series|Physician Decision|3
822521|NCT00205803|1776074|FG001|After Infant Series|Physician Decision|2
822522|NCT00205803|1776073|FG000|After Infant Series|Withdrawal by Subject|1
822523|NCT00205803|1776074|FG001|After Infant Series|Withdrawal by Subject|4
822524|NCT00205803|1776073|FG000|After Infant Series|Other|10
822525|NCT00205803|1776074|FG001|After Infant Series|Other|4
822526|NCT00205803|1776073|FG000|Toddler Dose|Lost to Follow-up|2
822527|NCT00205803|1776074|FG001|Toddler Dose|Lost to Follow-up|3
822528|NCT00205855|1776098|FG000|Overall Study|Only received temporary implants|16
822529|NCT00205855|1776098|FG000|Overall Study|Withdrawal by Subject|5
822530|NCT00205881|1776102|FG000|Overall Study|Withdrawal by Subject|16
822531|NCT00206076|1776109|FG000|Overall Study|Physician Decision|2
822532|NCT00206076|1776110|FG001|Overall Study|Physician Decision|0
822533|NCT00206076|1776109|FG000|Overall Study|Withdrawal by Subject|1
822534|NCT00206076|1776110|FG001|Overall Study|Withdrawal by Subject|1
822535|NCT00206102|1776120|FG000|Overall Study|Adverse Event|119
822536|NCT00206102|1776121|FG001|Overall Study|Adverse Event|82
822537|NCT00206102|1776120|FG000|Overall Study|Protocol Violation|0
822538|NCT00206102|1776121|FG001|Overall Study|Protocol Violation|2
822539|NCT00206102|1776120|FG000|Overall Study|Lack of therapeutic response|16
822540|NCT00206102|1776121|FG001|Overall Study|Lack of therapeutic response|11
822541|NCT00206102|1776120|FG000|Overall Study|Lost to Follow-up|95
822542|NCT00206102|1776121|FG001|Overall Study|Lost to Follow-up|66
822543|NCT00206102|1776120|FG000|Overall Study|Withdrawal by Subject|118
822544|NCT00206102|1776121|FG001|Overall Study|Withdrawal by Subject|101
822545|NCT00206102|1776120|FG000|Overall Study|Study-specific discontinuation criteria|18
822546|NCT00206102|1776121|FG001|Overall Study|Study-specific discontinuation criteria|17
822547|NCT00206102|1776120|FG000|Overall Study|None of those categories|42
822548|NCT00206102|1776121|FG001|Overall Study|None of those categories|36
822549|NCT00206323|1776129|FG000|Overall Study|Lack of Efficacy|4
822550|NCT00206323|1776130|FG001|Overall Study|Lack of Efficacy|1
822551|NCT00206323|1776129|FG000|Overall Study|Adverse Event|1
822552|NCT00206323|1776130|FG001|Overall Study|Adverse Event|1
822553|NCT00206323|1776129|FG000|Overall Study|Lost to Follow-up|1
822554|NCT00206323|1776130|FG001|Overall Study|Lost to Follow-up|1
822555|NCT00206427|1776140|FG000|Overall Study|Adverse Event|2
822556|NCT00206440|1776146|FG000|Overall Study|Protocol Violation|1
822557|NCT00206440|1776147|FG001|Overall Study|Protocol Violation|2
822558|NCT00206440|1776146|FG000|Overall Study|Adverse Event|4
822559|NCT00206440|1776147|FG001|Overall Study|Adverse Event|2
822560|NCT00206518|1776155|FG000|Overall Study|Lack of Efficacy|6
822561|NCT00206518|1776156|FG001|Overall Study|Lack of Efficacy|4
822562|NCT00206518|1776155|FG000|Overall Study|Adverse Event|2
822563|NCT00206518|1776156|FG001|Overall Study|Adverse Event|1
822564|NCT00206518|1776155|FG000|Overall Study|Physician Decision|1
822565|NCT00206518|1776156|FG001|Overall Study|Physician Decision|0
822566|NCT00206518|1776155|FG000|Overall Study|Protocol Violation|1
822567|NCT00206518|1776156|FG001|Overall Study|Protocol Violation|1
822568|NCT00206726|1776162|FG000|Overall Study|Delayed recovery of blood counts|1
822569|NCT00206726|1776162|FG000|Overall Study|Progressive disease or relapsed disease|18
822570|NCT00206726|1776162|FG000|Overall Study|Placed on new protocol|1
822571|NCT00206726|1776162|FG000|Overall Study|Bone marrow transplant|1
822572|NCT00206726|1776162|FG000|Overall Study|Adverse Event|17
822573|NCT00206726|1776162|FG000|Overall Study|Death|4
822574|NCT00206726|1776162|FG000|Overall Study|Protocol Violation|1
822575|NCT00206726|1776162|FG000|Overall Study|Withdrawal by Subject|8
822576|NCT00207090|1776166|FG000|Overall Study|Study drug toxicity|3
822577|NCT00207090|1776166|FG000|Overall Study|Chest wall mass larger|1
822578|NCT00207090|1776166|FG000|Overall Study|Disease progression/relapse|2
822579|NCT00207090|1776166|FG000|Overall Study|Physician Decision|1
822580|NCT00207142|1776178|FG000|Induction Phase|Adverse Event|9
822581|NCT00207142|1776179|FG001|Induction Phase|Adverse Event|0
822582|NCT00207142|1776180|FG002|Induction Phase|Adverse Event|0
822583|NCT00207142|1776181|FG003|Induction Phase|Adverse Event|0
822584|NCT00207142|1776178|FG000|Induction Phase|Death|1
822585|NCT00207142|1776179|FG001|Induction Phase|Death|0
822586|NCT00207142|1776180|FG002|Induction Phase|Death|0
822587|NCT00207142|1776181|FG003|Induction Phase|Death|0
822588|NCT00207142|1776178|FG000|Induction Phase|Lack of Efficacy|1
822589|NCT00207142|1776179|FG001|Induction Phase|Lack of Efficacy|0
822590|NCT00207142|1776180|FG002|Induction Phase|Lack of Efficacy|0
822591|NCT00207142|1776181|FG003|Induction Phase|Lack of Efficacy|0
822592|NCT00207142|1776178|FG000|Induction Phase|Lost to Follow-up|5
822593|NCT00207142|1776179|FG001|Induction Phase|Lost to Follow-up|0
822594|NCT00207142|1776180|FG002|Induction Phase|Lost to Follow-up|0
822595|NCT00207142|1776181|FG003|Induction Phase|Lost to Follow-up|0
822596|NCT00207142|1776178|FG000|Induction Phase|Physician Decision|2
822597|NCT00207142|1776179|FG001|Induction Phase|Physician Decision|0
822598|NCT00207142|1776180|FG002|Induction Phase|Physician Decision|0
822599|NCT00207142|1776181|FG003|Induction Phase|Physician Decision|0
822600|NCT00207142|1776178|FG000|Induction Phase|Poor/noncompliance|2
822601|NCT00207142|1776179|FG001|Induction Phase|Poor/noncompliance|0
822602|NCT00207142|1776180|FG002|Induction Phase|Poor/noncompliance|0
822603|NCT00207142|1776181|FG003|Induction Phase|Poor/noncompliance|0
822604|NCT00207142|1776178|FG000|Induction Phase|Pregnancy|1
822605|NCT00207142|1776179|FG001|Induction Phase|Pregnancy|0
822606|NCT00207142|1776180|FG002|Induction Phase|Pregnancy|0
822607|NCT00207142|1776181|FG003|Induction Phase|Pregnancy|0
822608|NCT00207142|1776178|FG000|Induction Phase|Subject no longer meets study criteria|3
822609|NCT00207142|1776179|FG001|Induction Phase|Subject no longer meets study criteria|0
822610|NCT00207142|1776180|FG002|Induction Phase|Subject no longer meets study criteria|0
822611|NCT00207142|1776181|FG003|Induction Phase|Subject no longer meets study criteria|0
822612|NCT00207142|1776178|FG000|Induction Phase|Withdrawal by Subject|4
822613|NCT00207142|1776179|FG001|Induction Phase|Withdrawal by Subject|0
822614|NCT00207142|1776180|FG002|Induction Phase|Withdrawal by Subject|0
822615|NCT00207142|1776181|FG003|Induction Phase|Withdrawal by Subject|0
822616|NCT00207142|1776178|FG000|Induction Phase|Incarceration|1
822617|NCT00207142|1776179|FG001|Induction Phase|Incarceration|0
822618|NCT00207142|1776180|FG002|Induction Phase|Incarceration|0
822619|NCT00207142|1776181|FG003|Induction Phase|Incarceration|0
822620|NCT00207142|1776178|FG000|Induction Phase|Missing lab data|1
822621|NCT00207142|1776179|FG001|Induction Phase|Missing lab data|0
822622|NCT00207142|1776180|FG002|Induction Phase|Missing lab data|0
822623|NCT00207142|1776181|FG003|Induction Phase|Missing lab data|0
822624|NCT00207142|1776178|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0
822625|NCT00207142|1776179|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1
822626|NCT00207142|1776180|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4
822627|NCT00207142|1776181|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1
822628|NCT00207142|1776178|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
822629|NCT00207142|1776179|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
822630|NCT00207142|1776180|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
822631|NCT00207142|1776181|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
822632|NCT00207142|1776178|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0
822633|NCT00207142|1776179|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0
822634|NCT00207142|1776180|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1
822635|NCT00207142|1776181|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0
822636|NCT00207142|1776178|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
822637|NCT00207142|1776179|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
822638|NCT00207142|1776180|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
822639|NCT00207142|1776181|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
822640|NCT00207142|1776178|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0
822641|NCT00207142|1776179|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2
822642|NCT00207142|1776180|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2
822643|NCT00207142|1776181|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0
822644|NCT00207142|1776178|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
822645|NCT00207142|1776179|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
822646|NCT00207142|1776180|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
822647|NCT00207142|1776181|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
822648|NCT00207142|1776178|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
822649|NCT00207142|1776179|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
822650|NCT00207142|1776180|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
822651|NCT00207142|1776181|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
822652|NCT00207142|1776178|FG000|Maintenance Phase/Rescue Phase|Death|0
822653|NCT00207142|1776179|FG001|Maintenance Phase/Rescue Phase|Death|0
822654|NCT00207142|1776180|FG002|Maintenance Phase/Rescue Phase|Death|0
822655|NCT00207142|1776181|FG003|Maintenance Phase/Rescue Phase|Death|1
822656|NCT00207142|1776178|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
822657|NCT00207142|1776179|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
822658|NCT00207142|1776180|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
822659|NCT00207142|1776181|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
822660|NCT00207714|1776201|FG000|Overall Study|Adverse Event|6
822661|NCT00207714|1776202|FG001|Overall Study|Adverse Event|2
822662|NCT00207714|1776203|FG002|Overall Study|Adverse Event|4
822663|NCT00207714|1776204|FG003|Overall Study|Adverse Event|3
822664|NCT00207714|1776205|FG004|Overall Study|Adverse Event|1
822665|NCT00207714|1776201|FG000|Overall Study|Unsatisfactory therapeutic effect|5
822666|NCT00207714|1776202|FG001|Overall Study|Unsatisfactory therapeutic effect|3
822667|NCT00207714|1776203|FG002|Overall Study|Unsatisfactory therapeutic effect|1
822668|NCT00207714|1776204|FG003|Overall Study|Unsatisfactory therapeutic effect|4
822669|NCT00207714|1776205|FG004|Overall Study|Unsatisfactory therapeutic effect|4
822670|NCT00207714|1776201|FG000|Overall Study|Other|3
822671|NCT00207714|1776202|FG001|Overall Study|Other|2
822672|NCT00207714|1776203|FG002|Overall Study|Other|5
822673|NCT00207714|1776204|FG003|Overall Study|Other|1
822674|NCT00207714|1776205|FG004|Overall Study|Other|0
822675|NCT00207727|1776229|FG000|Overall Study|Withdrawal by Subject|0
822676|NCT00207727|1776230|FG001|Overall Study|Withdrawal by Subject|0
822677|NCT00207727|1776231|FG002|Overall Study|Withdrawal by Subject|0
822678|NCT00207727|1776232|FG003|Overall Study|Withdrawal by Subject|0
822679|NCT00207727|1776233|FG004|Overall Study|Withdrawal by Subject|1
822680|NCT00207727|1776229|FG000|Overall Study|Lost to Follow-up|0
822681|NCT00207727|1776230|FG001|Overall Study|Lost to Follow-up|1
822682|NCT00207727|1776231|FG002|Overall Study|Lost to Follow-up|0
822683|NCT00207727|1776232|FG003|Overall Study|Lost to Follow-up|0
822684|NCT00207727|1776233|FG004|Overall Study|Lost to Follow-up|0
822685|NCT00207727|1776229|FG000|Overall Study|Other|38
822686|NCT00207727|1776230|FG001|Overall Study|Other|41
822687|NCT00207727|1776231|FG002|Overall Study|Other|41
822688|NCT00207727|1776232|FG003|Overall Study|Other|37
822689|NCT00207727|1776233|FG004|Overall Study|Other|33
822690|NCT00207740|1776249|FG000|Overall Study|Adverse Event|4
822691|NCT00207740|1776250|FG001|Overall Study|Adverse Event|14
822692|NCT00207740|1776251|FG002|Overall Study|Adverse Event|14
822693|NCT00207740|1776252|FG003|Overall Study|Adverse Event|11
822694|NCT00207740|1776249|FG000|Overall Study|Unsatisfactory therapeutic effect|1
822695|NCT00207740|1776250|FG001|Overall Study|Unsatisfactory therapeutic effect|0
822696|NCT00207740|1776251|FG002|Overall Study|Unsatisfactory therapeutic effect|2
822697|NCT00207740|1776252|FG003|Overall Study|Unsatisfactory therapeutic effect|4
822698|NCT00207740|1776249|FG000|Overall Study|Lost to Follow-up|0
822699|NCT00207740|1776250|FG001|Overall Study|Lost to Follow-up|2
822700|NCT00207740|1776251|FG002|Overall Study|Lost to Follow-up|1
822701|NCT00207740|1776252|FG003|Overall Study|Lost to Follow-up|1
822702|NCT00207740|1776249|FG000|Overall Study|Death|0
822703|NCT00207740|1776250|FG001|Overall Study|Death|0
822704|NCT00207740|1776251|FG002|Overall Study|Death|0
822705|NCT00207740|1776252|FG003|Overall Study|Death|1
822706|NCT00207740|1776249|FG000|Overall Study|Sponsor Directive|22
822707|NCT00207740|1776250|FG001|Overall Study|Sponsor Directive|15
822708|NCT00207740|1776251|FG002|Overall Study|Sponsor Directive|16
822709|NCT00207740|1776252|FG003|Overall Study|Sponsor Directive|21
822710|NCT00207740|1776249|FG000|Overall Study|Other|2
822711|NCT00207740|1776250|FG001|Overall Study|Other|10
822712|NCT00207740|1776251|FG002|Overall Study|Other|7
822713|NCT00207740|1776252|FG003|Overall Study|Other|5
822714|NCT00208325|1776293|FG000|Overall Study|Death|18
822715|NCT00208325|1776294|FG001|Overall Study|Death|19
822716|NCT00208325|1776295|FG002|Overall Study|Death|7
822717|NCT00208325|1776296|FG003|Overall Study|Death|5
822718|NCT00208325|1776293|FG000|Overall Study|Withdrawal by Subject|0
822719|NCT00208325|1776294|FG001|Overall Study|Withdrawal by Subject|1
822720|NCT00208325|1776295|FG002|Overall Study|Withdrawal by Subject|0
822721|NCT00208325|1776296|FG003|Overall Study|Withdrawal by Subject|0
822722|NCT00208325|1776293|FG000|Overall Study|Revision|4
822723|NCT00208325|1776294|FG001|Overall Study|Revision|1
822724|NCT00208325|1776295|FG002|Overall Study|Revision|0
822725|NCT00208325|1776296|FG003|Overall Study|Revision|4
822726|NCT00208325|1776293|FG000|Overall Study|Lost to Follow-up|1
822727|NCT00208325|1776294|FG001|Overall Study|Lost to Follow-up|0
822728|NCT00208325|1776295|FG002|Overall Study|Lost to Follow-up|2
822729|NCT00208325|1776296|FG003|Overall Study|Lost to Follow-up|0
822730|NCT00208325|1776293|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4
822731|NCT00208325|1776294|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4
822732|NCT00208325|1776295|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1
822733|NCT00208325|1776296|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3
822734|NCT00208325|1776293|FG000|Overall Study|Does not wish to Continue in Study|5
822735|NCT00208325|1776294|FG001|Overall Study|Does not wish to Continue in Study|8
822736|NCT00208325|1776295|FG002|Overall Study|Does not wish to Continue in Study|3
822737|NCT00208325|1776296|FG003|Overall Study|Does not wish to Continue in Study|2
822738|NCT00208325|1776293|FG000|Overall Study|Other|2
822739|NCT00208325|1776294|FG001|Overall Study|Other|1
822740|NCT00208325|1776295|FG002|Overall Study|Other|1
822741|NCT00208325|1776296|FG003|Overall Study|Other|0
822742|NCT00208325|1776293|FG000|Overall Study|Mis-Randomized|17
822743|NCT00208325|1776294|FG001|Overall Study|Mis-Randomized|20
822744|NCT00208325|1776295|FG002|Overall Study|Mis-Randomized|0
822745|NCT00208325|1776296|FG003|Overall Study|Mis-Randomized|0
822746|NCT00208767|1776326|FG000|Overall Study|Adverse Event|9
822747|NCT00208767|1776327|FG001|Overall Study|Adverse Event|1
822748|NCT00208767|1776326|FG000|Overall Study|Withdrawal by Subject|14
822749|NCT00208767|1776327|FG001|Overall Study|Withdrawal by Subject|3
822750|NCT00208767|1776326|FG000|Overall Study|Death|1
822751|NCT00208767|1776327|FG001|Overall Study|Death|0
822752|NCT00208767|1776326|FG000|Overall Study|Lost to Follow-up|3
822753|NCT00208767|1776327|FG001|Overall Study|Lost to Follow-up|3
822754|NCT00209092|1776349|FG000|Overall Study|Progression of disease|7
822755|NCT00209092|1776350|FG001|Overall Study|Progression of disease|1
822756|NCT00209092|1776349|FG000|Overall Study|Adverse Event|0
822757|NCT00209092|1776350|FG001|Overall Study|Adverse Event|1
822758|NCT00209092|1776349|FG000|Overall Study|Withdrawal by Subject|1
822759|NCT00209092|1776350|FG001|Overall Study|Withdrawal by Subject|0
822760|NCT00209170|1776358|FG000|Overall Study|Adverse Event|0
822761|NCT00209170|1776359|FG001|Overall Study|Adverse Event|1
822762|NCT00209170|1776358|FG000|Overall Study|Withdrawal by Subject|2
822763|NCT00209170|1776359|FG001|Overall Study|Withdrawal by Subject|1
822764|NCT00209170|1776358|FG000|Overall Study|Lack of Efficacy|0
822765|NCT00209170|1776359|FG001|Overall Study|Lack of Efficacy|1
822766|NCT00209274|1776367|FG000|Overall Study|Missed visit|3
822767|NCT00209274|1776368|FG001|Overall Study|Missed visit|2
822768|NCT00209274|1776367|FG000|Overall Study|Death|32
822769|NCT00209274|1776368|FG001|Overall Study|Death|15
822770|NCT00209274|1776367|FG000|Overall Study|Withdrawal by Subject|30
822771|NCT00209274|1776368|FG001|Overall Study|Withdrawal by Subject|15
822772|NCT00209274|1776367|FG000|Overall Study|Randomized not treated (RNT)|6
822773|NCT00209274|1776368|FG001|Overall Study|Randomized not treated (RNT)|15
822774|NCT00209339|1776374|FG000|At 12 Months Follow-up|Withdrawal by Subject|8
822775|NCT00209339|1776374|FG000|At 12 Months Follow-up|Death|1
822776|NCT00209339|1776374|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6
822777|NCT00209339|1776374|FG000|At 24 Months Follow-up|Withdrawal by Subject|4
822778|NCT00209339|1776374|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6
822779|NCT00209339|1776374|FG000|At 24 Months Follow-up|Death|1
822780|NCT00209339|1776374|FG000|At 3 Years Follow-up|Withdrawal by Subject|1
822781|NCT00209339|1776374|FG000|At 4 Years Follow-up|Withdrawal by Subject|4
822782|NCT00209339|1776374|FG000|At 4 Years Follow-up|Death|1
822783|NCT00209339|1776374|FG000|At 5 Years Follow-up|Withdrawal by Subject|2
822784|NCT00209339|1776374|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5
822785|NCT00209339|1776374|FG000|At 5 Years Follow-up|Death|1
822786|NCT00209560|1776389|FG000|Overall Study|Lack of Efficacy|1
822787|NCT00209560|1776390|FG001|Overall Study|Lack of Efficacy|0
822788|NCT00210106|1776396|FG000|Overall Study|Death|1
822789|NCT00210106|1776396|FG000|Overall Study|Protocol Violation|13
822790|NCT00210119|1776401|FG000|Overall Study|Protocol Violation|1
822791|NCT00210119|1776401|FG000|Overall Study|Withdrawal by Subject|1
822792|NCT00210184|1776405|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2
822793|NCT00210626|1776436|FG000|Overall Study|Adverse Event|1
822794|NCT00210626|1776437|FG001|Overall Study|Adverse Event|2
822795|NCT00210626|1776436|FG000|Overall Study|Protocol Violation|1
822796|NCT00210626|1776437|FG001|Overall Study|Protocol Violation|5
822797|NCT00210626|1776436|FG000|Overall Study|Lost to Follow-up|11
822798|NCT00210626|1776437|FG001|Overall Study|Lost to Follow-up|11
822799|NCT00210626|1776436|FG000|Overall Study|Death|1
822800|NCT00210626|1776437|FG001|Overall Study|Death|0
822801|NCT00210626|1776436|FG000|Overall Study|Withdrawal by Subject|29
822802|NCT00210626|1776437|FG001|Overall Study|Withdrawal by Subject|20
822803|NCT00210626|1776436|FG000|Overall Study|Physician Decision|0
822804|NCT00210626|1776437|FG001|Overall Study|Physician Decision|2
822805|NCT00210626|1776436|FG000|Overall Study|Sponser Request|1
822806|NCT00210626|1776437|FG001|Overall Study|Sponser Request|0
822807|NCT00210626|1776436|FG000|Overall Study|Other|4
822808|NCT00210626|1776437|FG001|Overall Study|Other|5
822809|NCT00210639|1776445|FG000|Overall Study|Lost to Follow-up|37
822810|NCT00210639|1776446|FG001|Overall Study|Lost to Follow-up|29
822811|NCT00210639|1776445|FG000|Overall Study|Withdrawal by Subject|8
822812|NCT00210639|1776446|FG001|Overall Study|Withdrawal by Subject|1
822813|NCT00210639|1776445|FG000|Overall Study|Other|18
822814|NCT00210639|1776446|FG001|Overall Study|Other|12
822815|NCT00211081|1776452|FG000|Overall Study|Withdrawal by Subject|2
822816|NCT00211172|1776458|FG000|Overall Study|Died or lost health plan eligibility|39
822817|NCT00211172|1776459|FG001|Overall Study|Died or lost health plan eligibility|32
822818|NCT00211185|1776465|FG000|Overall Study|Death|2
822819|NCT00211185|1776465|FG000|Overall Study|Disease progression|7
822820|NCT00211185|1776465|FG000|Overall Study|Withdrawal by Subject|6
822821|NCT00211185|1776465|FG000|Overall Study|Physician Decision|5
822822|NCT00211237|1776471|FG000|Baseline|Withdrew|1
822823|NCT00211237|1776472|FG001|Baseline|Withdrew|3
822824|NCT00211237|1776473|FG002|Baseline|Withdrew|0
822825|NCT00211237|1776471|FG000|Baseline|Refused random assignment|1
822826|NCT00211237|1776472|FG001|Baseline|Refused random assignment|0
822827|NCT00211237|1776473|FG002|Baseline|Refused random assignment|0
822828|NCT00211237|1776471|FG000|1 Month|Death|2
822829|NCT00211237|1776472|FG001|1 Month|Death|1
822830|NCT00211237|1776473|FG002|1 Month|Death|0
822831|NCT00211237|1776471|FG000|1 Month|Lost to Follow-up|0
822832|NCT00211237|1776472|FG001|1 Month|Lost to Follow-up|2
822833|NCT00211237|1776473|FG002|1 Month|Lost to Follow-up|0
822834|NCT00211237|1776471|FG000|1 Month|Withdrew|0
822835|NCT00211237|1776472|FG001|1 Month|Withdrew|4
822836|NCT00211237|1776473|FG002|1 Month|Withdrew|0
822837|NCT00211237|1776471|FG000|1 Month|Additional surgery needed|1
822838|NCT00211237|1776472|FG001|1 Month|Additional surgery needed|0
822839|NCT00211237|1776473|FG002|1 Month|Additional surgery needed|0
822840|NCT00211237|1776471|FG000|1 Month|Non-medical problem|0
822841|NCT00211237|1776472|FG001|1 Month|Non-medical problem|2
822842|NCT00211237|1776473|FG002|1 Month|Non-medical problem|0
822843|NCT00211237|1776471|FG000|3 Months|Death|7
822844|NCT00211237|1776472|FG001|3 Months|Death|3
822845|NCT00211237|1776473|FG002|3 Months|Death|0
822846|NCT00211237|1776471|FG000|3 Months|Could not comply with protocol|1
822847|NCT00211237|1776472|FG001|3 Months|Could not comply with protocol|0
822848|NCT00211237|1776473|FG002|3 Months|Could not comply with protocol|0
822849|NCT00211237|1776471|FG000|3 Months|Withdrew|0
822850|NCT00211237|1776472|FG001|3 Months|Withdrew|1
822851|NCT00211237|1776473|FG002|3 Months|Withdrew|0
822852|NCT00211237|1776471|FG000|3 Months|Non-medical problem|0
822853|NCT00211237|1776472|FG001|3 Months|Non-medical problem|0
822854|NCT00211237|1776473|FG002|3 Months|Non-medical problem|1
822855|NCT00211237|1776471|FG000|6 Months|Death|6
822856|NCT00211237|1776472|FG001|6 Months|Death|0
822857|NCT00211237|1776473|FG002|6 Months|Death|3
822858|NCT00211237|1776471|FG000|6 Months|Lost to Follow-up|2
822859|NCT00211237|1776472|FG001|6 Months|Lost to Follow-up|0
822860|NCT00211237|1776473|FG002|6 Months|Lost to Follow-up|0
822861|NCT00211237|1776471|FG000|6 Months|Could not comply with protocol|0
822862|NCT00211237|1776472|FG001|6 Months|Could not comply with protocol|2
822863|NCT00211237|1776473|FG002|6 Months|Could not comply with protocol|0
822864|NCT00211237|1776471|FG000|12 Months|Death|8
822865|NCT00211237|1776472|FG001|12 Months|Death|2
822866|NCT00211237|1776473|FG002|12 Months|Death|3
822867|NCT00211237|1776471|FG000|12 Months|Lost to Follow-up|1
822868|NCT00211237|1776472|FG001|12 Months|Lost to Follow-up|0
822869|NCT00211237|1776473|FG002|12 Months|Lost to Follow-up|1
822870|NCT00211237|1776471|FG000|12 Months|Withdrew|0
822871|NCT00211237|1776472|FG001|12 Months|Withdrew|0
822872|NCT00211237|1776473|FG002|12 Months|Withdrew|1
822873|NCT00211237|1776471|FG000|12 Months|unrelated medical problem|0
822874|NCT00211237|1776472|FG001|12 Months|unrelated medical problem|0
822875|NCT00211237|1776473|FG002|12 Months|unrelated medical problem|1
822876|NCT00211510|1776492|FG000|Overall Study|Physician Decision|3
822877|NCT00211510|1776493|FG001|Overall Study|Physician Decision|1
822878|NCT00211510|1776492|FG000|Overall Study|Withdrawal by Subject|3
822879|NCT00211510|1776493|FG001|Overall Study|Withdrawal by Subject|1
822880|NCT00211536|1776504|FG000|Overall Study|Withdrawal by Subject|2
822881|NCT00211536|1776505|FG001|Overall Study|Withdrawal by Subject|2
822882|NCT00211536|1776504|FG000|Overall Study|Physician Decision|0
822883|NCT00211536|1776505|FG001|Overall Study|Physician Decision|5
822884|NCT00211536|1776504|FG000|Overall Study|Adverse Event|2
822885|NCT00211536|1776505|FG001|Overall Study|Adverse Event|0
822886|NCT00211757|1776522|FG000|Overall Study|Withdrawal by Subject|1
822887|NCT00211757|1776523|FG001|Overall Study|Withdrawal by Subject|1
822888|NCT00211757|1776522|FG000|Overall Study|Lack of Efficacy|0
822889|NCT00211757|1776523|FG001|Overall Study|Lack of Efficacy|1
822890|NCT00211809|1776531|FG000|Overall Study|Lack of Efficacy|1
822891|NCT00211809|1776531|FG000|Overall Study|Lost to Follow-up|2
822892|NCT00211809|1776531|FG000|Overall Study|Pregnancy|1
822893|NCT00211809|1776531|FG000|Overall Study|side effects|2
822894|NCT00211887|1776540|FG000|Overall Study|Adverse Event|8
822895|NCT00211887|1776541|FG001|Overall Study|Adverse Event|4
822896|NCT00211887|1776542|FG002|Overall Study|Adverse Event|6
822897|NCT00211887|1776540|FG000|Overall Study|Death|1
822898|NCT00211887|1776541|FG001|Overall Study|Death|1
822899|NCT00211887|1776542|FG002|Overall Study|Death|1
822900|NCT00211887|1776540|FG000|Overall Study|Lost to Follow-up|28
822901|NCT00211887|1776541|FG001|Overall Study|Lost to Follow-up|13
822902|NCT00211887|1776542|FG002|Overall Study|Lost to Follow-up|9
822903|NCT00211887|1776540|FG000|Overall Study|Non-medical reason|31
822904|NCT00211887|1776541|FG001|Overall Study|Non-medical reason|14
822905|NCT00211887|1776542|FG002|Overall Study|Non-medical reason|8
822906|NCT00211887|1776540|FG000|Overall Study|Other medical reason|15
822907|NCT00211887|1776541|FG001|Overall Study|Other medical reason|11
822908|NCT00211887|1776542|FG002|Overall Study|Other medical reason|7
822909|NCT00211887|1776540|FG000|Overall Study|Side effects|19
822910|NCT00211887|1776541|FG001|Overall Study|Side effects|13
822911|NCT00211887|1776542|FG002|Overall Study|Side effects|5
822912|NCT00212355|1776576|FG000|Overall Study|Adverse Event|1
822913|NCT00212355|1776576|FG000|Overall Study|Withdrawal by Subject|1
822914|NCT00212355|1776576|FG000|Overall Study|A change of address|1
822915|NCT00212758|1776584|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1
822916|NCT00212758|1776585|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0
822917|NCT00212758|1776584|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
822918|NCT00212758|1776585|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
822919|NCT00213135|1776609|FG000|Overall Study|Adverse Event|9
822920|NCT00213135|1776610|FG001|Overall Study|Adverse Event|5
822921|NCT00213135|1776611|FG002|Overall Study|Adverse Event|5
822922|NCT00213135|1776609|FG000|Overall Study|Lost to Follow-up|11
822923|NCT00213135|1776610|FG001|Overall Study|Lost to Follow-up|8
822924|NCT00213135|1776611|FG002|Overall Study|Lost to Follow-up|4
822925|NCT00213135|1776609|FG000|Overall Study|Protocol Violation|4
822926|NCT00213135|1776610|FG001|Overall Study|Protocol Violation|4
822927|NCT00213135|1776611|FG002|Overall Study|Protocol Violation|10
822928|NCT00213135|1776609|FG000|Overall Study|Death|1
822929|NCT00213135|1776610|FG001|Overall Study|Death|1
822930|NCT00213135|1776611|FG002|Overall Study|Death|2
822931|NCT00213135|1776609|FG000|Overall Study|Disease progression|4
822932|NCT00213135|1776610|FG001|Overall Study|Disease progression|5
822933|NCT00213135|1776611|FG002|Overall Study|Disease progression|21
822934|NCT00213135|1776609|FG000|Overall Study|Other|21
822935|NCT00213135|1776610|FG001|Overall Study|Other|12
822936|NCT00213135|1776611|FG002|Overall Study|Other|15
822937|NCT00213148|1776623|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1
822938|NCT00213148|1776624|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0
822939|NCT00213148|1776625|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2
822940|NCT00213148|1776626|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2
822941|NCT00213148|1776627|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1
822942|NCT00213148|1776623|FG000|Cycle 1 (1 Month)|Adverse Event|0
822943|NCT00213148|1776624|FG001|Cycle 1 (1 Month)|Adverse Event|0
822944|NCT00213148|1776625|FG002|Cycle 1 (1 Month)|Adverse Event|1
822945|NCT00213148|1776626|FG003|Cycle 1 (1 Month)|Adverse Event|0
822946|NCT00213148|1776627|FG004|Cycle 1 (1 Month)|Adverse Event|0
822947|NCT00213148|1776623|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4
822948|NCT00213148|1776624|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0
822949|NCT00213148|1776625|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8
822950|NCT00213148|1776626|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5
822951|NCT00213148|1776627|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8
822952|NCT00213148|1776623|FG000|Cycle 1 (1 Month)|Protocol Violation|1
822953|NCT00213148|1776624|FG001|Cycle 1 (1 Month)|Protocol Violation|0
822954|NCT00213148|1776625|FG002|Cycle 1 (1 Month)|Protocol Violation|1
822955|NCT00213148|1776626|FG003|Cycle 1 (1 Month)|Protocol Violation|0
822956|NCT00213148|1776627|FG004|Cycle 1 (1 Month)|Protocol Violation|0
822957|NCT00213148|1776623|FG000|Cycle 1 (1 Month)|Other|3
822958|NCT00213148|1776624|FG001|Cycle 1 (1 Month)|Other|0
822959|NCT00213148|1776625|FG002|Cycle 1 (1 Month)|Other|2
822960|NCT00213148|1776626|FG003|Cycle 1 (1 Month)|Other|2
822961|NCT00213148|1776627|FG004|Cycle 1 (1 Month)|Other|7
822962|NCT00213148|1776623|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
822963|NCT00213148|1776624|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
822964|NCT00213148|1776625|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
822965|NCT00213148|1776626|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
822966|NCT00213148|1776627|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
822967|NCT00213148|1776623|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
822968|NCT00213148|1776624|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
822969|NCT00213148|1776625|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
822970|NCT00213148|1776626|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
822971|NCT00213148|1776627|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
822972|NCT00213148|1776623|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
822973|NCT00213148|1776624|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
822974|NCT00213148|1776625|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
822975|NCT00213148|1776626|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
822976|NCT00213148|1776627|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
822977|NCT00213148|1776623|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0
822978|NCT00213148|1776624|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0
822979|NCT00213148|1776625|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2
822980|NCT00213148|1776626|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2
822981|NCT00213148|1776627|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1
822982|NCT00213148|1776623|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1
822983|NCT00213148|1776624|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3
822984|NCT00213148|1776625|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7
822985|NCT00213148|1776626|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6
822986|NCT00213148|1776627|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16
822987|NCT00213148|1776623|FG000|Cycle 2 (1 Month)|Other|2
822988|NCT00213148|1776624|FG001|Cycle 2 (1 Month)|Other|1
822989|NCT00213148|1776625|FG002|Cycle 2 (1 Month)|Other|2
822990|NCT00213148|1776626|FG003|Cycle 2 (1 Month)|Other|8
822991|NCT00213148|1776627|FG004|Cycle 2 (1 Month)|Other|7
822992|NCT00213148|1776623|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
822993|NCT00213148|1776624|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
822994|NCT00213148|1776625|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
822995|NCT00213148|1776626|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
822996|NCT00213148|1776627|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
822997|NCT00213148|1776623|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
822998|NCT00213148|1776624|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
822999|NCT00213148|1776625|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
823000|NCT00213148|1776626|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
823001|NCT00213148|1776627|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
823002|NCT00213148|1776623|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
823003|NCT00213148|1776624|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
823004|NCT00213148|1776625|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
823005|NCT00213148|1776626|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
823006|NCT00213148|1776627|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
823007|NCT00213148|1776623|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0
823008|NCT00213148|1776624|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2
823009|NCT00213148|1776625|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0
823010|NCT00213148|1776626|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0
823011|NCT00213148|1776627|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1
823012|NCT00213148|1776623|FG000|Cycle 3 (1 Month)|Other|0
823013|NCT00213148|1776624|FG001|Cycle 3 (1 Month)|Other|0
823014|NCT00213148|1776625|FG002|Cycle 3 (1 Month)|Other|1
823015|NCT00213148|1776626|FG003|Cycle 3 (1 Month)|Other|1
823016|NCT00213148|1776627|FG004|Cycle 3 (1 Month)|Other|0
823017|NCT00213980|1776658|FG000|Overall Study|Withdrawal by Subject|3
823018|NCT00213980|1776659|FG001|Overall Study|Withdrawal by Subject|1
823019|NCT00213980|1776658|FG000|Overall Study|Adverse Event|1
823020|NCT00213980|1776659|FG001|Overall Study|Adverse Event|1
823021|NCT00213980|1776658|FG000|Overall Study|Disease progression|0
823022|NCT00213980|1776659|FG001|Overall Study|Disease progression|2
823023|NCT00213980|1776658|FG000|Overall Study|Developed ovarian cancer|1
823024|NCT00213980|1776659|FG001|Overall Study|Developed ovarian cancer|0
823025|NCT00213980|1776658|FG000|Overall Study|Failed to obtain all 3 DXAs|1
823026|NCT00213980|1776659|FG001|Overall Study|Failed to obtain all 3 DXAs|3
823027|NCT00214019|1776665|FG000|Overall Study|Lost to Follow-up|11
823028|NCT00214019|1776665|FG000|Overall Study|Withdrawal by Subject|2
823029|NCT00214019|1776665|FG000|Overall Study|Screen Failed prior to randomization|17
823030|NCT00214136|1776700|FG000|Overall Study|Death|5
823031|NCT00214201|1776706|FG000|Overall Study|Withdrawal by Subject|2
823032|NCT00214201|1776707|FG001|Overall Study|Withdrawal by Subject|0
823033|NCT00214201|1776706|FG000|Overall Study|Death|0
823034|NCT00214201|1776707|FG001|Overall Study|Death|2
823035|NCT00214383|1776716|FG000|Overall Study|Lost to Follow-up|16
823036|NCT00214383|1776717|FG001|Overall Study|Lost to Follow-up|26
823037|NCT00214422|1776726|FG000|Overall Study|Physician Decision|2
823038|NCT00214422|1776727|FG001|Overall Study|Physician Decision|0
823039|NCT00214422|1776728|FG002|Overall Study|Physician Decision|0
823040|NCT00214422|1776726|FG000|Overall Study|Developed esophageal ca|1
823041|NCT00214422|1776727|FG001|Overall Study|Developed esophageal ca|0
823042|NCT00214422|1776728|FG002|Overall Study|Developed esophageal ca|0
823043|NCT00214422|1776726|FG000|Overall Study|Pt taken off study|1
823044|NCT00214422|1776727|FG001|Overall Study|Pt taken off study|1
823045|NCT00214422|1776728|FG002|Overall Study|Pt taken off study|0
823046|NCT00214422|1776726|FG000|Overall Study|Disease progression on study|1
823047|NCT00214422|1776727|FG001|Overall Study|Disease progression on study|0
823048|NCT00214422|1776728|FG002|Overall Study|Disease progression on study|0
823049|NCT00214422|1776726|FG000|Overall Study|Unable to make a radiation treatment|0
823050|NCT00214422|1776727|FG001|Overall Study|Unable to make a radiation treatment|0
823051|NCT00214422|1776728|FG002|Overall Study|Unable to make a radiation treatment|1
823052|NCT00214461|1776744|FG000|Overall Study|Adverse Event|0
823053|NCT00214461|1776745|FG001|Overall Study|Adverse Event|0
823054|NCT00214461|1776746|FG002|Overall Study|Adverse Event|1
823055|NCT00214461|1776747|FG003|Overall Study|Adverse Event|1
823056|NCT00214461|1776744|FG000|Overall Study|Withdrawal by Subject|0
823057|NCT00214461|1776745|FG001|Overall Study|Withdrawal by Subject|0
823058|NCT00214461|1776746|FG002|Overall Study|Withdrawal by Subject|1
823059|NCT00214461|1776747|FG003|Overall Study|Withdrawal by Subject|0
823060|NCT00215137|1776827|FG000|Open Label Escitalopram|Lack of Efficacy|1
823061|NCT00215137|1776828|FG001|Open Label Escitalopram|Lack of Efficacy|0
823062|NCT00215137|1776829|FG002|Open Label Escitalopram|Lack of Efficacy|0
823063|NCT00215137|1776827|FG000|Randomization Period|Lost to Follow-up|0
823064|NCT00215137|1776828|FG001|Randomization Period|Lost to Follow-up|1
823065|NCT00215137|1776829|FG002|Randomization Period|Lost to Follow-up|0
823066|NCT00215137|1776827|FG000|Randomization Period|Withdrawal by Subject|0
823067|NCT00215137|1776828|FG001|Randomization Period|Withdrawal by Subject|1
823068|NCT00215137|1776829|FG002|Randomization Period|Withdrawal by Subject|0
823069|NCT00215150|1776837|FG000|Open Label Phase|Lost to Follow-up|7
823070|NCT00215150|1776837|FG000|Open Label Phase|Withdrawal by Subject|1
823071|NCT00215150|1776837|FG000|Open Label Phase|Did not complete a post base visit|13
823072|NCT00215150|1776837|FG000|Open Label Phase|Did not meet randomization criteria|9
823073|NCT00215150|1776837|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2
823074|NCT00215150|1776837|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1
823075|NCT00215150|1776837|FG000|Randomization Phase Placebo|Withdrawal by Subject|1
823076|NCT00215540|1776848|FG000|Overall Study|Withdrew from study medication|1
823077|NCT00215540|1776849|FG001|Overall Study|Withdrew from study medication|0
823078|NCT00215540|1776850|FG002|Overall Study|Withdrew from study medication|0
823079|NCT00215553|1776865|FG000|Overall Study|Adverse Event|0
823080|NCT00215553|1776866|FG001|Overall Study|Adverse Event|1
823081|NCT00215553|1776867|FG002|Overall Study|Adverse Event|2
823082|NCT00215553|1776868|FG003|Overall Study|Adverse Event|1
823083|NCT00215553|1776869|FG004|Overall Study|Adverse Event|2
823084|NCT00215553|1776870|FG005|Overall Study|Adverse Event|6
823085|NCT00215553|1776871|FG006|Overall Study|Adverse Event|0
823086|NCT00215644|1776889|FG000|Overall Study|Disease Progression|28
823087|NCT00215644|1776890|FG001|Overall Study|Disease Progression|10
823088|NCT00215644|1776889|FG000|Overall Study|Adverse Event|2
823089|NCT00215644|1776890|FG001|Overall Study|Adverse Event|9
823090|NCT00215644|1776889|FG000|Overall Study|Death|1
823091|NCT00215644|1776890|FG001|Overall Study|Death|2
823092|NCT00215644|1776889|FG000|Overall Study|Withdrawal by Subject|1
823093|NCT00215644|1776890|FG001|Overall Study|Withdrawal by Subject|0
823094|NCT00215644|1776889|FG000|Overall Study|Other|3
823095|NCT00215644|1776890|FG001|Overall Study|Other|15
823096|NCT00215644|1776889|FG000|Overall Study|Randomized but Not Treated|1
823097|NCT00215644|1776890|FG001|Overall Study|Randomized but Not Treated|0
823098|NCT00215657|1776904|FG000|Overall Study|Adverse Event|5
823099|NCT00215657|1776905|FG001|Overall Study|Adverse Event|1
823100|NCT00215657|1776906|FG002|Overall Study|Adverse Event|3
823101|NCT00215657|1776907|FG003|Overall Study|Adverse Event|0
823102|NCT00215657|1776908|FG004|Overall Study|Adverse Event|3
823103|NCT00215657|1776909|FG005|Overall Study|Adverse Event|1
823104|NCT00215657|1776910|FG006|Overall Study|Adverse Event|0
823105|NCT00215657|1776911|FG007|Overall Study|Adverse Event|3
823106|NCT00215657|1776904|FG000|Overall Study|Withdrawal by Subject|6
823107|NCT00215657|1776905|FG001|Overall Study|Withdrawal by Subject|3
823108|NCT00215657|1776906|FG002|Overall Study|Withdrawal by Subject|3
823109|NCT00215657|1776907|FG003|Overall Study|Withdrawal by Subject|1
823110|NCT00215657|1776908|FG004|Overall Study|Withdrawal by Subject|6
823111|NCT00215657|1776909|FG005|Overall Study|Withdrawal by Subject|1
823112|NCT00215657|1776910|FG006|Overall Study|Withdrawal by Subject|10
823113|NCT00215657|1776911|FG007|Overall Study|Withdrawal by Subject|3
823114|NCT00215657|1776904|FG000|Overall Study|Insuff prostate specific antigen resp|3
823115|NCT00215657|1776905|FG001|Overall Study|Insuff prostate specific antigen resp|2
823116|NCT00215657|1776906|FG002|Overall Study|Insuff prostate specific antigen resp|2
823117|NCT00215657|1776907|FG003|Overall Study|Insuff prostate specific antigen resp|2
823118|NCT00215657|1776908|FG004|Overall Study|Insuff prostate specific antigen resp|1
823119|NCT00215657|1776909|FG005|Overall Study|Insuff prostate specific antigen resp|2
823120|NCT00215657|1776910|FG006|Overall Study|Insuff prostate specific antigen resp|3
823121|NCT00215657|1776911|FG007|Overall Study|Insuff prostate specific antigen resp|2
823122|NCT00215657|1776904|FG000|Overall Study|Insufficient testosterone response|5
823123|NCT00215657|1776905|FG001|Overall Study|Insufficient testosterone response|4
823124|NCT00215657|1776906|FG002|Overall Study|Insufficient testosterone response|1
823125|NCT00215657|1776907|FG003|Overall Study|Insufficient testosterone response|12
823126|NCT00215657|1776908|FG004|Overall Study|Insufficient testosterone response|8
823127|NCT00215657|1776909|FG005|Overall Study|Insufficient testosterone response|12
823128|NCT00215657|1776910|FG006|Overall Study|Insufficient testosterone response|4
823129|NCT00215657|1776911|FG007|Overall Study|Insufficient testosterone response|7
823130|NCT00215657|1776904|FG000|Overall Study|Other|3
823131|NCT00215657|1776905|FG001|Overall Study|Other|1
823132|NCT00215657|1776906|FG002|Overall Study|Other|2
823133|NCT00215657|1776907|FG003|Overall Study|Other|3
823134|NCT00215657|1776908|FG004|Overall Study|Other|5
823135|NCT00215657|1776909|FG005|Overall Study|Other|4
823136|NCT00215657|1776910|FG006|Overall Study|Other|6
823137|NCT00215657|1776911|FG007|Overall Study|Other|1
823138|NCT00215683|1776932|FG000|Overall Study|Adverse Event|15
823139|NCT00215683|1776933|FG001|Overall Study|Adverse Event|16
823140|NCT00215683|1776934|FG002|Overall Study|Adverse Event|15
823141|NCT00215683|1776932|FG000|Overall Study|Lack of Efficacy|5
823142|NCT00215683|1776933|FG001|Overall Study|Lack of Efficacy|1
823143|NCT00215683|1776934|FG002|Overall Study|Lack of Efficacy|2
823144|NCT00215683|1776932|FG000|Overall Study|Lost to Follow-up|0
823145|NCT00215683|1776933|FG001|Overall Study|Lost to Follow-up|2
823146|NCT00215683|1776934|FG002|Overall Study|Lost to Follow-up|1
823147|NCT00215683|1776932|FG000|Overall Study|Withdrawal by Subject|9
823148|NCT00215683|1776933|FG001|Overall Study|Withdrawal by Subject|4
823149|NCT00215683|1776934|FG002|Overall Study|Withdrawal by Subject|13
823150|NCT00215683|1776932|FG000|Overall Study|Physician Decision|0
823151|NCT00215683|1776933|FG001|Overall Study|Physician Decision|0
823152|NCT00215683|1776934|FG002|Overall Study|Physician Decision|1
823153|NCT00215683|1776932|FG000|Overall Study|Difficult to attend visits|0
823154|NCT00215683|1776933|FG001|Overall Study|Difficult to attend visits|1
823155|NCT00215683|1776934|FG002|Overall Study|Difficult to attend visits|0
823156|NCT00215683|1776932|FG000|Overall Study|No study drug available|0
823157|NCT00215683|1776933|FG001|Overall Study|No study drug available|1
823158|NCT00215683|1776934|FG002|Overall Study|No study drug available|0
823159|NCT00215683|1776932|FG000|Overall Study|Intermittent therapy required|0
823160|NCT00215683|1776933|FG001|Overall Study|Intermittent therapy required|1
823161|NCT00215683|1776934|FG002|Overall Study|Intermittent therapy required|0
823162|NCT00215943|1776953|FG000|Overall Study|Disease Progression|3
823163|NCT00215943|1776954|FG001|Overall Study|Disease Progression|5
823164|NCT00215943|1776953|FG000|Overall Study|Alternate therapy|0
823165|NCT00215943|1776954|FG001|Overall Study|Alternate therapy|1
823166|NCT00215943|1776953|FG000|Overall Study|Adverse Event|3
823167|NCT00215943|1776954|FG001|Overall Study|Adverse Event|6
823168|NCT00215943|1776953|FG000|Overall Study|Other disease|0
823169|NCT00215943|1776954|FG001|Overall Study|Other disease|1
823170|NCT00215943|1776953|FG000|Overall Study|Other complications|3
823171|NCT00215943|1776954|FG001|Overall Study|Other complications|1
823172|NCT00216086|1776971|FG000|Overall Study|Protocol Violation|1
823173|NCT00216086|1776971|FG000|Overall Study|Diagnosis of Metastatic Disease|1
823174|NCT00216086|1776971|FG000|Overall Study|Social Reasons|2
823175|NCT00216203|1776988|FG000|Overall Study|Withdrawal by Subject|2
823176|NCT00216476|1777009|FG000|Overall Study|Withdrawal by Subject|59
823177|NCT00216476|1777010|FG001|Overall Study|Withdrawal by Subject|72
823178|NCT00216476|1777011|FG002|Overall Study|Withdrawal by Subject|9
823179|NCT00216476|1777009|FG000|Overall Study|Lost to Follow-up|10
823180|NCT00216476|1777010|FG001|Overall Study|Lost to Follow-up|9
823181|NCT00216476|1777011|FG002|Overall Study|Lost to Follow-up|1
823182|NCT00216476|1777009|FG000|Overall Study|Adverse Event|6
823183|NCT00216476|1777010|FG001|Overall Study|Adverse Event|10
823184|NCT00216476|1777011|FG002|Overall Study|Adverse Event|1
823185|NCT00216476|1777009|FG000|Overall Study|Lack of Efficacy|4
823186|NCT00216476|1777010|FG001|Overall Study|Lack of Efficacy|3
823187|NCT00216476|1777011|FG002|Overall Study|Lack of Efficacy|0
823188|NCT00216476|1777009|FG000|Overall Study|Death|2
823189|NCT00216476|1777010|FG001|Overall Study|Death|0
823190|NCT00216476|1777011|FG002|Overall Study|Death|0
823191|NCT00216476|1777009|FG000|Overall Study|Pregnancy|0
823192|NCT00216476|1777010|FG001|Overall Study|Pregnancy|1
823193|NCT00216476|1777011|FG002|Overall Study|Pregnancy|1
823194|NCT00216476|1777009|FG000|Overall Study|Other|0
823195|NCT00216476|1777010|FG001|Overall Study|Other|0
823196|NCT00216476|1777011|FG002|Overall Study|Other|1
823197|NCT00216476|1777009|FG000|Overall Study|Refuses Injection|11
823198|NCT00216476|1777010|FG001|Overall Study|Refuses Injection|0
823199|NCT00216476|1777011|FG002|Overall Study|Refuses Injection|0
823200|NCT00216476|1777009|FG000|Overall Study|No Further Need for Treatment|3
823201|NCT00216476|1777010|FG001|Overall Study|No Further Need for Treatment|4
823202|NCT00216476|1777011|FG002|Overall Study|No Further Need for Treatment|1
823203|NCT00216476|1777009|FG000|Overall Study|Non-compliance|0
823204|NCT00216476|1777010|FG001|Overall Study|Non-compliance|4
823205|NCT00216476|1777011|FG002|Overall Study|Non-compliance|1
823206|NCT00216476|1777009|FG000|Overall Study|Higher dose/Extra Medication Required|2
823207|NCT00216476|1777010|FG001|Overall Study|Higher dose/Extra Medication Required|0
823208|NCT00216476|1777011|FG002|Overall Study|Higher dose/Extra Medication Required|2
823209|NCT00216476|1777009|FG000|Overall Study|Administrative Reasons|1
823210|NCT00216476|1777010|FG001|Overall Study|Administrative Reasons|1
823211|NCT00216476|1777011|FG002|Overall Study|Administrative Reasons|0
823212|NCT00216476|1777009|FG000|Overall Study|Protocol Deviation|5
823213|NCT00216476|1777010|FG001|Overall Study|Protocol Deviation|1
823214|NCT00216476|1777011|FG002|Overall Study|Protocol Deviation|0
823215|NCT00216476|1777009|FG000|Overall Study|Patient Moved|2
823216|NCT00216476|1777010|FG001|Overall Study|Patient Moved|2
823217|NCT00216476|1777011|FG002|Overall Study|Patient Moved|0
823218|NCT00216671|1777024|FG000|Overall Study|Adverse Event|4
823219|NCT00216671|1777025|FG001|Overall Study|Adverse Event|9
823220|NCT00216671|1777024|FG000|Overall Study|Pregnancy|0
823221|NCT00216671|1777025|FG001|Overall Study|Pregnancy|1
823222|NCT00216671|1777024|FG000|Overall Study|Withdrawal by Subject|4
823223|NCT00216671|1777025|FG001|Overall Study|Withdrawal by Subject|2
823224|NCT00216671|1777024|FG000|Overall Study|Refused Injections|3
823225|NCT00216671|1777025|FG001|Overall Study|Refused Injections|13
823226|NCT00216671|1777024|FG000|Overall Study|No Need to Continue Medication|1
823227|NCT00216671|1777025|FG001|Overall Study|No Need to Continue Medication|1
823228|NCT00216671|1777024|FG000|Overall Study|Insufficient Response|9
823229|NCT00216671|1777025|FG001|Overall Study|Insufficient Response|4
823230|NCT00216671|1777024|FG000|Overall Study|Lost to Follow-up|3
823231|NCT00216671|1777025|FG001|Overall Study|Lost to Follow-up|5
823232|NCT00216671|1777024|FG000|Overall Study|Non compliant|2
823233|NCT00216671|1777025|FG001|Overall Study|Non compliant|2
823234|NCT00216671|1777024|FG000|Overall Study|Ineligible|0
823235|NCT00216671|1777025|FG001|Overall Study|Ineligible|2
823236|NCT00216671|1777024|FG000|Overall Study|Physician Decision|1
823237|NCT00216671|1777025|FG001|Overall Study|Physician Decision|1
823238|NCT00216671|1777024|FG000|Overall Study|Protocol Violation|3
823239|NCT00216671|1777025|FG001|Overall Study|Protocol Violation|5
823240|NCT00216671|1777024|FG000|Overall Study|Relapse|1
823241|NCT00216671|1777025|FG001|Overall Study|Relapse|0
823242|NCT00216671|1777024|FG000|Overall Study|Investigator Illness|0
823243|NCT00216671|1777025|FG001|Overall Study|Investigator Illness|1
823244|NCT00216671|1777024|FG000|Overall Study|Patient Moved|0
823245|NCT00216671|1777025|FG001|Overall Study|Patient Moved|1
823246|NCT00216671|1777024|FG000|Overall Study|Ineligible, no efficacy data|2
823247|NCT00216671|1777025|FG001|Overall Study|Ineligible, no efficacy data|2
823248|NCT00216671|1777024|FG000|Overall Study|Insufficient Response Adverse Event|2
823249|NCT00216671|1777025|FG001|Overall Study|Insufficient Response Adverse Event|1
823250|NCT00216736|1777033|FG000|Overall Study|Lost to Follow-up|1
823251|NCT00216736|1777034|FG001|Overall Study|Lost to Follow-up|1
823252|NCT00217022|1777042|FG000|Overall Study|Withdrawal by Subject|1
823253|NCT00217022|1777043|FG001|Overall Study|Withdrawal by Subject|1
823254|NCT00217087|1777051|FG000|Overall Study|decided to have esophagectomy|1
823255|NCT00217087|1777052|FG001|Overall Study|decided to have esophagectomy|2
823256|NCT00217087|1777051|FG000|Overall Study|completed less than 12 months return|10
823257|NCT00217087|1777052|FG001|Overall Study|completed less than 12 months return|18
823258|NCT00217425|1777070|FG000|Overall Study|Never started treatment|2
823259|NCT00217425|1777070|FG000|Overall Study|Patient ineligible|5
823260|NCT00217425|1777070|FG000|Overall Study|Lack of Efficacy|13
823261|NCT00217425|1777070|FG000|Overall Study|Adverse Event|8
823262|NCT00217425|1777070|FG000|Overall Study|Withdrawal by Subject|4
823263|NCT00217425|1777070|FG000|Overall Study|Other complicating disease|1
823264|NCT00217425|1777070|FG000|Overall Study|Other|4
823265|NCT00217464|1777083|FG000|Overall Study|Progression|15
823266|NCT00217464|1777083|FG000|Overall Study|Other|2
823267|NCT00217581|1777108|FG000|Overall Study|Withdrawal by Subject|1
823268|NCT00217620|1777117|FG000|Overall Study|Adverse Event|2
823269|NCT00217620|1777117|FG000|Overall Study|Progression|31
823270|NCT00217620|1777117|FG000|Overall Study|Not Protocol Specified|4
823271|NCT00217620|1777117|FG000|Overall Study|Ineligible|13
823272|NCT00217620|1777117|FG000|Overall Study|Never received treatment|1
823273|NCT00217672|1777125|FG000|Allocation|Ineligible|2
823274|NCT00217672|1777126|FG001|Allocation|Ineligible|0
823275|NCT00217672|1777125|FG000|Treatment|disease progression|33
823276|NCT00217672|1777126|FG001|Treatment|disease progression|4
823277|NCT00217672|1777125|FG000|Treatment|Adverse Event|18
823278|NCT00217672|1777126|FG001|Treatment|Adverse Event|2
823279|NCT00217672|1777125|FG000|Treatment|reqd treatment not permitted by protocol|6
823280|NCT00217672|1777126|FG001|Treatment|reqd treatment not permitted by protocol|0
823281|NCT00217672|1777125|FG000|Treatment|Physician Decision|6
823282|NCT00217672|1777126|FG001|Treatment|Physician Decision|0
823283|NCT00217672|1777125|FG000|Treatment|insurance issues|1
823284|NCT00217672|1777126|FG001|Treatment|insurance issues|1
823285|NCT00217672|1777125|FG000|Treatment|Death|2
823286|NCT00217672|1777126|FG001|Treatment|Death|0
823287|NCT00217672|1777125|FG000|Treatment|secondary malignancy|1
823288|NCT00217672|1777126|FG001|Treatment|secondary malignancy|0
823289|NCT00217672|1777125|FG000|Follow-up|Withdrawal by Subject|4
823290|NCT00217672|1777126|FG001|Follow-up|Withdrawal by Subject|0
823291|NCT00217672|1777125|FG000|Follow-up|Lost to Follow-up|1
823292|NCT00217672|1777126|FG001|Follow-up|Lost to Follow-up|0
823293|NCT00217971|1777139|FG000|Overall Study|Adverse Event|1
823294|NCT00217971|1777140|FG001|Overall Study|Adverse Event|1
823295|NCT00217971|1777139|FG000|Overall Study|Lost to Follow-up|15
823296|NCT00217971|1777140|FG001|Overall Study|Lost to Follow-up|19
823297|NCT00217971|1777139|FG000|Overall Study|Physician Decision|0
823298|NCT00217971|1777140|FG001|Overall Study|Physician Decision|1
823299|NCT00217971|1777139|FG000|Overall Study|Withdrawal by Subject|7
823300|NCT00217971|1777140|FG001|Overall Study|Withdrawal by Subject|12
823301|NCT00217971|1777139|FG000|Overall Study|non compliant|1
823302|NCT00217971|1777140|FG001|Overall Study|non compliant|0
823303|NCT00218257|1777180|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4
823304|NCT00218257|1777181|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3
823305|NCT00218296|1777192|FG000|Overall Study|Lost to Follow-up|9
823306|NCT00218296|1777193|FG001|Overall Study|Lost to Follow-up|7
823307|NCT00218296|1777192|FG000|Overall Study|Withdrawal by Subject|36
823308|NCT00218296|1777193|FG001|Overall Study|Withdrawal by Subject|47
823309|NCT00218296|1777192|FG000|Overall Study|Randomized but did not enter treatment|66
823310|NCT00218296|1777193|FG001|Overall Study|Randomized but did not enter treatment|67
823311|NCT00218543|1777288|FG000|Overall Study|Lost to Follow-up|8
823312|NCT00218543|1777288|FG000|Overall Study|relocated|1
823313|NCT00218543|1777288|FG000|Overall Study|Withdrawal by Subject|1
823314|NCT00218543|1777288|FG000|Overall Study|Physician Decision|3
823315|NCT00218543|1777288|FG000|Overall Study|Adverse Event|2
823316|NCT00218634|1777294|FG000|Overall Study|Lost to Follow-up|8
823317|NCT00218634|1777295|FG001|Overall Study|Lost to Follow-up|15
823318|NCT00219141|1777307|FG000|Overall Study|Adverse Event|4
823319|NCT00219141|1777308|FG001|Overall Study|Adverse Event|10
823320|NCT00219141|1777309|FG002|Overall Study|Adverse Event|5
823321|NCT00219141|1777307|FG000|Overall Study|Lack of Efficacy|3
823322|NCT00219141|1777308|FG001|Overall Study|Lack of Efficacy|2
823323|NCT00219141|1777309|FG002|Overall Study|Lack of Efficacy|0
823324|NCT00219141|1777307|FG000|Overall Study|Administrative problems|0
823325|NCT00219141|1777308|FG001|Overall Study|Administrative problems|1
823326|NCT00219141|1777309|FG002|Overall Study|Administrative problems|0
823327|NCT00219141|1777307|FG000|Overall Study|Lost to Follow-up|2
823328|NCT00219141|1777308|FG001|Overall Study|Lost to Follow-up|4
823329|NCT00219141|1777309|FG002|Overall Study|Lost to Follow-up|1
823330|NCT00219141|1777307|FG000|Overall Study|Protocol Violation|3
823331|NCT00219141|1777308|FG001|Overall Study|Protocol Violation|1
823332|NCT00219141|1777309|FG002|Overall Study|Protocol Violation|1
823333|NCT00219141|1777307|FG000|Overall Study|Withdrawal by Subject|1
823334|NCT00219141|1777308|FG001|Overall Study|Withdrawal by Subject|3
823335|NCT00219141|1777309|FG002|Overall Study|Withdrawal by Subject|5
823336|NCT00219141|1777307|FG000|Overall Study|Condition no longer requires study drug|1
823337|NCT00219141|1777308|FG001|Overall Study|Condition no longer requires study drug|0
823338|NCT00219141|1777309|FG002|Overall Study|Condition no longer requires study drug|0
823339|NCT00219284|1777319|FG000|Treatment Phase - 16 Weeks|Adverse Event|26
823340|NCT00219284|1777320|FG001|Treatment Phase - 16 Weeks|Adverse Event|24
823341|NCT00219284|1777319|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
823342|NCT00219284|1777320|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
823343|NCT00219284|1777319|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3
823344|NCT00219284|1777320|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10
823345|NCT00219284|1777319|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9
823346|NCT00219284|1777320|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5
823347|NCT00219284|1777319|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
823348|NCT00219284|1777320|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
823349|NCT00219284|1777319|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1
823350|NCT00219284|1777320|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2
823351|NCT00219284|1777319|FG000|Extension Phase - 8 Weeks|Adverse Event|2
823352|NCT00219284|1777320|FG001|Extension Phase - 8 Weeks|Adverse Event|3
823353|NCT00219284|1777319|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0
823354|NCT00219284|1777320|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2
823355|NCT00219284|1777319|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0
823356|NCT00219284|1777320|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2
823357|NCT00219349|1777326|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
823358|NCT00219349|1777326|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
823359|NCT00219349|1777326|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2
823360|NCT00219349|1777326|FG000|Escitalopram Phase|Withdrawal by Subject|3
823361|NCT00219544|1777330|FG000|Single Blind Treatment Period|Lack of Efficacy|5
823362|NCT00219544|1777331|FG001|Single Blind Treatment Period|Lack of Efficacy|0
823363|NCT00219544|1777330|FG000|Single Blind Treatment Period|Adverse Event|9
823364|NCT00219544|1777331|FG001|Single Blind Treatment Period|Adverse Event|0
823365|NCT00219544|1777330|FG000|Single Blind Treatment Period|Protocol Violation|4
823366|NCT00219544|1777331|FG001|Single Blind Treatment Period|Protocol Violation|0
823367|NCT00219544|1777330|FG000|Single Blind Treatment Period|Lost to Follow-up|2
823368|NCT00219544|1777331|FG001|Single Blind Treatment Period|Lost to Follow-up|0
823369|NCT00219544|1777330|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1
823370|NCT00219544|1777331|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0
823371|NCT00219544|1777330|FG000|Single Blind Treatment Period|Withdrawal by Subject|1
823372|NCT00219544|1777331|FG001|Single Blind Treatment Period|Withdrawal by Subject|0
823373|NCT00219557|1777342|FG000|Phase 1|Lack of Efficacy|3
823374|NCT00219557|1777343|FG001|Phase 1|Lack of Efficacy|0
823375|NCT00219557|1777344|FG002|Phase 1|Lack of Efficacy|0
823376|NCT00219557|1777342|FG000|Phase 1|Adverse Event|2
823377|NCT00219557|1777343|FG001|Phase 1|Adverse Event|0
823378|NCT00219557|1777344|FG002|Phase 1|Adverse Event|0
823379|NCT00219557|1777342|FG000|Phase 1|Withdrawal by Subject|1
823380|NCT00219557|1777343|FG001|Phase 1|Withdrawal by Subject|0
823381|NCT00219557|1777344|FG002|Phase 1|Withdrawal by Subject|0
823382|NCT00219557|1777342|FG000|Phase 1|Started chemotherapy at other institute|1
823383|NCT00219557|1777343|FG001|Phase 1|Started chemotherapy at other institute|0
823384|NCT00219557|1777344|FG002|Phase 1|Started chemotherapy at other institute|0
823385|NCT00219557|1777342|FG000|Phase 2|Lack of Efficacy|0
823386|NCT00219557|1777343|FG001|Phase 2|Lack of Efficacy|21
823387|NCT00219557|1777344|FG002|Phase 2|Lack of Efficacy|15
823388|NCT00219557|1777342|FG000|Phase 2|Adverse Event|0
823389|NCT00219557|1777343|FG001|Phase 2|Adverse Event|22
823390|NCT00219557|1777344|FG002|Phase 2|Adverse Event|2
823391|NCT00219557|1777342|FG000|Phase 2|Death|0
823392|NCT00219557|1777343|FG001|Phase 2|Death|8
823393|NCT00219557|1777344|FG002|Phase 2|Death|2
823394|NCT00219557|1777342|FG000|Phase 2|Other|0
823395|NCT00219557|1777343|FG001|Phase 2|Other|8
823396|NCT00219557|1777344|FG002|Phase 2|Other|6
823397|NCT00219557|1777342|FG000|Phase 2|Withdrawal by Subject|0
823398|NCT00219557|1777343|FG001|Phase 2|Withdrawal by Subject|9
823399|NCT00219557|1777344|FG002|Phase 2|Withdrawal by Subject|5
823400|NCT00219557|1777342|FG000|Phase 2|Treatment not received|0
823401|NCT00219557|1777343|FG001|Phase 2|Treatment not received|1
823402|NCT00219557|1777344|FG002|Phase 2|Treatment not received|3
823403|NCT00220636|1777353|FG000|Overall Study|Withdrawal by Subject|4
823404|NCT00220701|1777360|FG000|Overall Study|Lost to Follow-up|5
823405|NCT00220701|1777361|FG001|Overall Study|Lost to Follow-up|4
823406|NCT00220727|1777369|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1
823407|NCT00220727|1777370|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0
823408|NCT00220740|1777380|FG000|Efficacy Period|Entered rescue treatment with placebo|23
823409|NCT00220740|1777381|FG001|Efficacy Period|Entered rescue treatment with placebo|0
823410|NCT00220740|1777380|FG000|Efficacy Period|Adverse Event|1
823411|NCT00220740|1777381|FG001|Efficacy Period|Adverse Event|1
823412|NCT00220740|1777380|FG000|Efficacy Period|Withdrawal by Subject|1
823413|NCT00220740|1777381|FG001|Efficacy Period|Withdrawal by Subject|0
823414|NCT00220740|1777380|FG000|Efficacy Period|Protocol Violation|1
823415|NCT00220740|1777381|FG001|Efficacy Period|Protocol Violation|0
823416|NCT00220740|1777380|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
823417|NCT00220740|1777381|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
823418|NCT00220779|1777392|FG000|Overall Study|Adverse Event|1
823419|NCT00220779|1777393|FG001|Overall Study|Adverse Event|0
823420|NCT00220779|1777394|FG002|Overall Study|Adverse Event|0
823421|NCT00220779|1777392|FG000|Overall Study|Withdrawal by Subject|1
823422|NCT00220779|1777393|FG001|Overall Study|Withdrawal by Subject|4
823423|NCT00220779|1777394|FG002|Overall Study|Withdrawal by Subject|1
823424|NCT00220779|1777392|FG000|Overall Study|Non-compliance|1
823425|NCT00220779|1777393|FG001|Overall Study|Non-compliance|0
823426|NCT00220779|1777394|FG002|Overall Study|Non-compliance|0
823427|NCT00220779|1777392|FG000|Overall Study|Too time consuming|1
823428|NCT00220779|1777393|FG001|Overall Study|Too time consuming|0
823429|NCT00220779|1777394|FG002|Overall Study|Too time consuming|0
823430|NCT00220779|1777392|FG000|Overall Study|Pregnancy|0
823431|NCT00220779|1777393|FG001|Overall Study|Pregnancy|0
823432|NCT00220779|1777394|FG002|Overall Study|Pregnancy|2
823433|NCT00220779|1777392|FG000|Overall Study|Lack of Efficacy|3
823434|NCT00220779|1777393|FG001|Overall Study|Lack of Efficacy|0
823435|NCT00220779|1777394|FG002|Overall Study|Lack of Efficacy|1
823436|NCT00220805|1777404|FG000|Overall Study|Adverse Event|1
823437|NCT00220805|1777405|FG001|Overall Study|Adverse Event|3
823438|NCT00220805|1777404|FG000|Overall Study|Withdrawal by Subject|3
823439|NCT00220805|1777405|FG001|Overall Study|Withdrawal by Subject|0
823440|NCT00220805|1777404|FG000|Overall Study|Lack of Efficacy|1
823441|NCT00220805|1777405|FG001|Overall Study|Lack of Efficacy|0
823442|NCT00220805|1777404|FG000|Overall Study|Develop. of choroidal neovascularization|3
823443|NCT00220805|1777405|FG001|Overall Study|Develop. of choroidal neovascularization|8
823444|NCT00221104|1777422|FG000|Overall Study|Adverse Event|1
823445|NCT00221104|1777423|FG001|Overall Study|Adverse Event|0
823446|NCT00221104|1777422|FG000|Overall Study|Physician Decision|1
823447|NCT00221104|1777423|FG001|Overall Study|Physician Decision|0
823448|NCT00221104|1777422|FG000|Overall Study|Protocol Violation|2
823449|NCT00221104|1777423|FG001|Overall Study|Protocol Violation|0
823450|NCT00221104|1777422|FG000|Overall Study|Withdrawal by Subject|42
823451|NCT00221104|1777423|FG001|Overall Study|Withdrawal by Subject|29
823452|NCT00221104|1777422|FG000|Overall Study|Others|37
823453|NCT00221104|1777423|FG001|Overall Study|Others|47
823454|NCT00221195|1777444|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
823455|NCT00221195|1777445|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
823456|NCT00221195|1777444|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0
823457|NCT00221195|1777445|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1
823458|NCT00221195|1777444|FG000|Washout Period (Months 7-9)|Death|0
823459|NCT00221195|1777445|FG001|Washout Period (Months 7-9)|Death|1
823460|NCT00221195|1777444|FG000|Therapy 2 (Months 10-15)|Death|1
823461|NCT00221195|1777445|FG001|Therapy 2 (Months 10-15)|Death|0
823462|NCT00221195|1777444|FG000|Therapy 2 (Months 10-15)|Adverse Event|1
823463|NCT00221195|1777445|FG001|Therapy 2 (Months 10-15)|Adverse Event|0
823464|NCT00221403|1777478|FG000|Overall Study|Protocol Violation|1
823465|NCT00221403|1777479|FG001|Overall Study|Protocol Violation|0
823466|NCT00221403|1777480|FG002|Overall Study|Protocol Violation|0
823467|NCT00221403|1777478|FG000|Overall Study|Physician Decision|1
823468|NCT00221403|1777479|FG001|Overall Study|Physician Decision|0
823469|NCT00221403|1777480|FG002|Overall Study|Physician Decision|0
823470|NCT00221403|1777478|FG000|Overall Study|Withdrawal by Subject|0
823471|NCT00221403|1777479|FG001|Overall Study|Withdrawal by Subject|3
823472|NCT00221403|1777480|FG002|Overall Study|Withdrawal by Subject|0
823473|NCT00221403|1777478|FG000|Overall Study|Lack of Efficacy|0
823474|NCT00221403|1777479|FG001|Overall Study|Lack of Efficacy|1
823475|NCT00221403|1777480|FG002|Overall Study|Lack of Efficacy|0
823476|NCT00221403|1777478|FG000|Overall Study|Adverse Event|0
823477|NCT00221403|1777479|FG001|Overall Study|Adverse Event|1
823478|NCT00221403|1777480|FG002|Overall Study|Adverse Event|0
823479|NCT00222105|1777488|FG000|Overall Study|Removed due to wrong diagnosis|1
823480|NCT00222105|1777488|FG000|Overall Study|Withdrawal by Subject|1
823481|NCT00222105|1777488|FG000|Overall Study|Adverse Event|8
823482|NCT00222105|1777488|FG000|Overall Study|Treatment delays|2
823483|NCT00222105|1777488|FG000|Overall Study|Death|2
823484|NCT00222729|1777501|FG000|Overall Study|Adverse Event|3
823485|NCT00223080|1777507|FG000|Overall Study|Withdrawal by Subject|253
823486|NCT00223080|1777508|FG001|Overall Study|Withdrawal by Subject|232
823487|NCT00223080|1777507|FG000|Overall Study|Required contraindicated med|0
823488|NCT00223080|1777508|FG001|Overall Study|Required contraindicated med|1
823489|NCT00223080|1777507|FG000|Overall Study|Non-compliant|7
823490|NCT00223080|1777508|FG001|Overall Study|Non-compliant|7
823491|NCT00223080|1777507|FG000|Overall Study|Moved from study area|37
823492|NCT00223080|1777508|FG001|Overall Study|Moved from study area|47
823493|NCT00223080|1777507|FG000|Overall Study|Lost to Follow-up|259
823494|NCT00223080|1777508|FG001|Overall Study|Lost to Follow-up|284
823495|NCT00223080|1777507|FG000|Overall Study|Death|85
823496|NCT00223080|1777508|FG001|Overall Study|Death|74
823497|NCT00223080|1777507|FG000|Overall Study|Other|14
823498|NCT00223080|1777508|FG001|Overall Study|Other|11
823499|NCT00223080|1777507|FG000|Overall Study|Reason not provided|141
823500|NCT00223080|1777508|FG001|Overall Study|Reason not provided|140
823501|NCT00223080|1777507|FG000|Overall Study|Adverse Event|0
823502|NCT00223080|1777508|FG001|Overall Study|Adverse Event|1
823503|NCT00223496|1777532|FG000|Overall Study|screen failure|9
823504|NCT00223496|1777532|FG000|Overall Study|Lost to Follow-up|4
823505|NCT00223496|1777532|FG000|Overall Study|Lack of Efficacy|6
823506|NCT00223496|1777532|FG000|Overall Study|Withdrawal by Subject|1
823507|NCT00223496|1777532|FG000|Overall Study|Physician Decision|2
823508|NCT00223795|1777573|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7
823509|NCT00223795|1777574|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9
823510|NCT00223795|1777573|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
823511|NCT00223795|1777574|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
823512|NCT00223808|1777584|FG000|Overall Study|<5 hrs therapy before discharge|3
823513|NCT00223808|1777585|FG001|Overall Study|<5 hrs therapy before discharge|5
823514|NCT00223808|1777586|FG002|Overall Study|<5 hrs therapy before discharge|5
823515|NCT00223977|1777606|FG000|Overall Study|Adverse Event|7
823516|NCT00223977|1777607|FG001|Overall Study|Adverse Event|10
823517|NCT00223977|1777608|FG002|Overall Study|Adverse Event|0
823518|NCT00223977|1777606|FG000|Overall Study|Protocol Violation|0
823519|NCT00223977|1777607|FG001|Overall Study|Protocol Violation|0
823520|NCT00223977|1777608|FG002|Overall Study|Protocol Violation|1
823521|NCT00223977|1777606|FG000|Overall Study|Withdrawal by Subject|1
823522|NCT00223977|1777607|FG001|Overall Study|Withdrawal by Subject|1
823523|NCT00223977|1777608|FG002|Overall Study|Withdrawal by Subject|2
823524|NCT00223977|1777606|FG000|Overall Study|Other|1
823525|NCT00223977|1777607|FG001|Overall Study|Other|0
823526|NCT00223977|1777608|FG002|Overall Study|Other|0
823527|NCT00223990|1777618|FG000|Overall Study|Moved from area|2
823528|NCT00223990|1777619|FG001|Overall Study|Moved from area|1
823529|NCT00223990|1777618|FG000|Overall Study|Withdrawal by Subject|4
823530|NCT00223990|1777619|FG001|Overall Study|Withdrawal by Subject|8
823531|NCT00223990|1777618|FG000|Overall Study|Lost to Follow-up|1
823532|NCT00223990|1777619|FG001|Overall Study|Lost to Follow-up|0
823533|NCT00224003|1777625|FG000|Overall Study|Adverse Event|1
823534|NCT00224003|1777625|FG000|Overall Study|Protocol Violation|2
823535|NCT00224003|1777625|FG000|Overall Study|Withdrawal by Subject|1
823536|NCT00224003|1777625|FG000|Overall Study|unk|3
823537|NCT00224016|1777630|FG000|Titration Period|Withdrawal by Subject|0
823538|NCT00224016|1777631|FG001|Titration Period|Withdrawal by Subject|1
823539|NCT00224016|1777630|FG000|Titration Period|Lost to Follow-up|1
823540|NCT00224016|1777631|FG001|Titration Period|Lost to Follow-up|0
823541|NCT00224016|1777630|FG000|Maintenance Period|Withdrawal by Subject|2
823542|NCT00224016|1777631|FG001|Maintenance Period|Withdrawal by Subject|0
823543|NCT00224016|1777630|FG000|Maintenance Period|Lost to Follow-up|0
823544|NCT00224016|1777631|FG001|Maintenance Period|Lost to Follow-up|1
823545|NCT00224029|1777637|FG000|Overall Study|Lost to Follow-up|1
823546|NCT00224029|1777637|FG000|Overall Study|Withdrawal by Subject|4
823547|NCT00224029|1777637|FG000|Overall Study|Other|1
823548|NCT00224042|1777643|FG000|Overall Study|Adverse Event|2
823549|NCT00224042|1777644|FG001|Overall Study|Adverse Event|1
823550|NCT00224042|1777643|FG000|Overall Study|Protocol Violation|0
823551|NCT00224042|1777644|FG001|Overall Study|Protocol Violation|1
823552|NCT00224042|1777643|FG000|Overall Study|Physician Decision|0
823553|NCT00224042|1777644|FG001|Overall Study|Physician Decision|1
823554|NCT00224042|1777643|FG000|Overall Study|Did not meet lab incusion criteria|2
823555|NCT00224042|1777644|FG001|Overall Study|Did not meet lab incusion criteria|3
823556|NCT00224042|1777643|FG000|Overall Study|Other|2
823557|NCT00224042|1777644|FG001|Overall Study|Other|0
823558|NCT00224055|1777652|FG000|Overall Study|Adverse Event|9
823559|NCT00224055|1777653|FG001|Overall Study|Adverse Event|3
823560|NCT00224055|1777652|FG000|Overall Study|Lost to Follow-up|1
823561|NCT00224055|1777653|FG001|Overall Study|Lost to Follow-up|2
823562|NCT00224055|1777652|FG000|Overall Study|Protocol Violation|1
823563|NCT00224055|1777653|FG001|Overall Study|Protocol Violation|1
823564|NCT00224055|1777652|FG000|Overall Study|Inclusion Violation|3
823565|NCT00224055|1777653|FG001|Overall Study|Inclusion Violation|6
823566|NCT00224055|1777652|FG000|Overall Study|Withdrawal by Subject|0
823567|NCT00224055|1777653|FG001|Overall Study|Withdrawal by Subject|2
823568|NCT00224055|1777652|FG000|Overall Study|Other|1
823569|NCT00224055|1777653|FG001|Overall Study|Other|0
823570|NCT00224107|1777661|FG000|Overall Study|Adverse Event|20
823571|NCT00224107|1777662|FG001|Overall Study|Adverse Event|6
823572|NCT00224107|1777661|FG000|Overall Study|Protocol Violation|2
823573|NCT00224107|1777662|FG001|Overall Study|Protocol Violation|3
823574|NCT00224107|1777661|FG000|Overall Study|Withdrawal by Subject|1
823575|NCT00224107|1777662|FG001|Overall Study|Withdrawal by Subject|4
823576|NCT00224107|1777661|FG000|Overall Study|Lack of Efficacy|2
823577|NCT00224107|1777662|FG001|Overall Study|Lack of Efficacy|0
823578|NCT00224107|1777661|FG000|Overall Study|Lost to Follow-up|4
823579|NCT00224107|1777662|FG001|Overall Study|Lost to Follow-up|0
823580|NCT00224107|1777661|FG000|Overall Study|Physician Decision|1
823581|NCT00224107|1777662|FG001|Overall Study|Physician Decision|0
823582|NCT00224107|1777661|FG000|Overall Study|Other|1
823583|NCT00224107|1777662|FG001|Overall Study|Other|1
823584|NCT00224120|1777670|FG000|Overall Study|Adverse Event|10
823585|NCT00224120|1777671|FG001|Overall Study|Adverse Event|4
823586|NCT00224120|1777670|FG000|Overall Study|Protocol Violation|1
823587|NCT00224120|1777671|FG001|Overall Study|Protocol Violation|0
823588|NCT00224120|1777670|FG000|Overall Study|Withdrawal by Subject|5
823589|NCT00224120|1777671|FG001|Overall Study|Withdrawal by Subject|10
823590|NCT00224120|1777670|FG000|Overall Study|Lack of Efficacy|0
823591|NCT00224120|1777671|FG001|Overall Study|Lack of Efficacy|2
823592|NCT00224120|1777670|FG000|Overall Study|Lost to Follow-up|2
823593|NCT00224120|1777671|FG001|Overall Study|Lost to Follow-up|3
823594|NCT00224120|1777670|FG000|Overall Study|Other|4
823595|NCT00224120|1777671|FG001|Overall Study|Other|5
823596|NCT00224133|1777677|FG000|Overall Study|Adverse Event|93
823597|NCT00224133|1777677|FG000|Overall Study|Protocol Violation|6
823598|NCT00224133|1777677|FG000|Overall Study|Withdrawal by Subject|33
823599|NCT00224133|1777677|FG000|Overall Study|Lack of Efficacy|58
823600|NCT00224133|1777677|FG000|Overall Study|Lost to Follow-up|21
823601|NCT00224133|1777677|FG000|Overall Study|Physician Decision|1
823602|NCT00224133|1777677|FG000|Overall Study|Other|14
823603|NCT00224484|1777688|FG000|Overall Study|Serious Adverse Event|1
823604|NCT00224484|1777689|FG001|Overall Study|Serious Adverse Event|1
823605|NCT00224484|1777690|FG002|Overall Study|Serious Adverse Event|0
823606|NCT00224484|1777688|FG000|Overall Study|Non-Serious Adverse Event|5
823607|NCT00224484|1777689|FG001|Overall Study|Non-Serious Adverse Event|7
823608|NCT00224484|1777690|FG002|Overall Study|Non-Serious Adverse Event|3
823609|NCT00224484|1777688|FG000|Overall Study|Protocol Violation|2
823610|NCT00224484|1777689|FG001|Overall Study|Protocol Violation|2
823611|NCT00224484|1777690|FG002|Overall Study|Protocol Violation|0
823612|NCT00224484|1777688|FG000|Overall Study|Withdrawal by Subject|49
823613|NCT00224484|1777689|FG001|Overall Study|Withdrawal by Subject|18
823614|NCT00224484|1777690|FG002|Overall Study|Withdrawal by Subject|16
823615|NCT00224484|1777688|FG000|Overall Study|Migrated/moved from study area|18
823616|NCT00224484|1777689|FG001|Overall Study|Migrated/moved from study area|5
823617|NCT00224484|1777690|FG002|Overall Study|Migrated/moved from study area|5
823618|NCT00224484|1777688|FG000|Overall Study|Lost to Follow-up|66
823619|NCT00224484|1777689|FG001|Overall Study|Lost to Follow-up|28
823620|NCT00224484|1777690|FG002|Overall Study|Lost to Follow-up|36
823621|NCT00224484|1777688|FG000|Overall Study|Reason not specified|5
823622|NCT00224484|1777689|FG001|Overall Study|Reason not specified|4
823623|NCT00224484|1777690|FG002|Overall Study|Reason not specified|2
823624|NCT00224770|1777704|FG000|Overall Study|Lost to Follow-up|4
823625|NCT00224770|1777705|FG001|Overall Study|Lost to Follow-up|2
823626|NCT00224770|1777706|FG002|Overall Study|Lost to Follow-up|0
823627|NCT00224874|1777719|FG000|Overall Study|Withdrawal by Subject|0
823628|NCT00224874|1777720|FG001|Overall Study|Withdrawal by Subject|0
823629|NCT00224874|1777721|FG002|Overall Study|Withdrawal by Subject|1
823630|NCT00224874|1777722|FG003|Overall Study|Withdrawal by Subject|0
823631|NCT00224887|1777734|FG000|Overall Study|Pregnancy|6
823632|NCT00224887|1777735|FG001|Overall Study|Pregnancy|6
823633|NCT00225147|1777768|FG000|Open-label Phase|Lost to Follow-up|0
823634|NCT00225147|1777769|FG001|Open-label Phase|Lost to Follow-up|0
823635|NCT00225147|1777770|FG002|Open-label Phase|Lost to Follow-up|0
823636|NCT00225147|1777771|FG003|Open-label Phase|Lost to Follow-up|4
823637|NCT00225147|1777768|FG000|Open-label Phase|Withdrawal by Subject|0
823638|NCT00225147|1777769|FG001|Open-label Phase|Withdrawal by Subject|0
823639|NCT00225147|1777770|FG002|Open-label Phase|Withdrawal by Subject|0
823640|NCT00225147|1777771|FG003|Open-label Phase|Withdrawal by Subject|6
823641|NCT00225212|1777783|FG000|Overall Study|Disease progression|2
823642|NCT00225212|1777783|FG000|Overall Study|Death|1
823643|NCT00225212|1777783|FG000|Overall Study|Adverse Event|2
823644|NCT00225212|1777783|FG000|Overall Study|Intercurrent illness|1
823645|NCT00225251|1777789|FG000|Overall Study|Withdrawal by Subject|1
823646|NCT00225251|1777790|FG001|Overall Study|Withdrawal by Subject|1
823647|NCT00225277|1777798|FG000|Overall Study|Adverse Event|30
823648|NCT00225277|1777799|FG001|Overall Study|Adverse Event|34
823649|NCT00225277|1777798|FG000|Overall Study|Lack of Efficacy|4
823650|NCT00225277|1777799|FG001|Overall Study|Lack of Efficacy|1
823651|NCT00225277|1777798|FG000|Overall Study|Lost to Follow-up|4
823652|NCT00225277|1777799|FG001|Overall Study|Lost to Follow-up|6
823653|NCT00225277|1777798|FG000|Overall Study|Physician Decision|6
823654|NCT00225277|1777799|FG001|Overall Study|Physician Decision|8
823655|NCT00225277|1777798|FG000|Overall Study|Protocol Violation|6
823656|NCT00225277|1777799|FG001|Overall Study|Protocol Violation|3
823657|NCT00225277|1777798|FG000|Overall Study|Withdrawal by Subject|40
823658|NCT00225277|1777799|FG001|Overall Study|Withdrawal by Subject|34
823659|NCT00225277|1777798|FG000|Overall Study|Other|7
823660|NCT00225277|1777799|FG001|Overall Study|Other|9
823661|NCT00225758|1777827|FG000|Overall Study|Adverse Event|4
823662|NCT00226499|1777848|FG000|Overall Study|Adverse Event|10
823663|NCT00226499|1777849|FG001|Overall Study|Adverse Event|6
823664|NCT00226499|1777850|FG002|Overall Study|Adverse Event|3
823665|NCT00226499|1777848|FG000|Overall Study|Others|1064
823666|NCT00226499|1777849|FG001|Overall Study|Others|1066
823667|NCT00226499|1777850|FG002|Overall Study|Others|356
823668|NCT00226655|1777869|FG000|Overall Study|Death|13
823669|NCT00226655|1777869|FG000|Overall Study|Withdrawal by Subject|15
823670|NCT00226655|1777869|FG000|Overall Study|Adverse Event|35
823671|NCT00226655|1777869|FG000|Overall Study|Physician Decision|6
823672|NCT00226655|1777869|FG000|Overall Study|Clinical deterioration|10
823673|NCT00226811|1777873|FG000|Overall Study|Death|8
823674|NCT00226811|1777873|FG000|Overall Study|Adverse Event|11
823675|NCT00226811|1777873|FG000|Overall Study|Lack of Efficacy|55
823676|NCT00226811|1777873|FG000|Overall Study|Withdrawal by Subject|2
823677|NCT00226941|1777881|FG000|Overall Study|Withdrawal by subject - toxicity|0
823678|NCT00226941|1777882|FG001|Overall Study|Withdrawal by subject - toxicity|0
823679|NCT00226941|1777883|FG002|Overall Study|Withdrawal by subject - toxicity|0
823680|NCT00226941|1777884|FG003|Overall Study|Withdrawal by subject - toxicity|1
823681|NCT00226941|1777881|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0
823682|NCT00226941|1777882|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0
823683|NCT00226941|1777883|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0
823684|NCT00226941|1777884|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1
823685|NCT00227266|1777908|FG000|Overall Study|Withdrawal by Subject|0
823686|NCT00227266|1777909|FG001|Overall Study|Withdrawal by Subject|0
823687|NCT00227266|1777910|FG002|Overall Study|Withdrawal by Subject|1
823688|NCT00227266|1777908|FG000|Overall Study|Protocol Violation|1
823689|NCT00227266|1777909|FG001|Overall Study|Protocol Violation|0
823690|NCT00227266|1777910|FG002|Overall Study|Protocol Violation|1
823691|NCT00227266|1777908|FG000|Overall Study|Excessive weight gain|0
823692|NCT00227266|1777909|FG001|Overall Study|Excessive weight gain|0
823693|NCT00227266|1777910|FG002|Overall Study|Excessive weight gain|2
823694|NCT00227305|1777921|FG000|Overall Study|Adverse Event|40
823695|NCT00227305|1777921|FG000|Overall Study|Withdrawal by Subject|42
823696|NCT00227305|1777921|FG000|Overall Study|Lost to Follow-up|33
823697|NCT00227305|1777921|FG000|Overall Study|Study specific discontinuation|13
823698|NCT00227305|1777921|FG000|Overall Study|MOVED OUT OF AREA|3
823699|NCT00227305|1777921|FG000|Overall Study|Lack of Efficacy|7
823700|NCT00227305|1777921|FG000|Overall Study|Physician Decision|3
823701|NCT00227305|1777921|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
823702|NCT00227305|1777921|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
823703|NCT00227305|1777921|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
823704|NCT00227344|1777927|FG000|Overall Study|study terminated early|12
823705|NCT00227344|1777928|FG001|Overall Study|study terminated early|5
823706|NCT00227370|1777936|FG000|Overall Study|Withdrawal by Subject|1
823707|NCT00227370|1777937|FG001|Overall Study|Withdrawal by Subject|2
823708|NCT00227370|1777936|FG000|Overall Study|Death|3
823709|NCT00227370|1777937|FG001|Overall Study|Death|4
823710|NCT00227370|1777936|FG000|Overall Study|Adverse Event|6
823711|NCT00227370|1777937|FG001|Overall Study|Adverse Event|11
823712|NCT00227370|1777936|FG000|Overall Study|Physician Decision|9
823713|NCT00227370|1777937|FG001|Overall Study|Physician Decision|6
823714|NCT00227370|1777936|FG000|Overall Study|Other reasons|2
823715|NCT00227370|1777937|FG001|Overall Study|Other reasons|1
823716|NCT00227539|1777943|FG000|Overall Study|Protocol Violation|1
823717|NCT00227591|1777947|FG000|Overall Study|Withdrawal by Subject|1
823718|NCT00227721|1777965|FG000|Overall Study|On study, but never treated.|1
823719|NCT00227877|1777977|FG000|Pre-visit Assessment|Technical difficulties|7
823720|NCT00227877|1777978|FG001|Pre-visit Assessment|Technical difficulties|3
823721|NCT00227877|1777979|FG002|Pre-visit Assessment|Technical difficulties|0
823722|NCT00227877|1777980|FG003|Pre-visit Assessment|Technical difficulties|0
823723|NCT00227877|1777977|FG000|Post-visit Checklist|Lost to Follow-up|24
823724|NCT00227877|1777978|FG001|Post-visit Checklist|Lost to Follow-up|13
823725|NCT00227877|1777979|FG002|Post-visit Checklist|Lost to Follow-up|1
823726|NCT00227877|1777980|FG003|Post-visit Checklist|Lost to Follow-up|0
823727|NCT00227877|1777977|FG000|3-months Follow-up|Completed late|135
823728|NCT00227877|1777978|FG001|3-months Follow-up|Completed late|128
823729|NCT00227877|1777979|FG002|3-months Follow-up|Completed late|34
823730|NCT00227877|1777980|FG003|3-months Follow-up|Completed late|8
823731|NCT00227877|1777977|FG000|3-months Follow-up|Lost to Follow-up|178
823732|NCT00227877|1777978|FG001|3-months Follow-up|Lost to Follow-up|139
823733|NCT00227877|1777979|FG002|3-months Follow-up|Lost to Follow-up|18
823734|NCT00227877|1777980|FG003|3-months Follow-up|Lost to Follow-up|13
823735|NCT00227877|1777977|FG000|12-months Follow-up|Completed late|78
823736|NCT00227877|1777978|FG001|12-months Follow-up|Completed late|74
823737|NCT00227877|1777979|FG002|12-months Follow-up|Completed late|1
823738|NCT00227877|1777980|FG003|12-months Follow-up|Completed late|0
823739|NCT00227877|1777977|FG000|12-months Follow-up|Lost to Follow-up|232
823740|NCT00227877|1777978|FG001|12-months Follow-up|Lost to Follow-up|189
823741|NCT00227877|1777979|FG002|12-months Follow-up|Lost to Follow-up|30
823742|NCT00227877|1777980|FG003|12-months Follow-up|Lost to Follow-up|26
823743|NCT00227903|1777994|FG000|Overall Study|Withdrawal by Subject|2
823744|NCT00227903|1777995|FG001|Overall Study|Withdrawal by Subject|5
823745|NCT00227903|1777994|FG000|Overall Study|Subject moved out of area|1
823746|NCT00227903|1777995|FG001|Overall Study|Subject moved out of area|2
823747|NCT00227903|1777994|FG000|Overall Study|Lost to Follow-up|1
823748|NCT00227903|1777995|FG001|Overall Study|Lost to Follow-up|3
823749|NCT00227903|1777994|FG000|Overall Study|Miscarriage|1
823750|NCT00227903|1777995|FG001|Overall Study|Miscarriage|0
823751|NCT00228384|1778012|FG000|Overall Study|Death|9
823752|NCT00228384|1778013|FG001|Overall Study|Death|3
823753|NCT00228384|1778012|FG000|Overall Study|Lost to Follow-up|6
823754|NCT00228384|1778013|FG001|Overall Study|Lost to Follow-up|10
823755|NCT00228384|1778012|FG000|Overall Study|Surgical Intervention (bypass)|5
823756|NCT00228384|1778013|FG001|Overall Study|Surgical Intervention (bypass)|5
823757|NCT00228384|1778012|FG000|Overall Study|Withdrawal by Subject|9
823758|NCT00228384|1778013|FG001|Overall Study|Withdrawal by Subject|10
823759|NCT00228384|1778012|FG000|Overall Study|Physician Decision|0
823760|NCT00228384|1778013|FG001|Overall Study|Physician Decision|1
823761|NCT00228423|1778021|FG000|Overall Study|Adverse Event|2
823762|NCT00228423|1778022|FG001|Overall Study|Adverse Event|5
823763|NCT00228423|1778021|FG000|Overall Study|Withdrawal by Subject|7
823764|NCT00228423|1778022|FG001|Overall Study|Withdrawal by Subject|3
823765|NCT00228423|1778021|FG000|Overall Study|Protocol Violation|1
823766|NCT00228423|1778022|FG001|Overall Study|Protocol Violation|3
823767|NCT00228423|1778021|FG000|Overall Study|Physician Decision|0
823768|NCT00228423|1778022|FG001|Overall Study|Physician Decision|1
823769|NCT00228553|1778028|FG000|Overall Study|Adverse Event|112
823770|NCT00228553|1778028|FG000|Overall Study|Lack of Efficacy|34
823771|NCT00228553|1778028|FG000|Overall Study|Lost to Follow-up|67
823772|NCT00228553|1778028|FG000|Overall Study|Physician Decision|48
823773|NCT00228553|1778028|FG000|Overall Study|Protocol Violation|6
823774|NCT00228553|1778028|FG000|Overall Study|Withdrawal by Subject|115
823775|NCT00228553|1778028|FG000|Overall Study|Pregnancy|2
823776|NCT00228553|1778028|FG000|Overall Study|Miscellaneous|46
823777|NCT00228566|1778032|FG000|Overall Study|Adverse Event|31
823778|NCT00228566|1778032|FG000|Overall Study|Lack of Efficacy|14
823779|NCT00228566|1778032|FG000|Overall Study|Lost to Follow-up|16
823780|NCT00228566|1778032|FG000|Overall Study|Physician Decision|5
823781|NCT00228566|1778032|FG000|Overall Study|Withdrawal by Subject|4
823782|NCT00228566|1778032|FG000|Overall Study|Miscellaneous|1
823783|NCT00228813|1778036|FG000|Overall Study|Death|4
823784|NCT00228917|1778048|FG000|Overall Study|Migrated/moved from study area|0
823785|NCT00228917|1778049|FG001|Overall Study|Migrated/moved from study area|0
823786|NCT00228917|1778050|FG002|Overall Study|Migrated/moved from study area|0
823787|NCT00228917|1778051|FG003|Overall Study|Migrated/moved from study area|0
823788|NCT00228917|1778052|FG004|Overall Study|Migrated/moved from study area|0
823789|NCT00228917|1778053|FG005|Overall Study|Migrated/moved from study area|2
823790|NCT00228917|1778054|FG006|Overall Study|Migrated/moved from study area|0
823791|NCT00228917|1778055|FG007|Overall Study|Migrated/moved from study area|0
823792|NCT00229203|1778077|FG000|Overall Study|Progressive disease|18
823793|NCT00229203|1778078|FG001|Overall Study|Progressive disease|9
823794|NCT00229203|1778077|FG000|Overall Study|Toxicity|6
823795|NCT00229203|1778078|FG001|Overall Study|Toxicity|1
823796|NCT00229203|1778077|FG000|Overall Study|Death|4
823797|NCT00229203|1778078|FG001|Overall Study|Death|2
823798|NCT00229203|1778077|FG000|Overall Study|Other|3
823799|NCT00229203|1778078|FG001|Overall Study|Other|3
823800|NCT00229203|1778077|FG000|Overall Study|Withdrawal by Subject|1
823801|NCT00229203|1778078|FG001|Overall Study|Withdrawal by Subject|4
823802|NCT00229658|1778092|FG000|Overall Study|Administrative|2
823803|NCT00229658|1778093|FG001|Overall Study|Administrative|1
823804|NCT00229658|1778092|FG000|Overall Study|Investigator decision|13
823805|NCT00229658|1778093|FG001|Overall Study|Investigator decision|10
823806|NCT00229658|1778092|FG000|Overall Study|Other|80
823807|NCT00229658|1778093|FG001|Overall Study|Other|60
823808|NCT00229658|1778092|FG000|Overall Study|Lost to Follow-up|82
823809|NCT00229658|1778093|FG001|Overall Study|Lost to Follow-up|55
823810|NCT00229658|1778092|FG000|Overall Study|Serious Adverse Event|2
823811|NCT00229658|1778093|FG001|Overall Study|Serious Adverse Event|2
823812|NCT00229658|1778092|FG000|Overall Study|Withdrawal of consent|46
823813|NCT00229658|1778093|FG001|Overall Study|Withdrawal of consent|39
823814|NCT00229723|1778106|FG000|Concomitant Phase|Adverse Event|4
823815|NCT00229723|1778107|FG001|Concomitant Phase|Adverse Event|2
823816|NCT00229723|1778108|FG002|Concomitant Phase|Adverse Event|5
823817|NCT00229723|1778109|FG003|Concomitant Phase|Adverse Event|2
823818|NCT00229723|1778110|FG004|Concomitant Phase|Adverse Event|0
823819|NCT00229723|1778111|FG005|Concomitant Phase|Adverse Event|1
823820|NCT00229723|1778112|FG006|Concomitant Phase|Adverse Event|2
823821|NCT00229723|1778106|FG000|Concomitant Phase|Objective disease progression|0
823822|NCT00229723|1778107|FG001|Concomitant Phase|Objective disease progression|0
823823|NCT00229723|1778108|FG002|Concomitant Phase|Objective disease progression|0
823824|NCT00229723|1778109|FG003|Concomitant Phase|Objective disease progression|0
823825|NCT00229723|1778110|FG004|Concomitant Phase|Objective disease progression|0
823826|NCT00229723|1778111|FG005|Concomitant Phase|Objective disease progression|0
823827|NCT00229723|1778112|FG006|Concomitant Phase|Objective disease progression|0
823828|NCT00229723|1778106|FG000|Concomitant Phase|Clinical progression|0
823829|NCT00229723|1778107|FG001|Concomitant Phase|Clinical progression|0
823830|NCT00229723|1778108|FG002|Concomitant Phase|Clinical progression|0
823831|NCT00229723|1778109|FG003|Concomitant Phase|Clinical progression|0
823832|NCT00229723|1778110|FG004|Concomitant Phase|Clinical progression|0
823833|NCT00229723|1778111|FG005|Concomitant Phase|Clinical progression|0
823834|NCT00229723|1778112|FG006|Concomitant Phase|Clinical progression|1
823835|NCT00229723|1778106|FG000|Concomitant Phase|Lost to Follow-up|0
823836|NCT00229723|1778107|FG001|Concomitant Phase|Lost to Follow-up|0
823837|NCT00229723|1778108|FG002|Concomitant Phase|Lost to Follow-up|0
823838|NCT00229723|1778109|FG003|Concomitant Phase|Lost to Follow-up|0
823839|NCT00229723|1778110|FG004|Concomitant Phase|Lost to Follow-up|1
823840|NCT00229723|1778111|FG005|Concomitant Phase|Lost to Follow-up|0
823841|NCT00229723|1778112|FG006|Concomitant Phase|Lost to Follow-up|0
823842|NCT00229723|1778106|FG000|Concomitant Phase|Informed consent withdrawn|3
823843|NCT00229723|1778107|FG001|Concomitant Phase|Informed consent withdrawn|2
823844|NCT00229723|1778108|FG002|Concomitant Phase|Informed consent withdrawn|0
823845|NCT00229723|1778109|FG003|Concomitant Phase|Informed consent withdrawn|2
823846|NCT00229723|1778110|FG004|Concomitant Phase|Informed consent withdrawn|0
823847|NCT00229723|1778111|FG005|Concomitant Phase|Informed consent withdrawn|0
823848|NCT00229723|1778112|FG006|Concomitant Phase|Informed consent withdrawn|0
823849|NCT00229723|1778106|FG000|Concomitant Phase|Severe non-compliance|0
823850|NCT00229723|1778107|FG001|Concomitant Phase|Severe non-compliance|1
823851|NCT00229723|1778108|FG002|Concomitant Phase|Severe non-compliance|0
823852|NCT00229723|1778109|FG003|Concomitant Phase|Severe non-compliance|0
823853|NCT00229723|1778110|FG004|Concomitant Phase|Severe non-compliance|1
823854|NCT00229723|1778111|FG005|Concomitant Phase|Severe non-compliance|0
823855|NCT00229723|1778112|FG006|Concomitant Phase|Severe non-compliance|0
823856|NCT00229723|1778106|FG000|Concomitant Phase|Other|3
823857|NCT00229723|1778107|FG001|Concomitant Phase|Other|0
823858|NCT00229723|1778108|FG002|Concomitant Phase|Other|1
823859|NCT00229723|1778109|FG003|Concomitant Phase|Other|1
823860|NCT00229723|1778110|FG004|Concomitant Phase|Other|0
823861|NCT00229723|1778111|FG005|Concomitant Phase|Other|2
823862|NCT00229723|1778112|FG006|Concomitant Phase|Other|0
823863|NCT00229723|1778106|FG000|Maintenance Phase|Adverse Event|7
823864|NCT00229723|1778107|FG001|Maintenance Phase|Adverse Event|2
823865|NCT00229723|1778108|FG002|Maintenance Phase|Adverse Event|1
823866|NCT00229723|1778109|FG003|Maintenance Phase|Adverse Event|4
823867|NCT00229723|1778110|FG004|Maintenance Phase|Adverse Event|7
823868|NCT00229723|1778111|FG005|Maintenance Phase|Adverse Event|5
823869|NCT00229723|1778112|FG006|Maintenance Phase|Adverse Event|2
823870|NCT00229723|1778106|FG000|Maintenance Phase|Objective disease progression|5
823871|NCT00229723|1778107|FG001|Maintenance Phase|Objective disease progression|5
823872|NCT00229723|1778108|FG002|Maintenance Phase|Objective disease progression|3
823873|NCT00229723|1778109|FG003|Maintenance Phase|Objective disease progression|6
823874|NCT00229723|1778110|FG004|Maintenance Phase|Objective disease progression|2
823875|NCT00229723|1778111|FG005|Maintenance Phase|Objective disease progression|9
823876|NCT00229723|1778112|FG006|Maintenance Phase|Objective disease progression|5
823877|NCT00229723|1778106|FG000|Maintenance Phase|Clinical progression|4
823878|NCT00229723|1778107|FG001|Maintenance Phase|Clinical progression|1
823879|NCT00229723|1778108|FG002|Maintenance Phase|Clinical progression|2
823880|NCT00229723|1778109|FG003|Maintenance Phase|Clinical progression|2
823881|NCT00229723|1778110|FG004|Maintenance Phase|Clinical progression|1
823882|NCT00229723|1778111|FG005|Maintenance Phase|Clinical progression|1
823883|NCT00229723|1778112|FG006|Maintenance Phase|Clinical progression|1
823884|NCT00229723|1778106|FG000|Maintenance Phase|Lost to Follow-up|0
823885|NCT00229723|1778107|FG001|Maintenance Phase|Lost to Follow-up|1
823886|NCT00229723|1778108|FG002|Maintenance Phase|Lost to Follow-up|2
823887|NCT00229723|1778109|FG003|Maintenance Phase|Lost to Follow-up|2
823888|NCT00229723|1778110|FG004|Maintenance Phase|Lost to Follow-up|0
823889|NCT00229723|1778111|FG005|Maintenance Phase|Lost to Follow-up|0
823890|NCT00229723|1778112|FG006|Maintenance Phase|Lost to Follow-up|1
823891|NCT00229723|1778106|FG000|Maintenance Phase|Informed consent withdrawn|1
823892|NCT00229723|1778107|FG001|Maintenance Phase|Informed consent withdrawn|0
823893|NCT00229723|1778108|FG002|Maintenance Phase|Informed consent withdrawn|0
823894|NCT00229723|1778109|FG003|Maintenance Phase|Informed consent withdrawn|1
823895|NCT00229723|1778110|FG004|Maintenance Phase|Informed consent withdrawn|1
823896|NCT00229723|1778111|FG005|Maintenance Phase|Informed consent withdrawn|1
823897|NCT00229723|1778112|FG006|Maintenance Phase|Informed consent withdrawn|0
823898|NCT00229723|1778106|FG000|Maintenance Phase|Severe non-compliance|3
823899|NCT00229723|1778107|FG001|Maintenance Phase|Severe non-compliance|1
823900|NCT00229723|1778108|FG002|Maintenance Phase|Severe non-compliance|0
823901|NCT00229723|1778109|FG003|Maintenance Phase|Severe non-compliance|0
823902|NCT00229723|1778110|FG004|Maintenance Phase|Severe non-compliance|1
823903|NCT00229723|1778111|FG005|Maintenance Phase|Severe non-compliance|0
823904|NCT00229723|1778112|FG006|Maintenance Phase|Severe non-compliance|0
823905|NCT00229723|1778106|FG000|Maintenance Phase|Other|5
823906|NCT00229723|1778107|FG001|Maintenance Phase|Other|4
823907|NCT00229723|1778108|FG002|Maintenance Phase|Other|1
823908|NCT00229723|1778109|FG003|Maintenance Phase|Other|2
823909|NCT00229723|1778110|FG004|Maintenance Phase|Other|3
823910|NCT00229723|1778111|FG005|Maintenance Phase|Other|3
823911|NCT00229723|1778112|FG006|Maintenance Phase|Other|1
823912|NCT00230048|1778170|FG000|Overall Study|Lost to Follow-up|13
823913|NCT00230048|1778171|FG001|Overall Study|Lost to Follow-up|18
823914|NCT00230178|1778202|FG000|Overall Study|Adverse Event|1
823915|NCT00230178|1778203|FG001|Overall Study|Adverse Event|5
823916|NCT00230178|1778204|FG002|Overall Study|Adverse Event|2
823917|NCT00230178|1778202|FG000|Overall Study|Withdrawal by Subject|0
823918|NCT00230178|1778203|FG001|Overall Study|Withdrawal by Subject|0
823919|NCT00230178|1778204|FG002|Overall Study|Withdrawal by Subject|1
823920|NCT00230178|1778202|FG000|Overall Study|Various other reasons|3
823921|NCT00230178|1778203|FG001|Overall Study|Various other reasons|2
823922|NCT00230178|1778204|FG002|Overall Study|Various other reasons|4
823923|NCT00230282|1778212|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
823924|NCT00230282|1778212|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
823925|NCT00230282|1778212|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1
823926|NCT00230282|1778212|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
823927|NCT00230971|1778242|FG000|Randomization|No study drug administered|3
823928|NCT00230971|1778243|FG001|Randomization|No study drug administered|3
823929|NCT00230971|1778242|FG000|Baseline Participants|Lost to Follow-up|5
823930|NCT00230971|1778243|FG001|Baseline Participants|Lost to Follow-up|12
823931|NCT00230971|1778242|FG000|Baseline Participants|Death|6
823932|NCT00230971|1778243|FG001|Baseline Participants|Death|5
823933|NCT00230971|1778242|FG000|Baseline Participants|Withdrawal by Subject|7
823934|NCT00230971|1778243|FG001|Baseline Participants|Withdrawal by Subject|1
823935|NCT00230971|1778242|FG000|Baseline Participants|Adverse Event|1
823936|NCT00230971|1778243|FG001|Baseline Participants|Adverse Event|0
823937|NCT00230971|1778242|FG000|Baseline Participants|No bacteria observed|1
823938|NCT00230971|1778243|FG001|Baseline Participants|No bacteria observed|0
823939|NCT00230971|1778242|FG000|Baseline Participants|Failure to return|1
823940|NCT00230971|1778243|FG001|Baseline Participants|Failure to return|1
823941|NCT00230971|1778242|FG000|Baseline Participants|Reintervention|1
823942|NCT00230971|1778243|FG001|Baseline Participants|Reintervention|0
823943|NCT00231062|1778249|FG000|Overall Study|Physician Decision|6
823944|NCT00231114|1778255|FG000|Randomized|Withdrawal by Subject|6
823945|NCT00231114|1778256|FG001|Randomized|Withdrawal by Subject|3
823946|NCT00231114|1778255|FG000|Treatment Period|Death: Motor Vehicle Accident|1
823947|NCT00231114|1778256|FG001|Treatment Period|Death: Motor Vehicle Accident|0
823948|NCT00231114|1778255|FG000|Post-Treatment Period|Lost to Follow-up|6
823949|NCT00231114|1778256|FG001|Post-Treatment Period|Lost to Follow-up|1
823950|NCT00231114|1778255|FG000|Post-Treatment Period|Physician Decision|1
823951|NCT00231114|1778256|FG001|Post-Treatment Period|Physician Decision|0
823952|NCT00231114|1778255|FG000|Post-Treatment Period|Withdrawal by Subject|1
823953|NCT00231114|1778256|FG001|Post-Treatment Period|Withdrawal by Subject|0
823954|NCT00231179|1778273|FG000|Overall Study|Lost to Follow-up|21
823955|NCT00231179|1778274|FG001|Overall Study|Lost to Follow-up|21
823956|NCT00231179|1778273|FG000|Overall Study|Withdrawal by Subject|3
823957|NCT00231179|1778274|FG001|Overall Study|Withdrawal by Subject|3
823958|NCT00231413|1778296|FG000|Overall Study|Non-serious AE|0
823959|NCT00231413|1778297|FG001|Overall Study|Non-serious AE|0
823960|NCT00231413|1778298|FG002|Overall Study|Non-serious AE|1
823961|NCT00231413|1778299|FG003|Overall Study|Non-serious AE|0
823962|NCT00231413|1778300|FG004|Overall Study|Non-serious AE|0
823963|NCT00231413|1778301|FG005|Overall Study|Non-serious AE|0
823964|NCT00231413|1778302|FG006|Overall Study|Non-serious AE|1
823965|NCT00231413|1778296|FG000|Overall Study|Withdrawal by Subject|3
823966|NCT00231413|1778297|FG001|Overall Study|Withdrawal by Subject|1
823967|NCT00231413|1778298|FG002|Overall Study|Withdrawal by Subject|4
823968|NCT00231413|1778299|FG003|Overall Study|Withdrawal by Subject|2
823969|NCT00231413|1778300|FG004|Overall Study|Withdrawal by Subject|2
823970|NCT00231413|1778301|FG005|Overall Study|Withdrawal by Subject|0
823971|NCT00231413|1778302|FG006|Overall Study|Withdrawal by Subject|3
823972|NCT00231413|1778296|FG000|Overall Study|Migrated/moved from study area|0
823973|NCT00231413|1778297|FG001|Overall Study|Migrated/moved from study area|0
823974|NCT00231413|1778298|FG002|Overall Study|Migrated/moved from study area|1
823975|NCT00231413|1778299|FG003|Overall Study|Migrated/moved from study area|0
823976|NCT00231413|1778300|FG004|Overall Study|Migrated/moved from study area|0
823977|NCT00231413|1778301|FG005|Overall Study|Migrated/moved from study area|1
823978|NCT00231413|1778302|FG006|Overall Study|Migrated/moved from study area|0
823979|NCT00231413|1778296|FG000|Overall Study|Lost to Follow-up|4
823980|NCT00231413|1778297|FG001|Overall Study|Lost to Follow-up|4
823981|NCT00231413|1778298|FG002|Overall Study|Lost to Follow-up|1
823982|NCT00231413|1778299|FG003|Overall Study|Lost to Follow-up|1
823983|NCT00231413|1778300|FG004|Overall Study|Lost to Follow-up|1
823984|NCT00231413|1778301|FG005|Overall Study|Lost to Follow-up|4
823985|NCT00231413|1778302|FG006|Overall Study|Lost to Follow-up|0
823986|NCT00231413|1778296|FG000|Overall Study|Pregnancy|1
823987|NCT00231413|1778297|FG001|Overall Study|Pregnancy|0
823988|NCT00231413|1778298|FG002|Overall Study|Pregnancy|0
823989|NCT00231413|1778299|FG003|Overall Study|Pregnancy|0
823990|NCT00231413|1778300|FG004|Overall Study|Pregnancy|0
823991|NCT00231413|1778301|FG005|Overall Study|Pregnancy|0
823992|NCT00231413|1778302|FG006|Overall Study|Pregnancy|0
823993|NCT00231465|1778318|FG000|Overall Study|Completed only one cycle|1
823994|NCT00231465|1778318|FG000|Overall Study|Did not have follow up CT scans|1
823995|NCT00231478|1778324|FG000|Overall Study|Protocol Violation|3
823996|NCT00231478|1778325|FG001|Overall Study|Protocol Violation|2
823997|NCT00231478|1778324|FG000|Overall Study|Refused Treatment|1
823998|NCT00231478|1778325|FG001|Overall Study|Refused Treatment|1
823999|NCT00231478|1778324|FG000|Overall Study|Withdrawal by Subject|1
824000|NCT00231478|1778325|FG001|Overall Study|Withdrawal by Subject|0
824001|NCT00231478|1778324|FG000|Overall Study|Adverse Event|0
824002|NCT00231478|1778325|FG001|Overall Study|Adverse Event|1
824003|NCT00231478|1778324|FG000|Overall Study|Administrative|3
824004|NCT00231478|1778325|FG001|Overall Study|Administrative|2
824005|NCT00231777|1778333|FG000|Overall Study|Lost to Follow-up|3
824006|NCT00231777|1778334|FG001|Overall Study|Lost to Follow-up|0
824007|NCT00231777|1778333|FG000|Overall Study|Other|3
824008|NCT00231777|1778334|FG001|Overall Study|Other|2
824009|NCT00231816|1778342|FG000|Overall Study|Adverse Event|1
824010|NCT00231816|1778343|FG001|Overall Study|Adverse Event|0
824011|NCT00231816|1778342|FG000|Overall Study|Lost to Follow-up|8
824012|NCT00231816|1778343|FG001|Overall Study|Lost to Follow-up|5
824013|NCT00231816|1778342|FG000|Overall Study|Protocol Violation|2
824014|NCT00231816|1778343|FG001|Overall Study|Protocol Violation|3
824015|NCT00231816|1778342|FG000|Overall Study|Withdrawal by Subject|3
824016|NCT00231816|1778343|FG001|Overall Study|Withdrawal by Subject|3
824017|NCT00231816|1778342|FG000|Overall Study|Other|2
824018|NCT00231816|1778343|FG001|Overall Study|Other|1
824019|NCT00231842|1778350|FG000|Overall Study|Withdrawal by Subject|3
824020|NCT00231842|1778350|FG000|Overall Study|Did not complete the last 3 cycle|8
824021|NCT00231894|1778361|FG000|Overall Study|Withdrawal by Subject|1
824022|NCT00231894|1778362|FG001|Overall Study|Withdrawal by Subject|1
824023|NCT00232141|1778376|FG000|Overall Study|Adverse Event|9
824024|NCT00232141|1778377|FG001|Overall Study|Adverse Event|4
824025|NCT00232141|1778376|FG000|Overall Study|Lack of Efficacy|0
824026|NCT00232141|1778377|FG001|Overall Study|Lack of Efficacy|3
824027|NCT00232141|1778376|FG000|Overall Study|Lost to Follow-up|9
824028|NCT00232141|1778377|FG001|Overall Study|Lost to Follow-up|6
824029|NCT00232141|1778376|FG000|Overall Study|Other|8
824030|NCT00232141|1778377|FG001|Overall Study|Other|10
824031|NCT00232141|1778376|FG000|Overall Study|Withdrawal by Subject|5
824032|NCT00232141|1778377|FG001|Overall Study|Withdrawal by Subject|3
824033|NCT00232180|1778383|FG000|Double-blind (DB) Phase|Death|186
824034|NCT00232180|1778384|FG001|Double-blind (DB) Phase|Death|222
824035|NCT00232180|1778385|FG002|Double-blind (DB) Phase|Death|0
824036|NCT00232180|1778383|FG000|Double-blind (DB) Phase|Lost to Follow-up|34
824037|NCT00232180|1778384|FG001|Double-blind (DB) Phase|Lost to Follow-up|28
824038|NCT00232180|1778385|FG002|Double-blind (DB) Phase|Lost to Follow-up|0
824039|NCT00232180|1778383|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131
824040|NCT00232180|1778384|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148
824041|NCT00232180|1778385|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0
824042|NCT00232180|1778383|FG000|Double-blind (DB) Phase|Protocol Violation|28
824043|NCT00232180|1778384|FG001|Double-blind (DB) Phase|Protocol Violation|21
824044|NCT00232180|1778385|FG002|Double-blind (DB) Phase|Protocol Violation|0
824045|NCT00232180|1778383|FG000|Double-blind (DB) Phase|Adverse Event|83
824046|NCT00232180|1778384|FG001|Double-blind (DB) Phase|Adverse Event|100
824047|NCT00232180|1778385|FG002|Double-blind (DB) Phase|Adverse Event|0
824048|NCT00232180|1778383|FG000|Double-blind (DB) Phase|Other|70
824049|NCT00232180|1778384|FG001|Double-blind (DB) Phase|Other|75
824050|NCT00232180|1778385|FG002|Double-blind (DB) Phase|Other|0
824051|NCT00232180|1778383|FG000|Double-blind (DB) Phase|Randomized but not treated|3
824052|NCT00232180|1778384|FG001|Double-blind (DB) Phase|Randomized but not treated|4
824053|NCT00232180|1778385|FG002|Double-blind (DB) Phase|Randomized but not treated|0
824054|NCT00232180|1778383|FG000|Double-blind (DB) Phase|Laboratory abnormality|6
824055|NCT00232180|1778384|FG001|Double-blind (DB) Phase|Laboratory abnormality|7
824056|NCT00232180|1778385|FG002|Double-blind (DB) Phase|Laboratory abnormality|0
824057|NCT00232180|1778383|FG000|Open Label Phase|Death|0
824058|NCT00232180|1778384|FG001|Open Label Phase|Death|0
824059|NCT00232180|1778385|FG002|Open Label Phase|Death|48
824060|NCT00232180|1778383|FG000|Open Label Phase|Lost to Follow-up|0
824061|NCT00232180|1778384|FG001|Open Label Phase|Lost to Follow-up|0
824062|NCT00232180|1778385|FG002|Open Label Phase|Lost to Follow-up|5
824063|NCT00232180|1778383|FG000|Open Label Phase|Protocol Violation|0
824064|NCT00232180|1778384|FG001|Open Label Phase|Protocol Violation|0
824065|NCT00232180|1778385|FG002|Open Label Phase|Protocol Violation|3
824066|NCT00232180|1778383|FG000|Open Label Phase|Study terminated by sponsor|0
824067|NCT00232180|1778384|FG001|Open Label Phase|Study terminated by sponsor|0
824068|NCT00232180|1778385|FG002|Open Label Phase|Study terminated by sponsor|3
824069|NCT00232180|1778383|FG000|Open Label Phase|Withdrawal by Subject|0
824070|NCT00232180|1778384|FG001|Open Label Phase|Withdrawal by Subject|0
824071|NCT00232180|1778385|FG002|Open Label Phase|Withdrawal by Subject|37
824072|NCT00232180|1778383|FG000|Open Label Phase|Other|0
824073|NCT00232180|1778384|FG001|Open Label Phase|Other|0
824074|NCT00232180|1778385|FG002|Open Label Phase|Other|16
824075|NCT00232180|1778383|FG000|Open Label Phase|Adverse Event|0
824076|NCT00232180|1778384|FG001|Open Label Phase|Adverse Event|0
824077|NCT00232180|1778385|FG002|Open Label Phase|Adverse Event|25
824078|NCT00232180|1778383|FG000|Open Label Phase|Laboratory abnormality|0
824079|NCT00232180|1778384|FG001|Open Label Phase|Laboratory abnormality|0
824080|NCT00232180|1778385|FG002|Open Label Phase|Laboratory abnormality|10
824081|NCT00232180|1778383|FG000|Open Label Phase|Randomized but not treated|0
824082|NCT00232180|1778384|FG001|Open Label Phase|Randomized but not treated|0
824083|NCT00232180|1778385|FG002|Open Label Phase|Randomized but not treated|1
824084|NCT00232544|1778414|FG000|Overall Study|Lost to Follow-up|20
824085|NCT00232544|1778415|FG001|Overall Study|Lost to Follow-up|15
824086|NCT00232557|1778423|FG000|Overall Study|Lost to Follow-up|3
824087|NCT00232557|1778424|FG001|Overall Study|Lost to Follow-up|5
824088|NCT00232596|1778445|FG000|6-Week Titration Phase|Adverse Event|6
824089|NCT00232596|1778446|FG001|6-Week Titration Phase|Adverse Event|19
824090|NCT00232596|1778445|FG000|6-Week Titration Phase|Failed to Return|2
824091|NCT00232596|1778446|FG001|6-Week Titration Phase|Failed to Return|1
824092|NCT00232596|1778445|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
824093|NCT00232596|1778446|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
824094|NCT00232596|1778445|FG000|6-Week Titration Phase|Protocol Violation|1
824095|NCT00232596|1778446|FG001|6-Week Titration Phase|Protocol Violation|3
824096|NCT00232596|1778445|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1
824097|NCT00232596|1778446|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0
824098|NCT00232596|1778445|FG000|6-Week Titration Phase|Other|3
824099|NCT00232596|1778446|FG001|6-Week Titration Phase|Other|3
824100|NCT00232596|1778445|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
824101|NCT00232596|1778446|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
824102|NCT00232596|1778445|FG000|12-Week Maintenance Phase|Adverse Event|7
824103|NCT00232596|1778446|FG001|12-Week Maintenance Phase|Adverse Event|22
824104|NCT00232596|1778445|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
824105|NCT00232596|1778446|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
824106|NCT00232596|1778445|FG000|12-Week Maintenance Phase|Protocol Violation|3
824107|NCT00232596|1778446|FG001|12-Week Maintenance Phase|Protocol Violation|1
824108|NCT00232596|1778445|FG000|12-Week Maintenance Phase|Other|1
824109|NCT00232596|1778446|FG001|12-Week Maintenance Phase|Other|3
824110|NCT00233064|1778470|FG000|Overall Study|Lost to Follow-up|7
824111|NCT00233064|1778471|FG001|Overall Study|Lost to Follow-up|7
824112|NCT00233064|1778470|FG000|Overall Study|Withdrawal by Subject|5
824113|NCT00233064|1778471|FG001|Overall Study|Withdrawal by Subject|3
824114|NCT00233064|1778470|FG000|Overall Study|Death|0
824115|NCT00233064|1778471|FG001|Overall Study|Death|1
824116|NCT00233064|1778470|FG000|Overall Study|Relocation|0
824117|NCT00233064|1778471|FG001|Overall Study|Relocation|1
824118|NCT00233064|1778470|FG000|Overall Study|Protocol Violation|1
824119|NCT00233064|1778471|FG001|Overall Study|Protocol Violation|0
824120|NCT00233064|1778470|FG000|Overall Study|Moved to Dom. Republic|1
824121|NCT00233064|1778471|FG001|Overall Study|Moved to Dom. Republic|0
824122|NCT00233324|1778491|FG000|Main Study|Death|68
824123|NCT00233324|1778492|FG001|Main Study|Death|60
824124|NCT00233324|1778493|FG002|Main Study|Death|62
824125|NCT00233324|1778494|FG003|Main Study|Death|47
824126|NCT00233324|1778491|FG000|Follow up at 18-22 Months Corrected Age|Death|5
824127|NCT00233324|1778492|FG001|Follow up at 18-22 Months Corrected Age|Death|7
824128|NCT00233324|1778493|FG002|Follow up at 18-22 Months Corrected Age|Death|5
824129|NCT00233324|1778494|FG003|Follow up at 18-22 Months Corrected Age|Death|4
824130|NCT00233324|1778491|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
824131|NCT00233324|1778492|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
824132|NCT00233324|1778493|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
824133|NCT00233324|1778494|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
824134|NCT00233363|1778513|FG000|Overall Study|Adverse Event|1
824135|NCT00233363|1778514|FG001|Overall Study|Adverse Event|2
824136|NCT00233363|1778513|FG000|Overall Study|Lack of Efficacy|0
824137|NCT00233363|1778514|FG001|Overall Study|Lack of Efficacy|2
824138|NCT00233363|1778513|FG000|Overall Study|Withdrawal by Subject|1
824139|NCT00233363|1778514|FG001|Overall Study|Withdrawal by Subject|1
824140|NCT00233363|1778513|FG000|Overall Study|Aggravation of complication|1
824141|NCT00233363|1778514|FG001|Overall Study|Aggravation of complication|0
824142|NCT00233389|1778522|FG000|Overall Study|Adverse Event|5
824143|NCT00233389|1778523|FG001|Overall Study|Adverse Event|5
824144|NCT00233389|1778522|FG000|Overall Study|Lack of Efficacy|11
824145|NCT00233389|1778523|FG001|Overall Study|Lack of Efficacy|8
824146|NCT00233389|1778522|FG000|Overall Study|Lost to Follow-up|1
824147|NCT00233389|1778523|FG001|Overall Study|Lost to Follow-up|1
824148|NCT00233389|1778522|FG000|Overall Study|Physician Decision|1
824149|NCT00233389|1778523|FG001|Overall Study|Physician Decision|0
824150|NCT00233389|1778522|FG000|Overall Study|Protocol Violation|0
824151|NCT00233389|1778523|FG001|Overall Study|Protocol Violation|1
824152|NCT00233389|1778522|FG000|Overall Study|Withdrawal by Subject|0
824153|NCT00233389|1778523|FG001|Overall Study|Withdrawal by Subject|1
824154|NCT00233402|1778531|FG000|Overall Study|No pathology data|12
824155|NCT00233402|1778532|FG001|Overall Study|No pathology data|9
824156|NCT00233402|1778531|FG000|Overall Study|No Ta/T1|89
824157|NCT00233402|1778532|FG001|Overall Study|No Ta/T1|94
824158|NCT00233402|1778531|FG000|Overall Study|Lost to follow up etc|3
824159|NCT00233402|1778532|FG001|Overall Study|Lost to follow up etc|21
824160|NCT00233454|1778540|FG000|Overall Study|Death|6
824161|NCT00233480|1778546|FG000|Overall Study|Underwent status II heart transplant|0
824162|NCT00233480|1778547|FG001|Overall Study|Underwent status II heart transplant|1
824163|NCT00233948|1778566|FG000|Overall Study|Adverse Event|1
824164|NCT00233948|1778567|FG001|Overall Study|Adverse Event|0
824165|NCT00233948|1778568|FG002|Overall Study|Adverse Event|0
824166|NCT00233948|1778569|FG003|Overall Study|Adverse Event|0
824167|NCT00233948|1778570|FG004|Overall Study|Adverse Event|0
824168|NCT00233948|1778571|FG005|Overall Study|Adverse Event|0
824169|NCT00233987|1778586|FG000|Overall Study|Withdrawal by Subject|1
824170|NCT00233987|1778586|FG000|Overall Study|Lack of Efficacy|2
824171|NCT00233987|1778586|FG000|Overall Study|Reason Under Review|1
824172|NCT00233987|1778586|FG000|Overall Study|Other - Not Protocol Specified|5
824173|NCT00233987|1778586|FG000|Overall Study|Eligible but No Treatment Received|2
824174|NCT00233987|1778586|FG000|Overall Study|Ineligible|4
824175|NCT00234039|1778590|FG000|Overall Study|Adverse Event|2
824176|NCT00234039|1778590|FG000|Overall Study|Progression/relapse|34
824177|NCT00234039|1778590|FG000|Overall Study|Other - Not Protocol Specified|3
824178|NCT00234039|1778590|FG000|Overall Study|Ineligible|9
824179|NCT00234039|1778590|FG000|Overall Study|No Protocol Treatment Received|2
824180|NCT00234052|1778594|FG000|Treatment|Withdrawal by Subject|3
824181|NCT00234052|1778594|FG000|Treatment|Adverse Event|5
824182|NCT00234052|1778594|FG000|Treatment|Death|2
824183|NCT00234052|1778594|FG000|Treatment|Progressive Disease|11
824184|NCT00234052|1778594|FG000|Follow-up for 5 Years|Death|41
824185|NCT00234052|1778594|FG000|Follow-up for 5 Years|Lost to Follow-up|1
824186|NCT00234052|1778594|FG000|Follow-up for 5 Years|Other|7
824187|NCT00234065|1778600|FG000|Overall Study|Adverse Event|268
824188|NCT00234065|1778601|FG001|Overall Study|Adverse Event|166
824189|NCT00234065|1778600|FG000|Overall Study|Withdrawal by Subject|73
824190|NCT00234065|1778601|FG001|Overall Study|Withdrawal by Subject|56
824191|NCT00234065|1778600|FG000|Overall Study|Physician Decision|23
824192|NCT00234065|1778601|FG001|Overall Study|Physician Decision|22
824193|NCT00234065|1778600|FG000|Overall Study|Not Classified|111
824194|NCT00234065|1778601|FG001|Overall Study|Not Classified|112
824195|NCT00234104|1778628|FG000|Overall Study|Adverse Event|4
824196|NCT00234104|1778629|FG001|Overall Study|Adverse Event|0
824197|NCT00234104|1778630|FG002|Overall Study|Adverse Event|3
824198|NCT00234104|1778631|FG003|Overall Study|Adverse Event|5
824199|NCT00234104|1778628|FG000|Overall Study|Protocol Violation|0
824200|NCT00234104|1778629|FG001|Overall Study|Protocol Violation|0
824201|NCT00234104|1778630|FG002|Overall Study|Protocol Violation|0
824202|NCT00234104|1778631|FG003|Overall Study|Protocol Violation|1
824203|NCT00234104|1778628|FG000|Overall Study|Physician Decision|0
824204|NCT00234104|1778629|FG001|Overall Study|Physician Decision|1
824205|NCT00234104|1778630|FG002|Overall Study|Physician Decision|2
824206|NCT00234104|1778631|FG003|Overall Study|Physician Decision|2
824207|NCT00234494|1778674|FG000|Overall Study|Protocol Violation|2
824208|NCT00234533|1778678|FG000|Overall Study|Withdrawal by Subject|6
824209|NCT00234533|1778678|FG000|Overall Study|Adverse Event|2
824210|NCT00234533|1778678|FG000|Overall Study|Enrolled but not treated|3
824211|NCT00235326|1778705|FG000|Overall Study|Lost to Follow-up|746
824212|NCT00235326|1778706|FG001|Overall Study|Lost to Follow-up|1400
824213|NCT00235391|1778716|FG000|Overall Study|Adverse Event|4
824214|NCT00235391|1778717|FG001|Overall Study|Adverse Event|5
824215|NCT00235391|1778718|FG002|Overall Study|Adverse Event|10
824216|NCT00235391|1778719|FG003|Overall Study|Adverse Event|72
824217|NCT00235391|1778720|FG004|Overall Study|Adverse Event|5
824218|NCT00235391|1778721|FG005|Overall Study|Adverse Event|2
824219|NCT00235391|1778716|FG000|Overall Study|Abnormal laboratory value(s)|3
824220|NCT00235391|1778717|FG001|Overall Study|Abnormal laboratory value(s)|5
824221|NCT00235391|1778718|FG002|Overall Study|Abnormal laboratory value(s)|4
824222|NCT00235391|1778719|FG003|Overall Study|Abnormal laboratory value(s)|27
824223|NCT00235391|1778720|FG004|Overall Study|Abnormal laboratory value(s)|1
824224|NCT00235391|1778721|FG005|Overall Study|Abnormal laboratory value(s)|2
824225|NCT00235391|1778716|FG000|Overall Study|Unsatisfactory therapeutic effect|0
824226|NCT00235391|1778717|FG001|Overall Study|Unsatisfactory therapeutic effect|2
824227|NCT00235391|1778718|FG002|Overall Study|Unsatisfactory therapeutic effect|2
824228|NCT00235391|1778719|FG003|Overall Study|Unsatisfactory therapeutic effect|17
824229|NCT00235391|1778720|FG004|Overall Study|Unsatisfactory therapeutic effect|0
824230|NCT00235391|1778721|FG005|Overall Study|Unsatisfactory therapeutic effect|0
824231|NCT00235391|1778716|FG000|Overall Study|Condition no longer requires treatment|3
824232|NCT00235391|1778717|FG001|Overall Study|Condition no longer requires treatment|0
824233|NCT00235391|1778718|FG002|Overall Study|Condition no longer requires treatment|0
824234|NCT00235391|1778719|FG003|Overall Study|Condition no longer requires treatment|11
824235|NCT00235391|1778720|FG004|Overall Study|Condition no longer requires treatment|1
824236|NCT00235391|1778721|FG005|Overall Study|Condition no longer requires treatment|0
824237|NCT00235391|1778716|FG000|Overall Study|Protocol deviation|0
824238|NCT00235391|1778717|FG001|Overall Study|Protocol deviation|0
824239|NCT00235391|1778718|FG002|Overall Study|Protocol deviation|1
824240|NCT00235391|1778719|FG003|Overall Study|Protocol deviation|11
824241|NCT00235391|1778720|FG004|Overall Study|Protocol deviation|0
824242|NCT00235391|1778721|FG005|Overall Study|Protocol deviation|0
824243|NCT00235391|1778716|FG000|Overall Study|Withdrawal by Subject|2
824244|NCT00235391|1778717|FG001|Overall Study|Withdrawal by Subject|3
824245|NCT00235391|1778718|FG002|Overall Study|Withdrawal by Subject|3
824246|NCT00235391|1778719|FG003|Overall Study|Withdrawal by Subject|61
824247|NCT00235391|1778720|FG004|Overall Study|Withdrawal by Subject|5
824248|NCT00235391|1778721|FG005|Overall Study|Withdrawal by Subject|0
824249|NCT00235391|1778716|FG000|Overall Study|Lost to Follow-up|0
824250|NCT00235391|1778717|FG001|Overall Study|Lost to Follow-up|3
824251|NCT00235391|1778718|FG002|Overall Study|Lost to Follow-up|3
824252|NCT00235391|1778719|FG003|Overall Study|Lost to Follow-up|16
824253|NCT00235391|1778720|FG004|Overall Study|Lost to Follow-up|0
824254|NCT00235391|1778721|FG005|Overall Study|Lost to Follow-up|0
824255|NCT00235391|1778716|FG000|Overall Study|Administrative problems|0
824256|NCT00235391|1778717|FG001|Overall Study|Administrative problems|0
824257|NCT00235391|1778718|FG002|Overall Study|Administrative problems|0
824258|NCT00235391|1778719|FG003|Overall Study|Administrative problems|1
824259|NCT00235391|1778720|FG004|Overall Study|Administrative problems|0
824260|NCT00235391|1778721|FG005|Overall Study|Administrative problems|0
824261|NCT00235391|1778716|FG000|Overall Study|Death|0
824262|NCT00235391|1778717|FG001|Overall Study|Death|0
824263|NCT00235391|1778718|FG002|Overall Study|Death|1
824264|NCT00235391|1778719|FG003|Overall Study|Death|4
824265|NCT00235391|1778720|FG004|Overall Study|Death|0
824266|NCT00235391|1778721|FG005|Overall Study|Death|0
824267|NCT00235443|1778736|FG000|Overall Study|Adverse Event|4
824268|NCT00235443|1778737|FG001|Overall Study|Adverse Event|12
824269|NCT00235443|1778738|FG002|Overall Study|Adverse Event|17
824270|NCT00235443|1778739|FG003|Overall Study|Adverse Event|44
824271|NCT00235443|1778740|FG004|Overall Study|Adverse Event|10
824272|NCT00235443|1778741|FG005|Overall Study|Adverse Event|15
824273|NCT00235443|1778736|FG000|Overall Study|Lack of Efficacy|0
824274|NCT00235443|1778737|FG001|Overall Study|Lack of Efficacy|1
824275|NCT00235443|1778738|FG002|Overall Study|Lack of Efficacy|5
824276|NCT00235443|1778739|FG003|Overall Study|Lack of Efficacy|12
824277|NCT00235443|1778740|FG004|Overall Study|Lack of Efficacy|2
824278|NCT00235443|1778741|FG005|Overall Study|Lack of Efficacy|9
824279|NCT00235443|1778736|FG000|Overall Study|Withdrawal by Subject|3
824280|NCT00235443|1778737|FG001|Overall Study|Withdrawal by Subject|9
824281|NCT00235443|1778738|FG002|Overall Study|Withdrawal by Subject|25
824282|NCT00235443|1778739|FG003|Overall Study|Withdrawal by Subject|24
824283|NCT00235443|1778740|FG004|Overall Study|Withdrawal by Subject|10
824284|NCT00235443|1778741|FG005|Overall Study|Withdrawal by Subject|12
824285|NCT00235443|1778736|FG000|Overall Study|Lost to Follow-up|0
824286|NCT00235443|1778737|FG001|Overall Study|Lost to Follow-up|8
824287|NCT00235443|1778738|FG002|Overall Study|Lost to Follow-up|6
824288|NCT00235443|1778739|FG003|Overall Study|Lost to Follow-up|6
824289|NCT00235443|1778740|FG004|Overall Study|Lost to Follow-up|4
824290|NCT00235443|1778741|FG005|Overall Study|Lost to Follow-up|3
824291|NCT00235443|1778736|FG000|Overall Study|Unsatisfactory compliance|0
824292|NCT00235443|1778737|FG001|Overall Study|Unsatisfactory compliance|2
824293|NCT00235443|1778738|FG002|Overall Study|Unsatisfactory compliance|3
824294|NCT00235443|1778739|FG003|Overall Study|Unsatisfactory compliance|4
824295|NCT00235443|1778740|FG004|Overall Study|Unsatisfactory compliance|1
824296|NCT00235443|1778741|FG005|Overall Study|Unsatisfactory compliance|0
824297|NCT00235443|1778736|FG000|Overall Study|Other reasons for premature termination|1
824298|NCT00235443|1778737|FG001|Overall Study|Other reasons for premature termination|6
824299|NCT00235443|1778738|FG002|Overall Study|Other reasons for premature termination|6
824300|NCT00235443|1778739|FG003|Overall Study|Other reasons for premature termination|7
824301|NCT00235443|1778740|FG004|Overall Study|Other reasons for premature termination|3
824302|NCT00235443|1778741|FG005|Overall Study|Other reasons for premature termination|6
824303|NCT00235495|1778768|FG000|Overall Study|Death|52
824304|NCT00235495|1778769|FG001|Overall Study|Death|42
824305|NCT00235495|1778768|FG000|Overall Study|Withdrawal by Subject|5
824306|NCT00235495|1778769|FG001|Overall Study|Withdrawal by Subject|3
824307|NCT00235495|1778768|FG000|Overall Study|Lost to Follow-up|11
824308|NCT00235495|1778769|FG001|Overall Study|Lost to Follow-up|13
824309|NCT00235495|1778768|FG000|Overall Study|Visit/assessmen outside window/missing|0
824310|NCT00235495|1778769|FG001|Overall Study|Visit/assessmen outside window/missing|10
824311|NCT00235716|1778792|FG000|Overall Study|Death|26
824312|NCT00235716|1778793|FG001|Overall Study|Death|39
824313|NCT00235716|1778794|FG002|Overall Study|Death|32
824314|NCT00235716|1778795|FG003|Overall Study|Death|31
824315|NCT00235716|1778792|FG000|Overall Study|Withdrawal by Subject|23
824316|NCT00235716|1778793|FG001|Overall Study|Withdrawal by Subject|19
824317|NCT00235716|1778794|FG002|Overall Study|Withdrawal by Subject|17
824318|NCT00235716|1778795|FG003|Overall Study|Withdrawal by Subject|18
824319|NCT00235716|1778792|FG000|Overall Study|Lost to Follow-up|12
824320|NCT00235716|1778793|FG001|Overall Study|Lost to Follow-up|7
824321|NCT00235716|1778794|FG002|Overall Study|Lost to Follow-up|14
824322|NCT00235716|1778795|FG003|Overall Study|Lost to Follow-up|10
824323|NCT00235716|1778792|FG000|Overall Study|Adverse Event|1
824324|NCT00235716|1778793|FG001|Overall Study|Adverse Event|1
824325|NCT00235716|1778794|FG002|Overall Study|Adverse Event|1
824326|NCT00235716|1778795|FG003|Overall Study|Adverse Event|0
824327|NCT00235716|1778792|FG000|Overall Study|Physician Decision|0
824328|NCT00235716|1778793|FG001|Overall Study|Physician Decision|1
824329|NCT00235716|1778794|FG002|Overall Study|Physician Decision|1
824330|NCT00235716|1778795|FG003|Overall Study|Physician Decision|3
824331|NCT00235755|1778808|FG000|4-Week Titration Phase|Adverse Event|6
824332|NCT00235755|1778809|FG001|4-Week Titration Phase|Adverse Event|14
824333|NCT00235755|1778810|FG002|4-Week Titration Phase|Adverse Event|20
824334|NCT00235755|1778808|FG000|4-Week Titration Phase|Lost to Follow-up|0
824335|NCT00235755|1778809|FG001|4-Week Titration Phase|Lost to Follow-up|1
824336|NCT00235755|1778810|FG002|4-Week Titration Phase|Lost to Follow-up|1
824337|NCT00235755|1778808|FG000|4-Week Titration Phase|Protocol Violation|2
824338|NCT00235755|1778809|FG001|4-Week Titration Phase|Protocol Violation|2
824339|NCT00235755|1778810|FG002|4-Week Titration Phase|Protocol Violation|1
824340|NCT00235755|1778808|FG000|4-Week Titration Phase|Withdrawal by Subject|1
824341|NCT00235755|1778809|FG001|4-Week Titration Phase|Withdrawal by Subject|2
824342|NCT00235755|1778810|FG002|4-Week Titration Phase|Withdrawal by Subject|3
824343|NCT00235755|1778808|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
824344|NCT00235755|1778809|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
824345|NCT00235755|1778810|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
824346|NCT00235755|1778808|FG000|4-Week Titration Phase|Randomization Occurred in Error|1
824347|NCT00235755|1778809|FG001|4-Week Titration Phase|Randomization Occurred in Error|0
824348|NCT00235755|1778810|FG002|4-Week Titration Phase|Randomization Occurred in Error|0
824349|NCT00235755|1778808|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
824350|NCT00235755|1778809|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
824351|NCT00235755|1778810|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
824352|NCT00235755|1778808|FG000|12-Week Maintenance Phase|Adverse Event|8
824353|NCT00235755|1778809|FG001|12-Week Maintenance Phase|Adverse Event|12
824354|NCT00235755|1778810|FG002|12-Week Maintenance Phase|Adverse Event|26
824355|NCT00235755|1778808|FG000|12-Week Maintenance Phase|Lost to Follow-up|2
824356|NCT00235755|1778809|FG001|12-Week Maintenance Phase|Lost to Follow-up|3
824357|NCT00235755|1778810|FG002|12-Week Maintenance Phase|Lost to Follow-up|0
824358|NCT00235755|1778808|FG000|12-Week Maintenance Phase|Lack of Efficacy|5
824359|NCT00235755|1778809|FG001|12-Week Maintenance Phase|Lack of Efficacy|0
824360|NCT00235755|1778810|FG002|12-Week Maintenance Phase|Lack of Efficacy|0
824361|NCT00235755|1778808|FG000|12-Week Maintenance Phase|Protocol Violation|0
824362|NCT00235755|1778809|FG001|12-Week Maintenance Phase|Protocol Violation|4
824363|NCT00235755|1778810|FG002|12-Week Maintenance Phase|Protocol Violation|2
824364|NCT00235755|1778808|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0
824365|NCT00235755|1778809|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8
824366|NCT00235755|1778810|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3
824367|NCT00235755|1778808|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
824368|NCT00235755|1778809|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
824369|NCT00235755|1778810|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
824370|NCT00235872|1778837|FG000|Overall Study|Adverse Event|34
824371|NCT00235872|1778837|FG000|Overall Study|Death|1
824372|NCT00235872|1778837|FG000|Overall Study|Lost to Follow-up|1
824373|NCT00235872|1778837|FG000|Overall Study|Withdrawal by Subject|50
824374|NCT00235872|1778837|FG000|Overall Study|Administrative reason|61
824375|NCT00235989|1778845|FG000|Core Treatment Period (CT)|Lost to Follow-up|0
824376|NCT00235989|1778846|FG001|Core Treatment Period (CT)|Lost to Follow-up|0
824377|NCT00235989|1778847|FG002|Core Treatment Period (CT)|Lost to Follow-up|0
824378|NCT00235989|1778848|FG003|Core Treatment Period (CT)|Lost to Follow-up|0
824379|NCT00235989|1778849|FG004|Core Treatment Period (CT)|Lost to Follow-up|0
824380|NCT00235989|1778850|FG005|Core Treatment Period (CT)|Lost to Follow-up|2
824381|NCT00235989|1778845|FG000|Extension Treatment Period (ET)|Adverse Event|3
824382|NCT00235989|1778846|FG001|Extension Treatment Period (ET)|Adverse Event|0
824383|NCT00235989|1778847|FG002|Extension Treatment Period (ET)|Adverse Event|2
824384|NCT00235989|1778848|FG003|Extension Treatment Period (ET)|Adverse Event|0
824385|NCT00235989|1778849|FG004|Extension Treatment Period (ET)|Adverse Event|0
824386|NCT00235989|1778850|FG005|Extension Treatment Period (ET)|Adverse Event|0
824387|NCT00235989|1778845|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2
824388|NCT00235989|1778846|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0
824389|NCT00235989|1778847|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1
824390|NCT00235989|1778848|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0
824391|NCT00235989|1778849|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0
824392|NCT00235989|1778850|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0
824393|NCT00235989|1778845|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1
824394|NCT00235989|1778846|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1
824395|NCT00235989|1778847|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1
824396|NCT00235989|1778848|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4
824397|NCT00235989|1778849|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0
824398|NCT00235989|1778850|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0
824399|NCT00235989|1778845|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2
824400|NCT00235989|1778846|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3
824401|NCT00235989|1778847|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1
824402|NCT00235989|1778848|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2
824403|NCT00235989|1778849|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0
824404|NCT00235989|1778850|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0
824405|NCT00236080|1778865|FG000|Overall Study|Adverse Event|0
824406|NCT00236080|1778866|FG001|Overall Study|Adverse Event|0
824407|NCT00236080|1778867|FG002|Overall Study|Adverse Event|3
824408|NCT00236080|1778868|FG003|Overall Study|Adverse Event|1
824409|NCT00236080|1778869|FG004|Overall Study|Adverse Event|0
824410|NCT00236080|1778865|FG000|Overall Study|Lost to Follow-up|0
824411|NCT00236080|1778866|FG001|Overall Study|Lost to Follow-up|1
824412|NCT00236080|1778867|FG002|Overall Study|Lost to Follow-up|0
824413|NCT00236080|1778868|FG003|Overall Study|Lost to Follow-up|0
824414|NCT00236080|1778869|FG004|Overall Study|Lost to Follow-up|0
824415|NCT00236080|1778865|FG000|Overall Study|Physician Decision|1
824416|NCT00236080|1778866|FG001|Overall Study|Physician Decision|0
824417|NCT00236080|1778867|FG002|Overall Study|Physician Decision|1
824418|NCT00236080|1778868|FG003|Overall Study|Physician Decision|1
824419|NCT00236080|1778869|FG004|Overall Study|Physician Decision|1
824420|NCT00236080|1778865|FG000|Overall Study|Withdrawal by Subject|1
824421|NCT00236080|1778866|FG001|Overall Study|Withdrawal by Subject|0
824422|NCT00236080|1778867|FG002|Overall Study|Withdrawal by Subject|0
824423|NCT00236080|1778868|FG003|Overall Study|Withdrawal by Subject|0
824424|NCT00236080|1778869|FG004|Overall Study|Withdrawal by Subject|0
824425|NCT00236080|1778865|FG000|Overall Study|Miscellaneous|0
824426|NCT00236080|1778866|FG001|Overall Study|Miscellaneous|0
824427|NCT00236080|1778867|FG002|Overall Study|Miscellaneous|1
824428|NCT00236080|1778868|FG003|Overall Study|Miscellaneous|0
824429|NCT00236080|1778869|FG004|Overall Study|Miscellaneous|0
824430|NCT00236184|1778883|FG000|Overall Study|Adverse Event|5
824431|NCT00236184|1778884|FG001|Overall Study|Adverse Event|2
824432|NCT00236184|1778883|FG000|Overall Study|Lack of Efficacy|0
824433|NCT00236184|1778884|FG001|Overall Study|Lack of Efficacy|1
824434|NCT00236184|1778883|FG000|Overall Study|Lost to Follow-up|3
824435|NCT00236184|1778884|FG001|Overall Study|Lost to Follow-up|4
824436|NCT00236184|1778883|FG000|Overall Study|Physician Decision|1
824437|NCT00236184|1778884|FG001|Overall Study|Physician Decision|1
824438|NCT00236184|1778883|FG000|Overall Study|Withdrawal by Subject|3
824439|NCT00236184|1778884|FG001|Overall Study|Withdrawal by Subject|0
824440|NCT00236184|1778883|FG000|Overall Study|Protocol Violation|3
824441|NCT00236184|1778884|FG001|Overall Study|Protocol Violation|0
824442|NCT00236184|1778883|FG000|Overall Study|non-compliance with study drug|2
824443|NCT00236184|1778884|FG001|Overall Study|non-compliance with study drug|1
824444|NCT00236184|1778883|FG000|Overall Study|other|1
824445|NCT00236184|1778884|FG001|Overall Study|other|2
824446|NCT00236197|1778892|FG000|Overall Study|Withdrawal by Subject|3
824447|NCT00236197|1778893|FG001|Overall Study|Withdrawal by Subject|2
824448|NCT00236197|1778892|FG000|Overall Study|Lost to Follow-up|1
824449|NCT00236197|1778893|FG001|Overall Study|Lost to Follow-up|5
824450|NCT00236197|1778892|FG000|Overall Study|Protocol Violation|0
824451|NCT00236197|1778893|FG001|Overall Study|Protocol Violation|3
824452|NCT00236197|1778892|FG000|Overall Study|Medication non-compliance|1
824453|NCT00236197|1778893|FG001|Overall Study|Medication non-compliance|2
824454|NCT00236197|1778892|FG000|Overall Study|Other|0
824455|NCT00236197|1778893|FG001|Overall Study|Other|2
824456|NCT00236899|1778903|FG000|Overall Study|Adverse Event (Study Related)|1
824457|NCT00236899|1778904|FG001|Overall Study|Adverse Event (Study Related)|1
824458|NCT00236899|1778905|FG002|Overall Study|Adverse Event (Study Related)|2
824459|NCT00236899|1778906|FG003|Overall Study|Adverse Event (Study Related)|1
824460|NCT00236899|1778903|FG000|Overall Study|Adverse Event (Not Study Related)|3
824461|NCT00236899|1778904|FG001|Overall Study|Adverse Event (Not Study Related)|3
824462|NCT00236899|1778905|FG002|Overall Study|Adverse Event (Not Study Related)|4
824463|NCT00236899|1778906|FG003|Overall Study|Adverse Event (Not Study Related)|7
824464|NCT00236899|1778903|FG000|Overall Study|Death (Study Disease)|1
824465|NCT00236899|1778904|FG001|Overall Study|Death (Study Disease)|4
824466|NCT00236899|1778905|FG002|Overall Study|Death (Study Disease)|0
824467|NCT00236899|1778906|FG003|Overall Study|Death (Study Disease)|0
824468|NCT00236899|1778903|FG000|Overall Study|Death (Not Study Related)|2
824469|NCT00236899|1778904|FG001|Overall Study|Death (Not Study Related)|0
824470|NCT00236899|1778905|FG002|Overall Study|Death (Not Study Related)|0
824471|NCT00236899|1778906|FG003|Overall Study|Death (Not Study Related)|0
824472|NCT00236899|1778903|FG000|Overall Study|Death (Study Drug Toxicity)|1
824473|NCT00236899|1778904|FG001|Overall Study|Death (Study Drug Toxicity)|0
824474|NCT00236899|1778905|FG002|Overall Study|Death (Study Drug Toxicity)|0
824475|NCT00236899|1778906|FG003|Overall Study|Death (Study Drug Toxicity)|0
824476|NCT00236899|1778903|FG000|Overall Study|Lost to Follow-up|0
824477|NCT00236899|1778904|FG001|Overall Study|Lost to Follow-up|1
824478|NCT00236899|1778905|FG002|Overall Study|Lost to Follow-up|0
824479|NCT00236899|1778906|FG003|Overall Study|Lost to Follow-up|0
824480|NCT00236899|1778903|FG000|Overall Study|Entry Criteria Exclusion|0
824481|NCT00236899|1778904|FG001|Overall Study|Entry Criteria Exclusion|1
824482|NCT00236899|1778905|FG002|Overall Study|Entry Criteria Exclusion|1
824483|NCT00236899|1778906|FG003|Overall Study|Entry Criteria Exclusion|0
824484|NCT00236899|1778903|FG000|Overall Study|Protocol Violation|1
824485|NCT00236899|1778904|FG001|Overall Study|Protocol Violation|0
824486|NCT00236899|1778905|FG002|Overall Study|Protocol Violation|0
824487|NCT00236899|1778906|FG003|Overall Study|Protocol Violation|0
824488|NCT00236899|1778903|FG000|Overall Study|Withdrawal by Subject|6
824489|NCT00236899|1778904|FG001|Overall Study|Withdrawal by Subject|4
824490|NCT00236899|1778905|FG002|Overall Study|Withdrawal by Subject|5
824491|NCT00236899|1778906|FG003|Overall Study|Withdrawal by Subject|2
824492|NCT00236899|1778903|FG000|Overall Study|Physician Decision|7
824493|NCT00236899|1778904|FG001|Overall Study|Physician Decision|8
824494|NCT00236899|1778905|FG002|Overall Study|Physician Decision|7
824495|NCT00236899|1778906|FG003|Overall Study|Physician Decision|6
824496|NCT00236899|1778903|FG000|Overall Study|Satisfactory Response|2
824497|NCT00236899|1778904|FG001|Overall Study|Satisfactory Response|0
824498|NCT00236899|1778905|FG002|Overall Study|Satisfactory Response|0
824499|NCT00236899|1778906|FG003|Overall Study|Satisfactory Response|1
824500|NCT00236899|1778903|FG000|Overall Study|Lack of Efficacy|18
824501|NCT00236899|1778904|FG001|Overall Study|Lack of Efficacy|18
824502|NCT00236899|1778905|FG002|Overall Study|Lack of Efficacy|25
824503|NCT00236899|1778906|FG003|Overall Study|Lack of Efficacy|23
824504|NCT00237042|1778961|FG000|Treatment|Became ineligible post-randomization|0
824505|NCT00237042|1778962|FG001|Treatment|Became ineligible post-randomization|1
824506|NCT00237042|1778963|FG002|Treatment|Became ineligible post-randomization|16
824507|NCT00237042|1778961|FG000|Treatment|Moved out of state|1
824508|NCT00237042|1778962|FG001|Treatment|Moved out of state|1
824509|NCT00237042|1778963|FG002|Treatment|Moved out of state|1
824510|NCT00237042|1778961|FG000|Treatment|Completed no treatment|5
824511|NCT00237042|1778962|FG001|Treatment|Completed no treatment|5
824512|NCT00237042|1778963|FG002|Treatment|Completed no treatment|21
824513|NCT00237042|1778961|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9
824514|NCT00237042|1778962|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8
824515|NCT00237042|1778963|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11
824516|NCT00237042|1778961|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11
824517|NCT00237042|1778962|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9
824518|NCT00237042|1778963|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9
824519|NCT00237185|1778973|FG000|Core|Adverse Event|3
824520|NCT00237185|1778974|FG001|Core|Adverse Event|4
824521|NCT00237185|1778973|FG000|Core|Abnormal laboratory value|0
824522|NCT00237185|1778974|FG001|Core|Abnormal laboratory value|4
824523|NCT00237185|1778973|FG000|Core|Abnormal test procedure results|1
824524|NCT00237185|1778974|FG001|Core|Abnormal test procedure results|0
824525|NCT00237185|1778973|FG000|Core|Lack of Efficacy|30
824526|NCT00237185|1778974|FG001|Core|Lack of Efficacy|23
824527|NCT00237185|1778973|FG000|Core|Protocol Violation|1
824528|NCT00237185|1778974|FG001|Core|Protocol Violation|1
824529|NCT00237185|1778973|FG000|Core|Withdrawal by Subject|4
824530|NCT00237185|1778974|FG001|Core|Withdrawal by Subject|4
824531|NCT00237185|1778973|FG000|Core|Administrative problems|0
824532|NCT00237185|1778974|FG001|Core|Administrative problems|1
824533|NCT00237185|1778973|FG000|Core|Death|4
824534|NCT00237185|1778974|FG001|Core|Death|0
824535|NCT00237185|1778973|FG000|Core|Determined ineligible post randomization|1
824536|NCT00237185|1778974|FG001|Core|Determined ineligible post randomization|0
824537|NCT00237185|1778973|FG000|Extension|Adverse Event|1
824538|NCT00237185|1778974|FG001|Extension|Adverse Event|0
824539|NCT00237185|1778973|FG000|Extension|Abnormal laboratory value|0
824540|NCT00237185|1778974|FG001|Extension|Abnormal laboratory value|1
824541|NCT00237185|1778973|FG000|Extension|Lack of Efficacy|9
824542|NCT00237185|1778974|FG001|Extension|Lack of Efficacy|14
824543|NCT00237185|1778973|FG000|Extension|Condition no longer required study drug|0
824544|NCT00237185|1778974|FG001|Extension|Condition no longer required study drug|1
824545|NCT00237185|1778973|FG000|Extension|Withdrawal by Subject|3
824546|NCT00237185|1778974|FG001|Extension|Withdrawal by Subject|2
824547|NCT00237185|1778973|FG000|Extension|Lost to Follow-up|1
824548|NCT00237185|1778974|FG001|Extension|Lost to Follow-up|0
824549|NCT00237185|1778973|FG000|Extension|Administrative problems|1
824550|NCT00237185|1778974|FG001|Extension|Administrative problems|0
824551|NCT00237185|1778973|FG000|Extension|Death|1
824552|NCT00237185|1778974|FG001|Extension|Death|1
824553|NCT00237458|1778980|FG000|Overall Study|Lack of Efficacy|1
824554|NCT00237458|1778980|FG000|Overall Study|Adverse Event|1
824555|NCT00237458|1778980|FG000|Overall Study|Withdrawal by Subject|1
824556|NCT00237692|1778992|FG000|Overall Study|Lost to Follow-up|9
824557|NCT00237692|1778993|FG001|Overall Study|Lost to Follow-up|3
824558|NCT00237692|1778994|FG002|Overall Study|Lost to Follow-up|5
824559|NCT00237692|1778995|FG003|Overall Study|Lost to Follow-up|3
824560|NCT00237692|1778992|FG000|Overall Study|Death|1
824561|NCT00237692|1778993|FG001|Overall Study|Death|2
824562|NCT00237692|1778994|FG002|Overall Study|Death|2
824563|NCT00237692|1778995|FG003|Overall Study|Death|3
824564|NCT00237692|1778992|FG000|Overall Study|Excluded - did not meet criteria|4
824565|NCT00237692|1778993|FG001|Overall Study|Excluded - did not meet criteria|3
824566|NCT00237692|1778994|FG002|Overall Study|Excluded - did not meet criteria|5
824567|NCT00237692|1778995|FG003|Overall Study|Excluded - did not meet criteria|9
824568|NCT00237692|1778992|FG000|Overall Study|Withdrawal by Subject|4
824569|NCT00237692|1778993|FG001|Overall Study|Withdrawal by Subject|6
824570|NCT00237692|1778994|FG002|Overall Study|Withdrawal by Subject|10
824571|NCT00237692|1778995|FG003|Overall Study|Withdrawal by Subject|4
824572|NCT00237744|1779017|FG000|Overall Study|Withdrawal by Subject|3
824573|NCT00237744|1779018|FG001|Overall Study|Withdrawal by Subject|1
824574|NCT00237744|1779019|FG002|Overall Study|Withdrawal by Subject|0
824575|NCT00237796|1779045|FG000|Overall Study|Baseline and one other ILSS required|10
824576|NCT00237796|1779046|FG001|Overall Study|Baseline and one other ILSS required|5
824577|NCT00237809|1779057|FG000|Overall Study|Lost to Follow-up|11
824578|NCT00237809|1779058|FG001|Overall Study|Lost to Follow-up|10
824579|NCT00237809|1779059|FG002|Overall Study|Lost to Follow-up|9
824580|NCT00237809|1779060|FG003|Overall Study|Lost to Follow-up|9
824581|NCT00238121|1779081|FG000|Overall Study|Withdrawal by Subject|1
824582|NCT00238121|1779082|FG001|Overall Study|Withdrawal by Subject|1
824583|NCT00238121|1779081|FG000|Overall Study|Adverse Event|2
824584|NCT00238121|1779082|FG001|Overall Study|Adverse Event|1
824585|NCT00238238|1779090|FG000|Overall Study|Withdrawal by Subject|0
824586|NCT00238238|1779091|FG001|Overall Study|Withdrawal by Subject|3
824587|NCT00238238|1779092|FG002|Overall Study|Withdrawal by Subject|0
824588|NCT00238264|1779100|FG000|Overall Study|Death|7
824589|NCT00238264|1779100|FG000|Overall Study|Lost to Follow-up|18
824590|NCT00238264|1779100|FG000|Overall Study|Withdrawal by Subject|4
824591|NCT00238264|1779100|FG000|Overall Study|Ineligible|7
824592|NCT00238303|1779107|FG000|Overall Study|Withdrawal by Subject|11
824593|NCT00238303|1779108|FG001|Overall Study|Withdrawal by Subject|1
824594|NCT00238303|1779109|FG002|Overall Study|Withdrawal by Subject|2
824595|NCT00238303|1779107|FG000|Overall Study|Death|1
824596|NCT00238303|1779108|FG001|Overall Study|Death|0
824597|NCT00238303|1779109|FG002|Overall Study|Death|1
824598|NCT00238303|1779107|FG000|Overall Study|Other Medical Problems|2
824599|NCT00238303|1779108|FG001|Overall Study|Other Medical Problems|0
824600|NCT00238303|1779109|FG002|Overall Study|Other Medical Problems|2
824601|NCT00238303|1779107|FG000|Overall Study|Poor tolerance of study treatment|1
824602|NCT00238303|1779108|FG001|Overall Study|Poor tolerance of study treatment|0
824603|NCT00238303|1779109|FG002|Overall Study|Poor tolerance of study treatment|1
824604|NCT00238303|1779107|FG000|Overall Study|Adverse Event|0
824605|NCT00238303|1779108|FG001|Overall Study|Adverse Event|1
824606|NCT00238303|1779109|FG002|Overall Study|Adverse Event|3
824609|NCT00238433|1779131|FG000|Overall Study|Screen failure|1
824610|NCT00238433|1779131|FG000|Overall Study|Lost to Follow-up|1
824611|NCT00238433|1779131|FG000|Overall Study|Death|1
824612|NCT00239005|1779144|FG000|Overall Study|Adverse Event|6
824613|NCT00239005|1779145|FG001|Overall Study|Adverse Event|6
824614|NCT00239005|1779144|FG000|Overall Study|Withdrawal by Subject|3
824615|NCT00239005|1779145|FG001|Overall Study|Withdrawal by Subject|4
824616|NCT00239005|1779144|FG000|Overall Study|Unsatisfactory Therapeutic effect|2
824617|NCT00239005|1779145|FG001|Overall Study|Unsatisfactory Therapeutic effect|0
824618|NCT00239005|1779144|FG000|Overall Study|Protocol Violation|1
824619|NCT00239005|1779145|FG001|Overall Study|Protocol Violation|0
824620|NCT00239005|1779144|FG000|Overall Study|Subj. cond. no longer needs study drug|0
824621|NCT00239005|1779145|FG001|Overall Study|Subj. cond. no longer needs study drug|1
824622|NCT00239005|1779144|FG000|Overall Study|Lost to Follow-up|0
824623|NCT00239005|1779145|FG001|Overall Study|Lost to Follow-up|1
824624|NCT00239226|1779155|FG000|Overall Study|permAF during stabilization period|0
824625|NCT00239226|1779156|FG001|Overall Study|permAF during stabilization period|0
824626|NCT00239226|1779157|FG002|Overall Study|permAF during stabilization period|0
824627|NCT00239226|1779158|FG003|Overall Study|permAF during stabilization period|3
824628|NCT00239226|1779155|FG000|Overall Study|Lost to Follow-up|1
824629|NCT00239226|1779156|FG001|Overall Study|Lost to Follow-up|0
824630|NCT00239226|1779157|FG002|Overall Study|Lost to Follow-up|1
824631|NCT00239226|1779158|FG003|Overall Study|Lost to Follow-up|0
824632|NCT00239356|1779170|FG000|Overall Study|Lack of Efficacy|1
824633|NCT00239356|1779171|FG001|Overall Study|Lack of Efficacy|0
824634|NCT00239356|1779170|FG000|Overall Study|Adverse Event|6
824635|NCT00239356|1779171|FG001|Overall Study|Adverse Event|0
824636|NCT00239356|1779170|FG000|Overall Study|Withdrawal by Subject|15
824637|NCT00239356|1779171|FG001|Overall Study|Withdrawal by Subject|6
824638|NCT00239356|1779170|FG000|Overall Study|Lost to Follow-up|3
824639|NCT00239356|1779171|FG001|Overall Study|Lost to Follow-up|0
824640|NCT00239356|1779170|FG000|Overall Study|poor/non-compliance|2
824641|NCT00239356|1779171|FG001|Overall Study|poor/non-compliance|0
824642|NCT00239356|1779170|FG000|Overall Study|Pregnancy|1
824643|NCT00239356|1779171|FG001|Overall Study|Pregnancy|0
824644|NCT00239356|1779170|FG000|Overall Study|Administrative reason|0
824645|NCT00239356|1779171|FG001|Overall Study|Administrative reason|1
824646|NCT00239356|1779170|FG000|Overall Study|Drug available on market|11
824647|NCT00239356|1779171|FG001|Overall Study|Drug available on market|2
824648|NCT00239577|1779181|FG000|Primary Phase|Adverse Event|0
824649|NCT00239577|1779182|FG001|Primary Phase|Adverse Event|0
824650|NCT00239577|1779183|FG002|Primary Phase|Adverse Event|1
824651|NCT00239577|1779184|FG003|Primary Phase|Adverse Event|0
824652|NCT00239577|1779181|FG000|Primary Phase|Other|5
824653|NCT00239577|1779182|FG001|Primary Phase|Other|3
824654|NCT00239577|1779183|FG002|Primary Phase|Other|2
824655|NCT00239577|1779184|FG003|Primary Phase|Other|0
824656|NCT00239590|1779196|FG000|Randomized|Lost to Follow-up|0
824657|NCT00239590|1779197|FG001|Randomized|Lost to Follow-up|1
824658|NCT00239590|1779196|FG000|Randomized|Withdrawal by Subject|0
824659|NCT00239590|1779197|FG001|Randomized|Withdrawal by Subject|1
824660|NCT00239590|1779196|FG000|Completed Study Protocol|Adverse Event|1
824661|NCT00239590|1779197|FG001|Completed Study Protocol|Adverse Event|1
824662|NCT00239590|1779196|FG000|Completed Study Protocol|Withdrawal by Subject|0
824663|NCT00239590|1779197|FG001|Completed Study Protocol|Withdrawal by Subject|1
824664|NCT00239681|1779220|FG000|Overall Study|Adverse Event|100
824665|NCT00239681|1779221|FG001|Overall Study|Adverse Event|99
824666|NCT00239681|1779220|FG000|Overall Study|Withdrawal by Subject|458
824667|NCT00239681|1779221|FG001|Overall Study|Withdrawal by Subject|489
824668|NCT00239681|1779220|FG000|Overall Study|Lost to Follow-up|28
824669|NCT00239681|1779221|FG001|Overall Study|Lost to Follow-up|22
824670|NCT00239681|1779220|FG000|Overall Study|Protocol Violation|4
824671|NCT00239681|1779221|FG001|Overall Study|Protocol Violation|4
824672|NCT00239681|1779220|FG000|Overall Study|Physician Decision|13
824673|NCT00239681|1779221|FG001|Overall Study|Physician Decision|17
824674|NCT00239681|1779220|FG000|Overall Study|No information chacked on CaseReportForm|90
824675|NCT00239681|1779221|FG001|Overall Study|No information chacked on CaseReportForm|84
824676|NCT00239837|1779233|FG000|Overall Study|Lost to Follow-up|3
824677|NCT00239837|1779234|FG001|Overall Study|Lost to Follow-up|7
824678|NCT00239928|1779242|FG000|Overall Study|Lack of Efficacy|1
824679|NCT00239928|1779242|FG000|Overall Study|Adverse Event|4
824680|NCT00239928|1779242|FG000|Overall Study|Not need to continue study|3
824681|NCT00239928|1779242|FG000|Overall Study|Withdrawal by Subject|2
824682|NCT00240071|1779246|FG000|Overall Study|Withdrawal by Subject|3
824683|NCT00240097|1779251|FG000|Part I|Adverse Event|1
824684|NCT00240097|1779251|FG000|Part I|Death|1
824685|NCT00240097|1779251|FG000|Part I|histology|1
824686|NCT00240097|1779251|FG000|Part I|unevaluable|1
824687|NCT00240097|1779251|FG000|Part II|did not continue from Part I|23
824688|NCT00240110|1779261|FG000|Overall Study|Lost to Follow-up|6
824689|NCT00240110|1779262|FG001|Overall Study|Lost to Follow-up|7
824690|NCT00240331|1779276|FG000|Overall Study|Withdrawal by Subject|125
824691|NCT00240331|1779277|FG001|Overall Study|Withdrawal by Subject|132
824692|NCT00240331|1779276|FG000|Overall Study|Option selected by investigator|1
824693|NCT00240331|1779277|FG001|Overall Study|Option selected by investigator|2
824694|NCT00240994|1779359|FG000|Overall Study|Lost to Follow-up|1
824695|NCT00240994|1779359|FG000|Overall Study|Protocol Violation|1
824696|NCT00240994|1779359|FG000|Overall Study|Graft failure|1
824697|NCT00241280|1779370|FG000|Overall Study|Adverse Event|2
824698|NCT00241280|1779371|FG001|Overall Study|Adverse Event|6
824699|NCT00241280|1779370|FG000|Overall Study|Discomfort|11
824700|NCT00241280|1779371|FG001|Overall Study|Discomfort|16
824701|NCT00241280|1779370|FG000|Overall Study|Pregnancy|1
824702|NCT00241280|1779371|FG001|Overall Study|Pregnancy|5
824703|NCT00241280|1779370|FG000|Overall Study|Lost to Follow-up|5
824704|NCT00241280|1779371|FG001|Overall Study|Lost to Follow-up|8
824705|NCT00241280|1779370|FG000|Overall Study|Withdrawal by Subject|7
824706|NCT00241280|1779371|FG001|Overall Study|Withdrawal by Subject|4
824707|NCT00241280|1779370|FG000|Overall Study|Protocol Violation|4
824708|NCT00241280|1779371|FG001|Overall Study|Protocol Violation|10
824709|NCT00241280|1779370|FG000|Overall Study|Relocation|4
824710|NCT00241280|1779371|FG001|Overall Study|Relocation|4
824711|NCT00241280|1779370|FG000|Overall Study|Unsatisfactory Physiological Response|1
824712|NCT00241280|1779371|FG001|Overall Study|Unsatisfactory Physiological Response|1
824713|NCT00241280|1779370|FG000|Overall Study|Unsatisfactory Visual Response|1
824714|NCT00241280|1779371|FG001|Overall Study|Unsatisfactory Visual Response|1
824715|NCT00241280|1779370|FG000|Overall Study|Diabetic|1
824716|NCT00241280|1779371|FG001|Overall Study|Diabetic|0
824717|NCT00241280|1779370|FG000|Overall Study|Subject Ineligible/Dispensed|9
824718|NCT00241280|1779371|FG001|Overall Study|Subject Ineligible/Dispensed|6
824719|NCT00241280|1779370|FG000|Overall Study|Dispensed incorrect test article|1
824720|NCT00241280|1779371|FG001|Overall Study|Dispensed incorrect test article|2
824721|NCT00241280|1779370|FG000|Overall Study|Unacceptable Fit|0
824722|NCT00241280|1779371|FG001|Overall Study|Unacceptable Fit|1
824723|NCT00241280|1779370|FG000|Overall Study|Scheduling Conflict|0
824724|NCT00241280|1779371|FG001|Overall Study|Scheduling Conflict|2
824725|NCT00241280|1779370|FG000|Overall Study|History of Ocular Surgery|0
824726|NCT00241280|1779371|FG001|Overall Study|History of Ocular Surgery|1
824727|NCT00241280|1779370|FG000|Overall Study|Coating on Lens|1
824728|NCT00241280|1779371|FG001|Overall Study|Coating on Lens|0
824729|NCT00241280|1779370|FG000|Overall Study|Excessive Dryness|0
824730|NCT00241280|1779371|FG001|Overall Study|Excessive Dryness|1
824731|NCT00241358|1779381|FG000|Overall Study|Determined to be not ineligible|0
824732|NCT00241358|1779382|FG001|Overall Study|Determined to be not ineligible|1
824733|NCT00241358|1779383|FG002|Overall Study|Determined to be not ineligible|1
824734|NCT00241631|1779392|FG000|Run in (2 Weeks)|Physician Decision|3
824735|NCT00241631|1779393|FG001|Run in (2 Weeks)|Physician Decision|3
824736|NCT00241631|1779392|FG000|Phase 1 (4 Weeks)|sore throat|1
824737|NCT00241631|1779393|FG001|Phase 1 (4 Weeks)|sore throat|0
824738|NCT00241631|1779392|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4
824739|NCT00241631|1779393|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4
824740|NCT00241631|1779392|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3
824741|NCT00241631|1779393|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0
824742|NCT00241631|1779392|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0
824743|NCT00241631|1779393|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1
824744|NCT00241644|1779403|FG000|First Efficacy Period (Year 1)|Adverse Event|46
824745|NCT00241644|1779404|FG001|First Efficacy Period (Year 1)|Adverse Event|45
824746|NCT00241644|1779405|FG002|First Efficacy Period (Year 1)|Adverse Event|45
824747|NCT00241644|1779406|FG003|First Efficacy Period (Year 1)|Adverse Event|91
824748|NCT00241644|1779403|FG000|First Efficacy Period (Year 1)|Protocol Violation|3
824749|NCT00241644|1779404|FG001|First Efficacy Period (Year 1)|Protocol Violation|5
824750|NCT00241644|1779405|FG002|First Efficacy Period (Year 1)|Protocol Violation|4
824751|NCT00241644|1779406|FG003|First Efficacy Period (Year 1)|Protocol Violation|8
824752|NCT00241644|1779403|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59
824753|NCT00241644|1779404|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74
824754|NCT00241644|1779405|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81
824755|NCT00241644|1779406|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133
824756|NCT00241644|1779403|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116
824757|NCT00241644|1779404|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142
824758|NCT00241644|1779405|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116
824759|NCT00241644|1779406|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258
824760|NCT00241644|1779403|FG000|First Efficacy Period (Year 1)|Non-compliance|2
824761|NCT00241644|1779404|FG001|First Efficacy Period (Year 1)|Non-compliance|1
824762|NCT00241644|1779405|FG002|First Efficacy Period (Year 1)|Non-compliance|2
824763|NCT00241644|1779406|FG003|First Efficacy Period (Year 1)|Non-compliance|3
824764|NCT00241644|1779403|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1
824765|NCT00241644|1779404|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0
824766|NCT00241644|1779405|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0
824767|NCT00241644|1779406|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1
824768|NCT00241644|1779403|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
824769|NCT00241644|1779404|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
824770|NCT00241644|1779405|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
824771|NCT00241644|1779406|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
824772|NCT00241644|1779403|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0
824773|NCT00241644|1779404|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1
824774|NCT00241644|1779405|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0
824775|NCT00241644|1779406|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1
824776|NCT00241644|1779403|FG000|Second Efficacy Period (Year 2)|Adverse Event|11
824777|NCT00241644|1779404|FG001|Second Efficacy Period (Year 2)|Adverse Event|9
824778|NCT00241644|1779405|FG002|Second Efficacy Period (Year 2)|Adverse Event|12
824779|NCT00241644|1779406|FG003|Second Efficacy Period (Year 2)|Adverse Event|20
824780|NCT00241644|1779403|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2
824781|NCT00241644|1779404|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1
824782|NCT00241644|1779405|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2
824783|NCT00241644|1779406|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3
824784|NCT00241644|1779403|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
824785|NCT00241644|1779404|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
824786|NCT00241644|1779405|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
824787|NCT00241644|1779406|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
824788|NCT00241644|1779403|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43
824789|NCT00241644|1779404|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43
824790|NCT00241644|1779405|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46
824791|NCT00241644|1779406|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86
824792|NCT00241644|1779403|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1
824793|NCT00241644|1779404|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1
824794|NCT00241644|1779405|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2
824795|NCT00241644|1779406|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2
824796|NCT00241839|1779418|FG000|Overall Study|Withdrawal by Subject|18
824797|NCT00241839|1779419|FG001|Overall Study|Withdrawal by Subject|17
824798|NCT00241839|1779418|FG000|Overall Study|Adverse Event|1
824799|NCT00241839|1779419|FG001|Overall Study|Adverse Event|1
824800|NCT00242216|1779446|FG000|Overall Study|Lost to Follow-up|12
824801|NCT00242216|1779447|FG001|Overall Study|Lost to Follow-up|17
824802|NCT00242216|1779446|FG000|Overall Study|Death|4
824803|NCT00242216|1779447|FG001|Overall Study|Death|2
824804|NCT00242216|1779446|FG000|Overall Study|Lack of Efficacy|1
824805|NCT00242216|1779447|FG001|Overall Study|Lack of Efficacy|2
824806|NCT00242216|1779446|FG000|Overall Study|no medicaiton dispensed|1
824807|NCT00242216|1779447|FG001|Overall Study|no medicaiton dispensed|1
824808|NCT00242567|1779466|FG000|Overall Study|Adverse Event|70
824809|NCT00242567|1779467|FG001|Overall Study|Adverse Event|43
824810|NCT00242567|1779466|FG000|Overall Study|Disease Progression|17
824811|NCT00242567|1779467|FG001|Overall Study|Disease Progression|22
824812|NCT00242567|1779466|FG000|Overall Study|Symptomatic deterioration|9
824813|NCT00242567|1779467|FG001|Overall Study|Symptomatic deterioration|3
824814|NCT00242567|1779466|FG000|Overall Study|Lack of Efficacy|2
824815|NCT00242567|1779467|FG001|Overall Study|Lack of Efficacy|2
824816|NCT00242567|1779466|FG000|Overall Study|Lost to Follow-up|9
824817|NCT00242567|1779467|FG001|Overall Study|Lost to Follow-up|19
824818|NCT00242567|1779466|FG000|Overall Study|Withdrawal by Subject|33
824819|NCT00242567|1779467|FG001|Overall Study|Withdrawal by Subject|28
824820|NCT00242567|1779466|FG000|Overall Study|Protocol Violation|12
824821|NCT00242567|1779467|FG001|Overall Study|Protocol Violation|12
824822|NCT00242567|1779466|FG000|Overall Study|Use of an inhibitor of bone resorption|0
824823|NCT00242567|1779467|FG001|Overall Study|Use of an inhibitor of bone resorption|2
824824|NCT00242567|1779466|FG000|Overall Study|Other|14
824825|NCT00242567|1779467|FG001|Overall Study|Other|9
824826|NCT00242580|1779478|FG000|Overall Study|Adverse Event|3
824827|NCT00242580|1779479|FG001|Overall Study|Adverse Event|0
824828|NCT00242580|1779480|FG002|Overall Study|Adverse Event|2
824829|NCT00242580|1779478|FG000|Overall Study|Unsatisfactory therapeutic effect|4
824830|NCT00242580|1779479|FG001|Overall Study|Unsatisfactory therapeutic effect|5
824831|NCT00242580|1779480|FG002|Overall Study|Unsatisfactory therapeutic effect|5
824832|NCT00242580|1779478|FG000|Overall Study|Protocol Violation|0
824833|NCT00242580|1779479|FG001|Overall Study|Protocol Violation|0
824834|NCT00242580|1779480|FG002|Overall Study|Protocol Violation|1
824835|NCT00242580|1779478|FG000|Overall Study|Subject withdrew consent|2
824836|NCT00242580|1779479|FG001|Overall Study|Subject withdrew consent|2
824837|NCT00242580|1779480|FG002|Overall Study|Subject withdrew consent|5
824838|NCT00242580|1779478|FG000|Overall Study|Lost to Follow-up|0
824839|NCT00242580|1779479|FG001|Overall Study|Lost to Follow-up|3
824840|NCT00242580|1779480|FG002|Overall Study|Lost to Follow-up|0
824841|NCT00242580|1779478|FG000|Overall Study|Death|1
824842|NCT00242580|1779479|FG001|Overall Study|Death|2
824843|NCT00242580|1779480|FG002|Overall Study|Death|1
824844|NCT00242658|1779509|FG000|Overall Study|Lost to Follow-up|22
824845|NCT00242658|1779510|FG001|Overall Study|Lost to Follow-up|19
824846|NCT00242710|1779524|FG000|Core Study (up to Year 1)|Adverse Event|30
824847|NCT00242710|1779525|FG001|Core Study (up to Year 1)|Adverse Event|25
824848|NCT00242710|1779526|FG002|Core Study (up to Year 1)|Adverse Event|23
824849|NCT00242710|1779527|FG003|Core Study (up to Year 1)|Adverse Event|14
824850|NCT00242710|1779524|FG000|Core Study (up to Year 1)|Death|0
824851|NCT00242710|1779525|FG001|Core Study (up to Year 1)|Death|0
824852|NCT00242710|1779526|FG002|Core Study (up to Year 1)|Death|1
824853|NCT00242710|1779527|FG003|Core Study (up to Year 1)|Death|0
824854|NCT00242710|1779524|FG000|Core Study (up to Year 1)|Physician Decision|0
824855|NCT00242710|1779525|FG001|Core Study (up to Year 1)|Physician Decision|1
824856|NCT00242710|1779526|FG002|Core Study (up to Year 1)|Physician Decision|0
824857|NCT00242710|1779527|FG003|Core Study (up to Year 1)|Physician Decision|1
824858|NCT00242710|1779524|FG000|Core Study (up to Year 1)|Lost to Follow-up|8
824859|NCT00242710|1779525|FG001|Core Study (up to Year 1)|Lost to Follow-up|8
824860|NCT00242710|1779526|FG002|Core Study (up to Year 1)|Lost to Follow-up|7
824861|NCT00242710|1779527|FG003|Core Study (up to Year 1)|Lost to Follow-up|3
824862|NCT00242710|1779524|FG000|Core Study (up to Year 1)|Other|6
824863|NCT00242710|1779525|FG001|Core Study (up to Year 1)|Other|1
824864|NCT00242710|1779526|FG002|Core Study (up to Year 1)|Other|0
824865|NCT00242710|1779527|FG003|Core Study (up to Year 1)|Other|2
824866|NCT00242710|1779524|FG000|Core Study (up to Year 1)|Protocol Violation|2
824867|NCT00242710|1779525|FG001|Core Study (up to Year 1)|Protocol Violation|9
824868|NCT00242710|1779526|FG002|Core Study (up to Year 1)|Protocol Violation|1
824869|NCT00242710|1779527|FG003|Core Study (up to Year 1)|Protocol Violation|3
824870|NCT00242710|1779524|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27
824871|NCT00242710|1779525|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16
824872|NCT00242710|1779526|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15
824873|NCT00242710|1779527|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6
824874|NCT00242710|1779524|FG000|Core Study (up to Year 1)|Lack of Efficacy|1
824875|NCT00242710|1779525|FG001|Core Study (up to Year 1)|Lack of Efficacy|0
824876|NCT00242710|1779526|FG002|Core Study (up to Year 1)|Lack of Efficacy|0
824877|NCT00242710|1779527|FG003|Core Study (up to Year 1)|Lack of Efficacy|0
824878|NCT00242710|1779524|FG000|Core Study (up to Year 1)|Randomized but not Treated|12
824879|NCT00242710|1779525|FG001|Core Study (up to Year 1)|Randomized but not Treated|4
824880|NCT00242710|1779526|FG002|Core Study (up to Year 1)|Randomized but not Treated|4
824881|NCT00242710|1779527|FG003|Core Study (up to Year 1)|Randomized but not Treated|2
824882|NCT00242710|1779524|FG000|Period Between Core Study and Extension|Adverse Event|2
824883|NCT00242710|1779525|FG001|Period Between Core Study and Extension|Adverse Event|3
824884|NCT00242710|1779526|FG002|Period Between Core Study and Extension|Adverse Event|5
824885|NCT00242710|1779527|FG003|Period Between Core Study and Extension|Adverse Event|2
824886|NCT00242710|1779524|FG000|Period Between Core Study and Extension|Physician Decision|1
824887|NCT00242710|1779525|FG001|Period Between Core Study and Extension|Physician Decision|1
824888|NCT00242710|1779526|FG002|Period Between Core Study and Extension|Physician Decision|0
824889|NCT00242710|1779527|FG003|Period Between Core Study and Extension|Physician Decision|0
824890|NCT00242710|1779524|FG000|Period Between Core Study and Extension|Other|24
824891|NCT00242710|1779525|FG001|Period Between Core Study and Extension|Other|24
824892|NCT00242710|1779526|FG002|Period Between Core Study and Extension|Other|9
824893|NCT00242710|1779527|FG003|Period Between Core Study and Extension|Other|11
824894|NCT00242710|1779524|FG000|Period Between Core Study and Extension|Extension not Available|17
824895|NCT00242710|1779525|FG001|Period Between Core Study and Extension|Extension not Available|21
824896|NCT00242710|1779526|FG002|Period Between Core Study and Extension|Extension not Available|8
824897|NCT00242710|1779527|FG003|Period Between Core Study and Extension|Extension not Available|7
824898|NCT00242710|1779524|FG000|Period Between Core Study and Extension|Protocol Violation|0
824899|NCT00242710|1779525|FG001|Period Between Core Study and Extension|Protocol Violation|0
824900|NCT00242710|1779526|FG002|Period Between Core Study and Extension|Protocol Violation|2
824901|NCT00242710|1779527|FG003|Period Between Core Study and Extension|Protocol Violation|1
824902|NCT00242710|1779524|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75
824980|NCT00243230|1779573|FG001|Open Label Period|Withdrawal by Subject|0
824903|NCT00242710|1779525|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63
824904|NCT00242710|1779526|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24
824905|NCT00242710|1779527|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28
824906|NCT00242710|1779524|FG000|Study Extension (up to Year 2)|Adverse Event|7
824907|NCT00242710|1779525|FG001|Study Extension (up to Year 2)|Adverse Event|9
824908|NCT00242710|1779526|FG002|Study Extension (up to Year 2)|Adverse Event|2
824909|NCT00242710|1779527|FG003|Study Extension (up to Year 2)|Adverse Event|4
824910|NCT00242710|1779524|FG000|Study Extension (up to Year 2)|Death|0
824911|NCT00242710|1779525|FG001|Study Extension (up to Year 2)|Death|0
824912|NCT00242710|1779526|FG002|Study Extension (up to Year 2)|Death|0
824913|NCT00242710|1779527|FG003|Study Extension (up to Year 2)|Death|1
824914|NCT00242710|1779524|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7
824915|NCT00242710|1779525|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7
824916|NCT00242710|1779526|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5
824917|NCT00242710|1779527|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0
824918|NCT00242710|1779524|FG000|Study Extension (up to Year 2)|Other|3
824919|NCT00242710|1779525|FG001|Study Extension (up to Year 2)|Other|5
824920|NCT00242710|1779526|FG002|Study Extension (up to Year 2)|Other|4
824921|NCT00242710|1779527|FG003|Study Extension (up to Year 2)|Other|3
824922|NCT00242710|1779524|FG000|Study Extension (up to Year 2)|Protocol Violation|0
824923|NCT00242710|1779525|FG001|Study Extension (up to Year 2)|Protocol Violation|2
824924|NCT00242710|1779526|FG002|Study Extension (up to Year 2)|Protocol Violation|0
824925|NCT00242710|1779527|FG003|Study Extension (up to Year 2)|Protocol Violation|1
824926|NCT00242710|1779524|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10
824927|NCT00242710|1779525|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6
824928|NCT00242710|1779526|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4
824929|NCT00242710|1779527|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1
824930|NCT00243022|1779539|FG000|Overall Study|Withdrawal by Subject|1
824931|NCT00243022|1779540|FG001|Overall Study|Withdrawal by Subject|0
824932|NCT00243022|1779539|FG000|Overall Study|Death|1
824933|NCT00243022|1779540|FG001|Overall Study|Death|0
824934|NCT00243022|1779539|FG000|Overall Study|Difficult Travel Distance|0
824935|NCT00243022|1779540|FG001|Overall Study|Difficult Travel Distance|1
824936|NCT00243074|1779552|FG000|Overall Study|Ineligible|6
824937|NCT00243074|1779552|FG000|Overall Study|Adverse Event|6
824938|NCT00243074|1779552|FG000|Overall Study|Withdrawal by Subject|2
824939|NCT00243074|1779552|FG000|Overall Study|Lack of Efficacy|36
824940|NCT00243074|1779552|FG000|Overall Study|Death|2
824941|NCT00243074|1779552|FG000|Overall Study|not protocol specified|1
824942|NCT00243074|1779552|FG000|Overall Study|Did not receive any treatment|1
824943|NCT00243230|1779572|FG000|Double-Blind Period|Adverse Event|0
824944|NCT00243230|1779573|FG001|Double-Blind Period|Adverse Event|2
824945|NCT00243230|1779574|FG002|Double-Blind Period|Adverse Event|2
824946|NCT00243230|1779575|FG003|Double-Blind Period|Adverse Event|0
824947|NCT00243230|1779572|FG000|Double-Blind Period|Withdrawal by Subject|1
824948|NCT00243230|1779573|FG001|Double-Blind Period|Withdrawal by Subject|0
824949|NCT00243230|1779574|FG002|Double-Blind Period|Withdrawal by Subject|0
824950|NCT00243230|1779575|FG003|Double-Blind Period|Withdrawal by Subject|0
824951|NCT00243230|1779572|FG000|Double-Blind Period|Protocol Violation|0
824952|NCT00243230|1779573|FG001|Double-Blind Period|Protocol Violation|0
824953|NCT00243230|1779574|FG002|Double-Blind Period|Protocol Violation|1
824954|NCT00243230|1779575|FG003|Double-Blind Period|Protocol Violation|0
824955|NCT00243230|1779572|FG000|Double-Blind Period|Randomized but Not Treated|0
824956|NCT00243230|1779573|FG001|Double-Blind Period|Randomized but Not Treated|0
824957|NCT00243230|1779574|FG002|Double-Blind Period|Randomized but Not Treated|2
824958|NCT00243230|1779575|FG003|Double-Blind Period|Randomized but Not Treated|0
824959|NCT00243230|1779572|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5
824960|NCT00243230|1779573|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3
824961|NCT00243230|1779574|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14
824962|NCT00243230|1779575|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0
824963|NCT00243230|1779572|FG000|Open Label Period|Adverse Event|0
824964|NCT00243230|1779573|FG001|Open Label Period|Adverse Event|0
824965|NCT00243230|1779574|FG002|Open Label Period|Adverse Event|0
824966|NCT00243230|1779575|FG003|Open Label Period|Adverse Event|2
824967|NCT00243230|1779572|FG000|Open Label Period|Treatment Failure - Virologic Failure|0
824968|NCT00243230|1779573|FG001|Open Label Period|Treatment Failure - Virologic Failure|0
824969|NCT00243230|1779574|FG002|Open Label Period|Treatment Failure - Virologic Failure|0
824970|NCT00243230|1779575|FG003|Open Label Period|Treatment Failure - Virologic Failure|13
824971|NCT00243230|1779572|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0
824972|NCT00243230|1779573|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0
824973|NCT00243230|1779574|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0
824974|NCT00243230|1779575|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1
824975|NCT00243230|1779572|FG000|Open Label Period|Lost to Follow-up|0
824976|NCT00243230|1779573|FG001|Open Label Period|Lost to Follow-up|0
824977|NCT00243230|1779574|FG002|Open Label Period|Lost to Follow-up|0
824978|NCT00243230|1779575|FG003|Open Label Period|Lost to Follow-up|2
824979|NCT00243230|1779572|FG000|Open Label Period|Withdrawal by Subject|0
824981|NCT00243230|1779574|FG002|Open Label Period|Withdrawal by Subject|0
824982|NCT00243230|1779575|FG003|Open Label Period|Withdrawal by Subject|2
824983|NCT00243230|1779572|FG000|Open Label Period|Protocol Violation|0
824984|NCT00243230|1779573|FG001|Open Label Period|Protocol Violation|0
824985|NCT00243230|1779574|FG002|Open Label Period|Protocol Violation|0
824986|NCT00243230|1779575|FG003|Open Label Period|Protocol Violation|2
824987|NCT00243230|1779572|FG000|Open Label Period|Administrative Reason|0
824988|NCT00243230|1779573|FG001|Open Label Period|Administrative Reason|0
824989|NCT00243230|1779574|FG002|Open Label Period|Administrative Reason|0
824990|NCT00243230|1779575|FG003|Open Label Period|Administrative Reason|63
824991|NCT00243269|1779598|FG000|Overall Study|Protocol Violation|2
824992|NCT00243269|1779599|FG001|Overall Study|Protocol Violation|1
824993|NCT00243269|1779600|FG002|Overall Study|Protocol Violation|0
824994|NCT00243269|1779601|FG003|Overall Study|Protocol Violation|1
824995|NCT00243269|1779598|FG000|Overall Study|Lost to Follow-up|1
824996|NCT00243269|1779599|FG001|Overall Study|Lost to Follow-up|0
824997|NCT00243269|1779600|FG002|Overall Study|Lost to Follow-up|1
824998|NCT00243269|1779601|FG003|Overall Study|Lost to Follow-up|3
824999|NCT00243347|1779611|FG000|Overall Study|Lack of Efficacy|4
825000|NCT00243347|1779611|FG000|Overall Study|Adverse Event|2
825001|NCT00243347|1779611|FG000|Overall Study|Death|1
825002|NCT00243347|1779611|FG000|Overall Study|Withdrawal by Subject|5
825003|NCT00243347|1779611|FG000|Overall Study|Condition worsened|7
825004|NCT00243386|1779615|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
825005|NCT00243386|1779616|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
825006|NCT00243386|1779617|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
825007|NCT00243386|1779615|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
825008|NCT00243386|1779616|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
825009|NCT00243386|1779617|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
825010|NCT00243386|1779615|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2
825011|NCT00243386|1779616|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0
825012|NCT00243386|1779617|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0
825013|NCT00243386|1779615|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
825014|NCT00243386|1779616|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
825015|NCT00243386|1779617|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
825016|NCT00243386|1779615|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
825017|NCT00243386|1779616|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
825018|NCT00243386|1779617|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
825019|NCT00243386|1779615|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
825020|NCT00243386|1779616|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
825021|NCT00243386|1779617|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
825022|NCT00243386|1779615|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
825023|NCT00243386|1779616|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
825024|NCT00243386|1779617|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
825025|NCT00243386|1779615|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
825026|NCT00243386|1779616|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
825027|NCT00243386|1779617|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
825028|NCT00243412|1779655|FG000|Overall Study|Death|0
825029|NCT00243412|1779656|FG001|Overall Study|Death|1
825030|NCT00243412|1779655|FG000|Overall Study|Adverse Event|4
825031|NCT00243412|1779656|FG001|Overall Study|Adverse Event|2
825032|NCT00243412|1779655|FG000|Overall Study|Lost to Follow-up|0
825033|NCT00243412|1779656|FG001|Overall Study|Lost to Follow-up|1
825034|NCT00243412|1779655|FG000|Overall Study|Physician Decision|1
825035|NCT00243412|1779656|FG001|Overall Study|Physician Decision|1
825036|NCT00243412|1779655|FG000|Overall Study|Withdrawal by Subject|4
825037|NCT00243412|1779656|FG001|Overall Study|Withdrawal by Subject|5
825038|NCT00243412|1779655|FG000|Overall Study|Other|1
825039|NCT00243412|1779656|FG001|Overall Study|Other|1
825040|NCT00243503|1779662|FG000|Overall Study|Adverse Event|11
825041|NCT00243503|1779662|FG000|Overall Study|Withdrawal by Subject|1
825042|NCT00243503|1779662|FG000|Overall Study|Lack of Efficacy|44
825043|NCT00243503|1779662|FG000|Overall Study|Death|1
825044|NCT00243503|1779662|FG000|Overall Study|Other|1
825045|NCT00243659|1779669|FG000|Overall Study|Withdrawal by Subject|1
825046|NCT00243659|1779670|FG001|Overall Study|Withdrawal by Subject|1
825047|NCT00243659|1779669|FG000|Overall Study|Protocol Violation|1
825048|NCT00243659|1779670|FG001|Overall Study|Protocol Violation|2
825049|NCT00243841|1779679|FG000|Overall Study|Physician Decision|0
825050|NCT00243841|1779680|FG001|Overall Study|Physician Decision|0
825051|NCT00243841|1779681|FG002|Overall Study|Physician Decision|1
825052|NCT00243841|1779682|FG003|Overall Study|Physician Decision|0
825053|NCT00243841|1779683|FG004|Overall Study|Physician Decision|0
825054|NCT00243841|1779684|FG005|Overall Study|Physician Decision|2
825055|NCT00243919|1779703|FG000|Overall Study|Death|3
825056|NCT00243919|1779704|FG001|Overall Study|Death|4
825057|NCT00243919|1779705|FG002|Overall Study|Death|6
825058|NCT00243919|1779703|FG000|Overall Study|Withdrawal by Subject|6
825059|NCT00243919|1779704|FG001|Overall Study|Withdrawal by Subject|6
825060|NCT00243919|1779705|FG002|Overall Study|Withdrawal by Subject|2
825061|NCT00243919|1779703|FG000|Overall Study|Lost to Follow-up|6
825062|NCT00243919|1779704|FG001|Overall Study|Lost to Follow-up|7
825063|NCT00243919|1779705|FG002|Overall Study|Lost to Follow-up|3
825064|NCT00243919|1779703|FG000|Overall Study|Administrative Error|1
825065|NCT00243919|1779704|FG001|Overall Study|Administrative Error|0
825066|NCT00243919|1779705|FG002|Overall Study|Administrative Error|0
825067|NCT00243919|1779703|FG000|Overall Study|Physician Decision|1
825068|NCT00243919|1779704|FG001|Overall Study|Physician Decision|1
825069|NCT00243919|1779705|FG002|Overall Study|Physician Decision|0
825070|NCT00243932|1779716|FG000|Stage 1: Dose Selection|Lost to Follow-up|2
825071|NCT00243932|1779717|FG001|Stage 1: Dose Selection|Lost to Follow-up|0
825072|NCT00243932|1779718|FG002|Stage 1: Dose Selection|Lost to Follow-up|0
825073|NCT00244374|1779748|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
825074|NCT00244374|1779749|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
825075|NCT00244374|1779750|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
825076|NCT00244374|1779751|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
825077|NCT00244374|1779752|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
825078|NCT00244374|1779748|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
825079|NCT00244374|1779749|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
825080|NCT00244374|1779750|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
825081|NCT00244374|1779751|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
825082|NCT00244374|1779752|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
825083|NCT00244374|1779748|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
825084|NCT00244374|1779749|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
825085|NCT00244374|1779750|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
825086|NCT00244374|1779751|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
825087|NCT00244374|1779752|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
825088|NCT00244374|1779748|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
825089|NCT00244374|1779749|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
825090|NCT00244374|1779750|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
825091|NCT00244374|1779751|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
825092|NCT00244374|1779752|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
825093|NCT00244374|1779748|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
825094|NCT00244374|1779749|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
825095|NCT00244374|1779750|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
825096|NCT00244374|1779751|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
825097|NCT00244374|1779752|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
825098|NCT00244374|1779748|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
825099|NCT00244374|1779749|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
825100|NCT00244374|1779750|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
825101|NCT00244374|1779751|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
825102|NCT00244374|1779752|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
825103|NCT00244374|1779748|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
825104|NCT00244374|1779749|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
825105|NCT00244374|1779750|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
825106|NCT00244374|1779751|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
825107|NCT00244374|1779752|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
825108|NCT00244374|1779748|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
825109|NCT00244374|1779749|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
825110|NCT00244374|1779750|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
825111|NCT00244374|1779751|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
825112|NCT00244374|1779752|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
825113|NCT00244374|1779748|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
825114|NCT00244374|1779749|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
825115|NCT00244374|1779750|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
825116|NCT00244374|1779751|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
825117|NCT00244374|1779752|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
825118|NCT00244621|1779771|FG000|Double-blind Treatment Period|Lost to Follow-up|0
825119|NCT00244621|1779772|FG001|Double-blind Treatment Period|Lost to Follow-up|0
825120|NCT00244621|1779773|FG002|Double-blind Treatment Period|Lost to Follow-up|1
825121|NCT00244621|1779771|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
825122|NCT00244621|1779772|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
825123|NCT00244621|1779773|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
825124|NCT00244621|1779771|FG000|Double-blind Treatment Period|Lack of Efficacy|0
825125|NCT00244621|1779772|FG001|Double-blind Treatment Period|Lack of Efficacy|1
825126|NCT00244621|1779773|FG002|Double-blind Treatment Period|Lack of Efficacy|0
825127|NCT00244621|1779771|FG000|Double-blind Treatment Period|Multiple Reasons|2
825128|NCT00244621|1779772|FG001|Double-blind Treatment Period|Multiple Reasons|1
825129|NCT00244621|1779773|FG002|Double-blind Treatment Period|Multiple Reasons|1
825130|NCT00244621|1779771|FG000|Open-label Treatment Period|Lost to Follow-up|0
825131|NCT00244621|1779772|FG001|Open-label Treatment Period|Lost to Follow-up|1
825132|NCT00244621|1779773|FG002|Open-label Treatment Period|Lost to Follow-up|0
825133|NCT00244621|1779771|FG000|Open-label Treatment Period|Withdrawal by Subject|1
825134|NCT00244621|1779772|FG001|Open-label Treatment Period|Withdrawal by Subject|0
825135|NCT00244621|1779773|FG002|Open-label Treatment Period|Withdrawal by Subject|0
825136|NCT00244621|1779771|FG000|Open-label Treatment Period|Adverse Event|0
825137|NCT00244621|1779772|FG001|Open-label Treatment Period|Adverse Event|0
825138|NCT00244621|1779773|FG002|Open-label Treatment Period|Adverse Event|1
825139|NCT00244621|1779771|FG000|Open-label Treatment Period|Moved abroad|0
825140|NCT00244621|1779772|FG001|Open-label Treatment Period|Moved abroad|0
825141|NCT00244621|1779773|FG002|Open-label Treatment Period|Moved abroad|1
825142|NCT00244712|1779783|FG000|Overall Study|Adverse Event|20
825143|NCT00244712|1779784|FG001|Overall Study|Adverse Event|21
825144|NCT00244712|1779783|FG000|Overall Study|Protocol-Defined Virologic Failure|8
825145|NCT00244712|1779784|FG001|Overall Study|Protocol-Defined Virologic Failure|6
825146|NCT00244712|1779783|FG000|Overall Study|Lack of Compliance|10
825147|NCT00244712|1779784|FG001|Overall Study|Lack of Compliance|11
825148|NCT00244712|1779783|FG000|Overall Study|Lost to Follow-up|45
825149|NCT00244712|1779784|FG001|Overall Study|Lost to Follow-up|52
825150|NCT00244712|1779783|FG000|Overall Study|Withdrawal by Subject|13
825151|NCT00244712|1779784|FG001|Overall Study|Withdrawal by Subject|23
825152|NCT00244712|1779783|FG000|Overall Study|Protocol Violation, disease progression|13
825153|NCT00244712|1779784|FG001|Overall Study|Protocol Violation, disease progression|11
825154|NCT00244725|1779794|FG000|Overall Study|Lost to Follow-up|3
825155|NCT00244725|1779795|FG001|Overall Study|Lost to Follow-up|4
825156|NCT00244725|1779796|FG002|Overall Study|Lost to Follow-up|9
825157|NCT00244725|1779797|FG003|Overall Study|Lost to Follow-up|2
825158|NCT00244725|1779794|FG000|Overall Study|Withdrawal by Subject|9
825159|NCT00244725|1779795|FG001|Overall Study|Withdrawal by Subject|7
825160|NCT00244725|1779796|FG002|Overall Study|Withdrawal by Subject|7
825161|NCT00244725|1779797|FG003|Overall Study|Withdrawal by Subject|8
825162|NCT00244725|1779794|FG000|Overall Study|Not meet treatment eligibility criteria|1
825163|NCT00244725|1779795|FG001|Overall Study|Not meet treatment eligibility criteria|2
825164|NCT00244725|1779796|FG002|Overall Study|Not meet treatment eligibility criteria|0
825165|NCT00244725|1779797|FG003|Overall Study|Not meet treatment eligibility criteria|0
825166|NCT00244725|1779794|FG000|Overall Study|Physician Decision|3
825167|NCT00244725|1779795|FG001|Overall Study|Physician Decision|0
825168|NCT00244725|1779796|FG002|Overall Study|Physician Decision|1
825169|NCT00244725|1779797|FG003|Overall Study|Physician Decision|2
825170|NCT00244725|1779794|FG000|Overall Study|Adverse Events|3
825171|NCT00244725|1779795|FG001|Overall Study|Adverse Events|1
825172|NCT00244725|1779796|FG002|Overall Study|Adverse Events|4
825173|NCT00244725|1779797|FG003|Overall Study|Adverse Events|4
825174|NCT00244725|1779794|FG000|Overall Study|Withdrwal by participant|1
825175|NCT00244725|1779795|FG001|Overall Study|Withdrwal by participant|0
825176|NCT00244725|1779796|FG002|Overall Study|Withdrwal by participant|0
825177|NCT00244725|1779797|FG003|Overall Study|Withdrwal by participant|1
825178|NCT00244725|1779794|FG000|Overall Study|Liver function test abnormality|2
825179|NCT00244725|1779795|FG001|Overall Study|Liver function test abnormality|0
825180|NCT00244725|1779796|FG002|Overall Study|Liver function test abnormality|0
825181|NCT00244725|1779797|FG003|Overall Study|Liver function test abnormality|1
825182|NCT00244725|1779794|FG000|Overall Study|Sponsor withdrew the participant|1
825183|NCT00244725|1779795|FG001|Overall Study|Sponsor withdrew the participant|0
825184|NCT00244725|1779796|FG002|Overall Study|Sponsor withdrew the participant|0
825185|NCT00244725|1779797|FG003|Overall Study|Sponsor withdrew the participant|1
825186|NCT00244725|1779794|FG000|Overall Study|Mediciation Error|0
825187|NCT00244725|1779795|FG001|Overall Study|Mediciation Error|1
825188|NCT00244725|1779796|FG002|Overall Study|Mediciation Error|0
825189|NCT00244725|1779797|FG003|Overall Study|Mediciation Error|0
825190|NCT00244725|1779794|FG000|Overall Study|Rehab Refused to allow participantion|0
825191|NCT00244725|1779795|FG001|Overall Study|Rehab Refused to allow participantion|1
825192|NCT00244725|1779796|FG002|Overall Study|Rehab Refused to allow participantion|0
825193|NCT00244725|1779797|FG003|Overall Study|Rehab Refused to allow participantion|0
825194|NCT00244725|1779794|FG000|Overall Study|Headache|0
825195|NCT00244725|1779795|FG001|Overall Study|Headache|1
825196|NCT00244725|1779796|FG002|Overall Study|Headache|0
825197|NCT00244725|1779797|FG003|Overall Study|Headache|0
825198|NCT00244725|1779794|FG000|Overall Study|Received prohibited medication|0
825199|NCT00244725|1779795|FG001|Overall Study|Received prohibited medication|1
825200|NCT00244725|1779796|FG002|Overall Study|Received prohibited medication|0
825201|NCT00244725|1779797|FG003|Overall Study|Received prohibited medication|1
825202|NCT00244725|1779794|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0
825203|NCT00244725|1779795|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1
825204|NCT00244725|1779796|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0
825205|NCT00244725|1779797|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0
825206|NCT00244725|1779794|FG000|Overall Study|Administrative reason|0
825207|NCT00244725|1779795|FG001|Overall Study|Administrative reason|0
825208|NCT00244725|1779796|FG002|Overall Study|Administrative reason|1
825209|NCT00244725|1779797|FG003|Overall Study|Administrative reason|0
825210|NCT00244725|1779794|FG000|Overall Study|Vomit|0
825211|NCT00244725|1779795|FG001|Overall Study|Vomit|0
825212|NCT00244725|1779796|FG002|Overall Study|Vomit|1
825213|NCT00244725|1779797|FG003|Overall Study|Vomit|0
825214|NCT00244725|1779794|FG000|Overall Study|Failed to follow-up|0
825215|NCT00244725|1779795|FG001|Overall Study|Failed to follow-up|0
825216|NCT00244725|1779796|FG002|Overall Study|Failed to follow-up|1
825217|NCT00244725|1779797|FG003|Overall Study|Failed to follow-up|1
825218|NCT00244751|1779810|FG000|Overall Study|Adverse Event|7
825219|NCT00244751|1779811|FG001|Overall Study|Adverse Event|7
825220|NCT00244751|1779812|FG002|Overall Study|Adverse Event|5
825221|NCT00244751|1779810|FG000|Overall Study|Lost to Follow-up|0
825222|NCT00244751|1779811|FG001|Overall Study|Lost to Follow-up|1
825223|NCT00244751|1779812|FG002|Overall Study|Lost to Follow-up|0
825224|NCT00244751|1779810|FG000|Overall Study|Protocol Violation|1
825225|NCT00244751|1779811|FG001|Overall Study|Protocol Violation|0
825226|NCT00244751|1779812|FG002|Overall Study|Protocol Violation|1
825227|NCT00244751|1779810|FG000|Overall Study|Withdrawal by Subject|7
825228|NCT00244751|1779811|FG001|Overall Study|Withdrawal by Subject|5
825229|NCT00244751|1779812|FG002|Overall Study|Withdrawal by Subject|3
825230|NCT00244751|1779810|FG000|Overall Study|Elevated liver enzymes|1
825231|NCT00244751|1779811|FG001|Overall Study|Elevated liver enzymes|0
825232|NCT00244751|1779812|FG002|Overall Study|Elevated liver enzymes|0
825233|NCT00244751|1779810|FG000|Overall Study|Lack of compliance with protocol|0
825234|NCT00244751|1779811|FG001|Overall Study|Lack of compliance with protocol|1
825235|NCT00244751|1779812|FG002|Overall Study|Lack of compliance with protocol|0
825236|NCT00244751|1779810|FG000|Overall Study|Safety reasons|0
825237|NCT00244751|1779811|FG001|Overall Study|Safety reasons|1
825238|NCT00244751|1779812|FG002|Overall Study|Safety reasons|0
825239|NCT00244751|1779810|FG000|Overall Study|Participant randomized by mistake|0
825240|NCT00244751|1779811|FG001|Overall Study|Participant randomized by mistake|0
825241|NCT00244751|1779812|FG002|Overall Study|Participant randomized by mistake|1
825242|NCT00244764|1779829|FG000|Overall Study|Adverse Event|37
825243|NCT00244764|1779829|FG000|Overall Study|Lost to Follow-up|23
825244|NCT00244764|1779829|FG000|Overall Study|Withdrawal by Subject|12
825245|NCT00244764|1779829|FG000|Overall Study|Disease Progression|13
825246|NCT00244764|1779829|FG000|Overall Study|Protocol Violation|2
825247|NCT00244764|1779829|FG000|Overall Study|Death|1
825248|NCT00244764|1779829|FG000|Overall Study|Off Study Medication for >21 Days|1
825249|NCT00244764|1779829|FG000|Overall Study|Declining Performance Status|1
825250|NCT00244764|1779829|FG000|Overall Study|Participant was Hospitalized until Death|1
825251|NCT00244764|1779829|FG000|Overall Study|Primary Investigator Discretion|2
825252|NCT00244764|1779829|FG000|Overall Study|Sponsor Terminated Study|2
825253|NCT00244764|1779829|FG000|Overall Study|Developed Secondary Malignancy|1
825254|NCT00244855|1779836|FG000|Overall Study|Withdrawal by Subject|0
825255|NCT00244855|1779837|FG001|Overall Study|Withdrawal by Subject|1
825256|NCT00244881|1779845|FG000|Overall Study|Withdrawal by Subject|3
825257|NCT00244933|1779849|FG000|Overall Study|Not response evaluable|2
825258|NCT00245011|1779857|FG000|Overall Study|Lack of Efficacy|1
825259|NCT00245037|1779861|FG000|Overall Study|Death|17
825260|NCT00245050|1779867|FG000|Overall Study|Adverse Event|3
825261|NCT00245050|1779868|FG001|Overall Study|Adverse Event|2
825262|NCT00245063|1779876|FG000|Overall Study|Adverse Event|6
825263|NCT00245063|1779877|FG001|Overall Study|Adverse Event|5
825264|NCT00245063|1779876|FG000|Overall Study|Death|1
825265|NCT00245063|1779877|FG001|Overall Study|Death|0
825266|NCT00245102|1779889|FG000|Overall Study|Not Treated|1
825267|NCT00245102|1779890|FG001|Overall Study|Not Treated|0
825268|NCT00245102|1779891|FG002|Overall Study|Not Treated|1
825269|NCT00245102|1779892|FG003|Overall Study|Not Treated|0
825270|NCT00245102|1779893|FG004|Overall Study|Not Treated|0
825271|NCT00245102|1779894|FG005|Overall Study|Not Treated|0
825272|NCT00245102|1779889|FG000|Overall Study|Protocol Violation|1
825273|NCT00245102|1779890|FG001|Overall Study|Protocol Violation|0
825274|NCT00245102|1779891|FG002|Overall Study|Protocol Violation|0
825275|NCT00245102|1779892|FG003|Overall Study|Protocol Violation|0
825276|NCT00245102|1779893|FG004|Overall Study|Protocol Violation|0
825277|NCT00245102|1779894|FG005|Overall Study|Protocol Violation|0
825278|NCT00245102|1779889|FG000|Overall Study|Death|0
825279|NCT00245102|1779890|FG001|Overall Study|Death|0
825280|NCT00245102|1779891|FG002|Overall Study|Death|0
825281|NCT00245102|1779892|FG003|Overall Study|Death|1
825282|NCT00245102|1779893|FG004|Overall Study|Death|0
825283|NCT00245102|1779894|FG005|Overall Study|Death|0
825284|NCT00245102|1779889|FG000|Overall Study|Adverse Event|4
825285|NCT00245102|1779890|FG001|Overall Study|Adverse Event|2
825286|NCT00245102|1779891|FG002|Overall Study|Adverse Event|5
825287|NCT00245102|1779892|FG003|Overall Study|Adverse Event|1
825288|NCT00245102|1779893|FG004|Overall Study|Adverse Event|0
825289|NCT00245102|1779894|FG005|Overall Study|Adverse Event|2
825290|NCT00245102|1779889|FG000|Overall Study|Decline in performance|0
825291|NCT00245102|1779890|FG001|Overall Study|Decline in performance|2
825292|NCT00245102|1779891|FG002|Overall Study|Decline in performance|0
825293|NCT00245102|1779892|FG003|Overall Study|Decline in performance|1
825294|NCT00245102|1779893|FG004|Overall Study|Decline in performance|0
825295|NCT00245102|1779894|FG005|Overall Study|Decline in performance|2
825296|NCT00245102|1779889|FG000|Overall Study|Participant needed surgery|0
825297|NCT00245102|1779890|FG001|Overall Study|Participant needed surgery|0
825298|NCT00245102|1779891|FG002|Overall Study|Participant needed surgery|1
825299|NCT00245102|1779892|FG003|Overall Study|Participant needed surgery|0
825300|NCT00245102|1779893|FG004|Overall Study|Participant needed surgery|0
825301|NCT00245102|1779894|FG005|Overall Study|Participant needed surgery|0
825302|NCT00245102|1779889|FG000|Overall Study|Clinical progression|1
825303|NCT00245102|1779890|FG001|Overall Study|Clinical progression|0
825304|NCT00245102|1779891|FG002|Overall Study|Clinical progression|0
825305|NCT00245102|1779892|FG003|Overall Study|Clinical progression|0
825306|NCT00245102|1779893|FG004|Overall Study|Clinical progression|0
825307|NCT00245102|1779894|FG005|Overall Study|Clinical progression|0
825308|NCT00245466|1779924|FG000|Overall Study|Adverse Event|2
825309|NCT00245466|1779925|FG001|Overall Study|Adverse Event|8
825310|NCT00245466|1779926|FG002|Overall Study|Adverse Event|4
825311|NCT00245466|1779924|FG000|Overall Study|Low prostate specific antigen suppr|16
825312|NCT00245466|1779925|FG001|Overall Study|Low prostate specific antigen suppr|14
825313|NCT00245466|1779926|FG002|Overall Study|Low prostate specific antigen suppr|5
825314|NCT00245466|1779924|FG000|Overall Study|Insufficient testosterone suppr|12
825315|NCT00245466|1779925|FG001|Overall Study|Insufficient testosterone suppr|12
825316|NCT00245466|1779926|FG002|Overall Study|Insufficient testosterone suppr|21
825317|NCT00245466|1779924|FG000|Overall Study|Insufficient PSA and testosterone suppr|0
825318|NCT00245466|1779925|FG001|Overall Study|Insufficient PSA and testosterone suppr|0
825319|NCT00245466|1779926|FG002|Overall Study|Insufficient PSA and testosterone suppr|3
825320|NCT00245466|1779924|FG000|Overall Study|Withdrawal by Subject|2
825321|NCT00245466|1779925|FG001|Overall Study|Withdrawal by Subject|2
825322|NCT00245466|1779926|FG002|Overall Study|Withdrawal by Subject|1
825323|NCT00245466|1779924|FG000|Overall Study|Lost to Follow-up|3
825324|NCT00245466|1779925|FG001|Overall Study|Lost to Follow-up|0
825325|NCT00245466|1779926|FG002|Overall Study|Lost to Follow-up|0
825326|NCT00245466|1779924|FG000|Overall Study|Disease progression|0
825327|NCT00245466|1779925|FG001|Overall Study|Disease progression|3
825328|NCT00245466|1779926|FG002|Overall Study|Disease progression|1
825329|NCT00245466|1779924|FG000|Overall Study|Protocol Violation|1
825330|NCT00245466|1779925|FG001|Overall Study|Protocol Violation|2
825331|NCT00245466|1779926|FG002|Overall Study|Protocol Violation|2
825332|NCT00245466|1779924|FG000|Overall Study|Death|0
825333|NCT00245466|1779925|FG001|Overall Study|Death|2
825334|NCT00245466|1779926|FG002|Overall Study|Death|0
825335|NCT00245466|1779924|FG000|Overall Study|Administrative reasons|0
825336|NCT00245466|1779925|FG001|Overall Study|Administrative reasons|1
825337|NCT00245466|1779926|FG002|Overall Study|Administrative reasons|0
825338|NCT00245570|1779953|FG000|Washout Between Periods III and IV|Adverse Event|0
825339|NCT00245570|1779954|FG001|Washout Between Periods III and IV|Adverse Event|1
825340|NCT00245570|1779955|FG002|Washout Between Periods III and IV|Adverse Event|0
825341|NCT00245570|1779956|FG003|Washout Between Periods III and IV|Adverse Event|0
825342|NCT00245570|1779957|FG004|Washout Between Periods III and IV|Adverse Event|0
825343|NCT00245570|1779958|FG005|Washout Between Periods III and IV|Adverse Event|0
825344|NCT00245583|1779971|FG000|Overall Study|Lost to Follow-up|1
825345|NCT00245583|1779972|FG001|Overall Study|Lost to Follow-up|5
825346|NCT00245583|1779971|FG000|Overall Study|Adverse Event|2
825347|NCT00245583|1779972|FG001|Overall Study|Adverse Event|1
825348|NCT00245583|1779971|FG000|Overall Study|Lack of Efficacy|1
825349|NCT00245583|1779972|FG001|Overall Study|Lack of Efficacy|0
825350|NCT00245583|1779971|FG000|Overall Study|Withdrawal by Subject|2
825351|NCT00245583|1779972|FG001|Overall Study|Withdrawal by Subject|3
825352|NCT00245765|1779990|FG000|Overall Study|Adverse Event|1
825353|NCT00245765|1779991|FG001|Overall Study|Adverse Event|1
825354|NCT00245765|1779992|FG002|Overall Study|Adverse Event|0
825355|NCT00245765|1779990|FG000|Overall Study|Lack of Efficacy|14
825356|NCT00245765|1779991|FG001|Overall Study|Lack of Efficacy|7
825357|NCT00245765|1779992|FG002|Overall Study|Lack of Efficacy|0
825358|NCT00245765|1779990|FG000|Overall Study|Lost to Follow-up|1
825359|NCT00245765|1779991|FG001|Overall Study|Lost to Follow-up|2
825360|NCT00245765|1779992|FG002|Overall Study|Lost to Follow-up|0
825361|NCT00245765|1779990|FG000|Overall Study|Withdrawal by Subject|1
825362|NCT00245765|1779991|FG001|Overall Study|Withdrawal by Subject|0
825363|NCT00245765|1779992|FG002|Overall Study|Withdrawal by Subject|3
825364|NCT00245765|1779990|FG000|Overall Study|Other reason|2
825365|NCT00245765|1779991|FG001|Overall Study|Other reason|0
825366|NCT00245765|1779992|FG002|Overall Study|Other reason|1
825367|NCT00245765|1779990|FG000|Overall Study|Other|13
825368|NCT00245765|1779991|FG001|Overall Study|Other|4
825369|NCT00245765|1779992|FG002|Overall Study|Other|4
825370|NCT00245856|1780000|FG000|Period Two|Withdrawal by Subject|0
825371|NCT00245856|1780001|FG001|Period Two|Withdrawal by Subject|1
825382|NCT00246012|1780026|FG000|Overall Study|Adverse Event|0
825383|NCT00246012|1780027|FG001|Overall Study|Adverse Event|0
825384|NCT00246012|1780028|FG002|Overall Study|Adverse Event|0
825385|NCT00246012|1780029|FG003|Overall Study|Adverse Event|0
825386|NCT00246012|1780030|FG004|Overall Study|Adverse Event|0
825387|NCT00246012|1780031|FG005|Overall Study|Adverse Event|1
825388|NCT00246012|1780032|FG006|Overall Study|Adverse Event|0
825389|NCT00246012|1780033|FG007|Overall Study|Adverse Event|0
825390|NCT00246012|1780034|FG008|Overall Study|Adverse Event|2
825391|NCT00246012|1780026|FG000|Overall Study|Withdrawal by Subject|0
825392|NCT00246012|1780027|FG001|Overall Study|Withdrawal by Subject|0
825393|NCT00246012|1780028|FG002|Overall Study|Withdrawal by Subject|0
825394|NCT00246012|1780029|FG003|Overall Study|Withdrawal by Subject|0
825395|NCT00246012|1780030|FG004|Overall Study|Withdrawal by Subject|0
825396|NCT00246012|1780031|FG005|Overall Study|Withdrawal by Subject|1
825397|NCT00246012|1780032|FG006|Overall Study|Withdrawal by Subject|0
825398|NCT00246012|1780033|FG007|Overall Study|Withdrawal by Subject|0
825399|NCT00246012|1780034|FG008|Overall Study|Withdrawal by Subject|0
825400|NCT00246012|1780026|FG000|Overall Study|Disease progression|3
825401|NCT00246012|1780027|FG001|Overall Study|Disease progression|1
825402|NCT00246012|1780028|FG002|Overall Study|Disease progression|2
825403|NCT00246012|1780029|FG003|Overall Study|Disease progression|3
825404|NCT00246012|1780030|FG004|Overall Study|Disease progression|3
825405|NCT00246012|1780031|FG005|Overall Study|Disease progression|25
825406|NCT00246012|1780032|FG006|Overall Study|Disease progression|30
825407|NCT00246012|1780033|FG007|Overall Study|Disease progression|27
825408|NCT00246012|1780034|FG008|Overall Study|Disease progression|26
825409|NCT00246012|1780026|FG000|Overall Study|Other|0
825410|NCT00246012|1780027|FG001|Overall Study|Other|0
825411|NCT00246012|1780028|FG002|Overall Study|Other|0
825412|NCT00246012|1780029|FG003|Overall Study|Other|0
825413|NCT00246012|1780030|FG004|Overall Study|Other|0
825414|NCT00246012|1780031|FG005|Overall Study|Other|0
825415|NCT00246012|1780032|FG006|Overall Study|Other|0
825416|NCT00246012|1780033|FG007|Overall Study|Other|1
825417|NCT00246012|1780034|FG008|Overall Study|Other|0
825418|NCT00246012|1780026|FG000|Overall Study|Randomly assigned but not treated|0
825419|NCT00246012|1780027|FG001|Overall Study|Randomly assigned but not treated|0
825420|NCT00246012|1780028|FG002|Overall Study|Randomly assigned but not treated|0
825421|NCT00246012|1780029|FG003|Overall Study|Randomly assigned but not treated|0
825422|NCT00246012|1780030|FG004|Overall Study|Randomly assigned but not treated|0
825423|NCT00246012|1780031|FG005|Overall Study|Randomly assigned but not treated|1
825424|NCT00246012|1780032|FG006|Overall Study|Randomly assigned but not treated|1
825425|NCT00246012|1780033|FG007|Overall Study|Randomly assigned but not treated|0
825426|NCT00246012|1780034|FG008|Overall Study|Randomly assigned but not treated|0
825427|NCT00246025|1780060|FG000|Overall Study|Adverse Event|7
825428|NCT00246025|1780061|FG001|Overall Study|Adverse Event|9
825429|NCT00246025|1780062|FG002|Overall Study|Adverse Event|9
825430|NCT00246025|1780063|FG003|Overall Study|Adverse Event|10
825431|NCT00246025|1780060|FG000|Overall Study|Withdrawal by Subject|3
825432|NCT00246025|1780061|FG001|Overall Study|Withdrawal by Subject|0
825433|NCT00246025|1780062|FG002|Overall Study|Withdrawal by Subject|1
825434|NCT00246025|1780063|FG003|Overall Study|Withdrawal by Subject|2
825435|NCT00246025|1780060|FG000|Overall Study|unsuitable medical history was found|0
825436|NCT00246025|1780061|FG001|Overall Study|unsuitable medical history was found|0
825437|NCT00246025|1780062|FG002|Overall Study|unsuitable medical history was found|0
825438|NCT00246025|1780063|FG003|Overall Study|unsuitable medical history was found|1
825439|NCT00246090|1780073|FG000|Overall Study|Adverse Event|25
825440|NCT00246090|1780073|FG000|Overall Study|Withdrawal by Subject|7
825441|NCT00246090|1780073|FG000|Overall Study|Progressive Disease|212
825442|NCT00246090|1780073|FG000|Overall Study|Clinical Progression|30
825443|NCT00246090|1780073|FG000|Overall Study|Physician Decision|11
825444|NCT00246090|1780073|FG000|Overall Study|Not Otherwise Specified|10
825445|NCT00246129|1780079|FG000|Overall Study|Lost to Follow-up|1
825446|NCT00246129|1780080|FG001|Overall Study|Lost to Follow-up|0
825447|NCT00246129|1780079|FG000|Overall Study|Death|2
825448|NCT00246129|1780080|FG001|Overall Study|Death|1
825449|NCT00246129|1780079|FG000|Overall Study|suffered primary non-function|1
825450|NCT00246129|1780080|FG001|Overall Study|suffered primary non-function|0
825451|NCT00246129|1780079|FG000|Overall Study|grafts failed|3
825452|NCT00246129|1780080|FG001|Overall Study|grafts failed|1
825453|NCT00246259|1780091|FG000|Overall Study|Other|3
825454|NCT00246259|1780092|FG001|Overall Study|Other|3
825455|NCT00246259|1780091|FG000|Overall Study|Not stable by Week 18|2
825456|NCT00246259|1780092|FG001|Overall Study|Not stable by Week 18|1
825457|NCT00246259|1780091|FG000|Overall Study|Participant non-compliant|4
825458|NCT00246259|1780092|FG001|Overall Study|Participant non-compliant|9
825459|NCT00246259|1780091|FG000|Overall Study|Lack of Efficacy|2
825460|NCT00246259|1780092|FG001|Overall Study|Lack of Efficacy|2
825461|NCT00246259|1780091|FG000|Overall Study|Investigator withdrew participant|2
825462|NCT00246259|1780092|FG001|Overall Study|Investigator withdrew participant|0
825463|NCT00246259|1780091|FG000|Overall Study|Adverse Event|5
825464|NCT00246259|1780092|FG001|Overall Study|Adverse Event|0
825465|NCT00246259|1780091|FG000|Overall Study|Lost to Follow-up|3
825466|NCT00246259|1780092|FG001|Overall Study|Lost to Follow-up|4
825467|NCT00246259|1780091|FG000|Overall Study|Withdrawal by Subject|5
825468|NCT00246259|1780092|FG001|Overall Study|Withdrawal by Subject|1
825469|NCT00246259|1780091|FG000|Overall Study|randomly assigned, not eligible for ITT|2
825470|NCT00246259|1780092|FG001|Overall Study|randomly assigned, not eligible for ITT|6
825471|NCT00246324|1780098|FG000|Overall Study|Withdrawal by Subject|1
825472|NCT00246337|1780111|FG000|Overall Study|Lost to Follow-up|3
825473|NCT00246337|1780112|FG001|Overall Study|Lost to Follow-up|0
825474|NCT00246337|1780113|FG002|Overall Study|Lost to Follow-up|0
825475|NCT00246337|1780114|FG003|Overall Study|Lost to Follow-up|0
825476|NCT00246337|1780115|FG004|Overall Study|Lost to Follow-up|2
825477|NCT00246337|1780116|FG005|Overall Study|Lost to Follow-up|2
825478|NCT00246337|1780117|FG006|Overall Study|Lost to Follow-up|1
825479|NCT00246337|1780118|FG007|Overall Study|Lost to Follow-up|2
825480|NCT00246337|1780119|FG008|Overall Study|Lost to Follow-up|0
825481|NCT00246337|1780111|FG000|Overall Study|Protocol Violation|1
825482|NCT00246337|1780112|FG001|Overall Study|Protocol Violation|0
825483|NCT00246337|1780113|FG002|Overall Study|Protocol Violation|0
825484|NCT00246337|1780114|FG003|Overall Study|Protocol Violation|0
825485|NCT00246337|1780115|FG004|Overall Study|Protocol Violation|1
825486|NCT00246337|1780116|FG005|Overall Study|Protocol Violation|0
825487|NCT00246337|1780117|FG006|Overall Study|Protocol Violation|1
825488|NCT00246337|1780118|FG007|Overall Study|Protocol Violation|1
825489|NCT00246337|1780119|FG008|Overall Study|Protocol Violation|0
825490|NCT00246337|1780111|FG000|Overall Study|Withdrawal by Subject|2
825491|NCT00246337|1780112|FG001|Overall Study|Withdrawal by Subject|0
825492|NCT00246337|1780113|FG002|Overall Study|Withdrawal by Subject|0
825493|NCT00246337|1780114|FG003|Overall Study|Withdrawal by Subject|0
825494|NCT00246337|1780115|FG004|Overall Study|Withdrawal by Subject|0
825495|NCT00246337|1780116|FG005|Overall Study|Withdrawal by Subject|0
825496|NCT00246337|1780117|FG006|Overall Study|Withdrawal by Subject|1
825497|NCT00246337|1780118|FG007|Overall Study|Withdrawal by Subject|1
825498|NCT00246337|1780119|FG008|Overall Study|Withdrawal by Subject|0
825499|NCT00246337|1780111|FG000|Overall Study|Lack of Qualifying Event|8
825500|NCT00246337|1780112|FG001|Overall Study|Lack of Qualifying Event|2
825501|NCT00246337|1780113|FG002|Overall Study|Lack of Qualifying Event|1
825502|NCT00246337|1780114|FG003|Overall Study|Lack of Qualifying Event|1
825503|NCT00246337|1780115|FG004|Overall Study|Lack of Qualifying Event|1
825504|NCT00246337|1780116|FG005|Overall Study|Lack of Qualifying Event|3
825505|NCT00246337|1780117|FG006|Overall Study|Lack of Qualifying Event|3
825506|NCT00246337|1780118|FG007|Overall Study|Lack of Qualifying Event|2
825507|NCT00246337|1780119|FG008|Overall Study|Lack of Qualifying Event|5
825508|NCT00246337|1780111|FG000|Overall Study|Site Terminated|10
825509|NCT00246337|1780112|FG001|Overall Study|Site Terminated|0
825510|NCT00246337|1780113|FG002|Overall Study|Site Terminated|0
825511|NCT00246337|1780114|FG003|Overall Study|Site Terminated|0
825512|NCT00246337|1780115|FG004|Overall Study|Site Terminated|0
825513|NCT00246337|1780116|FG005|Overall Study|Site Terminated|7
825514|NCT00246337|1780117|FG006|Overall Study|Site Terminated|1
825515|NCT00246337|1780118|FG007|Overall Study|Site Terminated|6
825516|NCT00246337|1780119|FG008|Overall Study|Site Terminated|2
825517|NCT00246337|1780111|FG000|Overall Study|Abnormal baseline lab values|7
825518|NCT00246337|1780112|FG001|Overall Study|Abnormal baseline lab values|0
825519|NCT00246337|1780113|FG002|Overall Study|Abnormal baseline lab values|2
825520|NCT00246337|1780114|FG003|Overall Study|Abnormal baseline lab values|0
825521|NCT00246337|1780115|FG004|Overall Study|Abnormal baseline lab values|0
825522|NCT00246337|1780116|FG005|Overall Study|Abnormal baseline lab values|2
825523|NCT00246337|1780117|FG006|Overall Study|Abnormal baseline lab values|2
825524|NCT00246337|1780118|FG007|Overall Study|Abnormal baseline lab values|0
825525|NCT00246337|1780119|FG008|Overall Study|Abnormal baseline lab values|4
825526|NCT00246337|1780111|FG000|Overall Study|Overwhelmed|0
825527|NCT00246337|1780112|FG001|Overall Study|Overwhelmed|0
825528|NCT00246337|1780113|FG002|Overall Study|Overwhelmed|0
825529|NCT00246337|1780114|FG003|Overall Study|Overwhelmed|0
825530|NCT00246337|1780115|FG004|Overall Study|Overwhelmed|0
825531|NCT00246337|1780116|FG005|Overall Study|Overwhelmed|1
825532|NCT00246337|1780117|FG006|Overall Study|Overwhelmed|0
825533|NCT00246337|1780118|FG007|Overall Study|Overwhelmed|0
825534|NCT00246337|1780119|FG008|Overall Study|Overwhelmed|0
825535|NCT00246337|1780111|FG000|Overall Study|Protocol Violator|1
825536|NCT00246337|1780112|FG001|Overall Study|Protocol Violator|0
825537|NCT00246337|1780113|FG002|Overall Study|Protocol Violator|0
825538|NCT00246337|1780114|FG003|Overall Study|Protocol Violator|0
825539|NCT00246337|1780115|FG004|Overall Study|Protocol Violator|0
825540|NCT00246337|1780116|FG005|Overall Study|Protocol Violator|0
825541|NCT00246337|1780117|FG006|Overall Study|Protocol Violator|0
825542|NCT00246337|1780118|FG007|Overall Study|Protocol Violator|0
825543|NCT00246337|1780119|FG008|Overall Study|Protocol Violator|0
825544|NCT00246337|1780111|FG000|Overall Study|Reported as completing trial in error|0
825545|NCT00246337|1780112|FG001|Overall Study|Reported as completing trial in error|0
825546|NCT00246337|1780113|FG002|Overall Study|Reported as completing trial in error|0
825547|NCT00246337|1780114|FG003|Overall Study|Reported as completing trial in error|0
825548|NCT00246337|1780115|FG004|Overall Study|Reported as completing trial in error|0
825549|NCT00246337|1780116|FG005|Overall Study|Reported as completing trial in error|0
825550|NCT00246337|1780117|FG006|Overall Study|Reported as completing trial in error|0
825551|NCT00246337|1780118|FG007|Overall Study|Reported as completing trial in error|1
825552|NCT00246337|1780119|FG008|Overall Study|Reported as completing trial in error|0
825553|NCT00246376|1780144|FG000|Overall Study|Dropped/withdrew during dietary run-in|11
825554|NCT00246376|1780145|FG001|Overall Study|Dropped/withdrew during dietary run-in|5
825555|NCT00246376|1780146|FG002|Overall Study|Dropped/withdrew during dietary run-in|4
825556|NCT00246376|1780147|FG003|Overall Study|Dropped/withdrew during dietary run-in|7
825557|NCT00246376|1780148|FG004|Overall Study|Dropped/withdrew during dietary run-in|3
825558|NCT00246376|1780144|FG000|Overall Study|Adverse Event|2
825559|NCT00246376|1780145|FG001|Overall Study|Adverse Event|3
825560|NCT00246376|1780146|FG002|Overall Study|Adverse Event|1
825561|NCT00246376|1780147|FG003|Overall Study|Adverse Event|3
825562|NCT00246376|1780148|FG004|Overall Study|Adverse Event|1
825563|NCT00246376|1780144|FG000|Overall Study|Lost to Follow-up|2
825564|NCT00246376|1780145|FG001|Overall Study|Lost to Follow-up|11
825565|NCT00246376|1780146|FG002|Overall Study|Lost to Follow-up|11
825566|NCT00246376|1780147|FG003|Overall Study|Lost to Follow-up|16
825567|NCT00246376|1780148|FG004|Overall Study|Lost to Follow-up|13
825568|NCT00246571|1780186|FG000|Overall Study|Adverse Event|7
825569|NCT00246571|1780187|FG001|Overall Study|Adverse Event|0
825570|NCT00246571|1780186|FG000|Overall Study|Protocol Violation|0
825571|NCT00246571|1780187|FG001|Overall Study|Protocol Violation|1
825572|NCT00246571|1780186|FG000|Overall Study|Withdrawal by Subject|2
825573|NCT00246571|1780187|FG001|Overall Study|Withdrawal by Subject|3
825574|NCT00246571|1780186|FG000|Overall Study|Lack of Efficacy|84
825575|NCT00246571|1780187|FG001|Overall Study|Lack of Efficacy|21
825576|NCT00246571|1780186|FG000|Overall Study|Death|17
825577|NCT00246571|1780187|FG001|Overall Study|Death|3
825578|NCT00246571|1780186|FG000|Overall Study|Sponsor|0
825579|NCT00246571|1780187|FG001|Overall Study|Sponsor|1
825580|NCT00246571|1780186|FG000|Overall Study|Did not meet entrance criteria|2
825581|NCT00246571|1780187|FG001|Overall Study|Did not meet entrance criteria|1
825582|NCT00246571|1780186|FG000|Overall Study|Laboratory abnormalities|1
825583|NCT00246571|1780187|FG001|Overall Study|Laboratory abnormalities|0
825584|NCT00246571|1780186|FG000|Overall Study|Crossover participants|0
825585|NCT00246571|1780187|FG001|Overall Study|Crossover participants|74
825586|NCT00246740|1780195|FG000|Initial Enrollment|Death|1
825587|NCT00246740|1780196|FG001|Initial Enrollment|Death|0
825588|NCT00246740|1780195|FG000|Initial Enrollment|Additional surgery scheduled|0
825589|NCT00246740|1780196|FG001|Initial Enrollment|Additional surgery scheduled|2
825590|NCT00246740|1780195|FG000|Initial Enrollment|Surgery schedule change|4
825591|NCT00246740|1780196|FG001|Initial Enrollment|Surgery schedule change|4
825592|NCT00246740|1780195|FG000|Initial Enrollment|Other|1
825593|NCT00246740|1780196|FG001|Initial Enrollment|Other|2
825594|NCT00246753|1780202|FG000|Overall Study|Withdrawal by Subject|2
825595|NCT00246753|1780202|FG000|Overall Study|Physician Decision|2
825596|NCT00246753|1780202|FG000|Overall Study|Adverse Event|2
825597|NCT00246753|1780202|FG000|Overall Study|Unacceptable toxicity|2
825598|NCT00246805|1780208|FG000|Phase 1|Lost to Follow-up|1
825599|NCT00246805|1780209|FG001|Phase 1|Lost to Follow-up|0
825600|NCT00247273|1780217|FG000|Overall Study|Adverse Event|85
825601|NCT00247273|1780218|FG001|Overall Study|Adverse Event|80
825602|NCT00247273|1780217|FG000|Overall Study|Physician Decision|6
825603|NCT00247273|1780218|FG001|Overall Study|Physician Decision|3
825604|NCT00247273|1780217|FG000|Overall Study|Lost to Follow-up|7
825605|NCT00247273|1780218|FG001|Overall Study|Lost to Follow-up|7
825606|NCT00247273|1780217|FG000|Overall Study|Withdrawal by Subject|46
825607|NCT00247273|1780218|FG001|Overall Study|Withdrawal by Subject|47
825608|NCT00247273|1780217|FG000|Overall Study|Did not take any study drug|2
825609|NCT00247273|1780218|FG001|Overall Study|Did not take any study drug|0
825610|NCT00247416|1780235|FG000|Overall Study|3 patients were found to be ineligible|1
825611|NCT00247416|1780236|FG001|Overall Study|3 patients were found to be ineligible|2
825612|NCT00247611|1780246|FG000|Baselined|Completed baseline, never placed on ARVs|8
825613|NCT00247611|1780247|FG001|Baselined|Completed baseline, never placed on ARVs|5
825614|NCT00247611|1780246|FG000|Baselined|Completed baseline only|9
825615|NCT00247611|1780247|FG001|Baselined|Completed baseline only|8
825616|NCT00247676|1780268|FG000|Overall Study|Death|5
825617|NCT00247676|1780268|FG000|Overall Study|Adverse Event|11
825618|NCT00247676|1780268|FG000|Overall Study|Lack of Efficacy|15
825619|NCT00247676|1780268|FG000|Overall Study|Other|3
825620|NCT00247676|1780268|FG000|Overall Study|Withdrawal by Subject|2
825621|NCT00247962|1780289|FG000|Overall Study|Adverse Event|15
825622|NCT00247962|1780290|FG001|Overall Study|Adverse Event|12
825623|NCT00247962|1780289|FG000|Overall Study|Lost to Follow-up|3
825624|NCT00247962|1780290|FG001|Overall Study|Lost to Follow-up|1
825625|NCT00247962|1780289|FG000|Overall Study|Physician Decision|0
825626|NCT00247962|1780290|FG001|Overall Study|Physician Decision|1
825627|NCT00247962|1780289|FG000|Overall Study|Protocol Violation|1
825628|NCT00247962|1780290|FG001|Overall Study|Protocol Violation|1
825629|NCT00247962|1780289|FG000|Overall Study|Withdrawal by Subject|3
825630|NCT00247962|1780290|FG001|Overall Study|Withdrawal by Subject|2
825631|NCT00247962|1780289|FG000|Overall Study|Lack of Efficacy|4
825632|NCT00247962|1780290|FG001|Overall Study|Lack of Efficacy|2
825633|NCT00248040|1780299|FG000|Overall Study|transplantectomy|2
825634|NCT00248040|1780300|FG001|Overall Study|transplantectomy|1
825635|NCT00248040|1780301|FG002|Overall Study|transplantectomy|3
825636|NCT00248040|1780299|FG000|Overall Study|transplant cancelled post treat start|1
825637|NCT00248040|1780300|FG001|Overall Study|transplant cancelled post treat start|0
825638|NCT00248040|1780301|FG002|Overall Study|transplant cancelled post treat start|0
825639|NCT00248040|1780299|FG000|Overall Study|Death|0
825640|NCT00248040|1780300|FG001|Overall Study|Death|0
825641|NCT00248040|1780301|FG002|Overall Study|Death|1
825642|NCT00248170|1780312|FG000|Overall Study|Withdrawal by Subject|71
825643|NCT00248170|1780313|FG001|Overall Study|Withdrawal by Subject|79
825644|NCT00248170|1780312|FG000|Overall Study|Protocol Violation|35
825645|NCT00248170|1780313|FG001|Overall Study|Protocol Violation|30
825646|NCT00248170|1780312|FG000|Overall Study|Lost to Follow-up|28
825647|NCT00248170|1780313|FG001|Overall Study|Lost to Follow-up|35
825648|NCT00248170|1780312|FG000|Overall Study|Disease progression|196
825649|NCT00248170|1780313|FG001|Overall Study|Disease progression|216
825650|NCT00248170|1780312|FG000|Overall Study|Death|28
825651|NCT00248170|1780313|FG001|Overall Study|Death|47
825652|NCT00248170|1780312|FG000|Overall Study|Adverse Event|311
825653|NCT00248170|1780313|FG001|Overall Study|Adverse Event|296
825654|NCT00248170|1780312|FG000|Overall Study|Administrative problems|22
825655|NCT00248170|1780313|FG001|Overall Study|Administrative problems|25
825656|NCT00248170|1780312|FG000|Overall Study|Abnormal test procedure(s) result|49
825657|NCT00248170|1780313|FG001|Overall Study|Abnormal test procedure(s) result|61
825658|NCT00248170|1780312|FG000|Overall Study|Abnormal laboratory values|4
825659|NCT00248170|1780313|FG001|Overall Study|Abnormal laboratory values|0
825660|NCT00248170|1780312|FG000|Overall Study|Protocol deviation|17
825661|NCT00248170|1780313|FG001|Overall Study|Protocol deviation|19
825674|NCT00248495|1780328|FG000|Overall Study|Withdrawal by Subject|1
825675|NCT00248625|1780371|FG000|Overall Study|Withdrawal by Subject|0
825676|NCT00248625|1780372|FG001|Overall Study|Withdrawal by Subject|2
825677|NCT00248651|1780392|FG000|Overall Study|Withdrawal by Subject|28
825678|NCT00248651|1780393|FG001|Overall Study|Withdrawal by Subject|40
825679|NCT00248651|1780394|FG002|Overall Study|Withdrawal by Subject|32
825680|NCT00248794|1780414|FG000|Overall Study|Lost to Follow-up|6
825681|NCT00248794|1780415|FG001|Overall Study|Lost to Follow-up|8
825682|NCT00248794|1780416|FG002|Overall Study|Lost to Follow-up|3
825683|NCT00248833|1780448|FG000|Overall Study|Adverse Event|2
825684|NCT00248833|1780449|FG001|Overall Study|Adverse Event|0
825685|NCT00248833|1780450|FG002|Overall Study|Adverse Event|0
825686|NCT00248833|1780448|FG000|Overall Study|Withdrawal by Subject|0
825687|NCT00248833|1780449|FG001|Overall Study|Withdrawal by Subject|1
825688|NCT00248833|1780450|FG002|Overall Study|Withdrawal by Subject|1
825689|NCT00248833|1780448|FG000|Overall Study|Lost to Follow-up|1
825690|NCT00248833|1780449|FG001|Overall Study|Lost to Follow-up|1
825691|NCT00248833|1780450|FG002|Overall Study|Lost to Follow-up|1
825692|NCT00248833|1780448|FG000|Overall Study|Other|0
825693|NCT00248833|1780449|FG001|Overall Study|Other|1
825694|NCT00248833|1780450|FG002|Overall Study|Other|0
825695|NCT00249002|1780460|FG000|Overall Study|Adverse Event|2
825696|NCT00249002|1780460|FG000|Overall Study|Study cancellation|3
825697|NCT00249002|1780460|FG000|Overall Study|Other|2
825698|NCT00249288|1780483|FG000|Overall Study|Lost to Follow-up|3
825699|NCT00249288|1780484|FG001|Overall Study|Lost to Follow-up|3
825700|NCT00249288|1780483|FG000|Overall Study|Withdrawal by Subject|2
825701|NCT00249288|1780484|FG001|Overall Study|Withdrawal by Subject|2
825702|NCT00249444|1780509|FG000|Overall Study|Lost to Follow-up|2
825703|NCT00249444|1780510|FG001|Overall Study|Lost to Follow-up|2
825704|NCT00249444|1780509|FG000|Overall Study|non-compliant|9
825705|NCT00249444|1780510|FG001|Overall Study|non-compliant|11
825706|NCT00249444|1780509|FG000|Overall Study|Adverse Event|1
825707|NCT00249444|1780510|FG001|Overall Study|Adverse Event|1
825708|NCT00249444|1780509|FG000|Overall Study|life event|0
825709|NCT00249444|1780510|FG001|Overall Study|life event|1
825710|NCT00249613|1780538|FG000|12 Month Follow-up|Death|1
825711|NCT00249613|1780539|FG001|12 Month Follow-up|Death|1
825712|NCT00249613|1780538|FG000|12 Month Follow-up|Withdrawal by Subject|6
825713|NCT00249613|1780539|FG001|12 Month Follow-up|Withdrawal by Subject|6
825714|NCT00249613|1780538|FG000|12 Month Follow-up|Lost to Follow-up|10
825715|NCT00249613|1780539|FG001|12 Month Follow-up|Lost to Follow-up|8
825716|NCT00249769|1780551|FG000|Overall Study|Withdrawal by Subject|1
825717|NCT00249769|1780552|FG001|Overall Study|Withdrawal by Subject|10
825718|NCT00249769|1780553|FG002|Overall Study|Withdrawal by Subject|6
825719|NCT00249769|1780551|FG000|Overall Study|Migration from Study Area|1
825720|NCT00249769|1780552|FG001|Overall Study|Migration from Study Area|3
825721|NCT00249769|1780553|FG002|Overall Study|Migration from Study Area|14
825722|NCT00249769|1780551|FG000|Overall Study|Miscellaneous|0
825723|NCT00249769|1780552|FG001|Overall Study|Miscellaneous|2
825724|NCT00249769|1780553|FG002|Overall Study|Miscellaneous|2
825725|NCT00249769|1780551|FG000|Overall Study|Adverse Event|0
825726|NCT00249769|1780552|FG001|Overall Study|Adverse Event|0
825727|NCT00249769|1780553|FG002|Overall Study|Adverse Event|1
825728|NCT00249769|1780551|FG000|Overall Study|Physician Decision|0
825729|NCT00249769|1780552|FG001|Overall Study|Physician Decision|0
825730|NCT00249769|1780553|FG002|Overall Study|Physician Decision|2
825731|NCT00249769|1780551|FG000|Overall Study|Lost to Follow-up|0
825732|NCT00249769|1780552|FG001|Overall Study|Lost to Follow-up|0
825733|NCT00249769|1780553|FG002|Overall Study|Lost to Follow-up|3
825734|NCT00249795|1780563|FG000|Overall Study|Not treated|16
825735|NCT00249795|1780564|FG001|Overall Study|Not treated|14
825736|NCT00249795|1780563|FG000|Overall Study|Symptomatic hypotension|127
825737|NCT00249795|1780564|FG001|Overall Study|Symptomatic hypotension|64
825738|NCT00249795|1780563|FG000|Overall Study|Other Serious Adverse Event|84
825739|NCT00249795|1780564|FG001|Overall Study|Other Serious Adverse Event|93
825740|NCT00249795|1780563|FG000|Overall Study|Qualifying condition not present|26
825741|NCT00249795|1780564|FG001|Overall Study|Qualifying condition not present|29
825742|NCT00249795|1780563|FG000|Overall Study|Withdrawal by Subject|678
825743|NCT00249795|1780564|FG001|Overall Study|Withdrawal by Subject|742
825744|NCT00249795|1780563|FG000|Overall Study|Thromboembolic / outcome event|39
825745|NCT00249795|1780564|FG001|Overall Study|Thromboembolic / outcome event|45
825746|NCT00249795|1780563|FG000|Overall Study|Oral anticoagulant required|2
825747|NCT00249795|1780564|FG001|Overall Study|Oral anticoagulant required|0
825748|NCT00249795|1780563|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
825749|NCT00249795|1780564|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
825750|NCT00249795|1780563|FG000|Overall Study|Non-compliance|71
825751|NCT00249795|1780564|FG001|Overall Study|Non-compliance|69
825752|NCT00249795|1780563|FG000|Overall Study|Study drug intolerance|3
825753|NCT00249795|1780564|FG001|Overall Study|Study drug intolerance|3
825754|NCT00249795|1780563|FG000|Overall Study|Other adverse events (non-serious)|188
825755|NCT00249795|1780564|FG001|Overall Study|Other adverse events (non-serious)|159
825756|NCT00249795|1780563|FG000|Overall Study|Physician withdrew consent|71
825757|NCT00249795|1780564|FG001|Overall Study|Physician withdrew consent|63
825758|NCT00249795|1780563|FG000|Overall Study|Surgery / procedure|4
825759|NCT00249795|1780564|FG001|Overall Study|Surgery / procedure|5
825760|NCT00249795|1780563|FG000|Overall Study|Angiotensin II receptor blocker required|35
825761|NCT00249795|1780564|FG001|Overall Study|Angiotensin II receptor blocker required|58
825762|NCT00249795|1780563|FG000|Overall Study|Lightheadedness / dizziness|15
825763|NCT00249795|1780564|FG001|Overall Study|Lightheadedness / dizziness|11
825764|NCT00249795|1780563|FG000|Overall Study|Hypotension (non-symptomatic)|5
825765|NCT00249795|1780564|FG001|Overall Study|Hypotension (non-symptomatic)|5
825766|NCT00249795|1780563|FG000|Overall Study|Other contraindicated medication|1
825767|NCT00249795|1780564|FG001|Overall Study|Other contraindicated medication|1
825768|NCT00249795|1780563|FG000|Overall Study|Event related to cardiac condition|17
825769|NCT00249795|1780564|FG001|Overall Study|Event related to cardiac condition|16
825770|NCT00249795|1780563|FG000|Overall Study|Patient not wish to continue after May08|4
825771|NCT00249795|1780564|FG001|Overall Study|Patient not wish to continue after May08|6
825772|NCT00249795|1780563|FG000|Overall Study|Site not agree to continue after May08|1
825773|NCT00249795|1780564|FG001|Overall Study|Site not agree to continue after May08|1
825774|NCT00249795|1780563|FG000|Overall Study|Lost to Follow-up|0
825775|NCT00249795|1780564|FG001|Overall Study|Lost to Follow-up|2
825776|NCT00249795|1780563|FG000|Overall Study|Missing|0
825777|NCT00249795|1780564|FG001|Overall Study|Missing|1
825778|NCT00249808|1780570|FG000|Overall Study|Other|27
825779|NCT00249808|1780570|FG000|Overall Study|Protocol Violation|3
825780|NCT00249808|1780570|FG000|Overall Study|Lost to Follow-up|8
825781|NCT00249808|1780570|FG000|Overall Study|Adverse Event|81
825782|NCT00249808|1780570|FG000|Overall Study|Lack of Efficacy|52
825783|NCT00249808|1780570|FG000|Overall Study|Did Not Provide Post-Baseline Data|11
825784|NCT00249821|1780576|FG000|Overall Study|Technical problem|0
825785|NCT00249821|1780577|FG001|Overall Study|Technical problem|1
825786|NCT00249834|1780591|FG000|Overall Study|Ovarian stimulation failed|1
825787|NCT00249834|1780592|FG001|Overall Study|Ovarian stimulation failed|0
825788|NCT00249834|1780593|FG002|Overall Study|Ovarian stimulation failed|0
825789|NCT00249834|1780594|FG003|Overall Study|Ovarian stimulation failed|0
825790|NCT00249834|1780595|FG004|Overall Study|Ovarian stimulation failed|0
825791|NCT00249834|1780596|FG005|Overall Study|Ovarian stimulation failed|0
825792|NCT00249834|1780597|FG006|Overall Study|Ovarian stimulation failed|0
825793|NCT00249834|1780598|FG007|Overall Study|Ovarian stimulation failed|0
825794|NCT00249834|1780591|FG000|Overall Study|Failure of down-regulation|0
825795|NCT00249834|1780592|FG001|Overall Study|Failure of down-regulation|0
825796|NCT00249834|1780593|FG002|Overall Study|Failure of down-regulation|0
825797|NCT00249834|1780594|FG003|Overall Study|Failure of down-regulation|0
825798|NCT00249834|1780595|FG004|Overall Study|Failure of down-regulation|0
825799|NCT00249834|1780596|FG005|Overall Study|Failure of down-regulation|0
825800|NCT00249834|1780597|FG006|Overall Study|Failure of down-regulation|1
825801|NCT00249834|1780598|FG007|Overall Study|Failure of down-regulation|0
825802|NCT00249834|1780591|FG000|Overall Study|Protocol Violation|0
825803|NCT00249834|1780592|FG001|Overall Study|Protocol Violation|19
825804|NCT00249834|1780593|FG002|Overall Study|Protocol Violation|14
825805|NCT00249834|1780594|FG003|Overall Study|Protocol Violation|8
825806|NCT00249834|1780595|FG004|Overall Study|Protocol Violation|5
825807|NCT00249834|1780596|FG005|Overall Study|Protocol Violation|2
825808|NCT00249834|1780597|FG006|Overall Study|Protocol Violation|0
825809|NCT00249834|1780598|FG007|Overall Study|Protocol Violation|0
825810|NCT00249873|1780612|FG000|Overall Study|Not treated|7
825811|NCT00249873|1780613|FG001|Overall Study|Not treated|8
825812|NCT00249873|1780612|FG000|Overall Study|Significant thrombocytopenia|9
825813|NCT00249873|1780613|FG001|Overall Study|Significant thrombocytopenia|8
825814|NCT00249873|1780612|FG000|Overall Study|Severe allergic reaction|8
825815|NCT00249873|1780613|FG001|Overall Study|Severe allergic reaction|1
825816|NCT00249873|1780612|FG000|Overall Study|Serious haemorrhagic Adverse Event|74
825817|NCT00249873|1780613|FG001|Overall Study|Serious haemorrhagic Adverse Event|30
825818|NCT00249873|1780612|FG000|Overall Study|Other Serious Adverse Event|86
825819|NCT00249873|1780613|FG001|Overall Study|Other Serious Adverse Event|97
825820|NCT00249873|1780612|FG000|Overall Study|Qualifying condition not present|20
825821|NCT00249873|1780613|FG001|Overall Study|Qualifying condition not present|23
825822|NCT00249873|1780612|FG000|Overall Study|Contraindication to oral anticoagulant|4
825823|NCT00249873|1780613|FG001|Overall Study|Contraindication to oral anticoagulant|8
825824|NCT00249873|1780612|FG000|Overall Study|Withdrawal by Subject|504
825825|NCT00249873|1780613|FG001|Overall Study|Withdrawal by Subject|466
825826|NCT00249873|1780612|FG000|Overall Study|Lost to Follow-up|4
825827|NCT00249873|1780613|FG001|Overall Study|Lost to Follow-up|7
825828|NCT00249873|1780612|FG000|Overall Study|Minor bleeding|99
825829|NCT00249873|1780613|FG001|Overall Study|Minor bleeding|37
825830|NCT00249873|1780612|FG000|Overall Study|Non-compliance|41
825831|NCT00249873|1780613|FG001|Overall Study|Non-compliance|46
825832|NCT00249873|1780612|FG000|Overall Study|Other non serious Adverse Event|112
825833|NCT00249873|1780613|FG001|Overall Study|Other non serious Adverse Event|108
825834|NCT00249873|1780612|FG000|Overall Study|Other contraindicated medication|1
825835|NCT00249873|1780613|FG001|Overall Study|Other contraindicated medication|0
825836|NCT00249873|1780612|FG000|Overall Study|Patient not wish to continue after May08|3
825837|NCT00249873|1780613|FG001|Overall Study|Patient not wish to continue after May08|4
825838|NCT00249873|1780612|FG000|Overall Study|Physician withdrew consent|59
825839|NCT00249873|1780613|FG001|Overall Study|Physician withdrew consent|60
825840|NCT00249873|1780612|FG000|Overall Study|Open label clopidogrel required|31
825841|NCT00249873|1780613|FG001|Overall Study|Open label clopidogrel required|42
825842|NCT00249873|1780612|FG000|Overall Study|Angiotensin II receptor blocker required|1
825843|NCT00249873|1780613|FG001|Overall Study|Angiotensin II receptor blocker required|0
825844|NCT00249873|1780612|FG000|Overall Study|Oral anticoagulant required|159
825845|NCT00249873|1780613|FG001|Overall Study|Oral anticoagulant required|157
825846|NCT00249873|1780612|FG000|Overall Study|Study drug intolerance|5
825847|NCT00249873|1780613|FG001|Overall Study|Study drug intolerance|0
825848|NCT00249873|1780612|FG000|Overall Study|Surgery/ procedure|9
825849|NCT00249873|1780613|FG001|Overall Study|Surgery/ procedure|9
825850|NCT00249873|1780612|FG000|Overall Study|Event related to cardiac condition|12
825851|NCT00249873|1780613|FG001|Overall Study|Event related to cardiac condition|21
825852|NCT00249873|1780612|FG000|Overall Study|Thromboembolic/outcome event|82
825853|NCT00249873|1780613|FG001|Overall Study|Thromboembolic/outcome event|122
825854|NCT00250276|1780623|FG000|Overall Study|Serious Adverse Event|0
825855|NCT00250276|1780624|FG001|Overall Study|Serious Adverse Event|0
825856|NCT00250276|1780625|FG002|Overall Study|Serious Adverse Event|1
825857|NCT00250276|1780626|FG003|Overall Study|Serious Adverse Event|0
825858|NCT00250276|1780623|FG000|Overall Study|Non-serious Adverse Event|2
825859|NCT00250276|1780624|FG001|Overall Study|Non-serious Adverse Event|0
825860|NCT00250276|1780625|FG002|Overall Study|Non-serious Adverse Event|0
825861|NCT00250276|1780626|FG003|Overall Study|Non-serious Adverse Event|2
825862|NCT00250276|1780623|FG000|Overall Study|Protocol Violation|0
825863|NCT00250276|1780624|FG001|Overall Study|Protocol Violation|1
825864|NCT00250276|1780625|FG002|Overall Study|Protocol Violation|0
825865|NCT00250276|1780626|FG003|Overall Study|Protocol Violation|0
825866|NCT00250276|1780623|FG000|Overall Study|Withdrawal by Subject|1
825867|NCT00250276|1780624|FG001|Overall Study|Withdrawal by Subject|2
825868|NCT00250276|1780625|FG002|Overall Study|Withdrawal by Subject|3
825869|NCT00250276|1780626|FG003|Overall Study|Withdrawal by Subject|2
825870|NCT00250276|1780623|FG000|Overall Study|Migrated/moved from study area|3
825871|NCT00250276|1780624|FG001|Overall Study|Migrated/moved from study area|0
825872|NCT00250276|1780625|FG002|Overall Study|Migrated/moved from study area|2
825873|NCT00250276|1780626|FG003|Overall Study|Migrated/moved from study area|7
825874|NCT00250276|1780623|FG000|Overall Study|Lost to Follow-up|11
825875|NCT00250276|1780624|FG001|Overall Study|Lost to Follow-up|18
825876|NCT00250276|1780625|FG002|Overall Study|Lost to Follow-up|13
825877|NCT00250276|1780626|FG003|Overall Study|Lost to Follow-up|8
825878|NCT00250432|1780643|FG000|Overall Study|Adverse Event|25
825879|NCT00250432|1780644|FG001|Overall Study|Adverse Event|29
825880|NCT00250432|1780643|FG000|Overall Study|Lack of Efficacy|2
825881|NCT00250432|1780644|FG001|Overall Study|Lack of Efficacy|1
825882|NCT00250432|1780643|FG000|Overall Study|Lost to Follow-up|6
825883|NCT00250432|1780644|FG001|Overall Study|Lost to Follow-up|5
825884|NCT00250432|1780643|FG000|Overall Study|Patient Moved|0
825885|NCT00250432|1780644|FG001|Overall Study|Patient Moved|1
825886|NCT00250432|1780643|FG000|Overall Study|Protocol Violation|0
825887|NCT00250432|1780644|FG001|Overall Study|Protocol Violation|3
825888|NCT00250432|1780643|FG000|Overall Study|Withdrawal by Subject|6
825889|NCT00250432|1780644|FG001|Overall Study|Withdrawal by Subject|2
825890|NCT00250432|1780643|FG000|Overall Study|Pt died out of posttherapy report period|6
825891|NCT00250432|1780644|FG001|Overall Study|Pt died out of posttherapy report period|5
825892|NCT00250432|1780643|FG000|Overall Study|Pt was considered untreatable|0
825893|NCT00250432|1780644|FG001|Overall Study|Pt was considered untreatable|1
825894|NCT00250458|1780652|FG000|Overall Study|Lost to Follow-up|4
825895|NCT00250458|1780653|FG001|Overall Study|Lost to Follow-up|2
825896|NCT00250458|1780652|FG000|Overall Study|Protocol Violation|0
825897|NCT00250458|1780653|FG001|Overall Study|Protocol Violation|1
825898|NCT00250458|1780652|FG000|Overall Study|Withdrawal by Subject|4
825899|NCT00250458|1780653|FG001|Overall Study|Withdrawal by Subject|2
825900|NCT00250458|1780652|FG000|Overall Study|Lack of Migraine Attack|20
825901|NCT00250458|1780653|FG001|Overall Study|Lack of Migraine Attack|9
825902|NCT00250458|1780652|FG000|Overall Study|Qualifying migraine but did not treat|3
825903|NCT00250458|1780653|FG001|Overall Study|Qualifying migraine but did not treat|3
825904|NCT00250458|1780652|FG000|Overall Study|Other|1
825905|NCT00250458|1780653|FG001|Overall Study|Other|0
825906|NCT00250588|1780680|FG000|Overall Study|Withdrawal by Subject|3
825907|NCT00250588|1780681|FG001|Overall Study|Withdrawal by Subject|6
825908|NCT00250588|1780682|FG002|Overall Study|Withdrawal by Subject|0
825909|NCT00250588|1780680|FG000|Overall Study|Lost to Follow-up|6
825910|NCT00250588|1780681|FG001|Overall Study|Lost to Follow-up|13
825911|NCT00250588|1780682|FG002|Overall Study|Lost to Follow-up|13
825912|NCT00250679|1780693|FG000|Overall Study|Adverse Event|12
825913|NCT00250679|1780694|FG001|Overall Study|Adverse Event|15
825914|NCT00250679|1780695|FG002|Overall Study|Adverse Event|16
825915|NCT00250679|1780693|FG000|Overall Study|Protocol Violation|2
825916|NCT00250679|1780694|FG001|Overall Study|Protocol Violation|4
825917|NCT00250679|1780695|FG002|Overall Study|Protocol Violation|3
825918|NCT00250679|1780693|FG000|Overall Study|Withdrawal by Subject|15
825919|NCT00250679|1780694|FG001|Overall Study|Withdrawal by Subject|18
825920|NCT00250679|1780695|FG002|Overall Study|Withdrawal by Subject|15
825921|NCT00250679|1780693|FG000|Overall Study|Lost to Follow-up|3
825922|NCT00250679|1780694|FG001|Overall Study|Lost to Follow-up|4
825923|NCT00250679|1780695|FG002|Overall Study|Lost to Follow-up|2
825924|NCT00250679|1780693|FG000|Overall Study|Does Not Meet Entry Criteria|1
825925|NCT00250679|1780694|FG001|Overall Study|Does Not Meet Entry Criteria|4
825926|NCT00250679|1780695|FG002|Overall Study|Does Not Meet Entry Criteria|2
825927|NCT00250679|1780693|FG000|Overall Study|Lack of Efficacy|0
825928|NCT00250679|1780694|FG001|Overall Study|Lack of Efficacy|1
825929|NCT00250679|1780695|FG002|Overall Study|Lack of Efficacy|3
825930|NCT00250679|1780693|FG000|Overall Study|Technical Holter issues|1
825931|NCT00250679|1780694|FG001|Overall Study|Technical Holter issues|0
825932|NCT00250679|1780695|FG002|Overall Study|Technical Holter issues|2
825933|NCT00250679|1780693|FG000|Overall Study|Moved|1
825934|NCT00250679|1780694|FG001|Overall Study|Moved|1
825935|NCT00250679|1780695|FG002|Overall Study|Moved|0
825936|NCT00250679|1780693|FG000|Overall Study|Non-compliance|1
825937|NCT00250679|1780694|FG001|Overall Study|Non-compliance|1
825938|NCT00250679|1780695|FG002|Overall Study|Non-compliance|0
825939|NCT00250679|1780693|FG000|Overall Study|various single events: hip surgery,diary|3
825940|NCT00250679|1780694|FG001|Overall Study|various single events: hip surgery,diary|1
825941|NCT00250679|1780695|FG002|Overall Study|various single events: hip surgery,diary|1
825942|NCT00250705|1780703|FG000|Overall Study|Lack of Efficacy|2
825943|NCT00250835|1780709|FG000|Overall Study|Withdrawal by Subject|1
825944|NCT00251004|1780721|FG000|Overall Study|Withdrawal by Subject|23
825945|NCT00251004|1780722|FG001|Overall Study|Withdrawal by Subject|16
825946|NCT00251004|1780723|FG002|Overall Study|Withdrawal by Subject|14
825947|NCT00251004|1780721|FG000|Overall Study|Death|9
825948|NCT00251004|1780722|FG001|Overall Study|Death|10
825949|NCT00251004|1780723|FG002|Overall Study|Death|8
825950|NCT00251004|1780721|FG000|Overall Study|Lost to Follow-up|1
825951|NCT00251004|1780722|FG001|Overall Study|Lost to Follow-up|2
825952|NCT00251004|1780723|FG002|Overall Study|Lost to Follow-up|1
825953|NCT00251004|1780721|FG000|Overall Study|Graft Loss|12
825954|NCT00251004|1780722|FG001|Overall Study|Graft Loss|13
825955|NCT00251004|1780723|FG002|Overall Study|Graft Loss|8
825956|NCT00251316|1780757|FG000|Overall Study|Physician Decision|2
825957|NCT00251316|1780758|FG001|Overall Study|Physician Decision|3
825958|NCT00251589|1780768|FG000|Overall Study|Adverse Event|5
825959|NCT00251589|1780769|FG001|Overall Study|Adverse Event|1
825960|NCT00251589|1780770|FG002|Overall Study|Adverse Event|2
825961|NCT00251589|1780771|FG003|Overall Study|Adverse Event|1
825962|NCT00251589|1780768|FG000|Overall Study|Withdrawal by Subject|1
825963|NCT00251589|1780769|FG001|Overall Study|Withdrawal by Subject|1
825964|NCT00251589|1780770|FG002|Overall Study|Withdrawal by Subject|0
825965|NCT00251589|1780771|FG003|Overall Study|Withdrawal by Subject|0
825966|NCT00251589|1780768|FG000|Overall Study|Discontinued due to progressive disease|9
825967|NCT00251589|1780769|FG001|Overall Study|Discontinued due to progressive disease|1
825968|NCT00251589|1780770|FG002|Overall Study|Discontinued due to progressive disease|0
825969|NCT00251589|1780771|FG003|Overall Study|Discontinued due to progressive disease|1
825970|NCT00251641|1780783|FG000|Overall Study|Adverse Event|80
825971|NCT00251641|1780784|FG001|Overall Study|Adverse Event|8
825972|NCT00251641|1780783|FG000|Overall Study|Lack of Efficacy|2
825973|NCT00251641|1780784|FG001|Overall Study|Lack of Efficacy|1
825974|NCT00251641|1780783|FG000|Overall Study|Progression of Disease|0
825975|NCT00251641|1780784|FG001|Overall Study|Progression of Disease|2
825976|NCT00251641|1780783|FG000|Overall Study|Lost to Follow-up|3
825977|NCT00251641|1780784|FG001|Overall Study|Lost to Follow-up|3
825978|NCT00251641|1780783|FG000|Overall Study|Withdrawal by Subject|6
825979|NCT00251641|1780784|FG001|Overall Study|Withdrawal by Subject|8
825980|NCT00251641|1780783|FG000|Overall Study|Protocol Violation|10
825981|NCT00251641|1780784|FG001|Overall Study|Protocol Violation|2
825982|NCT00251641|1780783|FG000|Overall Study|Did not Meet protocol Eligibility|2
825983|NCT00251641|1780784|FG001|Overall Study|Did not Meet protocol Eligibility|1
825984|NCT00251641|1780783|FG000|Overall Study|Switched Treatment|9
825985|NCT00251641|1780784|FG001|Overall Study|Switched Treatment|63
825986|NCT00251693|1780795|FG000|Overall Study|Adverse Event|17
825987|NCT00251693|1780796|FG001|Overall Study|Adverse Event|9
825988|NCT00251693|1780797|FG002|Overall Study|Adverse Event|9
825989|NCT00251693|1780795|FG000|Overall Study|Protocol Violation|2
825990|NCT00251693|1780796|FG001|Overall Study|Protocol Violation|0
825991|NCT00251693|1780797|FG002|Overall Study|Protocol Violation|2
825992|NCT00251693|1780795|FG000|Overall Study|Lost to Follow-up|12
825993|NCT00251693|1780796|FG001|Overall Study|Lost to Follow-up|7
825994|NCT00251693|1780797|FG002|Overall Study|Lost to Follow-up|8
825995|NCT00251693|1780795|FG000|Overall Study|Withdrawal by Subject|11
825996|NCT00251693|1780796|FG001|Overall Study|Withdrawal by Subject|17
825997|NCT00251693|1780797|FG002|Overall Study|Withdrawal by Subject|14
825998|NCT00251693|1780795|FG000|Overall Study|Lack of Efficacy|0
825999|NCT00251693|1780796|FG001|Overall Study|Lack of Efficacy|1
826000|NCT00251693|1780797|FG002|Overall Study|Lack of Efficacy|0
826001|NCT00251693|1780795|FG000|Overall Study|Inclusion/exclusion criteria not met|5
826002|NCT00251693|1780796|FG001|Overall Study|Inclusion/exclusion criteria not met|3
826003|NCT00251693|1780797|FG002|Overall Study|Inclusion/exclusion criteria not met|8
826004|NCT00251693|1780795|FG000|Overall Study|Noncompliant|0
826005|NCT00251693|1780796|FG001|Overall Study|Noncompliant|0
826006|NCT00251693|1780797|FG002|Overall Study|Noncompliant|2
826007|NCT00251693|1780795|FG000|Overall Study|Possible Barrett's esophagus|3
826008|NCT00251693|1780796|FG001|Overall Study|Possible Barrett's esophagus|5
826009|NCT00251693|1780797|FG002|Overall Study|Possible Barrett's esophagus|2
826010|NCT00251693|1780795|FG000|Overall Study|Subject request/subject unavailable|1
826011|NCT00251693|1780796|FG001|Overall Study|Subject request/subject unavailable|2
826012|NCT00251693|1780797|FG002|Overall Study|Subject request/subject unavailable|0
826013|NCT00251693|1780795|FG000|Overall Study|Abnormal laboratory findings|0
826014|NCT00251693|1780796|FG001|Overall Study|Abnormal laboratory findings|0
826015|NCT00251693|1780797|FG002|Overall Study|Abnormal laboratory findings|1
826016|NCT00251719|1780808|FG000|Overall Study|Adverse Event|14
826017|NCT00251719|1780809|FG001|Overall Study|Adverse Event|8
826018|NCT00251719|1780810|FG002|Overall Study|Adverse Event|7
826019|NCT00251719|1780808|FG000|Overall Study|Protocol Violation|1
826020|NCT00251719|1780809|FG001|Overall Study|Protocol Violation|1
826021|NCT00251719|1780810|FG002|Overall Study|Protocol Violation|1
826022|NCT00251719|1780808|FG000|Overall Study|Lost to Follow-up|5
826023|NCT00251719|1780809|FG001|Overall Study|Lost to Follow-up|11
826024|NCT00251719|1780810|FG002|Overall Study|Lost to Follow-up|8
826025|NCT00251719|1780808|FG000|Overall Study|Withdrawal by Subject|14
826026|NCT00251719|1780809|FG001|Overall Study|Withdrawal by Subject|12
826027|NCT00251719|1780810|FG002|Overall Study|Withdrawal by Subject|11
826028|NCT00251719|1780808|FG000|Overall Study|Lack of Efficacy|2
826029|NCT00251719|1780809|FG001|Overall Study|Lack of Efficacy|1
826030|NCT00251719|1780810|FG002|Overall Study|Lack of Efficacy|0
826031|NCT00251719|1780808|FG000|Overall Study|Inclusion/exclusion criteria not met|12
826032|NCT00251719|1780809|FG001|Overall Study|Inclusion/exclusion criteria not met|6
826033|NCT00251719|1780810|FG002|Overall Study|Inclusion/exclusion criteria not met|2
826034|NCT00251719|1780808|FG000|Overall Study|Investigator decision|1
826035|NCT00251719|1780809|FG001|Overall Study|Investigator decision|1
826036|NCT00251719|1780810|FG002|Overall Study|Investigator decision|0
826037|NCT00251719|1780808|FG000|Overall Study|Noncompliance|2
826038|NCT00251719|1780809|FG001|Overall Study|Noncompliance|3
826039|NCT00251719|1780810|FG002|Overall Study|Noncompliance|1
826040|NCT00251719|1780808|FG000|Overall Study|Barrett's esophagus|2
826041|NCT00251719|1780809|FG001|Overall Study|Barrett's esophagus|2
826042|NCT00251719|1780810|FG002|Overall Study|Barrett's esophagus|0
826043|NCT00251745|1780821|FG000|Overall Study|Adverse Event|7
826044|NCT00251745|1780822|FG001|Overall Study|Adverse Event|9
826045|NCT00251745|1780823|FG002|Overall Study|Adverse Event|11
826046|NCT00251745|1780821|FG000|Overall Study|Lost to Follow-up|4
826047|NCT00251745|1780822|FG001|Overall Study|Lost to Follow-up|2
826048|NCT00251745|1780823|FG002|Overall Study|Lost to Follow-up|5
826049|NCT00251745|1780821|FG000|Overall Study|Withdrawal by Subject|13
826050|NCT00251745|1780822|FG001|Overall Study|Withdrawal by Subject|7
826051|NCT00251745|1780823|FG002|Overall Study|Withdrawal by Subject|3
826052|NCT00251745|1780821|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
826053|NCT00251745|1780822|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
826054|NCT00251745|1780823|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
826055|NCT00251745|1780821|FG000|Overall Study|Lack of Efficacy|3
826056|NCT00251745|1780822|FG001|Overall Study|Lack of Efficacy|0
826057|NCT00251745|1780823|FG002|Overall Study|Lack of Efficacy|0
826058|NCT00251745|1780821|FG000|Overall Study|Noncompliant|0
826059|NCT00251745|1780822|FG001|Overall Study|Noncompliant|2
826060|NCT00251745|1780823|FG002|Overall Study|Noncompliant|2
826061|NCT00251745|1780821|FG000|Overall Study|Pregnancy|0
826062|NCT00251745|1780822|FG001|Overall Study|Pregnancy|1
826063|NCT00251745|1780823|FG002|Overall Study|Pregnancy|0
826064|NCT00251745|1780821|FG000|Overall Study|Per Subject Request|0
826065|NCT00251745|1780822|FG001|Overall Study|Per Subject Request|0
826066|NCT00251745|1780823|FG002|Overall Study|Per Subject Request|1
826067|NCT00251745|1780821|FG000|Overall Study|Per Investigator Request|1
826068|NCT00251745|1780822|FG001|Overall Study|Per Investigator Request|0
826069|NCT00251745|1780823|FG002|Overall Study|Per Investigator Request|0
826070|NCT00251758|1780834|FG000|Overall Study|Adverse Event|7
826071|NCT00251758|1780835|FG001|Overall Study|Adverse Event|9
826072|NCT00251758|1780836|FG002|Overall Study|Adverse Event|11
826073|NCT00251758|1780834|FG000|Overall Study|Lost to Follow-up|4
826074|NCT00251758|1780835|FG001|Overall Study|Lost to Follow-up|2
826075|NCT00251758|1780836|FG002|Overall Study|Lost to Follow-up|5
826076|NCT00251758|1780834|FG000|Overall Study|Withdrawal by Subject|13
826077|NCT00251758|1780835|FG001|Overall Study|Withdrawal by Subject|7
826078|NCT00251758|1780836|FG002|Overall Study|Withdrawal by Subject|3
826079|NCT00251758|1780834|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
826080|NCT00251758|1780835|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
826081|NCT00251758|1780836|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
826082|NCT00251758|1780834|FG000|Overall Study|Lack of Efficacy|3
826083|NCT00251758|1780835|FG001|Overall Study|Lack of Efficacy|0
826084|NCT00251758|1780836|FG002|Overall Study|Lack of Efficacy|0
826085|NCT00251758|1780834|FG000|Overall Study|Noncompliant|0
826086|NCT00251758|1780835|FG001|Overall Study|Noncompliant|2
826087|NCT00251758|1780836|FG002|Overall Study|Noncompliant|2
826088|NCT00251758|1780834|FG000|Overall Study|Pregnancy|0
826089|NCT00251758|1780835|FG001|Overall Study|Pregnancy|1
826090|NCT00251758|1780836|FG002|Overall Study|Pregnancy|0
826091|NCT00251758|1780834|FG000|Overall Study|Per Subject Request|0
826092|NCT00251758|1780835|FG001|Overall Study|Per Subject Request|0
826093|NCT00251758|1780836|FG002|Overall Study|Per Subject Request|1
826094|NCT00251758|1780834|FG000|Overall Study|Per Investigator Request|1
826095|NCT00251758|1780835|FG001|Overall Study|Per Investigator Request|0
826096|NCT00251758|1780836|FG002|Overall Study|Per Investigator Request|0
826097|NCT00251927|1780859|FG000|Overall Study|Adverse Event|3
826098|NCT00251927|1780860|FG001|Overall Study|Adverse Event|15
826099|NCT00251927|1780859|FG000|Overall Study|Lack of Efficacy|22
826100|NCT00251927|1780860|FG001|Overall Study|Lack of Efficacy|16
826101|NCT00251927|1780859|FG000|Overall Study|Lost to Follow-up|22
826102|NCT00251927|1780860|FG001|Overall Study|Lost to Follow-up|8
826103|NCT00251927|1780859|FG000|Overall Study|Protocol Violation|1
826104|NCT00251927|1780860|FG001|Overall Study|Protocol Violation|2
826105|NCT00251927|1780859|FG000|Overall Study|Pregnancy|2
826106|NCT00251927|1780860|FG001|Overall Study|Pregnancy|0
826107|NCT00251927|1780859|FG000|Overall Study|Withdrawal by Subject|40
826108|NCT00251927|1780860|FG001|Overall Study|Withdrawal by Subject|25
826109|NCT00251927|1780859|FG000|Overall Study|Study-specific discont. achieved|13
826110|NCT00251927|1780860|FG001|Overall Study|Study-specific discont. achieved|2
826111|NCT00251927|1780859|FG000|Overall Study|Study procedure non-compliance|5
826112|NCT00251927|1780860|FG001|Overall Study|Study procedure non-compliance|6
826113|NCT00251979|1780869|FG000|Overall Study|Protocol Violation|3
826114|NCT00251979|1780870|FG001|Overall Study|Protocol Violation|5
826115|NCT00251979|1780869|FG000|Overall Study|Adverse Event|11
826116|NCT00251979|1780870|FG001|Overall Study|Adverse Event|17
826117|NCT00251979|1780869|FG000|Overall Study|Withdrawal by Subject|13
826118|NCT00251979|1780870|FG001|Overall Study|Withdrawal by Subject|7
826119|NCT00251979|1780869|FG000|Overall Study|Lost to Follow-up|8
826120|NCT00251979|1780870|FG001|Overall Study|Lost to Follow-up|6
826121|NCT00251979|1780869|FG000|Overall Study|Death|3
826122|NCT00251979|1780870|FG001|Overall Study|Death|5
826123|NCT00252057|1780878|FG000|Overall Study|Withdrawal by Subject|2
826124|NCT00252057|1780879|FG001|Overall Study|Withdrawal by Subject|5
826125|NCT00252057|1780878|FG000|Overall Study|Death|1
826126|NCT00252057|1780879|FG001|Overall Study|Death|2
826127|NCT00252057|1780878|FG000|Overall Study|Participant previously enrolled|0
826128|NCT00252057|1780879|FG001|Overall Study|Participant previously enrolled|1
826129|NCT00252187|1780887|FG000|Overall Study|Adverse Event|3
826130|NCT00252187|1780888|FG001|Overall Study|Adverse Event|1
826131|NCT00252187|1780887|FG000|Overall Study|Withdrawal by Subject|1
826132|NCT00252187|1780888|FG001|Overall Study|Withdrawal by Subject|0
826133|NCT00252239|1780898|FG000|Overall Study|Withdrawal by Subject|1
826134|NCT00252239|1780899|FG001|Overall Study|Withdrawal by Subject|0
826135|NCT00252239|1780900|FG002|Overall Study|Withdrawal by Subject|0
826136|NCT00252239|1780901|FG003|Overall Study|Withdrawal by Subject|1
826137|NCT00252239|1780898|FG000|Overall Study|Lost to Follow-up|0
826138|NCT00252239|1780899|FG001|Overall Study|Lost to Follow-up|0
826139|NCT00252239|1780900|FG002|Overall Study|Lost to Follow-up|2
826140|NCT00252239|1780901|FG003|Overall Study|Lost to Follow-up|0
826141|NCT00252499|1780918|FG000|Overall Study|Lost to Follow-up|1
826142|NCT00252499|1780919|FG001|Overall Study|Lost to Follow-up|0
826143|NCT00252499|1780920|FG002|Overall Study|Lost to Follow-up|0
826144|NCT00252564|1780945|FG000|Overall Study|Adverse Event|17
826145|NCT00252564|1780946|FG001|Overall Study|Adverse Event|13
826146|NCT00252564|1780945|FG000|Overall Study|Unrelated Complication|2
826147|NCT00252564|1780946|FG001|Overall Study|Unrelated Complication|1
826148|NCT00252564|1780945|FG000|Overall Study|Disease Progression|14
826149|NCT00252564|1780946|FG001|Overall Study|Disease Progression|20
826150|NCT00252564|1780945|FG000|Overall Study|Death|0
826151|NCT00252564|1780946|FG001|Overall Study|Death|3
826152|NCT00252564|1780945|FG000|Overall Study|Physician Decision|1
826153|NCT00252564|1780946|FG001|Overall Study|Physician Decision|0
826154|NCT00252564|1780945|FG000|Overall Study|Lost to Follow-up|1
826155|NCT00252564|1780946|FG001|Overall Study|Lost to Follow-up|0
826156|NCT00252564|1780945|FG000|Overall Study|Patient Request|4
826157|NCT00252564|1780946|FG001|Overall Study|Patient Request|5
826158|NCT00252564|1780945|FG000|Overall Study|Withdrawal by Subject|0
826159|NCT00252564|1780946|FG001|Overall Study|Withdrawal by Subject|2
826160|NCT00252577|1780952|FG000|Overall Study|Lost to Follow-up|20
826161|NCT00252694|1780989|FG000|Overall Study|Withdrawal by Subject|83
826162|NCT00252694|1780990|FG001|Overall Study|Withdrawal by Subject|91
826163|NCT00252694|1780989|FG000|Overall Study|Death|36
826164|NCT00252694|1780990|FG001|Overall Study|Death|34
826165|NCT00252694|1780989|FG000|Overall Study|Mostly Lost to Follow Up|8
826166|NCT00252694|1780990|FG001|Overall Study|Mostly Lost to Follow Up|13
826167|NCT00252694|1780989|FG000|Overall Study|Patient Moving|17
826168|NCT00252694|1780990|FG001|Overall Study|Patient Moving|16
826169|NCT00252720|1780998|FG000|Overall Study|Withdrawal by Subject|95
826170|NCT00252720|1780999|FG001|Overall Study|Withdrawal by Subject|97
826171|NCT00252720|1780998|FG000|Overall Study|Death|7
826172|NCT00252720|1780999|FG001|Overall Study|Death|8
826173|NCT00252720|1780998|FG000|Overall Study|Moving|23
826174|NCT00252720|1780999|FG001|Overall Study|Moving|42
826175|NCT00252720|1780998|FG000|Overall Study|Mainly patients lost to follow-up|7
826176|NCT00252720|1780999|FG001|Overall Study|Mainly patients lost to follow-up|18
826177|NCT00252733|1781007|FG000|Overall Study|Withdrawal by Subject|73
826178|NCT00252733|1781008|FG001|Overall Study|Withdrawal by Subject|67
826179|NCT00252733|1781007|FG000|Overall Study|Death|7
826180|NCT00252733|1781008|FG001|Overall Study|Death|5
826181|NCT00252733|1781007|FG000|Overall Study|Lost to Follow-up|12
826182|NCT00252733|1781008|FG001|Overall Study|Lost to Follow-up|6
826183|NCT00252733|1781007|FG000|Overall Study|Multiple Reasons|14
826184|NCT00252733|1781008|FG001|Overall Study|Multiple Reasons|14
826185|NCT00253370|1781036|FG000|Overall Study|Adverse Event|18
826186|NCT00253370|1781036|FG000|Overall Study|Disease progression|13
826187|NCT00253370|1781036|FG000|Overall Study|Death|2
826188|NCT00253370|1781036|FG000|Overall Study|Withdrawal by Subject|6
826189|NCT00253370|1781036|FG000|Overall Study|Non-protocol therapy|1
826190|NCT00253370|1781036|FG000|Overall Study|Physician Decision|1
826191|NCT00253370|1781036|FG000|Overall Study|Protocol Violation|1
826192|NCT00253370|1781036|FG000|Overall Study|Abdominal pain due to disease|1
826193|NCT00253448|1781050|FG000|Overall Study|Withdrawal by Subject|1
826194|NCT00253630|1781058|FG000|Overall Study|ineligible|2
826195|NCT00253643|1781066|FG000|Overall Study|Withdrawal by Subject|0
826196|NCT00253643|1781067|FG001|Overall Study|Withdrawal by Subject|0
826197|NCT00253643|1781068|FG002|Overall Study|Withdrawal by Subject|1
826198|NCT00253643|1781069|FG003|Overall Study|Withdrawal by Subject|1
826199|NCT00253643|1781066|FG000|Overall Study|Non-Compliance|0
826200|NCT00253643|1781067|FG001|Overall Study|Non-Compliance|0
826201|NCT00253643|1781068|FG002|Overall Study|Non-Compliance|0
826202|NCT00253643|1781069|FG003|Overall Study|Non-Compliance|2
826203|NCT00253747|1781094|FG000|Overall Study|Lost to Follow-up|13
826204|NCT00253747|1781095|FG001|Overall Study|Lost to Follow-up|14
826205|NCT00253747|1781094|FG000|Overall Study|Withdrawal by Subject|10
826206|NCT00253747|1781095|FG001|Overall Study|Withdrawal by Subject|11
826207|NCT00253747|1781094|FG000|Overall Study|Administrative Discharge (1), Other (2)|1
826208|NCT00253747|1781095|FG001|Overall Study|Administrative Discharge (1), Other (2)|2
826209|NCT00254163|1781131|FG000|Overall Study|Adverse Event|29
826210|NCT00254163|1781132|FG001|Overall Study|Adverse Event|26
826211|NCT00254163|1781131|FG000|Overall Study|Patient request/withdrew consent|6
826212|NCT00254163|1781132|FG001|Overall Study|Patient request/withdrew consent|4
826213|NCT00254163|1781131|FG000|Overall Study|Investigator request|1
826214|NCT00254163|1781132|FG001|Overall Study|Investigator request|3
826215|NCT00254163|1781131|FG000|Overall Study|Failed entry|1
826216|NCT00254163|1781132|FG001|Overall Study|Failed entry|3
826217|NCT00254163|1781131|FG000|Overall Study|Progressive disease|0
826218|NCT00254163|1781132|FG001|Overall Study|Progressive disease|1
826219|NCT00254163|1781131|FG000|Overall Study|Death|0
826220|NCT00254163|1781132|FG001|Overall Study|Death|1
826221|NCT00254163|1781131|FG000|Overall Study|Other|8
826222|NCT00254163|1781132|FG001|Overall Study|Other|8
826223|NCT00254293|1781144|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0
826224|NCT00254293|1781145|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1
826225|NCT00254293|1781146|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0
826226|NCT00254293|1781147|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1
826227|NCT00254293|1781148|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0
826228|NCT00254293|1781149|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0
826229|NCT00254293|1781150|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0
826230|NCT00254293|1781144|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
826231|NCT00254293|1781145|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
826232|NCT00254293|1781146|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
826233|NCT00254293|1781147|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
826234|NCT00254293|1781148|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
826235|NCT00254293|1781149|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
826236|NCT00254293|1781150|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
826237|NCT00254293|1781144|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
826238|NCT00254293|1781145|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
826239|NCT00254293|1781146|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
826240|NCT00254293|1781147|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
826241|NCT00254293|1781148|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
826242|NCT00254293|1781149|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
826243|NCT00254293|1781150|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
826244|NCT00254293|1781144|FG000|LTE Open Label Variable SC Dosing|Death|0
826245|NCT00254293|1781145|FG001|LTE Open Label Variable SC Dosing|Death|0
826246|NCT00254293|1781146|FG002|LTE Open Label Variable SC Dosing|Death|1
826247|NCT00254293|1781147|FG003|LTE Open Label Variable SC Dosing|Death|0
826248|NCT00254293|1781148|FG004|LTE Open Label Variable SC Dosing|Death|0
826249|NCT00254293|1781149|FG005|LTE Open Label Variable SC Dosing|Death|0
826250|NCT00254293|1781150|FG006|LTE Open Label Variable SC Dosing|Death|0
826251|NCT00254293|1781144|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1
826252|NCT00254293|1781145|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0
826253|NCT00254293|1781146|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2
826254|NCT00254293|1781147|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0
826255|NCT00254293|1781148|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1
826256|NCT00254293|1781149|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0
826257|NCT00254293|1781150|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0
826258|NCT00254293|1781144|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
826259|NCT00254293|1781145|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
826260|NCT00254293|1781146|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
826261|NCT00254293|1781147|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
826262|NCT00254293|1781148|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
826263|NCT00254293|1781149|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
826264|NCT00254293|1781150|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
826265|NCT00254293|1781144|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
826266|NCT00254293|1781145|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
826267|NCT00254293|1781146|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
826268|NCT00254293|1781147|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
826269|NCT00254293|1781148|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
826270|NCT00254293|1781149|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
826271|NCT00254293|1781150|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
826272|NCT00254293|1781144|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
826273|NCT00254293|1781145|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
826274|NCT00254293|1781146|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
826275|NCT00254293|1781147|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
826276|NCT00254293|1781148|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
826277|NCT00254293|1781149|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
826278|NCT00254293|1781150|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
826279|NCT00254293|1781144|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
826280|NCT00254293|1781145|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
826281|NCT00254293|1781146|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
826282|NCT00254293|1781147|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
826283|NCT00254293|1781148|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
826284|NCT00254293|1781149|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
826285|NCT00254293|1781150|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
826286|NCT00254293|1781144|FG000|LTE Open Label Variable SC Dosing|Other|0
826287|NCT00254293|1781145|FG001|LTE Open Label Variable SC Dosing|Other|0
826288|NCT00254293|1781146|FG002|LTE Open Label Variable SC Dosing|Other|2
826289|NCT00254293|1781147|FG003|LTE Open Label Variable SC Dosing|Other|0
826290|NCT00254293|1781148|FG004|LTE Open Label Variable SC Dosing|Other|0
826291|NCT00254293|1781149|FG005|LTE Open Label Variable SC Dosing|Other|0
826292|NCT00254293|1781150|FG006|LTE Open Label Variable SC Dosing|Other|0
826293|NCT00254293|1781144|FG000|LTE Open Label Fixed Dosing|Death|0
826294|NCT00254293|1781145|FG001|LTE Open Label Fixed Dosing|Death|0
826295|NCT00254293|1781146|FG002|LTE Open Label Fixed Dosing|Death|0
826296|NCT00254293|1781147|FG003|LTE Open Label Fixed Dosing|Death|0
826297|NCT00254293|1781148|FG004|LTE Open Label Fixed Dosing|Death|0
826298|NCT00254293|1781149|FG005|LTE Open Label Fixed Dosing|Death|0
826299|NCT00254293|1781150|FG006|LTE Open Label Fixed Dosing|Death|3
826300|NCT00254293|1781144|FG000|LTE Open Label Fixed Dosing|Adverse Event|0
826301|NCT00254293|1781145|FG001|LTE Open Label Fixed Dosing|Adverse Event|0
826302|NCT00254293|1781146|FG002|LTE Open Label Fixed Dosing|Adverse Event|0
826303|NCT00254293|1781147|FG003|LTE Open Label Fixed Dosing|Adverse Event|0
826304|NCT00254293|1781148|FG004|LTE Open Label Fixed Dosing|Adverse Event|0
826305|NCT00254293|1781149|FG005|LTE Open Label Fixed Dosing|Adverse Event|0
826306|NCT00254293|1781150|FG006|LTE Open Label Fixed Dosing|Adverse Event|1
826307|NCT00254293|1781144|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0
826308|NCT00254293|1781145|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0
826309|NCT00254293|1781146|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0
826310|NCT00254293|1781147|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0
826311|NCT00254293|1781148|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0
826312|NCT00254293|1781149|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0
826313|NCT00254293|1781150|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3
826314|NCT00254293|1781144|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0
826315|NCT00254293|1781145|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0
826316|NCT00254293|1781146|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0
826317|NCT00254293|1781147|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0
826318|NCT00254293|1781148|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0
826319|NCT00254293|1781149|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0
826320|NCT00254293|1781150|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1
826321|NCT00254293|1781144|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
826322|NCT00254293|1781145|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
826323|NCT00254293|1781146|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
826324|NCT00254293|1781147|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
826325|NCT00254293|1781148|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
826326|NCT00254293|1781149|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
826327|NCT00254293|1781150|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
826328|NCT00254293|1781144|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0
826329|NCT00254293|1781145|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0
826330|NCT00254293|1781146|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0
826331|NCT00254293|1781147|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0
826332|NCT00254293|1781148|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0
826333|NCT00254293|1781149|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0
826334|NCT00254293|1781150|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1
826335|NCT00254293|1781144|FG000|LTE Open Label Fixed Dosing|Other|0
826336|NCT00254293|1781145|FG001|LTE Open Label Fixed Dosing|Other|0
826337|NCT00254293|1781146|FG002|LTE Open Label Fixed Dosing|Other|0
826338|NCT00254293|1781147|FG003|LTE Open Label Fixed Dosing|Other|0
826339|NCT00254293|1781148|FG004|LTE Open Label Fixed Dosing|Other|0
826340|NCT00254293|1781149|FG005|LTE Open Label Fixed Dosing|Other|0
826341|NCT00254293|1781150|FG006|LTE Open Label Fixed Dosing|Other|1
826342|NCT00254397|1781197|FG000|Overall Study|Disease Progression|4
826343|NCT00254397|1781198|FG001|Overall Study|Disease Progression|1
826344|NCT00254397|1781199|FG002|Overall Study|Disease Progression|16
826345|NCT00254397|1781200|FG003|Overall Study|Disease Progression|23
826346|NCT00254397|1781197|FG000|Overall Study|Non-Compliant|0
826347|NCT00254397|1781198|FG001|Overall Study|Non-Compliant|0
826348|NCT00254397|1781199|FG002|Overall Study|Non-Compliant|0
826349|NCT00254397|1781200|FG003|Overall Study|Non-Compliant|1
826350|NCT00254397|1781197|FG000|Overall Study|Adverse Event|2
826351|NCT00254397|1781198|FG001|Overall Study|Adverse Event|0
826352|NCT00254397|1781199|FG002|Overall Study|Adverse Event|3
826353|NCT00254397|1781200|FG003|Overall Study|Adverse Event|1
826354|NCT00254501|1781235|FG000|Overall Study|Lost to Follow-up|1
826355|NCT00254501|1781236|FG001|Overall Study|Lost to Follow-up|1
826356|NCT00254540|1781246|FG000|Overall Study|Adverse Event|6
826357|NCT00254540|1781247|FG001|Overall Study|Adverse Event|7
826358|NCT00254540|1781246|FG000|Overall Study|Lack of Efficacy|13
826359|NCT00254540|1781247|FG001|Overall Study|Lack of Efficacy|13
826360|NCT00254540|1781246|FG000|Overall Study|Death|0
826361|NCT00254540|1781247|FG001|Overall Study|Death|1
826362|NCT00254540|1781246|FG000|Overall Study|Laboratory Test Abnormality|0
826363|NCT00254540|1781247|FG001|Overall Study|Laboratory Test Abnormality|1
826364|NCT00254566|1781256|FG000|Overall Study|Death|1
826365|NCT00254566|1781257|FG001|Overall Study|Death|0
826366|NCT00254566|1781256|FG000|Overall Study|Adverse Event|5
826367|NCT00254566|1781257|FG001|Overall Study|Adverse Event|4
826368|NCT00254566|1781256|FG000|Overall Study|Lack of Efficacy|12
826369|NCT00254566|1781257|FG001|Overall Study|Lack of Efficacy|9
826370|NCT00254566|1781256|FG000|Overall Study|Other|1
826371|NCT00254566|1781257|FG001|Overall Study|Other|5
826372|NCT00254566|1781256|FG000|Overall Study|Withdrawal by Subject|5
826373|NCT00254566|1781257|FG001|Overall Study|Withdrawal by Subject|6
826374|NCT00254566|1781256|FG000|Overall Study|Lost to Follow-up|7
826375|NCT00254566|1781257|FG001|Overall Study|Lost to Follow-up|2
826376|NCT00254982|1781269|FG000|Overall Study|Other|2
826377|NCT00254982|1781270|FG001|Overall Study|Other|1
826378|NCT00254982|1781269|FG000|Overall Study|Lack of Efficacy|5
826379|NCT00254982|1781270|FG001|Overall Study|Lack of Efficacy|3
826380|NCT00254982|1781269|FG000|Overall Study|Lost to Follow-up|5
826381|NCT00254982|1781270|FG001|Overall Study|Lost to Follow-up|3
826382|NCT00254982|1781269|FG000|Overall Study|Adverse Event|18
826383|NCT00254982|1781270|FG001|Overall Study|Adverse Event|16
826384|NCT00254982|1781269|FG000|Overall Study|Withdrawal by Subject|1
826385|NCT00254982|1781270|FG001|Overall Study|Withdrawal by Subject|1
826386|NCT00254982|1781269|FG000|Overall Study|Inclusion/exclusion criteria violation|0
826387|NCT00254982|1781270|FG001|Overall Study|Inclusion/exclusion criteria violation|2
826388|NCT00254982|1781269|FG000|Overall Study|Protocol deviation|1
826389|NCT00254982|1781270|FG001|Overall Study|Protocol deviation|1
826390|NCT00254982|1781269|FG000|Overall Study|Diagnosis of Tuberculosis|1
826391|NCT00254982|1781270|FG001|Overall Study|Diagnosis of Tuberculosis|1
826392|NCT00254982|1781269|FG000|Overall Study|Malignancy|0
826393|NCT00254982|1781270|FG001|Overall Study|Malignancy|2
826394|NCT00254982|1781269|FG000|Overall Study|Opportunistic infection|1
826395|NCT00254982|1781270|FG001|Overall Study|Opportunistic infection|0
826396|NCT00254982|1781269|FG000|Overall Study|Abnormal liver function tests|2
826397|NCT00254982|1781270|FG001|Overall Study|Abnormal liver function tests|1
826398|NCT00255008|1781291|FG000|Overall Study|Adverse Event|1
826399|NCT00255008|1781292|FG001|Overall Study|Adverse Event|1
826400|NCT00255008|1781293|FG002|Overall Study|Adverse Event|2
826401|NCT00255008|1781294|FG003|Overall Study|Adverse Event|0
826402|NCT00255008|1781291|FG000|Overall Study|Lost to Follow-up|1
826403|NCT00255008|1781292|FG001|Overall Study|Lost to Follow-up|0
826404|NCT00255008|1781293|FG002|Overall Study|Lost to Follow-up|1
826405|NCT00255008|1781294|FG003|Overall Study|Lost to Follow-up|2
826406|NCT00255008|1781291|FG000|Overall Study|Did not meet viral reduction criteria|4
826407|NCT00255008|1781292|FG001|Overall Study|Did not meet viral reduction criteria|5
826408|NCT00255008|1781293|FG002|Overall Study|Did not meet viral reduction criteria|0
826409|NCT00255008|1781294|FG003|Overall Study|Did not meet viral reduction criteria|1
826410|NCT00255008|1781291|FG000|Overall Study|Withdrew consent|0
826411|NCT00255008|1781292|FG001|Overall Study|Withdrew consent|0
826412|NCT00255008|1781293|FG002|Overall Study|Withdrew consent|2
826413|NCT00255008|1781294|FG003|Overall Study|Withdrew consent|0
826414|NCT00255008|1781291|FG000|Overall Study|Sponsor request|18
826415|NCT00255008|1781292|FG001|Overall Study|Sponsor request|3
826416|NCT00255008|1781293|FG002|Overall Study|Sponsor request|8
826417|NCT00255008|1781294|FG003|Overall Study|Sponsor request|17
826418|NCT00255008|1781291|FG000|Overall Study|Adverse lab experience|1
826419|NCT00255008|1781292|FG001|Overall Study|Adverse lab experience|0
826420|NCT00255008|1781293|FG002|Overall Study|Adverse lab experience|0
826421|NCT00255008|1781294|FG003|Overall Study|Adverse lab experience|0
826422|NCT00255008|1781291|FG000|Overall Study|Other|7
826423|NCT00255008|1781292|FG001|Overall Study|Other|0
826424|NCT00255008|1781293|FG002|Overall Study|Other|3
826425|NCT00255008|1781294|FG003|Overall Study|Other|2
826426|NCT00255034|1781306|FG000|Overall Study|Withdrawal by Subject|15
826427|NCT00255034|1781307|FG001|Overall Study|Withdrawal by Subject|38
826428|NCT00255047|1781317|FG000|Overall Study|Serious Adverse Events|2
826429|NCT00255047|1781318|FG001|Overall Study|Serious Adverse Events|1
826430|NCT00255047|1781319|FG002|Overall Study|Serious Adverse Events|2
826431|NCT00255047|1781320|FG003|Overall Study|Serious Adverse Events|1
826432|NCT00255047|1781317|FG000|Overall Study|Adverse Event|0
826433|NCT00255047|1781318|FG001|Overall Study|Adverse Event|3
826434|NCT00255047|1781319|FG002|Overall Study|Adverse Event|2
826435|NCT00255047|1781320|FG003|Overall Study|Adverse Event|1
826436|NCT00255047|1781317|FG000|Overall Study|Protocol Violation|13
826437|NCT00255047|1781318|FG001|Overall Study|Protocol Violation|13
826438|NCT00255047|1781319|FG002|Overall Study|Protocol Violation|16
826439|NCT00255047|1781320|FG003|Overall Study|Protocol Violation|20
826440|NCT00255047|1781317|FG000|Overall Study|Lost to Follow-up|9
826441|NCT00255047|1781318|FG001|Overall Study|Lost to Follow-up|8
826442|NCT00255047|1781319|FG002|Overall Study|Lost to Follow-up|5
826443|NCT00255047|1781320|FG003|Overall Study|Lost to Follow-up|6
826444|NCT00255047|1781317|FG000|Overall Study|Withdrawal by Subject|24
826445|NCT00255047|1781318|FG001|Overall Study|Withdrawal by Subject|23
826446|NCT00255047|1781319|FG002|Overall Study|Withdrawal by Subject|25
826447|NCT00255047|1781320|FG003|Overall Study|Withdrawal by Subject|18
826448|NCT00255086|1781332|FG000|Overall Study|Adverse Event|1
826449|NCT00255086|1781333|FG001|Overall Study|Adverse Event|1
826450|NCT00255086|1781332|FG000|Overall Study|Protocol Violation|1
826451|NCT00255086|1781333|FG001|Overall Study|Protocol Violation|1
826452|NCT00255151|1781354|FG000|Overall Study|Adverse Event|10
826453|NCT00255151|1781355|FG001|Overall Study|Adverse Event|6
826454|NCT00255151|1781356|FG002|Overall Study|Adverse Event|9
826455|NCT00255151|1781354|FG000|Overall Study|Lost to Follow-up|4
826456|NCT00255151|1781355|FG001|Overall Study|Lost to Follow-up|3
826457|NCT00255151|1781356|FG002|Overall Study|Lost to Follow-up|4
826458|NCT00255151|1781354|FG000|Overall Study|Withdrawal by Subject|18
826459|NCT00255151|1781355|FG001|Overall Study|Withdrawal by Subject|17
826460|NCT00255151|1781356|FG002|Overall Study|Withdrawal by Subject|8
826461|NCT00255151|1781354|FG000|Overall Study|Noncompliance|0
826462|NCT00255151|1781355|FG001|Overall Study|Noncompliance|1
826463|NCT00255151|1781356|FG002|Overall Study|Noncompliance|2
826464|NCT00255151|1781354|FG000|Overall Study|Subject Request/Subject Unavailable|1
826465|NCT00255151|1781355|FG001|Overall Study|Subject Request/Subject Unavailable|1
826466|NCT00255151|1781356|FG002|Overall Study|Subject Request/Subject Unavailable|2
826467|NCT00255151|1781354|FG000|Overall Study|Relapse of Erosive Esophagitis|78
826468|NCT00255151|1781355|FG001|Overall Study|Relapse of Erosive Esophagitis|16
826469|NCT00255151|1781356|FG002|Overall Study|Relapse of Erosive Esophagitis|12
826470|NCT00255151|1781354|FG000|Overall Study|Possible Barrett's Esophagus|1
826471|NCT00255151|1781355|FG001|Overall Study|Possible Barrett's Esophagus|3
826472|NCT00255151|1781356|FG002|Overall Study|Possible Barrett's Esophagus|8
826473|NCT00255151|1781354|FG000|Overall Study|Esophageal Stricture|0
826474|NCT00255151|1781355|FG001|Overall Study|Esophageal Stricture|0
826475|NCT00255151|1781356|FG002|Overall Study|Esophageal Stricture|1
826476|NCT00255151|1781354|FG000|Overall Study|Therapeutic Failure|11
826477|NCT00255151|1781355|FG001|Overall Study|Therapeutic Failure|2
826478|NCT00255151|1781356|FG002|Overall Study|Therapeutic Failure|3
826479|NCT00255164|1781367|FG000|Overall Study|Adverse Event|10
826480|NCT00255164|1781368|FG001|Overall Study|Adverse Event|6
826481|NCT00255164|1781369|FG002|Overall Study|Adverse Event|9
826482|NCT00255164|1781367|FG000|Overall Study|Lost to Follow-up|4
826483|NCT00255164|1781368|FG001|Overall Study|Lost to Follow-up|3
826484|NCT00255164|1781369|FG002|Overall Study|Lost to Follow-up|4
826485|NCT00255164|1781367|FG000|Overall Study|Withdrawal by Subject|18
826486|NCT00255164|1781368|FG001|Overall Study|Withdrawal by Subject|17
826487|NCT00255164|1781369|FG002|Overall Study|Withdrawal by Subject|8
826488|NCT00255164|1781367|FG000|Overall Study|Noncompliance|0
826489|NCT00255164|1781368|FG001|Overall Study|Noncompliance|1
826490|NCT00255164|1781369|FG002|Overall Study|Noncompliance|2
826491|NCT00255164|1781367|FG000|Overall Study|Subject Request/Subject Unavailable|1
826492|NCT00255164|1781368|FG001|Overall Study|Subject Request/Subject Unavailable|1
826493|NCT00255164|1781369|FG002|Overall Study|Subject Request/Subject Unavailable|2
826494|NCT00255164|1781367|FG000|Overall Study|Relapse of Erosive Esophagitis|78
826495|NCT00255164|1781368|FG001|Overall Study|Relapse of Erosive Esophagitis|16
826496|NCT00255164|1781369|FG002|Overall Study|Relapse of Erosive Esophagitis|12
826497|NCT00255164|1781367|FG000|Overall Study|Possible Barrett's Esophagus|1
826498|NCT00255164|1781368|FG001|Overall Study|Possible Barrett's Esophagus|3
826499|NCT00255164|1781369|FG002|Overall Study|Possible Barrett's Esophagus|8
826500|NCT00255164|1781367|FG000|Overall Study|Esophageal Stricture|0
826501|NCT00255164|1781368|FG001|Overall Study|Esophageal Stricture|0
826502|NCT00255164|1781369|FG002|Overall Study|Esophageal Stricture|1
826503|NCT00255164|1781367|FG000|Overall Study|Therapeutic Failure|11
826504|NCT00255164|1781368|FG001|Overall Study|Therapeutic Failure|2
826505|NCT00255164|1781369|FG002|Overall Study|Therapeutic Failure|3
826506|NCT00255190|1781396|FG000|Overall Study|Adverse Event|17
826507|NCT00255190|1781397|FG001|Overall Study|Adverse Event|36
826508|NCT00255190|1781396|FG000|Overall Study|Protocol Violation|2
826509|NCT00255190|1781397|FG001|Overall Study|Protocol Violation|2
826510|NCT00255190|1781396|FG000|Overall Study|Lost to Follow-up|10
826511|NCT00255190|1781397|FG001|Overall Study|Lost to Follow-up|27
826512|NCT00255190|1781396|FG000|Overall Study|Withdrew Consent|17
826513|NCT00255190|1781397|FG001|Overall Study|Withdrew Consent|48
826514|NCT00255190|1781396|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
826515|NCT00255190|1781397|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
826516|NCT00255190|1781396|FG000|Overall Study|Erosive esophagitis not healed|0
826517|NCT00255190|1781397|FG001|Overall Study|Erosive esophagitis not healed|20
826518|NCT00255190|1781396|FG000|Overall Study|Various|4
826519|NCT00255190|1781397|FG001|Overall Study|Various|23
826520|NCT00255346|1781408|FG000|Overall Study|Adverse Event|1
826521|NCT00255346|1781409|FG001|Overall Study|Adverse Event|0
826522|NCT00255346|1781410|FG002|Overall Study|Adverse Event|0
826523|NCT00255346|1781411|FG003|Overall Study|Adverse Event|0
826524|NCT00255346|1781412|FG004|Overall Study|Adverse Event|0
826525|NCT00255723|1781426|FG000|Overall Study|Adverse Event|1
826526|NCT00255723|1781427|FG001|Overall Study|Adverse Event|1
826527|NCT00255723|1781426|FG000|Overall Study|Death|0
826528|NCT00255723|1781427|FG001|Overall Study|Death|1
826529|NCT00255723|1781426|FG000|Overall Study|Response Data Not Available|1
826530|NCT00255723|1781427|FG001|Overall Study|Response Data Not Available|0
826531|NCT00255840|1781439|FG000|Overall Study|Lost to Follow-up|10
826532|NCT00255840|1781440|FG001|Overall Study|Lost to Follow-up|14
826533|NCT00255840|1781439|FG000|Overall Study|Discontinued intervention|53
826534|NCT00255840|1781440|FG001|Overall Study|Discontinued intervention|56
826535|NCT00255944|1781448|FG000|Overall Study|Lost to Follow-up|797
826536|NCT00255944|1781449|FG001|Overall Study|Lost to Follow-up|834
826537|NCT00256126|1781466|FG000|Overall Study|Adverse Event|1
826538|NCT00256126|1781467|FG001|Overall Study|Adverse Event|0
826539|NCT00256126|1781466|FG000|Overall Study|Other|1
826540|NCT00256126|1781467|FG001|Overall Study|Other|2
826541|NCT00256204|1781477|FG000|Overall Study|Adverse Event|10
826542|NCT00256204|1781478|FG001|Overall Study|Adverse Event|14
826543|NCT00256204|1781479|FG002|Overall Study|Adverse Event|16
826544|NCT00256204|1781480|FG003|Overall Study|Adverse Event|14
826545|NCT00256204|1781477|FG000|Overall Study|Death|0
826546|NCT00256204|1781478|FG001|Overall Study|Death|1
826547|NCT00256204|1781479|FG002|Overall Study|Death|0
826548|NCT00256204|1781480|FG003|Overall Study|Death|0
826549|NCT00256204|1781477|FG000|Overall Study|Lost to Follow-up|1
826550|NCT00256204|1781478|FG001|Overall Study|Lost to Follow-up|1
826551|NCT00256204|1781479|FG002|Overall Study|Lost to Follow-up|1
826552|NCT00256204|1781480|FG003|Overall Study|Lost to Follow-up|2
826553|NCT00256204|1781477|FG000|Overall Study|Protocol Violation|1
826554|NCT00256204|1781478|FG001|Overall Study|Protocol Violation|0
826555|NCT00256204|1781479|FG002|Overall Study|Protocol Violation|2
826556|NCT00256204|1781480|FG003|Overall Study|Protocol Violation|1
826557|NCT00256204|1781477|FG000|Overall Study|Physician Decision|0
826558|NCT00256204|1781478|FG001|Overall Study|Physician Decision|0
826559|NCT00256204|1781479|FG002|Overall Study|Physician Decision|1
826560|NCT00256204|1781480|FG003|Overall Study|Physician Decision|2
826561|NCT00256204|1781477|FG000|Overall Study|Withdrawal by Subject|17
826562|NCT00256204|1781478|FG001|Overall Study|Withdrawal by Subject|6
826563|NCT00256204|1781479|FG002|Overall Study|Withdrawal by Subject|7
826564|NCT00256204|1781480|FG003|Overall Study|Withdrawal by Subject|5
826565|NCT00256204|1781477|FG000|Overall Study|Need for additional prohibited treatment|38
826566|NCT00256204|1781478|FG001|Overall Study|Need for additional prohibited treatment|28
826567|NCT00256204|1781479|FG002|Overall Study|Need for additional prohibited treatment|27
826568|NCT00256204|1781480|FG003|Overall Study|Need for additional prohibited treatment|25
826569|NCT00256243|1781497|FG000|Overall Study|Lost to Follow-up|2
826570|NCT00256243|1781497|FG000|Overall Study|Death|7
826571|NCT00256243|1781497|FG000|Overall Study|Not treated|1
826572|NCT00256282|1781502|FG000|Overall Study|Disease progression, relapse during acti|12
826573|NCT00256282|1781502|FG000|Overall Study|Adverse Event|3
826574|NCT00256282|1781502|FG000|Overall Study|Physician Decision|1
826575|NCT00256308|1781506|FG000|Overall Study|Death|2
826576|NCT00256698|1781525|FG000|Overall Study|Withdrawal by Subject|7
826577|NCT00256698|1781526|FG001|Overall Study|Withdrawal by Subject|7
826578|NCT00256698|1781525|FG000|Overall Study|Adverse Event|13
826579|NCT00256698|1781526|FG001|Overall Study|Adverse Event|6
826580|NCT00256698|1781525|FG000|Overall Study|Protocol Violation|6
826581|NCT00256698|1781526|FG001|Overall Study|Protocol Violation|5
826582|NCT00256698|1781525|FG000|Overall Study|Lost to Follow-up|1
826583|NCT00256698|1781526|FG001|Overall Study|Lost to Follow-up|3
826584|NCT00256698|1781525|FG000|Overall Study|disease progression|97
826585|NCT00256698|1781526|FG001|Overall Study|disease progression|105
826586|NCT00256698|1781525|FG000|Overall Study|still ongoing at data cut-off|41
826587|NCT00256698|1781526|FG001|Overall Study|still ongoing at data cut-off|46
826588|NCT00256698|1781525|FG000|Overall Study|withdrawn due to osteoporosis|1
826589|NCT00256698|1781526|FG001|Overall Study|withdrawn due to osteoporosis|0
826590|NCT00256698|1781525|FG000|Overall Study|Prematurely Discontinued|1
826591|NCT00256698|1781526|FG001|Overall Study|Prematurely Discontinued|0
826592|NCT00256724|1781534|FG000|Overall Study|Physician Decision|2
826593|NCT00256724|1781535|FG001|Overall Study|Physician Decision|5
826594|NCT00256724|1781534|FG000|Overall Study|Protocol Violation|3
826595|NCT00256724|1781535|FG001|Overall Study|Protocol Violation|3
826596|NCT00256750|1781544|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3
826597|NCT00256750|1781545|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0
826598|NCT00256750|1781546|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0
826599|NCT00256750|1781544|FG000|Transplanted Pre-Treatment|Other|2
826600|NCT00256750|1781545|FG001|Transplanted Pre-Treatment|Other|0
826601|NCT00256750|1781546|FG002|Transplanted Pre-Treatment|Other|0
826602|NCT00256750|1781544|FG000|Transplanted Pre-Treatment|Death|1
826603|NCT00256750|1781545|FG001|Transplanted Pre-Treatment|Death|0
826604|NCT00256750|1781546|FG002|Transplanted Pre-Treatment|Death|0
826605|NCT00256750|1781544|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20
826606|NCT00256750|1781545|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12
826607|NCT00256750|1781546|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8
826608|NCT00256750|1781544|FG000|Post-Transplant Treated (12 Months)|Death|3
826609|NCT00256750|1781545|FG001|Post-Transplant Treated (12 Months)|Death|2
826610|NCT00256750|1781546|FG002|Post-Transplant Treated (12 Months)|Death|4
826611|NCT00256750|1781544|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
826612|NCT00256750|1781545|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
826613|NCT00256750|1781546|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
826614|NCT00256750|1781544|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
826615|NCT00256750|1781545|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
826616|NCT00256750|1781546|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
826617|NCT00256750|1781544|FG000|Post-Transplant Treated (12 Months)|Other|5
826618|NCT00256750|1781545|FG001|Post-Transplant Treated (12 Months)|Other|4
826619|NCT00256750|1781546|FG002|Post-Transplant Treated (12 Months)|Other|2
826620|NCT00256750|1781544|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
826621|NCT00256750|1781545|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
826622|NCT00256750|1781546|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
826623|NCT00256750|1781544|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2
826624|NCT00256750|1781545|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0
826625|NCT00256750|1781546|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0
826626|NCT00256750|1781544|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7
826627|NCT00256750|1781545|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3
826628|NCT00256750|1781546|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6
826629|NCT00256750|1781544|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
826630|NCT00256750|1781545|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
826631|NCT00256750|1781546|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
826632|NCT00256750|1781544|FG000|Post-Transplant Treated (24 Months)|Death|3
826633|NCT00256750|1781545|FG001|Post-Transplant Treated (24 Months)|Death|0
826634|NCT00256750|1781546|FG002|Post-Transplant Treated (24 Months)|Death|0
826635|NCT00256750|1781544|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
826636|NCT00256750|1781545|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
826637|NCT00256750|1781546|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
826638|NCT00256750|1781544|FG000|Post-Transplant Treated (24 Months)|Other|2
826639|NCT00256750|1781545|FG001|Post-Transplant Treated (24 Months)|Other|0
826640|NCT00256750|1781546|FG002|Post-Transplant Treated (24 Months)|Other|1
826641|NCT00256750|1781544|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5
826642|NCT00256750|1781545|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1
826643|NCT00256750|1781546|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2
826644|NCT00256750|1781544|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
826645|NCT00256750|1781545|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
826646|NCT00256750|1781546|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
826647|NCT00256750|1781544|FG000|Post-Transplant Treated (36 Months)|Death|0
826648|NCT00256750|1781545|FG001|Post-Transplant Treated (36 Months)|Death|2
826649|NCT00256750|1781546|FG002|Post-Transplant Treated (36 Months)|Death|1
826650|NCT00256750|1781544|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
826651|NCT00256750|1781545|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
826652|NCT00256750|1781546|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
826653|NCT00256750|1781544|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
826654|NCT00256750|1781545|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
826655|NCT00256750|1781546|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
826656|NCT00256750|1781544|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0
826657|NCT00256750|1781545|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1
826658|NCT00256750|1781546|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0
826659|NCT00256750|1781544|FG000|Post-Transplant Treated (36 Months)|Other|0
826660|NCT00256750|1781545|FG001|Post-Transplant Treated (36 Months)|Other|1
826661|NCT00256750|1781546|FG002|Post-Transplant Treated (36 Months)|Other|1
826662|NCT00256750|1781544|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13
826663|NCT00256750|1781545|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11
826664|NCT00256750|1781546|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14
826665|NCT00256750|1781544|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
826666|NCT00256750|1781545|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
826667|NCT00256750|1781546|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
826668|NCT00256750|1781544|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
826669|NCT00256750|1781545|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
826670|NCT00256750|1781546|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
826671|NCT00256750|1781544|FG000|Long Term Extension (LTE; 84 Months)|Death|9
826672|NCT00256750|1781545|FG001|Long Term Extension (LTE; 84 Months)|Death|4
826673|NCT00256750|1781546|FG002|Long Term Extension (LTE; 84 Months)|Death|4
826674|NCT00256750|1781544|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
826675|NCT00256750|1781545|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
826676|NCT00256750|1781546|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
826677|NCT00256750|1781544|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
826678|NCT00256750|1781545|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
826679|NCT00256750|1781546|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
826680|NCT00256750|1781544|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0
826681|NCT00256750|1781545|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1
826682|NCT00256750|1781546|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2
826683|NCT00256750|1781544|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
826684|NCT00256750|1781545|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
826685|NCT00256750|1781546|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
826686|NCT00256750|1781544|FG000|Long Term Extension (LTE; 84 Months)|Other|5
826687|NCT00256750|1781545|FG001|Long Term Extension (LTE; 84 Months)|Other|4
826688|NCT00256750|1781546|FG002|Long Term Extension (LTE; 84 Months)|Other|5
826689|NCT00256854|1781572|FG000|Overall Study|Withdrawal by Subject|2
826690|NCT00256854|1781573|FG001|Overall Study|Withdrawal by Subject|3
826691|NCT00256854|1781574|FG002|Overall Study|Withdrawal by Subject|0
826692|NCT00256854|1781575|FG003|Overall Study|Withdrawal by Subject|0
826693|NCT00256854|1781576|FG004|Overall Study|Withdrawal by Subject|0
826694|NCT00256854|1781577|FG005|Overall Study|Withdrawal by Subject|0
826695|NCT00256854|1781572|FG000|Overall Study|Lack of Efficacy|1
826696|NCT00256854|1781573|FG001|Overall Study|Lack of Efficacy|0
826697|NCT00256854|1781574|FG002|Overall Study|Lack of Efficacy|0
826698|NCT00256854|1781575|FG003|Overall Study|Lack of Efficacy|0
826699|NCT00256854|1781576|FG004|Overall Study|Lack of Efficacy|0
826700|NCT00256854|1781577|FG005|Overall Study|Lack of Efficacy|0
826701|NCT00256854|1781572|FG000|Overall Study|Protocol Violation|0
826702|NCT00256854|1781573|FG001|Overall Study|Protocol Violation|1
826703|NCT00256854|1781574|FG002|Overall Study|Protocol Violation|1
826704|NCT00256854|1781575|FG003|Overall Study|Protocol Violation|1
826705|NCT00256854|1781576|FG004|Overall Study|Protocol Violation|0
826706|NCT00256854|1781577|FG005|Overall Study|Protocol Violation|0
826707|NCT00256854|1781572|FG000|Overall Study|Adverse Event|0
826708|NCT00256854|1781573|FG001|Overall Study|Adverse Event|0
826709|NCT00256854|1781574|FG002|Overall Study|Adverse Event|2
826710|NCT00256854|1781575|FG003|Overall Study|Adverse Event|2
826711|NCT00256854|1781576|FG004|Overall Study|Adverse Event|0
826712|NCT00256854|1781577|FG005|Overall Study|Adverse Event|1
826713|NCT00256854|1781572|FG000|Overall Study|Not compliant with the study drug|0
826714|NCT00256854|1781573|FG001|Overall Study|Not compliant with the study drug|0
826715|NCT00256854|1781574|FG002|Overall Study|Not compliant with the study drug|0
826716|NCT00256854|1781575|FG003|Overall Study|Not compliant with the study drug|0
826717|NCT00256854|1781576|FG004|Overall Study|Not compliant with the study drug|1
826718|NCT00256854|1781577|FG005|Overall Study|Not compliant with the study drug|0
826719|NCT00256867|1781600|FG000|Overall Study|Adverse Event|0
826720|NCT00256867|1781601|FG001|Overall Study|Adverse Event|1
826721|NCT00256867|1781602|FG002|Overall Study|Adverse Event|1
826722|NCT00256867|1781603|FG003|Overall Study|Adverse Event|1
826723|NCT00256867|1781604|FG004|Overall Study|Adverse Event|2
826724|NCT00256867|1781605|FG005|Overall Study|Adverse Event|2
826725|NCT00256867|1781606|FG006|Overall Study|Adverse Event|1
826726|NCT00256867|1781607|FG007|Overall Study|Adverse Event|4
826727|NCT00256867|1781600|FG000|Overall Study|Lost to Follow-up|2
826728|NCT00256867|1781601|FG001|Overall Study|Lost to Follow-up|2
826729|NCT00256867|1781602|FG002|Overall Study|Lost to Follow-up|2
826730|NCT00256867|1781603|FG003|Overall Study|Lost to Follow-up|3
826731|NCT00256867|1781604|FG004|Overall Study|Lost to Follow-up|2
826732|NCT00256867|1781605|FG005|Overall Study|Lost to Follow-up|0
826733|NCT00256867|1781606|FG006|Overall Study|Lost to Follow-up|1
826734|NCT00256867|1781607|FG007|Overall Study|Lost to Follow-up|2
826735|NCT00256867|1781600|FG000|Overall Study|Protocol Violation|0
826736|NCT00256867|1781601|FG001|Overall Study|Protocol Violation|0
826737|NCT00256867|1781602|FG002|Overall Study|Protocol Violation|0
826738|NCT00256867|1781603|FG003|Overall Study|Protocol Violation|1
826739|NCT00256867|1781604|FG004|Overall Study|Protocol Violation|0
826740|NCT00256867|1781605|FG005|Overall Study|Protocol Violation|1
826741|NCT00256867|1781606|FG006|Overall Study|Protocol Violation|0
826742|NCT00256867|1781607|FG007|Overall Study|Protocol Violation|1
826743|NCT00256867|1781600|FG000|Overall Study|Withdrawal by Subject|0
826744|NCT00256867|1781601|FG001|Overall Study|Withdrawal by Subject|0
826745|NCT00256867|1781602|FG002|Overall Study|Withdrawal by Subject|1
826746|NCT00256867|1781603|FG003|Overall Study|Withdrawal by Subject|1
826747|NCT00256867|1781604|FG004|Overall Study|Withdrawal by Subject|2
826748|NCT00256867|1781605|FG005|Overall Study|Withdrawal by Subject|2
826749|NCT00256867|1781606|FG006|Overall Study|Withdrawal by Subject|3
826750|NCT00256867|1781607|FG007|Overall Study|Withdrawal by Subject|2
826751|NCT00256867|1781600|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0
826752|NCT00256867|1781601|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1
826753|NCT00256867|1781602|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0
826754|NCT00256867|1781603|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0
826755|NCT00256867|1781604|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0
826756|NCT00256867|1781605|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0
826757|NCT00256867|1781606|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0
826758|NCT00256867|1781607|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0
826759|NCT00256867|1781600|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0
826760|NCT00256867|1781601|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0
826761|NCT00256867|1781602|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0
826762|NCT00256867|1781603|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0
826763|NCT00256867|1781604|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0
826764|NCT00256867|1781605|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0
826765|NCT00256867|1781606|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0
826766|NCT00256867|1781607|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1
826767|NCT00256867|1781600|FG000|Overall Study|Investigator's Decision|0
826768|NCT00256867|1781601|FG001|Overall Study|Investigator's Decision|0
826769|NCT00256867|1781602|FG002|Overall Study|Investigator's Decision|0
826770|NCT00256867|1781603|FG003|Overall Study|Investigator's Decision|0
826771|NCT00256867|1781604|FG004|Overall Study|Investigator's Decision|1
826772|NCT00256867|1781605|FG005|Overall Study|Investigator's Decision|0
826773|NCT00256867|1781606|FG006|Overall Study|Investigator's Decision|0
826774|NCT00256867|1781607|FG007|Overall Study|Investigator's Decision|0
826775|NCT00256867|1781600|FG000|Overall Study|Non-compliance with study medication|0
826776|NCT00256867|1781601|FG001|Overall Study|Non-compliance with study medication|0
826777|NCT00256867|1781602|FG002|Overall Study|Non-compliance with study medication|0
826778|NCT00256867|1781603|FG003|Overall Study|Non-compliance with study medication|0
826779|NCT00256867|1781604|FG004|Overall Study|Non-compliance with study medication|0
826780|NCT00256867|1781605|FG005|Overall Study|Non-compliance with study medication|0
826781|NCT00256867|1781606|FG006|Overall Study|Non-compliance with study medication|0
826782|NCT00256867|1781607|FG007|Overall Study|Non-compliance with study medication|1
826783|NCT00256867|1781600|FG000|Overall Study|Participant travelled Overseas|0
826784|NCT00256867|1781601|FG001|Overall Study|Participant travelled Overseas|1
826785|NCT00256867|1781602|FG002|Overall Study|Participant travelled Overseas|0
826786|NCT00256867|1781603|FG003|Overall Study|Participant travelled Overseas|0
826787|NCT00256867|1781604|FG004|Overall Study|Participant travelled Overseas|0
826788|NCT00256867|1781605|FG005|Overall Study|Participant travelled Overseas|0
826789|NCT00256867|1781606|FG006|Overall Study|Participant travelled Overseas|0
826790|NCT00256867|1781607|FG007|Overall Study|Participant travelled Overseas|0
826791|NCT00256867|1781600|FG000|Overall Study|Participant out of assessment window|0
826792|NCT00256867|1781601|FG001|Overall Study|Participant out of assessment window|0
826793|NCT00256867|1781602|FG002|Overall Study|Participant out of assessment window|1
826794|NCT00256867|1781603|FG003|Overall Study|Participant out of assessment window|0
826795|NCT00256867|1781604|FG004|Overall Study|Participant out of assessment window|0
826796|NCT00256867|1781605|FG005|Overall Study|Participant out of assessment window|0
826797|NCT00256867|1781606|FG006|Overall Study|Participant out of assessment window|0
826798|NCT00256867|1781607|FG007|Overall Study|Participant out of assessment window|0
826799|NCT00256867|1781600|FG000|Overall Study|Withdrawal by participant|0
826800|NCT00256867|1781601|FG001|Overall Study|Withdrawal by participant|0
826801|NCT00256867|1781602|FG002|Overall Study|Withdrawal by participant|0
826802|NCT00256867|1781603|FG003|Overall Study|Withdrawal by participant|0
826803|NCT00256867|1781604|FG004|Overall Study|Withdrawal by participant|0
826804|NCT00256867|1781605|FG005|Overall Study|Withdrawal by participant|1
826805|NCT00256867|1781606|FG006|Overall Study|Withdrawal by participant|0
826806|NCT00256867|1781607|FG007|Overall Study|Withdrawal by participant|0
826807|NCT00256997|1781636|FG000|Overall Study|Protocol Violation|1
826808|NCT00256997|1781637|FG001|Overall Study|Protocol Violation|4
826809|NCT00256997|1781636|FG000|Overall Study|Lack of Efficacy|1
826810|NCT00256997|1781637|FG001|Overall Study|Lack of Efficacy|4
826811|NCT00256997|1781636|FG000|Overall Study|Death|2
826812|NCT00256997|1781637|FG001|Overall Study|Death|0
826813|NCT00256997|1781636|FG000|Overall Study|Adverse Event|4
826814|NCT00256997|1781637|FG001|Overall Study|Adverse Event|0
826815|NCT00256997|1781636|FG000|Overall Study|Lost to Follow-up|3
826816|NCT00256997|1781637|FG001|Overall Study|Lost to Follow-up|5
826817|NCT00256997|1781636|FG000|Overall Study|Withdrawal by Subject|13
826818|NCT00256997|1781637|FG001|Overall Study|Withdrawal by Subject|3
826819|NCT00256997|1781636|FG000|Overall Study|Started but not treated|2
826820|NCT00256997|1781637|FG001|Overall Study|Started but not treated|0
826821|NCT00256997|1781636|FG000|Overall Study|Other|5
826822|NCT00256997|1781637|FG001|Overall Study|Other|8
826823|NCT00256997|1781636|FG000|Overall Study|End of Study (As Per Sponsor)|12
826824|NCT00256997|1781637|FG001|Overall Study|End of Study (As Per Sponsor)|24
826825|NCT00256997|1781636|FG000|Overall Study|Participant Non-compliant|3
826826|NCT00256997|1781637|FG001|Overall Study|Participant Non-compliant|6
826827|NCT00256997|1781636|FG000|Overall Study|Investigator Withdrew Participant|2
826828|NCT00256997|1781637|FG001|Overall Study|Investigator Withdrew Participant|1
826829|NCT00257010|1781644|FG000|Overall Study|Lack of Efficacy|11
826830|NCT00257010|1781644|FG000|Overall Study|Lost to Follow-up|53
826831|NCT00257010|1781644|FG000|Overall Study|Withdrawal by Subject|34
826832|NCT00257010|1781644|FG000|Overall Study|Adverse Event|10
826833|NCT00257010|1781644|FG000|Overall Study|various|11
826834|NCT00257010|1781644|FG000|Overall Study|no headache reported|9
826835|NCT00257166|1781650|FG000|Overall Study|Adverse Event|18
826836|NCT00257166|1781651|FG001|Overall Study|Adverse Event|13
826837|NCT00257166|1781650|FG000|Overall Study|Laboratory abnormality|1
826838|NCT00257166|1781651|FG001|Overall Study|Laboratory abnormality|0
826839|NCT00257166|1781650|FG000|Overall Study|Lost to Follow-up|8
826840|NCT00257166|1781651|FG001|Overall Study|Lost to Follow-up|1
826841|NCT00257166|1781650|FG000|Overall Study|Withdrawal by Subject|9
826842|NCT00257166|1781651|FG001|Overall Study|Withdrawal by Subject|2
826843|NCT00257166|1781650|FG000|Overall Study|Other|16
826844|NCT00257166|1781651|FG001|Overall Study|Other|21
826845|NCT00257166|1781650|FG000|Overall Study|Randomized, but not treated|1
826846|NCT00257166|1781651|FG001|Overall Study|Randomized, but not treated|0
826847|NCT00257192|1781659|FG000|Overall Study|Adverse Event|21
826848|NCT00257192|1781660|FG001|Overall Study|Adverse Event|10
826849|NCT00257192|1781659|FG000|Overall Study|Laboratory abnormality|1
826850|NCT00257192|1781660|FG001|Overall Study|Laboratory abnormality|1
826851|NCT00257192|1781659|FG000|Overall Study|Lost to Follow-up|3
826852|NCT00257192|1781660|FG001|Overall Study|Lost to Follow-up|3
826853|NCT00257192|1781659|FG000|Overall Study|Insufficient clinical response|18
826854|NCT00257192|1781660|FG001|Overall Study|Insufficient clinical response|18
826855|NCT00257192|1781659|FG000|Overall Study|Withdrawal by Subject|14
826856|NCT00257192|1781660|FG001|Overall Study|Withdrawal by Subject|2
826857|NCT00257192|1781659|FG000|Overall Study|Randomized but not treated|0
826858|NCT00257192|1781660|FG001|Overall Study|Randomized but not treated|1
826859|NCT00257192|1781659|FG000|Overall Study|Study terminated by sponsor|1
826860|NCT00257192|1781660|FG001|Overall Study|Study terminated by sponsor|0
826861|NCT00257192|1781659|FG000|Overall Study|Miscellaneous|0
826862|NCT00257192|1781660|FG001|Overall Study|Miscellaneous|4
826863|NCT00257556|1781681|FG000|Overall Study|Adverse Event|1
826864|NCT00257556|1781682|FG001|Overall Study|Adverse Event|4
826865|NCT00257556|1781681|FG000|Overall Study|Physician Decision|6
826866|NCT00257556|1781682|FG001|Overall Study|Physician Decision|0
826867|NCT00257556|1781681|FG000|Overall Study|Did not meet hCG criterion|3
826868|NCT00257556|1781682|FG001|Overall Study|Did not meet hCG criterion|0
826869|NCT00257556|1781681|FG000|Overall Study|other reason|4
826870|NCT00257556|1781682|FG001|Overall Study|other reason|6
826871|NCT00257608|1781690|FG000|Chemotherapy Phase|Adverse Event|138
826872|NCT00257608|1781691|FG001|Chemotherapy Phase|Adverse Event|0
826873|NCT00257608|1781692|FG002|Chemotherapy Phase|Adverse Event|0
826874|NCT00257608|1781690|FG000|Chemotherapy Phase|Disease progression|139
826875|NCT00257608|1781691|FG001|Chemotherapy Phase|Disease progression|0
826876|NCT00257608|1781692|FG002|Chemotherapy Phase|Disease progression|0
826877|NCT00257608|1781690|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6
826878|NCT00257608|1781691|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0
826879|NCT00257608|1781692|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0
826880|NCT00257608|1781690|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
826881|NCT00257608|1781691|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
826882|NCT00257608|1781692|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
826883|NCT00257608|1781690|FG000|Chemotherapy Phase|Patient's decision to discontinue|35
826884|NCT00257608|1781691|FG001|Chemotherapy Phase|Patient's decision to discontinue|0
826885|NCT00257608|1781692|FG002|Chemotherapy Phase|Patient's decision to discontinue|0
826886|NCT00257608|1781690|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3
826887|NCT00257608|1781691|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0
826888|NCT00257608|1781692|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0
826889|NCT00257608|1781690|FG000|Chemotherapy Phase|Physician Decision|28
826890|NCT00257608|1781691|FG001|Chemotherapy Phase|Physician Decision|0
826891|NCT00257608|1781692|FG002|Chemotherapy Phase|Physician Decision|0
826892|NCT00257608|1781690|FG000|Post Chemotherapy Phase|Adverse Event|0
826893|NCT00257608|1781691|FG001|Post Chemotherapy Phase|Adverse Event|34
826894|NCT00257608|1781692|FG002|Post Chemotherapy Phase|Adverse Event|38
826895|NCT00257608|1781690|FG000|Post Chemotherapy Phase|Disease progression|0
826896|NCT00257608|1781691|FG001|Post Chemotherapy Phase|Disease progression|204
826897|NCT00257608|1781692|FG002|Post Chemotherapy Phase|Disease progression|168
826898|NCT00257608|1781690|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0
826899|NCT00257608|1781691|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4
826900|NCT00257608|1781692|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5
826901|NCT00257608|1781690|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
826902|NCT00257608|1781691|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
826903|NCT00257608|1781692|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
826904|NCT00257608|1781690|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0
826905|NCT00257608|1781691|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4
826906|NCT00257608|1781692|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8
826907|NCT00257608|1781690|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0
826908|NCT00257608|1781691|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0
826909|NCT00257608|1781692|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1
826910|NCT00257608|1781690|FG000|Post Chemotherapy Phase|Lost to Follow-up|0
826911|NCT00257608|1781691|FG001|Post Chemotherapy Phase|Lost to Follow-up|0
826912|NCT00257608|1781692|FG002|Post Chemotherapy Phase|Lost to Follow-up|1
826913|NCT00257608|1781690|FG000|Post Chemotherapy Phase|Physician Decision|0
826914|NCT00257608|1781691|FG001|Post Chemotherapy Phase|Physician Decision|8
826915|NCT00257608|1781692|FG002|Post Chemotherapy Phase|Physician Decision|11
826916|NCT00257608|1781690|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
826917|NCT00257608|1781691|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
826918|NCT00257608|1781692|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
826919|NCT00257608|1781690|FG000|Post Chemotherapy Phase|Not treated|0
826920|NCT00257608|1781691|FG001|Post Chemotherapy Phase|Not treated|4
826921|NCT00257608|1781692|FG002|Post Chemotherapy Phase|Not treated|7
826922|NCT00257660|1781707|FG000|Overall Study|Lack of Efficacy|5
826923|NCT00257660|1781708|FG001|Overall Study|Lack of Efficacy|23
826924|NCT00257660|1781707|FG000|Overall Study|Withdrawal by Subject|2
826925|NCT00257660|1781708|FG001|Overall Study|Withdrawal by Subject|0
826926|NCT00257660|1781707|FG000|Overall Study|Lost to Follow-up|1
826927|NCT00257660|1781708|FG001|Overall Study|Lost to Follow-up|0
826928|NCT00257660|1781707|FG000|Overall Study|PI & Subject Schedule Conflicts|1
826929|NCT00257660|1781708|FG001|Overall Study|PI & Subject Schedule Conflicts|0
826930|NCT00257660|1781707|FG000|Overall Study|No longer wanted to do blood draws|1
826931|NCT00257660|1781708|FG001|Overall Study|No longer wanted to do blood draws|0
826932|NCT00257725|1781739|FG000|Overall Study|Adverse Event|3
826933|NCT00257920|1781755|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0
826934|NCT00257920|1781756|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1
826935|NCT00257920|1781755|FG000|Period: Second Intervention|Other|2
826936|NCT00257920|1781756|FG001|Period: Second Intervention|Other|1
826937|NCT00258154|1781789|FG000|Overall Study|Adverse Event|1
826938|NCT00258154|1781790|FG001|Overall Study|Adverse Event|0
826939|NCT00258154|1781789|FG000|Overall Study|Lost to Follow-up|0
826940|NCT00258154|1781790|FG001|Overall Study|Lost to Follow-up|1
826941|NCT00258154|1781789|FG000|Overall Study|Protocol Violation|2
826942|NCT00258154|1781790|FG001|Overall Study|Protocol Violation|1
826943|NCT00258154|1781789|FG000|Overall Study|Withdrawal by Subject|3
826944|NCT00258154|1781790|FG001|Overall Study|Withdrawal by Subject|4
826945|NCT00258154|1781789|FG000|Overall Study|Patient Moved|3
826946|NCT00258154|1781790|FG001|Overall Study|Patient Moved|1
826947|NCT00258440|1781823|FG000|Overall Study|Withdrawal by Subject|0
826948|NCT00258440|1781824|FG001|Overall Study|Withdrawal by Subject|0
826949|NCT00258440|1781825|FG002|Overall Study|Withdrawal by Subject|1
826950|NCT00258674|1781836|FG000|Overall Study|Death|32
826951|NCT00258674|1781837|FG001|Overall Study|Death|53
826952|NCT00258674|1781838|FG002|Overall Study|Death|34
826953|NCT00258856|1781868|FG000|Overall Study|Lost to Follow-up|1
826954|NCT00258856|1781869|FG001|Overall Study|Lost to Follow-up|0
826955|NCT00258856|1781870|FG002|Overall Study|Lost to Follow-up|2
826956|NCT00258856|1781871|FG003|Overall Study|Lost to Follow-up|0
826957|NCT00258856|1781868|FG000|Overall Study|Non-compliance|2
826958|NCT00258856|1781869|FG001|Overall Study|Non-compliance|0
826959|NCT00258856|1781870|FG002|Overall Study|Non-compliance|0
826960|NCT00258856|1781871|FG003|Overall Study|Non-compliance|1
826961|NCT00258895|1781894|FG000|Overall Study|Lost to Follow-up|3
826962|NCT00258895|1781895|FG001|Overall Study|Lost to Follow-up|1
826963|NCT00258895|1781894|FG000|Overall Study|Protocol Violation|6
826964|NCT00258895|1781895|FG001|Overall Study|Protocol Violation|2
826965|NCT00258895|1781894|FG000|Overall Study|Withdrawal by Subject|1
826966|NCT00258895|1781895|FG001|Overall Study|Withdrawal by Subject|0
826967|NCT00258960|1781905|FG000|Overall Study|Death|2
826968|NCT00258960|1781905|FG000|Overall Study|Disease Progression|7
826969|NCT00258960|1781905|FG000|Overall Study|Adverse Event|4
826970|NCT00258960|1781905|FG000|Overall Study|Physician Decision|1
826971|NCT00258960|1781905|FG000|Overall Study|Withdrawal by Subject|1
826972|NCT00258960|1781905|FG000|Overall Study|Mistake|2
826973|NCT00259012|1781911|FG000|Overall Study|Adverse Event|0
826974|NCT00259012|1781912|FG001|Overall Study|Adverse Event|1
826975|NCT00259012|1781911|FG000|Overall Study|Withdrawal by Subject|1
826976|NCT00259012|1781912|FG001|Overall Study|Withdrawal by Subject|0
826977|NCT00259012|1781911|FG000|Overall Study|Physician Decision|0
826978|NCT00259012|1781912|FG001|Overall Study|Physician Decision|1
826979|NCT00259012|1781911|FG000|Overall Study|Lost to Follow-up|0
826980|NCT00259012|1781912|FG001|Overall Study|Lost to Follow-up|1
826981|NCT00259012|1781911|FG000|Overall Study|Protocol Violation|1
826982|NCT00259012|1781912|FG001|Overall Study|Protocol Violation|1
826983|NCT00259272|1781935|FG000|Overall Study|Adverse Event|2
826984|NCT00259272|1781936|FG001|Overall Study|Adverse Event|1
826985|NCT00259272|1781937|FG002|Overall Study|Adverse Event|0
826986|NCT00259272|1781938|FG003|Overall Study|Adverse Event|3
826987|NCT00259272|1781935|FG000|Overall Study|Lack of Efficacy|5
826988|NCT00259272|1781936|FG001|Overall Study|Lack of Efficacy|1
826989|NCT00259272|1781937|FG002|Overall Study|Lack of Efficacy|2
826990|NCT00259272|1781938|FG003|Overall Study|Lack of Efficacy|6
826991|NCT00259272|1781935|FG000|Overall Study|Physician Decision|1
826992|NCT00259272|1781936|FG001|Overall Study|Physician Decision|2
826993|NCT00259272|1781937|FG002|Overall Study|Physician Decision|1
826994|NCT00259272|1781938|FG003|Overall Study|Physician Decision|3
826995|NCT00259272|1781935|FG000|Overall Study|Protocol Violation|2
826996|NCT00259272|1781936|FG001|Overall Study|Protocol Violation|0
826997|NCT00259272|1781937|FG002|Overall Study|Protocol Violation|0
826998|NCT00259272|1781938|FG003|Overall Study|Protocol Violation|1
826999|NCT00259272|1781935|FG000|Overall Study|Sponsor Decision|0
827000|NCT00259272|1781936|FG001|Overall Study|Sponsor Decision|1
827001|NCT00259272|1781937|FG002|Overall Study|Sponsor Decision|0
827002|NCT00259272|1781938|FG003|Overall Study|Sponsor Decision|0
827003|NCT00259272|1781935|FG000|Overall Study|Withdrawal by Subject|4
827004|NCT00259272|1781936|FG001|Overall Study|Withdrawal by Subject|2
827005|NCT00259272|1781937|FG002|Overall Study|Withdrawal by Subject|2
827006|NCT00259272|1781938|FG003|Overall Study|Withdrawal by Subject|7
827007|NCT00259272|1781935|FG000|Overall Study|Lost to Follow-up|1
827008|NCT00259272|1781936|FG001|Overall Study|Lost to Follow-up|0
827009|NCT00259272|1781937|FG002|Overall Study|Lost to Follow-up|0
827010|NCT00259272|1781938|FG003|Overall Study|Lost to Follow-up|1
827011|NCT00259298|1781957|FG000|Overall Study|Withdrawal by Subject|1
827012|NCT00259298|1781957|FG000|Overall Study|Physician Decision|2
827013|NCT00259610|1781965|FG000|Overall Study|Withdrawal by Subject|33
827014|NCT00259610|1781966|FG001|Overall Study|Withdrawal by Subject|25
827015|NCT00259610|1781967|FG002|Overall Study|Withdrawal by Subject|29
827016|NCT00259610|1781968|FG003|Overall Study|Withdrawal by Subject|19
827017|NCT00259610|1781965|FG000|Overall Study|Lost to Follow-up|19
827018|NCT00259610|1781966|FG001|Overall Study|Lost to Follow-up|8
827019|NCT00259610|1781967|FG002|Overall Study|Lost to Follow-up|18
827020|NCT00259610|1781968|FG003|Overall Study|Lost to Follow-up|15
827021|NCT00259610|1781965|FG000|Overall Study|Physician Decision|6
827022|NCT00259610|1781966|FG001|Overall Study|Physician Decision|4
827023|NCT00259610|1781967|FG002|Overall Study|Physician Decision|7
827024|NCT00259610|1781968|FG003|Overall Study|Physician Decision|2
827025|NCT00259610|1781965|FG000|Overall Study|Death|1
827026|NCT00259610|1781966|FG001|Overall Study|Death|1
827027|NCT00259610|1781967|FG002|Overall Study|Death|2
827028|NCT00259610|1781968|FG003|Overall Study|Death|0
827029|NCT00259610|1781965|FG000|Overall Study|non medical reason|6
827030|NCT00259610|1781966|FG001|Overall Study|non medical reason|2
827031|NCT00259610|1781967|FG002|Overall Study|non medical reason|10
827032|NCT00259610|1781968|FG003|Overall Study|non medical reason|3
827033|NCT00259610|1781965|FG000|Overall Study|Adverse Event|3
827034|NCT00259610|1781966|FG001|Overall Study|Adverse Event|4
827035|NCT00259610|1781967|FG002|Overall Study|Adverse Event|5
827036|NCT00259610|1781968|FG003|Overall Study|Adverse Event|2
827037|NCT00259610|1781965|FG000|Overall Study|Serious Adverse Event|8
827038|NCT00259610|1781966|FG001|Overall Study|Serious Adverse Event|2
827039|NCT00259610|1781967|FG002|Overall Study|Serious Adverse Event|2
827040|NCT00259610|1781968|FG003|Overall Study|Serious Adverse Event|2
827041|NCT00259649|1781978|FG000|Overall Study|Lost to Follow-up|7
827042|NCT00259649|1781978|FG000|Overall Study|irregular menses|3
827043|NCT00259740|1781984|FG000|Overall Study|Physician Decision|1
827044|NCT00259740|1781985|FG001|Overall Study|Physician Decision|1
827045|NCT00259740|1781984|FG000|Overall Study|Adverse Event|0
827046|NCT00259740|1781985|FG001|Overall Study|Adverse Event|2
827047|NCT00259740|1781984|FG000|Overall Study|Withdrawal by Subject|2
827048|NCT00259740|1781985|FG001|Overall Study|Withdrawal by Subject|6
827049|NCT00259740|1781984|FG000|Overall Study|Death|1
827050|NCT00259740|1781985|FG001|Overall Study|Death|1
827051|NCT00259740|1781984|FG000|Overall Study|Disease progression|19
827052|NCT00259740|1781985|FG001|Overall Study|Disease progression|36
827053|NCT00259740|1781984|FG000|Overall Study|Ongoing|17
827054|NCT00259740|1781985|FG001|Overall Study|Ongoing|3
827055|NCT00259740|1781984|FG000|Overall Study|Other|3
827056|NCT00259740|1781985|FG001|Overall Study|Other|0
827057|NCT00259740|1781984|FG000|Overall Study|Requirement for alternative therapy|0
827058|NCT00259740|1781985|FG001|Overall Study|Requirement for alternative therapy|4
827059|NCT00259857|1781993|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
827060|NCT00259857|1781994|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
827061|NCT00259857|1781993|FG000|24 Months Treatment|Lost to Follow-up|0
827062|NCT00259857|1781994|FG001|24 Months Treatment|Lost to Follow-up|3
827063|NCT00260065|1782000|FG000|Overall Study|Progressive Disease|22
827064|NCT00260065|1782000|FG000|Overall Study|Adverse Event|17
827065|NCT00260065|1782000|FG000|Overall Study|Death|13
827066|NCT00260065|1782000|FG000|Overall Study|Withdrawal by Subject|13
827067|NCT00260065|1782000|FG000|Overall Study|Physician Decision|19
827068|NCT00260065|1782000|FG000|Overall Study|Not otherwise specified|8
827069|NCT00260065|1782000|FG000|Overall Study|Medication Noncompliance|1
827070|NCT00260208|1782016|FG000|Overall Study|Subject withdrew consent|11
827071|NCT00260208|1782017|FG001|Overall Study|Subject withdrew consent|7
827072|NCT00260208|1782016|FG000|Overall Study|Lost to Follow-up|6
827073|NCT00260208|1782017|FG001|Overall Study|Lost to Follow-up|1
827074|NCT00260208|1782016|FG000|Overall Study|Death|12
827075|NCT00260208|1782017|FG001|Overall Study|Death|10
827076|NCT00260208|1782016|FG000|Overall Study|Missing|18
827077|NCT00260208|1782017|FG001|Overall Study|Missing|16
827078|NCT00260429|1782025|FG000|Overall Study|failure to follow appointments|1
827079|NCT00260429|1782026|FG001|Overall Study|failure to follow appointments|0
827080|NCT00260429|1782025|FG000|Overall Study|scheduled hand surgery|1
827081|NCT00260429|1782026|FG001|Overall Study|scheduled hand surgery|0
827082|NCT00260533|1782034|FG000|Overall Study|Other|3
827083|NCT00260533|1782035|FG001|Overall Study|Other|3
827084|NCT00260832|1782056|FG000|Overall Study|Adverse Event|26
827085|NCT00260832|1782057|FG001|Overall Study|Adverse Event|19
827086|NCT00260832|1782056|FG000|Overall Study|Progression|116
827087|NCT00260832|1782057|FG001|Overall Study|Progression|96
827088|NCT00260832|1782056|FG000|Overall Study|Withdrawal by Subject|15
827089|NCT00260832|1782057|FG001|Overall Study|Withdrawal by Subject|17
827090|NCT00260832|1782056|FG000|Overall Study|Physician Decision|15
827091|NCT00260832|1782057|FG001|Overall Study|Physician Decision|9
827092|NCT00260832|1782056|FG000|Overall Study|Death|43
827093|NCT00260832|1782057|FG001|Overall Study|Death|62
827094|NCT00260832|1782056|FG000|Overall Study|Other|10
827095|NCT00260832|1782057|FG001|Overall Study|Other|7
827096|NCT00260832|1782056|FG000|Overall Study|Protocol Violation|3
827097|NCT00260832|1782057|FG001|Overall Study|Protocol Violation|1
827098|NCT00261443|1782083|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33
827099|NCT00261443|1782084|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0
827100|NCT00261443|1782085|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0
827101|NCT00261443|1782083|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
827102|NCT00261443|1782084|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
827103|NCT00261443|1782085|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
827104|NCT00261443|1782083|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
827105|NCT00261443|1782084|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
827106|NCT00261443|1782085|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
827107|NCT00261443|1782083|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
827108|NCT00261443|1782084|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
827109|NCT00261443|1782085|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
827110|NCT00261443|1782083|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1
827111|NCT00261443|1782084|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0
827112|NCT00261443|1782085|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0
827113|NCT00261443|1782083|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
827114|NCT00261443|1782084|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
827115|NCT00261443|1782085|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
827116|NCT00261443|1782083|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16
827117|NCT00261443|1782084|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0
827118|NCT00261443|1782085|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0
827119|NCT00261443|1782083|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43
827120|NCT00261443|1782084|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0
827121|NCT00261443|1782085|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0
827122|NCT00261443|1782083|FG000|2: Stability & Maintenance of Stability|Adverse Event|93
827123|NCT00261443|1782084|FG001|2: Stability & Maintenance of Stability|Adverse Event|0
827124|NCT00261443|1782085|FG002|2: Stability & Maintenance of Stability|Adverse Event|0
827125|NCT00261443|1782083|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
827126|NCT00261443|1782084|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
827127|NCT00261443|1782085|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
827128|NCT00261443|1782083|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59
827129|NCT00261443|1782084|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0
827130|NCT00261443|1782085|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0
827131|NCT00261443|1782083|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
827132|NCT00261443|1782084|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
827133|NCT00261443|1782085|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
827134|NCT00261443|1782083|FG000|2: Stability & Maintenance of Stability|Pregnancy|1
827135|NCT00261443|1782084|FG001|2: Stability & Maintenance of Stability|Pregnancy|0
827136|NCT00261443|1782085|FG002|2: Stability & Maintenance of Stability|Pregnancy|0
827137|NCT00261443|1782083|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
827138|NCT00261443|1782084|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
827139|NCT00261443|1782085|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
827140|NCT00261443|1782083|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
827141|NCT00261443|1782084|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
827142|NCT00261443|1782085|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
827143|NCT00261443|1782083|FG000|2: Stability & Maintenance of Stability|Other Reasons|13
827144|NCT00261443|1782084|FG001|2: Stability & Maintenance of Stability|Other Reasons|0
827145|NCT00261443|1782085|FG002|2: Stability & Maintenance of Stability|Other Reasons|0
827146|NCT00261443|1782083|FG000|3: Assessment of Relapse|Lack of Efficacy|0
827147|NCT00261443|1782084|FG001|3: Assessment of Relapse|Lack of Efficacy|31
827148|NCT00261443|1782085|FG002|3: Assessment of Relapse|Lack of Efficacy|14
827149|NCT00261443|1782083|FG000|3: Assessment of Relapse|Adverse Event|0
827150|NCT00261443|1782084|FG001|3: Assessment of Relapse|Adverse Event|15
827151|NCT00261443|1782085|FG002|3: Assessment of Relapse|Adverse Event|19
827152|NCT00261443|1782083|FG000|3: Assessment of Relapse|Withdrawal by Subject|0
827153|NCT00261443|1782084|FG001|3: Assessment of Relapse|Withdrawal by Subject|14
827154|NCT00261443|1782085|FG002|3: Assessment of Relapse|Withdrawal by Subject|15
827155|NCT00261443|1782083|FG000|3: Assessment of Relapse|Death|0
827156|NCT00261443|1782084|FG001|3: Assessment of Relapse|Death|0
827157|NCT00261443|1782085|FG002|3: Assessment of Relapse|Death|1
827158|NCT00261443|1782083|FG000|3: Assessment of Relapse|Lost to Follow-up|0
827159|NCT00261443|1782084|FG001|3: Assessment of Relapse|Lost to Follow-up|7
827160|NCT00261443|1782085|FG002|3: Assessment of Relapse|Lost to Follow-up|6
827161|NCT00261443|1782083|FG000|3: Assessment of Relapse|Poor/Noncompliance|0
827162|NCT00261443|1782084|FG001|3: Assessment of Relapse|Poor/Noncompliance|5
827163|NCT00261443|1782085|FG002|3: Assessment of Relapse|Poor/Noncompliance|3
827164|NCT00261443|1782083|FG000|3: Assessment of Relapse|Pregnancy|0
827165|NCT00261443|1782084|FG001|3: Assessment of Relapse|Pregnancy|2
827166|NCT00261443|1782085|FG002|3: Assessment of Relapse|Pregnancy|1
827167|NCT00261443|1782083|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
827168|NCT00261443|1782084|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
827169|NCT00261443|1782085|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
827170|NCT00261443|1782083|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0
827171|NCT00261443|1782084|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0
827172|NCT00261443|1782085|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2
827173|NCT00261443|1782083|FG000|3: Assessment of Relapse|Other Reasons|0
827174|NCT00261443|1782084|FG001|3: Assessment of Relapse|Other Reasons|4
827175|NCT00261443|1782085|FG002|3: Assessment of Relapse|Other Reasons|3
827176|NCT00261443|1782083|FG000|4: Extension Phase|Adverse Event|0
827177|NCT00261443|1782084|FG001|4: Extension Phase|Adverse Event|1
827178|NCT00261443|1782085|FG002|4: Extension Phase|Adverse Event|0
827179|NCT00261443|1782083|FG000|4: Extension Phase|Withdrawal by Subject|0
827180|NCT00261443|1782084|FG001|4: Extension Phase|Withdrawal by Subject|1
827181|NCT00261443|1782085|FG002|4: Extension Phase|Withdrawal by Subject|2
827182|NCT00261443|1782083|FG000|4: Extension Phase|Lost to Follow-up|0
827183|NCT00261443|1782084|FG001|4: Extension Phase|Lost to Follow-up|1
827184|NCT00261443|1782085|FG002|4: Extension Phase|Lost to Follow-up|0
827185|NCT00261495|1782098|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28
827186|NCT00261495|1782099|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36
827187|NCT00261495|1782098|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
827188|NCT00261495|1782099|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
827189|NCT00261495|1782098|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
827190|NCT00261495|1782099|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
827191|NCT00261495|1782098|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3
827192|NCT00261495|1782099|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1
827193|NCT00261495|1782098|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2
827194|NCT00261495|1782099|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5
827195|NCT00261495|1782098|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
827196|NCT00261495|1782099|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
827197|NCT00261495|1782098|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
827198|NCT00261495|1782099|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
827199|NCT00261495|1782098|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
827200|NCT00261495|1782099|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
827201|NCT00261495|1782098|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
827202|NCT00261495|1782099|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
827203|NCT00261495|1782098|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
827204|NCT00261495|1782099|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
827205|NCT00261495|1782098|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
827206|NCT00261495|1782099|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
827207|NCT00261495|1782098|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6
827208|NCT00261495|1782099|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5
827209|NCT00261495|1782098|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
827210|NCT00261495|1782099|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
827211|NCT00261495|1782098|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
827212|NCT00261495|1782099|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
827213|NCT00261495|1782098|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
827214|NCT00261495|1782099|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
827215|NCT00261495|1782098|FG000|Extension Phase (Weeks 24 to 52)|Other|4
827216|NCT00261495|1782099|FG001|Extension Phase (Weeks 24 to 52)|Other|2
827217|NCT00261495|1782098|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4
827218|NCT00261495|1782099|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
827219|NCT00261495|1782098|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
827220|NCT00261495|1782099|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
827221|NCT00261495|1782098|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
827222|NCT00261495|1782099|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
827223|NCT00261495|1782098|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1
827224|NCT00261495|1782099|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0
827225|NCT00261495|1782098|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
827226|NCT00261495|1782099|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
827227|NCT00261716|1782107|FG000|Overall Study|Withdrawal by Subject|6
827228|NCT00261716|1782108|FG001|Overall Study|Withdrawal by Subject|8
827229|NCT00261716|1782107|FG000|Overall Study|Lost to Follow-up|0
827230|NCT00261716|1782108|FG001|Overall Study|Lost to Follow-up|2
827235|NCT00261833|1782125|FG000|Overall Study|Death|1
827236|NCT00261833|1782126|FG001|Overall Study|Death|3
827237|NCT00261833|1782125|FG000|Overall Study|Adverse Event|1
827238|NCT00261833|1782126|FG001|Overall Study|Adverse Event|4
827239|NCT00261833|1782125|FG000|Overall Study|Withdrawal by Subject|5
827240|NCT00261833|1782126|FG001|Overall Study|Withdrawal by Subject|7
827241|NCT00261833|1782125|FG000|Overall Study|Protocol Violation|0
827242|NCT00261833|1782126|FG001|Overall Study|Protocol Violation|1
827243|NCT00261833|1782125|FG000|Overall Study|Suspicion of pulmonary cancer|0
827244|NCT00261833|1782126|FG001|Overall Study|Suspicion of pulmonary cancer|1
827245|NCT00261833|1782125|FG000|Overall Study|Lung transplantation|1
827246|NCT00261833|1782126|FG001|Overall Study|Lung transplantation|1
827247|NCT00261833|1782125|FG000|Overall Study|Missing reason|1
827248|NCT00261833|1782126|FG001|Overall Study|Missing reason|0
827249|NCT00261833|1782125|FG000|Overall Study|Not interested in being participant|0
827250|NCT00261833|1782126|FG001|Overall Study|Not interested in being participant|1
827251|NCT00261846|1782142|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
827252|NCT00261846|1782143|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
827253|NCT00261846|1782144|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
827254|NCT00261846|1782145|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
827255|NCT00261846|1782146|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
827256|NCT00261846|1782147|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
827257|NCT00261846|1782148|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
827258|NCT00261846|1782149|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
827259|NCT00261846|1782150|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
827260|NCT00261846|1782151|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
827261|NCT00261846|1782152|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
827262|NCT00261846|1782153|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
827263|NCT00261846|1782142|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
827264|NCT00261846|1782143|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
827265|NCT00261846|1782144|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
827266|NCT00261846|1782145|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
827267|NCT00261846|1782146|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
827268|NCT00261846|1782147|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
827269|NCT00261846|1782148|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
827270|NCT00261846|1782149|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
827271|NCT00261846|1782150|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
827272|NCT00261846|1782151|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
827273|NCT00261846|1782152|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
827274|NCT00261846|1782153|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
827275|NCT00261846|1782142|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
827276|NCT00261846|1782143|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
827277|NCT00261846|1782144|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
827278|NCT00261846|1782145|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
827279|NCT00261846|1782146|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
827280|NCT00261846|1782147|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
827281|NCT00261846|1782148|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
827282|NCT00261846|1782149|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
827283|NCT00261846|1782150|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
827284|NCT00261846|1782151|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
827285|NCT00261846|1782152|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
827286|NCT00261846|1782153|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
827287|NCT00261846|1782142|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
827288|NCT00261846|1782143|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
827289|NCT00261846|1782144|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
827290|NCT00261846|1782145|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
827291|NCT00261846|1782146|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
827292|NCT00261846|1782147|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
827293|NCT00261846|1782148|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
827294|NCT00261846|1782149|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
827295|NCT00261846|1782150|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
827296|NCT00261846|1782151|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
827297|NCT00261846|1782152|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
827298|NCT00261846|1782153|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
827299|NCT00261846|1782142|FG000|Period 2: Part 2 (Efficacy)|Other|0
827300|NCT00261846|1782143|FG001|Period 2: Part 2 (Efficacy)|Other|0
827301|NCT00261846|1782144|FG002|Period 2: Part 2 (Efficacy)|Other|0
827302|NCT00261846|1782145|FG003|Period 2: Part 2 (Efficacy)|Other|15
827303|NCT00261846|1782146|FG004|Period 2: Part 2 (Efficacy)|Other|4
827304|NCT00261846|1782147|FG005|Period 2: Part 2 (Efficacy)|Other|0
827305|NCT00261846|1782148|FG006|Period 2: Part 2 (Efficacy)|Other|1
827306|NCT00261846|1782149|FG007|Period 2: Part 2 (Efficacy)|Other|5
827307|NCT00261846|1782150|FG008|Period 2: Part 2 (Efficacy)|Other|4
827308|NCT00261846|1782151|FG009|Period 2: Part 2 (Efficacy)|Other|4
827309|NCT00261846|1782152|FG010|Period 2: Part 2 (Efficacy)|Other|0
827310|NCT00261846|1782153|FG011|Period 2: Part 2 (Efficacy)|Other|0
827311|NCT00261846|1782142|FG000|Period 2: Part 2 (Efficacy)|Death|0
827312|NCT00261846|1782143|FG001|Period 2: Part 2 (Efficacy)|Death|0
827313|NCT00261846|1782144|FG002|Period 2: Part 2 (Efficacy)|Death|0
827314|NCT00261846|1782145|FG003|Period 2: Part 2 (Efficacy)|Death|37
827315|NCT00261846|1782146|FG004|Period 2: Part 2 (Efficacy)|Death|7
827316|NCT00261846|1782147|FG005|Period 2: Part 2 (Efficacy)|Death|1
827317|NCT00261846|1782148|FG006|Period 2: Part 2 (Efficacy)|Death|10
827318|NCT00261846|1782149|FG007|Period 2: Part 2 (Efficacy)|Death|12
827319|NCT00261846|1782150|FG008|Period 2: Part 2 (Efficacy)|Death|3
827320|NCT00261846|1782151|FG009|Period 2: Part 2 (Efficacy)|Death|30
827321|NCT00261846|1782152|FG010|Period 2: Part 2 (Efficacy)|Death|44
827322|NCT00261846|1782153|FG011|Period 2: Part 2 (Efficacy)|Death|22
827323|NCT00261846|1782142|FG000|Period 2: Part 2 (Efficacy)|Extension study|0
827324|NCT00261846|1782143|FG001|Period 2: Part 2 (Efficacy)|Extension study|0
827325|NCT00261846|1782144|FG002|Period 2: Part 2 (Efficacy)|Extension study|0
827326|NCT00261846|1782145|FG003|Period 2: Part 2 (Efficacy)|Extension study|61
827327|NCT00261846|1782146|FG004|Period 2: Part 2 (Efficacy)|Extension study|27
827328|NCT00261846|1782147|FG005|Period 2: Part 2 (Efficacy)|Extension study|0
827329|NCT00261846|1782148|FG006|Period 2: Part 2 (Efficacy)|Extension study|4
827330|NCT00261846|1782149|FG007|Period 2: Part 2 (Efficacy)|Extension study|9
827331|NCT00261846|1782150|FG008|Period 2: Part 2 (Efficacy)|Extension study|5
827332|NCT00261846|1782151|FG009|Period 2: Part 2 (Efficacy)|Extension study|9
827333|NCT00261846|1782152|FG010|Period 2: Part 2 (Efficacy)|Extension study|1
827334|NCT00261846|1782153|FG011|Period 2: Part 2 (Efficacy)|Extension study|1
827335|NCT00261950|1782192|FG000|Overall Study|Lost to Follow-up|2
827336|NCT00261950|1782192|FG000|Overall Study|Death|6
827337|NCT00261950|1782192|FG000|Overall Study|Withdrawal by Subject|5
827338|NCT00261950|1782192|FG000|Overall Study|Other|1
827339|NCT00261950|1782192|FG000|Overall Study|Physician Decision|1
827340|NCT00261950|1782192|FG000|Overall Study|Protocol specified Criteria|11
827341|NCT00262002|1782203|FG000|Overall Study|Adverse Event|2
827342|NCT00262002|1782204|FG001|Overall Study|Adverse Event|1
827343|NCT00262002|1782205|FG002|Overall Study|Adverse Event|0
827344|NCT00262002|1782206|FG003|Overall Study|Adverse Event|0
827345|NCT00262002|1782207|FG004|Overall Study|Adverse Event|0
827346|NCT00262002|1782208|FG005|Overall Study|Adverse Event|1
827347|NCT00262002|1782209|FG006|Overall Study|Adverse Event|0
827348|NCT00262002|1782203|FG000|Overall Study|Withdrawal by Subject|4
827349|NCT00262002|1782204|FG001|Overall Study|Withdrawal by Subject|2
827350|NCT00262002|1782205|FG002|Overall Study|Withdrawal by Subject|0
827351|NCT00262002|1782206|FG003|Overall Study|Withdrawal by Subject|1
827352|NCT00262002|1782207|FG004|Overall Study|Withdrawal by Subject|2
827353|NCT00262002|1782208|FG005|Overall Study|Withdrawal by Subject|2
827354|NCT00262002|1782209|FG006|Overall Study|Withdrawal by Subject|2
827355|NCT00262002|1782203|FG000|Overall Study|Lost to Follow-up|2
827356|NCT00262002|1782204|FG001|Overall Study|Lost to Follow-up|0
827357|NCT00262002|1782205|FG002|Overall Study|Lost to Follow-up|0
827358|NCT00262002|1782206|FG003|Overall Study|Lost to Follow-up|2
827359|NCT00262002|1782207|FG004|Overall Study|Lost to Follow-up|0
827360|NCT00262002|1782208|FG005|Overall Study|Lost to Follow-up|1
827361|NCT00262002|1782209|FG006|Overall Study|Lost to Follow-up|0
827362|NCT00262002|1782203|FG000|Overall Study|Inapropriate enrollment|0
827363|NCT00262002|1782204|FG001|Overall Study|Inapropriate enrollment|1
827364|NCT00262002|1782205|FG002|Overall Study|Inapropriate enrollment|0
827365|NCT00262002|1782206|FG003|Overall Study|Inapropriate enrollment|0
827366|NCT00262002|1782207|FG004|Overall Study|Inapropriate enrollment|0
827367|NCT00262002|1782208|FG005|Overall Study|Inapropriate enrollment|0
827368|NCT00262002|1782209|FG006|Overall Study|Inapropriate enrollment|0
827369|NCT00262002|1782203|FG000|Overall Study|Protocol Violation|3
827370|NCT00262002|1782204|FG001|Overall Study|Protocol Violation|2
827371|NCT00262002|1782205|FG002|Overall Study|Protocol Violation|0
827372|NCT00262002|1782206|FG003|Overall Study|Protocol Violation|2
827373|NCT00262002|1782207|FG004|Overall Study|Protocol Violation|5
827374|NCT00262002|1782208|FG005|Overall Study|Protocol Violation|3
827375|NCT00262002|1782209|FG006|Overall Study|Protocol Violation|2
827376|NCT00262002|1782203|FG000|Overall Study|Unable to classify|0
827377|NCT00262002|1782204|FG001|Overall Study|Unable to classify|0
827378|NCT00262002|1782205|FG002|Overall Study|Unable to classify|0
827379|NCT00262002|1782206|FG003|Overall Study|Unable to classify|0
827380|NCT00262002|1782207|FG004|Overall Study|Unable to classify|0
827381|NCT00262002|1782208|FG005|Overall Study|Unable to classify|0
827382|NCT00262002|1782209|FG006|Overall Study|Unable to classify|2
827383|NCT00262028|1782283|FG000|Overall Study|Withdrawal by Subject|6
827384|NCT00262028|1782284|FG001|Overall Study|Withdrawal by Subject|3
827385|NCT00262028|1782285|FG002|Overall Study|Withdrawal by Subject|6
827386|NCT00262028|1782286|FG003|Overall Study|Withdrawal by Subject|5
827387|NCT00262028|1782287|FG004|Overall Study|Withdrawal by Subject|2
827388|NCT00262028|1782288|FG005|Overall Study|Withdrawal by Subject|3
827389|NCT00262028|1782289|FG006|Overall Study|Withdrawal by Subject|5
827390|NCT00262028|1782290|FG007|Overall Study|Withdrawal by Subject|7
827391|NCT00262028|1782291|FG008|Overall Study|Withdrawal by Subject|2
827392|NCT00262028|1782283|FG000|Overall Study|Lost to Follow-up|7
827393|NCT00262028|1782284|FG001|Overall Study|Lost to Follow-up|7
827394|NCT00262028|1782285|FG002|Overall Study|Lost to Follow-up|5
827395|NCT00262028|1782286|FG003|Overall Study|Lost to Follow-up|5
827396|NCT00262028|1782287|FG004|Overall Study|Lost to Follow-up|4
827397|NCT00262028|1782288|FG005|Overall Study|Lost to Follow-up|3
827398|NCT00262028|1782289|FG006|Overall Study|Lost to Follow-up|3
827399|NCT00262028|1782290|FG007|Overall Study|Lost to Follow-up|5
827400|NCT00262028|1782291|FG008|Overall Study|Lost to Follow-up|6
827401|NCT00262028|1782283|FG000|Overall Study|Administrative Reason|11
827402|NCT00262028|1782284|FG001|Overall Study|Administrative Reason|14
827403|NCT00262028|1782285|FG002|Overall Study|Administrative Reason|9
827404|NCT00262028|1782286|FG003|Overall Study|Administrative Reason|12
827405|NCT00262028|1782287|FG004|Overall Study|Administrative Reason|6
827406|NCT00262028|1782288|FG005|Overall Study|Administrative Reason|7
827407|NCT00262028|1782289|FG006|Overall Study|Administrative Reason|4
827408|NCT00262028|1782290|FG007|Overall Study|Administrative Reason|6
827409|NCT00262028|1782291|FG008|Overall Study|Administrative Reason|10
827410|NCT00262028|1782283|FG000|Overall Study|Protocol Violation|0
827411|NCT00262028|1782284|FG001|Overall Study|Protocol Violation|0
827412|NCT00262028|1782285|FG002|Overall Study|Protocol Violation|0
827413|NCT00262028|1782286|FG003|Overall Study|Protocol Violation|1
827414|NCT00262028|1782287|FG004|Overall Study|Protocol Violation|0
827415|NCT00262028|1782288|FG005|Overall Study|Protocol Violation|0
827416|NCT00262028|1782289|FG006|Overall Study|Protocol Violation|0
827417|NCT00262028|1782290|FG007|Overall Study|Protocol Violation|0
827418|NCT00262028|1782291|FG008|Overall Study|Protocol Violation|0
827419|NCT00262028|1782283|FG000|Overall Study|Unable to classify|0
827420|NCT00262028|1782284|FG001|Overall Study|Unable to classify|3
827421|NCT00262028|1782285|FG002|Overall Study|Unable to classify|0
827422|NCT00262028|1782286|FG003|Overall Study|Unable to classify|0
827423|NCT00262028|1782287|FG004|Overall Study|Unable to classify|0
827424|NCT00262028|1782288|FG005|Overall Study|Unable to classify|0
827425|NCT00262028|1782289|FG006|Overall Study|Unable to classify|0
827426|NCT00262028|1782290|FG007|Overall Study|Unable to classify|0
827427|NCT00262028|1782291|FG008|Overall Study|Unable to classify|1
827428|NCT00262041|1782337|FG000|Overall Study|Withdrawal by Subject|0
827429|NCT00262041|1782338|FG001|Overall Study|Withdrawal by Subject|3
827430|NCT00262041|1782339|FG002|Overall Study|Withdrawal by Subject|1
827431|NCT00262041|1782337|FG000|Overall Study|Lost to Follow-up|1
827432|NCT00262041|1782338|FG001|Overall Study|Lost to Follow-up|1
827433|NCT00262041|1782339|FG002|Overall Study|Lost to Follow-up|5
827434|NCT00262041|1782337|FG000|Overall Study|Unable to classify|1
827435|NCT00262041|1782338|FG001|Overall Study|Unable to classify|0
827436|NCT00262041|1782339|FG002|Overall Study|Unable to classify|0
827437|NCT00262067|1782357|FG000|Overall Study|Death|190
827438|NCT00262067|1782358|FG001|Overall Study|Death|89
827439|NCT00262067|1782359|FG002|Overall Study|Death|186
827440|NCT00262067|1782360|FG003|Overall Study|Death|99
827441|NCT00262067|1782357|FG000|Overall Study|Lost to Follow-up|5
827442|NCT00262067|1782358|FG001|Overall Study|Lost to Follow-up|4
827443|NCT00262067|1782359|FG002|Overall Study|Lost to Follow-up|7
827444|NCT00262067|1782360|FG003|Overall Study|Lost to Follow-up|5
827445|NCT00262067|1782357|FG000|Overall Study|Sponsor's Decision to Terminate Study|1
827446|NCT00262067|1782358|FG001|Overall Study|Sponsor's Decision to Terminate Study|0
827447|NCT00262067|1782359|FG002|Overall Study|Sponsor's Decision to Terminate Study|0
827448|NCT00262067|1782360|FG003|Overall Study|Sponsor's Decision to Terminate Study|0
827449|NCT00262067|1782357|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23
827450|NCT00262067|1782358|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7
827451|NCT00262067|1782359|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23
827452|NCT00262067|1782360|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9
827453|NCT00262080|1782373|FG000|Double Blind Treatment Period|Lost to Follow-up|1
827454|NCT00262080|1782374|FG001|Double Blind Treatment Period|Lost to Follow-up|0
827455|NCT00262080|1782375|FG002|Double Blind Treatment Period|Lost to Follow-up|0
827456|NCT00262080|1782373|FG000|Repeat Dose Treatment Period|Adverse Event|1
827457|NCT00262080|1782374|FG001|Repeat Dose Treatment Period|Adverse Event|0
827458|NCT00262080|1782375|FG002|Repeat Dose Treatment Period|Adverse Event|0
827459|NCT00262080|1782373|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0
827460|NCT00262080|1782374|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1
827461|NCT00262080|1782375|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1
827462|NCT00262080|1782373|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2
827463|NCT00262080|1782374|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0
827464|NCT00262080|1782375|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2
827465|NCT00262080|1782373|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0
827466|NCT00262080|1782374|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0
827467|NCT00262080|1782375|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2
827468|NCT00262080|1782373|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1
827469|NCT00262080|1782374|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0
827470|NCT00262080|1782375|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0
827471|NCT00262119|1782386|FG000|Overall Study|Lost to Follow-up|38
827472|NCT00262119|1782387|FG001|Overall Study|Lost to Follow-up|51
827473|NCT00262119|1782388|FG002|Overall Study|Lost to Follow-up|42
827474|NCT00262119|1782386|FG000|Overall Study|Death|20
827475|NCT00262119|1782387|FG001|Overall Study|Death|19
827476|NCT00262119|1782388|FG002|Overall Study|Death|16
827477|NCT00262223|1782398|FG000|Treatment Phase|Withdrawal by Subject|3
827478|NCT00262223|1782399|FG001|Treatment Phase|Withdrawal by Subject|6
827479|NCT00262223|1782398|FG000|Treatment Phase|Adverse Event|1
827480|NCT00262223|1782399|FG001|Treatment Phase|Adverse Event|2
827481|NCT00262223|1782398|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4
827482|NCT00262223|1782399|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4
827483|NCT00262223|1782398|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6
827484|NCT00262223|1782399|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1
827485|NCT00262223|1782398|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7
827486|NCT00262223|1782399|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7
827487|NCT00262301|1782409|FG000|Double-blind Phase|Lost to Follow-up|1
827488|NCT00262301|1782410|FG001|Double-blind Phase|Lost to Follow-up|0
827489|NCT00262301|1782411|FG002|Double-blind Phase|Lost to Follow-up|0
827490|NCT00262301|1782409|FG000|Double-blind Phase|"worsening of HAE symptoms"|0
827491|NCT00262301|1782410|FG001|Double-blind Phase|"worsening of HAE symptoms"|1
827492|NCT00262301|1782411|FG002|Double-blind Phase|"worsening of HAE symptoms"|0
827493|NCT00262314|1782419|FG000|Overall Study|Changing physicians|38
827494|NCT00262314|1782419|FG000|Overall Study|Death|12
827495|NCT00262314|1782419|FG000|Overall Study|Patient's decision|92
827496|NCT00262314|1782419|FG000|Overall Study|Other|95
827497|NCT00262314|1782419|FG000|Overall Study|Lost to Follow-up|70
827498|NCT00262314|1782419|FG000|Overall Study|Administrative withdrawal|30
827499|NCT00262522|1782436|FG000|Study Start Through 8 Weeks|Adverse Event|1
827500|NCT00262522|1782437|FG001|Study Start Through 8 Weeks|Adverse Event|2
827501|NCT00262522|1782438|FG002|Study Start Through 8 Weeks|Adverse Event|3
827502|NCT00262522|1782439|FG003|Study Start Through 8 Weeks|Adverse Event|1
827503|NCT00262522|1782436|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1
827504|NCT00262522|1782437|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1
827505|NCT00262522|1782438|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3
827506|NCT00262522|1782439|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0
827507|NCT00262522|1782436|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1
827508|NCT00262522|1782437|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2
827509|NCT00262522|1782438|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3
827510|NCT00262522|1782439|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2
827511|NCT00262522|1782436|FG000|Study Start Through 8 Weeks|Noncompliance|0
827512|NCT00262522|1782437|FG001|Study Start Through 8 Weeks|Noncompliance|0
827513|NCT00262522|1782438|FG002|Study Start Through 8 Weeks|Noncompliance|2
827514|NCT00262522|1782439|FG003|Study Start Through 8 Weeks|Noncompliance|2
827515|NCT00262522|1782436|FG000|Study Start Through 8 Weeks|Death|1
827516|NCT00262522|1782437|FG001|Study Start Through 8 Weeks|Death|0
827517|NCT00262522|1782438|FG002|Study Start Through 8 Weeks|Death|0
827518|NCT00262522|1782439|FG003|Study Start Through 8 Weeks|Death|0
827519|NCT00262522|1782436|FG000|Study Start Through 48 Weeks|Adverse Event|16
827520|NCT00262522|1782437|FG001|Study Start Through 48 Weeks|Adverse Event|0
827521|NCT00262522|1782438|FG002|Study Start Through 48 Weeks|Adverse Event|10
827522|NCT00262522|1782439|FG003|Study Start Through 48 Weeks|Adverse Event|0
827523|NCT00262522|1782436|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10
827524|NCT00262522|1782437|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0
827525|NCT00262522|1782438|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11
827526|NCT00262522|1782439|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0
827527|NCT00262522|1782436|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8
827528|NCT00262522|1782437|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0
827529|NCT00262522|1782438|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14
827530|NCT00262522|1782439|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0
827531|NCT00262522|1782436|FG000|Study Start Through 48 Weeks|Noncompliance|3
827532|NCT00262522|1782437|FG001|Study Start Through 48 Weeks|Noncompliance|0
827533|NCT00262522|1782438|FG002|Study Start Through 48 Weeks|Noncompliance|8
827534|NCT00262522|1782439|FG003|Study Start Through 48 Weeks|Noncompliance|0
827535|NCT00262522|1782436|FG000|Study Start Through 48 Weeks|Death|2
827536|NCT00262522|1782437|FG001|Study Start Through 48 Weeks|Death|0
827537|NCT00262522|1782438|FG002|Study Start Through 48 Weeks|Death|1
827538|NCT00262522|1782439|FG003|Study Start Through 48 Weeks|Death|0
827539|NCT00262522|1782436|FG000|Study Start Through 48 Weeks|Virologic failure|2
827540|NCT00262522|1782437|FG001|Study Start Through 48 Weeks|Virologic failure|0
827541|NCT00262522|1782438|FG002|Study Start Through 48 Weeks|Virologic failure|4
827542|NCT00262522|1782439|FG003|Study Start Through 48 Weeks|Virologic failure|0
827543|NCT00262522|1782436|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
827544|NCT00262522|1782437|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
827545|NCT00262522|1782438|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
827546|NCT00262522|1782439|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
827547|NCT00262522|1782436|FG000|Study Start Through 96 Weeks|Adverse Event|20
827548|NCT00262522|1782437|FG001|Study Start Through 96 Weeks|Adverse Event|0
827549|NCT00262522|1782438|FG002|Study Start Through 96 Weeks|Adverse Event|16
827550|NCT00262522|1782439|FG003|Study Start Through 96 Weeks|Adverse Event|0
827551|NCT00262522|1782436|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15
827552|NCT00262522|1782437|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0
827553|NCT00262522|1782438|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13
827554|NCT00262522|1782439|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0
827555|NCT00262522|1782436|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19
827556|NCT00262522|1782437|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0
827557|NCT00262522|1782438|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18
827558|NCT00262522|1782439|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0
827559|NCT00262522|1782436|FG000|Study Start Through 96 Weeks|Noncompliance|6
827560|NCT00262522|1782437|FG001|Study Start Through 96 Weeks|Noncompliance|0
827561|NCT00262522|1782438|FG002|Study Start Through 96 Weeks|Noncompliance|11
827562|NCT00262522|1782439|FG003|Study Start Through 96 Weeks|Noncompliance|0
827563|NCT00262522|1782436|FG000|Study Start Through 96 Weeks|Death|2
827564|NCT00262522|1782437|FG001|Study Start Through 96 Weeks|Death|0
827565|NCT00262522|1782438|FG002|Study Start Through 96 Weeks|Death|2
827566|NCT00262522|1782439|FG003|Study Start Through 96 Weeks|Death|0
827567|NCT00262522|1782436|FG000|Study Start Through 96 Weeks|Virologic failure|5
827568|NCT00262522|1782437|FG001|Study Start Through 96 Weeks|Virologic failure|0
827569|NCT00262522|1782438|FG002|Study Start Through 96 Weeks|Virologic failure|8
827570|NCT00262522|1782439|FG003|Study Start Through 96 Weeks|Virologic failure|0
827571|NCT00262522|1782436|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
827572|NCT00262522|1782437|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
827573|NCT00262522|1782438|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
827574|NCT00262522|1782439|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
827575|NCT00262600|1782450|FG000|Overall Study|Lost to Follow-up|17
827576|NCT00262600|1782451|FG001|Overall Study|Lost to Follow-up|31
827577|NCT00262600|1782452|FG002|Overall Study|Lost to Follow-up|41
827578|NCT00262600|1782450|FG000|Overall Study|Withdrawal by Subject|128
827579|NCT00262600|1782451|FG001|Overall Study|Withdrawal by Subject|145
827580|NCT00262600|1782452|FG002|Overall Study|Withdrawal by Subject|139
827581|NCT00262600|1782450|FG000|Overall Study|Not Treated|32
827582|NCT00262600|1782451|FG001|Overall Study|Not Treated|17
827583|NCT00262600|1782452|FG002|Overall Study|Not Treated|24
827584|NCT00262600|1782450|FG000|Overall Study|Other|58
827585|NCT00262600|1782451|FG001|Overall Study|Other|59
827586|NCT00262600|1782452|FG002|Overall Study|Other|62
827587|NCT00262743|1782483|FG000|Overall Study|Adverse Event|0
827588|NCT00262743|1782484|FG001|Overall Study|Adverse Event|9
827589|NCT00262743|1782483|FG000|Overall Study|Disease progression|0
827590|NCT00262743|1782484|FG001|Overall Study|Disease progression|3
827591|NCT00262821|1782490|FG000|Overall Study|Ineligible - wrong stage|0
827592|NCT00262821|1782491|FG001|Overall Study|Ineligible - wrong stage|3
827593|NCT00262821|1782490|FG000|Overall Study|Ineligible - wrong cell type|2
827594|NCT00262821|1782491|FG001|Overall Study|Ineligible - wrong cell type|2
827595|NCT00262821|1782490|FG000|Overall Study|Ineligible - wrong primary|0
827596|NCT00262821|1782491|FG001|Overall Study|Ineligible - wrong primary|1
827597|NCT00262821|1782490|FG000|Overall Study|Ineligible - inadequate pathology|1
827598|NCT00262821|1782491|FG001|Overall Study|Ineligible - inadequate pathology|3
827599|NCT00262821|1782490|FG000|Overall Study|Ineligible - elevated creatinine|0
827600|NCT00262821|1782491|FG001|Overall Study|Ineligible - elevated creatinine|2
827601|NCT00262821|1782490|FG000|Overall Study|Ineligible - required test not done|1
827602|NCT00262821|1782491|FG001|Overall Study|Ineligible - required test not done|4
827603|NCT00262821|1782490|FG000|Overall Study|Inevaluable - inadequate data|0
827604|NCT00262821|1782491|FG001|Overall Study|Inevaluable - inadequate data|4
827605|NCT00262834|1782499|FG000|Overall Study|Surgery delayed/tissue not collected|1
827606|NCT00262834|1782500|FG001|Overall Study|Surgery delayed/tissue not collected|4
827607|NCT00262847|1782509|FG000|Overall Study|Disease Progression|309
827608|NCT00262847|1782510|FG001|Overall Study|Disease Progression|274
827609|NCT00262847|1782511|FG002|Overall Study|Disease Progression|195
827610|NCT00262847|1782509|FG000|Overall Study|Patient Refusal|41
827611|NCT00262847|1782510|FG001|Overall Study|Patient Refusal|52
827612|NCT00262847|1782511|FG002|Overall Study|Patient Refusal|47
827613|NCT00262847|1782509|FG000|Overall Study|Adverse Event|74
827614|NCT00262847|1782510|FG001|Overall Study|Adverse Event|88
827615|NCT00262847|1782511|FG002|Overall Study|Adverse Event|108
827616|NCT00262847|1782509|FG000|Overall Study|Death|8
827617|NCT00262847|1782510|FG001|Overall Study|Death|8
827618|NCT00262847|1782511|FG002|Overall Study|Death|11
827619|NCT00262847|1782509|FG000|Overall Study|Concomitant disease|3
827620|NCT00262847|1782510|FG001|Overall Study|Concomitant disease|2
827621|NCT00262847|1782511|FG002|Overall Study|Concomitant disease|4
827622|NCT00262847|1782509|FG000|Overall Study|Other Reasons|79
827623|NCT00262847|1782510|FG001|Overall Study|Other Reasons|88
827624|NCT00262847|1782511|FG002|Overall Study|Other Reasons|27
827625|NCT00262847|1782509|FG000|Overall Study|Did not receive study treatment|4
827626|NCT00262847|1782510|FG001|Overall Study|Did not receive study treatment|1
827627|NCT00262847|1782511|FG002|Overall Study|Did not receive study treatment|4
827628|NCT00262860|1782522|FG000|Overall Study|Adverse Event|2
827629|NCT00262873|1782526|FG000|Overall Study|Adverse Event|3
827630|NCT00262873|1782526|FG000|Overall Study|Withdrawal by Subject|5
827631|NCT00262925|1782530|FG000|Overall Study|Lack of Efficacy|3
827632|NCT00262925|1782530|FG000|Overall Study|Adverse Event|4
827633|NCT00262925|1782530|FG000|Overall Study|Death|2
827634|NCT00262925|1782530|FG000|Overall Study|alternative therapy|1
827635|NCT00262925|1782530|FG000|Overall Study|Other|1
827636|NCT00262951|1782536|FG000|Overall Study|Progressive disease/relapse|3
827637|NCT00262951|1782536|FG000|Overall Study|Adverse Event|7
827638|NCT00262951|1782536|FG000|Overall Study|Death|1
827639|NCT00262951|1782536|FG000|Overall Study|Withdrawal by Subject|1
827640|NCT00262951|1782536|FG000|Overall Study|Alternative treatment|3
827641|NCT00262951|1782536|FG000|Overall Study|Off treatment for other disease|1
827642|NCT00263211|1782569|FG000|Overall Study|Death|1
827643|NCT00263211|1782570|FG001|Overall Study|Death|0
827644|NCT00263211|1782569|FG000|Overall Study|Withdrawal by Subject|3
827645|NCT00263211|1782570|FG001|Overall Study|Withdrawal by Subject|0
827646|NCT00263211|1782569|FG000|Overall Study|Protocol Violation|1
827647|NCT00263211|1782570|FG001|Overall Study|Protocol Violation|0
827648|NCT00263211|1782569|FG000|Overall Study|Disease Progression|0
827649|NCT00263211|1782570|FG001|Overall Study|Disease Progression|1
827650|NCT00263328|1782582|FG000|Overall Study|Death|0
827651|NCT00263328|1782583|FG001|Overall Study|Death|0
827652|NCT00263328|1782584|FG002|Overall Study|Death|1
827653|NCT00263328|1782582|FG000|Overall Study|Lost to Follow-up|1
827654|NCT00263328|1782583|FG001|Overall Study|Lost to Follow-up|1
827655|NCT00263328|1782584|FG002|Overall Study|Lost to Follow-up|0
827656|NCT00263328|1782582|FG000|Overall Study|Withdrawal by Subject|3
827657|NCT00263328|1782583|FG001|Overall Study|Withdrawal by Subject|0
827658|NCT00263328|1782584|FG002|Overall Study|Withdrawal by Subject|1
827659|NCT00263328|1782582|FG000|Overall Study|Other|3
827660|NCT00263328|1782583|FG001|Overall Study|Other|0
827661|NCT00263328|1782584|FG002|Overall Study|Other|1
827662|NCT00263328|1782582|FG000|Overall Study|Adverse Event|1
827663|NCT00263328|1782583|FG001|Overall Study|Adverse Event|1
827664|NCT00263328|1782584|FG002|Overall Study|Adverse Event|4
827665|NCT00263562|1782596|FG000|Overall Study|Protocol Violation|3
827666|NCT00263562|1782597|FG001|Overall Study|Protocol Violation|0
827667|NCT00263575|1782605|FG000|Titration Period|Adverse Event|14
827668|NCT00263575|1782605|FG000|Titration Period|Withdrawal by Subject|10
827669|NCT00263575|1782605|FG000|Titration Period|Protocol Violation|9
827670|NCT00263575|1782605|FG000|Titration Period|Sponsor Decision|2
827671|NCT00263575|1782605|FG000|Titration Period|Other|2
827672|NCT00263575|1782605|FG000|Titration Period|Lack of Efficacy|6
827673|NCT00263575|1782605|FG000|Maintence Period|Adverse Event|23
827674|NCT00263575|1782605|FG000|Maintence Period|Withdrawal by Subject|8
827675|NCT00263575|1782605|FG000|Maintence Period|Protocol Violation|4
827676|NCT00263575|1782605|FG000|Maintence Period|Lack of Efficacy|4
827677|NCT00263575|1782605|FG000|Maintence Period|Physician Decision|6
827678|NCT00263575|1782605|FG000|Maintence Period|Lost to Follow-up|1
827679|NCT00263575|1782605|FG000|Maintence Period|Sponsor Decision|24
827680|NCT00263575|1782605|FG000|Maintence Period|Other|7
827681|NCT00263588|1782613|FG000|Overall Study|Death|54
827682|NCT00263588|1782614|FG001|Overall Study|Death|90
827683|NCT00263588|1782613|FG000|Overall Study|disease progression, coma, 1 unknown|10
827684|NCT00263588|1782614|FG001|Overall Study|disease progression, coma, 1 unknown|11
827685|NCT00263588|1782613|FG000|Overall Study|Lost to Follow-up|7
827686|NCT00263588|1782614|FG001|Overall Study|Lost to Follow-up|10
827687|NCT00263588|1782613|FG000|Overall Study|Withdrawal by Subject|3
827688|NCT00263588|1782614|FG001|Overall Study|Withdrawal by Subject|4
827689|NCT00263588|1782613|FG000|Overall Study|Protocol Violation|0
827690|NCT00263588|1782614|FG001|Overall Study|Protocol Violation|1
827691|NCT00263588|1782613|FG000|Overall Study|Investigator decision|7
827692|NCT00263588|1782614|FG001|Overall Study|Investigator decision|15
827693|NCT00263588|1782613|FG000|Overall Study|Sponsor terminated study|0
827694|NCT00263588|1782614|FG001|Overall Study|Sponsor terminated study|1
827695|NCT00263666|1782623|FG000|Overall Study|Adverse Event|6
827696|NCT00263666|1782624|FG001|Overall Study|Adverse Event|8
827697|NCT00263666|1782623|FG000|Overall Study|Lost to Follow-up|1
827698|NCT00263666|1782624|FG001|Overall Study|Lost to Follow-up|2
827699|NCT00263666|1782623|FG000|Overall Study|Withdrawal by Subject|0
827700|NCT00263666|1782624|FG001|Overall Study|Withdrawal by Subject|1
827701|NCT00263757|1782632|FG000|Overall Study|Withdrawal by Subject|5
827702|NCT00263757|1782633|FG001|Overall Study|Withdrawal by Subject|4
827703|NCT00263757|1782632|FG000|Overall Study|Screen failure|0
827704|NCT00263757|1782633|FG001|Overall Study|Screen failure|1
827705|NCT00263757|1782632|FG000|Overall Study|Adverse Event|3
827706|NCT00263757|1782633|FG001|Overall Study|Adverse Event|3
827707|NCT00263887|1782641|FG000|Overall Study|Withdrawal by Subject|1
827708|NCT00263887|1782642|FG001|Overall Study|Withdrawal by Subject|1
827709|NCT00263887|1782641|FG000|Overall Study|Lung transplantation|1
827710|NCT00263887|1782642|FG001|Overall Study|Lung transplantation|2
827711|NCT00263887|1782641|FG000|Overall Study|Too ill to attend visit|1
827712|NCT00263887|1782642|FG001|Overall Study|Too ill to attend visit|0
827713|NCT00263887|1782641|FG000|Overall Study|Adverse Event|0
827714|NCT00263887|1782642|FG001|Overall Study|Adverse Event|2
827715|NCT00263887|1782641|FG000|Overall Study|Disease progression|0
827716|NCT00263887|1782642|FG001|Overall Study|Disease progression|1
827717|NCT00263887|1782641|FG000|Overall Study|Lack of Efficacy|0
827718|NCT00263887|1782642|FG001|Overall Study|Lack of Efficacy|1
827719|NCT00264004|1782652|FG000|Overall Study|Adverse Event|2
827720|NCT00264004|1782653|FG001|Overall Study|Adverse Event|3
827721|NCT00264004|1782654|FG002|Overall Study|Adverse Event|6
827722|NCT00264004|1782655|FG003|Overall Study|Adverse Event|4
827723|NCT00264004|1782652|FG000|Overall Study|Withdrawal by Subject|0
827724|NCT00264004|1782653|FG001|Overall Study|Withdrawal by Subject|1
827725|NCT00264004|1782654|FG002|Overall Study|Withdrawal by Subject|2
827726|NCT00264004|1782655|FG003|Overall Study|Withdrawal by Subject|2
827727|NCT00264004|1782652|FG000|Overall Study|Other|2
827728|NCT00264004|1782653|FG001|Overall Study|Other|2
827729|NCT00264004|1782654|FG002|Overall Study|Other|0
827730|NCT00264004|1782655|FG003|Overall Study|Other|3
827731|NCT00264004|1782652|FG000|Overall Study|Development study specific disc. crit.|1
827732|NCT00264004|1782653|FG001|Overall Study|Development study specific disc. crit.|0
827733|NCT00264004|1782654|FG002|Overall Study|Development study specific disc. crit.|1
827734|NCT00264004|1782655|FG003|Overall Study|Development study specific disc. crit.|0
827735|NCT00264004|1782652|FG000|Overall Study|Cond. under inv. worsened|9
827736|NCT00264004|1782653|FG001|Overall Study|Cond. under inv. worsened|5
827737|NCT00264004|1782654|FG002|Overall Study|Cond. under inv. worsened|3
827738|NCT00264004|1782655|FG003|Overall Study|Cond. under inv. worsened|4
827739|NCT00264004|1782652|FG000|Overall Study|Not treated|3
827740|NCT00264004|1782653|FG001|Overall Study|Not treated|0
827741|NCT00264004|1782654|FG002|Overall Study|Not treated|2
827742|NCT00264004|1782655|FG003|Overall Study|Not treated|2
827743|NCT00264147|1782670|FG000|Treatment I Period|Adverse Event|3
827744|NCT00264147|1782671|FG001|Treatment I Period|Adverse Event|6
827745|NCT00264147|1782672|FG002|Treatment I Period|Adverse Event|3
827746|NCT00264147|1782673|FG003|Treatment I Period|Adverse Event|5
827747|NCT00264147|1782674|FG004|Treatment I Period|Adverse Event|7
827748|NCT00264147|1782675|FG005|Treatment I Period|Adverse Event|0
827749|NCT00264147|1782670|FG000|Treatment I Period|Laboratory Adverse Event|0
827750|NCT00264147|1782671|FG001|Treatment I Period|Laboratory Adverse Event|0
827751|NCT00264147|1782672|FG002|Treatment I Period|Laboratory Adverse Event|0
827752|NCT00264147|1782673|FG003|Treatment I Period|Laboratory Adverse Event|1
827753|NCT00264147|1782674|FG004|Treatment I Period|Laboratory Adverse Event|0
827754|NCT00264147|1782675|FG005|Treatment I Period|Laboratory Adverse Event|0
827755|NCT00264147|1782670|FG000|Treatment I Period|Lack of Efficacy|6
827756|NCT00264147|1782671|FG001|Treatment I Period|Lack of Efficacy|2
827757|NCT00264147|1782672|FG002|Treatment I Period|Lack of Efficacy|8
827758|NCT00264147|1782673|FG003|Treatment I Period|Lack of Efficacy|0
827759|NCT00264147|1782674|FG004|Treatment I Period|Lack of Efficacy|1
827760|NCT00264147|1782675|FG005|Treatment I Period|Lack of Efficacy|0
827761|NCT00264147|1782670|FG000|Treatment I Period|Lost to Follow-up|1
827762|NCT00264147|1782671|FG001|Treatment I Period|Lost to Follow-up|0
827763|NCT00264147|1782672|FG002|Treatment I Period|Lost to Follow-up|0
827764|NCT00264147|1782673|FG003|Treatment I Period|Lost to Follow-up|1
827765|NCT00264147|1782674|FG004|Treatment I Period|Lost to Follow-up|1
827766|NCT00264147|1782675|FG005|Treatment I Period|Lost to Follow-up|0
827767|NCT00264147|1782670|FG000|Treatment I Period|Protocol Violation|2
827768|NCT00264147|1782671|FG001|Treatment I Period|Protocol Violation|2
827769|NCT00264147|1782672|FG002|Treatment I Period|Protocol Violation|0
827770|NCT00264147|1782673|FG003|Treatment I Period|Protocol Violation|0
827771|NCT00264147|1782674|FG004|Treatment I Period|Protocol Violation|0
827772|NCT00264147|1782675|FG005|Treatment I Period|Protocol Violation|0
827773|NCT00264147|1782670|FG000|Treatment I Period|Withdrawal by Subject|2
827774|NCT00264147|1782671|FG001|Treatment I Period|Withdrawal by Subject|0
827775|NCT00264147|1782672|FG002|Treatment I Period|Withdrawal by Subject|0
827776|NCT00264147|1782673|FG003|Treatment I Period|Withdrawal by Subject|2
827777|NCT00264147|1782674|FG004|Treatment I Period|Withdrawal by Subject|2
827778|NCT00264147|1782675|FG005|Treatment I Period|Withdrawal by Subject|0
827779|NCT00264147|1782670|FG000|Treatment I Period|Patient out of town for an extended time|0
827780|NCT00264147|1782671|FG001|Treatment I Period|Patient out of town for an extended time|1
827781|NCT00264147|1782672|FG002|Treatment I Period|Patient out of town for an extended time|0
827782|NCT00264147|1782673|FG003|Treatment I Period|Patient out of town for an extended time|0
827783|NCT00264147|1782674|FG004|Treatment I Period|Patient out of town for an extended time|0
827784|NCT00264147|1782675|FG005|Treatment I Period|Patient out of town for an extended time|0
827785|NCT00264147|1782670|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0
827786|NCT00264147|1782671|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0
827787|NCT00264147|1782672|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1
827788|NCT00264147|1782673|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0
827789|NCT00264147|1782674|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0
827790|NCT00264147|1782675|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0
827791|NCT00264147|1782670|FG000|Treatment I Period|Reassigned to Treatment II Period|84
827792|NCT00264147|1782671|FG001|Treatment I Period|Reassigned to Treatment II Period|72
827793|NCT00264147|1782672|FG002|Treatment I Period|Reassigned to Treatment II Period|65
827794|NCT00264147|1782673|FG003|Treatment I Period|Reassigned to Treatment II Period|63
827795|NCT00264147|1782674|FG004|Treatment I Period|Reassigned to Treatment II Period|45
827796|NCT00264147|1782675|FG005|Treatment I Period|Reassigned to Treatment II Period|0
827797|NCT00264147|1782670|FG000|Treatment II Period|Adverse Event|0
827798|NCT00264147|1782671|FG001|Treatment II Period|Adverse Event|0
827799|NCT00264147|1782672|FG002|Treatment II Period|Adverse Event|0
827800|NCT00264147|1782673|FG003|Treatment II Period|Adverse Event|0
827801|NCT00264147|1782674|FG004|Treatment II Period|Adverse Event|9
827802|NCT00264147|1782675|FG005|Treatment II Period|Adverse Event|9
827803|NCT00264147|1782670|FG000|Treatment II Period|Laboratory Adverse Event|0
827804|NCT00264147|1782671|FG001|Treatment II Period|Laboratory Adverse Event|0
827805|NCT00264147|1782672|FG002|Treatment II Period|Laboratory Adverse Event|0
827806|NCT00264147|1782673|FG003|Treatment II Period|Laboratory Adverse Event|0
827807|NCT00264147|1782674|FG004|Treatment II Period|Laboratory Adverse Event|0
827808|NCT00264147|1782675|FG005|Treatment II Period|Laboratory Adverse Event|1
827809|NCT00264147|1782670|FG000|Treatment II Period|Lack of Efficacy|0
827810|NCT00264147|1782671|FG001|Treatment II Period|Lack of Efficacy|0
827811|NCT00264147|1782672|FG002|Treatment II Period|Lack of Efficacy|0
827812|NCT00264147|1782673|FG003|Treatment II Period|Lack of Efficacy|0
827813|NCT00264147|1782674|FG004|Treatment II Period|Lack of Efficacy|20
827814|NCT00264147|1782675|FG005|Treatment II Period|Lack of Efficacy|19
827815|NCT00264147|1782670|FG000|Treatment II Period|Lost to Follow-up|0
827816|NCT00264147|1782671|FG001|Treatment II Period|Lost to Follow-up|0
827817|NCT00264147|1782672|FG002|Treatment II Period|Lost to Follow-up|0
827818|NCT00264147|1782673|FG003|Treatment II Period|Lost to Follow-up|0
827819|NCT00264147|1782674|FG004|Treatment II Period|Lost to Follow-up|1
827820|NCT00264147|1782675|FG005|Treatment II Period|Lost to Follow-up|1
827821|NCT00264147|1782670|FG000|Treatment II Period|Withdrawal by Subject|0
827822|NCT00264147|1782671|FG001|Treatment II Period|Withdrawal by Subject|0
827823|NCT00264147|1782672|FG002|Treatment II Period|Withdrawal by Subject|0
827824|NCT00264147|1782673|FG003|Treatment II Period|Withdrawal by Subject|0
827825|NCT00264147|1782674|FG004|Treatment II Period|Withdrawal by Subject|3
827826|NCT00264147|1782675|FG005|Treatment II Period|Withdrawal by Subject|2
827827|NCT00264147|1782670|FG000|Treatment II Period|Pre-scheduled total hip replacement|0
827828|NCT00264147|1782671|FG001|Treatment II Period|Pre-scheduled total hip replacement|0
827829|NCT00264147|1782672|FG002|Treatment II Period|Pre-scheduled total hip replacement|0
827830|NCT00264147|1782673|FG003|Treatment II Period|Pre-scheduled total hip replacement|0
827831|NCT00264147|1782674|FG004|Treatment II Period|Pre-scheduled total hip replacement|0
827832|NCT00264147|1782675|FG005|Treatment II Period|Pre-scheduled total hip replacement|1
827833|NCT00264238|1782689|FG000|Overall Study|Protocol Violation|1
827834|NCT00264290|1782697|FG000|Intervention (8 Weeks)|Adverse Event|1
827835|NCT00264290|1782698|FG001|Intervention (8 Weeks)|Adverse Event|0
827836|NCT00264303|1782710|FG000|Overall Study|Adverse Event|4
827837|NCT00264303|1782711|FG001|Overall Study|Adverse Event|3
827838|NCT00264303|1782710|FG000|Overall Study|Lack of Efficacy|10
827839|NCT00264303|1782711|FG001|Overall Study|Lack of Efficacy|13
827840|NCT00264303|1782710|FG000|Overall Study|Lost to Follow-up|3
827841|NCT00264303|1782711|FG001|Overall Study|Lost to Follow-up|3
827842|NCT00264303|1782710|FG000|Overall Study|Withdrawal by Subject|2
827843|NCT00264303|1782711|FG001|Overall Study|Withdrawal by Subject|3
827844|NCT00264303|1782710|FG000|Overall Study|Various reasons listed in study report|6
827845|NCT00264303|1782711|FG001|Overall Study|Various reasons listed in study report|7
827846|NCT00264498|1782728|FG000|Randomized Treatment|Death|0
827847|NCT00264498|1782729|FG001|Randomized Treatment|Death|3
827848|NCT00264498|1782728|FG000|Randomized Treatment|Withdrawal by Subject|0
827849|NCT00264498|1782729|FG001|Randomized Treatment|Withdrawal by Subject|1
827850|NCT00264498|1782728|FG000|Randomized Treatment|Objective disease Progression|13
827851|NCT00264498|1782729|FG001|Randomized Treatment|Objective disease Progression|14
827852|NCT00264498|1782728|FG000|Randomized Treatment|Physician Decision|1
827853|NCT00264498|1782729|FG001|Randomized Treatment|Physician Decision|0
827854|NCT00264498|1782728|FG000|Randomized Treatment|Incorrectly randomized|1
827855|NCT00264498|1782729|FG001|Randomized Treatment|Incorrectly randomized|0
827856|NCT00264498|1782728|FG000|Randomized Treatment|Study Closure|1
827857|NCT00264498|1782729|FG001|Randomized Treatment|Study Closure|0
827858|NCT00264498|1782728|FG000|Randomized Treatment|Protocol Violation|1
827859|NCT00264498|1782729|FG001|Randomized Treatment|Protocol Violation|0
827860|NCT00264498|1782728|FG000|Crossover Treatment|Death|1
827861|NCT00264498|1782729|FG001|Crossover Treatment|Death|3
827862|NCT00264498|1782728|FG000|Crossover Treatment|Objective disease progression|4
827863|NCT00264498|1782729|FG001|Crossover Treatment|Objective disease progression|5
827864|NCT00264498|1782728|FG000|Crossover Treatment|Study closure|0
827865|NCT00264498|1782729|FG001|Crossover Treatment|Study closure|1
827866|NCT00264498|1782728|FG000|Crossover Treatment|Withdrawal by Subject|1
827867|NCT00264498|1782729|FG001|Crossover Treatment|Withdrawal by Subject|0
827868|NCT00264537|1782739|FG000|Overall Study|Death|0
827869|NCT00264537|1782740|FG001|Overall Study|Death|3
827870|NCT00264537|1782741|FG002|Overall Study|Death|3
827871|NCT00264537|1782742|FG003|Overall Study|Death|2
827872|NCT00264537|1782739|FG000|Overall Study|Lost to Follow-up|3
827873|NCT00264537|1782740|FG001|Overall Study|Lost to Follow-up|4
827874|NCT00264537|1782741|FG002|Overall Study|Lost to Follow-up|7
827875|NCT00264537|1782742|FG003|Overall Study|Lost to Follow-up|6
827876|NCT00264537|1782739|FG000|Overall Study|Adverse Event|21
827877|NCT00264537|1782740|FG001|Overall Study|Adverse Event|32
827878|NCT00264537|1782741|FG002|Overall Study|Adverse Event|24
827879|NCT00264537|1782742|FG003|Overall Study|Adverse Event|34
827880|NCT00264537|1782739|FG000|Overall Study|Unsatisfactory therapeutic effect|5
827881|NCT00264537|1782740|FG001|Overall Study|Unsatisfactory therapeutic effect|6
827882|NCT00264537|1782741|FG002|Overall Study|Unsatisfactory therapeutic effect|5
827883|NCT00264537|1782742|FG003|Overall Study|Unsatisfactory therapeutic effect|7
827884|NCT00264537|1782739|FG000|Overall Study|Other|21
827885|NCT00264537|1782740|FG001|Overall Study|Other|11
827886|NCT00264537|1782741|FG002|Overall Study|Other|10
827887|NCT00264537|1782742|FG003|Overall Study|Other|11
827888|NCT00264537|1782739|FG000|Overall Study|Not treated|0
827889|NCT00264537|1782740|FG001|Overall Study|Not treated|2
827890|NCT00264537|1782741|FG002|Overall Study|Not treated|1
827891|NCT00264537|1782742|FG003|Overall Study|Not treated|0
827892|NCT00264550|1782758|FG000|Overall Study|Death|0
827893|NCT00264550|1782759|FG001|Overall Study|Death|3
827894|NCT00264550|1782760|FG002|Overall Study|Death|0
827895|NCT00264550|1782761|FG003|Overall Study|Death|0
827896|NCT00264550|1782758|FG000|Overall Study|Lost to Follow-up|3
827897|NCT00264550|1782759|FG001|Overall Study|Lost to Follow-up|1
827898|NCT00264550|1782760|FG002|Overall Study|Lost to Follow-up|1
827899|NCT00264550|1782761|FG003|Overall Study|Lost to Follow-up|1
827900|NCT00264550|1782758|FG000|Overall Study|Adverse Event|23
827901|NCT00264550|1782759|FG001|Overall Study|Adverse Event|18
827902|NCT00264550|1782760|FG002|Overall Study|Adverse Event|9
827903|NCT00264550|1782761|FG003|Overall Study|Adverse Event|14
827904|NCT00264550|1782758|FG000|Overall Study|Unsatisfactory therapeutic effect|4
827905|NCT00264550|1782759|FG001|Overall Study|Unsatisfactory therapeutic effect|11
827906|NCT00264550|1782760|FG002|Overall Study|Unsatisfactory therapeutic effect|4
827907|NCT00264550|1782761|FG003|Overall Study|Unsatisfactory therapeutic effect|6
827908|NCT00264550|1782758|FG000|Overall Study|Discontinued oral study agent|0
827909|NCT00264550|1782759|FG001|Overall Study|Discontinued oral study agent|1
827910|NCT00264550|1782760|FG002|Overall Study|Discontinued oral study agent|0
827911|NCT00264550|1782761|FG003|Overall Study|Discontinued oral study agent|0
827912|NCT00264550|1782758|FG000|Overall Study|Other|13
827913|NCT00264550|1782759|FG001|Overall Study|Other|7
827914|NCT00264550|1782760|FG002|Overall Study|Other|3
827915|NCT00264550|1782761|FG003|Overall Study|Other|9
827916|NCT00264576|1782773|FG000|Overall Study|Lost to Follow-up|1
827917|NCT00264576|1782774|FG001|Overall Study|Lost to Follow-up|1
827918|NCT00264797|1782791|FG000|Overall Study|Withdrawal by Subject|11
827919|NCT00264797|1782792|FG001|Overall Study|Withdrawal by Subject|11
827920|NCT00264797|1782791|FG000|Overall Study|Lost to Follow-up|9
827921|NCT00264797|1782792|FG001|Overall Study|Lost to Follow-up|17
827922|NCT00264797|1782791|FG000|Overall Study|Moved from area|3
827923|NCT00264797|1782792|FG001|Overall Study|Moved from area|1
827924|NCT00264797|1782791|FG000|Overall Study|Practical Problems|2
827925|NCT00264797|1782792|FG001|Overall Study|Practical Problems|3
827926|NCT00264797|1782791|FG000|Overall Study|Incarceration|4
827927|NCT00264797|1782792|FG001|Overall Study|Incarceration|5
827928|NCT00264797|1782791|FG000|Overall Study|Pressure/advice from Outsiders|1
827929|NCT00264797|1782792|FG001|Overall Study|Pressure/advice from Outsiders|1
827930|NCT00264797|1782791|FG000|Overall Study|Feels treatment not necessary, not worki|0
827931|NCT00264797|1782792|FG001|Overall Study|Feels treatment not necessary, not worki|1
827932|NCT00264797|1782791|FG000|Overall Study|Other|3
827933|NCT00264797|1782792|FG001|Overall Study|Other|4
827934|NCT00264810|1782800|FG000|Baseline|Withdrawal by Subject|10
827935|NCT00264810|1782801|FG001|Baseline|Withdrawal by Subject|10
827936|NCT00264810|1782800|FG000|Baseline|Physician Decision|7
827937|NCT00264810|1782801|FG001|Baseline|Physician Decision|8
827938|NCT00264810|1782800|FG000|Baseline|Subject Compliance Failure|3
827939|NCT00264810|1782801|FG001|Baseline|Subject Compliance Failure|3
827940|NCT00264810|1782800|FG000|Baseline|Insufficient Seizure Frequency|2
827941|NCT00264810|1782801|FG001|Baseline|Insufficient Seizure Frequency|2
827942|NCT00264810|1782800|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1
827943|NCT00264810|1782801|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2
827944|NCT00264810|1782800|FG000|Baseline|Other|0
827945|NCT00264810|1782801|FG001|Baseline|Other|1
827946|NCT00264810|1782800|FG000|Stimulation Optimization Period|Withdrawal by Subject|1
827947|NCT00264810|1782801|FG001|Stimulation Optimization Period|Withdrawal by Subject|0
827948|NCT00264810|1782800|FG000|Stimulation Optimization Period|Death|0
827949|NCT00264810|1782801|FG001|Stimulation Optimization Period|Death|1
827950|NCT00264810|1782800|FG000|Blinded Evaluation Period|Explant due to infection|1
827951|NCT00264810|1782801|FG001|Blinded Evaluation Period|Explant due to infection|1
827952|NCT00264810|1782800|FG000|Open Label Evaluation Period|Explant due to infection|1
827953|NCT00264810|1782801|FG001|Open Label Evaluation Period|Explant due to infection|1
827954|NCT00264810|1782800|FG000|Open Label Evaluation Period|Death|3
827955|NCT00264810|1782801|FG001|Open Label Evaluation Period|Death|2
827956|NCT00264810|1782800|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2
827957|NCT00264810|1782801|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3
827958|NCT00264849|1782811|FG000|Overall Study|Adverse Event|7
827959|NCT00264849|1782812|FG001|Overall Study|Adverse Event|2
827960|NCT00264849|1782811|FG000|Overall Study|Withdrawal by Subject|7
827961|NCT00264849|1782812|FG001|Overall Study|Withdrawal by Subject|11
827962|NCT00264849|1782811|FG000|Overall Study|Protocol Violation|5
827963|NCT00264849|1782812|FG001|Overall Study|Protocol Violation|3
827964|NCT00264849|1782811|FG000|Overall Study|Lack of Efficacy|1
827965|NCT00264849|1782812|FG001|Overall Study|Lack of Efficacy|6
827966|NCT00264849|1782811|FG000|Overall Study|Lost to Follow-up|0
827967|NCT00264849|1782812|FG001|Overall Study|Lost to Follow-up|2
827968|NCT00264849|1782811|FG000|Overall Study|Death|0
827969|NCT00264849|1782812|FG001|Overall Study|Death|1
827970|NCT00264849|1782811|FG000|Overall Study|Administrative Problems|2
827971|NCT00264849|1782812|FG001|Overall Study|Administrative Problems|0
827972|NCT00264875|1782818|FG000|Overall Study|Adverse Event|6
827973|NCT00264875|1782818|FG000|Overall Study|Lost to Follow-up|6
827974|NCT00264875|1782818|FG000|Overall Study|Protocol Violation|11
827975|NCT00264875|1782818|FG000|Overall Study|Withdrawal by Subject|7
827976|NCT00265083|1782825|FG000|Overall Study|Adverse Event|5
827977|NCT00265083|1782826|FG001|Overall Study|Adverse Event|13
827978|NCT00265083|1782827|FG002|Overall Study|Adverse Event|15
827979|NCT00265083|1782825|FG000|Overall Study|Lost to Follow-up|3
827980|NCT00265083|1782826|FG001|Overall Study|Lost to Follow-up|4
827981|NCT00265083|1782827|FG002|Overall Study|Lost to Follow-up|4
827982|NCT00265083|1782825|FG000|Overall Study|Unsatisfactory therapeutic effect|8
827983|NCT00265083|1782826|FG001|Overall Study|Unsatisfactory therapeutic effect|13
827984|NCT00265083|1782827|FG002|Overall Study|Unsatisfactory therapeutic effect|14
827985|NCT00265083|1782825|FG000|Overall Study|Other|1
827986|NCT00265083|1782826|FG001|Overall Study|Other|12
827987|NCT00265083|1782827|FG002|Overall Study|Other|9
827988|NCT00265096|1782839|FG000|Overall Study|Adverse Event|14
827989|NCT00265096|1782840|FG001|Overall Study|Adverse Event|18
827990|NCT00265096|1782841|FG002|Overall Study|Adverse Event|18
827991|NCT00265096|1782839|FG000|Overall Study|Lost to Follow-up|2
827992|NCT00265096|1782840|FG001|Overall Study|Lost to Follow-up|5
827993|NCT00265096|1782841|FG002|Overall Study|Lost to Follow-up|3
827994|NCT00265096|1782839|FG000|Overall Study|Death|0
827995|NCT00265096|1782840|FG001|Overall Study|Death|1
827996|NCT00265096|1782841|FG002|Overall Study|Death|2
827997|NCT00265096|1782839|FG000|Overall Study|Unsatisfactory therapeutic effect|9
827998|NCT00265096|1782840|FG001|Overall Study|Unsatisfactory therapeutic effect|8
827999|NCT00265096|1782841|FG002|Overall Study|Unsatisfactory therapeutic effect|6
828000|NCT00265096|1782839|FG000|Overall Study|Other|11
828001|NCT00265096|1782840|FG001|Overall Study|Other|19
828002|NCT00265096|1782841|FG002|Overall Study|Other|10
828003|NCT00265109|1782851|FG000|Overall Study|Withdrawal by Subject|5
828004|NCT00265109|1782851|FG000|Overall Study|Adverse Event|1
828005|NCT00265122|1782862|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
828006|NCT00265122|1782863|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
828007|NCT00265122|1782864|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
828008|NCT00265122|1782865|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
828009|NCT00265122|1782866|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
828010|NCT00265122|1782867|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
828011|NCT00265122|1782862|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
828012|NCT00265122|1782863|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
828013|NCT00265122|1782864|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
828014|NCT00265122|1782865|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
828015|NCT00265122|1782866|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
828016|NCT00265122|1782867|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
828017|NCT00265122|1782862|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0
828018|NCT00265122|1782863|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1
828019|NCT00265122|1782864|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2
828020|NCT00265122|1782865|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1
828021|NCT00265122|1782866|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0
828022|NCT00265122|1782867|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0
828023|NCT00265122|1782862|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
828024|NCT00265122|1782863|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
828025|NCT00265122|1782864|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
828026|NCT00265122|1782865|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
828027|NCT00265122|1782866|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
828028|NCT00265122|1782867|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
828029|NCT00265122|1782862|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
828030|NCT00265122|1782863|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
828031|NCT00265122|1782864|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
828032|NCT00265122|1782865|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
828033|NCT00265122|1782866|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
828034|NCT00265122|1782867|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
828035|NCT00265122|1782862|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4
828036|NCT00265122|1782863|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0
828037|NCT00265122|1782864|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1
828038|NCT00265122|1782865|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1
828039|NCT00265122|1782866|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0
828040|NCT00265122|1782867|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0
828041|NCT00265148|1782888|FG000|Overall Study|Adverse Event|2
828042|NCT00265148|1782889|FG001|Overall Study|Adverse Event|2
828043|NCT00265148|1782888|FG000|Overall Study|Lack of Efficacy|0
828044|NCT00265148|1782889|FG001|Overall Study|Lack of Efficacy|2
828045|NCT00265148|1782888|FG000|Overall Study|Protocol Violation|3
828046|NCT00265148|1782889|FG001|Overall Study|Protocol Violation|2
828047|NCT00265148|1782888|FG000|Overall Study|Lost to Follow-up|0
828048|NCT00265148|1782889|FG001|Overall Study|Lost to Follow-up|1
828049|NCT00265148|1782888|FG000|Overall Study|Withdrawal by Subject|2
828050|NCT00265148|1782889|FG001|Overall Study|Withdrawal by Subject|1
828051|NCT00265148|1782888|FG000|Overall Study|Physician Decision|1
828052|NCT00265148|1782889|FG001|Overall Study|Physician Decision|0
828053|NCT00265148|1782888|FG000|Overall Study|Increasing frailty|0
828054|NCT00265148|1782889|FG001|Overall Study|Increasing frailty|1
828055|NCT00265148|1782888|FG000|Overall Study|Subject chose to change of the dose|1
828056|NCT00265148|1782889|FG001|Overall Study|Subject chose to change of the dose|0
828057|NCT00265239|1782902|FG000|Overall Study|Adverse Event|2
828058|NCT00265239|1782903|FG001|Overall Study|Adverse Event|1
828059|NCT00265317|1782913|FG000|Lead-In|Objective progression or relapse|6
828060|NCT00265317|1782914|FG001|Lead-In|Objective progression or relapse|11
828061|NCT00265317|1782915|FG002|Lead-In|Objective progression or relapse|0
828062|NCT00265317|1782916|FG003|Lead-In|Objective progression or relapse|0
828063|NCT00265317|1782913|FG000|Lead-In|Adverse Event|2
828064|NCT00265317|1782914|FG001|Lead-In|Adverse Event|1
828065|NCT00265317|1782915|FG002|Lead-In|Adverse Event|0
828066|NCT00265317|1782916|FG003|Lead-In|Adverse Event|0
828067|NCT00265317|1782913|FG000|Lead-In|Death|3
828068|NCT00265317|1782914|FG001|Lead-In|Death|5
828069|NCT00265317|1782915|FG002|Lead-In|Death|0
828070|NCT00265317|1782916|FG003|Lead-In|Death|0
828071|NCT00265317|1782913|FG000|Lead-In|Withdrawal/other than adverse event|1
828072|NCT00265317|1782914|FG001|Lead-In|Withdrawal/other than adverse event|0
828073|NCT00265317|1782915|FG002|Lead-In|Withdrawal/other than adverse event|0
828074|NCT00265317|1782916|FG003|Lead-In|Withdrawal/other than adverse event|0
828075|NCT00265317|1782913|FG000|Phase 2|Objective progression or relapse|0
828076|NCT00265317|1782914|FG001|Phase 2|Objective progression or relapse|0
828077|NCT00265317|1782915|FG002|Phase 2|Objective progression or relapse|37
828078|NCT00265317|1782916|FG003|Phase 2|Objective progression or relapse|38
828079|NCT00265317|1782913|FG000|Phase 2|Global deterioration of health status|0
828080|NCT00265317|1782914|FG001|Phase 2|Global deterioration of health status|0
828081|NCT00265317|1782915|FG002|Phase 2|Global deterioration of health status|3
828082|NCT00265317|1782916|FG003|Phase 2|Global deterioration of health status|0
828083|NCT00265317|1782913|FG000|Phase 2|Adverse Event|0
828084|NCT00265317|1782914|FG001|Phase 2|Adverse Event|0
828085|NCT00265317|1782915|FG002|Phase 2|Adverse Event|7
828086|NCT00265317|1782916|FG003|Phase 2|Adverse Event|5
828087|NCT00265317|1782913|FG000|Phase 2|Death|0
828088|NCT00265317|1782914|FG001|Phase 2|Death|0
828089|NCT00265317|1782915|FG002|Phase 2|Death|12
828090|NCT00265317|1782916|FG003|Phase 2|Death|15
828091|NCT00265317|1782913|FG000|Phase 2|Protocol Violation|0
828092|NCT00265317|1782914|FG001|Phase 2|Protocol Violation|0
828093|NCT00265317|1782915|FG002|Phase 2|Protocol Violation|1
828094|NCT00265317|1782916|FG003|Phase 2|Protocol Violation|4
828095|NCT00265317|1782913|FG000|Phase 2|Lost to Follow-up|0
828096|NCT00265317|1782914|FG001|Phase 2|Lost to Follow-up|0
828097|NCT00265317|1782915|FG002|Phase 2|Lost to Follow-up|0
828098|NCT00265317|1782916|FG003|Phase 2|Lost to Follow-up|1
828099|NCT00265317|1782913|FG000|Phase 2|Withdrawal/other than adverse event|0
828100|NCT00265317|1782914|FG001|Phase 2|Withdrawal/other than adverse event|0
828101|NCT00265317|1782915|FG002|Phase 2|Withdrawal/other than adverse event|2
828102|NCT00265317|1782916|FG003|Phase 2|Withdrawal/other than adverse event|1
828103|NCT00265317|1782913|FG000|Phase 2|Study terminated by sponsor|0
828104|NCT00265317|1782914|FG001|Phase 2|Study terminated by sponsor|0
828105|NCT00265317|1782915|FG002|Phase 2|Study terminated by sponsor|1
828106|NCT00265317|1782916|FG003|Phase 2|Study terminated by sponsor|0
828107|NCT00265317|1782913|FG000|Phase 2|Other|0
828108|NCT00265317|1782914|FG001|Phase 2|Other|0
828109|NCT00265317|1782915|FG002|Phase 2|Other|1
828110|NCT00265317|1782916|FG003|Phase 2|Other|1
828111|NCT00265330|1782935|FG000|Overall Study|Adverse Event|41
828112|NCT00265330|1782935|FG000|Overall Study|Lost to Follow-up|8
828113|NCT00265330|1782935|FG000|Overall Study|Withdrawal by Subject|34
828114|NCT00265330|1782935|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1
828115|NCT00265330|1782935|FG000|Overall Study|Lack of Efficacy|4
828116|NCT00265330|1782935|FG000|Overall Study|Family Scheduling Conflicts|1
828117|NCT00265330|1782935|FG000|Overall Study|Began Taking Formulary Geodon|1
828118|NCT00265330|1782935|FG000|Overall Study|Discharged from Unit for Long Term Care|1
828119|NCT00265330|1782935|FG000|Overall Study|Site Closed by Sponsor|1
828120|NCT00265330|1782935|FG000|Overall Study|Principal Investigators Request|1
828121|NCT00265330|1782935|FG000|Overall Study|Withdrew Consent|1
828122|NCT00265330|1782935|FG000|Overall Study|Protocol Violation|1
828123|NCT00265343|1782941|FG000|Overall Study|Adverse Event|10
828124|NCT00265343|1782942|FG001|Overall Study|Adverse Event|7
828125|NCT00265343|1782941|FG000|Overall Study|Withdrawal by Subject|3
828126|NCT00265343|1782942|FG001|Overall Study|Withdrawal by Subject|9
828127|NCT00265343|1782941|FG000|Overall Study|Other|8
828128|NCT00265343|1782942|FG001|Overall Study|Other|3
828129|NCT00265382|1782948|FG000|Overall Study|Adverse Event|21
828130|NCT00265382|1782948|FG000|Overall Study|Laboratory Abnormality|1
828131|NCT00265382|1782948|FG000|Overall Study|Lost to Follow-up|3
828132|NCT00265382|1782948|FG000|Overall Study|Lack of Efficacy|6
828133|NCT00265382|1782948|FG000|Overall Study|Miscellaneous|6
828134|NCT00265382|1782948|FG000|Overall Study|Withdrawal by Subject|13
828135|NCT00265382|1782948|FG000|Overall Study|Study terminated by sponsor|94
828136|NCT00265382|1782948|FG000|Overall Study|Death|1
828137|NCT00265395|1782954|FG000|Overall Study|Adverse Event|3
828138|NCT00265395|1782955|FG001|Overall Study|Adverse Event|6
828139|NCT00265395|1782954|FG000|Overall Study|Lost to Follow-up|2
828140|NCT00265395|1782955|FG001|Overall Study|Lost to Follow-up|1
828141|NCT00265395|1782954|FG000|Overall Study|Withdrawal by Subject|1
828142|NCT00265395|1782955|FG001|Overall Study|Withdrawal by Subject|6
828143|NCT00265395|1782954|FG000|Overall Study|Protocol Violation|2
828144|NCT00265395|1782955|FG001|Overall Study|Protocol Violation|2
828145|NCT00265395|1782954|FG000|Overall Study|Lack of Efficacy|0
828146|NCT00265395|1782955|FG001|Overall Study|Lack of Efficacy|1
828147|NCT00265395|1782954|FG000|Overall Study|Administrative|0
828148|NCT00265395|1782955|FG001|Overall Study|Administrative|1
828149|NCT00265564|1782993|FG000|Overall Study|Lost to Follow-up|5
828150|NCT00265564|1782994|FG001|Overall Study|Lost to Follow-up|7
828151|NCT00265564|1782993|FG000|Overall Study|met exclusion criteria|5
828152|NCT00265564|1782994|FG001|Overall Study|met exclusion criteria|2
828153|NCT00265759|1783015|FG000|Overall Study|Withdrawal by Subject|0
828154|NCT00265759|1783016|FG001|Overall Study|Withdrawal by Subject|1
828155|NCT00265759|1783017|FG002|Overall Study|Withdrawal by Subject|2
828156|NCT00265759|1783018|FG003|Overall Study|Withdrawal by Subject|2
828157|NCT00265759|1783015|FG000|Overall Study|Cancel|0
828158|NCT00265759|1783016|FG001|Overall Study|Cancel|0
828159|NCT00265759|1783017|FG002|Overall Study|Cancel|0
828160|NCT00265759|1783018|FG003|Overall Study|Cancel|3
828161|NCT00265759|1783015|FG000|Overall Study|Ineligible|0
828162|NCT00265759|1783016|FG001|Overall Study|Ineligible|0
828163|NCT00265759|1783017|FG002|Overall Study|Ineligible|0
828164|NCT00265759|1783018|FG003|Overall Study|Ineligible|1
828165|NCT00265759|1783015|FG000|Overall Study|Bilateral disease|0
828166|NCT00265759|1783016|FG001|Overall Study|Bilateral disease|0
828167|NCT00265759|1783017|FG002|Overall Study|Bilateral disease|0
828168|NCT00265759|1783018|FG003|Overall Study|Bilateral disease|2
828169|NCT00265759|1783015|FG000|Overall Study|Discontinued due to intolerability|0
828170|NCT00265759|1783016|FG001|Overall Study|Discontinued due to intolerability|0
828171|NCT00265759|1783017|FG002|Overall Study|Discontinued due to intolerability|0
828172|NCT00265759|1783018|FG003|Overall Study|Discontinued due to intolerability|1
828173|NCT00265785|1783029|FG000|Overall Study|Adverse Event|4
828174|NCT00265785|1783029|FG000|Overall Study|Withdrawal by Subject|3
828175|NCT00265785|1783029|FG000|Overall Study|Progression/Relapse|15
828176|NCT00265785|1783029|FG000|Overall Study|Not protocol specified|2
828177|NCT00265785|1783029|FG000|Overall Study|Ineligible|1
828178|NCT00265785|1783029|FG000|Overall Study|Did not receive protocol treatment|2
828179|NCT00265889|1783049|FG000|Overall Study|Physician Decision|1
828180|NCT00265889|1783049|FG000|Overall Study|Protocol Violation|1
828181|NCT00265889|1783049|FG000|Overall Study|Insurance denied the request|3
828182|NCT00265941|1783055|FG000|Overall Study|Protocol Violation|22
828183|NCT00265941|1783056|FG001|Overall Study|Protocol Violation|25
828184|NCT00265941|1783055|FG000|Overall Study|Lost to Follow-up|1
828185|NCT00265941|1783056|FG001|Overall Study|Lost to Follow-up|1
828186|NCT00266032|1783077|FG000|Treatment|Adverse Event|42
828187|NCT00266032|1783078|FG001|Treatment|Adverse Event|26
828188|NCT00266032|1783079|FG002|Treatment|Adverse Event|10
828189|NCT00266032|1783077|FG000|Treatment|Lost to Follow-up|19
828190|NCT00266032|1783078|FG001|Treatment|Lost to Follow-up|4
828191|NCT00266032|1783079|FG002|Treatment|Lost to Follow-up|2
828192|NCT00266032|1783077|FG000|Treatment|Pregnancy|3
828193|NCT00266032|1783078|FG001|Treatment|Pregnancy|2
828194|NCT00266032|1783079|FG002|Treatment|Pregnancy|2
828195|NCT00266032|1783077|FG000|Treatment|Protocol Violation|6
828196|NCT00266032|1783078|FG001|Treatment|Protocol Violation|14
828197|NCT00266032|1783079|FG002|Treatment|Protocol Violation|13
828198|NCT00266032|1783077|FG000|Treatment|Withdrawal by Subject|28
828199|NCT00266032|1783078|FG001|Treatment|Withdrawal by Subject|13
828200|NCT00266032|1783079|FG002|Treatment|Withdrawal by Subject|12
828201|NCT00266032|1783077|FG000|Treatment|patient moved/wish for pregnancy/no need|13
828202|NCT00266032|1783078|FG001|Treatment|patient moved/wish for pregnancy/no need|5
828203|NCT00266032|1783079|FG002|Treatment|patient moved/wish for pregnancy/no need|8
828204|NCT00266032|1783077|FG000|Open-label Safety Extension|Adverse Event|5
828205|NCT00266032|1783078|FG001|Open-label Safety Extension|Adverse Event|0
828206|NCT00266032|1783079|FG002|Open-label Safety Extension|Adverse Event|4
828207|NCT00266032|1783077|FG000|Open-label Safety Extension|Lost to Follow-up|2
828208|NCT00266032|1783078|FG001|Open-label Safety Extension|Lost to Follow-up|5
828209|NCT00266032|1783079|FG002|Open-label Safety Extension|Lost to Follow-up|4
828210|NCT00266032|1783077|FG000|Open-label Safety Extension|Pregnancy|4
828211|NCT00266032|1783078|FG001|Open-label Safety Extension|Pregnancy|1
828212|NCT00266032|1783079|FG002|Open-label Safety Extension|Pregnancy|2
828213|NCT00266032|1783077|FG000|Open-label Safety Extension|Protocol Violation|1
828214|NCT00266032|1783078|FG001|Open-label Safety Extension|Protocol Violation|3
828215|NCT00266032|1783079|FG002|Open-label Safety Extension|Protocol Violation|2
828216|NCT00266032|1783077|FG000|Open-label Safety Extension|Withdrawal by Subject|19
828217|NCT00266032|1783078|FG001|Open-label Safety Extension|Withdrawal by Subject|3
828218|NCT00266032|1783079|FG002|Open-label Safety Extension|Withdrawal by Subject|12
828219|NCT00266032|1783077|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
828220|NCT00266032|1783078|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
828221|NCT00266032|1783079|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
828222|NCT00266227|1783094|FG000|Initial Treatment|Adverse Event|0
828223|NCT00266227|1783095|FG001|Initial Treatment|Adverse Event|0
828224|NCT00266227|1783096|FG002|Initial Treatment|Adverse Event|13
828225|NCT00266227|1783094|FG000|Initial Treatment|Lost to Follow-up|0
828226|NCT00266227|1783095|FG001|Initial Treatment|Lost to Follow-up|0
828227|NCT00266227|1783096|FG002|Initial Treatment|Lost to Follow-up|6
828228|NCT00266227|1783094|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0
828229|NCT00266227|1783095|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0
828230|NCT00266227|1783096|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45
828231|NCT00266227|1783094|FG000|Initial Treatment|Physician decision to withdraw|0
828232|NCT00266227|1783095|FG001|Initial Treatment|Physician decision to withdraw|0
828233|NCT00266227|1783096|FG002|Initial Treatment|Physician decision to withdraw|12
828234|NCT00266227|1783094|FG000|Initial Treatment|Pregnancy|0
828235|NCT00266227|1783095|FG001|Initial Treatment|Pregnancy|0
828236|NCT00266227|1783096|FG002|Initial Treatment|Pregnancy|1
828237|NCT00266227|1783094|FG000|Retreatment: Up to Week 48|Death|1
828238|NCT00266227|1783095|FG001|Retreatment: Up to Week 48|Death|0
828239|NCT00266227|1783096|FG002|Retreatment: Up to Week 48|Death|0
828240|NCT00266227|1783094|FG000|Retreatment: Up to Week 48|Adverse Event|7
828241|NCT00266227|1783095|FG001|Retreatment: Up to Week 48|Adverse Event|7
828242|NCT00266227|1783096|FG002|Retreatment: Up to Week 48|Adverse Event|0
828243|NCT00266227|1783094|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3
828244|NCT00266227|1783095|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0
828245|NCT00266227|1783096|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0
828246|NCT00266227|1783094|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
828247|NCT00266227|1783095|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
828248|NCT00266227|1783096|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
828249|NCT00266227|1783094|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
828250|NCT00266227|1783095|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
828251|NCT00266227|1783096|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
828252|NCT00266227|1783094|FG000|Retreatment: Up to Week 48|Pregnancy|1
828253|NCT00266227|1783095|FG001|Retreatment: Up to Week 48|Pregnancy|0
828254|NCT00266227|1783096|FG002|Retreatment: Up to Week 48|Pregnancy|0
828255|NCT00266227|1783094|FG000|Retreatment: Week 48 to Week 72|Death|1
828256|NCT00266227|1783095|FG001|Retreatment: Week 48 to Week 72|Death|1
828257|NCT00266227|1783096|FG002|Retreatment: Week 48 to Week 72|Death|0
828258|NCT00266227|1783094|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6
828259|NCT00266227|1783095|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2
828260|NCT00266227|1783096|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0
828261|NCT00266227|1783094|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
828262|NCT00266227|1783095|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
828263|NCT00266227|1783096|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
828264|NCT00266227|1783094|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
828265|NCT00266227|1783095|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
828266|NCT00266227|1783096|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
828267|NCT00266227|1783094|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
828268|NCT00266227|1783095|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
828269|NCT00266227|1783096|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
828270|NCT00266409|1783114|FG000|Overall Study|Lack of Efficacy|2
828271|NCT00266409|1783115|FG001|Overall Study|Lack of Efficacy|6
828272|NCT00266409|1783116|FG002|Overall Study|Lack of Efficacy|1
828273|NCT00266409|1783117|FG003|Overall Study|Lack of Efficacy|2
828274|NCT00266409|1783114|FG000|Overall Study|Adverse Event|7
828275|NCT00266409|1783115|FG001|Overall Study|Adverse Event|2
828276|NCT00266409|1783116|FG002|Overall Study|Adverse Event|1
828277|NCT00266409|1783117|FG003|Overall Study|Adverse Event|1
828278|NCT00266409|1783114|FG000|Overall Study|Lost to Follow-up|18
828279|NCT00266409|1783115|FG001|Overall Study|Lost to Follow-up|21
828280|NCT00266409|1783116|FG002|Overall Study|Lost to Follow-up|6
828281|NCT00266409|1783117|FG003|Overall Study|Lost to Follow-up|8
828282|NCT00266409|1783114|FG000|Overall Study|Withdrawal by Subject|6
828283|NCT00266409|1783115|FG001|Overall Study|Withdrawal by Subject|10
828284|NCT00266409|1783116|FG002|Overall Study|Withdrawal by Subject|3
828285|NCT00266409|1783117|FG003|Overall Study|Withdrawal by Subject|9
828286|NCT00266409|1783114|FG000|Overall Study|Protocol Violation|5
828287|NCT00266409|1783115|FG001|Overall Study|Protocol Violation|3
828288|NCT00266409|1783116|FG002|Overall Study|Protocol Violation|4
828289|NCT00266409|1783117|FG003|Overall Study|Protocol Violation|2
828290|NCT00266409|1783114|FG000|Overall Study|Other|7
828291|NCT00266409|1783115|FG001|Overall Study|Other|4
828292|NCT00266409|1783116|FG002|Overall Study|Other|2
828293|NCT00266409|1783117|FG003|Overall Study|Other|0
828294|NCT00266630|1783129|FG000|Overall Study|Adverse Event|8
828295|NCT00266630|1783130|FG001|Overall Study|Adverse Event|6
828296|NCT00266630|1783129|FG000|Overall Study|Lack of Efficacy|1
828297|NCT00266630|1783130|FG001|Overall Study|Lack of Efficacy|4
828298|NCT00266630|1783129|FG000|Overall Study|Entry Criteria not met|1
828299|NCT00266630|1783130|FG001|Overall Study|Entry Criteria not met|0
828300|NCT00266630|1783129|FG000|Overall Study|Protocol Violation|1
828301|NCT00266630|1783130|FG001|Overall Study|Protocol Violation|3
828302|NCT00266630|1783129|FG000|Overall Study|Physician Decision|1
828303|NCT00266630|1783130|FG001|Overall Study|Physician Decision|2
828304|NCT00266630|1783129|FG000|Overall Study|Withdrawal by Subject|10
828305|NCT00266630|1783130|FG001|Overall Study|Withdrawal by Subject|2
828306|NCT00266630|1783129|FG000|Overall Study|Lost to Follow-up|1
828307|NCT00266630|1783130|FG001|Overall Study|Lost to Follow-up|0
828308|NCT00266630|1783129|FG000|Overall Study|Other|19
828309|NCT00266630|1783130|FG001|Overall Study|Other|11
828310|NCT00266656|1783140|FG000|Overall Study|Death|1
828311|NCT00266656|1783141|FG001|Overall Study|Death|0
828312|NCT00266656|1783140|FG000|Overall Study|Lost to Follow-up|4
828313|NCT00266656|1783141|FG001|Overall Study|Lost to Follow-up|1
828314|NCT00266656|1783140|FG000|Overall Study|Withdrawal by Subject|4
828315|NCT00266656|1783141|FG001|Overall Study|Withdrawal by Subject|2
828316|NCT00266656|1783140|FG000|Overall Study|Did Not Reach Final Height|4
828317|NCT00266656|1783141|FG001|Overall Study|Did Not Reach Final Height|8
828318|NCT00266656|1783140|FG000|Overall Study|Parent/Caregiver Decision|1
828319|NCT00266656|1783141|FG001|Overall Study|Parent/Caregiver Decision|2
828320|NCT00266695|1783147|FG000|Overall Study|Adverse Event|1
828321|NCT00266695|1783147|FG000|Overall Study|Death|9
828322|NCT00266695|1783147|FG000|Overall Study|Physician Decision|1
828323|NCT00266695|1783147|FG000|Overall Study|Lost to Follow-up|3
828324|NCT00266695|1783147|FG000|Overall Study|Withdrawal by Subject|15
828325|NCT00266708|1783153|FG000|Overall Study|No renal function|1
828326|NCT00266708|1783154|FG001|Overall Study|No renal function|1
828327|NCT00266708|1783153|FG000|Overall Study|Refused biopsy|3
828328|NCT00266708|1783154|FG001|Overall Study|Refused biopsy|6
828329|NCT00266708|1783153|FG000|Overall Study|Asthma|0
828330|NCT00266708|1783154|FG001|Overall Study|Asthma|2
828331|NCT00266812|1783171|FG000|Overall Study|Disease Progression|9
828332|NCT00266812|1783172|FG001|Overall Study|Disease Progression|3
828333|NCT00266812|1783171|FG000|Overall Study|Death|5
828334|NCT00266812|1783172|FG001|Overall Study|Death|4
828335|NCT00266812|1783171|FG000|Overall Study|Adverse Event|3
828336|NCT00266812|1783172|FG001|Overall Study|Adverse Event|1
828337|NCT00266812|1783171|FG000|Overall Study|Protocol Violation|0
828338|NCT00266812|1783172|FG001|Overall Study|Protocol Violation|1
828339|NCT00266812|1783171|FG000|Overall Study|Withdrawal by Subject|0
828340|NCT00266812|1783172|FG001|Overall Study|Withdrawal by Subject|2
828341|NCT00266812|1783171|FG000|Overall Study|Discontinued before starting study drug|4
828342|NCT00266812|1783172|FG001|Overall Study|Discontinued before starting study drug|0
828343|NCT00266825|1783180|FG000|Completed Follow-Up|Lost to Follow-up|14
828344|NCT00266825|1783181|FG001|Completed Follow-Up|Lost to Follow-up|19
828345|NCT00266825|1783180|FG000|Completed Follow-Up|Withdrawal by Subject|11
828346|NCT00266825|1783181|FG001|Completed Follow-Up|Withdrawal by Subject|5
828347|NCT00266864|1783208|FG000|Overall Study|Lost to Follow-up|4
828348|NCT00266864|1783209|FG001|Overall Study|Lost to Follow-up|1
828349|NCT00266864|1783208|FG000|Overall Study|Withdrawal by Subject|1
828350|NCT00266864|1783209|FG001|Overall Study|Withdrawal by Subject|1
828351|NCT00266877|1783218|FG000|Overall Study|Death|1
828352|NCT00266877|1783219|FG001|Overall Study|Death|1
828353|NCT00266877|1783220|FG002|Overall Study|Death|1
828354|NCT00266877|1783218|FG000|Overall Study|Adverse Event|6
828355|NCT00266877|1783219|FG001|Overall Study|Adverse Event|4
828356|NCT00266877|1783220|FG002|Overall Study|Adverse Event|1
828357|NCT00266877|1783218|FG000|Overall Study|Physician Decision|2
828358|NCT00266877|1783219|FG001|Overall Study|Physician Decision|1
828359|NCT00266877|1783220|FG002|Overall Study|Physician Decision|1
828360|NCT00266877|1783218|FG000|Overall Study|Withdrawal by Subject|3
828361|NCT00266877|1783219|FG001|Overall Study|Withdrawal by Subject|1
828362|NCT00266877|1783220|FG002|Overall Study|Withdrawal by Subject|1
828363|NCT00266877|1783218|FG000|Overall Study|Disease Progression|72
828364|NCT00266877|1783219|FG001|Overall Study|Disease Progression|37
828365|NCT00266877|1783220|FG002|Overall Study|Disease Progression|23
828366|NCT00266877|1783218|FG000|Overall Study|Symptomatic Deterioration|6
828367|NCT00266877|1783219|FG001|Overall Study|Symptomatic Deterioration|3
828368|NCT00266877|1783220|FG002|Overall Study|Symptomatic Deterioration|1
828369|NCT00266877|1783218|FG000|Overall Study|Hospitalization|1
828370|NCT00266877|1783219|FG001|Overall Study|Hospitalization|0
828371|NCT00266877|1783220|FG002|Overall Study|Hospitalization|0
828372|NCT00266877|1783218|FG000|Overall Study|Concomitant Radiotherapy|0
828373|NCT00266877|1783219|FG001|Overall Study|Concomitant Radiotherapy|1
828374|NCT00266877|1783220|FG002|Overall Study|Concomitant Radiotherapy|0
828375|NCT00267007|1783230|FG000|Overall Study|Withdrawal by Subject|6
828376|NCT00267007|1783231|FG001|Overall Study|Withdrawal by Subject|0
828377|NCT00267007|1783230|FG000|Overall Study|Lost to Follow-up|1
828378|NCT00267007|1783231|FG001|Overall Study|Lost to Follow-up|0
828379|NCT00267007|1783230|FG000|Overall Study|Non-compliance|0
828380|NCT00267007|1783231|FG001|Overall Study|Non-compliance|1
828381|NCT00267007|1783230|FG000|Overall Study|Adverse Event|1
828382|NCT00267007|1783231|FG001|Overall Study|Adverse Event|0
828383|NCT00267020|1783239|FG000|Overall Study|Adverse Event|22
828384|NCT00267020|1783240|FG001|Overall Study|Adverse Event|5
828385|NCT00267020|1783239|FG000|Overall Study|Death|2
828386|NCT00267020|1783240|FG001|Overall Study|Death|1
828387|NCT00267020|1783239|FG000|Overall Study|Withdrawal by Subject|17
828388|NCT00267020|1783240|FG001|Overall Study|Withdrawal by Subject|7
828389|NCT00267020|1783239|FG000|Overall Study|Physician Decision|3
828390|NCT00267020|1783240|FG001|Overall Study|Physician Decision|2
828391|NCT00267020|1783239|FG000|Overall Study|Disease Progression|39
828392|NCT00267020|1783240|FG001|Overall Study|Disease Progression|25
828393|NCT00267020|1783239|FG000|Overall Study|Unrelated Complication|1
828394|NCT00267020|1783240|FG001|Overall Study|Unrelated Complication|1
828395|NCT00267020|1783239|FG000|Overall Study|Sponsor Request|1
828396|NCT00267020|1783240|FG001|Overall Study|Sponsor Request|0
828397|NCT00267020|1783239|FG000|Overall Study|Other|1
828398|NCT00267020|1783240|FG001|Overall Study|Other|2
828399|NCT00267046|1783248|FG000|Overall Study|Disease progression|4
828400|NCT00267046|1783249|FG001|Overall Study|Disease progression|2
828401|NCT00267046|1783248|FG000|Overall Study|Chemotoxicity|2
828402|NCT00267046|1783249|FG001|Overall Study|Chemotoxicity|0
828403|NCT00267046|1783248|FG000|Overall Study|Open-label palifermin|2
828404|NCT00267046|1783249|FG001|Overall Study|Open-label palifermin|7
828405|NCT00267046|1783248|FG000|Overall Study|Surgery|3
828406|NCT00267046|1783249|FG001|Overall Study|Surgery|1
828407|NCT00267046|1783248|FG000|Overall Study|Withdrawal by Subject|1
828408|NCT00267046|1783249|FG001|Overall Study|Withdrawal by Subject|0
828409|NCT00267046|1783248|FG000|Overall Study|Radiation|0
828410|NCT00267046|1783249|FG001|Overall Study|Radiation|1
828411|NCT00267098|1783271|FG000|Overall Study|Death|0
828412|NCT00267098|1783272|FG001|Overall Study|Death|0
828413|NCT00267098|1783273|FG002|Overall Study|Death|57
828414|NCT00267098|1783274|FG003|Overall Study|Death|66
828415|NCT00267098|1783275|FG004|Overall Study|Death|14
828416|NCT00267098|1783276|FG005|Overall Study|Death|23
828417|NCT00267098|1783277|FG006|Overall Study|Death|28
828418|NCT00267098|1783278|FG007|Overall Study|Death|9
828419|NCT00267098|1783271|FG000|Overall Study|Lost to Follow-up|0
828420|NCT00267098|1783272|FG001|Overall Study|Lost to Follow-up|0
828421|NCT00267098|1783273|FG002|Overall Study|Lost to Follow-up|6
828422|NCT00267098|1783274|FG003|Overall Study|Lost to Follow-up|5
828423|NCT00267098|1783275|FG004|Overall Study|Lost to Follow-up|2
828424|NCT00267098|1783276|FG005|Overall Study|Lost to Follow-up|3
828425|NCT00267098|1783277|FG006|Overall Study|Lost to Follow-up|1
828426|NCT00267098|1783278|FG007|Overall Study|Lost to Follow-up|1
828427|NCT00267098|1783271|FG000|Overall Study|Withdrawal by Subject|8
828428|NCT00267098|1783272|FG001|Overall Study|Withdrawal by Subject|0
828429|NCT00267098|1783273|FG002|Overall Study|Withdrawal by Subject|24
828430|NCT00267098|1783274|FG003|Overall Study|Withdrawal by Subject|21
828431|NCT00267098|1783275|FG004|Overall Study|Withdrawal by Subject|12
828432|NCT00267098|1783276|FG005|Overall Study|Withdrawal by Subject|9
828433|NCT00267098|1783277|FG006|Overall Study|Withdrawal by Subject|12
828434|NCT00267098|1783278|FG007|Overall Study|Withdrawal by Subject|5
828435|NCT00267098|1783271|FG000|Overall Study|Physician Decision|5
828436|NCT00267098|1783272|FG001|Overall Study|Physician Decision|0
828437|NCT00267098|1783273|FG002|Overall Study|Physician Decision|7
828438|NCT00267098|1783274|FG003|Overall Study|Physician Decision|11
828439|NCT00267098|1783275|FG004|Overall Study|Physician Decision|5
828440|NCT00267098|1783276|FG005|Overall Study|Physician Decision|4
828441|NCT00267098|1783277|FG006|Overall Study|Physician Decision|3
828442|NCT00267098|1783278|FG007|Overall Study|Physician Decision|0
828443|NCT00267098|1783271|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96
828444|NCT00267098|1783272|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
828445|NCT00267098|1783273|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
828446|NCT00267098|1783274|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
828447|NCT00267098|1783275|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2
828448|NCT00267098|1783276|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0
828449|NCT00267098|1783277|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0
828450|NCT00267098|1783278|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0
828451|NCT00267098|1783271|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0
828452|NCT00267098|1783272|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51
828453|NCT00267098|1783273|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0
828454|NCT00267098|1783274|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0
828455|NCT00267098|1783275|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0
828456|NCT00267098|1783276|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0
828457|NCT00267098|1783277|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0
828458|NCT00267098|1783278|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0
828459|NCT00267098|1783271|FG000|Overall Study|Site closure|0
828460|NCT00267098|1783272|FG001|Overall Study|Site closure|0
828461|NCT00267098|1783273|FG002|Overall Study|Site closure|0
828462|NCT00267098|1783274|FG003|Overall Study|Site closure|1
828463|NCT00267098|1783275|FG004|Overall Study|Site closure|0
828464|NCT00267098|1783276|FG005|Overall Study|Site closure|1
828465|NCT00267098|1783277|FG006|Overall Study|Site closure|1
828466|NCT00267098|1783278|FG007|Overall Study|Site closure|0
828467|NCT00267098|1783271|FG000|Overall Study|Explanted Medtronic device|0
828468|NCT00267098|1783272|FG001|Overall Study|Explanted Medtronic device|0
828469|NCT00267098|1783273|FG002|Overall Study|Explanted Medtronic device|0
828470|NCT00267098|1783274|FG003|Overall Study|Explanted Medtronic device|1
828471|NCT00267098|1783275|FG004|Overall Study|Explanted Medtronic device|0
828472|NCT00267098|1783276|FG005|Overall Study|Explanted Medtronic device|0
828473|NCT00267098|1783277|FG006|Overall Study|Explanted Medtronic device|0
828474|NCT00267098|1783278|FG007|Overall Study|Explanted Medtronic device|0
828475|NCT00267098|1783271|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0
828476|NCT00267098|1783272|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0
828477|NCT00267098|1783273|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0
828478|NCT00267098|1783274|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0
828479|NCT00267098|1783275|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2
828644|NCT00267969|1783427|FG001|After Controlled Period|Lack of Efficacy|0
828480|NCT00267098|1783276|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0
828481|NCT00267098|1783277|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0
828482|NCT00267098|1783278|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0
828483|NCT00267098|1783271|FG000|Overall Study|Subject listed for heart transplant|0
828484|NCT00267098|1783272|FG001|Overall Study|Subject listed for heart transplant|0
828485|NCT00267098|1783273|FG002|Overall Study|Subject listed for heart transplant|0
828486|NCT00267098|1783274|FG003|Overall Study|Subject listed for heart transplant|0
828487|NCT00267098|1783275|FG004|Overall Study|Subject listed for heart transplant|0
828488|NCT00267098|1783276|FG005|Overall Study|Subject listed for heart transplant|0
828489|NCT00267098|1783277|FG006|Overall Study|Subject listed for heart transplant|1
828490|NCT00267098|1783278|FG007|Overall Study|Subject listed for heart transplant|0
828491|NCT00267098|1783271|FG000|Overall Study|Sponsor withdrew subject|0
828492|NCT00267098|1783272|FG001|Overall Study|Sponsor withdrew subject|0
828493|NCT00267098|1783273|FG002|Overall Study|Sponsor withdrew subject|0
828494|NCT00267098|1783274|FG003|Overall Study|Sponsor withdrew subject|1
828495|NCT00267098|1783275|FG004|Overall Study|Sponsor withdrew subject|0
828496|NCT00267098|1783276|FG005|Overall Study|Sponsor withdrew subject|0
828497|NCT00267098|1783277|FG006|Overall Study|Sponsor withdrew subject|0
828498|NCT00267098|1783278|FG007|Overall Study|Sponsor withdrew subject|0
828499|NCT00267150|1783311|FG000|Overall Study|Adverse Event|1
828500|NCT00267189|1783317|FG000|Overall Study|Patient withdrew consent|1
828501|NCT00267189|1783318|FG001|Overall Study|Patient withdrew consent|1
828502|NCT00267189|1783317|FG000|Overall Study|Death|1
828503|NCT00267189|1783318|FG001|Overall Study|Death|0
828504|NCT00267189|1783317|FG000|Overall Study|Missing|3
828505|NCT00267189|1783318|FG001|Overall Study|Missing|0
828506|NCT00267202|1783326|FG000|Overall Study|Unsatisfactory therapeutic effect|21
828507|NCT00267202|1783327|FG001|Overall Study|Unsatisfactory therapeutic effect|8
828508|NCT00267202|1783326|FG000|Overall Study|Withdrawal by Subject|12
828509|NCT00267202|1783327|FG001|Overall Study|Withdrawal by Subject|15
828510|NCT00267202|1783326|FG000|Overall Study|Adverse Event|13
828511|NCT00267202|1783327|FG001|Overall Study|Adverse Event|7
828512|NCT00267202|1783326|FG000|Overall Study|Protocol Violation|2
828513|NCT00267202|1783327|FG001|Overall Study|Protocol Violation|3
828514|NCT00267202|1783326|FG000|Overall Study|Administrative problems|2
828515|NCT00267202|1783327|FG001|Overall Study|Administrative problems|1
828516|NCT00267202|1783326|FG000|Overall Study|Lost to Follow-up|3
828517|NCT00267202|1783327|FG001|Overall Study|Lost to Follow-up|0
828518|NCT00267488|1783347|FG000|Overall Study|Sponsor Terminated Study|9
828519|NCT00267488|1783347|FG000|Overall Study|Protocol Violation|1
828520|NCT00267488|1783347|FG000|Overall Study|Other (Disease Progression)|1
828521|NCT00267748|1783388|FG000|Non-randomized Period|Progressive disease|10
828522|NCT00267748|1783389|FG001|Non-randomized Period|Progressive disease|0
828523|NCT00267748|1783390|FG002|Non-randomized Period|Progressive disease|0
828524|NCT00267748|1783388|FG000|Non-randomized Period|Adverse Event|8
828525|NCT00267748|1783389|FG001|Non-randomized Period|Adverse Event|0
828526|NCT00267748|1783390|FG002|Non-randomized Period|Adverse Event|0
828527|NCT00267748|1783388|FG000|Non-randomized Period|Death|1
828528|NCT00267748|1783389|FG001|Non-randomized Period|Death|0
828529|NCT00267748|1783390|FG002|Non-randomized Period|Death|0
828530|NCT00267748|1783388|FG000|Non-randomized Period|Participant not willing to participate|1
828531|NCT00267748|1783389|FG001|Non-randomized Period|Participant not willing to participate|0
828532|NCT00267748|1783390|FG002|Non-randomized Period|Participant not willing to participate|0
828533|NCT00267748|1783388|FG000|Non-randomized Period|Other|3
828534|NCT00267748|1783389|FG001|Non-randomized Period|Other|0
828535|NCT00267748|1783390|FG002|Non-randomized Period|Other|0
828536|NCT00267748|1783388|FG000|Randomized Period|Death|0
828537|NCT00267748|1783389|FG001|Randomized Period|Death|2
828538|NCT00267748|1783390|FG002|Randomized Period|Death|3
828539|NCT00267748|1783388|FG000|Randomized Period|Adverse Event|0
828540|NCT00267748|1783389|FG001|Randomized Period|Adverse Event|23
828541|NCT00267748|1783390|FG002|Randomized Period|Adverse Event|25
828542|NCT00267748|1783388|FG000|Randomized Period|Global deterioration of health status|0
828543|NCT00267748|1783389|FG001|Randomized Period|Global deterioration of health status|6
828544|NCT00267748|1783390|FG002|Randomized Period|Global deterioration of health status|7
828545|NCT00267748|1783388|FG000|Randomized Period|Lost to Follow-up|0
828546|NCT00267748|1783389|FG001|Randomized Period|Lost to Follow-up|1
828547|NCT00267748|1783390|FG002|Randomized Period|Lost to Follow-up|0
828548|NCT00267748|1783388|FG000|Randomized Period|Objective progression or relapse|0
828549|NCT00267748|1783389|FG001|Randomized Period|Objective progression or relapse|77
828550|NCT00267748|1783390|FG002|Randomized Period|Objective progression or relapse|86
828551|NCT00267748|1783388|FG000|Randomized Period|Withdrawal by Subject|0
828552|NCT00267748|1783389|FG001|Randomized Period|Withdrawal by Subject|9
828553|NCT00267748|1783390|FG002|Randomized Period|Withdrawal by Subject|2
828554|NCT00267748|1783388|FG000|Randomized Period|Other|0
828555|NCT00267748|1783389|FG001|Randomized Period|Other|9
828556|NCT00267748|1783390|FG002|Randomized Period|Other|6
828557|NCT00267748|1783388|FG000|Randomized Period|randomized but not treated|0
828558|NCT00267748|1783389|FG001|Randomized Period|randomized but not treated|0
828559|NCT00267748|1783390|FG002|Randomized Period|randomized but not treated|3
828560|NCT00267865|1783406|FG000|Induction Treatment|Died before completing.|2
828561|NCT00267865|1783406|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
828562|NCT00267956|1783412|FG000|Controlled Period|Adverse Event|4
828563|NCT00267956|1783413|FG001|Controlled Period|Adverse Event|1
828564|NCT00267956|1783414|FG002|Controlled Period|Adverse Event|0
828565|NCT00267956|1783415|FG003|Controlled Period|Adverse Event|0
828566|NCT00267956|1783412|FG000|Controlled Period|Lack of Efficacy|4
828567|NCT00267956|1783413|FG001|Controlled Period|Lack of Efficacy|2
828568|NCT00267956|1783414|FG002|Controlled Period|Lack of Efficacy|0
828569|NCT00267956|1783415|FG003|Controlled Period|Lack of Efficacy|0
828570|NCT00267956|1783412|FG000|Controlled Period|Lost to Follow-up|2
828571|NCT00267956|1783413|FG001|Controlled Period|Lost to Follow-up|0
828572|NCT00267956|1783414|FG002|Controlled Period|Lost to Follow-up|0
828573|NCT00267956|1783415|FG003|Controlled Period|Lost to Follow-up|0
828574|NCT00267956|1783412|FG000|Controlled Period|Withdrew consent|3
828575|NCT00267956|1783413|FG001|Controlled Period|Withdrew consent|1
828576|NCT00267956|1783414|FG002|Controlled Period|Withdrew consent|0
828577|NCT00267956|1783415|FG003|Controlled Period|Withdrew consent|0
828578|NCT00267956|1783412|FG000|After Controlled Period|Adverse Event|0
828579|NCT00267956|1783413|FG001|After Controlled Period|Adverse Event|0
828580|NCT00267956|1783414|FG002|After Controlled Period|Adverse Event|2
828581|NCT00267956|1783415|FG003|After Controlled Period|Adverse Event|1
828582|NCT00267956|1783412|FG000|After Controlled Period|Lack of Efficacy|0
828583|NCT00267956|1783413|FG001|After Controlled Period|Lack of Efficacy|0
828584|NCT00267956|1783414|FG002|After Controlled Period|Lack of Efficacy|1
828585|NCT00267956|1783415|FG003|After Controlled Period|Lack of Efficacy|1
828586|NCT00267956|1783412|FG000|After Controlled Period|Lost to Follow-up|0
828587|NCT00267956|1783413|FG001|After Controlled Period|Lost to Follow-up|0
828588|NCT00267956|1783414|FG002|After Controlled Period|Lost to Follow-up|1
828589|NCT00267956|1783415|FG003|After Controlled Period|Lost to Follow-up|0
828590|NCT00267956|1783412|FG000|After Controlled Period|Withdrew consent|0
828591|NCT00267956|1783413|FG001|After Controlled Period|Withdrew consent|0
828592|NCT00267956|1783414|FG002|After Controlled Period|Withdrew consent|1
828593|NCT00267956|1783415|FG003|After Controlled Period|Withdrew consent|0
828594|NCT00267969|1783426|FG000|Controlled Period|Adverse Event|6
828595|NCT00267969|1783427|FG001|Controlled Period|Adverse Event|0
828596|NCT00267969|1783428|FG002|Controlled Period|Adverse Event|2
828597|NCT00267969|1783429|FG003|Controlled Period|Adverse Event|0
828598|NCT00267969|1783430|FG004|Controlled Period|Adverse Event|0
828599|NCT00267969|1783431|FG005|Controlled Period|Adverse Event|0
828600|NCT00267969|1783432|FG006|Controlled Period|Adverse Event|0
828601|NCT00267969|1783426|FG000|Controlled Period|Lack of Efficacy|3
828602|NCT00267969|1783427|FG001|Controlled Period|Lack of Efficacy|0
828603|NCT00267969|1783428|FG002|Controlled Period|Lack of Efficacy|1
828604|NCT00267969|1783429|FG003|Controlled Period|Lack of Efficacy|0
828605|NCT00267969|1783430|FG004|Controlled Period|Lack of Efficacy|0
828606|NCT00267969|1783431|FG005|Controlled Period|Lack of Efficacy|0
828607|NCT00267969|1783432|FG006|Controlled Period|Lack of Efficacy|0
828608|NCT00267969|1783426|FG000|Controlled Period|Lost to Follow-up|1
828609|NCT00267969|1783427|FG001|Controlled Period|Lost to Follow-up|0
828610|NCT00267969|1783428|FG002|Controlled Period|Lost to Follow-up|1
828611|NCT00267969|1783429|FG003|Controlled Period|Lost to Follow-up|0
828612|NCT00267969|1783430|FG004|Controlled Period|Lost to Follow-up|0
828613|NCT00267969|1783431|FG005|Controlled Period|Lost to Follow-up|0
828614|NCT00267969|1783432|FG006|Controlled Period|Lost to Follow-up|0
828615|NCT00267969|1783426|FG000|Controlled Period|Randomized but not treated|0
828616|NCT00267969|1783427|FG001|Controlled Period|Randomized but not treated|0
828617|NCT00267969|1783428|FG002|Controlled Period|Randomized but not treated|1
828618|NCT00267969|1783429|FG003|Controlled Period|Randomized but not treated|0
828619|NCT00267969|1783430|FG004|Controlled Period|Randomized but not treated|0
828620|NCT00267969|1783431|FG005|Controlled Period|Randomized but not treated|0
828621|NCT00267969|1783432|FG006|Controlled Period|Randomized but not treated|0
828622|NCT00267969|1783426|FG000|Controlled Period|Other|2
828623|NCT00267969|1783427|FG001|Controlled Period|Other|1
828624|NCT00267969|1783428|FG002|Controlled Period|Other|6
828625|NCT00267969|1783429|FG003|Controlled Period|Other|0
828626|NCT00267969|1783430|FG004|Controlled Period|Other|0
828627|NCT00267969|1783431|FG005|Controlled Period|Other|0
828628|NCT00267969|1783432|FG006|Controlled Period|Other|0
828629|NCT00267969|1783426|FG000|After Controlled Period|Adverse Event|0
828630|NCT00267969|1783427|FG001|After Controlled Period|Adverse Event|0
828631|NCT00267969|1783428|FG002|After Controlled Period|Adverse Event|0
828632|NCT00267969|1783429|FG003|After Controlled Period|Adverse Event|7
828633|NCT00267969|1783430|FG004|After Controlled Period|Adverse Event|8
828634|NCT00267969|1783431|FG005|After Controlled Period|Adverse Event|23
828635|NCT00267969|1783432|FG006|After Controlled Period|Adverse Event|21
828636|NCT00267969|1783426|FG000|After Controlled Period|Death|0
828637|NCT00267969|1783427|FG001|After Controlled Period|Death|0
828638|NCT00267969|1783428|FG002|After Controlled Period|Death|0
828639|NCT00267969|1783429|FG003|After Controlled Period|Death|1
828640|NCT00267969|1783430|FG004|After Controlled Period|Death|2
828641|NCT00267969|1783431|FG005|After Controlled Period|Death|0
828642|NCT00267969|1783432|FG006|After Controlled Period|Death|1
828643|NCT00267969|1783426|FG000|After Controlled Period|Lack of Efficacy|0
828645|NCT00267969|1783428|FG002|After Controlled Period|Lack of Efficacy|0
828646|NCT00267969|1783429|FG003|After Controlled Period|Lack of Efficacy|10
828647|NCT00267969|1783430|FG004|After Controlled Period|Lack of Efficacy|6
828648|NCT00267969|1783431|FG005|After Controlled Period|Lack of Efficacy|28
828649|NCT00267969|1783432|FG006|After Controlled Period|Lack of Efficacy|15
828650|NCT00267969|1783426|FG000|After Controlled Period|Lost to Follow-up|0
828651|NCT00267969|1783427|FG001|After Controlled Period|Lost to Follow-up|0
828652|NCT00267969|1783428|FG002|After Controlled Period|Lost to Follow-up|0
828653|NCT00267969|1783429|FG003|After Controlled Period|Lost to Follow-up|5
828654|NCT00267969|1783430|FG004|After Controlled Period|Lost to Follow-up|8
828655|NCT00267969|1783431|FG005|After Controlled Period|Lost to Follow-up|9
828656|NCT00267969|1783432|FG006|After Controlled Period|Lost to Follow-up|10
828657|NCT00267969|1783426|FG000|After Controlled Period|Other|0
828658|NCT00267969|1783427|FG001|After Controlled Period|Other|0
828659|NCT00267969|1783428|FG002|After Controlled Period|Other|0
828660|NCT00267969|1783429|FG003|After Controlled Period|Other|13
828661|NCT00267969|1783430|FG004|After Controlled Period|Other|11
828662|NCT00267969|1783431|FG005|After Controlled Period|Other|22
828663|NCT00267969|1783432|FG006|After Controlled Period|Other|25
828664|NCT00268203|1783450|FG000|Overall Study|Lost to Follow-up|92
828665|NCT00268203|1783450|FG000|Overall Study|Withdrawal by Subject|9
828666|NCT00268203|1783450|FG000|Overall Study|Received Other NHL Therapy|7
828667|NCT00268203|1783450|FG000|Overall Study|Progressive Disease|359
828668|NCT00268203|1783450|FG000|Overall Study|Death|84
828669|NCT00268203|1783450|FG000|Overall Study|Reason Not Specified|34
828670|NCT00268203|1783450|FG000|Overall Study|Completed 2 Years of Follow-up|62
828671|NCT00268242|1783454|FG000|Overall Study|Death|1
828672|NCT00268346|1783460|FG000|Overall Study|Adverse Event|0
828673|NCT00268346|1783461|FG001|Overall Study|Adverse Event|1
828674|NCT00268346|1783460|FG000|Overall Study|Death|0
828675|NCT00268346|1783461|FG001|Overall Study|Death|1
828676|NCT00268346|1783460|FG000|Overall Study|Withdrawal by Subject|0
828677|NCT00268346|1783461|FG001|Overall Study|Withdrawal by Subject|1
828678|NCT00268437|1783467|FG000|Overall Study|Ineligible|1
828679|NCT00268892|1783479|FG000|Overall Study|Adverse Event|14
828680|NCT00268892|1783480|FG001|Overall Study|Adverse Event|17
828681|NCT00268892|1783481|FG002|Overall Study|Adverse Event|20
828682|NCT00268892|1783479|FG000|Overall Study|Lack of Efficacy|1
828683|NCT00268892|1783480|FG001|Overall Study|Lack of Efficacy|3
828684|NCT00268892|1783481|FG002|Overall Study|Lack of Efficacy|0
828685|NCT00268892|1783479|FG000|Overall Study|Withdrawal by Subject|14
828686|NCT00268892|1783480|FG001|Overall Study|Withdrawal by Subject|15
828687|NCT00268892|1783481|FG002|Overall Study|Withdrawal by Subject|13
828688|NCT00268892|1783479|FG000|Overall Study|Physician Decision|0
828689|NCT00268892|1783480|FG001|Overall Study|Physician Decision|1
828690|NCT00268892|1783481|FG002|Overall Study|Physician Decision|0
828691|NCT00268892|1783479|FG000|Overall Study|Lost to Follow-up|5
828692|NCT00268892|1783480|FG001|Overall Study|Lost to Follow-up|2
828693|NCT00268892|1783481|FG002|Overall Study|Lost to Follow-up|4
828694|NCT00268892|1783479|FG000|Overall Study|Protocol Violation|0
828695|NCT00268892|1783480|FG001|Overall Study|Protocol Violation|1
828696|NCT00268892|1783481|FG002|Overall Study|Protocol Violation|0
828697|NCT00268892|1783479|FG000|Overall Study|Disease Progression|1
828698|NCT00268892|1783480|FG001|Overall Study|Disease Progression|1
828699|NCT00268892|1783481|FG002|Overall Study|Disease Progression|0
828700|NCT00268892|1783479|FG000|Overall Study|Trial Site Closed|4
828701|NCT00268892|1783480|FG001|Overall Study|Trial Site Closed|2
828702|NCT00268892|1783481|FG002|Overall Study|Trial Site Closed|2
828703|NCT00268905|1783492|FG000|Overall Study|Adverse Event|3
828704|NCT00268905|1783493|FG001|Overall Study|Adverse Event|0
828705|NCT00268905|1783494|FG002|Overall Study|Adverse Event|4
828706|NCT00268905|1783492|FG000|Overall Study|Lost to Follow-up|0
828707|NCT00268905|1783493|FG001|Overall Study|Lost to Follow-up|1
828708|NCT00268905|1783494|FG002|Overall Study|Lost to Follow-up|0
828709|NCT00268905|1783492|FG000|Overall Study|Withdrawal by Subject|0
828710|NCT00268905|1783493|FG001|Overall Study|Withdrawal by Subject|0
828711|NCT00268905|1783494|FG002|Overall Study|Withdrawal by Subject|3
828712|NCT00268905|1783492|FG000|Overall Study|Progressive Disease|28
828713|NCT00268905|1783493|FG001|Overall Study|Progressive Disease|4
828714|NCT00268905|1783494|FG002|Overall Study|Progressive Disease|3
828715|NCT00268905|1783492|FG000|Overall Study|Physician Decision|3
828716|NCT00268905|1783493|FG001|Overall Study|Physician Decision|0
828717|NCT00268905|1783494|FG002|Overall Study|Physician Decision|1
828718|NCT00268905|1783492|FG000|Overall Study|Clinical Progression|9
828719|NCT00268905|1783493|FG001|Overall Study|Clinical Progression|4
828720|NCT00268905|1783494|FG002|Overall Study|Clinical Progression|1
828721|NCT00268983|1783504|FG000|Overall Study|Death|3
828722|NCT00268983|1783505|FG001|Overall Study|Death|0
828723|NCT00268996|1783513|FG000|Overall Study|Adverse Event|11
828724|NCT00268996|1783514|FG001|Overall Study|Adverse Event|7
828725|NCT00268996|1783513|FG000|Overall Study|Lost to Follow-up|3
828726|NCT00268996|1783514|FG001|Overall Study|Lost to Follow-up|1
828727|NCT00268996|1783513|FG000|Overall Study|Withdrawal by Subject|5
828728|NCT00268996|1783514|FG001|Overall Study|Withdrawal by Subject|11
828729|NCT00268996|1783513|FG000|Overall Study|Non-compliance|1
828730|NCT00268996|1783514|FG001|Overall Study|Non-compliance|0
828731|NCT00268996|1783513|FG000|Overall Study|Other|1
828732|NCT00268996|1783514|FG001|Overall Study|Other|1
828733|NCT00269087|1783522|FG000|Overall Study|Adverse Event|20
828734|NCT00269087|1783522|FG000|Overall Study|Withdrawal by Subject|1
828735|NCT00269087|1783522|FG000|Overall Study|Exacerbation of COPD|13
828736|NCT00269113|1783528|FG000|Overall Study|Adverse Event|14
828737|NCT00269113|1783529|FG001|Overall Study|Adverse Event|7
828738|NCT00269113|1783528|FG000|Overall Study|Lack of Efficacy|35
828739|NCT00269113|1783529|FG001|Overall Study|Lack of Efficacy|18
828740|NCT00269113|1783528|FG000|Overall Study|Early Improvement|2
828741|NCT00269113|1783529|FG001|Overall Study|Early Improvement|0
828742|NCT00269113|1783528|FG000|Overall Study|Withdrawal by Subject|0
828743|NCT00269113|1783529|FG001|Overall Study|Withdrawal by Subject|2
828744|NCT00269113|1783528|FG000|Overall Study|Death|6
828745|NCT00269113|1783529|FG001|Overall Study|Death|2
828746|NCT00269113|1783528|FG000|Overall Study|Lost to Follow-up|2
828747|NCT00269113|1783529|FG001|Overall Study|Lost to Follow-up|1
828748|NCT00269113|1783528|FG000|Overall Study|Protocol Violation|15
828749|NCT00269113|1783529|FG001|Overall Study|Protocol Violation|5
828750|NCT00269113|1783528|FG000|Overall Study|Other|0
828751|NCT00269113|1783529|FG001|Overall Study|Other|2
828752|NCT00269152|1783537|FG000|Overall Study|Adverse Event|9
828753|NCT00269152|1783538|FG001|Overall Study|Adverse Event|3
828754|NCT00269152|1783537|FG000|Overall Study|Withdrawal by Subject|7
828755|NCT00269152|1783538|FG001|Overall Study|Withdrawal by Subject|3
828756|NCT00269152|1783537|FG000|Overall Study|Physician Decision|2
828757|NCT00269152|1783538|FG001|Overall Study|Physician Decision|3
828758|NCT00269152|1783537|FG000|Overall Study|Protocol Violation|0
828759|NCT00269152|1783538|FG001|Overall Study|Protocol Violation|1
828760|NCT00269399|1783546|FG000|Overall Study|Lack of Efficacy|27
828761|NCT00269399|1783547|FG001|Overall Study|Lack of Efficacy|10
828762|NCT00269399|1783546|FG000|Overall Study|Adverse Event|10
828763|NCT00269399|1783547|FG001|Overall Study|Adverse Event|4
828764|NCT00269399|1783546|FG000|Overall Study|Withdrawal by Subject|2
828765|NCT00269399|1783547|FG001|Overall Study|Withdrawal by Subject|5
828766|NCT00269399|1783546|FG000|Overall Study|Negative Lab Result for C. difficile|2
828767|NCT00269399|1783547|FG001|Overall Study|Negative Lab Result for C. difficile|3
828768|NCT00269399|1783546|FG000|Overall Study|Other|0
828769|NCT00269399|1783547|FG001|Overall Study|Other|4
828770|NCT00269399|1783546|FG000|Overall Study|Development of exclusion criteria|0
828771|NCT00269399|1783547|FG001|Overall Study|Development of exclusion criteria|1
828772|NCT00269477|1783557|FG000|Overall Study|Protocol Violation|5
828773|NCT00269477|1783558|FG001|Overall Study|Protocol Violation|5
828774|NCT00269477|1783559|FG002|Overall Study|Protocol Violation|1
828775|NCT00269477|1783560|FG003|Overall Study|Protocol Violation|0
828776|NCT00269477|1783557|FG000|Overall Study|Missed post-vaccination blood draw|0
828777|NCT00269477|1783558|FG001|Overall Study|Missed post-vaccination blood draw|1
828778|NCT00269477|1783559|FG002|Overall Study|Missed post-vaccination blood draw|0
828779|NCT00269477|1783560|FG003|Overall Study|Missed post-vaccination blood draw|0
828780|NCT00269633|1783572|FG000|Overall Study|Withdrawal by Subject|1
828781|NCT00269633|1783573|FG001|Overall Study|Withdrawal by Subject|0
828782|NCT00269919|1783579|FG000|Overall Study|Other|26
828783|NCT00269919|1783579|FG000|Overall Study|Started but not treated|1
828784|NCT00270205|1783588|FG000|Overall Study|Lost to Follow-up|1
828785|NCT00270205|1783589|FG001|Overall Study|Lost to Follow-up|0
828786|NCT00270205|1783590|FG002|Overall Study|Lost to Follow-up|0
828787|NCT00270205|1783591|FG003|Overall Study|Lost to Follow-up|1
828788|NCT00270231|1783601|FG000|First Intervention|Lost to Follow-up|1
828789|NCT00270231|1783602|FG001|First Intervention|Lost to Follow-up|1
828790|NCT00270231|1783601|FG000|Washout Period|Lost to Follow-up|1
828791|NCT00270231|1783602|FG001|Washout Period|Lost to Follow-up|0
828792|NCT00270231|1783601|FG000|Second Intervention|Lost to Follow-up|0
828793|NCT00270231|1783602|FG001|Second Intervention|Lost to Follow-up|1
828794|NCT00270257|1783610|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
828795|NCT00270257|1783611|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
828796|NCT00270855|1783672|FG000|Overall Study|Withdrawal by Subject|8
828797|NCT00270855|1783673|FG001|Overall Study|Withdrawal by Subject|8
828798|NCT00270894|1783681|FG000|Overall Study|Adverse Event|1
828799|NCT00270894|1783681|FG000|Overall Study|Withdrawal by Subject|1
828800|NCT00270998|1783688|FG000|3 Month Follow-up|Adverse Event|1
828801|NCT00270998|1783689|FG001|3 Month Follow-up|Adverse Event|0
828802|NCT00270998|1783690|FG002|3 Month Follow-up|Adverse Event|0
828803|NCT00270998|1783688|FG000|3 Month Follow-up|Lack of Efficacy|1
828804|NCT00270998|1783689|FG001|3 Month Follow-up|Lack of Efficacy|2
828805|NCT00270998|1783690|FG002|3 Month Follow-up|Lack of Efficacy|1
828806|NCT00270998|1783688|FG000|3 Month Follow-up|Withdrawal by Subject|11
828807|NCT00270998|1783689|FG001|3 Month Follow-up|Withdrawal by Subject|14
828808|NCT00270998|1783690|FG002|3 Month Follow-up|Withdrawal by Subject|15
828809|NCT00270998|1783688|FG000|3 Month Follow-up|Pessary did not fit|12
828810|NCT00270998|1783689|FG001|3 Month Follow-up|Pessary did not fit|0
828811|NCT00270998|1783690|FG002|3 Month Follow-up|Pessary did not fit|0
828812|NCT00270998|1783688|FG000|3 Month Follow-up|Personal/family health|1
828813|NCT00270998|1783689|FG001|3 Month Follow-up|Personal/family health|1
828814|NCT00270998|1783690|FG002|3 Month Follow-up|Personal/family health|0
828815|NCT00270998|1783688|FG000|3 Month Follow-up|Received/desired alternate treatment|13
828816|NCT00270998|1783689|FG001|3 Month Follow-up|Received/desired alternate treatment|5
828817|NCT00270998|1783690|FG002|3 Month Follow-up|Received/desired alternate treatment|2
828818|NCT00270998|1783688|FG000|12 Month Follow-up|Lack of Efficacy|5
828819|NCT00270998|1783689|FG001|12 Month Follow-up|Lack of Efficacy|4
828820|NCT00270998|1783690|FG002|12 Month Follow-up|Lack of Efficacy|3
828821|NCT00270998|1783688|FG000|12 Month Follow-up|Withdrawal by Subject|7
828822|NCT00270998|1783689|FG001|12 Month Follow-up|Withdrawal by Subject|12
828823|NCT00270998|1783690|FG002|12 Month Follow-up|Withdrawal by Subject|16
828824|NCT00270998|1783688|FG000|12 Month Follow-up|Pessary did not fit|1
828825|NCT00270998|1783689|FG001|12 Month Follow-up|Pessary did not fit|0
828826|NCT00270998|1783690|FG002|12 Month Follow-up|Pessary did not fit|0
828827|NCT00270998|1783688|FG000|12 Month Follow-up|Personal/family health|0
828828|NCT00270998|1783689|FG001|12 Month Follow-up|Personal/family health|5
828829|NCT00270998|1783690|FG002|12 Month Follow-up|Personal/family health|1
828830|NCT00270998|1783688|FG000|12 Month Follow-up|Received/desired alternate treatment|1
828831|NCT00270998|1783689|FG001|12 Month Follow-up|Received/desired alternate treatment|4
828832|NCT00270998|1783690|FG002|12 Month Follow-up|Received/desired alternate treatment|1
828833|NCT00271024|1783704|FG000|Overall Study|Lost Interest|3
828834|NCT00271024|1783705|FG001|Overall Study|Lost Interest|4
828835|NCT00271024|1783706|FG002|Overall Study|Lost Interest|2
828836|NCT00271024|1783707|FG003|Overall Study|Lost Interest|3
828837|NCT00271024|1783704|FG000|Overall Study|Unknown/Unspecified|11
828838|NCT00271024|1783705|FG001|Overall Study|Unknown/Unspecified|11
828839|NCT00271024|1783706|FG002|Overall Study|Unknown/Unspecified|8
828840|NCT00271024|1783707|FG003|Overall Study|Unknown/Unspecified|4
828841|NCT00271024|1783704|FG000|Overall Study|Protocol Violation|1
828842|NCT00271024|1783705|FG001|Overall Study|Protocol Violation|6
828843|NCT00271024|1783706|FG002|Overall Study|Protocol Violation|5
828844|NCT00271024|1783707|FG003|Overall Study|Protocol Violation|11
828845|NCT00271024|1783704|FG000|Overall Study|Unpleasant Reaction To Tablet|1
828846|NCT00271024|1783705|FG001|Overall Study|Unpleasant Reaction To Tablet|3
828847|NCT00271024|1783706|FG002|Overall Study|Unpleasant Reaction To Tablet|4
828848|NCT00271024|1783707|FG003|Overall Study|Unpleasant Reaction To Tablet|2
828849|NCT00271024|1783704|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6
828850|NCT00271024|1783705|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2
828851|NCT00271024|1783706|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4
828852|NCT00271024|1783707|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4
828853|NCT00271505|1783754|FG000|Overall Study|Screen Failure|3
828854|NCT00271505|1783754|FG000|Overall Study|Adverse Event|1
828855|NCT00271505|1783754|FG000|Overall Study|Death|1
828856|NCT00271544|1783759|FG000|Overall Study|Subjects did not receive a 4196 lead|7
828857|NCT00271544|1783759|FG000|Overall Study|Model 4196 lead not attempted|9
828858|NCT00271544|1783759|FG000|Overall Study|Implant not attempted|4
828859|NCT00271596|1783786|FG000|Overall Study|Protocol Violation|1
828860|NCT00271596|1783787|FG001|Overall Study|Protocol Violation|0
828861|NCT00271596|1783786|FG000|Overall Study|Withdrawal by Subject|0
828862|NCT00271596|1783787|FG001|Overall Study|Withdrawal by Subject|1
828863|NCT00271609|1783795|FG000|Overall Study|Adverse Event|11
828864|NCT00271609|1783796|FG001|Overall Study|Adverse Event|3
828865|NCT00271609|1783795|FG000|Overall Study|Withdrawal by Subject|2
828866|NCT00271609|1783796|FG001|Overall Study|Withdrawal by Subject|0
828867|NCT00271817|1783814|FG000|Part 1|Adverse Event|68
828868|NCT00271817|1783815|FG001|Part 1|Adverse Event|25
828869|NCT00271817|1783816|FG002|Part 1|Adverse Event|156
828870|NCT00271817|1783814|FG000|Part 1|Lost to Follow-up|6
828871|NCT00271817|1783815|FG001|Part 1|Lost to Follow-up|8
828872|NCT00271817|1783816|FG002|Part 1|Lost to Follow-up|24
828873|NCT00271817|1783814|FG000|Part 1|Protocol Violation|5
828874|NCT00271817|1783815|FG001|Part 1|Protocol Violation|4
828875|NCT00271817|1783816|FG002|Part 1|Protocol Violation|7
828876|NCT00271817|1783814|FG000|Part 1|Patient Moved|3
828877|NCT00271817|1783815|FG001|Part 1|Patient Moved|1
828878|NCT00271817|1783816|FG002|Part 1|Patient Moved|5
828879|NCT00271817|1783814|FG000|Part 1|Withdrawal by Subject|23
828880|NCT00271817|1783815|FG001|Part 1|Withdrawal by Subject|17
828881|NCT00271817|1783816|FG002|Part 1|Withdrawal by Subject|45
828882|NCT00271817|1783814|FG000|Part 1|LDL < 50 mg/dL|1
828883|NCT00271817|1783815|FG001|Part 1|LDL < 50 mg/dL|4
828884|NCT00271817|1783816|FG002|Part 1|LDL < 50 mg/dL|48
828885|NCT00271817|1783814|FG000|Part 2|Adverse Event|0
828886|NCT00271817|1783815|FG001|Part 2|Adverse Event|17
828887|NCT00271817|1783816|FG002|Part 2|Adverse Event|33
828888|NCT00271817|1783814|FG000|Part 2|Lack of Efficacy|0
828889|NCT00271817|1783815|FG001|Part 2|Lack of Efficacy|1
828890|NCT00271817|1783816|FG002|Part 2|Lack of Efficacy|6
828891|NCT00271817|1783814|FG000|Part 2|Lost to Follow-up|0
828892|NCT00271817|1783815|FG001|Part 2|Lost to Follow-up|6
828893|NCT00271817|1783816|FG002|Part 2|Lost to Follow-up|18
828894|NCT00271817|1783814|FG000|Part 2|Protocol Violation|0
828895|NCT00271817|1783815|FG001|Part 2|Protocol Violation|3
828896|NCT00271817|1783816|FG002|Part 2|Protocol Violation|5
828897|NCT00271817|1783814|FG000|Part 2|Patient Moved|0
828898|NCT00271817|1783815|FG001|Part 2|Patient Moved|0
828899|NCT00271817|1783816|FG002|Part 2|Patient Moved|5
828900|NCT00271817|1783814|FG000|Part 2|Withdrawal by Subject|0
828901|NCT00271817|1783815|FG001|Part 2|Withdrawal by Subject|2
828902|NCT00271817|1783816|FG002|Part 2|Withdrawal by Subject|13
828903|NCT00271817|1783814|FG000|Part 2|LDL < 50 mg/dL|0
828904|NCT00271817|1783815|FG001|Part 2|LDL < 50 mg/dL|3
828905|NCT00271817|1783816|FG002|Part 2|LDL < 50 mg/dL|4
828906|NCT00271856|1783830|FG000|Overall Study|Withdrawal by Subject|1
828907|NCT00271856|1783831|FG001|Overall Study|Withdrawal by Subject|7
828908|NCT00271856|1783830|FG000|Overall Study|Lost to Follow-up|10
828909|NCT00271856|1783831|FG001|Overall Study|Lost to Follow-up|11
828910|NCT00272038|1783837|FG000|Overall Study|withdrew before they received 2 cycles|7
828911|NCT00272779|1783895|FG000|Baseline Through Week 48|Adverse event before Week 48|10
828912|NCT00272779|1783896|FG001|Baseline Through Week 48|Adverse event before Week 48|14
828913|NCT00272779|1783895|FG000|Baseline Through Week 48|Death before Week 48|4
828914|NCT00272779|1783896|FG001|Baseline Through Week 48|Death before Week 48|4
828915|NCT00272779|1783895|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5
828916|NCT00272779|1783896|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8
828917|NCT00272779|1783895|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6
828918|NCT00272779|1783896|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6
828919|NCT00272779|1783895|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1
828920|NCT00272779|1783896|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0
828921|NCT00272779|1783895|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6
828922|NCT00272779|1783896|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9
828923|NCT00272779|1783895|FG000|Baseline Through Week 48|Pregnancy before Week 48|2
828924|NCT00272779|1783896|FG001|Baseline Through Week 48|Pregnancy before Week 48|2
828925|NCT00272779|1783895|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1
828926|NCT00272779|1783896|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0
828927|NCT00272779|1783895|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4
828928|NCT00272779|1783896|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13
828929|NCT00272779|1783895|FG000|Baseline Through Week 48|Participant's decision before wk 48|0
828930|NCT00272779|1783896|FG001|Baseline Through Week 48|Participant's decision before wk 48|1
828931|NCT00272779|1783895|FG000|Baseline Through Week 48|Chose different site before wk 48|0
828932|NCT00272779|1783896|FG001|Baseline Through Week 48|Chose different site before wk 48|1
828933|NCT00272779|1783895|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1
828934|NCT00272779|1783896|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1
828935|NCT00272779|1783895|FG000|Baseline Through Week 48|Death on/after Week 48|1
828936|NCT00272779|1783896|FG001|Baseline Through Week 48|Death on/after Week 48|1
828937|NCT00272779|1783895|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
828938|NCT00272779|1783896|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
828939|NCT00272779|1783895|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2
828940|NCT00272779|1783896|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2
828941|NCT00272779|1783895|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
828942|NCT00272779|1783896|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
828943|NCT00272779|1783895|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1
828944|NCT00272779|1783896|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2
828945|NCT00272779|1783895|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0
828946|NCT00272779|1783896|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2
828947|NCT00272779|1783895|FG000|Baseline Through Week 48|Continuing treatment|385
828948|NCT00272779|1783896|FG001|Baseline Through Week 48|Continuing treatment|368
828949|NCT00272779|1783895|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
828950|NCT00272779|1783896|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
828951|NCT00272779|1783895|FG000|Baseline Through Week 48|Never treated|2
828952|NCT00272779|1783896|FG001|Baseline Through Week 48|Never treated|3
828953|NCT00272779|1783895|FG000|Baseline Through Week 96|Adverse event before Week 96|13
828954|NCT00272779|1783896|FG001|Baseline Through Week 96|Adverse event before Week 96|22
828955|NCT00272779|1783895|FG000|Baseline Through Week 96|Death before Week 96|6
828956|NCT00272779|1783896|FG001|Baseline Through Week 96|Death before Week 96|5
828957|NCT00272779|1783895|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16
828958|NCT00272779|1783896|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10
828959|NCT00272779|1783895|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10
828960|NCT00272779|1783896|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13
828961|NCT00272779|1783895|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1
828962|NCT00272779|1783896|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0
828963|NCT00272779|1783895|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12
828964|NCT00272779|1783896|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16
828965|NCT00272779|1783895|FG000|Baseline Through Week 96|Pregnancy before Week 96|5
828966|NCT00272779|1783896|FG001|Baseline Through Week 96|Pregnancy before Week 96|7
828967|NCT00272779|1783895|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4
828968|NCT00272779|1783896|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3
828969|NCT00272779|1783895|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5
828970|NCT00272779|1783896|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18
828971|NCT00272779|1783895|FG000|Baseline Through Week 96|Changed address before Week 96|0
828972|NCT00272779|1783896|FG001|Baseline Through Week 96|Changed address before Week 96|1
828973|NCT00272779|1783895|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1
828974|NCT00272779|1783896|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0
828975|NCT00272779|1783895|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2
828976|NCT00272779|1783896|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0
828977|NCT00272779|1783895|FG000|Baseline Through Week 96|Pregnancy at Week 96|1
828978|NCT00272779|1783896|FG001|Baseline Through Week 96|Pregnancy at Week 96|0
828979|NCT00272779|1783895|FG000|Baseline Through Week 96|Never treated|2
828980|NCT00272779|1783896|FG001|Baseline Through Week 96|Never treated|3
828981|NCT00272779|1783895|FG000|Baseline Through Week 96|Continuing on treatment|61
828982|NCT00272779|1783896|FG001|Baseline Through Week 96|Continuing on treatment|38
828983|NCT00272792|1783905|FG000|Part 1: Responsiveness|Lost to Follow-up|1
828984|NCT00272792|1783906|FG001|Part 1: Responsiveness|Lost to Follow-up|0
828985|NCT00272792|1783905|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
828986|NCT00272792|1783906|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
828987|NCT00272792|1783905|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
828988|NCT00272792|1783906|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
828989|NCT00272792|1783905|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
828990|NCT00272792|1783906|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
828991|NCT00272844|1783912|FG000|Overall Study|Withdrawal by Subject|5
828992|NCT00272961|1783921|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
828993|NCT00272961|1783922|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
828994|NCT00272961|1783923|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
828995|NCT00272961|1783924|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
828996|NCT00272961|1783925|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
828997|NCT00272961|1783921|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
828998|NCT00272961|1783922|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
828999|NCT00272961|1783923|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
829000|NCT00272961|1783924|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
829001|NCT00272961|1783925|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
829002|NCT00272961|1783921|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
829003|NCT00272961|1783922|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
829004|NCT00272961|1783923|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
829005|NCT00272961|1783924|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
829006|NCT00272961|1783925|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
829007|NCT00272961|1783921|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
829008|NCT00272961|1783922|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
829009|NCT00272961|1783923|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
829010|NCT00272961|1783924|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
829011|NCT00272961|1783925|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
829012|NCT00272961|1783921|FG000|Placebo Run-in Phase: Up to Week 2|Other|2
829013|NCT00272961|1783922|FG001|Placebo Run-in Phase: Up to Week 2|Other|0
829014|NCT00272961|1783923|FG002|Placebo Run-in Phase: Up to Week 2|Other|0
829015|NCT00272961|1783924|FG003|Placebo Run-in Phase: Up to Week 2|Other|0
829016|NCT00272961|1783925|FG004|Placebo Run-in Phase: Up to Week 2|Other|0
829017|NCT00272961|1783921|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
829018|NCT00272961|1783922|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
829019|NCT00272961|1783923|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
829020|NCT00272961|1783924|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
829021|NCT00272961|1783925|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
829022|NCT00272961|1783921|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
829023|NCT00272961|1783922|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
829024|NCT00272961|1783923|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
829025|NCT00272961|1783924|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
829026|NCT00272961|1783925|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
829027|NCT00272961|1783921|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1
829028|NCT00272961|1783922|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3
829029|NCT00272961|1783923|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3
829030|NCT00272961|1783924|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2
829031|NCT00272961|1783925|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2
829032|NCT00272987|1783940|FG000|Overall Study|Adverse Event|1
829033|NCT00272987|1783941|FG001|Overall Study|Adverse Event|0
829034|NCT00272987|1783942|FG002|Overall Study|Adverse Event|0
829035|NCT00272987|1783940|FG000|Overall Study|Lost to Follow-up|3
829036|NCT00272987|1783941|FG001|Overall Study|Lost to Follow-up|1
829037|NCT00272987|1783942|FG002|Overall Study|Lost to Follow-up|1
829038|NCT00272987|1783940|FG000|Overall Study|Withdrawal by Subject|1
829039|NCT00272987|1783941|FG001|Overall Study|Withdrawal by Subject|0
829040|NCT00272987|1783942|FG002|Overall Study|Withdrawal by Subject|3
829041|NCT00272987|1783940|FG000|Overall Study|Sponsor Terminated study|0
829042|NCT00272987|1783941|FG001|Overall Study|Sponsor Terminated study|1
829043|NCT00272987|1783942|FG002|Overall Study|Sponsor Terminated study|1
829044|NCT00272987|1783940|FG000|Overall Study|Disease progression|1
829045|NCT00272987|1783941|FG001|Overall Study|Disease progression|1
829046|NCT00272987|1783942|FG002|Overall Study|Disease progression|2
829047|NCT00272987|1783940|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2
829048|NCT00272987|1783941|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1
829049|NCT00272987|1783942|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4
829050|NCT00272987|1783940|FG000|Overall Study|Death|1
829051|NCT00272987|1783941|FG001|Overall Study|Death|0
829052|NCT00272987|1783942|FG002|Overall Study|Death|0
829053|NCT00273052|1783952|FG000|Overall Study|Withdrawal by Subject|16
829054|NCT00273052|1783953|FG001|Overall Study|Withdrawal by Subject|19
829055|NCT00273052|1783952|FG000|Overall Study|Adverse Event|21
829056|NCT00273052|1783953|FG001|Overall Study|Adverse Event|19
829057|NCT00273052|1783952|FG000|Overall Study|Protocol Violation|14
829058|NCT00273052|1783953|FG001|Overall Study|Protocol Violation|18
829059|NCT00273052|1783952|FG000|Overall Study|Lost to Follow-up|7
829060|NCT00273052|1783953|FG001|Overall Study|Lost to Follow-up|25
829061|NCT00273052|1783952|FG000|Overall Study|Lack of Efficacy|6
829062|NCT00273052|1783953|FG001|Overall Study|Lack of Efficacy|4
829063|NCT00273052|1783952|FG000|Overall Study|Non-Compliance|3
829064|NCT00273052|1783953|FG001|Overall Study|Non-Compliance|1
829065|NCT00273052|1783952|FG000|Overall Study|Other|2
829066|NCT00273052|1783953|FG001|Overall Study|Other|0
829067|NCT00273052|1783952|FG000|Overall Study|Worsening serum lipid levels|0
829068|NCT00273052|1783953|FG001|Overall Study|Worsening serum lipid levels|2
829069|NCT00273182|1783959|FG000|Overall Study|Death|450
829070|NCT00273182|1783959|FG000|Overall Study|Lost to Follow-up|88
829071|NCT00273182|1783959|FG000|Overall Study|Withdrawal by Subject|257
829072|NCT00273182|1783959|FG000|Overall Study|Device/System Explant|154
829073|NCT00273182|1783959|FG000|Overall Study|Site exit, system change, 36 m FU missed|36
829074|NCT00273858|1784007|FG000|Overall Study|Not completed 24 month observation time|334
829075|NCT00273858|1784007|FG000|Overall Study|Lost to Follow-up|101
829076|NCT00273858|1784007|FG000|Overall Study|Withdrawal by Subject|21
829077|NCT00273858|1784007|FG000|Overall Study|Adverse Event|81
829078|NCT00274261|1784038|FG000|Overall Study|Adverse Event|19
829079|NCT00274261|1784039|FG001|Overall Study|Adverse Event|11
829080|NCT00274261|1784038|FG000|Overall Study|Pregnancy|114
829081|NCT00274261|1784039|FG001|Overall Study|Pregnancy|83
829082|NCT00274261|1784038|FG000|Overall Study|Withdrawal by Subject|179
829083|NCT00274261|1784039|FG001|Overall Study|Withdrawal by Subject|126
829084|NCT00274261|1784038|FG000|Overall Study|Protocol Violation|71
829085|NCT00274261|1784039|FG001|Overall Study|Protocol Violation|42
829086|NCT00274261|1784038|FG000|Overall Study|Lost to Follow-up|106
829087|NCT00274261|1784039|FG001|Overall Study|Lost to Follow-up|75
829088|NCT00274287|1784047|FG000|Overall Study|Withdrawal by Subject|1
829089|NCT00274287|1784047|FG000|Overall Study|subject non-compliance|1
829090|NCT00274456|1784056|FG000|Overall Study|Still on treatment|2
829091|NCT00274456|1784057|FG001|Overall Study|Still on treatment|3
829092|NCT00274456|1784058|FG002|Overall Study|Still on treatment|5
829093|NCT00274456|1784059|FG003|Overall Study|Still on treatment|1
829094|NCT00274456|1784056|FG000|Overall Study|Unacceptable toxicity|10
829095|NCT00274456|1784057|FG001|Overall Study|Unacceptable toxicity|5
829096|NCT00274456|1784058|FG002|Overall Study|Unacceptable toxicity|12
829097|NCT00274456|1784059|FG003|Overall Study|Unacceptable toxicity|16
829098|NCT00274456|1784056|FG000|Overall Study|Adverse Event|0
829099|NCT00274456|1784057|FG001|Overall Study|Adverse Event|1
829100|NCT00274456|1784058|FG002|Overall Study|Adverse Event|2
829101|NCT00274456|1784059|FG003|Overall Study|Adverse Event|2
829102|NCT00274456|1784056|FG000|Overall Study|Physician Decision|7
829103|NCT00274456|1784057|FG001|Overall Study|Physician Decision|5
829104|NCT00274456|1784058|FG002|Overall Study|Physician Decision|6
829105|NCT00274456|1784059|FG003|Overall Study|Physician Decision|13
829106|NCT00274456|1784056|FG000|Overall Study|Lost to Follow-up|0
829107|NCT00274456|1784057|FG001|Overall Study|Lost to Follow-up|0
829108|NCT00274456|1784058|FG002|Overall Study|Lost to Follow-up|1
829109|NCT00274456|1784059|FG003|Overall Study|Lost to Follow-up|0
829110|NCT00274456|1784056|FG000|Overall Study|Withdrawal by Subject|18
829111|NCT00274456|1784057|FG001|Overall Study|Withdrawal by Subject|13
829112|NCT00274456|1784058|FG002|Overall Study|Withdrawal by Subject|9
829113|NCT00274456|1784059|FG003|Overall Study|Withdrawal by Subject|13
829114|NCT00274469|1784071|FG000|Overall Study|Death|63
829115|NCT00274469|1784072|FG001|Overall Study|Death|74
829116|NCT00274469|1784071|FG000|Overall Study|Did not consent to OS follow-up|16
829117|NCT00274469|1784072|FG001|Overall Study|Did not consent to OS follow-up|19
829118|NCT00274625|1784080|FG000|Overall Study|Lost to Follow-up|46
829119|NCT00274625|1784081|FG001|Overall Study|Lost to Follow-up|54
829120|NCT00274625|1784080|FG000|Overall Study|Excluded from analysis|14
829121|NCT00274625|1784081|FG001|Overall Study|Excluded from analysis|8
829122|NCT00274651|1784089|FG000|Overall Study|Adverse Event|6
829123|NCT00274651|1784090|FG001|Overall Study|Adverse Event|3
829124|NCT00274651|1784089|FG000|Overall Study|Lack of Efficacy|13
829125|NCT00274651|1784090|FG001|Overall Study|Lack of Efficacy|6
829126|NCT00274651|1784089|FG000|Overall Study|Death|1
829127|NCT00274651|1784090|FG001|Overall Study|Death|3
829128|NCT00274651|1784089|FG000|Overall Study|Withdrawal by Subject|0
829129|NCT00274651|1784090|FG001|Overall Study|Withdrawal by Subject|1
829130|NCT00274651|1784089|FG000|Overall Study|Physician Decision|8
829131|NCT00274651|1784090|FG001|Overall Study|Physician Decision|7
829132|NCT00274716|1784103|FG000|Phase A|Other non-reported reason|4
829133|NCT00274716|1784104|FG001|Phase A|Other non-reported reason|2
829134|NCT00274716|1784105|FG002|Phase A|Other non-reported reason|1
829135|NCT00274716|1784106|FG003|Phase A|Other non-reported reason|2
829136|NCT00274716|1784107|FG004|Phase A|Other non-reported reason|0
829137|NCT00274716|1784108|FG005|Phase A|Other non-reported reason|1
829138|NCT00274716|1784103|FG000|Phase A|Participant moved|0
829139|NCT00274716|1784104|FG001|Phase A|Participant moved|0
829140|NCT00274716|1784105|FG002|Phase A|Participant moved|1
829141|NCT00274716|1784106|FG003|Phase A|Participant moved|0
829142|NCT00274716|1784107|FG004|Phase A|Participant moved|0
829143|NCT00274716|1784108|FG005|Phase A|Participant moved|1
829144|NCT00274716|1784103|FG000|Phase A|Site Terminated|0
829145|NCT00274716|1784104|FG001|Phase A|Site Terminated|0
829146|NCT00274716|1784105|FG002|Phase A|Site Terminated|0
829147|NCT00274716|1784106|FG003|Phase A|Site Terminated|1
829148|NCT00274716|1784107|FG004|Phase A|Site Terminated|0
829149|NCT00274716|1784108|FG005|Phase A|Site Terminated|0
829150|NCT00274716|1784103|FG000|Phase A|Protocol Violation|1
829151|NCT00274716|1784104|FG001|Phase A|Protocol Violation|0
829152|NCT00274716|1784105|FG002|Phase A|Protocol Violation|0
829153|NCT00274716|1784106|FG003|Phase A|Protocol Violation|1
829154|NCT00274716|1784107|FG004|Phase A|Protocol Violation|0
829155|NCT00274716|1784108|FG005|Phase A|Protocol Violation|0
829156|NCT00274716|1784103|FG000|Phase A|Met criteria for discontinuation|1
829157|NCT00274716|1784104|FG001|Phase A|Met criteria for discontinuation|1
829158|NCT00274716|1784105|FG002|Phase A|Met criteria for discontinuation|0
829159|NCT00274716|1784106|FG003|Phase A|Met criteria for discontinuation|0
829160|NCT00274716|1784107|FG004|Phase A|Met criteria for discontinuation|0
829161|NCT00274716|1784108|FG005|Phase A|Met criteria for discontinuation|0
829162|NCT00274716|1784103|FG000|Phase A|Withdrawal by Subject|2
829163|NCT00274716|1784104|FG001|Phase A|Withdrawal by Subject|2
829164|NCT00274716|1784105|FG002|Phase A|Withdrawal by Subject|1
829165|NCT00274716|1784106|FG003|Phase A|Withdrawal by Subject|3
829166|NCT00274716|1784107|FG004|Phase A|Withdrawal by Subject|0
829167|NCT00274716|1784108|FG005|Phase A|Withdrawal by Subject|1
829168|NCT00274716|1784103|FG000|Phase A|Adverse Event|2
829169|NCT00274716|1784104|FG001|Phase A|Adverse Event|3
829170|NCT00274716|1784105|FG002|Phase A|Adverse Event|3
829171|NCT00274716|1784106|FG003|Phase A|Adverse Event|0
829172|NCT00274716|1784107|FG004|Phase A|Adverse Event|2
829173|NCT00274716|1784108|FG005|Phase A|Adverse Event|0
829174|NCT00274716|1784103|FG000|Phase A|Completed but did not enter Phase B|1
829175|NCT00274716|1784104|FG001|Phase A|Completed but did not enter Phase B|2
829176|NCT00274716|1784105|FG002|Phase A|Completed but did not enter Phase B|2
829177|NCT00274716|1784106|FG003|Phase A|Completed but did not enter Phase B|2
829178|NCT00274716|1784107|FG004|Phase A|Completed but did not enter Phase B|1
829179|NCT00274716|1784108|FG005|Phase A|Completed but did not enter Phase B|1
829180|NCT00274716|1784103|FG000|Phase B|Adverse Event|0
829181|NCT00274716|1784104|FG001|Phase B|Adverse Event|0
829182|NCT00274716|1784105|FG002|Phase B|Adverse Event|2
829183|NCT00274716|1784106|FG003|Phase B|Adverse Event|0
829184|NCT00274716|1784107|FG004|Phase B|Adverse Event|0
829185|NCT00274716|1784108|FG005|Phase B|Adverse Event|1
829186|NCT00274716|1784103|FG000|Phase B|Protocol Violation|0
829187|NCT00274716|1784104|FG001|Phase B|Protocol Violation|2
829188|NCT00274716|1784105|FG002|Phase B|Protocol Violation|0
829189|NCT00274716|1784106|FG003|Phase B|Protocol Violation|0
829190|NCT00274716|1784107|FG004|Phase B|Protocol Violation|0
829191|NCT00274716|1784108|FG005|Phase B|Protocol Violation|0
829192|NCT00274716|1784103|FG000|Phase B|Withdrawal by Subject|0
829193|NCT00274716|1784104|FG001|Phase B|Withdrawal by Subject|1
829194|NCT00274716|1784105|FG002|Phase B|Withdrawal by Subject|0
829195|NCT00274716|1784106|FG003|Phase B|Withdrawal by Subject|0
829196|NCT00274716|1784107|FG004|Phase B|Withdrawal by Subject|0
829197|NCT00274716|1784108|FG005|Phase B|Withdrawal by Subject|0
829198|NCT00274716|1784103|FG000|Phase B|Participant moved|1
829199|NCT00274716|1784104|FG001|Phase B|Participant moved|0
829200|NCT00274716|1784105|FG002|Phase B|Participant moved|0
829201|NCT00274716|1784106|FG003|Phase B|Participant moved|0
829202|NCT00274716|1784107|FG004|Phase B|Participant moved|0
829203|NCT00274716|1784108|FG005|Phase B|Participant moved|0
829204|NCT00274716|1784103|FG000|Phase B|Other non-reported reason|0
829205|NCT00274716|1784104|FG001|Phase B|Other non-reported reason|0
829206|NCT00274716|1784105|FG002|Phase B|Other non-reported reason|1
829207|NCT00274716|1784106|FG003|Phase B|Other non-reported reason|1
829208|NCT00274716|1784107|FG004|Phase B|Other non-reported reason|0
829209|NCT00274716|1784108|FG005|Phase B|Other non-reported reason|0
829210|NCT00274716|1784103|FG000|Phase B|Lost to Follow-up|0
829211|NCT00274716|1784104|FG001|Phase B|Lost to Follow-up|1
829212|NCT00274716|1784105|FG002|Phase B|Lost to Follow-up|0
829213|NCT00274716|1784106|FG003|Phase B|Lost to Follow-up|0
829214|NCT00274716|1784107|FG004|Phase B|Lost to Follow-up|0
829215|NCT00274716|1784108|FG005|Phase B|Lost to Follow-up|0
829216|NCT00274742|1784132|FG000|Overall Study|Adverse Event|0
829217|NCT00274742|1784133|FG001|Overall Study|Adverse Event|4
829218|NCT00274742|1784134|FG002|Overall Study|Adverse Event|1
829219|NCT00274742|1784135|FG003|Overall Study|Adverse Event|4
829220|NCT00274742|1784136|FG004|Overall Study|Adverse Event|12
829221|NCT00274742|1784137|FG005|Overall Study|Adverse Event|3
829222|NCT00274742|1784132|FG000|Overall Study|Lost to Follow-up|0
829223|NCT00274742|1784133|FG001|Overall Study|Lost to Follow-up|0
829224|NCT00274742|1784134|FG002|Overall Study|Lost to Follow-up|0
829225|NCT00274742|1784135|FG003|Overall Study|Lost to Follow-up|0
829226|NCT00274742|1784136|FG004|Overall Study|Lost to Follow-up|1
829227|NCT00274742|1784137|FG005|Overall Study|Lost to Follow-up|0
829228|NCT00274742|1784132|FG000|Overall Study|End of Study|0
829229|NCT00274742|1784133|FG001|Overall Study|End of Study|0
829230|NCT00274742|1784134|FG002|Overall Study|End of Study|0
829231|NCT00274742|1784135|FG003|Overall Study|End of Study|1
829232|NCT00274742|1784136|FG004|Overall Study|End of Study|0
829233|NCT00274742|1784137|FG005|Overall Study|End of Study|0
829234|NCT00274742|1784132|FG000|Overall Study|Disease Progression|0
829235|NCT00274742|1784133|FG001|Overall Study|Disease Progression|1
829236|NCT00274742|1784134|FG002|Overall Study|Disease Progression|1
829237|NCT00274742|1784135|FG003|Overall Study|Disease Progression|0
829238|NCT00274742|1784136|FG004|Overall Study|Disease Progression|1
829239|NCT00274742|1784137|FG005|Overall Study|Disease Progression|0
829240|NCT00274742|1784132|FG000|Overall Study|Other|0
829241|NCT00274742|1784133|FG001|Overall Study|Other|3
829242|NCT00274742|1784134|FG002|Overall Study|Other|0
829243|NCT00274742|1784135|FG003|Overall Study|Other|0
829244|NCT00274742|1784136|FG004|Overall Study|Other|2
829245|NCT00274742|1784137|FG005|Overall Study|Other|0
829246|NCT00274846|1784166|FG000|Overall Study|Did not receive adequate NK cells|1
829247|NCT00274924|1784174|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
829248|NCT00274924|1784175|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
829249|NCT00274924|1784176|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
829250|NCT00274924|1784174|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
829251|NCT00274924|1784175|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
829252|NCT00274924|1784176|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
829253|NCT00274924|1784174|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
829254|NCT00274924|1784175|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
829255|NCT00274924|1784176|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
829256|NCT00274924|1784174|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
829257|NCT00274924|1784175|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
829258|NCT00274924|1784176|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
829259|NCT00274924|1784174|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
829260|NCT00274924|1784175|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
829261|NCT00274924|1784176|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
829262|NCT00274924|1784174|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
829263|NCT00274924|1784175|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
829264|NCT00274924|1784176|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
829265|NCT00274924|1784174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
829266|NCT00274924|1784175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
829267|NCT00274924|1784176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
829268|NCT00274924|1784174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
829269|NCT00274924|1784175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
829270|NCT00274924|1784176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
829271|NCT00274924|1784174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
829272|NCT00274924|1784175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
829273|NCT00274924|1784176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
829274|NCT00274924|1784174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
829275|NCT00274924|1784175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
829276|NCT00274924|1784176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
829277|NCT00274924|1784174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0
829278|NCT00274924|1784175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1
829279|NCT00274924|1784176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0
829280|NCT00274924|1784174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
829281|NCT00274924|1784175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
829282|NCT00274924|1784176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
829283|NCT00274924|1784174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
829284|NCT00274924|1784175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
829285|NCT00274924|1784176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
829286|NCT00274937|1784183|FG000|Overall Study|Physician Decision|10
829287|NCT00274937|1784183|FG000|Overall Study|Withdrawal by Subject|6
829288|NCT00274937|1784183|FG000|Overall Study|Progressive Disease|4
829289|NCT00275002|1784189|FG000|Overall Study|Death|1
829290|NCT00275002|1784190|FG001|Overall Study|Death|0
829291|NCT00275002|1784189|FG000|Overall Study|Disease progression|21
829292|NCT00275002|1784190|FG001|Overall Study|Disease progression|15
829293|NCT00275002|1784189|FG000|Overall Study|Adverse Event|0
829294|NCT00275002|1784190|FG001|Overall Study|Adverse Event|1
829295|NCT00275028|1784196|FG000|Overall Study|Withdrew consent before treatment began|1
829296|NCT00275028|1784196|FG000|Overall Study|Withdrawal by Subject|5
829297|NCT00275028|1784196|FG000|Overall Study|Adverse Event|9
829298|NCT00275028|1784196|FG000|Overall Study|Progressive Disease|30
829299|NCT00275028|1784196|FG000|Overall Study|Physician Decision|2
829300|NCT00275262|1784202|FG000|Overall Study|Adverse Event|2
829301|NCT00275262|1784203|FG001|Overall Study|Adverse Event|0
829302|NCT00275262|1784202|FG000|Overall Study|Disease progression|2
829303|NCT00275262|1784203|FG001|Overall Study|Disease progression|5
829304|NCT00275262|1784202|FG000|Overall Study|Lost to Follow-up|0
829305|NCT00275262|1784203|FG001|Overall Study|Lost to Follow-up|2
829306|NCT00275262|1784202|FG000|Overall Study|Protocol Violation|0
829307|NCT00275262|1784203|FG001|Overall Study|Protocol Violation|2
829308|NCT00275262|1784202|FG000|Overall Study|Death|1
829309|NCT00275262|1784203|FG001|Overall Study|Death|0
829310|NCT00275262|1784202|FG000|Overall Study|Started Chemotherapy|1
829311|NCT00275262|1784203|FG001|Overall Study|Started Chemotherapy|0
829312|NCT00275301|1784222|FG000|Overall Study|Adverse Event|5
829313|NCT00275340|1784228|FG000|Overall Study|Lost to Follow-up|2
829314|NCT00275340|1784229|FG001|Overall Study|Lost to Follow-up|4
829315|NCT00275509|1784244|FG000|Overall Study|graft thrombosis, post-operative day #8|0
829316|NCT00275509|1784245|FG001|Overall Study|graft thrombosis, post-operative day #8|1
829317|NCT00275561|1784253|FG000|Overall Study|Withdrawal by Subject|0
829318|NCT00275561|1784254|FG001|Overall Study|Withdrawal by Subject|1
829319|NCT00275561|1784253|FG000|Overall Study|Travel|1
829320|NCT00275561|1784254|FG001|Overall Study|Travel|1
829321|NCT00275561|1784253|FG000|Overall Study|Scheduling|1
829322|NCT00275561|1784254|FG001|Overall Study|Scheduling|2
829323|NCT00275561|1784253|FG000|Overall Study|Family Issues|0
829324|NCT00275561|1784254|FG001|Overall Study|Family Issues|2
829325|NCT00275821|1784263|FG000|Overall Study|Adverse Event|4
829326|NCT00275821|1784264|FG001|Overall Study|Adverse Event|12
829327|NCT00275821|1784265|FG002|Overall Study|Adverse Event|5
829328|NCT00275821|1784263|FG000|Overall Study|Administrative problems|3
829329|NCT00275821|1784264|FG001|Overall Study|Administrative problems|4
829330|NCT00275821|1784265|FG002|Overall Study|Administrative problems|4
829331|NCT00275821|1784263|FG000|Overall Study|Withdrawal by Subject|0
829332|NCT00275821|1784264|FG001|Overall Study|Withdrawal by Subject|2
829333|NCT00275821|1784265|FG002|Overall Study|Withdrawal by Subject|1
829334|NCT00275821|1784263|FG000|Overall Study|Lost to Follow-up|0
829335|NCT00275821|1784264|FG001|Overall Study|Lost to Follow-up|1
829336|NCT00275821|1784265|FG002|Overall Study|Lost to Follow-up|1
829337|NCT00275821|1784263|FG000|Overall Study|Death|0
829338|NCT00275821|1784264|FG001|Overall Study|Death|2
829339|NCT00275821|1784265|FG002|Overall Study|Death|1
829340|NCT00275821|1784263|FG000|Overall Study|Lack of Efficacy|2
829341|NCT00275821|1784264|FG001|Overall Study|Lack of Efficacy|1
829342|NCT00275821|1784265|FG002|Overall Study|Lack of Efficacy|0
829343|NCT00275821|1784263|FG000|Overall Study|Protocol Violation|5
829344|NCT00275821|1784264|FG001|Overall Study|Protocol Violation|1
829345|NCT00275821|1784265|FG002|Overall Study|Protocol Violation|0
829346|NCT00276016|1784294|FG000|Intervention 1|Withdrawal by Subject|0
829347|NCT00276016|1784295|FG001|Intervention 1|Withdrawal by Subject|1
829348|NCT00276016|1784296|FG002|Intervention 1|Withdrawal by Subject|0
829349|NCT00276016|1784297|FG003|Intervention 1|Withdrawal by Subject|0
829350|NCT00276016|1784298|FG004|Intervention 1|Withdrawal by Subject|0
829351|NCT00276016|1784299|FG005|Intervention 1|Withdrawal by Subject|0
829352|NCT00276094|1784311|FG000|Overall Study|Adverse Event|15
829353|NCT00276094|1784312|FG001|Overall Study|Adverse Event|13
829354|NCT00276094|1784313|FG002|Overall Study|Adverse Event|11
829355|NCT00276094|1784311|FG000|Overall Study|Withdrawal by Subject|14
829356|NCT00276094|1784312|FG001|Overall Study|Withdrawal by Subject|14
829357|NCT00276094|1784313|FG002|Overall Study|Withdrawal by Subject|12
829358|NCT00276094|1784311|FG000|Overall Study|Protocol Violation|16
829359|NCT00276094|1784312|FG001|Overall Study|Protocol Violation|7
829360|NCT00276094|1784313|FG002|Overall Study|Protocol Violation|10
829361|NCT00276094|1784311|FG000|Overall Study|Lost to Follow-up|8
829362|NCT00276094|1784312|FG001|Overall Study|Lost to Follow-up|6
829363|NCT00276094|1784313|FG002|Overall Study|Lost to Follow-up|4
829364|NCT00276094|1784311|FG000|Overall Study|Other-Subject moved out of country|1
829365|NCT00276094|1784312|FG001|Overall Study|Other-Subject moved out of country|0
829366|NCT00276094|1784313|FG002|Overall Study|Other-Subject moved out of country|0
829367|NCT00276094|1784311|FG000|Overall Study|Other-Scheduled gastroplasty|1
829368|NCT00276094|1784312|FG001|Overall Study|Other-Scheduled gastroplasty|0
829369|NCT00276094|1784313|FG002|Overall Study|Other-Scheduled gastroplasty|0
829370|NCT00276094|1784311|FG000|Overall Study|Other-Lack of efficacy|1
829371|NCT00276094|1784312|FG001|Overall Study|Other-Lack of efficacy|0
829372|NCT00276094|1784313|FG002|Overall Study|Other-Lack of efficacy|0
829373|NCT00276094|1784311|FG000|Overall Study|Other-Refused follow-up visit|1
829374|NCT00276094|1784312|FG001|Overall Study|Other-Refused follow-up visit|0
829375|NCT00276094|1784313|FG002|Overall Study|Other-Refused follow-up visit|0
829376|NCT00276094|1784311|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0
829377|NCT00276094|1784312|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1
829378|NCT00276094|1784313|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0
829379|NCT00276094|1784311|FG000|Overall Study|Other-Relocation|0
829380|NCT00276094|1784312|FG001|Overall Study|Other-Relocation|1
829381|NCT00276094|1784313|FG002|Overall Study|Other-Relocation|0
829382|NCT00276094|1784311|FG000|Overall Study|Other-Study medication lost|0
829383|NCT00276094|1784312|FG001|Overall Study|Other-Study medication lost|0
829384|NCT00276094|1784313|FG002|Overall Study|Other-Study medication lost|1
829385|NCT00276159|1784321|FG000|Overall Study|Did not receive all 24 doses of 852A|6
829386|NCT00276380|1784340|FG000|Overall Study|Adverse Event|5
829387|NCT00276380|1784341|FG001|Overall Study|Adverse Event|3
829388|NCT00276380|1784340|FG000|Overall Study|Lost to Follow-up|1
829389|NCT00276380|1784341|FG001|Overall Study|Lost to Follow-up|1
829390|NCT00276380|1784340|FG000|Overall Study|Withdrawal by Subject|3
829391|NCT00276380|1784341|FG001|Overall Study|Withdrawal by Subject|6
829392|NCT00276380|1784340|FG000|Overall Study|Death|5
829393|NCT00276380|1784341|FG001|Overall Study|Death|3
829394|NCT00276380|1784340|FG000|Overall Study|Abnormal aPPT Levels|0
829395|NCT00276380|1784341|FG001|Overall Study|Abnormal aPPT Levels|1
829396|NCT00276458|1784359|FG000|Overall Study|Adverse Event|0
829397|NCT00276458|1784360|FG001|Overall Study|Adverse Event|2
829398|NCT00276458|1784359|FG000|Overall Study|Lost to Follow-up|2
829399|NCT00276458|1784360|FG001|Overall Study|Lost to Follow-up|2
829400|NCT00276458|1784359|FG000|Overall Study|Protocol Violation|4
829401|NCT00276458|1784360|FG001|Overall Study|Protocol Violation|3
829402|NCT00276484|1784368|FG000|Overall Study|Adverse Event|4
829403|NCT00276484|1784369|FG001|Overall Study|Adverse Event|7
829404|NCT00276484|1784368|FG000|Overall Study|Lost to Follow-up|1
829405|NCT00276484|1784369|FG001|Overall Study|Lost to Follow-up|1
829406|NCT00276484|1784368|FG000|Overall Study|Protocol Violation|0
829407|NCT00276484|1784369|FG001|Overall Study|Protocol Violation|1
829408|NCT00276484|1784368|FG000|Overall Study|Withdrawal by Subject|4
829409|NCT00276484|1784369|FG001|Overall Study|Withdrawal by Subject|3
829410|NCT00276484|1784368|FG000|Overall Study|Could not take time off work|0
829411|NCT00276484|1784369|FG001|Overall Study|Could not take time off work|1
829412|NCT00276614|1784379|FG000|Overall Study|Progression of disease under study|3
829413|NCT00276744|1784383|FG000|PART A|Reason unknown|98
829414|NCT00277095|1784392|FG000|Overall Study|Death|2
829415|NCT00277095|1784392|FG000|Overall Study|Explanted|7
829416|NCT00277095|1784392|FG000|Overall Study|Lost to Follow-up|2
829417|NCT00277095|1784392|FG000|Overall Study|Missed Follow-up|9
829418|NCT00277095|1784392|FG000|Overall Study|Physician Decision|1
829419|NCT00277212|1784396|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
829420|NCT00277212|1784397|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
829421|NCT00277212|1784398|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
829422|NCT00277212|1784396|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93
829423|NCT00277212|1784397|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0
829424|NCT00277212|1784398|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0
829425|NCT00277212|1784396|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
829426|NCT00277212|1784397|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
829427|NCT00277212|1784398|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
829428|NCT00277212|1784396|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
829429|NCT00277212|1784397|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
829430|NCT00277212|1784398|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
829431|NCT00277212|1784396|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
829432|NCT00277212|1784397|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
829433|NCT00277212|1784398|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
829434|NCT00277212|1784396|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6
829435|NCT00277212|1784397|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0
829436|NCT00277212|1784398|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0
829437|NCT00277212|1784396|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
829438|NCT00277212|1784397|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
829439|NCT00277212|1784398|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
829440|NCT00277212|1784396|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
829441|NCT00277212|1784397|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
829442|NCT00277212|1784398|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
829443|NCT00277212|1784396|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12
829444|NCT00277212|1784397|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0
829445|NCT00277212|1784398|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0
829446|NCT00277212|1784396|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
829447|NCT00277212|1784397|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
829448|NCT00277212|1784398|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
829449|NCT00277212|1784396|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0
829450|NCT00277212|1784397|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10
829451|NCT00277212|1784398|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16
829452|NCT00277212|1784396|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
829453|NCT00277212|1784397|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
829454|NCT00277212|1784398|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
829455|NCT00277212|1784396|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
829456|NCT00277212|1784397|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
829457|NCT00277212|1784398|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
829458|NCT00277212|1784396|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
829459|NCT00277212|1784397|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
829460|NCT00277212|1784398|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
829461|NCT00277212|1784396|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0
829462|NCT00277212|1784397|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2
829463|NCT00277212|1784398|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2
829464|NCT00277212|1784396|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
829465|NCT00277212|1784397|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
829466|NCT00277212|1784398|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
829467|NCT00277212|1784396|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
829468|NCT00277212|1784397|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
829469|NCT00277212|1784398|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
829470|NCT00277212|1784396|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0
829471|NCT00277212|1784397|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7
829472|NCT00277212|1784398|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5
829473|NCT00277355|1784408|FG000|Overall Study|Withdrawal by Subject|3
829474|NCT00277355|1784409|FG001|Overall Study|Withdrawal by Subject|3
829475|NCT00277355|1784408|FG000|Overall Study|Lost to Follow-up|2
829476|NCT00277355|1784409|FG001|Overall Study|Lost to Follow-up|2
829477|NCT00277355|1784408|FG000|Overall Study|Adverse Event|5
829478|NCT00277355|1784409|FG001|Overall Study|Adverse Event|0
829479|NCT00277355|1784408|FG000|Overall Study|Death|3
829480|NCT00277355|1784409|FG001|Overall Study|Death|0
829481|NCT00277355|1784408|FG000|Overall Study|Physician Decision|1
829482|NCT00277355|1784409|FG001|Overall Study|Physician Decision|0
829483|NCT00278109|1784450|FG000|Overall Study|Adverse Event|3
829484|NCT00278109|1784450|FG000|Overall Study|social circumstances|1
829485|NCT00278148|1784454|FG000|Phase II - Expansion Phase|Disease progression|0
829486|NCT00278148|1784455|FG001|Phase II - Expansion Phase|Disease progression|0
829487|NCT00278148|1784456|FG002|Phase II - Expansion Phase|Disease progression|4
829488|NCT00278148|1784454|FG000|Phase II - Expansion Phase|Adverse Event|0
829489|NCT00278148|1784455|FG001|Phase II - Expansion Phase|Adverse Event|0
829490|NCT00278148|1784456|FG002|Phase II - Expansion Phase|Adverse Event|2
829491|NCT00278161|1784463|FG000|Overall Study|Death|11
829492|NCT00278200|1784469|FG000|Overall Study|Death|1
829493|NCT00278200|1784470|FG001|Overall Study|Death|3
829494|NCT00278200|1784469|FG000|Overall Study|Physician Decision|0
829495|NCT00278200|1784470|FG001|Overall Study|Physician Decision|1
829496|NCT00278395|1784481|FG000|Overall Study|Adverse Event|2
829497|NCT00278395|1784481|FG000|Overall Study|Nonevaluable|1
829498|NCT00278473|1784490|FG000|Overall Study|drop out|4
829499|NCT00278473|1784491|FG001|Overall Study|drop out|3
829500|NCT00278512|1784499|FG000|Overall Study|Death|1
829501|NCT00278512|1784500|FG001|Overall Study|Death|0
829502|NCT00278564|1784519|FG000|Overall Study|Lack of Efficacy|4
829503|NCT00278629|1784523|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14
829504|NCT00278889|1784549|FG000|Overall Study|Withdrawal by Subject|0
829505|NCT00278889|1784550|FG001|Overall Study|Withdrawal by Subject|5
829506|NCT00278889|1784551|FG002|Overall Study|Withdrawal by Subject|3
829507|NCT00278889|1784549|FG000|Overall Study|Lost to Follow-up|1
829508|NCT00278889|1784550|FG001|Overall Study|Lost to Follow-up|1
829509|NCT00278889|1784551|FG002|Overall Study|Lost to Follow-up|0
829510|NCT00278889|1784549|FG000|Overall Study|Death|24
829511|NCT00278889|1784550|FG001|Overall Study|Death|21
829512|NCT00278889|1784551|FG002|Overall Study|Death|17
829513|NCT00278915|1784559|FG000|Overall Study|Lack of Efficacy|1
829514|NCT00278954|1784563|FG000|Overall Study|Adverse Event|3
829515|NCT00278954|1784563|FG000|Overall Study|Lost to Follow-up|1
829516|NCT00278954|1784563|FG000|Overall Study|Withdrawal by Subject|1
829517|NCT00278993|1784567|FG000|Overall Study|Adverse Event|24
829518|NCT00278993|1784567|FG000|Overall Study|Withdrawal by Subject|5
829519|NCT00278993|1784567|FG000|Overall Study|Progressive Disease|65
829520|NCT00278993|1784567|FG000|Overall Study|Physician Decision|9
829521|NCT00278993|1784567|FG000|Overall Study|Not Otherwise Specified|4
829522|NCT00279201|1784573|FG000|Initiation|Death|1
829523|NCT00279201|1784574|FG001|Initiation|Death|5
829524|NCT00279201|1784575|FG002|Initiation|Death|0
829525|NCT00279201|1784576|FG003|Initiation|Death|0
829526|NCT00279201|1784577|FG004|Initiation|Death|0
829527|NCT00279201|1784578|FG005|Initiation|Death|0
829528|NCT00279201|1784573|FG000|Initiation|Adverse Event|6
829529|NCT00279201|1784574|FG001|Initiation|Adverse Event|15
829530|NCT00279201|1784575|FG002|Initiation|Adverse Event|0
829531|NCT00279201|1784576|FG003|Initiation|Adverse Event|0
829532|NCT00279201|1784577|FG004|Initiation|Adverse Event|0
829533|NCT00279201|1784578|FG005|Initiation|Adverse Event|0
829534|NCT00279201|1784573|FG000|Initiation|Lost to Follow-up|42
829535|NCT00279201|1784574|FG001|Initiation|Lost to Follow-up|41
829536|NCT00279201|1784575|FG002|Initiation|Lost to Follow-up|0
829537|NCT00279201|1784576|FG003|Initiation|Lost to Follow-up|0
829538|NCT00279201|1784577|FG004|Initiation|Lost to Follow-up|0
829539|NCT00279201|1784578|FG005|Initiation|Lost to Follow-up|0
829540|NCT00279201|1784573|FG000|Initiation|Entry Criteria Exclusion|7
829541|NCT00279201|1784574|FG001|Initiation|Entry Criteria Exclusion|9
829542|NCT00279201|1784575|FG002|Initiation|Entry Criteria Exclusion|0
829543|NCT00279201|1784576|FG003|Initiation|Entry Criteria Exclusion|0
829544|NCT00279201|1784577|FG004|Initiation|Entry Criteria Exclusion|0
829545|NCT00279201|1784578|FG005|Initiation|Entry Criteria Exclusion|0
829546|NCT00279201|1784573|FG000|Initiation|Protocol Violation|9
829547|NCT00279201|1784574|FG001|Initiation|Protocol Violation|10
829548|NCT00279201|1784575|FG002|Initiation|Protocol Violation|0
829549|NCT00279201|1784576|FG003|Initiation|Protocol Violation|0
829550|NCT00279201|1784577|FG004|Initiation|Protocol Violation|0
829551|NCT00279201|1784578|FG005|Initiation|Protocol Violation|0
829552|NCT00279201|1784573|FG000|Initiation|Withdrawal by Subject|35
829553|NCT00279201|1784574|FG001|Initiation|Withdrawal by Subject|41
829554|NCT00279201|1784575|FG002|Initiation|Withdrawal by Subject|0
829555|NCT00279201|1784576|FG003|Initiation|Withdrawal by Subject|0
829556|NCT00279201|1784577|FG004|Initiation|Withdrawal by Subject|0
829557|NCT00279201|1784578|FG005|Initiation|Withdrawal by Subject|0
829558|NCT00279201|1784573|FG000|Initiation|Physician Decision|15
829559|NCT00279201|1784574|FG001|Initiation|Physician Decision|18
829560|NCT00279201|1784575|FG002|Initiation|Physician Decision|0
829561|NCT00279201|1784576|FG003|Initiation|Physician Decision|0
829562|NCT00279201|1784577|FG004|Initiation|Physician Decision|0
829563|NCT00279201|1784578|FG005|Initiation|Physician Decision|0
829564|NCT00279201|1784573|FG000|Initiation|Sponsor Decision|13
829565|NCT00279201|1784574|FG001|Initiation|Sponsor Decision|5
829566|NCT00279201|1784575|FG002|Initiation|Sponsor Decision|0
829567|NCT00279201|1784576|FG003|Initiation|Sponsor Decision|0
829568|NCT00279201|1784577|FG004|Initiation|Sponsor Decision|0
829569|NCT00279201|1784578|FG005|Initiation|Sponsor Decision|0
829570|NCT00279201|1784573|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0
829571|NCT00279201|1784574|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1
829572|NCT00279201|1784575|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0
829573|NCT00279201|1784576|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0
829574|NCT00279201|1784577|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0
829575|NCT00279201|1784578|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0
829576|NCT00279201|1784573|FG000|Maintenance|Lack of Efficacy|32
829577|NCT00279201|1784574|FG001|Maintenance|Lack of Efficacy|30
829578|NCT00279201|1784575|FG002|Maintenance|Lack of Efficacy|0
829579|NCT00279201|1784576|FG003|Maintenance|Lack of Efficacy|0
829580|NCT00279201|1784577|FG004|Maintenance|Lack of Efficacy|0
829581|NCT00279201|1784578|FG005|Maintenance|Lack of Efficacy|0
829582|NCT00279201|1784573|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3
829583|NCT00279201|1784574|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2
829584|NCT00279201|1784575|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0
829585|NCT00279201|1784576|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0
829586|NCT00279201|1784577|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0
829587|NCT00279201|1784578|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0
829588|NCT00279201|1784573|FG000|Maintenance|Adverse Event|4
829589|NCT00279201|1784574|FG001|Maintenance|Adverse Event|4
829590|NCT00279201|1784575|FG002|Maintenance|Adverse Event|0
829591|NCT00279201|1784576|FG003|Maintenance|Adverse Event|0
829592|NCT00279201|1784577|FG004|Maintenance|Adverse Event|0
829593|NCT00279201|1784578|FG005|Maintenance|Adverse Event|0
829594|NCT00279201|1784573|FG000|Maintenance|Death|4
829595|NCT00279201|1784574|FG001|Maintenance|Death|4
829596|NCT00279201|1784575|FG002|Maintenance|Death|0
829597|NCT00279201|1784576|FG003|Maintenance|Death|0
829598|NCT00279201|1784577|FG004|Maintenance|Death|0
829599|NCT00279201|1784578|FG005|Maintenance|Death|0
829600|NCT00279201|1784573|FG000|Maintenance|Lost to Follow-up|17
829601|NCT00279201|1784574|FG001|Maintenance|Lost to Follow-up|13
829602|NCT00279201|1784575|FG002|Maintenance|Lost to Follow-up|0
829603|NCT00279201|1784576|FG003|Maintenance|Lost to Follow-up|0
829604|NCT00279201|1784577|FG004|Maintenance|Lost to Follow-up|0
829605|NCT00279201|1784578|FG005|Maintenance|Lost to Follow-up|0
829606|NCT00279201|1784573|FG000|Maintenance|Entry Criteria Exclusion|1
829607|NCT00279201|1784574|FG001|Maintenance|Entry Criteria Exclusion|4
829608|NCT00279201|1784575|FG002|Maintenance|Entry Criteria Exclusion|0
829609|NCT00279201|1784576|FG003|Maintenance|Entry Criteria Exclusion|0
829610|NCT00279201|1784577|FG004|Maintenance|Entry Criteria Exclusion|0
829611|NCT00279201|1784578|FG005|Maintenance|Entry Criteria Exclusion|0
829612|NCT00279201|1784573|FG000|Maintenance|Protocol Violation|16
829613|NCT00279201|1784574|FG001|Maintenance|Protocol Violation|24
829614|NCT00279201|1784575|FG002|Maintenance|Protocol Violation|0
829615|NCT00279201|1784576|FG003|Maintenance|Protocol Violation|0
829616|NCT00279201|1784577|FG004|Maintenance|Protocol Violation|0
829617|NCT00279201|1784578|FG005|Maintenance|Protocol Violation|0
829618|NCT00279201|1784573|FG000|Maintenance|Withdrawal by Subject|18
829619|NCT00279201|1784574|FG001|Maintenance|Withdrawal by Subject|18
829620|NCT00279201|1784575|FG002|Maintenance|Withdrawal by Subject|0
829621|NCT00279201|1784576|FG003|Maintenance|Withdrawal by Subject|0
829622|NCT00279201|1784577|FG004|Maintenance|Withdrawal by Subject|0
829623|NCT00279201|1784578|FG005|Maintenance|Withdrawal by Subject|0
829624|NCT00279201|1784573|FG000|Maintenance|Physician Decision|9
829625|NCT00279201|1784574|FG001|Maintenance|Physician Decision|9
829626|NCT00279201|1784575|FG002|Maintenance|Physician Decision|0
829627|NCT00279201|1784576|FG003|Maintenance|Physician Decision|0
829628|NCT00279201|1784577|FG004|Maintenance|Physician Decision|0
829629|NCT00279201|1784578|FG005|Maintenance|Physician Decision|0
829630|NCT00279201|1784573|FG000|Maintenance|Sponsor Decision|4
829631|NCT00279201|1784574|FG001|Maintenance|Sponsor Decision|0
829632|NCT00279201|1784575|FG002|Maintenance|Sponsor Decision|0
829633|NCT00279201|1784576|FG003|Maintenance|Sponsor Decision|0
829634|NCT00279201|1784577|FG004|Maintenance|Sponsor Decision|0
829635|NCT00279201|1784578|FG005|Maintenance|Sponsor Decision|0
829636|NCT00279201|1784573|FG000|Maintenance|HbA1c>7.5%|123
829637|NCT00279201|1784574|FG001|Maintenance|HbA1c>7.5%|126
829638|NCT00279201|1784575|FG002|Maintenance|HbA1c>7.5%|0
829639|NCT00279201|1784576|FG003|Maintenance|HbA1c>7.5%|0
829640|NCT00279201|1784577|FG004|Maintenance|HbA1c>7.5%|0
829641|NCT00279201|1784578|FG005|Maintenance|HbA1c>7.5%|0
829642|NCT00279201|1784573|FG000|Intensification Addendum|Withdrawal by Subject|0
829643|NCT00279201|1784574|FG001|Intensification Addendum|Withdrawal by Subject|0
829644|NCT00279201|1784575|FG002|Intensification Addendum|Withdrawal by Subject|12
829645|NCT00279201|1784576|FG003|Intensification Addendum|Withdrawal by Subject|14
829646|NCT00279201|1784577|FG004|Intensification Addendum|Withdrawal by Subject|9
829647|NCT00279201|1784578|FG005|Intensification Addendum|Withdrawal by Subject|18
829648|NCT00279201|1784573|FG000|Intensification Addendum|Lost to Follow-up|0
829649|NCT00279201|1784574|FG001|Intensification Addendum|Lost to Follow-up|0
829650|NCT00279201|1784575|FG002|Intensification Addendum|Lost to Follow-up|4
829651|NCT00279201|1784576|FG003|Intensification Addendum|Lost to Follow-up|6
829652|NCT00279201|1784577|FG004|Intensification Addendum|Lost to Follow-up|7
829653|NCT00279201|1784578|FG005|Intensification Addendum|Lost to Follow-up|7
829654|NCT00279201|1784573|FG000|Intensification Addendum|Protocol Violation|0
829655|NCT00279201|1784574|FG001|Intensification Addendum|Protocol Violation|0
829656|NCT00279201|1784575|FG002|Intensification Addendum|Protocol Violation|2
829657|NCT00279201|1784576|FG003|Intensification Addendum|Protocol Violation|2
829658|NCT00279201|1784577|FG004|Intensification Addendum|Protocol Violation|6
829659|NCT00279201|1784578|FG005|Intensification Addendum|Protocol Violation|6
829660|NCT00279201|1784573|FG000|Intensification Addendum|Adverse Event|0
829661|NCT00279201|1784574|FG001|Intensification Addendum|Adverse Event|0
829662|NCT00279201|1784575|FG002|Intensification Addendum|Adverse Event|0
829663|NCT00279201|1784576|FG003|Intensification Addendum|Adverse Event|4
829664|NCT00279201|1784577|FG004|Intensification Addendum|Adverse Event|1
829665|NCT00279201|1784578|FG005|Intensification Addendum|Adverse Event|3
829666|NCT00279201|1784573|FG000|Intensification Addendum|Physician Decision|0
829667|NCT00279201|1784574|FG001|Intensification Addendum|Physician Decision|0
829668|NCT00279201|1784575|FG002|Intensification Addendum|Physician Decision|4
829669|NCT00279201|1784576|FG003|Intensification Addendum|Physician Decision|1
829670|NCT00279201|1784577|FG004|Intensification Addendum|Physician Decision|3
829671|NCT00279201|1784578|FG005|Intensification Addendum|Physician Decision|2
829672|NCT00279201|1784573|FG000|Intensification Addendum|Sponsor Decision|0
829673|NCT00279201|1784574|FG001|Intensification Addendum|Sponsor Decision|0
829674|NCT00279201|1784575|FG002|Intensification Addendum|Sponsor Decision|0
829675|NCT00279201|1784576|FG003|Intensification Addendum|Sponsor Decision|0
829676|NCT00279201|1784577|FG004|Intensification Addendum|Sponsor Decision|1
829677|NCT00279201|1784578|FG005|Intensification Addendum|Sponsor Decision|1
829678|NCT00279201|1784573|FG000|Intensification Addendum|Entry Criteria Exclusion|0
829679|NCT00279201|1784574|FG001|Intensification Addendum|Entry Criteria Exclusion|0
829680|NCT00279201|1784575|FG002|Intensification Addendum|Entry Criteria Exclusion|1
829681|NCT00279201|1784576|FG003|Intensification Addendum|Entry Criteria Exclusion|0
829682|NCT00279201|1784577|FG004|Intensification Addendum|Entry Criteria Exclusion|0
829683|NCT00279201|1784578|FG005|Intensification Addendum|Entry Criteria Exclusion|0
829684|NCT00279201|1784573|FG000|Intensification Addendum|Lack of Efficacy|0
829685|NCT00279201|1784574|FG001|Intensification Addendum|Lack of Efficacy|0
829686|NCT00279201|1784575|FG002|Intensification Addendum|Lack of Efficacy|0
829687|NCT00279201|1784576|FG003|Intensification Addendum|Lack of Efficacy|1
829688|NCT00279201|1784577|FG004|Intensification Addendum|Lack of Efficacy|1
829689|NCT00279201|1784578|FG005|Intensification Addendum|Lack of Efficacy|0
829690|NCT00279201|1784573|FG000|Intensification Addendum|Death|0
829691|NCT00279201|1784574|FG001|Intensification Addendum|Death|0
829692|NCT00279201|1784575|FG002|Intensification Addendum|Death|0
829693|NCT00279201|1784576|FG003|Intensification Addendum|Death|0
829694|NCT00279201|1784577|FG004|Intensification Addendum|Death|1
829695|NCT00279201|1784578|FG005|Intensification Addendum|Death|0
829696|NCT00279214|1784613|FG000|Overall Study|Physician Decision|3
829697|NCT00279214|1784614|FG001|Overall Study|Physician Decision|2
829698|NCT00279305|1784622|FG000|Overall Study|Pregnancy|1
829699|NCT00279305|1784623|FG001|Overall Study|Pregnancy|0
829700|NCT00279305|1784622|FG000|Overall Study|Withdrawal by Subject|2
829701|NCT00279305|1784623|FG001|Overall Study|Withdrawal by Subject|0
829702|NCT00279305|1784622|FG000|Overall Study|Dificulting establishing IV|1
829703|NCT00279305|1784623|FG001|Overall Study|Dificulting establishing IV|0
829704|NCT00279305|1784622|FG000|Overall Study|FDA Safety Alert|4
829705|NCT00279305|1784623|FG001|Overall Study|FDA Safety Alert|1
829706|NCT00279708|1784646|FG000|Overall Study|Withdrawal by Subject|2
829707|NCT00279708|1784647|FG001|Overall Study|Withdrawal by Subject|3
829708|NCT00279708|1784646|FG000|Overall Study|Adverse Event|1
829709|NCT00279708|1784647|FG001|Overall Study|Adverse Event|1
829710|NCT00279812|1784659|FG000|Overall Study|Protocol Violation|1
829711|NCT00279812|1784660|FG001|Overall Study|Protocol Violation|1
829712|NCT00279812|1784661|FG002|Overall Study|Protocol Violation|0
829713|NCT00279812|1784662|FG003|Overall Study|Protocol Violation|0
829714|NCT00279812|1784663|FG004|Overall Study|Protocol Violation|1
829715|NCT00279812|1784664|FG005|Overall Study|Protocol Violation|0
829716|NCT00279812|1784659|FG000|Overall Study|Withdrawal by Subject|0
829717|NCT00279812|1784660|FG001|Overall Study|Withdrawal by Subject|4
829718|NCT00279812|1784661|FG002|Overall Study|Withdrawal by Subject|2
829719|NCT00279812|1784662|FG003|Overall Study|Withdrawal by Subject|0
829720|NCT00279812|1784663|FG004|Overall Study|Withdrawal by Subject|0
829721|NCT00279812|1784664|FG005|Overall Study|Withdrawal by Subject|0
829722|NCT00279812|1784659|FG000|Overall Study|Adverse Event|0
829723|NCT00279812|1784660|FG001|Overall Study|Adverse Event|1
829724|NCT00279812|1784661|FG002|Overall Study|Adverse Event|1
829725|NCT00279812|1784662|FG003|Overall Study|Adverse Event|0
829726|NCT00279812|1784663|FG004|Overall Study|Adverse Event|2
829727|NCT00279812|1784664|FG005|Overall Study|Adverse Event|1
829728|NCT00279916|1784680|FG000|Overall Study|Withdrawal by Subject|4
829729|NCT00279916|1784681|FG001|Overall Study|Withdrawal by Subject|3
829730|NCT00279916|1784680|FG000|Overall Study|Lost to Follow-up|3
829731|NCT00279916|1784681|FG001|Overall Study|Lost to Follow-up|2
829732|NCT00280059|1784701|FG000|Efficacy Assessment Phase|Death|2
829733|NCT00280059|1784702|FG001|Efficacy Assessment Phase|Death|0
829734|NCT00280059|1784701|FG000|Efficacy Assessment Phase|Adverse Event|33
829735|NCT00280059|1784702|FG001|Efficacy Assessment Phase|Adverse Event|31
829736|NCT00280059|1784701|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1
829737|NCT00280059|1784702|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0
829738|NCT00280059|1784701|FG000|Efficacy Assessment Phase|Lack of Efficacy|19
829739|NCT00280059|1784702|FG001|Efficacy Assessment Phase|Lack of Efficacy|3
829740|NCT00280059|1784701|FG000|Efficacy Assessment Phase|Lost to Follow-up|6
829741|NCT00280059|1784702|FG001|Efficacy Assessment Phase|Lost to Follow-up|13
829742|NCT00280059|1784701|FG000|Efficacy Assessment Phase|Other|7
829743|NCT00280059|1784702|FG001|Efficacy Assessment Phase|Other|8
829744|NCT00280059|1784701|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26
829745|NCT00280059|1784702|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25
829746|NCT00280150|1784720|FG000|Overall Study|Adverse Event|0
829747|NCT00280150|1784721|FG001|Overall Study|Adverse Event|1
829748|NCT00280150|1784722|FG002|Overall Study|Adverse Event|2
829749|NCT00280150|1784723|FG003|Overall Study|Adverse Event|3
829750|NCT00280150|1784720|FG000|Overall Study|Lack of Efficacy|0
829751|NCT00280150|1784721|FG001|Overall Study|Lack of Efficacy|0
829752|NCT00280150|1784722|FG002|Overall Study|Lack of Efficacy|0
829753|NCT00280150|1784723|FG003|Overall Study|Lack of Efficacy|3
829754|NCT00280150|1784720|FG000|Overall Study|Physician Decision|0
829755|NCT00280150|1784721|FG001|Overall Study|Physician Decision|0
829756|NCT00280150|1784722|FG002|Overall Study|Physician Decision|0
829757|NCT00280150|1784723|FG003|Overall Study|Physician Decision|1
829758|NCT00280150|1784720|FG000|Overall Study|Protocol Violation|0
829759|NCT00280150|1784721|FG001|Overall Study|Protocol Violation|0
829760|NCT00280150|1784722|FG002|Overall Study|Protocol Violation|0
829761|NCT00280150|1784723|FG003|Overall Study|Protocol Violation|1
829762|NCT00280150|1784720|FG000|Overall Study|Withdrawal by Subject|0
829763|NCT00280150|1784721|FG001|Overall Study|Withdrawal by Subject|0
829764|NCT00280150|1784722|FG002|Overall Study|Withdrawal by Subject|0
829765|NCT00280150|1784723|FG003|Overall Study|Withdrawal by Subject|1
829766|NCT00280150|1784720|FG000|Overall Study|Did not get consolidation therapy|3
829767|NCT00280150|1784721|FG001|Overall Study|Did not get consolidation therapy|0
829768|NCT00280150|1784722|FG002|Overall Study|Did not get consolidation therapy|3
829769|NCT00280150|1784723|FG003|Overall Study|Did not get consolidation therapy|0
829770|NCT00280150|1784720|FG000|Overall Study|Declining Performance Status|0
829771|NCT00280150|1784721|FG001|Overall Study|Declining Performance Status|0
829772|NCT00280150|1784722|FG002|Overall Study|Declining Performance Status|0
829773|NCT00280150|1784723|FG003|Overall Study|Declining Performance Status|1
829774|NCT00280293|1784740|FG000|Overall Study|Protocol Violation|3
829775|NCT00280293|1784741|FG001|Overall Study|Protocol Violation|0
829776|NCT00280293|1784740|FG000|Overall Study|Physician Decision|5
829777|NCT00280293|1784741|FG001|Overall Study|Physician Decision|4
829778|NCT00280293|1784740|FG000|Overall Study|Lost to Follow-up|14
829779|NCT00280293|1784741|FG001|Overall Study|Lost to Follow-up|12
829780|NCT00280293|1784740|FG000|Overall Study|Withdrawal by Subject|3
829781|NCT00280293|1784741|FG001|Overall Study|Withdrawal by Subject|5
829782|NCT00280293|1784740|FG000|Overall Study|Incarceration/Legal Reasons|1
829783|NCT00280293|1784741|FG001|Overall Study|Incarceration/Legal Reasons|1
829784|NCT00280293|1784740|FG000|Overall Study|Adverse Event|0
829785|NCT00280293|1784741|FG001|Overall Study|Adverse Event|1
829786|NCT00280397|1784780|FG000|Overall Study|Adverse Event|1
829787|NCT00280566|1784788|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
829788|NCT00280566|1784789|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
829789|NCT00280566|1784790|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
829790|NCT00280566|1784788|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
829791|NCT00280566|1784789|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
829792|NCT00280566|1784790|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
829793|NCT00280566|1784788|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148
829794|NCT00280566|1784789|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0
829795|NCT00280566|1784790|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0
829796|NCT00280566|1784788|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
829797|NCT00280566|1784789|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
829798|NCT00280566|1784790|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
829799|NCT00280566|1784788|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
829800|NCT00280566|1784789|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
829801|NCT00280566|1784790|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
829802|NCT00280566|1784788|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50
829803|NCT00280566|1784789|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0
829804|NCT00280566|1784790|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0
829805|NCT00280566|1784788|FG000|Period 2 Double Blind|Lack of Efficacy|0
829806|NCT00280566|1784789|FG001|Period 2 Double Blind|Lack of Efficacy|9
829807|NCT00280566|1784790|FG002|Period 2 Double Blind|Lack of Efficacy|22
829808|NCT00280566|1784788|FG000|Period 2 Double Blind|Laboratory Abnormality|0
829809|NCT00280566|1784789|FG001|Period 2 Double Blind|Laboratory Abnormality|1
829810|NCT00280566|1784790|FG002|Period 2 Double Blind|Laboratory Abnormality|0
829811|NCT00280566|1784788|FG000|Period 2 Double Blind|Adverse Event|0
829812|NCT00280566|1784789|FG001|Period 2 Double Blind|Adverse Event|11
829813|NCT00280566|1784790|FG002|Period 2 Double Blind|Adverse Event|15
829814|NCT00280566|1784788|FG000|Period 2 Double Blind|Lost to Follow-up|0
829815|NCT00280566|1784789|FG001|Period 2 Double Blind|Lost to Follow-up|3
829816|NCT00280566|1784790|FG002|Period 2 Double Blind|Lost to Follow-up|6
829817|NCT00280566|1784788|FG000|Period 2 Double Blind|Withdrawal by Subject|0
829818|NCT00280566|1784789|FG001|Period 2 Double Blind|Withdrawal by Subject|9
829819|NCT00280566|1784790|FG002|Period 2 Double Blind|Withdrawal by Subject|9
829820|NCT00280566|1784788|FG000|Period 2 Double Blind|miscellaneous|0
829821|NCT00280566|1784789|FG001|Period 2 Double Blind|miscellaneous|10
829822|NCT00280566|1784790|FG002|Period 2 Double Blind|miscellaneous|5
829823|NCT00280683|1784799|FG000|Overall Study|Withdrawal by Subject|1
829824|NCT00280683|1784800|FG001|Overall Study|Withdrawal by Subject|2
829825|NCT00280683|1784799|FG000|Overall Study|Adverse Event|1
829826|NCT00280683|1784800|FG001|Overall Study|Adverse Event|1
829827|NCT00280735|1784808|FG000|Overall Study|Adverse Event|5
829828|NCT00280735|1784808|FG000|Overall Study|Lack of Efficacy|3
829829|NCT00280735|1784808|FG000|Overall Study|Withdrawal by Subject|8
829830|NCT00280735|1784808|FG000|Overall Study|Intercurrent Illness|2
829831|NCT00280748|1784816|FG000|Overall Study|Decline in performance|3
829832|NCT00280748|1784816|FG000|Overall Study|Extra-cranial disease progression|1
829833|NCT00280917|1784833|FG000|Overall Study|Adverse Event|1
829834|NCT00280917|1784834|FG001|Overall Study|Adverse Event|1
829835|NCT00280917|1784835|FG002|Overall Study|Adverse Event|4
829836|NCT00280917|1784836|FG003|Overall Study|Adverse Event|1
829837|NCT00280917|1784833|FG000|Overall Study|Change Therapy|1
829838|NCT00280917|1784834|FG001|Overall Study|Change Therapy|2
829839|NCT00280917|1784835|FG002|Overall Study|Change Therapy|0
829840|NCT00280917|1784836|FG003|Overall Study|Change Therapy|0
829841|NCT00280917|1784833|FG000|Overall Study|Withdrawal by Subject|0
829842|NCT00280917|1784834|FG001|Overall Study|Withdrawal by Subject|2
829843|NCT00280917|1784835|FG002|Overall Study|Withdrawal by Subject|0
829844|NCT00280917|1784836|FG003|Overall Study|Withdrawal by Subject|1
829845|NCT00280917|1784833|FG000|Overall Study|Noncompliance|0
829846|NCT00280917|1784834|FG001|Overall Study|Noncompliance|1
829847|NCT00280917|1784835|FG002|Overall Study|Noncompliance|2
829848|NCT00280917|1784836|FG003|Overall Study|Noncompliance|0
829849|NCT00281099|1784852|FG000|Overall Study|Death|46
829850|NCT00281099|1784853|FG001|Overall Study|Death|57
829851|NCT00281099|1784852|FG000|Overall Study|Lost to Follow-up|10
829852|NCT00281099|1784853|FG001|Overall Study|Lost to Follow-up|19
829853|NCT00281099|1784852|FG000|Overall Study|Withdrawal by Subject|65
829854|NCT00281099|1784853|FG001|Overall Study|Withdrawal by Subject|70
829855|NCT00281099|1784852|FG000|Overall Study|Physician Decision|79
829856|NCT00281099|1784853|FG001|Overall Study|Physician Decision|72
829857|NCT00281099|1784852|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5
829858|NCT00281099|1784853|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4
829859|NCT00281320|1784862|FG000|Overall Study|Adverse Event|12
829860|NCT00281320|1784863|FG001|Overall Study|Adverse Event|9
829861|NCT00281320|1784862|FG000|Overall Study|Lack of Efficacy|4
829862|NCT00281320|1784863|FG001|Overall Study|Lack of Efficacy|3
829863|NCT00281320|1784862|FG000|Overall Study|Withdrawal by Subject|5
829864|NCT00281320|1784863|FG001|Overall Study|Withdrawal by Subject|6
829865|NCT00281320|1784862|FG000|Overall Study|Lost to Follow-up|1
829866|NCT00281320|1784863|FG001|Overall Study|Lost to Follow-up|2
829867|NCT00281320|1784862|FG000|Overall Study|Other|3
829868|NCT00281320|1784863|FG001|Overall Study|Other|1
829869|NCT00281528|1784882|FG000|Overall Study|Progressive Disease|28
829870|NCT00281528|1784883|FG001|Overall Study|Progressive Disease|18
829871|NCT00281528|1784884|FG002|Overall Study|Progressive Disease|27
829872|NCT00281528|1784882|FG000|Overall Study|Unacceptable Toxicity-related to trt|21
829873|NCT00281528|1784883|FG001|Overall Study|Unacceptable Toxicity-related to trt|24
829874|NCT00281528|1784884|FG002|Overall Study|Unacceptable Toxicity-related to trt|32
829875|NCT00281528|1784882|FG000|Overall Study|Adverse Event-unrelated to treatment|3
829962|NCT00281580|1784916|FG008|Overall Study|Lost to Follow-up|2
829876|NCT00281528|1784883|FG001|Overall Study|Adverse Event-unrelated to treatment|0
829877|NCT00281528|1784884|FG002|Overall Study|Adverse Event-unrelated to treatment|2
829878|NCT00281528|1784882|FG000|Overall Study|Physician Decision|11
829879|NCT00281528|1784883|FG001|Overall Study|Physician Decision|4
829880|NCT00281528|1784884|FG002|Overall Study|Physician Decision|5
829881|NCT00281528|1784882|FG000|Overall Study|Protocol Violation|1
829882|NCT00281528|1784883|FG001|Overall Study|Protocol Violation|0
829883|NCT00281528|1784884|FG002|Overall Study|Protocol Violation|1
829884|NCT00281528|1784882|FG000|Overall Study|Withdrawal by Subject|5
829885|NCT00281528|1784883|FG001|Overall Study|Withdrawal by Subject|5
829886|NCT00281528|1784884|FG002|Overall Study|Withdrawal by Subject|7
829887|NCT00281528|1784882|FG000|Overall Study|Other|6
829888|NCT00281528|1784883|FG001|Overall Study|Other|3
829889|NCT00281528|1784884|FG002|Overall Study|Other|5
829890|NCT00281580|1784908|FG000|Overall Study|Adverse Event|2
829891|NCT00281580|1784909|FG001|Overall Study|Adverse Event|0
829892|NCT00281580|1784910|FG002|Overall Study|Adverse Event|2
829893|NCT00281580|1784911|FG003|Overall Study|Adverse Event|4
829894|NCT00281580|1784912|FG004|Overall Study|Adverse Event|1
829895|NCT00281580|1784913|FG005|Overall Study|Adverse Event|0
829896|NCT00281580|1784914|FG006|Overall Study|Adverse Event|1
829897|NCT00281580|1784915|FG007|Overall Study|Adverse Event|0
829898|NCT00281580|1784916|FG008|Overall Study|Adverse Event|1
829899|NCT00281580|1784917|FG009|Overall Study|Adverse Event|6
829900|NCT00281580|1784918|FG010|Overall Study|Adverse Event|0
829901|NCT00281580|1784919|FG011|Overall Study|Adverse Event|5
829902|NCT00281580|1784920|FG012|Overall Study|Adverse Event|8
829903|NCT00281580|1784921|FG013|Overall Study|Adverse Event|2
829904|NCT00281580|1784922|FG014|Overall Study|Adverse Event|3
829905|NCT00281580|1784923|FG015|Overall Study|Adverse Event|3
829906|NCT00281580|1784908|FG000|Overall Study|Protocol Violation|0
829907|NCT00281580|1784909|FG001|Overall Study|Protocol Violation|0
829908|NCT00281580|1784910|FG002|Overall Study|Protocol Violation|1
829909|NCT00281580|1784911|FG003|Overall Study|Protocol Violation|1
829910|NCT00281580|1784912|FG004|Overall Study|Protocol Violation|0
829911|NCT00281580|1784913|FG005|Overall Study|Protocol Violation|0
829912|NCT00281580|1784914|FG006|Overall Study|Protocol Violation|1
829913|NCT00281580|1784915|FG007|Overall Study|Protocol Violation|0
829914|NCT00281580|1784916|FG008|Overall Study|Protocol Violation|2
829915|NCT00281580|1784917|FG009|Overall Study|Protocol Violation|0
829916|NCT00281580|1784918|FG010|Overall Study|Protocol Violation|1
829917|NCT00281580|1784919|FG011|Overall Study|Protocol Violation|2
829918|NCT00281580|1784920|FG012|Overall Study|Protocol Violation|0
829919|NCT00281580|1784921|FG013|Overall Study|Protocol Violation|1
829920|NCT00281580|1784922|FG014|Overall Study|Protocol Violation|1
829921|NCT00281580|1784923|FG015|Overall Study|Protocol Violation|3
829922|NCT00281580|1784908|FG000|Overall Study|Withdrawal by Subject|3
829923|NCT00281580|1784909|FG001|Overall Study|Withdrawal by Subject|0
829924|NCT00281580|1784910|FG002|Overall Study|Withdrawal by Subject|1
829925|NCT00281580|1784911|FG003|Overall Study|Withdrawal by Subject|1
829926|NCT00281580|1784912|FG004|Overall Study|Withdrawal by Subject|1
829927|NCT00281580|1784913|FG005|Overall Study|Withdrawal by Subject|2
829928|NCT00281580|1784914|FG006|Overall Study|Withdrawal by Subject|2
829929|NCT00281580|1784915|FG007|Overall Study|Withdrawal by Subject|0
829930|NCT00281580|1784916|FG008|Overall Study|Withdrawal by Subject|1
829931|NCT00281580|1784917|FG009|Overall Study|Withdrawal by Subject|4
829932|NCT00281580|1784918|FG010|Overall Study|Withdrawal by Subject|1
829933|NCT00281580|1784919|FG011|Overall Study|Withdrawal by Subject|1
829934|NCT00281580|1784920|FG012|Overall Study|Withdrawal by Subject|2
829935|NCT00281580|1784921|FG013|Overall Study|Withdrawal by Subject|2
829936|NCT00281580|1784922|FG014|Overall Study|Withdrawal by Subject|1
829937|NCT00281580|1784923|FG015|Overall Study|Withdrawal by Subject|5
829938|NCT00281580|1784908|FG000|Overall Study|Lack of Efficacy|2
829939|NCT00281580|1784909|FG001|Overall Study|Lack of Efficacy|1
829940|NCT00281580|1784910|FG002|Overall Study|Lack of Efficacy|1
829941|NCT00281580|1784911|FG003|Overall Study|Lack of Efficacy|6
829942|NCT00281580|1784912|FG004|Overall Study|Lack of Efficacy|2
829943|NCT00281580|1784913|FG005|Overall Study|Lack of Efficacy|0
829944|NCT00281580|1784914|FG006|Overall Study|Lack of Efficacy|0
829945|NCT00281580|1784915|FG007|Overall Study|Lack of Efficacy|0
829946|NCT00281580|1784916|FG008|Overall Study|Lack of Efficacy|0
829947|NCT00281580|1784917|FG009|Overall Study|Lack of Efficacy|0
829948|NCT00281580|1784918|FG010|Overall Study|Lack of Efficacy|0
829949|NCT00281580|1784919|FG011|Overall Study|Lack of Efficacy|1
829950|NCT00281580|1784920|FG012|Overall Study|Lack of Efficacy|0
829951|NCT00281580|1784921|FG013|Overall Study|Lack of Efficacy|2
829952|NCT00281580|1784922|FG014|Overall Study|Lack of Efficacy|1
829953|NCT00281580|1784923|FG015|Overall Study|Lack of Efficacy|0
829954|NCT00281580|1784908|FG000|Overall Study|Lost to Follow-up|0
829955|NCT00281580|1784909|FG001|Overall Study|Lost to Follow-up|0
829956|NCT00281580|1784910|FG002|Overall Study|Lost to Follow-up|0
829957|NCT00281580|1784911|FG003|Overall Study|Lost to Follow-up|3
829958|NCT00281580|1784912|FG004|Overall Study|Lost to Follow-up|0
829959|NCT00281580|1784913|FG005|Overall Study|Lost to Follow-up|1
829960|NCT00281580|1784914|FG006|Overall Study|Lost to Follow-up|0
829961|NCT00281580|1784915|FG007|Overall Study|Lost to Follow-up|1
829963|NCT00281580|1784917|FG009|Overall Study|Lost to Follow-up|1
829964|NCT00281580|1784918|FG010|Overall Study|Lost to Follow-up|1
829965|NCT00281580|1784919|FG011|Overall Study|Lost to Follow-up|0
829966|NCT00281580|1784920|FG012|Overall Study|Lost to Follow-up|1
829967|NCT00281580|1784921|FG013|Overall Study|Lost to Follow-up|0
829968|NCT00281580|1784922|FG014|Overall Study|Lost to Follow-up|0
829969|NCT00281580|1784923|FG015|Overall Study|Lost to Follow-up|0
829970|NCT00281580|1784908|FG000|Overall Study|Randomised in error; pregnancy; moving|0
829971|NCT00281580|1784909|FG001|Overall Study|Randomised in error; pregnancy; moving|0
829972|NCT00281580|1784910|FG002|Overall Study|Randomised in error; pregnancy; moving|0
829973|NCT00281580|1784911|FG003|Overall Study|Randomised in error; pregnancy; moving|2
829974|NCT00281580|1784912|FG004|Overall Study|Randomised in error; pregnancy; moving|0
829975|NCT00281580|1784913|FG005|Overall Study|Randomised in error; pregnancy; moving|0
829976|NCT00281580|1784914|FG006|Overall Study|Randomised in error; pregnancy; moving|1
829977|NCT00281580|1784915|FG007|Overall Study|Randomised in error; pregnancy; moving|0
829978|NCT00281580|1784916|FG008|Overall Study|Randomised in error; pregnancy; moving|2
829979|NCT00281580|1784917|FG009|Overall Study|Randomised in error; pregnancy; moving|1
829980|NCT00281580|1784918|FG010|Overall Study|Randomised in error; pregnancy; moving|1
829981|NCT00281580|1784919|FG011|Overall Study|Randomised in error; pregnancy; moving|1
829982|NCT00281580|1784920|FG012|Overall Study|Randomised in error; pregnancy; moving|2
829983|NCT00281580|1784921|FG013|Overall Study|Randomised in error; pregnancy; moving|0
829984|NCT00281580|1784922|FG014|Overall Study|Randomised in error; pregnancy; moving|1
829985|NCT00281580|1784923|FG015|Overall Study|Randomised in error; pregnancy; moving|2
829986|NCT00281632|1784992|FG000|Overall Study|Adverse Event|7
829987|NCT00281632|1784992|FG000|Overall Study|Withdrawal by Subject|2
829988|NCT00281632|1784992|FG000|Overall Study|Disease Progression|22
829989|NCT00281632|1784992|FG000|Overall Study|Death|1
829990|NCT00281632|1784992|FG000|Overall Study|Physician Decision|1
829991|NCT00281632|1784992|FG000|Overall Study|Ongoing|3
830016|NCT00281684|1785029|FG000|Overall Study|Lost to Follow-up|0
830017|NCT00281684|1785030|FG001|Overall Study|Lost to Follow-up|0
830018|NCT00281684|1785031|FG002|Overall Study|Lost to Follow-up|1
830019|NCT00281684|1785032|FG003|Overall Study|Lost to Follow-up|0
830020|NCT00281684|1785029|FG000|Overall Study|Withdrawal by Subject|1
830021|NCT00281684|1785030|FG001|Overall Study|Withdrawal by Subject|0
830022|NCT00281684|1785031|FG002|Overall Study|Withdrawal by Subject|0
830023|NCT00281684|1785032|FG003|Overall Study|Withdrawal by Subject|0
830024|NCT00281697|1785046|FG000|Overall Study|> 60 days since last dose of study drug|4
830025|NCT00281697|1785047|FG001|Overall Study|> 60 days since last dose of study drug|4
830026|NCT00281697|1785046|FG000|Overall Study|Adverse Event|54
830027|NCT00281697|1785047|FG001|Overall Study|Adverse Event|15
830028|NCT00281697|1785046|FG000|Overall Study|Death|8
830029|NCT00281697|1785047|FG001|Overall Study|Death|3
830030|NCT00281697|1785046|FG000|Overall Study|Disease progression|279
830031|NCT00281697|1785047|FG001|Overall Study|Disease progression|149
830032|NCT00281697|1785046|FG000|Overall Study|Other|5
830033|NCT00281697|1785047|FG001|Overall Study|Other|6
830034|NCT00281697|1785046|FG000|Overall Study|Physician's decision to withdraw|15
830035|NCT00281697|1785047|FG001|Overall Study|Physician's decision to withdraw|12
830036|NCT00281697|1785046|FG000|Overall Study|Subject/guardian's decision to withdraw|33
830037|NCT00281697|1785047|FG001|Overall Study|Subject/guardian's decision to withdraw|6
830038|NCT00281697|1785046|FG000|Overall Study|Did not receive study drug|3
830039|NCT00281697|1785047|FG001|Overall Study|Did not receive study drug|2
830040|NCT00281840|1785059|FG000|Overall Study|Adverse Event|12
830041|NCT00281840|1785059|FG000|Overall Study|Physician Decision|6
830042|NCT00281840|1785059|FG000|Overall Study|Withdrawal by Subject|3
830043|NCT00281840|1785059|FG000|Overall Study|Disease Progression|2
830044|NCT00281840|1785059|FG000|Overall Study|exceed maximum delay in treatment|1
830045|NCT00281840|1785059|FG000|Overall Study|Complicating Disease|1
830046|NCT00281957|1785075|FG000|Overall Study|Adverse Event|7
830047|NCT00281957|1785076|FG001|Overall Study|Adverse Event|2
830048|NCT00281957|1785075|FG000|Overall Study|Death|1
830049|NCT00281957|1785076|FG001|Overall Study|Death|0
830050|NCT00281957|1785075|FG000|Overall Study|Progression/relapse|47
830051|NCT00281957|1785076|FG001|Overall Study|Progression/relapse|35
830052|NCT00281957|1785075|FG000|Overall Study|Not protocol specified|8
830053|NCT00281957|1785076|FG001|Overall Study|Not protocol specified|1
830054|NCT00281957|1785075|FG000|Overall Study|Not eligible|1
830055|NCT00281957|1785076|FG001|Overall Study|Not eligible|2
830056|NCT00281957|1785075|FG000|Overall Study|Did not start treatment|3
830057|NCT00281957|1785076|FG001|Overall Study|Did not start treatment|1
830058|NCT00281957|1785075|FG000|Overall Study|Refusal unrelated to adverse events|0
830059|NCT00281957|1785076|FG001|Overall Study|Refusal unrelated to adverse events|1
830060|NCT00282048|1785084|FG000|Overall Study|Lack of Efficacy|30
830061|NCT00282048|1785084|FG000|Overall Study|Adverse Event|22
830062|NCT00282048|1785084|FG000|Overall Study|Withdrawal by Subject|1
830063|NCT00282048|1785084|FG000|Overall Study|Other|8
830064|NCT00282048|1785084|FG000|Overall Study|Ongoing|1
830065|NCT00282087|1785088|FG000|Overall Study|Death|1
830066|NCT00282113|1785096|FG000|Overall Study|Removed at parents request|1
830067|NCT00282113|1785097|FG001|Overall Study|Removed at parents request|0
830068|NCT00282113|1785098|FG002|Overall Study|Removed at parents request|0
830069|NCT00282152|1785108|FG000|Overall Study|Withdrawal by Subject|1
830070|NCT00282152|1785109|FG001|Overall Study|Withdrawal by Subject|0
830071|NCT00282243|1785116|FG000|Pharmacokinetic Treatment Period|Adverse Event|3
830072|NCT00282243|1785116|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
830073|NCT00282243|1785116|FG000|Extension Treatment Period|Adverse Event|15
830074|NCT00282243|1785116|FG000|Extension Treatment Period|Withdrawal by Subject|4
830075|NCT00282243|1785116|FG000|Extension Treatment Period|Non-compliance|2
830076|NCT00282243|1785116|FG000|Extension Treatment Period|Physician Decision|1
830077|NCT00282256|1785120|FG000|Pharmacokinetic Treatment Period|Poor venous access|1
830078|NCT00282256|1785120|FG000|Extension Treatment Period|Adverse Event|2
830079|NCT00282295|1785132|FG000|Overall Study|Adverse Event|0
830080|NCT00282295|1785133|FG001|Overall Study|Adverse Event|1
830081|NCT00282295|1785134|FG002|Overall Study|Adverse Event|0
830082|NCT00282295|1785132|FG000|Overall Study|Serious Adverse Events|0
830083|NCT00282295|1785133|FG001|Overall Study|Serious Adverse Events|0
830084|NCT00282295|1785134|FG002|Overall Study|Serious Adverse Events|1
830085|NCT00282295|1785132|FG000|Overall Study|Protocol Violation|0
830086|NCT00282295|1785133|FG001|Overall Study|Protocol Violation|2
830087|NCT00282295|1785134|FG002|Overall Study|Protocol Violation|1
830088|NCT00282295|1785132|FG000|Overall Study|Withdrawal by Subject|2
830089|NCT00282295|1785133|FG001|Overall Study|Withdrawal by Subject|6
830090|NCT00282295|1785134|FG002|Overall Study|Withdrawal by Subject|4
830091|NCT00282295|1785132|FG000|Overall Study|Lost to Follow-up|1
830092|NCT00282295|1785133|FG001|Overall Study|Lost to Follow-up|7
830093|NCT00282295|1785134|FG002|Overall Study|Lost to Follow-up|2
830094|NCT00282295|1785132|FG000|Overall Study|Other|0
830095|NCT00282295|1785133|FG001|Overall Study|Other|1
830096|NCT00282295|1785134|FG002|Overall Study|Other|0
830097|NCT00282308|1785149|FG000|Treatment Period|Lost to Follow-up|1
830098|NCT00282308|1785150|FG001|Treatment Period|Lost to Follow-up|0
830099|NCT00282308|1785151|FG002|Treatment Period|Lost to Follow-up|0
830100|NCT00282308|1785149|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2
830101|NCT00282308|1785150|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4
830102|NCT00282308|1785151|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0
830103|NCT00282308|1785149|FG000|Treatment Period|Adverse Event|0
830104|NCT00282308|1785150|FG001|Treatment Period|Adverse Event|2
830105|NCT00282308|1785151|FG002|Treatment Period|Adverse Event|0
830106|NCT00282308|1785149|FG000|Treatment Period|Not Treated with Study Drug|1
830107|NCT00282308|1785150|FG001|Treatment Period|Not Treated with Study Drug|0
830108|NCT00282308|1785151|FG002|Treatment Period|Not Treated with Study Drug|0
830109|NCT00282308|1785149|FG000|Optional Extension Re-treatment Period|Adverse Event|0
830110|NCT00282308|1785150|FG001|Optional Extension Re-treatment Period|Adverse Event|0
830111|NCT00282308|1785151|FG002|Optional Extension Re-treatment Period|Adverse Event|4
830112|NCT00282308|1785149|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
830113|NCT00282308|1785150|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
830114|NCT00282308|1785151|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
830115|NCT00282308|1785149|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
830116|NCT00282308|1785150|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
830117|NCT00282308|1785151|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
830118|NCT00282308|1785149|FG000|Safety Follow-up Period|Adverse Event|0
830119|NCT00282308|1785150|FG001|Safety Follow-up Period|Adverse Event|0
830120|NCT00282308|1785151|FG002|Safety Follow-up Period|Adverse Event|1
830121|NCT00282308|1785149|FG000|Safety Follow-up Period|Lost to Follow-up|0
830122|NCT00282308|1785150|FG001|Safety Follow-up Period|Lost to Follow-up|0
830123|NCT00282308|1785151|FG002|Safety Follow-up Period|Lost to Follow-up|5
830124|NCT00282308|1785149|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0
830125|NCT00282308|1785150|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0
830126|NCT00282308|1785151|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1
830127|NCT00282308|1785149|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
830128|NCT00282308|1785150|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
830129|NCT00282308|1785151|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
830130|NCT00282334|1785163|FG000|Overall Study|Withdrawal by Subject|8
830131|NCT00282334|1785164|FG001|Overall Study|Withdrawal by Subject|5
830132|NCT00282347|1785172|FG000|Treatment Period|Death|2
830133|NCT00282347|1785173|FG001|Treatment Period|Death|0
830134|NCT00282347|1785172|FG000|Treatment Period|Lost to Follow-up|2
830135|NCT00282347|1785173|FG001|Treatment Period|Lost to Follow-up|5
830136|NCT00282347|1785172|FG000|Treatment Period|Withdrawal by Subject|1
830137|NCT00282347|1785173|FG001|Treatment Period|Withdrawal by Subject|3
830138|NCT00282347|1785172|FG000|Treatment Period|Physician Decision|0
830139|NCT00282347|1785173|FG001|Treatment Period|Physician Decision|1
830140|NCT00282347|1785172|FG000|Safety Follow-up Period|Lost to Follow-up|0
830141|NCT00282347|1785173|FG001|Safety Follow-up Period|Lost to Follow-up|2
830142|NCT00282347|1785172|FG000|Safety Follow-up Period|Withdrawal by Subject|2
830143|NCT00282347|1785173|FG001|Safety Follow-up Period|Withdrawal by Subject|1
830144|NCT00282347|1785172|FG000|Safety Follow-up Period|Physician Decision|1
830145|NCT00282347|1785173|FG001|Safety Follow-up Period|Physician Decision|1
830146|NCT00282347|1785172|FG000|Safety Follow-up Period|Protocol Deviation|0
830147|NCT00282347|1785173|FG001|Safety Follow-up Period|Protocol Deviation|2
830148|NCT00282347|1785172|FG000|B Cell Follow-up Period|Withdrawal by Subject|2
830149|NCT00282347|1785173|FG001|B Cell Follow-up Period|Withdrawal by Subject|0
830150|NCT00282347|1785172|FG000|B Cell Follow-up Period|Physician Decision|1
830151|NCT00282347|1785173|FG001|B Cell Follow-up Period|Physician Decision|0
830152|NCT00282347|1785172|FG000|B Cell Follow-up Period|Reason Not Specified|2
830153|NCT00282347|1785173|FG001|B Cell Follow-up Period|Reason Not Specified|0
830154|NCT00282412|1785181|FG000|Overall Study|Death|2
830155|NCT00282438|1785187|FG000|Overall Study|Lack of Efficacy|1
830156|NCT00282438|1785188|FG001|Overall Study|Lack of Efficacy|0
830157|NCT00282438|1785187|FG000|Overall Study|Death|0
830158|NCT00282438|1785188|FG001|Overall Study|Death|1
830159|NCT00282464|1785196|FG000|Overall Study|Adverse Event|26
830160|NCT00282464|1785197|FG001|Overall Study|Adverse Event|20
830161|NCT00282464|1785196|FG000|Overall Study|Lack of Efficacy|8
830162|NCT00282464|1785197|FG001|Overall Study|Lack of Efficacy|8
830163|NCT00282464|1785196|FG000|Overall Study|Lost to Follow-up|10
830164|NCT00282464|1785197|FG001|Overall Study|Lost to Follow-up|10
830165|NCT00282464|1785196|FG000|Overall Study|Withdrawal by Subject|24
830166|NCT00282464|1785197|FG001|Overall Study|Withdrawal by Subject|10
830167|NCT00282464|1785196|FG000|Overall Study|laboratory abnormality|1
830168|NCT00282464|1785197|FG001|Overall Study|laboratory abnormality|2
830169|NCT00282464|1785196|FG000|Overall Study|Protocol Violation|0
830170|NCT00282464|1785197|FG001|Overall Study|Protocol Violation|7
830171|NCT00282464|1785196|FG000|Overall Study|Patient moved|1
830172|NCT00282464|1785197|FG001|Overall Study|Patient moved|0
830173|NCT00282464|1785196|FG000|Overall Study|patient non-compliant|3
830174|NCT00282464|1785197|FG001|Overall Study|patient non-compliant|0
830175|NCT00282464|1785196|FG000|Overall Study|patient no show|0
830176|NCT00282464|1785197|FG001|Overall Study|patient no show|1
830177|NCT00282464|1785196|FG000|Overall Study|patient incarcerated|0
830178|NCT00282464|1785197|FG001|Overall Study|patient incarcerated|1
830179|NCT00282464|1785196|FG000|Overall Study|family crisis|0
830180|NCT00282464|1785197|FG001|Overall Study|family crisis|1
830181|NCT00282464|1785196|FG000|Overall Study|dispensed wrong kit|0
830182|NCT00282464|1785197|FG001|Overall Study|dispensed wrong kit|1
830183|NCT00282464|1785196|FG000|Overall Study|dropped due to missed visits|0
830184|NCT00282464|1785197|FG001|Overall Study|dropped due to missed visits|1
830185|NCT00282568|1785203|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
830186|NCT00282568|1785203|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1
830187|NCT00282568|1785203|FG000|Extended Treatment Period|Adverse Event|17
830188|NCT00282568|1785203|FG000|Extended Treatment Period|Non-compliance|4
830189|NCT00282568|1785203|FG000|Extended Treatment Period|Physician Decision|1
830190|NCT00282568|1785203|FG000|Extended Treatment Period|Lost to Follow-up|2
830191|NCT00282867|1785281|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
830192|NCT00282867|1785282|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
830193|NCT00282867|1785283|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
830194|NCT00282919|1785288|FG000|Overall Study|Lack of Efficacy|4
830195|NCT00282919|1785288|FG000|Overall Study|Withdrawal by Subject|1
830196|NCT00282919|1785288|FG000|Overall Study|Asymptomatic Parasitemia|2
830197|NCT00282984|1785303|FG000|Overall Study|Death|2
830198|NCT00282984|1785304|FG001|Overall Study|Death|5
830199|NCT00282984|1785303|FG000|Overall Study|Adverse Event|8
830200|NCT00282984|1785304|FG001|Overall Study|Adverse Event|5
830201|NCT00282984|1785303|FG000|Overall Study|Lack of Efficacy|0
830202|NCT00282984|1785304|FG001|Overall Study|Lack of Efficacy|2
830203|NCT00282984|1785303|FG000|Overall Study|Lost to Follow-up|14
830204|NCT00282984|1785304|FG001|Overall Study|Lost to Follow-up|10
830205|NCT00282984|1785303|FG000|Overall Study|Withdrawal by Participant|22
830206|NCT00282984|1785304|FG001|Overall Study|Withdrawal by Participant|34
830207|NCT00282984|1785303|FG000|Overall Study|Participant stopped study medication|2
830208|NCT00282984|1785304|FG001|Overall Study|Participant stopped study medication|2
830209|NCT00282984|1785303|FG000|Overall Study|Participant only allowed phone follow-up|0
830210|NCT00282984|1785304|FG001|Overall Study|Participant only allowed phone follow-up|1
830211|NCT00282984|1785303|FG000|Overall Study|Participant used antipsychosis meds|0
830212|NCT00282984|1785304|FG001|Overall Study|Participant used antipsychosis meds|1
830213|NCT00282984|1785303|FG000|Overall Study|lack of motivation|1
830214|NCT00282984|1785304|FG001|Overall Study|lack of motivation|0
830215|NCT00282984|1785303|FG000|Overall Study|in prison|0
830216|NCT00282984|1785304|FG001|Overall Study|in prison|1
830217|NCT00282984|1785303|FG000|Overall Study|Protocol Violation|2
830218|NCT00282984|1785304|FG001|Overall Study|Protocol Violation|0
830219|NCT00283049|1785313|FG000|Overall Study|Adverse Event|6
830220|NCT00283049|1785314|FG001|Overall Study|Adverse Event|1
830221|NCT00283049|1785315|FG002|Overall Study|Adverse Event|4
830222|NCT00283049|1785313|FG000|Overall Study|Protocol Violation|3
830223|NCT00283049|1785314|FG001|Overall Study|Protocol Violation|0
830224|NCT00283049|1785315|FG002|Overall Study|Protocol Violation|3
830225|NCT00283049|1785313|FG000|Overall Study|Death|1
830226|NCT00283049|1785314|FG001|Overall Study|Death|1
830227|NCT00283049|1785315|FG002|Overall Study|Death|1
830228|NCT00283049|1785313|FG000|Overall Study|Lack of Efficacy|0
830229|NCT00283049|1785314|FG001|Overall Study|Lack of Efficacy|1
830230|NCT00283049|1785315|FG002|Overall Study|Lack of Efficacy|1
830231|NCT00283049|1785313|FG000|Overall Study|Lost to Follow-up|4
830232|NCT00283049|1785314|FG001|Overall Study|Lost to Follow-up|2
830233|NCT00283049|1785315|FG002|Overall Study|Lost to Follow-up|5
830234|NCT00283049|1785313|FG000|Overall Study|Withdrawal by Subject|26
830235|NCT00283049|1785314|FG001|Overall Study|Withdrawal by Subject|24
830236|NCT00283049|1785315|FG002|Overall Study|Withdrawal by Subject|19
830237|NCT00283049|1785313|FG000|Overall Study|Discontinuation of Study|18
830238|NCT00283049|1785314|FG001|Overall Study|Discontinuation of Study|16
830239|NCT00283049|1785315|FG002|Overall Study|Discontinuation of Study|20
830240|NCT00283049|1785313|FG000|Overall Study|No longer requires study treatment|0
830241|NCT00283049|1785314|FG001|Overall Study|No longer requires study treatment|0
830242|NCT00283049|1785315|FG002|Overall Study|No longer requires study treatment|1
830243|NCT00283062|1785327|FG000|Overall Study|Did not receive any study medication|5
830244|NCT00283062|1785328|FG001|Overall Study|Did not receive any study medication|4
830245|NCT00283062|1785329|FG002|Overall Study|Did not receive any study medication|36
830246|NCT00283062|1785330|FG003|Overall Study|Did not receive any study medication|45
830247|NCT00283062|1785327|FG000|Overall Study|Adverse Event|2
830248|NCT00283062|1785328|FG001|Overall Study|Adverse Event|0
830249|NCT00283062|1785329|FG002|Overall Study|Adverse Event|1
830250|NCT00283062|1785330|FG003|Overall Study|Adverse Event|0
830251|NCT00283062|1785327|FG000|Overall Study|Lost to Follow-up|1
830252|NCT00283062|1785328|FG001|Overall Study|Lost to Follow-up|0
830253|NCT00283062|1785329|FG002|Overall Study|Lost to Follow-up|1
830254|NCT00283062|1785330|FG003|Overall Study|Lost to Follow-up|0
830255|NCT00283062|1785327|FG000|Overall Study|Progressive disease|0
830256|NCT00283062|1785328|FG001|Overall Study|Progressive disease|0
830257|NCT00283062|1785329|FG002|Overall Study|Progressive disease|1
830258|NCT00283062|1785330|FG003|Overall Study|Progressive disease|0
830259|NCT00283062|1785327|FG000|Overall Study|Participant did not wish to continue|3
830260|NCT00283062|1785328|FG001|Overall Study|Participant did not wish to continue|2
830261|NCT00283062|1785329|FG002|Overall Study|Participant did not wish to continue|1
830262|NCT00283062|1785330|FG003|Overall Study|Participant did not wish to continue|0
830263|NCT00283062|1785327|FG000|Overall Study|Undefined|0
830264|NCT00283062|1785328|FG001|Overall Study|Undefined|1
830265|NCT00283062|1785329|FG002|Overall Study|Undefined|1
830266|NCT00283062|1785330|FG003|Overall Study|Undefined|4
830267|NCT00283062|1785327|FG000|Overall Study|chemotherapy not completed (cycle 6)|1
830268|NCT00283062|1785328|FG001|Overall Study|chemotherapy not completed (cycle 6)|0
830269|NCT00283062|1785329|FG002|Overall Study|chemotherapy not completed (cycle 6)|0
830270|NCT00283062|1785330|FG003|Overall Study|chemotherapy not completed (cycle 6)|0
830271|NCT00283244|1785355|FG000|Overall Study|Adverse Event|0
830272|NCT00283244|1785356|FG001|Overall Study|Adverse Event|8
830273|NCT00283244|1785357|FG002|Overall Study|Adverse Event|11
830274|NCT00283244|1785355|FG000|Overall Study|Death|4
830275|NCT00283244|1785356|FG001|Overall Study|Death|3
830276|NCT00283244|1785357|FG002|Overall Study|Death|2
830277|NCT00283244|1785355|FG000|Overall Study|Lack of Efficacy|8
830278|NCT00283244|1785356|FG001|Overall Study|Lack of Efficacy|32
830279|NCT00283244|1785357|FG002|Overall Study|Lack of Efficacy|26
830280|NCT00283244|1785355|FG000|Overall Study|Withdrawal by Subject|1
830281|NCT00283244|1785356|FG001|Overall Study|Withdrawal by Subject|2
830282|NCT00283244|1785357|FG002|Overall Study|Withdrawal by Subject|2
830283|NCT00283244|1785355|FG000|Overall Study|Physician Decision|0
830284|NCT00283244|1785356|FG001|Overall Study|Physician Decision|0
830285|NCT00283244|1785357|FG002|Overall Study|Physician Decision|1
830286|NCT00283244|1785355|FG000|Overall Study|Medical illness (other complicating dz)|4
830287|NCT00283244|1785356|FG001|Overall Study|Medical illness (other complicating dz)|3
830288|NCT00283244|1785357|FG002|Overall Study|Medical illness (other complicating dz)|6
830289|NCT00283244|1785355|FG000|Overall Study|Clinical deterioration|1
830290|NCT00283244|1785356|FG001|Overall Study|Clinical deterioration|3
830291|NCT00283244|1785357|FG002|Overall Study|Clinical deterioration|3
830292|NCT00283296|1785388|FG000|Overall Study|in-home trial not completed|5
830293|NCT00283387|1785393|FG000|First Intervention|Subject non-compliant|1
830294|NCT00283387|1785394|FG001|First Intervention|Subject non-compliant|1
830295|NCT00283387|1785393|FG000|First Intervention|Withdrawal by Subject|0
830296|NCT00283387|1785394|FG001|First Intervention|Withdrawal by Subject|1
830297|NCT00283400|1785404|FG000|Overall Study|Withdrawal by Subject|1
830298|NCT00283400|1785405|FG001|Overall Study|Withdrawal by Subject|1
830299|NCT00283400|1785406|FG002|Overall Study|Withdrawal by Subject|0
830300|NCT00283400|1785407|FG003|Overall Study|Withdrawal by Subject|0
830301|NCT00283400|1785404|FG000|Overall Study|Death|1
830302|NCT00283400|1785405|FG001|Overall Study|Death|0
830303|NCT00283400|1785406|FG002|Overall Study|Death|1
830304|NCT00283400|1785407|FG003|Overall Study|Death|0
830305|NCT00283439|1785421|FG000|Overall Study|Adverse Event|0
830306|NCT00283439|1785422|FG001|Overall Study|Adverse Event|0
830307|NCT00283439|1785423|FG002|Overall Study|Adverse Event|0
830308|NCT00283439|1785424|FG003|Overall Study|Adverse Event|1
830309|NCT00283439|1785421|FG000|Overall Study|Death|0
830310|NCT00283439|1785422|FG001|Overall Study|Death|0
830311|NCT00283439|1785423|FG002|Overall Study|Death|1
830312|NCT00283439|1785424|FG003|Overall Study|Death|0
830313|NCT00283439|1785421|FG000|Overall Study|Disease progression|0
830314|NCT00283439|1785422|FG001|Overall Study|Disease progression|1
830315|NCT00283439|1785423|FG002|Overall Study|Disease progression|0
830316|NCT00283439|1785424|FG003|Overall Study|Disease progression|0
830317|NCT00283439|1785421|FG000|Overall Study|Requirement for alternative therapy|1
830318|NCT00283439|1785422|FG001|Overall Study|Requirement for alternative therapy|2
830319|NCT00283439|1785423|FG002|Overall Study|Requirement for alternative therapy|5
830320|NCT00283439|1785424|FG003|Overall Study|Requirement for alternative therapy|2
830321|NCT00283439|1785421|FG000|Overall Study|Stem cell transplant|6
830322|NCT00283439|1785422|FG001|Overall Study|Stem cell transplant|6
830323|NCT00283439|1785423|FG002|Overall Study|Stem cell transplant|4
830324|NCT00283439|1785424|FG003|Overall Study|Stem cell transplant|3
830325|NCT00283439|1785421|FG000|Overall Study|Treatment discontinued|0
830326|NCT00283439|1785422|FG001|Overall Study|Treatment discontinued|2
830327|NCT00283439|1785423|FG002|Overall Study|Treatment discontinued|1
830328|NCT00283439|1785424|FG003|Overall Study|Treatment discontinued|3
830329|NCT00283439|1785421|FG000|Overall Study|Other|1
830330|NCT00283439|1785422|FG001|Overall Study|Other|0
830331|NCT00283439|1785423|FG002|Overall Study|Other|0
830332|NCT00283439|1785424|FG003|Overall Study|Other|0
830333|NCT00283595|1785447|FG000|Overall Study|Withdrawal by Subject|1
830334|NCT00283595|1785448|FG001|Overall Study|Withdrawal by Subject|2
830335|NCT00283686|1785458|FG000|Overall Study|Death|1
830336|NCT00283686|1785459|FG001|Overall Study|Death|1
830337|NCT00283686|1785460|FG002|Overall Study|Death|1
830338|NCT00283686|1785461|FG003|Overall Study|Death|0
830339|NCT00283686|1785458|FG000|Overall Study|Lost to Follow-up|21
830340|NCT00283686|1785459|FG001|Overall Study|Lost to Follow-up|31
830341|NCT00283686|1785460|FG002|Overall Study|Lost to Follow-up|26
830342|NCT00283686|1785461|FG003|Overall Study|Lost to Follow-up|20
830343|NCT00283686|1785458|FG000|Overall Study|Less than full participation|7
830344|NCT00283686|1785459|FG001|Overall Study|Less than full participation|9
830345|NCT00283686|1785460|FG002|Overall Study|Less than full participation|6
830346|NCT00283686|1785461|FG003|Overall Study|Less than full participation|12
830347|NCT00283712|1785473|FG000|Overall Study|Death|0
830348|NCT00283712|1785474|FG001|Overall Study|Death|1
830349|NCT00283803|1785480|FG000|Overall Study|Physician Decision|9
830350|NCT00283803|1785480|FG000|Overall Study|Withdrawal by Subject|4
830351|NCT00283842|1785500|FG000|Overall Study|Adverse Event|8
830352|NCT00283842|1785501|FG001|Overall Study|Adverse Event|7
830353|NCT00283842|1785502|FG002|Overall Study|Adverse Event|21
830354|NCT00283842|1785503|FG003|Overall Study|Adverse Event|21
830355|NCT00283842|1785504|FG004|Overall Study|Adverse Event|5
830356|NCT00283842|1785500|FG000|Overall Study|Protocol Violation|1
830357|NCT00283842|1785501|FG001|Overall Study|Protocol Violation|5
830358|NCT00283842|1785502|FG002|Overall Study|Protocol Violation|4
830359|NCT00283842|1785503|FG003|Overall Study|Protocol Violation|0
830360|NCT00283842|1785504|FG004|Overall Study|Protocol Violation|0
830361|NCT00283842|1785500|FG000|Overall Study|Protocol deviation|0
830362|NCT00283842|1785501|FG001|Overall Study|Protocol deviation|0
830363|NCT00283842|1785502|FG002|Overall Study|Protocol deviation|0
830364|NCT00283842|1785503|FG003|Overall Study|Protocol deviation|0
830365|NCT00283842|1785504|FG004|Overall Study|Protocol deviation|2
830366|NCT00283842|1785500|FG000|Overall Study|Withdrawal by Subject|2
830367|NCT00283842|1785501|FG001|Overall Study|Withdrawal by Subject|1
830368|NCT00283842|1785502|FG002|Overall Study|Withdrawal by Subject|1
830369|NCT00283842|1785503|FG003|Overall Study|Withdrawal by Subject|5
830370|NCT00283842|1785504|FG004|Overall Study|Withdrawal by Subject|4
830371|NCT00283842|1785500|FG000|Overall Study|Lack of Efficacy|1
830372|NCT00283842|1785501|FG001|Overall Study|Lack of Efficacy|3
830373|NCT00283842|1785502|FG002|Overall Study|Lack of Efficacy|1
830374|NCT00283842|1785503|FG003|Overall Study|Lack of Efficacy|0
830375|NCT00283842|1785504|FG004|Overall Study|Lack of Efficacy|3
830376|NCT00283842|1785500|FG000|Overall Study|Lost to Follow-up|0
830377|NCT00283842|1785501|FG001|Overall Study|Lost to Follow-up|2
830378|NCT00283842|1785502|FG002|Overall Study|Lost to Follow-up|4
830379|NCT00283842|1785503|FG003|Overall Study|Lost to Follow-up|1
830380|NCT00283842|1785504|FG004|Overall Study|Lost to Follow-up|1
830381|NCT00283868|1785518|FG000|Overall Study|Lost to Follow-up|7
830382|NCT00283868|1785519|FG001|Overall Study|Lost to Follow-up|8
830383|NCT00284050|1785534|FG000|Overall Study|Adverse Event|1
830384|NCT00284050|1785535|FG001|Overall Study|Adverse Event|1
830385|NCT00284050|1785536|FG002|Overall Study|Adverse Event|1
830386|NCT00284050|1785534|FG000|Overall Study|Lack of Efficacy|0
830387|NCT00284050|1785535|FG001|Overall Study|Lack of Efficacy|1
830388|NCT00284050|1785536|FG002|Overall Study|Lack of Efficacy|3
830389|NCT00284050|1785534|FG000|Overall Study|Protocol Violation|0
830390|NCT00284050|1785535|FG001|Overall Study|Protocol Violation|1
830391|NCT00284050|1785536|FG002|Overall Study|Protocol Violation|2
830392|NCT00284050|1785534|FG000|Overall Study|Withdrawal by Subject|2
830393|NCT00284050|1785535|FG001|Overall Study|Withdrawal by Subject|2
830394|NCT00284050|1785536|FG002|Overall Study|Withdrawal by Subject|2
830395|NCT00284050|1785534|FG000|Overall Study|Lost to Follow-up|1
830396|NCT00284050|1785535|FG001|Overall Study|Lost to Follow-up|0
830397|NCT00284050|1785536|FG002|Overall Study|Lost to Follow-up|1
830398|NCT00284050|1785534|FG000|Overall Study|Death|1
830399|NCT00284050|1785535|FG001|Overall Study|Death|0
830400|NCT00284050|1785536|FG002|Overall Study|Death|0
830401|NCT00284089|1785548|FG000|Multiple Dose Phase|Adverse Event|1
830402|NCT00284089|1785549|FG001|Multiple Dose Phase|Adverse Event|0
830403|NCT00284089|1785550|FG002|Multiple Dose Phase|Adverse Event|1
830404|NCT00284089|1785551|FG003|Multiple Dose Phase|Adverse Event|1
830405|NCT00284089|1785548|FG000|Multiple Dose Phase|Protocol Violation|0
830406|NCT00284089|1785549|FG001|Multiple Dose Phase|Protocol Violation|0
830407|NCT00284089|1785550|FG002|Multiple Dose Phase|Protocol Violation|1
830408|NCT00284089|1785551|FG003|Multiple Dose Phase|Protocol Violation|0
830409|NCT00284089|1785548|FG000|Multiple Dose Phase|Withdrawal by Subject|0
830410|NCT00284089|1785549|FG001|Multiple Dose Phase|Withdrawal by Subject|0
830411|NCT00284089|1785550|FG002|Multiple Dose Phase|Withdrawal by Subject|1
830412|NCT00284089|1785551|FG003|Multiple Dose Phase|Withdrawal by Subject|2
830413|NCT00284089|1785548|FG000|Multiple Dose Phase|Death|0
830414|NCT00284089|1785549|FG001|Multiple Dose Phase|Death|0
830415|NCT00284089|1785550|FG002|Multiple Dose Phase|Death|1
830416|NCT00284089|1785551|FG003|Multiple Dose Phase|Death|1
830417|NCT00284089|1785548|FG000|Extension Phase|Adverse Event|0
830418|NCT00284089|1785549|FG001|Extension Phase|Adverse Event|0
830419|NCT00284089|1785550|FG002|Extension Phase|Adverse Event|2
830420|NCT00284089|1785551|FG003|Extension Phase|Adverse Event|2
830421|NCT00284089|1785548|FG000|Extension Phase|condition no longer requires study drug|2
830422|NCT00284089|1785549|FG001|Extension Phase|condition no longer requires study drug|0
830423|NCT00284089|1785550|FG002|Extension Phase|condition no longer requires study drug|2
830424|NCT00284089|1785551|FG003|Extension Phase|condition no longer requires study drug|7
830425|NCT00284089|1785548|FG000|Extension Phase|Protocol Violation|0
830426|NCT00284089|1785549|FG001|Extension Phase|Protocol Violation|0
830427|NCT00284089|1785550|FG002|Extension Phase|Protocol Violation|1
830428|NCT00284089|1785551|FG003|Extension Phase|Protocol Violation|0
830429|NCT00284089|1785548|FG000|Extension Phase|Withdrawal by Subject|0
830430|NCT00284089|1785549|FG001|Extension Phase|Withdrawal by Subject|0
830431|NCT00284089|1785550|FG002|Extension Phase|Withdrawal by Subject|1
830432|NCT00284089|1785551|FG003|Extension Phase|Withdrawal by Subject|3
830433|NCT00284141|1785561|FG000|Overall Study|Disease Progression / Lack of efficacy|51
830434|NCT00284141|1785561|FG000|Overall Study|Adverse Event|19
830435|NCT00284141|1785561|FG000|Overall Study|Participant's request|9
830436|NCT00284141|1785561|FG000|Overall Study|Symptomatic / Clinical Progression|11
830437|NCT00284141|1785561|FG000|Overall Study|Clinical deterioration / death|2
830438|NCT00284141|1785561|FG000|Overall Study|General decline|1
830439|NCT00284141|1785561|FG000|Overall Study|Pneumonia|1
830440|NCT00284141|1785561|FG000|Overall Study|Did not take study medication|2
830441|NCT00284141|1785561|FG000|Overall Study|Ongoing treatment|2
830442|NCT00284856|1785618|FG000|Overall Study|Adverse Event|3
830443|NCT00284856|1785619|FG001|Overall Study|Adverse Event|3
830444|NCT00284856|1785620|FG002|Overall Study|Adverse Event|3
830445|NCT00284856|1785618|FG000|Overall Study|Lack of Efficacy|2
830446|NCT00284856|1785619|FG001|Overall Study|Lack of Efficacy|1
830447|NCT00284856|1785620|FG002|Overall Study|Lack of Efficacy|8
830448|NCT00284856|1785618|FG000|Overall Study|Lost to Follow-up|25
830449|NCT00284856|1785619|FG001|Overall Study|Lost to Follow-up|21
830450|NCT00284856|1785620|FG002|Overall Study|Lost to Follow-up|22
830451|NCT00284856|1785618|FG000|Overall Study|Protocol Violation|5
830452|NCT00284856|1785619|FG001|Overall Study|Protocol Violation|4
830453|NCT00284856|1785620|FG002|Overall Study|Protocol Violation|5
830454|NCT00284856|1785618|FG000|Overall Study|Withdrawal by Subject|12
830455|NCT00284856|1785619|FG001|Overall Study|Withdrawal by Subject|16
830456|NCT00284856|1785620|FG002|Overall Study|Withdrawal by Subject|18
830457|NCT00284856|1785618|FG000|Overall Study|Other|4
830458|NCT00284856|1785619|FG001|Overall Study|Other|5
830459|NCT00284856|1785620|FG002|Overall Study|Other|4
830460|NCT00284934|1785630|FG000|Overall Study|Adverse Event|1
830461|NCT00284934|1785631|FG001|Overall Study|Adverse Event|2
830462|NCT00284934|1785630|FG000|Overall Study|Other reasons|3
830463|NCT00284934|1785631|FG001|Overall Study|Other reasons|1
830464|NCT00285012|1785639|FG000|Assigned to Study Treatment (Tx)|Other|2
830465|NCT00285012|1785640|FG001|Assigned to Study Treatment (Tx)|Other|3
830466|NCT00285012|1785639|FG000|Received Study Tx|Death|2
830467|NCT00285012|1785640|FG001|Received Study Tx|Death|1
830468|NCT00285012|1785639|FG000|Received Study Tx|Adverse Event|5
830469|NCT00285012|1785640|FG001|Received Study Tx|Adverse Event|11
830470|NCT00285012|1785639|FG000|Received Study Tx|Lack of Efficacy|0
830471|NCT00285012|1785640|FG001|Received Study Tx|Lack of Efficacy|3
830472|NCT00285012|1785639|FG000|Received Study Tx|Lost to Follow-up|29
830473|NCT00285012|1785640|FG001|Received Study Tx|Lost to Follow-up|31
830474|NCT00285012|1785639|FG000|Received Study Tx|Withdrawal by Subject|31
830475|NCT00285012|1785640|FG001|Received Study Tx|Withdrawal by Subject|43
830476|NCT00285012|1785639|FG000|Received Study Tx|Other|5
830477|NCT00285012|1785640|FG001|Received Study Tx|Other|5
830478|NCT00285207|1785648|FG000|Overall Study|Lost to Follow-up|3
830479|NCT00285207|1785649|FG001|Overall Study|Lost to Follow-up|2
830480|NCT00285207|1785648|FG000|Overall Study|Withdrawal by Subject|5
830481|NCT00285207|1785649|FG001|Overall Study|Withdrawal by Subject|2
830482|NCT00285207|1785648|FG000|Overall Study|Pregnancy|1
830483|NCT00285207|1785649|FG001|Overall Study|Pregnancy|1
830484|NCT00285207|1785648|FG000|Overall Study|non-compliance|0
830485|NCT00285207|1785649|FG001|Overall Study|non-compliance|1
830486|NCT00285584|1785670|FG000|Month 3|Lost to Follow-up|3
830487|NCT00285584|1785671|FG001|Month 3|Lost to Follow-up|3
830488|NCT00285584|1785670|FG000|Month 3|Withdrawal by Subject|1
830489|NCT00285584|1785671|FG001|Month 3|Withdrawal by Subject|0
830490|NCT00285584|1785670|FG000|Month 6|Lost to Follow-up|0
830491|NCT00285584|1785671|FG001|Month 6|Lost to Follow-up|1
830492|NCT00285649|1785684|FG000|Overall Study|Lost to Follow-up|6
830493|NCT00285649|1785685|FG001|Overall Study|Lost to Follow-up|4
830494|NCT00285649|1785686|FG002|Overall Study|Lost to Follow-up|4
830495|NCT00285649|1785684|FG000|Overall Study|Withdrawal by Subject|3
830496|NCT00285649|1785685|FG001|Overall Study|Withdrawal by Subject|2
830497|NCT00285649|1785686|FG002|Overall Study|Withdrawal by Subject|2
830498|NCT00285818|1785705|FG000|Overall Study|Withdrawal by Subject|3
830499|NCT00285818|1785706|FG001|Overall Study|Withdrawal by Subject|2
830500|NCT00285818|1785705|FG000|Overall Study|Lost to Follow-up|1
830501|NCT00285818|1785706|FG001|Overall Study|Lost to Follow-up|0
830502|NCT00285857|1785712|FG000|Overall Study|Withdrawal by Subject|2
830503|NCT00285857|1785712|FG000|Overall Study|Inadequate initial breast cytology|1
830504|NCT00285857|1785712|FG000|Overall Study|Adverse Event|1
830505|NCT00286091|1785732|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103
830506|NCT00286091|1785733|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113
830507|NCT00286091|1785732|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307
830508|NCT00286091|1785733|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269
830509|NCT00286091|1785732|FG000|Double-blind Treatment Phase|Death|58
830510|NCT00286091|1785733|FG001|Double-blind Treatment Phase|Death|65
830511|NCT00286091|1785732|FG000|Double-blind Treatment Phase|Adverse Event|28
830512|NCT00286091|1785733|FG001|Double-blind Treatment Phase|Adverse Event|40
830513|NCT00286091|1785732|FG000|Double-blind Treatment Phase|Disease Progression|22
830514|NCT00286091|1785733|FG001|Double-blind Treatment Phase|Disease Progression|35
830515|NCT00286091|1785732|FG000|Double-blind Treatment Phase|Other|25
830516|NCT00286091|1785733|FG001|Double-blind Treatment Phase|Other|33
830517|NCT00286091|1785732|FG000|Double-blind Treatment Phase|Administrative Decision|20
830518|NCT00286091|1785733|FG001|Double-blind Treatment Phase|Administrative Decision|21
830519|NCT00286091|1785732|FG000|Double-blind Treatment Phase|Noncompliance|8
830520|NCT00286091|1785733|FG001|Double-blind Treatment Phase|Noncompliance|8
830521|NCT00286091|1785732|FG000|Double-blind Treatment Phase|Lost to Follow-up|11
830522|NCT00286091|1785733|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
830523|NCT00286091|1785732|FG000|Double-blind Treatment Phase|Protocol Deviation|1
830524|NCT00286091|1785733|FG001|Double-blind Treatment Phase|Protocol Deviation|3
830525|NCT00286091|1785732|FG000|Double-blind Treatment Phase|Ineligibility Determined|1
830526|NCT00286091|1785733|FG001|Double-blind Treatment Phase|Ineligibility Determined|2
830527|NCT00286091|1785732|FG000|Open-label Treatment Phase|Physician Decision|24
830528|NCT00286091|1785733|FG001|Open-label Treatment Phase|Physician Decision|21
830529|NCT00286091|1785732|FG000|Open-label Treatment Phase|Adverse Event|5
830530|NCT00286091|1785733|FG001|Open-label Treatment Phase|Adverse Event|16
830531|NCT00286091|1785732|FG000|Open-label Treatment Phase|Other|11
830532|NCT00286091|1785733|FG001|Open-label Treatment Phase|Other|11
830533|NCT00286091|1785732|FG000|Open-label Treatment Phase|Withdrawal by Subject|14
830534|NCT00286091|1785733|FG001|Open-label Treatment Phase|Withdrawal by Subject|10
830535|NCT00286091|1785732|FG000|Open-label Treatment Phase|Death|10
830536|NCT00286091|1785733|FG001|Open-label Treatment Phase|Death|7
830537|NCT00286091|1785732|FG000|Open-label Treatment Phase|Disease Progression|9
830538|NCT00286091|1785733|FG001|Open-label Treatment Phase|Disease Progression|3
830539|NCT00286091|1785732|FG000|Open-label Treatment Phase|Noncompliance|3
830540|NCT00286091|1785733|FG001|Open-label Treatment Phase|Noncompliance|1
830541|NCT00286091|1785732|FG000|Open-label Treatment Phase|Lost to Follow-up|0
830542|NCT00286091|1785733|FG001|Open-label Treatment Phase|Lost to Follow-up|1
830543|NCT00286091|1785732|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1
830544|NCT00286091|1785733|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0
830545|NCT00286091|1785732|FG000|Open-label Treatment Phase|Missing End of Study Information|0
830546|NCT00286091|1785733|FG001|Open-label Treatment Phase|Missing End of Study Information|1
830547|NCT00286156|1785744|FG000|Overall Study|Missed 12 month visit|0
830548|NCT00286156|1785745|FG001|Overall Study|Missed 12 month visit|0
830549|NCT00286156|1785746|FG002|Overall Study|Missed 12 month visit|1
830550|NCT00286156|1785744|FG000|Overall Study|AE: pulmonary embolus|0
830551|NCT00286156|1785745|FG001|Overall Study|AE: pulmonary embolus|1
830552|NCT00286156|1785746|FG002|Overall Study|AE: pulmonary embolus|0
830553|NCT00286156|1785744|FG000|Overall Study|AE: nephrotic-range proteinuruia|1
830554|NCT00286156|1785745|FG001|Overall Study|AE: nephrotic-range proteinuruia|0
830555|NCT00286156|1785746|FG002|Overall Study|AE: nephrotic-range proteinuruia|0
830556|NCT00286156|1785744|FG000|Overall Study|AE: pneumonia|1
830557|NCT00286156|1785745|FG001|Overall Study|AE: pneumonia|0
830558|NCT00286156|1785746|FG002|Overall Study|AE: pneumonia|0
830559|NCT00286221|1785767|FG000|Overall Study|Protocol Violation|2
830560|NCT00286221|1785768|FG001|Overall Study|Protocol Violation|1
830561|NCT00286221|1785769|FG002|Overall Study|Protocol Violation|6
830562|NCT00286221|1785770|FG003|Overall Study|Protocol Violation|4
830563|NCT00286221|1785767|FG000|Overall Study|Unanticipated Neurosurgical Complication|6
830564|NCT00286221|1785768|FG001|Overall Study|Unanticipated Neurosurgical Complication|3
830565|NCT00286221|1785769|FG002|Overall Study|Unanticipated Neurosurgical Complication|3
830566|NCT00286221|1785770|FG003|Overall Study|Unanticipated Neurosurgical Complication|2
830567|NCT00286221|1785767|FG000|Overall Study|Inability to trigger PCA|2
830568|NCT00286221|1785768|FG001|Overall Study|Inability to trigger PCA|0
830569|NCT00286221|1785769|FG002|Overall Study|Inability to trigger PCA|0
830570|NCT00286221|1785770|FG003|Overall Study|Inability to trigger PCA|0
830571|NCT00286221|1785767|FG000|Overall Study|Unrecognized exclusion criteria met|0
830572|NCT00286221|1785768|FG001|Overall Study|Unrecognized exclusion criteria met|1
830573|NCT00286221|1785769|FG002|Overall Study|Unrecognized exclusion criteria met|0
830574|NCT00286221|1785770|FG003|Overall Study|Unrecognized exclusion criteria met|0
830575|NCT00286234|1785784|FG000|Overall Study|Protocol Violation|1
830576|NCT00286234|1785785|FG001|Overall Study|Protocol Violation|2
830577|NCT00286234|1785786|FG002|Overall Study|Protocol Violation|0
830578|NCT00286234|1785787|FG003|Overall Study|Protocol Violation|1
830579|NCT00286234|1785784|FG000|Overall Study|Physician Decision|1
830580|NCT00286234|1785785|FG001|Overall Study|Physician Decision|0
830581|NCT00286234|1785786|FG002|Overall Study|Physician Decision|0
830582|NCT00286234|1785787|FG003|Overall Study|Physician Decision|1
830583|NCT00286234|1785784|FG000|Overall Study|Adverse Event|0
830584|NCT00286234|1785785|FG001|Overall Study|Adverse Event|0
830585|NCT00286234|1785786|FG002|Overall Study|Adverse Event|0
830586|NCT00286234|1785787|FG003|Overall Study|Adverse Event|1
830587|NCT00286234|1785784|FG000|Overall Study|Adverse Event|0
830588|NCT00286234|1785785|FG001|Overall Study|Adverse Event|0
830589|NCT00286234|1785786|FG002|Overall Study|Adverse Event|0
830590|NCT00286234|1785787|FG003|Overall Study|Adverse Event|1
830591|NCT00286429|1785804|FG000|Overall Study|Adverse Event|4
830592|NCT00286429|1785805|FG001|Overall Study|Adverse Event|1
830593|NCT00286429|1785806|FG002|Overall Study|Adverse Event|6
830594|NCT00286429|1785804|FG000|Overall Study|Lack of Efficacy|52
830595|NCT00286429|1785805|FG001|Overall Study|Lack of Efficacy|27
830596|NCT00286429|1785806|FG002|Overall Study|Lack of Efficacy|25
830597|NCT00286429|1785804|FG000|Overall Study|Lost to Follow-up|2
830598|NCT00286429|1785805|FG001|Overall Study|Lost to Follow-up|4
830599|NCT00286429|1785806|FG002|Overall Study|Lost to Follow-up|3
830600|NCT00286429|1785804|FG000|Overall Study|Physician Decision|10
830601|NCT00286429|1785805|FG001|Overall Study|Physician Decision|7
830602|NCT00286429|1785806|FG002|Overall Study|Physician Decision|7
830603|NCT00286429|1785804|FG000|Overall Study|Protocol Violation|3
830604|NCT00286429|1785805|FG001|Overall Study|Protocol Violation|5
830605|NCT00286429|1785806|FG002|Overall Study|Protocol Violation|4
830606|NCT00286429|1785804|FG000|Overall Study|Withdrawal by Subject|3
830607|NCT00286429|1785805|FG001|Overall Study|Withdrawal by Subject|2
830608|NCT00286429|1785806|FG002|Overall Study|Withdrawal by Subject|6
830609|NCT00286429|1785804|FG000|Overall Study|Administrative Error|1
830610|NCT00286429|1785805|FG001|Overall Study|Administrative Error|1
830611|NCT00286429|1785806|FG002|Overall Study|Administrative Error|1
830612|NCT00286429|1785804|FG000|Overall Study|Administrative Decision|0
830613|NCT00286429|1785805|FG001|Overall Study|Administrative Decision|1
830614|NCT00286429|1785806|FG002|Overall Study|Administrative Decision|0
830615|NCT00286442|1785817|FG000|Overall Study|Hyperglycemic Rescue|19
830616|NCT00286442|1785818|FG001|Overall Study|Hyperglycemic Rescue|17
830617|NCT00286442|1785819|FG002|Overall Study|Hyperglycemic Rescue|25
830618|NCT00286442|1785817|FG000|Overall Study|Adverse Event|7
830619|NCT00286442|1785818|FG001|Overall Study|Adverse Event|6
830620|NCT00286442|1785819|FG002|Overall Study|Adverse Event|1
830621|NCT00286442|1785817|FG000|Overall Study|Protocol Violation|2
830622|NCT00286442|1785818|FG001|Overall Study|Protocol Violation|4
830623|NCT00286442|1785819|FG002|Overall Study|Protocol Violation|2
830624|NCT00286442|1785817|FG000|Overall Study|Lost to Follow-up|5
830625|NCT00286442|1785818|FG001|Overall Study|Lost to Follow-up|2
830626|NCT00286442|1785819|FG002|Overall Study|Lost to Follow-up|1
830627|NCT00286442|1785817|FG000|Overall Study|Physician Decision|1
830628|NCT00286442|1785818|FG001|Overall Study|Physician Decision|1
830629|NCT00286442|1785819|FG002|Overall Study|Physician Decision|1
830630|NCT00286442|1785817|FG000|Overall Study|Administrative Error|1
830631|NCT00286442|1785818|FG001|Overall Study|Administrative Error|1
830632|NCT00286442|1785819|FG002|Overall Study|Administrative Error|0
830633|NCT00286442|1785817|FG000|Overall Study|Withdrawal by Subject|2
830634|NCT00286442|1785818|FG001|Overall Study|Withdrawal by Subject|14
830635|NCT00286442|1785819|FG002|Overall Study|Withdrawal by Subject|2
830636|NCT00286455|1785830|FG000|Overall Study|Hyperglycemia rescue|19
830637|NCT00286455|1785831|FG001|Overall Study|Hyperglycemia rescue|13
830638|NCT00286455|1785832|FG002|Overall Study|Hyperglycemia rescue|10
830639|NCT00286455|1785830|FG000|Overall Study|Adverse Event|1
830640|NCT00286455|1785831|FG001|Overall Study|Adverse Event|3
830641|NCT00286455|1785832|FG002|Overall Study|Adverse Event|2
830642|NCT00286455|1785830|FG000|Overall Study|Lost to Follow-up|0
830643|NCT00286455|1785831|FG001|Overall Study|Lost to Follow-up|3
830644|NCT00286455|1785832|FG002|Overall Study|Lost to Follow-up|3
830645|NCT00286455|1785830|FG000|Overall Study|Physician Decision|3
830646|NCT00286455|1785831|FG001|Overall Study|Physician Decision|0
830647|NCT00286455|1785832|FG002|Overall Study|Physician Decision|2
830648|NCT00286455|1785830|FG000|Overall Study|Protocol Violation|1
830649|NCT00286455|1785831|FG001|Overall Study|Protocol Violation|1
830650|NCT00286455|1785832|FG002|Overall Study|Protocol Violation|0
830651|NCT00286455|1785830|FG000|Overall Study|Participant Non-compliance|1
830652|NCT00286455|1785831|FG001|Overall Study|Participant Non-compliance|0
830653|NCT00286455|1785832|FG002|Overall Study|Participant Non-compliance|0
830654|NCT00286455|1785830|FG000|Overall Study|Withdrawal by Subject|0
830655|NCT00286455|1785831|FG001|Overall Study|Withdrawal by Subject|8
830656|NCT00286455|1785832|FG002|Overall Study|Withdrawal by Subject|7
830657|NCT00286468|1785843|FG000|Overall Study|Hyperglycemic Rescue|28
830658|NCT00286468|1785844|FG001|Overall Study|Hyperglycemic Rescue|30
830659|NCT00286468|1785845|FG002|Overall Study|Hyperglycemic Rescue|31
830660|NCT00286468|1785843|FG000|Overall Study|Adverse Event|2
830661|NCT00286468|1785844|FG001|Overall Study|Adverse Event|6
830662|NCT00286468|1785845|FG002|Overall Study|Adverse Event|4
830663|NCT00286468|1785843|FG000|Overall Study|Protocol Violation|0
830664|NCT00286468|1785844|FG001|Overall Study|Protocol Violation|3
830665|NCT00286468|1785845|FG002|Overall Study|Protocol Violation|1
830666|NCT00286468|1785843|FG000|Overall Study|Lost to Follow-up|1
830667|NCT00286468|1785844|FG001|Overall Study|Lost to Follow-up|1
830668|NCT00286468|1785845|FG002|Overall Study|Lost to Follow-up|2
830669|NCT00286468|1785843|FG000|Overall Study|Withdrawal by Subject|3
830670|NCT00286468|1785844|FG001|Overall Study|Withdrawal by Subject|8
830671|NCT00286468|1785845|FG002|Overall Study|Withdrawal by Subject|11
830672|NCT00286468|1785843|FG000|Overall Study|Physician Decision|3
830673|NCT00286468|1785844|FG001|Overall Study|Physician Decision|2
830674|NCT00286468|1785845|FG002|Overall Study|Physician Decision|1
830675|NCT00286494|1785856|FG000|Overall Study|Hyperglycemic rescue|12
830676|NCT00286494|1785857|FG001|Overall Study|Hyperglycemic rescue|19
830677|NCT00286494|1785858|FG002|Overall Study|Hyperglycemic rescue|18
830678|NCT00286494|1785856|FG000|Overall Study|Withdrawal by Subject|2
830679|NCT00286494|1785857|FG001|Overall Study|Withdrawal by Subject|10
830680|NCT00286494|1785858|FG002|Overall Study|Withdrawal by Subject|9
830681|NCT00286494|1785856|FG000|Overall Study|Adverse Event|3
830682|NCT00286494|1785857|FG001|Overall Study|Adverse Event|8
830683|NCT00286494|1785858|FG002|Overall Study|Adverse Event|6
830684|NCT00286494|1785856|FG000|Overall Study|Physician Decision|5
830685|NCT00286494|1785857|FG001|Overall Study|Physician Decision|5
830686|NCT00286494|1785858|FG002|Overall Study|Physician Decision|1
830687|NCT00286494|1785856|FG000|Overall Study|Lost to Follow-up|3
830688|NCT00286494|1785857|FG001|Overall Study|Lost to Follow-up|1
830689|NCT00286494|1785858|FG002|Overall Study|Lost to Follow-up|3
830690|NCT00286494|1785856|FG000|Overall Study|Protocol Violation|1
830691|NCT00286494|1785857|FG001|Overall Study|Protocol Violation|1
830692|NCT00286494|1785858|FG002|Overall Study|Protocol Violation|2
830693|NCT00286754|1785890|FG000|Overall Study|Adverse Event|2
830694|NCT00286754|1785891|FG001|Overall Study|Adverse Event|2
830695|NCT00286754|1785892|FG002|Overall Study|Adverse Event|3
830696|NCT00286754|1785890|FG000|Overall Study|Withdrawal by Subject|6
830697|NCT00286754|1785891|FG001|Overall Study|Withdrawal by Subject|2
830698|NCT00286754|1785892|FG002|Overall Study|Withdrawal by Subject|0
830699|NCT00286754|1785890|FG000|Overall Study|Lost to Follow-up|12
830700|NCT00286754|1785891|FG001|Overall Study|Lost to Follow-up|14
830701|NCT00286754|1785892|FG002|Overall Study|Lost to Follow-up|6
830702|NCT00286754|1785890|FG000|Overall Study|Moved out of state|0
830703|NCT00286754|1785891|FG001|Overall Study|Moved out of state|0
830704|NCT00286754|1785892|FG002|Overall Study|Moved out of state|1
830705|NCT00287079|1785923|FG000|Overall Study|Qualifying relapse|12
830706|NCT00287079|1785924|FG001|Overall Study|Qualifying relapse|1
830707|NCT00287079|1785923|FG000|Overall Study|Non-qualifying relapse|1
830708|NCT00287079|1785924|FG001|Overall Study|Non-qualifying relapse|0
830709|NCT00287079|1785923|FG000|Overall Study|Adverse Event|5
830710|NCT00287079|1785924|FG001|Overall Study|Adverse Event|0
830711|NCT00287079|1785923|FG000|Overall Study|Protocol Violation|1
830712|NCT00287079|1785924|FG001|Overall Study|Protocol Violation|0
830713|NCT00287079|1785923|FG000|Overall Study|Other|3
830714|NCT00287079|1785924|FG001|Overall Study|Other|0
830715|NCT00287118|1785930|FG000|Overall Study|Adverse Event|30
830716|NCT00287118|1785930|FG000|Overall Study|Death|1
830717|NCT00287118|1785930|FG000|Overall Study|Lack of Efficacy|11
830718|NCT00287118|1785930|FG000|Overall Study|Lost to Follow-up|1
830719|NCT00287118|1785930|FG000|Overall Study|Protocol Violation|2
830720|NCT00287118|1785930|FG000|Overall Study|Other|7
830721|NCT00287365|1785951|FG000|Overall Study|sample not acquired|13
830722|NCT00287469|1785958|FG000|Overall Study|serious adverse event|1
830723|NCT00287469|1785959|FG001|Overall Study|serious adverse event|6
830724|NCT00287469|1785958|FG000|Overall Study|Adverse Event|1
830725|NCT00287469|1785959|FG001|Overall Study|Adverse Event|1
830726|NCT00287469|1785958|FG000|Overall Study|moved from area|144
830727|NCT00287469|1785959|FG001|Overall Study|moved from area|138
830728|NCT00287469|1785958|FG000|Overall Study|Lost to Follow-up|74
830729|NCT00287469|1785959|FG001|Overall Study|Lost to Follow-up|69
830730|NCT00287586|1785969|FG000|Overall Study|Withdrew Consent|19
830731|NCT00287586|1785970|FG001|Overall Study|Withdrew Consent|30
830732|NCT00287586|1785969|FG000|Overall Study|Lost to Follow-up|5
830733|NCT00287586|1785970|FG001|Overall Study|Lost to Follow-up|4
830734|NCT00287586|1785969|FG000|Overall Study|Death|2
830735|NCT00287586|1785970|FG001|Overall Study|Death|3
830736|NCT00287586|1785969|FG000|Overall Study|Elevated Hematocrit|3
830737|NCT00287586|1785970|FG001|Overall Study|Elevated Hematocrit|0
830738|NCT00287586|1785969|FG000|Overall Study|Rash|3
830739|NCT00287586|1785970|FG001|Overall Study|Rash|0
830740|NCT00287586|1785969|FG000|Overall Study|Elevated Prostate Specific Antigen|2
830741|NCT00287586|1785970|FG001|Overall Study|Elevated Prostate Specific Antigen|0
830742|NCT00287586|1785969|FG000|Overall Study|Stroke|2
830743|NCT00287586|1785970|FG001|Overall Study|Stroke|0
830744|NCT00287586|1785969|FG000|Overall Study|Myocardial Infarction|1
830745|NCT00287586|1785970|FG001|Overall Study|Myocardial Infarction|0
830746|NCT00287586|1785969|FG000|Overall Study|Lower Urinary Tract Symptoms|1
830747|NCT00287586|1785970|FG001|Overall Study|Lower Urinary Tract Symptoms|0
830748|NCT00287586|1785969|FG000|Overall Study|Cognitive Impairment|1
830749|NCT00287586|1785970|FG001|Overall Study|Cognitive Impairment|0
830750|NCT00287586|1785969|FG000|Overall Study|Pancreatic Cancer|1
830751|NCT00287586|1785970|FG001|Overall Study|Pancreatic Cancer|3
830752|NCT00287586|1785969|FG000|Overall Study|Sleep Apnea|1
830753|NCT00287586|1785970|FG001|Overall Study|Sleep Apnea|0
830754|NCT00287586|1785969|FG000|Overall Study|Shoulder Pain|1
830755|NCT00287586|1785970|FG001|Overall Study|Shoulder Pain|0
830756|NCT00287586|1785969|FG000|Overall Study|Inappropriate Behaviour with Staff|1
830757|NCT00287586|1785970|FG001|Overall Study|Inappropriate Behaviour with Staff|0
830758|NCT00287586|1785969|FG000|Overall Study|Nonadherence|1
830759|NCT00287586|1785970|FG001|Overall Study|Nonadherence|1
830760|NCT00287586|1785969|FG000|Overall Study|Enrolled in Another Study|1
830761|NCT00287586|1785970|FG001|Overall Study|Enrolled in Another Study|0
830762|NCT00287586|1785969|FG000|Overall Study|Major Depression|0
830763|NCT00287586|1785970|FG001|Overall Study|Major Depression|2
830764|NCT00287586|1785969|FG000|Overall Study|Lung Cancer|0
830765|NCT00287586|1785970|FG001|Overall Study|Lung Cancer|2
830766|NCT00287586|1785969|FG000|Overall Study|Elevated IPSS Score|0
830767|NCT00287586|1785970|FG001|Overall Study|Elevated IPSS Score|1
830768|NCT00287586|1785969|FG000|Overall Study|Retroperitoneal Cancer|0
830769|NCT00287586|1785970|FG001|Overall Study|Retroperitoneal Cancer|1
830770|NCT00287586|1785969|FG000|Overall Study|Mastodynia and Gynecomastia|0
830771|NCT00287586|1785970|FG001|Overall Study|Mastodynia and Gynecomastia|1
830772|NCT00287586|1785969|FG000|Overall Study|Mood Swings and Irritability|0
830773|NCT00287586|1785970|FG001|Overall Study|Mood Swings and Irritability|1
830774|NCT00287586|1785969|FG000|Overall Study|Bradycardia|0
830775|NCT00287586|1785970|FG001|Overall Study|Bradycardia|1
830776|NCT00287586|1785969|FG000|Overall Study|Itchy Swollen Eyes|0
830777|NCT00287586|1785970|FG001|Overall Study|Itchy Swollen Eyes|1
830778|NCT00287586|1785969|FG000|Overall Study|Recurrent Melanoma|0
830779|NCT00287586|1785970|FG001|Overall Study|Recurrent Melanoma|1
830780|NCT00287690|1785978|FG000|Overall Study|Protocol Violation|20
830781|NCT00287690|1785979|FG001|Overall Study|Protocol Violation|26
830782|NCT00288015|1786025|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
830783|NCT00288015|1786025|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
830784|NCT00288015|1786025|FG000|First Response Assessment|Withdrawal by Subject|1
830785|NCT00288015|1786025|FG000|First Response Assessment|Death|1
830786|NCT00288015|1786025|FG000|First Response Assessment|Physician Decision|2
830787|NCT00288015|1786025|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7
830788|NCT00288015|1786025|FG000|Follow up for Survival x 2 Years|Death|13
830789|NCT00288015|1786025|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4
830790|NCT00288015|1786025|FG000|Follow up for Survival x 2 Years|Other|9
830791|NCT00288054|1786029|FG000|Overall Study|Protocol Violation|2
830792|NCT00288054|1786029|FG000|Overall Study|Lack of Efficacy|16
830793|NCT00288054|1786029|FG000|Overall Study|Adverse Event|3
830794|NCT00288054|1786029|FG000|Overall Study|Withdrawal by Subject|1
830795|NCT00288054|1786029|FG000|Overall Study|Not protocol specified|2
830796|NCT00288080|1786043|FG000|Overall Study|Withdrawal by Subject|1
830797|NCT00288080|1786044|FG001|Overall Study|Withdrawal by Subject|3
830798|NCT00288080|1786043|FG000|Overall Study|Protocol Violation|25
830799|NCT00288080|1786044|FG001|Overall Study|Protocol Violation|20
830800|NCT00288509|1786059|FG000|Treatment Cycle 1|Adverse Event|1
830801|NCT00288509|1786059|FG000|Treatment Cycle 1|Lack of Efficacy|1
830802|NCT00288509|1786059|FG000|Treatment Cycle 1|Withdrawal by Subject|1
830803|NCT00288509|1786059|FG000|Treatment Cycle 1|Lost to Follow-up|2
830804|NCT00288509|1786059|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1
830805|NCT00288509|1786059|FG000|Treatment Cycle 2|Lack of Efficacy|1
830806|NCT00288509|1786059|FG000|Treatment Cycle 2|Withdrawal by Subject|2
830807|NCT00288509|1786059|FG000|Treatment Cycle 3|Lack of Efficacy|1
830808|NCT00288509|1786059|FG000|Treatment Cycle 3|Withdrawal by Subject|1
830809|NCT00288509|1786059|FG000|Treatment Cycle 3|Lost to Follow-up|2
830810|NCT00288509|1786059|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1
830811|NCT00288509|1786059|FG000|Treatment Cycle 4|Withdrawal by Subject|3
830812|NCT00288509|1786059|FG000|Treatment Cycle 4|Physician Decision|4
830813|NCT00288509|1786059|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1
830814|NCT00288587|1786077|FG000|Overall Study|Death|4
830815|NCT00288587|1786078|FG001|Overall Study|Death|4
830816|NCT00288587|1786077|FG000|Overall Study|Transplant|0
830817|NCT00288587|1786078|FG001|Overall Study|Transplant|3
830818|NCT00288587|1786077|FG000|Overall Study|Adverse Event|0
830819|NCT00288587|1786078|FG001|Overall Study|Adverse Event|1
830820|NCT00288587|1786077|FG000|Overall Study|Physician Decision|0
830821|NCT00288587|1786078|FG001|Overall Study|Physician Decision|2
830822|NCT00288587|1786077|FG000|Overall Study|Severe Aortic Stenosis|1
830823|NCT00288587|1786078|FG001|Overall Study|Severe Aortic Stenosis|0
830824|NCT00288626|1786093|FG000|Overall Study|Death|3
830825|NCT00288626|1786093|FG000|Overall Study|Withdrawal by Subject|4
830826|NCT00288639|1786099|FG000|Overall Study|Adverse Event|5
830827|NCT00288639|1786099|FG000|Overall Study|Lack of Efficacy|4
830828|NCT00288639|1786099|FG000|Overall Study|Withdrawal by Subject|2
830829|NCT00288639|1786099|FG000|Overall Study|Other|1
830830|NCT00288704|1786106|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
830831|NCT00288704|1786107|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
830832|NCT00288704|1786108|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
830833|NCT00288704|1786106|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
830834|NCT00288704|1786107|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
830835|NCT00288704|1786108|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
830836|NCT00288704|1786106|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
830837|NCT00288704|1786107|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
830838|NCT00288704|1786108|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
830839|NCT00288704|1786106|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
830840|NCT00288704|1786107|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
830841|NCT00288704|1786108|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
830842|NCT00288704|1786106|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0
830843|NCT00288704|1786107|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0
830844|NCT00288704|1786108|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2
830845|NCT00288704|1786106|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
830846|NCT00288704|1786107|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
830847|NCT00288704|1786108|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
830848|NCT00288704|1786106|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
830849|NCT00288704|1786107|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
830850|NCT00288704|1786108|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
830851|NCT00288860|1786117|FG000|Overall Study|Did not complete intake|4
830852|NCT00288860|1786118|FG001|Overall Study|Did not complete intake|8
830853|NCT00288860|1786117|FG000|Overall Study|Death|4
830854|NCT00288860|1786118|FG001|Overall Study|Death|3
830855|NCT00288860|1786117|FG000|Overall Study|Withdrawal by Subject|20
830856|NCT00288860|1786118|FG001|Overall Study|Withdrawal by Subject|15
830857|NCT00288860|1786117|FG000|Overall Study|Lost to Follow-up|74
830858|NCT00288860|1786118|FG001|Overall Study|Lost to Follow-up|71
830859|NCT00288912|1786139|FG000|Overall Study|Developed exclusion criterion|4
830860|NCT00288912|1786140|FG001|Overall Study|Developed exclusion criterion|6
830861|NCT00288912|1786141|FG002|Overall Study|Developed exclusion criterion|7
830862|NCT00288912|1786139|FG000|Overall Study|Lost to Follow-up|9
830863|NCT00288912|1786140|FG001|Overall Study|Lost to Follow-up|6
830864|NCT00288912|1786141|FG002|Overall Study|Lost to Follow-up|9
830865|NCT00288912|1786139|FG000|Overall Study|Withdrawal by Subject|4
830866|NCT00288912|1786140|FG001|Overall Study|Withdrawal by Subject|5
830867|NCT00288912|1786141|FG002|Overall Study|Withdrawal by Subject|12
830868|NCT00289016|1786149|FG000|Overall Study|Disease Progression|29
830869|NCT00289016|1786149|FG000|Overall Study|Death|2
830870|NCT00289016|1786149|FG000|Overall Study|Unrelated Medical Condition or Accident|2
830871|NCT00289016|1786149|FG000|Overall Study|Withdrawal by Subject|2
830872|NCT00289016|1786149|FG000|Overall Study|Adverse Event|1
830873|NCT00289016|1786149|FG000|Overall Study|Other|1
830874|NCT00289133|1786181|FG000|Overall Study|Non-study device implanted|12
830875|NCT00289133|1786182|FG001|Overall Study|Non-study device implanted|0
830876|NCT00289133|1786181|FG000|Overall Study|Protocol Violation|32
830877|NCT00289133|1786182|FG001|Overall Study|Protocol Violation|38
830878|NCT00289133|1786181|FG000|Overall Study|Withdrawal by Subject|9
830879|NCT00289133|1786182|FG001|Overall Study|Withdrawal by Subject|10
830880|NCT00289133|1786181|FG000|Overall Study|Death|5
830881|NCT00289133|1786182|FG001|Overall Study|Death|10
830882|NCT00289133|1786181|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73
830883|NCT00289133|1786182|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74
830884|NCT00289133|1786181|FG000|Overall Study|Physician Decision|41
830885|NCT00289133|1786182|FG001|Overall Study|Physician Decision|45
830886|NCT00289133|1786181|FG000|Overall Study|Revision|8
830887|NCT00289133|1786182|FG001|Overall Study|Revision|6
830888|NCT00289133|1786181|FG000|Overall Study|Lost to Follow-up|92
830889|NCT00289133|1786182|FG001|Overall Study|Lost to Follow-up|115
830890|NCT00289185|1786194|FG000|Overall Study|Withdrawal by Subject|4
830891|NCT00289185|1786195|FG001|Overall Study|Withdrawal by Subject|8
830892|NCT00289185|1786194|FG000|Overall Study|Lost to Follow-up|23
830893|NCT00289185|1786195|FG001|Overall Study|Lost to Follow-up|17
830894|NCT00289185|1786194|FG000|Overall Study|Death|1
830895|NCT00289185|1786195|FG001|Overall Study|Death|1
830896|NCT00289198|1786204|FG000|Overall Study|Adverse Event|0
830897|NCT00289198|1786205|FG001|Overall Study|Adverse Event|2
830898|NCT00289198|1786204|FG000|Overall Study|Protocol Violation|2
830899|NCT00289198|1786205|FG001|Overall Study|Protocol Violation|1
830900|NCT00289198|1786204|FG000|Overall Study|Withdrawal by Subject|4
830901|NCT00289198|1786205|FG001|Overall Study|Withdrawal by Subject|1
830902|NCT00289198|1786204|FG000|Overall Study|Lack of Efficacy|2
830903|NCT00289198|1786205|FG001|Overall Study|Lack of Efficacy|0
830904|NCT00289198|1786204|FG000|Overall Study|Other: Low compliance|0
830905|NCT00289198|1786205|FG001|Overall Study|Other: Low compliance|1
830906|NCT00289198|1786204|FG000|Overall Study|Other: Physician's decision|0
830907|NCT00289198|1786205|FG001|Overall Study|Other: Physician's decision|1
830908|NCT00289198|1786204|FG000|Overall Study|Other: Unable to attend on schedule|2
830909|NCT00289198|1786205|FG001|Overall Study|Other: Unable to attend on schedule|1
830910|NCT00289198|1786204|FG000|Overall Study|Other: Miscalculation of the visit date|21
830911|NCT00289198|1786205|FG001|Overall Study|Other: Miscalculation of the visit date|22
830912|NCT00289198|1786204|FG000|Overall Study|Other: Impossible to come on visit|0
830913|NCT00289198|1786205|FG001|Overall Study|Other: Impossible to come on visit|1
830914|NCT00289276|1786225|FG000|Second Part of FAST Study (Expansion)|Death|0
830915|NCT00289276|1786226|FG001|Second Part of FAST Study (Expansion)|Death|2
830916|NCT00289276|1786225|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
830917|NCT00289276|1786226|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
830918|NCT00289289|1786235|FG000|Overall Study|Withdrawal by Subject|5
830919|NCT00289289|1786236|FG001|Overall Study|Withdrawal by Subject|3
830920|NCT00289289|1786237|FG002|Overall Study|Withdrawal by Subject|15
830921|NCT00289289|1786235|FG000|Overall Study|Lost to Follow-up|1
830922|NCT00289289|1786236|FG001|Overall Study|Lost to Follow-up|0
830923|NCT00289289|1786237|FG002|Overall Study|Lost to Follow-up|1
830924|NCT00289289|1786235|FG000|Overall Study|Death|4
830925|NCT00289289|1786236|FG001|Overall Study|Death|2
830926|NCT00289289|1786237|FG002|Overall Study|Death|5
830927|NCT00289289|1786235|FG000|Overall Study|No implant attempted|0
830928|NCT00289289|1786236|FG001|Overall Study|No implant attempted|0
830929|NCT00289289|1786237|FG002|Overall Study|No implant attempted|1
830930|NCT00289289|1786235|FG000|Overall Study|Physician Decision|1
830931|NCT00289289|1786236|FG001|Overall Study|Physician Decision|0
830932|NCT00289289|1786237|FG002|Overall Study|Physician Decision|6
830933|NCT00289289|1786235|FG000|Overall Study|Non-study device implanted|2
830934|NCT00289289|1786236|FG001|Overall Study|Non-study device implanted|1
830935|NCT00289289|1786237|FG002|Overall Study|Non-study device implanted|3
830936|NCT00289289|1786235|FG000|Overall Study|Did not meet inclusion/exclusion|0
830937|NCT00289289|1786236|FG001|Overall Study|Did not meet inclusion/exclusion|0
830938|NCT00289289|1786237|FG002|Overall Study|Did not meet inclusion/exclusion|6
830939|NCT00289289|1786235|FG000|Overall Study|Other Exit Reason|6
830940|NCT00289289|1786236|FG001|Overall Study|Other Exit Reason|4
830941|NCT00289289|1786237|FG002|Overall Study|Other Exit Reason|12
830942|NCT00289458|1786273|FG000|Overall Study|Death|1
830943|NCT00289458|1786274|FG001|Overall Study|Death|0
830944|NCT00289458|1786275|FG002|Overall Study|Death|0
830945|NCT00289458|1786273|FG000|Overall Study|Physician Decision|3
830946|NCT00289458|1786274|FG001|Overall Study|Physician Decision|4
830947|NCT00289458|1786275|FG002|Overall Study|Physician Decision|2
830948|NCT00289458|1786273|FG000|Overall Study|Withdrawal by Subject|2
830949|NCT00289458|1786274|FG001|Overall Study|Withdrawal by Subject|2
830950|NCT00289458|1786275|FG002|Overall Study|Withdrawal by Subject|4
830951|NCT00289536|1786287|FG000|Period 3|Lost to Follow-up|0
830952|NCT00289536|1786288|FG001|Period 3|Lost to Follow-up|0
830953|NCT00289536|1786289|FG002|Period 3|Lost to Follow-up|1
830954|NCT00289731|1786312|FG000|Overall Study|Adverse Event|1
830955|NCT00289731|1786313|FG001|Overall Study|Adverse Event|2
830956|NCT00289731|1786314|FG002|Overall Study|Adverse Event|2
830957|NCT00289731|1786312|FG000|Overall Study|Other|1
830958|NCT00289731|1786313|FG001|Overall Study|Other|0
830959|NCT00289731|1786314|FG002|Overall Study|Other|0
830960|NCT00289770|1786338|FG000|Year 15|Withdrawal by Subject|1
830961|NCT00289783|1786344|FG000|Primary Phase|Adverse Event|10
830962|NCT00289783|1786345|FG001|Primary Phase|Adverse Event|1
830963|NCT00289783|1786344|FG000|Primary Phase|Protocol Violation|27
830964|NCT00289783|1786345|FG001|Primary Phase|Protocol Violation|6
830965|NCT00289783|1786344|FG000|Primary Phase|Withdrawal by Subject|93
830966|NCT00289783|1786345|FG001|Primary Phase|Withdrawal by Subject|40
830967|NCT00289783|1786344|FG000|Primary Phase|Lost to Follow-up|60
830968|NCT00289783|1786345|FG001|Primary Phase|Lost to Follow-up|14
830969|NCT00289783|1786344|FG000|Primary Phase|Migration from the study area|26
830970|NCT00289783|1786345|FG001|Primary Phase|Migration from the study area|10
830971|NCT00289783|1786344|FG000|Primary Phase|Other|32
830972|NCT00289783|1786345|FG001|Primary Phase|Other|12
830973|NCT00289783|1786344|FG000|Fourth Dose Phase|Adverse Event|1
830974|NCT00289783|1786345|FG001|Fourth Dose Phase|Adverse Event|0
830975|NCT00289783|1786344|FG000|Fourth Dose Phase|Withdrawal by Subject|10
830976|NCT00289783|1786345|FG001|Fourth Dose Phase|Withdrawal by Subject|1
830977|NCT00289783|1786344|FG000|Fourth Dose Phase|Lost to Follow-up|53
830978|NCT00289783|1786345|FG001|Fourth Dose Phase|Lost to Follow-up|12
830979|NCT00289783|1786344|FG000|Fourth Dose Phase|Migration from the study area|1
830980|NCT00289783|1786345|FG001|Fourth Dose Phase|Migration from the study area|1
830981|NCT00289783|1786344|FG000|Fourth Dose Phase|Other|22
830982|NCT00289783|1786345|FG001|Fourth Dose Phase|Other|10
830983|NCT00289848|1786361|FG000|Overall Study|Adverse Event|6
830984|NCT00289848|1786362|FG001|Overall Study|Adverse Event|4
830985|NCT00289848|1786361|FG000|Overall Study|Death|1
830986|NCT00289848|1786362|FG001|Overall Study|Death|0
830987|NCT00289848|1786361|FG000|Overall Study|Lack of Efficacy|20
830988|NCT00289848|1786362|FG001|Overall Study|Lack of Efficacy|24
830989|NCT00289848|1786361|FG000|Overall Study|Lost to Follow-up|3
830990|NCT00289848|1786362|FG001|Overall Study|Lost to Follow-up|1
830991|NCT00289848|1786361|FG000|Overall Study|Protocol Violation|5
830992|NCT00289848|1786362|FG001|Overall Study|Protocol Violation|2
830993|NCT00289848|1786361|FG000|Overall Study|Withdrawal by Subject|5
830994|NCT00289848|1786362|FG001|Overall Study|Withdrawal by Subject|11
830995|NCT00289848|1786361|FG000|Overall Study|Patient Moved|6
830996|NCT00289848|1786362|FG001|Overall Study|Patient Moved|2
830997|NCT00289848|1786361|FG000|Overall Study|Open-Label AHA Treatment Requested|0
830998|NCT00289848|1786362|FG001|Overall Study|Open-Label AHA Treatment Requested|1
830999|NCT00289874|1786370|FG000|Overall Study|Adverse Event|1
831000|NCT00289874|1786371|FG001|Overall Study|Adverse Event|5
831001|NCT00289874|1786370|FG000|Overall Study|Lost to Follow-up|1
831002|NCT00289874|1786371|FG001|Overall Study|Lost to Follow-up|1
831003|NCT00289874|1786370|FG000|Overall Study|Protocol Violation|3
831004|NCT00289874|1786371|FG001|Overall Study|Protocol Violation|2
831005|NCT00289874|1786370|FG000|Overall Study|Did not meet eligibility|1
831006|NCT00289874|1786371|FG001|Overall Study|Did not meet eligibility|0
831007|NCT00289887|1786379|FG000|Overall Study|Adverse Event|3
831008|NCT00289887|1786380|FG001|Overall Study|Adverse Event|3
831009|NCT00289887|1786379|FG000|Overall Study|Lack of Efficacy|3
831010|NCT00289887|1786380|FG001|Overall Study|Lack of Efficacy|11
831011|NCT00289887|1786379|FG000|Overall Study|Lost to Follow-up|3
831012|NCT00289887|1786380|FG001|Overall Study|Lost to Follow-up|3
831013|NCT00289887|1786379|FG000|Overall Study|Protocol Violation|3
831014|NCT00289887|1786380|FG001|Overall Study|Protocol Violation|1
831015|NCT00289887|1786379|FG000|Overall Study|Withdrawal by Subject|3
831016|NCT00289887|1786380|FG001|Overall Study|Withdrawal by Subject|8
831017|NCT00289887|1786379|FG000|Overall Study|Other|7
831018|NCT00289887|1786380|FG001|Overall Study|Other|3
831019|NCT00289900|1786392|FG000|Overall Study|Adverse Event|28
831020|NCT00289900|1786393|FG001|Overall Study|Adverse Event|40
831021|NCT00289900|1786394|FG002|Overall Study|Adverse Event|13
831022|NCT00289900|1786395|FG003|Overall Study|Adverse Event|19
831023|NCT00289900|1786396|FG004|Overall Study|Adverse Event|20
831024|NCT00289900|1786397|FG005|Overall Study|Adverse Event|33
831025|NCT00289900|1786392|FG000|Overall Study|Lost to Follow-up|7
831026|NCT00289900|1786393|FG001|Overall Study|Lost to Follow-up|7
831027|NCT00289900|1786394|FG002|Overall Study|Lost to Follow-up|8
831028|NCT00289900|1786395|FG003|Overall Study|Lost to Follow-up|8
831029|NCT00289900|1786396|FG004|Overall Study|Lost to Follow-up|4
831030|NCT00289900|1786397|FG005|Overall Study|Lost to Follow-up|8
831031|NCT00289900|1786392|FG000|Overall Study|Participant had flushing|18
831032|NCT00289900|1786393|FG001|Overall Study|Participant had flushing|42
831033|NCT00289900|1786394|FG002|Overall Study|Participant had flushing|1
831034|NCT00289900|1786395|FG003|Overall Study|Participant had flushing|2
831035|NCT00289900|1786396|FG004|Overall Study|Participant had flushing|0
831036|NCT00289900|1786397|FG005|Overall Study|Participant had flushing|4
831037|NCT00289900|1786392|FG000|Overall Study|Other|0
831038|NCT00289900|1786393|FG001|Overall Study|Other|0
831039|NCT00289900|1786394|FG002|Overall Study|Other|0
831040|NCT00289900|1786395|FG003|Overall Study|Other|5
831041|NCT00289900|1786396|FG004|Overall Study|Other|1
831042|NCT00289900|1786397|FG005|Overall Study|Other|0
831043|NCT00289900|1786392|FG000|Overall Study|Participant moved|1
831044|NCT00289900|1786393|FG001|Overall Study|Participant moved|0
831045|NCT00289900|1786394|FG002|Overall Study|Participant moved|0
831046|NCT00289900|1786395|FG003|Overall Study|Participant moved|1
831047|NCT00289900|1786396|FG004|Overall Study|Participant moved|1
831048|NCT00289900|1786397|FG005|Overall Study|Participant moved|1
831049|NCT00289900|1786392|FG000|Overall Study|Withdrawal by Subject|10
831050|NCT00289900|1786393|FG001|Overall Study|Withdrawal by Subject|21
831051|NCT00289900|1786394|FG002|Overall Study|Withdrawal by Subject|8
831052|NCT00289900|1786395|FG003|Overall Study|Withdrawal by Subject|18
831053|NCT00289900|1786396|FG004|Overall Study|Withdrawal by Subject|12
831054|NCT00289900|1786397|FG005|Overall Study|Withdrawal by Subject|11
831055|NCT00289900|1786392|FG000|Overall Study|Protocol Violation|3
831056|NCT00289900|1786393|FG001|Overall Study|Protocol Violation|9
831057|NCT00289900|1786394|FG002|Overall Study|Protocol Violation|2
831058|NCT00289900|1786395|FG003|Overall Study|Protocol Violation|6
831059|NCT00289900|1786396|FG004|Overall Study|Protocol Violation|7
831060|NCT00289900|1786397|FG005|Overall Study|Protocol Violation|4
831061|NCT00289900|1786392|FG000|Overall Study|site terminated|1
831062|NCT00289900|1786393|FG001|Overall Study|site terminated|0
831063|NCT00289900|1786394|FG002|Overall Study|site terminated|1
831064|NCT00289900|1786395|FG003|Overall Study|site terminated|0
831065|NCT00289900|1786396|FG004|Overall Study|site terminated|0
831066|NCT00289900|1786397|FG005|Overall Study|site terminated|0
831067|NCT00289900|1786392|FG000|Overall Study|Not treated|0
831068|NCT00289900|1786393|FG001|Overall Study|Not treated|1
831069|NCT00289900|1786394|FG002|Overall Study|Not treated|0
831070|NCT00289900|1786395|FG003|Overall Study|Not treated|0
831071|NCT00289900|1786396|FG004|Overall Study|Not treated|0
831072|NCT00289900|1786397|FG005|Overall Study|Not treated|0
831073|NCT00289913|1786419|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831074|NCT00289913|1786420|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
831075|NCT00289913|1786421|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831076|NCT00289913|1786422|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831077|NCT00289913|1786423|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831078|NCT00289913|1786419|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
831079|NCT00289913|1786420|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
831080|NCT00289913|1786421|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
831081|NCT00289913|1786422|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
831082|NCT00289913|1786423|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
831083|NCT00289913|1786419|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
831084|NCT00289913|1786420|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
831085|NCT00289913|1786421|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
831086|NCT00289913|1786422|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
831087|NCT00289913|1786423|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
831088|NCT00289913|1786419|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
831089|NCT00289913|1786420|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
831090|NCT00289913|1786421|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
831091|NCT00289913|1786422|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
831092|NCT00289913|1786423|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
831093|NCT00289913|1786419|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
831094|NCT00289913|1786420|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
831095|NCT00289913|1786421|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
831096|NCT00289913|1786422|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
831097|NCT00289913|1786423|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
831098|NCT00289913|1786419|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
831099|NCT00289913|1786420|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
831100|NCT00289913|1786421|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
831101|NCT00289913|1786422|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
831102|NCT00289913|1786423|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
831103|NCT00289913|1786419|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
831104|NCT00289913|1786420|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
831105|NCT00289913|1786421|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
831106|NCT00289913|1786422|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
831107|NCT00289913|1786423|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
831108|NCT00289913|1786419|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
831109|NCT00289913|1786420|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
831110|NCT00289913|1786421|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
831111|NCT00289913|1786422|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
831112|NCT00289913|1786423|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
831113|NCT00289913|1786419|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
831114|NCT00289913|1786420|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
831115|NCT00289913|1786421|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
831116|NCT00289913|1786422|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
831117|NCT00289913|1786423|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
831118|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831119|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831120|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
831121|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831122|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831123|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
831124|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
831125|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
831126|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
831127|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
831128|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
831129|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
831130|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
831131|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
831132|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
831133|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
831134|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
831135|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
831136|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
831137|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
831138|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
831139|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
831140|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
831141|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
831142|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
831143|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
831144|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
831145|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
831146|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
831147|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
831148|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
831149|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
831150|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
831151|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
831152|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
831153|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
831154|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
831155|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
831156|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
831157|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
831158|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
831159|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
831160|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
831161|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
831162|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
831163|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
831164|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
831165|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
831166|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
831167|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
831168|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
831169|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
831170|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
831171|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
831172|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
831173|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
831174|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
831175|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
831176|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
831177|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
831178|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
831179|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
831180|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
831181|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
831182|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
831183|NCT00289913|1786419|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
831184|NCT00289913|1786420|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
831185|NCT00289913|1786421|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
831186|NCT00289913|1786422|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
831187|NCT00289913|1786423|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
831188|NCT00289913|1786419|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831189|NCT00289913|1786420|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
831190|NCT00289913|1786421|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831191|NCT00289913|1786422|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831192|NCT00289913|1786423|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
831193|NCT00289913|1786419|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
831194|NCT00289913|1786420|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
831195|NCT00289913|1786421|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
831196|NCT00289913|1786422|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
831197|NCT00289913|1786423|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
831198|NCT00289913|1786419|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
831199|NCT00289913|1786420|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
831200|NCT00289913|1786421|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
831201|NCT00289913|1786422|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
831202|NCT00289913|1786423|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
831203|NCT00289913|1786419|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
831204|NCT00289913|1786420|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
831205|NCT00289913|1786421|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
831206|NCT00289913|1786422|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
831207|NCT00289913|1786423|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
831208|NCT00289913|1786419|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
831209|NCT00289913|1786420|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
831210|NCT00289913|1786421|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
831211|NCT00289913|1786422|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
831212|NCT00289913|1786423|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
831213|NCT00289913|1786419|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
831214|NCT00289913|1786420|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
831215|NCT00289913|1786421|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
831216|NCT00289913|1786422|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
831217|NCT00289913|1786423|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
831218|NCT00289913|1786419|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
831219|NCT00289913|1786420|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
831220|NCT00289913|1786421|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
831221|NCT00289913|1786422|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
831222|NCT00289913|1786423|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
831223|NCT00289913|1786419|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
831224|NCT00289913|1786420|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
831225|NCT00289913|1786421|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
831226|NCT00289913|1786422|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
831227|NCT00289913|1786423|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
831228|NCT00289978|1786441|FG000|Overall Study|Withdrawal by Subject|31
831229|NCT00289978|1786442|FG001|Overall Study|Withdrawal by Subject|17
831230|NCT00289978|1786443|FG002|Overall Study|Withdrawal by Subject|28
831231|NCT00289978|1786441|FG000|Overall Study|Adverse Event|22
831232|NCT00289978|1786442|FG001|Overall Study|Adverse Event|13
831233|NCT00289978|1786443|FG002|Overall Study|Adverse Event|18
831234|NCT00289978|1786441|FG000|Overall Study|Lack of Efficacy|13
831235|NCT00289978|1786442|FG001|Overall Study|Lack of Efficacy|6
831236|NCT00289978|1786443|FG002|Overall Study|Lack of Efficacy|25
831237|NCT00289978|1786441|FG000|Overall Study|Abnormal laboratory value(s)|20
831238|NCT00289978|1786442|FG001|Overall Study|Abnormal laboratory value(s)|9
831239|NCT00289978|1786443|FG002|Overall Study|Abnormal laboratory value(s)|1
831240|NCT00289978|1786441|FG000|Overall Study|Lost to Follow-up|3
831241|NCT00289978|1786442|FG001|Overall Study|Lost to Follow-up|5
831242|NCT00289978|1786443|FG002|Overall Study|Lost to Follow-up|7
831243|NCT00289978|1786441|FG000|Overall Study|Protocol Violation|5
831244|NCT00289978|1786442|FG001|Overall Study|Protocol Violation|5
831245|NCT00289978|1786443|FG002|Overall Study|Protocol Violation|4
831246|NCT00289978|1786441|FG000|Overall Study|Abnormal test procedure result(s)|2
831247|NCT00289978|1786442|FG001|Overall Study|Abnormal test procedure result(s)|1
831248|NCT00289978|1786443|FG002|Overall Study|Abnormal test procedure result(s)|1
831249|NCT00289978|1786441|FG000|Overall Study|Death|1
831250|NCT00289978|1786442|FG001|Overall Study|Death|0
831251|NCT00289978|1786443|FG002|Overall Study|Death|2
831252|NCT00289991|1786453|FG000|Overall Study|Death|35
831253|NCT00289991|1786454|FG001|Overall Study|Death|38
831254|NCT00289991|1786453|FG000|Overall Study|Adverse Event|15
831255|NCT00289991|1786454|FG001|Overall Study|Adverse Event|13
831256|NCT00289991|1786453|FG000|Overall Study|Failure of prophylaxis|1
831257|NCT00289991|1786454|FG001|Overall Study|Failure of prophylaxis|1
831258|NCT00289991|1786453|FG000|Overall Study|Fungal breakthrough infection|0
831259|NCT00289991|1786454|FG001|Overall Study|Fungal breakthrough infection|1
831260|NCT00289991|1786453|FG000|Overall Study|Lost to Follow-up|0
831261|NCT00289991|1786454|FG001|Overall Study|Lost to Follow-up|1
831262|NCT00289991|1786453|FG000|Overall Study|Withdrawal by Subject|2
831263|NCT00289991|1786454|FG001|Overall Study|Withdrawal by Subject|12
831264|NCT00289991|1786453|FG000|Overall Study|Other|5
831265|NCT00289991|1786454|FG001|Overall Study|Other|14
831266|NCT00290186|1786471|FG000|Overall Study|Adverse Event|1
831267|NCT00290186|1786472|FG001|Overall Study|Adverse Event|1
831268|NCT00290186|1786471|FG000|Overall Study|Lost to Follow-up|3
831269|NCT00290186|1786472|FG001|Overall Study|Lost to Follow-up|2
831270|NCT00290186|1786471|FG000|Overall Study|Study was terminated prior to 3-month te|1
831271|NCT00290186|1786472|FG001|Overall Study|Study was terminated prior to 3-month te|1
831272|NCT00290186|1786471|FG000|Overall Study|Withdrawal by Subject|0
831273|NCT00290186|1786472|FG001|Overall Study|Withdrawal by Subject|1
831274|NCT00290238|1786493|FG000|Overall Study|Study terminated|27
831275|NCT00290238|1786494|FG001|Overall Study|Study terminated|27
831276|NCT00290238|1786493|FG000|Overall Study|Lost to Follow-up|0
831277|NCT00290238|1786494|FG001|Overall Study|Lost to Follow-up|1
831278|NCT00290238|1786493|FG000|Overall Study|Withdrawal by Subject|15
831279|NCT00290238|1786494|FG001|Overall Study|Withdrawal by Subject|13
831280|NCT00290251|1786500|FG000|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
831281|NCT00290251|1786501|FG001|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
831282|NCT00290251|1786502|FG002|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
831283|NCT00290251|1786500|FG000|Treatment 1 (Months 1 - 3)|headache|0
831284|NCT00290251|1786501|FG001|Treatment 1 (Months 1 - 3)|headache|1
831285|NCT00290251|1786502|FG002|Treatment 1 (Months 1 - 3)|headache|0
831286|NCT00290251|1786500|FG000|Treatment 1 (Months 1 - 3)|Out of body experience|1
831287|NCT00290251|1786501|FG001|Treatment 1 (Months 1 - 3)|Out of body experience|0
831288|NCT00290251|1786502|FG002|Treatment 1 (Months 1 - 3)|Out of body experience|0
831289|NCT00290251|1786500|FG000|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
831290|NCT00290251|1786501|FG001|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
831291|NCT00290251|1786502|FG002|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
831292|NCT00290290|1786514|FG000|Overall Study|Death|3
831293|NCT00290290|1786515|FG001|Overall Study|Death|4
831294|NCT00290290|1786514|FG000|Overall Study|Withdrawal by Subject|2
831295|NCT00290290|1786515|FG001|Overall Study|Withdrawal by Subject|2
831296|NCT00290290|1786514|FG000|Overall Study|Underwent clean surgical procedure|13
831297|NCT00290290|1786515|FG001|Overall Study|Underwent clean surgical procedure|12
831298|NCT00290342|1786538|FG000|Overall Study|Other|0
831299|NCT00290342|1786539|FG001|Overall Study|Other|1
831300|NCT00290342|1786538|FG000|Overall Study|Withdrawal by Subject|6
831301|NCT00290342|1786539|FG001|Overall Study|Withdrawal by Subject|4
831302|NCT00290342|1786538|FG000|Overall Study|Lost to Follow-up|1
831303|NCT00290342|1786539|FG001|Overall Study|Lost to Follow-up|0
831304|NCT00290355|1786547|FG000|Overall Study|Serious adverse event|7
831305|NCT00290355|1786548|FG001|Overall Study|Serious adverse event|4
831306|NCT00290355|1786547|FG000|Overall Study|Study product reactogenicity|1
831307|NCT00290355|1786548|FG001|Overall Study|Study product reactogenicity|0
831308|NCT00290355|1786547|FG000|Overall Study|Protocol Violation|1
831309|NCT00290355|1786548|FG001|Overall Study|Protocol Violation|0
831310|NCT00290355|1786547|FG000|Overall Study|Withdrawal by Subject|2
831311|NCT00290355|1786548|FG001|Overall Study|Withdrawal by Subject|0
831312|NCT00290355|1786547|FG000|Overall Study|Migrated / moved from the study area|1
831313|NCT00290355|1786548|FG001|Overall Study|Migrated / moved from the study area|0
831314|NCT00290355|1786547|FG000|Overall Study|Lost to Follow-up|3
831315|NCT00290355|1786548|FG001|Overall Study|Lost to Follow-up|1
831316|NCT00290355|1786547|FG000|Overall Study|Other|2
831317|NCT00290355|1786548|FG001|Overall Study|Other|0
831318|NCT00290433|1786554|FG000|Overall Study|Disease Progression|13
831319|NCT00290433|1786554|FG000|Overall Study|Adverse Event|14
831320|NCT00290433|1786554|FG000|Overall Study|Withdrawal by Subject|1
831321|NCT00290433|1786554|FG000|Overall Study|Non-Compliance|1
831322|NCT00290433|1786554|FG000|Overall Study|Congestive Heart Failure|1
831323|NCT00290433|1786554|FG000|Overall Study|Transplant in CR|5
831324|NCT00290433|1786554|FG000|Overall Study|Unrelated Infection/Death|1
831325|NCT00290498|1786571|FG000|Overall Study|Death|2
831326|NCT00290498|1786572|FG001|Overall Study|Death|0
831327|NCT00290498|1786571|FG000|Overall Study|Physician Decision|1
831328|NCT00290498|1786572|FG001|Overall Study|Physician Decision|0
831329|NCT00290498|1786571|FG000|Overall Study|Withdrawal by Subject|1
831330|NCT00290498|1786572|FG001|Overall Study|Withdrawal by Subject|0
831331|NCT00290498|1786571|FG000|Overall Study|Ineligible|3
831332|NCT00290498|1786572|FG001|Overall Study|Ineligible|0
831333|NCT00290498|1786571|FG000|Overall Study|Non-Compliance|1
831334|NCT00290498|1786572|FG001|Overall Study|Non-Compliance|0
831335|NCT00290589|1786587|FG000|Overall Study|Lost to Follow-up|2
831336|NCT00290589|1786588|FG001|Overall Study|Lost to Follow-up|2
831337|NCT00290693|1786602|FG000|Overall Study|Withdrawal by Subject|2
831338|NCT00290706|1786611|FG000|Overall Study|Withdrawal by Subject|2
831339|NCT00290706|1786612|FG001|Overall Study|Withdrawal by Subject|0
831340|NCT00290706|1786613|FG002|Overall Study|Withdrawal by Subject|0
831341|NCT00290706|1786614|FG003|Overall Study|Withdrawal by Subject|0
831342|NCT00290706|1786611|FG000|Overall Study|Progressive Disease|3
831343|NCT00290706|1786612|FG001|Overall Study|Progressive Disease|5
831344|NCT00290706|1786613|FG002|Overall Study|Progressive Disease|4
831345|NCT00290706|1786614|FG003|Overall Study|Progressive Disease|10
831346|NCT00290706|1786611|FG000|Overall Study|Adverse Event|0
831347|NCT00290706|1786612|FG001|Overall Study|Adverse Event|1
831348|NCT00290706|1786613|FG002|Overall Study|Adverse Event|2
831349|NCT00290706|1786614|FG003|Overall Study|Adverse Event|0
831350|NCT00290706|1786611|FG000|Overall Study|Receive auto transplant or radiation|0
831351|NCT00290706|1786612|FG001|Overall Study|Receive auto transplant or radiation|0
831352|NCT00290706|1786613|FG002|Overall Study|Receive auto transplant or radiation|0
831353|NCT00290706|1786614|FG003|Overall Study|Receive auto transplant or radiation|1
831354|NCT00290706|1786611|FG000|Overall Study|Physician Decision|0
831355|NCT00290706|1786612|FG001|Overall Study|Physician Decision|0
831356|NCT00290706|1786613|FG002|Overall Study|Physician Decision|0
831357|NCT00290706|1786614|FG003|Overall Study|Physician Decision|1
831358|NCT00290732|1786627|FG000|Overall Study|Inability to instill drug intraductally.|0
831359|NCT00290732|1786628|FG001|Overall Study|Inability to instill drug intraductally.|1
831360|NCT00290732|1786629|FG002|Overall Study|Inability to instill drug intraductally.|1
831361|NCT00290732|1786630|FG003|Overall Study|Inability to instill drug intraductally.|0
831362|NCT00290732|1786631|FG004|Overall Study|Inability to instill drug intraductally.|0
831363|NCT00290745|1786644|FG000|Overall Study|Withdrawal by Subject|4
831364|NCT00290745|1786644|FG000|Overall Study|Physician Decision|2
831365|NCT00290745|1786644|FG000|Overall Study|Surgery after 3 months for progression|3
831366|NCT00290745|1786644|FG000|Overall Study|Baseline MRI not available|3
831367|NCT00290771|1786663|FG000|Overall Study|Disease progression|95
831368|NCT00290771|1786664|FG001|Overall Study|Disease progression|73
831369|NCT00290771|1786663|FG000|Overall Study|Death|11
831370|NCT00290771|1786664|FG001|Overall Study|Death|10
831371|NCT00290771|1786663|FG000|Overall Study|Adverse Event|12
831372|NCT00290771|1786664|FG001|Overall Study|Adverse Event|6
831373|NCT00290771|1786663|FG000|Overall Study|Withdrawal by Subject|5
831374|NCT00290771|1786664|FG001|Overall Study|Withdrawal by Subject|6
831375|NCT00290771|1786663|FG000|Overall Study|Administrative problems|2
831376|NCT00290771|1786664|FG001|Overall Study|Administrative problems|1
831377|NCT00290771|1786663|FG000|Overall Study|Protocol Violation|2
831378|NCT00290771|1786664|FG001|Overall Study|Protocol Violation|0
831379|NCT00290771|1786663|FG000|Overall Study|Lost to Follow-up|0
831380|NCT00290771|1786664|FG001|Overall Study|Lost to Follow-up|1
831381|NCT00290888|1786677|FG000|Overall Study|Physician Decision|3
831382|NCT00290888|1786678|FG001|Overall Study|Physician Decision|1
831383|NCT00291018|1786688|FG000|Overall Study|Not Consented or Declined PAS|12
831384|NCT00291018|1786689|FG001|Overall Study|Not Consented or Declined PAS|15
831385|NCT00291018|1786690|FG002|Overall Study|Not Consented or Declined PAS|15
831386|NCT00291018|1786688|FG000|Overall Study|Death|3
831387|NCT00291018|1786689|FG001|Overall Study|Death|3
831388|NCT00291018|1786690|FG002|Overall Study|Death|4
831389|NCT00291018|1786688|FG000|Overall Study|Withdrawal by Subject|2
831390|NCT00291018|1786689|FG001|Overall Study|Withdrawal by Subject|8
831391|NCT00291018|1786690|FG002|Overall Study|Withdrawal by Subject|1
831392|NCT00291018|1786688|FG000|Overall Study|Failures|5
831393|NCT00291018|1786689|FG001|Overall Study|Failures|12
831394|NCT00291018|1786690|FG002|Overall Study|Failures|5
831395|NCT00291018|1786688|FG000|Overall Study|Lost to Follow-up|3
831396|NCT00291018|1786689|FG001|Overall Study|Lost to Follow-up|4
831397|NCT00291018|1786690|FG002|Overall Study|Lost to Follow-up|18
831398|NCT00291187|1786724|FG000|Overall Study|Protocol Violation- No Drug Administered|0
831399|NCT00291187|1786725|FG001|Overall Study|Protocol Violation- No Drug Administered|0
831400|NCT00291187|1786726|FG002|Overall Study|Protocol Violation- No Drug Administered|1
831401|NCT00291187|1786727|FG003|Overall Study|Protocol Violation- No Drug Administered|0
831402|NCT00291330|1786757|FG000|Overall Study|Adverse Event|47
831403|NCT00291330|1786758|FG001|Overall Study|Adverse Event|40
831404|NCT00291330|1786757|FG000|Overall Study|Protocol Violation|13
831405|NCT00291330|1786758|FG001|Overall Study|Protocol Violation|20
831406|NCT00291330|1786757|FG000|Overall Study|Lost to Follow-up|16
831407|NCT00291330|1786758|FG001|Overall Study|Lost to Follow-up|11
831408|NCT00291330|1786757|FG000|Overall Study|Withdrawal by Subject|22
831409|NCT00291330|1786758|FG001|Overall Study|Withdrawal by Subject|25
831410|NCT00291330|1786757|FG000|Overall Study|Other|3
831411|NCT00291330|1786758|FG001|Overall Study|Other|1
831412|NCT00291499|1786793|FG000|Overall Study|Adverse Event|3
831413|NCT00291499|1786794|FG001|Overall Study|Adverse Event|8
831414|NCT00291499|1786793|FG000|Overall Study|Change to other therapy|2
831415|NCT00291499|1786794|FG001|Overall Study|Change to other therapy|1
831416|NCT00291499|1786793|FG000|Overall Study|Intercurrent illness|1
831417|NCT00291499|1786794|FG001|Overall Study|Intercurrent illness|0
831418|NCT00291499|1786793|FG000|Overall Study|Protocol Violation|2
831419|NCT00291499|1786794|FG001|Overall Study|Protocol Violation|2
831420|NCT00291499|1786793|FG000|Overall Study|Other reasons|1
831421|NCT00291499|1786794|FG001|Overall Study|Other reasons|4
831422|NCT00291551|1786800|FG000|Overall Study|Death|7
831423|NCT00291551|1786800|FG000|Overall Study|Withdrawal by Subject|6
831424|NCT00291577|1786805|FG000|Overall Study|Adverse Event|1
831425|NCT00291577|1786805|FG000|Overall Study|Other|4
831426|NCT00291577|1786805|FG000|Overall Study|Withdrawal by Subject|2
831427|NCT00291577|1786805|FG000|Overall Study|Lack of Efficacy|14
831428|NCT00291642|1786814|FG000|Overall Study|Adverse Event|1
831429|NCT00291642|1786815|FG001|Overall Study|Adverse Event|0
831430|NCT00291642|1786816|FG002|Overall Study|Adverse Event|1
831431|NCT00291642|1786817|FG003|Overall Study|Adverse Event|0
831432|NCT00291642|1786818|FG004|Overall Study|Adverse Event|1
831433|NCT00291642|1786814|FG000|Overall Study|Patient missed visit|0
831434|NCT00291642|1786815|FG001|Overall Study|Patient missed visit|0
831435|NCT00291642|1786816|FG002|Overall Study|Patient missed visit|1
831436|NCT00291642|1786817|FG003|Overall Study|Patient missed visit|0
831437|NCT00291642|1786818|FG004|Overall Study|Patient missed visit|0
831438|NCT00291642|1786814|FG000|Overall Study|Intake of prohibited medication|1
831439|NCT00291642|1786815|FG001|Overall Study|Intake of prohibited medication|0
831440|NCT00291642|1786816|FG002|Overall Study|Intake of prohibited medication|0
831441|NCT00291642|1786817|FG003|Overall Study|Intake of prohibited medication|0
831442|NCT00291642|1786818|FG004|Overall Study|Intake of prohibited medication|0
831443|NCT00291668|1786837|FG000|Overall Study|Lack of Efficacy|1
831444|NCT00291668|1786838|FG001|Overall Study|Lack of Efficacy|0
831445|NCT00291668|1786839|FG002|Overall Study|Lack of Efficacy|0
831446|NCT00291668|1786837|FG000|Overall Study|SAE, non-fatal|1
831447|NCT00291668|1786838|FG001|Overall Study|SAE, non-fatal|1
831448|NCT00291668|1786839|FG002|Overall Study|SAE, non-fatal|1
831449|NCT00291668|1786837|FG000|Overall Study|AE, non-serious non-fatal|1
831450|NCT00291668|1786838|FG001|Overall Study|AE, non-serious non-fatal|0
831451|NCT00291668|1786839|FG002|Overall Study|AE, non-serious non-fatal|0
831452|NCT00291668|1786837|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
831453|NCT00291668|1786838|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
831454|NCT00291668|1786839|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
831455|NCT00292045|1786862|FG000|Core Study (Through Week 13)|Adverse Event|1
831456|NCT00292045|1786862|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1
831457|NCT00292188|1786877|FG000|Single-Blind|Adverse Event|14
831458|NCT00292188|1786878|FG001|Single-Blind|Adverse Event|0
831459|NCT00292188|1786879|FG002|Single-Blind|Adverse Event|0
831460|NCT00292188|1786877|FG000|Single-Blind|Lack of Efficacy|2
831461|NCT00292188|1786878|FG001|Single-Blind|Lack of Efficacy|0
831462|NCT00292188|1786879|FG002|Single-Blind|Lack of Efficacy|0
831463|NCT00292188|1786877|FG000|Single-Blind|Laboratory Abnormality|5
831464|NCT00292188|1786878|FG001|Single-Blind|Laboratory Abnormality|0
831465|NCT00292188|1786879|FG002|Single-Blind|Laboratory Abnormality|0
831466|NCT00292188|1786877|FG000|Single-Blind|Lost to Follow-up|3
831467|NCT00292188|1786878|FG001|Single-Blind|Lost to Follow-up|0
831468|NCT00292188|1786879|FG002|Single-Blind|Lost to Follow-up|0
831469|NCT00292188|1786877|FG000|Single-Blind|Other|77
831470|NCT00292188|1786878|FG001|Single-Blind|Other|0
831471|NCT00292188|1786879|FG002|Single-Blind|Other|0
831472|NCT00292188|1786877|FG000|Single-Blind|Withdrawal by Subject|12
831473|NCT00292188|1786878|FG001|Single-Blind|Withdrawal by Subject|0
831474|NCT00292188|1786879|FG002|Single-Blind|Withdrawal by Subject|0
831475|NCT00292188|1786877|FG000|Single-Blind|Did not receive treatment|1
831476|NCT00292188|1786878|FG001|Single-Blind|Did not receive treatment|0
831477|NCT00292188|1786879|FG002|Single-Blind|Did not receive treatment|0
831478|NCT00292188|1786877|FG000|Double-Blind|Adverse Event|0
831479|NCT00292188|1786878|FG001|Double-Blind|Adverse Event|25
831480|NCT00292188|1786879|FG002|Double-Blind|Adverse Event|9
831481|NCT00292188|1786877|FG000|Double-Blind|Lack of Efficacy|0
831482|NCT00292188|1786878|FG001|Double-Blind|Lack of Efficacy|2
831483|NCT00292188|1786879|FG002|Double-Blind|Lack of Efficacy|12
831484|NCT00292188|1786877|FG000|Double-Blind|Lost to Follow-up|0
831485|NCT00292188|1786878|FG001|Double-Blind|Lost to Follow-up|1
831486|NCT00292188|1786879|FG002|Double-Blind|Lost to Follow-up|0
831487|NCT00292188|1786877|FG000|Double-Blind|Other|0
831488|NCT00292188|1786878|FG001|Double-Blind|Other|3
831489|NCT00292188|1786879|FG002|Double-Blind|Other|4
831490|NCT00292188|1786877|FG000|Double-Blind|Withdrawal by Subject|0
831491|NCT00292188|1786878|FG001|Double-Blind|Withdrawal by Subject|0
831492|NCT00292188|1786879|FG002|Double-Blind|Withdrawal by Subject|3
831493|NCT00292188|1786877|FG000|Double-Blind|Laboratory Abnormality|0
831494|NCT00292188|1786878|FG001|Double-Blind|Laboratory Abnormality|0
831495|NCT00292188|1786879|FG002|Double-Blind|Laboratory Abnormality|1
831496|NCT00292227|1786888|FG000|Patch Period|Adverse Event|1
831497|NCT00292227|1786889|FG001|Patch Period|Adverse Event|0
831498|NCT00292227|1786890|FG002|Patch Period|Adverse Event|2
831499|NCT00292227|1786888|FG000|Patch Period|Withdrawal by Subject|0
831500|NCT00292227|1786889|FG001|Patch Period|Withdrawal by Subject|0
831501|NCT00292227|1786890|FG002|Patch Period|Withdrawal by Subject|1
831502|NCT00292318|1786900|FG000|Overall Study|Study terminated by officials|2
831503|NCT00292318|1786901|FG001|Overall Study|Study terminated by officials|1
831504|NCT00292370|1786910|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
831505|NCT00292370|1786911|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
831506|NCT00292370|1786912|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
831507|NCT00292370|1786910|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
831508|NCT00292370|1786911|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
831509|NCT00292370|1786912|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
831510|NCT00292370|1786910|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
831511|NCT00292370|1786911|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
831512|NCT00292370|1786912|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
831513|NCT00292370|1786910|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
831514|NCT00292370|1786911|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
831515|NCT00292370|1786912|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
831516|NCT00292370|1786910|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
831517|NCT00292370|1786911|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
831518|NCT00292370|1786912|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
831519|NCT00292370|1786910|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
831520|NCT00292370|1786911|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
831521|NCT00292370|1786912|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
831522|NCT00292461|1786921|FG000|Overall Study|Adverse Event|4
831523|NCT00292461|1786922|FG001|Overall Study|Adverse Event|2
831524|NCT00292461|1786921|FG000|Overall Study|Lack of Efficacy|1
831525|NCT00292461|1786922|FG001|Overall Study|Lack of Efficacy|0
831526|NCT00292461|1786921|FG000|Overall Study|Withdrawal by Subject|0
831527|NCT00292461|1786922|FG001|Overall Study|Withdrawal by Subject|1
831528|NCT00292461|1786921|FG000|Overall Study|Protocol Violation|4
831529|NCT00292461|1786922|FG001|Overall Study|Protocol Violation|3
831530|NCT00292461|1786921|FG000|Overall Study|Lost to Follow-up|1
831531|NCT00292461|1786922|FG001|Overall Study|Lost to Follow-up|0
831532|NCT00292942|1786945|FG000|Overall Study|Withdrawal by Subject|0
831533|NCT00292942|1786946|FG001|Overall Study|Withdrawal by Subject|0
831534|NCT00292942|1786947|FG002|Overall Study|Withdrawal by Subject|1
831535|NCT00292942|1786948|FG003|Overall Study|Withdrawal by Subject|0
831536|NCT00292942|1786945|FG000|Overall Study|Adverse Event|0
831537|NCT00292942|1786946|FG001|Overall Study|Adverse Event|0
831538|NCT00292942|1786947|FG002|Overall Study|Adverse Event|0
831539|NCT00292942|1786948|FG003|Overall Study|Adverse Event|1
831540|NCT00292981|1786961|FG000|Overall Study|Adverse Event|1
831541|NCT00292981|1786961|FG000|Overall Study|Lost to Follow-up|13
831542|NCT00292981|1786961|FG000|Overall Study|Withdrawal by Subject|22
831543|NCT00292981|1786961|FG000|Overall Study|Other|3
831544|NCT00293020|1786965|FG000|Overall Study|Withdrawal by Subject|34
831545|NCT00293020|1786965|FG000|Overall Study|Adverse Event|30
831546|NCT00293020|1786965|FG000|Overall Study|Death|32
831547|NCT00293020|1786965|FG000|Overall Study|Lack of Efficacy|12
831548|NCT00293020|1786965|FG000|Overall Study|Lost to Follow-up|4
831549|NCT00293020|1786965|FG000|Overall Study|Protocol Violation|6
831550|NCT00293020|1786965|FG000|Overall Study|Physician Decision|21
831551|NCT00293020|1786965|FG000|Overall Study|Other Reason|22
831552|NCT00293020|1786965|FG000|Overall Study|No dose taken|1
831553|NCT00293033|1786969|FG000|Open-label Titration Period|Adverse Event|10
831554|NCT00293033|1786969|FG000|Open-label Titration Period|Death|3
831555|NCT00293033|1786969|FG000|Open-label Titration Period|Lack of Efficacy|5
831556|NCT00293033|1786969|FG000|Open-label Titration Period|Protocol Violation|2
831557|NCT00293033|1786969|FG000|Open-label Titration Period|Withdrawal by Subject|22
831558|NCT00293033|1786969|FG000|Open-label Titration Period|Noncompliance and other|27
831559|NCT00293033|1786969|FG000|Double-blind Treatment Period|Adverse Event|3
831560|NCT00293033|1786969|FG000|Double-blind Treatment Period|Lack of Efficacy|1
831561|NCT00293033|1786969|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
831562|NCT00293033|1786969|FG000|Double-blind Treatment Period|Noncompliance|4
831563|NCT00293059|1786979|FG000|Overall Study|Adverse Event|12
831564|NCT00293059|1786980|FG001|Overall Study|Adverse Event|4
831565|NCT00293059|1786979|FG000|Overall Study|Lack of Efficacy|2
831566|NCT00293059|1786980|FG001|Overall Study|Lack of Efficacy|0
831567|NCT00293059|1786979|FG000|Overall Study|Lost to Follow-up|2
831568|NCT00293059|1786980|FG001|Overall Study|Lost to Follow-up|3
831569|NCT00293059|1786979|FG000|Overall Study|Pregnancy|1
831570|NCT00293059|1786980|FG001|Overall Study|Pregnancy|1
831571|NCT00293059|1786979|FG000|Overall Study|Protocol Violation|2
831572|NCT00293059|1786980|FG001|Overall Study|Protocol Violation|0
831573|NCT00293059|1786979|FG000|Overall Study|Withdrawal by Subject|11
831574|NCT00293059|1786980|FG001|Overall Study|Withdrawal by Subject|5
831575|NCT00293059|1786979|FG000|Overall Study|Participant moved out of state|1
831576|NCT00293059|1786980|FG001|Overall Study|Participant moved out of state|0
831577|NCT00293059|1786979|FG000|Overall Study|Participant stopped study drug|1
831578|NCT00293059|1786980|FG001|Overall Study|Participant stopped study drug|0
831579|NCT00293059|1786979|FG000|Overall Study|Noncompliant - sanitary pads collection|0
831580|NCT00293059|1786980|FG001|Overall Study|Noncompliant - sanitary pads collection|1
831581|NCT00293059|1786979|FG000|Overall Study|missing|3
831582|NCT00293059|1786980|FG001|Overall Study|missing|5
831583|NCT00293202|1786988|FG000|Overall Study|Withdrawal by Subject|1
831584|NCT00293202|1786989|FG001|Overall Study|Withdrawal by Subject|2
831585|NCT00293202|1786988|FG000|Overall Study|positive ANA (antinuclear antibody)|1
831586|NCT00293202|1786989|FG001|Overall Study|positive ANA (antinuclear antibody)|0
831587|NCT00293202|1786988|FG000|Overall Study|on-hold due to fistula maturation time|1
831588|NCT00293202|1786989|FG001|Overall Study|on-hold due to fistula maturation time|0
831589|NCT00293215|1787001|FG000|Overall Study|Progressive disease|3
831590|NCT00293215|1787002|FG001|Overall Study|Progressive disease|1
831591|NCT00293215|1787001|FG000|Overall Study|Adverse Event|2
831592|NCT00293215|1787002|FG001|Overall Study|Adverse Event|2
831593|NCT00293241|1787010|FG000|Overall Study|Lost to Follow-up|9
831594|NCT00293241|1787011|FG001|Overall Study|Lost to Follow-up|16
831595|NCT00293241|1787010|FG000|Overall Study|Physician Decision|23
831596|NCT00293241|1787011|FG001|Overall Study|Physician Decision|17
831597|NCT00293241|1787010|FG000|Overall Study|Withdrawal by Subject|4
831598|NCT00293241|1787011|FG001|Overall Study|Withdrawal by Subject|8
831599|NCT00293254|1787022|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
831600|NCT00293254|1787023|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
831601|NCT00293254|1787022|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2
831602|NCT00293254|1787023|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
831603|NCT00293254|1787022|FG000|Primary Study - Double-Blind Week 0-48|Death|5
831604|NCT00293254|1787023|FG001|Primary Study - Double-Blind Week 0-48|Death|2
831605|NCT00293254|1787022|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
831606|NCT00293254|1787023|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
831607|NCT00293254|1787022|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
831608|NCT00293254|1787023|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
831609|NCT00293254|1787022|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
831610|NCT00293254|1787023|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
831611|NCT00293254|1787022|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
831612|NCT00293254|1787023|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
831613|NCT00293254|1787022|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
831614|NCT00293254|1787023|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
831615|NCT00293254|1787022|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4
831616|NCT00293254|1787023|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1
831617|NCT00293254|1787022|FG000|Extension - Double-Blind Week 49-156|Death|4
831618|NCT00293254|1787023|FG001|Extension - Double-Blind Week 49-156|Death|1
831619|NCT00293254|1787022|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
831620|NCT00293254|1787023|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
831621|NCT00293254|1787022|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
831622|NCT00293254|1787023|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
831623|NCT00293254|1787022|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
831624|NCT00293254|1787023|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
831625|NCT00293254|1787022|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
831626|NCT00293254|1787023|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
831627|NCT00293254|1787022|FG000|Extension - Double-Blind Week 49-156|Other Reason|10
831628|NCT00293254|1787023|FG001|Extension - Double-Blind Week 49-156|Other Reason|2
831629|NCT00293254|1787022|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
831630|NCT00293254|1787023|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
831631|NCT00293254|1787022|FG000|Extension - Open-Label Week 157-240|Adverse Event|2
831632|NCT00293254|1787023|FG001|Extension - Open-Label Week 157-240|Adverse Event|1
831633|NCT00293254|1787022|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1
831634|NCT00293254|1787023|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
831635|NCT00293254|1787022|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
831636|NCT00293254|1787023|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
831637|NCT00293254|1787022|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2
831638|NCT00293254|1787023|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
831639|NCT00293254|1787022|FG000|Extension - Open-Label Week 157-240|Other Reason|4
831640|NCT00293254|1787023|FG001|Extension - Open-Label Week 157-240|Other Reason|0
831641|NCT00293254|1787022|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4
831642|NCT00293254|1787023|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7
831643|NCT00293254|1787022|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
831644|NCT00293254|1787023|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
831645|NCT00293254|1787022|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
831646|NCT00293254|1787023|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
831647|NCT00293254|1787022|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
831648|NCT00293254|1787023|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
831649|NCT00293254|1787022|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
831650|NCT00293254|1787023|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
831651|NCT00293254|1787022|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1
831652|NCT00293254|1787023|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2
831653|NCT00293267|1787033|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
831654|NCT00293267|1787034|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
831655|NCT00293267|1787033|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1
831656|NCT00293267|1787034|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
831657|NCT00293267|1787033|FG000|Primary Study - Double-Blind Week 0-48|Death|3
831658|NCT00293267|1787034|FG001|Primary Study - Double-Blind Week 0-48|Death|3
831659|NCT00293267|1787033|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
831660|NCT00293267|1787034|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
831661|NCT00293267|1787033|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
831662|NCT00293267|1787034|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
831663|NCT00293267|1787033|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
831664|NCT00293267|1787034|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
831665|NCT00293267|1787033|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
831666|NCT00293267|1787034|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
831667|NCT00293267|1787033|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1
831668|NCT00293267|1787034|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4
831669|NCT00293267|1787033|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
831670|NCT00293267|1787034|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
831671|NCT00293267|1787033|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
831672|NCT00293267|1787034|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
831673|NCT00293267|1787033|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
831674|NCT00293267|1787034|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
831675|NCT00293267|1787033|FG000|Extension - Double-Blind Week 49-156|Death|3
831676|NCT00293267|1787034|FG001|Extension - Double-Blind Week 49-156|Death|0
831677|NCT00293267|1787033|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
831678|NCT00293267|1787034|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
831679|NCT00293267|1787033|FG000|Extension - Double-Blind Week 49-156|Other Reason|7
831680|NCT00293267|1787034|FG001|Extension - Double-Blind Week 49-156|Other Reason|0
831681|NCT00293267|1787033|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
831682|NCT00293267|1787034|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
831683|NCT00293267|1787033|FG000|Extension - Open-Label Week 157-240|Adverse Event|5
831684|NCT00293267|1787034|FG001|Extension - Open-Label Week 157-240|Adverse Event|0
831685|NCT00293267|1787033|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7
831686|NCT00293267|1787034|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
831687|NCT00293267|1787033|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1
831688|NCT00293267|1787034|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
831689|NCT00293267|1787033|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
831690|NCT00293267|1787034|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
831691|NCT00293267|1787033|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
831692|NCT00293267|1787034|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
831693|NCT00293267|1787033|FG000|Extension - Open-Label Week 157-240|Other Reason|3
831694|NCT00293267|1787034|FG001|Extension - Open-Label Week 157-240|Other Reason|1
831695|NCT00293267|1787033|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2
831696|NCT00293267|1787034|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3
831697|NCT00293267|1787033|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
831698|NCT00293267|1787034|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
831699|NCT00293267|1787033|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
831700|NCT00293267|1787034|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
831701|NCT00293267|1787033|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
831702|NCT00293267|1787034|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
831703|NCT00293267|1787033|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
831704|NCT00293267|1787034|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
831705|NCT00293267|1787033|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
831706|NCT00293267|1787034|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
831707|NCT00293267|1787033|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4
831708|NCT00293267|1787034|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5
831709|NCT00293293|1787044|FG000|Overall Study|Withdrawal by Subject|1
831710|NCT00293293|1787045|FG001|Overall Study|Withdrawal by Subject|1
831711|NCT00293293|1787044|FG000|Overall Study|"Patient too anxious to complete trial"|1
831712|NCT00293293|1787045|FG001|Overall Study|"Patient too anxious to complete trial"|0
831713|NCT00293293|1787044|FG000|Overall Study|Patient discontinued chemotherapy|0
831714|NCT00293293|1787045|FG001|Overall Study|Patient discontinued chemotherapy|1
831715|NCT00293384|1787052|FG000|Overall Study|Non-compliance|2
831716|NCT00293384|1787052|FG000|Overall Study|Missed dosage/study drug|1
831717|NCT00293384|1787052|FG000|Overall Study|Ineligible|2
831718|NCT00293397|1787056|FG000|Overall Study|Death|2
831719|NCT00293423|1787063|FG000|Surgical Resection|Less than a 90% extent of resection|0
831720|NCT00293423|1787064|FG001|Surgical Resection|Less than a 90% extent of resection|1
831721|NCT00293423|1787063|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0
831722|NCT00293423|1787064|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4
831723|NCT00293423|1787063|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9
831724|NCT00293423|1787064|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13
831807|NCT00294047|1787121|FG001|Month 84|Lost to Follow-up|190
831725|NCT00293423|1787063|FG000|Surgical Resection|disease progression prior to initial vaccination|2
831726|NCT00293423|1787064|FG001|Surgical Resection|disease progression prior to initial vaccination|9
831727|NCT00293423|1787063|FG000|Surgical Resection|processing error during surgical resection|1
831728|NCT00293423|1787064|FG001|Surgical Resection|processing error during surgical resection|0
831729|NCT00293423|1787063|FG000|Surgical Resection|Withdrawal by Subject|4
831730|NCT00293423|1787064|FG001|Surgical Resection|Withdrawal by Subject|0
831731|NCT00293423|1787063|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0
831732|NCT00293423|1787064|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3
831733|NCT00293462|1787073|FG000|Overall Study|Withdrawal by Subject|4
831734|NCT00293462|1787074|FG001|Overall Study|Withdrawal by Subject|3
831735|NCT00293462|1787075|FG002|Overall Study|Withdrawal by Subject|8
831736|NCT00293462|1787073|FG000|Overall Study|Death|1
831737|NCT00293462|1787074|FG001|Overall Study|Death|0
831738|NCT00293462|1787075|FG002|Overall Study|Death|0
831739|NCT00293462|1787073|FG000|Overall Study|Lost to Follow-up|0
831740|NCT00293462|1787074|FG001|Overall Study|Lost to Follow-up|1
831741|NCT00293462|1787075|FG002|Overall Study|Lost to Follow-up|0
831742|NCT00293462|1787073|FG000|Overall Study|Change Treatment Regimen (ineligible)|1
831743|NCT00293462|1787074|FG001|Overall Study|Change Treatment Regimen (ineligible)|0
831744|NCT00293462|1787075|FG002|Overall Study|Change Treatment Regimen (ineligible)|0
831745|NCT00293462|1787073|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
831746|NCT00293462|1787074|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
831747|NCT00293462|1787075|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
831748|NCT00293462|1787073|FG000|Overall Study|Refuse Radiation Treatment|1
831749|NCT00293462|1787074|FG001|Overall Study|Refuse Radiation Treatment|0
831750|NCT00293462|1787075|FG002|Overall Study|Refuse Radiation Treatment|0
831751|NCT00293462|1787073|FG000|Overall Study|No Show|0
831752|NCT00293462|1787074|FG001|Overall Study|No Show|0
831753|NCT00293462|1787075|FG002|Overall Study|No Show|1
831754|NCT00293462|1787073|FG000|Overall Study|Went back to his home country|0
831755|NCT00293462|1787074|FG001|Overall Study|Went back to his home country|0
831756|NCT00293462|1787075|FG002|Overall Study|Went back to his home country|1
831757|NCT00293462|1787073|FG000|Overall Study|Blood clot after chemotherapy|0
831758|NCT00293462|1787074|FG001|Overall Study|Blood clot after chemotherapy|0
831759|NCT00293462|1787075|FG002|Overall Study|Blood clot after chemotherapy|1
831760|NCT00293462|1787073|FG000|Overall Study|Ischemic stroke after chemotherapy|0
831761|NCT00293462|1787074|FG001|Overall Study|Ischemic stroke after chemotherapy|0
831762|NCT00293462|1787075|FG002|Overall Study|Ischemic stroke after chemotherapy|1
831763|NCT00293462|1787073|FG000|Overall Study|Possible Tracheostomy leakage|0
831764|NCT00293462|1787074|FG001|Overall Study|Possible Tracheostomy leakage|1
831765|NCT00293462|1787075|FG002|Overall Study|Possible Tracheostomy leakage|0
831766|NCT00293462|1787073|FG000|Overall Study|Low radiation dose in oral cavity|0
831767|NCT00293462|1787074|FG001|Overall Study|Low radiation dose in oral cavity|1
831768|NCT00293462|1787075|FG002|Overall Study|Low radiation dose in oral cavity|0
831769|NCT00293462|1787073|FG000|Overall Study|Physician Decision|0
831770|NCT00293462|1787074|FG001|Overall Study|Physician Decision|1
831771|NCT00293462|1787075|FG002|Overall Study|Physician Decision|0
831772|NCT00293579|1787092|FG000|Overall Study|Withdrawal by Subject|1
831773|NCT00293709|1787097|FG000|Overall Study|Other|47
831774|NCT00293722|1787101|FG000|Overall Study|Other|427
831775|NCT00293813|1787108|FG000|Overall Study|Physician Decision|0
831776|NCT00293813|1787109|FG001|Overall Study|Physician Decision|1
831777|NCT00293813|1787110|FG002|Overall Study|Physician Decision|0
831778|NCT00293813|1787108|FG000|Overall Study|Adverse Event|3
831779|NCT00293813|1787109|FG001|Overall Study|Adverse Event|1
831780|NCT00293813|1787110|FG002|Overall Study|Adverse Event|1
831781|NCT00293813|1787108|FG000|Overall Study|Withdrawal by Subject|7
831782|NCT00293813|1787109|FG001|Overall Study|Withdrawal by Subject|4
831783|NCT00293813|1787110|FG002|Overall Study|Withdrawal by Subject|4
831784|NCT00293813|1787108|FG000|Overall Study|Lost to Follow-up|3
831785|NCT00293813|1787109|FG001|Overall Study|Lost to Follow-up|2
831786|NCT00293813|1787110|FG002|Overall Study|Lost to Follow-up|3
831787|NCT00293813|1787108|FG000|Overall Study|Noncompliance|0
831788|NCT00293813|1787109|FG001|Overall Study|Noncompliance|1
831789|NCT00293813|1787110|FG002|Overall Study|Noncompliance|0
831790|NCT00294047|1787120|FG000|Month 48|Adverse Event|28
831791|NCT00294047|1787121|FG001|Month 48|Adverse Event|13
831792|NCT00294047|1787120|FG000|Month 48|Protocol Violation|4
831793|NCT00294047|1787121|FG001|Month 48|Protocol Violation|4
831794|NCT00294047|1787120|FG000|Month 48|Withdrawal by Subject|111
831795|NCT00294047|1787121|FG001|Month 48|Withdrawal by Subject|115
831796|NCT00294047|1787120|FG000|Month 48|Lost to Follow-up|272
831797|NCT00294047|1787121|FG001|Month 48|Lost to Follow-up|287
831798|NCT00294047|1787120|FG000|Month 48|Other|10
831799|NCT00294047|1787121|FG001|Month 48|Other|14
831800|NCT00294047|1787120|FG000|Month 84|Adverse Event|4
831801|NCT00294047|1787121|FG001|Month 84|Adverse Event|2
831802|NCT00294047|1787120|FG000|Month 84|Protocol Violation|1
831803|NCT00294047|1787121|FG001|Month 84|Protocol Violation|1
831804|NCT00294047|1787120|FG000|Month 84|Withdrawal by Subject|33
831805|NCT00294047|1787121|FG001|Month 84|Withdrawal by Subject|31
831806|NCT00294047|1787120|FG000|Month 84|Lost to Follow-up|187
831808|NCT00294047|1787120|FG000|Month 84|Absent Cervix|2
831809|NCT00294047|1787121|FG001|Month 84|Absent Cervix|0
831810|NCT00294047|1787120|FG000|Month 84|Work related reasons|4
831811|NCT00294047|1787121|FG001|Month 84|Work related reasons|2
831812|NCT00294047|1787120|FG000|Month 84|Center closed, subject did not transfer|1
831813|NCT00294047|1787121|FG001|Month 84|Center closed, subject did not transfer|0
831814|NCT00294047|1787120|FG000|Month 84|Family problems|2
831815|NCT00294047|1787121|FG001|Month 84|Family problems|2
831816|NCT00294047|1787120|FG000|Month 84|Lack of time|3
831817|NCT00294047|1787121|FG001|Month 84|Lack of time|1
831818|NCT00294047|1787120|FG000|Month 84|Personal reason|2
831819|NCT00294047|1787121|FG001|Month 84|Personal reason|4
831820|NCT00294047|1787120|FG000|Month 84|Subject does not want male physician|1
831821|NCT00294047|1787121|FG001|Month 84|Subject does not want male physician|0
831822|NCT00294047|1787120|FG000|Month 84|Transport reimbursement delayed|0
831823|NCT00294047|1787121|FG001|Month 84|Transport reimbursement delayed|1
831824|NCT00294047|1787120|FG000|Month 84|Unable to reach study site|1
831825|NCT00294047|1787121|FG001|Month 84|Unable to reach study site|0
831826|NCT00294047|1787120|FG000|Month 84|Under investigation locally|1
831827|NCT00294047|1787121|FG001|Month 84|Under investigation locally|0
831828|NCT00294047|1787120|FG000|Month 84|Visit missed|0
831829|NCT00294047|1787121|FG001|Month 84|Visit missed|1
831830|NCT00294047|1787120|FG000|Month 84|No consent for Month 84 Follow-up|731
831831|NCT00294047|1787121|FG001|Month 84|No consent for Month 84 Follow-up|754
831832|NCT00294060|1787128|FG000|Overall Study|Death|225
831833|NCT00294060|1787128|FG000|Overall Study|Other|59
831834|NCT00294060|1787128|FG000|Overall Study|Lost to Follow-up|55
831835|NCT00294060|1787128|FG000|Overall Study|Withdrawal by Subject|11
831836|NCT00294060|1787128|FG000|Overall Study|Physician Decision|797
831837|NCT00294060|1787128|FG000|Overall Study|Medical condition|3
831838|NCT00294060|1787128|FG000|Overall Study|Device explanted/not replaced|23
831839|NCT00294398|1787134|FG000|Overall Study|Lost to Follow-up|21
831840|NCT00294398|1787135|FG001|Overall Study|Lost to Follow-up|26
831841|NCT00294554|1787152|FG000|Overall Study|Lack of Efficacy|0
831842|NCT00294554|1787153|FG001|Overall Study|Lack of Efficacy|1
831843|NCT00294554|1787152|FG000|Overall Study|Physician Decision|0
831844|NCT00294554|1787153|FG001|Overall Study|Physician Decision|1
831845|NCT00294645|1787171|FG000|Overall Study|Death|10
831846|NCT00294645|1787172|FG001|Overall Study|Death|18
831847|NCT00294645|1787171|FG000|Overall Study|Lost to Follow-up|1
831848|NCT00294645|1787172|FG001|Overall Study|Lost to Follow-up|10
831849|NCT00294645|1787171|FG000|Overall Study|Withdrawal by Subject|18
831850|NCT00294645|1787172|FG001|Overall Study|Withdrawal by Subject|34
831851|NCT00294645|1787171|FG000|Overall Study|Physician Decision|15
831852|NCT00294645|1787172|FG001|Overall Study|Physician Decision|20
831853|NCT00294645|1787171|FG000|Overall Study|Other|4
831854|NCT00294645|1787172|FG001|Overall Study|Other|10
831855|NCT00294658|1787180|FG000|Overall Study|Death|0
831856|NCT00294658|1787181|FG001|Overall Study|Death|1
831857|NCT00294658|1787180|FG000|Overall Study|Lost to Follow-up|4
831858|NCT00294658|1787181|FG001|Overall Study|Lost to Follow-up|0
831859|NCT00294658|1787180|FG000|Overall Study|Physician Decision|1
831860|NCT00294658|1787181|FG001|Overall Study|Physician Decision|2
831861|NCT00294658|1787180|FG000|Overall Study|Pregnancy|0
831862|NCT00294658|1787181|FG001|Overall Study|Pregnancy|1
831863|NCT00294658|1787180|FG000|Overall Study|Withdrawal by Subject|0
831864|NCT00294658|1787181|FG001|Overall Study|Withdrawal by Subject|4
831865|NCT00294658|1787180|FG000|Overall Study|Found to have invasive thymoma|1
831866|NCT00294658|1787181|FG001|Overall Study|Found to have invasive thymoma|0
831867|NCT00294658|1787180|FG000|Overall Study|Patient and family were not satisfied|0
831868|NCT00294658|1787181|FG001|Overall Study|Patient and family were not satisfied|1
831869|NCT00294671|1787189|FG000|Overall Study|Lack of Efficacy|11
831870|NCT00294671|1787190|FG001|Overall Study|Lack of Efficacy|23
831871|NCT00294671|1787189|FG000|Overall Study|Liver transplant|7
831872|NCT00294671|1787190|FG001|Overall Study|Liver transplant|9
831873|NCT00294671|1787189|FG000|Overall Study|Drug related adverse event (AE)|4
831874|NCT00294671|1787190|FG001|Overall Study|Drug related adverse event (AE)|2
831875|NCT00294671|1787189|FG000|Overall Study|Non-drug related AE|3
831876|NCT00294671|1787190|FG001|Overall Study|Non-drug related AE|2
831877|NCT00294671|1787189|FG000|Overall Study|Lost to Follow-up|1
831878|NCT00294671|1787190|FG001|Overall Study|Lost to Follow-up|3
831879|NCT00294671|1787189|FG000|Overall Study|Non-compliance|1
831880|NCT00294671|1787190|FG001|Overall Study|Non-compliance|0
831881|NCT00294671|1787189|FG000|Overall Study|Death|0
831882|NCT00294671|1787190|FG001|Overall Study|Death|1
831883|NCT00294684|1787198|FG000|Overall Study|Lost to Follow-up|5
831884|NCT00294684|1787199|FG001|Overall Study|Lost to Follow-up|8
831885|NCT00294723|1787208|FG000|Double-Blind Period 52 Weeks|Adverse Event|18
831886|NCT00294723|1787209|FG001|Double-Blind Period 52 Weeks|Adverse Event|25
831887|NCT00294723|1787210|FG002|Double-Blind Period 52 Weeks|Adverse Event|15
831888|NCT00294723|1787208|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9
831889|NCT00294723|1787209|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15
831890|NCT00294723|1787210|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25
831891|NCT00294723|1787208|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11
831892|NCT00294723|1787209|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11
831893|NCT00294723|1787210|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5
831894|NCT00294723|1787208|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36
831895|NCT00294723|1787209|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38
831896|NCT00294723|1787210|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51
831897|NCT00294723|1787208|FG000|Open-Label Extension 52 Weeks|Adverse Event|5
831898|NCT00294723|1787209|FG001|Open-Label Extension 52 Weeks|Adverse Event|5
831899|NCT00294723|1787210|FG002|Open-Label Extension 52 Weeks|Adverse Event|2
831900|NCT00294723|1787208|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12
831901|NCT00294723|1787209|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15
831902|NCT00294723|1787210|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21
831903|NCT00294723|1787208|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4
831904|NCT00294723|1787209|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3
831905|NCT00294723|1787210|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3
831906|NCT00294723|1787208|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19
831907|NCT00294723|1787209|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16
831908|NCT00294723|1787210|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14
831909|NCT00294723|1787208|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1
831910|NCT00294723|1787209|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1
831911|NCT00294723|1787210|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0
831912|NCT00294723|1787208|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
831913|NCT00294723|1787209|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
831914|NCT00294723|1787210|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
831915|NCT00294723|1787208|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
831916|NCT00294723|1787209|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
831917|NCT00294723|1787210|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
831918|NCT00294723|1787208|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
831919|NCT00294723|1787209|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
831920|NCT00294723|1787210|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
831921|NCT00294762|1787223|FG000|Overall Study|Did not receive study treatment|3
831922|NCT00294762|1787224|FG001|Overall Study|Did not receive study treatment|3
831923|NCT00295022|1787258|FG000|Overall Study|Adverse Event|1
831924|NCT00295022|1787259|FG001|Overall Study|Adverse Event|1
831925|NCT00295022|1787260|FG002|Overall Study|Adverse Event|2
831926|NCT00295022|1787258|FG000|Overall Study|Lost to Follow-up|0
831927|NCT00295022|1787259|FG001|Overall Study|Lost to Follow-up|0
831928|NCT00295022|1787260|FG002|Overall Study|Lost to Follow-up|1
831929|NCT00295022|1787258|FG000|Overall Study|Withdrawal by Subject|0
831930|NCT00295022|1787259|FG001|Overall Study|Withdrawal by Subject|0
831931|NCT00295022|1787260|FG002|Overall Study|Withdrawal by Subject|2
831932|NCT00295620|1787286|FG000|Overall Study|Lost to Follow-up|9
831933|NCT00295620|1787287|FG001|Overall Study|Lost to Follow-up|5
831934|NCT00295620|1787286|FG000|Overall Study|Withdrawal by Subject|37
831935|NCT00295620|1787287|FG001|Overall Study|Withdrawal by Subject|50
831936|NCT00295620|1787286|FG000|Overall Study|Death|206
831937|NCT00295620|1787287|FG001|Overall Study|Death|207
831938|NCT00295620|1787286|FG000|Overall Study|Other reasons|10
831939|NCT00295620|1787287|FG001|Overall Study|Other reasons|9
831940|NCT00295620|1787286|FG000|Overall Study|Discontinuation by sponsor|580
831941|NCT00295620|1787287|FG001|Overall Study|Discontinuation by sponsor|593
831942|NCT00295620|1787286|FG000|Overall Study|Protocol Violation|30
831943|NCT00295620|1787287|FG001|Overall Study|Protocol Violation|32
831944|NCT00295633|1787296|FG000|Overall Study|Lack of Efficacy|19
831945|NCT00295633|1787297|FG001|Overall Study|Lack of Efficacy|7
831946|NCT00295633|1787298|FG002|Overall Study|Lack of Efficacy|16
831947|NCT00295633|1787296|FG000|Overall Study|Withdrawal of consent by subject|16
831948|NCT00295633|1787297|FG001|Overall Study|Withdrawal of consent by subject|16
831949|NCT00295633|1787298|FG002|Overall Study|Withdrawal of consent by subject|26
831950|NCT00295633|1787296|FG000|Overall Study|Adverse Event|9
831951|NCT00295633|1787297|FG001|Overall Study|Adverse Event|17
831952|NCT00295633|1787298|FG002|Overall Study|Adverse Event|9
831953|NCT00295633|1787296|FG000|Overall Study|Lost to Follow-up|6
831954|NCT00295633|1787297|FG001|Overall Study|Lost to Follow-up|11
831955|NCT00295633|1787298|FG002|Overall Study|Lost to Follow-up|7
831956|NCT00295633|1787296|FG000|Overall Study|Physician Decision|9
831957|NCT00295633|1787297|FG001|Overall Study|Physician Decision|10
831958|NCT00295633|1787298|FG002|Overall Study|Physician Decision|8
831959|NCT00295633|1787296|FG000|Overall Study|Poor/Noncompliance|2
831960|NCT00295633|1787297|FG001|Overall Study|Poor/Noncompliance|2
831961|NCT00295633|1787298|FG002|Overall Study|Poor/Noncompliance|6
831962|NCT00295633|1787296|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
831963|NCT00295633|1787297|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
831964|NCT00295633|1787298|FG002|Overall Study|Subject No Longer Meets Study Criteria|3
831965|NCT00295633|1787296|FG000|Overall Study|Death|1
831966|NCT00295633|1787297|FG001|Overall Study|Death|1
831967|NCT00295633|1787298|FG002|Overall Study|Death|0
831968|NCT00295633|1787296|FG000|Overall Study|Administrative reason by sponsor|0
831969|NCT00295633|1787297|FG001|Overall Study|Administrative reason by sponsor|0
831970|NCT00295633|1787298|FG002|Overall Study|Administrative reason by sponsor|1
831971|NCT00295750|1787309|FG000|Overall Study|Adverse Event|19
831972|NCT00295750|1787310|FG001|Overall Study|Adverse Event|15
831973|NCT00295750|1787311|FG002|Overall Study|Adverse Event|12
831974|NCT00295750|1787309|FG000|Overall Study|Lack of Efficacy|1
831975|NCT00295750|1787310|FG001|Overall Study|Lack of Efficacy|1
831976|NCT00295750|1787311|FG002|Overall Study|Lack of Efficacy|0
831977|NCT00295750|1787309|FG000|Overall Study|Lost to Follow-up|1
831978|NCT00295750|1787310|FG001|Overall Study|Lost to Follow-up|4
831979|NCT00295750|1787311|FG002|Overall Study|Lost to Follow-up|1
831980|NCT00295750|1787309|FG000|Overall Study|Taking prohibited therapy|2
831981|NCT00295750|1787310|FG001|Overall Study|Taking prohibited therapy|3
831982|NCT00295750|1787311|FG002|Overall Study|Taking prohibited therapy|2
831983|NCT00295750|1787309|FG000|Overall Study|Administrative errors|2
831984|NCT00295750|1787310|FG001|Overall Study|Administrative errors|4
831985|NCT00295750|1787311|FG002|Overall Study|Administrative errors|5
831986|NCT00295750|1787309|FG000|Overall Study|Trial drug errors|1
831987|NCT00295750|1787310|FG001|Overall Study|Trial drug errors|1
831988|NCT00295750|1787311|FG002|Overall Study|Trial drug errors|0
831989|NCT00295750|1787309|FG000|Overall Study|Disease progression|2
831990|NCT00295750|1787310|FG001|Overall Study|Disease progression|1
831991|NCT00295750|1787311|FG002|Overall Study|Disease progression|0
831992|NCT00295750|1787309|FG000|Overall Study|Personal reasons|0
831993|NCT00295750|1787310|FG001|Overall Study|Personal reasons|1
831994|NCT00295750|1787311|FG002|Overall Study|Personal reasons|0
831995|NCT00295750|1787309|FG000|Overall Study|Randomized but never received trial drug|4
831996|NCT00295750|1787310|FG001|Overall Study|Randomized but never received trial drug|3
831997|NCT00295750|1787311|FG002|Overall Study|Randomized but never received trial drug|3
831998|NCT00295750|1787309|FG000|Overall Study|Withdrawal by Subject|9
831999|NCT00295750|1787310|FG001|Overall Study|Withdrawal by Subject|4
832000|NCT00295750|1787311|FG002|Overall Study|Withdrawal by Subject|7
832001|NCT00295750|1787309|FG000|Overall Study|Protocol Violation|2
832002|NCT00295750|1787310|FG001|Overall Study|Protocol Violation|4
832003|NCT00295750|1787311|FG002|Overall Study|Protocol Violation|2
832004|NCT00295854|1787322|FG000|Overall Study|Adverse Event|7
832005|NCT00295854|1787323|FG001|Overall Study|Adverse Event|7
832006|NCT00295854|1787324|FG002|Overall Study|Adverse Event|6
832007|NCT00295854|1787322|FG000|Overall Study|Protocol Violation|1
832008|NCT00295854|1787323|FG001|Overall Study|Protocol Violation|1
832009|NCT00295854|1787324|FG002|Overall Study|Protocol Violation|1
832010|NCT00295854|1787322|FG000|Overall Study|Lost to Follow-up|2
832011|NCT00295854|1787323|FG001|Overall Study|Lost to Follow-up|0
832012|NCT00295854|1787324|FG002|Overall Study|Lost to Follow-up|1
832013|NCT00295854|1787322|FG000|Overall Study|Withdrawal by Subject|3
832014|NCT00295854|1787323|FG001|Overall Study|Withdrawal by Subject|7
832015|NCT00295854|1787324|FG002|Overall Study|Withdrawal by Subject|4
832016|NCT00295854|1787322|FG000|Overall Study|did not continue to meet criteria|1
832017|NCT00295854|1787323|FG001|Overall Study|did not continue to meet criteria|1
832018|NCT00295854|1787324|FG002|Overall Study|did not continue to meet criteria|2
832019|NCT00295854|1787322|FG000|Overall Study|required a prohibited medication|1
832020|NCT00295854|1787323|FG001|Overall Study|required a prohibited medication|0
832021|NCT00295854|1787324|FG002|Overall Study|required a prohibited medication|0
832022|NCT00295854|1787322|FG000|Overall Study|Other|3
832023|NCT00295854|1787323|FG001|Overall Study|Other|5
832024|NCT00295854|1787324|FG002|Overall Study|Other|1
832025|NCT00295880|1787336|FG000|Overall Study|IBMI unit could not be volume reduced|1
832026|NCT00295880|1787336|FG000|Overall Study|Unit randomization did not occur|1
832027|NCT00295932|1787351|FG000|Overall Study|Not Treated|0
832028|NCT00295932|1787352|FG001|Overall Study|Not Treated|0
832029|NCT00295932|1787353|FG002|Overall Study|Not Treated|0
832030|NCT00295932|1787354|FG003|Overall Study|Not Treated|0
832031|NCT00295932|1787355|FG004|Overall Study|Not Treated|0
832032|NCT00295932|1787356|FG005|Overall Study|Not Treated|0
832033|NCT00295932|1787357|FG006|Overall Study|Not Treated|0
832034|NCT00295932|1787358|FG007|Overall Study|Not Treated|0
832035|NCT00295932|1787359|FG008|Overall Study|Not Treated|0
832036|NCT00295932|1787360|FG009|Overall Study|Not Treated|0
832037|NCT00295932|1787361|FG010|Overall Study|Not Treated|1
832038|NCT00296036|1787389|FG000|Overall Study|Withdrawal by Subject|1
832039|NCT00296036|1787390|FG001|Overall Study|Withdrawal by Subject|0
832040|NCT00296036|1787391|FG002|Overall Study|Withdrawal by Subject|2
832041|NCT00296036|1787392|FG003|Overall Study|Withdrawal by Subject|1
832042|NCT00296036|1787393|FG004|Overall Study|Withdrawal by Subject|2
832043|NCT00296036|1787394|FG005|Overall Study|Withdrawal by Subject|1
832044|NCT00296036|1787389|FG000|Overall Study|Protocol Violation|0
832045|NCT00296036|1787390|FG001|Overall Study|Protocol Violation|0
832046|NCT00296036|1787391|FG002|Overall Study|Protocol Violation|0
832047|NCT00296036|1787392|FG003|Overall Study|Protocol Violation|0
832048|NCT00296036|1787393|FG004|Overall Study|Protocol Violation|0
832049|NCT00296036|1787394|FG005|Overall Study|Protocol Violation|3
832050|NCT00296140|1787413|FG000|Overall Study|Lost to Follow-up|1
832051|NCT00296140|1787414|FG001|Overall Study|Lost to Follow-up|0
832052|NCT00296140|1787413|FG000|Overall Study|Withdrawal by Subject|1
832053|NCT00296140|1787414|FG001|Overall Study|Withdrawal by Subject|0
832054|NCT00296140|1787413|FG000|Overall Study|Discharge to Nursing Home|1
832055|NCT00296140|1787414|FG001|Overall Study|Discharge to Nursing Home|0
832056|NCT00296244|1787447|FG000|Overall Study|Underwent retransplant|0
832057|NCT00296244|1787448|FG001|Overall Study|Underwent retransplant|1
832058|NCT00296335|1787479|FG000|Overall Study|Recurrence|3
832059|NCT00296335|1787480|FG001|Overall Study|Recurrence|51
832060|NCT00296335|1787479|FG000|Overall Study|Adverse Event|17
832061|NCT00296335|1787480|FG001|Overall Study|Adverse Event|27
832062|NCT00296335|1787479|FG000|Overall Study|Lost to Follow-up|7
832063|NCT00296335|1787480|FG001|Overall Study|Lost to Follow-up|33
832064|NCT00296335|1787479|FG000|Overall Study|Physician Decision|3
832065|NCT00296335|1787480|FG001|Overall Study|Physician Decision|11
832066|NCT00296374|1787491|FG000|Overall Study|Adverse Event|14
832067|NCT00296374|1787492|FG001|Overall Study|Adverse Event|10
832068|NCT00296374|1787493|FG002|Overall Study|Adverse Event|7
832069|NCT00296374|1787491|FG000|Overall Study|Withdrawal by Subject|3
832070|NCT00296374|1787492|FG001|Overall Study|Withdrawal by Subject|5
832071|NCT00296374|1787493|FG002|Overall Study|Withdrawal by Subject|11
832072|NCT00296374|1787491|FG000|Overall Study|Incorrect enrollment|3
832073|NCT00296374|1787492|FG001|Overall Study|Incorrect enrollment|3
832074|NCT00296374|1787493|FG002|Overall Study|Incorrect enrollment|4
832075|NCT00296374|1787491|FG000|Overall Study|Protocol Violation|1
832076|NCT00296374|1787492|FG001|Overall Study|Protocol Violation|2
832077|NCT00296374|1787493|FG002|Overall Study|Protocol Violation|3
832078|NCT00296374|1787491|FG000|Overall Study|Lost to Follow-up|3
832079|NCT00296374|1787492|FG001|Overall Study|Lost to Follow-up|1
832080|NCT00296374|1787493|FG002|Overall Study|Lost to Follow-up|1
832081|NCT00296374|1787491|FG000|Overall Study|Relocated to another state|1
832082|NCT00296374|1787492|FG001|Overall Study|Relocated to another state|0
832083|NCT00296374|1787493|FG002|Overall Study|Relocated to another state|0
832084|NCT00296374|1787491|FG000|Overall Study|Stopped drug before end of study visit|0
832085|NCT00296374|1787492|FG001|Overall Study|Stopped drug before end of study visit|1
832086|NCT00296374|1787493|FG002|Overall Study|Stopped drug before end of study visit|0
832087|NCT00296374|1787491|FG000|Overall Study|Nephrologist introduced ACE|0
832088|NCT00296374|1787492|FG001|Overall Study|Nephrologist introduced ACE|1
832089|NCT00296374|1787493|FG002|Overall Study|Nephrologist introduced ACE|0
832090|NCT00296374|1787491|FG000|Overall Study|Pregnancy|0
832091|NCT00296374|1787492|FG001|Overall Study|Pregnancy|0
832092|NCT00296374|1787493|FG002|Overall Study|Pregnancy|2
832093|NCT00296374|1787491|FG000|Overall Study|Other|0
832094|NCT00296374|1787492|FG001|Overall Study|Other|0
832095|NCT00296374|1787493|FG002|Overall Study|Other|1
832096|NCT00296400|1787510|FG000|Overall Study|Adverse Event|7
832097|NCT00296400|1787511|FG001|Overall Study|Adverse Event|7
832098|NCT00296400|1787512|FG002|Overall Study|Adverse Event|7
832099|NCT00296400|1787510|FG000|Overall Study|Withdrawal by Subject|5
832100|NCT00296400|1787511|FG001|Overall Study|Withdrawal by Subject|6
832101|NCT00296400|1787512|FG002|Overall Study|Withdrawal by Subject|2
832102|NCT00296400|1787510|FG000|Overall Study|Incorrect enrollment|2
832103|NCT00296400|1787511|FG001|Overall Study|Incorrect enrollment|0
832104|NCT00296400|1787512|FG002|Overall Study|Incorrect enrollment|0
832105|NCT00296400|1787510|FG000|Overall Study|Protocol Violation|1
832106|NCT00296400|1787511|FG001|Overall Study|Protocol Violation|1
832107|NCT00296400|1787512|FG002|Overall Study|Protocol Violation|1
832108|NCT00296400|1787510|FG000|Overall Study|Lost to Follow-up|1
832109|NCT00296400|1787511|FG001|Overall Study|Lost to Follow-up|1
832110|NCT00296400|1787512|FG002|Overall Study|Lost to Follow-up|2
832111|NCT00296400|1787510|FG000|Overall Study|Study specific discontinuation criteria|0
832112|NCT00296400|1787511|FG001|Overall Study|Study specific discontinuation criteria|0
832113|NCT00296400|1787512|FG002|Overall Study|Study specific discontinuation criteria|1
832114|NCT00296400|1787510|FG000|Overall Study|Visit 10 was performed earlier|0
832115|NCT00296400|1787511|FG001|Overall Study|Visit 10 was performed earlier|1
832116|NCT00296400|1787512|FG002|Overall Study|Visit 10 was performed earlier|0
832117|NCT00296400|1787510|FG000|Overall Study|Pregnancy|1
832118|NCT00296400|1787511|FG001|Overall Study|Pregnancy|2
832119|NCT00296400|1787512|FG002|Overall Study|Pregnancy|0
832120|NCT00296491|1787527|FG000|Overall Study|Low Pollen Counts|18
832121|NCT00296491|1787528|FG001|Overall Study|Low Pollen Counts|26
832122|NCT00296491|1787529|FG002|Overall Study|Low Pollen Counts|25
832123|NCT00296491|1787530|FG003|Overall Study|Low Pollen Counts|16
832124|NCT00296491|1787527|FG000|Overall Study|Protocol Violation|4
832125|NCT00296491|1787528|FG001|Overall Study|Protocol Violation|6
832126|NCT00296491|1787529|FG002|Overall Study|Protocol Violation|2
832127|NCT00296491|1787530|FG003|Overall Study|Protocol Violation|3
832128|NCT00296491|1787527|FG000|Overall Study|Adverse Event|1
832129|NCT00296491|1787528|FG001|Overall Study|Adverse Event|3
832130|NCT00296491|1787529|FG002|Overall Study|Adverse Event|1
832131|NCT00296491|1787530|FG003|Overall Study|Adverse Event|4
832132|NCT00296491|1787527|FG000|Overall Study|Withdrawn due to Asthma|0
832133|NCT00296491|1787528|FG001|Overall Study|Withdrawn due to Asthma|0
832134|NCT00296491|1787529|FG002|Overall Study|Withdrawn due to Asthma|0
832135|NCT00296491|1787530|FG003|Overall Study|Withdrawn due to Asthma|4
832136|NCT00296491|1787527|FG000|Overall Study|Withdrawal by Subject|7
832137|NCT00296491|1787528|FG001|Overall Study|Withdrawal by Subject|3
832138|NCT00296491|1787529|FG002|Overall Study|Withdrawal by Subject|3
832139|NCT00296491|1787530|FG003|Overall Study|Withdrawal by Subject|2
832140|NCT00296491|1787527|FG000|Overall Study|Non-Compliance|12
832141|NCT00296491|1787528|FG001|Overall Study|Non-Compliance|13
832142|NCT00296491|1787529|FG002|Overall Study|Non-Compliance|10
832143|NCT00296491|1787530|FG003|Overall Study|Non-Compliance|14
832144|NCT00296491|1787527|FG000|Overall Study|Lost to Follow-up|0
832145|NCT00296491|1787528|FG001|Overall Study|Lost to Follow-up|2
832146|NCT00296491|1787529|FG002|Overall Study|Lost to Follow-up|2
832147|NCT00296491|1787530|FG003|Overall Study|Lost to Follow-up|0
832148|NCT00296504|1787555|FG000|Interim Analysis|Withdrawal by Subject|8
832149|NCT00296504|1787556|FG001|Interim Analysis|Withdrawal by Subject|0
832150|NCT00296504|1787557|FG002|Interim Analysis|Withdrawal by Subject|12
832151|NCT00296504|1787558|FG003|Interim Analysis|Withdrawal by Subject|0
832152|NCT00296504|1787559|FG004|Interim Analysis|Withdrawal by Subject|5
832153|NCT00296504|1787560|FG005|Interim Analysis|Withdrawal by Subject|5
832154|NCT00296504|1787561|FG006|Interim Analysis|Withdrawal by Subject|9
832155|NCT00296504|1787562|FG007|Interim Analysis|Withdrawal by Subject|3
832156|NCT00296504|1787563|FG008|Interim Analysis|Withdrawal by Subject|0
832157|NCT00296504|1787555|FG000|Interim Analysis|Lost to Follow-up|13
832158|NCT00296504|1787556|FG001|Interim Analysis|Lost to Follow-up|3
832159|NCT00296504|1787557|FG002|Interim Analysis|Lost to Follow-up|26
832160|NCT00296504|1787558|FG003|Interim Analysis|Lost to Follow-up|8
832161|NCT00296504|1787559|FG004|Interim Analysis|Lost to Follow-up|14
832162|NCT00296504|1787560|FG005|Interim Analysis|Lost to Follow-up|4
832163|NCT00296504|1787561|FG006|Interim Analysis|Lost to Follow-up|11
832164|NCT00296504|1787562|FG007|Interim Analysis|Lost to Follow-up|4
832165|NCT00296504|1787563|FG008|Interim Analysis|Lost to Follow-up|0
832166|NCT00296504|1787555|FG000|Interim Analysis|Clinical Progression|1
832167|NCT00296504|1787556|FG001|Interim Analysis|Clinical Progression|0
832168|NCT00296504|1787557|FG002|Interim Analysis|Clinical Progression|1
832169|NCT00296504|1787558|FG003|Interim Analysis|Clinical Progression|1
832170|NCT00296504|1787559|FG004|Interim Analysis|Clinical Progression|0
832171|NCT00296504|1787560|FG005|Interim Analysis|Clinical Progression|2
832172|NCT00296504|1787561|FG006|Interim Analysis|Clinical Progression|1
832173|NCT00296504|1787562|FG007|Interim Analysis|Clinical Progression|2
832174|NCT00296504|1787563|FG008|Interim Analysis|Clinical Progression|0
832175|NCT00296504|1787555|FG000|Interim Analysis|Insufficient Viral Load Response|5
832176|NCT00296504|1787556|FG001|Interim Analysis|Insufficient Viral Load Response|1
832177|NCT00296504|1787557|FG002|Interim Analysis|Insufficient Viral Load Response|12
832178|NCT00296504|1787558|FG003|Interim Analysis|Insufficient Viral Load Response|2
832179|NCT00296504|1787559|FG004|Interim Analysis|Insufficient Viral Load Response|7
832180|NCT00296504|1787560|FG005|Interim Analysis|Insufficient Viral Load Response|9
832181|NCT00296504|1787561|FG006|Interim Analysis|Insufficient Viral Load Response|2
832182|NCT00296504|1787562|FG007|Interim Analysis|Insufficient Viral Load Response|24
832183|NCT00296504|1787563|FG008|Interim Analysis|Insufficient Viral Load Response|0
832184|NCT00296504|1787555|FG000|Interim Analysis|Adverse Event|0
832185|NCT00296504|1787556|FG001|Interim Analysis|Adverse Event|0
832186|NCT00296504|1787557|FG002|Interim Analysis|Adverse Event|13
832187|NCT00296504|1787558|FG003|Interim Analysis|Adverse Event|4
832188|NCT00296504|1787559|FG004|Interim Analysis|Adverse Event|6
832189|NCT00296504|1787560|FG005|Interim Analysis|Adverse Event|3
832190|NCT00296504|1787561|FG006|Interim Analysis|Adverse Event|4
832191|NCT00296504|1787562|FG007|Interim Analysis|Adverse Event|5
832192|NCT00296504|1787563|FG008|Interim Analysis|Adverse Event|0
832193|NCT00296504|1787555|FG000|Interim Analysis|Protocol Violation|0
832194|NCT00296504|1787556|FG001|Interim Analysis|Protocol Violation|0
832195|NCT00296504|1787557|FG002|Interim Analysis|Protocol Violation|2
832196|NCT00296504|1787558|FG003|Interim Analysis|Protocol Violation|0
832197|NCT00296504|1787559|FG004|Interim Analysis|Protocol Violation|1
832198|NCT00296504|1787560|FG005|Interim Analysis|Protocol Violation|0
832199|NCT00296504|1787561|FG006|Interim Analysis|Protocol Violation|0
832200|NCT00296504|1787562|FG007|Interim Analysis|Protocol Violation|1
832201|NCT00296504|1787563|FG008|Interim Analysis|Protocol Violation|0
832202|NCT00296504|1787555|FG000|Interim Analysis|Insufficient CD4 Response|0
832203|NCT00296504|1787556|FG001|Interim Analysis|Insufficient CD4 Response|0
832204|NCT00296504|1787557|FG002|Interim Analysis|Insufficient CD4 Response|0
832205|NCT00296504|1787558|FG003|Interim Analysis|Insufficient CD4 Response|0
832206|NCT00296504|1787559|FG004|Interim Analysis|Insufficient CD4 Response|1
832207|NCT00296504|1787560|FG005|Interim Analysis|Insufficient CD4 Response|1
832208|NCT00296504|1787561|FG006|Interim Analysis|Insufficient CD4 Response|0
832209|NCT00296504|1787562|FG007|Interim Analysis|Insufficient CD4 Response|0
832210|NCT00296504|1787563|FG008|Interim Analysis|Insufficient CD4 Response|0
832211|NCT00296504|1787555|FG000|Interim Analysis|Switched to Commercially Available Drug|2
832212|NCT00296504|1787556|FG001|Interim Analysis|Switched to Commercially Available Drug|0
832213|NCT00296504|1787557|FG002|Interim Analysis|Switched to Commercially Available Drug|4
832214|NCT00296504|1787558|FG003|Interim Analysis|Switched to Commercially Available Drug|1
832215|NCT00296504|1787559|FG004|Interim Analysis|Switched to Commercially Available Drug|0
832216|NCT00296504|1787560|FG005|Interim Analysis|Switched to Commercially Available Drug|5
832217|NCT00296504|1787561|FG006|Interim Analysis|Switched to Commercially Available Drug|3
832218|NCT00296504|1787562|FG007|Interim Analysis|Switched to Commercially Available Drug|4
832219|NCT00296504|1787563|FG008|Interim Analysis|Switched to Commercially Available Drug|0
832220|NCT00296504|1787555|FG000|Interim Analysis|Pregnancy|4
832221|NCT00296504|1787556|FG001|Interim Analysis|Pregnancy|1
832222|NCT00296504|1787557|FG002|Interim Analysis|Pregnancy|4
832223|NCT00296504|1787558|FG003|Interim Analysis|Pregnancy|2
832224|NCT00296504|1787559|FG004|Interim Analysis|Pregnancy|0
832225|NCT00296504|1787560|FG005|Interim Analysis|Pregnancy|1
832226|NCT00296504|1787561|FG006|Interim Analysis|Pregnancy|1
832227|NCT00296504|1787562|FG007|Interim Analysis|Pregnancy|1
832228|NCT00296504|1787563|FG008|Interim Analysis|Pregnancy|0
832229|NCT00296504|1787555|FG000|Interim Analysis|Death|1
832230|NCT00296504|1787556|FG001|Interim Analysis|Death|0
832231|NCT00296504|1787557|FG002|Interim Analysis|Death|3
832232|NCT00296504|1787558|FG003|Interim Analysis|Death|0
832233|NCT00296504|1787559|FG004|Interim Analysis|Death|0
832234|NCT00296504|1787560|FG005|Interim Analysis|Death|0
832235|NCT00296504|1787561|FG006|Interim Analysis|Death|0
832236|NCT00296504|1787562|FG007|Interim Analysis|Death|0
832237|NCT00296504|1787563|FG008|Interim Analysis|Death|0
832238|NCT00296504|1787555|FG000|Interim Analysis|Participant Non-compliant|0
832239|NCT00296504|1787556|FG001|Interim Analysis|Participant Non-compliant|1
832240|NCT00296504|1787557|FG002|Interim Analysis|Participant Non-compliant|2
832241|NCT00296504|1787558|FG003|Interim Analysis|Participant Non-compliant|1
832242|NCT00296504|1787559|FG004|Interim Analysis|Participant Non-compliant|1
832243|NCT00296504|1787560|FG005|Interim Analysis|Participant Non-compliant|3
832244|NCT00296504|1787561|FG006|Interim Analysis|Participant Non-compliant|6
832245|NCT00296504|1787562|FG007|Interim Analysis|Participant Non-compliant|2
832246|NCT00296504|1787563|FG008|Interim Analysis|Participant Non-compliant|0
832247|NCT00296504|1787555|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0
832248|NCT00296504|1787556|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0
832249|NCT00296504|1787557|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2
832250|NCT00296504|1787558|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0
832251|NCT00296504|1787559|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0
832252|NCT00296504|1787560|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1
832253|NCT00296504|1787561|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0
832254|NCT00296504|1787562|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0
832255|NCT00296504|1787563|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0
832256|NCT00296504|1787555|FG000|Interim Analysis|To Simplify Treatment|0
832257|NCT00296504|1787556|FG001|Interim Analysis|To Simplify Treatment|0
832258|NCT00296504|1787557|FG002|Interim Analysis|To Simplify Treatment|1
832259|NCT00296504|1787558|FG003|Interim Analysis|To Simplify Treatment|0
832260|NCT00296504|1787559|FG004|Interim Analysis|To Simplify Treatment|0
832261|NCT00296504|1787560|FG005|Interim Analysis|To Simplify Treatment|0
832262|NCT00296504|1787561|FG006|Interim Analysis|To Simplify Treatment|2
832263|NCT00296504|1787562|FG007|Interim Analysis|To Simplify Treatment|0
832264|NCT00296504|1787563|FG008|Interim Analysis|To Simplify Treatment|0
832265|NCT00296504|1787555|FG000|Interim Analysis|Participant Had Problems with Alcohol|0
832266|NCT00296504|1787556|FG001|Interim Analysis|Participant Had Problems with Alcohol|0
832267|NCT00296504|1787557|FG002|Interim Analysis|Participant Had Problems with Alcohol|1
832268|NCT00296504|1787558|FG003|Interim Analysis|Participant Had Problems with Alcohol|0
832269|NCT00296504|1787559|FG004|Interim Analysis|Participant Had Problems with Alcohol|0
832270|NCT00296504|1787560|FG005|Interim Analysis|Participant Had Problems with Alcohol|0
832271|NCT00296504|1787561|FG006|Interim Analysis|Participant Had Problems with Alcohol|0
832272|NCT00296504|1787562|FG007|Interim Analysis|Participant Had Problems with Alcohol|0
832273|NCT00296504|1787563|FG008|Interim Analysis|Participant Had Problems with Alcohol|0
832274|NCT00296504|1787555|FG000|Interim Analysis|Participant Moved|1
832275|NCT00296504|1787556|FG001|Interim Analysis|Participant Moved|0
832276|NCT00296504|1787557|FG002|Interim Analysis|Participant Moved|1
832277|NCT00296504|1787558|FG003|Interim Analysis|Participant Moved|0
832278|NCT00296504|1787559|FG004|Interim Analysis|Participant Moved|0
832279|NCT00296504|1787560|FG005|Interim Analysis|Participant Moved|1
832280|NCT00296504|1787561|FG006|Interim Analysis|Participant Moved|1
832281|NCT00296504|1787562|FG007|Interim Analysis|Participant Moved|0
832282|NCT00296504|1787563|FG008|Interim Analysis|Participant Moved|0
832283|NCT00296504|1787555|FG000|Interim Analysis|Participant Was Incarcerated|2
832284|NCT00296504|1787556|FG001|Interim Analysis|Participant Was Incarcerated|0
832285|NCT00296504|1787557|FG002|Interim Analysis|Participant Was Incarcerated|1
832286|NCT00296504|1787558|FG003|Interim Analysis|Participant Was Incarcerated|0
832287|NCT00296504|1787559|FG004|Interim Analysis|Participant Was Incarcerated|0
832288|NCT00296504|1787560|FG005|Interim Analysis|Participant Was Incarcerated|0
832289|NCT00296504|1787561|FG006|Interim Analysis|Participant Was Incarcerated|0
832290|NCT00296504|1787562|FG007|Interim Analysis|Participant Was Incarcerated|0
832291|NCT00296504|1787563|FG008|Interim Analysis|Participant Was Incarcerated|0
832292|NCT00296504|1787555|FG000|Interim Analysis|Resistance to FPV|0
832293|NCT00296504|1787556|FG001|Interim Analysis|Resistance to FPV|0
832294|NCT00296504|1787557|FG002|Interim Analysis|Resistance to FPV|1
832295|NCT00296504|1787558|FG003|Interim Analysis|Resistance to FPV|0
832296|NCT00296504|1787559|FG004|Interim Analysis|Resistance to FPV|0
832297|NCT00296504|1787560|FG005|Interim Analysis|Resistance to FPV|0
832298|NCT00296504|1787561|FG006|Interim Analysis|Resistance to FPV|0
832299|NCT00296504|1787562|FG007|Interim Analysis|Resistance to FPV|0
832300|NCT00296504|1787563|FG008|Interim Analysis|Resistance to FPV|0
832301|NCT00296504|1787555|FG000|Interim Analysis|Physician Decision|0
832302|NCT00296504|1787556|FG001|Interim Analysis|Physician Decision|0
832303|NCT00296504|1787557|FG002|Interim Analysis|Physician Decision|1
832304|NCT00296504|1787558|FG003|Interim Analysis|Physician Decision|0
832305|NCT00296504|1787559|FG004|Interim Analysis|Physician Decision|0
832306|NCT00296504|1787560|FG005|Interim Analysis|Physician Decision|0
832307|NCT00296504|1787561|FG006|Interim Analysis|Physician Decision|0
832308|NCT00296504|1787562|FG007|Interim Analysis|Physician Decision|0
832309|NCT00296504|1787563|FG008|Interim Analysis|Physician Decision|0
832310|NCT00296504|1787555|FG000|Interim Analysis|Principle Investigator Discretion|2
832311|NCT00296504|1787556|FG001|Interim Analysis|Principle Investigator Discretion|0
832312|NCT00296504|1787557|FG002|Interim Analysis|Principle Investigator Discretion|1
832313|NCT00296504|1787558|FG003|Interim Analysis|Principle Investigator Discretion|1
832314|NCT00296504|1787559|FG004|Interim Analysis|Principle Investigator Discretion|0
832315|NCT00296504|1787560|FG005|Interim Analysis|Principle Investigator Discretion|0
832316|NCT00296504|1787561|FG006|Interim Analysis|Principle Investigator Discretion|0
832317|NCT00296504|1787562|FG007|Interim Analysis|Principle Investigator Discretion|0
832318|NCT00296504|1787563|FG008|Interim Analysis|Principle Investigator Discretion|0
832319|NCT00296504|1787555|FG000|Interim Analysis|Principle Investigator Terminated Study|0
832320|NCT00296504|1787556|FG001|Interim Analysis|Principle Investigator Terminated Study|0
832321|NCT00296504|1787557|FG002|Interim Analysis|Principle Investigator Terminated Study|1
832322|NCT00296504|1787558|FG003|Interim Analysis|Principle Investigator Terminated Study|0
832323|NCT00296504|1787559|FG004|Interim Analysis|Principle Investigator Terminated Study|0
832324|NCT00296504|1787560|FG005|Interim Analysis|Principle Investigator Terminated Study|0
832325|NCT00296504|1787561|FG006|Interim Analysis|Principle Investigator Terminated Study|0
832326|NCT00296504|1787562|FG007|Interim Analysis|Principle Investigator Terminated Study|0
832327|NCT00296504|1787563|FG008|Interim Analysis|Principle Investigator Terminated Study|0
832328|NCT00296504|1787555|FG000|Interim Analysis|Non-adherence|2
832329|NCT00296504|1787556|FG001|Interim Analysis|Non-adherence|0
832330|NCT00296504|1787557|FG002|Interim Analysis|Non-adherence|0
832331|NCT00296504|1787558|FG003|Interim Analysis|Non-adherence|0
832332|NCT00296504|1787559|FG004|Interim Analysis|Non-adherence|1
832333|NCT00296504|1787560|FG005|Interim Analysis|Non-adherence|0
832334|NCT00296504|1787561|FG006|Interim Analysis|Non-adherence|0
832335|NCT00296504|1787562|FG007|Interim Analysis|Non-adherence|1
832336|NCT00296504|1787563|FG008|Interim Analysis|Non-adherence|0
832337|NCT00296504|1787555|FG000|Interim Analysis|Site Closing|1
832338|NCT00296504|1787556|FG001|Interim Analysis|Site Closing|0
832339|NCT00296504|1787557|FG002|Interim Analysis|Site Closing|0
832340|NCT00296504|1787558|FG003|Interim Analysis|Site Closing|0
832341|NCT00296504|1787559|FG004|Interim Analysis|Site Closing|0
832342|NCT00296504|1787560|FG005|Interim Analysis|Site Closing|1
832343|NCT00296504|1787561|FG006|Interim Analysis|Site Closing|2
832344|NCT00296504|1787562|FG007|Interim Analysis|Site Closing|0
832345|NCT00296504|1787563|FG008|Interim Analysis|Site Closing|0
832346|NCT00296504|1787555|FG000|Interim Analysis|Lack of Personnel at Site|1
832347|NCT00296504|1787556|FG001|Interim Analysis|Lack of Personnel at Site|0
832348|NCT00296504|1787557|FG002|Interim Analysis|Lack of Personnel at Site|0
832349|NCT00296504|1787558|FG003|Interim Analysis|Lack of Personnel at Site|0
832350|NCT00296504|1787559|FG004|Interim Analysis|Lack of Personnel at Site|0
832351|NCT00296504|1787560|FG005|Interim Analysis|Lack of Personnel at Site|0
832352|NCT00296504|1787561|FG006|Interim Analysis|Lack of Personnel at Site|0
832353|NCT00296504|1787562|FG007|Interim Analysis|Lack of Personnel at Site|0
832354|NCT00296504|1787563|FG008|Interim Analysis|Lack of Personnel at Site|0
832355|NCT00296504|1787555|FG000|Interim Analysis|Missed Schedule Date|1
832356|NCT00296504|1787556|FG001|Interim Analysis|Missed Schedule Date|0
832357|NCT00296504|1787557|FG002|Interim Analysis|Missed Schedule Date|0
832358|NCT00296504|1787558|FG003|Interim Analysis|Missed Schedule Date|0
832359|NCT00296504|1787559|FG004|Interim Analysis|Missed Schedule Date|0
832360|NCT00296504|1787560|FG005|Interim Analysis|Missed Schedule Date|0
832361|NCT00296504|1787561|FG006|Interim Analysis|Missed Schedule Date|0
832362|NCT00296504|1787562|FG007|Interim Analysis|Missed Schedule Date|0
832363|NCT00296504|1787563|FG008|Interim Analysis|Missed Schedule Date|0
832364|NCT00296504|1787555|FG000|Interim Analysis|Inclusion in Other Protocol|0
832365|NCT00296504|1787556|FG001|Interim Analysis|Inclusion in Other Protocol|0
832366|NCT00296504|1787557|FG002|Interim Analysis|Inclusion in Other Protocol|0
832367|NCT00296504|1787558|FG003|Interim Analysis|Inclusion in Other Protocol|1
832368|NCT00296504|1787559|FG004|Interim Analysis|Inclusion in Other Protocol|0
832369|NCT00296504|1787560|FG005|Interim Analysis|Inclusion in Other Protocol|0
832370|NCT00296504|1787561|FG006|Interim Analysis|Inclusion in Other Protocol|0
832371|NCT00296504|1787562|FG007|Interim Analysis|Inclusion in Other Protocol|0
832372|NCT00296504|1787563|FG008|Interim Analysis|Inclusion in Other Protocol|0
832373|NCT00296504|1787555|FG000|Interim Analysis|Participant Stopped|0
832374|NCT00296504|1787556|FG001|Interim Analysis|Participant Stopped|0
832375|NCT00296504|1787557|FG002|Interim Analysis|Participant Stopped|0
832376|NCT00296504|1787558|FG003|Interim Analysis|Participant Stopped|0
832377|NCT00296504|1787559|FG004|Interim Analysis|Participant Stopped|1
832378|NCT00296504|1787560|FG005|Interim Analysis|Participant Stopped|0
832379|NCT00296504|1787561|FG006|Interim Analysis|Participant Stopped|0
832380|NCT00296504|1787562|FG007|Interim Analysis|Participant Stopped|0
832381|NCT00296504|1787563|FG008|Interim Analysis|Participant Stopped|0
832382|NCT00296504|1787555|FG000|Interim Analysis|Physician and Participant Decision|0
832383|NCT00296504|1787556|FG001|Interim Analysis|Physician and Participant Decision|0
832384|NCT00296504|1787557|FG002|Interim Analysis|Physician and Participant Decision|0
832385|NCT00296504|1787558|FG003|Interim Analysis|Physician and Participant Decision|0
832386|NCT00296504|1787559|FG004|Interim Analysis|Physician and Participant Decision|0
832387|NCT00296504|1787560|FG005|Interim Analysis|Physician and Participant Decision|1
832388|NCT00296504|1787561|FG006|Interim Analysis|Physician and Participant Decision|0
832389|NCT00296504|1787562|FG007|Interim Analysis|Physician and Participant Decision|0
832390|NCT00296504|1787563|FG008|Interim Analysis|Physician and Participant Decision|0
832391|NCT00296504|1787555|FG000|Interim Analysis|Participant Stopped HIV Medications|0
832392|NCT00296504|1787556|FG001|Interim Analysis|Participant Stopped HIV Medications|0
832393|NCT00296504|1787557|FG002|Interim Analysis|Participant Stopped HIV Medications|0
832394|NCT00296504|1787558|FG003|Interim Analysis|Participant Stopped HIV Medications|0
832395|NCT00296504|1787559|FG004|Interim Analysis|Participant Stopped HIV Medications|0
832396|NCT00296504|1787560|FG005|Interim Analysis|Participant Stopped HIV Medications|0
832397|NCT00296504|1787561|FG006|Interim Analysis|Participant Stopped HIV Medications|1
832398|NCT00296504|1787562|FG007|Interim Analysis|Participant Stopped HIV Medications|0
832399|NCT00296504|1787563|FG008|Interim Analysis|Participant Stopped HIV Medications|0
832400|NCT00296504|1787555|FG000|Interim Analysis|Study Ended|0
832401|NCT00296504|1787556|FG001|Interim Analysis|Study Ended|0
832402|NCT00296504|1787557|FG002|Interim Analysis|Study Ended|0
832403|NCT00296504|1787558|FG003|Interim Analysis|Study Ended|0
832404|NCT00296504|1787559|FG004|Interim Analysis|Study Ended|0
832405|NCT00296504|1787560|FG005|Interim Analysis|Study Ended|0
832406|NCT00296504|1787561|FG006|Interim Analysis|Study Ended|1
832407|NCT00296504|1787562|FG007|Interim Analysis|Study Ended|0
832408|NCT00296504|1787563|FG008|Interim Analysis|Study Ended|0
832409|NCT00296504|1787555|FG000|Interim Analysis|Participant Needed Interferon|0
832410|NCT00296504|1787556|FG001|Interim Analysis|Participant Needed Interferon|0
832411|NCT00296504|1787557|FG002|Interim Analysis|Participant Needed Interferon|0
832412|NCT00296504|1787558|FG003|Interim Analysis|Participant Needed Interferon|0
832413|NCT00296504|1787559|FG004|Interim Analysis|Participant Needed Interferon|0
832414|NCT00296504|1787560|FG005|Interim Analysis|Participant Needed Interferon|0
832415|NCT00296504|1787561|FG006|Interim Analysis|Participant Needed Interferon|0
832416|NCT00296504|1787562|FG007|Interim Analysis|Participant Needed Interferon|1
832417|NCT00296504|1787563|FG008|Interim Analysis|Participant Needed Interferon|0
832418|NCT00296504|1787555|FG000|Interim Analysis|Ongoing|32
832419|NCT00296504|1787556|FG001|Interim Analysis|Ongoing|12
832420|NCT00296504|1787557|FG002|Interim Analysis|Ongoing|16
832421|NCT00296504|1787558|FG003|Interim Analysis|Ongoing|22
832422|NCT00296504|1787559|FG004|Interim Analysis|Ongoing|0
832423|NCT00296504|1787560|FG005|Interim Analysis|Ongoing|0
832424|NCT00296504|1787561|FG006|Interim Analysis|Ongoing|30
832425|NCT00296504|1787562|FG007|Interim Analysis|Ongoing|1
832426|NCT00296504|1787563|FG008|Interim Analysis|Ongoing|0
832427|NCT00296504|1787555|FG000|Final Analysis|Withdrawal by Subject|0
832428|NCT00296504|1787556|FG001|Final Analysis|Withdrawal by Subject|0
832429|NCT00296504|1787557|FG002|Final Analysis|Withdrawal by Subject|0
832430|NCT00296504|1787558|FG003|Final Analysis|Withdrawal by Subject|0
832431|NCT00296504|1787559|FG004|Final Analysis|Withdrawal by Subject|0
832432|NCT00296504|1787560|FG005|Final Analysis|Withdrawal by Subject|0
832433|NCT00296504|1787561|FG006|Final Analysis|Withdrawal by Subject|0
832434|NCT00296504|1787562|FG007|Final Analysis|Withdrawal by Subject|0
832435|NCT00296504|1787563|FG008|Final Analysis|Withdrawal by Subject|1
832436|NCT00296504|1787555|FG000|Final Analysis|Lost to Follow-up|0
832437|NCT00296504|1787556|FG001|Final Analysis|Lost to Follow-up|0
832438|NCT00296504|1787557|FG002|Final Analysis|Lost to Follow-up|0
832439|NCT00296504|1787558|FG003|Final Analysis|Lost to Follow-up|0
832440|NCT00296504|1787559|FG004|Final Analysis|Lost to Follow-up|0
832441|NCT00296504|1787560|FG005|Final Analysis|Lost to Follow-up|0
832442|NCT00296504|1787561|FG006|Final Analysis|Lost to Follow-up|0
832443|NCT00296504|1787562|FG007|Final Analysis|Lost to Follow-up|0
832444|NCT00296504|1787563|FG008|Final Analysis|Lost to Follow-up|5
832445|NCT00296504|1787555|FG000|Final Analysis|Insufficient Viral Load Response|0
832446|NCT00296504|1787556|FG001|Final Analysis|Insufficient Viral Load Response|0
832447|NCT00296504|1787557|FG002|Final Analysis|Insufficient Viral Load Response|0
832448|NCT00296504|1787558|FG003|Final Analysis|Insufficient Viral Load Response|0
832449|NCT00296504|1787559|FG004|Final Analysis|Insufficient Viral Load Response|0
832450|NCT00296504|1787560|FG005|Final Analysis|Insufficient Viral Load Response|0
832451|NCT00296504|1787561|FG006|Final Analysis|Insufficient Viral Load Response|0
832452|NCT00296504|1787562|FG007|Final Analysis|Insufficient Viral Load Response|0
832453|NCT00296504|1787563|FG008|Final Analysis|Insufficient Viral Load Response|6
832454|NCT00296504|1787555|FG000|Final Analysis|Adverse Event|0
832455|NCT00296504|1787556|FG001|Final Analysis|Adverse Event|0
832456|NCT00296504|1787557|FG002|Final Analysis|Adverse Event|0
832457|NCT00296504|1787558|FG003|Final Analysis|Adverse Event|0
832458|NCT00296504|1787559|FG004|Final Analysis|Adverse Event|0
832459|NCT00296504|1787560|FG005|Final Analysis|Adverse Event|0
832460|NCT00296504|1787561|FG006|Final Analysis|Adverse Event|0
832461|NCT00296504|1787562|FG007|Final Analysis|Adverse Event|0
832462|NCT00296504|1787563|FG008|Final Analysis|Adverse Event|2
832463|NCT00296504|1787555|FG000|Final Analysis|Pregnancy|0
832464|NCT00296504|1787556|FG001|Final Analysis|Pregnancy|0
832465|NCT00296504|1787557|FG002|Final Analysis|Pregnancy|0
832466|NCT00296504|1787558|FG003|Final Analysis|Pregnancy|0
832467|NCT00296504|1787559|FG004|Final Analysis|Pregnancy|0
832468|NCT00296504|1787560|FG005|Final Analysis|Pregnancy|0
832469|NCT00296504|1787561|FG006|Final Analysis|Pregnancy|0
832470|NCT00296504|1787562|FG007|Final Analysis|Pregnancy|0
832471|NCT00296504|1787563|FG008|Final Analysis|Pregnancy|4
832472|NCT00296504|1787555|FG000|Final Analysis|Tuberculosis|0
832473|NCT00296504|1787556|FG001|Final Analysis|Tuberculosis|0
832474|NCT00296504|1787557|FG002|Final Analysis|Tuberculosis|0
832475|NCT00296504|1787558|FG003|Final Analysis|Tuberculosis|0
832476|NCT00296504|1787559|FG004|Final Analysis|Tuberculosis|0
832477|NCT00296504|1787560|FG005|Final Analysis|Tuberculosis|0
832478|NCT00296504|1787561|FG006|Final Analysis|Tuberculosis|0
832479|NCT00296504|1787562|FG007|Final Analysis|Tuberculosis|0
832480|NCT00296504|1787563|FG008|Final Analysis|Tuberculosis|1
832481|NCT00296504|1787555|FG000|Final Analysis|Participant Moved to Another Country|0
832482|NCT00296504|1787556|FG001|Final Analysis|Participant Moved to Another Country|0
832483|NCT00296504|1787557|FG002|Final Analysis|Participant Moved to Another Country|0
832484|NCT00296504|1787558|FG003|Final Analysis|Participant Moved to Another Country|0
832485|NCT00296504|1787559|FG004|Final Analysis|Participant Moved to Another Country|0
832486|NCT00296504|1787560|FG005|Final Analysis|Participant Moved to Another Country|0
832487|NCT00296504|1787561|FG006|Final Analysis|Participant Moved to Another Country|0
832488|NCT00296504|1787562|FG007|Final Analysis|Participant Moved to Another Country|0
832489|NCT00296504|1787563|FG008|Final Analysis|Participant Moved to Another Country|1
832490|NCT00296504|1787555|FG000|Final Analysis|Poor Adherence|0
832491|NCT00296504|1787556|FG001|Final Analysis|Poor Adherence|0
832492|NCT00296504|1787557|FG002|Final Analysis|Poor Adherence|0
832493|NCT00296504|1787558|FG003|Final Analysis|Poor Adherence|0
832494|NCT00296504|1787559|FG004|Final Analysis|Poor Adherence|0
832495|NCT00296504|1787560|FG005|Final Analysis|Poor Adherence|0
832496|NCT00296504|1787561|FG006|Final Analysis|Poor Adherence|0
832497|NCT00296504|1787562|FG007|Final Analysis|Poor Adherence|0
832498|NCT00296504|1787563|FG008|Final Analysis|Poor Adherence|1
832499|NCT00296517|1787590|FG000|Dose Level 2 - Week 2|Adverse Event|1
832500|NCT00296517|1787591|FG001|Dose Level 2 - Week 2|Adverse Event|5
832501|NCT00296517|1787590|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1
832502|NCT00296517|1787591|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0
832503|NCT00296517|1787590|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30
832504|NCT00296517|1787591|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34
832505|NCT00296517|1787590|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
832506|NCT00296517|1787591|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
832507|NCT00296517|1787590|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
832508|NCT00296517|1787591|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
832509|NCT00296517|1787590|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1
832510|NCT00296517|1787591|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0
832511|NCT00296517|1787590|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
832512|NCT00296517|1787591|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
832513|NCT00296517|1787590|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1
832514|NCT00296517|1787591|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0
832515|NCT00296517|1787590|FG000|Dose Level 3 - Weeks 3-12|Other|0
832516|NCT00296517|1787591|FG001|Dose Level 3 - Weeks 3-12|Other|2
832517|NCT00296647|1787602|FG000|Overall Study|Death|4
832518|NCT00296647|1787603|FG001|Overall Study|Death|1
832519|NCT00296647|1787604|FG002|Overall Study|Death|2
832520|NCT00296647|1787605|FG003|Overall Study|Death|1
832521|NCT00296647|1787606|FG004|Overall Study|Death|1
832522|NCT00296647|1787602|FG000|Overall Study|Withdrawal by Subject|28
832523|NCT00296647|1787603|FG001|Overall Study|Withdrawal by Subject|27
832524|NCT00296647|1787604|FG002|Overall Study|Withdrawal by Subject|32
832525|NCT00296647|1787605|FG003|Overall Study|Withdrawal by Subject|16
832526|NCT00296647|1787606|FG004|Overall Study|Withdrawal by Subject|19
832527|NCT00296725|1787618|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
832528|NCT00296725|1787618|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
832529|NCT00296725|1787618|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
832530|NCT00296816|1787626|FG000|Overall Study|Disease Progression|37
832531|NCT00296816|1787626|FG000|Overall Study|Adverse Event|18
832532|NCT00296816|1787626|FG000|Overall Study|Investigator/Participant request|5
832533|NCT00296816|1787626|FG000|Overall Study|Non-compliance|1
832534|NCT00296816|1787626|FG000|Overall Study|Missing for end of treatment|4
832535|NCT00296816|1787626|FG000|Overall Study|Progression based on CA-125 (biomarker)|2
832536|NCT00296816|1787626|FG000|Overall Study|Poor performance status|1
832537|NCT00296816|1787626|FG000|Overall Study|Relocation to Florida|1
832538|NCT00296816|1787626|FG000|Overall Study|Noncompliance/decision to discontinue|1
832539|NCT00296816|1787626|FG000|Overall Study|Urine protein/creatinine ratio delay|1
832540|NCT00296816|1787626|FG000|Overall Study|Neuropathy/patient preference|1
832541|NCT00296816|1787626|FG000|Overall Study|Proteinuria|1
832542|NCT00296816|1787626|FG000|Overall Study|ineligibility due to radiation treatment|1
832543|NCT00297037|1787632|FG000|Overall Study|Withdrawal by Subject|2
832544|NCT00297037|1787633|FG001|Overall Study|Withdrawal by Subject|0
832545|NCT00297167|1787659|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
832546|NCT00297167|1787660|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
832547|NCT00297167|1787661|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
832548|NCT00297167|1787659|FG000|Second Double-blind Intervention Period|Protocol Violation|1
832549|NCT00297167|1787660|FG001|Second Double-blind Intervention Period|Protocol Violation|0
832550|NCT00297167|1787661|FG002|Second Double-blind Intervention Period|Protocol Violation|0
832551|NCT00297232|1787668|FG000|Overall Study|Lack of Efficacy|7
832552|NCT00297232|1787668|FG000|Overall Study|Lost to Follow-up|10
832553|NCT00297232|1787668|FG000|Overall Study|Adverse Event|63
832554|NCT00297232|1787668|FG000|Overall Study|Voluntary Withdrawal|120
832555|NCT00297232|1787668|FG000|Overall Study|Subject was Noncompliant|9
832556|NCT00297232|1787668|FG000|Overall Study|Death|9
832557|NCT00297232|1787668|FG000|Overall Study|Anti-natalizumab Positive|8
832558|NCT00297232|1787668|FG000|Overall Study|Switched to Commercial Tysabri|22
832559|NCT00297232|1787668|FG000|Overall Study|Disease Progression|8
832560|NCT00297232|1787668|FG000|Overall Study|Fear of PML|10
832561|NCT00297232|1787668|FG000|Overall Study|Anti-JCV Antibody Positive|13
832562|NCT00297232|1787668|FG000|Overall Study|Miscellaneous|5
832563|NCT00297232|1787668|FG000|Overall Study|Sponsor Decision|34
832564|NCT00297232|1787668|FG000|Overall Study|Subject Relocated|7
832565|NCT00297232|1787668|FG000|Overall Study|Subject Withdrew Consent|37
832566|NCT00297232|1787668|FG000|Overall Study|Persistently Positive Antibodies|11
832567|NCT00297232|1787668|FG000|Overall Study|Investigator Withdrew From Program|19
832568|NCT00297232|1787668|FG000|Overall Study|Did Not Enroll to Week 264|34
832569|NCT00297232|1787668|FG000|Overall Study|Did Not Enroll to Week 480|17
832570|NCT00297232|1787668|FG000|Overall Study|No data available after Week 264|161
832571|NCT00297232|1787668|FG000|Overall Study|Other|1
832572|NCT00297258|1787672|FG000|Overall Study|Disease Progression, Relapse, Death|120
832573|NCT00297258|1787672|FG000|Overall Study|Toxicity (or Toxic Death)|10
832574|NCT00297258|1787672|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2
832575|NCT00297258|1787672|FG000|Overall Study|Intercurrent Illness|3
832576|NCT00297258|1787672|FG000|Overall Study|Intercurrent Death|2
832577|NCT00297258|1787672|FG000|Overall Study|Deteriorization of General Condition|1
832578|NCT00297258|1787672|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1
832579|NCT00297258|1787672|FG000|Overall Study|Surgery Performed on Target Lesion|1
832580|NCT00297258|1787672|FG000|Overall Study|Switch to Commercial Treatment|1
832581|NCT00297258|1787672|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1
832582|NCT00297427|1787681|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8
832583|NCT00297427|1787682|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5
832584|NCT00297427|1787681|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0
832585|NCT00297427|1787682|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3
832586|NCT00297427|1787681|FG000|Phase 1: Initial Intervention|Death|0
832587|NCT00297427|1787682|FG001|Phase 1: Initial Intervention|Death|1
832588|NCT00297427|1787681|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
832589|NCT00297427|1787682|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
832590|NCT00297427|1787681|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
832591|NCT00297427|1787682|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
832592|NCT00297427|1787681|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
832593|NCT00297427|1787682|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
832594|NCT00297427|1787681|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
832595|NCT00297427|1787682|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
832596|NCT00297427|1787681|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
832597|NCT00297427|1787682|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
832598|NCT00297479|1787699|FG000|Overall Study|Lost to Follow-up|37
832599|NCT00297479|1787700|FG001|Overall Study|Lost to Follow-up|54
832600|NCT00297479|1787701|FG002|Overall Study|Lost to Follow-up|51
832601|NCT00297492|1787712|FG000|Set Quit Date|Lost to Follow-up|7
832602|NCT00297492|1787713|FG001|Set Quit Date|Lost to Follow-up|13
832603|NCT00297492|1787714|FG002|Set Quit Date|Lost to Follow-up|5
832604|NCT00297492|1787712|FG000|6 Month Follow-up|Lost to Follow-up|63
832605|NCT00297492|1787713|FG001|6 Month Follow-up|Lost to Follow-up|49
832606|NCT00297492|1787714|FG002|6 Month Follow-up|Lost to Follow-up|27
832607|NCT00297648|1787726|FG000|Overall Study|Adverse Event|13
832608|NCT00297648|1787726|FG000|Overall Study|Lack of Efficacy|18
832609|NCT00297648|1787726|FG000|Overall Study|Lost to Follow-up|1
832610|NCT00297648|1787726|FG000|Overall Study|Withdrawal by Subject|3
832611|NCT00297648|1787726|FG000|Overall Study|Other: Incompliance|1
832612|NCT00297778|1787732|FG000|Overall Study|Adverse Event|16
832613|NCT00297778|1787733|FG001|Overall Study|Adverse Event|10
832614|NCT00297778|1787732|FG000|Overall Study|Withdrawal by Subject|1
832615|NCT00297778|1787733|FG001|Overall Study|Withdrawal by Subject|5
832616|NCT00297778|1787732|FG000|Overall Study|Lack of Efficacy|2
832617|NCT00297778|1787733|FG001|Overall Study|Lack of Efficacy|1
832618|NCT00297778|1787732|FG000|Overall Study|Non-compliant with trial protocol|0
832619|NCT00297778|1787733|FG001|Overall Study|Non-compliant with trial protocol|3
832620|NCT00297778|1787732|FG000|Overall Study|Other|0
832621|NCT00297778|1787733|FG001|Overall Study|Other|1
832622|NCT00297830|1787742|FG000|6 Month Visit|Death|1
832623|NCT00297830|1787743|FG001|6 Month Visit|Death|0
832624|NCT00297830|1787744|FG002|6 Month Visit|Death|2
832625|NCT00297830|1787742|FG000|6 Month Visit|Withdrawal by Subject|2
832626|NCT00297830|1787743|FG001|6 Month Visit|Withdrawal by Subject|1
832627|NCT00297830|1787744|FG002|6 Month Visit|Withdrawal by Subject|1
832628|NCT00297830|1787742|FG000|6 Month Visit|Adverse Event|0
832629|NCT00297830|1787743|FG001|6 Month Visit|Adverse Event|1
832630|NCT00297830|1787744|FG002|6 Month Visit|Adverse Event|0
832631|NCT00297830|1787742|FG000|12 Month Visit|Lost to Follow-up|1
832632|NCT00297830|1787743|FG001|12 Month Visit|Lost to Follow-up|0
832633|NCT00297830|1787744|FG002|12 Month Visit|Lost to Follow-up|0
832634|NCT00297830|1787742|FG000|12 Month Visit|Adverse Event|0
832635|NCT00297830|1787743|FG001|12 Month Visit|Adverse Event|3
832636|NCT00297830|1787744|FG002|12 Month Visit|Adverse Event|0
832637|NCT00297830|1787742|FG000|12 Month Visit|Withdrawal by Subject|0
832638|NCT00297830|1787743|FG001|12 Month Visit|Withdrawal by Subject|3
832639|NCT00297830|1787744|FG002|12 Month Visit|Withdrawal by Subject|0
832640|NCT00297882|1787754|FG000|Day 14|Lack of Efficacy|12
832641|NCT00297882|1787755|FG001|Day 14|Lack of Efficacy|49
832642|NCT00297882|1787754|FG000|Day 28|Lost to Follow-up|13
832643|NCT00297882|1787755|FG001|Day 28|Lost to Follow-up|23
832644|NCT00297882|1787754|FG000|Day 28|Lack of Efficacy|3
832645|NCT00297882|1787755|FG001|Day 28|Lack of Efficacy|0
832646|NCT00298038|1787765|FG000|Overall Study|Lost to Follow-up|0
832647|NCT00298038|1787766|FG001|Overall Study|Lost to Follow-up|1
832648|NCT00298038|1787765|FG000|Overall Study|Liver Transplant|0
832649|NCT00298038|1787766|FG001|Overall Study|Liver Transplant|1
832650|NCT00298038|1787765|FG000|Overall Study|Protocol Violation|1
832651|NCT00298038|1787766|FG001|Overall Study|Protocol Violation|3
832652|NCT00298038|1787765|FG000|Overall Study|Death|6
832653|NCT00298038|1787766|FG001|Overall Study|Death|3
832654|NCT00298038|1787765|FG000|Overall Study|Withdrawal by Subject|6
832655|NCT00298038|1787766|FG001|Overall Study|Withdrawal by Subject|9
832656|NCT00298038|1787765|FG000|Overall Study|Adverse Event|8
832657|NCT00298038|1787766|FG001|Overall Study|Adverse Event|7
832658|NCT00298038|1787765|FG000|Overall Study|Breakthrough overt HE episode|28
832659|NCT00298038|1787766|FG001|Overall Study|Breakthrough overt HE episode|69
832660|NCT00298038|1787765|FG000|Overall Study|Noncompliance|1
832661|NCT00298038|1787766|FG001|Overall Study|Noncompliance|0
832662|NCT00298038|1787765|FG000|Overall Study|Cocaine Abuse|1
832663|NCT00298038|1787766|FG001|Overall Study|Cocaine Abuse|0
832664|NCT00298038|1787765|FG000|Overall Study|Severe Gastrointestinal Bleed|1
832665|NCT00298038|1787766|FG001|Overall Study|Severe Gastrointestinal Bleed|0
832666|NCT00298272|1787802|FG000|Double-blind Phase|Adverse Event|2
832667|NCT00298272|1787803|FG001|Double-blind Phase|Adverse Event|0
832668|NCT00298272|1787802|FG000|Double-blind Phase|Failure to Return|2
832669|NCT00298272|1787803|FG001|Double-blind Phase|Failure to Return|0
832670|NCT00298272|1787802|FG000|Double-blind Phase|Protocol Violation|2
832671|NCT00298272|1787803|FG001|Double-blind Phase|Protocol Violation|0
832672|NCT00298272|1787802|FG000|Double-blind Phase|Withdrawal by Subject|2
832673|NCT00298272|1787803|FG001|Double-blind Phase|Withdrawal by Subject|0
832674|NCT00298272|1787802|FG000|Open Label Retreatment Phase|Adverse Event|1
832675|NCT00298272|1787803|FG001|Open Label Retreatment Phase|Adverse Event|2
832676|NCT00298272|1787802|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
832677|NCT00298272|1787803|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
832678|NCT00298272|1787802|FG000|Open Label Retreatment Phase|Failure to Return|1
832679|NCT00298272|1787803|FG001|Open Label Retreatment Phase|Failure to Return|0
832680|NCT00298272|1787802|FG000|Open Label Retreatment Phase|Protocol Violation|2
832681|NCT00298272|1787803|FG001|Open Label Retreatment Phase|Protocol Violation|1
832682|NCT00298272|1787802|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1
832683|NCT00298272|1787803|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0
832684|NCT00298272|1787802|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2
832685|NCT00298272|1787803|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0
832686|NCT00298272|1787802|FG000|Safety Follow-up Phase|Failure to Return|1
832687|NCT00298272|1787803|FG001|Safety Follow-up Phase|Failure to Return|1
832688|NCT00298272|1787802|FG000|Safety Follow-up Phase|Withdrawal by Subject|2
832689|NCT00298272|1787803|FG001|Safety Follow-up Phase|Withdrawal by Subject|2
832690|NCT00298272|1787802|FG000|Safety Follow-up Phase|Administrative/Other Reason|1
832691|NCT00298272|1787803|FG001|Safety Follow-up Phase|Administrative/Other Reason|1
832692|NCT00298363|1787815|FG000|Overall Study|Lost to Follow-up|0
832693|NCT00298363|1787816|FG001|Overall Study|Lost to Follow-up|0
832694|NCT00298363|1787817|FG002|Overall Study|Lost to Follow-up|1
832695|NCT00298363|1787815|FG000|Overall Study|Physician Decision|4
832696|NCT00298363|1787816|FG001|Overall Study|Physician Decision|1
832697|NCT00298363|1787817|FG002|Overall Study|Physician Decision|0
832698|NCT00298363|1787815|FG000|Overall Study|Protocol Violation|1
832699|NCT00298363|1787816|FG001|Overall Study|Protocol Violation|1
832700|NCT00298363|1787817|FG002|Overall Study|Protocol Violation|0
832701|NCT00298363|1787815|FG000|Overall Study|Withdrawal by Subject|5
832702|NCT00298363|1787816|FG001|Overall Study|Withdrawal by Subject|1
832703|NCT00298363|1787817|FG002|Overall Study|Withdrawal by Subject|3
832704|NCT00298363|1787815|FG000|Overall Study|Adverse Event|5
832705|NCT00298363|1787816|FG001|Overall Study|Adverse Event|2
832706|NCT00298363|1787817|FG002|Overall Study|Adverse Event|2
832707|NCT00298363|1787815|FG000|Overall Study|Lack of Efficacy|2
832708|NCT00298363|1787816|FG001|Overall Study|Lack of Efficacy|3
832709|NCT00298363|1787817|FG002|Overall Study|Lack of Efficacy|0
832710|NCT00298766|1787865|FG000|Overall Study|Adverse Event|18
832711|NCT00298766|1787865|FG000|Overall Study|Death|2
832712|NCT00298766|1787865|FG000|Overall Study|Withdrawal by Subject|9
832713|NCT00298766|1787865|FG000|Overall Study|Treatment ongoing|4
832714|NCT00298766|1787865|FG000|Overall Study|Progression of amyloid markers|4
832715|NCT00298766|1787865|FG000|Overall Study|Deterioration in KPS and organ function|1
832716|NCT00298766|1787865|FG000|Overall Study|Subjects overall condition deterioration|4
832717|NCT00298766|1787865|FG000|Overall Study|Other|4
832718|NCT00298831|1787869|FG000|Overall Study|Adverse Event|1
832719|NCT00298831|1787869|FG000|Overall Study|Lost to Follow-up|3
832720|NCT00298831|1787869|FG000|Overall Study|Withdrawal by Subject|1
832721|NCT00298831|1787869|FG000|Overall Study|Participants did not receive treatment|27
832722|NCT00298896|1787873|FG000|Overall Study|Death|3
832723|NCT00298896|1787873|FG000|Overall Study|Physician Decision|2
832724|NCT00298896|1787873|FG000|Overall Study|Intercurrent Illness|1
832725|NCT00298896|1787873|FG000|Overall Study|Disease Progression|41
832726|NCT00298896|1787873|FG000|Overall Study|Withdrawal by Subject|2
832727|NCT00298896|1787873|FG000|Overall Study|Assigned to treatment in error|1
832728|NCT00299104|1787889|FG000|Treatment Period|Adverse Event|14
832729|NCT00299104|1787890|FG001|Treatment Period|Adverse Event|9
832730|NCT00299104|1787891|FG002|Treatment Period|Adverse Event|7
832731|NCT00299104|1787889|FG000|Treatment Period|Death|1
832732|NCT00299104|1787890|FG001|Treatment Period|Death|1
832733|NCT00299104|1787891|FG002|Treatment Period|Death|1
832734|NCT00299104|1787889|FG000|Treatment Period|Insufficient therapeutic response|34
832735|NCT00299104|1787890|FG001|Treatment Period|Insufficient therapeutic response|13
832736|NCT00299104|1787891|FG002|Treatment Period|Insufficient therapeutic response|8
832737|NCT00299104|1787889|FG000|Treatment Period|Failure to return|9
832738|NCT00299104|1787890|FG001|Treatment Period|Failure to return|8
832739|NCT00299104|1787891|FG002|Treatment Period|Failure to return|8
832740|NCT00299104|1787889|FG000|Treatment Period|Violation of selection criteria|1
832741|NCT00299104|1787890|FG001|Treatment Period|Violation of selection criteria|2
832742|NCT00299104|1787891|FG002|Treatment Period|Violation of selection criteria|0
832743|NCT00299104|1787889|FG000|Treatment Period|Protocol Violation|1
832744|NCT00299104|1787890|FG001|Treatment Period|Protocol Violation|1
832745|NCT00299104|1787891|FG002|Treatment Period|Protocol Violation|0
832746|NCT00299104|1787889|FG000|Treatment Period|Refused treatment|9
832747|NCT00299104|1787890|FG001|Treatment Period|Refused treatment|2
832748|NCT00299104|1787891|FG002|Treatment Period|Refused treatment|2
832749|NCT00299104|1787889|FG000|Treatment Period|Withdrew consent|14
832750|NCT00299104|1787890|FG001|Treatment Period|Withdrew consent|19
832751|NCT00299104|1787891|FG002|Treatment Period|Withdrew consent|9
832752|NCT00299104|1787889|FG000|Treatment Period|Administrative reasons|106
832753|NCT00299104|1787890|FG001|Treatment Period|Administrative reasons|120
832754|NCT00299104|1787891|FG002|Treatment Period|Administrative reasons|137
832755|NCT00299104|1787889|FG000|Safety Follow-Up (SFU) Period|Death|3
832756|NCT00299104|1787890|FG001|Safety Follow-Up (SFU) Period|Death|2
832757|NCT00299104|1787891|FG002|Safety Follow-Up (SFU) Period|Death|1
832758|NCT00299104|1787889|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
832759|NCT00299104|1787890|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
832760|NCT00299104|1787891|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
832761|NCT00299104|1787889|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
832762|NCT00299104|1787890|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
832763|NCT00299104|1787891|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
832764|NCT00299104|1787889|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27
832765|NCT00299104|1787890|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7
832766|NCT00299104|1787891|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5
832767|NCT00299104|1787889|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0
832768|NCT00299104|1787890|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1
832769|NCT00299104|1787891|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0
832770|NCT00299104|1787889|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
832771|NCT00299104|1787890|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
832772|NCT00299104|1787891|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
832773|NCT00299104|1787889|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
832774|NCT00299104|1787890|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
832775|NCT00299104|1787891|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
832776|NCT00299104|1787889|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
832777|NCT00299104|1787890|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
832778|NCT00299104|1787891|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
832779|NCT00299130|1787902|FG000|Treatment Period (up to 5 Years)|Adverse Event|13
832780|NCT00299130|1787903|FG001|Treatment Period (up to 5 Years)|Adverse Event|8
832781|NCT00299130|1787904|FG002|Treatment Period (up to 5 Years)|Adverse Event|13
832782|NCT00299130|1787902|FG000|Treatment Period (up to 5 Years)|Death|1
832783|NCT00299130|1787903|FG001|Treatment Period (up to 5 Years)|Death|3
832784|NCT00299130|1787904|FG002|Treatment Period (up to 5 Years)|Death|1
832785|NCT00299130|1787902|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
832786|NCT00299130|1787903|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
832787|NCT00299130|1787904|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
832788|NCT00299130|1787902|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0
832789|NCT00299130|1787903|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1
832790|NCT00299130|1787904|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0
832791|NCT00299130|1787902|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12
832792|NCT00299130|1787903|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12
832793|NCT00299130|1787904|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19
832794|NCT00299130|1787902|FG000|Treatment Period (up to 5 Years)|Failure to Return|4
832795|NCT00299130|1787903|FG001|Treatment Period (up to 5 Years)|Failure to Return|6
832796|NCT00299130|1787904|FG002|Treatment Period (up to 5 Years)|Failure to Return|6
832797|NCT00299130|1787902|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4
832798|NCT00299130|1787903|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6
832799|NCT00299130|1787904|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4
832800|NCT00299130|1787902|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
832801|NCT00299130|1787903|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
832802|NCT00299130|1787904|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
832803|NCT00299130|1787902|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
832804|NCT00299130|1787903|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
832805|NCT00299130|1787904|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
832806|NCT00299130|1787902|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4
832807|NCT00299130|1787903|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5
832808|NCT00299130|1787904|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3
832809|NCT00299130|1787902|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
832810|NCT00299130|1787903|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
832811|NCT00299130|1787904|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
832812|NCT00299130|1787902|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
832813|NCT00299130|1787903|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
832814|NCT00299130|1787904|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
832815|NCT00299130|1787902|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
832816|NCT00299130|1787903|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
832817|NCT00299130|1787904|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
832818|NCT00299130|1787902|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
832819|NCT00299130|1787903|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
832820|NCT00299130|1787904|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
832821|NCT00299130|1787902|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
832822|NCT00299130|1787903|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
832823|NCT00299130|1787904|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
832824|NCT00299130|1787902|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
832825|NCT00299130|1787903|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
832826|NCT00299130|1787904|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
832827|NCT00299130|1787902|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
832828|NCT00299130|1787903|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
832829|NCT00299130|1787904|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
832830|NCT00299156|1787922|FG000|Period 2 (Randomized)|Screen Failure|0
832831|NCT00299156|1787923|FG001|Period 2 (Randomized)|Screen Failure|1
832832|NCT00299156|1787924|FG002|Period 2 (Randomized)|Screen Failure|0
832833|NCT00299182|1787939|FG000|Overall Study|Withdrawal by Subject|0
832834|NCT00299182|1787940|FG001|Overall Study|Withdrawal by Subject|0
832835|NCT00299182|1787941|FG002|Overall Study|Withdrawal by Subject|1
832836|NCT00299182|1787942|FG003|Overall Study|Withdrawal by Subject|0
832837|NCT00299182|1787943|FG004|Overall Study|Withdrawal by Subject|1
832838|NCT00299182|1787944|FG005|Overall Study|Withdrawal by Subject|2
832839|NCT00299182|1787945|FG006|Overall Study|Withdrawal by Subject|0
832840|NCT00299182|1787939|FG000|Overall Study|Chemotherapy Changed|0
832841|NCT00299182|1787940|FG001|Overall Study|Chemotherapy Changed|0
832842|NCT00299182|1787941|FG002|Overall Study|Chemotherapy Changed|1
832843|NCT00299182|1787942|FG003|Overall Study|Chemotherapy Changed|0
832844|NCT00299182|1787943|FG004|Overall Study|Chemotherapy Changed|1
832845|NCT00299182|1787944|FG005|Overall Study|Chemotherapy Changed|0
832846|NCT00299182|1787945|FG006|Overall Study|Chemotherapy Changed|1
832847|NCT00299182|1787939|FG000|Overall Study|Adverse Event|0
832848|NCT00299182|1787940|FG001|Overall Study|Adverse Event|0
832849|NCT00299182|1787941|FG002|Overall Study|Adverse Event|0
832850|NCT00299182|1787942|FG003|Overall Study|Adverse Event|0
832851|NCT00299182|1787943|FG004|Overall Study|Adverse Event|0
832852|NCT00299182|1787944|FG005|Overall Study|Adverse Event|1
832853|NCT00299182|1787945|FG006|Overall Study|Adverse Event|0
832854|NCT00299182|1787939|FG000|Overall Study|Not Eligible|0
832855|NCT00299182|1787940|FG001|Overall Study|Not Eligible|0
832856|NCT00299182|1787941|FG002|Overall Study|Not Eligible|0
832857|NCT00299182|1787942|FG003|Overall Study|Not Eligible|0
832858|NCT00299182|1787943|FG004|Overall Study|Not Eligible|1
832859|NCT00299182|1787944|FG005|Overall Study|Not Eligible|0
832860|NCT00299182|1787945|FG006|Overall Study|Not Eligible|0
832861|NCT00299494|1787982|FG000|Overall Study|Withdrawal by Subject|0
832862|NCT00299494|1787983|FG001|Overall Study|Withdrawal by Subject|0
832863|NCT00299494|1787984|FG002|Overall Study|Withdrawal by Subject|0
832864|NCT00299494|1787985|FG003|Overall Study|Withdrawal by Subject|3
832865|NCT00299494|1787986|FG004|Overall Study|Withdrawal by Subject|1
832866|NCT00299494|1787987|FG005|Overall Study|Withdrawal by Subject|4
832867|NCT00299494|1787982|FG000|Overall Study|Physician Decision|0
832868|NCT00299494|1787983|FG001|Overall Study|Physician Decision|0
832869|NCT00299494|1787984|FG002|Overall Study|Physician Decision|0
832870|NCT00299494|1787985|FG003|Overall Study|Physician Decision|0
832871|NCT00299494|1787986|FG004|Overall Study|Physician Decision|1
832872|NCT00299494|1787987|FG005|Overall Study|Physician Decision|0
832873|NCT00299494|1787982|FG000|Overall Study|Death|3
832874|NCT00299494|1787983|FG001|Overall Study|Death|1
832875|NCT00299494|1787984|FG002|Overall Study|Death|4
832876|NCT00299494|1787985|FG003|Overall Study|Death|6
832877|NCT00299494|1787986|FG004|Overall Study|Death|18
832878|NCT00299494|1787987|FG005|Overall Study|Death|19
832879|NCT00299494|1787982|FG000|Overall Study|Lost to Follow-up|0
832880|NCT00299494|1787983|FG001|Overall Study|Lost to Follow-up|0
832881|NCT00299494|1787984|FG002|Overall Study|Lost to Follow-up|0
832882|NCT00299494|1787985|FG003|Overall Study|Lost to Follow-up|0
832883|NCT00299494|1787986|FG004|Overall Study|Lost to Follow-up|3
832884|NCT00299494|1787987|FG005|Overall Study|Lost to Follow-up|1
832885|NCT00299494|1787982|FG000|Overall Study|Other - Unspecified|0
832886|NCT00299494|1787983|FG001|Overall Study|Other - Unspecified|0
832887|NCT00299494|1787984|FG002|Overall Study|Other - Unspecified|0
832888|NCT00299494|1787985|FG003|Overall Study|Other - Unspecified|0
832889|NCT00299494|1787986|FG004|Overall Study|Other - Unspecified|3
832890|NCT00299494|1787987|FG005|Overall Study|Other - Unspecified|1
832891|NCT00299494|1787982|FG000|Overall Study|Other - site closure|0
832892|NCT00299494|1787983|FG001|Overall Study|Other - site closure|0
832893|NCT00299494|1787984|FG002|Overall Study|Other - site closure|0
832894|NCT00299494|1787985|FG003|Overall Study|Other - site closure|1
832895|NCT00299494|1787986|FG004|Overall Study|Other - site closure|1
832896|NCT00299494|1787987|FG005|Overall Study|Other - site closure|1
832897|NCT00299546|1788015|FG000|Overall Study|Death|3
832898|NCT00299546|1788016|FG001|Overall Study|Death|2
832899|NCT00299546|1788017|FG002|Overall Study|Death|0
832900|NCT00299546|1788015|FG000|Overall Study|Lost to Follow-up|2
832901|NCT00299546|1788016|FG001|Overall Study|Lost to Follow-up|2
832902|NCT00299546|1788017|FG002|Overall Study|Lost to Follow-up|5
832903|NCT00299546|1788015|FG000|Overall Study|Adverse Event|37
832904|NCT00299546|1788016|FG001|Overall Study|Adverse Event|22
832905|NCT00299546|1788017|FG002|Overall Study|Adverse Event|27
832906|NCT00299546|1788015|FG000|Overall Study|Unsatisfactory therapeutic effect|34
832907|NCT00299546|1788016|FG001|Overall Study|Unsatisfactory therapeutic effect|39
832908|NCT00299546|1788017|FG002|Overall Study|Unsatisfactory therapeutic effect|34
832909|NCT00299546|1788015|FG000|Overall Study|Other|24
832910|NCT00299546|1788016|FG001|Overall Study|Other|26
832911|NCT00299546|1788017|FG002|Overall Study|Other|19
832912|NCT00299546|1788015|FG000|Overall Study|Not treated|0
832913|NCT00299546|1788016|FG001|Overall Study|Not treated|1
832914|NCT00299546|1788017|FG002|Overall Study|Not treated|1
832915|NCT00299702|1788032|FG000|Overall Study|Death|1
832916|NCT00299702|1788033|FG001|Overall Study|Death|0
832917|NCT00299702|1788032|FG000|Overall Study|Adverse Event|0
832918|NCT00299702|1788033|FG001|Overall Study|Adverse Event|4
832919|NCT00299702|1788032|FG000|Overall Study|Lost to Follow-up|18
832920|NCT00299702|1788033|FG001|Overall Study|Lost to Follow-up|10
832921|NCT00299702|1788032|FG000|Overall Study|Withdrawal by Subject|25
832922|NCT00299702|1788033|FG001|Overall Study|Withdrawal by Subject|23
832923|NCT00299702|1788032|FG000|Overall Study|Pregnancy|0
832924|NCT00299702|1788033|FG001|Overall Study|Pregnancy|1
832925|NCT00299702|1788032|FG000|Overall Study|Insufficient Response|4
832926|NCT00299702|1788033|FG001|Overall Study|Insufficient Response|3
832927|NCT00299702|1788032|FG000|Overall Study|Admin issues, sponsor decision, etc.|5
832928|NCT00299702|1788033|FG001|Overall Study|Admin issues, sponsor decision, etc.|9
832929|NCT00299975|1788046|FG000|Overall Study|Adverse Event|1
832930|NCT00299975|1788047|FG001|Overall Study|Adverse Event|0
832931|NCT00299975|1788048|FG002|Overall Study|Adverse Event|2
832932|NCT00299975|1788046|FG000|Overall Study|Pregnancy|0
832933|NCT00299975|1788047|FG001|Overall Study|Pregnancy|0
832934|NCT00299975|1788048|FG002|Overall Study|Pregnancy|1
832935|NCT00299975|1788046|FG000|Overall Study|Lack of Efficacy|1
832936|NCT00299975|1788047|FG001|Overall Study|Lack of Efficacy|0
832937|NCT00299975|1788048|FG002|Overall Study|Lack of Efficacy|1
832938|NCT00299975|1788046|FG000|Overall Study|Lost to Follow-up|1
832939|NCT00299975|1788047|FG001|Overall Study|Lost to Follow-up|0
832940|NCT00299975|1788048|FG002|Overall Study|Lost to Follow-up|0
832941|NCT00299975|1788046|FG000|Overall Study|Withdrawal by Subject|0
832942|NCT00299975|1788047|FG001|Overall Study|Withdrawal by Subject|1
832943|NCT00299975|1788048|FG002|Overall Study|Withdrawal by Subject|3
832944|NCT00299975|1788046|FG000|Overall Study|Physician Decision|0
832945|NCT00299975|1788047|FG001|Overall Study|Physician Decision|0
832946|NCT00299975|1788048|FG002|Overall Study|Physician Decision|1
832947|NCT00300053|1788069|FG000|Overall Study|Patient/Caregiver Preference|2
832948|NCT00300053|1788070|FG001|Overall Study|Patient/Caregiver Preference|2
832949|NCT00300053|1788071|FG002|Overall Study|Patient/Caregiver Preference|3
832950|NCT00300053|1788069|FG000|Overall Study|Death|0
832951|NCT00300053|1788070|FG001|Overall Study|Death|0
832952|NCT00300053|1788071|FG002|Overall Study|Death|3
832953|NCT00300053|1788069|FG000|Overall Study|Lost to Follow-up|0
832954|NCT00300053|1788070|FG001|Overall Study|Lost to Follow-up|1
832955|NCT00300053|1788071|FG002|Overall Study|Lost to Follow-up|0
832956|NCT00300274|1788104|FG000|Overall Study|Withdrawal by Subject|12
832957|NCT00300274|1788105|FG001|Overall Study|Withdrawal by Subject|3
832958|NCT00300274|1788106|FG002|Overall Study|Withdrawal by Subject|14
832959|NCT00300274|1788104|FG000|Overall Study|Lost to Follow-up|3
832960|NCT00300274|1788105|FG001|Overall Study|Lost to Follow-up|4
832961|NCT00300274|1788106|FG002|Overall Study|Lost to Follow-up|5
832962|NCT00300274|1788104|FG000|Overall Study|Death|31
832963|NCT00300274|1788105|FG001|Overall Study|Death|20
832964|NCT00300274|1788106|FG002|Overall Study|Death|25
832965|NCT00300274|1788104|FG000|Overall Study|Re-transplant|0
832966|NCT00300274|1788105|FG001|Overall Study|Re-transplant|0
832967|NCT00300274|1788106|FG002|Overall Study|Re-transplant|1
832968|NCT00300365|1788116|FG000|Overall Study|Lost to Follow-up|1
832969|NCT00300365|1788117|FG001|Overall Study|Lost to Follow-up|0
832970|NCT00300365|1788116|FG000|Overall Study|Physician Decision|2
832971|NCT00300365|1788117|FG001|Overall Study|Physician Decision|0
832972|NCT00300365|1788116|FG000|Overall Study|Withdrawal by Subject|1
832973|NCT00300365|1788117|FG001|Overall Study|Withdrawal by Subject|0
832974|NCT00300365|1788116|FG000|Overall Study|Adverse Event|0
832975|NCT00300365|1788117|FG001|Overall Study|Adverse Event|2
832976|NCT00300495|1788223|FG000|Overall Study|Protocol Violation|4
832977|NCT00300495|1788224|FG001|Overall Study|Protocol Violation|1
832978|NCT00300755|1788242|FG000|Overall Study|Adverse Event|1
832979|NCT00300755|1788243|FG001|Overall Study|Adverse Event|2
832980|NCT00300755|1788244|FG002|Overall Study|Adverse Event|1
832981|NCT00300755|1788242|FG000|Overall Study|Withdrawal by Subject|0
832982|NCT00300755|1788243|FG001|Overall Study|Withdrawal by Subject|2
832983|NCT00300755|1788244|FG002|Overall Study|Withdrawal by Subject|0
832984|NCT00300755|1788242|FG000|Overall Study|Protocol Violation|0
832985|NCT00300755|1788243|FG001|Overall Study|Protocol Violation|0
832986|NCT00300755|1788244|FG002|Overall Study|Protocol Violation|1
832987|NCT00300781|1788254|FG000|Overall Study|Disease Progression|55
832988|NCT00300781|1788255|FG001|Overall Study|Disease Progression|52
832989|NCT00300781|1788254|FG000|Overall Study|Adverse Event|5
832990|NCT00300781|1788255|FG001|Overall Study|Adverse Event|6
832991|NCT00300781|1788254|FG000|Overall Study|Withdrawal by Subject|1
832992|NCT00300781|1788255|FG001|Overall Study|Withdrawal by Subject|2
832993|NCT00300781|1788254|FG000|Overall Study|Physician Decision|1
832994|NCT00300781|1788255|FG001|Overall Study|Physician Decision|0
832995|NCT00300781|1788254|FG000|Overall Study|Not Recorded|0
832996|NCT00300781|1788255|FG001|Overall Study|Not Recorded|1
832997|NCT00300781|1788254|FG000|Overall Study|Symptomatic Deterioration|1
832998|NCT00300781|1788255|FG001|Overall Study|Symptomatic Deterioration|0
832999|NCT00300781|1788254|FG000|Overall Study|Lost to Follow-up|0
833000|NCT00300781|1788255|FG001|Overall Study|Lost to Follow-up|1
833001|NCT00300885|1788263|FG000|Treatment|Adverse Event|134
833002|NCT00300885|1788264|FG001|Treatment|Adverse Event|82
833003|NCT00300885|1788263|FG000|Treatment|Death|20
833004|NCT00300885|1788264|FG001|Treatment|Death|7
833005|NCT00300885|1788263|FG000|Treatment|Lack of Efficacy|1
833006|NCT00300885|1788264|FG001|Treatment|Lack of Efficacy|1
833007|NCT00300885|1788263|FG000|Treatment|Lost to Follow-up|3
833008|NCT00300885|1788264|FG001|Treatment|Lost to Follow-up|2
833009|NCT00300885|1788263|FG000|Treatment|Physician Decision|4
833010|NCT00300885|1788264|FG001|Treatment|Physician Decision|5
833011|NCT00300885|1788263|FG000|Treatment|Protocol Violation|11
833012|NCT00300885|1788264|FG001|Treatment|Protocol Violation|11
833013|NCT00300885|1788263|FG000|Treatment|Withdrawal by Subject|26
833014|NCT00300885|1788264|FG001|Treatment|Withdrawal by Subject|23
833015|NCT00300885|1788263|FG000|Treatment|Disease progression|171
833016|NCT00300885|1788264|FG001|Treatment|Disease progression|238
833017|NCT00300885|1788263|FG000|Treatment|Random code broken (subject died)|0
833018|NCT00300885|1788264|FG001|Treatment|Random code broken (subject died)|1
833019|NCT00300885|1788263|FG000|Treatment|Non-compliant with study medication|3
833020|NCT00300885|1788264|FG001|Treatment|Non-compliant with study medication|4
833021|NCT00300885|1788263|FG000|Follow-up|Death|141
833022|NCT00300885|1788264|FG001|Follow-up|Death|163
833023|NCT00300885|1788263|FG000|Follow-up|Lost to Follow-up|11
833024|NCT00300885|1788264|FG001|Follow-up|Lost to Follow-up|7
833025|NCT00300885|1788263|FG000|Follow-up|Withdrawal by Subject|26
833026|NCT00300885|1788264|FG001|Follow-up|Withdrawal by Subject|25
833027|NCT00301067|1788274|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1
833028|NCT00301067|1788275|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0
833029|NCT00301067|1788276|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0
833030|NCT00301067|1788277|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1
833031|NCT00301067|1788274|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2
833032|NCT00301067|1788275|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1
833033|NCT00301067|1788276|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1
833034|NCT00301067|1788277|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2
833035|NCT00301067|1788274|FG000|Completed 4 Cycles of Treatment|Progressive disease|1
833036|NCT00301067|1788275|FG001|Completed 4 Cycles of Treatment|Progressive disease|1
833037|NCT00301067|1788276|FG002|Completed 4 Cycles of Treatment|Progressive disease|2
833038|NCT00301067|1788277|FG003|Completed 4 Cycles of Treatment|Progressive disease|5
833039|NCT00301067|1788274|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0
833040|NCT00301067|1788275|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1
833041|NCT00301067|1788276|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0
833042|NCT00301067|1788277|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1
833043|NCT00301067|1788274|FG000|Completed 12 Cycles of Treatment|Adverse Event|0
833044|NCT00301067|1788275|FG001|Completed 12 Cycles of Treatment|Adverse Event|0
833045|NCT00301067|1788276|FG002|Completed 12 Cycles of Treatment|Adverse Event|0
833046|NCT00301067|1788277|FG003|Completed 12 Cycles of Treatment|Adverse Event|1
833047|NCT00301067|1788274|FG000|Follow up Until Death|Alive at last data cut point|1
833048|NCT00301067|1788275|FG001|Follow up Until Death|Alive at last data cut point|0
833049|NCT00301067|1788276|FG002|Follow up Until Death|Alive at last data cut point|0
833050|NCT00301067|1788277|FG003|Follow up Until Death|Alive at last data cut point|1
833051|NCT00301262|1788290|FG000|Double Blind Phase (DB)|Adverse Event|1
833052|NCT00301262|1788291|FG001|Double Blind Phase (DB)|Adverse Event|0
833053|NCT00301262|1788290|FG000|Double Blind Phase (DB)|Lack of Efficacy|0
833054|NCT00301262|1788291|FG001|Double Blind Phase (DB)|Lack of Efficacy|1
833055|NCT00301262|1788290|FG000|Double Blind Phase (DB)|Lost to Follow-up|3
833056|NCT00301262|1788291|FG001|Double Blind Phase (DB)|Lost to Follow-up|3
833057|NCT00301262|1788290|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5
833058|NCT00301262|1788291|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5
833059|NCT00301262|1788290|FG000|Double Blind Phase (DB)|Other|1
833060|NCT00301262|1788291|FG001|Double Blind Phase (DB)|Other|4
833061|NCT00301262|1788290|FG000|Open Label Phase (OL)|Adverse Event|1
833062|NCT00301262|1788291|FG001|Open Label Phase (OL)|Adverse Event|0
833063|NCT00301262|1788290|FG000|Open Label Phase (OL)|Lost to Follow-up|1
833064|NCT00301262|1788291|FG001|Open Label Phase (OL)|Lost to Follow-up|2
833065|NCT00301262|1788290|FG000|Open Label Phase (OL)|Other|2
833066|NCT00301262|1788291|FG001|Open Label Phase (OL)|Other|0
833067|NCT00301366|1788316|FG000|Overall Study|Adverse Event|1
833068|NCT00301808|1788330|FG000|Overall Study|Adverse Event|5
833069|NCT00301808|1788330|FG000|Overall Study|Death|3
833070|NCT00301808|1788330|FG000|Overall Study|Lack of Efficacy|4
833071|NCT00301821|1788334|FG000|Overall Study|Ineligible|25
833072|NCT00301821|1788334|FG000|Overall Study|Cancel|1
833073|NCT00301834|1788338|FG000|Overall Study|Death|1
833074|NCT00301964|1788349|FG000|Overall Study|Second primary|2
833075|NCT00301964|1788349|FG000|Overall Study|Wrong primary|1
833076|NCT00301964|1788349|FG000|Overall Study|Inadequate pathology|1
833077|NCT00302003|1788359|FG000|Overall Study|Lack of Efficacy|62
833078|NCT00302003|1788359|FG000|Overall Study|Lost to Follow-up|1
833079|NCT00302003|1788359|FG000|Overall Study|Physician Decision|2
833080|NCT00302003|1788359|FG000|Overall Study|Withdrawal by Subject|5
833081|NCT00302003|1788359|FG000|Overall Study|Ineligible|9
833082|NCT00302003|1788359|FG000|Overall Study|Protocol Violation|1
833083|NCT00302081|1788398|FG000|Overall Study|Adverse Event|6
833084|NCT00302081|1788399|FG001|Overall Study|Adverse Event|5
833085|NCT00302081|1788400|FG002|Overall Study|Adverse Event|4
833086|NCT00302081|1788398|FG000|Overall Study|Lost to Follow-up|21
833087|NCT00302081|1788399|FG001|Overall Study|Lost to Follow-up|18
833088|NCT00302081|1788400|FG002|Overall Study|Lost to Follow-up|28
833089|NCT00302081|1788398|FG000|Overall Study|Withdrawal by Subject|8
833090|NCT00302081|1788399|FG001|Overall Study|Withdrawal by Subject|12
833091|NCT00302081|1788400|FG002|Overall Study|Withdrawal by Subject|8
833092|NCT00302081|1788398|FG000|Overall Study|Protocol Violation|5
833093|NCT00302081|1788399|FG001|Overall Study|Protocol Violation|1
833094|NCT00302081|1788400|FG002|Overall Study|Protocol Violation|2
833095|NCT00302081|1788398|FG000|Overall Study|Lack of Efficacy|1
833096|NCT00302081|1788399|FG001|Overall Study|Lack of Efficacy|0
833097|NCT00302081|1788400|FG002|Overall Study|Lack of Efficacy|5
833098|NCT00302081|1788398|FG000|Overall Study|Death|2
833099|NCT00302081|1788399|FG001|Overall Study|Death|1
833100|NCT00302081|1788400|FG002|Overall Study|Death|0
833101|NCT00302081|1788398|FG000|Overall Study|Other|13
833102|NCT00302081|1788399|FG001|Overall Study|Other|6
833103|NCT00302081|1788400|FG002|Overall Study|Other|5
833104|NCT00302107|1788410|FG000|Overall Study|Lost to Follow-up|6
833105|NCT00302107|1788411|FG001|Overall Study|Lost to Follow-up|5
833106|NCT00302107|1788410|FG000|Overall Study|Protocol Violation|1
833107|NCT00302107|1788411|FG001|Overall Study|Protocol Violation|0
833108|NCT00302107|1788410|FG000|Overall Study|Relocation|0
833109|NCT00302107|1788411|FG001|Overall Study|Relocation|1
833110|NCT00302107|1788410|FG000|Overall Study|Withdrawal by Subject|0
833111|NCT00302107|1788411|FG001|Overall Study|Withdrawal by Subject|3
833112|NCT00302107|1788410|FG000|Overall Study|Adverse Event|1
833113|NCT00302107|1788411|FG001|Overall Study|Adverse Event|0
833114|NCT00302159|1788426|FG000|Overall Study|pt declined before treatment started|1
833115|NCT00302159|1788426|FG000|Overall Study|pt started Avastin|1
833116|NCT00302211|1788434|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2
833117|NCT00302211|1788435|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1
833118|NCT00302211|1788436|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0
833119|NCT00302211|1788437|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0
833120|NCT00302211|1788438|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0
833121|NCT00302211|1788434|FG000|Double Blind Period (New Patients)|Adverse Event|0
833122|NCT00302211|1788435|FG001|Double Blind Period (New Patients)|Adverse Event|0
833123|NCT00302211|1788436|FG002|Double Blind Period (New Patients)|Adverse Event|3
833124|NCT00302211|1788437|FG003|Double Blind Period (New Patients)|Adverse Event|0
833125|NCT00302211|1788438|FG004|Double Blind Period (New Patients)|Adverse Event|0
833126|NCT00302211|1788434|FG000|Double Blind Period (New Patients)|Investigator's judgement|1
833127|NCT00302211|1788435|FG001|Double Blind Period (New Patients)|Investigator's judgement|0
833128|NCT00302211|1788436|FG002|Double Blind Period (New Patients)|Investigator's judgement|0
833129|NCT00302211|1788437|FG003|Double Blind Period (New Patients)|Investigator's judgement|0
833130|NCT00302211|1788438|FG004|Double Blind Period (New Patients)|Investigator's judgement|0
833131|NCT00302211|1788434|FG000|Double Blind Period (New Patients)|Disease progression|0
833132|NCT00302211|1788435|FG001|Double Blind Period (New Patients)|Disease progression|1
833133|NCT00302211|1788436|FG002|Double Blind Period (New Patients)|Disease progression|1
833134|NCT00302211|1788437|FG003|Double Blind Period (New Patients)|Disease progression|0
833135|NCT00302211|1788438|FG004|Double Blind Period (New Patients)|Disease progression|0
833136|NCT00302211|1788434|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
833137|NCT00302211|1788435|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
833138|NCT00302211|1788436|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
833139|NCT00302211|1788437|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
833140|NCT00302211|1788438|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
833141|NCT00302211|1788434|FG000|Open Label-Patients From Double-Blind|Adverse Event|0
833142|NCT00302211|1788435|FG001|Open Label-Patients From Double-Blind|Adverse Event|0
833143|NCT00302211|1788436|FG002|Open Label-Patients From Double-Blind|Adverse Event|0
833144|NCT00302211|1788437|FG003|Open Label-Patients From Double-Blind|Adverse Event|1
833145|NCT00302211|1788438|FG004|Open Label-Patients From Double-Blind|Adverse Event|0
833146|NCT00302211|1788434|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0
833147|NCT00302211|1788435|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0
833148|NCT00302211|1788436|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0
833149|NCT00302211|1788437|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1
833150|NCT00302211|1788438|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0
833151|NCT00302211|1788434|FG000|Open Label-Patients From Double-Blind|Disease progression|0
833152|NCT00302211|1788435|FG001|Open Label-Patients From Double-Blind|Disease progression|0
833153|NCT00302211|1788436|FG002|Open Label-Patients From Double-Blind|Disease progression|0
833154|NCT00302211|1788437|FG003|Open Label-Patients From Double-Blind|Disease progression|1
833155|NCT00302211|1788438|FG004|Open Label-Patients From Double-Blind|Disease progression|2
833156|NCT00302211|1788434|FG000|Open Label-Patients From Double-Blind|Death|0
833157|NCT00302211|1788435|FG001|Open Label-Patients From Double-Blind|Death|0
833158|NCT00302211|1788436|FG002|Open Label-Patients From Double-Blind|Death|0
833159|NCT00302211|1788437|FG003|Open Label-Patients From Double-Blind|Death|1
833160|NCT00302211|1788438|FG004|Open Label-Patients From Double-Blind|Death|1
833161|NCT00302211|1788434|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0
833162|NCT00302211|1788435|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0
833163|NCT00302211|1788436|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0
833164|NCT00302211|1788437|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0
833165|NCT00302211|1788438|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1
833166|NCT00302211|1788434|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
833167|NCT00302211|1788435|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
833168|NCT00302211|1788436|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
833169|NCT00302211|1788437|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
833170|NCT00302211|1788438|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
833171|NCT00302211|1788434|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
833172|NCT00302211|1788435|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
833173|NCT00302211|1788436|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
833174|NCT00302211|1788437|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
833175|NCT00302211|1788438|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
833176|NCT00302328|1788453|FG000|Overall Study|Physician Decision|0
833177|NCT00302328|1788454|FG001|Overall Study|Physician Decision|1
833178|NCT00302328|1788455|FG002|Overall Study|Physician Decision|0
833179|NCT00302458|1788466|FG000|Overall Study|Lost to Follow-up|1
833180|NCT00302458|1788466|FG000|Overall Study|Ineligible after screening|1
833181|NCT00302458|1788466|FG000|Overall Study|Withdrawal by Subject|1
833182|NCT00302718|1788478|FG000|Overall Study|Participant left the hospital|1
833183|NCT00302718|1788479|FG001|Overall Study|Participant left the hospital|0
833184|NCT00302718|1788480|FG002|Overall Study|Participant left the hospital|0
833185|NCT00302718|1788481|FG003|Overall Study|Participant left the hospital|1
833186|NCT00302718|1788478|FG000|Overall Study|Withdrawal by Subject|0
833187|NCT00302718|1788479|FG001|Overall Study|Withdrawal by Subject|1
833188|NCT00302718|1788480|FG002|Overall Study|Withdrawal by Subject|0
833189|NCT00302718|1788481|FG003|Overall Study|Withdrawal by Subject|0
833190|NCT00302718|1788478|FG000|Overall Study|Participant left primary care setting|0
833191|NCT00302718|1788479|FG001|Overall Study|Participant left primary care setting|0
833192|NCT00302718|1788480|FG002|Overall Study|Participant left primary care setting|2
833193|NCT00302718|1788481|FG003|Overall Study|Participant left primary care setting|1
833194|NCT00302731|1788500|FG000|Overall Study|Lost to Follow-up|1
833195|NCT00302731|1788501|FG001|Overall Study|Lost to Follow-up|2
833196|NCT00302731|1788502|FG002|Overall Study|Lost to Follow-up|0
833197|NCT00302731|1788503|FG003|Overall Study|Lost to Follow-up|0
833198|NCT00302731|1788500|FG000|Overall Study|Adverse Event|0
833199|NCT00302731|1788501|FG001|Overall Study|Adverse Event|2
833200|NCT00302731|1788502|FG002|Overall Study|Adverse Event|2
833201|NCT00302731|1788503|FG003|Overall Study|Adverse Event|0
833202|NCT00302731|1788500|FG000|Overall Study|Withdrawal by Subject|1
833203|NCT00302731|1788501|FG001|Overall Study|Withdrawal by Subject|1
833204|NCT00302731|1788502|FG002|Overall Study|Withdrawal by Subject|0
833205|NCT00302731|1788503|FG003|Overall Study|Withdrawal by Subject|0
833206|NCT00302731|1788500|FG000|Overall Study|Protocol Violation|1
833207|NCT00302731|1788501|FG001|Overall Study|Protocol Violation|0
833208|NCT00302731|1788502|FG002|Overall Study|Protocol Violation|0
833209|NCT00302731|1788503|FG003|Overall Study|Protocol Violation|0
833210|NCT00302731|1788500|FG000|Overall Study|cancer unrelated to study discovered|1
833211|NCT00302731|1788501|FG001|Overall Study|cancer unrelated to study discovered|0
833212|NCT00302731|1788502|FG002|Overall Study|cancer unrelated to study discovered|1
833213|NCT00302731|1788503|FG003|Overall Study|cancer unrelated to study discovered|0
833214|NCT00302952|1788527|FG000|Overall Study|Physician Decision|1
833215|NCT00302952|1788528|FG001|Overall Study|Physician Decision|1
833216|NCT00302952|1788527|FG000|Overall Study|Withdrawal by Subject|2
833217|NCT00302952|1788528|FG001|Overall Study|Withdrawal by Subject|3
833218|NCT00302952|1788527|FG000|Overall Study|Elevated SGOT (AST) lab value|0
833219|NCT00302952|1788528|FG001|Overall Study|Elevated SGOT (AST) lab value|1
833220|NCT00303069|1788538|FG000|Overall Study|Lost to Follow-up|1
833221|NCT00303069|1788539|FG001|Overall Study|Lost to Follow-up|0
833222|NCT00303069|1788540|FG002|Overall Study|Lost to Follow-up|0
833223|NCT00303069|1788541|FG003|Overall Study|Lost to Follow-up|2
833224|NCT00303069|1788538|FG000|Overall Study|subject moved|1
833225|NCT00303069|1788539|FG001|Overall Study|subject moved|0
833226|NCT00303069|1788540|FG002|Overall Study|subject moved|0
833227|NCT00303069|1788541|FG003|Overall Study|subject moved|0
833228|NCT00303069|1788538|FG000|Overall Study|Recruitment into Army Reserves|0
833229|NCT00303069|1788539|FG001|Overall Study|Recruitment into Army Reserves|0
833230|NCT00303069|1788540|FG002|Overall Study|Recruitment into Army Reserves|1
833231|NCT00303069|1788541|FG003|Overall Study|Recruitment into Army Reserves|0
833232|NCT00303108|1788554|FG000|Overall Study|Adverse Event|5
833233|NCT00303108|1788555|FG001|Overall Study|Adverse Event|6
833234|NCT00303108|1788556|FG002|Overall Study|Adverse Event|7
833235|NCT00303108|1788554|FG000|Overall Study|Patient Request|4
833236|NCT00303108|1788555|FG001|Overall Study|Patient Request|2
833237|NCT00303108|1788556|FG002|Overall Study|Patient Request|8
833238|NCT00303108|1788554|FG000|Overall Study|Failed Entry|1
833239|NCT00303108|1788555|FG001|Overall Study|Failed Entry|0
833240|NCT00303108|1788556|FG002|Overall Study|Failed Entry|1
833241|NCT00303108|1788554|FG000|Overall Study|ineligible|2
833242|NCT00303108|1788555|FG001|Overall Study|ineligible|1
833243|NCT00303108|1788556|FG002|Overall Study|ineligible|0
833244|NCT00303186|1788563|FG000|Overall Study|Other|52
833245|NCT00303316|1788569|FG000|Overall Study|Protocol Violation|1
833246|NCT00303316|1788570|FG001|Overall Study|Protocol Violation|0
833247|NCT00303316|1788569|FG000|Overall Study|Lost to Follow-up|0
833248|NCT00303316|1788570|FG001|Overall Study|Lost to Follow-up|1
833249|NCT00303316|1788569|FG000|Overall Study|Withdrawal by Subject|1
833250|NCT00303316|1788570|FG001|Overall Study|Withdrawal by Subject|2
833251|NCT00303329|1788578|FG000|Overall Study|Adverse Event|7
833252|NCT00303329|1788579|FG001|Overall Study|Adverse Event|14
833253|NCT00303329|1788578|FG000|Overall Study|Abnormal Laboratory Values|0
833254|NCT00303329|1788579|FG001|Overall Study|Abnormal Laboratory Values|1
833255|NCT00303329|1788578|FG000|Overall Study|Unsatisfactory therapeutic effect|9
833256|NCT00303329|1788579|FG001|Overall Study|Unsatisfactory therapeutic effect|2
833257|NCT00303329|1788578|FG000|Overall Study|Condition no longer requires study drug|0
833258|NCT00303329|1788579|FG001|Overall Study|Condition no longer requires study drug|8
833259|NCT00303329|1788578|FG000|Overall Study|Protocol Violation|3
833260|NCT00303329|1788579|FG001|Overall Study|Protocol Violation|0
833261|NCT00303329|1788578|FG000|Overall Study|Withdrawal by Subject|9
833262|NCT00303329|1788579|FG001|Overall Study|Withdrawal by Subject|15
833263|NCT00303329|1788578|FG000|Overall Study|Lost to Follow-up|0
833264|NCT00303329|1788579|FG001|Overall Study|Lost to Follow-up|1
833265|NCT00303329|1788578|FG000|Overall Study|Administrative problems|1
833266|NCT00303329|1788579|FG001|Overall Study|Administrative problems|0
833267|NCT00303329|1788578|FG000|Overall Study|Death|2
833268|NCT00303329|1788579|FG001|Overall Study|Death|12
833269|NCT00303329|1788578|FG000|Overall Study|Stopped at end of core|3
833270|NCT00303329|1788579|FG001|Overall Study|Stopped at end of core|9
833271|NCT00303329|1788578|FG000|Overall Study|Stopped at end of extension 1|1
833272|NCT00303329|1788579|FG001|Overall Study|Stopped at end of extension 1|0
833273|NCT00303446|1788587|FG000|Overall Study|Withdrawal by Subject|2
833274|NCT00303446|1788588|FG001|Overall Study|Withdrawal by Subject|2
833275|NCT00303446|1788587|FG000|Overall Study|Death|0
833276|NCT00303446|1788588|FG001|Overall Study|Death|1
833277|NCT00303446|1788587|FG000|Overall Study|Physician Decision|0
833278|NCT00303446|1788588|FG001|Overall Study|Physician Decision|1
833279|NCT00303459|1788596|FG000|Overall Study|Death|33
833280|NCT00303459|1788597|FG001|Overall Study|Death|44
833281|NCT00303459|1788596|FG000|Overall Study|Withdrawal of consent|32
833282|NCT00303459|1788597|FG001|Overall Study|Withdrawal of consent|26
833283|NCT00303459|1788596|FG000|Overall Study|Lost to Follow-up|5
833284|NCT00303459|1788597|FG001|Overall Study|Lost to Follow-up|4
833285|NCT00303459|1788596|FG000|Overall Study|Administrative reason|7
833286|NCT00303459|1788597|FG001|Overall Study|Administrative reason|7
833287|NCT00303459|1788596|FG000|Overall Study|Decision by the investigator|5
833288|NCT00303459|1788597|FG001|Overall Study|Decision by the investigator|7
833289|NCT00303459|1788596|FG000|Overall Study|Lung transplantation|1
833290|NCT00303459|1788597|FG001|Overall Study|Lung transplantation|1
833291|NCT00303472|1788611|FG000|Treatment Period|Adverse Event|0
833292|NCT00303472|1788612|FG001|Treatment Period|Adverse Event|0
833293|NCT00303472|1788613|FG002|Treatment Period|Adverse Event|0
833294|NCT00303472|1788614|FG003|Treatment Period|Adverse Event|0
833295|NCT00303472|1788615|FG004|Treatment Period|Adverse Event|1
833296|NCT00303472|1788616|FG005|Treatment Period|Adverse Event|0
833297|NCT00303472|1788617|FG006|Treatment Period|Adverse Event|0
833298|NCT00303472|1788611|FG000|Treatment Period|Death|0
833299|NCT00303472|1788612|FG001|Treatment Period|Death|0
833300|NCT00303472|1788613|FG002|Treatment Period|Death|0
833301|NCT00303472|1788614|FG003|Treatment Period|Death|1
833302|NCT00303472|1788615|FG004|Treatment Period|Death|0
833303|NCT00303472|1788616|FG005|Treatment Period|Death|0
833304|NCT00303472|1788617|FG006|Treatment Period|Death|1
833305|NCT00303472|1788611|FG000|Treatment Period|Withdrawal by Subject|0
833306|NCT00303472|1788612|FG001|Treatment Period|Withdrawal by Subject|0
833307|NCT00303472|1788613|FG002|Treatment Period|Withdrawal by Subject|0
833308|NCT00303472|1788614|FG003|Treatment Period|Withdrawal by Subject|1
833309|NCT00303472|1788615|FG004|Treatment Period|Withdrawal by Subject|0
833310|NCT00303472|1788616|FG005|Treatment Period|Withdrawal by Subject|1
833311|NCT00303472|1788617|FG006|Treatment Period|Withdrawal by Subject|0
833312|NCT00303472|1788611|FG000|Treatment Period|Other|0
833313|NCT00303472|1788612|FG001|Treatment Period|Other|0
833314|NCT00303472|1788613|FG002|Treatment Period|Other|0
833315|NCT00303472|1788614|FG003|Treatment Period|Other|0
833316|NCT00303472|1788615|FG004|Treatment Period|Other|1
833317|NCT00303472|1788616|FG005|Treatment Period|Other|0
833318|NCT00303472|1788617|FG006|Treatment Period|Other|1
833319|NCT00303472|1788611|FG000|Treatment Period|Disease Progression (to AML)|0
833320|NCT00303472|1788612|FG001|Treatment Period|Disease Progression (to AML)|0
833321|NCT00303472|1788613|FG002|Treatment Period|Disease Progression (to AML)|0
833322|NCT00303472|1788614|FG003|Treatment Period|Disease Progression (to AML)|0
833323|NCT00303472|1788615|FG004|Treatment Period|Disease Progression (to AML)|1
833324|NCT00303472|1788616|FG005|Treatment Period|Disease Progression (to AML)|0
833325|NCT00303472|1788617|FG006|Treatment Period|Disease Progression (to AML)|0
833326|NCT00303472|1788611|FG000|Treatment Extension (Optional)|Adverse Event|1
833327|NCT00303472|1788612|FG001|Treatment Extension (Optional)|Adverse Event|0
833328|NCT00303472|1788613|FG002|Treatment Extension (Optional)|Adverse Event|1
833329|NCT00303472|1788614|FG003|Treatment Extension (Optional)|Adverse Event|0
833330|NCT00303472|1788615|FG004|Treatment Extension (Optional)|Adverse Event|0
833331|NCT00303472|1788616|FG005|Treatment Extension (Optional)|Adverse Event|0
833332|NCT00303472|1788617|FG006|Treatment Extension (Optional)|Adverse Event|0
833333|NCT00303472|1788611|FG000|Treatment Extension (Optional)|Death|2
833334|NCT00303472|1788612|FG001|Treatment Extension (Optional)|Death|0
833335|NCT00303472|1788613|FG002|Treatment Extension (Optional)|Death|1
833336|NCT00303472|1788614|FG003|Treatment Extension (Optional)|Death|0
833337|NCT00303472|1788615|FG004|Treatment Extension (Optional)|Death|0
833338|NCT00303472|1788616|FG005|Treatment Extension (Optional)|Death|0
833339|NCT00303472|1788617|FG006|Treatment Extension (Optional)|Death|0
833340|NCT00303472|1788611|FG000|Treatment Extension (Optional)|Lost to Follow-up|0
833341|NCT00303472|1788612|FG001|Treatment Extension (Optional)|Lost to Follow-up|0
833342|NCT00303472|1788613|FG002|Treatment Extension (Optional)|Lost to Follow-up|0
833343|NCT00303472|1788614|FG003|Treatment Extension (Optional)|Lost to Follow-up|1
833344|NCT00303472|1788615|FG004|Treatment Extension (Optional)|Lost to Follow-up|0
833345|NCT00303472|1788616|FG005|Treatment Extension (Optional)|Lost to Follow-up|0
833346|NCT00303472|1788617|FG006|Treatment Extension (Optional)|Lost to Follow-up|0
833347|NCT00303472|1788611|FG000|Treatment Extension (Optional)|Physician Decision|0
833348|NCT00303472|1788612|FG001|Treatment Extension (Optional)|Physician Decision|4
833349|NCT00303472|1788613|FG002|Treatment Extension (Optional)|Physician Decision|2
833350|NCT00303472|1788614|FG003|Treatment Extension (Optional)|Physician Decision|3
833351|NCT00303472|1788615|FG004|Treatment Extension (Optional)|Physician Decision|2
833352|NCT00303472|1788616|FG005|Treatment Extension (Optional)|Physician Decision|0
833353|NCT00303472|1788617|FG006|Treatment Extension (Optional)|Physician Decision|0
833354|NCT00303472|1788611|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1
833355|NCT00303472|1788612|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0
833356|NCT00303472|1788613|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1
833357|NCT00303472|1788614|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2
833358|NCT00303472|1788615|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1
833359|NCT00303472|1788616|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0
833360|NCT00303472|1788617|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0
833361|NCT00303472|1788611|FG000|Treatment Extension (Optional)|Other|0
833362|NCT00303472|1788612|FG001|Treatment Extension (Optional)|Other|2
833363|NCT00303472|1788613|FG002|Treatment Extension (Optional)|Other|4
833364|NCT00303472|1788614|FG003|Treatment Extension (Optional)|Other|2
833365|NCT00303472|1788615|FG004|Treatment Extension (Optional)|Other|1
833366|NCT00303472|1788616|FG005|Treatment Extension (Optional)|Other|0
833367|NCT00303472|1788617|FG006|Treatment Extension (Optional)|Other|0
833368|NCT00303472|1788611|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1
833369|NCT00303472|1788612|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0
833370|NCT00303472|1788613|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0
833371|NCT00303472|1788614|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0
833372|NCT00303472|1788615|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0
833373|NCT00303472|1788616|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1
833374|NCT00303472|1788617|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0
833375|NCT00303485|1788635|FG000|Overall Study|Adverse Event/Intercurrent Illness|0
833376|NCT00303485|1788636|FG001|Overall Study|Adverse Event/Intercurrent Illness|1
833377|NCT00303485|1788635|FG000|Overall Study|Failure to return|0
833378|NCT00303485|1788636|FG001|Overall Study|Failure to return|1
833379|NCT00303485|1788635|FG000|Overall Study|Withdrawal by Subject|1
833380|NCT00303485|1788636|FG001|Overall Study|Withdrawal by Subject|0
833381|NCT00303602|1788648|FG000|Overall Study|Adverse Event|2
833382|NCT00303602|1788649|FG001|Overall Study|Adverse Event|2
833383|NCT00303602|1788648|FG000|Overall Study|Withdrawal by Subject|5
833384|NCT00303602|1788649|FG001|Overall Study|Withdrawal by Subject|6
833385|NCT00303602|1788648|FG000|Overall Study|Lost to Follow-up|5
833386|NCT00303602|1788649|FG001|Overall Study|Lost to Follow-up|2
833387|NCT00303602|1788648|FG000|Overall Study|Protocol entry criteria not met|2
833388|NCT00303602|1788649|FG001|Overall Study|Protocol entry criteria not met|2
833389|NCT00303602|1788648|FG000|Overall Study|Physician Decision|2
833390|NCT00303602|1788649|FG001|Overall Study|Physician Decision|1
833391|NCT00303602|1788648|FG000|Overall Study|Noncompliance|2
833392|NCT00303602|1788649|FG001|Overall Study|Noncompliance|2
833393|NCT00303602|1788648|FG000|Overall Study|Protocol Violation|1
833394|NCT00303602|1788649|FG001|Overall Study|Protocol Violation|0
833395|NCT00303628|1788657|FG000|Overall Study|Disease progression|0
833396|NCT00303628|1788658|FG001|Overall Study|Disease progression|1
833397|NCT00303628|1788657|FG000|Overall Study|Adverse Event|26
833398|NCT00303628|1788658|FG001|Overall Study|Adverse Event|36
833399|NCT00303628|1788657|FG000|Overall Study|Death|0
833400|NCT00303628|1788658|FG001|Overall Study|Death|1
833401|NCT00303628|1788657|FG000|Overall Study|Withdrawal by Subject|11
833402|NCT00303628|1788658|FG001|Overall Study|Withdrawal by Subject|20
833403|NCT00303628|1788657|FG000|Overall Study|Alternative therapy|2
833404|NCT00303628|1788658|FG001|Overall Study|Alternative therapy|0
833405|NCT00303628|1788657|FG000|Overall Study|Other complicating disease|0
833406|NCT00303628|1788658|FG001|Overall Study|Other complicating disease|1
833407|NCT00303628|1788657|FG000|Overall Study|Not start protocol therapy|3
833408|NCT00303628|1788658|FG001|Overall Study|Not start protocol therapy|5
833409|NCT00303628|1788657|FG000|Overall Study|Other|8
833410|NCT00303628|1788658|FG001|Overall Study|Other|9
833411|NCT00303667|1788666|FG000|Overall Study|Death|0
833412|NCT00303667|1788667|FG001|Overall Study|Death|4
833413|NCT00303719|1788675|FG000|Overall Study|Not evaluable, prior therapies|0
833414|NCT00303719|1788676|FG001|Overall Study|Not evaluable, prior therapies|30
833415|NCT00303719|1788675|FG000|Overall Study|Lost to Follow-up|0
833416|NCT00303719|1788676|FG001|Overall Study|Lost to Follow-up|7
833417|NCT00303953|1788700|FG000|Overall Study|Ineligible|1
833418|NCT00303953|1788700|FG000|Overall Study|Death|1
833419|NCT00303953|1788700|FG000|Overall Study|Adverse Event|4
833420|NCT00303953|1788700|FG000|Overall Study|Lack of Efficacy|12
833421|NCT00303953|1788700|FG000|Overall Study|Physician Decision|1
833422|NCT00304031|1788733|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144
833423|NCT00304031|1788734|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
833424|NCT00304031|1788735|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
833425|NCT00304031|1788733|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48
833426|NCT00304031|1788734|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
833427|NCT00304031|1788735|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
833428|NCT00304031|1788733|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19
833429|NCT00304031|1788734|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
833430|NCT00304031|1788735|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
833431|NCT00304031|1788733|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18
833432|NCT00304031|1788734|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0
833433|NCT00304031|1788735|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0
833434|NCT00304031|1788733|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15
833435|NCT00304031|1788734|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
833436|NCT00304031|1788735|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
833437|NCT00304031|1788733|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10
833438|NCT00304031|1788734|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
833439|NCT00304031|1788735|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
833440|NCT00304031|1788733|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1
833441|NCT00304031|1788734|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
833442|NCT00304031|1788735|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
833443|NCT00304031|1788733|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37
833444|NCT00304031|1788734|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
833445|NCT00304031|1788735|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
833446|NCT00304031|1788733|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
833447|NCT00304031|1788734|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
833448|NCT00304031|1788735|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
833449|NCT00304070|1788753|FG000|Overall Study|Death|0
833450|NCT00304070|1788754|FG001|Overall Study|Death|0
833451|NCT00304070|1788755|FG002|Overall Study|Death|3
833452|NCT00304070|1788753|FG000|Overall Study|Lost to Follow-up|0
833453|NCT00304070|1788754|FG001|Overall Study|Lost to Follow-up|0
833454|NCT00304070|1788755|FG002|Overall Study|Lost to Follow-up|1
833455|NCT00304070|1788753|FG000|Overall Study|Physician Decision|0
833456|NCT00304070|1788754|FG001|Overall Study|Physician Decision|0
833457|NCT00304070|1788755|FG002|Overall Study|Physician Decision|3
833458|NCT00304070|1788753|FG000|Overall Study|Withdrawal by Subject|0
833459|NCT00304070|1788754|FG001|Overall Study|Withdrawal by Subject|0
833460|NCT00304070|1788755|FG002|Overall Study|Withdrawal by Subject|1
833461|NCT00304070|1788753|FG000|Overall Study|Progressive Disease|3
833462|NCT00304070|1788754|FG001|Overall Study|Progressive Disease|7
833463|NCT00304070|1788755|FG002|Overall Study|Progressive Disease|4
833464|NCT00304083|1788769|FG000|Overall Study|Withdrawal by Subject|4
833465|NCT00304083|1788770|FG001|Overall Study|Withdrawal by Subject|2
833466|NCT00304083|1788769|FG000|Overall Study|Physician Decision|8
833467|NCT00304083|1788770|FG001|Overall Study|Physician Decision|3
833468|NCT00304083|1788769|FG000|Overall Study|Disease Progression|5
833469|NCT00304083|1788770|FG001|Overall Study|Disease Progression|1
833470|NCT00304083|1788769|FG000|Overall Study|Other|5
833471|NCT00304083|1788770|FG001|Overall Study|Other|2
833472|NCT00304278|1788814|FG000|Overall Study|lack of insurance coverage for chemoRT|1
833473|NCT00304278|1788814|FG000|Overall Study|PT had medical condition preventing TX|1
833474|NCT00304356|1788818|FG000|Nitazoxanide|Physician Decision|5
833475|NCT00304356|1788818|FG000|Nitazoxanide|Physician Decision|1
833476|NCT00304356|1788818|FG000|Nitazoxanide|number is 0|1
833477|NCT00304356|1788818|FG000|Nitazoxanide|Physician Decision|1
833478|NCT00304356|1788818|FG000|Nitazoxanide|Physician Decision|1
833479|NCT00304356|1788818|FG000|Nitazoxanide|Physician Decision|1
833480|NCT00304915|1788855|FG000|Overall Study|Lost to Follow-up|11
833481|NCT00304915|1788856|FG001|Overall Study|Lost to Follow-up|11
833482|NCT00304915|1788855|FG000|Overall Study|Death|4
833483|NCT00304915|1788856|FG001|Overall Study|Death|5
833484|NCT00304915|1788855|FG000|Overall Study|Withdrawal by Subject|3
833485|NCT00304915|1788856|FG001|Overall Study|Withdrawal by Subject|0
833486|NCT00304954|1788866|FG000|Overall Study|Withdrawal by Subject|0
833487|NCT00304954|1788867|FG001|Overall Study|Withdrawal by Subject|0
833488|NCT00304954|1788868|FG002|Overall Study|Withdrawal by Subject|1
833489|NCT00304954|1788869|FG003|Overall Study|Withdrawal by Subject|0
833490|NCT00304954|1788866|FG000|Overall Study|Adverse Event|1
833491|NCT00304954|1788867|FG001|Overall Study|Adverse Event|0
833492|NCT00304954|1788868|FG002|Overall Study|Adverse Event|0
833493|NCT00304954|1788869|FG003|Overall Study|Adverse Event|0
833494|NCT00305006|1788889|FG000|Overall Study|Withdrawal by Subject|1
833495|NCT00305006|1788890|FG001|Overall Study|Withdrawal by Subject|0
833496|NCT00305006|1788889|FG000|Overall Study|Failure to complete pretest|0
833497|NCT00305006|1788890|FG001|Overall Study|Failure to complete pretest|1
833498|NCT00305058|1788898|FG000|Overall Study|Participant too young|1
833499|NCT00305058|1788899|FG001|Overall Study|Participant too young|0
833500|NCT00305058|1788898|FG000|Overall Study|Missing data collection instrument|3
833501|NCT00305058|1788899|FG001|Overall Study|Missing data collection instrument|2
833502|NCT00305058|1788898|FG000|Overall Study|Missing outcome data|3
833503|NCT00305058|1788899|FG001|Overall Study|Missing outcome data|2
833504|NCT00305110|1788954|FG000|Overall Study|Missing data|29
833505|NCT00305227|1788970|FG000|Overall Study|Lost to Follow-up|7
833506|NCT00305227|1788971|FG001|Overall Study|Lost to Follow-up|6
833507|NCT00305253|1788979|FG000|Overall Study|Withdrawal by Subject|0
833508|NCT00305253|1788980|FG001|Overall Study|Withdrawal by Subject|1
833509|NCT00305448|1788993|FG000|Overall Study|Protocol Violation|0
833510|NCT00305448|1788994|FG001|Overall Study|Protocol Violation|1
833511|NCT00305448|1788995|FG002|Overall Study|Protocol Violation|0
833512|NCT00305448|1788993|FG000|Overall Study|Withdrawal by Subject|2
833513|NCT00305448|1788994|FG001|Overall Study|Withdrawal by Subject|0
833514|NCT00305448|1788995|FG002|Overall Study|Withdrawal by Subject|1
833515|NCT00305448|1788993|FG000|Overall Study|Adverse Event|1
833516|NCT00305448|1788994|FG001|Overall Study|Adverse Event|0
833517|NCT00305448|1788995|FG002|Overall Study|Adverse Event|1
833518|NCT00305448|1788993|FG000|Overall Study|Disease Progression|27
833519|NCT00305448|1788994|FG001|Overall Study|Disease Progression|31
833520|NCT00305448|1788995|FG002|Overall Study|Disease Progression|28
833521|NCT00305448|1788993|FG000|Overall Study|Subjective Disease Progression|1
833522|NCT00305448|1788994|FG001|Overall Study|Subjective Disease Progression|2
833523|NCT00305448|1788995|FG002|Overall Study|Subjective Disease Progression|2
833524|NCT00305448|1788993|FG000|Overall Study|Tumor Marker Elevation|0
833525|NCT00305448|1788994|FG001|Overall Study|Tumor Marker Elevation|0
833526|NCT00305448|1788995|FG002|Overall Study|Tumor Marker Elevation|1
833527|NCT00305604|1789029|FG000|Overall Study|Adverse Event|6
833528|NCT00305604|1789030|FG001|Overall Study|Adverse Event|3
833529|NCT00305604|1789029|FG000|Overall Study|Lack of Efficacy|11
833530|NCT00305604|1789030|FG001|Overall Study|Lack of Efficacy|18
833531|NCT00305604|1789029|FG000|Overall Study|Lost to Follow-up|0
833532|NCT00305604|1789030|FG001|Overall Study|Lost to Follow-up|4
833533|NCT00305604|1789029|FG000|Overall Study|Protocol Violation|2
833534|NCT00305604|1789030|FG001|Overall Study|Protocol Violation|1
833535|NCT00305604|1789029|FG000|Overall Study|Withdrawal by Subject|12
833536|NCT00305604|1789030|FG001|Overall Study|Withdrawal by Subject|21
833537|NCT00305604|1789029|FG000|Overall Study|Patient moved|1
833538|NCT00305604|1789030|FG001|Overall Study|Patient moved|0
833539|NCT00305695|1789063|FG000|Overall Study|Withdrawal by subject prior to 18 month|40
833540|NCT00305695|1789064|FG001|Overall Study|Withdrawal by subject prior to 18 month|26
833541|NCT00305695|1789063|FG000|Overall Study|Did not have baseline scan|1
833542|NCT00305695|1789064|FG001|Overall Study|Did not have baseline scan|1
833543|NCT00305773|1789076|FG000|Overall Study|Death|3
833544|NCT00305773|1789077|FG001|Overall Study|Death|2
833545|NCT00305773|1789076|FG000|Overall Study|Adverse Event|1
833546|NCT00305773|1789077|FG001|Overall Study|Adverse Event|2
833547|NCT00305773|1789076|FG000|Overall Study|Alternative Treatment|4
833548|NCT00305773|1789077|FG001|Overall Study|Alternative Treatment|4
833549|NCT00305773|1789076|FG000|Overall Study|Physician Decision|1
833550|NCT00305773|1789077|FG001|Overall Study|Physician Decision|1
833551|NCT00305773|1789076|FG000|Overall Study|Withdrawal by Subject|1
833552|NCT00305773|1789077|FG001|Overall Study|Withdrawal by Subject|4
833553|NCT00305773|1789076|FG000|Overall Study|Disease Progression|1
833554|NCT00305773|1789077|FG001|Overall Study|Disease Progression|3
833555|NCT00305773|1789076|FG000|Overall Study|All other reasons|3
833556|NCT00305773|1789077|FG001|Overall Study|All other reasons|2
833557|NCT00305864|1789087|FG000|Overall Study|Ineligible / No protocol treatment|0
833558|NCT00305864|1789088|FG001|Overall Study|Ineligible / No protocol treatment|1
833559|NCT00305864|1789089|FG002|Overall Study|Ineligible / No protocol treatment|1
833560|NCT00305864|1789090|FG003|Overall Study|Ineligible / No protocol treatment|13
833561|NCT00305877|1789102|FG000|Overall Study|Lack of Efficacy|6
833562|NCT00305877|1789103|FG001|Overall Study|Lack of Efficacy|9
833563|NCT00305877|1789102|FG000|Overall Study|Adverse Event|9
833564|NCT00305877|1789103|FG001|Overall Study|Adverse Event|14
833565|NCT00305877|1789102|FG000|Overall Study|Death|0
833566|NCT00305877|1789103|FG001|Overall Study|Death|1
833567|NCT00305877|1789102|FG000|Overall Study|Withdrawal by Subject|4
833568|NCT00305877|1789103|FG001|Overall Study|Withdrawal by Subject|2
833569|NCT00305877|1789102|FG000|Overall Study|Physician Decision|1
833570|NCT00305877|1789103|FG001|Overall Study|Physician Decision|1
833571|NCT00305877|1789102|FG000|Overall Study|Never start treatment|2
833572|NCT00305877|1789103|FG001|Overall Study|Never start treatment|5
833573|NCT00305877|1789102|FG000|Overall Study|Ineligible|2
833574|NCT00305877|1789103|FG001|Overall Study|Ineligible|1
833575|NCT00305877|1789102|FG000|Overall Study|Transportation issue with daily RT|0
833576|NCT00305877|1789103|FG001|Overall Study|Transportation issue with daily RT|1
833577|NCT00306189|1789126|FG000|Overall Study|Physician Decision|0
833578|NCT00306189|1789127|FG001|Overall Study|Physician Decision|0
833579|NCT00306189|1789128|FG002|Overall Study|Physician Decision|0
833580|NCT00306189|1789129|FG003|Overall Study|Physician Decision|1
833581|NCT00306189|1789126|FG000|Overall Study|Adverse Event|3
833582|NCT00306189|1789127|FG001|Overall Study|Adverse Event|3
833583|NCT00306189|1789128|FG002|Overall Study|Adverse Event|2
833584|NCT00306189|1789129|FG003|Overall Study|Adverse Event|2
833585|NCT00306189|1789126|FG000|Overall Study|Withdrawal by Subject|4
833586|NCT00306189|1789127|FG001|Overall Study|Withdrawal by Subject|2
833587|NCT00306189|1789128|FG002|Overall Study|Withdrawal by Subject|8
833588|NCT00306189|1789129|FG003|Overall Study|Withdrawal by Subject|1
833589|NCT00306189|1789126|FG000|Overall Study|Ineligibility determined|1
833590|NCT00306189|1789127|FG001|Overall Study|Ineligibility determined|1
833591|NCT00306189|1789128|FG002|Overall Study|Ineligibility determined|1
833592|NCT00306189|1789129|FG003|Overall Study|Ineligibility determined|1
833593|NCT00306189|1789126|FG000|Overall Study|Other|1
833594|NCT00306189|1789127|FG001|Overall Study|Other|0
833595|NCT00306189|1789128|FG002|Overall Study|Other|0
833596|NCT00306189|1789129|FG003|Overall Study|Other|0
833597|NCT00306293|1789190|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1
833598|NCT00306293|1789191|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0
833599|NCT00306293|1789190|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
833600|NCT00306293|1789191|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
833601|NCT00306293|1789190|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
833602|NCT00306293|1789191|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
833603|NCT00306293|1789190|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
833604|NCT00306293|1789191|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
833605|NCT00306293|1789190|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1
833606|NCT00306293|1789191|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0
833607|NCT00306293|1789190|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
833608|NCT00306293|1789191|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
833609|NCT00306293|1789190|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
833610|NCT00306293|1789191|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
833611|NCT00306293|1789190|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1
833612|NCT00306293|1789191|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0
833613|NCT00306384|1789202|FG000|Overall Study|Adverse Event|103
833614|NCT00306384|1789203|FG001|Overall Study|Adverse Event|87
833615|NCT00306384|1789204|FG002|Overall Study|Adverse Event|40
833616|NCT00306384|1789202|FG000|Overall Study|Major protocol deviation|43
833617|NCT00306384|1789203|FG001|Overall Study|Major protocol deviation|51
833618|NCT00306384|1789204|FG002|Overall Study|Major protocol deviation|18
833619|NCT00306384|1789202|FG000|Overall Study|Lost to Follow-up|57
833620|NCT00306384|1789203|FG001|Overall Study|Lost to Follow-up|41
833621|NCT00306384|1789204|FG002|Overall Study|Lost to Follow-up|35
833622|NCT00306384|1789202|FG000|Overall Study|Voluntary withdrawal|199
833623|NCT00306384|1789203|FG001|Overall Study|Voluntary withdrawal|187
833624|NCT00306384|1789204|FG002|Overall Study|Voluntary withdrawal|91
833625|NCT00306384|1789202|FG000|Overall Study|Study termination|1
833626|NCT00306384|1789203|FG001|Overall Study|Study termination|0
833627|NCT00306384|1789204|FG002|Overall Study|Study termination|1
833628|NCT00306384|1789202|FG000|Overall Study|Pregnancy|3
833629|NCT00306384|1789203|FG001|Overall Study|Pregnancy|1
833630|NCT00306384|1789204|FG002|Overall Study|Pregnancy|1
833631|NCT00306384|1789202|FG000|Overall Study|Lack of Efficacy|26
833632|NCT00306384|1789203|FG001|Overall Study|Lack of Efficacy|40
833633|NCT00306384|1789204|FG002|Overall Study|Lack of Efficacy|38
833634|NCT00306384|1789202|FG000|Overall Study|Investigator discretion|28
833635|NCT00306384|1789203|FG001|Overall Study|Investigator discretion|31
833636|NCT00306384|1789204|FG002|Overall Study|Investigator discretion|21
833637|NCT00306384|1789202|FG000|Overall Study|Other|80
833638|NCT00306384|1789203|FG001|Overall Study|Other|70
833639|NCT00306384|1789204|FG002|Overall Study|Other|32
833640|NCT00306384|1789202|FG000|Overall Study|Site closure|2
833641|NCT00306384|1789203|FG001|Overall Study|Site closure|0
833642|NCT00306384|1789204|FG002|Overall Study|Site closure|0
833643|NCT00306527|1789221|FG000|Overall Study|Lost to Follow-up|3
833644|NCT00306527|1789222|FG001|Overall Study|Lost to Follow-up|4
833645|NCT00306527|1789223|FG002|Overall Study|Lost to Follow-up|3
833646|NCT00306527|1789224|FG003|Overall Study|Lost to Follow-up|0
833647|NCT00306527|1789221|FG000|Overall Study|Withdrawal by Subject|2
833648|NCT00306527|1789222|FG001|Overall Study|Withdrawal by Subject|3
833649|NCT00306527|1789223|FG002|Overall Study|Withdrawal by Subject|0
833650|NCT00306527|1789224|FG003|Overall Study|Withdrawal by Subject|3
833651|NCT00306527|1789221|FG000|Overall Study|Adverse Event|0
833652|NCT00306527|1789222|FG001|Overall Study|Adverse Event|0
833653|NCT00306527|1789223|FG002|Overall Study|Adverse Event|1
833654|NCT00306527|1789224|FG003|Overall Study|Adverse Event|1
833655|NCT00306527|1789221|FG000|Overall Study|Death|1
833656|NCT00306527|1789222|FG001|Overall Study|Death|0
833657|NCT00306527|1789223|FG002|Overall Study|Death|1
833658|NCT00306527|1789224|FG003|Overall Study|Death|2
833659|NCT00306592|1789238|FG000|Overall Study|Adverse Event|8
833660|NCT00306592|1789239|FG001|Overall Study|Adverse Event|15
833661|NCT00306592|1789238|FG000|Overall Study|Lost to Follow-up|1
833662|NCT00306592|1789239|FG001|Overall Study|Lost to Follow-up|0
833663|NCT00306592|1789238|FG000|Overall Study|Noncompliance|0
833664|NCT00306592|1789239|FG001|Overall Study|Noncompliance|2
833665|NCT00306592|1789238|FG000|Overall Study|Persistent Antibodies|6
833666|NCT00306592|1789239|FG001|Overall Study|Persistent Antibodies|3
833667|NCT00306592|1789238|FG000|Overall Study|Voluntary|10
833668|NCT00306592|1789239|FG001|Overall Study|Voluntary|6
833669|NCT00306592|1789238|FG000|Overall Study|Other|5
833670|NCT00306592|1789239|FG001|Overall Study|Other|10
833671|NCT00306592|1789238|FG000|Overall Study|Other|1
833672|NCT00306592|1789239|FG001|Overall Study|Other|2
833673|NCT00306592|1789238|FG000|Overall Study|48-week Treatment Period Ongoing|0
833674|NCT00306592|1789239|FG001|Overall Study|48-week Treatment Period Ongoing|20
833675|NCT00306670|1789245|FG000|Overall Study|patients recruited; Genentech, the st|0
833676|NCT00306670|1789246|FG001|Overall Study|patients recruited; Genentech, the st|2
833677|NCT00306787|1789254|FG000|Overall Study|Discontinued without taking study drug|208
833678|NCT00306787|1789255|FG001|Overall Study|Discontinued without taking study drug|215
833679|NCT00306787|1789254|FG000|Overall Study|Adverse Event|1
833680|NCT00306787|1789255|FG001|Overall Study|Adverse Event|1
833681|NCT00306787|1789254|FG000|Overall Study|Lack of Efficacy|1
833682|NCT00306787|1789255|FG001|Overall Study|Lack of Efficacy|0
833683|NCT00306787|1789254|FG000|Overall Study|Protocol Violation|8
833684|NCT00306787|1789255|FG001|Overall Study|Protocol Violation|10
833685|NCT00306787|1789254|FG000|Overall Study|Withdrawal by Subject|2
833686|NCT00306787|1789255|FG001|Overall Study|Withdrawal by Subject|9
833687|NCT00306787|1789254|FG000|Overall Study|Lost to Follow-up|9
833688|NCT00306787|1789255|FG001|Overall Study|Lost to Follow-up|6
833689|NCT00306787|1789254|FG000|Overall Study|Administrative problems|4
833690|NCT00306787|1789255|FG001|Overall Study|Administrative problems|0
833691|NCT00306787|1789254|FG000|Overall Study|Abnormal laboratory value(s)|1
833692|NCT00306787|1789255|FG001|Overall Study|Abnormal laboratory value(s)|0
833693|NCT00306852|1789263|FG000|Overall Study|Death|14
833694|NCT00306852|1789264|FG001|Overall Study|Death|14
833695|NCT00306852|1789263|FG000|Overall Study|Lost to Follow-up|15
833696|NCT00306852|1789264|FG001|Overall Study|Lost to Follow-up|24
833697|NCT00306891|1789274|FG000|Part A|Withdrawal by Subject|1
833698|NCT00306891|1789275|FG001|Part A|Withdrawal by Subject|1
833699|NCT00306891|1789276|FG002|Part A|Withdrawal by Subject|0
833700|NCT00306891|1789277|FG003|Part A|Withdrawal by Subject|0
833701|NCT00306891|1789274|FG000|Part A|Condition under investigation worsened|2
833702|NCT00306891|1789275|FG001|Part A|Condition under investigation worsened|2
833703|NCT00306891|1789276|FG002|Part A|Condition under investigation worsened|0
833704|NCT00306891|1789277|FG003|Part A|Condition under investigation worsened|0
833705|NCT00306891|1789274|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0
833706|NCT00306891|1789275|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1
833707|NCT00306891|1789276|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0
833708|NCT00306891|1789277|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0
833709|NCT00306891|1789274|FG000|Part A|Partial bowel obstruction|1
833710|NCT00306891|1789275|FG001|Part A|Partial bowel obstruction|0
833711|NCT00306891|1789276|FG002|Part A|Partial bowel obstruction|0
833712|NCT00306891|1789277|FG003|Part A|Partial bowel obstruction|0
833713|NCT00306891|1789274|FG000|Part A|Reaccumul. of ascites following drainage|0
833714|NCT00306891|1789275|FG001|Part A|Reaccumul. of ascites following drainage|1
833715|NCT00306891|1789276|FG002|Part A|Reaccumul. of ascites following drainage|0
833716|NCT00306891|1789277|FG003|Part A|Reaccumul. of ascites following drainage|0
833717|NCT00306891|1789274|FG000|Part A|Suspicion of second malignancy|0
833718|NCT00306891|1789275|FG001|Part A|Suspicion of second malignancy|1
833719|NCT00306891|1789276|FG002|Part A|Suspicion of second malignancy|0
833720|NCT00306891|1789277|FG003|Part A|Suspicion of second malignancy|0
833721|NCT00306891|1789274|FG000|Part A|QTC interval outwith elig. criteria|1
833722|NCT00306891|1789275|FG001|Part A|QTC interval outwith elig. criteria|0
833723|NCT00306891|1789276|FG002|Part A|QTC interval outwith elig. criteria|0
833724|NCT00306891|1789277|FG003|Part A|QTC interval outwith elig. criteria|0
833725|NCT00306891|1789274|FG000|Part B|Death|0
833726|NCT00306891|1789275|FG001|Part B|Death|0
833727|NCT00306891|1789276|FG002|Part B|Death|1
833728|NCT00306891|1789277|FG003|Part B|Death|2
833729|NCT00306891|1789274|FG000|Part B|Adverse Event|0
833730|NCT00306891|1789275|FG001|Part B|Adverse Event|0
833731|NCT00306891|1789276|FG002|Part B|Adverse Event|5
833732|NCT00306891|1789277|FG003|Part B|Adverse Event|5
833733|NCT00306891|1789274|FG000|Part B|Withdrawal by Subject|0
833734|NCT00306891|1789275|FG001|Part B|Withdrawal by Subject|0
833735|NCT00306891|1789276|FG002|Part B|Withdrawal by Subject|3
833736|NCT00306891|1789277|FG003|Part B|Withdrawal by Subject|1
833737|NCT00306891|1789274|FG000|Part B|Condition under investigation worsened|0
833738|NCT00306891|1789275|FG001|Part B|Condition under investigation worsened|0
833739|NCT00306891|1789276|FG002|Part B|Condition under investigation worsened|2
833740|NCT00306891|1789277|FG003|Part B|Condition under investigation worsened|8
833741|NCT00306891|1789274|FG000|Part B|Development of study specific disc crit.|0
833742|NCT00306891|1789275|FG001|Part B|Development of study specific disc crit.|0
833743|NCT00306891|1789276|FG002|Part B|Development of study specific disc crit.|0
833744|NCT00306891|1789277|FG003|Part B|Development of study specific disc crit.|1
833745|NCT00306995|1789304|FG000|Study Part I|Withdrawal by Subject|0
833746|NCT00306995|1789305|FG001|Study Part I|Withdrawal by Subject|0
833747|NCT00306995|1789306|FG002|Study Part I|Withdrawal by Subject|0
833748|NCT00306995|1789307|FG003|Study Part I|Withdrawal by Subject|0
833749|NCT00306995|1789308|FG004|Study Part I|Withdrawal by Subject|0
833750|NCT00306995|1789309|FG005|Study Part I|Withdrawal by Subject|0
833751|NCT00306995|1789310|FG006|Study Part I|Withdrawal by Subject|1
833752|NCT00306995|1789304|FG000|Study Part II for Subset 2|Serious Adverse Event|0
833753|NCT00306995|1789305|FG001|Study Part II for Subset 2|Serious Adverse Event|1
833754|NCT00306995|1789306|FG002|Study Part II for Subset 2|Serious Adverse Event|0
833755|NCT00306995|1789307|FG003|Study Part II for Subset 2|Serious Adverse Event|0
833756|NCT00306995|1789308|FG004|Study Part II for Subset 2|Serious Adverse Event|0
833757|NCT00306995|1789309|FG005|Study Part II for Subset 2|Serious Adverse Event|0
833758|NCT00306995|1789310|FG006|Study Part II for Subset 2|Serious Adverse Event|0
833759|NCT00307034|1789357|FG000|Overall Study|Adverse Event|1
833760|NCT00307034|1789358|FG001|Overall Study|Adverse Event|2
833761|NCT00307034|1789357|FG000|Overall Study|Withdrawal by Subject|1
833762|NCT00307034|1789358|FG001|Overall Study|Withdrawal by Subject|2
833763|NCT00307034|1789357|FG000|Overall Study|Lost to Follow-up|0
833764|NCT00307034|1789358|FG001|Overall Study|Lost to Follow-up|3
833765|NCT00307047|1789366|FG000|Overall Study|Lost to Follow-up|35
833766|NCT00307047|1789367|FG001|Overall Study|Lost to Follow-up|24
833767|NCT00307047|1789366|FG000|Overall Study|Withdrawal by Subject|6
833768|NCT00307047|1789367|FG001|Overall Study|Withdrawal by Subject|6
833769|NCT00307047|1789366|FG000|Overall Study|Physician Decision|1
833770|NCT00307047|1789367|FG001|Overall Study|Physician Decision|2
833771|NCT00307047|1789366|FG000|Overall Study|Lost to follow-up for other reasons|0
833772|NCT00307047|1789367|FG001|Overall Study|Lost to follow-up for other reasons|1
833773|NCT00307047|1789366|FG000|Overall Study|All death, all MI, all Revascularization|27
833774|NCT00307047|1789367|FG001|Overall Study|All death, all MI, all Revascularization|16
833775|NCT00307086|1789373|FG000|Overall Study|ineligible|5
833776|NCT00307125|1789379|FG000|Screening Phase|Adverse Event|1
833777|NCT00307125|1789380|FG001|Screening Phase|Adverse Event|0
833778|NCT00307125|1789381|FG002|Screening Phase|Adverse Event|0
833779|NCT00307125|1789379|FG000|Screening Phase|Protocol Violation|27
833780|NCT00307125|1789380|FG001|Screening Phase|Protocol Violation|0
833781|NCT00307125|1789381|FG002|Screening Phase|Protocol Violation|0
833782|NCT00307125|1789379|FG000|Screening Phase|Lost to Follow-up|87
833783|NCT00307125|1789380|FG001|Screening Phase|Lost to Follow-up|0
833784|NCT00307125|1789381|FG002|Screening Phase|Lost to Follow-up|0
833785|NCT00307125|1789379|FG000|Screening Phase|Death|10
833786|NCT00307125|1789380|FG001|Screening Phase|Death|0
833787|NCT00307125|1789381|FG002|Screening Phase|Death|0
833788|NCT00307125|1789379|FG000|Screening Phase|Withdrawal by Subject|77
833789|NCT00307125|1789380|FG001|Screening Phase|Withdrawal by Subject|0
833790|NCT00307125|1789381|FG002|Screening Phase|Withdrawal by Subject|0
833791|NCT00307125|1789379|FG000|Screening Phase|Physician Decision|26
833792|NCT00307125|1789380|FG001|Screening Phase|Physician Decision|0
833793|NCT00307125|1789381|FG002|Screening Phase|Physician Decision|0
833794|NCT00307125|1789379|FG000|Screening Phase|Sponsor Decision|4
833795|NCT00307125|1789380|FG001|Screening Phase|Sponsor Decision|0
833796|NCT00307125|1789381|FG002|Screening Phase|Sponsor Decision|0
833797|NCT00307125|1789379|FG000|Screening Phase|Study Terminated|17
833798|NCT00307125|1789380|FG001|Screening Phase|Study Terminated|0
833799|NCT00307125|1789381|FG002|Screening Phase|Study Terminated|0
833800|NCT00307125|1789379|FG000|Screening Phase|Graft Loss|3
833801|NCT00307125|1789380|FG001|Screening Phase|Graft Loss|0
833802|NCT00307125|1789381|FG002|Screening Phase|Graft Loss|0
833803|NCT00307125|1789379|FG000|Screening Phase|Graft Failure|8
833804|NCT00307125|1789380|FG001|Screening Phase|Graft Failure|0
833805|NCT00307125|1789381|FG002|Screening Phase|Graft Failure|0
833806|NCT00307125|1789379|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83
833807|NCT00307125|1789380|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0
833808|NCT00307125|1789381|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0
833809|NCT00307125|1789379|FG000|Screening Phase|Scheduling issues/Non-compliance|55
833810|NCT00307125|1789380|FG001|Screening Phase|Scheduling issues/Non-compliance|0
833811|NCT00307125|1789381|FG002|Screening Phase|Scheduling issues/Non-compliance|0
833812|NCT00307125|1789379|FG000|Screening Phase|Moved or transferred facilities|34
833813|NCT00307125|1789380|FG001|Screening Phase|Moved or transferred facilities|0
833814|NCT00307125|1789381|FG002|Screening Phase|Moved or transferred facilities|0
833815|NCT00307125|1789379|FG000|Screening Phase|Received Pancreas Transplant|8
833816|NCT00307125|1789380|FG001|Screening Phase|Received Pancreas Transplant|0
833817|NCT00307125|1789381|FG002|Screening Phase|Received Pancreas Transplant|0
833818|NCT00307125|1789379|FG000|Screening Phase|Ineligible for pilot|4
833819|NCT00307125|1789380|FG001|Screening Phase|Ineligible for pilot|0
833820|NCT00307125|1789381|FG002|Screening Phase|Ineligible for pilot|0
833821|NCT00307125|1789379|FG000|Screening Phase|Try to get pregnant|1
833822|NCT00307125|1789380|FG001|Screening Phase|Try to get pregnant|0
833823|NCT00307125|1789381|FG002|Screening Phase|Try to get pregnant|0
833824|NCT00307125|1789379|FG000|Screening Phase|Developed acute leukemia|1
833825|NCT00307125|1789380|FG001|Screening Phase|Developed acute leukemia|0
833826|NCT00307125|1789381|FG002|Screening Phase|Developed acute leukemia|0
833827|NCT00307125|1789379|FG000|Screening Phase|Metastatic colon cancer|1
833828|NCT00307125|1789380|FG001|Screening Phase|Metastatic colon cancer|0
833829|NCT00307125|1789381|FG002|Screening Phase|Metastatic colon cancer|0
833830|NCT00307125|1789379|FG000|Screening Phase|Malignancy|1
833831|NCT00307125|1789380|FG001|Screening Phase|Malignancy|0
833832|NCT00307125|1789381|FG002|Screening Phase|Malignancy|0
833833|NCT00307125|1789379|FG000|Screening Phase|PAK|1
833834|NCT00307125|1789380|FG001|Screening Phase|PAK|0
833835|NCT00307125|1789381|FG002|Screening Phase|PAK|0
833836|NCT00307125|1789379|FG000|Screening Phase|Ineligible|1
833837|NCT00307125|1789380|FG001|Screening Phase|Ineligible|0
833838|NCT00307125|1789381|FG002|Screening Phase|Ineligible|0
833839|NCT00307125|1789379|FG000|Screening Phase|Screen Error|1
833840|NCT00307125|1789380|FG001|Screening Phase|Screen Error|0
833841|NCT00307125|1789381|FG002|Screening Phase|Screen Error|0
833842|NCT00307125|1789379|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
833843|NCT00307125|1789380|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
833844|NCT00307125|1789381|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
833845|NCT00307125|1789379|FG000|Screening Phase|AMR and treated with rituximab|1
833846|NCT00307125|1789380|FG001|Screening Phase|AMR and treated with rituximab|0
833847|NCT00307125|1789381|FG002|Screening Phase|AMR and treated with rituximab|0
833848|NCT00307125|1789379|FG000|Screening Phase|Coronary artery bypass|1
833849|NCT00307125|1789380|FG001|Screening Phase|Coronary artery bypass|0
833850|NCT00307125|1789381|FG002|Screening Phase|Coronary artery bypass|0
833851|NCT00307125|1789379|FG000|Pilot Phase|Lost to Follow-up|0
833852|NCT00307125|1789380|FG001|Pilot Phase|Lost to Follow-up|1
833853|NCT00307125|1789381|FG002|Pilot Phase|Lost to Follow-up|0
833854|NCT00307125|1789379|FG000|Pilot Phase|Withdrawal by Subject|0
833855|NCT00307125|1789380|FG001|Pilot Phase|Withdrawal by Subject|1
833856|NCT00307125|1789381|FG002|Pilot Phase|Withdrawal by Subject|1
833857|NCT00307151|1789395|FG000|Overall Study|Death|4
833858|NCT00307151|1789396|FG001|Overall Study|Death|3
833859|NCT00307151|1789397|FG002|Overall Study|Death|10
833860|NCT00307151|1789398|FG003|Overall Study|Death|3
833861|NCT00307151|1789395|FG000|Overall Study|Severe debilitation, unable to continue|1
833862|NCT00307151|1789396|FG001|Overall Study|Severe debilitation, unable to continue|0
833863|NCT00307151|1789397|FG002|Overall Study|Severe debilitation, unable to continue|0
833864|NCT00307151|1789398|FG003|Overall Study|Severe debilitation, unable to continue|0
833865|NCT00307151|1789395|FG000|Overall Study|Subject unable to get to clinic|1
833866|NCT00307151|1789396|FG001|Overall Study|Subject unable to get to clinic|0
833867|NCT00307151|1789397|FG002|Overall Study|Subject unable to get to clinic|6
833868|NCT00307151|1789398|FG003|Overall Study|Subject unable to get to clinic|2
833869|NCT00307151|1789395|FG000|Overall Study|Withdrew consent|0
833870|NCT00307151|1789396|FG001|Overall Study|Withdrew consent|1
833871|NCT00307151|1789397|FG002|Overall Study|Withdrew consent|1
833872|NCT00307151|1789398|FG003|Overall Study|Withdrew consent|3
833873|NCT00307151|1789395|FG000|Overall Study|Not willing to adhere to study reqs|2
833874|NCT00307151|1789396|FG001|Overall Study|Not willing to adhere to study reqs|0
833875|NCT00307151|1789397|FG002|Overall Study|Not willing to adhere to study reqs|2
833876|NCT00307151|1789398|FG003|Overall Study|Not willing to adhere to study reqs|2
833877|NCT00307151|1789395|FG000|Overall Study|Clinic unable to contact subject|3
833878|NCT00307151|1789396|FG001|Overall Study|Clinic unable to contact subject|3
833879|NCT00307151|1789397|FG002|Overall Study|Clinic unable to contact subject|1
833880|NCT00307151|1789398|FG003|Overall Study|Clinic unable to contact subject|1
833881|NCT00307164|1789410|FG000|Overall Study|Death|1
833882|NCT00307164|1789411|FG001|Overall Study|Death|0
833883|NCT00307164|1789410|FG000|Overall Study|Severe debilitation, unable to continue|1
833884|NCT00307164|1789411|FG001|Overall Study|Severe debilitation, unable to continue|0
833885|NCT00307164|1789410|FG000|Overall Study|Subject/parent not able to get to clinic|2
833886|NCT00307164|1789411|FG001|Overall Study|Subject/parent not able to get to clinic|1
833887|NCT00307164|1789410|FG000|Overall Study|Withdrawal by Subject|1
833888|NCT00307164|1789411|FG001|Overall Study|Withdrawal by Subject|8
833889|NCT00307164|1789410|FG000|Overall Study|Not compliant with requirements|4
833890|NCT00307164|1789411|FG001|Overall Study|Not compliant with requirements|4
833891|NCT00307164|1789410|FG000|Overall Study|Lost to Follow-up|6
833892|NCT00307164|1789411|FG001|Overall Study|Lost to Follow-up|1
833893|NCT00307294|1789417|FG000|Overall Study|Withdrawal by Subject|1
833894|NCT00307333|1789424|FG000|Overall Study|Lost to Follow-up|11
833895|NCT00307333|1789425|FG001|Overall Study|Lost to Follow-up|3
833896|NCT00307437|1789434|FG000|Controlled Period|Adverse Event|7
833897|NCT00307437|1789435|FG001|Controlled Period|Adverse Event|2
833898|NCT00307437|1789436|FG002|Controlled Period|Adverse Event|5
833899|NCT00307437|1789437|FG003|Controlled Period|Adverse Event|0
833900|NCT00307437|1789438|FG004|Controlled Period|Adverse Event|0
833901|NCT00307437|1789439|FG005|Controlled Period|Adverse Event|0
833902|NCT00307437|1789440|FG006|Controlled Period|Adverse Event|0
833903|NCT00307437|1789434|FG000|Controlled Period|Death|0
833904|NCT00307437|1789435|FG001|Controlled Period|Death|0
833905|NCT00307437|1789436|FG002|Controlled Period|Death|1
833906|NCT00307437|1789437|FG003|Controlled Period|Death|0
833907|NCT00307437|1789438|FG004|Controlled Period|Death|0
833908|NCT00307437|1789439|FG005|Controlled Period|Death|0
833909|NCT00307437|1789440|FG006|Controlled Period|Death|0
833910|NCT00307437|1789434|FG000|Controlled Period|Lack of Efficacy|2
833911|NCT00307437|1789435|FG001|Controlled Period|Lack of Efficacy|0
833912|NCT00307437|1789436|FG002|Controlled Period|Lack of Efficacy|0
833913|NCT00307437|1789437|FG003|Controlled Period|Lack of Efficacy|0
833914|NCT00307437|1789438|FG004|Controlled Period|Lack of Efficacy|0
833915|NCT00307437|1789439|FG005|Controlled Period|Lack of Efficacy|0
833916|NCT00307437|1789440|FG006|Controlled Period|Lack of Efficacy|0
833917|NCT00307437|1789434|FG000|Controlled Period|Lost to Follow-up|2
833918|NCT00307437|1789435|FG001|Controlled Period|Lost to Follow-up|3
833919|NCT00307437|1789436|FG002|Controlled Period|Lost to Follow-up|0
833920|NCT00307437|1789437|FG003|Controlled Period|Lost to Follow-up|0
833921|NCT00307437|1789438|FG004|Controlled Period|Lost to Follow-up|0
833922|NCT00307437|1789439|FG005|Controlled Period|Lost to Follow-up|0
833923|NCT00307437|1789440|FG006|Controlled Period|Lost to Follow-up|0
833924|NCT00307437|1789434|FG000|Controlled Period|Other|5
833925|NCT00307437|1789435|FG001|Controlled Period|Other|1
833926|NCT00307437|1789436|FG002|Controlled Period|Other|3
833927|NCT00307437|1789437|FG003|Controlled Period|Other|0
833928|NCT00307437|1789438|FG004|Controlled Period|Other|0
833929|NCT00307437|1789439|FG005|Controlled Period|Other|0
833930|NCT00307437|1789440|FG006|Controlled Period|Other|0
833931|NCT00307437|1789434|FG000|After Controlled Period|Adverse Event|0
833932|NCT00307437|1789435|FG001|After Controlled Period|Adverse Event|0
833933|NCT00307437|1789436|FG002|After Controlled Period|Adverse Event|0
833934|NCT00307437|1789437|FG003|After Controlled Period|Adverse Event|18
833935|NCT00307437|1789438|FG004|After Controlled Period|Adverse Event|16
833936|NCT00307437|1789439|FG005|After Controlled Period|Adverse Event|31
833937|NCT00307437|1789440|FG006|After Controlled Period|Adverse Event|40
833938|NCT00307437|1789434|FG000|After Controlled Period|Death|0
833939|NCT00307437|1789435|FG001|After Controlled Period|Death|0
833940|NCT00307437|1789436|FG002|After Controlled Period|Death|0
833941|NCT00307437|1789437|FG003|After Controlled Period|Death|3
833942|NCT00307437|1789438|FG004|After Controlled Period|Death|1
833943|NCT00307437|1789439|FG005|After Controlled Period|Death|1
833944|NCT00307437|1789440|FG006|After Controlled Period|Death|3
833945|NCT00307437|1789434|FG000|After Controlled Period|Lack of Efficacy|0
833946|NCT00307437|1789435|FG001|After Controlled Period|Lack of Efficacy|0
833947|NCT00307437|1789436|FG002|After Controlled Period|Lack of Efficacy|0
833948|NCT00307437|1789437|FG003|After Controlled Period|Lack of Efficacy|15
833949|NCT00307437|1789438|FG004|After Controlled Period|Lack of Efficacy|17
833950|NCT00307437|1789439|FG005|After Controlled Period|Lack of Efficacy|37
833951|NCT00307437|1789440|FG006|After Controlled Period|Lack of Efficacy|24
833952|NCT00307437|1789434|FG000|After Controlled Period|Lost to Follow-up|0
833953|NCT00307437|1789435|FG001|After Controlled Period|Lost to Follow-up|0
833954|NCT00307437|1789436|FG002|After Controlled Period|Lost to Follow-up|0
833955|NCT00307437|1789437|FG003|After Controlled Period|Lost to Follow-up|7
833956|NCT00307437|1789438|FG004|After Controlled Period|Lost to Follow-up|12
833957|NCT00307437|1789439|FG005|After Controlled Period|Lost to Follow-up|13
833958|NCT00307437|1789440|FG006|After Controlled Period|Lost to Follow-up|18
833959|NCT00307437|1789434|FG000|After Controlled Period|Other|0
833960|NCT00307437|1789435|FG001|After Controlled Period|Other|0
833961|NCT00307437|1789436|FG002|After Controlled Period|Other|0
833962|NCT00307437|1789437|FG003|After Controlled Period|Other|15
833963|NCT00307437|1789438|FG004|After Controlled Period|Other|9
833964|NCT00307437|1789439|FG005|After Controlled Period|Other|40
833965|NCT00307437|1789440|FG006|After Controlled Period|Other|28
833966|NCT00307489|1789464|FG000|Baseline Through Week 48|Lost to Follow-up|0
833967|NCT00307489|1789465|FG001|Baseline Through Week 48|Lost to Follow-up|1
833968|NCT00307489|1789464|FG000|Baseline Through Week 48|Physician Decision|1
833969|NCT00307489|1789465|FG001|Baseline Through Week 48|Physician Decision|0
833970|NCT00307489|1789464|FG000|Baseline Through Week 48|Withdrawal by Subject|0
833971|NCT00307489|1789465|FG001|Baseline Through Week 48|Withdrawal by Subject|1
833972|NCT00307489|1789464|FG000|Week 48 Through Week 168|Adverse Event|1
833973|NCT00307489|1789465|FG001|Week 48 Through Week 168|Adverse Event|0
833974|NCT00307489|1789464|FG000|Week 48 Through Week 168|Physician Decision|1
833975|NCT00307489|1789465|FG001|Week 48 Through Week 168|Physician Decision|0
833976|NCT00307489|1789464|FG000|Week 48 Through Week 168|Withdrawal by Subject|1
833977|NCT00307489|1789465|FG001|Week 48 Through Week 168|Withdrawal by Subject|2
833978|NCT00307489|1789464|FG000|Week 48 Through Week 168|Lack of Efficacy|2
833979|NCT00307489|1789465|FG001|Week 48 Through Week 168|Lack of Efficacy|2
833980|NCT00307489|1789464|FG000|Week 48 Through Week 168|Death|0
833981|NCT00307489|1789465|FG001|Week 48 Through Week 168|Death|1
833982|NCT00307489|1789464|FG000|Week 48 Through Week 168|Lost to Follow-up|0
833983|NCT00307489|1789465|FG001|Week 48 Through Week 168|Lost to Follow-up|1
833984|NCT00307489|1789464|FG000|Week 48 Through Week 168|Seroconversion|1
833985|NCT00307489|1789465|FG001|Week 48 Through Week 168|Seroconversion|0
833986|NCT00307684|1789471|FG000|Open Label Phase|Lack of Efficacy|0
833987|NCT00307684|1789472|FG001|Open Label Phase|Lack of Efficacy|0
833988|NCT00307684|1789473|FG002|Open Label Phase|Lack of Efficacy|3
833989|NCT00307684|1789471|FG000|Open Label Phase|Adverse Event|0
833990|NCT00307684|1789472|FG001|Open Label Phase|Adverse Event|0
833991|NCT00307684|1789473|FG002|Open Label Phase|Adverse Event|16
833992|NCT00307684|1789471|FG000|Open Label Phase|Withdrawal by Subject|0
833993|NCT00307684|1789472|FG001|Open Label Phase|Withdrawal by Subject|0
833994|NCT00307684|1789473|FG002|Open Label Phase|Withdrawal by Subject|15
833995|NCT00307684|1789471|FG000|Open Label Phase|Lost to Follow-up|0
833996|NCT00307684|1789472|FG001|Open Label Phase|Lost to Follow-up|0
833997|NCT00307684|1789473|FG002|Open Label Phase|Lost to Follow-up|11
833998|NCT00307684|1789471|FG000|Open Label Phase|non compliance|0
833999|NCT00307684|1789472|FG001|Open Label Phase|non compliance|0
834000|NCT00307684|1789473|FG002|Open Label Phase|non compliance|5
834001|NCT00307684|1789471|FG000|Open Label Phase|other|0
834002|NCT00307684|1789472|FG001|Open Label Phase|other|0
834003|NCT00307684|1789473|FG002|Open Label Phase|other|6
834004|NCT00307684|1789471|FG000|Double Blind Phase|Lack of Efficacy|2
834005|NCT00307684|1789472|FG001|Double Blind Phase|Lack of Efficacy|5
834006|NCT00307684|1789473|FG002|Double Blind Phase|Lack of Efficacy|0
834007|NCT00307736|1789481|FG000|Overall Study|Adverse Event|0
834008|NCT00307736|1789482|FG001|Overall Study|Adverse Event|0
834009|NCT00307736|1789483|FG002|Overall Study|Adverse Event|1
834010|NCT00307736|1789484|FG003|Overall Study|Adverse Event|3
834011|NCT00307736|1789481|FG000|Overall Study|Withdrawal by Subject|0
834012|NCT00307736|1789482|FG001|Overall Study|Withdrawal by Subject|0
834013|NCT00307736|1789483|FG002|Overall Study|Withdrawal by Subject|2
834014|NCT00307736|1789484|FG003|Overall Study|Withdrawal by Subject|0
834015|NCT00307801|1789497|FG000|Overall Study|Adverse Event|12
834016|NCT00307801|1789498|FG001|Overall Study|Adverse Event|4
834017|NCT00307801|1789497|FG000|Overall Study|Withdrawal by Subject|9
834018|NCT00307801|1789498|FG001|Overall Study|Withdrawal by Subject|4
834019|NCT00307801|1789497|FG000|Overall Study|Non-compliance, not taken all tablets|1
834020|NCT00307801|1789498|FG001|Overall Study|Non-compliance, not taken all tablets|2
834021|NCT00307801|1789497|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2
834022|NCT00307801|1789498|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0
834023|NCT00307801|1789497|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0
834024|NCT00307801|1789498|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1
834025|NCT00307801|1789497|FG000|Overall Study|Wrong Randomization|1
834026|NCT00307801|1789498|FG001|Overall Study|Wrong Randomization|0
834027|NCT00307801|1789497|FG000|Overall Study|Lack of Efficacy|0
834028|NCT00307801|1789498|FG001|Overall Study|Lack of Efficacy|2
834029|NCT00307801|1789497|FG000|Overall Study|Lost to Follow-up, moved abroad|1
834030|NCT00307801|1789498|FG001|Overall Study|Lost to Follow-up, moved abroad|1
834031|NCT00307801|1789497|FG000|Overall Study|Frustration with e-diary|1
834032|NCT00307801|1789498|FG001|Overall Study|Frustration with e-diary|0
834033|NCT00307801|1789497|FG000|Overall Study|Protocol Violation|3
834034|NCT00307801|1789498|FG001|Overall Study|Protocol Violation|2
834035|NCT00307801|1789497|FG000|Overall Study|No reason specified|2
834036|NCT00307801|1789498|FG001|Overall Study|No reason specified|0
834037|NCT00307801|1789497|FG000|Overall Study|Pregnancy|0
834038|NCT00307801|1789498|FG001|Overall Study|Pregnancy|1
834039|NCT00307931|1789505|FG000|Overall Study|Adverse Event|1
834040|NCT00308074|1789519|FG000|Overall Study|Withdrawal by Subject|1
834041|NCT00308087|1789525|FG000|Overall Study|Progressive Disease|19
834042|NCT00308087|1789526|FG001|Overall Study|Progressive Disease|21
834043|NCT00308087|1789525|FG000|Overall Study|Study Closure|11
834044|NCT00308087|1789526|FG001|Overall Study|Study Closure|12
834045|NCT00308087|1789525|FG000|Overall Study|Withdrawal by Subject|2
834046|NCT00308087|1789526|FG001|Overall Study|Withdrawal by Subject|1
834047|NCT00308087|1789525|FG000|Overall Study|Other|4
834048|NCT00308087|1789526|FG001|Overall Study|Other|3
834049|NCT00308139|1789534|FG000|Overall Study|Adverse Event|20
834050|NCT00308139|1789535|FG001|Overall Study|Adverse Event|14
834051|NCT00308139|1789534|FG000|Overall Study|Lost to Follow-up|13
834052|NCT00308139|1789535|FG001|Overall Study|Lost to Follow-up|8
834053|NCT00308139|1789534|FG000|Overall Study|Protocol Violation|3
834054|NCT00308139|1789535|FG001|Overall Study|Protocol Violation|2
834055|NCT00308139|1789534|FG000|Overall Study|Withdrawal of Consent|40
834056|NCT00308139|1789535|FG001|Overall Study|Withdrawal of Consent|42
834057|NCT00308139|1789534|FG000|Overall Study|Investigator Decision|11
834058|NCT00308139|1789535|FG001|Overall Study|Investigator Decision|10
834059|NCT00308139|1789534|FG000|Overall Study|Loss of Glucose Control|5
834060|NCT00308139|1789535|FG001|Overall Study|Loss of Glucose Control|7
834061|NCT00308139|1789534|FG000|Overall Study|Administrative|1
834062|NCT00308139|1789535|FG001|Overall Study|Administrative|4
834063|NCT00308139|1789534|FG000|Overall Study|Other|1
834064|NCT00308139|1789535|FG001|Overall Study|Other|0
834065|NCT00308308|1789596|FG000|Overall Study|Adverse Event|17
834066|NCT00308308|1789597|FG001|Overall Study|Adverse Event|2
834067|NCT00308308|1789596|FG000|Overall Study|Lost to Follow-up|5
834068|NCT00308308|1789597|FG001|Overall Study|Lost to Follow-up|5
834069|NCT00308308|1789596|FG000|Overall Study|Physician Decision|15
834070|NCT00308308|1789597|FG001|Overall Study|Physician Decision|7
834071|NCT00308308|1789596|FG000|Overall Study|Protocol Violation|3
834072|NCT00308308|1789597|FG001|Overall Study|Protocol Violation|14
834073|NCT00308308|1789596|FG000|Overall Study|Withdrawal by Subject|47
834074|NCT00308308|1789597|FG001|Overall Study|Withdrawal by Subject|19
834075|NCT00308308|1789596|FG000|Overall Study|Various|7
834076|NCT00308308|1789597|FG001|Overall Study|Various|5
834077|NCT00308308|1789596|FG000|Overall Study|Randomized but not dosed|8
834078|NCT00308308|1789597|FG001|Overall Study|Randomized but not dosed|16
834079|NCT00308308|1789596|FG000|Overall Study|Other|1
834080|NCT00308308|1789597|FG001|Overall Study|Other|0
834081|NCT00308555|1789614|FG000|Overall Study|Withdrawal by Subject|1
834082|NCT00308555|1789615|FG001|Overall Study|Withdrawal by Subject|0
834083|NCT00308555|1789614|FG000|Overall Study|Physician Decision|2
834084|NCT00308555|1789615|FG001|Overall Study|Physician Decision|0
834085|NCT00308581|1789621|FG000|Induction Phase|Adverse Event|0
834086|NCT00308581|1789622|FG001|Induction Phase|Adverse Event|0
834087|NCT00308581|1789623|FG002|Induction Phase|Adverse Event|37
834088|NCT00308581|1789621|FG000|Induction Phase|Lack of Efficacy|0
834089|NCT00308581|1789622|FG001|Induction Phase|Lack of Efficacy|0
834090|NCT00308581|1789623|FG002|Induction Phase|Lack of Efficacy|121
834091|NCT00308581|1789621|FG000|Induction Phase|Withdrawal by Subject|0
834092|NCT00308581|1789622|FG001|Induction Phase|Withdrawal by Subject|0
834093|NCT00308581|1789623|FG002|Induction Phase|Withdrawal by Subject|5
834094|NCT00308581|1789621|FG000|Induction Phase|Unknown reason|0
834095|NCT00308581|1789622|FG001|Induction Phase|Unknown reason|0
834096|NCT00308581|1789623|FG002|Induction Phase|Unknown reason|3
834097|NCT00308581|1789621|FG000|Randomized Maintenance Phase|Adverse Event|10
834098|NCT00308581|1789622|FG001|Randomized Maintenance Phase|Adverse Event|17
834099|NCT00308581|1789623|FG002|Randomized Maintenance Phase|Adverse Event|0
834100|NCT00308581|1789621|FG000|Randomized Maintenance Phase|Lack of Efficacy|9
834101|NCT00308581|1789622|FG001|Randomized Maintenance Phase|Lack of Efficacy|21
834102|NCT00308581|1789623|FG002|Randomized Maintenance Phase|Lack of Efficacy|0
834103|NCT00308581|1789621|FG000|Randomized Maintenance Phase|Lost to Follow-up|0
834104|NCT00308581|1789622|FG001|Randomized Maintenance Phase|Lost to Follow-up|2
834105|NCT00308581|1789623|FG002|Randomized Maintenance Phase|Lost to Follow-up|0
834106|NCT00308581|1789621|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1
834107|NCT00308581|1789622|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4
834108|NCT00308581|1789623|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0
834109|NCT00308581|1789621|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
834110|NCT00308581|1789622|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
834111|NCT00308581|1789623|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
834112|NCT00308581|1789621|FG000|Randomized Maintenance Phase|Unknown reason|3
834113|NCT00308581|1789622|FG001|Randomized Maintenance Phase|Unknown reason|0
834114|NCT00308581|1789623|FG002|Randomized Maintenance Phase|Unknown reason|0
834115|NCT00308620|1789634|FG000|Overall Study|Death|1
834116|NCT00308620|1789635|FG001|Overall Study|Death|1
834117|NCT00308620|1789636|FG002|Overall Study|Death|0
834118|NCT00308620|1789634|FG000|Overall Study|Lost to Follow-up|0
834119|NCT00308620|1789635|FG001|Overall Study|Lost to Follow-up|0
834120|NCT00308620|1789636|FG002|Overall Study|Lost to Follow-up|1
834121|NCT00308711|1789647|FG000|Overall Study|Withdrawal by Subject|1
834122|NCT00308711|1789648|FG001|Overall Study|Withdrawal by Subject|0
834123|NCT00308711|1789649|FG002|Overall Study|Withdrawal by Subject|1
834124|NCT00308711|1789647|FG000|Overall Study|Protocol Violation|0
834125|NCT00308711|1789648|FG001|Overall Study|Protocol Violation|1
834126|NCT00308711|1789649|FG002|Overall Study|Protocol Violation|1
834127|NCT00308711|1789647|FG000|Overall Study|Lost to Follow-up|0
834128|NCT00308711|1789648|FG001|Overall Study|Lost to Follow-up|1
834129|NCT00308711|1789649|FG002|Overall Study|Lost to Follow-up|0
834130|NCT00308711|1789647|FG000|Overall Study|Baby not born within 7 days of treatment|1
834131|NCT00308711|1789648|FG001|Overall Study|Baby not born within 7 days of treatment|2
834132|NCT00308711|1789649|FG002|Overall Study|Baby not born within 7 days of treatment|2
834133|NCT00308711|1789647|FG000|Overall Study|Subject incarcerated, data not allowed|0
834134|NCT00308711|1789648|FG001|Overall Study|Subject incarcerated, data not allowed|0
834135|NCT00308711|1789649|FG002|Overall Study|Subject incarcerated, data not allowed|1
834136|NCT00308737|1789660|FG000|Overall Study|Adverse Event|104
834137|NCT00308737|1789661|FG001|Overall Study|Adverse Event|9
834138|NCT00308737|1789662|FG002|Overall Study|Adverse Event|0
834139|NCT00308737|1789660|FG000|Overall Study|Death|4
834140|NCT00308737|1789661|FG001|Overall Study|Death|3
834141|NCT00308737|1789662|FG002|Overall Study|Death|0
834142|NCT00308737|1789660|FG000|Overall Study|Lost to Follow-up|56
834143|NCT00308737|1789661|FG001|Overall Study|Lost to Follow-up|80
834144|NCT00308737|1789662|FG002|Overall Study|Lost to Follow-up|5
834145|NCT00308737|1789660|FG000|Overall Study|Physician Decision|15
834146|NCT00308737|1789661|FG001|Overall Study|Physician Decision|2
834147|NCT00308737|1789662|FG002|Overall Study|Physician Decision|1
834148|NCT00308737|1789660|FG000|Overall Study|Protocol Violation|34
834149|NCT00308737|1789661|FG001|Overall Study|Protocol Violation|9
834150|NCT00308737|1789662|FG002|Overall Study|Protocol Violation|5
834151|NCT00308737|1789660|FG000|Overall Study|Withdrawal by Subject|218
834152|NCT00308737|1789661|FG001|Overall Study|Withdrawal by Subject|166
834153|NCT00308737|1789662|FG002|Overall Study|Withdrawal by Subject|18
834154|NCT00308737|1789660|FG000|Overall Study|Various|32
834155|NCT00308737|1789661|FG001|Overall Study|Various|20
834156|NCT00308737|1789662|FG002|Overall Study|Various|8
834157|NCT00308750|1789673|FG000|Overall Study|Adverse Event|9
834158|NCT00308750|1789674|FG001|Overall Study|Adverse Event|9
834159|NCT00308750|1789675|FG002|Overall Study|Adverse Event|13
834160|NCT00308750|1789673|FG000|Overall Study|Withdrawal by Subject|6
834161|NCT00308750|1789674|FG001|Overall Study|Withdrawal by Subject|2
834162|NCT00308750|1789675|FG002|Overall Study|Withdrawal by Subject|3
834163|NCT00308750|1789673|FG000|Overall Study|Physician Decision|3
834164|NCT00308750|1789674|FG001|Overall Study|Physician Decision|4
834165|NCT00308750|1789675|FG002|Overall Study|Physician Decision|3
834166|NCT00308750|1789673|FG000|Overall Study|Sponsor Decision|1
834167|NCT00308750|1789674|FG001|Overall Study|Sponsor Decision|0
834168|NCT00308750|1789675|FG002|Overall Study|Sponsor Decision|0
834169|NCT00308750|1789673|FG000|Overall Study|Disease Progression|47
834170|NCT00308750|1789674|FG001|Overall Study|Disease Progression|24
834171|NCT00308750|1789675|FG002|Overall Study|Disease Progression|28
834172|NCT00308750|1789673|FG000|Overall Study|Unrelated Complication|3
834173|NCT00308750|1789674|FG001|Overall Study|Unrelated Complication|0
834174|NCT00308750|1789675|FG002|Overall Study|Unrelated Complication|1
834175|NCT00308750|1789673|FG000|Overall Study|Death|1
834176|NCT00308750|1789674|FG001|Overall Study|Death|0
834177|NCT00308750|1789675|FG002|Overall Study|Death|1
834178|NCT00308750|1789673|FG000|Overall Study|Protocol Violation|1
834179|NCT00308750|1789674|FG001|Overall Study|Protocol Violation|0
834180|NCT00308750|1789675|FG002|Overall Study|Protocol Violation|0
834181|NCT00308750|1789673|FG000|Overall Study|New Primary Disease Identified|1
834182|NCT00308750|1789674|FG001|Overall Study|New Primary Disease Identified|1
834183|NCT00308750|1789675|FG002|Overall Study|New Primary Disease Identified|0
834184|NCT00308997|1789686|FG000|Overall Study|Subject feigned clinical data|0
834185|NCT00308997|1789687|FG001|Overall Study|Subject feigned clinical data|1
834186|NCT00308997|1789686|FG000|Overall Study|Unable to tolerate intervention|1
834187|NCT00308997|1789687|FG001|Overall Study|Unable to tolerate intervention|0
834188|NCT00309166|1789699|FG000|Overall Study|Adverse event, non-fatal|1
834189|NCT00309166|1789700|FG001|Overall Study|Adverse event, non-fatal|0
834190|NCT00309166|1789699|FG000|Overall Study|Withdrawal by Subject|4
834191|NCT00309166|1789700|FG001|Overall Study|Withdrawal by Subject|3
834192|NCT00309244|1789708|FG000|Overall Study|Adverse Event|29
834193|NCT00309244|1789709|FG001|Overall Study|Adverse Event|12
834194|NCT00309244|1789708|FG000|Overall Study|Lost to Follow-up|6
834195|NCT00309244|1789709|FG001|Overall Study|Lost to Follow-up|22
834196|NCT00309244|1789708|FG000|Overall Study|Physician Decision|5
834197|NCT00309244|1789709|FG001|Overall Study|Physician Decision|8
834198|NCT00309244|1789708|FG000|Overall Study|Protocol Violation|6
834199|NCT00309244|1789709|FG001|Overall Study|Protocol Violation|3
834200|NCT00309244|1789708|FG000|Overall Study|Withdrawal by Subject|50
834201|NCT00309244|1789709|FG001|Overall Study|Withdrawal by Subject|32
834202|NCT00309244|1789708|FG000|Overall Study|Various|7
834203|NCT00309244|1789709|FG001|Overall Study|Various|7
834204|NCT00309244|1789708|FG000|Overall Study|Randomized but not dosed|11
834205|NCT00309244|1789709|FG001|Overall Study|Randomized but not dosed|12
834206|NCT00309244|1789708|FG000|Overall Study|Death|4
834207|NCT00309244|1789709|FG001|Overall Study|Death|1
834208|NCT00309387|1789717|FG000|Overall Study|Death|72
834209|NCT00309387|1789718|FG001|Overall Study|Death|73
834210|NCT00309387|1789717|FG000|Overall Study|Lost to Follow-up|70
834211|NCT00309387|1789718|FG001|Overall Study|Lost to Follow-up|86
834212|NCT00309452|1789727|FG000|Overall Study|Withdrawal by Subject|3
834213|NCT00309452|1789728|FG001|Overall Study|Withdrawal by Subject|0
834214|NCT00309608|1789764|FG000|Overall Study|Adverse Event|1
834215|NCT00309608|1789765|FG001|Overall Study|Adverse Event|5
834216|NCT00309608|1789766|FG002|Overall Study|Adverse Event|3
834217|NCT00309608|1789767|FG003|Overall Study|Adverse Event|2
834218|NCT00309608|1789768|FG004|Overall Study|Adverse Event|3
834219|NCT00309608|1789764|FG000|Overall Study|Protocol Violation|2
834220|NCT00309608|1789765|FG001|Overall Study|Protocol Violation|0
834221|NCT00309608|1789766|FG002|Overall Study|Protocol Violation|0
834222|NCT00309608|1789767|FG003|Overall Study|Protocol Violation|0
834223|NCT00309608|1789768|FG004|Overall Study|Protocol Violation|0
834224|NCT00309608|1789764|FG000|Overall Study|Lost to Follow-up|0
834225|NCT00309608|1789765|FG001|Overall Study|Lost to Follow-up|0
834226|NCT00309608|1789766|FG002|Overall Study|Lost to Follow-up|2
834227|NCT00309608|1789767|FG003|Overall Study|Lost to Follow-up|0
834228|NCT00309608|1789768|FG004|Overall Study|Lost to Follow-up|1
834229|NCT00309608|1789764|FG000|Overall Study|Withdrawal by Subject|1
834230|NCT00309608|1789765|FG001|Overall Study|Withdrawal by Subject|4
834231|NCT00309608|1789766|FG002|Overall Study|Withdrawal by Subject|2
834232|NCT00309608|1789767|FG003|Overall Study|Withdrawal by Subject|0
834233|NCT00309608|1789768|FG004|Overall Study|Withdrawal by Subject|0
834234|NCT00309608|1789764|FG000|Overall Study|Other incl. Lack of efficacy|10
834235|NCT00309608|1789765|FG001|Overall Study|Other incl. Lack of efficacy|4
834236|NCT00309608|1789766|FG002|Overall Study|Other incl. Lack of efficacy|3
834237|NCT00309608|1789767|FG003|Overall Study|Other incl. Lack of efficacy|4
834238|NCT00309608|1789768|FG004|Overall Study|Other incl. Lack of efficacy|0
834239|NCT00309777|1789802|FG000|Overall Study|Adverse Event|13
834240|NCT00309777|1789803|FG001|Overall Study|Adverse Event|2
834241|NCT00309777|1789804|FG002|Overall Study|Adverse Event|8
834242|NCT00309777|1789805|FG003|Overall Study|Adverse Event|1
834243|NCT00309777|1789802|FG000|Overall Study|Protocol Violation|4
834244|NCT00309777|1789803|FG001|Overall Study|Protocol Violation|1
834245|NCT00309777|1789804|FG002|Overall Study|Protocol Violation|3
834246|NCT00309777|1789805|FG003|Overall Study|Protocol Violation|1
834247|NCT00309777|1789802|FG000|Overall Study|Withdrawal by Subject|6
834248|NCT00309777|1789803|FG001|Overall Study|Withdrawal by Subject|5
834249|NCT00309777|1789804|FG002|Overall Study|Withdrawal by Subject|7
834250|NCT00309777|1789805|FG003|Overall Study|Withdrawal by Subject|2
834251|NCT00309777|1789802|FG000|Overall Study|Lost to Follow-up|0
834252|NCT00309777|1789803|FG001|Overall Study|Lost to Follow-up|0
834253|NCT00309777|1789804|FG002|Overall Study|Lost to Follow-up|1
834254|NCT00309777|1789805|FG003|Overall Study|Lost to Follow-up|0
834255|NCT00309777|1789802|FG000|Overall Study|Death|0
834256|NCT00309777|1789803|FG001|Overall Study|Death|1
834257|NCT00309777|1789804|FG002|Overall Study|Death|0
834258|NCT00309777|1789805|FG003|Overall Study|Death|0
834259|NCT00309842|1789815|FG000|Overall Study|Lost to Follow-up|1
834260|NCT00309907|1789819|FG000|Overall Study|Death|4
834261|NCT00309907|1789819|FG000|Overall Study|Physician Decision|1
834262|NCT00309907|1789819|FG000|Overall Study|Ineligible|11
834263|NCT00309907|1789819|FG000|Overall Study|Major infectious event|4
834264|NCT00309946|1789824|FG000|Overall Study|Withdrawal by Subject|1
834265|NCT00309959|1789828|FG000|Overall Study|Ineligible - no prior chemotherapy|2
834266|NCT00309985|1789839|FG000|Overall Study|Disease progression|12
834267|NCT00309985|1789840|FG001|Overall Study|Disease progression|0
834268|NCT00309985|1789839|FG000|Overall Study|Adverse Event|30
834269|NCT00309985|1789840|FG001|Overall Study|Adverse Event|0
834270|NCT00309985|1789839|FG000|Overall Study|Death|2
834271|NCT00309985|1789840|FG001|Overall Study|Death|0
834272|NCT00309985|1789839|FG000|Overall Study|Withdrawal by Subject|5
834273|NCT00309985|1789840|FG001|Overall Study|Withdrawal by Subject|1
834274|NCT00309985|1789839|FG000|Overall Study|Physician Decision|3
834275|NCT00309985|1789840|FG001|Overall Study|Physician Decision|0
834276|NCT00309985|1789839|FG000|Overall Study|Never started treatment|7
834277|NCT00309985|1789840|FG001|Overall Study|Never started treatment|0
834278|NCT00309985|1789839|FG000|Overall Study|Complicating disease|1
834279|NCT00309985|1789840|FG001|Overall Study|Complicating disease|0
834280|NCT00309985|1789839|FG000|Overall Study|Non-compliance|1
834281|NCT00309985|1789840|FG001|Overall Study|Non-compliance|0
834282|NCT00309985|1789839|FG000|Overall Study|Chemotherapy discontinued only|1
834283|NCT00309985|1789840|FG001|Overall Study|Chemotherapy discontinued only|0
834284|NCT00310037|1789848|FG000|Overall Study|Adverse Event|7
834285|NCT00310037|1789849|FG001|Overall Study|Adverse Event|14
834286|NCT00310037|1789848|FG000|Overall Study|Withdrawal by Subject|4
834287|NCT00310037|1789849|FG001|Overall Study|Withdrawal by Subject|3
834288|NCT00310037|1789848|FG000|Overall Study|Progression|6
834289|NCT00310037|1789849|FG001|Overall Study|Progression|0
834290|NCT00310037|1789848|FG000|Overall Study|Non-protocol treatment|1
834291|NCT00310037|1789849|FG001|Overall Study|Non-protocol treatment|0
834292|NCT00310375|1789910|FG000|Primary Reporting Phase|Adverse Event|28
834293|NCT00310375|1789911|FG001|Primary Reporting Phase|Adverse Event|22
834294|NCT00310375|1789912|FG002|Primary Reporting Phase|Adverse Event|0
834295|NCT00310375|1789910|FG000|Primary Reporting Phase|Lack of Efficacy|24
834296|NCT00310375|1789911|FG001|Primary Reporting Phase|Lack of Efficacy|19
834297|NCT00310375|1789912|FG002|Primary Reporting Phase|Lack of Efficacy|0
834298|NCT00310375|1789910|FG000|Primary Reporting Phase|Pregnancy|2
834299|NCT00310375|1789911|FG001|Primary Reporting Phase|Pregnancy|2
834300|NCT00310375|1789912|FG002|Primary Reporting Phase|Pregnancy|0
834301|NCT00310375|1789910|FG000|Primary Reporting Phase|Withdrawal by Subject|10
834302|NCT00310375|1789911|FG001|Primary Reporting Phase|Withdrawal by Subject|7
834303|NCT00310375|1789912|FG002|Primary Reporting Phase|Withdrawal by Subject|0
834304|NCT00310375|1789910|FG000|Primary Reporting Phase|Protocol Violation|8
834305|NCT00310375|1789911|FG001|Primary Reporting Phase|Protocol Violation|5
834306|NCT00310375|1789912|FG002|Primary Reporting Phase|Protocol Violation|0
834307|NCT00310375|1789910|FG000|Primary Reporting Phase|Change in Par medical condition|2
834308|NCT00310375|1789911|FG001|Primary Reporting Phase|Change in Par medical condition|0
834309|NCT00310375|1789912|FG002|Primary Reporting Phase|Change in Par medical condition|0
834310|NCT00310375|1789910|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
834311|NCT00310375|1789911|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
834312|NCT00310375|1789912|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
834313|NCT00310375|1789910|FG000|Primary Reporting Phase|Physician Decision|5
834314|NCT00310375|1789911|FG001|Primary Reporting Phase|Physician Decision|3
834315|NCT00310375|1789912|FG002|Primary Reporting Phase|Physician Decision|0
834316|NCT00310375|1789910|FG000|Primary Reporting Phase|Request of the sponsor|2
834317|NCT00310375|1789911|FG001|Primary Reporting Phase|Request of the sponsor|2
834318|NCT00310375|1789912|FG002|Primary Reporting Phase|Request of the sponsor|0
834319|NCT00310375|1789910|FG000|Primary Reporting Phase|Failed to return|1
834320|NCT00310375|1789911|FG001|Primary Reporting Phase|Failed to return|3
834321|NCT00310375|1789912|FG002|Primary Reporting Phase|Failed to return|0
834322|NCT00310375|1789910|FG000|Primary Reporting Phase|Participant request unrelated to study|1
834323|NCT00310375|1789911|FG001|Primary Reporting Phase|Participant request unrelated to study|2
834324|NCT00310375|1789912|FG002|Primary Reporting Phase|Participant request unrelated to study|0
834325|NCT00310375|1789910|FG000|Primary Reporting Phase|Going for temporal lobectomy|1
834326|NCT00310375|1789911|FG001|Primary Reporting Phase|Going for temporal lobectomy|0
834327|NCT00310375|1789912|FG002|Primary Reporting Phase|Going for temporal lobectomy|0
834328|NCT00310375|1789910|FG000|Primary Reporting Phase|Missed study drug >5 days|1
834329|NCT00310375|1789911|FG001|Primary Reporting Phase|Missed study drug >5 days|0
834330|NCT00310375|1789912|FG002|Primary Reporting Phase|Missed study drug >5 days|0
834331|NCT00310375|1789910|FG000|Primary Reporting Phase|Site closure|3
834332|NCT00310375|1789911|FG001|Primary Reporting Phase|Site closure|0
834333|NCT00310375|1789912|FG002|Primary Reporting Phase|Site closure|0
834334|NCT00310375|1789910|FG000|Primary Reporting Phase|Missed study drug for 2 months|1
834335|NCT00310375|1789911|FG001|Primary Reporting Phase|Missed study drug for 2 months|0
834336|NCT00310375|1789912|FG002|Primary Reporting Phase|Missed study drug for 2 months|0
834337|NCT00310375|1789910|FG000|Primary Reporting Phase|Par. switched to commercial product|0
834421|NCT00311311|1790090|FG001|Overall Study|Death|0
834338|NCT00310375|1789911|FG001|Primary Reporting Phase|Par. switched to commercial product|1
834339|NCT00310375|1789912|FG002|Primary Reporting Phase|Par. switched to commercial product|0
834340|NCT00310375|1789910|FG000|Primary Reporting Phase|Request of Ethics Committee|0
834341|NCT00310375|1789911|FG001|Primary Reporting Phase|Request of Ethics Committee|1
834342|NCT00310375|1789912|FG002|Primary Reporting Phase|Request of Ethics Committee|0
834343|NCT00310375|1789910|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0
834344|NCT00310375|1789911|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0
834345|NCT00310375|1789912|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1
834346|NCT00310440|1789949|FG000|Overall Study|Lost to Follow-up|17
834347|NCT00310440|1789950|FG001|Overall Study|Lost to Follow-up|8
834348|NCT00310440|1789949|FG000|Overall Study|Withdrawal by Subject|2
834349|NCT00310440|1789950|FG001|Overall Study|Withdrawal by Subject|1
834350|NCT00310440|1789949|FG000|Overall Study|Missed 12 Month Visit|7
834351|NCT00310440|1789950|FG001|Overall Study|Missed 12 Month Visit|4
834352|NCT00310804|1789976|FG000|Overall Study|Lost to Follow-up|2
834353|NCT00310804|1789977|FG001|Overall Study|Lost to Follow-up|0
834354|NCT00310804|1789976|FG000|Overall Study|Withdrawal by Subject|3
834355|NCT00310804|1789977|FG001|Overall Study|Withdrawal by Subject|0
834356|NCT00310817|1790001|FG000|Overall Study|AE or Death|3
834357|NCT00310817|1790002|FG001|Overall Study|AE or Death|1
834358|NCT00310817|1790003|FG002|Overall Study|AE or Death|0
834359|NCT00310817|1790004|FG003|Overall Study|AE or Death|0
834360|NCT00310817|1790001|FG000|Overall Study|Withdrawal by Subject|1
834361|NCT00310817|1790002|FG001|Overall Study|Withdrawal by Subject|4
834362|NCT00310817|1790003|FG002|Overall Study|Withdrawal by Subject|6
834363|NCT00310817|1790004|FG003|Overall Study|Withdrawal by Subject|7
834364|NCT00310817|1790001|FG000|Overall Study|Lost to Follow-up|2
834365|NCT00310817|1790002|FG001|Overall Study|Lost to Follow-up|1
834366|NCT00310817|1790003|FG002|Overall Study|Lost to Follow-up|0
834367|NCT00310817|1790004|FG003|Overall Study|Lost to Follow-up|0
834368|NCT00310817|1790001|FG000|Overall Study|Inappropriate Enrollment|1
834369|NCT00310817|1790002|FG001|Overall Study|Inappropriate Enrollment|0
834370|NCT00310817|1790003|FG002|Overall Study|Inappropriate Enrollment|1
834371|NCT00310817|1790004|FG003|Overall Study|Inappropriate Enrollment|0
834372|NCT00310817|1790001|FG000|Overall Study|Protocol Violation|1
834373|NCT00310817|1790002|FG001|Overall Study|Protocol Violation|1
834374|NCT00310817|1790003|FG002|Overall Study|Protocol Violation|1
834375|NCT00310817|1790004|FG003|Overall Study|Protocol Violation|1
834376|NCT00310817|1790001|FG000|Overall Study|Unable to classify|3
834377|NCT00310817|1790002|FG001|Overall Study|Unable to classify|1
834378|NCT00310817|1790003|FG002|Overall Study|Unable to classify|0
834379|NCT00310817|1790004|FG003|Overall Study|Unable to classify|0
834380|NCT00310856|1790050|FG000|Overall Study|Withdrawal by Subject|2
834381|NCT00310856|1790051|FG001|Overall Study|Withdrawal by Subject|2
834382|NCT00310856|1790052|FG002|Overall Study|Withdrawal by Subject|2
834383|NCT00310856|1790050|FG000|Overall Study|Lost to Follow-up|1
834384|NCT00310856|1790051|FG001|Overall Study|Lost to Follow-up|2
834385|NCT00310856|1790052|FG002|Overall Study|Lost to Follow-up|6
834386|NCT00310856|1790050|FG000|Overall Study|Inappropriate enrollment|1
834387|NCT00310856|1790051|FG001|Overall Study|Inappropriate enrollment|1
834388|NCT00310856|1790052|FG002|Overall Study|Inappropriate enrollment|0
834389|NCT00310856|1790050|FG000|Overall Study|Unable to classify|1
834390|NCT00310856|1790051|FG001|Overall Study|Unable to classify|0
834391|NCT00310856|1790052|FG002|Overall Study|Unable to classify|0
834392|NCT00311155|1790061|FG000|Overall Study|Adverse Event|21
834393|NCT00311155|1790061|FG000|Overall Study|Withdrawal by Subject|17
834394|NCT00311155|1790061|FG000|Overall Study|Did not meet entry criteria|55
834395|NCT00311168|1790067|FG000|First Intervention|Withdrawal by Subject|2
834396|NCT00311168|1790068|FG001|First Intervention|Withdrawal by Subject|2
834397|NCT00311168|1790067|FG000|First Intervention|Lost to Follow-up|1
834398|NCT00311168|1790068|FG001|First Intervention|Lost to Follow-up|1
834399|NCT00311168|1790067|FG000|First Intervention|Protocol Violation|1
834400|NCT00311168|1790068|FG001|First Intervention|Protocol Violation|1
834401|NCT00311168|1790067|FG000|First Intervention|Adverse Event|1
834402|NCT00311168|1790068|FG001|First Intervention|Adverse Event|0
834403|NCT00311168|1790067|FG000|First Intervention|Other|2
834404|NCT00311168|1790068|FG001|First Intervention|Other|2
834405|NCT00311168|1790067|FG000|Second Intervention|Lost to Follow-up|9
834406|NCT00311168|1790068|FG001|Second Intervention|Lost to Follow-up|2
834407|NCT00311168|1790067|FG000|Second Intervention|Withdrawal by Subject|0
834408|NCT00311168|1790068|FG001|Second Intervention|Withdrawal by Subject|1
834409|NCT00311168|1790067|FG000|Second Intervention|Other|1
834410|NCT00311168|1790068|FG001|Second Intervention|Other|1
834411|NCT00311181|1790076|FG000|Overall Study|Final DFTs were not obtained|96
834412|NCT00311311|1790089|FG000|Overall Study|Adverse Event|3
834413|NCT00311311|1790090|FG001|Overall Study|Adverse Event|2
834414|NCT00311311|1790089|FG000|Overall Study|Withdrawal by Subject|1
834415|NCT00311311|1790090|FG001|Overall Study|Withdrawal by Subject|1
834416|NCT00311311|1790089|FG000|Overall Study|Noncompliance|0
834417|NCT00311311|1790090|FG001|Overall Study|Noncompliance|1
834418|NCT00311311|1790089|FG000|Overall Study|Study Termination by Sponsor|3
834419|NCT00311311|1790090|FG001|Overall Study|Study Termination by Sponsor|4
834420|NCT00311311|1790089|FG000|Overall Study|Death|1
834422|NCT00311311|1790089|FG000|Overall Study|Lack of ancillary assistance|0
834423|NCT00311311|1790090|FG001|Overall Study|Lack of ancillary assistance|1
834424|NCT00311363|1790099|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42
834425|NCT00311363|1790100|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0
834426|NCT00311363|1790101|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0
834427|NCT00311363|1790099|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
834428|NCT00311363|1790100|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
834429|NCT00311363|1790101|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
834430|NCT00311363|1790099|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
834431|NCT00311363|1790100|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
834432|NCT00311363|1790101|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
834433|NCT00311363|1790099|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
834434|NCT00311363|1790100|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
834435|NCT00311363|1790101|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
834436|NCT00311363|1790099|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8
834437|NCT00311363|1790100|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0
834438|NCT00311363|1790101|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0
834439|NCT00311363|1790099|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1
834440|NCT00311363|1790100|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0
834441|NCT00311363|1790101|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0
834442|NCT00311363|1790099|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
834443|NCT00311363|1790100|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
834444|NCT00311363|1790101|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
834445|NCT00311363|1790099|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1
834446|NCT00311363|1790100|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0
834447|NCT00311363|1790101|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0
834448|NCT00311363|1790099|FG000|24-Week Single-Blind Treatment Period|Death|1
834449|NCT00311363|1790100|FG001|24-Week Single-Blind Treatment Period|Death|0
834450|NCT00311363|1790101|FG002|24-Week Single-Blind Treatment Period|Death|0
834451|NCT00311363|1790099|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0
834452|NCT00311363|1790100|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3
834453|NCT00311363|1790101|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0
834454|NCT00311363|1790099|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
834455|NCT00311363|1790100|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
834456|NCT00311363|1790101|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
834457|NCT00311363|1790099|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
834458|NCT00311363|1790100|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
834459|NCT00311363|1790101|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
834460|NCT00311363|1790099|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
834461|NCT00311363|1790100|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
834462|NCT00311363|1790101|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
834463|NCT00311363|1790099|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0
834464|NCT00311363|1790100|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1
834465|NCT00311363|1790101|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2
834466|NCT00311363|1790099|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
834467|NCT00311363|1790100|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
834468|NCT00311363|1790101|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
834469|NCT00311402|1790126|FG000|Overall Study|Adverse Event|118
834470|NCT00311402|1790127|FG001|Overall Study|Adverse Event|105
834471|NCT00311402|1790126|FG000|Overall Study|Lost to Follow-up|0
834472|NCT00311402|1790127|FG001|Overall Study|Lost to Follow-up|3
834473|NCT00311402|1790126|FG000|Overall Study|Withdrawal by Subject|17
834474|NCT00311402|1790127|FG001|Overall Study|Withdrawal by Subject|18
834475|NCT00311402|1790126|FG000|Overall Study|Lack of Efficacy|58
834476|NCT00311402|1790127|FG001|Overall Study|Lack of Efficacy|42
834477|NCT00311402|1790126|FG000|Overall Study|Protocol Violation|7
834478|NCT00311402|1790127|FG001|Overall Study|Protocol Violation|6
834479|NCT00311402|1790126|FG000|Overall Study|IRB's rejection etc.|10
834480|NCT00311402|1790127|FG001|Overall Study|IRB's rejection etc.|3
834481|NCT00311584|1790135|FG000|Overall Study|Death|1
834482|NCT00311584|1790136|FG001|Overall Study|Death|0
834483|NCT00311584|1790135|FG000|Overall Study|Lack of Efficacy|12
834484|NCT00311584|1790136|FG001|Overall Study|Lack of Efficacy|15
834485|NCT00311584|1790135|FG000|Overall Study|Physician Decision|4
834486|NCT00311584|1790136|FG001|Overall Study|Physician Decision|5
834487|NCT00311584|1790135|FG000|Overall Study|Withdrawal by Subject|1
834488|NCT00311584|1790136|FG001|Overall Study|Withdrawal by Subject|1
834489|NCT00311584|1790135|FG000|Overall Study|ineligible|2
834490|NCT00311584|1790136|FG001|Overall Study|ineligible|2
834491|NCT00311623|1790145|FG000|Overall Study|Physician Decision|0
834492|NCT00311623|1790146|FG001|Overall Study|Physician Decision|0
834493|NCT00311623|1790147|FG002|Overall Study|Physician Decision|2
834494|NCT00312195|1790167|FG000|Overall Study|Adverse Event|4
834495|NCT00312195|1790168|FG001|Overall Study|Adverse Event|6
834496|NCT00312195|1790167|FG000|Overall Study|Lost to Follow-up|1
834497|NCT00312195|1790168|FG001|Overall Study|Lost to Follow-up|0
834498|NCT00312195|1790167|FG000|Overall Study|Protocol Violation|1
834499|NCT00312195|1790168|FG001|Overall Study|Protocol Violation|0
834500|NCT00312208|1790178|FG000|Overall Study|Adverse Event|97
834501|NCT00312208|1790179|FG001|Overall Study|Adverse Event|61
834502|NCT00312208|1790178|FG000|Overall Study|Protocol Violation|5
834503|NCT00312208|1790179|FG001|Overall Study|Protocol Violation|3
834504|NCT00312208|1790178|FG000|Overall Study|Death|2
834505|NCT00312208|1790179|FG001|Overall Study|Death|1
834506|NCT00312208|1790178|FG000|Overall Study|Lack of Efficacy|7
834507|NCT00312208|1790179|FG001|Overall Study|Lack of Efficacy|4
834508|NCT00312208|1790178|FG000|Overall Study|Lost to Follow-up|3
834509|NCT00312208|1790179|FG001|Overall Study|Lost to Follow-up|5
834510|NCT00312208|1790178|FG000|Overall Study|Withdrawal by Subject|53
834511|NCT00312208|1790179|FG001|Overall Study|Withdrawal by Subject|42
834512|NCT00312208|1790178|FG000|Overall Study|Other|5
834513|NCT00312208|1790179|FG001|Overall Study|Other|7
834514|NCT00312221|1790188|FG000|Open-label Run-in Period|Withdrawal by Subject|6
834515|NCT00312221|1790189|FG001|Open-label Run-in Period|Withdrawal by Subject|0
834516|NCT00312221|1790190|FG002|Open-label Run-in Period|Withdrawal by Subject|0
834517|NCT00312221|1790191|FG003|Open-label Run-in Period|Withdrawal by Subject|0
834518|NCT00312221|1790188|FG000|Open-label Run-in Period|Adverse Event|74
834519|NCT00312221|1790189|FG001|Open-label Run-in Period|Adverse Event|0
834520|NCT00312221|1790190|FG002|Open-label Run-in Period|Adverse Event|0
834521|NCT00312221|1790191|FG003|Open-label Run-in Period|Adverse Event|0
834522|NCT00312221|1790188|FG000|Open-label Run-in Period|Lost to Follow-up|5
834523|NCT00312221|1790189|FG001|Open-label Run-in Period|Lost to Follow-up|0
834524|NCT00312221|1790190|FG002|Open-label Run-in Period|Lost to Follow-up|0
834525|NCT00312221|1790191|FG003|Open-label Run-in Period|Lost to Follow-up|0
834526|NCT00312221|1790188|FG000|Open-label Run-in Period|Administrative|42
834527|NCT00312221|1790189|FG001|Open-label Run-in Period|Administrative|0
834528|NCT00312221|1790190|FG002|Open-label Run-in Period|Administrative|0
834529|NCT00312221|1790191|FG003|Open-label Run-in Period|Administrative|0
834530|NCT00312221|1790188|FG000|Open-label Run-in Period|Lack of Efficacy|102
834531|NCT00312221|1790189|FG001|Open-label Run-in Period|Lack of Efficacy|0
834532|NCT00312221|1790190|FG002|Open-label Run-in Period|Lack of Efficacy|0
834533|NCT00312221|1790191|FG003|Open-label Run-in Period|Lack of Efficacy|0
834534|NCT00312221|1790188|FG000|Open-label Run-in Period|Did not qualify|5
834535|NCT00312221|1790189|FG001|Open-label Run-in Period|Did not qualify|0
834536|NCT00312221|1790190|FG002|Open-label Run-in Period|Did not qualify|0
834537|NCT00312221|1790191|FG003|Open-label Run-in Period|Did not qualify|0
834538|NCT00312221|1790188|FG000|Double-blind Phase|Withdrawal by Subject|0
834539|NCT00312221|1790189|FG001|Double-blind Phase|Withdrawal by Subject|6
834540|NCT00312221|1790190|FG002|Double-blind Phase|Withdrawal by Subject|8
834541|NCT00312221|1790191|FG003|Double-blind Phase|Withdrawal by Subject|7
834542|NCT00312221|1790188|FG000|Double-blind Phase|Adverse Event|0
834543|NCT00312221|1790189|FG001|Double-blind Phase|Adverse Event|10
834544|NCT00312221|1790190|FG002|Double-blind Phase|Adverse Event|19
834545|NCT00312221|1790191|FG003|Double-blind Phase|Adverse Event|18
834546|NCT00312221|1790188|FG000|Double-blind Phase|Lost to Follow-up|0
834547|NCT00312221|1790189|FG001|Double-blind Phase|Lost to Follow-up|0
834548|NCT00312221|1790190|FG002|Double-blind Phase|Lost to Follow-up|2
834549|NCT00312221|1790191|FG003|Double-blind Phase|Lost to Follow-up|2
834550|NCT00312221|1790188|FG000|Double-blind Phase|Administrative|0
834551|NCT00312221|1790189|FG001|Double-blind Phase|Administrative|26
834552|NCT00312221|1790190|FG002|Double-blind Phase|Administrative|37
834553|NCT00312221|1790191|FG003|Double-blind Phase|Administrative|33
834554|NCT00312221|1790188|FG000|Double-blind Phase|Lack of Efficacy|0
834555|NCT00312221|1790189|FG001|Double-blind Phase|Lack of Efficacy|17
834556|NCT00312221|1790190|FG002|Double-blind Phase|Lack of Efficacy|6
834557|NCT00312221|1790191|FG003|Double-blind Phase|Lack of Efficacy|10
834558|NCT00312338|1790202|FG000|Overall Study|Adverse Event|7
834559|NCT00312338|1790203|FG001|Overall Study|Adverse Event|2
834560|NCT00312338|1790202|FG000|Overall Study|Lost to Follow-up|9
834561|NCT00312338|1790203|FG001|Overall Study|Lost to Follow-up|1
834562|NCT00312338|1790202|FG000|Overall Study|Withdrawal by Subject|4
834563|NCT00312338|1790203|FG001|Overall Study|Withdrawal by Subject|0
834564|NCT00312338|1790202|FG000|Overall Study|Subsequent infection|2
834565|NCT00312338|1790203|FG001|Overall Study|Subsequent infection|0
834566|NCT00312377|1790211|FG000|Overall Study|Death|403
834567|NCT00312377|1790212|FG001|Overall Study|Death|418
834568|NCT00312377|1790211|FG000|Overall Study|Withdrawal by Subject|23
834569|NCT00312377|1790212|FG001|Overall Study|Withdrawal by Subject|30
834570|NCT00312377|1790211|FG000|Overall Study|Lost to Follow-up|9
834571|NCT00312377|1790212|FG001|Overall Study|Lost to Follow-up|12
834572|NCT00312377|1790211|FG000|Overall Study|Non-compliance|0
834573|NCT00312377|1790212|FG001|Overall Study|Non-compliance|2
834574|NCT00312377|1790211|FG000|Overall Study|Randomised but never received treatment|6
834575|NCT00312377|1790212|FG001|Overall Study|Randomised but never received treatment|6
834576|NCT00312377|1790211|FG000|Overall Study|Discontinue treatment survival follow up|202
834577|NCT00312377|1790212|FG001|Overall Study|Discontinue treatment survival follow up|200
834578|NCT00312377|1790211|FG000|Overall Study|Site ended participation in study|1
834579|NCT00312377|1790212|FG001|Overall Study|Site ended participation in study|0
834580|NCT00312494|1790221|FG000|Overall Study|Randomized; not treated with study drug|9
834581|NCT00312494|1790222|FG001|Overall Study|Randomized; not treated with study drug|10
834582|NCT00312494|1790223|FG002|Overall Study|Randomized; not treated with study drug|5
834583|NCT00312494|1790221|FG000|Overall Study|Adverse Event|33
834584|NCT00312494|1790222|FG001|Overall Study|Adverse Event|15
834585|NCT00312494|1790223|FG002|Overall Study|Adverse Event|11
834586|NCT00312494|1790221|FG000|Overall Study|Lack of Efficacy|4
834587|NCT00312494|1790222|FG001|Overall Study|Lack of Efficacy|6
834588|NCT00312494|1790223|FG002|Overall Study|Lack of Efficacy|8
834589|NCT00312494|1790221|FG000|Overall Study|Laboratory abnormality|1
834590|NCT00312494|1790222|FG001|Overall Study|Laboratory abnormality|0
834591|NCT00312494|1790223|FG002|Overall Study|Laboratory abnormality|0
834592|NCT00312494|1790221|FG000|Overall Study|Lost to Follow-up|8
834593|NCT00312494|1790222|FG001|Overall Study|Lost to Follow-up|8
834594|NCT00312494|1790223|FG002|Overall Study|Lost to Follow-up|8
834595|NCT00312494|1790221|FG000|Overall Study|Withdrawal by Subject|6
834596|NCT00312494|1790222|FG001|Overall Study|Withdrawal by Subject|9
834597|NCT00312494|1790223|FG002|Overall Study|Withdrawal by Subject|10
834598|NCT00312494|1790221|FG000|Overall Study|Other|10
834599|NCT00312494|1790222|FG001|Overall Study|Other|10
834600|NCT00312494|1790223|FG002|Overall Study|Other|1
834601|NCT00312572|1790233|FG000|Overall Study|Adverse Event|10
834602|NCT00312572|1790234|FG001|Overall Study|Adverse Event|16
834603|NCT00312572|1790233|FG000|Overall Study|Lost to Follow-up|1
834604|NCT00312572|1790234|FG001|Overall Study|Lost to Follow-up|1
834605|NCT00312572|1790233|FG000|Overall Study|Administrative|4
834606|NCT00312572|1790234|FG001|Overall Study|Administrative|2
834607|NCT00312572|1790233|FG000|Overall Study|Lack of Efficacy|1
834608|NCT00312572|1790234|FG001|Overall Study|Lack of Efficacy|2
834609|NCT00312663|1790245|FG000|Immunization Phase|Adverse Event|0
834610|NCT00312663|1790246|FG001|Immunization Phase|Adverse Event|1
834611|NCT00312663|1790247|FG002|Immunization Phase|Adverse Event|0
834612|NCT00312702|1790259|FG000|Immunization Phase|Lost to Follow-up|0
834613|NCT00312702|1790260|FG001|Immunization Phase|Lost to Follow-up|1
834614|NCT00312702|1790261|FG002|Immunization Phase|Lost to Follow-up|0
834615|NCT00312728|1790269|FG000|Overall Study|Progressive disease|53
834616|NCT00312728|1790269|FG000|Overall Study|Adverse Event|32
834617|NCT00312728|1790269|FG000|Overall Study|Withdrawal by Subject|10
834618|NCT00312728|1790269|FG000|Overall Study|Required non-protocol cancer treatment|2
834619|NCT00312728|1790269|FG000|Overall Study|Protocol Violation|2
834620|NCT00312728|1790269|FG000|Overall Study|Other|10
834621|NCT00312728|1790269|FG000|Overall Study|Other|1
834622|NCT00312845|1790275|FG000|Overall Study|Adverse Event|19
834623|NCT00312845|1790276|FG001|Overall Study|Adverse Event|5
834624|NCT00312845|1790275|FG000|Overall Study|Death|2
834625|NCT00312845|1790276|FG001|Overall Study|Death|2
834626|NCT00312845|1790275|FG000|Overall Study|Withdrawal by Subject|14
834627|NCT00312845|1790276|FG001|Overall Study|Withdrawal by Subject|6
834628|NCT00312845|1790275|FG000|Overall Study|Disease Progression|56
834629|NCT00312845|1790276|FG001|Overall Study|Disease Progression|77
834630|NCT00312845|1790275|FG000|Overall Study|Lost to Follow-up|2
834631|NCT00312845|1790276|FG001|Overall Study|Lost to Follow-up|0
834632|NCT00312845|1790275|FG000|Overall Study|Other|6
834633|NCT00312845|1790276|FG001|Overall Study|Other|5
834634|NCT00312858|1790284|FG000|Overall Study|Adverse Event|0
834635|NCT00312858|1790285|FG001|Overall Study|Adverse Event|1
834636|NCT00312858|1790284|FG000|Overall Study|Lost to Follow-up|25
834637|NCT00312858|1790285|FG001|Overall Study|Lost to Follow-up|42
834638|NCT00312858|1790284|FG000|Overall Study|Protocol Violation|3
834639|NCT00312858|1790285|FG001|Overall Study|Protocol Violation|8
834640|NCT00312858|1790284|FG000|Overall Study|Withdraw by Participant|20
834641|NCT00312858|1790285|FG001|Overall Study|Withdraw by Participant|20
834642|NCT00312858|1790284|FG000|Overall Study|Participant Moved|11
834643|NCT00312858|1790285|FG001|Overall Study|Participant Moved|10
834644|NCT00312858|1790284|FG000|Overall Study|Other|9
834645|NCT00312858|1790285|FG001|Overall Study|Other|12
834646|NCT00312897|1790302|FG000|Overall Study|Adverse Event|1
834647|NCT00312897|1790303|FG001|Overall Study|Adverse Event|0
834648|NCT00312897|1790302|FG000|Overall Study|Lost to Follow-up|2
834649|NCT00312897|1790303|FG001|Overall Study|Lost to Follow-up|0
834650|NCT00312897|1790302|FG000|Overall Study|Physician Decision|1
834651|NCT00312897|1790303|FG001|Overall Study|Physician Decision|0
834652|NCT00312897|1790302|FG000|Overall Study|Withdrawal by Subject|1
834653|NCT00312897|1790303|FG001|Overall Study|Withdrawal by Subject|3
834654|NCT00312897|1790302|FG000|Overall Study|Pregnancy|1
834655|NCT00312897|1790303|FG001|Overall Study|Pregnancy|0
834656|NCT00312897|1790302|FG000|Overall Study|discontinued prior to getting treatment|0
834657|NCT00312897|1790303|FG001|Overall Study|discontinued prior to getting treatment|3
834658|NCT00313014|1790321|FG000|Overall Study|Withdrawal by Subject|11
834659|NCT00313014|1790322|FG001|Overall Study|Withdrawal by Subject|7
834660|NCT00313014|1790323|FG002|Overall Study|Withdrawal by Subject|5
834661|NCT00313014|1790321|FG000|Overall Study|Adverse Event|14
834662|NCT00313014|1790322|FG001|Overall Study|Adverse Event|29
834663|NCT00313014|1790323|FG002|Overall Study|Adverse Event|16
834664|NCT00313014|1790321|FG000|Overall Study|Lost to Follow-up|7
834665|NCT00313014|1790322|FG001|Overall Study|Lost to Follow-up|6
834666|NCT00313014|1790323|FG002|Overall Study|Lost to Follow-up|10
834667|NCT00313014|1790321|FG000|Overall Study|Administrative|9
834668|NCT00313014|1790322|FG001|Overall Study|Administrative|6
834669|NCT00313014|1790323|FG002|Overall Study|Administrative|14
834670|NCT00313014|1790321|FG000|Overall Study|Lack of Efficacy|52
834671|NCT00313014|1790322|FG001|Overall Study|Lack of Efficacy|25
834672|NCT00313014|1790323|FG002|Overall Study|Lack of Efficacy|16
834673|NCT00313144|1790332|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
834674|NCT00313144|1790332|FG000|Overall Study|Death|7
834675|NCT00313144|1790332|FG000|Overall Study|Lost to Follow-up|5
834676|NCT00313144|1790332|FG000|Overall Study|Withdrawal by Subject|4
834677|NCT00313144|1790332|FG000|Overall Study|Terminated by sponsor/ homecare provider|4
834678|NCT00313144|1790332|FG000|Overall Study|Physician Decision|4
834679|NCT00313144|1790332|FG000|Overall Study|Adverse event - transient|5
834680|NCT00313144|1790332|FG000|Overall Study|Liver transplant|1
834681|NCT00313144|1790332|FG000|Overall Study|Insurance (homecare provider) change|1
834682|NCT00313144|1790332|FG000|Overall Study|Change to different product|1
834683|NCT00313144|1790332|FG000|Overall Study|Due to termination of the study|66
834684|NCT00313170|1790348|FG000|Overall Study|Death|2
834685|NCT00313170|1790349|FG001|Overall Study|Death|4
834686|NCT00313170|1790350|FG002|Overall Study|Death|2
834687|NCT00313170|1790348|FG000|Overall Study|Adverse Event|1
834688|NCT00313170|1790349|FG001|Overall Study|Adverse Event|2
834689|NCT00313170|1790350|FG002|Overall Study|Adverse Event|0
834690|NCT00313170|1790348|FG000|Overall Study|Disease progression|31
834691|NCT00313170|1790349|FG001|Overall Study|Disease progression|26
834692|NCT00313170|1790350|FG002|Overall Study|Disease progression|27
834693|NCT00313170|1790348|FG000|Overall Study|Withdrawal by Subject|1
834694|NCT00313170|1790349|FG001|Overall Study|Withdrawal by Subject|0
834695|NCT00313170|1790350|FG002|Overall Study|Withdrawal by Subject|1
834696|NCT00313170|1790348|FG000|Overall Study|Incorrect enrollment|0
834697|NCT00313170|1790349|FG001|Overall Study|Incorrect enrollment|2
834698|NCT00313170|1790350|FG002|Overall Study|Incorrect enrollment|1
834699|NCT00313170|1790348|FG000|Overall Study|Lost to Follow-up|0
834700|NCT00313170|1790349|FG001|Overall Study|Lost to Follow-up|0
834701|NCT00313170|1790350|FG002|Overall Study|Lost to Follow-up|1
834702|NCT00313170|1790348|FG000|Overall Study|Progression (investigators opinion)|1
834703|NCT00313170|1790349|FG001|Overall Study|Progression (investigators opinion)|0
834704|NCT00313170|1790350|FG002|Overall Study|Progression (investigators opinion)|0
834705|NCT00313300|1790373|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19
834706|NCT00313300|1790374|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14
834707|NCT00313300|1790375|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17
834708|NCT00313300|1790376|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0
834709|NCT00313300|1790377|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0
834710|NCT00313300|1790373|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
834711|NCT00313300|1790374|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
834712|NCT00313300|1790375|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
834713|NCT00313300|1790376|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
834714|NCT00313300|1790377|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
834715|NCT00313300|1790373|FG000|Randomized in Phase A (26 Weeks)|Death|3
834716|NCT00313300|1790374|FG001|Randomized in Phase A (26 Weeks)|Death|4
834717|NCT00313300|1790375|FG002|Randomized in Phase A (26 Weeks)|Death|0
834718|NCT00313300|1790376|FG003|Randomized in Phase A (26 Weeks)|Death|0
834719|NCT00313300|1790377|FG004|Randomized in Phase A (26 Weeks)|Death|0
834720|NCT00313300|1790373|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
834721|NCT00313300|1790374|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
834722|NCT00313300|1790375|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
834723|NCT00313300|1790376|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
834724|NCT00313300|1790377|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
834725|NCT00313300|1790373|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
834726|NCT00313300|1790374|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
834727|NCT00313300|1790375|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
834728|NCT00313300|1790376|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
834729|NCT00313300|1790377|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
834730|NCT00313300|1790373|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
834731|NCT00313300|1790374|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
834732|NCT00313300|1790375|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
834733|NCT00313300|1790376|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
834734|NCT00313300|1790377|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
834735|NCT00313300|1790373|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
834736|NCT00313300|1790374|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
834737|NCT00313300|1790375|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
834738|NCT00313300|1790376|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
834739|NCT00313300|1790377|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
834740|NCT00313300|1790373|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34
834741|NCT00313300|1790374|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9
834742|NCT00313300|1790375|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12
834743|NCT00313300|1790376|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23
834744|NCT00313300|1790377|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19
834745|NCT00313300|1790373|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
834746|NCT00313300|1790374|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
834747|NCT00313300|1790375|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
834748|NCT00313300|1790376|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
834749|NCT00313300|1790377|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
834750|NCT00313300|1790373|FG000|Randomized in Phase B (26 Weeks)|Death|5
834751|NCT00313300|1790374|FG001|Randomized in Phase B (26 Weeks)|Death|3
834752|NCT00313300|1790375|FG002|Randomized in Phase B (26 Weeks)|Death|1
834753|NCT00313300|1790376|FG003|Randomized in Phase B (26 Weeks)|Death|0
834754|NCT00313300|1790377|FG004|Randomized in Phase B (26 Weeks)|Death|1
834755|NCT00313300|1790373|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
834756|NCT00313300|1790374|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
834757|NCT00313300|1790375|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
834758|NCT00313300|1790376|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
834759|NCT00313300|1790377|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
834760|NCT00313300|1790373|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
834761|NCT00313300|1790374|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
834762|NCT00313300|1790375|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
834763|NCT00313300|1790376|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
834764|NCT00313300|1790377|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
834765|NCT00313300|1790373|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
834766|NCT00313300|1790374|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
834767|NCT00313300|1790375|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
834768|NCT00313300|1790376|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
834769|NCT00313300|1790377|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
834770|NCT00313300|1790373|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
834771|NCT00313300|1790374|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
834772|NCT00313300|1790375|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
834773|NCT00313300|1790376|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
834774|NCT00313300|1790377|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
834775|NCT00313300|1790373|FG000|Randomized in Phase B (26 Weeks)|non-specified|1
834776|NCT00313300|1790374|FG001|Randomized in Phase B (26 Weeks)|non-specified|0
834777|NCT00313300|1790375|FG002|Randomized in Phase B (26 Weeks)|non-specified|0
834778|NCT00313300|1790376|FG003|Randomized in Phase B (26 Weeks)|non-specified|0
834779|NCT00313300|1790377|FG004|Randomized in Phase B (26 Weeks)|non-specified|0
834780|NCT00313300|1790373|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
834781|NCT00313300|1790374|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
834782|NCT00313300|1790375|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
834783|NCT00313300|1790376|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
834784|NCT00313300|1790377|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
834785|NCT00313300|1790373|FG000|Follow-Up(30days)-Randomized Phase A|Death|0
834786|NCT00313300|1790374|FG001|Follow-Up(30days)-Randomized Phase A|Death|1
834787|NCT00313300|1790375|FG002|Follow-Up(30days)-Randomized Phase A|Death|0
834788|NCT00313300|1790376|FG003|Follow-Up(30days)-Randomized Phase A|Death|0
834789|NCT00313300|1790377|FG004|Follow-Up(30days)-Randomized Phase A|Death|0
834790|NCT00313300|1790373|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
834791|NCT00313300|1790374|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
834792|NCT00313300|1790375|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
834793|NCT00313300|1790376|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
834794|NCT00313300|1790377|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
834795|NCT00313300|1790373|FG000|Follow-Up(30days)-Randomized Phase B|Death|1
834796|NCT00313300|1790374|FG001|Follow-Up(30days)-Randomized Phase B|Death|0
834797|NCT00313300|1790375|FG002|Follow-Up(30days)-Randomized Phase B|Death|0
834798|NCT00313300|1790376|FG003|Follow-Up(30days)-Randomized Phase B|Death|0
834799|NCT00313300|1790377|FG004|Follow-Up(30days)-Randomized Phase B|Death|0
834800|NCT00313300|1790373|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
834801|NCT00313300|1790374|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
834802|NCT00313300|1790375|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
834803|NCT00313300|1790376|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
834804|NCT00313300|1790377|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
834805|NCT00313300|1790373|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
834806|NCT00313300|1790374|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
834807|NCT00313300|1790375|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
834808|NCT00313300|1790376|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
834809|NCT00313300|1790377|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
834810|NCT00313313|1790398|FG000|Overall Study|Lack of Efficacy|14
834811|NCT00313313|1790399|FG001|Overall Study|Lack of Efficacy|9
834812|NCT00313313|1790400|FG002|Overall Study|Lack of Efficacy|20
834813|NCT00313313|1790398|FG000|Overall Study|Withdrawal of consent by subject|18
834814|NCT00313313|1790399|FG001|Overall Study|Withdrawal of consent by subject|17
834815|NCT00313313|1790400|FG002|Overall Study|Withdrawal of consent by subject|31
834816|NCT00313313|1790398|FG000|Overall Study|Lost to Follow-up|10
834817|NCT00313313|1790399|FG001|Overall Study|Lost to Follow-up|7
834818|NCT00313313|1790400|FG002|Overall Study|Lost to Follow-up|9
834819|NCT00313313|1790398|FG000|Overall Study|Adverse Event|15
834820|NCT00313313|1790399|FG001|Overall Study|Adverse Event|16
834821|NCT00313313|1790400|FG002|Overall Study|Adverse Event|12
834822|NCT00313313|1790398|FG000|Overall Study|Physician Decision|2
834823|NCT00313313|1790399|FG001|Overall Study|Physician Decision|6
834824|NCT00313313|1790400|FG002|Overall Study|Physician Decision|4
834825|NCT00313313|1790398|FG000|Overall Study|Poor/Noncompliance|3
834826|NCT00313313|1790399|FG001|Overall Study|Poor/Noncompliance|6
834827|NCT00313313|1790400|FG002|Overall Study|Poor/Noncompliance|2
834828|NCT00313313|1790398|FG000|Overall Study|Pregnancy|1
834829|NCT00313313|1790399|FG001|Overall Study|Pregnancy|2
834830|NCT00313313|1790400|FG002|Overall Study|Pregnancy|0
834831|NCT00313313|1790398|FG000|Overall Study|Death|0
834832|NCT00313313|1790399|FG001|Overall Study|Death|0
834833|NCT00313313|1790400|FG002|Overall Study|Death|2
834834|NCT00313313|1790398|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
834835|NCT00313313|1790399|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
834836|NCT00313313|1790400|FG002|Overall Study|Subject No Longer Meets Study Criteria|2
834837|NCT00313586|1790424|FG000|Overall Study|Disease progression|14
834838|NCT00313586|1790425|FG001|Overall Study|Disease progression|19
834839|NCT00313586|1790426|FG002|Overall Study|Disease progression|10
834840|NCT00313586|1790427|FG003|Overall Study|Disease progression|3
834841|NCT00313586|1790424|FG000|Overall Study|Adverse Event|12
834842|NCT00313586|1790425|FG001|Overall Study|Adverse Event|18
834843|NCT00313586|1790426|FG002|Overall Study|Adverse Event|3
834844|NCT00313586|1790427|FG003|Overall Study|Adverse Event|10
834845|NCT00313586|1790424|FG000|Overall Study|Death|11
834846|NCT00313586|1790425|FG001|Overall Study|Death|8
834847|NCT00313586|1790426|FG002|Overall Study|Death|1
834848|NCT00313586|1790427|FG003|Overall Study|Death|7
834849|NCT00313586|1790424|FG000|Overall Study|Withdrawal by Subject|13
834850|NCT00313586|1790425|FG001|Overall Study|Withdrawal by Subject|6
834851|NCT00313586|1790426|FG002|Overall Study|Withdrawal by Subject|6
834852|NCT00313586|1790427|FG003|Overall Study|Withdrawal by Subject|2
834853|NCT00313586|1790424|FG000|Overall Study|Alternative therapy|3
834854|NCT00313586|1790425|FG001|Overall Study|Alternative therapy|6
834855|NCT00313586|1790426|FG002|Overall Study|Alternative therapy|2
834856|NCT00313586|1790427|FG003|Overall Study|Alternative therapy|0
834857|NCT00313586|1790424|FG000|Overall Study|Other complicating disease|2
834858|NCT00313586|1790425|FG001|Overall Study|Other complicating disease|2
834859|NCT00313586|1790426|FG002|Overall Study|Other complicating disease|0
834860|NCT00313586|1790427|FG003|Overall Study|Other complicating disease|0
834861|NCT00313586|1790424|FG000|Overall Study|Did not achieve HI-major/better response|10
834862|NCT00313586|1790425|FG001|Overall Study|Did not achieve HI-major/better response|7
834863|NCT00313586|1790426|FG002|Overall Study|Did not achieve HI-major/better response|2
834864|NCT00313586|1790427|FG003|Overall Study|Did not achieve HI-major/better response|1
834865|NCT00313586|1790424|FG000|Overall Study|Physician Decision|2
834866|NCT00313586|1790425|FG001|Overall Study|Physician Decision|1
834867|NCT00313586|1790426|FG002|Overall Study|Physician Decision|0
834868|NCT00313586|1790427|FG003|Overall Study|Physician Decision|0
834869|NCT00313586|1790424|FG000|Overall Study|Absolute neutrophil count not recovered|2
834870|NCT00313586|1790425|FG001|Overall Study|Absolute neutrophil count not recovered|1
834871|NCT00313586|1790426|FG002|Overall Study|Absolute neutrophil count not recovered|0
834872|NCT00313586|1790427|FG003|Overall Study|Absolute neutrophil count not recovered|0
834873|NCT00313586|1790424|FG000|Overall Study|Lost insurance|0
834874|NCT00313586|1790425|FG001|Overall Study|Lost insurance|1
834875|NCT00313586|1790426|FG002|Overall Study|Lost insurance|0
834876|NCT00313586|1790427|FG003|Overall Study|Lost insurance|0
834877|NCT00313586|1790424|FG000|Overall Study|Moved|0
834878|NCT00313586|1790425|FG001|Overall Study|Moved|1
834879|NCT00313586|1790426|FG002|Overall Study|Moved|0
834880|NCT00313586|1790427|FG003|Overall Study|Moved|0
834881|NCT00313586|1790424|FG000|Overall Study|Death before starting treatment|1
834882|NCT00313586|1790425|FG001|Overall Study|Death before starting treatment|0
834883|NCT00313586|1790426|FG002|Overall Study|Death before starting treatment|0
834884|NCT00313586|1790427|FG003|Overall Study|Death before starting treatment|0
834885|NCT00313612|1790437|FG000|Overall Study|Patient never received treatment|0
834886|NCT00313612|1790438|FG001|Overall Study|Patient never received treatment|1
834887|NCT00313703|1790448|FG000|Overall Study|Lost to Follow-up|11
834888|NCT00313703|1790449|FG001|Overall Study|Lost to Follow-up|2
834889|NCT00313703|1790450|FG002|Overall Study|Lost to Follow-up|5
834890|NCT00313703|1790451|FG003|Overall Study|Lost to Follow-up|12
834891|NCT00313716|1790467|FG000|Overall Study|Death|3
834892|NCT00313716|1790468|FG001|Overall Study|Death|2
834893|NCT00313716|1790469|FG002|Overall Study|Death|9
834894|NCT00313716|1790470|FG003|Overall Study|Death|3
834895|NCT00313716|1790471|FG004|Overall Study|Death|5
834896|NCT00313716|1790472|FG005|Overall Study|Death|9
834897|NCT00313716|1790467|FG000|Overall Study|Lost to Follow-up|2
834898|NCT00313716|1790468|FG001|Overall Study|Lost to Follow-up|5
834899|NCT00313716|1790469|FG002|Overall Study|Lost to Follow-up|2
834900|NCT00313716|1790470|FG003|Overall Study|Lost to Follow-up|1
834901|NCT00313716|1790471|FG004|Overall Study|Lost to Follow-up|0
834902|NCT00313716|1790472|FG005|Overall Study|Lost to Follow-up|4
834903|NCT00313716|1790467|FG000|Overall Study|Withdrawal by Subject|0
834904|NCT00313716|1790468|FG001|Overall Study|Withdrawal by Subject|1
834905|NCT00313716|1790469|FG002|Overall Study|Withdrawal by Subject|1
834906|NCT00313716|1790470|FG003|Overall Study|Withdrawal by Subject|0
834907|NCT00313716|1790471|FG004|Overall Study|Withdrawal by Subject|1
834908|NCT00313716|1790472|FG005|Overall Study|Withdrawal by Subject|0
834909|NCT00313781|1790496|FG000|Before Crossover|Death|22
834910|NCT00313781|1790497|FG001|Before Crossover|Death|8
834911|NCT00313781|1790498|FG002|Before Crossover|Death|0
834912|NCT00313781|1790496|FG000|Before Crossover|Lost to Follow-up|0
834913|NCT00313781|1790497|FG001|Before Crossover|Lost to Follow-up|3
834914|NCT00313781|1790498|FG002|Before Crossover|Lost to Follow-up|0
834915|NCT00313781|1790496|FG000|Before Crossover|Withdrawal by Subject|3
834916|NCT00313781|1790497|FG001|Before Crossover|Withdrawal by Subject|1
834917|NCT00313781|1790498|FG002|Before Crossover|Withdrawal by Subject|0
834918|NCT00313781|1790496|FG000|Before Crossover|Other|45
834919|NCT00313781|1790497|FG001|Before Crossover|Other|30
834920|NCT00313781|1790498|FG002|Before Crossover|Other|0
834921|NCT00313781|1790496|FG000|Before Crossover|Crossover|0
834922|NCT00313781|1790497|FG001|Before Crossover|Crossover|37
834923|NCT00313781|1790498|FG002|Before Crossover|Crossover|0
834924|NCT00313781|1790496|FG000|Before Crossover|Randomized, not treated|5
834925|NCT00313781|1790497|FG001|Before Crossover|Randomized, not treated|0
834926|NCT00313781|1790498|FG002|Before Crossover|Randomized, not treated|0
834927|NCT00313781|1790496|FG000|After Crossover|Death|0
834928|NCT00313781|1790497|FG001|After Crossover|Death|0
834929|NCT00313781|1790498|FG002|After Crossover|Death|6
834930|NCT00313781|1790496|FG000|After Crossover|Withdrawal by Subject|0
834931|NCT00313781|1790497|FG001|After Crossover|Withdrawal by Subject|0
834932|NCT00313781|1790498|FG002|After Crossover|Withdrawal by Subject|3
834933|NCT00313781|1790496|FG000|After Crossover|Other|0
834934|NCT00313781|1790497|FG001|After Crossover|Other|0
834935|NCT00313781|1790498|FG002|After Crossover|Other|18
834936|NCT00313820|1790509|FG000|Assigned to Treatment|Other|1
834937|NCT00313820|1790510|FG001|Assigned to Treatment|Other|0
834938|NCT00313820|1790509|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9
834939|NCT00313820|1790510|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4
834940|NCT00313820|1790509|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
834941|NCT00313820|1790510|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
834942|NCT00313820|1790509|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
834943|NCT00313820|1790510|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
834944|NCT00313820|1790509|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
834945|NCT00313820|1790510|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
834946|NCT00313820|1790509|FG000|Pregabalin or Placebo Treatment Period|Other|2
834947|NCT00313820|1790510|FG001|Pregabalin or Placebo Treatment Period|Other|3
834948|NCT00313846|1790518|FG000|Overall Study|Withdrawal by Subject|2
834949|NCT00313846|1790519|FG001|Overall Study|Withdrawal by Subject|0
834950|NCT00313846|1790518|FG000|Overall Study|Adverse Event|1
834951|NCT00313846|1790519|FG001|Overall Study|Adverse Event|8
834952|NCT00313846|1790518|FG000|Overall Study|Administrative|2
834953|NCT00313846|1790519|FG001|Overall Study|Administrative|3
834954|NCT00313911|1790528|FG000|Overall Study|Serious adverse event|6
834955|NCT00313911|1790529|FG001|Overall Study|Serious adverse event|1
834956|NCT00313911|1790528|FG000|Overall Study|Adverse Event|2
834957|NCT00313911|1790529|FG001|Overall Study|Adverse Event|3
834958|NCT00313911|1790528|FG000|Overall Study|Protocol Violation|19
834959|NCT00313911|1790529|FG001|Overall Study|Protocol Violation|10
834960|NCT00313911|1790528|FG000|Overall Study|Lost to Follow-up|27
834961|NCT00313911|1790529|FG001|Overall Study|Lost to Follow-up|14
834962|NCT00313911|1790528|FG000|Overall Study|Withdrawal by Subject|39
834963|NCT00313911|1790529|FG001|Overall Study|Withdrawal by Subject|12
834964|NCT00313911|1790528|FG000|Overall Study|Did not meet age criteria|1
834965|NCT00313911|1790529|FG001|Overall Study|Did not meet age criteria|1
834966|NCT00314132|1790546|FG000|Overall Study|Lost to Follow-up|3
834967|NCT00314132|1790547|FG001|Overall Study|Lost to Follow-up|13
834968|NCT00314132|1790546|FG000|Overall Study|Withdrawal by Subject|3
834969|NCT00314132|1790547|FG001|Overall Study|Withdrawal by Subject|5
834970|NCT00314132|1790546|FG000|Overall Study|Adverse Event|1
834971|NCT00314132|1790547|FG001|Overall Study|Adverse Event|0
834972|NCT00314132|1790546|FG000|Overall Study|Physician Decision|1
834973|NCT00314132|1790547|FG001|Overall Study|Physician Decision|0
834974|NCT00314145|1790557|FG000|Overall Study|Withdrawal by Subject|8
834975|NCT00314145|1790558|FG001|Overall Study|Withdrawal by Subject|10
834976|NCT00314145|1790557|FG000|Overall Study|Lost to Follow-up|5
834977|NCT00314145|1790558|FG001|Overall Study|Lost to Follow-up|12
834978|NCT00314145|1790557|FG000|Overall Study|Physician Decision|3
834979|NCT00314145|1790558|FG001|Overall Study|Physician Decision|4
834980|NCT00314145|1790557|FG000|Overall Study|Adverse Event|0
834981|NCT00314145|1790558|FG001|Overall Study|Adverse Event|3
834982|NCT00314145|1790557|FG000|Overall Study|Protocol Violation|3
834983|NCT00314145|1790558|FG001|Overall Study|Protocol Violation|0
834984|NCT00314145|1790557|FG000|Overall Study|Sponsor Decision|2
834985|NCT00314145|1790558|FG001|Overall Study|Sponsor Decision|0
834986|NCT00314249|1790576|FG000|Overall Study|Adverse Event|73
834987|NCT00314249|1790577|FG001|Overall Study|Adverse Event|94
834988|NCT00314249|1790576|FG000|Overall Study|Lack of Efficacy|33
834989|NCT00314249|1790577|FG001|Overall Study|Lack of Efficacy|24
834990|NCT00314249|1790576|FG000|Overall Study|Withdrawal by Subject|21
834991|NCT00314249|1790577|FG001|Overall Study|Withdrawal by Subject|28
834992|NCT00314249|1790576|FG000|Overall Study|Lost to Follow-up|15
834993|NCT00314249|1790577|FG001|Overall Study|Lost to Follow-up|9
834994|NCT00314249|1790576|FG000|Overall Study|Physician Decision|1
834995|NCT00314249|1790577|FG001|Overall Study|Physician Decision|1
834996|NCT00314249|1790576|FG000|Overall Study|Withdrawn for other reasons|4
834997|NCT00314249|1790577|FG001|Overall Study|Withdrawn for other reasons|1
834998|NCT00314249|1790576|FG000|Overall Study|Non-Compliant|5
834999|NCT00314249|1790577|FG001|Overall Study|Non-Compliant|6
835000|NCT00314262|1790583|FG000|Overall Study|Adverse Event|2
835001|NCT00314262|1790583|FG000|Overall Study|Withdrawal by Subject|2
835002|NCT00314262|1790583|FG000|Overall Study|Physician Decision|1
835003|NCT00314340|1790587|FG000|Overall Study|lost interest|1
835004|NCT00314366|1790595|FG000|Overall Study|not treated due to patient medical condi|1
835005|NCT00314366|1790596|FG001|Overall Study|not treated due to patient medical condi|0
835006|NCT00314574|1790607|FG000|Overall Study|Death|3
835007|NCT00314574|1790608|FG001|Overall Study|Death|0
835008|NCT00314574|1790607|FG000|Overall Study|Adverse Event|11
835009|NCT00314574|1790608|FG001|Overall Study|Adverse Event|16
835010|NCT00314574|1790607|FG000|Overall Study|Lost to Follow-up|19
835011|NCT00314574|1790608|FG001|Overall Study|Lost to Follow-up|25
835012|NCT00314574|1790607|FG000|Overall Study|Withdrawal by Subject|33
835013|NCT00314574|1790608|FG001|Overall Study|Withdrawal by Subject|22
835014|NCT00314574|1790607|FG000|Overall Study|Physician Decision|22
835015|NCT00314574|1790608|FG001|Overall Study|Physician Decision|15
835016|NCT00314574|1790607|FG000|Overall Study|Pregnancy|6
835017|NCT00314574|1790608|FG001|Overall Study|Pregnancy|4
835018|NCT00314574|1790607|FG000|Overall Study|Data unknown at database lock|0
835019|NCT00314574|1790608|FG001|Overall Study|Data unknown at database lock|1
835020|NCT00314795|1790614|FG000|Overall Study|Adverse Event|8
835021|NCT00314795|1790614|FG000|Overall Study|Death|4
835022|NCT00314795|1790614|FG000|Overall Study|Reason not Specified|3
835023|NCT00314795|1790614|FG000|Overall Study|Renal Transplant|3
835024|NCT00314795|1790614|FG000|Overall Study|Participants Withdrew Consent|2
835025|NCT00314808|1790618|FG000|Overall Study|Disease Progression without AE|4
835026|NCT00314808|1790618|FG000|Overall Study|Withdrawal by Subject/PI without AE|4
835027|NCT00314951|1790624|FG000|Treatment|Didn't meet criteria for mITT population|16
835028|NCT00314951|1790625|FG001|Treatment|Didn't meet criteria for mITT population|11
835029|NCT00314951|1790624|FG000|Follow-up|mITT failure|44
835030|NCT00314951|1790625|FG001|Follow-up|mITT failure|34
835031|NCT00315055|1790633|FG000|Overall Study|Protocol Violation|2
835032|NCT00315055|1790634|FG001|Overall Study|Protocol Violation|4
835033|NCT00315055|1790633|FG000|Overall Study|Lost to Follow-up|1
835034|NCT00315055|1790634|FG001|Overall Study|Lost to Follow-up|1
835035|NCT00315445|1790729|FG000|Overall Study|Adverse Event|7
835036|NCT00315445|1790730|FG001|Overall Study|Adverse Event|12
835037|NCT00315445|1790731|FG002|Overall Study|Adverse Event|15
835038|NCT00315445|1790729|FG000|Overall Study|Lack of Efficacy|16
835039|NCT00315445|1790730|FG001|Overall Study|Lack of Efficacy|1
835040|NCT00315445|1790731|FG002|Overall Study|Lack of Efficacy|7
835041|NCT00315445|1790729|FG000|Overall Study|Lost to Follow-up|1
835042|NCT00315445|1790730|FG001|Overall Study|Lost to Follow-up|0
835043|NCT00315445|1790731|FG002|Overall Study|Lost to Follow-up|1
835044|NCT00315445|1790729|FG000|Overall Study|Protocol Violation|2
835045|NCT00315445|1790730|FG001|Overall Study|Protocol Violation|0
835046|NCT00315445|1790731|FG002|Overall Study|Protocol Violation|1
835047|NCT00315445|1790729|FG000|Overall Study|Other|1
835048|NCT00315445|1790730|FG001|Overall Study|Other|3
835049|NCT00315445|1790731|FG002|Overall Study|Other|0
835050|NCT00315458|1790741|FG000|Overall Study|Administrative|0
835051|NCT00315458|1790742|FG001|Overall Study|Administrative|3
835052|NCT00315458|1790743|FG002|Overall Study|Administrative|8
835053|NCT00315458|1790744|FG003|Overall Study|Administrative|21
835054|NCT00315458|1790741|FG000|Overall Study|Adverse Event|2
835055|NCT00315458|1790742|FG001|Overall Study|Adverse Event|4
835056|NCT00315458|1790743|FG002|Overall Study|Adverse Event|23
835057|NCT00315458|1790744|FG003|Overall Study|Adverse Event|3
835058|NCT00315458|1790741|FG000|Overall Study|Lost to Follow-up|1
835059|NCT00315458|1790742|FG001|Overall Study|Lost to Follow-up|2
835060|NCT00315458|1790743|FG002|Overall Study|Lost to Follow-up|0
835061|NCT00315458|1790744|FG003|Overall Study|Lost to Follow-up|2
835062|NCT00315458|1790741|FG000|Overall Study|Withdrawal by Subject|0
835063|NCT00315458|1790742|FG001|Overall Study|Withdrawal by Subject|3
835064|NCT00315458|1790743|FG002|Overall Study|Withdrawal by Subject|0
835065|NCT00315458|1790744|FG003|Overall Study|Withdrawal by Subject|2
835066|NCT00315458|1790741|FG000|Overall Study|Lack of Efficacy|0
835067|NCT00315458|1790742|FG001|Overall Study|Lack of Efficacy|0
835068|NCT00315458|1790743|FG002|Overall Study|Lack of Efficacy|20
835069|NCT00315458|1790744|FG003|Overall Study|Lack of Efficacy|1
835070|NCT00315458|1790741|FG000|Overall Study|Did not qualify|0
835071|NCT00315458|1790742|FG001|Overall Study|Did not qualify|0
835072|NCT00315458|1790743|FG002|Overall Study|Did not qualify|1
835073|NCT00315458|1790744|FG003|Overall Study|Did not qualify|0
835074|NCT00315705|1790773|FG000|Phase 1|Refused further treatment|1
835075|NCT00315705|1790773|FG000|Phase 1|Failure to achieve response|8
835076|NCT00315705|1790773|FG000|Phase 1|Disease relapse|4
835077|NCT00315705|1790773|FG000|Phase 1|Scheduled for transplant|9
835078|NCT00315705|1790773|FG000|Phase 1|Death|3
835079|NCT00315705|1790773|FG000|Phase 2|Physician Decision|4
835080|NCT00315705|1790773|FG000|Phase 2|Adverse Event|1
835081|NCT00315705|1790773|FG000|Phase 2|Failure to achieve response|3
835082|NCT00315705|1790773|FG000|Phase 2|Disease relapse|1
835083|NCT00315705|1790773|FG000|Phase 2|Scheduled for transplant|8
835084|NCT00315705|1790773|FG000|Phase 2|Other|1
835085|NCT00315705|1790773|FG000|Phase 2|Death|7
835086|NCT00315731|1790790|FG000|Overall Study|Lost to Follow-up|1
835087|NCT00315731|1790790|FG000|Overall Study|Death|5
835088|NCT00316004|1790816|FG000|Overall Study|Subject was not given study fluid.|14
835089|NCT00316004|1790817|FG001|Overall Study|Subject was not given study fluid.|14
835090|NCT00316004|1790818|FG002|Overall Study|Subject was not given study fluid.|21
835091|NCT00316017|1790829|FG000|Overall Study|Protocol Violation|11
835092|NCT00316017|1790830|FG001|Overall Study|Protocol Violation|13
835093|NCT00316017|1790831|FG002|Overall Study|Protocol Violation|19
835094|NCT00316082|1790844|FG000|Overall Study|Lack of Efficacy|2
835095|NCT00316082|1790845|FG001|Overall Study|Lack of Efficacy|3
835096|NCT00316082|1790846|FG002|Overall Study|Lack of Efficacy|3
835097|NCT00316082|1790847|FG003|Overall Study|Lack of Efficacy|4
835098|NCT00316082|1790848|FG004|Overall Study|Lack of Efficacy|6
835099|NCT00316082|1790844|FG000|Overall Study|Withdrawal of Consent by Subject|10
835100|NCT00316082|1790845|FG001|Overall Study|Withdrawal of Consent by Subject|8
835101|NCT00316082|1790846|FG002|Overall Study|Withdrawal of Consent by Subject|2
835102|NCT00316082|1790847|FG003|Overall Study|Withdrawal of Consent by Subject|9
835103|NCT00316082|1790848|FG004|Overall Study|Withdrawal of Consent by Subject|5
835104|NCT00316082|1790844|FG000|Overall Study|Lost to Follow-up|7
835105|NCT00316082|1790845|FG001|Overall Study|Lost to Follow-up|6
835106|NCT00316082|1790846|FG002|Overall Study|Lost to Follow-up|7
835107|NCT00316082|1790847|FG003|Overall Study|Lost to Follow-up|8
835108|NCT00316082|1790848|FG004|Overall Study|Lost to Follow-up|6
835109|NCT00316082|1790844|FG000|Overall Study|Poor/noncompliance|6
835110|NCT00316082|1790845|FG001|Overall Study|Poor/noncompliance|1
835111|NCT00316082|1790846|FG002|Overall Study|Poor/noncompliance|4
835112|NCT00316082|1790847|FG003|Overall Study|Poor/noncompliance|1
835113|NCT00316082|1790848|FG004|Overall Study|Poor/noncompliance|4
835114|NCT00316082|1790844|FG000|Overall Study|Adverse Event|4
835115|NCT00316082|1790845|FG001|Overall Study|Adverse Event|2
835116|NCT00316082|1790846|FG002|Overall Study|Adverse Event|5
835117|NCT00316082|1790847|FG003|Overall Study|Adverse Event|1
835118|NCT00316082|1790848|FG004|Overall Study|Adverse Event|3
835119|NCT00316082|1790844|FG000|Overall Study|Subject no longer meets study criteria|3
835120|NCT00316082|1790845|FG001|Overall Study|Subject no longer meets study criteria|1
835121|NCT00316082|1790846|FG002|Overall Study|Subject no longer meets study criteria|2
835122|NCT00316082|1790847|FG003|Overall Study|Subject no longer meets study criteria|2
835123|NCT00316082|1790848|FG004|Overall Study|Subject no longer meets study criteria|1
835124|NCT00316082|1790844|FG000|Overall Study|Physician Decision|1
835125|NCT00316082|1790845|FG001|Overall Study|Physician Decision|1
835126|NCT00316082|1790846|FG002|Overall Study|Physician Decision|2
835127|NCT00316082|1790847|FG003|Overall Study|Physician Decision|1
835128|NCT00316082|1790848|FG004|Overall Study|Physician Decision|1
835129|NCT00316082|1790844|FG000|Overall Study|Death|0
835130|NCT00316082|1790845|FG001|Overall Study|Death|0
835131|NCT00316082|1790846|FG002|Overall Study|Death|1
835132|NCT00316082|1790847|FG003|Overall Study|Death|0
835133|NCT00316082|1790848|FG004|Overall Study|Death|0
835134|NCT00316082|1790844|FG000|Overall Study|Administrative reason by sponsor|0
835135|NCT00316082|1790845|FG001|Overall Study|Administrative reason by sponsor|0
835136|NCT00316082|1790846|FG002|Overall Study|Administrative reason by sponsor|1
835137|NCT00316082|1790847|FG003|Overall Study|Administrative reason by sponsor|0
835138|NCT00316082|1790848|FG004|Overall Study|Administrative reason by sponsor|0
835139|NCT00316121|1790866|FG000|Overall Study|Death|1
835140|NCT00316121|1790867|FG001|Overall Study|Death|0
835141|NCT00316121|1790866|FG000|Overall Study|Lost to Follow-up|14
835142|NCT00316121|1790867|FG001|Overall Study|Lost to Follow-up|8
835143|NCT00316121|1790866|FG000|Overall Study|Withdrawal by Subject|2
835144|NCT00316121|1790867|FG001|Overall Study|Withdrawal by Subject|0
835145|NCT00316121|1790866|FG000|Overall Study|Reason is missing|1
835146|NCT00316121|1790867|FG001|Overall Study|Reason is missing|0
835147|NCT00316121|1790866|FG000|Overall Study|Subject relocated|1
835148|NCT00316121|1790867|FG001|Overall Study|Subject relocated|1
835149|NCT00316121|1790866|FG000|Overall Study|Subject refused to return|1
835150|NCT00316121|1790867|FG001|Overall Study|Subject refused to return|0
835151|NCT00316121|1790866|FG000|Overall Study|Subject no show for visit x 3|1
835152|NCT00316121|1790867|FG001|Overall Study|Subject no show for visit x 3|0
835153|NCT00316121|1790866|FG000|Overall Study|Subject did not have 24 month visit|1
835154|NCT00316121|1790867|FG001|Overall Study|Subject did not have 24 month visit|0
835155|NCT00316173|1790875|FG000|Run-in Phase|Adverse Event|1
835156|NCT00316173|1790876|FG001|Run-in Phase|Adverse Event|0
835157|NCT00316173|1790875|FG000|Run-in Phase|Protocol Violation|1
835158|NCT00316173|1790876|FG001|Run-in Phase|Protocol Violation|0
835159|NCT00316173|1790875|FG000|Run-in Phase|Study Follow-up Stopped|5
835160|NCT00316173|1790876|FG001|Run-in Phase|Study Follow-up Stopped|0
835161|NCT00316173|1790875|FG000|Treatment Phase|Adverse Event|0
835162|NCT00316173|1790876|FG001|Treatment Phase|Adverse Event|1
835163|NCT00316173|1790875|FG000|Treatment Phase|Lack of Efficacy|0
835164|NCT00316173|1790876|FG001|Treatment Phase|Lack of Efficacy|3
835165|NCT00316173|1790875|FG000|Treatment Phase|Lost to Follow-up|0
835166|NCT00316173|1790876|FG001|Treatment Phase|Lost to Follow-up|3
835167|NCT00316173|1790875|FG000|Treatment Phase|Withdrawal by Subject|0
835168|NCT00316173|1790876|FG001|Treatment Phase|Withdrawal by Subject|1
835169|NCT00316173|1790875|FG000|Treatment Phase|Study Follow-up Stopped|0
835170|NCT00316173|1790876|FG001|Treatment Phase|Study Follow-up Stopped|34
835171|NCT00316186|1790881|FG000|Overall Study|Adverse Event|6
835172|NCT00316186|1790881|FG000|Overall Study|Disease Progression|4
835173|NCT00316186|1790881|FG000|Overall Study|Lost to Follow-up|1
835174|NCT00316186|1790881|FG000|Overall Study|Other|1
835175|NCT00316199|1790885|FG000|Overall Study|Adverse Event|2
835176|NCT00316199|1790885|FG000|Overall Study|Death|8
835177|NCT00316199|1790885|FG000|Overall Study|Lost to Follow-up|2
835178|NCT00316225|1790889|FG000|Overall Study|Adverse Event|2
835179|NCT00316225|1790889|FG000|Overall Study|Physician Decision|3
835180|NCT00316225|1790889|FG000|Overall Study|Progressive Disease|15
835181|NCT00316225|1790889|FG000|Overall Study|Withdrawal by Subject|3
835182|NCT00316225|1790889|FG000|Overall Study|Death|2
835183|NCT00316264|1790896|FG000|Overall Study|Lost to Follow-up|0
835184|NCT00316264|1790897|FG001|Overall Study|Lost to Follow-up|1
835185|NCT00316264|1790898|FG002|Overall Study|Lost to Follow-up|0
835186|NCT00316264|1790896|FG000|Overall Study|Withdrawal of Consent|3
835187|NCT00316264|1790897|FG001|Overall Study|Withdrawal of Consent|5
835188|NCT00316264|1790898|FG002|Overall Study|Withdrawal of Consent|6
835189|NCT00316264|1790896|FG000|Overall Study|Death|2
835190|NCT00316264|1790897|FG001|Overall Study|Death|0
835191|NCT00316264|1790898|FG002|Overall Study|Death|0
835192|NCT00316264|1790896|FG000|Overall Study|Other|1
835193|NCT00316264|1790897|FG001|Overall Study|Other|1
835194|NCT00316264|1790898|FG002|Overall Study|Other|0
835195|NCT00316277|1790908|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88
835196|NCT00316277|1790909|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75
835197|NCT00316277|1790908|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2
835198|NCT00316277|1790909|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0
835199|NCT00316277|1790908|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220
835200|NCT00316277|1790909|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225
835201|NCT00316277|1790908|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
835202|NCT00316277|1790909|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
835203|NCT00316277|1790908|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
835204|NCT00316277|1790909|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
835205|NCT00316303|1790925|FG000|Overall Study|Lost to Follow-up|11
835206|NCT00316303|1790926|FG001|Overall Study|Lost to Follow-up|16
835207|NCT00316589|1790969|FG000|Overall Study|Withdrawal by Subject|0
835208|NCT00316589|1790970|FG001|Overall Study|Withdrawal by Subject|5
835209|NCT00316589|1790971|FG002|Overall Study|Withdrawal by Subject|0
835210|NCT00316589|1790972|FG003|Overall Study|Withdrawal by Subject|1
835211|NCT00316589|1790969|FG000|Overall Study|Subject unwilling/unable to comply|0
835212|NCT00316589|1790970|FG001|Overall Study|Subject unwilling/unable to comply|6
835213|NCT00316589|1790971|FG002|Overall Study|Subject unwilling/unable to comply|0
835214|NCT00316589|1790972|FG003|Overall Study|Subject unwilling/unable to comply|2
835215|NCT00316589|1790969|FG000|Overall Study|Adverse Event|1
835216|NCT00316589|1790970|FG001|Overall Study|Adverse Event|0
835217|NCT00316589|1790971|FG002|Overall Study|Adverse Event|0
835218|NCT00316589|1790972|FG003|Overall Study|Adverse Event|1
835219|NCT00316589|1790969|FG000|Overall Study|Physician Decision|0
835220|NCT00316589|1790970|FG001|Overall Study|Physician Decision|1
835221|NCT00316589|1790971|FG002|Overall Study|Physician Decision|0
835222|NCT00316589|1790972|FG003|Overall Study|Physician Decision|0
835223|NCT00316589|1790969|FG000|Overall Study|Other reason|0
835224|NCT00316589|1790970|FG001|Overall Study|Other reason|12
835225|NCT00316589|1790971|FG002|Overall Study|Other reason|1
835226|NCT00316589|1790972|FG003|Overall Study|Other reason|1
835227|NCT00316602|1790986|FG000|Overall Study|Withdrawal by Subject|3
835228|NCT00316602|1790987|FG001|Overall Study|Withdrawal by Subject|2
835229|NCT00316602|1790986|FG000|Overall Study|Subject unwilling/unable to comply with|3
835230|NCT00316602|1790987|FG001|Overall Study|Subject unwilling/unable to comply with|17
835231|NCT00316602|1790986|FG000|Overall Study|Adverse Event|1
835232|NCT00316602|1790987|FG001|Overall Study|Adverse Event|0
835233|NCT00316602|1790986|FG000|Overall Study|Other|3
835234|NCT00316602|1790987|FG001|Overall Study|Other|6
835235|NCT00316693|1790995|FG000|Overall Study|Adverse Event|6
835236|NCT00316693|1790996|FG001|Overall Study|Adverse Event|1
835237|NCT00316693|1790995|FG000|Overall Study|Protocol Violation|1
835238|NCT00316693|1790996|FG001|Overall Study|Protocol Violation|0
835239|NCT00316693|1790995|FG000|Overall Study|Withdrawal by Subject|6
835240|NCT00316693|1790996|FG001|Overall Study|Withdrawal by Subject|6
835241|NCT00316693|1790995|FG000|Overall Study|Lost to Follow-up|26
835242|NCT00316693|1790996|FG001|Overall Study|Lost to Follow-up|34
835243|NCT00316693|1790995|FG000|Overall Study|Other|38
835244|NCT00316693|1790996|FG001|Overall Study|Other|44
835245|NCT00316706|1791004|FG000|Overall Study|Lost to Follow-up|38
835246|NCT00316706|1791005|FG001|Overall Study|Lost to Follow-up|48
835247|NCT00316719|1791013|FG000|Overall Study|Adverse Event|0
835248|NCT00316719|1791014|FG001|Overall Study|Adverse Event|6
835249|NCT00316719|1791013|FG000|Overall Study|Consent withdrawn|2
835250|NCT00316719|1791014|FG001|Overall Study|Consent withdrawn|0
835251|NCT00316888|1791026|FG000|Overall Study|Adverse Event|4
835252|NCT00316888|1791027|FG001|Overall Study|Adverse Event|5
835253|NCT00316888|1791026|FG000|Overall Study|Withdrawal by Subject|2
835254|NCT00316888|1791027|FG001|Overall Study|Withdrawal by Subject|2
835255|NCT00316888|1791026|FG000|Overall Study|Not start protocol therapy|0
835256|NCT00316888|1791027|FG001|Overall Study|Not start protocol therapy|1
835257|NCT00316914|1791035|FG000|Overall Study|Withdrawal by Subject|5
835258|NCT00316914|1791036|FG001|Overall Study|Withdrawal by Subject|3
835259|NCT00316914|1791035|FG000|Overall Study|Adverse Event|8
835260|NCT00316914|1791036|FG001|Overall Study|Adverse Event|7
835261|NCT00316914|1791035|FG000|Overall Study|Other Problems|6
835262|NCT00316914|1791036|FG001|Overall Study|Other Problems|11
835263|NCT00316914|1791035|FG000|Overall Study|Missing end of treatment documentation|14
835264|NCT00316914|1791036|FG001|Overall Study|Missing end of treatment documentation|15
835265|NCT00317044|1791045|FG000|Overall Study|Protocol Violation|28
835266|NCT00317044|1791046|FG001|Overall Study|Protocol Violation|22
835267|NCT00317044|1791047|FG002|Overall Study|Protocol Violation|20
835268|NCT00317044|1791045|FG000|Overall Study|Adverse Event|4
835269|NCT00317044|1791046|FG001|Overall Study|Adverse Event|7
835270|NCT00317044|1791047|FG002|Overall Study|Adverse Event|4
835271|NCT00317044|1791045|FG000|Overall Study|Withdrawal by Subject|10
835272|NCT00317044|1791046|FG001|Overall Study|Withdrawal by Subject|7
835273|NCT00317044|1791047|FG002|Overall Study|Withdrawal by Subject|12
835274|NCT00317044|1791045|FG000|Overall Study|Lost to Follow-up|0
835275|NCT00317044|1791046|FG001|Overall Study|Lost to Follow-up|2
835276|NCT00317044|1791047|FG002|Overall Study|Lost to Follow-up|3
835277|NCT00317044|1791045|FG000|Overall Study|Multiple Reasons|6
835278|NCT00317044|1791046|FG001|Overall Study|Multiple Reasons|2
835279|NCT00317044|1791047|FG002|Overall Study|Multiple Reasons|6
835280|NCT00317109|1791057|FG000|Overall Study|Withdrawal by Subject|2
835281|NCT00317109|1791058|FG001|Overall Study|Withdrawal by Subject|0
835282|NCT00317109|1791057|FG000|Overall Study|Migated/moved from study area|1
835283|NCT00317109|1791058|FG001|Overall Study|Migated/moved from study area|0
835284|NCT00317356|1791081|FG000|Overall Study|Adverse Event|0
835285|NCT00317356|1791082|FG001|Overall Study|Adverse Event|0
835286|NCT00317356|1791083|FG002|Overall Study|Adverse Event|1
835287|NCT00317356|1791084|FG003|Overall Study|Adverse Event|0
835288|NCT00317356|1791081|FG000|Overall Study|Lack of Efficacy|1
835289|NCT00317356|1791082|FG001|Overall Study|Lack of Efficacy|1
835290|NCT00317356|1791083|FG002|Overall Study|Lack of Efficacy|0
835291|NCT00317356|1791084|FG003|Overall Study|Lack of Efficacy|3
835292|NCT00317356|1791081|FG000|Overall Study|Physician Decision|0
835293|NCT00317356|1791082|FG001|Overall Study|Physician Decision|1
835294|NCT00317356|1791083|FG002|Overall Study|Physician Decision|0
835295|NCT00317356|1791084|FG003|Overall Study|Physician Decision|0
835296|NCT00317369|1791097|FG000|Overall Study|Adverse Event|2
835297|NCT00317369|1791098|FG001|Overall Study|Adverse Event|1
835298|NCT00317369|1791099|FG002|Overall Study|Adverse Event|0
835299|NCT00317369|1791097|FG000|Overall Study|Lack of Efficacy|0
835300|NCT00317369|1791098|FG001|Overall Study|Lack of Efficacy|1
835301|NCT00317369|1791099|FG002|Overall Study|Lack of Efficacy|1
835302|NCT00317369|1791097|FG000|Overall Study|Withdrawal by Subject|0
835303|NCT00317369|1791098|FG001|Overall Study|Withdrawal by Subject|0
835304|NCT00317369|1791099|FG002|Overall Study|Withdrawal by Subject|1
835305|NCT00317473|1791113|FG000|Overall Study|Withdrawal by Subject|2
835306|NCT00317473|1791114|FG001|Overall Study|Withdrawal by Subject|1
835307|NCT00317473|1791115|FG002|Overall Study|Withdrawal by Subject|2
835308|NCT00317473|1791116|FG003|Overall Study|Withdrawal by Subject|1
835309|NCT00317473|1791117|FG004|Overall Study|Withdrawal by Subject|3
835310|NCT00317473|1791118|FG005|Overall Study|Withdrawal by Subject|1
835311|NCT00317473|1791113|FG000|Overall Study|Relocation|1
835312|NCT00317473|1791114|FG001|Overall Study|Relocation|0
835313|NCT00317473|1791115|FG002|Overall Study|Relocation|1
835314|NCT00317473|1791116|FG003|Overall Study|Relocation|1
835315|NCT00317473|1791117|FG004|Overall Study|Relocation|5
835316|NCT00317473|1791118|FG005|Overall Study|Relocation|2
835317|NCT00317473|1791113|FG000|Overall Study|Death|1
835318|NCT00317473|1791114|FG001|Overall Study|Death|0
835319|NCT00317473|1791115|FG002|Overall Study|Death|0
835320|NCT00317473|1791116|FG003|Overall Study|Death|0
835321|NCT00317473|1791117|FG004|Overall Study|Death|0
835322|NCT00317473|1791118|FG005|Overall Study|Death|0
835323|NCT00317473|1791113|FG000|Overall Study|Other|0
835324|NCT00317473|1791114|FG001|Overall Study|Other|2
835325|NCT00317473|1791115|FG002|Overall Study|Other|0
835326|NCT00317473|1791116|FG003|Overall Study|Other|0
835327|NCT00317473|1791117|FG004|Overall Study|Other|0
835328|NCT00317473|1791118|FG005|Overall Study|Other|0
835329|NCT00317603|1791142|FG000|Overall Study|Progressive Disease|3
835330|NCT00317642|1791148|FG000|Overall Study|Not Received Either Study Drug|1
835331|NCT00317642|1791149|FG001|Overall Study|Not Received Either Study Drug|3
835332|NCT00317642|1791148|FG000|Overall Study|Physician Decision|15
835333|NCT00317642|1791149|FG001|Overall Study|Physician Decision|7
835334|NCT00317642|1791148|FG000|Overall Study|Participant declined treatment|14
835335|NCT00317642|1791149|FG001|Overall Study|Participant declined treatment|3
835336|NCT00317642|1791148|FG000|Overall Study|Adverse Event|17
835337|NCT00317642|1791149|FG001|Overall Study|Adverse Event|5
835338|NCT00317642|1791148|FG000|Overall Study|Treatment Failure|56
835339|NCT00317642|1791149|FG001|Overall Study|Treatment Failure|102
835340|NCT00317642|1791148|FG000|Overall Study|Disease Recurrence|1
835341|NCT00317642|1791149|FG001|Overall Study|Disease Recurrence|2
835342|NCT00317642|1791148|FG000|Overall Study|Death|14
835343|NCT00317642|1791149|FG001|Overall Study|Death|7
835344|NCT00317642|1791148|FG000|Overall Study|Not Continue to Consolidation|2
835345|NCT00317642|1791149|FG001|Overall Study|Not Continue to Consolidation|0
835346|NCT00317642|1791148|FG000|Overall Study|Withdrawal by Subject|0
835347|NCT00317642|1791149|FG001|Overall Study|Withdrawal by Subject|1
835348|NCT00317642|1791148|FG000|Overall Study|Referred For Transplantation|1
835349|NCT00317642|1791149|FG001|Overall Study|Referred For Transplantation|0
835350|NCT00317642|1791148|FG000|Overall Study|AML Not Centrally Confirmed|1
835351|NCT00317642|1791149|FG001|Overall Study|AML Not Centrally Confirmed|5
835352|NCT00318149|1791190|FG000|Overall Study|Adverse Event|0
835353|NCT00318149|1791191|FG001|Overall Study|Adverse Event|0
835354|NCT00318149|1791192|FG002|Overall Study|Adverse Event|0
835355|NCT00318149|1791193|FG003|Overall Study|Adverse Event|0
835356|NCT00318149|1791194|FG004|Overall Study|Adverse Event|0
835357|NCT00318149|1791195|FG005|Overall Study|Adverse Event|2
835358|NCT00318370|1791229|FG000|Period 1|Lack of Efficacy|5
835359|NCT00318370|1791230|FG001|Period 1|Lack of Efficacy|0
835360|NCT00318370|1791231|FG002|Period 1|Lack of Efficacy|0
835361|NCT00318370|1791229|FG000|Period 1|Physician Decision|1
835362|NCT00318370|1791230|FG001|Period 1|Physician Decision|0
835363|NCT00318370|1791231|FG002|Period 1|Physician Decision|0
835364|NCT00318370|1791229|FG000|Period 1|Withdrawal by Subject|1
835365|NCT00318370|1791230|FG001|Period 1|Withdrawal by Subject|0
835366|NCT00318370|1791231|FG002|Period 1|Withdrawal by Subject|0
835367|NCT00318370|1791229|FG000|Period 2|Adverse Event|0
835368|NCT00318370|1791230|FG001|Period 2|Adverse Event|3
835369|NCT00318370|1791231|FG002|Period 2|Adverse Event|0
835370|NCT00318370|1791229|FG000|Period 2|Lack of Efficacy|0
835371|NCT00318370|1791230|FG001|Period 2|Lack of Efficacy|5
835372|NCT00318370|1791231|FG002|Period 2|Lack of Efficacy|0
835373|NCT00318370|1791229|FG000|Period 2|Physician Decision|0
835374|NCT00318370|1791230|FG001|Period 2|Physician Decision|1
835375|NCT00318370|1791231|FG002|Period 2|Physician Decision|0
835376|NCT00318370|1791229|FG000|Period 2|Withdrawal by Subject|0
835377|NCT00318370|1791230|FG001|Period 2|Withdrawal by Subject|1
835378|NCT00318370|1791231|FG002|Period 2|Withdrawal by Subject|0
835379|NCT00318370|1791229|FG000|Period 2|Other|0
835380|NCT00318370|1791230|FG001|Period 2|Other|1
835381|NCT00318370|1791231|FG002|Period 2|Other|0
835382|NCT00318370|1791229|FG000|Period 3|Adverse Event|0
835383|NCT00318370|1791230|FG001|Period 3|Adverse Event|0
835384|NCT00318370|1791231|FG002|Period 3|Adverse Event|1
835385|NCT00318370|1791229|FG000|Period 3|Lack of Efficacy|0
835386|NCT00318370|1791230|FG001|Period 3|Lack of Efficacy|0
835387|NCT00318370|1791231|FG002|Period 3|Lack of Efficacy|24
835388|NCT00318370|1791229|FG000|Period 3|Death|0
835389|NCT00318370|1791230|FG001|Period 3|Death|0
835390|NCT00318370|1791231|FG002|Period 3|Death|1
835391|NCT00318370|1791229|FG000|Period 3|Physician Decision|0
835392|NCT00318370|1791230|FG001|Period 3|Physician Decision|0
835393|NCT00318370|1791231|FG002|Period 3|Physician Decision|1
835394|NCT00318370|1791229|FG000|Period 3|Withdrawal by Subject|0
835395|NCT00318370|1791230|FG001|Period 3|Withdrawal by Subject|0
835396|NCT00318370|1791231|FG002|Period 3|Withdrawal by Subject|3
835397|NCT00318370|1791229|FG000|Period 3|Other|0
835398|NCT00318370|1791230|FG001|Period 3|Other|0
835399|NCT00318370|1791231|FG002|Period 3|Other|3
835400|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Adverse Event|11
835401|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Adverse Event|23
835402|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Adverse Event|29
835403|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Adverse Event|2
835404|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Adverse Event|8
835405|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Lack of Efficacy|19
835406|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Lack of Efficacy|8
835407|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Lack of Efficacy|13
835408|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Lack of Efficacy|29
835409|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Lack of Efficacy|9
835410|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Protocol Violation|2
835411|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Protocol Violation|4
835412|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Protocol Violation|4
835413|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Protocol Violation|4
835414|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Protocol Violation|5
835415|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Lost to follow up|0
835416|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Lost to follow up|1
835417|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Lost to follow up|0
835418|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Lost to follow up|0
835419|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Lost to follow up|0
835420|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
835421|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
835422|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
835423|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
835424|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
835425|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Consent withdrawn|0
835426|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Consent withdrawn|3
835427|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Consent withdrawn|4
835428|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Consent withdrawn|10
835429|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Consent withdrawn|4
835430|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0
835431|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2
835432|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1
835433|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0
835434|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2
835435|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Move|0
835436|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Move|1
835437|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Move|0
835438|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Move|0
835439|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Move|0
835440|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
835441|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
835442|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
835443|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
835444|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
835445|NCT00318461|1791252|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1
835446|NCT00318461|1791253|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0
835447|NCT00318461|1791254|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0
835448|NCT00318461|1791255|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2
835449|NCT00318461|1791256|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0
835450|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Work commitment|0
835451|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Work commitment|0
835452|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Work commitment|0
835453|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Work commitment|0
835454|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Work commitment|1
835455|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Investigator decision|0
835456|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Investigator decision|0
835457|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Investigator decision|0
835458|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Investigator decision|0
835459|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Investigator decision|1
835460|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Lack of time|1
835461|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Lack of time|0
835462|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Lack of time|0
835463|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Lack of time|0
835464|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Lack of time|0
835465|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
835466|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
835467|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
835468|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
835469|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
835470|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Hyperglicaemia|0
835471|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Hyperglicaemia|0
835472|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Hyperglicaemia|0
835473|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Hyperglicaemia|1
835474|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Hyperglicaemia|0
835475|NCT00318461|1791252|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
835476|NCT00318461|1791253|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
835477|NCT00318461|1791254|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
835478|NCT00318461|1791255|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
835479|NCT00318461|1791256|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
835480|NCT00318461|1791252|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0
835481|NCT00318461|1791253|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1
835482|NCT00318461|1791254|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0
835483|NCT00318461|1791255|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0
835484|NCT00318461|1791256|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0
835485|NCT00318461|1791252|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
835486|NCT00318461|1791253|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
835487|NCT00318461|1791254|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
835488|NCT00318461|1791255|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
835489|NCT00318461|1791256|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
835490|NCT00318461|1791252|FG000|Open-Label Extension, 18 Months|Adverse Event|11
835491|NCT00318461|1791253|FG001|Open-Label Extension, 18 Months|Adverse Event|8
835492|NCT00318461|1791254|FG002|Open-Label Extension, 18 Months|Adverse Event|6
835493|NCT00318461|1791255|FG003|Open-Label Extension, 18 Months|Adverse Event|1
835494|NCT00318461|1791256|FG004|Open-Label Extension, 18 Months|Adverse Event|6
835495|NCT00318461|1791252|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41
835496|NCT00318461|1791253|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33
835497|NCT00318461|1791254|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37
835498|NCT00318461|1791255|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27
835499|NCT00318461|1791256|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63
835500|NCT00318461|1791252|FG000|Open-Label Extension, 18 Months|Protocol Violation|7
835501|NCT00318461|1791253|FG001|Open-Label Extension, 18 Months|Protocol Violation|5
835502|NCT00318461|1791254|FG002|Open-Label Extension, 18 Months|Protocol Violation|3
835503|NCT00318461|1791255|FG003|Open-Label Extension, 18 Months|Protocol Violation|4
835504|NCT00318461|1791256|FG004|Open-Label Extension, 18 Months|Protocol Violation|6
835505|NCT00318474|1791270|FG000|Overall Study|Adverse Event|1
835506|NCT00318474|1791271|FG001|Overall Study|Adverse Event|1
835507|NCT00318474|1791270|FG000|Overall Study|Lost to Follow-up|0
835508|NCT00318474|1791271|FG001|Overall Study|Lost to Follow-up|1
835509|NCT00318474|1791270|FG000|Overall Study|Pregnancy|0
835510|NCT00318474|1791271|FG001|Overall Study|Pregnancy|2
835511|NCT00318474|1791270|FG000|Overall Study|Protocol Violation|1
835512|NCT00318474|1791271|FG001|Overall Study|Protocol Violation|0
835513|NCT00318474|1791270|FG000|Overall Study|Withdrawal by Subject|3
835514|NCT00318474|1791271|FG001|Overall Study|Withdrawal by Subject|2
835515|NCT00318474|1791270|FG000|Overall Study|Fall in GFR|3
835516|NCT00318474|1791271|FG001|Overall Study|Fall in GFR|3
835517|NCT00318474|1791270|FG000|Overall Study|Post-therapy hyperflycemia|0
835518|NCT00318474|1791271|FG001|Overall Study|Post-therapy hyperflycemia|1
835519|NCT00318474|1791270|FG000|Overall Study|Trial terminated|10
835520|NCT00318474|1791271|FG001|Overall Study|Trial terminated|7
835521|NCT00318565|1791277|FG000|Overall Study|Excluded per protocol|24
835522|NCT00318643|1791297|FG000|Overall Study|Adverse Event|0
835523|NCT00318643|1791298|FG001|Overall Study|Adverse Event|0
835524|NCT00318643|1791299|FG002|Overall Study|Adverse Event|0
835525|NCT00318643|1791300|FG003|Overall Study|Adverse Event|0
835526|NCT00318643|1791301|FG004|Overall Study|Adverse Event|1
835527|NCT00318643|1791297|FG000|Overall Study|Participant's Decision|0
835528|NCT00318643|1791298|FG001|Overall Study|Participant's Decision|0
835529|NCT00318643|1791299|FG002|Overall Study|Participant's Decision|0
835530|NCT00318643|1791300|FG003|Overall Study|Participant's Decision|0
835531|NCT00318643|1791301|FG004|Overall Study|Participant's Decision|1
835532|NCT00318643|1791297|FG000|Overall Study|Investigator's Decision|0
835533|NCT00318643|1791298|FG001|Overall Study|Investigator's Decision|0
835534|NCT00318643|1791299|FG002|Overall Study|Investigator's Decision|0
835535|NCT00318643|1791300|FG003|Overall Study|Investigator's Decision|0
835536|NCT00318643|1791301|FG004|Overall Study|Investigator's Decision|1
835537|NCT00318656|1791316|FG000|Overall Study|Took Avandamet instead of Glim/Met|0
835538|NCT00318656|1791317|FG001|Overall Study|Took Avandamet instead of Glim/Met|1
835539|NCT00318656|1791316|FG000|Overall Study|Did not receive any treatment|0
835540|NCT00318656|1791317|FG001|Overall Study|Did not receive any treatment|1
835541|NCT00319020|1791349|FG000|Overall Study|Death|2
835542|NCT00319020|1791350|FG001|Overall Study|Death|2
835543|NCT00319020|1791349|FG000|Overall Study|Withdrawal by Subject|4
835544|NCT00319020|1791350|FG001|Overall Study|Withdrawal by Subject|1
835545|NCT00319020|1791349|FG000|Overall Study|F-1 completed but not enrolled in F-2|1
835546|NCT00319020|1791350|FG001|Overall Study|F-1 completed but not enrolled in F-2|0
835547|NCT00319020|1791349|FG000|Overall Study|Administrative reason|0
835548|NCT00319020|1791350|FG001|Overall Study|Administrative reason|5
835549|NCT00319020|1791349|FG000|Overall Study|Disease progression|0
835550|NCT00319020|1791350|FG001|Overall Study|Disease progression|2
835551|NCT00319020|1791349|FG000|Overall Study|Transplant|0
835552|NCT00319020|1791350|FG001|Overall Study|Transplant|1
835553|NCT00319020|1791349|FG000|Overall Study|Treatment failure|0
835554|NCT00319020|1791350|FG001|Overall Study|Treatment failure|1
835555|NCT00319020|1791349|FG000|Overall Study|Adverse Event|0
835556|NCT00319020|1791350|FG001|Overall Study|Adverse Event|1
835557|NCT00319046|1791358|FG000|Overall Study|withdrawal of subject's consent|7
835558|NCT00319046|1791358|FG000|Overall Study|administrative reason|1
835559|NCT00319098|1791366|FG000|Overall Study|Serious adverse event|3
835560|NCT00319098|1791367|FG001|Overall Study|Serious adverse event|0
835561|NCT00319098|1791366|FG000|Overall Study|Adverse Event|20
835562|NCT00319098|1791367|FG001|Overall Study|Adverse Event|1
835563|NCT00319098|1791366|FG000|Overall Study|Withdrawal by Subject|37
835564|NCT00319098|1791367|FG001|Overall Study|Withdrawal by Subject|8
835565|NCT00319098|1791366|FG000|Overall Study|Migrated/moved from study area|2
835566|NCT00319098|1791367|FG001|Overall Study|Migrated/moved from study area|1
835567|NCT00319098|1791366|FG000|Overall Study|Lost to Follow-up|37
835568|NCT00319098|1791367|FG001|Overall Study|Lost to Follow-up|13
835569|NCT00319098|1791366|FG000|Overall Study|Others|33
835570|NCT00319098|1791367|FG001|Overall Study|Others|8
835571|NCT00319098|1791366|FG000|Overall Study|Protocol Violation|3
835572|NCT00319098|1791367|FG001|Overall Study|Protocol Violation|1
835573|NCT00319111|1791377|FG000|Overall Study|Adverse Event|20
835574|NCT00319111|1791377|FG000|Overall Study|Withdrawal of consent|11
835575|NCT00319111|1791377|FG000|Overall Study|Death|9
835576|NCT00319111|1791377|FG000|Overall Study|Lack of clinical improvement|4
835577|NCT00319111|1791377|FG000|Overall Study|Administrative|2
835578|NCT00319111|1791377|FG000|Overall Study|Treatment failure|1
835579|NCT00319254|1791381|FG000|Overall Study|Withdrawal by Subject|4
835580|NCT00319254|1791381|FG000|Overall Study|Death|46
835581|NCT00319254|1791381|FG000|Overall Study|Lost to Follow-up|2
835582|NCT00319254|1791381|FG000|Overall Study|Enrolled, Not Treated|2
835583|NCT00319436|1791387|FG000|Overall Study|Withdrawal by Subject|6
835584|NCT00319436|1791388|FG001|Overall Study|Withdrawal by Subject|7
835585|NCT00319449|1791396|FG000|Overall Study|Subject did not wish to continue|1
835586|NCT00319449|1791397|FG001|Overall Study|Subject did not wish to continue|0
835587|NCT00319449|1791396|FG000|Overall Study|Noncompliance with the protocol|1
835588|NCT00319449|1791397|FG001|Overall Study|Noncompliance with the protocol|0
835589|NCT00319501|1791405|FG000|Double-blind Period|Withdrawal by Subject|0
835590|NCT00319501|1791406|FG001|Double-blind Period|Withdrawal by Subject|3
835591|NCT00319501|1791405|FG000|Double-blind Period|Sponsor Request|1
835592|NCT00319501|1791406|FG001|Double-blind Period|Sponsor Request|0
835593|NCT00319501|1791405|FG000|Double-blind Period|Did not receive treatment|42
835594|NCT00319501|1791406|FG001|Double-blind Period|Did not receive treatment|29
835595|NCT00319501|1791405|FG000|Open-label Period|Adverse Event|5
835596|NCT00319501|1791406|FG001|Open-label Period|Adverse Event|0
835597|NCT00319501|1791405|FG000|Open-label Period|Protocol Violation|6
835598|NCT00319501|1791406|FG001|Open-label Period|Protocol Violation|0
835599|NCT00319501|1791405|FG000|Open-label Period|Withdrawal by Subject|38
835600|NCT00319501|1791406|FG001|Open-label Period|Withdrawal by Subject|0
835601|NCT00319501|1791405|FG000|Open-label Period|Principal Investigator decision|6
835602|NCT00319501|1791406|FG001|Open-label Period|Principal Investigator decision|0
835603|NCT00319501|1791405|FG000|Open-label Period|Sponsor request|12
835604|NCT00319501|1791406|FG001|Open-label Period|Sponsor request|0
835605|NCT00319501|1791405|FG000|Open-label Period|Lost to Follow-up|5
835606|NCT00319501|1791406|FG001|Open-label Period|Lost to Follow-up|0
835607|NCT00319501|1791405|FG000|Open-label Period|Did not receive treatment|33
835608|NCT00319501|1791406|FG001|Open-label Period|Did not receive treatment|0
835609|NCT00319501|1791405|FG000|Open-label Period|Other|11
835610|NCT00319501|1791406|FG001|Open-label Period|Other|0
835611|NCT00319501|1791405|FG000|Open-label Extension Period|Adverse Event|2
835612|NCT00319501|1791406|FG001|Open-label Extension Period|Adverse Event|0
835613|NCT00319501|1791405|FG000|Open-label Extension Period|Did not receive treatment|18
835614|NCT00319501|1791406|FG001|Open-label Extension Period|Did not receive treatment|0
835615|NCT00319501|1791405|FG000|Open-label Extension Period|Other|1
835616|NCT00319501|1791406|FG001|Open-label Extension Period|Other|0
835617|NCT00319501|1791405|FG000|Open-label Extension Period|Principal investigator decision|2
835618|NCT00319501|1791406|FG001|Open-label Extension Period|Principal investigator decision|0
835619|NCT00319501|1791405|FG000|Open-label Extension Period|Sponsor request|26
835620|NCT00319501|1791406|FG001|Open-label Extension Period|Sponsor request|0
835621|NCT00319501|1791405|FG000|Open-label Extension Period|Withdrawal by Subject|2
835622|NCT00319501|1791406|FG001|Open-label Extension Period|Withdrawal by Subject|0
835623|NCT00319553|1791419|FG000|Overall Study|Protocol Violation|1
835624|NCT00319553|1791420|FG001|Overall Study|Protocol Violation|2
835625|NCT00319553|1791419|FG000|Overall Study|Lost to Follow-up|2
835626|NCT00319553|1791420|FG001|Overall Study|Lost to Follow-up|1
835627|NCT00319553|1791419|FG000|Overall Study|Withdrawal by Subject|1
835628|NCT00319553|1791420|FG001|Overall Study|Withdrawal by Subject|1
835629|NCT00319592|1791428|FG000|Overall Study|Protocol Violation|1
835630|NCT00319592|1791429|FG001|Overall Study|Protocol Violation|0
835631|NCT00319592|1791428|FG000|Overall Study|Physician Decision|0
835632|NCT00319592|1791429|FG001|Overall Study|Physician Decision|1
835633|NCT00319696|1791444|FG000|Overall Study|Adverse Event|36
835634|NCT00319696|1791444|FG000|Overall Study|withdrawal of consent|14
835635|NCT00319696|1791444|FG000|Overall Study|administrative|7
835636|NCT00319696|1791444|FG000|Overall Study|Lost to Follow-up|3
835637|NCT00319735|1791454|FG000|Overall Study|Death|2
835638|NCT00319956|1791471|FG000|Overall Study|Death|20
835639|NCT00319956|1791472|FG001|Overall Study|Death|24
835640|NCT00319982|1791480|FG000|Overall Study|Withdrawal by Subject|1
835641|NCT00319982|1791481|FG001|Overall Study|Withdrawal by Subject|0
835642|NCT00320112|1791489|FG000|Overall Study|Lost to Follow-up|3
835643|NCT00320112|1791490|FG001|Overall Study|Lost to Follow-up|4
835644|NCT00320112|1791489|FG000|Overall Study|Withdrawal by Subject|3
835645|NCT00320112|1791490|FG001|Overall Study|Withdrawal by Subject|0
835646|NCT00320112|1791489|FG000|Overall Study|Death|2
835647|NCT00320112|1791490|FG001|Overall Study|Death|1
835648|NCT00320190|1791504|FG000|First 12 Months|Completed but did not enter extension|5
835649|NCT00320190|1791505|FG001|First 12 Months|Completed but did not enter extension|3
835650|NCT00320190|1791504|FG000|First 12 Months|Sponsor terminated study|2
835651|NCT00320190|1791505|FG001|First 12 Months|Sponsor terminated study|2
835652|NCT00320190|1791504|FG000|First 12 Months|Lost to Follow-up|0
835653|NCT00320190|1791505|FG001|First 12 Months|Lost to Follow-up|1
835654|NCT00320190|1791504|FG000|First 12 Months|Enrollment failure|0
835655|NCT00320190|1791505|FG001|First 12 Months|Enrollment failure|1
835656|NCT00320190|1791504|FG000|First 12 Months|Adverse event unrelated to study drug|1
835657|NCT00320190|1791505|FG001|First 12 Months|Adverse event unrelated to study drug|0
835658|NCT00320190|1791504|FG000|First 12 Months|Investigator request|0
835659|NCT00320190|1791505|FG001|First 12 Months|Investigator request|1
835660|NCT00320190|1791504|FG000|First 12 Months|Study drug toxicity|0
835661|NCT00320190|1791505|FG001|First 12 Months|Study drug toxicity|1
835662|NCT00320190|1791504|FG000|First 12 Months|Withdrawal by Subject|0
835663|NCT00320190|1791505|FG001|First 12 Months|Withdrawal by Subject|1
835664|NCT00320190|1791504|FG000|Long-term (12-month) Extension|Sponsor terminated study|7
835665|NCT00320190|1791505|FG001|Long-term (12-month) Extension|Sponsor terminated study|0
835666|NCT00320190|1791504|FG000|Long-term (12-month) Extension|Lack of major molecular response|1
835667|NCT00320190|1791505|FG001|Long-term (12-month) Extension|Lack of major molecular response|2
835668|NCT00320190|1791504|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1
835669|NCT00320190|1791505|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0
835670|NCT00320216|1791516|FG000|Overall Study|Adverse Event|0
835671|NCT00320216|1791517|FG001|Overall Study|Adverse Event|6
835672|NCT00320216|1791518|FG002|Overall Study|Adverse Event|0
835673|NCT00320216|1791519|FG003|Overall Study|Adverse Event|2
835674|NCT00320216|1791520|FG004|Overall Study|Adverse Event|2
835675|NCT00320216|1791516|FG000|Overall Study|Lack of Efficacy|6
835676|NCT00320216|1791517|FG001|Overall Study|Lack of Efficacy|2
835677|NCT00320216|1791518|FG002|Overall Study|Lack of Efficacy|1
835678|NCT00320216|1791519|FG003|Overall Study|Lack of Efficacy|0
835679|NCT00320216|1791520|FG004|Overall Study|Lack of Efficacy|1
835680|NCT00320216|1791516|FG000|Overall Study|Lost to Follow-up|3
835681|NCT00320216|1791517|FG001|Overall Study|Lost to Follow-up|0
835682|NCT00320216|1791518|FG002|Overall Study|Lost to Follow-up|0
835683|NCT00320216|1791519|FG003|Overall Study|Lost to Follow-up|0
835684|NCT00320216|1791520|FG004|Overall Study|Lost to Follow-up|0
835685|NCT00320216|1791516|FG000|Overall Study|Other|7
835686|NCT00320216|1791517|FG001|Overall Study|Other|2
835687|NCT00320216|1791518|FG002|Overall Study|Other|5
835688|NCT00320216|1791519|FG003|Overall Study|Other|1
835689|NCT00320216|1791520|FG004|Overall Study|Other|3
835690|NCT00320255|1791551|FG000|Overall Study|Lack of Efficacy|1
835691|NCT00320255|1791552|FG001|Overall Study|Lack of Efficacy|0
835692|NCT00320255|1791553|FG002|Overall Study|Lack of Efficacy|0
835693|NCT00320255|1791554|FG003|Overall Study|Lack of Efficacy|0
835694|NCT00320255|1791555|FG004|Overall Study|Lack of Efficacy|0
835695|NCT00320255|1791556|FG005|Overall Study|Lack of Efficacy|0
835696|NCT00320255|1791551|FG000|Overall Study|Adverse Event|5
835697|NCT00320255|1791552|FG001|Overall Study|Adverse Event|2
835698|NCT00320255|1791553|FG002|Overall Study|Adverse Event|3
835699|NCT00320255|1791554|FG003|Overall Study|Adverse Event|2
835700|NCT00320255|1791555|FG004|Overall Study|Adverse Event|0
835701|NCT00320255|1791556|FG005|Overall Study|Adverse Event|0
835702|NCT00320255|1791551|FG000|Overall Study|Withdrawal by Subject|1
835703|NCT00320255|1791552|FG001|Overall Study|Withdrawal by Subject|2
835704|NCT00320255|1791553|FG002|Overall Study|Withdrawal by Subject|2
835705|NCT00320255|1791554|FG003|Overall Study|Withdrawal by Subject|4
835706|NCT00320255|1791555|FG004|Overall Study|Withdrawal by Subject|0
835707|NCT00320255|1791556|FG005|Overall Study|Withdrawal by Subject|0
835708|NCT00320255|1791551|FG000|Overall Study|Poor compliance/noncompliance|1
835709|NCT00320255|1791552|FG001|Overall Study|Poor compliance/noncompliance|1
835710|NCT00320255|1791553|FG002|Overall Study|Poor compliance/noncompliance|0
835711|NCT00320255|1791554|FG003|Overall Study|Poor compliance/noncompliance|1
835712|NCT00320255|1791555|FG004|Overall Study|Poor compliance/noncompliance|0
835713|NCT00320255|1791556|FG005|Overall Study|Poor compliance/noncompliance|0
835714|NCT00320255|1791551|FG000|Overall Study|No longer meets study criteria|0
835715|NCT00320255|1791552|FG001|Overall Study|No longer meets study criteria|0
835716|NCT00320255|1791553|FG002|Overall Study|No longer meets study criteria|0
835717|NCT00320255|1791554|FG003|Overall Study|No longer meets study criteria|1
835718|NCT00320255|1791555|FG004|Overall Study|No longer meets study criteria|0
835719|NCT00320255|1791556|FG005|Overall Study|No longer meets study criteria|0
835720|NCT00320255|1791551|FG000|Overall Study|Other|3
835721|NCT00320255|1791552|FG001|Overall Study|Other|2
835722|NCT00320255|1791553|FG002|Overall Study|Other|1
835723|NCT00320255|1791554|FG003|Overall Study|Other|0
835724|NCT00320255|1791555|FG004|Overall Study|Other|0
835725|NCT00320255|1791556|FG005|Overall Study|Other|0
835726|NCT00320372|1791585|FG000|Overall Study|Physician Decision|4
835727|NCT00320372|1791586|FG001|Overall Study|Physician Decision|7
835728|NCT00320372|1791585|FG000|Overall Study|Death|7
835729|NCT00320372|1791586|FG001|Overall Study|Death|8
835730|NCT00320372|1791585|FG000|Overall Study|Withdrawal by Subject|55
835731|NCT00320372|1791586|FG001|Overall Study|Withdrawal by Subject|37
835732|NCT00320372|1791585|FG000|Overall Study|Non-Compliance|40
835733|NCT00320372|1791586|FG001|Overall Study|Non-Compliance|39
835734|NCT00320372|1791585|FG000|Overall Study|Did not Meet (I/E)|3
835735|NCT00320372|1791586|FG001|Overall Study|Did not Meet (I/E)|1
835906|NCT00320788|1791710|FG001|Overall Study|Physician Decision|1
835736|NCT00320372|1791585|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86
835737|NCT00320372|1791586|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71
835738|NCT00320385|1791602|FG000|Overall Study|Lost to Follow-up|7
835739|NCT00320385|1791603|FG001|Overall Study|Lost to Follow-up|10
835740|NCT00320385|1791602|FG000|Overall Study|Withdrawal by Subject|6
835741|NCT00320385|1791603|FG001|Overall Study|Withdrawal by Subject|7
835742|NCT00320385|1791602|FG000|Overall Study|Sponsor Terminated Study|2
835743|NCT00320385|1791603|FG001|Overall Study|Sponsor Terminated Study|1
835744|NCT00320385|1791602|FG000|Overall Study|Investigator Decision|0
835745|NCT00320385|1791603|FG001|Overall Study|Investigator Decision|1
835746|NCT00320385|1791602|FG000|Overall Study|Death|1
835747|NCT00320385|1791603|FG001|Overall Study|Death|2
835748|NCT00320385|1791602|FG000|Overall Study|Serious Adverse Event|1
835749|NCT00320385|1791603|FG001|Overall Study|Serious Adverse Event|0
835750|NCT00320385|1791602|FG000|Overall Study|Withdrew Consent|1
835751|NCT00320385|1791603|FG001|Overall Study|Withdrew Consent|0
835752|NCT00320385|1791602|FG000|Overall Study|Adverse Event|0
835753|NCT00320385|1791603|FG001|Overall Study|Adverse Event|1
835754|NCT00320398|1791611|FG000|Overall Study|Adverse Event|1
835755|NCT00320398|1791612|FG001|Overall Study|Adverse Event|4
835756|NCT00320398|1791611|FG000|Overall Study|Other|1
835757|NCT00320398|1791612|FG001|Overall Study|Other|0
835758|NCT00320411|1791619|FG000|Overall Study|No investigational product admin.|4
835759|NCT00320424|1791623|FG000|Overall Study|Adverse Event|3
835760|NCT00320424|1791623|FG000|Overall Study|Other|3
835761|NCT00320489|1791629|FG000|Overall Study|Adverse Event|26
835762|NCT00320489|1791630|FG001|Overall Study|Adverse Event|25
835763|NCT00320489|1791629|FG000|Overall Study|Clinical Relapse|26
835764|NCT00320489|1791630|FG001|Overall Study|Clinical Relapse|20
835765|NCT00320489|1791629|FG000|Overall Study|Death|0
835766|NCT00320489|1791630|FG001|Overall Study|Death|2
835767|NCT00320489|1791629|FG000|Overall Study|Entry Criteria Exclusion|2
835768|NCT00320489|1791630|FG001|Overall Study|Entry Criteria Exclusion|4
835769|NCT00320489|1791629|FG000|Overall Study|Lack of Efficacy|16
835770|NCT00320489|1791630|FG001|Overall Study|Lack of Efficacy|7
835771|NCT00320489|1791629|FG000|Overall Study|Lost to Follow-up|21
835772|NCT00320489|1791630|FG001|Overall Study|Lost to Follow-up|22
835773|NCT00320489|1791629|FG000|Overall Study|Physician Decision|8
835774|NCT00320489|1791630|FG001|Overall Study|Physician Decision|8
835775|NCT00320489|1791629|FG000|Overall Study|Protocol Violation|4
835776|NCT00320489|1791630|FG001|Overall Study|Protocol Violation|4
835777|NCT00320489|1791629|FG000|Overall Study|Sponsor Decision|3
835778|NCT00320489|1791630|FG001|Overall Study|Sponsor Decision|3
835779|NCT00320489|1791629|FG000|Overall Study|Withdrawal by Subject|39
835780|NCT00320489|1791630|FG001|Overall Study|Withdrawal by Subject|41
835781|NCT00320515|1791636|FG000|Overall Study|Death|33
835782|NCT00320515|1791636|FG000|Overall Study|Lost to Follow-up|6
835783|NCT00320515|1791636|FG000|Overall Study|Physician Decision|2
835784|NCT00320515|1791636|FG000|Overall Study|Withdrawal by Subject|8
835785|NCT00320528|1791643|FG000|Study Period II|Adverse Event|3
835786|NCT00320528|1791644|FG001|Study Period II|Adverse Event|4
835787|NCT00320528|1791645|FG002|Study Period II|Adverse Event|8
835788|NCT00320528|1791643|FG000|Study Period II|Parent/Caregiver Decision|8
835789|NCT00320528|1791644|FG001|Study Period II|Parent/Caregiver Decision|3
835790|NCT00320528|1791645|FG002|Study Period II|Parent/Caregiver Decision|11
835791|NCT00320528|1791643|FG000|Study Period II|Withdrawal by Subject|0
835792|NCT00320528|1791644|FG001|Study Period II|Withdrawal by Subject|1
835793|NCT00320528|1791645|FG002|Study Period II|Withdrawal by Subject|1
835794|NCT00320528|1791643|FG000|Study Period II|Entry Criteria Exclusion|0
835795|NCT00320528|1791644|FG001|Study Period II|Entry Criteria Exclusion|2
835796|NCT00320528|1791645|FG002|Study Period II|Entry Criteria Exclusion|2
835797|NCT00320528|1791643|FG000|Study Period III|Adverse Event|1
835798|NCT00320528|1791644|FG001|Study Period III|Adverse Event|0
835799|NCT00320528|1791645|FG002|Study Period III|Adverse Event|0
835800|NCT00320528|1791643|FG000|Study Period III|Lost to Follow-up|1
835801|NCT00320528|1791644|FG001|Study Period III|Lost to Follow-up|0
835802|NCT00320528|1791645|FG002|Study Period III|Lost to Follow-up|0
835803|NCT00320528|1791643|FG000|Study Period III|Withdrawal by Subject|1
835804|NCT00320528|1791644|FG001|Study Period III|Withdrawal by Subject|1
835805|NCT00320528|1791645|FG002|Study Period III|Withdrawal by Subject|2
835806|NCT00320528|1791643|FG000|Study Period III|Lack of Efficacy|2
835807|NCT00320528|1791644|FG001|Study Period III|Lack of Efficacy|0
835808|NCT00320528|1791645|FG002|Study Period III|Lack of Efficacy|0
835809|NCT00320528|1791643|FG000|Study Period III|Parent/Caregiver Decision|14
835810|NCT00320528|1791644|FG001|Study Period III|Parent/Caregiver Decision|3
835811|NCT00320528|1791645|FG002|Study Period III|Parent/Caregiver Decision|11
835812|NCT00320528|1791643|FG000|Study Period III|Protocol Violation|0
835813|NCT00320528|1791644|FG001|Study Period III|Protocol Violation|1
835814|NCT00320528|1791645|FG002|Study Period III|Protocol Violation|0
835815|NCT00320528|1791643|FG000|Study Period III|Physician Decision|0
835816|NCT00320528|1791644|FG001|Study Period III|Physician Decision|1
835817|NCT00320528|1791645|FG002|Study Period III|Physician Decision|2
835818|NCT00320528|1791643|FG000|Study Period III|Sponsor Decision|0
835819|NCT00320528|1791644|FG001|Study Period III|Sponsor Decision|0
835820|NCT00320528|1791645|FG002|Study Period III|Sponsor Decision|1
835821|NCT00320528|1791643|FG000|Study Period III|Atomoxetine Commercially Available|68
835822|NCT00320528|1791644|FG001|Study Period III|Atomoxetine Commercially Available|25
835823|NCT00320528|1791645|FG002|Study Period III|Atomoxetine Commercially Available|90
835824|NCT00320541|1791655|FG000|Overall Study|Adverse Event|21
835825|NCT00320541|1791656|FG001|Overall Study|Adverse Event|19
835826|NCT00320541|1791655|FG000|Overall Study|Protocol Violation|0
835827|NCT00320541|1791656|FG001|Overall Study|Protocol Violation|1
835828|NCT00320541|1791655|FG000|Overall Study|Withdrawal by Subject|12
835829|NCT00320541|1791656|FG001|Overall Study|Withdrawal by Subject|16
835830|NCT00320541|1791655|FG000|Overall Study|Physician Decision|9
835831|NCT00320541|1791656|FG001|Overall Study|Physician Decision|13
835832|NCT00320541|1791655|FG000|Overall Study|Other|3
835833|NCT00320541|1791656|FG001|Overall Study|Other|4
835834|NCT00320541|1791655|FG000|Overall Study|Sponsor Decision|2
835835|NCT00320541|1791656|FG001|Overall Study|Sponsor Decision|1
835836|NCT00320541|1791655|FG000|Overall Study|Death due to Study Disease|1
835837|NCT00320541|1791656|FG001|Overall Study|Death due to Study Disease|3
835838|NCT00320541|1791655|FG000|Overall Study|Death due to Adverse Event(s)|1
835839|NCT00320541|1791656|FG001|Overall Study|Death due to Adverse Event(s)|0
835840|NCT00320541|1791655|FG000|Overall Study|Protocol Entry Criterion Not Met|1
835841|NCT00320541|1791656|FG001|Overall Study|Protocol Entry Criterion Not Met|0
835842|NCT00320593|1791664|FG000|Overall Study|Lost to Follow-up|3
835843|NCT00320593|1791665|FG001|Overall Study|Lost to Follow-up|0
835844|NCT00320593|1791664|FG000|Overall Study|Moved to another state|1
835845|NCT00320593|1791665|FG001|Overall Study|Moved to another state|0
835846|NCT00320593|1791664|FG000|Overall Study|Withdrawal by Subject|2
835847|NCT00320593|1791665|FG001|Overall Study|Withdrawal by Subject|1
835848|NCT00320593|1791664|FG000|Overall Study|Withdrawal by clinical center|1
835849|NCT00320593|1791665|FG001|Overall Study|Withdrawal by clinical center|0
835850|NCT00320606|1791671|FG000|Overall Study|Adverse Event|1
835851|NCT00320606|1791671|FG000|Overall Study|Protocol Violation|1
835852|NCT00320606|1791671|FG000|Overall Study|Withdrawal by Subject|1
835853|NCT00320710|1791688|FG000|Overall Study|Disease progression|24
835854|NCT00320710|1791689|FG001|Overall Study|Disease progression|19
835855|NCT00320710|1791690|FG002|Overall Study|Disease progression|2
835856|NCT00320710|1791688|FG000|Overall Study|Death|10
835857|NCT00320710|1791689|FG001|Overall Study|Death|7
835858|NCT00320710|1791690|FG002|Overall Study|Death|1
835859|NCT00320710|1791688|FG000|Overall Study|Administrative problems|1
835860|NCT00320710|1791689|FG001|Overall Study|Administrative problems|2
835861|NCT00320710|1791690|FG002|Overall Study|Administrative problems|0
835862|NCT00320710|1791688|FG000|Overall Study|Withdrawal by Subject|20
835863|NCT00320710|1791689|FG001|Overall Study|Withdrawal by Subject|26
835864|NCT00320710|1791690|FG002|Overall Study|Withdrawal by Subject|1
835865|NCT00320710|1791688|FG000|Overall Study|Protocol Violation|6
835866|NCT00320710|1791689|FG001|Overall Study|Protocol Violation|5
835867|NCT00320710|1791690|FG002|Overall Study|Protocol Violation|0
835868|NCT00320710|1791688|FG000|Overall Study|Abnormal test procedure result(s)|2
835869|NCT00320710|1791689|FG001|Overall Study|Abnormal test procedure result(s)|0
835870|NCT00320710|1791690|FG002|Overall Study|Abnormal test procedure result(s)|0
835871|NCT00320710|1791688|FG000|Overall Study|Abnormal laboratory value(s)|12
835872|NCT00320710|1791689|FG001|Overall Study|Abnormal laboratory value(s)|3
835873|NCT00320710|1791690|FG002|Overall Study|Abnormal laboratory value(s)|0
835874|NCT00320710|1791688|FG000|Overall Study|Adverse Event|18
835875|NCT00320710|1791689|FG001|Overall Study|Adverse Event|14
835876|NCT00320710|1791690|FG002|Overall Study|Adverse Event|1
835877|NCT00320710|1791688|FG000|Overall Study|Lost to Follow-up|1
835878|NCT00320710|1791689|FG001|Overall Study|Lost to Follow-up|0
835879|NCT00320710|1791690|FG002|Overall Study|Lost to Follow-up|0
835880|NCT00320788|1791709|FG000|Overall Study|Adverse Event|0
835881|NCT00320788|1791710|FG001|Overall Study|Adverse Event|0
835882|NCT00320788|1791711|FG002|Overall Study|Adverse Event|0
835883|NCT00320788|1791712|FG003|Overall Study|Adverse Event|1
835884|NCT00320788|1791713|FG004|Overall Study|Adverse Event|0
835885|NCT00320788|1791709|FG000|Overall Study|Death|0
835886|NCT00320788|1791710|FG001|Overall Study|Death|0
835887|NCT00320788|1791711|FG002|Overall Study|Death|1
835888|NCT00320788|1791712|FG003|Overall Study|Death|0
835889|NCT00320788|1791713|FG004|Overall Study|Death|1
835890|NCT00320788|1791709|FG000|Overall Study|Lost to Follow-up|0
835891|NCT00320788|1791710|FG001|Overall Study|Lost to Follow-up|2
835892|NCT00320788|1791711|FG002|Overall Study|Lost to Follow-up|1
835893|NCT00320788|1791712|FG003|Overall Study|Lost to Follow-up|0
835894|NCT00320788|1791713|FG004|Overall Study|Lost to Follow-up|0
835895|NCT00320788|1791709|FG000|Overall Study|Decision by the Sponsor|1
835896|NCT00320788|1791710|FG001|Overall Study|Decision by the Sponsor|1
835897|NCT00320788|1791711|FG002|Overall Study|Decision by the Sponsor|0
835898|NCT00320788|1791712|FG003|Overall Study|Decision by the Sponsor|0
835899|NCT00320788|1791713|FG004|Overall Study|Decision by the Sponsor|1
835900|NCT00320788|1791709|FG000|Overall Study|Other|1
835901|NCT00320788|1791710|FG001|Overall Study|Other|2
835902|NCT00320788|1791711|FG002|Overall Study|Other|1
835903|NCT00320788|1791712|FG003|Overall Study|Other|1
835904|NCT00320788|1791713|FG004|Overall Study|Other|1
835905|NCT00320788|1791709|FG000|Overall Study|Physician Decision|1
835907|NCT00320788|1791711|FG002|Overall Study|Physician Decision|0
835908|NCT00320788|1791712|FG003|Overall Study|Physician Decision|0
835909|NCT00320788|1791713|FG004|Overall Study|Physician Decision|0
835910|NCT00320788|1791709|FG000|Overall Study|Protocol Violation|0
835911|NCT00320788|1791710|FG001|Overall Study|Protocol Violation|0
835912|NCT00320788|1791711|FG002|Overall Study|Protocol Violation|0
835913|NCT00320788|1791712|FG003|Overall Study|Protocol Violation|0
835914|NCT00320788|1791713|FG004|Overall Study|Protocol Violation|1
835915|NCT00320788|1791709|FG000|Overall Study|Withdrawal by Subject|3
835916|NCT00320788|1791710|FG001|Overall Study|Withdrawal by Subject|0
835917|NCT00320788|1791711|FG002|Overall Study|Withdrawal by Subject|0
835918|NCT00320788|1791712|FG003|Overall Study|Withdrawal by Subject|3
835919|NCT00320788|1791713|FG004|Overall Study|Withdrawal by Subject|1
835920|NCT00320801|1791733|FG000|Open-label Run-in Period|Withdrawal by Subject|2
835921|NCT00320801|1791734|FG001|Open-label Run-in Period|Withdrawal by Subject|0
835922|NCT00320801|1791735|FG002|Open-label Run-in Period|Withdrawal by Subject|0
835923|NCT00320801|1791736|FG003|Open-label Run-in Period|Withdrawal by Subject|0
835924|NCT00320801|1791733|FG000|Open-label Run-in Period|Adverse Event|33
835925|NCT00320801|1791734|FG001|Open-label Run-in Period|Adverse Event|0
835926|NCT00320801|1791735|FG002|Open-label Run-in Period|Adverse Event|0
835927|NCT00320801|1791736|FG003|Open-label Run-in Period|Adverse Event|0
835928|NCT00320801|1791733|FG000|Open-label Run-in Period|Administrative|10
835929|NCT00320801|1791734|FG001|Open-label Run-in Period|Administrative|0
835930|NCT00320801|1791735|FG002|Open-label Run-in Period|Administrative|0
835931|NCT00320801|1791736|FG003|Open-label Run-in Period|Administrative|0
835932|NCT00320801|1791733|FG000|Open-label Run-in Period|Lack of Efficacy|44
835933|NCT00320801|1791734|FG001|Open-label Run-in Period|Lack of Efficacy|0
835934|NCT00320801|1791735|FG002|Open-label Run-in Period|Lack of Efficacy|0
835935|NCT00320801|1791736|FG003|Open-label Run-in Period|Lack of Efficacy|0
835936|NCT00320801|1791733|FG000|Open-label Run-in Period|Lost to Follow-up|2
835937|NCT00320801|1791734|FG001|Open-label Run-in Period|Lost to Follow-up|0
835938|NCT00320801|1791735|FG002|Open-label Run-in Period|Lost to Follow-up|0
835939|NCT00320801|1791736|FG003|Open-label Run-in Period|Lost to Follow-up|0
835940|NCT00320801|1791733|FG000|Open-label Run-in Period|Did not qualify|1
835941|NCT00320801|1791734|FG001|Open-label Run-in Period|Did not qualify|0
835942|NCT00320801|1791735|FG002|Open-label Run-in Period|Did not qualify|0
835943|NCT00320801|1791736|FG003|Open-label Run-in Period|Did not qualify|0
835944|NCT00320801|1791733|FG000|Double-blind Phase|Withdrawal by Subject|0
835945|NCT00320801|1791734|FG001|Double-blind Phase|Withdrawal by Subject|0
835946|NCT00320801|1791735|FG002|Double-blind Phase|Withdrawal by Subject|1
835947|NCT00320801|1791736|FG003|Double-blind Phase|Withdrawal by Subject|0
835948|NCT00320801|1791733|FG000|Double-blind Phase|Adverse Event|0
835949|NCT00320801|1791734|FG001|Double-blind Phase|Adverse Event|2
835950|NCT00320801|1791735|FG002|Double-blind Phase|Adverse Event|8
835951|NCT00320801|1791736|FG003|Double-blind Phase|Adverse Event|0
835952|NCT00320801|1791733|FG000|Double-blind Phase|Administrative|0
835953|NCT00320801|1791734|FG001|Double-blind Phase|Administrative|0
835954|NCT00320801|1791735|FG002|Double-blind Phase|Administrative|4
835955|NCT00320801|1791736|FG003|Double-blind Phase|Administrative|0
835956|NCT00320801|1791733|FG000|Double-blind Phase|Lack of Efficacy|0
835957|NCT00320801|1791734|FG001|Double-blind Phase|Lack of Efficacy|9
835958|NCT00320801|1791735|FG002|Double-blind Phase|Lack of Efficacy|1
835959|NCT00320801|1791736|FG003|Double-blind Phase|Lack of Efficacy|0
835960|NCT00320801|1791733|FG000|Extension Phase|Withdrawal by Subject|0
835961|NCT00320801|1791734|FG001|Extension Phase|Withdrawal by Subject|0
835962|NCT00320801|1791735|FG002|Extension Phase|Withdrawal by Subject|0
835963|NCT00320801|1791736|FG003|Extension Phase|Withdrawal by Subject|6
835964|NCT00320801|1791733|FG000|Extension Phase|Adverse Event|0
835965|NCT00320801|1791734|FG001|Extension Phase|Adverse Event|0
835966|NCT00320801|1791735|FG002|Extension Phase|Adverse Event|0
835967|NCT00320801|1791736|FG003|Extension Phase|Adverse Event|8
835968|NCT00320801|1791733|FG000|Extension Phase|Administrative|0
835969|NCT00320801|1791734|FG001|Extension Phase|Administrative|0
835970|NCT00320801|1791735|FG002|Extension Phase|Administrative|0
835971|NCT00320801|1791736|FG003|Extension Phase|Administrative|29
835972|NCT00320801|1791733|FG000|Extension Phase|Lack of Efficacy|0
835973|NCT00320801|1791734|FG001|Extension Phase|Lack of Efficacy|0
835974|NCT00320801|1791735|FG002|Extension Phase|Lack of Efficacy|0
835975|NCT00320801|1791736|FG003|Extension Phase|Lack of Efficacy|2
835976|NCT00320801|1791733|FG000|Extension Phase|Lost to Follow-up|0
835977|NCT00320801|1791734|FG001|Extension Phase|Lost to Follow-up|0
835978|NCT00320801|1791735|FG002|Extension Phase|Lost to Follow-up|0
835979|NCT00320801|1791736|FG003|Extension Phase|Lost to Follow-up|3
835980|NCT00321048|1791748|FG000|Overall Study|Withdrawal by Subject|6
835981|NCT00321048|1791749|FG001|Overall Study|Withdrawal by Subject|8
835982|NCT00321373|1791773|FG000|Overall Study|Adverse Event|0
835983|NCT00321373|1791774|FG001|Overall Study|Adverse Event|0
835984|NCT00321373|1791775|FG002|Overall Study|Adverse Event|1
835985|NCT00321373|1791773|FG000|Overall Study|Lost to Follow-up|1
835986|NCT00321373|1791774|FG001|Overall Study|Lost to Follow-up|0
835987|NCT00321373|1791775|FG002|Overall Study|Lost to Follow-up|1
835988|NCT00321373|1791773|FG000|Overall Study|Withdrawal by Subject|1
835989|NCT00321373|1791774|FG001|Overall Study|Withdrawal by Subject|0
835990|NCT00321373|1791775|FG002|Overall Study|Withdrawal by Subject|0
835991|NCT00321373|1791773|FG000|Overall Study|Other|0
835992|NCT00321373|1791774|FG001|Overall Study|Other|0
835993|NCT00321373|1791775|FG002|Overall Study|Other|1
835994|NCT00321464|1791785|FG000|Overall Study|Death|169
835995|NCT00321464|1791786|FG001|Overall Study|Death|174
835996|NCT00321464|1791785|FG000|Overall Study|Disease progression|124
835997|NCT00321464|1791786|FG001|Overall Study|Disease progression|124
835998|NCT00321464|1791785|FG000|Overall Study|Withdrawal by Subject|117
835999|NCT00321464|1791786|FG001|Overall Study|Withdrawal by Subject|118
836000|NCT00321464|1791785|FG000|Overall Study|Participant request|57
836001|NCT00321464|1791786|FG001|Overall Study|Participant request|61
836002|NCT00321464|1791785|FG000|Overall Study|Adverse Event|43
836003|NCT00321464|1791786|FG001|Overall Study|Adverse Event|28
836004|NCT00321464|1791785|FG000|Overall Study|Physician Decision|15
836005|NCT00321464|1791786|FG001|Overall Study|Physician Decision|14
836006|NCT00321464|1791785|FG000|Overall Study|Noncompliance|4
836007|NCT00321464|1791786|FG001|Overall Study|Noncompliance|10
836008|NCT00321464|1791785|FG000|Overall Study|Lost to Follow-up|7
836009|NCT00321464|1791786|FG001|Overall Study|Lost to Follow-up|8
836010|NCT00321464|1791785|FG000|Overall Study|Protocol deviation|0
836011|NCT00321464|1791786|FG001|Overall Study|Protocol deviation|2
836012|NCT00321464|1791785|FG000|Overall Study|Ineligibility determined|2
836013|NCT00321464|1791786|FG001|Overall Study|Ineligibility determined|1
836014|NCT00321464|1791785|FG000|Overall Study|Other|21
836015|NCT00321464|1791786|FG001|Overall Study|Other|18
836016|NCT00321555|1791792|FG000|Overall Study|Developed antibodies|1
836017|NCT00321555|1791792|FG000|Overall Study|Switched to alternative treatment|3
836018|NCT00321555|1791792|FG000|Overall Study|Physician Decision|1
836019|NCT00321555|1791792|FG000|Overall Study|Disease progression on study|1
836020|NCT00321620|1791816|FG000|Overall Study|Death|269
836021|NCT00321620|1791817|FG001|Overall Study|Death|294
836022|NCT00321620|1791816|FG000|Overall Study|Withdrawal by Subject|164
836023|NCT00321620|1791817|FG001|Overall Study|Withdrawal by Subject|147
836024|NCT00321620|1791816|FG000|Overall Study|Disease progression|113
836025|NCT00321620|1791817|FG001|Overall Study|Disease progression|117
836026|NCT00321620|1791816|FG000|Overall Study|Adverse Event|43
836027|NCT00321620|1791817|FG001|Overall Study|Adverse Event|56
836028|NCT00321620|1791816|FG000|Overall Study|Lost to Follow-up|13
836029|NCT00321620|1791817|FG001|Overall Study|Lost to Follow-up|9
836030|NCT00321620|1791816|FG000|Overall Study|Physician Decision|4
836031|NCT00321620|1791817|FG001|Overall Study|Physician Decision|1
836032|NCT00321620|1791816|FG000|Overall Study|Noncompliance|14
836033|NCT00321620|1791817|FG001|Overall Study|Noncompliance|7
836034|NCT00321620|1791816|FG000|Overall Study|Protocol deviation|4
836035|NCT00321620|1791817|FG001|Overall Study|Protocol deviation|3
836036|NCT00321620|1791816|FG000|Overall Study|Ineligibility determined|2
836037|NCT00321620|1791817|FG001|Overall Study|Ineligibility determined|3
836038|NCT00321620|1791816|FG000|Overall Study|Participant request|75
836039|NCT00321620|1791817|FG001|Overall Study|Participant request|52
836040|NCT00321620|1791816|FG000|Overall Study|Other|42
836041|NCT00321620|1791817|FG001|Overall Study|Other|33
836042|NCT00321646|1791823|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
836043|NCT00321646|1791823|FG000|Neoadjuvant Chemotherapy|Adverse Event|2
836044|NCT00321646|1791823|FG000|Neoadjuvant Chemotherapy|Disease progression|1
836045|NCT00321672|1791831|FG000|Overall Study|Withdrawal by Subject|5
836046|NCT00321672|1791832|FG001|Overall Study|Withdrawal by Subject|1
836047|NCT00321672|1791833|FG002|Overall Study|Withdrawal by Subject|2
836048|NCT00321672|1791834|FG003|Overall Study|Withdrawal by Subject|0
836049|NCT00321672|1791831|FG000|Overall Study|Noncompliance|1
836050|NCT00321672|1791832|FG001|Overall Study|Noncompliance|2
836051|NCT00321672|1791833|FG002|Overall Study|Noncompliance|1
836052|NCT00321672|1791834|FG003|Overall Study|Noncompliance|0
836053|NCT00321672|1791831|FG000|Overall Study|Adverse Event|1
836054|NCT00321672|1791832|FG001|Overall Study|Adverse Event|1
836055|NCT00321672|1791833|FG002|Overall Study|Adverse Event|0
836056|NCT00321672|1791834|FG003|Overall Study|Adverse Event|0
836057|NCT00321672|1791831|FG000|Overall Study|Lack of Efficacy|1
836058|NCT00321672|1791832|FG001|Overall Study|Lack of Efficacy|1
836059|NCT00321672|1791833|FG002|Overall Study|Lack of Efficacy|0
836060|NCT00321672|1791834|FG003|Overall Study|Lack of Efficacy|0
836061|NCT00321672|1791831|FG000|Overall Study|Lost to Follow-up|2
836062|NCT00321672|1791832|FG001|Overall Study|Lost to Follow-up|0
836063|NCT00321672|1791833|FG002|Overall Study|Lost to Follow-up|4
836064|NCT00321672|1791834|FG003|Overall Study|Lost to Follow-up|2
836065|NCT00321672|1791831|FG000|Overall Study|Death|1
836066|NCT00321672|1791832|FG001|Overall Study|Death|0
836067|NCT00321672|1791833|FG002|Overall Study|Death|0
836068|NCT00321672|1791834|FG003|Overall Study|Death|0
836069|NCT00321672|1791831|FG000|Overall Study|Too far to travel for visits|1
836070|NCT00321672|1791832|FG001|Overall Study|Too far to travel for visits|0
836071|NCT00321672|1791833|FG002|Overall Study|Too far to travel for visits|0
836072|NCT00321672|1791834|FG003|Overall Study|Too far to travel for visits|0
836073|NCT00321672|1791831|FG000|Overall Study|Incarcerated|0
836074|NCT00321672|1791832|FG001|Overall Study|Incarcerated|0
836075|NCT00321672|1791833|FG002|Overall Study|Incarcerated|2
836076|NCT00321672|1791834|FG003|Overall Study|Incarcerated|0
836077|NCT00321672|1791831|FG000|Overall Study|Moved out of state|0
836078|NCT00321672|1791832|FG001|Overall Study|Moved out of state|1
836079|NCT00321672|1791833|FG002|Overall Study|Moved out of state|1
836080|NCT00321672|1791834|FG003|Overall Study|Moved out of state|0
836081|NCT00321672|1791831|FG000|Overall Study|Protocol Violation|0
836082|NCT00321672|1791832|FG001|Overall Study|Protocol Violation|0
836083|NCT00321672|1791833|FG002|Overall Study|Protocol Violation|1
836084|NCT00321672|1791834|FG003|Overall Study|Protocol Violation|0
836085|NCT00321672|1791831|FG000|Overall Study|Diagnosis of testicular cancer|0
836086|NCT00321672|1791832|FG001|Overall Study|Diagnosis of testicular cancer|1
836087|NCT00321672|1791833|FG002|Overall Study|Diagnosis of testicular cancer|0
836088|NCT00321672|1791834|FG003|Overall Study|Diagnosis of testicular cancer|0
836089|NCT00321672|1791831|FG000|Overall Study|Extensive travel required for new job|0
836090|NCT00321672|1791832|FG001|Overall Study|Extensive travel required for new job|1
836091|NCT00321672|1791833|FG002|Overall Study|Extensive travel required for new job|0
836092|NCT00321672|1791834|FG003|Overall Study|Extensive travel required for new job|0
836093|NCT00321685|1791848|FG000|Overall Study|Adverse Event|18
836094|NCT00321685|1791848|FG000|Overall Study|Death|2
836095|NCT00321685|1791848|FG000|Overall Study|Withdrawal by Subject|8
836096|NCT00321685|1791848|FG000|Overall Study|Alternative therapy|1
836097|NCT00321685|1791848|FG000|Overall Study|Complicating disese|1
836098|NCT00321685|1791848|FG000|Overall Study|Other|5
836099|NCT00321685|1791848|FG000|Overall Study|Not start protocol therapy|2
836100|NCT00321685|1791848|FG000|Overall Study|Ineligible|2
836101|NCT00321711|1791878|FG000|Part A|Adverse Event|3
836102|NCT00321711|1791879|FG001|Part A|Adverse Event|3
836103|NCT00321711|1791880|FG002|Part A|Adverse Event|2
836104|NCT00321711|1791881|FG003|Part A|Adverse Event|0
836105|NCT00321711|1791882|FG004|Part A|Adverse Event|0
836106|NCT00321711|1791878|FG000|Part A|Withdrawal by Subject|1
836107|NCT00321711|1791879|FG001|Part A|Withdrawal by Subject|1
836108|NCT00321711|1791880|FG002|Part A|Withdrawal by Subject|1
836109|NCT00321711|1791881|FG003|Part A|Withdrawal by Subject|0
836110|NCT00321711|1791882|FG004|Part A|Withdrawal by Subject|0
836111|NCT00321711|1791878|FG000|Part A|Disease progression|0
836112|NCT00321711|1791879|FG001|Part A|Disease progression|1
836113|NCT00321711|1791880|FG002|Part A|Disease progression|0
836114|NCT00321711|1791881|FG003|Part A|Disease progression|0
836115|NCT00321711|1791882|FG004|Part A|Disease progression|0
836116|NCT00321711|1791878|FG000|Part A|Requirement for alternative therapy|0
836117|NCT00321711|1791879|FG001|Part A|Requirement for alternative therapy|2
836118|NCT00321711|1791880|FG002|Part A|Requirement for alternative therapy|1
836119|NCT00321711|1791881|FG003|Part A|Requirement for alternative therapy|0
836120|NCT00321711|1791882|FG004|Part A|Requirement for alternative therapy|0
836121|NCT00321711|1791878|FG000|Part A|Physician Decision|0
836122|NCT00321711|1791879|FG001|Part A|Physician Decision|1
836123|NCT00321711|1791880|FG002|Part A|Physician Decision|3
836124|NCT00321711|1791881|FG003|Part A|Physician Decision|0
836125|NCT00321711|1791882|FG004|Part A|Physician Decision|0
836126|NCT00321711|1791878|FG000|Part A|Other|1
836127|NCT00321711|1791879|FG001|Part A|Other|2
836128|NCT00321711|1791880|FG002|Part A|Other|3
836129|NCT00321711|1791881|FG003|Part A|Other|0
836130|NCT00321711|1791882|FG004|Part A|Other|0
836131|NCT00321711|1791878|FG000|Part A|Protocol deviation|0
836132|NCT00321711|1791879|FG001|Part A|Protocol deviation|0
836133|NCT00321711|1791880|FG002|Part A|Protocol deviation|1
836134|NCT00321711|1791881|FG003|Part A|Protocol deviation|0
836135|NCT00321711|1791882|FG004|Part A|Protocol deviation|0
836136|NCT00321711|1791878|FG000|Part B|Noncompliance|0
836137|NCT00321711|1791879|FG001|Part B|Noncompliance|0
836138|NCT00321711|1791880|FG002|Part B|Noncompliance|0
836139|NCT00321711|1791881|FG003|Part B|Noncompliance|0
836140|NCT00321711|1791882|FG004|Part B|Noncompliance|1
836141|NCT00321711|1791878|FG000|Part B|Adverse Event|0
836142|NCT00321711|1791879|FG001|Part B|Adverse Event|0
836143|NCT00321711|1791880|FG002|Part B|Adverse Event|0
836144|NCT00321711|1791881|FG003|Part B|Adverse Event|2
836145|NCT00321711|1791882|FG004|Part B|Adverse Event|1
836146|NCT00321711|1791878|FG000|Part B|Disease progression|0
836147|NCT00321711|1791879|FG001|Part B|Disease progression|0
836148|NCT00321711|1791880|FG002|Part B|Disease progression|0
836149|NCT00321711|1791881|FG003|Part B|Disease progression|1
836150|NCT00321711|1791882|FG004|Part B|Disease progression|0
836151|NCT00321711|1791878|FG000|Part B|Physician Decision|0
836152|NCT00321711|1791879|FG001|Part B|Physician Decision|0
836153|NCT00321711|1791880|FG002|Part B|Physician Decision|0
836154|NCT00321711|1791881|FG003|Part B|Physician Decision|1
836155|NCT00321711|1791882|FG004|Part B|Physician Decision|2
836156|NCT00321711|1791878|FG000|Part B|Death|0
836157|NCT00321711|1791879|FG001|Part B|Death|0
836158|NCT00321711|1791880|FG002|Part B|Death|0
836159|NCT00321711|1791881|FG003|Part B|Death|2
836160|NCT00321711|1791882|FG004|Part B|Death|1
836161|NCT00321737|1791897|FG000|Overall Study|Relapse of Erosive Esophagitis|76
836162|NCT00321737|1791898|FG001|Overall Study|Relapse of Erosive Esophagitis|25
836163|NCT00321737|1791899|FG002|Overall Study|Relapse of Erosive Esophagitis|19
836164|NCT00321737|1791897|FG000|Overall Study|Adverse Event|11
836165|NCT00321737|1791898|FG001|Overall Study|Adverse Event|3
836166|NCT00321737|1791899|FG002|Overall Study|Adverse Event|6
836167|NCT00321737|1791897|FG000|Overall Study|Lost to Follow-up|5
836168|NCT00321737|1791898|FG001|Overall Study|Lost to Follow-up|5
836169|NCT00321737|1791899|FG002|Overall Study|Lost to Follow-up|6
836170|NCT00321737|1791897|FG000|Overall Study|Withdrawal by Subject|19
836171|NCT00321737|1791898|FG001|Overall Study|Withdrawal by Subject|12
836172|NCT00321737|1791899|FG002|Overall Study|Withdrawal by Subject|17
836173|NCT00321737|1791897|FG000|Overall Study|Protocol Violation|0
836174|NCT00321737|1791898|FG001|Overall Study|Protocol Violation|0
836175|NCT00321737|1791899|FG002|Overall Study|Protocol Violation|1
836176|NCT00321737|1791897|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1
836177|NCT00321737|1791898|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0
836178|NCT00321737|1791899|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0
836179|NCT00321737|1791897|FG000|Overall Study|Possible Barrett's Esophagus|2
836180|NCT00321737|1791898|FG001|Overall Study|Possible Barrett's Esophagus|1
836181|NCT00321737|1791899|FG002|Overall Study|Possible Barrett's Esophagus|1
836182|NCT00321737|1791897|FG000|Overall Study|Therapeutic Failure|6
836183|NCT00321737|1791898|FG001|Overall Study|Therapeutic Failure|0
836184|NCT00321737|1791899|FG002|Overall Study|Therapeutic Failure|2
836185|NCT00321737|1791897|FG000|Overall Study|Pregnancy|0
836186|NCT00321737|1791898|FG001|Overall Study|Pregnancy|2
836187|NCT00321737|1791899|FG002|Overall Study|Pregnancy|0
836188|NCT00321737|1791897|FG000|Overall Study|Noncompliance|2
836189|NCT00321737|1791898|FG001|Overall Study|Noncompliance|0
836190|NCT00321737|1791899|FG002|Overall Study|Noncompliance|0
836191|NCT00321737|1791897|FG000|Overall Study|Subject Request/ Subject Unavailable|0
836192|NCT00321737|1791898|FG001|Overall Study|Subject Request/ Subject Unavailable|0
836193|NCT00321737|1791899|FG002|Overall Study|Subject Request/ Subject Unavailable|2
836194|NCT00321763|1791911|FG000|Overall Study|Adverse Event|1
836195|NCT00321763|1791912|FG001|Overall Study|Adverse Event|1
836196|NCT00321763|1791913|FG002|Overall Study|Adverse Event|0
836197|NCT00321763|1791914|FG003|Overall Study|Adverse Event|1
836198|NCT00321763|1791911|FG000|Overall Study|Withdrawal by Subject|2
836199|NCT00321763|1791912|FG001|Overall Study|Withdrawal by Subject|0
836200|NCT00321763|1791913|FG002|Overall Study|Withdrawal by Subject|1
836201|NCT00321763|1791914|FG003|Overall Study|Withdrawal by Subject|0
836202|NCT00321763|1791911|FG000|Overall Study|Lost to Follow-up|3
836203|NCT00321763|1791912|FG001|Overall Study|Lost to Follow-up|1
836204|NCT00321763|1791913|FG002|Overall Study|Lost to Follow-up|5
836205|NCT00321763|1791914|FG003|Overall Study|Lost to Follow-up|4
836206|NCT00321789|1791928|FG000|Overall Study|Lost to Follow-up|4
836207|NCT00321789|1791929|FG001|Overall Study|Lost to Follow-up|7
836208|NCT00321789|1791928|FG000|Overall Study|Withdrawal by Subject|6
836209|NCT00321789|1791929|FG001|Overall Study|Withdrawal by Subject|6
836210|NCT00321789|1791928|FG000|Overall Study|Protocol Violation|5
836211|NCT00321789|1791929|FG001|Overall Study|Protocol Violation|3
836212|NCT00321828|1791935|FG000|Overall Study|Ineligible|3
836213|NCT00321828|1791935|FG000|Overall Study|No follow up data|1
836214|NCT00321854|1791941|FG000|Overall Study|Adverse Event|41
836215|NCT00321854|1791942|FG001|Overall Study|Adverse Event|43
836216|NCT00321854|1791941|FG000|Overall Study|Lack of Efficacy|9
836217|NCT00321854|1791942|FG001|Overall Study|Lack of Efficacy|14
836218|NCT00321854|1791941|FG000|Overall Study|Protocol Violation|6
836219|NCT00321854|1791942|FG001|Overall Study|Protocol Violation|5
836220|NCT00321854|1791941|FG000|Overall Study|Lost to Follow-up|0
836221|NCT00321854|1791942|FG001|Overall Study|Lost to Follow-up|2
836222|NCT00321854|1791941|FG000|Overall Study|Withdrawal by Subject|6
836223|NCT00321854|1791942|FG001|Overall Study|Withdrawal by Subject|17
836224|NCT00321854|1791941|FG000|Overall Study|Other|1
836225|NCT00321854|1791942|FG001|Overall Study|Other|1
836226|NCT00321893|1791952|FG000|Overall Study|Non-Compliance/Refusal|16
836227|NCT00321893|1791953|FG001|Overall Study|Non-Compliance/Refusal|10
836228|NCT00321893|1791952|FG000|Overall Study|Lost to Follow-up|2
836229|NCT00321893|1791953|FG001|Overall Study|Lost to Follow-up|1
836230|NCT00321893|1791952|FG000|Overall Study|Adverse Event|6
836231|NCT00321893|1791953|FG001|Overall Study|Adverse Event|3
836232|NCT00321906|1791961|FG000|Overall Study|Adverse Event|36
836233|NCT00321906|1791962|FG001|Overall Study|Adverse Event|44
836234|NCT00321906|1791961|FG000|Overall Study|Death|9
836235|NCT00321906|1791962|FG001|Overall Study|Death|6
836236|NCT00321906|1791961|FG000|Overall Study|Lost to Follow-up|1
836237|NCT00321906|1791962|FG001|Overall Study|Lost to Follow-up|2
836238|NCT00321906|1791961|FG000|Overall Study|Withdrawal by Subject|0
836239|NCT00321906|1791962|FG001|Overall Study|Withdrawal by Subject|4
836240|NCT00321919|1791970|FG000|Overall Study|Adverse Event|17
836241|NCT00321919|1791971|FG001|Overall Study|Adverse Event|10
836242|NCT00321919|1791970|FG000|Overall Study|Death|21
836243|NCT00321919|1791971|FG001|Overall Study|Death|17
836244|NCT00321919|1791970|FG000|Overall Study|Insufficient Therapeutic Response|1
836245|NCT00321919|1791971|FG001|Overall Study|Insufficient Therapeutic Response|0
836246|NCT00321919|1791970|FG000|Overall Study|Violation of Selection Criteria at Entry|1
836247|NCT00321919|1791971|FG001|Overall Study|Violation of Selection Criteria at Entry|1
836248|NCT00321919|1791970|FG000|Overall Study|Refused Treatment|23
836249|NCT00321919|1791971|FG001|Overall Study|Refused Treatment|14
836250|NCT00321919|1791970|FG000|Overall Study|Other Protocol Violation|2
836251|NCT00321919|1791971|FG001|Overall Study|Other Protocol Violation|3
836252|NCT00321919|1791970|FG000|Overall Study|Failure to Return|3
836253|NCT00321919|1791971|FG001|Overall Study|Failure to Return|1
836254|NCT00321919|1791970|FG000|Overall Study|Other withdrawal reason|7
836255|NCT00321919|1791971|FG001|Overall Study|Other withdrawal reason|6
836256|NCT00321932|1791980|FG000|Overall Study|Death|3
836257|NCT00321932|1791981|FG001|Overall Study|Death|6
836258|NCT00321932|1791980|FG000|Overall Study|Withdrawal by Subject|3
836259|NCT00321932|1791981|FG001|Overall Study|Withdrawal by Subject|6
836260|NCT00321932|1791980|FG000|Overall Study|Early relapse|2
836261|NCT00321932|1791981|FG001|Overall Study|Early relapse|8
836262|NCT00321932|1791980|FG000|Overall Study|Missing data|2
836263|NCT00321932|1791981|FG001|Overall Study|Missing data|1
836264|NCT00321984|1792000|FG000|Overall Study|Adverse Event|9
836265|NCT00321984|1792001|FG001|Overall Study|Adverse Event|6
836266|NCT00321984|1792002|FG002|Overall Study|Adverse Event|8
836267|NCT00321984|1792000|FG000|Overall Study|Protocol Violation|0
836268|NCT00321984|1792001|FG001|Overall Study|Protocol Violation|1
836269|NCT00321984|1792002|FG002|Overall Study|Protocol Violation|1
836270|NCT00321984|1792000|FG000|Overall Study|Lost to Follow-up|2
836271|NCT00321984|1792001|FG001|Overall Study|Lost to Follow-up|4
836272|NCT00321984|1792002|FG002|Overall Study|Lost to Follow-up|2
836273|NCT00321984|1792000|FG000|Overall Study|Withdrawal by Subject|8
836274|NCT00321984|1792001|FG001|Overall Study|Withdrawal by Subject|6
836275|NCT00321984|1792002|FG002|Overall Study|Withdrawal by Subject|5
836276|NCT00321984|1792000|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3
836277|NCT00321984|1792001|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1
836278|NCT00321984|1792002|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
836279|NCT00321984|1792000|FG000|Overall Study|Lack of Efficacy|3
836280|NCT00321984|1792001|FG001|Overall Study|Lack of Efficacy|1
836281|NCT00321984|1792002|FG002|Overall Study|Lack of Efficacy|3
836282|NCT00321984|1792000|FG000|Overall Study|Noncompliant|0
836283|NCT00321984|1792001|FG001|Overall Study|Noncompliant|0
836284|NCT00321984|1792002|FG002|Overall Study|Noncompliant|2
836285|NCT00321984|1792000|FG000|Overall Study|Pregnancy|0
836286|NCT00321984|1792001|FG001|Overall Study|Pregnancy|1
836287|NCT00321984|1792002|FG002|Overall Study|Pregnancy|0
836288|NCT00321984|1792000|FG000|Overall Study|Per Subject Request|1
836289|NCT00321984|1792001|FG001|Overall Study|Per Subject Request|0
836290|NCT00321984|1792002|FG002|Overall Study|Per Subject Request|0
836291|NCT00321984|1792000|FG000|Overall Study|Per Investigator Request|1
836292|NCT00321984|1792001|FG001|Overall Study|Per Investigator Request|0
836293|NCT00321984|1792002|FG002|Overall Study|Per Investigator Request|0
836294|NCT00321984|1792000|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
836295|NCT00321984|1792001|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
836296|NCT00321984|1792002|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
836297|NCT00322023|1792013|FG000|Overall Study|various|0
836298|NCT00322023|1792014|FG001|Overall Study|various|2
836299|NCT00322023|1792015|FG002|Overall Study|various|6
836300|NCT00322049|1792027|FG000|Overall Study|Moved out of area|0
836301|NCT00322049|1792028|FG001|Overall Study|Moved out of area|0
836302|NCT00322049|1792029|FG002|Overall Study|Moved out of area|0
836303|NCT00322049|1792030|FG003|Overall Study|Moved out of area|1
836304|NCT00322049|1792027|FG000|Overall Study|Infected with Dengue during study|0
836305|NCT00322049|1792028|FG001|Overall Study|Infected with Dengue during study|1
836306|NCT00322049|1792029|FG002|Overall Study|Infected with Dengue during study|0
836307|NCT00322049|1792030|FG003|Overall Study|Infected with Dengue during study|0
836308|NCT00322153|1792060|FG000|Overall Study|Adverse Event|21
836309|NCT00322153|1792061|FG001|Overall Study|Adverse Event|34
836310|NCT00322153|1792060|FG000|Overall Study|Protocol Violation|6
836311|NCT00322153|1792061|FG001|Overall Study|Protocol Violation|14
836312|NCT00322153|1792060|FG000|Overall Study|Withdrawal by Subject|18
836313|NCT00322153|1792061|FG001|Overall Study|Withdrawal by Subject|10
836314|NCT00322153|1792060|FG000|Overall Study|Lack of Efficacy|8
836315|NCT00322153|1792061|FG001|Overall Study|Lack of Efficacy|3
836316|NCT00322153|1792060|FG000|Overall Study|Lost to Follow-up|5
836317|NCT00322153|1792061|FG001|Overall Study|Lost to Follow-up|4
836318|NCT00322153|1792060|FG000|Overall Study|Withdrawn for other reasons|5
836319|NCT00322153|1792061|FG001|Overall Study|Withdrawn for other reasons|4
836320|NCT00322348|1792107|FG000|Overall Study|Adverse Event|0
836321|NCT00322348|1792108|FG001|Overall Study|Adverse Event|1
836322|NCT00322348|1792107|FG000|Overall Study|Withdrawal by Subject|1
836323|NCT00322348|1792108|FG001|Overall Study|Withdrawal by Subject|4
836324|NCT00322348|1792107|FG000|Overall Study|Lost to Follow-up|1
836325|NCT00322348|1792108|FG001|Overall Study|Lost to Follow-up|0
836326|NCT00322348|1792107|FG000|Overall Study|Death|0
836327|NCT00322348|1792108|FG001|Overall Study|Death|2
836328|NCT00322348|1792107|FG000|Overall Study|Disease Progression|30
836329|NCT00322348|1792108|FG001|Overall Study|Disease Progression|25
836330|NCT00322348|1792107|FG000|Overall Study|Reasons not specified|5
836331|NCT00322348|1792108|FG001|Overall Study|Reasons not specified|1
836332|NCT00322374|1792117|FG000|Starting Dose|Physician Decision|2
836333|NCT00322374|1792118|FG001|Starting Dose|Physician Decision|0
836334|NCT00322374|1792119|FG002|Starting Dose|Physician Decision|0
836335|NCT00322374|1792120|FG003|Starting Dose|Physician Decision|0
836336|NCT00322374|1792117|FG000|Starting Dose|Study Drug Toxicity|4
836337|NCT00322374|1792118|FG001|Starting Dose|Study Drug Toxicity|0
836338|NCT00322374|1792119|FG002|Starting Dose|Study Drug Toxicity|0
836339|NCT00322374|1792120|FG003|Starting Dose|Study Drug Toxicity|0
836340|NCT00322374|1792117|FG000|First Escalation|Documented Disease Progression|0
836341|NCT00322374|1792118|FG001|First Escalation|Documented Disease Progression|6
836342|NCT00322374|1792119|FG002|First Escalation|Documented Disease Progression|0
836343|NCT00322374|1792120|FG003|First Escalation|Documented Disease Progression|0
836344|NCT00322374|1792117|FG000|First Escalation|Physician Decision|0
836345|NCT00322374|1792118|FG001|First Escalation|Physician Decision|12
836346|NCT00322374|1792119|FG002|First Escalation|Physician Decision|0
836347|NCT00322374|1792120|FG003|First Escalation|Physician Decision|0
836348|NCT00322374|1792117|FG000|First Escalation|Study Drug Toxicity|0
836349|NCT00322374|1792118|FG001|First Escalation|Study Drug Toxicity|11
836350|NCT00322374|1792119|FG002|First Escalation|Study Drug Toxicity|0
836351|NCT00322374|1792120|FG003|First Escalation|Study Drug Toxicity|0
836352|NCT00322374|1792117|FG000|First Escalation|Participant Request|0
836353|NCT00322374|1792118|FG001|First Escalation|Participant Request|1
836354|NCT00322374|1792119|FG002|First Escalation|Participant Request|0
836355|NCT00322374|1792120|FG003|First Escalation|Participant Request|0
836356|NCT00322374|1792117|FG000|Second Escalation|Physician Decision|0
836357|NCT00322374|1792118|FG001|Second Escalation|Physician Decision|0
836358|NCT00322374|1792119|FG002|Second Escalation|Physician Decision|5
836359|NCT00322374|1792120|FG003|Second Escalation|Physician Decision|0
836360|NCT00322374|1792117|FG000|Second Escalation|Study Drug Toxicity|0
836361|NCT00322374|1792118|FG001|Second Escalation|Study Drug Toxicity|0
836362|NCT00322374|1792119|FG002|Second Escalation|Study Drug Toxicity|1
836363|NCT00322374|1792120|FG003|Second Escalation|Study Drug Toxicity|0
836364|NCT00322387|1792135|FG000|Treatment Period|Adverse Event|0
836365|NCT00322387|1792136|FG001|Treatment Period|Adverse Event|1
836366|NCT00322387|1792135|FG000|Follow-up Period|Final assessment not done|1
836367|NCT00322387|1792136|FG001|Follow-up Period|Final assessment not done|3
836368|NCT00322387|1792135|FG000|Follow-up Period|Death|1
836369|NCT00322387|1792136|FG001|Follow-up Period|Death|0
836370|NCT00322452|1792159|FG000|Overall Study|Eligibility criteria not fulfilled|0
836371|NCT00322452|1792160|FG001|Overall Study|Eligibility criteria not fulfilled|1
836372|NCT00322452|1792159|FG000|Overall Study|Lost to Follow-up|5
836373|NCT00322452|1792160|FG001|Overall Study|Lost to Follow-up|2
836374|NCT00322452|1792159|FG000|Overall Study|Withdrawal by Subject|19
836375|NCT00322452|1792160|FG001|Overall Study|Withdrawal by Subject|46
836376|NCT00322452|1792159|FG000|Overall Study|Death|223
836377|NCT00322452|1792160|FG001|Overall Study|Death|227
836378|NCT00322491|1792188|FG000|Overall Study|Adverse Event|1
836379|NCT00322491|1792189|FG001|Overall Study|Adverse Event|0
836380|NCT00322491|1792188|FG000|Overall Study|Death|1
836381|NCT00322491|1792189|FG001|Overall Study|Death|2
836382|NCT00322556|1792196|FG000|Overall Study|Adverse Event|1
836383|NCT00322556|1792196|FG000|Overall Study|Withdrawal by Subject|1
836384|NCT00322556|1792196|FG000|Overall Study|Lost to Follow-up|3
836385|NCT00322556|1792196|FG000|Overall Study|Other Reason|7
836386|NCT00322621|1792203|FG000|Period II - Acute Therapy Phase|Adverse Event|20
836387|NCT00322621|1792204|FG001|Period II - Acute Therapy Phase|Adverse Event|0
836388|NCT00322621|1792205|FG002|Period II - Acute Therapy Phase|Adverse Event|0
836389|NCT00322621|1792203|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1
836390|NCT00322621|1792204|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0
836391|NCT00322621|1792205|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0
836392|NCT00322621|1792203|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8
836393|NCT00322621|1792204|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0
836394|NCT00322621|1792205|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0
836395|NCT00322621|1792203|FG000|Period II - Acute Therapy Phase|Protocol Violation|2
836396|NCT00322621|1792204|FG001|Period II - Acute Therapy Phase|Protocol Violation|0
836397|NCT00322621|1792205|FG002|Period II - Acute Therapy Phase|Protocol Violation|0
836398|NCT00322621|1792203|FG000|Period II - Acute Therapy Phase|Physician Decision|1
836399|NCT00322621|1792204|FG001|Period II - Acute Therapy Phase|Physician Decision|0
836400|NCT00322621|1792205|FG002|Period II - Acute Therapy Phase|Physician Decision|0
836401|NCT00322621|1792203|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0
836402|NCT00322621|1792204|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14
836403|NCT00322621|1792205|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5
836404|NCT00322621|1792203|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
836405|NCT00322621|1792204|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
836406|NCT00322621|1792205|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
836407|NCT00322621|1792203|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
836408|NCT00322621|1792204|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
836409|NCT00322621|1792205|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
836410|NCT00322621|1792203|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0
836411|NCT00322621|1792204|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2
836412|NCT00322621|1792205|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5
836413|NCT00322621|1792203|FG000|Period III - Maintenance / Rescue Phase|Death|0
836414|NCT00322621|1792204|FG001|Period III - Maintenance / Rescue Phase|Death|1
836415|NCT00322621|1792205|FG002|Period III - Maintenance / Rescue Phase|Death|0
836416|NCT00322621|1792203|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
836417|NCT00322621|1792204|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
836418|NCT00322621|1792205|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
836419|NCT00322712|1792218|FG000|Overall Study|treated with bevacizumab not cetuximab|1
836420|NCT00322842|1792233|FG000|Overall Study|Withdrawal by Subject|0
836421|NCT00322842|1792234|FG001|Overall Study|Withdrawal by Subject|1
836422|NCT00322842|1792233|FG000|Overall Study|Lost to Follow-up|0
836423|NCT00322842|1792234|FG001|Overall Study|Lost to Follow-up|1
836424|NCT00322842|1792233|FG000|Overall Study|Refused transplant|1
836425|NCT00322842|1792234|FG001|Overall Study|Refused transplant|0
836426|NCT00322842|1792233|FG000|Overall Study|Death|1
836427|NCT00322842|1792234|FG001|Overall Study|Death|0
836428|NCT00322868|1792241|FG000|Overall Study|disease progression|1
836429|NCT00322881|1792246|FG000|Overall Study|Death|2
836430|NCT00322881|1792246|FG000|Overall Study|Adverse Event|1
836431|NCT00322881|1792246|FG000|Overall Study|Disease Progression|2
836432|NCT00323063|1792259|FG000|Overall Study|Adverse Event|1
836433|NCT00323063|1792260|FG001|Overall Study|Adverse Event|0
836434|NCT00323063|1792259|FG000|Overall Study|brain mets discovered prior to treatment|1
836435|NCT00323063|1792260|FG001|Overall Study|brain mets discovered prior to treatment|0
836436|NCT00323115|1792266|FG000|Vaccine Administration|Adverse Event|1
836437|NCT00323115|1792266|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8
836438|NCT00323258|1792286|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1
836439|NCT00323258|1792287|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2
836440|NCT00323258|1792286|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
836441|NCT00323258|1792287|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
836442|NCT00323258|1792286|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
836443|NCT00323258|1792287|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
836444|NCT00323258|1792286|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
836445|NCT00323258|1792287|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
836446|NCT00323258|1792286|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1
836447|NCT00323258|1792287|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2
836448|NCT00323258|1792286|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
836449|NCT00323258|1792287|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
836450|NCT00323258|1792286|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
836451|NCT00323258|1792287|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
836452|NCT00323297|1792313|FG000|Part A (Double Blind Randomized)|Reason unspecified|0
836453|NCT00323297|1792314|FG001|Part A (Double Blind Randomized)|Reason unspecified|1
836454|NCT00323297|1792313|FG000|Part A (Double Blind Randomized)|Death|0
836455|NCT00323297|1792314|FG001|Part A (Double Blind Randomized)|Death|1
836456|NCT00323297|1792313|FG000|Part A (Double Blind Randomized)|Protocol Violation|1
836457|NCT00323297|1792314|FG001|Part A (Double Blind Randomized)|Protocol Violation|3
836458|NCT00323297|1792313|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1
836459|NCT00323297|1792314|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0
836460|NCT00323297|1792313|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
836461|NCT00323297|1792314|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
836462|NCT00323297|1792313|FG000|Part A (Double Blind Randomized)|Related adverse event|2
836463|NCT00323297|1792314|FG001|Part A (Double Blind Randomized)|Related adverse event|2
836464|NCT00323297|1792313|FG000|Part B (Open-label)|Death|0
836465|NCT00323297|1792314|FG001|Part B (Open-label)|Death|1
836466|NCT00323297|1792313|FG000|Part B (Open-label)|Reason unspecified|0
836467|NCT00323297|1792314|FG001|Part B (Open-label)|Reason unspecified|1
836468|NCT00323297|1792313|FG000|Part B (Open-label)|Withdrawal by Subject|1
836469|NCT00323297|1792314|FG001|Part B (Open-label)|Withdrawal by Subject|3
836470|NCT00323297|1792313|FG000|Part B (Open-label)|Lack of Efficacy|3
836471|NCT00323297|1792314|FG001|Part B (Open-label)|Lack of Efficacy|1
836472|NCT00323297|1792313|FG000|Part B (Open-label)|Adverse Event|5
836473|NCT00323297|1792314|FG001|Part B (Open-label)|Adverse Event|5
836474|NCT00323297|1792313|FG000|Part B (Open-label)|Protocol Violation|0
836475|NCT00323297|1792314|FG001|Part B (Open-label)|Protocol Violation|1
836476|NCT00323310|1792320|FG000|Overall Study|Withdrawal by Subject|1
836477|NCT00323310|1792320|FG000|Overall Study|a parent refused blood draw|1
836478|NCT00323310|1792320|FG000|Overall Study|did not complete the 24-hr f-up visit|1
836479|NCT00323414|1792330|FG000|Overall Study|Withdrawal by Subject|0
836480|NCT00323414|1792331|FG001|Overall Study|Withdrawal by Subject|1
836481|NCT00323479|1792355|FG000|Overall Study|Adverse Event|2
836482|NCT00323479|1792355|FG000|Overall Study|Withdrawal by Subject|2
836483|NCT00323479|1792355|FG000|Overall Study|Protocol Violation|3
836484|NCT00323479|1792355|FG000|Overall Study|house moving|1
836485|NCT00323492|1792361|FG000|Study Phase 1|Adverse Event|2
836486|NCT00323492|1792362|FG001|Study Phase 1|Adverse Event|0
836487|NCT00323492|1792363|FG002|Study Phase 1|Adverse Event|0
836488|NCT00323492|1792361|FG000|Study Phase 2|Adverse Event|1
836489|NCT00323492|1792362|FG001|Study Phase 2|Adverse Event|0
836490|NCT00323492|1792363|FG002|Study Phase 2|Adverse Event|0
836491|NCT00323492|1792361|FG000|Study Phase 2|Physician Decision|1
836492|NCT00323492|1792362|FG001|Study Phase 2|Physician Decision|0
836493|NCT00323492|1792363|FG002|Study Phase 2|Physician Decision|0
836494|NCT00323492|1792361|FG000|Study Phase 2|Lost to Follow-up|1
836495|NCT00323492|1792362|FG001|Study Phase 2|Lost to Follow-up|0
836496|NCT00323492|1792363|FG002|Study Phase 2|Lost to Follow-up|0
836497|NCT00323492|1792361|FG000|Study Phase 2|Withdrawal by Subject|0
836498|NCT00323492|1792362|FG001|Study Phase 2|Withdrawal by Subject|1
836499|NCT00323492|1792363|FG002|Study Phase 2|Withdrawal by Subject|0
836500|NCT00323492|1792361|FG000|Study Phase 2|Noncompliance with study schedule|0
836501|NCT00323492|1792362|FG001|Study Phase 2|Noncompliance with study schedule|0
836502|NCT00323492|1792363|FG002|Study Phase 2|Noncompliance with study schedule|1
836503|NCT00323492|1792361|FG000|Study Phase 2|Protocol Violation|1
836504|NCT00323492|1792362|FG001|Study Phase 2|Protocol Violation|0
836505|NCT00323492|1792363|FG002|Study Phase 2|Protocol Violation|0
836506|NCT00323557|1792372|FG000|Overall Study|Physician Decision|1
836507|NCT00323557|1792373|FG001|Overall Study|Physician Decision|0
836508|NCT00323609|1792382|FG000|Overall Study|Death|16
836509|NCT00323609|1792383|FG001|Overall Study|Death|21
836510|NCT00323609|1792384|FG002|Overall Study|Death|0
836511|NCT00323609|1792385|FG003|Overall Study|Death|0
836512|NCT00323609|1792382|FG000|Overall Study|Lost to Follow-up|9
836513|NCT00323609|1792383|FG001|Overall Study|Lost to Follow-up|10
836514|NCT00323609|1792384|FG002|Overall Study|Lost to Follow-up|0
836515|NCT00323609|1792385|FG003|Overall Study|Lost to Follow-up|0
836516|NCT00323609|1792382|FG000|Overall Study|Physician Decision|2
836517|NCT00323609|1792383|FG001|Overall Study|Physician Decision|0
836518|NCT00323609|1792384|FG002|Overall Study|Physician Decision|0
836519|NCT00323609|1792385|FG003|Overall Study|Physician Decision|1
836520|NCT00323609|1792382|FG000|Overall Study|Withdrawal by Subject|11
836521|NCT00323609|1792383|FG001|Overall Study|Withdrawal by Subject|23
836522|NCT00323609|1792384|FG002|Overall Study|Withdrawal by Subject|4
836523|NCT00323609|1792385|FG003|Overall Study|Withdrawal by Subject|4
836524|NCT00323609|1792382|FG000|Overall Study|Other non-VCF-related medical condition|3
836525|NCT00323609|1792383|FG001|Overall Study|Other non-VCF-related medical condition|2
836526|NCT00323609|1792384|FG002|Overall Study|Other non-VCF-related medical condition|0
836527|NCT00323609|1792385|FG003|Overall Study|Other non-VCF-related medical condition|0
836528|NCT00323609|1792382|FG000|Overall Study|Sponsor discontinued trial|29
836529|NCT00323609|1792383|FG001|Overall Study|Sponsor discontinued trial|29
836530|NCT00323609|1792384|FG002|Overall Study|Sponsor discontinued trial|0
836531|NCT00323609|1792385|FG003|Overall Study|Sponsor discontinued trial|0
836532|NCT00323609|1792382|FG000|Overall Study|Unrelenting or severe back pain|1
836533|NCT00323609|1792383|FG001|Overall Study|Unrelenting or severe back pain|1
836534|NCT00323609|1792384|FG002|Overall Study|Unrelenting or severe back pain|0
836535|NCT00323609|1792385|FG003|Overall Study|Unrelenting or severe back pain|0
836536|NCT00323609|1792382|FG000|Overall Study|Logistical withdrawal|9
836537|NCT00323609|1792383|FG001|Overall Study|Logistical withdrawal|5
836538|NCT00323609|1792384|FG002|Overall Study|Logistical withdrawal|0
836539|NCT00323609|1792385|FG003|Overall Study|Logistical withdrawal|1
836540|NCT00323609|1792382|FG000|Overall Study|Other reason|11
836541|NCT00323609|1792383|FG001|Overall Study|Other reason|8
836542|NCT00323609|1792384|FG002|Overall Study|Other reason|4
836543|NCT00323609|1792385|FG003|Overall Study|Other reason|9
836544|NCT00323622|1792399|FG000|Overall Study|Other|30
836545|NCT00323622|1792400|FG001|Overall Study|Other|91
836546|NCT00323622|1792401|FG002|Overall Study|Other|4
836547|NCT00323622|1792402|FG003|Overall Study|Other|12
836548|NCT00323622|1792403|FG004|Overall Study|Other|32
836549|NCT00323622|1792404|FG005|Overall Study|Other|74
836550|NCT00323622|1792405|FG006|Overall Study|Other|5
836551|NCT00323622|1792406|FG007|Overall Study|Other|13
836552|NCT00323622|1792399|FG000|Overall Study|Death|1
836553|NCT00323622|1792400|FG001|Overall Study|Death|1
836554|NCT00323622|1792401|FG002|Overall Study|Death|0
836555|NCT00323622|1792402|FG003|Overall Study|Death|0
836556|NCT00323622|1792403|FG004|Overall Study|Death|7
836557|NCT00323622|1792404|FG005|Overall Study|Death|0
836558|NCT00323622|1792405|FG006|Overall Study|Death|0
836559|NCT00323622|1792406|FG007|Overall Study|Death|2
836560|NCT00323869|1792436|FG000|Overall Study|Death|1
836561|NCT00323882|1792445|FG000|Overall Study|Adverse Event|2
836562|NCT00323882|1792446|FG001|Overall Study|Adverse Event|1
836563|NCT00323882|1792447|FG002|Overall Study|Adverse Event|1
836564|NCT00323882|1792448|FG003|Overall Study|Adverse Event|1
836565|NCT00323882|1792449|FG004|Overall Study|Adverse Event|3
836566|NCT00323882|1792445|FG000|Overall Study|Disease Progression|6
836567|NCT00323882|1792446|FG001|Overall Study|Disease Progression|4
836568|NCT00323882|1792447|FG002|Overall Study|Disease Progression|10
836569|NCT00323882|1792448|FG003|Overall Study|Disease Progression|5
836570|NCT00323882|1792449|FG004|Overall Study|Disease Progression|22
836571|NCT00323882|1792445|FG000|Overall Study|Death|0
836572|NCT00323882|1792446|FG001|Overall Study|Death|1
836573|NCT00323882|1792447|FG002|Overall Study|Death|1
836574|NCT00323882|1792448|FG003|Overall Study|Death|0
836575|NCT00323882|1792449|FG004|Overall Study|Death|5
836576|NCT00323882|1792445|FG000|Overall Study|Lost to Follow-up|0
836577|NCT00323882|1792446|FG001|Overall Study|Lost to Follow-up|0
836578|NCT00323882|1792447|FG002|Overall Study|Lost to Follow-up|1
836579|NCT00323882|1792448|FG003|Overall Study|Lost to Follow-up|0
836580|NCT00323882|1792449|FG004|Overall Study|Lost to Follow-up|1
836581|NCT00323882|1792445|FG000|Overall Study|Other|0
836582|NCT00323882|1792446|FG001|Overall Study|Other|0
836583|NCT00323882|1792447|FG002|Overall Study|Other|0
836584|NCT00323882|1792448|FG003|Overall Study|Other|1
836585|NCT00323882|1792449|FG004|Overall Study|Other|1
836586|NCT00324038|1792488|FG000|Overall Study|Adverse Event|38
836587|NCT00324038|1792489|FG001|Overall Study|Adverse Event|23
836588|NCT00324038|1792488|FG000|Overall Study|Lack of Efficacy|5
836589|NCT00324038|1792489|FG001|Overall Study|Lack of Efficacy|13
836590|NCT00324038|1792488|FG000|Overall Study|Lost to Follow-up|0
836591|NCT00324038|1792489|FG001|Overall Study|Lost to Follow-up|2
836592|NCT00324038|1792488|FG000|Overall Study|Other|6
836593|NCT00324038|1792489|FG001|Overall Study|Other|13
836594|NCT00324116|1792495|FG000|Overall Study|Adverse Event|5
836595|NCT00324116|1792495|FG000|Overall Study|Lack of Efficacy|17
836596|NCT00324116|1792495|FG000|Overall Study|Withdrawal by Subject|5
836597|NCT00324116|1792495|FG000|Overall Study|Other|5
836598|NCT00324155|1792501|FG000|Enrolled and Randomized|No longer met study criteria|3
836599|NCT00324155|1792502|FG001|Enrolled and Randomized|No longer met study criteria|0
836600|NCT00324155|1792501|FG000|Enrolled and Randomized|Lost to Follow-up|0
836601|NCT00324155|1792502|FG001|Enrolled and Randomized|Lost to Follow-up|1
836602|NCT00324155|1792501|FG000|Received Treatment in Induction Phase|Disease Progression|88
836603|NCT00324155|1792502|FG001|Received Treatment in Induction Phase|Disease Progression|152
836604|NCT00324155|1792501|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83
836605|NCT00324155|1792502|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10
836606|NCT00324155|1792501|FG000|Received Treatment in Induction Phase|Death|8
836607|NCT00324155|1792502|FG001|Received Treatment in Induction Phase|Death|15
836608|NCT00324155|1792501|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
836609|NCT00324155|1792502|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
836610|NCT00324155|1792501|FG000|Received Treatment in Induction Phase|Adverse Event|6
836611|NCT00324155|1792502|FG001|Received Treatment in Induction Phase|Adverse Event|7
836612|NCT00324155|1792501|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6
836613|NCT00324155|1792502|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5
836614|NCT00324155|1792501|FG000|Received Treatment in Induction Phase|Physician Decision|2
836615|NCT00324155|1792502|FG001|Received Treatment in Induction Phase|Physician Decision|0
836616|NCT00324155|1792501|FG000|Received Treatment in Maintenance Phase|Disease Progression|26
836617|NCT00324155|1792502|FG001|Received Treatment in Maintenance Phase|Disease Progression|41
836618|NCT00324155|1792501|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
836619|NCT00324155|1792502|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
836620|NCT00324155|1792501|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
836621|NCT00324155|1792502|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
836622|NCT00324155|1792501|FG000|Received Treatment in Maintenance Phase|Adverse Event|0
836623|NCT00324155|1792502|FG001|Received Treatment in Maintenance Phase|Adverse Event|3
836624|NCT00324155|1792501|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
836625|NCT00324155|1792502|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
836626|NCT00324155|1792501|FG000|Follow-up Phase|On-going participants still on drug|11
836627|NCT00324155|1792502|FG001|Follow-up Phase|On-going participants still on drug|6
836628|NCT00324168|1792523|FG000|Overall Study|Lost to Follow-up|19
836629|NCT00324168|1792524|FG001|Overall Study|Lost to Follow-up|18
836630|NCT00324168|1792523|FG000|Overall Study|Death|3
836631|NCT00324168|1792524|FG001|Overall Study|Death|3
836632|NCT00324168|1792523|FG000|Overall Study|Patient did not visit in f/u window|6
836633|NCT00324168|1792524|FG001|Overall Study|Patient did not visit in f/u window|9
836634|NCT00324233|1792532|FG000|First Period|unable to insert catheter|1
836635|NCT00324233|1792533|FG001|First Period|unable to insert catheter|0
836636|NCT00324233|1792532|FG000|Second Period|unable to insert catheter|1
836637|NCT00324233|1792533|FG001|Second Period|unable to insert catheter|1
836638|NCT00324233|1792532|FG000|Second Period|Protocol Violation|4
836639|NCT00324233|1792533|FG001|Second Period|Protocol Violation|6
836640|NCT00324649|1792583|FG000|Overall Study|Adverse Event|1
836641|NCT00324649|1792584|FG001|Overall Study|Adverse Event|4
836642|NCT00324649|1792583|FG000|Overall Study|Withdrawal by Subject|0
836643|NCT00324649|1792584|FG001|Overall Study|Withdrawal by Subject|1
836644|NCT00324649|1792583|FG000|Overall Study|Noncompliance|1
836645|NCT00324649|1792584|FG001|Overall Study|Noncompliance|0
836646|NCT00324675|1792592|FG000|Overall Study|Adverse Event|1
836647|NCT00324675|1792593|FG001|Overall Study|Adverse Event|0
836648|NCT00324740|1792608|FG000|Overall Study|Withdrawal by Subject|1
836649|NCT00324740|1792609|FG001|Overall Study|Withdrawal by Subject|0
836650|NCT00324740|1792610|FG002|Overall Study|Withdrawal by Subject|1
836651|NCT00324805|1792630|FG000|Overall Study|Adverse Event|62
836652|NCT00324805|1792631|FG001|Overall Study|Adverse Event|203
836653|NCT00324805|1792630|FG000|Overall Study|Progression|7
836654|NCT00324805|1792631|FG001|Overall Study|Progression|35
836655|NCT00324805|1792630|FG000|Overall Study|Withdrawal by Subject|51
836656|NCT00324805|1792631|FG001|Overall Study|Withdrawal by Subject|174
836657|NCT00324805|1792630|FG000|Overall Study|Death|6
836658|NCT00324805|1792631|FG001|Overall Study|Death|9
836659|NCT00324805|1792630|FG000|Overall Study|Alternative therapy|4
836660|NCT00324805|1792631|FG001|Overall Study|Alternative therapy|8
836661|NCT00324805|1792630|FG000|Overall Study|Other complicating disease|1
836662|NCT00324805|1792631|FG001|Overall Study|Other complicating disease|9
836663|NCT00324805|1792630|FG000|Overall Study|Other reasons|7
836664|NCT00324805|1792631|FG001|Overall Study|Other reasons|26
836665|NCT00324805|1792630|FG000|Overall Study|Other|0
836666|NCT00324805|1792631|FG001|Overall Study|Other|2
836667|NCT00324805|1792630|FG000|Overall Study|Did not start therapy|12
836668|NCT00324805|1792631|FG001|Overall Study|Did not start therapy|17
836669|NCT00324961|1792671|FG000|Overall Study|Adverse Event|5
836670|NCT00324961|1792671|FG000|Overall Study|Consent Withdrawn|11
836671|NCT00324961|1792671|FG000|Overall Study|Lost to Follow-up|22
836672|NCT00324961|1792671|FG000|Overall Study|Protocol Violation|3
836673|NCT00324961|1792671|FG000|Overall Study|Other|2
836674|NCT00324987|1792679|FG000|Overall Study|Adverse Event|2
836675|NCT00324987|1792680|FG001|Overall Study|Adverse Event|1
836676|NCT00324987|1792679|FG000|Overall Study|Withdrawal by Subject|1
836677|NCT00324987|1792680|FG001|Overall Study|Withdrawal by Subject|1
836678|NCT00324987|1792679|FG000|Overall Study|Progression|1
836679|NCT00324987|1792680|FG001|Overall Study|Progression|1
836680|NCT00324987|1792679|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2
836681|NCT00324987|1792680|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3
836682|NCT00325039|1792688|FG000|Overall Study|Lost to Follow-up|18
836683|NCT00325039|1792689|FG001|Overall Study|Lost to Follow-up|14
836684|NCT00325130|1792711|FG000|Overall Study|Lost to Follow-up|6
836685|NCT00325130|1792712|FG001|Overall Study|Lost to Follow-up|14
836686|NCT00325130|1792711|FG000|Overall Study|Withdrawal by Subject|12
836687|NCT00325130|1792712|FG001|Overall Study|Withdrawal by Subject|14
836688|NCT00325130|1792711|FG000|Overall Study|Protocol Deviation|0
836689|NCT00325130|1792712|FG001|Overall Study|Protocol Deviation|1
836690|NCT00325130|1792711|FG000|Overall Study|Moved|0
836691|NCT00325130|1792712|FG001|Overall Study|Moved|1
836692|NCT00325130|1792711|FG000|Overall Study|Patient Discontinued for Other|1
836693|NCT00325130|1792712|FG001|Overall Study|Patient Discontinued for Other|0
836694|NCT00325143|1792718|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13
836695|NCT00325143|1792718|FG000|Overall Study|Migrated/moved from study area|1
836696|NCT00325143|1792718|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4
836697|NCT00325143|1792718|FG000|Overall Study|Withdrawal by Subject|8
836698|NCT00325156|1792722|FG000|Overall Study|Protocol Violation|8
836699|NCT00325156|1792722|FG000|Overall Study|Lost to follow-up (complete vaccination)|41
836700|NCT00325156|1792722|FG000|Overall Study|Migrated/moved from study area|12
836701|NCT00325156|1792722|FG000|Overall Study|Adverse event, non-fatal|3
836702|NCT00325156|1792722|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16
836703|NCT00325156|1792722|FG000|Overall Study|Other|1
836704|NCT00325156|1792722|FG000|Overall Study|Withdrawal by Subject|31
836705|NCT00325195|1792729|FG000|Randomized|Not dosed|5
836706|NCT00325195|1792730|FG001|Randomized|Not dosed|5
836707|NCT00325195|1792731|FG002|Randomized|Not dosed|3
836708|NCT00325195|1792729|FG000|Received Intervention: ITT Population|Adverse Event|15
836709|NCT00325195|1792730|FG001|Received Intervention: ITT Population|Adverse Event|17
836710|NCT00325195|1792731|FG002|Received Intervention: ITT Population|Adverse Event|1
836711|NCT00325195|1792729|FG000|Received Intervention: ITT Population|Death|3
836712|NCT00325195|1792730|FG001|Received Intervention: ITT Population|Death|1
836713|NCT00325195|1792731|FG002|Received Intervention: ITT Population|Death|0
836714|NCT00325195|1792729|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7
836715|NCT00325195|1792730|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6
836716|NCT00325195|1792731|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1
836717|NCT00325195|1792729|FG000|Received Intervention: ITT Population|Lost to Follow-up|0
836718|NCT00325195|1792730|FG001|Received Intervention: ITT Population|Lost to Follow-up|0
836719|NCT00325195|1792731|FG002|Received Intervention: ITT Population|Lost to Follow-up|2
836720|NCT00325195|1792729|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1
836721|NCT00325195|1792730|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1
836722|NCT00325195|1792731|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0
836723|NCT00325234|1792741|FG000|Overall Study|Adverse Event|10
836724|NCT00325234|1792742|FG001|Overall Study|Adverse Event|7
836725|NCT00325234|1792741|FG000|Overall Study|Death due to Study Disease|1
836726|NCT00325234|1792742|FG001|Overall Study|Death due to Study Disease|0
836727|NCT00325234|1792741|FG000|Overall Study|Entry Criteria Not Met|1
836728|NCT00325234|1792742|FG001|Overall Study|Entry Criteria Not Met|2
836729|NCT00325234|1792741|FG000|Overall Study|Subject Decision|6
836730|NCT00325234|1792742|FG001|Overall Study|Subject Decision|8
836731|NCT00325234|1792741|FG000|Overall Study|Physician Decision|17
836732|NCT00325234|1792742|FG001|Overall Study|Physician Decision|12
836733|NCT00325234|1792741|FG000|Overall Study|Progressive Disease|34
836734|NCT00325234|1792742|FG001|Overall Study|Progressive Disease|37
836735|NCT00325416|1792763|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8
836736|NCT00325416|1792764|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9
836737|NCT00325416|1792763|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7
836738|NCT00325416|1792764|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4
836739|NCT00325416|1792763|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7
836740|NCT00325416|1792764|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2
836741|NCT00325416|1792763|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
836742|NCT00325416|1792764|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
836743|NCT00325416|1792763|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0
836744|NCT00325416|1792764|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1
836745|NCT00325416|1792763|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0
836746|NCT00325416|1792764|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1
836747|NCT00325468|1792787|FG000|Overall Study|Adverse Event|1
836748|NCT00325468|1792788|FG001|Overall Study|Adverse Event|1
836749|NCT00325468|1792789|FG002|Overall Study|Adverse Event|0
836750|NCT00325468|1792790|FG003|Overall Study|Adverse Event|5
836751|NCT00325468|1792791|FG004|Overall Study|Adverse Event|1
836752|NCT00325468|1792787|FG000|Overall Study|Death|2
836753|NCT00325468|1792788|FG001|Overall Study|Death|0
836754|NCT00325468|1792789|FG002|Overall Study|Death|2
836755|NCT00325468|1792790|FG003|Overall Study|Death|4
836756|NCT00325468|1792791|FG004|Overall Study|Death|0
836757|NCT00325468|1792787|FG000|Overall Study|Lost to Follow-up|0
836758|NCT00325468|1792788|FG001|Overall Study|Lost to Follow-up|0
836759|NCT00325468|1792789|FG002|Overall Study|Lost to Follow-up|1
836760|NCT00325468|1792790|FG003|Overall Study|Lost to Follow-up|2
836761|NCT00325468|1792791|FG004|Overall Study|Lost to Follow-up|2
836762|NCT00325468|1792787|FG000|Overall Study|Physician Decision|1
836763|NCT00325468|1792788|FG001|Overall Study|Physician Decision|1
836764|NCT00325468|1792789|FG002|Overall Study|Physician Decision|0
836765|NCT00325468|1792790|FG003|Overall Study|Physician Decision|1
836766|NCT00325468|1792791|FG004|Overall Study|Physician Decision|0
836767|NCT00325468|1792787|FG000|Overall Study|Withdrawal by Subject|3
836768|NCT00325468|1792788|FG001|Overall Study|Withdrawal by Subject|1
836769|NCT00325468|1792789|FG002|Overall Study|Withdrawal by Subject|0
836770|NCT00325468|1792790|FG003|Overall Study|Withdrawal by Subject|14
836771|NCT00325468|1792791|FG004|Overall Study|Withdrawal by Subject|4
836772|NCT00325468|1792787|FG000|Overall Study|site closure etc|4
836773|NCT00325468|1792788|FG001|Overall Study|site closure etc|2
836774|NCT00325468|1792789|FG002|Overall Study|site closure etc|1
836775|NCT00325468|1792790|FG003|Overall Study|site closure etc|8
836776|NCT00325468|1792791|FG004|Overall Study|site closure etc|1
836777|NCT00325754|1792817|FG000|Overall Study|Adverse Event|4
836778|NCT00325754|1792818|FG001|Overall Study|Adverse Event|1
836779|NCT00325819|1792830|FG000|Overall Study|Study product lost in mail|2
836780|NCT00325819|1792831|FG001|Overall Study|Study product lost in mail|1
836781|NCT00325819|1792830|FG000|Overall Study|Did not take a dose of study product|4
836782|NCT00325819|1792831|FG001|Overall Study|Did not take a dose of study product|9
836783|NCT00325819|1792830|FG000|Overall Study|Lost to Follow-up|3
836784|NCT00325819|1792831|FG001|Overall Study|Lost to Follow-up|3
836785|NCT00325897|1792841|FG000|Overall Study|Lost to Follow-up|12
836786|NCT00325897|1792842|FG001|Overall Study|Lost to Follow-up|13
836787|NCT00326001|1792853|FG000|Overall Study|Adverse Event|4
836788|NCT00326001|1792854|FG001|Overall Study|Adverse Event|5
836789|NCT00326001|1792853|FG000|Overall Study|Physician Decision|3
836790|NCT00326001|1792854|FG001|Overall Study|Physician Decision|3
836791|NCT00326118|1792862|FG000|Active Phase|Withdrawal by Subject|4
836792|NCT00326118|1792863|FG001|Active Phase|Withdrawal by Subject|1
836793|NCT00326183|1792876|FG000|Overall Study|Lost to Follow-up|104
836794|NCT00326183|1792877|FG001|Overall Study|Lost to Follow-up|56
836795|NCT00326183|1792876|FG000|Overall Study|Protocol Violation|6
836796|NCT00326183|1792877|FG001|Overall Study|Protocol Violation|3
836797|NCT00326183|1792876|FG000|Overall Study|Withdrawal by Subject|35
836798|NCT00326183|1792877|FG001|Overall Study|Withdrawal by Subject|7
836799|NCT00326183|1792876|FG000|Overall Study|Subject Moved|7
836800|NCT00326183|1792877|FG001|Overall Study|Subject Moved|4
836801|NCT00326183|1792876|FG000|Overall Study|Other|47
836802|NCT00326183|1792877|FG001|Overall Study|Other|13
836803|NCT00326183|1792876|FG000|Overall Study|Adverse Event|1
836804|NCT00326183|1792877|FG001|Overall Study|Adverse Event|0
836805|NCT00326209|1792890|FG000|Overall Study|Adverse Event|28
836806|NCT00326209|1792890|FG000|Overall Study|Withdrawal by Subject|22
836807|NCT00326209|1792890|FG000|Overall Study|Lack of Efficacy|31
836808|NCT00326209|1792890|FG000|Overall Study|Lost to Follow-up|18
836809|NCT00326209|1792890|FG000|Overall Study|Participant non-compliant|6
836810|NCT00326209|1792890|FG000|Overall Study|Sponsor closed study|173
836811|NCT00326209|1792890|FG000|Overall Study|Prohibited medication use|1
836812|NCT00326209|1792890|FG000|Overall Study|Violation of entry criteria|1
836813|NCT00326209|1792890|FG000|Overall Study|Withdrawn in error|1
836814|NCT00326209|1792890|FG000|Overall Study|Pregnancy|1
836815|NCT00326417|1792896|FG000|Overall Study|Withdrawal by Subject|0
836816|NCT00326417|1792897|FG001|Overall Study|Withdrawal by Subject|0
836817|NCT00326417|1792898|FG002|Overall Study|Withdrawal by Subject|1
836818|NCT00326417|1792899|FG003|Overall Study|Withdrawal by Subject|0
836819|NCT00326417|1792896|FG000|Overall Study|Arm Closed|7
836820|NCT00326417|1792897|FG001|Overall Study|Arm Closed|0
836821|NCT00326417|1792898|FG002|Overall Study|Arm Closed|0
836822|NCT00326417|1792899|FG003|Overall Study|Arm Closed|3
836823|NCT00326417|1792896|FG000|Overall Study|Death|7
836824|NCT00326417|1792897|FG001|Overall Study|Death|0
836825|NCT00326417|1792898|FG002|Overall Study|Death|0
836826|NCT00326417|1792899|FG003|Overall Study|Death|0
836827|NCT00326495|1792907|FG000|Overall Study|Switched to alternative treatment|1
836828|NCT00326495|1792907|FG000|Overall Study|Disease progression before treatment|1
836829|NCT00326495|1792907|FG000|Overall Study|Refused further treatment|2
836830|NCT00326495|1792907|FG000|Overall Study|Subject off study before assessment|1
836831|NCT00326599|1792915|FG000|Overall Study|Withdrawal by Subject|1
836832|NCT00326599|1792916|FG001|Overall Study|Withdrawal by Subject|0
836833|NCT00326599|1792917|FG002|Overall Study|Withdrawal by Subject|5
836834|NCT00326599|1792918|FG003|Overall Study|Withdrawal by Subject|2
836835|NCT00326599|1792915|FG000|Overall Study|Adverse Event|1
836836|NCT00326599|1792916|FG001|Overall Study|Adverse Event|0
836837|NCT00326599|1792917|FG002|Overall Study|Adverse Event|32
836838|NCT00326599|1792918|FG003|Overall Study|Adverse Event|3
836839|NCT00326599|1792915|FG000|Overall Study|Disease Progression|3
836840|NCT00326599|1792916|FG001|Overall Study|Disease Progression|1
836841|NCT00326599|1792917|FG002|Overall Study|Disease Progression|13
836842|NCT00326599|1792918|FG003|Overall Study|Disease Progression|11
836843|NCT00326599|1792915|FG000|Overall Study|Alternate Treatment|1
836844|NCT00326599|1792916|FG001|Overall Study|Alternate Treatment|0
836845|NCT00326599|1792917|FG002|Overall Study|Alternate Treatment|0
836846|NCT00326599|1792918|FG003|Overall Study|Alternate Treatment|0
836847|NCT00326599|1792915|FG000|Overall Study|Death|0
836848|NCT00326599|1792916|FG001|Overall Study|Death|0
836849|NCT00326599|1792917|FG002|Overall Study|Death|1
836850|NCT00326599|1792918|FG003|Overall Study|Death|2
836851|NCT00326599|1792915|FG000|Overall Study|Other Unspecified Reason|0
836852|NCT00326599|1792916|FG001|Overall Study|Other Unspecified Reason|0
836853|NCT00326599|1792917|FG002|Overall Study|Other Unspecified Reason|2
836854|NCT00326599|1792918|FG003|Overall Study|Other Unspecified Reason|1
836855|NCT00326612|1792929|FG000|Overall Study|They did not have a seizure requiring tx|129
836856|NCT00326612|1792930|FG001|Overall Study|They did not have a seizure requiring tx|137
836857|NCT00326625|1792942|FG000|Overall Study|Adverse Event|20
836858|NCT00326625|1792943|FG001|Overall Study|Adverse Event|9
836859|NCT00326625|1792942|FG000|Overall Study|Withdrawal by Subject|15
836860|NCT00326625|1792943|FG001|Overall Study|Withdrawal by Subject|12
836861|NCT00326625|1792942|FG000|Overall Study|Death|18
836862|NCT00326625|1792943|FG001|Overall Study|Death|16
836863|NCT00326625|1792942|FG000|Overall Study|Lost to Follow-up|1
836864|NCT00326625|1792943|FG001|Overall Study|Lost to Follow-up|0
836865|NCT00326625|1792942|FG000|Overall Study|prescheduled medical intervention|0
836866|NCT00326625|1792943|FG001|Overall Study|prescheduled medical intervention|1
836867|NCT00326716|1792951|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
836868|NCT00326716|1792952|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
836869|NCT00326716|1792953|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
836870|NCT00326716|1792954|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
836871|NCT00326885|1792997|FG000|Overall Study|Adverse Event|1
836872|NCT00326885|1792997|FG000|Overall Study|Withdrawal by Subject|3
836873|NCT00326885|1792997|FG000|Overall Study|Physician Decision|1
836874|NCT00326885|1792997|FG000|Overall Study|Hospice withdrew consent|2
836875|NCT00326898|1793005|FG000|Overall Study|Disease progression|52
836876|NCT00326898|1793006|FG001|Overall Study|Disease progression|54
836877|NCT00326898|1793007|FG002|Overall Study|Disease progression|102
836878|NCT00326898|1793005|FG000|Overall Study|Adverse Event|124
836879|NCT00326898|1793006|FG001|Overall Study|Adverse Event|128
836880|NCT00326898|1793007|FG002|Overall Study|Adverse Event|33
836881|NCT00326898|1793005|FG000|Overall Study|Death|2
836882|NCT00326898|1793006|FG001|Overall Study|Death|0
836883|NCT00326898|1793007|FG002|Overall Study|Death|0
836884|NCT00326898|1793005|FG000|Overall Study|Withdrawal by Subject|134
836885|NCT00326898|1793006|FG001|Overall Study|Withdrawal by Subject|128
836886|NCT00326898|1793007|FG002|Overall Study|Withdrawal by Subject|32
836887|NCT00326898|1793005|FG000|Overall Study|Alternative therapy|1
836888|NCT00326898|1793006|FG001|Overall Study|Alternative therapy|0
836889|NCT00326898|1793007|FG002|Overall Study|Alternative therapy|0
836890|NCT00326898|1793005|FG000|Overall Study|Other complicating disease|5
836891|NCT00326898|1793006|FG001|Overall Study|Other complicating disease|5
836892|NCT00326898|1793007|FG002|Overall Study|Other complicating disease|4
836893|NCT00326898|1793005|FG000|Overall Study|Other/Missing/Unknown|33
836894|NCT00326898|1793006|FG001|Overall Study|Other/Missing/Unknown|28
836895|NCT00326898|1793007|FG002|Overall Study|Other/Missing/Unknown|32
836896|NCT00326911|1793017|FG000|Overall Study|Hospitalization prior to treatment|0
836897|NCT00326911|1793018|FG001|Overall Study|Hospitalization prior to treatment|1
836898|NCT00326911|1793017|FG000|Overall Study|Physician decision prior to treatment|1
836899|NCT00326911|1793018|FG001|Overall Study|Physician decision prior to treatment|0
836900|NCT00326911|1793017|FG000|Overall Study|Withdrawal by subject prior to treatment|0
836901|NCT00326911|1793018|FG001|Overall Study|Withdrawal by subject prior to treatment|1
836902|NCT00326950|1793033|FG000|Overall Study|Progressive Disease|1
836903|NCT00326963|1793037|FG000|Overall Study|Adverse Event|2
836904|NCT00326963|1793037|FG000|Overall Study|Injection site reaction|1
836905|NCT00326963|1793037|FG000|Overall Study|Death|1
836906|NCT00326963|1793037|FG000|Overall Study|Failure to return|10
836907|NCT00326963|1793037|FG000|Overall Study|Withdrawal by Subject|10
836908|NCT00326963|1793037|FG000|Overall Study|Refused treatment / did not cooperate|5
836909|NCT00326963|1793037|FG000|Overall Study|Violation of selection criteria at entry|2
836910|NCT00326963|1793037|FG000|Overall Study|Other protocol violation|1
836911|NCT00326963|1793037|FG000|Overall Study|Administrative / other|1
836912|NCT00327015|1793046|FG000|Overall Study|Lack of Efficacy|18
836913|NCT00327015|1793047|FG001|Overall Study|Lack of Efficacy|18
836914|NCT00327015|1793048|FG002|Overall Study|Lack of Efficacy|35
836915|NCT00327015|1793049|FG003|Overall Study|Lack of Efficacy|29
836916|NCT00327015|1793046|FG000|Overall Study|Withdrawal of Consent by Subject|20
836917|NCT00327015|1793047|FG001|Overall Study|Withdrawal of Consent by Subject|24
836918|NCT00327015|1793048|FG002|Overall Study|Withdrawal of Consent by Subject|28
836919|NCT00327015|1793049|FG003|Overall Study|Withdrawal of Consent by Subject|25
836920|NCT00327015|1793046|FG000|Overall Study|Lost to Follow-up|22
836921|NCT00327015|1793047|FG001|Overall Study|Lost to Follow-up|23
836922|NCT00327015|1793048|FG002|Overall Study|Lost to Follow-up|29
836923|NCT00327015|1793049|FG003|Overall Study|Lost to Follow-up|22
836924|NCT00327015|1793046|FG000|Overall Study|Adverse Event|14
836925|NCT00327015|1793047|FG001|Overall Study|Adverse Event|10
836926|NCT00327015|1793048|FG002|Overall Study|Adverse Event|14
836927|NCT00327015|1793049|FG003|Overall Study|Adverse Event|14
836928|NCT00327015|1793046|FG000|Overall Study|Subject no longer meets study criteria|4
836929|NCT00327015|1793047|FG001|Overall Study|Subject no longer meets study criteria|2
836930|NCT00327015|1793048|FG002|Overall Study|Subject no longer meets study criteria|8
836931|NCT00327015|1793049|FG003|Overall Study|Subject no longer meets study criteria|7
836932|NCT00327015|1793046|FG000|Overall Study|Poor/Noncompliance|11
836933|NCT00327015|1793047|FG001|Overall Study|Poor/Noncompliance|8
836934|NCT00327015|1793048|FG002|Overall Study|Poor/Noncompliance|4
836935|NCT00327015|1793049|FG003|Overall Study|Poor/Noncompliance|5
836936|NCT00327015|1793046|FG000|Overall Study|Physician Decision|0
836937|NCT00327015|1793047|FG001|Overall Study|Physician Decision|1
836938|NCT00327015|1793048|FG002|Overall Study|Physician Decision|3
836939|NCT00327015|1793049|FG003|Overall Study|Physician Decision|2
836940|NCT00327015|1793046|FG000|Overall Study|Death|1
836941|NCT00327015|1793047|FG001|Overall Study|Death|2
836942|NCT00327015|1793048|FG002|Overall Study|Death|2
836943|NCT00327015|1793049|FG003|Overall Study|Death|3
836944|NCT00327015|1793046|FG000|Overall Study|Pregnancy|0
836945|NCT00327015|1793047|FG001|Overall Study|Pregnancy|2
836946|NCT00327015|1793048|FG002|Overall Study|Pregnancy|1
836947|NCT00327015|1793049|FG003|Overall Study|Pregnancy|1
836948|NCT00327015|1793046|FG000|Overall Study|Administrative Reason by Sponsor|1
836949|NCT00327015|1793047|FG001|Overall Study|Administrative Reason by Sponsor|2
836950|NCT00327015|1793048|FG002|Overall Study|Administrative Reason by Sponsor|2
836951|NCT00327015|1793049|FG003|Overall Study|Administrative Reason by Sponsor|1
836952|NCT00327171|1793061|FG000|Overall Study|Did not receive study medication|3
836953|NCT00327171|1793062|FG001|Overall Study|Did not receive study medication|0
836954|NCT00327171|1793061|FG000|Overall Study|Adverse Event|23
836955|NCT00327171|1793062|FG001|Overall Study|Adverse Event|23
836956|NCT00327171|1793061|FG000|Overall Study|Disease progression/lack of efficacy|68
836957|NCT00327171|1793062|FG001|Overall Study|Disease progression/lack of efficacy|69
836958|NCT00327171|1793061|FG000|Overall Study|Investigator/participant request|1
836959|NCT00327171|1793062|FG001|Overall Study|Investigator/participant request|8
836960|NCT00327171|1793061|FG000|Overall Study|Clinical progression|12
836961|NCT00327171|1793062|FG001|Overall Study|Clinical progression|8
836962|NCT00327171|1793061|FG000|Overall Study|Undisclosed history of ischemia|0
836963|NCT00327171|1793062|FG001|Overall Study|Undisclosed history of ischemia|1
836964|NCT00327171|1793061|FG000|Overall Study|Other|1
836965|NCT00327171|1793062|FG001|Overall Study|Other|0
836966|NCT00327340|1793070|FG000|Overall Study|Withdrawal by Subject|1
836967|NCT00327340|1793071|FG001|Overall Study|Withdrawal by Subject|5
836968|NCT00327340|1793070|FG000|Overall Study|Physician Decision|1
836969|NCT00327340|1793071|FG001|Overall Study|Physician Decision|1
836970|NCT00327340|1793070|FG000|Overall Study|Disease Progression|10
836971|NCT00327340|1793071|FG001|Overall Study|Disease Progression|19
836972|NCT00327340|1793070|FG000|Overall Study|Symptomatic Disease|0
836973|NCT00327340|1793071|FG001|Overall Study|Symptomatic Disease|2
836974|NCT00327340|1793070|FG000|Overall Study|Adverse Event|3
836975|NCT00327340|1793071|FG001|Overall Study|Adverse Event|3
836976|NCT00327444|1793085|FG000|Double Blind Treatment (DB) Period|Disease progression|10
836977|NCT00327444|1793086|FG001|Double Blind Treatment (DB) Period|Disease progression|13
836978|NCT00327444|1793085|FG000|Double Blind Treatment (DB) Period|Adverse Event|5
836979|NCT00327444|1793086|FG001|Double Blind Treatment (DB) Period|Adverse Event|5
836980|NCT00327444|1793085|FG000|Double Blind Treatment (DB) Period|Subject request|0
836981|NCT00327444|1793086|FG001|Double Blind Treatment (DB) Period|Subject request|1
836982|NCT00327444|1793085|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
836983|NCT00327444|1793086|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
836984|NCT00327444|1793085|FG000|Open Label Treatment (OL) Period|Disease progression|8
836985|NCT00327444|1793086|FG001|Open Label Treatment (OL) Period|Disease progression|7
836986|NCT00327444|1793085|FG000|Open Label Treatment (OL) Period|Adverse Event|2
836987|NCT00327444|1793086|FG001|Open Label Treatment (OL) Period|Adverse Event|2
836988|NCT00327444|1793085|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0
836989|NCT00327444|1793086|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1
836990|NCT00327444|1793085|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1
836991|NCT00327444|1793086|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0
836992|NCT00327470|1793096|FG000|Overall Study|Randomized, but not treated|0
836993|NCT00327470|1793097|FG001|Overall Study|Randomized, but not treated|2
836994|NCT00327470|1793096|FG000|Overall Study|Adverse Event|9
836995|NCT00327470|1793097|FG001|Overall Study|Adverse Event|14
836996|NCT00327470|1793096|FG000|Overall Study|Lack of Efficacy|7
836997|NCT00327470|1793097|FG001|Overall Study|Lack of Efficacy|19
836998|NCT00327470|1793096|FG000|Overall Study|Other|5
836999|NCT00327470|1793097|FG001|Overall Study|Other|9
837000|NCT00327470|1793096|FG000|Overall Study|Lost to Follow-up|1
837001|NCT00327470|1793097|FG001|Overall Study|Lost to Follow-up|3
837002|NCT00327470|1793096|FG000|Overall Study|Withdrawal by Subject|6
837003|NCT00327470|1793097|FG001|Overall Study|Withdrawal by Subject|12
837004|NCT00327470|1793096|FG000|Overall Study|Death|1
837005|NCT00327470|1793097|FG001|Overall Study|Death|4
837006|NCT00327717|1793105|FG000|Overall Study|Adverse Event|6
837007|NCT00327717|1793106|FG001|Overall Study|Adverse Event|6
837008|NCT00327717|1793105|FG000|Overall Study|Lack of Efficacy|0
837009|NCT00327717|1793106|FG001|Overall Study|Lack of Efficacy|1
837010|NCT00327717|1793105|FG000|Overall Study|Withdrawal by Subject|3
837011|NCT00327717|1793106|FG001|Overall Study|Withdrawal by Subject|7
837012|NCT00328094|1793135|FG000|Overall Study|Physician Decision|3
837013|NCT00328094|1793136|FG001|Overall Study|Physician Decision|3
837014|NCT00328172|1793147|FG000|Overall Study|Adverse Event|3
837015|NCT00328172|1793148|FG001|Overall Study|Adverse Event|2
837016|NCT00328172|1793149|FG002|Overall Study|Adverse Event|1
837017|NCT00328172|1793150|FG003|Overall Study|Adverse Event|2
837018|NCT00328172|1793151|FG004|Overall Study|Adverse Event|1
837019|NCT00328172|1793147|FG000|Overall Study|Protocol Violation|0
837020|NCT00328172|1793148|FG001|Overall Study|Protocol Violation|1
837021|NCT00328172|1793149|FG002|Overall Study|Protocol Violation|1
837022|NCT00328172|1793150|FG003|Overall Study|Protocol Violation|0
837023|NCT00328172|1793151|FG004|Overall Study|Protocol Violation|0
837024|NCT00328172|1793147|FG000|Overall Study|Lost to Follow-up|1
837025|NCT00328172|1793148|FG001|Overall Study|Lost to Follow-up|1
837026|NCT00328172|1793149|FG002|Overall Study|Lost to Follow-up|2
837027|NCT00328172|1793150|FG003|Overall Study|Lost to Follow-up|1
837028|NCT00328172|1793151|FG004|Overall Study|Lost to Follow-up|1
837029|NCT00328172|1793147|FG000|Overall Study|Withdrawal by Subject|1
837030|NCT00328172|1793148|FG001|Overall Study|Withdrawal by Subject|1
837031|NCT00328172|1793149|FG002|Overall Study|Withdrawal by Subject|1
837032|NCT00328172|1793150|FG003|Overall Study|Withdrawal by Subject|6
837033|NCT00328172|1793151|FG004|Overall Study|Withdrawal by Subject|0
837034|NCT00328172|1793147|FG000|Overall Study|Lack of Efficacy|14
837035|NCT00328172|1793148|FG001|Overall Study|Lack of Efficacy|9
837036|NCT00328172|1793149|FG002|Overall Study|Lack of Efficacy|4
837037|NCT00328172|1793150|FG003|Overall Study|Lack of Efficacy|4
837038|NCT00328172|1793151|FG004|Overall Study|Lack of Efficacy|3
837039|NCT00328172|1793147|FG000|Overall Study|Other reason (not specified)|3
837040|NCT00328172|1793148|FG001|Overall Study|Other reason (not specified)|0
837041|NCT00328172|1793149|FG002|Overall Study|Other reason (not specified)|1
837042|NCT00328172|1793150|FG003|Overall Study|Other reason (not specified)|0
837043|NCT00328172|1793151|FG004|Overall Study|Other reason (not specified)|0
837044|NCT00328198|1793163|FG000|Treatment|Adverse Event|21
837045|NCT00328198|1793163|FG000|Treatment|Death|1
837046|NCT00328198|1793163|FG000|Treatment|Physician Decision|5
837047|NCT00328198|1793163|FG000|Treatment|Withdrawal by Subject|5
837048|NCT00328198|1793163|FG000|Treatment|Evidence of disease progression|2
837049|NCT00328198|1793163|FG000|Treatment|Non-compliance|1
837050|NCT00328198|1793163|FG000|Treatment|Confirmed complete response, MRD -|3
837051|NCT00328198|1793163|FG000|Follow-up|Lost to Follow-up|4
837052|NCT00328198|1793163|FG000|Follow-up|Death|31
837053|NCT00328510|1793178|FG000|Overall Study|Gag disorder, could not use frame|4
837054|NCT00328510|1793179|FG001|Overall Study|Gag disorder, could not use frame|0
837055|NCT00328510|1793178|FG000|Overall Study|Dentition problems, could not use frame|1
837056|NCT00328510|1793179|FG001|Overall Study|Dentition problems, could not use frame|0
837057|NCT00328510|1793178|FG000|Overall Study|Withdrawal by Subject|4
837058|NCT00328510|1793179|FG001|Overall Study|Withdrawal by Subject|2
837059|NCT00328510|1793178|FG000|Overall Study|Severe kyphosis, could not use mask|0
837060|NCT00328510|1793179|FG001|Overall Study|Severe kyphosis, could not use mask|1
837061|NCT00328510|1793178|FG000|Overall Study|Treatment changed to a single fraction|1
837062|NCT00328510|1793179|FG001|Overall Study|Treatment changed to a single fraction|1
837063|NCT00328562|1793185|FG000|Overall Study|Disease progression|1
837064|NCT00328627|1793221|FG000|Overall Study|Hyperglycemic Rescue|41
837065|NCT00328627|1793222|FG001|Overall Study|Hyperglycemic Rescue|18
837066|NCT00328627|1793223|FG002|Overall Study|Hyperglycemic Rescue|16
837067|NCT00328627|1793224|FG003|Overall Study|Hyperglycemic Rescue|13
837068|NCT00328627|1793225|FG004|Overall Study|Hyperglycemic Rescue|6
837069|NCT00328627|1793226|FG005|Overall Study|Hyperglycemic Rescue|5
837070|NCT00328627|1793227|FG006|Overall Study|Hyperglycemic Rescue|19
837071|NCT00328627|1793228|FG007|Overall Study|Hyperglycemic Rescue|6
837072|NCT00328627|1793229|FG008|Overall Study|Hyperglycemic Rescue|6
837073|NCT00328627|1793230|FG009|Overall Study|Hyperglycemic Rescue|11
837074|NCT00328627|1793231|FG010|Overall Study|Hyperglycemic Rescue|3
837075|NCT00328627|1793232|FG011|Overall Study|Hyperglycemic Rescue|2
837076|NCT00328627|1793221|FG000|Overall Study|Adverse Event|3
837077|NCT00328627|1793222|FG001|Overall Study|Adverse Event|1
837078|NCT00328627|1793223|FG002|Overall Study|Adverse Event|2
837079|NCT00328627|1793224|FG003|Overall Study|Adverse Event|3
837080|NCT00328627|1793225|FG004|Overall Study|Adverse Event|1
837081|NCT00328627|1793226|FG005|Overall Study|Adverse Event|2
837082|NCT00328627|1793227|FG006|Overall Study|Adverse Event|1
837083|NCT00328627|1793228|FG007|Overall Study|Adverse Event|2
837084|NCT00328627|1793229|FG008|Overall Study|Adverse Event|0
837085|NCT00328627|1793230|FG009|Overall Study|Adverse Event|7
837086|NCT00328627|1793231|FG010|Overall Study|Adverse Event|5
837087|NCT00328627|1793232|FG011|Overall Study|Adverse Event|4
837088|NCT00328627|1793221|FG000|Overall Study|Protocol Violation|2
837089|NCT00328627|1793222|FG001|Overall Study|Protocol Violation|2
837090|NCT00328627|1793223|FG002|Overall Study|Protocol Violation|2
837091|NCT00328627|1793224|FG003|Overall Study|Protocol Violation|8
837092|NCT00328627|1793225|FG004|Overall Study|Protocol Violation|5
837093|NCT00328627|1793226|FG005|Overall Study|Protocol Violation|5
837094|NCT00328627|1793227|FG006|Overall Study|Protocol Violation|6
837095|NCT00328627|1793228|FG007|Overall Study|Protocol Violation|2
837096|NCT00328627|1793229|FG008|Overall Study|Protocol Violation|1
837097|NCT00328627|1793230|FG009|Overall Study|Protocol Violation|4
837098|NCT00328627|1793231|FG010|Overall Study|Protocol Violation|6
837099|NCT00328627|1793232|FG011|Overall Study|Protocol Violation|2
837100|NCT00328627|1793221|FG000|Overall Study|Lost to Follow-up|4
837101|NCT00328627|1793222|FG001|Overall Study|Lost to Follow-up|2
837102|NCT00328627|1793223|FG002|Overall Study|Lost to Follow-up|2
837103|NCT00328627|1793224|FG003|Overall Study|Lost to Follow-up|4
837104|NCT00328627|1793225|FG004|Overall Study|Lost to Follow-up|0
837105|NCT00328627|1793226|FG005|Overall Study|Lost to Follow-up|2
837106|NCT00328627|1793227|FG006|Overall Study|Lost to Follow-up|3
837107|NCT00328627|1793228|FG007|Overall Study|Lost to Follow-up|0
837108|NCT00328627|1793229|FG008|Overall Study|Lost to Follow-up|3
837109|NCT00328627|1793230|FG009|Overall Study|Lost to Follow-up|2
837110|NCT00328627|1793231|FG010|Overall Study|Lost to Follow-up|0
837111|NCT00328627|1793232|FG011|Overall Study|Lost to Follow-up|1
837112|NCT00328627|1793221|FG000|Overall Study|Withdrawal by Subject|5
837113|NCT00328627|1793222|FG001|Overall Study|Withdrawal by Subject|4
837114|NCT00328627|1793223|FG002|Overall Study|Withdrawal by Subject|5
837115|NCT00328627|1793224|FG003|Overall Study|Withdrawal by Subject|6
837116|NCT00328627|1793225|FG004|Overall Study|Withdrawal by Subject|2
837117|NCT00328627|1793226|FG005|Overall Study|Withdrawal by Subject|5
837118|NCT00328627|1793227|FG006|Overall Study|Withdrawal by Subject|4
837119|NCT00328627|1793228|FG007|Overall Study|Withdrawal by Subject|4
837120|NCT00328627|1793229|FG008|Overall Study|Withdrawal by Subject|4
837121|NCT00328627|1793230|FG009|Overall Study|Withdrawal by Subject|5
837122|NCT00328627|1793231|FG010|Overall Study|Withdrawal by Subject|2
837123|NCT00328627|1793232|FG011|Overall Study|Withdrawal by Subject|7
837124|NCT00328627|1793221|FG000|Overall Study|Pregnancy|0
837125|NCT00328627|1793222|FG001|Overall Study|Pregnancy|1
837126|NCT00328627|1793223|FG002|Overall Study|Pregnancy|0
837127|NCT00328627|1793224|FG003|Overall Study|Pregnancy|0
837128|NCT00328627|1793225|FG004|Overall Study|Pregnancy|0
837129|NCT00328627|1793226|FG005|Overall Study|Pregnancy|0
837130|NCT00328627|1793227|FG006|Overall Study|Pregnancy|0
837131|NCT00328627|1793228|FG007|Overall Study|Pregnancy|0
837132|NCT00328627|1793229|FG008|Overall Study|Pregnancy|0
837133|NCT00328627|1793230|FG009|Overall Study|Pregnancy|0
837134|NCT00328627|1793231|FG010|Overall Study|Pregnancy|0
837135|NCT00328627|1793232|FG011|Overall Study|Pregnancy|0
837136|NCT00328627|1793221|FG000|Overall Study|Physician Decision|4
837137|NCT00328627|1793222|FG001|Overall Study|Physician Decision|3
837138|NCT00328627|1793223|FG002|Overall Study|Physician Decision|1
837139|NCT00328627|1793224|FG003|Overall Study|Physician Decision|2
837140|NCT00328627|1793225|FG004|Overall Study|Physician Decision|1
837141|NCT00328627|1793226|FG005|Overall Study|Physician Decision|1
837142|NCT00328627|1793227|FG006|Overall Study|Physician Decision|1
837143|NCT00328627|1793228|FG007|Overall Study|Physician Decision|0
837144|NCT00328627|1793229|FG008|Overall Study|Physician Decision|3
837145|NCT00328627|1793230|FG009|Overall Study|Physician Decision|2
837146|NCT00328627|1793231|FG010|Overall Study|Physician Decision|1
837147|NCT00328627|1793232|FG011|Overall Study|Physician Decision|0
837148|NCT00328627|1793221|FG000|Overall Study|Other|0
837149|NCT00328627|1793222|FG001|Overall Study|Other|0
837150|NCT00328627|1793223|FG002|Overall Study|Other|0
837151|NCT00328627|1793224|FG003|Overall Study|Other|1
837152|NCT00328627|1793225|FG004|Overall Study|Other|0
837153|NCT00328627|1793226|FG005|Overall Study|Other|0
837154|NCT00328627|1793227|FG006|Overall Study|Other|1
837155|NCT00328627|1793228|FG007|Overall Study|Other|0
837156|NCT00328627|1793229|FG008|Overall Study|Other|0
837157|NCT00328627|1793230|FG009|Overall Study|Other|1
837158|NCT00328627|1793231|FG010|Overall Study|Other|1
837159|NCT00328627|1793232|FG011|Overall Study|Other|0
837160|NCT00328783|1793271|FG000|Overall Study|Could not tolerate ABC|21
837161|NCT00328783|1793271|FG000|Overall Study|No heart in RT field|4
837162|NCT00328783|1793271|FG000|Overall Study|Withdrawal by Subject|1
837163|NCT00328926|1793289|FG000|Overall Study|Pregnancy|2
837164|NCT00328926|1793290|FG001|Overall Study|Pregnancy|1
837165|NCT00328926|1793291|FG002|Overall Study|Pregnancy|0
837166|NCT00328926|1793289|FG000|Overall Study|Lost to Follow-up|0
837167|NCT00328926|1793290|FG001|Overall Study|Lost to Follow-up|1
837168|NCT00328926|1793291|FG002|Overall Study|Lost to Follow-up|0
837169|NCT00328926|1793289|FG000|Overall Study|Death|0
837170|NCT00328926|1793290|FG001|Overall Study|Death|0
837171|NCT00328926|1793291|FG002|Overall Study|Death|1
837172|NCT00328926|1793289|FG000|Overall Study|In vitro fertilization treatment|0
837173|NCT00328926|1793290|FG001|Overall Study|In vitro fertilization treatment|0
837174|NCT00328926|1793291|FG002|Overall Study|In vitro fertilization treatment|1
837175|NCT00328926|1793289|FG000|Overall Study|Lack of ovarian response|0
837176|NCT00328926|1793290|FG001|Overall Study|Lack of ovarian response|1
837177|NCT00328926|1793291|FG002|Overall Study|Lack of ovarian response|0
837178|NCT00329030|1793301|FG000|Overall Study|Withdrawal by Subject|1
837179|NCT00329030|1793302|FG001|Overall Study|Withdrawal by Subject|3
837180|NCT00329030|1793301|FG000|Overall Study|Progressive Disease|6
837181|NCT00329030|1793302|FG001|Overall Study|Progressive Disease|2
837182|NCT00329030|1793301|FG000|Overall Study|Ineligible Pathology|1
837183|NCT00329030|1793302|FG001|Overall Study|Ineligible Pathology|1
837184|NCT00329160|1793308|FG000|Overall Study|Adverse Event|27
837185|NCT00329160|1793308|FG000|Overall Study|Withdrawal by Subject|13
837186|NCT00329160|1793308|FG000|Overall Study|Protocol Violation|2
837187|NCT00329160|1793308|FG000|Overall Study|Did not Receive Study Drug|1
837188|NCT00329160|1793308|FG000|Overall Study|Incomplete IVUS|45
837189|NCT00329238|1793314|FG000|Overall Study|Adverse Event|147
837190|NCT00329238|1793315|FG001|Overall Study|Adverse Event|129
837191|NCT00329238|1793314|FG000|Overall Study|Protocol Violation|23
837192|NCT00329238|1793315|FG001|Overall Study|Protocol Violation|34
837193|NCT00329238|1793314|FG000|Overall Study|Lost to Follow-up|2
837194|NCT00329238|1793315|FG001|Overall Study|Lost to Follow-up|6
837195|NCT00329238|1793314|FG000|Overall Study|Withdrawal by Subject|64
837196|NCT00329238|1793315|FG001|Overall Study|Withdrawal by Subject|58
837197|NCT00329238|1793314|FG000|Overall Study|Other reason (not specified)|40
837198|NCT00329238|1793315|FG001|Overall Study|Other reason (not specified)|54
837199|NCT00329303|1793325|FG000|Overall Study|Lack of Efficacy|1
837200|NCT00329303|1793326|FG001|Overall Study|Lack of Efficacy|0
837201|NCT00329303|1793325|FG000|Overall Study|Decision of the sponsor|0
837202|NCT00329303|1793326|FG001|Overall Study|Decision of the sponsor|1
837203|NCT00329303|1793325|FG000|Overall Study|Patient no longer available|1
837204|NCT00329303|1793326|FG001|Overall Study|Patient no longer available|0
837205|NCT00329303|1793325|FG000|Overall Study|Patient relocated|0
837206|NCT00329303|1793326|FG001|Overall Study|Patient relocated|1
837207|NCT00329407|1793333|FG000|Overall Study|Withdrawal by Subject|1
837208|NCT00329420|1793340|FG000|Re-induction Phase|Lack of Efficacy|0
837209|NCT00329420|1793341|FG001|Re-induction Phase|Lack of Efficacy|1
837210|NCT00329420|1793342|FG002|Re-induction Phase|Lack of Efficacy|0
837211|NCT00329420|1793340|FG000|Re-induction Phase|Withdrawal of Consent|0
837212|NCT00329420|1793341|FG001|Re-induction Phase|Withdrawal of Consent|0
837213|NCT00329420|1793342|FG002|Re-induction Phase|Withdrawal of Consent|1
837214|NCT00329420|1793340|FG000|Re-induction Phase|Did not respond to re-induction|6
837215|NCT00329420|1793341|FG001|Re-induction Phase|Did not respond to re-induction|5
837216|NCT00329420|1793342|FG002|Re-induction Phase|Did not respond to re-induction|7
837217|NCT00329420|1793340|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
837218|NCT00329420|1793341|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
837219|NCT00329420|1793342|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
837220|NCT00329420|1793340|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
837221|NCT00329420|1793341|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
837222|NCT00329420|1793342|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
837223|NCT00329420|1793340|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
837224|NCT00329420|1793341|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
837225|NCT00329420|1793342|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
837226|NCT00329550|1793368|FG000|Overall Study|Adverse Event|3
837227|NCT00329550|1793369|FG001|Overall Study|Adverse Event|4
837228|NCT00329550|1793370|FG002|Overall Study|Adverse Event|2
837229|NCT00329550|1793368|FG000|Overall Study|Withdrawal of Consent|1
837230|NCT00329550|1793369|FG001|Overall Study|Withdrawal of Consent|0
837231|NCT00329550|1793370|FG002|Overall Study|Withdrawal of Consent|1
837232|NCT00329550|1793368|FG000|Overall Study|Due to Relocation|0
837233|NCT00329550|1793369|FG001|Overall Study|Due to Relocation|0
837234|NCT00329550|1793370|FG002|Overall Study|Due to Relocation|1
837235|NCT00329602|1793382|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
837236|NCT00329602|1793383|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
837237|NCT00329602|1793384|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
837238|NCT00329602|1793382|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0
837239|NCT00329602|1793383|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0
837240|NCT00329602|1793384|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20
837241|NCT00329602|1793382|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
837242|NCT00329602|1793383|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
837326|NCT00330460|1793548|FG000|Overall Study|Lost to Follow-up|8
837243|NCT00329602|1793384|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
837244|NCT00329602|1793382|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0
837245|NCT00329602|1793383|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0
837246|NCT00329602|1793384|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2
837247|NCT00329602|1793382|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
837248|NCT00329602|1793383|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
837249|NCT00329602|1793384|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
837250|NCT00329602|1793382|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0
837251|NCT00329602|1793383|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0
837252|NCT00329602|1793384|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4
837253|NCT00329641|1793400|FG000|Overall Study|Did not start treatment|1
837254|NCT00329641|1793400|FG000|Overall Study|Not eligible|1
837255|NCT00329641|1793400|FG000|Overall Study|Adverse Event|3
837256|NCT00329641|1793400|FG000|Overall Study|Other reason, not protocol specified|1
837257|NCT00329719|1793409|FG000|Overall Study|Lost to Follow-up|0
837258|NCT00329719|1793410|FG001|Overall Study|Lost to Follow-up|0
837259|NCT00329719|1793411|FG002|Overall Study|Lost to Follow-up|0
837260|NCT00329719|1793412|FG003|Overall Study|Lost to Follow-up|1
837261|NCT00329745|1793424|FG000|Overall Study|Protocol Violation|1
837262|NCT00329745|1793425|FG001|Overall Study|Protocol Violation|0
837263|NCT00329745|1793424|FG000|Overall Study|Withdrawal by Subject|0
837264|NCT00329745|1793425|FG001|Overall Study|Withdrawal by Subject|1
837265|NCT00329745|1793424|FG000|Overall Study|Lost to Follow-up|86
837266|NCT00329745|1793425|FG001|Overall Study|Lost to Follow-up|101
837267|NCT00329784|1793439|FG000|Overall Study|Lost to Follow-up|0
837268|NCT00329784|1793440|FG001|Overall Study|Lost to Follow-up|1
837269|NCT00329784|1793441|FG002|Overall Study|Lost to Follow-up|0
837270|NCT00329784|1793442|FG003|Overall Study|Lost to Follow-up|0
837271|NCT00329784|1793439|FG000|Overall Study|Withdrawal by Subject|4
837272|NCT00329784|1793440|FG001|Overall Study|Withdrawal by Subject|2
837273|NCT00329784|1793441|FG002|Overall Study|Withdrawal by Subject|0
837274|NCT00329784|1793442|FG003|Overall Study|Withdrawal by Subject|0
837275|NCT00329784|1793439|FG000|Overall Study|Other|1
837276|NCT00329784|1793440|FG001|Overall Study|Other|2
837277|NCT00329784|1793441|FG002|Overall Study|Other|0
837278|NCT00329784|1793442|FG003|Overall Study|Other|0
837279|NCT00329797|1793456|FG000|Overall Study|Protocol Violation|1
837280|NCT00329797|1793457|FG001|Overall Study|Protocol Violation|0
837281|NCT00329797|1793456|FG000|Overall Study|Withdrawal by Subject|6
837282|NCT00329797|1793457|FG001|Overall Study|Withdrawal by Subject|6
837283|NCT00329849|1793469|FG000|Overall Study|Withdrawal by Subject|6
837284|NCT00329849|1793470|FG001|Overall Study|Withdrawal by Subject|4
837285|NCT00329901|1793483|FG000|Overall Study|Withdrawal by Subject|4
837286|NCT00329901|1793484|FG001|Overall Study|Withdrawal by Subject|3
837287|NCT00329901|1793485|FG002|Overall Study|Withdrawal by Subject|2
837288|NCT00329901|1793483|FG000|Overall Study|Lost to Follow-up|2
837289|NCT00329901|1793484|FG001|Overall Study|Lost to Follow-up|0
837290|NCT00329901|1793485|FG002|Overall Study|Lost to Follow-up|1
837291|NCT00329901|1793483|FG000|Overall Study|Protocol Violation|1
837292|NCT00329901|1793484|FG001|Overall Study|Protocol Violation|0
837293|NCT00329901|1793485|FG002|Overall Study|Protocol Violation|1
837294|NCT00329901|1793483|FG000|Overall Study|Unable to classify|2
837295|NCT00329901|1793484|FG001|Overall Study|Unable to classify|2
837296|NCT00329901|1793485|FG002|Overall Study|Unable to classify|0
837297|NCT00330174|1793503|FG000|Overall Study|Withdrawal by Subject|7
837298|NCT00330174|1793504|FG001|Overall Study|Withdrawal by Subject|7
837299|NCT00330174|1793503|FG000|Overall Study|Lost to Follow-up|4
837300|NCT00330174|1793504|FG001|Overall Study|Lost to Follow-up|1
837301|NCT00330174|1793503|FG000|Overall Study|Clinical deterioration|1
837302|NCT00330174|1793504|FG001|Overall Study|Clinical deterioration|2
837303|NCT00330174|1793503|FG000|Overall Study|Excessive missed visits|3
837304|NCT00330174|1793504|FG001|Overall Study|Excessive missed visits|8
837305|NCT00330174|1793503|FG000|Overall Study|Miscellaneous reasons|7
837306|NCT00330174|1793504|FG001|Overall Study|Miscellaneous reasons|1
837307|NCT00330187|1793514|FG000|Overall Study|Lost to Follow-up|12
837308|NCT00330187|1793515|FG001|Overall Study|Lost to Follow-up|13
837309|NCT00330187|1793516|FG002|Overall Study|Lost to Follow-up|14
837310|NCT00330187|1793517|FG003|Overall Study|Lost to Follow-up|10
837311|NCT00330187|1793514|FG000|Overall Study|Withdrawal by Subject|8
837312|NCT00330187|1793515|FG001|Overall Study|Withdrawal by Subject|5
837313|NCT00330187|1793516|FG002|Overall Study|Withdrawal by Subject|4
837314|NCT00330187|1793517|FG003|Overall Study|Withdrawal by Subject|4
837315|NCT00330343|1793527|FG000|Overall Study|Lost to Follow-up|5
837316|NCT00330460|1793548|FG000|Overall Study|Physician Decision|1
837317|NCT00330460|1793549|FG001|Overall Study|Physician Decision|0
837318|NCT00330460|1793548|FG000|Overall Study|Adverse Event|10
837319|NCT00330460|1793549|FG001|Overall Study|Adverse Event|8
837320|NCT00330460|1793548|FG000|Overall Study|Withdrawal by Subject|18
837321|NCT00330460|1793549|FG001|Overall Study|Withdrawal by Subject|17
837322|NCT00330460|1793548|FG000|Overall Study|Death|1
837323|NCT00330460|1793549|FG001|Overall Study|Death|1
837324|NCT00330460|1793548|FG000|Overall Study|Ineligibility determined|1
837325|NCT00330460|1793549|FG001|Overall Study|Ineligibility determined|3
837327|NCT00330460|1793549|FG001|Overall Study|Lost to Follow-up|3
837328|NCT00330460|1793548|FG000|Overall Study|Noncompliance|2
837329|NCT00330460|1793549|FG001|Overall Study|Noncompliance|1
837330|NCT00330460|1793548|FG000|Overall Study|Other|1
837331|NCT00330460|1793549|FG001|Overall Study|Other|0
837332|NCT00330616|1793570|FG000|Overall Study|Adverse Event|13
837333|NCT00330616|1793570|FG000|Overall Study|Lack of Efficacy|1
837334|NCT00330616|1793570|FG000|Overall Study|Lost to Follow-up|2
837335|NCT00330616|1793570|FG000|Overall Study|Withdrawal by Subject|4
837336|NCT00330616|1793570|FG000|Overall Study|Other|1
837337|NCT00330668|1793574|FG000|BID Dosing Period|Adverse Event|1
837338|NCT00330668|1793574|FG000|BID Dosing Period|Lost to Follow-up|7
837339|NCT00330668|1793574|FG000|BID Dosing Period|Non-Compliance|5
837340|NCT00330668|1793574|FG000|BID Dosing Period|Withdrawal by Subject|19
837341|NCT00330668|1793574|FG000|BID Dosing Period|Sponsor's decision|1
837342|NCT00330668|1793574|FG000|BID Dosing Period|Other|3
837343|NCT00330668|1793574|FG000|QD Dosing Period|Sponsor decision to terminate study|74
837344|NCT00330668|1793574|FG000|QD Dosing Period|Other|1
837345|NCT00330668|1793574|FG000|QD Dosing Period|Withdrawal by Subject|1
837346|NCT00330668|1793574|FG000|QD Dosing Period|Lost to Follow-up|2
837347|NCT00330681|1793580|FG000|Overall Study|Adverse Event|3
837348|NCT00330681|1793581|FG001|Overall Study|Adverse Event|6
837349|NCT00330681|1793580|FG000|Overall Study|Protocol Violation|0
837350|NCT00330681|1793581|FG001|Overall Study|Protocol Violation|1
837351|NCT00330681|1793580|FG000|Overall Study|Withdrawal by Subject|5
837352|NCT00330681|1793581|FG001|Overall Study|Withdrawal by Subject|5
837353|NCT00330681|1793580|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
837354|NCT00330681|1793581|FG001|Overall Study|Tracheotomy due to worsening of ALS|2
837355|NCT00330759|1793598|FG000|Overall Study|Death|316
837356|NCT00330759|1793599|FG001|Overall Study|Death|310
837357|NCT00330759|1793598|FG000|Overall Study|Disease progression|104
837358|NCT00330759|1793599|FG001|Overall Study|Disease progression|126
837359|NCT00330759|1793598|FG000|Overall Study|Withdrawal by Subject|143
837360|NCT00330759|1793599|FG001|Overall Study|Withdrawal by Subject|124
837361|NCT00330759|1793598|FG000|Overall Study|Adverse Event|48
837362|NCT00330759|1793599|FG001|Overall Study|Adverse Event|36
837363|NCT00330759|1793598|FG000|Overall Study|Participant request|31
837364|NCT00330759|1793599|FG001|Overall Study|Participant request|22
837365|NCT00330759|1793598|FG000|Overall Study|Lost to Follow-up|16
837366|NCT00330759|1793599|FG001|Overall Study|Lost to Follow-up|22
837367|NCT00330759|1793598|FG000|Overall Study|Noncompliance|15
837368|NCT00330759|1793599|FG001|Overall Study|Noncompliance|17
837369|NCT00330759|1793598|FG000|Overall Study|Physician Decision|1
837370|NCT00330759|1793599|FG001|Overall Study|Physician Decision|2
837371|NCT00330759|1793598|FG000|Overall Study|Protocol deviation|0
837372|NCT00330759|1793599|FG001|Overall Study|Protocol deviation|2
837373|NCT00330759|1793598|FG000|Overall Study|Ineligibility determined|2
837374|NCT00330759|1793599|FG001|Overall Study|Ineligibility determined|1
837375|NCT00330759|1793598|FG000|Overall Study|Other|36
837376|NCT00330759|1793599|FG001|Overall Study|Other|44
837377|NCT00330928|1793625|FG000|Overall Study|Lost to Follow-up|6
837378|NCT00330928|1793625|FG000|Overall Study|Physician Decision|9
837379|NCT00330928|1793625|FG000|Overall Study|Death|1
837380|NCT00330928|1793625|FG000|Overall Study|IVUS could not be performed.|1
837381|NCT00330967|1793631|FG000|Overall Study|Withdrawal by Subject|0
837382|NCT00330967|1793632|FG001|Overall Study|Withdrawal by Subject|5
837383|NCT00330967|1793631|FG000|Overall Study|Physician Decision|0
837384|NCT00330967|1793632|FG001|Overall Study|Physician Decision|9
837385|NCT00331006|1793638|FG000|Screening Phase|Withdrawal by Subject|1
837386|NCT00331006|1793638|FG000|Screening Phase|enrollment halted|1
837387|NCT00331006|1793638|FG000|Screening Phase|Lost to Follow-up|1
837388|NCT00331006|1793638|FG000|Screening Phase|Ineligible for treatment phase|4
837389|NCT00331006|1793638|FG000|Treatment Phase|Withdrawal by Subject|1
837390|NCT00331006|1793638|FG000|Follow-Up Phase I|Lost to Follow-up|1
837391|NCT00331006|1793638|FG000|Follow-Up Phase II|Lost to Follow-up|3
837392|NCT00331136|1793646|FG000|Overall Study|Adverse Event|3
837393|NCT00331136|1793647|FG001|Overall Study|Adverse Event|5
837394|NCT00331136|1793648|FG002|Overall Study|Adverse Event|0
837395|NCT00331136|1793649|FG003|Overall Study|Adverse Event|1
837396|NCT00331136|1793646|FG000|Overall Study|Withdrawal by Subject|0
837397|NCT00331136|1793647|FG001|Overall Study|Withdrawal by Subject|1
837398|NCT00331136|1793648|FG002|Overall Study|Withdrawal by Subject|0
837399|NCT00331136|1793649|FG003|Overall Study|Withdrawal by Subject|0
837400|NCT00331136|1793646|FG000|Overall Study|Lost to Follow-up|0
837401|NCT00331136|1793647|FG001|Overall Study|Lost to Follow-up|1
837402|NCT00331136|1793648|FG002|Overall Study|Lost to Follow-up|0
837403|NCT00331136|1793649|FG003|Overall Study|Lost to Follow-up|0
837404|NCT00331136|1793646|FG000|Overall Study|Protocol Violation|1
837405|NCT00331136|1793647|FG001|Overall Study|Protocol Violation|0
837406|NCT00331136|1793648|FG002|Overall Study|Protocol Violation|0
837407|NCT00331136|1793649|FG003|Overall Study|Protocol Violation|0
837408|NCT00331136|1793646|FG000|Overall Study|Not treated|1
837409|NCT00331136|1793647|FG001|Overall Study|Not treated|0
837410|NCT00331136|1793648|FG002|Overall Study|Not treated|0
837411|NCT00331136|1793649|FG003|Overall Study|Not treated|0
837412|NCT00331344|1793668|FG000|Phase I|Adverse Event|0
837413|NCT00331344|1793669|FG001|Phase I|Adverse Event|0
837414|NCT00331344|1793670|FG002|Phase I|Adverse Event|0
837415|NCT00331344|1793671|FG003|Phase I|Adverse Event|1
837416|NCT00331344|1793672|FG004|Phase I|Adverse Event|2
837417|NCT00331344|1793673|FG005|Phase I|Adverse Event|2
837418|NCT00331344|1793674|FG006|Phase I|Adverse Event|0
837419|NCT00331344|1793675|FG007|Phase I|Adverse Event|1
837420|NCT00331344|1793676|FG008|Phase I|Adverse Event|0
837421|NCT00331344|1793668|FG000|Phase II|Death|0
837422|NCT00331344|1793669|FG001|Phase II|Death|0
837423|NCT00331344|1793670|FG002|Phase II|Death|0
837424|NCT00331344|1793671|FG003|Phase II|Death|0
837425|NCT00331344|1793672|FG004|Phase II|Death|0
837426|NCT00331344|1793673|FG005|Phase II|Death|0
837427|NCT00331344|1793674|FG006|Phase II|Death|0
837428|NCT00331344|1793675|FG007|Phase II|Death|0
837429|NCT00331344|1793676|FG008|Phase II|Death|4
837430|NCT00331409|1793689|FG000|Overall Study|Lack of Efficacy|4
837431|NCT00331422|1793693|FG000|Overall Study|Did not receive entire study regimen|5
837432|NCT00331552|1793700|FG000|Period 3: Phase II|Neurological Symptoms|1
837433|NCT00331552|1793701|FG001|Period 3: Phase II|Neurological Symptoms|0
837434|NCT00331552|1793700|FG000|Period 3: Phase II|Severe Nausea|1
837435|NCT00331552|1793701|FG001|Period 3: Phase II|Severe Nausea|0
837436|NCT00331630|1793712|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1
837437|NCT00331630|1793712|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
837438|NCT00331630|1793712|FG000|Follow up for 5 Years|Death|5
837439|NCT00331630|1793712|FG000|Follow up for 5 Years|Data collection was stopped|24
837440|NCT00331682|1793716|FG000|Overall Study|Adverse Event|1
837441|NCT00331760|1793722|FG000|Overall Study|Ineligible / no protocol treatment|15
837442|NCT00331760|1793723|FG001|Overall Study|Ineligible / no protocol treatment|8
837443|NCT00331773|1793732|FG000|Overall Study|Withdrawal by Subject|6
837444|NCT00331773|1793733|FG001|Overall Study|Withdrawal by Subject|4
837445|NCT00331773|1793732|FG000|Overall Study|Protocol Violation|10
837446|NCT00331773|1793733|FG001|Overall Study|Protocol Violation|3
837447|NCT00331799|1793740|FG000|Overall Study|Withdrawal by Subject|2
837448|NCT00331799|1793740|FG000|Overall Study|Sedation|1
837449|NCT00331864|1793746|FG000|Overall Study|Adverse Event|30
837450|NCT00331864|1793747|FG001|Overall Study|Adverse Event|1
837451|NCT00331864|1793746|FG000|Overall Study|Lack of Efficacy|4
837452|NCT00331864|1793747|FG001|Overall Study|Lack of Efficacy|0
837453|NCT00331864|1793746|FG000|Overall Study|Protocol Violation|3
837454|NCT00331864|1793747|FG001|Overall Study|Protocol Violation|0
837455|NCT00331864|1793746|FG000|Overall Study|Withdrawal by Subject|10
837456|NCT00331864|1793747|FG001|Overall Study|Withdrawal by Subject|0
837457|NCT00331864|1793746|FG000|Overall Study|Lost to Follow-up|4
837458|NCT00331864|1793747|FG001|Overall Study|Lost to Follow-up|3
837459|NCT00331864|1793746|FG000|Overall Study|Administrative Problems|1
837460|NCT00331864|1793747|FG001|Overall Study|Administrative Problems|0
837461|NCT00331864|1793746|FG000|Overall Study|Death|6
837462|NCT00331864|1793747|FG001|Overall Study|Death|0
837463|NCT00332189|1793762|FG000|Overall Study|Adverse Event|3
837464|NCT00332189|1793762|FG000|Overall Study|Uncooperative/Noncompliant|3
837465|NCT00332189|1793762|FG000|Overall Study|Withdrawal by Subject|9
837466|NCT00332189|1793762|FG000|Overall Study|Lack of Efficacy|4
837467|NCT00332189|1793762|FG000|Overall Study|Moved out of country|2
837468|NCT00332202|1793769|FG000|Overall Study|Adverse Event|72
837469|NCT00332202|1793770|FG001|Overall Study|Adverse Event|28
837470|NCT00332202|1793769|FG000|Overall Study|Lost to Follow-up|2
837471|NCT00332202|1793770|FG001|Overall Study|Lost to Follow-up|1
837472|NCT00332202|1793769|FG000|Overall Study|Physician Decision|6
837473|NCT00332202|1793770|FG001|Overall Study|Physician Decision|8
837474|NCT00332202|1793769|FG000|Overall Study|Protocol Entry Criteria Not Met|6
837475|NCT00332202|1793770|FG001|Overall Study|Protocol Entry Criteria Not Met|5
837476|NCT00332202|1793769|FG000|Overall Study|Protocol Violation|7
837477|NCT00332202|1793770|FG001|Overall Study|Protocol Violation|2
837478|NCT00332202|1793769|FG000|Overall Study|Sponsor Decision|1
837479|NCT00332202|1793770|FG001|Overall Study|Sponsor Decision|2
837480|NCT00332202|1793769|FG000|Overall Study|Withdrawal by Subject|36
837481|NCT00332202|1793770|FG001|Overall Study|Withdrawal by Subject|17
837482|NCT00332202|1793769|FG000|Overall Study|Progressive Disease|106
837483|NCT00332202|1793770|FG001|Overall Study|Progressive Disease|60
837484|NCT00332202|1793769|FG000|Overall Study|Death|5
837485|NCT00332202|1793770|FG001|Overall Study|Death|2
837486|NCT00332241|1793787|FG000|Overall Study|Lack of Efficacy|6
837487|NCT00332241|1793788|FG001|Overall Study|Lack of Efficacy|1
837488|NCT00332241|1793787|FG000|Overall Study|Adverse Event|3
837489|NCT00332241|1793788|FG001|Overall Study|Adverse Event|5
837490|NCT00332241|1793787|FG000|Overall Study|Withdrawal by Subject|2
837491|NCT00332241|1793788|FG001|Overall Study|Withdrawal by Subject|1
837492|NCT00332241|1793787|FG000|Overall Study|Lost to Follow-up|4
837493|NCT00332241|1793788|FG001|Overall Study|Lost to Follow-up|1
837494|NCT00332332|1793794|FG000|Overall Study|Adverse Event|13
837495|NCT00332332|1793794|FG000|Overall Study|Death|1
837496|NCT00332332|1793794|FG000|Overall Study|Withdrawal by Subject|8
837497|NCT00332332|1793794|FG000|Overall Study|Physician Decision|1
837498|NCT00332332|1793794|FG000|Overall Study|Lost to Follow-up|3
837499|NCT00332332|1793794|FG000|Overall Study|Protocol deviation|4
837500|NCT00332332|1793794|FG000|Overall Study|Noncompliance|2
837501|NCT00332332|1793794|FG000|Overall Study|Disease progression|2
837502|NCT00332332|1793794|FG000|Overall Study|Other|18
837503|NCT00332332|1793794|FG000|Overall Study|Did not receive study treatment|16
837504|NCT00332462|1793798|FG000|Overall Study|Adverse Event|5
837505|NCT00332462|1793798|FG000|Overall Study|Abnormal Lab Value|1
837506|NCT00332462|1793798|FG000|Overall Study|Unsatisfactory therapeutic effect|4
837507|NCT00332462|1793798|FG000|Overall Study|no longer requires study drug|1
837508|NCT00332462|1793798|FG000|Overall Study|Death|3
837509|NCT00332462|1793798|FG000|Overall Study|Graft Loss|2
837510|NCT00332488|1793808|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
837511|NCT00332488|1793809|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
837512|NCT00332488|1793810|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
837513|NCT00332488|1793808|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
837514|NCT00332488|1793809|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
837515|NCT00332488|1793810|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
837516|NCT00332488|1793808|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
837517|NCT00332488|1793809|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
837518|NCT00332488|1793810|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
837519|NCT00332488|1793808|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4
837520|NCT00332488|1793809|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0
837521|NCT00332488|1793810|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20
837522|NCT00332488|1793808|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
837523|NCT00332488|1793809|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
837524|NCT00332488|1793810|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
837525|NCT00332488|1793808|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
837526|NCT00332488|1793809|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
837527|NCT00332488|1793810|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
837528|NCT00332488|1793808|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
837529|NCT00332488|1793809|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
837530|NCT00332488|1793810|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3
837531|NCT00332488|1793808|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
837532|NCT00332488|1793809|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
837533|NCT00332488|1793810|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1
837534|NCT00332488|1793808|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
837535|NCT00332488|1793809|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
837536|NCT00332488|1793810|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3
837537|NCT00332488|1793808|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
837538|NCT00332488|1793809|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
837539|NCT00332488|1793810|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1
837540|NCT00332488|1793808|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
837541|NCT00332488|1793809|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
837542|NCT00332488|1793810|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8
837543|NCT00332488|1793808|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
837544|NCT00332488|1793809|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
837545|NCT00332488|1793810|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5
837546|NCT00332696|1793869|FG000|Overall Study|Death|24
837547|NCT00332696|1793870|FG001|Overall Study|Death|14
837548|NCT00332696|1793869|FG000|Overall Study|Insufficient therapeutic effect|4
837549|NCT00332696|1793870|FG001|Overall Study|Insufficient therapeutic effect|11
837550|NCT00332696|1793869|FG000|Overall Study|Adverse Event|1
837551|NCT00332696|1793870|FG001|Overall Study|Adverse Event|2
837552|NCT00332696|1793869|FG000|Overall Study|Condition does not justify treatment|0
837553|NCT00332696|1793870|FG001|Overall Study|Condition does not justify treatment|2
837554|NCT00332696|1793869|FG000|Overall Study|Lost to Follow-up|0
837555|NCT00332696|1793870|FG001|Overall Study|Lost to Follow-up|1
837556|NCT00332696|1793869|FG000|Overall Study|Withdrawal by Subject|1
837557|NCT00332696|1793870|FG001|Overall Study|Withdrawal by Subject|0
837558|NCT00332709|1793878|FG000|Overall Study|Adverse Event|11
837559|NCT00332709|1793879|FG001|Overall Study|Adverse Event|14
837560|NCT00332709|1793878|FG000|Overall Study|Withdrawal by Subject|2
837561|NCT00332709|1793879|FG001|Overall Study|Withdrawal by Subject|3
837562|NCT00332709|1793878|FG000|Overall Study|Lost to Follow-up|2
837563|NCT00332709|1793879|FG001|Overall Study|Lost to Follow-up|0
837564|NCT00332709|1793878|FG000|Overall Study|Administrative Problems|0
837565|NCT00332709|1793879|FG001|Overall Study|Administrative Problems|3
837566|NCT00332709|1793878|FG000|Overall Study|Abnormal test procedure result|1
837567|NCT00332709|1793879|FG001|Overall Study|Abnormal test procedure result|0
837568|NCT00332839|1793896|FG000|Core (Months 0 - 12)|Administrative problems|1
837569|NCT00332839|1793897|FG001|Core (Months 0 - 12)|Administrative problems|1
837570|NCT00332839|1793896|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3
837571|NCT00332839|1793897|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1
837572|NCT00332839|1793896|FG000|Core (Months 0 - 12)|Protocol deviation|1
837573|NCT00332839|1793897|FG001|Core (Months 0 - 12)|Protocol deviation|1
837574|NCT00332839|1793896|FG000|Core (Months 0 - 12)|Adverse Event|5
837575|NCT00332839|1793897|FG001|Core (Months 0 - 12)|Adverse Event|15
837576|NCT00332839|1793896|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
837577|NCT00332839|1793897|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
837578|NCT00332839|1793896|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2
837579|NCT00332839|1793897|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1
837580|NCT00332839|1793896|FG000|Follow-up (Months 12 - 60)|Death|1
837581|NCT00332839|1793897|FG001|Follow-up (Months 12 - 60)|Death|1
837582|NCT00333138|1793906|FG000|Core Study (6 Months)|Adverse Event|4
837583|NCT00333138|1793907|FG001|Core Study (6 Months)|Adverse Event|5
837584|NCT00333138|1793908|FG002|Core Study (6 Months)|Adverse Event|8
837585|NCT00333138|1793906|FG000|Core Study (6 Months)|Withdrawal by Subject|1
837586|NCT00333138|1793907|FG001|Core Study (6 Months)|Withdrawal by Subject|1
837587|NCT00333138|1793908|FG002|Core Study (6 Months)|Withdrawal by Subject|2
837588|NCT00333138|1793906|FG000|Core Study (6 Months)|Lack of Efficacy|1
837589|NCT00333138|1793907|FG001|Core Study (6 Months)|Lack of Efficacy|0
837590|NCT00333138|1793908|FG002|Core Study (6 Months)|Lack of Efficacy|0
837591|NCT00333138|1793906|FG000|Core Study (6 Months)|Protocol Violation|1
837592|NCT00333138|1793907|FG001|Core Study (6 Months)|Protocol Violation|0
837593|NCT00333138|1793908|FG002|Core Study (6 Months)|Protocol Violation|1
837594|NCT00333138|1793906|FG000|Core Study (6 Months)|Laboratory abnormality|0
837595|NCT00333138|1793907|FG001|Core Study (6 Months)|Laboratory abnormality|0
837596|NCT00333138|1793908|FG002|Core Study (6 Months)|Laboratory abnormality|1
837597|NCT00333138|1793906|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
837598|NCT00333138|1793907|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
837599|NCT00333138|1793908|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
837600|NCT00333138|1793906|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1
837601|NCT00333138|1793907|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1
837602|NCT00333138|1793908|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2
837603|NCT00333138|1793906|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15
837604|NCT00333138|1793907|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19
837605|NCT00333138|1793908|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15
837606|NCT00333138|1793906|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0
837607|NCT00333138|1793907|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0
837608|NCT00333138|1793908|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3
837609|NCT00333138|1793906|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
837610|NCT00333138|1793907|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
837611|NCT00333138|1793908|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
837612|NCT00333138|1793906|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
837613|NCT00333138|1793907|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
837614|NCT00333138|1793908|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
837615|NCT00333138|1793906|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
837616|NCT00333138|1793907|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
837617|NCT00333138|1793908|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
837618|NCT00333138|1793906|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
837619|NCT00333138|1793907|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
837620|NCT00333138|1793908|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
837621|NCT00333138|1793906|FG000|Extension Study (Month6 to End of Study)|Death|0
837622|NCT00333138|1793907|FG001|Extension Study (Month6 to End of Study)|Death|1
837623|NCT00333138|1793908|FG002|Extension Study (Month6 to End of Study)|Death|0
837624|NCT00333359|1793939|FG000|Overall Study|Adverse Event|29
837625|NCT00333359|1793940|FG001|Overall Study|Adverse Event|35
837626|NCT00333359|1793939|FG000|Overall Study|Withdrawal by Subject|19
837627|NCT00333359|1793940|FG001|Overall Study|Withdrawal by Subject|37
837628|NCT00333359|1793939|FG000|Overall Study|Physician Decision|2
837629|NCT00333359|1793940|FG001|Overall Study|Physician Decision|2
837630|NCT00333359|1793939|FG000|Overall Study|Protocol Non-compliance|2
837631|NCT00333359|1793940|FG001|Overall Study|Protocol Non-compliance|8
837632|NCT00333359|1793939|FG000|Overall Study|Lost to Follow-up|15
837633|NCT00333359|1793940|FG001|Overall Study|Lost to Follow-up|25
837634|NCT00333359|1793939|FG000|Overall Study|Termination or Withdrawal by Sponsor|1
837635|NCT00333359|1793940|FG001|Overall Study|Termination or Withdrawal by Sponsor|1
837636|NCT00333359|1793939|FG000|Overall Study|Treatment Failure|3
837637|NCT00333359|1793940|FG001|Overall Study|Treatment Failure|8
837638|NCT00333359|1793939|FG000|Overall Study|Withdrew before Receiving One Dose|2
837639|NCT00333359|1793940|FG001|Overall Study|Withdrew before Receiving One Dose|6
837640|NCT00333619|1793966|FG000|Overall Study|Death|12
837641|NCT00333619|1793967|FG001|Overall Study|Death|6
837642|NCT00333619|1793966|FG000|Overall Study|Withdrawal by Subject|6
837643|NCT00333619|1793967|FG001|Overall Study|Withdrawal by Subject|1
837644|NCT00333619|1793966|FG000|Overall Study|Lost to Follow-up|3
837645|NCT00333619|1793967|FG001|Overall Study|Lost to Follow-up|3
837646|NCT00333775|1793991|FG000|Overall Study|Death|144
837647|NCT00333775|1793992|FG001|Overall Study|Death|149
837648|NCT00333775|1793993|FG002|Overall Study|Death|143
837649|NCT00333775|1793991|FG000|Overall Study|In Follow-up When Study Stopped|87
837650|NCT00333775|1793992|FG001|Overall Study|In Follow-up When Study Stopped|92
837651|NCT00333775|1793993|FG002|Overall Study|In Follow-up When Study Stopped|96
837652|NCT00333775|1793991|FG000|Overall Study|Lost to Follow-up|10
837653|NCT00333775|1793992|FG001|Overall Study|Lost to Follow-up|7
837654|NCT00333775|1793993|FG002|Overall Study|Lost to Follow-up|8
837655|NCT00333788|1794001|FG000|Overall Study|Adverse Event|44
837656|NCT00333788|1794001|FG000|Overall Study|Lack of Efficacy|80
837657|NCT00333788|1794001|FG000|Overall Study|Lost to Follow-up|2
837658|NCT00333788|1794001|FG000|Overall Study|Withdrawal by Subject|24
837659|NCT00333788|1794001|FG000|Overall Study|Other: Non-compliance|2
837660|NCT00333788|1794001|FG000|Overall Study|Other: Moved|2
837661|NCT00333788|1794001|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1
837662|NCT00333788|1794001|FG000|Overall Study|Other: Investigator decision|1
837663|NCT00333788|1794001|FG000|Overall Study|Other: Quality of life concern|1
837664|NCT00333788|1794001|FG000|Overall Study|Other: Sponsor decision|1
837665|NCT00333788|1794001|FG000|Overall Study|Other: Subject in need of an Entocort|1
837666|NCT00333788|1794001|FG000|Overall Study|Other: Medical monitor decision|1
837667|NCT00333788|1794001|FG000|Overall Study|Other: Physician decision|1
837668|NCT00333788|1794001|FG000|Overall Study|Other: Signed consent for another study|1
837669|NCT00333801|1794007|FG000|Overall Study|Moved to another state|5
837670|NCT00333801|1794008|FG001|Overall Study|Moved to another state|3
837671|NCT00333801|1794007|FG000|Overall Study|Lost to Follow-up|2
837672|NCT00333801|1794008|FG001|Overall Study|Lost to Follow-up|0
837673|NCT00333801|1794007|FG000|Overall Study|Incarcerated|1
837674|NCT00333801|1794008|FG001|Overall Study|Incarcerated|2
837675|NCT00333801|1794007|FG000|Overall Study|Withdrawal by Subject|0
837676|NCT00333801|1794008|FG001|Overall Study|Withdrawal by Subject|1
837677|NCT00333840|1794029|FG000|First-line Treatment Period|Adverse Event|38
837678|NCT00333840|1794030|FG001|First-line Treatment Period|Adverse Event|37
837679|NCT00333840|1794031|FG002|First-line Treatment Period|Adverse Event|0
837680|NCT00333840|1794032|FG003|First-line Treatment Period|Adverse Event|0
837681|NCT00333840|1794029|FG000|First-line Treatment Period|Abnormal laboratory values|3
837682|NCT00333840|1794030|FG001|First-line Treatment Period|Abnormal laboratory values|1
837683|NCT00333840|1794031|FG002|First-line Treatment Period|Abnormal laboratory values|0
837684|NCT00333840|1794032|FG003|First-line Treatment Period|Abnormal laboratory values|0
837685|NCT00333840|1794029|FG000|First-line Treatment Period|Abnormal procedure|2
837686|NCT00333840|1794030|FG001|First-line Treatment Period|Abnormal procedure|0
837687|NCT00333840|1794031|FG002|First-line Treatment Period|Abnormal procedure|0
837688|NCT00333840|1794032|FG003|First-line Treatment Period|Abnormal procedure|0
837689|NCT00333840|1794029|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88
837690|NCT00333840|1794030|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29
837691|NCT00333840|1794031|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0
837692|NCT00333840|1794032|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0
837693|NCT00333840|1794029|FG000|First-line Treatment Period|No longer required study drug|21
837694|NCT00333840|1794030|FG001|First-line Treatment Period|No longer required study drug|8
837695|NCT00333840|1794031|FG002|First-line Treatment Period|No longer required study drug|0
837696|NCT00333840|1794032|FG003|First-line Treatment Period|No longer required study drug|0
837697|NCT00333840|1794029|FG000|First-line Treatment Period|Protocol Violation|17
837698|NCT00333840|1794030|FG001|First-line Treatment Period|Protocol Violation|17
837699|NCT00333840|1794031|FG002|First-line Treatment Period|Protocol Violation|0
837700|NCT00333840|1794032|FG003|First-line Treatment Period|Protocol Violation|0
837701|NCT00333840|1794029|FG000|First-line Treatment Period|Subject withdrew consent|57
837702|NCT00333840|1794030|FG001|First-line Treatment Period|Subject withdrew consent|77
837703|NCT00333840|1794031|FG002|First-line Treatment Period|Subject withdrew consent|0
837704|NCT00333840|1794032|FG003|First-line Treatment Period|Subject withdrew consent|0
837705|NCT00333840|1794029|FG000|First-line Treatment Period|Lost to Follow-up|15
837706|NCT00333840|1794030|FG001|First-line Treatment Period|Lost to Follow-up|6
837707|NCT00333840|1794031|FG002|First-line Treatment Period|Lost to Follow-up|0
837708|NCT00333840|1794032|FG003|First-line Treatment Period|Lost to Follow-up|0
837709|NCT00333840|1794029|FG000|First-line Treatment Period|Administrative problems|12
837710|NCT00333840|1794030|FG001|First-line Treatment Period|Administrative problems|6
837711|NCT00333840|1794031|FG002|First-line Treatment Period|Administrative problems|0
837712|NCT00333840|1794032|FG003|First-line Treatment Period|Administrative problems|0
837713|NCT00333840|1794029|FG000|First-line Treatment Period|Death|19
837714|NCT00333840|1794030|FG001|First-line Treatment Period|Death|2
837715|NCT00333840|1794031|FG002|First-line Treatment Period|Death|0
837716|NCT00333840|1794032|FG003|First-line Treatment Period|Death|0
837717|NCT00333840|1794029|FG000|First-line Treatment Period|Crossed over to other treatment arm|14
837718|NCT00333840|1794030|FG001|First-line Treatment Period|Crossed over to other treatment arm|363
837719|NCT00333840|1794031|FG002|First-line Treatment Period|Crossed over to other treatment arm|0
837720|NCT00333840|1794032|FG003|First-line Treatment Period|Crossed over to other treatment arm|0
837721|NCT00333840|1794029|FG000|Second-line Treatment Period|Adverse Event|0
837722|NCT00333840|1794030|FG001|Second-line Treatment Period|Adverse Event|0
837723|NCT00333840|1794031|FG002|Second-line Treatment Period|Adverse Event|3
837724|NCT00333840|1794032|FG003|Second-line Treatment Period|Adverse Event|34
837725|NCT00333840|1794029|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0
837726|NCT00333840|1794030|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0
837890|NCT00335556|1794315|FG004|Overall Study|Death|1
837727|NCT00333840|1794031|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0
837728|NCT00333840|1794032|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3
837729|NCT00333840|1794029|FG000|Second-line Treatment Period|Abnormal procedure|0
837730|NCT00333840|1794030|FG001|Second-line Treatment Period|Abnormal procedure|0
837731|NCT00333840|1794031|FG002|Second-line Treatment Period|Abnormal procedure|0
837732|NCT00333840|1794032|FG003|Second-line Treatment Period|Abnormal procedure|1
837733|NCT00333840|1794029|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
837734|NCT00333840|1794030|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
837735|NCT00333840|1794031|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
837736|NCT00333840|1794032|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
837737|NCT00333840|1794029|FG000|Second-line Treatment Period|No longer required study drug|0
837738|NCT00333840|1794030|FG001|Second-line Treatment Period|No longer required study drug|0
837739|NCT00333840|1794031|FG002|Second-line Treatment Period|No longer required study drug|1
837740|NCT00333840|1794032|FG003|Second-line Treatment Period|No longer required study drug|14
837741|NCT00333840|1794029|FG000|Second-line Treatment Period|Protocol Violation|0
837742|NCT00333840|1794030|FG001|Second-line Treatment Period|Protocol Violation|0
837743|NCT00333840|1794031|FG002|Second-line Treatment Period|Protocol Violation|1
837744|NCT00333840|1794032|FG003|Second-line Treatment Period|Protocol Violation|10
837745|NCT00333840|1794029|FG000|Second-line Treatment Period|Subject withdrew consent|0
837746|NCT00333840|1794030|FG001|Second-line Treatment Period|Subject withdrew consent|0
837747|NCT00333840|1794031|FG002|Second-line Treatment Period|Subject withdrew consent|0
837748|NCT00333840|1794032|FG003|Second-line Treatment Period|Subject withdrew consent|34
837749|NCT00333840|1794029|FG000|Second-line Treatment Period|Lost to Follow-up|0
837750|NCT00333840|1794030|FG001|Second-line Treatment Period|Lost to Follow-up|0
837751|NCT00333840|1794031|FG002|Second-line Treatment Period|Lost to Follow-up|0
837752|NCT00333840|1794032|FG003|Second-line Treatment Period|Lost to Follow-up|6
837753|NCT00333840|1794029|FG000|Second-line Treatment Period|Administrative problems|0
837754|NCT00333840|1794030|FG001|Second-line Treatment Period|Administrative problems|0
837755|NCT00333840|1794031|FG002|Second-line Treatment Period|Administrative problems|0
837756|NCT00333840|1794032|FG003|Second-line Treatment Period|Administrative problems|7
837757|NCT00333840|1794029|FG000|Second-line Treatment Period|Death|0
837758|NCT00333840|1794030|FG001|Second-line Treatment Period|Death|0
837759|NCT00333840|1794031|FG002|Second-line Treatment Period|Death|0
837760|NCT00333840|1794032|FG003|Second-line Treatment Period|Death|9
837761|NCT00333866|1794050|FG000|Overall Study|Adverse Event|23
837762|NCT00333866|1794051|FG001|Overall Study|Adverse Event|37
837763|NCT00333866|1794052|FG002|Overall Study|Adverse Event|38
837764|NCT00333866|1794053|FG003|Overall Study|Adverse Event|47
837765|NCT00333866|1794050|FG000|Overall Study|Other|3
837766|NCT00333866|1794051|FG001|Overall Study|Other|2
837767|NCT00333866|1794052|FG002|Overall Study|Other|2
837768|NCT00333866|1794053|FG003|Overall Study|Other|2
837769|NCT00333866|1794050|FG000|Overall Study|Lack of Efficacy|8
837770|NCT00333866|1794051|FG001|Overall Study|Lack of Efficacy|6
837771|NCT00333866|1794052|FG002|Overall Study|Lack of Efficacy|3
837772|NCT00333866|1794053|FG003|Overall Study|Lack of Efficacy|5
837773|NCT00333866|1794050|FG000|Overall Study|Lost to Follow-up|1
837774|NCT00333866|1794051|FG001|Overall Study|Lost to Follow-up|2
837775|NCT00333866|1794052|FG002|Overall Study|Lost to Follow-up|2
837776|NCT00333866|1794053|FG003|Overall Study|Lost to Follow-up|2
837777|NCT00333866|1794050|FG000|Overall Study|Withdrawal by Subject|8
837778|NCT00333866|1794051|FG001|Overall Study|Withdrawal by Subject|14
837779|NCT00333866|1794052|FG002|Overall Study|Withdrawal by Subject|4
837780|NCT00333866|1794053|FG003|Overall Study|Withdrawal by Subject|9
837781|NCT00333866|1794050|FG000|Overall Study|Randomized but not Treated|5
837782|NCT00333866|1794051|FG001|Overall Study|Randomized but not Treated|3
837783|NCT00333866|1794052|FG002|Overall Study|Randomized but not Treated|2
837784|NCT00333866|1794053|FG003|Overall Study|Randomized but not Treated|1
837785|NCT00333970|1794069|FG000|Overall Study|Withdrawal by Subject|13
837786|NCT00333970|1794070|FG001|Overall Study|Withdrawal by Subject|7
837787|NCT00333983|1794079|FG000|Overall Study|Lost to Follow-up|2
837788|NCT00333983|1794080|FG001|Overall Study|Lost to Follow-up|1
837789|NCT00333983|1794081|FG002|Overall Study|Lost to Follow-up|0
837790|NCT00333983|1794079|FG000|Overall Study|Adverse Event|1
837791|NCT00333983|1794080|FG001|Overall Study|Adverse Event|1
837792|NCT00333983|1794081|FG002|Overall Study|Adverse Event|1
837793|NCT00333983|1794079|FG000|Overall Study|Withdrawal by Subject|0
837794|NCT00333983|1794080|FG001|Overall Study|Withdrawal by Subject|3
837795|NCT00333983|1794081|FG002|Overall Study|Withdrawal by Subject|1
837796|NCT00334113|1794100|FG000|Overall Study|Lost to Follow-up|2
837797|NCT00334113|1794101|FG001|Overall Study|Lost to Follow-up|2
837798|NCT00334113|1794100|FG000|Overall Study|Withdrawal by Subject|0
837799|NCT00334113|1794101|FG001|Overall Study|Withdrawal by Subject|1
837800|NCT00334282|1794114|FG000|Overall Study|Lost to Follow-up|11
837801|NCT00334282|1794115|FG001|Overall Study|Lost to Follow-up|5
837802|NCT00334282|1794114|FG000|Overall Study|Withdrawal by Subject|17
837803|NCT00334282|1794115|FG001|Overall Study|Withdrawal by Subject|3
837804|NCT00334282|1794114|FG000|Overall Study|Death|194
837805|NCT00334282|1794115|FG001|Overall Study|Death|100
837806|NCT00334295|1794125|FG000|Overall Study|Patients received fewer than 3 injection|5
837807|NCT00334542|1794129|FG000|Overall Study|Adverse Event|3
837808|NCT00334542|1794129|FG000|Overall Study|Withdrawal by Subject|1
837809|NCT00334542|1794129|FG000|Overall Study|New cancer diagnosis|1
837810|NCT00334737|1794153|FG000|Hospital Phase|Death|1
837811|NCT00334737|1794154|FG001|Hospital Phase|Death|2
837812|NCT00334737|1794155|FG002|Hospital Phase|Death|3
837813|NCT00334737|1794153|FG000|Hospital Phase|Withdrawal by Subject|0
837814|NCT00334737|1794154|FG001|Hospital Phase|Withdrawal by Subject|0
837815|NCT00334737|1794155|FG002|Hospital Phase|Withdrawal by Subject|1
837816|NCT00334737|1794153|FG000|Hospital Phase|Did not receive study drug|1
837817|NCT00334737|1794154|FG001|Hospital Phase|Did not receive study drug|0
837818|NCT00334737|1794155|FG002|Hospital Phase|Did not receive study drug|0
837819|NCT00334737|1794153|FG000|Follow up Phase|Lost to Follow-up|5
837820|NCT00334737|1794154|FG001|Follow up Phase|Lost to Follow-up|3
837821|NCT00334737|1794155|FG002|Follow up Phase|Lost to Follow-up|6
837822|NCT00334802|1794165|FG000|Overall Study|Progressive Disease|2
837823|NCT00334802|1794166|FG001|Overall Study|Progressive Disease|24
837824|NCT00334802|1794165|FG000|Overall Study|Toxicity|1
837825|NCT00334802|1794166|FG001|Overall Study|Toxicity|5
837826|NCT00334802|1794165|FG000|Overall Study|Lack of Efficacy|1
837827|NCT00334802|1794166|FG001|Overall Study|Lack of Efficacy|3
837828|NCT00334802|1794165|FG000|Overall Study|Patient Condition Aggrevated|1
837829|NCT00334802|1794166|FG001|Overall Study|Patient Condition Aggrevated|0
837830|NCT00334802|1794165|FG000|Overall Study|Physician Decision|1
837831|NCT00334802|1794166|FG001|Overall Study|Physician Decision|0
837832|NCT00334802|1794165|FG000|Overall Study|Withdrawal by Subject|0
837833|NCT00334802|1794166|FG001|Overall Study|Withdrawal by Subject|4
837834|NCT00334802|1794165|FG000|Overall Study|Adverse Event|0
837835|NCT00334802|1794166|FG001|Overall Study|Adverse Event|3
837836|NCT00334802|1794165|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0
837837|NCT00334802|1794166|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1
837838|NCT00334815|1794177|FG000|Overall Study|Adverse Event|3
837839|NCT00334815|1794178|FG001|Overall Study|Adverse Event|2
837840|NCT00334815|1794177|FG000|Overall Study|Death|0
837841|NCT00334815|1794178|FG001|Overall Study|Death|2
837842|NCT00334815|1794177|FG000|Overall Study|Progression|1
837843|NCT00334815|1794178|FG001|Overall Study|Progression|0
837844|NCT00334815|1794177|FG000|Overall Study|ineligible|1
837845|NCT00334815|1794178|FG001|Overall Study|ineligible|1
837846|NCT00334815|1794177|FG000|Overall Study|patient refused treatment|0
837847|NCT00334815|1794178|FG001|Overall Study|patient refused treatment|1
837848|NCT00334815|1794177|FG000|Overall Study|Physician Decision|2
837849|NCT00334815|1794178|FG001|Overall Study|Physician Decision|4
837850|NCT00334893|1794188|FG000|Overall Study|Not Treated|1
837851|NCT00334893|1794189|FG001|Overall Study|Not Treated|0
837852|NCT00334958|1794199|FG000|Overall Study|Medication Noncompliance|0
837853|NCT00334958|1794200|FG001|Overall Study|Medication Noncompliance|3
837854|NCT00334958|1794199|FG000|Overall Study|Protocol Violation|2
837855|NCT00334958|1794200|FG001|Overall Study|Protocol Violation|2
837856|NCT00334958|1794199|FG000|Overall Study|Request of the investigator or sponsor|0
837857|NCT00334958|1794200|FG001|Overall Study|Request of the investigator or sponsor|1
837858|NCT00334958|1794199|FG000|Overall Study|Withdrawal by Subject|7
837859|NCT00334958|1794200|FG001|Overall Study|Withdrawal by Subject|4
837860|NCT00334958|1794199|FG000|Overall Study|Adverse Event|27
837861|NCT00334958|1794200|FG001|Overall Study|Adverse Event|12
837862|NCT00334958|1794199|FG000|Overall Study|Other|1
837863|NCT00334958|1794200|FG001|Overall Study|Other|2
837864|NCT00335140|1794206|FG000|Overall Study|Ineligible|1
837865|NCT00335153|1794210|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5
837866|NCT00335153|1794210|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
837867|NCT00335153|1794210|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
837868|NCT00335153|1794210|FG000|Nasojejunal (NJ) Test Period|Administrative|1
837869|NCT00335153|1794210|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7
837870|NCT00335153|1794210|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
837871|NCT00335153|1794210|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
837872|NCT00335153|1794210|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
837873|NCT00335153|1794210|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13
837874|NCT00335153|1794210|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
837875|NCT00335322|1794245|FG000|Overall Study|Randomised but withdrew prior to ART sta|1
837876|NCT00335322|1794246|FG001|Overall Study|Randomised but withdrew prior to ART sta|2
837877|NCT00335322|1794247|FG002|Overall Study|Randomised but withdrew prior to ART sta|2
837878|NCT00335452|1794262|FG000|Overall Study|Death|156
837879|NCT00335452|1794263|FG001|Overall Study|Death|144
837880|NCT00335452|1794264|FG002|Overall Study|Death|158
837881|NCT00335452|1794265|FG003|Overall Study|Death|129
837882|NCT00335452|1794262|FG000|Overall Study|Lost to Follow-up|2
837883|NCT00335452|1794263|FG001|Overall Study|Lost to Follow-up|3
837884|NCT00335452|1794264|FG002|Overall Study|Lost to Follow-up|1
837885|NCT00335452|1794265|FG003|Overall Study|Lost to Follow-up|2
837886|NCT00335556|1794311|FG000|Overall Study|Death|0
837887|NCT00335556|1794312|FG001|Overall Study|Death|5
837888|NCT00335556|1794313|FG002|Overall Study|Death|0
837889|NCT00335556|1794314|FG003|Overall Study|Death|0
837891|NCT00335556|1794316|FG005|Overall Study|Death|0
837892|NCT00335556|1794311|FG000|Overall Study|Lack of Efficacy|0
837893|NCT00335556|1794312|FG001|Overall Study|Lack of Efficacy|19
837894|NCT00335556|1794313|FG002|Overall Study|Lack of Efficacy|3
837895|NCT00335556|1794314|FG003|Overall Study|Lack of Efficacy|3
837896|NCT00335556|1794315|FG004|Overall Study|Lack of Efficacy|0
837897|NCT00335556|1794316|FG005|Overall Study|Lack of Efficacy|1
837898|NCT00335556|1794311|FG000|Overall Study|Physician Decision|0
837899|NCT00335556|1794312|FG001|Overall Study|Physician Decision|6
837900|NCT00335556|1794313|FG002|Overall Study|Physician Decision|2
837901|NCT00335556|1794314|FG003|Overall Study|Physician Decision|1
837902|NCT00335556|1794315|FG004|Overall Study|Physician Decision|0
837903|NCT00335556|1794316|FG005|Overall Study|Physician Decision|0
837904|NCT00335556|1794311|FG000|Overall Study|Ineligible|2
837905|NCT00335556|1794312|FG001|Overall Study|Ineligible|0
837906|NCT00335556|1794313|FG002|Overall Study|Ineligible|0
837907|NCT00335556|1794314|FG003|Overall Study|Ineligible|0
837908|NCT00335556|1794315|FG004|Overall Study|Ineligible|0
837909|NCT00335556|1794316|FG005|Overall Study|Ineligible|0
837910|NCT00335556|1794311|FG000|Overall Study|Refusal of further protocol therapy|0
837911|NCT00335556|1794312|FG001|Overall Study|Refusal of further protocol therapy|4
837912|NCT00335556|1794313|FG002|Overall Study|Refusal of further protocol therapy|0
837913|NCT00335556|1794314|FG003|Overall Study|Refusal of further protocol therapy|1
837914|NCT00335556|1794315|FG004|Overall Study|Refusal of further protocol therapy|0
837915|NCT00335556|1794316|FG005|Overall Study|Refusal of further protocol therapy|0
837916|NCT00335738|1794347|FG000|Overall Study|Physician Decision|6
837917|NCT00335738|1794348|FG001|Overall Study|Physician Decision|0
837918|NCT00335738|1794347|FG000|Overall Study|Withdrawal by Subject|2
837919|NCT00335738|1794348|FG001|Overall Study|Withdrawal by Subject|0
837920|NCT00335738|1794347|FG000|Overall Study|Ineligible|3
837921|NCT00335738|1794348|FG001|Overall Study|Ineligible|4
837922|NCT00335764|1794360|FG000|Overall Study|wrong histology|1
837923|NCT00335764|1794361|FG001|Overall Study|wrong histology|0
837924|NCT00335764|1794362|FG002|Overall Study|wrong histology|0
837925|NCT00335764|1794363|FG003|Overall Study|wrong histology|0
837926|NCT00335764|1794364|FG004|Overall Study|wrong histology|1
837927|NCT00335777|1794400|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
837928|NCT00335777|1794400|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
837929|NCT00335777|1794400|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
837930|NCT00335777|1794400|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
837931|NCT00335777|1794400|FG000|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
837932|NCT00335829|1794405|FG000|Overall Study|Withdrawal by Subject|1
837933|NCT00335829|1794405|FG000|Overall Study|Lost to Follow-up|1
837934|NCT00335829|1794405|FG000|Overall Study|Adverse Event|1
837935|NCT00335959|1794409|FG000|Overall Study|Adverse Event|2
837936|NCT00335959|1794409|FG000|Overall Study|Ineligible|1
837937|NCT00335972|1794416|FG000|Overall Study|not given treatments|0
837938|NCT00335972|1794417|FG001|Overall Study|not given treatments|3
837939|NCT00336024|1794425|FG000|Overall Study|Death|2
837940|NCT00336024|1794426|FG001|Overall Study|Death|1
837941|NCT00336024|1794425|FG000|Overall Study|Physician Decision|4
837942|NCT00336024|1794426|FG001|Overall Study|Physician Decision|1
837943|NCT00336024|1794425|FG000|Overall Study|Protocol Violation|1
837944|NCT00336024|1794426|FG001|Overall Study|Protocol Violation|0
837945|NCT00336024|1794425|FG000|Overall Study|Withdrawal by Subject|1
837946|NCT00336024|1794426|FG001|Overall Study|Withdrawal by Subject|2
837947|NCT00336024|1794425|FG000|Overall Study|Failure to fulfill consolidation|1
837948|NCT00336024|1794426|FG001|Overall Study|Failure to fulfill consolidation|1
837949|NCT00336024|1794425|FG000|Overall Study|Progressive Disease|4
837950|NCT00336024|1794426|FG001|Overall Study|Progressive Disease|7
837951|NCT00336024|1794425|FG000|Overall Study|Ineligible|7
837952|NCT00336024|1794426|FG001|Overall Study|Ineligible|7
837953|NCT00336284|1794438|FG000|Overall Study|Death|52
837954|NCT00336284|1794439|FG001|Overall Study|Death|26
837955|NCT00336284|1794438|FG000|Overall Study|Lost to Follow-up|82
837956|NCT00336284|1794439|FG001|Overall Study|Lost to Follow-up|61
837957|NCT00336284|1794438|FG000|Overall Study|Withdrawal by Physician or Subject|102
837958|NCT00336284|1794439|FG001|Overall Study|Withdrawal by Physician or Subject|64
837959|NCT00336479|1794474|FG000|Overall Study|Adverse Event|8
837960|NCT00336479|1794475|FG001|Overall Study|Adverse Event|11
837961|NCT00336479|1794476|FG002|Overall Study|Adverse Event|18
837962|NCT00336479|1794477|FG003|Overall Study|Adverse Event|4
837963|NCT00336479|1794474|FG000|Overall Study|Noncompliant|1
837964|NCT00336479|1794475|FG001|Overall Study|Noncompliant|7
837965|NCT00336479|1794476|FG002|Overall Study|Noncompliant|3
837966|NCT00336479|1794477|FG003|Overall Study|Noncompliant|0
837967|NCT00336479|1794474|FG000|Overall Study|Physician Decision|2
837968|NCT00336479|1794475|FG001|Overall Study|Physician Decision|3
837969|NCT00336479|1794476|FG002|Overall Study|Physician Decision|1
837970|NCT00336479|1794477|FG003|Overall Study|Physician Decision|0
837971|NCT00336479|1794474|FG000|Overall Study|Lost to Follow-up|3
837972|NCT00336479|1794475|FG001|Overall Study|Lost to Follow-up|2
837973|NCT00336479|1794476|FG002|Overall Study|Lost to Follow-up|0
837974|NCT00336479|1794477|FG003|Overall Study|Lost to Follow-up|0
837975|NCT00336479|1794474|FG000|Overall Study|Withdrawal by Subject|3
837976|NCT00336479|1794475|FG001|Overall Study|Withdrawal by Subject|2
837977|NCT00336479|1794476|FG002|Overall Study|Withdrawal by Subject|3
837978|NCT00336479|1794477|FG003|Overall Study|Withdrawal by Subject|0
837979|NCT00336479|1794474|FG000|Overall Study|Other|0
837980|NCT00336479|1794475|FG001|Overall Study|Other|0
837981|NCT00336479|1794476|FG002|Overall Study|Other|1
837982|NCT00336479|1794477|FG003|Overall Study|Other|0
837983|NCT00336479|1794474|FG000|Overall Study|Virologic Stopping Rule|20
837984|NCT00336479|1794475|FG001|Overall Study|Virologic Stopping Rule|0
837985|NCT00336479|1794476|FG002|Overall Study|Virologic Stopping Rule|0
837986|NCT00336479|1794477|FG003|Overall Study|Virologic Stopping Rule|0
837987|NCT00336492|1794491|FG000|Overall Study|Adverse Event|4
837988|NCT00336492|1794492|FG001|Overall Study|Adverse Event|3
837989|NCT00336492|1794493|FG002|Overall Study|Adverse Event|6
837990|NCT00336492|1794491|FG000|Overall Study|Lack of Efficacy|6
837991|NCT00336492|1794492|FG001|Overall Study|Lack of Efficacy|1
837992|NCT00336492|1794493|FG002|Overall Study|Lack of Efficacy|4
837993|NCT00336492|1794491|FG000|Overall Study|Other|5
837994|NCT00336492|1794492|FG001|Overall Study|Other|0
837995|NCT00336492|1794493|FG002|Overall Study|Other|1
837996|NCT00336505|1794503|FG000|Overall Study|Adverse Event|10
837997|NCT00336505|1794504|FG001|Overall Study|Adverse Event|9
837998|NCT00336505|1794503|FG000|Overall Study|Lack of Efficacy|8
837999|NCT00336505|1794504|FG001|Overall Study|Lack of Efficacy|4
838000|NCT00336505|1794503|FG000|Overall Study|Lost to Follow-up|7
838001|NCT00336505|1794504|FG001|Overall Study|Lost to Follow-up|4
838002|NCT00336505|1794503|FG000|Overall Study|Withdrawal by Subject|5
838003|NCT00336505|1794504|FG001|Overall Study|Withdrawal by Subject|3
838004|NCT00336505|1794503|FG000|Overall Study|Other|7
838005|NCT00336505|1794504|FG001|Overall Study|Other|7
838006|NCT00336544|1794512|FG000|Overall Study|Lack of Efficacy|8
838007|NCT00336544|1794513|FG001|Overall Study|Lack of Efficacy|5
838008|NCT00336544|1794512|FG000|Overall Study|Adverse Event|4
838009|NCT00336544|1794513|FG001|Overall Study|Adverse Event|9
838010|NCT00336544|1794512|FG000|Overall Study|Withdrawal by Subject|4
838011|NCT00336544|1794513|FG001|Overall Study|Withdrawal by Subject|3
838012|NCT00336544|1794512|FG000|Overall Study|Other|3
838013|NCT00336544|1794513|FG001|Overall Study|Other|5
838014|NCT00336583|1794519|FG000|Overall Study|Lost to Follow-up|1
838015|NCT00336583|1794519|FG000|Overall Study|Death|1
838016|NCT00336856|1794538|FG000|Overall Study|Withdrawal by Subject|3
838017|NCT00336856|1794538|FG000|Overall Study|Found ineligible at time of analysis|1
838018|NCT00336895|1794542|FG000|Overall Study|diarrhea|1
838019|NCT00336895|1794542|FG000|Overall Study|nausea and upset stomach|1
838020|NCT00336895|1794542|FG000|Overall Study|Physician Decision|1
838021|NCT00336895|1794542|FG000|Overall Study|screen failed|1
838022|NCT00337077|1794552|FG000|Overall Study|Progressive disease|25
838023|NCT00337077|1794553|FG001|Overall Study|Progressive disease|37
838024|NCT00337077|1794554|FG002|Overall Study|Progressive disease|19
838025|NCT00337077|1794552|FG000|Overall Study|Adverse Event|7
838026|NCT00337077|1794553|FG001|Overall Study|Adverse Event|7
838027|NCT00337077|1794554|FG002|Overall Study|Adverse Event|1
838028|NCT00337077|1794552|FG000|Overall Study|Death|0
838029|NCT00337077|1794553|FG001|Overall Study|Death|1
838030|NCT00337077|1794554|FG002|Overall Study|Death|0
838031|NCT00337077|1794552|FG000|Overall Study|Withdrawal by Subject|7
838032|NCT00337077|1794553|FG001|Overall Study|Withdrawal by Subject|2
838033|NCT00337077|1794554|FG002|Overall Study|Withdrawal by Subject|2
838034|NCT00337077|1794552|FG000|Overall Study|Alternative therapy|1
838035|NCT00337077|1794553|FG001|Overall Study|Alternative therapy|0
838036|NCT00337077|1794554|FG002|Overall Study|Alternative therapy|0
838037|NCT00337077|1794552|FG000|Overall Study|Physician Decision|1
838038|NCT00337077|1794553|FG001|Overall Study|Physician Decision|4
838039|NCT00337077|1794554|FG002|Overall Study|Physician Decision|2
838040|NCT00337077|1794552|FG000|Overall Study|Never started treatment|1
838041|NCT00337077|1794553|FG001|Overall Study|Never started treatment|1
838042|NCT00337077|1794554|FG002|Overall Study|Never started treatment|0
838043|NCT00337077|1794552|FG000|Overall Study|Ineligible|1
838044|NCT00337077|1794553|FG001|Overall Study|Ineligible|1
838045|NCT00337077|1794554|FG002|Overall Study|Ineligible|1
838046|NCT00337103|1794562|FG000|Overall Study|Progressive Disease|414
838047|NCT00337103|1794563|FG001|Overall Study|Progressive Disease|410
838048|NCT00337103|1794562|FG000|Overall Study|Adverse Event|45
838049|NCT00337103|1794563|FG001|Overall Study|Adverse Event|59
838050|NCT00337103|1794562|FG000|Overall Study|Subject Choice|34
838051|NCT00337103|1794563|FG001|Overall Study|Subject Choice|27
838052|NCT00337103|1794562|FG000|Overall Study|Clinical Progression|27
838053|NCT00337103|1794563|FG001|Overall Study|Clinical Progression|24
838054|NCT00337103|1794562|FG000|Overall Study|Physician Decision|15
838055|NCT00337103|1794563|FG001|Overall Study|Physician Decision|14
838056|NCT00337103|1794562|FG000|Overall Study|Withdrawal by Subject|8
838057|NCT00337103|1794563|FG001|Overall Study|Withdrawal by Subject|5
838058|NCT00337103|1794562|FG000|Overall Study|Other|5
838059|NCT00337103|1794563|FG001|Overall Study|Other|6
838060|NCT00337103|1794562|FG000|Overall Study|Entry Criteria Not Met|4
838061|NCT00337103|1794563|FG001|Overall Study|Entry Criteria Not Met|1
838062|NCT00337103|1794562|FG000|Overall Study|Lost to Follow-up|1
838063|NCT00337103|1794563|FG001|Overall Study|Lost to Follow-up|2
838064|NCT00337103|1794562|FG000|Overall Study|Death|1
838065|NCT00337103|1794563|FG001|Overall Study|Death|0
838066|NCT00337129|1794570|FG000|Overall Study|Adverse Event|4
838067|NCT00337129|1794570|FG000|Overall Study|Withdrawal by Subject|1
838068|NCT00337129|1794570|FG000|Overall Study|Lack of Efficacy|32
838069|NCT00337129|1794570|FG000|Overall Study|Death|2
838070|NCT00337129|1794570|FG000|Overall Study|not protocol specified|1
838071|NCT00337168|1794574|FG000|Overall Study|Death|5
838072|NCT00337168|1794574|FG000|Overall Study|Not protocol specified|2
838073|NCT00337168|1794574|FG000|Overall Study|Did not start therapy|1
838074|NCT00337194|1794590|FG000|Overall Study|Adverse Event|5
838075|NCT00337194|1794591|FG001|Overall Study|Adverse Event|1
838076|NCT00337194|1794590|FG000|Overall Study|Death|2
838077|NCT00337194|1794591|FG001|Overall Study|Death|0
838078|NCT00337194|1794590|FG000|Overall Study|Withdrawal by Subject|1
838079|NCT00337194|1794591|FG001|Overall Study|Withdrawal by Subject|0
838080|NCT00337194|1794590|FG000|Overall Study|Disease progression|1
838081|NCT00337194|1794591|FG001|Overall Study|Disease progression|2
838082|NCT00337194|1794590|FG000|Overall Study|Subsequent non-protocol therapy|3
838083|NCT00337194|1794591|FG001|Overall Study|Subsequent non-protocol therapy|1
838084|NCT00337207|1794599|FG000|Overall Study|Withdrawal by Subject|3
838085|NCT00337272|1794606|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2
838086|NCT00337272|1794607|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0
838087|NCT00337272|1794606|FG000|Screening Period (Pre-randomization)|Non-compliance|1
838088|NCT00337272|1794607|FG001|Screening Period (Pre-randomization)|Non-compliance|0
838089|NCT00337272|1794606|FG000|Screening Period (Pre-randomization)|Screen failure|3
838090|NCT00337272|1794607|FG001|Screening Period (Pre-randomization)|Screen failure|0
838091|NCT00337272|1794606|FG000|Treatment Period|Non-compliance|1
838092|NCT00337272|1794607|FG001|Treatment Period|Non-compliance|1
838093|NCT00337272|1794606|FG000|Treatment Period|Withdrawal by Subject|0
838094|NCT00337272|1794607|FG001|Treatment Period|Withdrawal by Subject|1
838095|NCT00337272|1794606|FG000|Withdrawal Period|Non-compliance|0
838096|NCT00337272|1794607|FG001|Withdrawal Period|Non-compliance|1
838097|NCT00337285|1794613|FG000|Overall Study|Withdrawal by Subject|42
838098|NCT00337285|1794613|FG000|Overall Study|Lost to Follow-up|41
838099|NCT00337285|1794613|FG000|Overall Study|Adverse Event|28
838100|NCT00337285|1794613|FG000|Overall Study|Protocol Violation|27
838101|NCT00337285|1794613|FG000|Overall Study|Lack of Efficacy|11
838102|NCT00337285|1794613|FG000|Overall Study|Death|1
838103|NCT00337285|1794613|FG000|Overall Study|Physician Decision|1
838104|NCT00337285|1794613|FG000|Overall Study|Lack of protocol compliance|7
838105|NCT00337428|1794628|FG000|Overall Study|Withdrawal by Subject|1
838106|NCT00337428|1794629|FG001|Overall Study|Withdrawal by Subject|2
838107|NCT00337428|1794628|FG000|Overall Study|Lack of Time|1
838108|NCT00337428|1794629|FG001|Overall Study|Lack of Time|1
838109|NCT00337428|1794628|FG000|Overall Study|Unwilling to Continue|1
838110|NCT00337428|1794629|FG001|Overall Study|Unwilling to Continue|0
838111|NCT00337428|1794628|FG000|Overall Study|Anorexia|1
838112|NCT00337428|1794629|FG001|Overall Study|Anorexia|0
838113|NCT00337467|1794635|FG000|Overall Study|Adverse Event|3
838114|NCT00337467|1794635|FG000|Overall Study|Subject Withdrew Consent|2
838115|NCT00337467|1794635|FG000|Overall Study|Pregnancy|1
838116|NCT00337467|1794635|FG000|Overall Study|Lost to Follow-up|2
838117|NCT00337467|1794635|FG000|Overall Study|Subject No Longer Met Study Criteria|2
838118|NCT00337571|1794646|FG000|Overall Study|Lack of Efficacy|3
838119|NCT00337571|1794647|FG001|Overall Study|Lack of Efficacy|0
838120|NCT00337571|1794648|FG002|Overall Study|Lack of Efficacy|0
838121|NCT00337571|1794649|FG003|Overall Study|Lack of Efficacy|0
838122|NCT00337571|1794646|FG000|Overall Study|Adverse Event|4
838123|NCT00337571|1794647|FG001|Overall Study|Adverse Event|5
838124|NCT00337571|1794648|FG002|Overall Study|Adverse Event|8
838125|NCT00337571|1794649|FG003|Overall Study|Adverse Event|4
838126|NCT00337571|1794646|FG000|Overall Study|Withdrawal by Subject|2
838127|NCT00337571|1794647|FG001|Overall Study|Withdrawal by Subject|2
838128|NCT00337571|1794648|FG002|Overall Study|Withdrawal by Subject|1
838129|NCT00337571|1794649|FG003|Overall Study|Withdrawal by Subject|0
838130|NCT00337571|1794646|FG000|Overall Study|Lost to Follow-up|3
838131|NCT00337571|1794647|FG001|Overall Study|Lost to Follow-up|1
838132|NCT00337571|1794648|FG002|Overall Study|Lost to Follow-up|0
838133|NCT00337571|1794649|FG003|Overall Study|Lost to Follow-up|1
838134|NCT00337571|1794646|FG000|Overall Study|Poor/noncompliance|1
838135|NCT00337571|1794647|FG001|Overall Study|Poor/noncompliance|1
838136|NCT00337571|1794648|FG002|Overall Study|Poor/noncompliance|1
838137|NCT00337571|1794649|FG003|Overall Study|Poor/noncompliance|1
838138|NCT00337571|1794646|FG000|Overall Study|No longer met study criteria|1
838139|NCT00337571|1794647|FG001|Overall Study|No longer met study criteria|0
838140|NCT00337571|1794648|FG002|Overall Study|No longer met study criteria|0
838141|NCT00337571|1794649|FG003|Overall Study|No longer met study criteria|0
838142|NCT00337571|1794646|FG000|Overall Study|High Potassium level|0
838143|NCT00337571|1794647|FG001|Overall Study|High Potassium level|0
838144|NCT00337571|1794648|FG002|Overall Study|High Potassium level|0
838145|NCT00337571|1794649|FG003|Overall Study|High Potassium level|1
838146|NCT00337610|1794661|FG000|Overall Study|Adverse Event|2
838147|NCT00337610|1794662|FG001|Overall Study|Adverse Event|2
838148|NCT00337610|1794661|FG000|Overall Study|Death|0
838149|NCT00337610|1794662|FG001|Overall Study|Death|1
838150|NCT00337610|1794661|FG000|Overall Study|Lack of Efficacy|6
838151|NCT00337610|1794662|FG001|Overall Study|Lack of Efficacy|3
838152|NCT00337610|1794661|FG000|Overall Study|Lost to Follow-up|3
838153|NCT00337610|1794662|FG001|Overall Study|Lost to Follow-up|3
838154|NCT00337610|1794661|FG000|Overall Study|Withdrawal by Subject|6
838155|NCT00337610|1794662|FG001|Overall Study|Withdrawal by Subject|5
838156|NCT00337662|1794671|FG000|Study Period II|Lost to Follow-up|0
838157|NCT00337662|1794672|FG001|Study Period II|Lost to Follow-up|0
838158|NCT00337662|1794673|FG002|Study Period II|Lost to Follow-up|0
838159|NCT00337662|1794674|FG003|Study Period II|Lost to Follow-up|35
838160|NCT00337662|1794671|FG000|Study Period II|Withdrawal by Subject|0
838161|NCT00337662|1794672|FG001|Study Period II|Withdrawal by Subject|0
838162|NCT00337662|1794673|FG002|Study Period II|Withdrawal by Subject|0
838163|NCT00337662|1794674|FG003|Study Period II|Withdrawal by Subject|20
838164|NCT00337662|1794671|FG000|Study Period II|Adverse Event|0
838165|NCT00337662|1794672|FG001|Study Period II|Adverse Event|0
838166|NCT00337662|1794673|FG002|Study Period II|Adverse Event|0
838167|NCT00337662|1794674|FG003|Study Period II|Adverse Event|16
838168|NCT00337662|1794671|FG000|Study Period II|Physician Decision|0
838169|NCT00337662|1794672|FG001|Study Period II|Physician Decision|0
838170|NCT00337662|1794673|FG002|Study Period II|Physician Decision|0
838171|NCT00337662|1794674|FG003|Study Period II|Physician Decision|13
838172|NCT00337662|1794671|FG000|Study Period II|Entry Criteria Not Met|0
838173|NCT00337662|1794672|FG001|Study Period II|Entry Criteria Not Met|0
838174|NCT00337662|1794673|FG002|Study Period II|Entry Criteria Not Met|0
838175|NCT00337662|1794674|FG003|Study Period II|Entry Criteria Not Met|6
838176|NCT00337662|1794671|FG000|Study Period II|Protocol Violation|0
838177|NCT00337662|1794672|FG001|Study Period II|Protocol Violation|0
838178|NCT00337662|1794673|FG002|Study Period II|Protocol Violation|0
838179|NCT00337662|1794674|FG003|Study Period II|Protocol Violation|6
838180|NCT00337662|1794671|FG000|Study Period II|Lack of Efficacy|0
838181|NCT00337662|1794672|FG001|Study Period II|Lack of Efficacy|0
838182|NCT00337662|1794673|FG002|Study Period II|Lack of Efficacy|0
838183|NCT00337662|1794674|FG003|Study Period II|Lack of Efficacy|7
838184|NCT00337662|1794671|FG000|Study Period II|Sponsor Decision|0
838185|NCT00337662|1794672|FG001|Study Period II|Sponsor Decision|0
838186|NCT00337662|1794673|FG002|Study Period II|Sponsor Decision|0
838187|NCT00337662|1794674|FG003|Study Period II|Sponsor Decision|2
838188|NCT00337662|1794671|FG000|Study Period II|Parent/Caregiver Decision|0
838189|NCT00337662|1794672|FG001|Study Period II|Parent/Caregiver Decision|0
838190|NCT00337662|1794673|FG002|Study Period II|Parent/Caregiver Decision|0
838191|NCT00337662|1794674|FG003|Study Period II|Parent/Caregiver Decision|1
838192|NCT00337662|1794671|FG000|Study Period III|Lost to Follow-up|14
838193|NCT00337662|1794672|FG001|Study Period III|Lost to Follow-up|16
838194|NCT00337662|1794673|FG002|Study Period III|Lost to Follow-up|14
838195|NCT00337662|1794674|FG003|Study Period III|Lost to Follow-up|0
838196|NCT00337662|1794671|FG000|Study Period III|Withdrawal by Subject|18
838197|NCT00337662|1794672|FG001|Study Period III|Withdrawal by Subject|14
838198|NCT00337662|1794673|FG002|Study Period III|Withdrawal by Subject|12
838199|NCT00337662|1794674|FG003|Study Period III|Withdrawal by Subject|0
838200|NCT00337662|1794671|FG000|Study Period III|Adverse Event|9
838201|NCT00337662|1794672|FG001|Study Period III|Adverse Event|10
838202|NCT00337662|1794673|FG002|Study Period III|Adverse Event|8
838203|NCT00337662|1794674|FG003|Study Period III|Adverse Event|0
838204|NCT00337662|1794671|FG000|Study Period III|Protocol Violation|3
838205|NCT00337662|1794672|FG001|Study Period III|Protocol Violation|8
838206|NCT00337662|1794673|FG002|Study Period III|Protocol Violation|2
838207|NCT00337662|1794674|FG003|Study Period III|Protocol Violation|0
838208|NCT00337662|1794671|FG000|Study Period III|Physician Decision|6
838209|NCT00337662|1794672|FG001|Study Period III|Physician Decision|5
838210|NCT00337662|1794673|FG002|Study Period III|Physician Decision|0
838211|NCT00337662|1794674|FG003|Study Period III|Physician Decision|0
838212|NCT00337662|1794671|FG000|Study Period III|Entry Criteria Not Met|4
838213|NCT00337662|1794672|FG001|Study Period III|Entry Criteria Not Met|1
838214|NCT00337662|1794673|FG002|Study Period III|Entry Criteria Not Met|3
838215|NCT00337662|1794674|FG003|Study Period III|Entry Criteria Not Met|0
838216|NCT00337662|1794671|FG000|Study Period III|Lack of Efficacy|4
838217|NCT00337662|1794672|FG001|Study Period III|Lack of Efficacy|4
838218|NCT00337662|1794673|FG002|Study Period III|Lack of Efficacy|2
838219|NCT00337662|1794674|FG003|Study Period III|Lack of Efficacy|0
838220|NCT00337662|1794671|FG000|Study Period III|Parent/Caregiver Decision|0
838221|NCT00337662|1794672|FG001|Study Period III|Parent/Caregiver Decision|0
838222|NCT00337662|1794673|FG002|Study Period III|Parent/Caregiver Decision|2
838223|NCT00337662|1794674|FG003|Study Period III|Parent/Caregiver Decision|0
838224|NCT00337662|1794671|FG000|Study Period III|Sponsor Decision|1
838225|NCT00337662|1794672|FG001|Study Period III|Sponsor Decision|0
838226|NCT00337662|1794673|FG002|Study Period III|Sponsor Decision|1
838227|NCT00337662|1794674|FG003|Study Period III|Sponsor Decision|0
838228|NCT00337662|1794671|FG000|Study Period III|Clinical Relapse|1
838229|NCT00337662|1794672|FG001|Study Period III|Clinical Relapse|0
838230|NCT00337662|1794673|FG002|Study Period III|Clinical Relapse|0
838231|NCT00337662|1794674|FG003|Study Period III|Clinical Relapse|0
838232|NCT00337675|1794688|FG000|Overall Study|Adverse Event|10
838233|NCT00337675|1794689|FG001|Overall Study|Adverse Event|9
838234|NCT00337675|1794690|FG002|Overall Study|Adverse Event|19
838235|NCT00337675|1794688|FG000|Overall Study|Lack of Efficacy|10
838236|NCT00337675|1794689|FG001|Overall Study|Lack of Efficacy|7
838237|NCT00337675|1794690|FG002|Overall Study|Lack of Efficacy|9
838238|NCT00337675|1794688|FG000|Overall Study|Lost to Follow-up|22
838239|NCT00337675|1794689|FG001|Overall Study|Lost to Follow-up|19
838240|NCT00337675|1794690|FG002|Overall Study|Lost to Follow-up|17
838241|NCT00337675|1794688|FG000|Overall Study|Physician Decision|9
838242|NCT00337675|1794689|FG001|Overall Study|Physician Decision|17
838243|NCT00337675|1794690|FG002|Overall Study|Physician Decision|14
838244|NCT00337675|1794688|FG000|Overall Study|Protocol Violation|21
838245|NCT00337675|1794689|FG001|Overall Study|Protocol Violation|24
838246|NCT00337675|1794690|FG002|Overall Study|Protocol Violation|19
838247|NCT00337675|1794688|FG000|Overall Study|Withdrawal by Subject|25
838248|NCT00337675|1794689|FG001|Overall Study|Withdrawal by Subject|25
838249|NCT00337675|1794690|FG002|Overall Study|Withdrawal by Subject|19
838250|NCT00337675|1794688|FG000|Overall Study|Progressive Disease|0
838251|NCT00337675|1794689|FG001|Overall Study|Progressive Disease|2
838252|NCT00337675|1794690|FG002|Overall Study|Progressive Disease|0
838253|NCT00337675|1794688|FG000|Overall Study|Trial Terminated|0
838254|NCT00337675|1794689|FG001|Overall Study|Trial Terminated|0
838255|NCT00337675|1794690|FG002|Overall Study|Trial Terminated|2
838256|NCT00337727|1794700|FG000|Overall Study|Adverse Event|5
838257|NCT00337727|1794701|FG001|Overall Study|Adverse Event|3
838258|NCT00337727|1794700|FG000|Overall Study|Lost to Follow-up|5
838259|NCT00337727|1794701|FG001|Overall Study|Lost to Follow-up|4
838260|NCT00337727|1794700|FG000|Overall Study|Physician Decision|1
838261|NCT00337727|1794701|FG001|Overall Study|Physician Decision|0
838262|NCT00337727|1794700|FG000|Overall Study|Protocol Violation|4
838263|NCT00337727|1794701|FG001|Overall Study|Protocol Violation|0
838264|NCT00337727|1794700|FG000|Overall Study|Withdrawal by Subject|3
838265|NCT00337727|1794701|FG001|Overall Study|Withdrawal by Subject|5
838266|NCT00337779|1794709|FG000|Overall Study|Withdrawal by Subject|10
838267|NCT00337779|1794710|FG001|Overall Study|Withdrawal by Subject|12
838268|NCT00337779|1794709|FG000|Overall Study|Sponsor decision|1
838269|NCT00337779|1794710|FG001|Overall Study|Sponsor decision|1
838270|NCT00337779|1794709|FG000|Overall Study|Physician Decision|3
838271|NCT00337779|1794710|FG001|Overall Study|Physician Decision|6
838272|NCT00337779|1794709|FG000|Overall Study|Protocol Violation|1
838273|NCT00337779|1794710|FG001|Overall Study|Protocol Violation|1
838274|NCT00337779|1794709|FG000|Overall Study|Lost to Follow-up|6
838275|NCT00337779|1794710|FG001|Overall Study|Lost to Follow-up|5
838276|NCT00337779|1794709|FG000|Overall Study|Adverse Event|28
838277|NCT00337779|1794710|FG001|Overall Study|Adverse Event|51
838278|NCT00337779|1794709|FG000|Overall Study|Pregnancy|3
838279|NCT00337779|1794710|FG001|Overall Study|Pregnancy|2
838280|NCT00337779|1794709|FG000|Overall Study|Death|0
838281|NCT00337779|1794710|FG001|Overall Study|Death|1
838282|NCT00337818|1794719|FG000|Overall Study|Lost to Follow-up|289
838283|NCT00337818|1794720|FG001|Overall Study|Lost to Follow-up|91
838284|NCT00337818|1794721|FG002|Overall Study|Lost to Follow-up|107
838285|NCT00337935|1794731|FG000|Overall Study|Adverse Event|2
838286|NCT00337935|1794732|FG001|Overall Study|Adverse Event|5
838287|NCT00337935|1794731|FG000|Overall Study|Death|2
838288|NCT00337935|1794732|FG001|Overall Study|Death|8
838289|NCT00337935|1794731|FG000|Overall Study|Physician Decision|1
838290|NCT00337935|1794732|FG001|Overall Study|Physician Decision|1
838291|NCT00337935|1794731|FG000|Overall Study|Lost to Follow-up|0
838292|NCT00337935|1794732|FG001|Overall Study|Lost to Follow-up|1
838293|NCT00337935|1794731|FG000|Overall Study|Protocol Violation|4
838294|NCT00337935|1794732|FG001|Overall Study|Protocol Violation|3
838295|NCT00337935|1794731|FG000|Overall Study|Withdrawal by Subject|1
838296|NCT00337935|1794732|FG001|Overall Study|Withdrawal by Subject|7
838297|NCT00337935|1794731|FG000|Overall Study|Other|0
838298|NCT00337935|1794732|FG001|Overall Study|Other|1
838299|NCT00337935|1794731|FG000|Overall Study|Lack of Efficacy|0
838300|NCT00337935|1794732|FG001|Overall Study|Lack of Efficacy|1
838301|NCT00338104|1794750|FG000|Overall Study|Protocol Violation|2
838302|NCT00338104|1794751|FG001|Overall Study|Protocol Violation|1
838303|NCT00338104|1794752|FG002|Overall Study|Protocol Violation|3
838304|NCT00338286|1794759|FG000|Overall Study|Withdrawal by Subject|50
838305|NCT00338286|1794760|FG001|Overall Study|Withdrawal by Subject|54
838306|NCT00338286|1794759|FG000|Overall Study|Lost to Follow-up|80
838307|NCT00338286|1794760|FG001|Overall Study|Lost to Follow-up|66
838308|NCT00338286|1794759|FG000|Overall Study|Other|103
838309|NCT00338286|1794760|FG001|Overall Study|Other|93
838310|NCT00338728|1794775|FG000|Overall Study|Screen Failure|14
838311|NCT00338741|1794781|FG000|Overall Study|Lost to Follow-up|2
838312|NCT00338741|1794782|FG001|Overall Study|Lost to Follow-up|0
838313|NCT00338806|1794790|FG000|Acute Phase|Withdrawal by Subject|0
838314|NCT00338806|1794791|FG001|Acute Phase|Withdrawal by Subject|1
838315|NCT00338806|1794790|FG000|Follow-up|Lost to Follow-up|1
838316|NCT00338806|1794791|FG001|Follow-up|Lost to Follow-up|3
838317|NCT00338884|1794799|FG000|Overall Study|Objective Disease Progression or Relapse|44
838318|NCT00338884|1794799|FG000|Overall Study|Adverse Event|14
838319|NCT00338884|1794799|FG000|Overall Study|Death|8
838320|NCT00338884|1794799|FG000|Overall Study|Other|4
838321|NCT00338884|1794799|FG000|Overall Study|Global Deterioration of Health Status|3
838322|NCT00338884|1794799|FG000|Overall Study|Withdrawal by Subject|3
838323|NCT00338884|1794799|FG000|Overall Study|Lost to Follow-up|1
838324|NCT00338884|1794799|FG000|Overall Study|Randomized But Did Not Receive Treatment|1
838325|NCT00338949|1794805|FG000|Subject Screening|Screen failures|11
838326|NCT00338949|1794806|FG001|Subject Screening|Screen failures|11
838327|NCT00338949|1794805|FG000|Randomization|Withdrawal by Subject|1
838328|NCT00338949|1794806|FG001|Randomization|Withdrawal by Subject|0
838329|NCT00338949|1794805|FG000|Randomization|Adverse Event|0
838330|NCT00338949|1794806|FG001|Randomization|Adverse Event|5
838331|NCT00338962|1794816|FG000|Overall Study|Lost to Follow-up|3
838332|NCT00338962|1794817|FG001|Overall Study|Lost to Follow-up|3
838333|NCT00338962|1794818|FG002|Overall Study|Lost to Follow-up|2
838334|NCT00338962|1794819|FG003|Overall Study|Lost to Follow-up|3
838335|NCT00338962|1794816|FG000|Overall Study|Withdrawal by Subject|1
838336|NCT00338962|1794817|FG001|Overall Study|Withdrawal by Subject|0
838337|NCT00338962|1794818|FG002|Overall Study|Withdrawal by Subject|0
838338|NCT00338962|1794819|FG003|Overall Study|Withdrawal by Subject|0
838339|NCT00338962|1794816|FG000|Overall Study|No Transportation|2
838340|NCT00338962|1794817|FG001|Overall Study|No Transportation|0
838341|NCT00338962|1794818|FG002|Overall Study|No Transportation|0
838342|NCT00338962|1794819|FG003|Overall Study|No Transportation|0
838343|NCT00338962|1794816|FG000|Overall Study|Time Constraint|2
838344|NCT00338962|1794817|FG001|Overall Study|Time Constraint|0
838345|NCT00338962|1794818|FG002|Overall Study|Time Constraint|0
838346|NCT00338962|1794819|FG003|Overall Study|Time Constraint|0
838347|NCT00338962|1794816|FG000|Overall Study|Moved|0
838348|NCT00338962|1794817|FG001|Overall Study|Moved|1
838349|NCT00338962|1794818|FG002|Overall Study|Moved|0
838350|NCT00338962|1794819|FG003|Overall Study|Moved|0
838351|NCT00338962|1794816|FG000|Overall Study|Adverse Event|0
838352|NCT00338962|1794817|FG001|Overall Study|Adverse Event|0
838353|NCT00338962|1794818|FG002|Overall Study|Adverse Event|2
838354|NCT00338962|1794819|FG003|Overall Study|Adverse Event|0
838355|NCT00338962|1794816|FG000|Overall Study|Poor Compliance|0
838356|NCT00338962|1794817|FG001|Overall Study|Poor Compliance|0
838357|NCT00338962|1794818|FG002|Overall Study|Poor Compliance|2
838358|NCT00338962|1794819|FG003|Overall Study|Poor Compliance|0
838359|NCT00339040|1794836|FG000|Stage I|Not able to attend clinic|1
838360|NCT00339040|1794837|FG001|Stage I|Not able to attend clinic|0
838361|NCT00339040|1794836|FG000|Stage I|Protocol Violation|1
838362|NCT00339040|1794837|FG001|Stage I|Protocol Violation|1
838363|NCT00339040|1794836|FG000|Stage II|Lost to Follow-up|3
838364|NCT00339040|1794837|FG001|Stage II|Lost to Follow-up|0
838365|NCT00339040|1794836|FG000|Stage II|Withdrawal by Subject|1
838366|NCT00339040|1794837|FG001|Stage II|Withdrawal by Subject|2
838367|NCT00339040|1794836|FG000|Stage II|Protocol Violation|3
838368|NCT00339040|1794837|FG001|Stage II|Protocol Violation|0
838369|NCT00339040|1794836|FG000|Stage II|Not able to attend clinic|1
838370|NCT00339040|1794837|FG001|Stage II|Not able to attend clinic|0
838371|NCT00339040|1794836|FG000|Stage II|Site closing|2
838372|NCT00339040|1794837|FG001|Stage II|Site closing|0
838373|NCT00339144|1794867|FG000|Overall Study|Disease progression|5
838374|NCT00339144|1794868|FG001|Overall Study|Disease progression|2
838375|NCT00339144|1794869|FG002|Overall Study|Disease progression|2
838376|NCT00339144|1794867|FG000|Overall Study|Study drug toxicity|3
838377|NCT00339144|1794868|FG001|Overall Study|Study drug toxicity|1
838378|NCT00339144|1794869|FG002|Overall Study|Study drug toxicity|1
838379|NCT00339144|1794867|FG000|Overall Study|Participant's request to discontinuation|1
838380|NCT00339144|1794868|FG001|Overall Study|Participant's request to discontinuation|0
838381|NCT00339144|1794869|FG002|Overall Study|Participant's request to discontinuation|1
838382|NCT00339183|1794880|FG000|Overall Study|Adverse Event|5
838383|NCT00339183|1794881|FG001|Overall Study|Adverse Event|3
838384|NCT00339183|1794880|FG000|Overall Study|Withdrawal by Subject|16
838385|NCT00339183|1794881|FG001|Overall Study|Withdrawal by Subject|19
838386|NCT00339183|1794880|FG000|Overall Study|Physician Decision|2
838387|NCT00339183|1794881|FG001|Overall Study|Physician Decision|4
838388|NCT00339183|1794880|FG000|Overall Study|Lost to Follow-up|17
838389|NCT00339183|1794881|FG001|Overall Study|Lost to Follow-up|17
838390|NCT00339183|1794880|FG000|Overall Study|Protocol-specified criteria|12
838391|NCT00339183|1794881|FG001|Overall Study|Protocol-specified criteria|8
838392|NCT00339183|1794880|FG000|Overall Study|Missing reason|3
838393|NCT00339183|1794881|FG001|Overall Study|Missing reason|1
838394|NCT00339183|1794880|FG000|Overall Study|Other|46
838395|NCT00339183|1794881|FG001|Overall Study|Other|40
838396|NCT00339183|1794880|FG000|Overall Study|Ongoing|20
838397|NCT00339183|1794881|FG001|Overall Study|Ongoing|13
838398|NCT00339833|1794893|FG000|Overall Study|Withdrawal by Subject|1
838399|NCT00339833|1794894|FG001|Overall Study|Withdrawal by Subject|2
838400|NCT00339833|1794893|FG000|Overall Study|toothache|0
838401|NCT00339833|1794894|FG001|Overall Study|toothache|1
838402|NCT00339833|1794893|FG000|Overall Study|indigestion|0
838403|NCT00339833|1794894|FG001|Overall Study|indigestion|1
838404|NCT00339833|1794893|FG000|Overall Study|Chest pain|0
838405|NCT00339833|1794894|FG001|Overall Study|Chest pain|1
838406|NCT00339833|1794893|FG000|Overall Study|minor infection|0
838407|NCT00339833|1794894|FG001|Overall Study|minor infection|1
838408|NCT00339833|1794893|FG000|Overall Study|Poor venous access|2
838409|NCT00339833|1794894|FG001|Overall Study|Poor venous access|2
838410|NCT00339833|1794893|FG000|Overall Study|anaemia or excess drop in glycaemia|2
838411|NCT00339833|1794894|FG001|Overall Study|anaemia or excess drop in glycaemia|0
838412|NCT00339833|1794893|FG000|Overall Study|Error in data records|1
838413|NCT00339833|1794894|FG001|Overall Study|Error in data records|0
838414|NCT00340678|1794913|FG000|Overall Study|Lost to Follow-up|1
838415|NCT00340678|1794914|FG001|Overall Study|Lost to Follow-up|0
838416|NCT00340678|1794915|FG002|Overall Study|Lost to Follow-up|0
838417|NCT00340678|1794916|FG003|Overall Study|Lost to Follow-up|0
838418|NCT00340704|1794933|FG000|PK Study|Adverse Event|0
838419|NCT00340704|1794934|FG001|PK Study|Adverse Event|1
838420|NCT00340704|1794935|FG002|PK Study|Adverse Event|0
838421|NCT00340704|1794936|FG003|PK Study|Adverse Event|0
838422|NCT00340704|1794937|FG004|PK Study|Adverse Event|0
838423|NCT00340704|1794938|FG005|PK Study|Adverse Event|0
838424|NCT00340704|1794939|FG006|PK Study|Adverse Event|0
838425|NCT00340704|1794940|FG007|PK Study|Adverse Event|0
838426|NCT00340704|1794941|FG008|PK Study|Adverse Event|0
838427|NCT00340704|1794933|FG000|PK Study|Not treated|0
838428|NCT00340704|1794934|FG001|PK Study|Not treated|0
838429|NCT00340704|1794935|FG002|PK Study|Not treated|1
838430|NCT00340704|1794936|FG003|PK Study|Not treated|0
838431|NCT00340704|1794937|FG004|PK Study|Not treated|0
838432|NCT00340704|1794938|FG005|PK Study|Not treated|0
838433|NCT00340704|1794939|FG006|PK Study|Not treated|0
838434|NCT00340704|1794940|FG007|PK Study|Not treated|0
838435|NCT00340704|1794941|FG008|PK Study|Not treated|0
838436|NCT00340704|1794933|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
838437|NCT00340704|1794934|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
838438|NCT00340704|1794935|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
838439|NCT00340704|1794936|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
838440|NCT00340704|1794937|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
838441|NCT00340704|1794938|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
838442|NCT00340704|1794939|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
838443|NCT00340704|1794940|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
838444|NCT00340704|1794941|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
838445|NCT00340704|1794933|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
838446|NCT00340704|1794934|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
838447|NCT00340704|1794935|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
838448|NCT00340704|1794936|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
838449|NCT00340704|1794937|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
838450|NCT00340704|1794938|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
838451|NCT00340704|1794939|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
838452|NCT00340704|1794940|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
838453|NCT00340704|1794941|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
838454|NCT00340704|1794933|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
838455|NCT00340704|1794934|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
838456|NCT00340704|1794935|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
838457|NCT00340704|1794936|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
838458|NCT00340704|1794937|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
838459|NCT00340704|1794938|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
838460|NCT00340704|1794939|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
838461|NCT00340704|1794940|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
838462|NCT00340704|1794941|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
838463|NCT00340704|1794933|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
838464|NCT00340704|1794934|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
838465|NCT00340704|1794935|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
838466|NCT00340704|1794936|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
838467|NCT00340704|1794937|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
838468|NCT00340704|1794938|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
838469|NCT00340704|1794939|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
838470|NCT00340704|1794940|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
838471|NCT00340704|1794941|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
838472|NCT00340834|1794972|FG000|Core Phase of Study|Adverse Event|26
838473|NCT00340834|1794973|FG001|Core Phase of Study|Adverse Event|9
838474|NCT00340834|1794974|FG002|Core Phase of Study|Adverse Event|9
838475|NCT00340834|1794975|FG003|Core Phase of Study|Adverse Event|0
838476|NCT00340834|1794976|FG004|Core Phase of Study|Adverse Event|0
838477|NCT00340834|1794972|FG000|Core Phase of Study|Withdrawal by Subject|11
838478|NCT00340834|1794973|FG001|Core Phase of Study|Withdrawal by Subject|9
838479|NCT00340834|1794974|FG002|Core Phase of Study|Withdrawal by Subject|16
838480|NCT00340834|1794975|FG003|Core Phase of Study|Withdrawal by Subject|0
838481|NCT00340834|1794976|FG004|Core Phase of Study|Withdrawal by Subject|0
838482|NCT00340834|1794972|FG000|Core Phase of Study|Administrative Problems|6
838483|NCT00340834|1794973|FG001|Core Phase of Study|Administrative Problems|2
838484|NCT00340834|1794974|FG002|Core Phase of Study|Administrative Problems|7
838485|NCT00340834|1794975|FG003|Core Phase of Study|Administrative Problems|0
838486|NCT00340834|1794976|FG004|Core Phase of Study|Administrative Problems|0
838487|NCT00340834|1794972|FG000|Core Phase of Study|Lack of Efficacy|3
838488|NCT00340834|1794973|FG001|Core Phase of Study|Lack of Efficacy|3
838489|NCT00340834|1794974|FG002|Core Phase of Study|Lack of Efficacy|7
838490|NCT00340834|1794975|FG003|Core Phase of Study|Lack of Efficacy|0
838491|NCT00340834|1794976|FG004|Core Phase of Study|Lack of Efficacy|0
838492|NCT00340834|1794972|FG000|Core Phase of Study|Abnormal laboratory value(s)|4
838493|NCT00340834|1794973|FG001|Core Phase of Study|Abnormal laboratory value(s)|6
838494|NCT00340834|1794974|FG002|Core Phase of Study|Abnormal laboratory value(s)|1
838495|NCT00340834|1794975|FG003|Core Phase of Study|Abnormal laboratory value(s)|0
838496|NCT00340834|1794976|FG004|Core Phase of Study|Abnormal laboratory value(s)|0
838497|NCT00340834|1794972|FG000|Core Phase of Study|Abnormal test procedure result(s)|4
838498|NCT00340834|1794973|FG001|Core Phase of Study|Abnormal test procedure result(s)|3
838499|NCT00340834|1794974|FG002|Core Phase of Study|Abnormal test procedure result(s)|3
838500|NCT00340834|1794975|FG003|Core Phase of Study|Abnormal test procedure result(s)|0
838501|NCT00340834|1794976|FG004|Core Phase of Study|Abnormal test procedure result(s)|0
838502|NCT00340834|1794972|FG000|Core Phase of Study|Lost to Follow-up|1
838503|NCT00340834|1794973|FG001|Core Phase of Study|Lost to Follow-up|1
838504|NCT00340834|1794974|FG002|Core Phase of Study|Lost to Follow-up|4
838505|NCT00340834|1794975|FG003|Core Phase of Study|Lost to Follow-up|0
838506|NCT00340834|1794976|FG004|Core Phase of Study|Lost to Follow-up|0
838507|NCT00340834|1794972|FG000|Core Phase of Study|Death|2
838508|NCT00340834|1794973|FG001|Core Phase of Study|Death|0
838509|NCT00340834|1794974|FG002|Core Phase of Study|Death|0
838510|NCT00340834|1794975|FG003|Core Phase of Study|Death|0
838511|NCT00340834|1794976|FG004|Core Phase of Study|Death|0
838512|NCT00340834|1794972|FG000|Core Phase of Study|Protocol Violation|0
838513|NCT00340834|1794973|FG001|Core Phase of Study|Protocol Violation|0
838514|NCT00340834|1794974|FG002|Core Phase of Study|Protocol Violation|2
838515|NCT00340834|1794975|FG003|Core Phase of Study|Protocol Violation|0
838516|NCT00340834|1794976|FG004|Core Phase of Study|Protocol Violation|0
838517|NCT00340834|1794972|FG000|Extension Phase of Study|Subject did not receive study drug|0
838518|NCT00340834|1794973|FG001|Extension Phase of Study|Subject did not receive study drug|1
838519|NCT00340834|1794974|FG002|Extension Phase of Study|Subject did not receive study drug|0
838520|NCT00340834|1794975|FG003|Extension Phase of Study|Subject did not receive study drug|2
838521|NCT00340834|1794976|FG004|Extension Phase of Study|Subject did not receive study drug|0
838522|NCT00340834|1794972|FG000|Extension Phase of Study|Subject withdrew consent|26
838523|NCT00340834|1794973|FG001|Extension Phase of Study|Subject withdrew consent|31
838524|NCT00340834|1794974|FG002|Extension Phase of Study|Subject withdrew consent|0
838525|NCT00340834|1794975|FG003|Extension Phase of Study|Subject withdrew consent|12
838526|NCT00340834|1794976|FG004|Extension Phase of Study|Subject withdrew consent|15
838527|NCT00340834|1794972|FG000|Extension Phase of Study|Adverse Event|21
838528|NCT00340834|1794973|FG001|Extension Phase of Study|Adverse Event|22
838529|NCT00340834|1794974|FG002|Extension Phase of Study|Adverse Event|0
838530|NCT00340834|1794975|FG003|Extension Phase of Study|Adverse Event|19
838531|NCT00340834|1794976|FG004|Extension Phase of Study|Adverse Event|7
838532|NCT00340834|1794972|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14
838533|NCT00340834|1794973|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13
838534|NCT00340834|1794974|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0
838535|NCT00340834|1794975|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13
838536|NCT00340834|1794976|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4
838537|NCT00340834|1794972|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13
838538|NCT00340834|1794973|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7
838539|NCT00340834|1794974|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0
838540|NCT00340834|1794975|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4
838541|NCT00340834|1794976|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9
838542|NCT00340834|1794972|FG000|Extension Phase of Study|Lost to Follow-up|1
838543|NCT00340834|1794973|FG001|Extension Phase of Study|Lost to Follow-up|1
838544|NCT00340834|1794974|FG002|Extension Phase of Study|Lost to Follow-up|0
838545|NCT00340834|1794975|FG003|Extension Phase of Study|Lost to Follow-up|2
838546|NCT00340834|1794976|FG004|Extension Phase of Study|Lost to Follow-up|3
838547|NCT00340834|1794972|FG000|Extension Phase of Study|Subject no longer requires study drug|4
838548|NCT00340834|1794973|FG001|Extension Phase of Study|Subject no longer requires study drug|0
838549|NCT00340834|1794974|FG002|Extension Phase of Study|Subject no longer requires study drug|0
838550|NCT00340834|1794975|FG003|Extension Phase of Study|Subject no longer requires study drug|0
838551|NCT00340834|1794976|FG004|Extension Phase of Study|Subject no longer requires study drug|2
838552|NCT00340834|1794972|FG000|Extension Phase of Study|Administrative problems|3
838553|NCT00340834|1794973|FG001|Extension Phase of Study|Administrative problems|0
838554|NCT00340834|1794974|FG002|Extension Phase of Study|Administrative problems|0
838555|NCT00340834|1794975|FG003|Extension Phase of Study|Administrative problems|1
838556|NCT00340834|1794976|FG004|Extension Phase of Study|Administrative problems|1
838557|NCT00340834|1794972|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0
838558|NCT00340834|1794973|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1
838559|NCT00340834|1794974|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0
838560|NCT00340834|1794975|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0
838561|NCT00340834|1794976|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2
838562|NCT00340834|1794972|FG000|Extension Phase of Study|Protocol Violation|3
838563|NCT00340834|1794973|FG001|Extension Phase of Study|Protocol Violation|0
838564|NCT00340834|1794974|FG002|Extension Phase of Study|Protocol Violation|0
838565|NCT00340834|1794975|FG003|Extension Phase of Study|Protocol Violation|0
838566|NCT00340834|1794976|FG004|Extension Phase of Study|Protocol Violation|0
838567|NCT00340834|1794972|FG000|Extension Phase of Study|Death|0
838568|NCT00340834|1794973|FG001|Extension Phase of Study|Death|0
838569|NCT00340834|1794974|FG002|Extension Phase of Study|Death|0
838570|NCT00340834|1794975|FG003|Extension Phase of Study|Death|0
838571|NCT00340834|1794976|FG004|Extension Phase of Study|Death|1
838572|NCT00342628|1795025|FG000|Overall Study|Withdrawal by Subject|19
838573|NCT00342628|1795026|FG001|Overall Study|Withdrawal by Subject|19
838574|NCT00342628|1795027|FG002|Overall Study|Withdrawal by Subject|18
838575|NCT00342628|1795025|FG000|Overall Study|Death|1
838576|NCT00342628|1795026|FG001|Overall Study|Death|1
838577|NCT00342628|1795027|FG002|Overall Study|Death|0
838578|NCT00342628|1795025|FG000|Overall Study|moved residence|0
838579|NCT00342628|1795026|FG001|Overall Study|moved residence|1
838580|NCT00342628|1795027|FG002|Overall Study|moved residence|1
838581|NCT00343252|1795046|FG000|6 Months (All Treated Participants)|Adverse Event|17
838582|NCT00343252|1795047|FG001|6 Months (All Treated Participants)|Adverse Event|11
838583|NCT00343252|1795046|FG000|6 Months (All Treated Participants)|Death|0
838584|NCT00343252|1795047|FG001|6 Months (All Treated Participants)|Death|2
838585|NCT00343252|1795046|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10
838586|NCT00343252|1795047|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8
838587|NCT00343252|1795046|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0
838588|NCT00343252|1795047|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1
838589|NCT00343252|1795046|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0
838590|NCT00343252|1795047|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4
838591|NCT00343252|1795046|FG000|6 Months (All Treated Participants)|Physician Decision|1
838592|NCT00343252|1795047|FG001|6 Months (All Treated Participants)|Physician Decision|3
838593|NCT00343252|1795046|FG000|6 Months (All Treated Participants)|Protocol Violation|2
838594|NCT00343252|1795047|FG001|6 Months (All Treated Participants)|Protocol Violation|2
838595|NCT00343252|1795046|FG000|6 Months (All Treated Participants)|Sponsor Decision|7
838596|NCT00343252|1795047|FG001|6 Months (All Treated Participants)|Sponsor Decision|4
838597|NCT00343252|1795046|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19
838598|NCT00343252|1795047|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9
838599|NCT00343252|1795046|FG000|12 Months (All Treated Participants)|Adverse Event|22
838600|NCT00343252|1795047|FG001|12 Months (All Treated Participants)|Adverse Event|20
838601|NCT00343252|1795046|FG000|12 Months (All Treated Participants)|Death|3
838602|NCT00343252|1795047|FG001|12 Months (All Treated Participants)|Death|3
838603|NCT00343252|1795046|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10
838604|NCT00343252|1795047|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10
838605|NCT00343252|1795046|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1
838606|NCT00343252|1795047|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1
838607|NCT00343252|1795046|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1
838608|NCT00343252|1795047|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5
838609|NCT00343252|1795046|FG000|12 Months (All Treated Participants)|Physician Decision|4
838610|NCT00343252|1795047|FG001|12 Months (All Treated Participants)|Physician Decision|5
838611|NCT00343252|1795046|FG000|12 Months (All Treated Participants)|Protocol Violation|3
838612|NCT00343252|1795047|FG001|12 Months (All Treated Participants)|Protocol Violation|2
838613|NCT00343252|1795046|FG000|12 Months (All Treated Participants)|Sponsor Decision|9
838614|NCT00343252|1795047|FG001|12 Months (All Treated Participants)|Sponsor Decision|6
838615|NCT00343252|1795046|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33
838616|NCT00343252|1795047|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17
838617|NCT00343252|1795046|FG000|18 Months (All Treated Participants)|Adverse Event|31
838618|NCT00343252|1795047|FG001|18 Months (All Treated Participants)|Adverse Event|23
838619|NCT00343252|1795046|FG000|18 Months (All Treated Participants)|Death|4
838620|NCT00343252|1795047|FG001|18 Months (All Treated Participants)|Death|5
838621|NCT00343252|1795046|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11
838622|NCT00343252|1795047|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10
838623|NCT00343252|1795046|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1
838624|NCT00343252|1795047|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1
838625|NCT00343252|1795046|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3
838626|NCT00343252|1795047|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7
838627|NCT00343252|1795046|FG000|18 Months (All Treated Participants)|Physician Decision|4
838628|NCT00343252|1795047|FG001|18 Months (All Treated Participants)|Physician Decision|7
838629|NCT00343252|1795046|FG000|18 Months (All Treated Participants)|Protocol Violation|3
838630|NCT00343252|1795047|FG001|18 Months (All Treated Participants)|Protocol Violation|3
838631|NCT00343252|1795046|FG000|18 Months (All Treated Participants)|Sponsor Decision|8
838632|NCT00343252|1795047|FG001|18 Months (All Treated Participants)|Sponsor Decision|5
838633|NCT00343252|1795046|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36
838634|NCT00343252|1795047|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20
838635|NCT00343291|1795055|FG000|Overall Study|Adverse Event|13
838636|NCT00343291|1795056|FG001|Overall Study|Adverse Event|13
838637|NCT00343291|1795055|FG000|Overall Study|Death|3
838638|NCT00343291|1795056|FG001|Overall Study|Death|2
838639|NCT00343291|1795055|FG000|Overall Study|Progressive disease|33
838640|NCT00343291|1795056|FG001|Overall Study|Progressive disease|34
838641|NCT00343291|1795055|FG000|Overall Study|Withdrawal by Subject|0
838642|NCT00343291|1795056|FG001|Overall Study|Withdrawal by Subject|2
838643|NCT00343291|1795055|FG000|Overall Study|Other|8
838644|NCT00343291|1795056|FG001|Overall Study|Other|5
838645|NCT00343382|1795065|FG000|Overall Study|Adverse Event|2
838646|NCT00343382|1795066|FG001|Overall Study|Adverse Event|10
838647|NCT00343382|1795067|FG002|Overall Study|Adverse Event|7
838648|NCT00343382|1795065|FG000|Overall Study|Withdrawal by Subject|1
838649|NCT00343382|1795066|FG001|Overall Study|Withdrawal by Subject|2
838650|NCT00343382|1795067|FG002|Overall Study|Withdrawal by Subject|6
838651|NCT00343382|1795065|FG000|Overall Study|Other Reason Not Specified|1
838652|NCT00343382|1795066|FG001|Overall Study|Other Reason Not Specified|2
838653|NCT00343382|1795067|FG002|Overall Study|Other Reason Not Specified|4
838654|NCT00343512|1795101|FG000|Overall Study|Withdrawal by Subject|2
838655|NCT00343642|1795225|FG000|Overall Study|Lost to Follow-up|0
838656|NCT00343642|1795226|FG001|Overall Study|Lost to Follow-up|1
838657|NCT00343642|1795227|FG002|Overall Study|Lost to Follow-up|0
838658|NCT00343642|1795225|FG000|Overall Study|Pregnancy|1
838659|NCT00343642|1795226|FG001|Overall Study|Pregnancy|0
838660|NCT00343642|1795227|FG002|Overall Study|Pregnancy|2
838661|NCT00343642|1795225|FG000|Overall Study|Withdrawal by Subject|2
838662|NCT00343642|1795226|FG001|Overall Study|Withdrawal by Subject|3
838663|NCT00343642|1795227|FG002|Overall Study|Withdrawal by Subject|4
838664|NCT00343642|1795225|FG000|Overall Study|Adverse Event|0
838665|NCT00343642|1795226|FG001|Overall Study|Adverse Event|0
838666|NCT00343642|1795227|FG002|Overall Study|Adverse Event|1
838667|NCT00343642|1795225|FG000|Overall Study|Flare up|6
838668|NCT00343642|1795226|FG001|Overall Study|Flare up|4
838669|NCT00343642|1795227|FG002|Overall Study|Flare up|0
838670|NCT00343889|1795256|FG000|Overall Study|Lost to Follow-up|2
838671|NCT00343889|1795257|FG001|Overall Study|Lost to Follow-up|0
838672|NCT00343889|1795256|FG000|Overall Study|Withdrawal by Subject|0
838673|NCT00343889|1795257|FG001|Overall Study|Withdrawal by Subject|1
838674|NCT00343889|1795256|FG000|Overall Study|Protocol Violation|1
838675|NCT00343889|1795257|FG001|Overall Study|Protocol Violation|0
838676|NCT00343915|1795265|FG000|Primary Study|Withdrawal by Subject|1
838677|NCT00343915|1795266|FG001|Primary Study|Withdrawal by Subject|0
838678|NCT00343915|1795265|FG000|Primary Study|Lost to Follow-up|2
838679|NCT00343915|1795266|FG001|Primary Study|Lost to Follow-up|3
838680|NCT00343915|1795265|FG000|Primary Study|Other|1
838681|NCT00343915|1795266|FG001|Primary Study|Other|0
838682|NCT00344032|1795277|FG000|Overall Study|Adverse Event|0
838683|NCT00344032|1795278|FG001|Overall Study|Adverse Event|1
838684|NCT00344032|1795277|FG000|Overall Study|Withdrawal by Subject|6
838685|NCT00344032|1795278|FG001|Overall Study|Withdrawal by Subject|2
838686|NCT00344032|1795277|FG000|Overall Study|Lost to Follow-up|4
838687|NCT00344032|1795278|FG001|Overall Study|Lost to Follow-up|6
838688|NCT00344032|1795277|FG000|Overall Study|Physician Decision|4
838689|NCT00344032|1795278|FG001|Overall Study|Physician Decision|1
838690|NCT00344305|1795295|FG000|Overall Study|Lost to Follow-up|2
838691|NCT00344305|1795296|FG001|Overall Study|Lost to Follow-up|0
838692|NCT00344305|1795295|FG000|Overall Study|Participant was not contacted in window|0
838693|NCT00344305|1795296|FG001|Overall Study|Participant was not contacted in window|1
838694|NCT00344318|1795307|FG000|Overall Study|Adverse Event|0
838695|NCT00344318|1795308|FG001|Overall Study|Adverse Event|3
838696|NCT00344318|1795309|FG002|Overall Study|Adverse Event|0
838697|NCT00344318|1795310|FG003|Overall Study|Adverse Event|1
838698|NCT00344318|1795307|FG000|Overall Study|Withdrawal by Subject|2
838699|NCT00344318|1795308|FG001|Overall Study|Withdrawal by Subject|2
838700|NCT00344318|1795309|FG002|Overall Study|Withdrawal by Subject|0
838701|NCT00344318|1795310|FG003|Overall Study|Withdrawal by Subject|2
838702|NCT00344318|1795307|FG000|Overall Study|Lost to Follow-up|2
838703|NCT00344318|1795308|FG001|Overall Study|Lost to Follow-up|0
838704|NCT00344318|1795309|FG002|Overall Study|Lost to Follow-up|1
838705|NCT00344318|1795310|FG003|Overall Study|Lost to Follow-up|0
838706|NCT00344448|1795333|FG000|Screening|Withdrawal by Subject|0
838707|NCT00344448|1795334|FG001|Screening|Withdrawal by Subject|1
838708|NCT00344448|1795333|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1
838709|NCT00344448|1795334|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0
838710|NCT00344448|1795333|FG000|Double Blind, Placebo Controlled|Study terminated|1
838711|NCT00344448|1795334|FG001|Double Blind, Placebo Controlled|Study terminated|0
838712|NCT00344448|1795333|FG000|Open Label|Withdrawal by Subject|1
838713|NCT00344448|1795334|FG001|Open Label|Withdrawal by Subject|1
838714|NCT00344448|1795333|FG000|Open Label|Study terminated|1
838715|NCT00344448|1795334|FG001|Open Label|Study terminated|0
838716|NCT00344461|1795340|FG000|Overall Study|Adverse Event|6
838717|NCT00344461|1795340|FG000|Overall Study|Death|1
838718|NCT00344461|1795340|FG000|Overall Study|Lack of Efficacy|2
838719|NCT00344461|1795340|FG000|Overall Study|Lost to Follow-up|2
838720|NCT00344461|1795340|FG000|Overall Study|Physician Decision|2
838721|NCT00344461|1795340|FG000|Overall Study|Protocol Violation|6
838722|NCT00344461|1795340|FG000|Overall Study|Withdrawal by Subject|2
838723|NCT00344500|1795347|FG000|Overall Study|Adverse Event|6
838724|NCT00344500|1795348|FG001|Overall Study|Adverse Event|2
838725|NCT00344500|1795349|FG002|Overall Study|Adverse Event|0
838726|NCT00344500|1795347|FG000|Overall Study|Lost to Follow-up|5
838727|NCT00344500|1795348|FG001|Overall Study|Lost to Follow-up|13
838728|NCT00344500|1795349|FG002|Overall Study|Lost to Follow-up|1
838729|NCT00344500|1795347|FG000|Overall Study|Withdrawal by Subject|7
838730|NCT00344500|1795348|FG001|Overall Study|Withdrawal by Subject|10
838731|NCT00344500|1795349|FG002|Overall Study|Withdrawal by Subject|0
838732|NCT00344500|1795347|FG000|Overall Study|Protocol Violation|4
838733|NCT00344500|1795348|FG001|Overall Study|Protocol Violation|7
838734|NCT00344500|1795349|FG002|Overall Study|Protocol Violation|1
838735|NCT00344500|1795347|FG000|Overall Study|Not Noted|1
838736|NCT00344500|1795348|FG001|Overall Study|Not Noted|3
838737|NCT00344500|1795349|FG002|Overall Study|Not Noted|0
838738|NCT00344773|1795365|FG000|Overall Study|Adverse Event|2
838739|NCT00344773|1795365|FG000|Overall Study|Objective Disease Progression|16
838740|NCT00344773|1795365|FG000|Overall Study|Withdrawal by Subject|1
838741|NCT00344773|1795365|FG000|Overall Study|Not Eligible for the study|2
838742|NCT00344968|1795372|FG000|Overall Study|Adverse Event|5
838743|NCT00344968|1795373|FG001|Overall Study|Adverse Event|4
838744|NCT00344968|1795374|FG002|Overall Study|Adverse Event|15
838745|NCT00344968|1795372|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
838746|NCT00344968|1795373|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
838747|NCT00344968|1795374|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
838748|NCT00344968|1795372|FG000|Overall Study|Protocol Violation|2
838749|NCT00344968|1795373|FG001|Overall Study|Protocol Violation|2
838750|NCT00344968|1795374|FG002|Overall Study|Protocol Violation|5
838751|NCT00344968|1795372|FG000|Overall Study|Withdrawal by Subject|14
838752|NCT00344968|1795373|FG001|Overall Study|Withdrawal by Subject|31
838753|NCT00344968|1795374|FG002|Overall Study|Withdrawal by Subject|27
838754|NCT00344968|1795372|FG000|Overall Study|Lost to Follow-up|24
838755|NCT00344968|1795373|FG001|Overall Study|Lost to Follow-up|37
838756|NCT00344968|1795374|FG002|Overall Study|Lost to Follow-up|37
838757|NCT00344968|1795372|FG000|Overall Study|Death|11
838758|NCT00344968|1795373|FG001|Overall Study|Death|27
838759|NCT00344968|1795374|FG002|Overall Study|Death|31
838760|NCT00344968|1795372|FG000|Overall Study|Other|0
838761|NCT00344968|1795373|FG001|Overall Study|Other|1
838762|NCT00344968|1795374|FG002|Overall Study|Other|0
838763|NCT00345046|1795395|FG000|Overall Study|Protocol Violation|1
838764|NCT00345046|1795396|FG001|Overall Study|Protocol Violation|1
838765|NCT00345046|1795397|FG002|Overall Study|Protocol Violation|2
838766|NCT00345293|1795433|FG000|Overall Study|Unable to access line for sample|1
838767|NCT00345293|1795434|FG001|Overall Study|Unable to access line for sample|0
838768|NCT00345293|1795433|FG000|Overall Study|Withdrawal by Subject|1
838769|NCT00345293|1795434|FG001|Overall Study|Withdrawal by Subject|0
838770|NCT00345397|1795490|FG000|Overall Study|Death|1
838771|NCT00345540|1795495|FG000|Overall Study|Withdrawal by Subject|1
838772|NCT00345579|1795501|FG000|Overall Study|Adverse Event|9
838773|NCT00345579|1795502|FG001|Overall Study|Adverse Event|6
838774|NCT00345579|1795501|FG000|Overall Study|Protocol Violation|14
838775|NCT00345579|1795502|FG001|Overall Study|Protocol Violation|5
838776|NCT00345579|1795501|FG000|Overall Study|Withdrawal by Subject|50
838777|NCT00345579|1795502|FG001|Overall Study|Withdrawal by Subject|17
838778|NCT00345579|1795501|FG000|Overall Study|Lost to Follow-up|82
838779|NCT00345579|1795502|FG001|Overall Study|Lost to Follow-up|36
838780|NCT00345579|1795501|FG000|Overall Study|Other|9
838781|NCT00345579|1795502|FG001|Overall Study|Other|1
838782|NCT00345592|1795511|FG000|Overall Study|Death|14
838783|NCT00345592|1795512|FG001|Overall Study|Death|16
838784|NCT00345592|1795511|FG000|Overall Study|Withdrawal by Subject|11
838785|NCT00345592|1795512|FG001|Overall Study|Withdrawal by Subject|8
838786|NCT00345605|1795518|FG000|Arm 1|Adverse Event|0
838787|NCT00345605|1795519|FG001|Arm 1|Adverse Event|1
838788|NCT00345605|1795518|FG000|Arm 2, Opposite Treatment|Adverse Event|1
838789|NCT00345605|1795519|FG001|Arm 2, Opposite Treatment|Adverse Event|0
838790|NCT00345631|1795530|FG000|Overall Study|Withdrawal by Subject|1
838791|NCT00345631|1795531|FG001|Overall Study|Withdrawal by Subject|0
838792|NCT00345631|1795532|FG002|Overall Study|Withdrawal by Subject|1
838793|NCT00345631|1795530|FG000|Overall Study|Adverse Event|0
838794|NCT00345631|1795531|FG001|Overall Study|Adverse Event|1
838795|NCT00345631|1795532|FG002|Overall Study|Adverse Event|0
838796|NCT00345631|1795530|FG000|Overall Study|Lost to Follow-up|3
838797|NCT00345631|1795531|FG001|Overall Study|Lost to Follow-up|7
838798|NCT00345631|1795532|FG002|Overall Study|Lost to Follow-up|4
838799|NCT00345631|1795530|FG000|Overall Study|Other reasons|0
838800|NCT00345631|1795531|FG001|Overall Study|Other reasons|0
838801|NCT00345631|1795532|FG002|Overall Study|Other reasons|1
838802|NCT00345683|1795544|FG000|Overall Study|Lost to Follow-up|19
838803|NCT00345683|1795545|FG001|Overall Study|Lost to Follow-up|7
838804|NCT00345683|1795544|FG000|Overall Study|Other|6
838805|NCT00345683|1795545|FG001|Overall Study|Other|2
838806|NCT00345839|1795553|FG000|Overall Study|Withdrawal by Subject|91
838807|NCT00345839|1795554|FG001|Overall Study|Withdrawal by Subject|98
838808|NCT00345839|1795553|FG000|Overall Study|Lost to Follow-up|58
838809|NCT00345839|1795554|FG001|Overall Study|Lost to Follow-up|61
838810|NCT00345878|1795583|FG000|Overall Study|Adverse Event|1
838811|NCT00345878|1795584|FG001|Overall Study|Adverse Event|0
838812|NCT00345878|1795583|FG000|Overall Study|Lost to Follow-up|2
838813|NCT00345878|1795584|FG001|Overall Study|Lost to Follow-up|1
838814|NCT00345878|1795583|FG000|Overall Study|Other|1
838815|NCT00345878|1795584|FG001|Overall Study|Other|0
838816|NCT00346034|1795599|FG000|Overall Study|Adverse Event|34
838817|NCT00346034|1795599|FG000|Overall Study|Lack of Efficacy|8
838818|NCT00346034|1795599|FG000|Overall Study|Withdrawal by Subject|13
838819|NCT00346034|1795599|FG000|Overall Study|Patient Stopped Taking Study Drug|1
838820|NCT00346034|1795599|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1
838821|NCT00346073|1795605|FG000|Overall Study|Serious Adverse Event|2
838822|NCT00346073|1795606|FG001|Overall Study|Serious Adverse Event|0
838823|NCT00346073|1795605|FG000|Overall Study|Lost to Follow-up|39
838824|NCT00346073|1795606|FG001|Overall Study|Lost to Follow-up|24
838825|NCT00346151|1795612|FG000|Overall Study|Withdrawal by Subject|3
838826|NCT00346164|1795620|FG000|Overall Study|Adverse Event|0
838827|NCT00346164|1795621|FG001|Overall Study|Adverse Event|0
838828|NCT00346164|1795622|FG002|Overall Study|Adverse Event|0
838829|NCT00346164|1795623|FG003|Overall Study|Adverse Event|1
838830|NCT00346164|1795620|FG000|Overall Study|Lack of Efficacy|0
838831|NCT00346164|1795621|FG001|Overall Study|Lack of Efficacy|1
838832|NCT00346164|1795622|FG002|Overall Study|Lack of Efficacy|7
838833|NCT00346164|1795623|FG003|Overall Study|Lack of Efficacy|25
838834|NCT00346164|1795620|FG000|Overall Study|Physician Decision|0
838835|NCT00346164|1795621|FG001|Overall Study|Physician Decision|1
838836|NCT00346164|1795622|FG002|Overall Study|Physician Decision|2
838837|NCT00346164|1795623|FG003|Overall Study|Physician Decision|27
838838|NCT00346164|1795620|FG000|Overall Study|Protocol Violation|6
838839|NCT00346164|1795621|FG001|Overall Study|Protocol Violation|2
838840|NCT00346164|1795622|FG002|Overall Study|Protocol Violation|10
838841|NCT00346164|1795623|FG003|Overall Study|Protocol Violation|4
838842|NCT00346164|1795620|FG000|Overall Study|Withdrawal by Subject|0
838843|NCT00346164|1795621|FG001|Overall Study|Withdrawal by Subject|0
838844|NCT00346164|1795622|FG002|Overall Study|Withdrawal by Subject|2
838845|NCT00346164|1795623|FG003|Overall Study|Withdrawal by Subject|0
838846|NCT00346164|1795620|FG000|Overall Study|Ineligible|11
838847|NCT00346164|1795621|FG001|Overall Study|Ineligible|2
838848|NCT00346164|1795622|FG002|Overall Study|Ineligible|2
838849|NCT00346164|1795623|FG003|Overall Study|Ineligible|23
838850|NCT00346164|1795620|FG000|Overall Study|Refusal of further protocol therapy|0
838851|NCT00346164|1795621|FG001|Overall Study|Refusal of further protocol therapy|1
838852|NCT00346164|1795622|FG002|Overall Study|Refusal of further protocol therapy|3
838853|NCT00346164|1795623|FG003|Overall Study|Refusal of further protocol therapy|15
838854|NCT00346164|1795620|FG000|Overall Study|Inability to start week 16 tx on time|0
838855|NCT00346164|1795621|FG001|Overall Study|Inability to start week 16 tx on time|0
838856|NCT00346164|1795622|FG002|Overall Study|Inability to start week 16 tx on time|0
838857|NCT00346164|1795623|FG003|Overall Study|Inability to start week 16 tx on time|11
838858|NCT00346216|1795652|FG000|Overall Study|Other|181
838859|NCT00346216|1795653|FG001|Overall Study|Other|231
838860|NCT00346216|1795654|FG002|Overall Study|Other|205
838861|NCT00346216|1795652|FG000|Overall Study|No longer willing to participate|600
838862|NCT00346216|1795653|FG001|Overall Study|No longer willing to participate|606
838863|NCT00346216|1795654|FG002|Overall Study|No longer willing to participate|585
838864|NCT00346216|1795652|FG000|Overall Study|Withdrawal by Subject|661
838865|NCT00346216|1795653|FG001|Overall Study|Withdrawal by Subject|692
838866|NCT00346216|1795654|FG002|Overall Study|Withdrawal by Subject|651
838867|NCT00346216|1795652|FG000|Overall Study|Lost to Follow-up|611
838868|NCT00346216|1795653|FG001|Overall Study|Lost to Follow-up|588
838869|NCT00346216|1795654|FG002|Overall Study|Lost to Follow-up|542
838870|NCT00346216|1795652|FG000|Overall Study|Physician Decision|80
838871|NCT00346216|1795653|FG001|Overall Study|Physician Decision|76
838872|NCT00346216|1795654|FG002|Overall Study|Physician Decision|59
838873|NCT00346216|1795652|FG000|Overall Study|Does not meet entrance criteria|13
838874|NCT00346216|1795653|FG001|Overall Study|Does not meet entrance criteria|10
838875|NCT00346216|1795654|FG002|Overall Study|Does not meet entrance criteria|8
838876|NCT00346216|1795652|FG000|Overall Study|Death|189
838877|NCT00346216|1795653|FG001|Overall Study|Death|192
838878|NCT00346216|1795654|FG002|Overall Study|Death|228
838879|NCT00346216|1795652|FG000|Overall Study|Study terminated by sponsor|11
838880|NCT00346216|1795653|FG001|Overall Study|Study terminated by sponsor|4
838881|NCT00346216|1795654|FG002|Overall Study|Study terminated by sponsor|8
838882|NCT00346216|1795652|FG000|Overall Study|Missing Subject Summary Status|62
838883|NCT00346216|1795653|FG001|Overall Study|Missing Subject Summary Status|61
838884|NCT00346216|1795654|FG002|Overall Study|Missing Subject Summary Status|62
838885|NCT00346268|1795664|FG000|Overall Study|Adverse Event|1
838886|NCT00346268|1795665|FG001|Overall Study|Adverse Event|0
838887|NCT00346268|1795664|FG000|Overall Study|Protocol Violation|1
838888|NCT00346268|1795665|FG001|Overall Study|Protocol Violation|0
838889|NCT00346268|1795664|FG000|Overall Study|Participant refused|0
838890|NCT00346268|1795665|FG001|Overall Study|Participant refused|3
838891|NCT00346333|1795673|FG000|Overall Study|Death|1
838892|NCT00346333|1795674|FG001|Overall Study|Death|0
838893|NCT00346333|1795673|FG000|Overall Study|unwilling or unable to continue|4
838894|NCT00346333|1795674|FG001|Overall Study|unwilling or unable to continue|8
838895|NCT00346398|1795684|FG000|Overall Study|Lost to Follow-up|3
838896|NCT00346398|1795685|FG001|Overall Study|Lost to Follow-up|0
838897|NCT00346398|1795684|FG000|Overall Study|Withdrawal by Subject|0
838898|NCT00346398|1795685|FG001|Overall Study|Withdrawal by Subject|2
838899|NCT00346632|1795697|FG000|Overall Study|Progressive Disease|2
838900|NCT00346632|1795698|FG001|Overall Study|Progressive Disease|2
838901|NCT00346632|1795699|FG002|Overall Study|Progressive Disease|4
838902|NCT00346632|1795700|FG003|Overall Study|Progressive Disease|3
838903|NCT00346632|1795701|FG004|Overall Study|Progressive Disease|3
838904|NCT00346632|1795702|FG005|Overall Study|Progressive Disease|1
838905|NCT00346632|1795703|FG006|Overall Study|Progressive Disease|2
838906|NCT00346632|1795704|FG007|Overall Study|Progressive Disease|2
838907|NCT00346632|1795705|FG008|Overall Study|Progressive Disease|2
838908|NCT00346632|1795706|FG009|Overall Study|Progressive Disease|2
838909|NCT00346632|1795697|FG000|Overall Study|Adverse Event|0
838910|NCT00346632|1795698|FG001|Overall Study|Adverse Event|0
838911|NCT00346632|1795699|FG002|Overall Study|Adverse Event|0
838912|NCT00346632|1795700|FG003|Overall Study|Adverse Event|0
838913|NCT00346632|1795701|FG004|Overall Study|Adverse Event|1
838914|NCT00346632|1795702|FG005|Overall Study|Adverse Event|1
838915|NCT00346632|1795703|FG006|Overall Study|Adverse Event|1
838916|NCT00346632|1795704|FG007|Overall Study|Adverse Event|0
838917|NCT00346632|1795705|FG008|Overall Study|Adverse Event|0
838918|NCT00346632|1795706|FG009|Overall Study|Adverse Event|0
838919|NCT00346632|1795697|FG000|Overall Study|Death|0
838920|NCT00346632|1795698|FG001|Overall Study|Death|0
838921|NCT00346632|1795699|FG002|Overall Study|Death|1
838922|NCT00346632|1795700|FG003|Overall Study|Death|0
838923|NCT00346632|1795701|FG004|Overall Study|Death|0
838924|NCT00346632|1795702|FG005|Overall Study|Death|0
838925|NCT00346632|1795703|FG006|Overall Study|Death|0
838926|NCT00346632|1795704|FG007|Overall Study|Death|0
838927|NCT00346632|1795705|FG008|Overall Study|Death|0
838928|NCT00346632|1795706|FG009|Overall Study|Death|0
838929|NCT00346632|1795697|FG000|Overall Study|Protocol Violation|0
838930|NCT00346632|1795698|FG001|Overall Study|Protocol Violation|0
838931|NCT00346632|1795699|FG002|Overall Study|Protocol Violation|0
838932|NCT00346632|1795700|FG003|Overall Study|Protocol Violation|0
838933|NCT00346632|1795701|FG004|Overall Study|Protocol Violation|0
838934|NCT00346632|1795702|FG005|Overall Study|Protocol Violation|0
838935|NCT00346632|1795703|FG006|Overall Study|Protocol Violation|1
838936|NCT00346632|1795704|FG007|Overall Study|Protocol Violation|0
838937|NCT00346632|1795705|FG008|Overall Study|Protocol Violation|0
838938|NCT00346632|1795706|FG009|Overall Study|Protocol Violation|0
838939|NCT00346632|1795697|FG000|Overall Study|Withdrawal by Subject|0
838940|NCT00346632|1795698|FG001|Overall Study|Withdrawal by Subject|0
838941|NCT00346632|1795699|FG002|Overall Study|Withdrawal by Subject|0
838942|NCT00346632|1795700|FG003|Overall Study|Withdrawal by Subject|0
838943|NCT00346632|1795701|FG004|Overall Study|Withdrawal by Subject|0
838944|NCT00346632|1795702|FG005|Overall Study|Withdrawal by Subject|0
838945|NCT00346632|1795703|FG006|Overall Study|Withdrawal by Subject|1
838946|NCT00346632|1795704|FG007|Overall Study|Withdrawal by Subject|0
838947|NCT00346632|1795705|FG008|Overall Study|Withdrawal by Subject|0
838948|NCT00346632|1795706|FG009|Overall Study|Withdrawal by Subject|0
838949|NCT00346632|1795697|FG000|Overall Study|Switched to alternative treatment|0
838950|NCT00346632|1795698|FG001|Overall Study|Switched to alternative treatment|0
838951|NCT00346632|1795699|FG002|Overall Study|Switched to alternative treatment|1
838952|NCT00346632|1795700|FG003|Overall Study|Switched to alternative treatment|0
838953|NCT00346632|1795701|FG004|Overall Study|Switched to alternative treatment|0
838954|NCT00346632|1795702|FG005|Overall Study|Switched to alternative treatment|0
838955|NCT00346632|1795703|FG006|Overall Study|Switched to alternative treatment|0
838956|NCT00346632|1795704|FG007|Overall Study|Switched to alternative treatment|0
838957|NCT00346632|1795705|FG008|Overall Study|Switched to alternative treatment|0
838958|NCT00346632|1795706|FG009|Overall Study|Switched to alternative treatment|0
838959|NCT00346632|1795697|FG000|Overall Study|Not Stated|1
838960|NCT00346632|1795698|FG001|Overall Study|Not Stated|1
838961|NCT00346632|1795699|FG002|Overall Study|Not Stated|0
838962|NCT00346632|1795700|FG003|Overall Study|Not Stated|0
838963|NCT00346632|1795701|FG004|Overall Study|Not Stated|0
838964|NCT00346632|1795702|FG005|Overall Study|Not Stated|0
838965|NCT00346632|1795703|FG006|Overall Study|Not Stated|0
838966|NCT00346632|1795704|FG007|Overall Study|Not Stated|2
838967|NCT00346632|1795705|FG008|Overall Study|Not Stated|2
838968|NCT00346632|1795706|FG009|Overall Study|Not Stated|1
838969|NCT00346697|1795770|FG000|Overall Study|Lost to Follow-up|0
838970|NCT00346697|1795771|FG001|Overall Study|Lost to Follow-up|1
838971|NCT00346775|1795779|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1
838972|NCT00346775|1795780|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1
839058|NCT00347360|1795840|FG005|Overall Study|Lack of Efficacy|1
838973|NCT00346775|1795779|FG000|Period 1: Intervention Period 1|Protocol Violation|3
838974|NCT00346775|1795780|FG001|Period 1: Intervention Period 1|Protocol Violation|2
838975|NCT00346775|1795779|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
838976|NCT00346775|1795780|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
838977|NCT00347009|1795794|FG000|Overall Study|Death|1
838978|NCT00347009|1795794|FG000|Overall Study|Adverse Event|6
838979|NCT00347009|1795794|FG000|Overall Study|Withdrawal by Subject|3
838980|NCT00347009|1795794|FG000|Overall Study|Physician Decision|5
838981|NCT00347009|1795794|FG000|Overall Study|Lost to Follow-up|4
838982|NCT00347009|1795794|FG000|Overall Study|Protocol Violation|2
838983|NCT00347009|1795794|FG000|Overall Study|Adverse Laboratory Experience|1
838984|NCT00347009|1795794|FG000|Overall Study|Insufficient Viral Suppression|3
838985|NCT00347009|1795794|FG000|Overall Study|Increased ALT/HBV DNA|1
838986|NCT00347009|1795794|FG000|Overall Study|Serious Adverse Event|1
838987|NCT00347269|1795809|FG000|Overall Study|Lost to Follow-up|74
838988|NCT00347269|1795810|FG001|Overall Study|Lost to Follow-up|65
838989|NCT00347269|1795809|FG000|Overall Study|Withdrawal by Subject|18
838990|NCT00347269|1795810|FG001|Overall Study|Withdrawal by Subject|38
838991|NCT00347269|1795809|FG000|Overall Study|Death|2
838992|NCT00347269|1795810|FG001|Overall Study|Death|3
838993|NCT00347360|1795835|FG000|Overall Study|Adverse Event|1
838994|NCT00347360|1795836|FG001|Overall Study|Adverse Event|2
838995|NCT00347360|1795837|FG002|Overall Study|Adverse Event|0
838996|NCT00347360|1795838|FG003|Overall Study|Adverse Event|4
838997|NCT00347360|1795839|FG004|Overall Study|Adverse Event|1
838998|NCT00347360|1795840|FG005|Overall Study|Adverse Event|2
838999|NCT00347360|1795841|FG006|Overall Study|Adverse Event|2
839000|NCT00347360|1795842|FG007|Overall Study|Adverse Event|0
839001|NCT00347360|1795843|FG008|Overall Study|Adverse Event|2
839002|NCT00347360|1795844|FG009|Overall Study|Adverse Event|3
839003|NCT00347360|1795845|FG010|Overall Study|Adverse Event|3
839004|NCT00347360|1795846|FG011|Overall Study|Adverse Event|1
839005|NCT00347360|1795847|FG012|Overall Study|Adverse Event|3
839006|NCT00347360|1795848|FG013|Overall Study|Adverse Event|2
839007|NCT00347360|1795849|FG014|Overall Study|Adverse Event|2
839008|NCT00347360|1795835|FG000|Overall Study|Lost to Follow-up|0
839009|NCT00347360|1795836|FG001|Overall Study|Lost to Follow-up|0
839010|NCT00347360|1795837|FG002|Overall Study|Lost to Follow-up|0
839011|NCT00347360|1795838|FG003|Overall Study|Lost to Follow-up|2
839012|NCT00347360|1795839|FG004|Overall Study|Lost to Follow-up|1
839013|NCT00347360|1795840|FG005|Overall Study|Lost to Follow-up|1
839014|NCT00347360|1795841|FG006|Overall Study|Lost to Follow-up|0
839015|NCT00347360|1795842|FG007|Overall Study|Lost to Follow-up|1
839016|NCT00347360|1795843|FG008|Overall Study|Lost to Follow-up|1
839017|NCT00347360|1795844|FG009|Overall Study|Lost to Follow-up|2
839018|NCT00347360|1795845|FG010|Overall Study|Lost to Follow-up|0
839019|NCT00347360|1795846|FG011|Overall Study|Lost to Follow-up|0
839020|NCT00347360|1795847|FG012|Overall Study|Lost to Follow-up|1
839021|NCT00347360|1795848|FG013|Overall Study|Lost to Follow-up|0
839022|NCT00347360|1795849|FG014|Overall Study|Lost to Follow-up|0
839023|NCT00347360|1795835|FG000|Overall Study|Protocol Violation|2
839024|NCT00347360|1795836|FG001|Overall Study|Protocol Violation|3
839025|NCT00347360|1795837|FG002|Overall Study|Protocol Violation|1
839026|NCT00347360|1795838|FG003|Overall Study|Protocol Violation|2
839027|NCT00347360|1795839|FG004|Overall Study|Protocol Violation|1
839028|NCT00347360|1795840|FG005|Overall Study|Protocol Violation|2
839029|NCT00347360|1795841|FG006|Overall Study|Protocol Violation|0
839030|NCT00347360|1795842|FG007|Overall Study|Protocol Violation|0
839031|NCT00347360|1795843|FG008|Overall Study|Protocol Violation|1
839032|NCT00347360|1795844|FG009|Overall Study|Protocol Violation|2
839033|NCT00347360|1795845|FG010|Overall Study|Protocol Violation|0
839034|NCT00347360|1795846|FG011|Overall Study|Protocol Violation|0
839035|NCT00347360|1795847|FG012|Overall Study|Protocol Violation|0
839036|NCT00347360|1795848|FG013|Overall Study|Protocol Violation|1
839037|NCT00347360|1795849|FG014|Overall Study|Protocol Violation|0
839038|NCT00347360|1795835|FG000|Overall Study|Withdrawal by Subject|0
839039|NCT00347360|1795836|FG001|Overall Study|Withdrawal by Subject|1
839040|NCT00347360|1795837|FG002|Overall Study|Withdrawal by Subject|2
839041|NCT00347360|1795838|FG003|Overall Study|Withdrawal by Subject|4
839042|NCT00347360|1795839|FG004|Overall Study|Withdrawal by Subject|1
839043|NCT00347360|1795840|FG005|Overall Study|Withdrawal by Subject|2
839044|NCT00347360|1795841|FG006|Overall Study|Withdrawal by Subject|1
839045|NCT00347360|1795842|FG007|Overall Study|Withdrawal by Subject|1
839046|NCT00347360|1795843|FG008|Overall Study|Withdrawal by Subject|1
839047|NCT00347360|1795844|FG009|Overall Study|Withdrawal by Subject|1
839048|NCT00347360|1795845|FG010|Overall Study|Withdrawal by Subject|0
839049|NCT00347360|1795846|FG011|Overall Study|Withdrawal by Subject|3
839050|NCT00347360|1795847|FG012|Overall Study|Withdrawal by Subject|4
839051|NCT00347360|1795848|FG013|Overall Study|Withdrawal by Subject|2
839052|NCT00347360|1795849|FG014|Overall Study|Withdrawal by Subject|1
839053|NCT00347360|1795835|FG000|Overall Study|Lack of Efficacy|1
839054|NCT00347360|1795836|FG001|Overall Study|Lack of Efficacy|1
839055|NCT00347360|1795837|FG002|Overall Study|Lack of Efficacy|3
839056|NCT00347360|1795838|FG003|Overall Study|Lack of Efficacy|1
839057|NCT00347360|1795839|FG004|Overall Study|Lack of Efficacy|0
839059|NCT00347360|1795841|FG006|Overall Study|Lack of Efficacy|0
839060|NCT00347360|1795842|FG007|Overall Study|Lack of Efficacy|1
839061|NCT00347360|1795843|FG008|Overall Study|Lack of Efficacy|1
839062|NCT00347360|1795844|FG009|Overall Study|Lack of Efficacy|0
839063|NCT00347360|1795845|FG010|Overall Study|Lack of Efficacy|0
839064|NCT00347360|1795846|FG011|Overall Study|Lack of Efficacy|0
839065|NCT00347360|1795847|FG012|Overall Study|Lack of Efficacy|0
839066|NCT00347360|1795848|FG013|Overall Study|Lack of Efficacy|0
839067|NCT00347360|1795849|FG014|Overall Study|Lack of Efficacy|0
839068|NCT00347360|1795835|FG000|Overall Study|Reason not listed/blank|1
839069|NCT00347360|1795836|FG001|Overall Study|Reason not listed/blank|0
839070|NCT00347360|1795837|FG002|Overall Study|Reason not listed/blank|0
839071|NCT00347360|1795838|FG003|Overall Study|Reason not listed/blank|0
839072|NCT00347360|1795839|FG004|Overall Study|Reason not listed/blank|0
839073|NCT00347360|1795840|FG005|Overall Study|Reason not listed/blank|0
839074|NCT00347360|1795841|FG006|Overall Study|Reason not listed/blank|1
839075|NCT00347360|1795842|FG007|Overall Study|Reason not listed/blank|0
839076|NCT00347360|1795843|FG008|Overall Study|Reason not listed/blank|0
839077|NCT00347360|1795844|FG009|Overall Study|Reason not listed/blank|0
839078|NCT00347360|1795845|FG010|Overall Study|Reason not listed/blank|0
839079|NCT00347360|1795846|FG011|Overall Study|Reason not listed/blank|0
839080|NCT00347360|1795847|FG012|Overall Study|Reason not listed/blank|0
839081|NCT00347360|1795848|FG013|Overall Study|Reason not listed/blank|1
839082|NCT00347360|1795849|FG014|Overall Study|Reason not listed/blank|0
839083|NCT00347360|1795835|FG000|Overall Study|Per sponsors instruction|0
839084|NCT00347360|1795836|FG001|Overall Study|Per sponsors instruction|1
839085|NCT00347360|1795837|FG002|Overall Study|Per sponsors instruction|0
839086|NCT00347360|1795838|FG003|Overall Study|Per sponsors instruction|0
839087|NCT00347360|1795839|FG004|Overall Study|Per sponsors instruction|0
839088|NCT00347360|1795840|FG005|Overall Study|Per sponsors instruction|0
839089|NCT00347360|1795841|FG006|Overall Study|Per sponsors instruction|0
839090|NCT00347360|1795842|FG007|Overall Study|Per sponsors instruction|0
839091|NCT00347360|1795843|FG008|Overall Study|Per sponsors instruction|0
839092|NCT00347360|1795844|FG009|Overall Study|Per sponsors instruction|0
839093|NCT00347360|1795845|FG010|Overall Study|Per sponsors instruction|0
839094|NCT00347360|1795846|FG011|Overall Study|Per sponsors instruction|0
839095|NCT00347360|1795847|FG012|Overall Study|Per sponsors instruction|0
839096|NCT00347360|1795848|FG013|Overall Study|Per sponsors instruction|0
839097|NCT00347360|1795849|FG014|Overall Study|Per sponsors instruction|0
839098|NCT00347360|1795835|FG000|Overall Study|P.I. recommended due to blood pressure|0
839099|NCT00347360|1795836|FG001|Overall Study|P.I. recommended due to blood pressure|0
839100|NCT00347360|1795837|FG002|Overall Study|P.I. recommended due to blood pressure|0
839101|NCT00347360|1795838|FG003|Overall Study|P.I. recommended due to blood pressure|0
839102|NCT00347360|1795839|FG004|Overall Study|P.I. recommended due to blood pressure|1
839103|NCT00347360|1795840|FG005|Overall Study|P.I. recommended due to blood pressure|0
839104|NCT00347360|1795841|FG006|Overall Study|P.I. recommended due to blood pressure|0
839105|NCT00347360|1795842|FG007|Overall Study|P.I. recommended due to blood pressure|0
839106|NCT00347360|1795843|FG008|Overall Study|P.I. recommended due to blood pressure|0
839107|NCT00347360|1795844|FG009|Overall Study|P.I. recommended due to blood pressure|0
839108|NCT00347360|1795845|FG010|Overall Study|P.I. recommended due to blood pressure|0
839109|NCT00347360|1795846|FG011|Overall Study|P.I. recommended due to blood pressure|0
839110|NCT00347360|1795847|FG012|Overall Study|P.I. recommended due to blood pressure|0
839111|NCT00347360|1795848|FG013|Overall Study|P.I. recommended due to blood pressure|0
839112|NCT00347360|1795849|FG014|Overall Study|P.I. recommended due to blood pressure|0
839113|NCT00347360|1795835|FG000|Overall Study|Subject did not meet end of study ABPM|0
839114|NCT00347360|1795836|FG001|Overall Study|Subject did not meet end of study ABPM|0
839115|NCT00347360|1795837|FG002|Overall Study|Subject did not meet end of study ABPM|0
839116|NCT00347360|1795838|FG003|Overall Study|Subject did not meet end of study ABPM|0
839117|NCT00347360|1795839|FG004|Overall Study|Subject did not meet end of study ABPM|0
839118|NCT00347360|1795840|FG005|Overall Study|Subject did not meet end of study ABPM|0
839119|NCT00347360|1795841|FG006|Overall Study|Subject did not meet end of study ABPM|1
839120|NCT00347360|1795842|FG007|Overall Study|Subject did not meet end of study ABPM|0
839121|NCT00347360|1795843|FG008|Overall Study|Subject did not meet end of study ABPM|0
839122|NCT00347360|1795844|FG009|Overall Study|Subject did not meet end of study ABPM|0
839123|NCT00347360|1795845|FG010|Overall Study|Subject did not meet end of study ABPM|1
839124|NCT00347360|1795846|FG011|Overall Study|Subject did not meet end of study ABPM|0
839125|NCT00347360|1795847|FG012|Overall Study|Subject did not meet end of study ABPM|1
839126|NCT00347360|1795848|FG013|Overall Study|Subject did not meet end of study ABPM|1
839127|NCT00347360|1795849|FG014|Overall Study|Subject did not meet end of study ABPM|0
839128|NCT00347360|1795835|FG000|Overall Study|Abnormal lab values|0
839129|NCT00347360|1795836|FG001|Overall Study|Abnormal lab values|0
839130|NCT00347360|1795837|FG002|Overall Study|Abnormal lab values|0
839131|NCT00347360|1795838|FG003|Overall Study|Abnormal lab values|0
839132|NCT00347360|1795839|FG004|Overall Study|Abnormal lab values|0
839133|NCT00347360|1795840|FG005|Overall Study|Abnormal lab values|0
839134|NCT00347360|1795841|FG006|Overall Study|Abnormal lab values|1
839135|NCT00347360|1795842|FG007|Overall Study|Abnormal lab values|0
839136|NCT00347360|1795843|FG008|Overall Study|Abnormal lab values|0
839137|NCT00347360|1795844|FG009|Overall Study|Abnormal lab values|0
839138|NCT00347360|1795845|FG010|Overall Study|Abnormal lab values|0
839139|NCT00347360|1795846|FG011|Overall Study|Abnormal lab values|0
839140|NCT00347360|1795847|FG012|Overall Study|Abnormal lab values|0
839141|NCT00347360|1795848|FG013|Overall Study|Abnormal lab values|0
839142|NCT00347360|1795849|FG014|Overall Study|Abnormal lab values|0
839143|NCT00347360|1795835|FG000|Overall Study|PI recommended early withdrawal|0
839144|NCT00347360|1795836|FG001|Overall Study|PI recommended early withdrawal|0
839145|NCT00347360|1795837|FG002|Overall Study|PI recommended early withdrawal|0
839146|NCT00347360|1795838|FG003|Overall Study|PI recommended early withdrawal|0
839147|NCT00347360|1795839|FG004|Overall Study|PI recommended early withdrawal|0
839148|NCT00347360|1795840|FG005|Overall Study|PI recommended early withdrawal|0
839149|NCT00347360|1795841|FG006|Overall Study|PI recommended early withdrawal|0
839150|NCT00347360|1795842|FG007|Overall Study|PI recommended early withdrawal|0
839151|NCT00347360|1795843|FG008|Overall Study|PI recommended early withdrawal|0
839152|NCT00347360|1795844|FG009|Overall Study|PI recommended early withdrawal|1
839153|NCT00347360|1795845|FG010|Overall Study|PI recommended early withdrawal|0
839154|NCT00347360|1795846|FG011|Overall Study|PI recommended early withdrawal|0
839155|NCT00347360|1795847|FG012|Overall Study|PI recommended early withdrawal|0
839156|NCT00347360|1795848|FG013|Overall Study|PI recommended early withdrawal|0
839157|NCT00347360|1795849|FG014|Overall Study|PI recommended early withdrawal|0
839158|NCT00347360|1795835|FG000|Overall Study|Did not meet criteria before ABPM|0
839159|NCT00347360|1795836|FG001|Overall Study|Did not meet criteria before ABPM|0
839160|NCT00347360|1795837|FG002|Overall Study|Did not meet criteria before ABPM|0
839161|NCT00347360|1795838|FG003|Overall Study|Did not meet criteria before ABPM|0
839162|NCT00347360|1795839|FG004|Overall Study|Did not meet criteria before ABPM|0
839163|NCT00347360|1795840|FG005|Overall Study|Did not meet criteria before ABPM|0
839164|NCT00347360|1795841|FG006|Overall Study|Did not meet criteria before ABPM|0
839165|NCT00347360|1795842|FG007|Overall Study|Did not meet criteria before ABPM|0
839166|NCT00347360|1795843|FG008|Overall Study|Did not meet criteria before ABPM|0
839167|NCT00347360|1795844|FG009|Overall Study|Did not meet criteria before ABPM|0
839168|NCT00347360|1795845|FG010|Overall Study|Did not meet criteria before ABPM|1
839169|NCT00347360|1795846|FG011|Overall Study|Did not meet criteria before ABPM|0
839170|NCT00347360|1795847|FG012|Overall Study|Did not meet criteria before ABPM|0
839171|NCT00347360|1795848|FG013|Overall Study|Did not meet criteria before ABPM|0
839172|NCT00347360|1795849|FG014|Overall Study|Did not meet criteria before ABPM|0
839173|NCT00347360|1795835|FG000|Overall Study|Randomized in error|0
839174|NCT00347360|1795836|FG001|Overall Study|Randomized in error|0
839175|NCT00347360|1795837|FG002|Overall Study|Randomized in error|0
839176|NCT00347360|1795838|FG003|Overall Study|Randomized in error|0
839177|NCT00347360|1795839|FG004|Overall Study|Randomized in error|0
839178|NCT00347360|1795840|FG005|Overall Study|Randomized in error|0
839179|NCT00347360|1795841|FG006|Overall Study|Randomized in error|0
839180|NCT00347360|1795842|FG007|Overall Study|Randomized in error|0
839181|NCT00347360|1795843|FG008|Overall Study|Randomized in error|0
839182|NCT00347360|1795844|FG009|Overall Study|Randomized in error|0
839183|NCT00347360|1795845|FG010|Overall Study|Randomized in error|0
839184|NCT00347360|1795846|FG011|Overall Study|Randomized in error|1
839185|NCT00347360|1795847|FG012|Overall Study|Randomized in error|0
839186|NCT00347360|1795848|FG013|Overall Study|Randomized in error|0
839187|NCT00347360|1795849|FG014|Overall Study|Randomized in error|0
839188|NCT00347360|1795835|FG000|Overall Study|Failed inclusion criteria #4|0
839189|NCT00347360|1795836|FG001|Overall Study|Failed inclusion criteria #4|0
839190|NCT00347360|1795837|FG002|Overall Study|Failed inclusion criteria #4|0
839191|NCT00347360|1795838|FG003|Overall Study|Failed inclusion criteria #4|0
839192|NCT00347360|1795839|FG004|Overall Study|Failed inclusion criteria #4|0
839193|NCT00347360|1795840|FG005|Overall Study|Failed inclusion criteria #4|0
839194|NCT00347360|1795841|FG006|Overall Study|Failed inclusion criteria #4|0
839195|NCT00347360|1795842|FG007|Overall Study|Failed inclusion criteria #4|0
839196|NCT00347360|1795843|FG008|Overall Study|Failed inclusion criteria #4|0
839197|NCT00347360|1795844|FG009|Overall Study|Failed inclusion criteria #4|0
839198|NCT00347360|1795845|FG010|Overall Study|Failed inclusion criteria #4|0
839199|NCT00347360|1795846|FG011|Overall Study|Failed inclusion criteria #4|1
839200|NCT00347360|1795847|FG012|Overall Study|Failed inclusion criteria #4|0
839201|NCT00347360|1795848|FG013|Overall Study|Failed inclusion criteria #4|0
839202|NCT00347360|1795849|FG014|Overall Study|Failed inclusion criteria #4|0
839203|NCT00347360|1795835|FG000|Overall Study|Prolonged duration between visits|0
839204|NCT00347360|1795836|FG001|Overall Study|Prolonged duration between visits|0
839205|NCT00347360|1795837|FG002|Overall Study|Prolonged duration between visits|0
839206|NCT00347360|1795838|FG003|Overall Study|Prolonged duration between visits|0
839207|NCT00347360|1795839|FG004|Overall Study|Prolonged duration between visits|0
839208|NCT00347360|1795840|FG005|Overall Study|Prolonged duration between visits|0
839209|NCT00347360|1795841|FG006|Overall Study|Prolonged duration between visits|0
839210|NCT00347360|1795842|FG007|Overall Study|Prolonged duration between visits|0
839211|NCT00347360|1795843|FG008|Overall Study|Prolonged duration between visits|0
839212|NCT00347360|1795844|FG009|Overall Study|Prolonged duration between visits|0
839213|NCT00347360|1795845|FG010|Overall Study|Prolonged duration between visits|0
839214|NCT00347360|1795846|FG011|Overall Study|Prolonged duration between visits|0
839215|NCT00347360|1795847|FG012|Overall Study|Prolonged duration between visits|1
839216|NCT00347360|1795848|FG013|Overall Study|Prolonged duration between visits|0
839217|NCT00347360|1795849|FG014|Overall Study|Prolonged duration between visits|0
839218|NCT00347360|1795835|FG000|Overall Study|Subject left town, ran out of study drug|0
839219|NCT00347360|1795836|FG001|Overall Study|Subject left town, ran out of study drug|0
839220|NCT00347360|1795837|FG002|Overall Study|Subject left town, ran out of study drug|0
839221|NCT00347360|1795838|FG003|Overall Study|Subject left town, ran out of study drug|0
839222|NCT00347360|1795839|FG004|Overall Study|Subject left town, ran out of study drug|0
839223|NCT00347360|1795840|FG005|Overall Study|Subject left town, ran out of study drug|0
839224|NCT00347360|1795841|FG006|Overall Study|Subject left town, ran out of study drug|0
839225|NCT00347360|1795842|FG007|Overall Study|Subject left town, ran out of study drug|0
839226|NCT00347360|1795843|FG008|Overall Study|Subject left town, ran out of study drug|0
839227|NCT00347360|1795844|FG009|Overall Study|Subject left town, ran out of study drug|0
839228|NCT00347360|1795845|FG010|Overall Study|Subject left town, ran out of study drug|0
839229|NCT00347360|1795846|FG011|Overall Study|Subject left town, ran out of study drug|0
839230|NCT00347360|1795847|FG012|Overall Study|Subject left town, ran out of study drug|0
839231|NCT00347360|1795848|FG013|Overall Study|Subject left town, ran out of study drug|1
839232|NCT00347360|1795849|FG014|Overall Study|Subject left town, ran out of study drug|0
839233|NCT00347360|1795835|FG000|Overall Study|Subject refuse to sign updated consent|0
839234|NCT00347360|1795836|FG001|Overall Study|Subject refuse to sign updated consent|0
839235|NCT00347360|1795837|FG002|Overall Study|Subject refuse to sign updated consent|0
839236|NCT00347360|1795838|FG003|Overall Study|Subject refuse to sign updated consent|0
839237|NCT00347360|1795839|FG004|Overall Study|Subject refuse to sign updated consent|0
839238|NCT00347360|1795840|FG005|Overall Study|Subject refuse to sign updated consent|0
839239|NCT00347360|1795841|FG006|Overall Study|Subject refuse to sign updated consent|0
839240|NCT00347360|1795842|FG007|Overall Study|Subject refuse to sign updated consent|0
839241|NCT00347360|1795843|FG008|Overall Study|Subject refuse to sign updated consent|0
839242|NCT00347360|1795844|FG009|Overall Study|Subject refuse to sign updated consent|0
839243|NCT00347360|1795845|FG010|Overall Study|Subject refuse to sign updated consent|0
839244|NCT00347360|1795846|FG011|Overall Study|Subject refuse to sign updated consent|0
839245|NCT00347360|1795847|FG012|Overall Study|Subject refuse to sign updated consent|0
839246|NCT00347360|1795848|FG013|Overall Study|Subject refuse to sign updated consent|0
839247|NCT00347360|1795849|FG014|Overall Study|Subject refuse to sign updated consent|1
839248|NCT00347360|1795835|FG000|Overall Study|Visits conflicted with new job|0
839249|NCT00347360|1795836|FG001|Overall Study|Visits conflicted with new job|0
839250|NCT00347360|1795837|FG002|Overall Study|Visits conflicted with new job|0
839251|NCT00347360|1795838|FG003|Overall Study|Visits conflicted with new job|0
839252|NCT00347360|1795839|FG004|Overall Study|Visits conflicted with new job|0
839253|NCT00347360|1795840|FG005|Overall Study|Visits conflicted with new job|0
839254|NCT00347360|1795841|FG006|Overall Study|Visits conflicted with new job|1
839255|NCT00347360|1795842|FG007|Overall Study|Visits conflicted with new job|0
839256|NCT00347360|1795843|FG008|Overall Study|Visits conflicted with new job|0
839257|NCT00347360|1795844|FG009|Overall Study|Visits conflicted with new job|0
839258|NCT00347360|1795845|FG010|Overall Study|Visits conflicted with new job|0
839259|NCT00347360|1795846|FG011|Overall Study|Visits conflicted with new job|0
839260|NCT00347360|1795847|FG012|Overall Study|Visits conflicted with new job|0
839261|NCT00347360|1795848|FG013|Overall Study|Visits conflicted with new job|0
839262|NCT00347360|1795849|FG014|Overall Study|Visits conflicted with new job|0
839263|NCT00347438|1795881|FG000|Overall Study|Withdrawal by Subject|1
839264|NCT00347438|1795881|FG000|Overall Study|Physician Decision|1
839265|NCT00347776|1795888|FG000|1.5 Month Follow-up|Death|2
839266|NCT00347776|1795889|FG001|1.5 Month Follow-up|Death|0
839267|NCT00347776|1795890|FG002|1.5 Month Follow-up|Death|0
839268|NCT00347776|1795888|FG000|1.5 Month Follow-up|reached the endpoint|12
839269|NCT00347776|1795889|FG001|1.5 Month Follow-up|reached the endpoint|8
839270|NCT00347776|1795890|FG002|1.5 Month Follow-up|reached the endpoint|12
839271|NCT00347776|1795888|FG000|6 Month Follow-up|Death|2
839272|NCT00347776|1795889|FG001|6 Month Follow-up|Death|1
839273|NCT00347776|1795890|FG002|6 Month Follow-up|Death|3
839274|NCT00347776|1795888|FG000|6 Month Follow-up|reached endpont|20
839275|NCT00347776|1795889|FG001|6 Month Follow-up|reached endpont|12
839276|NCT00347776|1795890|FG002|6 Month Follow-up|reached endpont|15
839277|NCT00347776|1795888|FG000|12 Month Follow-up|Lost to Follow-up|7
839278|NCT00347776|1795889|FG001|12 Month Follow-up|Lost to Follow-up|6
839279|NCT00347776|1795890|FG002|12 Month Follow-up|Lost to Follow-up|6
839280|NCT00347776|1795888|FG000|12 Month Follow-up|Death|3
839281|NCT00347776|1795889|FG001|12 Month Follow-up|Death|4
839282|NCT00347776|1795890|FG002|12 Month Follow-up|Death|4
839283|NCT00347776|1795888|FG000|12 Month Follow-up|Reached endpoint|13
839284|NCT00347776|1795889|FG001|12 Month Follow-up|Reached endpoint|6
839285|NCT00347776|1795890|FG002|12 Month Follow-up|Reached endpoint|9
839286|NCT00347919|1795901|FG000|Overall Study|Lost to Follow-up|11
839287|NCT00347919|1795902|FG001|Overall Study|Lost to Follow-up|13
839288|NCT00347919|1795903|FG002|Overall Study|Lost to Follow-up|0
839289|NCT00347919|1795901|FG000|Overall Study|Withdrawal by Subject|6
839290|NCT00347919|1795902|FG001|Overall Study|Withdrawal by Subject|8
839291|NCT00347919|1795903|FG002|Overall Study|Withdrawal by Subject|0
839292|NCT00347919|1795901|FG000|Overall Study|Physician Decision|1
839293|NCT00347919|1795902|FG001|Overall Study|Physician Decision|1
839294|NCT00347919|1795903|FG002|Overall Study|Physician Decision|0
839295|NCT00347919|1795901|FG000|Overall Study|Sponsor terminated study|15
839296|NCT00347919|1795902|FG001|Overall Study|Sponsor terminated study|10
839297|NCT00347919|1795903|FG002|Overall Study|Sponsor terminated study|16
839298|NCT00347919|1795901|FG000|Overall Study|Death|35
839299|NCT00347919|1795902|FG001|Overall Study|Death|42
839300|NCT00347919|1795903|FG002|Overall Study|Death|19
839301|NCT00347919|1795901|FG000|Overall Study|Par. Started Other Treatment|1
839302|NCT00347919|1795902|FG001|Overall Study|Par. Started Other Treatment|1
839303|NCT00347919|1795903|FG002|Overall Study|Par. Started Other Treatment|1
839304|NCT00347919|1795901|FG000|Overall Study|Missing|2
839305|NCT00347919|1795902|FG001|Overall Study|Missing|1
839306|NCT00347919|1795903|FG002|Overall Study|Missing|2
839307|NCT00347932|1795915|FG000|Overall Study|Adverse Event|4
839308|NCT00347932|1795916|FG001|Overall Study|Adverse Event|5
839309|NCT00347932|1795915|FG000|Overall Study|Lack of Efficacy|3
839310|NCT00347932|1795916|FG001|Overall Study|Lack of Efficacy|14
839311|NCT00347932|1795915|FG000|Overall Study|Lost to Follow-up|10
839312|NCT00347932|1795916|FG001|Overall Study|Lost to Follow-up|9
839313|NCT00347932|1795915|FG000|Overall Study|Withdrawal by Subject|10
839314|NCT00347932|1795916|FG001|Overall Study|Withdrawal by Subject|16
839315|NCT00347932|1795915|FG000|Overall Study|Did not meet inclusion criteria|4
839316|NCT00347932|1795916|FG001|Overall Study|Did not meet inclusion criteria|8
839317|NCT00347958|1795922|FG000|Overall Study|Adverse Event|1
839318|NCT00347958|1795922|FG000|Overall Study|Protocol Violation|2
839319|NCT00347958|1795922|FG000|Overall Study|Withdrawal by Subject|1
839320|NCT00348140|1795929|FG000|Overall Study|Adverse Event|46
839321|NCT00348140|1795930|FG001|Overall Study|Adverse Event|49
839322|NCT00348140|1795931|FG002|Overall Study|Adverse Event|78
839323|NCT00348140|1795929|FG000|Overall Study|Lost to Follow-up|4
839324|NCT00348140|1795930|FG001|Overall Study|Lost to Follow-up|4
839325|NCT00348140|1795931|FG002|Overall Study|Lost to Follow-up|4
839326|NCT00348140|1795929|FG000|Overall Study|Protocol Violation|12
839327|NCT00348140|1795930|FG001|Overall Study|Protocol Violation|13
839328|NCT00348140|1795931|FG002|Overall Study|Protocol Violation|14
839329|NCT00348140|1795929|FG000|Overall Study|Withdrawal by Subject|32
839330|NCT00348140|1795930|FG001|Overall Study|Withdrawal by Subject|40
839331|NCT00348140|1795931|FG002|Overall Study|Withdrawal by Subject|40
839332|NCT00348140|1795929|FG000|Overall Study|Non-compliance|8
839333|NCT00348140|1795930|FG001|Overall Study|Non-compliance|13
839334|NCT00348140|1795931|FG002|Overall Study|Non-compliance|5
839335|NCT00348140|1795929|FG000|Overall Study|Participant at risk due to study drug|2
839336|NCT00348140|1795930|FG001|Overall Study|Participant at risk due to study drug|0
839337|NCT00348140|1795931|FG002|Overall Study|Participant at risk due to study drug|0
839338|NCT00348140|1795929|FG000|Overall Study|Conditional medication increased dose|1
839339|NCT00348140|1795930|FG001|Overall Study|Conditional medication increased dose|0
839340|NCT00348140|1795931|FG002|Overall Study|Conditional medication increased dose|0
839341|NCT00348140|1795929|FG000|Overall Study|Caregiver related|4
839342|NCT00348140|1795930|FG001|Overall Study|Caregiver related|7
839343|NCT00348140|1795931|FG002|Overall Study|Caregiver related|3
839344|NCT00348140|1795929|FG000|Overall Study|Participant hospitalised|3
839345|NCT00348140|1795930|FG001|Overall Study|Participant hospitalised|0
839346|NCT00348140|1795931|FG002|Overall Study|Participant hospitalised|0
839347|NCT00348140|1795929|FG000|Overall Study|Efficacy related|1
839348|NCT00348140|1795930|FG001|Overall Study|Efficacy related|1
839349|NCT00348140|1795931|FG002|Overall Study|Efficacy related|0
839350|NCT00348140|1795929|FG000|Overall Study|Administration related|3
839351|NCT00348140|1795930|FG001|Overall Study|Administration related|1
839352|NCT00348140|1795931|FG002|Overall Study|Administration related|1
839353|NCT00348140|1795929|FG000|Overall Study|Unmet inclusion-exclusion criteria|1
839354|NCT00348140|1795930|FG001|Overall Study|Unmet inclusion-exclusion criteria|0
839355|NCT00348140|1795931|FG002|Overall Study|Unmet inclusion-exclusion criteria|1
839356|NCT00348140|1795929|FG000|Overall Study|Participant unwell|1
839357|NCT00348140|1795930|FG001|Overall Study|Participant unwell|0
839358|NCT00348140|1795931|FG002|Overall Study|Participant unwell|0
839359|NCT00348140|1795929|FG000|Overall Study|Screen failure|1
839360|NCT00348140|1795930|FG001|Overall Study|Screen failure|0
839361|NCT00348140|1795931|FG002|Overall Study|Screen failure|0
839362|NCT00348140|1795929|FG000|Overall Study|Investigator decided to discontinue|4
839363|NCT00348140|1795930|FG001|Overall Study|Investigator decided to discontinue|1
839364|NCT00348140|1795931|FG002|Overall Study|Investigator decided to discontinue|4
839365|NCT00348140|1795929|FG000|Overall Study|Decided to discontinue on their own|1
839366|NCT00348140|1795930|FG001|Overall Study|Decided to discontinue on their own|4
839367|NCT00348140|1795931|FG002|Overall Study|Decided to discontinue on their own|1
839368|NCT00348140|1795929|FG000|Overall Study|Use of prohibited drug|1
839369|NCT00348140|1795930|FG001|Overall Study|Use of prohibited drug|0
839370|NCT00348140|1795931|FG002|Overall Study|Use of prohibited drug|2
839371|NCT00348140|1795929|FG000|Overall Study|Disease progression|1
839372|NCT00348140|1795930|FG001|Overall Study|Disease progression|2
839373|NCT00348140|1795931|FG002|Overall Study|Disease progression|5
839374|NCT00348140|1795929|FG000|Overall Study|Increased risk of cardiac infarction|0
839375|NCT00348140|1795930|FG001|Overall Study|Increased risk of cardiac infarction|1
839376|NCT00348140|1795931|FG002|Overall Study|Increased risk of cardiac infarction|0
839377|NCT00348140|1795929|FG000|Overall Study|Serious adverse event|0
839378|NCT00348140|1795930|FG001|Overall Study|Serious adverse event|1
839379|NCT00348140|1795931|FG002|Overall Study|Serious adverse event|0
839380|NCT00348140|1795929|FG000|Overall Study|Abnormal ECG|0
839381|NCT00348140|1795930|FG001|Overall Study|Abnormal ECG|1
839382|NCT00348140|1795931|FG002|Overall Study|Abnormal ECG|3
839383|NCT00348140|1795929|FG000|Overall Study|Participant died|0
839384|NCT00348140|1795930|FG001|Overall Study|Participant died|1
839385|NCT00348140|1795931|FG002|Overall Study|Participant died|0
839386|NCT00348140|1795929|FG000|Overall Study|Exclusion criteria met|0
839387|NCT00348140|1795930|FG001|Overall Study|Exclusion criteria met|0
839388|NCT00348140|1795931|FG002|Overall Study|Exclusion criteria met|1
839389|NCT00348140|1795929|FG000|Overall Study|Memory declined|0
839390|NCT00348140|1795930|FG001|Overall Study|Memory declined|0
839391|NCT00348140|1795931|FG002|Overall Study|Memory declined|1
839392|NCT00348283|1795946|FG000|Induction|Adverse Event|0
839393|NCT00348283|1795947|FG001|Induction|Adverse Event|2
839394|NCT00348283|1795946|FG000|Induction|Protocol Violation|0
839395|NCT00348283|1795947|FG001|Induction|Protocol Violation|4
839396|NCT00348283|1795946|FG000|Double Blind|Adverse Event|2
839397|NCT00348283|1795947|FG001|Double Blind|Adverse Event|5
839398|NCT00348283|1795946|FG000|Double Blind|Withdrawal by Subject|1
839399|NCT00348283|1795947|FG001|Double Blind|Withdrawal by Subject|1
839400|NCT00348283|1795946|FG000|Double Blind|Protocol Violation|0
839401|NCT00348283|1795947|FG001|Double Blind|Protocol Violation|1
839402|NCT00348283|1795946|FG000|Double Blind|Lack of Efficacy|2
839403|NCT00348283|1795947|FG001|Double Blind|Lack of Efficacy|2
839404|NCT00348283|1795946|FG000|Double Blind|Pregnancy|0
839405|NCT00348283|1795947|FG001|Double Blind|Pregnancy|1
839406|NCT00348283|1795946|FG000|Open Label|Adverse Event|0
839407|NCT00348283|1795947|FG001|Open Label|Adverse Event|8
839408|NCT00348283|1795946|FG000|Open Label|Withdrawal by Subject|0
839409|NCT00348283|1795947|FG001|Open Label|Withdrawal by Subject|4
839410|NCT00348283|1795946|FG000|Open Label|Lost to Follow-up|0
839411|NCT00348283|1795947|FG001|Open Label|Lost to Follow-up|1
839412|NCT00348283|1795946|FG000|Open Label|Lack of Efficacy|0
839413|NCT00348283|1795947|FG001|Open Label|Lack of Efficacy|13
839414|NCT00348283|1795946|FG000|Open Label|Administrative reasons|0
839415|NCT00348283|1795947|FG001|Open Label|Administrative reasons|5
839416|NCT00348283|1795946|FG000|Open Label|Subject moved to the United States|0
839417|NCT00348283|1795947|FG001|Open Label|Subject moved to the United States|1
839418|NCT00348283|1795946|FG000|Open Label|Pregnancy|0
839419|NCT00348283|1795947|FG001|Open Label|Pregnancy|1
839420|NCT00348283|1795946|FG000|Open Label|Sponsor decision|0
839421|NCT00348283|1795947|FG001|Open Label|Sponsor decision|1
839422|NCT00348309|1795956|FG000|Overall Study|Adverse Event|56
839423|NCT00348309|1795957|FG001|Overall Study|Adverse Event|28
839424|NCT00348309|1795958|FG002|Overall Study|Adverse Event|63
839425|NCT00348309|1795956|FG000|Overall Study|Lost to Follow-up|6
839426|NCT00348309|1795957|FG001|Overall Study|Lost to Follow-up|7
839427|NCT00348309|1795958|FG002|Overall Study|Lost to Follow-up|4
839428|NCT00348309|1795956|FG000|Overall Study|Protocol Violation|7
839429|NCT00348309|1795957|FG001|Overall Study|Protocol Violation|12
839430|NCT00348309|1795958|FG002|Overall Study|Protocol Violation|7
839431|NCT00348309|1795956|FG000|Overall Study|Withdrawal by Subject|33
839432|NCT00348309|1795957|FG001|Overall Study|Withdrawal by Subject|37
839433|NCT00348309|1795958|FG002|Overall Study|Withdrawal by Subject|40
839434|NCT00348309|1795956|FG000|Overall Study|Non-compliance|8
839435|NCT00348309|1795957|FG001|Overall Study|Non-compliance|6
839436|NCT00348309|1795958|FG002|Overall Study|Non-compliance|8
839437|NCT00348309|1795956|FG000|Overall Study|Death of caregiver|1
839438|NCT00348309|1795957|FG001|Overall Study|Death of caregiver|0
839439|NCT00348309|1795958|FG002|Overall Study|Death of caregiver|1
839440|NCT00348309|1795956|FG000|Overall Study|Lack of insight, dementia|1
839441|NCT00348309|1795957|FG001|Overall Study|Lack of insight, dementia|0
839442|NCT00348309|1795958|FG002|Overall Study|Lack of insight, dementia|0
839443|NCT00348309|1795956|FG000|Overall Study|Wrong bottle allocated|1
839444|NCT00348309|1795957|FG001|Overall Study|Wrong bottle allocated|0
839445|NCT00348309|1795958|FG002|Overall Study|Wrong bottle allocated|0
839446|NCT00348309|1795956|FG000|Overall Study|Caregiver sick|1
839447|NCT00348309|1795957|FG001|Overall Study|Caregiver sick|0
839448|NCT00348309|1795958|FG002|Overall Study|Caregiver sick|0
839449|NCT00348309|1795956|FG000|Overall Study|Use of prohibited medication|5
839450|NCT00348309|1795957|FG001|Overall Study|Use of prohibited medication|2
839451|NCT00348309|1795958|FG002|Overall Study|Use of prohibited medication|2
839452|NCT00348309|1795956|FG000|Overall Study|Caregiver withdrawal|3
839453|NCT00348309|1795957|FG001|Overall Study|Caregiver withdrawal|0
839454|NCT00348309|1795958|FG002|Overall Study|Caregiver withdrawal|7
839455|NCT00348309|1795956|FG000|Overall Study|Unable to complete ET visit|1
839456|NCT00348309|1795957|FG001|Overall Study|Unable to complete ET visit|0
839457|NCT00348309|1795958|FG002|Overall Study|Unable to complete ET visit|0
839458|NCT00348309|1795956|FG000|Overall Study|PI closing medical practice|1
839459|NCT00348309|1795957|FG001|Overall Study|PI closing medical practice|0
839460|NCT00348309|1795958|FG002|Overall Study|PI closing medical practice|0
839461|NCT00348309|1795956|FG000|Overall Study|Principal investigator's decision|1
839462|NCT00348309|1795957|FG001|Overall Study|Principal investigator's decision|0
839463|NCT00348309|1795958|FG002|Overall Study|Principal investigator's decision|0
839464|NCT00348309|1795956|FG000|Overall Study|No disponibility of medication|1
839465|NCT00348309|1795957|FG001|Overall Study|No disponibility of medication|0
839466|NCT00348309|1795958|FG002|Overall Study|No disponibility of medication|0
839467|NCT00348309|1795956|FG000|Overall Study|Worsened neurodegenerative disease|1
839468|NCT00348309|1795957|FG001|Overall Study|Worsened neurodegenerative disease|0
839469|NCT00348309|1795958|FG002|Overall Study|Worsened neurodegenerative disease|0
839470|NCT00348309|1795956|FG000|Overall Study|Cognitive and behaviour worsening|2
839471|NCT00348309|1795957|FG001|Overall Study|Cognitive and behaviour worsening|0
839472|NCT00348309|1795958|FG002|Overall Study|Cognitive and behaviour worsening|0
839473|NCT00348309|1795956|FG000|Overall Study|Worsening of alzheimer|1
839474|NCT00348309|1795957|FG001|Overall Study|Worsening of alzheimer|0
839475|NCT00348309|1795958|FG002|Overall Study|Worsening of alzheimer|1
839476|NCT00348309|1795956|FG000|Overall Study|Did not appear in time for Visit 3|1
839477|NCT00348309|1795957|FG001|Overall Study|Did not appear in time for Visit 3|0
839478|NCT00348309|1795958|FG002|Overall Study|Did not appear in time for Visit 3|0
839479|NCT00348309|1795956|FG000|Overall Study|Participant died|2
839480|NCT00348309|1795957|FG001|Overall Study|Participant died|1
839481|NCT00348309|1795958|FG002|Overall Study|Participant died|1
839482|NCT00348309|1795956|FG000|Overall Study|Decision of sponsor|1
839483|NCT00348309|1795957|FG001|Overall Study|Decision of sponsor|0
839484|NCT00348309|1795958|FG002|Overall Study|Decision of sponsor|0
839485|NCT00348309|1795956|FG000|Overall Study|Ineffectiveness of treatment|0
839486|NCT00348309|1795957|FG001|Overall Study|Ineffectiveness of treatment|1
839487|NCT00348309|1795958|FG002|Overall Study|Ineffectiveness of treatment|0
839488|NCT00348309|1795956|FG000|Overall Study|A foul of exclusion criteria|0
839489|NCT00348309|1795957|FG001|Overall Study|A foul of exclusion criteria|1
839490|NCT00348309|1795958|FG002|Overall Study|A foul of exclusion criteria|0
839491|NCT00348309|1795956|FG000|Overall Study|Participant was hospitalized|0
839492|NCT00348309|1795957|FG001|Overall Study|Participant was hospitalized|1
839493|NCT00348309|1795958|FG002|Overall Study|Participant was hospitalized|0
839494|NCT00348309|1795956|FG000|Overall Study|Sponsor refuseal|0
839495|NCT00348309|1795957|FG001|Overall Study|Sponsor refuseal|1
839496|NCT00348309|1795958|FG002|Overall Study|Sponsor refuseal|1
839497|NCT00348309|1795956|FG000|Overall Study|Forgot often medication|0
839498|NCT00348309|1795957|FG001|Overall Study|Forgot often medication|1
839499|NCT00348309|1795958|FG002|Overall Study|Forgot often medication|0
839500|NCT00348309|1795956|FG000|Overall Study|Medical Monitor decision|0
839501|NCT00348309|1795957|FG001|Overall Study|Medical Monitor decision|0
839502|NCT00348309|1795958|FG002|Overall Study|Medical Monitor decision|1
839503|NCT00348309|1795956|FG000|Overall Study|Increased dose of Aricept|0
839504|NCT00348309|1795957|FG001|Overall Study|Increased dose of Aricept|0
839505|NCT00348309|1795958|FG002|Overall Study|Increased dose of Aricept|1
839506|NCT00348309|1795956|FG000|Overall Study|Site closure|0
839507|NCT00348309|1795957|FG001|Overall Study|Site closure|0
839508|NCT00348309|1795958|FG002|Overall Study|Site closure|1
839509|NCT00348309|1795956|FG000|Overall Study|Adverse event not attended|0
839510|NCT00348309|1795957|FG001|Overall Study|Adverse event not attended|0
839511|NCT00348309|1795958|FG002|Overall Study|Adverse event not attended|1
839512|NCT00348309|1795956|FG000|Overall Study|ECG abnormal|0
839513|NCT00348309|1795957|FG001|Overall Study|ECG abnormal|0
839514|NCT00348309|1795958|FG002|Overall Study|ECG abnormal|2
839515|NCT00348309|1795956|FG000|Overall Study|Cardiologist recommendations|0
839516|NCT00348309|1795957|FG001|Overall Study|Cardiologist recommendations|0
839517|NCT00348309|1795958|FG002|Overall Study|Cardiologist recommendations|1
839518|NCT00348309|1795956|FG000|Overall Study|HCV career|0
839519|NCT00348309|1795957|FG001|Overall Study|HCV career|0
839520|NCT00348309|1795958|FG002|Overall Study|HCV career|1
839521|NCT00348348|1795969|FG000|Overall Study|Adverse event - unrelated to study drug|0
839522|NCT00348348|1795970|FG001|Overall Study|Adverse event - unrelated to study drug|1
839523|NCT00348348|1795969|FG000|Overall Study|Lack of Efficacy|1
839524|NCT00348348|1795970|FG001|Overall Study|Lack of Efficacy|1
839525|NCT00348348|1795969|FG000|Overall Study|Lost to Follow-up|8
839526|NCT00348348|1795970|FG001|Overall Study|Lost to Follow-up|10
839527|NCT00348348|1795969|FG000|Overall Study|Withdrawal by Subject|4
839528|NCT00348348|1795970|FG001|Overall Study|Withdrawal by Subject|1
839529|NCT00348348|1795969|FG000|Overall Study|Other|7
839530|NCT00348348|1795970|FG001|Overall Study|Other|4
839531|NCT00348348|1795969|FG000|Overall Study|Dissallowed Meds - unrelated to study|1
839532|NCT00348348|1795970|FG001|Overall Study|Dissallowed Meds - unrelated to study|3
839533|NCT00348348|1795969|FG000|Overall Study|Dissallowed Meds - unlikley related|1
839534|NCT00348348|1795970|FG001|Overall Study|Dissallowed Meds - unlikley related|1
839535|NCT00348348|1795969|FG000|Overall Study|Dissallowed Meds - possibly releated|1
839536|NCT00348348|1795970|FG001|Overall Study|Dissallowed Meds - possibly releated|1
839537|NCT00348348|1795969|FG000|Overall Study|Worsening of BC - Unrelated to study|0
839538|NCT00348348|1795970|FG001|Overall Study|Worsening of BC - Unrelated to study|3
839539|NCT00348348|1795969|FG000|Overall Study|Worsening of BC - Unlikely related|1
839540|NCT00348348|1795970|FG001|Overall Study|Worsening of BC - Unlikely related|2
839541|NCT00348348|1795969|FG000|Overall Study|Adverse event probably related to study|1
839542|NCT00348348|1795970|FG001|Overall Study|Adverse event probably related to study|0
839543|NCT00348374|1795978|FG000|Overall Study|Adverse Event|1
839544|NCT00348374|1795979|FG001|Overall Study|Adverse Event|4
839545|NCT00348374|1795978|FG000|Overall Study|Lost to Follow-up|1
839546|NCT00348374|1795979|FG001|Overall Study|Lost to Follow-up|3
839547|NCT00348374|1795978|FG000|Overall Study|Withdrawal by Subject|5
839548|NCT00348374|1795979|FG001|Overall Study|Withdrawal by Subject|5
839549|NCT00348374|1795978|FG000|Overall Study|Other|11
839550|NCT00348374|1795979|FG001|Overall Study|Other|12
839551|NCT00348374|1795978|FG000|Overall Study|ongoing at date of cutoff|1
839552|NCT00348374|1795979|FG001|Overall Study|ongoing at date of cutoff|1
839553|NCT00348374|1795978|FG000|Overall Study|randomized but did not receive treatment|0
839554|NCT00348374|1795979|FG001|Overall Study|randomized but did not receive treatment|7
839555|NCT00348595|1795988|FG000|Overall Study|Adverse Event|5
839556|NCT00348595|1795989|FG001|Overall Study|Adverse Event|8
839557|NCT00348673|1796003|FG000|Stage 1|Randomized but not Treated|0
839558|NCT00348673|1796004|FG001|Stage 1|Randomized but not Treated|0
839559|NCT00348673|1796005|FG002|Stage 1|Randomized but not Treated|1
839560|NCT00348673|1796006|FG003|Stage 1|Randomized but not Treated|0
839561|NCT00348673|1796007|FG004|Stage 1|Randomized but not Treated|0
839562|NCT00348673|1796008|FG005|Stage 1|Randomized but not Treated|0
839563|NCT00348673|1796009|FG006|Stage 1|Randomized but not Treated|0
839564|NCT00348673|1796010|FG007|Stage 1|Randomized but not Treated|0
839565|NCT00348673|1796011|FG008|Stage 1|Randomized but not Treated|0
839566|NCT00348686|1796029|FG000|Overall Study|Withdrawal by Subject|45
839567|NCT00348686|1796029|FG000|Overall Study|Adverse Event|5
839568|NCT00348686|1796029|FG000|Overall Study|Protocol Violation|6
839569|NCT00348686|1796029|FG000|Overall Study|Lost to Follow-up|2
839570|NCT00348686|1796029|FG000|Overall Study|Multiple Reasons|8
839571|NCT00348790|1796033|FG000|Completed Treatment|Withdrawal by Subject|4
839572|NCT00348790|1796033|FG000|Completed Treatment|Disease progression|14
839573|NCT00348790|1796033|FG000|Completed Treatment|Adverse Event|4
839574|NCT00348790|1796033|FG000|Completed Treatment|Required surgery|2
839575|NCT00348790|1796033|FG000|Completed Treatment|Unable to travel to study site|1
839576|NCT00348816|1796038|FG000|Overall Study|Noncompliance with radiation treatment|1
839577|NCT00348881|1796046|FG000|Overall Study|Lost to Follow-up|12
839578|NCT00348881|1796047|FG001|Overall Study|Lost to Follow-up|6
839579|NCT00348881|1796046|FG000|Overall Study|Withdrawal by Subject|3
839580|NCT00348881|1796047|FG001|Overall Study|Withdrawal by Subject|4
839581|NCT00348881|1796046|FG000|Overall Study|Adverse Event|2
839582|NCT00348881|1796047|FG001|Overall Study|Adverse Event|0
839583|NCT00348881|1796046|FG000|Overall Study|Serious Adverse Event|0
839584|NCT00348881|1796047|FG001|Overall Study|Serious Adverse Event|2
839585|NCT00348933|1796057|FG000|Overall Study|Withdrawal by Subject|10
839586|NCT00348933|1796057|FG000|Overall Study|Lost to Follow-up|6
839587|NCT00348933|1796057|FG000|Overall Study|Protocol Violation|2
839588|NCT00348933|1796057|FG000|Overall Study|Adverse Event|7
839589|NCT00349349|1796085|FG000|Overall Study|Adverse Event|5
839590|NCT00349349|1796086|FG001|Overall Study|Adverse Event|6
839591|NCT00349349|1796087|FG002|Overall Study|Adverse Event|2
839592|NCT00349349|1796085|FG000|Overall Study|Withdrawal by Subject|5
839593|NCT00349349|1796086|FG001|Overall Study|Withdrawal by Subject|2
839594|NCT00349349|1796087|FG002|Overall Study|Withdrawal by Subject|1
839595|NCT00349349|1796085|FG000|Overall Study|Withdrawn due to Disease Progression|27
839596|NCT00349349|1796086|FG001|Overall Study|Withdrawn due to Disease Progression|37
839597|NCT00349349|1796087|FG002|Overall Study|Withdrawn due to Disease Progression|1
839598|NCT00349349|1796085|FG000|Overall Study|Death|13
839599|NCT00349349|1796086|FG001|Overall Study|Death|10
839600|NCT00349349|1796087|FG002|Overall Study|Death|1
839601|NCT00349349|1796085|FG000|Overall Study|Other Treatment Selected|2
839602|NCT00349349|1796086|FG001|Overall Study|Other Treatment Selected|0
839603|NCT00349349|1796087|FG002|Overall Study|Other Treatment Selected|0
839604|NCT00349349|1796085|FG000|Overall Study|Participant Reduced General Condition|0
839605|NCT00349349|1796086|FG001|Overall Study|Participant Reduced General Condition|1
839606|NCT00349349|1796087|FG002|Overall Study|Participant Reduced General Condition|0
839607|NCT00349349|1796085|FG000|Overall Study|Physician Decision|1
839608|NCT00349349|1796086|FG001|Overall Study|Physician Decision|2
839609|NCT00349349|1796087|FG002|Overall Study|Physician Decision|1
839610|NCT00349349|1796085|FG000|Overall Study|No Response|0
839611|NCT00349349|1796086|FG001|Overall Study|No Response|3
839612|NCT00349349|1796087|FG002|Overall Study|No Response|0
839613|NCT00349349|1796085|FG000|Overall Study|New Malignancy (Bladder Cancer)|0
839614|NCT00349349|1796086|FG001|Overall Study|New Malignancy (Bladder Cancer)|1
839615|NCT00349349|1796087|FG002|Overall Study|New Malignancy (Bladder Cancer)|0
839616|NCT00349622|1796117|FG000|Overall Study|Death|168
839617|NCT00349622|1796118|FG001|Overall Study|Death|86
839618|NCT00349622|1796117|FG000|Overall Study|Lost to Follow-up|5
839619|NCT00349622|1796118|FG001|Overall Study|Lost to Follow-up|1
839620|NCT00349622|1796117|FG000|Overall Study|Withdrawal by Subject|5
839621|NCT00349622|1796118|FG001|Overall Study|Withdrawal by Subject|9
839622|NCT00349752|1796139|FG000|Overall Study|Adverse Event|8
839623|NCT00349752|1796140|FG001|Overall Study|Adverse Event|12
839624|NCT00349752|1796139|FG000|Overall Study|Lack of Efficacy|37
839625|NCT00349752|1796140|FG001|Overall Study|Lack of Efficacy|42
839626|NCT00349752|1796139|FG000|Overall Study|Lost to Follow-up|4
839627|NCT00349752|1796140|FG001|Overall Study|Lost to Follow-up|2
839628|NCT00349752|1796139|FG000|Overall Study|Personal reasons|6
839629|NCT00349752|1796140|FG001|Overall Study|Personal reasons|5
839630|NCT00349752|1796139|FG000|Overall Study|Other: Required exclusionary medication|0
839631|NCT00349752|1796140|FG001|Overall Study|Other: Required exclusionary medication|1
839632|NCT00349752|1796139|FG000|Overall Study|Other: Non compliance|0
839633|NCT00349752|1796140|FG001|Overall Study|Other: Non compliance|1
839634|NCT00349752|1796139|FG000|Overall Study|Other: Patient stopped steroids|0
839635|NCT00349752|1796140|FG001|Overall Study|Other: Patient stopped steroids|1
839636|NCT00349752|1796139|FG000|Overall Study|Other: Patient's steroid use|1
839637|NCT00349752|1796140|FG001|Overall Study|Other: Patient's steroid use|0
839638|NCT00349752|1796139|FG000|Overall Study|Other: Ineligible|1
839639|NCT00349752|1796140|FG001|Overall Study|Other: Ineligible|0
839640|NCT00349752|1796139|FG000|Overall Study|Other: Inadvertently unblinded|1
839641|NCT00349752|1796140|FG001|Overall Study|Other: Inadvertently unblinded|0
839642|NCT00349752|1796139|FG000|Overall Study|Other:History of squamous cell carcinoma|1
839643|NCT00349752|1796140|FG001|Overall Study|Other:History of squamous cell carcinoma|0
839644|NCT00349908|1796152|FG000|Overall Study|Withdrawal by Subject|0
839645|NCT00349908|1796153|FG001|Overall Study|Withdrawal by Subject|4
839646|NCT00349921|1796164|FG000|First Spinal Injection|Physician Decision|1
839647|NCT00349921|1796165|FG001|First Spinal Injection|Physician Decision|0
839648|NCT00349921|1796166|FG002|First Spinal Injection|Physician Decision|0
839649|NCT00349921|1796167|FG003|First Spinal Injection|Physician Decision|0
839650|NCT00349921|1796164|FG000|First Spinal Injection|Adverse Event|0
839651|NCT00349921|1796165|FG001|First Spinal Injection|Adverse Event|0
839652|NCT00349921|1796166|FG002|First Spinal Injection|Adverse Event|1
839653|NCT00349921|1796167|FG003|First Spinal Injection|Adverse Event|0
839654|NCT00349973|1796178|FG000|Overall Study|Adverse Event|3
839655|NCT00349973|1796179|FG001|Overall Study|Adverse Event|3
839656|NCT00349973|1796178|FG000|Overall Study|Withdrawal by Subject|1
839657|NCT00349973|1796179|FG001|Overall Study|Withdrawal by Subject|0
839658|NCT00350207|1796202|FG000|Overall Study|Adverse Event|5
839659|NCT00350207|1796203|FG001|Overall Study|Adverse Event|2
839660|NCT00350207|1796204|FG002|Overall Study|Adverse Event|2
839661|NCT00350207|1796202|FG000|Overall Study|Lack of Efficacy|1
839662|NCT00350207|1796203|FG001|Overall Study|Lack of Efficacy|0
839663|NCT00350207|1796204|FG002|Overall Study|Lack of Efficacy|2
839664|NCT00350207|1796202|FG000|Overall Study|Lost to Follow-up|1
839665|NCT00350207|1796203|FG001|Overall Study|Lost to Follow-up|0
839666|NCT00350207|1796204|FG002|Overall Study|Lost to Follow-up|1
839667|NCT00350207|1796202|FG000|Overall Study|Withdrawal by Subject|0
839668|NCT00350207|1796203|FG001|Overall Study|Withdrawal by Subject|1
839669|NCT00350207|1796204|FG002|Overall Study|Withdrawal by Subject|1
839670|NCT00350207|1796202|FG000|Overall Study|Other|1
839671|NCT00350207|1796203|FG001|Overall Study|Other|3
839672|NCT00350207|1796204|FG002|Overall Study|Other|1
839673|NCT00350272|1796223|FG000|Blinded 12 Week Treatment|Adverse Event|1
839674|NCT00350272|1796224|FG001|Blinded 12 Week Treatment|Adverse Event|0
839675|NCT00350272|1796223|FG000|Blinded 12 Week Treatment|Death|1
839676|NCT00350272|1796224|FG001|Blinded 12 Week Treatment|Death|0
839677|NCT00350272|1796223|FG000|Blinded 12 Week Treatment|Lost to Follow-up|2
839678|NCT00350272|1796224|FG001|Blinded 12 Week Treatment|Lost to Follow-up|0
839679|NCT00350272|1796223|FG000|Blinded 12 Week Treatment|Withdrawal by Subject|3
839680|NCT00350272|1796224|FG001|Blinded 12 Week Treatment|Withdrawal by Subject|0
839681|NCT00350272|1796223|FG000|Blinded 12 Week Treatment|Physician Decision|2
839682|NCT00350272|1796224|FG001|Blinded 12 Week Treatment|Physician Decision|1
839683|NCT00350272|1796223|FG000|Blinded 12 Week Treatment|Sponsor decision|0
839684|NCT00350272|1796224|FG001|Blinded 12 Week Treatment|Sponsor decision|1
839685|NCT00350272|1796223|FG000|Open-Label 84 Week Treatment|Adverse Event|2
839686|NCT00350272|1796224|FG001|Open-Label 84 Week Treatment|Adverse Event|1
839687|NCT00350272|1796223|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3
839688|NCT00350272|1796224|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2
839689|NCT00350272|1796223|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1
839690|NCT00350272|1796224|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2
839691|NCT00350272|1796223|FG000|Open-Label 84 Week Treatment|Physician Decision|1
839692|NCT00350272|1796224|FG001|Open-Label 84 Week Treatment|Physician Decision|2
839693|NCT00350272|1796223|FG000|Open-Label 84 Week Treatment|Sponsor decision|2
839694|NCT00350272|1796224|FG001|Open-Label 84 Week Treatment|Sponsor decision|1
839695|NCT00350298|1796234|FG000|Overall Study|Death|7
839696|NCT00350298|1796235|FG001|Overall Study|Death|8
839697|NCT00350298|1796234|FG000|Overall Study|Lost to Follow-up|1
839698|NCT00350298|1796235|FG001|Overall Study|Lost to Follow-up|2
839699|NCT00350298|1796234|FG000|Overall Study|Withdrawal by Subject|1
839700|NCT00350298|1796235|FG001|Overall Study|Withdrawal by Subject|3
839701|NCT00350402|1796265|FG000|Overall Study|Lost to Follow-up|1
839702|NCT00350402|1796266|FG001|Overall Study|Lost to Follow-up|1
839703|NCT00350519|1796280|FG000|Overall Study|Death|0
839704|NCT00350519|1796281|FG001|Overall Study|Death|1
839705|NCT00350519|1796280|FG000|Overall Study|Physician Decision|0
839706|NCT00350519|1796281|FG001|Overall Study|Physician Decision|1
839707|NCT00350519|1796280|FG000|Overall Study|Protocol Violation|1
839708|NCT00350519|1796281|FG001|Overall Study|Protocol Violation|2
839709|NCT00350519|1796280|FG000|Overall Study|Withdrawal by Subject|3
839710|NCT00350519|1796281|FG001|Overall Study|Withdrawal by Subject|2
839711|NCT00350545|1796296|FG000|Overall Study|Withdrawal by Subject|2
839712|NCT00350636|1796302|FG000|Overall Study|Adverse Event|19
839713|NCT00350636|1796303|FG001|Overall Study|Adverse Event|13
839714|NCT00350636|1796302|FG000|Overall Study|Protocol Violation|1
839715|NCT00350636|1796303|FG001|Overall Study|Protocol Violation|3
839716|NCT00350636|1796302|FG000|Overall Study|Withdrawal by Subject|13
839717|NCT00350636|1796303|FG001|Overall Study|Withdrawal by Subject|17
839718|NCT00350636|1796302|FG000|Overall Study|Lost to Follow-up|9
839719|NCT00350636|1796303|FG001|Overall Study|Lost to Follow-up|8
839720|NCT00350636|1796302|FG000|Overall Study|Physician Decision|0
839721|NCT00350636|1796303|FG001|Overall Study|Physician Decision|2
839722|NCT00350636|1796302|FG000|Overall Study|Other|1
839723|NCT00350636|1796303|FG001|Overall Study|Other|2
839724|NCT00350727|1796312|FG000|Phase I: Dose Escalation|Adverse Event|4
839725|NCT00350727|1796313|FG001|Phase I: Dose Escalation|Adverse Event|0
839726|NCT00350727|1796314|FG002|Phase I: Dose Escalation|Adverse Event|0
839727|NCT00350727|1796312|FG000|Phase I: Dose Escalation|Lack of Efficacy|25
839728|NCT00350727|1796313|FG001|Phase I: Dose Escalation|Lack of Efficacy|0
839729|NCT00350727|1796314|FG002|Phase I: Dose Escalation|Lack of Efficacy|0
839730|NCT00350727|1796312|FG000|Phase I: Dose Escalation|Death|1
839731|NCT00350727|1796313|FG001|Phase I: Dose Escalation|Death|0
839732|NCT00350727|1796314|FG002|Phase I: Dose Escalation|Death|0
839733|NCT00350727|1796312|FG000|Phase I: Dose Escalation|Physician Decision|1
839734|NCT00350727|1796313|FG001|Phase I: Dose Escalation|Physician Decision|0
839735|NCT00350727|1796314|FG002|Phase I: Dose Escalation|Physician Decision|0
839736|NCT00350727|1796312|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3
839737|NCT00350727|1796313|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0
839738|NCT00350727|1796314|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0
839739|NCT00350727|1796312|FG000|Phase II|Disease Progression|0
839740|NCT00350727|1796313|FG001|Phase II|Disease Progression|15
839741|NCT00350727|1796314|FG002|Phase II|Disease Progression|16
839742|NCT00350727|1796312|FG000|Phase II|Clinical Deterioration|0
839743|NCT00350727|1796313|FG001|Phase II|Clinical Deterioration|1
839744|NCT00350727|1796314|FG002|Phase II|Clinical Deterioration|0
839745|NCT00350727|1796312|FG000|Phase II|Withdrawal by Subject|0
839746|NCT00350727|1796313|FG001|Phase II|Withdrawal by Subject|2
839747|NCT00350727|1796314|FG002|Phase II|Withdrawal by Subject|1
839748|NCT00350727|1796312|FG000|Phase II|Adverse Event|0
839749|NCT00350727|1796313|FG001|Phase II|Adverse Event|1
839750|NCT00350727|1796314|FG002|Phase II|Adverse Event|1
839751|NCT00350727|1796312|FG000|Phase II|Death|0
839752|NCT00350727|1796313|FG001|Phase II|Death|0
839753|NCT00350727|1796314|FG002|Phase II|Death|2
839754|NCT00350727|1796312|FG000|Phase II|Sponsor Terminated Study|0
839755|NCT00350727|1796313|FG001|Phase II|Sponsor Terminated Study|0
839756|NCT00350727|1796314|FG002|Phase II|Sponsor Terminated Study|1
839757|NCT00350727|1796312|FG000|Phase II|Enrolled in Rollover Study|0
839758|NCT00350727|1796313|FG001|Phase II|Enrolled in Rollover Study|0
839759|NCT00350727|1796314|FG002|Phase II|Enrolled in Rollover Study|1
839760|NCT00350779|1796335|FG000|Overall Study|Adverse Event|4
839761|NCT00350779|1796336|FG001|Overall Study|Adverse Event|2
839762|NCT00350779|1796335|FG000|Overall Study|Lack of Efficacy|0
839763|NCT00350779|1796336|FG001|Overall Study|Lack of Efficacy|4
839764|NCT00350779|1796335|FG000|Overall Study|Lost to Follow-up|2
839765|NCT00350779|1796336|FG001|Overall Study|Lost to Follow-up|0
839766|NCT00350779|1796335|FG000|Overall Study|Physician Decision|2
839767|NCT00350779|1796336|FG001|Overall Study|Physician Decision|4
839768|NCT00350779|1796335|FG000|Overall Study|Protocol Violation|3
839769|NCT00350779|1796336|FG001|Overall Study|Protocol Violation|1
839770|NCT00350779|1796335|FG000|Overall Study|Withdrawal by Subject|9
839771|NCT00350779|1796336|FG001|Overall Study|Withdrawal by Subject|8
839772|NCT00350779|1796335|FG000|Overall Study|Patient Moved|2
839773|NCT00350779|1796336|FG001|Overall Study|Patient Moved|1
839774|NCT00350779|1796335|FG000|Overall Study|Non-compliance with study procedures|0
839775|NCT00350779|1796336|FG001|Overall Study|Non-compliance with study procedures|1
839776|NCT00350792|1796344|FG000|Overall Study|Adverse Event|11
839777|NCT00350792|1796344|FG000|Overall Study|Death from Study Disease|1
839778|NCT00350792|1796344|FG000|Overall Study|Death from Study Drug Toxicity|1
839779|NCT00350792|1796344|FG000|Overall Study|Death Not Study Drug Related|2
839780|NCT00350792|1796344|FG000|Overall Study|Protocol Violation|1
839781|NCT00350792|1796344|FG000|Overall Study|Withdrawal by Subject|4
839782|NCT00350792|1796344|FG000|Overall Study|Physician Decision|2
839783|NCT00350792|1796344|FG000|Overall Study|Lack of Efficacy|11
839784|NCT00350870|1796352|FG000|Overall Study|Withdrawal by Subject|21
839785|NCT00350870|1796353|FG001|Overall Study|Withdrawal by Subject|17
839786|NCT00350870|1796354|FG002|Overall Study|Withdrawal by Subject|15
839787|NCT00350870|1796355|FG003|Overall Study|Withdrawal by Subject|14
839788|NCT00350870|1796352|FG000|Overall Study|Physician Decision|1
839789|NCT00350870|1796353|FG001|Overall Study|Physician Decision|0
839790|NCT00350870|1796354|FG002|Overall Study|Physician Decision|1
839791|NCT00350870|1796355|FG003|Overall Study|Physician Decision|1
839792|NCT00351273|1796380|FG000|Overall Study|Lost to Follow-up|1
839793|NCT00351273|1796381|FG001|Overall Study|Lost to Follow-up|2
839794|NCT00351273|1796382|FG002|Overall Study|Lost to Follow-up|5
839795|NCT00351351|1796410|FG000|Overall Study|surgical access pbs; device issues|9
839796|NCT00351351|1796411|FG001|Overall Study|surgical access pbs; device issues|4
839797|NCT00351377|1796417|FG000|Overall Study|Adverse Event|5
839798|NCT00351377|1796417|FG000|Overall Study|Death|1
839799|NCT00351377|1796417|FG000|Overall Study|Unsatisfactory therapeutic effect|1
839800|NCT00351468|1796430|FG000|Overall Study|Adverse Event|42
839801|NCT00351468|1796430|FG000|Overall Study|Withdrawal by Subject|39
839802|NCT00351468|1796430|FG000|Overall Study|Various -follow up w clinical team|39
839803|NCT00351468|1796430|FG000|Overall Study|Lack of Efficacy|32
839804|NCT00351468|1796430|FG000|Overall Study|Non-compliance|8
839805|NCT00351468|1796430|FG000|Overall Study|Lost to Follow-up|4
839806|NCT00351468|1796430|FG000|Overall Study|Protocol Violation|3
839807|NCT00351533|1796437|FG000|Overall Study|Extubated before first BAL|1
839808|NCT00351533|1796438|FG001|Overall Study|Extubated before first BAL|0
839809|NCT00351533|1796437|FG000|Overall Study|Lost to Follow-up|1
839810|NCT00351533|1796438|FG001|Overall Study|Lost to Follow-up|3
839811|NCT00351533|1796437|FG000|Overall Study|Physician Decision|0
839812|NCT00351533|1796438|FG001|Overall Study|Physician Decision|1
839813|NCT00351533|1796437|FG000|Overall Study|Withdrawal by Subject|0
839814|NCT00351533|1796438|FG001|Overall Study|Withdrawal by Subject|1
839815|NCT00351611|1796446|FG000|Overall Study|Adverse Event|11
839816|NCT00351611|1796447|FG001|Overall Study|Adverse Event|3
839817|NCT00351611|1796446|FG000|Overall Study|Death|1
839818|NCT00351611|1796447|FG001|Overall Study|Death|0
839819|NCT00351611|1796446|FG000|Overall Study|Lost to Follow-up|1
839820|NCT00351611|1796447|FG001|Overall Study|Lost to Follow-up|0
839821|NCT00351611|1796446|FG000|Overall Study|No Longer Willing to Participate in Study|0
839822|NCT00351611|1796447|FG001|Overall Study|No Longer Willing to Participate in Study|5
839823|NCT00351611|1796446|FG000|Overall Study|Other|1
839824|NCT00351611|1796447|FG001|Overall Study|Other|0
839825|NCT00351611|1796446|FG000|Overall Study|Protocol Violation|0
839826|NCT00351611|1796447|FG001|Overall Study|Protocol Violation|2
839827|NCT00351819|1796464|FG000|Overall Study|Lost to Follow-up|4
839828|NCT00351819|1796465|FG001|Overall Study|Lost to Follow-up|4
839829|NCT00351819|1796464|FG000|Overall Study|Withdrawal by Subject|0
839830|NCT00351819|1796465|FG001|Overall Study|Withdrawal by Subject|4
839831|NCT00351819|1796464|FG000|Overall Study|Elevated PSA|1
839832|NCT00351819|1796465|FG001|Overall Study|Elevated PSA|1
839833|NCT00351819|1796464|FG000|Overall Study|Traumatic ankle fracture|1
839834|NCT00351819|1796465|FG001|Overall Study|Traumatic ankle fracture|0
839835|NCT00351819|1796464|FG000|Overall Study|Unprofessional behavior|1
839836|NCT00351819|1796465|FG001|Overall Study|Unprofessional behavior|0
839837|NCT00351819|1796464|FG000|Overall Study|Non-compliance|0
839838|NCT00351819|1796465|FG001|Overall Study|Non-compliance|1
839839|NCT00351819|1796464|FG000|Overall Study|Incarcerated|0
839840|NCT00351819|1796465|FG001|Overall Study|Incarcerated|1
839841|NCT00351819|1796464|FG000|Overall Study|Enrolled in another trial|0
839842|NCT00351819|1796465|FG001|Overall Study|Enrolled in another trial|1
839843|NCT00352027|1796480|FG000|Overall Study|Progressive disease|3
839844|NCT00352053|1796508|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14
839845|NCT00352053|1796509|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10
839846|NCT00352053|1796508|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2
839847|NCT00352053|1796509|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2
839848|NCT00352053|1796508|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1
839849|NCT00352053|1796509|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0
839850|NCT00352053|1796508|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
839851|NCT00352053|1796509|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
839852|NCT00352053|1796508|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
839853|NCT00352053|1796509|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
839854|NCT00352053|1796508|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9
839855|NCT00352053|1796509|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13
839856|NCT00352053|1796508|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
839857|NCT00352053|1796509|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
839858|NCT00352053|1796508|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1
839859|NCT00352053|1796509|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0
839860|NCT00352053|1796508|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
839861|NCT00352053|1796509|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
839862|NCT00352053|1796508|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4
839863|NCT00352053|1796509|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4
839864|NCT00352053|1796508|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
839865|NCT00352053|1796509|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
839866|NCT00352053|1796508|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
839867|NCT00352053|1796509|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
839868|NCT00352053|1796508|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
839869|NCT00352053|1796509|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
839870|NCT00352105|1796523|FG000|Overall Study|Death|5
839871|NCT00352105|1796523|FG000|Overall Study|Withdrawal by Subject|5
839872|NCT00352105|1796523|FG000|Overall Study|Lack of Efficacy|9
839873|NCT00352105|1796523|FG000|Overall Study|Adverse Event|19
839874|NCT00352105|1796523|FG000|Overall Study|Protocol Violation|2
839875|NCT00352365|1796527|FG000|Induction Therapy|Adverse Event|7
839876|NCT00352365|1796527|FG000|Induction Therapy|Progression/Relapse|8
839877|NCT00352365|1796527|FG000|Induction Therapy|Death|7
839878|NCT00352365|1796527|FG000|Induction Therapy|Not protocol specified|1
839879|NCT00352365|1796527|FG000|Induction Therapy|Not eligible|3
839880|NCT00352365|1796527|FG000|Induction Therapy|Death before starting protocol therapy|1
839881|NCT00352365|1796527|FG000|Maintenance Therapy|Progression/Relapse|3
839882|NCT00352365|1796527|FG000|Maintenance Therapy|Death|2
839883|NCT00352365|1796527|FG000|Maintenance Therapy|Not protocol specified|3
839884|NCT00352365|1796527|FG000|Maintenance Therapy|Not eligible|4
839885|NCT00352417|1796537|FG000|Overall Study|Adverse Event|1
839886|NCT00352417|1796538|FG001|Overall Study|Adverse Event|0
839887|NCT00352417|1796537|FG000|Overall Study|Protocol Violation|0
839888|NCT00352417|1796538|FG001|Overall Study|Protocol Violation|2
839889|NCT00352417|1796537|FG000|Overall Study|Withdrawal by Subject|1
839890|NCT00352417|1796538|FG001|Overall Study|Withdrawal by Subject|2
839891|NCT00352417|1796537|FG000|Overall Study|Lost to Follow-up|1
839892|NCT00352417|1796538|FG001|Overall Study|Lost to Follow-up|0
839893|NCT00352417|1796537|FG000|Overall Study|Schedule Change|2
839894|NCT00352417|1796538|FG001|Overall Study|Schedule Change|1
839951|NCT00352664|1796573|FG000|Overall Study|Withdrawal by Subject|7
839952|NCT00352664|1796574|FG001|Overall Study|Withdrawal by Subject|0
839953|NCT00352690|1796582|FG000|Overall Study|Determined to be ineligible|2
839954|NCT00352690|1796583|FG001|Overall Study|Determined to be ineligible|0
839955|NCT00352755|1796589|FG000|Overall Study|Physician Decision|1
839956|NCT00352755|1796589|FG000|Overall Study|Adverse Event|1
839957|NCT00352846|1796603|FG000|Overall Study|Disease progression|0
839958|NCT00352846|1796604|FG001|Overall Study|Disease progression|2
839959|NCT00352846|1796603|FG000|Overall Study|Withdrawal by Subject|3
839960|NCT00352846|1796604|FG001|Overall Study|Withdrawal by Subject|8
839961|NCT00352846|1796603|FG000|Overall Study|Ineligible|3
839962|NCT00352846|1796604|FG001|Overall Study|Ineligible|2
839963|NCT00352846|1796603|FG000|Overall Study|Non-compliance|2
839964|NCT00352846|1796604|FG001|Overall Study|Non-compliance|0
839965|NCT00352846|1796603|FG000|Overall Study|Death|0
839966|NCT00352846|1796604|FG001|Overall Study|Death|1
839967|NCT00352885|1796612|FG000|Overall Study|Withdrawal by Subject|0
839968|NCT00352885|1796613|FG001|Overall Study|Withdrawal by Subject|3
839969|NCT00352885|1796612|FG000|Overall Study|Development of major depression|0
839970|NCT00352885|1796613|FG001|Overall Study|Development of major depression|1
839971|NCT00352885|1796612|FG000|Overall Study|Progression of metastatic melanoma|5
839972|NCT00352885|1796613|FG001|Overall Study|Progression of metastatic melanoma|3
839973|NCT00352885|1796612|FG000|Overall Study|Side effects of IL-2 administration|1
839974|NCT00352885|1796613|FG001|Overall Study|Side effects of IL-2 administration|0
839975|NCT00353262|1796645|FG000|Overall Study|Adverse Event|8
839976|NCT00353262|1796645|FG000|Overall Study|Withdrawal by Subject|2
839977|NCT00353262|1796645|FG000|Overall Study|Insufficient Therapeutic Response|13
839978|NCT00353262|1796645|FG000|Overall Study|Progression|1
839979|NCT00353262|1796645|FG000|Overall Study|Surgery|4
839980|NCT00353262|1796645|FG000|Overall Study|Break from Chemotherapy|1
839981|NCT00353366|1796653|FG000|Overall Study|Adverse Event|8
839982|NCT00353366|1796653|FG000|Overall Study|Protocol Violation|12
839983|NCT00353366|1796653|FG000|Overall Study|Withdrawal by Subject|12
839984|NCT00353366|1796653|FG000|Overall Study|Lost to Follow-up|92
839985|NCT00353366|1796653|FG000|Overall Study|Other|19
839986|NCT00353496|1796677|FG000|Overall Study|Adverse Event|1
839987|NCT00353496|1796678|FG001|Overall Study|Adverse Event|0
839988|NCT00353496|1796677|FG000|Overall Study|Protocol Violation|2
839989|NCT00353496|1796678|FG001|Overall Study|Protocol Violation|2
839990|NCT00353496|1796677|FG000|Overall Study|Withdrawal by Subject|3
839991|NCT00353496|1796678|FG001|Overall Study|Withdrawal by Subject|4
839992|NCT00353496|1796677|FG000|Overall Study|Physician Decision|6
839993|NCT00353496|1796678|FG001|Overall Study|Physician Decision|9
839994|NCT00353496|1796677|FG000|Overall Study|Not otherwise specified|4
839995|NCT00353496|1796678|FG001|Overall Study|Not otherwise specified|2
839996|NCT00353704|1796720|FG000|Overall Study|Protocol Violation|3
839997|NCT00353704|1796721|FG001|Overall Study|Protocol Violation|1
839998|NCT00353873|1796742|FG000|Overall Study|Protocol Violation|1
839999|NCT00353873|1796743|FG001|Overall Study|Protocol Violation|2
840000|NCT00353873|1796742|FG000|Overall Study|Exacerbation|1
840001|NCT00353873|1796743|FG001|Overall Study|Exacerbation|0
840002|NCT00353873|1796742|FG000|Overall Study|Adverse Event|1
840003|NCT00353873|1796743|FG001|Overall Study|Adverse Event|0
840004|NCT00353873|1796742|FG000|Overall Study|Physician Decision|2
840005|NCT00353873|1796743|FG001|Overall Study|Physician Decision|0
840006|NCT00353873|1796742|FG000|Overall Study|Withdrawal by Subject|1
840007|NCT00353873|1796743|FG001|Overall Study|Withdrawal by Subject|1
840008|NCT00354029|1796764|FG000|Overall Study|Protocol Violation|4
840009|NCT00354029|1796765|FG001|Overall Study|Protocol Violation|2
840010|NCT00354107|1796771|FG000|Overall Study|Adverse Event|2
840011|NCT00354107|1796771|FG000|Overall Study|Physician Decision|2
840012|NCT00354107|1796771|FG000|Overall Study|Withdrawal by Subject|1
840013|NCT00354159|1796777|FG000|Randomized Study Period|Withdrawal by Subject|5
840014|NCT00354159|1796778|FG001|Randomized Study Period|Withdrawal by Subject|3
840015|NCT00354159|1796777|FG000|Randomized Study Period|Physician Decision|6
840016|NCT00354159|1796778|FG001|Randomized Study Period|Physician Decision|10
840017|NCT00354159|1796777|FG000|Randomized Study Period|Lost to Follow-up|4
840018|NCT00354159|1796778|FG001|Randomized Study Period|Lost to Follow-up|0
840019|NCT00354159|1796777|FG000|Randomized Study Period|Death|7
840020|NCT00354159|1796778|FG001|Randomized Study Period|Death|9
840021|NCT00354159|1796777|FG000|Long-term Follow-up|Withdrawal by Subject|9
840022|NCT00354159|1796778|FG001|Long-term Follow-up|Withdrawal by Subject|9
840023|NCT00354159|1796777|FG000|Long-term Follow-up|Physician Decision|127
840024|NCT00354159|1796778|FG001|Long-term Follow-up|Physician Decision|122
840025|NCT00354159|1796777|FG000|Long-term Follow-up|Lost to Follow-up|1
840026|NCT00354159|1796778|FG001|Long-term Follow-up|Lost to Follow-up|0
840027|NCT00354159|1796777|FG000|Long-term Follow-up|Death|14
840028|NCT00354159|1796778|FG001|Long-term Follow-up|Death|11
840029|NCT00354159|1796777|FG000|Long-term Follow-up|Study Closed|29
840030|NCT00354159|1796778|FG001|Long-term Follow-up|Study Closed|34
840031|NCT00354172|1796791|FG000|Overall Study|Did not receive transplant|1
840032|NCT00354341|1796801|FG000|Overall Study|Adverse Event|1
840033|NCT00354341|1796802|FG001|Overall Study|Adverse Event|0
840034|NCT00354341|1796801|FG000|Overall Study|Death|0
840035|NCT00354341|1796802|FG001|Overall Study|Death|2
840036|NCT00354341|1796801|FG000|Overall Study|Refused treatment|1
840037|NCT00354341|1796802|FG001|Overall Study|Refused treatment|2
840038|NCT00354341|1796801|FG000|Overall Study|Failure to return|0
840039|NCT00354341|1796802|FG001|Overall Study|Failure to return|1
840040|NCT00354341|1796801|FG000|Overall Study|Other|1
840041|NCT00354341|1796802|FG001|Overall Study|Other|2
840042|NCT00354432|1796812|FG000|Overall Study|Adverse Event|3
840043|NCT00354432|1796813|FG001|Overall Study|Adverse Event|1
840044|NCT00354432|1796814|FG002|Overall Study|Adverse Event|5
840045|NCT00354432|1796815|FG003|Overall Study|Adverse Event|5
840046|NCT00354432|1796812|FG000|Overall Study|Off/Toxicity|3
840047|NCT00354432|1796813|FG001|Overall Study|Off/Toxicity|7
840048|NCT00354432|1796814|FG002|Overall Study|Off/Toxicity|5
840049|NCT00354432|1796815|FG003|Overall Study|Off/Toxicity|5
840050|NCT00354601|1796834|FG000|Overall Study|Protocol Violation|1
840051|NCT00354601|1796834|FG000|Overall Study|progression|1
840052|NCT00354614|1796838|FG000|Overall Study|Lack of Efficacy|28
840053|NCT00354679|1796846|FG000|Overall Study|Patient Not Treated|1
840054|NCT00354744|1796850|FG000|Overall Study|Adverse Event|2
840055|NCT00354744|1796850|FG000|Overall Study|Death|2
840056|NCT00354744|1796850|FG000|Overall Study|Lack of Efficacy|11
840057|NCT00354744|1796850|FG000|Overall Study|Lost to Follow-up|2
840058|NCT00354744|1796850|FG000|Overall Study|Physician Decision|11
840059|NCT00354744|1796850|FG000|Overall Study|Withdrawal by Subject|14
840074|NCT00355030|1796903|FG000|Study Period 1 Treatment|Adverse Event|1
840075|NCT00355030|1796904|FG001|Study Period 1 Treatment|Adverse Event|1
840076|NCT00355030|1796903|FG000|Study Period 1 Treatment|Lost to Follow-up|3
840077|NCT00355030|1796904|FG001|Study Period 1 Treatment|Lost to Follow-up|0
840078|NCT00355030|1796903|FG000|Study Period 1 Treatment|Withdrawal by Subject|4
840079|NCT00355030|1796904|FG001|Study Period 1 Treatment|Withdrawal by Subject|1
840080|NCT00355030|1796903|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1
840081|NCT00355030|1796904|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2
840082|NCT00355030|1796903|FG000|Study Period 1 Treatment|Physician Decision|0
840083|NCT00355030|1796904|FG001|Study Period 1 Treatment|Physician Decision|1
840084|NCT00355030|1796903|FG000|Study Period 1 Treatment|Sponsor Decision|34
840085|NCT00355030|1796904|FG001|Study Period 1 Treatment|Sponsor Decision|32
840086|NCT00355030|1796903|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
840087|NCT00355030|1796904|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
840088|NCT00355030|1796903|FG000|Study Period 1 Treatment|Other|2
840089|NCT00355030|1796904|FG001|Study Period 1 Treatment|Other|6
840090|NCT00355030|1796903|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
840091|NCT00355030|1796904|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
840092|NCT00355030|1796903|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
840093|NCT00355030|1796904|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
840094|NCT00355056|1796912|FG000|Randomization Period|Early Termination|4
840095|NCT00355056|1796913|FG001|Randomization Period|Early Termination|6
840096|NCT00355082|1796929|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4
840097|NCT00355082|1796930|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10
840098|NCT00355082|1796931|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0
840099|NCT00355082|1796929|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
840100|NCT00355082|1796930|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
840101|NCT00355082|1796931|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
840102|NCT00355082|1796929|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
840103|NCT00355082|1796930|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
840104|NCT00355082|1796931|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
840105|NCT00355082|1796929|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
840106|NCT00355082|1796930|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
840107|NCT00355082|1796931|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
840108|NCT00355082|1796929|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0
840109|NCT00355082|1796930|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4
840110|NCT00355082|1796931|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0
840111|NCT00355082|1796929|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0
840112|NCT00355082|1796930|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1
840113|NCT00355082|1796931|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0
840114|NCT00355082|1796929|FG000|Continuation Phase|Adverse Event|2
840115|NCT00355082|1796930|FG001|Continuation Phase|Adverse Event|0
840116|NCT00355082|1796931|FG002|Continuation Phase|Adverse Event|1
840117|NCT00355082|1796929|FG000|Continuation Phase|Lost to Follow-up|2
840118|NCT00355082|1796930|FG001|Continuation Phase|Lost to Follow-up|0
840119|NCT00355082|1796931|FG002|Continuation Phase|Lost to Follow-up|1
840120|NCT00355082|1796929|FG000|Continuation Phase|Protocol Violation|1
840121|NCT00355082|1796930|FG001|Continuation Phase|Protocol Violation|0
840122|NCT00355082|1796931|FG002|Continuation Phase|Protocol Violation|1
840123|NCT00355082|1796929|FG000|Continuation Phase|Withdrawal by Subject|4
840124|NCT00355082|1796930|FG001|Continuation Phase|Withdrawal by Subject|0
840125|NCT00355082|1796931|FG002|Continuation Phase|Withdrawal by Subject|0
840126|NCT00355082|1796929|FG000|Continuation Phase|Lack of Efficacy|5
840127|NCT00355082|1796930|FG001|Continuation Phase|Lack of Efficacy|0
840128|NCT00355082|1796931|FG002|Continuation Phase|Lack of Efficacy|0
840129|NCT00355082|1796929|FG000|Continuation Phase|Site Closed by Sponsor|8
840130|NCT00355082|1796930|FG001|Continuation Phase|Site Closed by Sponsor|0
840131|NCT00355082|1796931|FG002|Continuation Phase|Site Closed by Sponsor|0
840132|NCT00355082|1796929|FG000|Continuation Phase|Scheduling Error|1
840133|NCT00355082|1796930|FG001|Continuation Phase|Scheduling Error|0
840134|NCT00355082|1796931|FG002|Continuation Phase|Scheduling Error|0
840135|NCT00355082|1796929|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1
840136|NCT00355082|1796930|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0
840137|NCT00355082|1796931|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0
840138|NCT00355121|1796945|FG000|Overall Study|Did not receive study vaccine|1
840139|NCT00355121|1796946|FG001|Overall Study|Did not receive study vaccine|0
840140|NCT00355121|1796947|FG002|Overall Study|Did not receive study vaccine|1
840141|NCT00355121|1796945|FG000|Overall Study|Adverse Event|0
840142|NCT00355121|1796946|FG001|Overall Study|Adverse Event|1
840143|NCT00355121|1796947|FG002|Overall Study|Adverse Event|0
840144|NCT00355121|1796945|FG000|Overall Study|Protocol Violation|7
840145|NCT00355121|1796946|FG001|Overall Study|Protocol Violation|9
840146|NCT00355121|1796947|FG002|Overall Study|Protocol Violation|1
840147|NCT00355121|1796945|FG000|Overall Study|Lost to Follow-up|4
840148|NCT00355121|1796946|FG001|Overall Study|Lost to Follow-up|7
840149|NCT00355121|1796947|FG002|Overall Study|Lost to Follow-up|1
840150|NCT00355121|1796945|FG000|Overall Study|Withdrawal by Subject|9
840151|NCT00355121|1796946|FG001|Overall Study|Withdrawal by Subject|10
840152|NCT00355121|1796947|FG002|Overall Study|Withdrawal by Subject|2
840153|NCT00355121|1796945|FG000|Overall Study|Serious adverse events|0
840154|NCT00355121|1796946|FG001|Overall Study|Serious adverse events|2
840155|NCT00355121|1796947|FG002|Overall Study|Serious adverse events|0
840156|NCT00355134|1796963|FG000|Core Phase|Withdrawal by Subject|35
840157|NCT00355134|1796964|FG001|Core Phase|Withdrawal by Subject|24
840158|NCT00355134|1796965|FG002|Core Phase|Withdrawal by Subject|35
840159|NCT00355134|1796966|FG003|Core Phase|Withdrawal by Subject|0
840160|NCT00355134|1796967|FG004|Core Phase|Withdrawal by Subject|0
840161|NCT00355134|1796963|FG000|Core Phase|Adverse Event|28
840162|NCT00355134|1796964|FG001|Core Phase|Adverse Event|22
840163|NCT00355134|1796965|FG002|Core Phase|Adverse Event|16
840164|NCT00355134|1796966|FG003|Core Phase|Adverse Event|0
840165|NCT00355134|1796967|FG004|Core Phase|Adverse Event|0
840166|NCT00355134|1796963|FG000|Core Phase|Lost to Follow-up|17
840167|NCT00355134|1796964|FG001|Core Phase|Lost to Follow-up|13
840168|NCT00355134|1796965|FG002|Core Phase|Lost to Follow-up|21
840169|NCT00355134|1796966|FG003|Core Phase|Lost to Follow-up|0
840170|NCT00355134|1796967|FG004|Core Phase|Lost to Follow-up|0
840171|NCT00355134|1796963|FG000|Core Phase|Abnormal laboratory value(s)|19
840172|NCT00355134|1796964|FG001|Core Phase|Abnormal laboratory value(s)|14
840173|NCT00355134|1796965|FG002|Core Phase|Abnormal laboratory value(s)|2
840174|NCT00355134|1796966|FG003|Core Phase|Abnormal laboratory value(s)|0
840175|NCT00355134|1796967|FG004|Core Phase|Abnormal laboratory value(s)|0
840176|NCT00355134|1796963|FG000|Core Phase|Unsatisfactory therapeutic effect|10
840177|NCT00355134|1796964|FG001|Core Phase|Unsatisfactory therapeutic effect|6
840178|NCT00355134|1796965|FG002|Core Phase|Unsatisfactory therapeutic effect|17
840179|NCT00355134|1796966|FG003|Core Phase|Unsatisfactory therapeutic effect|0
840180|NCT00355134|1796967|FG004|Core Phase|Unsatisfactory therapeutic effect|0
840181|NCT00355134|1796963|FG000|Core Phase|Administrative problems|5
840182|NCT00355134|1796964|FG001|Core Phase|Administrative problems|3
840183|NCT00355134|1796965|FG002|Core Phase|Administrative problems|5
840184|NCT00355134|1796966|FG003|Core Phase|Administrative problems|0
840185|NCT00355134|1796967|FG004|Core Phase|Administrative problems|0
840186|NCT00355134|1796963|FG000|Core Phase|Protocol Violation|3
840187|NCT00355134|1796964|FG001|Core Phase|Protocol Violation|2
840188|NCT00355134|1796965|FG002|Core Phase|Protocol Violation|2
840189|NCT00355134|1796966|FG003|Core Phase|Protocol Violation|0
840190|NCT00355134|1796967|FG004|Core Phase|Protocol Violation|0
840191|NCT00355134|1796963|FG000|Core Phase|Abnormal test procedure result(s)|1
840192|NCT00355134|1796964|FG001|Core Phase|Abnormal test procedure result(s)|2
840193|NCT00355134|1796965|FG002|Core Phase|Abnormal test procedure result(s)|1
840194|NCT00355134|1796966|FG003|Core Phase|Abnormal test procedure result(s)|0
840195|NCT00355134|1796967|FG004|Core Phase|Abnormal test procedure result(s)|0
840196|NCT00355134|1796963|FG000|Core Phase|Condition no longer requires study drug|1
840197|NCT00355134|1796964|FG001|Core Phase|Condition no longer requires study drug|0
840198|NCT00355134|1796965|FG002|Core Phase|Condition no longer requires study drug|1
840199|NCT00355134|1796966|FG003|Core Phase|Condition no longer requires study drug|0
840200|NCT00355134|1796967|FG004|Core Phase|Condition no longer requires study drug|0
840201|NCT00355134|1796963|FG000|Extension Phase|Withdrawal by Subject|7
840202|NCT00355134|1796964|FG001|Extension Phase|Withdrawal by Subject|11
840203|NCT00355134|1796965|FG002|Extension Phase|Withdrawal by Subject|0
840204|NCT00355134|1796966|FG003|Extension Phase|Withdrawal by Subject|7
840205|NCT00355134|1796967|FG004|Extension Phase|Withdrawal by Subject|5
840206|NCT00355134|1796963|FG000|Extension Phase|Adverse Event|13
840207|NCT00355134|1796964|FG001|Extension Phase|Adverse Event|9
840208|NCT00355134|1796965|FG002|Extension Phase|Adverse Event|0
840209|NCT00355134|1796966|FG003|Extension Phase|Adverse Event|3
840210|NCT00355134|1796967|FG004|Extension Phase|Adverse Event|5
840211|NCT00355134|1796963|FG000|Extension Phase|Lost to Follow-up|2
840212|NCT00355134|1796964|FG001|Extension Phase|Lost to Follow-up|6
840213|NCT00355134|1796965|FG002|Extension Phase|Lost to Follow-up|0
840214|NCT00355134|1796966|FG003|Extension Phase|Lost to Follow-up|2
840215|NCT00355134|1796967|FG004|Extension Phase|Lost to Follow-up|4
840216|NCT00355134|1796963|FG000|Extension Phase|Abnormal laboratory value(s)|4
840217|NCT00355134|1796964|FG001|Extension Phase|Abnormal laboratory value(s)|2
840218|NCT00355134|1796965|FG002|Extension Phase|Abnormal laboratory value(s)|0
840219|NCT00355134|1796966|FG003|Extension Phase|Abnormal laboratory value(s)|2
840220|NCT00355134|1796967|FG004|Extension Phase|Abnormal laboratory value(s)|2
840221|NCT00355134|1796963|FG000|Extension Phase|Administrative problems|2
840222|NCT00355134|1796964|FG001|Extension Phase|Administrative problems|4
840223|NCT00355134|1796965|FG002|Extension Phase|Administrative problems|0
840224|NCT00355134|1796966|FG003|Extension Phase|Administrative problems|1
840225|NCT00355134|1796967|FG004|Extension Phase|Administrative problems|1
840226|NCT00355134|1796963|FG000|Extension Phase|Unsatisfactory therapeutic effect|3
840227|NCT00355134|1796964|FG001|Extension Phase|Unsatisfactory therapeutic effect|4
840228|NCT00355134|1796965|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
840229|NCT00355134|1796966|FG003|Extension Phase|Unsatisfactory therapeutic effect|0
840230|NCT00355134|1796967|FG004|Extension Phase|Unsatisfactory therapeutic effect|1
840231|NCT00355134|1796963|FG000|Extension Phase|Abnormal test procedure result(s)|0
840232|NCT00355134|1796964|FG001|Extension Phase|Abnormal test procedure result(s)|1
840233|NCT00355134|1796965|FG002|Extension Phase|Abnormal test procedure result(s)|0
840234|NCT00355134|1796966|FG003|Extension Phase|Abnormal test procedure result(s)|0
840235|NCT00355134|1796967|FG004|Extension Phase|Abnormal test procedure result(s)|1
840236|NCT00355134|1796963|FG000|Extension Phase|Protocol Violation|0
840237|NCT00355134|1796964|FG001|Extension Phase|Protocol Violation|0
840238|NCT00355134|1796965|FG002|Extension Phase|Protocol Violation|0
840239|NCT00355134|1796966|FG003|Extension Phase|Protocol Violation|1
840240|NCT00355134|1796967|FG004|Extension Phase|Protocol Violation|0
840241|NCT00355147|1796979|FG000|Overall Study|Lost to Follow-up|10
840242|NCT00355147|1796980|FG001|Overall Study|Lost to Follow-up|8
840243|NCT00355147|1796979|FG000|Overall Study|Withdrawal by Subject|8
840244|NCT00355147|1796980|FG001|Overall Study|Withdrawal by Subject|12
840245|NCT00355264|1796999|FG000|Extension (Variable Duration)|Adverse Event|1
840246|NCT00355264|1796999|FG000|Extension (Variable Duration)|Withdrew Consent|1
840247|NCT00355342|1797010|FG000|Overall Study|Adverse Event|13
840248|NCT00355342|1797011|FG001|Overall Study|Adverse Event|15
840249|NCT00355342|1797010|FG000|Overall Study|Lost to Follow-up|4
840250|NCT00355342|1797011|FG001|Overall Study|Lost to Follow-up|2
840251|NCT00355342|1797010|FG000|Overall Study|Withdrawal by Subject|14
840252|NCT00355342|1797011|FG001|Overall Study|Withdrawal by Subject|11
840253|NCT00355342|1797010|FG000|Overall Study|Sponsor terminated study|2
840254|NCT00355342|1797011|FG001|Overall Study|Sponsor terminated study|2
840255|NCT00355342|1797010|FG000|Overall Study|Overcompliant-PI discretion|1
840256|NCT00355342|1797011|FG001|Overall Study|Overcompliant-PI discretion|0
840257|NCT00355342|1797010|FG000|Overall Study|Use of prohibited medication|1
840258|NCT00355342|1797011|FG001|Overall Study|Use of prohibited medication|0
840259|NCT00355342|1797010|FG000|Overall Study|COPD exacerbation|1
840260|NCT00355342|1797011|FG001|Overall Study|COPD exacerbation|1
840261|NCT00355342|1797010|FG000|Overall Study|Dispensed wrong study drug kit|1
840262|NCT00355342|1797011|FG001|Overall Study|Dispensed wrong study drug kit|0
840263|NCT00355342|1797010|FG000|Overall Study|Non-compliance with Dexa scans|1
840264|NCT00355342|1797011|FG001|Overall Study|Non-compliance with Dexa scans|0
840265|NCT00355342|1797010|FG000|Overall Study|Withdrawal by participant and physician|1
840266|NCT00355342|1797011|FG001|Overall Study|Withdrawal by participant and physician|0
840267|NCT00355342|1797010|FG000|Overall Study|Participant relocated|0
840268|NCT00355342|1797011|FG001|Overall Study|Participant relocated|1
840269|NCT00355342|1797010|FG000|Overall Study|Participant discontinued study drug|0
840270|NCT00355342|1797011|FG001|Overall Study|Participant discontinued study drug|1
840271|NCT00355342|1797010|FG000|Overall Study|Study management|0
840272|NCT00355342|1797011|FG001|Overall Study|Study management|1
840273|NCT00355342|1797010|FG000|Overall Study|Protocol Violation|0
840274|NCT00355342|1797011|FG001|Overall Study|Protocol Violation|1
840275|NCT00355342|1797010|FG000|Overall Study|Use of protocol excluded medication|0
840276|NCT00355342|1797011|FG001|Overall Study|Use of protocol excluded medication|1
840277|NCT00355368|1797019|FG000|Overall Study|Protocol Violation|8
840278|NCT00355368|1797020|FG001|Overall Study|Protocol Violation|7
840279|NCT00355368|1797019|FG000|Overall Study|cardiac arrest prior to intubation|2
840280|NCT00355368|1797020|FG001|Overall Study|cardiac arrest prior to intubation|2
840281|NCT00355472|1797037|FG000|Overall Study|Physician Decision|1
840282|NCT00355615|1797053|FG000|Randomized Double Blind Period|Adverse Event|1
840283|NCT00355615|1797054|FG001|Randomized Double Blind Period|Adverse Event|0
840284|NCT00355615|1797055|FG002|Randomized Double Blind Period|Adverse Event|0
840285|NCT00355615|1797056|FG003|Randomized Double Blind Period|Adverse Event|0
840286|NCT00355615|1797057|FG004|Randomized Double Blind Period|Adverse Event|0
840287|NCT00355615|1797053|FG000|Randomized Double Blind Period|Protocol Violation|0
840288|NCT00355615|1797054|FG001|Randomized Double Blind Period|Protocol Violation|0
840289|NCT00355615|1797055|FG002|Randomized Double Blind Period|Protocol Violation|1
840290|NCT00355615|1797056|FG003|Randomized Double Blind Period|Protocol Violation|1
840291|NCT00355615|1797057|FG004|Randomized Double Blind Period|Protocol Violation|0
840292|NCT00355615|1797053|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0
840293|NCT00355615|1797054|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0
840294|NCT00355615|1797055|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0
840295|NCT00355615|1797056|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0
840296|NCT00355615|1797057|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4
840297|NCT00355615|1797053|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0
840298|NCT00355615|1797054|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0
840299|NCT00355615|1797055|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0
840300|NCT00355615|1797056|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0
840301|NCT00355615|1797057|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1
840302|NCT00355615|1797053|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
840303|NCT00355615|1797054|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
840304|NCT00355615|1797055|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
840305|NCT00355615|1797056|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
840306|NCT00355615|1797057|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
840307|NCT00355615|1797053|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0
840308|NCT00355615|1797054|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0
840309|NCT00355615|1797055|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0
840310|NCT00355615|1797056|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0
840311|NCT00355615|1797057|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1
840312|NCT00355784|1797082|FG000|Overall Study|Withdrawal by Subject|0
840313|NCT00355784|1797083|FG001|Overall Study|Withdrawal by Subject|0
840314|NCT00355784|1797084|FG002|Overall Study|Withdrawal by Subject|2
840315|NCT00356122|1797140|FG000|TREATMENT|Lack of Efficacy|26
840316|NCT00356122|1797140|FG000|TREATMENT|Adverse Event|10
840317|NCT00356122|1797140|FG000|TREATMENT|Subject's request|4
840318|NCT00356122|1797140|FG000|TREATMENT|Other|4
840319|NCT00356122|1797140|FG000|TREATMENT|Did not receive study medication|1
840320|NCT00356122|1797140|FG000|FOLLOW-UP|Death|37
840321|NCT00356122|1797140|FG000|FOLLOW-UP|Lost to Follow-up|2
840322|NCT00356122|1797140|FG000|FOLLOW-UP|Other|2
840323|NCT00356135|1797147|FG000|Overall Study|Protocol Violation|1
840324|NCT00356135|1797148|FG001|Overall Study|Protocol Violation|0
840325|NCT00356135|1797149|FG002|Overall Study|Protocol Violation|0
840326|NCT00356135|1797147|FG000|Overall Study|Adverse Event|1
840327|NCT00356135|1797148|FG001|Overall Study|Adverse Event|0
840328|NCT00356135|1797149|FG002|Overall Study|Adverse Event|0
840329|NCT00356135|1797147|FG000|Overall Study|Lost to Follow-up|0
840330|NCT00356135|1797148|FG001|Overall Study|Lost to Follow-up|0
840331|NCT00356135|1797149|FG002|Overall Study|Lost to Follow-up|1
840332|NCT00356135|1797147|FG000|Overall Study|Physician Decision|1
840333|NCT00356135|1797148|FG001|Overall Study|Physician Decision|1
840334|NCT00356135|1797149|FG002|Overall Study|Physician Decision|1
840335|NCT00356135|1797147|FG000|Overall Study|Subject non-compliance|1
840336|NCT00356135|1797148|FG001|Overall Study|Subject non-compliance|1
840337|NCT00356135|1797149|FG002|Overall Study|Subject non-compliance|3
840338|NCT00356148|1797161|FG000|Overall Study|Reoperation within 30 days|2
840339|NCT00356148|1797162|FG001|Overall Study|Reoperation within 30 days|1
840340|NCT00356200|1797171|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1
840341|NCT00356200|1797172|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0
840342|NCT00356200|1797171|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
840343|NCT00356200|1797172|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
840344|NCT00356265|1797187|FG000|Overall Study|Withdrawal by Subject|0
840345|NCT00356265|1797188|FG001|Overall Study|Withdrawal by Subject|0
840346|NCT00356265|1797189|FG002|Overall Study|Withdrawal by Subject|1
840347|NCT00356278|1797201|FG000|Overall Study|Withdrawal by Subject|25
840348|NCT00356278|1797202|FG001|Overall Study|Withdrawal by Subject|15
840349|NCT00356278|1797203|FG002|Overall Study|Withdrawal by Subject|19
840350|NCT00356369|1797222|FG000|Active Phase|Withdrawal by Subject|2
840351|NCT00356369|1797223|FG001|Active Phase|Withdrawal by Subject|1
840352|NCT00356408|1797233|FG000|Overall Study|Adverse Event|9
840353|NCT00356408|1797233|FG000|Overall Study|Lack of Efficacy|36
840354|NCT00356408|1797233|FG000|Overall Study|Lost to Follow-up|2
840355|NCT00356408|1797233|FG000|Overall Study|Withdrawal by Subject|6
840356|NCT00356408|1797233|FG000|Overall Study|Other: Principal investigator discretion|3
840357|NCT00356408|1797233|FG000|Overall Study|Other: Sponsor request|1
840358|NCT00356408|1797233|FG000|Overall Study|Other: Azathioprine stopped|1
840359|NCT00356408|1797233|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1
840360|NCT00356408|1797233|FG000|Overall Study|Other: Subject chose commerical dosing|1
840361|NCT00356525|1797258|FG000|Overall Study|Progressive Disease|8
840362|NCT00356525|1797259|FG001|Overall Study|Progressive Disease|5
840363|NCT00356525|1797260|FG002|Overall Study|Progressive Disease|4
840364|NCT00356525|1797261|FG003|Overall Study|Progressive Disease|2
840365|NCT00356525|1797258|FG000|Overall Study|Adverse Event|1
840366|NCT00356525|1797259|FG001|Overall Study|Adverse Event|3
840367|NCT00356525|1797260|FG002|Overall Study|Adverse Event|1
840368|NCT00356525|1797261|FG003|Overall Study|Adverse Event|1
840369|NCT00356525|1797258|FG000|Overall Study|Lost to Follow-up|1
840370|NCT00356525|1797259|FG001|Overall Study|Lost to Follow-up|0
840371|NCT00356525|1797260|FG002|Overall Study|Lost to Follow-up|0
840372|NCT00356525|1797261|FG003|Overall Study|Lost to Follow-up|0
840373|NCT00356525|1797258|FG000|Overall Study|Physician Decision|2
840374|NCT00356525|1797259|FG001|Overall Study|Physician Decision|2
840375|NCT00356525|1797260|FG002|Overall Study|Physician Decision|2
840376|NCT00356525|1797261|FG003|Overall Study|Physician Decision|1
840377|NCT00356525|1797258|FG000|Overall Study|Protocol Entry Criteria Not Met|1
840378|NCT00356525|1797259|FG001|Overall Study|Protocol Entry Criteria Not Met|0
840379|NCT00356525|1797260|FG002|Overall Study|Protocol Entry Criteria Not Met|0
840380|NCT00356525|1797261|FG003|Overall Study|Protocol Entry Criteria Not Met|0
840381|NCT00356525|1797258|FG000|Overall Study|Withdrawal by Subject|1
840382|NCT00356525|1797259|FG001|Overall Study|Withdrawal by Subject|1
840383|NCT00356525|1797260|FG002|Overall Study|Withdrawal by Subject|0
840384|NCT00356525|1797261|FG003|Overall Study|Withdrawal by Subject|3
840385|NCT00356525|1797258|FG000|Overall Study|Death|0
840386|NCT00356525|1797259|FG001|Overall Study|Death|0
840387|NCT00356525|1797260|FG002|Overall Study|Death|0
840388|NCT00356525|1797261|FG003|Overall Study|Death|1
840389|NCT00356525|1797258|FG000|Overall Study|Sponsor Decision|0
840390|NCT00356525|1797259|FG001|Overall Study|Sponsor Decision|0
840391|NCT00356525|1797260|FG002|Overall Study|Sponsor Decision|0
840392|NCT00356525|1797261|FG003|Overall Study|Sponsor Decision|1
840393|NCT00356590|1797271|FG000|Overall Study|Adverse Event|54
840394|NCT00356590|1797271|FG000|Overall Study|Death|10
840395|NCT00356590|1797271|FG000|Overall Study|Lost to Follow-up|35
840396|NCT00356590|1797271|FG000|Overall Study|Physician Decision|46
840397|NCT00356590|1797271|FG000|Overall Study|Withdrawal by Subject|41
840398|NCT00356590|1797271|FG000|Overall Study|Completed month 12 only|2
840399|NCT00356590|1797271|FG000|Overall Study|Protocol issues|6
840400|NCT00356590|1797271|FG000|Overall Study|Response status|28
840401|NCT00356590|1797271|FG000|Overall Study|Other|52
840402|NCT00356603|1797277|FG000|Overall Study|Other|6
840403|NCT00356603|1797278|FG001|Overall Study|Other|3
840404|NCT00356759|1797288|FG000|Overall Study|Death|5
840405|NCT00356759|1797289|FG001|Overall Study|Death|2
840406|NCT00356759|1797288|FG000|Overall Study|Withdrawal by Subject|2
840407|NCT00356759|1797289|FG001|Overall Study|Withdrawal by Subject|2
840408|NCT00356759|1797288|FG000|Overall Study|Adverse Event|1
840409|NCT00356759|1797289|FG001|Overall Study|Adverse Event|3
840410|NCT00356759|1797288|FG000|Overall Study|Lost to Follow-up|1
840411|NCT00356759|1797289|FG001|Overall Study|Lost to Follow-up|1
840412|NCT00356759|1797288|FG000|Overall Study|Intercurrent disease or persistent extre|5
840413|NCT00356759|1797289|FG001|Overall Study|Intercurrent disease or persistent extre|2
840414|NCT00356811|1797295|FG000|Overall Study|Death|35
840415|NCT00356811|1797295|FG000|Overall Study|Lost to Follow-up|2
840416|NCT00356811|1797295|FG000|Overall Study|Withdrawal by Subject|6
840417|NCT00356811|1797295|FG000|Overall Study|Participant Could Not Make a Checkup|1
840418|NCT00356811|1797295|FG000|Overall Study|Study Is Terminating|3
840419|NCT00356811|1797295|FG000|Overall Study|Site Closed during Follow-up|2
840420|NCT00356863|1797302|FG000|Overall Study|Death|16
840421|NCT00356863|1797303|FG001|Overall Study|Death|32
840422|NCT00356863|1797302|FG000|Overall Study|Lost to Follow-up|76
840423|NCT00356863|1797303|FG001|Overall Study|Lost to Follow-up|43
840424|NCT00356889|1797313|FG000|Overall Study|Protocol Violation|2
840425|NCT00356889|1797313|FG000|Overall Study|Adverse Event|1
840426|NCT00356915|1797321|FG000|Overall Study|Non compliance|1
840427|NCT00356915|1797322|FG001|Overall Study|Non compliance|2
840428|NCT00356915|1797323|FG002|Overall Study|Non compliance|1
840429|NCT00356915|1797321|FG000|Overall Study|Protocol Violation|2
840430|NCT00356915|1797322|FG001|Overall Study|Protocol Violation|3
840431|NCT00356915|1797323|FG002|Overall Study|Protocol Violation|2
840432|NCT00356915|1797321|FG000|Overall Study|Withdrawal by Subject|14
840433|NCT00356915|1797322|FG001|Overall Study|Withdrawal by Subject|14
840434|NCT00356915|1797323|FG002|Overall Study|Withdrawal by Subject|10
840435|NCT00356915|1797321|FG000|Overall Study|Lack of Efficacy|0
840436|NCT00356915|1797322|FG001|Overall Study|Lack of Efficacy|0
840437|NCT00356915|1797323|FG002|Overall Study|Lack of Efficacy|3
840438|NCT00356915|1797321|FG000|Overall Study|Lost to Follow-up|27
840439|NCT00356915|1797322|FG001|Overall Study|Lost to Follow-up|34
840440|NCT00356915|1797323|FG002|Overall Study|Lost to Follow-up|14
840441|NCT00356915|1797321|FG000|Overall Study|Administrative Decision|0
840442|NCT00356915|1797322|FG001|Overall Study|Administrative Decision|0
840443|NCT00356915|1797323|FG002|Overall Study|Administrative Decision|1
840444|NCT00356915|1797321|FG000|Overall Study|Physician Decision|0
840445|NCT00356915|1797322|FG001|Overall Study|Physician Decision|2
840446|NCT00356915|1797323|FG002|Overall Study|Physician Decision|0
840447|NCT00356915|1797321|FG000|Overall Study|Adverse Event|21
840448|NCT00356915|1797322|FG001|Overall Study|Adverse Event|31
840449|NCT00356915|1797323|FG002|Overall Study|Adverse Event|8
840450|NCT00356915|1797321|FG000|Overall Study|Miscellaneous reasons|11
840451|NCT00356915|1797322|FG001|Overall Study|Miscellaneous reasons|8
840452|NCT00356915|1797323|FG002|Overall Study|Miscellaneous reasons|3
840453|NCT00357006|1797344|FG000|Overall Study|Lost to Follow-up|1
840454|NCT00357006|1797345|FG001|Overall Study|Lost to Follow-up|2
840455|NCT00357006|1797346|FG002|Overall Study|Lost to Follow-up|1
840456|NCT00357006|1797344|FG000|Overall Study|Withdrawal by Subject|1
840457|NCT00357006|1797345|FG001|Overall Study|Withdrawal by Subject|3
840458|NCT00357006|1797346|FG002|Overall Study|Withdrawal by Subject|2
840459|NCT00357097|1797360|FG000|Overall Study|Did not meet inclusion criteria|5
840460|NCT00357097|1797361|FG001|Overall Study|Did not meet inclusion criteria|3
840461|NCT00357097|1797360|FG000|Overall Study|Adverse Event|34
840462|NCT00357097|1797361|FG001|Overall Study|Adverse Event|6
840463|NCT00357097|1797360|FG000|Overall Study|Withdrawal by Subject|8
840464|NCT00357097|1797361|FG001|Overall Study|Withdrawal by Subject|7
840465|NCT00357097|1797360|FG000|Overall Study|Non-compliance|1
840466|NCT00357097|1797361|FG001|Overall Study|Non-compliance|2
840467|NCT00357097|1797360|FG000|Overall Study|Lack of Efficacy|2
840468|NCT00357097|1797361|FG001|Overall Study|Lack of Efficacy|8
840469|NCT00357097|1797360|FG000|Overall Study|Met Exclusion Criteria|3
840470|NCT00357097|1797361|FG001|Overall Study|Met Exclusion Criteria|1
840471|NCT00357097|1797360|FG000|Overall Study|Other|1
840472|NCT00357097|1797361|FG001|Overall Study|Other|1
840473|NCT00357097|1797360|FG000|Overall Study|Increase of RLS Symptoms|0
840474|NCT00357097|1797361|FG001|Overall Study|Increase of RLS Symptoms|1
840475|NCT00357110|1797369|FG000|Overall Study|Early study termination|5
840476|NCT00357110|1797370|FG001|Overall Study|Early study termination|5
840477|NCT00357370|1797409|FG000|Cohort 2|Lack of Efficacy|0
840478|NCT00357370|1797410|FG001|Cohort 2|Lack of Efficacy|2
840479|NCT00357370|1797411|FG002|Cohort 2|Lack of Efficacy|1
840480|NCT00357370|1797409|FG000|Cohort 2|Adverse Event|1
840481|NCT00357370|1797410|FG001|Cohort 2|Adverse Event|1
840482|NCT00357370|1797411|FG002|Cohort 2|Adverse Event|1
840483|NCT00357370|1797409|FG000|Cohort 2|Lost to Follow-up|0
840484|NCT00357370|1797410|FG001|Cohort 2|Lost to Follow-up|1
840485|NCT00357370|1797411|FG002|Cohort 2|Lost to Follow-up|0
840486|NCT00357370|1797409|FG000|Cohort 2|non-compliance, not met criteria, etc|1
840487|NCT00357370|1797410|FG001|Cohort 2|non-compliance, not met criteria, etc|1
840488|NCT00357370|1797411|FG002|Cohort 2|non-compliance, not met criteria, etc|0
840489|NCT00357370|1797409|FG000|Cohort 2|Withdrawal by Subject|0
840490|NCT00357370|1797410|FG001|Cohort 2|Withdrawal by Subject|2
840491|NCT00357370|1797411|FG002|Cohort 2|Withdrawal by Subject|0
840492|NCT00357396|1797421|FG000|Overall Study|Adverse Event|1
840493|NCT00357396|1797422|FG001|Overall Study|Adverse Event|0
840494|NCT00357500|1797427|FG000|Overall Study|Adverse Event|3
840495|NCT00357500|1797427|FG000|Overall Study|Withdrawal by Subject|5
840496|NCT00357500|1797427|FG000|Overall Study|Progressive Disease|65
840497|NCT00357500|1797427|FG000|Overall Study|Not Started Protocol Therapy|4
840498|NCT00357552|1797431|FG000|Screening|Did not meet eligibility criteria|84
840499|NCT00357552|1797431|FG000|Weeks 0 to 24|Death|1
840500|NCT00357552|1797431|FG000|Weeks 24 to 104|Death|3
840501|NCT00357552|1797431|FG000|Weeks 24 to 104|Not able to get to clinic|2
840502|NCT00357656|1797441|FG000|Overall Study|Other, No surgery performed|0
840503|NCT00357656|1797442|FG001|Overall Study|Other, No surgery performed|3
840504|NCT00357760|1797466|FG000|Overall Study|Disease progression|44
840505|NCT00357760|1797467|FG001|Overall Study|Disease progression|17
840506|NCT00357760|1797466|FG000|Overall Study|Adverse Event|10
840507|NCT00357760|1797467|FG001|Overall Study|Adverse Event|7
840508|NCT00357760|1797466|FG000|Overall Study|Death|0
840509|NCT00357760|1797467|FG001|Overall Study|Death|3
840510|NCT00357760|1797466|FG000|Overall Study|Alternative therapy|1
840511|NCT00357760|1797467|FG001|Overall Study|Alternative therapy|0
840512|NCT00357760|1797466|FG000|Overall Study|Withdrawal by Subject|0
840513|NCT00357760|1797467|FG001|Overall Study|Withdrawal by Subject|2
840514|NCT00357760|1797466|FG000|Overall Study|Never started treatment|2
840515|NCT00357760|1797467|FG001|Overall Study|Never started treatment|1
840516|NCT00357760|1797466|FG000|Overall Study|Ineligible|0
840517|NCT00357760|1797467|FG001|Overall Study|Ineligible|2
840518|NCT00357760|1797466|FG000|Overall Study|Physician Decision|2
840519|NCT00357760|1797467|FG001|Overall Study|Physician Decision|1
840520|NCT00357760|1797466|FG000|Overall Study|Protocol Violation|0
840521|NCT00357760|1797467|FG001|Overall Study|Protocol Violation|1
840522|NCT00357760|1797466|FG000|Overall Study|To receive hospice care|0
840523|NCT00357760|1797467|FG001|Overall Study|To receive hospice care|1
840524|NCT00357877|1797475|FG000|Overall Study|Death|2
840525|NCT00357877|1797476|FG001|Overall Study|Death|1
840526|NCT00357877|1797475|FG000|Overall Study|Lost to Follow-up|20
840527|NCT00357877|1797476|FG001|Overall Study|Lost to Follow-up|23
840528|NCT00357877|1797475|FG000|Overall Study|Withdrawal by Subject|3
840529|NCT00357877|1797476|FG001|Overall Study|Withdrawal by Subject|3
840530|NCT00357877|1797475|FG000|Overall Study|Administrative withdrawal|1
840531|NCT00357877|1797476|FG001|Overall Study|Administrative withdrawal|1
840532|NCT00357877|1797475|FG000|Overall Study|Other|0
840533|NCT00357877|1797476|FG001|Overall Study|Other|2
840534|NCT00357903|1797486|FG000|Overall Study|Adverse Event|87
840535|NCT00357903|1797487|FG001|Overall Study|Adverse Event|4
840536|NCT00357903|1797486|FG000|Overall Study|Death|33
840537|NCT00357903|1797487|FG001|Overall Study|Death|0
840538|NCT00357903|1797486|FG000|Overall Study|Lost to Follow-up|23
840539|NCT00357903|1797487|FG001|Overall Study|Lost to Follow-up|4
840540|NCT00357903|1797486|FG000|Overall Study|Physician Decision|39
840541|NCT00357903|1797487|FG001|Overall Study|Physician Decision|5
840542|NCT00357903|1797486|FG000|Overall Study|Withdrawal by Subject|57
840543|NCT00357903|1797487|FG001|Overall Study|Withdrawal by Subject|7
840544|NCT00357903|1797486|FG000|Overall Study|Completed month 12 only|0
840545|NCT00357903|1797487|FG001|Overall Study|Completed month 12 only|1
840546|NCT00357903|1797486|FG000|Overall Study|Protocol issues|14
840547|NCT00357903|1797487|FG001|Overall Study|Protocol issues|3
840548|NCT00357903|1797486|FG000|Overall Study|Response status|61
840549|NCT00357903|1797487|FG001|Overall Study|Response status|9
840550|NCT00357903|1797486|FG000|Overall Study|Other|49
840551|NCT00357903|1797487|FG001|Overall Study|Other|10
840552|NCT00357968|1797505|FG000|First Maintenance Dose Phase|Not a PCI patient|47
840553|NCT00357968|1797506|FG001|First Maintenance Dose Phase|Not a PCI patient|42
840554|NCT00357968|1797505|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1
840555|NCT00357968|1797506|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2
840556|NCT00357994|1797529|FG000|Overall Study|Adverse Event|1
840557|NCT00357994|1797530|FG001|Overall Study|Adverse Event|2
840558|NCT00357994|1797529|FG000|Overall Study|Lack of Efficacy|0
840559|NCT00357994|1797530|FG001|Overall Study|Lack of Efficacy|1
840560|NCT00357994|1797529|FG000|Overall Study|Protocol Violation|1
840561|NCT00357994|1797530|FG001|Overall Study|Protocol Violation|0
840562|NCT00358150|1797540|FG000|Overall Study|Adverse Event|3
840563|NCT00358150|1797540|FG000|Overall Study|Withdrawal by Subject|1
840564|NCT00358150|1797540|FG000|Overall Study|Undefined|3
840565|NCT00358215|1797549|FG000|Overall Study|Ineligibility determined|4
840566|NCT00358215|1797550|FG001|Overall Study|Ineligibility determined|3
840567|NCT00358215|1797549|FG000|Overall Study|Adverse Event|83
840568|NCT00358215|1797550|FG001|Overall Study|Adverse Event|65
840569|NCT00358215|1797549|FG000|Overall Study|Withdrawal by Subject|111
840570|NCT00358215|1797550|FG001|Overall Study|Withdrawal by Subject|102
840571|NCT00358215|1797549|FG000|Overall Study|Participant request|65
840572|NCT00358215|1797550|FG001|Overall Study|Participant request|64
840573|NCT00358215|1797549|FG000|Overall Study|Physician Decision|47
840574|NCT00358215|1797550|FG001|Overall Study|Physician Decision|39
840575|NCT00358215|1797549|FG000|Overall Study|Lost to Follow-up|16
840576|NCT00358215|1797550|FG001|Overall Study|Lost to Follow-up|22
840577|NCT00358215|1797549|FG000|Overall Study|Death|265
840578|NCT00358215|1797550|FG001|Overall Study|Death|281
840579|NCT00358215|1797549|FG000|Overall Study|Protocol Violation|64
840580|NCT00358215|1797550|FG001|Overall Study|Protocol Violation|59
840581|NCT00358215|1797549|FG000|Overall Study|Pregnancy|1
840582|NCT00358215|1797550|FG001|Overall Study|Pregnancy|0
840583|NCT00358215|1797549|FG000|Overall Study|Other|21
840584|NCT00358215|1797550|FG001|Overall Study|Other|14
840585|NCT00358215|1797549|FG000|Overall Study|Did not receive investigational product|2
840586|NCT00358215|1797550|FG001|Overall Study|Did not receive investigational product|3
840587|NCT00358436|1797575|FG000|Overall Study|Adverse Event|29
840588|NCT00358436|1797576|FG001|Overall Study|Adverse Event|13
840589|NCT00358436|1797575|FG000|Overall Study|Lack of Efficacy|34
840590|NCT00358436|1797576|FG001|Overall Study|Lack of Efficacy|36
840591|NCT00358436|1797575|FG000|Overall Study|Lost to Follow-up|11
840592|NCT00358436|1797576|FG001|Overall Study|Lost to Follow-up|6
840593|NCT00358436|1797575|FG000|Overall Study|Protocol Violation|8
840594|NCT00358436|1797576|FG001|Overall Study|Protocol Violation|3
840595|NCT00358436|1797575|FG000|Overall Study|Withdrawal by Subject|40
840596|NCT00358436|1797576|FG001|Overall Study|Withdrawal by Subject|17
840597|NCT00358436|1797575|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4
840598|NCT00358436|1797576|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0
840599|NCT00358436|1797575|FG000|Overall Study|COPD exacerbation|22
840600|NCT00358436|1797576|FG001|Overall Study|COPD exacerbation|10
840601|NCT00358436|1797575|FG000|Overall Study|Other|6
840602|NCT00358436|1797576|FG001|Overall Study|Other|1
840603|NCT00358449|1797587|FG000|Overall Study|Adverse Event|1
840604|NCT00358449|1797588|FG001|Overall Study|Adverse Event|0
840605|NCT00358449|1797589|FG002|Overall Study|Adverse Event|1
840606|NCT00358449|1797587|FG000|Overall Study|Lost to Follow-up|1
840607|NCT00358449|1797588|FG001|Overall Study|Lost to Follow-up|0
840608|NCT00358449|1797589|FG002|Overall Study|Lost to Follow-up|0
840609|NCT00358449|1797587|FG000|Overall Study|Withdrawal by Subject|2
840610|NCT00358449|1797588|FG001|Overall Study|Withdrawal by Subject|0
840611|NCT00358449|1797589|FG002|Overall Study|Withdrawal by Subject|0
840612|NCT00358449|1797587|FG000|Overall Study|Lack of Efficacy|0
840613|NCT00358449|1797588|FG001|Overall Study|Lack of Efficacy|1
840614|NCT00358449|1797589|FG002|Overall Study|Lack of Efficacy|0
840615|NCT00358449|1797587|FG000|Overall Study|Steriod Inhaler was Increased|0
840616|NCT00358449|1797588|FG001|Overall Study|Steriod Inhaler was Increased|0
840617|NCT00358449|1797589|FG002|Overall Study|Steriod Inhaler was Increased|1
840618|NCT00358527|1797630|FG000|Overall Study|Adverse Event|4
840619|NCT00358527|1797631|FG001|Overall Study|Adverse Event|0
840620|NCT00358527|1797630|FG000|Overall Study|Withdrawal by Subject|1
840621|NCT00358527|1797631|FG001|Overall Study|Withdrawal by Subject|1
840622|NCT00358527|1797630|FG000|Overall Study|Non-compliance with protocol|6
840623|NCT00358527|1797631|FG001|Overall Study|Non-compliance with protocol|1
840624|NCT00358527|1797630|FG000|Overall Study|Administrative|2
840625|NCT00358527|1797631|FG001|Overall Study|Administrative|1
840626|NCT00358644|1797646|FG000|Overall Study|Progressive Disease|21
840627|NCT00358644|1797646|FG000|Overall Study|Adverse Event|7
840628|NCT00358644|1797646|FG000|Overall Study|Death|11
840629|NCT00358644|1797646|FG000|Overall Study|Withdrawal by Subject|4
840630|NCT00358644|1797646|FG000|Overall Study|Physician Decision|6
840631|NCT00358644|1797646|FG000|Overall Study|Patient not eligible for study|1
840632|NCT00358670|1797656|FG000|Overall Study|Adverse Event|26
840633|NCT00358670|1797657|FG001|Overall Study|Adverse Event|29
840634|NCT00358670|1797656|FG000|Overall Study|Lack of Efficacy|20
840635|NCT00358670|1797657|FG001|Overall Study|Lack of Efficacy|23
840636|NCT00358670|1797656|FG000|Overall Study|Protocol Violation|6
840637|NCT00358670|1797657|FG001|Overall Study|Protocol Violation|9
840638|NCT00358670|1797656|FG000|Overall Study|Lost to Follow-up|4
840639|NCT00358670|1797657|FG001|Overall Study|Lost to Follow-up|5
840640|NCT00358670|1797656|FG000|Overall Study|Withdrawal by Subject|13
840641|NCT00358670|1797657|FG001|Overall Study|Withdrawal by Subject|24
840642|NCT00358670|1797656|FG000|Overall Study|Protocol Defined Clinical Event|0
840643|NCT00358670|1797657|FG001|Overall Study|Protocol Defined Clinical Event|1
840644|NCT00358670|1797656|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
840645|NCT00358670|1797657|FG001|Overall Study|Did Not Meet Protocol Eligibility|3
840646|NCT00358670|1797656|FG000|Overall Study|Administrative|153
840647|NCT00358670|1797657|FG001|Overall Study|Administrative|125
840648|NCT00358826|1797676|FG000|Core Study|Adverse Event|1
840649|NCT00358826|1797677|FG001|Core Study|Adverse Event|3
840650|NCT00358826|1797678|FG002|Core Study|Adverse Event|1
840651|NCT00358826|1797679|FG003|Core Study|Adverse Event|1
840652|NCT00358826|1797680|FG004|Core Study|Adverse Event|0
840653|NCT00358826|1797681|FG005|Core Study|Adverse Event|0
840654|NCT00358826|1797682|FG006|Core Study|Adverse Event|0
840655|NCT00358826|1797683|FG007|Core Study|Adverse Event|0
840656|NCT00358826|1797676|FG000|Core Study|Withdrawal by Subject|2
840657|NCT00358826|1797677|FG001|Core Study|Withdrawal by Subject|2
840658|NCT00358826|1797678|FG002|Core Study|Withdrawal by Subject|0
840659|NCT00358826|1797679|FG003|Core Study|Withdrawal by Subject|0
840660|NCT00358826|1797680|FG004|Core Study|Withdrawal by Subject|0
840661|NCT00358826|1797681|FG005|Core Study|Withdrawal by Subject|0
840662|NCT00358826|1797682|FG006|Core Study|Withdrawal by Subject|0
840663|NCT00358826|1797683|FG007|Core Study|Withdrawal by Subject|0
840664|NCT00358826|1797676|FG000|Core Study|Lost to Follow-up|0
840665|NCT00358826|1797677|FG001|Core Study|Lost to Follow-up|0
840666|NCT00358826|1797678|FG002|Core Study|Lost to Follow-up|0
840667|NCT00358826|1797679|FG003|Core Study|Lost to Follow-up|1
840668|NCT00358826|1797680|FG004|Core Study|Lost to Follow-up|0
840669|NCT00358826|1797681|FG005|Core Study|Lost to Follow-up|0
840670|NCT00358826|1797682|FG006|Core Study|Lost to Follow-up|0
840671|NCT00358826|1797683|FG007|Core Study|Lost to Follow-up|0
840672|NCT00358826|1797676|FG000|Core Study|Physician Decision|0
840673|NCT00358826|1797677|FG001|Core Study|Physician Decision|0
840674|NCT00358826|1797678|FG002|Core Study|Physician Decision|1
840675|NCT00358826|1797679|FG003|Core Study|Physician Decision|0
840676|NCT00358826|1797680|FG004|Core Study|Physician Decision|0
840677|NCT00358826|1797681|FG005|Core Study|Physician Decision|0
840678|NCT00358826|1797682|FG006|Core Study|Physician Decision|0
840679|NCT00358826|1797683|FG007|Core Study|Physician Decision|0
840680|NCT00358826|1797676|FG000|MDCT Substudy|Adverse Event|0
840681|NCT00358826|1797677|FG001|MDCT Substudy|Adverse Event|0
840682|NCT00358826|1797678|FG002|MDCT Substudy|Adverse Event|0
840683|NCT00358826|1797679|FG003|MDCT Substudy|Adverse Event|0
840684|NCT00358826|1797680|FG004|MDCT Substudy|Adverse Event|1
840685|NCT00358826|1797681|FG005|MDCT Substudy|Adverse Event|0
840686|NCT00358826|1797682|FG006|MDCT Substudy|Adverse Event|0
840687|NCT00358826|1797683|FG007|MDCT Substudy|Adverse Event|0
840688|NCT00358826|1797676|FG000|MDCT Substudy|Lost to Follow-up|0
840689|NCT00358826|1797677|FG001|MDCT Substudy|Lost to Follow-up|0
840690|NCT00358826|1797678|FG002|MDCT Substudy|Lost to Follow-up|0
840691|NCT00358826|1797679|FG003|MDCT Substudy|Lost to Follow-up|0
840692|NCT00358826|1797680|FG004|MDCT Substudy|Lost to Follow-up|0
840693|NCT00358826|1797681|FG005|MDCT Substudy|Lost to Follow-up|1
840694|NCT00358826|1797682|FG006|MDCT Substudy|Lost to Follow-up|0
840695|NCT00358826|1797683|FG007|MDCT Substudy|Lost to Follow-up|0
840696|NCT00358826|1797676|FG000|MDCT Substudy|Withdrawal by Subject|0
840697|NCT00358826|1797677|FG001|MDCT Substudy|Withdrawal by Subject|0
840698|NCT00358826|1797678|FG002|MDCT Substudy|Withdrawal by Subject|0
840699|NCT00358826|1797679|FG003|MDCT Substudy|Withdrawal by Subject|0
840700|NCT00358826|1797680|FG004|MDCT Substudy|Withdrawal by Subject|0
840701|NCT00358826|1797681|FG005|MDCT Substudy|Withdrawal by Subject|1
840702|NCT00358826|1797682|FG006|MDCT Substudy|Withdrawal by Subject|0
840703|NCT00358826|1797683|FG007|MDCT Substudy|Withdrawal by Subject|0
840704|NCT00358917|1797699|FG000|Overall Study|Adverse Event|14
840705|NCT00358917|1797700|FG001|Overall Study|Adverse Event|21
840706|NCT00358917|1797699|FG000|Overall Study|Withdrawal by Subject|5
840707|NCT00358917|1797700|FG001|Overall Study|Withdrawal by Subject|7
840708|NCT00358917|1797699|FG000|Overall Study|Lost to Follow-up|20
840709|NCT00358917|1797700|FG001|Overall Study|Lost to Follow-up|17
840710|NCT00358917|1797699|FG000|Overall Study|Noncompliance|12
840711|NCT00358917|1797700|FG001|Overall Study|Noncompliance|11
840712|NCT00358917|1797699|FG000|Overall Study|Death|2
840713|NCT00358917|1797700|FG001|Overall Study|Death|3
840714|NCT00358917|1797699|FG000|Overall Study|Virologic failure|11
840715|NCT00358917|1797700|FG001|Overall Study|Virologic failure|8
840716|NCT00358917|1797699|FG000|Overall Study|Unable to Continue Participation|2
840717|NCT00358917|1797700|FG001|Overall Study|Unable to Continue Participation|2
840718|NCT00358956|1797708|FG000|Overall Study|Adverse Event|3
840719|NCT00358956|1797708|FG000|Overall Study|condition under investigation worsened|4
840720|NCT00358956|1797708|FG000|Overall Study|Withdrawal by Subject|1
840721|NCT00359021|1797714|FG000|Overall Study|Adverse Event|26
840722|NCT00359021|1797715|FG001|Overall Study|Adverse Event|8
840723|NCT00359021|1797714|FG000|Overall Study|Subject Non-Compliant|1
840724|NCT00359021|1797715|FG001|Overall Study|Subject Non-Compliant|2
840725|NCT00359021|1797714|FG000|Overall Study|Subject Ineligible To Continue The Trial|1
840726|NCT00359021|1797715|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
840727|NCT00359021|1797714|FG000|Overall Study|Subject Reached A Virologic Endpoint|45
840728|NCT00359021|1797715|FG001|Overall Study|Subject Reached A Virologic Endpoint|32
840729|NCT00359021|1797714|FG000|Overall Study|Withdrawal by Subject|2
840730|NCT00359021|1797715|FG001|Overall Study|Withdrawal by Subject|9
840731|NCT00359021|1797714|FG000|Overall Study|Lost to Follow-up|1
840732|NCT00359021|1797715|FG001|Overall Study|Lost to Follow-up|0
840733|NCT00359021|1797714|FG000|Overall Study|Other|4
840734|NCT00359021|1797715|FG001|Overall Study|Other|1
840735|NCT00359021|1797714|FG000|Overall Study|Pregnancy|1
840736|NCT00359021|1797715|FG001|Overall Study|Pregnancy|0
840737|NCT00359073|1797725|FG000|Overall Study|Withdrawal by Subject|1
840738|NCT00359073|1797726|FG001|Overall Study|Withdrawal by Subject|1
840739|NCT00359073|1797725|FG000|Overall Study|Eligibility criteria no longer met|3
840740|NCT00359073|1797726|FG001|Overall Study|Eligibility criteria no longer met|0
840741|NCT00359073|1797725|FG000|Overall Study|developed RV16 antibody|0
840742|NCT00359073|1797726|FG001|Overall Study|developed RV16 antibody|1
840743|NCT00359281|1797774|FG000|Overall Study|Adverse Event|1
840744|NCT00359281|1797775|FG001|Overall Study|Adverse Event|0
840745|NCT00359281|1797776|FG002|Overall Study|Adverse Event|0
840746|NCT00359281|1797777|FG003|Overall Study|Adverse Event|0
840747|NCT00359281|1797778|FG004|Overall Study|Adverse Event|0
840748|NCT00359281|1797779|FG005|Overall Study|Adverse Event|0
840749|NCT00359281|1797780|FG006|Overall Study|Adverse Event|1
840750|NCT00359281|1797781|FG007|Overall Study|Adverse Event|0
840751|NCT00359281|1797782|FG008|Overall Study|Adverse Event|0
840752|NCT00359281|1797774|FG000|Overall Study|Withdrawal by Subject|0
840753|NCT00359281|1797775|FG001|Overall Study|Withdrawal by Subject|0
840754|NCT00359281|1797776|FG002|Overall Study|Withdrawal by Subject|0
840755|NCT00359281|1797777|FG003|Overall Study|Withdrawal by Subject|0
840756|NCT00359281|1797778|FG004|Overall Study|Withdrawal by Subject|0
840757|NCT00359281|1797779|FG005|Overall Study|Withdrawal by Subject|0
840758|NCT00359281|1797780|FG006|Overall Study|Withdrawal by Subject|1
840759|NCT00359281|1797781|FG007|Overall Study|Withdrawal by Subject|0
840760|NCT00359281|1797782|FG008|Overall Study|Withdrawal by Subject|0
840761|NCT00359294|1797814|FG000|Overall Study|Progressive disease|1
840762|NCT00359294|1797815|FG001|Overall Study|Progressive disease|1
840763|NCT00359294|1797816|FG002|Overall Study|Progressive disease|2
840764|NCT00359294|1797817|FG003|Overall Study|Progressive disease|3
840765|NCT00359294|1797818|FG004|Overall Study|Progressive disease|2
840766|NCT00359294|1797814|FG000|Overall Study|Withdrawal by Subject|0
840767|NCT00359294|1797815|FG001|Overall Study|Withdrawal by Subject|0
840768|NCT00359294|1797816|FG002|Overall Study|Withdrawal by Subject|0
840769|NCT00359294|1797817|FG003|Overall Study|Withdrawal by Subject|0
840770|NCT00359294|1797818|FG004|Overall Study|Withdrawal by Subject|1
840771|NCT00359294|1797814|FG000|Overall Study|Not treated|0
840772|NCT00359294|1797815|FG001|Overall Study|Not treated|0
840773|NCT00359294|1797816|FG002|Overall Study|Not treated|0
840774|NCT00359294|1797817|FG003|Overall Study|Not treated|1
840775|NCT00359294|1797818|FG004|Overall Study|Not treated|0
840776|NCT00359294|1797814|FG000|Overall Study|Physician Decision|0
840777|NCT00359294|1797815|FG001|Overall Study|Physician Decision|0
840778|NCT00359294|1797816|FG002|Overall Study|Physician Decision|1
840779|NCT00359294|1797817|FG003|Overall Study|Physician Decision|0
840780|NCT00359294|1797818|FG004|Overall Study|Physician Decision|0
840781|NCT00359424|1797828|FG000|Overall Study|Death|99
840782|NCT00359424|1797829|FG001|Overall Study|Death|58
840783|NCT00359424|1797828|FG000|Overall Study|Lost to Follow-up|19
840784|NCT00359424|1797829|FG001|Overall Study|Lost to Follow-up|7
840785|NCT00359424|1797828|FG000|Overall Study|Withdrawal by Subject|10
840786|NCT00359424|1797829|FG001|Overall Study|Withdrawal by Subject|2
840787|NCT00359424|1797828|FG000|Overall Study|follow up not conducted|2
840788|NCT00359424|1797829|FG001|Overall Study|follow up not conducted|0
840789|NCT00359619|1797842|FG000|Overall Study|Adverse Event|0
840790|NCT00359619|1797843|FG001|Overall Study|Adverse Event|0
840791|NCT00359619|1797844|FG002|Overall Study|Adverse Event|1
840792|NCT00359619|1797845|FG003|Overall Study|Adverse Event|0
840793|NCT00359619|1797846|FG004|Overall Study|Adverse Event|0
840794|NCT00359619|1797847|FG005|Overall Study|Adverse Event|0
840795|NCT00359619|1797848|FG006|Overall Study|Adverse Event|1
840796|NCT00359619|1797842|FG000|Overall Study|Withdrawal by Subject|3
840797|NCT00359619|1797843|FG001|Overall Study|Withdrawal by Subject|1
840798|NCT00359619|1797844|FG002|Overall Study|Withdrawal by Subject|4
840799|NCT00359619|1797845|FG003|Overall Study|Withdrawal by Subject|2
840800|NCT00359619|1797846|FG004|Overall Study|Withdrawal by Subject|2
840801|NCT00359619|1797847|FG005|Overall Study|Withdrawal by Subject|0
840802|NCT00359619|1797848|FG006|Overall Study|Withdrawal by Subject|3
840803|NCT00359619|1797842|FG000|Overall Study|Other|1
840804|NCT00359619|1797843|FG001|Overall Study|Other|0
840805|NCT00359619|1797844|FG002|Overall Study|Other|0
840806|NCT00359619|1797845|FG003|Overall Study|Other|0
840807|NCT00359619|1797846|FG004|Overall Study|Other|0
840808|NCT00359619|1797847|FG005|Overall Study|Other|0
840809|NCT00359619|1797848|FG006|Overall Study|Other|0
840810|NCT00359619|1797842|FG000|Overall Study|Lost to Follow-up|4
840811|NCT00359619|1797843|FG001|Overall Study|Lost to Follow-up|4
840812|NCT00359619|1797844|FG002|Overall Study|Lost to Follow-up|2
840813|NCT00359619|1797845|FG003|Overall Study|Lost to Follow-up|1
840814|NCT00359619|1797846|FG004|Overall Study|Lost to Follow-up|1
840815|NCT00359619|1797847|FG005|Overall Study|Lost to Follow-up|5
840816|NCT00359619|1797848|FG006|Overall Study|Lost to Follow-up|0
840817|NCT00359632|1797866|FG000|Overall Study|Death|2
840818|NCT00359632|1797867|FG001|Overall Study|Death|0
840819|NCT00359632|1797866|FG000|Overall Study|Adverse Event|1
840820|NCT00359632|1797867|FG001|Overall Study|Adverse Event|0
840821|NCT00359632|1797866|FG000|Overall Study|Non-compliance with visit schedule|1
840822|NCT00359632|1797867|FG001|Overall Study|Non-compliance with visit schedule|0
840823|NCT00359762|1797886|FG000|Period II|Adverse Event|17
840824|NCT00359762|1797887|FG001|Period II|Adverse Event|0
840825|NCT00359762|1797888|FG002|Period II|Adverse Event|0
840826|NCT00359762|1797889|FG003|Period II|Adverse Event|0
840827|NCT00359762|1797890|FG004|Period II|Adverse Event|49
840828|NCT00359762|1797886|FG000|Period II|Protocol Violation|18
840829|NCT00359762|1797887|FG001|Period II|Protocol Violation|0
840830|NCT00359762|1797888|FG002|Period II|Protocol Violation|0
840831|NCT00359762|1797889|FG003|Period II|Protocol Violation|0
840832|NCT00359762|1797890|FG004|Period II|Protocol Violation|11
840833|NCT00359762|1797886|FG000|Period II|Physician Decision|17
840834|NCT00359762|1797887|FG001|Period II|Physician Decision|0
840835|NCT00359762|1797888|FG002|Period II|Physician Decision|0
840836|NCT00359762|1797889|FG003|Period II|Physician Decision|0
840837|NCT00359762|1797890|FG004|Period II|Physician Decision|23
840838|NCT00359762|1797886|FG000|Period II|Death|2
840839|NCT00359762|1797887|FG001|Period II|Death|0
840840|NCT00359762|1797888|FG002|Period II|Death|0
840841|NCT00359762|1797889|FG003|Period II|Death|0
840842|NCT00359762|1797890|FG004|Period II|Death|4
840843|NCT00359762|1797886|FG000|Period II|Lack of Efficacy|11
840844|NCT00359762|1797887|FG001|Period II|Lack of Efficacy|0
840845|NCT00359762|1797888|FG002|Period II|Lack of Efficacy|0
840846|NCT00359762|1797889|FG003|Period II|Lack of Efficacy|0
840847|NCT00359762|1797890|FG004|Period II|Lack of Efficacy|8
840848|NCT00359762|1797886|FG000|Period II|Lost to follow up|5
840849|NCT00359762|1797887|FG001|Period II|Lost to follow up|0
840850|NCT00359762|1797888|FG002|Period II|Lost to follow up|0
840851|NCT00359762|1797889|FG003|Period II|Lost to follow up|0
840852|NCT00359762|1797890|FG004|Period II|Lost to follow up|5
840853|NCT00359762|1797886|FG000|Period II|Entry Criteria Not Met|8
840854|NCT00359762|1797887|FG001|Period II|Entry Criteria Not Met|0
840855|NCT00359762|1797888|FG002|Period II|Entry Criteria Not Met|0
840856|NCT00359762|1797889|FG003|Period II|Entry Criteria Not Met|0
840857|NCT00359762|1797890|FG004|Period II|Entry Criteria Not Met|4
840858|NCT00359762|1797886|FG000|Period II|Subject Decision|50
840859|NCT00359762|1797887|FG001|Period II|Subject Decision|0
840860|NCT00359762|1797888|FG002|Period II|Subject Decision|0
840861|NCT00359762|1797889|FG003|Period II|Subject Decision|0
840862|NCT00359762|1797890|FG004|Period II|Subject Decision|70
840863|NCT00359762|1797886|FG000|Period III|Protocol Violation|0
840864|NCT00359762|1797887|FG001|Period III|Protocol Violation|5
840865|NCT00359762|1797888|FG002|Period III|Protocol Violation|3
840866|NCT00359762|1797889|FG003|Period III|Protocol Violation|8
840867|NCT00359762|1797890|FG004|Period III|Protocol Violation|0
840868|NCT00359762|1797886|FG000|Period III|Adverse Event|0
840869|NCT00359762|1797887|FG001|Period III|Adverse Event|3
840870|NCT00359762|1797888|FG002|Period III|Adverse Event|4
840871|NCT00359762|1797889|FG003|Period III|Adverse Event|10
840872|NCT00359762|1797890|FG004|Period III|Adverse Event|0
840873|NCT00359762|1797886|FG000|Period III|Physician Decision|0
840874|NCT00359762|1797887|FG001|Period III|Physician Decision|5
840875|NCT00359762|1797888|FG002|Period III|Physician Decision|9
840876|NCT00359762|1797889|FG003|Period III|Physician Decision|15
840877|NCT00359762|1797890|FG004|Period III|Physician Decision|0
840878|NCT00359762|1797886|FG000|Period III|Lack of Efficacy|0
840879|NCT00359762|1797887|FG001|Period III|Lack of Efficacy|7
840880|NCT00359762|1797888|FG002|Period III|Lack of Efficacy|5
840881|NCT00359762|1797889|FG003|Period III|Lack of Efficacy|9
840882|NCT00359762|1797890|FG004|Period III|Lack of Efficacy|0
840883|NCT00359762|1797886|FG000|Period III|Lost to follow up|0
840884|NCT00359762|1797887|FG001|Period III|Lost to follow up|1
840885|NCT00359762|1797888|FG002|Period III|Lost to follow up|1
840886|NCT00359762|1797889|FG003|Period III|Lost to follow up|2
840887|NCT00359762|1797890|FG004|Period III|Lost to follow up|0
840888|NCT00359762|1797886|FG000|Period III|Entry Criteria Not Met|0
840889|NCT00359762|1797887|FG001|Period III|Entry Criteria Not Met|1
840890|NCT00359762|1797888|FG002|Period III|Entry Criteria Not Met|0
840891|NCT00359762|1797889|FG003|Period III|Entry Criteria Not Met|1
840892|NCT00359762|1797890|FG004|Period III|Entry Criteria Not Met|0
840893|NCT00359762|1797886|FG000|Period III|Subject Decision|0
840894|NCT00359762|1797887|FG001|Period III|Subject Decision|7
840895|NCT00359762|1797888|FG002|Period III|Subject Decision|8
840896|NCT00359762|1797889|FG003|Period III|Subject Decision|20
840897|NCT00359762|1797890|FG004|Period III|Subject Decision|0
840898|NCT00359788|1797906|FG000|Overall Study|Adverse Event|11
840899|NCT00359788|1797907|FG001|Overall Study|Adverse Event|10
840900|NCT00359788|1797906|FG000|Overall Study|Lack of Efficacy|1
840901|NCT00359788|1797907|FG001|Overall Study|Lack of Efficacy|2
840902|NCT00359788|1797906|FG000|Overall Study|Lost to Follow-up|3
840903|NCT00359788|1797907|FG001|Overall Study|Lost to Follow-up|2
840904|NCT00359788|1797906|FG000|Overall Study|Withdrawal by Subject|4
840905|NCT00359788|1797907|FG001|Overall Study|Withdrawal by Subject|1
840906|NCT00359788|1797906|FG000|Overall Study|Protocol Violation|4
840907|NCT00359788|1797907|FG001|Overall Study|Protocol Violation|2
840908|NCT00359801|1797915|FG000|Overall Study|Lost to Follow-up|72
840909|NCT00359801|1797916|FG001|Overall Study|Lost to Follow-up|58
840910|NCT00359801|1797915|FG000|Overall Study|Withdrawal by Subject|143
840911|NCT00359801|1797916|FG001|Overall Study|Withdrawal by Subject|96
840912|NCT00359801|1797915|FG000|Overall Study|Other|66
840913|NCT00359801|1797916|FG001|Overall Study|Other|46
840914|NCT00359801|1797915|FG000|Overall Study|Final Status Unknown: missing data|7
840915|NCT00359801|1797916|FG001|Overall Study|Final Status Unknown: missing data|4
840916|NCT00359801|1797915|FG000|Overall Study|Sponsor Decision|17
840917|NCT00359801|1797916|FG001|Overall Study|Sponsor Decision|16
840918|NCT00360230|1797972|FG000|Overall Study|Withdrawal by Subject|1
840919|NCT00360230|1797973|FG001|Overall Study|Withdrawal by Subject|1
840920|NCT00360230|1797974|FG002|Overall Study|Withdrawal by Subject|0
840921|NCT00360230|1797975|FG003|Overall Study|Withdrawal by Subject|1
840922|NCT00360230|1797976|FG004|Overall Study|Withdrawal by Subject|1
840923|NCT00360230|1797977|FG005|Overall Study|Withdrawal by Subject|1
840924|NCT00360230|1797978|FG006|Overall Study|Withdrawal by Subject|0
840925|NCT00360230|1797972|FG000|Overall Study|Migrated|4
840926|NCT00360230|1797973|FG001|Overall Study|Migrated|1
840927|NCT00360230|1797974|FG002|Overall Study|Migrated|3
840928|NCT00360230|1797975|FG003|Overall Study|Migrated|1
840929|NCT00360230|1797976|FG004|Overall Study|Migrated|4
840930|NCT00360230|1797977|FG005|Overall Study|Migrated|1
840931|NCT00360230|1797978|FG006|Overall Study|Migrated|1
840932|NCT00360230|1797972|FG000|Overall Study|Other|1
840933|NCT00360230|1797973|FG001|Overall Study|Other|0
840934|NCT00360230|1797974|FG002|Overall Study|Other|0
840935|NCT00360230|1797975|FG003|Overall Study|Other|0
840936|NCT00360230|1797976|FG004|Overall Study|Other|0
840937|NCT00360230|1797977|FG005|Overall Study|Other|0
840938|NCT00360230|1797978|FG006|Overall Study|Other|0
840939|NCT00360230|1797972|FG000|Overall Study|Protocol Violation|0
840940|NCT00360230|1797973|FG001|Overall Study|Protocol Violation|0
840941|NCT00360230|1797974|FG002|Overall Study|Protocol Violation|0
840942|NCT00360230|1797975|FG003|Overall Study|Protocol Violation|0
840943|NCT00360230|1797976|FG004|Overall Study|Protocol Violation|0
840944|NCT00360230|1797977|FG005|Overall Study|Protocol Violation|1
840945|NCT00360230|1797978|FG006|Overall Study|Protocol Violation|0
840946|NCT00360230|1797972|FG000|Overall Study|Death|0
840947|NCT00360230|1797973|FG001|Overall Study|Death|1
840948|NCT00360230|1797974|FG002|Overall Study|Death|0
840949|NCT00360230|1797975|FG003|Overall Study|Death|0
840950|NCT00360230|1797976|FG004|Overall Study|Death|0
840951|NCT00360230|1797977|FG005|Overall Study|Death|1
840952|NCT00360230|1797978|FG006|Overall Study|Death|1
840953|NCT00360269|1798015|FG000|Overall Study|Lost to Follow-up|7
840954|NCT00360269|1798016|FG001|Overall Study|Lost to Follow-up|9
840955|NCT00360269|1798015|FG000|Overall Study|Physician Decision|1
840956|NCT00360269|1798016|FG001|Overall Study|Physician Decision|2
840957|NCT00360269|1798015|FG000|Overall Study|Adverse Event|1
840958|NCT00360269|1798016|FG001|Overall Study|Adverse Event|0
840959|NCT00360269|1798015|FG000|Overall Study|Withdrawal by Subject|1
840960|NCT00360269|1798016|FG001|Overall Study|Withdrawal by Subject|1
840961|NCT00360282|1798022|FG000|Washout 1-3 Weeks|Lost to Follow-up|0
840962|NCT00360282|1798023|FG001|Washout 1-3 Weeks|Lost to Follow-up|0
840963|NCT00360282|1798024|FG002|Washout 1-3 Weeks|Lost to Follow-up|1
840964|NCT00360282|1798025|FG003|Washout 1-3 Weeks|Lost to Follow-up|0
840965|NCT00360282|1798022|FG000|Second Intervention|Adverse Event|0
840966|NCT00360282|1798023|FG001|Second Intervention|Adverse Event|1
840967|NCT00360282|1798024|FG002|Second Intervention|Adverse Event|0
840968|NCT00360282|1798025|FG003|Second Intervention|Adverse Event|0
840969|NCT00360308|1798036|FG000|Overall Study|Adverse Event|15
840970|NCT00360308|1798037|FG001|Overall Study|Adverse Event|14
840971|NCT00360308|1798038|FG002|Overall Study|Adverse Event|25
840972|NCT00360308|1798036|FG000|Overall Study|Abnormal Laboratory Value(s)|0
840973|NCT00360308|1798037|FG001|Overall Study|Abnormal Laboratory Value(s)|1
840974|NCT00360308|1798038|FG002|Overall Study|Abnormal Laboratory Value(s)|0
840975|NCT00360308|1798036|FG000|Overall Study|Protocol Violation|2
840976|NCT00360308|1798037|FG001|Overall Study|Protocol Violation|1
840977|NCT00360308|1798038|FG002|Overall Study|Protocol Violation|2
840978|NCT00360308|1798036|FG000|Overall Study|Withdrawal by Subject|11
840979|NCT00360308|1798037|FG001|Overall Study|Withdrawal by Subject|7
840980|NCT00360308|1798038|FG002|Overall Study|Withdrawal by Subject|14
840981|NCT00360308|1798036|FG000|Overall Study|Lack of Efficacy|3
840982|NCT00360308|1798037|FG001|Overall Study|Lack of Efficacy|0
840983|NCT00360308|1798038|FG002|Overall Study|Lack of Efficacy|2
840984|NCT00360308|1798036|FG000|Overall Study|Other|2
840985|NCT00360308|1798037|FG001|Overall Study|Other|1
840986|NCT00360308|1798038|FG002|Overall Study|Other|1
840987|NCT00360308|1798036|FG000|Overall Study|Study termination by sponsor|43
840988|NCT00360308|1798037|FG001|Overall Study|Study termination by sponsor|55
840989|NCT00360308|1798038|FG002|Overall Study|Study termination by sponsor|44
840990|NCT00360334|1798052|FG000|Overall Study|Adverse Event|7
840991|NCT00360334|1798053|FG001|Overall Study|Adverse Event|4
840992|NCT00360334|1798052|FG000|Overall Study|Protocol Violation|1
840993|NCT00360334|1798053|FG001|Overall Study|Protocol Violation|1
840994|NCT00360334|1798052|FG000|Overall Study|Physician Decision|2
840995|NCT00360334|1798053|FG001|Overall Study|Physician Decision|3
840996|NCT00360334|1798052|FG000|Overall Study|Lack of Efficacy|0
840997|NCT00360334|1798053|FG001|Overall Study|Lack of Efficacy|1
840998|NCT00360334|1798052|FG000|Overall Study|Entry criterion not met|1
840999|NCT00360334|1798053|FG001|Overall Study|Entry criterion not met|2
841000|NCT00360334|1798052|FG000|Overall Study|Subject decision|8
841001|NCT00360334|1798053|FG001|Overall Study|Subject decision|2
841002|NCT00360412|1798078|FG000|Overall Study|Adverse Event|37
841003|NCT00360412|1798079|FG001|Overall Study|Adverse Event|65
841004|NCT00360412|1798078|FG000|Overall Study|Protocol Violation|2
841005|NCT00360412|1798079|FG001|Overall Study|Protocol Violation|5
841006|NCT00360412|1798078|FG000|Overall Study|Patient withdrew consent|27
841007|NCT00360412|1798079|FG001|Overall Study|Patient withdrew consent|52
841008|NCT00360412|1798078|FG000|Overall Study|Lack of therapeutic efficacy|46
841009|NCT00360412|1798079|FG001|Overall Study|Lack of therapeutic efficacy|61
841010|NCT00360412|1798078|FG000|Overall Study|Physician Decision|2
841011|NCT00360412|1798079|FG001|Overall Study|Physician Decision|4
841012|NCT00360412|1798078|FG000|Overall Study|Other|5
841013|NCT00360412|1798079|FG001|Overall Study|Other|6
841014|NCT00360412|1798078|FG000|Overall Study|Study termination by Sponsor|214
841015|NCT00360412|1798079|FG001|Overall Study|Study termination by Sponsor|469
841016|NCT00360490|1798087|FG000|Overall Study|Adverse Event|4
841017|NCT00360490|1798088|FG001|Overall Study|Adverse Event|2
841018|NCT00360490|1798087|FG000|Overall Study|Lost to Follow-up|2
841019|NCT00360490|1798088|FG001|Overall Study|Lost to Follow-up|1
841020|NCT00360490|1798087|FG000|Overall Study|Physician Decision|2
841021|NCT00360490|1798088|FG001|Overall Study|Physician Decision|1
841022|NCT00360490|1798087|FG000|Overall Study|Protocol Violation|0
841023|NCT00360490|1798088|FG001|Overall Study|Protocol Violation|4
841024|NCT00360490|1798087|FG000|Overall Study|Withdrawal by Subject|1
841025|NCT00360490|1798088|FG001|Overall Study|Withdrawal by Subject|3
841026|NCT00360529|1798097|FG000|Overall Study|Adverse Event|10
841027|NCT00360529|1798098|FG001|Overall Study|Adverse Event|23
841028|NCT00360529|1798099|FG002|Overall Study|Adverse Event|33
841029|NCT00360529|1798097|FG000|Overall Study|Protocol Violation|3
841030|NCT00360529|1798098|FG001|Overall Study|Protocol Violation|3
841031|NCT00360529|1798099|FG002|Overall Study|Protocol Violation|11
841032|NCT00360529|1798097|FG000|Overall Study|Lost to Follow-up|14
841033|NCT00360529|1798098|FG001|Overall Study|Lost to Follow-up|10
841034|NCT00360529|1798099|FG002|Overall Study|Lost to Follow-up|13
841035|NCT00360529|1798097|FG000|Overall Study|Withdrawal by Subject|22
841036|NCT00360529|1798098|FG001|Overall Study|Withdrawal by Subject|14
841037|NCT00360529|1798099|FG002|Overall Study|Withdrawal by Subject|18
841038|NCT00360529|1798097|FG000|Overall Study|Lack of Efficacy|8
841039|NCT00360529|1798098|FG001|Overall Study|Lack of Efficacy|6
841040|NCT00360529|1798099|FG002|Overall Study|Lack of Efficacy|5
841041|NCT00360529|1798097|FG000|Overall Study|Reason discontinued not explained above|4
841042|NCT00360529|1798098|FG001|Overall Study|Reason discontinued not explained above|9
841043|NCT00360529|1798099|FG002|Overall Study|Reason discontinued not explained above|11
841044|NCT00360568|1798126|FG000|Overall Study|Adverse Event|1
841045|NCT00360568|1798127|FG001|Overall Study|Adverse Event|2
841046|NCT00360568|1798126|FG000|Overall Study|Lack of Efficacy|1
841047|NCT00360568|1798127|FG001|Overall Study|Lack of Efficacy|0
841048|NCT00360568|1798126|FG000|Overall Study|Withdrawal by Subject|0
841049|NCT00360568|1798127|FG001|Overall Study|Withdrawal by Subject|3
841050|NCT00360698|1798151|FG000|Run-In|Physician Decision|0
841051|NCT00360698|1798152|FG001|Run-In|Physician Decision|1
841052|NCT00360698|1798151|FG000|Run-In|Withdrawal by Subject|0
841053|NCT00360698|1798152|FG001|Run-In|Withdrawal by Subject|2
841054|NCT00360698|1798151|FG000|Run-In|Non compliance with treatment procedure|0
841055|NCT00360698|1798152|FG001|Run-In|Non compliance with treatment procedure|1
841056|NCT00360698|1798151|FG000|Run-In|Sponsor request|0
841057|NCT00360698|1798152|FG001|Run-In|Sponsor request|2
841058|NCT00360698|1798151|FG000|Run-In|Patient did not meet inclusion criteria|0
841059|NCT00360698|1798152|FG001|Run-In|Patient did not meet inclusion criteria|1
841060|NCT00360698|1798151|FG000|Run-In|Patient personal reasons|0
841061|NCT00360698|1798152|FG001|Run-In|Patient personal reasons|2
841062|NCT00360698|1798151|FG000|Run-In|Need of insulin with meals|0
841063|NCT00360698|1798152|FG001|Run-In|Need of insulin with meals|1
841064|NCT00360698|1798151|FG000|Treatment Period|Non compliance with treatment procedure|1
841065|NCT00360698|1798152|FG001|Treatment Period|Non compliance with treatment procedure|0
841066|NCT00360698|1798151|FG000|Treatment Period|Early termination by error|0
841067|NCT00360698|1798152|FG001|Treatment Period|Early termination by error|1
841068|NCT00361218|1798196|FG000|Overall Study|Lost to Follow-up|11
841069|NCT00361218|1798196|FG000|Overall Study|Personal Reasons|7
841070|NCT00361218|1798196|FG000|Overall Study|terminated / withdrawn due to toxicity /|5
841071|NCT00361231|1798200|FG000|Overall Study|Physician Decision|3
841072|NCT00361231|1798200|FG000|Overall Study|Symptomatic deterioration|5
841073|NCT00361231|1798200|FG000|Overall Study|Radiographic disease progression|16
841074|NCT00361231|1798200|FG000|Overall Study|Withdrawal by Subject|4
841075|NCT00361231|1798200|FG000|Overall Study|Adverse Event|6
841076|NCT00361270|1798219|FG000|Overall Study|Death|0
841077|NCT00361270|1798220|FG001|Overall Study|Death|0
841078|NCT00361270|1798221|FG002|Overall Study|Death|0
841079|NCT00361270|1798222|FG003|Overall Study|Death|2
841080|NCT00361270|1798219|FG000|Overall Study|Lost to Follow-up|4
841081|NCT00361270|1798220|FG001|Overall Study|Lost to Follow-up|1
841082|NCT00361270|1798221|FG002|Overall Study|Lost to Follow-up|0
841083|NCT00361270|1798222|FG003|Overall Study|Lost to Follow-up|0
841084|NCT00361270|1798219|FG000|Overall Study|Physician Decision|0
841085|NCT00361270|1798220|FG001|Overall Study|Physician Decision|0
841086|NCT00361270|1798221|FG002|Overall Study|Physician Decision|1
841087|NCT00361270|1798222|FG003|Overall Study|Physician Decision|0
841088|NCT00361270|1798219|FG000|Overall Study|Protocol Violation|9
841089|NCT00361270|1798220|FG001|Overall Study|Protocol Violation|4
841090|NCT00361270|1798221|FG002|Overall Study|Protocol Violation|5
841091|NCT00361270|1798222|FG003|Overall Study|Protocol Violation|4
841092|NCT00361270|1798219|FG000|Overall Study|Withdrawal by Subject|6
841093|NCT00361270|1798220|FG001|Overall Study|Withdrawal by Subject|6
841094|NCT00361270|1798221|FG002|Overall Study|Withdrawal by Subject|3
841095|NCT00361270|1798222|FG003|Overall Study|Withdrawal by Subject|7
841096|NCT00361270|1798219|FG000|Overall Study|Afraid of Hypnosis|1
841097|NCT00361270|1798220|FG001|Overall Study|Afraid of Hypnosis|2
841098|NCT00361270|1798221|FG002|Overall Study|Afraid of Hypnosis|0
841099|NCT00361270|1798222|FG003|Overall Study|Afraid of Hypnosis|0
841100|NCT00361270|1798219|FG000|Overall Study|Problems with Transportation|4
841101|NCT00361270|1798220|FG001|Overall Study|Problems with Transportation|0
841102|NCT00361270|1798221|FG002|Overall Study|Problems with Transportation|0
841103|NCT00361270|1798222|FG003|Overall Study|Problems with Transportation|0
841104|NCT00361270|1798219|FG000|Overall Study|Adverse Event|0
841105|NCT00361270|1798220|FG001|Overall Study|Adverse Event|1
841106|NCT00361270|1798221|FG002|Overall Study|Adverse Event|1
841107|NCT00361270|1798222|FG003|Overall Study|Adverse Event|0
841108|NCT00361283|1798239|FG000|Overall Study|Lost to Follow-up|27
841109|NCT00361296|1798243|FG000|Overall Study|Physician Decision|1
841110|NCT00361296|1798243|FG000|Overall Study|Lack of Efficacy|2
841111|NCT00361335|1798252|FG000|IV Period: Baseline to E0|Adverse Event|9
841112|NCT00361335|1798253|FG001|IV Period: Baseline to E0|Adverse Event|4
841113|NCT00361335|1798254|FG002|IV Period: Baseline to E0|Adverse Event|5
841114|NCT00361335|1798255|FG003|IV Period: Baseline to E0|Adverse Event|9
841115|NCT00361335|1798256|FG004|IV Period: Baseline to E0|Adverse Event|8
841116|NCT00361335|1798257|FG005|IV Period: Baseline to E0|Adverse Event|0
841117|NCT00361335|1798258|FG006|IV Period: Baseline to E0|Adverse Event|0
841118|NCT00361335|1798252|FG000|IV Period: Baseline to E0|Lost to Follow-up|1
841119|NCT00361335|1798253|FG001|IV Period: Baseline to E0|Lost to Follow-up|0
841120|NCT00361335|1798254|FG002|IV Period: Baseline to E0|Lost to Follow-up|0
841121|NCT00361335|1798255|FG003|IV Period: Baseline to E0|Lost to Follow-up|2
841122|NCT00361335|1798256|FG004|IV Period: Baseline to E0|Lost to Follow-up|2
841123|NCT00361335|1798257|FG005|IV Period: Baseline to E0|Lost to Follow-up|0
841124|NCT00361335|1798258|FG006|IV Period: Baseline to E0|Lost to Follow-up|0
841125|NCT00361335|1798252|FG000|IV Period: Baseline to E0|Death|1
841126|NCT00361335|1798253|FG001|IV Period: Baseline to E0|Death|1
841127|NCT00361335|1798254|FG002|IV Period: Baseline to E0|Death|1
841128|NCT00361335|1798255|FG003|IV Period: Baseline to E0|Death|1
841129|NCT00361335|1798256|FG004|IV Period: Baseline to E0|Death|0
841130|NCT00361335|1798257|FG005|IV Period: Baseline to E0|Death|0
841131|NCT00361335|1798258|FG006|IV Period: Baseline to E0|Death|0
841132|NCT00361335|1798252|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2
841133|NCT00361335|1798253|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1
841134|NCT00361335|1798254|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1
841135|NCT00361335|1798255|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1
841136|NCT00361335|1798256|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2
841137|NCT00361335|1798257|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0
841138|NCT00361335|1798258|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0
841139|NCT00361335|1798252|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0
841140|NCT00361335|1798253|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0
841141|NCT00361335|1798254|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1
841142|NCT00361335|1798255|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0
841143|NCT00361335|1798256|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0
841144|NCT00361335|1798257|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0
841145|NCT00361335|1798258|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0
841146|NCT00361335|1798252|FG000|IV Period: Baseline to E0|Worsening of RA|0
841147|NCT00361335|1798253|FG001|IV Period: Baseline to E0|Worsening of RA|5
841148|NCT00361335|1798254|FG002|IV Period: Baseline to E0|Worsening of RA|1
841149|NCT00361335|1798255|FG003|IV Period: Baseline to E0|Worsening of RA|4
841150|NCT00361335|1798256|FG004|IV Period: Baseline to E0|Worsening of RA|2
841151|NCT00361335|1798257|FG005|IV Period: Baseline to E0|Worsening of RA|0
841152|NCT00361335|1798258|FG006|IV Period: Baseline to E0|Worsening of RA|0
841153|NCT00361335|1798252|FG000|IV Period: Baseline to E0|Other|2
841154|NCT00361335|1798253|FG001|IV Period: Baseline to E0|Other|9
841155|NCT00361335|1798254|FG002|IV Period: Baseline to E0|Other|9
841156|NCT00361335|1798255|FG003|IV Period: Baseline to E0|Other|3
841157|NCT00361335|1798256|FG004|IV Period: Baseline to E0|Other|2
841158|NCT00361335|1798257|FG005|IV Period: Baseline to E0|Other|0
841159|NCT00361335|1798258|FG006|IV Period: Baseline to E0|Other|0
841160|NCT00361335|1798252|FG000|IV Period: Baseline to E0|Lack of Efficacy|5
841161|NCT00361335|1798253|FG001|IV Period: Baseline to E0|Lack of Efficacy|9
841162|NCT00361335|1798254|FG002|IV Period: Baseline to E0|Lack of Efficacy|3
841163|NCT00361335|1798255|FG003|IV Period: Baseline to E0|Lack of Efficacy|7
841164|NCT00361335|1798256|FG004|IV Period: Baseline to E0|Lack of Efficacy|8
841165|NCT00361335|1798257|FG005|IV Period: Baseline to E0|Lack of Efficacy|0
841166|NCT00361335|1798258|FG006|IV Period: Baseline to E0|Lack of Efficacy|0
841167|NCT00361335|1798252|FG000|SC Period: Week E0 to Week E24|Adverse Event|0
841168|NCT00361335|1798253|FG001|SC Period: Week E0 to Week E24|Adverse Event|2
841169|NCT00361335|1798254|FG002|SC Period: Week E0 to Week E24|Adverse Event|1
841170|NCT00361335|1798255|FG003|SC Period: Week E0 to Week E24|Adverse Event|2
841171|NCT00361335|1798256|FG004|SC Period: Week E0 to Week E24|Adverse Event|0
841172|NCT00361335|1798257|FG005|SC Period: Week E0 to Week E24|Adverse Event|0
841173|NCT00361335|1798258|FG006|SC Period: Week E0 to Week E24|Adverse Event|2
841174|NCT00361335|1798252|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1
841175|NCT00361335|1798253|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0
841176|NCT00361335|1798254|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1
841177|NCT00361335|1798255|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0
841178|NCT00361335|1798256|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0
841179|NCT00361335|1798257|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0
841180|NCT00361335|1798258|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1
841181|NCT00361335|1798252|FG000|SC Period: Week E0 to Week E24|Death|0
841182|NCT00361335|1798253|FG001|SC Period: Week E0 to Week E24|Death|0
841183|NCT00361335|1798254|FG002|SC Period: Week E0 to Week E24|Death|0
841184|NCT00361335|1798255|FG003|SC Period: Week E0 to Week E24|Death|0
841185|NCT00361335|1798256|FG004|SC Period: Week E0 to Week E24|Death|0
841186|NCT00361335|1798257|FG005|SC Period: Week E0 to Week E24|Death|0
841187|NCT00361335|1798258|FG006|SC Period: Week E0 to Week E24|Death|1
841188|NCT00361335|1798252|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0
841189|NCT00361335|1798253|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1
841190|NCT00361335|1798254|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1
841191|NCT00361335|1798255|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1
841192|NCT00361335|1798256|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0
841193|NCT00361335|1798257|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0
841194|NCT00361335|1798258|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0
841195|NCT00361335|1798252|FG000|SC Period: Week E0 to Week E24|Other|1
841196|NCT00361335|1798253|FG001|SC Period: Week E0 to Week E24|Other|0
841197|NCT00361335|1798254|FG002|SC Period: Week E0 to Week E24|Other|0
841198|NCT00361335|1798255|FG003|SC Period: Week E0 to Week E24|Other|1
841199|NCT00361335|1798256|FG004|SC Period: Week E0 to Week E24|Other|0
841200|NCT00361335|1798257|FG005|SC Period: Week E0 to Week E24|Other|1
841201|NCT00361335|1798258|FG006|SC Period: Week E0 to Week E24|Other|2
841202|NCT00361335|1798252|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0
841203|NCT00361335|1798253|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0
841204|NCT00361335|1798254|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2
841205|NCT00361335|1798255|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0
841206|NCT00361335|1798256|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0
841207|NCT00361335|1798257|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0
841208|NCT00361335|1798258|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3
841209|NCT00361504|1798298|FG000|Overall Study|Withdrawal by Subject|94
841210|NCT00361504|1798299|FG001|Overall Study|Withdrawal by Subject|31
841211|NCT00361504|1798298|FG000|Overall Study|Lost to Follow-up|40
841212|NCT00361504|1798299|FG001|Overall Study|Lost to Follow-up|7
841213|NCT00361504|1798298|FG000|Overall Study|Adverse Event|203
841214|NCT00361504|1798299|FG001|Overall Study|Adverse Event|82
841215|NCT00361504|1798298|FG000|Overall Study|Lack of Efficacy|72
841216|NCT00361504|1798299|FG001|Overall Study|Lack of Efficacy|7
841217|NCT00361504|1798298|FG000|Overall Study|Resolution of Pain|2
841218|NCT00361504|1798299|FG001|Overall Study|Resolution of Pain|0
841219|NCT00361504|1798298|FG000|Overall Study|Study medication non compliant|42
841220|NCT00361504|1798299|FG001|Overall Study|Study medication non compliant|15
841221|NCT00361504|1798298|FG000|Overall Study|All other|28
841222|NCT00361504|1798299|FG001|Overall Study|All other|3
841223|NCT00361569|1798309|FG000|Overall Study|Protocol Violation|3
841224|NCT00361569|1798310|FG001|Overall Study|Protocol Violation|2
841225|NCT00361569|1798311|FG002|Overall Study|Protocol Violation|4
841226|NCT00361569|1798312|FG003|Overall Study|Protocol Violation|2
841227|NCT00361569|1798309|FG000|Overall Study|Withdrawal by Subject|2
841228|NCT00361569|1798310|FG001|Overall Study|Withdrawal by Subject|1
841229|NCT00361569|1798311|FG002|Overall Study|Withdrawal by Subject|9
841230|NCT00361569|1798312|FG003|Overall Study|Withdrawal by Subject|14
841231|NCT00361569|1798309|FG000|Overall Study|Adverse Event|3
841232|NCT00361569|1798310|FG001|Overall Study|Adverse Event|5
841233|NCT00361569|1798311|FG002|Overall Study|Adverse Event|2
841234|NCT00361569|1798312|FG003|Overall Study|Adverse Event|2
841235|NCT00361569|1798309|FG000|Overall Study|Lost to Follow-up|2
841236|NCT00361569|1798310|FG001|Overall Study|Lost to Follow-up|3
841237|NCT00361569|1798311|FG002|Overall Study|Lost to Follow-up|3
841238|NCT00361569|1798312|FG003|Overall Study|Lost to Follow-up|2
841239|NCT00361569|1798309|FG000|Overall Study|Not specified by investigator|2
841240|NCT00361569|1798310|FG001|Overall Study|Not specified by investigator|0
841241|NCT00361569|1798311|FG002|Overall Study|Not specified by investigator|0
841242|NCT00361569|1798312|FG003|Overall Study|Not specified by investigator|1
841243|NCT00361634|1798326|FG000|Overall Study|Lost to Follow-up|1
841244|NCT00361634|1798326|FG000|Overall Study|Withdrawal by Subject|1
841245|NCT00361842|1798341|FG000|Overall Study|Withdrawal by Subject|2
841246|NCT00361842|1798342|FG001|Overall Study|Withdrawal by Subject|3
841247|NCT00361842|1798341|FG000|Overall Study|Death|2
841248|NCT00361842|1798342|FG001|Overall Study|Death|1
841249|NCT00361842|1798341|FG000|Overall Study|Disease progression|19
841250|NCT00361842|1798342|FG001|Overall Study|Disease progression|20
841251|NCT00361842|1798341|FG000|Overall Study|Adverse Event|2
841252|NCT00361842|1798342|FG001|Overall Study|Adverse Event|3
841253|NCT00361842|1798341|FG000|Overall Study|Occurrence of unacceptable toxicity|1
841254|NCT00361842|1798342|FG001|Overall Study|Occurrence of unacceptable toxicity|5
841255|NCT00361842|1798341|FG000|Overall Study|Other|1
841256|NCT00361842|1798342|FG001|Overall Study|Other|0
841257|NCT00361842|1798341|FG000|Overall Study|Other|0
841258|NCT00361842|1798342|FG001|Overall Study|Other|2
841259|NCT00362115|1798367|FG000|Overall Study|Adverse Event|0
841260|NCT00362115|1798368|FG001|Overall Study|Adverse Event|1
841261|NCT00362115|1798369|FG002|Overall Study|Adverse Event|1
841262|NCT00362115|1798370|FG003|Overall Study|Adverse Event|1
841263|NCT00362115|1798371|FG004|Overall Study|Adverse Event|2
841264|NCT00362115|1798372|FG005|Overall Study|Adverse Event|2
841265|NCT00362115|1798373|FG006|Overall Study|Adverse Event|1
841266|NCT00362115|1798367|FG000|Overall Study|Protocol Violation|0
841267|NCT00362115|1798368|FG001|Overall Study|Protocol Violation|0
841268|NCT00362115|1798369|FG002|Overall Study|Protocol Violation|0
841269|NCT00362115|1798370|FG003|Overall Study|Protocol Violation|0
841270|NCT00362115|1798371|FG004|Overall Study|Protocol Violation|0
841271|NCT00362115|1798372|FG005|Overall Study|Protocol Violation|1
841272|NCT00362115|1798373|FG006|Overall Study|Protocol Violation|0
841273|NCT00362115|1798367|FG000|Overall Study|Lost to Follow-up|0
841274|NCT00362115|1798368|FG001|Overall Study|Lost to Follow-up|1
841275|NCT00362115|1798369|FG002|Overall Study|Lost to Follow-up|0
841276|NCT00362115|1798370|FG003|Overall Study|Lost to Follow-up|0
841277|NCT00362115|1798371|FG004|Overall Study|Lost to Follow-up|2
841278|NCT00362115|1798372|FG005|Overall Study|Lost to Follow-up|0
841279|NCT00362115|1798373|FG006|Overall Study|Lost to Follow-up|1
841280|NCT00362115|1798367|FG000|Overall Study|Withdrawal by Subject|1
841281|NCT00362115|1798368|FG001|Overall Study|Withdrawal by Subject|3
841282|NCT00362115|1798369|FG002|Overall Study|Withdrawal by Subject|1
841283|NCT00362115|1798370|FG003|Overall Study|Withdrawal by Subject|0
841284|NCT00362115|1798371|FG004|Overall Study|Withdrawal by Subject|1
841285|NCT00362115|1798372|FG005|Overall Study|Withdrawal by Subject|3
841286|NCT00362115|1798373|FG006|Overall Study|Withdrawal by Subject|4
841287|NCT00362115|1798367|FG000|Overall Study|Lack of Efficacy|1
841288|NCT00362115|1798368|FG001|Overall Study|Lack of Efficacy|0
841289|NCT00362115|1798369|FG002|Overall Study|Lack of Efficacy|5
841290|NCT00362115|1798370|FG003|Overall Study|Lack of Efficacy|2
841291|NCT00362115|1798371|FG004|Overall Study|Lack of Efficacy|2
841292|NCT00362115|1798372|FG005|Overall Study|Lack of Efficacy|0
841293|NCT00362115|1798373|FG006|Overall Study|Lack of Efficacy|3
841294|NCT00362115|1798367|FG000|Overall Study|Physician Decision|0
841295|NCT00362115|1798368|FG001|Overall Study|Physician Decision|0
841296|NCT00362115|1798369|FG002|Overall Study|Physician Decision|0
841297|NCT00362115|1798370|FG003|Overall Study|Physician Decision|0
841298|NCT00362115|1798371|FG004|Overall Study|Physician Decision|0
841299|NCT00362115|1798372|FG005|Overall Study|Physician Decision|0
841300|NCT00362115|1798373|FG006|Overall Study|Physician Decision|3
841301|NCT00362115|1798367|FG000|Overall Study|Other|0
841302|NCT00362115|1798368|FG001|Overall Study|Other|1
841303|NCT00362115|1798369|FG002|Overall Study|Other|0
841304|NCT00362115|1798370|FG003|Overall Study|Other|1
841305|NCT00362115|1798371|FG004|Overall Study|Other|0
841306|NCT00362115|1798372|FG005|Overall Study|Other|1
841307|NCT00362115|1798373|FG006|Overall Study|Other|0
841308|NCT00362180|1798402|FG000|Treated Period|Withdrawal by Subject|1
841309|NCT00362180|1798403|FG001|Treated Period|Withdrawal by Subject|0
841310|NCT00362180|1798404|FG002|Treated Period|Withdrawal by Subject|0
841311|NCT00362180|1798405|FG003|Treated Period|Withdrawal by Subject|0
841312|NCT00362180|1798406|FG004|Treated Period|Withdrawal by Subject|0
841313|NCT00362180|1798407|FG005|Treated Period|Withdrawal by Subject|0
841314|NCT00362180|1798408|FG006|Treated Period|Withdrawal by Subject|0
841315|NCT00362180|1798409|FG007|Treated Period|Withdrawal by Subject|0
841316|NCT00362180|1798410|FG008|Treated Period|Withdrawal by Subject|0
841317|NCT00362180|1798402|FG000|Treated Period|Adverse Event|0
841318|NCT00362180|1798403|FG001|Treated Period|Adverse Event|0
841319|NCT00362180|1798404|FG002|Treated Period|Adverse Event|0
841320|NCT00362180|1798405|FG003|Treated Period|Adverse Event|0
841321|NCT00362180|1798406|FG004|Treated Period|Adverse Event|0
841322|NCT00362180|1798407|FG005|Treated Period|Adverse Event|1
841323|NCT00362180|1798408|FG006|Treated Period|Adverse Event|0
841324|NCT00362180|1798409|FG007|Treated Period|Adverse Event|1
841325|NCT00362180|1798410|FG008|Treated Period|Adverse Event|0
841326|NCT00362232|1798430|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62
841327|NCT00362232|1798431|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56
841328|NCT00362232|1798430|FG000|Treatment (12 +/- 2 Days)|Death|1
841329|NCT00362232|1798431|FG001|Treatment (12 +/- 2 Days)|Death|3
841330|NCT00362232|1798430|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
841331|NCT00362232|1798431|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
841332|NCT00362232|1798430|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2
841333|NCT00362232|1798431|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5
841334|NCT00362232|1798430|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22
841335|NCT00362232|1798431|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21
841336|NCT00362232|1798430|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
841337|NCT00362232|1798431|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
841338|NCT00362232|1798430|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
841339|NCT00362232|1798431|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
841340|NCT00362232|1798430|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1
841341|NCT00362232|1798431|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0
841342|NCT00362232|1798430|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
841343|NCT00362232|1798431|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
841344|NCT00362232|1798430|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2
841345|NCT00362232|1798431|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3
841346|NCT00362232|1798430|FG000|Follow-up (30 (+ 5) Days)|Death|1
841347|NCT00362232|1798431|FG001|Follow-up (30 (+ 5) Days)|Death|1
841348|NCT00362232|1798430|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
841349|NCT00362232|1798431|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
841350|NCT00362232|1798430|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
841351|NCT00362232|1798431|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
841352|NCT00362297|1798439|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
841353|NCT00362297|1798440|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
841354|NCT00362336|1798449|FG000|Overall Study|Serious Adverse Event|1
841355|NCT00362336|1798450|FG001|Overall Study|Serious Adverse Event|0
841356|NCT00362336|1798451|FG002|Overall Study|Serious Adverse Event|1
841357|NCT00362336|1798449|FG000|Overall Study|Protocol Violation|0
841358|NCT00362336|1798450|FG001|Overall Study|Protocol Violation|0
841359|NCT00362336|1798451|FG002|Overall Study|Protocol Violation|1
841360|NCT00362336|1798449|FG000|Overall Study|Lost to Follow-up|6
841361|NCT00362336|1798450|FG001|Overall Study|Lost to Follow-up|4
841362|NCT00362336|1798451|FG002|Overall Study|Lost to Follow-up|0
841363|NCT00362336|1798449|FG000|Overall Study|Withdrawal by Subject|3
841364|NCT00362336|1798450|FG001|Overall Study|Withdrawal by Subject|3
841365|NCT00362336|1798451|FG002|Overall Study|Withdrawal by Subject|1
841366|NCT00362375|1798468|FG000|Overall Study|Lost to Follow-up|40
841367|NCT00362375|1798469|FG001|Overall Study|Lost to Follow-up|35
841368|NCT00362414|1798485|FG000|Overall Study|Death|2
841369|NCT00362414|1798485|FG000|Overall Study|Adverse Event|1
841370|NCT00362609|1798521|FG000|Overall Study|Withdrawal by Subject|0
841371|NCT00362609|1798522|FG001|Overall Study|Withdrawal by Subject|1
841372|NCT00362609|1798521|FG000|Overall Study|Protocol Violation|0
841373|NCT00362609|1798522|FG001|Overall Study|Protocol Violation|1
841374|NCT00362648|1798532|FG000|Overall Study|Adverse Event|12
841375|NCT00362648|1798533|FG001|Overall Study|Adverse Event|21
841376|NCT00362648|1798534|FG002|Overall Study|Adverse Event|1
841377|NCT00362648|1798535|FG003|Overall Study|Adverse Event|0
841378|NCT00362648|1798532|FG000|Overall Study|Lost to Follow-up|62
841379|NCT00362648|1798533|FG001|Overall Study|Lost to Follow-up|69
841380|NCT00362648|1798534|FG002|Overall Study|Lost to Follow-up|4
841381|NCT00362648|1798535|FG003|Overall Study|Lost to Follow-up|3
841382|NCT00362648|1798532|FG000|Overall Study|Protocol Violation|4
841383|NCT00362648|1798533|FG001|Overall Study|Protocol Violation|2
841384|NCT00362648|1798534|FG002|Overall Study|Protocol Violation|2
841385|NCT00362648|1798535|FG003|Overall Study|Protocol Violation|2
841386|NCT00362648|1798532|FG000|Overall Study|Withdrawal by Subject|48
841387|NCT00362648|1798533|FG001|Overall Study|Withdrawal by Subject|42
841388|NCT00362648|1798534|FG002|Overall Study|Withdrawal by Subject|2
841389|NCT00362648|1798535|FG003|Overall Study|Withdrawal by Subject|6
841390|NCT00363051|1798569|FG000|Overall Study|Adminstrative problems|1
841391|NCT00363051|1798570|FG001|Overall Study|Adminstrative problems|1
841392|NCT00363051|1798569|FG000|Overall Study|Adverse Event|21
841393|NCT00363051|1798570|FG001|Overall Study|Adverse Event|12
841394|NCT00363051|1798569|FG000|Overall Study|New Cancer Therapy|2
841395|NCT00363051|1798570|FG001|Overall Study|New Cancer Therapy|1
841396|NCT00363051|1798569|FG000|Overall Study|Withdrawal by Subject|11
841397|NCT00363051|1798570|FG001|Overall Study|Withdrawal by Subject|3
841398|NCT00363051|1798569|FG000|Overall Study|Lost to Follow-up|0
841399|NCT00363051|1798570|FG001|Overall Study|Lost to Follow-up|1
841400|NCT00363051|1798569|FG000|Overall Study|Protocol Violation|0
841401|NCT00363051|1798570|FG001|Overall Study|Protocol Violation|2
841402|NCT00363051|1798569|FG000|Overall Study|Death|3
841403|NCT00363051|1798570|FG001|Overall Study|Death|2
841404|NCT00363129|1798589|FG000|Overall Study|Withdrawal by Subject|11
841405|NCT00363129|1798590|FG001|Overall Study|Withdrawal by Subject|18
841406|NCT00363129|1798589|FG000|Overall Study|Adverse Event|8
841407|NCT00363129|1798590|FG001|Overall Study|Adverse Event|3
841408|NCT00363129|1798589|FG000|Overall Study|Alternate Treatment|2
841409|NCT00363129|1798590|FG001|Overall Study|Alternate Treatment|4
841410|NCT00363129|1798589|FG000|Overall Study|Other Medical Problems|2
841411|NCT00363129|1798590|FG001|Overall Study|Other Medical Problems|4
841412|NCT00363129|1798589|FG000|Overall Study|Death|0
841413|NCT00363129|1798590|FG001|Overall Study|Death|1
841414|NCT00363129|1798589|FG000|Overall Study|Other Reasons|6
841415|NCT00363129|1798590|FG001|Overall Study|Other Reasons|3
841416|NCT00363142|1798598|FG000|Overall Study|Adverse Event|2
841417|NCT00363142|1798599|FG001|Overall Study|Adverse Event|0
841418|NCT00363142|1798598|FG000|Overall Study|Lack of Efficacy|0
841419|NCT00363142|1798599|FG001|Overall Study|Lack of Efficacy|1
841420|NCT00363142|1798598|FG000|Overall Study|Lost to Follow-up|1
841421|NCT00363142|1798599|FG001|Overall Study|Lost to Follow-up|0
841422|NCT00363142|1798598|FG000|Overall Study|Non-compliance|1
841423|NCT00363142|1798599|FG001|Overall Study|Non-compliance|1
841424|NCT00363142|1798598|FG000|Overall Study|Withdrawal by Subject|3
841425|NCT00363142|1798599|FG001|Overall Study|Withdrawal by Subject|1
841426|NCT00363246|1798617|FG000|Overall Study|Death|40
841427|NCT00363246|1798617|FG000|Overall Study|Withdrawal by Subject|19
841428|NCT00363246|1798617|FG000|Overall Study|Lost to Follow-up|14
841429|NCT00363246|1798617|FG000|Overall Study|Bad health|6
841430|NCT00363246|1798617|FG000|Overall Study|Stopped using wheelchair|11
841431|NCT00363246|1798617|FG000|Overall Study|Subject expressed security concerns|2
841432|NCT00363246|1798617|FG000|Overall Study|Eligibility changed due to Hospice move|5
841433|NCT00363298|1798624|FG000|First Study Week|Lack of Efficacy|6
841434|NCT00363298|1798625|FG001|First Study Week|Lack of Efficacy|5
841435|NCT00363298|1798624|FG000|4-week Study Continuation Phase|Lack of Efficacy|1
841436|NCT00363298|1798625|FG001|4-week Study Continuation Phase|Lack of Efficacy|0
841437|NCT00363311|1798634|FG000|Overall Study|Adverse Event|6
841438|NCT00363311|1798635|FG001|Overall Study|Adverse Event|4
841439|NCT00363311|1798634|FG000|Overall Study|Lost to Follow-up|3
841440|NCT00363311|1798635|FG001|Overall Study|Lost to Follow-up|0
841441|NCT00363311|1798634|FG000|Overall Study|Protocol Violation|1
841442|NCT00363311|1798635|FG001|Overall Study|Protocol Violation|2
841443|NCT00363311|1798634|FG000|Overall Study|Withdrawal by Subject|12
841444|NCT00363311|1798635|FG001|Overall Study|Withdrawal by Subject|6
841445|NCT00363311|1798634|FG000|Overall Study|Physician Decision|1
841446|NCT00363311|1798635|FG001|Overall Study|Physician Decision|1
841447|NCT00363311|1798634|FG000|Overall Study|Sponsor Terminated Study|2
841448|NCT00363311|1798635|FG001|Overall Study|Sponsor Terminated Study|2
841449|NCT00363311|1798634|FG000|Overall Study|Disease Progression|46
841450|NCT00363311|1798635|FG001|Overall Study|Disease Progression|26
841451|NCT00363311|1798634|FG000|Overall Study|Non-Compliance|1
841452|NCT00363311|1798635|FG001|Overall Study|Non-Compliance|1
841453|NCT00363311|1798634|FG000|Overall Study|Participant Refused Biopsy|1
841454|NCT00363311|1798635|FG001|Overall Study|Participant Refused Biopsy|0
841455|NCT00363311|1798634|FG000|Overall Study|Prostate Volume/PSA Doubled|1
841456|NCT00363311|1798635|FG001|Overall Study|Prostate Volume/PSA Doubled|0
841457|NCT00363311|1798634|FG000|Overall Study|Participant Opted for Treatment|1
841458|NCT00363311|1798635|FG001|Overall Study|Participant Opted for Treatment|0
841459|NCT00363311|1798634|FG000|Overall Study|Participant Moved to Another Country|1
841460|NCT00363311|1798635|FG001|Overall Study|Participant Moved to Another Country|0
841461|NCT00363311|1798634|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0
841462|NCT00363311|1798635|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1
841463|NCT00363311|1798634|FG000|Overall Study|Withdrawn per Instructions of Monitor|0
841464|NCT00363311|1798635|FG001|Overall Study|Withdrawn per Instructions of Monitor|1
841465|NCT00363311|1798634|FG000|Overall Study|Participant Moved to Louisiana|0
841466|NCT00363311|1798635|FG001|Overall Study|Participant Moved to Louisiana|1
841467|NCT00363415|1798643|FG000|Overall Study|Progressive Disease|196
841468|NCT00363415|1798644|FG001|Overall Study|Progressive Disease|107
841469|NCT00363415|1798643|FG000|Overall Study|Sponsor Decision|67
841470|NCT00363415|1798644|FG001|Overall Study|Sponsor Decision|31
841471|NCT00363415|1798643|FG000|Overall Study|Death|32
841472|NCT00363415|1798644|FG001|Overall Study|Death|29
841473|NCT00363415|1798643|FG000|Overall Study|Adverse Event|24
841474|NCT00363415|1798644|FG001|Overall Study|Adverse Event|15
841475|NCT00363415|1798643|FG000|Overall Study|Physician Decision|18
841476|NCT00363415|1798644|FG001|Overall Study|Physician Decision|35
841477|NCT00363415|1798643|FG000|Overall Study|Entry Criteria Not Met|11
841478|NCT00363415|1798644|FG001|Overall Study|Entry Criteria Not Met|10
841479|NCT00363415|1798643|FG000|Overall Study|Withdrawal by Subject|9
841480|NCT00363415|1798644|FG001|Overall Study|Withdrawal by Subject|15
841481|NCT00363415|1798643|FG000|Overall Study|Lost to Follow-up|3
841482|NCT00363415|1798644|FG001|Overall Study|Lost to Follow-up|3
841483|NCT00363415|1798643|FG000|Overall Study|Protocol Violation|1
841484|NCT00363415|1798644|FG001|Overall Study|Protocol Violation|4
841485|NCT00363467|1798650|FG000|Overall Study|Physician Decision|1
841486|NCT00363480|1798654|FG000|Overall Study|Criteria for treatment period not fulfil|1
841487|NCT00363480|1798654|FG000|Overall Study|Adverse Event|4
841488|NCT00363480|1798654|FG000|Overall Study|Lost to Follow-up|5
841489|NCT00363480|1798654|FG000|Overall Study|Withdrawal by Subject|5
841490|NCT00363480|1798654|FG000|Overall Study|Non-compliance of subject|1
841491|NCT00363480|1798654|FG000|Overall Study|Participant discontinued on its own|1
841492|NCT00363545|1798660|FG000|Overall Study|Serious Adverse Event|0
841493|NCT00363545|1798661|FG001|Overall Study|Serious Adverse Event|1
841494|NCT00363545|1798660|FG000|Overall Study|Withdrawal by Subject|12
841495|NCT00363545|1798661|FG001|Overall Study|Withdrawal by Subject|15
841496|NCT00363545|1798660|FG000|Overall Study|Migrated/moved from study area|3
841497|NCT00363545|1798661|FG001|Overall Study|Migrated/moved from study area|6
841498|NCT00363545|1798660|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14
841499|NCT00363545|1798661|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18
841500|NCT00363545|1798660|FG000|Overall Study|Lost to follow-up (complete vaccination)|14
841501|NCT00363545|1798661|FG001|Overall Study|Lost to follow-up (complete vaccination)|17
841502|NCT00363545|1798660|FG000|Overall Study|Others|1
841503|NCT00363545|1798661|FG001|Overall Study|Others|0
841504|NCT00363649|1798669|FG000|Overall Study|Withdrawal by Subject|1
841505|NCT00363649|1798670|FG001|Overall Study|Withdrawal by Subject|1
841506|NCT00363649|1798669|FG000|Overall Study|Adverse Event|6
841507|NCT00363649|1798670|FG001|Overall Study|Adverse Event|0
841508|NCT00363766|1798683|FG000|Overall Study|Progressive Disease|15
841509|NCT00363766|1798684|FG001|Overall Study|Progressive Disease|9
841510|NCT00363766|1798683|FG000|Overall Study|Adverse Event|10
841511|NCT00363766|1798684|FG001|Overall Study|Adverse Event|2
841512|NCT00363766|1798683|FG000|Overall Study|Disease Related Death|1
841513|NCT00363766|1798684|FG001|Overall Study|Disease Related Death|3
841514|NCT00363766|1798683|FG000|Overall Study|Not Disease Related Death|3
841515|NCT00363766|1798684|FG001|Overall Study|Not Disease Related Death|4
841516|NCT00363766|1798683|FG000|Overall Study|Withdrawal by Subject|2
841517|NCT00363766|1798684|FG001|Overall Study|Withdrawal by Subject|0
841518|NCT00363766|1798683|FG000|Overall Study|Physician Decision|1
841519|NCT00363766|1798684|FG001|Overall Study|Physician Decision|2
841520|NCT00363896|1798714|FG000|Overall Study|Withdrawal by Subject|29
841521|NCT00363896|1798715|FG001|Overall Study|Withdrawal by Subject|16
841522|NCT00363896|1798714|FG000|Overall Study|Adverse Event|24
841523|NCT00363896|1798715|FG001|Overall Study|Adverse Event|13
841524|NCT00363896|1798714|FG000|Overall Study|COPD exacerbation|13
841525|NCT00363896|1798715|FG001|Overall Study|COPD exacerbation|7
841526|NCT00363896|1798714|FG000|Overall Study|Lack of Efficacy|12
841527|NCT00363896|1798715|FG001|Overall Study|Lack of Efficacy|8
841528|NCT00363896|1798714|FG000|Overall Study|Protocol Violation|6
841529|NCT00363896|1798715|FG001|Overall Study|Protocol Violation|1
841530|NCT00363896|1798714|FG000|Overall Study|Lost to Follow-up|3
841531|NCT00363896|1798715|FG001|Overall Study|Lost to Follow-up|0
841532|NCT00363896|1798714|FG000|Overall Study|Non-fulfilment of entry criteria|1
841533|NCT00363896|1798715|FG001|Overall Study|Non-fulfilment of entry criteria|0
841534|NCT00363896|1798714|FG000|Overall Study|Other|1
841535|NCT00363896|1798715|FG001|Overall Study|Other|2
841536|NCT00364013|1798726|FG000|Overall Study|Ineligibility determined|4
841537|NCT00364013|1798727|FG001|Overall Study|Ineligibility determined|2
841538|NCT00364013|1798726|FG000|Overall Study|Adverse Event|4
841539|NCT00364013|1798727|FG001|Overall Study|Adverse Event|3
841540|NCT00364013|1798726|FG000|Overall Study|Withdrawal by Subject|13
841541|NCT00364013|1798727|FG001|Overall Study|Withdrawal by Subject|18
841542|NCT00364013|1798726|FG000|Overall Study|Physician Decision|3
841543|NCT00364013|1798727|FG001|Overall Study|Physician Decision|3
841544|NCT00364013|1798726|FG000|Overall Study|Lost to Follow-up|10
841545|NCT00364013|1798727|FG001|Overall Study|Lost to Follow-up|3
841546|NCT00364013|1798726|FG000|Overall Study|Protocol-specified criteria|6
841547|NCT00364013|1798727|FG001|Overall Study|Protocol-specified criteria|6
841548|NCT00364013|1798726|FG000|Overall Study|Other|41
841549|NCT00364013|1798727|FG001|Overall Study|Other|47
841550|NCT00364013|1798726|FG000|Overall Study|Ongoing|20
841551|NCT00364013|1798727|FG001|Overall Study|Ongoing|13
841552|NCT00364130|1798739|FG000|Intervention Period|Lost to Follow-up|4
841553|NCT00364130|1798740|FG001|Intervention Period|Lost to Follow-up|3
841554|NCT00364130|1798739|FG000|Intervention Period|Pregnancy|1
841555|NCT00364130|1798740|FG001|Intervention Period|Pregnancy|0
841556|NCT00364130|1798739|FG000|Intervention Period|Withdrawal by Subject|4
841557|NCT00364130|1798740|FG001|Intervention Period|Withdrawal by Subject|5
841558|NCT00364130|1798739|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5
841559|NCT00364130|1798740|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11
841560|NCT00364156|1798750|FG000|Overall Study|Withdrawal by Subject|73
841561|NCT00364156|1798751|FG001|Overall Study|Withdrawal by Subject|80
841562|NCT00364156|1798750|FG000|Overall Study|Protocol Violation|6
841563|NCT00364156|1798751|FG001|Overall Study|Protocol Violation|1
841564|NCT00364182|1798760|FG000|First Intervention|Secondary prophylaxis|1
841565|NCT00364182|1798761|FG001|First Intervention|Secondary prophylaxis|0
841566|NCT00364182|1798762|FG002|First Intervention|Secondary prophylaxis|0
841567|NCT00364182|1798760|FG000|First Intervention|Withdrawal by Subject|2
841568|NCT00364182|1798761|FG001|First Intervention|Withdrawal by Subject|0
841569|NCT00364182|1798762|FG002|First Intervention|Withdrawal by Subject|0
841570|NCT00364182|1798760|FG000|Second Intervention|non-compliance|0
841571|NCT00364182|1798761|FG001|Second Intervention|non-compliance|1
841572|NCT00364182|1798762|FG002|Second Intervention|non-compliance|1
841573|NCT00364182|1798760|FG000|Second Intervention|Protocol Violation|0
841574|NCT00364182|1798761|FG001|Second Intervention|Protocol Violation|1
841575|NCT00364182|1798762|FG002|Second Intervention|Protocol Violation|0
841576|NCT00364182|1798760|FG000|Second Intervention|Adverse Event|0
841577|NCT00364182|1798761|FG001|Second Intervention|Adverse Event|0
841578|NCT00364182|1798762|FG002|Second Intervention|Adverse Event|1
841579|NCT00364182|1798760|FG000|Third Intervention|non-compliance|0
841580|NCT00364182|1798761|FG001|Third Intervention|non-compliance|1
841581|NCT00364182|1798762|FG002|Third Intervention|non-compliance|0
841582|NCT00364182|1798760|FG000|Third Intervention|Lost to Follow-up|0
841583|NCT00364182|1798761|FG001|Third Intervention|Lost to Follow-up|0
841584|NCT00364182|1798762|FG002|Third Intervention|Lost to Follow-up|1
841585|NCT00364286|1798772|FG000|Overall Study|Withdrawal by Subject|1
841586|NCT00364286|1798772|FG000|Overall Study|Adverse Event|2
841587|NCT00364351|1798778|FG000|Overall Study|Adverse Event|90
841588|NCT00364351|1798779|FG001|Overall Study|Adverse Event|44
841589|NCT00364351|1798778|FG000|Overall Study|Condition under investigation worsened|469
841590|NCT00364351|1798779|FG001|Overall Study|Condition under investigation worsened|497
841591|NCT00364351|1798778|FG000|Overall Study|Prohibited concomitant medication|0
841592|NCT00364351|1798779|FG001|Overall Study|Prohibited concomitant medication|2
841593|NCT00364351|1798778|FG000|Overall Study|Lost to Follow-up|1
841594|NCT00364351|1798779|FG001|Overall Study|Lost to Follow-up|1
841595|NCT00364351|1798778|FG000|Overall Study|Withdrawal by Subject|30
841596|NCT00364351|1798779|FG001|Overall Study|Withdrawal by Subject|29
841597|NCT00364351|1798778|FG000|Overall Study|Incorrect enrollment|1
841598|NCT00364351|1798779|FG001|Overall Study|Incorrect enrollment|1
841599|NCT00364351|1798778|FG000|Overall Study|Sponsor decision|1
841600|NCT00364351|1798779|FG001|Overall Study|Sponsor decision|0
841601|NCT00364351|1798778|FG000|Overall Study|Poor treatment compliance|0
841602|NCT00364351|1798779|FG001|Overall Study|Poor treatment compliance|3
841603|NCT00364351|1798778|FG000|Overall Study|Investigator error|0
841604|NCT00364351|1798779|FG001|Overall Study|Investigator error|2
841605|NCT00364351|1798778|FG000|Overall Study|Patient could not travel to site|0
841606|NCT00364351|1798779|FG001|Overall Study|Patient could not travel to site|1
841607|NCT00364351|1798778|FG000|Overall Study|Randomised treatment not started|0
841608|NCT00364351|1798779|FG001|Overall Study|Randomised treatment not started|3
841609|NCT00364533|1798799|FG000|Overall Study|Adverse Event|8
841610|NCT00364533|1798800|FG001|Overall Study|Adverse Event|7
841611|NCT00364533|1798801|FG002|Overall Study|Adverse Event|15
841612|NCT00364533|1798802|FG003|Overall Study|Adverse Event|5
841613|NCT00364533|1798803|FG004|Overall Study|Adverse Event|2
841614|NCT00364533|1798799|FG000|Overall Study|Withdrawal by Subject|4
841615|NCT00364533|1798800|FG001|Overall Study|Withdrawal by Subject|8
841616|NCT00364533|1798801|FG002|Overall Study|Withdrawal by Subject|6
841617|NCT00364533|1798802|FG003|Overall Study|Withdrawal by Subject|6
841618|NCT00364533|1798803|FG004|Overall Study|Withdrawal by Subject|6
841619|NCT00364533|1798799|FG000|Overall Study|Lack of Efficacy|22
841620|NCT00364533|1798800|FG001|Overall Study|Lack of Efficacy|22
841621|NCT00364533|1798801|FG002|Overall Study|Lack of Efficacy|21
841622|NCT00364533|1798802|FG003|Overall Study|Lack of Efficacy|17
841623|NCT00364533|1798803|FG004|Overall Study|Lack of Efficacy|42
841624|NCT00364533|1798799|FG000|Overall Study|Subject discharged from hospital|4
841625|NCT00364533|1798800|FG001|Overall Study|Subject discharged from hospital|1
841626|NCT00364533|1798801|FG002|Overall Study|Subject discharged from hospital|2
841627|NCT00364533|1798802|FG003|Overall Study|Subject discharged from hospital|3
841628|NCT00364533|1798803|FG004|Overall Study|Subject discharged from hospital|1
841629|NCT00364533|1798799|FG000|Overall Study|Variations in drug compliance|2
841630|NCT00364533|1798800|FG001|Overall Study|Variations in drug compliance|1
841631|NCT00364533|1798801|FG002|Overall Study|Variations in drug compliance|1
841632|NCT00364533|1798802|FG003|Overall Study|Variations in drug compliance|0
841633|NCT00364533|1798803|FG004|Overall Study|Variations in drug compliance|0
841634|NCT00364533|1798799|FG000|Overall Study|Non-compliance|1
841635|NCT00364533|1798800|FG001|Overall Study|Non-compliance|0
841636|NCT00364533|1798801|FG002|Overall Study|Non-compliance|0
841637|NCT00364533|1798802|FG003|Overall Study|Non-compliance|0
841638|NCT00364533|1798803|FG004|Overall Study|Non-compliance|0
841639|NCT00364533|1798799|FG000|Overall Study|Protocol Violation|1
841640|NCT00364533|1798800|FG001|Overall Study|Protocol Violation|1
841641|NCT00364533|1798801|FG002|Overall Study|Protocol Violation|0
841642|NCT00364533|1798802|FG003|Overall Study|Protocol Violation|0
841643|NCT00364533|1798803|FG004|Overall Study|Protocol Violation|0
841644|NCT00364611|1798817|FG000|Overall Study|Did not receive study medication|0
841645|NCT00364611|1798818|FG001|Overall Study|Did not receive study medication|1
841646|NCT00364611|1798817|FG000|Overall Study|Adverse Event|7
841647|NCT00364611|1798818|FG001|Overall Study|Adverse Event|4
841648|NCT00364611|1798817|FG000|Overall Study|Participant's Request|3
841649|NCT00364611|1798818|FG001|Overall Study|Participant's Request|4
841650|NCT00364611|1798817|FG000|Overall Study|Disease Progression|38
841651|NCT00364611|1798818|FG001|Overall Study|Disease Progression|8
841652|NCT00364611|1798817|FG000|Overall Study|Investigator decision|2
841653|NCT00364611|1798818|FG001|Overall Study|Investigator decision|2
841654|NCT00364611|1798817|FG000|Overall Study|Found Ineligible|1
841655|NCT00364611|1798818|FG001|Overall Study|Found Ineligible|0
841656|NCT00364611|1798817|FG000|Overall Study|Presumed CR on Study|0
841657|NCT00364611|1798818|FG001|Overall Study|Presumed CR on Study|1
841658|NCT00364611|1798817|FG000|Overall Study|Receiving Liver Ablation|0
841659|NCT00364611|1798818|FG001|Overall Study|Receiving Liver Ablation|1
841660|NCT00364793|1798828|FG000|Overall Study|Adverse Event|2
841661|NCT00364793|1798829|FG001|Overall Study|Adverse Event|0
841662|NCT00364793|1798830|FG002|Overall Study|Adverse Event|0
841663|NCT00364793|1798831|FG003|Overall Study|Adverse Event|0
841664|NCT00364793|1798828|FG000|Overall Study|Death|1
841665|NCT00364793|1798829|FG001|Overall Study|Death|0
841666|NCT00364793|1798830|FG002|Overall Study|Death|1
841667|NCT00364793|1798831|FG003|Overall Study|Death|0
841668|NCT00364793|1798828|FG000|Overall Study|Lack of Efficacy|3
841669|NCT00364793|1798829|FG001|Overall Study|Lack of Efficacy|3
841670|NCT00364793|1798830|FG002|Overall Study|Lack of Efficacy|1
841671|NCT00364793|1798831|FG003|Overall Study|Lack of Efficacy|1
841672|NCT00364793|1798828|FG000|Overall Study|Lost to Follow-up|1
841673|NCT00364793|1798829|FG001|Overall Study|Lost to Follow-up|0
841674|NCT00364793|1798830|FG002|Overall Study|Lost to Follow-up|2
841675|NCT00364793|1798831|FG003|Overall Study|Lost to Follow-up|0
841676|NCT00364793|1798828|FG000|Overall Study|Poor or non-compliance|1
841677|NCT00364793|1798829|FG001|Overall Study|Poor or non-compliance|1
841678|NCT00364793|1798830|FG002|Overall Study|Poor or non-compliance|0
841679|NCT00364793|1798831|FG003|Overall Study|Poor or non-compliance|1
841680|NCT00364793|1798828|FG000|Overall Study|No longer meets criteria|0
841681|NCT00364793|1798829|FG001|Overall Study|No longer meets criteria|0
841682|NCT00364793|1798830|FG002|Overall Study|No longer meets criteria|0
841683|NCT00364793|1798831|FG003|Overall Study|No longer meets criteria|1
841684|NCT00364793|1798828|FG000|Overall Study|Withdrawal by Subject|0
841685|NCT00364793|1798829|FG001|Overall Study|Withdrawal by Subject|1
841686|NCT00364793|1798830|FG002|Overall Study|Withdrawal by Subject|0
841687|NCT00364793|1798831|FG003|Overall Study|Withdrawal by Subject|0
841688|NCT00364832|1798857|FG000|Core Period|Early Withdrawals|2
841689|NCT00364832|1798858|FG001|Core Period|Early Withdrawals|2
841690|NCT00364832|1798859|FG002|Core Period|Early Withdrawals|1
841691|NCT00364832|1798860|FG003|Core Period|Early Withdrawals|1
841692|NCT00364832|1798861|FG004|Core Period|Early Withdrawals|0
841693|NCT00364832|1798862|FG005|Core Period|Early Withdrawals|0
841694|NCT00364832|1798863|FG006|Core Period|Early Withdrawals|4
841695|NCT00364832|1798864|FG007|Core Period|Early Withdrawals|1
841696|NCT00364832|1798865|FG008|Core Period|Early Withdrawals|0
841697|NCT00364832|1798866|FG009|Core Period|Early Withdrawals|0
841698|NCT00364832|1798867|FG010|Core Period|Early Withdrawals|0
841699|NCT00364832|1798868|FG011|Core Period|Early Withdrawals|0
841700|NCT00364832|1798857|FG000|Extension Year 1|Early Withdrawals|0
841701|NCT00364832|1798858|FG001|Extension Year 1|Early Withdrawals|0
841702|NCT00364832|1798859|FG002|Extension Year 1|Early Withdrawals|0
841703|NCT00364832|1798860|FG003|Extension Year 1|Early Withdrawals|0
841704|NCT00364832|1798861|FG004|Extension Year 1|Early Withdrawals|0
841705|NCT00364832|1798862|FG005|Extension Year 1|Early Withdrawals|0
841706|NCT00364832|1798863|FG006|Extension Year 1|Early Withdrawals|0
841707|NCT00364832|1798864|FG007|Extension Year 1|Early Withdrawals|0
841708|NCT00364832|1798865|FG008|Extension Year 1|Early Withdrawals|0
841709|NCT00364832|1798866|FG009|Extension Year 1|Early Withdrawals|4
841710|NCT00364832|1798867|FG010|Extension Year 1|Early Withdrawals|2
841711|NCT00364832|1798868|FG011|Extension Year 1|Early Withdrawals|10
841712|NCT00364832|1798857|FG000|Extension Year 2|Early Withdrawals|0
841713|NCT00364832|1798858|FG001|Extension Year 2|Early Withdrawals|0
841714|NCT00364832|1798859|FG002|Extension Year 2|Early Withdrawals|0
841715|NCT00364832|1798860|FG003|Extension Year 2|Early Withdrawals|0
841716|NCT00364832|1798861|FG004|Extension Year 2|Early Withdrawals|0
841717|NCT00364832|1798862|FG005|Extension Year 2|Early Withdrawals|0
841718|NCT00364832|1798863|FG006|Extension Year 2|Early Withdrawals|0
841719|NCT00364832|1798864|FG007|Extension Year 2|Early Withdrawals|0
841720|NCT00364832|1798865|FG008|Extension Year 2|Early Withdrawals|0
841721|NCT00364832|1798866|FG009|Extension Year 2|Early Withdrawals|5
841722|NCT00364832|1798867|FG010|Extension Year 2|Early Withdrawals|5
841723|NCT00364832|1798868|FG011|Extension Year 2|Early Withdrawals|3
841724|NCT00364845|1798887|FG000|Overall Study|Adverse Event|1
841725|NCT00364845|1798888|FG001|Overall Study|Adverse Event|0
841726|NCT00364845|1798887|FG000|Overall Study|Withdrawal by Subject|2
841727|NCT00364845|1798888|FG001|Overall Study|Withdrawal by Subject|1
841728|NCT00364845|1798887|FG000|Overall Study|Physician Decision|8
841729|NCT00364845|1798888|FG001|Overall Study|Physician Decision|8
841730|NCT00364845|1798887|FG000|Overall Study|Lost to Follow-up|0
841731|NCT00364845|1798888|FG001|Overall Study|Lost to Follow-up|1
841732|NCT00364845|1798887|FG000|Overall Study|Death|0
841733|NCT00364845|1798888|FG001|Overall Study|Death|1
841734|NCT00364858|1798896|FG000|Overall Study|Adverse Event|1
841735|NCT00364858|1798897|FG001|Overall Study|Adverse Event|5
841736|NCT00364858|1798896|FG000|Overall Study|Withdrawal by Subject|1
841737|NCT00364858|1798897|FG001|Overall Study|Withdrawal by Subject|1
841738|NCT00364858|1798896|FG000|Overall Study|Pregnancy|1
841739|NCT00364858|1798897|FG001|Overall Study|Pregnancy|1
841740|NCT00364858|1798896|FG000|Overall Study|Clinical failure|2
841741|NCT00364858|1798897|FG001|Overall Study|Clinical failure|13
841742|NCT00364858|1798896|FG000|Overall Study|Discontinuation at baseline|1
841743|NCT00364858|1798897|FG001|Overall Study|Discontinuation at baseline|0
841744|NCT00364858|1798896|FG000|Overall Study|Non-compliant|1
841745|NCT00364858|1798897|FG001|Overall Study|Non-compliant|0
841746|NCT00364858|1798896|FG000|Overall Study|Return to Q2 regimen|0
841747|NCT00364858|1798897|FG001|Overall Study|Return to Q2 regimen|1
841748|NCT00364858|1798896|FG000|Overall Study|Clinical baseline issue|0
841749|NCT00364858|1798897|FG001|Overall Study|Clinical baseline issue|1
841750|NCT00364923|1798904|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
841751|NCT00364923|1798904|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
841752|NCT00365105|1798923|FG000|Overall Study|Protocol Violation|5
841753|NCT00365105|1798924|FG001|Overall Study|Protocol Violation|8
841754|NCT00365300|1798957|FG000|Open-label Phase|Adverse Event|4
841755|NCT00365300|1798958|FG001|Open-label Phase|Adverse Event|0
841756|NCT00365300|1798957|FG000|Open-label Phase|Failed to Return|1
841757|NCT00365300|1798958|FG001|Open-label Phase|Failed to Return|0
841758|NCT00365300|1798957|FG000|Open-label Phase|Physician Decision|1
841759|NCT00365300|1798958|FG001|Open-label Phase|Physician Decision|0
841760|NCT00365300|1798957|FG000|Open-label Phase|Noncompliance|9
841761|NCT00365300|1798958|FG001|Open-label Phase|Noncompliance|0
841762|NCT00365300|1798957|FG000|Open-label Phase|Parent/Legal Guardian Request|4
841763|NCT00365300|1798958|FG001|Open-label Phase|Parent/Legal Guardian Request|0
841764|NCT00365300|1798957|FG000|Open-label Phase|Protocol Violation|1
841765|NCT00365300|1798958|FG001|Open-label Phase|Protocol Violation|0
841766|NCT00365300|1798957|FG000|Open-label Phase|Lack of Efficacy|1
841767|NCT00365300|1798958|FG001|Open-label Phase|Lack of Efficacy|0
841768|NCT00365300|1798957|FG000|Open-label Phase|Patient skipped open label phase|1
841769|NCT00365300|1798958|FG001|Open-label Phase|Patient skipped open label phase|0
841770|NCT00365300|1798957|FG000|Double-blind Phase|Failed to return|1
841771|NCT00365300|1798958|FG001|Double-blind Phase|Failed to return|0
841772|NCT00365300|1798957|FG000|Double-blind Phase|Noncompliance|1
841773|NCT00365300|1798958|FG001|Double-blind Phase|Noncompliance|1
841774|NCT00365300|1798957|FG000|Double-blind Phase|Withdrawal by Subject|0
841775|NCT00365300|1798958|FG001|Double-blind Phase|Withdrawal by Subject|1
841776|NCT00365300|1798957|FG000|Double-blind Phase|Protocol Violation|3
841777|NCT00365300|1798958|FG001|Double-blind Phase|Protocol Violation|1
841778|NCT00365300|1798957|FG000|Double-blind Phase|Lack of Efficacy|6
841779|NCT00365300|1798958|FG001|Double-blind Phase|Lack of Efficacy|6
841780|NCT00365352|1798970|FG000|Overall Study|Adverse Event|6
841781|NCT00365352|1798971|FG001|Overall Study|Adverse Event|7
841782|NCT00365352|1798972|FG002|Overall Study|Adverse Event|8
841783|NCT00365352|1798970|FG000|Overall Study|Participant Withdrew Consent|8
841784|NCT00365352|1798971|FG001|Overall Study|Participant Withdrew Consent|3
841785|NCT00365352|1798972|FG002|Overall Study|Participant Withdrew Consent|4
841786|NCT00365352|1798970|FG000|Overall Study|Lack of Efficacy|3
841787|NCT00365352|1798971|FG001|Overall Study|Lack of Efficacy|0
841788|NCT00365352|1798972|FG002|Overall Study|Lack of Efficacy|0
841789|NCT00365352|1798970|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
841790|NCT00365352|1798971|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
841791|NCT00365352|1798972|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
841792|NCT00365352|1798970|FG000|Overall Study|Non-Compliance (after Randomization)|1
841793|NCT00365352|1798971|FG001|Overall Study|Non-Compliance (after Randomization)|0
841794|NCT00365352|1798972|FG002|Overall Study|Non-Compliance (after Randomization)|1
841795|NCT00365352|1798970|FG000|Overall Study|Lost to Follow-up|1
841796|NCT00365352|1798971|FG001|Overall Study|Lost to Follow-up|1
841797|NCT00365352|1798972|FG002|Overall Study|Lost to Follow-up|0
841798|NCT00365352|1798970|FG000|Overall Study|Withdrawal of Participant by Sponsor|1
841799|NCT00365352|1798971|FG001|Overall Study|Withdrawal of Participant by Sponsor|0
841800|NCT00365352|1798972|FG002|Overall Study|Withdrawal of Participant by Sponsor|0
841801|NCT00365365|1798986|FG000|Overall Study|Randomized but not treated|0
841802|NCT00365365|1798987|FG001|Overall Study|Randomized but not treated|2
841803|NCT00365365|1798988|FG002|Overall Study|Randomized but not treated|0
841804|NCT00365365|1798986|FG000|Overall Study|Poor compliance to protocol|0
841805|NCT00365365|1798987|FG001|Overall Study|Poor compliance to protocol|1
841806|NCT00365365|1798988|FG002|Overall Study|Poor compliance to protocol|0
841807|NCT00365365|1798986|FG000|Overall Study|Lost to Follow-up|3
841808|NCT00365365|1798987|FG001|Overall Study|Lost to Follow-up|3
841809|NCT00365365|1798988|FG002|Overall Study|Lost to Follow-up|3
841810|NCT00365365|1798986|FG000|Overall Study|Death|1
841811|NCT00365365|1798987|FG001|Overall Study|Death|3
841812|NCT00365365|1798988|FG002|Overall Study|Death|0
841813|NCT00365365|1798986|FG000|Overall Study|Subject's request|11
841814|NCT00365365|1798987|FG001|Overall Study|Subject's request|13
841815|NCT00365365|1798988|FG002|Overall Study|Subject's request|1
841816|NCT00365365|1798986|FG000|Overall Study|Disease progression/relapse|9
841817|NCT00365365|1798987|FG001|Overall Study|Disease progression/relapse|6
841818|NCT00365365|1798988|FG002|Overall Study|Disease progression/relapse|7
841819|NCT00365365|1798986|FG000|Overall Study|Adverse Event|6
841820|NCT00365365|1798987|FG001|Overall Study|Adverse Event|6
841821|NCT00365365|1798988|FG002|Overall Study|Adverse Event|3
841822|NCT00365365|1798986|FG000|Overall Study|Moved|2
841823|NCT00365365|1798987|FG001|Overall Study|Moved|0
841824|NCT00365365|1798988|FG002|Overall Study|Moved|0
841825|NCT00365365|1798986|FG000|Overall Study|New cancer|1
841826|NCT00365365|1798987|FG001|Overall Study|New cancer|0
841827|NCT00365365|1798988|FG002|Overall Study|New cancer|0
841828|NCT00365365|1798986|FG000|Overall Study|Withdrew consent|1
841829|NCT00365365|1798987|FG001|Overall Study|Withdrew consent|1
841830|NCT00365365|1798988|FG002|Overall Study|Withdrew consent|0
841831|NCT00365365|1798986|FG000|Overall Study|Second malignancy|0
841832|NCT00365365|1798987|FG001|Overall Study|Second malignancy|1
841833|NCT00365365|1798988|FG002|Overall Study|Second malignancy|0
841834|NCT00365365|1798986|FG000|Overall Study|Patient/physician decision|0
841835|NCT00365365|1798987|FG001|Overall Study|Patient/physician decision|0
841836|NCT00365365|1798988|FG002|Overall Study|Patient/physician decision|1
841837|NCT00365378|1798998|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
841838|NCT00365378|1798999|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
841839|NCT00365378|1799000|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
841840|NCT00365378|1798998|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4
841841|NCT00365378|1798999|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5
841842|NCT00365378|1799000|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0
841843|NCT00365378|1798998|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
841844|NCT00365378|1798999|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
841845|NCT00365378|1799000|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
841846|NCT00365378|1798998|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19
841847|NCT00365378|1798999|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14
841848|NCT00365378|1799000|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0
841849|NCT00365378|1798998|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22
841850|NCT00365378|1798999|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13
841851|NCT00365378|1799000|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0
841852|NCT00365378|1798998|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
841853|NCT00365378|1798999|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
841854|NCT00365378|1799000|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
841855|NCT00365378|1798998|FG000|Vaccination (Day 1 to Month 7)|Other|17
841856|NCT00365378|1798999|FG001|Vaccination (Day 1 to Month 7)|Other|9
841857|NCT00365378|1799000|FG002|Vaccination (Day 1 to Month 7)|Other|0
841858|NCT00365378|1798998|FG000|Follow-up (Month 7 Though Month 48)|Moved|6
841859|NCT00365378|1798999|FG001|Follow-up (Month 7 Though Month 48)|Moved|5
841860|NCT00365378|1799000|FG002|Follow-up (Month 7 Though Month 48)|Moved|0
841861|NCT00365378|1798998|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
841862|NCT00365378|1798999|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
841863|NCT00365378|1799000|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
841864|NCT00365378|1798998|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0
841865|NCT00365378|1798999|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1
841866|NCT00365378|1799000|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0
841867|NCT00365378|1798998|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
841868|NCT00365378|1798999|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
841869|NCT00365378|1799000|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
841870|NCT00365378|1798998|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
841871|NCT00365378|1798999|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
841872|NCT00365378|1799000|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
841873|NCT00365378|1798998|FG000|Follow-up (Month 7 Though Month 48)|Other|11
841874|NCT00365378|1798999|FG001|Follow-up (Month 7 Though Month 48)|Other|21
841875|NCT00365378|1799000|FG002|Follow-up (Month 7 Though Month 48)|Other|0
841876|NCT00365378|1798998|FG000|Extension|Adverse Event|0
841877|NCT00365378|1798999|FG001|Extension|Adverse Event|0
841878|NCT00365378|1799000|FG002|Extension|Adverse Event|1
841879|NCT00365378|1798998|FG000|Extension|Moved|0
841880|NCT00365378|1798999|FG001|Extension|Moved|0
841881|NCT00365378|1799000|FG002|Extension|Moved|8
841882|NCT00365378|1798998|FG000|Extension|Lost to Follow-up|0
841883|NCT00365378|1798999|FG001|Extension|Lost to Follow-up|0
841884|NCT00365378|1799000|FG002|Extension|Lost to Follow-up|57
841885|NCT00365378|1798998|FG000|Extension|Protocol Violation|0
841886|NCT00365378|1798999|FG001|Extension|Protocol Violation|0
841887|NCT00365378|1799000|FG002|Extension|Protocol Violation|2
841888|NCT00365378|1798998|FG000|Extension|Withdrawal by Subject|0
841889|NCT00365378|1798999|FG001|Extension|Withdrawal by Subject|0
841890|NCT00365378|1799000|FG002|Extension|Withdrawal by Subject|98
841891|NCT00365378|1798998|FG000|Extension|Other|0
841892|NCT00365378|1798999|FG001|Extension|Other|0
841893|NCT00365378|1799000|FG002|Extension|Other|31
841894|NCT00365456|1799016|FG000|Trial Period I (12 Months)|Adverse Event|84
841895|NCT00365456|1799017|FG001|Trial Period I (12 Months)|Adverse Event|0
841896|NCT00365456|1799016|FG000|Trial Period I (12 Months)|Non-compliance|3
841897|NCT00365456|1799017|FG001|Trial Period I (12 Months)|Non-compliance|0
841898|NCT00365456|1799016|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27
841899|NCT00365456|1799017|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0
841900|NCT00365456|1799016|FG000|Trial Period I (12 Months)|Other|11
841901|NCT00365456|1799017|FG001|Trial Period I (12 Months)|Other|0
841902|NCT00365456|1799016|FG000|Trial Period II (12 Months)|Adverse Event|0
841903|NCT00365456|1799017|FG001|Trial Period II (12 Months)|Adverse Event|6
841904|NCT00365456|1799016|FG000|Trial Period II (12 Months)|Non-compliance|0
841905|NCT00365456|1799017|FG001|Trial Period II (12 Months)|Non-compliance|2
841906|NCT00365456|1799016|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0
841907|NCT00365456|1799017|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5
841908|NCT00365456|1799016|FG000|Trial Period II (12 Months)|Other|0
841909|NCT00365456|1799017|FG001|Trial Period II (12 Months)|Other|1
841910|NCT00365456|1799016|FG000|Trial Period III (12 Months)|Adverse Event|13
841911|NCT00365456|1799017|FG001|Trial Period III (12 Months)|Adverse Event|3
841912|NCT00365456|1799016|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4
841913|NCT00365456|1799017|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1
841914|NCT00365456|1799016|FG000|Trial Period III (12 Months)|Other|1
841915|NCT00365456|1799017|FG001|Trial Period III (12 Months)|Other|1
841916|NCT00365508|1799025|FG000|Overall Study|Lost to Follow-up|139
841917|NCT00365508|1799026|FG001|Overall Study|Lost to Follow-up|154
841918|NCT00365547|1799032|FG000|Overall Study|Insurance did not cover Avastin|1
841919|NCT00365547|1799032|FG000|Overall Study|Screen failure|1
841920|NCT00365547|1799032|FG000|Overall Study|Withdrawal by Subject|1
841921|NCT00365716|1799048|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
841922|NCT00365716|1799049|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
841923|NCT00365716|1799050|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
841924|NCT00365716|1799051|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
841925|NCT00365716|1799052|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
841926|NCT00365716|1799053|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
841927|NCT00365716|1799054|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
841928|NCT00365716|1799048|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0
841929|NCT00365716|1799049|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2
841930|NCT00365716|1799050|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0
841931|NCT00365716|1799051|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0
841932|NCT00365716|1799052|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1
841933|NCT00365716|1799053|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0
841934|NCT00365716|1799054|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0
841935|NCT00365716|1799048|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
841936|NCT00365716|1799049|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
841937|NCT00365716|1799050|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
841938|NCT00365716|1799051|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
841939|NCT00365716|1799052|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
841940|NCT00365716|1799053|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
841941|NCT00365716|1799054|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
841942|NCT00365716|1799048|FG000|Base Study (Day 1 to Month 7)|Other|0
841943|NCT00365716|1799049|FG001|Base Study (Day 1 to Month 7)|Other|1
841944|NCT00365716|1799050|FG002|Base Study (Day 1 to Month 7)|Other|0
841945|NCT00365716|1799051|FG003|Base Study (Day 1 to Month 7)|Other|0
841946|NCT00365716|1799052|FG004|Base Study (Day 1 to Month 7)|Other|0
841947|NCT00365716|1799053|FG005|Base Study (Day 1 to Month 7)|Other|0
841948|NCT00365716|1799054|FG006|Base Study (Day 1 to Month 7)|Other|0
841949|NCT00365716|1799048|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3
841950|NCT00365716|1799049|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2
841951|NCT00365716|1799050|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3
841952|NCT00365716|1799051|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1
841953|NCT00365716|1799052|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1
841954|NCT00365716|1799053|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0
841955|NCT00365716|1799054|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0
841956|NCT00365716|1799048|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1
841957|NCT00365716|1799049|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2
841958|NCT00365716|1799050|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0
841959|NCT00365716|1799051|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1
841960|NCT00365716|1799052|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2
841961|NCT00365716|1799053|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0
841962|NCT00365716|1799054|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0
841963|NCT00365716|1799048|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
841964|NCT00365716|1799049|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
841965|NCT00365716|1799050|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
841966|NCT00365716|1799051|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
841967|NCT00365716|1799052|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
841968|NCT00365716|1799053|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
841969|NCT00365716|1799054|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
841970|NCT00365716|1799048|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
841971|NCT00365716|1799049|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
841972|NCT00365716|1799050|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
841973|NCT00365716|1799051|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
841974|NCT00365716|1799052|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
841975|NCT00365716|1799053|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
841976|NCT00365716|1799054|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
841977|NCT00365716|1799048|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
841978|NCT00365716|1799049|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
841979|NCT00365716|1799050|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
841980|NCT00365716|1799051|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
841981|NCT00365716|1799052|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
841982|NCT00365716|1799053|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
841983|NCT00365716|1799054|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
841984|NCT00365716|1799048|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
841985|NCT00365716|1799049|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
841986|NCT00365716|1799050|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
841987|NCT00365716|1799051|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
841988|NCT00365716|1799052|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
841989|NCT00365716|1799053|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
841990|NCT00365716|1799054|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
841991|NCT00365716|1799048|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2
841992|NCT00365716|1799049|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0
841993|NCT00365716|1799050|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0
841994|NCT00365716|1799051|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0
841995|NCT00365716|1799052|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1
841996|NCT00365716|1799053|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0
841997|NCT00365716|1799054|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0
841998|NCT00365716|1799048|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
841999|NCT00365716|1799049|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
842000|NCT00365716|1799050|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
842001|NCT00365716|1799051|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
842002|NCT00365716|1799052|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
842003|NCT00365716|1799053|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
842004|NCT00365716|1799054|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
842005|NCT00365716|1799048|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
842006|NCT00365716|1799049|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
842007|NCT00365716|1799050|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
842008|NCT00365716|1799051|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
842009|NCT00365716|1799052|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
842010|NCT00365716|1799053|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
842011|NCT00365716|1799054|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
842012|NCT00365716|1799048|FG000|Extension 1|Lost to Follow-up|0
842013|NCT00365716|1799049|FG001|Extension 1|Lost to Follow-up|0
842014|NCT00365716|1799050|FG002|Extension 1|Lost to Follow-up|0
842015|NCT00365716|1799051|FG003|Extension 1|Lost to Follow-up|0
842016|NCT00365716|1799052|FG004|Extension 1|Lost to Follow-up|0
842017|NCT00365716|1799053|FG005|Extension 1|Lost to Follow-up|1
842018|NCT00365716|1799054|FG006|Extension 1|Lost to Follow-up|0
842019|NCT00365716|1799048|FG000|Extension 1|Other|0
842020|NCT00365716|1799049|FG001|Extension 1|Other|0
842021|NCT00365716|1799050|FG002|Extension 1|Other|0
842022|NCT00365716|1799051|FG003|Extension 1|Other|0
842023|NCT00365716|1799052|FG004|Extension 1|Other|0
842024|NCT00365716|1799053|FG005|Extension 1|Other|9
842025|NCT00365716|1799054|FG006|Extension 1|Other|0
842026|NCT00365716|1799048|FG000|Extension 1|Moved|0
842027|NCT00365716|1799049|FG001|Extension 1|Moved|0
842028|NCT00365716|1799050|FG002|Extension 1|Moved|0
842029|NCT00365716|1799051|FG003|Extension 1|Moved|0
842030|NCT00365716|1799052|FG004|Extension 1|Moved|0
842031|NCT00365716|1799053|FG005|Extension 1|Moved|4
842032|NCT00365716|1799054|FG006|Extension 1|Moved|0
842033|NCT00365716|1799048|FG000|Extension 1|Withdrawal by Subject|0
842034|NCT00365716|1799049|FG001|Extension 1|Withdrawal by Subject|0
842035|NCT00365716|1799050|FG002|Extension 1|Withdrawal by Subject|0
842036|NCT00365716|1799051|FG003|Extension 1|Withdrawal by Subject|0
842037|NCT00365716|1799052|FG004|Extension 1|Withdrawal by Subject|0
842038|NCT00365716|1799053|FG005|Extension 1|Withdrawal by Subject|3
842039|NCT00365716|1799054|FG006|Extension 1|Withdrawal by Subject|0
842040|NCT00365716|1799048|FG000|Extension 1|Pregnancy|0
842041|NCT00365716|1799049|FG001|Extension 1|Pregnancy|0
842042|NCT00365716|1799050|FG002|Extension 1|Pregnancy|0
842043|NCT00365716|1799051|FG003|Extension 1|Pregnancy|0
842044|NCT00365716|1799052|FG004|Extension 1|Pregnancy|0
842045|NCT00365716|1799053|FG005|Extension 1|Pregnancy|4
842046|NCT00365716|1799054|FG006|Extension 1|Pregnancy|0
842047|NCT00365716|1799048|FG000|Extension 1|Protocol Violation|0
842048|NCT00365716|1799049|FG001|Extension 1|Protocol Violation|0
842049|NCT00365716|1799050|FG002|Extension 1|Protocol Violation|0
842050|NCT00365716|1799051|FG003|Extension 1|Protocol Violation|0
842051|NCT00365716|1799052|FG004|Extension 1|Protocol Violation|0
842052|NCT00365716|1799053|FG005|Extension 1|Protocol Violation|1
842053|NCT00365716|1799054|FG006|Extension 1|Protocol Violation|0
842054|NCT00365716|1799048|FG000|Extension 2|Lost to Follow-up|0
842055|NCT00365716|1799049|FG001|Extension 2|Lost to Follow-up|0
842056|NCT00365716|1799050|FG002|Extension 2|Lost to Follow-up|0
842057|NCT00365716|1799051|FG003|Extension 2|Lost to Follow-up|0
842058|NCT00365716|1799052|FG004|Extension 2|Lost to Follow-up|0
842059|NCT00365716|1799053|FG005|Extension 2|Lost to Follow-up|0
842060|NCT00365716|1799054|FG006|Extension 2|Lost to Follow-up|2
842061|NCT00365716|1799048|FG000|Extension 2|Other|0
842062|NCT00365716|1799049|FG001|Extension 2|Other|0
842063|NCT00365716|1799050|FG002|Extension 2|Other|0
842064|NCT00365716|1799051|FG003|Extension 2|Other|0
842065|NCT00365716|1799052|FG004|Extension 2|Other|0
842066|NCT00365716|1799053|FG005|Extension 2|Other|0
842067|NCT00365716|1799054|FG006|Extension 2|Other|3
842068|NCT00365716|1799048|FG000|Extension 2|Withdrawal by Subject|0
842069|NCT00365716|1799049|FG001|Extension 2|Withdrawal by Subject|0
842070|NCT00365716|1799050|FG002|Extension 2|Withdrawal by Subject|0
842071|NCT00365716|1799051|FG003|Extension 2|Withdrawal by Subject|0
842072|NCT00365716|1799052|FG004|Extension 2|Withdrawal by Subject|0
842073|NCT00365716|1799053|FG005|Extension 2|Withdrawal by Subject|0
842074|NCT00365716|1799054|FG006|Extension 2|Withdrawal by Subject|5
842075|NCT00365794|1799077|FG000|Overall Study|Withdrawal by Subject|2
842076|NCT00365846|1799082|FG000|Overall Study|Lost to Follow-up|1
842077|NCT00365976|1799117|FG000|Overall Study|Withdrawal by Subject|1
842078|NCT00365976|1799118|FG001|Overall Study|Withdrawal by Subject|5
842079|NCT00365989|1799124|FG000|Overall Study|Withdrawal by Subject|1
842080|NCT00365989|1799124|FG000|Overall Study|Non-compliance|1
842081|NCT00366249|1799146|FG000|Overall Study|Adverse Event|53
842082|NCT00366249|1799147|FG001|Overall Study|Adverse Event|28
842083|NCT00366249|1799146|FG000|Overall Study|Death|0
842084|NCT00366249|1799147|FG001|Overall Study|Death|1
842085|NCT00366249|1799146|FG000|Overall Study|Physician Decision|5
842086|NCT00366249|1799147|FG001|Overall Study|Physician Decision|2
842087|NCT00366249|1799146|FG000|Overall Study|Lost to Follow-up|2
842088|NCT00366249|1799147|FG001|Overall Study|Lost to Follow-up|0
842089|NCT00366249|1799146|FG000|Overall Study|Protocol Violation|1
842090|NCT00366249|1799147|FG001|Overall Study|Protocol Violation|2
842091|NCT00366249|1799146|FG000|Overall Study|Withdrawal by Subject|18
842092|NCT00366249|1799147|FG001|Overall Study|Withdrawal by Subject|4
842093|NCT00366249|1799146|FG000|Overall Study|Lack of Efficacy|21
842094|NCT00366249|1799147|FG001|Overall Study|Lack of Efficacy|21
842095|NCT00366249|1799146|FG000|Overall Study|Most due to osteomylitis status|31
842096|NCT00366249|1799147|FG001|Overall Study|Most due to osteomylitis status|20
842097|NCT00366301|1799161|FG000|Overall Study|Lost to Follow-up|4
842098|NCT00366301|1799162|FG001|Overall Study|Lost to Follow-up|4
842099|NCT00366301|1799163|FG002|Overall Study|Lost to Follow-up|3
842100|NCT00366301|1799164|FG003|Overall Study|Lost to Follow-up|7
842101|NCT00366301|1799161|FG000|Overall Study|Withdrawal by Subject|4
842102|NCT00366301|1799162|FG001|Overall Study|Withdrawal by Subject|2
842103|NCT00366301|1799163|FG002|Overall Study|Withdrawal by Subject|1
842104|NCT00366301|1799164|FG003|Overall Study|Withdrawal by Subject|1
842105|NCT00366340|1799176|FG000|Infant Series|Protocol Violation|3
842106|NCT00366340|1799177|FG001|Infant Series|Protocol Violation|4
842107|NCT00366340|1799176|FG000|Infant Series|Withdrawal by Subject|3
842108|NCT00366340|1799177|FG001|Infant Series|Withdrawal by Subject|3
842109|NCT00366340|1799176|FG000|Infant Series|Adverse Event|0
842110|NCT00366340|1799177|FG001|Infant Series|Adverse Event|2
842111|NCT00366340|1799176|FG000|Infant Series|Lost to Follow-up|1
842112|NCT00366340|1799177|FG001|Infant Series|Lost to Follow-up|1
842113|NCT00366340|1799176|FG000|Infant Series|Failure to return|1
842114|NCT00366340|1799177|FG001|Infant Series|Failure to return|0
842115|NCT00366340|1799176|FG000|After the Infant Series|Parent/legal guardian request|1
842116|NCT00366340|1799177|FG001|After the Infant Series|Parent/legal guardian request|1
842117|NCT00366340|1799176|FG000|After the Infant Series|Failed to return|0
842118|NCT00366340|1799177|FG001|After the Infant Series|Failed to return|1
842119|NCT00366340|1799176|FG000|After the Infant Series|Protocol Violation|2
842120|NCT00366340|1799177|FG001|After the Infant Series|Protocol Violation|2
842121|NCT00366340|1799176|FG000|After the Infant Series|Adverse Event|0
842122|NCT00366340|1799177|FG001|After the Infant Series|Adverse Event|1
842123|NCT00366340|1799176|FG000|After the Infant Series|Lost to Follow-up|0
842124|NCT00366340|1799177|FG001|After the Infant Series|Lost to Follow-up|1
842125|NCT00366340|1799176|FG000|Toddler Dose|Failed to return|1
842126|NCT00366340|1799177|FG001|Toddler Dose|Failed to return|0
842127|NCT00366340|1799176|FG000|Toddler Dose|Parent/legal guardian request|0
842128|NCT00366340|1799177|FG001|Toddler Dose|Parent/legal guardian request|1
842129|NCT00366444|1799209|FG000|Overall Study|Withdrawal by Subject|1
842130|NCT00366444|1799210|FG001|Overall Study|Withdrawal by Subject|1
842131|NCT00366444|1799209|FG000|Overall Study|Lack of Efficacy|0
842132|NCT00366444|1799210|FG001|Overall Study|Lack of Efficacy|1
842133|NCT00366457|1799216|FG000|Overall Study|never began study therapy|2
842134|NCT00366535|1799222|FG000|First Phase: 12 Weeks|Adverse Event|1
842135|NCT00366535|1799223|FG001|First Phase: 12 Weeks|Adverse Event|3
842136|NCT00366535|1799222|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2
842137|NCT00366535|1799223|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5
842138|NCT00366535|1799222|FG000|Second Phase: 12 Weeks|Adverse Event|1
842139|NCT00366535|1799223|FG001|Second Phase: 12 Weeks|Adverse Event|1
842140|NCT00366535|1799222|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2
842141|NCT00366535|1799223|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2
842142|NCT00366548|1799239|FG000|Infant Series|Adverse Event|1
842143|NCT00366548|1799240|FG001|Infant Series|Adverse Event|3
842144|NCT00366548|1799239|FG000|Infant Series|Protocol Violation|0
842145|NCT00366548|1799240|FG001|Infant Series|Protocol Violation|1
842146|NCT00366548|1799239|FG000|Infant Series|Withdrawal by Subject|3
842147|NCT00366548|1799240|FG001|Infant Series|Withdrawal by Subject|1
842148|NCT00366548|1799239|FG000|After Infant Series|Withdrawal by Subject|3
842149|NCT00366548|1799240|FG001|After Infant Series|Withdrawal by Subject|1
842150|NCT00366548|1799239|FG000|After Infant Series|Adverse Event|2
842151|NCT00366548|1799240|FG001|After Infant Series|Adverse Event|0
842152|NCT00366548|1799239|FG000|After Infant Series|Lost to Follow-up|1
842153|NCT00366548|1799240|FG001|After Infant Series|Lost to Follow-up|0
842154|NCT00366678|1799277|FG000|Infant Series|Withdrawal by Subject|8
842155|NCT00366678|1799278|FG001|Infant Series|Withdrawal by Subject|6
842156|NCT00366678|1799279|FG002|Infant Series|Withdrawal by Subject|0
842157|NCT00366678|1799277|FG000|Infant Series|Protocol Violation|4
842158|NCT00366678|1799278|FG001|Infant Series|Protocol Violation|3
842159|NCT00366678|1799279|FG002|Infant Series|Protocol Violation|0
842160|NCT00366678|1799277|FG000|Infant Series|Failed to return|1
842161|NCT00366678|1799278|FG001|Infant Series|Failed to return|1
842162|NCT00366678|1799279|FG002|Infant Series|Failed to return|0
842163|NCT00366678|1799277|FG000|Infant Series|Adverse Event|1
842164|NCT00366678|1799278|FG001|Infant Series|Adverse Event|0
842165|NCT00366678|1799279|FG002|Infant Series|Adverse Event|0
842166|NCT00366678|1799277|FG000|After Infant|Withdrawal by Subject|8
842167|NCT00366678|1799278|FG001|After Infant|Withdrawal by Subject|4
842168|NCT00366678|1799279|FG002|After Infant|Withdrawal by Subject|0
842169|NCT00366678|1799277|FG000|After Infant|Lost to Follow-up|2
842170|NCT00366678|1799278|FG001|After Infant|Lost to Follow-up|1
842171|NCT00366678|1799279|FG002|After Infant|Lost to Follow-up|0
842172|NCT00366678|1799277|FG000|After Infant|Failed to return|5
842173|NCT00366678|1799278|FG001|After Infant|Failed to return|5
842174|NCT00366678|1799279|FG002|After Infant|Failed to return|0
842175|NCT00366678|1799277|FG000|After Infant|Adverse Event|1
842176|NCT00366678|1799278|FG001|After Infant|Adverse Event|0
842177|NCT00366678|1799279|FG002|After Infant|Adverse Event|0
842178|NCT00366678|1799277|FG000|After Infant|Protocol Violation|1
842179|NCT00366678|1799278|FG001|After Infant|Protocol Violation|0
842180|NCT00366678|1799279|FG002|After Infant|Protocol Violation|0
842181|NCT00366678|1799277|FG000|Toddler Dose|Protocol Violation|2
842182|NCT00366678|1799278|FG001|Toddler Dose|Protocol Violation|1
842183|NCT00366678|1799279|FG002|Toddler Dose|Protocol Violation|0
842184|NCT00366678|1799277|FG000|Toddler Dose|Failed to return|1
842185|NCT00366678|1799278|FG001|Toddler Dose|Failed to return|0
842186|NCT00366678|1799279|FG002|Toddler Dose|Failed to return|0
842187|NCT00366678|1799277|FG000|Toddler Dose|Withdrawal by Subject|1
842188|NCT00366678|1799278|FG001|Toddler Dose|Withdrawal by Subject|0
842189|NCT00366678|1799279|FG002|Toddler Dose|Withdrawal by Subject|0
842190|NCT00366678|1799277|FG000|Toddler Dose|protocol deviation|1
842191|NCT00366678|1799278|FG001|Toddler Dose|protocol deviation|0
842192|NCT00366678|1799279|FG002|Toddler Dose|protocol deviation|0
842193|NCT00366899|1799326|FG000|Infant Series|Withdrawal by Subject|4
842194|NCT00366899|1799327|FG001|Infant Series|Withdrawal by Subject|7
842195|NCT00366899|1799326|FG000|Infant Series|Protocol Violation|2
842196|NCT00366899|1799327|FG001|Infant Series|Protocol Violation|1
842197|NCT00366899|1799326|FG000|Infant Series|Failed to return|1
842198|NCT00366899|1799327|FG001|Infant Series|Failed to return|1
842199|NCT00366899|1799326|FG000|Infant Series|Lost to Follow-up|0
842200|NCT00366899|1799327|FG001|Infant Series|Lost to Follow-up|2
842201|NCT00366899|1799326|FG000|Infant Series|Adverse Event|0
842202|NCT00366899|1799327|FG001|Infant Series|Adverse Event|1
842203|NCT00366899|1799326|FG000|Infant Series|Physician Decision|1
842204|NCT00366899|1799327|FG001|Infant Series|Physician Decision|0
842205|NCT00366899|1799326|FG000|Infant Series|Randomized but not consented|1
842206|NCT00366899|1799327|FG001|Infant Series|Randomized but not consented|0
842207|NCT00366899|1799326|FG000|After Infant Series|Lost to Follow-up|4
842208|NCT00366899|1799327|FG001|After Infant Series|Lost to Follow-up|3
842209|NCT00366899|1799326|FG000|After Infant Series|Withdrawal by Subject|1
842210|NCT00366899|1799327|FG001|After Infant Series|Withdrawal by Subject|4
842211|NCT00366899|1799326|FG000|After Infant Series|Adverse Event|1
842212|NCT00366899|1799327|FG001|After Infant Series|Adverse Event|2
842213|NCT00366899|1799326|FG000|After Infant Series|Protocol Violation|1
842214|NCT00366899|1799327|FG001|After Infant Series|Protocol Violation|0
842215|NCT00366899|1799326|FG000|Toddler Dose|Withdrawal by Subject|1
842216|NCT00366899|1799327|FG001|Toddler Dose|Withdrawal by Subject|1
842217|NCT00366899|1799326|FG000|Toddler Dose|Protocol Violation|1
842218|NCT00366899|1799327|FG001|Toddler Dose|Protocol Violation|0
842219|NCT00367055|1799376|FG000|Overall Study|Adverse Event|6
842220|NCT00367055|1799377|FG001|Overall Study|Adverse Event|3
842221|NCT00367055|1799376|FG000|Overall Study|Patient's Willing|3
842222|NCT00367055|1799377|FG001|Overall Study|Patient's Willing|2
842223|NCT00367055|1799376|FG000|Overall Study|Lack of Efficacy|1
842224|NCT00367055|1799377|FG001|Overall Study|Lack of Efficacy|2
842225|NCT00367055|1799376|FG000|Overall Study|Lost to Follow-up|1
842226|NCT00367055|1799377|FG001|Overall Study|Lost to Follow-up|1
842227|NCT00367055|1799376|FG000|Overall Study|Protocol Violation|0
842228|NCT00367055|1799377|FG001|Overall Study|Protocol Violation|1
842229|NCT00367055|1799376|FG000|Overall Study|Stopping Criterion Met|0
842230|NCT00367055|1799377|FG001|Overall Study|Stopping Criterion Met|1
842231|NCT00367055|1799376|FG000|Overall Study|Participant Living too Far from Hospital|0
842232|NCT00367055|1799377|FG001|Overall Study|Participant Living too Far from Hospital|1
842233|NCT00367133|1799386|FG000|2 Years|Death|20
842234|NCT00367133|1799387|FG001|2 Years|Death|12
842235|NCT00367133|1799388|FG002|2 Years|Death|12
842236|NCT00367133|1799386|FG000|2 Years|Dropped|34
842237|NCT00367133|1799387|FG001|2 Years|Dropped|19
842238|NCT00367133|1799388|FG002|2 Years|Dropped|33
842239|NCT00367133|1799386|FG000|2 Years|Missed visit|4
842240|NCT00367133|1799387|FG001|2 Years|Missed visit|5
842241|NCT00367133|1799388|FG002|2 Years|Missed visit|4
842242|NCT00367237|1799398|FG000|Overall Study|Adverse Event|7
842243|NCT00367237|1799399|FG001|Overall Study|Adverse Event|2
842244|NCT00367237|1799398|FG000|Overall Study|Lost to Follow-up|1
842245|NCT00367237|1799399|FG001|Overall Study|Lost to Follow-up|0
842246|NCT00367237|1799398|FG000|Overall Study|Withdrawal by Subject|0
842247|NCT00367237|1799399|FG001|Overall Study|Withdrawal by Subject|4
842248|NCT00367237|1799398|FG000|Overall Study|Protocol Violation|2
842249|NCT00367237|1799399|FG001|Overall Study|Protocol Violation|5
842250|NCT00367341|1799407|FG000|Overall Study|Physician Decision|1
842251|NCT00367341|1799408|FG001|Overall Study|Physician Decision|0
842252|NCT00367341|1799407|FG000|Overall Study|Protocol Violation|1
842253|NCT00367341|1799408|FG001|Overall Study|Protocol Violation|0
842254|NCT00367432|1799427|FG000|First Period (16 Weeks)|Adverse Event|6
842255|NCT00367432|1799428|FG001|First Period (16 Weeks)|Adverse Event|0
842256|NCT00367432|1799427|FG000|First Period (16 Weeks)|Lack of Efficacy|24
842257|NCT00367432|1799428|FG001|First Period (16 Weeks)|Lack of Efficacy|0
842258|NCT00367432|1799427|FG000|First Period (16 Weeks)|Withdrawal by Subject|6
842259|NCT00367432|1799428|FG001|First Period (16 Weeks)|Withdrawal by Subject|0
842260|NCT00367432|1799427|FG000|First Period (16 Weeks)|Other Reason|2
842261|NCT00367432|1799428|FG001|First Period (16 Weeks)|Other Reason|0
842262|NCT00367432|1799427|FG000|Second Period (up to 54 Months)|Adverse Event|14
842263|NCT00367432|1799428|FG001|Second Period (up to 54 Months)|Adverse Event|3
842264|NCT00367432|1799427|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59
842265|NCT00367432|1799428|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5
842266|NCT00367432|1799427|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0
842267|NCT00367432|1799428|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1
842268|NCT00367432|1799427|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8
842269|NCT00367432|1799428|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5
842270|NCT00367432|1799427|FG000|Second Period (up to 54 Months)|Other Reason|6
842271|NCT00367432|1799428|FG001|Second Period (up to 54 Months)|Other Reason|2
842272|NCT00367458|1799434|FG000|First Intervention - 8 Weeks|Adverse Event|2
842273|NCT00367458|1799435|FG001|First Intervention - 8 Weeks|Adverse Event|0
842274|NCT00367484|1799441|FG000|Overall Study|Adverse Event|7
842275|NCT00367484|1799441|FG000|Overall Study|Withdrew informed consent|5
842276|NCT00367484|1799441|FG000|Overall Study|Travel to USA|1
842277|NCT00367484|1799441|FG000|Overall Study|Lost to Follow-up|1
842278|NCT00367484|1799441|FG000|Overall Study|Protocol Violation|1
842279|NCT00367484|1799441|FG000|Overall Study|The choice of the patient|1
842280|NCT00367484|1799441|FG000|Overall Study|Lack of Efficacy|1
842281|NCT00367640|1799454|FG000|Overall Study|Adverse Event|3
842282|NCT00367640|1799455|FG001|Overall Study|Adverse Event|6
842283|NCT00367640|1799456|FG002|Overall Study|Adverse Event|8
842284|NCT00367640|1799457|FG003|Overall Study|Adverse Event|0
842285|NCT00367640|1799454|FG000|Overall Study|Withdrawal by Subject|8
842286|NCT00367640|1799455|FG001|Overall Study|Withdrawal by Subject|11
842287|NCT00367640|1799456|FG002|Overall Study|Withdrawal by Subject|8
842288|NCT00367640|1799457|FG003|Overall Study|Withdrawal by Subject|6
842289|NCT00367640|1799454|FG000|Overall Study|Any other reason not above-mentioned|7
842290|NCT00367640|1799455|FG001|Overall Study|Any other reason not above-mentioned|5
842291|NCT00367640|1799456|FG002|Overall Study|Any other reason not above-mentioned|3
842292|NCT00367640|1799457|FG003|Overall Study|Any other reason not above-mentioned|4
842293|NCT00367744|1799475|FG000|Overall Study|Lost to Follow-up|4
842294|NCT00367744|1799476|FG001|Overall Study|Lost to Follow-up|5
842295|NCT00367770|1799483|FG000|Overall Study|Adverse Event|1
842296|NCT00367770|1799483|FG000|Overall Study|Withdrawal by Subject|1
842297|NCT00367835|1799489|FG000|Overall Study|Adverse Event|14
842298|NCT00367835|1799490|FG001|Overall Study|Adverse Event|1
842299|NCT00367835|1799489|FG000|Overall Study|Protocol Violation|1
842300|NCT00367835|1799490|FG001|Overall Study|Protocol Violation|7
842301|NCT00367835|1799489|FG000|Overall Study|Withdrawal by Subject|7
842302|NCT00367835|1799490|FG001|Overall Study|Withdrawal by Subject|6
842303|NCT00367835|1799489|FG000|Overall Study|Lost to Follow-up|1
842304|NCT00367835|1799490|FG001|Overall Study|Lost to Follow-up|4
842305|NCT00367835|1799489|FG000|Overall Study|Lack of Efficacy|3
842306|NCT00367835|1799490|FG001|Overall Study|Lack of Efficacy|12
842307|NCT00367835|1799489|FG000|Overall Study|Subject in juvenile detention center|1
842308|NCT00367835|1799490|FG001|Overall Study|Subject in juvenile detention center|0
842309|NCT00367835|1799489|FG000|Overall Study|refused blood collection|1
842310|NCT00367835|1799490|FG001|Overall Study|refused blood collection|0
842311|NCT00367835|1799489|FG000|Overall Study|Did not respond to calls|1
842312|NCT00367835|1799490|FG001|Overall Study|Did not respond to calls|0
842313|NCT00367835|1799489|FG000|Overall Study|History of lead poisoning|0
842314|NCT00367835|1799490|FG001|Overall Study|History of lead poisoning|1
842315|NCT00367991|1799498|FG000|Overall Study|Withdrawal by Subject|1
842316|NCT00367991|1799499|FG001|Overall Study|Withdrawal by Subject|1
842317|NCT00367991|1799498|FG000|Overall Study|Adverse Event|1
842318|NCT00367991|1799499|FG001|Overall Study|Adverse Event|1
842319|NCT00368069|1799507|FG000|Overall Study|Adverse Event|5
842320|NCT00368069|1799508|FG001|Overall Study|Adverse Event|2
842321|NCT00368069|1799507|FG000|Overall Study|Lack of Efficacy|0
842322|NCT00368069|1799508|FG001|Overall Study|Lack of Efficacy|1
842323|NCT00368069|1799507|FG000|Overall Study|Lost to Follow-up|1
842324|NCT00368069|1799508|FG001|Overall Study|Lost to Follow-up|0
842325|NCT00368069|1799507|FG000|Overall Study|Protocol Violation|0
842326|NCT00368069|1799508|FG001|Overall Study|Protocol Violation|2
842327|NCT00368069|1799507|FG000|Overall Study|Withdrawal of Consent|2
842328|NCT00368069|1799508|FG001|Overall Study|Withdrawal of Consent|1
842329|NCT00368069|1799507|FG000|Overall Study|no blood sampling possible|0
842330|NCT00368069|1799508|FG001|Overall Study|no blood sampling possible|1
842331|NCT00368108|1799517|FG000|Overall Study|Adverse Event|38
842332|NCT00368108|1799518|FG001|Overall Study|Adverse Event|26
842333|NCT00368108|1799519|FG002|Overall Study|Adverse Event|44
842334|NCT00368108|1799517|FG000|Overall Study|Abnormal Laboratory Value|0
842335|NCT00368108|1799518|FG001|Overall Study|Abnormal Laboratory Value|0
842336|NCT00368108|1799519|FG002|Overall Study|Abnormal Laboratory Value|3
842337|NCT00368108|1799517|FG000|Overall Study|Protocol Violation|5
842338|NCT00368108|1799518|FG001|Overall Study|Protocol Violation|9
842339|NCT00368108|1799519|FG002|Overall Study|Protocol Violation|9
842340|NCT00368108|1799517|FG000|Overall Study|Withdrawal by Subject|9
842341|NCT00368108|1799518|FG001|Overall Study|Withdrawal by Subject|3
842342|NCT00368108|1799519|FG002|Overall Study|Withdrawal by Subject|5
842343|NCT00368108|1799517|FG000|Overall Study|Lack of Efficacy|7
842344|NCT00368108|1799518|FG001|Overall Study|Lack of Efficacy|8
842345|NCT00368108|1799519|FG002|Overall Study|Lack of Efficacy|5
842346|NCT00368108|1799517|FG000|Overall Study|Physician Decision|2
842347|NCT00368108|1799518|FG001|Overall Study|Physician Decision|0
842348|NCT00368108|1799519|FG002|Overall Study|Physician Decision|1
842349|NCT00368108|1799517|FG000|Overall Study|Other|3
842350|NCT00368108|1799518|FG001|Overall Study|Other|7
842351|NCT00368108|1799519|FG002|Overall Study|Other|1
842352|NCT00368251|1799530|FG000|Overall Study|SAE, non-fatal|1
842353|NCT00368251|1799531|FG001|Overall Study|SAE, non-fatal|0
842354|NCT00368251|1799532|FG002|Overall Study|SAE, non-fatal|0
842355|NCT00368251|1799530|FG000|Overall Study|AE, non-serious non-fatal|0
842356|NCT00368251|1799531|FG001|Overall Study|AE, non-serious non-fatal|0
842357|NCT00368251|1799532|FG002|Overall Study|AE, non-serious non-fatal|1
842358|NCT00368277|1799542|FG000|Overall Study|Adverse Event|33
842359|NCT00368277|1799543|FG001|Overall Study|Adverse Event|49
842360|NCT00368277|1799542|FG000|Overall Study|Death|2
842361|NCT00368277|1799543|FG001|Overall Study|Death|1
842362|NCT00368277|1799542|FG000|Overall Study|Unsatisfactory therapeutic effect|31
842363|NCT00368277|1799543|FG001|Overall Study|Unsatisfactory therapeutic effect|24
842364|NCT00368277|1799542|FG000|Overall Study|Protocol deviation|7
842365|NCT00368277|1799543|FG001|Overall Study|Protocol deviation|0
842366|NCT00368277|1799542|FG000|Overall Study|Patient withdrew consent|32
842367|NCT00368277|1799543|FG001|Overall Study|Patient withdrew consent|28
842368|NCT00368277|1799542|FG000|Overall Study|Lost to Follow-up|8
842369|NCT00368277|1799543|FG001|Overall Study|Lost to Follow-up|6
842370|NCT00368355|1799569|FG000|Overall Study|Adverse Event|1
842371|NCT00368355|1799570|FG001|Overall Study|Adverse Event|0
842372|NCT00368355|1799569|FG000|Overall Study|Death|2
842373|NCT00368355|1799570|FG001|Overall Study|Death|4
842374|NCT00368355|1799569|FG000|Overall Study|Relapse|6
842375|NCT00368355|1799570|FG001|Overall Study|Relapse|10
842376|NCT00368355|1799569|FG000|Overall Study|Subsequent transplant|0
842377|NCT00368355|1799570|FG001|Overall Study|Subsequent transplant|3
842378|NCT00368355|1799569|FG000|Overall Study|Treatment - hematopoietic cell product|2
842379|NCT00368355|1799570|FG001|Overall Study|Treatment - hematopoietic cell product|0
842380|NCT00368472|1799585|FG000|Overall Study|Adverse Event|22
842381|NCT00368472|1799585|FG000|Overall Study|Medication non-compliance|4
842382|NCT00368472|1799585|FG000|Overall Study|Protocol Violation|2
842383|NCT00368472|1799585|FG000|Overall Study|Request of Investigator or Sponsor|3
842384|NCT00368472|1799585|FG000|Overall Study|Withdrawal by Subject|40
842385|NCT00368472|1799585|FG000|Overall Study|Diary non-compliance|1
842386|NCT00368472|1799585|FG000|Overall Study|Other|32
842387|NCT00368472|1799585|FG000|Overall Study|Missing Final Disposition Date|1
842388|NCT00368537|1799591|FG000|Randomization|No study drug dosed|13
842389|NCT00368537|1799592|FG001|Randomization|No study drug dosed|6
842390|NCT00368537|1799591|FG000|Baseline Participants|Lost to Follow-up|16
842391|NCT00368537|1799592|FG001|Baseline Participants|Lost to Follow-up|17
842392|NCT00368537|1799591|FG000|Baseline Participants|Withdrawal by Subject|6
842393|NCT00368537|1799592|FG001|Baseline Participants|Withdrawal by Subject|4
842394|NCT00368537|1799591|FG000|Baseline Participants|Death|1
842395|NCT00368537|1799592|FG001|Baseline Participants|Death|2
842396|NCT00368537|1799591|FG000|Baseline Participants|No susceptibility|1
842397|NCT00368537|1799592|FG001|Baseline Participants|No susceptibility|0
842398|NCT00368537|1799591|FG000|Baseline Participants|Patient uncompliant|0
842399|NCT00368537|1799592|FG001|Baseline Participants|Patient uncompliant|1
842400|NCT00368550|1799600|FG000|Overall Study|Adverse Event|7
842401|NCT00368550|1799601|FG001|Overall Study|Adverse Event|4
842402|NCT00368550|1799600|FG000|Overall Study|Lack of Efficacy|4
842403|NCT00368550|1799601|FG001|Overall Study|Lack of Efficacy|9
842404|NCT00368550|1799600|FG000|Overall Study|Withdrawal by Subject|17
842405|NCT00368550|1799601|FG001|Overall Study|Withdrawal by Subject|10
842406|NCT00368641|1799609|FG000|Overall Study|Adverse Event|2
842407|NCT00368641|1799610|FG001|Overall Study|Adverse Event|1
842408|NCT00368641|1799609|FG000|Overall Study|Death|1
842409|NCT00368641|1799610|FG001|Overall Study|Death|0
842410|NCT00368641|1799609|FG000|Overall Study|Withdrawal by Subject|1
842411|NCT00368641|1799610|FG001|Overall Study|Withdrawal by Subject|0
842412|NCT00368641|1799609|FG000|Overall Study|Sponsor decision to terminate study|2
842413|NCT00368641|1799610|FG001|Overall Study|Sponsor decision to terminate study|5
842414|NCT00368745|1799618|FG000|Double-blind Treatment Period|Adverse Event|6
842415|NCT00368745|1799619|FG001|Double-blind Treatment Period|Adverse Event|6
842416|NCT00368745|1799618|FG000|Double-blind Treatment Period|Lack of Efficacy|7
842417|NCT00368745|1799619|FG001|Double-blind Treatment Period|Lack of Efficacy|16
842418|NCT00368745|1799618|FG000|Double-blind Treatment Period|Lost to Follow-up|1
842419|NCT00368745|1799619|FG001|Double-blind Treatment Period|Lost to Follow-up|0
842420|NCT00368745|1799618|FG000|Double-blind Treatment Period|Withdrawal by Subject|5
842421|NCT00368745|1799619|FG001|Double-blind Treatment Period|Withdrawal by Subject|3
842422|NCT00368745|1799618|FG000|Double-blind Treatment Period|Other|7
842423|NCT00368745|1799619|FG001|Double-blind Treatment Period|Other|6
842424|NCT00368836|1799627|FG000|Phase II|Screen Failure|1
842425|NCT00368836|1799627|FG000|Phase II|Withdrawal by Subject|1
842426|NCT00368836|1799627|FG000|Phase II|unable to collect blood and/or breath|17
842427|NCT00368836|1799627|FG000|Phase II|Protocol Violation|2
842428|NCT00368849|1799634|FG000|Overall Study|Withdrawal by Subject|0
842429|NCT00368849|1799635|FG001|Overall Study|Withdrawal by Subject|1
842430|NCT00368849|1799634|FG000|Overall Study|Physician Decision|0
842431|NCT00368849|1799635|FG001|Overall Study|Physician Decision|1
842432|NCT00368875|1799642|FG000|Overall Study|Adverse Event|0
842433|NCT00368875|1799643|FG001|Overall Study|Adverse Event|12
842434|NCT00368875|1799642|FG000|Overall Study|Progressive disease|3
842435|NCT00368875|1799643|FG001|Overall Study|Progressive disease|27
842436|NCT00368875|1799642|FG000|Overall Study|Withdrawal by Subject|2
842437|NCT00368875|1799643|FG001|Overall Study|Withdrawal by Subject|6
842438|NCT00368875|1799642|FG000|Overall Study|Other Reason|0
842439|NCT00368875|1799643|FG001|Overall Study|Other Reason|2
842440|NCT00368875|1799642|FG000|Overall Study|Alternative Therapy|1
842441|NCT00368875|1799643|FG001|Overall Study|Alternative Therapy|1
842442|NCT00368927|1799651|FG000|Overall Study|Lost to Follow-up|2
842443|NCT00368927|1799652|FG001|Overall Study|Lost to Follow-up|0
842444|NCT00368927|1799651|FG000|Overall Study|Adverse Event|1
842445|NCT00368927|1799652|FG001|Overall Study|Adverse Event|1
842446|NCT00368927|1799651|FG000|Overall Study|Withdrawal by Subject|1
842447|NCT00368927|1799652|FG001|Overall Study|Withdrawal by Subject|2
842448|NCT00368927|1799651|FG000|Overall Study|Physician Decision|1
842449|NCT00368927|1799652|FG001|Overall Study|Physician Decision|0
842450|NCT00368966|1799670|FG000|Infant Series|Withdrawal by Subject|11
842451|NCT00368966|1799671|FG001|Infant Series|Withdrawal by Subject|6
842452|NCT00368966|1799670|FG000|Infant Series|Protocol Violation|2
842453|NCT00368966|1799671|FG001|Infant Series|Protocol Violation|1
842454|NCT00368966|1799670|FG000|Infant Series|Lost to Follow-up|2
842455|NCT00368966|1799671|FG001|Infant Series|Lost to Follow-up|0
842456|NCT00368966|1799670|FG000|Infant Series|Randomization error|0
842457|NCT00368966|1799671|FG001|Infant Series|Randomization error|1
842458|NCT00368966|1799670|FG000|Infant Series|Failed to meet eligibility criteria|0
842459|NCT00368966|1799671|FG001|Infant Series|Failed to meet eligibility criteria|1
842460|NCT00368966|1799670|FG000|Infant Series|Adverse Event|0
842461|NCT00368966|1799671|FG001|Infant Series|Adverse Event|1
842462|NCT00368966|1799670|FG000|Infant Series|Failed to return|1
842463|NCT00368966|1799671|FG001|Infant Series|Failed to return|0
842464|NCT00368966|1799670|FG000|After Infant|Failed to return|3
842465|NCT00368966|1799671|FG001|After Infant|Failed to return|1
842466|NCT00368966|1799670|FG000|After Infant|Adverse Event|1
842467|NCT00368966|1799671|FG001|After Infant|Adverse Event|2
842468|NCT00368966|1799670|FG000|After Infant|Withdrawal by Subject|1
842469|NCT00368966|1799671|FG001|After Infant|Withdrawal by Subject|1
842470|NCT00368966|1799670|FG000|After Infant|Death|1
842471|NCT00368966|1799671|FG001|After Infant|Death|0
842472|NCT00368966|1799670|FG000|After Infant|Lost to Follow-up|0
842473|NCT00368966|1799671|FG001|After Infant|Lost to Follow-up|1
842474|NCT00368966|1799670|FG000|Toddler Dose|Withdrawal by Subject|1
842475|NCT00368966|1799671|FG001|Toddler Dose|Withdrawal by Subject|1
842476|NCT00368966|1799670|FG000|Toddler Dose|Lost to Follow-up|0
842477|NCT00368966|1799671|FG001|Toddler Dose|Lost to Follow-up|2
842478|NCT00368979|1799704|FG000|Overall Study|Adverse Event|9
842479|NCT00368979|1799705|FG001|Overall Study|Adverse Event|16
842480|NCT00368979|1799704|FG000|Overall Study|Lack of Efficacy|5
842481|NCT00368979|1799705|FG001|Overall Study|Lack of Efficacy|3
842482|NCT00368979|1799704|FG000|Overall Study|Other|3
842483|NCT00368979|1799705|FG001|Overall Study|Other|1
842484|NCT00368979|1799704|FG000|Overall Study|Lost to Follow-up|1
842485|NCT00368979|1799705|FG001|Overall Study|Lost to Follow-up|0
842486|NCT00368979|1799704|FG000|Overall Study|Protocol Violation|2
842487|NCT00368979|1799705|FG001|Overall Study|Protocol Violation|1
842488|NCT00368979|1799704|FG000|Overall Study|Withdrawal by Subject|5
842489|NCT00368979|1799705|FG001|Overall Study|Withdrawal by Subject|9
842490|NCT00368992|1799711|FG000|Overall Study|Ineligible|5
842491|NCT00368992|1799711|FG000|Overall Study|Refused treatment|3
842492|NCT00368992|1799711|FG000|Overall Study|Lack of Efficacy|63
842493|NCT00368992|1799711|FG000|Overall Study|Adverse Event|26
842494|NCT00368992|1799711|FG000|Overall Study|Death|4
842495|NCT00368992|1799711|FG000|Overall Study|Other|9
842496|NCT00369122|1799716|FG000|Overall Study|Ineligible|10
842497|NCT00369122|1799716|FG000|Overall Study|No protocol treatment|1
842498|NCT00369161|1799722|FG000|Overall Study|Adverse Event|15
842499|NCT00369161|1799723|FG001|Overall Study|Adverse Event|13
842500|NCT00369161|1799722|FG000|Overall Study|Abnormal laboratory value|0
842501|NCT00369161|1799723|FG001|Overall Study|Abnormal laboratory value|1
842502|NCT00369161|1799722|FG000|Overall Study|Lack of Efficacy|3
842503|NCT00369161|1799723|FG001|Overall Study|Lack of Efficacy|1
842504|NCT00369161|1799722|FG000|Overall Study|Protocol Violation|0
842505|NCT00369161|1799723|FG001|Overall Study|Protocol Violation|2
842506|NCT00369161|1799722|FG000|Overall Study|Withdrawal by Subject|2
842507|NCT00369161|1799723|FG001|Overall Study|Withdrawal by Subject|3
842508|NCT00369161|1799722|FG000|Overall Study|Death|1
842509|NCT00369161|1799723|FG001|Overall Study|Death|2
842510|NCT00369161|1799722|FG000|Overall Study|Graft loss|4
842511|NCT00369161|1799723|FG001|Overall Study|Graft loss|0
842512|NCT00369161|1799722|FG000|Overall Study|Administrative Problem|2
842513|NCT00369161|1799723|FG001|Overall Study|Administrative Problem|2
842514|NCT00369278|1799743|FG000|Overall Study|Adverse Event|14
842515|NCT00369278|1799744|FG001|Overall Study|Adverse Event|11
842516|NCT00369278|1799743|FG000|Overall Study|Unsatisfactory therapeutic effect|4
842517|NCT00369278|1799744|FG001|Overall Study|Unsatisfactory therapeutic effect|5
842518|NCT00369278|1799743|FG000|Overall Study|Protocol Violation|2
842519|NCT00369278|1799744|FG001|Overall Study|Protocol Violation|1
842520|NCT00369278|1799743|FG000|Overall Study|Withdrawal by Subject|2
842521|NCT00369278|1799744|FG001|Overall Study|Withdrawal by Subject|2
842522|NCT00369278|1799743|FG000|Overall Study|Lost to Follow-up|1
842523|NCT00369278|1799744|FG001|Overall Study|Lost to Follow-up|0
842524|NCT00369278|1799743|FG000|Overall Study|Graft loss|1
842525|NCT00369278|1799744|FG001|Overall Study|Graft loss|2
842532|NCT00369343|1799757|FG000|Double-blind Phase|Adverse Event|19
842533|NCT00369343|1799758|FG001|Double-blind Phase|Adverse Event|4
842534|NCT00369343|1799757|FG000|Double-blind Phase|Failed to return|2
842535|NCT00369343|1799758|FG001|Double-blind Phase|Failed to return|0
842536|NCT00369343|1799757|FG000|Double-blind Phase|Lost to Follow-up|9
842537|NCT00369343|1799758|FG001|Double-blind Phase|Lost to Follow-up|2
842538|NCT00369343|1799757|FG000|Double-blind Phase|Protocol Violation|2
842539|NCT00369343|1799758|FG001|Double-blind Phase|Protocol Violation|0
842540|NCT00369343|1799757|FG000|Double-blind Phase|Withdrawal by Subject|8
842541|NCT00369343|1799758|FG001|Double-blind Phase|Withdrawal by Subject|6
842542|NCT00369343|1799757|FG000|Double-blind Phase|Lack of Efficacy|0
842543|NCT00369343|1799758|FG001|Double-blind Phase|Lack of Efficacy|4
842544|NCT00369343|1799757|FG000|Double-blind Phase|Protocol deviation|4
842545|NCT00369343|1799758|FG001|Double-blind Phase|Protocol deviation|0
842546|NCT00369343|1799757|FG000|Open-label Phase|Adverse Event|19
842547|NCT00369343|1799758|FG001|Open-label Phase|Adverse Event|7
842548|NCT00369343|1799757|FG000|Open-label Phase|Failed to return|4
842549|NCT00369343|1799758|FG001|Open-label Phase|Failed to return|0
842550|NCT00369343|1799757|FG000|Open-label Phase|Physician Decision|2
842551|NCT00369343|1799758|FG001|Open-label Phase|Physician Decision|0
842552|NCT00369343|1799757|FG000|Open-label Phase|Lost to Follow-up|5
842553|NCT00369343|1799758|FG001|Open-label Phase|Lost to Follow-up|3
842554|NCT00369343|1799757|FG000|Open-label Phase|inadvertently reported study completers|3
842555|NCT00369343|1799758|FG001|Open-label Phase|inadvertently reported study completers|2
842556|NCT00369343|1799757|FG000|Open-label Phase|Protocol Violation|1
842557|NCT00369343|1799758|FG001|Open-label Phase|Protocol Violation|3
842558|NCT00369343|1799757|FG000|Open-label Phase|Withdrawal by Subject|15
842559|NCT00369343|1799758|FG001|Open-label Phase|Withdrawal by Subject|6
842560|NCT00369343|1799757|FG000|Open-label Phase|Lack of Efficacy|4
842561|NCT00369343|1799758|FG001|Open-label Phase|Lack of Efficacy|3
842562|NCT00369343|1799757|FG000|Open-label Phase|Lack of continuance tolerability|3
842563|NCT00369343|1799758|FG001|Open-label Phase|Lack of continuance tolerability|4
842564|NCT00369343|1799757|FG000|Open-label Phase|did not take study drug|1
842565|NCT00369343|1799758|FG001|Open-label Phase|did not take study drug|2
842566|NCT00369382|1799773|FG000|Overall Study|Death|0
842567|NCT00369382|1799774|FG001|Overall Study|Death|2
842568|NCT00369382|1799773|FG000|Overall Study|Physician Decision|2
842569|NCT00369382|1799774|FG001|Overall Study|Physician Decision|1
842570|NCT00369382|1799773|FG000|Overall Study|Withdrawal by Subject|5
842571|NCT00369382|1799774|FG001|Overall Study|Withdrawal by Subject|0
842572|NCT00369382|1799773|FG000|Overall Study|Randomized, not treated|2
842573|NCT00369382|1799774|FG001|Overall Study|Randomized, not treated|0
842574|NCT00369382|1799773|FG000|Overall Study|Other|1
842575|NCT00369382|1799774|FG001|Overall Study|Other|0
842576|NCT00369486|1799786|FG000|4-Week Visit|Missed visit|2
842577|NCT00369486|1799787|FG001|4-Week Visit|Missed visit|2
842578|NCT00369486|1799788|FG002|4-Week Visit|Missed visit|0
842579|NCT00369486|1799789|FG003|4-Week Visit|Missed visit|2
842580|NCT00369486|1799790|FG004|4-Week Visit|Missed visit|1
842581|NCT00369486|1799786|FG000|4-Week Visit|Dropped|0
842582|NCT00369486|1799787|FG001|4-Week Visit|Dropped|0
842583|NCT00369486|1799788|FG002|4-Week Visit|Dropped|1
842584|NCT00369486|1799789|FG003|4-Week Visit|Dropped|0
842585|NCT00369486|1799790|FG004|4-Week Visit|Dropped|0
842586|NCT00369486|1799786|FG000|8-Week Visit|Missed visit|0
842587|NCT00369486|1799787|FG001|8-Week Visit|Missed visit|1
842588|NCT00369486|1799788|FG002|8-Week Visit|Missed visit|0
842589|NCT00369486|1799789|FG003|8-Week Visit|Missed visit|0
842590|NCT00369486|1799790|FG004|8-Week Visit|Missed visit|1
842591|NCT00369486|1799786|FG000|8-Week Visit|Dropped|0
842592|NCT00369486|1799787|FG001|8-Week Visit|Dropped|0
842593|NCT00369486|1799788|FG002|8-Week Visit|Dropped|0
842594|NCT00369486|1799789|FG003|8-Week Visit|Dropped|1
842595|NCT00369486|1799790|FG004|8-Week Visit|Dropped|0
842596|NCT00369486|1799786|FG000|17-Week Visit|Missed visit|0
842597|NCT00369486|1799787|FG001|17-Week Visit|Missed visit|0
842598|NCT00369486|1799788|FG002|17-Week Visit|Missed visit|1
842599|NCT00369486|1799789|FG003|17-Week Visit|Missed visit|1
842600|NCT00369486|1799790|FG004|17-Week Visit|Missed visit|1
842601|NCT00369486|1799786|FG000|34-Week Visit|Dropped|0
842602|NCT00369486|1799787|FG001|34-Week Visit|Dropped|1
842603|NCT00369486|1799788|FG002|34-Week Visit|Dropped|1
842604|NCT00369486|1799789|FG003|34-Week Visit|Dropped|3
842605|NCT00369486|1799790|FG004|34-Week Visit|Dropped|3
842606|NCT00369577|1799822|FG000|Overall Study|Withdrawal by Subject|0
842607|NCT00369577|1799823|FG001|Overall Study|Withdrawal by Subject|0
842608|NCT00369577|1799824|FG002|Overall Study|Withdrawal by Subject|1
842609|NCT00369629|1799840|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0
842610|NCT00369629|1799841|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1
842611|NCT00369629|1799842|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1
842612|NCT00369629|1799843|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0
842613|NCT00369629|1799840|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0
842614|NCT00369629|1799841|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0
842615|NCT00369629|1799842|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1
842616|NCT00369629|1799843|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0
842617|NCT00369629|1799840|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2
842618|NCT00369629|1799841|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0
842619|NCT00369629|1799842|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0
842620|NCT00369629|1799843|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0
842621|NCT00369629|1799840|FG000|Moved on to 4 More Cycles|Progressive Disease|0
842622|NCT00369629|1799841|FG001|Moved on to 4 More Cycles|Progressive Disease|0
842623|NCT00369629|1799842|FG002|Moved on to 4 More Cycles|Progressive Disease|1
842624|NCT00369629|1799843|FG003|Moved on to 4 More Cycles|Progressive Disease|0
842625|NCT00369629|1799840|FG000|Completed 4 More Cycles|Withdrawal by Subject|2
842626|NCT00369629|1799841|FG001|Completed 4 More Cycles|Withdrawal by Subject|1
842627|NCT00369629|1799842|FG002|Completed 4 More Cycles|Withdrawal by Subject|0
842628|NCT00369629|1799843|FG003|Completed 4 More Cycles|Withdrawal by Subject|0
842629|NCT00369629|1799840|FG000|Completed 4 More Cycles|Progressive disease|2
842630|NCT00369629|1799841|FG001|Completed 4 More Cycles|Progressive disease|1
842631|NCT00369629|1799842|FG002|Completed 4 More Cycles|Progressive disease|2
842632|NCT00369629|1799843|FG003|Completed 4 More Cycles|Progressive disease|0
842633|NCT00369629|1799840|FG000|Follow up for 1 Year|Death|2
842634|NCT00369629|1799841|FG001|Follow up for 1 Year|Death|1
842635|NCT00369629|1799842|FG002|Follow up for 1 Year|Death|1
842636|NCT00369629|1799843|FG003|Follow up for 1 Year|Death|0
842637|NCT00369629|1799840|FG000|Follow up for 1 Year|Lost to Follow-up|0
842638|NCT00369629|1799841|FG001|Follow up for 1 Year|Lost to Follow-up|1
842639|NCT00369629|1799842|FG002|Follow up for 1 Year|Lost to Follow-up|0
842640|NCT00369629|1799843|FG003|Follow up for 1 Year|Lost to Follow-up|0
842641|NCT00369629|1799840|FG000|Follow up for 1 Year|stopped being followed as study closed|0
842642|NCT00369629|1799841|FG001|Follow up for 1 Year|stopped being followed as study closed|0
842643|NCT00369629|1799842|FG002|Follow up for 1 Year|stopped being followed as study closed|2
842644|NCT00369629|1799843|FG003|Follow up for 1 Year|stopped being followed as study closed|0
842645|NCT00369655|1799853|FG000|Overall Study|Refusal of further treatment|2
842646|NCT00369668|1799860|FG000|Overall Study|Lack of Efficacy|4
842647|NCT00369668|1799861|FG001|Overall Study|Lack of Efficacy|5
842648|NCT00369668|1799862|FG002|Overall Study|Lack of Efficacy|7
842649|NCT00369681|1799873|FG000|Overall Study|Death|1
842650|NCT00369707|1799877|FG000|Induction Part B (2 Cycles)|Adverse Event|3
842651|NCT00369707|1799877|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2
842652|NCT00369707|1799877|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
842653|NCT00369707|1799877|FG000|Induction Part B (2 Cycles)|Progressive disease|1
842654|NCT00369707|1799877|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
842655|NCT00369707|1799877|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
842656|NCT00369707|1799877|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4
842657|NCT00369707|1799877|FG000|Follow up for 2 Years After Treatment|Death|1
842658|NCT00369707|1799877|FG000|Follow up for 2 Years After Treatment|Other|2
842659|NCT00369785|1799892|FG000|Overall Study|Physician Decision|3
842660|NCT00369785|1799893|FG001|Overall Study|Physician Decision|2
842661|NCT00369785|1799892|FG000|Overall Study|Death|1
842662|NCT00369785|1799893|FG001|Overall Study|Death|2
842663|NCT00369785|1799892|FG000|Overall Study|Withdrawal by Subject|7
842664|NCT00369785|1799893|FG001|Overall Study|Withdrawal by Subject|6
842665|NCT00369785|1799892|FG000|Overall Study|Toxicity|6
842666|NCT00369785|1799893|FG001|Overall Study|Toxicity|4
842667|NCT00369785|1799892|FG000|Overall Study|Never started|0
842668|NCT00369785|1799893|FG001|Overall Study|Never started|2
842669|NCT00369785|1799892|FG000|Overall Study|Progression|4
842670|NCT00369785|1799893|FG001|Overall Study|Progression|4
842671|NCT00369785|1799892|FG000|Overall Study|Multiple reasons|6
842672|NCT00369785|1799893|FG001|Overall Study|Multiple reasons|5
842673|NCT00369824|1799905|FG000|Overall Study|Adverse Event|0
842674|NCT00369824|1799906|FG001|Overall Study|Adverse Event|2
842675|NCT00369824|1799907|FG002|Overall Study|Adverse Event|0
842676|NCT00369824|1799908|FG003|Overall Study|Adverse Event|0
842677|NCT00369824|1799909|FG004|Overall Study|Adverse Event|1
842678|NCT00369824|1799910|FG005|Overall Study|Adverse Event|0
842679|NCT00369824|1799905|FG000|Overall Study|Protocol Violation|0
842680|NCT00369824|1799906|FG001|Overall Study|Protocol Violation|1
842681|NCT00369824|1799907|FG002|Overall Study|Protocol Violation|0
842682|NCT00369824|1799908|FG003|Overall Study|Protocol Violation|1
842683|NCT00369824|1799909|FG004|Overall Study|Protocol Violation|1
842684|NCT00369824|1799910|FG005|Overall Study|Protocol Violation|0
842685|NCT00369824|1799905|FG000|Overall Study|Withdrawal by Subject|9
842686|NCT00369824|1799906|FG001|Overall Study|Withdrawal by Subject|5
842687|NCT00369824|1799907|FG002|Overall Study|Withdrawal by Subject|5
842688|NCT00369824|1799908|FG003|Overall Study|Withdrawal by Subject|4
842689|NCT00369824|1799909|FG004|Overall Study|Withdrawal by Subject|6
842690|NCT00369824|1799910|FG005|Overall Study|Withdrawal by Subject|2
842691|NCT00369824|1799905|FG000|Overall Study|Lost to Follow-up|6
842692|NCT00369824|1799906|FG001|Overall Study|Lost to Follow-up|11
842693|NCT00369824|1799907|FG002|Overall Study|Lost to Follow-up|7
842694|NCT00369824|1799908|FG003|Overall Study|Lost to Follow-up|8
842695|NCT00369824|1799909|FG004|Overall Study|Lost to Follow-up|9
842696|NCT00369824|1799910|FG005|Overall Study|Lost to Follow-up|6
842697|NCT00369824|1799905|FG000|Overall Study|Other|0
842698|NCT00369824|1799906|FG001|Overall Study|Other|0
842699|NCT00369824|1799907|FG002|Overall Study|Other|0
842700|NCT00369824|1799908|FG003|Overall Study|Other|2
842701|NCT00369824|1799909|FG004|Overall Study|Other|1
842702|NCT00369824|1799910|FG005|Overall Study|Other|3
842703|NCT00369915|1799926|FG000|Overall Study|expected side effects|2
842704|NCT00369915|1799927|FG001|Overall Study|expected side effects|1
842705|NCT00369915|1799926|FG000|Overall Study|Withdrawal by Subject|4
842706|NCT00369915|1799927|FG001|Overall Study|Withdrawal by Subject|1
842707|NCT00369915|1799926|FG000|Overall Study|W/drawl by investigators|0
842708|NCT00369915|1799927|FG001|Overall Study|W/drawl by investigators|1
842709|NCT00369941|1799948|FG000|Overall Study|Never Treated|1
842710|NCT00369941|1799949|FG001|Overall Study|Never Treated|2
842711|NCT00369941|1799948|FG000|Overall Study|Adverse Event|14
842712|NCT00369941|1799949|FG001|Overall Study|Adverse Event|28
842713|NCT00369941|1799948|FG000|Overall Study|Lack of Efficacy|6
842714|NCT00369941|1799949|FG001|Overall Study|Lack of Efficacy|10
842715|NCT00369941|1799948|FG000|Overall Study|Lost to Follow-up|12
842716|NCT00369941|1799949|FG001|Overall Study|Lost to Follow-up|22
842717|NCT00369941|1799948|FG000|Overall Study|Protocol Violation|5
842718|NCT00369941|1799949|FG001|Overall Study|Protocol Violation|3
842719|NCT00369941|1799948|FG000|Overall Study|Withdrawal by Subject|5
842720|NCT00369941|1799949|FG001|Overall Study|Withdrawal by Subject|18
842721|NCT00369941|1799948|FG000|Overall Study|Pregnancy|4
842722|NCT00369941|1799949|FG001|Overall Study|Pregnancy|2
842723|NCT00369941|1799948|FG000|Overall Study|Completed, Did Not Enter Extension|5
842724|NCT00369941|1799949|FG001|Overall Study|Completed, Did Not Enter Extension|6
842725|NCT00369941|1799948|FG000|Overall Study|Moved|11
842726|NCT00369941|1799949|FG001|Overall Study|Moved|5
842727|NCT00369941|1799948|FG000|Overall Study|Treatment with Prohibited Medication|3
842728|NCT00369941|1799949|FG001|Overall Study|Treatment with Prohibited Medication|1
842729|NCT00369941|1799948|FG000|Overall Study|Employment Interfered with Study Visits|1
842730|NCT00369941|1799949|FG001|Overall Study|Employment Interfered with Study Visits|0
842731|NCT00369941|1799948|FG000|Overall Study|Study Site Terminated|2
842732|NCT00369941|1799949|FG001|Overall Study|Study Site Terminated|0
842733|NCT00369941|1799948|FG000|Overall Study|Miscellaneous|3
842734|NCT00369941|1799949|FG001|Overall Study|Miscellaneous|3
842735|NCT00369967|1799958|FG000|Overall Study|Lost to Follow-up|23
842736|NCT00369967|1799959|FG001|Overall Study|Lost to Follow-up|12
842737|NCT00370032|1799971|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
842738|NCT00370032|1799972|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
842739|NCT00370032|1799971|FG000|Washout Period|Withdrawal by Subject|0
842740|NCT00370032|1799972|FG001|Washout Period|Withdrawal by Subject|1
842741|NCT00370032|1799971|FG000|Washout Period|Lost to Follow-up|0
842742|NCT00370032|1799972|FG001|Washout Period|Lost to Follow-up|1
842743|NCT00370032|1799971|FG000|Washout Period|Adverse Event|1
842744|NCT00370032|1799972|FG001|Washout Period|Adverse Event|0
842745|NCT00370032|1799971|FG000|Follow-up Period|Withdrawal by Subject|1
842746|NCT00370032|1799972|FG001|Follow-up Period|Withdrawal by Subject|0
842747|NCT00370071|1799987|FG000|Overall Study|Withdrawal by Subject|2
842748|NCT00370149|1799993|FG000|Overall Study|Physician Decision|16
842749|NCT00370149|1799994|FG001|Overall Study|Physician Decision|16
842750|NCT00370149|1799993|FG000|Overall Study|Protocol Violation|1
842751|NCT00370149|1799994|FG001|Overall Study|Protocol Violation|0
842752|NCT00370149|1799993|FG000|Overall Study|Catheter inserted in wrong vessel-|2
842753|NCT00370149|1799994|FG001|Overall Study|Catheter inserted in wrong vessel-|1
842754|NCT00370149|1799993|FG000|Overall Study|Pre-existing infection|0
842755|NCT00370149|1799994|FG001|Overall Study|Pre-existing infection|1
842756|NCT00370149|1799993|FG000|Overall Study|Antibiotic coated dressing placed|0
842757|NCT00370149|1799994|FG001|Overall Study|Antibiotic coated dressing placed|1
842758|NCT00370292|1800005|FG000|Overall Study|Disease Progression|4
842759|NCT00370292|1800005|FG000|Overall Study|Adverse Event|7
842760|NCT00370292|1800005|FG000|Overall Study|Physician Decision|2
842761|NCT00370331|1800018|FG000|Overall Study|Adverse Event|4
842762|NCT00370331|1800019|FG001|Overall Study|Adverse Event|13
842763|NCT00370331|1800018|FG000|Overall Study|Withdrawal by Subject|2
842764|NCT00370331|1800019|FG001|Overall Study|Withdrawal by Subject|4
842765|NCT00370331|1800018|FG000|Overall Study|Lost to Follow-up|0
842766|NCT00370331|1800019|FG001|Overall Study|Lost to Follow-up|3
842767|NCT00370331|1800018|FG000|Overall Study|Lack of Efficacy|0
842768|NCT00370331|1800019|FG001|Overall Study|Lack of Efficacy|1
842769|NCT00370331|1800018|FG000|Overall Study|Non-compliance|0
842770|NCT00370331|1800019|FG001|Overall Study|Non-compliance|1
842771|NCT00370331|1800018|FG000|Overall Study|Protocol Violation|1
842772|NCT00370331|1800019|FG001|Overall Study|Protocol Violation|1
842773|NCT00370396|1800028|FG000|Overall Study|Withdrawal by Subject|0
842774|NCT00370396|1800029|FG001|Overall Study|Withdrawal by Subject|0
842775|NCT00370396|1800030|FG002|Overall Study|Withdrawal by Subject|1
842776|NCT00370396|1800028|FG000|Overall Study|Lost to Follow-up|11
842777|NCT00370396|1800029|FG001|Overall Study|Lost to Follow-up|1
842778|NCT00370396|1800030|FG002|Overall Study|Lost to Follow-up|0
842779|NCT00370552|1800041|FG000|Overall Study|Adverse Event|2
842780|NCT00370552|1800042|FG001|Overall Study|Adverse Event|2
842781|NCT00370552|1800043|FG002|Overall Study|Adverse Event|2
842782|NCT00370552|1800041|FG000|Overall Study|Disease progression|23
842783|NCT00370552|1800042|FG001|Overall Study|Disease progression|23
842784|NCT00370552|1800043|FG002|Overall Study|Disease progression|15
842785|NCT00370552|1800041|FG000|Overall Study|Maximum clinical benefit|3
842786|NCT00370552|1800042|FG001|Overall Study|Maximum clinical benefit|5
842787|NCT00370552|1800043|FG002|Overall Study|Maximum clinical benefit|5
842788|NCT00370552|1800041|FG000|Overall Study|Poor or noncompliance|0
842789|NCT00370552|1800042|FG001|Overall Study|Poor or noncompliance|0
842790|NCT00370552|1800043|FG002|Overall Study|Poor or noncompliance|1
842791|NCT00370552|1800041|FG000|Overall Study|Study drug toxicity|11
842792|NCT00370552|1800042|FG001|Overall Study|Study drug toxicity|8
842793|NCT00370552|1800043|FG002|Overall Study|Study drug toxicity|6
842794|NCT00370552|1800041|FG000|Overall Study|Withdrawal by Subject|2
842795|NCT00370552|1800042|FG001|Overall Study|Withdrawal by Subject|0
842796|NCT00370552|1800043|FG002|Overall Study|Withdrawal by Subject|1
842797|NCT00370552|1800041|FG000|Overall Study|Still on treatment|1
842798|NCT00370552|1800042|FG001|Overall Study|Still on treatment|3
842799|NCT00370552|1800043|FG002|Overall Study|Still on treatment|2
842800|NCT00370552|1800041|FG000|Overall Study|Never treated|1
842801|NCT00370552|1800042|FG001|Overall Study|Never treated|0
842802|NCT00370552|1800043|FG002|Overall Study|Never treated|0
842803|NCT00370552|1800041|FG000|Overall Study|Physician Decision|1
842804|NCT00370552|1800042|FG001|Overall Study|Physician Decision|1
842805|NCT00370552|1800043|FG002|Overall Study|Physician Decision|0
842806|NCT00370552|1800041|FG000|Overall Study|Investigator decision|2
842807|NCT00370552|1800042|FG001|Overall Study|Investigator decision|1
842808|NCT00370552|1800043|FG002|Overall Study|Investigator decision|0
842809|NCT00370552|1800041|FG000|Overall Study|High risk of allergic reaction|0
842810|NCT00370552|1800042|FG001|Overall Study|High risk of allergic reaction|1
842811|NCT00370552|1800043|FG002|Overall Study|High risk of allergic reaction|0
842812|NCT00370552|1800041|FG000|Overall Study|Planned radiation for palliation|0
842813|NCT00370552|1800042|FG001|Overall Study|Planned radiation for palliation|1
842814|NCT00370552|1800043|FG002|Overall Study|Planned radiation for palliation|0
842815|NCT00370682|1800054|FG000|Overall Study|Moved from area|0
842816|NCT00370682|1800055|FG001|Overall Study|Moved from area|2
842817|NCT00370682|1800056|FG002|Overall Study|Moved from area|0
842818|NCT00370682|1800054|FG000|Overall Study|Lost to Follow-up|0
842819|NCT00370682|1800055|FG001|Overall Study|Lost to Follow-up|1
842820|NCT00370682|1800056|FG002|Overall Study|Lost to Follow-up|1
842821|NCT00371137|1800089|FG000|Overall Study|Adverse Event|20
842822|NCT00371137|1800090|FG001|Overall Study|Adverse Event|35
842823|NCT00371137|1800091|FG002|Overall Study|Adverse Event|42
842824|NCT00371137|1800089|FG000|Overall Study|Withdrawal by Subject|11
842825|NCT00371137|1800090|FG001|Overall Study|Withdrawal by Subject|10
842826|NCT00371137|1800091|FG002|Overall Study|Withdrawal by Subject|15
842827|NCT00371137|1800089|FG000|Overall Study|Lost to Follow-up|6
842828|NCT00371137|1800090|FG001|Overall Study|Lost to Follow-up|3
842829|NCT00371137|1800091|FG002|Overall Study|Lost to Follow-up|5
842830|NCT00371137|1800089|FG000|Overall Study|Lack of Efficacy|30
842831|NCT00371137|1800090|FG001|Overall Study|Lack of Efficacy|12
842832|NCT00371137|1800091|FG002|Overall Study|Lack of Efficacy|13
842833|NCT00371137|1800089|FG000|Overall Study|Sponsor Decision|2
842834|NCT00371137|1800090|FG001|Overall Study|Sponsor Decision|1
842835|NCT00371137|1800091|FG002|Overall Study|Sponsor Decision|2
842836|NCT00371137|1800089|FG000|Overall Study|Physician Decision|1
842837|NCT00371137|1800090|FG001|Overall Study|Physician Decision|1
842838|NCT00371137|1800091|FG002|Overall Study|Physician Decision|1
842839|NCT00371137|1800089|FG000|Overall Study|Protocol Violation|2
842840|NCT00371137|1800090|FG001|Overall Study|Protocol Violation|1
842841|NCT00371137|1800091|FG002|Overall Study|Protocol Violation|1
842842|NCT00371150|1800101|FG000|Overall Study|Lost to Follow-up|3
842843|NCT00371150|1800102|FG001|Overall Study|Lost to Follow-up|2
842844|NCT00371254|1800123|FG000|Overall Study|Disease progression|13
842845|NCT00371254|1800124|FG001|Overall Study|Disease progression|13
842846|NCT00371254|1800123|FG000|Overall Study|Study drug toxicity|3
842847|NCT00371254|1800124|FG001|Overall Study|Study drug toxicity|5
842848|NCT00371254|1800123|FG000|Overall Study|Subject request|5
842849|NCT00371254|1800124|FG001|Overall Study|Subject request|0
842850|NCT00371254|1800123|FG000|Overall Study|Investigator Decision|2
842851|NCT00371254|1800124|FG001|Overall Study|Investigator Decision|0
842852|NCT00371254|1800123|FG000|Overall Study|Adverse event unrelated to study drug|0
842853|NCT00371254|1800124|FG001|Overall Study|Adverse event unrelated to study drug|1
842854|NCT00371254|1800123|FG000|Overall Study|Lost to Follow-up|0
842855|NCT00371254|1800124|FG001|Overall Study|Lost to Follow-up|1
842856|NCT00371254|1800123|FG000|Overall Study|Withdrawal by Subject|0
842857|NCT00371254|1800124|FG001|Overall Study|Withdrawal by Subject|1
842858|NCT00371345|1800155|FG000|Overall Study|Disease Progression|21
842859|NCT00371345|1800156|FG001|Overall Study|Disease Progression|35
842860|NCT00371345|1800155|FG000|Overall Study|Study Drug Toxicity|1
842861|NCT00371345|1800156|FG001|Overall Study|Study Drug Toxicity|7
842862|NCT00371345|1800155|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1
842863|NCT00371345|1800156|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2
842864|NCT00371345|1800155|FG000|Overall Study|Participant Request|1
842865|NCT00371345|1800156|FG001|Overall Study|Participant Request|1
842866|NCT00371345|1800155|FG000|Overall Study|Participant Withdrew Consent|0
842867|NCT00371345|1800156|FG001|Overall Study|Participant Withdrew Consent|1
842868|NCT00371397|1800176|FG000|Session 1|Withdrawal by Subject|1
842869|NCT00371397|1800177|FG001|Session 1|Withdrawal by Subject|0
842870|NCT00371397|1800178|FG002|Session 1|Withdrawal by Subject|0
842871|NCT00371397|1800179|FG003|Session 1|Withdrawal by Subject|0
842872|NCT00371397|1800180|FG004|Session 1|Withdrawal by Subject|0
842873|NCT00371397|1800181|FG005|Session 1|Withdrawal by Subject|0
842874|NCT00371397|1800182|FG006|Session 1|Withdrawal by Subject|0
842875|NCT00371397|1800183|FG007|Session 1|Withdrawal by Subject|1
842876|NCT00371397|1800184|FG008|Session 1|Withdrawal by Subject|0
842877|NCT00371397|1800185|FG009|Session 1|Withdrawal by Subject|0
842878|NCT00371397|1800186|FG010|Session 1|Withdrawal by Subject|0
842879|NCT00371397|1800187|FG011|Session 1|Withdrawal by Subject|0
842880|NCT00371566|1800219|FG000|Treatment Phase|Withdrawal by Subject|0
842881|NCT00371566|1800220|FG001|Treatment Phase|Withdrawal by Subject|1
842882|NCT00371566|1800219|FG000|Treatment Phase|Adverse Event|0
842883|NCT00371566|1800220|FG001|Treatment Phase|Adverse Event|1
842884|NCT00371566|1800219|FG000|Treatment Phase|Protocol Violation|0
842885|NCT00371566|1800220|FG001|Treatment Phase|Protocol Violation|1
842886|NCT00371566|1800219|FG000|Chemoradiation Phase|Physician Decision|2
842887|NCT00371566|1800220|FG001|Chemoradiation Phase|Physician Decision|0
842888|NCT00371566|1800219|FG000|Chemoradiation Phase|Withdrawal by Subject|0
842889|NCT00371566|1800220|FG001|Chemoradiation Phase|Withdrawal by Subject|1
842890|NCT00371566|1800219|FG000|Chemoradiation Phase|Non compliant|0
842891|NCT00371566|1800220|FG001|Chemoradiation Phase|Non compliant|1
842892|NCT00371566|1800219|FG000|Chemoradiation Phase|Progressive Disease|1
842893|NCT00371566|1800220|FG001|Chemoradiation Phase|Progressive Disease|1
842894|NCT00371566|1800219|FG000|Chemoradiation Phase|Death|2
842895|NCT00371566|1800220|FG001|Chemoradiation Phase|Death|0
842896|NCT00371566|1800219|FG000|Follow Up Phase|Death|0
842897|NCT00371566|1800220|FG001|Follow Up Phase|Death|5
842898|NCT00371566|1800219|FG000|Follow Up Phase|Disease progression|1
842899|NCT00371566|1800220|FG001|Follow Up Phase|Disease progression|0
842900|NCT00371566|1800219|FG000|Follow Up Phase|Withdrawal by Subject|0
842901|NCT00371566|1800220|FG001|Follow Up Phase|Withdrawal by Subject|1
842902|NCT00371566|1800219|FG000|Follow Up Phase|Physician Decision|1
842903|NCT00371566|1800220|FG001|Follow Up Phase|Physician Decision|1
842904|NCT00371566|1800219|FG000|Follow Up Phase|Lost to Follow-up|1
842905|NCT00371566|1800220|FG001|Follow Up Phase|Lost to Follow-up|0
842906|NCT00371683|1800241|FG000|DB Treatment Period-Randomized Patients|Death|1
842907|NCT00371683|1800242|FG001|DB Treatment Period-Randomized Patients|Death|1
842908|NCT00371683|1800241|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60
842909|NCT00371683|1800242|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58
842910|NCT00371683|1800241|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
842911|NCT00371683|1800242|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
842912|NCT00371683|1800241|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
842913|NCT00371683|1800242|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
842914|NCT00371683|1800241|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
842915|NCT00371683|1800242|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
842916|NCT00371683|1800241|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
842917|NCT00371683|1800242|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
842918|NCT00371683|1800241|FG000|DB Treatment Period-Randomized Patients|non-specified|9
842919|NCT00371683|1800242|FG001|DB Treatment Period-Randomized Patients|non-specified|8
842920|NCT00371683|1800241|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
842921|NCT00371683|1800242|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
842922|NCT00371683|1800241|FG000|Follow-Up Period - Randomized Patients|Death|0
842923|NCT00371683|1800242|FG001|Follow-Up Period - Randomized Patients|Death|2
842924|NCT00371683|1800241|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
842925|NCT00371683|1800242|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
842926|NCT00371683|1800241|FG000|Follow-Up Period - Randomized Patients|non-specified|6
842927|NCT00371683|1800242|FG001|Follow-Up Period - Randomized Patients|non-specified|12
842928|NCT00371761|1800260|FG000|Overall Study|Adverse Event|1
842929|NCT00371761|1800261|FG001|Overall Study|Adverse Event|1
842930|NCT00371761|1800260|FG000|Overall Study|Withdrawal by Subject|1
842931|NCT00371761|1800261|FG001|Overall Study|Withdrawal by Subject|3
842932|NCT00371761|1800260|FG000|Overall Study|Investigator Judgment|2
842933|NCT00371761|1800261|FG001|Overall Study|Investigator Judgment|3
842934|NCT00371761|1800260|FG000|Overall Study|Study termination|4
842935|NCT00371761|1800261|FG001|Overall Study|Study termination|3
842936|NCT00371787|1800269|FG000|Overall Study|Withdrawal by Subject|3
842937|NCT00371787|1800270|FG001|Overall Study|Withdrawal by Subject|1
842938|NCT00371826|1800279|FG000|Core Phase (12 Months)|Adverse Event|15
842939|NCT00371826|1800280|FG001|Core Phase (12 Months)|Adverse Event|4
842940|NCT00371826|1800281|FG002|Core Phase (12 Months)|Adverse Event|9
842941|NCT00371826|1800279|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1
842942|NCT00371826|1800280|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0
842943|NCT00371826|1800281|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1
842944|NCT00371826|1800279|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
842945|NCT00371826|1800280|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
842946|NCT00371826|1800281|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
842947|NCT00371826|1800279|FG000|Core Phase (12 Months)|Protocol Violation|1
842948|NCT00371826|1800280|FG001|Core Phase (12 Months)|Protocol Violation|0
842949|NCT00371826|1800281|FG002|Core Phase (12 Months)|Protocol Violation|1
842950|NCT00371826|1800279|FG000|Core Phase (12 Months)|Subject withdrew consent|0
842951|NCT00371826|1800280|FG001|Core Phase (12 Months)|Subject withdrew consent|0
842952|NCT00371826|1800281|FG002|Core Phase (12 Months)|Subject withdrew consent|3
842953|NCT00371826|1800279|FG000|Core Phase (12 Months)|Administrative problems|1
842954|NCT00371826|1800280|FG001|Core Phase (12 Months)|Administrative problems|0
842955|NCT00371826|1800281|FG002|Core Phase (12 Months)|Administrative problems|8
842956|NCT00371826|1800279|FG000|Core Phase (12 Months)|Graft Loss|0
842957|NCT00371826|1800280|FG001|Core Phase (12 Months)|Graft Loss|1
842958|NCT00371826|1800281|FG002|Core Phase (12 Months)|Graft Loss|0
842959|NCT00371826|1800279|FG000|Extension Phase (24 Months)|Adverse Event|4
842960|NCT00371826|1800280|FG001|Extension Phase (24 Months)|Adverse Event|5
842961|NCT00371826|1800281|FG002|Extension Phase (24 Months)|Adverse Event|0
842962|NCT00371826|1800279|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
842963|NCT00371826|1800280|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
842964|NCT00371826|1800281|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
842965|NCT00371826|1800279|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
842966|NCT00371826|1800280|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
842967|NCT00371826|1800281|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
842968|NCT00371826|1800279|FG000|Extension Phase (24 Months)|Subject withdrew consent|1
842969|NCT00371826|1800280|FG001|Extension Phase (24 Months)|Subject withdrew consent|2
842970|NCT00371826|1800281|FG002|Extension Phase (24 Months)|Subject withdrew consent|0
842971|NCT00371826|1800279|FG000|Extension Phase (24 Months)|Administrative problems|0
842972|NCT00371826|1800280|FG001|Extension Phase (24 Months)|Administrative problems|0
842973|NCT00371826|1800281|FG002|Extension Phase (24 Months)|Administrative problems|2
842974|NCT00371839|1800292|FG000|Overall Study|Death|4
842975|NCT00371839|1800293|FG001|Overall Study|Death|0
842976|NCT00371839|1800294|FG002|Overall Study|Death|0
842977|NCT00371839|1800292|FG000|Overall Study|Withdrawal by Subject|7
842978|NCT00371839|1800293|FG001|Overall Study|Withdrawal by Subject|4
842979|NCT00371839|1800294|FG002|Overall Study|Withdrawal by Subject|0
842980|NCT00371839|1800292|FG000|Overall Study|Lost to Follow-up|6
842981|NCT00371839|1800293|FG001|Overall Study|Lost to Follow-up|3
842982|NCT00371839|1800294|FG002|Overall Study|Lost to Follow-up|2
842983|NCT00371865|1800302|FG000|Overall Study|Lack of Efficacy|0
842984|NCT00371865|1800303|FG001|Overall Study|Lack of Efficacy|2
842985|NCT00371865|1800302|FG000|Overall Study|Protocol Violation|3
842986|NCT00371865|1800303|FG001|Overall Study|Protocol Violation|2
842987|NCT00371865|1800302|FG000|Overall Study|Withdrawal by Subject|12
842988|NCT00371865|1800303|FG001|Overall Study|Withdrawal by Subject|10
842989|NCT00372060|1800311|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
842990|NCT00372060|1800312|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
842991|NCT00372060|1800311|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
842992|NCT00372060|1800312|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
842993|NCT00372060|1800311|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
842994|NCT00372060|1800312|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
842995|NCT00372060|1800311|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3
842996|NCT00372060|1800312|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0
842997|NCT00372060|1800311|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
842998|NCT00372060|1800312|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
842999|NCT00372060|1800311|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
843000|NCT00372060|1800312|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
843001|NCT00372112|1800325|FG000|Overall Study|Adverse Event|0
843002|NCT00372112|1800326|FG001|Overall Study|Adverse Event|1
843003|NCT00372112|1800327|FG002|Overall Study|Adverse Event|1
843004|NCT00372112|1800328|FG003|Overall Study|Adverse Event|1
843005|NCT00372112|1800325|FG000|Overall Study|Withdrawal by Subject|0
843006|NCT00372112|1800326|FG001|Overall Study|Withdrawal by Subject|0
843007|NCT00372112|1800327|FG002|Overall Study|Withdrawal by Subject|2
843008|NCT00372112|1800328|FG003|Overall Study|Withdrawal by Subject|1
843009|NCT00372112|1800325|FG000|Overall Study|Exacerbation|0
843010|NCT00372112|1800326|FG001|Overall Study|Exacerbation|0
843011|NCT00372112|1800327|FG002|Overall Study|Exacerbation|0
843012|NCT00372112|1800328|FG003|Overall Study|Exacerbation|1
843013|NCT00372112|1800325|FG000|Overall Study|PR >240 at Visit 3|0
843014|NCT00372112|1800326|FG001|Overall Study|PR >240 at Visit 3|0
843015|NCT00372112|1800327|FG002|Overall Study|PR >240 at Visit 3|0
843016|NCT00372112|1800328|FG003|Overall Study|PR >240 at Visit 3|1
843017|NCT00372112|1800325|FG000|Overall Study|Hepatitis B|1
843018|NCT00372112|1800326|FG001|Overall Study|Hepatitis B|0
843019|NCT00372112|1800327|FG002|Overall Study|Hepatitis B|0
843020|NCT00372112|1800328|FG003|Overall Study|Hepatitis B|0
843021|NCT00372112|1800325|FG000|Overall Study|Other-protocol violation|0
843022|NCT00372112|1800326|FG001|Overall Study|Other-protocol violation|0
843023|NCT00372112|1800327|FG002|Overall Study|Other-protocol violation|1
843024|NCT00372112|1800328|FG003|Overall Study|Other-protocol violation|0
843025|NCT00372190|1800343|FG000|Overall Study|Lost to Follow-up|3
843026|NCT00372190|1800344|FG001|Overall Study|Lost to Follow-up|1
843027|NCT00372255|1800367|FG000|Overall Study|Withdrawn for other reasons|2
843028|NCT00372255|1800368|FG001|Overall Study|Withdrawn for other reasons|1
843029|NCT00372385|1800379|FG000|Overall Study|Adverse Event|6
843030|NCT00372385|1800380|FG001|Overall Study|Adverse Event|11
843031|NCT00372385|1800381|FG002|Overall Study|Adverse Event|9
843032|NCT00372385|1800382|FG003|Overall Study|Adverse Event|7
843033|NCT00372385|1800379|FG000|Overall Study|Noncompliance|0
843034|NCT00372385|1800380|FG001|Overall Study|Noncompliance|1
843035|NCT00372385|1800381|FG002|Overall Study|Noncompliance|1
843036|NCT00372385|1800382|FG003|Overall Study|Noncompliance|1
843037|NCT00372385|1800379|FG000|Overall Study|Physician Decision|1
843038|NCT00372385|1800380|FG001|Overall Study|Physician Decision|0
843039|NCT00372385|1800381|FG002|Overall Study|Physician Decision|0
843040|NCT00372385|1800382|FG003|Overall Study|Physician Decision|0
843041|NCT00372385|1800379|FG000|Overall Study|Lost to Follow-up|2
843042|NCT00372385|1800380|FG001|Overall Study|Lost to Follow-up|0
843043|NCT00372385|1800381|FG002|Overall Study|Lost to Follow-up|0
843044|NCT00372385|1800382|FG003|Overall Study|Lost to Follow-up|0
843045|NCT00372385|1800379|FG000|Overall Study|Withdrawal by Subject|2
843046|NCT00372385|1800380|FG001|Overall Study|Withdrawal by Subject|1
843047|NCT00372385|1800381|FG002|Overall Study|Withdrawal by Subject|0
843048|NCT00372385|1800382|FG003|Overall Study|Withdrawal by Subject|0
843049|NCT00372385|1800379|FG000|Overall Study|Refusal of Treatment|3
843050|NCT00372385|1800380|FG001|Overall Study|Refusal of Treatment|6
843051|NCT00372385|1800381|FG002|Overall Study|Refusal of Treatment|0
843052|NCT00372385|1800382|FG003|Overall Study|Refusal of Treatment|0
843053|NCT00372385|1800379|FG000|Overall Study|No Response|1
843054|NCT00372385|1800380|FG001|Overall Study|No Response|1
843055|NCT00372385|1800381|FG002|Overall Study|No Response|0
843056|NCT00372385|1800382|FG003|Overall Study|No Response|0
843057|NCT00372385|1800379|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1
843058|NCT00372385|1800380|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0
843059|NCT00372385|1800381|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0
843060|NCT00372385|1800382|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0
843061|NCT00372385|1800379|FG000|Overall Study|Virologic Stopping Rule|17
843062|NCT00372385|1800380|FG001|Overall Study|Virologic Stopping Rule|0
843063|NCT00372385|1800381|FG002|Overall Study|Virologic Stopping Rule|0
843064|NCT00372385|1800382|FG003|Overall Study|Virologic Stopping Rule|0
843065|NCT00372411|1800396|FG000|Overall Study|Withdrawal by Subject|3
843066|NCT00372411|1800397|FG001|Overall Study|Withdrawal by Subject|4
843067|NCT00372411|1800398|FG002|Overall Study|Withdrawal by Subject|1
843068|NCT00372411|1800396|FG000|Overall Study|Death|0
843069|NCT00372411|1800397|FG001|Overall Study|Death|2
843070|NCT00372411|1800398|FG002|Overall Study|Death|1
843071|NCT00372411|1800396|FG000|Overall Study|Lost to Follow-up|1
843072|NCT00372411|1800397|FG001|Overall Study|Lost to Follow-up|1
843073|NCT00372411|1800398|FG002|Overall Study|Lost to Follow-up|1
843074|NCT00372411|1800396|FG000|Overall Study|Adverse Event|1
843075|NCT00372411|1800397|FG001|Overall Study|Adverse Event|1
843076|NCT00372411|1800398|FG002|Overall Study|Adverse Event|0
843077|NCT00372424|1800406|FG000|Overall Study|Adverse Event|2
843078|NCT00372424|1800406|FG000|Overall Study|Withdrawal by Subject|1
843079|NCT00372424|1800406|FG000|Overall Study|Death|1
843080|NCT00372424|1800406|FG000|Overall Study|Objective Progression or Relapse|14
843081|NCT00372424|1800406|FG000|Overall Study|Other|7
843082|NCT00372424|1800406|FG000|Overall Study|Enrolled, Not Treated|1
843083|NCT00372489|1800410|FG000|Overall Study|Adverse Event|18
843084|NCT00372489|1800410|FG000|Overall Study|Lack of Efficacy|1
843085|NCT00372489|1800410|FG000|Overall Study|Lost to Follow-up|3
843086|NCT00372489|1800410|FG000|Overall Study|Physician Decision|3
843087|NCT00372489|1800410|FG000|Overall Study|Withdrawal by Subject|5
843088|NCT00372489|1800410|FG000|Overall Study|Patient Relocation|2
843089|NCT00372489|1800410|FG000|Overall Study|Renal transplant|6
843090|NCT00372489|1800410|FG000|Overall Study|Sponsor Decision to Terminate Study|41
843091|NCT00372528|1800414|FG000|Overall Study|Lack of Efficacy|1
843092|NCT00372528|1800414|FG000|Overall Study|Adverse Event|1
843093|NCT00372528|1800414|FG000|Overall Study|Study Terminated by Sponsor|18
843094|NCT00372528|1800414|FG000|Overall Study|Other|1
843095|NCT00372567|1800421|FG000|Phase 3 Study|Adverse Event|5
843096|NCT00372567|1800422|FG001|Phase 3 Study|Adverse Event|1
843097|NCT00372567|1800423|FG002|Phase 3 Study|Adverse Event|1
843098|NCT00372567|1800421|FG000|Phase 3 Study|Death|1
843099|NCT00372567|1800422|FG001|Phase 3 Study|Death|1
843100|NCT00372567|1800423|FG002|Phase 3 Study|Death|0
843101|NCT00372567|1800421|FG000|Phase 3 Study|Protocol Violation|0
843102|NCT00372567|1800422|FG001|Phase 3 Study|Protocol Violation|0
843103|NCT00372567|1800423|FG002|Phase 3 Study|Protocol Violation|1
843104|NCT00372567|1800421|FG000|Phase 3 Study|Objective progression or relapse|10
843105|NCT00372567|1800422|FG001|Phase 3 Study|Objective progression or relapse|13
843106|NCT00372567|1800423|FG002|Phase 3 Study|Objective progression or relapse|4
843107|NCT00372567|1800421|FG000|Phase 3 Study|Global deterioration of health status|0
843108|NCT00372567|1800422|FG001|Phase 3 Study|Global deterioration of health status|1
843109|NCT00372567|1800423|FG002|Phase 3 Study|Global deterioration of health status|0
843110|NCT00372567|1800421|FG000|Phase 3 Study|Other|2
843111|NCT00372567|1800422|FG001|Phase 3 Study|Other|2
843112|NCT00372567|1800423|FG002|Phase 3 Study|Other|1
843113|NCT00372567|1800421|FG000|Phase 3 Study|study terminated by sponsor|13
843114|NCT00372567|1800422|FG001|Phase 3 Study|study terminated by sponsor|8
843115|NCT00372567|1800423|FG002|Phase 3 Study|study terminated by sponsor|5
843116|NCT00372593|1800434|FG000|Overall Study|Adverse Event|43
843117|NCT00372593|1800435|FG001|Overall Study|Adverse Event|45
843118|NCT00372593|1800436|FG002|Overall Study|Adverse Event|0
843119|NCT00372593|1800434|FG000|Overall Study|Death|16
843120|NCT00372593|1800435|FG001|Overall Study|Death|20
843121|NCT00372593|1800436|FG002|Overall Study|Death|1
843122|NCT00372593|1800434|FG000|Overall Study|Lack of Efficacy|82
843123|NCT00372593|1800435|FG001|Overall Study|Lack of Efficacy|71
843124|NCT00372593|1800436|FG002|Overall Study|Lack of Efficacy|2
843125|NCT00372593|1800434|FG000|Overall Study|Lost to Follow-up|1
843126|NCT00372593|1800435|FG001|Overall Study|Lost to Follow-up|0
843127|NCT00372593|1800436|FG002|Overall Study|Lost to Follow-up|0
843128|NCT00372593|1800434|FG000|Overall Study|Physician Decision|42
843129|NCT00372593|1800435|FG001|Overall Study|Physician Decision|41
843130|NCT00372593|1800436|FG002|Overall Study|Physician Decision|0
843131|NCT00372593|1800434|FG000|Overall Study|Ineligible|20
843132|NCT00372593|1800435|FG001|Overall Study|Ineligible|21
843133|NCT00372593|1800436|FG002|Overall Study|Ineligible|1
843134|NCT00372619|1800452|FG000|Overall Study|Ineligible|0
843135|NCT00372619|1800453|FG001|Overall Study|Ineligible|0
843136|NCT00372619|1800454|FG002|Overall Study|Ineligible|0
843137|NCT00372619|1800455|FG003|Overall Study|Ineligible|0
843138|NCT00372619|1800456|FG004|Overall Study|Ineligible|0
843139|NCT00372619|1800457|FG005|Overall Study|Ineligible|2
843140|NCT00372619|1800458|FG006|Overall Study|Ineligible|0
843141|NCT00372619|1800452|FG000|Overall Study|Inevaluable|0
843142|NCT00372619|1800453|FG001|Overall Study|Inevaluable|0
843143|NCT00372619|1800454|FG002|Overall Study|Inevaluable|0
843144|NCT00372619|1800455|FG003|Overall Study|Inevaluable|0
843145|NCT00372619|1800456|FG004|Overall Study|Inevaluable|0
843146|NCT00372619|1800457|FG005|Overall Study|Inevaluable|1
843147|NCT00372619|1800458|FG006|Overall Study|Inevaluable|0
843148|NCT00372697|1800476|FG000|Overall Study|Protocol Violation|1
843149|NCT00372697|1800477|FG001|Overall Study|Protocol Violation|1
843150|NCT00372775|1800483|FG000|Overall Study|Adverse Event|8
843151|NCT00372775|1800483|FG000|Overall Study|Death|15
843152|NCT00372775|1800483|FG000|Overall Study|Objective progression or relapse|30
843153|NCT00372775|1800483|FG000|Overall Study|Global deterioration of health status|6
843154|NCT00372775|1800483|FG000|Overall Study|Withdrawal by Subject|1
843155|NCT00372775|1800483|FG000|Overall Study|Other|1
843156|NCT00372775|1800483|FG000|Overall Study|Not Treated|2
843157|NCT00372905|1800487|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
843158|NCT00372905|1800488|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
843159|NCT00372905|1800489|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
843160|NCT00372905|1800490|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
843161|NCT00372905|1800487|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
843162|NCT00372905|1800488|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
843163|NCT00372905|1800489|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
843164|NCT00372905|1800490|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
843165|NCT00372905|1800487|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
843166|NCT00372905|1800488|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
843167|NCT00372905|1800489|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
843168|NCT00372905|1800490|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
843169|NCT00372905|1800487|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
843170|NCT00372905|1800488|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
843171|NCT00372905|1800489|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
843172|NCT00372905|1800490|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
843173|NCT00372905|1800487|FG000|Follow up Until Relapse or Progression|Study closed|0
843174|NCT00372905|1800488|FG001|Follow up Until Relapse or Progression|Study closed|0
843175|NCT00372905|1800489|FG002|Follow up Until Relapse or Progression|Study closed|0
843176|NCT00372905|1800490|FG003|Follow up Until Relapse or Progression|Study closed|3
843177|NCT00372905|1800487|FG000|Follow up Until Relapse or Progression|Other|0
843178|NCT00372905|1800488|FG001|Follow up Until Relapse or Progression|Other|1
843179|NCT00372905|1800489|FG002|Follow up Until Relapse or Progression|Other|0
843180|NCT00372905|1800490|FG003|Follow up Until Relapse or Progression|Other|0
843181|NCT00372996|1800526|FG000|Overall Study|Death|11
843182|NCT00372996|1800527|FG001|Overall Study|Death|4
843183|NCT00372996|1800528|FG002|Overall Study|Death|8
843184|NCT00372996|1800529|FG003|Overall Study|Death|7
843185|NCT00372996|1800526|FG000|Overall Study|Lost to Follow-up|0
843186|NCT00372996|1800527|FG001|Overall Study|Lost to Follow-up|2
843187|NCT00372996|1800528|FG002|Overall Study|Lost to Follow-up|0
843188|NCT00372996|1800529|FG003|Overall Study|Lost to Follow-up|1
843189|NCT00372996|1800526|FG000|Overall Study|Withdrawal by Subject|12
843190|NCT00372996|1800527|FG001|Overall Study|Withdrawal by Subject|6
843191|NCT00372996|1800528|FG002|Overall Study|Withdrawal by Subject|9
843192|NCT00372996|1800529|FG003|Overall Study|Withdrawal by Subject|5
843193|NCT00372996|1800526|FG000|Overall Study|Study Terminated by Sponsor|4
843194|NCT00372996|1800527|FG001|Overall Study|Study Terminated by Sponsor|0
843195|NCT00372996|1800528|FG002|Overall Study|Study Terminated by Sponsor|4
843196|NCT00372996|1800529|FG003|Overall Study|Study Terminated by Sponsor|0
843197|NCT00372996|1800526|FG000|Overall Study|Other|10
843198|NCT00372996|1800527|FG001|Overall Study|Other|2
843199|NCT00372996|1800528|FG002|Overall Study|Other|7
843200|NCT00372996|1800529|FG003|Overall Study|Other|7
843201|NCT00373113|1800541|FG000|Overall Study|Death|1
843202|NCT00373113|1800542|FG001|Overall Study|Death|7
843203|NCT00373113|1800541|FG000|Overall Study|Adverse Event|38
843204|NCT00373113|1800542|FG001|Overall Study|Adverse Event|24
843205|NCT00373113|1800541|FG000|Overall Study|Study terminated by sponsor|9
843206|NCT00373113|1800542|FG001|Overall Study|Study terminated by sponsor|1
843207|NCT00373113|1800541|FG000|Overall Study|Global deterioration of health status|10
843208|NCT00373113|1800542|FG001|Overall Study|Global deterioration of health status|7
843209|NCT00373113|1800541|FG000|Overall Study|Lost to Follow-up|1
843210|NCT00373113|1800542|FG001|Overall Study|Lost to Follow-up|3
843211|NCT00373113|1800541|FG000|Overall Study|Objective progression or relapse|150
843212|NCT00373113|1800542|FG001|Overall Study|Objective progression or relapse|169
843213|NCT00373113|1800541|FG000|Overall Study|Other|14
843214|NCT00373113|1800542|FG001|Overall Study|Other|17
843215|NCT00373113|1800541|FG000|Overall Study|Protocol Violation|5
843216|NCT00373113|1800542|FG001|Overall Study|Protocol Violation|1
843217|NCT00373113|1800541|FG000|Overall Study|Withdrawal by Subject|10
843218|NCT00373113|1800542|FG001|Overall Study|Withdrawal by Subject|15
843219|NCT00373256|1800550|FG000|Overall Study|Adverse Event (AE)|1
843220|NCT00373256|1800551|FG001|Overall Study|Adverse Event (AE)|5
843221|NCT00373256|1800550|FG000|Overall Study|Lost to Follow-up|2
843222|NCT00373256|1800551|FG001|Overall Study|Lost to Follow-up|1
843223|NCT00373256|1800550|FG000|Overall Study|Death|9
843224|NCT00373256|1800551|FG001|Overall Study|Death|8
843225|NCT00373256|1800550|FG000|Overall Study|Objective Progression or Relapse|111
843226|NCT00373256|1800551|FG001|Overall Study|Objective Progression or Relapse|104
843227|NCT00373256|1800550|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4
843228|NCT00373256|1800551|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7
843229|NCT00373256|1800550|FG000|Overall Study|Other|73
843230|NCT00373256|1800551|FG001|Overall Study|Other|107
843231|NCT00373256|1800550|FG000|Overall Study|Protocol Violation|0
843232|NCT00373256|1800551|FG001|Overall Study|Protocol Violation|2
843233|NCT00373256|1800550|FG000|Overall Study|Study Terminated by Sponsor|41
843234|NCT00373256|1800551|FG001|Overall Study|Study Terminated by Sponsor|13
843235|NCT00373295|1800566|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0
843236|NCT00373295|1800567|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2
843237|NCT00373295|1800568|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0
843238|NCT00373295|1800569|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0
843239|NCT00373295|1800570|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1
843240|NCT00373295|1800571|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0
843241|NCT00373425|1800620|FG000|Overall Study|Relapse of NSCLC|116
843242|NCT00373425|1800621|FG001|Overall Study|Relapse of NSCLC|104
843243|NCT00373425|1800622|FG002|Overall Study|Relapse of NSCLC|19
843244|NCT00373425|1800623|FG003|Overall Study|Relapse of NSCLC|2
843245|NCT00373425|1800624|FG004|Overall Study|Relapse of NSCLC|26
843246|NCT00373425|1800620|FG000|Overall Study|Adverse Event|191
843247|NCT00373425|1800621|FG001|Overall Study|Adverse Event|22
843248|NCT00373425|1800622|FG002|Overall Study|Adverse Event|59
843249|NCT00373425|1800623|FG003|Overall Study|Adverse Event|0
843250|NCT00373425|1800624|FG004|Overall Study|Adverse Event|34
843251|NCT00373425|1800620|FG000|Overall Study|Patient request|35
843252|NCT00373425|1800621|FG001|Overall Study|Patient request|18
843253|NCT00373425|1800622|FG002|Overall Study|Patient request|43
843254|NCT00373425|1800623|FG003|Overall Study|Patient request|6
843255|NCT00373425|1800624|FG004|Overall Study|Patient request|7
843256|NCT00373425|1800620|FG000|Overall Study|Medical/ethical/noncompliance reason|21
843257|NCT00373425|1800621|FG001|Overall Study|Medical/ethical/noncompliance reason|9
843258|NCT00373425|1800622|FG002|Overall Study|Medical/ethical/noncompliance reason|10
843259|NCT00373425|1800623|FG003|Overall Study|Medical/ethical/noncompliance reason|2
843260|NCT00373425|1800624|FG004|Overall Study|Medical/ethical/noncompliance reason|5
843261|NCT00373425|1800620|FG000|Overall Study|Death|7
843262|NCT00373425|1800621|FG001|Overall Study|Death|0
843263|NCT00373425|1800622|FG002|Overall Study|Death|3
843264|NCT00373425|1800623|FG003|Overall Study|Death|1
843265|NCT00373425|1800624|FG004|Overall Study|Death|0
843266|NCT00373490|1800635|FG000|Overall Study|Adverse Event|0
843267|NCT00373490|1800636|FG001|Overall Study|Adverse Event|1
843268|NCT00373490|1800635|FG000|Overall Study|Lack of Efficacy|9
843269|NCT00373490|1800636|FG001|Overall Study|Lack of Efficacy|4
843270|NCT00373490|1800635|FG000|Overall Study|Withdrawal by Subject|0
843271|NCT00373490|1800636|FG001|Overall Study|Withdrawal by Subject|1
843272|NCT00373529|1800642|FG000|Overall Study|Physician Decision|19
843273|NCT00373529|1800642|FG000|Overall Study|Withdrawal by Subject|7
843274|NCT00373529|1800642|FG000|Overall Study|Adverse Event|7
843275|NCT00373529|1800642|FG000|Overall Study|Treatment failure|36
843276|NCT00373529|1800642|FG000|Overall Study|Disease recurrence|10
843277|NCT00373529|1800642|FG000|Overall Study|Death|16
843278|NCT00373529|1800642|FG000|Overall Study|Need for treatment prohibited by study|1
843279|NCT00373529|1800642|FG000|Overall Study|Other|8
843280|NCT00373529|1800642|FG000|Overall Study|Failed independent confirmation of AML|3
843281|NCT00373529|1800642|FG000|Overall Study|Consent violation|1
843282|NCT00373685|1800648|FG000|Overall Study|Death|2
843283|NCT00373685|1800649|FG001|Overall Study|Death|1
843284|NCT00373685|1800648|FG000|Overall Study|Adverse Event|278
843285|NCT00373685|1800649|FG001|Overall Study|Adverse Event|253
843286|NCT00373685|1800648|FG000|Overall Study|Insufficient clinical response|169
843287|NCT00373685|1800649|FG001|Overall Study|Insufficient clinical response|119
843288|NCT00373685|1800648|FG000|Overall Study|Did not meet entrance criteria|167
843289|NCT00373685|1800649|FG001|Overall Study|Did not meet entrance criteria|184
843290|NCT00373685|1800648|FG000|Overall Study|Lost to follow up|83
843291|NCT00373685|1800649|FG001|Overall Study|Lost to follow up|103
843292|NCT00373685|1800648|FG000|Overall Study|No longer willing to participate|337
843293|NCT00373685|1800649|FG001|Overall Study|No longer willing to participate|352
843294|NCT00373685|1800648|FG000|Overall Study|Other|149
843295|NCT00373685|1800649|FG001|Overall Study|Other|146
843296|NCT00373685|1800648|FG000|Overall Study|Protocol Violation|191
843297|NCT00373685|1800649|FG001|Overall Study|Protocol Violation|182
843298|NCT00373685|1800648|FG000|Overall Study|Final Status Unknown|12
843299|NCT00373685|1800649|FG001|Overall Study|Final Status Unknown|4
843300|NCT00373685|1800648|FG000|Overall Study|Randomized, not treated|51
843301|NCT00373685|1800649|FG001|Overall Study|Randomized, not treated|77
843302|NCT00373880|1800666|FG000|Overall Study|Physician Decision|3
843303|NCT00373880|1800666|FG000|Overall Study|Arrested|1
843304|NCT00373880|1800666|FG000|Overall Study|Protocol Violation|14
843305|NCT00373958|1800680|FG000|Infant Series|Withdrawal by Subject|13
843306|NCT00373958|1800681|FG001|Infant Series|Withdrawal by Subject|15
843307|NCT00373958|1800680|FG000|Infant Series|Failed to return|8
843308|NCT00373958|1800681|FG001|Infant Series|Failed to return|13
843309|NCT00373958|1800680|FG000|Infant Series|Lost to Follow-up|6
843310|NCT00373958|1800681|FG001|Infant Series|Lost to Follow-up|5
843311|NCT00373958|1800680|FG000|Infant Series|Protocol Violation|3
843312|NCT00373958|1800681|FG001|Infant Series|Protocol Violation|7
843313|NCT00373958|1800680|FG000|Infant Series|Lost Kaiser coverage|4
843314|NCT00373958|1800681|FG001|Infant Series|Lost Kaiser coverage|0
843315|NCT00373958|1800680|FG000|Infant Series|Child relocated|1
843316|NCT00373958|1800681|FG001|Infant Series|Child relocated|0
843317|NCT00373958|1800680|FG000|Infant Series|Consent was not received|1
843318|NCT00373958|1800681|FG001|Infant Series|Consent was not received|0
843319|NCT00373958|1800680|FG000|Infant Series|Adverse Event|3
843320|NCT00373958|1800681|FG001|Infant Series|Adverse Event|1
843321|NCT00373958|1800680|FG000|Infant Series|Physician Decision|1
843322|NCT00373958|1800681|FG001|Infant Series|Physician Decision|1
843323|NCT00373958|1800680|FG000|Toddler Dose|Lost to Follow-up|5
843324|NCT00373958|1800681|FG001|Toddler Dose|Lost to Follow-up|8
843325|NCT00373958|1800680|FG000|Toddler Dose|Withdrawal by Subject|2
843326|NCT00373958|1800681|FG001|Toddler Dose|Withdrawal by Subject|2
843327|NCT00373958|1800680|FG000|Toddler Dose|Failed to return|1
843328|NCT00373958|1800681|FG001|Toddler Dose|Failed to return|2
843329|NCT00373958|1800680|FG000|Toddler Dose|Protocol Violation|0
843330|NCT00373958|1800681|FG001|Toddler Dose|Protocol Violation|1
843331|NCT00373958|1800680|FG000|Toddler Dose|Withdrawn after infant series|22
843332|NCT00373958|1800681|FG001|Toddler Dose|Withdrawn after infant series|25
843333|NCT00374127|1800719|FG000|Overall Study|Did not inhale during smoking procedure.|3
843334|NCT00374127|1800719|FG000|Overall Study|Blood could not be drawn.|2
843335|NCT00374127|1800719|FG000|Overall Study|Protocol Violation|5
843336|NCT00374127|1800719|FG000|Overall Study|Pregnancy|1
843337|NCT00374140|1800729|FG000|Overall Study|Lost to Follow-up|1
843338|NCT00374140|1800729|FG000|Overall Study|Protocol Violation|1
843339|NCT00374322|1800749|FG000|Overall Study|Lost to Follow-up|92
843340|NCT00374322|1800750|FG001|Overall Study|Lost to Follow-up|90
843341|NCT00374322|1800749|FG000|Overall Study|Protocol Violation|8
843342|NCT00374322|1800750|FG001|Overall Study|Protocol Violation|3
843343|NCT00374322|1800749|FG000|Overall Study|Withdrawal by Subject|235
843344|NCT00374322|1800750|FG001|Overall Study|Withdrawal by Subject|167
843345|NCT00374322|1800749|FG000|Overall Study|Sponsor Terminated Study|866
843346|NCT00374322|1800750|FG001|Overall Study|Sponsor Terminated Study|990
843347|NCT00374322|1800749|FG000|Overall Study|Physician Decision|36
843348|NCT00374322|1800750|FG001|Overall Study|Physician Decision|32
843349|NCT00374322|1800749|FG000|Overall Study|Par. Consented to Survival FU Only|3
843350|NCT00374322|1800750|FG001|Overall Study|Par. Consented to Survival FU Only|1
843351|NCT00374322|1800749|FG000|Overall Study|Sponsor Decision|2
843352|NCT00374322|1800750|FG001|Overall Study|Sponsor Decision|3
843353|NCT00374322|1800749|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2
843354|NCT00374322|1800750|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3
843355|NCT00374322|1800749|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1
843356|NCT00374322|1800750|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0
843357|NCT00374322|1800749|FG000|Overall Study|Severe Toxicity|1
843358|NCT00374322|1800750|FG001|Overall Study|Severe Toxicity|0
843359|NCT00374322|1800749|FG000|Overall Study|Site Closed|2
843360|NCT00374322|1800750|FG001|Overall Study|Site Closed|2
843361|NCT00374322|1800749|FG000|Overall Study|Participant Changed Physician|1
843362|NCT00374322|1800750|FG001|Overall Study|Participant Changed Physician|0
843363|NCT00374322|1800749|FG000|Overall Study|Started Another Chemotherapy Regimen|0
843364|NCT00374322|1800750|FG001|Overall Study|Started Another Chemotherapy Regimen|1
843365|NCT00374322|1800749|FG000|Overall Study|Noncompliance with Study Requirements|0
843366|NCT00374322|1800750|FG001|Overall Study|Noncompliance with Study Requirements|1
843367|NCT00374322|1800749|FG000|Overall Study|Withdrew Consent During Follow-up|0
843368|NCT00374322|1800750|FG001|Overall Study|Withdrew Consent During Follow-up|5
843369|NCT00374322|1800749|FG000|Overall Study|Did Not Receive Study Medication|8
843370|NCT00374322|1800750|FG001|Overall Study|Did Not Receive Study Medication|6
843371|NCT00374452|1800763|FG000|Overall Study|Left clinic before intervention started|4
843372|NCT00374452|1800764|FG001|Overall Study|Left clinic before intervention started|1
843373|NCT00374452|1800763|FG000|Overall Study|Change in job role before intervention|0
843374|NCT00374452|1800764|FG001|Overall Study|Change in job role before intervention|1
843375|NCT00374452|1800763|FG000|Overall Study|Left clinic after intervention started|1
843376|NCT00374452|1800764|FG001|Overall Study|Left clinic after intervention started|1
843377|NCT00374452|1800763|FG000|Overall Study|Withdrawal by Subject|0
843378|NCT00374452|1800764|FG001|Overall Study|Withdrawal by Subject|2
843379|NCT00374556|1800772|FG000|Overall Study|Lost to Follow-up|1
843380|NCT00374556|1800773|FG001|Overall Study|Lost to Follow-up|0
843381|NCT00374556|1800772|FG000|Overall Study|Removed at baseline due to medical cond|0
843382|NCT00374556|1800773|FG001|Overall Study|Removed at baseline due to medical cond|1
843383|NCT00374868|1800805|FG000|Overall Study|Adverse Event|12
843384|NCT00374868|1800805|FG000|Overall Study|Progressive Disease|7
843385|NCT00374868|1800805|FG000|Overall Study|Physician Decision|13
843386|NCT00374868|1800805|FG000|Overall Study|Lost to Follow-up|1
843387|NCT00374868|1800805|FG000|Overall Study|Death|2
843388|NCT00374868|1800805|FG000|Overall Study|Other - Not Specified|1
843389|NCT00374907|1800811|FG000|12-Week Short-term Period|Subject Withdrew Consent|3
843390|NCT00374907|1800812|FG001|12-Week Short-term Period|Subject Withdrew Consent|1
843391|NCT00374907|1800811|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
843392|NCT00374907|1800812|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
843393|NCT00374907|1800811|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4
843394|NCT00374907|1800812|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2
843395|NCT00374907|1800811|FG000|116-Week Short-term + Long-term Period|Adverse Event|0
843396|NCT00374907|1800812|FG001|116-Week Short-term + Long-term Period|Adverse Event|2
843397|NCT00374907|1800811|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1
843398|NCT00374907|1800812|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1
843399|NCT00375219|1800834|FG000|Overall Study|Failure to achieve a response|16
843400|NCT00375219|1800835|FG001|Overall Study|Failure to achieve a response|2
843401|NCT00375219|1800836|FG002|Overall Study|Failure to achieve a response|0
843402|NCT00375219|1800834|FG000|Overall Study|Adverse Event|8
843403|NCT00375219|1800835|FG001|Overall Study|Adverse Event|2
843404|NCT00375219|1800836|FG002|Overall Study|Adverse Event|1
843405|NCT00375219|1800834|FG000|Overall Study|Protocol Violation|1
843406|NCT00375219|1800835|FG001|Overall Study|Protocol Violation|0
843407|NCT00375219|1800836|FG002|Overall Study|Protocol Violation|1
843408|NCT00375219|1800834|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5
843409|NCT00375219|1800835|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3
843410|NCT00375219|1800836|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0
843411|NCT00375219|1800834|FG000|Overall Study|Lost to Follow-up|1
843412|NCT00375219|1800835|FG001|Overall Study|Lost to Follow-up|1
843413|NCT00375219|1800836|FG002|Overall Study|Lost to Follow-up|0
843414|NCT00375219|1800834|FG000|Overall Study|Disease progression|18
843415|NCT00375219|1800835|FG001|Overall Study|Disease progression|9
843416|NCT00375219|1800836|FG002|Overall Study|Disease progression|12
843417|NCT00375219|1800834|FG000|Overall Study|Death|4
843418|NCT00375219|1800835|FG001|Overall Study|Death|3
843419|NCT00375219|1800836|FG002|Overall Study|Death|7
843420|NCT00375219|1800834|FG000|Overall Study|Hematologic resistance|1
843421|NCT00375219|1800835|FG001|Overall Study|Hematologic resistance|0
843422|NCT00375219|1800836|FG002|Overall Study|Hematologic resistance|0
843423|NCT00375219|1800834|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1
843424|NCT00375219|1800835|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0
843425|NCT00375219|1800836|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0
843426|NCT00375219|1800834|FG000|Overall Study|Allograft|2
843427|NCT00375219|1800835|FG001|Overall Study|Allograft|0
843428|NCT00375219|1800836|FG002|Overall Study|Allograft|0
843429|NCT00375219|1800834|FG000|Overall Study|Cord blood transplantation|1
843430|NCT00375219|1800835|FG001|Overall Study|Cord blood transplantation|0
843431|NCT00375219|1800836|FG002|Overall Study|Cord blood transplantation|0
843432|NCT00375219|1800834|FG000|Overall Study|Withdrawal by Subject|1
843433|NCT00375219|1800835|FG001|Overall Study|Withdrawal by Subject|0
843434|NCT00375219|1800836|FG002|Overall Study|Withdrawal by Subject|0
843435|NCT00375427|1800845|FG000|Overall Study|Adverse Event|21
843436|NCT00375427|1800846|FG001|Overall Study|Adverse Event|27
843437|NCT00375427|1800845|FG000|Overall Study|Abnormal test procedure result(s)|0
843438|NCT00375427|1800846|FG001|Overall Study|Abnormal test procedure result(s)|1
843439|NCT00375427|1800845|FG000|Overall Study|Abnormal laboratory value(s)|1
843440|NCT00375427|1800846|FG001|Overall Study|Abnormal laboratory value(s)|2
843441|NCT00375427|1800845|FG000|Overall Study|Unsatisfactory therapeutic effect|4
843442|NCT00375427|1800846|FG001|Overall Study|Unsatisfactory therapeutic effect|4
843443|NCT00375427|1800845|FG000|Overall Study|Patient no longer requires study drug|3
843444|NCT00375427|1800846|FG001|Overall Study|Patient no longer requires study drug|7
843445|NCT00375427|1800845|FG000|Overall Study|Protocol Violation|10
843446|NCT00375427|1800846|FG001|Overall Study|Protocol Violation|8
843447|NCT00375427|1800845|FG000|Overall Study|Withdrawal by Subject|9
843448|NCT00375427|1800846|FG001|Overall Study|Withdrawal by Subject|13
843449|NCT00375427|1800845|FG000|Overall Study|Lost to Follow-up|1
843450|NCT00375427|1800846|FG001|Overall Study|Lost to Follow-up|1
843451|NCT00375427|1800845|FG000|Overall Study|Administrative reasons|0
843452|NCT00375427|1800846|FG001|Overall Study|Administrative reasons|1
843453|NCT00375427|1800845|FG000|Overall Study|Death|11
843454|NCT00375427|1800846|FG001|Overall Study|Death|10
843455|NCT00375492|1800854|FG000|Overall Study|Adverse Event|4
843456|NCT00375492|1800855|FG001|Overall Study|Adverse Event|5
843457|NCT00375492|1800854|FG000|Overall Study|Entry Criteria Not Met|0
843458|NCT00375492|1800855|FG001|Overall Study|Entry Criteria Not Met|1
843459|NCT00375492|1800854|FG000|Overall Study|Loss of Glucose Control|0
843460|NCT00375492|1800855|FG001|Overall Study|Loss of Glucose Control|1
843461|NCT00375492|1800854|FG000|Overall Study|Lost to Follow-up|10
843462|NCT00375492|1800855|FG001|Overall Study|Lost to Follow-up|5
843463|NCT00375492|1800854|FG000|Overall Study|Physician Decision|0
843464|NCT00375492|1800855|FG001|Overall Study|Physician Decision|4
843465|NCT00375492|1800854|FG000|Overall Study|Protocol Violation|6
843466|NCT00375492|1800855|FG001|Overall Study|Protocol Violation|3
843467|NCT00375492|1800854|FG000|Overall Study|Sponsor Decision|0
843468|NCT00375492|1800855|FG001|Overall Study|Sponsor Decision|1
843469|NCT00375492|1800854|FG000|Overall Study|Withdrawal by Subject|6
843470|NCT00375492|1800855|FG001|Overall Study|Withdrawal by Subject|6
843471|NCT00375505|1800863|FG000|Overall Study|Adverse Event|1
843472|NCT00375505|1800864|FG001|Overall Study|Adverse Event|2
843473|NCT00375518|1800872|FG000|Overall Study|Withdrawal by Subject|2
843474|NCT00375518|1800873|FG001|Overall Study|Withdrawal by Subject|10
843475|NCT00375518|1800872|FG000|Overall Study|Patient Not Treated|6
843476|NCT00375518|1800873|FG001|Overall Study|Patient Not Treated|6
843477|NCT00375518|1800872|FG000|Overall Study|Death|0
843478|NCT00375518|1800873|FG001|Overall Study|Death|1
843479|NCT00375609|1800882|FG000|Overall Study|Did not receive treatment|1
843480|NCT00375609|1800883|FG001|Overall Study|Did not receive treatment|0
843481|NCT00375609|1800884|FG002|Overall Study|Did not receive treatment|0
843482|NCT00375609|1800882|FG000|Overall Study|Adverse Event|0
843483|NCT00375609|1800883|FG001|Overall Study|Adverse Event|3
843484|NCT00375609|1800884|FG002|Overall Study|Adverse Event|0
843485|NCT00375609|1800882|FG000|Overall Study|Lost to Follow-up|1
843486|NCT00375609|1800883|FG001|Overall Study|Lost to Follow-up|0
843487|NCT00375609|1800884|FG002|Overall Study|Lost to Follow-up|0
843488|NCT00375609|1800882|FG000|Overall Study|Physician Decision|0
843489|NCT00375609|1800883|FG001|Overall Study|Physician Decision|0
843490|NCT00375609|1800884|FG002|Overall Study|Physician Decision|1
843491|NCT00375609|1800882|FG000|Overall Study|Withdrawal by Subject|1
843492|NCT00375609|1800883|FG001|Overall Study|Withdrawal by Subject|4
843493|NCT00375609|1800884|FG002|Overall Study|Withdrawal by Subject|0
843494|NCT00375609|1800882|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1
843495|NCT00375609|1800883|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0
843496|NCT00375609|1800884|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0
843497|NCT00375674|1800894|FG000|Overall Study|Other|26
843498|NCT00375674|1800895|FG001|Overall Study|Other|18
843499|NCT00375674|1800894|FG000|Overall Study|Death|67
843500|NCT00375674|1800895|FG001|Overall Study|Death|76
843501|NCT00375674|1800894|FG000|Overall Study|Participants refused further follow-up|31
843502|NCT00375674|1800895|FG001|Overall Study|Participants refused further follow-up|30
843503|NCT00375674|1800894|FG000|Overall Study|Lost to Follow-up|17
843504|NCT00375674|1800895|FG001|Overall Study|Lost to Follow-up|15
843505|NCT00375674|1800894|FG000|Overall Study|Enrolled but not treated|3
843506|NCT00375674|1800895|FG001|Overall Study|Enrolled but not treated|2
843507|NCT00375752|1800912|FG000|Overall Study|Lack of Efficacy|4
843508|NCT00375752|1800913|FG001|Overall Study|Lack of Efficacy|4
843509|NCT00375752|1800912|FG000|Overall Study|Adverse Event|1
843510|NCT00375752|1800913|FG001|Overall Study|Adverse Event|6
843511|NCT00375752|1800912|FG000|Overall Study|Withdrawal by Subject|6
843512|NCT00375752|1800913|FG001|Overall Study|Withdrawal by Subject|1
843513|NCT00375752|1800912|FG000|Overall Study|Abnormal Laboratory Value(s)|1
843514|NCT00375752|1800913|FG001|Overall Study|Abnormal Laboratory Value(s)|1
843515|NCT00375752|1800912|FG000|Overall Study|Protocol Violation|0
843516|NCT00375752|1800913|FG001|Overall Study|Protocol Violation|2
843517|NCT00375752|1800912|FG000|Overall Study|Administrative Problems|0
843518|NCT00375752|1800913|FG001|Overall Study|Administrative Problems|1
843519|NCT00375934|1800946|FG000|Overall Study|Adverse Event|1
843520|NCT00375934|1800947|FG001|Overall Study|Adverse Event|1
843521|NCT00375934|1800946|FG000|Overall Study|Withdrawal by Subject|2
843522|NCT00375934|1800947|FG001|Overall Study|Withdrawal by Subject|2
843523|NCT00375934|1800946|FG000|Overall Study|Lack of Efficacy|0
843524|NCT00375934|1800947|FG001|Overall Study|Lack of Efficacy|2
843525|NCT00375934|1800946|FG000|Overall Study|Physician Decision|0
843526|NCT00375934|1800947|FG001|Overall Study|Physician Decision|1
843527|NCT00376168|1800968|FG000|Overall Study|Adverse Event|1
843528|NCT00376168|1800969|FG001|Overall Study|Adverse Event|1
843529|NCT00376168|1800968|FG000|Overall Study|Pregnancy|1
843530|NCT00376168|1800969|FG001|Overall Study|Pregnancy|0
843531|NCT00376220|1800977|FG000|Overall Study|Lost to Follow-up|7
843532|NCT00376220|1800978|FG001|Overall Study|Lost to Follow-up|10
843533|NCT00376220|1800977|FG000|Overall Study|Withdrawal by Subject|3
843534|NCT00376220|1800978|FG001|Overall Study|Withdrawal by Subject|2
843535|NCT00376246|1800984|FG000|First Intervention (2 Weeks)|Adverse Event|2
843536|NCT00376246|1800985|FG001|First Intervention (2 Weeks)|Adverse Event|0
843537|NCT00376246|1800984|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1
843623|NCT00377611|1801194|FG001|Overall Study|Adverse Event|9
843538|NCT00376246|1800985|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2
843539|NCT00376246|1800984|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1
843540|NCT00376246|1800985|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
843541|NCT00376259|1800995|FG000|Overall Study|Sponsor request - study termination|21
843542|NCT00376259|1800996|FG001|Overall Study|Sponsor request - study termination|21
843543|NCT00376259|1800995|FG000|Overall Study|Patient request|1
843544|NCT00376259|1800996|FG001|Overall Study|Patient request|0
843545|NCT00376506|1801013|FG000|Overall Study|Death|0
843546|NCT00376506|1801014|FG001|Overall Study|Death|2
843547|NCT00376532|1801025|FG000|Overall Study|Lack sufficient blood sample|6
843548|NCT00376532|1801026|FG001|Overall Study|Lack sufficient blood sample|6
843549|NCT00376675|1801055|FG000|Overall Study|Withdrawal by Subject|9
843550|NCT00376675|1801056|FG001|Overall Study|Withdrawal by Subject|2
843551|NCT00376675|1801055|FG000|Overall Study|Adverse Event|10
843552|NCT00376675|1801056|FG001|Overall Study|Adverse Event|5
843553|NCT00376675|1801055|FG000|Overall Study|Other Reason|1
843554|NCT00376675|1801056|FG001|Overall Study|Other Reason|7
843555|NCT00376688|1801062|FG000|Overall Study|Adverse Event|3
843556|NCT00376688|1801062|FG000|Overall Study|Death|1
843557|NCT00376961|1801091|FG000|Initial Registration|Adverse Event|1
843558|NCT00376961|1801092|FG001|Initial Registration|Adverse Event|0
843559|NCT00376961|1801091|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2
843560|NCT00376961|1801092|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
843561|NCT00376961|1801091|FG000|Initial Registration|Progression/relapse|1
843562|NCT00376961|1801092|FG001|Initial Registration|Progression/relapse|0
843563|NCT00376961|1801091|FG000|Initial Registration|Ineligible|3
843564|NCT00376961|1801092|FG001|Initial Registration|Ineligible|0
843565|NCT00376961|1801091|FG000|Maintenance|Adverse Event|0
843566|NCT00376961|1801092|FG001|Maintenance|Adverse Event|1
843567|NCT00376961|1801091|FG000|Maintenance|Refusal Unrelated to Adverse Event|0
843568|NCT00376961|1801092|FG001|Maintenance|Refusal Unrelated to Adverse Event|1
843569|NCT00376961|1801091|FG000|Maintenance|Progression/relapse|0
843570|NCT00376961|1801092|FG001|Maintenance|Progression/relapse|18
843571|NCT00376961|1801091|FG000|Maintenance|Ineligible|0
843572|NCT00376961|1801092|FG001|Maintenance|Ineligible|3
843573|NCT00377156|1801102|FG000|Overall Study|Death|23
843574|NCT00377156|1801103|FG001|Overall Study|Death|19
843575|NCT00377156|1801102|FG000|Overall Study|Withdrawal by Subject|16
843576|NCT00377156|1801103|FG001|Overall Study|Withdrawal by Subject|24
843577|NCT00377156|1801102|FG000|Overall Study|Had follow-up <90 d|3
843578|NCT00377156|1801103|FG001|Overall Study|Had follow-up <90 d|6
843579|NCT00377156|1801102|FG000|Overall Study|Cancellation|1
843580|NCT00377156|1801103|FG001|Overall Study|Cancellation|0
843581|NCT00377156|1801102|FG000|Overall Study|Refused testing|0
843582|NCT00377156|1801103|FG001|Overall Study|Refused testing|1
843583|NCT00377156|1801102|FG000|Overall Study|Ineligible|0
843584|NCT00377156|1801103|FG001|Overall Study|Ineligible|1
843585|NCT00377156|1801102|FG000|Overall Study|Disability or language problem|0
843586|NCT00377156|1801103|FG001|Overall Study|Disability or language problem|1
843587|NCT00377156|1801102|FG000|Overall Study|Other|5
843588|NCT00377156|1801103|FG001|Overall Study|Other|2
843589|NCT00377234|1801113|FG000|Overall Study|Adverse Event|14
843590|NCT00377234|1801114|FG001|Overall Study|Adverse Event|17
843591|NCT00377234|1801113|FG000|Overall Study|Withdrawal by Subject|11
843592|NCT00377234|1801114|FG001|Overall Study|Withdrawal by Subject|9
843593|NCT00377234|1801113|FG000|Overall Study|Lost to Follow-up|4
843594|NCT00377234|1801114|FG001|Overall Study|Lost to Follow-up|2
843595|NCT00377234|1801113|FG000|Overall Study|Administrative|2
843596|NCT00377234|1801114|FG001|Overall Study|Administrative|1
843597|NCT00377234|1801113|FG000|Overall Study|Not assigned|3
843598|NCT00377234|1801114|FG001|Overall Study|Not assigned|2
843599|NCT00377260|1801128|FG000|Overall Study|Lost to Follow-up|0
843600|NCT00377260|1801129|FG001|Overall Study|Lost to Follow-up|1
843601|NCT00377260|1801128|FG000|Overall Study|Withdrawal by Subject|2
843602|NCT00377260|1801129|FG001|Overall Study|Withdrawal by Subject|4
843603|NCT00377299|1801137|FG000|Overall Study|Lost to Follow-up|14
843604|NCT00377299|1801138|FG001|Overall Study|Lost to Follow-up|19
843605|NCT00377299|1801137|FG000|Overall Study|Adverse Event|0
843606|NCT00377299|1801138|FG001|Overall Study|Adverse Event|1
843607|NCT00377299|1801137|FG000|Overall Study|Withdrawal by Subject|5
843608|NCT00377299|1801138|FG001|Overall Study|Withdrawal by Subject|4
843609|NCT00377312|1801147|FG000|Overall Study|Adverse Event|1
843610|NCT00377312|1801148|FG001|Overall Study|Adverse Event|1
843611|NCT00377364|1801156|FG000|Overall Study|Lost to Follow-up|1
843612|NCT00377364|1801157|FG001|Overall Study|Lost to Follow-up|0
843613|NCT00377364|1801156|FG000|Overall Study|Withdrawal by Subject|1
843614|NCT00377364|1801157|FG001|Overall Study|Withdrawal by Subject|0
843615|NCT00377403|1801167|FG000|Overall Study|Unable to contact for telephone intervie|4
843616|NCT00377403|1801168|FG001|Overall Study|Unable to contact for telephone intervie|7
843617|NCT00377429|1801174|FG000|Overall Study|Withdrawal by Subject|5
843618|NCT00377429|1801174|FG000|Overall Study|Adverse Event|8
843619|NCT00377429|1801174|FG000|Overall Study|Physician Decision|1
843620|NCT00377429|1801174|FG000|Overall Study|Patient non-compliance|1
843621|NCT00377520|1801178|FG000|Overall Study|Ineligible (Prior radiation)|1
843622|NCT00377611|1801193|FG000|Overall Study|Adverse Event|2
843624|NCT00377611|1801193|FG000|Overall Study|Protocol Violation|2
843625|NCT00377611|1801194|FG001|Overall Study|Protocol Violation|0
843626|NCT00377611|1801193|FG000|Overall Study|Withdrawal by Subject|0
843627|NCT00377611|1801194|FG001|Overall Study|Withdrawal by Subject|5
843628|NCT00377611|1801193|FG000|Overall Study|Lost to Follow-up|18
843629|NCT00377611|1801194|FG001|Overall Study|Lost to Follow-up|16
843630|NCT00377611|1801193|FG000|Overall Study|Other|0
843631|NCT00377611|1801194|FG001|Overall Study|Other|3
843632|NCT00377637|1801205|FG000|Induction Phase|Adverse Event|12
843633|NCT00377637|1801206|FG001|Induction Phase|Adverse Event|21
843634|NCT00377637|1801207|FG002|Induction Phase|Adverse Event|0
843635|NCT00377637|1801208|FG003|Induction Phase|Adverse Event|0
843636|NCT00377637|1801205|FG000|Induction Phase|Deterioration/serum creatinine|2
843637|NCT00377637|1801206|FG001|Induction Phase|Deterioration/serum creatinine|0
843638|NCT00377637|1801207|FG002|Induction Phase|Deterioration/serum creatinine|0
843639|NCT00377637|1801208|FG003|Induction Phase|Deterioration/serum creatinine|0
843640|NCT00377637|1801205|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
843641|NCT00377637|1801206|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
843642|NCT00377637|1801207|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
843643|NCT00377637|1801208|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
843644|NCT00377637|1801205|FG000|Induction Phase|Lost to Follow-up|2
843645|NCT00377637|1801206|FG001|Induction Phase|Lost to Follow-up|1
843646|NCT00377637|1801207|FG002|Induction Phase|Lost to Follow-up|0
843647|NCT00377637|1801208|FG003|Induction Phase|Lost to Follow-up|0
843648|NCT00377637|1801205|FG000|Induction Phase|Death|1
843649|NCT00377637|1801206|FG001|Induction Phase|Death|3
843650|NCT00377637|1801207|FG002|Induction Phase|Death|0
843651|NCT00377637|1801208|FG003|Induction Phase|Death|0
843652|NCT00377637|1801205|FG000|Induction Phase|Withdrawal by Subject|5
843653|NCT00377637|1801206|FG001|Induction Phase|Withdrawal by Subject|6
843654|NCT00377637|1801207|FG002|Induction Phase|Withdrawal by Subject|0
843655|NCT00377637|1801208|FG003|Induction Phase|Withdrawal by Subject|0
843656|NCT00377637|1801205|FG000|Induction Phase|Physician Decision|3
843657|NCT00377637|1801206|FG001|Induction Phase|Physician Decision|1
843658|NCT00377637|1801207|FG002|Induction Phase|Physician Decision|0
843659|NCT00377637|1801208|FG003|Induction Phase|Physician Decision|0
843660|NCT00377637|1801205|FG000|Induction Phase|Sponsor decision|1
843661|NCT00377637|1801206|FG001|Induction Phase|Sponsor decision|2
843662|NCT00377637|1801207|FG002|Induction Phase|Sponsor decision|0
843663|NCT00377637|1801208|FG003|Induction Phase|Sponsor decision|0
843664|NCT00377637|1801205|FG000|Induction Phase|Non-Compliance|1
843665|NCT00377637|1801206|FG001|Induction Phase|Non-Compliance|0
843666|NCT00377637|1801207|FG002|Induction Phase|Non-Compliance|0
843667|NCT00377637|1801208|FG003|Induction Phase|Non-Compliance|0
843668|NCT00377637|1801205|FG000|Induction Phase|Reason for withdrawal is not noted|2
843669|NCT00377637|1801206|FG001|Induction Phase|Reason for withdrawal is not noted|0
843670|NCT00377637|1801207|FG002|Induction Phase|Reason for withdrawal is not noted|0
843671|NCT00377637|1801208|FG003|Induction Phase|Reason for withdrawal is not noted|0
843672|NCT00377637|1801205|FG000|Maintenance Phase|Adverse Event|0
843673|NCT00377637|1801206|FG001|Maintenance Phase|Adverse Event|0
843674|NCT00377637|1801207|FG002|Maintenance Phase|Adverse Event|29
843675|NCT00377637|1801208|FG003|Maintenance Phase|Adverse Event|43
843676|NCT00377637|1801205|FG000|Maintenance Phase|Physician Decision|0
843677|NCT00377637|1801206|FG001|Maintenance Phase|Physician Decision|0
843678|NCT00377637|1801207|FG002|Maintenance Phase|Physician Decision|5
843679|NCT00377637|1801208|FG003|Maintenance Phase|Physician Decision|4
843680|NCT00377637|1801205|FG000|Maintenance Phase|Lost to Follow-up|0
843681|NCT00377637|1801206|FG001|Maintenance Phase|Lost to Follow-up|0
843682|NCT00377637|1801207|FG002|Maintenance Phase|Lost to Follow-up|3
843683|NCT00377637|1801208|FG003|Maintenance Phase|Lost to Follow-up|1
843684|NCT00377637|1801205|FG000|Maintenance Phase|Withdrawal by Subject|0
843685|NCT00377637|1801206|FG001|Maintenance Phase|Withdrawal by Subject|0
843686|NCT00377637|1801207|FG002|Maintenance Phase|Withdrawal by Subject|3
843687|NCT00377637|1801208|FG003|Maintenance Phase|Withdrawal by Subject|3
843688|NCT00377637|1801205|FG000|Maintenance Phase|Sponsor decision|0
843689|NCT00377637|1801206|FG001|Maintenance Phase|Sponsor decision|0
843690|NCT00377637|1801207|FG002|Maintenance Phase|Sponsor decision|2
843691|NCT00377637|1801208|FG003|Maintenance Phase|Sponsor decision|3
843692|NCT00377637|1801205|FG000|Maintenance Phase|Non-compliance|0
843693|NCT00377637|1801206|FG001|Maintenance Phase|Non-compliance|0
843694|NCT00377637|1801207|FG002|Maintenance Phase|Non-compliance|1
843695|NCT00377637|1801208|FG003|Maintenance Phase|Non-compliance|1
843696|NCT00377637|1801205|FG000|Maintenance Phase|Study medication stopped > 14 days|0
843697|NCT00377637|1801206|FG001|Maintenance Phase|Study medication stopped > 14 days|0
843698|NCT00377637|1801207|FG002|Maintenance Phase|Study medication stopped > 14 days|0
843699|NCT00377637|1801208|FG003|Maintenance Phase|Study medication stopped > 14 days|1
843700|NCT00377637|1801205|FG000|Maintenance Phase|Death|0
843701|NCT00377637|1801206|FG001|Maintenance Phase|Death|0
843702|NCT00377637|1801207|FG002|Maintenance Phase|Death|0
843703|NCT00377637|1801208|FG003|Maintenance Phase|Death|1
843704|NCT00377676|1801224|FG000|Overall Study|Adverse Event|498
843705|NCT00377676|1801225|FG001|Overall Study|Adverse Event|107
843706|NCT00377676|1801224|FG000|Overall Study|Protocol Violation|33
843707|NCT00377676|1801225|FG001|Overall Study|Protocol Violation|27
843708|NCT00377676|1801224|FG000|Overall Study|Death|5
843709|NCT00377676|1801225|FG001|Overall Study|Death|2
843710|NCT00377676|1801224|FG000|Overall Study|Withdrawal by Subject|187
843711|NCT00377676|1801225|FG001|Overall Study|Withdrawal by Subject|72
843712|NCT00377676|1801224|FG000|Overall Study|Lost to Follow-up|120
843713|NCT00377676|1801225|FG001|Overall Study|Lost to Follow-up|56
843714|NCT00377676|1801224|FG000|Overall Study|Other|118
843715|NCT00377676|1801225|FG001|Overall Study|Other|58
843716|NCT00377819|1801242|FG000|Overall Study|Adverse Event|2
843717|NCT00377819|1801243|FG001|Overall Study|Adverse Event|3
843718|NCT00377819|1801242|FG000|Overall Study|Withdrawal by Subject|10
843719|NCT00377819|1801243|FG001|Overall Study|Withdrawal by Subject|4
843720|NCT00377819|1801242|FG000|Overall Study|Death|0
843721|NCT00377819|1801243|FG001|Overall Study|Death|1
843722|NCT00377819|1801242|FG000|Overall Study|Lost to Follow-up|0
843723|NCT00377819|1801243|FG001|Overall Study|Lost to Follow-up|1
843724|NCT00377819|1801242|FG000|Overall Study|Protocol Violation|1
843725|NCT00377819|1801243|FG001|Overall Study|Protocol Violation|1
843726|NCT00377858|1801263|FG000|Overall Study|Withdrawal by Subject|12
843727|NCT00377858|1801264|FG001|Overall Study|Withdrawal by Subject|11
843728|NCT00377858|1801263|FG000|Overall Study|Lost to Follow-up|6
843729|NCT00377858|1801264|FG001|Overall Study|Lost to Follow-up|1
843730|NCT00377858|1801263|FG000|Overall Study|Physician Decision|5
843731|NCT00377858|1801264|FG001|Overall Study|Physician Decision|5
843732|NCT00377858|1801263|FG000|Overall Study|Protocol Violation|3
843733|NCT00377858|1801264|FG001|Overall Study|Protocol Violation|4
843734|NCT00377858|1801263|FG000|Overall Study|Adverse Event|2
843735|NCT00377858|1801264|FG001|Overall Study|Adverse Event|1
843736|NCT00377858|1801263|FG000|Overall Study|Entry Criteria Not Met|2
843737|NCT00377858|1801264|FG001|Overall Study|Entry Criteria Not Met|0
843738|NCT00377858|1801263|FG000|Overall Study|Sponsor Decision|1
843739|NCT00377858|1801264|FG001|Overall Study|Sponsor Decision|2
843740|NCT00377858|1801263|FG000|Overall Study|Death|0
843741|NCT00377858|1801264|FG001|Overall Study|Death|3
843742|NCT00377962|1801272|FG000|Core Study: 0-12 Months|Adverse Event|18
843743|NCT00377962|1801273|FG001|Core Study: 0-12 Months|Adverse Event|2
843744|NCT00377962|1801272|FG000|Core Study: 0-12 Months|Death|3
843745|NCT00377962|1801273|FG001|Core Study: 0-12 Months|Death|0
843746|NCT00377962|1801272|FG000|Core Study: 0-12 Months|Withdrew Consent|5
843747|NCT00377962|1801273|FG001|Core Study: 0-12 Months|Withdrew Consent|2
843748|NCT00377962|1801272|FG000|Core Study: 0-12 Months|Administrative Reason|1
843749|NCT00377962|1801273|FG001|Core Study: 0-12 Months|Administrative Reason|1
843750|NCT00377962|1801272|FG000|Core Study: 0-12 Months|Unspecified reasons|1
843751|NCT00377962|1801273|FG001|Core Study: 0-12 Months|Unspecified reasons|4
843752|NCT00377962|1801272|FG000|Extension Study: 12-24 Months|Death|1
843753|NCT00377962|1801273|FG001|Extension Study: 12-24 Months|Death|1
843754|NCT00377962|1801272|FG000|Extension Study: 12-24 Months|Adverse Event|8
843755|NCT00377962|1801273|FG001|Extension Study: 12-24 Months|Adverse Event|0
843756|NCT00377962|1801272|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1
843757|NCT00377962|1801273|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0
843758|NCT00377962|1801272|FG000|Extension Study: 12-24 Months|Unspecified reason|0
843759|NCT00377962|1801273|FG001|Extension Study: 12-24 Months|Unspecified reason|3
843760|NCT00378014|1801287|FG000|Core (Randomization to Month 11)|Adverse Event|1
843761|NCT00378014|1801288|FG001|Core (Randomization to Month 11)|Adverse Event|0
843762|NCT00378014|1801287|FG000|Core (Randomization to Month 11)|Graft loss|1
843763|NCT00378014|1801288|FG001|Core (Randomization to Month 11)|Graft loss|2
843764|NCT00378014|1801287|FG000|Core (Randomization to Month 11)|Death|5
843765|NCT00378014|1801288|FG001|Core (Randomization to Month 11)|Death|3
843766|NCT00378014|1801287|FG000|Core (Randomization to Month 11)|Administrative Problems|2
843767|NCT00378014|1801288|FG001|Core (Randomization to Month 11)|Administrative Problems|2
843768|NCT00378014|1801287|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0
843769|NCT00378014|1801288|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1
843770|NCT00378014|1801287|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5
843771|NCT00378014|1801288|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2
843772|NCT00378014|1801287|FG000|Core (Randomization to Month 11)|Protocol deviation|0
843773|NCT00378014|1801288|FG001|Core (Randomization to Month 11)|Protocol deviation|1
843774|NCT00378014|1801287|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0
843775|NCT00378014|1801288|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1
843776|NCT00378014|1801287|FG000|Extension (Month 12 to Month 59)|Adverse Event|8
843777|NCT00378014|1801288|FG001|Extension (Month 12 to Month 59)|Adverse Event|7
843778|NCT00378014|1801287|FG000|Extension (Month 12 to Month 59)|Death|1
843779|NCT00378014|1801288|FG001|Extension (Month 12 to Month 59)|Death|2
843780|NCT00378014|1801287|FG000|Extension (Month 12 to Month 59)|Administrative problems|1
843781|NCT00378014|1801288|FG001|Extension (Month 12 to Month 59)|Administrative problems|0
843782|NCT00378014|1801287|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1
843783|NCT00378014|1801288|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1
843784|NCT00378014|1801287|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
843785|NCT00378014|1801288|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
843786|NCT00378014|1801287|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3
843787|NCT00378014|1801288|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1
843788|NCT00378079|1801299|FG000|Overall Study|Lost to Follow-up|6
843789|NCT00378079|1801300|FG001|Overall Study|Lost to Follow-up|1
843790|NCT00378079|1801301|FG002|Overall Study|Lost to Follow-up|0
843791|NCT00378105|1801311|FG000|Overall Study|Adverse Event|3
843792|NCT00378105|1801312|FG001|Overall Study|Adverse Event|1
843793|NCT00378105|1801311|FG000|Overall Study|Withdrawal by Subject|3
843794|NCT00378105|1801312|FG001|Overall Study|Withdrawal by Subject|3
843795|NCT00378105|1801311|FG000|Overall Study|Death|1
843796|NCT00378105|1801312|FG001|Overall Study|Death|0
843797|NCT00378105|1801311|FG000|Overall Study|Going to transplant|7
843798|NCT00378105|1801312|FG001|Overall Study|Going to transplant|8
843799|NCT00378105|1801311|FG000|Overall Study|Progressive disease|3
843800|NCT00378105|1801312|FG001|Overall Study|Progressive disease|3
843801|NCT00378105|1801311|FG000|Overall Study|remain on study|3
843802|NCT00378105|1801312|FG001|Overall Study|remain on study|11
843803|NCT00378105|1801311|FG000|Overall Study|Physician Decision|0
843804|NCT00378105|1801312|FG001|Overall Study|Physician Decision|2
843805|NCT00378105|1801311|FG000|Overall Study|Going non-protocol therapy|0
843806|NCT00378105|1801312|FG001|Overall Study|Going non-protocol therapy|1
843807|NCT00378105|1801311|FG000|Overall Study|necessity to increase lenalidomide dose|0
843808|NCT00378105|1801312|FG001|Overall Study|necessity to increase lenalidomide dose|1
843809|NCT00378209|1801319|FG000|Overall Study|Progressive disease|11
843810|NCT00378209|1801319|FG000|Overall Study|Adverse Event|3
843811|NCT00378209|1801319|FG000|Overall Study|Initiation of non-protocol therapy|3
843812|NCT00378209|1801319|FG000|Overall Study|Physician Decision|3
843813|NCT00378209|1801319|FG000|Overall Study|Death|1
843814|NCT00378209|1801319|FG000|Overall Study|Treatment delay|1
843815|NCT00378378|1801348|FG000|Overall Study|Withdrawal by Subject|0
843816|NCT00378378|1801349|FG001|Overall Study|Withdrawal by Subject|1
843817|NCT00378378|1801350|FG002|Overall Study|Withdrawal by Subject|0
843818|NCT00378378|1801348|FG000|Overall Study|Treatment Failure|0
843819|NCT00378378|1801349|FG001|Overall Study|Treatment Failure|0
843820|NCT00378378|1801350|FG002|Overall Study|Treatment Failure|1
843821|NCT00378378|1801348|FG000|Overall Study|Non-compliance with protocol|0
843822|NCT00378378|1801349|FG001|Overall Study|Non-compliance with protocol|0
843823|NCT00378378|1801350|FG002|Overall Study|Non-compliance with protocol|1
843824|NCT00378482|1801358|FG000|Overall Study|Lost to Follow-up|1
843825|NCT00378482|1801358|FG000|Overall Study|Lack of Efficacy|8
843826|NCT00378482|1801358|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9
843827|NCT00378482|1801358|FG000|Overall Study|Withdrawal by Subject|4
843828|NCT00378482|1801358|FG000|Overall Study|Adverse Event|9
843829|NCT00378508|1801364|FG000|Overall Study|Withdrawal by Subject|1
843830|NCT00378508|1801365|FG001|Overall Study|Withdrawal by Subject|3
843831|NCT00378508|1801364|FG000|Overall Study|Lost to Follow-up|1
843832|NCT00378508|1801365|FG001|Overall Study|Lost to Follow-up|0
843833|NCT00378534|1801374|FG000|Overall Study|Participants did not receive transplant|3
843834|NCT00378534|1801375|FG001|Overall Study|Participants did not receive transplant|0
843835|NCT00378560|1801382|FG000|Overall Study|Adverse Event|1
843836|NCT00378560|1801383|FG001|Overall Study|Adverse Event|0
843837|NCT00378560|1801382|FG000|Overall Study|Lost to Follow-up|24
843838|NCT00378560|1801383|FG001|Overall Study|Lost to Follow-up|29
843839|NCT00378560|1801382|FG000|Overall Study|Protocol Violation|2
843840|NCT00378560|1801383|FG001|Overall Study|Protocol Violation|0
843841|NCT00378560|1801382|FG000|Overall Study|Withdrawal by Subject|17
843842|NCT00378560|1801383|FG001|Overall Study|Withdrawal by Subject|21
843843|NCT00378560|1801382|FG000|Overall Study|Moved|4
843844|NCT00378560|1801383|FG001|Overall Study|Moved|3
843845|NCT00378560|1801382|FG000|Overall Study|Pregnancy|7
843846|NCT00378560|1801383|FG001|Overall Study|Pregnancy|5
843847|NCT00378560|1801382|FG000|Overall Study|Laboratory test values abnormal|1
843848|NCT00378560|1801383|FG001|Overall Study|Laboratory test values abnormal|0
843849|NCT00378573|1801389|FG000|Treatment Period|Adverse Event|9
843850|NCT00378573|1801389|FG000|Treatment Period|Physician Decision|1
843851|NCT00378573|1801389|FG000|Treatment Period|Withdrawal by Subject|2
843852|NCT00378573|1801389|FG000|Treatment Period|Disease Progression|4
843853|NCT00378573|1801389|FG000|Treatment Period|Sponsor decision to close study|1
843854|NCT00378573|1801389|FG000|Follow-up|Death|12
843855|NCT00378573|1801389|FG000|Follow-up|Lost to Follow-up|1
843856|NCT00378573|1801389|FG000|Follow-up|Withdrawal by Subject|1
843857|NCT00378599|1801393|FG000|Overall Study|Adverse Event|38
843858|NCT00378599|1801393|FG000|Overall Study|Protocol Violation|2
843859|NCT00378599|1801393|FG000|Overall Study|Treatment failure|7
843860|NCT00378599|1801393|FG000|Overall Study|Withdrawal by Subject|5
843861|NCT00378703|1801401|FG000|Overall Study|Disease progression|59
843862|NCT00378703|1801402|FG001|Overall Study|Disease progression|43
843863|NCT00378703|1801403|FG002|Overall Study|Disease progression|48
843864|NCT00378703|1801404|FG003|Overall Study|Disease progression|49
843865|NCT00378703|1801401|FG000|Overall Study|Adverse Event|11
843866|NCT00378703|1801402|FG001|Overall Study|Adverse Event|17
843867|NCT00378703|1801403|FG002|Overall Study|Adverse Event|20
843868|NCT00378703|1801404|FG003|Overall Study|Adverse Event|18
843869|NCT00378703|1801401|FG000|Overall Study|Death|2
843870|NCT00378703|1801402|FG001|Overall Study|Death|2
843871|NCT00378703|1801403|FG002|Overall Study|Death|4
843872|NCT00378703|1801404|FG003|Overall Study|Death|3
843873|NCT00378703|1801401|FG000|Overall Study|Withdrawal by Subject|4
843874|NCT00378703|1801402|FG001|Overall Study|Withdrawal by Subject|8
843875|NCT00378703|1801403|FG002|Overall Study|Withdrawal by Subject|5
843876|NCT00378703|1801404|FG003|Overall Study|Withdrawal by Subject|7
843877|NCT00378703|1801401|FG000|Overall Study|Physician Decision|1
843878|NCT00378703|1801402|FG001|Overall Study|Physician Decision|4
843879|NCT00378703|1801403|FG002|Overall Study|Physician Decision|1
843880|NCT00378703|1801404|FG003|Overall Study|Physician Decision|0
843881|NCT00378703|1801401|FG000|Overall Study|Alternative therapy|4
843882|NCT00378703|1801402|FG001|Overall Study|Alternative therapy|2
843883|NCT00378703|1801403|FG002|Overall Study|Alternative therapy|0
843884|NCT00378703|1801404|FG003|Overall Study|Alternative therapy|0
843885|NCT00378703|1801401|FG000|Overall Study|Other complicated disease|0
843886|NCT00378703|1801402|FG001|Overall Study|Other complicated disease|2
843887|NCT00378703|1801403|FG002|Overall Study|Other complicated disease|2
843888|NCT00378703|1801404|FG003|Overall Study|Other complicated disease|0
843889|NCT00378703|1801401|FG000|Overall Study|Symptomatic deterioration|0
843890|NCT00378703|1801402|FG001|Overall Study|Symptomatic deterioration|1
843891|NCT00378703|1801403|FG002|Overall Study|Symptomatic deterioration|0
843892|NCT00378703|1801404|FG003|Overall Study|Symptomatic deterioration|2
843893|NCT00378703|1801401|FG000|Overall Study|Surgery|1
843894|NCT00378703|1801402|FG001|Overall Study|Surgery|0
843895|NCT00378703|1801403|FG002|Overall Study|Surgery|0
843896|NCT00378703|1801404|FG003|Overall Study|Surgery|1
843897|NCT00378703|1801401|FG000|Overall Study|Joint decision of physician and patient|1
843898|NCT00378703|1801402|FG001|Overall Study|Joint decision of physician and patient|0
843899|NCT00378703|1801403|FG002|Overall Study|Joint decision of physician and patient|0
843900|NCT00378703|1801404|FG003|Overall Study|Joint decision of physician and patient|0
843901|NCT00378703|1801401|FG000|Overall Study|Adverse events and progressive disease|0
843902|NCT00378703|1801402|FG001|Overall Study|Adverse events and progressive disease|0
843903|NCT00378703|1801403|FG002|Overall Study|Adverse events and progressive disease|0
843904|NCT00378703|1801404|FG003|Overall Study|Adverse events and progressive disease|1
843905|NCT00378703|1801401|FG000|Overall Study|Relocation|0
843906|NCT00378703|1801402|FG001|Overall Study|Relocation|0
843907|NCT00378703|1801403|FG002|Overall Study|Relocation|1
843908|NCT00378703|1801404|FG003|Overall Study|Relocation|0
843909|NCT00378703|1801401|FG000|Overall Study|Ineligible|4
843910|NCT00378703|1801402|FG001|Overall Study|Ineligible|7
843911|NCT00378703|1801403|FG002|Overall Study|Ineligible|7
843912|NCT00378703|1801404|FG003|Overall Study|Ineligible|7
843913|NCT00378703|1801401|FG000|Overall Study|Never started treatment|1
843914|NCT00378703|1801402|FG001|Overall Study|Never started treatment|4
843915|NCT00378703|1801403|FG002|Overall Study|Never started treatment|0
843916|NCT00378703|1801404|FG003|Overall Study|Never started treatment|0
843917|NCT00378703|1801401|FG000|Overall Study|Other|1
843918|NCT00378703|1801402|FG001|Overall Study|Other|1
843919|NCT00378703|1801403|FG002|Overall Study|Other|2
843920|NCT00378703|1801404|FG003|Overall Study|Other|3
843921|NCT00378898|1801416|FG000|Overall Study|Withdrawal by Subject|10
843922|NCT00378898|1801417|FG001|Overall Study|Withdrawal by Subject|5
843923|NCT00378898|1801416|FG000|Overall Study|Protocol Violation|1
843924|NCT00378898|1801417|FG001|Overall Study|Protocol Violation|1
843925|NCT00379080|1801428|FG000|Overall Study|Withdrawal by Subject|0
843926|NCT00379080|1801429|FG001|Overall Study|Withdrawal by Subject|4
843927|NCT00379080|1801430|FG002|Overall Study|Withdrawal by Subject|0
843928|NCT00379210|1801469|FG000|Overall Study|Withdrawal by Subject|10
843929|NCT00379210|1801470|FG001|Overall Study|Withdrawal by Subject|7
843930|NCT00379236|1801478|FG000|Double-blind|Adverse Event|11
843931|NCT00379236|1801479|FG001|Double-blind|Adverse Event|6
843932|NCT00379236|1801480|FG002|Double-blind|Adverse Event|0
843933|NCT00379236|1801478|FG000|Double-blind|Protocol Violation|3
843934|NCT00379236|1801479|FG001|Double-blind|Protocol Violation|3
843935|NCT00379236|1801480|FG002|Double-blind|Protocol Violation|0
843936|NCT00379236|1801478|FG000|Double-blind|Withdrawal by Subject|12
843937|NCT00379236|1801479|FG001|Double-blind|Withdrawal by Subject|13
843938|NCT00379236|1801480|FG002|Double-blind|Withdrawal by Subject|0
843939|NCT00379236|1801478|FG000|Double-blind|Lost to Follow-up|4
843940|NCT00379236|1801479|FG001|Double-blind|Lost to Follow-up|3
843941|NCT00379236|1801480|FG002|Double-blind|Lost to Follow-up|0
843942|NCT00379236|1801478|FG000|Double-blind|Use of exclusionary medication|1
843943|NCT00379236|1801479|FG001|Double-blind|Use of exclusionary medication|2
843944|NCT00379236|1801480|FG002|Double-blind|Use of exclusionary medication|0
843945|NCT00379236|1801478|FG000|Double-blind|Other|3
843946|NCT00379236|1801479|FG001|Double-blind|Other|7
843947|NCT00379236|1801480|FG002|Double-blind|Other|0
843948|NCT00379236|1801478|FG000|Double-blind|Data could not be retrieved|2
843949|NCT00379236|1801479|FG001|Double-blind|Data could not be retrieved|2
843950|NCT00379236|1801480|FG002|Double-blind|Data could not be retrieved|0
843951|NCT00379236|1801478|FG000|Open-label Extension|Adverse Event|0
843952|NCT00379236|1801479|FG001|Open-label Extension|Adverse Event|0
843953|NCT00379236|1801480|FG002|Open-label Extension|Adverse Event|13
843954|NCT00379236|1801478|FG000|Open-label Extension|Protocol Violation|0
843955|NCT00379236|1801479|FG001|Open-label Extension|Protocol Violation|0
843956|NCT00379236|1801480|FG002|Open-label Extension|Protocol Violation|7
843957|NCT00379236|1801478|FG000|Open-label Extension|Withdrawal by Subject|0
843958|NCT00379236|1801479|FG001|Open-label Extension|Withdrawal by Subject|0
843959|NCT00379236|1801480|FG002|Open-label Extension|Withdrawal by Subject|13
843960|NCT00379236|1801478|FG000|Open-label Extension|Lost to Follow-up|0
843961|NCT00379236|1801479|FG001|Open-label Extension|Lost to Follow-up|0
843962|NCT00379236|1801480|FG002|Open-label Extension|Lost to Follow-up|12
843963|NCT00379236|1801478|FG000|Open-label Extension|Use of exclusionary medication|0
843964|NCT00379236|1801479|FG001|Open-label Extension|Use of exclusionary medication|0
843965|NCT00379236|1801480|FG002|Open-label Extension|Use of exclusionary medication|3
843966|NCT00379236|1801478|FG000|Open-label Extension|Other|0
843967|NCT00379236|1801479|FG001|Open-label Extension|Other|0
843968|NCT00379236|1801480|FG002|Open-label Extension|Other|7
843969|NCT00379288|1801496|FG000|Overall Study|Adverse Event|5
843970|NCT00379288|1801497|FG001|Overall Study|Adverse Event|6
843971|NCT00379288|1801498|FG002|Overall Study|Adverse Event|2
843972|NCT00379288|1801499|FG003|Overall Study|Adverse Event|0
843973|NCT00379288|1801496|FG000|Overall Study|Treatment Failure|0
843974|NCT00379288|1801497|FG001|Overall Study|Treatment Failure|1
843975|NCT00379288|1801498|FG002|Overall Study|Treatment Failure|0
843976|NCT00379288|1801499|FG003|Overall Study|Treatment Failure|1
843977|NCT00379288|1801496|FG000|Overall Study|Lost to Follow-up|3
843978|NCT00379288|1801497|FG001|Overall Study|Lost to Follow-up|3
843979|NCT00379288|1801498|FG002|Overall Study|Lost to Follow-up|2
843980|NCT00379288|1801499|FG003|Overall Study|Lost to Follow-up|0
843981|NCT00379288|1801496|FG000|Overall Study|Subject withdrew-unrelated to study drug|0
843982|NCT00379288|1801497|FG001|Overall Study|Subject withdrew-unrelated to study drug|3
843983|NCT00379288|1801498|FG002|Overall Study|Subject withdrew-unrelated to study drug|4
843984|NCT00379288|1801499|FG003|Overall Study|Subject withdrew-unrelated to study drug|2
843985|NCT00379288|1801496|FG000|Overall Study|Subject withdrew-related to study drug|1
843986|NCT00379288|1801497|FG001|Overall Study|Subject withdrew-related to study drug|0
843987|NCT00379288|1801498|FG002|Overall Study|Subject withdrew-related to study drug|0
843988|NCT00379288|1801499|FG003|Overall Study|Subject withdrew-related to study drug|1
843989|NCT00379288|1801496|FG000|Overall Study|Noncompliance with protocol|8
843990|NCT00379288|1801497|FG001|Overall Study|Noncompliance with protocol|6
843991|NCT00379288|1801498|FG002|Overall Study|Noncompliance with protocol|2
843992|NCT00379288|1801499|FG003|Overall Study|Noncompliance with protocol|1
843993|NCT00379288|1801496|FG000|Overall Study|Did not meet protocol eligibility|0
843994|NCT00379288|1801497|FG001|Overall Study|Did not meet protocol eligibility|1
843995|NCT00379288|1801498|FG002|Overall Study|Did not meet protocol eligibility|0
843996|NCT00379288|1801499|FG003|Overall Study|Did not meet protocol eligibility|2
843997|NCT00379288|1801496|FG000|Overall Study|Administrative|2
843998|NCT00379288|1801497|FG001|Overall Study|Administrative|2
843999|NCT00379288|1801498|FG002|Overall Study|Administrative|0
844000|NCT00379288|1801499|FG003|Overall Study|Administrative|1
844001|NCT00379340|1801514|FG000|Overall Study|Death|0
844002|NCT00379340|1801515|FG001|Overall Study|Death|0
844003|NCT00379340|1801516|FG002|Overall Study|Death|0
844004|NCT00379340|1801517|FG003|Overall Study|Death|2
844005|NCT00379340|1801518|FG004|Overall Study|Death|0
844006|NCT00379340|1801514|FG000|Overall Study|Lack of Efficacy|6
844007|NCT00379340|1801515|FG001|Overall Study|Lack of Efficacy|1
844008|NCT00379340|1801516|FG002|Overall Study|Lack of Efficacy|0
844009|NCT00379340|1801517|FG003|Overall Study|Lack of Efficacy|4
844010|NCT00379340|1801518|FG004|Overall Study|Lack of Efficacy|3
844011|NCT00379340|1801514|FG000|Overall Study|Physician Decision|6
844012|NCT00379340|1801515|FG001|Overall Study|Physician Decision|2
844013|NCT00379340|1801516|FG002|Overall Study|Physician Decision|1
844014|NCT00379340|1801517|FG003|Overall Study|Physician Decision|2
844015|NCT00379340|1801518|FG004|Overall Study|Physician Decision|3
844016|NCT00379340|1801514|FG000|Overall Study|Withdrawal by Subject|0
844017|NCT00379340|1801515|FG001|Overall Study|Withdrawal by Subject|0
844018|NCT00379340|1801516|FG002|Overall Study|Withdrawal by Subject|0
844019|NCT00379340|1801517|FG003|Overall Study|Withdrawal by Subject|1
844020|NCT00379340|1801518|FG004|Overall Study|Withdrawal by Subject|0
844021|NCT00379340|1801514|FG000|Overall Study|Refusal of further protocol therapy|1
844022|NCT00379340|1801515|FG001|Overall Study|Refusal of further protocol therapy|0
844023|NCT00379340|1801516|FG002|Overall Study|Refusal of further protocol therapy|1
844024|NCT00379340|1801517|FG003|Overall Study|Refusal of further protocol therapy|1
844025|NCT00379340|1801518|FG004|Overall Study|Refusal of further protocol therapy|7
844026|NCT00379340|1801514|FG000|Overall Study|On more than 1 tumor therapeutic study|0
844027|NCT00379340|1801515|FG001|Overall Study|On more than 1 tumor therapeutic study|0
844028|NCT00379340|1801516|FG002|Overall Study|On more than 1 tumor therapeutic study|0
844029|NCT00379340|1801517|FG003|Overall Study|On more than 1 tumor therapeutic study|2
844030|NCT00379340|1801518|FG004|Overall Study|On more than 1 tumor therapeutic study|0
844031|NCT00379340|1801514|FG000|Overall Study|Delayed nephrectomy and anaplasia|0
844032|NCT00379340|1801515|FG001|Overall Study|Delayed nephrectomy and anaplasia|0
844033|NCT00379340|1801516|FG002|Overall Study|Delayed nephrectomy and anaplasia|0
844034|NCT00379340|1801517|FG003|Overall Study|Delayed nephrectomy and anaplasia|1
844035|NCT00379340|1801518|FG004|Overall Study|Delayed nephrectomy and anaplasia|1
844036|NCT00379353|1801533|FG000|Overall Study|Hospitalization|3
844037|NCT00379353|1801534|FG001|Overall Study|Hospitalization|3
844038|NCT00379353|1801533|FG000|Overall Study|Withdrawal by Subject|5
844039|NCT00379353|1801534|FG001|Overall Study|Withdrawal by Subject|2
844040|NCT00379353|1801533|FG000|Overall Study|Death|1
844041|NCT00379353|1801534|FG001|Overall Study|Death|0
844042|NCT00379353|1801533|FG000|Overall Study|Cardiac Tamponade|1
844043|NCT00379353|1801534|FG001|Overall Study|Cardiac Tamponade|0
844044|NCT00379353|1801533|FG000|Overall Study|Non-compliance|1
844045|NCT00379353|1801534|FG001|Overall Study|Non-compliance|0
844046|NCT00379353|1801533|FG000|Overall Study|Conflicting drug treatment|0
844047|NCT00379353|1801534|FG001|Overall Study|Conflicting drug treatment|1
844048|NCT00379587|1801554|FG000|Overall Study|Lost to Follow-up|2
844049|NCT00379639|1801563|FG000|Overall Study|Disease Progression|3
844050|NCT00379639|1801564|FG001|Overall Study|Disease Progression|3
844051|NCT00379639|1801565|FG002|Overall Study|Disease Progression|3
844052|NCT00379639|1801566|FG003|Overall Study|Disease Progression|4
844053|NCT00379639|1801567|FG004|Overall Study|Disease Progression|4
844054|NCT00379639|1801563|FG000|Overall Study|Physician Decision|0
844055|NCT00379639|1801564|FG001|Overall Study|Physician Decision|2
844056|NCT00379639|1801565|FG002|Overall Study|Physician Decision|1
844057|NCT00379639|1801566|FG003|Overall Study|Physician Decision|1
844058|NCT00379639|1801567|FG004|Overall Study|Physician Decision|0
844059|NCT00379639|1801563|FG000|Overall Study|Symptomatic Deterioration|0
844060|NCT00379639|1801564|FG001|Overall Study|Symptomatic Deterioration|0
844061|NCT00379639|1801565|FG002|Overall Study|Symptomatic Deterioration|1
844062|NCT00379639|1801566|FG003|Overall Study|Symptomatic Deterioration|0
844063|NCT00379639|1801567|FG004|Overall Study|Symptomatic Deterioration|1
844064|NCT00379639|1801563|FG000|Overall Study|Adverse Event|0
844065|NCT00379639|1801564|FG001|Overall Study|Adverse Event|0
844066|NCT00379639|1801565|FG002|Overall Study|Adverse Event|1
844067|NCT00379639|1801566|FG003|Overall Study|Adverse Event|0
844068|NCT00379639|1801567|FG004|Overall Study|Adverse Event|1
844069|NCT00379639|1801563|FG000|Overall Study|Lost to Follow-up|0
844070|NCT00379639|1801564|FG001|Overall Study|Lost to Follow-up|0
844071|NCT00379639|1801565|FG002|Overall Study|Lost to Follow-up|0
844072|NCT00379639|1801566|FG003|Overall Study|Lost to Follow-up|1
844073|NCT00379639|1801567|FG004|Overall Study|Lost to Follow-up|0
844074|NCT00379639|1801563|FG000|Overall Study|Other|0
844075|NCT00379639|1801564|FG001|Overall Study|Other|0
844076|NCT00379639|1801565|FG002|Overall Study|Other|3
844077|NCT00379639|1801566|FG003|Overall Study|Other|0
844078|NCT00379639|1801567|FG004|Overall Study|Other|0
844079|NCT00379769|1801583|FG000|Main Study|Death|57
844080|NCT00379769|1801584|FG001|Main Study|Death|67
844081|NCT00379769|1801585|FG002|Main Study|Death|54
844082|NCT00379769|1801586|FG003|Main Study|Death|72
844083|NCT00379769|1801587|FG004|Main Study|Death|0
844084|NCT00379769|1801588|FG005|Main Study|Death|0
844085|NCT00379769|1801583|FG000|Main Study|Adverse Event|5
844086|NCT00379769|1801584|FG001|Main Study|Adverse Event|8
844087|NCT00379769|1801585|FG002|Main Study|Adverse Event|10
844088|NCT00379769|1801586|FG003|Main Study|Adverse Event|11
844089|NCT00379769|1801587|FG004|Main Study|Adverse Event|0
844090|NCT00379769|1801588|FG005|Main Study|Adverse Event|0
844091|NCT00379769|1801583|FG000|Main Study|Lost to Follow-up|29
844092|NCT00379769|1801584|FG001|Main Study|Lost to Follow-up|29
844093|NCT00379769|1801585|FG002|Main Study|Lost to Follow-up|25
844094|NCT00379769|1801586|FG003|Main Study|Lost to Follow-up|26
844095|NCT00379769|1801587|FG004|Main Study|Lost to Follow-up|0
844096|NCT00379769|1801588|FG005|Main Study|Lost to Follow-up|0
844097|NCT00379769|1801583|FG000|Main Study|Withdrawal by Subject|46
844098|NCT00379769|1801584|FG001|Main Study|Withdrawal by Subject|56
844099|NCT00379769|1801585|FG002|Main Study|Withdrawal by Subject|72
844100|NCT00379769|1801586|FG003|Main Study|Withdrawal by Subject|70
844101|NCT00379769|1801587|FG004|Main Study|Withdrawal by Subject|0
844102|NCT00379769|1801588|FG005|Main Study|Withdrawal by Subject|0
844103|NCT00379769|1801583|FG000|Main Study|Moved to survival status follow-up only|27
844104|NCT00379769|1801584|FG001|Main Study|Moved to survival status follow-up only|25
844105|NCT00379769|1801585|FG002|Main Study|Moved to survival status follow-up only|32
844106|NCT00379769|1801586|FG003|Main Study|Moved to survival status follow-up only|36
844107|NCT00379769|1801587|FG004|Main Study|Moved to survival status follow-up only|0
844108|NCT00379769|1801588|FG005|Main Study|Moved to survival status follow-up only|0
844109|NCT00379769|1801583|FG000|Main Study|Participant moved|3
844110|NCT00379769|1801584|FG001|Main Study|Participant moved|2
844111|NCT00379769|1801585|FG002|Main Study|Participant moved|3
844112|NCT00379769|1801586|FG003|Main Study|Participant moved|3
844113|NCT00379769|1801587|FG004|Main Study|Participant moved|0
844114|NCT00379769|1801588|FG005|Main Study|Participant moved|0
844115|NCT00379769|1801583|FG000|Main Study|Poor compliance|3
844116|NCT00379769|1801584|FG001|Main Study|Poor compliance|2
844117|NCT00379769|1801585|FG002|Main Study|Poor compliance|2
844118|NCT00379769|1801586|FG003|Main Study|Poor compliance|1
844119|NCT00379769|1801587|FG004|Main Study|Poor compliance|0
844120|NCT00379769|1801588|FG005|Main Study|Poor compliance|0
844121|NCT00379769|1801583|FG000|Main Study|Prohibited glucose lowering medication|0
844122|NCT00379769|1801584|FG001|Main Study|Prohibited glucose lowering medication|3
844123|NCT00379769|1801585|FG002|Main Study|Prohibited glucose lowering medication|0
844124|NCT00379769|1801586|FG003|Main Study|Prohibited glucose lowering medication|1
844125|NCT00379769|1801587|FG004|Main Study|Prohibited glucose lowering medication|0
844126|NCT00379769|1801588|FG005|Main Study|Prohibited glucose lowering medication|0
844127|NCT00379769|1801583|FG000|Main Study|Site closed|4
844128|NCT00379769|1801584|FG001|Main Study|Site closed|4
844129|NCT00379769|1801585|FG002|Main Study|Site closed|4
844130|NCT00379769|1801586|FG003|Main Study|Site closed|8
844131|NCT00379769|1801587|FG004|Main Study|Site closed|0
844132|NCT00379769|1801588|FG005|Main Study|Site closed|0
844133|NCT00379769|1801583|FG000|Main Study|Entry criteria violation|0
844134|NCT00379769|1801584|FG001|Main Study|Entry criteria violation|0
844135|NCT00379769|1801585|FG002|Main Study|Entry criteria violation|1
844136|NCT00379769|1801586|FG003|Main Study|Entry criteria violation|1
844137|NCT00379769|1801587|FG004|Main Study|Entry criteria violation|0
844138|NCT00379769|1801588|FG005|Main Study|Entry criteria violation|0
844139|NCT00379769|1801583|FG000|Main Study|Participant did not take study drug|0
844140|NCT00379769|1801584|FG001|Main Study|Participant did not take study drug|0
844141|NCT00379769|1801585|FG002|Main Study|Participant did not take study drug|1
844142|NCT00379769|1801586|FG003|Main Study|Participant did not take study drug|0
844143|NCT00379769|1801587|FG004|Main Study|Participant did not take study drug|0
844144|NCT00379769|1801588|FG005|Main Study|Participant did not take study drug|0
844145|NCT00379769|1801583|FG000|Main Study|Physician Decision|2
844146|NCT00379769|1801584|FG001|Main Study|Physician Decision|2
844147|NCT00379769|1801585|FG002|Main Study|Physician Decision|1
844148|NCT00379769|1801586|FG003|Main Study|Physician Decision|1
844149|NCT00379769|1801587|FG004|Main Study|Physician Decision|0
844150|NCT00379769|1801588|FG005|Main Study|Physician Decision|0
844151|NCT00379769|1801583|FG000|Main Study|Participant completed study at visit 27|1
844152|NCT00379769|1801584|FG001|Main Study|Participant completed study at visit 27|0
844153|NCT00379769|1801585|FG002|Main Study|Participant completed study at visit 27|0
844154|NCT00379769|1801586|FG003|Main Study|Participant completed study at visit 27|0
844155|NCT00379769|1801587|FG004|Main Study|Participant completed study at visit 27|0
844156|NCT00379769|1801588|FG005|Main Study|Participant completed study at visit 27|0
844157|NCT00379769|1801583|FG000|Main Study|Personal reasons|1
844158|NCT00379769|1801584|FG001|Main Study|Personal reasons|0
844159|NCT00379769|1801585|FG002|Main Study|Personal reasons|0
844160|NCT00379769|1801586|FG003|Main Study|Personal reasons|0
844161|NCT00379769|1801587|FG004|Main Study|Personal reasons|0
844162|NCT00379769|1801588|FG005|Main Study|Personal reasons|0
844163|NCT00379769|1801583|FG000|Main Study|Risk of heart failure|0
844164|NCT00379769|1801584|FG001|Main Study|Risk of heart failure|1
844165|NCT00379769|1801585|FG002|Main Study|Risk of heart failure|0
844166|NCT00379769|1801586|FG003|Main Study|Risk of heart failure|0
844167|NCT00379769|1801587|FG004|Main Study|Risk of heart failure|0
844168|NCT00379769|1801588|FG005|Main Study|Risk of heart failure|0
844169|NCT00379769|1801583|FG000|Main Study|Investigator refused to log temperature|0
844170|NCT00379769|1801584|FG001|Main Study|Investigator refused to log temperature|0
844171|NCT00379769|1801585|FG002|Main Study|Investigator refused to log temperature|1
844172|NCT00379769|1801586|FG003|Main Study|Investigator refused to log temperature|0
844173|NCT00379769|1801587|FG004|Main Study|Investigator refused to log temperature|0
844174|NCT00379769|1801588|FG005|Main Study|Investigator refused to log temperature|0
844175|NCT00379769|1801583|FG000|Main Study|Reason unspecified|0
844176|NCT00379769|1801584|FG001|Main Study|Reason unspecified|0
844177|NCT00379769|1801585|FG002|Main Study|Reason unspecified|1
844178|NCT00379769|1801586|FG003|Main Study|Reason unspecified|0
844179|NCT00379769|1801587|FG004|Main Study|Reason unspecified|0
844180|NCT00379769|1801588|FG005|Main Study|Reason unspecified|0
844181|NCT00379769|1801583|FG000|Observational Follow-up|Death|0
844182|NCT00379769|1801584|FG001|Observational Follow-up|Death|0
844183|NCT00379769|1801585|FG002|Observational Follow-up|Death|0
844184|NCT00379769|1801586|FG003|Observational Follow-up|Death|0
844185|NCT00379769|1801587|FG004|Observational Follow-up|Death|78
844186|NCT00379769|1801588|FG005|Observational Follow-up|Death|70
844187|NCT00379769|1801583|FG000|Observational Follow-up|Adverse Event|0
844188|NCT00379769|1801584|FG001|Observational Follow-up|Adverse Event|0
844189|NCT00379769|1801585|FG002|Observational Follow-up|Adverse Event|0
844190|NCT00379769|1801586|FG003|Observational Follow-up|Adverse Event|0
844191|NCT00379769|1801587|FG004|Observational Follow-up|Adverse Event|1
844192|NCT00379769|1801588|FG005|Observational Follow-up|Adverse Event|0
844193|NCT00379769|1801583|FG000|Observational Follow-up|Lost to Follow-up|0
844194|NCT00379769|1801584|FG001|Observational Follow-up|Lost to Follow-up|0
844195|NCT00379769|1801585|FG002|Observational Follow-up|Lost to Follow-up|0
844196|NCT00379769|1801586|FG003|Observational Follow-up|Lost to Follow-up|0
844197|NCT00379769|1801587|FG004|Observational Follow-up|Lost to Follow-up|25
844198|NCT00379769|1801588|FG005|Observational Follow-up|Lost to Follow-up|27
844199|NCT00379769|1801583|FG000|Observational Follow-up|Withdrawal by Subject|0
844200|NCT00379769|1801584|FG001|Observational Follow-up|Withdrawal by Subject|0
844201|NCT00379769|1801585|FG002|Observational Follow-up|Withdrawal by Subject|0
844202|NCT00379769|1801586|FG003|Observational Follow-up|Withdrawal by Subject|0
844203|NCT00379769|1801587|FG004|Observational Follow-up|Withdrawal by Subject|12
844204|NCT00379769|1801588|FG005|Observational Follow-up|Withdrawal by Subject|12
844205|NCT00379769|1801583|FG000|Observational Follow-up|Entered into Another Clinical Trial|0
844206|NCT00379769|1801584|FG001|Observational Follow-up|Entered into Another Clinical Trial|0
844207|NCT00379769|1801585|FG002|Observational Follow-up|Entered into Another Clinical Trial|0
844208|NCT00379769|1801586|FG003|Observational Follow-up|Entered into Another Clinical Trial|0
844209|NCT00379769|1801587|FG004|Observational Follow-up|Entered into Another Clinical Trial|18
844210|NCT00379769|1801588|FG005|Observational Follow-up|Entered into Another Clinical Trial|22
844211|NCT00379769|1801583|FG000|Observational Follow-up|Physician Decision|0
844212|NCT00379769|1801584|FG001|Observational Follow-up|Physician Decision|0
844213|NCT00379769|1801585|FG002|Observational Follow-up|Physician Decision|0
844214|NCT00379769|1801586|FG003|Observational Follow-up|Physician Decision|0
844215|NCT00379769|1801587|FG004|Observational Follow-up|Physician Decision|8
844216|NCT00379769|1801588|FG005|Observational Follow-up|Physician Decision|8
844217|NCT00379769|1801583|FG000|Observational Follow-up|Site Closed Early|0
844218|NCT00379769|1801584|FG001|Observational Follow-up|Site Closed Early|0
844219|NCT00379769|1801585|FG002|Observational Follow-up|Site Closed Early|0
844220|NCT00379769|1801586|FG003|Observational Follow-up|Site Closed Early|0
844221|NCT00379769|1801587|FG004|Observational Follow-up|Site Closed Early|6
844222|NCT00379769|1801588|FG005|Observational Follow-up|Site Closed Early|7
844223|NCT00379769|1801583|FG000|Observational Follow-up|Participant Moved|0
844224|NCT00379769|1801584|FG001|Observational Follow-up|Participant Moved|0
844225|NCT00379769|1801585|FG002|Observational Follow-up|Participant Moved|0
844226|NCT00379769|1801586|FG003|Observational Follow-up|Participant Moved|0
844227|NCT00379769|1801587|FG004|Observational Follow-up|Participant Moved|0
844228|NCT00379769|1801588|FG005|Observational Follow-up|Participant Moved|1
844229|NCT00379769|1801583|FG000|Observational Follow-up|Unknown; Reason Not Provided|0
844230|NCT00379769|1801584|FG001|Observational Follow-up|Unknown; Reason Not Provided|0
844231|NCT00379769|1801585|FG002|Observational Follow-up|Unknown; Reason Not Provided|0
844232|NCT00379769|1801586|FG003|Observational Follow-up|Unknown; Reason Not Provided|0
844233|NCT00379769|1801587|FG004|Observational Follow-up|Unknown; Reason Not Provided|1
844234|NCT00379769|1801588|FG005|Observational Follow-up|Unknown; Reason Not Provided|1
844235|NCT00379795|1801620|FG000|Overall Study|Death|31
844236|NCT00379795|1801621|FG001|Overall Study|Death|8
844237|NCT00379795|1801622|FG002|Overall Study|Death|6
844238|NCT00379795|1801623|FG003|Overall Study|Death|4
844239|NCT00379795|1801624|FG004|Overall Study|Death|7
844240|NCT00379795|1801620|FG000|Overall Study|Adverse Event|17
844241|NCT00379795|1801621|FG001|Overall Study|Adverse Event|3
844242|NCT00379795|1801622|FG002|Overall Study|Adverse Event|3
844243|NCT00379795|1801623|FG003|Overall Study|Adverse Event|1
844244|NCT00379795|1801624|FG004|Overall Study|Adverse Event|4
844245|NCT00379795|1801620|FG000|Overall Study|Lost to Follow-up|8
844246|NCT00379795|1801621|FG001|Overall Study|Lost to Follow-up|1
844247|NCT00379795|1801622|FG002|Overall Study|Lost to Follow-up|2
844248|NCT00379795|1801623|FG003|Overall Study|Lost to Follow-up|1
844249|NCT00379795|1801624|FG004|Overall Study|Lost to Follow-up|4
844250|NCT00379795|1801620|FG000|Overall Study|Physician Decision|25
844251|NCT00379795|1801621|FG001|Overall Study|Physician Decision|0
844252|NCT00379795|1801622|FG002|Overall Study|Physician Decision|2
844253|NCT00379795|1801623|FG003|Overall Study|Physician Decision|2
844254|NCT00379795|1801624|FG004|Overall Study|Physician Decision|2
844255|NCT00379795|1801620|FG000|Overall Study|Withdrawal by Subject|94
844256|NCT00379795|1801621|FG001|Overall Study|Withdrawal by Subject|11
844257|NCT00379795|1801622|FG002|Overall Study|Withdrawal by Subject|19
844258|NCT00379795|1801623|FG003|Overall Study|Withdrawal by Subject|7
844259|NCT00379795|1801624|FG004|Overall Study|Withdrawal by Subject|14
844260|NCT00379795|1801620|FG000|Overall Study|Subject non-compliance|7
844261|NCT00379795|1801621|FG001|Overall Study|Subject non-compliance|2
844262|NCT00379795|1801622|FG002|Overall Study|Subject non-compliance|0
844263|NCT00379795|1801623|FG003|Overall Study|Subject non-compliance|0
844264|NCT00379795|1801624|FG004|Overall Study|Subject non-compliance|1
844265|NCT00379795|1801620|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3
844266|NCT00379795|1801621|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0
844267|NCT00379795|1801622|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0
844268|NCT00379795|1801623|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1
844269|NCT00379795|1801624|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0
844270|NCT00379795|1801620|FG000|Overall Study|Subjects condition mandated intervention|34
844271|NCT00379795|1801621|FG001|Overall Study|Subjects condition mandated intervention|9
844272|NCT00379795|1801622|FG002|Overall Study|Subjects condition mandated intervention|7
844273|NCT00379795|1801623|FG003|Overall Study|Subjects condition mandated intervention|5
844274|NCT00379795|1801624|FG004|Overall Study|Subjects condition mandated intervention|7
844275|NCT00379795|1801620|FG000|Overall Study|Sponsor's decision|257
844276|NCT00379795|1801621|FG001|Overall Study|Sponsor's decision|17
844277|NCT00379795|1801622|FG002|Overall Study|Sponsor's decision|54
844278|NCT00379795|1801623|FG003|Overall Study|Sponsor's decision|47
844279|NCT00379795|1801624|FG004|Overall Study|Sponsor's decision|10
844280|NCT00379808|1801639|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
844281|NCT00379808|1801640|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
844282|NCT00379834|1801670|FG000|Overall Study|Time constraints|2
844283|NCT00379899|1801676|FG000|Overall Study|Adverse Event|7
844284|NCT00379899|1801677|FG001|Overall Study|Adverse Event|3
844285|NCT00379899|1801676|FG000|Overall Study|Death|10
844286|NCT00379899|1801677|FG001|Overall Study|Death|10
844287|NCT00379899|1801676|FG000|Overall Study|Lost to Follow-up|2
844288|NCT00379899|1801677|FG001|Overall Study|Lost to Follow-up|4
844289|NCT00379899|1801676|FG000|Overall Study|Physician Decision|3
844290|NCT00379899|1801677|FG001|Overall Study|Physician Decision|4
844291|NCT00379899|1801676|FG000|Overall Study|Withdrawal by Subject|5
844292|NCT00379899|1801677|FG001|Overall Study|Withdrawal by Subject|5
844293|NCT00379899|1801676|FG000|Overall Study|Ineligibility determined|0
844294|NCT00379899|1801677|FG001|Overall Study|Ineligibility determined|1
844295|NCT00379899|1801676|FG000|Overall Study|Noncompliance|1
844296|NCT00379899|1801677|FG001|Overall Study|Noncompliance|1
844297|NCT00379899|1801676|FG000|Overall Study|Parathyroidectomy|0
844298|NCT00379899|1801677|FG001|Overall Study|Parathyroidectomy|2
844299|NCT00379899|1801676|FG000|Overall Study|Renal transplantation|5
844300|NCT00379899|1801677|FG001|Overall Study|Renal transplantation|4
844301|NCT00379899|1801676|FG000|Overall Study|Coronary artery bypass graft|1
844302|NCT00379899|1801677|FG001|Overall Study|Coronary artery bypass graft|1
844303|NCT00379899|1801676|FG000|Overall Study|Other protocol-specified criteria|3
844304|NCT00379899|1801677|FG001|Overall Study|Other protocol-specified criteria|4
844305|NCT00379899|1801676|FG000|Overall Study|Other|3
844306|NCT00379899|1801677|FG001|Overall Study|Other|1
844307|NCT00379912|1801685|FG000|Overall Study|Lack of Efficacy|1
844308|NCT00379912|1801686|FG001|Overall Study|Lack of Efficacy|0
844309|NCT00380068|1801706|FG000|Overall Study|Adverse Event|40
844310|NCT00380068|1801706|FG000|Overall Study|Withdrawal by Subject|10
844311|NCT00380068|1801706|FG000|Overall Study|Not compliant|6
844312|NCT00380068|1801706|FG000|Overall Study|Lost to Follow-up|1
844313|NCT00380068|1801706|FG000|Overall Study|Addition of other PAH therapeutic agent|1
844314|NCT00380068|1801706|FG000|Overall Study|Lung transplant|3
844315|NCT00380068|1801706|FG000|Overall Study|Physician Decision|2
844316|NCT00380068|1801706|FG000|Overall Study|Partipant moved away|1
844317|NCT00380068|1801706|FG000|Overall Study|Lack of Efficacy|5
844318|NCT00380081|1801716|FG000|Overall Study|Withdrawal by Subject|0
844319|NCT00380081|1801717|FG001|Overall Study|Withdrawal by Subject|0
844320|NCT00380081|1801718|FG002|Overall Study|Withdrawal by Subject|0
844321|NCT00380081|1801719|FG003|Overall Study|Withdrawal by Subject|0
844322|NCT00380081|1801720|FG004|Overall Study|Withdrawal by Subject|1
844323|NCT00380081|1801721|FG005|Overall Study|Withdrawal by Subject|0
844324|NCT00380081|1801716|FG000|Overall Study|Family Emergency|0
844325|NCT00380081|1801717|FG001|Overall Study|Family Emergency|0
844326|NCT00380081|1801718|FG002|Overall Study|Family Emergency|0
844327|NCT00380081|1801719|FG003|Overall Study|Family Emergency|0
844328|NCT00380081|1801720|FG004|Overall Study|Family Emergency|0
844329|NCT00380081|1801721|FG005|Overall Study|Family Emergency|1
844330|NCT00380250|1801731|FG000|Overall Study|Withdrawal by Subject|39
844331|NCT00380250|1801732|FG001|Overall Study|Withdrawal by Subject|28
844332|NCT00380250|1801731|FG000|Overall Study|Adverse Event|20
844333|NCT00380250|1801732|FG001|Overall Study|Adverse Event|9
844334|NCT00380250|1801731|FG000|Overall Study|Lack of Efficacy|10
844335|NCT00380250|1801732|FG001|Overall Study|Lack of Efficacy|8
844336|NCT00380250|1801731|FG000|Overall Study|Protocol Violation|15
844337|NCT00380250|1801732|FG001|Overall Study|Protocol Violation|5
844338|NCT00380250|1801731|FG000|Overall Study|Lost to Follow-up|14
844339|NCT00380250|1801732|FG001|Overall Study|Lost to Follow-up|5
844340|NCT00380250|1801731|FG000|Overall Study|Physician Decision|1
844341|NCT00380250|1801732|FG001|Overall Study|Physician Decision|0
844342|NCT00380367|1801738|FG000|Overall Study|Lost to Follow-up|1
844343|NCT00380367|1801738|FG000|Overall Study|Withdrawal by Subject|1
844344|NCT00380393|1801744|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
844345|NCT00380393|1801745|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
844346|NCT00380393|1801744|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
844347|NCT00380393|1801745|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
844348|NCT00380393|1801744|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
844349|NCT00380393|1801745|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
844350|NCT00380393|1801744|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
844351|NCT00380393|1801745|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
844352|NCT00380393|1801744|FG000|Month 8 (Cross-sectional Visit)|Others|5
844353|NCT00380393|1801745|FG001|Month 8 (Cross-sectional Visit)|Others|4
844354|NCT00380393|1801744|FG000|Month 14|Withdrawal by Subject|9
844355|NCT00380393|1801745|FG001|Month 14|Withdrawal by Subject|7
844356|NCT00380393|1801744|FG000|Month 14|Death|1
844357|NCT00380393|1801745|FG001|Month 14|Death|0
844358|NCT00380393|1801744|FG000|Month 14|Lost to Follow-up|0
844359|NCT00380393|1801745|FG001|Month 14|Lost to Follow-up|1
844360|NCT00380393|1801744|FG000|Month 14|Migrated/moved from study area|39
844361|NCT00380393|1801745|FG001|Month 14|Migrated/moved from study area|42
844362|NCT00380393|1801744|FG000|Month 14|Protocol Violation|2
844363|NCT00380393|1801745|FG001|Month 14|Protocol Violation|0
844364|NCT00380393|1801744|FG000|Month 14|Others|6
844365|NCT00380393|1801745|FG001|Month 14|Others|6
844366|NCT00380588|1801753|FG000|Overall Study|Unequivocal Disease Progression|25
844367|NCT00380588|1801754|FG001|Overall Study|Unequivocal Disease Progression|34
844368|NCT00380588|1801753|FG000|Overall Study|Next Cycle Not Started|4
844369|NCT00380588|1801754|FG001|Overall Study|Next Cycle Not Started|0
844370|NCT00380588|1801753|FG000|Overall Study|Adverse Event|7
844371|NCT00380588|1801754|FG001|Overall Study|Adverse Event|3
844372|NCT00380588|1801753|FG000|Overall Study|Withdrawal by Subject|1
844373|NCT00380588|1801754|FG001|Overall Study|Withdrawal by Subject|3
844374|NCT00380588|1801753|FG000|Overall Study|Physician Decision|2
844375|NCT00380588|1801754|FG001|Overall Study|Physician Decision|0
844376|NCT00380692|1801762|FG000|Study Period II - Double Blind|Adverse Event|1
844377|NCT00380692|1801763|FG001|Study Period II - Double Blind|Adverse Event|0
844378|NCT00380692|1801762|FG000|Study Period II - Double Blind|Protocol Violation|2
844379|NCT00380692|1801763|FG001|Study Period II - Double Blind|Protocol Violation|2
844380|NCT00380692|1801762|FG000|Study Period II - Double Blind|Withdrawal by Subject|0
844381|NCT00380692|1801763|FG001|Study Period II - Double Blind|Withdrawal by Subject|0
844382|NCT00380692|1801762|FG000|Study Period II - Double Blind|Physician Decision|0
844383|NCT00380692|1801763|FG001|Study Period II - Double Blind|Physician Decision|1
844384|NCT00380692|1801762|FG000|Study Period II - Double Blind|Lack of Efficacy|1
844385|NCT00380692|1801763|FG001|Study Period II - Double Blind|Lack of Efficacy|0
844386|NCT00380692|1801762|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1
844387|NCT00380692|1801763|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0
844388|NCT00380692|1801762|FG000|Study Period III - Open Label|Adverse Event|5
844389|NCT00380692|1801763|FG001|Study Period III - Open Label|Adverse Event|3
844390|NCT00380692|1801762|FG000|Study Period III - Open Label|Protocol Violation|0
844391|NCT00380692|1801763|FG001|Study Period III - Open Label|Protocol Violation|0
844392|NCT00380692|1801762|FG000|Study Period III - Open Label|Withdrawal by Subject|0
844393|NCT00380692|1801763|FG001|Study Period III - Open Label|Withdrawal by Subject|1
844394|NCT00380692|1801762|FG000|Study Period III - Open Label|Physician Decision|0
844395|NCT00380692|1801763|FG001|Study Period III - Open Label|Physician Decision|3
844396|NCT00380692|1801762|FG000|Study Period III - Open Label|Lack of Efficacy|0
844397|NCT00380692|1801763|FG001|Study Period III - Open Label|Lack of Efficacy|4
844398|NCT00380692|1801762|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1
844399|NCT00380692|1801763|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1
844400|NCT00380718|1801769|FG000|Overall Study|Adverse Event|1
844401|NCT00380718|1801769|FG000|Overall Study|Death after 30-day post-therapy followup|17
844402|NCT00380744|1801780|FG000|Overall Study|Death|0
844403|NCT00380744|1801781|FG001|Overall Study|Death|0
844404|NCT00380744|1801782|FG002|Overall Study|Death|0
844405|NCT00380744|1801783|FG003|Overall Study|Death|0
844406|NCT00380744|1801784|FG004|Overall Study|Death|0
844407|NCT00380744|1801785|FG005|Overall Study|Death|0
844408|NCT00380744|1801786|FG006|Overall Study|Death|1
844409|NCT00380744|1801780|FG000|Overall Study|Withdrawal by Subject|1
844410|NCT00380744|1801781|FG001|Overall Study|Withdrawal by Subject|0
844411|NCT00380744|1801782|FG002|Overall Study|Withdrawal by Subject|0
844412|NCT00380744|1801783|FG003|Overall Study|Withdrawal by Subject|0
844413|NCT00380744|1801784|FG004|Overall Study|Withdrawal by Subject|0
844414|NCT00380744|1801785|FG005|Overall Study|Withdrawal by Subject|0
844415|NCT00380744|1801786|FG006|Overall Study|Withdrawal by Subject|0
844416|NCT00380874|1801814|FG000|Overall Study|Adverse Event|7
844417|NCT00380874|1801815|FG001|Overall Study|Adverse Event|7
844418|NCT00380874|1801814|FG000|Overall Study|Death|1
844419|NCT00380874|1801815|FG001|Overall Study|Death|0
844420|NCT00380874|1801814|FG000|Overall Study|Withdrawal by Subject|2
844421|NCT00380874|1801815|FG001|Overall Study|Withdrawal by Subject|1
844422|NCT00380874|1801814|FG000|Overall Study|Not related to study drug|3
844423|NCT00380874|1801815|FG001|Overall Study|Not related to study drug|2
844424|NCT00380978|1801823|FG000|Overall Study|Refused allocated intervention|0
844425|NCT00380978|1801824|FG001|Overall Study|Refused allocated intervention|6
844426|NCT00380978|1801823|FG000|Overall Study|Wrong study envelope|0
844427|NCT00380978|1801824|FG001|Overall Study|Wrong study envelope|2
844428|NCT00380978|1801823|FG000|Overall Study|Allocation prior to analgesia request|1
844429|NCT00380978|1801824|FG001|Overall Study|Allocation prior to analgesia request|2
844430|NCT00380978|1801823|FG000|Overall Study|Parous patient|1
844431|NCT00380978|1801824|FG001|Overall Study|Parous patient|0
844432|NCT00381043|1801836|FG000|Overall Study|Lost to Follow-up|8
844433|NCT00381043|1801837|FG001|Overall Study|Lost to Follow-up|6
844434|NCT00381043|1801836|FG000|Overall Study|Withdrawal by Subject|3
844435|NCT00381043|1801837|FG001|Overall Study|Withdrawal by Subject|1
844436|NCT00381043|1801836|FG000|Overall Study|wanted more care|0
844437|NCT00381043|1801837|FG001|Overall Study|wanted more care|1
844438|NCT00381043|1801836|FG000|Overall Study|incarcerated|1
844439|NCT00381043|1801837|FG001|Overall Study|incarcerated|0
844440|NCT00381095|1801845|FG000|Overall Study|Death|3
844441|NCT00381095|1801846|FG001|Overall Study|Death|4
844442|NCT00381095|1801845|FG000|Overall Study|Lack of Efficacy|2
844443|NCT00381095|1801846|FG001|Overall Study|Lack of Efficacy|4
844444|NCT00381095|1801845|FG000|Overall Study|Other|2
844445|NCT00381095|1801846|FG001|Overall Study|Other|2
844446|NCT00381095|1801845|FG000|Overall Study|Protocol Violation|1
844447|NCT00381095|1801846|FG001|Overall Study|Protocol Violation|1
844448|NCT00381095|1801845|FG000|Overall Study|Withdrawal by Subject|3
844449|NCT00381095|1801846|FG001|Overall Study|Withdrawal by Subject|3
844450|NCT00381095|1801845|FG000|Overall Study|Adverse Event|2
844451|NCT00381095|1801846|FG001|Overall Study|Adverse Event|7
844452|NCT00381238|1801852|FG000|Overall Study|Adverse Event|3
844453|NCT00381238|1801852|FG000|Overall Study|Protocol Violation|1
844454|NCT00381238|1801852|FG000|Overall Study|Withdrawal by Subject|4
844455|NCT00381238|1801852|FG000|Overall Study|Lack of Efficacy|2
844456|NCT00381238|1801852|FG000|Overall Study|Withdrew by physician|1
844457|NCT00381238|1801852|FG000|Overall Study|Disease progression|1
844458|NCT00381303|1801858|FG000|Overall Study|Lost to Follow-up|25
844459|NCT00381303|1801859|FG001|Overall Study|Lost to Follow-up|9
844460|NCT00381303|1801858|FG000|Overall Study|AE/HIV-related event|22
844461|NCT00381303|1801859|FG001|Overall Study|AE/HIV-related event|6
844462|NCT00381303|1801858|FG000|Overall Study|Non-Adherence|13
844463|NCT00381303|1801859|FG001|Overall Study|Non-Adherence|6
844464|NCT00381303|1801858|FG000|Overall Study|Withdrawal by Subject|13
844465|NCT00381303|1801859|FG001|Overall Study|Withdrawal by Subject|6
844466|NCT00381303|1801858|FG000|Overall Study|Virologic failure|6
844467|NCT00381303|1801859|FG001|Overall Study|Virologic failure|4
844468|NCT00381303|1801858|FG000|Overall Study|Ineligible to continue the trial|2
844469|NCT00381303|1801859|FG001|Overall Study|Ineligible to continue the trial|1
844470|NCT00381303|1801858|FG000|Overall Study|Pregnancy|2
844471|NCT00381303|1801859|FG001|Overall Study|Pregnancy|0
844472|NCT00381303|1801858|FG000|Overall Study|Physician Decision|1
844473|NCT00381303|1801859|FG001|Overall Study|Physician Decision|0
844474|NCT00381303|1801858|FG000|Overall Study|Physician's decision to close the site|3
844475|NCT00381303|1801859|FG001|Overall Study|Physician's decision to close the site|1
844476|NCT00381303|1801858|FG000|Overall Study|Subject moved out of state|2
844477|NCT00381303|1801859|FG001|Overall Study|Subject moved out of state|0
844478|NCT00381303|1801858|FG000|Overall Study|Subject taking too many different meds|1
844479|NCT00381303|1801859|FG001|Overall Study|Subject taking too many different meds|0
844480|NCT00381303|1801858|FG000|Overall Study|No virologic response by week 12|1
844481|NCT00381303|1801859|FG001|Overall Study|No virologic response by week 12|0
844482|NCT00381303|1801858|FG000|Overall Study|Subject was too busy for appointments|1
844483|NCT00381303|1801859|FG001|Overall Study|Subject was too busy for appointments|0
844484|NCT00381303|1801858|FG000|Overall Study|Subject did not continue visits|1
844485|NCT00381303|1801859|FG001|Overall Study|Subject did not continue visits|0
844486|NCT00381303|1801858|FG000|Overall Study|Subject primary physician's decision|1
844487|NCT00381303|1801859|FG001|Overall Study|Subject primary physician's decision|0
844491|NCT00381485|1801884|FG000|Open-Label Run-In Period|Adverse Event|9
844492|NCT00381485|1801885|FG001|Open-Label Run-In Period|Adverse Event|0
844493|NCT00381485|1801886|FG002|Open-Label Run-In Period|Adverse Event|0
844494|NCT00381485|1801887|FG003|Open-Label Run-In Period|Adverse Event|0
844495|NCT00381485|1801884|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76
844496|NCT00381485|1801885|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0
844497|NCT00381485|1801886|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0
844498|NCT00381485|1801887|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0
844499|NCT00381485|1801884|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
844500|NCT00381485|1801885|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
844501|NCT00381485|1801886|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
844502|NCT00381485|1801887|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
844503|NCT00381485|1801884|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
844504|NCT00381485|1801885|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
844505|NCT00381485|1801886|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
844506|NCT00381485|1801887|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
844507|NCT00381485|1801884|FG000|Open-Label Run-In Period|Lost to Follow-up|3
844508|NCT00381485|1801885|FG001|Open-Label Run-In Period|Lost to Follow-up|0
844509|NCT00381485|1801886|FG002|Open-Label Run-In Period|Lost to Follow-up|0
844510|NCT00381485|1801887|FG003|Open-Label Run-In Period|Lost to Follow-up|0
844511|NCT00381485|1801884|FG000|Open-Label Run-In Period|Treatment failure|1
844512|NCT00381485|1801885|FG001|Open-Label Run-In Period|Treatment failure|0
844513|NCT00381485|1801886|FG002|Open-Label Run-In Period|Treatment failure|0
844514|NCT00381485|1801887|FG003|Open-Label Run-In Period|Treatment failure|0
844515|NCT00381485|1801884|FG000|Double-Blind Treatment Period|Adverse Event|0
844516|NCT00381485|1801885|FG001|Double-Blind Treatment Period|Adverse Event|2
844517|NCT00381485|1801886|FG002|Double-Blind Treatment Period|Adverse Event|2
844518|NCT00381485|1801887|FG003|Double-Blind Treatment Period|Adverse Event|5
844519|NCT00381485|1801884|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
844520|NCT00381485|1801885|FG001|Double-Blind Treatment Period|Lack of Efficacy|8
844521|NCT00381485|1801886|FG002|Double-Blind Treatment Period|Lack of Efficacy|11
844522|NCT00381485|1801887|FG003|Double-Blind Treatment Period|Lack of Efficacy|13
844523|NCT00381485|1801884|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
844524|NCT00381485|1801885|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
844525|NCT00381485|1801886|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
844526|NCT00381485|1801887|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
844527|NCT00381485|1801884|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0
844528|NCT00381485|1801885|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9
844529|NCT00381485|1801886|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3
844530|NCT00381485|1801887|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3
844531|NCT00381485|1801884|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0
844532|NCT00381485|1801885|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5
844533|NCT00381485|1801886|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7
844534|NCT00381485|1801887|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5
844535|NCT00381485|1801884|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
844536|NCT00381485|1801885|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
844537|NCT00381485|1801886|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
844538|NCT00381485|1801887|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
844539|NCT00381485|1801884|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
844540|NCT00381485|1801885|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
844541|NCT00381485|1801886|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
844542|NCT00381485|1801887|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
844543|NCT00381485|1801884|FG000|Double-Blind Treatment Period|Administrative|0
844544|NCT00381485|1801885|FG001|Double-Blind Treatment Period|Administrative|1
844545|NCT00381485|1801886|FG002|Double-Blind Treatment Period|Administrative|0
844546|NCT00381485|1801887|FG003|Double-Blind Treatment Period|Administrative|1
844547|NCT00381563|1801902|FG000|Overall Study|Withdrawal by Subject|5
844548|NCT00381563|1801903|FG001|Overall Study|Withdrawal by Subject|5
844549|NCT00381563|1801902|FG000|Overall Study|Lost to Follow-up|2
844550|NCT00381563|1801903|FG001|Overall Study|Lost to Follow-up|0
844551|NCT00381563|1801902|FG000|Overall Study|Protocol Violation|0
844552|NCT00381563|1801903|FG001|Overall Study|Protocol Violation|1
844553|NCT00381615|1801912|FG000|Overall Study|Withdrawal by Subject|1
844554|NCT00381615|1801913|FG001|Overall Study|Withdrawal by Subject|3
844555|NCT00381615|1801914|FG002|Overall Study|Withdrawal by Subject|0
844556|NCT00381615|1801915|FG003|Overall Study|Withdrawal by Subject|1
844557|NCT00381615|1801912|FG000|Overall Study|Lost to Follow-up|3
844558|NCT00381615|1801913|FG001|Overall Study|Lost to Follow-up|2
844559|NCT00381615|1801914|FG002|Overall Study|Lost to Follow-up|0
844560|NCT00381615|1801915|FG003|Overall Study|Lost to Follow-up|1
844561|NCT00381615|1801912|FG000|Overall Study|Protocol Violation|0
844562|NCT00381615|1801913|FG001|Overall Study|Protocol Violation|0
844563|NCT00381615|1801914|FG002|Overall Study|Protocol Violation|1
844564|NCT00381615|1801915|FG003|Overall Study|Protocol Violation|0
844565|NCT00381641|1801946|FG000|Overall Study|Withdrawal by Subject|0
844566|NCT00381641|1801947|FG001|Overall Study|Withdrawal by Subject|2
844567|NCT00381680|1801955|FG000|Overall Study|Adverse Event|9
844568|NCT00381680|1801956|FG001|Overall Study|Adverse Event|3
844569|NCT00381680|1801955|FG000|Overall Study|Death|10
844570|NCT00381680|1801956|FG001|Overall Study|Death|7
844571|NCT00381680|1801955|FG000|Overall Study|Lost to Follow-up|3
844572|NCT00381680|1801956|FG001|Overall Study|Lost to Follow-up|2
844573|NCT00381680|1801955|FG000|Overall Study|Physician Decision|25
844574|NCT00381680|1801956|FG001|Overall Study|Physician Decision|6
844575|NCT00381680|1801955|FG000|Overall Study|Withdrawal by Subject|3
844576|NCT00381680|1801956|FG001|Overall Study|Withdrawal by Subject|1
844577|NCT00381680|1801955|FG000|Overall Study|Entry onto another COG Trial|1
844578|NCT00381680|1801956|FG001|Overall Study|Entry onto another COG Trial|2
844579|NCT00381680|1801955|FG000|Overall Study|Alternative Therapy|11
844580|NCT00381680|1801956|FG001|Overall Study|Alternative Therapy|5
844581|NCT00381680|1801955|FG000|Overall Study|Secondary Malignancy|3
844582|NCT00381680|1801956|FG001|Overall Study|Secondary Malignancy|0
844583|NCT00381680|1801955|FG000|Overall Study|Delay initiation|1
844584|NCT00381680|1801956|FG001|Overall Study|Delay initiation|0
844585|NCT00381680|1801955|FG000|Overall Study|Stem Cell Transplant|26
844586|NCT00381680|1801956|FG001|Overall Study|Stem Cell Transplant|10
844587|NCT00381680|1801955|FG000|Overall Study|Relapse|18
844588|NCT00381680|1801956|FG001|Overall Study|Relapse|9
844589|NCT00381680|1801955|FG000|Overall Study|Induction Failure|4
844590|NCT00381680|1801956|FG001|Overall Study|Induction Failure|1
844591|NCT00381680|1801955|FG000|Overall Study|Progression|1
844592|NCT00381680|1801956|FG001|Overall Study|Progression|1
844593|NCT00381680|1801955|FG000|Overall Study|Other not otherwise specified|7
844594|NCT00381680|1801956|FG001|Overall Study|Other not otherwise specified|2
844595|NCT00381680|1801955|FG000|Overall Study|Ineligible|3
844596|NCT00381680|1801956|FG001|Overall Study|Ineligible|1
844597|NCT00381693|1801966|FG000|Overall Study|Death|1
844598|NCT00381693|1801966|FG000|Overall Study|Adverse Event|4
844599|NCT00381693|1801966|FG000|Overall Study|Patient Choice|1
844600|NCT00381693|1801966|FG000|Overall Study|Progression|2
844601|NCT00381706|1801976|FG000|Overall Study|Never treated|7
844602|NCT00381706|1801977|FG001|Overall Study|Never treated|2
844603|NCT00381706|1801978|FG002|Overall Study|Never treated|1
844604|NCT00381797|1801997|FG000|Overall Study|Withdrawal by Subject|1
844605|NCT00381797|1801998|FG001|Overall Study|Withdrawal by Subject|1
844606|NCT00381797|1801999|FG002|Overall Study|Withdrawal by Subject|0
844607|NCT00381797|1802000|FG003|Overall Study|Withdrawal by Subject|0
844608|NCT00381797|1802001|FG004|Overall Study|Withdrawal by Subject|2
844609|NCT00381797|1801997|FG000|Overall Study|Ineligible|0
844610|NCT00381797|1801998|FG001|Overall Study|Ineligible|0
844611|NCT00381797|1801999|FG002|Overall Study|Ineligible|0
844612|NCT00381797|1802000|FG003|Overall Study|Ineligible|1
844613|NCT00381797|1802001|FG004|Overall Study|Ineligible|0
844614|NCT00381849|1802040|FG000|Wash Out|Withdrawal by Subject|0
844615|NCT00381849|1802041|FG001|Wash Out|Withdrawal by Subject|1
844616|NCT00381888|1802051|FG000|Overall Study|Death|1
844617|NCT00381888|1802051|FG000|Overall Study|Withdrawal by Subject|1
844618|NCT00381888|1802051|FG000|Overall Study|Physician Decision|1
844619|NCT00381888|1802051|FG000|Overall Study|Protocol Violation|9
844620|NCT00381888|1802051|FG000|Overall Study|Had laparoscopic surgery|2
844621|NCT00381888|1802051|FG000|Overall Study|Surgery was cancelled|2
844622|NCT00381888|1802051|FG000|Overall Study|Adverse Event|1
844623|NCT00381940|1802055|FG000|Overall Study|Lack of Efficacy|3
844624|NCT00381940|1802055|FG000|Overall Study|Protocol Violation|1
844625|NCT00381940|1802055|FG000|Overall Study|Ineligible|1
844626|NCT00382018|1802067|FG000|Overall Study|Progression|0
844627|NCT00382018|1802068|FG001|Overall Study|Progression|136
844628|NCT00382018|1802069|FG002|Overall Study|Progression|51
844629|NCT00382018|1802070|FG003|Overall Study|Progression|43
844630|NCT00382018|1802067|FG000|Overall Study|Death|0
844631|NCT00382018|1802068|FG001|Overall Study|Death|9
844632|NCT00382018|1802069|FG002|Overall Study|Death|7
844633|NCT00382018|1802070|FG003|Overall Study|Death|11
844634|NCT00382018|1802067|FG000|Overall Study|Withdrawal by Subject|0
844635|NCT00382018|1802068|FG001|Overall Study|Withdrawal by Subject|4
844636|NCT00382018|1802069|FG002|Overall Study|Withdrawal by Subject|3
844637|NCT00382018|1802070|FG003|Overall Study|Withdrawal by Subject|4
844638|NCT00382018|1802067|FG000|Overall Study|Other, not protocol specified|0
844639|NCT00382018|1802068|FG001|Overall Study|Other, not protocol specified|16
844640|NCT00382018|1802069|FG002|Overall Study|Other, not protocol specified|3
844641|NCT00382018|1802070|FG003|Overall Study|Other, not protocol specified|1
844642|NCT00382070|1802094|FG000|Overall Study|No follow up data mapped to Other|17
844643|NCT00382070|1802095|FG001|Overall Study|No follow up data mapped to Other|19
844644|NCT00382070|1802094|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7
844645|NCT00382070|1802095|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0
844646|NCT00382070|1802094|FG000|Overall Study|No clinical assessment|9
844647|NCT00382070|1802095|FG001|Overall Study|No clinical assessment|11
844648|NCT00382109|1802103|FG000|Overall Study|Adverse Event|3
844649|NCT00382109|1802104|FG001|Overall Study|Adverse Event|0
844650|NCT00382109|1802103|FG000|Overall Study|Physician Decision|6
844651|NCT00382109|1802104|FG001|Overall Study|Physician Decision|1
844652|NCT00382109|1802103|FG000|Overall Study|Withdrawal by Subject|1
844653|NCT00382109|1802104|FG001|Overall Study|Withdrawal by Subject|0
844654|NCT00382109|1802103|FG000|Overall Study|ineligible|2
844655|NCT00382109|1802104|FG001|Overall Study|ineligible|0
844656|NCT00382109|1802103|FG000|Overall Study|Other|0
844657|NCT00382109|1802104|FG001|Overall Study|Other|2
844658|NCT00382109|1802103|FG000|Overall Study|consent withdrawal|0
844659|NCT00382109|1802104|FG001|Overall Study|consent withdrawal|1
844660|NCT00382174|1802124|FG000|Overall Study|Lost to Follow-up|1
844661|NCT00382174|1802125|FG001|Overall Study|Lost to Follow-up|4
844662|NCT00382174|1802126|FG002|Overall Study|Lost to Follow-up|5
844663|NCT00382174|1802124|FG000|Overall Study|Adverse Event|1
844664|NCT00382174|1802125|FG001|Overall Study|Adverse Event|4
844665|NCT00382174|1802126|FG002|Overall Study|Adverse Event|5
844666|NCT00382174|1802124|FG000|Overall Study|Withdrawal by Subject|1
844667|NCT00382174|1802125|FG001|Overall Study|Withdrawal by Subject|4
844668|NCT00382174|1802126|FG002|Overall Study|Withdrawal by Subject|5
844669|NCT00382174|1802124|FG000|Overall Study|Non compliance|1
844670|NCT00382174|1802125|FG001|Overall Study|Non compliance|0
844671|NCT00382174|1802126|FG002|Overall Study|Non compliance|1
844672|NCT00382174|1802124|FG000|Overall Study|Physician Decision|0
844673|NCT00382174|1802125|FG001|Overall Study|Physician Decision|2
844674|NCT00382174|1802126|FG002|Overall Study|Physician Decision|2
844675|NCT00382174|1802124|FG000|Overall Study|Failed to meet criteria|0
844676|NCT00382174|1802125|FG001|Overall Study|Failed to meet criteria|1
844677|NCT00382174|1802126|FG002|Overall Study|Failed to meet criteria|1
844678|NCT00382174|1802124|FG000|Overall Study|Wounds merged|0
844679|NCT00382174|1802125|FG001|Overall Study|Wounds merged|2
844680|NCT00382174|1802126|FG002|Overall Study|Wounds merged|2
844681|NCT00382291|1802150|FG000|Overall Study|Adverse Event|1
844682|NCT00382291|1802151|FG001|Overall Study|Adverse Event|2
844683|NCT00382291|1802152|FG002|Overall Study|Adverse Event|2
844684|NCT00382291|1802150|FG000|Overall Study|Protocol Violation|1
844685|NCT00382291|1802151|FG001|Overall Study|Protocol Violation|0
844686|NCT00382291|1802152|FG002|Overall Study|Protocol Violation|0
844687|NCT00382291|1802150|FG000|Overall Study|Temporary study suspension|2
844688|NCT00382291|1802151|FG001|Overall Study|Temporary study suspension|2
844689|NCT00382291|1802152|FG002|Overall Study|Temporary study suspension|5
844690|NCT00382291|1802150|FG000|Overall Study|Withdrawal by Subject|0
844691|NCT00382291|1802151|FG001|Overall Study|Withdrawal by Subject|2
844692|NCT00382291|1802152|FG002|Overall Study|Withdrawal by Subject|0
844693|NCT00382291|1802150|FG000|Overall Study|Physician Decision|0
844694|NCT00382291|1802151|FG001|Overall Study|Physician Decision|1
844695|NCT00382291|1802152|FG002|Overall Study|Physician Decision|0
844696|NCT00382291|1802150|FG000|Overall Study|Lack of Efficacy|0
844697|NCT00382291|1802151|FG001|Overall Study|Lack of Efficacy|0
844698|NCT00382291|1802152|FG002|Overall Study|Lack of Efficacy|1
844699|NCT00382408|1802164|FG000|Overall Study|Did not meet protocol requirement|3
844700|NCT00382408|1802165|FG001|Overall Study|Did not meet protocol requirement|3
844701|NCT00382408|1802164|FG000|Overall Study|Protocol Violation|2
844702|NCT00382408|1802165|FG001|Overall Study|Protocol Violation|2
844703|NCT00382408|1802164|FG000|Overall Study|Physician Decision|1
844704|NCT00382408|1802165|FG001|Overall Study|Physician Decision|0
844705|NCT00382408|1802164|FG000|Overall Study|Withdrawal by Subject|17
844706|NCT00382408|1802165|FG001|Overall Study|Withdrawal by Subject|6
844707|NCT00382408|1802164|FG000|Overall Study|Pregnancy|2
844708|NCT00382408|1802165|FG001|Overall Study|Pregnancy|0
844709|NCT00382408|1802164|FG000|Overall Study|Lost to Follow-up|19
844710|NCT00382408|1802165|FG001|Overall Study|Lost to Follow-up|8
844711|NCT00382408|1802164|FG000|Overall Study|Other|100
844712|NCT00382408|1802165|FG001|Overall Study|Other|35
844713|NCT00382720|1802183|FG000|Overall Study|Adverse Event|21
844714|NCT00382720|1802184|FG001|Overall Study|Adverse Event|23
844715|NCT00382720|1802185|FG002|Overall Study|Adverse Event|15
844716|NCT00382720|1802183|FG000|Overall Study|Protocol Violation|2
844717|NCT00382720|1802184|FG001|Overall Study|Protocol Violation|5
844718|NCT00382720|1802185|FG002|Overall Study|Protocol Violation|1
844719|NCT00382720|1802183|FG000|Overall Study|Death|0
844720|NCT00382720|1802184|FG001|Overall Study|Death|1
844721|NCT00382720|1802185|FG002|Overall Study|Death|2
844722|NCT00382720|1802183|FG000|Overall Study|Progressive disease|37
844723|NCT00382720|1802184|FG001|Overall Study|Progressive disease|28
844724|NCT00382720|1802185|FG002|Overall Study|Progressive disease|38
844725|NCT00382720|1802183|FG000|Overall Study|Withdrew consent|1
844726|NCT00382720|1802184|FG001|Overall Study|Withdrew consent|1
844727|NCT00382720|1802185|FG002|Overall Study|Withdrew consent|2
844728|NCT00382720|1802183|FG000|Overall Study|Withdrawal by Subject|11
844729|NCT00382720|1802184|FG001|Overall Study|Withdrawal by Subject|20
844730|NCT00382720|1802185|FG002|Overall Study|Withdrawal by Subject|12
844731|NCT00382720|1802183|FG000|Overall Study|Surgery|1
844732|NCT00382720|1802184|FG001|Overall Study|Surgery|1
844733|NCT00382720|1802185|FG002|Overall Study|Surgery|4
844734|NCT00382720|1802183|FG000|Overall Study|Patient did not receive study medication|1
844735|NCT00382720|1802184|FG001|Overall Study|Patient did not receive study medication|1
844736|NCT00382720|1802185|FG002|Overall Study|Patient did not receive study medication|4
844737|NCT00382720|1802183|FG000|Overall Study|Clinically progressive disease|0
844738|NCT00382720|1802184|FG001|Overall Study|Clinically progressive disease|1
844739|NCT00382720|1802185|FG002|Overall Study|Clinically progressive disease|0
844740|NCT00382720|1802183|FG000|Overall Study|Good prognosis|0
844741|NCT00382720|1802184|FG001|Overall Study|Good prognosis|1
844742|NCT00382720|1802185|FG002|Overall Study|Good prognosis|0
844743|NCT00382720|1802183|FG000|Overall Study|Investigator/Clinical decision|5
844744|NCT00382720|1802184|FG001|Overall Study|Investigator/Clinical decision|6
844745|NCT00382720|1802185|FG002|Overall Study|Investigator/Clinical decision|6
844746|NCT00382720|1802183|FG000|Overall Study|Discontinued at end of study|0
844747|NCT00382720|1802184|FG001|Overall Study|Discontinued at end of study|1
844748|NCT00382720|1802185|FG002|Overall Study|Discontinued at end of study|2
844749|NCT00382733|1802193|FG000|Overall Study|Withdrawal by Subject|0
844750|NCT00382733|1802194|FG001|Overall Study|Withdrawal by Subject|1
844751|NCT00382733|1802195|FG002|Overall Study|Withdrawal by Subject|0
844752|NCT00382733|1802196|FG003|Overall Study|Withdrawal by Subject|0
844753|NCT00382733|1802197|FG004|Overall Study|Withdrawal by Subject|0
844754|NCT00382863|1802230|FG000|Overall Study|Death|9
844755|NCT00382863|1802231|FG001|Overall Study|Death|9
844756|NCT00382863|1802230|FG000|Overall Study|Lost to Follow-up|1
844757|NCT00382863|1802231|FG001|Overall Study|Lost to Follow-up|2
844758|NCT00382863|1802230|FG000|Overall Study|Withdrawal by Subject|5
844759|NCT00382863|1802231|FG001|Overall Study|Withdrawal by Subject|25
844760|NCT00382967|1802253|FG000|Overall Study|Protocol Violation|1
844761|NCT00382967|1802254|FG001|Overall Study|Protocol Violation|1
844762|NCT00382993|1802260|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
844763|NCT00382993|1802261|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
844764|NCT00382993|1802260|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
844765|NCT00382993|1802261|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
844766|NCT00382993|1802260|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
844767|NCT00382993|1802261|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
844768|NCT00382993|1802260|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
844769|NCT00382993|1802261|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
844770|NCT00382993|1802260|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
844771|NCT00382993|1802261|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
844772|NCT00382993|1802260|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
844773|NCT00382993|1802261|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
844774|NCT00382993|1802260|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
844775|NCT00382993|1802261|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
844776|NCT00382993|1802260|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
844777|NCT00382993|1802261|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
844778|NCT00382993|1802260|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0
844779|NCT00382993|1802261|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1
844780|NCT00382993|1802260|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
844781|NCT00382993|1802261|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
844782|NCT00383019|1802269|FG000|Overall Study|Adverse Event|5
844783|NCT00383019|1802270|FG001|Overall Study|Adverse Event|1
844784|NCT00383019|1802269|FG000|Overall Study|Withdrawal by Subject|0
844785|NCT00383019|1802270|FG001|Overall Study|Withdrawal by Subject|1
844786|NCT00383084|1802295|FG000|Overall Study|Withdrawal by Subject|12
844787|NCT00383084|1802296|FG001|Overall Study|Withdrawal by Subject|10
844788|NCT00383123|1802314|FG000|Overall Study|Adverse Event|1
844789|NCT00383123|1802315|FG001|Overall Study|Adverse Event|0
844790|NCT00383123|1802314|FG000|Overall Study|Lost to Follow-up|68
844791|NCT00383123|1802315|FG001|Overall Study|Lost to Follow-up|61
844792|NCT00383123|1802314|FG000|Overall Study|Protocol Violation|5
844793|NCT00383123|1802315|FG001|Overall Study|Protocol Violation|1
844794|NCT00383123|1802314|FG000|Overall Study|Withdrawal by Subject|27
844795|NCT00383123|1802315|FG001|Overall Study|Withdrawal by Subject|18
844796|NCT00383123|1802314|FG000|Overall Study|Other reason|10
844797|NCT00383123|1802315|FG001|Overall Study|Other reason|6
844798|NCT00383149|1802321|FG000|Overall Study|Adverse Event not Related to Study Drug|3
844799|NCT00383149|1802321|FG000|Overall Study|Death|2
844800|NCT00383149|1802321|FG000|Overall Study|Disease Progression|38
844801|NCT00383149|1802321|FG000|Overall Study|Lost to Follow-up|1
844802|NCT00383149|1802321|FG000|Overall Study|Other|1
844803|NCT00383149|1802321|FG000|Overall Study|Study Drug Toxicity|4
844804|NCT00383149|1802321|FG000|Overall Study|Request to Discontinue Treatment|4
844805|NCT00383149|1802321|FG000|Overall Study|Participant Withdrew Consent|1
844806|NCT00383162|1802327|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
844807|NCT00383162|1802328|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
844808|NCT00383162|1802327|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
844809|NCT00383162|1802328|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
844810|NCT00383162|1802327|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
844811|NCT00383162|1802328|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
844812|NCT00383162|1802327|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
844813|NCT00383162|1802328|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
844814|NCT00383162|1802327|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3
844815|NCT00383162|1802328|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0
844816|NCT00383162|1802327|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
844817|NCT00383162|1802328|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
844818|NCT00383162|1802327|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
844819|NCT00383162|1802328|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
844820|NCT00383162|1802327|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1
844821|NCT00383162|1802328|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0
844822|NCT00383162|1802327|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0
844823|NCT00383162|1802328|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3
844824|NCT00383188|1802339|FG000|Overall Study|Adverse Event|4
844825|NCT00383188|1802340|FG001|Overall Study|Adverse Event|7
844826|NCT00383188|1802341|FG002|Overall Study|Adverse Event|9
844827|NCT00383188|1802342|FG003|Overall Study|Adverse Event|8
844828|NCT00383188|1802343|FG004|Overall Study|Adverse Event|8
844829|NCT00383188|1802339|FG000|Overall Study|Lack of Efficacy|9
844830|NCT00383188|1802340|FG001|Overall Study|Lack of Efficacy|3
844831|NCT00383188|1802341|FG002|Overall Study|Lack of Efficacy|3
844832|NCT00383188|1802342|FG003|Overall Study|Lack of Efficacy|2
844833|NCT00383188|1802343|FG004|Overall Study|Lack of Efficacy|6
844834|NCT00383188|1802339|FG000|Overall Study|Other|3
844835|NCT00383188|1802340|FG001|Overall Study|Other|1
844836|NCT00383188|1802341|FG002|Overall Study|Other|0
844837|NCT00383188|1802342|FG003|Overall Study|Other|2
844838|NCT00383188|1802343|FG004|Overall Study|Other|6
844839|NCT00383188|1802339|FG000|Overall Study|No longer willing to participate|1
844840|NCT00383188|1802340|FG001|Overall Study|No longer willing to participate|0
844841|NCT00383188|1802341|FG002|Overall Study|No longer willing to participate|1
844842|NCT00383188|1802342|FG003|Overall Study|No longer willing to participate|0
844843|NCT00383188|1802343|FG004|Overall Study|No longer willing to participate|2
844844|NCT00383188|1802339|FG000|Overall Study|Lost to Follow-up|0
844845|NCT00383188|1802340|FG001|Overall Study|Lost to Follow-up|0
844846|NCT00383188|1802341|FG002|Overall Study|Lost to Follow-up|0
844847|NCT00383188|1802342|FG003|Overall Study|Lost to Follow-up|0
844848|NCT00383188|1802343|FG004|Overall Study|Lost to Follow-up|1
844849|NCT00383240|1802361|FG000|Overall Study|Adverse Event|4
844850|NCT00383240|1802362|FG001|Overall Study|Adverse Event|6
844851|NCT00383240|1802363|FG002|Overall Study|Adverse Event|9
844852|NCT00383240|1802364|FG003|Overall Study|Adverse Event|7
844853|NCT00383240|1802361|FG000|Overall Study|Treatment Failure|8
844854|NCT00383240|1802362|FG001|Overall Study|Treatment Failure|13
844855|NCT00383240|1802363|FG002|Overall Study|Treatment Failure|47
844856|NCT00383240|1802364|FG003|Overall Study|Treatment Failure|46
844857|NCT00383240|1802361|FG000|Overall Study|Lost to Follow-up|3
844858|NCT00383240|1802362|FG001|Overall Study|Lost to Follow-up|0
844859|NCT00383240|1802363|FG002|Overall Study|Lost to Follow-up|0
844860|NCT00383240|1802364|FG003|Overall Study|Lost to Follow-up|2
844861|NCT00383240|1802361|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6
844862|NCT00383240|1802362|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3
844863|NCT00383240|1802363|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8
844864|NCT00383240|1802364|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8
844865|NCT00383240|1802361|FG000|Overall Study|Withdrawal by subjects, reasons related|0
844866|NCT00383240|1802362|FG001|Overall Study|Withdrawal by subjects, reasons related|1
844867|NCT00383240|1802363|FG002|Overall Study|Withdrawal by subjects, reasons related|3
844868|NCT00383240|1802364|FG003|Overall Study|Withdrawal by subjects, reasons related|5
844869|NCT00383240|1802361|FG000|Overall Study|Protocol Violation|4
844870|NCT00383240|1802362|FG001|Overall Study|Protocol Violation|5
844871|NCT00383240|1802363|FG002|Overall Study|Protocol Violation|9
844872|NCT00383240|1802364|FG003|Overall Study|Protocol Violation|6
844873|NCT00383240|1802361|FG000|Overall Study|Did not meet protocol eligibility|9
844874|NCT00383240|1802362|FG001|Overall Study|Did not meet protocol eligibility|4
844875|NCT00383240|1802363|FG002|Overall Study|Did not meet protocol eligibility|9
844876|NCT00383240|1802364|FG003|Overall Study|Did not meet protocol eligibility|3
844877|NCT00383240|1802361|FG000|Overall Study|Administrative|1
844878|NCT00383240|1802362|FG001|Overall Study|Administrative|1
844879|NCT00383240|1802363|FG002|Overall Study|Administrative|0
844880|NCT00383240|1802364|FG003|Overall Study|Administrative|0
844881|NCT00383292|1802382|FG000|Overall Study|Adverse Event|4
844882|NCT00383292|1802383|FG001|Overall Study|Adverse Event|1
844883|NCT00383292|1802384|FG002|Overall Study|Adverse Event|2
844884|NCT00383292|1802382|FG000|Overall Study|Death|3
844885|NCT00383292|1802383|FG001|Overall Study|Death|3
844886|NCT00383292|1802384|FG002|Overall Study|Death|3
844887|NCT00383292|1802382|FG000|Overall Study|Physician Decision|4
844888|NCT00383292|1802383|FG001|Overall Study|Physician Decision|0
844889|NCT00383292|1802384|FG002|Overall Study|Physician Decision|1
844890|NCT00383292|1802382|FG000|Overall Study|Withdrawal by Subject|3
844891|NCT00383292|1802383|FG001|Overall Study|Withdrawal by Subject|2
844892|NCT00383292|1802384|FG002|Overall Study|Withdrawal by Subject|2
844893|NCT00383292|1802382|FG000|Overall Study|Other|1
844894|NCT00383292|1802383|FG001|Overall Study|Other|0
844895|NCT00383292|1802384|FG002|Overall Study|Other|0
844896|NCT00383331|1802395|FG000|Overall Study|Protocol Violation|0
844897|NCT00383331|1802396|FG001|Overall Study|Protocol Violation|1
844898|NCT00383435|1802407|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10
844899|NCT00383435|1802408|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2
844900|NCT00383435|1802409|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8
844901|NCT00383435|1802410|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6
844902|NCT00383435|1802411|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8
844903|NCT00383435|1802407|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
844904|NCT00383435|1802408|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
844905|NCT00383435|1802409|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
844906|NCT00383435|1802410|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
844907|NCT00383435|1802411|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
844908|NCT00383435|1802407|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
844909|NCT00383435|1802408|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
844910|NCT00383435|1802409|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
844911|NCT00383435|1802410|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
844912|NCT00383435|1802411|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
844913|NCT00383435|1802407|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
844914|NCT00383435|1802408|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
844915|NCT00383435|1802409|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
844916|NCT00383435|1802410|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
844917|NCT00383435|1802411|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
844918|NCT00383435|1802407|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
844919|NCT00383435|1802408|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
844920|NCT00383435|1802409|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
844921|NCT00383435|1802410|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
844922|NCT00383435|1802411|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
844923|NCT00383435|1802407|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
844924|NCT00383435|1802408|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
844925|NCT00383435|1802409|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
844926|NCT00383435|1802410|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
844927|NCT00383435|1802411|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
844928|NCT00383435|1802407|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
845147|NCT00384059|1802567|FG000|Infant Series|Adverse Event|1
844929|NCT00383435|1802408|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
844930|NCT00383435|1802409|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
844931|NCT00383435|1802410|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
844932|NCT00383435|1802411|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
844933|NCT00383435|1802407|FG000|26-Week Double-Blind Treatment Period|Administrative|5
844934|NCT00383435|1802408|FG001|26-Week Double-Blind Treatment Period|Administrative|3
844935|NCT00383435|1802409|FG002|26-Week Double-Blind Treatment Period|Administrative|1
844936|NCT00383435|1802410|FG003|26-Week Double-Blind Treatment Period|Administrative|1
844937|NCT00383435|1802411|FG004|26-Week Double-Blind Treatment Period|Administrative|1
844938|NCT00383435|1802407|FG000|26-Week Treatment Safety Extension|Adverse Event|4
844939|NCT00383435|1802408|FG001|26-Week Treatment Safety Extension|Adverse Event|2
844940|NCT00383435|1802409|FG002|26-Week Treatment Safety Extension|Adverse Event|5
844941|NCT00383435|1802410|FG003|26-Week Treatment Safety Extension|Adverse Event|5
844942|NCT00383435|1802411|FG004|26-Week Treatment Safety Extension|Adverse Event|1
844943|NCT00383435|1802407|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1
844944|NCT00383435|1802408|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1
844945|NCT00383435|1802409|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1
844946|NCT00383435|1802410|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
844947|NCT00383435|1802411|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
844948|NCT00383435|1802407|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0
844949|NCT00383435|1802408|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2
844950|NCT00383435|1802409|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
844951|NCT00383435|1802410|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0
844952|NCT00383435|1802411|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1
844953|NCT00383435|1802407|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
844954|NCT00383435|1802408|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
844955|NCT00383435|1802409|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
844956|NCT00383435|1802410|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
844957|NCT00383435|1802411|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
844958|NCT00383435|1802407|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
844959|NCT00383435|1802408|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0
844960|NCT00383435|1802409|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2
844961|NCT00383435|1802410|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0
844962|NCT00383435|1802411|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1
844963|NCT00383435|1802407|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4
844964|NCT00383435|1802408|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
844965|NCT00383435|1802409|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
844966|NCT00383435|1802410|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1
844967|NCT00383435|1802411|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
844968|NCT00383435|1802407|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
844969|NCT00383435|1802408|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
844970|NCT00383435|1802409|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
844971|NCT00383435|1802410|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
844972|NCT00383435|1802411|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
844973|NCT00383435|1802407|FG000|26-Week Treatment Safety Extension|Administrative|1
844974|NCT00383435|1802408|FG001|26-Week Treatment Safety Extension|Administrative|1
844975|NCT00383435|1802409|FG002|26-Week Treatment Safety Extension|Administrative|0
844976|NCT00383435|1802410|FG003|26-Week Treatment Safety Extension|Administrative|1
844977|NCT00383435|1802411|FG004|26-Week Treatment Safety Extension|Administrative|0
844978|NCT00383500|1802431|FG000|Overall Study|Withdrawal by Subject|8
844979|NCT00383500|1802432|FG001|Overall Study|Withdrawal by Subject|3
844980|NCT00383500|1802433|FG002|Overall Study|Withdrawal by Subject|0
844981|NCT00383500|1802431|FG000|Overall Study|Lost to Follow-up|0
844982|NCT00383500|1802432|FG001|Overall Study|Lost to Follow-up|0
844983|NCT00383500|1802433|FG002|Overall Study|Lost to Follow-up|2
844984|NCT00383552|1802446|FG000|Overall Study|Adverse Event|7
844985|NCT00383552|1802447|FG001|Overall Study|Adverse Event|6
844986|NCT00383552|1802448|FG002|Overall Study|Adverse Event|9
844987|NCT00383552|1802449|FG003|Overall Study|Adverse Event|6
844988|NCT00383552|1802446|FG000|Overall Study|Lack of Efficacy|4
844989|NCT00383552|1802447|FG001|Overall Study|Lack of Efficacy|13
844990|NCT00383552|1802448|FG002|Overall Study|Lack of Efficacy|29
844991|NCT00383552|1802449|FG003|Overall Study|Lack of Efficacy|42
844992|NCT00383552|1802446|FG000|Overall Study|Lost to Follow-up|0
844993|NCT00383552|1802447|FG001|Overall Study|Lost to Follow-up|1
844994|NCT00383552|1802448|FG002|Overall Study|Lost to Follow-up|5
844995|NCT00383552|1802449|FG003|Overall Study|Lost to Follow-up|1
844996|NCT00383552|1802446|FG000|Overall Study|Did not wish to continue (unrelated)|4
844997|NCT00383552|1802447|FG001|Overall Study|Did not wish to continue (unrelated)|9
844998|NCT00383552|1802448|FG002|Overall Study|Did not wish to continue (unrelated)|5
844999|NCT00383552|1802449|FG003|Overall Study|Did not wish to continue (unrelated)|6
845000|NCT00383552|1802446|FG000|Overall Study|Did not wish to continue (related)|1
845001|NCT00383552|1802447|FG001|Overall Study|Did not wish to continue (related)|0
845002|NCT00383552|1802448|FG002|Overall Study|Did not wish to continue (related)|2
845003|NCT00383552|1802449|FG003|Overall Study|Did not wish to continue (related)|3
845004|NCT00383552|1802446|FG000|Overall Study|Noncompliance with the protocol|11
845005|NCT00383552|1802447|FG001|Overall Study|Noncompliance with the protocol|6
845006|NCT00383552|1802448|FG002|Overall Study|Noncompliance with the protocol|8
845007|NCT00383552|1802449|FG003|Overall Study|Noncompliance with the protocol|10
845008|NCT00383552|1802446|FG000|Overall Study|Did not meet protocol eligibility|8
845009|NCT00383552|1802447|FG001|Overall Study|Did not meet protocol eligibility|6
845010|NCT00383552|1802448|FG002|Overall Study|Did not meet protocol eligibility|2
845011|NCT00383552|1802449|FG003|Overall Study|Did not meet protocol eligibility|3
845012|NCT00383552|1802446|FG000|Overall Study|Administrative|1
845013|NCT00383552|1802447|FG001|Overall Study|Administrative|0
845014|NCT00383552|1802448|FG002|Overall Study|Administrative|1
845015|NCT00383552|1802449|FG003|Overall Study|Administrative|1
845016|NCT00383721|1802491|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11
845017|NCT00383721|1802492|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5
845018|NCT00383721|1802493|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7
845019|NCT00383721|1802494|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14
845020|NCT00383721|1802495|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13
845021|NCT00383721|1802491|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
845022|NCT00383721|1802492|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
845023|NCT00383721|1802493|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
845024|NCT00383721|1802494|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
845025|NCT00383721|1802495|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
845026|NCT00383721|1802491|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
845027|NCT00383721|1802492|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
845028|NCT00383721|1802493|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
845029|NCT00383721|1802494|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
845030|NCT00383721|1802495|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
845031|NCT00383721|1802491|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
845032|NCT00383721|1802492|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
845033|NCT00383721|1802493|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
845034|NCT00383721|1802494|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
845035|NCT00383721|1802495|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
845036|NCT00383721|1802491|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
845037|NCT00383721|1802492|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
845038|NCT00383721|1802493|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
845039|NCT00383721|1802494|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
845040|NCT00383721|1802495|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
845041|NCT00383721|1802491|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
845042|NCT00383721|1802492|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
845043|NCT00383721|1802493|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
845044|NCT00383721|1802494|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
845045|NCT00383721|1802495|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
845046|NCT00383721|1802491|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
845047|NCT00383721|1802492|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
845048|NCT00383721|1802493|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
845049|NCT00383721|1802494|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
845050|NCT00383721|1802495|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
845051|NCT00383721|1802491|FG000|26-Week Double-Blind Treatment Period|Administrative|1
845052|NCT00383721|1802492|FG001|26-Week Double-Blind Treatment Period|Administrative|3
845053|NCT00383721|1802493|FG002|26-Week Double-Blind Treatment Period|Administrative|3
845054|NCT00383721|1802494|FG003|26-Week Double-Blind Treatment Period|Administrative|3
845055|NCT00383721|1802495|FG004|26-Week Double-Blind Treatment Period|Administrative|3
845056|NCT00383721|1802491|FG000|26-Week Double-Blind Treatment Period|Ongoing|1
845057|NCT00383721|1802492|FG001|26-Week Double-Blind Treatment Period|Ongoing|0
845058|NCT00383721|1802493|FG002|26-Week Double-Blind Treatment Period|Ongoing|0
845059|NCT00383721|1802494|FG003|26-Week Double-Blind Treatment Period|Ongoing|0
845060|NCT00383721|1802495|FG004|26-Week Double-Blind Treatment Period|Ongoing|0
845061|NCT00383721|1802491|FG000|26-Week Treatment Safety Extension|Adverse Event|6
845062|NCT00383721|1802492|FG001|26-Week Treatment Safety Extension|Adverse Event|7
845063|NCT00383721|1802493|FG002|26-Week Treatment Safety Extension|Adverse Event|10
845064|NCT00383721|1802494|FG003|26-Week Treatment Safety Extension|Adverse Event|1
845065|NCT00383721|1802495|FG004|26-Week Treatment Safety Extension|Adverse Event|0
845066|NCT00383721|1802491|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0
845067|NCT00383721|1802492|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2
845068|NCT00383721|1802493|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4
845069|NCT00383721|1802494|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
845148|NCT00384059|1802568|FG001|Infant Series|Adverse Event|2
845070|NCT00383721|1802495|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
845071|NCT00383721|1802491|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2
845072|NCT00383721|1802492|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0
845073|NCT00383721|1802493|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
845074|NCT00383721|1802494|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1
845075|NCT00383721|1802495|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0
845076|NCT00383721|1802491|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
845077|NCT00383721|1802492|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
845078|NCT00383721|1802493|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
845079|NCT00383721|1802494|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
845080|NCT00383721|1802495|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
845081|NCT00383721|1802491|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
845082|NCT00383721|1802492|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1
845083|NCT00383721|1802493|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1
845084|NCT00383721|1802494|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1
845085|NCT00383721|1802495|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0
845086|NCT00383721|1802491|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2
845087|NCT00383721|1802492|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
845088|NCT00383721|1802493|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
845089|NCT00383721|1802494|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4
845090|NCT00383721|1802495|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
845091|NCT00383721|1802491|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
845092|NCT00383721|1802492|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
845093|NCT00383721|1802493|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
845094|NCT00383721|1802494|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
845095|NCT00383721|1802495|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
845096|NCT00383721|1802491|FG000|26-Week Treatment Safety Extension|Administrative|1
845097|NCT00383721|1802492|FG001|26-Week Treatment Safety Extension|Administrative|2
845098|NCT00383721|1802493|FG002|26-Week Treatment Safety Extension|Administrative|3
845099|NCT00383721|1802494|FG003|26-Week Treatment Safety Extension|Administrative|1
845100|NCT00383721|1802495|FG004|26-Week Treatment Safety Extension|Administrative|0
845101|NCT00383786|1802532|FG000|Overall Study|Protocol Violation|2
845102|NCT00383786|1802533|FG001|Overall Study|Protocol Violation|6
845103|NCT00383786|1802532|FG000|Overall Study|Withdrawal by Subject|2
845104|NCT00383786|1802533|FG001|Overall Study|Withdrawal by Subject|5
845105|NCT00383786|1802532|FG000|Overall Study|Physician Decision|0
845106|NCT00383786|1802533|FG001|Overall Study|Physician Decision|1
845107|NCT00384033|1802552|FG000|Overall Study|Adverse Event|10
845108|NCT00384033|1802553|FG001|Overall Study|Adverse Event|8
845109|NCT00384033|1802554|FG002|Overall Study|Adverse Event|11
845110|NCT00384033|1802555|FG003|Overall Study|Adverse Event|20
845111|NCT00384033|1802552|FG000|Overall Study|Failed to return|1
845112|NCT00384033|1802553|FG001|Overall Study|Failed to return|3
845113|NCT00384033|1802554|FG002|Overall Study|Failed to return|2
845114|NCT00384033|1802555|FG003|Overall Study|Failed to return|2
845115|NCT00384033|1802552|FG000|Overall Study|Physician Decision|1
845116|NCT00384033|1802553|FG001|Overall Study|Physician Decision|0
845117|NCT00384033|1802554|FG002|Overall Study|Physician Decision|0
845118|NCT00384033|1802555|FG003|Overall Study|Physician Decision|0
845119|NCT00384033|1802552|FG000|Overall Study|Lost to Follow-up|6
845120|NCT00384033|1802553|FG001|Overall Study|Lost to Follow-up|12
845121|NCT00384033|1802554|FG002|Overall Study|Lost to Follow-up|7
845122|NCT00384033|1802555|FG003|Overall Study|Lost to Follow-up|7
845123|NCT00384033|1802552|FG000|Overall Study|Other|2
845124|NCT00384033|1802553|FG001|Overall Study|Other|0
845125|NCT00384033|1802554|FG002|Overall Study|Other|0
845126|NCT00384033|1802555|FG003|Overall Study|Other|0
845127|NCT00384033|1802552|FG000|Overall Study|Protocol Violation|5
845128|NCT00384033|1802553|FG001|Overall Study|Protocol Violation|0
845129|NCT00384033|1802554|FG002|Overall Study|Protocol Violation|5
845130|NCT00384033|1802555|FG003|Overall Study|Protocol Violation|6
845131|NCT00384033|1802552|FG000|Overall Study|Withdrawal by Subject|6
845132|NCT00384033|1802553|FG001|Overall Study|Withdrawal by Subject|2
845133|NCT00384033|1802554|FG002|Overall Study|Withdrawal by Subject|5
845134|NCT00384033|1802555|FG003|Overall Study|Withdrawal by Subject|2
845135|NCT00384033|1802552|FG000|Overall Study|Lack of Efficacy|7
845136|NCT00384033|1802553|FG001|Overall Study|Lack of Efficacy|3
845137|NCT00384033|1802554|FG002|Overall Study|Lack of Efficacy|3
845138|NCT00384033|1802555|FG003|Overall Study|Lack of Efficacy|1
845139|NCT00384033|1802552|FG000|Overall Study|Randomized but not treated|3
845140|NCT00384033|1802553|FG001|Overall Study|Randomized but not treated|7
845141|NCT00384033|1802554|FG002|Overall Study|Randomized but not treated|10
845142|NCT00384033|1802555|FG003|Overall Study|Randomized but not treated|2
845143|NCT00384059|1802567|FG000|Infant Series|Not consented|2
845144|NCT00384059|1802568|FG001|Infant Series|Not consented|6
845145|NCT00384059|1802567|FG000|Infant Series|Withdrawal by Subject|2
845146|NCT00384059|1802568|FG001|Infant Series|Withdrawal by Subject|2
845149|NCT00384059|1802567|FG000|Infant Series|Protocol Violation|1
845150|NCT00384059|1802568|FG001|Infant Series|Protocol Violation|2
845151|NCT00384059|1802567|FG000|Infant Series|Lost to Follow-up|0
845152|NCT00384059|1802568|FG001|Infant Series|Lost to Follow-up|1
845153|NCT00384059|1802567|FG000|After Infant Series|Protocol Violation|2
845154|NCT00384059|1802568|FG001|After Infant Series|Protocol Violation|3
845155|NCT00384059|1802567|FG000|After Infant Series|Withdrawal by Subject|2
845156|NCT00384059|1802568|FG001|After Infant Series|Withdrawal by Subject|2
845157|NCT00384059|1802567|FG000|After Infant Series|Failed to Return|0
845158|NCT00384059|1802568|FG001|After Infant Series|Failed to Return|2
845159|NCT00384059|1802567|FG000|After Infant Series|Adverse Event|0
845160|NCT00384059|1802568|FG001|After Infant Series|Adverse Event|1
845161|NCT00384059|1802567|FG000|After Infant Series|Physician Decision|0
845162|NCT00384059|1802568|FG001|After Infant Series|Physician Decision|1
845163|NCT00384059|1802567|FG000|After Infant Series|Lost to Follow-up|0
845164|NCT00384059|1802568|FG001|After Infant Series|Lost to Follow-up|1
845165|NCT00384059|1802567|FG000|Toddler Dose|Lost to Follow-up|1
845166|NCT00384059|1802568|FG001|Toddler Dose|Lost to Follow-up|1
845167|NCT00384059|1802567|FG000|Toddler Dose|Failed to return|0
845168|NCT00384059|1802568|FG001|Toddler Dose|Failed to return|1
845169|NCT00384085|1802598|FG000|Overall Study|Adverse Event|5
845170|NCT00384085|1802599|FG001|Overall Study|Adverse Event|5
845171|NCT00384085|1802600|FG002|Overall Study|Adverse Event|4
845172|NCT00384085|1802598|FG000|Overall Study|Lack of Efficacy|0
845173|NCT00384085|1802599|FG001|Overall Study|Lack of Efficacy|3
845174|NCT00384085|1802600|FG002|Overall Study|Lack of Efficacy|2
845175|NCT00384085|1802598|FG000|Overall Study|No longer Requires Study Treatment|1
845176|NCT00384085|1802599|FG001|Overall Study|No longer Requires Study Treatment|0
845177|NCT00384085|1802600|FG002|Overall Study|No longer Requires Study Treatment|1
845178|NCT00384085|1802598|FG000|Overall Study|Protocol Violation|2
845179|NCT00384085|1802599|FG001|Overall Study|Protocol Violation|2
845180|NCT00384085|1802600|FG002|Overall Study|Protocol Violation|2
845181|NCT00384085|1802598|FG000|Overall Study|Lost to Follow-up|9
845182|NCT00384085|1802599|FG001|Overall Study|Lost to Follow-up|9
845183|NCT00384085|1802600|FG002|Overall Study|Lost to Follow-up|10
845184|NCT00384085|1802598|FG000|Overall Study|Progressive Disease|0
845185|NCT00384085|1802599|FG001|Overall Study|Progressive Disease|1
845186|NCT00384085|1802600|FG002|Overall Study|Progressive Disease|0
845187|NCT00384085|1802598|FG000|Overall Study|Withdrawal by Subject|14
845188|NCT00384085|1802599|FG001|Overall Study|Withdrawal by Subject|19
845189|NCT00384085|1802600|FG002|Overall Study|Withdrawal by Subject|29
845190|NCT00384085|1802598|FG000|Overall Study|Patient non-compliant|4
845191|NCT00384085|1802599|FG001|Overall Study|Patient non-compliant|4
845192|NCT00384085|1802600|FG002|Overall Study|Patient non-compliant|5
845193|NCT00384085|1802598|FG000|Overall Study|Physician Decision|1
845194|NCT00384085|1802599|FG001|Overall Study|Physician Decision|0
845195|NCT00384085|1802600|FG002|Overall Study|Physician Decision|0
845196|NCT00384085|1802598|FG000|Overall Study|Loss of site personnel|1
845197|NCT00384085|1802599|FG001|Overall Study|Loss of site personnel|0
845198|NCT00384085|1802600|FG002|Overall Study|Loss of site personnel|1
845199|NCT00384085|1802598|FG000|Overall Study|Sponsor decision|1
845200|NCT00384085|1802599|FG001|Overall Study|Sponsor decision|2
845201|NCT00384085|1802600|FG002|Overall Study|Sponsor decision|1
845202|NCT00384085|1802598|FG000|Overall Study|Patient moved|1
845203|NCT00384085|1802599|FG001|Overall Study|Patient moved|0
845204|NCT00384085|1802600|FG002|Overall Study|Patient moved|1
845205|NCT00384085|1802598|FG000|Overall Study|Patient required surgery|0
845206|NCT00384085|1802599|FG001|Overall Study|Patient required surgery|1
845207|NCT00384085|1802600|FG002|Overall Study|Patient required surgery|0
845208|NCT00384176|1802613|FG000|Overall Study|Death|239
845209|NCT00384176|1802614|FG001|Overall Study|Death|247
845210|NCT00384176|1802615|FG002|Overall Study|Death|105
845211|NCT00384176|1802613|FG000|Overall Study|Withdrawal by Subject|52
845212|NCT00384176|1802614|FG001|Overall Study|Withdrawal by Subject|48
845213|NCT00384176|1802615|FG002|Overall Study|Withdrawal by Subject|22
845214|NCT00384176|1802613|FG000|Overall Study|Lost to Follow-up|16
845215|NCT00384176|1802614|FG001|Overall Study|Lost to Follow-up|18
845216|NCT00384176|1802615|FG002|Overall Study|Lost to Follow-up|4
845217|NCT00384176|1802613|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2
845218|NCT00384176|1802614|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3
845219|NCT00384176|1802615|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0
845220|NCT00384176|1802613|FG000|Overall Study|Longer QTC as Visit 1|1
845221|NCT00384176|1802614|FG001|Overall Study|Longer QTC as Visit 1|0
845222|NCT00384176|1802615|FG002|Overall Study|Longer QTC as Visit 1|0
845223|NCT00384176|1802613|FG000|Overall Study|Toxicity of treatment|1
845224|NCT00384176|1802614|FG001|Overall Study|Toxicity of treatment|0
845225|NCT00384176|1802615|FG002|Overall Study|Toxicity of treatment|0
845226|NCT00384176|1802613|FG000|Overall Study|Did not receive study treatment|0
845227|NCT00384176|1802614|FG001|Overall Study|Did not receive study treatment|1
845228|NCT00384176|1802615|FG002|Overall Study|Did not receive study treatment|1
845229|NCT00384176|1802613|FG000|Overall Study|Physician Decision|0
845230|NCT00384176|1802614|FG001|Overall Study|Physician Decision|2
845231|NCT00384176|1802615|FG002|Overall Study|Physician Decision|0
845232|NCT00384176|1802613|FG000|Overall Study|Liver metastases, colon resec. planned|1
845233|NCT00384176|1802614|FG001|Overall Study|Liver metastases, colon resec. planned|0
845234|NCT00384176|1802615|FG002|Overall Study|Liver metastases, colon resec. planned|0
845235|NCT00384189|1802627|FG000|Overall Study|Reason Not Specified|50
845236|NCT00384189|1802628|FG001|Overall Study|Reason Not Specified|57
845237|NCT00384189|1802629|FG002|Overall Study|Reason Not Specified|58
845238|NCT00384189|1802630|FG003|Overall Study|Reason Not Specified|40
845239|NCT00384332|1802650|FG000|Overall Study|Lost to Follow-up|4
845240|NCT00384332|1802651|FG001|Overall Study|Lost to Follow-up|0
845241|NCT00384397|1802662|FG000|Overall Study|Adverse Event|0
845242|NCT00384397|1802663|FG001|Overall Study|Adverse Event|1
845243|NCT00384397|1802664|FG002|Overall Study|Adverse Event|2
845244|NCT00384397|1802662|FG000|Overall Study|Protocol Violation|7
845245|NCT00384397|1802663|FG001|Overall Study|Protocol Violation|15
845246|NCT00384397|1802664|FG002|Overall Study|Protocol Violation|13
845247|NCT00384397|1802662|FG000|Overall Study|Lost to Follow-up|11
845248|NCT00384397|1802663|FG001|Overall Study|Lost to Follow-up|13
845249|NCT00384397|1802664|FG002|Overall Study|Lost to Follow-up|3
845250|NCT00384397|1802662|FG000|Overall Study|Withdrawal by Subject|14
845251|NCT00384397|1802663|FG001|Overall Study|Withdrawal by Subject|17
845252|NCT00384397|1802664|FG002|Overall Study|Withdrawal by Subject|15
845253|NCT00384839|1802727|FG000|Overall Study|Adverse Event|4
845254|NCT00384839|1802727|FG000|Overall Study|Investigator Request|1
845255|NCT00384839|1802727|FG000|Overall Study|Patient Request|1
845256|NCT00384839|1802727|FG000|Overall Study|Ineligible|2
845257|NCT00384930|1802753|FG000|Overall Study|Adverse Event|5
845258|NCT00384930|1802754|FG001|Overall Study|Adverse Event|4
845259|NCT00384930|1802755|FG002|Overall Study|Adverse Event|12
845260|NCT00384930|1802756|FG003|Overall Study|Adverse Event|11
845261|NCT00384930|1802757|FG004|Overall Study|Adverse Event|14
845262|NCT00384930|1802753|FG000|Overall Study|Entry Criteria Not Met|2
845263|NCT00384930|1802754|FG001|Overall Study|Entry Criteria Not Met|6
845264|NCT00384930|1802755|FG002|Overall Study|Entry Criteria Not Met|7
845265|NCT00384930|1802756|FG003|Overall Study|Entry Criteria Not Met|8
845266|NCT00384930|1802757|FG004|Overall Study|Entry Criteria Not Met|4
845267|NCT00384930|1802753|FG000|Overall Study|Lack of Efficacy|1
845268|NCT00384930|1802754|FG001|Overall Study|Lack of Efficacy|1
845269|NCT00384930|1802755|FG002|Overall Study|Lack of Efficacy|2
845270|NCT00384930|1802756|FG003|Overall Study|Lack of Efficacy|1
845271|NCT00384930|1802757|FG004|Overall Study|Lack of Efficacy|2
845272|NCT00384930|1802753|FG000|Overall Study|Lost to Follow-up|5
845273|NCT00384930|1802754|FG001|Overall Study|Lost to Follow-up|3
845274|NCT00384930|1802755|FG002|Overall Study|Lost to Follow-up|0
845275|NCT00384930|1802756|FG003|Overall Study|Lost to Follow-up|4
845276|NCT00384930|1802757|FG004|Overall Study|Lost to Follow-up|6
845277|NCT00384930|1802753|FG000|Overall Study|Physician Decision|0
845278|NCT00384930|1802754|FG001|Overall Study|Physician Decision|1
845279|NCT00384930|1802755|FG002|Overall Study|Physician Decision|1
845280|NCT00384930|1802756|FG003|Overall Study|Physician Decision|0
845281|NCT00384930|1802757|FG004|Overall Study|Physician Decision|1
845282|NCT00384930|1802753|FG000|Overall Study|Protocol Violation|1
845283|NCT00384930|1802754|FG001|Overall Study|Protocol Violation|0
845284|NCT00384930|1802755|FG002|Overall Study|Protocol Violation|1
845285|NCT00384930|1802756|FG003|Overall Study|Protocol Violation|6
845286|NCT00384930|1802757|FG004|Overall Study|Protocol Violation|4
845287|NCT00384930|1802753|FG000|Overall Study|Sponsor Decision|3
845288|NCT00384930|1802754|FG001|Overall Study|Sponsor Decision|4
845289|NCT00384930|1802755|FG002|Overall Study|Sponsor Decision|0
845290|NCT00384930|1802756|FG003|Overall Study|Sponsor Decision|5
845291|NCT00384930|1802757|FG004|Overall Study|Sponsor Decision|0
845292|NCT00384930|1802753|FG000|Overall Study|Withdrawal by Subject|9
845293|NCT00384930|1802754|FG001|Overall Study|Withdrawal by Subject|7
845294|NCT00384930|1802755|FG002|Overall Study|Withdrawal by Subject|7
845295|NCT00384930|1802756|FG003|Overall Study|Withdrawal by Subject|6
845296|NCT00384930|1802757|FG004|Overall Study|Withdrawal by Subject|16
845297|NCT00384930|1802753|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1
845298|NCT00384930|1802754|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1
845299|NCT00384930|1802755|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0
845300|NCT00384930|1802756|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0
845301|NCT00384930|1802757|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0
845302|NCT00384956|1802772|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3
845303|NCT00385203|1802797|FG000|Overall Study|Adverse Event|5
845304|NCT00385203|1802798|FG001|Overall Study|Adverse Event|4
845305|NCT00385203|1802797|FG000|Overall Study|Death|1
845306|NCT00385203|1802798|FG001|Overall Study|Death|0
845307|NCT00385203|1802797|FG000|Overall Study|Condition under investigation worsened|18
845308|NCT00385203|1802798|FG001|Overall Study|Condition under investigation worsened|3
845309|NCT00385203|1802797|FG000|Overall Study|Incorrect enrollment|2
845310|NCT00385203|1802798|FG001|Overall Study|Incorrect enrollment|0
845311|NCT00385255|1802814|FG000|Overall Study|Serious Adverse Event|1
845312|NCT00385255|1802815|FG001|Overall Study|Serious Adverse Event|2
845313|NCT00385255|1802814|FG000|Overall Study|Protocol Violation|0
845314|NCT00385255|1802815|FG001|Overall Study|Protocol Violation|4
845315|NCT00385255|1802814|FG000|Overall Study|Withdrawal by Subject|0
845316|NCT00385255|1802815|FG001|Overall Study|Withdrawal by Subject|8
845317|NCT00385255|1802814|FG000|Overall Study|Migrated/moved from study area|0
845318|NCT00385255|1802815|FG001|Overall Study|Migrated/moved from study area|1
845319|NCT00385255|1802814|FG000|Overall Study|Lost to Follow-up|20
845320|NCT00385255|1802815|FG001|Overall Study|Lost to Follow-up|58
845321|NCT00385541|1802843|FG000|Overall Study|severe pain, clinician requested unblind|0
845322|NCT00385541|1802844|FG001|Overall Study|severe pain, clinician requested unblind|1
845323|NCT00385593|1802871|FG000|Overall Study|Adverse Event|3
845324|NCT00385593|1802872|FG001|Overall Study|Adverse Event|2
845325|NCT00385593|1802871|FG000|Overall Study|Withdrawal by Subject|17
845326|NCT00385593|1802872|FG001|Overall Study|Withdrawal by Subject|7
845327|NCT00385593|1802871|FG000|Overall Study|Lost to Follow-up|12
845328|NCT00385593|1802872|FG001|Overall Study|Lost to Follow-up|8
845329|NCT00385593|1802871|FG000|Overall Study|Protocol Violation|7
845330|NCT00385593|1802872|FG001|Overall Study|Protocol Violation|4
845331|NCT00385593|1802871|FG000|Overall Study|Several reasons|17
845332|NCT00385593|1802872|FG001|Overall Study|Several reasons|15
845333|NCT00385593|1802871|FG000|Overall Study|Incorrect inclusion|2
845334|NCT00385593|1802872|FG001|Overall Study|Incorrect inclusion|0
845335|NCT00385593|1802871|FG000|Overall Study|Incorrect randomization|0
845336|NCT00385593|1802872|FG001|Overall Study|Incorrect randomization|1
845337|NCT00385671|1802881|FG000|Overall Study|Adverse Event|14
845338|NCT00385671|1802882|FG001|Overall Study|Adverse Event|27
845339|NCT00385671|1802883|FG002|Overall Study|Adverse Event|18
845340|NCT00385671|1802881|FG000|Overall Study|Lack of Efficacy|5
845341|NCT00385671|1802882|FG001|Overall Study|Lack of Efficacy|9
845342|NCT00385671|1802883|FG002|Overall Study|Lack of Efficacy|5
845343|NCT00385671|1802881|FG000|Overall Study|Lost to Follow-up|6
845344|NCT00385671|1802882|FG001|Overall Study|Lost to Follow-up|6
845345|NCT00385671|1802883|FG002|Overall Study|Lost to Follow-up|5
845346|NCT00385671|1802881|FG000|Overall Study|Physician Decision|2
845347|NCT00385671|1802882|FG001|Overall Study|Physician Decision|1
845348|NCT00385671|1802883|FG002|Overall Study|Physician Decision|2
845349|NCT00385671|1802881|FG000|Overall Study|Protocol Violation|5
845350|NCT00385671|1802882|FG001|Overall Study|Protocol Violation|2
845351|NCT00385671|1802883|FG002|Overall Study|Protocol Violation|1
845352|NCT00385671|1802881|FG000|Overall Study|Sponsor Decision|2
845353|NCT00385671|1802882|FG001|Overall Study|Sponsor Decision|2
845354|NCT00385671|1802883|FG002|Overall Study|Sponsor Decision|1
845355|NCT00385671|1802881|FG000|Overall Study|Withdrawal by Subject|4
845356|NCT00385671|1802882|FG001|Overall Study|Withdrawal by Subject|4
845357|NCT00385671|1802883|FG002|Overall Study|Withdrawal by Subject|4
845358|NCT00385684|1802893|FG000|FIRST INTERVENTION OF PHASE A|Death|1
845359|NCT00385684|1802894|FG001|FIRST INTERVENTION OF PHASE A|Death|0
845360|NCT00385684|1802893|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0
845361|NCT00385684|1802894|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1
845362|NCT00385684|1802893|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0
845363|NCT00385684|1802894|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1
845364|NCT00385723|1802903|FG000|Overall Study|Lost to Follow-up|1
845365|NCT00385723|1802904|FG001|Overall Study|Lost to Follow-up|1
845366|NCT00385723|1802905|FG002|Overall Study|Lost to Follow-up|0
845367|NCT00385723|1802903|FG000|Overall Study|Withdrawal by Subject|1
845368|NCT00385723|1802904|FG001|Overall Study|Withdrawal by Subject|0
845369|NCT00385723|1802905|FG002|Overall Study|Withdrawal by Subject|2
845370|NCT00385736|1802916|FG000|Efficacy Analysis Set - Induction|Adverse Event|5
845371|NCT00385736|1802917|FG001|Efficacy Analysis Set - Induction|Adverse Event|6
845372|NCT00385736|1802918|FG002|Efficacy Analysis Set - Induction|Adverse Event|4
845373|NCT00385736|1802916|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
845374|NCT00385736|1802917|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
845375|NCT00385736|1802918|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
845376|NCT00385736|1802916|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0
845377|NCT00385736|1802917|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2
845378|NCT00385736|1802918|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0
845379|NCT00385736|1802916|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4
845380|NCT00385736|1802917|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2
845381|NCT00385736|1802918|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1
845382|NCT00385736|1802916|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0
845383|NCT00385736|1802917|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0
845384|NCT00385736|1802918|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2
845385|NCT00385736|1802916|FG000|Efficacy Analysis Set - Induction|Other|0
845386|NCT00385736|1802917|FG001|Efficacy Analysis Set - Induction|Other|0
845387|NCT00385736|1802918|FG002|Efficacy Analysis Set - Induction|Other|1
845388|NCT00385736|1802916|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23
845389|NCT00385736|1802917|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15
845390|NCT00385736|1802918|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23
845391|NCT00385736|1802916|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
845392|NCT00385736|1802917|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
845393|NCT00385736|1802918|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
845394|NCT00385736|1802916|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
845395|NCT00385736|1802917|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
845396|NCT00385736|1802918|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
845397|NCT00385736|1802916|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
845398|NCT00385736|1802917|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
845399|NCT00385736|1802918|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
845400|NCT00385736|1802916|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2
845401|NCT00385736|1802917|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1
845402|NCT00385736|1802918|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6
845403|NCT00385736|1802916|FG000|Efficacy Analysis Set - Maintenance|Other|0
845404|NCT00385736|1802917|FG001|Efficacy Analysis Set - Maintenance|Other|4
845405|NCT00385736|1802918|FG002|Efficacy Analysis Set - Maintenance|Other|4
845406|NCT00385736|1802916|FG000|Safety Analysis Set|Adverse Event|23
845407|NCT00385736|1802917|FG001|Safety Analysis Set|Adverse Event|15
845408|NCT00385736|1802918|FG002|Safety Analysis Set|Adverse Event|23
845409|NCT00385736|1802916|FG000|Safety Analysis Set|Withdrawal by Subject|6
845410|NCT00385736|1802917|FG001|Safety Analysis Set|Withdrawal by Subject|6
845411|NCT00385736|1802918|FG002|Safety Analysis Set|Withdrawal by Subject|14
845412|NCT00385736|1802916|FG000|Safety Analysis Set|Lost to Follow-up|0
845413|NCT00385736|1802917|FG001|Safety Analysis Set|Lost to Follow-up|2
845414|NCT00385736|1802918|FG002|Safety Analysis Set|Lost to Follow-up|2
845415|NCT00385736|1802916|FG000|Safety Analysis Set|Lack of Efficacy|38
845416|NCT00385736|1802917|FG001|Safety Analysis Set|Lack of Efficacy|16
845417|NCT00385736|1802918|FG002|Safety Analysis Set|Lack of Efficacy|31
845418|NCT00385736|1802916|FG000|Safety Analysis Set|Protocol Violation|2
845419|NCT00385736|1802917|FG001|Safety Analysis Set|Protocol Violation|1
845420|NCT00385736|1802918|FG002|Safety Analysis Set|Protocol Violation|6
845421|NCT00385736|1802916|FG000|Safety Analysis Set|Other|1
845422|NCT00385736|1802917|FG001|Safety Analysis Set|Other|4
845423|NCT00385736|1802918|FG002|Safety Analysis Set|Other|4
845424|NCT00385762|1802929|FG000|Overall Study|Adverse Event|1
845425|NCT00385762|1802929|FG000|Overall Study|Lost to Follow-up|1
845426|NCT00385827|1802955|FG000|Part 1|Adverse Event|1
845427|NCT00385827|1802956|FG001|Part 1|Adverse Event|0
845428|NCT00385827|1802957|FG002|Part 1|Adverse Event|0
845429|NCT00385827|1802955|FG000|Part 1|Death|2
845430|NCT00385827|1802956|FG001|Part 1|Death|0
845431|NCT00385827|1802957|FG002|Part 1|Death|0
845432|NCT00385827|1802955|FG000|Part 1|Lack of Efficacy|5
845433|NCT00385827|1802956|FG001|Part 1|Lack of Efficacy|0
845434|NCT00385827|1802957|FG002|Part 1|Lack of Efficacy|0
845435|NCT00385827|1802955|FG000|Part 1|Other|1
845436|NCT00385827|1802956|FG001|Part 1|Other|0
845437|NCT00385827|1802957|FG002|Part 1|Other|0
845438|NCT00385827|1802955|FG000|Part 2|Adverse Event|0
845439|NCT00385827|1802956|FG001|Part 2|Adverse Event|6
845440|NCT00385827|1802957|FG002|Part 2|Adverse Event|10
845441|NCT00385827|1802955|FG000|Part 2|Death|0
845442|NCT00385827|1802956|FG001|Part 2|Death|0
845443|NCT00385827|1802957|FG002|Part 2|Death|2
845444|NCT00385827|1802955|FG000|Part 2|Lack of Efficacy|0
845445|NCT00385827|1802956|FG001|Part 2|Lack of Efficacy|14
845446|NCT00385827|1802957|FG002|Part 2|Lack of Efficacy|13
845447|NCT00385827|1802955|FG000|Part 2|Randomized but not treated|0
845448|NCT00385827|1802956|FG001|Part 2|Randomized but not treated|2
845449|NCT00385827|1802957|FG002|Part 2|Randomized but not treated|2
845450|NCT00385827|1802955|FG000|Part 2|Other|0
845451|NCT00385827|1802956|FG001|Part 2|Other|11
845452|NCT00385827|1802957|FG002|Part 2|Other|21
845453|NCT00385840|1802969|FG000|Overall Study|Adverse Event|1
845454|NCT00385840|1802970|FG001|Overall Study|Adverse Event|1
845455|NCT00385840|1802969|FG000|Overall Study|Lost to Follow-up|3
845456|NCT00385840|1802970|FG001|Overall Study|Lost to Follow-up|13
845457|NCT00385918|1802978|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
845458|NCT00385918|1802979|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
845459|NCT00385918|1802980|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
845460|NCT00385918|1802978|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
845461|NCT00385918|1802979|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
845462|NCT00385918|1802980|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
845463|NCT00385918|1802978|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0
845464|NCT00385918|1802979|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0
845465|NCT00385918|1802980|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1
845466|NCT00385918|1802978|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1
845467|NCT00385918|1802979|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0
845468|NCT00385918|1802980|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0
845469|NCT00385918|1802978|FG000|Intervention Phase After Randomization|Physician Decision|1
845470|NCT00385918|1802979|FG001|Intervention Phase After Randomization|Physician Decision|0
845471|NCT00385918|1802980|FG002|Intervention Phase After Randomization|Physician Decision|0
845472|NCT00385918|1802978|FG000|Intervention Phase After Randomization|Lost to Follow-up|1
845473|NCT00385918|1802979|FG001|Intervention Phase After Randomization|Lost to Follow-up|0
845474|NCT00385918|1802980|FG002|Intervention Phase After Randomization|Lost to Follow-up|0
845475|NCT00385944|1802989|FG000|1st Maintenance Dose Period|Physician Decision|1
845476|NCT00385944|1802990|FG001|1st Maintenance Dose Period|Physician Decision|0
845477|NCT00385944|1802991|FG002|1st Maintenance Dose Period|Physician Decision|0
845478|NCT00385944|1802989|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0
845479|NCT00385944|1802990|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1
845480|NCT00385944|1802991|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0
845481|NCT00385944|1802989|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
845482|NCT00385944|1802990|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
845483|NCT00385944|1802991|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
845484|NCT00385944|1802989|FG000|2nd Maintenance Dose Period|Invalid PD Data|2
845485|NCT00385944|1802990|FG001|2nd Maintenance Dose Period|Invalid PD Data|3
845486|NCT00385944|1802991|FG002|2nd Maintenance Dose Period|Invalid PD Data|0
845487|NCT00386009|1803013|FG000|Overall Study|Adverse Event|0
845488|NCT00386009|1803014|FG001|Overall Study|Adverse Event|2
845489|NCT00386009|1803013|FG000|Overall Study|Death|1
845490|NCT00386009|1803014|FG001|Overall Study|Death|0
845491|NCT00386009|1803013|FG000|Overall Study|Entry Criteria Not Met|0
845492|NCT00386009|1803014|FG001|Overall Study|Entry Criteria Not Met|2
845493|NCT00386009|1803013|FG000|Overall Study|Lost to Follow-up|1
845494|NCT00386009|1803014|FG001|Overall Study|Lost to Follow-up|1
845495|NCT00386009|1803013|FG000|Overall Study|Protocol Violation|1
845496|NCT00386009|1803014|FG001|Overall Study|Protocol Violation|0
845497|NCT00386009|1803013|FG000|Overall Study|Sponsor Decision|1
845498|NCT00386009|1803014|FG001|Overall Study|Sponsor Decision|1
845499|NCT00386009|1803013|FG000|Overall Study|Withdrawal by Subject|5
845500|NCT00386009|1803014|FG001|Overall Study|Withdrawal by Subject|4
845501|NCT00386022|1803022|FG000|Plus Estrogen|Lost to Follow-up|2
845502|NCT00386022|1803023|FG001|Plus Estrogen|Lost to Follow-up|0
845503|NCT00386022|1803022|FG000|Plus Estrogen|Adverse Event|0
845504|NCT00386022|1803023|FG001|Plus Estrogen|Adverse Event|1
845505|NCT00386100|1803033|FG000|Overall Study|Did not receive study medication|6
845506|NCT00386100|1803034|FG001|Overall Study|Did not receive study medication|4
845507|NCT00386100|1803033|FG000|Overall Study|Adverse Event|15
845508|NCT00386100|1803034|FG001|Overall Study|Adverse Event|25
845509|NCT00386100|1803033|FG000|Overall Study|Death|0
845510|NCT00386100|1803034|FG001|Overall Study|Death|1
845511|NCT00386100|1803033|FG000|Overall Study|Insufficient therapeutic effect|30
845512|NCT00386100|1803034|FG001|Overall Study|Insufficient therapeutic effect|6
845513|NCT00386100|1803033|FG000|Overall Study|Lost to Follow-up|29
845514|NCT00386100|1803034|FG001|Overall Study|Lost to Follow-up|29
845515|NCT00386100|1803033|FG000|Overall Study|Non-compliance|18
845516|NCT00386100|1803034|FG001|Overall Study|Non-compliance|19
845517|NCT00386100|1803033|FG000|Overall Study|Protocol Violation|5
845518|NCT00386100|1803034|FG001|Overall Study|Protocol Violation|3
845519|NCT00386100|1803033|FG000|Overall Study|Withdrawal by Subject|32
845520|NCT00386100|1803034|FG001|Overall Study|Withdrawal by Subject|31
845521|NCT00386100|1803033|FG000|Overall Study|Bone mass density (BMD) loss >6%|4
845522|NCT00386100|1803034|FG001|Overall Study|Bone mass density (BMD) loss >6%|4
845523|NCT00386100|1803033|FG000|Overall Study|BMD <2.5|1
845524|NCT00386100|1803034|FG001|Overall Study|BMD <2.5|0
845525|NCT00386100|1803033|FG000|Overall Study|Consecutive elevated Hba1C|1
845526|NCT00386100|1803034|FG001|Overall Study|Consecutive elevated Hba1C|0
845527|NCT00386100|1803033|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0
845528|NCT00386100|1803034|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1
845529|NCT00386100|1803033|FG000|Overall Study|Laboratory findings|1
845530|NCT00386100|1803034|FG001|Overall Study|Laboratory findings|0
845531|NCT00386100|1803033|FG000|Overall Study|Participant's concern due to CPK levels|1
845532|NCT00386100|1803034|FG001|Overall Study|Participant's concern due to CPK levels|0
845533|NCT00386100|1803033|FG000|Overall Study|Participant moving out of state|2
845534|NCT00386100|1803034|FG001|Overall Study|Participant moving out of state|0
845535|NCT00386100|1803033|FG000|Overall Study|Excessive bone loss vs. baseline value|0
845536|NCT00386100|1803034|FG001|Overall Study|Excessive bone loss vs. baseline value|1
845537|NCT00386100|1803033|FG000|Overall Study|Didn't meet entry criteria|1
845538|NCT00386100|1803034|FG001|Overall Study|Didn't meet entry criteria|1
845539|NCT00386100|1803033|FG000|Overall Study|Participant's PCP wanted to stop drug|1
845540|NCT00386100|1803034|FG001|Overall Study|Participant's PCP wanted to stop drug|0
845541|NCT00386100|1803033|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0
845542|NCT00386100|1803034|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1
845543|NCT00386100|1803033|FG000|Overall Study|Bad metabolic control & patient security|1
845544|NCT00386100|1803034|FG001|Overall Study|Bad metabolic control & patient security|0
845545|NCT00386100|1803033|FG000|Overall Study|Bone loss by DXA bone scan|1
845546|NCT00386100|1803034|FG001|Overall Study|Bone loss by DXA bone scan|0
845547|NCT00386100|1803033|FG000|Overall Study|DBP 93 mmHg at randomization|1
845548|NCT00386100|1803034|FG001|Overall Study|DBP 93 mmHg at randomization|0
845549|NCT00386100|1803033|FG000|Overall Study|7.6% bone loss|1
845550|NCT00386100|1803034|FG001|Overall Study|7.6% bone loss|0
845551|NCT00386100|1803033|FG000|Overall Study|Osteoporosis|0
845552|NCT00386100|1803034|FG001|Overall Study|Osteoporosis|1
845553|NCT00386100|1803033|FG000|Overall Study|Positive pregnancy test|1
845554|NCT00386100|1803034|FG001|Overall Study|Positive pregnancy test|3
845555|NCT00386100|1803033|FG000|Overall Study|Out of country for 5 months|1
845556|NCT00386100|1803034|FG001|Overall Study|Out of country for 5 months|0
845557|NCT00386100|1803033|FG000|Overall Study|Hb1Ac >8%|0
845558|NCT00386100|1803034|FG001|Overall Study|Hb1Ac >8%|1
845559|NCT00386100|1803033|FG000|Overall Study|Participant randomized in error|1
845560|NCT00386100|1803034|FG001|Overall Study|Participant randomized in error|0
845561|NCT00386152|1803043|FG000|Overall Study|Adverse Event|6
845562|NCT00386152|1803044|FG001|Overall Study|Adverse Event|5
845563|NCT00386152|1803045|FG002|Overall Study|Adverse Event|4
845564|NCT00386152|1803043|FG000|Overall Study|Chang from original chemo stratification|4
845565|NCT00386152|1803044|FG001|Overall Study|Chang from original chemo stratification|5
845566|NCT00386152|1803045|FG002|Overall Study|Chang from original chemo stratification|6
845567|NCT00386152|1803043|FG000|Overall Study|Death|3
845568|NCT00386152|1803044|FG001|Overall Study|Death|0
845569|NCT00386152|1803045|FG002|Overall Study|Death|1
845570|NCT00386152|1803043|FG000|Overall Study|Disease progression|7
845571|NCT00386152|1803044|FG001|Overall Study|Disease progression|4
845572|NCT00386152|1803045|FG002|Overall Study|Disease progression|5
845573|NCT00386152|1803043|FG000|Overall Study|Physician Decision|13
845574|NCT00386152|1803044|FG001|Overall Study|Physician Decision|10
845575|NCT00386152|1803045|FG002|Overall Study|Physician Decision|4
845576|NCT00386152|1803043|FG000|Overall Study|Lost to Follow-up|1
845577|NCT00386152|1803044|FG001|Overall Study|Lost to Follow-up|0
845578|NCT00386152|1803045|FG002|Overall Study|Lost to Follow-up|0
845579|NCT00386152|1803043|FG000|Overall Study|Completed chemotherapy|4
845580|NCT00386152|1803044|FG001|Overall Study|Completed chemotherapy|5
845581|NCT00386152|1803045|FG002|Overall Study|Completed chemotherapy|1
845582|NCT00386152|1803043|FG000|Overall Study|Protocol Violation|3
845583|NCT00386152|1803044|FG001|Overall Study|Protocol Violation|5
845584|NCT00386152|1803045|FG002|Overall Study|Protocol Violation|2
845585|NCT00386152|1803043|FG000|Overall Study|Withdrawal by Subject|3
845586|NCT00386152|1803044|FG001|Overall Study|Withdrawal by Subject|6
845587|NCT00386152|1803045|FG002|Overall Study|Withdrawal by Subject|10
845588|NCT00386308|1803081|FG000|Overall Study|Adverse Event|3
845589|NCT00386308|1803082|FG001|Overall Study|Adverse Event|3
845590|NCT00386308|1803081|FG000|Overall Study|Protocol Violation|2
845591|NCT00386308|1803082|FG001|Overall Study|Protocol Violation|5
845592|NCT00386308|1803081|FG000|Overall Study|Lack of Efficacy|0
845593|NCT00386308|1803082|FG001|Overall Study|Lack of Efficacy|2
845594|NCT00386308|1803081|FG000|Overall Study|Lost to Follow-up|10
845595|NCT00386308|1803082|FG001|Overall Study|Lost to Follow-up|6
845596|NCT00386308|1803081|FG000|Overall Study|Withdrawal by Subject|6
845597|NCT00386308|1803082|FG001|Overall Study|Withdrawal by Subject|2
845598|NCT00386308|1803081|FG000|Overall Study|Other Event|8
845599|NCT00386308|1803082|FG001|Overall Study|Other Event|1
845600|NCT00386334|1803090|FG000|Double Blind Period|Adverse Event|9
845601|NCT00386334|1803091|FG001|Double Blind Period|Adverse Event|14
845602|NCT00386334|1803090|FG000|Double Blind Period|Protocol Violation|1
845603|NCT00386334|1803091|FG001|Double Blind Period|Protocol Violation|1
845604|NCT00386334|1803090|FG000|Double Blind Period|Withdrawal by Subject|9
845605|NCT00386334|1803091|FG001|Double Blind Period|Withdrawal by Subject|13
845606|NCT00386334|1803090|FG000|Double Blind Period|Lack of Efficacy|20
845607|NCT00386334|1803091|FG001|Double Blind Period|Lack of Efficacy|11
845608|NCT00386334|1803090|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
845609|NCT00386334|1803091|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
845610|NCT00386334|1803090|FG000|Double Blind Period|Other|3
845611|NCT00386334|1803091|FG001|Double Blind Period|Other|3
845612|NCT00386334|1803090|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
845613|NCT00386334|1803091|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
845614|NCT00386360|1803099|FG000|Overall Study|Adverse Event|4
845615|NCT00386360|1803100|FG001|Overall Study|Adverse Event|2
845616|NCT00386360|1803099|FG000|Overall Study|Physician Decision|2
845617|NCT00386360|1803100|FG001|Overall Study|Physician Decision|2
845618|NCT00386360|1803099|FG000|Overall Study|Lost to Follow-up|0
845619|NCT00386360|1803100|FG001|Overall Study|Lost to Follow-up|2
845620|NCT00386360|1803099|FG000|Overall Study|Protocol Violation|0
845621|NCT00386360|1803100|FG001|Overall Study|Protocol Violation|3
845622|NCT00386360|1803099|FG000|Overall Study|Withdrawal by Subject|3
845623|NCT00386360|1803100|FG001|Overall Study|Withdrawal by Subject|6
845624|NCT00386360|1803099|FG000|Overall Study|Did not take any study medication|0
845625|NCT00386360|1803100|FG001|Overall Study|Did not take any study medication|2
845626|NCT00386425|1803109|FG000|Overall Study|Physician Decision|3
845627|NCT00386425|1803110|FG001|Overall Study|Physician Decision|0
845628|NCT00386425|1803111|FG002|Overall Study|Physician Decision|0
845629|NCT00386425|1803109|FG000|Overall Study|Withdrawal by Subject|0
845630|NCT00386425|1803110|FG001|Overall Study|Withdrawal by Subject|1
845631|NCT00386425|1803111|FG002|Overall Study|Withdrawal by Subject|0
845632|NCT00386607|1803132|FG000|Core|Adverse Event|40
845633|NCT00386607|1803133|FG001|Core|Adverse Event|0
845634|NCT00386607|1803132|FG000|Core|Abnormal laboratory value(s)|3
845635|NCT00386607|1803133|FG001|Core|Abnormal laboratory value(s)|0
845636|NCT00386607|1803132|FG000|Core|Unsatisfactory therapeutic effect|23
845637|NCT00386607|1803133|FG001|Core|Unsatisfactory therapeutic effect|0
845638|NCT00386607|1803132|FG000|Core|Condition no longer requires study drug|4
845639|NCT00386607|1803133|FG001|Core|Condition no longer requires study drug|0
845640|NCT00386607|1803132|FG000|Core|Patient withdrew consent|15
845641|NCT00386607|1803133|FG001|Core|Patient withdrew consent|0
845642|NCT00386607|1803132|FG000|Core|Lost to Follow-up|23
845643|NCT00386607|1803133|FG001|Core|Lost to Follow-up|0
845644|NCT00386607|1803132|FG000|Core|Administrative problems|1
845645|NCT00386607|1803133|FG001|Core|Administrative problems|0
845646|NCT00386607|1803132|FG000|Core|Protocol Deviation|6
845647|NCT00386607|1803133|FG001|Core|Protocol Deviation|0
845648|NCT00386607|1803132|FG000|Extension|Adverse Event|0
845649|NCT00386607|1803133|FG001|Extension|Adverse Event|6
845650|NCT00386607|1803132|FG000|Extension|Abnormal laboratory value(s)|0
845651|NCT00386607|1803133|FG001|Extension|Abnormal laboratory value(s)|1
845652|NCT00386607|1803132|FG000|Extension|Administrative problems|0
845653|NCT00386607|1803133|FG001|Extension|Administrative problems|1
845654|NCT00386607|1803132|FG000|Extension|Lost to Follow-up|0
845655|NCT00386607|1803133|FG001|Extension|Lost to Follow-up|3
845656|NCT00386607|1803132|FG000|Extension|Patient withdrew consent|0
845657|NCT00386607|1803133|FG001|Extension|Patient withdrew consent|5
845658|NCT00386607|1803132|FG000|Extension|Unsatisfactory therapeutic effect|0
845659|NCT00386607|1803133|FG001|Extension|Unsatisfactory therapeutic effect|1
845660|NCT00386776|1803145|FG000|Overall Study|Withdrawal by Subject|8
845661|NCT00387010|1803157|FG000|Dose Titration Period|Adverse Event|12
845662|NCT00387010|1803157|FG000|Dose Titration Period|Lack of Efficacy|5
845663|NCT00387010|1803157|FG000|Dose Titration Period|Withdrawal by Subject|3
845664|NCT00387010|1803157|FG000|Dose Titration Period|Protocol Violation|1
845665|NCT00387010|1803157|FG000|Dose Titration Period|Lost to Follow-up|2
845666|NCT00387010|1803157|FG000|Dose Titration Period|Noncompliance with study medication|8
845667|NCT00387010|1803157|FG000|Dose Titration Period|Noncompliance with study procedures|7
845668|NCT00387010|1803157|FG000|Treatment Period|Adverse Event|4
845669|NCT00387010|1803157|FG000|Treatment Period|Withdrawal by Subject|1
845670|NCT00387010|1803157|FG000|Treatment Period|Noncompliance with study medication|2
845671|NCT00387010|1803157|FG000|Treatment Period|Noncompliance with study procedures|3
845672|NCT00387010|1803157|FG000|Treatment Period|Participant reported study drug stolen|1
845673|NCT00387088|1803174|FG000|Overall Study|Adverse Event|143
845674|NCT00387088|1803175|FG001|Overall Study|Adverse Event|156
845675|NCT00387088|1803174|FG000|Overall Study|Protocol Violation|47
845676|NCT00387088|1803175|FG001|Overall Study|Protocol Violation|35
845677|NCT00387088|1803174|FG000|Overall Study|Withdrawal by Subject|20
845678|NCT00387088|1803175|FG001|Overall Study|Withdrawal by Subject|35
845679|NCT00387088|1803174|FG000|Overall Study|Lack of Efficacy|28
845680|NCT00387088|1803175|FG001|Overall Study|Lack of Efficacy|67
845681|NCT00387088|1803174|FG000|Overall Study|Lost to Follow-up|22
845682|NCT00387088|1803175|FG001|Overall Study|Lost to Follow-up|28
845683|NCT00387088|1803174|FG000|Overall Study|Other|58
845684|NCT00387088|1803175|FG001|Overall Study|Other|52
845685|NCT00387127|1803183|FG000|Overall Study|Lost to Follow-up|0
845686|NCT00387127|1803184|FG001|Overall Study|Lost to Follow-up|4
845687|NCT00387127|1803183|FG000|Overall Study|Death|16
845688|NCT00387127|1803184|FG001|Overall Study|Death|16
845689|NCT00387127|1803183|FG000|Overall Study|Physician Decision|0
845690|NCT00387127|1803184|FG001|Overall Study|Physician Decision|1
845691|NCT00387127|1803183|FG000|Overall Study|Withdrawal by Subject|3
845692|NCT00387127|1803184|FG001|Overall Study|Withdrawal by Subject|2
845693|NCT00387127|1803183|FG000|Overall Study|Required by Protocol Amendment #4|12
845694|NCT00387127|1803184|FG001|Overall Study|Required by Protocol Amendment #4|10
845695|NCT00387127|1803183|FG000|Overall Study|Serious Adverse Event|1
845696|NCT00387127|1803184|FG001|Overall Study|Serious Adverse Event|1
845697|NCT00387127|1803183|FG000|Overall Study|Sponsor Unblinded|1
845698|NCT00387127|1803184|FG001|Overall Study|Sponsor Unblinded|0
845699|NCT00387153|1803192|FG000|Overall Study|Adverse Event|1
845700|NCT00387153|1803192|FG000|Overall Study|Disease Progression|3
845701|NCT00387153|1803192|FG000|Overall Study|Lack of Response|4
845702|NCT00387348|1803208|FG000|Overall Study|Death|1
845703|NCT00387348|1803209|FG001|Overall Study|Death|1
845704|NCT00387348|1803210|FG002|Overall Study|Death|0
845705|NCT00387348|1803208|FG000|Overall Study|Physician Decision|1
845706|NCT00387348|1803209|FG001|Overall Study|Physician Decision|0
845707|NCT00387348|1803210|FG002|Overall Study|Physician Decision|1
845708|NCT00387348|1803208|FG000|Overall Study|Withdrawal by Subject|0
845709|NCT00387348|1803209|FG001|Overall Study|Withdrawal by Subject|2
845710|NCT00387348|1803210|FG002|Overall Study|Withdrawal by Subject|2
845711|NCT00387348|1803208|FG000|Overall Study|Adverse Event|1
845712|NCT00387348|1803209|FG001|Overall Study|Adverse Event|0
845713|NCT00387348|1803210|FG002|Overall Study|Adverse Event|1
845714|NCT00387426|1803223|FG000|Overall Study|Lack of Response|7
845715|NCT00387426|1803223|FG000|Overall Study|Toxicities|4
845716|NCT00387426|1803223|FG000|Overall Study|Disease Progression|3
845717|NCT00387465|1803230|FG000|Overall Study|Withdrawal by Subject|0
845718|NCT00387465|1803231|FG001|Overall Study|Withdrawal by Subject|1
845719|NCT00387465|1803232|FG002|Overall Study|Withdrawal by Subject|0
845720|NCT00387647|1803256|FG000|Overall Study|Death|18
845721|NCT00387712|1803271|FG000|Overall Study|Physician Decision|6
845722|NCT00387712|1803272|FG001|Overall Study|Physician Decision|4
845723|NCT00387712|1803271|FG000|Overall Study|Lost to Follow-up|17
845724|NCT00387712|1803272|FG001|Overall Study|Lost to Follow-up|20
845725|NCT00387712|1803271|FG000|Overall Study|Withdrawal by Subject|6
845726|NCT00387712|1803272|FG001|Overall Study|Withdrawal by Subject|12
845727|NCT00387725|1803282|FG000|Overall Study|Adverse Event|0
845728|NCT00387725|1803283|FG001|Overall Study|Adverse Event|0
845729|NCT00387725|1803284|FG002|Overall Study|Adverse Event|0
845730|NCT00387725|1803285|FG003|Overall Study|Adverse Event|1
845731|NCT00387725|1803282|FG000|Overall Study|Protocol Violation|0
845732|NCT00387725|1803283|FG001|Overall Study|Protocol Violation|1
845733|NCT00387725|1803284|FG002|Overall Study|Protocol Violation|0
845734|NCT00387725|1803285|FG003|Overall Study|Protocol Violation|0
845735|NCT00387725|1803282|FG000|Overall Study|Withdrawal by Subject|1
845736|NCT00387725|1803283|FG001|Overall Study|Withdrawal by Subject|0
845737|NCT00387725|1803284|FG002|Overall Study|Withdrawal by Subject|1
845738|NCT00387725|1803285|FG003|Overall Study|Withdrawal by Subject|0
845739|NCT00387725|1803282|FG000|Overall Study|Parent/legal guardian request|0
845740|NCT00387725|1803283|FG001|Overall Study|Parent/legal guardian request|0
845741|NCT00387725|1803284|FG002|Overall Study|Parent/legal guardian request|1
845742|NCT00387725|1803285|FG003|Overall Study|Parent/legal guardian request|1
845743|NCT00387764|1803301|FG000|Overall Study|Adverse Event|12
845744|NCT00387764|1803301|FG000|Overall Study|Withdrawal by Subject|8
845745|NCT00387764|1803301|FG000|Overall Study|Sponsor Terminated Study|1
845746|NCT00387764|1803301|FG000|Overall Study|Physician Decision|1
845747|NCT00387764|1803301|FG000|Overall Study|Other|2
845748|NCT00387764|1803301|FG000|Overall Study|Death|7
845749|NCT00387790|1803305|FG000|Overall Study|Adverse Event|5
845750|NCT00387790|1803305|FG000|Overall Study|Lack of Efficacy|2
845751|NCT00387790|1803305|FG000|Overall Study|Physician Decision|2
845752|NCT00387790|1803305|FG000|Overall Study|Withdrawal by Subject|3
845753|NCT00387790|1803305|FG000|Overall Study|Ineligible for study|2
845754|NCT00387881|1803320|FG000|Overall Study|Lost to Follow-up|23
845755|NCT00387881|1803321|FG001|Overall Study|Lost to Follow-up|23
845756|NCT00387881|1803320|FG000|Overall Study|Protocol Violation|2
845757|NCT00387881|1803321|FG001|Overall Study|Protocol Violation|12
845758|NCT00387881|1803320|FG000|Overall Study|Withdrawal by Subject|15
845759|NCT00387881|1803321|FG001|Overall Study|Withdrawal by Subject|18
845760|NCT00387881|1803320|FG000|Overall Study|Sponsor terminated Study|0
845761|NCT00387881|1803321|FG001|Overall Study|Sponsor terminated Study|1
845762|NCT00387881|1803320|FG000|Overall Study|Not eligible|6
845763|NCT00387881|1803321|FG001|Overall Study|Not eligible|7
845764|NCT00387881|1803320|FG000|Overall Study|No opportunity to treat headache|32
845765|NCT00387881|1803321|FG001|Overall Study|No opportunity to treat headache|34
845766|NCT00387881|1803320|FG000|Overall Study|Not otherwise specified|11
845767|NCT00387881|1803321|FG001|Overall Study|Not otherwise specified|7
845768|NCT00387894|1803327|FG000|Overall Study|Withdrawal by Subject|1
845769|NCT00388037|1803335|FG000|Overall Study|Protocol Violation|1
845770|NCT00388154|1803339|FG000|Overall Study|Withdrawal by Subject|1
845771|NCT00388297|1803347|FG000|Overall Study|Lost to Follow-up|16
845772|NCT00388297|1803348|FG001|Overall Study|Lost to Follow-up|12
845773|NCT00388297|1803349|FG002|Overall Study|Lost to Follow-up|11
845774|NCT00388297|1803350|FG003|Overall Study|Lost to Follow-up|8
845775|NCT00388349|1803360|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0
845776|NCT00388349|1803361|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3
845777|NCT00388362|1803369|FG000|Enrolled|Ineligible|1
845778|NCT00388362|1803369|FG000|Enrolled|Adverse Event|9
845779|NCT00388362|1803369|FG000|Enrolled|Death|1
845780|NCT00388362|1803369|FG000|Enrolled|Loss insurance|1
845781|NCT00388362|1803369|FG000|Enrolled|Withdrawal by Subject|1
845782|NCT00388362|1803369|FG000|Remained on Study Median of 514 Days|Death|2
845783|NCT00388505|1803399|FG000|Overall Study|Adverse Event or Death|43
845784|NCT00388505|1803400|FG001|Overall Study|Adverse Event or Death|17
845785|NCT00388505|1803399|FG000|Overall Study|Withdrawal by Subject|24
845786|NCT00388505|1803400|FG001|Overall Study|Withdrawal by Subject|9
845787|NCT00388505|1803399|FG000|Overall Study|Lost to Follow-up|5
845788|NCT00388505|1803400|FG001|Overall Study|Lost to Follow-up|3
845789|NCT00388505|1803399|FG000|Overall Study|Inappropriate Enrollment|0
845790|NCT00388505|1803400|FG001|Overall Study|Inappropriate Enrollment|1
845791|NCT00388505|1803399|FG000|Overall Study|Administrative Reason|1
845792|NCT00388505|1803400|FG001|Overall Study|Administrative Reason|0
845793|NCT00388505|1803399|FG000|Overall Study|Protocol Violation|6
845794|NCT00388505|1803400|FG001|Overall Study|Protocol Violation|5
845795|NCT00388505|1803399|FG000|Overall Study|Unable to classify|4
845796|NCT00388505|1803400|FG001|Overall Study|Unable to classify|3
845797|NCT00388583|1803408|FG000|Overall Study|Protocol Violation|1
845798|NCT00388583|1803409|FG001|Overall Study|Protocol Violation|0
845799|NCT00388583|1803408|FG000|Overall Study|Withdrawal by Subject|3
845800|NCT00388583|1803409|FG001|Overall Study|Withdrawal by Subject|3
845801|NCT00388583|1803408|FG000|Overall Study|Serious Adverse Event|2
845802|NCT00388583|1803409|FG001|Overall Study|Serious Adverse Event|0
845803|NCT00388583|1803408|FG000|Overall Study|Did not receive vaccine|0
845804|NCT00388583|1803409|FG001|Overall Study|Did not receive vaccine|1
845805|NCT00388674|1803417|FG000|Initial Treatment|Administrative Reason by Sponsor|241
845806|NCT00388674|1803418|FG001|Initial Treatment|Administrative Reason by Sponsor|158
845807|NCT00388674|1803417|FG000|Initial Treatment|Adverse Event|22
845808|NCT00388674|1803418|FG001|Initial Treatment|Adverse Event|87
845809|NCT00388674|1803417|FG000|Initial Treatment|Death|215
845810|NCT00388674|1803418|FG001|Initial Treatment|Death|216
845811|NCT00388674|1803417|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11
845812|NCT00388674|1803418|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17
845813|NCT00388674|1803417|FG000|Initial Treatment|HCC|12
845814|NCT00388674|1803418|FG001|Initial Treatment|HCC|20
845815|NCT00388674|1803417|FG000|Initial Treatment|Lost to Follow-up|526
845816|NCT00388674|1803418|FG001|Initial Treatment|Lost to Follow-up|624
845817|NCT00388674|1803417|FG000|Initial Treatment|Malignancy (Non-HCC)|7
845818|NCT00388674|1803418|FG001|Initial Treatment|Malignancy (Non-HCC)|3
845819|NCT00388674|1803417|FG000|Initial Treatment|Never Treated with Study Medication|1
845820|NCT00388674|1803418|FG001|Initial Treatment|Never Treated with Study Medication|7
845821|NCT00388674|1803417|FG000|Initial Treatment|Non-Study related Comorbidities|3
845822|NCT00388674|1803418|FG001|Initial Treatment|Non-Study related Comorbidities|4
845823|NCT00388674|1803417|FG000|Initial Treatment|Not Defined|125
845824|NCT00388674|1803418|FG001|Initial Treatment|Not Defined|172
845825|NCT00388674|1803417|FG000|Initial Treatment|Partial or inadequate Treatment|112
845826|NCT00388674|1803418|FG001|Initial Treatment|Partial or inadequate Treatment|472
845827|NCT00388674|1803417|FG000|Initial Treatment|Pregnancy|26
845828|NCT00388674|1803418|FG001|Initial Treatment|Pregnancy|16
845829|NCT00388674|1803417|FG000|Initial Treatment|Study Drug Toxicity|5
845830|NCT00388674|1803418|FG001|Initial Treatment|Study Drug Toxicity|92
845831|NCT00388674|1803417|FG000|Initial Treatment|Participant Request|501
845832|NCT00388674|1803418|FG001|Initial Treatment|Participant Request|673
845833|NCT00388674|1803417|FG000|Initial Treatment|No Off-Treatment Status Data|11
845834|NCT00388674|1803418|FG001|Initial Treatment|No Off-Treatment Status Data|13
845835|NCT00388674|1803417|FG000|Initial Treatment|Not Reported|10
845836|NCT00388674|1803418|FG001|Initial Treatment|Not Reported|12
845837|NCT00388674|1803417|FG000|End of Study|Administrative Reason By Sponsor|299
845838|NCT00388674|1803418|FG001|End of Study|Administrative Reason By Sponsor|253
845839|NCT00388674|1803417|FG000|End of Study|Death|239
845840|NCT00388674|1803418|FG001|End of Study|Death|262
845841|NCT00388674|1803417|FG000|End of Study|HBV Disease Progression (Non-HCC)|3
845842|NCT00388674|1803418|FG001|End of Study|HBV Disease Progression (Non-HCC)|9
845843|NCT00388674|1803417|FG000|End of Study|HCC|8
845844|NCT00388674|1803418|FG001|End of Study|HCC|7
845845|NCT00388674|1803417|FG000|End of Study|Lost to Follow-up|587
845846|NCT00388674|1803418|FG001|End of Study|Lost to Follow-up|715
845847|NCT00388674|1803417|FG000|End of Study|Malignancy (Non-HCC)|1
845848|NCT00388674|1803418|FG001|End of Study|Malignancy (Non-HCC)|1
845849|NCT00388674|1803417|FG000|End of Study|Non-Study Related Comorbidities|3
845850|NCT00388674|1803418|FG001|End of Study|Non-Study Related Comorbidities|4
845851|NCT00388674|1803417|FG000|End of Study|Not Defined|135
845852|NCT00388674|1803418|FG001|End of Study|Not Defined|214
845853|NCT00388674|1803417|FG000|End of Study|Participant Withdrew Consent|437
845854|NCT00388674|1803418|FG001|End of Study|Participant Withdrew Consent|673
845855|NCT00388674|1803417|FG000|End of Study|No Off-Treatment Status Data|22
845856|NCT00388674|1803418|FG001|End of Study|No Off-Treatment Status Data|30
845857|NCT00388674|1803417|FG000|End of Study|Not Reported|0
845858|NCT00388674|1803418|FG001|End of Study|Not Reported|1
845859|NCT00388726|1803426|FG000|Overall Study|Adverse Event|50
845860|NCT00388726|1803427|FG001|Overall Study|Adverse Event|24
845861|NCT00388726|1803426|FG000|Overall Study|Progressive Disease|336
845862|NCT00388726|1803427|FG001|Overall Study|Progressive Disease|153
845863|NCT00388726|1803426|FG000|Overall Study|Clinical Progression|61
845864|NCT00388726|1803427|FG001|Overall Study|Clinical Progression|36
845865|NCT00388726|1803426|FG000|Overall Study|Withdrawal by Subject|10
845866|NCT00388726|1803427|FG001|Overall Study|Withdrawal by Subject|7
845867|NCT00388726|1803426|FG000|Overall Study|Administrative|6
845868|NCT00388726|1803427|FG001|Overall Study|Administrative|9
845869|NCT00388726|1803426|FG000|Overall Study|Physician Decision|18
845870|NCT00388726|1803427|FG001|Overall Study|Physician Decision|13
845871|NCT00388726|1803426|FG000|Overall Study|Death|3
845872|NCT00388726|1803427|FG001|Overall Study|Death|2
845873|NCT00388947|1803442|FG000|Overall Study|Protocol Violation|47
845874|NCT00388973|1803448|FG000|Overall Study|Adverse Event|16
845875|NCT00388973|1803449|FG001|Overall Study|Adverse Event|6
845876|NCT00388973|1803448|FG000|Overall Study|Lack of Efficacy|1
845877|NCT00388973|1803449|FG001|Overall Study|Lack of Efficacy|12
845878|NCT00388973|1803448|FG000|Overall Study|Protocol Violation|3
845879|NCT00388973|1803449|FG001|Overall Study|Protocol Violation|0
845880|NCT00388973|1803448|FG000|Overall Study|Withdrawal by Subject|14
845881|NCT00388973|1803449|FG001|Overall Study|Withdrawal by Subject|17
845882|NCT00388973|1803448|FG000|Overall Study|Study specific Discontinuation Criteria|0
845883|NCT00388973|1803449|FG001|Overall Study|Study specific Discontinuation Criteria|1
845884|NCT00388973|1803448|FG000|Overall Study|Did not complete 61 days of treatment|5
845885|NCT00388973|1803449|FG001|Overall Study|Did not complete 61 days of treatment|4
845886|NCT00388973|1803448|FG000|Overall Study|Left region|0
845887|NCT00388973|1803449|FG001|Overall Study|Left region|1
845888|NCT00388973|1803448|FG000|Overall Study|Did not complete 2-week follow-up visit|17
845889|NCT00388973|1803449|FG001|Overall Study|Did not complete 2-week follow-up visit|17
845890|NCT00389064|1803457|FG000|Overall Study|Adverse Event|11
845891|NCT00389064|1803458|FG001|Overall Study|Adverse Event|3
845892|NCT00389064|1803457|FG000|Overall Study|Lack of Efficacy|3
845893|NCT00389064|1803458|FG001|Overall Study|Lack of Efficacy|14
845894|NCT00389064|1803457|FG000|Overall Study|Withdrawal by Subject|17
845895|NCT00389064|1803458|FG001|Overall Study|Withdrawal by Subject|27
845896|NCT00389064|1803457|FG000|Overall Study|Physician Decision|2
845897|NCT00389064|1803458|FG001|Overall Study|Physician Decision|2
845898|NCT00389064|1803457|FG000|Overall Study|Lost to Follow-up|1
845899|NCT00389064|1803458|FG001|Overall Study|Lost to Follow-up|2
845900|NCT00389064|1803457|FG000|Overall Study|Protocol Violation|2
845901|NCT00389064|1803458|FG001|Overall Study|Protocol Violation|0
845902|NCT00389064|1803457|FG000|Overall Study|Multiple Reasons|9
845903|NCT00389064|1803458|FG001|Overall Study|Multiple Reasons|11
845904|NCT00389207|1803476|FG000|Overall Study|Adverse Event|26
845905|NCT00389207|1803477|FG001|Overall Study|Adverse Event|32
845906|NCT00389207|1803478|FG002|Overall Study|Adverse Event|10
845907|NCT00389207|1803476|FG000|Overall Study|Protocol Violation|3
845908|NCT00389207|1803477|FG001|Overall Study|Protocol Violation|1
845909|NCT00389207|1803478|FG002|Overall Study|Protocol Violation|4
845910|NCT00389207|1803476|FG000|Overall Study|Lost to Follow-up|12
845911|NCT00389207|1803477|FG001|Overall Study|Lost to Follow-up|9
845912|NCT00389207|1803478|FG002|Overall Study|Lost to Follow-up|7
845913|NCT00389207|1803476|FG000|Overall Study|Withdrawal by Subject|5
845914|NCT00389207|1803477|FG001|Overall Study|Withdrawal by Subject|7
845915|NCT00389207|1803478|FG002|Overall Study|Withdrawal by Subject|11
845916|NCT00389207|1803476|FG000|Overall Study|Other|17
845917|NCT00389207|1803477|FG001|Overall Study|Other|23
845918|NCT00389207|1803478|FG002|Overall Study|Other|9
845919|NCT00389324|1803491|FG000|Run-In Phase|Adverse Event|1
845920|NCT00389324|1803491|FG000|Run-In Phase|Lost to Follow-up|1
845921|NCT00389324|1803491|FG000|Run-In Phase|Withdrawal by Subject|1
845922|NCT00389324|1803491|FG000|Subcutaneous Phase|Adverse Event|2
845923|NCT00389324|1803491|FG000|Subcutaneous Phase|Non-compliance with study medication|2
845924|NCT00389324|1803491|FG000|Subcutaneous Phase|Withdrawal by Subject|2
845925|NCT00389324|1803491|FG000|Subcutaneous Phase|Lost to Follow-up|1
845926|NCT00389441|1803498|FG000|Overall Study|Adverse Event|7
845927|NCT00389441|1803498|FG000|Overall Study|Death|4
845928|NCT00389441|1803498|FG000|Overall Study|Lost to Follow-up|2
845929|NCT00389441|1803498|FG000|Overall Study|Withdrawal by Subject|4
845930|NCT00389441|1803498|FG000|Overall Study|Physician Decision|1
845931|NCT00389441|1803498|FG000|Overall Study|Protocol Violation|1
845932|NCT00389441|1803498|FG000|Overall Study|Global deterioration of health status|4
845933|NCT00389441|1803498|FG000|Overall Study|Objective progression or relapse|26
845934|NCT00389441|1803498|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
845935|NCT00389441|1803498|FG000|Overall Study|Clinical progression|1
845936|NCT00389519|1803540|FG000|Placebo Run-In|Did not meet blood pressure criteria|119
845937|NCT00389519|1803541|FG001|Placebo Run-In|Did not meet blood pressure criteria|0
845938|NCT00389519|1803542|FG002|Placebo Run-In|Did not meet blood pressure criteria|0
845939|NCT00389519|1803543|FG003|Placebo Run-In|Did not meet blood pressure criteria|0
845940|NCT00389519|1803540|FG000|Placebo Run-In|Withdrawal by Subject|19
845941|NCT00389519|1803541|FG001|Placebo Run-In|Withdrawal by Subject|0
845942|NCT00389519|1803542|FG002|Placebo Run-In|Withdrawal by Subject|0
845943|NCT00389519|1803543|FG003|Placebo Run-In|Withdrawal by Subject|0
845944|NCT00389519|1803540|FG000|Placebo Run-In|Reason not specified|40
845945|NCT00389519|1803541|FG001|Placebo Run-In|Reason not specified|0
845946|NCT00389519|1803542|FG002|Placebo Run-In|Reason not specified|0
845947|NCT00389519|1803543|FG003|Placebo Run-In|Reason not specified|0
845948|NCT00389519|1803540|FG000|Randomized|Did not receive study drug|2
845949|NCT00389519|1803541|FG001|Randomized|Did not receive study drug|0
845950|NCT00389519|1803542|FG002|Randomized|Did not receive study drug|0
845951|NCT00389519|1803543|FG003|Randomized|Did not receive study drug|0
845952|NCT00389519|1803540|FG000|Treated|Adverse Event|1
845953|NCT00389519|1803541|FG001|Treated|Adverse Event|0
845954|NCT00389519|1803542|FG002|Treated|Adverse Event|0
845955|NCT00389519|1803543|FG003|Treated|Adverse Event|2
845956|NCT00389519|1803540|FG000|Treated|Reason not specified|1
845957|NCT00389519|1803541|FG001|Treated|Reason not specified|1
845958|NCT00389519|1803542|FG002|Treated|Reason not specified|0
845959|NCT00389519|1803543|FG003|Treated|Reason not specified|2
845960|NCT00389597|1803566|FG000|Overall Study|Lost to Follow-up|8
845961|NCT00389597|1803567|FG001|Overall Study|Lost to Follow-up|6
845962|NCT00389597|1803568|FG002|Overall Study|Lost to Follow-up|4
845963|NCT00389597|1803569|FG003|Overall Study|Lost to Follow-up|6
845964|NCT00389831|1803594|FG000|Overall Study|Lack of Efficacy|0
845965|NCT00389831|1803595|FG001|Overall Study|Lack of Efficacy|2
845966|NCT00389831|1803594|FG000|Overall Study|Did not receive treatment.|0
845967|NCT00389831|1803595|FG001|Overall Study|Did not receive treatment.|2
845968|NCT00389831|1803594|FG000|Overall Study|Other reasons|0
845969|NCT00389831|1803595|FG001|Overall Study|Other reasons|2
845970|NCT00389831|1803594|FG000|Overall Study|Lost to Follow-up|0
845971|NCT00389831|1803595|FG001|Overall Study|Lost to Follow-up|1
845972|NCT00390013|1803629|FG000|Phase 1|tired|0
845973|NCT00390013|1803630|FG001|Phase 1|tired|0
845974|NCT00390013|1803631|FG002|Phase 1|tired|0
845975|NCT00390013|1803632|FG003|Phase 1|tired|1
845976|NCT00390013|1803629|FG000|Phase 2 First Treatment|tired|1
845977|NCT00390013|1803630|FG001|Phase 2 First Treatment|tired|0
845978|NCT00390013|1803631|FG002|Phase 2 First Treatment|tired|0
845979|NCT00390013|1803632|FG003|Phase 2 First Treatment|tired|0
845980|NCT00390013|1803629|FG000|Phase 2 First Treatment|Withdrawal by Subject|0
845981|NCT00390013|1803630|FG001|Phase 2 First Treatment|Withdrawal by Subject|1
845982|NCT00390013|1803631|FG002|Phase 2 First Treatment|Withdrawal by Subject|0
845983|NCT00390013|1803632|FG003|Phase 2 First Treatment|Withdrawal by Subject|0
845984|NCT00390221|1803645|FG000|Overall Study|Lost to Follow-up|0
845985|NCT00390221|1803646|FG001|Overall Study|Lost to Follow-up|3
845986|NCT00390221|1803647|FG002|Overall Study|Lost to Follow-up|0
845987|NCT00390221|1803645|FG000|Overall Study|Adverse Event|1
845988|NCT00390221|1803646|FG001|Overall Study|Adverse Event|4
845989|NCT00390221|1803647|FG002|Overall Study|Adverse Event|3
845990|NCT00390221|1803645|FG000|Overall Study|Investigator Decision|0
845991|NCT00390221|1803646|FG001|Overall Study|Investigator Decision|0
845992|NCT00390221|1803647|FG002|Overall Study|Investigator Decision|1
845993|NCT00390221|1803645|FG000|Overall Study|Withdrawal by Subject|13
845994|NCT00390221|1803646|FG001|Overall Study|Withdrawal by Subject|9
845995|NCT00390221|1803647|FG002|Overall Study|Withdrawal by Subject|7
845996|NCT00390221|1803645|FG000|Overall Study|Subject Non-compliance|1
845997|NCT00390221|1803646|FG001|Overall Study|Subject Non-compliance|0
845998|NCT00390221|1803647|FG002|Overall Study|Subject Non-compliance|2
845999|NCT00390221|1803645|FG000|Overall Study|Other|3
846000|NCT00390221|1803646|FG001|Overall Study|Other|4
846001|NCT00390221|1803647|FG002|Overall Study|Other|2
846002|NCT00390299|1803666|FG000|Overall Study|Cancellation|1
846003|NCT00390299|1803667|FG001|Overall Study|Cancellation|0
846004|NCT00390299|1803668|FG002|Overall Study|Cancellation|0
846005|NCT00390299|1803669|FG003|Overall Study|Cancellation|0
846006|NCT00390299|1803670|FG004|Overall Study|Cancellation|0
846007|NCT00390416|1803701|FG000|Overall Study|Withdrawal by Subject|1
846008|NCT00390416|1803701|FG000|Overall Study|Not treated|3
846009|NCT00390455|1803724|FG000|Overall Study|Adverse Event|17
846010|NCT00390455|1803725|FG001|Overall Study|Adverse Event|3
846011|NCT00390455|1803724|FG000|Overall Study|Withdrawal by Subject|8
846012|NCT00390455|1803725|FG001|Overall Study|Withdrawal by Subject|8
846013|NCT00390455|1803724|FG000|Overall Study|Alternate Treatment|0
846014|NCT00390455|1803725|FG001|Overall Study|Alternate Treatment|1
846015|NCT00390455|1803724|FG000|Overall Study|Other Medical Reasons|7
846016|NCT00390455|1803725|FG001|Overall Study|Other Medical Reasons|11
846017|NCT00390468|1803731|FG000|Overall Study|Protocol Violation|2
846018|NCT00390468|1803731|FG000|Overall Study|Lack of Efficacy|1
846019|NCT00390546|1803737|FG000|Overall Study|Renal impairment|1
846020|NCT00390546|1803738|FG001|Overall Study|Renal impairment|0
846021|NCT00390546|1803737|FG000|Overall Study|Physician Decision|5
846022|NCT00390546|1803738|FG001|Overall Study|Physician Decision|5
846023|NCT00390572|1803757|FG000|Overall Study|Lost to Follow-up|8
846024|NCT00390572|1803758|FG001|Overall Study|Lost to Follow-up|4
846025|NCT00390572|1803757|FG000|Overall Study|health condition|0
846026|NCT00390572|1803758|FG001|Overall Study|health condition|1
846027|NCT00390689|1803778|FG000|Overall Study|Adverse Event|2
846028|NCT00390689|1803779|FG001|Overall Study|Adverse Event|5
846029|NCT00390689|1803780|FG002|Overall Study|Adverse Event|2
846030|NCT00390689|1803778|FG000|Overall Study|Lack of Efficacy|0
846031|NCT00390689|1803779|FG001|Overall Study|Lack of Efficacy|0
846032|NCT00390689|1803780|FG002|Overall Study|Lack of Efficacy|1
846033|NCT00390689|1803778|FG000|Overall Study|Protocol Violation|1
846034|NCT00390689|1803779|FG001|Overall Study|Protocol Violation|0
846035|NCT00390689|1803780|FG002|Overall Study|Protocol Violation|0
846036|NCT00390689|1803778|FG000|Overall Study|Investigator's judgement|2
846037|NCT00390689|1803779|FG001|Overall Study|Investigator's judgement|0
846038|NCT00390689|1803780|FG002|Overall Study|Investigator's judgement|0
846039|NCT00390780|1803799|FG000|Overall Study|Not completed|10
846040|NCT00390780|1803800|FG001|Overall Study|Not completed|4
846041|NCT00390780|1803799|FG000|Overall Study|Protocol Violation|6
846042|NCT00390780|1803800|FG001|Overall Study|Protocol Violation|4
846043|NCT00390780|1803799|FG000|Overall Study|Lost to Follow-up|3
846044|NCT00390780|1803800|FG001|Overall Study|Lost to Follow-up|6
846045|NCT00390780|1803799|FG000|Overall Study|Adverse Event|2
846046|NCT00390780|1803800|FG001|Overall Study|Adverse Event|3
846047|NCT00390780|1803799|FG000|Overall Study|Death|1
846048|NCT00390780|1803800|FG001|Overall Study|Death|3
846049|NCT00390780|1803799|FG000|Overall Study|Withdrawal by Subject|1
846050|NCT00390780|1803800|FG001|Overall Study|Withdrawal by Subject|2
846051|NCT00390780|1803799|FG000|Overall Study|Inclusion criteria not satisfied|0
846052|NCT00390780|1803800|FG001|Overall Study|Inclusion criteria not satisfied|2
846053|NCT00390780|1803799|FG000|Overall Study|Lost to follow up and other reasons|0
846054|NCT00390780|1803800|FG001|Overall Study|Lost to follow up and other reasons|1
846055|NCT00390780|1803799|FG000|Overall Study|Investigator decision, SAE, other reason|0
846056|NCT00390780|1803800|FG001|Overall Study|Investigator decision, SAE, other reason|1
846057|NCT00390780|1803799|FG000|Overall Study|SAE, death|0
846058|NCT00390780|1803800|FG001|Overall Study|SAE, death|1
846059|NCT00390806|1803808|FG000|Overall Study|Lost to Follow-up|7
846060|NCT00390806|1803809|FG001|Overall Study|Lost to Follow-up|6
846061|NCT00390806|1803808|FG000|Overall Study|Protocol Violation|2
846062|NCT00390806|1803809|FG001|Overall Study|Protocol Violation|2
846063|NCT00390806|1803808|FG000|Overall Study|Withdrawal by Subject|12
846064|NCT00390806|1803809|FG001|Overall Study|Withdrawal by Subject|15
846065|NCT00390806|1803808|FG000|Overall Study|Investigator Decision|4
846066|NCT00390806|1803809|FG001|Overall Study|Investigator Decision|6
846067|NCT00390806|1803808|FG000|Overall Study|Death|1
846068|NCT00390806|1803809|FG001|Overall Study|Death|0
846069|NCT00390806|1803808|FG000|Overall Study|Physician Decision|0
846070|NCT00390806|1803809|FG001|Overall Study|Physician Decision|1
846071|NCT00390806|1803808|FG000|Overall Study|Ongoing|4
846072|NCT00390806|1803809|FG001|Overall Study|Ongoing|2
846073|NCT00390858|1803817|FG000|Overall Study|Adverse Event|6
846074|NCT00390858|1803818|FG001|Overall Study|Adverse Event|2
846075|NCT00390858|1803817|FG000|Overall Study|Lack of Efficacy|0
846076|NCT00390858|1803818|FG001|Overall Study|Lack of Efficacy|1
846077|NCT00390858|1803817|FG000|Overall Study|Withdrawal by Subject|3
846078|NCT00390858|1803818|FG001|Overall Study|Withdrawal by Subject|4
846079|NCT00390884|1803826|FG000|Overall Study|Withdrawal by Subject|2
846080|NCT00390884|1803827|FG001|Overall Study|Withdrawal by Subject|2
846081|NCT00390910|1803836|FG000|Overall Study|Adverse Event|1
846082|NCT00390910|1803837|FG001|Overall Study|Adverse Event|0
846083|NCT00390910|1803838|FG002|Overall Study|Adverse Event|0
846084|NCT00390910|1803836|FG000|Overall Study|Lost to Follow-up|0
846085|NCT00390910|1803837|FG001|Overall Study|Lost to Follow-up|1
846086|NCT00390910|1803838|FG002|Overall Study|Lost to Follow-up|5
846087|NCT00390910|1803836|FG000|Overall Study|Withdrawal by Subject|1
846088|NCT00390910|1803837|FG001|Overall Study|Withdrawal by Subject|3
846089|NCT00390910|1803838|FG002|Overall Study|Withdrawal by Subject|2
846090|NCT00390910|1803836|FG000|Overall Study|Migrated/moved from study area|0
846091|NCT00390910|1803837|FG001|Overall Study|Migrated/moved from study area|0
846092|NCT00390910|1803838|FG002|Overall Study|Migrated/moved from study area|3
846093|NCT00391027|1803859|FG000|Overall Study|Adverse Event|8
846094|NCT00391027|1803860|FG001|Overall Study|Adverse Event|8
846095|NCT00391027|1803859|FG000|Overall Study|Lack of Efficacy|3
846096|NCT00391027|1803860|FG001|Overall Study|Lack of Efficacy|0
846097|NCT00391027|1803859|FG000|Overall Study|Withdrawal by Subject|10
846098|NCT00391027|1803860|FG001|Overall Study|Withdrawal by Subject|1
846099|NCT00391027|1803859|FG000|Overall Study|Other|4
846100|NCT00391027|1803860|FG001|Overall Study|Other|3
846101|NCT00391053|1803870|FG000|Overall Study|Serious Adverse Events|1
846102|NCT00391053|1803871|FG001|Overall Study|Serious Adverse Events|0
846103|NCT00391053|1803872|FG002|Overall Study|Serious Adverse Events|1
846104|NCT00391053|1803873|FG003|Overall Study|Serious Adverse Events|4
846105|NCT00391053|1803870|FG000|Overall Study|Protocol Violation|2
846106|NCT00391053|1803871|FG001|Overall Study|Protocol Violation|0
846107|NCT00391053|1803872|FG002|Overall Study|Protocol Violation|0
846108|NCT00391053|1803873|FG003|Overall Study|Protocol Violation|0
846109|NCT00391053|1803870|FG000|Overall Study|Lost to Follow-up|1
846110|NCT00391053|1803871|FG001|Overall Study|Lost to Follow-up|0
846111|NCT00391053|1803872|FG002|Overall Study|Lost to Follow-up|0
846112|NCT00391053|1803873|FG003|Overall Study|Lost to Follow-up|5
846113|NCT00391053|1803870|FG000|Overall Study|Withdrawal by Subject|5
846114|NCT00391053|1803871|FG001|Overall Study|Withdrawal by Subject|1
846115|NCT00391053|1803872|FG002|Overall Study|Withdrawal by Subject|1
846116|NCT00391053|1803873|FG003|Overall Study|Withdrawal by Subject|1
846117|NCT00391092|1803894|FG000|Overall Study|Death|78
846118|NCT00391092|1803895|FG001|Overall Study|Death|81
846119|NCT00391092|1803894|FG000|Overall Study|Lost to Follow-up|13
846120|NCT00391092|1803895|FG001|Overall Study|Lost to Follow-up|18
846121|NCT00391092|1803894|FG000|Overall Study|Alive on treatment|29
846122|NCT00391092|1803895|FG001|Overall Study|Alive on treatment|33
846123|NCT00391092|1803894|FG000|Overall Study|Alive in follow-up|88
846124|NCT00391092|1803895|FG001|Overall Study|Alive in follow-up|84
846125|NCT00391118|1803904|FG000|Overall Study|Adverse Event|3
846126|NCT00391118|1803905|FG001|Overall Study|Adverse Event|10
846127|NCT00391118|1803906|FG002|Overall Study|Adverse Event|7
846128|NCT00391118|1803904|FG000|Overall Study|Lost to Follow-up|0
846129|NCT00391118|1803905|FG001|Overall Study|Lost to Follow-up|2
846130|NCT00391118|1803906|FG002|Overall Study|Lost to Follow-up|3
846131|NCT00391118|1803904|FG000|Overall Study|Withdrawal by Subject|0
846132|NCT00391118|1803905|FG001|Overall Study|Withdrawal by Subject|9
846133|NCT00391118|1803906|FG002|Overall Study|Withdrawal by Subject|1
846134|NCT00391118|1803904|FG000|Overall Study|Death|0
846135|NCT00391118|1803905|FG001|Overall Study|Death|1
846136|NCT00391118|1803906|FG002|Overall Study|Death|0
846137|NCT00391118|1803904|FG000|Overall Study|Physician Decision|0
846138|NCT00391118|1803905|FG001|Overall Study|Physician Decision|3
846139|NCT00391118|1803906|FG002|Overall Study|Physician Decision|0
846140|NCT00391118|1803904|FG000|Overall Study|Protocol Entry Criteria Not Met|0
846141|NCT00391118|1803905|FG001|Overall Study|Protocol Entry Criteria Not Met|3
846142|NCT00391118|1803906|FG002|Overall Study|Protocol Entry Criteria Not Met|1
846143|NCT00391118|1803904|FG000|Overall Study|Progressive Disease|7
846144|NCT00391118|1803905|FG001|Overall Study|Progressive Disease|26
846145|NCT00391118|1803906|FG002|Overall Study|Progressive Disease|43
846146|NCT00391118|1803904|FG000|Overall Study|Sponsor Decision|0
846147|NCT00391118|1803905|FG001|Overall Study|Sponsor Decision|1
846148|NCT00391118|1803906|FG002|Overall Study|Sponsor Decision|3
846149|NCT00391118|1803904|FG000|Overall Study|Protocol Violation|1
846150|NCT00391118|1803905|FG001|Overall Study|Protocol Violation|0
846151|NCT00391118|1803906|FG002|Overall Study|Protocol Violation|0
846152|NCT00391222|1803920|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
846153|NCT00391222|1803921|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
846154|NCT00391222|1803922|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
846155|NCT00391222|1803923|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
846156|NCT00391222|1803920|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
846157|NCT00391222|1803921|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
846158|NCT00391222|1803922|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
846159|NCT00391222|1803923|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
846160|NCT00391222|1803920|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0
846161|NCT00391222|1803921|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0
846162|NCT00391222|1803922|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0
846163|NCT00391222|1803923|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10
846164|NCT00391222|1803920|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0
846165|NCT00391222|1803921|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0
846166|NCT00391222|1803922|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0
846167|NCT00391222|1803923|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97
846168|NCT00391222|1803920|FG000|Period II (Open-label Risperidone LAI)|Other|0
846169|NCT00391222|1803921|FG001|Period II (Open-label Risperidone LAI)|Other|0
846170|NCT00391222|1803922|FG002|Period II (Open-label Risperidone LAI)|Other|0
846171|NCT00391222|1803923|FG003|Period II (Open-label Risperidone LAI)|Other|24
846172|NCT00391222|1803920|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
846173|NCT00391222|1803921|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
846174|NCT00391222|1803922|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
846175|NCT00391222|1803923|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
846176|NCT00391222|1803920|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2
846177|NCT00391222|1803921|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4
846178|NCT00391222|1803922|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4
846179|NCT00391222|1803923|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0
846180|NCT00391222|1803920|FG000|Period III (Double-Blind Treatment)|Adverse Event|5
846181|NCT00391222|1803921|FG001|Period III (Double-Blind Treatment)|Adverse Event|2
846182|NCT00391222|1803922|FG002|Period III (Double-Blind Treatment)|Adverse Event|4
846183|NCT00391222|1803923|FG003|Period III (Double-Blind Treatment)|Adverse Event|0
846184|NCT00391222|1803920|FG000|Period III (Double-Blind Treatment)|Pregnancy|0
846185|NCT00391222|1803921|FG001|Period III (Double-Blind Treatment)|Pregnancy|2
846186|NCT00391222|1803922|FG002|Period III (Double-Blind Treatment)|Pregnancy|0
846187|NCT00391222|1803923|FG003|Period III (Double-Blind Treatment)|Pregnancy|0
846188|NCT00391222|1803920|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
846189|NCT00391222|1803921|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
846190|NCT00391222|1803922|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
846191|NCT00391222|1803923|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
846192|NCT00391222|1803920|FG000|Period III (Double-Blind Treatment)|Other|6
846193|NCT00391222|1803921|FG001|Period III (Double-Blind Treatment)|Other|1
846194|NCT00391222|1803922|FG002|Period III (Double-Blind Treatment)|Other|6
846195|NCT00391222|1803923|FG003|Period III (Double-Blind Treatment)|Other|0
846196|NCT00391274|1803935|FG000|Overall Study|Death Due to Study Disease|55
846197|NCT00391274|1803936|FG001|Overall Study|Death Due to Study Disease|45
846198|NCT00391274|1803935|FG000|Overall Study|Lost to Follow-up|0
846199|NCT00391274|1803936|FG001|Overall Study|Lost to Follow-up|3
846200|NCT00391274|1803935|FG000|Overall Study|Physician Decision|4
846201|NCT00391274|1803936|FG001|Overall Study|Physician Decision|2
846202|NCT00391274|1803935|FG000|Overall Study|Withdrawal by Subject|0
846203|NCT00391274|1803936|FG001|Overall Study|Withdrawal by Subject|3
846204|NCT00391274|1803935|FG000|Overall Study|Death Due to Adverse Event|1
846205|NCT00391274|1803936|FG001|Overall Study|Death Due to Adverse Event|3
846206|NCT00391274|1803935|FG000|Overall Study|Death Due to Indeterminate Cause|1
846207|NCT00391274|1803936|FG001|Overall Study|Death Due to Indeterminate Cause|0
846208|NCT00391274|1803935|FG000|Overall Study|Death Not Study Related|0
846209|NCT00391274|1803936|FG001|Overall Study|Death Not Study Related|1
846210|NCT00391391|1803956|FG000|Overall Study|Adverse Event|0
846211|NCT00391391|1803957|FG001|Overall Study|Adverse Event|0
846212|NCT00391391|1803958|FG002|Overall Study|Adverse Event|0
846213|NCT00391391|1803959|FG003|Overall Study|Adverse Event|1
846214|NCT00391391|1803956|FG000|Overall Study|Lost to Follow-up|1
846215|NCT00391391|1803957|FG001|Overall Study|Lost to Follow-up|3
846216|NCT00391391|1803958|FG002|Overall Study|Lost to Follow-up|7
846217|NCT00391391|1803959|FG003|Overall Study|Lost to Follow-up|4
846218|NCT00391391|1803956|FG000|Overall Study|Protocol Violation|2
846219|NCT00391391|1803957|FG001|Overall Study|Protocol Violation|3
846220|NCT00391391|1803958|FG002|Overall Study|Protocol Violation|6
846221|NCT00391391|1803959|FG003|Overall Study|Protocol Violation|7
846222|NCT00391391|1803956|FG000|Overall Study|Withdrawal by Subject|6
846223|NCT00391391|1803957|FG001|Overall Study|Withdrawal by Subject|4
846224|NCT00391391|1803958|FG002|Overall Study|Withdrawal by Subject|10
846225|NCT00391391|1803959|FG003|Overall Study|Withdrawal by Subject|7
846226|NCT00391586|1803991|FG000|Overall Study|Progressive disease|13
846227|NCT00391586|1803991|FG000|Overall Study|Adverse Event|5
846228|NCT00391586|1803991|FG000|Overall Study|Physician Decision|2
846229|NCT00391586|1803991|FG000|Overall Study|Death|4
846230|NCT00391625|1804006|FG000|Month 14|Withdrawal by Subject|1
846231|NCT00391625|1804006|FG000|Month 50|Physician Decision|1
846232|NCT00391768|1804053|FG000|Overall Study|Withdrawal by Subject|0
846233|NCT00391768|1804054|FG001|Overall Study|Withdrawal by Subject|0
846234|NCT00391768|1804055|FG002|Overall Study|Withdrawal by Subject|1
846235|NCT00391768|1804056|FG003|Overall Study|Withdrawal by Subject|0
846236|NCT00391768|1804057|FG004|Overall Study|Withdrawal by Subject|0
846237|NCT00391768|1804058|FG005|Overall Study|Withdrawal by Subject|1
846238|NCT00391768|1804059|FG006|Overall Study|Withdrawal by Subject|1
846239|NCT00391768|1804053|FG000|Overall Study|Lost to Follow-up|0
846240|NCT00391768|1804054|FG001|Overall Study|Lost to Follow-up|0
846241|NCT00391768|1804055|FG002|Overall Study|Lost to Follow-up|0
846242|NCT00391768|1804056|FG003|Overall Study|Lost to Follow-up|1
846243|NCT00391768|1804057|FG004|Overall Study|Lost to Follow-up|2
846244|NCT00391768|1804058|FG005|Overall Study|Lost to Follow-up|2
846245|NCT00391768|1804059|FG006|Overall Study|Lost to Follow-up|3
846246|NCT00391807|1804093|FG000|Overall Study|Did not receive study medication|23
846247|NCT00391807|1804093|FG000|Overall Study|Adverse Event|177
846248|NCT00391807|1804093|FG000|Overall Study|Pregnancy|25
846249|NCT00391807|1804093|FG000|Overall Study|Lost to Follow-up|227
846250|NCT00391807|1804093|FG000|Overall Study|Withdrawal by Subject|147
846251|NCT00391807|1804093|FG000|Overall Study|Protocol Violation|20
846252|NCT00391807|1804093|FG000|Overall Study|Various|96
846253|NCT00391846|1804099|FG000|Overall Study|Adverse Event|4
846254|NCT00391846|1804100|FG001|Overall Study|Adverse Event|1
846255|NCT00391846|1804099|FG000|Overall Study|Did not meet the required elig. crit|2
846256|NCT00391846|1804100|FG001|Overall Study|Did not meet the required elig. crit|2
846257|NCT00391846|1804099|FG000|Overall Study|Withdrawal by Subject|2
846258|NCT00391846|1804100|FG001|Overall Study|Withdrawal by Subject|3
846259|NCT00391846|1804099|FG000|Overall Study|Developed study specific DC criteria|0
846260|NCT00391846|1804100|FG001|Overall Study|Developed study specific DC criteria|1
846261|NCT00391872|1804108|FG000|Overall Study|Protocol Violation|7
846262|NCT00391872|1804109|FG001|Overall Study|Protocol Violation|2
846263|NCT00391872|1804108|FG000|Overall Study|Withdrawal by Subject|296
846264|NCT00391872|1804109|FG001|Overall Study|Withdrawal by Subject|249
846265|NCT00391872|1804108|FG000|Overall Study|Reason unknown|2
846266|NCT00391872|1804109|FG001|Overall Study|Reason unknown|4
846267|NCT00391872|1804108|FG000|Overall Study|Lost to Follow-up|2
846268|NCT00391872|1804109|FG001|Overall Study|Lost to Follow-up|0
846269|NCT00391898|1804117|FG000|Overall Study|Adverse Event|3
846270|NCT00391898|1804118|FG001|Overall Study|Adverse Event|0
846271|NCT00391898|1804117|FG000|Overall Study|Other|8
846272|NCT00391898|1804118|FG001|Overall Study|Other|10
846273|NCT00391976|1804127|FG000|Overall Study|Adverse Event|0
846274|NCT00391976|1804128|FG001|Overall Study|Adverse Event|0
846275|NCT00391976|1804129|FG002|Overall Study|Adverse Event|1
846276|NCT00391976|1804127|FG000|Overall Study|Withdrawal of consent|0
846277|NCT00391976|1804128|FG001|Overall Study|Withdrawal of consent|1
846278|NCT00391976|1804129|FG002|Overall Study|Withdrawal of consent|1
846279|NCT00391976|1804127|FG000|Overall Study|Lost to Follow-up|1
846280|NCT00391976|1804128|FG001|Overall Study|Lost to Follow-up|2
846281|NCT00391976|1804129|FG002|Overall Study|Lost to Follow-up|0
846282|NCT00391976|1804127|FG000|Overall Study|Inappropriate enrollment|1
846283|NCT00391976|1804128|FG001|Overall Study|Inappropriate enrollment|1
846284|NCT00391976|1804129|FG002|Overall Study|Inappropriate enrollment|0
846285|NCT00391976|1804127|FG000|Overall Study|Protocol deviation/violation|4
846286|NCT00391976|1804128|FG001|Overall Study|Protocol deviation/violation|2
846287|NCT00391976|1804129|FG002|Overall Study|Protocol deviation/violation|1
846288|NCT00391976|1804127|FG000|Overall Study|Recurrence/no eradication of infection|21
846289|NCT00391976|1804128|FG001|Overall Study|Recurrence/no eradication of infection|19
846290|NCT00391976|1804129|FG002|Overall Study|Recurrence/no eradication of infection|0
846291|NCT00391976|1804127|FG000|Overall Study|Unable to classify|0
846292|NCT00391976|1804128|FG001|Overall Study|Unable to classify|0
846293|NCT00391976|1804129|FG002|Overall Study|Unable to classify|1
846294|NCT00391976|1804127|FG000|Overall Study|Positive P. aeruginosa antibody test|0
846295|NCT00391976|1804128|FG001|Overall Study|Positive P. aeruginosa antibody test|0
846296|NCT00391976|1804129|FG002|Overall Study|Positive P. aeruginosa antibody test|31
846297|NCT00392015|1804149|FG000|Overall Study|Lost to Follow-up|2
846298|NCT00392015|1804150|FG001|Overall Study|Lost to Follow-up|0
846299|NCT00392015|1804151|FG002|Overall Study|Lost to Follow-up|2
846300|NCT00392015|1804152|FG003|Overall Study|Lost to Follow-up|1
846301|NCT00392015|1804153|FG004|Overall Study|Lost to Follow-up|1
846302|NCT00392015|1804154|FG005|Overall Study|Lost to Follow-up|0
846303|NCT00392015|1804149|FG000|Overall Study|Withdrawal by Subject|0
846304|NCT00392015|1804150|FG001|Overall Study|Withdrawal by Subject|0
846305|NCT00392015|1804151|FG002|Overall Study|Withdrawal by Subject|2
846306|NCT00392015|1804152|FG003|Overall Study|Withdrawal by Subject|0
846307|NCT00392015|1804153|FG004|Overall Study|Withdrawal by Subject|0
846308|NCT00392015|1804154|FG005|Overall Study|Withdrawal by Subject|0
846309|NCT00392015|1804149|FG000|Overall Study|Adverse Event|0
846310|NCT00392015|1804150|FG001|Overall Study|Adverse Event|0
846311|NCT00392015|1804151|FG002|Overall Study|Adverse Event|0
846312|NCT00392015|1804152|FG003|Overall Study|Adverse Event|0
846313|NCT00392015|1804153|FG004|Overall Study|Adverse Event|1
846314|NCT00392015|1804154|FG005|Overall Study|Adverse Event|0
846315|NCT00392015|1804149|FG000|Overall Study|Previous trial recipient|0
846316|NCT00392015|1804150|FG001|Overall Study|Previous trial recipient|0
846317|NCT00392015|1804151|FG002|Overall Study|Previous trial recipient|0
846318|NCT00392015|1804152|FG003|Overall Study|Previous trial recipient|0
846319|NCT00392015|1804153|FG004|Overall Study|Previous trial recipient|1
846320|NCT00392015|1804154|FG005|Overall Study|Previous trial recipient|0
846321|NCT00392171|1804195|FG000|Overall Study|Did not meet inclusion criteria|4
846322|NCT00392171|1804195|FG000|Overall Study|Disease progression|101
846323|NCT00392197|1804201|FG000|Overall Study|Adverse Event|4
846324|NCT00392197|1804202|FG001|Overall Study|Adverse Event|12
846325|NCT00392197|1804201|FG000|Overall Study|Lack of Efficacy|3
846326|NCT00392197|1804202|FG001|Overall Study|Lack of Efficacy|4
846327|NCT00392197|1804201|FG000|Overall Study|Lost to Follow-up|0
846328|NCT00392197|1804202|FG001|Overall Study|Lost to Follow-up|1
846329|NCT00392197|1804201|FG000|Overall Study|Physician Decision|3
846330|NCT00392197|1804202|FG001|Overall Study|Physician Decision|2
846331|NCT00392197|1804201|FG000|Overall Study|Protocol Violation|7
846332|NCT00392197|1804202|FG001|Overall Study|Protocol Violation|5
846333|NCT00392197|1804201|FG000|Overall Study|Withdrawal by Subject|4
846334|NCT00392197|1804202|FG001|Overall Study|Withdrawal by Subject|6
846335|NCT00392210|1804210|FG000|First Voiding Trial|Physician Decision|2
846336|NCT00392210|1804211|FG001|First Voiding Trial|Physician Decision|2
846337|NCT00392223|1804219|FG000|Overall Study|Adverse Event|5
846338|NCT00392223|1804220|FG001|Overall Study|Adverse Event|4
846339|NCT00392223|1804219|FG000|Overall Study|Lost to Follow-up|1
846340|NCT00392223|1804220|FG001|Overall Study|Lost to Follow-up|4
846341|NCT00392223|1804219|FG000|Overall Study|Protocol Violation|0
846342|NCT00392223|1804220|FG001|Overall Study|Protocol Violation|3
846343|NCT00392223|1804219|FG000|Overall Study|Withdrawal by Subject|3
846344|NCT00392223|1804220|FG001|Overall Study|Withdrawal by Subject|2
846345|NCT00392288|1804238|FG000|Overall Study|Adverse Event|17
846346|NCT00392288|1804239|FG001|Overall Study|Adverse Event|7
846347|NCT00392288|1804240|FG002|Overall Study|Adverse Event|8
846348|NCT00392288|1804238|FG000|Overall Study|Lack of Efficacy|8
846349|NCT00392288|1804239|FG001|Overall Study|Lack of Efficacy|5
846350|NCT00392288|1804240|FG002|Overall Study|Lack of Efficacy|3
846351|NCT00392288|1804238|FG000|Overall Study|Protocol Violation|1
846352|NCT00392288|1804239|FG001|Overall Study|Protocol Violation|3
846353|NCT00392288|1804240|FG002|Overall Study|Protocol Violation|1
846354|NCT00392288|1804238|FG000|Overall Study|Lost to Follow-up|1
846355|NCT00392288|1804239|FG001|Overall Study|Lost to Follow-up|1
846356|NCT00392288|1804240|FG002|Overall Study|Lost to Follow-up|1
846357|NCT00392288|1804238|FG000|Overall Study|Withdrawal by Subject|1
846358|NCT00392288|1804239|FG001|Overall Study|Withdrawal by Subject|0
846359|NCT00392288|1804240|FG002|Overall Study|Withdrawal by Subject|2
846360|NCT00392288|1804238|FG000|Overall Study|Parent/legal guardian withdrawal|1
846361|NCT00392288|1804239|FG001|Overall Study|Parent/legal guardian withdrawal|2
846362|NCT00392288|1804240|FG002|Overall Study|Parent/legal guardian withdrawal|1
846363|NCT00392288|1804238|FG000|Overall Study|Other|3
846364|NCT00392288|1804239|FG001|Overall Study|Other|4
846365|NCT00392288|1804240|FG002|Overall Study|Other|1
846414|NCT00392379|1804283|FG000|Overall Study|Withdrawal by Subject|17
846415|NCT00392379|1804284|FG001|Overall Study|Withdrawal by Subject|28
846416|NCT00392379|1804283|FG000|Overall Study|Lost to Follow-up|4
846417|NCT00392379|1804284|FG001|Overall Study|Lost to Follow-up|9
846418|NCT00392379|1804283|FG000|Overall Study|Adverse Event|1
846419|NCT00392379|1804284|FG001|Overall Study|Adverse Event|1
846420|NCT00392665|1804304|FG000|Overall Study|Death|16
846421|NCT00392665|1804305|FG001|Overall Study|Death|14
846422|NCT00392665|1804304|FG000|Overall Study|Lost to Follow-up|1
846423|NCT00392665|1804305|FG001|Overall Study|Lost to Follow-up|1
846424|NCT00392769|1804341|FG000|Overall Study|Clinical Deterioration|9
846425|NCT00392769|1804341|FG000|Overall Study|Adverse Event|1
846426|NCT00392808|1804353|FG000|Overall Study|Lost to Follow-up|3
846427|NCT00392808|1804354|FG001|Overall Study|Lost to Follow-up|2
846428|NCT00392808|1804355|FG002|Overall Study|Lost to Follow-up|1
846429|NCT00392808|1804356|FG003|Overall Study|Lost to Follow-up|2
846430|NCT00392808|1804353|FG000|Overall Study|Unable to withdraw blood|3
846431|NCT00392808|1804354|FG001|Overall Study|Unable to withdraw blood|1
846432|NCT00392808|1804355|FG002|Overall Study|Unable to withdraw blood|1
846433|NCT00392808|1804356|FG003|Overall Study|Unable to withdraw blood|2
846434|NCT00392925|1804383|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
846435|NCT00392925|1804384|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
846436|NCT00392925|1804385|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
846437|NCT00392925|1804386|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
846438|NCT00392925|1804383|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
846439|NCT00392925|1804384|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
846440|NCT00392925|1804385|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
846441|NCT00392925|1804386|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
846442|NCT00392925|1804383|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
846443|NCT00392925|1804384|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
846444|NCT00392925|1804385|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
846445|NCT00392925|1804386|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
846446|NCT00392925|1804383|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
846447|NCT00392925|1804384|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
846448|NCT00392925|1804385|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
846449|NCT00392925|1804386|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
846450|NCT00392925|1804383|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
846451|NCT00392925|1804384|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
846452|NCT00392925|1804385|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
846453|NCT00392925|1804386|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
846454|NCT00392925|1804383|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0
846455|NCT00392925|1804384|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2
846456|NCT00392925|1804385|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6
846457|NCT00392925|1804386|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8
846458|NCT00392925|1804383|FG000|Randomization to Treatment Group Period|Adverse Event|0
846459|NCT00392925|1804384|FG001|Randomization to Treatment Group Period|Adverse Event|3
846460|NCT00392925|1804385|FG002|Randomization to Treatment Group Period|Adverse Event|3
846461|NCT00392925|1804386|FG003|Randomization to Treatment Group Period|Adverse Event|5
846462|NCT00392925|1804383|FG000|Randomization to Treatment Group Period|Protocol Violation|0
846463|NCT00392925|1804384|FG001|Randomization to Treatment Group Period|Protocol Violation|0
846464|NCT00392925|1804385|FG002|Randomization to Treatment Group Period|Protocol Violation|2
846465|NCT00392925|1804386|FG003|Randomization to Treatment Group Period|Protocol Violation|1
846466|NCT00392925|1804383|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0
846467|NCT00392925|1804384|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3
846468|NCT00392925|1804385|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8
846469|NCT00392925|1804386|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4
846470|NCT00392990|1804408|FG000|Treatment on Study|Adverse Event|3
846471|NCT00392990|1804409|FG001|Treatment on Study|Adverse Event|1
846472|NCT00392990|1804408|FG000|Follow up for 2 Years|Death|4
846473|NCT00392990|1804409|FG001|Follow up for 2 Years|Death|0
846474|NCT00393029|1804417|FG000|Overall Study|Not treated|0
846475|NCT00393029|1804418|FG001|Overall Study|Not treated|1
846476|NCT00393042|1804425|FG000|First Intervention|Withdrawal by Subject|1
846477|NCT00393042|1804426|FG001|First Intervention|Withdrawal by Subject|2
846478|NCT00393042|1804425|FG000|First Intervention|Lost to Follow-up|3
846479|NCT00393042|1804426|FG001|First Intervention|Lost to Follow-up|3
846480|NCT00393042|1804425|FG000|First Intervention|Protocol Violation|1
846481|NCT00393042|1804426|FG001|First Intervention|Protocol Violation|0
846482|NCT00393042|1804425|FG000|First Intervention|Adverse Event|0
846483|NCT00393042|1804426|FG001|First Intervention|Adverse Event|1
846484|NCT00393042|1804425|FG000|Second Intervetion|Adverse Event|0
846485|NCT00393042|1804426|FG001|Second Intervetion|Adverse Event|3
846486|NCT00393042|1804425|FG000|Second Intervetion|Withdrawal by Subject|0
846487|NCT00393042|1804426|FG001|Second Intervetion|Withdrawal by Subject|2
846488|NCT00393042|1804425|FG000|Second Intervetion|Lack of Efficacy|1
846489|NCT00393042|1804426|FG001|Second Intervetion|Lack of Efficacy|0
846490|NCT00393042|1804425|FG000|Second Intervetion|Lost to Follow-up|0
846491|NCT00393042|1804426|FG001|Second Intervetion|Lost to Follow-up|2
846492|NCT00393042|1804425|FG000|Second Intervetion|Protocol Violation|1
846493|NCT00393042|1804426|FG001|Second Intervetion|Protocol Violation|1
846494|NCT00393094|1804484|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
846495|NCT00393094|1804484|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
846496|NCT00393367|1804492|FG000|Overall Study|Protocol Violation|2
846497|NCT00393367|1804493|FG001|Overall Study|Protocol Violation|5
846498|NCT00393367|1804492|FG000|Overall Study|Withdrawal by Subject|0
846499|NCT00393367|1804493|FG001|Overall Study|Withdrawal by Subject|2
846500|NCT00393458|1804509|FG000|Overall Study|Adverse Event|35
846501|NCT00393458|1804510|FG001|Overall Study|Adverse Event|24
846502|NCT00393458|1804511|FG002|Overall Study|Adverse Event|40
846503|NCT00393458|1804512|FG003|Overall Study|Adverse Event|35
846504|NCT00393458|1804509|FG000|Overall Study|Subject withdrew consent|27
846505|NCT00393458|1804510|FG001|Overall Study|Subject withdrew consent|40
846506|NCT00393458|1804511|FG002|Overall Study|Subject withdrew consent|33
846507|NCT00393458|1804512|FG003|Overall Study|Subject withdrew consent|50
846508|NCT00393458|1804509|FG000|Overall Study|Unsatisfactory therapeutic effect|12
846509|NCT00393458|1804510|FG001|Overall Study|Unsatisfactory therapeutic effect|9
846510|NCT00393458|1804511|FG002|Overall Study|Unsatisfactory therapeutic effect|12
846511|NCT00393458|1804512|FG003|Overall Study|Unsatisfactory therapeutic effect|30
846512|NCT00393458|1804509|FG000|Overall Study|Protocol deviation|11
846513|NCT00393458|1804510|FG001|Overall Study|Protocol deviation|11
846514|NCT00393458|1804511|FG002|Overall Study|Protocol deviation|11
846515|NCT00393458|1804512|FG003|Overall Study|Protocol deviation|10
846516|NCT00393458|1804509|FG000|Overall Study|Administrative problems|7
846517|NCT00393458|1804510|FG001|Overall Study|Administrative problems|8
846518|NCT00393458|1804511|FG002|Overall Study|Administrative problems|5
846519|NCT00393458|1804512|FG003|Overall Study|Administrative problems|2
846520|NCT00393458|1804509|FG000|Overall Study|Lost to Follow-up|5
846521|NCT00393458|1804510|FG001|Overall Study|Lost to Follow-up|6
846522|NCT00393458|1804511|FG002|Overall Study|Lost to Follow-up|5
846523|NCT00393458|1804512|FG003|Overall Study|Lost to Follow-up|3
846524|NCT00393458|1804509|FG000|Overall Study|Abnormal laboratory value(s)|1
846525|NCT00393458|1804510|FG001|Overall Study|Abnormal laboratory value(s)|1
846526|NCT00393458|1804511|FG002|Overall Study|Abnormal laboratory value(s)|0
846527|NCT00393458|1804512|FG003|Overall Study|Abnormal laboratory value(s)|0
846528|NCT00393458|1804509|FG000|Overall Study|Death|1
846529|NCT00393458|1804510|FG001|Overall Study|Death|1
846530|NCT00393458|1804511|FG002|Overall Study|Death|5
846531|NCT00393458|1804512|FG003|Overall Study|Death|5
846532|NCT00393458|1804509|FG000|Overall Study|Abnormal test procedure result(s)|0
846533|NCT00393458|1804510|FG001|Overall Study|Abnormal test procedure result(s)|1
846534|NCT00393458|1804511|FG002|Overall Study|Abnormal test procedure result(s)|1
846535|NCT00393458|1804512|FG003|Overall Study|Abnormal test procedure result(s)|2
846536|NCT00393458|1804509|FG000|Overall Study|Subject no longer requires study drug|0
846537|NCT00393458|1804510|FG001|Overall Study|Subject no longer requires study drug|1
846538|NCT00393458|1804511|FG002|Overall Study|Subject no longer requires study drug|0
846539|NCT00393458|1804512|FG003|Overall Study|Subject no longer requires study drug|0
846540|NCT00393484|1804524|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
846541|NCT00393484|1804525|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
846542|NCT00393484|1804524|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
846543|NCT00393484|1804525|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
846544|NCT00393484|1804524|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
846545|NCT00393484|1804525|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
846546|NCT00393484|1804524|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
846547|NCT00393484|1804525|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
846548|NCT00393484|1804524|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
846549|NCT00393484|1804525|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
846550|NCT00393484|1804524|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
846551|NCT00393484|1804525|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
846552|NCT00393484|1804524|FG000|Open-label Period (Weeks 96 to 240)|Death|1
846553|NCT00393484|1804525|FG001|Open-label Period (Weeks 96 to 240)|Death|0
846554|NCT00393484|1804524|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
846555|NCT00393484|1804525|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
846556|NCT00393484|1804524|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2
846557|NCT00393484|1804525|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2
846558|NCT00393484|1804524|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
846559|NCT00393484|1804525|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
846560|NCT00393510|1804535|FG000|Overall Study|Physician Decision|3
846561|NCT00393510|1804536|FG001|Overall Study|Physician Decision|9
846562|NCT00393523|1804547|FG000|Overall Study|Lost to Follow-up|0
846563|NCT00393523|1804548|FG001|Overall Study|Lost to Follow-up|0
846564|NCT00393523|1804549|FG002|Overall Study|Lost to Follow-up|0
846565|NCT00393523|1804550|FG003|Overall Study|Lost to Follow-up|2
846566|NCT00393523|1804551|FG004|Overall Study|Lost to Follow-up|1
846567|NCT00393523|1804547|FG000|Overall Study|Protocol Violation|6
846568|NCT00393523|1804548|FG001|Overall Study|Protocol Violation|2
846569|NCT00393523|1804549|FG002|Overall Study|Protocol Violation|0
846570|NCT00393523|1804550|FG003|Overall Study|Protocol Violation|1
846571|NCT00393523|1804551|FG004|Overall Study|Protocol Violation|0
846572|NCT00393523|1804547|FG000|Overall Study|Withdrawal by Subject|6
846573|NCT00393523|1804548|FG001|Overall Study|Withdrawal by Subject|7
846574|NCT00393523|1804549|FG002|Overall Study|Withdrawal by Subject|2
846575|NCT00393523|1804550|FG003|Overall Study|Withdrawal by Subject|3
846576|NCT00393523|1804551|FG004|Overall Study|Withdrawal by Subject|0
846577|NCT00393523|1804547|FG000|Overall Study|Difficulties in specimen collection|0
846578|NCT00393523|1804548|FG001|Overall Study|Difficulties in specimen collection|0
846579|NCT00393523|1804549|FG002|Overall Study|Difficulties in specimen collection|1
846580|NCT00393523|1804550|FG003|Overall Study|Difficulties in specimen collection|0
846581|NCT00393523|1804551|FG004|Overall Study|Difficulties in specimen collection|0
846582|NCT00393523|1804547|FG000|Overall Study|Vaccine supply issue|0
846583|NCT00393523|1804548|FG001|Overall Study|Vaccine supply issue|0
846584|NCT00393523|1804549|FG002|Overall Study|Vaccine supply issue|1
846585|NCT00393523|1804550|FG003|Overall Study|Vaccine supply issue|0
846586|NCT00393523|1804551|FG004|Overall Study|Vaccine supply issue|0
846587|NCT00393705|1804564|FG000|Overall Study|Adverse Event|0
846588|NCT00393705|1804565|FG001|Overall Study|Adverse Event|2
846589|NCT00393705|1804564|FG000|Overall Study|Death|0
846590|NCT00393705|1804565|FG001|Overall Study|Death|1
846591|NCT00393705|1804564|FG000|Overall Study|Lost to Follow-up|2
846592|NCT00393705|1804565|FG001|Overall Study|Lost to Follow-up|2
846593|NCT00393705|1804564|FG000|Overall Study|Entry Criteria Not Met|10
846594|NCT00393705|1804565|FG001|Overall Study|Entry Criteria Not Met|10
846595|NCT00393705|1804564|FG000|Overall Study|Protocol Violation|4
846596|NCT00393705|1804565|FG001|Overall Study|Protocol Violation|3
846597|NCT00393705|1804564|FG000|Overall Study|Withdrawal by Subject|5
846598|NCT00393705|1804565|FG001|Overall Study|Withdrawal by Subject|3
846599|NCT00393705|1804564|FG000|Overall Study|Physician Decision|2
846600|NCT00393705|1804565|FG001|Overall Study|Physician Decision|2
846601|NCT00393718|1804573|FG000|Overall Study|Adverse Event|20
846602|NCT00393718|1804574|FG001|Overall Study|Adverse Event|8
846603|NCT00393718|1804573|FG000|Overall Study|Protocol Violation|1
846604|NCT00393718|1804574|FG001|Overall Study|Protocol Violation|2
846605|NCT00393718|1804573|FG000|Overall Study|Lack of Efficacy|10
846606|NCT00393718|1804574|FG001|Overall Study|Lack of Efficacy|9
846607|NCT00393718|1804573|FG000|Overall Study|Hypoglycaemia|3
846608|NCT00393718|1804574|FG001|Overall Study|Hypoglycaemia|2
846609|NCT00393718|1804573|FG000|Overall Study|Subject decision|5
846610|NCT00393718|1804574|FG001|Overall Study|Subject decision|0
846611|NCT00393718|1804573|FG000|Overall Study|Withdrawal of consent|2
846612|NCT00393718|1804574|FG001|Overall Study|Withdrawal of consent|1
846613|NCT00393718|1804573|FG000|Overall Study|Missed measurement|1
846614|NCT00393718|1804574|FG001|Overall Study|Missed measurement|0
846615|NCT00393718|1804573|FG000|Overall Study|Move|1
846616|NCT00393718|1804574|FG001|Overall Study|Move|0
846617|NCT00393848|1804593|FG000|Overall Study|Surgical schedule|0
846618|NCT00393848|1804594|FG001|Overall Study|Surgical schedule|0
846619|NCT00393848|1804595|FG002|Overall Study|Surgical schedule|0
846620|NCT00393848|1804596|FG003|Overall Study|Surgical schedule|1
846621|NCT00393848|1804593|FG000|Overall Study|Personal reasons|0
846622|NCT00393848|1804594|FG001|Overall Study|Personal reasons|0
846623|NCT00393848|1804595|FG002|Overall Study|Personal reasons|2
846624|NCT00393848|1804596|FG003|Overall Study|Personal reasons|0
846625|NCT00393861|1804607|FG000|Overall Study|Adverse Event|2
846626|NCT00393861|1804607|FG000|Overall Study|Disease Progression|24
846627|NCT00393887|1804629|FG000|Overall Study|Physician Decision|5
846628|NCT00393887|1804630|FG001|Overall Study|Physician Decision|0
846629|NCT00393887|1804629|FG000|Overall Study|Lost to Follow-up|11
846630|NCT00393887|1804630|FG001|Overall Study|Lost to Follow-up|9
846631|NCT00393913|1804636|FG000|Initial Assessment|diagnosed with other sleep disorder|21
846632|NCT00393913|1804636|FG000|Initial Assessment|Withdrawal by Subject|16
846633|NCT00393913|1804636|FG000|CPAP|Withdrawal by Subject|3
846634|NCT00393913|1804636|FG000|CPAP|Physician Decision|1
846635|NCT00393913|1804636|FG000|CPAP|TEchnical problem with CPAP|3
846636|NCT00393939|1804643|FG000|Overall Study|Protocol Violation|1
846637|NCT00393939|1804644|FG001|Overall Study|Protocol Violation|1
846638|NCT00393939|1804643|FG000|Overall Study|Lost to Follow-up|2
846639|NCT00393939|1804644|FG001|Overall Study|Lost to Follow-up|4
846640|NCT00393939|1804643|FG000|Overall Study|Death|10
846641|NCT00393939|1804644|FG001|Overall Study|Death|4
846642|NCT00393939|1804643|FG000|Overall Study|Sponsor|5
846643|NCT00393939|1804644|FG001|Overall Study|Sponsor|13
846644|NCT00393939|1804643|FG000|Overall Study|Objective progression or relapse|239
846645|NCT00393939|1804644|FG001|Overall Study|Objective progression or relapse|223
846646|NCT00393939|1804643|FG000|Overall Study|Withdrawal by Subject|2
846647|NCT00393939|1804644|FG001|Overall Study|Withdrawal by Subject|7
846648|NCT00393939|1804643|FG000|Overall Study|Other|37
846649|NCT00393939|1804644|FG001|Overall Study|Other|45
846650|NCT00394082|1804659|FG000|Overall Study|Unacceptable toxicity|15
846651|NCT00394082|1804659|FG000|Overall Study|Adverse Event|4
846652|NCT00394082|1804659|FG000|Overall Study|Physician Decision|4
846653|NCT00394082|1804659|FG000|Overall Study|Withdrawal by Subject|2
846654|NCT00394082|1804659|FG000|Overall Study|Other|1
846655|NCT00394095|1804665|FG000|Overall Study|Adverse Event|1
846656|NCT00394095|1804666|FG001|Overall Study|Adverse Event|0
846657|NCT00394212|1804675|FG000|Overall Study|Lost to Follow-up|3
846658|NCT00394212|1804676|FG001|Overall Study|Lost to Follow-up|0
846659|NCT00394212|1804675|FG000|Overall Study|Withdrawal by Subject|4
846660|NCT00394212|1804676|FG001|Overall Study|Withdrawal by Subject|1
846661|NCT00394251|1804684|FG000|Overall Study|Adverse Event|7
846662|NCT00394251|1804685|FG001|Overall Study|Adverse Event|5
846663|NCT00394251|1804684|FG000|Overall Study|Unacceptable Toxicity|20
846664|NCT00394251|1804685|FG001|Overall Study|Unacceptable Toxicity|18
846665|NCT00394251|1804684|FG000|Overall Study|Physician Decision|1
846666|NCT00394251|1804685|FG001|Overall Study|Physician Decision|1
846667|NCT00394251|1804684|FG000|Overall Study|Protocol Violation|0
846668|NCT00394251|1804685|FG001|Overall Study|Protocol Violation|1
846669|NCT00394251|1804684|FG000|Overall Study|Withdrawal by Subject|7
846670|NCT00394251|1804685|FG001|Overall Study|Withdrawal by Subject|11
846671|NCT00394251|1804684|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2
846672|NCT00394251|1804685|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2
846673|NCT00394355|1804739|FG000|Overall Study|Adverse Event|10
846674|NCT00394355|1804740|FG001|Overall Study|Adverse Event|6
846675|NCT00394355|1804741|FG002|Overall Study|Adverse Event|7
846676|NCT00394355|1804742|FG003|Overall Study|Adverse Event|8
846677|NCT00394355|1804739|FG000|Overall Study|Did not meet protocol eligibility|1
846678|NCT00394355|1804740|FG001|Overall Study|Did not meet protocol eligibility|5
846679|NCT00394355|1804741|FG002|Overall Study|Did not meet protocol eligibility|4
846680|NCT00394355|1804742|FG003|Overall Study|Did not meet protocol eligibility|2
846681|NCT00394355|1804739|FG000|Overall Study|Subject withdrawal - unrelated to drug|12
846682|NCT00394355|1804740|FG001|Overall Study|Subject withdrawal - unrelated to drug|14
846683|NCT00394355|1804741|FG002|Overall Study|Subject withdrawal - unrelated to drug|10
846684|NCT00394355|1804742|FG003|Overall Study|Subject withdrawal - unrelated to drug|6
846685|NCT00394355|1804739|FG000|Overall Study|Subject withdrawal - related to drug|1
846686|NCT00394355|1804740|FG001|Overall Study|Subject withdrawal - related to drug|0
846687|NCT00394355|1804741|FG002|Overall Study|Subject withdrawal - related to drug|0
846688|NCT00394355|1804742|FG003|Overall Study|Subject withdrawal - related to drug|0
846689|NCT00394355|1804739|FG000|Overall Study|Lost to Follow-up|7
846690|NCT00394355|1804740|FG001|Overall Study|Lost to Follow-up|5
846691|NCT00394355|1804741|FG002|Overall Study|Lost to Follow-up|4
846692|NCT00394355|1804742|FG003|Overall Study|Lost to Follow-up|3
846693|NCT00394355|1804739|FG000|Overall Study|Noncompliance with protocol|4
846694|NCT00394355|1804740|FG001|Overall Study|Noncompliance with protocol|3
846695|NCT00394355|1804741|FG002|Overall Study|Noncompliance with protocol|10
846696|NCT00394355|1804742|FG003|Overall Study|Noncompliance with protocol|8
846697|NCT00394355|1804739|FG000|Overall Study|Administrative|0
846698|NCT00394355|1804740|FG001|Overall Study|Administrative|1
846699|NCT00394355|1804741|FG002|Overall Study|Administrative|1
846700|NCT00394355|1804742|FG003|Overall Study|Administrative|1
846701|NCT00394355|1804739|FG000|Overall Study|Lack of Efficacy|0
846702|NCT00394355|1804740|FG001|Overall Study|Lack of Efficacy|0
846703|NCT00394355|1804741|FG002|Overall Study|Lack of Efficacy|2
846704|NCT00394355|1804742|FG003|Overall Study|Lack of Efficacy|3
846705|NCT00394433|1804752|FG000|Overall Study|Adverse Event|2
846706|NCT00394433|1804752|FG000|Overall Study|Alternative Therapy|1
846707|NCT00394472|1804758|FG000|Overall Study|Protocol Violation|1
846708|NCT00394472|1804759|FG001|Overall Study|Protocol Violation|3
846709|NCT00394472|1804758|FG000|Overall Study|incorrect enrolment|4
846710|NCT00394472|1804759|FG001|Overall Study|incorrect enrolment|2
846711|NCT00394472|1804758|FG000|Overall Study|Adverse Event|4
846712|NCT00394472|1804759|FG001|Overall Study|Adverse Event|2
846713|NCT00394472|1804758|FG000|Overall Study|Withdrawal by Subject|0
846714|NCT00394472|1804759|FG001|Overall Study|Withdrawal by Subject|2
846715|NCT00394472|1804758|FG000|Overall Study|Physician Decision|0
846716|NCT00394472|1804759|FG001|Overall Study|Physician Decision|1
846717|NCT00394472|1804758|FG000|Overall Study|Lost to Follow-up|0
846718|NCT00394472|1804759|FG001|Overall Study|Lost to Follow-up|1
846719|NCT00394524|1804767|FG000|Overall Study|Protocol Violation|2
846720|NCT00394524|1804768|FG001|Overall Study|Protocol Violation|3
846721|NCT00394524|1804767|FG000|Overall Study|Death|1
846722|NCT00394524|1804768|FG001|Overall Study|Death|0
846723|NCT00394524|1804767|FG000|Overall Study|Withdrawal by Subject|0
846724|NCT00394524|1804768|FG001|Overall Study|Withdrawal by Subject|1
846725|NCT00394589|1804779|FG000|Overall Study|Adverse Event|2
846726|NCT00394589|1804780|FG001|Overall Study|Adverse Event|1
846727|NCT00394589|1804781|FG002|Overall Study|Adverse Event|2
846728|NCT00394589|1804779|FG000|Overall Study|Lack of Efficacy|2
846729|NCT00394589|1804780|FG001|Overall Study|Lack of Efficacy|2
846730|NCT00394589|1804781|FG002|Overall Study|Lack of Efficacy|3
846731|NCT00394589|1804779|FG000|Overall Study|Protocol Violation|4
846732|NCT00394589|1804780|FG001|Overall Study|Protocol Violation|0
846733|NCT00394589|1804781|FG002|Overall Study|Protocol Violation|2
846734|NCT00394654|1804791|FG000|Overall Study|Lost to Follow-up|1
846735|NCT00394654|1804792|FG001|Overall Study|Lost to Follow-up|0
846736|NCT00394654|1804791|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1
846737|NCT00394654|1804792|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0
846738|NCT00394706|1804806|FG000|Overall Study|Withdrawal by Subject|2
846739|NCT00394706|1804807|FG001|Overall Study|Withdrawal by Subject|0
846740|NCT00394706|1804808|FG002|Overall Study|Withdrawal by Subject|1
846741|NCT00394706|1804809|FG003|Overall Study|Withdrawal by Subject|0
846742|NCT00394706|1804810|FG004|Overall Study|Withdrawal by Subject|0
846743|NCT00394706|1804811|FG005|Overall Study|Withdrawal by Subject|2
846744|NCT00394706|1804812|FG006|Overall Study|Withdrawal by Subject|1
846745|NCT00394706|1804813|FG007|Overall Study|Withdrawal by Subject|0
846746|NCT00394706|1804806|FG000|Overall Study|Lost to Follow-up|2
846747|NCT00394706|1804807|FG001|Overall Study|Lost to Follow-up|2
846748|NCT00394706|1804808|FG002|Overall Study|Lost to Follow-up|8
846749|NCT00394706|1804809|FG003|Overall Study|Lost to Follow-up|1
846750|NCT00394706|1804810|FG004|Overall Study|Lost to Follow-up|2
846751|NCT00394706|1804811|FG005|Overall Study|Lost to Follow-up|5
846752|NCT00394706|1804812|FG006|Overall Study|Lost to Follow-up|2
846753|NCT00394706|1804813|FG007|Overall Study|Lost to Follow-up|0
846754|NCT00394771|1804831|FG000|Overall Study|Did not meet protocol requirements|1
846755|NCT00394771|1804832|FG001|Overall Study|Did not meet protocol requirements|0
846756|NCT00394771|1804833|FG002|Overall Study|Did not meet protocol requirements|2
846757|NCT00394771|1804834|FG003|Overall Study|Did not meet protocol requirements|0
846758|NCT00394771|1804831|FG000|Overall Study|Protocol Violation|2
846759|NCT00394771|1804832|FG001|Overall Study|Protocol Violation|4
846760|NCT00394771|1804833|FG002|Overall Study|Protocol Violation|9
846761|NCT00394771|1804834|FG003|Overall Study|Protocol Violation|7
846762|NCT00394771|1804831|FG000|Overall Study|Withdrawal by Subject|10
846763|NCT00394771|1804832|FG001|Overall Study|Withdrawal by Subject|6
846764|NCT00394771|1804833|FG002|Overall Study|Withdrawal by Subject|8
846765|NCT00394771|1804834|FG003|Overall Study|Withdrawal by Subject|12
846766|NCT00394771|1804831|FG000|Overall Study|Adverse Event|10
846767|NCT00394771|1804832|FG001|Overall Study|Adverse Event|5
846768|NCT00394771|1804833|FG002|Overall Study|Adverse Event|12
846769|NCT00394771|1804834|FG003|Overall Study|Adverse Event|8
846770|NCT00394771|1804831|FG000|Overall Study|Participant pregnant|0
846771|NCT00394771|1804832|FG001|Overall Study|Participant pregnant|1
846772|NCT00394771|1804833|FG002|Overall Study|Participant pregnant|2
846773|NCT00394771|1804834|FG003|Overall Study|Participant pregnant|2
846774|NCT00394771|1804831|FG000|Overall Study|Lost to Follow-up|15
846775|NCT00394771|1804832|FG001|Overall Study|Lost to Follow-up|15
846776|NCT00394771|1804833|FG002|Overall Study|Lost to Follow-up|13
846777|NCT00394771|1804834|FG003|Overall Study|Lost to Follow-up|10
846778|NCT00394771|1804831|FG000|Overall Study|Other|3
846779|NCT00394771|1804832|FG001|Overall Study|Other|3
846780|NCT00394771|1804833|FG002|Overall Study|Other|1
846781|NCT00394771|1804834|FG003|Overall Study|Other|0
846782|NCT00394836|1804846|FG000|Teatment or Follow-up Phase|Adverse Event|0
846783|NCT00394836|1804847|FG001|Teatment or Follow-up Phase|Adverse Event|2
846784|NCT00394836|1804846|FG000|Teatment or Follow-up Phase|Protocol Violation|0
846785|NCT00394836|1804847|FG001|Teatment or Follow-up Phase|Protocol Violation|2
846786|NCT00394836|1804846|FG000|Teatment or Follow-up Phase|Disease Progression|27
846787|NCT00394836|1804847|FG001|Teatment or Follow-up Phase|Disease Progression|60
846788|NCT00394836|1804846|FG000|Teatment or Follow-up Phase|Patient Refusal|1
846789|NCT00394836|1804847|FG001|Teatment or Follow-up Phase|Patient Refusal|2
846790|NCT00394836|1804846|FG000|Teatment or Follow-up Phase|Death|0
846791|NCT00394836|1804847|FG001|Teatment or Follow-up Phase|Death|1
846792|NCT00394836|1804846|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
846793|NCT00394836|1804847|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
846794|NCT00394836|1804846|FG000|Teatment or Follow-up Phase|Started alternative treatment|0
846795|NCT00394836|1804847|FG001|Teatment or Follow-up Phase|Started alternative treatment|6
846796|NCT00394836|1804846|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
846797|NCT00394836|1804847|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
846798|NCT00394836|1804846|FG000|Teatment or Follow-up Phase|Physician Decision|0
846799|NCT00394836|1804847|FG001|Teatment or Follow-up Phase|Physician Decision|1
846800|NCT00394836|1804846|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
846801|NCT00394836|1804847|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
846802|NCT00394836|1804846|FG000|Teatment or Follow-up Phase|Non compliance|0
846803|NCT00394836|1804847|FG001|Teatment or Follow-up Phase|Non compliance|1
846804|NCT00394836|1804846|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
846805|NCT00394836|1804847|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
846806|NCT00394836|1804846|FG000|Extended Follow-up Phase (2-5 Years)|Death|0
846807|NCT00394836|1804847|FG001|Extended Follow-up Phase (2-5 Years)|Death|1
846808|NCT00394836|1804846|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
846809|NCT00394836|1804847|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
846810|NCT00394836|1804846|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
846811|NCT00394836|1804847|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
846812|NCT00394901|1804870|FG000|Baseline Phase|Protocol Violation|0
846813|NCT00394901|1804871|FG001|Baseline Phase|Protocol Violation|0
846814|NCT00394901|1804872|FG002|Baseline Phase|Protocol Violation|1
846815|NCT00394901|1804873|FG003|Baseline Phase|Protocol Violation|0
846816|NCT00394901|1804870|FG000|Double-blind Phase|Adverse Event|5
846817|NCT00394901|1804871|FG001|Double-blind Phase|Adverse Event|7
846818|NCT00394901|1804872|FG002|Double-blind Phase|Adverse Event|16
846819|NCT00394901|1804873|FG003|Double-blind Phase|Adverse Event|20
846820|NCT00394901|1804870|FG000|Double-blind Phase|Lack of Efficacy|6
846821|NCT00394901|1804871|FG001|Double-blind Phase|Lack of Efficacy|4
846822|NCT00394901|1804872|FG002|Double-blind Phase|Lack of Efficacy|1
846823|NCT00394901|1804873|FG003|Double-blind Phase|Lack of Efficacy|3
846824|NCT00394901|1804870|FG000|Double-blind Phase|Withdrawal by Subject|2
846825|NCT00394901|1804871|FG001|Double-blind Phase|Withdrawal by Subject|0
846826|NCT00394901|1804872|FG002|Double-blind Phase|Withdrawal by Subject|0
846827|NCT00394901|1804873|FG003|Double-blind Phase|Withdrawal by Subject|0
846828|NCT00394901|1804870|FG000|Double-blind Phase|Lost to Follow-up|0
846829|NCT00394901|1804871|FG001|Double-blind Phase|Lost to Follow-up|0
846830|NCT00394901|1804872|FG002|Double-blind Phase|Lost to Follow-up|0
846831|NCT00394901|1804873|FG003|Double-blind Phase|Lost to Follow-up|1
846832|NCT00394901|1804870|FG000|Double-blind Phase|Protocol Violation|0
846833|NCT00394901|1804871|FG001|Double-blind Phase|Protocol Violation|0
846834|NCT00394901|1804872|FG002|Double-blind Phase|Protocol Violation|0
846835|NCT00394901|1804873|FG003|Double-blind Phase|Protocol Violation|1
846836|NCT00394901|1804870|FG000|Double-blind Phase|Death|1
846837|NCT00394901|1804871|FG001|Double-blind Phase|Death|0
846838|NCT00394901|1804872|FG002|Double-blind Phase|Death|0
846839|NCT00394901|1804873|FG003|Double-blind Phase|Death|0
846840|NCT00394901|1804870|FG000|Double-blind Phase|Subject's Personal Reason|1
846841|NCT00394901|1804871|FG001|Double-blind Phase|Subject's Personal Reason|0
846842|NCT00394901|1804872|FG002|Double-blind Phase|Subject's Personal Reason|0
846843|NCT00394901|1804873|FG003|Double-blind Phase|Subject's Personal Reason|1
846844|NCT00394901|1804870|FG000|Double-blind Phase|Lack of Compliance|0
846845|NCT00394901|1804871|FG001|Double-blind Phase|Lack of Compliance|3
846846|NCT00394901|1804872|FG002|Double-blind Phase|Lack of Compliance|0
846847|NCT00394901|1804873|FG003|Double-blind Phase|Lack of Compliance|0
846848|NCT00394901|1804870|FG000|Double-blind Phase|Entry into another study was found|0
846849|NCT00394901|1804871|FG001|Double-blind Phase|Entry into another study was found|0
846850|NCT00394901|1804872|FG002|Double-blind Phase|Entry into another study was found|1
846851|NCT00394901|1804873|FG003|Double-blind Phase|Entry into another study was found|0
846852|NCT00394901|1804870|FG000|Double-blind Phase|Found not to meet entrance criteria|0
846853|NCT00394901|1804871|FG001|Double-blind Phase|Found not to meet entrance criteria|0
846854|NCT00394901|1804872|FG002|Double-blind Phase|Found not to meet entrance criteria|0
846855|NCT00394901|1804873|FG003|Double-blind Phase|Found not to meet entrance criteria|1
846856|NCT00394914|1804888|FG000|Treatment Period|Adverse Event|0
846857|NCT00394914|1804889|FG001|Treatment Period|Adverse Event|3
846858|NCT00394914|1804890|FG002|Treatment Period|Adverse Event|1
846859|NCT00394914|1804888|FG000|Treatment Period|Lost to Follow-up|0
846860|NCT00394914|1804889|FG001|Treatment Period|Lost to Follow-up|1
846861|NCT00394914|1804890|FG002|Treatment Period|Lost to Follow-up|0
846862|NCT00394914|1804888|FG000|Treatment Period|Withdrawal by Subject|0
846863|NCT00394914|1804889|FG001|Treatment Period|Withdrawal by Subject|2
846864|NCT00394914|1804890|FG002|Treatment Period|Withdrawal by Subject|2
846865|NCT00394914|1804888|FG000|Treatment Period|Noncompliance with protocol|0
846866|NCT00394914|1804889|FG001|Treatment Period|Noncompliance with protocol|3
846867|NCT00394914|1804890|FG002|Treatment Period|Noncompliance with protocol|2
846868|NCT00394914|1804888|FG000|Treatment Period|Did not meet protocol eligibility|0
846869|NCT00394914|1804889|FG001|Treatment Period|Did not meet protocol eligibility|1
846870|NCT00394914|1804890|FG002|Treatment Period|Did not meet protocol eligibility|1
846871|NCT00394953|1804898|FG000|First Treatment Period|Adverse Event|1
846872|NCT00394953|1804899|FG001|First Treatment Period|Adverse Event|2
846873|NCT00394953|1804898|FG000|First Treatment Period|Death|6
846874|NCT00394953|1804899|FG001|First Treatment Period|Death|7
846875|NCT00394953|1804898|FG000|First Treatment Period|Lack of Efficacy|1
846876|NCT00394953|1804899|FG001|First Treatment Period|Lack of Efficacy|1
846877|NCT00394953|1804898|FG000|First Treatment Period|Withdrawal by Subject|6
846878|NCT00394953|1804899|FG001|First Treatment Period|Withdrawal by Subject|3
846879|NCT00394953|1804898|FG000|First Treatment Period|Lost to Follow-up|0
846880|NCT00394953|1804899|FG001|First Treatment Period|Lost to Follow-up|1
846881|NCT00394953|1804898|FG000|First Treatment Period|Renal transplant|11
846882|NCT00394953|1804899|FG001|First Treatment Period|Renal transplant|7
846883|NCT00394953|1804898|FG000|First Treatment Period|Not defined|4
846884|NCT00394953|1804899|FG001|First Treatment Period|Not defined|1
846885|NCT00394953|1804898|FG000|Second Treatment Period|Adverse Event|2
846886|NCT00394953|1804899|FG001|Second Treatment Period|Adverse Event|5
846887|NCT00394953|1804898|FG000|Second Treatment Period|Death|8
846888|NCT00394953|1804899|FG001|Second Treatment Period|Death|4
846889|NCT00394953|1804898|FG000|Second Treatment Period|Lack of Efficacy|9
846890|NCT00394953|1804899|FG001|Second Treatment Period|Lack of Efficacy|47
846891|NCT00394953|1804898|FG000|Second Treatment Period|Withdrawal by Subject|3
846892|NCT00394953|1804899|FG001|Second Treatment Period|Withdrawal by Subject|3
846893|NCT00394953|1804898|FG000|Second Treatment Period|Lost to Follow-up|0
846894|NCT00394953|1804899|FG001|Second Treatment Period|Lost to Follow-up|1
846895|NCT00394953|1804898|FG000|Second Treatment Period|Renal transplant|4
846896|NCT00394953|1804899|FG001|Second Treatment Period|Renal transplant|6
846897|NCT00394953|1804898|FG000|Second Treatment Period|Not defined|3
846898|NCT00394953|1804899|FG001|Second Treatment Period|Not defined|8
846899|NCT00395018|1804905|FG000|On-Treatment|Death|4
846900|NCT00395018|1804905|FG000|On-Treatment|Other Reason|2
846901|NCT00395018|1804905|FG000|On-Treatment|Poor/non-compliance|2
846902|NCT00395018|1804905|FG000|On-Treatment|Subject no longer meets study criteria|2
846903|NCT00395018|1804905|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1
846904|NCT00395018|1804905|FG000|Off-Treatment Follow-up|Lost to Follow-up|2
846905|NCT00395018|1804905|FG000|Off-Treatment Follow-up|Poor/non-compliance|1
846906|NCT00395083|1804937|FG000|Overall Study|Withdrawal by Subject|6
846907|NCT00395083|1804938|FG001|Overall Study|Withdrawal by Subject|5
846908|NCT00395083|1804937|FG000|Overall Study|Developed another disease|4
846909|NCT00395083|1804938|FG001|Overall Study|Developed another disease|3
846910|NCT00395226|1804977|FG000|Overall Study|Adverse Event|4
846911|NCT00395226|1804978|FG001|Overall Study|Adverse Event|3
846912|NCT00395226|1804977|FG000|Overall Study|Withdrawal by Subject|0
846913|NCT00395226|1804978|FG001|Overall Study|Withdrawal by Subject|1
846914|NCT00395226|1804977|FG000|Overall Study|Lost to Follow-up|0
846915|NCT00395226|1804978|FG001|Overall Study|Lost to Follow-up|1
846916|NCT00395304|1804991|FG000|Treatment Period 1|Withdrawal by Subject|0
846917|NCT00395304|1804992|FG001|Treatment Period 1|Withdrawal by Subject|3
846918|NCT00395304|1804993|FG002|Treatment Period 1|Withdrawal by Subject|0
846919|NCT00395304|1804994|FG003|Treatment Period 1|Withdrawal by Subject|2
846920|NCT00395304|1804995|FG004|Treatment Period 1|Withdrawal by Subject|1
846921|NCT00395304|1804996|FG005|Treatment Period 1|Withdrawal by Subject|1
846922|NCT00395304|1804991|FG000|Treatment Period 1|Lost to Follow-up|1
846923|NCT00395304|1804992|FG001|Treatment Period 1|Lost to Follow-up|0
846924|NCT00395304|1804993|FG002|Treatment Period 1|Lost to Follow-up|0
846925|NCT00395304|1804994|FG003|Treatment Period 1|Lost to Follow-up|1
846926|NCT00395304|1804995|FG004|Treatment Period 1|Lost to Follow-up|0
846927|NCT00395304|1804996|FG005|Treatment Period 1|Lost to Follow-up|1
846928|NCT00395304|1804991|FG000|Treatment Period 1|Physician Decision|0
846929|NCT00395304|1804992|FG001|Treatment Period 1|Physician Decision|1
846930|NCT00395304|1804993|FG002|Treatment Period 1|Physician Decision|0
846931|NCT00395304|1804994|FG003|Treatment Period 1|Physician Decision|0
846932|NCT00395304|1804995|FG004|Treatment Period 1|Physician Decision|0
846933|NCT00395304|1804996|FG005|Treatment Period 1|Physician Decision|0
846934|NCT00395304|1804991|FG000|Treatment Period 2|Withdrawal by Subject|0
846935|NCT00395304|1804992|FG001|Treatment Period 2|Withdrawal by Subject|0
846936|NCT00395304|1804993|FG002|Treatment Period 2|Withdrawal by Subject|0
846937|NCT00395304|1804994|FG003|Treatment Period 2|Withdrawal by Subject|1
846938|NCT00395304|1804995|FG004|Treatment Period 2|Withdrawal by Subject|0
846939|NCT00395304|1804996|FG005|Treatment Period 2|Withdrawal by Subject|2
846940|NCT00395304|1804991|FG000|Treatment Period 2|Lost to Follow-up|0
846941|NCT00395304|1804992|FG001|Treatment Period 2|Lost to Follow-up|3
846942|NCT00395304|1804993|FG002|Treatment Period 2|Lost to Follow-up|0
846943|NCT00395304|1804994|FG003|Treatment Period 2|Lost to Follow-up|0
846944|NCT00395304|1804995|FG004|Treatment Period 2|Lost to Follow-up|0
846945|NCT00395304|1804996|FG005|Treatment Period 2|Lost to Follow-up|0
846946|NCT00395304|1804991|FG000|Treatment Period 2|Physician Decision|0
846947|NCT00395304|1804992|FG001|Treatment Period 2|Physician Decision|0
846948|NCT00395304|1804993|FG002|Treatment Period 2|Physician Decision|1
846949|NCT00395304|1804994|FG003|Treatment Period 2|Physician Decision|0
846950|NCT00395304|1804995|FG004|Treatment Period 2|Physician Decision|0
846951|NCT00395304|1804996|FG005|Treatment Period 2|Physician Decision|0
846952|NCT00395304|1804991|FG000|Treatment Period 2|Other|0
846953|NCT00395304|1804992|FG001|Treatment Period 2|Other|1
846954|NCT00395304|1804993|FG002|Treatment Period 2|Other|0
846955|NCT00395304|1804994|FG003|Treatment Period 2|Other|0
846956|NCT00395304|1804995|FG004|Treatment Period 2|Other|0
846957|NCT00395304|1804996|FG005|Treatment Period 2|Other|0
846958|NCT00395304|1804991|FG000|Treatment Period 3|Withdrawal by Subject|0
846959|NCT00395304|1804992|FG001|Treatment Period 3|Withdrawal by Subject|0
846960|NCT00395304|1804993|FG002|Treatment Period 3|Withdrawal by Subject|0
846961|NCT00395304|1804994|FG003|Treatment Period 3|Withdrawal by Subject|1
846962|NCT00395304|1804995|FG004|Treatment Period 3|Withdrawal by Subject|0
846963|NCT00395304|1804996|FG005|Treatment Period 3|Withdrawal by Subject|1
846964|NCT00395304|1804991|FG000|Treatment Period 3|Lost to Follow-up|1
846965|NCT00395304|1804992|FG001|Treatment Period 3|Lost to Follow-up|1
846966|NCT00395304|1804993|FG002|Treatment Period 3|Lost to Follow-up|0
846967|NCT00395304|1804994|FG003|Treatment Period 3|Lost to Follow-up|0
846968|NCT00395304|1804995|FG004|Treatment Period 3|Lost to Follow-up|0
846969|NCT00395304|1804996|FG005|Treatment Period 3|Lost to Follow-up|0
846970|NCT00395304|1804991|FG000|Treatment Period 3|Physician Decision|0
846971|NCT00395304|1804992|FG001|Treatment Period 3|Physician Decision|1
846972|NCT00395304|1804993|FG002|Treatment Period 3|Physician Decision|0
846973|NCT00395304|1804994|FG003|Treatment Period 3|Physician Decision|0
846974|NCT00395304|1804995|FG004|Treatment Period 3|Physician Decision|0
846975|NCT00395304|1804996|FG005|Treatment Period 3|Physician Decision|0
846976|NCT00395304|1804991|FG000|Treatment Period 3|Other|0
846977|NCT00395304|1804992|FG001|Treatment Period 3|Other|0
846978|NCT00395304|1804993|FG002|Treatment Period 3|Other|0
846979|NCT00395304|1804994|FG003|Treatment Period 3|Other|1
846980|NCT00395304|1804995|FG004|Treatment Period 3|Other|0
846981|NCT00395304|1804996|FG005|Treatment Period 3|Other|0
846982|NCT00395343|1805005|FG000|Overall Study|Adverse Event|13
846983|NCT00395343|1805006|FG001|Overall Study|Adverse Event|5
846984|NCT00395343|1805005|FG000|Overall Study|Lack of Efficacy|0
846985|NCT00395343|1805006|FG001|Overall Study|Lack of Efficacy|1
846986|NCT00395343|1805005|FG000|Overall Study|Lost to Follow-up|4
846987|NCT00395343|1805006|FG001|Overall Study|Lost to Follow-up|4
846988|NCT00395343|1805005|FG000|Overall Study|Physician Decision|2
846989|NCT00395343|1805006|FG001|Overall Study|Physician Decision|4
846990|NCT00395343|1805005|FG000|Overall Study|Protocol Violation|6
846991|NCT00395343|1805006|FG001|Overall Study|Protocol Violation|8
846992|NCT00395343|1805005|FG000|Overall Study|Withdrawal by Subject|11
846993|NCT00395343|1805006|FG001|Overall Study|Withdrawal by Subject|12
846994|NCT00395343|1805005|FG000|Overall Study|Other|5
846995|NCT00395343|1805006|FG001|Overall Study|Other|2
846996|NCT00395447|1805014|FG000|Overall Study|Death|37
846997|NCT00395447|1805015|FG001|Overall Study|Death|32
846998|NCT00395447|1805014|FG000|Overall Study|Lost to Follow-up|52
846999|NCT00395447|1805015|FG001|Overall Study|Lost to Follow-up|43
847000|NCT00395447|1805014|FG000|Overall Study|Withdrawal by Subject|24
847001|NCT00395447|1805015|FG001|Overall Study|Withdrawal by Subject|19
847002|NCT00395447|1805014|FG000|Overall Study|Withdrawl - Other (not subject)|8
847003|NCT00395447|1805015|FG001|Overall Study|Withdrawl - Other (not subject)|17
847004|NCT00395460|1805023|FG000|Overall Study|Withdrawal by Subject|1
847005|NCT00395460|1805024|FG001|Overall Study|Withdrawal by Subject|0
847006|NCT00395486|1805032|FG000|Overall Study|Adverse Event|1
847007|NCT00395486|1805033|FG001|Overall Study|Adverse Event|2
847008|NCT00395486|1805032|FG000|Overall Study|Withdrawal by Subject|5
847009|NCT00395486|1805033|FG001|Overall Study|Withdrawal by Subject|2
847010|NCT00395486|1805032|FG000|Overall Study|Lost to Follow-up|0
847011|NCT00395486|1805033|FG001|Overall Study|Lost to Follow-up|1
847012|NCT00395512|1805043|FG000|Overall Study|Adverse Event|3
847013|NCT00395512|1805044|FG001|Overall Study|Adverse Event|8
847014|NCT00395512|1805045|FG002|Overall Study|Adverse Event|6
847015|NCT00395512|1805046|FG003|Overall Study|Adverse Event|6
847016|NCT00395512|1805043|FG000|Overall Study|Protocol Violation|2
847017|NCT00395512|1805044|FG001|Overall Study|Protocol Violation|3
847018|NCT00395512|1805045|FG002|Overall Study|Protocol Violation|6
847019|NCT00395512|1805046|FG003|Overall Study|Protocol Violation|7
847020|NCT00395512|1805043|FG000|Overall Study|Lost to Follow-up|2
847021|NCT00395512|1805044|FG001|Overall Study|Lost to Follow-up|6
847022|NCT00395512|1805045|FG002|Overall Study|Lost to Follow-up|5
847023|NCT00395512|1805046|FG003|Overall Study|Lost to Follow-up|5
847024|NCT00395512|1805043|FG000|Overall Study|Withdrawal by Subject|6
847025|NCT00395512|1805044|FG001|Overall Study|Withdrawal by Subject|5
847026|NCT00395512|1805045|FG002|Overall Study|Withdrawal by Subject|5
847027|NCT00395512|1805046|FG003|Overall Study|Withdrawal by Subject|12
847028|NCT00395512|1805043|FG000|Overall Study|Physician Decision|6
847029|NCT00395512|1805044|FG001|Overall Study|Physician Decision|4
847030|NCT00395512|1805045|FG002|Overall Study|Physician Decision|2
847031|NCT00395512|1805046|FG003|Overall Study|Physician Decision|2
847032|NCT00395512|1805043|FG000|Overall Study|Other|1
847033|NCT00395512|1805044|FG001|Overall Study|Other|1
847034|NCT00395512|1805045|FG002|Overall Study|Other|0
847035|NCT00395512|1805046|FG003|Overall Study|Other|0
847036|NCT00395512|1805043|FG000|Overall Study|Hyperglycemic Rescue|18
847037|NCT00395512|1805044|FG001|Overall Study|Hyperglycemic Rescue|10
847038|NCT00395512|1805045|FG002|Overall Study|Hyperglycemic Rescue|4
847039|NCT00395512|1805046|FG003|Overall Study|Hyperglycemic Rescue|6
847040|NCT00395538|1805059|FG000|Overall Study|Did not re-consent to revised protocol|1
847041|NCT00395538|1805060|FG001|Overall Study|Did not re-consent to revised protocol|10
847042|NCT00395538|1805061|FG002|Overall Study|Did not re-consent to revised protocol|0
847043|NCT00395538|1805059|FG000|Overall Study|FDA partial hold on PTH|0
847044|NCT00395538|1805060|FG001|Overall Study|FDA partial hold on PTH|0
847045|NCT00395538|1805061|FG002|Overall Study|FDA partial hold on PTH|11
847046|NCT00395538|1805059|FG000|Overall Study|Failed screening|0
847047|NCT00395538|1805060|FG001|Overall Study|Failed screening|0
847048|NCT00395538|1805061|FG002|Overall Study|Failed screening|4
847049|NCT00395538|1805059|FG000|Overall Study|Switch to Natpara|0
847050|NCT00395538|1805060|FG001|Overall Study|Switch to Natpara|0
847051|NCT00395538|1805061|FG002|Overall Study|Switch to Natpara|3
847052|NCT00395538|1805059|FG000|Overall Study|Adverse Event|1
847053|NCT00395538|1805060|FG001|Overall Study|Adverse Event|0
847054|NCT00395538|1805061|FG002|Overall Study|Adverse Event|2
847055|NCT00395538|1805059|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0
847056|NCT00395538|1805060|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2
847057|NCT00395538|1805061|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0
847058|NCT00395538|1805059|FG000|Overall Study|Non-compliance with study protocol|0
847059|NCT00395538|1805060|FG001|Overall Study|Non-compliance with study protocol|1
847060|NCT00395538|1805061|FG002|Overall Study|Non-compliance with study protocol|0
847061|NCT00395538|1805059|FG000|Overall Study|PTH resistance|0
847062|NCT00395538|1805060|FG001|Overall Study|PTH resistance|0
847063|NCT00395538|1805061|FG002|Overall Study|PTH resistance|1
847064|NCT00395538|1805059|FG000|Overall Study|Pregnancy|1
847065|NCT00395538|1805060|FG001|Overall Study|Pregnancy|0
847066|NCT00395538|1805061|FG002|Overall Study|Pregnancy|0
847067|NCT00395538|1805059|FG000|Overall Study|Partial recovery of parathyroid function|0
847068|NCT00395538|1805060|FG001|Overall Study|Partial recovery of parathyroid function|0
847069|NCT00395538|1805061|FG002|Overall Study|Partial recovery of parathyroid function|1
847070|NCT00395538|1805059|FG000|Overall Study|Participant elected to discontinue|0
847071|NCT00395538|1805060|FG001|Overall Study|Participant elected to discontinue|0
847072|NCT00395538|1805061|FG002|Overall Study|Participant elected to discontinue|1
847073|NCT00395629|1805072|FG000|Core Study|Adverse Event|0
847074|NCT00395629|1805073|FG001|Core Study|Adverse Event|3
847075|NCT00395629|1805074|FG002|Core Study|Adverse Event|4
847076|NCT00395629|1805072|FG000|Core Study|Abnormal laboratory value(s)|0
847077|NCT00395629|1805073|FG001|Core Study|Abnormal laboratory value(s)|0
847078|NCT00395629|1805074|FG002|Core Study|Abnormal laboratory value(s)|1
847079|NCT00395629|1805072|FG000|Core Study|Protocol Violation|1
847080|NCT00395629|1805073|FG001|Core Study|Protocol Violation|0
847081|NCT00395629|1805074|FG002|Core Study|Protocol Violation|0
847082|NCT00395629|1805072|FG000|Core Study|Withdrawal by Subject|0
847083|NCT00395629|1805073|FG001|Core Study|Withdrawal by Subject|1
847084|NCT00395629|1805074|FG002|Core Study|Withdrawal by Subject|1
847085|NCT00395629|1805072|FG000|Core Study|Lost to Follow-up|0
847086|NCT00395629|1805073|FG001|Core Study|Lost to Follow-up|0
847087|NCT00395629|1805074|FG002|Core Study|Lost to Follow-up|1
847088|NCT00395629|1805072|FG000|Extension Study|Adverse Event|0
847089|NCT00395629|1805073|FG001|Extension Study|Adverse Event|0
847090|NCT00395629|1805074|FG002|Extension Study|Adverse Event|2
847091|NCT00395629|1805072|FG000|Extension Study|Administrative problems|0
847092|NCT00395629|1805073|FG001|Extension Study|Administrative problems|0
847093|NCT00395629|1805074|FG002|Extension Study|Administrative problems|1
847094|NCT00395642|1805085|FG000|Overall Study|Death|4
847095|NCT00395642|1805085|FG000|Overall Study|Lost to Follow-up|1
847096|NCT00395642|1805085|FG000|Overall Study|Physician Decision|7
847097|NCT00395642|1805085|FG000|Overall Study|Withdrawal by Subject|1
847098|NCT00395694|1805091|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1
847099|NCT00395694|1805092|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2
847100|NCT00395694|1805091|FG000|Continuation Phase|Adverse Event|1
847101|NCT00395694|1805092|FG001|Continuation Phase|Adverse Event|0
847102|NCT00395694|1805091|FG000|Continuation Phase|Lack of Efficacy|12
847103|NCT00395694|1805092|FG001|Continuation Phase|Lack of Efficacy|11
847104|NCT00395694|1805091|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1
847105|NCT00395694|1805092|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0
847106|NCT00395694|1805091|FG000|Continuation Phase|Poor Compliance|1
847107|NCT00395694|1805092|FG001|Continuation Phase|Poor Compliance|0
847108|NCT00395694|1805091|FG000|Continuation Phase|Withdrawal by Subject|0
847109|NCT00395694|1805092|FG001|Continuation Phase|Withdrawal by Subject|2
847110|NCT00395733|1805103|FG000|Period 2|Withdrawal by Subject|1
847111|NCT00395733|1805104|FG001|Period 2|Withdrawal by Subject|2
847112|NCT00395733|1805103|FG000|Period 2|Protocol Violation|0
847113|NCT00395733|1805104|FG001|Period 2|Protocol Violation|1
847114|NCT00395733|1805103|FG000|Period 2|Adverse Event|0
847115|NCT00395733|1805104|FG001|Period 2|Adverse Event|2
847116|NCT00395733|1805103|FG000|Period 2|Technical problems|1
847117|NCT00395733|1805104|FG001|Period 2|Technical problems|0
847118|NCT00395746|1805113|FG000|Overall Study|Adverse Event|5
847119|NCT00395746|1805114|FG001|Overall Study|Adverse Event|2
847120|NCT00395746|1805115|FG002|Overall Study|Adverse Event|2
847121|NCT00395746|1805113|FG000|Overall Study|Protocol Violation|0
847122|NCT00395746|1805114|FG001|Overall Study|Protocol Violation|1
847123|NCT00395746|1805115|FG002|Overall Study|Protocol Violation|0
847124|NCT00395746|1805113|FG000|Overall Study|Lack of Efficacy|2
847125|NCT00395746|1805114|FG001|Overall Study|Lack of Efficacy|0
847126|NCT00395746|1805115|FG002|Overall Study|Lack of Efficacy|17
847127|NCT00395746|1805113|FG000|Overall Study|Hypoglycaemia|2
847128|NCT00395746|1805114|FG001|Overall Study|Hypoglycaemia|1
847129|NCT00395746|1805115|FG002|Overall Study|Hypoglycaemia|0
847130|NCT00395746|1805113|FG000|Overall Study|Subject decision|0
847131|NCT00395746|1805114|FG001|Overall Study|Subject decision|0
847132|NCT00395746|1805115|FG002|Overall Study|Subject decision|1
847133|NCT00395746|1805113|FG000|Overall Study|Withdrawal of consent|0
847134|NCT00395746|1805114|FG001|Overall Study|Withdrawal of consent|0
847135|NCT00395746|1805115|FG002|Overall Study|Withdrawal of consent|1
847136|NCT00395746|1805113|FG000|Overall Study|Difficultulty in use of device|0
847137|NCT00395746|1805114|FG001|Overall Study|Difficultulty in use of device|0
847138|NCT00395746|1805115|FG002|Overall Study|Difficultulty in use of device|1
847139|NCT00395746|1805113|FG000|Overall Study|Unable to visit site on schedule|1
847140|NCT00395746|1805114|FG001|Overall Study|Unable to visit site on schedule|0
847141|NCT00395746|1805115|FG002|Overall Study|Unable to visit site on schedule|0
847142|NCT00395850|1805127|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
847143|NCT00395850|1805128|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
847144|NCT00395850|1805129|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
847145|NCT00395850|1805130|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
847146|NCT00395850|1805127|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
847147|NCT00395850|1805128|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
847148|NCT00395850|1805129|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
847149|NCT00395850|1805130|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
847150|NCT00395850|1805127|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1
847151|NCT00395850|1805128|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0
847152|NCT00395850|1805129|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0
847153|NCT00395850|1805130|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0
847154|NCT00395850|1805127|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
847155|NCT00395850|1805128|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
847156|NCT00395850|1805129|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
847157|NCT00395850|1805130|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
847158|NCT00395850|1805127|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
847159|NCT00395850|1805128|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
847160|NCT00395850|1805129|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
847161|NCT00395850|1805130|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
847162|NCT00395850|1805127|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
847163|NCT00395850|1805128|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
847164|NCT00395850|1805129|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
847165|NCT00395850|1805130|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
847166|NCT00395850|1805127|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
847167|NCT00395850|1805128|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
847168|NCT00395850|1805129|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
847169|NCT00395850|1805130|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
847170|NCT00395863|1805142|FG000|Overall Study|Patients did not complete both exams|2
847171|NCT00395863|1805143|FG001|Overall Study|Patients did not complete both exams|3
847172|NCT00395967|1805161|FG000|Treatment Period|Failed Mobilization|1
847173|NCT00395967|1805161|FG000|Follow-up Period|Death|1
847174|NCT00395967|1805161|FG000|Follow-up Period|Lost to Follow-up|1
847175|NCT00396084|1805208|FG000|Overall Study|Adverse Event|0
847176|NCT00396084|1805209|FG001|Overall Study|Adverse Event|0
847177|NCT00396084|1805210|FG002|Overall Study|Adverse Event|0
847178|NCT00396084|1805211|FG003|Overall Study|Adverse Event|0
847179|NCT00396084|1805212|FG004|Overall Study|Adverse Event|1
847180|NCT00396084|1805213|FG005|Overall Study|Adverse Event|2
847181|NCT00396084|1805208|FG000|Overall Study|Withdrawal by Subject|0
847182|NCT00396084|1805209|FG001|Overall Study|Withdrawal by Subject|0
847183|NCT00396084|1805210|FG002|Overall Study|Withdrawal by Subject|0
847184|NCT00396084|1805211|FG003|Overall Study|Withdrawal by Subject|1
847185|NCT00396084|1805212|FG004|Overall Study|Withdrawal by Subject|0
847186|NCT00396084|1805213|FG005|Overall Study|Withdrawal by Subject|0
847187|NCT00396097|1805233|FG000|Overall Study|Withdrawal by Subject|17
847188|NCT00396097|1805234|FG001|Overall Study|Withdrawal by Subject|17
847189|NCT00396097|1805233|FG000|Overall Study|Lost to Follow-up|4
847190|NCT00396097|1805234|FG001|Overall Study|Lost to Follow-up|9
847191|NCT00396097|1805233|FG000|Overall Study|Other|3
847192|NCT00396097|1805234|FG001|Overall Study|Other|5
847193|NCT00396097|1805233|FG000|Overall Study|Protocol Violation|0
847194|NCT00396097|1805234|FG001|Overall Study|Protocol Violation|6
847195|NCT00396097|1805233|FG000|Overall Study|Adverse Event|1
847196|NCT00396097|1805234|FG001|Overall Study|Adverse Event|5
847197|NCT00396097|1805233|FG000|Overall Study|Insufficient Clinical Response|1
847198|NCT00396097|1805234|FG001|Overall Study|Insufficient Clinical Response|4
847199|NCT00396136|1805244|FG000|Overall Study|Death|43
847200|NCT00396136|1805244|FG000|Overall Study|Withdrawal by Subject|59
847201|NCT00396136|1805244|FG000|Overall Study|Lost to Follow-up|15
847202|NCT00396136|1805244|FG000|Overall Study|Study device explanted|8
847203|NCT00396162|1805250|FG000|Overall Study|Withdrawal by Subject|2
847204|NCT00396162|1805251|FG001|Overall Study|Withdrawal by Subject|3
847205|NCT00396253|1805266|FG000|Overall Study|Protocol Violation|1
847206|NCT00396253|1805266|FG000|Overall Study|Withdrawal by Subject|7
847207|NCT00396253|1805266|FG000|Overall Study|Death|3
847208|NCT00396253|1805266|FG000|Overall Study|Physician Decision|1
847209|NCT00396253|1805266|FG000|Overall Study|Change in eligibility status|1
847210|NCT00396279|1805283|FG000|Overall Study|Ongoing in study|26
847211|NCT00396279|1805283|FG000|Overall Study|Disease progression|2
847212|NCT00396279|1805283|FG000|Overall Study|Withdrawal by Subject|1
847213|NCT00396279|1805283|FG000|Overall Study|Physician Decision|1
847214|NCT00396318|1805296|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
847215|NCT00396331|1805304|FG000|Overall Study|Failed to mobilize - no transplant|8
847216|NCT00396331|1805304|FG000|Overall Study|Did not go on to transplant|5
847217|NCT00396331|1805304|FG000|Overall Study|Lost to Follow-up|3
847218|NCT00396331|1805304|FG000|Overall Study|Death|16
847219|NCT00396383|1805316|FG000|Overall Study|Death|2
847220|NCT00396383|1805316|FG000|Overall Study|Lost to Follow-up|1
847221|NCT00396409|1805322|FG000|Period 1 - 2007|Adverse Event|0
847222|NCT00396409|1805323|FG001|Period 1 - 2007|Adverse Event|1
847223|NCT00396409|1805322|FG000|Period 1 - 2007|Lack of Efficacy|0
847224|NCT00396409|1805323|FG001|Period 1 - 2007|Lack of Efficacy|1
847225|NCT00396409|1805322|FG000|Period 1 - 2007|Withdrawal by Subject|1
847226|NCT00396409|1805323|FG001|Period 1 - 2007|Withdrawal by Subject|1
847227|NCT00396409|1805322|FG000|Period 1 - 2007|Lost to Follow-up|2
847228|NCT00396409|1805323|FG001|Period 1 - 2007|Lost to Follow-up|3
847229|NCT00396409|1805322|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3
847230|NCT00396409|1805323|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2
847231|NCT00396409|1805322|FG000|Period 2 - 2008|Protocol Violation|1
847232|NCT00396409|1805323|FG001|Period 2 - 2008|Protocol Violation|0
847233|NCT00396409|1805322|FG000|Period 2 - 2008|Withdrawal by Subject|3
847234|NCT00396409|1805323|FG001|Period 2 - 2008|Withdrawal by Subject|1
847235|NCT00396409|1805322|FG000|Period 2 - 2008|Lost to Follow-up|3
847236|NCT00396409|1805323|FG001|Period 2 - 2008|Lost to Follow-up|1
847237|NCT00396565|1805334|FG000|Overall Study|Physician Decision|3
847238|NCT00396565|1805335|FG001|Overall Study|Physician Decision|1
847239|NCT00396565|1805336|FG002|Overall Study|Physician Decision|2
847240|NCT00396565|1805334|FG000|Overall Study|Adverse Event|5
847241|NCT00396565|1805335|FG001|Overall Study|Adverse Event|13
847242|NCT00396565|1805336|FG002|Overall Study|Adverse Event|3
847243|NCT00396565|1805334|FG000|Overall Study|Withdrawal by Subject|8
847244|NCT00396565|1805335|FG001|Overall Study|Withdrawal by Subject|13
847245|NCT00396565|1805336|FG002|Overall Study|Withdrawal by Subject|1
847246|NCT00396565|1805334|FG000|Overall Study|Lack of Efficacy|32
847247|NCT00396565|1805335|FG001|Overall Study|Lack of Efficacy|64
847248|NCT00396565|1805336|FG002|Overall Study|Lack of Efficacy|11
847249|NCT00396591|1805344|FG000|Overall Study|Disease Progression|13
847250|NCT00396591|1805344|FG000|Overall Study|Adverse Event|2
847251|NCT00396591|1805344|FG000|Overall Study|Participant request|1
847252|NCT00396630|1805350|FG000|Overall Study|Lost to Follow-up|1
847253|NCT00396630|1805351|FG001|Overall Study|Lost to Follow-up|1
847254|NCT00396630|1805350|FG000|Overall Study|Withdrawal by Subject|1
847255|NCT00396630|1805351|FG001|Overall Study|Withdrawal by Subject|1
847256|NCT00396630|1805350|FG000|Overall Study|Not vaccinated at Visit 3|3
847257|NCT00396630|1805351|FG001|Overall Study|Not vaccinated at Visit 3|3
847258|NCT00396656|1805358|FG000|First Treatment Period|Withdrawal by Subject|0
847259|NCT00396656|1805359|FG001|First Treatment Period|Withdrawal by Subject|2
847260|NCT00396656|1805358|FG000|Second Treatment Period|Adverse Event|0
847261|NCT00396656|1805359|FG001|Second Treatment Period|Adverse Event|1
847262|NCT00396812|1805365|FG000|Overall Study|Physician Decision|1
847263|NCT00396877|1805371|FG000|Overall Study|Lost to Follow-up|2
847264|NCT00396877|1805372|FG001|Overall Study|Lost to Follow-up|1
847265|NCT00396877|1805371|FG000|Overall Study|Parent(s)/guardian(s)'s request|4
847266|NCT00396877|1805372|FG001|Overall Study|Parent(s)/guardian(s)'s request|7
847267|NCT00397033|1805399|FG000|Overall Study|Adverse Event|7
847268|NCT00397033|1805400|FG001|Overall Study|Adverse Event|10
847269|NCT00397033|1805401|FG002|Overall Study|Adverse Event|4
847270|NCT00397033|1805399|FG000|Overall Study|Lack of Efficacy|22
847271|NCT00397033|1805400|FG001|Overall Study|Lack of Efficacy|12
847272|NCT00397033|1805401|FG002|Overall Study|Lack of Efficacy|9
847273|NCT00397033|1805399|FG000|Overall Study|Lost to Follow-up|3
847274|NCT00397033|1805400|FG001|Overall Study|Lost to Follow-up|3
847275|NCT00397033|1805401|FG002|Overall Study|Lost to Follow-up|3
847276|NCT00397033|1805399|FG000|Overall Study|Withdrawal by Subject|12
847277|NCT00397033|1805400|FG001|Overall Study|Withdrawal by Subject|7
847278|NCT00397033|1805401|FG002|Overall Study|Withdrawal by Subject|5
847279|NCT00397033|1805399|FG000|Overall Study|Other|0
847280|NCT00397033|1805400|FG001|Overall Study|Other|5
847281|NCT00397033|1805401|FG002|Overall Study|Other|2
847282|NCT00397046|1805413|FG000|Overall Study|Disease Progression|3
847283|NCT00397046|1805414|FG001|Overall Study|Disease Progression|3
847284|NCT00397046|1805415|FG002|Overall Study|Disease Progression|10
847285|NCT00397046|1805416|FG003|Overall Study|Disease Progression|5
847286|NCT00397189|1805438|FG000|3 Weeks Period|Lost to Follow-up|5
847287|NCT00397189|1805439|FG001|3 Weeks Period|Lost to Follow-up|4
847288|NCT00397189|1805438|FG000|3 Weeks Period|Adverse Event|3
847289|NCT00397189|1805439|FG001|3 Weeks Period|Adverse Event|2
847290|NCT00397189|1805438|FG000|3 Weeks Period|Withdrawal by Subject|13
847291|NCT00397189|1805439|FG001|3 Weeks Period|Withdrawal by Subject|9
847292|NCT00397189|1805438|FG000|3 Weeks Period|Physician Decision|0
847293|NCT00397189|1805439|FG001|3 Weeks Period|Physician Decision|2
847294|NCT00397189|1805438|FG000|3 Weeks Period|Protocol Violation|0
847295|NCT00397189|1805439|FG001|3 Weeks Period|Protocol Violation|3
847296|NCT00397189|1805438|FG000|3 Weeks Period|Other|0
847297|NCT00397189|1805439|FG001|3 Weeks Period|Other|2
847298|NCT00397215|1805451|FG000|Month 0 (Day 0)|Adverse Event|0
847299|NCT00397215|1805452|FG001|Month 0 (Day 0)|Adverse Event|1
847300|NCT00397215|1805453|FG002|Month 0 (Day 0)|Adverse Event|0
847301|NCT00397215|1805454|FG003|Month 0 (Day 0)|Adverse Event|0
847302|NCT00397215|1805451|FG000|Month 0 (Day 0)|Withdrawal by Subject|3
847303|NCT00397215|1805452|FG001|Month 0 (Day 0)|Withdrawal by Subject|3
847304|NCT00397215|1805453|FG002|Month 0 (Day 0)|Withdrawal by Subject|3
847305|NCT00397215|1805454|FG003|Month 0 (Day 0)|Withdrawal by Subject|1
847306|NCT00397215|1805451|FG000|Month 0 (Day 0)|Other|4
847307|NCT00397215|1805452|FG001|Month 0 (Day 0)|Other|1
847308|NCT00397215|1805453|FG002|Month 0 (Day 0)|Other|3
847309|NCT00397215|1805454|FG003|Month 0 (Day 0)|Other|3
847310|NCT00397215|1805451|FG000|Month 6 (Day 180)|Adverse Event|0
847311|NCT00397215|1805452|FG001|Month 6 (Day 180)|Adverse Event|3
847312|NCT00397215|1805453|FG002|Month 6 (Day 180)|Adverse Event|2
847313|NCT00397215|1805454|FG003|Month 6 (Day 180)|Adverse Event|0
847314|NCT00397215|1805451|FG000|Month 6 (Day 180)|Other|2
847315|NCT00397215|1805452|FG001|Month 6 (Day 180)|Other|0
847316|NCT00397215|1805453|FG002|Month 6 (Day 180)|Other|3
847317|NCT00397215|1805454|FG003|Month 6 (Day 180)|Other|0
847318|NCT00397254|1805467|FG000|Overall Study|Lost to Follow-up|2
847319|NCT00397254|1805468|FG001|Overall Study|Lost to Follow-up|2
847320|NCT00397488|1805485|FG000|Overall Study|Withdrawal by Subject|3
847321|NCT00397488|1805485|FG000|Overall Study|Adverse Event|3
847322|NCT00397488|1805485|FG000|Overall Study|Death|1
847323|NCT00397514|1805489|FG000|Overall Study|Withdrawal by Subject|1
847324|NCT00397514|1805489|FG000|Overall Study|Pacing wire malfunction|1
847325|NCT00397514|1805489|FG000|Overall Study|Not able to capture & pace LV intraoper.|4
847326|NCT00397514|1805489|FG000|Overall Study|early extubation|2
847327|NCT00397514|1805489|FG000|Overall Study|poor echocardiographic windows|1
847328|NCT00397540|1805501|FG000|Overall Study|short follow-up duration < 12 months|1
847329|NCT00397540|1805502|FG001|Overall Study|short follow-up duration < 12 months|0
847330|NCT00397631|1805515|FG000|Overall Study|Adverse Event|5
847331|NCT00397631|1805516|FG001|Overall Study|Adverse Event|6
847332|NCT00397631|1805515|FG000|Overall Study|Lack of Efficacy|7
847333|NCT00397631|1805516|FG001|Overall Study|Lack of Efficacy|10
847334|NCT00397631|1805515|FG000|Overall Study|Lost to Follow-up|8
847335|NCT00397631|1805516|FG001|Overall Study|Lost to Follow-up|9
847336|NCT00397631|1805515|FG000|Overall Study|Physician Decision|2
847337|NCT00397631|1805516|FG001|Overall Study|Physician Decision|0
847338|NCT00397631|1805515|FG000|Overall Study|Protocol Violation|0
847339|NCT00397631|1805516|FG001|Overall Study|Protocol Violation|1
847340|NCT00397631|1805515|FG000|Overall Study|Withdrawal by Subject|7
847341|NCT00397631|1805516|FG001|Overall Study|Withdrawal by Subject|14
847342|NCT00397631|1805515|FG000|Overall Study|protocol discontinuation criteria|1
847343|NCT00397631|1805516|FG001|Overall Study|protocol discontinuation criteria|4
847344|NCT00397891|1805565|FG000|Overall Study|Withdrawal by Subject|1
847345|NCT00397891|1805566|FG001|Overall Study|Withdrawal by Subject|0
847346|NCT00397891|1805567|FG002|Overall Study|Withdrawal by Subject|0
847347|NCT00397891|1805568|FG003|Overall Study|Withdrawal by Subject|0
847348|NCT00397891|1805569|FG004|Overall Study|Withdrawal by Subject|1
847349|NCT00397930|1805587|FG000|Overall Study|Personal reasons|14
847350|NCT00397930|1805588|FG001|Overall Study|Personal reasons|8
847351|NCT00397930|1805587|FG000|Overall Study|Other medical|9
847352|NCT00397930|1805588|FG001|Overall Study|Other medical|4
847353|NCT00397930|1805587|FG000|Overall Study|Unknown reasons|9
847354|NCT00397930|1805588|FG001|Overall Study|Unknown reasons|14
847355|NCT00397930|1805587|FG000|Overall Study|Noncompliant|3
847356|NCT00397930|1805588|FG001|Overall Study|Noncompliant|2
847357|NCT00397930|1805587|FG000|Overall Study|Too time-consuming|2
847358|NCT00397930|1805588|FG001|Overall Study|Too time-consuming|9
847359|NCT00397930|1805587|FG000|Overall Study|Started own yoga program|1
847360|NCT00397930|1805588|FG001|Overall Study|Started own yoga program|1
847361|NCT00397930|1805587|FG000|Overall Study|Did not want to be in control group|0
847362|NCT00397930|1805588|FG001|Overall Study|Did not want to be in control group|1
847363|NCT00397930|1805587|FG000|Overall Study|Withdrawal by Subject|0
847364|NCT00397930|1805588|FG001|Overall Study|Withdrawal by Subject|8
847365|NCT00397930|1805587|FG000|Overall Study|Missing data|0
847366|NCT00397930|1805588|FG001|Overall Study|Missing data|4
847367|NCT00397943|1805599|FG000|Overall Study|Unspecified reasons|12
847368|NCT00397943|1805600|FG001|Overall Study|Unspecified reasons|9
847369|NCT00397943|1805601|FG002|Overall Study|Unspecified reasons|0
847370|NCT00397943|1805602|FG003|Overall Study|Unspecified reasons|0
847371|NCT00397943|1805603|FG004|Overall Study|Unspecified reasons|0
847372|NCT00397982|1805615|FG000|Overall Study|Withdrawal by Subject|1
847373|NCT00397982|1805615|FG000|Overall Study|Adverse Event|1
847374|NCT00397982|1805615|FG000|Overall Study|noncompliance|1
847375|NCT00397982|1805615|FG000|Overall Study|Unrelated health issues|1
847376|NCT00398047|1805620|FG000|Overall Study|all patient progressed before completion|3
847377|NCT00398073|1805627|FG000|Overall Study|Withdrawal by Subject|1
847378|NCT00398073|1805628|FG001|Overall Study|Withdrawal by Subject|0
847379|NCT00398086|1805637|FG000|Overall Study|Unacceptable Toxicity|2
847380|NCT00398086|1805638|FG001|Overall Study|Unacceptable Toxicity|8
847381|NCT00398086|1805639|FG002|Overall Study|Unacceptable Toxicity|2
847382|NCT00398086|1805637|FG000|Overall Study|Adverse Event|1
847383|NCT00398086|1805638|FG001|Overall Study|Adverse Event|4
847384|NCT00398086|1805639|FG002|Overall Study|Adverse Event|0
847385|NCT00398086|1805637|FG000|Overall Study|Physician Decision|1
847386|NCT00398086|1805638|FG001|Overall Study|Physician Decision|4
847387|NCT00398086|1805639|FG002|Overall Study|Physician Decision|0
847388|NCT00398086|1805637|FG000|Overall Study|Withdrawal by Subject|5
847389|NCT00398086|1805638|FG001|Overall Study|Withdrawal by Subject|7
847390|NCT00398086|1805639|FG002|Overall Study|Withdrawal by Subject|0
847391|NCT00398112|1805647|FG000|Overall Study|Adverse Event|4
847392|NCT00398112|1805647|FG000|Overall Study|Disease progression|9
847393|NCT00398112|1805647|FG000|Overall Study|Alternative treatment|1
847394|NCT00398112|1805647|FG000|Overall Study|Withdrawal by Subject|3
847395|NCT00398112|1805647|FG000|Overall Study|Death|1
847396|NCT00398138|1805651|FG000|Overall Study|Adverse Event|2
847397|NCT00398216|1805660|FG000|Overall Study|Adverse Event|4
847398|NCT00398216|1805661|FG001|Overall Study|Adverse Event|2
847399|NCT00398216|1805662|FG002|Overall Study|Adverse Event|5
847400|NCT00398216|1805663|FG003|Overall Study|Adverse Event|7
847401|NCT00398216|1805664|FG004|Overall Study|Adverse Event|2
847402|NCT00398216|1805660|FG000|Overall Study|Protocol Violation|2
847403|NCT00398216|1805661|FG001|Overall Study|Protocol Violation|4
847404|NCT00398216|1805662|FG002|Overall Study|Protocol Violation|5
847405|NCT00398216|1805663|FG003|Overall Study|Protocol Violation|7
847406|NCT00398216|1805664|FG004|Overall Study|Protocol Violation|5
847407|NCT00398216|1805660|FG000|Overall Study|Lost to Follow-up|1
847408|NCT00398216|1805661|FG001|Overall Study|Lost to Follow-up|6
847409|NCT00398216|1805662|FG002|Overall Study|Lost to Follow-up|4
847410|NCT00398216|1805663|FG003|Overall Study|Lost to Follow-up|4
847411|NCT00398216|1805664|FG004|Overall Study|Lost to Follow-up|1
847412|NCT00398216|1805660|FG000|Overall Study|Death|0
847413|NCT00398216|1805661|FG001|Overall Study|Death|3
847414|NCT00398216|1805662|FG002|Overall Study|Death|0
847415|NCT00398216|1805663|FG003|Overall Study|Death|0
847416|NCT00398216|1805664|FG004|Overall Study|Death|0
847417|NCT00398216|1805660|FG000|Overall Study|Withdrawal by Subject|1
847418|NCT00398216|1805661|FG001|Overall Study|Withdrawal by Subject|0
847419|NCT00398216|1805662|FG002|Overall Study|Withdrawal by Subject|3
847420|NCT00398216|1805663|FG003|Overall Study|Withdrawal by Subject|1
847421|NCT00398216|1805664|FG004|Overall Study|Withdrawal by Subject|2
847422|NCT00398216|1805660|FG000|Overall Study|administrative reasons|3
847423|NCT00398216|1805661|FG001|Overall Study|administrative reasons|4
847424|NCT00398216|1805662|FG002|Overall Study|administrative reasons|4
847425|NCT00398216|1805663|FG003|Overall Study|administrative reasons|3
847426|NCT00398216|1805664|FG004|Overall Study|administrative reasons|3
847427|NCT00398216|1805660|FG000|Overall Study|entrance criteria|0
847428|NCT00398216|1805661|FG001|Overall Study|entrance criteria|0
847429|NCT00398216|1805662|FG002|Overall Study|entrance criteria|0
847430|NCT00398216|1805663|FG003|Overall Study|entrance criteria|0
847431|NCT00398216|1805664|FG004|Overall Study|entrance criteria|2
847432|NCT00398320|1805676|FG000|Overall Study|Death|1
847433|NCT00398320|1805676|FG000|Overall Study|Adverse Event|4
847434|NCT00398320|1805676|FG000|Overall Study|Physician Decision|1
847435|NCT00398411|1805686|FG000|Overall Study|Death|0
847436|NCT00398411|1805687|FG001|Overall Study|Death|1
847437|NCT00398567|1805705|FG000|Overall Study|Disease Progression|3
847438|NCT00398567|1805706|FG001|Overall Study|Disease Progression|4
847439|NCT00398567|1805707|FG002|Overall Study|Disease Progression|27
847440|NCT00398567|1805705|FG000|Overall Study|Withdrawal by Subject|1
847441|NCT00398567|1805706|FG001|Overall Study|Withdrawal by Subject|0
847442|NCT00398567|1805707|FG002|Overall Study|Withdrawal by Subject|4
847443|NCT00398567|1805705|FG000|Overall Study|Adverse Event|0
847444|NCT00398567|1805706|FG001|Overall Study|Adverse Event|0
847445|NCT00398567|1805707|FG002|Overall Study|Adverse Event|2
847446|NCT00398567|1805705|FG000|Overall Study|Protocol Violation|0
847447|NCT00398567|1805706|FG001|Overall Study|Protocol Violation|0
847448|NCT00398567|1805707|FG002|Overall Study|Protocol Violation|1
847449|NCT00398632|1805713|FG000|Overall Study|Withdrawal by Subject|1
847450|NCT00398632|1805713|FG000|Overall Study|Lack of Efficacy|1
847451|NCT00398866|1805721|FG000|Overall Study|Adverse Event|1
847452|NCT00398866|1805722|FG001|Overall Study|Adverse Event|0
847453|NCT00398866|1805723|FG002|Overall Study|Adverse Event|0
847454|NCT00398866|1805721|FG000|Overall Study|Lack of Efficacy|0
847455|NCT00398866|1805722|FG001|Overall Study|Lack of Efficacy|0
847456|NCT00398866|1805723|FG002|Overall Study|Lack of Efficacy|1
847457|NCT00398866|1805721|FG000|Overall Study|Lost to Follow-up|7
847458|NCT00398866|1805722|FG001|Overall Study|Lost to Follow-up|6
847459|NCT00398866|1805723|FG002|Overall Study|Lost to Follow-up|4
847460|NCT00398866|1805721|FG000|Overall Study|Withdrawal by Subject|5
847461|NCT00398866|1805722|FG001|Overall Study|Withdrawal by Subject|1
847462|NCT00398866|1805723|FG002|Overall Study|Withdrawal by Subject|2
847463|NCT00398866|1805721|FG000|Overall Study|Unable to complete requirements of study|1
847464|NCT00398866|1805722|FG001|Overall Study|Unable to complete requirements of study|1
847465|NCT00398866|1805723|FG002|Overall Study|Unable to complete requirements of study|1
847466|NCT00399035|1805748|FG000|Overall Study|Death|289
847467|NCT00399035|1805749|FG001|Overall Study|Death|141
847468|NCT00399035|1805750|FG002|Overall Study|Death|234
847469|NCT00399035|1805748|FG000|Overall Study|Lost to Follow-up|2
847470|NCT00399035|1805749|FG001|Overall Study|Lost to Follow-up|1
847471|NCT00399035|1805750|FG002|Overall Study|Lost to Follow-up|5
847472|NCT00399035|1805748|FG000|Overall Study|Withdrawal by Subject|19
847473|NCT00399035|1805749|FG001|Overall Study|Withdrawal by Subject|15
847474|NCT00399035|1805750|FG002|Overall Study|Withdrawal by Subject|12
847475|NCT00399035|1805748|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1
847476|NCT00399035|1805749|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0
847477|NCT00399035|1805750|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1
847478|NCT00399035|1805748|FG000|Overall Study|Severe non-compliance with protocol|2
847479|NCT00399035|1805749|FG001|Overall Study|Severe non-compliance with protocol|1
847480|NCT00399035|1805750|FG002|Overall Study|Severe non-compliance with protocol|0
847481|NCT00399360|1805774|FG000|Overall Study|Lost to Follow-up|2
847482|NCT00399360|1805775|FG001|Overall Study|Lost to Follow-up|1
847483|NCT00399360|1805776|FG002|Overall Study|Lost to Follow-up|2
847484|NCT00399360|1805777|FG003|Overall Study|Lost to Follow-up|4
847485|NCT00399360|1805774|FG000|Overall Study|Adverse Event|0
847486|NCT00399360|1805775|FG001|Overall Study|Adverse Event|0
847487|NCT00399360|1805776|FG002|Overall Study|Adverse Event|1
847488|NCT00399360|1805777|FG003|Overall Study|Adverse Event|0
847489|NCT00399360|1805774|FG000|Overall Study|Withdrawal by Subject|0
847490|NCT00399360|1805775|FG001|Overall Study|Withdrawal by Subject|2
847491|NCT00399360|1805776|FG002|Overall Study|Withdrawal by Subject|0
847492|NCT00399360|1805777|FG003|Overall Study|Withdrawal by Subject|2
847493|NCT00399490|1805792|FG000|Overall Study|Adverse Event|19
847494|NCT00399490|1805792|FG000|Overall Study|Lack of Efficacy|31
847495|NCT00399490|1805792|FG000|Overall Study|Lost to Follow-up|5
847496|NCT00399490|1805792|FG000|Overall Study|Withdrawal by Subject|18
847497|NCT00399490|1805792|FG000|Overall Study|Other|25
847498|NCT00399516|1805798|FG000|Overall Study|Lost to Follow-up|2
847499|NCT00399529|1805802|FG000|Overall Study|Off Study Prior to Treatment|2
847500|NCT00399542|1805809|FG000|Overall Study|Adverse Event|18
847501|NCT00399542|1805810|FG001|Overall Study|Adverse Event|15
847502|NCT00399542|1805809|FG000|Overall Study|Protocol Violation|13
847503|NCT00399542|1805810|FG001|Overall Study|Protocol Violation|3
847504|NCT00399542|1805809|FG000|Overall Study|Withdrawal by Subject|28
847505|NCT00399542|1805810|FG001|Overall Study|Withdrawal by Subject|10
847506|NCT00399542|1805809|FG000|Overall Study|Lack of Efficacy|18
847507|NCT00399542|1805810|FG001|Overall Study|Lack of Efficacy|8
847508|NCT00399542|1805809|FG000|Overall Study|Lost to Follow-up|6
847509|NCT00399542|1805810|FG001|Overall Study|Lost to Follow-up|6
847510|NCT00399542|1805809|FG000|Overall Study|Other|1
847511|NCT00399542|1805810|FG001|Overall Study|Other|0
847512|NCT00399542|1805809|FG000|Overall Study|Physician Decision|0
847513|NCT00399542|1805810|FG001|Overall Study|Physician Decision|1
847514|NCT00399568|1805818|FG000|Overall Study|Adverse Event|1
847515|NCT00399568|1805819|FG001|Overall Study|Adverse Event|2
847516|NCT00399568|1805818|FG000|Overall Study|Withdrawal by Subject|7
847517|NCT00399568|1805819|FG001|Overall Study|Withdrawal by Subject|3
847518|NCT00399568|1805818|FG000|Overall Study|Protocol non-compliance|2
847519|NCT00399568|1805819|FG001|Overall Study|Protocol non-compliance|2
847520|NCT00399568|1805818|FG000|Overall Study|Lost to Follow-up|2
847521|NCT00399568|1805819|FG001|Overall Study|Lost to Follow-up|2
847522|NCT00399763|1805829|FG000|Overall Study|Lost to Follow-up|2
847523|NCT00399763|1805830|FG001|Overall Study|Lost to Follow-up|3
847524|NCT00399802|1805838|FG000|Overall Study|Adverse Event|0
847525|NCT00399802|1805839|FG001|Overall Study|Adverse Event|2
847526|NCT00399802|1805838|FG000|Overall Study|Participant discontinued by mistake|0
847527|NCT00399802|1805839|FG001|Overall Study|Participant discontinued by mistake|1
847528|NCT00399893|1805856|FG000|Overall Study|Withdrawal by Subject|1
847529|NCT00399893|1805857|FG001|Overall Study|Withdrawal by Subject|0
847530|NCT00400153|1805866|FG000|Overall Study|AE due to study disease worsening|14
847531|NCT00400153|1805867|FG001|Overall Study|AE due to study disease worsening|19
847532|NCT00400153|1805868|FG002|Overall Study|AE due to study disease worsening|20
847533|NCT00400153|1805866|FG000|Overall Study|AE due to other disease worsening|2
847534|NCT00400153|1805867|FG001|Overall Study|AE due to other disease worsening|1
847535|NCT00400153|1805868|FG002|Overall Study|AE due to other disease worsening|0
847536|NCT00400153|1805866|FG000|Overall Study|AE due to other condition|3
847537|NCT00400153|1805867|FG001|Overall Study|AE due to other condition|14
847538|NCT00400153|1805868|FG002|Overall Study|AE due to other condition|15
847539|NCT00400153|1805866|FG000|Overall Study|Protocol Violation|7
847540|NCT00400153|1805867|FG001|Overall Study|Protocol Violation|4
847541|NCT00400153|1805868|FG002|Overall Study|Protocol Violation|9
847542|NCT00400153|1805866|FG000|Overall Study|Lost to Follow-up|2
847543|NCT00400153|1805867|FG001|Overall Study|Lost to Follow-up|1
847544|NCT00400153|1805868|FG002|Overall Study|Lost to Follow-up|4
847545|NCT00400153|1805866|FG000|Overall Study|Withdrawal by Subject|12
847546|NCT00400153|1805867|FG001|Overall Study|Withdrawal by Subject|11
847547|NCT00400153|1805868|FG002|Overall Study|Withdrawal by Subject|10
847548|NCT00400153|1805866|FG000|Overall Study|Other reasons - not mentioned above|8
847549|NCT00400153|1805867|FG001|Overall Study|Other reasons - not mentioned above|5
847550|NCT00400153|1805868|FG002|Overall Study|Other reasons - not mentioned above|3
847551|NCT00400179|1805883|FG000|Overall Study|Adverse Event|2
847552|NCT00400179|1805884|FG001|Overall Study|Adverse Event|2
847553|NCT00400179|1805883|FG000|Overall Study|Death|1
847554|NCT00400179|1805884|FG001|Overall Study|Death|2
847555|NCT00400179|1805883|FG000|Overall Study|Withdrew Consent|1
847556|NCT00400179|1805884|FG001|Overall Study|Withdrew Consent|5
847557|NCT00400179|1805883|FG000|Overall Study|Disease progression|1
847558|NCT00400179|1805884|FG001|Overall Study|Disease progression|1
847559|NCT00400179|1805883|FG000|Overall Study|Intercurrent illness|0
847560|NCT00400179|1805884|FG001|Overall Study|Intercurrent illness|1
847561|NCT00400179|1805883|FG000|Overall Study|Investigator judgment|0
847562|NCT00400179|1805884|FG001|Overall Study|Investigator judgment|1
847563|NCT00400179|1805883|FG000|Overall Study|Randomization error/patient ineligible|1
847564|NCT00400179|1805884|FG001|Overall Study|Randomization error/patient ineligible|6
847565|NCT00400400|1805897|FG000|Overall Study|Adverse Event|9
847566|NCT00400400|1805898|FG001|Overall Study|Adverse Event|8
847567|NCT00400400|1805897|FG000|Overall Study|Protocol Violation|2
847568|NCT00400400|1805898|FG001|Overall Study|Protocol Violation|0
847569|NCT00400400|1805897|FG000|Overall Study|Withdrawal by Subject|1
847570|NCT00400400|1805898|FG001|Overall Study|Withdrawal by Subject|3
847571|NCT00400400|1805897|FG000|Overall Study|Administrative Problem|1
847572|NCT00400400|1805898|FG001|Overall Study|Administrative Problem|0
847573|NCT00400400|1805897|FG000|Overall Study|Lost to Follow-up|0
847574|NCT00400400|1805898|FG001|Overall Study|Lost to Follow-up|1
847575|NCT00400400|1805897|FG000|Overall Study|Did not receive study drug|1
847576|NCT00400400|1805898|FG001|Overall Study|Did not receive study drug|3
847577|NCT00400517|1805913|FG000|Overall Study|Withdrawal by Subject|1
847578|NCT00400517|1805913|FG000|Overall Study|Physician Decision|1
847579|NCT00400569|1805917|FG000|Overall Study|Death|1
847580|NCT00400712|1805939|FG000|Overall Study|Death|1
847581|NCT00400712|1805940|FG001|Overall Study|Death|0
847582|NCT00400712|1805939|FG000|Overall Study|Withdrawal by Subject|11
847583|NCT00400712|1805940|FG001|Overall Study|Withdrawal by Subject|12
847584|NCT00400712|1805939|FG000|Overall Study|Physician Decision|5
847585|NCT00400712|1805940|FG001|Overall Study|Physician Decision|4
847586|NCT00400764|1805953|FG000|Phase Ib|Adverse Event|1
847587|NCT00400764|1805954|FG001|Phase Ib|Adverse Event|0
847588|NCT00400764|1805955|FG002|Phase Ib|Adverse Event|0
847589|NCT00400764|1805956|FG003|Phase Ib|Adverse Event|0
847590|NCT00400764|1805957|FG004|Phase Ib|Adverse Event|0
847591|NCT00400764|1805953|FG000|Phase Ib|Death|1
847592|NCT00400764|1805954|FG001|Phase Ib|Death|0
847593|NCT00400764|1805955|FG002|Phase Ib|Death|0
847594|NCT00400764|1805956|FG003|Phase Ib|Death|0
847595|NCT00400764|1805957|FG004|Phase Ib|Death|0
847596|NCT00400764|1805953|FG000|Phase Ib|Disease Progression|4
847597|NCT00400764|1805954|FG001|Phase Ib|Disease Progression|4
847598|NCT00400764|1805955|FG002|Phase Ib|Disease Progression|0
847599|NCT00400764|1805956|FG003|Phase Ib|Disease Progression|0
847600|NCT00400764|1805957|FG004|Phase Ib|Disease Progression|0
847601|NCT00400764|1805953|FG000|Phase II|Death|0
847602|NCT00400764|1805954|FG001|Phase II|Death|0
847603|NCT00400764|1805955|FG002|Phase II|Death|1
847604|NCT00400764|1805956|FG003|Phase II|Death|2
847605|NCT00400764|1805957|FG004|Phase II|Death|0
847606|NCT00400764|1805953|FG000|Phase II|Lost to Follow-up|0
847607|NCT00400764|1805954|FG001|Phase II|Lost to Follow-up|0
847608|NCT00400764|1805955|FG002|Phase II|Lost to Follow-up|1
847609|NCT00400764|1805956|FG003|Phase II|Lost to Follow-up|0
847610|NCT00400764|1805957|FG004|Phase II|Lost to Follow-up|0
847611|NCT00400764|1805953|FG000|Phase II|Physician Decision|0
847612|NCT00400764|1805954|FG001|Phase II|Physician Decision|0
847613|NCT00400764|1805955|FG002|Phase II|Physician Decision|1
847614|NCT00400764|1805956|FG003|Phase II|Physician Decision|1
847615|NCT00400764|1805957|FG004|Phase II|Physician Decision|0
847616|NCT00400764|1805953|FG000|Phase II|Sponsor's decision to terminate|0
847617|NCT00400764|1805954|FG001|Phase II|Sponsor's decision to terminate|0
847618|NCT00400764|1805955|FG002|Phase II|Sponsor's decision to terminate|18
847619|NCT00400764|1805956|FG003|Phase II|Sponsor's decision to terminate|22
847620|NCT00400764|1805957|FG004|Phase II|Sponsor's decision to terminate|11
847621|NCT00400764|1805953|FG000|Phase II|Patient began new, non-protocol, therapy|0
847622|NCT00400764|1805954|FG001|Phase II|Patient began new, non-protocol, therapy|0
847623|NCT00400764|1805955|FG002|Phase II|Patient began new, non-protocol, therapy|1
847624|NCT00400764|1805956|FG003|Phase II|Patient began new, non-protocol, therapy|0
847625|NCT00400764|1805957|FG004|Phase II|Patient began new, non-protocol, therapy|0
847626|NCT00400764|1805953|FG000|Phase II|Withdrawal by Subject|0
847627|NCT00400764|1805954|FG001|Phase II|Withdrawal by Subject|0
847628|NCT00400764|1805955|FG002|Phase II|Withdrawal by Subject|1
847629|NCT00400764|1805956|FG003|Phase II|Withdrawal by Subject|1
847630|NCT00400764|1805957|FG004|Phase II|Withdrawal by Subject|0
847631|NCT00400946|1806001|FG000|Overall Study|Ineligible|0
847632|NCT00400946|1806002|FG001|Overall Study|Ineligible|0
847633|NCT00400946|1806003|FG002|Overall Study|Ineligible|0
847634|NCT00400946|1806004|FG003|Overall Study|Ineligible|5
847635|NCT00400946|1806005|FG004|Overall Study|Ineligible|1
847636|NCT00400946|1806001|FG000|Overall Study|Induction Failure|0
847637|NCT00400946|1806002|FG001|Overall Study|Induction Failure|0
847638|NCT00400946|1806003|FG002|Overall Study|Induction Failure|0
847639|NCT00400946|1806004|FG003|Overall Study|Induction Failure|11
847640|NCT00400946|1806005|FG004|Overall Study|Induction Failure|8
847641|NCT00400946|1806001|FG000|Overall Study|Induction Death|0
847642|NCT00400946|1806002|FG001|Overall Study|Induction Death|0
847643|NCT00400946|1806003|FG002|Overall Study|Induction Death|0
847644|NCT00400946|1806004|FG003|Overall Study|Induction Death|13
847645|NCT00400946|1806005|FG004|Overall Study|Induction Death|3
847646|NCT00400946|1806001|FG000|Overall Study|Lost to Follow-up|1
847647|NCT00400946|1806002|FG001|Overall Study|Lost to Follow-up|1
847648|NCT00400946|1806003|FG002|Overall Study|Lost to Follow-up|0
847649|NCT00400946|1806004|FG003|Overall Study|Lost to Follow-up|0
847650|NCT00400946|1806005|FG004|Overall Study|Lost to Follow-up|1
847651|NCT00400946|1806001|FG000|Overall Study|Remission Death|1
847652|NCT00400946|1806002|FG001|Overall Study|Remission Death|1
847653|NCT00400946|1806003|FG002|Overall Study|Remission Death|0
847654|NCT00400946|1806004|FG003|Overall Study|Remission Death|0
847655|NCT00400946|1806005|FG004|Overall Study|Remission Death|1
847656|NCT00400946|1806001|FG000|Overall Study|Relapse|9
847657|NCT00400946|1806002|FG001|Overall Study|Relapse|2
847658|NCT00400946|1806003|FG002|Overall Study|Relapse|1
847659|NCT00400946|1806004|FG003|Overall Study|Relapse|1
847660|NCT00400946|1806005|FG004|Overall Study|Relapse|5
847661|NCT00400946|1806001|FG000|Overall Study|Transplant in CR1|0
847662|NCT00400946|1806002|FG001|Overall Study|Transplant in CR1|0
847663|NCT00400946|1806003|FG002|Overall Study|Transplant in CR1|0
847664|NCT00400946|1806004|FG003|Overall Study|Transplant in CR1|10
847665|NCT00400946|1806005|FG004|Overall Study|Transplant in CR1|1
847666|NCT00400946|1806001|FG000|Overall Study|Withdrawal by Subject|2
847667|NCT00400946|1806002|FG001|Overall Study|Withdrawal by Subject|5
847668|NCT00400946|1806003|FG002|Overall Study|Withdrawal by Subject|1
847669|NCT00400946|1806004|FG003|Overall Study|Withdrawal by Subject|5
847670|NCT00400946|1806005|FG004|Overall Study|Withdrawal by Subject|8
847671|NCT00400946|1806001|FG000|Overall Study|Clinical|1
847672|NCT00400946|1806002|FG001|Overall Study|Clinical|2
847673|NCT00400946|1806003|FG002|Overall Study|Clinical|0
847674|NCT00400946|1806004|FG003|Overall Study|Clinical|2
847675|NCT00400946|1806005|FG004|Overall Study|Clinical|9
847676|NCT00400946|1806001|FG000|Overall Study|Other|0
847677|NCT00400946|1806002|FG001|Overall Study|Other|0
847678|NCT00400946|1806003|FG002|Overall Study|Other|0
847679|NCT00400946|1806004|FG003|Overall Study|Other|0
847680|NCT00400946|1806005|FG004|Overall Study|Other|1
847681|NCT00400985|1806023|FG000|Overall Study|Withdrawal by Subject|5
847682|NCT00400985|1806023|FG000|Overall Study|system modification|8
847683|NCT00400985|1806023|FG000|Overall Study|Death|30
847684|NCT00400985|1806023|FG000|Overall Study|Lost to Follow-up|9
847685|NCT00401193|1806034|FG000|Overall Study|Adverse Event|1
847686|NCT00401193|1806035|FG001|Overall Study|Adverse Event|3
847687|NCT00401193|1806036|FG002|Overall Study|Adverse Event|1
847688|NCT00401193|1806034|FG000|Overall Study|Protocol Violation|3
847689|NCT00401193|1806035|FG001|Overall Study|Protocol Violation|1
847690|NCT00401193|1806036|FG002|Overall Study|Protocol Violation|1
847691|NCT00401193|1806034|FG000|Overall Study|Lost to Follow-up|6
847692|NCT00401193|1806035|FG001|Overall Study|Lost to Follow-up|5
847693|NCT00401193|1806036|FG002|Overall Study|Lost to Follow-up|1
847694|NCT00401193|1806034|FG000|Overall Study|Withdrawal by Subject|2
847695|NCT00401193|1806035|FG001|Overall Study|Withdrawal by Subject|0
847696|NCT00401193|1806036|FG002|Overall Study|Withdrawal by Subject|1
847697|NCT00401193|1806034|FG000|Overall Study|Other Event|3
847698|NCT00401193|1806035|FG001|Overall Study|Other Event|2
847699|NCT00401193|1806036|FG002|Overall Study|Other Event|2
847700|NCT00401245|1806049|FG000|Double Blind Titration Phase|Adverse Event|3
847701|NCT00401245|1806050|FG001|Double Blind Titration Phase|Adverse Event|2
847702|NCT00401245|1806051|FG002|Double Blind Titration Phase|Adverse Event|5
847703|NCT00401245|1806052|FG003|Double Blind Titration Phase|Adverse Event|12
847704|NCT00401245|1806053|FG004|Double Blind Titration Phase|Adverse Event|0
847705|NCT00401245|1806054|FG005|Double Blind Titration Phase|Adverse Event|0
847706|NCT00401245|1806055|FG006|Double Blind Titration Phase|Adverse Event|0
847707|NCT00401245|1806056|FG007|Double Blind Titration Phase|Adverse Event|0
847708|NCT00401245|1806049|FG000|Double Blind Titration Phase|Other|0
847709|NCT00401245|1806050|FG001|Double Blind Titration Phase|Other|0
847710|NCT00401245|1806051|FG002|Double Blind Titration Phase|Other|1
847711|NCT00401245|1806052|FG003|Double Blind Titration Phase|Other|0
847712|NCT00401245|1806053|FG004|Double Blind Titration Phase|Other|0
847713|NCT00401245|1806054|FG005|Double Blind Titration Phase|Other|0
847714|NCT00401245|1806055|FG006|Double Blind Titration Phase|Other|0
847715|NCT00401245|1806056|FG007|Double Blind Titration Phase|Other|0
847716|NCT00401245|1806049|FG000|Double Blind Titration Phase|Protocol Violation|0
847717|NCT00401245|1806050|FG001|Double Blind Titration Phase|Protocol Violation|0
847718|NCT00401245|1806051|FG002|Double Blind Titration Phase|Protocol Violation|0
847719|NCT00401245|1806052|FG003|Double Blind Titration Phase|Protocol Violation|1
847720|NCT00401245|1806053|FG004|Double Blind Titration Phase|Protocol Violation|0
847721|NCT00401245|1806054|FG005|Double Blind Titration Phase|Protocol Violation|0
847722|NCT00401245|1806055|FG006|Double Blind Titration Phase|Protocol Violation|0
847723|NCT00401245|1806056|FG007|Double Blind Titration Phase|Protocol Violation|0
847724|NCT00401245|1806049|FG000|Double Blind Titration Phase|Withdrawal by Subject|1
847725|NCT00401245|1806050|FG001|Double Blind Titration Phase|Withdrawal by Subject|1
847726|NCT00401245|1806051|FG002|Double Blind Titration Phase|Withdrawal by Subject|0
847727|NCT00401245|1806052|FG003|Double Blind Titration Phase|Withdrawal by Subject|2
847728|NCT00401245|1806053|FG004|Double Blind Titration Phase|Withdrawal by Subject|0
847729|NCT00401245|1806054|FG005|Double Blind Titration Phase|Withdrawal by Subject|0
847730|NCT00401245|1806055|FG006|Double Blind Titration Phase|Withdrawal by Subject|0
847731|NCT00401245|1806056|FG007|Double Blind Titration Phase|Withdrawal by Subject|0
847732|NCT00401245|1806049|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0
847733|NCT00401245|1806050|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2
847734|NCT00401245|1806051|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0
847735|NCT00401245|1806052|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2
847736|NCT00401245|1806053|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0
847737|NCT00401245|1806054|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0
847738|NCT00401245|1806055|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0
847739|NCT00401245|1806056|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0
847740|NCT00401245|1806049|FG000|Open Label Phase|Adverse Event|5
847741|NCT00401245|1806050|FG001|Open Label Phase|Adverse Event|14
847742|NCT00401245|1806051|FG002|Open Label Phase|Adverse Event|6
847743|NCT00401245|1806052|FG003|Open Label Phase|Adverse Event|7
847744|NCT00401245|1806053|FG004|Open Label Phase|Adverse Event|0
847745|NCT00401245|1806054|FG005|Open Label Phase|Adverse Event|0
847746|NCT00401245|1806055|FG006|Open Label Phase|Adverse Event|0
847747|NCT00401245|1806056|FG007|Open Label Phase|Adverse Event|0
847748|NCT00401245|1806049|FG000|Open Label Phase|Lost to Follow-up|5
847749|NCT00401245|1806050|FG001|Open Label Phase|Lost to Follow-up|7
847750|NCT00401245|1806051|FG002|Open Label Phase|Lost to Follow-up|5
847751|NCT00401245|1806052|FG003|Open Label Phase|Lost to Follow-up|4
847752|NCT00401245|1806053|FG004|Open Label Phase|Lost to Follow-up|0
847753|NCT00401245|1806054|FG005|Open Label Phase|Lost to Follow-up|0
847754|NCT00401245|1806055|FG006|Open Label Phase|Lost to Follow-up|0
847755|NCT00401245|1806056|FG007|Open Label Phase|Lost to Follow-up|0
847756|NCT00401245|1806049|FG000|Open Label Phase|Other|4
847757|NCT00401245|1806050|FG001|Open Label Phase|Other|8
847758|NCT00401245|1806051|FG002|Open Label Phase|Other|7
847759|NCT00401245|1806052|FG003|Open Label Phase|Other|8
847760|NCT00401245|1806053|FG004|Open Label Phase|Other|0
847761|NCT00401245|1806054|FG005|Open Label Phase|Other|0
847762|NCT00401245|1806055|FG006|Open Label Phase|Other|0
847763|NCT00401245|1806056|FG007|Open Label Phase|Other|0
847764|NCT00401245|1806049|FG000|Open Label Phase|Protocol Violation|0
847765|NCT00401245|1806050|FG001|Open Label Phase|Protocol Violation|1
847766|NCT00401245|1806051|FG002|Open Label Phase|Protocol Violation|0
847767|NCT00401245|1806052|FG003|Open Label Phase|Protocol Violation|1
847768|NCT00401245|1806053|FG004|Open Label Phase|Protocol Violation|0
847769|NCT00401245|1806054|FG005|Open Label Phase|Protocol Violation|0
847770|NCT00401245|1806055|FG006|Open Label Phase|Protocol Violation|0
847771|NCT00401245|1806056|FG007|Open Label Phase|Protocol Violation|0
847772|NCT00401245|1806049|FG000|Open Label Phase|Withdrawal by Subject|3
847773|NCT00401245|1806050|FG001|Open Label Phase|Withdrawal by Subject|3
847774|NCT00401245|1806051|FG002|Open Label Phase|Withdrawal by Subject|2
847775|NCT00401245|1806052|FG003|Open Label Phase|Withdrawal by Subject|1
847776|NCT00401245|1806053|FG004|Open Label Phase|Withdrawal by Subject|0
847777|NCT00401245|1806054|FG005|Open Label Phase|Withdrawal by Subject|0
847778|NCT00401245|1806055|FG006|Open Label Phase|Withdrawal by Subject|0
847779|NCT00401245|1806056|FG007|Open Label Phase|Withdrawal by Subject|0
847780|NCT00401245|1806049|FG000|Open Label Phase|Lack of Efficacy|4
847781|NCT00401245|1806050|FG001|Open Label Phase|Lack of Efficacy|2
847782|NCT00401245|1806051|FG002|Open Label Phase|Lack of Efficacy|3
847783|NCT00401245|1806052|FG003|Open Label Phase|Lack of Efficacy|0
847784|NCT00401245|1806053|FG004|Open Label Phase|Lack of Efficacy|0
847785|NCT00401245|1806054|FG005|Open Label Phase|Lack of Efficacy|0
847786|NCT00401245|1806055|FG006|Open Label Phase|Lack of Efficacy|0
847787|NCT00401245|1806056|FG007|Open Label Phase|Lack of Efficacy|0
847788|NCT00401245|1806049|FG000|Double Blind Tapering Phase|Adverse Event|0
847789|NCT00401245|1806050|FG001|Double Blind Tapering Phase|Adverse Event|0
847790|NCT00401245|1806051|FG002|Double Blind Tapering Phase|Adverse Event|0
847791|NCT00401245|1806052|FG003|Double Blind Tapering Phase|Adverse Event|0
847792|NCT00401245|1806053|FG004|Double Blind Tapering Phase|Adverse Event|1
847793|NCT00401245|1806054|FG005|Double Blind Tapering Phase|Adverse Event|1
847794|NCT00401245|1806055|FG006|Double Blind Tapering Phase|Adverse Event|2
847795|NCT00401245|1806056|FG007|Double Blind Tapering Phase|Adverse Event|4
847796|NCT00401245|1806049|FG000|Double Blind Tapering Phase|Investigator request|0
847797|NCT00401245|1806050|FG001|Double Blind Tapering Phase|Investigator request|0
847798|NCT00401245|1806051|FG002|Double Blind Tapering Phase|Investigator request|0
847799|NCT00401245|1806052|FG003|Double Blind Tapering Phase|Investigator request|0
847800|NCT00401245|1806053|FG004|Double Blind Tapering Phase|Investigator request|0
847801|NCT00401245|1806054|FG005|Double Blind Tapering Phase|Investigator request|0
847802|NCT00401245|1806055|FG006|Double Blind Tapering Phase|Investigator request|0
847803|NCT00401245|1806056|FG007|Double Blind Tapering Phase|Investigator request|1
847804|NCT00401245|1806049|FG000|Double Blind Tapering Phase|Other|0
847805|NCT00401245|1806050|FG001|Double Blind Tapering Phase|Other|0
847806|NCT00401245|1806051|FG002|Double Blind Tapering Phase|Other|0
847807|NCT00401245|1806052|FG003|Double Blind Tapering Phase|Other|0
847808|NCT00401245|1806053|FG004|Double Blind Tapering Phase|Other|1
847809|NCT00401245|1806054|FG005|Double Blind Tapering Phase|Other|0
847810|NCT00401245|1806055|FG006|Double Blind Tapering Phase|Other|2
847811|NCT00401245|1806056|FG007|Double Blind Tapering Phase|Other|2
847812|NCT00401245|1806049|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0
847813|NCT00401245|1806050|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0
847814|NCT00401245|1806051|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0
847815|NCT00401245|1806052|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0
847816|NCT00401245|1806053|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2
847817|NCT00401245|1806054|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2
847818|NCT00401245|1806055|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3
847819|NCT00401245|1806056|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0
847820|NCT00401245|1806049|FG000|Double Blind Tapering Phase|Lack of Efficacy|0
847821|NCT00401245|1806050|FG001|Double Blind Tapering Phase|Lack of Efficacy|0
847822|NCT00401245|1806051|FG002|Double Blind Tapering Phase|Lack of Efficacy|0
847823|NCT00401245|1806052|FG003|Double Blind Tapering Phase|Lack of Efficacy|0
847824|NCT00401245|1806053|FG004|Double Blind Tapering Phase|Lack of Efficacy|0
847825|NCT00401245|1806054|FG005|Double Blind Tapering Phase|Lack of Efficacy|1
847826|NCT00401245|1806055|FG006|Double Blind Tapering Phase|Lack of Efficacy|0
847827|NCT00401245|1806056|FG007|Double Blind Tapering Phase|Lack of Efficacy|0
847828|NCT00401258|1806076|FG000|Overall Study|Adverse Event|7
847829|NCT00401375|1806083|FG000|Overall Study|Protocol Violation|2
847830|NCT00401375|1806084|FG001|Overall Study|Protocol Violation|2
847831|NCT00401375|1806085|FG002|Overall Study|Protocol Violation|1
847832|NCT00401375|1806083|FG000|Overall Study|Adverse Event|6
847833|NCT00401375|1806084|FG001|Overall Study|Adverse Event|11
847834|NCT00401375|1806085|FG002|Overall Study|Adverse Event|10
847835|NCT00401375|1806083|FG000|Overall Study|Withdrawal by Subject|9
847836|NCT00401375|1806084|FG001|Overall Study|Withdrawal by Subject|7
847837|NCT00401375|1806085|FG002|Overall Study|Withdrawal by Subject|7
847838|NCT00401375|1806083|FG000|Overall Study|Lost to Follow-up|0
847839|NCT00401375|1806084|FG001|Overall Study|Lost to Follow-up|1
847840|NCT00401375|1806085|FG002|Overall Study|Lost to Follow-up|1
847841|NCT00401375|1806083|FG000|Overall Study|Other than specified|2
847842|NCT00401375|1806084|FG001|Overall Study|Other than specified|1
847843|NCT00401375|1806085|FG002|Overall Study|Other than specified|3
847844|NCT00401375|1806083|FG000|Overall Study|Randomized but not treated|3
847845|NCT00401375|1806084|FG001|Overall Study|Randomized but not treated|3
847846|NCT00401375|1806085|FG002|Overall Study|Randomized but not treated|3
847847|NCT00401531|1806144|FG000|Overall Study|Adverse Event|2
847848|NCT00401531|1806145|FG001|Overall Study|Adverse Event|0
847849|NCT00401531|1806144|FG000|Overall Study|Protocol Violation|3
847850|NCT00401531|1806145|FG001|Overall Study|Protocol Violation|7
847851|NCT00401531|1806144|FG000|Overall Study|Lost to Follow-up|1
847852|NCT00401531|1806145|FG001|Overall Study|Lost to Follow-up|1
847853|NCT00401531|1806144|FG000|Overall Study|Withdrawal by Subject|3
847854|NCT00401531|1806145|FG001|Overall Study|Withdrawal by Subject|2
847855|NCT00401544|1806155|FG000|Overall Study|Adverse Event|5
847856|NCT00401544|1806156|FG001|Overall Study|Adverse Event|1
847857|NCT00401544|1806157|FG002|Overall Study|Adverse Event|1
847858|NCT00401544|1806158|FG003|Overall Study|Adverse Event|1
847859|NCT00401544|1806155|FG000|Overall Study|Death|3
847860|NCT00401544|1806156|FG001|Overall Study|Death|6
847861|NCT00401544|1806157|FG002|Overall Study|Death|2
847862|NCT00401544|1806158|FG003|Overall Study|Death|5
847863|NCT00401544|1806155|FG000|Overall Study|Lost to Follow-up|2
847864|NCT00401544|1806156|FG001|Overall Study|Lost to Follow-up|0
847865|NCT00401544|1806157|FG002|Overall Study|Lost to Follow-up|1
847866|NCT00401544|1806158|FG003|Overall Study|Lost to Follow-up|1
847867|NCT00401544|1806155|FG000|Overall Study|Withdrawal by Subject|7
847868|NCT00401544|1806156|FG001|Overall Study|Withdrawal by Subject|6
847869|NCT00401544|1806157|FG002|Overall Study|Withdrawal by Subject|6
847870|NCT00401544|1806158|FG003|Overall Study|Withdrawal by Subject|5
847871|NCT00401544|1806155|FG000|Overall Study|Physician Decision|1
847872|NCT00401544|1806156|FG001|Overall Study|Physician Decision|3
847873|NCT00401544|1806157|FG002|Overall Study|Physician Decision|0
847874|NCT00401544|1806158|FG003|Overall Study|Physician Decision|0
847875|NCT00401544|1806155|FG000|Overall Study|Ineligibility determined|0
847876|NCT00401544|1806156|FG001|Overall Study|Ineligibility determined|1
847877|NCT00401544|1806157|FG002|Overall Study|Ineligibility determined|0
847878|NCT00401544|1806158|FG003|Overall Study|Ineligibility determined|2
847879|NCT00401544|1806155|FG000|Overall Study|Disease progression|0
847880|NCT00401544|1806156|FG001|Overall Study|Disease progression|1
847881|NCT00401544|1806157|FG002|Overall Study|Disease progression|0
847882|NCT00401544|1806158|FG003|Overall Study|Disease progression|0
847883|NCT00401544|1806155|FG000|Overall Study|Other|0
847884|NCT00401544|1806156|FG001|Overall Study|Other|0
847885|NCT00401544|1806157|FG002|Overall Study|Other|2
847886|NCT00401544|1806158|FG003|Overall Study|Other|2
847887|NCT00401726|1806184|FG000|Overall Study|Adverse Event|34
847888|NCT00401726|1806185|FG001|Overall Study|Adverse Event|45
847889|NCT00401726|1806184|FG000|Overall Study|Death|0
847890|NCT00401726|1806185|FG001|Overall Study|Death|3
847891|NCT00401726|1806184|FG000|Overall Study|Sponsor Request|0
847892|NCT00401726|1806185|FG001|Overall Study|Sponsor Request|1
847893|NCT00401726|1806184|FG000|Overall Study|Physician Decision|3
847894|NCT00401726|1806185|FG001|Overall Study|Physician Decision|6
847895|NCT00401726|1806184|FG000|Overall Study|Lost to Follow-up|23
847896|NCT00401726|1806185|FG001|Overall Study|Lost to Follow-up|20
847897|NCT00401726|1806184|FG000|Overall Study|Protocol Violation|6
847898|NCT00401726|1806185|FG001|Overall Study|Protocol Violation|3
847899|NCT00401726|1806184|FG000|Overall Study|Withdrawal by Subject|18
847900|NCT00401726|1806185|FG001|Overall Study|Withdrawal by Subject|24
847901|NCT00401726|1806184|FG000|Overall Study|Lack of Efficacy|4
847902|NCT00401726|1806185|FG001|Overall Study|Lack of Efficacy|6
847903|NCT00401726|1806184|FG000|Overall Study|Protocol Deviation|9
847904|NCT00401726|1806185|FG001|Overall Study|Protocol Deviation|4
847905|NCT00401752|1806193|FG000|Overall Study|Adverse Event|2
847906|NCT00401752|1806194|FG001|Overall Study|Adverse Event|5
847907|NCT00401752|1806193|FG000|Overall Study|Withdrawal by Subject|2
847908|NCT00401752|1806194|FG001|Overall Study|Withdrawal by Subject|6
847909|NCT00401752|1806193|FG000|Overall Study|Lost to Follow-up|1
847910|NCT00401752|1806194|FG001|Overall Study|Lost to Follow-up|4
847911|NCT00401752|1806193|FG000|Overall Study|Development of any exclusion criteria|4
847912|NCT00401752|1806194|FG001|Overall Study|Development of any exclusion criteria|2
847913|NCT00401752|1806193|FG000|Overall Study|Physician Decision|1
847914|NCT00401752|1806194|FG001|Overall Study|Physician Decision|1
847915|NCT00401830|1806220|FG000|Overall Study|Adverse Event|10
847916|NCT00401830|1806221|FG001|Overall Study|Adverse Event|18
847917|NCT00401830|1806220|FG000|Overall Study|Lack of Efficacy|11
847918|NCT00401830|1806221|FG001|Overall Study|Lack of Efficacy|5
847919|NCT00401830|1806220|FG000|Overall Study|Withdrawal by Subject|4
847920|NCT00401830|1806221|FG001|Overall Study|Withdrawal by Subject|3
847921|NCT00401830|1806220|FG000|Overall Study|Protocol Violation|3
847922|NCT00401830|1806221|FG001|Overall Study|Protocol Violation|3
847923|NCT00401830|1806220|FG000|Overall Study|Non-compliance with drug study|1
847924|NCT00401830|1806221|FG001|Overall Study|Non-compliance with drug study|0
847925|NCT00401830|1806220|FG000|Overall Study|Lost to Follow-up|1
847926|NCT00401830|1806221|FG001|Overall Study|Lost to Follow-up|3
847927|NCT00401830|1806220|FG000|Overall Study|Other: Personal / Family problems|1
847928|NCT00401830|1806221|FG001|Overall Study|Other: Personal / Family problems|0
847929|NCT00401843|1806230|FG000|Overall Study|Achieved Complete Response|1
847930|NCT00401843|1806231|FG001|Overall Study|Achieved Complete Response|5
847931|NCT00401843|1806232|FG002|Overall Study|Achieved Complete Response|11
847932|NCT00401843|1806230|FG000|Overall Study|Adverse Event|7
847933|NCT00401843|1806231|FG001|Overall Study|Adverse Event|26
847934|NCT00401843|1806232|FG002|Overall Study|Adverse Event|27
847935|NCT00401843|1806230|FG000|Overall Study|Death|0
847936|NCT00401843|1806231|FG001|Overall Study|Death|8
847937|NCT00401843|1806232|FG002|Overall Study|Death|10
847938|NCT00401843|1806230|FG000|Overall Study|Disease progression|10
847939|NCT00401843|1806231|FG001|Overall Study|Disease progression|60
847940|NCT00401843|1806232|FG002|Overall Study|Disease progression|49
847941|NCT00401843|1806230|FG000|Overall Study|End of Study|1
847942|NCT00401843|1806231|FG001|Overall Study|End of Study|1
847943|NCT00401843|1806232|FG002|Overall Study|End of Study|2
847944|NCT00401843|1806230|FG000|Overall Study|Lost to Follow-up|0
847945|NCT00401843|1806231|FG001|Overall Study|Lost to Follow-up|0
847946|NCT00401843|1806232|FG002|Overall Study|Lost to Follow-up|2
847947|NCT00401843|1806230|FG000|Overall Study|Other Unspecified|0
847948|NCT00401843|1806231|FG001|Overall Study|Other Unspecified|3
847949|NCT00401843|1806232|FG002|Overall Study|Other Unspecified|5
847950|NCT00401843|1806230|FG000|Overall Study|Physician Decision|0
847951|NCT00401843|1806231|FG001|Overall Study|Physician Decision|16
847952|NCT00401843|1806232|FG002|Overall Study|Physician Decision|10
847953|NCT00401843|1806230|FG000|Overall Study|Protocol Violation|0
847954|NCT00401843|1806231|FG001|Overall Study|Protocol Violation|0
847955|NCT00401843|1806232|FG002|Overall Study|Protocol Violation|1
847956|NCT00401843|1806230|FG000|Overall Study|Withdrawal by Subject|1
847957|NCT00401843|1806231|FG001|Overall Study|Withdrawal by Subject|5
847958|NCT00401843|1806232|FG002|Overall Study|Withdrawal by Subject|5
847959|NCT00401843|1806230|FG000|Overall Study|Withdrawal of consent to study agent|1
847960|NCT00401843|1806231|FG001|Overall Study|Withdrawal of consent to study agent|15
847961|NCT00401843|1806232|FG002|Overall Study|Withdrawal of consent to study agent|17
847962|NCT00401843|1806230|FG000|Overall Study|Randomized but not Treated|0
847963|NCT00401843|1806231|FG001|Overall Study|Randomized but not Treated|2
847964|NCT00401843|1806232|FG002|Overall Study|Randomized but not Treated|3
847965|NCT00401843|1806230|FG000|Overall Study|Received incorrect treatment|0
847966|NCT00401843|1806231|FG001|Overall Study|Received incorrect treatment|3
847967|NCT00401843|1806232|FG002|Overall Study|Received incorrect treatment|0
847968|NCT00401960|1806259|FG000|Overall Study|Lost to Follow-up|3
847969|NCT00401960|1806260|FG001|Overall Study|Lost to Follow-up|0
847970|NCT00401960|1806259|FG000|Overall Study|Death|2
847971|NCT00401960|1806260|FG001|Overall Study|Death|0
847972|NCT00401973|1806271|FG000|Overall Study|Adverse Event|2
847973|NCT00401973|1806272|FG001|Overall Study|Adverse Event|8
847974|NCT00401973|1806273|FG002|Overall Study|Adverse Event|4
847975|NCT00401973|1806271|FG000|Overall Study|Clinical Relapse|0
847976|NCT00401973|1806272|FG001|Overall Study|Clinical Relapse|1
847977|NCT00401973|1806273|FG002|Overall Study|Clinical Relapse|1
847978|NCT00401973|1806271|FG000|Overall Study|Lack of Efficacy|0
847979|NCT00401973|1806272|FG001|Overall Study|Lack of Efficacy|0
847980|NCT00401973|1806273|FG002|Overall Study|Lack of Efficacy|3
847981|NCT00401973|1806271|FG000|Overall Study|Lost to Follow-up|2
847982|NCT00401973|1806272|FG001|Overall Study|Lost to Follow-up|2
847983|NCT00401973|1806273|FG002|Overall Study|Lost to Follow-up|2
847984|NCT00401973|1806271|FG000|Overall Study|Physician Decision|2
847985|NCT00401973|1806272|FG001|Overall Study|Physician Decision|0
847986|NCT00401973|1806273|FG002|Overall Study|Physician Decision|1
847987|NCT00401973|1806271|FG000|Overall Study|Protocol Violation|1
847988|NCT00401973|1806272|FG001|Overall Study|Protocol Violation|2
847989|NCT00401973|1806273|FG002|Overall Study|Protocol Violation|3
847990|NCT00401973|1806271|FG000|Overall Study|Sponsor Decision|0
847991|NCT00401973|1806272|FG001|Overall Study|Sponsor Decision|1
847992|NCT00401973|1806273|FG002|Overall Study|Sponsor Decision|0
847993|NCT00401973|1806271|FG000|Overall Study|Withdrawal by Subject|4
847994|NCT00401973|1806272|FG001|Overall Study|Withdrawal by Subject|12
847995|NCT00401973|1806273|FG002|Overall Study|Withdrawal by Subject|9
847996|NCT00402025|1806295|FG000|Overall Study|Adverse Event|0
847997|NCT00402025|1806296|FG001|Overall Study|Adverse Event|0
847998|NCT00402025|1806297|FG002|Overall Study|Adverse Event|2
847999|NCT00402025|1806295|FG000|Overall Study|Death|0
848000|NCT00402025|1806296|FG001|Overall Study|Death|1
848001|NCT00402025|1806297|FG002|Overall Study|Death|5
848002|NCT00402025|1806295|FG000|Overall Study|Disease Progression|1
848003|NCT00402025|1806296|FG001|Overall Study|Disease Progression|1
848004|NCT00402025|1806297|FG002|Overall Study|Disease Progression|2
848005|NCT00402025|1806295|FG000|Overall Study|Physician Decision|1
848006|NCT00402025|1806296|FG001|Overall Study|Physician Decision|1
848007|NCT00402025|1806297|FG002|Overall Study|Physician Decision|0
848008|NCT00402025|1806295|FG000|Overall Study|Participant Decision|0
848009|NCT00402025|1806296|FG001|Overall Study|Participant Decision|0
848010|NCT00402025|1806297|FG002|Overall Study|Participant Decision|1
848011|NCT00402051|1806307|FG000|Overall Study|Progressive Disease|13
848012|NCT00402051|1806308|FG001|Overall Study|Progressive Disease|20
848013|NCT00402051|1806307|FG000|Overall Study|Adverse Event|11
848014|NCT00402051|1806308|FG001|Overall Study|Adverse Event|4
848015|NCT00402051|1806307|FG000|Overall Study|Physician Decision|7
848016|NCT00402051|1806308|FG001|Overall Study|Physician Decision|3
848017|NCT00402051|1806307|FG000|Overall Study|Withdrawal by Subject|3
848018|NCT00402051|1806308|FG001|Overall Study|Withdrawal by Subject|3
848019|NCT00402051|1806307|FG000|Overall Study|Death - Related to Study Drug|1
848020|NCT00402051|1806308|FG001|Overall Study|Death - Related to Study Drug|2
848021|NCT00402051|1806307|FG000|Overall Study|Death Due to Study Disease|2
848022|NCT00402051|1806308|FG001|Overall Study|Death Due to Study Disease|1
848023|NCT00402051|1806307|FG000|Overall Study|Death Due to Adverse Event|0
848024|NCT00402051|1806308|FG001|Overall Study|Death Due to Adverse Event|2
848025|NCT00402051|1806307|FG000|Overall Study|Lost to Follow-up|1
848026|NCT00402051|1806308|FG001|Overall Study|Lost to Follow-up|0
848027|NCT00402103|1806316|FG000|Overall Study|Adverse Event|60
848028|NCT00402103|1806317|FG001|Overall Study|Adverse Event|7
848029|NCT00402103|1806316|FG000|Overall Study|Unsatisfactory therapeutic effect|1
848030|NCT00402103|1806317|FG001|Overall Study|Unsatisfactory therapeutic effect|2
848031|NCT00402103|1806316|FG000|Overall Study|Condition no longer requires study drug|2
848032|NCT00402103|1806317|FG001|Overall Study|Condition no longer requires study drug|0
848033|NCT00402103|1806316|FG000|Overall Study|Protocol Deviation|8
848034|NCT00402103|1806317|FG001|Overall Study|Protocol Deviation|0
848035|NCT00402103|1806316|FG000|Overall Study|Patient withdrew consent|12
848036|NCT00402103|1806317|FG001|Overall Study|Patient withdrew consent|1
848037|NCT00402103|1806316|FG000|Overall Study|Lost to Follow-up|6
848038|NCT00402103|1806317|FG001|Overall Study|Lost to Follow-up|3
848039|NCT00402103|1806316|FG000|Overall Study|Administrative problems|2
848040|NCT00402103|1806317|FG001|Overall Study|Administrative problems|0
848041|NCT00402116|1806330|FG000|Overall Study|Jaw infection after surgery-other|1
848042|NCT00402116|1806331|FG001|Overall Study|Jaw infection after surgery-other|0
848043|NCT00402116|1806332|FG002|Overall Study|Jaw infection after surgery-other|0
848044|NCT00402116|1806330|FG000|Overall Study|Withdrawal by Subject|1
848045|NCT00402116|1806331|FG001|Overall Study|Withdrawal by Subject|0
848046|NCT00402116|1806332|FG002|Overall Study|Withdrawal by Subject|5
848047|NCT00402116|1806330|FG000|Overall Study|Treatment completed per protocol|1
848048|NCT00402116|1806331|FG001|Overall Study|Treatment completed per protocol|1
848049|NCT00402116|1806332|FG002|Overall Study|Treatment completed per protocol|2
848050|NCT00402116|1806330|FG000|Overall Study|other complicating disease|0
848051|NCT00402116|1806331|FG001|Overall Study|other complicating disease|0
848052|NCT00402116|1806332|FG002|Overall Study|other complicating disease|2
848053|NCT00402116|1806330|FG000|Overall Study|Disease Progression|0
848054|NCT00402116|1806331|FG001|Overall Study|Disease Progression|4
848055|NCT00402116|1806332|FG002|Overall Study|Disease Progression|38
848056|NCT00402116|1806330|FG000|Overall Study|mistaken thrombocytopenia|0
848057|NCT00402116|1806331|FG001|Overall Study|mistaken thrombocytopenia|0
848058|NCT00402116|1806332|FG002|Overall Study|mistaken thrombocytopenia|1
848059|NCT00402116|1806330|FG000|Overall Study|decline related hyponatremia/tumor|0
848060|NCT00402116|1806331|FG001|Overall Study|decline related hyponatremia/tumor|0
848061|NCT00402116|1806332|FG002|Overall Study|decline related hyponatremia/tumor|1
848062|NCT00402116|1806330|FG000|Overall Study|Adverse Event|0
848063|NCT00402116|1806331|FG001|Overall Study|Adverse Event|1
848064|NCT00402116|1806332|FG002|Overall Study|Adverse Event|6
848065|NCT00402168|1806362|FG000|Randomized|Lost to Follow-up|1
848066|NCT00402168|1806363|FG001|Randomized|Lost to Follow-up|0
848067|NCT00402168|1806362|FG000|Randomized|Withdrawal by Subject|0
848068|NCT00402168|1806363|FG001|Randomized|Withdrawal by Subject|1
848069|NCT00402168|1806362|FG000|Treatment (up to 12 Months)|Death|0
848070|NCT00402168|1806363|FG001|Treatment (up to 12 Months)|Death|1
848071|NCT00402168|1806362|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2
848072|NCT00402168|1806363|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0
848073|NCT00402168|1806362|FG000|Treatment (up to 12 Months)|non-specified|0
848074|NCT00402168|1806363|FG001|Treatment (up to 12 Months)|non-specified|1
848075|NCT00402168|1806362|FG000|Long Term (LT)|Adverse Event|1
848076|NCT00402168|1806363|FG001|Long Term (LT)|Adverse Event|5
848077|NCT00402168|1806362|FG000|Long Term (LT)|Withdrawal by Subject|4
848078|NCT00402168|1806363|FG001|Long Term (LT)|Withdrawal by Subject|7
848079|NCT00402168|1806362|FG000|Long Term (LT)|Pregnancy|0
848080|NCT00402168|1806363|FG001|Long Term (LT)|Pregnancy|1
848081|NCT00402168|1806362|FG000|Long Term (LT)|Lost to Follow-up|1
848082|NCT00402168|1806363|FG001|Long Term (LT)|Lost to Follow-up|0
848083|NCT00402168|1806362|FG000|Long Term (LT)|Death|4
848084|NCT00402168|1806363|FG001|Long Term (LT)|Death|0
848085|NCT00402168|1806362|FG000|Long Term (LT)|Lack of Efficacy|0
848086|NCT00402168|1806363|FG001|Long Term (LT)|Lack of Efficacy|2
848087|NCT00402168|1806362|FG000|Long Term (LT)|non-specified|1
848088|NCT00402168|1806363|FG001|Long Term (LT)|non-specified|2
848089|NCT00402168|1806362|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
848090|NCT00402168|1806363|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
848091|NCT00402168|1806362|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4
848092|NCT00402168|1806363|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0
848093|NCT00402233|1806390|FG000|Overall Study|Adverse Event|1
848094|NCT00402233|1806391|FG001|Overall Study|Adverse Event|7
848095|NCT00402233|1806392|FG002|Overall Study|Adverse Event|9
848096|NCT00402233|1806393|FG003|Overall Study|Adverse Event|9
848097|NCT00402233|1806390|FG000|Overall Study|Protocol Violation|0
848098|NCT00402233|1806391|FG001|Overall Study|Protocol Violation|1
848099|NCT00402233|1806392|FG002|Overall Study|Protocol Violation|0
848100|NCT00402233|1806393|FG003|Overall Study|Protocol Violation|0
848101|NCT00402233|1806390|FG000|Overall Study|Withdrawal by Subject|2
848102|NCT00402233|1806391|FG001|Overall Study|Withdrawal by Subject|1
848103|NCT00402233|1806392|FG002|Overall Study|Withdrawal by Subject|2
848104|NCT00402233|1806393|FG003|Overall Study|Withdrawal by Subject|2
848105|NCT00402233|1806390|FG000|Overall Study|Worsening of disease under study|2
848106|NCT00402233|1806391|FG001|Overall Study|Worsening of disease under study|0
848107|NCT00402233|1806392|FG002|Overall Study|Worsening of disease under study|0
848108|NCT00402233|1806393|FG003|Overall Study|Worsening of disease under study|0
848109|NCT00402233|1806390|FG000|Overall Study|Worsening of other pre-existing disease|0
848110|NCT00402233|1806391|FG001|Overall Study|Worsening of other pre-existing disease|1
848111|NCT00402233|1806392|FG002|Overall Study|Worsening of other pre-existing disease|0
848112|NCT00402233|1806393|FG003|Overall Study|Worsening of other pre-existing disease|0
848113|NCT00402246|1806405|FG000|Overall Study|Death|62
848114|NCT00402246|1806406|FG001|Overall Study|Death|58
848115|NCT00402246|1806405|FG000|Overall Study|Lost to Follow-up|20
848116|NCT00402246|1806406|FG001|Overall Study|Lost to Follow-up|28
848117|NCT00402246|1806405|FG000|Overall Study|Withdrawal by Subject|72
848118|NCT00402246|1806406|FG001|Overall Study|Withdrawal by Subject|87
848119|NCT00402246|1806405|FG000|Overall Study|Physician Decision|24
848120|NCT00402246|1806406|FG001|Overall Study|Physician Decision|26
848121|NCT00402246|1806405|FG000|Overall Study|Protocol Violation|25
848122|NCT00402246|1806406|FG001|Overall Study|Protocol Violation|24
848123|NCT00402246|1806405|FG000|Overall Study|Missed Final Visit|1
848124|NCT00402246|1806406|FG001|Overall Study|Missed Final Visit|2
848125|NCT00402246|1806405|FG000|Overall Study|Insurance Issues|2
848126|NCT00402246|1806406|FG001|Overall Study|Insurance Issues|1
848127|NCT00402246|1806405|FG000|Overall Study|Heart Transplant|0
848128|NCT00402246|1806406|FG001|Overall Study|Heart Transplant|1
848129|NCT00402246|1806405|FG000|Overall Study|Patient's device explanted|6
848130|NCT00402246|1806406|FG001|Overall Study|Patient's device explanted|2
848131|NCT00402246|1806405|FG000|Overall Study|Center Closure|5
848132|NCT00402246|1806406|FG001|Overall Study|Center Closure|3
848133|NCT00402246|1806405|FG000|Overall Study|Deterioriating Condition|3
848134|NCT00402246|1806406|FG001|Overall Study|Deterioriating Condition|2
848135|NCT00402285|1806417|FG000|Overall Study|insufficient RNA quality|7
848136|NCT00402285|1806418|FG001|Overall Study|insufficient RNA quality|6
848137|NCT00402285|1806419|FG002|Overall Study|insufficient RNA quality|2
848138|NCT00402298|1806427|FG000|Overall Study|Withdrawal by Subject|1
848139|NCT00402298|1806428|FG001|Overall Study|Withdrawal by Subject|0
848140|NCT00402324|1806436|FG000|Overall Study|Lost to Follow-up|11
848141|NCT00402324|1806437|FG001|Overall Study|Lost to Follow-up|11
848142|NCT00402324|1806436|FG000|Overall Study|Protocol Entry Criteria Not Met|5
848143|NCT00402324|1806437|FG001|Overall Study|Protocol Entry Criteria Not Met|4
848144|NCT00402324|1806436|FG000|Overall Study|Protocol Violation|8
848145|NCT00402324|1806437|FG001|Overall Study|Protocol Violation|7
848146|NCT00402324|1806436|FG000|Overall Study|Withdrawal by Subject|5
848147|NCT00402324|1806437|FG001|Overall Study|Withdrawal by Subject|2
848148|NCT00402324|1806436|FG000|Overall Study|Physician Decision|2
848149|NCT00402324|1806437|FG001|Overall Study|Physician Decision|4
848150|NCT00402324|1806436|FG000|Overall Study|Sponsor Decision|4
848151|NCT00402324|1806437|FG001|Overall Study|Sponsor Decision|5
848152|NCT00402324|1806436|FG000|Overall Study|Lack of Efficacy|1
848153|NCT00402324|1806437|FG001|Overall Study|Lack of Efficacy|4
848154|NCT00402324|1806436|FG000|Overall Study|Adverse Event|6
848155|NCT00402324|1806437|FG001|Overall Study|Adverse Event|4
848156|NCT00402324|1806436|FG000|Overall Study|Death|1
848157|NCT00402324|1806437|FG001|Overall Study|Death|0
848158|NCT00402337|1806448|FG000|Overall Study|Adverse Event|0
848159|NCT00402337|1806449|FG001|Overall Study|Adverse Event|2
848160|NCT00402337|1806450|FG002|Overall Study|Adverse Event|2
848161|NCT00402337|1806451|FG003|Overall Study|Adverse Event|3
848162|NCT00402337|1806452|FG004|Overall Study|Adverse Event|2
848163|NCT00402337|1806448|FG000|Overall Study|Noncompliance|0
848164|NCT00402337|1806449|FG001|Overall Study|Noncompliance|0
848165|NCT00402337|1806450|FG002|Overall Study|Noncompliance|0
848166|NCT00402337|1806451|FG003|Overall Study|Noncompliance|0
848167|NCT00402337|1806452|FG004|Overall Study|Noncompliance|2
848168|NCT00402337|1806448|FG000|Overall Study|Withdrawal by Subject|5
848169|NCT00402337|1806449|FG001|Overall Study|Withdrawal by Subject|3
848170|NCT00402337|1806450|FG002|Overall Study|Withdrawal by Subject|1
848171|NCT00402337|1806451|FG003|Overall Study|Withdrawal by Subject|6
848172|NCT00402337|1806452|FG004|Overall Study|Withdrawal by Subject|4
848173|NCT00402337|1806448|FG000|Overall Study|Lost to Follow-up|0
848174|NCT00402337|1806449|FG001|Overall Study|Lost to Follow-up|0
848175|NCT00402337|1806450|FG002|Overall Study|Lost to Follow-up|1
848176|NCT00402337|1806451|FG003|Overall Study|Lost to Follow-up|2
848177|NCT00402337|1806452|FG004|Overall Study|Lost to Follow-up|0
848178|NCT00402337|1806448|FG000|Overall Study|Physician Decision|0
848179|NCT00402337|1806449|FG001|Overall Study|Physician Decision|0
848180|NCT00402337|1806450|FG002|Overall Study|Physician Decision|0
848181|NCT00402337|1806451|FG003|Overall Study|Physician Decision|1
848182|NCT00402337|1806452|FG004|Overall Study|Physician Decision|0
848183|NCT00402337|1806448|FG000|Overall Study|Other Reason|0
848184|NCT00402337|1806449|FG001|Overall Study|Other Reason|1
848185|NCT00402337|1806450|FG002|Overall Study|Other Reason|0
848186|NCT00402337|1806451|FG003|Overall Study|Other Reason|0
848187|NCT00402337|1806452|FG004|Overall Study|Other Reason|0
848188|NCT00402363|1806468|FG000|Overall Study|Adverse Event|9
848189|NCT00402363|1806469|FG001|Overall Study|Adverse Event|14
848190|NCT00402363|1806470|FG002|Overall Study|Adverse Event|2
848191|NCT00402363|1806471|FG003|Overall Study|Adverse Event|2
848192|NCT00402363|1806468|FG000|Overall Study|Withdrew Consent|10
848193|NCT00402363|1806469|FG001|Overall Study|Withdrew Consent|5
848194|NCT00402363|1806470|FG002|Overall Study|Withdrew Consent|2
848195|NCT00402363|1806471|FG003|Overall Study|Withdrew Consent|1
848196|NCT00402363|1806468|FG000|Overall Study|Protocol Violation|3
848197|NCT00402363|1806469|FG001|Overall Study|Protocol Violation|5
848198|NCT00402363|1806470|FG002|Overall Study|Protocol Violation|0
848199|NCT00402363|1806471|FG003|Overall Study|Protocol Violation|3
848200|NCT00402363|1806468|FG000|Overall Study|Lost to Follow-up|5
848201|NCT00402363|1806469|FG001|Overall Study|Lost to Follow-up|4
848202|NCT00402363|1806470|FG002|Overall Study|Lost to Follow-up|0
848203|NCT00402363|1806471|FG003|Overall Study|Lost to Follow-up|2
848204|NCT00402363|1806468|FG000|Overall Study|"Captured as Other"|6
848205|NCT00402363|1806469|FG001|Overall Study|"Captured as Other"|2
848206|NCT00402363|1806470|FG002|Overall Study|"Captured as Other"|2
848207|NCT00402363|1806471|FG003|Overall Study|"Captured as Other"|2
848208|NCT00402597|1806492|FG000|Overall Study|Death|15
848209|NCT00402597|1806493|FG001|Overall Study|Death|7
848210|NCT00402597|1806494|FG002|Overall Study|Death|6
848211|NCT00402597|1806495|FG003|Overall Study|Death|4
848212|NCT00402597|1806496|FG004|Overall Study|Death|6
848213|NCT00402597|1806492|FG000|Overall Study|Adverse Event|81
848214|NCT00402597|1806493|FG001|Overall Study|Adverse Event|18
848215|NCT00402597|1806494|FG002|Overall Study|Adverse Event|106
848216|NCT00402597|1806495|FG003|Overall Study|Adverse Event|39
848217|NCT00402597|1806496|FG004|Overall Study|Adverse Event|71
848218|NCT00402597|1806492|FG000|Overall Study|Lost to Follow-up|8
848219|NCT00402597|1806493|FG001|Overall Study|Lost to Follow-up|1
848220|NCT00402597|1806494|FG002|Overall Study|Lost to Follow-up|8
848221|NCT00402597|1806495|FG003|Overall Study|Lost to Follow-up|2
848222|NCT00402597|1806496|FG004|Overall Study|Lost to Follow-up|3
848223|NCT00402597|1806492|FG000|Overall Study|Withdrawal by Subject|57
848224|NCT00402597|1806493|FG001|Overall Study|Withdrawal by Subject|16
848225|NCT00402597|1806494|FG002|Overall Study|Withdrawal by Subject|65
848226|NCT00402597|1806495|FG003|Overall Study|Withdrawal by Subject|15
848227|NCT00402597|1806496|FG004|Overall Study|Withdrawal by Subject|24
848228|NCT00402597|1806492|FG000|Overall Study|reason not specified|30
848229|NCT00402597|1806493|FG001|Overall Study|reason not specified|4
848230|NCT00402597|1806494|FG002|Overall Study|reason not specified|27
848231|NCT00402597|1806495|FG003|Overall Study|reason not specified|14
848232|NCT00402597|1806496|FG004|Overall Study|reason not specified|20
848233|NCT00402649|1806508|FG000|Overall Study|Lost to Follow-up|1
848234|NCT00402649|1806508|FG000|Overall Study|Withdrawal by Subject|1
848235|NCT00402688|1806515|FG000|Overall Study|Adverse Event|12
848236|NCT00402688|1806516|FG001|Overall Study|Adverse Event|9
848237|NCT00402688|1806517|FG002|Overall Study|Adverse Event|3
848238|NCT00402688|1806515|FG000|Overall Study|Withdrawal by Subject|3
848239|NCT00402688|1806516|FG001|Overall Study|Withdrawal by Subject|1
848240|NCT00402688|1806517|FG002|Overall Study|Withdrawal by Subject|1
848241|NCT00402688|1806515|FG000|Overall Study|Physician Decision|0
848242|NCT00402688|1806516|FG001|Overall Study|Physician Decision|0
848243|NCT00402688|1806517|FG002|Overall Study|Physician Decision|1
848244|NCT00402688|1806515|FG000|Overall Study|Lack of Efficacy|4
848245|NCT00402688|1806516|FG001|Overall Study|Lack of Efficacy|4
848246|NCT00402688|1806517|FG002|Overall Study|Lack of Efficacy|5
848247|NCT00402688|1806515|FG000|Overall Study|Protocol Violation|1
848248|NCT00402688|1806516|FG001|Overall Study|Protocol Violation|1
848249|NCT00402688|1806517|FG002|Overall Study|Protocol Violation|1
848250|NCT00402688|1806515|FG000|Overall Study|Lost to Follow-up|1
848251|NCT00402688|1806516|FG001|Overall Study|Lost to Follow-up|0
848252|NCT00402688|1806517|FG002|Overall Study|Lost to Follow-up|2
848253|NCT00402688|1806515|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0
848254|NCT00402688|1806516|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1
848255|NCT00402688|1806517|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0
848256|NCT00402688|1806515|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
848257|NCT00402688|1806516|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
848258|NCT00402688|1806517|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
848259|NCT00402688|1806515|FG000|Overall Study|Patient Left Town and Forgot Medication|0
848260|NCT00402688|1806516|FG001|Overall Study|Patient Left Town and Forgot Medication|0
848261|NCT00402688|1806517|FG002|Overall Study|Patient Left Town and Forgot Medication|1
848262|NCT00402727|1806538|FG000|Overall Study|Adverse Event|10
848263|NCT00402727|1806539|FG001|Overall Study|Adverse Event|6
848264|NCT00402727|1806538|FG000|Overall Study|Death|1
848265|NCT00402727|1806539|FG001|Overall Study|Death|0
848266|NCT00402727|1806538|FG000|Overall Study|Lack of Efficacy|1
848267|NCT00402727|1806539|FG001|Overall Study|Lack of Efficacy|3
848268|NCT00402727|1806538|FG000|Overall Study|Lost to Follow-up|24
848269|NCT00402727|1806539|FG001|Overall Study|Lost to Follow-up|11
848270|NCT00402727|1806538|FG000|Overall Study|Physician Decision|1
848271|NCT00402727|1806539|FG001|Overall Study|Physician Decision|1
848272|NCT00402727|1806538|FG000|Overall Study|Protocol Violation|0
848273|NCT00402727|1806539|FG001|Overall Study|Protocol Violation|4
848274|NCT00402727|1806538|FG000|Overall Study|Withdrawal by Subject|3
848275|NCT00402727|1806539|FG001|Overall Study|Withdrawal by Subject|7
848276|NCT00402727|1806538|FG000|Overall Study|supply problems|2
848277|NCT00402727|1806539|FG001|Overall Study|supply problems|1
848278|NCT00402727|1806538|FG000|Overall Study|non-compliance|0
848279|NCT00402727|1806539|FG001|Overall Study|non-compliance|1
848280|NCT00402740|1806545|FG000|Overall Study|Withdrawal by Subject|18
848281|NCT00402740|1806545|FG000|Overall Study|Death|50
848282|NCT00402740|1806545|FG000|Overall Study|Lost to Follow-up|6
848283|NCT00402740|1806545|FG000|Overall Study|No stent. Completed FU at 30 days.|5
848284|NCT00402740|1806545|FG000|Overall Study|Subject disposition unknown.|1
848285|NCT00402779|1806555|FG000|Overall Study|Screen Failure|77
848286|NCT00402779|1806556|FG001|Overall Study|Screen Failure|76
848287|NCT00402831|1806564|FG000|Overall Study|Lost to Follow-up|1
848288|NCT00402831|1806565|FG001|Overall Study|Lost to Follow-up|2
848289|NCT00402831|1806564|FG000|Overall Study|Non-compliance with protocol|0
848290|NCT00402831|1806565|FG001|Overall Study|Non-compliance with protocol|1
848291|NCT00402987|1806581|FG000|Overall Study|Lack of Efficacy|0
848292|NCT00402987|1806582|FG001|Overall Study|Lack of Efficacy|0
848293|NCT00402987|1806583|FG002|Overall Study|Lack of Efficacy|1
848294|NCT00402987|1806584|FG003|Overall Study|Lack of Efficacy|0
848295|NCT00403130|1806639|FG000|2 Years From Start of Treatment|Not Eligible|3
848296|NCT00403130|1806639|FG000|2 Years From Start of Treatment|Lost to Follow up|1
848297|NCT00403130|1806639|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1
848298|NCT00403130|1806639|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10
848299|NCT00403234|1806647|FG000|Overall Study|Withdrawal by Subject|0
848300|NCT00403234|1806648|FG001|Overall Study|Withdrawal by Subject|1
848301|NCT00403234|1806649|FG002|Overall Study|Withdrawal by Subject|0
848302|NCT00403234|1806650|FG003|Overall Study|Withdrawal by Subject|0
848303|NCT00403234|1806647|FG000|Overall Study|Adverse Event|1
848304|NCT00403234|1806648|FG001|Overall Study|Adverse Event|0
848305|NCT00403234|1806649|FG002|Overall Study|Adverse Event|1
848306|NCT00403234|1806650|FG003|Overall Study|Adverse Event|0
848307|NCT00403260|1806662|FG000|Overall Study|Adverse Event|5
848308|NCT00403260|1806663|FG001|Overall Study|Adverse Event|4
848309|NCT00403260|1806662|FG000|Overall Study|Withdrawal by Subject|5
848310|NCT00403260|1806663|FG001|Overall Study|Withdrawal by Subject|6
848311|NCT00403260|1806662|FG000|Overall Study|Lost to Follow-up|49
848312|NCT00403260|1806663|FG001|Overall Study|Lost to Follow-up|25
848313|NCT00403260|1806662|FG000|Overall Study|Re-appearance of P. falciparum|34
848314|NCT00403260|1806663|FG001|Overall Study|Re-appearance of P. falciparum|25
848315|NCT00403260|1806662|FG000|Overall Study|P. vivax infection|26
848316|NCT00403260|1806663|FG001|Overall Study|P. vivax infection|4
848317|NCT00403260|1806662|FG000|Overall Study|Mixed infection with P. vivax|2
848318|NCT00403260|1806663|FG001|Overall Study|Mixed infection with P. vivax|0
848319|NCT00403260|1806662|FG000|Overall Study|Mixed infection with P. falciparum|1
848320|NCT00403260|1806663|FG001|Overall Study|Mixed infection with P. falciparum|0
848321|NCT00403260|1806662|FG000|Overall Study|P. vivax infection at screening|1
848322|NCT00403260|1806663|FG001|Overall Study|P. vivax infection at screening|0
848323|NCT00403260|1806662|FG000|Overall Study|P. ovale infection|1
848324|NCT00403260|1806663|FG001|Overall Study|P. ovale infection|0
848325|NCT00403260|1806662|FG000|Overall Study|Gametocyte re-appearance|1
848326|NCT00403260|1806663|FG001|Overall Study|Gametocyte re-appearance|1
848327|NCT00403260|1806662|FG000|Overall Study|Withdrawn from study accidentally|0
848328|NCT00403260|1806663|FG001|Overall Study|Withdrawn from study accidentally|1
848329|NCT00403273|1806671|FG000|Overall Study|Lost to Follow-up|3
848330|NCT00403273|1806672|FG001|Overall Study|Lost to Follow-up|2
848331|NCT00403273|1806671|FG000|Overall Study|Physician Decision|0
848332|NCT00403273|1806672|FG001|Overall Study|Physician Decision|1
848333|NCT00403273|1806671|FG000|Overall Study|pt. wanted to have a surgical procedure|0
848334|NCT00403273|1806672|FG001|Overall Study|pt. wanted to have a surgical procedure|1
848335|NCT00403390|1806682|FG000|Overall Study|Withdrawal by Subject|1
848336|NCT00403390|1806683|FG001|Overall Study|Withdrawal by Subject|0
848337|NCT00403390|1806682|FG000|Overall Study|samples lost|1
848338|NCT00403390|1806683|FG001|Overall Study|samples lost|0
848339|NCT00403390|1806682|FG000|Overall Study|non-compliant|1
848340|NCT00403390|1806683|FG001|Overall Study|non-compliant|0
848341|NCT00403455|1806698|FG000|Overall Study|Withdrawal by Subject|1
848342|NCT00403481|1806702|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
848343|NCT00403481|1806702|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
848344|NCT00403481|1806702|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
848345|NCT00403481|1806702|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
848346|NCT00403481|1806702|FG000|Olm 40 mg|Adverse Event|2
848347|NCT00403481|1806702|FG000|Olm 40 mg|Protocol Violation|1
848348|NCT00403481|1806702|FG000|Olm 40 mg|Withdrawal by Subject|1
848349|NCT00403481|1806702|FG000|Olm 40 mg|Other|1
848350|NCT00403481|1806702|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
848351|NCT00403481|1806702|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
848352|NCT00403481|1806702|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
848353|NCT00403481|1806702|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
848354|NCT00403481|1806702|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
848355|NCT00403481|1806702|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
848356|NCT00403494|1806711|FG000|Overall Study|Adverse Event|10
848357|NCT00403494|1806712|FG001|Overall Study|Adverse Event|8
848358|NCT00403494|1806711|FG000|Overall Study|Withdrew Consent|3
848359|NCT00403494|1806712|FG001|Overall Study|Withdrew Consent|2
848360|NCT00403494|1806711|FG000|Overall Study|Inappropriately enrolled|0
848361|NCT00403494|1806712|FG001|Overall Study|Inappropriately enrolled|1
848362|NCT00403494|1806711|FG000|Overall Study|Lost to Follow-up|0
848363|NCT00403494|1806712|FG001|Overall Study|Lost to Follow-up|2
848364|NCT00403494|1806711|FG000|Overall Study|Protocol noncompliance|0
848365|NCT00403494|1806712|FG001|Overall Study|Protocol noncompliance|1
848366|NCT00403494|1806711|FG000|Overall Study|Death|1
848367|NCT00403494|1806712|FG001|Overall Study|Death|0
848368|NCT00403494|1806711|FG000|Overall Study|Sponsor Request|1
848369|NCT00403494|1806712|FG001|Overall Study|Sponsor Request|0
848370|NCT00403546|1806722|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6
848371|NCT00403546|1806723|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0
848372|NCT00403546|1806724|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0
848373|NCT00403546|1806722|FG000|Signed Informed Consent/Open-Label|Early Termination|8
848374|NCT00403546|1806723|FG001|Signed Informed Consent/Open-Label|Early Termination|0
848375|NCT00403546|1806724|FG002|Signed Informed Consent/Open-Label|Early Termination|0
848376|NCT00403546|1806722|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9
848377|NCT00403546|1806723|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0
848378|NCT00403546|1806724|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0
848379|NCT00403546|1806722|FG000|Signed Informed Consent/Open-Label|Adverse Event|5
848380|NCT00403546|1806723|FG001|Signed Informed Consent/Open-Label|Adverse Event|0
848381|NCT00403546|1806724|FG002|Signed Informed Consent/Open-Label|Adverse Event|0
848382|NCT00403546|1806722|FG000|Screening Phase|Screening Failure|22
848383|NCT00403546|1806723|FG001|Screening Phase|Screening Failure|0
848384|NCT00403546|1806724|FG002|Screening Phase|Screening Failure|0
848385|NCT00403546|1806722|FG000|Screening Phase|Adverse Event|1
848386|NCT00403546|1806723|FG001|Screening Phase|Adverse Event|0
848387|NCT00403546|1806724|FG002|Screening Phase|Adverse Event|0
848388|NCT00403546|1806722|FG000|Screening Phase|Terminated Prior to Randomization|5
848389|NCT00403546|1806723|FG001|Screening Phase|Terminated Prior to Randomization|0
848390|NCT00403546|1806724|FG002|Screening Phase|Terminated Prior to Randomization|0
848391|NCT00403546|1806722|FG000|Randomized Trial|Early Terminations|0
848392|NCT00403546|1806723|FG001|Randomized Trial|Early Terminations|17
848393|NCT00403546|1806724|FG002|Randomized Trial|Early Terminations|16
848394|NCT00403585|1806733|FG000|Initial Treatment Phase|Lost to Follow-up|2
848395|NCT00403585|1806733|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2
848396|NCT00403585|1806733|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
848397|NCT00403754|1806737|FG000|Core Treatment Period 1|Withdrawal by Subject|0
848398|NCT00403754|1806738|FG001|Core Treatment Period 1|Withdrawal by Subject|1
848399|NCT00403754|1806739|FG002|Core Treatment Period 1|Withdrawal by Subject|0
848400|NCT00403754|1806740|FG003|Core Treatment Period 1|Withdrawal by Subject|0
848401|NCT00403754|1806737|FG000|Core Treatment Period 2|Lack of Efficacy|0
848402|NCT00403754|1806738|FG001|Core Treatment Period 2|Lack of Efficacy|0
848403|NCT00403754|1806739|FG002|Core Treatment Period 2|Lack of Efficacy|1
848404|NCT00403754|1806740|FG003|Core Treatment Period 2|Lack of Efficacy|0
848405|NCT00403767|1806754|FG000|Overall Study|Adverse Event|993
848406|NCT00403767|1806755|FG001|Overall Study|Adverse Event|919
848407|NCT00403767|1806754|FG000|Overall Study|Non-compliant with study medication|134
848408|NCT00403767|1806755|FG001|Overall Study|Non-compliant with study medication|164
848409|NCT00403767|1806754|FG000|Overall Study|Consent withdrawn|671
848410|NCT00403767|1806755|FG001|Overall Study|Consent withdrawn|673
848411|NCT00403767|1806754|FG000|Overall Study|Investigator dec./not protocol-related|191
848412|NCT00403767|1806755|FG001|Overall Study|Investigator dec./not protocol-related|178
848413|NCT00403767|1806754|FG000|Overall Study|Lost to Follow-up|6
848414|NCT00403767|1806755|FG001|Overall Study|Lost to Follow-up|8
848415|NCT00403767|1806754|FG000|Overall Study|Protocol Violation|142
848416|NCT00403767|1806755|FG001|Overall Study|Protocol Violation|124
848417|NCT00403767|1806754|FG000|Overall Study|Clinical efficacy endpoint reached|300
848418|NCT00403767|1806755|FG001|Overall Study|Clinical efficacy endpoint reached|332
848419|NCT00403767|1806754|FG000|Overall Study|Study terminated by sponsor|82
848420|NCT00403767|1806755|FG001|Overall Study|Study terminated by sponsor|69
848421|NCT00403767|1806754|FG000|Overall Study|Missing/incomplete data|1
848422|NCT00403767|1806755|FG001|Overall Study|Missing/incomplete data|1
848423|NCT00403845|1806761|FG000|Treatment Period 1|Subject withdrew consent|1
848424|NCT00403845|1806762|FG001|Treatment Period 1|Subject withdrew consent|0
848425|NCT00403845|1806763|FG002|Treatment Period 1|Subject withdrew consent|0
848426|NCT00403845|1806764|FG003|Treatment Period 1|Subject withdrew consent|0
848427|NCT00403845|1806761|FG000|Treatment Period 1|Subject no longer needs study drug|0
848428|NCT00403845|1806762|FG001|Treatment Period 1|Subject no longer needs study drug|0
848429|NCT00403845|1806763|FG002|Treatment Period 1|Subject no longer needs study drug|0
848430|NCT00403845|1806764|FG003|Treatment Period 1|Subject no longer needs study drug|1
848431|NCT00403845|1806761|FG000|Treatment Period 2|Subject withdrew consent|1
848432|NCT00403845|1806762|FG001|Treatment Period 2|Subject withdrew consent|0
848433|NCT00403845|1806763|FG002|Treatment Period 2|Subject withdrew consent|0
848434|NCT00403845|1806764|FG003|Treatment Period 2|Subject withdrew consent|0
848435|NCT00403845|1806761|FG000|Treatment Period 3|Subject withdrew consent|0
848436|NCT00403845|1806762|FG001|Treatment Period 3|Subject withdrew consent|0
848437|NCT00403845|1806763|FG002|Treatment Period 3|Subject withdrew consent|0
848438|NCT00403845|1806764|FG003|Treatment Period 3|Subject withdrew consent|1
848439|NCT00403845|1806761|FG000|Treatment Period 3|Adverse Event|0
848440|NCT00403845|1806762|FG001|Treatment Period 3|Adverse Event|0
848441|NCT00403845|1806763|FG002|Treatment Period 3|Adverse Event|0
848442|NCT00403845|1806764|FG003|Treatment Period 3|Adverse Event|1
848443|NCT00404066|1806774|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1
848444|NCT00404066|1806774|FG000|Overall Study|Withdrawal by Subject - Adverse event|2
848445|NCT00404079|1806780|FG000|Overall Study|Lost to follow up, adverse event etc|22
848446|NCT00404079|1806781|FG001|Overall Study|Lost to follow up, adverse event etc|20
848447|NCT00404092|1806791|FG000|Overall Study|Death|1
848448|NCT00404092|1806792|FG001|Overall Study|Death|0
848449|NCT00404092|1806793|FG002|Overall Study|Death|0
848450|NCT00404092|1806794|FG003|Overall Study|Death|0
848451|NCT00404092|1806791|FG000|Overall Study|Adverse Event|0
848452|NCT00404092|1806792|FG001|Overall Study|Adverse Event|0
848453|NCT00404092|1806793|FG002|Overall Study|Adverse Event|1
848454|NCT00404092|1806794|FG003|Overall Study|Adverse Event|0
848455|NCT00404235|1806806|FG000|Overall Study|Withdrawal by Subject|1
848456|NCT00404235|1806807|FG001|Overall Study|Withdrawal by Subject|2
848457|NCT00404248|1806816|FG000|Overall Study|pts declining status|0
848458|NCT00404248|1806817|FG001|Overall Study|pts declining status|1
848459|NCT00404248|1806818|FG002|Overall Study|pts declining status|0
848460|NCT00404248|1806819|FG003|Overall Study|pts declining status|0
848461|NCT00404248|1806820|FG004|Overall Study|pts declining status|0
848462|NCT00404248|1806821|FG005|Overall Study|pts declining status|0
848463|NCT00404248|1806822|FG006|Overall Study|pts declining status|0
848464|NCT00404248|1806823|FG007|Overall Study|pts declining status|0
848465|NCT00404248|1806824|FG008|Overall Study|pts declining status|0
848466|NCT00404352|1806853|FG000|Double Blind (up to 24 Month)|Adverse Event|5
848467|NCT00404352|1806854|FG001|Double Blind (up to 24 Month)|Adverse Event|4
848468|NCT00404352|1806855|FG002|Double Blind (up to 24 Month)|Adverse Event|6
848469|NCT00404352|1806856|FG003|Double Blind (up to 24 Month)|Adverse Event|0
848470|NCT00404352|1806857|FG004|Double Blind (up to 24 Month)|Adverse Event|0
848471|NCT00404352|1806858|FG005|Double Blind (up to 24 Month)|Adverse Event|0
848472|NCT00404352|1806859|FG006|Double Blind (up to 24 Month)|Adverse Event|0
848473|NCT00404352|1806860|FG007|Double Blind (up to 24 Month)|Adverse Event|0
848474|NCT00404352|1806861|FG008|Double Blind (up to 24 Month)|Adverse Event|0
848475|NCT00404352|1806853|FG000|Double Blind (up to 24 Month)|Pregnancy|0
848476|NCT00404352|1806854|FG001|Double Blind (up to 24 Month)|Pregnancy|0
848477|NCT00404352|1806855|FG002|Double Blind (up to 24 Month)|Pregnancy|2
848478|NCT00404352|1806856|FG003|Double Blind (up to 24 Month)|Pregnancy|0
848479|NCT00404352|1806857|FG004|Double Blind (up to 24 Month)|Pregnancy|0
848480|NCT00404352|1806858|FG005|Double Blind (up to 24 Month)|Pregnancy|0
848481|NCT00404352|1806859|FG006|Double Blind (up to 24 Month)|Pregnancy|0
848482|NCT00404352|1806860|FG007|Double Blind (up to 24 Month)|Pregnancy|0
848483|NCT00404352|1806861|FG008|Double Blind (up to 24 Month)|Pregnancy|0
848484|NCT00404352|1806853|FG000|Double Blind (up to 24 Month)|Death|0
848485|NCT00404352|1806854|FG001|Double Blind (up to 24 Month)|Death|0
848486|NCT00404352|1806855|FG002|Double Blind (up to 24 Month)|Death|1
848487|NCT00404352|1806856|FG003|Double Blind (up to 24 Month)|Death|0
848488|NCT00404352|1806857|FG004|Double Blind (up to 24 Month)|Death|0
848489|NCT00404352|1806858|FG005|Double Blind (up to 24 Month)|Death|0
848490|NCT00404352|1806859|FG006|Double Blind (up to 24 Month)|Death|0
848491|NCT00404352|1806860|FG007|Double Blind (up to 24 Month)|Death|0
848492|NCT00404352|1806861|FG008|Double Blind (up to 24 Month)|Death|0
848493|NCT00404352|1806853|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1
848494|NCT00404352|1806854|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2
848495|NCT00404352|1806855|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1
848496|NCT00404352|1806856|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0
848497|NCT00404352|1806857|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0
848498|NCT00404352|1806858|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0
848499|NCT00404352|1806859|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0
848500|NCT00404352|1806860|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0
848501|NCT00404352|1806861|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0
848502|NCT00404352|1806853|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11
848503|NCT00404352|1806854|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8
848504|NCT00404352|1806855|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7
848505|NCT00404352|1806856|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0
848506|NCT00404352|1806857|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0
848507|NCT00404352|1806858|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0
848508|NCT00404352|1806859|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0
848509|NCT00404352|1806860|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0
848510|NCT00404352|1806861|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0
848511|NCT00404352|1806853|FG000|Double Blind (up to 24 Month)|Disease progression|3
848512|NCT00404352|1806854|FG001|Double Blind (up to 24 Month)|Disease progression|0
848513|NCT00404352|1806855|FG002|Double Blind (up to 24 Month)|Disease progression|2
848514|NCT00404352|1806856|FG003|Double Blind (up to 24 Month)|Disease progression|0
848515|NCT00404352|1806857|FG004|Double Blind (up to 24 Month)|Disease progression|0
848516|NCT00404352|1806858|FG005|Double Blind (up to 24 Month)|Disease progression|0
848517|NCT00404352|1806859|FG006|Double Blind (up to 24 Month)|Disease progression|0
848518|NCT00404352|1806860|FG007|Double Blind (up to 24 Month)|Disease progression|0
848519|NCT00404352|1806861|FG008|Double Blind (up to 24 Month)|Disease progression|0
848520|NCT00404352|1806853|FG000|Double Blind (up to 24 Month)|Poor compliance|1
848521|NCT00404352|1806854|FG001|Double Blind (up to 24 Month)|Poor compliance|0
848522|NCT00404352|1806855|FG002|Double Blind (up to 24 Month)|Poor compliance|0
848523|NCT00404352|1806856|FG003|Double Blind (up to 24 Month)|Poor compliance|0
848524|NCT00404352|1806857|FG004|Double Blind (up to 24 Month)|Poor compliance|0
848525|NCT00404352|1806858|FG005|Double Blind (up to 24 Month)|Poor compliance|0
848526|NCT00404352|1806859|FG006|Double Blind (up to 24 Month)|Poor compliance|0
848527|NCT00404352|1806860|FG007|Double Blind (up to 24 Month)|Poor compliance|0
848528|NCT00404352|1806861|FG008|Double Blind (up to 24 Month)|Poor compliance|0
848529|NCT00404352|1806853|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31
848530|NCT00404352|1806854|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30
848531|NCT00404352|1806855|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59
848532|NCT00404352|1806856|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0
848533|NCT00404352|1806857|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0
848534|NCT00404352|1806858|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0
848535|NCT00404352|1806859|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0
848536|NCT00404352|1806860|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0
848537|NCT00404352|1806861|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0
848538|NCT00404352|1806853|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0
848539|NCT00404352|1806854|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2
848540|NCT00404352|1806855|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0
848541|NCT00404352|1806856|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0
848542|NCT00404352|1806857|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0
848543|NCT00404352|1806858|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0
848544|NCT00404352|1806859|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0
848545|NCT00404352|1806860|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0
848546|NCT00404352|1806861|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0
848547|NCT00404352|1806853|FG000|Double Blind (up to 24 Month)|Physician Decision|0
848548|NCT00404352|1806854|FG001|Double Blind (up to 24 Month)|Physician Decision|0
848549|NCT00404352|1806855|FG002|Double Blind (up to 24 Month)|Physician Decision|1
848550|NCT00404352|1806856|FG003|Double Blind (up to 24 Month)|Physician Decision|0
848551|NCT00404352|1806857|FG004|Double Blind (up to 24 Month)|Physician Decision|0
848552|NCT00404352|1806858|FG005|Double Blind (up to 24 Month)|Physician Decision|0
848553|NCT00404352|1806859|FG006|Double Blind (up to 24 Month)|Physician Decision|0
848554|NCT00404352|1806860|FG007|Double Blind (up to 24 Month)|Physician Decision|0
848555|NCT00404352|1806861|FG008|Double Blind (up to 24 Month)|Physician Decision|0
848556|NCT00404352|1806853|FG000|Double Blind (up to 24 Month)|Other|0
848557|NCT00404352|1806854|FG001|Double Blind (up to 24 Month)|Other|1
848558|NCT00404352|1806855|FG002|Double Blind (up to 24 Month)|Other|0
848559|NCT00404352|1806856|FG003|Double Blind (up to 24 Month)|Other|0
848560|NCT00404352|1806857|FG004|Double Blind (up to 24 Month)|Other|0
848561|NCT00404352|1806858|FG005|Double Blind (up to 24 Month)|Other|0
848562|NCT00404352|1806859|FG006|Double Blind (up to 24 Month)|Other|0
848563|NCT00404352|1806860|FG007|Double Blind (up to 24 Month)|Other|0
848564|NCT00404352|1806861|FG008|Double Blind (up to 24 Month)|Other|0
848565|NCT00404352|1806853|FG000|Open Label (up to 24 Month)|Adverse Event|0
848566|NCT00404352|1806854|FG001|Open Label (up to 24 Month)|Adverse Event|0
848567|NCT00404352|1806855|FG002|Open Label (up to 24 Month)|Adverse Event|0
848568|NCT00404352|1806856|FG003|Open Label (up to 24 Month)|Adverse Event|2
848569|NCT00404352|1806857|FG004|Open Label (up to 24 Month)|Adverse Event|1
848570|NCT00404352|1806858|FG005|Open Label (up to 24 Month)|Adverse Event|1
848571|NCT00404352|1806859|FG006|Open Label (up to 24 Month)|Adverse Event|0
848572|NCT00404352|1806860|FG007|Open Label (up to 24 Month)|Adverse Event|0
848573|NCT00404352|1806861|FG008|Open Label (up to 24 Month)|Adverse Event|0
848574|NCT00404352|1806853|FG000|Open Label (up to 24 Month)|Pregnancy|0
848575|NCT00404352|1806854|FG001|Open Label (up to 24 Month)|Pregnancy|0
848576|NCT00404352|1806855|FG002|Open Label (up to 24 Month)|Pregnancy|0
848577|NCT00404352|1806856|FG003|Open Label (up to 24 Month)|Pregnancy|0
848578|NCT00404352|1806857|FG004|Open Label (up to 24 Month)|Pregnancy|0
848579|NCT00404352|1806858|FG005|Open Label (up to 24 Month)|Pregnancy|1
848580|NCT00404352|1806859|FG006|Open Label (up to 24 Month)|Pregnancy|0
848581|NCT00404352|1806860|FG007|Open Label (up to 24 Month)|Pregnancy|0
848582|NCT00404352|1806861|FG008|Open Label (up to 24 Month)|Pregnancy|0
848583|NCT00404352|1806853|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0
848584|NCT00404352|1806854|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0
848585|NCT00404352|1806855|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0
848586|NCT00404352|1806856|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0
848587|NCT00404352|1806857|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1
848588|NCT00404352|1806858|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0
848589|NCT00404352|1806859|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0
848590|NCT00404352|1806860|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0
848591|NCT00404352|1806861|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0
848592|NCT00404352|1806853|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0
848593|NCT00404352|1806854|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0
848594|NCT00404352|1806855|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0
848595|NCT00404352|1806856|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0
848596|NCT00404352|1806857|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0
848597|NCT00404352|1806858|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5
848598|NCT00404352|1806859|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0
848599|NCT00404352|1806860|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0
848600|NCT00404352|1806861|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0
848601|NCT00404352|1806853|FG000|Open Label (up to 24 Month)|Disease progression|0
848602|NCT00404352|1806854|FG001|Open Label (up to 24 Month)|Disease progression|0
848603|NCT00404352|1806855|FG002|Open Label (up to 24 Month)|Disease progression|0
848604|NCT00404352|1806856|FG003|Open Label (up to 24 Month)|Disease progression|1
848605|NCT00404352|1806857|FG004|Open Label (up to 24 Month)|Disease progression|0
848606|NCT00404352|1806858|FG005|Open Label (up to 24 Month)|Disease progression|0
848607|NCT00404352|1806859|FG006|Open Label (up to 24 Month)|Disease progression|0
848608|NCT00404352|1806860|FG007|Open Label (up to 24 Month)|Disease progression|0
848609|NCT00404352|1806861|FG008|Open Label (up to 24 Month)|Disease progression|0
848610|NCT00404352|1806853|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0
848611|NCT00404352|1806854|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0
848612|NCT00404352|1806855|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0
848613|NCT00404352|1806856|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0
848614|NCT00404352|1806857|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0
848615|NCT00404352|1806858|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0
848616|NCT00404352|1806859|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1
848617|NCT00404352|1806860|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1
848618|NCT00404352|1806861|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0
848619|NCT00404352|1806853|FG000|Open Label Extension (up to 36 Months)|Other|0
848620|NCT00404352|1806854|FG001|Open Label Extension (up to 36 Months)|Other|0
848621|NCT00404352|1806855|FG002|Open Label Extension (up to 36 Months)|Other|0
848622|NCT00404352|1806856|FG003|Open Label Extension (up to 36 Months)|Other|0
848623|NCT00404352|1806857|FG004|Open Label Extension (up to 36 Months)|Other|0
848624|NCT00404352|1806858|FG005|Open Label Extension (up to 36 Months)|Other|0
848625|NCT00404352|1806859|FG006|Open Label Extension (up to 36 Months)|Other|0
848626|NCT00404352|1806860|FG007|Open Label Extension (up to 36 Months)|Other|0
848627|NCT00404352|1806861|FG008|Open Label Extension (up to 36 Months)|Other|2
848628|NCT00404495|1806880|FG000|Overall Study|Death|37
848629|NCT00404495|1806881|FG001|Overall Study|Death|11
848630|NCT00404495|1806880|FG000|Overall Study|Lost to Follow-up|5
848631|NCT00404495|1806881|FG001|Overall Study|Lost to Follow-up|0
848632|NCT00404495|1806880|FG000|Overall Study|Other|1
848633|NCT00404495|1806881|FG001|Overall Study|Other|0
848634|NCT00404495|1806880|FG000|Overall Study|Withdrawal by Subject|1
848635|NCT00404495|1806881|FG001|Overall Study|Withdrawal by Subject|0
848636|NCT00404547|1806889|FG000|Overall Study|Adverse Event|39
848637|NCT00404547|1806890|FG001|Overall Study|Adverse Event|6
848638|NCT00404547|1806889|FG000|Overall Study|Withdrawal by Subject|19
848639|NCT00404547|1806890|FG001|Overall Study|Withdrawal by Subject|2
848640|NCT00404547|1806889|FG000|Overall Study|Protocol Violation|0
848641|NCT00404547|1806890|FG001|Overall Study|Protocol Violation|1
848642|NCT00404547|1806889|FG000|Overall Study|Lost to Follow-up|20
848643|NCT00404547|1806890|FG001|Overall Study|Lost to Follow-up|9
848644|NCT00404547|1806889|FG000|Overall Study|Lack of compliance|5
848645|NCT00404547|1806890|FG001|Overall Study|Lack of compliance|1
848646|NCT00404547|1806889|FG000|Overall Study|Other|4
848647|NCT00404547|1806890|FG001|Overall Study|Other|0
848648|NCT00404547|1806889|FG000|Overall Study|Reason not stated|3
848649|NCT00404547|1806890|FG001|Overall Study|Reason not stated|6
848650|NCT00404651|1806900|FG000|Overall Study|Serious Adverse Event|0
848651|NCT00404651|1806901|FG001|Overall Study|Serious Adverse Event|0
848652|NCT00404651|1806902|FG002|Overall Study|Serious Adverse Event|2
848653|NCT00404651|1806903|FG003|Overall Study|Serious Adverse Event|0
848654|NCT00404651|1806900|FG000|Overall Study|Protocol Violation|10
848655|NCT00404651|1806901|FG001|Overall Study|Protocol Violation|5
848656|NCT00404651|1806902|FG002|Overall Study|Protocol Violation|14
848657|NCT00404651|1806903|FG003|Overall Study|Protocol Violation|5
848658|NCT00404651|1806900|FG000|Overall Study|Lost to Follow-up|15
848659|NCT00404651|1806901|FG001|Overall Study|Lost to Follow-up|11
848660|NCT00404651|1806902|FG002|Overall Study|Lost to Follow-up|13
848661|NCT00404651|1806903|FG003|Overall Study|Lost to Follow-up|10
848662|NCT00404651|1806900|FG000|Overall Study|Withdrawal by Subject|14
848663|NCT00404651|1806901|FG001|Overall Study|Withdrawal by Subject|12
848664|NCT00404651|1806902|FG002|Overall Study|Withdrawal by Subject|16
848665|NCT00404651|1806903|FG003|Overall Study|Withdrawal by Subject|6
848666|NCT00404755|1806913|FG000|Phase I (Bupropion)|Adverse Event|3
848667|NCT00404755|1806913|FG000|Phase I (Bupropion)|Other|1
848668|NCT00404755|1806913|FG000|Phase II (Escitalopram)|Lost to Follow-up|2
848669|NCT00404768|1806925|FG000|Part A and B|Withdrawn due to labor progression|1
848670|NCT00404768|1806926|FG001|Part A and B|Withdrawn due to labor progression|0
848671|NCT00404768|1806927|FG002|Part A and B|Withdrawn due to labor progression|0
848672|NCT00404768|1806928|FG003|Part A and B|Withdrawn due to labor progression|0
848673|NCT00404768|1806925|FG000|Part A and B|Withdrawn as delivery imminemnt|0
848674|NCT00404768|1806926|FG001|Part A and B|Withdrawn as delivery imminemnt|1
848675|NCT00404768|1806927|FG002|Part A and B|Withdrawn as delivery imminemnt|0
848676|NCT00404768|1806928|FG003|Part A and B|Withdrawn as delivery imminemnt|0
848677|NCT00404768|1806925|FG000|Part C|Adverse Event|0
848678|NCT00404768|1806926|FG001|Part C|Adverse Event|0
848679|NCT00404768|1806927|FG002|Part C|Adverse Event|0
848680|NCT00404768|1806928|FG003|Part C|Adverse Event|3
848681|NCT00404768|1806925|FG000|Part C|Lost to Follow-up|0
848682|NCT00404768|1806926|FG001|Part C|Lost to Follow-up|0
848683|NCT00404768|1806927|FG002|Part C|Lost to Follow-up|3
848684|NCT00404768|1806928|FG003|Part C|Lost to Follow-up|1
848685|NCT00404768|1806925|FG000|Part C|Withdrawal by Subject|0
848686|NCT00404768|1806926|FG001|Part C|Withdrawal by Subject|0
848687|NCT00404768|1806927|FG002|Part C|Withdrawal by Subject|2
848688|NCT00404768|1806928|FG003|Part C|Withdrawal by Subject|1
848689|NCT00404768|1806925|FG000|Part C|Early withdrawal from study medication|0
848690|NCT00404768|1806926|FG001|Part C|Early withdrawal from study medication|0
848691|NCT00404768|1806927|FG002|Part C|Early withdrawal from study medication|1
848692|NCT00404768|1806928|FG003|Part C|Early withdrawal from study medication|0
848693|NCT00404768|1806925|FG000|Part C|Participant did not respond to therapy|0
848694|NCT00404768|1806926|FG001|Part C|Participant did not respond to therapy|0
848695|NCT00404768|1806927|FG002|Part C|Participant did not respond to therapy|1
848696|NCT00404768|1806928|FG003|Part C|Participant did not respond to therapy|1
848697|NCT00404768|1806925|FG000|Part C|Physician withdrew the study medication|0
848698|NCT00404768|1806926|FG001|Part C|Physician withdrew the study medication|0
848699|NCT00404768|1806927|FG002|Part C|Physician withdrew the study medication|1
848700|NCT00404768|1806928|FG003|Part C|Physician withdrew the study medication|0
848701|NCT00404768|1806925|FG000|Part C|Participant delivered baby|0
848702|NCT00404768|1806926|FG001|Part C|Participant delivered baby|0
848703|NCT00404768|1806927|FG002|Part C|Participant delivered baby|0
848704|NCT00404768|1806928|FG003|Part C|Participant delivered baby|1
848705|NCT00404768|1806925|FG000|Part C|Unsatisfactory uterine response to IP|0
848706|NCT00404768|1806926|FG001|Part C|Unsatisfactory uterine response to IP|0
848707|NCT00404768|1806927|FG002|Part C|Unsatisfactory uterine response to IP|0
848708|NCT00404768|1806928|FG003|Part C|Unsatisfactory uterine response to IP|1
848709|NCT00404768|1806925|FG000|Part C|Active labor|0
848710|NCT00404768|1806926|FG001|Part C|Active labor|0
848711|NCT00404768|1806927|FG002|Part C|Active labor|0
848712|NCT00404768|1806928|FG003|Part C|Active labor|1
848713|NCT00404768|1806925|FG000|Part C|Lack of Efficacy|0
848714|NCT00404768|1806926|FG001|Part C|Lack of Efficacy|0
848715|NCT00404768|1806927|FG002|Part C|Lack of Efficacy|0
848716|NCT00404768|1806928|FG003|Part C|Lack of Efficacy|2
848717|NCT00404768|1806925|FG000|Part C|Treatment failure|0
848718|NCT00404768|1806926|FG001|Part C|Treatment failure|0
848719|NCT00404768|1806927|FG002|Part C|Treatment failure|0
848720|NCT00404768|1806928|FG003|Part C|Treatment failure|1
848721|NCT00404768|1806925|FG000|Part C|Investigator discretion|0
848722|NCT00404768|1806926|FG001|Part C|Investigator discretion|0
848723|NCT00404768|1806927|FG002|Part C|Investigator discretion|0
848724|NCT00404768|1806928|FG003|Part C|Investigator discretion|1
848725|NCT00404768|1806925|FG000|Part C|Researcher suspended study medication|0
848726|NCT00404768|1806926|FG001|Part C|Researcher suspended study medication|0
848727|NCT00404768|1806927|FG002|Part C|Researcher suspended study medication|0
848728|NCT00404768|1806928|FG003|Part C|Researcher suspended study medication|1
848729|NCT00404820|1806945|FG000|Overall Study|Adverse Event|4
848730|NCT00404820|1806946|FG001|Overall Study|Adverse Event|16
848731|NCT00404820|1806945|FG000|Overall Study|Withdrawal by Subject|5
848732|NCT00404820|1806946|FG001|Overall Study|Withdrawal by Subject|3
848733|NCT00404820|1806945|FG000|Overall Study|Lost to Follow-up|7
848734|NCT00404820|1806946|FG001|Overall Study|Lost to Follow-up|3
848735|NCT00404820|1806945|FG000|Overall Study|Administrative problems|2
848736|NCT00404820|1806946|FG001|Overall Study|Administrative problems|0
848737|NCT00404820|1806945|FG000|Overall Study|Death|1
848738|NCT00404820|1806946|FG001|Overall Study|Death|0
848739|NCT00404820|1806945|FG000|Overall Study|Other|0
848740|NCT00404820|1806946|FG001|Overall Study|Other|2
848741|NCT00404924|1806954|FG000|Overall Study|Adverse Event|75
848742|NCT00404924|1806955|FG001|Overall Study|Adverse Event|16
848743|NCT00404924|1806954|FG000|Overall Study|Condition under investigation worsened|475
848744|NCT00404924|1806955|FG001|Overall Study|Condition under investigation worsened|264
848745|NCT00404924|1806954|FG000|Overall Study|Lost to Follow-up|1
848746|NCT00404924|1806955|FG001|Overall Study|Lost to Follow-up|1
848747|NCT00404924|1806954|FG000|Overall Study|Withdrawal by Subject|26
848748|NCT00404924|1806955|FG001|Overall Study|Withdrawal by Subject|13
848749|NCT00404924|1806954|FG000|Overall Study|Other|25
848750|NCT00404924|1806955|FG001|Overall Study|Other|11
848751|NCT00404924|1806954|FG000|Overall Study|Randomised but not received treatment|1
848752|NCT00404924|1806955|FG001|Overall Study|Randomised but not received treatment|1
848753|NCT00405067|1806964|FG000|Overall Study|Adverse Event|4
848754|NCT00405067|1806965|FG001|Overall Study|Adverse Event|9
848755|NCT00405067|1806966|FG002|Overall Study|Adverse Event|4
848756|NCT00405067|1806964|FG000|Overall Study|Lost to Follow-up|0
848757|NCT00405067|1806965|FG001|Overall Study|Lost to Follow-up|0
848758|NCT00405067|1806966|FG002|Overall Study|Lost to Follow-up|1
848759|NCT00405275|1806976|FG000|Overall Study|Death|1
848760|NCT00405275|1806977|FG001|Overall Study|Death|0
848761|NCT00405275|1806976|FG000|Overall Study|Lost to Follow-up|5
848762|NCT00405275|1806977|FG001|Overall Study|Lost to Follow-up|1
848763|NCT00405275|1806976|FG000|Overall Study|Withdrawal by Subject|7
848764|NCT00405275|1806977|FG001|Overall Study|Withdrawal by Subject|9
848765|NCT00405275|1806976|FG000|Overall Study|Unwilling to continue|10
848766|NCT00405275|1806977|FG001|Overall Study|Unwilling to continue|9
848767|NCT00405392|1806998|FG000|Overall Study|Adverse Event|15
848768|NCT00405392|1806999|FG001|Overall Study|Adverse Event|14
848769|NCT00405392|1806998|FG000|Overall Study|Did not meet Eligibility criteria|7
848770|NCT00405392|1806999|FG001|Overall Study|Did not meet Eligibility criteria|2
848771|NCT00405392|1806998|FG000|Overall Study|Withdrawal by Subject|4
848772|NCT00405392|1806999|FG001|Overall Study|Withdrawal by Subject|3
848773|NCT00405392|1806998|FG000|Overall Study|Lost to Follow-up|1
848774|NCT00405392|1806999|FG001|Overall Study|Lost to Follow-up|2
848775|NCT00405392|1806998|FG000|Overall Study|Data missing|2
848776|NCT00405392|1806999|FG001|Overall Study|Data missing|0
848777|NCT00405392|1806998|FG000|Overall Study|Non-compliance|0
848778|NCT00405392|1806999|FG001|Overall Study|Non-compliance|1
848779|NCT00405392|1806998|FG000|Overall Study|Other|1
848780|NCT00405392|1806999|FG001|Overall Study|Other|5
848781|NCT00405548|1807025|FG000|Overall Study|Cognitive Memory problems on study day|1
848782|NCT00405548|1807026|FG001|Overall Study|Cognitive Memory problems on study day|0
848783|NCT00405548|1807025|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0
848784|NCT00405548|1807026|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1
848785|NCT00405548|1807025|FG000|Overall Study|Unable to self-administer shots|1
848786|NCT00405548|1807026|FG001|Overall Study|Unable to self-administer shots|0
848787|NCT00405548|1807025|FG000|Overall Study|Venous access failed during study day|1
848870|NCT00405756|1807102|FG001|Open-label Extension|Death|2
848788|NCT00405548|1807026|FG001|Overall Study|Venous access failed during study day|0
848789|NCT00405548|1807025|FG000|Overall Study|Withdrawal by Subject|1
848790|NCT00405548|1807026|FG001|Overall Study|Withdrawal by Subject|0
848791|NCT00405587|1807036|FG000|Overall Study|Death|0
848792|NCT00405587|1807037|FG001|Overall Study|Death|0
848793|NCT00405587|1807038|FG002|Overall Study|Death|0
848794|NCT00405587|1807039|FG003|Overall Study|Death|1
848795|NCT00405587|1807036|FG000|Overall Study|Disease Progression|22
848796|NCT00405587|1807037|FG001|Overall Study|Disease Progression|23
848797|NCT00405587|1807038|FG002|Overall Study|Disease Progression|21
848798|NCT00405587|1807039|FG003|Overall Study|Disease Progression|17
848799|NCT00405587|1807036|FG000|Overall Study|Physician Decision|3
848800|NCT00405587|1807037|FG001|Overall Study|Physician Decision|2
848801|NCT00405587|1807038|FG002|Overall Study|Physician Decision|0
848802|NCT00405587|1807039|FG003|Overall Study|Physician Decision|0
848803|NCT00405587|1807036|FG000|Overall Study|Adverse Event|1
848804|NCT00405587|1807037|FG001|Overall Study|Adverse Event|0
848805|NCT00405587|1807038|FG002|Overall Study|Adverse Event|0
848806|NCT00405587|1807039|FG003|Overall Study|Adverse Event|0
848807|NCT00405587|1807036|FG000|Overall Study|Lost to Follow-up|0
848808|NCT00405587|1807037|FG001|Overall Study|Lost to Follow-up|1
848809|NCT00405587|1807038|FG002|Overall Study|Lost to Follow-up|1
848810|NCT00405587|1807039|FG003|Overall Study|Lost to Follow-up|0
848811|NCT00405587|1807036|FG000|Overall Study|Radiation induced necrosis|0
848812|NCT00405587|1807037|FG001|Overall Study|Radiation induced necrosis|1
848813|NCT00405587|1807038|FG002|Overall Study|Radiation induced necrosis|0
848814|NCT00405587|1807039|FG003|Overall Study|Radiation induced necrosis|0
848815|NCT00405587|1807036|FG000|Overall Study|Withdrawal by Subject|0
848816|NCT00405587|1807037|FG001|Overall Study|Withdrawal by Subject|0
848817|NCT00405587|1807038|FG002|Overall Study|Withdrawal by Subject|0
848818|NCT00405587|1807039|FG003|Overall Study|Withdrawal by Subject|2
848819|NCT00405587|1807036|FG000|Overall Study|Participant not dosed|0
848820|NCT00405587|1807037|FG001|Overall Study|Participant not dosed|1
848821|NCT00405587|1807038|FG002|Overall Study|Participant not dosed|0
848822|NCT00405587|1807039|FG003|Overall Study|Participant not dosed|0
848823|NCT00405639|1807077|FG000|Overall Study|Withdrawal by Subject|1
848824|NCT00405639|1807078|FG001|Overall Study|Withdrawal by Subject|0
848825|NCT00405639|1807077|FG000|Overall Study|Adverse Event|1
848826|NCT00405639|1807078|FG001|Overall Study|Adverse Event|0
848827|NCT00405639|1807077|FG000|Overall Study|Seizure prior to receiving BNP|1
848828|NCT00405639|1807078|FG001|Overall Study|Seizure prior to receiving BNP|0
848829|NCT00405652|1807084|FG000|Overall Study|Adverse Event|4
848830|NCT00405756|1807101|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45
848831|NCT00405756|1807102|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24
848832|NCT00405756|1807103|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18
848833|NCT00405756|1807101|FG000|Double-blind Treatment|Adverse Event|31
848834|NCT00405756|1807102|FG001|Double-blind Treatment|Adverse Event|27
848835|NCT00405756|1807103|FG002|Double-blind Treatment|Adverse Event|12
848836|NCT00405756|1807101|FG000|Double-blind Treatment|Disease Progression|47
848837|NCT00405756|1807102|FG001|Double-blind Treatment|Disease Progression|81
848838|NCT00405756|1807103|FG002|Double-blind Treatment|Disease Progression|102
848839|NCT00405756|1807101|FG000|Double-blind Treatment|Lack of Efficacy|1
848840|NCT00405756|1807102|FG001|Double-blind Treatment|Lack of Efficacy|4
848841|NCT00405756|1807103|FG002|Double-blind Treatment|Lack of Efficacy|2
848842|NCT00405756|1807101|FG000|Double-blind Treatment|Withdrawal by Subject|15
848843|NCT00405756|1807102|FG001|Double-blind Treatment|Withdrawal by Subject|9
848844|NCT00405756|1807103|FG002|Double-blind Treatment|Withdrawal by Subject|10
848845|NCT00405756|1807101|FG000|Double-blind Treatment|Lost to Follow-up|1
848846|NCT00405756|1807102|FG001|Double-blind Treatment|Lost to Follow-up|0
848847|NCT00405756|1807103|FG002|Double-blind Treatment|Lost to Follow-up|0
848848|NCT00405756|1807101|FG000|Double-blind Treatment|Death|4
848849|NCT00405756|1807102|FG001|Double-blind Treatment|Death|4
848850|NCT00405756|1807103|FG002|Double-blind Treatment|Death|4
848851|NCT00405756|1807101|FG000|Double-blind Treatment|Protocol Violation|1
848852|NCT00405756|1807102|FG001|Double-blind Treatment|Protocol Violation|0
848853|NCT00405756|1807103|FG002|Double-blind Treatment|Protocol Violation|2
848854|NCT00405756|1807101|FG000|Double-blind Treatment|Other|7
848855|NCT00405756|1807102|FG001|Double-blind Treatment|Other|4
848856|NCT00405756|1807103|FG002|Double-blind Treatment|Other|4
848857|NCT00405756|1807101|FG000|Open-label Extension|Ongoing in Open Label Period|7
848858|NCT00405756|1807102|FG001|Open-label Extension|Ongoing in Open Label Period|15
848859|NCT00405756|1807103|FG002|Open-label Extension|Ongoing in Open Label Period|25
848860|NCT00405756|1807101|FG000|Open-label Extension|Adverse Event|1
848861|NCT00405756|1807102|FG001|Open-label Extension|Adverse Event|3
848862|NCT00405756|1807103|FG002|Open-label Extension|Adverse Event|7
848863|NCT00405756|1807101|FG000|Open-label Extension|Disease Progression|8
848864|NCT00405756|1807102|FG001|Open-label Extension|Disease Progression|23
848865|NCT00405756|1807103|FG002|Open-label Extension|Disease Progression|26
848866|NCT00405756|1807101|FG000|Open-label Extension|Withdrawal by Subject|2
848867|NCT00405756|1807102|FG001|Open-label Extension|Withdrawal by Subject|3
848868|NCT00405756|1807103|FG002|Open-label Extension|Withdrawal by Subject|3
848869|NCT00405756|1807101|FG000|Open-label Extension|Death|1
848871|NCT00405756|1807103|FG002|Open-label Extension|Death|4
848872|NCT00405756|1807101|FG000|Open-label Extension|Other|0
848873|NCT00405756|1807102|FG001|Open-label Extension|Other|1
848874|NCT00405756|1807103|FG002|Open-label Extension|Other|7
848875|NCT00405756|1807101|FG000|Follow-up|Ongoing in Follow-up Period|52
848876|NCT00405756|1807102|FG001|Follow-up|Ongoing in Follow-up Period|51
848877|NCT00405756|1807103|FG002|Follow-up|Ongoing in Follow-up Period|60
848878|NCT00405756|1807101|FG000|Follow-up|Death|21
848879|NCT00405756|1807102|FG001|Follow-up|Death|31
848880|NCT00405756|1807103|FG002|Follow-up|Death|24
848881|NCT00405756|1807101|FG000|Follow-up|Lost to Follow-up|2
848882|NCT00405756|1807102|FG001|Follow-up|Lost to Follow-up|8
848883|NCT00405756|1807103|FG002|Follow-up|Lost to Follow-up|4
848884|NCT00405821|1807113|FG000|Overall Study|Death|5
848885|NCT00405821|1807114|FG001|Overall Study|Death|7
848886|NCT00405821|1807113|FG000|Overall Study|Lost to Follow-up|7
848887|NCT00405821|1807114|FG001|Overall Study|Lost to Follow-up|7
848888|NCT00405821|1807113|FG000|Overall Study|Protocol Violation|1
848889|NCT00405821|1807114|FG001|Overall Study|Protocol Violation|0
848890|NCT00405821|1807113|FG000|Overall Study|initiated ART|9
848891|NCT00405821|1807114|FG001|Overall Study|initiated ART|8
848892|NCT00405912|1807123|FG000|Overall Study|Withdrawal by Subject|12
848893|NCT00405912|1807124|FG001|Overall Study|Withdrawal by Subject|11
848894|NCT00405912|1807125|FG002|Overall Study|Withdrawal by Subject|12
848895|NCT00405912|1807123|FG000|Overall Study|Lost to Follow-up|4
848896|NCT00405912|1807124|FG001|Overall Study|Lost to Follow-up|8
848897|NCT00405912|1807125|FG002|Overall Study|Lost to Follow-up|4
848898|NCT00405964|1807144|FG000|Overall Study|Treatment Failure|17
848899|NCT00405964|1807145|FG001|Overall Study|Treatment Failure|45
848900|NCT00405964|1807144|FG000|Overall Study|Adverse Event|7
848901|NCT00405964|1807145|FG001|Overall Study|Adverse Event|16
848902|NCT00405964|1807144|FG000|Overall Study|Lost to Follow-up|5
848903|NCT00405964|1807145|FG001|Overall Study|Lost to Follow-up|5
848904|NCT00405964|1807144|FG000|Overall Study|Withdrawal by Subject|19
848905|NCT00405964|1807145|FG001|Overall Study|Withdrawal by Subject|23
848906|NCT00405964|1807144|FG000|Overall Study|Protocol Violation|11
848907|NCT00405964|1807145|FG001|Overall Study|Protocol Violation|6
848908|NCT00406029|1807156|FG000|Overall Study|Adverse Event|12
848909|NCT00406029|1807157|FG001|Overall Study|Adverse Event|2
848910|NCT00406029|1807158|FG002|Overall Study|Adverse Event|5
848911|NCT00406029|1807159|FG003|Overall Study|Adverse Event|10
848912|NCT00406029|1807160|FG004|Overall Study|Adverse Event|7
848913|NCT00406029|1807156|FG000|Overall Study|Withdrawal by Subject|3
848914|NCT00406029|1807157|FG001|Overall Study|Withdrawal by Subject|4
848915|NCT00406029|1807158|FG002|Overall Study|Withdrawal by Subject|2
848916|NCT00406029|1807159|FG003|Overall Study|Withdrawal by Subject|2
848917|NCT00406029|1807160|FG004|Overall Study|Withdrawal by Subject|0
848918|NCT00406029|1807156|FG000|Overall Study|Protocol Violation|1
848919|NCT00406029|1807157|FG001|Overall Study|Protocol Violation|2
848920|NCT00406029|1807158|FG002|Overall Study|Protocol Violation|0
848921|NCT00406029|1807159|FG003|Overall Study|Protocol Violation|2
848922|NCT00406029|1807160|FG004|Overall Study|Protocol Violation|0
848923|NCT00406029|1807156|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
848924|NCT00406029|1807157|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
848925|NCT00406029|1807158|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
848926|NCT00406029|1807159|FG003|Overall Study|Did Not Meet Eligibility Criteria|0
848927|NCT00406029|1807160|FG004|Overall Study|Did Not Meet Eligibility Criteria|0
848928|NCT00406029|1807156|FG000|Overall Study|Randomized in Error|0
848929|NCT00406029|1807157|FG001|Overall Study|Randomized in Error|0
848930|NCT00406029|1807158|FG002|Overall Study|Randomized in Error|2
848931|NCT00406029|1807159|FG003|Overall Study|Randomized in Error|3
848932|NCT00406029|1807160|FG004|Overall Study|Randomized in Error|1
848933|NCT00406315|1807209|FG000|Overall Study|Death|1
848934|NCT00406315|1807209|FG000|Overall Study|Adverse Event|39
848935|NCT00406315|1807209|FG000|Overall Study|Laboratory Abnormality|4
848936|NCT00406315|1807209|FG000|Overall Study|Lack of Efficacy|13
848937|NCT00406315|1807209|FG000|Overall Study|Other|33
848938|NCT00406315|1807209|FG000|Overall Study|Lost to Follow-up|21
848939|NCT00406315|1807209|FG000|Overall Study|Withdrawal by Subject|30
848940|NCT00406354|1807216|FG000|All Randomized Patients|Protocol Violation|0
848941|NCT00406354|1807217|FG001|All Randomized Patients|Protocol Violation|0
848942|NCT00406354|1807218|FG002|All Randomized Patients|Protocol Violation|1
848943|NCT00406354|1807216|FG000|All Randomized and Treated Patients|Lack of Efficacy|7
848944|NCT00406354|1807217|FG001|All Randomized and Treated Patients|Lack of Efficacy|4
848945|NCT00406354|1807218|FG002|All Randomized and Treated Patients|Lack of Efficacy|17
848946|NCT00406354|1807216|FG000|All Randomized and Treated Patients|Adverse Event|6
848947|NCT00406354|1807217|FG001|All Randomized and Treated Patients|Adverse Event|2
848948|NCT00406354|1807218|FG002|All Randomized and Treated Patients|Adverse Event|1
848949|NCT00406354|1807216|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2
848950|NCT00406354|1807217|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6
848951|NCT00406354|1807218|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1
848952|NCT00406354|1807216|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1
848953|NCT00406354|1807217|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1
849107|NCT00406653|1807278|FG002|Induction Period|Given prohibited drug|2
848954|NCT00406354|1807218|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2
848955|NCT00406354|1807216|FG000|All Randomized and Treated Patients|Physician Decision|0
848956|NCT00406354|1807217|FG001|All Randomized and Treated Patients|Physician Decision|0
848957|NCT00406354|1807218|FG002|All Randomized and Treated Patients|Physician Decision|1
848958|NCT00406367|1807228|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
848959|NCT00406367|1807229|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
848960|NCT00406367|1807228|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
848961|NCT00406367|1807229|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
848962|NCT00406367|1807228|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
848963|NCT00406367|1807229|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
848964|NCT00406367|1807228|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
848965|NCT00406367|1807229|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
848966|NCT00406367|1807228|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
848967|NCT00406367|1807229|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
848968|NCT00406367|1807228|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
848969|NCT00406367|1807229|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
848970|NCT00406367|1807228|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
848971|NCT00406367|1807229|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
848972|NCT00406367|1807228|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
848973|NCT00406367|1807229|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
848974|NCT00406367|1807228|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
848975|NCT00406367|1807229|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
848976|NCT00406367|1807228|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
848977|NCT00406367|1807229|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
848978|NCT00406367|1807228|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
848979|NCT00406367|1807229|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
848980|NCT00406367|1807228|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
848981|NCT00406367|1807229|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
848982|NCT00406393|1807237|FG000|Overall Study|Did not undergo transplantation|2
848983|NCT00406393|1807238|FG001|Overall Study|Did not undergo transplantation|1
848984|NCT00406419|1807247|FG000|Overall Study|Death|3
848985|NCT00406419|1807248|FG001|Overall Study|Death|1
848986|NCT00406419|1807249|FG002|Overall Study|Death|4
848987|NCT00406419|1807247|FG000|Overall Study|Protocol Violation|6
848988|NCT00406419|1807248|FG001|Overall Study|Protocol Violation|2
848989|NCT00406419|1807249|FG002|Overall Study|Protocol Violation|5
848990|NCT00406419|1807247|FG000|Overall Study|Study Terminated by Sponsor|260
848991|NCT00406419|1807248|FG001|Overall Study|Study Terminated by Sponsor|288
848992|NCT00406419|1807249|FG002|Overall Study|Study Terminated by Sponsor|282
848993|NCT00406419|1807247|FG000|Overall Study|Withdrawal by Subject|17
848994|NCT00406419|1807248|FG001|Overall Study|Withdrawal by Subject|24
848995|NCT00406419|1807249|FG002|Overall Study|Withdrawal by Subject|26
848996|NCT00406419|1807247|FG000|Overall Study|Lack of Efficacy|12
848997|NCT00406419|1807248|FG001|Overall Study|Lack of Efficacy|1
848998|NCT00406419|1807249|FG002|Overall Study|Lack of Efficacy|6
848999|NCT00406419|1807247|FG000|Overall Study|Non-Compliance with Study Drug|5
849000|NCT00406419|1807248|FG001|Overall Study|Non-Compliance with Study Drug|6
849001|NCT00406419|1807249|FG002|Overall Study|Non-Compliance with Study Drug|3
849002|NCT00406419|1807247|FG000|Overall Study|Adverse Event|10
849003|NCT00406419|1807248|FG001|Overall Study|Adverse Event|12
849004|NCT00406419|1807249|FG002|Overall Study|Adverse Event|16
849005|NCT00406419|1807247|FG000|Overall Study|Lost to Follow-up|11
849006|NCT00406419|1807248|FG001|Overall Study|Lost to Follow-up|10
849007|NCT00406419|1807249|FG002|Overall Study|Lost to Follow-up|5
849008|NCT00406640|1807259|FG000|Acute Phase|Adverse Event|18
849009|NCT00406640|1807260|FG001|Acute Phase|Adverse Event|13
849010|NCT00406640|1807259|FG000|Acute Phase|Failed to Return|5
849011|NCT00406640|1807260|FG001|Acute Phase|Failed to Return|1
849012|NCT00406640|1807259|FG000|Acute Phase|Physician Decision|0
849013|NCT00406640|1807260|FG001|Acute Phase|Physician Decision|1
849014|NCT00406640|1807259|FG000|Acute Phase|Lost to Follow-up|7
849015|NCT00406640|1807260|FG001|Acute Phase|Lost to Follow-up|4
849016|NCT00406640|1807259|FG000|Acute Phase|Protocol deviation|4
849017|NCT00406640|1807260|FG001|Acute Phase|Protocol deviation|10
849018|NCT00406640|1807259|FG000|Acute Phase|Protocol Violation|3
849019|NCT00406640|1807260|FG001|Acute Phase|Protocol Violation|2
849020|NCT00406640|1807259|FG000|Acute Phase|Withdrawal by Subject|11
849021|NCT00406640|1807260|FG001|Acute Phase|Withdrawal by Subject|9
849022|NCT00406640|1807259|FG000|Acute Phase|Lack of Efficacy|3
849023|NCT00406640|1807260|FG001|Acute Phase|Lack of Efficacy|3
849024|NCT00406640|1807259|FG000|DB Continuation Phase for Responders|Adverse Event|11
849025|NCT00406640|1807260|FG001|DB Continuation Phase for Responders|Adverse Event|11
849026|NCT00406640|1807259|FG000|DB Continuation Phase for Responders|Death|1
849027|NCT00406640|1807260|FG001|DB Continuation Phase for Responders|Death|0
849028|NCT00406640|1807259|FG000|DB Continuation Phase for Responders|Failed to Return|0
849029|NCT00406640|1807260|FG001|DB Continuation Phase for Responders|Failed to Return|2
849030|NCT00406640|1807259|FG000|DB Continuation Phase for Responders|Physician Decision|2
849031|NCT00406640|1807260|FG001|DB Continuation Phase for Responders|Physician Decision|3
849032|NCT00406640|1807259|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1
849033|NCT00406640|1807260|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7
849034|NCT00406640|1807259|FG000|DB Continuation Phase for Responders|non-compliance|7
849035|NCT00406640|1807260|FG001|DB Continuation Phase for Responders|non-compliance|5
849036|NCT00406640|1807259|FG000|DB Continuation Phase for Responders|Protocol Violation|2
849037|NCT00406640|1807260|FG001|DB Continuation Phase for Responders|Protocol Violation|2
849038|NCT00406640|1807259|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8
849039|NCT00406640|1807260|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6
849040|NCT00406640|1807259|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1
849041|NCT00406640|1807260|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1
849042|NCT00406640|1807259|FG000|OL Extension Phase for Non-Responders|Adverse Event|6
849043|NCT00406640|1807260|FG001|OL Extension Phase for Non-Responders|Adverse Event|6
849044|NCT00406640|1807259|FG000|OL Extension Phase for Non-Responders|Failed to Return|1
849045|NCT00406640|1807260|FG001|OL Extension Phase for Non-Responders|Failed to Return|0
849046|NCT00406640|1807259|FG000|OL Extension Phase for Non-Responders|Physician Decision|1
849047|NCT00406640|1807260|FG001|OL Extension Phase for Non-Responders|Physician Decision|0
849048|NCT00406640|1807259|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2
849049|NCT00406640|1807260|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3
849050|NCT00406640|1807259|FG000|OL Extension Phase for Non-Responders|non-compliance|3
849051|NCT00406640|1807260|FG001|OL Extension Phase for Non-Responders|non-compliance|2
849052|NCT00406640|1807259|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
849053|NCT00406640|1807260|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
849054|NCT00406640|1807259|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6
849055|NCT00406640|1807260|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7
849056|NCT00406653|1807276|FG000|Induction Period|Adverse Event|1
849057|NCT00406653|1807277|FG001|Induction Period|Adverse Event|10
849058|NCT00406653|1807278|FG002|Induction Period|Adverse Event|4
849059|NCT00406653|1807279|FG003|Induction Period|Adverse Event|11
849060|NCT00406653|1807280|FG004|Induction Period|Adverse Event|0
849061|NCT00406653|1807281|FG005|Induction Period|Adverse Event|0
849062|NCT00406653|1807282|FG006|Induction Period|Adverse Event|0
849063|NCT00406653|1807276|FG000|Induction Period|Lack of Efficacy|11
849064|NCT00406653|1807277|FG001|Induction Period|Lack of Efficacy|14
849065|NCT00406653|1807278|FG002|Induction Period|Lack of Efficacy|8
849066|NCT00406653|1807279|FG003|Induction Period|Lack of Efficacy|10
849067|NCT00406653|1807280|FG004|Induction Period|Lack of Efficacy|0
849068|NCT00406653|1807281|FG005|Induction Period|Lack of Efficacy|0
849069|NCT00406653|1807282|FG006|Induction Period|Lack of Efficacy|0
849070|NCT00406653|1807276|FG000|Induction Period|Lost to Follow-up|0
849071|NCT00406653|1807277|FG001|Induction Period|Lost to Follow-up|2
849072|NCT00406653|1807278|FG002|Induction Period|Lost to Follow-up|0
849073|NCT00406653|1807279|FG003|Induction Period|Lost to Follow-up|0
849074|NCT00406653|1807280|FG004|Induction Period|Lost to Follow-up|0
849075|NCT00406653|1807281|FG005|Induction Period|Lost to Follow-up|0
849076|NCT00406653|1807282|FG006|Induction Period|Lost to Follow-up|0
849077|NCT00406653|1807276|FG000|Induction Period|Withdrawal of Consent|2
849078|NCT00406653|1807277|FG001|Induction Period|Withdrawal of Consent|5
849079|NCT00406653|1807278|FG002|Induction Period|Withdrawal of Consent|1
849080|NCT00406653|1807279|FG003|Induction Period|Withdrawal of Consent|2
849081|NCT00406653|1807280|FG004|Induction Period|Withdrawal of Consent|0
849082|NCT00406653|1807281|FG005|Induction Period|Withdrawal of Consent|0
849083|NCT00406653|1807282|FG006|Induction Period|Withdrawal of Consent|0
849084|NCT00406653|1807276|FG000|Induction Period|Subject No Longer Meets Study Criteria|0
849085|NCT00406653|1807277|FG001|Induction Period|Subject No Longer Meets Study Criteria|0
849086|NCT00406653|1807278|FG002|Induction Period|Subject No Longer Meets Study Criteria|0
849087|NCT00406653|1807279|FG003|Induction Period|Subject No Longer Meets Study Criteria|2
849088|NCT00406653|1807280|FG004|Induction Period|Subject No Longer Meets Study Criteria|0
849089|NCT00406653|1807281|FG005|Induction Period|Subject No Longer Meets Study Criteria|0
849090|NCT00406653|1807282|FG006|Induction Period|Subject No Longer Meets Study Criteria|0
849091|NCT00406653|1807276|FG000|Induction Period|Pregnancy|1
849092|NCT00406653|1807277|FG001|Induction Period|Pregnancy|0
849093|NCT00406653|1807278|FG002|Induction Period|Pregnancy|0
849094|NCT00406653|1807279|FG003|Induction Period|Pregnancy|0
849095|NCT00406653|1807280|FG004|Induction Period|Pregnancy|0
849096|NCT00406653|1807281|FG005|Induction Period|Pregnancy|0
849097|NCT00406653|1807282|FG006|Induction Period|Pregnancy|0
849098|NCT00406653|1807276|FG000|Induction Period|Declined participation but followup done|0
849099|NCT00406653|1807277|FG001|Induction Period|Declined participation but followup done|2
849100|NCT00406653|1807278|FG002|Induction Period|Declined participation but followup done|1
849101|NCT00406653|1807279|FG003|Induction Period|Declined participation but followup done|1
849102|NCT00406653|1807280|FG004|Induction Period|Declined participation but followup done|0
849103|NCT00406653|1807281|FG005|Induction Period|Declined participation but followup done|0
849104|NCT00406653|1807282|FG006|Induction Period|Declined participation but followup done|0
849105|NCT00406653|1807276|FG000|Induction Period|Given prohibited drug|0
849106|NCT00406653|1807277|FG001|Induction Period|Given prohibited drug|1
849108|NCT00406653|1807279|FG003|Induction Period|Given prohibited drug|0
849109|NCT00406653|1807280|FG004|Induction Period|Given prohibited drug|0
849110|NCT00406653|1807281|FG005|Induction Period|Given prohibited drug|0
849111|NCT00406653|1807282|FG006|Induction Period|Given prohibited drug|0
849112|NCT00406653|1807276|FG000|Induction Period|Incarcerated|0
849113|NCT00406653|1807277|FG001|Induction Period|Incarcerated|0
849114|NCT00406653|1807278|FG002|Induction Period|Incarcerated|1
849115|NCT00406653|1807279|FG003|Induction Period|Incarcerated|0
849116|NCT00406653|1807280|FG004|Induction Period|Incarcerated|0
849117|NCT00406653|1807281|FG005|Induction Period|Incarcerated|0
849118|NCT00406653|1807282|FG006|Induction Period|Incarcerated|0
849119|NCT00406653|1807276|FG000|Induction Period|Patient relocated|0
849120|NCT00406653|1807277|FG001|Induction Period|Patient relocated|0
849121|NCT00406653|1807278|FG002|Induction Period|Patient relocated|1
849122|NCT00406653|1807279|FG003|Induction Period|Patient relocated|0
849123|NCT00406653|1807280|FG004|Induction Period|Patient relocated|0
849124|NCT00406653|1807281|FG005|Induction Period|Patient relocated|0
849125|NCT00406653|1807282|FG006|Induction Period|Patient relocated|0
849126|NCT00406653|1807276|FG000|Maintenance Period|Adverse Event|0
849127|NCT00406653|1807277|FG001|Maintenance Period|Adverse Event|0
849128|NCT00406653|1807278|FG002|Maintenance Period|Adverse Event|0
849129|NCT00406653|1807279|FG003|Maintenance Period|Adverse Event|0
849130|NCT00406653|1807280|FG004|Maintenance Period|Adverse Event|1
849131|NCT00406653|1807281|FG005|Maintenance Period|Adverse Event|1
849132|NCT00406653|1807282|FG006|Maintenance Period|Adverse Event|0
849133|NCT00406653|1807276|FG000|Maintenance Period|Lack of Efficacy|0
849134|NCT00406653|1807277|FG001|Maintenance Period|Lack of Efficacy|0
849135|NCT00406653|1807278|FG002|Maintenance Period|Lack of Efficacy|0
849136|NCT00406653|1807279|FG003|Maintenance Period|Lack of Efficacy|0
849137|NCT00406653|1807280|FG004|Maintenance Period|Lack of Efficacy|20
849138|NCT00406653|1807281|FG005|Maintenance Period|Lack of Efficacy|26
849139|NCT00406653|1807282|FG006|Maintenance Period|Lack of Efficacy|0
849140|NCT00406653|1807276|FG000|Maintenance Period|Lost to Follow-up|0
849141|NCT00406653|1807277|FG001|Maintenance Period|Lost to Follow-up|0
849142|NCT00406653|1807278|FG002|Maintenance Period|Lost to Follow-up|0
849143|NCT00406653|1807279|FG003|Maintenance Period|Lost to Follow-up|0
849144|NCT00406653|1807280|FG004|Maintenance Period|Lost to Follow-up|2
849145|NCT00406653|1807281|FG005|Maintenance Period|Lost to Follow-up|1
849146|NCT00406653|1807282|FG006|Maintenance Period|Lost to Follow-up|0
849147|NCT00406653|1807276|FG000|Maintenance Period|Withdrawal of Consent|0
849148|NCT00406653|1807277|FG001|Maintenance Period|Withdrawal of Consent|0
849149|NCT00406653|1807278|FG002|Maintenance Period|Withdrawal of Consent|0
849150|NCT00406653|1807279|FG003|Maintenance Period|Withdrawal of Consent|0
849151|NCT00406653|1807280|FG004|Maintenance Period|Withdrawal of Consent|2
849152|NCT00406653|1807281|FG005|Maintenance Period|Withdrawal of Consent|0
849153|NCT00406653|1807282|FG006|Maintenance Period|Withdrawal of Consent|0
849154|NCT00406653|1807276|FG000|Maintenance Period|Pregnancy|0
849155|NCT00406653|1807277|FG001|Maintenance Period|Pregnancy|0
849156|NCT00406653|1807278|FG002|Maintenance Period|Pregnancy|0
849157|NCT00406653|1807279|FG003|Maintenance Period|Pregnancy|0
849158|NCT00406653|1807280|FG004|Maintenance Period|Pregnancy|0
849159|NCT00406653|1807281|FG005|Maintenance Period|Pregnancy|1
849160|NCT00406653|1807282|FG006|Maintenance Period|Pregnancy|0
849161|NCT00406653|1807276|FG000|Maintenance Period|Administrative Reason By Sponsor|0
849162|NCT00406653|1807277|FG001|Maintenance Period|Administrative Reason By Sponsor|0
849163|NCT00406653|1807278|FG002|Maintenance Period|Administrative Reason By Sponsor|0
849164|NCT00406653|1807279|FG003|Maintenance Period|Administrative Reason By Sponsor|0
849165|NCT00406653|1807280|FG004|Maintenance Period|Administrative Reason By Sponsor|4
849166|NCT00406653|1807281|FG005|Maintenance Period|Administrative Reason By Sponsor|7
849167|NCT00406653|1807282|FG006|Maintenance Period|Administrative Reason By Sponsor|0
849168|NCT00406653|1807276|FG000|Maintenance Period|Error in disease score evaluation|0
849169|NCT00406653|1807277|FG001|Maintenance Period|Error in disease score evaluation|0
849170|NCT00406653|1807278|FG002|Maintenance Period|Error in disease score evaluation|0
849171|NCT00406653|1807279|FG003|Maintenance Period|Error in disease score evaluation|0
849172|NCT00406653|1807280|FG004|Maintenance Period|Error in disease score evaluation|1
849173|NCT00406653|1807281|FG005|Maintenance Period|Error in disease score evaluation|0
849174|NCT00406653|1807282|FG006|Maintenance Period|Error in disease score evaluation|0
849175|NCT00406653|1807276|FG000|Open-Label Period|Death|0
849176|NCT00406653|1807277|FG001|Open-Label Period|Death|0
849177|NCT00406653|1807278|FG002|Open-Label Period|Death|0
849178|NCT00406653|1807279|FG003|Open-Label Period|Death|0
849179|NCT00406653|1807280|FG004|Open-Label Period|Death|0
849180|NCT00406653|1807281|FG005|Open-Label Period|Death|0
849181|NCT00406653|1807282|FG006|Open-Label Period|Death|1
849182|NCT00406653|1807276|FG000|Open-Label Period|Adverse Event|0
849183|NCT00406653|1807277|FG001|Open-Label Period|Adverse Event|0
849184|NCT00406653|1807278|FG002|Open-Label Period|Adverse Event|0
849185|NCT00406653|1807279|FG003|Open-Label Period|Adverse Event|0
849186|NCT00406653|1807280|FG004|Open-Label Period|Adverse Event|0
849187|NCT00406653|1807281|FG005|Open-Label Period|Adverse Event|0
849188|NCT00406653|1807282|FG006|Open-Label Period|Adverse Event|18
849189|NCT00406653|1807276|FG000|Open-Label Period|Lack of Efficacy|0
849190|NCT00406653|1807277|FG001|Open-Label Period|Lack of Efficacy|0
849191|NCT00406653|1807278|FG002|Open-Label Period|Lack of Efficacy|0
849192|NCT00406653|1807279|FG003|Open-Label Period|Lack of Efficacy|0
849193|NCT00406653|1807280|FG004|Open-Label Period|Lack of Efficacy|0
849194|NCT00406653|1807281|FG005|Open-Label Period|Lack of Efficacy|0
849195|NCT00406653|1807282|FG006|Open-Label Period|Lack of Efficacy|160
849196|NCT00406653|1807276|FG000|Open-Label Period|Lost to Follow-up|0
849197|NCT00406653|1807277|FG001|Open-Label Period|Lost to Follow-up|0
849198|NCT00406653|1807278|FG002|Open-Label Period|Lost to Follow-up|0
849199|NCT00406653|1807279|FG003|Open-Label Period|Lost to Follow-up|0
849200|NCT00406653|1807280|FG004|Open-Label Period|Lost to Follow-up|0
849201|NCT00406653|1807281|FG005|Open-Label Period|Lost to Follow-up|0
849202|NCT00406653|1807282|FG006|Open-Label Period|Lost to Follow-up|6
849203|NCT00406653|1807276|FG000|Open-Label Period|Withdrawal of Consent|0
849204|NCT00406653|1807277|FG001|Open-Label Period|Withdrawal of Consent|0
849205|NCT00406653|1807278|FG002|Open-Label Period|Withdrawal of Consent|0
849206|NCT00406653|1807279|FG003|Open-Label Period|Withdrawal of Consent|0
849207|NCT00406653|1807280|FG004|Open-Label Period|Withdrawal of Consent|0
849208|NCT00406653|1807281|FG005|Open-Label Period|Withdrawal of Consent|0
849209|NCT00406653|1807282|FG006|Open-Label Period|Withdrawal of Consent|11
849210|NCT00406653|1807276|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0
849211|NCT00406653|1807277|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0
849212|NCT00406653|1807278|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0
849213|NCT00406653|1807279|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0
849214|NCT00406653|1807280|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0
849215|NCT00406653|1807281|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0
849216|NCT00406653|1807282|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1
849217|NCT00406653|1807276|FG000|Open-Label Period|Pregnancy|0
849218|NCT00406653|1807277|FG001|Open-Label Period|Pregnancy|0
849219|NCT00406653|1807278|FG002|Open-Label Period|Pregnancy|0
849220|NCT00406653|1807279|FG003|Open-Label Period|Pregnancy|0
849221|NCT00406653|1807280|FG004|Open-Label Period|Pregnancy|0
849222|NCT00406653|1807281|FG005|Open-Label Period|Pregnancy|0
849223|NCT00406653|1807282|FG006|Open-Label Period|Pregnancy|2
849224|NCT00406653|1807276|FG000|Open-Label Period|Administrative Reason By Sponsor|0
849225|NCT00406653|1807277|FG001|Open-Label Period|Administrative Reason By Sponsor|0
849226|NCT00406653|1807278|FG002|Open-Label Period|Administrative Reason By Sponsor|0
849227|NCT00406653|1807279|FG003|Open-Label Period|Administrative Reason By Sponsor|0
849228|NCT00406653|1807280|FG004|Open-Label Period|Administrative Reason By Sponsor|0
849229|NCT00406653|1807281|FG005|Open-Label Period|Administrative Reason By Sponsor|0
849230|NCT00406653|1807282|FG006|Open-Label Period|Administrative Reason By Sponsor|115
849231|NCT00406653|1807276|FG000|Open-Label Period|Declined participation but followup done|0
849232|NCT00406653|1807277|FG001|Open-Label Period|Declined participation but followup done|0
849233|NCT00406653|1807278|FG002|Open-Label Period|Declined participation but followup done|0
849234|NCT00406653|1807279|FG003|Open-Label Period|Declined participation but followup done|0
849235|NCT00406653|1807280|FG004|Open-Label Period|Declined participation but followup done|0
849236|NCT00406653|1807281|FG005|Open-Label Period|Declined participation but followup done|0
849237|NCT00406653|1807282|FG006|Open-Label Period|Declined participation but followup done|8
849238|NCT00406653|1807276|FG000|Open-Label Period|Discontinued by Sponsor|0
849239|NCT00406653|1807277|FG001|Open-Label Period|Discontinued by Sponsor|0
849240|NCT00406653|1807278|FG002|Open-Label Period|Discontinued by Sponsor|0
849241|NCT00406653|1807279|FG003|Open-Label Period|Discontinued by Sponsor|0
849242|NCT00406653|1807280|FG004|Open-Label Period|Discontinued by Sponsor|0
849243|NCT00406653|1807281|FG005|Open-Label Period|Discontinued by Sponsor|0
849244|NCT00406653|1807282|FG006|Open-Label Period|Discontinued by Sponsor|1
849245|NCT00406653|1807276|FG000|Open-Label Period|Refused followup|0
849246|NCT00406653|1807277|FG001|Open-Label Period|Refused followup|0
849247|NCT00406653|1807278|FG002|Open-Label Period|Refused followup|0
849248|NCT00406653|1807279|FG003|Open-Label Period|Refused followup|0
849249|NCT00406653|1807280|FG004|Open-Label Period|Refused followup|0
849250|NCT00406653|1807281|FG005|Open-Label Period|Refused followup|0
849251|NCT00406653|1807282|FG006|Open-Label Period|Refused followup|1
849252|NCT00406692|1807302|FG000|Overall Study|Withdrawal by Subject|4
849253|NCT00406692|1807302|FG000|Overall Study|Physician Decision|1
849254|NCT00406692|1807302|FG000|Overall Study|Adverse Event|1
849255|NCT00406692|1807302|FG000|Overall Study|Lack of Efficacy|1
849256|NCT00406718|1807309|FG000|Overall Study|Withdrawal by Subject|2
849257|NCT00406718|1807310|FG001|Overall Study|Withdrawal by Subject|9
849258|NCT00406718|1807311|FG002|Overall Study|Withdrawal by Subject|4
849259|NCT00406718|1807309|FG000|Overall Study|Lost to Follow-up|2
849260|NCT00406718|1807310|FG001|Overall Study|Lost to Follow-up|5
849261|NCT00406718|1807311|FG002|Overall Study|Lost to Follow-up|4
849262|NCT00406783|1807323|FG000|Overall Study|Adverse Event|4
849263|NCT00406783|1807324|FG001|Overall Study|Adverse Event|4
849264|NCT00406783|1807323|FG000|Overall Study|Treatment Failure|2
849265|NCT00406783|1807324|FG001|Overall Study|Treatment Failure|3
849266|NCT00406783|1807323|FG000|Overall Study|Lost to Follow-up|3
849267|NCT00406783|1807324|FG001|Overall Study|Lost to Follow-up|0
849268|NCT00406783|1807323|FG000|Overall Study|Withdrawal by Subject|1
849269|NCT00406783|1807324|FG001|Overall Study|Withdrawal by Subject|4
849270|NCT00406783|1807323|FG000|Overall Study|Protocol Violation|4
849271|NCT00406783|1807324|FG001|Overall Study|Protocol Violation|4
849272|NCT00406848|1807332|FG000|Overall Study|Withdrawal by Subject|27
849273|NCT00406848|1807333|FG001|Overall Study|Withdrawal by Subject|22
849274|NCT00406848|1807332|FG000|Overall Study|Adverse Event|38
849275|NCT00406848|1807333|FG001|Overall Study|Adverse Event|7
849276|NCT00406848|1807332|FG000|Overall Study|Lack of Efficacy|9
849277|NCT00406848|1807333|FG001|Overall Study|Lack of Efficacy|14
849278|NCT00406848|1807332|FG000|Overall Study|Protocol Violation|10
849279|NCT00406848|1807333|FG001|Overall Study|Protocol Violation|6
849280|NCT00406848|1807332|FG000|Overall Study|Lost to Follow-up|6
849281|NCT00406848|1807333|FG001|Overall Study|Lost to Follow-up|2
849282|NCT00406848|1807332|FG000|Overall Study|Physician Decision|2
849283|NCT00406848|1807333|FG001|Overall Study|Physician Decision|2
849284|NCT00406848|1807332|FG000|Overall Study|Sponsor Decision|1
849285|NCT00406848|1807333|FG001|Overall Study|Sponsor Decision|1
849286|NCT00407030|1807345|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2
849287|NCT00407030|1807346|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1
849288|NCT00407030|1807347|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0
849289|NCT00407030|1807345|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
849290|NCT00407030|1807346|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
849291|NCT00407030|1807347|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
849292|NCT00407030|1807345|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
849293|NCT00407030|1807346|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
849294|NCT00407030|1807347|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
849295|NCT00407030|1807345|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
849296|NCT00407030|1807346|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
849297|NCT00407030|1807347|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
849298|NCT00407030|1807345|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
849299|NCT00407030|1807346|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
849300|NCT00407030|1807347|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
849301|NCT00407030|1807345|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1
849302|NCT00407030|1807346|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0
849303|NCT00407030|1807347|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0
849304|NCT00407030|1807345|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
849305|NCT00407030|1807346|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
849306|NCT00407030|1807347|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
849307|NCT00407030|1807345|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11
849308|NCT00407030|1807346|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11
849309|NCT00407030|1807347|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0
849310|NCT00407030|1807345|FG000|Extension Period - up to 68 Weeks|Adverse Event|1
849311|NCT00407030|1807346|FG001|Extension Period - up to 68 Weeks|Adverse Event|0
849312|NCT00407030|1807347|FG002|Extension Period - up to 68 Weeks|Adverse Event|0
849313|NCT00407030|1807345|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4
849314|NCT00407030|1807346|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4
849315|NCT00407030|1807347|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0
849316|NCT00407030|1807345|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5
849317|NCT00407030|1807346|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5
849318|NCT00407030|1807347|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0
849319|NCT00407030|1807345|FG000|Extension Period - up to 68 Weeks|Patient Decision|1
849320|NCT00407030|1807346|FG001|Extension Period - up to 68 Weeks|Patient Decision|2
849321|NCT00407030|1807347|FG002|Extension Period - up to 68 Weeks|Patient Decision|0
849322|NCT00407030|1807345|FG000|Extension Period - up to 68 Weeks|Physician Decision|1
849323|NCT00407030|1807346|FG001|Extension Period - up to 68 Weeks|Physician Decision|2
849324|NCT00407030|1807347|FG002|Extension Period - up to 68 Weeks|Physician Decision|0
849325|NCT00407511|1807395|FG000|Overall Study|Adverse Event|9
849326|NCT00407511|1807395|FG000|Overall Study|Lost to Follow-up|4
849327|NCT00407511|1807395|FG000|Overall Study|Other|5
849328|NCT00407511|1807395|FG000|Overall Study|Withdrawal by Subject|4
849329|NCT00407537|1807401|FG000|Overall Study|Death|5
849330|NCT00407537|1807402|FG001|Overall Study|Death|2
849331|NCT00407537|1807401|FG000|Overall Study|Adverse Event|36
849332|NCT00407537|1807402|FG001|Overall Study|Adverse Event|0
849333|NCT00407537|1807401|FG000|Overall Study|Lost to Follow-up|12
849334|NCT00407537|1807402|FG001|Overall Study|Lost to Follow-up|19
849335|NCT00407537|1807401|FG000|Overall Study|Other|6
849336|NCT00407537|1807402|FG001|Overall Study|Other|7
849337|NCT00407537|1807401|FG000|Overall Study|Withdrawal by Subject|34
849338|NCT00407537|1807402|FG001|Overall Study|Withdrawal by Subject|16
849339|NCT00407550|1807410|FG000|Overall Study|Adverse Event|0
849340|NCT00407550|1807411|FG001|Overall Study|Adverse Event|1
849341|NCT00407550|1807410|FG000|Overall Study|Withdrawal by Subject|0
849342|NCT00407550|1807411|FG001|Overall Study|Withdrawal by Subject|2
849343|NCT00407550|1807410|FG000|Overall Study|Death|1
849344|NCT00407550|1807411|FG001|Overall Study|Death|0
849345|NCT00407550|1807410|FG000|Overall Study|Insurance or Other medical condition|2
849346|NCT00407550|1807411|FG001|Overall Study|Insurance or Other medical condition|1
849347|NCT00407563|1807417|FG000|Overall Study|Patient continues on treatment|1
849348|NCT00407745|1807428|FG000|Overall Study|Lack of Efficacy|1
849349|NCT00407745|1807429|FG001|Overall Study|Lack of Efficacy|2
849350|NCT00407745|1807428|FG000|Overall Study|Withdrawal by Subject|3
849351|NCT00407745|1807429|FG001|Overall Study|Withdrawal by Subject|3
849352|NCT00407745|1807428|FG000|Overall Study|Protocol Violation|5
849353|NCT00407745|1807429|FG001|Overall Study|Protocol Violation|3
849354|NCT00407745|1807428|FG000|Overall Study|Adverse Event|8
849355|NCT00407745|1807429|FG001|Overall Study|Adverse Event|8
849356|NCT00407745|1807428|FG000|Overall Study|Other|2
849357|NCT00407745|1807429|FG001|Overall Study|Other|0
849358|NCT00407745|1807428|FG000|Overall Study|Randomized, unknown if treated|0
849359|NCT00407745|1807429|FG001|Overall Study|Randomized, unknown if treated|1
849360|NCT00407758|1807435|FG000|Overall Study|ineligible -improper prior treatment|1
849361|NCT00407797|1807439|FG000|Overall Study|Lost to Follow-up|2
849362|NCT00407797|1807439|FG000|Overall Study|Adverse Event|6
849363|NCT00407797|1807439|FG000|Overall Study|Other|7
849364|NCT00407797|1807439|FG000|Overall Study|Withdrawal by Subject|3
849365|NCT00408005|1807453|FG000|Induction|Adverse Event|19
849366|NCT00408005|1807454|FG001|Induction|Adverse Event|3
849367|NCT00408005|1807455|FG002|Induction|Adverse Event|0
849368|NCT00408005|1807456|FG003|Induction|Adverse Event|0
849369|NCT00408005|1807457|FG004|Induction|Adverse Event|0
849370|NCT00408005|1807458|FG005|Induction|Adverse Event|0
849371|NCT00408005|1807459|FG006|Induction|Adverse Event|0
849372|NCT00408005|1807460|FG007|Induction|Adverse Event|0
849373|NCT00408005|1807453|FG000|Induction|Death|6
849374|NCT00408005|1807454|FG001|Induction|Death|0
849375|NCT00408005|1807455|FG002|Induction|Death|0
849376|NCT00408005|1807456|FG003|Induction|Death|0
849377|NCT00408005|1807457|FG004|Induction|Death|0
849378|NCT00408005|1807458|FG005|Induction|Death|0
849379|NCT00408005|1807459|FG006|Induction|Death|0
849380|NCT00408005|1807460|FG007|Induction|Death|0
849381|NCT00408005|1807453|FG000|Induction|Physician Decision|83
849382|NCT00408005|1807454|FG001|Induction|Physician Decision|9
849383|NCT00408005|1807455|FG002|Induction|Physician Decision|0
849384|NCT00408005|1807456|FG003|Induction|Physician Decision|0
849385|NCT00408005|1807457|FG004|Induction|Physician Decision|0
849386|NCT00408005|1807458|FG005|Induction|Physician Decision|0
849387|NCT00408005|1807459|FG006|Induction|Physician Decision|0
849388|NCT00408005|1807460|FG007|Induction|Physician Decision|0
849389|NCT00408005|1807453|FG000|Induction|Withdrawal by Subject|2
849390|NCT00408005|1807454|FG001|Induction|Withdrawal by Subject|4
849391|NCT00408005|1807455|FG002|Induction|Withdrawal by Subject|0
849392|NCT00408005|1807456|FG003|Induction|Withdrawal by Subject|0
849393|NCT00408005|1807457|FG004|Induction|Withdrawal by Subject|0
849394|NCT00408005|1807458|FG005|Induction|Withdrawal by Subject|0
849395|NCT00408005|1807459|FG006|Induction|Withdrawal by Subject|0
849396|NCT00408005|1807460|FG007|Induction|Withdrawal by Subject|0
849397|NCT00408005|1807453|FG000|Induction|Ineligible|33
849398|NCT00408005|1807454|FG001|Induction|Ineligible|14
849399|NCT00408005|1807455|FG002|Induction|Ineligible|0
849400|NCT00408005|1807456|FG003|Induction|Ineligible|0
849401|NCT00408005|1807457|FG004|Induction|Ineligible|0
849402|NCT00408005|1807458|FG005|Induction|Ineligible|0
849403|NCT00408005|1807459|FG006|Induction|Ineligible|0
849404|NCT00408005|1807460|FG007|Induction|Ineligible|0
849405|NCT00408005|1807453|FG000|Induction|Refusal of Further Protocol Therapy|225
849406|NCT00408005|1807454|FG001|Induction|Refusal of Further Protocol Therapy|44
849407|NCT00408005|1807455|FG002|Induction|Refusal of Further Protocol Therapy|0
849408|NCT00408005|1807456|FG003|Induction|Refusal of Further Protocol Therapy|0
849409|NCT00408005|1807457|FG004|Induction|Refusal of Further Protocol Therapy|0
849410|NCT00408005|1807458|FG005|Induction|Refusal of Further Protocol Therapy|0
849411|NCT00408005|1807459|FG006|Induction|Refusal of Further Protocol Therapy|0
849412|NCT00408005|1807460|FG007|Induction|Refusal of Further Protocol Therapy|0
849413|NCT00408005|1807453|FG000|Induction|Entered another COG therapeutic protocol|4
849414|NCT00408005|1807454|FG001|Induction|Entered another COG therapeutic protocol|0
849415|NCT00408005|1807455|FG002|Induction|Entered another COG therapeutic protocol|0
849416|NCT00408005|1807456|FG003|Induction|Entered another COG therapeutic protocol|0
849417|NCT00408005|1807457|FG004|Induction|Entered another COG therapeutic protocol|0
849418|NCT00408005|1807458|FG005|Induction|Entered another COG therapeutic protocol|0
849419|NCT00408005|1807459|FG006|Induction|Entered another COG therapeutic protocol|0
849420|NCT00408005|1807460|FG007|Induction|Entered another COG therapeutic protocol|0
849421|NCT00408005|1807453|FG000|Induction|Patient transferred Tx to Non-COG Site|3
849422|NCT00408005|1807454|FG001|Induction|Patient transferred Tx to Non-COG Site|2
849423|NCT00408005|1807455|FG002|Induction|Patient transferred Tx to Non-COG Site|0
849424|NCT00408005|1807456|FG003|Induction|Patient transferred Tx to Non-COG Site|0
849425|NCT00408005|1807457|FG004|Induction|Patient transferred Tx to Non-COG Site|0
849426|NCT00408005|1807458|FG005|Induction|Patient transferred Tx to Non-COG Site|0
849427|NCT00408005|1807459|FG006|Induction|Patient transferred Tx to Non-COG Site|0
849428|NCT00408005|1807460|FG007|Induction|Patient transferred Tx to Non-COG Site|0
849429|NCT00408005|1807453|FG000|Induction|Identified as Philadelphia Chr. Positive|6
849430|NCT00408005|1807454|FG001|Induction|Identified as Philadelphia Chr. Positive|0
849431|NCT00408005|1807455|FG002|Induction|Identified as Philadelphia Chr. Positive|0
849432|NCT00408005|1807456|FG003|Induction|Identified as Philadelphia Chr. Positive|0
849433|NCT00408005|1807457|FG004|Induction|Identified as Philadelphia Chr. Positive|0
849434|NCT00408005|1807458|FG005|Induction|Identified as Philadelphia Chr. Positive|0
849435|NCT00408005|1807459|FG006|Induction|Identified as Philadelphia Chr. Positive|0
849436|NCT00408005|1807460|FG007|Induction|Identified as Philadelphia Chr. Positive|0
849437|NCT00408005|1807453|FG000|Induction|Progressive Disease|0
849438|NCT00408005|1807454|FG001|Induction|Progressive Disease|1
849439|NCT00408005|1807455|FG002|Induction|Progressive Disease|0
849440|NCT00408005|1807456|FG003|Induction|Progressive Disease|0
849441|NCT00408005|1807457|FG004|Induction|Progressive Disease|0
849442|NCT00408005|1807458|FG005|Induction|Progressive Disease|0
849443|NCT00408005|1807459|FG006|Induction|Progressive Disease|0
849444|NCT00408005|1807460|FG007|Induction|Progressive Disease|0
849445|NCT00408005|1807453|FG000|Induction|Inevaluable|18
849446|NCT00408005|1807454|FG001|Induction|Inevaluable|14
849447|NCT00408005|1807455|FG002|Induction|Inevaluable|0
849448|NCT00408005|1807456|FG003|Induction|Inevaluable|0
849449|NCT00408005|1807457|FG004|Induction|Inevaluable|0
849450|NCT00408005|1807458|FG005|Induction|Inevaluable|0
849451|NCT00408005|1807459|FG006|Induction|Inevaluable|0
849452|NCT00408005|1807460|FG007|Induction|Inevaluable|0
849453|NCT00408005|1807453|FG000|Induction|Failed to Complete Randomization|3
849454|NCT00408005|1807454|FG001|Induction|Failed to Complete Randomization|2
849455|NCT00408005|1807455|FG002|Induction|Failed to Complete Randomization|0
849456|NCT00408005|1807456|FG003|Induction|Failed to Complete Randomization|0
849457|NCT00408005|1807457|FG004|Induction|Failed to Complete Randomization|0
849458|NCT00408005|1807458|FG005|Induction|Failed to Complete Randomization|0
849459|NCT00408005|1807459|FG006|Induction|Failed to Complete Randomization|0
849460|NCT00408005|1807460|FG007|Induction|Failed to Complete Randomization|0
849461|NCT00408005|1807453|FG000|Induction|Protocol Deviation|3
849462|NCT00408005|1807454|FG001|Induction|Protocol Deviation|1
849463|NCT00408005|1807455|FG002|Induction|Protocol Deviation|0
849464|NCT00408005|1807456|FG003|Induction|Protocol Deviation|0
849465|NCT00408005|1807457|FG004|Induction|Protocol Deviation|0
849466|NCT00408005|1807458|FG005|Induction|Protocol Deviation|0
849467|NCT00408005|1807459|FG006|Induction|Protocol Deviation|0
849468|NCT00408005|1807460|FG007|Induction|Protocol Deviation|0
849469|NCT00408005|1807453|FG000|Induction|Hematopoietic Stem Cell Transplantation|1
849470|NCT00408005|1807454|FG001|Induction|Hematopoietic Stem Cell Transplantation|0
849471|NCT00408005|1807455|FG002|Induction|Hematopoietic Stem Cell Transplantation|0
849472|NCT00408005|1807456|FG003|Induction|Hematopoietic Stem Cell Transplantation|0
849473|NCT00408005|1807457|FG004|Induction|Hematopoietic Stem Cell Transplantation|0
849474|NCT00408005|1807458|FG005|Induction|Hematopoietic Stem Cell Transplantation|0
849475|NCT00408005|1807459|FG006|Induction|Hematopoietic Stem Cell Transplantation|0
849476|NCT00408005|1807460|FG007|Induction|Hematopoietic Stem Cell Transplantation|0
849477|NCT00408005|1807453|FG000|Induction|Recurrent leukemia|1
849478|NCT00408005|1807454|FG001|Induction|Recurrent leukemia|0
849479|NCT00408005|1807455|FG002|Induction|Recurrent leukemia|0
849480|NCT00408005|1807456|FG003|Induction|Recurrent leukemia|0
849481|NCT00408005|1807457|FG004|Induction|Recurrent leukemia|0
849482|NCT00408005|1807458|FG005|Induction|Recurrent leukemia|0
849483|NCT00408005|1807459|FG006|Induction|Recurrent leukemia|0
849484|NCT00408005|1807460|FG007|Induction|Recurrent leukemia|0
849485|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
849486|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0
849487|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7
849488|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4
849489|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8
849490|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12
849491|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2
849492|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0
849493|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Death|0
849494|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Death|0
849495|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Death|3
849496|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Death|0
849497|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Death|5
849498|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Death|5
849499|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Death|3
849500|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Death|1
849501|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
849502|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
849503|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
849504|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
849505|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
849506|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
849507|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
849508|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
849509|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
849510|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0
849511|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24
849512|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19
849513|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27
849514|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45
849515|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10
849516|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4
849517|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
849518|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
849519|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
849520|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
849521|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
849522|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
849523|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
849524|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
849525|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
849526|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
849527|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
849528|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
849529|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
849530|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
849531|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
849532|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
849533|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
849534|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
849535|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
849536|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
849537|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
849538|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
849539|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
849540|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
849541|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
849542|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
849543|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
849544|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
849545|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
849546|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
849547|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
849548|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
849549|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0
849550|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0
849551|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0
849552|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0
849553|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1
849554|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0
849555|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7
849556|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7
849557|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0
849558|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0
849559|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0
849560|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0
849561|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0
849562|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1
849563|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0
849564|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0
849565|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
849566|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
849567|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
849568|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
849569|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
849570|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
849571|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
849572|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
849573|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
849574|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
849575|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
849576|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
849577|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
849578|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
849579|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
849580|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
849581|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
849582|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
849583|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
849584|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
849585|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
849586|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
849587|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
849588|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
849589|NCT00408005|1807453|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0
849590|NCT00408005|1807454|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0
849591|NCT00408005|1807455|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3
849592|NCT00408005|1807456|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1
849593|NCT00408005|1807457|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1
849594|NCT00408005|1807458|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1
849595|NCT00408005|1807459|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0
849596|NCT00408005|1807460|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0
849597|NCT00408317|1807493|FG000|First Intervention Period|Adverse Event|0
849598|NCT00408317|1807494|FG001|First Intervention Period|Adverse Event|1
849599|NCT00408317|1807493|FG000|Second Intervention Period|Adverse Event|2
849600|NCT00408317|1807494|FG001|Second Intervention Period|Adverse Event|0
849601|NCT00408317|1807493|FG000|Second Intervention Period|Protocol Violation|0
849602|NCT00408317|1807494|FG001|Second Intervention Period|Protocol Violation|1
849603|NCT00408317|1807493|FG000|Second Intervention Period|Withdrawal of consent|0
849604|NCT00408317|1807494|FG001|Second Intervention Period|Withdrawal of consent|1
849605|NCT00408408|1807506|FG000|Overall Study|No follow up data|2
849606|NCT00408408|1807507|FG001|Overall Study|No follow up data|3
849607|NCT00408408|1807508|FG002|Overall Study|No follow up data|0
849608|NCT00408408|1807509|FG003|Overall Study|No follow up data|7
849609|NCT00408408|1807510|FG004|Overall Study|No follow up data|5
849610|NCT00408408|1807511|FG005|Overall Study|No follow up data|3
849611|NCT00408421|1807527|FG000|Treatment Initial Randomization|Adverse Event|5
849612|NCT00408421|1807528|FG001|Treatment Initial Randomization|Adverse Event|9
849613|NCT00408421|1807529|FG002|Treatment Initial Randomization|Adverse Event|0
849614|NCT00408421|1807527|FG000|Treatment Initial Randomization|Lack of Efficacy|2
849615|NCT00408421|1807528|FG001|Treatment Initial Randomization|Lack of Efficacy|2
849616|NCT00408421|1807529|FG002|Treatment Initial Randomization|Lack of Efficacy|0
849617|NCT00408421|1807527|FG000|Treatment Initial Randomization|Lost to Follow-up|0
849618|NCT00408421|1807528|FG001|Treatment Initial Randomization|Lost to Follow-up|3
849619|NCT00408421|1807529|FG002|Treatment Initial Randomization|Lost to Follow-up|0
849620|NCT00408421|1807527|FG000|Treatment Initial Randomization|Physician Decision|1
849621|NCT00408421|1807528|FG001|Treatment Initial Randomization|Physician Decision|0
849622|NCT00408421|1807529|FG002|Treatment Initial Randomization|Physician Decision|0
849623|NCT00408421|1807527|FG000|Treatment Initial Randomization|Protocol Violation|0
849624|NCT00408421|1807528|FG001|Treatment Initial Randomization|Protocol Violation|1
849625|NCT00408421|1807529|FG002|Treatment Initial Randomization|Protocol Violation|0
849626|NCT00408421|1807527|FG000|Treatment Initial Randomization|Withdrawal by Subject|7
849627|NCT00408421|1807528|FG001|Treatment Initial Randomization|Withdrawal by Subject|7
849628|NCT00408421|1807529|FG002|Treatment Initial Randomization|Withdrawal by Subject|0
849629|NCT00408421|1807527|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1
849630|NCT00408421|1807528|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0
849631|NCT00408421|1807529|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0
849632|NCT00408421|1807527|FG000|Treatment Initial Randomization|Sponsor Decision|1
849633|NCT00408421|1807528|FG001|Treatment Initial Randomization|Sponsor Decision|0
849634|NCT00408421|1807529|FG002|Treatment Initial Randomization|Sponsor Decision|0
849635|NCT00408421|1807527|FG000|Treatment Re-Randomization|Adverse Event|2
849636|NCT00408421|1807528|FG001|Treatment Re-Randomization|Adverse Event|2
849637|NCT00408421|1807529|FG002|Treatment Re-Randomization|Adverse Event|4
849638|NCT00408421|1807527|FG000|Treatment Re-Randomization|Lack of Efficacy|1
849639|NCT00408421|1807528|FG001|Treatment Re-Randomization|Lack of Efficacy|0
849640|NCT00408421|1807529|FG002|Treatment Re-Randomization|Lack of Efficacy|0
849641|NCT00408421|1807527|FG000|Treatment Re-Randomization|Lost to Follow-up|0
849642|NCT00408421|1807528|FG001|Treatment Re-Randomization|Lost to Follow-up|0
849643|NCT00408421|1807529|FG002|Treatment Re-Randomization|Lost to Follow-up|1
849644|NCT00408421|1807527|FG000|Treatment Re-Randomization|Physician Decision|1
849645|NCT00408421|1807528|FG001|Treatment Re-Randomization|Physician Decision|3
849646|NCT00408421|1807529|FG002|Treatment Re-Randomization|Physician Decision|0
849647|NCT00408421|1807527|FG000|Treatment Re-Randomization|Protocol Violation|1
849648|NCT00408421|1807528|FG001|Treatment Re-Randomization|Protocol Violation|1
849649|NCT00408421|1807529|FG002|Treatment Re-Randomization|Protocol Violation|0
849650|NCT00408421|1807527|FG000|Treatment Re-Randomization|Withdrawal by Subject|2
849651|NCT00408421|1807528|FG001|Treatment Re-Randomization|Withdrawal by Subject|1
849652|NCT00408421|1807529|FG002|Treatment Re-Randomization|Withdrawal by Subject|0
849653|NCT00408434|1807544|FG000|Overall Study|Adverse Event|0
849654|NCT00408434|1807545|FG001|Overall Study|Adverse Event|0
849655|NCT00408434|1807546|FG002|Overall Study|Adverse Event|1
849656|NCT00408434|1807547|FG003|Overall Study|Adverse Event|0
849657|NCT00408434|1807548|FG004|Overall Study|Adverse Event|0
849658|NCT00408434|1807549|FG005|Overall Study|Adverse Event|0
849659|NCT00408434|1807550|FG006|Overall Study|Adverse Event|0
849660|NCT00408434|1807544|FG000|Overall Study|Progressive disease|6
849661|NCT00408434|1807545|FG001|Overall Study|Progressive disease|3
849662|NCT00408434|1807546|FG002|Overall Study|Progressive disease|4
849663|NCT00408434|1807547|FG003|Overall Study|Progressive disease|3
849664|NCT00408434|1807548|FG004|Overall Study|Progressive disease|3
849665|NCT00408434|1807549|FG005|Overall Study|Progressive disease|1
849666|NCT00408434|1807550|FG006|Overall Study|Progressive disease|4
849667|NCT00408434|1807544|FG000|Overall Study|Other|0
849668|NCT00408434|1807545|FG001|Overall Study|Other|0
849669|NCT00408434|1807546|FG002|Overall Study|Other|1
849670|NCT00408434|1807547|FG003|Overall Study|Other|0
849671|NCT00408434|1807548|FG004|Overall Study|Other|2
849672|NCT00408434|1807549|FG005|Overall Study|Other|1
849673|NCT00408434|1807550|FG006|Overall Study|Other|0
849674|NCT00408434|1807544|FG000|Overall Study|Terminated by Investigator|0
849675|NCT00408434|1807545|FG001|Overall Study|Terminated by Investigator|0
849676|NCT00408434|1807546|FG002|Overall Study|Terminated by Investigator|0
849677|NCT00408434|1807547|FG003|Overall Study|Terminated by Investigator|0
849678|NCT00408434|1807548|FG004|Overall Study|Terminated by Investigator|1
849679|NCT00408434|1807549|FG005|Overall Study|Terminated by Investigator|1
849680|NCT00408434|1807550|FG006|Overall Study|Terminated by Investigator|0
849681|NCT00408499|1807571|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0
849682|NCT00408499|1807572|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0
849683|NCT00408499|1807573|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1
849684|NCT00408499|1807574|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0
849685|NCT00408499|1807575|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0
849686|NCT00408499|1807571|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
849687|NCT00408499|1807572|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
849688|NCT00408499|1807573|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
849689|NCT00408499|1807574|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
849690|NCT00408499|1807575|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
849691|NCT00408499|1807571|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1
849692|NCT00408499|1807572|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1
849693|NCT00408499|1807573|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0
849694|NCT00408499|1807574|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0
849695|NCT00408499|1807575|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0
849696|NCT00408499|1807571|FG000|Phase II- MTD Expansion|Adverse Event|0
849697|NCT00408499|1807572|FG001|Phase II- MTD Expansion|Adverse Event|0
849698|NCT00408499|1807573|FG002|Phase II- MTD Expansion|Adverse Event|0
849699|NCT00408499|1807574|FG003|Phase II- MTD Expansion|Adverse Event|0
849700|NCT00408499|1807575|FG004|Phase II- MTD Expansion|Adverse Event|9
849701|NCT00408499|1807571|FG000|Phase II- MTD Expansion|Death|0
849702|NCT00408499|1807572|FG001|Phase II- MTD Expansion|Death|0
849703|NCT00408499|1807573|FG002|Phase II- MTD Expansion|Death|0
849704|NCT00408499|1807574|FG003|Phase II- MTD Expansion|Death|0
849705|NCT00408499|1807575|FG004|Phase II- MTD Expansion|Death|2
849706|NCT00408499|1807571|FG000|Phase II- MTD Expansion|Physician Decision|0
849707|NCT00408499|1807572|FG001|Phase II- MTD Expansion|Physician Decision|0
849708|NCT00408499|1807573|FG002|Phase II- MTD Expansion|Physician Decision|0
849709|NCT00408499|1807574|FG003|Phase II- MTD Expansion|Physician Decision|0
849710|NCT00408499|1807575|FG004|Phase II- MTD Expansion|Physician Decision|1
849711|NCT00408499|1807571|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0
849712|NCT00408499|1807572|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0
849713|NCT00408499|1807573|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0
849714|NCT00408499|1807574|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0
849715|NCT00408499|1807575|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5
849716|NCT00408499|1807571|FG000|Phase II- MTD Expansion|treatment delay|0
849717|NCT00408499|1807572|FG001|Phase II- MTD Expansion|treatment delay|0
849718|NCT00408499|1807573|FG002|Phase II- MTD Expansion|treatment delay|0
849719|NCT00408499|1807574|FG003|Phase II- MTD Expansion|treatment delay|0
849720|NCT00408499|1807575|FG004|Phase II- MTD Expansion|treatment delay|3
849721|NCT00408629|1807631|FG000|Overall Study|Adverse Event|13
849722|NCT00408629|1807632|FG001|Overall Study|Adverse Event|27
849723|NCT00408629|1807631|FG000|Overall Study|Withdrawal by Subject|8
849724|NCT00408629|1807632|FG001|Overall Study|Withdrawal by Subject|4
849725|NCT00408629|1807631|FG000|Overall Study|Lost to Follow-up|1
849726|NCT00408629|1807632|FG001|Overall Study|Lost to Follow-up|1
849727|NCT00408629|1807631|FG000|Overall Study|Lack of Efficacy|63
849728|NCT00408629|1807632|FG001|Overall Study|Lack of Efficacy|73
849729|NCT00408629|1807631|FG000|Overall Study|Protocol Violation|1
849730|NCT00408629|1807632|FG001|Overall Study|Protocol Violation|5
849731|NCT00408629|1807631|FG000|Overall Study|Miscellaneous|11
849732|NCT00408629|1807632|FG001|Overall Study|Miscellaneous|15
849733|NCT00408681|1807639|FG000|Overall Study|Lack of Efficacy|2
849734|NCT00408681|1807639|FG000|Overall Study|Adverse Event|7
849735|NCT00408694|1807644|FG000|Overall Study|Ineligible|1
849736|NCT00408694|1807644|FG000|Overall Study|No protocol treatment|1
849737|NCT00408876|1807652|FG000|Overall Study|Adverse Event|9
849738|NCT00408876|1807653|FG001|Overall Study|Adverse Event|17
849739|NCT00408876|1807654|FG002|Overall Study|Adverse Event|27
849740|NCT00408876|1807655|FG003|Overall Study|Adverse Event|10
849741|NCT00408876|1807652|FG000|Overall Study|Withdrawal by Subject|3
849742|NCT00408876|1807653|FG001|Overall Study|Withdrawal by Subject|6
849743|NCT00408876|1807654|FG002|Overall Study|Withdrawal by Subject|6
849744|NCT00408876|1807655|FG003|Overall Study|Withdrawal by Subject|14
849745|NCT00408876|1807652|FG000|Overall Study|Lack of Efficacy|2
849746|NCT00408876|1807653|FG001|Overall Study|Lack of Efficacy|4
849747|NCT00408876|1807654|FG002|Overall Study|Lack of Efficacy|5
849748|NCT00408876|1807655|FG003|Overall Study|Lack of Efficacy|6
849749|NCT00408876|1807652|FG000|Overall Study|Lost to Follow-up|1
849750|NCT00408876|1807653|FG001|Overall Study|Lost to Follow-up|6
849751|NCT00408876|1807654|FG002|Overall Study|Lost to Follow-up|5
849752|NCT00408876|1807655|FG003|Overall Study|Lost to Follow-up|2
849753|NCT00408876|1807652|FG000|Overall Study|Protocol Violation|0
849754|NCT00408876|1807653|FG001|Overall Study|Protocol Violation|3
849755|NCT00408876|1807654|FG002|Overall Study|Protocol Violation|4
849756|NCT00408876|1807655|FG003|Overall Study|Protocol Violation|3
849757|NCT00408876|1807652|FG000|Overall Study|Physician Decision|1
849758|NCT00408876|1807653|FG001|Overall Study|Physician Decision|0
849759|NCT00408876|1807654|FG002|Overall Study|Physician Decision|3
849760|NCT00408876|1807655|FG003|Overall Study|Physician Decision|0
849761|NCT00408902|1807665|FG000|Overall Study|Lack of Efficacy|7
849762|NCT00408902|1807665|FG000|Overall Study|Adverse Event|3
849763|NCT00408928|1807670|FG000|Overall Study|Withdrawal by Subject|1
849764|NCT00408928|1807670|FG000|Overall Study|Death|1
849765|NCT00408928|1807670|FG000|Overall Study|Infection indistinguishable from GVHD|1
849766|NCT00408993|1807676|FG000|Overall Study|Adverse Event|15
849767|NCT00408993|1807677|FG001|Overall Study|Adverse Event|4
849768|NCT00408993|1807676|FG000|Overall Study|Protocol Violation|1
849769|NCT00408993|1807677|FG001|Overall Study|Protocol Violation|6
849770|NCT00408993|1807676|FG000|Overall Study|Lack of Efficacy|1
849771|NCT00408993|1807677|FG001|Overall Study|Lack of Efficacy|4
849772|NCT00408993|1807676|FG000|Overall Study|Withdrawal by Subject|2
849773|NCT00408993|1807677|FG001|Overall Study|Withdrawal by Subject|3
849774|NCT00409006|1807689|FG000|Overall Study|Death|15
849775|NCT00409006|1807690|FG001|Overall Study|Death|6
849776|NCT00409006|1807689|FG000|Overall Study|Lost to Follow-up|1
849777|NCT00409006|1807690|FG001|Overall Study|Lost to Follow-up|2
849778|NCT00409006|1807689|FG000|Overall Study|Withdrawal by Subject|3
849779|NCT00409006|1807690|FG001|Overall Study|Withdrawal by Subject|2
849780|NCT00409006|1807689|FG000|Overall Study|Physician Decision|1
849781|NCT00409006|1807690|FG001|Overall Study|Physician Decision|2
849782|NCT00409175|1807698|FG000|Overall Study|Adverse Event|4
849783|NCT00409175|1807699|FG001|Overall Study|Adverse Event|3
849784|NCT00409175|1807698|FG000|Overall Study|Withdrawal by Subject|1
849785|NCT00409175|1807699|FG001|Overall Study|Withdrawal by Subject|2
849786|NCT00409175|1807698|FG000|Overall Study|Negative genotype|0
849787|NCT00409175|1807699|FG001|Overall Study|Negative genotype|1
849788|NCT00409175|1807698|FG000|Overall Study|Liver transplantation|13
849789|NCT00409175|1807699|FG001|Overall Study|Liver transplantation|13
849790|NCT00409188|1807707|FG000|Overall Study|Ongoing at data cut-off|383
849791|NCT00409188|1807708|FG001|Overall Study|Ongoing at data cut-off|175
849792|NCT00409409|1807731|FG000|Overall Study|Adverse Event|7
849793|NCT00409409|1807732|FG001|Overall Study|Adverse Event|2
849794|NCT00409409|1807731|FG000|Overall Study|Withdrawal by Subject|1
849795|NCT00409409|1807732|FG001|Overall Study|Withdrawal by Subject|1
849796|NCT00409409|1807731|FG000|Overall Study|Any other reason not above-mentioned|0
849797|NCT00409409|1807732|FG001|Overall Study|Any other reason not above-mentioned|1
849798|NCT00409578|1807767|FG000|Overall Study|Adverse Event|27
849799|NCT00409578|1807768|FG001|Overall Study|Adverse Event|37
849800|NCT00409578|1807769|FG002|Overall Study|Adverse Event|25
849801|NCT00409578|1807770|FG003|Overall Study|Adverse Event|33
849802|NCT00409578|1807767|FG000|Overall Study|Abnormal laboratory value(s)|2
849803|NCT00409578|1807768|FG001|Overall Study|Abnormal laboratory value(s)|2
849804|NCT00409578|1807769|FG002|Overall Study|Abnormal laboratory value(s)|2
849805|NCT00409578|1807770|FG003|Overall Study|Abnormal laboratory value(s)|4
849806|NCT00409578|1807767|FG000|Overall Study|Lack of Efficacy|0
849807|NCT00409578|1807768|FG001|Overall Study|Lack of Efficacy|0
849808|NCT00409578|1807769|FG002|Overall Study|Lack of Efficacy|0
849809|NCT00409578|1807770|FG003|Overall Study|Lack of Efficacy|2
849810|NCT00409578|1807767|FG000|Overall Study|Subject no longer requires study drug|0
849811|NCT00409578|1807768|FG001|Overall Study|Subject no longer requires study drug|0
849812|NCT00409578|1807769|FG002|Overall Study|Subject no longer requires study drug|0
849813|NCT00409578|1807770|FG003|Overall Study|Subject no longer requires study drug|1
849814|NCT00409578|1807767|FG000|Overall Study|Withdrawal by Subject|8
849815|NCT00409578|1807768|FG001|Overall Study|Withdrawal by Subject|15
849816|NCT00409578|1807769|FG002|Overall Study|Withdrawal by Subject|16
849817|NCT00409578|1807770|FG003|Overall Study|Withdrawal by Subject|17
849818|NCT00409578|1807767|FG000|Overall Study|Lost to Follow-up|2
849819|NCT00409578|1807768|FG001|Overall Study|Lost to Follow-up|0
849820|NCT00409578|1807769|FG002|Overall Study|Lost to Follow-up|2
849821|NCT00409578|1807770|FG003|Overall Study|Lost to Follow-up|2
849822|NCT00409578|1807767|FG000|Overall Study|Administrative problems|8
849823|NCT00409578|1807768|FG001|Overall Study|Administrative problems|9
849824|NCT00409578|1807769|FG002|Overall Study|Administrative problems|2
849825|NCT00409578|1807770|FG003|Overall Study|Administrative problems|4
849826|NCT00409578|1807767|FG000|Overall Study|Death|2
849827|NCT00409578|1807768|FG001|Overall Study|Death|4
849828|NCT00409578|1807769|FG002|Overall Study|Death|4
849829|NCT00409578|1807770|FG003|Overall Study|Death|2
849830|NCT00409578|1807767|FG000|Overall Study|Protocol Violation|3
849831|NCT00409578|1807768|FG001|Overall Study|Protocol Violation|2
849832|NCT00409578|1807769|FG002|Overall Study|Protocol Violation|3
849833|NCT00409578|1807770|FG003|Overall Study|Protocol Violation|1
849834|NCT00409578|1807767|FG000|Overall Study|Missing|0
849835|NCT00409578|1807768|FG001|Overall Study|Missing|1
849836|NCT00409578|1807769|FG002|Overall Study|Missing|0
849837|NCT00409578|1807770|FG003|Overall Study|Missing|1
849838|NCT00409617|1807780|FG000|Overall Study|Adverse Event|57
849839|NCT00409617|1807780|FG000|Overall Study|Lack of Efficacy|54
849840|NCT00409617|1807780|FG000|Overall Study|Lost to Follow-up|2
849841|NCT00409617|1807780|FG000|Overall Study|Protocol Violation|24
849842|NCT00409617|1807780|FG000|Overall Study|Withdrawal by Subject|8
849843|NCT00409617|1807780|FG000|Overall Study|Administrative reasons|1
849844|NCT00409617|1807780|FG000|Overall Study|Not described|14
849845|NCT00409682|1807787|FG000|Open-label Induction Period|Adverse Event|1
849846|NCT00409682|1807788|FG001|Open-label Induction Period|Adverse Event|0
849847|NCT00409682|1807789|FG002|Open-label Induction Period|Adverse Event|0
849848|NCT00409682|1807787|FG000|Open-label Induction Period|Lack of Efficacy|1
849849|NCT00409682|1807788|FG001|Open-label Induction Period|Lack of Efficacy|0
849850|NCT00409682|1807789|FG002|Open-label Induction Period|Lack of Efficacy|0
849851|NCT00409682|1807787|FG000|Open-label Induction Period|Protocol Violation|1
849852|NCT00409682|1807788|FG001|Open-label Induction Period|Protocol Violation|0
849853|NCT00409682|1807789|FG002|Open-label Induction Period|Protocol Violation|0
849854|NCT00409682|1807787|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1
849855|NCT00409682|1807788|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0
849856|NCT00409682|1807789|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0
849857|NCT00409682|1807787|FG000|EOW Double-blind Maintenance Period|Adverse Event|0
849858|NCT00409682|1807788|FG001|EOW Double-blind Maintenance Period|Adverse Event|10
849859|NCT00409682|1807789|FG002|EOW Double-blind Maintenance Period|Adverse Event|12
849860|NCT00409682|1807787|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0
849861|NCT00409682|1807788|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18
849862|NCT00409682|1807789|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11
849863|NCT00409682|1807787|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0
849864|NCT00409682|1807788|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1
849865|NCT00409682|1807789|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0
849866|NCT00409682|1807787|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
849867|NCT00409682|1807788|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
849868|NCT00409682|1807789|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
849869|NCT00409682|1807787|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0
849870|NCT00409682|1807788|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4
849871|NCT00409682|1807789|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1
849872|NCT00409682|1807787|FG000|EOW Double-blind Maintenance Period|Non-compliance|0
849873|NCT00409682|1807788|FG001|EOW Double-blind Maintenance Period|Non-compliance|0
849874|NCT00409682|1807789|FG002|EOW Double-blind Maintenance Period|Non-compliance|1
849875|NCT00409708|1807798|FG000|Treatment|Abnormal test procedure result(s)|1
849876|NCT00409708|1807799|FG001|Treatment|Abnormal test procedure result(s)|0
849877|NCT00409708|1807798|FG000|Treatment|Lack of Efficacy|0
849878|NCT00409708|1807799|FG001|Treatment|Lack of Efficacy|1
849879|NCT00409708|1807798|FG000|Treatment|Protocol Violation|6
849880|NCT00409708|1807799|FG001|Treatment|Protocol Violation|2
849881|NCT00409708|1807798|FG000|Treatment|Withdrawal by Subject|3
849882|NCT00409708|1807799|FG001|Treatment|Withdrawal by Subject|8
849883|NCT00409708|1807798|FG000|Treatment|Lost to Follow-up|0
849884|NCT00409708|1807799|FG001|Treatment|Lost to Follow-up|6
849885|NCT00409708|1807798|FG000|Treatment|Administrative problems|5
849886|NCT00409708|1807799|FG001|Treatment|Administrative problems|0
849887|NCT00409708|1807798|FG000|Washout|Lack of Efficacy|9
849888|NCT00409708|1807799|FG001|Washout|Lack of Efficacy|1
849889|NCT00409708|1807798|FG000|Washout|Protocol Violation|0
849890|NCT00409708|1807799|FG001|Washout|Protocol Violation|1
849891|NCT00409708|1807798|FG000|Washout|Withdrawal by Subject|11
849892|NCT00409708|1807799|FG001|Washout|Withdrawal by Subject|5
849893|NCT00409708|1807798|FG000|Washout|Lost to Follow-up|1
849894|NCT00409708|1807799|FG001|Washout|Lost to Follow-up|3
849895|NCT00409747|1807805|FG000|Overall Study|Withdrawal by Subject|1
849896|NCT00409773|1807814|FG000|Overall Study|Adverse Event|3
849897|NCT00409773|1807815|FG001|Overall Study|Adverse Event|4
849898|NCT00409773|1807816|FG002|Overall Study|Adverse Event|4
849899|NCT00409773|1807817|FG003|Overall Study|Adverse Event|2
849900|NCT00409773|1807818|FG004|Overall Study|Adverse Event|6
849901|NCT00409773|1807814|FG000|Overall Study|Lost to Follow-up|6
849902|NCT00409773|1807815|FG001|Overall Study|Lost to Follow-up|1
849903|NCT00409773|1807816|FG002|Overall Study|Lost to Follow-up|2
849904|NCT00409773|1807817|FG003|Overall Study|Lost to Follow-up|3
849905|NCT00409773|1807818|FG004|Overall Study|Lost to Follow-up|1
849906|NCT00409773|1807814|FG000|Overall Study|Physician Decision|0
849907|NCT00409773|1807815|FG001|Overall Study|Physician Decision|0
849908|NCT00409773|1807816|FG002|Overall Study|Physician Decision|0
849909|NCT00409773|1807817|FG003|Overall Study|Physician Decision|2
849910|NCT00409773|1807818|FG004|Overall Study|Physician Decision|0
849911|NCT00409773|1807814|FG000|Overall Study|Protocol Violation|0
849912|NCT00409773|1807815|FG001|Overall Study|Protocol Violation|2
849913|NCT00409773|1807816|FG002|Overall Study|Protocol Violation|3
849914|NCT00409773|1807817|FG003|Overall Study|Protocol Violation|3
849915|NCT00409773|1807818|FG004|Overall Study|Protocol Violation|1
849916|NCT00409773|1807814|FG000|Overall Study|Withdrawal by Subject|0
849917|NCT00409773|1807815|FG001|Overall Study|Withdrawal by Subject|0
849918|NCT00409773|1807816|FG002|Overall Study|Withdrawal by Subject|0
849919|NCT00409773|1807817|FG003|Overall Study|Withdrawal by Subject|2
849920|NCT00409773|1807818|FG004|Overall Study|Withdrawal by Subject|1
849921|NCT00409773|1807814|FG000|Overall Study|Lack of Eligibility|0
849922|NCT00409773|1807815|FG001|Overall Study|Lack of Eligibility|0
849923|NCT00409773|1807816|FG002|Overall Study|Lack of Eligibility|0
849924|NCT00409773|1807817|FG003|Overall Study|Lack of Eligibility|0
849925|NCT00409773|1807818|FG004|Overall Study|Lack of Eligibility|1
849926|NCT00409786|1807830|FG000|Overall Study|Withdrawal by Subject|3
849927|NCT00409838|1807840|FG000|Short-term Period|Adverse Event|0
849928|NCT00409838|1807841|FG001|Short-term Period|Adverse Event|1
849929|NCT00409838|1807840|FG000|Short-term Period|Lost to Follow-up|0
849930|NCT00409838|1807841|FG001|Short-term Period|Lost to Follow-up|1
849931|NCT00409838|1807840|FG000|Short-term Period|Withdrawal by Subject|2
849932|NCT00409838|1807841|FG001|Short-term Period|Withdrawal by Subject|3
849933|NCT00409838|1807840|FG000|Short-term Period|Never Treated|1
849934|NCT00409838|1807841|FG001|Short-term Period|Never Treated|0
849935|NCT00409838|1807840|FG000|Long-term Extension Period|Adverse Event|10
849936|NCT00409838|1807841|FG001|Long-term Extension Period|Adverse Event|0
849937|NCT00409838|1807840|FG000|Long-term Extension Period|Death|1
849938|NCT00409838|1807841|FG001|Long-term Extension Period|Death|0
849939|NCT00409838|1807840|FG000|Long-term Extension Period|Lack of Efficacy|2
849940|NCT00409838|1807841|FG001|Long-term Extension Period|Lack of Efficacy|0
849941|NCT00409838|1807840|FG000|Long-term Extension Period|Withdrawal by Subject|3
849942|NCT00409838|1807841|FG001|Long-term Extension Period|Withdrawal by Subject|0
849943|NCT00409838|1807840|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
849944|NCT00409838|1807841|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
849945|NCT00409838|1807840|FG000|Long-term Extension Period|Pregnancy|1
849946|NCT00409838|1807841|FG001|Long-term Extension Period|Pregnancy|0
849947|NCT00410046|1807864|FG000|Overall Study|Adverse Event|3
849948|NCT00410046|1807864|FG000|Overall Study|Withdrawal by Subject|1
849949|NCT00410046|1807864|FG000|Overall Study|Lost to Follow-up|1
849950|NCT00410072|1807875|FG000|Day 1 to Week 48|Adverse Event|1
849951|NCT00410072|1807876|FG001|Day 1 to Week 48|Adverse Event|2
849952|NCT00410072|1807875|FG000|Day 1 to Week 48|Lost to Follow-up|5
849953|NCT00410072|1807876|FG001|Day 1 to Week 48|Lost to Follow-up|2
849954|NCT00410072|1807875|FG000|Day 1 to Week 48|Other|0
849955|NCT00410072|1807876|FG001|Day 1 to Week 48|Other|1
849956|NCT00410072|1807875|FG000|Day 1 to Week 48|poor compliance/noncompliance|0
849957|NCT00410072|1807876|FG001|Day 1 to Week 48|poor compliance/noncompliance|3
849958|NCT00410072|1807875|FG000|Day 1 to Week 48|Pregnancy|0
849959|NCT00410072|1807876|FG001|Day 1 to Week 48|Pregnancy|2
849960|NCT00410072|1807875|FG000|Day 1 to Week 48|Withdrawal by Subject|0
849961|NCT00410072|1807876|FG001|Day 1 to Week 48|Withdrawal by Subject|2
849962|NCT00410072|1807875|FG000|After Week 48 to Week 96|Adverse Event|1
849963|NCT00410072|1807876|FG001|After Week 48 to Week 96|Adverse Event|2
849964|NCT00410072|1807875|FG000|After Week 48 to Week 96|Death|0
849965|NCT00410072|1807876|FG001|After Week 48 to Week 96|Death|1
849966|NCT00410072|1807875|FG000|After Week 48 to Week 96|Lack of Efficacy|1
849967|NCT00410072|1807876|FG001|After Week 48 to Week 96|Lack of Efficacy|0
849968|NCT00410072|1807875|FG000|After Week 48 to Week 96|Lost to Follow-up|2
849969|NCT00410072|1807876|FG001|After Week 48 to Week 96|Lost to Follow-up|4
849970|NCT00410072|1807875|FG000|After Week 48 to Week 96|Other|2
849971|NCT00410072|1807876|FG001|After Week 48 to Week 96|Other|0
849972|NCT00410072|1807875|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0
849973|NCT00410072|1807876|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1
849974|NCT00410072|1807875|FG000|After Week 48 to Week 96|Pregnancy|0
849975|NCT00410072|1807876|FG001|After Week 48 to Week 96|Pregnancy|2
849976|NCT00410072|1807875|FG000|After Week 48 to Week 96|Withdrawal by Subject|0
849977|NCT00410072|1807876|FG001|After Week 48 to Week 96|Withdrawal by Subject|1
849978|NCT00410124|1807884|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36
849979|NCT00410124|1807885|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2
849980|NCT00410124|1807884|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
849981|NCT00410124|1807885|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
849982|NCT00410124|1807884|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2
849983|NCT00410124|1807885|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1
849984|NCT00410124|1807884|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
849985|NCT00410124|1807885|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
849986|NCT00410124|1807884|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
849987|NCT00410124|1807885|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
849988|NCT00410124|1807884|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2
849989|NCT00410124|1807885|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0
849990|NCT00410124|1807884|FG000|Core Phase Double Blind (15 Months)|Death|7
849991|NCT00410124|1807885|FG001|Core Phase Double Blind (15 Months)|Death|4
849992|NCT00410124|1807884|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137
849993|NCT00410124|1807885|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124
849994|NCT00410124|1807884|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7
849995|NCT00410124|1807885|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19
849996|NCT00410124|1807884|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
849997|NCT00410124|1807885|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
849998|NCT00410124|1807884|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
849999|NCT00410124|1807885|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
850000|NCT00410124|1807884|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
850001|NCT00410124|1807885|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
850002|NCT00410124|1807884|FG000|Extension Phase - Open Label (45 Months)|Death|2
850003|NCT00410124|1807885|FG001|Extension Phase - Open Label (45 Months)|Death|10
850004|NCT00410124|1807884|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56
850005|NCT00410124|1807885|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78
850006|NCT00410124|1807884|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
850007|NCT00410124|1807885|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
850008|NCT00410124|1807884|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
850009|NCT00410124|1807885|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
850010|NCT00410163|1807906|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
850011|NCT00410163|1807907|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
850012|NCT00410163|1807906|FG000|Treatment and Follow-up Phase (2 Years)|Death|1
850013|NCT00410163|1807907|FG001|Treatment and Follow-up Phase (2 Years)|Death|1
850014|NCT00410163|1807906|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
850015|NCT00410163|1807907|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
850016|NCT00410163|1807906|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
850017|NCT00410163|1807907|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
850018|NCT00410163|1807906|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
850019|NCT00410163|1807907|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
850020|NCT00410163|1807906|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
850021|NCT00410163|1807907|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
850022|NCT00410163|1807906|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
850023|NCT00410163|1807907|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
850024|NCT00410163|1807906|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
850025|NCT00410163|1807907|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
850026|NCT00410163|1807906|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
850027|NCT00410163|1807907|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
850028|NCT00410163|1807906|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
850029|NCT00410163|1807907|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
850030|NCT00410163|1807906|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1
850031|NCT00410163|1807907|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1
850032|NCT00410163|1807906|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
850033|NCT00410163|1807907|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
850034|NCT00410163|1807906|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
850035|NCT00410163|1807907|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
850036|NCT00410163|1807906|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
850037|NCT00410163|1807907|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
850038|NCT00410202|1807924|FG000|On-Treatment|Continuing treatment|69
850039|NCT00410202|1807925|FG001|On-Treatment|Continuing treatment|71
850040|NCT00410202|1807926|FG002|On-Treatment|Continuing treatment|66
850041|NCT00410202|1807924|FG000|On-Treatment|Adverse Event|1
850042|NCT00410202|1807925|FG001|On-Treatment|Adverse Event|3
850043|NCT00410202|1807926|FG002|On-Treatment|Adverse Event|2
850044|NCT00410202|1807924|FG000|On-Treatment|Death|1
850045|NCT00410202|1807925|FG001|On-Treatment|Death|0
850046|NCT00410202|1807926|FG002|On-Treatment|Death|0
850047|NCT00410202|1807924|FG000|On-Treatment|Lost to Follow-up|1
850048|NCT00410202|1807925|FG001|On-Treatment|Lost to Follow-up|0
850049|NCT00410202|1807926|FG002|On-Treatment|Lost to Follow-up|1
850050|NCT00410202|1807924|FG000|On-Treatment|Lack of Efficacy|1
850051|NCT00410202|1807925|FG001|On-Treatment|Lack of Efficacy|4
850052|NCT00410202|1807926|FG002|On-Treatment|Lack of Efficacy|0
850053|NCT00410202|1807924|FG000|On-Treatment|Withdrawal by Subject|2
850054|NCT00410202|1807925|FG001|On-Treatment|Withdrawal by Subject|1
850055|NCT00410202|1807926|FG002|On-Treatment|Withdrawal by Subject|1
850056|NCT00410202|1807924|FG000|On-Treatment|Other Reason|0
850057|NCT00410202|1807925|FG001|On-Treatment|Other Reason|0
850058|NCT00410202|1807926|FG002|On-Treatment|Other Reason|1
850059|NCT00410202|1807924|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10
850060|NCT00410202|1807925|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8
850061|NCT00410202|1807926|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11
850062|NCT00410202|1807924|FG000|Off-treatment Follow up|Follow up not required per protocol|3
850063|NCT00410202|1807925|FG001|Off-treatment Follow up|Follow up not required per protocol|0
850064|NCT00410202|1807926|FG002|Off-treatment Follow up|Follow up not required per protocol|1
850065|NCT00410202|1807924|FG000|Off-treatment Follow up|Lost to Follow-up|1
850066|NCT00410202|1807925|FG001|Off-treatment Follow up|Lost to Follow-up|0
850067|NCT00410202|1807926|FG002|Off-treatment Follow up|Lost to Follow-up|0
850068|NCT00410384|1807947|FG000|Overall Study|Withdrawal by Subject|28
850069|NCT00410384|1807948|FG001|Overall Study|Withdrawal by Subject|17
850070|NCT00410384|1807949|FG002|Overall Study|Withdrawal by Subject|20
850071|NCT00410384|1807947|FG000|Overall Study|Adverse Event|23
850072|NCT00410384|1807948|FG001|Overall Study|Adverse Event|18
850073|NCT00410384|1807949|FG002|Overall Study|Adverse Event|23
850074|NCT00410384|1807947|FG000|Overall Study|Lack of Efficacy|20
850075|NCT00410384|1807948|FG001|Overall Study|Lack of Efficacy|12
850076|NCT00410384|1807949|FG002|Overall Study|Lack of Efficacy|17
850077|NCT00410384|1807947|FG000|Overall Study|Lack of Compliance|2
850078|NCT00410384|1807948|FG001|Overall Study|Lack of Compliance|2
850079|NCT00410384|1807949|FG002|Overall Study|Lack of Compliance|2
850080|NCT00410384|1807947|FG000|Overall Study|Lost to Follow-up|4
850081|NCT00410384|1807948|FG001|Overall Study|Lost to Follow-up|6
850082|NCT00410384|1807949|FG002|Overall Study|Lost to Follow-up|6
850083|NCT00410384|1807947|FG000|Overall Study|Protocol Violation|6
850084|NCT00410384|1807948|FG001|Overall Study|Protocol Violation|6
850085|NCT00410384|1807949|FG002|Overall Study|Protocol Violation|6
850086|NCT00410384|1807947|FG000|Overall Study|Physician Decision|3
850087|NCT00410384|1807948|FG001|Overall Study|Physician Decision|3
850088|NCT00410384|1807949|FG002|Overall Study|Physician Decision|4
850089|NCT00410384|1807947|FG000|Overall Study|Other|3
850090|NCT00410384|1807948|FG001|Overall Study|Other|8
850091|NCT00410384|1807949|FG002|Overall Study|Other|4
850092|NCT00410410|1807963|FG000|Induction Period (IP)|Death|1
850093|NCT00410410|1807964|FG001|Induction Period (IP)|Death|0
850094|NCT00410410|1807965|FG002|Induction Period (IP)|Death|0
850095|NCT00410410|1807966|FG003|Induction Period (IP)|Death|0
850096|NCT00410410|1807967|FG004|Induction Period (IP)|Death|0
850097|NCT00410410|1807968|FG005|Induction Period (IP)|Death|0
850098|NCT00410410|1807969|FG006|Induction Period (IP)|Death|0
850099|NCT00410410|1807970|FG007|Induction Period (IP)|Death|0
850100|NCT00410410|1807971|FG008|Induction Period (IP)|Death|0
850101|NCT00410410|1807963|FG000|Induction Period (IP)|Adverse Event|3
850102|NCT00410410|1807964|FG001|Induction Period (IP)|Adverse Event|4
850103|NCT00410410|1807965|FG002|Induction Period (IP)|Adverse Event|2
850104|NCT00410410|1807966|FG003|Induction Period (IP)|Adverse Event|4
850105|NCT00410410|1807967|FG004|Induction Period (IP)|Adverse Event|1
850106|NCT00410410|1807968|FG005|Induction Period (IP)|Adverse Event|0
850107|NCT00410410|1807969|FG006|Induction Period (IP)|Adverse Event|0
850108|NCT00410410|1807970|FG007|Induction Period (IP)|Adverse Event|0
850109|NCT00410410|1807971|FG008|Induction Period (IP)|Adverse Event|0
850110|NCT00410410|1807963|FG000|Induction Period (IP)|Lack of Efficacy|26
850111|NCT00410410|1807964|FG001|Induction Period (IP)|Lack of Efficacy|24
850112|NCT00410410|1807965|FG002|Induction Period (IP)|Lack of Efficacy|8
850113|NCT00410410|1807966|FG003|Induction Period (IP)|Lack of Efficacy|8
850114|NCT00410410|1807967|FG004|Induction Period (IP)|Lack of Efficacy|7
850115|NCT00410410|1807968|FG005|Induction Period (IP)|Lack of Efficacy|7
850116|NCT00410410|1807969|FG006|Induction Period (IP)|Lack of Efficacy|0
850117|NCT00410410|1807970|FG007|Induction Period (IP)|Lack of Efficacy|0
850118|NCT00410410|1807971|FG008|Induction Period (IP)|Lack of Efficacy|0
850119|NCT00410410|1807963|FG000|Induction Period (IP)|Lost to Follow-up|2
850120|NCT00410410|1807964|FG001|Induction Period (IP)|Lost to Follow-up|2
850121|NCT00410410|1807965|FG002|Induction Period (IP)|Lost to Follow-up|2
850122|NCT00410410|1807966|FG003|Induction Period (IP)|Lost to Follow-up|3
850123|NCT00410410|1807967|FG004|Induction Period (IP)|Lost to Follow-up|0
850124|NCT00410410|1807968|FG005|Induction Period (IP)|Lost to Follow-up|1
850125|NCT00410410|1807969|FG006|Induction Period (IP)|Lost to Follow-up|0
850126|NCT00410410|1807970|FG007|Induction Period (IP)|Lost to Follow-up|0
850127|NCT00410410|1807971|FG008|Induction Period (IP)|Lost to Follow-up|0
850128|NCT00410410|1807963|FG000|Induction Period (IP)|Withdrawal by Subject|3
850129|NCT00410410|1807964|FG001|Induction Period (IP)|Withdrawal by Subject|5
850130|NCT00410410|1807965|FG002|Induction Period (IP)|Withdrawal by Subject|3
850131|NCT00410410|1807966|FG003|Induction Period (IP)|Withdrawal by Subject|5
850132|NCT00410410|1807967|FG004|Induction Period (IP)|Withdrawal by Subject|2
850133|NCT00410410|1807968|FG005|Induction Period (IP)|Withdrawal by Subject|0
850134|NCT00410410|1807969|FG006|Induction Period (IP)|Withdrawal by Subject|0
850135|NCT00410410|1807970|FG007|Induction Period (IP)|Withdrawal by Subject|0
850136|NCT00410410|1807971|FG008|Induction Period (IP)|Withdrawal by Subject|0
850137|NCT00410410|1807963|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
850138|NCT00410410|1807964|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
850139|NCT00410410|1807965|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
850140|NCT00410410|1807966|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
850141|NCT00410410|1807967|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
850142|NCT00410410|1807968|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
850143|NCT00410410|1807969|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
850144|NCT00410410|1807970|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
850145|NCT00410410|1807971|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
850146|NCT00410410|1807963|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0
850147|NCT00410410|1807964|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0
850148|NCT00410410|1807965|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0
850149|NCT00410410|1807966|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0
850150|NCT00410410|1807967|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22
850151|NCT00410410|1807968|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21
850152|NCT00410410|1807969|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0
850153|NCT00410410|1807970|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0
850154|NCT00410410|1807971|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0
850155|NCT00410410|1807963|FG000|Induction Period (IP)|Other|0
850156|NCT00410410|1807964|FG001|Induction Period (IP)|Other|0
850157|NCT00410410|1807965|FG002|Induction Period (IP)|Other|1
850158|NCT00410410|1807966|FG003|Induction Period (IP)|Other|0
850159|NCT00410410|1807967|FG004|Induction Period (IP)|Other|0
850160|NCT00410410|1807968|FG005|Induction Period (IP)|Other|0
850161|NCT00410410|1807969|FG006|Induction Period (IP)|Other|0
850162|NCT00410410|1807970|FG007|Induction Period (IP)|Other|0
850163|NCT00410410|1807971|FG008|Induction Period (IP)|Other|0
850164|NCT00410410|1807963|FG000|Maintenance Period (MP)|Death|0
850165|NCT00410410|1807964|FG001|Maintenance Period (MP)|Death|0
850166|NCT00410410|1807965|FG002|Maintenance Period (MP)|Death|0
850167|NCT00410410|1807966|FG003|Maintenance Period (MP)|Death|0
850168|NCT00410410|1807967|FG004|Maintenance Period (MP)|Death|0
850169|NCT00410410|1807968|FG005|Maintenance Period (MP)|Death|0
850170|NCT00410410|1807969|FG006|Maintenance Period (MP)|Death|1
850171|NCT00410410|1807970|FG007|Maintenance Period (MP)|Death|0
850172|NCT00410410|1807971|FG008|Maintenance Period (MP)|Death|0
850173|NCT00410410|1807963|FG000|Maintenance Period (MP)|Adverse Event|0
850174|NCT00410410|1807964|FG001|Maintenance Period (MP)|Adverse Event|0
850175|NCT00410410|1807965|FG002|Maintenance Period (MP)|Adverse Event|0
850176|NCT00410410|1807966|FG003|Maintenance Period (MP)|Adverse Event|0
850177|NCT00410410|1807967|FG004|Maintenance Period (MP)|Adverse Event|0
850178|NCT00410410|1807968|FG005|Maintenance Period (MP)|Adverse Event|0
850179|NCT00410410|1807969|FG006|Maintenance Period (MP)|Adverse Event|1
850180|NCT00410410|1807970|FG007|Maintenance Period (MP)|Adverse Event|3
850181|NCT00410410|1807971|FG008|Maintenance Period (MP)|Adverse Event|0
850182|NCT00410410|1807963|FG000|Maintenance Period (MP)|Lack of Efficacy|0
850183|NCT00410410|1807964|FG001|Maintenance Period (MP)|Lack of Efficacy|0
850184|NCT00410410|1807965|FG002|Maintenance Period (MP)|Lack of Efficacy|0
850185|NCT00410410|1807966|FG003|Maintenance Period (MP)|Lack of Efficacy|0
850186|NCT00410410|1807967|FG004|Maintenance Period (MP)|Lack of Efficacy|0
850187|NCT00410410|1807968|FG005|Maintenance Period (MP)|Lack of Efficacy|0
850188|NCT00410410|1807969|FG006|Maintenance Period (MP)|Lack of Efficacy|25
850189|NCT00410410|1807970|FG007|Maintenance Period (MP)|Lack of Efficacy|24
850190|NCT00410410|1807971|FG008|Maintenance Period (MP)|Lack of Efficacy|0
850191|NCT00410410|1807963|FG000|Maintenance Period (MP)|Lost to Follow-up|0
850192|NCT00410410|1807964|FG001|Maintenance Period (MP)|Lost to Follow-up|0
850193|NCT00410410|1807965|FG002|Maintenance Period (MP)|Lost to Follow-up|0
850194|NCT00410410|1807966|FG003|Maintenance Period (MP)|Lost to Follow-up|0
850195|NCT00410410|1807967|FG004|Maintenance Period (MP)|Lost to Follow-up|0
850196|NCT00410410|1807968|FG005|Maintenance Period (MP)|Lost to Follow-up|0
850197|NCT00410410|1807969|FG006|Maintenance Period (MP)|Lost to Follow-up|1
850198|NCT00410410|1807970|FG007|Maintenance Period (MP)|Lost to Follow-up|2
850199|NCT00410410|1807971|FG008|Maintenance Period (MP)|Lost to Follow-up|0
850200|NCT00410410|1807963|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
850201|NCT00410410|1807964|FG001|Maintenance Period (MP)|Withdrawal by Subject|0
850202|NCT00410410|1807965|FG002|Maintenance Period (MP)|Withdrawal by Subject|0
850203|NCT00410410|1807966|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
850204|NCT00410410|1807967|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
850205|NCT00410410|1807968|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
850206|NCT00410410|1807969|FG006|Maintenance Period (MP)|Withdrawal by Subject|1
850207|NCT00410410|1807970|FG007|Maintenance Period (MP)|Withdrawal by Subject|1
850208|NCT00410410|1807971|FG008|Maintenance Period (MP)|Withdrawal by Subject|0
850209|NCT00410410|1807963|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0
850210|NCT00410410|1807964|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0
850211|NCT00410410|1807965|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0
850212|NCT00410410|1807966|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0
850213|NCT00410410|1807967|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0
850214|NCT00410410|1807968|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0
850215|NCT00410410|1807969|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21
850216|NCT00410410|1807970|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25
850217|NCT00410410|1807971|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0
850218|NCT00410410|1807963|FG000|Open-Label Period (OL)|Death|0
850219|NCT00410410|1807964|FG001|Open-Label Period (OL)|Death|0
850220|NCT00410410|1807965|FG002|Open-Label Period (OL)|Death|0
850221|NCT00410410|1807966|FG003|Open-Label Period (OL)|Death|0
850222|NCT00410410|1807967|FG004|Open-Label Period (OL)|Death|0
850223|NCT00410410|1807968|FG005|Open-Label Period (OL)|Death|0
850224|NCT00410410|1807969|FG006|Open-Label Period (OL)|Death|0
850225|NCT00410410|1807970|FG007|Open-Label Period (OL)|Death|0
850226|NCT00410410|1807971|FG008|Open-Label Period (OL)|Death|1
850227|NCT00410410|1807963|FG000|Open-Label Period (OL)|Adverse Event|0
850228|NCT00410410|1807964|FG001|Open-Label Period (OL)|Adverse Event|0
850229|NCT00410410|1807965|FG002|Open-Label Period (OL)|Adverse Event|0
850230|NCT00410410|1807966|FG003|Open-Label Period (OL)|Adverse Event|0
850231|NCT00410410|1807967|FG004|Open-Label Period (OL)|Adverse Event|0
850232|NCT00410410|1807968|FG005|Open-Label Period (OL)|Adverse Event|0
850233|NCT00410410|1807969|FG006|Open-Label Period (OL)|Adverse Event|0
850234|NCT00410410|1807970|FG007|Open-Label Period (OL)|Adverse Event|0
850235|NCT00410410|1807971|FG008|Open-Label Period (OL)|Adverse Event|10
850236|NCT00410410|1807963|FG000|Open-Label Period (OL)|Lack of Efficacy|0
850237|NCT00410410|1807964|FG001|Open-Label Period (OL)|Lack of Efficacy|0
850238|NCT00410410|1807965|FG002|Open-Label Period (OL)|Lack of Efficacy|0
850239|NCT00410410|1807966|FG003|Open-Label Period (OL)|Lack of Efficacy|0
850240|NCT00410410|1807967|FG004|Open-Label Period (OL)|Lack of Efficacy|0
850241|NCT00410410|1807968|FG005|Open-Label Period (OL)|Lack of Efficacy|0
850242|NCT00410410|1807969|FG006|Open-Label Period (OL)|Lack of Efficacy|0
850243|NCT00410410|1807970|FG007|Open-Label Period (OL)|Lack of Efficacy|0
850244|NCT00410410|1807971|FG008|Open-Label Period (OL)|Lack of Efficacy|161
850245|NCT00410410|1807963|FG000|Open-Label Period (OL)|Lost to Follow-up|0
850246|NCT00410410|1807964|FG001|Open-Label Period (OL)|Lost to Follow-up|0
850247|NCT00410410|1807965|FG002|Open-Label Period (OL)|Lost to Follow-up|0
850248|NCT00410410|1807966|FG003|Open-Label Period (OL)|Lost to Follow-up|0
850249|NCT00410410|1807967|FG004|Open-Label Period (OL)|Lost to Follow-up|0
850250|NCT00410410|1807968|FG005|Open-Label Period (OL)|Lost to Follow-up|0
850251|NCT00410410|1807969|FG006|Open-Label Period (OL)|Lost to Follow-up|0
850252|NCT00410410|1807970|FG007|Open-Label Period (OL)|Lost to Follow-up|0
850253|NCT00410410|1807971|FG008|Open-Label Period (OL)|Lost to Follow-up|4
850254|NCT00410410|1807963|FG000|Open-Label Period (OL)|Withdrawal by Subject|0
850255|NCT00410410|1807964|FG001|Open-Label Period (OL)|Withdrawal by Subject|0
850256|NCT00410410|1807965|FG002|Open-Label Period (OL)|Withdrawal by Subject|0
850257|NCT00410410|1807966|FG003|Open-Label Period (OL)|Withdrawal by Subject|0
850258|NCT00410410|1807967|FG004|Open-Label Period (OL)|Withdrawal by Subject|0
850259|NCT00410410|1807968|FG005|Open-Label Period (OL)|Withdrawal by Subject|0
850260|NCT00410410|1807969|FG006|Open-Label Period (OL)|Withdrawal by Subject|0
850261|NCT00410410|1807970|FG007|Open-Label Period (OL)|Withdrawal by Subject|0
850262|NCT00410410|1807971|FG008|Open-Label Period (OL)|Withdrawal by Subject|20
850263|NCT00410410|1807963|FG000|Open-Label Period (OL)|Pregnancy|0
850264|NCT00410410|1807964|FG001|Open-Label Period (OL)|Pregnancy|0
850265|NCT00410410|1807965|FG002|Open-Label Period (OL)|Pregnancy|0
850266|NCT00410410|1807966|FG003|Open-Label Period (OL)|Pregnancy|0
850267|NCT00410410|1807967|FG004|Open-Label Period (OL)|Pregnancy|0
850268|NCT00410410|1807968|FG005|Open-Label Period (OL)|Pregnancy|0
850269|NCT00410410|1807969|FG006|Open-Label Period (OL)|Pregnancy|0
850270|NCT00410410|1807970|FG007|Open-Label Period (OL)|Pregnancy|0
850271|NCT00410410|1807971|FG008|Open-Label Period (OL)|Pregnancy|1
850272|NCT00410410|1807963|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0
850273|NCT00410410|1807964|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0
850274|NCT00410410|1807965|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0
850275|NCT00410410|1807966|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0
850276|NCT00410410|1807967|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0
850277|NCT00410410|1807968|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0
850278|NCT00410410|1807969|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0
850279|NCT00410410|1807970|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0
850280|NCT00410410|1807971|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145
850281|NCT00410410|1807963|FG000|Open-Label Period (OL)|Other|0
850282|NCT00410410|1807964|FG001|Open-Label Period (OL)|Other|0
850283|NCT00410410|1807965|FG002|Open-Label Period (OL)|Other|0
850284|NCT00410410|1807966|FG003|Open-Label Period (OL)|Other|0
850285|NCT00410410|1807967|FG004|Open-Label Period (OL)|Other|0
850286|NCT00410410|1807968|FG005|Open-Label Period (OL)|Other|0
850287|NCT00410410|1807969|FG006|Open-Label Period (OL)|Other|0
850288|NCT00410410|1807970|FG007|Open-Label Period (OL)|Other|0
850289|NCT00410410|1807971|FG008|Open-Label Period (OL)|Other|7
850290|NCT00410514|1808027|FG000|Overall Study|Adverse Event|2
850291|NCT00410514|1808028|FG001|Overall Study|Adverse Event|2
850292|NCT00410514|1808029|FG002|Overall Study|Adverse Event|2
850293|NCT00410514|1808027|FG000|Overall Study|Protocol Violation|0
850294|NCT00410514|1808028|FG001|Overall Study|Protocol Violation|1
850295|NCT00410514|1808029|FG002|Overall Study|Protocol Violation|1
850296|NCT00410514|1808027|FG000|Overall Study|Lost to Follow-up|0
850297|NCT00410514|1808028|FG001|Overall Study|Lost to Follow-up|0
850298|NCT00410514|1808029|FG002|Overall Study|Lost to Follow-up|2
850299|NCT00410514|1808027|FG000|Overall Study|Non-compliant with study procedures|0
850300|NCT00410514|1808028|FG001|Overall Study|Non-compliant with study procedures|0
850301|NCT00410514|1808029|FG002|Overall Study|Non-compliant with study procedures|2
850302|NCT00410605|1808037|FG000|Overall Study|Adverse Event|12
850303|NCT00410605|1808037|FG000|Overall Study|Physician Decision|3
850304|NCT00410605|1808037|FG000|Overall Study|Withdrawal by Subject|5
850305|NCT00410605|1808037|FG000|Overall Study|Started Non-Protocol Therapy|3
850306|NCT00410605|1808037|FG000|Overall Study|Stopped treatmen to collect stem cells|1
850307|NCT00410605|1808037|FG000|Overall Study|Transferred to another Institution|1
850308|NCT00410761|1808043|FG000|Overall Study|Adverse Event|29
850309|NCT00410761|1808044|FG001|Overall Study|Adverse Event|3
850310|NCT00410761|1808043|FG000|Overall Study|objective disease progression|71
850311|NCT00410761|1808044|FG001|Overall Study|objective disease progression|55
850312|NCT00410761|1808043|FG000|Overall Study|Withdrawal by Subject|8
850313|NCT00410761|1808044|FG001|Overall Study|Withdrawal by Subject|4
850314|NCT00410761|1808043|FG000|Overall Study|Other|12
850315|NCT00410761|1808044|FG001|Overall Study|Other|9
850316|NCT00410761|1808043|FG000|Overall Study|Never received randomised treatment|0
850317|NCT00410761|1808044|FG001|Overall Study|Never received randomised treatment|1
850318|NCT00410813|1808052|FG000|Overall Study|Adverse Event|6
850319|NCT00410813|1808053|FG001|Overall Study|Adverse Event|11
850320|NCT00410813|1808052|FG000|Overall Study|Progression|32
850321|NCT00410813|1808053|FG001|Overall Study|Progression|21
850322|NCT00410813|1808052|FG000|Overall Study|Not protocol specified|3
850323|NCT00410813|1808053|FG001|Overall Study|Not protocol specified|4
850324|NCT00410813|1808052|FG000|Overall Study|Ineligible|2
850325|NCT00410813|1808053|FG001|Overall Study|Ineligible|4
850326|NCT00410813|1808052|FG000|Overall Study|Death|0
850327|NCT00410813|1808053|FG001|Overall Study|Death|2
850328|NCT00411151|1808109|FG000|Overall Study|Death|38
850329|NCT00411151|1808109|FG000|Overall Study|Withdrawal by Subject|2
850330|NCT00411151|1808109|FG000|Overall Study|Lost to Follow-up|2
850331|NCT00411151|1808109|FG000|Overall Study|Protocol Violation|1
850332|NCT00411151|1808109|FG000|Overall Study|Trial prematurely closed|4
850333|NCT00411216|1808115|FG000|Overall Study|Ten participants were entered into the c|0
850334|NCT00411216|1808116|FG001|Overall Study|Ten participants were entered into the c|2
850335|NCT00411450|1808136|FG000|Overall Study|Ongoing at time of data cut-off.|3
850336|NCT00411554|1808156|FG000|Overall Study|Adverse Event|2
850337|NCT00411554|1808157|FG001|Overall Study|Adverse Event|4
850338|NCT00411554|1808156|FG000|Overall Study|Lack of Efficacy|2
850339|NCT00411554|1808157|FG001|Overall Study|Lack of Efficacy|5
850340|NCT00411554|1808156|FG000|Overall Study|Withdrawal by Subject|3
850341|NCT00411554|1808157|FG001|Overall Study|Withdrawal by Subject|0
850342|NCT00411554|1808156|FG000|Overall Study|Patient Moved|1
850343|NCT00411554|1808157|FG001|Overall Study|Patient Moved|0
850344|NCT00411632|1808168|FG000|Overall Study|Death|1
850345|NCT00411645|1808174|FG000|Overall Study|Consent Withdrawn|13
850346|NCT00411645|1808175|FG001|Overall Study|Consent Withdrawn|22
850347|NCT00411645|1808174|FG000|Overall Study|Death|56
850348|NCT00411645|1808175|FG001|Overall Study|Death|135
850349|NCT00411645|1808174|FG000|Overall Study|Investigator/Sponsor Decision|10
850350|NCT00411645|1808175|FG001|Overall Study|Investigator/Sponsor Decision|7
850351|NCT00411645|1808174|FG000|Overall Study|Lost to Follow-up|2
850352|NCT00411645|1808175|FG001|Overall Study|Lost to Follow-up|0
850353|NCT00411671|1808182|FG000|Overall Study|Adverse Event|15
850354|NCT00411671|1808182|FG000|Overall Study|Death|2
850355|NCT00411671|1808182|FG000|Overall Study|Lost to Follow-up|3
850356|NCT00411762|1808203|FG000|Overall Study|Withdrawal by Subject|5
850357|NCT00411788|1808207|FG000|Overall Study|Protocol Violation|1
850358|NCT00411788|1808207|FG000|Overall Study|Adverse Event|1
850359|NCT00412061|1808213|FG000|Double Blind Phase|Disease Progression|101
850360|NCT00412061|1808214|FG001|Double Blind Phase|Disease Progression|154
850361|NCT00412061|1808213|FG000|Double Blind Phase|Adverse Event|61
850362|NCT00412061|1808214|FG001|Double Blind Phase|Adverse Event|16
850363|NCT00412061|1808213|FG000|Double Blind Phase|Final Primary Analysis|26
850364|NCT00412061|1808214|FG001|Double Blind Phase|Final Primary Analysis|14
850365|NCT00412061|1808213|FG000|Double Blind Phase|Withdrawal by Subject|18
850366|NCT00412061|1808214|FG001|Double Blind Phase|Withdrawal by Subject|20
850367|NCT00412061|1808213|FG000|Double Blind Phase|Death|6
850368|NCT00412061|1808214|FG001|Double Blind Phase|Death|3
850369|NCT00412061|1808213|FG000|Double Blind Phase|Protocol Violation|3
850370|NCT00412061|1808214|FG001|Double Blind Phase|Protocol Violation|4
850371|NCT00412061|1808213|FG000|Double Blind Phase|New Cander Therapy|1
850372|NCT00412061|1808214|FG001|Double Blind Phase|New Cander Therapy|1
850373|NCT00412061|1808213|FG000|Double Blind Phase|Lost to Follow-up|0
850374|NCT00412061|1808214|FG001|Double Blind Phase|Lost to Follow-up|1
850375|NCT00412061|1808213|FG000|Open Label Phase|Disease Progression|0
850376|NCT00412061|1808214|FG001|Open Label Phase|Disease Progression|86
850377|NCT00412061|1808213|FG000|Open Label Phase|Adverse Event|0
850378|NCT00412061|1808214|FG001|Open Label Phase|Adverse Event|46
850379|NCT00412061|1808213|FG000|Open Label Phase|Withdrawal by Subject|0
850380|NCT00412061|1808214|FG001|Open Label Phase|Withdrawal by Subject|15
850381|NCT00412061|1808213|FG000|Open Label Phase|Administrative Problems|0
850382|NCT00412061|1808214|FG001|Open Label Phase|Administrative Problems|13
850383|NCT00412061|1808213|FG000|Open Label Phase|Death|0
850384|NCT00412061|1808214|FG001|Open Label Phase|Death|7
850385|NCT00412061|1808213|FG000|Open Label Phase|Lost to Follow-up|0
850386|NCT00412061|1808214|FG001|Open Label Phase|Lost to Follow-up|2
850387|NCT00412061|1808213|FG000|Open Label Phase|New Cancer Therapy|0
850388|NCT00412061|1808214|FG001|Open Label Phase|New Cancer Therapy|1
850389|NCT00412113|1808250|FG000|Overall Study|Adverse Event|11
850390|NCT00412113|1808251|FG001|Overall Study|Adverse Event|15
850391|NCT00412113|1808250|FG000|Overall Study|did not receive treatment|1
850392|NCT00412113|1808251|FG001|Overall Study|did not receive treatment|0
850393|NCT00412217|1808259|FG000|Overall Study|Insufficient Data Available|8
850394|NCT00412217|1808260|FG001|Overall Study|Insufficient Data Available|3
850395|NCT00412217|1808259|FG000|Overall Study|Death|5
850396|NCT00412217|1808260|FG001|Overall Study|Death|4
850397|NCT00412217|1808259|FG000|Overall Study|Disease Progression|2
850398|NCT00412217|1808260|FG001|Overall Study|Disease Progression|3
850399|NCT00412217|1808259|FG000|Overall Study|Investigator Decision|1
850400|NCT00412217|1808260|FG001|Overall Study|Investigator Decision|0
850401|NCT00412217|1808259|FG000|Overall Study|Withdrawal by Subject|2
850402|NCT00412217|1808260|FG001|Overall Study|Withdrawal by Subject|0
850403|NCT00412217|1808259|FG000|Overall Study|Lost to Follow-up|1
850404|NCT00412217|1808260|FG001|Overall Study|Lost to Follow-up|4
850405|NCT00412217|1808259|FG000|Overall Study|Study Terminated by Sponsor|26
850406|NCT00412217|1808260|FG001|Overall Study|Study Terminated by Sponsor|33
850407|NCT00412217|1808259|FG000|Overall Study|Other|1
850408|NCT00412217|1808260|FG001|Overall Study|Other|1
850409|NCT00412360|1808272|FG000|Overall Study|Lost to Follow-up|0
850410|NCT00412360|1808273|FG001|Overall Study|Lost to Follow-up|1
850411|NCT00412360|1808272|FG000|Overall Study|Not Transplanted|1
850412|NCT00412360|1808273|FG001|Overall Study|Not Transplanted|2
850413|NCT00412373|1808281|FG000|Overall Study|Adverse Event|8
850414|NCT00412373|1808282|FG001|Overall Study|Adverse Event|13
850415|NCT00412373|1808281|FG000|Overall Study|Lack of Efficacy|16
850416|NCT00412373|1808282|FG001|Overall Study|Lack of Efficacy|22
850417|NCT00412373|1808281|FG000|Overall Study|Lost to Follow-up|7
850418|NCT00412373|1808282|FG001|Overall Study|Lost to Follow-up|13
850419|NCT00412373|1808281|FG000|Overall Study|Withdrawal by Subject|8
850420|NCT00412373|1808282|FG001|Overall Study|Withdrawal by Subject|27
850421|NCT00412373|1808281|FG000|Overall Study|Other|2
850422|NCT00412373|1808282|FG001|Overall Study|Other|2
850423|NCT00412542|1808342|FG000|Overall Study|Withdrawal by Subject|0
850424|NCT00412542|1808343|FG001|Overall Study|Withdrawal by Subject|2
850425|NCT00412542|1808342|FG000|Overall Study|Not Eligible|0
850426|NCT00412542|1808343|FG001|Overall Study|Not Eligible|1
850427|NCT00412607|1808347|FG000|Overall Study|Withdrawal by Subject|9
850428|NCT00412607|1808347|FG000|Overall Study|Lost to Follow-up|19
850429|NCT00412607|1808347|FG000|Overall Study|Death|61
850430|NCT00412607|1808347|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15
850431|NCT00412737|1808356|FG000|Overall Study|Death|1
850432|NCT00412737|1808357|FG001|Overall Study|Death|0
850433|NCT00412737|1808356|FG000|Overall Study|Adverse Event|3
850434|NCT00412737|1808357|FG001|Overall Study|Adverse Event|2
850435|NCT00412737|1808356|FG000|Overall Study|Refused Treatment|6
850436|NCT00412737|1808357|FG001|Overall Study|Refused Treatment|2
850437|NCT00412737|1808356|FG000|Overall Study|Failure to Return|6
850438|NCT00412737|1808357|FG001|Overall Study|Failure to Return|2
850439|NCT00412750|1808366|FG000|Overall Study|Abnormal laboratory value(s)|1
850440|NCT00412750|1808367|FG001|Overall Study|Abnormal laboratory value(s)|0
850441|NCT00412750|1808368|FG002|Overall Study|Abnormal laboratory value(s)|0
850442|NCT00412750|1808366|FG000|Overall Study|Administrative problems|21
850443|NCT00412750|1808367|FG001|Overall Study|Administrative problems|17
850444|NCT00412750|1808368|FG002|Overall Study|Administrative problems|14
850445|NCT00412750|1808366|FG000|Overall Study|Adverse Event|8
850446|NCT00412750|1808367|FG001|Overall Study|Adverse Event|3
850447|NCT00412750|1808368|FG002|Overall Study|Adverse Event|3
850448|NCT00412750|1808366|FG000|Overall Study|Lost to Follow-up|1
850449|NCT00412750|1808367|FG001|Overall Study|Lost to Follow-up|0
850450|NCT00412750|1808368|FG002|Overall Study|Lost to Follow-up|1
850451|NCT00412750|1808366|FG000|Overall Study|Withdrawal by Subject|0
850452|NCT00412750|1808367|FG001|Overall Study|Withdrawal by Subject|1
850453|NCT00412750|1808368|FG002|Overall Study|Withdrawal by Subject|2
850454|NCT00412750|1808366|FG000|Overall Study|Lack of Efficacy|0
850455|NCT00412750|1808367|FG001|Overall Study|Lack of Efficacy|0
850456|NCT00412750|1808368|FG002|Overall Study|Lack of Efficacy|3
850457|NCT00412854|1808390|FG000|Overall Study|Withdrawn due to adverse events|1
850458|NCT00412854|1808391|FG001|Overall Study|Withdrawn due to adverse events|5
850459|NCT00412854|1808390|FG000|Overall Study|Withdrawn for other reasons|13
850460|NCT00412854|1808391|FG001|Overall Study|Withdrawn for other reasons|11
850461|NCT00412893|1808404|FG000|Overall Study|Adverse Event|31
850462|NCT00412893|1808405|FG001|Overall Study|Adverse Event|53
850463|NCT00412893|1808404|FG000|Overall Study|Death|17
850464|NCT00412893|1808405|FG001|Overall Study|Death|21
850465|NCT00412893|1808404|FG000|Overall Study|Insufficient Therapeutic Response|39
850466|NCT00412893|1808405|FG001|Overall Study|Insufficient Therapeutic Response|23
850467|NCT00412893|1808404|FG000|Overall Study|Lost to Follow-up|2
850468|NCT00412893|1808405|FG001|Overall Study|Lost to Follow-up|1
850469|NCT00412893|1808404|FG000|Overall Study|Violation of Selection at Entry|17
850470|NCT00412893|1808405|FG001|Overall Study|Violation of Selection at Entry|10
850471|NCT00412893|1808404|FG000|Overall Study|Other Protocol Violation|10
850472|NCT00412893|1808405|FG001|Overall Study|Other Protocol Violation|6
850473|NCT00412893|1808404|FG000|Overall Study|Did Not Cooperate|12
850474|NCT00412893|1808405|FG001|Overall Study|Did Not Cooperate|9
850475|NCT00412893|1808404|FG000|Overall Study|Administrative Reason|12
850476|NCT00412893|1808405|FG001|Overall Study|Administrative Reason|15
850477|NCT00412893|1808404|FG000|Overall Study|Randomized but Never Received Study Drug|5
850478|NCT00412893|1808405|FG001|Overall Study|Randomized but Never Received Study Drug|6
850479|NCT00412932|1808411|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1
850480|NCT00412932|1808411|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
850481|NCT00412932|1808411|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1
850482|NCT00412932|1808411|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
850483|NCT00412932|1808411|FG000|Olmesartan (Olm) 20 mg|Other|1
850484|NCT00412932|1808411|FG000|Olmesartan 40 mg|Adverse Event|4
850485|NCT00412932|1808411|FG000|Olmesartan 40 mg|Lack of Efficacy|3
850486|NCT00412932|1808411|FG000|Olmesartan 40 mg|Withdrawal by Subject|1
850487|NCT00412932|1808411|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
850488|NCT00412932|1808411|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
850489|NCT00412932|1808411|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
850490|NCT00412932|1808411|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
850491|NCT00412958|1808418|FG000|Overall Study|Withdrawal by Subject|3
850492|NCT00412958|1808419|FG001|Overall Study|Withdrawal by Subject|0
850493|NCT00412958|1808420|FG002|Overall Study|Withdrawal by Subject|0
850494|NCT00412958|1808421|FG003|Overall Study|Withdrawal by Subject|1
850495|NCT00412958|1808418|FG000|Overall Study|Adverse Event|0
850496|NCT00412958|1808419|FG001|Overall Study|Adverse Event|1
850497|NCT00412958|1808420|FG002|Overall Study|Adverse Event|0
850498|NCT00412958|1808421|FG003|Overall Study|Adverse Event|0
850499|NCT00412958|1808418|FG000|Overall Study|Lost to Follow-up|0
850500|NCT00412958|1808419|FG001|Overall Study|Lost to Follow-up|1
850501|NCT00412958|1808420|FG002|Overall Study|Lost to Follow-up|0
850502|NCT00412958|1808421|FG003|Overall Study|Lost to Follow-up|0
850503|NCT00412958|1808418|FG000|Overall Study|Death|0
850504|NCT00412958|1808419|FG001|Overall Study|Death|1
850505|NCT00412958|1808420|FG002|Overall Study|Death|0
850506|NCT00412958|1808421|FG003|Overall Study|Death|0
850507|NCT00412958|1808418|FG000|Overall Study|Transport issue|0
850508|NCT00412958|1808419|FG001|Overall Study|Transport issue|1
850509|NCT00412958|1808420|FG002|Overall Study|Transport issue|0
850510|NCT00412958|1808421|FG003|Overall Study|Transport issue|0
850511|NCT00412971|1808433|FG000|Overall Study|Lost to Follow-up|17
850512|NCT00412971|1808434|FG001|Overall Study|Lost to Follow-up|9
850513|NCT00412971|1808433|FG000|Overall Study|Protocol Violation|13
850514|NCT00412971|1808434|FG001|Overall Study|Protocol Violation|1
850515|NCT00412984|1808442|FG000|Overall Study|Death|331
850516|NCT00412984|1808443|FG001|Overall Study|Death|349
850517|NCT00412984|1808442|FG000|Overall Study|Adverse Event|679
850518|NCT00412984|1808443|FG001|Overall Study|Adverse Event|738
850519|NCT00412984|1808442|FG000|Overall Study|Withdrawal by Subject|921
850520|NCT00412984|1808443|FG001|Overall Study|Withdrawal by Subject|989
850521|NCT00412984|1808442|FG000|Overall Study|Lost to Follow-up|51
850522|NCT00412984|1808443|FG001|Overall Study|Lost to Follow-up|39
850523|NCT00412984|1808442|FG000|Overall Study|Poor/Noncompliance|57
850524|NCT00412984|1808443|FG001|Overall Study|Poor/Noncompliance|77
850525|NCT00412984|1808442|FG000|Overall Study|Pregnancy|1
850526|NCT00412984|1808443|FG001|Overall Study|Pregnancy|0
850527|NCT00412984|1808442|FG000|Overall Study|Subject No Longer Meets Study Criteria|87
850528|NCT00412984|1808443|FG001|Overall Study|Subject No Longer Meets Study Criteria|100
850529|NCT00412984|1808442|FG000|Overall Study|Administrative Reason by Sponsor|11
850530|NCT00412984|1808443|FG001|Overall Study|Administrative Reason by Sponsor|8
850531|NCT00412984|1808442|FG000|Overall Study|Physician Refused to Continue Treatment|81
850532|NCT00412984|1808443|FG001|Overall Study|Physician Refused to Continue Treatment|89
850533|NCT00412984|1808442|FG000|Overall Study|Other Reason|80
850534|NCT00412984|1808443|FG001|Overall Study|Other Reason|92
850535|NCT00412984|1808442|FG000|Overall Study|Not Reported|11
850536|NCT00412984|1808443|FG001|Overall Study|Not Reported|12
850537|NCT00413010|1808451|FG000|Overall Study|Adverse Event|8
850538|NCT00413010|1808452|FG001|Overall Study|Adverse Event|4
850539|NCT00413010|1808451|FG000|Overall Study|Laboratory abnormality|0
850540|NCT00413010|1808452|FG001|Overall Study|Laboratory abnormality|2
850541|NCT00413010|1808451|FG000|Overall Study|Lack of Efficacy|0
850542|NCT00413010|1808452|FG001|Overall Study|Lack of Efficacy|3
850543|NCT00413010|1808451|FG000|Overall Study|Lost to Follow-up|3
850544|NCT00413010|1808452|FG001|Overall Study|Lost to Follow-up|0
850545|NCT00413010|1808451|FG000|Overall Study|Withdrawal by Subject|7
850546|NCT00413010|1808452|FG001|Overall Study|Withdrawal by Subject|2
850547|NCT00413010|1808451|FG000|Overall Study|Due to termination of the study|54
850548|NCT00413010|1808452|FG001|Overall Study|Due to termination of the study|52
850549|NCT00413036|1808458|FG000|Overall Study|Adverse Event|44
850550|NCT00413036|1808458|FG000|Overall Study|Lack of Efficacy|129
850551|NCT00413036|1808458|FG000|Overall Study|Withdrawal by Subject|7
850552|NCT00413036|1808458|FG000|Overall Study|Death|9
850553|NCT00413036|1808458|FG000|Overall Study|Other|26
850554|NCT00413036|1808458|FG000|Overall Study|Missing|2
850555|NCT00413049|1808464|FG000|Overall Study|Adverse Event|10
850556|NCT00413049|1808465|FG001|Overall Study|Adverse Event|8
850557|NCT00413049|1808464|FG000|Overall Study|Withdrawal by Subject|7
850558|NCT00413049|1808465|FG001|Overall Study|Withdrawal by Subject|5
850559|NCT00413049|1808464|FG000|Overall Study|Lost to Follow-up|2
850560|NCT00413049|1808465|FG001|Overall Study|Lost to Follow-up|3
850561|NCT00413049|1808464|FG000|Overall Study|Protocol Violation|3
850562|NCT00413049|1808465|FG001|Overall Study|Protocol Violation|1
850563|NCT00413049|1808464|FG000|Overall Study|Subject no longer requires study drug|0
850564|NCT00413049|1808465|FG001|Overall Study|Subject no longer requires study drug|1
850565|NCT00413049|1808464|FG000|Overall Study|Abnormal laboratory value(s)|1
850566|NCT00413049|1808465|FG001|Overall Study|Abnormal laboratory value(s)|0
850567|NCT00413049|1808464|FG000|Overall Study|Lack of Efficacy|1
850568|NCT00413049|1808465|FG001|Overall Study|Lack of Efficacy|0
850569|NCT00413062|1808473|FG000|Overall Study|Adverse event/serious adverse event|289
850570|NCT00413062|1808474|FG001|Overall Study|Adverse event/serious adverse event|56
850571|NCT00413062|1808473|FG000|Overall Study|Pre-treatment (serious) adverse event|1
850572|NCT00413062|1808474|FG001|Overall Study|Pre-treatment (serious) adverse event|0
850573|NCT00413062|1808473|FG000|Overall Study|Withdrawal of informed consent|111
850574|NCT00413062|1808474|FG001|Overall Study|Withdrawal of informed consent|36
850575|NCT00413062|1808473|FG000|Overall Study|Pregnancy|15
850576|NCT00413062|1808474|FG001|Overall Study|Pregnancy|5
850577|NCT00413062|1808473|FG000|Overall Study|Pregnancy wish|17
850578|NCT00413062|1808474|FG001|Overall Study|Pregnancy wish|6
850579|NCT00413062|1808473|FG000|Overall Study|Lost to Follow-up|175
850580|NCT00413062|1808474|FG001|Overall Study|Lost to Follow-up|73
850581|NCT00413062|1808473|FG000|Overall Study|Other reason|70
850582|NCT00413062|1808474|FG001|Overall Study|Other reason|34
850583|NCT00413153|1808484|FG000|Overall Study|Withdrawal by Subject|1
850584|NCT00413153|1808485|FG001|Overall Study|Withdrawal by Subject|1
850585|NCT00413153|1808484|FG000|Overall Study|Adverse Event|1
850586|NCT00413153|1808485|FG001|Overall Study|Adverse Event|0
850587|NCT00413192|1808508|FG000|Overall Study|Disease progression|26
850588|NCT00413192|1808509|FG001|Overall Study|Disease progression|31
850589|NCT00413192|1808510|FG002|Overall Study|Disease progression|16
850590|NCT00413192|1808511|FG003|Overall Study|Disease progression|25
850591|NCT00413192|1808508|FG000|Overall Study|Toxicity|3
850592|NCT00413192|1808509|FG001|Overall Study|Toxicity|2
850593|NCT00413192|1808510|FG002|Overall Study|Toxicity|2
850594|NCT00413192|1808511|FG003|Overall Study|Toxicity|2
850595|NCT00413192|1808508|FG000|Overall Study|Withdrawal by Subject|3
850596|NCT00413192|1808509|FG001|Overall Study|Withdrawal by Subject|5
850597|NCT00413192|1808510|FG002|Overall Study|Withdrawal by Subject|0
850598|NCT00413192|1808511|FG003|Overall Study|Withdrawal by Subject|1
850599|NCT00413192|1808508|FG000|Overall Study|Intercurrent illness|0
850600|NCT00413192|1808509|FG001|Overall Study|Intercurrent illness|0
850601|NCT00413192|1808510|FG002|Overall Study|Intercurrent illness|0
850602|NCT00413192|1808511|FG003|Overall Study|Intercurrent illness|1
850603|NCT00413192|1808508|FG000|Overall Study|Intercurrent death|0
850604|NCT00413192|1808509|FG001|Overall Study|Intercurrent death|1
850605|NCT00413192|1808510|FG002|Overall Study|Intercurrent death|0
850606|NCT00413192|1808511|FG003|Overall Study|Intercurrent death|0
850607|NCT00413192|1808508|FG000|Overall Study|Other|5
850608|NCT00413192|1808509|FG001|Overall Study|Other|1
850609|NCT00413192|1808510|FG002|Overall Study|Other|1
850610|NCT00413192|1808511|FG003|Overall Study|Other|2
850611|NCT00413192|1808508|FG000|Overall Study|Not treated|0
850612|NCT00413192|1808509|FG001|Overall Study|Not treated|0
850613|NCT00413192|1808510|FG002|Overall Study|Not treated|0
850614|NCT00413192|1808511|FG003|Overall Study|Not treated|1
850615|NCT00413218|1808523|FG000|Overall Study|Randomized but didn't receive study drug|2
850616|NCT00413218|1808524|FG001|Overall Study|Randomized but didn't receive study drug|8
850617|NCT00413218|1808523|FG000|Overall Study|Death|57
850618|NCT00413218|1808524|FG001|Overall Study|Death|56
850619|NCT00413218|1808523|FG000|Overall Study|Lost to Follow-up|14
850620|NCT00413218|1808524|FG001|Overall Study|Lost to Follow-up|17
850621|NCT00413218|1808523|FG000|Overall Study|Admin|20
850622|NCT00413218|1808524|FG001|Overall Study|Admin|14
850623|NCT00413218|1808523|FG000|Overall Study|Missing|1
850624|NCT00413218|1808524|FG001|Overall Study|Missing|0
850625|NCT00413218|1808523|FG000|Overall Study|Withdrawal by Subject|9
850626|NCT00413218|1808524|FG001|Overall Study|Withdrawal by Subject|1
850627|NCT00413231|1808531|FG000|0 to 30-day Post Treatment|Death|5
850628|NCT00413231|1808531|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
850629|NCT00413231|1808531|FG000|30-day to 365-day Post Treatment|Death|13
850630|NCT00413231|1808531|FG000|365-day to 60-month Post Treatment|Death|36
850631|NCT00413231|1808531|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5
850632|NCT00413231|1808531|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4
850633|NCT00413231|1808531|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1
850634|NCT00413244|1808538|FG000|Overall Study|Withdrawal by Subject|10
850635|NCT00413244|1808539|FG001|Overall Study|Withdrawal by Subject|1
850636|NCT00413283|1808549|FG000|Overall Study|Withdrawal by Subject|1
850637|NCT00413283|1808550|FG001|Overall Study|Withdrawal by Subject|0
850638|NCT00413283|1808551|FG002|Overall Study|Withdrawal by Subject|0
850639|NCT00413283|1808552|FG003|Overall Study|Withdrawal by Subject|1
850640|NCT00413283|1808549|FG000|Overall Study|Death|0
850641|NCT00413283|1808550|FG001|Overall Study|Death|0
850642|NCT00413283|1808551|FG002|Overall Study|Death|1
850643|NCT00413283|1808552|FG003|Overall Study|Death|1
850644|NCT00413283|1808549|FG000|Overall Study|Adverse Event|0
850645|NCT00413283|1808550|FG001|Overall Study|Adverse Event|0
850646|NCT00413283|1808551|FG002|Overall Study|Adverse Event|0
850647|NCT00413283|1808552|FG003|Overall Study|Adverse Event|1
850648|NCT00413283|1808549|FG000|Overall Study|Ineligibility determined|0
850649|NCT00413283|1808550|FG001|Overall Study|Ineligibility determined|0
850650|NCT00413283|1808551|FG002|Overall Study|Ineligibility determined|0
850651|NCT00413283|1808552|FG003|Overall Study|Ineligibility determined|1
850652|NCT00413283|1808549|FG000|Overall Study|Protocol deviation|0
850653|NCT00413283|1808550|FG001|Overall Study|Protocol deviation|1
850654|NCT00413283|1808551|FG002|Overall Study|Protocol deviation|0
850655|NCT00413283|1808552|FG003|Overall Study|Protocol deviation|0
850656|NCT00413283|1808549|FG000|Overall Study|Requirement for alternative therapy|0
850657|NCT00413283|1808550|FG001|Overall Study|Requirement for alternative therapy|2
850658|NCT00413283|1808551|FG002|Overall Study|Requirement for alternative therapy|0
850659|NCT00413283|1808552|FG003|Overall Study|Requirement for alternative therapy|0
850660|NCT00413283|1808549|FG000|Overall Study|Other|0
850661|NCT00413283|1808550|FG001|Overall Study|Other|0
850662|NCT00413283|1808551|FG002|Overall Study|Other|1
850663|NCT00413283|1808552|FG003|Overall Study|Other|0
850664|NCT00413374|1808573|FG000|Overall Study|Ineligible due to screening criteria.|3
850665|NCT00413374|1808574|FG001|Overall Study|Ineligible due to screening criteria.|0
850666|NCT00413374|1808573|FG000|Overall Study|Adverse Event|1
850667|NCT00413374|1808574|FG001|Overall Study|Adverse Event|0
850668|NCT00413374|1808573|FG000|Overall Study|Lost to Follow-up|1
850669|NCT00413374|1808574|FG001|Overall Study|Lost to Follow-up|0
850670|NCT00413374|1808573|FG000|Overall Study|Surgery|1
850671|NCT00413374|1808574|FG001|Overall Study|Surgery|0
850672|NCT00413413|1808595|FG000|Single-Blind|Adverse Event|0
850673|NCT00413413|1808596|FG001|Single-Blind|Adverse Event|9
850674|NCT00413413|1808597|FG002|Single-Blind|Adverse Event|0
850675|NCT00413413|1808595|FG000|Single-Blind|Lack of Efficacy|0
850676|NCT00413413|1808596|FG001|Single-Blind|Lack of Efficacy|5
850677|NCT00413413|1808597|FG002|Single-Blind|Lack of Efficacy|0
850678|NCT00413413|1808595|FG000|Single-Blind|Subject no longer requires study drug|0
850679|NCT00413413|1808596|FG001|Single-Blind|Subject no longer requires study drug|151
850680|NCT00413413|1808597|FG002|Single-Blind|Subject no longer requires study drug|0
850681|NCT00413413|1808595|FG000|Single-Blind|Protocol Violation|0
850682|NCT00413413|1808596|FG001|Single-Blind|Protocol Violation|16
850683|NCT00413413|1808597|FG002|Single-Blind|Protocol Violation|0
850684|NCT00413413|1808595|FG000|Single-Blind|Withdrawal by Subject|0
850685|NCT00413413|1808596|FG001|Single-Blind|Withdrawal by Subject|27
850686|NCT00413413|1808597|FG002|Single-Blind|Withdrawal by Subject|0
850687|NCT00413413|1808595|FG000|Single-Blind|Lost to Follow-up|0
850688|NCT00413413|1808596|FG001|Single-Blind|Lost to Follow-up|8
850689|NCT00413413|1808597|FG002|Single-Blind|Lost to Follow-up|0
850690|NCT00413413|1808595|FG000|Double-Blind|Adverse Event|6
850691|NCT00413413|1808596|FG001|Double-Blind|Adverse Event|0
850692|NCT00413413|1808597|FG002|Double-Blind|Adverse Event|5
850693|NCT00413413|1808595|FG000|Double-Blind|Unsatisfactory therapeutic effect|1
850694|NCT00413413|1808596|FG001|Double-Blind|Unsatisfactory therapeutic effect|2
850695|NCT00413413|1808597|FG002|Double-Blind|Unsatisfactory therapeutic effect|1
850696|NCT00413413|1808595|FG000|Double-Blind|Protocol deviation|1
850697|NCT00413413|1808596|FG001|Double-Blind|Protocol deviation|2
850698|NCT00413413|1808597|FG002|Double-Blind|Protocol deviation|1
850699|NCT00413413|1808595|FG000|Double-Blind|Subject withdrew consent|4
850700|NCT00413413|1808596|FG001|Double-Blind|Subject withdrew consent|6
850701|NCT00413413|1808597|FG002|Double-Blind|Subject withdrew consent|9
850702|NCT00413413|1808595|FG000|Double-Blind|Lost to Follow-up|3
850703|NCT00413413|1808596|FG001|Double-Blind|Lost to Follow-up|4
850704|NCT00413413|1808597|FG002|Double-Blind|Lost to Follow-up|2
850705|NCT00413660|1808636|FG000|Up To Week 12|Adverse Event|1
850706|NCT00413660|1808637|FG001|Up To Week 12|Adverse Event|3
850707|NCT00413660|1808638|FG002|Up To Week 12|Adverse Event|1
850708|NCT00413660|1808639|FG003|Up To Week 12|Adverse Event|4
850709|NCT00413660|1808640|FG004|Up To Week 12|Adverse Event|6
850710|NCT00413660|1808641|FG005|Up To Week 12|Adverse Event|4
850711|NCT00413660|1808642|FG006|Up To Week 12|Adverse Event|1
850712|NCT00413660|1808643|FG007|Up To Week 12|Adverse Event|0
850713|NCT00413660|1808644|FG008|Up To Week 12|Adverse Event|0
850714|NCT00413660|1808645|FG009|Up To Week 12|Adverse Event|0
850715|NCT00413660|1808646|FG010|Up To Week 12|Adverse Event|0
850716|NCT00413660|1808636|FG000|Up To Week 12|Lack of Efficacy|2
850717|NCT00413660|1808637|FG001|Up To Week 12|Lack of Efficacy|0
850718|NCT00413660|1808638|FG002|Up To Week 12|Lack of Efficacy|0
850719|NCT00413660|1808639|FG003|Up To Week 12|Lack of Efficacy|0
850720|NCT00413660|1808640|FG004|Up To Week 12|Lack of Efficacy|0
850721|NCT00413660|1808641|FG005|Up To Week 12|Lack of Efficacy|0
850722|NCT00413660|1808642|FG006|Up To Week 12|Lack of Efficacy|5
850723|NCT00413660|1808643|FG007|Up To Week 12|Lack of Efficacy|0
850724|NCT00413660|1808644|FG008|Up To Week 12|Lack of Efficacy|0
850725|NCT00413660|1808645|FG009|Up To Week 12|Lack of Efficacy|0
850726|NCT00413660|1808646|FG010|Up To Week 12|Lack of Efficacy|0
850727|NCT00413660|1808636|FG000|Up To Week 12|Lost to Follow-up|0
850728|NCT00413660|1808637|FG001|Up To Week 12|Lost to Follow-up|1
850729|NCT00413660|1808638|FG002|Up To Week 12|Lost to Follow-up|0
850730|NCT00413660|1808639|FG003|Up To Week 12|Lost to Follow-up|0
850731|NCT00413660|1808640|FG004|Up To Week 12|Lost to Follow-up|1
850732|NCT00413660|1808641|FG005|Up To Week 12|Lost to Follow-up|0
850733|NCT00413660|1808642|FG006|Up To Week 12|Lost to Follow-up|0
850734|NCT00413660|1808643|FG007|Up To Week 12|Lost to Follow-up|0
850735|NCT00413660|1808644|FG008|Up To Week 12|Lost to Follow-up|0
850736|NCT00413660|1808645|FG009|Up To Week 12|Lost to Follow-up|0
850737|NCT00413660|1808646|FG010|Up To Week 12|Lost to Follow-up|0
850738|NCT00413660|1808636|FG000|Up To Week 12|Withdrawal by Subject|0
850739|NCT00413660|1808637|FG001|Up To Week 12|Withdrawal by Subject|2
850740|NCT00413660|1808638|FG002|Up To Week 12|Withdrawal by Subject|0
850741|NCT00413660|1808639|FG003|Up To Week 12|Withdrawal by Subject|2
850742|NCT00413660|1808640|FG004|Up To Week 12|Withdrawal by Subject|0
850743|NCT00413660|1808641|FG005|Up To Week 12|Withdrawal by Subject|2
850744|NCT00413660|1808642|FG006|Up To Week 12|Withdrawal by Subject|2
850745|NCT00413660|1808643|FG007|Up To Week 12|Withdrawal by Subject|0
850746|NCT00413660|1808644|FG008|Up To Week 12|Withdrawal by Subject|0
850747|NCT00413660|1808645|FG009|Up To Week 12|Withdrawal by Subject|0
850748|NCT00413660|1808646|FG010|Up To Week 12|Withdrawal by Subject|0
850749|NCT00413660|1808636|FG000|Up To Week 12|Randomized, Not Treated|1
850750|NCT00413660|1808637|FG001|Up To Week 12|Randomized, Not Treated|0
850751|NCT00413660|1808638|FG002|Up To Week 12|Randomized, Not Treated|0
850752|NCT00413660|1808639|FG003|Up To Week 12|Randomized, Not Treated|1
850753|NCT00413660|1808640|FG004|Up To Week 12|Randomized, Not Treated|0
850754|NCT00413660|1808641|FG005|Up To Week 12|Randomized, Not Treated|0
850755|NCT00413660|1808642|FG006|Up To Week 12|Randomized, Not Treated|0
850756|NCT00413660|1808643|FG007|Up To Week 12|Randomized, Not Treated|0
850757|NCT00413660|1808644|FG008|Up To Week 12|Randomized, Not Treated|0
850758|NCT00413660|1808645|FG009|Up To Week 12|Randomized, Not Treated|0
850759|NCT00413660|1808646|FG010|Up To Week 12|Randomized, Not Treated|0
850760|NCT00413660|1808636|FG000|Up To Week 12|Other|3
850761|NCT00413660|1808637|FG001|Up To Week 12|Other|1
850762|NCT00413660|1808638|FG002|Up To Week 12|Other|6
850763|NCT00413660|1808639|FG003|Up To Week 12|Other|1
850764|NCT00413660|1808640|FG004|Up To Week 12|Other|2
850765|NCT00413660|1808641|FG005|Up To Week 12|Other|4
850766|NCT00413660|1808642|FG006|Up To Week 12|Other|3
850767|NCT00413660|1808643|FG007|Up To Week 12|Other|0
850768|NCT00413660|1808644|FG008|Up To Week 12|Other|0
850769|NCT00413660|1808645|FG009|Up To Week 12|Other|0
850770|NCT00413660|1808646|FG010|Up To Week 12|Other|0
850771|NCT00413660|1808636|FG000|Post Week 12|Adverse Event|2
850772|NCT00413660|1808637|FG001|Post Week 12|Adverse Event|0
850773|NCT00413660|1808638|FG002|Post Week 12|Adverse Event|2
850774|NCT00413660|1808639|FG003|Post Week 12|Adverse Event|1
850775|NCT00413660|1808640|FG004|Post Week 12|Adverse Event|4
850776|NCT00413660|1808641|FG005|Post Week 12|Adverse Event|2
850777|NCT00413660|1808642|FG006|Post Week 12|Adverse Event|2
850778|NCT00413660|1808643|FG007|Post Week 12|Adverse Event|0
850779|NCT00413660|1808644|FG008|Post Week 12|Adverse Event|0
850780|NCT00413660|1808645|FG009|Post Week 12|Adverse Event|0
850781|NCT00413660|1808646|FG010|Post Week 12|Adverse Event|0
850782|NCT00413660|1808636|FG000|Post Week 12|Lack of Efficacy|0
850783|NCT00413660|1808637|FG001|Post Week 12|Lack of Efficacy|0
850784|NCT00413660|1808638|FG002|Post Week 12|Lack of Efficacy|1
850785|NCT00413660|1808639|FG003|Post Week 12|Lack of Efficacy|0
850786|NCT00413660|1808640|FG004|Post Week 12|Lack of Efficacy|0
850787|NCT00413660|1808641|FG005|Post Week 12|Lack of Efficacy|0
850788|NCT00413660|1808642|FG006|Post Week 12|Lack of Efficacy|0
850789|NCT00413660|1808643|FG007|Post Week 12|Lack of Efficacy|0
850790|NCT00413660|1808644|FG008|Post Week 12|Lack of Efficacy|0
850791|NCT00413660|1808645|FG009|Post Week 12|Lack of Efficacy|1
850792|NCT00413660|1808646|FG010|Post Week 12|Lack of Efficacy|0
850793|NCT00413660|1808636|FG000|Post Week 12|Lost to Follow-up|0
850794|NCT00413660|1808637|FG001|Post Week 12|Lost to Follow-up|1
850795|NCT00413660|1808638|FG002|Post Week 12|Lost to Follow-up|1
850796|NCT00413660|1808639|FG003|Post Week 12|Lost to Follow-up|0
850797|NCT00413660|1808640|FG004|Post Week 12|Lost to Follow-up|0
850798|NCT00413660|1808641|FG005|Post Week 12|Lost to Follow-up|0
850799|NCT00413660|1808642|FG006|Post Week 12|Lost to Follow-up|0
850800|NCT00413660|1808643|FG007|Post Week 12|Lost to Follow-up|0
850801|NCT00413660|1808644|FG008|Post Week 12|Lost to Follow-up|0
850802|NCT00413660|1808645|FG009|Post Week 12|Lost to Follow-up|0
850803|NCT00413660|1808646|FG010|Post Week 12|Lost to Follow-up|0
850804|NCT00413660|1808636|FG000|Post Week 12|Withdrawal by Subject|0
850805|NCT00413660|1808637|FG001|Post Week 12|Withdrawal by Subject|1
850806|NCT00413660|1808638|FG002|Post Week 12|Withdrawal by Subject|1
850807|NCT00413660|1808639|FG003|Post Week 12|Withdrawal by Subject|0
850808|NCT00413660|1808640|FG004|Post Week 12|Withdrawal by Subject|1
850809|NCT00413660|1808641|FG005|Post Week 12|Withdrawal by Subject|0
850810|NCT00413660|1808642|FG006|Post Week 12|Withdrawal by Subject|0
850811|NCT00413660|1808643|FG007|Post Week 12|Withdrawal by Subject|0
850812|NCT00413660|1808644|FG008|Post Week 12|Withdrawal by Subject|0
850813|NCT00413660|1808645|FG009|Post Week 12|Withdrawal by Subject|0
850814|NCT00413660|1808646|FG010|Post Week 12|Withdrawal by Subject|1
850815|NCT00413660|1808636|FG000|Post Week 12|Other|1
850816|NCT00413660|1808637|FG001|Post Week 12|Other|2
850817|NCT00413660|1808638|FG002|Post Week 12|Other|3
850818|NCT00413660|1808639|FG003|Post Week 12|Other|0
850819|NCT00413660|1808640|FG004|Post Week 12|Other|1
850820|NCT00413660|1808641|FG005|Post Week 12|Other|1
850821|NCT00413660|1808642|FG006|Post Week 12|Other|1
850822|NCT00413660|1808643|FG007|Post Week 12|Other|0
850823|NCT00413660|1808644|FG008|Post Week 12|Other|0
850824|NCT00413660|1808645|FG009|Post Week 12|Other|0
850825|NCT00413660|1808646|FG010|Post Week 12|Other|0
850826|NCT00413777|1808708|FG000|Fixed-dose Period|Lost to Follow-up|1
850827|NCT00413777|1808709|FG001|Fixed-dose Period|Lost to Follow-up|1
850828|NCT00413777|1808708|FG000|Fixed-dose Period|Adverse Event|2
850829|NCT00413777|1808709|FG001|Fixed-dose Period|Adverse Event|1
850830|NCT00413777|1808708|FG000|Fixed-dose Period|Met Withdrawal Criteria|1
850831|NCT00413777|1808709|FG001|Fixed-dose Period|Met Withdrawal Criteria|0
850832|NCT00413777|1808708|FG000|Fixed-dose Period|Withdrew Consent|0
850833|NCT00413777|1808709|FG001|Fixed-dose Period|Withdrew Consent|1
850834|NCT00413894|1808715|FG000|Overall Study|Withdrawal by Subject|10
850835|NCT00413894|1808715|FG000|Overall Study|Administrative Reasons|1
850836|NCT00413894|1808715|FG000|Overall Study|Hb <10 grams/deciliter|12
850837|NCT00413894|1808715|FG000|Overall Study|Adverse Event|28
850838|NCT00413894|1808715|FG000|Overall Study|Protocol Violation|11
850839|NCT00413894|1808715|FG000|Overall Study|Other|18
850840|NCT00413920|1808724|FG000|Overall Study|Adverse Event|9
850841|NCT00413920|1808725|FG001|Overall Study|Adverse Event|11
850842|NCT00413920|1808724|FG000|Overall Study|Lack of Efficacy|11
850843|NCT00413920|1808725|FG001|Overall Study|Lack of Efficacy|9
850844|NCT00413920|1808724|FG000|Overall Study|Death|3
850845|NCT00413920|1808725|FG001|Overall Study|Death|5
850846|NCT00413920|1808724|FG000|Overall Study|Graft Loss|5
850847|NCT00413920|1808725|FG001|Overall Study|Graft Loss|3
850848|NCT00413959|1808731|FG000|Overall Study|Pt had only one cycle.|1
850849|NCT00413972|1808739|FG000|Overall Study|Adverse Event|2
850850|NCT00413972|1808740|FG001|Overall Study|Adverse Event|1
850851|NCT00413972|1808741|FG002|Overall Study|Adverse Event|0
850852|NCT00413972|1808742|FG003|Overall Study|Adverse Event|0
850853|NCT00413972|1808739|FG000|Overall Study|Lost to Follow-up|1
850854|NCT00413972|1808740|FG001|Overall Study|Lost to Follow-up|2
850855|NCT00413972|1808741|FG002|Overall Study|Lost to Follow-up|1
850856|NCT00413972|1808742|FG003|Overall Study|Lost to Follow-up|0
850857|NCT00413972|1808739|FG000|Overall Study|Withdrawal by Subject|4
850858|NCT00413972|1808740|FG001|Overall Study|Withdrawal by Subject|5
850859|NCT00413972|1808741|FG002|Overall Study|Withdrawal by Subject|7
850860|NCT00413972|1808742|FG003|Overall Study|Withdrawal by Subject|2
850861|NCT00413972|1808739|FG000|Overall Study|Protocol Violation|0
850862|NCT00413972|1808740|FG001|Overall Study|Protocol Violation|0
850863|NCT00413972|1808741|FG002|Overall Study|Protocol Violation|2
850864|NCT00413972|1808742|FG003|Overall Study|Protocol Violation|0
850865|NCT00413972|1808739|FG000|Overall Study|Other|0
850866|NCT00413972|1808740|FG001|Overall Study|Other|0
850867|NCT00413972|1808741|FG002|Overall Study|Other|0
850868|NCT00413972|1808742|FG003|Overall Study|Other|1
850869|NCT00414011|1808752|FG000|Overall Study|Physician Decision|3
850870|NCT00414011|1808752|FG000|Overall Study|Withdrawal by Subject|2
850871|NCT00414050|1808761|FG000|Overall Study|Adverse Event|1
850872|NCT00414050|1808762|FG001|Overall Study|Adverse Event|1
850873|NCT00414050|1808763|FG002|Overall Study|Adverse Event|1
850874|NCT00414050|1808764|FG003|Overall Study|Adverse Event|1
850875|NCT00414050|1808761|FG000|Overall Study|Lost to Follow-up|2
850876|NCT00414050|1808762|FG001|Overall Study|Lost to Follow-up|2
850877|NCT00414050|1808763|FG002|Overall Study|Lost to Follow-up|1
850878|NCT00414050|1808764|FG003|Overall Study|Lost to Follow-up|1
850879|NCT00414050|1808761|FG000|Overall Study|Withdrawal by Subject|5
850880|NCT00414050|1808762|FG001|Overall Study|Withdrawal by Subject|3
850881|NCT00414050|1808763|FG002|Overall Study|Withdrawal by Subject|2
850882|NCT00414050|1808764|FG003|Overall Study|Withdrawal by Subject|4
850883|NCT00414050|1808761|FG000|Overall Study|Subject discontinued for other reason|1
850884|NCT00414050|1808762|FG001|Overall Study|Subject discontinued for other reason|2
850885|NCT00414050|1808763|FG002|Overall Study|Subject discontinued for other reason|2
850886|NCT00414050|1808764|FG003|Overall Study|Subject discontinued for other reason|1
850887|NCT00414050|1808761|FG000|Overall Study|Subject Moved|0
850888|NCT00414050|1808762|FG001|Overall Study|Subject Moved|0
850889|NCT00414050|1808763|FG002|Overall Study|Subject Moved|0
850890|NCT00414050|1808764|FG003|Overall Study|Subject Moved|1
850891|NCT00414076|1808776|FG000|Overall Study|Progression|1
850892|NCT00414076|1808777|FG001|Overall Study|Progression|2
850893|NCT00414076|1808776|FG000|Overall Study|Withdrawal by Subject|1
850894|NCT00414076|1808777|FG001|Overall Study|Withdrawal by Subject|3
850895|NCT00414076|1808776|FG000|Overall Study|Adverse Event|1
850896|NCT00414076|1808777|FG001|Overall Study|Adverse Event|0
850897|NCT00414310|1808813|FG000|Overall Study|Not treated|1
850898|NCT00414310|1808814|FG001|Overall Study|Not treated|0
850899|NCT00414388|1808822|FG000|Overall Study|Adverse Event|1
850900|NCT00414440|1808829|FG000|Core Period|Withdrawal by Subject|70
850901|NCT00414440|1808830|FG001|Core Period|Withdrawal by Subject|32
850902|NCT00414440|1808829|FG000|Extension Period|Lost to Follow-up|44
850903|NCT00414440|1808830|FG001|Extension Period|Lost to Follow-up|52
850904|NCT00414440|1808829|FG000|Extension Period|Did not consent to continue follow up|61
850905|NCT00414440|1808830|FG001|Extension Period|Did not consent to continue follow up|54
850906|NCT00414440|1808829|FG000|Extension Period|Other|1
850907|NCT00414440|1808830|FG001|Extension Period|Other|1
850908|NCT00414440|1808829|FG000|Extension Period|Administrative|16
850909|NCT00414440|1808830|FG001|Extension Period|Administrative|16
850910|NCT00414440|1808829|FG000|Extension Period|Death|1
850911|NCT00414440|1808830|FG001|Extension Period|Death|2
850912|NCT00414440|1808829|FG000|Extension Period|Withdrawal by Subject|9
850913|NCT00414440|1808830|FG001|Extension Period|Withdrawal by Subject|7
850914|NCT00414440|1808829|FG000|Extension Period|Not included in follow up period|18
850915|NCT00414440|1808830|FG001|Extension Period|Not included in follow up period|8
850916|NCT00414466|1808840|FG000|Overall Study|Adverse Event|0
850917|NCT00414466|1808841|FG001|Overall Study|Adverse Event|0
850918|NCT00414466|1808842|FG002|Overall Study|Adverse Event|1
850919|NCT00414466|1808843|FG003|Overall Study|Adverse Event|1
850920|NCT00414466|1808840|FG000|Overall Study|Lack of Efficacy|1
850921|NCT00414466|1808841|FG001|Overall Study|Lack of Efficacy|0
850922|NCT00414466|1808842|FG002|Overall Study|Lack of Efficacy|0
850923|NCT00414466|1808843|FG003|Overall Study|Lack of Efficacy|0
850924|NCT00414466|1808840|FG000|Overall Study|Withdrawn by Sponsor|1
850925|NCT00414466|1808841|FG001|Overall Study|Withdrawn by Sponsor|0
850926|NCT00414466|1808842|FG002|Overall Study|Withdrawn by Sponsor|0
850927|NCT00414466|1808843|FG003|Overall Study|Withdrawn by Sponsor|0
850928|NCT00414544|1808869|FG000|Overall Study|Lost to Follow-up|14
850929|NCT00414596|1808875|FG000|Overall Study|Protocol Violation|2
850930|NCT00414609|1808881|FG000|Core Study|Adverse Event|9
850931|NCT00414609|1808882|FG001|Core Study|Adverse Event|11
850932|NCT00414609|1808883|FG002|Core Study|Adverse Event|0
850933|NCT00414609|1808881|FG000|Core Study|Abnormal laboratory values|0
850934|NCT00414609|1808882|FG001|Core Study|Abnormal laboratory values|1
850935|NCT00414609|1808883|FG002|Core Study|Abnormal laboratory values|0
850936|NCT00414609|1808881|FG000|Core Study|Abnormal test procedure results|1
850937|NCT00414609|1808882|FG001|Core Study|Abnormal test procedure results|1
850938|NCT00414609|1808883|FG002|Core Study|Abnormal test procedure results|0
850939|NCT00414609|1808881|FG000|Core Study|Protocol deviation|0
850940|NCT00414609|1808882|FG001|Core Study|Protocol deviation|1
850941|NCT00414609|1808883|FG002|Core Study|Protocol deviation|0
850942|NCT00414609|1808881|FG000|Core Study|Patient withdrew consent|10
850943|NCT00414609|1808882|FG001|Core Study|Patient withdrew consent|11
850944|NCT00414609|1808883|FG002|Core Study|Patient withdrew consent|0
850945|NCT00414609|1808881|FG000|Core Study|Lost to Follow-up|7
850946|NCT00414609|1808882|FG001|Core Study|Lost to Follow-up|4
850947|NCT00414609|1808883|FG002|Core Study|Lost to Follow-up|0
850948|NCT00414609|1808881|FG000|Core Study|Administrative problems|0
850949|NCT00414609|1808882|FG001|Core Study|Administrative problems|2
850950|NCT00414609|1808883|FG002|Core Study|Administrative problems|0
850951|NCT00414609|1808881|FG000|Core Study|Death|7
850952|NCT00414609|1808882|FG001|Core Study|Death|14
850953|NCT00414609|1808883|FG002|Core Study|Death|0
850954|NCT00414609|1808881|FG000|Extension Study|Adverse Event|0
850955|NCT00414609|1808882|FG001|Extension Study|Adverse Event|0
850956|NCT00414609|1808883|FG002|Extension Study|Adverse Event|14
850957|NCT00414609|1808881|FG000|Extension Study|Unsatisfactory therapeutic effect|0
850958|NCT00414609|1808882|FG001|Extension Study|Unsatisfactory therapeutic effect|0
850959|NCT00414609|1808883|FG002|Extension Study|Unsatisfactory therapeutic effect|2
850960|NCT00414609|1808881|FG000|Extension Study|Withdrawal by Subject|0
850961|NCT00414609|1808882|FG001|Extension Study|Withdrawal by Subject|0
850962|NCT00414609|1808883|FG002|Extension Study|Withdrawal by Subject|13
850963|NCT00414609|1808881|FG000|Extension Study|Lost to Follow-up|0
850964|NCT00414609|1808882|FG001|Extension Study|Lost to Follow-up|0
850965|NCT00414609|1808883|FG002|Extension Study|Lost to Follow-up|10
850966|NCT00414609|1808881|FG000|Extension Study|Administrative problems|0
850967|NCT00414609|1808882|FG001|Extension Study|Administrative problems|0
850968|NCT00414609|1808883|FG002|Extension Study|Administrative problems|1
850969|NCT00414609|1808881|FG000|Extension Study|Death|0
850970|NCT00414609|1808882|FG001|Extension Study|Death|0
850971|NCT00414609|1808883|FG002|Extension Study|Death|17
850972|NCT00414661|1808905|FG000|Overall Study|Death|2
850973|NCT00414661|1808906|FG001|Overall Study|Death|5
850974|NCT00414661|1808907|FG002|Overall Study|Death|0
850975|NCT00414661|1808908|FG003|Overall Study|Death|0
850976|NCT00414661|1808905|FG000|Overall Study|Lost to Follow-up|1
850977|NCT00414661|1808906|FG001|Overall Study|Lost to Follow-up|4
850978|NCT00414661|1808907|FG002|Overall Study|Lost to Follow-up|0
850979|NCT00414661|1808908|FG003|Overall Study|Lost to Follow-up|1
850980|NCT00414661|1808905|FG000|Overall Study|Withdrawal by Subject|5
850981|NCT00414661|1808906|FG001|Overall Study|Withdrawal by Subject|2
850982|NCT00414661|1808907|FG002|Overall Study|Withdrawal by Subject|2
850983|NCT00414661|1808908|FG003|Overall Study|Withdrawal by Subject|2
850984|NCT00414661|1808905|FG000|Overall Study|Other|6
850985|NCT00414661|1808906|FG001|Overall Study|Other|3
850986|NCT00414661|1808907|FG002|Overall Study|Other|0
850987|NCT00414661|1808908|FG003|Overall Study|Other|0
850988|NCT00414726|1808929|FG000|Overall Study|Withdrawal by Subject|0
850989|NCT00414726|1808930|FG001|Overall Study|Withdrawal by Subject|1
850990|NCT00414765|1808938|FG000|Overall Study|Adverse Event|5
850991|NCT00414765|1808939|FG001|Overall Study|Adverse Event|9
850992|NCT00414765|1808938|FG000|Overall Study|Withdrawal by Subject|1
850993|NCT00414765|1808939|FG001|Overall Study|Withdrawal by Subject|1
850994|NCT00414765|1808938|FG000|Overall Study|Disease Progression|0
850995|NCT00414765|1808939|FG001|Overall Study|Disease Progression|1
850996|NCT00414908|1808956|FG000|Overall Study|Protocol Violation|1
850997|NCT00414908|1808957|FG001|Overall Study|Protocol Violation|1
850998|NCT00414960|1808967|FG000|Overall Study|Adverse Event|4
850999|NCT00414960|1808968|FG001|Overall Study|Adverse Event|0
851000|NCT00414960|1808967|FG000|Overall Study|Withdrawal by Subject|3
851001|NCT00414960|1808968|FG001|Overall Study|Withdrawal by Subject|0
851002|NCT00414960|1808967|FG000|Overall Study|Physician Decision|0
851003|NCT00414960|1808968|FG001|Overall Study|Physician Decision|1
851004|NCT00414973|1808978|FG000|Overall Study|Withdrawal by Subject|14
851005|NCT00414973|1808979|FG001|Overall Study|Withdrawal by Subject|4
851006|NCT00414973|1808980|FG002|Overall Study|Withdrawal by Subject|1
851007|NCT00414973|1808981|FG003|Overall Study|Withdrawal by Subject|0
851008|NCT00414973|1808978|FG000|Overall Study|Adverse Event|10
851009|NCT00414973|1808979|FG001|Overall Study|Adverse Event|0
851010|NCT00414973|1808980|FG002|Overall Study|Adverse Event|1
851011|NCT00414973|1808981|FG003|Overall Study|Adverse Event|0
851012|NCT00414973|1808978|FG000|Overall Study|Protocol Violation|3
851013|NCT00414973|1808979|FG001|Overall Study|Protocol Violation|4
851014|NCT00414973|1808980|FG002|Overall Study|Protocol Violation|0
851015|NCT00414973|1808981|FG003|Overall Study|Protocol Violation|0
851016|NCT00414973|1808978|FG000|Overall Study|Lost to Follow-up|0
851017|NCT00414973|1808979|FG001|Overall Study|Lost to Follow-up|2
851018|NCT00414973|1808980|FG002|Overall Study|Lost to Follow-up|0
851019|NCT00414973|1808981|FG003|Overall Study|Lost to Follow-up|0
851020|NCT00414973|1808978|FG000|Overall Study|Sponsor Decision|1
851021|NCT00414973|1808979|FG001|Overall Study|Sponsor Decision|0
851022|NCT00414973|1808980|FG002|Overall Study|Sponsor Decision|0
851023|NCT00414973|1808981|FG003|Overall Study|Sponsor Decision|0
851024|NCT00414973|1808978|FG000|Overall Study|Death|0
851025|NCT00414973|1808979|FG001|Overall Study|Death|0
851026|NCT00414973|1808980|FG002|Overall Study|Death|1
851027|NCT00414973|1808981|FG003|Overall Study|Death|0
851028|NCT00415051|1808991|FG000|Overall Study|Protocol Violation|1
851029|NCT00415168|1808995|FG000|Overall Study|Death|26
851030|NCT00415168|1808995|FG000|Overall Study|Lost to Follow-up|3
851031|NCT00415168|1808995|FG000|Overall Study|Physician Decision|13
851032|NCT00415168|1808995|FG000|Overall Study|Sponsor Decision|4
851033|NCT00415168|1808995|FG000|Overall Study|Withdrawal by Subject|6
851034|NCT00415194|1809001|FG000|Overall Study|Adverse Event|37
851035|NCT00415194|1809002|FG001|Overall Study|Adverse Event|32
851036|NCT00415194|1809001|FG000|Overall Study|Entry Criteria Not Met|4
851037|NCT00415194|1809002|FG001|Overall Study|Entry Criteria Not Met|8
851038|NCT00415194|1809001|FG000|Overall Study|Lost to Follow-up|1
851039|NCT00415194|1809002|FG001|Overall Study|Lost to Follow-up|0
851040|NCT00415194|1809001|FG000|Overall Study|Physician Decision|10
851041|NCT00415194|1809002|FG001|Overall Study|Physician Decision|16
851042|NCT00415194|1809001|FG000|Overall Study|Progressive Disease|180
851043|NCT00415194|1809002|FG001|Overall Study|Progressive Disease|217
851044|NCT00415194|1809001|FG000|Overall Study|Protocol Violation|4
851045|NCT00415194|1809002|FG001|Overall Study|Protocol Violation|2
851046|NCT00415194|1809001|FG000|Overall Study|Withdrawal by Subject|28
851047|NCT00415194|1809002|FG001|Overall Study|Withdrawal by Subject|21
851048|NCT00415194|1809001|FG000|Overall Study|Death Due to Study Disease|26
851049|NCT00415194|1809002|FG001|Overall Study|Death Due to Study Disease|29
851050|NCT00415194|1809001|FG000|Overall Study|Death Due to Study Drug Related AE|11
851051|NCT00415194|1809002|FG001|Overall Study|Death Due to Study Drug Related AE|1
851052|NCT00415194|1809001|FG000|Overall Study|Death Due to Procedural Related AE|0
851053|NCT00415194|1809002|FG001|Overall Study|Death Due to Procedural Related AE|1
851054|NCT00415194|1809001|FG000|Overall Study|Death Due to AE (Other Causes)|27
851055|NCT00415194|1809002|FG001|Overall Study|Death Due to AE (Other Causes)|15
851056|NCT00415363|1809010|FG000|Overall Study|Withdrawal by Subject|4
851057|NCT00415363|1809011|FG001|Overall Study|Withdrawal by Subject|4
851058|NCT00415363|1809010|FG000|Overall Study|Adverse Event|4
851059|NCT00415363|1809011|FG001|Overall Study|Adverse Event|4
851060|NCT00415363|1809010|FG000|Overall Study|Lost to Follow-up|2
851061|NCT00415363|1809011|FG001|Overall Study|Lost to Follow-up|1
851062|NCT00415363|1809010|FG000|Overall Study|Physician Decision|3
851063|NCT00415363|1809011|FG001|Overall Study|Physician Decision|1
851064|NCT00415363|1809010|FG000|Overall Study|Death|16
851065|NCT00415363|1809011|FG001|Overall Study|Death|12
851066|NCT00415363|1809010|FG000|Overall Study|Progressive disease|26
851067|NCT00415363|1809011|FG001|Overall Study|Progressive disease|32
851068|NCT00415519|1809038|FG000|Overall Study|Adverse Event|1
851069|NCT00415519|1809039|FG001|Overall Study|Adverse Event|0
851070|NCT00415519|1809038|FG000|Overall Study|Withdrawal by Subject|2
851071|NCT00415519|1809039|FG001|Overall Study|Withdrawal by Subject|0
851072|NCT00415519|1809038|FG000|Overall Study|Patient's convenience|1
851073|NCT00415519|1809039|FG001|Overall Study|Patient's convenience|0
851074|NCT00415532|1809047|FG000|Treatment Period|Adverse Event|2
851075|NCT00415532|1809048|FG001|Treatment Period|Adverse Event|3
851076|NCT00415532|1809047|FG000|Treatment Period|Death|2
851077|NCT00415532|1809048|FG001|Treatment Period|Death|1
851078|NCT00415532|1809047|FG000|Treatment Period|Lost to Follow-up|1
851079|NCT00415532|1809048|FG001|Treatment Period|Lost to Follow-up|1
851080|NCT00415532|1809047|FG000|Treatment Period|Protocol Violation|1
851081|NCT00415532|1809048|FG001|Treatment Period|Protocol Violation|0
851082|NCT00415532|1809047|FG000|Treatment Period|Withdrawal by Subject|6
851083|NCT00415532|1809048|FG001|Treatment Period|Withdrawal by Subject|6
851084|NCT00415532|1809047|FG000|Treatment Period|Other|2
851085|NCT00415532|1809048|FG001|Treatment Period|Other|2
851086|NCT00415532|1809047|FG000|Treatment Period|Ineligibility determined|1
851087|NCT00415532|1809048|FG001|Treatment Period|Ineligibility determined|1
851088|NCT00415532|1809047|FG000|Treatment Period|Noncompliance|1
851089|NCT00415532|1809048|FG001|Treatment Period|Noncompliance|1
851090|NCT00415532|1809047|FG000|Treatment Period|Requirement for alternative therapy|1
851091|NCT00415532|1809048|FG001|Treatment Period|Requirement for alternative therapy|0
851092|NCT00415532|1809047|FG000|Safety Follow Up Period|Adverse Event|1
851093|NCT00415532|1809048|FG001|Safety Follow Up Period|Adverse Event|3
851094|NCT00415532|1809047|FG000|Safety Follow Up Period|Death|3
851095|NCT00415532|1809048|FG001|Safety Follow Up Period|Death|0
851096|NCT00415532|1809047|FG000|Safety Follow Up Period|Withdrawal by Subject|2
851097|NCT00415532|1809048|FG001|Safety Follow Up Period|Withdrawal by Subject|3
851098|NCT00415532|1809047|FG000|Safety Follow Up Period|Other|1
851099|NCT00415532|1809048|FG001|Safety Follow Up Period|Other|4
851100|NCT00415532|1809047|FG000|Safety Follow Up Period|Ineligibility determined|1
851101|NCT00415532|1809048|FG001|Safety Follow Up Period|Ineligibility determined|1
851102|NCT00415532|1809047|FG000|Safety Follow Up Period|Noncompliance|1
851103|NCT00415532|1809048|FG001|Safety Follow Up Period|Noncompliance|0
851104|NCT00415532|1809047|FG000|Safety Follow Up Period|Requirement for alternative therapy|0
851105|NCT00415532|1809048|FG001|Safety Follow Up Period|Requirement for alternative therapy|1
851106|NCT00415597|1809054|FG000|Enrollment|Withdrawal by Subject|1
851107|NCT00415597|1809054|FG000|Enrollment|Protocol Violation|1
851108|NCT00415597|1809054|FG000|Treatment|Adverse Event|110
851109|NCT00415597|1809054|FG000|Treatment|Lack of Efficacy|39
851110|NCT00415597|1809054|FG000|Treatment|Protocol Violation|67
851111|NCT00415597|1809054|FG000|Treatment|Physician Decision|3
851112|NCT00415597|1809054|FG000|Treatment|Withdrawal by Subject|51
851113|NCT00415597|1809054|FG000|Treatment|Lost to Follow-up|28
851114|NCT00415597|1809054|FG000|Treatment|Drug Screen|2
851115|NCT00415597|1809054|FG000|Treatment|Administrative|3
851116|NCT00415597|1809054|FG000|Treatment|Sponsor Decision|1
851117|NCT00415597|1809054|FG000|Treatment|Multiple Reasons|1
851118|NCT00415610|1809061|FG000|Overall Study|Death|3
851119|NCT00415610|1809062|FG001|Overall Study|Death|2
851120|NCT00415610|1809063|FG002|Overall Study|Death|5
851121|NCT00415623|1809073|FG000|Overall Study|Adverse Event|3
851122|NCT00415623|1809074|FG001|Overall Study|Adverse Event|4
851123|NCT00415623|1809073|FG000|Overall Study|Death|1
851124|NCT00415623|1809074|FG001|Overall Study|Death|0
851125|NCT00415623|1809073|FG000|Overall Study|Withdrawal by Subject|1
851126|NCT00415623|1809074|FG001|Overall Study|Withdrawal by Subject|1
851127|NCT00415636|1809087|FG000|Overall Study|Symptomatic deterioration|1
851128|NCT00415636|1809088|FG001|Overall Study|Symptomatic deterioration|0
851129|NCT00415636|1809089|FG002|Overall Study|Symptomatic deterioration|1
851130|NCT00415636|1809090|FG003|Overall Study|Symptomatic deterioration|2
851131|NCT00415636|1809091|FG004|Overall Study|Symptomatic deterioration|0
851132|NCT00415636|1809092|FG005|Overall Study|Symptomatic deterioration|1
851133|NCT00415636|1809087|FG000|Overall Study|Adverse Event|0
851134|NCT00415636|1809088|FG001|Overall Study|Adverse Event|0
851135|NCT00415636|1809089|FG002|Overall Study|Adverse Event|0
851136|NCT00415636|1809090|FG003|Overall Study|Adverse Event|1
851137|NCT00415636|1809091|FG004|Overall Study|Adverse Event|1
851138|NCT00415636|1809092|FG005|Overall Study|Adverse Event|0
851139|NCT00415636|1809087|FG000|Overall Study|Withdrawal by Subject|0
851140|NCT00415636|1809088|FG001|Overall Study|Withdrawal by Subject|0
851141|NCT00415636|1809089|FG002|Overall Study|Withdrawal by Subject|0
851142|NCT00415636|1809090|FG003|Overall Study|Withdrawal by Subject|0
851143|NCT00415636|1809091|FG004|Overall Study|Withdrawal by Subject|1
851144|NCT00415636|1809092|FG005|Overall Study|Withdrawal by Subject|0
851145|NCT00415636|1809087|FG000|Overall Study|Disease progression|0
851146|NCT00415636|1809088|FG001|Overall Study|Disease progression|0
851147|NCT00415636|1809089|FG002|Overall Study|Disease progression|0
851148|NCT00415636|1809090|FG003|Overall Study|Disease progression|3
851149|NCT00415636|1809091|FG004|Overall Study|Disease progression|0
851150|NCT00415636|1809092|FG005|Overall Study|Disease progression|1
851151|NCT00415909|1809132|FG000|Overall Study|Withdrawal by Subject|2
851152|NCT00415909|1809132|FG000|Overall Study|Death|1
851153|NCT00416078|1809138|FG000|Overall Study|Death|3
851154|NCT00416078|1809139|FG001|Overall Study|Death|4
851155|NCT00416078|1809138|FG000|Overall Study|Withdrawal by Subject|3
851156|NCT00416078|1809139|FG001|Overall Study|Withdrawal by Subject|2
851157|NCT00416078|1809138|FG000|Overall Study|Physician Decision|1
851158|NCT00416078|1809139|FG001|Overall Study|Physician Decision|0
851159|NCT00416078|1809138|FG000|Overall Study|Lost to Follow-up|4
851160|NCT00416078|1809139|FG001|Overall Study|Lost to Follow-up|2
851161|NCT00416195|1809162|FG000|Overall Study|Adverse Event|1
851162|NCT00416195|1809163|FG001|Overall Study|Adverse Event|2
851163|NCT00416195|1809162|FG000|Overall Study|Protocol Violation|1
851164|NCT00416195|1809163|FG001|Overall Study|Protocol Violation|1
851165|NCT00416195|1809162|FG000|Overall Study|Other|0
851166|NCT00416195|1809163|FG001|Overall Study|Other|1
851167|NCT00416312|1809169|FG000|Overall Study|tumors not visible on imaging|2
851168|NCT00416455|1809175|FG000|Overall Study|PET / CT not done|3
851169|NCT00416455|1809176|FG001|Overall Study|PET / CT not done|5
851170|NCT00416455|1809175|FG000|Overall Study|PET / CT poor quality|2
851171|NCT00416455|1809176|FG001|Overall Study|PET / CT poor quality|1
851172|NCT00416455|1809175|FG000|Overall Study|Inadequate pathology|11
851173|NCT00416455|1809176|FG001|Overall Study|Inadequate pathology|2
851174|NCT00416520|1809204|FG000|Open-label Period|Adverse Event|28
851175|NCT00416520|1809205|FG001|Open-label Period|Adverse Event|10
851176|NCT00416520|1809206|FG002|Open-label Period|Adverse Event|0
851177|NCT00416520|1809207|FG003|Open-label Period|Adverse Event|0
851178|NCT00416520|1809204|FG000|Open-label Period|Death|2
851179|NCT00416520|1809205|FG001|Open-label Period|Death|1
851180|NCT00416520|1809206|FG002|Open-label Period|Death|0
851181|NCT00416520|1809207|FG003|Open-label Period|Death|0
851182|NCT00416520|1809204|FG000|Open-label Period|Lack of Efficacy|8
851183|NCT00416520|1809205|FG001|Open-label Period|Lack of Efficacy|1
851184|NCT00416520|1809206|FG002|Open-label Period|Lack of Efficacy|0
851185|NCT00416520|1809207|FG003|Open-label Period|Lack of Efficacy|0
851186|NCT00416520|1809204|FG000|Open-label Period|Protocol Violation|3
851187|NCT00416520|1809205|FG001|Open-label Period|Protocol Violation|3
851188|NCT00416520|1809206|FG002|Open-label Period|Protocol Violation|0
851189|NCT00416520|1809207|FG003|Open-label Period|Protocol Violation|0
851190|NCT00416520|1809204|FG000|Open-label Period|Withdrawal by Subject|16
851191|NCT00416520|1809205|FG001|Open-label Period|Withdrawal by Subject|5
851192|NCT00416520|1809206|FG002|Open-label Period|Withdrawal by Subject|0
851193|NCT00416520|1809207|FG003|Open-label Period|Withdrawal by Subject|0
851194|NCT00416520|1809204|FG000|Open-label Period|Other Reasons|3
851195|NCT00416520|1809205|FG001|Open-label Period|Other Reasons|12
851196|NCT00416520|1809206|FG002|Open-label Period|Other Reasons|0
851197|NCT00416520|1809207|FG003|Open-label Period|Other Reasons|0
851198|NCT00416520|1809204|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0
851199|NCT00416520|1809205|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0
851200|NCT00416520|1809206|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0
851201|NCT00416520|1809207|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1
851202|NCT00416520|1809204|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
851203|NCT00416520|1809205|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
851204|NCT00416520|1809206|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
851205|NCT00416520|1809207|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
851206|NCT00416520|1809204|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0
851207|NCT00416520|1809205|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0
851208|NCT00416520|1809206|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1
851209|NCT00416520|1809207|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1
851210|NCT00416598|1809230|FG000|Induction & Intensification|Adverse Event|38
851211|NCT00416598|1809230|FG000|Induction & Intensification|Death|32
851212|NCT00416598|1809230|FG000|Induction & Intensification|Withdrawal by Subject|46
851213|NCT00416598|1809230|FG000|Induction & Intensification|Alternative Treatment|135
851214|NCT00416598|1809230|FG000|Induction & Intensification|Physician discretion/other medical issue|45
851215|NCT00416598|1809230|FG000|Induction & Intensification|Relapse/progression|29
851216|NCT00416598|1809230|FG000|Induction & Intensification|Failed induction|87
851217|NCT00416598|1809230|FG000|Decitabine Maintenance|Adverse Event|5
851218|NCT00416598|1809230|FG000|Decitabine Maintenance|Withdrawal by Subject|18
851219|NCT00416598|1809230|FG000|Decitabine Maintenance|Progression/relapse|38
851220|NCT00416598|1809230|FG000|Decitabine Maintenance|Alternative treatment|2
851221|NCT00416598|1809230|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9
851222|NCT00416624|1809238|FG000|Overall Study|Withdrawal by Subject|1
851223|NCT00416624|1809239|FG001|Overall Study|Withdrawal by Subject|6
851224|NCT00416624|1809240|FG002|Overall Study|Withdrawal by Subject|4
851225|NCT00416624|1809241|FG003|Overall Study|Withdrawal by Subject|9
851226|NCT00416624|1809238|FG000|Overall Study|Death|4
851227|NCT00416624|1809239|FG001|Overall Study|Death|7
851228|NCT00416624|1809240|FG002|Overall Study|Death|7
851229|NCT00416624|1809241|FG003|Overall Study|Death|1
851230|NCT00416624|1809238|FG000|Overall Study|Adverse Event|8
851231|NCT00416624|1809239|FG001|Overall Study|Adverse Event|3
851232|NCT00416624|1809240|FG002|Overall Study|Adverse Event|2
851233|NCT00416624|1809241|FG003|Overall Study|Adverse Event|2
851234|NCT00416624|1809238|FG000|Overall Study|Other|8
851235|NCT00416624|1809239|FG001|Overall Study|Other|11
851236|NCT00416624|1809240|FG002|Overall Study|Other|5
851237|NCT00416624|1809241|FG003|Overall Study|Other|5
851238|NCT00416624|1809238|FG000|Overall Study|Cancel|1
851239|NCT00416624|1809239|FG001|Overall Study|Cancel|0
851240|NCT00416624|1809240|FG002|Overall Study|Cancel|0
851241|NCT00416624|1809241|FG003|Overall Study|Cancel|0
851242|NCT00416715|1809251|FG000|Overall Study|Not evaluable for joint aches|7
851243|NCT00416715|1809251|FG000|Overall Study|Vitamin D levels not evaluable|8
851244|NCT00416884|1809262|FG000|Overall Study|Study terminated due to low accrual|1
851245|NCT00416949|1809266|FG000|Overall Study|Patients refused to participate|5
851246|NCT00417027|1809273|FG000|Overall Study|Protocol Violation|0
851247|NCT00417027|1809274|FG001|Overall Study|Protocol Violation|5
851248|NCT00417027|1809275|FG002|Overall Study|Protocol Violation|5
851249|NCT00417079|1809285|FG000|Overall Study|Disease progression|267
851250|NCT00417079|1809286|FG001|Overall Study|Disease progression|180
851251|NCT00417079|1809285|FG000|Overall Study|Adverse Event|32
851252|NCT00417079|1809286|FG001|Overall Study|Adverse Event|67
851253|NCT00417079|1809285|FG000|Overall Study|Non-compliance to protocol|0
851254|NCT00417079|1809286|FG001|Overall Study|Non-compliance to protocol|1
851255|NCT00417079|1809285|FG000|Overall Study|Lost to Follow-up|2
851256|NCT00417079|1809286|FG001|Overall Study|Lost to Follow-up|0
851257|NCT00417079|1809285|FG000|Overall Study|Withdrawal by Subject|17
851258|NCT00417079|1809286|FG001|Overall Study|Withdrawal by Subject|8
851259|NCT00417079|1809285|FG000|Overall Study|Not treated|6
851260|NCT00417079|1809286|FG001|Overall Study|Not treated|7
851261|NCT00417079|1809285|FG000|Overall Study|Screened failure|2
851262|NCT00417079|1809286|FG001|Overall Study|Screened failure|1
851263|NCT00417079|1809285|FG000|Overall Study|Investigator's decision|1
851264|NCT00417079|1809286|FG001|Overall Study|Investigator's decision|4
851265|NCT00417079|1809285|FG000|Overall Study|Non-confirmed Disease progression|1
851266|NCT00417079|1809286|FG001|Overall Study|Non-confirmed Disease progression|1
851267|NCT00417079|1809285|FG000|Overall Study|Clinical deterioration|1
851268|NCT00417079|1809286|FG001|Overall Study|Clinical deterioration|0
851269|NCT00417079|1809285|FG000|Overall Study|Screening error|2
851270|NCT00417079|1809286|FG001|Overall Study|Screening error|1
851271|NCT00417079|1809285|FG000|Overall Study|Withdrawal by subject's family|0
851272|NCT00417079|1809286|FG001|Overall Study|Withdrawal by subject's family|1
851273|NCT00417079|1809285|FG000|Overall Study|Patient unable to come to the clinic|0
851274|NCT00417079|1809286|FG001|Overall Study|Patient unable to come to the clinic|1
851275|NCT00417079|1809285|FG000|Overall Study|abnormal liver function tests|0
851276|NCT00417079|1809286|FG001|Overall Study|abnormal liver function tests|1
851277|NCT00417170|1809294|FG000|Overall Study|Adverse Event|1
851278|NCT00417170|1809295|FG001|Overall Study|Adverse Event|1
851279|NCT00417170|1809294|FG000|Overall Study|Withdrawal by Subject|1
851280|NCT00417170|1809295|FG001|Overall Study|Withdrawal by Subject|1
851281|NCT00417170|1809294|FG000|Overall Study|Lost to Follow-up|0
851282|NCT00417170|1809295|FG001|Overall Study|Lost to Follow-up|1
851283|NCT00417482|1809319|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14
851284|NCT00417482|1809320|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8
851285|NCT00417482|1809321|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24
851286|NCT00417482|1809319|FG000|Phase B 1st 16 Weeks|Adverse Event|2
851287|NCT00417482|1809320|FG001|Phase B 1st 16 Weeks|Adverse Event|0
851288|NCT00417482|1809321|FG002|Phase B 1st 16 Weeks|Adverse Event|1
851289|NCT00417482|1809319|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
851290|NCT00417482|1809320|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
851291|NCT00417482|1809321|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
851292|NCT00417482|1809319|FG000|Phase B 1st 16 Weeks|Death|1
851293|NCT00417482|1809320|FG001|Phase B 1st 16 Weeks|Death|0
851294|NCT00417482|1809321|FG002|Phase B 1st 16 Weeks|Death|0
851295|NCT00417482|1809319|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1
851296|NCT00417482|1809320|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12
851297|NCT00417482|1809321|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2
851298|NCT00417482|1809319|FG000|Phase B 2nd 16 Weeks|Adverse Event|0
851299|NCT00417482|1809320|FG001|Phase B 2nd 16 Weeks|Adverse Event|0
851300|NCT00417482|1809321|FG002|Phase B 2nd 16 Weeks|Adverse Event|1
851301|NCT00417482|1809319|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1
851302|NCT00417482|1809320|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0
851303|NCT00417482|1809321|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0
851304|NCT00417482|1809319|FG000|Phase B 2nd 16 Weeks|Death|1
851305|NCT00417482|1809320|FG001|Phase B 2nd 16 Weeks|Death|1
851306|NCT00417482|1809321|FG002|Phase B 2nd 16 Weeks|Death|0
851307|NCT00417612|1809337|FG000|Overall Study|Errant diagnosis|0
851308|NCT00417612|1809338|FG001|Overall Study|Errant diagnosis|1
851309|NCT00417612|1809337|FG000|Overall Study|Adverse Event|2
851310|NCT00417612|1809338|FG001|Overall Study|Adverse Event|0
851311|NCT00417612|1809337|FG000|Overall Study|Protocol Violation|0
851312|NCT00417612|1809338|FG001|Overall Study|Protocol Violation|2
851313|NCT00417612|1809337|FG000|Overall Study|Lost to Follow-up|1
851314|NCT00417612|1809338|FG001|Overall Study|Lost to Follow-up|0
851315|NCT00417885|1809357|FG000|Overall Study|Adverse Event|1
851316|NCT00417885|1809357|FG000|Overall Study|Objective Progression or Relapse|3
851317|NCT00417885|1809357|FG000|Overall Study|Transferred to Another Sunitinib Study|2
851318|NCT00417963|1809361|FG000|Overall Study|Lost to Follow-up|3
851319|NCT00417963|1809361|FG000|Overall Study|Withdrawal by Subject|18
851320|NCT00417963|1809361|FG000|Overall Study|Death|17
851321|NCT00417963|1809361|FG000|Overall Study|Study device could not be deployed|3
851322|NCT00417976|1809370|FG000|Overall Study|Non compliance unrelated to toxicity|1
851323|NCT00417976|1809370|FG000|Overall Study|Treatment -related toxicity|2
851324|NCT00417989|1809377|FG000|Overall Study|Withdrawal by Subject|13
851325|NCT00417989|1809378|FG001|Overall Study|Withdrawal by Subject|13
851326|NCT00417989|1809377|FG000|Overall Study|Lost to Follow-up|1
851327|NCT00417989|1809378|FG001|Overall Study|Lost to Follow-up|6
851328|NCT00417989|1809377|FG000|Overall Study|Protocol Violation|1
851329|NCT00417989|1809378|FG001|Overall Study|Protocol Violation|0
851330|NCT00417989|1809377|FG000|Overall Study|Death|0
851331|NCT00417989|1809378|FG001|Overall Study|Death|1
851332|NCT00417989|1809377|FG000|Overall Study|Physician Decision|5
851333|NCT00417989|1809378|FG001|Overall Study|Physician Decision|2
851334|NCT00418184|1809418|FG000|Double-blind Phase|Withdrawal by Subject|22
851335|NCT00418184|1809419|FG001|Double-blind Phase|Withdrawal by Subject|9
851336|NCT00418184|1809418|FG000|Double-blind Phase|Adverse Event|2
851337|NCT00418184|1809419|FG001|Double-blind Phase|Adverse Event|1
851338|NCT00418184|1809418|FG000|Double-blind Phase|Poor compliance|3
851339|NCT00418184|1809419|FG001|Double-blind Phase|Poor compliance|1
851340|NCT00418314|1809435|FG000|Overall Study|Withdrawal by Subject|1
851341|NCT00418314|1809436|FG001|Overall Study|Withdrawal by Subject|2
851342|NCT00418379|1809445|FG000|Year 1|Adverse Event|9
851343|NCT00418379|1809446|FG001|Year 1|Adverse Event|15
851344|NCT00418379|1809447|FG002|Year 1|Adverse Event|3
851345|NCT00418379|1809445|FG000|Year 1|Withdrawal by Subject|7
851346|NCT00418379|1809446|FG001|Year 1|Withdrawal by Subject|8
851347|NCT00418379|1809447|FG002|Year 1|Withdrawal by Subject|5
851348|NCT00418379|1809445|FG000|Year 1|Any other reason not above-mentioned|2
851349|NCT00418379|1809446|FG001|Year 1|Any other reason not above-mentioned|5
851350|NCT00418379|1809447|FG002|Year 1|Any other reason not above-mentioned|7
851351|NCT00418379|1809445|FG000|Year 2|Adverse Event|5
851352|NCT00418379|1809446|FG001|Year 2|Adverse Event|2
851353|NCT00418379|1809447|FG002|Year 2|Adverse Event|1
851354|NCT00418379|1809445|FG000|Year 2|Withdrawal by Subject|1
851355|NCT00418379|1809446|FG001|Year 2|Withdrawal by Subject|1
851356|NCT00418379|1809447|FG002|Year 2|Withdrawal by Subject|3
851357|NCT00418379|1809445|FG000|Year 2|Any other reason not above-mentioned|2
851358|NCT00418379|1809446|FG001|Year 2|Any other reason not above-mentioned|1
851359|NCT00418379|1809447|FG002|Year 2|Any other reason not above-mentioned|6
851360|NCT00418379|1809445|FG000|Year 3|Withdrawal by Subject|1
851361|NCT00418379|1809446|FG001|Year 3|Withdrawal by Subject|1
851362|NCT00418379|1809447|FG002|Year 3|Withdrawal by Subject|2
851363|NCT00418379|1809445|FG000|Year 3|Any other reason not above-mentioned|2
851364|NCT00418379|1809446|FG001|Year 3|Any other reason not above-mentioned|1
851365|NCT00418379|1809447|FG002|Year 3|Any other reason not above-mentioned|1
851366|NCT00418379|1809445|FG000|Year 4|Adverse Event|0
851367|NCT00418379|1809446|FG001|Year 4|Adverse Event|1
851368|NCT00418379|1809447|FG002|Year 4|Adverse Event|0
851369|NCT00418379|1809445|FG000|Year 4|Withdrawal by Subject|2
851370|NCT00418379|1809446|FG001|Year 4|Withdrawal by Subject|3
851371|NCT00418379|1809447|FG002|Year 4|Withdrawal by Subject|2
851372|NCT00418379|1809445|FG000|Year 4|Any other reason not above-mentioned|1
851373|NCT00418379|1809446|FG001|Year 4|Any other reason not above-mentioned|1
851374|NCT00418379|1809447|FG002|Year 4|Any other reason not above-mentioned|0
851375|NCT00418379|1809445|FG000|Year 5|Adverse Event|0
851376|NCT00418379|1809446|FG001|Year 5|Adverse Event|1
851377|NCT00418379|1809447|FG002|Year 5|Adverse Event|0
851378|NCT00418379|1809445|FG000|Year 5|Any other reason not above-mentioned|2
851379|NCT00418379|1809446|FG001|Year 5|Any other reason not above-mentioned|4
851380|NCT00418379|1809447|FG002|Year 5|Any other reason not above-mentioned|3
851381|NCT00418522|1809466|FG000|Overall Study|Adverse Event|7
851382|NCT00418522|1809467|FG001|Overall Study|Adverse Event|1
851383|NCT00418522|1809466|FG000|Overall Study|Lack of Efficacy|1
851384|NCT00418522|1809467|FG001|Overall Study|Lack of Efficacy|3
851385|NCT00418522|1809466|FG000|Overall Study|Lost to Follow-up|10
851386|NCT00418522|1809467|FG001|Overall Study|Lost to Follow-up|4
851387|NCT00418522|1809466|FG000|Overall Study|Withdrawal by Subject|31
851388|NCT00418522|1809467|FG001|Overall Study|Withdrawal by Subject|7
851389|NCT00418522|1809466|FG000|Overall Study|Other|27
851390|NCT00418522|1809467|FG001|Overall Study|Other|23
851391|NCT00418522|1809466|FG000|Overall Study|Randomized but did not receive treatment|7
851392|NCT00418522|1809467|FG001|Overall Study|Randomized but did not receive treatment|4
851393|NCT00418561|1809476|FG000|Overall Study|Participant's (guardian's) decision|0
851394|NCT00418561|1809477|FG001|Overall Study|Participant's (guardian's) decision|1
851395|NCT00418561|1809478|FG002|Overall Study|Participant's (guardian's) decision|0
851396|NCT00418665|1809498|FG000|Treatment Period|Ineligibility determined|1
851397|NCT00418665|1809499|FG001|Treatment Period|Ineligibility determined|1
851398|NCT00418665|1809500|FG002|Treatment Period|Ineligibility determined|0
851399|NCT00418665|1809498|FG000|Treatment Period|Adverse Event|2
851400|NCT00418665|1809499|FG001|Treatment Period|Adverse Event|2
851401|NCT00418665|1809500|FG002|Treatment Period|Adverse Event|0
851402|NCT00418665|1809498|FG000|Treatment Period|Withdrawal by Subject|0
851403|NCT00418665|1809499|FG001|Treatment Period|Withdrawal by Subject|3
851404|NCT00418665|1809500|FG002|Treatment Period|Withdrawal by Subject|1
851405|NCT00418665|1809498|FG000|Treatment Period|Requirement for alternative therapy|1
851406|NCT00418665|1809499|FG001|Treatment Period|Requirement for alternative therapy|0
851407|NCT00418665|1809500|FG002|Treatment Period|Requirement for alternative therapy|0
851408|NCT00418665|1809498|FG000|Treatment Period|Physician Decision|1
851409|NCT00418665|1809499|FG001|Treatment Period|Physician Decision|0
851410|NCT00418665|1809500|FG002|Treatment Period|Physician Decision|3
851411|NCT00418665|1809498|FG000|Treatment Extension|Adverse Event|1
851412|NCT00418665|1809499|FG001|Treatment Extension|Adverse Event|0
851413|NCT00418665|1809500|FG002|Treatment Extension|Adverse Event|0
851414|NCT00418665|1809498|FG000|Treatment Extension|Withdrawal by Subject|1
851415|NCT00418665|1809499|FG001|Treatment Extension|Withdrawal by Subject|0
851416|NCT00418665|1809500|FG002|Treatment Extension|Withdrawal by Subject|0
851417|NCT00418665|1809498|FG000|Treatment Extension|Requirement for alternative therapy|2
851418|NCT00418665|1809499|FG001|Treatment Extension|Requirement for alternative therapy|2
851419|NCT00418665|1809500|FG002|Treatment Extension|Requirement for alternative therapy|0
851420|NCT00418665|1809498|FG000|Treatment Extension|Physician Decision|2
851421|NCT00418665|1809499|FG001|Treatment Extension|Physician Decision|2
851422|NCT00418665|1809500|FG002|Treatment Extension|Physician Decision|1
851423|NCT00418665|1809498|FG000|Treatment Extension|Death|0
851424|NCT00418665|1809499|FG001|Treatment Extension|Death|0
851425|NCT00418665|1809500|FG002|Treatment Extension|Death|1
851426|NCT00418691|1809511|FG000|Overall Study|Lost to Follow-up|1
851427|NCT00418691|1809512|FG001|Overall Study|Lost to Follow-up|2
851428|NCT00418691|1809513|FG002|Overall Study|Lost to Follow-up|3
851429|NCT00418691|1809511|FG000|Overall Study|Started new medication voiding entry|0
851430|NCT00418691|1809512|FG001|Overall Study|Started new medication voiding entry|0
851431|NCT00418691|1809513|FG002|Overall Study|Started new medication voiding entry|1
851432|NCT00418691|1809511|FG000|Overall Study|Progressive Disease|1
851433|NCT00418691|1809512|FG001|Overall Study|Progressive Disease|0
851434|NCT00418691|1809513|FG002|Overall Study|Progressive Disease|1
851435|NCT00418717|1809521|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1
851436|NCT00418717|1809521|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2
851437|NCT00418834|1809527|FG000|Overall Study|Adverse Event|16
851438|NCT00418834|1809528|FG001|Overall Study|Adverse Event|9
851439|NCT00418834|1809527|FG000|Overall Study|Lost to Follow-up|0
851440|NCT00418834|1809528|FG001|Overall Study|Lost to Follow-up|1
851441|NCT00418834|1809527|FG000|Overall Study|Protocol Violation|4
851442|NCT00418834|1809528|FG001|Overall Study|Protocol Violation|3
851443|NCT00418834|1809527|FG000|Overall Study|Withdrawal by Subject|3
851444|NCT00418834|1809528|FG001|Overall Study|Withdrawal by Subject|7
851445|NCT00418886|1809536|FG000|Overall Study|discontinue treatment survival follow up|90
851446|NCT00418886|1809537|FG001|Overall Study|discontinue treatment survival follow up|91
851447|NCT00418886|1809536|FG000|Overall Study|Death|122
851448|NCT00418886|1809537|FG001|Overall Study|Death|147
851449|NCT00418886|1809536|FG000|Overall Study|Withdrawal by Subject|9
851450|NCT00418886|1809537|FG001|Overall Study|Withdrawal by Subject|10
851451|NCT00418886|1809536|FG000|Overall Study|Lost to Follow-up|4
851452|NCT00418886|1809537|FG001|Overall Study|Lost to Follow-up|6
851453|NCT00418886|1809536|FG000|Overall Study|withdrawn due to other reason|1
851454|NCT00418886|1809537|FG001|Overall Study|withdrawn due to other reason|0
851455|NCT00418886|1809536|FG000|Overall Study|randomised but no treatment received|0
851456|NCT00418886|1809537|FG001|Overall Study|randomised but no treatment received|1
851457|NCT00418938|1809545|FG000|Overall Study|Reimbursement|1
851458|NCT00418938|1809546|FG001|Overall Study|Reimbursement|0
851459|NCT00418938|1809545|FG000|Overall Study|Administrative decision|3
851460|NCT00418938|1809546|FG001|Overall Study|Administrative decision|3
851461|NCT00418938|1809545|FG000|Overall Study|Withdrawal by Subject|16
851462|NCT00418938|1809546|FG001|Overall Study|Withdrawal by Subject|15
851463|NCT00418938|1809545|FG000|Overall Study|Lost to Follow-up|1
851464|NCT00418938|1809546|FG001|Overall Study|Lost to Follow-up|3
851465|NCT00418938|1809545|FG000|Overall Study|Adverse Event|1
851466|NCT00418938|1809546|FG001|Overall Study|Adverse Event|1
851467|NCT00418938|1809545|FG000|Overall Study|On-going|1
851468|NCT00418938|1809546|FG001|Overall Study|On-going|1
851469|NCT00418938|1809545|FG000|Overall Study|Ineligibility Determined|1
851470|NCT00418938|1809546|FG001|Overall Study|Ineligibility Determined|0
851471|NCT00419003|1809589|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6
851472|NCT00419003|1809590|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6
851473|NCT00419003|1809589|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
851474|NCT00419003|1809590|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
851475|NCT00419094|1809601|FG000|Overall Study|Adverse Event|3
851476|NCT00419094|1809602|FG001|Overall Study|Adverse Event|7
851477|NCT00419094|1809601|FG000|Overall Study|Lack of Efficacy|1
851478|NCT00419094|1809602|FG001|Overall Study|Lack of Efficacy|0
851479|NCT00419094|1809601|FG000|Overall Study|Lost to Follow-up|0
851480|NCT00419094|1809602|FG001|Overall Study|Lost to Follow-up|2
851481|NCT00419094|1809601|FG000|Overall Study|Protocol Violation|1
851482|NCT00419094|1809602|FG001|Overall Study|Protocol Violation|14
851483|NCT00419094|1809601|FG000|Overall Study|Withdrawal of consent|1
851484|NCT00419094|1809602|FG001|Overall Study|Withdrawal of consent|5
851485|NCT00419094|1809601|FG000|Overall Study|Other: Error determining exit criteria|1
851486|NCT00419094|1809602|FG001|Overall Study|Other: Error determining exit criteria|0
851487|NCT00419094|1809601|FG000|Overall Study|Other: Patient non-compliant|0
851488|NCT00419094|1809602|FG001|Overall Study|Other: Patient non-compliant|1
851489|NCT00419094|1809601|FG000|Overall Study|Other: No contact for extended period|0
851490|NCT00419094|1809602|FG001|Overall Study|Other: No contact for extended period|1
851491|NCT00419120|1809608|FG000|Long Term Follow up Period|study ongoing|10
851492|NCT00419159|1809614|FG000|Overall Study|Adverse Event|7
851493|NCT00419159|1809615|FG001|Overall Study|Adverse Event|15
851494|NCT00419159|1809614|FG000|Overall Study|Abnormal laboratory value(s)|0
851495|NCT00419159|1809615|FG001|Overall Study|Abnormal laboratory value(s)|2
851496|NCT00419159|1809614|FG000|Overall Study|Subject's no longer requires study drug|0
851497|NCT00419159|1809615|FG001|Overall Study|Subject's no longer requires study drug|1
851498|NCT00419159|1809614|FG000|Overall Study|Protocol Violation|1
851499|NCT00419159|1809615|FG001|Overall Study|Protocol Violation|0
851500|NCT00419159|1809614|FG000|Overall Study|Withdrawal by Subject|10
851501|NCT00419159|1809615|FG001|Overall Study|Withdrawal by Subject|3
851502|NCT00419159|1809614|FG000|Overall Study|Lost to Follow-up|0
851503|NCT00419159|1809615|FG001|Overall Study|Lost to Follow-up|1
851504|NCT00419159|1809614|FG000|Overall Study|Death|2
851505|NCT00419159|1809615|FG001|Overall Study|Death|2
851506|NCT00419159|1809614|FG000|Overall Study|Disease progression|79
851507|NCT00419159|1809615|FG001|Overall Study|Disease progression|76
851508|NCT00419263|1809632|FG000|Overall Study|Lost to Follow-up|2
851509|NCT00419263|1809633|FG001|Overall Study|Lost to Follow-up|1
851510|NCT00419263|1809634|FG002|Overall Study|Lost to Follow-up|1
851511|NCT00419263|1809632|FG000|Overall Study|Randomized in Error, Not Treated|1
851512|NCT00419263|1809633|FG001|Overall Study|Randomized in Error, Not Treated|1
851513|NCT00419263|1809634|FG002|Overall Study|Randomized in Error, Not Treated|0
851514|NCT00419263|1809632|FG000|Overall Study|Adverse Event|0
851515|NCT00419263|1809633|FG001|Overall Study|Adverse Event|0
851516|NCT00419263|1809634|FG002|Overall Study|Adverse Event|1
851517|NCT00419263|1809632|FG000|Overall Study|Withdrawal by Subject|0
851518|NCT00419263|1809633|FG001|Overall Study|Withdrawal by Subject|0
851519|NCT00419263|1809634|FG002|Overall Study|Withdrawal by Subject|1
851520|NCT00419341|1809652|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8
851521|NCT00419341|1809652|FG000|Wash in/Wash Out Period|Adverse Event|2
851522|NCT00419341|1809652|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1
851523|NCT00419341|1809652|FG000|Efficacy Period|Withdrawal by Subject|6
851524|NCT00419341|1809652|FG000|Efficacy Period|Protocol Violation|1
851525|NCT00419341|1809652|FG000|Efficacy Period|Lost to Follow-up|1
851526|NCT00419341|1809652|FG000|Efficacy Period|Non-compliance|1
851527|NCT00419341|1809652|FG000|Efficacy Period|Termination of study site|1
851528|NCT00419380|1809660|FG000|Overall Study|Lack of Efficacy|1
851529|NCT00419380|1809661|FG001|Overall Study|Lack of Efficacy|7
851530|NCT00419380|1809660|FG000|Overall Study|Physician Decision|0
851531|NCT00419380|1809661|FG001|Overall Study|Physician Decision|1
851532|NCT00419380|1809660|FG000|Overall Study|Lost to Follow-up|0
851533|NCT00419380|1809661|FG001|Overall Study|Lost to Follow-up|1
851534|NCT00419380|1809660|FG000|Overall Study|Withdrawal by Subject|0
851535|NCT00419380|1809661|FG001|Overall Study|Withdrawal by Subject|1
851536|NCT00419393|1809667|FG000|Overall Study|Adverse Event|5
851537|NCT00419393|1809667|FG000|Overall Study|Protocol Violation|5
851538|NCT00419393|1809667|FG000|Overall Study|Withdrawal by Subject|7
851539|NCT00419393|1809667|FG000|Overall Study|Other: Sponsor request|3
851540|NCT00419393|1809667|FG000|Overall Study|Other: Subject had temporal lobectomy|1
851541|NCT00419393|1809667|FG000|Overall Study|Other: Site closure|1
851542|NCT00419393|1809667|FG000|Overall Study|Other: Other health problems|1
851543|NCT00419393|1809667|FG000|Overall Study|Other: Investigator decision|1
851544|NCT00419562|1809686|FG000|Overall Study|Lost to Follow-up|12
851545|NCT00419562|1809687|FG001|Overall Study|Lost to Follow-up|13
851546|NCT00419562|1809686|FG000|Overall Study|Withdrawal by Subject|20
851547|NCT00419562|1809687|FG001|Overall Study|Withdrawal by Subject|18
851548|NCT00419562|1809686|FG000|Overall Study|Participant Institutionalized|1
851549|NCT00419562|1809687|FG001|Overall Study|Participant Institutionalized|0
851550|NCT00419744|1809700|FG000|Overall Study|Adverse Event|39
851551|NCT00419744|1809701|FG001|Overall Study|Adverse Event|40
851552|NCT00419744|1809702|FG002|Overall Study|Adverse Event|50
851553|NCT00419744|1809700|FG000|Overall Study|Withdrawal by Subject|45
851554|NCT00419744|1809701|FG001|Overall Study|Withdrawal by Subject|49
851555|NCT00419744|1809702|FG002|Overall Study|Withdrawal by Subject|52
851556|NCT00419744|1809700|FG000|Overall Study|Lost to Follow-up|8
851557|NCT00419744|1809701|FG001|Overall Study|Lost to Follow-up|10
851558|NCT00419744|1809702|FG002|Overall Study|Lost to Follow-up|6
851559|NCT00419744|1809700|FG000|Overall Study|Protocol Violation|4
851560|NCT00419744|1809701|FG001|Overall Study|Protocol Violation|7
851561|NCT00419744|1809702|FG002|Overall Study|Protocol Violation|8
851562|NCT00419744|1809700|FG000|Overall Study|Randomized in error|9
851563|NCT00419744|1809701|FG001|Overall Study|Randomized in error|6
851564|NCT00419744|1809702|FG002|Overall Study|Randomized in error|7
851565|NCT00419744|1809700|FG000|Overall Study|Moving out of state|2
851566|NCT00419744|1809701|FG001|Overall Study|Moving out of state|0
851567|NCT00419744|1809702|FG002|Overall Study|Moving out of state|1
851568|NCT00419744|1809700|FG000|Overall Study|Physician Decision|10
851569|NCT00419744|1809701|FG001|Overall Study|Physician Decision|5
851570|NCT00419744|1809702|FG002|Overall Study|Physician Decision|6
851571|NCT00419744|1809700|FG000|Overall Study|Spirometry mouthpiece issues|0
851572|NCT00419744|1809701|FG001|Overall Study|Spirometry mouthpiece issues|1
851573|NCT00419744|1809702|FG002|Overall Study|Spirometry mouthpiece issues|2
851574|NCT00419744|1809700|FG000|Overall Study|Incorrect medication kit dispensed|0
851575|NCT00419744|1809701|FG001|Overall Study|Incorrect medication kit dispensed|0
851576|NCT00419744|1809702|FG002|Overall Study|Incorrect medication kit dispensed|1
851577|NCT00419757|1809712|FG000|Overall Study|Adverse Event|1
851578|NCT00419757|1809713|FG001|Overall Study|Adverse Event|4
851579|NCT00419757|1809712|FG000|Overall Study|Lost to Follow-up|1
851580|NCT00419757|1809713|FG001|Overall Study|Lost to Follow-up|4
851581|NCT00419757|1809712|FG000|Overall Study|Withdrawal by Subject|7
851582|NCT00419757|1809713|FG001|Overall Study|Withdrawal by Subject|1
851583|NCT00419757|1809712|FG000|Overall Study|Protocol Violation|2
851584|NCT00419757|1809713|FG001|Overall Study|Protocol Violation|3
851585|NCT00419757|1809712|FG000|Overall Study|Study specific discontinuation criteria|4
851586|NCT00419757|1809713|FG001|Overall Study|Study specific discontinuation criteria|8
851587|NCT00419757|1809712|FG000|Overall Study|Multiple reasons|3
851588|NCT00419757|1809713|FG001|Overall Study|Multiple reasons|1
851589|NCT00419770|1809723|FG000|Overall Study|Withdrawal by Subject|5
851590|NCT00419770|1809724|FG001|Overall Study|Withdrawal by Subject|1
851591|NCT00419926|1809732|FG000|Overall Study|Withdrawal by Subject|7
851592|NCT00419926|1809733|FG001|Overall Study|Withdrawal by Subject|3
851593|NCT00419926|1809732|FG000|Overall Study|Administrative Problem|4
851594|NCT00419926|1809733|FG001|Overall Study|Administrative Problem|4
851595|NCT00419926|1809732|FG000|Overall Study|Lost to Follow-up|1
851596|NCT00419926|1809733|FG001|Overall Study|Lost to Follow-up|2
851597|NCT00419926|1809732|FG000|Overall Study|Death|2
851598|NCT00419926|1809733|FG001|Overall Study|Death|1
851599|NCT00419952|1809741|FG000|Overall Study|Adverse Event|8
851600|NCT00419952|1809742|FG001|Overall Study|Adverse Event|10
851601|NCT00419952|1809741|FG000|Overall Study|Withdrawal by Subject|44
851602|NCT00419952|1809742|FG001|Overall Study|Withdrawal by Subject|43
851603|NCT00419952|1809741|FG000|Overall Study|Lost to Follow-up|43
851604|NCT00419952|1809742|FG001|Overall Study|Lost to Follow-up|34
851605|NCT00419952|1809741|FG000|Overall Study|Protocol Violation|32
851606|NCT00419952|1809742|FG001|Overall Study|Protocol Violation|24
851607|NCT00419952|1809741|FG000|Overall Study|Pregnancy|4
851608|NCT00419952|1809742|FG001|Overall Study|Pregnancy|2
851609|NCT00419952|1809741|FG000|Overall Study|Physician Decision|1
851610|NCT00419952|1809742|FG001|Overall Study|Physician Decision|3
851611|NCT00419952|1809741|FG000|Overall Study|Incorrectly enrolled|10
851612|NCT00419952|1809742|FG001|Overall Study|Incorrectly enrolled|3
851613|NCT00419952|1809741|FG000|Overall Study|Intake of prohibited medication|2
851614|NCT00419952|1809742|FG001|Overall Study|Intake of prohibited medication|2
851615|NCT00419952|1809741|FG000|Overall Study|Occurence of 2 or more exacerbations|2
851616|NCT00419952|1809742|FG001|Overall Study|Occurence of 2 or more exacerbations|0
851617|NCT00419952|1809741|FG000|Overall Study|Diary or medication non-compliance|2
851618|NCT00419952|1809742|FG001|Overall Study|Diary or medication non-compliance|4
851619|NCT00419952|1809741|FG000|Overall Study|Abnormal ECG|1
851620|NCT00419952|1809742|FG001|Overall Study|Abnormal ECG|0
851621|NCT00420004|1809751|FG000|Overall Study|Adverse Event|4
851622|NCT00420004|1809752|FG001|Overall Study|Adverse Event|1
851623|NCT00420004|1809753|FG002|Overall Study|Adverse Event|1
851624|NCT00420004|1809751|FG000|Overall Study|Lack of Efficacy|5
851625|NCT00420004|1809752|FG001|Overall Study|Lack of Efficacy|4
851626|NCT00420004|1809753|FG002|Overall Study|Lack of Efficacy|1
851627|NCT00420004|1809751|FG000|Overall Study|Lost to Follow-up|31
851628|NCT00420004|1809752|FG001|Overall Study|Lost to Follow-up|12
851629|NCT00420004|1809753|FG002|Overall Study|Lost to Follow-up|10
851630|NCT00420004|1809751|FG000|Overall Study|Entry Criteria Not Met|0
851631|NCT00420004|1809752|FG001|Overall Study|Entry Criteria Not Met|1
851632|NCT00420004|1809753|FG002|Overall Study|Entry Criteria Not Met|0
851633|NCT00420004|1809751|FG000|Overall Study|Physician Decision|14
851634|NCT00420004|1809752|FG001|Overall Study|Physician Decision|4
851635|NCT00420004|1809753|FG002|Overall Study|Physician Decision|2
851636|NCT00420004|1809751|FG000|Overall Study|Protocol Violation|5
851637|NCT00420004|1809752|FG001|Overall Study|Protocol Violation|4
851638|NCT00420004|1809753|FG002|Overall Study|Protocol Violation|3
851639|NCT00420004|1809751|FG000|Overall Study|Withdrawal by Subject|67
851640|NCT00420004|1809752|FG001|Overall Study|Withdrawal by Subject|42
851641|NCT00420004|1809753|FG002|Overall Study|Withdrawal by Subject|14
851642|NCT00420004|1809751|FG000|Overall Study|Sponsor Decision|3
851643|NCT00420004|1809752|FG001|Overall Study|Sponsor Decision|3
851644|NCT00420004|1809753|FG002|Overall Study|Sponsor Decision|1
851645|NCT00420056|1809774|FG000|Overall Study|Objective progression or relapse|17
851646|NCT00420095|1809780|FG000|Overall Study|Adverse Event|1
851647|NCT00420095|1809781|FG001|Overall Study|Adverse Event|0
851648|NCT00420095|1809780|FG000|Overall Study|Protocol Violation|1
851649|NCT00420095|1809781|FG001|Overall Study|Protocol Violation|1
851650|NCT00420095|1809780|FG000|Overall Study|Lost to Follow-up|1
851651|NCT00420095|1809781|FG001|Overall Study|Lost to Follow-up|0
851652|NCT00420199|1809798|FG000|Overall Study|Participant no longer met study criteria|1
851653|NCT00420199|1809799|FG001|Overall Study|Participant no longer met study criteria|0
851654|NCT00420212|1809813|FG000|Overall Study|Adverse Event|22
851655|NCT00420212|1809814|FG001|Overall Study|Adverse Event|40
851656|NCT00420212|1809815|FG002|Overall Study|Adverse Event|36
851657|NCT00420212|1809813|FG000|Overall Study|Lost to Follow-up|9
851658|NCT00420212|1809814|FG001|Overall Study|Lost to Follow-up|11
851659|NCT00420212|1809815|FG002|Overall Study|Lost to Follow-up|11
851660|NCT00420212|1809813|FG000|Overall Study|Withdrawal by Subject|31
851661|NCT00420212|1809814|FG001|Overall Study|Withdrawal by Subject|22
851662|NCT00420212|1809815|FG002|Overall Study|Withdrawal by Subject|19
851663|NCT00420212|1809813|FG000|Overall Study|Physician Decision|4
851664|NCT00420212|1809814|FG001|Overall Study|Physician Decision|4
851665|NCT00420212|1809815|FG002|Overall Study|Physician Decision|3
851666|NCT00420212|1809813|FG000|Overall Study|Protocol Violation|4
851667|NCT00420212|1809814|FG001|Overall Study|Protocol Violation|4
851668|NCT00420212|1809815|FG002|Overall Study|Protocol Violation|8
851669|NCT00420212|1809813|FG000|Overall Study|Death|0
851670|NCT00420212|1809814|FG001|Overall Study|Death|0
851671|NCT00420212|1809815|FG002|Overall Study|Death|1
851672|NCT00420212|1809813|FG000|Overall Study|Other-Unspecified|21
851673|NCT00420212|1809814|FG001|Overall Study|Other-Unspecified|14
851674|NCT00420212|1809815|FG002|Overall Study|Other-Unspecified|18
851675|NCT00420238|1809828|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1
851676|NCT00420238|1809829|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0
851677|NCT00420238|1809828|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
851678|NCT00420238|1809829|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
851679|NCT00420238|1809828|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
851680|NCT00420238|1809829|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
851681|NCT00420238|1809828|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
851682|NCT00420238|1809829|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
851683|NCT00420238|1809828|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
851684|NCT00420238|1809829|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
851685|NCT00420238|1809828|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
851686|NCT00420238|1809829|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
851687|NCT00420290|1809843|FG000|Overall Study|Adverse Event|3
851688|NCT00420290|1809844|FG001|Overall Study|Adverse Event|1
851689|NCT00420290|1809843|FG000|Overall Study|Withdrawal by Subject|0
851690|NCT00420290|1809844|FG001|Overall Study|Withdrawal by Subject|2
851691|NCT00420290|1809843|FG000|Overall Study|did not meet inclusion/exclusion|1
851692|NCT00420290|1809844|FG001|Overall Study|did not meet inclusion/exclusion|1
851693|NCT00420303|1809852|FG000|Overall Study|Serious Adverse Event|1
851694|NCT00420303|1809853|FG001|Overall Study|Serious Adverse Event|0
851695|NCT00420303|1809852|FG000|Overall Study|Lack of Efficacy|0
851696|NCT00420303|1809853|FG001|Overall Study|Lack of Efficacy|3
851697|NCT00420303|1809852|FG000|Overall Study|Physician Decision|0
851698|NCT00420303|1809853|FG001|Overall Study|Physician Decision|1
851699|NCT00420316|1809861|FG000|Overall Study|Withdrawal by Subject|0
851700|NCT00420316|1809862|FG001|Overall Study|Withdrawal by Subject|1
851701|NCT00420316|1809861|FG000|Overall Study|Lost to Follow-up|12
851702|NCT00420316|1809862|FG001|Overall Study|Lost to Follow-up|8
851703|NCT00420342|1809871|FG000|Overall Study|Lost to Follow-up|1
851704|NCT00420342|1809872|FG001|Overall Study|Lost to Follow-up|0
851705|NCT00420342|1809873|FG002|Overall Study|Lost to Follow-up|1
851706|NCT00420342|1809871|FG000|Overall Study|Withdrawal by Subject|0
851707|NCT00420342|1809872|FG001|Overall Study|Withdrawal by Subject|2
851708|NCT00420342|1809873|FG002|Overall Study|Withdrawal by Subject|0
851709|NCT00420381|1809881|FG000|Overall Study|Protocol Violation|1
851710|NCT00420407|1809887|FG000|Overall Study|Lost to Follow-up|0
851711|NCT00420407|1809888|FG001|Overall Study|Lost to Follow-up|3
851712|NCT00420407|1809887|FG000|Overall Study|Physician Decision|2
851713|NCT00420407|1809888|FG001|Overall Study|Physician Decision|1
851714|NCT00420407|1809887|FG000|Overall Study|subject identified as detainee|1
851715|NCT00420407|1809888|FG001|Overall Study|subject identified as detainee|0
851716|NCT00420407|1809887|FG000|Overall Study|subject identified as Jehovah's witness|1
851717|NCT00420407|1809888|FG001|Overall Study|subject identified as Jehovah's witness|0
851718|NCT00420407|1809887|FG000|Overall Study|Withdrawal by Subject|0
851719|NCT00420407|1809888|FG001|Overall Study|Withdrawal by Subject|2
851720|NCT00420420|1809897|FG000|Overall Study|Adverse Event|5
851721|NCT00420420|1809898|FG001|Overall Study|Adverse Event|3
851722|NCT00420420|1809897|FG000|Overall Study|Protocol Violation|1
851723|NCT00420420|1809898|FG001|Overall Study|Protocol Violation|1
851724|NCT00420420|1809897|FG000|Overall Study|Withdrawal by Subject|1
851725|NCT00420420|1809898|FG001|Overall Study|Withdrawal by Subject|0
851726|NCT00420420|1809897|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1
851727|NCT00420420|1809898|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0
851728|NCT00420511|1809912|FG000|Overall Study|Adverse Event|1
851729|NCT00420511|1809913|FG001|Overall Study|Adverse Event|1
851730|NCT00420511|1809912|FG000|Overall Study|Lost to Follow-up|1
851731|NCT00420511|1809913|FG001|Overall Study|Lost to Follow-up|0
851732|NCT00420628|1809923|FG000|Overall Study|Withdrawn by parent or gaurdian|5
851733|NCT00420628|1809924|FG001|Overall Study|Withdrawn by parent or gaurdian|2
851734|NCT00420628|1809923|FG000|Overall Study|Lost to Follow-up|3
851735|NCT00420628|1809924|FG001|Overall Study|Lost to Follow-up|2
851736|NCT00420628|1809923|FG000|Overall Study|Adverse Event|1
851737|NCT00420628|1809924|FG001|Overall Study|Adverse Event|0
851738|NCT00420641|1809933|FG000|Overall Study|Adverse Event|3
851739|NCT00420641|1809934|FG001|Overall Study|Adverse Event|25
851740|NCT00420641|1809935|FG002|Overall Study|Adverse Event|10
851741|NCT00420641|1809933|FG000|Overall Study|Lost to Follow-up|2
851742|NCT00420641|1809934|FG001|Overall Study|Lost to Follow-up|4
851743|NCT00420641|1809935|FG002|Overall Study|Lost to Follow-up|2
851744|NCT00420641|1809933|FG000|Overall Study|Protocol Violation|8
851745|NCT00420641|1809934|FG001|Overall Study|Protocol Violation|8
851746|NCT00420641|1809935|FG002|Overall Study|Protocol Violation|7
851747|NCT00420641|1809933|FG000|Overall Study|Withdrawal by Subject|15
851748|NCT00420641|1809934|FG001|Overall Study|Withdrawal by Subject|21
851749|NCT00420641|1809935|FG002|Overall Study|Withdrawal by Subject|14
851750|NCT00420641|1809933|FG000|Overall Study|Lack of Efficacy|6
851751|NCT00420641|1809934|FG001|Overall Study|Lack of Efficacy|5
851752|NCT00420641|1809935|FG002|Overall Study|Lack of Efficacy|4
851753|NCT00420641|1809933|FG000|Overall Study|Non-compliance|7
851754|NCT00420641|1809934|FG001|Overall Study|Non-compliance|5
851755|NCT00420641|1809935|FG002|Overall Study|Non-compliance|4
851756|NCT00420641|1809933|FG000|Overall Study|Other|4
851757|NCT00420641|1809934|FG001|Overall Study|Other|4
851758|NCT00420641|1809935|FG002|Overall Study|Other|3
851759|NCT00420745|1809945|FG000|Overall Study|Adverse Event|2
851760|NCT00420745|1809946|FG001|Overall Study|Adverse Event|2
851761|NCT00420745|1809945|FG000|Overall Study|Lost to Follow-up|10
851762|NCT00420745|1809946|FG001|Overall Study|Lost to Follow-up|2
851763|NCT00420745|1809945|FG000|Overall Study|Protocol Violation|1
851764|NCT00420745|1809946|FG001|Overall Study|Protocol Violation|0
851765|NCT00420745|1809945|FG000|Overall Study|Physician Decision|1
851766|NCT00420745|1809946|FG001|Overall Study|Physician Decision|1
851767|NCT00420745|1809945|FG000|Overall Study|Recurrent pneumonia & bronchitis|0
851768|NCT00420745|1809946|FG001|Overall Study|Recurrent pneumonia & bronchitis|1
851769|NCT00420745|1809945|FG000|Overall Study|Age limit exceeded for Dose 2|1
851770|NCT00420745|1809946|FG001|Overall Study|Age limit exceeded for Dose 2|0
851771|NCT00420784|1809965|FG000|Overall Study|Adverse Event|11
851772|NCT00420784|1809966|FG001|Overall Study|Adverse Event|29
851773|NCT00420784|1809967|FG002|Overall Study|Adverse Event|10
851774|NCT00420784|1809968|FG003|Overall Study|Adverse Event|5
851775|NCT00420784|1809965|FG000|Overall Study|Withdrawal by Subject|0
851776|NCT00420784|1809966|FG001|Overall Study|Withdrawal by Subject|1
851777|NCT00420784|1809967|FG002|Overall Study|Withdrawal by Subject|0
851778|NCT00420784|1809968|FG003|Overall Study|Withdrawal by Subject|0
851779|NCT00420784|1809965|FG000|Overall Study|Lost to Follow-up|0
851780|NCT00420784|1809966|FG001|Overall Study|Lost to Follow-up|0
851781|NCT00420784|1809967|FG002|Overall Study|Lost to Follow-up|2
851782|NCT00420784|1809968|FG003|Overall Study|Lost to Follow-up|1
851783|NCT00420784|1809965|FG000|Overall Study|Virologic Stopping Rule|17
851784|NCT00420784|1809966|FG001|Overall Study|Virologic Stopping Rule|26
851785|NCT00420784|1809967|FG002|Overall Study|Virologic Stopping Rule|41
851786|NCT00420784|1809968|FG003|Overall Study|Virologic Stopping Rule|67
851787|NCT00420784|1809965|FG000|Overall Study|Other|1
851788|NCT00420784|1809966|FG001|Overall Study|Other|2
851789|NCT00420784|1809967|FG002|Overall Study|Other|0
851790|NCT00420784|1809968|FG003|Overall Study|Other|5
851791|NCT00420849|1809979|FG000|Overall Study|Lack of Efficacy|154
851792|NCT00420849|1809979|FG000|Overall Study|Adverse Event|107
851793|NCT00420849|1809979|FG000|Overall Study|Withdrawal by Subject|28
851794|NCT00420849|1809979|FG000|Overall Study|Death|18
851795|NCT00420849|1809979|FG000|Overall Study|Other|14
851796|NCT00420849|1809979|FG000|Overall Study|Transplant|8
851797|NCT00420849|1809979|FG000|Overall Study|Protocol Violation|1
851798|NCT00420849|1809979|FG000|Overall Study|Lost to Follow-up|1
851799|NCT00420927|1809993|FG000|Period 1|Adverse Event|19
851800|NCT00420927|1809994|FG001|Period 1|Adverse Event|15
851801|NCT00420927|1809995|FG002|Period 1|Adverse Event|0
851802|NCT00420927|1809996|FG003|Period 1|Adverse Event|0
851803|NCT00420927|1809997|FG004|Period 1|Adverse Event|0
851804|NCT00420927|1809998|FG005|Period 1|Adverse Event|0
851805|NCT00420927|1809999|FG006|Period 1|Adverse Event|0
851806|NCT00420927|1809993|FG000|Period 1|Withdrawal by Subject|7
851807|NCT00420927|1809994|FG001|Period 1|Withdrawal by Subject|12
851808|NCT00420927|1809995|FG002|Period 1|Withdrawal by Subject|0
851809|NCT00420927|1809996|FG003|Period 1|Withdrawal by Subject|0
851810|NCT00420927|1809997|FG004|Period 1|Withdrawal by Subject|0
851811|NCT00420927|1809998|FG005|Period 1|Withdrawal by Subject|0
851812|NCT00420927|1809999|FG006|Period 1|Withdrawal by Subject|0
851813|NCT00420927|1809993|FG000|Period 1|Lost to Follow-up|8
851814|NCT00420927|1809994|FG001|Period 1|Lost to Follow-up|6
851815|NCT00420927|1809995|FG002|Period 1|Lost to Follow-up|0
851816|NCT00420927|1809996|FG003|Period 1|Lost to Follow-up|0
851817|NCT00420927|1809997|FG004|Period 1|Lost to Follow-up|0
851818|NCT00420927|1809998|FG005|Period 1|Lost to Follow-up|0
851819|NCT00420927|1809999|FG006|Period 1|Lost to Follow-up|0
851820|NCT00420927|1809993|FG000|Period 1|Lack of efficacy/Loss of efficacy|1
851821|NCT00420927|1809994|FG001|Period 1|Lack of efficacy/Loss of efficacy|6
851822|NCT00420927|1809995|FG002|Period 1|Lack of efficacy/Loss of efficacy|0
851823|NCT00420927|1809996|FG003|Period 1|Lack of efficacy/Loss of efficacy|0
851824|NCT00420927|1809997|FG004|Period 1|Lack of efficacy/Loss of efficacy|0
851825|NCT00420927|1809998|FG005|Period 1|Lack of efficacy/Loss of efficacy|0
851826|NCT00420927|1809999|FG006|Period 1|Lack of efficacy/Loss of efficacy|0
851827|NCT00420927|1809993|FG000|Period 1|Death|2
851828|NCT00420927|1809994|FG001|Period 1|Death|0
851829|NCT00420927|1809995|FG002|Period 1|Death|0
851830|NCT00420927|1809996|FG003|Period 1|Death|0
851831|NCT00420927|1809997|FG004|Period 1|Death|0
851832|NCT00420927|1809998|FG005|Period 1|Death|0
851833|NCT00420927|1809999|FG006|Period 1|Death|0
851834|NCT00420927|1809993|FG000|Period 1|Subject moved/relocated|0
851835|NCT00420927|1809994|FG001|Period 1|Subject moved/relocated|2
851836|NCT00420927|1809995|FG002|Period 1|Subject moved/relocated|0
851837|NCT00420927|1809996|FG003|Period 1|Subject moved/relocated|0
851838|NCT00420927|1809997|FG004|Period 1|Subject moved/relocated|0
851839|NCT00420927|1809998|FG005|Period 1|Subject moved/relocated|0
851840|NCT00420927|1809999|FG006|Period 1|Subject moved/relocated|0
851841|NCT00420927|1809993|FG000|Period 1|Noncompliant with study drug|1
851842|NCT00420927|1809994|FG001|Period 1|Noncompliant with study drug|1
851843|NCT00420927|1809995|FG002|Period 1|Noncompliant with study drug|0
851844|NCT00420927|1809996|FG003|Period 1|Noncompliant with study drug|0
851845|NCT00420927|1809997|FG004|Period 1|Noncompliant with study drug|0
851846|NCT00420927|1809998|FG005|Period 1|Noncompliant with study drug|0
851847|NCT00420927|1809999|FG006|Period 1|Noncompliant with study drug|0
851848|NCT00420927|1809993|FG000|Period 1|Randomization error|1
851849|NCT00420927|1809994|FG001|Period 1|Randomization error|0
851850|NCT00420927|1809995|FG002|Period 1|Randomization error|0
851851|NCT00420927|1809996|FG003|Period 1|Randomization error|0
851852|NCT00420927|1809997|FG004|Period 1|Randomization error|0
851853|NCT00420927|1809998|FG005|Period 1|Randomization error|0
851854|NCT00420927|1809999|FG006|Period 1|Randomization error|0
851855|NCT00420927|1809993|FG000|Period 1|Suspected tuberculosis/positive test|1
851856|NCT00420927|1809994|FG001|Period 1|Suspected tuberculosis/positive test|1
851857|NCT00420927|1809995|FG002|Period 1|Suspected tuberculosis/positive test|0
851858|NCT00420927|1809996|FG003|Period 1|Suspected tuberculosis/positive test|0
851859|NCT00420927|1809997|FG004|Period 1|Suspected tuberculosis/positive test|0
851860|NCT00420927|1809998|FG005|Period 1|Suspected tuberculosis/positive test|0
851861|NCT00420927|1809999|FG006|Period 1|Suspected tuberculosis/positive test|0
851862|NCT00420927|1809993|FG000|Period 1|Study site closure|0
851863|NCT00420927|1809994|FG001|Period 1|Study site closure|1
851864|NCT00420927|1809995|FG002|Period 1|Study site closure|0
851865|NCT00420927|1809996|FG003|Period 1|Study site closure|0
851866|NCT00420927|1809997|FG004|Period 1|Study site closure|0
851867|NCT00420927|1809998|FG005|Period 1|Study site closure|0
851868|NCT00420927|1809999|FG006|Period 1|Study site closure|0
851869|NCT00420927|1809993|FG000|Period 1|Subject received new diagnosis|0
851870|NCT00420927|1809994|FG001|Period 1|Subject received new diagnosis|2
851871|NCT00420927|1809995|FG002|Period 1|Subject received new diagnosis|0
851872|NCT00420927|1809996|FG003|Period 1|Subject received new diagnosis|0
851873|NCT00420927|1809997|FG004|Period 1|Subject received new diagnosis|0
851874|NCT00420927|1809998|FG005|Period 1|Subject received new diagnosis|0
851875|NCT00420927|1809999|FG006|Period 1|Subject received new diagnosis|0
851876|NCT00420927|1809993|FG000|Period 1|Received wrong treatment/incorrect dose|0
851877|NCT00420927|1809994|FG001|Period 1|Received wrong treatment/incorrect dose|1
851878|NCT00420927|1809995|FG002|Period 1|Received wrong treatment/incorrect dose|0
851879|NCT00420927|1809996|FG003|Period 1|Received wrong treatment/incorrect dose|0
851880|NCT00420927|1809997|FG004|Period 1|Received wrong treatment/incorrect dose|0
851881|NCT00420927|1809998|FG005|Period 1|Received wrong treatment/incorrect dose|0
851882|NCT00420927|1809999|FG006|Period 1|Received wrong treatment/incorrect dose|0
851883|NCT00420927|1809993|FG000|Period 1|Failed to meet entry criteria|8
851884|NCT00420927|1809994|FG001|Period 1|Failed to meet entry criteria|7
851885|NCT00420927|1809995|FG002|Period 1|Failed to meet entry criteria|0
851886|NCT00420927|1809996|FG003|Period 1|Failed to meet entry criteria|0
851887|NCT00420927|1809997|FG004|Period 1|Failed to meet entry criteria|0
851888|NCT00420927|1809998|FG005|Period 1|Failed to meet entry criteria|0
851889|NCT00420927|1809999|FG006|Period 1|Failed to meet entry criteria|0
851890|NCT00420927|1809993|FG000|Period 1|Took prohibited medication|1
851891|NCT00420927|1809994|FG001|Period 1|Took prohibited medication|3
851892|NCT00420927|1809995|FG002|Period 1|Took prohibited medication|0
851893|NCT00420927|1809996|FG003|Period 1|Took prohibited medication|0
851894|NCT00420927|1809997|FG004|Period 1|Took prohibited medication|0
851895|NCT00420927|1809998|FG005|Period 1|Took prohibited medication|0
851896|NCT00420927|1809999|FG006|Period 1|Took prohibited medication|0
851897|NCT00420927|1809993|FG000|Period 2|Adverse Event|0
851898|NCT00420927|1809994|FG001|Period 2|Adverse Event|0
851899|NCT00420927|1809995|FG002|Period 2|Adverse Event|7
851900|NCT00420927|1809996|FG003|Period 2|Adverse Event|3
851901|NCT00420927|1809997|FG004|Period 2|Adverse Event|17
851902|NCT00420927|1809998|FG005|Period 2|Adverse Event|6
851903|NCT00420927|1809999|FG006|Period 2|Adverse Event|20
851904|NCT00420927|1809993|FG000|Period 2|Withdrawal by Subject|0
851905|NCT00420927|1809994|FG001|Period 2|Withdrawal by Subject|0
851906|NCT00420927|1809995|FG002|Period 2|Withdrawal by Subject|1
851907|NCT00420927|1809996|FG003|Period 2|Withdrawal by Subject|3
851908|NCT00420927|1809997|FG004|Period 2|Withdrawal by Subject|11
851909|NCT00420927|1809998|FG005|Period 2|Withdrawal by Subject|2
851910|NCT00420927|1809999|FG006|Period 2|Withdrawal by Subject|12
851911|NCT00420927|1809993|FG000|Period 2|Lost to Follow-up|0
851912|NCT00420927|1809994|FG001|Period 2|Lost to Follow-up|0
851913|NCT00420927|1809995|FG002|Period 2|Lost to Follow-up|2
851914|NCT00420927|1809996|FG003|Period 2|Lost to Follow-up|2
851915|NCT00420927|1809997|FG004|Period 2|Lost to Follow-up|6
851916|NCT00420927|1809998|FG005|Period 2|Lost to Follow-up|3
851917|NCT00420927|1809999|FG006|Period 2|Lost to Follow-up|9
851918|NCT00420927|1809993|FG000|Period 2|Lack of efficacy/Loss of efficacy|0
851919|NCT00420927|1809994|FG001|Period 2|Lack of efficacy/Loss of efficacy|0
851920|NCT00420927|1809995|FG002|Period 2|Lack of efficacy/Loss of efficacy|2
851921|NCT00420927|1809996|FG003|Period 2|Lack of efficacy/Loss of efficacy|1
851922|NCT00420927|1809997|FG004|Period 2|Lack of efficacy/Loss of efficacy|6
851923|NCT00420927|1809998|FG005|Period 2|Lack of efficacy/Loss of efficacy|2
851924|NCT00420927|1809999|FG006|Period 2|Lack of efficacy/Loss of efficacy|6
851925|NCT00420927|1809993|FG000|Period 2|Received wrong treatment/incorrect dose|0
851926|NCT00420927|1809994|FG001|Period 2|Received wrong treatment/incorrect dose|0
851927|NCT00420927|1809995|FG002|Period 2|Received wrong treatment/incorrect dose|0
851928|NCT00420927|1809996|FG003|Period 2|Received wrong treatment/incorrect dose|0
851929|NCT00420927|1809997|FG004|Period 2|Received wrong treatment/incorrect dose|0
851930|NCT00420927|1809998|FG005|Period 2|Received wrong treatment/incorrect dose|0
851931|NCT00420927|1809999|FG006|Period 2|Received wrong treatment/incorrect dose|1
851932|NCT00420927|1809993|FG000|Period 2|Subject unable to find transportation|0
851933|NCT00420927|1809994|FG001|Period 2|Subject unable to find transportation|0
851934|NCT00420927|1809995|FG002|Period 2|Subject unable to find transportation|0
851935|NCT00420927|1809996|FG003|Period 2|Subject unable to find transportation|0
851936|NCT00420927|1809997|FG004|Period 2|Subject unable to find transportation|0
851937|NCT00420927|1809998|FG005|Period 2|Subject unable to find transportation|0
851938|NCT00420927|1809999|FG006|Period 2|Subject unable to find transportation|1
851939|NCT00420927|1809993|FG000|Period 2|Physician Decision|0
851940|NCT00420927|1809994|FG001|Period 2|Physician Decision|0
851941|NCT00420927|1809995|FG002|Period 2|Physician Decision|0
851942|NCT00420927|1809996|FG003|Period 2|Physician Decision|0
851943|NCT00420927|1809997|FG004|Period 2|Physician Decision|1
851944|NCT00420927|1809998|FG005|Period 2|Physician Decision|1
851945|NCT00420927|1809999|FG006|Period 2|Physician Decision|0
851946|NCT00420927|1809993|FG000|Period 2|Sponsor decision|0
851947|NCT00420927|1809994|FG001|Period 2|Sponsor decision|0
851948|NCT00420927|1809995|FG002|Period 2|Sponsor decision|1
851949|NCT00420927|1809996|FG003|Period 2|Sponsor decision|0
851950|NCT00420927|1809997|FG004|Period 2|Sponsor decision|0
851951|NCT00420927|1809998|FG005|Period 2|Sponsor decision|0
851952|NCT00420927|1809999|FG006|Period 2|Sponsor decision|1
851953|NCT00420927|1809993|FG000|Period 2|Randomization error|0
851954|NCT00420927|1809994|FG001|Period 2|Randomization error|0
851955|NCT00420927|1809995|FG002|Period 2|Randomization error|0
851956|NCT00420927|1809996|FG003|Period 2|Randomization error|0
851957|NCT00420927|1809997|FG004|Period 2|Randomization error|1
851958|NCT00420927|1809998|FG005|Period 2|Randomization error|1
851959|NCT00420927|1809999|FG006|Period 2|Randomization error|0
851960|NCT00420927|1809993|FG000|Period 2|Noncompliant with study drug|0
851961|NCT00420927|1809994|FG001|Period 2|Noncompliant with study drug|0
851962|NCT00420927|1809995|FG002|Period 2|Noncompliant with study drug|0
851963|NCT00420927|1809996|FG003|Period 2|Noncompliant with study drug|1
851964|NCT00420927|1809997|FG004|Period 2|Noncompliant with study drug|0
851965|NCT00420927|1809998|FG005|Period 2|Noncompliant with study drug|0
851966|NCT00420927|1809999|FG006|Period 2|Noncompliant with study drug|2
851967|NCT00420927|1809993|FG000|Period 2|Methotrexate intolerance|0
851968|NCT00420927|1809994|FG001|Period 2|Methotrexate intolerance|0
851969|NCT00420927|1809995|FG002|Period 2|Methotrexate intolerance|0
851970|NCT00420927|1809996|FG003|Period 2|Methotrexate intolerance|0
851971|NCT00420927|1809997|FG004|Period 2|Methotrexate intolerance|0
851972|NCT00420927|1809998|FG005|Period 2|Methotrexate intolerance|0
851973|NCT00420927|1809999|FG006|Period 2|Methotrexate intolerance|1
851974|NCT00420927|1809993|FG000|Period 2|Took prohibited medication|0
851975|NCT00420927|1809994|FG001|Period 2|Took prohibited medication|0
851976|NCT00420927|1809995|FG002|Period 2|Took prohibited medication|0
851977|NCT00420927|1809996|FG003|Period 2|Took prohibited medication|0
851978|NCT00420927|1809997|FG004|Period 2|Took prohibited medication|1
851979|NCT00420927|1809998|FG005|Period 2|Took prohibited medication|0
851980|NCT00420927|1809999|FG006|Period 2|Took prohibited medication|0
851981|NCT00421148|1810043|FG000|Overall Study|Lost to Follow-up|0
851982|NCT00421148|1810044|FG001|Overall Study|Lost to Follow-up|0
851983|NCT00421148|1810045|FG002|Overall Study|Lost to Follow-up|0
851984|NCT00421148|1810046|FG003|Overall Study|Lost to Follow-up|0
851985|NCT00421148|1810047|FG004|Overall Study|Lost to Follow-up|0
851986|NCT00421148|1810048|FG005|Overall Study|Lost to Follow-up|0
851987|NCT00421148|1810049|FG006|Overall Study|Lost to Follow-up|0
851988|NCT00421148|1810050|FG007|Overall Study|Lost to Follow-up|0
851989|NCT00421148|1810051|FG008|Overall Study|Lost to Follow-up|0
851990|NCT00421148|1810052|FG009|Overall Study|Lost to Follow-up|0
851991|NCT00421148|1810053|FG010|Overall Study|Lost to Follow-up|0
851992|NCT00421148|1810054|FG011|Overall Study|Lost to Follow-up|0
851993|NCT00421148|1810055|FG012|Overall Study|Lost to Follow-up|0
851994|NCT00421148|1810056|FG013|Overall Study|Lost to Follow-up|0
851995|NCT00421148|1810057|FG014|Overall Study|Lost to Follow-up|0
851996|NCT00421148|1810058|FG015|Overall Study|Lost to Follow-up|0
851997|NCT00421148|1810059|FG016|Overall Study|Lost to Follow-up|0
851998|NCT00421148|1810060|FG017|Overall Study|Lost to Follow-up|1
851999|NCT00421148|1810061|FG018|Overall Study|Lost to Follow-up|0
852000|NCT00421148|1810062|FG019|Overall Study|Lost to Follow-up|0
852001|NCT00421148|1810043|FG000|Overall Study|Withdrawal by Subject|0
852002|NCT00421148|1810044|FG001|Overall Study|Withdrawal by Subject|0
852003|NCT00421148|1810045|FG002|Overall Study|Withdrawal by Subject|0
852004|NCT00421148|1810046|FG003|Overall Study|Withdrawal by Subject|0
852005|NCT00421148|1810047|FG004|Overall Study|Withdrawal by Subject|0
852006|NCT00421148|1810048|FG005|Overall Study|Withdrawal by Subject|0
852007|NCT00421148|1810049|FG006|Overall Study|Withdrawal by Subject|0
852008|NCT00421148|1810050|FG007|Overall Study|Withdrawal by Subject|0
852009|NCT00421148|1810051|FG008|Overall Study|Withdrawal by Subject|0
852010|NCT00421148|1810052|FG009|Overall Study|Withdrawal by Subject|0
852011|NCT00421148|1810053|FG010|Overall Study|Withdrawal by Subject|0
852012|NCT00421148|1810054|FG011|Overall Study|Withdrawal by Subject|0
852013|NCT00421148|1810055|FG012|Overall Study|Withdrawal by Subject|0
852014|NCT00421148|1810056|FG013|Overall Study|Withdrawal by Subject|0
852015|NCT00421148|1810057|FG014|Overall Study|Withdrawal by Subject|0
852016|NCT00421148|1810058|FG015|Overall Study|Withdrawal by Subject|0
852017|NCT00421148|1810059|FG016|Overall Study|Withdrawal by Subject|0
852018|NCT00421148|1810060|FG017|Overall Study|Withdrawal by Subject|1
852019|NCT00421148|1810061|FG018|Overall Study|Withdrawal by Subject|0
852020|NCT00421148|1810062|FG019|Overall Study|Withdrawal by Subject|0
852021|NCT00421148|1810043|FG000|Overall Study|Protocol Violation|0
852022|NCT00421148|1810044|FG001|Overall Study|Protocol Violation|0
852023|NCT00421148|1810045|FG002|Overall Study|Protocol Violation|0
852024|NCT00421148|1810046|FG003|Overall Study|Protocol Violation|0
852025|NCT00421148|1810047|FG004|Overall Study|Protocol Violation|0
852026|NCT00421148|1810048|FG005|Overall Study|Protocol Violation|1
852027|NCT00421148|1810049|FG006|Overall Study|Protocol Violation|0
852028|NCT00421148|1810050|FG007|Overall Study|Protocol Violation|0
852029|NCT00421148|1810051|FG008|Overall Study|Protocol Violation|0
852030|NCT00421148|1810052|FG009|Overall Study|Protocol Violation|0
852031|NCT00421148|1810053|FG010|Overall Study|Protocol Violation|0
852032|NCT00421148|1810054|FG011|Overall Study|Protocol Violation|0
852033|NCT00421148|1810055|FG012|Overall Study|Protocol Violation|0
852034|NCT00421148|1810056|FG013|Overall Study|Protocol Violation|0
852035|NCT00421148|1810057|FG014|Overall Study|Protocol Violation|0
852036|NCT00421148|1810058|FG015|Overall Study|Protocol Violation|0
852037|NCT00421148|1810059|FG016|Overall Study|Protocol Violation|0
852038|NCT00421148|1810060|FG017|Overall Study|Protocol Violation|0
852039|NCT00421148|1810061|FG018|Overall Study|Protocol Violation|1
852040|NCT00421148|1810062|FG019|Overall Study|Protocol Violation|0
852041|NCT00421174|1810106|FG000|Overall Study|Withdrawal by Subject|0
852042|NCT00421174|1810107|FG001|Overall Study|Withdrawal by Subject|1
852043|NCT00421174|1810106|FG000|Overall Study|Ineligible due to infection|2
852044|NCT00421174|1810107|FG001|Overall Study|Ineligible due to infection|0
852045|NCT00421304|1810116|FG000|Overall Study|Lost to Follow-up|5
852046|NCT00421304|1810117|FG001|Overall Study|Lost to Follow-up|2
852047|NCT00421304|1810118|FG002|Overall Study|Lost to Follow-up|5
852048|NCT00421304|1810116|FG000|Overall Study|Withdrawal by Subject|2
852049|NCT00421304|1810117|FG001|Overall Study|Withdrawal by Subject|2
852050|NCT00421304|1810118|FG002|Overall Study|Withdrawal by Subject|2
852051|NCT00421304|1810116|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1
852052|NCT00421304|1810117|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0
852053|NCT00421304|1810118|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0
852054|NCT00421304|1810116|FG000|Overall Study|Did not attend Day 360 visit|0
852055|NCT00421304|1810117|FG001|Overall Study|Did not attend Day 360 visit|0
852056|NCT00421304|1810118|FG002|Overall Study|Did not attend Day 360 visit|1
852057|NCT00421343|1810128|FG000|Overall Study|Death|1
852058|NCT00421343|1810128|FG000|Overall Study|Withdrawal by Subject|2
852059|NCT00421343|1810128|FG000|Overall Study|Lost to Follow-up|3
852060|NCT00421408|1810134|FG000|Overall Study|Lost to Follow-up|30
852061|NCT00421408|1810135|FG001|Overall Study|Lost to Follow-up|20
852062|NCT00421408|1810134|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12
852063|NCT00421408|1810135|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25
852064|NCT00421707|1810152|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1
852065|NCT00421707|1810153|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5
852066|NCT00421707|1810152|FG000|Period 1: Treatment Period 1|Adverse Event|7
852067|NCT00421707|1810153|FG001|Period 1: Treatment Period 1|Adverse Event|2
852068|NCT00421707|1810152|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2
852069|NCT00421707|1810153|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2
852070|NCT00421707|1810152|FG000|Period 1: Treatment Period 1|Protocol Violation|1
852071|NCT00421707|1810153|FG001|Period 1: Treatment Period 1|Protocol Violation|0
852072|NCT00421707|1810152|FG000|Period 2: Washout|Adverse Event|1
852073|NCT00421707|1810153|FG001|Period 2: Washout|Adverse Event|1
852074|NCT00421707|1810152|FG000|Period 2: Washout|Withdrawal by Subject|0
852075|NCT00421707|1810153|FG001|Period 2: Washout|Withdrawal by Subject|1
852076|NCT00421707|1810152|FG000|Period 2: Washout|Lost to Follow-up|0
852077|NCT00421707|1810153|FG001|Period 2: Washout|Lost to Follow-up|1
852078|NCT00421707|1810152|FG000|Period 2: Washout|Other: Pregnancy|0
852079|NCT00421707|1810153|FG001|Period 2: Washout|Other: Pregnancy|1
852080|NCT00421707|1810152|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1
852081|NCT00421707|1810153|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1
852082|NCT00421707|1810152|FG000|Period 3:Treatment Period 2|Protocol Violation|1
852083|NCT00421707|1810153|FG001|Period 3:Treatment Period 2|Protocol Violation|0
852084|NCT00421707|1810152|FG000|Period 3:Treatment Period 2|Adverse Event|0
852085|NCT00421707|1810153|FG001|Period 3:Treatment Period 2|Adverse Event|2
852086|NCT00421733|1810165|FG000|Overall Study|Adverse Event|4
852087|NCT00421733|1810166|FG001|Overall Study|Adverse Event|9
852088|NCT00421733|1810167|FG002|Overall Study|Adverse Event|2
852089|NCT00421733|1810165|FG000|Overall Study|Lost to Follow-up|1
852090|NCT00421733|1810166|FG001|Overall Study|Lost to Follow-up|2
852091|NCT00421733|1810167|FG002|Overall Study|Lost to Follow-up|4
852092|NCT00421733|1810165|FG000|Overall Study|Withdrawal by Subject|1
852093|NCT00421733|1810166|FG001|Overall Study|Withdrawal by Subject|2
852094|NCT00421733|1810167|FG002|Overall Study|Withdrawal by Subject|7
852095|NCT00421733|1810165|FG000|Overall Study|Death|0
852096|NCT00421733|1810166|FG001|Overall Study|Death|3
852097|NCT00421733|1810167|FG002|Overall Study|Death|0
852098|NCT00421733|1810165|FG000|Overall Study|Required dialysis|1
852099|NCT00421733|1810166|FG001|Overall Study|Required dialysis|0
852100|NCT00421733|1810167|FG002|Overall Study|Required dialysis|0
852101|NCT00421733|1810165|FG000|Overall Study|Administrative|2
852102|NCT00421733|1810166|FG001|Overall Study|Administrative|0
852103|NCT00421733|1810167|FG002|Overall Study|Administrative|0
852104|NCT00421733|1810165|FG000|Overall Study|Did not satisfy entry criteria|1
852105|NCT00421733|1810166|FG001|Overall Study|Did not satisfy entry criteria|3
852106|NCT00421733|1810167|FG002|Overall Study|Did not satisfy entry criteria|2
852107|NCT00421733|1810165|FG000|Overall Study|Sponsor request|1
852108|NCT00421733|1810166|FG001|Overall Study|Sponsor request|0
852109|NCT00421733|1810167|FG002|Overall Study|Sponsor request|3
852110|NCT00421733|1810165|FG000|Overall Study|Protocol deviation|4
852111|NCT00421733|1810166|FG001|Overall Study|Protocol deviation|7
852112|NCT00421733|1810167|FG002|Overall Study|Protocol deviation|2
852113|NCT00421889|1810188|FG000|Overall Study|Adverse Event|1
852114|NCT00421889|1810189|FG001|Overall Study|Adverse Event|0
852115|NCT00421889|1810190|FG002|Overall Study|Adverse Event|1
852116|NCT00421889|1810191|FG003|Overall Study|Adverse Event|1
852117|NCT00421889|1810192|FG004|Overall Study|Adverse Event|1
852118|NCT00421889|1810193|FG005|Overall Study|Adverse Event|4
852119|NCT00421889|1810194|FG006|Overall Study|Adverse Event|1
852120|NCT00421889|1810195|FG007|Overall Study|Adverse Event|0
852121|NCT00421889|1810196|FG008|Overall Study|Adverse Event|2
852122|NCT00421889|1810188|FG000|Overall Study|Withdrawal by Subject|1
852123|NCT00421889|1810189|FG001|Overall Study|Withdrawal by Subject|3
852124|NCT00421889|1810190|FG002|Overall Study|Withdrawal by Subject|0
852125|NCT00421889|1810191|FG003|Overall Study|Withdrawal by Subject|0
852126|NCT00421889|1810192|FG004|Overall Study|Withdrawal by Subject|2
852127|NCT00421889|1810193|FG005|Overall Study|Withdrawal by Subject|0
852128|NCT00421889|1810194|FG006|Overall Study|Withdrawal by Subject|0
852129|NCT00421889|1810195|FG007|Overall Study|Withdrawal by Subject|0
852130|NCT00421889|1810196|FG008|Overall Study|Withdrawal by Subject|0
852131|NCT00421889|1810188|FG000|Overall Study|Death|0
852132|NCT00421889|1810189|FG001|Overall Study|Death|0
852133|NCT00421889|1810190|FG002|Overall Study|Death|0
852134|NCT00421889|1810191|FG003|Overall Study|Death|0
852135|NCT00421889|1810192|FG004|Overall Study|Death|1
852136|NCT00421889|1810193|FG005|Overall Study|Death|1
852137|NCT00421889|1810194|FG006|Overall Study|Death|0
852138|NCT00421889|1810195|FG007|Overall Study|Death|0
852139|NCT00421889|1810196|FG008|Overall Study|Death|0
852140|NCT00421889|1810188|FG000|Overall Study|Progressive disease|3
852141|NCT00421889|1810189|FG001|Overall Study|Progressive disease|2
852142|NCT00421889|1810190|FG002|Overall Study|Progressive disease|2
852143|NCT00421889|1810191|FG003|Overall Study|Progressive disease|3
852144|NCT00421889|1810192|FG004|Overall Study|Progressive disease|2
852145|NCT00421889|1810193|FG005|Overall Study|Progressive disease|21
852146|NCT00421889|1810194|FG006|Overall Study|Progressive disease|3
852147|NCT00421889|1810195|FG007|Overall Study|Progressive disease|1
852148|NCT00421889|1810196|FG008|Overall Study|Progressive disease|5
852149|NCT00421889|1810188|FG000|Overall Study|Patient/Investigator request|0
852150|NCT00421889|1810189|FG001|Overall Study|Patient/Investigator request|0
852151|NCT00421889|1810190|FG002|Overall Study|Patient/Investigator request|0
852152|NCT00421889|1810191|FG003|Overall Study|Patient/Investigator request|0
852153|NCT00421889|1810192|FG004|Overall Study|Patient/Investigator request|0
852154|NCT00421889|1810193|FG005|Overall Study|Patient/Investigator request|9
852155|NCT00421889|1810194|FG006|Overall Study|Patient/Investigator request|0
852156|NCT00421889|1810195|FG007|Overall Study|Patient/Investigator request|1
852157|NCT00421889|1810196|FG008|Overall Study|Patient/Investigator request|3
852158|NCT00421889|1810188|FG000|Overall Study|Lost to Follow-up|0
852159|NCT00421889|1810189|FG001|Overall Study|Lost to Follow-up|0
852160|NCT00421889|1810190|FG002|Overall Study|Lost to Follow-up|0
852161|NCT00421889|1810191|FG003|Overall Study|Lost to Follow-up|0
852162|NCT00421889|1810192|FG004|Overall Study|Lost to Follow-up|0
852163|NCT00421889|1810193|FG005|Overall Study|Lost to Follow-up|0
852164|NCT00421889|1810194|FG006|Overall Study|Lost to Follow-up|0
852165|NCT00421889|1810195|FG007|Overall Study|Lost to Follow-up|0
852166|NCT00421889|1810196|FG008|Overall Study|Lost to Follow-up|1
852167|NCT00421928|1810223|FG000|Overall Study|Adverse Event|61
852168|NCT00421928|1810224|FG001|Overall Study|Adverse Event|140
852169|NCT00421928|1810225|FG002|Overall Study|Adverse Event|22
852170|NCT00421928|1810223|FG000|Overall Study|Lost to Follow-up|5
852171|NCT00421928|1810224|FG001|Overall Study|Lost to Follow-up|0
852172|NCT00421928|1810225|FG002|Overall Study|Lost to Follow-up|3
852173|NCT00421928|1810223|FG000|Overall Study|Withdrawal by Subject|50
852174|NCT00421928|1810224|FG001|Overall Study|Withdrawal by Subject|48
852175|NCT00421928|1810225|FG002|Overall Study|Withdrawal by Subject|43
852176|NCT00421928|1810223|FG000|Overall Study|Lack of Efficacy|15
852177|NCT00421928|1810224|FG001|Overall Study|Lack of Efficacy|7
852178|NCT00421928|1810225|FG002|Overall Study|Lack of Efficacy|35
852179|NCT00421928|1810223|FG000|Overall Study|Study drug non-compliant|6
852180|NCT00421928|1810224|FG001|Overall Study|Study drug non-compliant|7
852181|NCT00421928|1810225|FG002|Overall Study|Study drug non-compliant|4
852182|NCT00421928|1810223|FG000|Overall Study|All other|26
852183|NCT00421928|1810224|FG001|Overall Study|All other|21
852184|NCT00421928|1810225|FG002|Overall Study|All other|27
852185|NCT00421928|1810223|FG000|Overall Study|Death|0
852186|NCT00421928|1810224|FG001|Overall Study|Death|1
852187|NCT00421928|1810225|FG002|Overall Study|Death|0
852188|NCT00421993|1810237|FG000|Overall Study|Withdrawal by Subject|22
852189|NCT00421993|1810238|FG001|Overall Study|Withdrawal by Subject|23
852190|NCT00421993|1810239|FG002|Overall Study|Withdrawal by Subject|23
852191|NCT00421993|1810240|FG003|Overall Study|Withdrawal by Subject|24
852192|NCT00421993|1810237|FG000|Overall Study|Lost to Follow-up|18
852193|NCT00421993|1810238|FG001|Overall Study|Lost to Follow-up|19
852194|NCT00421993|1810239|FG002|Overall Study|Lost to Follow-up|22
852195|NCT00421993|1810240|FG003|Overall Study|Lost to Follow-up|20
852196|NCT00421993|1810237|FG000|Overall Study|Adverse Event|11
852197|NCT00421993|1810238|FG001|Overall Study|Adverse Event|1
852198|NCT00421993|1810239|FG002|Overall Study|Adverse Event|6
852199|NCT00421993|1810240|FG003|Overall Study|Adverse Event|4
852200|NCT00421993|1810237|FG000|Overall Study|Protocol Violation|2
852201|NCT00421993|1810238|FG001|Overall Study|Protocol Violation|2
852202|NCT00421993|1810239|FG002|Overall Study|Protocol Violation|0
852203|NCT00421993|1810240|FG003|Overall Study|Protocol Violation|1
852204|NCT00421993|1810237|FG000|Overall Study|Lack of Efficacy|0
852205|NCT00421993|1810238|FG001|Overall Study|Lack of Efficacy|3
852206|NCT00421993|1810239|FG002|Overall Study|Lack of Efficacy|0
852207|NCT00421993|1810240|FG003|Overall Study|Lack of Efficacy|5
852208|NCT00421993|1810237|FG000|Overall Study|Pregnancy|0
852209|NCT00421993|1810238|FG001|Overall Study|Pregnancy|1
852210|NCT00421993|1810239|FG002|Overall Study|Pregnancy|1
852211|NCT00421993|1810240|FG003|Overall Study|Pregnancy|2
852212|NCT00421993|1810237|FG000|Overall Study|Subject transportation issues|0
852213|NCT00421993|1810238|FG001|Overall Study|Subject transportation issues|0
852214|NCT00421993|1810239|FG002|Overall Study|Subject transportation issues|0
852215|NCT00421993|1810240|FG003|Overall Study|Subject transportation issues|1
852216|NCT00422058|1810265|FG000|Double-Blind, Week 0-20|Adverse Event|3
852217|NCT00422058|1810266|FG001|Double-Blind, Week 0-20|Adverse Event|4
852218|NCT00422058|1810267|FG002|Double-Blind, Week 0-20|Adverse Event|5
852219|NCT00422058|1810268|FG003|Double-Blind, Week 0-20|Adverse Event|9
852220|NCT00422058|1810269|FG004|Double-Blind, Week 0-20|Adverse Event|5
852221|NCT00422058|1810270|FG005|Double-Blind, Week 0-20|Adverse Event|3
852222|NCT00422058|1810265|FG000|Double-Blind, Week 0-20|Protocol Violation|3
852223|NCT00422058|1810266|FG001|Double-Blind, Week 0-20|Protocol Violation|2
852224|NCT00422058|1810267|FG002|Double-Blind, Week 0-20|Protocol Violation|2
852225|NCT00422058|1810268|FG003|Double-Blind, Week 0-20|Protocol Violation|3
852226|NCT00422058|1810269|FG004|Double-Blind, Week 0-20|Protocol Violation|2
852227|NCT00422058|1810270|FG005|Double-Blind, Week 0-20|Protocol Violation|2
852228|NCT00422058|1810265|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2
852229|NCT00422058|1810266|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1
852230|NCT00422058|1810267|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1
852231|NCT00422058|1810268|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0
852232|NCT00422058|1810269|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0
852233|NCT00422058|1810270|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1
852234|NCT00422058|1810265|FG000|Double-Blind, Week 0-20|Other|11
852235|NCT00422058|1810266|FG001|Double-Blind, Week 0-20|Other|3
852236|NCT00422058|1810267|FG002|Double-Blind, Week 0-20|Other|8
852237|NCT00422058|1810268|FG003|Double-Blind, Week 0-20|Other|8
852238|NCT00422058|1810269|FG004|Double-Blind, Week 0-20|Other|4
852239|NCT00422058|1810270|FG005|Double-Blind, Week 0-20|Other|10
852240|NCT00422058|1810265|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12
852241|NCT00422058|1810266|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17
852242|NCT00422058|1810267|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15
852243|NCT00422058|1810268|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8
852244|NCT00422058|1810269|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10
852245|NCT00422058|1810270|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12
852246|NCT00422058|1810265|FG000|Open-Label Extension, Week 20-104|Adverse Event|3
852247|NCT00422058|1810266|FG001|Open-Label Extension, Week 20-104|Adverse Event|4
852248|NCT00422058|1810267|FG002|Open-Label Extension, Week 20-104|Adverse Event|7
852249|NCT00422058|1810268|FG003|Open-Label Extension, Week 20-104|Adverse Event|4
852250|NCT00422058|1810269|FG004|Open-Label Extension, Week 20-104|Adverse Event|4
852251|NCT00422058|1810270|FG005|Open-Label Extension, Week 20-104|Adverse Event|0
852252|NCT00422058|1810265|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1
852253|NCT00422058|1810266|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2
852254|NCT00422058|1810267|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3
852255|NCT00422058|1810268|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1
852256|NCT00422058|1810269|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5
852257|NCT00422058|1810270|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3
852258|NCT00422058|1810265|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3
852259|NCT00422058|1810266|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2
852260|NCT00422058|1810267|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5
852261|NCT00422058|1810268|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2
852262|NCT00422058|1810269|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0
852263|NCT00422058|1810270|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1
852264|NCT00422058|1810265|FG000|Open-Label Extension, Week 20-104|Other|13
852265|NCT00422058|1810266|FG001|Open-Label Extension, Week 20-104|Other|14
852266|NCT00422058|1810267|FG002|Open-Label Extension, Week 20-104|Other|6
852267|NCT00422058|1810268|FG003|Open-Label Extension, Week 20-104|Other|13
852268|NCT00422058|1810269|FG004|Open-Label Extension, Week 20-104|Other|16
852269|NCT00422058|1810270|FG005|Open-Label Extension, Week 20-104|Other|18
852270|NCT00422084|1810286|FG000|Overall Study|Adverse Event|21
852271|NCT00422084|1810287|FG001|Overall Study|Adverse Event|7
852272|NCT00422084|1810286|FG000|Overall Study|Withdrawal by Subject|12
852273|NCT00422084|1810287|FG001|Overall Study|Withdrawal by Subject|9
852274|NCT00422084|1810286|FG000|Overall Study|Lost to Follow-up|14
852275|NCT00422084|1810287|FG001|Overall Study|Lost to Follow-up|9
852276|NCT00422084|1810286|FG000|Overall Study|Protocol Violation|4
852277|NCT00422084|1810287|FG001|Overall Study|Protocol Violation|1
852278|NCT00422084|1810286|FG000|Overall Study|Lack of Efficacy|40
852279|NCT00422084|1810287|FG001|Overall Study|Lack of Efficacy|42
852280|NCT00422084|1810286|FG000|Overall Study|P. vivax infection|3
852281|NCT00422084|1810287|FG001|Overall Study|P. vivax infection|6
852282|NCT00422084|1810286|FG000|Overall Study|Cyesis|1
852283|NCT00422084|1810287|FG001|Overall Study|Cyesis|0
852284|NCT00422084|1810286|FG000|Overall Study|Withdrawn from study accidentally|1
852285|NCT00422084|1810287|FG001|Overall Study|Withdrawn from study accidentally|0
852286|NCT00422084|1810286|FG000|Overall Study|Non-compliance|1
852287|NCT00422084|1810287|FG001|Overall Study|Non-compliance|0
852288|NCT00422084|1810286|FG000|Overall Study|Re-location|0
852289|NCT00422084|1810287|FG001|Overall Study|Re-location|1
852290|NCT00422084|1810286|FG000|Overall Study|Not defined|1
852291|NCT00422084|1810287|FG001|Overall Study|Not defined|1
852292|NCT00422097|1810299|FG000|Dose Level 2|Still on treatment|0
852293|NCT00422097|1810300|FG001|Dose Level 2|Still on treatment|1
852294|NCT00422097|1810301|FG002|Dose Level 2|Still on treatment|0
852295|NCT00422097|1810302|FG003|Dose Level 2|Still on treatment|0
852296|NCT00422097|1810303|FG004|Dose Level 2|Still on treatment|0
852297|NCT00422097|1810304|FG005|Dose Level 2|Still on treatment|0
852298|NCT00422097|1810305|FG006|Dose Level 2|Still on treatment|0
852299|NCT00422097|1810306|FG007|Dose Level 2|Still on treatment|0
852300|NCT00422162|1810332|FG000|Overall Study|Adverse Event|11
852301|NCT00422162|1810333|FG001|Overall Study|Adverse Event|9
852302|NCT00422162|1810332|FG000|Overall Study|Lack of Efficacy|4
852303|NCT00422162|1810333|FG001|Overall Study|Lack of Efficacy|10
852304|NCT00422162|1810332|FG000|Overall Study|Withdrawal by Subject|7
852305|NCT00422162|1810333|FG001|Overall Study|Withdrawal by Subject|6
852306|NCT00422162|1810332|FG000|Overall Study|Lost to Follow-up|1
852307|NCT00422162|1810333|FG001|Overall Study|Lost to Follow-up|2
852308|NCT00422162|1810332|FG000|Overall Study|Non-Compliant with Protocol|1
852309|NCT00422162|1810333|FG001|Overall Study|Non-Compliant with Protocol|1
852310|NCT00422162|1810332|FG000|Overall Study|Other|0
852311|NCT00422162|1810333|FG001|Overall Study|Other|1
852312|NCT00422162|1810332|FG000|Overall Study|Didn't Receive Treatment|0
852313|NCT00422162|1810333|FG001|Overall Study|Didn't Receive Treatment|1
852314|NCT00422227|1810356|FG000|Overall Study|Adverse Event|3
852315|NCT00422227|1810357|FG001|Overall Study|Adverse Event|8
852316|NCT00422227|1810356|FG000|Overall Study|Lost to Follow-up|1
852317|NCT00422227|1810357|FG001|Overall Study|Lost to Follow-up|3
852318|NCT00422227|1810356|FG000|Overall Study|Withdrawal by Subject|0
852319|NCT00422227|1810357|FG001|Overall Study|Withdrawal by Subject|4
852320|NCT00422292|1810378|FG000|Overall Study|Serious adverse events|1
852321|NCT00422292|1810379|FG001|Overall Study|Serious adverse events|4
852322|NCT00422292|1810380|FG002|Overall Study|Serious adverse events|0
852323|NCT00422292|1810381|FG003|Overall Study|Serious adverse events|0
852324|NCT00422292|1810378|FG000|Overall Study|Adverse Event|1
852325|NCT00422292|1810379|FG001|Overall Study|Adverse Event|0
852326|NCT00422292|1810380|FG002|Overall Study|Adverse Event|1
852327|NCT00422292|1810381|FG003|Overall Study|Adverse Event|0
852328|NCT00422292|1810378|FG000|Overall Study|Protocol Violation|4
852329|NCT00422292|1810379|FG001|Overall Study|Protocol Violation|25
852330|NCT00422292|1810380|FG002|Overall Study|Protocol Violation|8
852331|NCT00422292|1810381|FG003|Overall Study|Protocol Violation|5
852332|NCT00422292|1810378|FG000|Overall Study|Lost to Follow-up|6
852333|NCT00422292|1810379|FG001|Overall Study|Lost to Follow-up|12
852334|NCT00422292|1810380|FG002|Overall Study|Lost to Follow-up|6
852335|NCT00422292|1810381|FG003|Overall Study|Lost to Follow-up|6
852336|NCT00422292|1810378|FG000|Overall Study|Withdrawal by Subject|6
852337|NCT00422292|1810379|FG001|Overall Study|Withdrawal by Subject|25
852338|NCT00422292|1810380|FG002|Overall Study|Withdrawal by Subject|7
852339|NCT00422292|1810381|FG003|Overall Study|Withdrawal by Subject|13
852340|NCT00422383|1810396|FG000|Overall Study|Adverse Event|5
852341|NCT00422383|1810397|FG001|Overall Study|Adverse Event|3
852342|NCT00422383|1810398|FG002|Overall Study|Adverse Event|1
852343|NCT00422383|1810399|FG003|Overall Study|Adverse Event|1
852344|NCT00422383|1810400|FG004|Overall Study|Adverse Event|0
852345|NCT00422383|1810396|FG000|Overall Study|Lack of Efficacy|4
852346|NCT00422383|1810397|FG001|Overall Study|Lack of Efficacy|4
852347|NCT00422383|1810398|FG002|Overall Study|Lack of Efficacy|2
852348|NCT00422383|1810399|FG003|Overall Study|Lack of Efficacy|1
852349|NCT00422383|1810400|FG004|Overall Study|Lack of Efficacy|1
852350|NCT00422383|1810396|FG000|Overall Study|Lost to Follow-up|0
852351|NCT00422383|1810397|FG001|Overall Study|Lost to Follow-up|1
852352|NCT00422383|1810398|FG002|Overall Study|Lost to Follow-up|0
852353|NCT00422383|1810399|FG003|Overall Study|Lost to Follow-up|0
852354|NCT00422383|1810400|FG004|Overall Study|Lost to Follow-up|1
852355|NCT00422383|1810396|FG000|Overall Study|Protocol Violation|1
852356|NCT00422383|1810397|FG001|Overall Study|Protocol Violation|1
852357|NCT00422383|1810398|FG002|Overall Study|Protocol Violation|1
852358|NCT00422383|1810399|FG003|Overall Study|Protocol Violation|0
852359|NCT00422383|1810400|FG004|Overall Study|Protocol Violation|0
852360|NCT00422383|1810396|FG000|Overall Study|Withdrawal by Subject|5
852361|NCT00422383|1810397|FG001|Overall Study|Withdrawal by Subject|5
852362|NCT00422383|1810398|FG002|Overall Study|Withdrawal by Subject|0
852363|NCT00422383|1810399|FG003|Overall Study|Withdrawal by Subject|0
852364|NCT00422383|1810400|FG004|Overall Study|Withdrawal by Subject|1
852365|NCT00422422|1810418|FG000|Overall Study|Lack of Efficacy|1
852366|NCT00422422|1810418|FG000|Overall Study|Protocol Violation|1
852367|NCT00422422|1810418|FG000|Overall Study|Withdrawal by Subject|2
852368|NCT00422422|1810418|FG000|Overall Study|SAE, non-fatal|1
852369|NCT00422422|1810418|FG000|Overall Study|AE, non-serious non-fatal|5
852370|NCT00422461|1810432|FG000|Overall Study|Adverse Event|1
852371|NCT00422461|1810433|FG001|Overall Study|Adverse Event|2
852372|NCT00422461|1810434|FG002|Overall Study|Adverse Event|1
852373|NCT00422461|1810435|FG003|Overall Study|Adverse Event|1
852374|NCT00422461|1810432|FG000|Overall Study|Other|0
852375|NCT00422461|1810433|FG001|Overall Study|Other|0
852376|NCT00422461|1810434|FG002|Overall Study|Other|0
852377|NCT00422461|1810435|FG003|Overall Study|Other|2
852378|NCT00422461|1810432|FG000|Overall Study|Participants no longer willing to participate in study|1
852379|NCT00422461|1810433|FG001|Overall Study|Participants no longer willing to participate in study|0
852380|NCT00422461|1810434|FG002|Overall Study|Participants no longer willing to participate in study|0
852381|NCT00422461|1810435|FG003|Overall Study|Participants no longer willing to participate in study|0
852382|NCT00422461|1810432|FG000|Overall Study|Randomized but not treated|1
852383|NCT00422461|1810433|FG001|Overall Study|Randomized but not treated|1
852384|NCT00422461|1810434|FG002|Overall Study|Randomized but not treated|0
852385|NCT00422461|1810435|FG003|Overall Study|Randomized but not treated|0
852386|NCT00422513|1810447|FG000|Overall Study|Lack of Efficacy|4
852387|NCT00422513|1810448|FG001|Overall Study|Lack of Efficacy|5
852388|NCT00422513|1810447|FG000|Overall Study|Protocol Violation|23
852389|NCT00422513|1810448|FG001|Overall Study|Protocol Violation|7
852390|NCT00422513|1810447|FG000|Overall Study|Refused Treatment|4
852391|NCT00422513|1810448|FG001|Overall Study|Refused Treatment|2
852392|NCT00422513|1810447|FG000|Overall Study|Withdrawal by Subject|2
852393|NCT00422513|1810448|FG001|Overall Study|Withdrawal by Subject|1
852394|NCT00422513|1810447|FG000|Overall Study|early termination of the study|67
852395|NCT00422513|1810448|FG001|Overall Study|early termination of the study|80
852396|NCT00422513|1810447|FG000|Overall Study|Adverse Event|4
852397|NCT00422513|1810448|FG001|Overall Study|Adverse Event|4
852398|NCT00422513|1810447|FG000|Overall Study|Death|3
852399|NCT00422513|1810448|FG001|Overall Study|Death|7
852400|NCT00422591|1810454|FG000|Overall Study|Physician Decision|4
852401|NCT00422591|1810454|FG000|Overall Study|Withdrawal by Subject|2
852402|NCT00422734|1810473|FG000|Overall Study|Physician Decision|1
852403|NCT00422734|1810474|FG001|Overall Study|Physician Decision|1
852404|NCT00422734|1810473|FG000|Overall Study|Protocol Violation|1
852405|NCT00422734|1810474|FG001|Overall Study|Protocol Violation|6
852406|NCT00422734|1810473|FG000|Overall Study|Withdrawal by Subject|12
852407|NCT00422734|1810474|FG001|Overall Study|Withdrawal by Subject|8
852408|NCT00422734|1810473|FG000|Overall Study|Adverse Event|0
852409|NCT00422734|1810474|FG001|Overall Study|Adverse Event|3
852410|NCT00422734|1810473|FG000|Overall Study|Partner Decision|0
852411|NCT00422734|1810474|FG001|Overall Study|Partner Decision|3
852412|NCT00422799|1810480|FG000|Overall Study|Withdrawal by Subject|6
852413|NCT00422799|1810480|FG000|Overall Study|Adverse Event|7
852414|NCT00422903|1810503|FG000|Overall Study|Disease Progression|3
852415|NCT00422903|1810504|FG001|Overall Study|Disease Progression|1
852416|NCT00422903|1810503|FG000|Overall Study|Adverse Event|0
852417|NCT00422903|1810504|FG001|Overall Study|Adverse Event|2
852418|NCT00422903|1810503|FG000|Overall Study|Informed Consent Withdrawn|1
852419|NCT00422903|1810504|FG001|Overall Study|Informed Consent Withdrawn|2
852420|NCT00423046|1810512|FG000|Overall Study|Other|340
852421|NCT00423046|1810513|FG001|Overall Study|Other|345
852422|NCT00423085|1810524|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21
852423|NCT00423085|1810525|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38
852424|NCT00423085|1810526|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34
852425|NCT00423085|1810527|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0
852426|NCT00423085|1810524|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
852427|NCT00423085|1810525|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
852428|NCT00423085|1810526|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
852429|NCT00423085|1810527|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
852430|NCT00423085|1810524|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
852431|NCT00423085|1810525|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
852432|NCT00423085|1810526|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
852433|NCT00423085|1810527|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
852434|NCT00423085|1810524|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8
852435|NCT00423085|1810525|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3
852436|NCT00423085|1810526|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7
852437|NCT00423085|1810527|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0
852438|NCT00423085|1810524|FG000|24-Week Double-Blind Treatment Phase|Death|1
852439|NCT00423085|1810525|FG001|24-Week Double-Blind Treatment Phase|Death|1
852440|NCT00423085|1810526|FG002|24-Week Double-Blind Treatment Phase|Death|0
852441|NCT00423085|1810527|FG003|24-Week Double-Blind Treatment Phase|Death|0
852442|NCT00423085|1810524|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
852443|NCT00423085|1810525|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
852444|NCT00423085|1810526|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
852445|NCT00423085|1810527|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
852446|NCT00423085|1810524|FG000|52-Week Open-Label Extension Phase|Adverse Event|0
852447|NCT00423085|1810525|FG001|52-Week Open-Label Extension Phase|Adverse Event|0
852448|NCT00423085|1810526|FG002|52-Week Open-Label Extension Phase|Adverse Event|0
852449|NCT00423085|1810527|FG003|52-Week Open-Label Extension Phase|Adverse Event|97
852450|NCT00423085|1810524|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
852451|NCT00423085|1810525|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
852452|NCT00423085|1810526|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
852453|NCT00423085|1810527|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
852454|NCT00423085|1810524|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
852455|NCT00423085|1810525|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
852456|NCT00423085|1810526|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
852457|NCT00423085|1810527|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
852458|NCT00423085|1810524|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0
852459|NCT00423085|1810525|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0
852460|NCT00423085|1810526|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0
852461|NCT00423085|1810527|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9
852462|NCT00423085|1810524|FG000|52-Week Open-Label Extension Phase|Death|0
852463|NCT00423085|1810525|FG001|52-Week Open-Label Extension Phase|Death|0
852464|NCT00423085|1810526|FG002|52-Week Open-Label Extension Phase|Death|0
852465|NCT00423085|1810527|FG003|52-Week Open-Label Extension Phase|Death|2
852466|NCT00423098|1810539|FG000|Overall Study|Adverse Event|1
852467|NCT00423098|1810540|FG001|Overall Study|Adverse Event|2
852468|NCT00423098|1810539|FG000|Overall Study|Unsatisfactory therapeutic effect|0
852469|NCT00423098|1810540|FG001|Overall Study|Unsatisfactory therapeutic effect|1
852470|NCT00423098|1810539|FG000|Overall Study|Administrative problems|0
852471|NCT00423098|1810540|FG001|Overall Study|Administrative problems|1
852472|NCT00423098|1810539|FG000|Overall Study|Death|2
852473|NCT00423098|1810540|FG001|Overall Study|Death|0
852474|NCT00423137|1810550|FG000|Overall Study|Lost to Follow-up|0
852475|NCT00423137|1810551|FG001|Overall Study|Lost to Follow-up|0
852476|NCT00423137|1810552|FG002|Overall Study|Lost to Follow-up|1
852477|NCT00423137|1810553|FG003|Overall Study|Lost to Follow-up|0
852478|NCT00423137|1810550|FG000|Overall Study|Protocol Violation|0
852479|NCT00423137|1810551|FG001|Overall Study|Protocol Violation|0
852480|NCT00423137|1810552|FG002|Overall Study|Protocol Violation|0
852481|NCT00423137|1810553|FG003|Overall Study|Protocol Violation|1
852482|NCT00423137|1810550|FG000|Overall Study|Adverse Event Study disease worse|1
852483|NCT00423137|1810551|FG001|Overall Study|Adverse Event Study disease worse|0
852484|NCT00423137|1810552|FG002|Overall Study|Adverse Event Study disease worse|3
852485|NCT00423137|1810553|FG003|Overall Study|Adverse Event Study disease worse|1
852486|NCT00423137|1810550|FG000|Overall Study|Adverse Event Other|0
852487|NCT00423137|1810551|FG001|Overall Study|Adverse Event Other|0
852488|NCT00423137|1810552|FG002|Overall Study|Adverse Event Other|2
852489|NCT00423137|1810553|FG003|Overall Study|Adverse Event Other|0
852490|NCT00423150|1810566|FG000|Overall Study|Adverse Event|11
852491|NCT00423150|1810566|FG000|Overall Study|Progression of disease being studied|69
852492|NCT00423150|1810566|FG000|Overall Study|Withdrawal by Subject|1
852493|NCT00423150|1810566|FG000|Overall Study|Non-compliance with protocol|1
852494|NCT00423150|1810566|FG000|Overall Study|Administrative|4
852495|NCT00423176|1810572|FG000|Overall Study|Adverse Event|4
852496|NCT00423176|1810573|FG001|Overall Study|Adverse Event|6
852497|NCT00423176|1810572|FG000|Overall Study|Treatment Failure|1
852498|NCT00423176|1810573|FG001|Overall Study|Treatment Failure|6
852499|NCT00423176|1810572|FG000|Overall Study|Lost to Follow-up|4
852500|NCT00423176|1810573|FG001|Overall Study|Lost to Follow-up|7
852501|NCT00423176|1810572|FG000|Overall Study|Withdrawal by Subject|4
852502|NCT00423176|1810573|FG001|Overall Study|Withdrawal by Subject|3
852503|NCT00423176|1810572|FG000|Overall Study|Protocol Violation|1
852504|NCT00423176|1810573|FG001|Overall Study|Protocol Violation|3
852505|NCT00423176|1810572|FG000|Overall Study|Did not meet protocol eligibility|2
852506|NCT00423176|1810573|FG001|Overall Study|Did not meet protocol eligibility|4
852507|NCT00423189|1810582|FG000|Overall Study|Death|0
852508|NCT00423189|1810583|FG001|Overall Study|Death|1
852509|NCT00423189|1810584|FG002|Overall Study|Death|0
852510|NCT00423267|1810599|FG000|Period A|Withdrawal by Subject|0
852511|NCT00423267|1810600|FG001|Period A|Withdrawal by Subject|1
852512|NCT00423267|1810599|FG000|Period A|Non-compliance with protocol|1
852513|NCT00423267|1810600|FG001|Period A|Non-compliance with protocol|0
852514|NCT00423267|1810599|FG000|Period A|Administrative|1
852515|NCT00423267|1810600|FG001|Period A|Administrative|0
852516|NCT00423293|1810608|FG000|Overall Study|Ineligible / No protocol treatment|11
852517|NCT00423319|1810614|FG000|Overall Study|Death|2
852518|NCT00423319|1810615|FG001|Overall Study|Death|0
852519|NCT00423319|1810614|FG000|Overall Study|Adverse Event|93
852520|NCT00423319|1810615|FG001|Overall Study|Adverse Event|112
852521|NCT00423319|1810614|FG000|Overall Study|Withdrawal by Subject|86
852522|NCT00423319|1810615|FG001|Overall Study|Withdrawal by Subject|99
852523|NCT00423319|1810614|FG000|Overall Study|Lost to Follow-up|4
852524|NCT00423319|1810615|FG001|Overall Study|Lost to Follow-up|3
852525|NCT00423319|1810614|FG000|Overall Study|Poor compliance or noncompliance|1
852526|NCT00423319|1810615|FG001|Overall Study|Poor compliance or noncompliance|1
852527|NCT00423319|1810614|FG000|Overall Study|No longer meets study criteria|15
852528|NCT00423319|1810615|FG001|Overall Study|No longer meets study criteria|15
852529|NCT00423319|1810614|FG000|Overall Study|Other|23
852530|NCT00423319|1810615|FG001|Overall Study|Other|22
852531|NCT00423332|1810624|FG000|Overall Study|Adverse Event|6
852532|NCT00423332|1810625|FG001|Overall Study|Adverse Event|2
852533|NCT00423332|1810624|FG000|Overall Study|Withdrawal by Subject|1
852534|NCT00423332|1810625|FG001|Overall Study|Withdrawal by Subject|0
852535|NCT00423332|1810624|FG000|Overall Study|Condition under investigation worsened|1
852536|NCT00423332|1810625|FG001|Overall Study|Condition under investigation worsened|1
852537|NCT00423332|1810624|FG000|Overall Study|Progressive at Week 6|0
852538|NCT00423332|1810625|FG001|Overall Study|Progressive at Week 6|1
852539|NCT00423332|1810624|FG000|Overall Study|Unblinded before 12 weeks|1
852540|NCT00423332|1810625|FG001|Overall Study|Unblinded before 12 weeks|3
852541|NCT00423449|1810650|FG000|Overall Study|Clinical Adverse Event|1
852542|NCT00423449|1810651|FG001|Overall Study|Clinical Adverse Event|0
852543|NCT00423449|1810652|FG002|Overall Study|Clinical Adverse Event|1
852544|NCT00423449|1810653|FG003|Overall Study|Clinical Adverse Event|8
852545|NCT00423449|1810654|FG004|Overall Study|Clinical Adverse Event|2
852546|NCT00423449|1810650|FG000|Overall Study|Death|1
852547|NCT00423449|1810651|FG001|Overall Study|Death|0
852548|NCT00423449|1810652|FG002|Overall Study|Death|2
852549|NCT00423449|1810653|FG003|Overall Study|Death|1
852550|NCT00423449|1810654|FG004|Overall Study|Death|1
852551|NCT00423449|1810650|FG000|Overall Study|Progressive Disease|1
852552|NCT00423449|1810651|FG001|Overall Study|Progressive Disease|3
852553|NCT00423449|1810652|FG002|Overall Study|Progressive Disease|8
852554|NCT00423449|1810653|FG003|Overall Study|Progressive Disease|11
852555|NCT00423449|1810654|FG004|Overall Study|Progressive Disease|4
852556|NCT00423449|1810650|FG000|Overall Study|Laboratory Adverse Event|0
852557|NCT00423449|1810651|FG001|Overall Study|Laboratory Adverse Event|1
852558|NCT00423449|1810652|FG002|Overall Study|Laboratory Adverse Event|2
852559|NCT00423449|1810653|FG003|Overall Study|Laboratory Adverse Event|0
852560|NCT00423449|1810654|FG004|Overall Study|Laboratory Adverse Event|0
852561|NCT00423449|1810650|FG000|Overall Study|Other|0
852562|NCT00423449|1810651|FG001|Overall Study|Other|0
852563|NCT00423449|1810652|FG002|Overall Study|Other|0
852564|NCT00423449|1810653|FG003|Overall Study|Other|1
852565|NCT00423449|1810654|FG004|Overall Study|Other|0
852566|NCT00423449|1810650|FG000|Overall Study|Protocol Violation|0
852567|NCT00423449|1810651|FG001|Overall Study|Protocol Violation|0
852568|NCT00423449|1810652|FG002|Overall Study|Protocol Violation|2
852569|NCT00423449|1810653|FG003|Overall Study|Protocol Violation|1
852570|NCT00423449|1810654|FG004|Overall Study|Protocol Violation|0
852571|NCT00423488|1810669|FG000|Overall Study|No evidence of study drug intake|2
852572|NCT00423488|1810670|FG001|Overall Study|No evidence of study drug intake|1
852573|NCT00423488|1810669|FG000|Overall Study|No post baseline data|3
852574|NCT00423488|1810670|FG001|Overall Study|No post baseline data|0
852575|NCT00423579|1810678|FG000|Overall Study|Lost to Follow-up|3
852576|NCT00423579|1810679|FG001|Overall Study|Lost to Follow-up|0
852577|NCT00423579|1810678|FG000|Overall Study|Protocol Violation|1
852578|NCT00423579|1810679|FG001|Overall Study|Protocol Violation|3
852579|NCT00423579|1810678|FG000|Overall Study|Diagnosis of diabetes|0
852580|NCT00423579|1810679|FG001|Overall Study|Diagnosis of diabetes|1
852581|NCT00423592|1810685|FG000|Overall Study|Adverse Event (through Week 12)|2
852582|NCT00423592|1810685|FG000|Overall Study|Adverse Event (post Week 12)|5
852583|NCT00423605|1810689|FG000|Overall Study|Adverse Event|129
852584|NCT00423605|1810689|FG000|Overall Study|Withdrawal by Subject|36
852585|NCT00423605|1810689|FG000|Overall Study|Lost to Follow-up|15
852586|NCT00423605|1810689|FG000|Overall Study|Lack of Efficacy|38
852587|NCT00423605|1810689|FG000|Overall Study|Sponsor Decision|3
852588|NCT00423605|1810689|FG000|Overall Study|Physician Decision|8
852589|NCT00423605|1810689|FG000|Overall Study|Protocol Violation|7
852590|NCT00423605|1810689|FG000|Overall Study|Not one of the pre-specified options|5
852591|NCT00423657|1810695|FG000|Overall Study|Withdrew consent|10
852592|NCT00423657|1810696|FG001|Overall Study|Withdrew consent|8
852593|NCT00423657|1810695|FG000|Overall Study|Non-compliance|0
852594|NCT00423657|1810696|FG001|Overall Study|Non-compliance|1
852595|NCT00423657|1810695|FG000|Overall Study|Other|15
852596|NCT00423657|1810696|FG001|Overall Study|Other|16
852597|NCT00423657|1810695|FG000|Overall Study|Request of sponsor/investigator|1
852598|NCT00423657|1810696|FG001|Overall Study|Request of sponsor/investigator|0
852599|NCT00423670|1810709|FG000|Treatment Period|Switched to Arm 8 at TW 24|36
852600|NCT00423670|1810710|FG001|Treatment Period|Switched to Arm 8 at TW 24|0
852601|NCT00423670|1810711|FG002|Treatment Period|Switched to Arm 8 at TW 24|0
852602|NCT00423670|1810712|FG003|Treatment Period|Switched to Arm 8 at TW 24|0
852603|NCT00423670|1810713|FG004|Treatment Period|Switched to Arm 8 at TW 24|0
852604|NCT00423670|1810714|FG005|Treatment Period|Switched to Arm 8 at TW 24|0
852605|NCT00423670|1810715|FG006|Treatment Period|Switched to Arm 8 at TW 24|0
852606|NCT00423670|1810716|FG007|Treatment Period|Switched to Arm 8 at TW 24|0
852607|NCT00423670|1810709|FG000|Treatment Period|Adverse Event|8
852608|NCT00423670|1810710|FG001|Treatment Period|Adverse Event|12
852609|NCT00423670|1810711|FG002|Treatment Period|Adverse Event|15
852610|NCT00423670|1810712|FG003|Treatment Period|Adverse Event|20
852611|NCT00423670|1810713|FG004|Treatment Period|Adverse Event|9
852612|NCT00423670|1810714|FG005|Treatment Period|Adverse Event|4
852613|NCT00423670|1810715|FG006|Treatment Period|Adverse Event|7
852614|NCT00423670|1810716|FG007|Treatment Period|Adverse Event|2
852615|NCT00423670|1810709|FG000|Treatment Period|Protocol-defined clinical event|0
852616|NCT00423670|1810710|FG001|Treatment Period|Protocol-defined clinical event|7
852617|NCT00423670|1810711|FG002|Treatment Period|Protocol-defined clinical event|4
852618|NCT00423670|1810712|FG003|Treatment Period|Protocol-defined clinical event|12
852619|NCT00423670|1810713|FG004|Treatment Period|Protocol-defined clinical event|5
852620|NCT00423670|1810714|FG005|Treatment Period|Protocol-defined clinical event|4
852621|NCT00423670|1810715|FG006|Treatment Period|Protocol-defined clinical event|16
852622|NCT00423670|1810716|FG007|Treatment Period|Protocol-defined clinical event|15
852623|NCT00423670|1810709|FG000|Treatment Period|Lost to Follow-up|2
852624|NCT00423670|1810710|FG001|Treatment Period|Lost to Follow-up|1
852625|NCT00423670|1810711|FG002|Treatment Period|Lost to Follow-up|3
852626|NCT00423670|1810712|FG003|Treatment Period|Lost to Follow-up|1
852627|NCT00423670|1810713|FG004|Treatment Period|Lost to Follow-up|6
852628|NCT00423670|1810714|FG005|Treatment Period|Lost to Follow-up|0
852629|NCT00423670|1810715|FG006|Treatment Period|Lost to Follow-up|3
852630|NCT00423670|1810716|FG007|Treatment Period|Lost to Follow-up|1
852631|NCT00423670|1810709|FG000|Treatment Period|Subject withdrew (not treatment related)|3
852632|NCT00423670|1810710|FG001|Treatment Period|Subject withdrew (not treatment related)|9
852633|NCT00423670|1810711|FG002|Treatment Period|Subject withdrew (not treatment related)|4
852634|NCT00423670|1810712|FG003|Treatment Period|Subject withdrew (not treatment related)|4
852635|NCT00423670|1810713|FG004|Treatment Period|Subject withdrew (not treatment related)|5
852636|NCT00423670|1810714|FG005|Treatment Period|Subject withdrew (not treatment related)|0
852637|NCT00423670|1810715|FG006|Treatment Period|Subject withdrew (not treatment related)|3
852638|NCT00423670|1810716|FG007|Treatment Period|Subject withdrew (not treatment related)|0
852639|NCT00423670|1810709|FG000|Treatment Period|Investigator decision|0
852640|NCT00423670|1810710|FG001|Treatment Period|Investigator decision|0
852641|NCT00423670|1810711|FG002|Treatment Period|Investigator decision|0
852642|NCT00423670|1810712|FG003|Treatment Period|Investigator decision|0
852643|NCT00423670|1810713|FG004|Treatment Period|Investigator decision|0
852644|NCT00423670|1810714|FG005|Treatment Period|Investigator decision|0
852645|NCT00423670|1810715|FG006|Treatment Period|Investigator decision|0
852646|NCT00423670|1810716|FG007|Treatment Period|Investigator decision|1
852647|NCT00423670|1810709|FG000|Treatment Period|Non-compliance with protocol|3
852648|NCT00423670|1810710|FG001|Treatment Period|Non-compliance with protocol|1
852649|NCT00423670|1810711|FG002|Treatment Period|Non-compliance with protocol|1
852650|NCT00423670|1810712|FG003|Treatment Period|Non-compliance with protocol|3
852651|NCT00423670|1810713|FG004|Treatment Period|Non-compliance with protocol|2
852652|NCT00423670|1810714|FG005|Treatment Period|Non-compliance with protocol|0
852653|NCT00423670|1810715|FG006|Treatment Period|Non-compliance with protocol|2
852654|NCT00423670|1810716|FG007|Treatment Period|Non-compliance with protocol|2
852655|NCT00423670|1810709|FG000|Follow-up Period|Lost to Follow-up|0
852656|NCT00423670|1810710|FG001|Follow-up Period|Lost to Follow-up|12
852657|NCT00423670|1810711|FG002|Follow-up Period|Lost to Follow-up|8
852658|NCT00423670|1810712|FG003|Follow-up Period|Lost to Follow-up|3
852659|NCT00423670|1810713|FG004|Follow-up Period|Lost to Follow-up|1
852660|NCT00423670|1810714|FG005|Follow-up Period|Lost to Follow-up|0
852661|NCT00423670|1810715|FG006|Follow-up Period|Lost to Follow-up|5
852662|NCT00423670|1810716|FG007|Follow-up Period|Lost to Follow-up|0
852663|NCT00423670|1810709|FG000|Follow-up Period|Subject withdrew (not treatment related)|1
852664|NCT00423670|1810710|FG001|Follow-up Period|Subject withdrew (not treatment related)|4
852665|NCT00423670|1810711|FG002|Follow-up Period|Subject withdrew (not treatment related)|2
852666|NCT00423670|1810712|FG003|Follow-up Period|Subject withdrew (not treatment related)|1
852667|NCT00423670|1810713|FG004|Follow-up Period|Subject withdrew (not treatment related)|1
852668|NCT00423670|1810714|FG005|Follow-up Period|Subject withdrew (not treatment related)|0
852669|NCT00423670|1810715|FG006|Follow-up Period|Subject withdrew (not treatment related)|1
852670|NCT00423670|1810716|FG007|Follow-up Period|Subject withdrew (not treatment related)|1
852671|NCT00423670|1810709|FG000|Follow-up Period|Non-compliance with protocol|2
852672|NCT00423670|1810710|FG001|Follow-up Period|Non-compliance with protocol|0
852673|NCT00423670|1810711|FG002|Follow-up Period|Non-compliance with protocol|1
852674|NCT00423670|1810712|FG003|Follow-up Period|Non-compliance with protocol|1
852675|NCT00423670|1810713|FG004|Follow-up Period|Non-compliance with protocol|0
852676|NCT00423670|1810714|FG005|Follow-up Period|Non-compliance with protocol|0
852677|NCT00423670|1810715|FG006|Follow-up Period|Non-compliance with protocol|3
852678|NCT00423670|1810716|FG007|Follow-up Period|Non-compliance with protocol|2
852679|NCT00423722|1810750|FG000|Overall Study|Death|4
852680|NCT00423722|1810751|FG001|Overall Study|Death|4
852681|NCT00423722|1810750|FG000|Overall Study|Declined to participate|2
852682|NCT00423722|1810751|FG001|Overall Study|Declined to participate|3
852683|NCT00423722|1810750|FG000|Overall Study|Unable to complete questionnaires|4
852684|NCT00423722|1810751|FG001|Overall Study|Unable to complete questionnaires|4
852685|NCT00423722|1810750|FG000|Overall Study|Withdrawal by Subject|4
852686|NCT00423722|1810751|FG001|Overall Study|Withdrawal by Subject|2
852687|NCT00423735|1810766|FG000|Overall Study|Ineligible / No protocol treatment|8
852688|NCT00423735|1810767|FG001|Overall Study|Ineligible / No protocol treatment|6
852689|NCT00423735|1810768|FG002|Overall Study|Ineligible / No protocol treatment|0
852690|NCT00423800|1810780|FG000|Overall Study|Protocol Violation|0
852691|NCT00423800|1810781|FG001|Overall Study|Protocol Violation|1
852692|NCT00423813|1810791|FG000|Overall Study|Adverse Event|11
852693|NCT00423813|1810792|FG001|Overall Study|Adverse Event|30
852694|NCT00423813|1810793|FG002|Overall Study|Adverse Event|40
852695|NCT00423813|1810791|FG000|Overall Study|Withdrawal by Subject|6
852696|NCT00423813|1810792|FG001|Overall Study|Withdrawal by Subject|8
852697|NCT00423813|1810793|FG002|Overall Study|Withdrawal by Subject|5
852698|NCT00423813|1810791|FG000|Overall Study|Lost to Follow-up|5
852699|NCT00423813|1810792|FG001|Overall Study|Lost to Follow-up|4
852700|NCT00423813|1810793|FG002|Overall Study|Lost to Follow-up|4
852701|NCT00423813|1810791|FG000|Overall Study|Lack of Efficacy|23
852702|NCT00423813|1810792|FG001|Overall Study|Lack of Efficacy|18
852703|NCT00423813|1810793|FG002|Overall Study|Lack of Efficacy|19
852704|NCT00423813|1810791|FG000|Overall Study|Physician Decision|2
852705|NCT00423813|1810792|FG001|Overall Study|Physician Decision|0
852706|NCT00423813|1810793|FG002|Overall Study|Physician Decision|0
852707|NCT00423813|1810791|FG000|Overall Study|Sponsor Decision|0
852708|NCT00423813|1810792|FG001|Overall Study|Sponsor Decision|1
852709|NCT00423813|1810793|FG002|Overall Study|Sponsor Decision|0
852710|NCT00423813|1810791|FG000|Overall Study|Protocol Violation|9
852711|NCT00423813|1810792|FG001|Overall Study|Protocol Violation|4
852712|NCT00423813|1810793|FG002|Overall Study|Protocol Violation|4
852713|NCT00423813|1810791|FG000|Overall Study|Pregnancy|0
852714|NCT00423813|1810792|FG001|Overall Study|Pregnancy|0
852715|NCT00423813|1810793|FG002|Overall Study|Pregnancy|1
852716|NCT00423813|1810791|FG000|Overall Study|Subject started night shift work|1
852717|NCT00423813|1810792|FG001|Overall Study|Subject started night shift work|0
852718|NCT00423813|1810793|FG002|Overall Study|Subject started night shift work|0
852719|NCT00423813|1810791|FG000|Overall Study|Will start exclusionary medications|0
852720|NCT00423813|1810792|FG001|Overall Study|Will start exclusionary medications|1
852721|NCT00423813|1810793|FG002|Overall Study|Will start exclusionary medications|0
852722|NCT00423813|1810791|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0
852723|NCT00423813|1810792|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0
852724|NCT00423813|1810793|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1
852725|NCT00423852|1810801|FG000|Overall Study|Removed pior to the high-dose portion|3
852726|NCT00423891|1810817|FG000|Enrolled|Withdrawal by Subject|0
852727|NCT00423891|1810818|FG001|Enrolled|Withdrawal by Subject|0
852728|NCT00423891|1810819|FG002|Enrolled|Withdrawal by Subject|1
852729|NCT00423891|1810817|FG000|Enrolled|Lost to Follow-up|0
852730|NCT00423891|1810818|FG001|Enrolled|Lost to Follow-up|0
852731|NCT00423891|1810819|FG002|Enrolled|Lost to Follow-up|1
852732|NCT00423891|1810817|FG000|Enrolled|No longer met criteria|11
852733|NCT00423891|1810818|FG001|Enrolled|No longer met criteria|2
852734|NCT00423891|1810819|FG002|Enrolled|No longer met criteria|1
852735|NCT00423891|1810817|FG000|Treatment|Withdrawal by Subject|1
852736|NCT00423891|1810818|FG001|Treatment|Withdrawal by Subject|0
852737|NCT00423891|1810819|FG002|Treatment|Withdrawal by Subject|0
852738|NCT00423891|1810817|FG000|Treatment|Lost to Follow-up|1
852739|NCT00423891|1810818|FG001|Treatment|Lost to Follow-up|0
852740|NCT00423891|1810819|FG002|Treatment|Lost to Follow-up|0
852741|NCT00423891|1810817|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0
852742|NCT00423891|1810818|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3
852743|NCT00423891|1810819|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2
852744|NCT00423891|1810817|FG000|Post-Dosing Follow Up|Lost to Follow-up|2
852745|NCT00423891|1810818|FG001|Post-Dosing Follow Up|Lost to Follow-up|0
852746|NCT00423891|1810819|FG002|Post-Dosing Follow Up|Lost to Follow-up|0
852747|NCT00423917|1810829|FG000|Overall Study|Cancel|2
852748|NCT00423917|1810829|FG000|Overall Study|Ineligible|1
852749|NCT00423930|1810833|FG000|Overall Study|Withdrawal by Subject|2
852750|NCT00423943|1810839|FG000|Overall Study|Withdrawal by Subject|3
852751|NCT00423943|1810840|FG001|Overall Study|Withdrawal by Subject|1
852752|NCT00424008|1810848|FG000|Overall Study|Adverse Event|8
852753|NCT00424008|1810849|FG001|Overall Study|Adverse Event|6
852754|NCT00424008|1810848|FG000|Overall Study|Lack of Efficacy|40
852755|NCT00424008|1810849|FG001|Overall Study|Lack of Efficacy|34
852756|NCT00424008|1810848|FG000|Overall Study|Lost to Follow-up|1
852757|NCT00424008|1810849|FG001|Overall Study|Lost to Follow-up|2
852758|NCT00424008|1810848|FG000|Overall Study|Withdrawal by Subject|5
852759|NCT00424008|1810849|FG001|Overall Study|Withdrawal by Subject|8
852760|NCT00424008|1810848|FG000|Overall Study|Noncompliance with protocol|13
852761|NCT00424008|1810849|FG001|Overall Study|Noncompliance with protocol|7
852762|NCT00424008|1810848|FG000|Overall Study|Did not meet protocol eligibility|16
852763|NCT00424008|1810849|FG001|Overall Study|Did not meet protocol eligibility|21
852764|NCT00424008|1810848|FG000|Overall Study|Administrative|266
852765|NCT00424008|1810849|FG001|Overall Study|Administrative|257
852766|NCT00424021|1810860|FG000|NCT00046319 Study Period|Adverse Event|1
852767|NCT00424021|1810861|FG001|NCT00046319 Study Period|Adverse Event|0
852768|NCT00424021|1810862|FG002|NCT00046319 Study Period|Adverse Event|1
852769|NCT00424021|1810863|FG003|NCT00046319 Study Period|Adverse Event|1
852770|NCT00424021|1810860|FG000|NCT00046319 Study Period|Withdrawal by Subject|0
852771|NCT00424021|1810861|FG001|NCT00046319 Study Period|Withdrawal by Subject|1
852772|NCT00424021|1810862|FG002|NCT00046319 Study Period|Withdrawal by Subject|0
852773|NCT00424021|1810863|FG003|NCT00046319 Study Period|Withdrawal by Subject|0
852774|NCT00424021|1810860|FG000|NCT00046319 Study Period|Sponsor discretion|0
852775|NCT00424021|1810861|FG001|NCT00046319 Study Period|Sponsor discretion|1
852776|NCT00424021|1810862|FG002|NCT00046319 Study Period|Sponsor discretion|0
852777|NCT00424021|1810863|FG003|NCT00046319 Study Period|Sponsor discretion|0
852778|NCT00424021|1810860|FG000|NCT00046319 Study Period|Lost to Follow-up|0
852779|NCT00424021|1810861|FG001|NCT00046319 Study Period|Lost to Follow-up|1
852780|NCT00424021|1810862|FG002|NCT00046319 Study Period|Lost to Follow-up|0
852781|NCT00424021|1810863|FG003|NCT00046319 Study Period|Lost to Follow-up|0
852782|NCT00424021|1810860|FG000|AMB-220-E Study Period|Adverse Event|1
852783|NCT00424021|1810861|FG001|AMB-220-E Study Period|Adverse Event|1
852784|NCT00424021|1810862|FG002|AMB-220-E Study Period|Adverse Event|3
852785|NCT00424021|1810863|FG003|AMB-220-E Study Period|Adverse Event|7
852786|NCT00424021|1810860|FG000|AMB-220-E Study Period|Death|0
852787|NCT00424021|1810861|FG001|AMB-220-E Study Period|Death|0
852788|NCT00424021|1810862|FG002|AMB-220-E Study Period|Death|1
852789|NCT00424021|1810863|FG003|AMB-220-E Study Period|Death|1
852790|NCT00424021|1810860|FG000|AMB-220-E Study Period|Lost to Follow-up|0
852791|NCT00424021|1810861|FG001|AMB-220-E Study Period|Lost to Follow-up|1
852792|NCT00424021|1810862|FG002|AMB-220-E Study Period|Lost to Follow-up|1
852793|NCT00424021|1810863|FG003|AMB-220-E Study Period|Lost to Follow-up|1
852794|NCT00424021|1810860|FG000|AMB-220-E Study Period|Physician Decision|0
852795|NCT00424021|1810861|FG001|AMB-220-E Study Period|Physician Decision|0
852796|NCT00424021|1810862|FG002|AMB-220-E Study Period|Physician Decision|0
852797|NCT00424021|1810863|FG003|AMB-220-E Study Period|Physician Decision|1
852798|NCT00424047|1810882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
852799|NCT00424047|1810883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
852800|NCT00424047|1810882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
852801|NCT00424047|1810883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
852802|NCT00424047|1810882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
852803|NCT00424047|1810883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
852804|NCT00424047|1810882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
852805|NCT00424047|1810883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
852806|NCT00424047|1810882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11
852807|NCT00424047|1810883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10
852808|NCT00424047|1810882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2
852809|NCT00424047|1810883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1
852810|NCT00424047|1810882|FG000|On Study at Time of Unblinding|Adverse Event|22
852811|NCT00424047|1810883|FG001|On Study at Time of Unblinding|Adverse Event|12
852812|NCT00424047|1810882|FG000|On Study at Time of Unblinding|Progression of disease|92
852813|NCT00424047|1810883|FG001|On Study at Time of Unblinding|Progression of disease|128
852814|NCT00424047|1810882|FG000|On Study at Time of Unblinding|Lack of Efficacy|1
852815|NCT00424047|1810883|FG001|On Study at Time of Unblinding|Lack of Efficacy|3
852816|NCT00424047|1810882|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24
852817|NCT00424047|1810883|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9
852818|NCT00424047|1810882|FG000|On Study at Time of Unblinding|Death|11
852819|NCT00424047|1810883|FG001|On Study at Time of Unblinding|Death|11
852820|NCT00424047|1810882|FG000|On Study at Time of Unblinding|Other|5
852821|NCT00424047|1810883|FG001|On Study at Time of Unblinding|Other|4
852822|NCT00424047|1810882|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
852823|NCT00424047|1810883|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
852824|NCT00424047|1810882|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0
852825|NCT00424047|1810883|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1
852826|NCT00424047|1810882|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12
852827|NCT00424047|1810883|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4
852828|NCT00424047|1810882|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
852829|NCT00424047|1810883|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
852830|NCT00424047|1810882|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
852831|NCT00424047|1810883|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
852832|NCT00424177|1810894|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
852833|NCT00424177|1810894|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
852834|NCT00424177|1810894|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
852835|NCT00424177|1810894|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
852836|NCT00424177|1810894|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
852837|NCT00424177|1810894|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
852838|NCT00424177|1810894|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
852839|NCT00424177|1810894|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
852840|NCT00424177|1810894|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
852841|NCT00424177|1810894|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
852842|NCT00424190|1810908|FG000|Overall Study|Withdrew consent|3
852843|NCT00424190|1810909|FG001|Overall Study|Withdrew consent|4
852844|NCT00424190|1810908|FG000|Overall Study|Death|3
852845|NCT00424190|1810909|FG001|Overall Study|Death|0
852846|NCT00424190|1810908|FG000|Overall Study|Noncompliance|1
852847|NCT00424190|1810909|FG001|Overall Study|Noncompliance|2
852848|NCT00424190|1810908|FG000|Overall Study|Request of sponsor or investigator|0
852849|NCT00424190|1810909|FG001|Overall Study|Request of sponsor or investigator|2
852850|NCT00424190|1810908|FG000|Overall Study|Diagnosis of osteomyelitis|0
852851|NCT00424190|1810909|FG001|Overall Study|Diagnosis of osteomyelitis|1
852852|NCT00424190|1810908|FG000|Overall Study|Other|15
852853|NCT00424190|1810909|FG001|Overall Study|Other|21
852854|NCT00424255|1810917|FG000|Overall Study|Death|115
852855|NCT00424255|1810918|FG001|Overall Study|Death|111
852856|NCT00424255|1810917|FG000|Overall Study|Lost to Follow-up|26
852857|NCT00424255|1810918|FG001|Overall Study|Lost to Follow-up|20
852858|NCT00424255|1810917|FG000|Overall Study|Protocol Violation|0
852859|NCT00424255|1810918|FG001|Overall Study|Protocol Violation|1
852860|NCT00424255|1810917|FG000|Overall Study|Withdrawal by Subject|34
852861|NCT00424255|1810918|FG001|Overall Study|Withdrawal by Subject|38
852862|NCT00424255|1810917|FG000|Overall Study|Physician Decision|3
852863|NCT00424255|1810918|FG001|Overall Study|Physician Decision|7
852864|NCT00424255|1810917|FG000|Overall Study|Cognitive Disturbance|1
852865|NCT00424255|1810918|FG001|Overall Study|Cognitive Disturbance|0
852866|NCT00424255|1810917|FG000|Overall Study|Non-compliance by Participants|1
852867|NCT00424255|1810918|FG001|Overall Study|Non-compliance by Participants|0
852868|NCT00424255|1810917|FG000|Overall Study|Fatigue|1
852869|NCT00424255|1810918|FG001|Overall Study|Fatigue|0
852870|NCT00424255|1810917|FG000|Overall Study|Disease Progression|0
852871|NCT00424255|1810918|FG001|Overall Study|Disease Progression|2
852872|NCT00424255|1810917|FG000|Overall Study|Sponsor Terminated Study|161
852873|NCT00424255|1810918|FG001|Overall Study|Sponsor Terminated Study|167
852874|NCT00424294|1810935|FG000|Overall Study|Adverse Event|4
852875|NCT00424294|1810936|FG001|Overall Study|Adverse Event|10
852876|NCT00424294|1810935|FG000|Overall Study|Lack of Efficacy|2
852877|NCT00424294|1810936|FG001|Overall Study|Lack of Efficacy|1
852878|NCT00424294|1810935|FG000|Overall Study|Withdrawal by Subject|1
852879|NCT00424294|1810936|FG001|Overall Study|Withdrawal by Subject|2
852880|NCT00424294|1810935|FG000|Overall Study|Other|0
852881|NCT00424294|1810936|FG001|Overall Study|Other|2
852882|NCT00424294|1810935|FG000|Overall Study|Randomized but not Treated|1
852883|NCT00424294|1810936|FG001|Overall Study|Randomized but not Treated|0
852884|NCT00424346|1810946|FG000|Core Study|Adverse Event|5
852885|NCT00424346|1810947|FG001|Core Study|Adverse Event|3
852886|NCT00424346|1810948|FG002|Core Study|Adverse Event|1
852887|NCT00424346|1810949|FG003|Core Study|Adverse Event|1
852888|NCT00424346|1810946|FG000|Core Study|Abnormal Laboratory Values|0
852889|NCT00424346|1810947|FG001|Core Study|Abnormal Laboratory Values|1
852890|NCT00424346|1810948|FG002|Core Study|Abnormal Laboratory Values|0
852891|NCT00424346|1810949|FG003|Core Study|Abnormal Laboratory Values|0
852892|NCT00424346|1810946|FG000|Core Study|Lack of Efficacy|1
852893|NCT00424346|1810947|FG001|Core Study|Lack of Efficacy|3
852894|NCT00424346|1810948|FG002|Core Study|Lack of Efficacy|0
852895|NCT00424346|1810949|FG003|Core Study|Lack of Efficacy|4
852896|NCT00424346|1810946|FG000|Core Study|Withdrawal by Subject|1
852897|NCT00424346|1810947|FG001|Core Study|Withdrawal by Subject|0
852898|NCT00424346|1810948|FG002|Core Study|Withdrawal by Subject|0
852899|NCT00424346|1810949|FG003|Core Study|Withdrawal by Subject|2
852900|NCT00424346|1810946|FG000|Core Study|Lost to Follow-up|1
852901|NCT00424346|1810947|FG001|Core Study|Lost to Follow-up|1
852902|NCT00424346|1810948|FG002|Core Study|Lost to Follow-up|0
852903|NCT00424346|1810949|FG003|Core Study|Lost to Follow-up|0
852904|NCT00424346|1810946|FG000|Core Study|Administrative Problems|1
852905|NCT00424346|1810947|FG001|Core Study|Administrative Problems|0
852906|NCT00424346|1810948|FG002|Core Study|Administrative Problems|1
852907|NCT00424346|1810949|FG003|Core Study|Administrative Problems|0
852908|NCT00424346|1810946|FG000|Core Study|Protocol Violation|0
852909|NCT00424346|1810947|FG001|Core Study|Protocol Violation|0
852910|NCT00424346|1810948|FG002|Core Study|Protocol Violation|2
852911|NCT00424346|1810949|FG003|Core Study|Protocol Violation|0
852912|NCT00424346|1810946|FG000|Extension Phase|Adverse Event|0
852913|NCT00424346|1810947|FG001|Extension Phase|Adverse Event|9
852914|NCT00424346|1810948|FG002|Extension Phase|Adverse Event|5
852915|NCT00424346|1810949|FG003|Extension Phase|Adverse Event|4
852916|NCT00424346|1810946|FG000|Extension Phase|Lack of Efficacy|0
852917|NCT00424346|1810947|FG001|Extension Phase|Lack of Efficacy|16
852918|NCT00424346|1810948|FG002|Extension Phase|Lack of Efficacy|14
852919|NCT00424346|1810949|FG003|Extension Phase|Lack of Efficacy|11
852920|NCT00424346|1810946|FG000|Extension Phase|Withdrawal by Subject|0
852921|NCT00424346|1810947|FG001|Extension Phase|Withdrawal by Subject|5
852922|NCT00424346|1810948|FG002|Extension Phase|Withdrawal by Subject|3
852923|NCT00424346|1810949|FG003|Extension Phase|Withdrawal by Subject|4
852924|NCT00424346|1810946|FG000|Extension Phase|Lost to Follow-up|0
852925|NCT00424346|1810947|FG001|Extension Phase|Lost to Follow-up|2
852926|NCT00424346|1810948|FG002|Extension Phase|Lost to Follow-up|0
852927|NCT00424346|1810949|FG003|Extension Phase|Lost to Follow-up|0
852928|NCT00424346|1810946|FG000|Extension Phase|Administrative Problems|0
852929|NCT00424346|1810947|FG001|Extension Phase|Administrative Problems|69
852930|NCT00424346|1810948|FG002|Extension Phase|Administrative Problems|32
852931|NCT00424346|1810949|FG003|Extension Phase|Administrative Problems|35
852932|NCT00424346|1810946|FG000|Extension Phase|Death|0
852933|NCT00424346|1810947|FG001|Extension Phase|Death|0
852934|NCT00424346|1810948|FG002|Extension Phase|Death|0
852935|NCT00424346|1810949|FG003|Extension Phase|Death|1
852936|NCT00424346|1810946|FG000|Extension Phase|Protocol Violation|0
852937|NCT00424346|1810947|FG001|Extension Phase|Protocol Violation|1
852938|NCT00424346|1810948|FG002|Extension Phase|Protocol Violation|1
852939|NCT00424346|1810949|FG003|Extension Phase|Protocol Violation|0
852940|NCT00424372|1810962|FG000|Overall Study|Death|1
852941|NCT00424372|1810962|FG000|Overall Study|Adverse Event|18
852942|NCT00424372|1810962|FG000|Overall Study|Lack of Efficacy|6
852943|NCT00424372|1810962|FG000|Overall Study|Withdrawal by Subject|4
852944|NCT00424372|1810962|FG000|Overall Study|Protocol Violation|1
852945|NCT00424372|1810962|FG000|Overall Study|Health deterioration|1
852946|NCT00424385|1810966|FG000|Cohort 0|Withdrawal by Subject|5
852947|NCT00424385|1810966|FG000|Cohort 0|Physician Decision|1
852948|NCT00424385|1810966|FG000|Cohort 1|Withdrawal by Subject|1
852949|NCT00424398|1810975|FG000|Overall Study|Withdrawal by Subject|2
852950|NCT00424398|1810976|FG001|Overall Study|Withdrawal by Subject|1
852951|NCT00424398|1810977|FG002|Overall Study|Withdrawal by Subject|0
852952|NCT00424398|1810975|FG000|Overall Study|Subject met exclusion criteria|1
852953|NCT00424398|1810976|FG001|Overall Study|Subject met exclusion criteria|0
852954|NCT00424398|1810977|FG002|Overall Study|Subject met exclusion criteria|0
852955|NCT00424463|1810988|FG000|Overall Study|Adverse Event|2
852956|NCT00424463|1810989|FG001|Overall Study|Adverse Event|3
852957|NCT00424463|1810990|FG002|Overall Study|Adverse Event|2
852958|NCT00424463|1810988|FG000|Overall Study|Physician Decision|0
852959|NCT00424463|1810989|FG001|Overall Study|Physician Decision|2
852960|NCT00424463|1810990|FG002|Overall Study|Physician Decision|2
852961|NCT00424463|1810988|FG000|Overall Study|Withdrawal by Subject|4
852962|NCT00424463|1810989|FG001|Overall Study|Withdrawal by Subject|2
852963|NCT00424463|1810990|FG002|Overall Study|Withdrawal by Subject|5
852964|NCT00424463|1810988|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
852965|NCT00424463|1810989|FG001|Overall Study|Tracheotomy due to worsening of ALS|7
852966|NCT00424463|1810990|FG002|Overall Study|Tracheotomy due to worsening of ALS|6
852967|NCT00424463|1810988|FG000|Overall Study|Patient's convenience|0
852968|NCT00424463|1810989|FG001|Overall Study|Patient's convenience|0
852969|NCT00424463|1810990|FG002|Overall Study|Patient's convenience|1
852970|NCT00424476|1811001|FG000|Overall Study|Withdrawal by Subject|7
852971|NCT00424476|1811002|FG001|Overall Study|Withdrawal by Subject|6
852972|NCT00424476|1811003|FG002|Overall Study|Withdrawal by Subject|3
852973|NCT00424476|1811001|FG000|Overall Study|Adverse Event|19
852974|NCT00424476|1811002|FG001|Overall Study|Adverse Event|16
852975|NCT00424476|1811003|FG002|Overall Study|Adverse Event|15
852976|NCT00424476|1811001|FG000|Overall Study|Lack of Efficacy|16
852977|NCT00424476|1811002|FG001|Overall Study|Lack of Efficacy|12
852978|NCT00424476|1811003|FG002|Overall Study|Lack of Efficacy|12
852979|NCT00424476|1811001|FG000|Overall Study|Lack of Compliance|1
852980|NCT00424476|1811002|FG001|Overall Study|Lack of Compliance|1
852981|NCT00424476|1811003|FG002|Overall Study|Lack of Compliance|1
852982|NCT00424476|1811001|FG000|Overall Study|Lost to Follow-up|4
852983|NCT00424476|1811002|FG001|Overall Study|Lost to Follow-up|6
852984|NCT00424476|1811003|FG002|Overall Study|Lost to Follow-up|3
852985|NCT00424476|1811001|FG000|Overall Study|Protocol Violation|7
852986|NCT00424476|1811002|FG001|Overall Study|Protocol Violation|2
852987|NCT00424476|1811003|FG002|Overall Study|Protocol Violation|3
852988|NCT00424476|1811001|FG000|Overall Study|Physician Decision|3
852989|NCT00424476|1811002|FG001|Overall Study|Physician Decision|2
852990|NCT00424476|1811003|FG002|Overall Study|Physician Decision|3
852991|NCT00424476|1811001|FG000|Overall Study|Other|4
852992|NCT00424476|1811002|FG001|Overall Study|Other|3
852993|NCT00424476|1811003|FG002|Overall Study|Other|9
852994|NCT00424489|1811011|FG000|Overall Study|Death|3
852995|NCT00424515|1811021|FG000|Overall Study|Progressive Disease|10
852996|NCT00424515|1811022|FG001|Overall Study|Progressive Disease|11
852997|NCT00424515|1811021|FG000|Overall Study|Adverse Event|0
852998|NCT00424515|1811022|FG001|Overall Study|Adverse Event|1
852999|NCT00424515|1811021|FG000|Overall Study|Intercurrent Illness|0
853000|NCT00424515|1811022|FG001|Overall Study|Intercurrent Illness|1
853001|NCT00424515|1811021|FG000|Overall Study|Withdrawal by Subject|1
853002|NCT00424515|1811022|FG001|Overall Study|Withdrawal by Subject|0
853003|NCT00424528|1811031|FG000|Overall Study|Adverse Event|2
853004|NCT00424528|1811032|FG001|Overall Study|Adverse Event|1
853005|NCT00424528|1811033|FG002|Overall Study|Adverse Event|2
853006|NCT00424528|1811031|FG000|Overall Study|Protocol Violation|1
853007|NCT00424528|1811032|FG001|Overall Study|Protocol Violation|1
853008|NCT00424528|1811033|FG002|Overall Study|Protocol Violation|0
853009|NCT00424528|1811031|FG000|Overall Study|Lost to Follow-up|0
853010|NCT00424528|1811032|FG001|Overall Study|Lost to Follow-up|1
853011|NCT00424528|1811033|FG002|Overall Study|Lost to Follow-up|0
853012|NCT00424528|1811031|FG000|Overall Study|noncompliance with study requirements|2
853013|NCT00424528|1811032|FG001|Overall Study|noncompliance with study requirements|1
853014|NCT00424528|1811033|FG002|Overall Study|noncompliance with study requirements|2
853015|NCT00424593|1811052|FG000|Acute Double-Blind Period|Adverse Event|16
853016|NCT00424593|1811053|FG001|Acute Double-Blind Period|Adverse Event|7
853017|NCT00424593|1811052|FG000|Acute Double-Blind Period|Withdrawal by Subject|11
853018|NCT00424593|1811053|FG001|Acute Double-Blind Period|Withdrawal by Subject|10
853019|NCT00424593|1811052|FG000|Acute Double-Blind Period|Protocol Violation|2
853020|NCT00424593|1811053|FG001|Acute Double-Blind Period|Protocol Violation|2
853021|NCT00424593|1811052|FG000|Acute Double-Blind Period|Physician Decision|1
853022|NCT00424593|1811053|FG001|Acute Double-Blind Period|Physician Decision|2
853023|NCT00424593|1811052|FG000|Acute Double-Blind Period|Lost to Follow-up|1
853024|NCT00424593|1811053|FG001|Acute Double-Blind Period|Lost to Follow-up|1
853025|NCT00424593|1811052|FG000|Acute Double-Blind Period|Lack of Efficacy|0
853026|NCT00424593|1811053|FG001|Acute Double-Blind Period|Lack of Efficacy|1
853027|NCT00424593|1811052|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19
853028|NCT00424593|1811053|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0
853029|NCT00424593|1811052|FG000|Dose-Blind Extension Period|Adverse Event|18
853030|NCT00424593|1811053|FG001|Dose-Blind Extension Period|Adverse Event|0
853031|NCT00424593|1811052|FG000|Dose-Blind Extension Period|Lack of Efficacy|9
853032|NCT00424593|1811053|FG001|Dose-Blind Extension Period|Lack of Efficacy|0
853033|NCT00424593|1811052|FG000|Dose-Blind Extension Period|Protocol Violation|9
853034|NCT00424593|1811053|FG001|Dose-Blind Extension Period|Protocol Violation|0
853035|NCT00424593|1811052|FG000|Dose-Blind Extension Period|Lost to Follow-up|6
853036|NCT00424593|1811053|FG001|Dose-Blind Extension Period|Lost to Follow-up|0
853037|NCT00424593|1811052|FG000|Dose-Blind Extension Period|Physician Decision|3
853038|NCT00424593|1811053|FG001|Dose-Blind Extension Period|Physician Decision|0
853039|NCT00424632|1811074|FG000|Overall Study|Death|0
853040|NCT00424632|1811075|FG001|Overall Study|Death|0
853041|NCT00424632|1811076|FG002|Overall Study|Death|0
853042|NCT00424632|1811077|FG003|Overall Study|Death|0
853043|NCT00424632|1811078|FG004|Overall Study|Death|0
853044|NCT00424632|1811079|FG005|Overall Study|Death|2
853045|NCT00424632|1811080|FG006|Overall Study|Death|0
853046|NCT00424632|1811081|FG007|Overall Study|Death|0
853047|NCT00424632|1811082|FG008|Overall Study|Death|0
853048|NCT00424632|1811083|FG009|Overall Study|Death|0
853049|NCT00424632|1811074|FG000|Overall Study|Adverse Event|0
853050|NCT00424632|1811075|FG001|Overall Study|Adverse Event|0
853051|NCT00424632|1811076|FG002|Overall Study|Adverse Event|0
853052|NCT00424632|1811077|FG003|Overall Study|Adverse Event|0
853053|NCT00424632|1811078|FG004|Overall Study|Adverse Event|0
853054|NCT00424632|1811079|FG005|Overall Study|Adverse Event|0
853055|NCT00424632|1811080|FG006|Overall Study|Adverse Event|0
853056|NCT00424632|1811081|FG007|Overall Study|Adverse Event|0
853057|NCT00424632|1811082|FG008|Overall Study|Adverse Event|3
853058|NCT00424632|1811083|FG009|Overall Study|Adverse Event|2
853059|NCT00424632|1811074|FG000|Overall Study|Global deterioration of health status|0
853060|NCT00424632|1811075|FG001|Overall Study|Global deterioration of health status|0
853061|NCT00424632|1811076|FG002|Overall Study|Global deterioration of health status|0
853062|NCT00424632|1811077|FG003|Overall Study|Global deterioration of health status|1
853063|NCT00424632|1811078|FG004|Overall Study|Global deterioration of health status|1
853064|NCT00424632|1811079|FG005|Overall Study|Global deterioration of health status|0
853065|NCT00424632|1811080|FG006|Overall Study|Global deterioration of health status|0
853066|NCT00424632|1811081|FG007|Overall Study|Global deterioration of health status|0
853067|NCT00424632|1811082|FG008|Overall Study|Global deterioration of health status|0
853068|NCT00424632|1811083|FG009|Overall Study|Global deterioration of health status|0
853069|NCT00424632|1811074|FG000|Overall Study|Objective progression or relapse|1
853070|NCT00424632|1811075|FG001|Overall Study|Objective progression or relapse|1
853071|NCT00424632|1811076|FG002|Overall Study|Objective progression or relapse|1
853072|NCT00424632|1811077|FG003|Overall Study|Objective progression or relapse|2
853073|NCT00424632|1811078|FG004|Overall Study|Objective progression or relapse|2
853074|NCT00424632|1811079|FG005|Overall Study|Objective progression or relapse|13
853075|NCT00424632|1811080|FG006|Overall Study|Objective progression or relapse|7
853076|NCT00424632|1811081|FG007|Overall Study|Objective progression or relapse|3
853077|NCT00424632|1811082|FG008|Overall Study|Objective progression or relapse|12
853078|NCT00424632|1811083|FG009|Overall Study|Objective progression or relapse|4
853079|NCT00424632|1811074|FG000|Overall Study|Other|0
853080|NCT00424632|1811075|FG001|Overall Study|Other|0
853081|NCT00424632|1811076|FG002|Overall Study|Other|0
853082|NCT00424632|1811077|FG003|Overall Study|Other|1
853083|NCT00424632|1811078|FG004|Overall Study|Other|0
853084|NCT00424632|1811079|FG005|Overall Study|Other|0
853085|NCT00424632|1811080|FG006|Overall Study|Other|0
853086|NCT00424632|1811081|FG007|Overall Study|Other|0
853087|NCT00424632|1811082|FG008|Overall Study|Other|1
853088|NCT00424632|1811083|FG009|Overall Study|Other|0
853089|NCT00424749|1811114|FG000|Overall Study|Withdrawal by Subject|1
853090|NCT00424762|1811120|FG000|Overall Study|Withdrawal by Subject|18
853091|NCT00424762|1811121|FG001|Overall Study|Withdrawal by Subject|19
853092|NCT00424762|1811120|FG000|Overall Study|Lost to Follow-up|2
853093|NCT00424762|1811121|FG001|Overall Study|Lost to Follow-up|3
853094|NCT00424775|1811127|FG000|Overall Study|Adverse Event|2
853095|NCT00424775|1811128|FG001|Overall Study|Adverse Event|0
853096|NCT00424775|1811127|FG000|Overall Study|Lack of Efficacy|1
853097|NCT00424775|1811128|FG001|Overall Study|Lack of Efficacy|0
853098|NCT00424827|1811132|FG000|Overall Study|Adverse Event|1
853099|NCT00425061|1811152|FG000|Overall Study|Adverse Event|1
853100|NCT00425061|1811153|FG001|Overall Study|Adverse Event|0
853101|NCT00425061|1811154|FG002|Overall Study|Adverse Event|0
853102|NCT00425061|1811155|FG003|Overall Study|Adverse Event|2
853103|NCT00425061|1811156|FG004|Overall Study|Adverse Event|2
853104|NCT00425061|1811157|FG005|Overall Study|Adverse Event|0
853105|NCT00425061|1811158|FG006|Overall Study|Adverse Event|0
853106|NCT00425061|1811152|FG000|Overall Study|Lost to Follow-up|0
853107|NCT00425061|1811153|FG001|Overall Study|Lost to Follow-up|1
853108|NCT00425061|1811154|FG002|Overall Study|Lost to Follow-up|0
853109|NCT00425061|1811155|FG003|Overall Study|Lost to Follow-up|0
853110|NCT00425061|1811156|FG004|Overall Study|Lost to Follow-up|0
853111|NCT00425061|1811157|FG005|Overall Study|Lost to Follow-up|0
853112|NCT00425061|1811158|FG006|Overall Study|Lost to Follow-up|0
853113|NCT00425061|1811152|FG000|Overall Study|Protocol Violation|1
853114|NCT00425061|1811153|FG001|Overall Study|Protocol Violation|0
853115|NCT00425061|1811154|FG002|Overall Study|Protocol Violation|0
853116|NCT00425061|1811155|FG003|Overall Study|Protocol Violation|0
853117|NCT00425061|1811156|FG004|Overall Study|Protocol Violation|0
853118|NCT00425061|1811157|FG005|Overall Study|Protocol Violation|0
853119|NCT00425061|1811158|FG006|Overall Study|Protocol Violation|0
853120|NCT00425061|1811152|FG000|Overall Study|Withdrawal by Subject|0
853121|NCT00425061|1811153|FG001|Overall Study|Withdrawal by Subject|1
853122|NCT00425061|1811154|FG002|Overall Study|Withdrawal by Subject|0
853123|NCT00425061|1811155|FG003|Overall Study|Withdrawal by Subject|0
853124|NCT00425061|1811156|FG004|Overall Study|Withdrawal by Subject|1
853125|NCT00425061|1811157|FG005|Overall Study|Withdrawal by Subject|0
853126|NCT00425061|1811158|FG006|Overall Study|Withdrawal by Subject|3
853127|NCT00425061|1811152|FG000|Overall Study|Sponsor's request|0
853128|NCT00425061|1811153|FG001|Overall Study|Sponsor's request|0
853129|NCT00425061|1811154|FG002|Overall Study|Sponsor's request|0
853130|NCT00425061|1811155|FG003|Overall Study|Sponsor's request|0
853131|NCT00425061|1811156|FG004|Overall Study|Sponsor's request|19
853132|NCT00425061|1811157|FG005|Overall Study|Sponsor's request|4
853133|NCT00425061|1811158|FG006|Overall Study|Sponsor's request|15
853134|NCT00425061|1811152|FG000|Overall Study|Physician Decision|0
853135|NCT00425061|1811153|FG001|Overall Study|Physician Decision|0
853136|NCT00425061|1811154|FG002|Overall Study|Physician Decision|0
853137|NCT00425061|1811155|FG003|Overall Study|Physician Decision|0
853138|NCT00425061|1811156|FG004|Overall Study|Physician Decision|1
853139|NCT00425061|1811157|FG005|Overall Study|Physician Decision|0
853140|NCT00425061|1811158|FG006|Overall Study|Physician Decision|0
853141|NCT00425061|1811152|FG000|Overall Study|Other|0
853142|NCT00425061|1811153|FG001|Overall Study|Other|0
853143|NCT00425061|1811154|FG002|Overall Study|Other|0
853144|NCT00425061|1811155|FG003|Overall Study|Other|0
853145|NCT00425061|1811156|FG004|Overall Study|Other|3
853146|NCT00425061|1811157|FG005|Overall Study|Other|0
853147|NCT00425061|1811158|FG006|Overall Study|Other|1
853148|NCT00425100|1811176|FG000|Overall Study|Adverse Event|36
853149|NCT00425100|1811176|FG000|Overall Study|Lack of Efficacy|4
853150|NCT00425100|1811176|FG000|Overall Study|Lost to Follow-up|2
853151|NCT00425100|1811176|FG000|Overall Study|Protocol Violation|4
853152|NCT00425100|1811176|FG000|Overall Study|Withdrawal by Subject|7
853153|NCT00425113|1811183|FG000|Overall Study|uncontrolled diabetes mellitus|1
853154|NCT00425113|1811184|FG001|Overall Study|uncontrolled diabetes mellitus|0
853155|NCT00425113|1811183|FG000|Overall Study|diagnosis of abdominal TB|0
853156|NCT00425113|1811184|FG001|Overall Study|diagnosis of abdominal TB|1
853157|NCT00425113|1811183|FG000|Overall Study|missing study drug more than 14 days|0
853158|NCT00425113|1811184|FG001|Overall Study|missing study drug more than 14 days|1
853159|NCT00425113|1811183|FG000|Overall Study|Withdrawal by Subject|1
853160|NCT00425113|1811184|FG001|Overall Study|Withdrawal by Subject|0
853161|NCT00425269|1811193|FG000|Overall Study|Pregnancy|5
853162|NCT00425269|1811194|FG001|Overall Study|Pregnancy|7
853163|NCT00425269|1811193|FG000|Overall Study|Lost to Follow-up|9
853164|NCT00425269|1811194|FG001|Overall Study|Lost to Follow-up|9
853165|NCT00425269|1811193|FG000|Overall Study|moved or medical reason|5
853166|NCT00425269|1811194|FG001|Overall Study|moved or medical reason|4
853167|NCT00425308|1811202|FG000|Overall Study|Adverse Event|2
853168|NCT00425308|1811203|FG001|Overall Study|Adverse Event|1
853169|NCT00425308|1811202|FG000|Overall Study|Withdrawal by Subject|1
853170|NCT00425308|1811203|FG001|Overall Study|Withdrawal by Subject|0
853171|NCT00425308|1811202|FG000|Overall Study|Death|1
853172|NCT00425308|1811203|FG001|Overall Study|Death|0
853173|NCT00425373|1811218|FG000|Overall Study|Adverse Event|2
853174|NCT00425373|1811219|FG001|Overall Study|Adverse Event|2
853175|NCT00425373|1811220|FG002|Overall Study|Adverse Event|0
853176|NCT00425373|1811221|FG003|Overall Study|Adverse Event|1
853177|NCT00425373|1811222|FG004|Overall Study|Adverse Event|4
853178|NCT00425373|1811223|FG005|Overall Study|Adverse Event|6
853179|NCT00425373|1811224|FG006|Overall Study|Adverse Event|2
853180|NCT00425373|1811225|FG007|Overall Study|Adverse Event|3
853181|NCT00425373|1811226|FG008|Overall Study|Adverse Event|8
853182|NCT00425373|1811218|FG000|Overall Study|Lost to Follow-up|0
853183|NCT00425373|1811219|FG001|Overall Study|Lost to Follow-up|1
853184|NCT00425373|1811220|FG002|Overall Study|Lost to Follow-up|0
853185|NCT00425373|1811221|FG003|Overall Study|Lost to Follow-up|0
853186|NCT00425373|1811222|FG004|Overall Study|Lost to Follow-up|1
853187|NCT00425373|1811223|FG005|Overall Study|Lost to Follow-up|0
853188|NCT00425373|1811224|FG006|Overall Study|Lost to Follow-up|0
853189|NCT00425373|1811225|FG007|Overall Study|Lost to Follow-up|0
853190|NCT00425373|1811226|FG008|Overall Study|Lost to Follow-up|0
853191|NCT00425373|1811218|FG000|Overall Study|Protocol Violation|1
853192|NCT00425373|1811219|FG001|Overall Study|Protocol Violation|0
853193|NCT00425373|1811220|FG002|Overall Study|Protocol Violation|1
853194|NCT00425373|1811221|FG003|Overall Study|Protocol Violation|0
853195|NCT00425373|1811222|FG004|Overall Study|Protocol Violation|0
853196|NCT00425373|1811223|FG005|Overall Study|Protocol Violation|0
853197|NCT00425373|1811224|FG006|Overall Study|Protocol Violation|0
853198|NCT00425373|1811225|FG007|Overall Study|Protocol Violation|5
853199|NCT00425373|1811226|FG008|Overall Study|Protocol Violation|3
853200|NCT00425373|1811218|FG000|Overall Study|Withdrawal by Subject|2
853201|NCT00425373|1811219|FG001|Overall Study|Withdrawal by Subject|0
853202|NCT00425373|1811220|FG002|Overall Study|Withdrawal by Subject|2
853203|NCT00425373|1811221|FG003|Overall Study|Withdrawal by Subject|1
853204|NCT00425373|1811222|FG004|Overall Study|Withdrawal by Subject|4
853205|NCT00425373|1811223|FG005|Overall Study|Withdrawal by Subject|0
853206|NCT00425373|1811224|FG006|Overall Study|Withdrawal by Subject|2
853207|NCT00425373|1811225|FG007|Overall Study|Withdrawal by Subject|2
853208|NCT00425373|1811226|FG008|Overall Study|Withdrawal by Subject|2
853209|NCT00425373|1811218|FG000|Overall Study|Lack of Efficacy|0
853210|NCT00425373|1811219|FG001|Overall Study|Lack of Efficacy|0
853211|NCT00425373|1811220|FG002|Overall Study|Lack of Efficacy|0
853212|NCT00425373|1811221|FG003|Overall Study|Lack of Efficacy|0
853213|NCT00425373|1811222|FG004|Overall Study|Lack of Efficacy|1
853214|NCT00425373|1811223|FG005|Overall Study|Lack of Efficacy|3
853215|NCT00425373|1811224|FG006|Overall Study|Lack of Efficacy|3
853216|NCT00425373|1811225|FG007|Overall Study|Lack of Efficacy|0
853217|NCT00425373|1811226|FG008|Overall Study|Lack of Efficacy|5
853218|NCT00425503|1811254|FG000|Overall Study|Adverse Event|2
853219|NCT00425503|1811254|FG000|Overall Study|Protocol Violation|1
853220|NCT00425555|1811260|FG000|Overall Study|Withdrawal by Subject|11
853221|NCT00425555|1811261|FG001|Overall Study|Withdrawal by Subject|8
853222|NCT00425555|1811260|FG000|Overall Study|Lost to Follow-up|0
853223|NCT00425555|1811261|FG001|Overall Study|Lost to Follow-up|1
853224|NCT00425555|1811260|FG000|Overall Study|Administrative problems|3
853225|NCT00425555|1811261|FG001|Overall Study|Administrative problems|0
853226|NCT00425555|1811260|FG000|Overall Study|Death|1
853227|NCT00425555|1811261|FG001|Overall Study|Death|2
853228|NCT00425555|1811260|FG000|Overall Study|New cancer therapy|2
853229|NCT00425555|1811261|FG001|Overall Study|New cancer therapy|1
853230|NCT00425555|1811260|FG000|Overall Study|Disease progression|36
853231|NCT00425555|1811261|FG001|Overall Study|Disease progression|33
853232|NCT00425555|1811260|FG000|Overall Study|Adverse Event|25
853233|NCT00425555|1811261|FG001|Overall Study|Adverse Event|15
853234|NCT00425555|1811260|FG000|Overall Study|Protocol Violation|1
853235|NCT00425555|1811261|FG001|Overall Study|Protocol Violation|0
853236|NCT00425607|1811270|FG000|Overall Study|Death|1
853237|NCT00425607|1811270|FG000|Overall Study|Withdrawal by Subject|1
853238|NCT00425698|1811280|FG000|Overall Study|Adverse Event|3
853239|NCT00425698|1811281|FG001|Overall Study|Adverse Event|1
853240|NCT00425698|1811280|FG000|Overall Study|Withdrawal by Subject|0
853241|NCT00425698|1811281|FG001|Overall Study|Withdrawal by Subject|1
853242|NCT00425750|1811287|FG000|Overall Study|Death|1
853243|NCT00425750|1811287|FG000|Overall Study|Withdrawal by Subject|3
853244|NCT00425750|1811287|FG000|Overall Study|Adverse Event|3
853245|NCT00425750|1811287|FG000|Overall Study|Progression of disease|18
853246|NCT00425854|1811297|FG000|Overall Study|Progressive Disease|19
853247|NCT00425854|1811298|FG001|Overall Study|Progressive Disease|12
853248|NCT00425854|1811297|FG000|Overall Study|Dose reduction toxicity AE|8
853249|NCT00425854|1811298|FG001|Overall Study|Dose reduction toxicity AE|7
853250|NCT00425854|1811297|FG000|Overall Study|Other Adverse Event|2
853251|NCT00425854|1811298|FG001|Overall Study|Other Adverse Event|2
853252|NCT00425945|1811307|FG000|Overall Study|Concern about Supplement|2
853253|NCT00425945|1811308|FG001|Overall Study|Concern about Supplement|0
853254|NCT00425945|1811307|FG000|Overall Study|Inconvenience|0
853255|NCT00425945|1811308|FG001|Overall Study|Inconvenience|2
853256|NCT00425945|1811307|FG000|Overall Study|Lost to Follow-up|0
853257|NCT00425945|1811308|FG001|Overall Study|Lost to Follow-up|2
853258|NCT00425945|1811307|FG000|Overall Study|Began hypertension medication|1
853259|NCT00425945|1811308|FG001|Overall Study|Began hypertension medication|0
853260|NCT00425945|1811307|FG000|Overall Study|Began cancer treatments|1
853261|NCT00425945|1811308|FG001|Overall Study|Began cancer treatments|0
853262|NCT00425945|1811307|FG000|Overall Study|Moved from area|0
853263|NCT00425945|1811308|FG001|Overall Study|Moved from area|1
853264|NCT00426127|1811316|FG000|Overall Study|Adverse Event|1
853265|NCT00426127|1811316|FG000|Overall Study|Removed due to disease progression|1
853266|NCT00426231|1811331|FG000|Overall Study|Withdrawal by Subject|9
853267|NCT00426231|1811332|FG001|Overall Study|Withdrawal by Subject|12
853268|NCT00426270|1811338|FG000|Overall Study|Incorrectly Enrolled in the Study|1
853269|NCT00426270|1811338|FG000|Overall Study|Adverse Event|5
853270|NCT00426361|1811358|FG000|Overall Study|Lost to Follow-up|3
853271|NCT00426361|1811359|FG001|Overall Study|Lost to Follow-up|2
853272|NCT00426361|1811360|FG002|Overall Study|Lost to Follow-up|5
853273|NCT00426361|1811358|FG000|Overall Study|Withdrawal by Subject|1
853274|NCT00426361|1811359|FG001|Overall Study|Withdrawal by Subject|3
853275|NCT00426361|1811360|FG002|Overall Study|Withdrawal by Subject|0
853276|NCT00426556|1811389|FG000|Phase I - Core Phase|Disease Progression|0
853277|NCT00426556|1811390|FG001|Phase I - Core Phase|Disease Progression|6
853278|NCT00426556|1811391|FG002|Phase I - Core Phase|Disease Progression|2
853279|NCT00426556|1811392|FG003|Phase I - Core Phase|Disease Progression|0
853280|NCT00426556|1811389|FG000|Phase I - Core Phase|Adverse Event|1
853281|NCT00426556|1811390|FG001|Phase I - Core Phase|Adverse Event|3
853282|NCT00426556|1811391|FG002|Phase I - Core Phase|Adverse Event|1
853283|NCT00426556|1811392|FG003|Phase I - Core Phase|Adverse Event|0
853284|NCT00426556|1811389|FG000|Phase I - Core Phase|Death|0
853285|NCT00426556|1811390|FG001|Phase I - Core Phase|Death|1
853286|NCT00426556|1811391|FG002|Phase I - Core Phase|Death|0
853287|NCT00426556|1811392|FG003|Phase I - Core Phase|Death|0
853288|NCT00426556|1811389|FG000|Phase I - Extension Phase|Adverse Event|0
853289|NCT00426556|1811390|FG001|Phase I - Extension Phase|Adverse Event|1
853290|NCT00426556|1811391|FG002|Phase I - Extension Phase|Adverse Event|1
853291|NCT00426556|1811392|FG003|Phase I - Extension Phase|Adverse Event|0
853292|NCT00426556|1811389|FG000|Phase I - Extension Phase|Disease Progression|5
853293|NCT00426556|1811390|FG001|Phase I - Extension Phase|Disease Progression|5
853294|NCT00426556|1811391|FG002|Phase I - Extension Phase|Disease Progression|6
853295|NCT00426556|1811392|FG003|Phase I - Extension Phase|Disease Progression|0
853296|NCT00426556|1811389|FG000|Phase II - Core Phase|Withdrawal by Subject|0
853297|NCT00426556|1811390|FG001|Phase II - Core Phase|Withdrawal by Subject|0
853298|NCT00426556|1811391|FG002|Phase II - Core Phase|Withdrawal by Subject|0
853299|NCT00426556|1811392|FG003|Phase II - Core Phase|Withdrawal by Subject|3
853300|NCT00426556|1811389|FG000|Phase II - Core Phase|Disease Progression|0
853301|NCT00426556|1811390|FG001|Phase II - Core Phase|Disease Progression|0
853302|NCT00426556|1811391|FG002|Phase II - Core Phase|Disease Progression|0
853303|NCT00426556|1811392|FG003|Phase II - Core Phase|Disease Progression|16
853304|NCT00426556|1811389|FG000|Phase II - Core Phase|Adverse Event|0
853305|NCT00426556|1811390|FG001|Phase II - Core Phase|Adverse Event|0
853306|NCT00426556|1811391|FG002|Phase II - Core Phase|Adverse Event|0
853307|NCT00426556|1811392|FG003|Phase II - Core Phase|Adverse Event|8
853308|NCT00426556|1811389|FG000|Phase II - Extension Phase|Disease Progression|0
853309|NCT00426556|1811390|FG001|Phase II - Extension Phase|Disease Progression|0
853310|NCT00426556|1811391|FG002|Phase II - Extension Phase|Disease Progression|0
853311|NCT00426556|1811392|FG003|Phase II - Extension Phase|Disease Progression|21
853312|NCT00426556|1811389|FG000|Phase II - Extension Phase|Adverse Event|0
853313|NCT00426556|1811390|FG001|Phase II - Extension Phase|Adverse Event|0
853314|NCT00426556|1811391|FG002|Phase II - Extension Phase|Adverse Event|0
853315|NCT00426556|1811392|FG003|Phase II - Extension Phase|Adverse Event|2
853316|NCT00426660|1811402|FG000|Overall Study|Death|14
853317|NCT00426660|1811402|FG000|Overall Study|Adverse Event|23
853318|NCT00426660|1811402|FG000|Overall Study|Insufficient Clinical Response|22
853319|NCT00426660|1811402|FG000|Overall Study|Lost to Follow-up|15
853320|NCT00426660|1811402|FG000|Overall Study|Other|23
853321|NCT00426660|1811402|FG000|Overall Study|Withdrawal by Subject|18
853322|NCT00426660|1811402|FG000|Overall Study|Protocol Violation|1
853323|NCT00426660|1811402|FG000|Overall Study|Enrolled Not Treated|15
853324|NCT00426751|1811408|FG000|Overall Study|Adverse Event|8
853325|NCT00426751|1811409|FG001|Overall Study|Adverse Event|1
853326|NCT00426751|1811408|FG000|Overall Study|Lost to Follow-up|7
853327|NCT00426751|1811409|FG001|Overall Study|Lost to Follow-up|6
853328|NCT00426751|1811408|FG000|Overall Study|Consent Withdrawn|0
853329|NCT00426751|1811409|FG001|Overall Study|Consent Withdrawn|1
853330|NCT00426751|1811408|FG000|Overall Study|Other Reasons|7
853331|NCT00426751|1811409|FG001|Overall Study|Other Reasons|12
853332|NCT00426764|1811415|FG000|Overall Study|Protocol Violation|1
853333|NCT00426764|1811415|FG000|Overall Study|Withdrawal by Subject|4
853334|NCT00426764|1811415|FG000|Overall Study|Physician Decision|6
853335|NCT00426764|1811415|FG000|Overall Study|Compassionate Use|1
853336|NCT00426764|1811415|FG000|Overall Study|Progressive Disease|83
853337|NCT00426764|1811415|FG000|Overall Study|Adverse Event|24
853338|NCT00426764|1811415|FG000|Overall Study|Other|1
853339|NCT00426764|1811415|FG000|Overall Study|Death|1
853340|NCT00426764|1811415|FG000|Overall Study|Other Reasons (Miscellaneous)|10
853341|NCT00426842|1811425|FG000|Overall Study|Lost to Follow-up|1
853342|NCT00427011|1811435|FG000|Overall Study|Adverse Event|10
853343|NCT00427011|1811435|FG000|Overall Study|Withdrawal by Subject|1
853344|NCT00427011|1811435|FG000|Overall Study|Lack of Efficacy|2
853345|NCT00427011|1811435|FG000|Overall Study|Other|12
853346|NCT00427349|1811475|FG000|Overall Study|Lack of Efficacy|23
853347|NCT00427349|1811475|FG000|Overall Study|Adverse Event|14
853348|NCT00427349|1811475|FG000|Overall Study|Death|1
853349|NCT00427349|1811475|FG000|Overall Study|Withdrawal by Subject|3
853350|NCT00427349|1811475|FG000|Overall Study|Alternative therapy|1
853351|NCT00427349|1811475|FG000|Overall Study|Other|2
853352|NCT00427349|1811475|FG000|Overall Study|Ineligible|1
853353|NCT00427349|1811475|FG000|Overall Study|Never started therapy|1
853354|NCT00427635|1811485|FG000|Treatment Phase|Withdrawal by Subject|1
853355|NCT00427635|1811486|FG001|Treatment Phase|Withdrawal by Subject|0
853356|NCT00427635|1811485|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0
853357|NCT00427635|1811486|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1
853358|NCT00427648|1811494|FG000|Overall Study|Protocol Violation|1
853359|NCT00427648|1811495|FG001|Overall Study|Protocol Violation|2
853360|NCT00427648|1811494|FG000|Overall Study|Adverse Event|0
853361|NCT00427648|1811495|FG001|Overall Study|Adverse Event|1
853362|NCT00427700|1811510|FG000|Overall Study|Lost to Follow-up|2
853363|NCT00427700|1811511|FG001|Overall Study|Lost to Follow-up|5
853364|NCT00427700|1811510|FG000|Overall Study|no induction of menses|1
853365|NCT00427700|1811511|FG001|Overall Study|no induction of menses|4
853366|NCT00427700|1811510|FG000|Overall Study|Pregnancy|0
853367|NCT00427700|1811511|FG001|Overall Study|Pregnancy|2
853368|NCT00427778|1811522|FG000|First Intervention (4 Weeks)|no longer interested|1
853369|NCT00427778|1811523|FG001|First Intervention (4 Weeks)|no longer interested|0
853370|NCT00427778|1811522|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2
853371|NCT00427778|1811523|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0
853372|NCT00427778|1811522|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
853373|NCT00427778|1811523|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
853374|NCT00427778|1811522|FG000|First Intervention (4 Weeks)|anxious about using ring|1
853375|NCT00427778|1811523|FG001|First Intervention (4 Weeks)|anxious about using ring|0
853376|NCT00427895|1811564|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
853377|NCT00427895|1811565|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
853378|NCT00427895|1811566|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
853379|NCT00427895|1811567|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
853380|NCT00427895|1811568|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
853381|NCT00427895|1811569|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
853382|NCT00427895|1811570|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
853383|NCT00427895|1811571|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
853384|NCT00427895|1811564|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0
853385|NCT00427895|1811565|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0
853386|NCT00427895|1811566|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0
853387|NCT00427895|1811567|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0
853388|NCT00427895|1811568|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0
853389|NCT00427895|1811569|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0
853390|NCT00427895|1811570|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0
853391|NCT00427895|1811571|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1
853392|NCT00427895|1811564|FG000|Vax 2/Year 3 to 4|Protocol Violation|0
853393|NCT00427895|1811565|FG001|Vax 2/Year 3 to 4|Protocol Violation|0
853394|NCT00427895|1811566|FG002|Vax 2/Year 3 to 4|Protocol Violation|0
853395|NCT00427895|1811567|FG003|Vax 2/Year 3 to 4|Protocol Violation|0
853396|NCT00427895|1811568|FG004|Vax 2/Year 3 to 4|Protocol Violation|0
853397|NCT00427895|1811569|FG005|Vax 2/Year 3 to 4|Protocol Violation|0
853398|NCT00427895|1811570|FG006|Vax 2/Year 3 to 4|Protocol Violation|0
853399|NCT00427895|1811571|FG007|Vax 2/Year 3 to 4|Protocol Violation|1
853400|NCT00427895|1811564|FG000|Vax 2/Year 3 to 4|Failed to Return|0
853401|NCT00427895|1811565|FG001|Vax 2/Year 3 to 4|Failed to Return|0
853402|NCT00427895|1811566|FG002|Vax 2/Year 3 to 4|Failed to Return|0
853403|NCT00427895|1811567|FG003|Vax 2/Year 3 to 4|Failed to Return|0
853404|NCT00427895|1811568|FG004|Vax 2/Year 3 to 4|Failed to Return|1
853405|NCT00427895|1811569|FG005|Vax 2/Year 3 to 4|Failed to Return|0
853406|NCT00427895|1811570|FG006|Vax 2/Year 3 to 4|Failed to Return|0
853407|NCT00427895|1811571|FG007|Vax 2/Year 3 to 4|Failed to Return|0
853408|NCT00427895|1811564|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
853409|NCT00427895|1811565|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
853410|NCT00427895|1811566|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
853411|NCT00427895|1811567|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
853412|NCT00427895|1811568|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
853413|NCT00427895|1811569|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
853414|NCT00427895|1811570|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
853415|NCT00427895|1811571|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
853416|NCT00427895|1811564|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
853417|NCT00427895|1811565|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
853418|NCT00427895|1811566|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
853419|NCT00427895|1811567|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
853420|NCT00427895|1811568|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
853421|NCT00427895|1811569|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
853422|NCT00427895|1811570|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
853423|NCT00427895|1811571|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
853424|NCT00427895|1811564|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
853425|NCT00427895|1811565|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
853426|NCT00427895|1811566|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
853427|NCT00427895|1811567|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
853428|NCT00427895|1811568|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
853429|NCT00427895|1811569|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
853430|NCT00427895|1811570|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
853431|NCT00427895|1811571|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
853432|NCT00427895|1811564|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
853433|NCT00427895|1811565|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
853434|NCT00427895|1811566|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
853435|NCT00427895|1811567|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
853436|NCT00427895|1811568|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
853437|NCT00427895|1811569|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
853438|NCT00427895|1811570|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
853439|NCT00427895|1811571|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
853440|NCT00427895|1811564|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
853441|NCT00427895|1811565|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
853442|NCT00427895|1811566|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
853443|NCT00427895|1811567|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
853444|NCT00427895|1811568|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
853445|NCT00427895|1811569|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
853446|NCT00427895|1811570|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
853447|NCT00427895|1811571|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
853448|NCT00427895|1811564|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
853449|NCT00427895|1811565|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
853450|NCT00427895|1811566|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
853451|NCT00427895|1811567|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
853452|NCT00427895|1811568|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
853453|NCT00427895|1811569|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
853454|NCT00427895|1811570|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
853455|NCT00427895|1811571|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
853456|NCT00427895|1811564|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0
853457|NCT00427895|1811565|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0
853458|NCT00427895|1811566|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1
853459|NCT00427895|1811567|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2
853460|NCT00427895|1811568|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0
853461|NCT00427895|1811569|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0
853462|NCT00427895|1811570|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0
853463|NCT00427895|1811571|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0
853464|NCT00427895|1811564|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
853465|NCT00427895|1811565|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
853466|NCT00427895|1811566|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
853467|NCT00427895|1811567|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
853468|NCT00427895|1811568|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
853469|NCT00427895|1811569|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
853470|NCT00427895|1811570|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
853471|NCT00427895|1811571|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
853472|NCT00427895|1811564|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3
853473|NCT00427895|1811565|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3
853474|NCT00427895|1811566|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0
853475|NCT00427895|1811567|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1
853476|NCT00427895|1811568|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0
853477|NCT00427895|1811569|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0
853478|NCT00427895|1811570|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0
853479|NCT00427895|1811571|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0
853480|NCT00427895|1811564|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
853481|NCT00427895|1811565|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
853482|NCT00427895|1811566|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
853483|NCT00427895|1811567|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
853484|NCT00427895|1811568|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
853485|NCT00427895|1811569|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
853486|NCT00427895|1811570|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
853487|NCT00427895|1811571|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
853488|NCT00427895|1811564|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0
853489|NCT00427895|1811565|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1
853490|NCT00427895|1811566|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0
853491|NCT00427895|1811567|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0
853492|NCT00427895|1811568|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0
853493|NCT00427895|1811569|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0
853494|NCT00427895|1811570|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0
853495|NCT00427895|1811571|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0
853496|NCT00427895|1811564|FG000|Vax 1/Year 1 Follow-up|Death|1
853497|NCT00427895|1811565|FG001|Vax 1/Year 1 Follow-up|Death|0
853498|NCT00427895|1811566|FG002|Vax 1/Year 1 Follow-up|Death|0
853499|NCT00427895|1811567|FG003|Vax 1/Year 1 Follow-up|Death|0
853500|NCT00427895|1811568|FG004|Vax 1/Year 1 Follow-up|Death|0
853501|NCT00427895|1811569|FG005|Vax 1/Year 1 Follow-up|Death|0
853502|NCT00427895|1811570|FG006|Vax 1/Year 1 Follow-up|Death|0
853503|NCT00427895|1811571|FG007|Vax 1/Year 1 Follow-up|Death|0
853504|NCT00427895|1811564|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0
853505|NCT00427895|1811565|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0
853506|NCT00427895|1811566|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12
853507|NCT00427895|1811567|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5
853508|NCT00427895|1811568|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0
853509|NCT00427895|1811569|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0
853510|NCT00427895|1811570|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0
853511|NCT00427895|1811571|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0
853512|NCT00427895|1811564|FG000|Vax 1/Year 1 Follow-up|Other|0
853513|NCT00427895|1811565|FG001|Vax 1/Year 1 Follow-up|Other|0
853514|NCT00427895|1811566|FG002|Vax 1/Year 1 Follow-up|Other|0
853515|NCT00427895|1811567|FG003|Vax 1/Year 1 Follow-up|Other|2
853516|NCT00427895|1811568|FG004|Vax 1/Year 1 Follow-up|Other|0
853517|NCT00427895|1811569|FG005|Vax 1/Year 1 Follow-up|Other|0
853518|NCT00427895|1811570|FG006|Vax 1/Year 1 Follow-up|Other|0
853519|NCT00427895|1811571|FG007|Vax 1/Year 1 Follow-up|Other|0
853520|NCT00427895|1811564|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
853521|NCT00427895|1811565|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
853522|NCT00427895|1811566|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
853523|NCT00427895|1811567|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
853524|NCT00427895|1811568|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
853525|NCT00427895|1811569|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
853526|NCT00427895|1811570|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
853527|NCT00427895|1811571|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
853528|NCT00427908|1811614|FG000|Primary Phase|Lost to Follow-up|4
853529|NCT00427908|1811615|FG001|Primary Phase|Lost to Follow-up|0
853530|NCT00427908|1811616|FG002|Primary Phase|Lost to Follow-up|2
853531|NCT00427908|1811617|FG003|Primary Phase|Lost to Follow-up|0
853532|NCT00427908|1811614|FG000|Primary Phase|Withdrawal by Subject|1
853533|NCT00427908|1811615|FG001|Primary Phase|Withdrawal by Subject|2
853534|NCT00427908|1811616|FG002|Primary Phase|Withdrawal by Subject|1
853535|NCT00427908|1811617|FG003|Primary Phase|Withdrawal by Subject|0
853536|NCT00427908|1811614|FG000|Primary Phase|Adverse Event|0
853537|NCT00427908|1811615|FG001|Primary Phase|Adverse Event|1
853538|NCT00427908|1811616|FG002|Primary Phase|Adverse Event|0
853539|NCT00427908|1811617|FG003|Primary Phase|Adverse Event|0
853540|NCT00427921|1811652|FG000|Overall Study|Adverse Event|26
853541|NCT00427921|1811652|FG000|Overall Study|Withdrawal by Subject|4
853542|NCT00427921|1811652|FG000|Overall Study|Lost to Follow-up|2
853543|NCT00427921|1811652|FG000|Overall Study|Other reason not specified|10
853544|NCT00427921|1811652|FG000|Overall Study|Adverse Event + Hospitalization|1
853545|NCT00427921|1811652|FG000|Overall Study|Adverse Event + Withdrew Consent|1
853546|NCT00427921|1811652|FG000|Overall Study|Adverse Event + No Response|1
853547|NCT00427921|1811652|FG000|Overall Study|Adverse Event + Worsening of CD|1
853548|NCT00427921|1811652|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1
853549|NCT00427921|1811652|FG000|Overall Study|Adverse Event + Lost Response|1
853550|NCT00427921|1811652|FG000|Overall Study|Adverse Event + Withdrawn from Study|1
853551|NCT00427921|1811652|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1
853552|NCT00427934|1811660|FG000|Overall Study|Adverse Event|1
853553|NCT00427934|1811661|FG001|Overall Study|Adverse Event|0
853554|NCT00427934|1811662|FG002|Overall Study|Adverse Event|5
853555|NCT00427934|1811663|FG003|Overall Study|Adverse Event|4
853556|NCT00427934|1811660|FG000|Overall Study|Lack of Efficacy|0
853557|NCT00427934|1811661|FG001|Overall Study|Lack of Efficacy|0
853558|NCT00427934|1811662|FG002|Overall Study|Lack of Efficacy|5
853559|NCT00427934|1811663|FG003|Overall Study|Lack of Efficacy|2
853560|NCT00427934|1811660|FG000|Overall Study|Randomized But Did Not Receive Treatment|0
853561|NCT00427934|1811661|FG001|Overall Study|Randomized But Did Not Receive Treatment|0
853562|NCT00427934|1811662|FG002|Overall Study|Randomized But Did Not Receive Treatment|1
853563|NCT00427934|1811663|FG003|Overall Study|Randomized But Did Not Receive Treatment|1
853564|NCT00427934|1811660|FG000|Overall Study|Other|0
853565|NCT00427934|1811661|FG001|Overall Study|Other|0
853566|NCT00427934|1811662|FG002|Overall Study|Other|11
853567|NCT00427934|1811663|FG003|Overall Study|Other|5
853568|NCT00427934|1811660|FG000|Overall Study|Withdrawal by Subject|0
853569|NCT00427934|1811661|FG001|Overall Study|Withdrawal by Subject|0
853570|NCT00427934|1811662|FG002|Overall Study|Withdrawal by Subject|1
853571|NCT00427934|1811663|FG003|Overall Study|Withdrawal by Subject|3
853572|NCT00427960|1811677|FG000|Overall Study|Adverse Event|2
853573|NCT00427960|1811678|FG001|Overall Study|Adverse Event|0
853574|NCT00427960|1811677|FG000|Overall Study|Withdrawal by Subject|0
853575|NCT00427960|1811678|FG001|Overall Study|Withdrawal by Subject|3
853576|NCT00427960|1811677|FG000|Overall Study|Other|0
853577|NCT00427960|1811678|FG001|Overall Study|Other|1
853578|NCT00427999|1811688|FG000|Overall Study|Adverse Event|6
853579|NCT00427999|1811688|FG000|Overall Study|Abnormal laboratory values|1
853580|NCT00427999|1811688|FG000|Overall Study|Unsatisfactory therapeutic effect|13
853581|NCT00427999|1811688|FG000|Overall Study|Protocol Violation|2
853582|NCT00427999|1811688|FG000|Overall Study|Withdrawal by Subject|9
853583|NCT00427999|1811688|FG000|Overall Study|Death|1
853584|NCT00428090|1811701|FG000|Overall Study|Adverse Event|10
853585|NCT00428090|1811702|FG001|Overall Study|Adverse Event|8
853586|NCT00428090|1811703|FG002|Overall Study|Adverse Event|10
853587|NCT00428090|1811704|FG003|Overall Study|Adverse Event|11
853588|NCT00428090|1811701|FG000|Overall Study|Lost to Follow-up|3
853589|NCT00428090|1811702|FG001|Overall Study|Lost to Follow-up|6
853590|NCT00428090|1811703|FG002|Overall Study|Lost to Follow-up|1
853591|NCT00428090|1811704|FG003|Overall Study|Lost to Follow-up|4
853592|NCT00428090|1811701|FG000|Overall Study|Protocol Violation|3
853593|NCT00428090|1811702|FG001|Overall Study|Protocol Violation|1
853594|NCT00428090|1811703|FG002|Overall Study|Protocol Violation|3
853595|NCT00428090|1811704|FG003|Overall Study|Protocol Violation|3
853596|NCT00428090|1811701|FG000|Overall Study|Withdrawal by Subject|10
853597|NCT00428090|1811702|FG001|Overall Study|Withdrawal by Subject|12
853598|NCT00428090|1811703|FG002|Overall Study|Withdrawal by Subject|15
853599|NCT00428090|1811704|FG003|Overall Study|Withdrawal by Subject|5
853600|NCT00428090|1811701|FG000|Overall Study|Sponsor terminated study|0
853601|NCT00428090|1811702|FG001|Overall Study|Sponsor terminated study|1
853602|NCT00428090|1811703|FG002|Overall Study|Sponsor terminated study|0
853603|NCT00428090|1811704|FG003|Overall Study|Sponsor terminated study|0
853604|NCT00428090|1811701|FG000|Overall Study|Non-compliance|4
853605|NCT00428090|1811702|FG001|Overall Study|Non-compliance|0
853606|NCT00428090|1811703|FG002|Overall Study|Non-compliance|1
853607|NCT00428090|1811704|FG003|Overall Study|Non-compliance|3
853608|NCT00428090|1811701|FG000|Overall Study|Par. did not returned to visit|1
853609|NCT00428090|1811702|FG001|Overall Study|Par. did not returned to visit|0
853610|NCT00428090|1811703|FG002|Overall Study|Par. did not returned to visit|0
853611|NCT00428090|1811704|FG003|Overall Study|Par. did not returned to visit|1
853612|NCT00428090|1811701|FG000|Overall Study|Follow-Up visit not possible|1
853613|NCT00428090|1811702|FG001|Overall Study|Follow-Up visit not possible|0
853614|NCT00428090|1811703|FG002|Overall Study|Follow-Up visit not possible|0
853615|NCT00428090|1811704|FG003|Overall Study|Follow-Up visit not possible|0
853616|NCT00428090|1811701|FG000|Overall Study|Prohibited medication used for SAE|1
853617|NCT00428090|1811702|FG001|Overall Study|Prohibited medication used for SAE|0
853618|NCT00428090|1811703|FG002|Overall Study|Prohibited medication used for SAE|0
853619|NCT00428090|1811704|FG003|Overall Study|Prohibited medication used for SAE|0
853620|NCT00428090|1811701|FG000|Overall Study|Death of par.|1
853621|NCT00428090|1811702|FG001|Overall Study|Death of par.|0
853622|NCT00428090|1811703|FG002|Overall Study|Death of par.|1
853623|NCT00428090|1811704|FG003|Overall Study|Death of par.|0
853624|NCT00428090|1811701|FG000|Overall Study|Visit 7 exceed the visit window|0
853625|NCT00428090|1811702|FG001|Overall Study|Visit 7 exceed the visit window|1
853626|NCT00428090|1811703|FG002|Overall Study|Visit 7 exceed the visit window|0
853627|NCT00428090|1811704|FG003|Overall Study|Visit 7 exceed the visit window|0
853628|NCT00428090|1811701|FG000|Overall Study|Medical monitor terminated par.|0
853629|NCT00428090|1811702|FG001|Overall Study|Medical monitor terminated par.|1
853630|NCT00428090|1811703|FG002|Overall Study|Medical monitor terminated par.|0
853631|NCT00428090|1811704|FG003|Overall Study|Medical monitor terminated par.|0
853632|NCT00428090|1811701|FG000|Overall Study|Mental status of par. was|0
853633|NCT00428090|1811702|FG001|Overall Study|Mental status of par. was|1
853634|NCT00428090|1811703|FG002|Overall Study|Mental status of par. was|0
853635|NCT00428090|1811704|FG003|Overall Study|Mental status of par. was|0
853636|NCT00428090|1811701|FG000|Overall Study|Worsening of AD|0
853637|NCT00428090|1811702|FG001|Overall Study|Worsening of AD|0
853638|NCT00428090|1811703|FG002|Overall Study|Worsening of AD|1
853639|NCT00428090|1811704|FG003|Overall Study|Worsening of AD|0
853640|NCT00428090|1811701|FG000|Overall Study|Excluded for concerning QTc value|0
853641|NCT00428090|1811702|FG001|Overall Study|Excluded for concerning QTc value|0
853642|NCT00428090|1811703|FG002|Overall Study|Excluded for concerning QTc value|1
853643|NCT00428090|1811704|FG003|Overall Study|Excluded for concerning QTc value|0
853644|NCT00428090|1811701|FG000|Overall Study|Insufficient AD documentation|0
853645|NCT00428090|1811702|FG001|Overall Study|Insufficient AD documentation|0
853646|NCT00428090|1811703|FG002|Overall Study|Insufficient AD documentation|1
853647|NCT00428090|1811704|FG003|Overall Study|Insufficient AD documentation|0
853648|NCT00428090|1811701|FG000|Overall Study|High MMSE scores|0
853649|NCT00428090|1811702|FG001|Overall Study|High MMSE scores|0
853650|NCT00428090|1811703|FG002|Overall Study|High MMSE scores|1
853651|NCT00428090|1811704|FG003|Overall Study|High MMSE scores|0
853652|NCT00428090|1811701|FG000|Overall Study|Deterioration of cognitive status|0
853653|NCT00428090|1811702|FG001|Overall Study|Deterioration of cognitive status|0
853654|NCT00428090|1811703|FG002|Overall Study|Deterioration of cognitive status|1
853655|NCT00428090|1811704|FG003|Overall Study|Deterioration of cognitive status|0
853656|NCT00428090|1811701|FG000|Overall Study|Serious adverse event|0
853657|NCT00428090|1811702|FG001|Overall Study|Serious adverse event|0
853658|NCT00428090|1811703|FG002|Overall Study|Serious adverse event|1
853659|NCT00428090|1811704|FG003|Overall Study|Serious adverse event|0
853660|NCT00428090|1811701|FG000|Overall Study|Excluded for heart insufficiency|0
853661|NCT00428090|1811702|FG001|Overall Study|Excluded for heart insufficiency|0
853662|NCT00428090|1811703|FG002|Overall Study|Excluded for heart insufficiency|1
853663|NCT00428090|1811704|FG003|Overall Study|Excluded for heart insufficiency|0
853664|NCT00428090|1811701|FG000|Overall Study|Raised Creatinine Value|0
853665|NCT00428090|1811702|FG001|Overall Study|Raised Creatinine Value|0
853666|NCT00428090|1811703|FG002|Overall Study|Raised Creatinine Value|0
853667|NCT00428090|1811704|FG003|Overall Study|Raised Creatinine Value|1
853668|NCT00428116|1811724|FG000|Overall Study|Death|1
853669|NCT00428116|1811725|FG001|Overall Study|Death|0
853670|NCT00428116|1811724|FG000|Overall Study|Withdrawal by Subject|1
853671|NCT00428116|1811725|FG001|Overall Study|Withdrawal by Subject|0
853672|NCT00428116|1811724|FG000|Overall Study|Lost to Follow-up|1
853673|NCT00428116|1811725|FG001|Overall Study|Lost to Follow-up|0
853674|NCT00428220|1811732|FG000|Overall Study|Participant died|8
853675|NCT00428220|1811732|FG000|Overall Study|Global deterioration of health status|7
853676|NCT00428220|1811732|FG000|Overall Study|Lost to Follow-up|4
853677|NCT00428220|1811732|FG000|Overall Study|Objective progression or relapse|123
853678|NCT00428220|1811732|FG000|Overall Study|Participant refused continued treatment|7
853679|NCT00428220|1811732|FG000|Overall Study|Adverse Event|51
853680|NCT00428220|1811732|FG000|Overall Study|Other|23
853681|NCT00428246|1811750|FG000|Overall Study|Withdrawal by Subject|0
853682|NCT00428246|1811751|FG001|Overall Study|Withdrawal by Subject|0
853683|NCT00428246|1811752|FG002|Overall Study|Withdrawal by Subject|1
853684|NCT00428246|1811750|FG000|Overall Study|Adverse Event|1
853685|NCT00428246|1811751|FG001|Overall Study|Adverse Event|0
853686|NCT00428246|1811752|FG002|Overall Study|Adverse Event|0
853687|NCT00428389|1811773|FG000|Core Phase|Adverse Event|6
853688|NCT00428389|1811774|FG001|Core Phase|Adverse Event|4
853689|NCT00428389|1811773|FG000|Core Phase|Lack of Efficacy|2
853690|NCT00428389|1811774|FG001|Core Phase|Lack of Efficacy|0
853691|NCT00428389|1811773|FG000|Core Phase|Abnormal test procedure result(s)|0
853692|NCT00428389|1811774|FG001|Core Phase|Abnormal test procedure result(s)|1
853693|NCT00428389|1811773|FG000|Core Phase|Withdrawal by Subject|3
853694|NCT00428389|1811774|FG001|Core Phase|Withdrawal by Subject|4
853695|NCT00428389|1811773|FG000|Core Phase|Protocol deviation|0
853696|NCT00428389|1811774|FG001|Core Phase|Protocol deviation|2
853697|NCT00428389|1811773|FG000|Extension Phase|Adverse Event|17
853698|NCT00428389|1811774|FG001|Extension Phase|Adverse Event|11
853699|NCT00428389|1811773|FG000|Extension Phase|Lack of Efficacy|4
853700|NCT00428389|1811774|FG001|Extension Phase|Lack of Efficacy|3
853701|NCT00428389|1811773|FG000|Extension Phase|Withdrawal by Subject|6
853702|NCT00428389|1811774|FG001|Extension Phase|Withdrawal by Subject|6
853703|NCT00428389|1811773|FG000|Extension Phase|Lost to Follow-up|0
853704|NCT00428389|1811774|FG001|Extension Phase|Lost to Follow-up|3
853705|NCT00428389|1811773|FG000|Extension Phase|Death|1
853706|NCT00428389|1811774|FG001|Extension Phase|Death|0
853707|NCT00428389|1811773|FG000|Extension Phase|Protocol Violation|3
853708|NCT00428389|1811774|FG001|Extension Phase|Protocol Violation|2
853709|NCT00428389|1811773|FG000|Extension Phase|Administrative problems|1
853710|NCT00428389|1811774|FG001|Extension Phase|Administrative problems|1
853711|NCT00428441|1811780|FG000|Overall Study|Lost to Follow-up|1
853712|NCT00428597|1811799|FG000|Overall Study|Randomized but not treated|3
853713|NCT00428597|1811800|FG001|Overall Study|Randomized but not treated|3
853714|NCT00428597|1811799|FG000|Overall Study|Objective Progression or Relapse|19
853715|NCT00428597|1811800|FG001|Overall Study|Objective Progression or Relapse|47
853716|NCT00428597|1811799|FG000|Overall Study|Study Terminated by Sponsor|41
853717|NCT00428597|1811800|FG001|Overall Study|Study Terminated by Sponsor|16
853718|NCT00428597|1811799|FG000|Overall Study|Adverse Event|15
853719|NCT00428597|1811800|FG001|Overall Study|Adverse Event|7
853720|NCT00428597|1811799|FG000|Overall Study|Global Deterioration of Health Status|1
853721|NCT00428597|1811800|FG001|Overall Study|Global Deterioration of Health Status|5
853722|NCT00428597|1811799|FG000|Overall Study|Protocol Violation|2
853723|NCT00428597|1811800|FG001|Overall Study|Protocol Violation|1
853724|NCT00428597|1811799|FG000|Overall Study|Withdrawal by Subject|2
853725|NCT00428597|1811800|FG001|Overall Study|Withdrawal by Subject|1
853726|NCT00428597|1811799|FG000|Overall Study|Other|1
853727|NCT00428597|1811800|FG001|Overall Study|Other|1
853728|NCT00428597|1811799|FG000|Overall Study|Lost to Follow-up|0
853729|NCT00428597|1811800|FG001|Overall Study|Lost to Follow-up|1
853730|NCT00428597|1811799|FG000|Overall Study|Pregnancy|1
853731|NCT00428597|1811800|FG001|Overall Study|Pregnancy|0
853732|NCT00428597|1811799|FG000|Overall Study|Death|1
853733|NCT00428597|1811800|FG001|Overall Study|Death|3
853734|NCT00428610|1811809|FG000|Overall Study|Death Due to Adverse Event|3
853735|NCT00428610|1811810|FG001|Overall Study|Death Due to Adverse Event|0
853736|NCT00428610|1811811|FG002|Overall Study|Death Due to Adverse Event|5
853737|NCT00428610|1811809|FG000|Overall Study|Death Due to Progressive Disease|0
853738|NCT00428610|1811810|FG001|Overall Study|Death Due to Progressive Disease|0
853739|NCT00428610|1811811|FG002|Overall Study|Death Due to Progressive Disease|2
853740|NCT00428610|1811809|FG000|Overall Study|Adverse Event|2
853741|NCT00428610|1811810|FG001|Overall Study|Adverse Event|3
853742|NCT00428610|1811811|FG002|Overall Study|Adverse Event|2
853743|NCT00428610|1811809|FG000|Overall Study|Investigator Decision|2
853744|NCT00428610|1811810|FG001|Overall Study|Investigator Decision|1
853745|NCT00428610|1811811|FG002|Overall Study|Investigator Decision|1
853746|NCT00428610|1811809|FG000|Overall Study|Progressive Disease|42
853747|NCT00428610|1811810|FG001|Overall Study|Progressive Disease|14
853748|NCT00428610|1811811|FG002|Overall Study|Progressive Disease|22
853749|NCT00428610|1811809|FG000|Overall Study|Withdrawal by Subject|4
853750|NCT00428610|1811810|FG001|Overall Study|Withdrawal by Subject|0
853751|NCT00428610|1811811|FG002|Overall Study|Withdrawal by Subject|0
853752|NCT00428714|1811821|FG000|Overall Study|Progressive Disease|28
853753|NCT00428714|1811822|FG001|Overall Study|Progressive Disease|36
853754|NCT00428714|1811821|FG000|Overall Study|Withdrawal by Subject|0
853755|NCT00428714|1811822|FG001|Overall Study|Withdrawal by Subject|3
853756|NCT00428714|1811821|FG000|Overall Study|Adverse Event|0
853757|NCT00428714|1811822|FG001|Overall Study|Adverse Event|2
853758|NCT00428714|1811821|FG000|Overall Study|Physician Decision|1
853759|NCT00428714|1811822|FG001|Overall Study|Physician Decision|1
853760|NCT00428714|1811821|FG000|Overall Study|Death due to Progressive Disease (PD)|1
853761|NCT00428714|1811822|FG001|Overall Study|Death due to Progressive Disease (PD)|0
853762|NCT00428714|1811821|FG000|Overall Study|Death due to other then PD|1
853763|NCT00428714|1811822|FG001|Overall Study|Death due to other then PD|0
853764|NCT00428792|1811831|FG000|Overall Study|Lack of Efficacy|1
853765|NCT00428792|1811832|FG001|Overall Study|Lack of Efficacy|3
853766|NCT00428792|1811831|FG000|Overall Study|Lost to Follow-up|0
853767|NCT00428792|1811832|FG001|Overall Study|Lost to Follow-up|1
853768|NCT00428844|1811841|FG000|Completed Study Drug Treatment|Adverse Event|2
853769|NCT00428844|1811842|FG001|Completed Study Drug Treatment|Adverse Event|4
853770|NCT00428844|1811843|FG002|Completed Study Drug Treatment|Adverse Event|4
853771|NCT00428844|1811841|FG000|Completed Study Drug Treatment|Protocol Violation|0
853772|NCT00428844|1811842|FG001|Completed Study Drug Treatment|Protocol Violation|1
853773|NCT00428844|1811843|FG002|Completed Study Drug Treatment|Protocol Violation|1
853774|NCT00428844|1811841|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0
853775|NCT00428844|1811842|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1
853776|NCT00428844|1811843|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1
853777|NCT00428844|1811841|FG000|Completed Study Drug Treatment|Randomized Not Treated|0
853778|NCT00428844|1811842|FG001|Completed Study Drug Treatment|Randomized Not Treated|0
853779|NCT00428844|1811843|FG002|Completed Study Drug Treatment|Randomized Not Treated|1
853780|NCT00428844|1811841|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0
853781|NCT00428844|1811842|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1
853782|NCT00428844|1811843|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1
853783|NCT00428844|1811841|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0
853784|NCT00428844|1811842|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0
853785|NCT00428844|1811843|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1
853786|NCT00428844|1811841|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
853787|NCT00428844|1811842|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
853788|NCT00428844|1811843|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
853789|NCT00428844|1811841|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
853790|NCT00428844|1811842|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
853791|NCT00428844|1811843|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
853792|NCT00428844|1811841|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
853793|NCT00428844|1811842|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
853794|NCT00428844|1811843|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
853795|NCT00428948|1811857|FG000|Overall Study|Lost to Follow-up|15
853796|NCT00428948|1811858|FG001|Overall Study|Lost to Follow-up|8
853797|NCT00428948|1811857|FG000|Overall Study|Adverse Event|148
853798|NCT00428948|1811858|FG001|Overall Study|Adverse Event|24
853799|NCT00428948|1811857|FG000|Overall Study|Subject Met Withdrawal Criteria|4
853800|NCT00428948|1811858|FG001|Overall Study|Subject Met Withdrawal Criteria|0
853801|NCT00428948|1811857|FG000|Overall Study|Investigator Withdrew Subject|3
853802|NCT00428948|1811858|FG001|Overall Study|Investigator Withdrew Subject|4
853803|NCT00428948|1811857|FG000|Overall Study|Subject Withdrew Consent|50
853804|NCT00428948|1811858|FG001|Overall Study|Subject Withdrew Consent|30
853805|NCT00428948|1811857|FG000|Overall Study|Protocol Deviation|1
853806|NCT00428948|1811858|FG001|Overall Study|Protocol Deviation|1
853807|NCT00429104|1811882|FG000|Overall Study|Protocol Violation|1
853808|NCT00429169|1811892|FG000|Overall Study|Lost to Follow-up|0
853809|NCT00429169|1811893|FG001|Overall Study|Lost to Follow-up|1
853810|NCT00429169|1811892|FG000|Overall Study|Ineligibility discovered after entry|2
853811|NCT00429169|1811893|FG001|Overall Study|Ineligibility discovered after entry|1
853812|NCT00429182|1811901|FG000|Overall Study|Not evaluable, Disease Progression|2
853813|NCT00429182|1811901|FG000|Overall Study|Not eligible|5
853814|NCT00429273|1811908|FG000|Overall Study|Lost to Follow-up|1
853815|NCT00429273|1811909|FG001|Overall Study|Lost to Follow-up|2
853816|NCT00429273|1811910|FG002|Overall Study|Lost to Follow-up|2
853817|NCT00429273|1811908|FG000|Overall Study|Physician Decision|6
853818|NCT00429273|1811909|FG001|Overall Study|Physician Decision|5
853819|NCT00429273|1811910|FG002|Overall Study|Physician Decision|5
853820|NCT00429273|1811908|FG000|Overall Study|Adverse Event|1
853821|NCT00429273|1811909|FG001|Overall Study|Adverse Event|1
853822|NCT00429273|1811910|FG002|Overall Study|Adverse Event|2
853823|NCT00429299|1811921|FG000|Overall Study|Disease Progression|1
853824|NCT00429299|1811922|FG001|Overall Study|Disease Progression|1
853825|NCT00429299|1811923|FG002|Overall Study|Disease Progression|0
853826|NCT00429299|1811921|FG000|Overall Study|Adverse Event|2
853827|NCT00429299|1811922|FG001|Overall Study|Adverse Event|5
853828|NCT00429299|1811923|FG002|Overall Study|Adverse Event|1
853829|NCT00429299|1811921|FG000|Overall Study|Protocol Violation|1
853830|NCT00429299|1811922|FG001|Overall Study|Protocol Violation|0
853831|NCT00429299|1811923|FG002|Overall Study|Protocol Violation|0
853832|NCT00429299|1811921|FG000|Overall Study|Withdrawal by Subject|0
853833|NCT00429299|1811922|FG001|Overall Study|Withdrawal by Subject|1
853834|NCT00429299|1811923|FG002|Overall Study|Withdrawal by Subject|3
853835|NCT00429364|1811933|FG000|Overall Study|Withdrawal by Subject|11
853836|NCT00429364|1811934|FG001|Overall Study|Withdrawal by Subject|5
853837|NCT00429364|1811933|FG000|Overall Study|Physician Decision|4
853838|NCT00429364|1811934|FG001|Overall Study|Physician Decision|2
853839|NCT00429364|1811933|FG000|Overall Study|Lost to Follow-up|7
853840|NCT00429364|1811934|FG001|Overall Study|Lost to Follow-up|6
853841|NCT00429364|1811933|FG000|Overall Study|Death|0
853842|NCT00429364|1811934|FG001|Overall Study|Death|1
853843|NCT00429364|1811933|FG000|Overall Study|Underwent aortic root surgery|10
853844|NCT00429364|1811934|FG001|Overall Study|Underwent aortic root surgery|18
853845|NCT00429364|1811933|FG000|Overall Study|Pregnancy|0
853846|NCT00429364|1811934|FG001|Overall Study|Pregnancy|1
853847|NCT00429416|1811949|FG000|Overall Study|Death|1
853848|NCT00429494|1811953|FG000|Overall Study|Withdrawal by Subject|9
853849|NCT00429494|1811953|FG000|Overall Study|Death|6
853850|NCT00429572|1811961|FG000|Overall Study|Disease progression|1
853851|NCT00429585|1811967|FG000|Overall Study|Death|1
853852|NCT00429585|1811968|FG001|Overall Study|Death|0
853853|NCT00429585|1811967|FG000|Overall Study|Lost to Follow-up|27
853854|NCT00429585|1811968|FG001|Overall Study|Lost to Follow-up|20
853855|NCT00429585|1811967|FG000|Overall Study|Physician Decision|2
853856|NCT00429585|1811968|FG001|Overall Study|Physician Decision|0
853857|NCT00429663|1811976|FG000|Overall Study|Lost to Follow-up|24
853858|NCT00429663|1811977|FG001|Overall Study|Lost to Follow-up|31
853859|NCT00429663|1811976|FG000|Overall Study|Physician Decision|6
853860|NCT00429663|1811977|FG001|Overall Study|Physician Decision|3
853861|NCT00429663|1811976|FG000|Overall Study|Withdrawal by Subject|2
853862|NCT00429663|1811977|FG001|Overall Study|Withdrawal by Subject|5
853863|NCT00429663|1811976|FG000|Overall Study|Death|4
853864|NCT00429663|1811977|FG001|Overall Study|Death|0
853865|NCT00429793|1811992|FG000|Overall Study|Improper pre-protocol treatment|3
853866|NCT00429793|1811992|FG000|Overall Study|Required test not done|1
853867|NCT00429793|1811992|FG000|Overall Study|Never treated|1
853868|NCT00429793|1811992|FG000|Overall Study|Non-measurable|1
853869|NCT00429923|1812004|FG000|Overall Study|Adverse Event|0
853870|NCT00429923|1812005|FG001|Overall Study|Adverse Event|2
853871|NCT00429923|1812006|FG002|Overall Study|Adverse Event|3
853872|NCT00429923|1812004|FG000|Overall Study|Lack of Efficacy|4
853873|NCT00429923|1812005|FG001|Overall Study|Lack of Efficacy|1
853874|NCT00429923|1812006|FG002|Overall Study|Lack of Efficacy|33
853875|NCT00429923|1812004|FG000|Overall Study|Lost to Follow-up|0
853876|NCT00429923|1812005|FG001|Overall Study|Lost to Follow-up|0
853877|NCT00429923|1812006|FG002|Overall Study|Lost to Follow-up|2
853878|NCT00429923|1812004|FG000|Overall Study|Withdrew Consent|1
853879|NCT00429923|1812005|FG001|Overall Study|Withdrew Consent|0
853880|NCT00429923|1812006|FG002|Overall Study|Withdrew Consent|1
853881|NCT00429923|1812004|FG000|Overall Study|Early Termination|0
853882|NCT00429923|1812005|FG001|Overall Study|Early Termination|1
853883|NCT00429923|1812006|FG002|Overall Study|Early Termination|0
853884|NCT00430092|1812020|FG000|Overall Study|Adverse Event|0
853885|NCT00430092|1812021|FG001|Overall Study|Adverse Event|0
853886|NCT00430092|1812022|FG002|Overall Study|Adverse Event|1
853887|NCT00430092|1812020|FG000|Overall Study|Lack of Efficacy|5
853888|NCT00430092|1812021|FG001|Overall Study|Lack of Efficacy|2
853889|NCT00430092|1812022|FG002|Overall Study|Lack of Efficacy|54
853890|NCT00430092|1812020|FG000|Overall Study|Lost to Follow-up|1
853891|NCT00430092|1812021|FG001|Overall Study|Lost to Follow-up|0
853892|NCT00430092|1812022|FG002|Overall Study|Lost to Follow-up|0
853893|NCT00430092|1812020|FG000|Overall Study|Protocol Violation|0
853894|NCT00430092|1812021|FG001|Overall Study|Protocol Violation|1
853895|NCT00430092|1812022|FG002|Overall Study|Protocol Violation|1
853896|NCT00430092|1812020|FG000|Overall Study|Withdrawal by Subject|0
853897|NCT00430092|1812021|FG001|Overall Study|Withdrawal by Subject|1
853898|NCT00430092|1812022|FG002|Overall Study|Withdrawal by Subject|1
853899|NCT00430248|1812039|FG000|Overall Study|Adverse Event|49
853900|NCT00430248|1812040|FG001|Overall Study|Adverse Event|61
853901|NCT00430248|1812041|FG002|Overall Study|Adverse Event|64
853902|NCT00430248|1812039|FG000|Overall Study|Protocol Violation|10
853903|NCT00430248|1812040|FG001|Overall Study|Protocol Violation|2
853904|NCT00430248|1812041|FG002|Overall Study|Protocol Violation|4
853905|NCT00430248|1812039|FG000|Overall Study|Personal Reasons|12
853906|NCT00430248|1812040|FG001|Overall Study|Personal Reasons|24
853907|NCT00430248|1812041|FG002|Overall Study|Personal Reasons|9
853908|NCT00430248|1812039|FG000|Overall Study|Lost to Follow-up|28
853909|NCT00430248|1812040|FG001|Overall Study|Lost to Follow-up|33
853910|NCT00430248|1812041|FG002|Overall Study|Lost to Follow-up|28
853911|NCT00430248|1812039|FG000|Overall Study|Therapeutic Failure|1
853912|NCT00430248|1812040|FG001|Overall Study|Therapeutic Failure|1
853913|NCT00430248|1812041|FG002|Overall Study|Therapeutic Failure|1
853914|NCT00430248|1812039|FG000|Overall Study|Withdrawal by Subject|14
853915|NCT00430248|1812040|FG001|Overall Study|Withdrawal by Subject|20
853916|NCT00430248|1812041|FG002|Overall Study|Withdrawal by Subject|16
853917|NCT00430248|1812039|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0
853918|NCT00430248|1812040|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
853919|NCT00430248|1812041|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
853920|NCT00430248|1812039|FG000|Overall Study|Gout Flare|3
853921|NCT00430248|1812040|FG001|Overall Study|Gout Flare|7
853922|NCT00430248|1812041|FG002|Overall Study|Gout Flare|2
853923|NCT00430248|1812039|FG000|Overall Study|Reason Not Specified|8
853924|NCT00430248|1812040|FG001|Overall Study|Reason Not Specified|8
853925|NCT00430248|1812041|FG002|Overall Study|Reason Not Specified|11
853926|NCT00430300|1812053|FG000|Overall Study|Adverse Event|0
853927|NCT00430300|1812054|FG001|Overall Study|Adverse Event|2
853928|NCT00430300|1812055|FG002|Overall Study|Adverse Event|1
853929|NCT00430300|1812056|FG003|Overall Study|Adverse Event|1
853930|NCT00430300|1812053|FG000|Overall Study|Withdrawal by Subject|1
853931|NCT00430300|1812054|FG001|Overall Study|Withdrawal by Subject|0
853932|NCT00430300|1812055|FG002|Overall Study|Withdrawal by Subject|5
853933|NCT00430300|1812056|FG003|Overall Study|Withdrawal by Subject|0
853934|NCT00430300|1812053|FG000|Overall Study|Laboratory abnormality|1
853935|NCT00430300|1812054|FG001|Overall Study|Laboratory abnormality|0
853936|NCT00430300|1812055|FG002|Overall Study|Laboratory abnormality|0
853937|NCT00430300|1812056|FG003|Overall Study|Laboratory abnormality|0
853938|NCT00430300|1812053|FG000|Overall Study|Other|0
853939|NCT00430300|1812054|FG001|Overall Study|Other|0
853940|NCT00430300|1812055|FG002|Overall Study|Other|0
853941|NCT00430300|1812056|FG003|Overall Study|Other|1
853942|NCT00430352|1812066|FG000|Overall Study|Disease progression|58
853943|NCT00430352|1812066|FG000|Overall Study|Withdrawal by Subject|11
853944|NCT00430352|1812066|FG000|Overall Study|Adverse Event|16
853945|NCT00430352|1812066|FG000|Overall Study|Death|5
853946|NCT00430352|1812066|FG000|Overall Study|Other|48
853947|NCT00430482|1812072|FG000|Completed Treatment|Insufficient Treatment|7
853948|NCT00430482|1812073|FG001|Completed Treatment|Insufficient Treatment|11
853949|NCT00430495|1812083|FG000|Overall Study|Adverse Event|2
853950|NCT00430495|1812084|FG001|Overall Study|Adverse Event|3
853951|NCT00430495|1812085|FG002|Overall Study|Adverse Event|2
853952|NCT00430495|1812086|FG003|Overall Study|Adverse Event|0
853953|NCT00430495|1812083|FG000|Overall Study|Death|0
853954|NCT00430495|1812084|FG001|Overall Study|Death|0
853955|NCT00430495|1812085|FG002|Overall Study|Death|1
853956|NCT00430495|1812086|FG003|Overall Study|Death|0
853957|NCT00430495|1812083|FG000|Overall Study|Lost to Follow-up|0
853958|NCT00430495|1812084|FG001|Overall Study|Lost to Follow-up|1
853959|NCT00430495|1812085|FG002|Overall Study|Lost to Follow-up|4
853960|NCT00430495|1812086|FG003|Overall Study|Lost to Follow-up|0
853961|NCT00430495|1812083|FG000|Overall Study|Protocol Violation|1
853962|NCT00430495|1812084|FG001|Overall Study|Protocol Violation|0
853963|NCT00430495|1812085|FG002|Overall Study|Protocol Violation|1
853964|NCT00430495|1812086|FG003|Overall Study|Protocol Violation|0
853965|NCT00430495|1812083|FG000|Overall Study|Disease Progression|1
853966|NCT00430495|1812084|FG001|Overall Study|Disease Progression|1
853967|NCT00430495|1812085|FG002|Overall Study|Disease Progression|0
853968|NCT00430495|1812086|FG003|Overall Study|Disease Progression|0
853969|NCT00430495|1812083|FG000|Overall Study|Other|8
853970|NCT00430495|1812084|FG001|Overall Study|Other|2
853971|NCT00430495|1812085|FG002|Overall Study|Other|5
853972|NCT00430495|1812086|FG003|Overall Study|Other|4
853973|NCT00430495|1812083|FG000|Overall Study|Randomized but not Treated|2
853974|NCT00430495|1812084|FG001|Overall Study|Randomized but not Treated|0
853975|NCT00430495|1812085|FG002|Overall Study|Randomized but not Treated|0
853976|NCT00430495|1812086|FG003|Overall Study|Randomized but not Treated|0
853977|NCT00430508|1812100|FG000|Overall Study|Adverse Event|2
853978|NCT00430508|1812101|FG001|Overall Study|Adverse Event|3
853979|NCT00430508|1812102|FG002|Overall Study|Adverse Event|5
853980|NCT00430508|1812103|FG003|Overall Study|Adverse Event|3
853981|NCT00430508|1812100|FG000|Overall Study|Withdrawal by Subject|0
853982|NCT00430508|1812101|FG001|Overall Study|Withdrawal by Subject|1
853983|NCT00430508|1812102|FG002|Overall Study|Withdrawal by Subject|1
853984|NCT00430508|1812103|FG003|Overall Study|Withdrawal by Subject|1
853985|NCT00430508|1812100|FG000|Overall Study|responder at visit 4|0
853986|NCT00430508|1812101|FG001|Overall Study|responder at visit 4|0
853987|NCT00430508|1812102|FG002|Overall Study|responder at visit 4|2
853988|NCT00430508|1812103|FG003|Overall Study|responder at visit 4|0
853989|NCT00430508|1812100|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
853990|NCT00430508|1812101|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
853991|NCT00430508|1812102|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
853992|NCT00430508|1812103|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
853993|NCT00430508|1812100|FG000|Overall Study|Other|1
853994|NCT00430508|1812101|FG001|Overall Study|Other|1
853995|NCT00430508|1812102|FG002|Overall Study|Other|3
853996|NCT00430508|1812103|FG003|Overall Study|Other|0
853997|NCT00430521|1812117|FG000|Overall Study|Adverse Event|0
853998|NCT00430521|1812118|FG001|Overall Study|Adverse Event|0
853999|NCT00430521|1812119|FG002|Overall Study|Adverse Event|0
854000|NCT00430521|1812120|FG003|Overall Study|Adverse Event|0
854001|NCT00430521|1812121|FG004|Overall Study|Adverse Event|0
854002|NCT00430521|1812122|FG005|Overall Study|Adverse Event|2
854003|NCT00430521|1812123|FG006|Overall Study|Adverse Event|1
854004|NCT00430521|1812124|FG007|Overall Study|Adverse Event|0
854005|NCT00430521|1812117|FG000|Overall Study|Lost to Follow-up|7
854006|NCT00430521|1812118|FG001|Overall Study|Lost to Follow-up|8
854007|NCT00430521|1812119|FG002|Overall Study|Lost to Follow-up|3
854008|NCT00430521|1812120|FG003|Overall Study|Lost to Follow-up|5
854009|NCT00430521|1812121|FG004|Overall Study|Lost to Follow-up|5
854010|NCT00430521|1812122|FG005|Overall Study|Lost to Follow-up|2
854011|NCT00430521|1812123|FG006|Overall Study|Lost to Follow-up|8
854012|NCT00430521|1812124|FG007|Overall Study|Lost to Follow-up|10
854013|NCT00430521|1812117|FG000|Overall Study|Pregnancy|0
854014|NCT00430521|1812118|FG001|Overall Study|Pregnancy|0
854015|NCT00430521|1812119|FG002|Overall Study|Pregnancy|0
854016|NCT00430521|1812120|FG003|Overall Study|Pregnancy|0
854017|NCT00430521|1812121|FG004|Overall Study|Pregnancy|0
854018|NCT00430521|1812122|FG005|Overall Study|Pregnancy|0
854019|NCT00430521|1812123|FG006|Overall Study|Pregnancy|1
854020|NCT00430521|1812124|FG007|Overall Study|Pregnancy|0
854021|NCT00430521|1812117|FG000|Overall Study|Vaccine Expired|0
854022|NCT00430521|1812118|FG001|Overall Study|Vaccine Expired|0
854023|NCT00430521|1812119|FG002|Overall Study|Vaccine Expired|0
854024|NCT00430521|1812120|FG003|Overall Study|Vaccine Expired|0
854025|NCT00430521|1812121|FG004|Overall Study|Vaccine Expired|0
854026|NCT00430521|1812122|FG005|Overall Study|Vaccine Expired|1
854027|NCT00430521|1812123|FG006|Overall Study|Vaccine Expired|0
854028|NCT00430521|1812124|FG007|Overall Study|Vaccine Expired|0
854029|NCT00430521|1812117|FG000|Overall Study|Protocol Violation|1
854030|NCT00430521|1812118|FG001|Overall Study|Protocol Violation|0
854031|NCT00430521|1812119|FG002|Overall Study|Protocol Violation|0
854032|NCT00430521|1812120|FG003|Overall Study|Protocol Violation|0
854033|NCT00430521|1812121|FG004|Overall Study|Protocol Violation|0
854034|NCT00430521|1812122|FG005|Overall Study|Protocol Violation|0
854035|NCT00430521|1812123|FG006|Overall Study|Protocol Violation|0
854036|NCT00430521|1812124|FG007|Overall Study|Protocol Violation|0
854037|NCT00430521|1812117|FG000|Overall Study|Withdrawal by Subject|3
854038|NCT00430521|1812118|FG001|Overall Study|Withdrawal by Subject|1
854039|NCT00430521|1812119|FG002|Overall Study|Withdrawal by Subject|0
854040|NCT00430521|1812120|FG003|Overall Study|Withdrawal by Subject|3
854041|NCT00430521|1812121|FG004|Overall Study|Withdrawal by Subject|0
854042|NCT00430521|1812122|FG005|Overall Study|Withdrawal by Subject|0
854043|NCT00430521|1812123|FG006|Overall Study|Withdrawal by Subject|0
854044|NCT00430521|1812124|FG007|Overall Study|Withdrawal by Subject|2
854045|NCT00430573|1812155|FG000|Overall Study|Withdrawal by Subject|5
854046|NCT00430638|1812172|FG000|Overall Study|Adverse Event|15
854047|NCT00430638|1812173|FG001|Overall Study|Adverse Event|15
854048|NCT00430638|1812172|FG000|Overall Study|Uncontrolled blood pressure|48
854049|NCT00430638|1812173|FG001|Overall Study|Uncontrolled blood pressure|13
854050|NCT00430638|1812172|FG000|Overall Study|Lost to Follow-up|1
854051|NCT00430638|1812173|FG001|Overall Study|Lost to Follow-up|7
854052|NCT00430638|1812172|FG000|Overall Study|Protocol Violation|6
854053|NCT00430638|1812173|FG001|Overall Study|Protocol Violation|4
854054|NCT00430638|1812172|FG000|Overall Study|Withdrawal by Subject|4
854055|NCT00430638|1812173|FG001|Overall Study|Withdrawal by Subject|6
854056|NCT00430638|1812172|FG000|Overall Study|Non-compliant|2
854057|NCT00430638|1812173|FG001|Overall Study|Non-compliant|1
854058|NCT00430638|1812172|FG000|Overall Study|Other|2
854059|NCT00430638|1812173|FG001|Overall Study|Other|2
854060|NCT00430677|1812186|FG000|Short-term Period|Death|1
854061|NCT00430677|1812187|FG001|Short-term Period|Death|1
854062|NCT00430677|1812188|FG002|Short-term Period|Death|5
854063|NCT00430677|1812186|FG000|Short-term Period|Adverse Event|15
854064|NCT00430677|1812187|FG001|Short-term Period|Adverse Event|13
854065|NCT00430677|1812188|FG002|Short-term Period|Adverse Event|9
854066|NCT00430677|1812186|FG000|Short-term Period|Lack of Efficacy|5
854067|NCT00430677|1812187|FG001|Short-term Period|Lack of Efficacy|6
854068|NCT00430677|1812188|FG002|Short-term Period|Lack of Efficacy|4
854069|NCT00430677|1812186|FG000|Short-term Period|Withdrawal by Subject|1
854070|NCT00430677|1812187|FG001|Short-term Period|Withdrawal by Subject|1
854071|NCT00430677|1812188|FG002|Short-term Period|Withdrawal by Subject|2
854072|NCT00430677|1812186|FG000|Short-term Period|Participant no longer met study criteria|1
854073|NCT00430677|1812187|FG001|Short-term Period|Participant no longer met study criteria|1
854074|NCT00430677|1812188|FG002|Short-term Period|Participant no longer met study criteria|2
854075|NCT00430677|1812186|FG000|Short-term Period|Poor compliance/ noncompliance|0
854076|NCT00430677|1812187|FG001|Short-term Period|Poor compliance/ noncompliance|1
854077|NCT00430677|1812188|FG002|Short-term Period|Poor compliance/ noncompliance|0
854078|NCT00430677|1812186|FG000|Short-term Period|Pregnancy|0
854079|NCT00430677|1812187|FG001|Short-term Period|Pregnancy|2
854080|NCT00430677|1812188|FG002|Short-term Period|Pregnancy|0
854081|NCT00430677|1812186|FG000|Long-term Extension Period|Death|1
854082|NCT00430677|1812187|FG001|Long-term Extension Period|Death|0
854083|NCT00430677|1812188|FG002|Long-term Extension Period|Death|0
854084|NCT00430677|1812186|FG000|Long-term Extension Period|Adverse Event|3
854085|NCT00430677|1812187|FG001|Long-term Extension Period|Adverse Event|2
854086|NCT00430677|1812188|FG002|Long-term Extension Period|Adverse Event|5
854087|NCT00430677|1812186|FG000|Long-term Extension Period|Lack of Efficacy|5
854088|NCT00430677|1812187|FG001|Long-term Extension Period|Lack of Efficacy|3
854089|NCT00430677|1812188|FG002|Long-term Extension Period|Lack of Efficacy|8
854090|NCT00430677|1812186|FG000|Long-term Extension Period|Lost to Follow-up|1
854091|NCT00430677|1812187|FG001|Long-term Extension Period|Lost to Follow-up|1
854092|NCT00430677|1812188|FG002|Long-term Extension Period|Lost to Follow-up|1
854093|NCT00430677|1812186|FG000|Long-term Extension Period|Withdrawal by Subject|5
854094|NCT00430677|1812187|FG001|Long-term Extension Period|Withdrawal by Subject|1
854095|NCT00430677|1812188|FG002|Long-term Extension Period|Withdrawal by Subject|2
854096|NCT00430677|1812186|FG000|Long-term Extension Period|Pregnancy|1
854097|NCT00430677|1812187|FG001|Long-term Extension Period|Pregnancy|1
854098|NCT00430677|1812188|FG002|Long-term Extension Period|Pregnancy|0
854099|NCT00430677|1812186|FG000|Long-term Extension Period|Administrative reason by sponsor|41
854100|NCT00430677|1812187|FG001|Long-term Extension Period|Administrative reason by sponsor|49
854101|NCT00430677|1812188|FG002|Long-term Extension Period|Administrative reason by sponsor|46
854102|NCT00430677|1812186|FG000|Long-term Extension Period|Other|2
854103|NCT00430677|1812187|FG001|Long-term Extension Period|Other|1
854104|NCT00430677|1812188|FG002|Long-term Extension Period|Other|1
854105|NCT00430677|1812186|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
854106|NCT00430677|1812187|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
854107|NCT00430677|1812188|FG002|Long-term Extension Period|Poor compliance/noncompliance|0
854108|NCT00430716|1812217|FG000|Double Blind Phase|Death|1
854109|NCT00430716|1812218|FG001|Double Blind Phase|Death|0
854110|NCT00430716|1812219|FG002|Double Blind Phase|Death|0
854111|NCT00430716|1812217|FG000|Double Blind Phase|No longer willing to participate|2
854112|NCT00430716|1812218|FG001|Double Blind Phase|No longer willing to participate|1
854113|NCT00430716|1812219|FG002|Double Blind Phase|No longer willing to participate|1
854114|NCT00430716|1812217|FG000|Double Blind Phase|Other|0
854115|NCT00430716|1812218|FG001|Double Blind Phase|Other|2
854116|NCT00430716|1812219|FG002|Double Blind Phase|Other|0
854117|NCT00430716|1812217|FG000|Double Blind Phase|Study terminated by sponsor|1
854118|NCT00430716|1812218|FG001|Double Blind Phase|Study terminated by sponsor|1
854119|NCT00430716|1812219|FG002|Double Blind Phase|Study terminated by sponsor|2
854120|NCT00430716|1812217|FG000|Double Blind Phase|Adverse Event|1
854121|NCT00430716|1812218|FG001|Double Blind Phase|Adverse Event|1
854122|NCT00430716|1812219|FG002|Double Blind Phase|Adverse Event|3
854123|NCT00430716|1812217|FG000|Double Blind Phase|Not treated|1
854124|NCT00430716|1812218|FG001|Double Blind Phase|Not treated|0
854125|NCT00430716|1812219|FG002|Double Blind Phase|Not treated|0
854126|NCT00430716|1812217|FG000|Open Label Phase|Lost to Follow-up|1
854127|NCT00430716|1812218|FG001|Open Label Phase|Lost to Follow-up|0
854128|NCT00430716|1812219|FG002|Open Label Phase|Lost to Follow-up|1
854129|NCT00430716|1812217|FG000|Open Label Phase|No longer willing to participate|0
854130|NCT00430716|1812218|FG001|Open Label Phase|No longer willing to participate|1
854131|NCT00430716|1812219|FG002|Open Label Phase|No longer willing to participate|1
854132|NCT00430716|1812217|FG000|Open Label Phase|Other|3
854133|NCT00430716|1812218|FG001|Open Label Phase|Other|1
854134|NCT00430716|1812219|FG002|Open Label Phase|Other|1
854135|NCT00430716|1812217|FG000|Open Label Phase|Protocol Violation|1
854136|NCT00430716|1812218|FG001|Open Label Phase|Protocol Violation|0
854137|NCT00430716|1812219|FG002|Open Label Phase|Protocol Violation|0
854138|NCT00430716|1812217|FG000|Open Label Phase|Study terminated by sponsor|4
854139|NCT00430716|1812218|FG001|Open Label Phase|Study terminated by sponsor|5
854140|NCT00430716|1812219|FG002|Open Label Phase|Study terminated by sponsor|4
854141|NCT00430755|1812227|FG000|Overall Study|Withdrawal by Subject|53
854142|NCT00430781|1812253|FG000|Interim Analysis; 11 February 2008|Adverse Event|10
854143|NCT00430781|1812254|FG001|Interim Analysis; 11 February 2008|Adverse Event|3
854144|NCT00430781|1812255|FG002|Interim Analysis; 11 February 2008|Adverse Event|7
854145|NCT00430781|1812253|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1
854146|NCT00430781|1812254|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0
854147|NCT00430781|1812255|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1
854148|NCT00430781|1812253|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0
854149|NCT00430781|1812254|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1
854150|NCT00430781|1812255|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0
854151|NCT00430781|1812253|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
854152|NCT00430781|1812254|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
854153|NCT00430781|1812255|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
854154|NCT00430781|1812253|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
854155|NCT00430781|1812254|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
854156|NCT00430781|1812255|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
854157|NCT00430781|1812253|FG000|Interim Analysis; 11 February 2008|Disease Progression|16
854158|NCT00430781|1812254|FG001|Interim Analysis; 11 February 2008|Disease Progression|30
854159|NCT00430781|1812255|FG002|Interim Analysis; 11 February 2008|Disease Progression|22
854160|NCT00430781|1812253|FG000|Interim Analysis; 11 February 2008|Death|0
854161|NCT00430781|1812254|FG001|Interim Analysis; 11 February 2008|Death|1
854162|NCT00430781|1812255|FG002|Interim Analysis; 11 February 2008|Death|0
854163|NCT00430781|1812253|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
854164|NCT00430781|1812254|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
854165|NCT00430781|1812255|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
854166|NCT00430781|1812253|FG000|Interim Analysis; 11 February 2008|Physician Decision|2
854167|NCT00430781|1812254|FG001|Interim Analysis; 11 February 2008|Physician Decision|3
854168|NCT00430781|1812255|FG002|Interim Analysis; 11 February 2008|Physician Decision|3
854169|NCT00430781|1812253|FG000|Interim Analysis; 11 February 2008|Ongoing|23
854170|NCT00430781|1812254|FG001|Interim Analysis; 11 February 2008|Ongoing|20
854171|NCT00430781|1812255|FG002|Interim Analysis; 11 February 2008|Ongoing|25
854172|NCT00430781|1812253|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0
854173|NCT00430781|1812254|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0
854174|NCT00430781|1812255|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3
854175|NCT00430781|1812253|FG000|Final Analysis; 31 July 2008|Protocol Violation|0
854176|NCT00430781|1812254|FG001|Final Analysis; 31 July 2008|Protocol Violation|1
854177|NCT00430781|1812255|FG002|Final Analysis; 31 July 2008|Protocol Violation|0
854178|NCT00430781|1812253|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0
854179|NCT00430781|1812254|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2
854180|NCT00430781|1812255|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7
854181|NCT00430781|1812253|FG000|Final Analysis; 31 July 2008|Physician Decision|0
854182|NCT00430781|1812254|FG001|Final Analysis; 31 July 2008|Physician Decision|6
854183|NCT00430781|1812255|FG002|Final Analysis; 31 July 2008|Physician Decision|6
854184|NCT00430781|1812253|FG000|Final Analysis; 31 July 2008|Other|0
854185|NCT00430781|1812254|FG001|Final Analysis; 31 July 2008|Other|1
854186|NCT00430781|1812255|FG002|Final Analysis; 31 July 2008|Other|0
854187|NCT00430781|1812253|FG000|Final Analysis; 31 July 2008|Ongoing|0
854188|NCT00430781|1812254|FG001|Final Analysis; 31 July 2008|Ongoing|29
854189|NCT00430781|1812255|FG002|Final Analysis; 31 July 2008|Ongoing|32
854190|NCT00430781|1812253|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
854191|NCT00430781|1812254|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
854192|NCT00430781|1812255|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
854193|NCT00430781|1812253|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
854194|NCT00430781|1812254|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
854195|NCT00430781|1812255|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
854196|NCT00430781|1812253|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
854197|NCT00430781|1812254|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
854198|NCT00430781|1812255|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
854199|NCT00430781|1812253|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
854200|NCT00430781|1812254|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
854201|NCT00430781|1812255|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
854202|NCT00430781|1812253|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4
854203|NCT00430781|1812254|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6
854204|NCT00430781|1812255|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6
854205|NCT00430781|1812253|FG000|End-of-Study Analysis; 28 July 2011|Other|4
854206|NCT00430781|1812254|FG001|End-of-Study Analysis; 28 July 2011|Other|1
854207|NCT00430781|1812255|FG002|End-of-Study Analysis; 28 July 2011|Other|0
854208|NCT00430937|1812268|FG000|Overall Study|Adverse Event|3
854209|NCT00430937|1812269|FG001|Overall Study|Adverse Event|8
854210|NCT00430937|1812268|FG000|Overall Study|Death|0
854211|NCT00430937|1812269|FG001|Overall Study|Death|1
854212|NCT00430937|1812268|FG000|Overall Study|Lost to Follow-up|6
854213|NCT00430937|1812269|FG001|Overall Study|Lost to Follow-up|6
854214|NCT00430937|1812268|FG000|Overall Study|Withdrawal by Subject|5
854215|NCT00430937|1812269|FG001|Overall Study|Withdrawal by Subject|2
854216|NCT00430937|1812268|FG000|Overall Study|Protocol Violation|3
854217|NCT00430937|1812269|FG001|Overall Study|Protocol Violation|2
854218|NCT00430937|1812268|FG000|Overall Study|Lack of Efficacy|6
854219|NCT00430937|1812269|FG001|Overall Study|Lack of Efficacy|5
854220|NCT00430937|1812268|FG000|Overall Study|Inappropriate enrollment|2
854221|NCT00430937|1812269|FG001|Overall Study|Inappropriate enrollment|1
854222|NCT00430937|1812268|FG000|Overall Study|Administrative reasons|1
854223|NCT00430937|1812269|FG001|Overall Study|Administrative reasons|0
854224|NCT00430937|1812268|FG000|Overall Study|Protocol discontinuation criteria met|1
854225|NCT00430937|1812269|FG001|Overall Study|Protocol discontinuation criteria met|2
854226|NCT00430937|1812268|FG000|Overall Study|Unable to classify|0
854227|NCT00430937|1812269|FG001|Overall Study|Unable to classify|1
854228|NCT00430950|1812277|FG000|Overall Study|Adverse Event|7
854229|NCT00430950|1812278|FG001|Overall Study|Adverse Event|6
854230|NCT00430950|1812277|FG000|Overall Study|Withdrawal by Subject|1
854231|NCT00430950|1812278|FG001|Overall Study|Withdrawal by Subject|0
854232|NCT00430950|1812277|FG000|Overall Study|concomitant medication,etc.|5
854233|NCT00430950|1812278|FG001|Overall Study|concomitant medication,etc.|7
854234|NCT00430989|1812284|FG000|Overall Study|Lost to Follow-up|2
854235|NCT00430989|1812285|FG001|Overall Study|Lost to Follow-up|3
854236|NCT00430989|1812284|FG000|Overall Study|Withdrawal by Subject|15
854237|NCT00430989|1812285|FG001|Overall Study|Withdrawal by Subject|14
854238|NCT00430989|1812284|FG000|Overall Study|Protocol Violation|30
854239|NCT00430989|1812285|FG001|Overall Study|Protocol Violation|37
854240|NCT00430989|1812284|FG000|Overall Study|Not eligible|13
854241|NCT00430989|1812285|FG001|Overall Study|Not eligible|6
854242|NCT00431067|1812302|FG000|Overall Study|Other Adverse Event|9
854243|NCT00431067|1812302|FG000|Overall Study|Progressive disease|30
854244|NCT00431067|1812302|FG000|Overall Study|Non-compliance,lost to follow-up|2
854245|NCT00431444|1812323|FG000|Overall Study|Protocol Violation|1
854246|NCT00431444|1812324|FG001|Overall Study|Protocol Violation|4
854247|NCT00431444|1812323|FG000|Overall Study|Adverse Event|2
854248|NCT00431444|1812324|FG001|Overall Study|Adverse Event|1
854249|NCT00431444|1812323|FG000|Overall Study|Withdrawal by Subject|1
854250|NCT00431444|1812324|FG001|Overall Study|Withdrawal by Subject|1
854251|NCT00431444|1812323|FG000|Overall Study|Lost to Follow-up|1
854252|NCT00431444|1812324|FG001|Overall Study|Lost to Follow-up|0
854253|NCT00431444|1812323|FG000|Overall Study|Administrative Problems|0
854254|NCT00431444|1812324|FG001|Overall Study|Administrative Problems|1
854255|NCT00431496|1812330|FG000|Overall Study|Adverse Event|3
854256|NCT00431496|1812330|FG000|Overall Study|Lost to Follow-up|1
854257|NCT00431496|1812330|FG000|Overall Study|Withdrawal by Subject|2
854258|NCT00431496|1812330|FG000|Overall Study|Protocol-specified criteria|5
854259|NCT00431834|1812343|FG000|Overall Study|Withdrawal by Subject|7
854260|NCT00431834|1812343|FG000|Overall Study|Death|3
854261|NCT00431834|1812343|FG000|Overall Study|Missed Endpoint Visit|2
854262|NCT00431834|1812343|FG000|Overall Study|Lost to Follow-up|1
854263|NCT00431847|1812354|FG000|Overall Study|completion of less than two study visits|6
854264|NCT00431847|1812355|FG001|Overall Study|completion of less than two study visits|3
854265|NCT00431847|1812356|FG002|Overall Study|completion of less than two study visits|4
854266|NCT00431847|1812357|FG003|Overall Study|completion of less than two study visits|14
854267|NCT00431847|1812358|FG004|Overall Study|completion of less than two study visits|0
854268|NCT00431847|1812354|FG000|Overall Study|Protocol Violation|0
854269|NCT00431847|1812355|FG001|Overall Study|Protocol Violation|0
854270|NCT00431847|1812356|FG002|Overall Study|Protocol Violation|0
854271|NCT00431847|1812357|FG003|Overall Study|Protocol Violation|0
854272|NCT00431847|1812358|FG004|Overall Study|Protocol Violation|1
854273|NCT00431951|1812372|FG000|Overall Study|Inability to follow study procedures|1
854274|NCT00431951|1812373|FG001|Overall Study|Inability to follow study procedures|0
854275|NCT00431951|1812374|FG002|Overall Study|Inability to follow study procedures|1
854276|NCT00431951|1812375|FG003|Overall Study|Inability to follow study procedures|2
854277|NCT00431951|1812372|FG000|Overall Study|Lost to Follow-up|0
854278|NCT00431951|1812373|FG001|Overall Study|Lost to Follow-up|1
854279|NCT00431951|1812374|FG002|Overall Study|Lost to Follow-up|0
854280|NCT00431951|1812375|FG003|Overall Study|Lost to Follow-up|0
854281|NCT00431951|1812372|FG000|Overall Study|Withdrawal by Subject|0
854282|NCT00431951|1812373|FG001|Overall Study|Withdrawal by Subject|1
854283|NCT00431951|1812374|FG002|Overall Study|Withdrawal by Subject|0
854284|NCT00431951|1812375|FG003|Overall Study|Withdrawal by Subject|0
854285|NCT00431951|1812372|FG000|Overall Study|Adverse Event|0
854286|NCT00431951|1812373|FG001|Overall Study|Adverse Event|0
854287|NCT00431951|1812374|FG002|Overall Study|Adverse Event|1
854288|NCT00431951|1812375|FG003|Overall Study|Adverse Event|0
854289|NCT00431964|1812391|FG000|Overall Study|Adverse Event|1
854290|NCT00431964|1812392|FG001|Overall Study|Adverse Event|0
854291|NCT00431964|1812391|FG000|Overall Study|Lost to Follow-up|1
854292|NCT00431964|1812392|FG001|Overall Study|Lost to Follow-up|2
854293|NCT00431964|1812391|FG000|Overall Study|Physician Decision|2
854294|NCT00431964|1812392|FG001|Overall Study|Physician Decision|2
854295|NCT00431964|1812391|FG000|Overall Study|Withdrawal by Subject|2
854296|NCT00431964|1812392|FG001|Overall Study|Withdrawal by Subject|1
854297|NCT00431964|1812391|FG000|Overall Study|Parental Consent Withdrawn|0
854298|NCT00431964|1812392|FG001|Overall Study|Parental Consent Withdrawn|2
854299|NCT00431964|1812391|FG000|Overall Study|Due to Unstable Health|0
854300|NCT00431964|1812392|FG001|Overall Study|Due to Unstable Health|1
854301|NCT00432042|1812401|FG000|Overall Study|Protocol Violation|2
854302|NCT00432042|1812402|FG001|Overall Study|Protocol Violation|0
854303|NCT00432042|1812403|FG002|Overall Study|Protocol Violation|0
854304|NCT00432042|1812401|FG000|Overall Study|Withdrawal by Subject|0
854305|NCT00432042|1812402|FG001|Overall Study|Withdrawal by Subject|0
854306|NCT00432042|1812403|FG002|Overall Study|Withdrawal by Subject|2
854307|NCT00432042|1812401|FG000|Overall Study|Lost to Follow-up|5
854308|NCT00432042|1812402|FG001|Overall Study|Lost to Follow-up|1
854309|NCT00432042|1812403|FG002|Overall Study|Lost to Follow-up|0
854310|NCT00432159|1812416|FG000|Overall Study|Death|0
854311|NCT00432159|1812417|FG001|Overall Study|Death|1
854312|NCT00432159|1812418|FG002|Overall Study|Death|0
854313|NCT00432159|1812419|FG003|Overall Study|Death|0
854314|NCT00432159|1812420|FG004|Overall Study|Death|0
854315|NCT00432159|1812416|FG000|Overall Study|Failure|9
854316|NCT00432159|1812417|FG001|Overall Study|Failure|5
854317|NCT00432159|1812418|FG002|Overall Study|Failure|3
854318|NCT00432159|1812419|FG003|Overall Study|Failure|2
854319|NCT00432159|1812420|FG004|Overall Study|Failure|3
854320|NCT00432159|1812416|FG000|Overall Study|Missing NDI and/or neuro. assessment|13
854321|NCT00432159|1812417|FG001|Overall Study|Missing NDI and/or neuro. assessment|24
854322|NCT00432159|1812418|FG002|Overall Study|Missing NDI and/or neuro. assessment|1
854323|NCT00432159|1812419|FG003|Overall Study|Missing NDI and/or neuro. assessment|3
854324|NCT00432159|1812420|FG004|Overall Study|Missing NDI and/or neuro. assessment|7
854325|NCT00432172|1812436|FG000|Overall Study|Physician Decision|0
854326|NCT00432172|1812437|FG001|Overall Study|Physician Decision|0
854327|NCT00432172|1812438|FG002|Overall Study|Physician Decision|2
854328|NCT00432172|1812439|FG003|Overall Study|Physician Decision|0
854329|NCT00432172|1812436|FG000|Overall Study|Adverse Event|4
854330|NCT00432172|1812437|FG001|Overall Study|Adverse Event|2
854331|NCT00432172|1812438|FG002|Overall Study|Adverse Event|4
854332|NCT00432172|1812439|FG003|Overall Study|Adverse Event|3
854333|NCT00432172|1812436|FG000|Overall Study|Disease progression|0
854334|NCT00432172|1812437|FG001|Overall Study|Disease progression|2
854335|NCT00432172|1812438|FG002|Overall Study|Disease progression|5
854336|NCT00432172|1812439|FG003|Overall Study|Disease progression|1
854337|NCT00432172|1812436|FG000|Overall Study|Withdrawal by Subject|0
854338|NCT00432172|1812437|FG001|Overall Study|Withdrawal by Subject|1
854339|NCT00432172|1812438|FG002|Overall Study|Withdrawal by Subject|0
854340|NCT00432172|1812439|FG003|Overall Study|Withdrawal by Subject|2
854341|NCT00432172|1812436|FG000|Overall Study|No treatment received|2
854342|NCT00432172|1812437|FG001|Overall Study|No treatment received|2
854343|NCT00432172|1812438|FG002|Overall Study|No treatment received|0
854344|NCT00432172|1812439|FG003|Overall Study|No treatment received|1
854345|NCT00432237|1812455|FG000|Overall Study|Adverse Event|0
854346|NCT00432237|1812456|FG001|Overall Study|Adverse Event|0
854347|NCT00432237|1812457|FG002|Overall Study|Adverse Event|0
854348|NCT00432237|1812458|FG003|Overall Study|Adverse Event|1
854349|NCT00432237|1812455|FG000|Overall Study|Lack of Efficacy|0
854350|NCT00432237|1812456|FG001|Overall Study|Lack of Efficacy|0
854351|NCT00432237|1812457|FG002|Overall Study|Lack of Efficacy|0
854352|NCT00432237|1812458|FG003|Overall Study|Lack of Efficacy|1
854353|NCT00432237|1812455|FG000|Overall Study|Lost to Follow-up|10
854354|NCT00432237|1812456|FG001|Overall Study|Lost to Follow-up|10
854355|NCT00432237|1812457|FG002|Overall Study|Lost to Follow-up|18
854356|NCT00432237|1812458|FG003|Overall Study|Lost to Follow-up|18
854357|NCT00432237|1812455|FG000|Overall Study|Physician Decision|1
854358|NCT00432237|1812456|FG001|Overall Study|Physician Decision|3
854359|NCT00432237|1812457|FG002|Overall Study|Physician Decision|2
854360|NCT00432237|1812458|FG003|Overall Study|Physician Decision|1
854361|NCT00432237|1812455|FG000|Overall Study|Pregnancy|0
854362|NCT00432237|1812456|FG001|Overall Study|Pregnancy|1
854363|NCT00432237|1812457|FG002|Overall Study|Pregnancy|0
854364|NCT00432237|1812458|FG003|Overall Study|Pregnancy|0
854365|NCT00432237|1812455|FG000|Overall Study|Protocol Violation|13
854366|NCT00432237|1812456|FG001|Overall Study|Protocol Violation|10
854367|NCT00432237|1812457|FG002|Overall Study|Protocol Violation|11
854368|NCT00432237|1812458|FG003|Overall Study|Protocol Violation|8
854369|NCT00432237|1812455|FG000|Overall Study|Withdrawal by Subject|5
854370|NCT00432237|1812456|FG001|Overall Study|Withdrawal by Subject|6
854371|NCT00432237|1812457|FG002|Overall Study|Withdrawal by Subject|9
854372|NCT00432237|1812458|FG003|Overall Study|Withdrawal by Subject|11
854373|NCT00432237|1812455|FG000|Overall Study|Lack of Qualifying Event|38
854374|NCT00432237|1812456|FG001|Overall Study|Lack of Qualifying Event|71
854375|NCT00432237|1812457|FG002|Overall Study|Lack of Qualifying Event|69
854376|NCT00432237|1812458|FG003|Overall Study|Lack of Qualifying Event|84
854377|NCT00432276|1812470|FG000|Overall Study|Hyperglycemic Rescue|44
854378|NCT00432276|1812471|FG001|Overall Study|Hyperglycemic Rescue|87
854379|NCT00432276|1812470|FG000|Overall Study|Adverse Event|13
854380|NCT00432276|1812471|FG001|Overall Study|Adverse Event|16
854381|NCT00432276|1812470|FG000|Overall Study|Protocol Violation|25
854382|NCT00432276|1812471|FG001|Overall Study|Protocol Violation|20
854383|NCT00432276|1812470|FG000|Overall Study|Lost to Follow-up|6
854384|NCT00432276|1812471|FG001|Overall Study|Lost to Follow-up|2
854385|NCT00432276|1812470|FG000|Overall Study|Withdrawal by Subject|25
854386|NCT00432276|1812471|FG001|Overall Study|Withdrawal by Subject|20
854387|NCT00432276|1812470|FG000|Overall Study|Physician Decision|6
854388|NCT00432276|1812471|FG001|Overall Study|Physician Decision|8
854389|NCT00432276|1812470|FG000|Overall Study|Other|2
854390|NCT00432276|1812471|FG001|Overall Study|Other|3
854391|NCT00432380|1812489|FG000|Overall Study|Migrated/moved from study area|3
854392|NCT00432380|1812490|FG001|Overall Study|Migrated/moved from study area|4
854393|NCT00432380|1812491|FG002|Overall Study|Migrated/moved from study area|1
854394|NCT00432380|1812489|FG000|Overall Study|Adverse Event|1
854395|NCT00432380|1812490|FG001|Overall Study|Adverse Event|0
854396|NCT00432380|1812491|FG002|Overall Study|Adverse Event|0
854397|NCT00432562|1812511|FG000|Overall Study|Death|3
854398|NCT00432562|1812512|FG001|Overall Study|Death|0
854399|NCT00432666|1812529|FG000|Main Period|Adverse Event|1
854400|NCT00432666|1812530|FG001|Main Period|Adverse Event|1
854401|NCT00432666|1812529|FG000|Main Period|Consent Withdrawn|1
854402|NCT00432666|1812530|FG001|Main Period|Consent Withdrawn|0
854403|NCT00432666|1812529|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1
854404|NCT00432666|1812530|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0
854405|NCT00432666|1812529|FG000|Open-Label Extension Period|Lack of Efficacy|6
854406|NCT00432666|1812530|FG001|Open-Label Extension Period|Lack of Efficacy|0
854407|NCT00432666|1812529|FG000|Open-Label Extension Period|Adverse Event|5
854408|NCT00432666|1812530|FG001|Open-Label Extension Period|Adverse Event|0
854409|NCT00432666|1812529|FG000|Open-Label Extension Period|Consent withdrawn|10
854410|NCT00432666|1812530|FG001|Open-Label Extension Period|Consent withdrawn|0
854411|NCT00432666|1812529|FG000|Open-Label Extension Period|Physician Decision|3
854412|NCT00432666|1812530|FG001|Open-Label Extension Period|Physician Decision|0
854413|NCT00432679|1812538|FG000|Overall Study|Adverse Event|2
854414|NCT00432679|1812539|FG001|Overall Study|Adverse Event|1
854415|NCT00432679|1812538|FG000|Overall Study|Withdrawal by Subject|3
854416|NCT00432679|1812539|FG001|Overall Study|Withdrawal by Subject|2
854417|NCT00432744|1812547|FG000|Months 0-6|Withdrawal by Subject|4
854418|NCT00432744|1812548|FG001|Months 0-6|Withdrawal by Subject|4
854419|NCT00432744|1812547|FG000|Months 0-6|Too disabled to score|1
854420|NCT00432744|1812548|FG001|Months 0-6|Too disabled to score|0
854421|NCT00432744|1812547|FG000|Months 7 - 12|Withdrawal by Subject|1
854422|NCT00432744|1812548|FG001|Months 7 - 12|Withdrawal by Subject|0
854423|NCT00432744|1812547|FG000|Months 7 - 12|Too disabled to score|0
854424|NCT00432744|1812548|FG001|Months 7 - 12|Too disabled to score|1
854425|NCT00432809|1812557|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2
854426|NCT00432809|1812558|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0
854427|NCT00432809|1812559|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0
854428|NCT00432809|1812557|FG000|1 Year Follow-up|Withdrawal by Subject|7
854429|NCT00432809|1812558|FG001|1 Year Follow-up|Withdrawal by Subject|0
854430|NCT00432809|1812559|FG002|1 Year Follow-up|Withdrawal by Subject|1
854431|NCT00432835|1812569|FG000|Overall Study|Adverse event: lead dislodgement.|6
854432|NCT00432835|1812570|FG001|Overall Study|Adverse event: lead dislodgement.|7
854433|NCT00432965|1812578|FG000|Overall Study|Lost to Follow-up|22
854434|NCT00432965|1812579|FG001|Overall Study|Lost to Follow-up|19
854435|NCT00432965|1812578|FG000|Overall Study|Withdrawal by Subject|13
854436|NCT00432965|1812579|FG001|Overall Study|Withdrawal by Subject|13
854437|NCT00432965|1812578|FG000|Overall Study|Physician Decision|14
854438|NCT00432965|1812579|FG001|Overall Study|Physician Decision|13
854439|NCT00432965|1812578|FG000|Overall Study|Lack of Efficacy|8
854440|NCT00432965|1812579|FG001|Overall Study|Lack of Efficacy|13
854441|NCT00432965|1812578|FG000|Overall Study|Non-compliance|7
854442|NCT00432965|1812579|FG001|Overall Study|Non-compliance|0
854443|NCT00432965|1812578|FG000|Overall Study|Adverse Event|22
854444|NCT00432965|1812579|FG001|Overall Study|Adverse Event|19
854445|NCT00432965|1812578|FG000|Overall Study|Death|3
854446|NCT00432965|1812579|FG001|Overall Study|Death|4
854447|NCT00432965|1812578|FG000|Overall Study|Exclusionary Methods|1
854448|NCT00432965|1812579|FG001|Overall Study|Exclusionary Methods|2
854449|NCT00432965|1812578|FG000|Overall Study|Incomplete Data|4
854450|NCT00432965|1812579|FG001|Overall Study|Incomplete Data|3
854451|NCT00432991|1812587|FG000|Overall Study|Protocol Violation|7
854452|NCT00432991|1812588|FG001|Overall Study|Protocol Violation|12
854453|NCT00433004|1812596|FG000|Overall Study|Lost to Follow-up|5
854454|NCT00433004|1812597|FG001|Overall Study|Lost to Follow-up|7
854455|NCT00433017|1812605|FG000|Overall Study|Adverse Event|5
854456|NCT00433017|1812606|FG001|Overall Study|Adverse Event|3
854457|NCT00433017|1812605|FG000|Overall Study|Withdrawal by Subject|4
854458|NCT00433017|1812606|FG001|Overall Study|Withdrawal by Subject|5
854459|NCT00433017|1812605|FG000|Overall Study|Lost to Follow-up|3
854460|NCT00433017|1812606|FG001|Overall Study|Lost to Follow-up|4
854461|NCT00433017|1812605|FG000|Overall Study|Administrative problems|80
854462|NCT00433017|1812606|FG001|Overall Study|Administrative problems|86
854463|NCT00433017|1812605|FG000|Overall Study|Protocol Violation|1
854464|NCT00433017|1812606|FG001|Overall Study|Protocol Violation|0
854465|NCT00433017|1812605|FG000|Overall Study|Death|2
854466|NCT00433017|1812606|FG001|Overall Study|Death|2
854467|NCT00433017|1812605|FG000|Overall Study|Subject no longer requires study drug|1
854468|NCT00433017|1812606|FG001|Overall Study|Subject no longer requires study drug|1
854469|NCT00433147|1812616|FG000|Overall Study|Adverse Event|0
854470|NCT00433147|1812617|FG001|Overall Study|Adverse Event|1
854471|NCT00433147|1812618|FG002|Overall Study|Adverse Event|0
854472|NCT00433147|1812619|FG003|Overall Study|Adverse Event|0
854473|NCT00433160|1812631|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6
854474|NCT00433160|1812632|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2
854475|NCT00433160|1812631|FG000|52-Week Double-Blind (DB) Period|Death|0
854476|NCT00433160|1812632|FG001|52-Week Double-Blind (DB) Period|Death|0
854477|NCT00433160|1812631|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
854478|NCT00433160|1812632|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
854479|NCT00433160|1812631|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
854480|NCT00433160|1812632|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
854481|NCT00433160|1812631|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0
854482|NCT00433160|1812632|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2
854483|NCT00433160|1812631|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
854484|NCT00433160|1812632|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
854485|NCT00433160|1812631|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4
854486|NCT00433160|1812632|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2
854487|NCT00433160|1812631|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0
854488|NCT00433160|1812632|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0
854489|NCT00433160|1812631|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
854490|NCT00433160|1812632|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
854491|NCT00433160|1812631|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
854492|NCT00433160|1812632|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
854493|NCT00433160|1812631|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
854494|NCT00433160|1812632|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
854495|NCT00433160|1812631|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
854496|NCT00433160|1812632|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
854497|NCT00433160|1812631|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
854498|NCT00433160|1812632|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
854499|NCT00433160|1812631|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2
854500|NCT00433160|1812632|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0
854501|NCT00433160|1812631|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
854502|NCT00433160|1812632|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
854503|NCT00433160|1812631|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0
854504|NCT00433160|1812632|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1
854505|NCT00433199|1812644|FG000|Double-Blind Period|Adverse Event|0
854506|NCT00433199|1812645|FG001|Double-Blind Period|Adverse Event|25
854507|NCT00433199|1812644|FG000|Double-Blind Period|Lack of Efficacy|0
854508|NCT00433199|1812645|FG001|Double-Blind Period|Lack of Efficacy|2
854509|NCT00433199|1812644|FG000|Double-Blind Period|Lost to Follow-up|2
854510|NCT00433199|1812645|FG001|Double-Blind Period|Lost to Follow-up|5
854511|NCT00433199|1812644|FG000|Double-Blind Period|Withdrawal by Subject|8
854512|NCT00433199|1812645|FG001|Double-Blind Period|Withdrawal by Subject|19
854513|NCT00433199|1812644|FG000|Double-Blind Period|Protocol Violation|1
854514|NCT00433199|1812645|FG001|Double-Blind Period|Protocol Violation|10
854515|NCT00433199|1812644|FG000|Double-Blind Period|Administrative|1
854516|NCT00433199|1812645|FG001|Double-Blind Period|Administrative|5
854517|NCT00433199|1812644|FG000|Open-Label Period|Adverse Event|0
854518|NCT00433199|1812645|FG001|Open-Label Period|Adverse Event|19
854519|NCT00433199|1812644|FG000|Open-Label Period|Lack of Efficacy|0
854520|NCT00433199|1812645|FG001|Open-Label Period|Lack of Efficacy|2
854521|NCT00433199|1812644|FG000|Open-Label Period|Lost to Follow-up|0
854522|NCT00433199|1812645|FG001|Open-Label Period|Lost to Follow-up|3
854523|NCT00433199|1812644|FG000|Open-Label Period|Withdrawal by Subject|0
854524|NCT00433199|1812645|FG001|Open-Label Period|Withdrawal by Subject|7
854525|NCT00433199|1812644|FG000|Open-Label Period|Protocol Violation|0
854526|NCT00433199|1812645|FG001|Open-Label Period|Protocol Violation|2
854527|NCT00433199|1812644|FG000|Open-Label Period|Administrative|0
854528|NCT00433199|1812645|FG001|Open-Label Period|Administrative|1
854529|NCT00433290|1812658|FG000|Overall Study|Adverse Event|24
854530|NCT00433290|1812659|FG001|Overall Study|Adverse Event|7
854531|NCT00433290|1812658|FG000|Overall Study|Lack of Efficacy|1
854532|NCT00433290|1812659|FG001|Overall Study|Lack of Efficacy|5
854533|NCT00433290|1812658|FG000|Overall Study|Withdrawal by Subject|4
854534|NCT00433290|1812659|FG001|Overall Study|Withdrawal by Subject|2
854535|NCT00433290|1812658|FG000|Overall Study|Protocol Violation|3
854536|NCT00433290|1812659|FG001|Overall Study|Protocol Violation|2
854537|NCT00433290|1812658|FG000|Overall Study|Physician Decision|2
854538|NCT00433290|1812659|FG001|Overall Study|Physician Decision|0
854539|NCT00433290|1812658|FG000|Overall Study|Entry Criteria Not Met|0
854540|NCT00433290|1812659|FG001|Overall Study|Entry Criteria Not Met|1
854541|NCT00433290|1812658|FG000|Overall Study|Lost to Follow-up|1
854542|NCT00433290|1812659|FG001|Overall Study|Lost to Follow-up|0
854543|NCT00433329|1812665|FG000|Overall Study|Adverse Event|9
854544|NCT00433329|1812665|FG000|Overall Study|Death|4
854545|NCT00433329|1812665|FG000|Overall Study|Withdrew consent|3
854546|NCT00433329|1812665|FG000|Overall Study|Discontinued sildenafil|2
854547|NCT00433329|1812665|FG000|Overall Study|Moved out of state|1
854548|NCT00433329|1812665|FG000|Overall Study|Lost to Follow-up|1
854549|NCT00433329|1812665|FG000|Overall Study|Physician Decision|1
854550|NCT00433381|1812671|FG000|Overall Study|Ineligible / no protocol treatment|3
854551|NCT00433381|1812672|FG001|Overall Study|Ineligible / no protocol treatment|3
854552|NCT00433446|1812686|FG000|Overall Study|Adverse Event|4
854553|NCT00433446|1812686|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
854554|NCT00433446|1812686|FG000|Overall Study|Progression|44
854555|NCT00433446|1812686|FG000|Overall Study|Other - Not Protocol specified|3
854556|NCT00433446|1812686|FG000|Overall Study|Ineligible|9
854557|NCT00433511|1812693|FG000|Step 1|Adverse Event|50
854558|NCT00433511|1812694|FG001|Step 1|Adverse Event|157
854559|NCT00433511|1812695|FG002|Step 1|Adverse Event|153
854560|NCT00433511|1812693|FG000|Step 1|Withdrawal by Subject|45
854561|NCT00433511|1812694|FG001|Step 1|Withdrawal by Subject|143
854562|NCT00433511|1812695|FG002|Step 1|Withdrawal by Subject|154
854563|NCT00433511|1812693|FG000|Step 1|Death|3
854564|NCT00433511|1812694|FG001|Step 1|Death|1
854565|NCT00433511|1812695|FG002|Step 1|Death|1
854566|NCT00433511|1812693|FG000|Step 1|Physician Decision|1
854567|NCT00433511|1812694|FG001|Step 1|Physician Decision|4
854568|NCT00433511|1812695|FG002|Step 1|Physician Decision|3
854569|NCT00433511|1812693|FG000|Step 1|Never started protocol therapy|28
854570|NCT00433511|1812694|FG001|Step 1|Never started protocol therapy|64
854571|NCT00433511|1812695|FG002|Step 1|Never started protocol therapy|66
854572|NCT00433511|1812693|FG000|Step 1|Alternative therapy|2
854573|NCT00433511|1812694|FG001|Step 1|Alternative therapy|1
854574|NCT00433511|1812695|FG002|Step 1|Alternative therapy|3
854575|NCT00433511|1812693|FG000|Step 1|Disease progression, relapse|5
854576|NCT00433511|1812694|FG001|Step 1|Disease progression, relapse|3
854577|NCT00433511|1812695|FG002|Step 1|Disease progression, relapse|3
854578|NCT00433511|1812693|FG000|Step 1|Other complicating disease|2
854579|NCT00433511|1812694|FG001|Step 1|Other complicating disease|6
854580|NCT00433511|1812695|FG002|Step 1|Other complicating disease|3
854581|NCT00433511|1812693|FG000|Step 1|Non-breast cancer surgery/wound issues|0
854582|NCT00433511|1812694|FG001|Step 1|Non-breast cancer surgery/wound issues|4
854583|NCT00433511|1812695|FG002|Step 1|Non-breast cancer surgery/wound issues|1
854584|NCT00433511|1812693|FG000|Step 1|Suspected recurrence|0
854585|NCT00433511|1812694|FG001|Step 1|Suspected recurrence|1
854586|NCT00433511|1812695|FG002|Step 1|Suspected recurrence|0
854587|NCT00433511|1812693|FG000|Step 1|Insurance/drug distribution issues|0
854588|NCT00433511|1812694|FG001|Step 1|Insurance/drug distribution issues|1
854589|NCT00433511|1812695|FG002|Step 1|Insurance/drug distribution issues|2
854590|NCT00433511|1812693|FG000|Step 1|Patient moved|0
854591|NCT00433511|1812694|FG001|Step 1|Patient moved|0
854592|NCT00433511|1812695|FG002|Step 1|Patient moved|1
854593|NCT00433511|1812693|FG000|Step 2 (Arm D)|Adverse Event|0
854594|NCT00433511|1812694|FG001|Step 2 (Arm D)|Adverse Event|0
854595|NCT00433511|1812695|FG002|Step 2 (Arm D)|Adverse Event|135
854596|NCT00433511|1812693|FG000|Step 2 (Arm D)|Withdrawal by Subject|0
854597|NCT00433511|1812694|FG001|Step 2 (Arm D)|Withdrawal by Subject|0
854598|NCT00433511|1812695|FG002|Step 2 (Arm D)|Withdrawal by Subject|181
854599|NCT00433511|1812693|FG000|Step 2 (Arm D)|Never started protocol therapy|0
854600|NCT00433511|1812694|FG001|Step 2 (Arm D)|Never started protocol therapy|0
854601|NCT00433511|1812695|FG002|Step 2 (Arm D)|Never started protocol therapy|148
854602|NCT00433511|1812693|FG000|Step 2 (Arm D)|Physician Decision|0
854603|NCT00433511|1812694|FG001|Step 2 (Arm D)|Physician Decision|0
854604|NCT00433511|1812695|FG002|Step 2 (Arm D)|Physician Decision|9
854605|NCT00433511|1812693|FG000|Step 2 (Arm D)|Disease progression, relapse|0
854606|NCT00433511|1812694|FG001|Step 2 (Arm D)|Disease progression, relapse|0
854607|NCT00433511|1812695|FG002|Step 2 (Arm D)|Disease progression, relapse|7
854608|NCT00433511|1812693|FG000|Step 2 (Arm D)|Other complicating disease|0
854609|NCT00433511|1812694|FG001|Step 2 (Arm D)|Other complicating disease|0
854610|NCT00433511|1812695|FG002|Step 2 (Arm D)|Other complicating disease|3
854611|NCT00433511|1812693|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
854612|NCT00433511|1812694|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
854613|NCT00433511|1812695|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
854614|NCT00433511|1812693|FG000|Step 2 (Arm D)|Suspected recurrence|0
854615|NCT00433511|1812694|FG001|Step 2 (Arm D)|Suspected recurrence|0
854616|NCT00433511|1812695|FG002|Step 2 (Arm D)|Suspected recurrence|1
854617|NCT00433511|1812693|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0
854618|NCT00433511|1812694|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0
854619|NCT00433511|1812695|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4
854620|NCT00433511|1812693|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
854621|NCT00433511|1812694|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
854622|NCT00433511|1812695|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
854623|NCT00433537|1812706|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
854624|NCT00433537|1812707|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
854625|NCT00433537|1812708|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
854626|NCT00433537|1812706|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
854627|NCT00433537|1812707|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
854628|NCT00433537|1812708|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
854629|NCT00433537|1812706|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0
854630|NCT00433537|1812707|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0
854631|NCT00433537|1812708|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4
854632|NCT00433537|1812706|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
854633|NCT00433537|1812707|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
854634|NCT00433537|1812708|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
854635|NCT00433537|1812706|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
854636|NCT00433537|1812707|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
854637|NCT00433537|1812708|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
854638|NCT00433537|1812706|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
854639|NCT00433537|1812707|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
854640|NCT00433537|1812708|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
854641|NCT00433537|1812706|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
854642|NCT00433537|1812707|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
854643|NCT00433537|1812708|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
854644|NCT00433537|1812706|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
854645|NCT00433537|1812707|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
854646|NCT00433537|1812708|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
854647|NCT00433537|1812706|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1
854648|NCT00433537|1812707|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0
854649|NCT00433537|1812708|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0
854650|NCT00433654|1812730|FG000|Overall Study|Death|4
854651|NCT00433654|1812731|FG001|Overall Study|Death|0
854652|NCT00433654|1812730|FG000|Overall Study|Missed visit|6
854653|NCT00433654|1812731|FG001|Overall Study|Missed visit|3
854654|NCT00433654|1812730|FG000|Overall Study|Subject not yet due for visit|4
854655|NCT00433654|1812731|FG001|Overall Study|Subject not yet due for visit|0
854656|NCT00433654|1812730|FG000|Overall Study|Withdrawal by Subject|1
854657|NCT00433654|1812731|FG001|Overall Study|Withdrawal by Subject|2
854658|NCT00433771|1812748|FG000|Overall Study|screen fail|14
854659|NCT00433771|1812748|FG000|Overall Study|Treated and later found to be ineligible|2
854660|NCT00433771|1812748|FG000|Overall Study|Death|2
854661|NCT00433771|1812748|FG000|Overall Study|Failure to deploy stent|1
854662|NCT00433836|1812754|FG000|Overall Study|Adverse Event|7
854663|NCT00433836|1812755|FG001|Overall Study|Adverse Event|0
854664|NCT00433836|1812754|FG000|Overall Study|Lost to Follow-up|3
854665|NCT00433836|1812755|FG001|Overall Study|Lost to Follow-up|0
854666|NCT00433836|1812754|FG000|Overall Study|Withdrawal by Subject|2
854667|NCT00433836|1812755|FG001|Overall Study|Withdrawal by Subject|1
854668|NCT00433836|1812754|FG000|Overall Study|Unsatisfactory therapeutic effect|1
854669|NCT00433836|1812755|FG001|Overall Study|Unsatisfactory therapeutic effect|1
854670|NCT00433836|1812754|FG000|Overall Study|Protocol Violation|0
854671|NCT00433836|1812755|FG001|Overall Study|Protocol Violation|2
854672|NCT00433836|1812754|FG000|Overall Study|Condition no longer requires study drug|0
854673|NCT00433836|1812755|FG001|Overall Study|Condition no longer requires study drug|1
854674|NCT00433836|1812754|FG000|Overall Study|Abnormal laboratory values|0
854675|NCT00433836|1812755|FG001|Overall Study|Abnormal laboratory values|1
854676|NCT00433914|1812763|FG000|Overall Study|Withdrawal by Subject|0
854677|NCT00433914|1812764|FG001|Overall Study|Withdrawal by Subject|2
854678|NCT00433914|1812763|FG000|Overall Study|Lost to Follow-up|0
854679|NCT00433914|1812764|FG001|Overall Study|Lost to Follow-up|1
854680|NCT00433966|1812772|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
854681|NCT00433966|1812773|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
854682|NCT00433966|1812774|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
854683|NCT00433966|1812775|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
854684|NCT00433966|1812772|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97
854685|NCT00433966|1812773|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103
854686|NCT00433966|1812774|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0
854687|NCT00433966|1812775|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0
854688|NCT00433966|1812772|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
854689|NCT00433966|1812773|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
854690|NCT00433966|1812774|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
854691|NCT00433966|1812775|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
854692|NCT00433966|1812772|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0
854693|NCT00433966|1812773|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0
854694|NCT00433966|1812774|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41
854695|NCT00433966|1812775|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15
854696|NCT00433966|1812772|FG000|Stent Intervention/Randomization|Lost to Follow-up|0
854697|NCT00433966|1812773|FG001|Stent Intervention/Randomization|Lost to Follow-up|0
854698|NCT00433966|1812774|FG002|Stent Intervention/Randomization|Lost to Follow-up|113
854699|NCT00433966|1812775|FG003|Stent Intervention/Randomization|Lost to Follow-up|47
854700|NCT00434057|1812808|FG000|Overall Study|Withdrawal by Subject|1
854701|NCT00434109|1812812|FG000|Overall Study|Physician Decision|9
854702|NCT00434109|1812812|FG000|Overall Study|Adverse Event|5
854703|NCT00434109|1812812|FG000|Overall Study|Protocol Violation|1
854704|NCT00434109|1812812|FG000|Overall Study|had embolism, did not receive sunitinib|3
854705|NCT00434122|1812818|FG000|Overall Study|Non-compliance with protocol|0
854706|NCT00434122|1812819|FG001|Overall Study|Non-compliance with protocol|1
854707|NCT00434122|1812818|FG000|Overall Study|loss of subject contact|1
854708|NCT00434122|1812819|FG001|Overall Study|loss of subject contact|1
854709|NCT00434122|1812818|FG000|Overall Study|Personal reasons|1
854710|NCT00434122|1812819|FG001|Overall Study|Personal reasons|1
854711|NCT00434122|1812818|FG000|Overall Study|Large follicle size|2
854712|NCT00434122|1812819|FG001|Overall Study|Large follicle size|2
854713|NCT00434122|1812818|FG000|Overall Study|Low follicular response.|1
854714|NCT00434122|1812819|FG001|Overall Study|Low follicular response.|2
854715|NCT00434122|1812818|FG000|Overall Study|Travelling of subject.|1
854716|NCT00434122|1812819|FG001|Overall Study|Travelling of subject.|0
854717|NCT00434148|1812829|FG000|Overall Study|Adverse Event|18
854718|NCT00434148|1812830|FG001|Overall Study|Adverse Event|18
854719|NCT00434148|1812829|FG000|Overall Study|Lack of Efficacy|25
854720|NCT00434148|1812830|FG001|Overall Study|Lack of Efficacy|28
854721|NCT00434148|1812829|FG000|Overall Study|Withdrawal by Subject|15
854722|NCT00434148|1812830|FG001|Overall Study|Withdrawal by Subject|15
854723|NCT00434148|1812829|FG000|Overall Study|Protocol Violation|4
854724|NCT00434148|1812830|FG001|Overall Study|Protocol Violation|0
854725|NCT00434148|1812829|FG000|Overall Study|Administrative problems|6
854726|NCT00434148|1812830|FG001|Overall Study|Administrative problems|10
854727|NCT00434148|1812829|FG000|Overall Study|Lost to Follow-up|0
854728|NCT00434148|1812830|FG001|Overall Study|Lost to Follow-up|1
854729|NCT00434148|1812829|FG000|Overall Study|Condition no longer requires study drug|1
854730|NCT00434148|1812830|FG001|Overall Study|Condition no longer requires study drug|0
854731|NCT00434148|1812829|FG000|Overall Study|Abnormal test procedure result|0
854732|NCT00434148|1812830|FG001|Overall Study|Abnormal test procedure result|1
854733|NCT00434161|1812839|FG000|Overall Study|Adverse Event|5
854734|NCT00434161|1812840|FG001|Overall Study|Adverse Event|1
854735|NCT00434161|1812841|FG002|Overall Study|Adverse Event|4
854736|NCT00434161|1812839|FG000|Overall Study|Lost to Follow-up|0
854737|NCT00434161|1812840|FG001|Overall Study|Lost to Follow-up|1
854738|NCT00434161|1812841|FG002|Overall Study|Lost to Follow-up|0
854739|NCT00434161|1812839|FG000|Overall Study|Death|1
854740|NCT00434161|1812840|FG001|Overall Study|Death|0
854741|NCT00434161|1812841|FG002|Overall Study|Death|1
854742|NCT00434161|1812839|FG000|Overall Study|Non-Compliance|1
854743|NCT00434161|1812840|FG001|Overall Study|Non-Compliance|1
854744|NCT00434161|1812841|FG002|Overall Study|Non-Compliance|0
854745|NCT00434161|1812839|FG000|Overall Study|Withdrawal by Subject|2
854746|NCT00434161|1812840|FG001|Overall Study|Withdrawal by Subject|0
854747|NCT00434161|1812841|FG002|Overall Study|Withdrawal by Subject|3
854748|NCT00434161|1812839|FG000|Overall Study|Logistical error study assessments|1
854749|NCT00434161|1812840|FG001|Overall Study|Logistical error study assessments|0
854750|NCT00434161|1812841|FG002|Overall Study|Logistical error study assessments|3
854751|NCT00434213|1812856|FG000|Overall Study|Adverse Event|12
854752|NCT00434213|1812856|FG000|Overall Study|Lack of Efficacy|9
854753|NCT00434213|1812856|FG000|Overall Study|Lost to Follow-up|14
854754|NCT00434213|1812856|FG000|Overall Study|Withdrawal by Subject|7
854755|NCT00434213|1812856|FG000|Overall Study|Protocol Violation|3
854756|NCT00434213|1812856|FG000|Overall Study|Unable to comply with study visit window|2
854757|NCT00434213|1812856|FG000|Overall Study|Application site reaction|1
854758|NCT00434213|1812856|FG000|Overall Study|Non-compliant to study schedule|1
854759|NCT00434252|1812869|FG000|Overall Study|Lack of Efficacy|50
854760|NCT00434252|1812870|FG001|Overall Study|Lack of Efficacy|100
854761|NCT00434252|1812869|FG000|Overall Study|Adverse Event|6
854762|NCT00434252|1812870|FG001|Overall Study|Adverse Event|13
854763|NCT00434252|1812869|FG000|Overall Study|Death|1
854764|NCT00434252|1812870|FG001|Overall Study|Death|2
854765|NCT00434252|1812869|FG000|Overall Study|Lost to Follow-up|0
854766|NCT00434252|1812870|FG001|Overall Study|Lost to Follow-up|1
854767|NCT00434252|1812869|FG000|Overall Study|Physician Decision|4
854768|NCT00434252|1812870|FG001|Overall Study|Physician Decision|8
854769|NCT00434252|1812869|FG000|Overall Study|Withdrawal by Subject|3
854770|NCT00434252|1812870|FG001|Overall Study|Withdrawal by Subject|7
854771|NCT00434304|1812885|FG000|Overall Study|Adverse Event|14
854772|NCT00434304|1812885|FG000|Overall Study|Lack of Efficacy|2
854773|NCT00434304|1812885|FG000|Overall Study|Withdrawal by Subject|4
854774|NCT00434330|1812896|FG000|Overall Study|Adverse Event|0
854775|NCT00434330|1812897|FG001|Overall Study|Adverse Event|0
854776|NCT00434330|1812898|FG002|Overall Study|Adverse Event|1
854777|NCT00434330|1812899|FG003|Overall Study|Adverse Event|0
854778|NCT00434330|1812900|FG004|Overall Study|Adverse Event|0
854779|NCT00434330|1812901|FG005|Overall Study|Adverse Event|0
854780|NCT00434330|1812896|FG000|Overall Study|Death|1
854781|NCT00434330|1812897|FG001|Overall Study|Death|0
854782|NCT00434330|1812898|FG002|Overall Study|Death|0
854783|NCT00434330|1812899|FG003|Overall Study|Death|0
854784|NCT00434330|1812900|FG004|Overall Study|Death|1
854785|NCT00434330|1812901|FG005|Overall Study|Death|1
854786|NCT00434330|1812896|FG000|Overall Study|Withdrawal by Subject|0
854787|NCT00434330|1812897|FG001|Overall Study|Withdrawal by Subject|0
854788|NCT00434330|1812898|FG002|Overall Study|Withdrawal by Subject|1
854789|NCT00434330|1812899|FG003|Overall Study|Withdrawal by Subject|1
854790|NCT00434330|1812900|FG004|Overall Study|Withdrawal by Subject|0
854791|NCT00434330|1812901|FG005|Overall Study|Withdrawal by Subject|0
854792|NCT00434330|1812896|FG000|Overall Study|Renal transplant|0
854793|NCT00434330|1812897|FG001|Overall Study|Renal transplant|0
854794|NCT00434330|1812898|FG002|Overall Study|Renal transplant|0
854795|NCT00434330|1812899|FG003|Overall Study|Renal transplant|1
854796|NCT00434330|1812900|FG004|Overall Study|Renal transplant|0
854797|NCT00434330|1812901|FG005|Overall Study|Renal transplant|0
854798|NCT00434330|1812896|FG000|Overall Study|Subject Not Compliant With Study|0
854799|NCT00434330|1812897|FG001|Overall Study|Subject Not Compliant With Study|0
854800|NCT00434330|1812898|FG002|Overall Study|Subject Not Compliant With Study|1
854801|NCT00434330|1812899|FG003|Overall Study|Subject Not Compliant With Study|0
854802|NCT00434330|1812900|FG004|Overall Study|Subject Not Compliant With Study|0
854803|NCT00434330|1812901|FG005|Overall Study|Subject Not Compliant With Study|0
854804|NCT00434421|1812924|FG000|Overall Study|Withdrawal by Subject|1
854805|NCT00434421|1812924|FG000|Overall Study|Non-compliance with study treatment|1
854806|NCT00434512|1812947|FG000|Overall Study|Migrated/moved from study area|0
854807|NCT00434512|1812948|FG001|Overall Study|Migrated/moved from study area|0
854808|NCT00434512|1812949|FG002|Overall Study|Migrated/moved from study area|0
854809|NCT00434512|1812950|FG003|Overall Study|Migrated/moved from study area|1
854810|NCT00434512|1812951|FG004|Overall Study|Migrated/moved from study area|1
854811|NCT00434512|1812952|FG005|Overall Study|Migrated/moved from study area|1
854812|NCT00434512|1812947|FG000|Overall Study|Other|0
854813|NCT00434512|1812948|FG001|Overall Study|Other|1
854814|NCT00434512|1812949|FG002|Overall Study|Other|0
854815|NCT00434512|1812950|FG003|Overall Study|Other|0
854816|NCT00434512|1812951|FG004|Overall Study|Other|0
854817|NCT00434512|1812952|FG005|Overall Study|Other|0
854818|NCT00434577|1812975|FG000|Months 0-3|Serious Adverse Event|0
854819|NCT00434577|1812976|FG001|Months 0-3|Serious Adverse Event|0
854820|NCT00434577|1812977|FG002|Months 0-3|Serious Adverse Event|1
854821|NCT00434577|1812978|FG003|Months 0-3|Serious Adverse Event|0
854822|NCT00434577|1812979|FG004|Months 0-3|Serious Adverse Event|0
854823|NCT00434577|1812975|FG000|Months 0-3|Adverse Event|0
854824|NCT00434577|1812976|FG001|Months 0-3|Adverse Event|1
854825|NCT00434577|1812977|FG002|Months 0-3|Adverse Event|1
854826|NCT00434577|1812978|FG003|Months 0-3|Adverse Event|0
854827|NCT00434577|1812979|FG004|Months 0-3|Adverse Event|0
854828|NCT00434577|1812975|FG000|Months 0-3|Lost to Follow-up|0
854829|NCT00434577|1812976|FG001|Months 0-3|Lost to Follow-up|0
854830|NCT00434577|1812977|FG002|Months 0-3|Lost to Follow-up|0
854831|NCT00434577|1812978|FG003|Months 0-3|Lost to Follow-up|0
854832|NCT00434577|1812979|FG004|Months 0-3|Lost to Follow-up|2
854833|NCT00434577|1812975|FG000|Months 0-3|Protocol Violation|1
854834|NCT00434577|1812976|FG001|Months 0-3|Protocol Violation|0
854835|NCT00434577|1812977|FG002|Months 0-3|Protocol Violation|1
854836|NCT00434577|1812978|FG003|Months 0-3|Protocol Violation|0
854837|NCT00434577|1812979|FG004|Months 0-3|Protocol Violation|0
854838|NCT00434577|1812975|FG000|Months 0-3|Withdrawal by Subject|2
854839|NCT00434577|1812976|FG001|Months 0-3|Withdrawal by Subject|1
854840|NCT00434577|1812977|FG002|Months 0-3|Withdrawal by Subject|1
854841|NCT00434577|1812978|FG003|Months 0-3|Withdrawal by Subject|1
854842|NCT00434577|1812979|FG004|Months 0-3|Withdrawal by Subject|1
854843|NCT00434642|1812993|FG000|Blinded Treatment Phase|Adverse Event|12
854844|NCT00434642|1812994|FG001|Blinded Treatment Phase|Adverse Event|58
854845|NCT00434642|1812993|FG000|Blinded Treatment Phase|Clinical Disease Progression|4
854846|NCT00434642|1812994|FG001|Blinded Treatment Phase|Clinical Disease Progression|5
854847|NCT00434642|1812993|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168
854848|NCT00434642|1812994|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109
854849|NCT00434642|1812993|FG000|Blinded Treatment Phase|Physician Decision|19
854850|NCT00434642|1812994|FG001|Blinded Treatment Phase|Physician Decision|27
854851|NCT00434642|1812993|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
854852|NCT00434642|1812994|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
854853|NCT00434642|1812993|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
854854|NCT00434642|1812994|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
854855|NCT00434642|1812993|FG000|Blinded Treatment Phase|Did not Receive Treatment|4
854856|NCT00434642|1812994|FG001|Blinded Treatment Phase|Did not Receive Treatment|1
854857|NCT00434642|1812993|FG000|Open-label Treatment Phase|Adverse Event|0
854858|NCT00434642|1812994|FG001|Open-label Treatment Phase|Adverse Event|5
854859|NCT00434642|1812993|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0
854860|NCT00434642|1812994|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6
854861|NCT00434759|1813002|FG000|Overall Study|Lack of Efficacy|5
854862|NCT00434759|1813003|FG001|Overall Study|Lack of Efficacy|4
854863|NCT00434759|1813002|FG000|Overall Study|Withdrawal by Subject|17
854864|NCT00434759|1813003|FG001|Overall Study|Withdrawal by Subject|1
854865|NCT00434759|1813002|FG000|Overall Study|family affairs|2
854866|NCT00434759|1813003|FG001|Overall Study|family affairs|0
854867|NCT00434876|1813013|FG000|Overall Study|Lost to Follow-up|1
854868|NCT00434876|1813014|FG001|Overall Study|Lost to Follow-up|1
854869|NCT00434954|1813022|FG000|Overall Study|Adverse Event|17
854870|NCT00434954|1813023|FG001|Overall Study|Adverse Event|2
854871|NCT00434954|1813022|FG000|Overall Study|Entry criteria not met|14
854872|NCT00434954|1813023|FG001|Overall Study|Entry criteria not met|16
854873|NCT00434954|1813022|FG000|Overall Study|Lost to Follow-up|0
854874|NCT00434954|1813023|FG001|Overall Study|Lost to Follow-up|1
854875|NCT00434954|1813022|FG000|Overall Study|Physician Decision|6
854876|NCT00434954|1813023|FG001|Overall Study|Physician Decision|3
854877|NCT00434954|1813022|FG000|Overall Study|Protocol Violation|36
854878|NCT00434954|1813023|FG001|Overall Study|Protocol Violation|27
854879|NCT00434954|1813022|FG000|Overall Study|Sponsor decision|1
854880|NCT00434954|1813023|FG001|Overall Study|Sponsor decision|0
854881|NCT00434954|1813022|FG000|Overall Study|Subject decision|8
854882|NCT00434954|1813023|FG001|Overall Study|Subject decision|22
854883|NCT00434967|1813033|FG000|Overall Study|Adverse Event|2
854884|NCT00434967|1813034|FG001|Overall Study|Adverse Event|4
854885|NCT00434967|1813035|FG002|Overall Study|Adverse Event|3
854886|NCT00434967|1813036|FG003|Overall Study|Adverse Event|3
854887|NCT00434967|1813033|FG000|Overall Study|Lost to Follow-up|0
854888|NCT00434967|1813034|FG001|Overall Study|Lost to Follow-up|0
854889|NCT00434967|1813035|FG002|Overall Study|Lost to Follow-up|1
854890|NCT00434967|1813036|FG003|Overall Study|Lost to Follow-up|0
854891|NCT00434967|1813033|FG000|Overall Study|Withdrawal by Subject|2
854892|NCT00434967|1813034|FG001|Overall Study|Withdrawal by Subject|2
854893|NCT00434967|1813035|FG002|Overall Study|Withdrawal by Subject|4
854894|NCT00434967|1813036|FG003|Overall Study|Withdrawal by Subject|6
854895|NCT00434967|1813033|FG000|Overall Study|Randomized in error|0
854896|NCT00434967|1813034|FG001|Overall Study|Randomized in error|0
854897|NCT00434967|1813035|FG002|Overall Study|Randomized in error|0
854898|NCT00434967|1813036|FG003|Overall Study|Randomized in error|1
854899|NCT00434967|1813033|FG000|Overall Study|Protocol Violation|0
854900|NCT00434967|1813034|FG001|Overall Study|Protocol Violation|1
854901|NCT00434967|1813035|FG002|Overall Study|Protocol Violation|0
854902|NCT00434967|1813036|FG003|Overall Study|Protocol Violation|1
854903|NCT00434967|1813033|FG000|Overall Study|Physician Decision|1
854904|NCT00434967|1813034|FG001|Overall Study|Physician Decision|1
854905|NCT00434967|1813035|FG002|Overall Study|Physician Decision|1
854906|NCT00434967|1813036|FG003|Overall Study|Physician Decision|0
854907|NCT00434967|1813033|FG000|Overall Study|Patient Disposition Challenges|2
854908|NCT00434967|1813034|FG001|Overall Study|Patient Disposition Challenges|0
854909|NCT00434967|1813035|FG002|Overall Study|Patient Disposition Challenges|0
854910|NCT00434967|1813036|FG003|Overall Study|Patient Disposition Challenges|3
854911|NCT00435019|1813057|FG000|Overall Study|Adverse Event|1
854912|NCT00435019|1813058|FG001|Overall Study|Adverse Event|0
854913|NCT00435019|1813057|FG000|Overall Study|Lack of Efficacy|1
854914|NCT00435019|1813058|FG001|Overall Study|Lack of Efficacy|2
854915|NCT00435019|1813057|FG000|Overall Study|Protocol Violation|3
854916|NCT00435019|1813058|FG001|Overall Study|Protocol Violation|1
854917|NCT00435019|1813057|FG000|Overall Study|Personal reasons for withdrawal|8
854918|NCT00435019|1813058|FG001|Overall Study|Personal reasons for withdrawal|7
854919|NCT00435045|1813066|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
854920|NCT00435045|1813067|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
854921|NCT00435045|1813066|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
854922|NCT00435045|1813067|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
854923|NCT00435045|1813066|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
854924|NCT00435045|1813067|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
854925|NCT00435045|1813066|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
854926|NCT00435045|1813067|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
854927|NCT00435045|1813066|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
854928|NCT00435045|1813067|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
854929|NCT00435045|1813066|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
854930|NCT00435045|1813067|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
854931|NCT00435045|1813066|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
854932|NCT00435045|1813067|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
854933|NCT00435045|1813066|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
854934|NCT00435045|1813067|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
854935|NCT00435045|1813066|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
854936|NCT00435045|1813067|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
854937|NCT00435045|1813066|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
854938|NCT00435045|1813067|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
854939|NCT00435045|1813066|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
854940|NCT00435045|1813067|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
854941|NCT00435162|1813076|FG000|Period 2 (2 Weeks)|Adverse Event|0
854942|NCT00435162|1813077|FG001|Period 2 (2 Weeks)|Adverse Event|1
854943|NCT00435162|1813078|FG002|Period 2 (2 Weeks)|Adverse Event|0
854944|NCT00435162|1813079|FG003|Period 2 (2 Weeks)|Adverse Event|0
854945|NCT00435162|1813080|FG004|Period 2 (2 Weeks)|Adverse Event|0
854946|NCT00435162|1813081|FG005|Period 2 (2 Weeks)|Adverse Event|0
854947|NCT00435188|1813096|FG000|Overall Study|Death|1
854948|NCT00435188|1813097|FG001|Overall Study|Death|6
854949|NCT00435188|1813096|FG000|Overall Study|Withdrawal by Subject|16
854950|NCT00435188|1813097|FG001|Overall Study|Withdrawal by Subject|11
854951|NCT00435188|1813096|FG000|Overall Study|Lost to Follow-up|5
854952|NCT00435188|1813097|FG001|Overall Study|Lost to Follow-up|6
854953|NCT00435370|1813117|FG000|Overall Study|Adverse Event|8
854954|NCT00435370|1813118|FG001|Overall Study|Adverse Event|8
854955|NCT00435370|1813117|FG000|Overall Study|Withdrawal by Subject|10
854956|NCT00435370|1813118|FG001|Overall Study|Withdrawal by Subject|10
854957|NCT00435370|1813117|FG000|Overall Study|Antipsychotic medication changed|4
854958|NCT00435370|1813118|FG001|Overall Study|Antipsychotic medication changed|2
854959|NCT00435409|1813126|FG000|Overall Study|Protocol Violation|1
854960|NCT00435409|1813127|FG001|Overall Study|Protocol Violation|2
854961|NCT00435409|1813128|FG002|Overall Study|Protocol Violation|0
854962|NCT00435409|1813126|FG000|Overall Study|Lost to Follow-up|1
854963|NCT00435409|1813127|FG001|Overall Study|Lost to Follow-up|2
854964|NCT00435409|1813128|FG002|Overall Study|Lost to Follow-up|0
854965|NCT00435409|1813126|FG000|Overall Study|Death|8
854966|NCT00435409|1813127|FG001|Overall Study|Death|6
854967|NCT00435409|1813128|FG002|Overall Study|Death|6
854968|NCT00435409|1813126|FG000|Overall Study|Objective progression or relapse|158
854969|NCT00435409|1813127|FG001|Overall Study|Objective progression or relapse|93
854970|NCT00435409|1813128|FG002|Overall Study|Objective progression or relapse|58
854971|NCT00435409|1813126|FG000|Overall Study|Global deterioration of health status|0
854972|NCT00435409|1813127|FG001|Overall Study|Global deterioration of health status|0
854973|NCT00435409|1813128|FG002|Overall Study|Global deterioration of health status|4
854974|NCT00435409|1813126|FG000|Overall Study|Withdrawal by Subject|8
854975|NCT00435409|1813127|FG001|Overall Study|Withdrawal by Subject|7
854976|NCT00435409|1813128|FG002|Overall Study|Withdrawal by Subject|1
854977|NCT00435409|1813126|FG000|Overall Study|Other|45
854978|NCT00435409|1813127|FG001|Overall Study|Other|30
854979|NCT00435409|1813128|FG002|Overall Study|Other|1
854980|NCT00435409|1813126|FG000|Overall Study|Adverse Event|0
854981|NCT00435409|1813127|FG001|Overall Study|Adverse Event|0
854982|NCT00435409|1813128|FG002|Overall Study|Adverse Event|8
854983|NCT00435409|1813126|FG000|Overall Study|Sponsor decision|0
854984|NCT00435409|1813127|FG001|Overall Study|Sponsor decision|3
854985|NCT00435409|1813128|FG002|Overall Study|Sponsor decision|0
854986|NCT00435461|1813137|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1
854987|NCT00435461|1813138|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0
854988|NCT00435461|1813139|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0
854989|NCT00435461|1813137|FG000|Overall Study|Protocol Violation|6
854990|NCT00435461|1813138|FG001|Overall Study|Protocol Violation|9
854991|NCT00435461|1813139|FG002|Overall Study|Protocol Violation|10
854992|NCT00435461|1813137|FG000|Overall Study|Participant randomized(inadequate score)|1
854993|NCT00435461|1813138|FG001|Overall Study|Participant randomized(inadequate score)|0
854994|NCT00435461|1813139|FG002|Overall Study|Participant randomized(inadequate score)|0
854995|NCT00435461|1813137|FG000|Overall Study|Compliance less than 80 percent|1
854996|NCT00435461|1813138|FG001|Overall Study|Compliance less than 80 percent|0
854997|NCT00435461|1813139|FG002|Overall Study|Compliance less than 80 percent|0
854998|NCT00435461|1813137|FG000|Overall Study|In error, two study medications switched|1
854999|NCT00435461|1813138|FG001|Overall Study|In error, two study medications switched|0
855000|NCT00435461|1813139|FG002|Overall Study|In error, two study medications switched|0
855001|NCT00435461|1813137|FG000|Overall Study|Lack of Efficacy|2
855002|NCT00435461|1813138|FG001|Overall Study|Lack of Efficacy|1
855003|NCT00435461|1813139|FG002|Overall Study|Lack of Efficacy|0
855004|NCT00435461|1813137|FG000|Overall Study|Withdrawal by Subject|1
855005|NCT00435461|1813138|FG001|Overall Study|Withdrawal by Subject|0
855006|NCT00435461|1813139|FG002|Overall Study|Withdrawal by Subject|2
855007|NCT00435461|1813137|FG000|Overall Study|Randomized in error|1
855008|NCT00435461|1813138|FG001|Overall Study|Randomized in error|0
855009|NCT00435461|1813139|FG002|Overall Study|Randomized in error|0
855010|NCT00435461|1813137|FG000|Overall Study|Participant could not tolerate symptoms|0
855011|NCT00435461|1813138|FG001|Overall Study|Participant could not tolerate symptoms|0
855012|NCT00435461|1813139|FG002|Overall Study|Participant could not tolerate symptoms|1
855013|NCT00435461|1813137|FG000|Overall Study|Participant could not swallow capsule|0
855014|NCT00435461|1813138|FG001|Overall Study|Participant could not swallow capsule|0
855015|NCT00435461|1813139|FG002|Overall Study|Participant could not swallow capsule|1
855016|NCT00435461|1813137|FG000|Overall Study|Pregnancy|2
855017|NCT00435461|1813138|FG001|Overall Study|Pregnancy|0
855018|NCT00435461|1813139|FG002|Overall Study|Pregnancy|0
855019|NCT00435461|1813137|FG000|Overall Study|Participant moved eDiary,studymedication|1
855020|NCT00435461|1813138|FG001|Overall Study|Participant moved eDiary,studymedication|0
855021|NCT00435461|1813139|FG002|Overall Study|Participant moved eDiary,studymedication|0
855022|NCT00435461|1813137|FG000|Overall Study|Participant ended study one day early|1
855023|NCT00435461|1813138|FG001|Overall Study|Participant ended study one day early|0
855024|NCT00435461|1813139|FG002|Overall Study|Participant ended study one day early|0
855025|NCT00435461|1813137|FG000|Overall Study|Noncompliance with study requirements|1
855026|NCT00435461|1813138|FG001|Overall Study|Noncompliance with study requirements|1
855027|NCT00435461|1813139|FG002|Overall Study|Noncompliance with study requirements|1
855028|NCT00435461|1813137|FG000|Overall Study|Adverse Event|1
855029|NCT00435461|1813138|FG001|Overall Study|Adverse Event|2
855030|NCT00435461|1813139|FG002|Overall Study|Adverse Event|6
855031|NCT00435461|1813137|FG000|Overall Study|Non-Compliance of diary|2
855032|NCT00435461|1813138|FG001|Overall Study|Non-Compliance of diary|0
855033|NCT00435461|1813139|FG002|Overall Study|Non-Compliance of diary|1
855034|NCT00435461|1813137|FG000|Overall Study|Lost to Follow-up|1
855035|NCT00435461|1813138|FG001|Overall Study|Lost to Follow-up|1
855036|NCT00435461|1813139|FG002|Overall Study|Lost to Follow-up|2
855037|NCT00435487|1813149|FG000|Overall Study|Death|3
855038|NCT00435487|1813150|FG001|Overall Study|Death|4
855039|NCT00435487|1813149|FG000|Overall Study|Adverse Event|0
855040|NCT00435487|1813150|FG001|Overall Study|Adverse Event|3
855041|NCT00435487|1813149|FG000|Overall Study|Lost to Follow-up|2
855042|NCT00435487|1813150|FG001|Overall Study|Lost to Follow-up|2
855043|NCT00435487|1813149|FG000|Overall Study|Other|5
855044|NCT00435487|1813150|FG001|Overall Study|Other|2
855045|NCT00435487|1813149|FG000|Overall Study|Withdrawal by Subject|2
855046|NCT00435487|1813150|FG001|Overall Study|Withdrawal by Subject|1
855047|NCT00435487|1813149|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0
855048|NCT00435487|1813150|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2
855049|NCT00435487|1813149|FG000|Overall Study|Received Drug in Other Treatment Group|0
855050|NCT00435487|1813150|FG001|Overall Study|Received Drug in Other Treatment Group|1
855051|NCT00435825|1813209|FG000|Overall Study|Abnormality of Laboratory Test|0
855052|NCT00435825|1813210|FG001|Overall Study|Abnormality of Laboratory Test|1
855053|NCT00435825|1813211|FG002|Overall Study|Abnormality of Laboratory Test|0
855054|NCT00435825|1813212|FG003|Overall Study|Abnormality of Laboratory Test|0
855055|NCT00435825|1813209|FG000|Overall Study|Insufficient Therapeutic Response|3
855056|NCT00435825|1813210|FG001|Overall Study|Insufficient Therapeutic Response|1
855057|NCT00435825|1813211|FG002|Overall Study|Insufficient Therapeutic Response|0
855058|NCT00435825|1813212|FG003|Overall Study|Insufficient Therapeutic Response|3
855059|NCT00435825|1813209|FG000|Overall Study|Other Protocol Violation|1
855060|NCT00435825|1813210|FG001|Overall Study|Other Protocol Violation|0
855061|NCT00435825|1813211|FG002|Overall Study|Other Protocol Violation|0
855062|NCT00435825|1813212|FG003|Overall Study|Other Protocol Violation|0
855063|NCT00435825|1813209|FG000|Overall Study|Refused treatment|2
855064|NCT00435825|1813210|FG001|Overall Study|Refused treatment|0
855065|NCT00435825|1813211|FG002|Overall Study|Refused treatment|0
855066|NCT00435825|1813212|FG003|Overall Study|Refused treatment|5
855067|NCT00435825|1813209|FG000|Overall Study|Failure to return|5
855068|NCT00435825|1813210|FG001|Overall Study|Failure to return|0
855069|NCT00435825|1813211|FG002|Overall Study|Failure to return|4
855070|NCT00435825|1813212|FG003|Overall Study|Failure to return|0
855071|NCT00435825|1813209|FG000|Overall Study|Did not receive study drug|1
855072|NCT00435825|1813210|FG001|Overall Study|Did not receive study drug|0
855073|NCT00435825|1813211|FG002|Overall Study|Did not receive study drug|2
855074|NCT00435825|1813212|FG003|Overall Study|Did not receive study drug|0
855075|NCT00435825|1813209|FG000|Overall Study|Did not enter follow-up|0
855076|NCT00435825|1813210|FG001|Overall Study|Did not enter follow-up|4
855077|NCT00435825|1813211|FG002|Overall Study|Did not enter follow-up|1
855078|NCT00435825|1813212|FG003|Overall Study|Did not enter follow-up|3
855079|NCT00435825|1813209|FG000|Overall Study|Did not complete full follow-up period|6
855080|NCT00435825|1813210|FG001|Overall Study|Did not complete full follow-up period|6
855081|NCT00435825|1813211|FG002|Overall Study|Did not complete full follow-up period|4
855082|NCT00435825|1813212|FG003|Overall Study|Did not complete full follow-up period|5
855083|NCT00435942|1813233|FG000|Overall Study|Death|17
855084|NCT00435942|1813234|FG001|Overall Study|Death|10
855085|NCT00435942|1813233|FG000|Overall Study|Withdrawal by Subject|2
855086|NCT00435942|1813234|FG001|Overall Study|Withdrawal by Subject|0
855087|NCT00435942|1813233|FG000|Overall Study|Lost to Follow-up|0
855088|NCT00435942|1813234|FG001|Overall Study|Lost to Follow-up|16
855089|NCT00435942|1813233|FG000|Overall Study|Conversion to Open Repair|1
855090|NCT00435942|1813234|FG001|Overall Study|Conversion to Open Repair|0
855091|NCT00435942|1813233|FG000|Overall Study|Technical Failure|3
855092|NCT00435942|1813234|FG001|Overall Study|Technical Failure|0
855093|NCT00435942|1813233|FG000|Overall Study|Other|0
855094|NCT00435942|1813234|FG001|Overall Study|Other|1
855095|NCT00435994|1813243|FG000|Overall Study|Lost to Follow-up|7
855096|NCT00435994|1813244|FG001|Overall Study|Lost to Follow-up|0
855097|NCT00435994|1813245|FG002|Overall Study|Lost to Follow-up|0
855098|NCT00436007|1813257|FG000|Overall Study|Withdrawal by Subject|5
855099|NCT00436007|1813258|FG001|Overall Study|Withdrawal by Subject|3
855100|NCT00436007|1813259|FG002|Overall Study|Withdrawal by Subject|4
855101|NCT00436007|1813257|FG000|Overall Study|Lost to Follow-up|14
855102|NCT00436007|1813258|FG001|Overall Study|Lost to Follow-up|10
855103|NCT00436007|1813259|FG002|Overall Study|Lost to Follow-up|13
855104|NCT00436007|1813257|FG000|Overall Study|Physician Decision|0
855105|NCT00436007|1813258|FG001|Overall Study|Physician Decision|0
855106|NCT00436007|1813259|FG002|Overall Study|Physician Decision|2
855107|NCT00436007|1813257|FG000|Overall Study|Death|0
855108|NCT00436007|1813258|FG001|Overall Study|Death|1
855109|NCT00436007|1813259|FG002|Overall Study|Death|3
855110|NCT00436007|1813257|FG000|Overall Study|Other|0
855111|NCT00436007|1813258|FG001|Overall Study|Other|0
855112|NCT00436007|1813259|FG002|Overall Study|Other|1
855113|NCT00436163|1813285|FG000|Overall Study|Lost to Follow-up|2
855114|NCT00436163|1813285|FG000|Overall Study|Adverse Event|1
855115|NCT00436215|1813290|FG000|Overall Study|Refused further treatment|3
855116|NCT00436215|1813290|FG000|Overall Study|Small bowel obstruction|1
855117|NCT00436280|1813294|FG000|Period 1: Induction|Adverse Event|8
855118|NCT00436280|1813294|FG000|Period 1: Induction|Progressive Disease|12
855119|NCT00436280|1813294|FG000|Period 1: Induction|Stable Disease|6
855120|NCT00436280|1813294|FG000|Period 1: Induction|Withdrawal by Subject|1
855121|NCT00436280|1813294|FG000|Period 1: Induction|Death|1
855122|NCT00436280|1813294|FG000|Period 2: Consolidation|Adverse Event|1
855123|NCT00436280|1813294|FG000|Period 2: Consolidation|Progressive Disease|10
855124|NCT00436280|1813294|FG000|Period 2: Consolidation|Stable Disease|1
855125|NCT00436280|1813294|FG000|Period 2: Consolidation|Physician Decision|2
855126|NCT00436280|1813294|FG000|Period 2: Consolidation|Withdrawal by Subject|2
855127|NCT00436280|1813294|FG000|Period 2: Consolidation|Death|1
855128|NCT00436280|1813294|FG000|Period 3: Maintenance|Adverse Event|6
855129|NCT00436280|1813294|FG000|Period 3: Maintenance|Progressive Disease|12
855130|NCT00436332|1813298|FG000|Overall Study|Adverse Event|9
855131|NCT00436332|1813298|FG000|Overall Study|Withdrawal by Subject|2
855132|NCT00436332|1813298|FG000|Overall Study|Progression|59
855133|NCT00436332|1813298|FG000|Overall Study|Death|2
855134|NCT00436332|1813298|FG000|Overall Study|Not Protocol Specified|6
855135|NCT00436332|1813298|FG000|Overall Study|Ineligible|2
855136|NCT00436332|1813298|FG000|Overall Study|Never Received Treatment|3
855137|NCT00436345|1813304|FG000|Overall Study|ICU resident beyond follow-up period|3
855138|NCT00436345|1813305|FG001|Overall Study|ICU resident beyond follow-up period|0
855139|NCT00436436|1813312|FG000|Overall Study|Progression|4
855140|NCT00436436|1813312|FG000|Overall Study|Adverse Event|2
855141|NCT00436436|1813312|FG000|Overall Study|Death|6
855142|NCT00436501|1813335|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
855143|NCT00436501|1813336|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
855144|NCT00436501|1813335|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
855145|NCT00436501|1813336|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
855146|NCT00436553|1813346|FG000|Overall Study|Adverse Event|4
855147|NCT00436553|1813347|FG001|Overall Study|Adverse Event|3
855148|NCT00436553|1813348|FG002|Overall Study|Adverse Event|4
855149|NCT00436553|1813346|FG000|Overall Study|Death|3
855150|NCT00436553|1813347|FG001|Overall Study|Death|1
855151|NCT00436553|1813348|FG002|Overall Study|Death|3
855152|NCT00436553|1813346|FG000|Overall Study|Lost to Follow-up|0
855153|NCT00436553|1813347|FG001|Overall Study|Lost to Follow-up|2
855154|NCT00436553|1813348|FG002|Overall Study|Lost to Follow-up|0
855155|NCT00436553|1813346|FG000|Overall Study|Protocol Violation|1
855156|NCT00436553|1813347|FG001|Overall Study|Protocol Violation|0
855157|NCT00436553|1813348|FG002|Overall Study|Protocol Violation|0
855158|NCT00436553|1813346|FG000|Overall Study|Withdrawal by Subject|5
855159|NCT00436553|1813347|FG001|Overall Study|Withdrawal by Subject|6
855160|NCT00436553|1813348|FG002|Overall Study|Withdrawal by Subject|3
855161|NCT00436566|1813356|FG000|Overall Study|Withdrawal by Subject|2
855162|NCT00436566|1813356|FG000|Overall Study|Protocol Violation|1
855163|NCT00436605|1813360|FG000|Overall Study|Protocol Violation|3
855164|NCT00436618|1813367|FG000|Overall Study|Withdrawal by Subject|5
855165|NCT00436618|1813368|FG001|Overall Study|Withdrawal by Subject|8
855166|NCT00436618|1813369|FG002|Overall Study|Withdrawal by Subject|11
855167|NCT00436618|1813367|FG000|Overall Study|Adverse Event|8
855168|NCT00436618|1813368|FG001|Overall Study|Adverse Event|8
855169|NCT00436618|1813369|FG002|Overall Study|Adverse Event|9
855170|NCT00436618|1813367|FG000|Overall Study|Alternate Treatment|3
855171|NCT00436618|1813368|FG001|Overall Study|Alternate Treatment|4
855172|NCT00436618|1813369|FG002|Overall Study|Alternate Treatment|12
855173|NCT00436618|1813367|FG000|Overall Study|Other Medical Problems|3
855174|NCT00436618|1813368|FG001|Overall Study|Other Medical Problems|1
855175|NCT00436618|1813369|FG002|Overall Study|Other Medical Problems|7
855176|NCT00436618|1813367|FG000|Overall Study|Death|4
855177|NCT00436618|1813368|FG001|Overall Study|Death|2
855178|NCT00436618|1813369|FG002|Overall Study|Death|3
855179|NCT00436618|1813367|FG000|Overall Study|New Primary or Other Reasons|6
855180|NCT00436618|1813368|FG001|Overall Study|New Primary or Other Reasons|2
855181|NCT00436618|1813369|FG002|Overall Study|New Primary or Other Reasons|12
855182|NCT00436618|1813367|FG000|Overall Study|Still on treatment|1
855183|NCT00436618|1813368|FG001|Overall Study|Still on treatment|2
855184|NCT00436618|1813369|FG002|Overall Study|Still on treatment|7
855185|NCT00436644|1813377|FG000|Overall Study|Adverse Event|2
855186|NCT00436644|1813377|FG000|Overall Study|Death|1
855187|NCT00436748|1813383|FG000|Overall Study|Ineligibility Determined|1
855188|NCT00436748|1813384|FG001|Overall Study|Ineligibility Determined|1
855189|NCT00436748|1813383|FG000|Overall Study|Adverse Event|0
855190|NCT00436748|1813384|FG001|Overall Study|Adverse Event|2
855191|NCT00436748|1813383|FG000|Overall Study|Consent Withdrawn|1
855192|NCT00436748|1813384|FG001|Overall Study|Consent Withdrawn|4
855193|NCT00436748|1813383|FG000|Overall Study|Administrative Decision|1
855194|NCT00436748|1813384|FG001|Overall Study|Administrative Decision|0
855195|NCT00436748|1813383|FG000|Overall Study|Lost to Follow-up|0
855196|NCT00436748|1813384|FG001|Overall Study|Lost to Follow-up|1
855197|NCT00436748|1813383|FG000|Overall Study|Protocol-specified Criteria|5
855198|NCT00436748|1813384|FG001|Overall Study|Protocol-specified Criteria|4
855199|NCT00436748|1813383|FG000|Overall Study|Other|3
855200|NCT00436748|1813384|FG001|Overall Study|Other|0
855201|NCT00436852|1813415|FG000|Overall Study|Death|23
855202|NCT00436852|1813416|FG001|Overall Study|Death|34
855203|NCT00436852|1813415|FG000|Overall Study|Lack of Efficacy|9
855204|NCT00436852|1813416|FG001|Overall Study|Lack of Efficacy|7
855205|NCT00436852|1813415|FG000|Overall Study|Withdrawal by Subject|2
855206|NCT00436852|1813416|FG001|Overall Study|Withdrawal by Subject|4
855207|NCT00436852|1813415|FG000|Overall Study|Ineligible|1
855208|NCT00436852|1813416|FG001|Overall Study|Ineligible|0
855209|NCT00436917|1813429|FG000|Overall Study|Withdrawal by Subject|13
855210|NCT00436917|1813429|FG000|Overall Study|Adverse Event|2
855211|NCT00436917|1813429|FG000|Overall Study|Physician Decision|1
855212|NCT00436917|1813429|FG000|Overall Study|Death|1
855213|NCT00436917|1813429|FG000|Overall Study|Lost to Follow-up|1
855214|NCT00436917|1813429|FG000|Overall Study|Treatment for polymyalgia rheumatic|1
855215|NCT00436917|1813429|FG000|Overall Study|Increased creatinine|1
855216|NCT00436917|1813429|FG000|Overall Study|Personal conflicts of patient|1
855217|NCT00436956|1813433|FG000|Overall Study|Not evaluable|1
855218|NCT00436956|1813434|FG001|Overall Study|Not evaluable|0
855219|NCT00436982|1813452|FG000|Overall Study|Withdrawal by Subject|3
855220|NCT00436982|1813453|FG001|Overall Study|Withdrawal by Subject|1
855221|NCT00436982|1813452|FG000|Overall Study|Did not receive allocated intervention|0
855222|NCT00436982|1813453|FG001|Overall Study|Did not receive allocated intervention|1
855223|NCT00436982|1813452|FG000|Overall Study|no RSA data|1
855224|NCT00436982|1813453|FG001|Overall Study|no RSA data|2
855225|NCT00437034|1813463|FG000|Overall Study|Adverse Event|1
855226|NCT00437034|1813463|FG000|Overall Study|Disease progression during treatment|5
855227|NCT00437073|1813469|FG000|Overall Study|Sponsor Terminated Study|1
855228|NCT00437073|1813470|FG001|Overall Study|Sponsor Terminated Study|0
855229|NCT00437073|1813469|FG000|Overall Study|Physician Decision|0
855230|NCT00437073|1813470|FG001|Overall Study|Physician Decision|1
855231|NCT00437125|1813476|FG000|Overall Study|Adverse Event|12
855232|NCT00437125|1813476|FG000|Overall Study|Death|1
855233|NCT00437125|1813476|FG000|Overall Study|Clinical Relapse|1
855234|NCT00437125|1813476|FG000|Overall Study|Lack of Efficacy|1
855235|NCT00437125|1813476|FG000|Overall Study|Lost to Follow-up|1
855236|NCT00437125|1813476|FG000|Overall Study|Withdrawal by Subject|13
855237|NCT00437125|1813476|FG000|Overall Study|Withdrawal by Caregiver|2
855238|NCT00437125|1813476|FG000|Overall Study|Physician Decision|1
855239|NCT00437203|1813490|FG000|Overall Study|Death|0
855240|NCT00437203|1813491|FG001|Overall Study|Death|0
855241|NCT00437203|1813492|FG002|Overall Study|Death|1
855242|NCT00437203|1813493|FG003|Overall Study|Death|0
855243|NCT00437203|1813494|FG004|Overall Study|Death|0
855244|NCT00437203|1813495|FG005|Overall Study|Death|0
855245|NCT00437203|1813496|FG006|Overall Study|Death|0
855246|NCT00437203|1813497|FG007|Overall Study|Death|1
855247|NCT00437203|1813498|FG008|Overall Study|Death|0
855248|NCT00437203|1813499|FG009|Overall Study|Death|1
855249|NCT00437203|1813490|FG000|Overall Study|Adverse Event|1
855250|NCT00437203|1813491|FG001|Overall Study|Adverse Event|1
855251|NCT00437203|1813492|FG002|Overall Study|Adverse Event|0
855252|NCT00437203|1813493|FG003|Overall Study|Adverse Event|0
855253|NCT00437203|1813494|FG004|Overall Study|Adverse Event|0
855254|NCT00437203|1813495|FG005|Overall Study|Adverse Event|0
855255|NCT00437203|1813496|FG006|Overall Study|Adverse Event|0
855256|NCT00437203|1813497|FG007|Overall Study|Adverse Event|1
855257|NCT00437203|1813498|FG008|Overall Study|Adverse Event|0
855258|NCT00437203|1813499|FG009|Overall Study|Adverse Event|1
855259|NCT00437203|1813490|FG000|Overall Study|Study terminated by sponsor|0
855260|NCT00437203|1813491|FG001|Overall Study|Study terminated by sponsor|0
855261|NCT00437203|1813492|FG002|Overall Study|Study terminated by sponsor|0
855262|NCT00437203|1813493|FG003|Overall Study|Study terminated by sponsor|0
855263|NCT00437203|1813494|FG004|Overall Study|Study terminated by sponsor|0
855264|NCT00437203|1813495|FG005|Overall Study|Study terminated by sponsor|0
855265|NCT00437203|1813496|FG006|Overall Study|Study terminated by sponsor|0
855266|NCT00437203|1813497|FG007|Overall Study|Study terminated by sponsor|0
855267|NCT00437203|1813498|FG008|Overall Study|Study terminated by sponsor|1
855268|NCT00437203|1813499|FG009|Overall Study|Study terminated by sponsor|0
855269|NCT00437203|1813490|FG000|Overall Study|Objective progression or relapse|5
855270|NCT00437203|1813491|FG001|Overall Study|Objective progression or relapse|6
855271|NCT00437203|1813492|FG002|Overall Study|Objective progression or relapse|2
855272|NCT00437203|1813493|FG003|Overall Study|Objective progression or relapse|3
855273|NCT00437203|1813494|FG004|Overall Study|Objective progression or relapse|3
855274|NCT00437203|1813495|FG005|Overall Study|Objective progression or relapse|3
855275|NCT00437203|1813496|FG006|Overall Study|Objective progression or relapse|6
855276|NCT00437203|1813497|FG007|Overall Study|Objective progression or relapse|1
855277|NCT00437203|1813498|FG008|Overall Study|Objective progression or relapse|2
855278|NCT00437203|1813499|FG009|Overall Study|Objective progression or relapse|2
855279|NCT00437203|1813490|FG000|Overall Study|Other|0
855280|NCT00437203|1813491|FG001|Overall Study|Other|1
855281|NCT00437203|1813492|FG002|Overall Study|Other|0
855282|NCT00437203|1813493|FG003|Overall Study|Other|0
855283|NCT00437203|1813494|FG004|Overall Study|Other|0
855284|NCT00437203|1813495|FG005|Overall Study|Other|0
855285|NCT00437203|1813496|FG006|Overall Study|Other|1
855286|NCT00437203|1813497|FG007|Overall Study|Other|0
855287|NCT00437203|1813498|FG008|Overall Study|Other|0
855288|NCT00437203|1813499|FG009|Overall Study|Other|0
855289|NCT00437268|1813532|FG000|Overall Study|Adverse Event|1
855290|NCT00437268|1813533|FG001|Overall Study|Adverse Event|1
855291|NCT00437268|1813532|FG000|Overall Study|Withdrawal by Subject|2
855292|NCT00437268|1813533|FG001|Overall Study|Withdrawal by Subject|2
855293|NCT00437268|1813532|FG000|Overall Study|Progressive disease|9
855294|NCT00437268|1813533|FG001|Overall Study|Progressive disease|9
855295|NCT00437268|1813532|FG000|Overall Study|Physician Decision|1
855296|NCT00437268|1813533|FG001|Overall Study|Physician Decision|0
855297|NCT00437268|1813532|FG000|Overall Study|Death|0
855298|NCT00437268|1813533|FG001|Overall Study|Death|1
855299|NCT00437281|1813561|FG000|Overall Study|Adverse Event|0
855300|NCT00437281|1813562|FG001|Overall Study|Adverse Event|0
855301|NCT00437281|1813563|FG002|Overall Study|Adverse Event|0
855302|NCT00437281|1813564|FG003|Overall Study|Adverse Event|1
855303|NCT00437281|1813565|FG004|Overall Study|Adverse Event|0
855304|NCT00437281|1813566|FG005|Overall Study|Adverse Event|1
855305|NCT00437281|1813567|FG006|Overall Study|Adverse Event|0
855306|NCT00437281|1813568|FG007|Overall Study|Adverse Event|0
855307|NCT00437281|1813569|FG008|Overall Study|Adverse Event|0
855308|NCT00437281|1813570|FG009|Overall Study|Adverse Event|1
855309|NCT00437281|1813571|FG010|Overall Study|Adverse Event|0
855310|NCT00437281|1813572|FG011|Overall Study|Adverse Event|0
855311|NCT00437281|1813573|FG012|Overall Study|Adverse Event|0
855312|NCT00437281|1813574|FG013|Overall Study|Adverse Event|1
855313|NCT00437281|1813575|FG014|Overall Study|Adverse Event|1
855314|NCT00437281|1813576|FG015|Overall Study|Adverse Event|0
855315|NCT00437281|1813577|FG016|Overall Study|Adverse Event|0
855316|NCT00437281|1813578|FG017|Overall Study|Adverse Event|0
855317|NCT00437281|1813579|FG018|Overall Study|Adverse Event|1
855318|NCT00437281|1813580|FG019|Overall Study|Adverse Event|0
855319|NCT00437281|1813561|FG000|Overall Study|Lost to Follow-up|0
855320|NCT00437281|1813562|FG001|Overall Study|Lost to Follow-up|0
855321|NCT00437281|1813563|FG002|Overall Study|Lost to Follow-up|0
855322|NCT00437281|1813564|FG003|Overall Study|Lost to Follow-up|0
855323|NCT00437281|1813565|FG004|Overall Study|Lost to Follow-up|0
855324|NCT00437281|1813566|FG005|Overall Study|Lost to Follow-up|0
855325|NCT00437281|1813567|FG006|Overall Study|Lost to Follow-up|0
855326|NCT00437281|1813568|FG007|Overall Study|Lost to Follow-up|0
855327|NCT00437281|1813569|FG008|Overall Study|Lost to Follow-up|0
855328|NCT00437281|1813570|FG009|Overall Study|Lost to Follow-up|0
855329|NCT00437281|1813571|FG010|Overall Study|Lost to Follow-up|0
855330|NCT00437281|1813572|FG011|Overall Study|Lost to Follow-up|0
855331|NCT00437281|1813573|FG012|Overall Study|Lost to Follow-up|0
855332|NCT00437281|1813574|FG013|Overall Study|Lost to Follow-up|0
855333|NCT00437281|1813575|FG014|Overall Study|Lost to Follow-up|0
855334|NCT00437281|1813576|FG015|Overall Study|Lost to Follow-up|0
855335|NCT00437281|1813577|FG016|Overall Study|Lost to Follow-up|0
855336|NCT00437281|1813578|FG017|Overall Study|Lost to Follow-up|0
855337|NCT00437281|1813579|FG018|Overall Study|Lost to Follow-up|0
855338|NCT00437281|1813580|FG019|Overall Study|Lost to Follow-up|1
855339|NCT00437294|1813654|FG000|Overall Study|Adverse Event|5
855340|NCT00437294|1813655|FG001|Overall Study|Adverse Event|4
855341|NCT00437294|1813654|FG000|Overall Study|Death|5
855342|NCT00437294|1813655|FG001|Overall Study|Death|2
855343|NCT00437294|1813654|FG000|Overall Study|Physician Decision|0
855344|NCT00437294|1813655|FG001|Overall Study|Physician Decision|3
855345|NCT00437294|1813654|FG000|Overall Study|Withdrawal by Subject|5
855346|NCT00437294|1813655|FG001|Overall Study|Withdrawal by Subject|0
855347|NCT00437294|1813654|FG000|Overall Study|Progressive Disease|19
855348|NCT00437294|1813655|FG001|Overall Study|Progressive Disease|23
855349|NCT00437294|1813654|FG000|Overall Study|Sponsor Decision|8
855350|NCT00437294|1813655|FG001|Overall Study|Sponsor Decision|9
855351|NCT00437294|1813654|FG000|Overall Study|Protocol Violation|0
855352|NCT00437294|1813655|FG001|Overall Study|Protocol Violation|1
855353|NCT00437294|1813654|FG000|Overall Study|Entry criteria not met|1
855354|NCT00437294|1813655|FG001|Overall Study|Entry criteria not met|1
855355|NCT00437489|1813669|FG000|Overall Study|Study terminated by sponsor|23
855356|NCT00437489|1813670|FG001|Overall Study|Study terminated by sponsor|21
855357|NCT00437489|1813669|FG000|Overall Study|Lost to Follow-up|0
855358|NCT00437489|1813670|FG001|Overall Study|Lost to Follow-up|1
855359|NCT00437645|1813678|FG000|Overall Study|Adverse Event|15
855360|NCT00437645|1813679|FG001|Overall Study|Adverse Event|84
855361|NCT00437645|1813678|FG000|Overall Study|Withdrawal by Subject|10
855362|NCT00437645|1813679|FG001|Overall Study|Withdrawal by Subject|22
855363|NCT00437645|1813678|FG000|Overall Study|Protocol Violation|3
855364|NCT00437645|1813679|FG001|Overall Study|Protocol Violation|3
855365|NCT00437645|1813678|FG000|Overall Study|Lost to Follow-up|2
855366|NCT00437645|1813679|FG001|Overall Study|Lost to Follow-up|3
855367|NCT00437645|1813678|FG000|Overall Study|Administrative problems|2
855368|NCT00437645|1813679|FG001|Overall Study|Administrative problems|1
855369|NCT00437645|1813678|FG000|Overall Study|Lack of Efficacy|2
855370|NCT00437645|1813679|FG001|Overall Study|Lack of Efficacy|1
855371|NCT00437645|1813678|FG000|Overall Study|Condition no longer requires study drug|1
855372|NCT00437645|1813679|FG001|Overall Study|Condition no longer requires study drug|1
855373|NCT00437658|1813688|FG000|Treatment Period (24 Weeks)|Adverse Event|4
855374|NCT00437658|1813689|FG001|Treatment Period (24 Weeks)|Adverse Event|7
855375|NCT00437658|1813690|FG002|Treatment Period (24 Weeks)|Adverse Event|14
855376|NCT00437658|1813688|FG000|Treatment Period (24 Weeks)|Non-compliance|1
855377|NCT00437658|1813689|FG001|Treatment Period (24 Weeks)|Non-compliance|1
855378|NCT00437658|1813690|FG002|Treatment Period (24 Weeks)|Non-compliance|4
855379|NCT00437658|1813688|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9
855380|NCT00437658|1813689|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7
855381|NCT00437658|1813690|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7
855382|NCT00437658|1813688|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4
855383|NCT00437658|1813689|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2
855384|NCT00437658|1813690|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3
855385|NCT00437658|1813688|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5
855386|NCT00437658|1813689|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4
855387|NCT00437658|1813690|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5
855388|NCT00437658|1813688|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
855389|NCT00437658|1813689|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
855390|NCT00437658|1813690|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
855391|NCT00437658|1813688|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1
855392|NCT00437658|1813689|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0
855393|NCT00437658|1813690|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1
855394|NCT00437658|1813688|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3
855395|NCT00437658|1813689|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0
855396|NCT00437658|1813690|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1
855397|NCT00437658|1813688|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
855398|NCT00437658|1813689|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
855399|NCT00437658|1813690|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
855400|NCT00437658|1813688|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
855401|NCT00437658|1813689|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
855402|NCT00437658|1813690|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
855403|NCT00437658|1813688|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
855404|NCT00437658|1813689|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
855405|NCT00437658|1813690|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
855406|NCT00437658|1813688|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
855407|NCT00437658|1813689|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
855408|NCT00437658|1813690|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
855409|NCT00437983|1813700|FG000|Overall Study|Adverse Event|6
855410|NCT00437983|1813701|FG001|Overall Study|Adverse Event|6
855411|NCT00437983|1813700|FG000|Overall Study|Protocol Violation|2
855412|NCT00437983|1813701|FG001|Overall Study|Protocol Violation|1
855413|NCT00437983|1813700|FG000|Overall Study|Withdrawal by Subject|5
855414|NCT00437983|1813701|FG001|Overall Study|Withdrawal by Subject|6
855415|NCT00438256|1813730|FG000|Overall Study|Ineligible for Resection|2
855416|NCT00438256|1813731|FG001|Overall Study|Ineligible for Resection|1
855417|NCT00438256|1813732|FG002|Overall Study|Ineligible for Resection|1
855418|NCT00438256|1813733|FG003|Overall Study|Ineligible for Resection|7
855419|NCT00438256|1813730|FG000|Overall Study|Excluded final Diagnosis|0
855420|NCT00438256|1813731|FG001|Overall Study|Excluded final Diagnosis|0
855421|NCT00438256|1813732|FG002|Overall Study|Excluded final Diagnosis|0
855422|NCT00438256|1813733|FG003|Overall Study|Excluded final Diagnosis|2
855423|NCT00438360|1813748|FG000|Overall Study|Adverse Event|6
855424|NCT00438360|1813749|FG001|Overall Study|Adverse Event|1
855425|NCT00438360|1813748|FG000|Overall Study|Lack of Efficacy|42
855426|NCT00438360|1813749|FG001|Overall Study|Lack of Efficacy|27
855427|NCT00438360|1813748|FG000|Overall Study|Other|24
855428|NCT00438360|1813749|FG001|Overall Study|Other|15
855429|NCT00438399|1813758|FG000|Overall Study|Lost to Follow-up|2
855430|NCT00438399|1813759|FG001|Overall Study|Lost to Follow-up|2
855431|NCT00438399|1813760|FG002|Overall Study|Lost to Follow-up|1
855432|NCT00438399|1813761|FG003|Overall Study|Lost to Follow-up|1
855433|NCT00438399|1813762|FG004|Overall Study|Lost to Follow-up|1
855434|NCT00438399|1813763|FG005|Overall Study|Lost to Follow-up|1
855435|NCT00438399|1813758|FG000|Overall Study|Adverse Event|0
855436|NCT00438399|1813759|FG001|Overall Study|Adverse Event|0
855437|NCT00438399|1813760|FG002|Overall Study|Adverse Event|1
855438|NCT00438399|1813761|FG003|Overall Study|Adverse Event|1
855439|NCT00438399|1813762|FG004|Overall Study|Adverse Event|0
855440|NCT00438399|1813763|FG005|Overall Study|Adverse Event|1
855441|NCT00438399|1813758|FG000|Overall Study|Withdrawal by Subject|5
855442|NCT00438399|1813759|FG001|Overall Study|Withdrawal by Subject|6
855443|NCT00438399|1813760|FG002|Overall Study|Withdrawal by Subject|3
855444|NCT00438399|1813761|FG003|Overall Study|Withdrawal by Subject|2
855445|NCT00438399|1813762|FG004|Overall Study|Withdrawal by Subject|2
855446|NCT00438399|1813763|FG005|Overall Study|Withdrawal by Subject|2
855447|NCT00438399|1813758|FG000|Overall Study|Protocol Violation|0
855448|NCT00438399|1813759|FG001|Overall Study|Protocol Violation|0
855449|NCT00438399|1813760|FG002|Overall Study|Protocol Violation|1
855450|NCT00438399|1813761|FG003|Overall Study|Protocol Violation|0
855451|NCT00438399|1813762|FG004|Overall Study|Protocol Violation|0
855452|NCT00438399|1813763|FG005|Overall Study|Protocol Violation|1
855453|NCT00438399|1813758|FG000|Overall Study|Subje stopped study|0
855454|NCT00438399|1813759|FG001|Overall Study|Subje stopped study|0
855455|NCT00438399|1813760|FG002|Overall Study|Subje stopped study|1
855456|NCT00438399|1813761|FG003|Overall Study|Subje stopped study|0
855457|NCT00438399|1813762|FG004|Overall Study|Subje stopped study|0
855458|NCT00438399|1813763|FG005|Overall Study|Subje stopped study|0
855459|NCT00438399|1813758|FG000|Overall Study|Pregnancy|0
855460|NCT00438399|1813759|FG001|Overall Study|Pregnancy|0
855461|NCT00438399|1813760|FG002|Overall Study|Pregnancy|0
855462|NCT00438399|1813761|FG003|Overall Study|Pregnancy|0
855463|NCT00438399|1813762|FG004|Overall Study|Pregnancy|0
855464|NCT00438399|1813763|FG005|Overall Study|Pregnancy|1
855465|NCT00438399|1813758|FG000|Overall Study|Patien stopped study at visit 4 by error|1
855466|NCT00438399|1813759|FG001|Overall Study|Patien stopped study at visit 4 by error|0
855467|NCT00438399|1813760|FG002|Overall Study|Patien stopped study at visit 4 by error|0
855468|NCT00438399|1813761|FG003|Overall Study|Patien stopped study at visit 4 by error|0
855469|NCT00438399|1813762|FG004|Overall Study|Patien stopped study at visit 4 by error|0
855470|NCT00438399|1813763|FG005|Overall Study|Patien stopped study at visit 4 by error|0
855471|NCT00438464|1813787|FG000|Overall Study|Terminated Early|14
855472|NCT00438464|1813788|FG001|Overall Study|Terminated Early|5
855473|NCT00438464|1813787|FG000|Overall Study|Incomplete data submission|0
855474|NCT00438464|1813788|FG001|Overall Study|Incomplete data submission|2
855475|NCT00438633|1813821|FG000|Overall Study|Withdrawal by Subject|1
855476|NCT00438633|1813822|FG001|Overall Study|Withdrawal by Subject|0
855477|NCT00438633|1813821|FG000|Overall Study|Lost to Follow-up|15
855478|NCT00438633|1813822|FG001|Overall Study|Lost to Follow-up|17
855479|NCT00438659|1813830|FG000|Overall Study|Discontinued Mometasone/Placebo|1
855480|NCT00438659|1813831|FG001|Overall Study|Discontinued Mometasone/Placebo|2
855481|NCT00438659|1813830|FG000|Overall Study|Cancel|5
855482|NCT00438659|1813831|FG001|Overall Study|Cancel|2
855483|NCT00438672|1813840|FG000|Overall Study|Lost to Follow-up|7
855484|NCT00438672|1813841|FG001|Overall Study|Lost to Follow-up|9
855485|NCT00438815|1813871|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
855486|NCT00438815|1813871|FG000|Overall Study|3-month follow-up no longer required|12
855487|NCT00438815|1813871|FG000|Overall Study|Noncompliance with protocol requirements|9
855488|NCT00438815|1813871|FG000|Overall Study|Transitioned to commercial C1INH-nf|6
855489|NCT00438815|1813871|FG000|Overall Study|Lost to Follow-up|6
855490|NCT00438815|1813871|FG000|Overall Study|Withdrawal by Subject|6
855491|NCT00438815|1813871|FG000|Overall Study|Death|1
855492|NCT00439140|1813913|FG000|Treatment Cycle 1|Lost to Follow-up|1
855493|NCT00439140|1813914|FG001|Treatment Cycle 1|Lost to Follow-up|1
855494|NCT00439140|1813915|FG002|Treatment Cycle 1|Lost to Follow-up|1
855495|NCT00439140|1813913|FG000|Treatment Cycle 1|Personal reasons|0
855496|NCT00439140|1813914|FG001|Treatment Cycle 1|Personal reasons|2
855497|NCT00439140|1813915|FG002|Treatment Cycle 1|Personal reasons|0
855498|NCT00439140|1813913|FG000|Treatment Cycle 1|Withdrawal by Subject|0
855499|NCT00439140|1813914|FG001|Treatment Cycle 1|Withdrawal by Subject|1
855500|NCT00439140|1813915|FG002|Treatment Cycle 1|Withdrawal by Subject|0
855501|NCT00439140|1813913|FG000|Treatment Cycle 2|Withdrawal by Subject|1
855502|NCT00439140|1813914|FG001|Treatment Cycle 2|Withdrawal by Subject|0
855503|NCT00439140|1813915|FG002|Treatment Cycle 2|Withdrawal by Subject|0
855504|NCT00439140|1813913|FG000|Treatment Cycle 2|Lost to Follow-up|1
855505|NCT00439140|1813914|FG001|Treatment Cycle 2|Lost to Follow-up|1
855506|NCT00439140|1813915|FG002|Treatment Cycle 2|Lost to Follow-up|0
855507|NCT00439179|1813927|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0
855508|NCT00439179|1813928|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2
855509|NCT00439179|1813929|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0
855510|NCT00439179|1813930|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0
855511|NCT00439218|1813943|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
855512|NCT00439231|1813947|FG000|Overall Study|Lack of Efficacy|28
855513|NCT00439244|1813954|FG000|Overall Study|Adverse Event|5
855514|NCT00439244|1813955|FG001|Overall Study|Adverse Event|2
855515|NCT00439244|1813956|FG002|Overall Study|Adverse Event|3
855516|NCT00439244|1813954|FG000|Overall Study|Withdrawal by Subject|3
855517|NCT00439244|1813955|FG001|Overall Study|Withdrawal by Subject|1
855518|NCT00439244|1813956|FG002|Overall Study|Withdrawal by Subject|2
855519|NCT00439244|1813954|FG000|Overall Study|Lost to Follow-up|2
855520|NCT00439244|1813955|FG001|Overall Study|Lost to Follow-up|1
855521|NCT00439244|1813956|FG002|Overall Study|Lost to Follow-up|2
855522|NCT00439244|1813954|FG000|Overall Study|Death|0
855523|NCT00439244|1813955|FG001|Overall Study|Death|1
855524|NCT00439244|1813956|FG002|Overall Study|Death|0
855525|NCT00439244|1813954|FG000|Overall Study|Protocol Violation|0
855526|NCT00439244|1813955|FG001|Overall Study|Protocol Violation|1
855527|NCT00439244|1813956|FG002|Overall Study|Protocol Violation|0
855528|NCT00439244|1813954|FG000|Overall Study|Administrative problems|1
855529|NCT00439244|1813955|FG001|Overall Study|Administrative problems|0
855530|NCT00439244|1813956|FG002|Overall Study|Administrative problems|0
855531|NCT00439270|1813969|FG000|Phase 1 (18.1 Months)|Disease progression|3
855532|NCT00439270|1813970|FG001|Phase 1 (18.1 Months)|Disease progression|2
855533|NCT00439270|1813971|FG002|Phase 1 (18.1 Months)|Disease progression|3
855534|NCT00439270|1813972|FG003|Phase 1 (18.1 Months)|Disease progression|0
855535|NCT00439270|1813973|FG004|Phase 1 (18.1 Months)|Disease progression|3
855536|NCT00439270|1813969|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0
855537|NCT00439270|1813970|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1
855538|NCT00439270|1813971|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0
855539|NCT00439270|1813972|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0
855540|NCT00439270|1813973|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0
855541|NCT00439270|1813969|FG000|Phase 2 (51.6 Months)|Disease progression|0
855542|NCT00439270|1813970|FG001|Phase 2 (51.6 Months)|Disease progression|0
855543|NCT00439270|1813971|FG002|Phase 2 (51.6 Months)|Disease progression|0
855544|NCT00439270|1813972|FG003|Phase 2 (51.6 Months)|Disease progression|18
855545|NCT00439270|1813973|FG004|Phase 2 (51.6 Months)|Disease progression|0
855546|NCT00439270|1813969|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
855547|NCT00439270|1813970|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
855548|NCT00439270|1813971|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
855549|NCT00439270|1813972|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
855550|NCT00439270|1813973|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
855551|NCT00439270|1813969|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0
855552|NCT00439270|1813970|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0
855553|NCT00439270|1813971|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0
855554|NCT00439270|1813972|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6
855555|NCT00439270|1813973|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0
855556|NCT00439270|1813969|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0
855557|NCT00439270|1813970|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0
855558|NCT00439270|1813971|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0
855559|NCT00439270|1813972|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3
855560|NCT00439270|1813973|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0
855561|NCT00439270|1813969|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0
855562|NCT00439270|1813970|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0
855563|NCT00439270|1813971|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0
855564|NCT00439270|1813972|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1
855565|NCT00439270|1813973|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0
855566|NCT00439270|1813969|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0
855567|NCT00439270|1813970|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0
855568|NCT00439270|1813971|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0
855569|NCT00439270|1813972|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2
855570|NCT00439270|1813973|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0
855571|NCT00439270|1813969|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
855572|NCT00439270|1813970|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
855573|NCT00439270|1813971|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
855574|NCT00439270|1813972|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
855575|NCT00439270|1813973|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
855576|NCT00439270|1813969|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
855577|NCT00439270|1813970|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
855578|NCT00439270|1813971|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
855579|NCT00439270|1813972|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
855580|NCT00439270|1813973|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
855581|NCT00439309|1814003|FG000|Follow-Up|Death|1
855582|NCT00439309|1814004|FG001|Follow-Up|Death|0
855583|NCT00439309|1814003|FG000|Follow-Up|Lost to Follow-up|2
855584|NCT00439309|1814004|FG001|Follow-Up|Lost to Follow-up|0
855585|NCT00439309|1814003|FG000|Follow-Up|Withdrawal by Subject|0
855586|NCT00439309|1814004|FG001|Follow-Up|Withdrawal by Subject|1
855587|NCT00439309|1814003|FG000|Follow-Up|Late response by subject|0
855588|NCT00439309|1814004|FG001|Follow-Up|Late response by subject|1
855589|NCT00439517|1814048|FG000|Overall Study|Subject on treatment|1
855590|NCT00439517|1814049|FG001|Overall Study|Subject on treatment|0
855591|NCT00439517|1814048|FG000|Overall Study|Subject in survival follow-up|1
855592|NCT00439517|1814049|FG001|Overall Study|Subject in survival follow-up|0
855593|NCT00439556|1814058|FG000|Overall Study|Patient was taken off study for non-comp|0
855594|NCT00439556|1814059|FG001|Overall Study|Patient was taken off study for non-comp|1
855595|NCT00439556|1814060|FG002|Overall Study|Patient was taken off study for non-comp|0
855596|NCT00439647|1814075|FG000|Overall Study|Withdrawal by Subject|25
855597|NCT00439647|1814076|FG001|Overall Study|Withdrawal by Subject|22
855598|NCT00439647|1814075|FG000|Overall Study|Death|15
855599|NCT00439647|1814076|FG001|Overall Study|Death|18
855600|NCT00439647|1814075|FG000|Overall Study|Adverse Event|11
855601|NCT00439647|1814076|FG001|Overall Study|Adverse Event|11
855602|NCT00439647|1814075|FG000|Overall Study|Lost to Follow-up|4
855603|NCT00439647|1814076|FG001|Overall Study|Lost to Follow-up|12
855604|NCT00439647|1814075|FG000|Overall Study|Protocol Violation|3
855605|NCT00439647|1814076|FG001|Overall Study|Protocol Violation|4
855606|NCT00439647|1814075|FG000|Overall Study|Lack of Efficacy|0
855607|NCT00439647|1814076|FG001|Overall Study|Lack of Efficacy|4
855608|NCT00439725|1814088|FG000|Treatment Period|Withdrawal by Subject|22
855609|NCT00439725|1814089|FG001|Treatment Period|Withdrawal by Subject|19
855610|NCT00439725|1814088|FG000|Treatment Period|Study terminated by sponsor|156
855611|NCT00439725|1814089|FG001|Treatment Period|Study terminated by sponsor|148
855612|NCT00439725|1814088|FG000|Treatment Period|Site closed by investigator|1
855613|NCT00439725|1814089|FG001|Treatment Period|Site closed by investigator|2
855614|NCT00439725|1814088|FG000|Treatment Period|Adverse Event|39
855615|NCT00439725|1814089|FG001|Treatment Period|Adverse Event|18
855616|NCT00439725|1814088|FG000|Treatment Period|Physician Decision|1
855617|NCT00439725|1814089|FG001|Treatment Period|Physician Decision|1
855618|NCT00439725|1814088|FG000|Treatment Period|Protocol Violation|2
855619|NCT00439725|1814089|FG001|Treatment Period|Protocol Violation|1
855620|NCT00439725|1814088|FG000|Treatment Period|Clinical endpoint reached|6
855621|NCT00439725|1814089|FG001|Treatment Period|Clinical endpoint reached|50
855622|NCT00439725|1814088|FG000|Treatment Period|Technical problems|1
855623|NCT00439725|1814089|FG001|Treatment Period|Technical problems|0
855624|NCT00439725|1814088|FG000|Treatment Period|Lost to Follow-up|1
855625|NCT00439725|1814089|FG001|Treatment Period|Lost to Follow-up|1
855626|NCT00439725|1814088|FG000|Treatment Period|Participant convenience|1
855627|NCT00439725|1814089|FG001|Treatment Period|Participant convenience|0
855628|NCT00439725|1814088|FG000|Treatment Period|Protocol driven decision point|1
855629|NCT00439725|1814089|FG001|Treatment Period|Protocol driven decision point|1
855630|NCT00439725|1814088|FG000|Treatment Period|Death|1
855631|NCT00439725|1814089|FG001|Treatment Period|Death|1
855632|NCT00439725|1814088|FG000|Treatment Period|Participant did not receive treatment|4
855633|NCT00439725|1814089|FG001|Treatment Period|Participant did not receive treatment|4
855634|NCT00439725|1814088|FG000|Observational Period|Withdrawal by Subject|2
855635|NCT00439725|1814089|FG001|Observational Period|Withdrawal by Subject|2
855636|NCT00439725|1814088|FG000|Observational Period|Lost to Follow-up|0
855637|NCT00439725|1814089|FG001|Observational Period|Lost to Follow-up|1
855638|NCT00439725|1814088|FG000|Observational Period|Death|0
855639|NCT00439725|1814089|FG001|Observational Period|Death|2
855640|NCT00439725|1814088|FG000|Observational Period|Study termination by sponsor|1
855641|NCT00439725|1814089|FG001|Observational Period|Study termination by sponsor|1
855642|NCT00439725|1814088|FG000|Observational Period|Clinical endpoint reached|3
855643|NCT00439725|1814089|FG001|Observational Period|Clinical endpoint reached|1
855644|NCT00439725|1814088|FG000|Observational Period|Technical problems|1
855645|NCT00439725|1814089|FG001|Observational Period|Technical problems|0
855646|NCT00439725|1814088|FG000|Observational Period|Participant convenience|1
855647|NCT00439725|1814089|FG001|Observational Period|Participant convenience|0
855648|NCT00439738|1814097|FG000|Overall Study|Withdrawal by Subject|16
855649|NCT00439738|1814098|FG001|Overall Study|Withdrawal by Subject|13
855650|NCT00439738|1814097|FG000|Overall Study|Adverse Event|6
855651|NCT00439738|1814098|FG001|Overall Study|Adverse Event|4
855652|NCT00439738|1814097|FG000|Overall Study|Lost to Follow-up|5
855653|NCT00439738|1814098|FG001|Overall Study|Lost to Follow-up|6
855654|NCT00439738|1814097|FG000|Overall Study|Protocol Violation|6
855655|NCT00439738|1814098|FG001|Overall Study|Protocol Violation|3
855656|NCT00439738|1814097|FG000|Overall Study|Lack of Efficacy|2
855657|NCT00439738|1814098|FG001|Overall Study|Lack of Efficacy|2
855658|NCT00439738|1814097|FG000|Overall Study|Abnormal Lab Values|1
855659|NCT00439738|1814098|FG001|Overall Study|Abnormal Lab Values|0
855660|NCT00439777|1814104|FG000|Treatment Period|Death|29
855661|NCT00439777|1814105|FG001|Treatment Period|Death|21
855662|NCT00439777|1814104|FG000|Treatment Period|Study terminated by sponsor|125
855663|NCT00439777|1814105|FG001|Treatment Period|Study terminated by sponsor|132
855664|NCT00439777|1814104|FG000|Treatment Period|Site closed by investigator|0
855665|NCT00439777|1814105|FG001|Treatment Period|Site closed by investigator|1
855666|NCT00439777|1814104|FG000|Treatment Period|Did not take study treatment|7
855667|NCT00439777|1814105|FG001|Treatment Period|Did not take study treatment|8
855668|NCT00439777|1814104|FG000|Treatment Period|Adverse Event|111
855669|NCT00439777|1814105|FG001|Treatment Period|Adverse Event|92
855670|NCT00439777|1814104|FG000|Treatment Period|Protocol Violation|23
855671|NCT00439777|1814105|FG001|Treatment Period|Protocol Violation|30
855672|NCT00439777|1814104|FG000|Treatment Period|Withdrawal by Subject|66
855673|NCT00439777|1814105|FG001|Treatment Period|Withdrawal by Subject|118
855674|NCT00439777|1814104|FG000|Treatment Period|Lack of Efficacy|1
855675|NCT00439777|1814105|FG001|Treatment Period|Lack of Efficacy|4
855676|NCT00439777|1814104|FG000|Treatment Period|Lost to Follow-up|8
855677|NCT00439777|1814105|FG001|Treatment Period|Lost to Follow-up|10
855678|NCT00439777|1814104|FG000|Treatment Period|Protocol driven decision point|1
855679|NCT00439777|1814105|FG001|Treatment Period|Protocol driven decision point|3
855680|NCT00439777|1814104|FG000|Treatment Period|Physician Decision|7
855681|NCT00439777|1814105|FG001|Treatment Period|Physician Decision|18
855682|NCT00439777|1814104|FG000|Treatment Period|Clinical endpoint reached|26
855683|NCT00439777|1814105|FG001|Treatment Period|Clinical endpoint reached|13
855684|NCT00439777|1814104|FG000|Treatment Period|Technical problems|3
855685|NCT00439777|1814105|FG001|Treatment Period|Technical problems|1
855686|NCT00439777|1814104|FG000|Treatment Period|Participant convenience|12
855687|NCT00439777|1814105|FG001|Treatment Period|Participant convenience|8
855688|NCT00439777|1814104|FG000|Observational Period|Protocol Violation|0
855689|NCT00439777|1814105|FG001|Observational Period|Protocol Violation|2
855690|NCT00439777|1814104|FG000|Observational Period|Withdrawal by Subject|9
855691|NCT00439777|1814105|FG001|Observational Period|Withdrawal by Subject|5
855692|NCT00439777|1814104|FG000|Observational Period|Lost to Follow-up|1
855693|NCT00439777|1814105|FG001|Observational Period|Lost to Follow-up|11
855694|NCT00439777|1814104|FG000|Observational Period|Death|27
855695|NCT00439777|1814105|FG001|Observational Period|Death|20
855696|NCT00439777|1814104|FG000|Observational Period|Study terminated by sponsor|3
855697|NCT00439777|1814105|FG001|Observational Period|Study terminated by sponsor|1
855698|NCT00439777|1814104|FG000|Observational Period|Protocol driven decision point|0
855699|NCT00439777|1814105|FG001|Observational Period|Protocol driven decision point|1
855700|NCT00439777|1814104|FG000|Observational Period|Lack of Efficacy|1
855701|NCT00439777|1814105|FG001|Observational Period|Lack of Efficacy|0
855702|NCT00439777|1814104|FG000|Observational Period|Technical problems|0
855703|NCT00439777|1814105|FG001|Observational Period|Technical problems|1
855704|NCT00440011|1814117|FG000|Overall Study|Adverse Event|2
855705|NCT00440011|1814118|FG001|Overall Study|Adverse Event|0
855706|NCT00440011|1814117|FG000|Overall Study|Lost to Follow-up|0
855707|NCT00440011|1814118|FG001|Overall Study|Lost to Follow-up|2
855708|NCT00440011|1814117|FG000|Overall Study|Protocol Violation|1
855709|NCT00440011|1814118|FG001|Overall Study|Protocol Violation|1
855710|NCT00440011|1814117|FG000|Overall Study|Withdrawal by Subject|1
855711|NCT00440011|1814118|FG001|Overall Study|Withdrawal by Subject|0
855712|NCT00440037|1814124|FG000|Overall Study|Withdrawal by Subject|6
855713|NCT00440037|1814124|FG000|Overall Study|Administrative decision|3
855714|NCT00440115|1814140|FG000|Overall Study|Death|7
855715|NCT00440115|1814141|FG001|Overall Study|Death|9
855716|NCT00440115|1814142|FG002|Overall Study|Death|5
855717|NCT00440115|1814140|FG000|Overall Study|Incarceration|0
855718|NCT00440115|1814141|FG001|Overall Study|Incarceration|2
855719|NCT00440115|1814142|FG002|Overall Study|Incarceration|1
855720|NCT00440193|1814161|FG000|Treatment Period|Adverse Event|74
855721|NCT00440193|1814162|FG001|Treatment Period|Adverse Event|67
855722|NCT00440193|1814161|FG000|Treatment Period|Death|19
855723|NCT00440193|1814162|FG001|Treatment Period|Death|22
855724|NCT00440193|1814161|FG000|Treatment Period|Lack of Efficacy|0
855725|NCT00440193|1814162|FG001|Treatment Period|Lack of Efficacy|1
855726|NCT00440193|1814161|FG000|Treatment Period|Lost to Follow-up|12
855727|NCT00440193|1814162|FG001|Treatment Period|Lost to Follow-up|18
855728|NCT00440193|1814161|FG000|Treatment Period|Physician Decision|3
855729|NCT00440193|1814162|FG001|Treatment Period|Physician Decision|6
855730|NCT00440193|1814161|FG000|Treatment Period|Protocol Violation|16
855731|NCT00440193|1814162|FG001|Treatment Period|Protocol Violation|19
855732|NCT00440193|1814161|FG000|Treatment Period|Withdrawal by Subject|36
855733|NCT00440193|1814162|FG001|Treatment Period|Withdrawal by Subject|77
855734|NCT00440193|1814161|FG000|Treatment Period|Clinical endpoint reached|28
855735|NCT00440193|1814162|FG001|Treatment Period|Clinical endpoint reached|25
855736|NCT00440193|1814161|FG000|Treatment Period|Study terminated by sponsor|102
855737|NCT00440193|1814162|FG001|Treatment Period|Study terminated by sponsor|94
855738|NCT00440193|1814161|FG000|Treatment Period|Protocol driven decision point|2
855739|NCT00440193|1814162|FG001|Treatment Period|Protocol driven decision point|2
855740|NCT00440193|1814161|FG000|Treatment Period|Switch to commercial drug|0
855741|NCT00440193|1814162|FG001|Treatment Period|Switch to commercial drug|2
855742|NCT00440193|1814161|FG000|Treatment Period|Technical problems|1
855743|NCT00440193|1814162|FG001|Treatment Period|Technical problems|1
855744|NCT00440193|1814161|FG000|Treatment Period|Participant convenience|5
855745|NCT00440193|1814162|FG001|Treatment Period|Participant convenience|2
855746|NCT00440193|1814161|FG000|Treatment Period|Participant did not receive treatment|7
855747|NCT00440193|1814162|FG001|Treatment Period|Participant did not receive treatment|13
855748|NCT00440193|1814161|FG000|Treatment Period|Site closed by investigator|0
855749|NCT00440193|1814162|FG001|Treatment Period|Site closed by investigator|2
855750|NCT00440193|1814161|FG000|Observational Period|Adverse Event|2
855751|NCT00440193|1814162|FG001|Observational Period|Adverse Event|2
855752|NCT00440193|1814161|FG000|Observational Period|Death|15
855753|NCT00440193|1814162|FG001|Observational Period|Death|20
855754|NCT00440193|1814161|FG000|Observational Period|Lost to Follow-up|12
855755|NCT00440193|1814162|FG001|Observational Period|Lost to Follow-up|8
855756|NCT00440193|1814161|FG000|Observational Period|Protocol Violation|1
855757|NCT00440193|1814162|FG001|Observational Period|Protocol Violation|0
855758|NCT00440193|1814161|FG000|Observational Period|Withdrawal by Subject|11
855759|NCT00440193|1814162|FG001|Observational Period|Withdrawal by Subject|8
855760|NCT00440193|1814161|FG000|Observational Period|Physician Decision|1
855761|NCT00440193|1814162|FG001|Observational Period|Physician Decision|0
855762|NCT00440193|1814161|FG000|Observational Period|Clinical endpoint reached|1
855763|NCT00440193|1814162|FG001|Observational Period|Clinical endpoint reached|0
855764|NCT00440193|1814161|FG000|Observational Period|Participant convenience|2
855765|NCT00440193|1814162|FG001|Observational Period|Participant convenience|0
855766|NCT00440232|1814170|FG000|Overall Study|Lost to Follow-up|1
855767|NCT00440232|1814171|FG001|Overall Study|Lost to Follow-up|1
855768|NCT00440232|1814170|FG000|Overall Study|Unable to treat within allowed time|0
855769|NCT00440232|1814171|FG001|Overall Study|Unable to treat within allowed time|1
855770|NCT00440232|1814170|FG000|Overall Study|Onset of headache within 4 hours of fast|2
855771|NCT00440232|1814171|FG001|Overall Study|Onset of headache within 4 hours of fast|2
855772|NCT00440297|1814179|FG000|Overall Study|Adverse Event|8
855773|NCT00440297|1814180|FG001|Overall Study|Adverse Event|5
855774|NCT00440297|1814179|FG000|Overall Study|Lost to Follow-up|1
855775|NCT00440297|1814180|FG001|Overall Study|Lost to Follow-up|0
855776|NCT00440297|1814179|FG000|Overall Study|Physician Decision|1
855777|NCT00440297|1814180|FG001|Overall Study|Physician Decision|0
855778|NCT00440297|1814179|FG000|Overall Study|Protocol Violation|11
855779|NCT00440297|1814180|FG001|Overall Study|Protocol Violation|7
855780|NCT00440297|1814179|FG000|Overall Study|Withdrawal by Subject|1
855781|NCT00440297|1814180|FG001|Overall Study|Withdrawal by Subject|6
855782|NCT00440297|1814179|FG000|Overall Study|Randomized by mistake|1
855783|NCT00440297|1814180|FG001|Overall Study|Randomized by mistake|0
855784|NCT00440310|1814188|FG000|Overall Study|Lost to Follow-up|4
855785|NCT00440310|1814189|FG001|Overall Study|Lost to Follow-up|5
855786|NCT00440310|1814188|FG000|Overall Study|Protocol Violation|0
855787|NCT00440310|1814189|FG001|Overall Study|Protocol Violation|1
855788|NCT00440310|1814188|FG000|Overall Study|Withdrawal by Subject|15
855789|NCT00440310|1814189|FG001|Overall Study|Withdrawal by Subject|14
855790|NCT00440310|1814188|FG000|Overall Study|No Reply at EOS|7
855791|NCT00440310|1814189|FG001|Overall Study|No Reply at EOS|7
855792|NCT00440310|1814188|FG000|Overall Study|Other|1
855793|NCT00440310|1814189|FG001|Overall Study|Other|0
855794|NCT00440310|1814188|FG000|Overall Study|Status Unknown|1
855795|NCT00440310|1814189|FG001|Overall Study|Status Unknown|3
855796|NCT00440401|1814197|FG000|Overall Study|Adverse Event|2
855797|NCT00440401|1814198|FG001|Overall Study|Adverse Event|1
855798|NCT00440401|1814197|FG000|Overall Study|Other|2
855799|NCT00440401|1814198|FG001|Overall Study|Other|5
855800|NCT00440466|1814207|FG000|Overall Study|Death|3
855801|NCT00440466|1814208|FG001|Overall Study|Death|2
855802|NCT00440466|1814209|FG002|Overall Study|Death|9
855803|NCT00440466|1814207|FG000|Overall Study|Adverse Event|3
855804|NCT00440466|1814208|FG001|Overall Study|Adverse Event|4
855805|NCT00440466|1814209|FG002|Overall Study|Adverse Event|11
855806|NCT00440466|1814207|FG000|Overall Study|Lost to Follow-up|1
855807|NCT00440466|1814208|FG001|Overall Study|Lost to Follow-up|0
855808|NCT00440466|1814209|FG002|Overall Study|Lost to Follow-up|2
855809|NCT00440466|1814207|FG000|Overall Study|Physician Decision|2
855810|NCT00440466|1814208|FG001|Overall Study|Physician Decision|0
855811|NCT00440466|1814209|FG002|Overall Study|Physician Decision|1
855812|NCT00440466|1814207|FG000|Overall Study|Protocol Violation|2
855813|NCT00440466|1814208|FG001|Overall Study|Protocol Violation|0
855814|NCT00440466|1814209|FG002|Overall Study|Protocol Violation|4
855815|NCT00440466|1814207|FG000|Overall Study|Withdrawal by Subject|2
855816|NCT00440466|1814208|FG001|Overall Study|Withdrawal by Subject|5
855817|NCT00440466|1814209|FG002|Overall Study|Withdrawal by Subject|9
855818|NCT00440466|1814207|FG000|Overall Study|Began Dialysis|0
855819|NCT00440466|1814208|FG001|Overall Study|Began Dialysis|0
855820|NCT00440466|1814209|FG002|Overall Study|Began Dialysis|1
855821|NCT00440466|1814207|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0
855822|NCT00440466|1814208|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4
855823|NCT00440466|1814209|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4
855824|NCT00440518|1814233|FG000|Randomized /Titration Period|Lack of Efficacy|1
855825|NCT00440518|1814234|FG001|Randomized /Titration Period|Lack of Efficacy|0
855826|NCT00440518|1814235|FG002|Randomized /Titration Period|Lack of Efficacy|1
855827|NCT00440518|1814233|FG000|Randomized /Titration Period|Subject Withdrew Consent|4
855828|NCT00440518|1814234|FG001|Randomized /Titration Period|Subject Withdrew Consent|1
855829|NCT00440518|1814235|FG002|Randomized /Titration Period|Subject Withdrew Consent|0
855830|NCT00440518|1814233|FG000|Randomized /Titration Period|Protocol Deviation|1
855831|NCT00440518|1814234|FG001|Randomized /Titration Period|Protocol Deviation|0
855832|NCT00440518|1814235|FG002|Randomized /Titration Period|Protocol Deviation|0
855833|NCT00440518|1814233|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2
855834|NCT00440518|1814234|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3
855835|NCT00440518|1814235|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2
855836|NCT00440518|1814233|FG000|Randomized /Titration Period|Other|1
855837|NCT00440518|1814234|FG001|Randomized /Titration Period|Other|0
855838|NCT00440518|1814235|FG002|Randomized /Titration Period|Other|0
855839|NCT00440518|1814233|FG000|Randomized /Titration Period|Lost to Follow-up|2
855840|NCT00440518|1814234|FG001|Randomized /Titration Period|Lost to Follow-up|2
855841|NCT00440518|1814235|FG002|Randomized /Titration Period|Lost to Follow-up|1
855842|NCT00440518|1814233|FG000|Randomized /Titration Period|Adverse Event|2
855843|NCT00440518|1814234|FG001|Randomized /Titration Period|Adverse Event|3
855844|NCT00440518|1814235|FG002|Randomized /Titration Period|Adverse Event|0
855845|NCT00440518|1814233|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3
855846|NCT00440518|1814234|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4
855847|NCT00440518|1814235|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2
855848|NCT00440518|1814233|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
855849|NCT00440518|1814234|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
855850|NCT00440518|1814235|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
855851|NCT00440518|1814233|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
855852|NCT00440518|1814234|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
855853|NCT00440518|1814235|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
855854|NCT00440518|1814233|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
855855|NCT00440518|1814234|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
855856|NCT00440518|1814235|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
855857|NCT00440518|1814233|FG000|Maintenance and Safety Follow-up Periods|Other|0
855858|NCT00440518|1814234|FG001|Maintenance and Safety Follow-up Periods|Other|0
855859|NCT00440518|1814235|FG002|Maintenance and Safety Follow-up Periods|Other|2
855860|NCT00440518|1814233|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
855861|NCT00440518|1814234|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
855862|NCT00440518|1814235|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
855863|NCT00440531|1814246|FG000|Overall Study|Adverse Event|1
855864|NCT00440531|1814247|FG001|Overall Study|Adverse Event|0
855865|NCT00440531|1814248|FG002|Overall Study|Adverse Event|2
855866|NCT00440531|1814246|FG000|Overall Study|Withdrawal by Subject|2
855867|NCT00440531|1814247|FG001|Overall Study|Withdrawal by Subject|0
855868|NCT00440531|1814248|FG002|Overall Study|Withdrawal by Subject|0
855869|NCT00440531|1814246|FG000|Overall Study|Protocol Violation|1
855870|NCT00440531|1814247|FG001|Overall Study|Protocol Violation|2
855871|NCT00440531|1814248|FG002|Overall Study|Protocol Violation|0
855872|NCT00440531|1814246|FG000|Overall Study|Lost to Follow-up|4
855873|NCT00440531|1814247|FG001|Overall Study|Lost to Follow-up|3
855874|NCT00440531|1814248|FG002|Overall Study|Lost to Follow-up|5
855875|NCT00440531|1814246|FG000|Overall Study|see pre-assignment details|2
855876|NCT00440531|1814247|FG001|Overall Study|see pre-assignment details|0
855877|NCT00440531|1814248|FG002|Overall Study|see pre-assignment details|0
855878|NCT00440557|1814257|FG000|Overall Study|Withdrawal by Subject|10
855879|NCT00440557|1814258|FG001|Overall Study|Withdrawal by Subject|5
855880|NCT00440557|1814259|FG002|Overall Study|Withdrawal by Subject|11
855881|NCT00440557|1814257|FG000|Overall Study|Lost to Follow-up|1
855882|NCT00440557|1814258|FG001|Overall Study|Lost to Follow-up|2
855883|NCT00440557|1814259|FG002|Overall Study|Lost to Follow-up|6
855884|NCT00440557|1814257|FG000|Overall Study|Adverse Event|3
855885|NCT00440557|1814258|FG001|Overall Study|Adverse Event|3
855886|NCT00440557|1814259|FG002|Overall Study|Adverse Event|5
855887|NCT00440557|1814257|FG000|Overall Study|Death|2
855888|NCT00440557|1814258|FG001|Overall Study|Death|6
855889|NCT00440557|1814259|FG002|Overall Study|Death|3
855890|NCT00440557|1814257|FG000|Overall Study|Began Dialysis|4
855891|NCT00440557|1814258|FG001|Overall Study|Began Dialysis|1
855892|NCT00440557|1814259|FG002|Overall Study|Began Dialysis|4
855893|NCT00440557|1814257|FG000|Overall Study|Principal Investigator decision|0
855894|NCT00440557|1814258|FG001|Overall Study|Principal Investigator decision|3
855895|NCT00440557|1814259|FG002|Overall Study|Principal Investigator decision|1
855896|NCT00440557|1814257|FG000|Overall Study|Patient moved|1
855897|NCT00440557|1814258|FG001|Overall Study|Patient moved|2
855898|NCT00440557|1814259|FG002|Overall Study|Patient moved|1
855899|NCT00440557|1814257|FG000|Overall Study|Principal Investigator's office closed|3
855900|NCT00440557|1814258|FG001|Overall Study|Principal Investigator's office closed|6
855901|NCT00440557|1814259|FG002|Overall Study|Principal Investigator's office closed|4
855902|NCT00440557|1814257|FG000|Overall Study|Patient transferred to nursing home|0
855903|NCT00440557|1814258|FG001|Overall Study|Patient transferred to nursing home|1
855904|NCT00440557|1814259|FG002|Overall Study|Patient transferred to nursing home|0
855905|NCT00440557|1814257|FG000|Overall Study|Patient had surgery|1
855906|NCT00440557|1814258|FG001|Overall Study|Patient had surgery|0
855907|NCT00440557|1814259|FG002|Overall Study|Patient had surgery|0
855908|NCT00440700|1814281|FG000|Overall Study|Withdrawal by Subject|8
855909|NCT00440700|1814282|FG001|Overall Study|Withdrawal by Subject|8
855910|NCT00440700|1814283|FG002|Overall Study|Withdrawal by Subject|4
855911|NCT00440726|1814294|FG000|Phase 1|Dose-Limiting Toxicity|0
855912|NCT00440726|1814295|FG001|Phase 1|Dose-Limiting Toxicity|1
855913|NCT00440726|1814296|FG002|Phase 1|Dose-Limiting Toxicity|0
855914|NCT00440726|1814294|FG000|Phase 1|Physician Decision|1
855915|NCT00440726|1814295|FG001|Phase 1|Physician Decision|0
855916|NCT00440726|1814296|FG002|Phase 1|Physician Decision|0
855917|NCT00440726|1814294|FG000|Phase 2|Death|0
855918|NCT00440726|1814295|FG001|Phase 2|Death|0
855919|NCT00440726|1814296|FG002|Phase 2|Death|1
855920|NCT00440726|1814294|FG000|Phase 2|Adverse Event|0
855921|NCT00440726|1814295|FG001|Phase 2|Adverse Event|0
855922|NCT00440726|1814296|FG002|Phase 2|Adverse Event|1
855923|NCT00440947|1814328|FG000|36-Week Induction Phase|Adverse Event|16
855924|NCT00440947|1814329|FG001|36-Week Induction Phase|Adverse Event|0
855925|NCT00440947|1814330|FG002|36-Week Induction Phase|Adverse Event|0
855926|NCT00440947|1814331|FG003|36-Week Induction Phase|Adverse Event|0
855927|NCT00440947|1814332|FG004|36-Week Induction Phase|Adverse Event|0
855928|NCT00440947|1814328|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11
855929|NCT00440947|1814329|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0
855930|NCT00440947|1814330|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0
855931|NCT00440947|1814331|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0
855932|NCT00440947|1814332|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0
855933|NCT00440947|1814328|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5
855934|NCT00440947|1814329|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0
855935|NCT00440947|1814330|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0
855936|NCT00440947|1814331|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0
855937|NCT00440947|1814332|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0
855938|NCT00440947|1814328|FG000|36-Week Induction Phase|Non-compliance|10
855939|NCT00440947|1814329|FG001|36-Week Induction Phase|Non-compliance|0
855940|NCT00440947|1814330|FG002|36-Week Induction Phase|Non-compliance|0
855941|NCT00440947|1814331|FG003|36-Week Induction Phase|Non-compliance|0
855942|NCT00440947|1814332|FG004|36-Week Induction Phase|Non-compliance|0
855943|NCT00440947|1814328|FG000|36-Week Induction Phase|Lost to Follow-up|16
855944|NCT00440947|1814329|FG001|36-Week Induction Phase|Lost to Follow-up|0
855945|NCT00440947|1814330|FG002|36-Week Induction Phase|Lost to Follow-up|0
855946|NCT00440947|1814331|FG003|36-Week Induction Phase|Lost to Follow-up|0
855947|NCT00440947|1814332|FG004|36-Week Induction Phase|Lost to Follow-up|0
855948|NCT00440947|1814328|FG000|36-Week Induction Phase|Withdrawal by Subject|7
855949|NCT00440947|1814329|FG001|36-Week Induction Phase|Withdrawal by Subject|0
855950|NCT00440947|1814330|FG002|36-Week Induction Phase|Withdrawal by Subject|0
855951|NCT00440947|1814331|FG003|36-Week Induction Phase|Withdrawal by Subject|0
855952|NCT00440947|1814332|FG004|36-Week Induction Phase|Withdrawal by Subject|0
855953|NCT00440947|1814328|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
855954|NCT00440947|1814329|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
855955|NCT00440947|1814330|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
855956|NCT00440947|1814331|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
855957|NCT00440947|1814332|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
855958|NCT00440947|1814328|FG000|36-Week Induction Phase|Took Exclusionary Medications|1
855959|NCT00440947|1814329|FG001|36-Week Induction Phase|Took Exclusionary Medications|0
855960|NCT00440947|1814330|FG002|36-Week Induction Phase|Took Exclusionary Medications|0
855961|NCT00440947|1814331|FG003|36-Week Induction Phase|Took Exclusionary Medications|0
855962|NCT00440947|1814332|FG004|36-Week Induction Phase|Took Exclusionary Medications|0
855963|NCT00440947|1814328|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
855964|NCT00440947|1814329|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
855965|NCT00440947|1814330|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
855966|NCT00440947|1814331|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
855967|NCT00440947|1814332|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
855968|NCT00440947|1814328|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
855969|NCT00440947|1814329|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
855970|NCT00440947|1814330|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
855971|NCT00440947|1814331|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
855972|NCT00440947|1814332|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
855973|NCT00440947|1814328|FG000|36-Week Induction Phase|Incarceration|3
855974|NCT00440947|1814329|FG001|36-Week Induction Phase|Incarceration|0
855975|NCT00440947|1814330|FG002|36-Week Induction Phase|Incarceration|0
855976|NCT00440947|1814331|FG003|36-Week Induction Phase|Incarceration|0
855977|NCT00440947|1814332|FG004|36-Week Induction Phase|Incarceration|0
855978|NCT00440947|1814328|FG000|36-Week Induction Phase|Pregnancy|1
855979|NCT00440947|1814329|FG001|36-Week Induction Phase|Pregnancy|0
855980|NCT00440947|1814330|FG002|36-Week Induction Phase|Pregnancy|0
855981|NCT00440947|1814331|FG003|36-Week Induction Phase|Pregnancy|0
855982|NCT00440947|1814332|FG004|36-Week Induction Phase|Pregnancy|0
855983|NCT00440947|1814328|FG000|48-Week Randomization Phase|Adverse Event|0
855984|NCT00440947|1814329|FG001|48-Week Randomization Phase|Adverse Event|2
855985|NCT00440947|1814330|FG002|48-Week Randomization Phase|Adverse Event|5
855986|NCT00440947|1814331|FG003|48-Week Randomization Phase|Adverse Event|0
855987|NCT00440947|1814332|FG004|48-Week Randomization Phase|Adverse Event|0
855988|NCT00440947|1814328|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
855989|NCT00440947|1814329|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
856221|NCT00441168|1814443|FG000|Treatment Period|Adverse Event|1
855990|NCT00440947|1814330|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
855991|NCT00440947|1814331|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
855992|NCT00440947|1814332|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
855993|NCT00440947|1814328|FG000|48-Week Randomization Phase|Non-compliance|0
855994|NCT00440947|1814329|FG001|48-Week Randomization Phase|Non-compliance|3
855995|NCT00440947|1814330|FG002|48-Week Randomization Phase|Non-compliance|4
855996|NCT00440947|1814331|FG003|48-Week Randomization Phase|Non-compliance|0
855997|NCT00440947|1814332|FG004|48-Week Randomization Phase|Non-compliance|0
855998|NCT00440947|1814328|FG000|48-Week Randomization Phase|Lost to Follow-up|0
855999|NCT00440947|1814329|FG001|48-Week Randomization Phase|Lost to Follow-up|2
856000|NCT00440947|1814330|FG002|48-Week Randomization Phase|Lost to Follow-up|8
856001|NCT00440947|1814331|FG003|48-Week Randomization Phase|Lost to Follow-up|0
856002|NCT00440947|1814332|FG004|48-Week Randomization Phase|Lost to Follow-up|0
856003|NCT00440947|1814328|FG000|48-Week Randomization Phase|Protocol Violation|0
856004|NCT00440947|1814329|FG001|48-Week Randomization Phase|Protocol Violation|0
856005|NCT00440947|1814330|FG002|48-Week Randomization Phase|Protocol Violation|1
856006|NCT00440947|1814331|FG003|48-Week Randomization Phase|Protocol Violation|0
856007|NCT00440947|1814332|FG004|48-Week Randomization Phase|Protocol Violation|0
856008|NCT00440947|1814328|FG000|48-Week Randomization Phase|Withdrawal by Subject|0
856009|NCT00440947|1814329|FG001|48-Week Randomization Phase|Withdrawal by Subject|2
856010|NCT00440947|1814330|FG002|48-Week Randomization Phase|Withdrawal by Subject|4
856011|NCT00440947|1814331|FG003|48-Week Randomization Phase|Withdrawal by Subject|0
856012|NCT00440947|1814332|FG004|48-Week Randomization Phase|Withdrawal by Subject|0
856013|NCT00440947|1814328|FG000|48-Week Randomization Phase|Pregnancy|0
856014|NCT00440947|1814329|FG001|48-Week Randomization Phase|Pregnancy|0
856015|NCT00440947|1814330|FG002|48-Week Randomization Phase|Pregnancy|1
856016|NCT00440947|1814331|FG003|48-Week Randomization Phase|Pregnancy|0
856017|NCT00440947|1814332|FG004|48-Week Randomization Phase|Pregnancy|0
856018|NCT00440947|1814328|FG000|48-Week Randomization Phase|Incarceration|0
856019|NCT00440947|1814329|FG001|48-Week Randomization Phase|Incarceration|3
856020|NCT00440947|1814330|FG002|48-Week Randomization Phase|Incarceration|0
856021|NCT00440947|1814331|FG003|48-Week Randomization Phase|Incarceration|0
856022|NCT00440947|1814332|FG004|48-Week Randomization Phase|Incarceration|0
856023|NCT00440947|1814328|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0
856024|NCT00440947|1814329|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1
856025|NCT00440947|1814330|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0
856026|NCT00440947|1814331|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0
856027|NCT00440947|1814332|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0
856028|NCT00440947|1814328|FG000|48-Week Randomization Phase|Physician Decision|0
856029|NCT00440947|1814329|FG001|48-Week Randomization Phase|Physician Decision|2
856030|NCT00440947|1814330|FG002|48-Week Randomization Phase|Physician Decision|0
856031|NCT00440947|1814331|FG003|48-Week Randomization Phase|Physician Decision|0
856032|NCT00440947|1814332|FG004|48-Week Randomization Phase|Physician Decision|0
856033|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Adverse Event|0
856034|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Adverse Event|0
856035|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Adverse Event|0
856036|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Adverse Event|1
856037|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Adverse Event|3
856038|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
856039|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
856040|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
856041|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
856042|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
856043|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
856044|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
856045|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
856046|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
856047|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
856048|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Non-compliance|0
856049|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Non-compliance|0
856050|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Non-compliance|0
856051|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Non-compliance|1
856052|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Non-compliance|1
856053|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0
856054|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0
856055|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0
856056|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9
856057|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9
856058|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Protocol Violation|0
856059|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Protocol Violation|0
856060|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Protocol Violation|0
856061|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Protocol Violation|1
856222|NCT00441168|1814444|FG001|Treatment Period|Adverse Event|2
856062|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Protocol Violation|0
856063|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0
856064|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0
856065|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0
856066|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4
856067|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3
856068|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Pregnancy|0
856069|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Pregnancy|0
856070|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Pregnancy|0
856071|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Pregnancy|3
856072|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Pregnancy|0
856073|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Participant Moved|0
856074|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Participant Moved|0
856075|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Participant Moved|0
856076|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Participant Moved|1
856077|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Participant Moved|1
856078|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Sponsor Request|0
856079|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Sponsor Request|0
856080|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Sponsor Request|0
856081|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Sponsor Request|1
856082|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Sponsor Request|1
856083|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
856084|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
856085|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
856086|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
856087|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
856088|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Other|0
856089|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Other|0
856090|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Other|0
856091|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Other|1
856092|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Other|0
856093|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Physician Decision|0
856094|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Physician Decision|0
856095|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Physician Decision|0
856096|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Physician Decision|0
856097|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Physician Decision|1
856098|NCT00440947|1814328|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
856099|NCT00440947|1814329|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
856100|NCT00440947|1814330|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
856101|NCT00440947|1814331|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
856102|NCT00440947|1814332|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
856103|NCT00440999|1814346|FG000|Overall Study|Adverse Event|0
856104|NCT00440999|1814347|FG001|Overall Study|Adverse Event|2
856105|NCT00440999|1814346|FG000|Overall Study|Lack of Efficacy|6
856106|NCT00440999|1814347|FG001|Overall Study|Lack of Efficacy|7
856107|NCT00440999|1814346|FG000|Overall Study|Lost to Follow-up|19
856108|NCT00440999|1814347|FG001|Overall Study|Lost to Follow-up|12
856109|NCT00440999|1814346|FG000|Overall Study|Protocol Violation|1
856110|NCT00440999|1814347|FG001|Overall Study|Protocol Violation|0
856111|NCT00440999|1814346|FG000|Overall Study|Withdrawal by Subject|2
856112|NCT00440999|1814347|FG001|Overall Study|Withdrawal by Subject|5
856113|NCT00440999|1814346|FG000|Overall Study|Subjets missed the visit|1
856114|NCT00440999|1814347|FG001|Overall Study|Subjets missed the visit|0
856115|NCT00440999|1814346|FG000|Overall Study|Mixed infection at entry|1
856116|NCT00440999|1814347|FG001|Overall Study|Mixed infection at entry|0
856117|NCT00440999|1814346|FG000|Overall Study|P. falciparum malaria|5
856118|NCT00440999|1814347|FG001|Overall Study|P. falciparum malaria|14
856119|NCT00440999|1814346|FG000|Overall Study|Subj left hosp without inform staff|0
856120|NCT00440999|1814347|FG001|Overall Study|Subj left hosp without inform staff|1
856121|NCT00441012|1814357|FG000|Overall Study|Adverse Event|0
856122|NCT00441012|1814358|FG001|Overall Study|Adverse Event|1
856123|NCT00441012|1814357|FG000|Overall Study|Lost to Follow-up|3
856124|NCT00441012|1814358|FG001|Overall Study|Lost to Follow-up|3
856125|NCT00441012|1814357|FG000|Overall Study|Protocol Violation|10
856126|NCT00441012|1814358|FG001|Overall Study|Protocol Violation|9
856127|NCT00441012|1814357|FG000|Overall Study|Withdrawal by Subject|4
856128|NCT00441012|1814358|FG001|Overall Study|Withdrawal by Subject|0
856129|NCT00441012|1814357|FG000|Overall Study|Subject Randomized but Not Vaccinated|1
856130|NCT00441012|1814358|FG001|Overall Study|Subject Randomized but Not Vaccinated|0
856131|NCT00441064|1814366|FG000|Overall Study|Adverse Event|1
856132|NCT00441064|1814367|FG001|Overall Study|Adverse Event|0
856133|NCT00441064|1814366|FG000|Overall Study|Abnormal laboratory values|0
856134|NCT00441064|1814367|FG001|Overall Study|Abnormal laboratory values|2
856135|NCT00441064|1814366|FG000|Overall Study|Abnormal test procedure results|0
856136|NCT00441064|1814367|FG001|Overall Study|Abnormal test procedure results|1
856137|NCT00441064|1814366|FG000|Overall Study|Unsatisfactory therapeutic effect|1
856138|NCT00441064|1814367|FG001|Overall Study|Unsatisfactory therapeutic effect|0
856139|NCT00441064|1814366|FG000|Overall Study|Protocol Deviation|3
856140|NCT00441064|1814367|FG001|Overall Study|Protocol Deviation|2
856141|NCT00441064|1814366|FG000|Overall Study|Patient withdrew consent|5
856142|NCT00441064|1814367|FG001|Overall Study|Patient withdrew consent|2
856143|NCT00441090|1814378|FG000|Overall Study|Adverse Event|0
856144|NCT00441090|1814379|FG001|Overall Study|Adverse Event|1
856145|NCT00441090|1814380|FG002|Overall Study|Adverse Event|1
856146|NCT00441090|1814381|FG003|Overall Study|Adverse Event|0
856147|NCT00441090|1814382|FG004|Overall Study|Adverse Event|0
856148|NCT00441090|1814378|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0
856149|NCT00441090|1814379|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0
856150|NCT00441090|1814380|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0
856151|NCT00441090|1814381|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2
856152|NCT00441090|1814382|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0
856153|NCT00441090|1814378|FG000|Overall Study|Withdrawal by Subject|1
856154|NCT00441090|1814379|FG001|Overall Study|Withdrawal by Subject|0
856155|NCT00441090|1814380|FG002|Overall Study|Withdrawal by Subject|1
856156|NCT00441090|1814381|FG003|Overall Study|Withdrawal by Subject|0
856157|NCT00441090|1814382|FG004|Overall Study|Withdrawal by Subject|0
856158|NCT00441090|1814378|FG000|Overall Study|Lack of Efficacy|1
856159|NCT00441090|1814379|FG001|Overall Study|Lack of Efficacy|0
856160|NCT00441090|1814380|FG002|Overall Study|Lack of Efficacy|0
856161|NCT00441090|1814381|FG003|Overall Study|Lack of Efficacy|0
856162|NCT00441090|1814382|FG004|Overall Study|Lack of Efficacy|0
856163|NCT00441103|1814396|FG000|Overall Study|Adverse Event|2
856164|NCT00441103|1814397|FG001|Overall Study|Adverse Event|1
856165|NCT00441103|1814396|FG000|Overall Study|Death|1
856166|NCT00441103|1814397|FG001|Overall Study|Death|0
856167|NCT00441103|1814396|FG000|Overall Study|Disease Progression|2
856168|NCT00441103|1814397|FG001|Overall Study|Disease Progression|0
856169|NCT00441103|1814396|FG000|Overall Study|Lost to Follow-up|1
856170|NCT00441103|1814397|FG001|Overall Study|Lost to Follow-up|0
856171|NCT00441103|1814396|FG000|Overall Study|Protocol Violation|1
856172|NCT00441103|1814397|FG001|Overall Study|Protocol Violation|0
856173|NCT00441103|1814396|FG000|Overall Study|Participant unable to use Rebiject II|1
856174|NCT00441103|1814397|FG001|Overall Study|Participant unable to use Rebiject II|0
856175|NCT00441103|1814396|FG000|Overall Study|Participant refused MRI|1
856176|NCT00441103|1814397|FG001|Overall Study|Participant refused MRI|0
856177|NCT00441103|1814396|FG000|Overall Study|Inclusion criteria absent|1
856178|NCT00441103|1814397|FG001|Overall Study|Inclusion criteria absent|0
856179|NCT00441103|1814396|FG000|Overall Study|Non-compliant|0
856180|NCT00441103|1814397|FG001|Overall Study|Non-compliant|1
856181|NCT00441103|1814396|FG000|Overall Study|Participant decided to withdraw|1
856182|NCT00441103|1814397|FG001|Overall Study|Participant decided to withdraw|0
856183|NCT00441103|1814396|FG000|Overall Study|Participant's reason|0
856184|NCT00441103|1814397|FG001|Overall Study|Participant's reason|1
856185|NCT00441103|1814396|FG000|Overall Study|Participant decided to stop|0
856186|NCT00441103|1814397|FG001|Overall Study|Participant decided to stop|1
856187|NCT00441116|1814406|FG000|Overall Study|Adverse Event|1
856188|NCT00441116|1814407|FG001|Overall Study|Adverse Event|1
856189|NCT00441116|1814406|FG000|Overall Study|Withdrawal by Subject|1
856190|NCT00441116|1814407|FG001|Overall Study|Withdrawal by Subject|0
856191|NCT00441116|1814406|FG000|Overall Study|Did not meet Eligibility Criteria|1
856192|NCT00441116|1814407|FG001|Overall Study|Did not meet Eligibility Criteria|1
856193|NCT00441129|1814415|FG000|Overall Study|Withdrawal by Subject|6
856194|NCT00441129|1814416|FG001|Overall Study|Withdrawal by Subject|14
856195|NCT00441142|1814426|FG000|Overall Study|Adverse Event|2
856196|NCT00441142|1814427|FG001|Overall Study|Adverse Event|3
856197|NCT00441142|1814428|FG002|Overall Study|Adverse Event|3
856198|NCT00441142|1814429|FG003|Overall Study|Adverse Event|22
856199|NCT00441142|1814426|FG000|Overall Study|Lack of Efficacy|3
856200|NCT00441142|1814427|FG001|Overall Study|Lack of Efficacy|3
856201|NCT00441142|1814428|FG002|Overall Study|Lack of Efficacy|17
856202|NCT00441142|1814429|FG003|Overall Study|Lack of Efficacy|32
856203|NCT00441142|1814426|FG000|Overall Study|Withdrawal by Subject|0
856204|NCT00441142|1814427|FG001|Overall Study|Withdrawal by Subject|0
856205|NCT00441142|1814428|FG002|Overall Study|Withdrawal by Subject|2
856206|NCT00441142|1814429|FG003|Overall Study|Withdrawal by Subject|10
856207|NCT00441142|1814426|FG000|Overall Study|Patient still receiving active study tx|1
856208|NCT00441142|1814427|FG001|Overall Study|Patient still receiving active study tx|0
856209|NCT00441142|1814428|FG002|Overall Study|Patient still receiving active study tx|0
856210|NCT00441142|1814429|FG003|Overall Study|Patient still receiving active study tx|2
856211|NCT00441142|1814426|FG000|Overall Study|Physician Decision|0
856212|NCT00441142|1814427|FG001|Overall Study|Physician Decision|1
856213|NCT00441142|1814428|FG002|Overall Study|Physician Decision|0
856214|NCT00441142|1814429|FG003|Overall Study|Physician Decision|1
856215|NCT00441142|1814426|FG000|Overall Study|Death|0
856216|NCT00441142|1814427|FG001|Overall Study|Death|0
856217|NCT00441142|1814428|FG002|Overall Study|Death|0
856218|NCT00441142|1814429|FG003|Overall Study|Death|1
856219|NCT00441168|1814443|FG000|Treatment Period|Death|3
856220|NCT00441168|1814444|FG001|Treatment Period|Death|0
856223|NCT00441168|1814443|FG000|Treatment Period|Progressive Disease|0
856224|NCT00441168|1814444|FG001|Treatment Period|Progressive Disease|2
856225|NCT00441168|1814443|FG000|Treatment Period|Protocol Violation|0
856226|NCT00441168|1814444|FG001|Treatment Period|Protocol Violation|1
856227|NCT00441168|1814443|FG000|Treatment Period|Lost to Follow-up|0
856228|NCT00441168|1814444|FG001|Treatment Period|Lost to Follow-up|1
856229|NCT00441168|1814443|FG000|Treatment Period|Withdrawal by Subject|3
856230|NCT00441168|1814444|FG001|Treatment Period|Withdrawal by Subject|0
856231|NCT00441168|1814443|FG000|Treatment Period|qualified for stem-cell transplantation|3
856232|NCT00441168|1814444|FG001|Treatment Period|qualified for stem-cell transplantation|0
856233|NCT00441168|1814443|FG000|Treatment Period|refractory disease|1
856234|NCT00441168|1814444|FG001|Treatment Period|refractory disease|0
856235|NCT00441168|1814443|FG000|Follow-up Period|Death|3
856236|NCT00441168|1814444|FG001|Follow-up Period|Death|0
856237|NCT00441168|1814443|FG000|Follow-up Period|Lost to Follow-up|5
856238|NCT00441168|1814444|FG001|Follow-up Period|Lost to Follow-up|6
856239|NCT00441168|1814443|FG000|Follow-up Period|Withdrawal by Subject|3
856240|NCT00441168|1814444|FG001|Follow-up Period|Withdrawal by Subject|0
856241|NCT00441168|1814443|FG000|Follow-up Period|Other|1
856242|NCT00441168|1814444|FG001|Follow-up Period|Other|3
856243|NCT00441337|1814484|FG000|Overall Study|Disease Progression|6
856244|NCT00441337|1814485|FG001|Overall Study|Disease Progression|6
856245|NCT00441337|1814486|FG002|Overall Study|Disease Progression|4
856246|NCT00441337|1814487|FG003|Overall Study|Disease Progression|18
856247|NCT00441337|1814484|FG000|Overall Study|Lost to Follow-up|0
856248|NCT00441337|1814485|FG001|Overall Study|Lost to Follow-up|0
856249|NCT00441337|1814486|FG002|Overall Study|Lost to Follow-up|0
856250|NCT00441337|1814487|FG003|Overall Study|Lost to Follow-up|1
856251|NCT00441337|1814484|FG000|Overall Study|Sponsor Decision|0
856252|NCT00441337|1814485|FG001|Overall Study|Sponsor Decision|0
856253|NCT00441337|1814486|FG002|Overall Study|Sponsor Decision|1
856254|NCT00441337|1814487|FG003|Overall Study|Sponsor Decision|2
856255|NCT00441337|1814484|FG000|Overall Study|Did not meet inclusion criteria|0
856256|NCT00441337|1814485|FG001|Overall Study|Did not meet inclusion criteria|0
856257|NCT00441337|1814486|FG002|Overall Study|Did not meet inclusion criteria|1
856258|NCT00441337|1814487|FG003|Overall Study|Did not meet inclusion criteria|0
856259|NCT00441363|1814528|FG000|Overall Study|Adverse Event|4
856260|NCT00441363|1814529|FG001|Overall Study|Adverse Event|2
856261|NCT00441363|1814528|FG000|Overall Study|Withdrawal by Subject|3
856262|NCT00441363|1814529|FG001|Overall Study|Withdrawal by Subject|4
856263|NCT00441363|1814528|FG000|Overall Study|Physician Decision|6
856264|NCT00441363|1814529|FG001|Overall Study|Physician Decision|7
856265|NCT00441363|1814528|FG000|Overall Study|Lost to Follow-up|2
856266|NCT00441363|1814529|FG001|Overall Study|Lost to Follow-up|2
856267|NCT00441363|1814528|FG000|Overall Study|Other|2
856268|NCT00441363|1814529|FG001|Overall Study|Other|0
856269|NCT00441441|1814537|FG000|Overall Study|Adverse Event|2
856270|NCT00441441|1814538|FG001|Overall Study|Adverse Event|1
856271|NCT00441441|1814537|FG000|Overall Study|Protocol Violation|4
856272|NCT00441441|1814538|FG001|Overall Study|Protocol Violation|6
856273|NCT00441441|1814537|FG000|Overall Study|Exacerbation of asthma|1
856274|NCT00441441|1814538|FG001|Overall Study|Exacerbation of asthma|2
856275|NCT00441441|1814537|FG000|Overall Study|Withdrawal by Subject|1
856276|NCT00441441|1814538|FG001|Overall Study|Withdrawal by Subject|2
856277|NCT00441441|1814537|FG000|Overall Study|Other|3
856278|NCT00441441|1814538|FG001|Overall Study|Other|3
856279|NCT00441467|1814558|FG000|Overall Study|Adverse Event|6
856280|NCT00441467|1814558|FG000|Overall Study|Withdrawal by Subject|3
856281|NCT00441467|1814558|FG000|Overall Study|Progressive disease|9
856282|NCT00441480|1814564|FG000|Overall Study|Protocol Violation|1
856283|NCT00441480|1814565|FG001|Overall Study|Protocol Violation|1
856284|NCT00441480|1814564|FG000|Overall Study|Withdrawal by Subject|2
856285|NCT00441480|1814565|FG001|Overall Study|Withdrawal by Subject|3
856286|NCT00441545|1814571|FG000|First Intervention|Adverse Event|6
856287|NCT00441545|1814572|FG001|First Intervention|Adverse Event|5
856288|NCT00441545|1814571|FG000|First Intervention|Protocol Violation|2
856289|NCT00441545|1814572|FG001|First Intervention|Protocol Violation|2
856290|NCT00441545|1814571|FG000|First Intervention|Withdrawal by Subject|3
856291|NCT00441545|1814572|FG001|First Intervention|Withdrawal by Subject|3
856292|NCT00441545|1814571|FG000|First Intervention|Kidney transplant|1
856293|NCT00441545|1814572|FG001|First Intervention|Kidney transplant|1
856294|NCT00441545|1814571|FG000|First Intervention|Lack of Efficacy|2
856295|NCT00441545|1814572|FG001|First Intervention|Lack of Efficacy|0
856296|NCT00441545|1814571|FG000|First Intervention|Subject exceeded safety criteria|0
856297|NCT00441545|1814572|FG001|First Intervention|Subject exceeded safety criteria|1
856298|NCT00441545|1814571|FG000|First Intervention|Subject met an exclusionary criteria|1
856299|NCT00441545|1814572|FG001|First Intervention|Subject met an exclusionary criteria|0
856300|NCT00441545|1814571|FG000|First Intervention|Extended hospitalization|1
856301|NCT00441545|1814572|FG001|First Intervention|Extended hospitalization|0
856302|NCT00441545|1814571|FG000|First Intervention|Site error|1
856303|NCT00441545|1814572|FG001|First Intervention|Site error|0
856304|NCT00441545|1814571|FG000|First Intervention|Sponsor's request|1
856305|NCT00441545|1814572|FG001|First Intervention|Sponsor's request|0
856306|NCT00441545|1814571|FG000|Second Intervention|Adverse Event|5
856307|NCT00441545|1814572|FG001|Second Intervention|Adverse Event|2
856308|NCT00441545|1814571|FG000|Second Intervention|Protocol Violation|4
856309|NCT00441545|1814572|FG001|Second Intervention|Protocol Violation|1
856310|NCT00441545|1814571|FG000|Second Intervention|Withdrawal by Subject|1
856311|NCT00441545|1814572|FG001|Second Intervention|Withdrawal by Subject|1
856312|NCT00441545|1814571|FG000|Second Intervention|Kidney Transplant|1
856313|NCT00441545|1814572|FG001|Second Intervention|Kidney Transplant|1
856314|NCT00441545|1814571|FG000|Second Intervention|Lack of Efficacy|0
856315|NCT00441545|1814572|FG001|Second Intervention|Lack of Efficacy|1
856316|NCT00441545|1814571|FG000|Second Intervention|Subject exceeded safety criteria|1
856317|NCT00441545|1814572|FG001|Second Intervention|Subject exceeded safety criteria|0
856318|NCT00441545|1814571|FG000|Second Intervention|Subject moved|0
856319|NCT00441545|1814572|FG001|Second Intervention|Subject moved|1
856320|NCT00441584|1814582|FG000|Overall Study|Lack of Efficacy|79
856321|NCT00441584|1814582|FG000|Overall Study|Withdrawal by Subject|8
856322|NCT00441584|1814582|FG000|Overall Study|Adverse Event|6
856323|NCT00441584|1814582|FG000|Overall Study|Protocol Violation|5
856324|NCT00441584|1814582|FG000|Overall Study|Lost to Follow-up|4
856325|NCT00441584|1814582|FG000|Overall Study|Failure to meet eligibility criteria|3
856326|NCT00441701|1814596|FG000|Overall Study|Adverse Event|3
856327|NCT00441701|1814597|FG001|Overall Study|Adverse Event|2
856328|NCT00441701|1814598|FG002|Overall Study|Adverse Event|1
856329|NCT00441701|1814599|FG003|Overall Study|Adverse Event|0
856330|NCT00441701|1814600|FG004|Overall Study|Adverse Event|2
856331|NCT00441701|1814601|FG005|Overall Study|Adverse Event|2
856332|NCT00441701|1814602|FG006|Overall Study|Adverse Event|0
856333|NCT00441701|1814603|FG007|Overall Study|Adverse Event|0
856334|NCT00441701|1814604|FG008|Overall Study|Adverse Event|0
856335|NCT00441701|1814605|FG009|Overall Study|Adverse Event|0
856336|NCT00441701|1814596|FG000|Overall Study|Lack of Efficacy|2
856337|NCT00441701|1814597|FG001|Overall Study|Lack of Efficacy|0
856338|NCT00441701|1814598|FG002|Overall Study|Lack of Efficacy|2
856339|NCT00441701|1814599|FG003|Overall Study|Lack of Efficacy|2
856340|NCT00441701|1814600|FG004|Overall Study|Lack of Efficacy|0
856341|NCT00441701|1814601|FG005|Overall Study|Lack of Efficacy|1
856342|NCT00441701|1814602|FG006|Overall Study|Lack of Efficacy|0
856343|NCT00441701|1814603|FG007|Overall Study|Lack of Efficacy|0
856344|NCT00441701|1814604|FG008|Overall Study|Lack of Efficacy|0
856345|NCT00441701|1814605|FG009|Overall Study|Lack of Efficacy|0
856346|NCT00441701|1814596|FG000|Overall Study|Withdrawal by Subject|0
856347|NCT00441701|1814597|FG001|Overall Study|Withdrawal by Subject|2
856348|NCT00441701|1814598|FG002|Overall Study|Withdrawal by Subject|1
856349|NCT00441701|1814599|FG003|Overall Study|Withdrawal by Subject|1
856350|NCT00441701|1814600|FG004|Overall Study|Withdrawal by Subject|0
856351|NCT00441701|1814601|FG005|Overall Study|Withdrawal by Subject|0
856352|NCT00441701|1814602|FG006|Overall Study|Withdrawal by Subject|0
856353|NCT00441701|1814603|FG007|Overall Study|Withdrawal by Subject|0
856354|NCT00441701|1814604|FG008|Overall Study|Withdrawal by Subject|0
856355|NCT00441701|1814605|FG009|Overall Study|Withdrawal by Subject|0
856356|NCT00441727|1814626|FG000|Overall Study|Protocol Violation|19
856357|NCT00441727|1814627|FG001|Overall Study|Protocol Violation|28
856358|NCT00441727|1814628|FG002|Overall Study|Protocol Violation|32
856359|NCT00441727|1814626|FG000|Overall Study|Adverse Event|26
856360|NCT00441727|1814627|FG001|Overall Study|Adverse Event|33
856361|NCT00441727|1814628|FG002|Overall Study|Adverse Event|28
856362|NCT00441727|1814626|FG000|Overall Study|Lack of Efficacy|7
856363|NCT00441727|1814627|FG001|Overall Study|Lack of Efficacy|8
856364|NCT00441727|1814628|FG002|Overall Study|Lack of Efficacy|48
856365|NCT00441727|1814626|FG000|Overall Study|Withdrawal by Subject|40
856366|NCT00441727|1814627|FG001|Overall Study|Withdrawal by Subject|34
856367|NCT00441727|1814628|FG002|Overall Study|Withdrawal by Subject|47
856368|NCT00441727|1814626|FG000|Overall Study|Lost to Follow-up|5
856369|NCT00441727|1814627|FG001|Overall Study|Lost to Follow-up|6
856370|NCT00441727|1814628|FG002|Overall Study|Lost to Follow-up|5
856371|NCT00441727|1814626|FG000|Overall Study|Safety Reasons|3
856372|NCT00441727|1814627|FG001|Overall Study|Safety Reasons|1
856373|NCT00441727|1814628|FG002|Overall Study|Safety Reasons|3
856374|NCT00441727|1814626|FG000|Overall Study|Various reason specified|6
856375|NCT00441727|1814627|FG001|Overall Study|Various reason specified|8
856376|NCT00441727|1814628|FG002|Overall Study|Various reason specified|5
856377|NCT00441792|1814660|FG000|Overall Study|Lost to Follow-up|0
856378|NCT00441792|1814661|FG001|Overall Study|Lost to Follow-up|2
856379|NCT00441974|1814688|FG000|Overall Study|Adverse Event|6
856380|NCT00441974|1814688|FG000|Overall Study|Consent Withdrawn|35
856381|NCT00441974|1814688|FG000|Overall Study|Lost to Follow-up|80
856382|NCT00441974|1814688|FG000|Overall Study|Protocol Violation|7
856383|NCT00442117|1814707|FG000|Overall Study|Adverse Event|3
856384|NCT00442117|1814708|FG001|Overall Study|Adverse Event|2
856385|NCT00442117|1814707|FG000|Overall Study|Lack of Efficacy|2
856386|NCT00442117|1814708|FG001|Overall Study|Lack of Efficacy|6
856387|NCT00442117|1814707|FG000|Overall Study|Lost to Follow-up|1
856388|NCT00442117|1814708|FG001|Overall Study|Lost to Follow-up|2
856389|NCT00442117|1814707|FG000|Overall Study|Withdrawal by Subject|2
856390|NCT00442117|1814708|FG001|Overall Study|Withdrawal by Subject|2
856391|NCT00442117|1814707|FG000|Overall Study|Major Deviation|25
856392|NCT00442117|1814708|FG001|Overall Study|Major Deviation|20
856393|NCT00442117|1814707|FG000|Overall Study|Non compliance with protocol|3
856394|NCT00442117|1814708|FG001|Overall Study|Non compliance with protocol|5
856395|NCT00442117|1814707|FG000|Overall Study|Met Withdrawal Criteria|2
856396|NCT00442117|1814708|FG001|Overall Study|Met Withdrawal Criteria|1
856397|NCT00442286|1814742|FG000|Overall Study|Death|2
856398|NCT00442286|1814743|FG001|Overall Study|Death|2
856399|NCT00442286|1814742|FG000|Overall Study|Lost to Follow-up|1
856400|NCT00442286|1814743|FG001|Overall Study|Lost to Follow-up|0
856401|NCT00442286|1814742|FG000|Overall Study|Withdrawal by Subject|2
856402|NCT00442286|1814743|FG001|Overall Study|Withdrawal by Subject|0
856403|NCT00442286|1814742|FG000|Overall Study|System explanted|1
856404|NCT00442286|1814743|FG001|Overall Study|System explanted|0
856405|NCT00442286|1814742|FG000|Overall Study|Patient Injury|1
856406|NCT00442286|1814743|FG001|Overall Study|Patient Injury|0
856407|NCT00442416|1814770|FG000|Overall Study|Adverse Event|4
856408|NCT00442416|1814771|FG001|Overall Study|Adverse Event|1
856409|NCT00442416|1814770|FG000|Overall Study|Death|1
856410|NCT00442416|1814771|FG001|Overall Study|Death|0
856411|NCT00442416|1814770|FG000|Overall Study|Lack of Efficacy|2
856412|NCT00442416|1814771|FG001|Overall Study|Lack of Efficacy|0
856413|NCT00442416|1814770|FG000|Overall Study|Protocol Violation|2
856414|NCT00442416|1814771|FG001|Overall Study|Protocol Violation|3
856415|NCT00442416|1814770|FG000|Overall Study|Withdrew consent|1
856416|NCT00442416|1814771|FG001|Overall Study|Withdrew consent|2
856417|NCT00442416|1814770|FG000|Overall Study|Administrative/Other|27
856418|NCT00442416|1814771|FG001|Overall Study|Administrative/Other|33
856419|NCT00442468|1814777|FG000|Overall Study|Adverse Event|4
856420|NCT00442468|1814777|FG000|Overall Study|Withdrawal by Subject|91
856421|NCT00442468|1814777|FG000|Overall Study|Did not complete all study procedures|88
856422|NCT00442559|1814802|FG000|Overall Study|Lost to Follow-up|32
856423|NCT00442559|1814803|FG001|Overall Study|Lost to Follow-up|34
856424|NCT00442559|1814802|FG000|Overall Study|Protocol Violation|1
856425|NCT00442559|1814803|FG001|Overall Study|Protocol Violation|1
856426|NCT00442559|1814802|FG000|Overall Study|Withdrawal by Subject|1
856427|NCT00442559|1814803|FG001|Overall Study|Withdrawal by Subject|0
856428|NCT00442572|1814817|FG000|Overall Study|Relapse|8
856429|NCT00442572|1814818|FG001|Overall Study|Relapse|1
856430|NCT00442572|1814817|FG000|Overall Study|Lost to Follow-up|0
856431|NCT00442572|1814818|FG001|Overall Study|Lost to Follow-up|1
856432|NCT00442572|1814817|FG000|Overall Study|Withdrawal by Subject|0
856433|NCT00442572|1814818|FG001|Overall Study|Withdrawal by Subject|1
856434|NCT00442598|1814828|FG000|Overall Study|Adverse Event|1
856435|NCT00442598|1814829|FG001|Overall Study|Adverse Event|0
856436|NCT00442598|1814830|FG002|Overall Study|Adverse Event|0
856437|NCT00442598|1814828|FG000|Overall Study|Tumor progression|3
856438|NCT00442598|1814829|FG001|Overall Study|Tumor progression|4
856439|NCT00442598|1814830|FG002|Overall Study|Tumor progression|0
856440|NCT00442598|1814828|FG000|Overall Study|Clinical deterioration|1
856441|NCT00442598|1814829|FG001|Overall Study|Clinical deterioration|2
856442|NCT00442598|1814830|FG002|Overall Study|Clinical deterioration|0
856443|NCT00442598|1814828|FG000|Overall Study|CA125 progression|0
856444|NCT00442598|1814829|FG001|Overall Study|CA125 progression|1
856445|NCT00442598|1814830|FG002|Overall Study|CA125 progression|0
856446|NCT00442598|1814828|FG000|Overall Study|Reduced creatinine clearance|1
856447|NCT00442598|1814829|FG001|Overall Study|Reduced creatinine clearance|0
856448|NCT00442598|1814830|FG002|Overall Study|Reduced creatinine clearance|0
856449|NCT00442598|1814828|FG000|Overall Study|Death|0
856450|NCT00442598|1814829|FG001|Overall Study|Death|1
856451|NCT00442598|1814830|FG002|Overall Study|Death|0
856452|NCT00442702|1814861|FG000|Titration Period|Adverse Event|2
856453|NCT00442702|1814862|FG001|Titration Period|Adverse Event|0
856454|NCT00442702|1814861|FG000|Titration Period|Death|3
856455|NCT00442702|1814862|FG001|Titration Period|Death|2
856456|NCT00442702|1814861|FG000|Titration Period|Insufficient Therapeutic Response|1
856457|NCT00442702|1814862|FG001|Titration Period|Insufficient Therapeutic Response|0
856458|NCT00442702|1814861|FG000|Titration Period|Refused Treatment|4
856459|NCT00442702|1814862|FG001|Titration Period|Refused Treatment|1
856460|NCT00442702|1814861|FG000|Titration Period|Failure to return|1
856461|NCT00442702|1814862|FG001|Titration Period|Failure to return|0
856462|NCT00442702|1814861|FG000|Titration Period|Hospitalized in another hospital|1
856463|NCT00442702|1814862|FG001|Titration Period|Hospitalized in another hospital|0
856464|NCT00442702|1814861|FG000|Evaluation Period|Adverse Event|1
856465|NCT00442702|1814862|FG001|Evaluation Period|Adverse Event|0
856466|NCT00442702|1814861|FG000|Evaluation Period|Death|1
856467|NCT00442702|1814862|FG001|Evaluation Period|Death|1
856468|NCT00442702|1814861|FG000|Evaluation Period|Insufficient Therapeutic Response|1
856469|NCT00442702|1814862|FG001|Evaluation Period|Insufficient Therapeutic Response|0
856470|NCT00442702|1814861|FG000|Evaluation Period|Refused treatment|1
856471|NCT00442702|1814862|FG001|Evaluation Period|Refused treatment|1
856472|NCT00442702|1814861|FG000|Evaluation Period|Renal transplant|0
856473|NCT00442702|1814862|FG001|Evaluation Period|Renal transplant|1
856474|NCT00442702|1814861|FG000|Evaluation Period|Failure to return|1
856475|NCT00442702|1814862|FG001|Evaluation Period|Failure to return|0
856476|NCT00442702|1814861|FG000|Evaluation Period|Site closure|0
856477|NCT00442702|1814862|FG001|Evaluation Period|Site closure|1
856478|NCT00442897|1814876|FG000|Base Study (12 Week Follow-up)|Adverse Event|1
856479|NCT00442897|1814877|FG001|Base Study (12 Week Follow-up)|Adverse Event|0
856480|NCT00442897|1814876|FG000|Base Study (12 Week Follow-up)|Death|0
856481|NCT00442897|1814877|FG001|Base Study (12 Week Follow-up)|Death|1
856482|NCT00442897|1814876|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7
856483|NCT00442897|1814877|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3
856484|NCT00442897|1814876|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
856485|NCT00442897|1814877|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
856486|NCT00442897|1814876|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1
856487|NCT00442897|1814877|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0
856488|NCT00442897|1814876|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
856489|NCT00442897|1814877|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
856490|NCT00442897|1814876|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
856491|NCT00442897|1814877|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
856492|NCT00442897|1814876|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
856493|NCT00442897|1814877|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
856494|NCT00442936|1814887|FG000|Overall Study|Protocol Violation|1
856495|NCT00442936|1814888|FG001|Overall Study|Protocol Violation|0
856496|NCT00442936|1814889|FG002|Overall Study|Protocol Violation|1
856497|NCT00442936|1814890|FG003|Overall Study|Protocol Violation|1
856498|NCT00442962|1814900|FG000|Overall Study|Pregnancy|1
856499|NCT00442962|1814900|FG000|Overall Study|Lost to Follow-up|7
856500|NCT00443053|1814906|FG000|Overall Study|Adverse Event|2
856501|NCT00443053|1814907|FG001|Overall Study|Adverse Event|1
856502|NCT00443053|1814906|FG000|Overall Study|Withdrawal by Subject|9
856503|NCT00443053|1814907|FG001|Overall Study|Withdrawal by Subject|18
856504|NCT00443053|1814906|FG000|Overall Study|Lost to Follow-up|4
856505|NCT00443053|1814907|FG001|Overall Study|Lost to Follow-up|5
856506|NCT00443053|1814906|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
856507|NCT00443053|1814907|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
856508|NCT00443053|1814906|FG000|Overall Study|Noncompliance|2
856509|NCT00443053|1814907|FG001|Overall Study|Noncompliance|1
856510|NCT00443053|1814906|FG000|Overall Study|Other|3
856511|NCT00443053|1814907|FG001|Overall Study|Other|4
856512|NCT00443053|1814906|FG000|Overall Study|Physician Decision|0
856513|NCT00443053|1814907|FG001|Overall Study|Physician Decision|4
856514|NCT00443079|1814915|FG000|Overall Study|Lost to Follow-up|0
856515|NCT00443079|1814916|FG001|Overall Study|Lost to Follow-up|1
856516|NCT00443118|1814927|FG000|Overall Study|unknown primary outcome|3
856517|NCT00443118|1814928|FG001|Overall Study|unknown primary outcome|1
856518|NCT00443118|1814929|FG002|Overall Study|unknown primary outcome|0
856519|NCT00443118|1814927|FG000|Overall Study|Withdrawal by Subject|1
856520|NCT00443118|1814928|FG001|Overall Study|Withdrawal by Subject|0
856521|NCT00443118|1814929|FG002|Overall Study|Withdrawal by Subject|0
856522|NCT00443209|1814957|FG000|Months 1 to 12 Treatment Period|Adverse Event|22
856523|NCT00443209|1814958|FG001|Months 1 to 12 Treatment Period|Adverse Event|11
856524|NCT00443209|1814957|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14
856525|NCT00443209|1814958|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7
856526|NCT00443209|1814957|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50
856527|NCT00443209|1814958|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11
856528|NCT00443209|1814957|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
856529|NCT00443209|1814958|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
856530|NCT00443209|1814957|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36
856531|NCT00443209|1814958|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15
856532|NCT00443209|1814957|FG000|Months 1 to 12 Treatment Period|Physician Decision|8
856533|NCT00443209|1814958|FG001|Months 1 to 12 Treatment Period|Physician Decision|4
856534|NCT00443209|1814957|FG000|Months 1 to 12 Treatment Period|Pregnancy|3
856535|NCT00443209|1814958|FG001|Months 1 to 12 Treatment Period|Pregnancy|4
856536|NCT00443209|1814957|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43
856537|NCT00443209|1814958|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23
856538|NCT00443209|1814957|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
856539|NCT00443209|1814958|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
856540|NCT00443209|1814957|FG000|Months 1 to 12 Treatment Period|Missing|2
856541|NCT00443209|1814958|FG001|Months 1 to 12 Treatment Period|Missing|1
856542|NCT00443209|1814957|FG000|Months 1 to 12 Treatment Period|Not Treated|71
856543|NCT00443209|1814958|FG001|Months 1 to 12 Treatment Period|Not Treated|43
856544|NCT00443209|1814957|FG000|Months 13 to 18 Treatment Period|Adverse Event|1
856545|NCT00443209|1814958|FG001|Months 13 to 18 Treatment Period|Adverse Event|0
856546|NCT00443209|1814957|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1
856547|NCT00443209|1814958|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0
856548|NCT00443209|1814957|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1
856549|NCT00443209|1814958|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0
856550|NCT00443209|1814957|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2
856551|NCT00443209|1814958|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2
856552|NCT00443209|1814957|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87
856553|NCT00443209|1814958|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43
856554|NCT00443209|1814957|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
856555|NCT00443209|1814958|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
856556|NCT00443261|1814964|FG000|Overall Study|Death|1
856557|NCT00443430|1814974|FG000|Overall Study|Lack of Efficacy|3
856558|NCT00443430|1814975|FG001|Overall Study|Lack of Efficacy|3
856559|NCT00443430|1814974|FG000|Overall Study|Adverse Event|1
856560|NCT00443430|1814975|FG001|Overall Study|Adverse Event|1
856561|NCT00443456|1814981|FG000|Overall Study|Adverse Event|16
856562|NCT00443456|1814981|FG000|Overall Study|Move|1
856563|NCT00443456|1814981|FG000|Overall Study|Withdrawal by Subject|1
856564|NCT00443534|1814989|FG000|Overall Study|Lack of Efficacy|67
856565|NCT00443534|1814989|FG000|Overall Study|Adverse Event|16
856566|NCT00443534|1814989|FG000|Overall Study|Death|9
856567|NCT00443534|1814989|FG000|Overall Study|Withdrawal by Subject|8
856568|NCT00443534|1814989|FG000|Overall Study|Study Terminated by Sponsor|12
856569|NCT00443534|1814989|FG000|Overall Study|Other|10
856570|NCT00443534|1814989|FG000|Overall Study|Enrolled, Not Treated|1
856571|NCT00443560|1815012|FG000|Overall Study|No intrathecal dose|58
856572|NCT00443560|1815013|FG001|Overall Study|No intrathecal dose|26
856573|NCT00443560|1815012|FG000|Overall Study|Multiple pregnancies or fetal demise|2
856574|NCT00443560|1815013|FG001|Overall Study|Multiple pregnancies or fetal demise|4
856575|NCT00443599|1815021|FG000|Overall Study|Physician Decision|2
856576|NCT00443599|1815022|FG001|Overall Study|Physician Decision|1
856577|NCT00443599|1815021|FG000|Overall Study|Death|1
856578|NCT00443599|1815022|FG001|Overall Study|Death|1
856579|NCT00443599|1815021|FG000|Overall Study|Cardiopulmonary bypass canceled|3
856580|NCT00443599|1815022|FG001|Overall Study|Cardiopulmonary bypass canceled|1
856581|NCT00443651|1815030|FG000|Overall Study|Death|1
856582|NCT00443651|1815031|FG001|Overall Study|Death|5
856583|NCT00443651|1815030|FG000|Overall Study|Adverse Event|5
856584|NCT00443651|1815031|FG001|Overall Study|Adverse Event|6
856585|NCT00443651|1815030|FG000|Overall Study|Lost to Follow-up|18
856586|NCT00443651|1815031|FG001|Overall Study|Lost to Follow-up|12
856587|NCT00443651|1815030|FG000|Overall Study|Patient's/Guardian's Decision|58
856588|NCT00443651|1815031|FG001|Overall Study|Patient's/Guardian's Decision|30
856589|NCT00443651|1815030|FG000|Overall Study|Physician Decision|13
856590|NCT00443651|1815031|FG001|Overall Study|Physician Decision|4
856591|NCT00443651|1815030|FG000|Overall Study|Pregnancy|0
856592|NCT00443651|1815031|FG001|Overall Study|Pregnancy|1
856593|NCT00443703|1815039|FG000|Overall Study|Never Treated|3
856594|NCT00443703|1815040|FG001|Overall Study|Never Treated|1
856595|NCT00443703|1815039|FG000|Overall Study|Adverse Event|7
856596|NCT00443703|1815040|FG001|Overall Study|Adverse Event|3
856597|NCT00443703|1815039|FG000|Overall Study|Lack of Efficacy|3
856598|NCT00443703|1815040|FG001|Overall Study|Lack of Efficacy|1
856599|NCT00443703|1815039|FG000|Overall Study|Lost to Follow-up|0
856600|NCT00443703|1815040|FG001|Overall Study|Lost to Follow-up|4
856601|NCT00443703|1815039|FG000|Overall Study|Physician Decision|4
856602|NCT00443703|1815040|FG001|Overall Study|Physician Decision|2
856603|NCT00443703|1815039|FG000|Overall Study|Protocol Violation|1
856604|NCT00443703|1815040|FG001|Overall Study|Protocol Violation|1
856605|NCT00443703|1815039|FG000|Overall Study|Withdrawal by Subject|9
856606|NCT00443703|1815040|FG001|Overall Study|Withdrawal by Subject|6
856607|NCT00443703|1815039|FG000|Overall Study|Progressive Disease|1
856608|NCT00443703|1815040|FG001|Overall Study|Progressive Disease|0
856609|NCT00443729|1815048|FG000|Overall Study|Never Treated|0
856610|NCT00443729|1815049|FG001|Overall Study|Never Treated|1
856611|NCT00443729|1815048|FG000|Overall Study|Lack of Efficacy|4
856612|NCT00443729|1815049|FG001|Overall Study|Lack of Efficacy|2
856613|NCT00443729|1815048|FG000|Overall Study|Lost to Follow-up|0
856614|NCT00443729|1815049|FG001|Overall Study|Lost to Follow-up|1
856615|NCT00443729|1815048|FG000|Overall Study|Physician Decision|2
856616|NCT00443729|1815049|FG001|Overall Study|Physician Decision|1
856617|NCT00443729|1815048|FG000|Overall Study|Protocol Violation|1
856618|NCT00443729|1815049|FG001|Overall Study|Protocol Violation|1
856619|NCT00443729|1815048|FG000|Overall Study|Withdrawal by Subject|3
856620|NCT00443729|1815049|FG001|Overall Study|Withdrawal by Subject|1
856621|NCT00443755|1815057|FG000|Overall Study|Withdrawal by Subject|2
856622|NCT00443755|1815058|FG001|Overall Study|Withdrawal by Subject|1
856623|NCT00443781|1815064|FG000|Overall Study|Lost to Follow-up|10
856624|NCT00443781|1815064|FG000|Overall Study|Physician Decision|2
856625|NCT00443781|1815064|FG000|Overall Study|Protocol Violation|1
856626|NCT00443781|1815064|FG000|Overall Study|Withdrawal by Subject|6
856627|NCT00443781|1815064|FG000|Overall Study|Unable to comply with study follow up|2
856628|NCT00443781|1815064|FG000|Overall Study|Investigator terminated participation|1
856629|NCT00443781|1815064|FG000|Overall Study|Insurance not covered|2
856630|NCT00443781|1815064|FG000|Overall Study|PD/FAD not done|1
856631|NCT00443820|1815072|FG000|Overall Study|Adverse Event|1
856632|NCT00443820|1815073|FG001|Overall Study|Adverse Event|1
856633|NCT00443820|1815074|FG002|Overall Study|Adverse Event|0
856634|NCT00443820|1815075|FG003|Overall Study|Adverse Event|0
856635|NCT00443820|1815072|FG000|Overall Study|Lack of Efficacy|3
856636|NCT00443820|1815073|FG001|Overall Study|Lack of Efficacy|2
856637|NCT00443820|1815074|FG002|Overall Study|Lack of Efficacy|1
856638|NCT00443820|1815075|FG003|Overall Study|Lack of Efficacy|1
856639|NCT00443820|1815072|FG000|Overall Study|Protocol Violation|2
856640|NCT00443820|1815073|FG001|Overall Study|Protocol Violation|1
856641|NCT00443820|1815074|FG002|Overall Study|Protocol Violation|2
856642|NCT00443820|1815075|FG003|Overall Study|Protocol Violation|1
856643|NCT00443820|1815072|FG000|Overall Study|Withdrawal by Subject|6
856644|NCT00443820|1815073|FG001|Overall Study|Withdrawal by Subject|7
856645|NCT00443820|1815074|FG002|Overall Study|Withdrawal by Subject|8
856646|NCT00443820|1815075|FG003|Overall Study|Withdrawal by Subject|9
856647|NCT00443820|1815072|FG000|Overall Study|Lost to Follow-up|9
856648|NCT00443820|1815073|FG001|Overall Study|Lost to Follow-up|8
856649|NCT00443820|1815074|FG002|Overall Study|Lost to Follow-up|6
856650|NCT00443820|1815075|FG003|Overall Study|Lost to Follow-up|5
856651|NCT00443820|1815072|FG000|Overall Study|Administrative problems|0
856652|NCT00443820|1815073|FG001|Overall Study|Administrative problems|0
856653|NCT00443820|1815074|FG002|Overall Study|Administrative problems|0
856654|NCT00443820|1815075|FG003|Overall Study|Administrative problems|1
856655|NCT00443820|1815072|FG000|Overall Study|Death|0
856656|NCT00443820|1815073|FG001|Overall Study|Death|0
856657|NCT00443820|1815074|FG002|Overall Study|Death|1
856658|NCT00443820|1815075|FG003|Overall Study|Death|0
856659|NCT00443846|1815087|FG000|Overall Study|Withdrawn due to intercurrent disease|1
856660|NCT00443846|1815088|FG001|Overall Study|Withdrawn due to intercurrent disease|0
856661|NCT00443846|1815087|FG000|Overall Study|Not vaccinated, no blood sample drawn|1
856662|NCT00443846|1815088|FG001|Overall Study|Not vaccinated, no blood sample drawn|0
856663|NCT00443846|1815087|FG000|Overall Study|Adverse Event|0
856664|NCT00443846|1815088|FG001|Overall Study|Adverse Event|1
856665|NCT00443846|1815087|FG000|Overall Study|Personal reason|8
856666|NCT00443846|1815088|FG001|Overall Study|Personal reason|3
856667|NCT00443846|1815087|FG000|Overall Study|Lost to Follow-up|1
856668|NCT00443846|1815088|FG001|Overall Study|Lost to Follow-up|2
856669|NCT00443872|1815094|FG000|Overall Study|Protocol Violation|7
856670|NCT00443872|1815094|FG000|Overall Study|Lost to Follow-up|2
856671|NCT00443872|1815094|FG000|Overall Study|Adverse Event|8
856672|NCT00443898|1815111|FG000|Overall Study|Adverse Event|0
856673|NCT00443898|1815112|FG001|Overall Study|Adverse Event|0
856674|NCT00443898|1815113|FG002|Overall Study|Adverse Event|1
856675|NCT00443898|1815114|FG003|Overall Study|Adverse Event|1
856676|NCT00443898|1815111|FG000|Overall Study|Lack of Efficacy|2
856677|NCT00443898|1815112|FG001|Overall Study|Lack of Efficacy|3
856678|NCT00443898|1815113|FG002|Overall Study|Lack of Efficacy|3
856679|NCT00443898|1815114|FG003|Overall Study|Lack of Efficacy|1
856680|NCT00443898|1815111|FG000|Overall Study|Protocol Violation|1
856681|NCT00443898|1815112|FG001|Overall Study|Protocol Violation|1
856682|NCT00443898|1815113|FG002|Overall Study|Protocol Violation|1
856683|NCT00443898|1815114|FG003|Overall Study|Protocol Violation|0
856684|NCT00443898|1815111|FG000|Overall Study|Withdrawal by Subject|11
856685|NCT00443898|1815112|FG001|Overall Study|Withdrawal by Subject|10
856686|NCT00443898|1815113|FG002|Overall Study|Withdrawal by Subject|10
856687|NCT00443898|1815114|FG003|Overall Study|Withdrawal by Subject|6
856688|NCT00443898|1815111|FG000|Overall Study|Lost to Follow-up|10
856689|NCT00443898|1815112|FG001|Overall Study|Lost to Follow-up|10
856690|NCT00443898|1815113|FG002|Overall Study|Lost to Follow-up|14
856691|NCT00443898|1815114|FG003|Overall Study|Lost to Follow-up|10
856692|NCT00443898|1815111|FG000|Overall Study|Death|0
856693|NCT00443898|1815112|FG001|Overall Study|Death|1
856694|NCT00443898|1815113|FG002|Overall Study|Death|0
856695|NCT00443898|1815114|FG003|Overall Study|Death|0
856696|NCT00444067|1815150|FG000|Overall Study|Lost to Follow-up|0
856697|NCT00444067|1815151|FG001|Overall Study|Lost to Follow-up|1
856698|NCT00444106|1815172|FG000|Overall Study|Lost to Follow-up|2
856699|NCT00444106|1815173|FG001|Overall Study|Lost to Follow-up|1
856700|NCT00444106|1815174|FG002|Overall Study|Lost to Follow-up|0
856701|NCT00444106|1815172|FG000|Overall Study|Abnormal Test Procedure Results|0
856702|NCT00444106|1815173|FG001|Overall Study|Abnormal Test Procedure Results|0
856703|NCT00444106|1815174|FG002|Overall Study|Abnormal Test Procedure Results|1
856704|NCT00444145|1815185|FG000|Overall Study|Withdrawal by Subject|2
856705|NCT00444145|1815185|FG000|Overall Study|Lost to Follow-up|1
856706|NCT00444145|1815185|FG000|Overall Study|non-compliant|11
856707|NCT00444145|1815185|FG000|Overall Study|Screen Failures|5
856708|NCT00444275|1815192|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0
856709|NCT00444275|1815193|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0
856710|NCT00444275|1815194|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22
856711|NCT00444275|1815195|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17
856712|NCT00444275|1815196|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29
856713|NCT00444275|1815192|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
856714|NCT00444275|1815193|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
856715|NCT00444275|1815194|FG002|Maintenance Treatment Phase|Lost to Follow-up|8
856716|NCT00444275|1815195|FG003|Maintenance Treatment Phase|Lost to Follow-up|14
856717|NCT00444275|1815196|FG004|Maintenance Treatment Phase|Lost to Follow-up|10
856718|NCT00444275|1815192|FG000|Maintenance Treatment Phase|Adverse Event|0
856719|NCT00444275|1815193|FG001|Maintenance Treatment Phase|Adverse Event|0
856720|NCT00444275|1815194|FG002|Maintenance Treatment Phase|Adverse Event|3
856721|NCT00444275|1815195|FG003|Maintenance Treatment Phase|Adverse Event|2
856722|NCT00444275|1815196|FG004|Maintenance Treatment Phase|Adverse Event|13
856723|NCT00444275|1815192|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0
856724|NCT00444275|1815193|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0
856725|NCT00444275|1815194|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1
856726|NCT00444275|1815195|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0
856727|NCT00444275|1815196|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6
856728|NCT00444275|1815192|FG000|Maintenance Treatment Phase|Patient's wish|0
856729|NCT00444275|1815193|FG001|Maintenance Treatment Phase|Patient's wish|0
856730|NCT00444275|1815194|FG002|Maintenance Treatment Phase|Patient's wish|19
856731|NCT00444275|1815195|FG003|Maintenance Treatment Phase|Patient's wish|9
856732|NCT00444275|1815196|FG004|Maintenance Treatment Phase|Patient's wish|20
856733|NCT00444275|1815192|FG000|Maintenance Treatment Phase|Protocol Violation|0
856734|NCT00444275|1815193|FG001|Maintenance Treatment Phase|Protocol Violation|0
856735|NCT00444275|1815194|FG002|Maintenance Treatment Phase|Protocol Violation|103
856736|NCT00444275|1815195|FG003|Maintenance Treatment Phase|Protocol Violation|88
856737|NCT00444275|1815196|FG004|Maintenance Treatment Phase|Protocol Violation|87
856738|NCT00444275|1815192|FG000|Maintenance Treatment Phase|Ineffectiveness|0
856739|NCT00444275|1815193|FG001|Maintenance Treatment Phase|Ineffectiveness|0
856740|NCT00444275|1815194|FG002|Maintenance Treatment Phase|Ineffectiveness|5
856741|NCT00444275|1815195|FG003|Maintenance Treatment Phase|Ineffectiveness|3
856742|NCT00444275|1815196|FG004|Maintenance Treatment Phase|Ineffectiveness|14
856743|NCT00444457|1815215|FG000|Infant Series|Other|0
856744|NCT00444457|1815216|FG001|Infant Series|Other|1
856745|NCT00444457|1815217|FG002|Infant Series|Other|0
856746|NCT00444457|1815218|FG003|Infant Series|Other|0
856747|NCT00444457|1815215|FG000|Infant Series|Parent or legal guardian request|18
856748|NCT00444457|1815216|FG001|Infant Series|Parent or legal guardian request|29
856749|NCT00444457|1815217|FG002|Infant Series|Parent or legal guardian request|34
856750|NCT00444457|1815218|FG003|Infant Series|Parent or legal guardian request|14
856751|NCT00444457|1815215|FG000|Infant Series|Lost to Follow-up|10
856752|NCT00444457|1815216|FG001|Infant Series|Lost to Follow-up|11
856753|NCT00444457|1815217|FG002|Infant Series|Lost to Follow-up|7
856754|NCT00444457|1815218|FG003|Infant Series|Lost to Follow-up|6
856755|NCT00444457|1815215|FG000|Infant Series|Protocol Violation|16
856756|NCT00444457|1815216|FG001|Infant Series|Protocol Violation|8
856757|NCT00444457|1815217|FG002|Infant Series|Protocol Violation|6
856758|NCT00444457|1815218|FG003|Infant Series|Protocol Violation|3
856759|NCT00444457|1815215|FG000|Infant Series|Failed to return|5
856760|NCT00444457|1815216|FG001|Infant Series|Failed to return|4
856761|NCT00444457|1815217|FG002|Infant Series|Failed to return|4
856762|NCT00444457|1815218|FG003|Infant Series|Failed to return|2
856763|NCT00444457|1815215|FG000|Infant Series|Investigator request|4
856764|NCT00444457|1815216|FG001|Infant Series|Investigator request|3
856765|NCT00444457|1815217|FG002|Infant Series|Investigator request|3
856766|NCT00444457|1815218|FG003|Infant Series|Investigator request|2
856767|NCT00444457|1815215|FG000|Infant Series|Other|0
856768|NCT00444457|1815216|FG001|Infant Series|Other|2
856769|NCT00444457|1815217|FG002|Infant Series|Other|4
856770|NCT00444457|1815218|FG003|Infant Series|Other|0
856771|NCT00444457|1815215|FG000|Infant Series|Adverse Event|1
856772|NCT00444457|1815216|FG001|Infant Series|Adverse Event|2
856773|NCT00444457|1815217|FG002|Infant Series|Adverse Event|2
856774|NCT00444457|1815218|FG003|Infant Series|Adverse Event|0
856775|NCT00444457|1815215|FG000|Infant Series|Death|0
856776|NCT00444457|1815216|FG001|Infant Series|Death|1
856777|NCT00444457|1815217|FG002|Infant Series|Death|1
856778|NCT00444457|1815218|FG003|Infant Series|Death|1
856779|NCT00444457|1815215|FG000|After Infant Series|Other|0
856780|NCT00444457|1815216|FG001|After Infant Series|Other|1
856781|NCT00444457|1815217|FG002|After Infant Series|Other|1
856782|NCT00444457|1815218|FG003|After Infant Series|Other|1
856783|NCT00444457|1815215|FG000|After Infant Series|Parent or legal guardian request|4
856784|NCT00444457|1815216|FG001|After Infant Series|Parent or legal guardian request|11
856785|NCT00444457|1815217|FG002|After Infant Series|Parent or legal guardian request|6
856786|NCT00444457|1815218|FG003|After Infant Series|Parent or legal guardian request|3
856787|NCT00444457|1815215|FG000|After Infant Series|Failed to return|7
856788|NCT00444457|1815216|FG001|After Infant Series|Failed to return|6
856789|NCT00444457|1815217|FG002|After Infant Series|Failed to return|5
856790|NCT00444457|1815218|FG003|After Infant Series|Failed to return|1
856791|NCT00444457|1815215|FG000|After Infant Series|Lost to Follow-up|5
856792|NCT00444457|1815216|FG001|After Infant Series|Lost to Follow-up|5
856793|NCT00444457|1815217|FG002|After Infant Series|Lost to Follow-up|5
856794|NCT00444457|1815218|FG003|After Infant Series|Lost to Follow-up|2
856795|NCT00444457|1815215|FG000|After Infant Series|Protocol Violation|2
856796|NCT00444457|1815216|FG001|After Infant Series|Protocol Violation|4
856797|NCT00444457|1815217|FG002|After Infant Series|Protocol Violation|2
856798|NCT00444457|1815218|FG003|After Infant Series|Protocol Violation|2
856799|NCT00444457|1815215|FG000|After Infant Series|Adverse Event|2
856800|NCT00444457|1815216|FG001|After Infant Series|Adverse Event|2
856801|NCT00444457|1815217|FG002|After Infant Series|Adverse Event|0
856802|NCT00444457|1815218|FG003|After Infant Series|Adverse Event|0
856803|NCT00444457|1815215|FG000|After Infant Series|Investigator request|0
856804|NCT00444457|1815216|FG001|After Infant Series|Investigator request|0
856805|NCT00444457|1815217|FG002|After Infant Series|Investigator request|0
856806|NCT00444457|1815218|FG003|After Infant Series|Investigator request|1
856807|NCT00444457|1815215|FG000|After Infant Series|Other|0
856808|NCT00444457|1815216|FG001|After Infant Series|Other|1
856809|NCT00444457|1815217|FG002|After Infant Series|Other|0
856810|NCT00444457|1815218|FG003|After Infant Series|Other|0
856811|NCT00444457|1815215|FG000|Toddler Dose|Lost to Follow-up|4
856812|NCT00444457|1815216|FG001|Toddler Dose|Lost to Follow-up|1
856813|NCT00444457|1815217|FG002|Toddler Dose|Lost to Follow-up|1
856814|NCT00444457|1815218|FG003|Toddler Dose|Lost to Follow-up|3
856815|NCT00444457|1815215|FG000|Toddler Dose|Failed to return|2
856816|NCT00444457|1815216|FG001|Toddler Dose|Failed to return|2
856817|NCT00444457|1815217|FG002|Toddler Dose|Failed to return|1
856818|NCT00444457|1815218|FG003|Toddler Dose|Failed to return|3
856819|NCT00444457|1815215|FG000|Toddler Dose|Parent or legal guardian request|0
856820|NCT00444457|1815216|FG001|Toddler Dose|Parent or legal guardian request|3
856821|NCT00444457|1815217|FG002|Toddler Dose|Parent or legal guardian request|2
856822|NCT00444457|1815218|FG003|Toddler Dose|Parent or legal guardian request|1
856823|NCT00444457|1815215|FG000|Toddler Dose|Protocol Violation|1
856824|NCT00444457|1815216|FG001|Toddler Dose|Protocol Violation|0
856825|NCT00444457|1815217|FG002|Toddler Dose|Protocol Violation|0
856826|NCT00444457|1815218|FG003|Toddler Dose|Protocol Violation|1
856827|NCT00444535|1815239|FG000|Overall Study|Withdrawal by Subject|5
856828|NCT00444535|1815239|FG000|Overall Study|Physician Decision|5
856829|NCT00444535|1815239|FG000|Overall Study|progressive disease|1
856830|NCT00444535|1815239|FG000|Overall Study|Adverse Event|2
856831|NCT00444587|1815245|FG000|Overall Study|Death|2
856832|NCT00444587|1815246|FG001|Overall Study|Death|1
856833|NCT00444587|1815245|FG000|Overall Study|Progression of the disease|73
856834|NCT00444587|1815246|FG001|Overall Study|Progression of the disease|8
856835|NCT00444587|1815245|FG000|Overall Study|Refused treatment/did not cooperate|4
856836|NCT00444587|1815246|FG001|Overall Study|Refused treatment/did not cooperate|1
856837|NCT00444587|1815245|FG000|Overall Study|Investigator decision|3
856838|NCT00444587|1815246|FG001|Overall Study|Investigator decision|0
856839|NCT00444587|1815245|FG000|Overall Study|Protocol Violation|1
856840|NCT00444587|1815246|FG001|Overall Study|Protocol Violation|0
856841|NCT00444587|1815245|FG000|Overall Study|Missing|0
856842|NCT00444587|1815246|FG001|Overall Study|Missing|5
856843|NCT00444600|1815258|FG000|Overall Study|Death|7
856844|NCT00444600|1815259|FG001|Overall Study|Death|5
856845|NCT00444600|1815260|FG002|Overall Study|Death|3
856846|NCT00444600|1815261|FG003|Overall Study|Death|2
856847|NCT00444600|1815258|FG000|Overall Study|Dropped|11
856848|NCT00444600|1815259|FG001|Overall Study|Dropped|11
856849|NCT00444600|1815260|FG002|Overall Study|Dropped|7
856850|NCT00444600|1815261|FG003|Overall Study|Dropped|7
856851|NCT00444600|1815258|FG000|Overall Study|Missed visit|1
856852|NCT00444600|1815259|FG001|Overall Study|Missed visit|0
856853|NCT00444600|1815260|FG002|Overall Study|Missed visit|0
856854|NCT00444600|1815261|FG003|Overall Study|Missed visit|1
856855|NCT00444626|1815277|FG000|Initial Treatment Period|Withdrawal by Subject|2
856856|NCT00444626|1815277|FG000|Initial Treatment Period|Adverse Event|1
856857|NCT00444626|1815277|FG000|Initial Treatment Period|Lost to Follow-up|9
856858|NCT00444678|1815290|FG000|Overall Study|Toxicity|11
856859|NCT00444678|1815290|FG000|Overall Study|Disease Progression|12
856860|NCT00444678|1815290|FG000|Overall Study|Death|3
856861|NCT00444678|1815290|FG000|Overall Study|Physician Decision|3
856862|NCT00444678|1815290|FG000|Overall Study|Withdrawal by Subject|2
856863|NCT00444795|1815294|FG000|Overall Study|Not Treated|1
856864|NCT00444795|1815294|FG000|Overall Study|Treated Prior to the Contract Date|2
856865|NCT00444912|1815309|FG000|Overall Study|Death|1
856866|NCT00444912|1815310|FG001|Overall Study|Death|2
856867|NCT00444912|1815309|FG000|Overall Study|Lost to Follow-up|1
856868|NCT00444912|1815310|FG001|Overall Study|Lost to Follow-up|0
856869|NCT00444912|1815309|FG000|Overall Study|Participant Failed Mobilization|1
856870|NCT00444912|1815310|FG001|Overall Study|Participant Failed Mobilization|0
856871|NCT00444925|1815319|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3
856872|NCT00444925|1815320|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6
856873|NCT00444925|1815321|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6
856874|NCT00444925|1815319|FG000|Double-blind Treatment Period|Death|2
856875|NCT00444925|1815320|FG001|Double-blind Treatment Period|Death|0
856876|NCT00444925|1815321|FG002|Double-blind Treatment Period|Death|0
856877|NCT00444925|1815319|FG000|Double-blind Treatment Period|Adverse Event|6
856878|NCT00444925|1815320|FG001|Double-blind Treatment Period|Adverse Event|28
856879|NCT00444925|1815321|FG002|Double-blind Treatment Period|Adverse Event|44
856880|NCT00444925|1815319|FG000|Double-blind Treatment Period|Lack of Efficacy|5
856881|NCT00444925|1815320|FG001|Double-blind Treatment Period|Lack of Efficacy|5
856882|NCT00444925|1815321|FG002|Double-blind Treatment Period|Lack of Efficacy|13
856883|NCT00444925|1815319|FG000|Double-blind Treatment Period|Lost to Follow-up|4
856884|NCT00444925|1815320|FG001|Double-blind Treatment Period|Lost to Follow-up|8
856885|NCT00444925|1815321|FG002|Double-blind Treatment Period|Lost to Follow-up|5
856886|NCT00444925|1815319|FG000|Double-blind Treatment Period|Withdrawal by Subject|6
856887|NCT00444925|1815320|FG001|Double-blind Treatment Period|Withdrawal by Subject|8
856888|NCT00444925|1815321|FG002|Double-blind Treatment Period|Withdrawal by Subject|7
856889|NCT00444925|1815319|FG000|Double-blind Treatment Period|Other|7
856890|NCT00444925|1815320|FG001|Double-blind Treatment Period|Other|7
856891|NCT00444925|1815321|FG002|Double-blind Treatment Period|Other|12
856892|NCT00444951|1815332|FG000|Overall Study|Lost to Follow-up|1
856893|NCT00444951|1815333|FG001|Overall Study|Lost to Follow-up|1
856894|NCT00444951|1815334|FG002|Overall Study|Lost to Follow-up|0
856895|NCT00444951|1815332|FG000|Overall Study|Withdrawal by Subject|4
856896|NCT00444951|1815333|FG001|Overall Study|Withdrawal by Subject|5
856897|NCT00444951|1815334|FG002|Overall Study|Withdrawal by Subject|3
856898|NCT00445003|1815349|FG000|Overall Study|Death|1
856899|NCT00445003|1815350|FG001|Overall Study|Death|2
856900|NCT00445003|1815351|FG002|Overall Study|Death|1
856901|NCT00445003|1815349|FG000|Overall Study|Missed Visit|3
856902|NCT00445003|1815350|FG001|Overall Study|Missed Visit|5
856903|NCT00445003|1815351|FG002|Overall Study|Missed Visit|1
856904|NCT00445003|1815349|FG000|Overall Study|Dropped|1
856905|NCT00445003|1815350|FG001|Overall Study|Dropped|3
856906|NCT00445003|1815351|FG002|Overall Study|Dropped|2
856907|NCT00445068|1815359|FG000|Overall Study|Disease progression|26
856908|NCT00445068|1815359|FG000|Overall Study|Adverse Event|5
856909|NCT00445068|1815359|FG000|Overall Study|Abnormal laboratory value|2
856910|NCT00445068|1815359|FG000|Overall Study|Withdrawal by Subject|2
856911|NCT00445068|1815359|FG000|Overall Study|Death|1
856912|NCT00445146|1815363|FG000|Overall Study|Withdrew Consent|29
856913|NCT00445146|1815363|FG000|Overall Study|Lack of Efficacy|28
856914|NCT00445146|1815363|FG000|Overall Study|Investigator's Discretion|22
856915|NCT00445146|1815363|FG000|Overall Study|Adverse Event|13
856916|NCT00445146|1815363|FG000|Overall Study|Lost to Follow-up|13
856917|NCT00445146|1815363|FG000|Overall Study|Death|9
856918|NCT00445146|1815363|FG000|Overall Study|Protocol Violation|4
856919|NCT00445146|1815363|FG000|Overall Study|Pregnancy|1
856920|NCT00445224|1815378|FG000|Specific Exercises|Withdrawal by Subject|3
856921|NCT00445224|1815379|FG001|Specific Exercises|Withdrawal by Subject|3
856922|NCT00445224|1815378|FG000|Specific Exercises|Withdrawal by Subject|1
856923|NCT00445224|1815379|FG001|Specific Exercises|Withdrawal by Subject|0
856924|NCT00445328|1815435|FG000|Overall Study|Death|0
856925|NCT00445328|1815436|FG001|Overall Study|Death|1
856926|NCT00445328|1815435|FG000|Overall Study|Adverse Event|0
856927|NCT00445328|1815436|FG001|Overall Study|Adverse Event|3
856928|NCT00445328|1815435|FG000|Overall Study|Other|0
856929|NCT00445328|1815436|FG001|Overall Study|Other|2
856930|NCT00445328|1815435|FG000|Overall Study|Withdrawal by Subject|2
856931|NCT00445328|1815436|FG001|Overall Study|Withdrawal by Subject|0
856932|NCT00445328|1815435|FG000|Overall Study|Protocol Violation|1
856933|NCT00445328|1815436|FG001|Overall Study|Protocol Violation|0
856934|NCT00445341|1815442|FG000|Overall Study|refused further treatment|1
856935|NCT00445341|1815442|FG000|Overall Study|taken off treatment too early|1
856936|NCT00445432|1815449|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
856937|NCT00445432|1815450|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
856938|NCT00445432|1815451|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
856939|NCT00445432|1815452|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
856940|NCT00445432|1815449|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
856941|NCT00445432|1815450|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
856942|NCT00445432|1815451|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
856943|NCT00445432|1815452|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
856944|NCT00445432|1815449|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
856945|NCT00445432|1815450|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
856946|NCT00445432|1815451|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
856947|NCT00445432|1815452|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
856948|NCT00445432|1815449|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0
856949|NCT00445432|1815450|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1
856950|NCT00445432|1815451|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2
856951|NCT00445432|1815452|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0
856952|NCT00445432|1815449|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0
856953|NCT00445432|1815450|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0
856954|NCT00445432|1815451|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0
856955|NCT00445432|1815452|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32
856956|NCT00445432|1815449|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
856957|NCT00445432|1815450|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
856958|NCT00445432|1815451|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
856959|NCT00445432|1815452|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
856960|NCT00445432|1815449|FG000|148 Weeks of Adalimumab Treatment|Other|0
856961|NCT00445432|1815450|FG001|148 Weeks of Adalimumab Treatment|Other|0
856962|NCT00445432|1815451|FG002|148 Weeks of Adalimumab Treatment|Other|0
856963|NCT00445432|1815452|FG003|148 Weeks of Adalimumab Treatment|Other|9
856964|NCT00445458|1815467|FG000|Overall Study|Disease Progression|3
856965|NCT00445458|1815468|FG001|Overall Study|Disease Progression|4
856966|NCT00445458|1815469|FG002|Overall Study|Disease Progression|54
856967|NCT00445458|1815470|FG003|Overall Study|Disease Progression|27
856968|NCT00445458|1815467|FG000|Overall Study|Withdrawal by Subject|0
856969|NCT00445458|1815468|FG001|Overall Study|Withdrawal by Subject|0
856970|NCT00445458|1815469|FG002|Overall Study|Withdrawal by Subject|7
856971|NCT00445458|1815470|FG003|Overall Study|Withdrawal by Subject|0
856972|NCT00445458|1815467|FG000|Overall Study|Adverse Event|0
856973|NCT00445458|1815468|FG001|Overall Study|Adverse Event|0
856974|NCT00445458|1815469|FG002|Overall Study|Adverse Event|3
856975|NCT00445458|1815470|FG003|Overall Study|Adverse Event|0
856976|NCT00445458|1815467|FG000|Overall Study|Death|0
856977|NCT00445458|1815468|FG001|Overall Study|Death|1
856978|NCT00445458|1815469|FG002|Overall Study|Death|2
856979|NCT00445458|1815470|FG003|Overall Study|Death|0
856980|NCT00445458|1815467|FG000|Overall Study|Physician Decision|0
856981|NCT00445458|1815468|FG001|Overall Study|Physician Decision|0
856982|NCT00445458|1815469|FG002|Overall Study|Physician Decision|1
856983|NCT00445458|1815470|FG003|Overall Study|Physician Decision|1
856984|NCT00445458|1815467|FG000|Overall Study|Surgery|0
856985|NCT00445458|1815468|FG001|Overall Study|Surgery|0
856986|NCT00445458|1815469|FG002|Overall Study|Surgery|1
856987|NCT00445458|1815470|FG003|Overall Study|Surgery|0
856988|NCT00445549|1815492|FG000|Overall Study|progressive disease|12
856989|NCT00445601|1815503|FG000|Overall Study|Withdrawal by Subject|11
856990|NCT00445601|1815504|FG001|Overall Study|Withdrawal by Subject|11
856991|NCT00445601|1815503|FG000|Overall Study|TURBT Complication|12
856992|NCT00445601|1815504|FG001|Overall Study|TURBT Complication|8
856993|NCT00445601|1815503|FG000|Overall Study|Incorrect Disease Status|6
856994|NCT00445601|1815504|FG001|Overall Study|Incorrect Disease Status|6
856995|NCT00445601|1815503|FG000|Overall Study|Drug Delivery Issue|2
856996|NCT00445601|1815504|FG001|Overall Study|Drug Delivery Issue|2
856997|NCT00445601|1815503|FG000|Overall Study|Adverse Event|2
856998|NCT00445601|1815504|FG001|Overall Study|Adverse Event|0
856999|NCT00445601|1815503|FG000|Overall Study|Death prior to TURBT|0
857000|NCT00445601|1815504|FG001|Overall Study|Death prior to TURBT|1
857001|NCT00445679|1815518|FG000|Overall Study|Adverse Event|22
857002|NCT00445679|1815519|FG001|Overall Study|Adverse Event|12
857003|NCT00445679|1815520|FG002|Overall Study|Adverse Event|30
857004|NCT00445679|1815521|FG003|Overall Study|Adverse Event|19
857005|NCT00445679|1815518|FG000|Overall Study|Failed to return|1
857006|NCT00445679|1815519|FG001|Overall Study|Failed to return|3
857007|NCT00445679|1815520|FG002|Overall Study|Failed to return|2
857008|NCT00445679|1815521|FG003|Overall Study|Failed to return|2
857009|NCT00445679|1815518|FG000|Overall Study|Physician Decision|0
857010|NCT00445679|1815519|FG001|Overall Study|Physician Decision|0
857011|NCT00445679|1815520|FG002|Overall Study|Physician Decision|1
857012|NCT00445679|1815521|FG003|Overall Study|Physician Decision|0
857013|NCT00445679|1815518|FG000|Overall Study|Lost to Follow-up|10
857014|NCT00445679|1815519|FG001|Overall Study|Lost to Follow-up|6
857015|NCT00445679|1815520|FG002|Overall Study|Lost to Follow-up|6
857016|NCT00445679|1815521|FG003|Overall Study|Lost to Follow-up|5
857017|NCT00445679|1815518|FG000|Overall Study|Compliance|3
857018|NCT00445679|1815519|FG001|Overall Study|Compliance|2
857019|NCT00445679|1815520|FG002|Overall Study|Compliance|1
857020|NCT00445679|1815521|FG003|Overall Study|Compliance|2
857021|NCT00445679|1815518|FG000|Overall Study|Withdrawal of Informed Consent|0
857022|NCT00445679|1815519|FG001|Overall Study|Withdrawal of Informed Consent|0
857023|NCT00445679|1815520|FG002|Overall Study|Withdrawal of Informed Consent|1
857024|NCT00445679|1815521|FG003|Overall Study|Withdrawal of Informed Consent|0
857025|NCT00445679|1815518|FG000|Overall Study|Protocol Violation|2
857026|NCT00445679|1815519|FG001|Overall Study|Protocol Violation|3
857027|NCT00445679|1815520|FG002|Overall Study|Protocol Violation|3
857028|NCT00445679|1815521|FG003|Overall Study|Protocol Violation|1
857029|NCT00445679|1815518|FG000|Overall Study|Withdrawal by Subject|8
857030|NCT00445679|1815519|FG001|Overall Study|Withdrawal by Subject|14
857031|NCT00445679|1815520|FG002|Overall Study|Withdrawal by Subject|20
857032|NCT00445679|1815521|FG003|Overall Study|Withdrawal by Subject|18
857033|NCT00445679|1815518|FG000|Overall Study|Lack of Efficacy|2
857034|NCT00445679|1815519|FG001|Overall Study|Lack of Efficacy|6
857035|NCT00445679|1815520|FG002|Overall Study|Lack of Efficacy|2
857036|NCT00445679|1815521|FG003|Overall Study|Lack of Efficacy|0
857037|NCT00445692|1815531|FG000|Overall Study|Adverse Event|11
857038|NCT00445692|1815531|FG000|Overall Study|Lack of Efficacy|5
857039|NCT00445770|1815561|FG000|Overall Study|Adverse Event|9
857040|NCT00445770|1815562|FG001|Overall Study|Adverse Event|15
857041|NCT00445770|1815563|FG002|Overall Study|Adverse Event|19
857042|NCT00445770|1815561|FG000|Overall Study|Lack of Efficacy|38
857043|NCT00445770|1815562|FG001|Overall Study|Lack of Efficacy|13
857044|NCT00445770|1815563|FG002|Overall Study|Lack of Efficacy|6
857045|NCT00445770|1815561|FG000|Overall Study|Lost to Follow-up|0
857046|NCT00445770|1815562|FG001|Overall Study|Lost to Follow-up|2
857047|NCT00445770|1815563|FG002|Overall Study|Lost to Follow-up|0
857048|NCT00445770|1815561|FG000|Overall Study|Other|6
857049|NCT00445770|1815562|FG001|Overall Study|Other|5
857050|NCT00445770|1815563|FG002|Overall Study|Other|6
857051|NCT00445848|1815573|FG000|Overall Study|Adverse Event|14
857052|NCT00445848|1815573|FG000|Overall Study|Withdrawal by Subject|4
857053|NCT00445848|1815573|FG000|Overall Study|Progression|62
857054|NCT00445848|1815573|FG000|Overall Study|Other-Not protocol specified|5
857055|NCT00445939|1815599|FG000|Period A - Week 0 - Week 4|Adverse Event|1
857056|NCT00445939|1815600|FG001|Period A - Week 0 - Week 4|Adverse Event|2
857057|NCT00445939|1815601|FG002|Period A - Week 0 - Week 4|Adverse Event|0
857058|NCT00445939|1815602|FG003|Period A - Week 0 - Week 4|Adverse Event|0
857059|NCT00445939|1815599|FG000|Period B - Week 4 - Week 8|Adverse Event|2
857060|NCT00445939|1815600|FG001|Period B - Week 4 - Week 8|Adverse Event|0
857061|NCT00445939|1815601|FG002|Period B - Week 4 - Week 8|Adverse Event|0
857062|NCT00445939|1815602|FG003|Period B - Week 4 - Week 8|Adverse Event|1
857063|NCT00445978|1815622|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1
857064|NCT00445978|1815622|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1
857065|NCT00445978|1815622|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1
857066|NCT00445978|1815622|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1
857067|NCT00445978|1815622|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1
857068|NCT00445978|1815622|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1
857069|NCT00445978|1815622|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1
857070|NCT00445978|1815622|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1
857071|NCT00445978|1815622|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1
857072|NCT00446030|1815635|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29
857073|NCT00446030|1815636|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8
857074|NCT00446030|1815635|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9
857075|NCT00446030|1815636|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1
857076|NCT00446030|1815635|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1
857077|NCT00446030|1815636|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0
857078|NCT00446030|1815635|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
857079|NCT00446030|1815636|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
857080|NCT00446030|1815635|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1
857081|NCT00446030|1815636|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0
857082|NCT00446030|1815635|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1
857083|NCT00446030|1815636|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0
857084|NCT00446030|1815635|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1
857085|NCT00446030|1815636|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0
857086|NCT00446030|1815635|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
857087|NCT00446030|1815636|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
857088|NCT00446030|1815635|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9
857089|NCT00446030|1815636|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4
857090|NCT00446030|1815635|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
857091|NCT00446030|1815636|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
857092|NCT00446030|1815635|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
857093|NCT00446030|1815636|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
857094|NCT00446030|1815635|FG000|FOLLOW-UP (up to 2-years)|Death|2
857095|NCT00446030|1815636|FG001|FOLLOW-UP (up to 2-years)|Death|2
857096|NCT00446030|1815635|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
857097|NCT00446030|1815636|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
857098|NCT00446030|1815635|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
857099|NCT00446030|1815636|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
857100|NCT00446030|1815635|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2
857101|NCT00446030|1815636|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0
857102|NCT00446030|1815635|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1
857103|NCT00446030|1815636|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0
857104|NCT00446030|1815635|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1
857105|NCT00446030|1815636|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0
857106|NCT00446030|1815635|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1
857107|NCT00446030|1815636|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0
857108|NCT00446030|1815635|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
857109|NCT00446030|1815636|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
857110|NCT00446095|1815647|FG000|Phase II (8 Weeks)|Lost to Follow-up|1
857111|NCT00446095|1815648|FG001|Phase II (8 Weeks)|Lost to Follow-up|0
857112|NCT00446095|1815649|FG002|Phase II (8 Weeks)|Lost to Follow-up|0
857113|NCT00446095|1815650|FG003|Phase II (8 Weeks)|Lost to Follow-up|0
857114|NCT00446095|1815651|FG004|Phase II (8 Weeks)|Lost to Follow-up|0
857115|NCT00446095|1815647|FG000|Phase II (8 Weeks)|Adverse Event|0
857116|NCT00446095|1815648|FG001|Phase II (8 Weeks)|Adverse Event|1
857117|NCT00446095|1815649|FG002|Phase II (8 Weeks)|Adverse Event|1
857118|NCT00446095|1815650|FG003|Phase II (8 Weeks)|Adverse Event|0
857119|NCT00446095|1815651|FG004|Phase II (8 Weeks)|Adverse Event|0
857120|NCT00446095|1815647|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1
857121|NCT00446095|1815648|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0
857122|NCT00446095|1815649|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0
857123|NCT00446095|1815650|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0
857124|NCT00446095|1815651|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0
857125|NCT00446095|1815647|FG000|Phase II (8 Weeks)|Physician Decision|1
857126|NCT00446095|1815648|FG001|Phase II (8 Weeks)|Physician Decision|0
857127|NCT00446095|1815649|FG002|Phase II (8 Weeks)|Physician Decision|0
857128|NCT00446095|1815650|FG003|Phase II (8 Weeks)|Physician Decision|0
857129|NCT00446095|1815651|FG004|Phase II (8 Weeks)|Physician Decision|0
857130|NCT00446095|1815647|FG000|Phase II (8 Weeks)|Lack of Efficacy|9
857131|NCT00446095|1815648|FG001|Phase II (8 Weeks)|Lack of Efficacy|2
857132|NCT00446095|1815649|FG002|Phase II (8 Weeks)|Lack of Efficacy|1
857133|NCT00446095|1815650|FG003|Phase II (8 Weeks)|Lack of Efficacy|0
857134|NCT00446095|1815651|FG004|Phase II (8 Weeks)|Lack of Efficacy|0
857135|NCT00446095|1815647|FG000|Phase II (8 Weeks)|Ongoing|0
857136|NCT00446095|1815648|FG001|Phase II (8 Weeks)|Ongoing|0
857137|NCT00446095|1815649|FG002|Phase II (8 Weeks)|Ongoing|1
857138|NCT00446095|1815650|FG003|Phase II (8 Weeks)|Ongoing|0
857139|NCT00446095|1815651|FG004|Phase II (8 Weeks)|Ongoing|0
857140|NCT00446095|1815647|FG000|Phase I (28 Days)|Adverse Event|0
857141|NCT00446095|1815648|FG001|Phase I (28 Days)|Adverse Event|0
857142|NCT00446095|1815649|FG002|Phase I (28 Days)|Adverse Event|0
857143|NCT00446095|1815650|FG003|Phase I (28 Days)|Adverse Event|1
857144|NCT00446095|1815651|FG004|Phase I (28 Days)|Adverse Event|0
857145|NCT00446095|1815647|FG000|Phase I (28 Days)|Lack of Efficacy|0
857146|NCT00446095|1815648|FG001|Phase I (28 Days)|Lack of Efficacy|0
857147|NCT00446095|1815649|FG002|Phase I (28 Days)|Lack of Efficacy|0
857148|NCT00446095|1815650|FG003|Phase I (28 Days)|Lack of Efficacy|0
857149|NCT00446095|1815651|FG004|Phase I (28 Days)|Lack of Efficacy|3
857150|NCT00446134|1815666|FG000|Overall Study|Adverse Event|7
857151|NCT00446134|1815667|FG001|Overall Study|Adverse Event|17
857152|NCT00446134|1815668|FG002|Overall Study|Adverse Event|13
857153|NCT00446134|1815669|FG003|Overall Study|Adverse Event|18
857154|NCT00446134|1815666|FG000|Overall Study|Lack of Efficacy|19
857155|NCT00446134|1815667|FG001|Overall Study|Lack of Efficacy|19
857156|NCT00446134|1815668|FG002|Overall Study|Lack of Efficacy|24
857157|NCT00446134|1815669|FG003|Overall Study|Lack of Efficacy|19
857158|NCT00446134|1815666|FG000|Overall Study|Protocol Violation|0
857159|NCT00446134|1815667|FG001|Overall Study|Protocol Violation|2
857160|NCT00446134|1815668|FG002|Overall Study|Protocol Violation|1
857161|NCT00446134|1815669|FG003|Overall Study|Protocol Violation|0
857162|NCT00446134|1815666|FG000|Overall Study|Lost to Follow-up|1
857163|NCT00446134|1815667|FG001|Overall Study|Lost to Follow-up|3
857164|NCT00446134|1815668|FG002|Overall Study|Lost to Follow-up|1
857165|NCT00446134|1815669|FG003|Overall Study|Lost to Follow-up|1
857166|NCT00446134|1815666|FG000|Overall Study|Withdrawal by Subject|3
857167|NCT00446134|1815667|FG001|Overall Study|Withdrawal by Subject|3
857168|NCT00446134|1815668|FG002|Overall Study|Withdrawal by Subject|1
857169|NCT00446134|1815669|FG003|Overall Study|Withdrawal by Subject|3
857170|NCT00446134|1815666|FG000|Overall Study|Physician Decision|0
857171|NCT00446134|1815667|FG001|Overall Study|Physician Decision|0
857172|NCT00446134|1815668|FG002|Overall Study|Physician Decision|0
857173|NCT00446134|1815669|FG003|Overall Study|Physician Decision|2
857174|NCT00446134|1815666|FG000|Overall Study|Adverse Event-Diarrhea|1
857175|NCT00446134|1815667|FG001|Overall Study|Adverse Event-Diarrhea|1
857176|NCT00446134|1815668|FG002|Overall Study|Adverse Event-Diarrhea|2
857177|NCT00446134|1815669|FG003|Overall Study|Adverse Event-Diarrhea|0
857178|NCT00446134|1815666|FG000|Overall Study|Reason Not Completed|3
857179|NCT00446134|1815667|FG001|Overall Study|Reason Not Completed|0
857180|NCT00446134|1815668|FG002|Overall Study|Reason Not Completed|1
857181|NCT00446134|1815669|FG003|Overall Study|Reason Not Completed|2
857182|NCT00446199|1815692|FG000|Overall Study|Adverse Event|7
857183|NCT00446199|1815693|FG001|Overall Study|Adverse Event|4
857184|NCT00446199|1815694|FG002|Overall Study|Adverse Event|6
857185|NCT00446199|1815695|FG003|Overall Study|Adverse Event|4
857186|NCT00446199|1815692|FG000|Overall Study|Lost to Follow-up|4
857187|NCT00446199|1815693|FG001|Overall Study|Lost to Follow-up|5
857188|NCT00446199|1815694|FG002|Overall Study|Lost to Follow-up|2
857189|NCT00446199|1815695|FG003|Overall Study|Lost to Follow-up|6
857190|NCT00446199|1815692|FG000|Overall Study|Protocol Violation|1
857191|NCT00446199|1815693|FG001|Overall Study|Protocol Violation|2
857192|NCT00446199|1815694|FG002|Overall Study|Protocol Violation|1
857193|NCT00446199|1815695|FG003|Overall Study|Protocol Violation|3
857194|NCT00446199|1815692|FG000|Overall Study|Withdrawal by Subject|2
857195|NCT00446199|1815693|FG001|Overall Study|Withdrawal by Subject|5
857196|NCT00446199|1815694|FG002|Overall Study|Withdrawal by Subject|9
857197|NCT00446199|1815695|FG003|Overall Study|Withdrawal by Subject|10
857198|NCT00446199|1815692|FG000|Overall Study|Site termination|2
857199|NCT00446199|1815693|FG001|Overall Study|Site termination|0
857200|NCT00446199|1815694|FG002|Overall Study|Site termination|0
857201|NCT00446199|1815695|FG003|Overall Study|Site termination|1
857202|NCT00446199|1815692|FG000|Overall Study|Randomization in Error|2
857203|NCT00446199|1815693|FG001|Overall Study|Randomization in Error|0
857204|NCT00446199|1815694|FG002|Overall Study|Randomization in Error|1
857205|NCT00446199|1815695|FG003|Overall Study|Randomization in Error|1
857206|NCT00446199|1815692|FG000|Overall Study|Lack of Efficacy|1
857207|NCT00446199|1815693|FG001|Overall Study|Lack of Efficacy|0
857208|NCT00446199|1815694|FG002|Overall Study|Lack of Efficacy|0
857209|NCT00446199|1815695|FG003|Overall Study|Lack of Efficacy|1
857210|NCT00446199|1815692|FG000|Overall Study|Non-compliant with study drug|1
857211|NCT00446199|1815693|FG001|Overall Study|Non-compliant with study drug|0
857212|NCT00446199|1815694|FG002|Overall Study|Non-compliant with study drug|5
857213|NCT00446199|1815695|FG003|Overall Study|Non-compliant with study drug|0
857214|NCT00446199|1815692|FG000|Overall Study|Non-compliant with visit schedule|1
857215|NCT00446199|1815693|FG001|Overall Study|Non-compliant with visit schedule|1
857216|NCT00446199|1815694|FG002|Overall Study|Non-compliant with visit schedule|1
857217|NCT00446199|1815695|FG003|Overall Study|Non-compliant with visit schedule|2
857218|NCT00446199|1815692|FG000|Overall Study|Hormone fear|0
857219|NCT00446199|1815693|FG001|Overall Study|Hormone fear|0
857220|NCT00446199|1815694|FG002|Overall Study|Hormone fear|0
857221|NCT00446199|1815695|FG003|Overall Study|Hormone fear|1
857222|NCT00446199|1815692|FG000|Overall Study|Lost interest in study participation|0
857223|NCT00446199|1815693|FG001|Overall Study|Lost interest in study participation|1
857224|NCT00446199|1815694|FG002|Overall Study|Lost interest in study participation|0
857225|NCT00446199|1815695|FG003|Overall Study|Lost interest in study participation|0
857226|NCT00446199|1815692|FG000|Overall Study|In-/Exclusion criterion violated|2
857227|NCT00446199|1815693|FG001|Overall Study|In-/Exclusion criterion violated|1
857228|NCT00446199|1815694|FG002|Overall Study|In-/Exclusion criterion violated|2
857229|NCT00446199|1815695|FG003|Overall Study|In-/Exclusion criterion violated|1
857230|NCT00446199|1815692|FG000|Overall Study|Move|0
857231|NCT00446199|1815693|FG001|Overall Study|Move|1
857232|NCT00446199|1815694|FG002|Overall Study|Move|0
857233|NCT00446199|1815695|FG003|Overall Study|Move|0
857234|NCT00446251|1815705|FG000|Overall Study|On-study Transplants|2
857235|NCT00446251|1815705|FG000|Overall Study|Rituximab Infusion Reaction|2
857236|NCT00446251|1815705|FG000|Overall Study|Lost to Follow-up|1
857237|NCT00446446|1815717|FG000|Overall Study|Death|10
857238|NCT00446446|1815717|FG000|Overall Study|Withdrawal by Subject|6
857239|NCT00446446|1815717|FG000|Overall Study|Other|4
857240|NCT00446446|1815717|FG000|Overall Study|Disease Progession|2
857241|NCT00446446|1815717|FG000|Overall Study|Adverse Event|1
857242|NCT00446446|1815717|FG000|Overall Study|On Treatment at Time of Data Cut-off|1
857243|NCT00446459|1815721|FG000|8 Months|Protocol Violation|12
857244|NCT00446459|1815721|FG000|12 Months|Protocol Violation|4
857245|NCT00446459|1815721|FG000|12 Months|14 subjects to MMF + Rituximab Study|14
857246|NCT00446511|1815729|FG000|Overall Study|Adverse Event|7
857247|NCT00446511|1815730|FG001|Overall Study|Adverse Event|2
857248|NCT00446511|1815731|FG002|Overall Study|Adverse Event|3
857249|NCT00446511|1815732|FG003|Overall Study|Adverse Event|1
857250|NCT00446511|1815729|FG000|Overall Study|Protocol Violation|0
857251|NCT00446511|1815730|FG001|Overall Study|Protocol Violation|0
857252|NCT00446511|1815731|FG002|Overall Study|Protocol Violation|0
857253|NCT00446511|1815732|FG003|Overall Study|Protocol Violation|1
857254|NCT00446511|1815729|FG000|Overall Study|Withdrawal by Subject|0
857255|NCT00446511|1815730|FG001|Overall Study|Withdrawal by Subject|0
857256|NCT00446511|1815731|FG002|Overall Study|Withdrawal by Subject|0
857257|NCT00446511|1815732|FG003|Overall Study|Withdrawal by Subject|3
857258|NCT00446511|1815729|FG000|Overall Study|Administrative Problems|3
857259|NCT00446511|1815730|FG001|Overall Study|Administrative Problems|0
857260|NCT00446511|1815731|FG002|Overall Study|Administrative Problems|4
857261|NCT00446511|1815732|FG003|Overall Study|Administrative Problems|1
857262|NCT00446550|1815746|FG000|Overall Study|Adverse Event|1
857263|NCT00446550|1815747|FG001|Overall Study|Adverse Event|0
857264|NCT00446563|1815756|FG000|Overall Study|Adverse Event|4
857265|NCT00446563|1815757|FG001|Overall Study|Adverse Event|3
857266|NCT00446563|1815756|FG000|Overall Study|Abnormal laboratory value(s)|0
857267|NCT00446563|1815757|FG001|Overall Study|Abnormal laboratory value(s)|1
857268|NCT00446563|1815756|FG000|Overall Study|Abnormal test procedure result(s)|1
857269|NCT00446563|1815757|FG001|Overall Study|Abnormal test procedure result(s)|0
857270|NCT00446563|1815756|FG000|Overall Study|Unsatisfactory therapeutic effect|0
857271|NCT00446563|1815757|FG001|Overall Study|Unsatisfactory therapeutic effect|3
857272|NCT00446563|1815756|FG000|Overall Study|Withdrawal by Subject|2
857273|NCT00446563|1815757|FG001|Overall Study|Withdrawal by Subject|1
857274|NCT00446563|1815756|FG000|Overall Study|Administrative problems|0
857275|NCT00446563|1815757|FG001|Overall Study|Administrative problems|1
857276|NCT00446641|1815765|FG000|Overall Study|Withdrawal by Subject|8
857277|NCT00446641|1815766|FG001|Overall Study|Withdrawal by Subject|3
857278|NCT00446641|1815765|FG000|Overall Study|poor compliance|8
857279|NCT00446641|1815766|FG001|Overall Study|poor compliance|6
857280|NCT00446641|1815765|FG000|Overall Study|Lost to Follow-up|1
857281|NCT00446641|1815766|FG001|Overall Study|Lost to Follow-up|1
857282|NCT00446654|1815774|FG000|Overall Study|Withdrawal by Subject|1
857283|NCT00446654|1815775|FG001|Overall Study|Withdrawal by Subject|0
857284|NCT00446654|1815774|FG000|Overall Study|Adverse Event|1
857285|NCT00446654|1815775|FG001|Overall Study|Adverse Event|0
857286|NCT00446797|1815783|FG000|Overall Study|Lack of Efficacy|0
857287|NCT00446797|1815784|FG001|Overall Study|Lack of Efficacy|2
857288|NCT00446797|1815783|FG000|Overall Study|Lost to Follow-up|5
857289|NCT00446797|1815784|FG001|Overall Study|Lost to Follow-up|3
857290|NCT00446797|1815783|FG000|Overall Study|Withdrawal by Subject|2
857291|NCT00446797|1815784|FG001|Overall Study|Withdrawal by Subject|2
857292|NCT00446797|1815783|FG000|Overall Study|Protocol Violation|1
857293|NCT00446797|1815784|FG001|Overall Study|Protocol Violation|3
857294|NCT00446797|1815783|FG000|Overall Study|subject entered at another site|0
857295|NCT00446797|1815784|FG001|Overall Study|subject entered at another site|1
857296|NCT00446797|1815783|FG000|Overall Study|did not meet entrance criteria|0
857297|NCT00446797|1815784|FG001|Overall Study|did not meet entrance criteria|1
857298|NCT00446849|1815790|FG000|Acute Phase|Lack of Efficacy|64
857299|NCT00446849|1815790|FG000|Acute Phase|Protocol Violation|10
857300|NCT00446849|1815790|FG000|Acute Phase|Consent withdrawn|4
857301|NCT00446849|1815790|FG000|Acute Phase|Lost to Follow-up|2
857302|NCT00446849|1815790|FG000|Acute Phase|Physician Decision|1
857303|NCT00446849|1815790|FG000|Acute Phase|noncompliance|1
857304|NCT00446849|1815790|FG000|Maintenance Phase|Lack of Efficacy|40
857305|NCT00446849|1815790|FG000|Maintenance Phase|Protocol Violation|7
857306|NCT00446849|1815790|FG000|Maintenance Phase|Adverse Event|6
857307|NCT00446849|1815790|FG000|Maintenance Phase|Consent withdrawn|5
857308|NCT00446849|1815790|FG000|Maintenance Phase|Lost to Follow-up|3
857309|NCT00446849|1815790|FG000|Maintenance Phase|Pregnancy|1
857310|NCT00446849|1815790|FG000|Maintenance Phase|noncompliance|2
857311|NCT00446849|1815790|FG000|Maintenance Phase|prohibited medication use|2
857312|NCT00446849|1815790|FG000|Maintenance Phase|antibiotic use|1
857313|NCT00446849|1815790|FG000|Maintenance Phase|study closure|1
857314|NCT00446849|1815790|FG000|Maintenance Phase|hydrocodone use|1
857315|NCT00446849|1815790|FG000|Maintenance Phase|concomitant medication use|1
857316|NCT00446966|1815797|FG000|Overall Study|Lost to Follow-up|10
857317|NCT00446966|1815798|FG001|Overall Study|Lost to Follow-up|7
857318|NCT00446992|1815804|FG000|Overall Study|Adverse Event|11
857319|NCT00446992|1815804|FG000|Overall Study|Lost to Follow-up|5
857320|NCT00447005|1815808|FG000|Overall Study|Adverse Event|1
857321|NCT00447005|1815808|FG000|Overall Study|Lack of Efficacy|11
857322|NCT00447057|1815816|FG000|Overall Study|Adverse Event|4
857323|NCT00447057|1815817|FG001|Overall Study|Adverse Event|10
857324|NCT00447057|1815818|FG002|Overall Study|Adverse Event|0
857325|NCT00447057|1815819|FG003|Overall Study|Adverse Event|3
857326|NCT00447057|1815816|FG000|Overall Study|Death due to study disease|6
857327|NCT00447057|1815817|FG001|Overall Study|Death due to study disease|4
857328|NCT00447057|1815818|FG002|Overall Study|Death due to study disease|1
857329|NCT00447057|1815819|FG003|Overall Study|Death due to study disease|1
857330|NCT00447057|1815816|FG000|Overall Study|Lost to Follow-up|0
857331|NCT00447057|1815817|FG001|Overall Study|Lost to Follow-up|1
857332|NCT00447057|1815818|FG002|Overall Study|Lost to Follow-up|0
857333|NCT00447057|1815819|FG003|Overall Study|Lost to Follow-up|0
857334|NCT00447057|1815816|FG000|Overall Study|Entry criteria not met|1
857335|NCT00447057|1815817|FG001|Overall Study|Entry criteria not met|1
857336|NCT00447057|1815818|FG002|Overall Study|Entry criteria not met|0
857337|NCT00447057|1815819|FG003|Overall Study|Entry criteria not met|0
857338|NCT00447057|1815816|FG000|Overall Study|Protocol Violation|0
857339|NCT00447057|1815817|FG001|Overall Study|Protocol Violation|1
857340|NCT00447057|1815818|FG002|Overall Study|Protocol Violation|0
857341|NCT00447057|1815819|FG003|Overall Study|Protocol Violation|0
857342|NCT00447057|1815816|FG000|Overall Study|Withdrawal by Subject|4
857343|NCT00447057|1815817|FG001|Overall Study|Withdrawal by Subject|5
857344|NCT00447057|1815818|FG002|Overall Study|Withdrawal by Subject|1
857345|NCT00447057|1815819|FG003|Overall Study|Withdrawal by Subject|1
857346|NCT00447057|1815816|FG000|Overall Study|Physician Decision|9
857347|NCT00447057|1815817|FG001|Overall Study|Physician Decision|6
857348|NCT00447057|1815818|FG002|Overall Study|Physician Decision|3
857349|NCT00447057|1815819|FG003|Overall Study|Physician Decision|1
857350|NCT00447057|1815816|FG000|Overall Study|Sponsor decision|1
857351|NCT00447057|1815817|FG001|Overall Study|Sponsor decision|1
857352|NCT00447057|1815818|FG002|Overall Study|Sponsor decision|0
857353|NCT00447057|1815819|FG003|Overall Study|Sponsor decision|0
857354|NCT00447057|1815816|FG000|Overall Study|Progressive disease|58
857355|NCT00447057|1815817|FG001|Overall Study|Progressive disease|43
857356|NCT00447057|1815818|FG002|Overall Study|Progressive disease|13
857357|NCT00447057|1815819|FG003|Overall Study|Progressive disease|18
857358|NCT00447057|1815816|FG000|Overall Study|Death due to adverse event|0
857359|NCT00447057|1815817|FG001|Overall Study|Death due to adverse event|0
857360|NCT00447057|1815818|FG002|Overall Study|Death due to adverse event|1
857361|NCT00447057|1815819|FG003|Overall Study|Death due to adverse event|2
857362|NCT00447057|1815816|FG000|Overall Study|Death, study drug related|0
857363|NCT00447057|1815817|FG001|Overall Study|Death, study drug related|1
857364|NCT00447057|1815818|FG002|Overall Study|Death, study drug related|0
857365|NCT00447057|1815819|FG003|Overall Study|Death, study drug related|0
857366|NCT00447226|1815844|FG000|12-Week Open-label Phase|Adverse Event|0
857367|NCT00447226|1815845|FG001|12-Week Open-label Phase|Adverse Event|3
857368|NCT00447226|1815844|FG000|12-Week Open-label Phase|Protocol Violation|0
857369|NCT00447226|1815845|FG001|12-Week Open-label Phase|Protocol Violation|1
857370|NCT00447226|1815844|FG000|12-Week Open-label Phase|Disease Progression|0
857371|NCT00447226|1815845|FG001|12-Week Open-label Phase|Disease Progression|20
857372|NCT00447226|1815844|FG000|12-Week Open-label Phase|Physician Decision|0
857373|NCT00447226|1815845|FG001|12-Week Open-label Phase|Physician Decision|1
857374|NCT00447226|1815844|FG000|Double-blind Phase|Disease Progression|4
857375|NCT00447226|1815845|FG001|Double-blind Phase|Disease Progression|3
857376|NCT00447265|1815860|FG000|Overall Study|Physician Decision|1
857377|NCT00447265|1815861|FG001|Overall Study|Physician Decision|0
857378|NCT00447278|1815867|FG000|Period II (6 Month Open-Label)|Adverse Event|7
857379|NCT00447278|1815868|FG001|Period II (6 Month Open-Label)|Adverse Event|3
857380|NCT00447278|1815867|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0
857381|NCT00447278|1815868|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4
857382|NCT00447278|1815867|FG000|Period II (6 Month Open-Label)|Protocol Violation|10
857383|NCT00447278|1815868|FG001|Period II (6 Month Open-Label)|Protocol Violation|7
857384|NCT00447278|1815867|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1
857385|NCT00447278|1815868|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3
857386|NCT00447278|1815867|FG000|Period II (6 Month Open-Label)|Physician Decision|4
857387|NCT00447278|1815868|FG001|Period II (6 Month Open-Label)|Physician Decision|1
857388|NCT00447278|1815867|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11
857389|NCT00447278|1815868|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1
857390|NCT00447278|1815867|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
857391|NCT00447278|1815868|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
857392|NCT00447278|1815867|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2
857393|NCT00447278|1815868|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2
857394|NCT00447278|1815867|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
857395|NCT00447278|1815868|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
857396|NCT00447278|1815867|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6
857397|NCT00447278|1815868|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1
857398|NCT00447278|1815867|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
857399|NCT00447278|1815868|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
857400|NCT00447278|1815867|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1
857401|NCT00447278|1815868|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1
857402|NCT00447278|1815867|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
857403|NCT00447278|1815868|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
857404|NCT00447278|1815867|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
857405|NCT00447278|1815868|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
857406|NCT00447382|1815882|FG000|Overall Study|Adverse Event|1
857407|NCT00447382|1815883|FG001|Overall Study|Adverse Event|1
857408|NCT00447382|1815882|FG000|Overall Study|Lack of Efficacy|1
857409|NCT00447382|1815883|FG001|Overall Study|Lack of Efficacy|0
857410|NCT00447382|1815882|FG000|Overall Study|Protocol Violation|2
857411|NCT00447382|1815883|FG001|Overall Study|Protocol Violation|0
857412|NCT00447382|1815882|FG000|Overall Study|Unclassified|2
857413|NCT00447382|1815883|FG001|Overall Study|Unclassified|5
857414|NCT00447499|1815889|FG000|Overall Study|Adverse Event|1
857415|NCT00447499|1815889|FG000|Overall Study|Patient Decision|4
857416|NCT00447499|1815889|FG000|Overall Study|Sponsor Decision|1
857417|NCT00447499|1815889|FG000|Overall Study|Physician Decision|1
857418|NCT00447590|1815895|FG000|Overall Study|Withdrawal by Subject|26
857419|NCT00447590|1815895|FG000|Overall Study|Lost to Follow-up|24
857420|NCT00447590|1815895|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
857421|NCT00447694|1815899|FG000|Overall Study|Adverse Event|2
857422|NCT00447694|1815899|FG000|Overall Study|Abnormal laboratory value|1
857423|NCT00447694|1815899|FG000|Overall Study|Abnormal test procedure result|1
857424|NCT00447694|1815899|FG000|Overall Study|Withdrawal by Subject|2
857425|NCT00447772|1815903|FG000|Overall Study|Lack of Efficacy|3
857426|NCT00447772|1815903|FG000|Overall Study|Insufficient compliance|6
857427|NCT00447772|1815903|FG000|Overall Study|Discontinuation of drug therapy|1
857428|NCT00447772|1815903|FG000|Overall Study|Lost to Follow-up|9
857429|NCT00447772|1815903|FG000|Overall Study|Withdrawal by Subject|1
857430|NCT00447772|1815903|FG000|Overall Study|Unable to attend all study visits|2
857431|NCT00447772|1815903|FG000|Overall Study|Adverse Event|1
857432|NCT00447772|1815903|FG000|Overall Study|Patient relocated|1
857433|NCT00447772|1815903|FG000|Overall Study|Incomplete documentation at visit 1|1
857434|NCT00447772|1815903|FG000|Overall Study|Chemotherapy for lung cancer|1
857435|NCT00447772|1815903|FG000|Overall Study|Premature re-injection required|1
857436|NCT00447876|1815912|FG000|Overall Study|Withdrawal by Subject|1
857437|NCT00447876|1815913|FG001|Overall Study|Withdrawal by Subject|4
857438|NCT00447876|1815912|FG000|Overall Study|Lost to Follow-up|1
857439|NCT00447876|1815913|FG001|Overall Study|Lost to Follow-up|0
857440|NCT00447876|1815912|FG000|Overall Study|Deterioration of symptomology|1
857441|NCT00447876|1815913|FG001|Overall Study|Deterioration of symptomology|0
857442|NCT00447902|1815921|FG000|Overall Study|Adverse Event|0
857443|NCT00447902|1815922|FG001|Overall Study|Adverse Event|3
857444|NCT00447902|1815921|FG000|Overall Study|Protocol Violation|1
857445|NCT00447902|1815922|FG001|Overall Study|Protocol Violation|0
857446|NCT00447902|1815921|FG000|Overall Study|Withdrawal by Subject|0
857447|NCT00447902|1815922|FG001|Overall Study|Withdrawal by Subject|1
857448|NCT00447902|1815921|FG000|Overall Study|included patients who discontinued|1
857449|NCT00447902|1815922|FG001|Overall Study|included patients who discontinued|1
857450|NCT00447902|1815921|FG000|Overall Study|Lack of Efficacy|2
857451|NCT00447902|1815922|FG001|Overall Study|Lack of Efficacy|1
857452|NCT00448019|1815928|FG000|Overall Study|Withdrawal by Subject|3
857453|NCT00448019|1815928|FG000|Overall Study|Disease progression|1
857454|NCT00448019|1815928|FG000|Overall Study|Death|2
857455|NCT00448019|1815928|FG000|Overall Study|Insurance Issues|1
857456|NCT00448123|1815934|FG000|Overall Study|Lost to Follow-up|9
857457|NCT00448123|1815935|FG001|Overall Study|Lost to Follow-up|6
857458|NCT00448123|1815934|FG000|Overall Study|Physician Decision|6
857459|NCT00448123|1815935|FG001|Overall Study|Physician Decision|6
857460|NCT00448136|1815946|FG000|Overall Study|Death|3
857461|NCT00448136|1815947|FG001|Overall Study|Death|8
857462|NCT00448136|1815946|FG000|Overall Study|Investigator's decision (progression)|1
857463|NCT00448136|1815947|FG001|Overall Study|Investigator's decision (progression)|0
857464|NCT00448279|1815977|FG000|Overall Study|Lost to Follow-up|2
857465|NCT00448279|1815978|FG001|Overall Study|Lost to Follow-up|2
857466|NCT00448279|1815977|FG000|Overall Study|Adverse Event|1
857467|NCT00448279|1815978|FG001|Overall Study|Adverse Event|1
857468|NCT00448279|1815977|FG000|Overall Study|Disease progression|16
857469|NCT00448279|1815978|FG001|Overall Study|Disease progression|18
857470|NCT00448279|1815977|FG000|Overall Study|Withdrawal by Subject|4
857471|NCT00448279|1815978|FG001|Overall Study|Withdrawal by Subject|3
857472|NCT00448279|1815977|FG000|Overall Study|Other|6
857473|NCT00448279|1815978|FG001|Overall Study|Other|4
857474|NCT00448279|1815977|FG000|Overall Study|Protocol Violation|0
857475|NCT00448279|1815978|FG001|Overall Study|Protocol Violation|1
857476|NCT00448344|1815986|FG000|Overall Study|Lost to Follow-up|20
857477|NCT00448344|1815987|FG001|Overall Study|Lost to Follow-up|22
857478|NCT00448344|1815986|FG000|Overall Study|Withdrawal by Subject|6
857479|NCT00448344|1815987|FG001|Overall Study|Withdrawal by Subject|8
857480|NCT00448344|1815986|FG000|Overall Study|Death|3
857481|NCT00448344|1815987|FG001|Overall Study|Death|4
857482|NCT00448344|1815986|FG000|Overall Study|Physician Decision|1
857483|NCT00448344|1815987|FG001|Overall Study|Physician Decision|2
857484|NCT00448435|1816009|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1
857485|NCT00448435|1816010|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0
857486|NCT00448448|1816021|FG000|Overall Study|Withdrawal by Subject|13
857487|NCT00448448|1816022|FG001|Overall Study|Withdrawal by Subject|2
857488|NCT00448448|1816021|FG000|Overall Study|On protocol when study ended|83
857489|NCT00448448|1816022|FG001|Overall Study|On protocol when study ended|36
857490|NCT00448448|1816021|FG000|Overall Study|Lost to Follow-up|2
857491|NCT00448448|1816022|FG001|Overall Study|Lost to Follow-up|1
857492|NCT00448448|1816021|FG000|Overall Study|Wrong diagnosis (n=3) or other|2
857493|NCT00448448|1816022|FG001|Overall Study|Wrong diagnosis (n=3) or other|1
857494|NCT00448448|1816021|FG000|Overall Study|Signed consent lost|0
857495|NCT00448448|1816022|FG001|Overall Study|Signed consent lost|1
857496|NCT00448539|1816030|FG000|Overall Study|Medication non-compliance|4
857497|NCT00448539|1816031|FG001|Overall Study|Medication non-compliance|1
857498|NCT00448539|1816030|FG000|Overall Study|Protocol Violation|1
857499|NCT00448539|1816031|FG001|Overall Study|Protocol Violation|0
857500|NCT00448539|1816030|FG000|Overall Study|Request of the investigator or sponsor|67
857501|NCT00448539|1816031|FG001|Overall Study|Request of the investigator or sponsor|54
857502|NCT00448539|1816030|FG000|Overall Study|Withdrawal by Subject|20
857503|NCT00448539|1816031|FG001|Overall Study|Withdrawal by Subject|24
857504|NCT00448539|1816030|FG000|Overall Study|Diary non-compliance|1
857505|NCT00448539|1816031|FG001|Overall Study|Diary non-compliance|0
857506|NCT00448539|1816030|FG000|Overall Study|Adverse Event|9
857507|NCT00448539|1816031|FG001|Overall Study|Adverse Event|26
857508|NCT00448539|1816030|FG000|Overall Study|Lack of Efficacy|27
857509|NCT00448539|1816031|FG001|Overall Study|Lack of Efficacy|40
857510|NCT00448539|1816030|FG000|Overall Study|Miscellaneous|2
857511|NCT00448539|1816031|FG001|Overall Study|Miscellaneous|1
857512|NCT00448539|1816030|FG000|Overall Study|Change of meds|2
857513|NCT00448539|1816031|FG001|Overall Study|Change of meds|3
857514|NCT00448539|1816030|FG000|Overall Study|Lost to Follow-up|1
857515|NCT00448539|1816031|FG001|Overall Study|Lost to Follow-up|3
857516|NCT00448591|1816037|FG000|Overall Study|Withdrawal by Subject|178
857517|NCT00448591|1816037|FG000|Overall Study|Progressive Disease|1382
857518|NCT00448591|1816037|FG000|Overall Study|Adverse Event|382
857519|NCT00448591|1816037|FG000|Overall Study|Protocol Violation|41
857520|NCT00448591|1816037|FG000|Overall Study|Lost to Follow-up|19
857521|NCT00448591|1816037|FG000|Overall Study|Treatment Regimen Completed|70
857522|NCT00448591|1816037|FG000|Overall Study|Other|154
857523|NCT00448591|1816037|FG000|Overall Study|Termination of Study|70
857524|NCT00448669|1816062|FG000|Overall Study|Lost to Follow-up|52
857525|NCT00448669|1816063|FG001|Overall Study|Lost to Follow-up|63
857526|NCT00448669|1816062|FG000|Overall Study|Withdrawal by Subject|90
857527|NCT00448669|1816063|FG001|Overall Study|Withdrawal by Subject|74
857528|NCT00448669|1816062|FG000|Overall Study|Relocated|49
857529|NCT00448669|1816063|FG001|Overall Study|Relocated|36
857530|NCT00448669|1816062|FG000|Overall Study|Were withdrawn by investigator|10
857531|NCT00448669|1816063|FG001|Overall Study|Were withdrawn by investigator|6
857532|NCT00448669|1816062|FG000|Overall Study|Death|2
857533|NCT00448669|1816063|FG001|Overall Study|Death|4
857534|NCT00448669|1816062|FG000|Overall Study|Had other reasons|5
857535|NCT00448669|1816063|FG001|Overall Study|Had other reasons|6
857536|NCT00448669|1816062|FG000|Overall Study|HIV-infected at enrollment|1
857537|NCT00448669|1816063|FG001|Overall Study|HIV-infected at enrollment|2
857538|NCT00448669|1816062|FG000|Overall Study|Never started drug|9
857539|NCT00448669|1816063|FG001|Overall Study|Never started drug|7
857540|NCT00448708|1816073|FG000|Overall Study|Death|21
857541|NCT00448708|1816074|FG001|Overall Study|Death|17
857542|NCT00448708|1816073|FG000|Overall Study|Withdrawal by Subject|8
857543|NCT00448708|1816074|FG001|Overall Study|Withdrawal by Subject|4
857544|NCT00448708|1816073|FG000|Overall Study|Lost to Follow-up|6
857545|NCT00448708|1816074|FG001|Overall Study|Lost to Follow-up|8
857546|NCT00448708|1816073|FG000|Overall Study|not listed|0
857547|NCT00448708|1816074|FG001|Overall Study|not listed|2
857548|NCT00448747|1816082|FG000|Overall Study|collapsed veins|1
857549|NCT00448747|1816083|FG001|Overall Study|collapsed veins|0
857550|NCT00448760|1816099|FG000|Overall Study|Death|3
857551|NCT00448812|1816105|FG000|Year 2|Missed visit but remained in study|4
857552|NCT00448812|1816106|FG001|Year 2|Missed visit but remained in study|1
857553|NCT00448812|1816105|FG000|Year 3|Withdrawal by Subject|1
857554|NCT00448812|1816106|FG001|Year 3|Withdrawal by Subject|3
857555|NCT00448812|1816105|FG000|Year 3|Lost to Follow-up|1
857556|NCT00448812|1816106|FG001|Year 3|Lost to Follow-up|0
857557|NCT00448812|1816105|FG000|Year 3|Missed visit but remained in study|2
857558|NCT00448812|1816106|FG001|Year 3|Missed visit but remained in study|0
857559|NCT00448812|1816105|FG000|Year 5|Missed visit but remained in study|1
857560|NCT00448812|1816106|FG001|Year 5|Missed visit but remained in study|0
857561|NCT00448864|1816127|FG000|Overall Study|Death|1
857562|NCT00448864|1816128|FG001|Overall Study|Death|0
857563|NCT00448864|1816129|FG002|Overall Study|Death|0
857564|NCT00448864|1816127|FG000|Overall Study|Lost to Follow-up|3
857565|NCT00448864|1816128|FG001|Overall Study|Lost to Follow-up|1
857566|NCT00448864|1816129|FG002|Overall Study|Lost to Follow-up|0
857567|NCT00448864|1816127|FG000|Overall Study|Physician Decision|1
857568|NCT00448864|1816128|FG001|Overall Study|Physician Decision|0
857569|NCT00448864|1816129|FG002|Overall Study|Physician Decision|1
857570|NCT00448864|1816127|FG000|Overall Study|Withdrawal by Subject|0
857571|NCT00448864|1816128|FG001|Overall Study|Withdrawal by Subject|2
857572|NCT00448864|1816129|FG002|Overall Study|Withdrawal by Subject|0
857573|NCT00448864|1816127|FG000|Overall Study|Protocol Violation|0
857574|NCT00448864|1816128|FG001|Overall Study|Protocol Violation|2
857575|NCT00448864|1816129|FG002|Overall Study|Protocol Violation|0
857576|NCT00448916|1816143|FG000|Overall Study|Adverse Event|2
857577|NCT00448916|1816144|FG001|Overall Study|Adverse Event|2
857578|NCT00448916|1816145|FG002|Overall Study|Adverse Event|3
857579|NCT00448916|1816146|FG003|Overall Study|Adverse Event|2
857580|NCT00448916|1816143|FG000|Overall Study|Lack of Efficacy|1
857581|NCT00448916|1816144|FG001|Overall Study|Lack of Efficacy|0
857582|NCT00448916|1816145|FG002|Overall Study|Lack of Efficacy|2
857583|NCT00448916|1816146|FG003|Overall Study|Lack of Efficacy|1
857584|NCT00448916|1816143|FG000|Overall Study|Withdrawal by Subject|3
857585|NCT00448916|1816144|FG001|Overall Study|Withdrawal by Subject|3
857586|NCT00448916|1816145|FG002|Overall Study|Withdrawal by Subject|1
857587|NCT00448916|1816146|FG003|Overall Study|Withdrawal by Subject|1
857588|NCT00448916|1816143|FG000|Overall Study|Other|1
857589|NCT00448916|1816144|FG001|Overall Study|Other|0
857590|NCT00448916|1816145|FG002|Overall Study|Other|0
857591|NCT00448916|1816146|FG003|Overall Study|Other|0
857592|NCT00448916|1816143|FG000|Overall Study|Lost to Follow-up|0
857593|NCT00448916|1816144|FG001|Overall Study|Lost to Follow-up|1
857594|NCT00448916|1816145|FG002|Overall Study|Lost to Follow-up|0
857595|NCT00448916|1816146|FG003|Overall Study|Lost to Follow-up|1
857596|NCT00448916|1816143|FG000|Overall Study|Protocol Violation|0
857597|NCT00448916|1816144|FG001|Overall Study|Protocol Violation|0
857598|NCT00448916|1816145|FG002|Overall Study|Protocol Violation|0
857599|NCT00448916|1816146|FG003|Overall Study|Protocol Violation|1
857600|NCT00449033|1816171|FG000|Treatment Period|Adverse Event|117
857601|NCT00449033|1816172|FG001|Treatment Period|Adverse Event|83
857602|NCT00449033|1816171|FG000|Treatment Period|Death|21
857603|NCT00449033|1816172|FG001|Treatment Period|Death|12
857604|NCT00449033|1816171|FG000|Treatment Period|Lost to Follow-up|0
857605|NCT00449033|1816172|FG001|Treatment Period|Lost to Follow-up|2
857606|NCT00449033|1816171|FG000|Treatment Period|Physician Decision|4
857607|NCT00449033|1816172|FG001|Treatment Period|Physician Decision|5
857608|NCT00449033|1816171|FG000|Treatment Period|Protocol Violation|8
857609|NCT00449033|1816172|FG001|Treatment Period|Protocol Violation|7
857610|NCT00449033|1816171|FG000|Treatment Period|Disease Progression|231
857611|NCT00449033|1816172|FG001|Treatment Period|Disease Progression|288
857612|NCT00449033|1816171|FG000|Treatment Period|Consent Withdrawn|36
857613|NCT00449033|1816172|FG001|Treatment Period|Consent Withdrawn|20
857614|NCT00449033|1816171|FG000|Treatment Period|Amended Protocol Criteria|22
857615|NCT00449033|1816172|FG001|Treatment Period|Amended Protocol Criteria|18
857616|NCT00449033|1816171|FG000|Treatment Period|Non-compliance|7
857617|NCT00449033|1816172|FG001|Treatment Period|Non-compliance|8
857618|NCT00449033|1816171|FG000|Treatment Period|Second Malignancy|0
857619|NCT00449033|1816172|FG001|Treatment Period|Second Malignancy|1
857620|NCT00449033|1816171|FG000|Treatment Period|Reason Missing|0
857621|NCT00449033|1816172|FG001|Treatment Period|Reason Missing|4
857622|NCT00449033|1816171|FG000|Treatment Period|Treatment Ongoing|6
857623|NCT00449033|1816172|FG001|Treatment Period|Treatment Ongoing|4
857624|NCT00449033|1816171|FG000|Follow-up Period|Death|299
857625|NCT00449033|1816172|FG001|Follow-up Period|Death|311
857626|NCT00449033|1816171|FG000|Follow-up Period|Lost to Follow-up|6
857627|NCT00449033|1816172|FG001|Follow-up Period|Lost to Follow-up|10
857628|NCT00449033|1816171|FG000|Follow-up Period|Reason Missing|120
857629|NCT00449033|1816172|FG001|Follow-up Period|Reason Missing|113
857630|NCT00449072|1816184|FG000|Overall Study|Adverse Event|3
857631|NCT00449072|1816185|FG001|Overall Study|Adverse Event|1
857632|NCT00449072|1816184|FG000|Overall Study|Protocol Violation|14
857633|NCT00449072|1816185|FG001|Overall Study|Protocol Violation|12
857634|NCT00449072|1816184|FG000|Overall Study|Lost to Follow-up|5
857635|NCT00449072|1816185|FG001|Overall Study|Lost to Follow-up|7
857636|NCT00449072|1816184|FG000|Overall Study|Withdrawal by Subject|11
857637|NCT00449072|1816185|FG001|Overall Study|Withdrawal by Subject|8
857638|NCT00449072|1816184|FG000|Overall Study|Lack of Efficacy|1
857639|NCT00449072|1816185|FG001|Overall Study|Lack of Efficacy|1
857640|NCT00449072|1816184|FG000|Overall Study|Physician Decision|1
857641|NCT00449072|1816185|FG001|Overall Study|Physician Decision|0
857642|NCT00449072|1816184|FG000|Overall Study|Not treated|0
857643|NCT00449072|1816185|FG001|Overall Study|Not treated|1
857644|NCT00449072|1816184|FG000|Overall Study|Excluded medication|0
857645|NCT00449072|1816185|FG001|Overall Study|Excluded medication|2
857646|NCT00449072|1816184|FG000|Overall Study|Non-compliance|2
857647|NCT00449072|1816185|FG001|Overall Study|Non-compliance|5
857648|NCT00449072|1816184|FG000|Overall Study|Sponsor decision|1
857649|NCT00449072|1816185|FG001|Overall Study|Sponsor decision|3
857650|NCT00449072|1816184|FG000|Overall Study|Relocation|3
857651|NCT00449072|1816185|FG001|Overall Study|Relocation|2
857652|NCT00449150|1816194|FG000|Overall Study|Adverse Event|11
857653|NCT00449150|1816195|FG001|Overall Study|Adverse Event|18
857654|NCT00449150|1816196|FG002|Overall Study|Adverse Event|9
857655|NCT00449150|1816194|FG000|Overall Study|Lack of Efficacy|1
857656|NCT00449150|1816195|FG001|Overall Study|Lack of Efficacy|2
857657|NCT00449150|1816196|FG002|Overall Study|Lack of Efficacy|2
857658|NCT00449150|1816194|FG000|Overall Study|Other|16
857659|NCT00449150|1816195|FG001|Overall Study|Other|13
857660|NCT00449150|1816196|FG002|Overall Study|Other|14
857661|NCT00449150|1816194|FG000|Overall Study|Withdrawal by Subject|17
857662|NCT00449150|1816195|FG001|Overall Study|Withdrawal by Subject|18
857663|NCT00449150|1816196|FG002|Overall Study|Withdrawal by Subject|21
857664|NCT00449150|1816194|FG000|Overall Study|Protocol Violation|1
857665|NCT00449150|1816195|FG001|Overall Study|Protocol Violation|2
857666|NCT00449150|1816196|FG002|Overall Study|Protocol Violation|1
857667|NCT00449163|1816207|FG000|Overall Study|Physician Decision|3
857668|NCT00449176|1816214|FG000|Overall Study|Withdrawal by Subject|39
857669|NCT00449176|1816215|FG001|Overall Study|Withdrawal by Subject|43
857670|NCT00449176|1816216|FG002|Overall Study|Withdrawal by Subject|59
857671|NCT00449176|1816214|FG000|Overall Study|Lost to Follow-up|13
857672|NCT00449176|1816215|FG001|Overall Study|Lost to Follow-up|8
857673|NCT00449176|1816216|FG002|Overall Study|Lost to Follow-up|12
857674|NCT00449176|1816214|FG000|Overall Study|Adverse Event|51
857675|NCT00449176|1816215|FG001|Overall Study|Adverse Event|107
857676|NCT00449176|1816216|FG002|Overall Study|Adverse Event|15
857677|NCT00449176|1816214|FG000|Overall Study|Lack of Efficacy|13
857678|NCT00449176|1816215|FG001|Overall Study|Lack of Efficacy|7
857679|NCT00449176|1816216|FG002|Overall Study|Lack of Efficacy|50
857680|NCT00449176|1816214|FG000|Overall Study|Study drug non-compliant|14
857681|NCT00449176|1816215|FG001|Overall Study|Study drug non-compliant|11
857682|NCT00449176|1816216|FG002|Overall Study|Study drug non-compliant|11
857683|NCT00449176|1816214|FG000|Overall Study|all other|22
857684|NCT00449176|1816215|FG001|Overall Study|all other|19
857685|NCT00449176|1816216|FG002|Overall Study|all other|20
857686|NCT00449540|1816226|FG000|Pretreatment Phase|No migraine experienced|66
857687|NCT00449540|1816227|FG001|Pretreatment Phase|No migraine experienced|0
857688|NCT00449540|1816228|FG002|Pretreatment Phase|No migraine experienced|0
857689|NCT00449540|1816226|FG000|Treatment Phase|did not experience or treat migraine|0
857690|NCT00449540|1816227|FG001|Treatment Phase|did not experience or treat migraine|20
857691|NCT00449540|1816228|FG002|Treatment Phase|did not experience or treat migraine|17
857692|NCT00449644|1816240|FG000|Overall Study|Adverse Event|0
857693|NCT00449644|1816241|FG001|Overall Study|Adverse Event|0
857694|NCT00449644|1816242|FG002|Overall Study|Adverse Event|3
857695|NCT00449644|1816243|FG003|Overall Study|Adverse Event|5
857696|NCT00449644|1816240|FG000|Overall Study|Death|1
857697|NCT00449644|1816241|FG001|Overall Study|Death|0
857698|NCT00449644|1816242|FG002|Overall Study|Death|6
857699|NCT00449644|1816243|FG003|Overall Study|Death|1
857700|NCT00449644|1816240|FG000|Overall Study|Lost to Follow-up|1
857701|NCT00449644|1816241|FG001|Overall Study|Lost to Follow-up|1
857702|NCT00449644|1816242|FG002|Overall Study|Lost to Follow-up|5
857703|NCT00449644|1816243|FG003|Overall Study|Lost to Follow-up|3
857704|NCT00449644|1816240|FG000|Overall Study|Pregnancy|0
857705|NCT00449644|1816241|FG001|Overall Study|Pregnancy|0
857706|NCT00449644|1816242|FG002|Overall Study|Pregnancy|3
857707|NCT00449644|1816243|FG003|Overall Study|Pregnancy|2
857708|NCT00449644|1816240|FG000|Overall Study|Protocol Violation|4
857709|NCT00449644|1816241|FG001|Overall Study|Protocol Violation|4
857710|NCT00449644|1816242|FG002|Overall Study|Protocol Violation|3
857711|NCT00449644|1816243|FG003|Overall Study|Protocol Violation|7
857712|NCT00449644|1816240|FG000|Overall Study|Withdrawal by Subject|3
857713|NCT00449644|1816241|FG001|Overall Study|Withdrawal by Subject|4
857714|NCT00449644|1816242|FG002|Overall Study|Withdrawal by Subject|6
857715|NCT00449644|1816243|FG003|Overall Study|Withdrawal by Subject|7
857716|NCT00449644|1816240|FG000|Overall Study|Inclusion/exclusion criteria not met|0
857717|NCT00449644|1816241|FG001|Overall Study|Inclusion/exclusion criteria not met|0
857718|NCT00449644|1816242|FG002|Overall Study|Inclusion/exclusion criteria not met|2
857719|NCT00449644|1816243|FG003|Overall Study|Inclusion/exclusion criteria not met|6
857720|NCT00449644|1816240|FG000|Overall Study|Other|1
857721|NCT00449644|1816241|FG001|Overall Study|Other|4
857722|NCT00449644|1816242|FG002|Overall Study|Other|1
857723|NCT00449644|1816243|FG003|Overall Study|Other|0
857724|NCT00449644|1816240|FG000|Overall Study|Rolled-over to treatment with TMC207|0
857725|NCT00449644|1816241|FG001|Overall Study|Rolled-over to treatment with TMC207|0
857726|NCT00449644|1816242|FG002|Overall Study|Rolled-over to treatment with TMC207|0
857727|NCT00449644|1816243|FG003|Overall Study|Rolled-over to treatment with TMC207|1
857728|NCT00449670|1816258|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1
857729|NCT00449670|1816259|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0
857730|NCT00449670|1816258|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4
857731|NCT00449670|1816259|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0
857732|NCT00449670|1816258|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4
857733|NCT00449670|1816259|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1
857734|NCT00449670|1816258|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5
857735|NCT00449670|1816259|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1
857736|NCT00449670|1816258|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0
857737|NCT00449670|1816259|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1
857738|NCT00449670|1816258|FG000|Booster Phase (Study no.109873)|Other|0
857739|NCT00449670|1816259|FG001|Booster Phase (Study no.109873)|Other|2
857740|NCT00449696|1816274|FG000|Overall Study|Other Treatment Required|6
857741|NCT00449696|1816275|FG001|Overall Study|Other Treatment Required|1
857742|NCT00449696|1816274|FG000|Overall Study|Withdrawal by Subject|5
857743|NCT00449696|1816275|FG001|Overall Study|Withdrawal by Subject|5
857744|NCT00449696|1816274|FG000|Overall Study|Lost to Follow-up|2
857745|NCT00449696|1816275|FG001|Overall Study|Lost to Follow-up|3
857746|NCT00449696|1816274|FG000|Overall Study|Others|7
857747|NCT00449696|1816275|FG001|Overall Study|Others|0
857748|NCT00449761|1816285|FG000|Overall Study|Disease progression|12
857749|NCT00449761|1816285|FG000|Overall Study|Death|5
857750|NCT00449761|1816285|FG000|Overall Study|New cancer therapy|1
857751|NCT00449787|1816292|FG000|Overall Study|Lost to Follow-up|10
857752|NCT00449787|1816293|FG001|Overall Study|Lost to Follow-up|8
857753|NCT00449787|1816292|FG000|Overall Study|Did not require medication|95
857754|NCT00449787|1816293|FG001|Overall Study|Did not require medication|92
857755|NCT00449865|1816303|FG000|Overall Study|Withdrawal by Subject|110
857756|NCT00449865|1816304|FG001|Overall Study|Withdrawal by Subject|110
857757|NCT00449865|1816303|FG000|Overall Study|Lost to Follow-up|36
857758|NCT00449865|1816304|FG001|Overall Study|Lost to Follow-up|37
857759|NCT00449865|1816303|FG000|Overall Study|Physician Decision|13
857760|NCT00449865|1816304|FG001|Overall Study|Physician Decision|12
857761|NCT00449865|1816303|FG000|Overall Study|Death|31
857762|NCT00449865|1816304|FG001|Overall Study|Death|40
857763|NCT00449865|1816303|FG000|Overall Study|Protocol Violation|8
857764|NCT00449865|1816304|FG001|Overall Study|Protocol Violation|7
857765|NCT00449865|1816303|FG000|Overall Study|Study was stopped|324
857766|NCT00449865|1816304|FG001|Overall Study|Study was stopped|328
857767|NCT00449930|1816312|FG000|Overall Study|Adverse Event|9
857768|NCT00449930|1816313|FG001|Overall Study|Adverse Event|19
857769|NCT00449930|1816312|FG000|Overall Study|Trial Terminated ( Site Closed)|1
857770|NCT00449930|1816313|FG001|Overall Study|Trial Terminated ( Site Closed)|0
857771|NCT00449930|1816312|FG000|Overall Study|Lack of Efficacy|10
857772|NCT00449930|1816313|FG001|Overall Study|Lack of Efficacy|1
857773|NCT00449930|1816312|FG000|Overall Study|Lost to Follow-up|9
857774|NCT00449930|1816313|FG001|Overall Study|Lost to Follow-up|14
857775|NCT00449930|1816312|FG000|Overall Study|Physician Decision|1
857776|NCT00449930|1816313|FG001|Overall Study|Physician Decision|2
857777|NCT00449930|1816312|FG000|Overall Study|Protocol Violation|14
857778|NCT00449930|1816313|FG001|Overall Study|Protocol Violation|15
857779|NCT00449930|1816312|FG000|Overall Study|Withdrawal by Subject|16
857780|NCT00449930|1816313|FG001|Overall Study|Withdrawal by Subject|23
857781|NCT00449930|1816312|FG000|Overall Study|Glycemic discontinuation criteria|1
857782|NCT00449930|1816313|FG001|Overall Study|Glycemic discontinuation criteria|1
857783|NCT00449956|1816322|FG000|Overall Study|Adverse Event|7
857784|NCT00449956|1816323|FG001|Overall Study|Adverse Event|1
857785|NCT00449956|1816324|FG002|Overall Study|Adverse Event|6
857786|NCT00449956|1816322|FG000|Overall Study|Lack of Efficacy|0
857787|NCT00449956|1816323|FG001|Overall Study|Lack of Efficacy|0
857788|NCT00449956|1816324|FG002|Overall Study|Lack of Efficacy|1
857789|NCT00449956|1816322|FG000|Overall Study|Protocol Violation|1
857790|NCT00449956|1816323|FG001|Overall Study|Protocol Violation|1
857791|NCT00449956|1816324|FG002|Overall Study|Protocol Violation|1
857792|NCT00449956|1816322|FG000|Overall Study|Withdrawal by Subject|0
857793|NCT00449956|1816323|FG001|Overall Study|Withdrawal by Subject|1
857794|NCT00449956|1816324|FG002|Overall Study|Withdrawal by Subject|0
857795|NCT00449956|1816322|FG000|Overall Study|Physician Decision|2
857796|NCT00449956|1816323|FG001|Overall Study|Physician Decision|1
857797|NCT00449956|1816324|FG002|Overall Study|Physician Decision|1
857798|NCT00450112|1816347|FG000|Overall Study|Other Treatment Required|5
857799|NCT00450112|1816348|FG001|Overall Study|Other Treatment Required|1
857800|NCT00450112|1816347|FG000|Overall Study|Withdrawal by Subject|4
857801|NCT00450112|1816348|FG001|Overall Study|Withdrawal by Subject|1
857802|NCT00450112|1816347|FG000|Overall Study|Lost to Follow-up|2
857803|NCT00450112|1816348|FG001|Overall Study|Lost to Follow-up|1
857804|NCT00450112|1816347|FG000|Overall Study|Others|2
857805|NCT00450112|1816348|FG001|Overall Study|Others|3
857806|NCT00450177|1816356|FG000|Overall Study|Adverse Event|7
857807|NCT00450177|1816357|FG001|Overall Study|Adverse Event|4
857808|NCT00450177|1816356|FG000|Overall Study|Withdrawal by Subject|1
857809|NCT00450177|1816357|FG001|Overall Study|Withdrawal by Subject|6
857810|NCT00450177|1816356|FG000|Overall Study|Withdrawal by Primary Team|1
857811|NCT00450177|1816357|FG001|Overall Study|Withdrawal by Primary Team|1
857812|NCT00450190|1816363|FG000|Overall Study|Withdrawal by Subject|2
857813|NCT00450216|1816369|FG000|Overall Study|Adverse Event|38
857814|NCT00450216|1816370|FG001|Overall Study|Adverse Event|23
857815|NCT00450216|1816369|FG000|Overall Study|Withdrawal by Subject|48
857816|NCT00450216|1816370|FG001|Overall Study|Withdrawal by Subject|26
857817|NCT00450216|1816369|FG000|Overall Study|Lost to Follow-up|16
857818|NCT00450216|1816370|FG001|Overall Study|Lost to Follow-up|9
857819|NCT00450216|1816369|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51
857820|NCT00450216|1816370|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51
857821|NCT00450216|1816369|FG000|Overall Study|misc|21
857822|NCT00450216|1816370|FG001|Overall Study|misc|20
857823|NCT00450255|1816387|FG000|Overall Study|Prior RFA ablation of liver|1
857824|NCT00450372|1816397|FG000|Overall Study|Physician Decision|1
857825|NCT00450385|1816404|FG000|Overall Study|Death|3
857826|NCT00450385|1816404|FG000|Overall Study|Protocol Violation|1
857827|NCT00450385|1816404|FG000|Overall Study|Withdrawal by Subject|2
857828|NCT00450385|1816404|FG000|Overall Study|Lack of Efficacy|2
857829|NCT00450385|1816404|FG000|Overall Study|Adverse Event|1
857830|NCT00450385|1816404|FG000|Overall Study|Physician Decision|1
857831|NCT00450385|1816404|FG000|Overall Study|Other|3
857832|NCT00450411|1816409|FG000|Overall Study|Protocol Violation|6
857833|NCT00450411|1816409|FG000|Overall Study|No protocol treatment|2
857834|NCT00450437|1816424|FG000|Overall Study|Withdrawal by Subject|10
857835|NCT00450437|1816425|FG001|Overall Study|Withdrawal by Subject|2
857836|NCT00450437|1816426|FG002|Overall Study|Withdrawal by Subject|0
857837|NCT00450437|1816427|FG003|Overall Study|Withdrawal by Subject|1
857838|NCT00450437|1816424|FG000|Overall Study|Lost to Follow-up|31
857839|NCT00450437|1816425|FG001|Overall Study|Lost to Follow-up|12
857840|NCT00450437|1816426|FG002|Overall Study|Lost to Follow-up|19
857841|NCT00450437|1816427|FG003|Overall Study|Lost to Follow-up|9
857842|NCT00450437|1816424|FG000|Overall Study|Protocol Violation|0
857843|NCT00450437|1816425|FG001|Overall Study|Protocol Violation|1
857844|NCT00450437|1816426|FG002|Overall Study|Protocol Violation|0
857845|NCT00450437|1816427|FG003|Overall Study|Protocol Violation|1
857846|NCT00450437|1816424|FG000|Overall Study|Inappropriate enrollment|4
857847|NCT00450437|1816425|FG001|Overall Study|Inappropriate enrollment|1
857848|NCT00450437|1816426|FG002|Overall Study|Inappropriate enrollment|3
857849|NCT00450437|1816427|FG003|Overall Study|Inappropriate enrollment|0
857850|NCT00450437|1816424|FG000|Overall Study|Administrative reason|0
857851|NCT00450437|1816425|FG001|Overall Study|Administrative reason|0
857852|NCT00450437|1816426|FG002|Overall Study|Administrative reason|1
857853|NCT00450437|1816427|FG003|Overall Study|Administrative reason|0
857854|NCT00450437|1816424|FG000|Overall Study|Unable to Classify|1
857855|NCT00450437|1816425|FG001|Overall Study|Unable to Classify|0
857856|NCT00450437|1816426|FG002|Overall Study|Unable to Classify|1
857857|NCT00450437|1816427|FG003|Overall Study|Unable to Classify|0
857858|NCT00450450|1816443|FG000|Overall Study|Death|1
857859|NCT00450450|1816444|FG001|Overall Study|Death|3
857860|NCT00450450|1816443|FG000|Overall Study|Relapse|2
857861|NCT00450450|1816444|FG001|Overall Study|Relapse|0
857862|NCT00450450|1816443|FG000|Overall Study|Missing Data|2
857863|NCT00450450|1816444|FG001|Overall Study|Missing Data|0
857864|NCT00450580|1816464|FG000|Overall Study|Adverse Event|5
857865|NCT00450580|1816465|FG001|Overall Study|Adverse Event|7
857866|NCT00450580|1816464|FG000|Overall Study|Lost to Follow-up|4
857867|NCT00450580|1816465|FG001|Overall Study|Lost to Follow-up|5
857868|NCT00450580|1816464|FG000|Overall Study|Withdrawal by Subject|2
857869|NCT00450580|1816465|FG001|Overall Study|Withdrawal by Subject|2
857870|NCT00450580|1816464|FG000|Overall Study|Protocol Violation|1
857871|NCT00450580|1816465|FG001|Overall Study|Protocol Violation|1
857872|NCT00450580|1816464|FG000|Overall Study|Protocol-defined virologic failure|1
857873|NCT00450580|1816465|FG001|Overall Study|Protocol-defined virologic failure|0
857874|NCT00450580|1816464|FG000|Overall Study|Could not comply with scheduled visits|1
857875|NCT00450580|1816465|FG001|Overall Study|Could not comply with scheduled visits|0
857876|NCT00450580|1816464|FG000|Overall Study|Patient went to Brazil|1
857877|NCT00450580|1816465|FG001|Overall Study|Patient went to Brazil|0
857878|NCT00450580|1816464|FG000|Overall Study|Patient could not swallow Norvir|1
857879|NCT00450580|1816465|FG001|Overall Study|Patient could not swallow Norvir|0
857880|NCT00450580|1816464|FG000|Overall Study|Withdrawal due to pregnancy|0
857881|NCT00450580|1816465|FG001|Overall Study|Withdrawal due to pregnancy|1
857882|NCT00450619|1816473|FG000|Overall Study|refused treatment after randomization|2
857883|NCT00450619|1816474|FG001|Overall Study|refused treatment after randomization|0
857884|NCT00450619|1816473|FG000|Overall Study|did not progress; refused further trmt|1
857885|NCT00450619|1816474|FG001|Overall Study|did not progress; refused further trmt|1
857886|NCT00450619|1816473|FG000|Overall Study|Adverse Event|1
857887|NCT00450619|1816474|FG001|Overall Study|Adverse Event|0
857888|NCT00450658|1816483|FG000|Overall Study|Adverse Event|24
857889|NCT00450658|1816484|FG001|Overall Study|Adverse Event|15
857890|NCT00450658|1816483|FG000|Overall Study|Withdrawal by Subject|43
857891|NCT00450658|1816484|FG001|Overall Study|Withdrawal by Subject|26
857892|NCT00450658|1816483|FG000|Overall Study|Lost to Follow-up|22
857893|NCT00450658|1816484|FG001|Overall Study|Lost to Follow-up|5
857894|NCT00450658|1816483|FG000|Overall Study|UGI ulcer|33
857895|NCT00450658|1816484|FG001|Overall Study|UGI ulcer|34
857896|NCT00450658|1816483|FG000|Overall Study|misc|21
857897|NCT00450658|1816484|FG001|Overall Study|misc|10
857898|NCT00450723|1816490|FG000|Overall Study|Physician Decision|5
857899|NCT00450749|1816498|FG000|Overall Study|Withdrawal by Subject|0
857900|NCT00450749|1816499|FG001|Overall Study|Withdrawal by Subject|0
857901|NCT00450749|1816500|FG002|Overall Study|Withdrawal by Subject|2
857902|NCT00450749|1816498|FG000|Overall Study|Noncompliant|0
857903|NCT00450749|1816499|FG001|Overall Study|Noncompliant|1
857904|NCT00450749|1816500|FG002|Overall Study|Noncompliant|0
857905|NCT00450801|1816508|FG000|Overall Study|Death|1
857906|NCT00450814|1816527|FG000|Overall Study|Failed to complete the initial therapy|0
857907|NCT00450814|1816528|FG001|Overall Study|Failed to complete the initial therapy|0
857908|NCT00450814|1816529|FG002|Overall Study|Failed to complete the initial therapy|0
857909|NCT00450814|1816530|FG003|Overall Study|Failed to complete the initial therapy|1
857910|NCT00450814|1816531|FG004|Overall Study|Failed to complete the initial therapy|1
857911|NCT00450814|1816532|FG005|Overall Study|Failed to complete the initial therapy|1
857912|NCT00450814|1816533|FG006|Overall Study|Failed to complete the initial therapy|0
857913|NCT00450814|1816534|FG007|Overall Study|Failed to complete the initial therapy|0
857914|NCT00450814|1816535|FG008|Overall Study|Failed to complete the initial therapy|0
857915|NCT00450814|1816536|FG009|Overall Study|Failed to complete the initial therapy|0
857916|NCT00450814|1816537|FG010|Overall Study|Failed to complete the initial therapy|0
857917|NCT00450814|1816527|FG000|Overall Study|Patient withdrawal prior to treatment|0
857918|NCT00450814|1816528|FG001|Overall Study|Patient withdrawal prior to treatment|0
857919|NCT00450814|1816529|FG002|Overall Study|Patient withdrawal prior to treatment|0
857920|NCT00450814|1816530|FG003|Overall Study|Patient withdrawal prior to treatment|0
857921|NCT00450814|1816531|FG004|Overall Study|Patient withdrawal prior to treatment|0
857922|NCT00450814|1816532|FG005|Overall Study|Patient withdrawal prior to treatment|0
857923|NCT00450814|1816533|FG006|Overall Study|Patient withdrawal prior to treatment|0
857924|NCT00450814|1816534|FG007|Overall Study|Patient withdrawal prior to treatment|0
857925|NCT00450814|1816535|FG008|Overall Study|Patient withdrawal prior to treatment|0
857926|NCT00450814|1816536|FG009|Overall Study|Patient withdrawal prior to treatment|1
857927|NCT00450814|1816537|FG010|Overall Study|Patient withdrawal prior to treatment|0
857928|NCT00450866|1816562|FG000|Overall Study|Adverse Event|0
857929|NCT00450866|1816563|FG001|Overall Study|Adverse Event|1
857930|NCT00450866|1816562|FG000|Overall Study|Withdrawal by Subject|5
857931|NCT00450866|1816563|FG001|Overall Study|Withdrawal by Subject|2
857932|NCT00450866|1816562|FG000|Overall Study|Death|1
857933|NCT00450866|1816563|FG001|Overall Study|Death|0
857934|NCT00450866|1816562|FG000|Overall Study|Physician Decision|1
857935|NCT00450866|1816563|FG001|Overall Study|Physician Decision|0
857936|NCT00451035|1816573|FG000|Overall Study|Disease progression|11
857937|NCT00451035|1816573|FG000|Overall Study|Death|3
857938|NCT00451035|1816573|FG000|Overall Study|New anti-neoplastic therapy|3
857939|NCT00451178|1816584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
857940|NCT00451178|1816585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
857941|NCT00451178|1816584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4
857942|NCT00451178|1816585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3
857943|NCT00451178|1816584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2
857944|NCT00451178|1816585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1
857945|NCT00451178|1816584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1
857946|NCT00451178|1816585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2
857947|NCT00451178|1816584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4
857948|NCT00451178|1816585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3
857949|NCT00451178|1816584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1
857950|NCT00451178|1816585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2
857951|NCT00451178|1816584|FG000|Prior to Maintenance Therapy|Physician Decision|2
857952|NCT00451178|1816585|FG001|Prior to Maintenance Therapy|Physician Decision|0
857953|NCT00451178|1816584|FG000|Prior to Maintenance Therapy|PD|2
857954|NCT00451178|1816585|FG001|Prior to Maintenance Therapy|PD|0
857955|NCT00451178|1816584|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4
857956|NCT00451178|1816585|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0
857957|NCT00451178|1816584|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5
857958|NCT00451178|1816585|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0
857959|NCT00451178|1816584|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1
857960|NCT00451178|1816585|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0
857961|NCT00451178|1816584|FG000|Maintenance Therapy (up to 3 Years)|Death|1
857962|NCT00451178|1816585|FG001|Maintenance Therapy (up to 3 Years)|Death|0
857963|NCT00451178|1816584|FG000|Maintenance Therapy (up to 3 Years)|PD|10
857964|NCT00451178|1816585|FG001|Maintenance Therapy (up to 3 Years)|PD|0
857965|NCT00451178|1816584|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9
857966|NCT00451178|1816585|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0
857967|NCT00451178|1816584|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6
857968|NCT00451178|1816585|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26
857969|NCT00451191|1816597|FG000|Overall Study|withdrawal or received alternate tx|15
857970|NCT00451191|1816598|FG001|Overall Study|withdrawal or received alternate tx|11
857971|NCT00451204|1816606|FG000|Overall Study|Adverse Event|4
857972|NCT00451204|1816607|FG001|Overall Study|Adverse Event|6
857973|NCT00451204|1816606|FG000|Overall Study|Lack of Efficacy|4
857974|NCT00451204|1816607|FG001|Overall Study|Lack of Efficacy|4
857975|NCT00451204|1816606|FG000|Overall Study|Lost to Follow-up|4
857976|NCT00451204|1816607|FG001|Overall Study|Lost to Follow-up|4
857977|NCT00451204|1816606|FG000|Overall Study|Protocol Violation|1
857978|NCT00451204|1816607|FG001|Overall Study|Protocol Violation|0
857979|NCT00451204|1816606|FG000|Overall Study|Patient refusal|8
857980|NCT00451204|1816607|FG001|Overall Study|Patient refusal|4
857981|NCT00451204|1816606|FG000|Overall Study|Other|1
857982|NCT00451204|1816607|FG001|Overall Study|Other|2
857983|NCT00451217|1816620|FG000|Overall Study|Lost to Follow-up|0
857984|NCT00451217|1816621|FG001|Overall Study|Lost to Follow-up|1
857985|NCT00451217|1816622|FG002|Overall Study|Lost to Follow-up|1
857986|NCT00451217|1816623|FG003|Overall Study|Lost to Follow-up|1
857987|NCT00451217|1816620|FG000|Overall Study|Withdrawal by Subject|1
857988|NCT00451217|1816621|FG001|Overall Study|Withdrawal by Subject|0
857989|NCT00451217|1816622|FG002|Overall Study|Withdrawal by Subject|0
857990|NCT00451217|1816623|FG003|Overall Study|Withdrawal by Subject|0
857991|NCT00451217|1816620|FG000|Overall Study|Not Treated|1
857992|NCT00451217|1816621|FG001|Overall Study|Not Treated|1
857993|NCT00451217|1816622|FG002|Overall Study|Not Treated|3
857994|NCT00451217|1816623|FG003|Overall Study|Not Treated|4
857995|NCT00451282|1816635|FG000|Overall Study|Lost to Follow-up|6
857996|NCT00451282|1816636|FG001|Overall Study|Lost to Follow-up|5
857997|NCT00451321|1816650|FG000|Overall Study|Lost to Follow-up|3
857998|NCT00451321|1816651|FG001|Overall Study|Lost to Follow-up|3
857999|NCT00451321|1816652|FG002|Overall Study|Lost to Follow-up|1
858000|NCT00451321|1816653|FG003|Overall Study|Lost to Follow-up|3
858001|NCT00451321|1816654|FG004|Overall Study|Lost to Follow-up|0
858002|NCT00451321|1816655|FG005|Overall Study|Lost to Follow-up|1
858003|NCT00451321|1816656|FG006|Overall Study|Lost to Follow-up|0
858004|NCT00451321|1816657|FG007|Overall Study|Lost to Follow-up|0
858005|NCT00451321|1816650|FG000|Overall Study|Withdrawal by Subject|3
858006|NCT00451321|1816651|FG001|Overall Study|Withdrawal by Subject|1
858007|NCT00451321|1816652|FG002|Overall Study|Withdrawal by Subject|0
858008|NCT00451321|1816653|FG003|Overall Study|Withdrawal by Subject|4
858009|NCT00451321|1816654|FG004|Overall Study|Withdrawal by Subject|0
858010|NCT00451321|1816655|FG005|Overall Study|Withdrawal by Subject|0
858011|NCT00451321|1816656|FG006|Overall Study|Withdrawal by Subject|0
858012|NCT00451321|1816657|FG007|Overall Study|Withdrawal by Subject|0
858013|NCT00451321|1816650|FG000|Overall Study|Study closed/terminated|1
858014|NCT00451321|1816651|FG001|Overall Study|Study closed/terminated|1
858015|NCT00451321|1816652|FG002|Overall Study|Study closed/terminated|17
858016|NCT00451321|1816653|FG003|Overall Study|Study closed/terminated|5
858017|NCT00451321|1816654|FG004|Overall Study|Study closed/terminated|7
858018|NCT00451321|1816655|FG005|Overall Study|Study closed/terminated|7
858019|NCT00451321|1816656|FG006|Overall Study|Study closed/terminated|5
858020|NCT00451321|1816657|FG007|Overall Study|Study closed/terminated|3
858021|NCT00451321|1816650|FG000|Overall Study|Sponsor decision to amend protocol|0
858022|NCT00451321|1816651|FG001|Overall Study|Sponsor decision to amend protocol|0
858023|NCT00451321|1816652|FG002|Overall Study|Sponsor decision to amend protocol|0
858024|NCT00451321|1816653|FG003|Overall Study|Sponsor decision to amend protocol|0
858025|NCT00451321|1816654|FG004|Overall Study|Sponsor decision to amend protocol|0
858026|NCT00451321|1816655|FG005|Overall Study|Sponsor decision to amend protocol|1
858027|NCT00451321|1816656|FG006|Overall Study|Sponsor decision to amend protocol|1
858028|NCT00451321|1816657|FG007|Overall Study|Sponsor decision to amend protocol|3
858029|NCT00451451|1816679|FG000|Overall Study|Adverse Event|11
858030|NCT00451451|1816680|FG001|Overall Study|Adverse Event|21
858031|NCT00451451|1816681|FG002|Overall Study|Adverse Event|26
858032|NCT00451451|1816682|FG003|Overall Study|Adverse Event|10
858033|NCT00451451|1816679|FG000|Overall Study|Lost to Follow-up|11
858034|NCT00451451|1816680|FG001|Overall Study|Lost to Follow-up|9
858035|NCT00451451|1816681|FG002|Overall Study|Lost to Follow-up|8
858036|NCT00451451|1816682|FG003|Overall Study|Lost to Follow-up|11
858037|NCT00451451|1816679|FG000|Overall Study|Consent Withdrawn|14
858038|NCT00451451|1816680|FG001|Overall Study|Consent Withdrawn|9
858039|NCT00451451|1816681|FG002|Overall Study|Consent Withdrawn|17
858040|NCT00451451|1816682|FG003|Overall Study|Consent Withdrawn|17
858041|NCT00451451|1816679|FG000|Overall Study|Investigator Decision|6
858042|NCT00451451|1816680|FG001|Overall Study|Investigator Decision|2
858043|NCT00451451|1816681|FG002|Overall Study|Investigator Decision|1
858044|NCT00451451|1816682|FG003|Overall Study|Investigator Decision|2
858045|NCT00451451|1816679|FG000|Overall Study|Subject Non-Compliance|8
858046|NCT00451451|1816680|FG001|Overall Study|Subject Non-Compliance|4
858047|NCT00451451|1816681|FG002|Overall Study|Subject Non-Compliance|3
858048|NCT00451451|1816682|FG003|Overall Study|Subject Non-Compliance|3
858049|NCT00451451|1816679|FG000|Overall Study|Death|1
858050|NCT00451451|1816680|FG001|Overall Study|Death|0
858051|NCT00451451|1816681|FG002|Overall Study|Death|0
858052|NCT00451451|1816682|FG003|Overall Study|Death|1
858053|NCT00451451|1816679|FG000|Overall Study|Other Reasons for Not Completing Study|34
858054|NCT00451451|1816680|FG001|Overall Study|Other Reasons for Not Completing Study|30
858055|NCT00451451|1816681|FG002|Overall Study|Other Reasons for Not Completing Study|17
858056|NCT00451451|1816682|FG003|Overall Study|Other Reasons for Not Completing Study|14
858057|NCT00451555|1816697|FG000|Overall Study|Protocol Violation|2
858058|NCT00451555|1816698|FG001|Overall Study|Protocol Violation|2
858059|NCT00451555|1816697|FG000|Overall Study|Adverse Event|3
858060|NCT00451555|1816698|FG001|Overall Study|Adverse Event|1
858061|NCT00451555|1816697|FG000|Overall Study|Withdrawal by Subject|6
858062|NCT00451555|1816698|FG001|Overall Study|Withdrawal by Subject|0
858063|NCT00451555|1816697|FG000|Overall Study|Physician Decision|2
858064|NCT00451555|1816698|FG001|Overall Study|Physician Decision|1
858065|NCT00451906|1816724|FG000|Overall Study|Adverse Event|515
858066|NCT00451906|1816724|FG000|Overall Study|Lost to Follow-up|31
858067|NCT00451906|1816724|FG000|Overall Study|Withdrawal by Subject|111
858068|NCT00451906|1816724|FG000|Overall Study|Protocol Violation|21
858069|NCT00451906|1816724|FG000|Overall Study|Progressive disease|1328
858070|NCT00451906|1816724|FG000|Overall Study|Termination of the study|108
858071|NCT00451906|1816724|FG000|Overall Study|Other Reasons|121
858072|NCT00451906|1816724|FG000|Overall Study|Did not complete final visit|4
858073|NCT00451958|1816732|FG000|CS21A (NCT00451958)|Adverse Event|21
858074|NCT00451958|1816733|FG001|CS21A (NCT00451958)|Adverse Event|34
858075|NCT00451958|1816734|FG002|CS21A (NCT00451958)|Adverse Event|14
858076|NCT00451958|1816735|FG003|CS21A (NCT00451958)|Adverse Event|17
858077|NCT00451958|1816736|FG004|CS21A (NCT00451958)|Adverse Event|0
858078|NCT00451958|1816732|FG000|CS21A (NCT00451958)|Lost to Follow-up|6
858079|NCT00451958|1816733|FG001|CS21A (NCT00451958)|Lost to Follow-up|5
858080|NCT00451958|1816734|FG002|CS21A (NCT00451958)|Lost to Follow-up|1
858081|NCT00451958|1816735|FG003|CS21A (NCT00451958)|Lost to Follow-up|1
858082|NCT00451958|1816736|FG004|CS21A (NCT00451958)|Lost to Follow-up|0
858083|NCT00451958|1816732|FG000|CS21A (NCT00451958)|Protocol Violation|1
858084|NCT00451958|1816733|FG001|CS21A (NCT00451958)|Protocol Violation|3
858085|NCT00451958|1816734|FG002|CS21A (NCT00451958)|Protocol Violation|2
858086|NCT00451958|1816735|FG003|CS21A (NCT00451958)|Protocol Violation|0
858087|NCT00451958|1816736|FG004|CS21A (NCT00451958)|Protocol Violation|0
858088|NCT00451958|1816732|FG000|CS21A (NCT00451958)|Physician Decision|2
858089|NCT00451958|1816733|FG001|CS21A (NCT00451958)|Physician Decision|4
858090|NCT00451958|1816734|FG002|CS21A (NCT00451958)|Physician Decision|4
858091|NCT00451958|1816735|FG003|CS21A (NCT00451958)|Physician Decision|4
858092|NCT00451958|1816736|FG004|CS21A (NCT00451958)|Physician Decision|0
858093|NCT00451958|1816732|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7
858094|NCT00451958|1816733|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4
858095|NCT00451958|1816734|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4
858096|NCT00451958|1816735|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3
858097|NCT00451958|1816736|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0
858098|NCT00451958|1816732|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28
858099|NCT00451958|1816733|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27
858100|NCT00451958|1816734|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17
858101|NCT00451958|1816735|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14
858102|NCT00451958|1816736|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0
858103|NCT00452114|1816752|FG000|Overall Study|Physician Decision|3
858104|NCT00452114|1816753|FG001|Overall Study|Physician Decision|3
858105|NCT00452348|1816777|FG000|Overall Study|Adverse Event|6
858106|NCT00452348|1816778|FG001|Overall Study|Adverse Event|9
858107|NCT00452348|1816777|FG000|Overall Study|Lack of Efficacy|10
858108|NCT00452348|1816778|FG001|Overall Study|Lack of Efficacy|9
858109|NCT00452348|1816777|FG000|Overall Study|Lost to Follow-up|14
858110|NCT00452348|1816778|FG001|Overall Study|Lost to Follow-up|8
858111|NCT00452348|1816777|FG000|Overall Study|Protocol Violation|22
858112|NCT00452348|1816778|FG001|Overall Study|Protocol Violation|28
858113|NCT00452348|1816777|FG000|Overall Study|Withdrawal by Subject|18
858114|NCT00452348|1816778|FG001|Overall Study|Withdrawal by Subject|21
858115|NCT00452348|1816777|FG000|Overall Study|Other|9
858116|NCT00452348|1816778|FG001|Overall Study|Other|9
858117|NCT00452400|1816799|FG000|Overall Study|Adverse Event|1
858118|NCT00452400|1816800|FG001|Overall Study|Adverse Event|1
858119|NCT00452400|1816801|FG002|Overall Study|Adverse Event|5
858120|NCT00452400|1816802|FG003|Overall Study|Adverse Event|0
858121|NCT00452400|1816803|FG004|Overall Study|Adverse Event|2
858122|NCT00452400|1816799|FG000|Overall Study|Protocol Violation|0
858123|NCT00452400|1816800|FG001|Overall Study|Protocol Violation|0
858124|NCT00452400|1816801|FG002|Overall Study|Protocol Violation|1
858125|NCT00452400|1816802|FG003|Overall Study|Protocol Violation|0
858126|NCT00452400|1816803|FG004|Overall Study|Protocol Violation|0
858127|NCT00452400|1816799|FG000|Overall Study|Lost to Follow-up|1
858128|NCT00452400|1816800|FG001|Overall Study|Lost to Follow-up|0
858129|NCT00452400|1816801|FG002|Overall Study|Lost to Follow-up|0
858130|NCT00452400|1816802|FG003|Overall Study|Lost to Follow-up|0
858131|NCT00452400|1816803|FG004|Overall Study|Lost to Follow-up|0
858132|NCT00452400|1816799|FG000|Overall Study|Withdrawal by Subject|1
858133|NCT00452400|1816800|FG001|Overall Study|Withdrawal by Subject|0
858134|NCT00452400|1816801|FG002|Overall Study|Withdrawal by Subject|1
858135|NCT00452400|1816802|FG003|Overall Study|Withdrawal by Subject|0
858136|NCT00452400|1816803|FG004|Overall Study|Withdrawal by Subject|0
858137|NCT00452400|1816799|FG000|Overall Study|Lack of Efficacy|2
858138|NCT00452400|1816800|FG001|Overall Study|Lack of Efficacy|0
858139|NCT00452400|1816801|FG002|Overall Study|Lack of Efficacy|0
858140|NCT00452400|1816802|FG003|Overall Study|Lack of Efficacy|0
858141|NCT00452400|1816803|FG004|Overall Study|Lack of Efficacy|0
858142|NCT00452400|1816799|FG000|Overall Study|Other reasons not listed above|0
858143|NCT00452400|1816800|FG001|Overall Study|Other reasons not listed above|0
858144|NCT00452400|1816801|FG002|Overall Study|Other reasons not listed above|0
858145|NCT00452400|1816802|FG003|Overall Study|Other reasons not listed above|1
858146|NCT00452400|1816803|FG004|Overall Study|Other reasons not listed above|1
858147|NCT00452413|1816818|FG000|Overall Study|Progressive Disease|4
858148|NCT00452413|1816819|FG001|Overall Study|Progressive Disease|11
858149|NCT00452413|1816820|FG002|Overall Study|Progressive Disease|30
858150|NCT00452413|1816818|FG000|Overall Study|Withdrawal by Subject|0
858151|NCT00452413|1816819|FG001|Overall Study|Withdrawal by Subject|1
858152|NCT00452413|1816820|FG002|Overall Study|Withdrawal by Subject|4
858153|NCT00452413|1816818|FG000|Overall Study|Adverse Event|0
858154|NCT00452413|1816819|FG001|Overall Study|Adverse Event|0
858155|NCT00452413|1816820|FG002|Overall Study|Adverse Event|5
858156|NCT00452413|1816818|FG000|Overall Study|Physician Decision|0
858157|NCT00452413|1816819|FG001|Overall Study|Physician Decision|0
858158|NCT00452413|1816820|FG002|Overall Study|Physician Decision|4
858159|NCT00452413|1816818|FG000|Overall Study|Death due to study disease|0
858160|NCT00452413|1816819|FG001|Overall Study|Death due to study disease|0
858161|NCT00452413|1816820|FG002|Overall Study|Death due to study disease|2
858162|NCT00452413|1816818|FG000|Overall Study|Death due to adverse event (AE)|0
858163|NCT00452413|1816819|FG001|Overall Study|Death due to adverse event (AE)|0
858164|NCT00452413|1816820|FG002|Overall Study|Death due to adverse event (AE)|1
858165|NCT00452413|1816818|FG000|Overall Study|On treatment|0
858166|NCT00452413|1816819|FG001|Overall Study|On treatment|0
858167|NCT00452413|1816820|FG002|Overall Study|On treatment|3
858168|NCT00452439|1816840|FG000|Overall Study|Lost to Follow-up|1
858169|NCT00452439|1816841|FG001|Overall Study|Lost to Follow-up|1
858170|NCT00452439|1816840|FG000|Overall Study|Refused Treatment|4
858171|NCT00452439|1816841|FG001|Overall Study|Refused Treatment|3
858172|NCT00452439|1816840|FG000|Overall Study|Death|3
858173|NCT00452439|1816841|FG001|Overall Study|Death|1
858174|NCT00452439|1816840|FG000|Overall Study|Bone Marrow Transplant|0
858175|NCT00452439|1816841|FG001|Overall Study|Bone Marrow Transplant|1
858176|NCT00452439|1816840|FG000|Overall Study|Too Ill to Continue|0
858177|NCT00452439|1816841|FG001|Overall Study|Too Ill to Continue|1
858178|NCT00452439|1816840|FG000|Overall Study|Failed to achieve complete response|2
858179|NCT00452439|1816841|FG001|Overall Study|Failed to achieve complete response|0
858180|NCT00452439|1816840|FG000|Overall Study|Relapse|3
858181|NCT00452439|1816841|FG001|Overall Study|Relapse|0
858182|NCT00452439|1816840|FG000|Overall Study|Fracture|1
858183|NCT00452439|1816841|FG001|Overall Study|Fracture|0
858184|NCT00452452|1816850|FG000|Overall Study|Protocol Violation|0
858185|NCT00452452|1816851|FG001|Overall Study|Protocol Violation|0
858186|NCT00452452|1816852|FG002|Overall Study|Protocol Violation|1
858187|NCT00452452|1816850|FG000|Overall Study|Withdrawal by Subject|1
858188|NCT00452452|1816851|FG001|Overall Study|Withdrawal by Subject|0
858189|NCT00452452|1816852|FG002|Overall Study|Withdrawal by Subject|0
858190|NCT00452452|1816850|FG000|Overall Study|Lost to Follow-up|1
858191|NCT00452452|1816851|FG001|Overall Study|Lost to Follow-up|0
858192|NCT00452452|1816852|FG002|Overall Study|Lost to Follow-up|0
858193|NCT00452530|1816868|FG000|Overall Study|Death|1
858194|NCT00452530|1816869|FG001|Overall Study|Death|0
858195|NCT00452530|1816868|FG000|Overall Study|Adverse Event|40
858196|NCT00452530|1816869|FG001|Overall Study|Adverse Event|44
858197|NCT00452530|1816868|FG000|Overall Study|Withdrawal by Subject|68
858198|NCT00452530|1816869|FG001|Overall Study|Withdrawal by Subject|57
858199|NCT00452530|1816868|FG000|Overall Study|Lost to Follow-up|1
858200|NCT00452530|1816869|FG001|Overall Study|Lost to Follow-up|0
858201|NCT00452530|1816868|FG000|Overall Study|Poor compliance/noncompliance|1
858202|NCT00452530|1816869|FG001|Overall Study|Poor compliance/noncompliance|2
858203|NCT00452530|1816868|FG000|Overall Study|No longer met study criteria|18
858204|NCT00452530|1816869|FG001|Overall Study|No longer met study criteria|22
858205|NCT00452530|1816868|FG000|Overall Study|Other|7
858206|NCT00452530|1816869|FG001|Overall Study|Other|11
858207|NCT00452673|1816892|FG000|Dose Escalation Period|Disease Progression|6
858208|NCT00452673|1816893|FG001|Dose Escalation Period|Disease Progression|6
858209|NCT00452673|1816894|FG002|Dose Escalation Period|Disease Progression|2
858210|NCT00452673|1816895|FG003|Dose Escalation Period|Disease Progression|6
858211|NCT00452673|1816896|FG004|Dose Escalation Period|Disease Progression|0
858212|NCT00452673|1816892|FG000|Dose Escalation Period|study drug toxicity|1
858213|NCT00452673|1816893|FG001|Dose Escalation Period|study drug toxicity|3
858214|NCT00452673|1816894|FG002|Dose Escalation Period|study drug toxicity|3
858215|NCT00452673|1816895|FG003|Dose Escalation Period|study drug toxicity|1
858216|NCT00452673|1816896|FG004|Dose Escalation Period|study drug toxicity|0
858217|NCT00452673|1816892|FG000|Dose Escalation Period|Other|0
858218|NCT00452673|1816893|FG001|Dose Escalation Period|Other|0
858219|NCT00452673|1816894|FG002|Dose Escalation Period|Other|1
858220|NCT00452673|1816895|FG003|Dose Escalation Period|Other|0
858221|NCT00452673|1816896|FG004|Dose Escalation Period|Other|0
858222|NCT00452673|1816892|FG000|Dose Escalation Period|Adverse Event|0
858223|NCT00452673|1816893|FG001|Dose Escalation Period|Adverse Event|0
858224|NCT00452673|1816894|FG002|Dose Escalation Period|Adverse Event|0
858225|NCT00452673|1816895|FG003|Dose Escalation Period|Adverse Event|1
858226|NCT00452673|1816896|FG004|Dose Escalation Period|Adverse Event|0
858227|NCT00452673|1816892|FG000|Dose Escalation Period|Withdrawal by Subject|0
858228|NCT00452673|1816893|FG001|Dose Escalation Period|Withdrawal by Subject|0
858229|NCT00452673|1816894|FG002|Dose Escalation Period|Withdrawal by Subject|0
858230|NCT00452673|1816895|FG003|Dose Escalation Period|Withdrawal by Subject|1
858231|NCT00452673|1816896|FG004|Dose Escalation Period|Withdrawal by Subject|0
858232|NCT00452673|1816892|FG000|Dose Expansion Period|Disease Progression|0
858233|NCT00452673|1816893|FG001|Dose Expansion Period|Disease Progression|0
858234|NCT00452673|1816894|FG002|Dose Expansion Period|Disease Progression|0
858235|NCT00452673|1816895|FG003|Dose Expansion Period|Disease Progression|0
858236|NCT00452673|1816896|FG004|Dose Expansion Period|Disease Progression|19
858237|NCT00452673|1816892|FG000|Dose Expansion Period|Other|0
858238|NCT00452673|1816893|FG001|Dose Expansion Period|Other|0
858239|NCT00452673|1816894|FG002|Dose Expansion Period|Other|0
858240|NCT00452673|1816895|FG003|Dose Expansion Period|Other|0
858241|NCT00452673|1816896|FG004|Dose Expansion Period|Other|2
858242|NCT00452699|1816909|FG000|Overall Study|Adverse Event|10
858243|NCT00452699|1816910|FG001|Overall Study|Adverse Event|3
858244|NCT00452699|1816909|FG000|Overall Study|Lack of Efficacy|6
858245|NCT00452699|1816910|FG001|Overall Study|Lack of Efficacy|4
858246|NCT00452699|1816909|FG000|Overall Study|Lost to Follow-up|6
858247|NCT00452699|1816910|FG001|Overall Study|Lost to Follow-up|9
858248|NCT00452699|1816909|FG000|Overall Study|Protocol Violation|21
858249|NCT00452699|1816910|FG001|Overall Study|Protocol Violation|25
858250|NCT00452699|1816909|FG000|Overall Study|Withdrawal by Subject|26
858251|NCT00452699|1816910|FG001|Overall Study|Withdrawal by Subject|25
858252|NCT00452699|1816909|FG000|Overall Study|Other|12
858253|NCT00452699|1816910|FG001|Overall Study|Other|7
858254|NCT00452790|1816918|FG000|Infant Series|Clinical hold - consent withdrawn|118
858255|NCT00452790|1816919|FG001|Infant Series|Clinical hold - consent withdrawn|123
858256|NCT00452790|1816918|FG000|Infant Series|Parent/legal guardian request|8
858257|NCT00452790|1816919|FG001|Infant Series|Parent/legal guardian request|6
858258|NCT00452790|1816918|FG000|Infant Series|Failed to return|4
858259|NCT00452790|1816919|FG001|Infant Series|Failed to return|1
858260|NCT00452790|1816918|FG000|Infant Series|Protocol Violation|1
858261|NCT00452790|1816919|FG001|Infant Series|Protocol Violation|3
858262|NCT00452790|1816918|FG000|Infant Series|Lost to Follow-up|2
858263|NCT00452790|1816919|FG001|Infant Series|Lost to Follow-up|2
858264|NCT00452790|1816918|FG000|Infant Series|Adverse Event|1
858265|NCT00452790|1816919|FG001|Infant Series|Adverse Event|2
858266|NCT00452790|1816918|FG000|Infant Series|Other reasons|1
858267|NCT00452790|1816919|FG001|Infant Series|Other reasons|2
858268|NCT00452790|1816918|FG000|Infant Series|Investigator request|0
858269|NCT00452790|1816919|FG001|Infant Series|Investigator request|1
858270|NCT00452790|1816918|FG000|Infant Series|Death|0
858271|NCT00452790|1816919|FG001|Infant Series|Death|1
858272|NCT00452790|1816918|FG000|After Infant Series|Investigator request|10
858273|NCT00452790|1816919|FG001|After Infant Series|Investigator request|10
858274|NCT00452790|1816918|FG000|After Infant Series|Adverse Event|4
858275|NCT00452790|1816919|FG001|After Infant Series|Adverse Event|1
858276|NCT00452790|1816918|FG000|After Infant Series|Parent/legal guardian request|1
858277|NCT00452790|1816919|FG001|After Infant Series|Parent/legal guardian request|3
858278|NCT00452790|1816918|FG000|After Infant Series|Lost to Follow-up|4
858279|NCT00452790|1816919|FG001|After Infant Series|Lost to Follow-up|0
858280|NCT00452790|1816918|FG000|After Infant Series|Failed to return|1
858281|NCT00452790|1816919|FG001|After Infant Series|Failed to return|0
858282|NCT00452790|1816918|FG000|After Infant Series|Other reasons|1
858283|NCT00452790|1816919|FG001|After Infant Series|Other reasons|0
858284|NCT00452790|1816918|FG000|Toddler Dose|Failed to return|0
858285|NCT00452790|1816919|FG001|Toddler Dose|Failed to return|1
858286|NCT00452790|1816918|FG000|Toddler Dose|Parent/legal guardian request|0
858287|NCT00452790|1816919|FG001|Toddler Dose|Parent/legal guardian request|1
858288|NCT00453063|1816935|FG000|Overall Study|Adverse Event|1
858289|NCT00453063|1816936|FG001|Overall Study|Adverse Event|2
858290|NCT00453063|1816935|FG000|Overall Study|Withdrawal by Subject|1
858291|NCT00453063|1816936|FG001|Overall Study|Withdrawal by Subject|1
858292|NCT00453063|1816935|FG000|Overall Study|Protocol Violation|1
858293|NCT00453063|1816936|FG001|Overall Study|Protocol Violation|0
858294|NCT00453102|1816942|FG000|Overall Study|Withdrawal by Subject|2
858295|NCT00453154|1816949|FG000|Double BIind Maintenance|Adverse Event|0
858296|NCT00453154|1816950|FG001|Double BIind Maintenance|Adverse Event|0
858297|NCT00453154|1816951|FG002|Double BIind Maintenance|Adverse Event|3
858298|NCT00453154|1816952|FG003|Double BIind Maintenance|Adverse Event|12
858299|NCT00453154|1816949|FG000|Double BIind Maintenance|Death|0
858300|NCT00453154|1816950|FG001|Double BIind Maintenance|Death|0
858301|NCT00453154|1816951|FG002|Double BIind Maintenance|Death|2
858302|NCT00453154|1816952|FG003|Double BIind Maintenance|Death|1
858303|NCT00453154|1816949|FG000|Double BIind Maintenance|Withdrawal by Subject|0
858304|NCT00453154|1816950|FG001|Double BIind Maintenance|Withdrawal by Subject|0
858305|NCT00453154|1816951|FG002|Double BIind Maintenance|Withdrawal by Subject|4
858306|NCT00453154|1816952|FG003|Double BIind Maintenance|Withdrawal by Subject|4
858307|NCT00453154|1816949|FG000|Double BIind Maintenance|Progression|0
858308|NCT00453154|1816950|FG001|Double BIind Maintenance|Progression|0
858309|NCT00453154|1816951|FG002|Double BIind Maintenance|Progression|29
858310|NCT00453154|1816952|FG003|Double BIind Maintenance|Progression|26
858311|NCT00453154|1816949|FG000|Double BIind Maintenance|Medical Issues|0
858312|NCT00453154|1816950|FG001|Double BIind Maintenance|Medical Issues|0
858313|NCT00453154|1816951|FG002|Double BIind Maintenance|Medical Issues|3
858314|NCT00453154|1816952|FG003|Double BIind Maintenance|Medical Issues|1
858315|NCT00453154|1816949|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0
858316|NCT00453154|1816950|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0
858317|NCT00453154|1816951|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5
858318|NCT00453154|1816952|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5
858319|NCT00453180|1816963|FG000|Overall Study|Lost to Follow-up|2
858320|NCT00453180|1816964|FG001|Overall Study|Lost to Follow-up|1
858321|NCT00453180|1816963|FG000|Overall Study|Adverse Event|1
858322|NCT00453180|1816964|FG001|Overall Study|Adverse Event|2
858323|NCT00453206|1816974|FG000|Overall Study|Death|1
858324|NCT00453310|1816978|FG000|Overall Study|Progression of Disease|10
858325|NCT00453349|1816988|FG000|Randomized|Adverse Event|12
858326|NCT00453349|1816989|FG001|Randomized|Adverse Event|11
858327|NCT00453349|1816988|FG000|Randomized|Lack of Efficacy|2
858328|NCT00453349|1816989|FG001|Randomized|Lack of Efficacy|1
858329|NCT00453349|1816988|FG000|Randomized|Lost to Follow-up|7
858330|NCT00453349|1816989|FG001|Randomized|Lost to Follow-up|5
858331|NCT00453349|1816988|FG000|Randomized|Protocol Violation|1
858332|NCT00453349|1816989|FG001|Randomized|Protocol Violation|1
858333|NCT00453349|1816988|FG000|Randomized|Withdrawal by Subject|3
858334|NCT00453349|1816989|FG001|Randomized|Withdrawal by Subject|5
858335|NCT00453349|1816988|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10
858336|NCT00453349|1816989|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11
858337|NCT00453349|1816988|FG000|Completed Study|Adverse Event|12
858338|NCT00453349|1816989|FG001|Completed Study|Adverse Event|11
858339|NCT00453349|1816988|FG000|Completed Study|Lack of Efficacy|2
858340|NCT00453349|1816989|FG001|Completed Study|Lack of Efficacy|1
858341|NCT00453349|1816988|FG000|Completed Study|Lost to Follow-up|7
858342|NCT00453349|1816989|FG001|Completed Study|Lost to Follow-up|5
858343|NCT00453349|1816988|FG000|Completed Study|Protocol Violation|1
858344|NCT00453349|1816989|FG001|Completed Study|Protocol Violation|1
858345|NCT00453349|1816988|FG000|Completed Study|Withdrawal by Subject|3
858346|NCT00453349|1816989|FG001|Completed Study|Withdrawal by Subject|5
858347|NCT00453349|1816988|FG000|Completed Study|Lost to follow up after study treatment|2
858348|NCT00453349|1816989|FG001|Completed Study|Lost to follow up after study treatment|11
858349|NCT00453362|1816995|FG000|Overall Study|Adverse Event|5
858350|NCT00453362|1816995|FG000|Overall Study|Death|7
858351|NCT00453362|1816995|FG000|Overall Study|Physician Decision|2
858352|NCT00453362|1816995|FG000|Overall Study|Withdrawal by Subject|3
858353|NCT00453362|1816995|FG000|Overall Study|Progression of disease|56
858354|NCT00453362|1816995|FG000|Overall Study|Screening Failure|14
858355|NCT00453921|1817051|FG000|Overall Study|Withdrawal by Subject|1
858356|NCT00453921|1817052|FG001|Overall Study|Withdrawal by Subject|1
858357|NCT00453921|1817053|FG002|Overall Study|Withdrawal by Subject|1
858358|NCT00453921|1817054|FG003|Overall Study|Withdrawal by Subject|1
858359|NCT00453921|1817051|FG000|Overall Study|Lost to Follow-up|0
858360|NCT00453921|1817052|FG001|Overall Study|Lost to Follow-up|0
858361|NCT00453921|1817053|FG002|Overall Study|Lost to Follow-up|1
858362|NCT00453921|1817054|FG003|Overall Study|Lost to Follow-up|0
858363|NCT00453973|1817070|FG000|Overall Study|Adverse Event|4
858364|NCT00453973|1817071|FG001|Overall Study|Adverse Event|9
858365|NCT00453973|1817070|FG000|Overall Study|Withdrawal by Subject|7
858366|NCT00453973|1817071|FG001|Overall Study|Withdrawal by Subject|6
858367|NCT00453973|1817070|FG000|Overall Study|PI Decision|0
858368|NCT00453973|1817071|FG001|Overall Study|PI Decision|2
858369|NCT00453973|1817070|FG000|Overall Study|Relocation|1
858370|NCT00453973|1817071|FG001|Overall Study|Relocation|0
858371|NCT00453973|1817070|FG000|Overall Study|Renal transplant|1
858372|NCT00453973|1817071|FG001|Overall Study|Renal transplant|1
858373|NCT00453973|1817070|FG000|Overall Study|Site closed by sponsor|3
858374|NCT00453973|1817071|FG001|Overall Study|Site closed by sponsor|0
858375|NCT00453973|1817070|FG000|Overall Study|Sponsor Decision to Terminate Study|35
858376|NCT00453973|1817071|FG001|Overall Study|Sponsor Decision to Terminate Study|30
858377|NCT00453986|1817082|FG000|Overall Study|Lost to Follow-up|6
858378|NCT00453986|1817083|FG001|Overall Study|Lost to Follow-up|5
858379|NCT00453986|1817084|FG002|Overall Study|Lost to Follow-up|6
858380|NCT00453986|1817085|FG003|Overall Study|Lost to Follow-up|2
858381|NCT00453986|1817086|FG004|Overall Study|Lost to Follow-up|0
858382|NCT00453999|1817105|FG000|Overall Study|Adverse Event|1
858383|NCT00453999|1817106|FG001|Overall Study|Adverse Event|2
858384|NCT00453999|1817107|FG002|Overall Study|Adverse Event|1
858385|NCT00453999|1817105|FG000|Overall Study|Lost to Follow-up|0
858386|NCT00453999|1817106|FG001|Overall Study|Lost to Follow-up|1
858387|NCT00453999|1817107|FG002|Overall Study|Lost to Follow-up|1
858388|NCT00453999|1817105|FG000|Overall Study|Withdrawal by Subject|2
858389|NCT00453999|1817106|FG001|Overall Study|Withdrawal by Subject|1
858390|NCT00453999|1817107|FG002|Overall Study|Withdrawal by Subject|1
858391|NCT00453999|1817105|FG000|Overall Study|Subject Request|2
858392|NCT00453999|1817106|FG001|Overall Study|Subject Request|1
858393|NCT00453999|1817107|FG002|Overall Study|Subject Request|0
858394|NCT00454051|1817118|FG000|Overall Study|Adverse Event|1
858395|NCT00454051|1817119|FG001|Overall Study|Adverse Event|2
858396|NCT00454051|1817118|FG000|Overall Study|Withdrawal by Subject|1
858397|NCT00454051|1817119|FG001|Overall Study|Withdrawal by Subject|0
858398|NCT00454051|1817118|FG000|Overall Study|Protocol Violation|1
858399|NCT00454051|1817119|FG001|Overall Study|Protocol Violation|1
858400|NCT00454116|1817128|FG000|Overall Study|Adverse Event|5
858401|NCT00454116|1817129|FG001|Overall Study|Adverse Event|11
858402|NCT00454116|1817130|FG002|Overall Study|Adverse Event|9
858403|NCT00454116|1817128|FG000|Overall Study|Condition under investigation worsened|17
858404|NCT00454116|1817129|FG001|Overall Study|Condition under investigation worsened|13
858405|NCT00454116|1817130|FG002|Overall Study|Condition under investigation worsened|18
858406|NCT00454116|1817128|FG000|Overall Study|Withdrawal by Subject|3
858407|NCT00454116|1817129|FG001|Overall Study|Withdrawal by Subject|3
858408|NCT00454116|1817130|FG002|Overall Study|Withdrawal by Subject|1
858409|NCT00454116|1817128|FG000|Overall Study|Other|2
858410|NCT00454116|1817129|FG001|Overall Study|Other|2
858411|NCT00454116|1817130|FG002|Overall Study|Other|0
858412|NCT00454142|1817138|FG000|Overall Study|Withdrawal by Subject|1
858413|NCT00454181|1817146|FG000|Overall Study|Adverse Event|1
858414|NCT00454181|1817147|FG001|Overall Study|Adverse Event|1
858415|NCT00454181|1817146|FG000|Overall Study|Lost to Follow-up|11
858416|NCT00454181|1817147|FG001|Overall Study|Lost to Follow-up|1
858417|NCT00454181|1817146|FG000|Overall Study|Protocol Violation|1
858418|NCT00454181|1817147|FG001|Overall Study|Protocol Violation|1
858419|NCT00454181|1817146|FG000|Overall Study|Withdrawal by Subject|2
858420|NCT00454181|1817147|FG001|Overall Study|Withdrawal by Subject|0
858421|NCT00454194|1817155|FG000|Overall Study|Adverse Event|7
858422|NCT00454194|1817156|FG001|Overall Study|Adverse Event|2
858423|NCT00454194|1817155|FG000|Overall Study|Withdrawal by Subject|12
858424|NCT00454194|1817156|FG001|Overall Study|Withdrawal by Subject|8
858425|NCT00454194|1817155|FG000|Overall Study|Other Medical Problems|1
858426|NCT00454194|1817156|FG001|Overall Study|Other Medical Problems|2
858427|NCT00454194|1817155|FG000|Overall Study|Other Unspecified Reason|2
858428|NCT00454194|1817156|FG001|Overall Study|Other Unspecified Reason|2
858429|NCT00454207|1817164|FG000|Overall Study|Adverse Event|3
858430|NCT00454207|1817165|FG001|Overall Study|Adverse Event|1
858431|NCT00454207|1817164|FG000|Overall Study|Lack of Efficacy|1
858432|NCT00454207|1817165|FG001|Overall Study|Lack of Efficacy|0
858433|NCT00454207|1817164|FG000|Overall Study|Protocol Violation|0
858434|NCT00454207|1817165|FG001|Overall Study|Protocol Violation|1
858435|NCT00454246|1817186|FG000|Overall Study|Adverse Event|2
858436|NCT00454246|1817187|FG001|Overall Study|Adverse Event|2
858437|NCT00454246|1817188|FG002|Overall Study|Adverse Event|0
858438|NCT00454246|1817186|FG000|Overall Study|Violation of selection criteria at entry|6
858439|NCT00454246|1817187|FG001|Overall Study|Violation of selection criteria at entry|0
858440|NCT00454246|1817188|FG002|Overall Study|Violation of selection criteria at entry|0
858441|NCT00454246|1817186|FG000|Overall Study|Protocol Violation|1
858442|NCT00454246|1817187|FG001|Overall Study|Protocol Violation|0
858443|NCT00454246|1817188|FG002|Overall Study|Protocol Violation|0
858444|NCT00454246|1817186|FG000|Overall Study|Refused Treatment|1
858445|NCT00454246|1817187|FG001|Overall Study|Refused Treatment|1
858446|NCT00454246|1817188|FG002|Overall Study|Refused Treatment|0
858447|NCT00454246|1817186|FG000|Overall Study|Failure to return|1
858448|NCT00454246|1817187|FG001|Overall Study|Failure to return|0
858449|NCT00454246|1817188|FG002|Overall Study|Failure to return|0
858450|NCT00454246|1817186|FG000|Overall Study|Early termination of study|62
858451|NCT00454246|1817187|FG001|Overall Study|Early termination of study|26
858452|NCT00454246|1817188|FG002|Overall Study|Early termination of study|9
858453|NCT00454363|1817207|FG000|Overall Study|Adverse Event|1
858454|NCT00454363|1817208|FG001|Overall Study|Adverse Event|2
858455|NCT00454363|1817207|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4
858456|NCT00454363|1817208|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0
858457|NCT00454584|1817233|FG000|Controlled Period|Adverse Event|5
858458|NCT00454584|1817234|FG001|Controlled Period|Adverse Event|2
858459|NCT00454584|1817235|FG002|Controlled Period|Adverse Event|1
858460|NCT00454584|1817236|FG003|Controlled Period|Adverse Event|0
858461|NCT00454584|1817237|FG004|Controlled Period|Adverse Event|0
858462|NCT00454584|1817238|FG005|Controlled Period|Adverse Event|0
858463|NCT00454584|1817233|FG000|Controlled Period|Lost to Follow-up|1
858464|NCT00454584|1817234|FG001|Controlled Period|Lost to Follow-up|2
858465|NCT00454584|1817235|FG002|Controlled Period|Lost to Follow-up|2
858466|NCT00454584|1817236|FG003|Controlled Period|Lost to Follow-up|0
858467|NCT00454584|1817237|FG004|Controlled Period|Lost to Follow-up|0
858468|NCT00454584|1817238|FG005|Controlled Period|Lost to Follow-up|0
858469|NCT00454584|1817233|FG000|Controlled Period|Other|5
858470|NCT00454584|1817234|FG001|Controlled Period|Other|4
858471|NCT00454584|1817235|FG002|Controlled Period|Other|2
858472|NCT00454584|1817236|FG003|Controlled Period|Other|0
858473|NCT00454584|1817237|FG004|Controlled Period|Other|0
858474|NCT00454584|1817238|FG005|Controlled Period|Other|0
858475|NCT00454584|1817233|FG000|After Controlled Period|Adverse Event|0
858476|NCT00454584|1817234|FG001|After Controlled Period|Adverse Event|0
858477|NCT00454584|1817235|FG002|After Controlled Period|Adverse Event|0
858478|NCT00454584|1817236|FG003|After Controlled Period|Adverse Event|9
858479|NCT00454584|1817237|FG004|After Controlled Period|Adverse Event|3
858480|NCT00454584|1817238|FG005|After Controlled Period|Adverse Event|9
858481|NCT00454584|1817233|FG000|After Controlled Period|Lack of Efficacy|0
858482|NCT00454584|1817234|FG001|After Controlled Period|Lack of Efficacy|0
858483|NCT00454584|1817235|FG002|After Controlled Period|Lack of Efficacy|0
858484|NCT00454584|1817236|FG003|After Controlled Period|Lack of Efficacy|1
858485|NCT00454584|1817237|FG004|After Controlled Period|Lack of Efficacy|0
858486|NCT00454584|1817238|FG005|After Controlled Period|Lack of Efficacy|0
858487|NCT00454584|1817233|FG000|After Controlled Period|Lost to Follow-up|0
858488|NCT00454584|1817234|FG001|After Controlled Period|Lost to Follow-up|0
858489|NCT00454584|1817235|FG002|After Controlled Period|Lost to Follow-up|0
858490|NCT00454584|1817236|FG003|After Controlled Period|Lost to Follow-up|2
858491|NCT00454584|1817237|FG004|After Controlled Period|Lost to Follow-up|4
858492|NCT00454584|1817238|FG005|After Controlled Period|Lost to Follow-up|6
858493|NCT00454584|1817233|FG000|After Controlled Period|Other|0
858494|NCT00454584|1817234|FG001|After Controlled Period|Other|0
858495|NCT00454584|1817235|FG002|After Controlled Period|Other|0
858496|NCT00454584|1817236|FG003|After Controlled Period|Other|1
858497|NCT00454584|1817237|FG004|After Controlled Period|Other|0
858498|NCT00454584|1817238|FG005|After Controlled Period|Other|0
858499|NCT00454584|1817233|FG000|After Controlled Period|Other|0
858500|NCT00454584|1817234|FG001|After Controlled Period|Other|0
858501|NCT00454584|1817235|FG002|After Controlled Period|Other|0
858502|NCT00454584|1817236|FG003|After Controlled Period|Other|13
858503|NCT00454584|1817237|FG004|After Controlled Period|Other|5
858504|NCT00454584|1817238|FG005|After Controlled Period|Other|17
858505|NCT00454636|1817256|FG000|Overall Study|Adverse Event|10
858506|NCT00454636|1817257|FG001|Overall Study|Adverse Event|6
858507|NCT00454636|1817258|FG002|Overall Study|Adverse Event|9
858508|NCT00454636|1817259|FG003|Overall Study|Adverse Event|15
858509|NCT00454636|1817256|FG000|Overall Study|Disease Progression|11
858510|NCT00454636|1817257|FG001|Overall Study|Disease Progression|12
858511|NCT00454636|1817258|FG002|Overall Study|Disease Progression|4
858512|NCT00454636|1817259|FG003|Overall Study|Disease Progression|11
858513|NCT00454636|1817256|FG000|Overall Study|Protocol Violation|3
858514|NCT00454636|1817257|FG001|Overall Study|Protocol Violation|2
858515|NCT00454636|1817258|FG002|Overall Study|Protocol Violation|3
858516|NCT00454636|1817259|FG003|Overall Study|Protocol Violation|3
858517|NCT00454636|1817256|FG000|Overall Study|Death|6
858518|NCT00454636|1817257|FG001|Overall Study|Death|1
858519|NCT00454636|1817258|FG002|Overall Study|Death|1
858520|NCT00454636|1817259|FG003|Overall Study|Death|1
858521|NCT00454636|1817256|FG000|Overall Study|Patient refusal|1
858522|NCT00454636|1817257|FG001|Overall Study|Patient refusal|1
858523|NCT00454636|1817258|FG002|Overall Study|Patient refusal|3
858524|NCT00454636|1817259|FG003|Overall Study|Patient refusal|2
858525|NCT00454636|1817256|FG000|Overall Study|Lost to Follow-up|0
858526|NCT00454636|1817257|FG001|Overall Study|Lost to Follow-up|1
858527|NCT00454636|1817258|FG002|Overall Study|Lost to Follow-up|0
858528|NCT00454636|1817259|FG003|Overall Study|Lost to Follow-up|0
858529|NCT00454649|1817279|FG000|Overall Study|Lack of Efficacy|2
858530|NCT00454649|1817280|FG001|Overall Study|Lack of Efficacy|2
858531|NCT00454649|1817281|FG002|Overall Study|Lack of Efficacy|10
858532|NCT00454649|1817282|FG003|Overall Study|Lack of Efficacy|3
858533|NCT00454649|1817283|FG004|Overall Study|Lack of Efficacy|0
858534|NCT00454649|1817284|FG005|Overall Study|Lack of Efficacy|4
858535|NCT00454649|1817285|FG006|Overall Study|Lack of Efficacy|5
858536|NCT00454649|1817286|FG007|Overall Study|Lack of Efficacy|13
858537|NCT00454649|1817287|FG008|Overall Study|Lack of Efficacy|10
858538|NCT00454649|1817288|FG009|Overall Study|Lack of Efficacy|2
858539|NCT00454649|1817279|FG000|Overall Study|Adverse Event|0
858540|NCT00454649|1817280|FG001|Overall Study|Adverse Event|1
858541|NCT00454649|1817281|FG002|Overall Study|Adverse Event|3
858542|NCT00454649|1817282|FG003|Overall Study|Adverse Event|0
858543|NCT00454649|1817283|FG004|Overall Study|Adverse Event|1
858544|NCT00454649|1817284|FG005|Overall Study|Adverse Event|2
858545|NCT00454649|1817285|FG006|Overall Study|Adverse Event|3
858546|NCT00454649|1817286|FG007|Overall Study|Adverse Event|4
858547|NCT00454649|1817287|FG008|Overall Study|Adverse Event|6
858548|NCT00454649|1817288|FG009|Overall Study|Adverse Event|2
858549|NCT00454649|1817279|FG000|Overall Study|Lost to Follow-up|0
858550|NCT00454649|1817280|FG001|Overall Study|Lost to Follow-up|0
858551|NCT00454649|1817281|FG002|Overall Study|Lost to Follow-up|1
858552|NCT00454649|1817282|FG003|Overall Study|Lost to Follow-up|0
858553|NCT00454649|1817283|FG004|Overall Study|Lost to Follow-up|0
858554|NCT00454649|1817284|FG005|Overall Study|Lost to Follow-up|0
858555|NCT00454649|1817285|FG006|Overall Study|Lost to Follow-up|1
858556|NCT00454649|1817286|FG007|Overall Study|Lost to Follow-up|0
858557|NCT00454649|1817287|FG008|Overall Study|Lost to Follow-up|0
858558|NCT00454649|1817288|FG009|Overall Study|Lost to Follow-up|0
858559|NCT00454649|1817279|FG000|Overall Study|Other|1
858560|NCT00454649|1817280|FG001|Overall Study|Other|1
858561|NCT00454649|1817281|FG002|Overall Study|Other|5
858562|NCT00454649|1817282|FG003|Overall Study|Other|3
858563|NCT00454649|1817283|FG004|Overall Study|Other|0
858564|NCT00454649|1817284|FG005|Overall Study|Other|0
858565|NCT00454649|1817285|FG006|Overall Study|Other|0
858566|NCT00454649|1817286|FG007|Overall Study|Other|0
858567|NCT00454649|1817287|FG008|Overall Study|Other|3
858568|NCT00454649|1817288|FG009|Overall Study|Other|1
858569|NCT00454649|1817279|FG000|Overall Study|Withdrawal by Subject|0
858570|NCT00454649|1817280|FG001|Overall Study|Withdrawal by Subject|0
858571|NCT00454649|1817281|FG002|Overall Study|Withdrawal by Subject|0
858572|NCT00454649|1817282|FG003|Overall Study|Withdrawal by Subject|0
858573|NCT00454649|1817283|FG004|Overall Study|Withdrawal by Subject|0
858574|NCT00454649|1817284|FG005|Overall Study|Withdrawal by Subject|1
858575|NCT00454649|1817285|FG006|Overall Study|Withdrawal by Subject|0
858576|NCT00454649|1817286|FG007|Overall Study|Withdrawal by Subject|2
858577|NCT00454649|1817287|FG008|Overall Study|Withdrawal by Subject|1
858578|NCT00454649|1817288|FG009|Overall Study|Withdrawal by Subject|0
858579|NCT00454779|1817331|FG000|First-line Treatment Phase|Lack of Efficacy|0
858580|NCT00454779|1817332|FG001|First-line Treatment Phase|Lack of Efficacy|2
858581|NCT00454779|1817331|FG000|First-line Treatment Phase|Withdrawal by Subject|2
858582|NCT00454779|1817332|FG001|First-line Treatment Phase|Withdrawal by Subject|4
858583|NCT00454779|1817331|FG000|First-line Treatment Phase|Lost to Follow-up|1
858584|NCT00454779|1817332|FG001|First-line Treatment Phase|Lost to Follow-up|0
858585|NCT00454779|1817331|FG000|First-line Treatment Phase|Protocol Violation|0
858586|NCT00454779|1817332|FG001|First-line Treatment Phase|Protocol Violation|1
858587|NCT00454779|1817331|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1
858588|NCT00454779|1817332|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1
858589|NCT00454779|1817331|FG000|First-line Treatment Phase|Ongoing|1
858590|NCT00454779|1817332|FG001|First-line Treatment Phase|Ongoing|0
858591|NCT00454779|1817331|FG000|Second-line Treatment Phase|Withdrawal by Subject|0
858592|NCT00454779|1817332|FG001|Second-line Treatment Phase|Withdrawal by Subject|1
858593|NCT00454779|1817331|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0
858594|NCT00454779|1817332|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1
858595|NCT00454779|1817331|FG000|Second-line Treatment Phase|Ongoing|0
858596|NCT00454779|1817332|FG001|Second-line Treatment Phase|Ongoing|1
858597|NCT00454805|1817340|FG000|Overall Study|Withdrawal by Subject|9
858598|NCT00454805|1817341|FG001|Overall Study|Withdrawal by Subject|2
858599|NCT00454805|1817340|FG000|Overall Study|Death|0
858600|NCT00454805|1817341|FG001|Overall Study|Death|2
858601|NCT00454805|1817340|FG000|Overall Study|Disease progression|16
858602|NCT00454805|1817341|FG001|Overall Study|Disease progression|19
858603|NCT00454805|1817340|FG000|Overall Study|In order to begin radiotherapy|1
858604|NCT00454805|1817341|FG001|Overall Study|In order to begin radiotherapy|0
858605|NCT00454818|1817355|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1
858606|NCT00454818|1817356|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0
858607|NCT00454818|1817357|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0
858608|NCT00454818|1817358|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0
858609|NCT00454818|1817359|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0
858610|NCT00454818|1817355|FG000|Phase I: Open-label Dose-escalation|Death|0
858611|NCT00454818|1817356|FG001|Phase I: Open-label Dose-escalation|Death|1
858612|NCT00454818|1817357|FG002|Phase I: Open-label Dose-escalation|Death|0
858613|NCT00454818|1817358|FG003|Phase I: Open-label Dose-escalation|Death|0
858614|NCT00454818|1817359|FG004|Phase I: Open-label Dose-escalation|Death|0
858615|NCT00454818|1817355|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
858616|NCT00454818|1817356|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
858617|NCT00454818|1817357|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
858618|NCT00454818|1817358|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
858619|NCT00454818|1817359|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
858620|NCT00454818|1817355|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
858621|NCT00454818|1817356|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
858622|NCT00454818|1817357|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
858623|NCT00454818|1817358|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
858624|NCT00454818|1817359|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
858625|NCT00454818|1817355|FG000|Phase 2: Randomized Double-blind|Death|0
858626|NCT00454818|1817356|FG001|Phase 2: Randomized Double-blind|Death|1
858627|NCT00454818|1817357|FG002|Phase 2: Randomized Double-blind|Death|0
858628|NCT00454818|1817358|FG003|Phase 2: Randomized Double-blind|Death|0
858629|NCT00454818|1817359|FG004|Phase 2: Randomized Double-blind|Death|1
858630|NCT00454818|1817355|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0
858631|NCT00454818|1817356|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0
858632|NCT00454818|1817357|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2
858633|NCT00454818|1817358|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0
858634|NCT00454818|1817359|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1
858635|NCT00454818|1817355|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
858636|NCT00454818|1817356|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
858637|NCT00454818|1817357|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
858638|NCT00454818|1817358|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
858639|NCT00454818|1817359|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
858640|NCT00454857|1817376|FG000|Overall Study|Withdrawal by Subject|15
858641|NCT00454857|1817376|FG000|Overall Study|Lost to Follow-up|16
858642|NCT00454857|1817376|FG000|Overall Study|Noncompliance|6
858643|NCT00454857|1817376|FG000|Overall Study|Death|5
858644|NCT00454857|1817376|FG000|Overall Study|Other|11
858645|NCT00454857|1817376|FG000|Overall Study|Reason unknown|1
858646|NCT00454909|1817383|FG000|Overall Study|Withdrawal by Subject|1
858647|NCT00454909|1817384|FG001|Overall Study|Withdrawal by Subject|0
858648|NCT00454909|1817385|FG002|Overall Study|Withdrawal by Subject|0
858649|NCT00454909|1817383|FG000|Overall Study|Migrated/moved from study area|0
858650|NCT00454909|1817384|FG001|Overall Study|Migrated/moved from study area|0
858651|NCT00454909|1817385|FG002|Overall Study|Migrated/moved from study area|1
858652|NCT00454909|1817383|FG000|Overall Study|Lost to follow-up (complete vaccination)|5
858653|NCT00454909|1817384|FG001|Overall Study|Lost to follow-up (complete vaccination)|3
858654|NCT00454909|1817385|FG002|Overall Study|Lost to follow-up (complete vaccination)|1
858655|NCT00454909|1817383|FG000|Overall Study|Others|1
858656|NCT00454909|1817384|FG001|Overall Study|Others|0
858657|NCT00454909|1817385|FG002|Overall Study|Others|0
858658|NCT00454987|1817397|FG000|Booster Period (NCT00258700)|Adverse Event|1
858659|NCT00454987|1817398|FG001|Booster Period (NCT00258700)|Adverse Event|0
858660|NCT00454987|1817399|FG002|Booster Period (NCT00258700)|Adverse Event|0
858661|NCT00454987|1817397|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0
858662|NCT00454987|1817398|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1
858663|NCT00454987|1817399|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0
858664|NCT00454987|1817397|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1
858665|NCT00454987|1817398|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0
858666|NCT00454987|1817399|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0
858667|NCT00455013|1817411|FG000|Short Term Period|Adverse Event|2
858668|NCT00455013|1817412|FG001|Short Term Period|Adverse Event|5
858669|NCT00455013|1817413|FG002|Short Term Period|Adverse Event|0
858670|NCT00455013|1817411|FG000|Short Term Period|Withdrawal by Subject|0
858671|NCT00455013|1817412|FG001|Short Term Period|Withdrawal by Subject|0
858672|NCT00455013|1817413|FG002|Short Term Period|Withdrawal by Subject|1
858673|NCT00455013|1817411|FG000|Short Term Period|Lack of Efficacy|4
858674|NCT00455013|1817412|FG001|Short Term Period|Lack of Efficacy|0
858675|NCT00455013|1817413|FG002|Short Term Period|Lack of Efficacy|0
858676|NCT00455013|1817411|FG000|Short Term Period|Other|0
858677|NCT00455013|1817412|FG001|Short Term Period|Other|0
858678|NCT00455013|1817413|FG002|Short Term Period|Other|1
858679|NCT00455013|1817411|FG000|Long Term Extension (LTE)|Adverse Event|0
858680|NCT00455013|1817412|FG001|Long Term Extension (LTE)|Adverse Event|1
858681|NCT00455013|1817413|FG002|Long Term Extension (LTE)|Adverse Event|1
858682|NCT00455013|1817411|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1
858683|NCT00455013|1817412|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0
858684|NCT00455013|1817413|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1
858685|NCT00455013|1817411|FG000|Long Term Extension (LTE)|Death|1
858686|NCT00455013|1817412|FG001|Long Term Extension (LTE)|Death|1
858687|NCT00455013|1817413|FG002|Long Term Extension (LTE)|Death|0
858688|NCT00455013|1817411|FG000|Long Term Extension (LTE)|No longer met criteria|0
858689|NCT00455013|1817412|FG001|Long Term Extension (LTE)|No longer met criteria|0
858690|NCT00455013|1817413|FG002|Long Term Extension (LTE)|No longer met criteria|1
858691|NCT00455013|1817411|FG000|Long Term Extension (LTE)|Subject Request or refused|0
858692|NCT00455013|1817412|FG001|Long Term Extension (LTE)|Subject Request or refused|0
858693|NCT00455013|1817413|FG002|Long Term Extension (LTE)|Subject Request or refused|3
858694|NCT00455013|1817411|FG000|Long Term Extension (LTE)|Poor non-compliance|0
858695|NCT00455013|1817412|FG001|Long Term Extension (LTE)|Poor non-compliance|1
858696|NCT00455013|1817413|FG002|Long Term Extension (LTE)|Poor non-compliance|0
858697|NCT00455013|1817411|FG000|Long Term Extension (LTE)|non-specified|0
858698|NCT00455013|1817412|FG001|Long Term Extension (LTE)|non-specified|0
858699|NCT00455013|1817413|FG002|Long Term Extension (LTE)|non-specified|1
858700|NCT00455195|1817423|FG000|Double-blind Study AGLU02704|Adverse Event|2
858701|NCT00455195|1817424|FG001|Double-blind Study AGLU02704|Adverse Event|1
858702|NCT00455195|1817423|FG000|Double-blind Study AGLU02704|Death|1
858703|NCT00455195|1817424|FG001|Double-blind Study AGLU02704|Death|0
858704|NCT00455195|1817423|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2
858705|NCT00455195|1817424|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2
858706|NCT00455195|1817423|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0
858707|NCT00455195|1817424|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1
858708|NCT00455312|1817432|FG000|Overall Study|Death|0
858709|NCT00455312|1817433|FG001|Overall Study|Death|1
858716|NCT00455429|1817452|FG000|Overall Study|Study Terminated by Sponsor|0
858717|NCT00455429|1817453|FG001|Overall Study|Study Terminated by Sponsor|0
858718|NCT00455429|1817454|FG002|Overall Study|Study Terminated by Sponsor|0
858719|NCT00455429|1817455|FG003|Overall Study|Study Terminated by Sponsor|3
858720|NCT00455429|1817452|FG000|Overall Study|Lost to Follow-up|1
858721|NCT00455429|1817453|FG001|Overall Study|Lost to Follow-up|0
858722|NCT00455429|1817454|FG002|Overall Study|Lost to Follow-up|0
858723|NCT00455429|1817455|FG003|Overall Study|Lost to Follow-up|3
858724|NCT00455429|1817452|FG000|Overall Study|Withdrawal by Subject|0
858725|NCT00455429|1817453|FG001|Overall Study|Withdrawal by Subject|1
858726|NCT00455429|1817454|FG002|Overall Study|Withdrawal by Subject|1
858727|NCT00455429|1817455|FG003|Overall Study|Withdrawal by Subject|0
858728|NCT00455429|1817452|FG000|Overall Study|Lack of Efficacy|0
858729|NCT00455429|1817453|FG001|Overall Study|Lack of Efficacy|1
858730|NCT00455429|1817454|FG002|Overall Study|Lack of Efficacy|0
858731|NCT00455429|1817455|FG003|Overall Study|Lack of Efficacy|1
858732|NCT00455429|1817452|FG000|Overall Study|Adverse Event|0
858733|NCT00455429|1817453|FG001|Overall Study|Adverse Event|1
858734|NCT00455429|1817454|FG002|Overall Study|Adverse Event|0
858735|NCT00455429|1817455|FG003|Overall Study|Adverse Event|3
858736|NCT00455429|1817452|FG000|Overall Study|Randomly assigned but not treated|0
858737|NCT00455429|1817453|FG001|Overall Study|Randomly assigned but not treated|0
858738|NCT00455429|1817454|FG002|Overall Study|Randomly assigned but not treated|0
858739|NCT00455429|1817455|FG003|Overall Study|Randomly assigned but not treated|2
858740|NCT00455429|1817452|FG000|Overall Study|Personal Reason|1
858741|NCT00455429|1817453|FG001|Overall Study|Personal Reason|0
858742|NCT00455429|1817454|FG002|Overall Study|Personal Reason|0
858743|NCT00455429|1817455|FG003|Overall Study|Personal Reason|0
858744|NCT00455429|1817452|FG000|Overall Study|Non-compliance|0
858745|NCT00455429|1817453|FG001|Overall Study|Non-compliance|0
858746|NCT00455429|1817454|FG002|Overall Study|Non-compliance|0
858747|NCT00455429|1817455|FG003|Overall Study|Non-compliance|1
858748|NCT00455429|1817452|FG000|Overall Study|Other|0
858749|NCT00455429|1817453|FG001|Overall Study|Other|2
858750|NCT00455429|1817454|FG002|Overall Study|Other|0
858751|NCT00455429|1817455|FG003|Overall Study|Other|1
858752|NCT00455455|1817468|FG000|Washout|Withdrawal by Subject|0
858753|NCT00455455|1817469|FG001|Washout|Withdrawal by Subject|1
858754|NCT00455455|1817468|FG000|Washout|Withdrawal by Subject|1
858755|NCT00455455|1817469|FG001|Washout|Withdrawal by Subject|0
858756|NCT00455520|1817480|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
858757|NCT00455520|1817481|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
858758|NCT00455520|1817480|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3
858759|NCT00455520|1817481|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0
858760|NCT00455520|1817480|FG000|Open Label Tapentadol Extended Release|Adverse Event|100
858761|NCT00455520|1817481|FG001|Open Label Tapentadol Extended Release|Adverse Event|0
858762|NCT00455520|1817480|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23
858763|NCT00455520|1817481|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0
858764|NCT00455520|1817480|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13
858765|NCT00455520|1817481|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0
858766|NCT00455520|1817480|FG000|Open Label Tapentadol Extended Release|All other|33
858767|NCT00455520|1817481|FG001|Open Label Tapentadol Extended Release|All other|0
858768|NCT00455520|1817480|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
858769|NCT00455520|1817481|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
858770|NCT00455520|1817480|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
858771|NCT00455520|1817481|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
858772|NCT00455520|1817480|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
858773|NCT00455520|1817481|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
858774|NCT00455520|1817480|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
858775|NCT00455520|1817481|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
858776|NCT00455520|1817480|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
858777|NCT00455520|1817481|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
858778|NCT00455520|1817480|FG000|Double Blind Tapentadol ER vs Placebo|All other|4
858779|NCT00455520|1817481|FG001|Double Blind Tapentadol ER vs Placebo|All other|6
858780|NCT00455533|1817489|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
858781|NCT00455533|1817490|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
858782|NCT00455533|1817491|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
858783|NCT00455533|1817489|FG000|Period One: Initial Chemotherapy|Disease Progression|5
858784|NCT00455533|1817490|FG001|Period One: Initial Chemotherapy|Disease Progression|0
858785|NCT00455533|1817491|FG002|Period One: Initial Chemotherapy|Disease Progression|0
858786|NCT00455533|1817489|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2
858787|NCT00455533|1817490|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0
858788|NCT00455533|1817491|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0
858943|NCT00456846|1817715|FG001|Overall Study|Physician Decision|6
858789|NCT00455533|1817489|FG000|Period One: Initial Chemotherapy|Not Reported|1
858790|NCT00455533|1817490|FG001|Period One: Initial Chemotherapy|Not Reported|0
858791|NCT00455533|1817491|FG002|Period One: Initial Chemotherapy|Not Reported|0
858792|NCT00455533|1817489|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2
858793|NCT00455533|1817490|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0
858794|NCT00455533|1817491|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0
858795|NCT00455533|1817489|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2
858796|NCT00455533|1817490|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0
858797|NCT00455533|1817491|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0
858798|NCT00455533|1817489|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
858799|NCT00455533|1817490|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
858800|NCT00455533|1817491|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
858801|NCT00455533|1817489|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
858802|NCT00455533|1817490|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
858803|NCT00455533|1817491|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
858804|NCT00455533|1817489|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
858805|NCT00455533|1817490|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
858806|NCT00455533|1817491|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
858807|NCT00455533|1817489|FG000|Period Two: Randomized Period|Death|0
858808|NCT00455533|1817490|FG001|Period Two: Randomized Period|Death|0
858809|NCT00455533|1817491|FG002|Period Two: Randomized Period|Death|3
858810|NCT00455533|1817489|FG000|Period Two: Randomized Period|Disease Progression|0
858811|NCT00455533|1817490|FG001|Period Two: Randomized Period|Disease Progression|1
858812|NCT00455533|1817491|FG002|Period Two: Randomized Period|Disease Progression|1
858813|NCT00455533|1817489|FG000|Period Two: Randomized Period|Lost to Follow-up|0
858814|NCT00455533|1817490|FG001|Period Two: Randomized Period|Lost to Follow-up|0
858815|NCT00455533|1817491|FG002|Period Two: Randomized Period|Lost to Follow-up|1
858816|NCT00455533|1817489|FG000|Period Two: Randomized Period|Other - need reasons|0
858817|NCT00455533|1817490|FG001|Period Two: Randomized Period|Other - need reasons|1
858818|NCT00455533|1817491|FG002|Period Two: Randomized Period|Other - need reasons|0
858819|NCT00455533|1817489|FG000|Period Two: Randomized Period|Study Drug Toxicity|0
858820|NCT00455533|1817490|FG001|Period Two: Randomized Period|Study Drug Toxicity|2
858821|NCT00455533|1817491|FG002|Period Two: Randomized Period|Study Drug Toxicity|0
858822|NCT00455533|1817489|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0
858823|NCT00455533|1817490|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2
858824|NCT00455533|1817491|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1
858825|NCT00455741|1817554|FG000|Overall Study|Physician Decision|0
858826|NCT00455741|1817555|FG001|Overall Study|Physician Decision|1
858827|NCT00455858|1817571|FG000|Overall Study|Lost to Follow-up|2
858828|NCT00455858|1817571|FG000|Overall Study|Protocol Violation|1
858829|NCT00455858|1817571|FG000|Overall Study|Lack of Efficacy|1
858830|NCT00455858|1817571|FG000|Overall Study|Well controlled FPG without insulin|1
858831|NCT00455858|1817571|FG000|Overall Study|Withdrawal|1
858832|NCT00455923|1817577|FG000|Overall Study|Pregnancy|0
858833|NCT00455923|1817578|FG001|Overall Study|Pregnancy|2
858834|NCT00455923|1817577|FG000|Overall Study|Other|3
858835|NCT00455923|1817578|FG001|Overall Study|Other|1
858836|NCT00456092|1817611|FG000|Extension Phase|Grade 2 or Greater AE|2
858837|NCT00456092|1817612|FG001|Extension Phase|Grade 2 or Greater AE|2
858838|NCT00456092|1817613|FG002|Extension Phase|Grade 2 or Greater AE|0
858839|NCT00456092|1817614|FG003|Extension Phase|Grade 2 or Greater AE|0
858840|NCT00456092|1817615|FG004|Extension Phase|Grade 2 or Greater AE|2
858841|NCT00456092|1817611|FG000|Extension Phase|Flare of Psoriatic Arthritis|1
858842|NCT00456092|1817612|FG001|Extension Phase|Flare of Psoriatic Arthritis|0
858843|NCT00456092|1817613|FG002|Extension Phase|Flare of Psoriatic Arthritis|0
858844|NCT00456092|1817614|FG003|Extension Phase|Flare of Psoriatic Arthritis|0
858845|NCT00456092|1817615|FG004|Extension Phase|Flare of Psoriatic Arthritis|1
858846|NCT00456092|1817611|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3
858847|NCT00456092|1817612|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1
858848|NCT00456092|1817613|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0
858849|NCT00456092|1817614|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0
858850|NCT00456092|1817615|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2
858851|NCT00456092|1817611|FG000|Extension Phase|Withdrew Consent|2
858852|NCT00456092|1817612|FG001|Extension Phase|Withdrew Consent|0
858853|NCT00456092|1817613|FG002|Extension Phase|Withdrew Consent|0
858854|NCT00456092|1817614|FG003|Extension Phase|Withdrew Consent|0
858855|NCT00456092|1817615|FG004|Extension Phase|Withdrew Consent|0
858856|NCT00456092|1817611|FG000|Extension Phase|Lost to Follow-up|1
858857|NCT00456092|1817612|FG001|Extension Phase|Lost to Follow-up|1
858858|NCT00456092|1817613|FG002|Extension Phase|Lost to Follow-up|0
858859|NCT00456092|1817614|FG003|Extension Phase|Lost to Follow-up|0
858860|NCT00456092|1817615|FG004|Extension Phase|Lost to Follow-up|1
858861|NCT00456092|1817611|FG000|Extension Phase|Other|2
858862|NCT00456092|1817612|FG001|Extension Phase|Other|0
858863|NCT00456092|1817613|FG002|Extension Phase|Other|0
858864|NCT00456092|1817614|FG003|Extension Phase|Other|1
858865|NCT00456092|1817615|FG004|Extension Phase|Other|1
858866|NCT00456092|1817611|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
858867|NCT00456092|1817612|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
858868|NCT00456092|1817613|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
858869|NCT00456092|1817614|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
858870|NCT00456092|1817615|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
858871|NCT00456092|1817611|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
858872|NCT00456092|1817612|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
858873|NCT00456092|1817613|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
858874|NCT00456092|1817614|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
858875|NCT00456092|1817615|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
858876|NCT00456092|1817611|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
858877|NCT00456092|1817612|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
858878|NCT00456092|1817613|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
858879|NCT00456092|1817614|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
858880|NCT00456092|1817615|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
858881|NCT00456092|1817611|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
858882|NCT00456092|1817612|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
858883|NCT00456092|1817613|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
858884|NCT00456092|1817614|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
858885|NCT00456092|1817615|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
858886|NCT00456092|1817611|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
858887|NCT00456092|1817612|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
858888|NCT00456092|1817613|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
858889|NCT00456092|1817614|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
858890|NCT00456092|1817615|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
858891|NCT00456092|1817611|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
858892|NCT00456092|1817612|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
858893|NCT00456092|1817613|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
858894|NCT00456092|1817614|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
858895|NCT00456092|1817615|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
858896|NCT00456092|1817611|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0
858897|NCT00456092|1817612|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1
858898|NCT00456092|1817613|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2
858899|NCT00456092|1817614|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0
858900|NCT00456092|1817615|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0
858901|NCT00456092|1817611|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0
858902|NCT00456092|1817612|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1
858903|NCT00456092|1817613|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1
858904|NCT00456092|1817614|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0
858905|NCT00456092|1817615|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0
858906|NCT00456092|1817611|FG000|Treatment Phase (12 Weeks)|Other|1
858907|NCT00456092|1817612|FG001|Treatment Phase (12 Weeks)|Other|0
858908|NCT00456092|1817613|FG002|Treatment Phase (12 Weeks)|Other|1
858909|NCT00456092|1817614|FG003|Treatment Phase (12 Weeks)|Other|0
858910|NCT00456092|1817615|FG004|Treatment Phase (12 Weeks)|Other|0
858911|NCT00456300|1817638|FG000|Overall Study|Adverse Event|1
858912|NCT00456300|1817639|FG001|Overall Study|Adverse Event|0
858913|NCT00456365|1817649|FG000|Overall Study|Lost to Follow-up|1
858914|NCT00456365|1817650|FG001|Overall Study|Lost to Follow-up|3
858915|NCT00456365|1817649|FG000|Overall Study|Withdrawal by Subject|4
858916|NCT00456365|1817650|FG001|Overall Study|Withdrawal by Subject|7
858917|NCT00456365|1817649|FG000|Overall Study|Pregnancy|1
858918|NCT00456365|1817650|FG001|Overall Study|Pregnancy|1
858919|NCT00456365|1817649|FG000|Overall Study|oncologic diagnosis|1
858920|NCT00456365|1817650|FG001|Overall Study|oncologic diagnosis|1
858921|NCT00456495|1817658|FG000|Overall Study|Physician Decision|2
858922|NCT00456521|1817669|FG000|Overall Study|Adverse Event|150
858923|NCT00456521|1817670|FG001|Overall Study|Adverse Event|25
858924|NCT00456521|1817669|FG000|Overall Study|Withdrawal by Subject|43
858925|NCT00456521|1817670|FG001|Overall Study|Withdrawal by Subject|24
858926|NCT00456521|1817669|FG000|Overall Study|Lost to Follow-up|22
858927|NCT00456521|1817670|FG001|Overall Study|Lost to Follow-up|17
858928|NCT00456521|1817669|FG000|Overall Study|Lack of Efficacy|3
858929|NCT00456521|1817670|FG001|Overall Study|Lack of Efficacy|6
858930|NCT00456521|1817669|FG000|Overall Study|Protocol Violation|4
858931|NCT00456521|1817670|FG001|Overall Study|Protocol Violation|0
858932|NCT00456521|1817669|FG000|Overall Study|Pregnancy|1
858933|NCT00456521|1817670|FG001|Overall Study|Pregnancy|1
858934|NCT00456521|1817669|FG000|Overall Study|Drug non-compliance, moved, other|26
858935|NCT00456521|1817670|FG001|Overall Study|Drug non-compliance, moved, other|11
858936|NCT00456599|1817686|FG000|Overall Study|Non-compliance|1
858937|NCT00456599|1817686|FG000|Overall Study|Withdrawal by Subject|2
858938|NCT00456755|1817696|FG000|Overall Study|Lost to Follow-up|2
858939|NCT00456755|1817697|FG001|Overall Study|Lost to Follow-up|1
858940|NCT00456846|1817714|FG000|Overall Study|Adverse Event|2
858941|NCT00456846|1817715|FG001|Overall Study|Adverse Event|15
858942|NCT00456846|1817714|FG000|Overall Study|Physician Decision|11
858944|NCT00456846|1817714|FG000|Overall Study|Protocol Deviation|2
858945|NCT00456846|1817715|FG001|Overall Study|Protocol Deviation|0
858946|NCT00456846|1817714|FG000|Overall Study|Participant Discretion|1
858947|NCT00456846|1817715|FG001|Overall Study|Participant Discretion|5
858948|NCT00456846|1817714|FG000|Overall Study|Other|0
858949|NCT00456846|1817715|FG001|Overall Study|Other|2
858950|NCT00457002|1817729|FG000|Overall Study|Death|40
858951|NCT00457002|1817730|FG001|Overall Study|Death|47
858952|NCT00457002|1817729|FG000|Overall Study|Adverse Event|284
858953|NCT00457002|1817730|FG001|Overall Study|Adverse Event|260
858954|NCT00457002|1817729|FG000|Overall Study|Withdrawal by Subject|299
858955|NCT00457002|1817730|FG001|Overall Study|Withdrawal by Subject|271
858956|NCT00457002|1817729|FG000|Overall Study|Lost to Follow-up|72
858957|NCT00457002|1817730|FG001|Overall Study|Lost to Follow-up|71
858958|NCT00457002|1817729|FG000|Overall Study|Poor/Non-compliance|46
858959|NCT00457002|1817730|FG001|Overall Study|Poor/Non-compliance|33
858960|NCT00457002|1817729|FG000|Overall Study|No longer met criteria|41
858961|NCT00457002|1817730|FG001|Overall Study|No longer met criteria|37
858962|NCT00457002|1817729|FG000|Overall Study|Administrative reason by Sponsor|1
858963|NCT00457002|1817730|FG001|Overall Study|Administrative reason by Sponsor|0
858964|NCT00457002|1817729|FG000|Overall Study|non-specified|29
858965|NCT00457002|1817730|FG001|Overall Study|non-specified|38
858966|NCT00457002|1817729|FG000|Overall Study|treated for 1 day; missing status/reason|1
858967|NCT00457002|1817730|FG001|Overall Study|treated for 1 day; missing status/reason|0
858968|NCT00457015|1817738|FG000|Overall Study|Left study site against medical advice|0
858969|NCT00457015|1817739|FG001|Overall Study|Left study site against medical advice|1
858970|NCT00457249|1817756|FG000|Overall Study|Lost to Follow-up|3
858971|NCT00457249|1817757|FG001|Overall Study|Lost to Follow-up|0
858972|NCT00457249|1817756|FG000|Overall Study|Protocol Violation|4
858973|NCT00457249|1817757|FG001|Overall Study|Protocol Violation|1
858974|NCT00457249|1817756|FG000|Overall Study|Withdrawal by Subject|3
858975|NCT00457249|1817757|FG001|Overall Study|Withdrawal by Subject|1
858976|NCT00457249|1817756|FG000|Overall Study|Serious Adverse Events|2
858977|NCT00457249|1817757|FG001|Overall Study|Serious Adverse Events|0
858978|NCT00457301|1817767|FG000|Overall Study|Withdrawal by Subject|3
858979|NCT00457301|1817768|FG001|Overall Study|Withdrawal by Subject|3
858980|NCT00457301|1817767|FG000|Overall Study|Censored out of the study|15
858981|NCT00457301|1817768|FG001|Overall Study|Censored out of the study|14
858982|NCT00457301|1817767|FG000|Overall Study|Death|5
858983|NCT00457301|1817768|FG001|Overall Study|Death|7
858984|NCT00457392|1817785|FG000|Overall Study|Objective Progression or Relapse|229
858985|NCT00457392|1817786|FG001|Overall Study|Objective Progression or Relapse|296
858986|NCT00457392|1817785|FG000|Overall Study|Death|106
858987|NCT00457392|1817786|FG001|Overall Study|Death|106
858988|NCT00457392|1817785|FG000|Overall Study|Adverse Event|84
858989|NCT00457392|1817786|FG001|Overall Study|Adverse Event|41
858990|NCT00457392|1817785|FG000|Overall Study|Global Deterioration of Health Status|22
858991|NCT00457392|1817786|FG001|Overall Study|Global Deterioration of Health Status|8
858992|NCT00457392|1817785|FG000|Overall Study|Withdrawal by Subject|14
858993|NCT00457392|1817786|FG001|Overall Study|Withdrawal by Subject|8
858994|NCT00457392|1817785|FG000|Overall Study|Lost to Follow-up|6
858995|NCT00457392|1817786|FG001|Overall Study|Lost to Follow-up|7
858996|NCT00457392|1817785|FG000|Overall Study|Protocol Violation|4
858997|NCT00457392|1817786|FG001|Overall Study|Protocol Violation|3
858998|NCT00457392|1817785|FG000|Overall Study|Other|7
858999|NCT00457392|1817786|FG001|Overall Study|Other|4
859000|NCT00457392|1817785|FG000|Overall Study|Study Terminated by Sponsor|1
859001|NCT00457392|1817786|FG001|Overall Study|Study Terminated by Sponsor|4
859002|NCT00457392|1817785|FG000|Overall Study|Randomized, Not Treated|7
859003|NCT00457392|1817786|FG001|Overall Study|Randomized, Not Treated|3
859004|NCT00457418|1817792|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
859005|NCT00457418|1817792|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
859006|NCT00457418|1817792|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
859007|NCT00457418|1817792|FG000|Post PK Maintenance|Adverse Event|10
859008|NCT00457418|1817792|FG000|Post PK Maintenance|Progression of Disease|6
859009|NCT00457418|1817792|FG000|Post PK Maintenance|Withdrawal by Subject|11
859010|NCT00457418|1817792|FG000|Post PK Maintenance|Lost to Follow-up|1
859011|NCT00457626|1817796|FG000|Overall Study|Adverse Event|3
859012|NCT00457626|1817796|FG000|Overall Study|Administrative Problems|2
859013|NCT00457626|1817796|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1
859014|NCT00457639|1817800|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3
859015|NCT00457639|1817801|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0
859016|NCT00457639|1817800|FG000|Intervention 1 (6 Months)|unrelated illness|0
859017|NCT00457639|1817801|FG001|Intervention 1 (6 Months)|unrelated illness|2
859018|NCT00457639|1817800|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
859019|NCT00457639|1817801|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
859020|NCT00457665|1817809|FG000|12 Months|Drug allergy|1
859021|NCT00457665|1817810|FG001|12 Months|Drug allergy|1
859022|NCT00457665|1817809|FG000|12 Months|High HIV viral load|5
859023|NCT00457665|1817810|FG001|12 Months|High HIV viral load|1
859024|NCT00457665|1817809|FG000|12 Months|Lipodystrophy|2
859025|NCT00457665|1817810|FG001|12 Months|Lipodystrophy|0
859026|NCT00457665|1817809|FG000|12 Months|Withdrawal by Subject|0
859027|NCT00457665|1817810|FG001|12 Months|Withdrawal by Subject|2
859028|NCT00457665|1817809|FG000|12 Months|Abnormal Liver function tests|0
859029|NCT00457665|1817810|FG001|12 Months|Abnormal Liver function tests|5
859030|NCT00457665|1817809|FG000|24 Months|Withdrawal by Subject|3
859031|NCT00457665|1817810|FG001|24 Months|Withdrawal by Subject|2
859032|NCT00457665|1817809|FG000|24 Months|Lipodystrophy|1
859033|NCT00457665|1817810|FG001|24 Months|Lipodystrophy|1
859034|NCT00457665|1817809|FG000|24 Months|Abnormal liver function tests|1
859035|NCT00457665|1817810|FG001|24 Months|Abnormal liver function tests|5
859036|NCT00457691|1817818|FG000|Overall Study|Adverse Event|4
859037|NCT00457691|1817819|FG001|Overall Study|Adverse Event|1
859038|NCT00457691|1817818|FG000|Overall Study|Death|163
859039|NCT00457691|1817819|FG001|Overall Study|Death|148
859040|NCT00457691|1817818|FG000|Overall Study|Protocol Violation|1
859041|NCT00457691|1817819|FG001|Overall Study|Protocol Violation|3
859042|NCT00457691|1817818|FG000|Overall Study|Lost to Follow-up|23
859043|NCT00457691|1817819|FG001|Overall Study|Lost to Follow-up|14
859044|NCT00457691|1817818|FG000|Overall Study|Study terminated by Sponsor|1
859045|NCT00457691|1817819|FG001|Overall Study|Study terminated by Sponsor|1
859046|NCT00457691|1817818|FG000|Overall Study|Subject refused (reason other than AE)|14
859047|NCT00457691|1817819|FG001|Overall Study|Subject refused (reason other than AE)|19
859048|NCT00457691|1817818|FG000|Overall Study|Disease progression, study terminated|180
859049|NCT00457691|1817819|FG001|Overall Study|Disease progression, study terminated|196
859050|NCT00457743|1817841|FG000|Overall Study|Adverse Event|0
859051|NCT00457743|1817842|FG001|Overall Study|Adverse Event|4
859052|NCT00457743|1817843|FG002|Overall Study|Adverse Event|0
859053|NCT00457743|1817841|FG000|Overall Study|Lack of Efficacy|3
859054|NCT00457743|1817842|FG001|Overall Study|Lack of Efficacy|23
859055|NCT00457743|1817843|FG002|Overall Study|Lack of Efficacy|3
859056|NCT00457821|1817864|FG000|Part 2|Withdrawal by Subject|0
859057|NCT00457821|1817865|FG001|Part 2|Withdrawal by Subject|0
859058|NCT00457821|1817866|FG002|Part 2|Withdrawal by Subject|0
859059|NCT00457821|1817867|FG003|Part 2|Withdrawal by Subject|0
859060|NCT00457821|1817868|FG004|Part 2|Withdrawal by Subject|0
859061|NCT00457821|1817869|FG005|Part 2|Withdrawal by Subject|0
859062|NCT00457821|1817870|FG006|Part 2|Withdrawal by Subject|0
859063|NCT00457821|1817871|FG007|Part 2|Withdrawal by Subject|1
859064|NCT00458211|1817897|FG000|Overall Study|Lack of Efficacy|12
859065|NCT00458211|1817897|FG000|Overall Study|Withdrawal by Subject|2
859066|NCT00458211|1817897|FG000|Overall Study|Protocol Violation|2
859067|NCT00458302|1817921|FG000|Overall Study|Adverse Event|4
859068|NCT00458302|1817922|FG001|Overall Study|Adverse Event|14
859069|NCT00458302|1817921|FG000|Overall Study|Pregnancy|2
859070|NCT00458302|1817922|FG001|Overall Study|Pregnancy|1
859071|NCT00458302|1817921|FG000|Overall Study|Protocol Violation|0
859072|NCT00458302|1817922|FG001|Overall Study|Protocol Violation|2
859073|NCT00458302|1817921|FG000|Overall Study|Withdrawal by Subject|6
859074|NCT00458302|1817922|FG001|Overall Study|Withdrawal by Subject|4
859075|NCT00458302|1817921|FG000|Overall Study|Inc/Exc Criteria Not Met|1
859076|NCT00458302|1817922|FG001|Overall Study|Inc/Exc Criteria Not Met|1
859077|NCT00458302|1817921|FG000|Overall Study|Study Termination By Sponsor|1
859078|NCT00458302|1817922|FG001|Overall Study|Study Termination By Sponsor|0
859079|NCT00458302|1817921|FG000|Overall Study|Lost to Follow-up|2
859080|NCT00458302|1817922|FG001|Overall Study|Lost to Follow-up|0
859081|NCT00458302|1817921|FG000|Overall Study|Other|4
859082|NCT00458302|1817922|FG001|Overall Study|Other|2
859083|NCT00458341|1817931|FG000|Cycle 1|Adverse Event|1
859084|NCT00458341|1817932|FG001|Cycle 1|Adverse Event|0
859085|NCT00458393|1817940|FG000|Overall Study|Withdrawal by Subject|67
859086|NCT00458393|1817941|FG001|Overall Study|Withdrawal by Subject|80
859087|NCT00458393|1817940|FG000|Overall Study|Physician Decision|31
859088|NCT00458393|1817941|FG001|Overall Study|Physician Decision|22
859089|NCT00458393|1817940|FG000|Overall Study|Relocated|77
859090|NCT00458393|1817941|FG001|Overall Study|Relocated|81
859091|NCT00458393|1817940|FG000|Overall Study|Lost to Follow-up|115
859092|NCT00458393|1817941|FG001|Overall Study|Lost to Follow-up|92
859093|NCT00458393|1817940|FG000|Overall Study|Sites marked other on the form.|19
859094|NCT00458393|1817941|FG001|Overall Study|Sites marked other on the form.|20
859095|NCT00458484|1817972|FG000|Overall Study|Not eligible b/c prior radiation history|0
859096|NCT00458484|1817973|FG001|Overall Study|Not eligible b/c prior radiation history|0
859097|NCT00458484|1817974|FG002|Overall Study|Not eligible b/c prior radiation history|0
859098|NCT00458484|1817975|FG003|Overall Study|Not eligible b/c prior radiation history|0
859099|NCT00458484|1817976|FG004|Overall Study|Not eligible b/c prior radiation history|0
859100|NCT00458484|1817977|FG005|Overall Study|Not eligible b/c prior radiation history|1
859101|NCT00458484|1817978|FG006|Overall Study|Not eligible b/c prior radiation history|0
859364|NCT00460603|1818363|FG008|Phase 1|Withdrawal by Subject|2
859110|NCT00458705|1818007|FG000|Overall Study|Adverse Event|4
859111|NCT00458705|1818007|FG000|Overall Study|Not Treated|1
859112|NCT00458783|1818013|FG000|Overall Study|Protocol Violation|1228
859113|NCT00458783|1818014|FG001|Overall Study|Protocol Violation|1220
859114|NCT00459043|1818037|FG000|Overall Study|Withdrawal by Subject|1
859115|NCT00459043|1818038|FG001|Overall Study|Withdrawal by Subject|0
859116|NCT00459056|1818046|FG000|First Intervention (First Three Months)|Lost to Follow-up|1
859117|NCT00459056|1818047|FG001|First Intervention (First Three Months)|Lost to Follow-up|1
859118|NCT00459108|1818053|FG000|Overall Study|Withdrawal by Subject|5
859119|NCT00459108|1818053|FG000|Overall Study|Adverse Event|3
859120|NCT00459108|1818053|FG000|Overall Study|Death|2
859121|NCT00459108|1818053|FG000|Overall Study|Progression|1
859122|NCT00459134|1818060|FG000|Overall Study|Physician Decision|1
859123|NCT00459134|1818061|FG001|Overall Study|Physician Decision|1
859124|NCT00459134|1818060|FG000|Overall Study|Withdrawal by Subject|8
859125|NCT00459134|1818061|FG001|Overall Study|Withdrawal by Subject|7
859126|NCT00459134|1818060|FG000|Overall Study|Lost to Follow-up|6
859127|NCT00459134|1818061|FG001|Overall Study|Lost to Follow-up|7
859128|NCT00459134|1818060|FG000|Overall Study|Surgery|1
859129|NCT00459134|1818061|FG001|Overall Study|Surgery|2
859130|NCT00459134|1818060|FG000|Overall Study|Toxicity|4
859131|NCT00459134|1818061|FG001|Overall Study|Toxicity|5
859132|NCT00459134|1818060|FG000|Overall Study|Progression|1
859133|NCT00459134|1818061|FG001|Overall Study|Progression|0
859134|NCT00459134|1818060|FG000|Overall Study|Multiple Reasons|2
859135|NCT00459134|1818061|FG001|Overall Study|Multiple Reasons|3
859136|NCT00459186|1818067|FG000|Single Agent RAD001|Withdrawal by Subject|1
859137|NCT00459186|1818067|FG000|PET Imaging and Assessment|Adverse Event|3
859138|NCT00459290|1818071|FG000|Overall Study|Adverse Event|3
859139|NCT00459290|1818071|FG000|Overall Study|Ineligible|2
859140|NCT00459316|1818094|FG000|Steps 1 & 2|Other eligibility failure|1
859141|NCT00459316|1818095|FG001|Steps 1 & 2|Other eligibility failure|1
859142|NCT00459316|1818096|FG002|Steps 1 & 2|Other eligibility failure|0
859143|NCT00459316|1818094|FG000|Steps 1 & 2|Death|1
859144|NCT00459316|1818095|FG001|Steps 1 & 2|Death|1
859145|NCT00459316|1818096|FG002|Steps 1 & 2|Death|0
859146|NCT00459316|1818094|FG000|Steps 1 & 2|Not able to get to clinic|7
859147|NCT00459316|1818095|FG001|Steps 1 & 2|Not able to get to clinic|4
859148|NCT00459316|1818096|FG002|Steps 1 & 2|Not able to get to clinic|0
859149|NCT00459316|1818094|FG000|Steps 1 & 2|Withdrawal by Subject|6
859150|NCT00459316|1818095|FG001|Steps 1 & 2|Withdrawal by Subject|1
859151|NCT00459316|1818096|FG002|Steps 1 & 2|Withdrawal by Subject|0
859152|NCT00459316|1818094|FG000|Steps 1 & 2|Not willing to adhere to regulations|1
859153|NCT00459316|1818095|FG001|Steps 1 & 2|Not willing to adhere to regulations|0
859154|NCT00459316|1818096|FG002|Steps 1 & 2|Not willing to adhere to regulations|0
859155|NCT00459316|1818094|FG000|Steps 1 & 2|Lost to Follow-up|5
859156|NCT00459316|1818095|FG001|Steps 1 & 2|Lost to Follow-up|0
859157|NCT00459316|1818096|FG002|Steps 1 & 2|Lost to Follow-up|2
859158|NCT00459316|1818094|FG000|Step 3|Withdrawal by Subject|3
859159|NCT00459316|1818095|FG001|Step 3|Withdrawal by Subject|0
859160|NCT00459316|1818096|FG002|Step 3|Withdrawal by Subject|1
859161|NCT00459342|1818119|FG000|Overall Study|Not eligible|1
859162|NCT00459355|1818125|FG000|Overall Study|Subject no longer met inc criteria|20
859163|NCT00459355|1818126|FG001|Overall Study|Subject no longer met inc criteria|18
859164|NCT00459537|1818151|FG000|Overall Study|Adverse Event|1
859165|NCT00459537|1818152|FG001|Overall Study|Adverse Event|6
859166|NCT00459537|1818151|FG000|Overall Study|Lack of Efficacy|10
859167|NCT00459537|1818152|FG001|Overall Study|Lack of Efficacy|11
859168|NCT00459537|1818151|FG000|Overall Study|Withdrawal by Subject|20
859169|NCT00459537|1818152|FG001|Overall Study|Withdrawal by Subject|26
859170|NCT00459537|1818151|FG000|Overall Study|Lost to Follow-up|27
859171|NCT00459537|1818152|FG001|Overall Study|Lost to Follow-up|30
859172|NCT00459537|1818151|FG000|Overall Study|Administrative problems|3
859173|NCT00459537|1818152|FG001|Overall Study|Administrative problems|0
859174|NCT00459537|1818151|FG000|Overall Study|Protocol Violation|4
859175|NCT00459537|1818152|FG001|Overall Study|Protocol Violation|3
859176|NCT00459537|1818151|FG000|Overall Study|Missing|1
859177|NCT00459537|1818152|FG001|Overall Study|Missing|0
859178|NCT00459667|1818161|FG000|Overall Study|Adverse Event|9
859179|NCT00459667|1818162|FG001|Overall Study|Adverse Event|12
859180|NCT00459667|1818163|FG002|Overall Study|Adverse Event|8
859181|NCT00459667|1818161|FG000|Overall Study|Lost to Follow-up|5
859182|NCT00459667|1818162|FG001|Overall Study|Lost to Follow-up|9
859183|NCT00459667|1818163|FG002|Overall Study|Lost to Follow-up|3
859184|NCT00459667|1818161|FG000|Overall Study|Pregnancy|1
859185|NCT00459667|1818162|FG001|Overall Study|Pregnancy|1
859186|NCT00459667|1818163|FG002|Overall Study|Pregnancy|1
859187|NCT00459667|1818161|FG000|Overall Study|Protocol Violation|1
859188|NCT00459667|1818162|FG001|Overall Study|Protocol Violation|0
859189|NCT00459667|1818163|FG002|Overall Study|Protocol Violation|0
859190|NCT00459667|1818161|FG000|Overall Study|Withdrawal by Subject|3
859191|NCT00459667|1818162|FG001|Overall Study|Withdrawal by Subject|5
859192|NCT00459667|1818163|FG002|Overall Study|Withdrawal by Subject|5
859193|NCT00459667|1818161|FG000|Overall Study|Other disease modifying treatment|1
859194|NCT00459667|1818162|FG001|Overall Study|Other disease modifying treatment|2
859195|NCT00459667|1818163|FG002|Overall Study|Other disease modifying treatment|1
859196|NCT00459667|1818161|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12
859197|NCT00459667|1818162|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15
859198|NCT00459667|1818163|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1
859199|NCT00459667|1818161|FG000|Overall Study|No treatment administered|6
859200|NCT00459667|1818162|FG001|Overall Study|No treatment administered|3
859201|NCT00459667|1818163|FG002|Overall Study|No treatment administered|1
859202|NCT00459706|1818173|FG000|Overall Study|Adverse Event|19
859203|NCT00459706|1818174|FG001|Overall Study|Adverse Event|13
859204|NCT00459706|1818173|FG000|Overall Study|Withdrawal by Subject|1
859205|NCT00459706|1818174|FG001|Overall Study|Withdrawal by Subject|6
859206|NCT00459706|1818173|FG000|Overall Study|Physician Decision|2
859207|NCT00459706|1818174|FG001|Overall Study|Physician Decision|0
859208|NCT00459706|1818173|FG000|Overall Study|Discontinuation of Study by Sponsor|1
859209|NCT00459706|1818174|FG001|Overall Study|Discontinuation of Study by Sponsor|0
859210|NCT00459706|1818173|FG000|Overall Study|Protocol Violation|2
859211|NCT00459706|1818174|FG001|Overall Study|Protocol Violation|1
859212|NCT00459706|1818173|FG000|Overall Study|Failed to Return|1
859213|NCT00459706|1818174|FG001|Overall Study|Failed to Return|0
859214|NCT00459706|1818173|FG000|Overall Study|Other|0
859215|NCT00459706|1818174|FG001|Overall Study|Other|1
859216|NCT00459875|1818197|FG000|Overall Study|Ineligible participant|1
859217|NCT00459875|1818197|FG000|Overall Study|Adverse Event|2
859218|NCT00459953|1818203|FG000|Overall Study|not analyzed-household member in study|1
859219|NCT00459953|1818204|FG001|Overall Study|not analyzed-household member in study|1
859220|NCT00459979|1818210|FG000|Overall Study|Withdrawal by Subject|1
859221|NCT00459979|1818210|FG000|Overall Study|Protocol Violation|1
859222|NCT00460031|1818214|FG000|Overall Study|Adverse Event|5
859223|NCT00460031|1818214|FG000|Overall Study|Withdrawal by Subject|5
859224|NCT00460031|1818214|FG000|Overall Study|Death|1
859225|NCT00460109|1818218|FG000|Overall Study|Death|1
859226|NCT00460239|1818222|FG000|Overall Study|Physician Decision|0
859227|NCT00460239|1818223|FG001|Overall Study|Physician Decision|1
859228|NCT00460239|1818224|FG002|Overall Study|Physician Decision|0
859229|NCT00460239|1818225|FG003|Overall Study|Physician Decision|0
859230|NCT00460239|1818226|FG004|Overall Study|Physician Decision|0
859231|NCT00460239|1818227|FG005|Overall Study|Physician Decision|2
859232|NCT00460239|1818228|FG006|Overall Study|Physician Decision|0
859233|NCT00460239|1818229|FG007|Overall Study|Physician Decision|0
859234|NCT00460239|1818230|FG008|Overall Study|Physician Decision|0
859235|NCT00460239|1818222|FG000|Overall Study|Withdrawal by Subject|0
859236|NCT00460239|1818223|FG001|Overall Study|Withdrawal by Subject|0
859237|NCT00460239|1818224|FG002|Overall Study|Withdrawal by Subject|0
859238|NCT00460239|1818225|FG003|Overall Study|Withdrawal by Subject|0
859239|NCT00460239|1818226|FG004|Overall Study|Withdrawal by Subject|0
859240|NCT00460239|1818227|FG005|Overall Study|Withdrawal by Subject|1
859241|NCT00460239|1818228|FG006|Overall Study|Withdrawal by Subject|0
859242|NCT00460239|1818229|FG007|Overall Study|Withdrawal by Subject|0
859243|NCT00460239|1818230|FG008|Overall Study|Withdrawal by Subject|0
859244|NCT00460265|1818245|FG000|Overall Study|Lost to Follow-up|14
859245|NCT00460265|1818246|FG001|Overall Study|Lost to Follow-up|15
859246|NCT00460265|1818245|FG000|Overall Study|Physician Decision|1
859247|NCT00460265|1818246|FG001|Overall Study|Physician Decision|2
859248|NCT00460265|1818245|FG000|Overall Study|Withdrawal by Subject|10
859249|NCT00460265|1818246|FG001|Overall Study|Withdrawal by Subject|25
859250|NCT00460265|1818245|FG000|Overall Study|Ongoing|60
859251|NCT00460265|1818246|FG001|Overall Study|Ongoing|47
859252|NCT00460408|1818256|FG000|Overall Study|Adverse Event|1
859253|NCT00460408|1818257|FG001|Overall Study|Adverse Event|0
859254|NCT00460408|1818258|FG002|Overall Study|Adverse Event|0
859255|NCT00460408|1818259|FG003|Overall Study|Adverse Event|0
859256|NCT00460408|1818256|FG000|Overall Study|Death|7
859257|NCT00460408|1818257|FG001|Overall Study|Death|0
859258|NCT00460408|1818258|FG002|Overall Study|Death|0
859259|NCT00460408|1818259|FG003|Overall Study|Death|0
859260|NCT00460408|1818256|FG000|Overall Study|Lost to Follow-up|11
859261|NCT00460408|1818257|FG001|Overall Study|Lost to Follow-up|0
859262|NCT00460408|1818258|FG002|Overall Study|Lost to Follow-up|1
859263|NCT00460408|1818259|FG003|Overall Study|Lost to Follow-up|0
859264|NCT00460408|1818256|FG000|Overall Study|Withdrawal by Subject|31
859265|NCT00460408|1818257|FG001|Overall Study|Withdrawal by Subject|0
859266|NCT00460408|1818258|FG002|Overall Study|Withdrawal by Subject|0
859267|NCT00460408|1818259|FG003|Overall Study|Withdrawal by Subject|0
859268|NCT00460408|1818256|FG000|Overall Study|Insufficient clinical response|5
859269|NCT00460408|1818257|FG001|Overall Study|Insufficient clinical response|1
859270|NCT00460408|1818258|FG002|Overall Study|Insufficient clinical response|5
859271|NCT00460408|1818259|FG003|Overall Study|Insufficient clinical response|0
859272|NCT00460408|1818256|FG000|Overall Study|Other|12
859273|NCT00460408|1818257|FG001|Overall Study|Other|2
859274|NCT00460408|1818258|FG002|Overall Study|Other|0
859275|NCT00460408|1818259|FG003|Overall Study|Other|0
859276|NCT00460434|1818283|FG000|Overall Study|Lost to Follow-up|3
859277|NCT00460434|1818284|FG001|Overall Study|Lost to Follow-up|7
859278|NCT00460564|1818307|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
859279|NCT00460564|1818308|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1
859280|NCT00460564|1818309|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
859281|NCT00460564|1818310|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
859282|NCT00460564|1818311|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0
859283|NCT00460564|1818312|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0
859284|NCT00460564|1818313|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0
859285|NCT00460564|1818314|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0
859286|NCT00460564|1818307|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
859287|NCT00460564|1818308|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
859288|NCT00460564|1818309|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
859289|NCT00460564|1818310|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
859290|NCT00460564|1818311|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
859291|NCT00460564|1818312|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
859292|NCT00460564|1818313|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
859293|NCT00460564|1818314|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
859294|NCT00460564|1818307|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
859295|NCT00460564|1818308|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
859296|NCT00460564|1818309|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0
859297|NCT00460564|1818310|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0
859298|NCT00460564|1818311|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3
859299|NCT00460564|1818312|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5
859300|NCT00460564|1818313|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2
859301|NCT00460564|1818314|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0
859302|NCT00460564|1818307|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
859303|NCT00460564|1818308|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
859304|NCT00460564|1818309|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
859305|NCT00460564|1818310|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
859306|NCT00460564|1818311|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
859307|NCT00460564|1818312|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
859308|NCT00460564|1818313|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
859309|NCT00460564|1818314|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
859310|NCT00460564|1818307|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
859311|NCT00460564|1818308|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
859312|NCT00460564|1818309|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
859313|NCT00460564|1818310|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
859314|NCT00460564|1818311|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
859315|NCT00460564|1818312|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
859316|NCT00460564|1818313|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
859317|NCT00460564|1818314|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
859318|NCT00460577|1818336|FG000|Overall Study|Protocol Violation|2
859319|NCT00460577|1818337|FG001|Overall Study|Protocol Violation|6
859320|NCT00460603|1818355|FG000|Phase 1|Death|1
859321|NCT00460603|1818356|FG001|Phase 1|Death|0
859322|NCT00460603|1818357|FG002|Phase 1|Death|0
859323|NCT00460603|1818358|FG003|Phase 1|Death|2
859324|NCT00460603|1818359|FG004|Phase 1|Death|0
859325|NCT00460603|1818360|FG005|Phase 1|Death|0
859326|NCT00460603|1818361|FG006|Phase 1|Death|0
859327|NCT00460603|1818362|FG007|Phase 1|Death|0
859328|NCT00460603|1818363|FG008|Phase 1|Death|1
859329|NCT00460603|1818364|FG009|Phase 1|Death|0
859330|NCT00460603|1818365|FG010|Phase 1|Death|0
859331|NCT00460603|1818366|FG011|Phase 1|Death|0
859332|NCT00460603|1818355|FG000|Phase 1|Adverse Event|3
859333|NCT00460603|1818356|FG001|Phase 1|Adverse Event|1
859334|NCT00460603|1818357|FG002|Phase 1|Adverse Event|1
859335|NCT00460603|1818358|FG003|Phase 1|Adverse Event|2
859336|NCT00460603|1818359|FG004|Phase 1|Adverse Event|0
859337|NCT00460603|1818360|FG005|Phase 1|Adverse Event|0
859338|NCT00460603|1818361|FG006|Phase 1|Adverse Event|3
859339|NCT00460603|1818362|FG007|Phase 1|Adverse Event|0
859340|NCT00460603|1818363|FG008|Phase 1|Adverse Event|4
859341|NCT00460603|1818364|FG009|Phase 1|Adverse Event|0
859342|NCT00460603|1818365|FG010|Phase 1|Adverse Event|0
859343|NCT00460603|1818366|FG011|Phase 1|Adverse Event|0
859344|NCT00460603|1818355|FG000|Phase 1|Lack of Efficacy|1
859345|NCT00460603|1818356|FG001|Phase 1|Lack of Efficacy|0
859346|NCT00460603|1818357|FG002|Phase 1|Lack of Efficacy|1
859347|NCT00460603|1818358|FG003|Phase 1|Lack of Efficacy|2
859348|NCT00460603|1818359|FG004|Phase 1|Lack of Efficacy|2
859349|NCT00460603|1818360|FG005|Phase 1|Lack of Efficacy|2
859350|NCT00460603|1818361|FG006|Phase 1|Lack of Efficacy|2
859351|NCT00460603|1818362|FG007|Phase 1|Lack of Efficacy|2
859352|NCT00460603|1818363|FG008|Phase 1|Lack of Efficacy|11
859353|NCT00460603|1818364|FG009|Phase 1|Lack of Efficacy|0
859354|NCT00460603|1818365|FG010|Phase 1|Lack of Efficacy|0
859355|NCT00460603|1818366|FG011|Phase 1|Lack of Efficacy|0
859356|NCT00460603|1818355|FG000|Phase 1|Withdrawal by Subject|1
859357|NCT00460603|1818356|FG001|Phase 1|Withdrawal by Subject|2
859358|NCT00460603|1818357|FG002|Phase 1|Withdrawal by Subject|1
859359|NCT00460603|1818358|FG003|Phase 1|Withdrawal by Subject|1
859360|NCT00460603|1818359|FG004|Phase 1|Withdrawal by Subject|3
859361|NCT00460603|1818360|FG005|Phase 1|Withdrawal by Subject|0
859362|NCT00460603|1818361|FG006|Phase 1|Withdrawal by Subject|1
859363|NCT00460603|1818362|FG007|Phase 1|Withdrawal by Subject|0
859365|NCT00460603|1818364|FG009|Phase 1|Withdrawal by Subject|0
859366|NCT00460603|1818365|FG010|Phase 1|Withdrawal by Subject|0
859367|NCT00460603|1818366|FG011|Phase 1|Withdrawal by Subject|0
859368|NCT00460603|1818355|FG000|Phase 1|Other|0
859369|NCT00460603|1818356|FG001|Phase 1|Other|3
859370|NCT00460603|1818357|FG002|Phase 1|Other|1
859371|NCT00460603|1818358|FG003|Phase 1|Other|1
859372|NCT00460603|1818359|FG004|Phase 1|Other|1
859373|NCT00460603|1818360|FG005|Phase 1|Other|2
859374|NCT00460603|1818361|FG006|Phase 1|Other|0
859375|NCT00460603|1818362|FG007|Phase 1|Other|1
859376|NCT00460603|1818363|FG008|Phase 1|Other|0
859377|NCT00460603|1818364|FG009|Phase 1|Other|0
859378|NCT00460603|1818365|FG010|Phase 1|Other|0
859379|NCT00460603|1818366|FG011|Phase 1|Other|0
859380|NCT00460603|1818355|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
859381|NCT00460603|1818356|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
859382|NCT00460603|1818357|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
859383|NCT00460603|1818358|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
859384|NCT00460603|1818359|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
859385|NCT00460603|1818360|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
859386|NCT00460603|1818361|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
859387|NCT00460603|1818362|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
859388|NCT00460603|1818363|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
859389|NCT00460603|1818364|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
859390|NCT00460603|1818365|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
859391|NCT00460603|1818366|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
859392|NCT00460603|1818355|FG000|Phase 2|Adverse Event|0
859393|NCT00460603|1818356|FG001|Phase 2|Adverse Event|0
859394|NCT00460603|1818357|FG002|Phase 2|Adverse Event|0
859395|NCT00460603|1818358|FG003|Phase 2|Adverse Event|0
859396|NCT00460603|1818359|FG004|Phase 2|Adverse Event|0
859397|NCT00460603|1818360|FG005|Phase 2|Adverse Event|0
859398|NCT00460603|1818361|FG006|Phase 2|Adverse Event|0
859399|NCT00460603|1818362|FG007|Phase 2|Adverse Event|0
859400|NCT00460603|1818363|FG008|Phase 2|Adverse Event|0
859401|NCT00460603|1818364|FG009|Phase 2|Adverse Event|12
859402|NCT00460603|1818365|FG010|Phase 2|Adverse Event|9
859403|NCT00460603|1818366|FG011|Phase 2|Adverse Event|10
859404|NCT00460603|1818355|FG000|Phase 2|Death|0
859405|NCT00460603|1818356|FG001|Phase 2|Death|0
859406|NCT00460603|1818357|FG002|Phase 2|Death|0
859407|NCT00460603|1818358|FG003|Phase 2|Death|0
859408|NCT00460603|1818359|FG004|Phase 2|Death|0
859409|NCT00460603|1818360|FG005|Phase 2|Death|0
859410|NCT00460603|1818361|FG006|Phase 2|Death|0
859411|NCT00460603|1818362|FG007|Phase 2|Death|0
859412|NCT00460603|1818363|FG008|Phase 2|Death|0
859413|NCT00460603|1818364|FG009|Phase 2|Death|4
859414|NCT00460603|1818365|FG010|Phase 2|Death|2
859415|NCT00460603|1818366|FG011|Phase 2|Death|2
859416|NCT00460603|1818355|FG000|Phase 2|Protocol Violation|0
859417|NCT00460603|1818356|FG001|Phase 2|Protocol Violation|0
859418|NCT00460603|1818357|FG002|Phase 2|Protocol Violation|0
859419|NCT00460603|1818358|FG003|Phase 2|Protocol Violation|0
859420|NCT00460603|1818359|FG004|Phase 2|Protocol Violation|0
859421|NCT00460603|1818360|FG005|Phase 2|Protocol Violation|0
859422|NCT00460603|1818361|FG006|Phase 2|Protocol Violation|0
859423|NCT00460603|1818362|FG007|Phase 2|Protocol Violation|0
859424|NCT00460603|1818363|FG008|Phase 2|Protocol Violation|0
859425|NCT00460603|1818364|FG009|Phase 2|Protocol Violation|1
859426|NCT00460603|1818365|FG010|Phase 2|Protocol Violation|1
859427|NCT00460603|1818366|FG011|Phase 2|Protocol Violation|0
859428|NCT00460603|1818355|FG000|Phase 2|Lost to Follow-up|0
859429|NCT00460603|1818356|FG001|Phase 2|Lost to Follow-up|0
859430|NCT00460603|1818357|FG002|Phase 2|Lost to Follow-up|0
859431|NCT00460603|1818358|FG003|Phase 2|Lost to Follow-up|0
859432|NCT00460603|1818359|FG004|Phase 2|Lost to Follow-up|0
859433|NCT00460603|1818360|FG005|Phase 2|Lost to Follow-up|0
859434|NCT00460603|1818361|FG006|Phase 2|Lost to Follow-up|0
859435|NCT00460603|1818362|FG007|Phase 2|Lost to Follow-up|0
859436|NCT00460603|1818363|FG008|Phase 2|Lost to Follow-up|0
859437|NCT00460603|1818364|FG009|Phase 2|Lost to Follow-up|1
859438|NCT00460603|1818365|FG010|Phase 2|Lost to Follow-up|0
859439|NCT00460603|1818366|FG011|Phase 2|Lost to Follow-up|0
859440|NCT00460603|1818355|FG000|Phase 2|Other|0
859441|NCT00460603|1818356|FG001|Phase 2|Other|0
859442|NCT00460603|1818357|FG002|Phase 2|Other|0
859443|NCT00460603|1818358|FG003|Phase 2|Other|0
859444|NCT00460603|1818359|FG004|Phase 2|Other|0
859445|NCT00460603|1818360|FG005|Phase 2|Other|0
859446|NCT00460603|1818361|FG006|Phase 2|Other|0
859447|NCT00460603|1818362|FG007|Phase 2|Other|0
859448|NCT00460603|1818363|FG008|Phase 2|Other|0
859449|NCT00460603|1818364|FG009|Phase 2|Other|6
859450|NCT00460603|1818365|FG010|Phase 2|Other|16
859451|NCT00460603|1818366|FG011|Phase 2|Other|7
859452|NCT00460603|1818355|FG000|Phase 2|Objective Progression or Relapse|0
859453|NCT00460603|1818356|FG001|Phase 2|Objective Progression or Relapse|0
859454|NCT00460603|1818357|FG002|Phase 2|Objective Progression or Relapse|0
859455|NCT00460603|1818358|FG003|Phase 2|Objective Progression or Relapse|0
859456|NCT00460603|1818359|FG004|Phase 2|Objective Progression or Relapse|0
859457|NCT00460603|1818360|FG005|Phase 2|Objective Progression or Relapse|0
859458|NCT00460603|1818361|FG006|Phase 2|Objective Progression or Relapse|0
859459|NCT00460603|1818362|FG007|Phase 2|Objective Progression or Relapse|0
859460|NCT00460603|1818363|FG008|Phase 2|Objective Progression or Relapse|0
859461|NCT00460603|1818364|FG009|Phase 2|Objective Progression or Relapse|9
859462|NCT00460603|1818365|FG010|Phase 2|Objective Progression or Relapse|10
859463|NCT00460603|1818366|FG011|Phase 2|Objective Progression or Relapse|17
859464|NCT00460603|1818355|FG000|Phase 2|Global Deterioration of Health Status|0
859465|NCT00460603|1818356|FG001|Phase 2|Global Deterioration of Health Status|0
859466|NCT00460603|1818357|FG002|Phase 2|Global Deterioration of Health Status|0
859467|NCT00460603|1818358|FG003|Phase 2|Global Deterioration of Health Status|0
859468|NCT00460603|1818359|FG004|Phase 2|Global Deterioration of Health Status|0
859469|NCT00460603|1818360|FG005|Phase 2|Global Deterioration of Health Status|0
859470|NCT00460603|1818361|FG006|Phase 2|Global Deterioration of Health Status|0
859471|NCT00460603|1818362|FG007|Phase 2|Global Deterioration of Health Status|0
859472|NCT00460603|1818363|FG008|Phase 2|Global Deterioration of Health Status|0
859473|NCT00460603|1818364|FG009|Phase 2|Global Deterioration of Health Status|0
859474|NCT00460603|1818365|FG010|Phase 2|Global Deterioration of Health Status|1
859475|NCT00460603|1818366|FG011|Phase 2|Global Deterioration of Health Status|0
859476|NCT00460603|1818355|FG000|Phase 2|Withdrawal by Subject|0
859477|NCT00460603|1818356|FG001|Phase 2|Withdrawal by Subject|0
859478|NCT00460603|1818357|FG002|Phase 2|Withdrawal by Subject|0
859479|NCT00460603|1818358|FG003|Phase 2|Withdrawal by Subject|0
859480|NCT00460603|1818359|FG004|Phase 2|Withdrawal by Subject|0
859481|NCT00460603|1818360|FG005|Phase 2|Withdrawal by Subject|0
859482|NCT00460603|1818361|FG006|Phase 2|Withdrawal by Subject|0
859483|NCT00460603|1818362|FG007|Phase 2|Withdrawal by Subject|0
859484|NCT00460603|1818363|FG008|Phase 2|Withdrawal by Subject|0
859485|NCT00460603|1818364|FG009|Phase 2|Withdrawal by Subject|5
859486|NCT00460603|1818365|FG010|Phase 2|Withdrawal by Subject|4
859487|NCT00460603|1818366|FG011|Phase 2|Withdrawal by Subject|5
859488|NCT00460603|1818355|FG000|Phase 2|Randomized, but not treated|0
859489|NCT00460603|1818356|FG001|Phase 2|Randomized, but not treated|0
859490|NCT00460603|1818357|FG002|Phase 2|Randomized, but not treated|0
859491|NCT00460603|1818358|FG003|Phase 2|Randomized, but not treated|0
859492|NCT00460603|1818359|FG004|Phase 2|Randomized, but not treated|0
859493|NCT00460603|1818360|FG005|Phase 2|Randomized, but not treated|0
859494|NCT00460603|1818361|FG006|Phase 2|Randomized, but not treated|0
859495|NCT00460603|1818362|FG007|Phase 2|Randomized, but not treated|0
859496|NCT00460603|1818363|FG008|Phase 2|Randomized, but not treated|0
859497|NCT00460603|1818364|FG009|Phase 2|Randomized, but not treated|3
859498|NCT00460603|1818365|FG010|Phase 2|Randomized, but not treated|0
859499|NCT00460603|1818366|FG011|Phase 2|Randomized, but not treated|0
859500|NCT00460655|1818394|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
859501|NCT00460655|1818395|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0
859502|NCT00460655|1818396|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
859503|NCT00460655|1818397|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
859504|NCT00460655|1818394|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
859505|NCT00460655|1818395|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
859506|NCT00460655|1818396|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
859507|NCT00460655|1818397|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
859508|NCT00460655|1818394|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0
859509|NCT00460655|1818395|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1
859510|NCT00460655|1818396|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0
859511|NCT00460655|1818397|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0
859512|NCT00460655|1818394|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
859513|NCT00460655|1818395|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
859514|NCT00460655|1818396|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1
859515|NCT00460655|1818397|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6
859516|NCT00460655|1818394|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
859517|NCT00460655|1818395|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
859518|NCT00460655|1818396|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
859519|NCT00460655|1818397|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
859520|NCT00460655|1818394|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
859521|NCT00460655|1818395|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
859522|NCT00460655|1818396|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
859523|NCT00460655|1818397|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
859524|NCT00460746|1818407|FG000|Overall Study|Adverse Event|1
859525|NCT00460746|1818407|FG000|Overall Study|Lost to Follow-up|1
859526|NCT00460798|1818411|FG000|Overall Study|Death|59
859527|NCT00460798|1818411|FG000|Overall Study|Adverse Event|27
859528|NCT00460798|1818411|FG000|Overall Study|Lost to Follow-up|19
859529|NCT00460798|1818411|FG000|Overall Study|Progressive Disease|99
859530|NCT00460798|1818411|FG000|Overall Study|Other|27
859531|NCT00460798|1818411|FG000|Overall Study|Ongoing at Date of Cut-Off|82
859532|NCT00460798|1818411|FG000|Overall Study|Missing/Incomplete Dosing Information|27
859533|NCT00460811|1818420|FG000|Overall Study|Adverse Event|4
859534|NCT00460811|1818421|FG001|Overall Study|Adverse Event|6
859535|NCT00460811|1818422|FG002|Overall Study|Adverse Event|3
859536|NCT00460811|1818423|FG003|Overall Study|Adverse Event|10
859537|NCT00460811|1818424|FG004|Overall Study|Adverse Event|2
859538|NCT00460811|1818420|FG000|Overall Study|Noncompliance|1
859539|NCT00460811|1818421|FG001|Overall Study|Noncompliance|0
859540|NCT00460811|1818422|FG002|Overall Study|Noncompliance|0
859541|NCT00460811|1818423|FG003|Overall Study|Noncompliance|2
859542|NCT00460811|1818424|FG004|Overall Study|Noncompliance|1
859543|NCT00460811|1818420|FG000|Overall Study|Withdrawal by Subject|7
859544|NCT00460811|1818421|FG001|Overall Study|Withdrawal by Subject|7
859545|NCT00460811|1818422|FG002|Overall Study|Withdrawal by Subject|6
859546|NCT00460811|1818423|FG003|Overall Study|Withdrawal by Subject|3
859547|NCT00460811|1818424|FG004|Overall Study|Withdrawal by Subject|11
859548|NCT00460811|1818420|FG000|Overall Study|Physician Decision|1
859549|NCT00460811|1818421|FG001|Overall Study|Physician Decision|0
859550|NCT00460811|1818422|FG002|Overall Study|Physician Decision|0
859551|NCT00460811|1818423|FG003|Overall Study|Physician Decision|0
859552|NCT00460811|1818424|FG004|Overall Study|Physician Decision|0
859553|NCT00460811|1818420|FG000|Overall Study|Lost to Follow-up|3
859554|NCT00460811|1818421|FG001|Overall Study|Lost to Follow-up|2
859555|NCT00460811|1818422|FG002|Overall Study|Lost to Follow-up|5
859556|NCT00460811|1818423|FG003|Overall Study|Lost to Follow-up|3
859557|NCT00460811|1818424|FG004|Overall Study|Lost to Follow-up|6
859558|NCT00461032|1818452|FG000|Overall Study|Adverse Event|5
859559|NCT00461032|1818453|FG001|Overall Study|Adverse Event|6
859560|NCT00461032|1818452|FG000|Overall Study|Lack of Efficacy|5
859561|NCT00461032|1818453|FG001|Overall Study|Lack of Efficacy|1
859562|NCT00461032|1818452|FG000|Overall Study|Lost to Follow-up|7
859563|NCT00461032|1818453|FG001|Overall Study|Lost to Follow-up|12
859564|NCT00461032|1818452|FG000|Overall Study|Protocol Violation|4
859565|NCT00461032|1818453|FG001|Overall Study|Protocol Violation|4
859566|NCT00461032|1818452|FG000|Overall Study|Withdrawal by Subject|7
859567|NCT00461032|1818453|FG001|Overall Study|Withdrawal by Subject|15
859568|NCT00461032|1818452|FG000|Overall Study|Patient Moved or Relocated|2
859569|NCT00461032|1818453|FG001|Overall Study|Patient Moved or Relocated|1
859570|NCT00461032|1818452|FG000|Overall Study|Other|7
859571|NCT00461032|1818453|FG001|Overall Study|Other|5
859572|NCT00461123|1818475|FG000|Overall Study|Adverse Event|1
859573|NCT00461123|1818476|FG001|Overall Study|Adverse Event|0
859574|NCT00461123|1818475|FG000|Overall Study|Lost to Follow-up|1
859575|NCT00461123|1818476|FG001|Overall Study|Lost to Follow-up|1
859576|NCT00461123|1818475|FG000|Overall Study|Protocol Violation|3
859577|NCT00461123|1818476|FG001|Overall Study|Protocol Violation|2
859578|NCT00461123|1818475|FG000|Overall Study|Withdrawal by Subject|1
859579|NCT00461123|1818476|FG001|Overall Study|Withdrawal by Subject|3
859580|NCT00461175|1818484|FG000|Overall Study|Protocol Violation|522
859581|NCT00461175|1818485|FG001|Overall Study|Protocol Violation|365
859582|NCT00461253|1818493|FG000|Overall Study|Death|985
859583|NCT00461253|1818494|FG001|Overall Study|Death|0
859584|NCT00461253|1818493|FG000|Overall Study|Protocol Violation|613
859585|NCT00461253|1818494|FG001|Overall Study|Protocol Violation|236
859586|NCT00461253|1818493|FG000|Overall Study|no response|2609
859587|NCT00461253|1818494|FG001|Overall Study|no response|11789
859588|NCT00461253|1818493|FG000|Overall Study|administrative|773
859589|NCT00461253|1818494|FG001|Overall Study|administrative|7773
859590|NCT00461305|1818515|FG000|Treatment|Adverse Event|26
859591|NCT00461305|1818516|FG001|Treatment|Adverse Event|3
859592|NCT00461305|1818515|FG000|Treatment|Lost to Follow-up|4
859593|NCT00461305|1818516|FG001|Treatment|Lost to Follow-up|2
859594|NCT00461305|1818515|FG000|Treatment|Protocol Violation|13
859595|NCT00461305|1818516|FG001|Treatment|Protocol Violation|2
859596|NCT00461305|1818515|FG000|Treatment|Withdrawal by Subject|48
859597|NCT00461305|1818516|FG001|Treatment|Withdrawal by Subject|2
859598|NCT00461305|1818515|FG000|Treatment|Never dispensed|5
859599|NCT00461305|1818516|FG001|Treatment|Never dispensed|0
859600|NCT00461305|1818515|FG000|Treatment|Study drug not taken|1
859601|NCT00461305|1818516|FG001|Treatment|Study drug not taken|0
859602|NCT00461305|1818515|FG000|Treatment|Partially missing diary|2
859603|NCT00461305|1818516|FG001|Treatment|Partially missing diary|0
859604|NCT00461305|1818515|FG000|Treatment|Other (missing drug etc)|2
859605|NCT00461305|1818516|FG001|Treatment|Other (missing drug etc)|0
859606|NCT00461305|1818515|FG000|Continued Treatment|Adverse Event|26
859607|NCT00461305|1818516|FG001|Continued Treatment|Adverse Event|0
859608|NCT00461305|1818515|FG000|Continued Treatment|Lost to Follow-up|4
859609|NCT00461305|1818516|FG001|Continued Treatment|Lost to Follow-up|0
859610|NCT00461305|1818515|FG000|Continued Treatment|Protocol Violation|13
859611|NCT00461305|1818516|FG001|Continued Treatment|Protocol Violation|0
859612|NCT00461305|1818515|FG000|Continued Treatment|Withdrawal by Subject|48
859613|NCT00461305|1818516|FG001|Continued Treatment|Withdrawal by Subject|0
859614|NCT00461305|1818515|FG000|Continued Treatment|Partially missing diary|2
859615|NCT00461305|1818516|FG001|Continued Treatment|Partially missing diary|0
859616|NCT00461305|1818515|FG000|Continued Treatment|Other (missing drug etc)|2
859617|NCT00461305|1818516|FG001|Continued Treatment|Other (missing drug etc)|0
859618|NCT00461500|1818533|FG000|Overall Study|Adverse Event|1
859619|NCT00461500|1818534|FG001|Overall Study|Adverse Event|0
859620|NCT00461500|1818533|FG000|Overall Study|Lack of Efficacy|0
859621|NCT00461500|1818534|FG001|Overall Study|Lack of Efficacy|1
859622|NCT00461500|1818533|FG000|Overall Study|Expired Drug Treatment|1
859623|NCT00461500|1818534|FG001|Overall Study|Expired Drug Treatment|1
859624|NCT00461500|1818533|FG000|Overall Study|Study Stopped|1
859625|NCT00461500|1818534|FG001|Overall Study|Study Stopped|2
859626|NCT00461500|1818533|FG000|Overall Study|Drug Treatment Misuse|1
859627|NCT00461500|1818534|FG001|Overall Study|Drug Treatment Misuse|0
859628|NCT00461500|1818533|FG000|Overall Study|No Longer Willing to Take Part in Study|1
859629|NCT00461500|1818534|FG001|Overall Study|No Longer Willing to Take Part in Study|0
859630|NCT00461500|1818533|FG000|Overall Study|Lost to Follow-up|2
859631|NCT00461500|1818534|FG001|Overall Study|Lost to Follow-up|2
859632|NCT00461552|1818555|FG000|Overall Study|Drug Dispensing error|0
859633|NCT00461552|1818556|FG001|Overall Study|Drug Dispensing error|2
859634|NCT00461630|1818573|FG000|Overall Study|Death|798
859635|NCT00461630|1818574|FG001|Overall Study|Death|732
859636|NCT00461630|1818573|FG000|Overall Study|Lost to Follow-up|108
859637|NCT00461630|1818574|FG001|Overall Study|Lost to Follow-up|95
859638|NCT00461708|1818582|FG000|Overall Study|Adverse Event|17
859639|NCT00461708|1818583|FG001|Overall Study|Adverse Event|7
859640|NCT00461708|1818582|FG000|Overall Study|Lack of Efficacy|68
859641|NCT00461708|1818583|FG001|Overall Study|Lack of Efficacy|20
859642|NCT00461708|1818582|FG000|Overall Study|Physician Decision|10
859643|NCT00461708|1818583|FG001|Overall Study|Physician Decision|4
859644|NCT00461708|1818582|FG000|Overall Study|Withdrawal by Subject|8
859645|NCT00461708|1818583|FG001|Overall Study|Withdrawal by Subject|2
859646|NCT00461708|1818582|FG000|Overall Study|Other|4
859647|NCT00461708|1818583|FG001|Overall Study|Other|4
859648|NCT00461708|1818582|FG000|Overall Study|Death|8
859649|NCT00461708|1818583|FG001|Overall Study|Death|1
859650|NCT00461786|1818615|FG000|Overall Study|Entry Criteria Not Met|2
859651|NCT00461786|1818615|FG000|Overall Study|Inevaluable (Never Treated)|1
859652|NCT00461981|1818625|FG000|Overall Study|Lost to Follow-up|9
859653|NCT00461981|1818626|FG001|Overall Study|Lost to Follow-up|6
859654|NCT00461981|1818625|FG000|Overall Study|Withdrawal by Subject|2
859655|NCT00461981|1818626|FG001|Overall Study|Withdrawal by Subject|3
859656|NCT00462306|1818691|FG000|Overall Study|insufficient data|0
859657|NCT00462306|1818692|FG001|Overall Study|insufficient data|13
859658|NCT00462345|1818711|FG000|Overall Study|Withdrawal by Subject|2
859659|NCT00462345|1818711|FG000|Overall Study|Did not complete second course|1
859660|NCT00462384|1818715|FG000|Overall Study|Adverse Event|2
859661|NCT00462384|1818715|FG000|Overall Study|Death|2
859662|NCT00462384|1818715|FG000|Overall Study|Withdrawal by Subject|1
859663|NCT00462384|1818715|FG000|Overall Study|Other|4
859664|NCT00462462|1818735|FG000|Overall Study|Physician Decision|0
859665|NCT00462462|1818736|FG001|Overall Study|Physician Decision|1
859666|NCT00462488|1818746|FG000|Overall Study|Protocol Violation|1
859667|NCT00462488|1818747|FG001|Overall Study|Protocol Violation|0
859668|NCT00462488|1818746|FG000|Overall Study|Lack of Efficacy|19
859669|NCT00462488|1818747|FG001|Overall Study|Lack of Efficacy|17
859670|NCT00462501|1818753|FG000|Overall Study|Not treated|3
859671|NCT00462501|1818753|FG000|Overall Study|Adverse Event|2
859672|NCT00462670|1818772|FG000|Overall Study|Adverse Event|3
859673|NCT00462670|1818773|FG001|Overall Study|Adverse Event|5
859674|NCT00462670|1818772|FG000|Overall Study|Lack of Efficacy|1
859675|NCT00462670|1818773|FG001|Overall Study|Lack of Efficacy|0
859676|NCT00462670|1818772|FG000|Overall Study|Protocol Violation|1
859677|NCT00462670|1818773|FG001|Overall Study|Protocol Violation|0
859678|NCT00462670|1818772|FG000|Overall Study|Resolution of signs and symptoms|0
859679|NCT00462670|1818773|FG001|Overall Study|Resolution of signs and symptoms|2
859680|NCT00462709|1818779|FG000|Overall Study|Transitioned to commercial C1INH-nf|40
859681|NCT00462709|1818779|FG000|Overall Study|Lost to Follow-up|10
859682|NCT00462709|1818779|FG000|Overall Study|Withdrawal by Subject|8
859683|NCT00462709|1818779|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
859684|NCT00462709|1818779|FG000|Overall Study|Death|2
859685|NCT00462709|1818779|FG000|Overall Study|Logistical reasons|2
859686|NCT00462709|1818779|FG000|Overall Study|Physician Decision|1
859687|NCT00462709|1818779|FG000|Overall Study|Withdrew to start treatment with Cetor|1
859688|NCT00462748|1818804|FG000|Overall Study|Adverse Event|7
859689|NCT00462748|1818805|FG001|Overall Study|Adverse Event|5
859690|NCT00462748|1818806|FG002|Overall Study|Adverse Event|9
859691|NCT00462748|1818804|FG000|Overall Study|Protocol Violation|0
859692|NCT00462748|1818805|FG001|Overall Study|Protocol Violation|2
859693|NCT00462748|1818806|FG002|Overall Study|Protocol Violation|1
859694|NCT00462748|1818804|FG000|Overall Study|Withdrew consent|3
859695|NCT00462748|1818805|FG001|Overall Study|Withdrew consent|3
859696|NCT00462748|1818806|FG002|Overall Study|Withdrew consent|0
859697|NCT00462748|1818804|FG000|Overall Study|Lost to Follow-up|1
859698|NCT00462748|1818805|FG001|Overall Study|Lost to Follow-up|1
859699|NCT00462748|1818806|FG002|Overall Study|Lost to Follow-up|1
859700|NCT00462748|1818804|FG000|Overall Study|Discontinued after 41 days Rx|1
859701|NCT00462748|1818805|FG001|Overall Study|Discontinued after 41 days Rx|0
859702|NCT00462748|1818806|FG002|Overall Study|Discontinued after 41 days Rx|0
859703|NCT00462761|1818814|FG000|Overall Study|Adverse Event|6
859704|NCT00462761|1818814|FG000|Overall Study|Withdrawal by Subject|9
859705|NCT00462761|1818814|FG000|Overall Study|Physician Decision|5
859706|NCT00462761|1818814|FG000|Overall Study|Disease progression|43
859707|NCT00462761|1818814|FG000|Overall Study|Death|12
859708|NCT00462761|1818814|FG000|Overall Study|Other|1
859709|NCT00462826|1818846|FG000|Overall Study|Ineligible - second primary|1
859710|NCT00462826|1818846|FG000|Overall Study|Ineligible - wrong cell type|1
859711|NCT00462826|1818846|FG000|Overall Study|Ineligible - wrong primary|2
859712|NCT00462826|1818846|FG000|Overall Study|Never treated|1
859713|NCT00462865|1818865|FG000|Overall Study|Adverse Event|1
859750|NCT00462982|1818899|FG000|Overall Study|Adverse Event|1
859751|NCT00462982|1818899|FG000|Overall Study|Patient Not Treated|2
859752|NCT00463047|1818903|FG000|Titration Period 1|Adverse Event|10
859753|NCT00463047|1818904|FG001|Titration Period 1|Adverse Event|8
859754|NCT00463047|1818903|FG000|Titration Period 1|Lack of Efficacy|10
859755|NCT00463047|1818904|FG001|Titration Period 1|Lack of Efficacy|4
859756|NCT00463047|1818903|FG000|Titration Period 1|Lost to Follow-up|2
859757|NCT00463047|1818904|FG001|Titration Period 1|Lost to Follow-up|0
859758|NCT00463047|1818903|FG000|Titration Period 1|Non-compliance with study medication|3
859759|NCT00463047|1818904|FG001|Titration Period 1|Non-compliance with study medication|5
859760|NCT00463047|1818903|FG000|Titration Period 1|Protocol Violation|5
859761|NCT00463047|1818904|FG001|Titration Period 1|Protocol Violation|5
859762|NCT00463047|1818903|FG000|Titration Period 1|Withdrawal by Subject|3
859763|NCT00463047|1818904|FG001|Titration Period 1|Withdrawal by Subject|5
859764|NCT00463047|1818903|FG000|Titration Period 1|Non-compliance procedures|4
859765|NCT00463047|1818904|FG001|Titration Period 1|Non-compliance procedures|10
859766|NCT00463047|1818903|FG000|Titration Period 1|Other|0
859767|NCT00463047|1818904|FG001|Titration Period 1|Other|2
859768|NCT00463047|1818903|FG000|Titration Period 2|Adverse Event|9
859769|NCT00463047|1818904|FG001|Titration Period 2|Adverse Event|9
859770|NCT00463047|1818903|FG000|Titration Period 2|Lack of Efficacy|6
859771|NCT00463047|1818904|FG001|Titration Period 2|Lack of Efficacy|4
859772|NCT00463047|1818903|FG000|Titration Period 2|Withdrawal by Subject|1
859773|NCT00463047|1818904|FG001|Titration Period 2|Withdrawal by Subject|0
859774|NCT00463047|1818903|FG000|Titration Period 2|Protocol Violation|2
859775|NCT00463047|1818904|FG001|Titration Period 2|Protocol Violation|3
859776|NCT00463047|1818903|FG000|Titration Period 2|Lost to Follow-up|1
859777|NCT00463047|1818904|FG001|Titration Period 2|Lost to Follow-up|2
859778|NCT00463047|1818903|FG000|Titration Period 2|Non-compliance study medication|4
859779|NCT00463047|1818904|FG001|Titration Period 2|Non-compliance study medication|2
859780|NCT00463047|1818903|FG000|Titration Period 2|Non-compliance procedures|4
859781|NCT00463047|1818904|FG001|Titration Period 2|Non-compliance procedures|1
859782|NCT00463047|1818903|FG000|Titration Period 2|Other|3
859783|NCT00463047|1818904|FG001|Titration Period 2|Other|2
859784|NCT00463047|1818903|FG000|Double-Blind Treatment Period 1|Adverse Event|0
859785|NCT00463047|1818904|FG001|Double-Blind Treatment Period 1|Adverse Event|2
859786|NCT00463047|1818903|FG000|Double-Blind Treatment Period 1|Protocol Violation|1
859787|NCT00463047|1818904|FG001|Double-Blind Treatment Period 1|Protocol Violation|2
859788|NCT00463047|1818903|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1
859789|NCT00463047|1818904|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0
859790|NCT00463047|1818903|FG000|Double-Blind Treatment Period 1|Other|1
859791|NCT00463047|1818904|FG001|Double-Blind Treatment Period 1|Other|0
859792|NCT00463047|1818903|FG000|Double-Blind Treatment Period 2|Adverse Event|0
859793|NCT00463047|1818904|FG001|Double-Blind Treatment Period 2|Adverse Event|1
859794|NCT00463047|1818903|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
859795|NCT00463047|1818904|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1
859796|NCT00463047|1818903|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1
859797|NCT00463047|1818904|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0
859798|NCT00463060|1818913|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
859799|NCT00463060|1818913|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
859800|NCT00463151|1818926|FG000|Overall Study|Adverse Event|0
859801|NCT00463151|1818927|FG001|Overall Study|Adverse Event|0
859802|NCT00463151|1818928|FG002|Overall Study|Adverse Event|1
859803|NCT00463151|1818929|FG003|Overall Study|Adverse Event|0
859804|NCT00463151|1818926|FG000|Overall Study|Lack of Efficacy|2
859805|NCT00463151|1818927|FG001|Overall Study|Lack of Efficacy|5
859806|NCT00463151|1818928|FG002|Overall Study|Lack of Efficacy|2
859807|NCT00463151|1818929|FG003|Overall Study|Lack of Efficacy|5
859808|NCT00463151|1818926|FG000|Overall Study|Protocol Violation|0
859809|NCT00463151|1818927|FG001|Overall Study|Protocol Violation|0
859810|NCT00463151|1818928|FG002|Overall Study|Protocol Violation|0
859811|NCT00463151|1818929|FG003|Overall Study|Protocol Violation|1
859812|NCT00463151|1818926|FG000|Overall Study|Withdrawal by Subject|0
859813|NCT00463151|1818927|FG001|Overall Study|Withdrawal by Subject|0
859814|NCT00463151|1818928|FG002|Overall Study|Withdrawal by Subject|0
859815|NCT00463151|1818929|FG003|Overall Study|Withdrawal by Subject|1
859816|NCT00463229|1818941|FG000|Overall Study|Lost to Follow-up|5
859817|NCT00463229|1818942|FG001|Overall Study|Lost to Follow-up|7
859818|NCT00463229|1818941|FG000|Overall Study|Death|4
859819|NCT00463229|1818942|FG001|Overall Study|Death|3
859820|NCT00463346|1818951|FG000|Overall Study|Withdrawal by Subject|3
859821|NCT00463346|1818952|FG001|Overall Study|Withdrawal by Subject|3
859822|NCT00463385|1818964|FG000|Overall Study|Other|4
859823|NCT00463385|1818965|FG001|Overall Study|Other|3
859824|NCT00463385|1818966|FG002|Overall Study|Other|6
859825|NCT00463385|1818967|FG003|Overall Study|Other|4
859826|NCT00463385|1818964|FG000|Overall Study|Adverse Event|5
859827|NCT00463385|1818965|FG001|Overall Study|Adverse Event|8
859828|NCT00463385|1818966|FG002|Overall Study|Adverse Event|4
859829|NCT00463385|1818967|FG003|Overall Study|Adverse Event|2
859830|NCT00463385|1818964|FG000|Overall Study|Lack of Efficacy|6
859831|NCT00463385|1818965|FG001|Overall Study|Lack of Efficacy|6
859832|NCT00463385|1818966|FG002|Overall Study|Lack of Efficacy|7
859833|NCT00463385|1818967|FG003|Overall Study|Lack of Efficacy|9
859834|NCT00463385|1818964|FG000|Overall Study|Withdrawal by Subject|3
859835|NCT00463385|1818965|FG001|Overall Study|Withdrawal by Subject|3
859836|NCT00463385|1818966|FG002|Overall Study|Withdrawal by Subject|3
859837|NCT00463385|1818967|FG003|Overall Study|Withdrawal by Subject|4
859838|NCT00463385|1818964|FG000|Overall Study|Lost to Follow-up|0
859839|NCT00463385|1818965|FG001|Overall Study|Lost to Follow-up|0
859840|NCT00463385|1818966|FG002|Overall Study|Lost to Follow-up|0
859841|NCT00463385|1818967|FG003|Overall Study|Lost to Follow-up|1
859842|NCT00463385|1818964|FG000|Overall Study|Death|2
859843|NCT00463385|1818965|FG001|Overall Study|Death|1
859844|NCT00463385|1818966|FG002|Overall Study|Death|2
859845|NCT00463385|1818967|FG003|Overall Study|Death|0
859846|NCT00463385|1818964|FG000|Overall Study|Missing|2
859847|NCT00463385|1818965|FG001|Overall Study|Missing|0
859848|NCT00463385|1818966|FG002|Overall Study|Missing|0
859849|NCT00463385|1818967|FG003|Overall Study|Missing|2
859850|NCT00463385|1818964|FG000|Overall Study|1 participant received commercial drug|0
859851|NCT00463385|1818965|FG001|Overall Study|1 participant received commercial drug|1
859852|NCT00463385|1818966|FG002|Overall Study|1 participant received commercial drug|0
859853|NCT00463385|1818967|FG003|Overall Study|1 participant received commercial drug|0
859854|NCT00463476|1819004|FG000|Overall Study|Withdrawal by Subject|1
859855|NCT00463476|1819005|FG001|Overall Study|Withdrawal by Subject|2
859856|NCT00463476|1819004|FG000|Overall Study|Lost to Follow-up|1
859857|NCT00463476|1819005|FG001|Overall Study|Lost to Follow-up|1
859858|NCT00463567|1819018|FG000|Overall Study|Adverse Event|29
859859|NCT00463567|1819019|FG001|Overall Study|Adverse Event|26
859860|NCT00463567|1819020|FG002|Overall Study|Adverse Event|17
859861|NCT00463567|1819021|FG003|Overall Study|Adverse Event|46
859862|NCT00463567|1819022|FG004|Overall Study|Adverse Event|10
859863|NCT00463567|1819023|FG005|Overall Study|Adverse Event|10
859864|NCT00463567|1819024|FG006|Overall Study|Adverse Event|4
859865|NCT00463567|1819018|FG000|Overall Study|Withdrawal by Subject|29
859866|NCT00463567|1819019|FG001|Overall Study|Withdrawal by Subject|22
859867|NCT00463567|1819020|FG002|Overall Study|Withdrawal by Subject|20
859868|NCT00463567|1819021|FG003|Overall Study|Withdrawal by Subject|37
859869|NCT00463567|1819022|FG004|Overall Study|Withdrawal by Subject|6
859870|NCT00463567|1819023|FG005|Overall Study|Withdrawal by Subject|5
859871|NCT00463567|1819024|FG006|Overall Study|Withdrawal by Subject|1
859872|NCT00463567|1819018|FG000|Overall Study|Protocol Deviation|13
859873|NCT00463567|1819019|FG001|Overall Study|Protocol Deviation|9
859874|NCT00463567|1819020|FG002|Overall Study|Protocol Deviation|14
859875|NCT00463567|1819021|FG003|Overall Study|Protocol Deviation|11
859876|NCT00463567|1819022|FG004|Overall Study|Protocol Deviation|1
859877|NCT00463567|1819023|FG005|Overall Study|Protocol Deviation|1
859878|NCT00463567|1819024|FG006|Overall Study|Protocol Deviation|2
859879|NCT00463567|1819018|FG000|Overall Study|Lost to Follow-up|12
859880|NCT00463567|1819019|FG001|Overall Study|Lost to Follow-up|6
859881|NCT00463567|1819020|FG002|Overall Study|Lost to Follow-up|13
859882|NCT00463567|1819021|FG003|Overall Study|Lost to Follow-up|8
859883|NCT00463567|1819022|FG004|Overall Study|Lost to Follow-up|1
859884|NCT00463567|1819023|FG005|Overall Study|Lost to Follow-up|1
859885|NCT00463567|1819024|FG006|Overall Study|Lost to Follow-up|1
859886|NCT00463567|1819018|FG000|Overall Study|Administrative problems|5
859887|NCT00463567|1819019|FG001|Overall Study|Administrative problems|3
859888|NCT00463567|1819020|FG002|Overall Study|Administrative problems|6
859889|NCT00463567|1819021|FG003|Overall Study|Administrative problems|9
859890|NCT00463567|1819022|FG004|Overall Study|Administrative problems|3
859891|NCT00463567|1819023|FG005|Overall Study|Administrative problems|2
859892|NCT00463567|1819024|FG006|Overall Study|Administrative problems|2
859893|NCT00463567|1819018|FG000|Overall Study|Lack of Efficacy|4
859894|NCT00463567|1819019|FG001|Overall Study|Lack of Efficacy|9
859895|NCT00463567|1819020|FG002|Overall Study|Lack of Efficacy|9
859896|NCT00463567|1819021|FG003|Overall Study|Lack of Efficacy|17
859897|NCT00463567|1819022|FG004|Overall Study|Lack of Efficacy|1
859898|NCT00463567|1819023|FG005|Overall Study|Lack of Efficacy|0
859899|NCT00463567|1819024|FG006|Overall Study|Lack of Efficacy|1
859900|NCT00463567|1819018|FG000|Overall Study|Abnormal lab value(s)|1
859901|NCT00463567|1819019|FG001|Overall Study|Abnormal lab value(s)|1
859902|NCT00463567|1819020|FG002|Overall Study|Abnormal lab value(s)|2
859903|NCT00463567|1819021|FG003|Overall Study|Abnormal lab value(s)|1
859904|NCT00463567|1819022|FG004|Overall Study|Abnormal lab value(s)|1
859905|NCT00463567|1819023|FG005|Overall Study|Abnormal lab value(s)|0
859906|NCT00463567|1819024|FG006|Overall Study|Abnormal lab value(s)|0
859907|NCT00463567|1819018|FG000|Overall Study|Abnormal test procedure result(s)|1
859908|NCT00463567|1819019|FG001|Overall Study|Abnormal test procedure result(s)|1
859909|NCT00463567|1819020|FG002|Overall Study|Abnormal test procedure result(s)|6
859910|NCT00463567|1819021|FG003|Overall Study|Abnormal test procedure result(s)|2
859911|NCT00463567|1819022|FG004|Overall Study|Abnormal test procedure result(s)|0
859912|NCT00463567|1819023|FG005|Overall Study|Abnormal test procedure result(s)|2
859913|NCT00463567|1819024|FG006|Overall Study|Abnormal test procedure result(s)|0
859914|NCT00463567|1819018|FG000|Overall Study|Death|1
859915|NCT00463567|1819019|FG001|Overall Study|Death|0
859916|NCT00463567|1819020|FG002|Overall Study|Death|2
859917|NCT00463567|1819021|FG003|Overall Study|Death|0
859918|NCT00463567|1819022|FG004|Overall Study|Death|0
859919|NCT00463567|1819023|FG005|Overall Study|Death|0
859920|NCT00463567|1819024|FG006|Overall Study|Death|0
859921|NCT00463580|1819048|FG000|Overall Study|Lost to Follow-up|1
859922|NCT00463580|1819049|FG001|Overall Study|Lost to Follow-up|0
859923|NCT00463580|1819048|FG000|Overall Study|Schedule conflict|2
859924|NCT00463580|1819049|FG001|Overall Study|Schedule conflict|0
859925|NCT00463580|1819048|FG000|Overall Study|Medical/psychiatric complications|0
859926|NCT00463580|1819049|FG001|Overall Study|Medical/psychiatric complications|2
859927|NCT00463606|1819064|FG000|Overall Study|Adverse Event|21
859928|NCT00463606|1819065|FG001|Overall Study|Adverse Event|18
859929|NCT00463606|1819066|FG002|Overall Study|Adverse Event|11
859930|NCT00463606|1819064|FG000|Overall Study|Withdrawal by Subject|11
859931|NCT00463606|1819065|FG001|Overall Study|Withdrawal by Subject|11
859932|NCT00463606|1819066|FG002|Overall Study|Withdrawal by Subject|5
859933|NCT00463606|1819064|FG000|Overall Study|Lost to Follow-up|2
859934|NCT00463606|1819065|FG001|Overall Study|Lost to Follow-up|2
859935|NCT00463606|1819066|FG002|Overall Study|Lost to Follow-up|3
859936|NCT00463606|1819064|FG000|Overall Study|Subject noncompliance|1
859937|NCT00463606|1819065|FG001|Overall Study|Subject noncompliance|1
859938|NCT00463606|1819066|FG002|Overall Study|Subject noncompliance|0
859939|NCT00463606|1819064|FG000|Overall Study|Subject moved out of town|1
859940|NCT00463606|1819065|FG001|Overall Study|Subject moved out of town|0
859941|NCT00463606|1819066|FG002|Overall Study|Subject moved out of town|0
859942|NCT00463606|1819064|FG000|Overall Study|Physician Decision|0
859943|NCT00463606|1819065|FG001|Overall Study|Physician Decision|1
859944|NCT00463606|1819066|FG002|Overall Study|Physician Decision|0
859945|NCT00463606|1819064|FG000|Overall Study|Sponsor request|0
859946|NCT00463606|1819065|FG001|Overall Study|Sponsor request|1
859947|NCT00463606|1819066|FG002|Overall Study|Sponsor request|0
859948|NCT00463606|1819064|FG000|Overall Study|Exclusion criteria violation|2
859949|NCT00463606|1819065|FG001|Overall Study|Exclusion criteria violation|0
859950|NCT00463606|1819066|FG002|Overall Study|Exclusion criteria violation|0
859951|NCT00463606|1819064|FG000|Overall Study|Coordinator error|1
859952|NCT00463606|1819065|FG001|Overall Study|Coordinator error|0
859953|NCT00463606|1819066|FG002|Overall Study|Coordinator error|0
859954|NCT00463606|1819064|FG000|Overall Study|Patient randomized in error|1
859955|NCT00463606|1819065|FG001|Overall Study|Patient randomized in error|0
859956|NCT00463606|1819066|FG002|Overall Study|Patient randomized in error|0
859957|NCT00463606|1819064|FG000|Overall Study|Participation in another ABT-335 trial|1
859958|NCT00463606|1819065|FG001|Overall Study|Participation in another ABT-335 trial|0
859959|NCT00463606|1819066|FG002|Overall Study|Participation in another ABT-335 trial|0
859960|NCT00463606|1819064|FG000|Overall Study|Protocol Violation|0
859961|NCT00463606|1819065|FG001|Overall Study|Protocol Violation|0
859962|NCT00463606|1819066|FG002|Overall Study|Protocol Violation|1
859963|NCT00463684|1819074|FG000|Overall Study|Withdrawal by Subject|1
859964|NCT00463684|1819074|FG000|Overall Study|Lost to Follow-up|3
859965|NCT00463788|1819080|FG000|Overall Study|Progressive Disease|86
859966|NCT00463788|1819081|FG001|Overall Study|Progressive Disease|42
859967|NCT00463788|1819080|FG000|Overall Study|Adverse Event|6
859968|NCT00463788|1819081|FG001|Overall Study|Adverse Event|2
859969|NCT00463788|1819080|FG000|Overall Study|Withdrawal by Subject|6
859970|NCT00463788|1819081|FG001|Overall Study|Withdrawal by Subject|2
859971|NCT00463788|1819080|FG000|Overall Study|Death|4
859972|NCT00463788|1819081|FG001|Overall Study|Death|3
859973|NCT00463788|1819080|FG000|Overall Study|Symptomatic Deterioration|2
859974|NCT00463788|1819081|FG001|Overall Study|Symptomatic Deterioration|3
859975|NCT00463788|1819080|FG000|Overall Study|Lost to Follow-up|1
859976|NCT00463788|1819081|FG001|Overall Study|Lost to Follow-up|0
859977|NCT00463788|1819080|FG000|Overall Study|Protocol Violation|0
859978|NCT00463788|1819081|FG001|Overall Study|Protocol Violation|1
859979|NCT00463788|1819080|FG000|Overall Study|Other|3
859980|NCT00463788|1819081|FG001|Overall Study|Other|0
859981|NCT00463788|1819080|FG000|Overall Study|Randomized but not treated|1
859982|NCT00463788|1819081|FG001|Overall Study|Randomized but not treated|1
859983|NCT00463801|1819088|FG000|Overall Study|Protocol Violation|1
859984|NCT00463801|1819088|FG000|Overall Study|Lack of Efficacy|2
859985|NCT00463801|1819088|FG000|Overall Study|Adverse Event|4
859986|NCT00463801|1819088|FG000|Overall Study|Lost to Follow-up|5
859987|NCT00463801|1819088|FG000|Overall Study|No longer require therapy|1
859988|NCT00463840|1819092|FG000|Overall Study|Disease progression|7
859989|NCT00463840|1819092|FG000|Overall Study|Withdrawal by Subject|2
859990|NCT00463840|1819092|FG000|Overall Study|Adverse Event|3
859991|NCT00463866|1819098|FG000|Overall Study|Adverse Event|70
859992|NCT00463866|1819099|FG001|Overall Study|Adverse Event|93
859993|NCT00463866|1819098|FG000|Overall Study|Withdrawal by Subject|81
859994|NCT00463866|1819099|FG001|Overall Study|Withdrawal by Subject|79
859995|NCT00463866|1819098|FG000|Overall Study|Lost to Follow-up|46
859996|NCT00463866|1819099|FG001|Overall Study|Lost to Follow-up|55
859997|NCT00463866|1819098|FG000|Overall Study|Incorrect Enrolment|64
859998|NCT00463866|1819099|FG001|Overall Study|Incorrect Enrolment|66
859999|NCT00463866|1819098|FG000|Overall Study|Severe Non-Compliance to Protocol|25
860000|NCT00463866|1819099|FG001|Overall Study|Severe Non-Compliance to Protocol|21
860001|NCT00463866|1819098|FG000|Overall Study|Safety Reason|1
860002|NCT00463866|1819099|FG001|Overall Study|Safety Reason|3
860003|NCT00463866|1819098|FG000|Overall Study|Mis-Randomization of subject|0
860004|NCT00463866|1819099|FG001|Overall Study|Mis-Randomization of subject|1
860005|NCT00463866|1819098|FG000|Overall Study|Other|22
860006|NCT00463866|1819099|FG001|Overall Study|Other|22
860007|NCT00464087|1819108|FG000|Overall Study|No PCI per inclusion criteria|0
860008|NCT00464087|1819109|FG001|Overall Study|No PCI per inclusion criteria|0
860009|NCT00464087|1819110|FG002|Overall Study|No PCI per inclusion criteria|29
860010|NCT00464269|1819133|FG000|Overall Study|Lack of Efficacy|1
860011|NCT00464269|1819134|FG001|Overall Study|Lack of Efficacy|0
860012|NCT00464269|1819135|FG002|Overall Study|Lack of Efficacy|0
860013|NCT00464269|1819136|FG003|Overall Study|Lack of Efficacy|0
860014|NCT00464269|1819133|FG000|Overall Study|Lost to Follow-up|0
860015|NCT00464269|1819134|FG001|Overall Study|Lost to Follow-up|4
860016|NCT00464269|1819135|FG002|Overall Study|Lost to Follow-up|0
860017|NCT00464269|1819136|FG003|Overall Study|Lost to Follow-up|1
860018|NCT00464269|1819133|FG000|Overall Study|Withdrawal by Subject|0
860019|NCT00464269|1819134|FG001|Overall Study|Withdrawal by Subject|2
860020|NCT00464269|1819135|FG002|Overall Study|Withdrawal by Subject|1
860021|NCT00464269|1819136|FG003|Overall Study|Withdrawal by Subject|1
860022|NCT00464269|1819133|FG000|Overall Study|Other reason|3
860023|NCT00464269|1819134|FG001|Overall Study|Other reason|3
860024|NCT00464269|1819135|FG002|Overall Study|Other reason|1
860025|NCT00464269|1819136|FG003|Overall Study|Other reason|1
860026|NCT00464269|1819133|FG000|Overall Study|AE, serious fatal|0
860027|NCT00464269|1819134|FG001|Overall Study|AE, serious fatal|0
860028|NCT00464269|1819135|FG002|Overall Study|AE, serious fatal|1
860029|NCT00464269|1819136|FG003|Overall Study|AE, serious fatal|1
860030|NCT00464269|1819133|FG000|Overall Study|SAE, non-fatal|0
860031|NCT00464269|1819134|FG001|Overall Study|SAE, non-fatal|0
860032|NCT00464269|1819135|FG002|Overall Study|SAE, non-fatal|0
860033|NCT00464269|1819136|FG003|Overall Study|SAE, non-fatal|1
860034|NCT00464269|1819133|FG000|Overall Study|AE, non-serious non-fatal|2
860035|NCT00464269|1819134|FG001|Overall Study|AE, non-serious non-fatal|8
860036|NCT00464269|1819135|FG002|Overall Study|AE, non-serious non-fatal|3
860037|NCT00464269|1819136|FG003|Overall Study|AE, non-serious non-fatal|4
860038|NCT00464269|1819133|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
860039|NCT00464269|1819134|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
860040|NCT00464269|1819135|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
860041|NCT00464269|1819136|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
860042|NCT00464308|1819151|FG000|Overall Study|Adverse Event|22
860043|NCT00464308|1819152|FG001|Overall Study|Adverse Event|27
860044|NCT00464308|1819153|FG002|Overall Study|Adverse Event|16
860045|NCT00464308|1819151|FG000|Overall Study|Lost to Follow-up|29
860046|NCT00464308|1819152|FG001|Overall Study|Lost to Follow-up|19
860047|NCT00464308|1819153|FG002|Overall Study|Lost to Follow-up|20
860048|NCT00464308|1819151|FG000|Overall Study|Patient discontinued and other reasons|17
860049|NCT00464308|1819152|FG001|Overall Study|Patient discontinued and other reasons|17
860050|NCT00464308|1819153|FG002|Overall Study|Patient discontinued and other reasons|23
860051|NCT00464308|1819151|FG000|Overall Study|Physician Decision|1
860052|NCT00464308|1819152|FG001|Overall Study|Physician Decision|0
860053|NCT00464308|1819153|FG002|Overall Study|Physician Decision|0
860054|NCT00464334|1819172|FG000|Overall Study|Adverse Event|0
860055|NCT00464334|1819173|FG001|Overall Study|Adverse Event|0
860056|NCT00464334|1819174|FG002|Overall Study|Adverse Event|0
860057|NCT00464334|1819175|FG003|Overall Study|Adverse Event|1
860058|NCT00464334|1819176|FG004|Overall Study|Adverse Event|1
860059|NCT00464334|1819177|FG005|Overall Study|Adverse Event|1
860060|NCT00464334|1819178|FG006|Overall Study|Adverse Event|0
860061|NCT00464334|1819179|FG007|Overall Study|Adverse Event|0
860062|NCT00464334|1819180|FG008|Overall Study|Adverse Event|2
860063|NCT00464334|1819181|FG009|Overall Study|Adverse Event|1
860064|NCT00464334|1819182|FG010|Overall Study|Adverse Event|2
860065|NCT00464334|1819172|FG000|Overall Study|Lack of Efficacy|0
860066|NCT00464334|1819173|FG001|Overall Study|Lack of Efficacy|1
860067|NCT00464334|1819174|FG002|Overall Study|Lack of Efficacy|0
860068|NCT00464334|1819175|FG003|Overall Study|Lack of Efficacy|0
860069|NCT00464334|1819176|FG004|Overall Study|Lack of Efficacy|0
860070|NCT00464334|1819177|FG005|Overall Study|Lack of Efficacy|0
860071|NCT00464334|1819178|FG006|Overall Study|Lack of Efficacy|0
860072|NCT00464334|1819179|FG007|Overall Study|Lack of Efficacy|0
860073|NCT00464334|1819180|FG008|Overall Study|Lack of Efficacy|0
860074|NCT00464334|1819181|FG009|Overall Study|Lack of Efficacy|0
860075|NCT00464334|1819182|FG010|Overall Study|Lack of Efficacy|0
860076|NCT00464334|1819172|FG000|Overall Study|Lost to Follow-up|0
860077|NCT00464334|1819173|FG001|Overall Study|Lost to Follow-up|0
860078|NCT00464334|1819174|FG002|Overall Study|Lost to Follow-up|1
860079|NCT00464334|1819175|FG003|Overall Study|Lost to Follow-up|0
860080|NCT00464334|1819176|FG004|Overall Study|Lost to Follow-up|1
860081|NCT00464334|1819177|FG005|Overall Study|Lost to Follow-up|0
860082|NCT00464334|1819178|FG006|Overall Study|Lost to Follow-up|1
860083|NCT00464334|1819179|FG007|Overall Study|Lost to Follow-up|0
860084|NCT00464334|1819180|FG008|Overall Study|Lost to Follow-up|0
860085|NCT00464334|1819181|FG009|Overall Study|Lost to Follow-up|0
860086|NCT00464334|1819182|FG010|Overall Study|Lost to Follow-up|2
860087|NCT00464334|1819172|FG000|Overall Study|Progressive Disease|0
860088|NCT00464334|1819173|FG001|Overall Study|Progressive Disease|0
860089|NCT00464334|1819174|FG002|Overall Study|Progressive Disease|0
860090|NCT00464334|1819175|FG003|Overall Study|Progressive Disease|0
860091|NCT00464334|1819176|FG004|Overall Study|Progressive Disease|0
860092|NCT00464334|1819177|FG005|Overall Study|Progressive Disease|1
860093|NCT00464334|1819178|FG006|Overall Study|Progressive Disease|0
860094|NCT00464334|1819179|FG007|Overall Study|Progressive Disease|0
860095|NCT00464334|1819180|FG008|Overall Study|Progressive Disease|1
860096|NCT00464334|1819181|FG009|Overall Study|Progressive Disease|0
860097|NCT00464334|1819182|FG010|Overall Study|Progressive Disease|0
860098|NCT00464334|1819172|FG000|Overall Study|Study Terminated by Sponsor|0
860099|NCT00464334|1819173|FG001|Overall Study|Study Terminated by Sponsor|0
860100|NCT00464334|1819174|FG002|Overall Study|Study Terminated by Sponsor|0
860101|NCT00464334|1819175|FG003|Overall Study|Study Terminated by Sponsor|1
860102|NCT00464334|1819176|FG004|Overall Study|Study Terminated by Sponsor|0
860103|NCT00464334|1819177|FG005|Overall Study|Study Terminated by Sponsor|0
860104|NCT00464334|1819178|FG006|Overall Study|Study Terminated by Sponsor|0
860105|NCT00464334|1819179|FG007|Overall Study|Study Terminated by Sponsor|0
860106|NCT00464334|1819180|FG008|Overall Study|Study Terminated by Sponsor|0
860107|NCT00464334|1819181|FG009|Overall Study|Study Terminated by Sponsor|0
860108|NCT00464334|1819182|FG010|Overall Study|Study Terminated by Sponsor|0
860109|NCT00464334|1819172|FG000|Overall Study|Withdrawal by Subject|1
860110|NCT00464334|1819173|FG001|Overall Study|Withdrawal by Subject|7
860111|NCT00464334|1819174|FG002|Overall Study|Withdrawal by Subject|4
860112|NCT00464334|1819175|FG003|Overall Study|Withdrawal by Subject|2
860113|NCT00464334|1819176|FG004|Overall Study|Withdrawal by Subject|2
860114|NCT00464334|1819177|FG005|Overall Study|Withdrawal by Subject|2
860115|NCT00464334|1819178|FG006|Overall Study|Withdrawal by Subject|2
860116|NCT00464334|1819179|FG007|Overall Study|Withdrawal by Subject|1
860117|NCT00464334|1819180|FG008|Overall Study|Withdrawal by Subject|3
860118|NCT00464334|1819181|FG009|Overall Study|Withdrawal by Subject|0
860119|NCT00464334|1819182|FG010|Overall Study|Withdrawal by Subject|0
860120|NCT00464490|1819237|FG000|Overall Study|Physician Decision|11
860121|NCT00464490|1819238|FG001|Overall Study|Physician Decision|11
860122|NCT00464542|1819244|FG000|Pre-treatment|Withdrawal by Subject|2
860123|NCT00464568|1819248|FG000|Overall Study|Adverse Event|2
860124|NCT00464620|1819265|FG000|Overall Study|Physician Decision|1
860125|NCT00464620|1819266|FG001|Overall Study|Physician Decision|0
860126|NCT00464620|1819267|FG002|Overall Study|Physician Decision|0
860127|NCT00464620|1819265|FG000|Overall Study|Withdrawal by Subject|1
860128|NCT00464620|1819266|FG001|Overall Study|Withdrawal by Subject|0
860129|NCT00464620|1819267|FG002|Overall Study|Withdrawal by Subject|3
860130|NCT00464620|1819265|FG000|Overall Study|Ineligible sarcoma subtype|0
860131|NCT00464620|1819266|FG001|Overall Study|Ineligible sarcoma subtype|2
860132|NCT00464620|1819267|FG002|Overall Study|Ineligible sarcoma subtype|2
860133|NCT00464620|1819265|FG000|Overall Study|Use of prohibited concomitant medication|0
860134|NCT00464620|1819266|FG001|Overall Study|Use of prohibited concomitant medication|0
860135|NCT00464620|1819267|FG002|Overall Study|Use of prohibited concomitant medication|2
860136|NCT00464672|1819292|FG000|Overall Study|withdrawal of consent|0
860137|NCT00464672|1819293|FG001|Overall Study|withdrawal of consent|0
860138|NCT00464672|1819294|FG002|Overall Study|withdrawal of consent|0
860139|NCT00464672|1819295|FG003|Overall Study|withdrawal of consent|1
860140|NCT00464672|1819296|FG004|Overall Study|withdrawal of consent|9
860141|NCT00464672|1819297|FG005|Overall Study|withdrawal of consent|4
860142|NCT00464672|1819292|FG000|Overall Study|Lost to Follow-up|25
860143|NCT00464672|1819293|FG001|Overall Study|Lost to Follow-up|10
860144|NCT00464672|1819294|FG002|Overall Study|Lost to Follow-up|0
860145|NCT00464672|1819295|FG003|Overall Study|Lost to Follow-up|0
860146|NCT00464672|1819296|FG004|Overall Study|Lost to Follow-up|1
860147|NCT00464672|1819297|FG005|Overall Study|Lost to Follow-up|0
860148|NCT00464737|1819347|FG000|Overall Study|Adverse Event|12
860149|NCT00464737|1819348|FG001|Overall Study|Adverse Event|17
860150|NCT00464737|1819349|FG002|Overall Study|Adverse Event|33
860151|NCT00464737|1819347|FG000|Overall Study|Lack of Efficacy|7
860152|NCT00464737|1819348|FG001|Overall Study|Lack of Efficacy|7
860153|NCT00464737|1819349|FG002|Overall Study|Lack of Efficacy|4
860154|NCT00464737|1819347|FG000|Overall Study|Withdrawal by Subject|5
860155|NCT00464737|1819348|FG001|Overall Study|Withdrawal by Subject|3
860156|NCT00464737|1819349|FG002|Overall Study|Withdrawal by Subject|5
860157|NCT00464737|1819347|FG000|Overall Study|Protocol Violation|1
860158|NCT00464737|1819348|FG001|Overall Study|Protocol Violation|1
860159|NCT00464737|1819349|FG002|Overall Study|Protocol Violation|5
860160|NCT00464737|1819347|FG000|Overall Study|Non-compliance|0
860161|NCT00464737|1819348|FG001|Overall Study|Non-compliance|1
860162|NCT00464737|1819349|FG002|Overall Study|Non-compliance|1
860163|NCT00464737|1819347|FG000|Overall Study|Lost to Follow-up|5
860164|NCT00464737|1819348|FG001|Overall Study|Lost to Follow-up|2
860165|NCT00464737|1819349|FG002|Overall Study|Lost to Follow-up|5
860166|NCT00464737|1819347|FG000|Overall Study|Other: Subject's schedule doesn't permit|1
860167|NCT00464737|1819348|FG001|Overall Study|Other: Subject's schedule doesn't permit|0
860168|NCT00464737|1819349|FG002|Overall Study|Other: Subject's schedule doesn't permit|0
860169|NCT00464737|1819347|FG000|Overall Study|Other: Subject left town; family illness|1
860170|NCT00464737|1819348|FG001|Overall Study|Other: Subject left town; family illness|0
860171|NCT00464737|1819349|FG002|Overall Study|Other: Subject left town; family illness|0
860172|NCT00464737|1819347|FG000|Overall Study|Other: Study demands too great|0
860173|NCT00464737|1819348|FG001|Overall Study|Other: Study demands too great|1
860174|NCT00464737|1819349|FG002|Overall Study|Other: Study demands too great|0
860175|NCT00464737|1819347|FG000|Overall Study|Other: Personal family reasons|0
860176|NCT00464737|1819348|FG001|Overall Study|Other: Personal family reasons|0
860177|NCT00464737|1819349|FG002|Overall Study|Other: Personal family reasons|1
860178|NCT00464737|1819347|FG000|Overall Study|Other: Subject's disability per sponsor|0
860179|NCT00464737|1819348|FG001|Overall Study|Other: Subject's disability per sponsor|0
860180|NCT00464737|1819349|FG002|Overall Study|Other: Subject's disability per sponsor|1
860181|NCT00464815|1819359|FG000|Overall Study|Withdrawal by Subject|6
860182|NCT00464815|1819360|FG001|Overall Study|Withdrawal by Subject|3
860183|NCT00464945|1819368|FG000|Infant Series|Withdrawal by parent/guardian request|2
860184|NCT00464945|1819369|FG001|Infant Series|Withdrawal by parent/guardian request|1
860185|NCT00464945|1819368|FG000|Infant Series|Protocol Violation|1
860186|NCT00464945|1819369|FG001|Infant Series|Protocol Violation|0
860187|NCT00464945|1819368|FG000|Infant Series|Lost to Follow-up|1
860188|NCT00464945|1819369|FG001|Infant Series|Lost to Follow-up|0
860189|NCT00464945|1819368|FG000|After Infant Series|Withdrawal by Subject|0
860190|NCT00464945|1819369|FG001|After Infant Series|Withdrawal by Subject|2
860191|NCT00464945|1819368|FG000|Toddler Dose|Lost to Follow-up|0
860192|NCT00464945|1819369|FG001|Toddler Dose|Lost to Follow-up|1
860193|NCT00465101|1819400|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3
860194|NCT00465101|1819400|FG000|Overall Study|Change in health precluded follow up|4
860195|NCT00465101|1819400|FG000|Overall Study|Did not meet study criteria|4
860196|NCT00465101|1819400|FG000|Overall Study|Lost to Follow-up|5
860197|NCT00465101|1819400|FG000|Overall Study|Other|6
860198|NCT00465101|1819400|FG000|Overall Study|Pt. Insurance not accepted at center|2
860199|NCT00465101|1819400|FG000|Overall Study|Patient postponed procedure|1
860200|NCT00465101|1819400|FG000|Overall Study|Site closed due to IRB expiration|1
860201|NCT00465101|1819400|FG000|Overall Study|Unable to obtain IRB approval|1
860202|NCT00465101|1819400|FG000|Overall Study|Death|3
860203|NCT00465101|1819400|FG000|Overall Study|Withdrawal by Subject|25
860204|NCT00465101|1819400|FG000|Overall Study|Physician Decision|1
860205|NCT00465101|1819400|FG000|Overall Study|Withdrew consent prior to procedure|3
860206|NCT00465179|1819426|FG000|Overall Study|Adverse Event|4
860207|NCT00465179|1819426|FG000|Overall Study|Withdrawal by Subject|2
860208|NCT00465179|1819426|FG000|Overall Study|Progression of Disease|47
860209|NCT00465270|1819432|FG000|Overall Study|Death|7
860210|NCT00465270|1819433|FG001|Overall Study|Death|11
860211|NCT00465270|1819432|FG000|Overall Study|Withdrawal by Subject|34
860212|NCT00465270|1819433|FG001|Overall Study|Withdrawal by Subject|78
860213|NCT00465270|1819432|FG000|Overall Study|Lost to Follow-up|60
860214|NCT00465270|1819433|FG001|Overall Study|Lost to Follow-up|67
860215|NCT00465270|1819432|FG000|Overall Study|Investigator request|3
860216|NCT00465270|1819433|FG001|Overall Study|Investigator request|4
860217|NCT00465361|1819439|FG000|Baseline Assessment|Personal Issues/Scheduling|4
860218|NCT00465569|1819454|FG000|Overall Study|persistent eczema during dose escalation|1
860219|NCT00465569|1819455|FG001|Overall Study|persistent eczema during dose escalation|0
860220|NCT00465647|1819480|FG000|Overall Study|Administrative|2
860221|NCT00465647|1819481|FG001|Overall Study|Administrative|2
860222|NCT00465647|1819482|FG002|Overall Study|Administrative|3
860223|NCT00465647|1819483|FG003|Overall Study|Administrative|2
860224|NCT00465647|1819480|FG000|Overall Study|Adverse Event|2
860225|NCT00465647|1819481|FG001|Overall Study|Adverse Event|0
860226|NCT00465647|1819482|FG002|Overall Study|Adverse Event|3
860227|NCT00465647|1819483|FG003|Overall Study|Adverse Event|2
860228|NCT00465647|1819480|FG000|Overall Study|Withdrawal by Subject|1
860229|NCT00465647|1819481|FG001|Overall Study|Withdrawal by Subject|2
860230|NCT00465647|1819482|FG002|Overall Study|Withdrawal by Subject|2
860231|NCT00465647|1819483|FG003|Overall Study|Withdrawal by Subject|7
860232|NCT00465647|1819480|FG000|Overall Study|"The other reasons included loss of IV"|8
860233|NCT00465647|1819481|FG001|Overall Study|"The other reasons included loss of IV"|4
860234|NCT00465647|1819482|FG002|Overall Study|"The other reasons included loss of IV"|3
860235|NCT00465647|1819483|FG003|Overall Study|"The other reasons included loss of IV"|2
860236|NCT00465738|1819505|FG000|Overall Study|Lost to Follow-up|2
860237|NCT00465738|1819506|FG001|Overall Study|Lost to Follow-up|0
860238|NCT00465738|1819505|FG000|Overall Study|Adverse Event|0
860239|NCT00465738|1819506|FG001|Overall Study|Adverse Event|1
860240|NCT00465738|1819505|FG000|Overall Study|Withdrawal by Subject|2
860241|NCT00465738|1819506|FG001|Overall Study|Withdrawal by Subject|0
860242|NCT00465738|1819505|FG000|Overall Study|Other|2
860243|NCT00465738|1819506|FG001|Overall Study|Other|5
860244|NCT00465816|1819515|FG000|Overall Study|Lost to Follow-up|0
860245|NCT00465816|1819516|FG001|Overall Study|Lost to Follow-up|0
860246|NCT00465816|1819517|FG002|Overall Study|Lost to Follow-up|2
860247|NCT00465894|1819528|FG000|Treatment For 12 Weeks|Lost to Follow-up|4
860248|NCT00465894|1819529|FG001|Treatment For 12 Weeks|Lost to Follow-up|1
860249|NCT00465894|1819528|FG000|Treatment For 12 Weeks|Family Issues|1
860250|NCT00465894|1819529|FG001|Treatment For 12 Weeks|Family Issues|1
860251|NCT00465894|1819528|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0
860252|NCT00465894|1819529|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1
860253|NCT00465972|1819553|FG000|Overall Study|Withdrawal by Subject|2
860254|NCT00465972|1819554|FG001|Overall Study|Withdrawal by Subject|1
860255|NCT00465985|1819562|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
860256|NCT00465985|1819563|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
860257|NCT00465985|1819562|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
860258|NCT00465985|1819563|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
860259|NCT00465985|1819562|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
860260|NCT00465985|1819563|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
860261|NCT00465985|1819562|FG000|Part III - Open-label Treatment Period|Adverse Event|1
860262|NCT00465985|1819563|FG001|Part III - Open-label Treatment Period|Adverse Event|0
860263|NCT00466167|1819580|FG000|Overall Study|Adverse Event|8
860264|NCT00466167|1819581|FG001|Overall Study|Adverse Event|8
860265|NCT00466167|1819582|FG002|Overall Study|Adverse Event|7
860266|NCT00466167|1819580|FG000|Overall Study|Lack of Efficacy|2
860267|NCT00466167|1819581|FG001|Overall Study|Lack of Efficacy|0
860268|NCT00466167|1819582|FG002|Overall Study|Lack of Efficacy|3
860269|NCT00466167|1819580|FG000|Overall Study|Protocol Violation|1
860270|NCT00466167|1819581|FG001|Overall Study|Protocol Violation|1
860271|NCT00466167|1819582|FG002|Overall Study|Protocol Violation|2
860272|NCT00466167|1819580|FG000|Overall Study|Lost to Follow-up|3
860273|NCT00466167|1819581|FG001|Overall Study|Lost to Follow-up|2
860274|NCT00466167|1819582|FG002|Overall Study|Lost to Follow-up|2
860275|NCT00466167|1819580|FG000|Overall Study|Withdrawal by Subject|4
860276|NCT00466167|1819581|FG001|Overall Study|Withdrawal by Subject|1
860277|NCT00466167|1819582|FG002|Overall Study|Withdrawal by Subject|6
860278|NCT00466167|1819580|FG000|Overall Study|patient did not meet inclusion criteria|1
860279|NCT00466167|1819581|FG001|Overall Study|patient did not meet inclusion criteria|0
860280|NCT00466167|1819582|FG002|Overall Study|patient did not meet inclusion criteria|1
860281|NCT00466167|1819580|FG000|Overall Study|Not treated|1
860282|NCT00466167|1819581|FG001|Overall Study|Not treated|0
860283|NCT00466167|1819582|FG002|Overall Study|Not treated|0
860284|NCT00466193|1819592|FG000|Overall Study|Adverse Event|0
860285|NCT00466193|1819593|FG001|Overall Study|Adverse Event|1
860286|NCT00466193|1819592|FG000|Overall Study|Lost to Follow-up|2
860287|NCT00466193|1819593|FG001|Overall Study|Lost to Follow-up|4
860288|NCT00466193|1819592|FG000|Overall Study|Physician Decision|1
860289|NCT00466193|1819593|FG001|Overall Study|Physician Decision|0
860290|NCT00466193|1819592|FG000|Overall Study|Protocol Violation|1
860291|NCT00466193|1819593|FG001|Overall Study|Protocol Violation|1
860292|NCT00466193|1819592|FG000|Overall Study|Withdrawal by Subject|7
860293|NCT00466193|1819593|FG001|Overall Study|Withdrawal by Subject|2
860294|NCT00466193|1819592|FG000|Overall Study|Patient refused Visit 4 procedures|1
860295|NCT00466193|1819593|FG001|Overall Study|Patient refused Visit 4 procedures|0
860296|NCT00466440|1819631|FG000|Overall Study|Adverse Event|0
860297|NCT00466440|1819632|FG001|Overall Study|Adverse Event|3
860298|NCT00466440|1819633|FG002|Overall Study|Adverse Event|1
860299|NCT00466440|1819631|FG000|Overall Study|Death|1
860300|NCT00466440|1819632|FG001|Overall Study|Death|1
860301|NCT00466440|1819633|FG002|Overall Study|Death|0
860302|NCT00466440|1819631|FG000|Overall Study|Progressive disease|13
860303|NCT00466440|1819632|FG001|Overall Study|Progressive disease|5
860304|NCT00466440|1819633|FG002|Overall Study|Progressive disease|4
860305|NCT00466440|1819631|FG000|Overall Study|Lost to Follow-up|0
860306|NCT00466440|1819632|FG001|Overall Study|Lost to Follow-up|1
860307|NCT00466440|1819633|FG002|Overall Study|Lost to Follow-up|0
860308|NCT00466440|1819631|FG000|Overall Study|Physician Decision|0
860309|NCT00466440|1819632|FG001|Overall Study|Physician Decision|1
860310|NCT00466440|1819633|FG002|Overall Study|Physician Decision|2
860311|NCT00466440|1819631|FG000|Overall Study|Protocol entry criteria not met|0
860312|NCT00466440|1819632|FG001|Overall Study|Protocol entry criteria not met|0
860313|NCT00466440|1819633|FG002|Overall Study|Protocol entry criteria not met|4
860314|NCT00466440|1819631|FG000|Overall Study|Withdrawal by Subject|0
860315|NCT00466440|1819632|FG001|Overall Study|Withdrawal by Subject|1
860316|NCT00466440|1819633|FG002|Overall Study|Withdrawal by Subject|0
860317|NCT00466440|1819631|FG000|Overall Study|Sponsor decision|0
860318|NCT00466440|1819632|FG001|Overall Study|Sponsor decision|0
860319|NCT00466440|1819633|FG002|Overall Study|Sponsor decision|1
860320|NCT00466505|1819650|FG000|Overall Study|disease progression|13
860321|NCT00466505|1819650|FG000|Overall Study|Adverse Event|4
860322|NCT00466687|1819663|FG000|Overall Study|Adverse Event|1
860323|NCT00466687|1819663|FG000|Overall Study|Other complicating illness|3
860324|NCT00466687|1819663|FG000|Overall Study|Withdrawal by Subject|1
860325|NCT00466687|1819663|FG000|Overall Study|Disease progression|29
860326|NCT00466726|1819669|FG000|Overall Study|Not evaluable for response|14
860327|NCT00466921|1819700|FG000|First 3 Cycles of Treatment|Adverse Event|2
860328|NCT00466921|1819700|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5
860329|NCT00466921|1819700|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2
860330|NCT00466921|1819700|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2
860331|NCT00466921|1819700|FG000|Completed 4 Cycles/Reached 1st Response|Other|1
860332|NCT00466921|1819700|FG000|Follow up for a Minimum of 1 Year|Death|6
860333|NCT00466947|1819706|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875
860334|NCT00466947|1819707|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863
860335|NCT00466947|1819706|FG000|Study End Analysis Period|Adverse Event|35
860336|NCT00466947|1819707|FG001|Study End Analysis Period|Adverse Event|43
860337|NCT00466947|1819706|FG000|Study End Analysis Period|Lost to Follow-up|1137
860338|NCT00466947|1819707|FG001|Study End Analysis Period|Lost to Follow-up|1167
860339|NCT00466947|1819706|FG000|Study End Analysis Period|Physician Decision|29
860340|NCT00466947|1819707|FG001|Study End Analysis Period|Physician Decision|29
860341|NCT00466947|1819706|FG000|Study End Analysis Period|Protocol Violation|9
860342|NCT00466947|1819707|FG001|Study End Analysis Period|Protocol Violation|17
860343|NCT00466947|1819706|FG000|Study End Analysis Period|Withdrawal by Subject|1264
860344|NCT00466947|1819707|FG001|Study End Analysis Period|Withdrawal by Subject|1267
860345|NCT00466947|1819706|FG000|Study End Analysis Period|Other - Forbidden vaccination|21
860346|NCT00466947|1819707|FG001|Study End Analysis Period|Other - Forbidden vaccination|10
860347|NCT00466947|1819706|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1
860348|NCT00466947|1819707|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0
860349|NCT00466947|1819706|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0
860350|NCT00466947|1819707|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1
860351|NCT00467051|1819728|FG000|Overall Study|Adverse Event|2
860352|NCT00467259|1819739|FG000|Overall Study|Adverse Event|24
860353|NCT00467259|1819740|FG001|Overall Study|Adverse Event|90
860354|NCT00467259|1819739|FG000|Overall Study|Protocol Violation|1
860355|NCT00467259|1819740|FG001|Overall Study|Protocol Violation|7
860356|NCT00467259|1819739|FG000|Overall Study|Withdrawal by Subject|34
860357|NCT00467259|1819740|FG001|Overall Study|Withdrawal by Subject|108
860358|NCT00467259|1819739|FG000|Overall Study|Physician Decision|0
860359|NCT00467259|1819740|FG001|Overall Study|Physician Decision|2
860360|NCT00467259|1819739|FG000|Overall Study|Lost to Follow-up|14
860361|NCT00467259|1819740|FG001|Overall Study|Lost to Follow-up|34
860362|NCT00467259|1819739|FG000|Overall Study|Site Closed|2
860363|NCT00467259|1819740|FG001|Overall Study|Site Closed|1
860364|NCT00467272|1819746|FG000|Overall Study|Pneumonia|2
860365|NCT00467272|1819746|FG000|Overall Study|Thrombophlebitis|1
860366|NCT00467285|1819752|FG000|Overall Study|Lost to Follow-up|4
860367|NCT00467285|1819753|FG001|Overall Study|Lost to Follow-up|4
860368|NCT00467363|1819781|FG000|Overall Study|Lost to Follow-up|80
860369|NCT00467363|1819782|FG001|Overall Study|Lost to Follow-up|70
860370|NCT00467519|1819797|FG000|Overall Study|Protocol Violation|8
860371|NCT00467519|1819798|FG001|Overall Study|Protocol Violation|4
860372|NCT00467519|1819797|FG000|Overall Study|Lost to Follow-up|2
860373|NCT00467519|1819798|FG001|Overall Study|Lost to Follow-up|9
860374|NCT00467519|1819797|FG000|Overall Study|Withdrawal by Subject|4
860375|NCT00467519|1819798|FG001|Overall Study|Withdrawal by Subject|10
860376|NCT00467558|1819806|FG000|Overall Study|Lost to Follow-up|2
860377|NCT00467558|1819807|FG001|Overall Study|Lost to Follow-up|0
860378|NCT00467584|1819816|FG000|Overall Study|Withdrawal by Subject|4
860379|NCT00467584|1819817|FG001|Overall Study|Withdrawal by Subject|5
860380|NCT00467584|1819818|FG002|Overall Study|Withdrawal by Subject|1
860381|NCT00467597|1819830|FG000|Overall Study|Withdrawal by Subject|2
860382|NCT00467597|1819831|FG001|Overall Study|Withdrawal by Subject|0
860383|NCT00467610|1819841|FG000|Overall Study|Withdrawal by Subject|1
860384|NCT00467649|1819847|FG000|Phase 1 (Randomized Population)|Adverse Event|2
860385|NCT00467649|1819848|FG001|Phase 1 (Randomized Population)|Adverse Event|0
860386|NCT00467649|1819849|FG002|Phase 1 (Randomized Population)|Adverse Event|0
860387|NCT00467649|1819850|FG003|Phase 1 (Randomized Population)|Adverse Event|0
860388|NCT00467649|1819851|FG004|Phase 1 (Randomized Population)|Adverse Event|0
860389|NCT00467649|1819852|FG005|Phase 1 (Randomized Population)|Adverse Event|0
860390|NCT00467649|1819847|FG000|Phase 1 (Randomized Population)|Investigator Decision|1
860391|NCT00467649|1819848|FG001|Phase 1 (Randomized Population)|Investigator Decision|0
860392|NCT00467649|1819849|FG002|Phase 1 (Randomized Population)|Investigator Decision|0
860393|NCT00467649|1819850|FG003|Phase 1 (Randomized Population)|Investigator Decision|0
860394|NCT00467649|1819851|FG004|Phase 1 (Randomized Population)|Investigator Decision|0
860395|NCT00467649|1819852|FG005|Phase 1 (Randomized Population)|Investigator Decision|0
860396|NCT00467649|1819847|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2
860397|NCT00467649|1819848|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4
860398|NCT00467649|1819849|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0
860399|NCT00467649|1819850|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0
860400|NCT00467649|1819851|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0
860401|NCT00467649|1819852|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0
860402|NCT00467649|1819847|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4
860403|NCT00467649|1819848|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2
860404|NCT00467649|1819849|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0
860405|NCT00467649|1819850|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0
860406|NCT00467649|1819851|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0
860407|NCT00467649|1819852|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0
860408|NCT00467649|1819847|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
860409|NCT00467649|1819848|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
860410|NCT00467649|1819849|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
860411|NCT00467649|1819850|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
860412|NCT00467649|1819851|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
860413|NCT00467649|1819852|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
860414|NCT00467649|1819847|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
860415|NCT00467649|1819848|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
860416|NCT00467649|1819849|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
860417|NCT00467649|1819850|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
860418|NCT00467649|1819851|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
860419|NCT00467649|1819852|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
860420|NCT00467649|1819847|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
860421|NCT00467649|1819848|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
860422|NCT00467649|1819849|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
860423|NCT00467649|1819850|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
860424|NCT00467649|1819851|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
860425|NCT00467649|1819852|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
860426|NCT00467740|1819875|FG000|Overall Study|Adverse Event|0
860427|NCT00467740|1819876|FG001|Overall Study|Adverse Event|0
860428|NCT00467740|1819877|FG002|Overall Study|Adverse Event|1
860429|NCT00467740|1819878|FG003|Overall Study|Adverse Event|0
860430|NCT00467740|1819879|FG004|Overall Study|Adverse Event|0
860431|NCT00467740|1819875|FG000|Overall Study|Protocol Violation|0
860432|NCT00467740|1819876|FG001|Overall Study|Protocol Violation|0
860433|NCT00467740|1819877|FG002|Overall Study|Protocol Violation|1
860434|NCT00467740|1819878|FG003|Overall Study|Protocol Violation|0
860435|NCT00467740|1819879|FG004|Overall Study|Protocol Violation|0
860436|NCT00467740|1819875|FG000|Overall Study|Lost to Follow-up|0
860437|NCT00467740|1819876|FG001|Overall Study|Lost to Follow-up|1
860438|NCT00467740|1819877|FG002|Overall Study|Lost to Follow-up|0
860439|NCT00467740|1819878|FG003|Overall Study|Lost to Follow-up|0
860440|NCT00467740|1819879|FG004|Overall Study|Lost to Follow-up|0
860441|NCT00467740|1819875|FG000|Overall Study|Withdrawal by Subject|1
860442|NCT00467740|1819876|FG001|Overall Study|Withdrawal by Subject|1
860443|NCT00467740|1819877|FG002|Overall Study|Withdrawal by Subject|0
860444|NCT00467740|1819878|FG003|Overall Study|Withdrawal by Subject|1
860445|NCT00467740|1819879|FG004|Overall Study|Withdrawal by Subject|0
860446|NCT00467740|1819875|FG000|Overall Study|Lack of Efficacy|0
860447|NCT00467740|1819876|FG001|Overall Study|Lack of Efficacy|1
860448|NCT00467740|1819877|FG002|Overall Study|Lack of Efficacy|0
860449|NCT00467740|1819878|FG003|Overall Study|Lack of Efficacy|0
860450|NCT00467740|1819879|FG004|Overall Study|Lack of Efficacy|0
860451|NCT00467779|1819906|FG000|Stage 1|Adverse Event|1
860452|NCT00467779|1819907|FG001|Stage 1|Adverse Event|0
860453|NCT00467779|1819908|FG002|Stage 1|Adverse Event|0
860454|NCT00467779|1819909|FG003|Stage 1|Adverse Event|0
860455|NCT00467779|1819910|FG004|Stage 1|Adverse Event|0
860456|NCT00467779|1819911|FG005|Stage 1|Adverse Event|1
860457|NCT00467779|1819912|FG006|Stage 1|Adverse Event|2
860458|NCT00467779|1819913|FG007|Stage 1|Adverse Event|1
860459|NCT00467779|1819914|FG008|Stage 1|Adverse Event|0
860460|NCT00467779|1819915|FG009|Stage 1|Adverse Event|0
860461|NCT00467779|1819916|FG010|Stage 1|Adverse Event|0
860462|NCT00467779|1819917|FG011|Stage 1|Adverse Event|0
860463|NCT00467779|1819918|FG012|Stage 1|Adverse Event|0
860464|NCT00467779|1819919|FG013|Stage 1|Adverse Event|0
860465|NCT00467779|1819920|FG014|Stage 1|Adverse Event|0
860466|NCT00467779|1819906|FG000|Stage 1|Disease Progression|2
860467|NCT00467779|1819907|FG001|Stage 1|Disease Progression|2
860468|NCT00467779|1819908|FG002|Stage 1|Disease Progression|2
860469|NCT00467779|1819909|FG003|Stage 1|Disease Progression|3
860470|NCT00467779|1819910|FG004|Stage 1|Disease Progression|2
860471|NCT00467779|1819911|FG005|Stage 1|Disease Progression|2
860472|NCT00467779|1819912|FG006|Stage 1|Disease Progression|4
860473|NCT00467779|1819913|FG007|Stage 1|Disease Progression|5
860474|NCT00467779|1819914|FG008|Stage 1|Disease Progression|0
860475|NCT00467779|1819915|FG009|Stage 1|Disease Progression|0
860476|NCT00467779|1819916|FG010|Stage 1|Disease Progression|0
860477|NCT00467779|1819917|FG011|Stage 1|Disease Progression|0
860478|NCT00467779|1819918|FG012|Stage 1|Disease Progression|0
860479|NCT00467779|1819919|FG013|Stage 1|Disease Progression|0
860480|NCT00467779|1819920|FG014|Stage 1|Disease Progression|0
860481|NCT00467779|1819906|FG000|Stage 1|Unspecified Reason|1
860482|NCT00467779|1819907|FG001|Stage 1|Unspecified Reason|0
860483|NCT00467779|1819908|FG002|Stage 1|Unspecified Reason|1
860484|NCT00467779|1819909|FG003|Stage 1|Unspecified Reason|0
860485|NCT00467779|1819910|FG004|Stage 1|Unspecified Reason|1
860486|NCT00467779|1819911|FG005|Stage 1|Unspecified Reason|2
860487|NCT00467779|1819912|FG006|Stage 1|Unspecified Reason|0
860488|NCT00467779|1819913|FG007|Stage 1|Unspecified Reason|0
860489|NCT00467779|1819914|FG008|Stage 1|Unspecified Reason|0
860490|NCT00467779|1819915|FG009|Stage 1|Unspecified Reason|0
860491|NCT00467779|1819916|FG010|Stage 1|Unspecified Reason|0
860492|NCT00467779|1819917|FG011|Stage 1|Unspecified Reason|0
860493|NCT00467779|1819918|FG012|Stage 1|Unspecified Reason|0
860494|NCT00467779|1819919|FG013|Stage 1|Unspecified Reason|0
860495|NCT00467779|1819920|FG014|Stage 1|Unspecified Reason|0
860496|NCT00467779|1819906|FG000|Stage 1|Physician Decision|0
860497|NCT00467779|1819907|FG001|Stage 1|Physician Decision|1
860498|NCT00467779|1819908|FG002|Stage 1|Physician Decision|0
860499|NCT00467779|1819909|FG003|Stage 1|Physician Decision|0
860500|NCT00467779|1819910|FG004|Stage 1|Physician Decision|0
860501|NCT00467779|1819911|FG005|Stage 1|Physician Decision|0
860502|NCT00467779|1819912|FG006|Stage 1|Physician Decision|0
860503|NCT00467779|1819913|FG007|Stage 1|Physician Decision|0
860504|NCT00467779|1819914|FG008|Stage 1|Physician Decision|0
860505|NCT00467779|1819915|FG009|Stage 1|Physician Decision|0
860506|NCT00467779|1819916|FG010|Stage 1|Physician Decision|0
860507|NCT00467779|1819917|FG011|Stage 1|Physician Decision|0
860508|NCT00467779|1819918|FG012|Stage 1|Physician Decision|0
860509|NCT00467779|1819919|FG013|Stage 1|Physician Decision|0
860510|NCT00467779|1819920|FG014|Stage 1|Physician Decision|0
860511|NCT00467779|1819906|FG000|Stage 1|Withdrawal by Subject|0
860512|NCT00467779|1819907|FG001|Stage 1|Withdrawal by Subject|0
860513|NCT00467779|1819908|FG002|Stage 1|Withdrawal by Subject|0
860514|NCT00467779|1819909|FG003|Stage 1|Withdrawal by Subject|0
860515|NCT00467779|1819910|FG004|Stage 1|Withdrawal by Subject|0
860516|NCT00467779|1819911|FG005|Stage 1|Withdrawal by Subject|0
860517|NCT00467779|1819912|FG006|Stage 1|Withdrawal by Subject|1
860518|NCT00467779|1819913|FG007|Stage 1|Withdrawal by Subject|1
860519|NCT00467779|1819914|FG008|Stage 1|Withdrawal by Subject|0
860520|NCT00467779|1819915|FG009|Stage 1|Withdrawal by Subject|0
860521|NCT00467779|1819916|FG010|Stage 1|Withdrawal by Subject|0
860522|NCT00467779|1819917|FG011|Stage 1|Withdrawal by Subject|0
860523|NCT00467779|1819918|FG012|Stage 1|Withdrawal by Subject|0
860524|NCT00467779|1819919|FG013|Stage 1|Withdrawal by Subject|0
860525|NCT00467779|1819920|FG014|Stage 1|Withdrawal by Subject|0
860526|NCT00467779|1819906|FG000|Stage 1A|Adverse Event|0
860527|NCT00467779|1819907|FG001|Stage 1A|Adverse Event|0
860528|NCT00467779|1819908|FG002|Stage 1A|Adverse Event|0
860529|NCT00467779|1819909|FG003|Stage 1A|Adverse Event|0
860530|NCT00467779|1819910|FG004|Stage 1A|Adverse Event|0
860531|NCT00467779|1819911|FG005|Stage 1A|Adverse Event|0
860532|NCT00467779|1819912|FG006|Stage 1A|Adverse Event|0
860533|NCT00467779|1819913|FG007|Stage 1A|Adverse Event|0
860534|NCT00467779|1819914|FG008|Stage 1A|Adverse Event|0
860535|NCT00467779|1819915|FG009|Stage 1A|Adverse Event|0
860536|NCT00467779|1819916|FG010|Stage 1A|Adverse Event|0
860537|NCT00467779|1819917|FG011|Stage 1A|Adverse Event|0
860538|NCT00467779|1819918|FG012|Stage 1A|Adverse Event|1
860539|NCT00467779|1819919|FG013|Stage 1A|Adverse Event|0
860540|NCT00467779|1819920|FG014|Stage 1A|Adverse Event|0
860541|NCT00467779|1819906|FG000|Stage 1A|Death|0
860542|NCT00467779|1819907|FG001|Stage 1A|Death|0
860543|NCT00467779|1819908|FG002|Stage 1A|Death|0
860544|NCT00467779|1819909|FG003|Stage 1A|Death|0
860545|NCT00467779|1819910|FG004|Stage 1A|Death|0
860546|NCT00467779|1819911|FG005|Stage 1A|Death|0
860547|NCT00467779|1819912|FG006|Stage 1A|Death|0
860548|NCT00467779|1819913|FG007|Stage 1A|Death|0
860549|NCT00467779|1819914|FG008|Stage 1A|Death|0
860550|NCT00467779|1819915|FG009|Stage 1A|Death|0
860551|NCT00467779|1819916|FG010|Stage 1A|Death|0
860552|NCT00467779|1819917|FG011|Stage 1A|Death|1
860553|NCT00467779|1819918|FG012|Stage 1A|Death|1
860554|NCT00467779|1819919|FG013|Stage 1A|Death|0
860555|NCT00467779|1819920|FG014|Stage 1A|Death|0
860556|NCT00467779|1819906|FG000|Stage 1A|Disease Progression|0
860557|NCT00467779|1819907|FG001|Stage 1A|Disease Progression|0
860558|NCT00467779|1819908|FG002|Stage 1A|Disease Progression|0
860559|NCT00467779|1819909|FG003|Stage 1A|Disease Progression|0
860560|NCT00467779|1819910|FG004|Stage 1A|Disease Progression|0
860561|NCT00467779|1819911|FG005|Stage 1A|Disease Progression|0
860562|NCT00467779|1819912|FG006|Stage 1A|Disease Progression|0
860563|NCT00467779|1819913|FG007|Stage 1A|Disease Progression|0
860564|NCT00467779|1819914|FG008|Stage 1A|Disease Progression|0
860565|NCT00467779|1819915|FG009|Stage 1A|Disease Progression|2
860566|NCT00467779|1819916|FG010|Stage 1A|Disease Progression|2
860567|NCT00467779|1819917|FG011|Stage 1A|Disease Progression|5
860568|NCT00467779|1819918|FG012|Stage 1A|Disease Progression|2
860569|NCT00467779|1819919|FG013|Stage 1A|Disease Progression|0
860570|NCT00467779|1819920|FG014|Stage 1A|Disease Progression|0
860571|NCT00467779|1819906|FG000|Stage 1A|Physician Decision|0
860572|NCT00467779|1819907|FG001|Stage 1A|Physician Decision|0
860573|NCT00467779|1819908|FG002|Stage 1A|Physician Decision|0
860574|NCT00467779|1819909|FG003|Stage 1A|Physician Decision|0
860575|NCT00467779|1819910|FG004|Stage 1A|Physician Decision|0
860576|NCT00467779|1819911|FG005|Stage 1A|Physician Decision|0
860577|NCT00467779|1819912|FG006|Stage 1A|Physician Decision|0
860578|NCT00467779|1819913|FG007|Stage 1A|Physician Decision|0
860579|NCT00467779|1819914|FG008|Stage 1A|Physician Decision|0
860580|NCT00467779|1819915|FG009|Stage 1A|Physician Decision|1
860581|NCT00467779|1819916|FG010|Stage 1A|Physician Decision|0
860582|NCT00467779|1819917|FG011|Stage 1A|Physician Decision|0
860583|NCT00467779|1819918|FG012|Stage 1A|Physician Decision|0
860584|NCT00467779|1819919|FG013|Stage 1A|Physician Decision|0
860585|NCT00467779|1819920|FG014|Stage 1A|Physician Decision|0
860586|NCT00467779|1819906|FG000|Stage 1A|Withdrawal by Subject|0
860587|NCT00467779|1819907|FG001|Stage 1A|Withdrawal by Subject|0
860588|NCT00467779|1819908|FG002|Stage 1A|Withdrawal by Subject|0
860589|NCT00467779|1819909|FG003|Stage 1A|Withdrawal by Subject|0
860590|NCT00467779|1819910|FG004|Stage 1A|Withdrawal by Subject|0
860591|NCT00467779|1819911|FG005|Stage 1A|Withdrawal by Subject|0
860592|NCT00467779|1819912|FG006|Stage 1A|Withdrawal by Subject|0
860593|NCT00467779|1819913|FG007|Stage 1A|Withdrawal by Subject|0
860594|NCT00467779|1819914|FG008|Stage 1A|Withdrawal by Subject|0
860595|NCT00467779|1819915|FG009|Stage 1A|Withdrawal by Subject|0
860596|NCT00467779|1819916|FG010|Stage 1A|Withdrawal by Subject|1
860597|NCT00467779|1819917|FG011|Stage 1A|Withdrawal by Subject|1
860598|NCT00467779|1819918|FG012|Stage 1A|Withdrawal by Subject|1
860599|NCT00467779|1819919|FG013|Stage 1A|Withdrawal by Subject|0
860600|NCT00467779|1819920|FG014|Stage 1A|Withdrawal by Subject|0
860601|NCT00467779|1819906|FG000|Stage 1A|Unspecified Reason|0
860602|NCT00467779|1819907|FG001|Stage 1A|Unspecified Reason|0
860603|NCT00467779|1819908|FG002|Stage 1A|Unspecified Reason|0
860604|NCT00467779|1819909|FG003|Stage 1A|Unspecified Reason|0
860605|NCT00467779|1819910|FG004|Stage 1A|Unspecified Reason|0
860606|NCT00467779|1819911|FG005|Stage 1A|Unspecified Reason|0
860607|NCT00467779|1819912|FG006|Stage 1A|Unspecified Reason|0
860608|NCT00467779|1819913|FG007|Stage 1A|Unspecified Reason|0
860609|NCT00467779|1819914|FG008|Stage 1A|Unspecified Reason|0
860610|NCT00467779|1819915|FG009|Stage 1A|Unspecified Reason|0
860611|NCT00467779|1819916|FG010|Stage 1A|Unspecified Reason|0
860612|NCT00467779|1819917|FG011|Stage 1A|Unspecified Reason|1
860613|NCT00467779|1819918|FG012|Stage 1A|Unspecified Reason|1
860614|NCT00467779|1819919|FG013|Stage 1A|Unspecified Reason|0
860615|NCT00467779|1819920|FG014|Stage 1A|Unspecified Reason|0
860616|NCT00467779|1819906|FG000|Stage 2|Adverse Event|0
860617|NCT00467779|1819907|FG001|Stage 2|Adverse Event|0
860618|NCT00467779|1819908|FG002|Stage 2|Adverse Event|0
860619|NCT00467779|1819909|FG003|Stage 2|Adverse Event|0
860620|NCT00467779|1819910|FG004|Stage 2|Adverse Event|0
860621|NCT00467779|1819911|FG005|Stage 2|Adverse Event|0
860622|NCT00467779|1819912|FG006|Stage 2|Adverse Event|0
860623|NCT00467779|1819913|FG007|Stage 2|Adverse Event|0
860624|NCT00467779|1819914|FG008|Stage 2|Adverse Event|1
860625|NCT00467779|1819915|FG009|Stage 2|Adverse Event|0
860626|NCT00467779|1819916|FG010|Stage 2|Adverse Event|0
860627|NCT00467779|1819917|FG011|Stage 2|Adverse Event|0
860628|NCT00467779|1819918|FG012|Stage 2|Adverse Event|0
860629|NCT00467779|1819919|FG013|Stage 2|Adverse Event|0
860630|NCT00467779|1819920|FG014|Stage 2|Adverse Event|0
860631|NCT00467779|1819906|FG000|Stage 2|Death|0
860632|NCT00467779|1819907|FG001|Stage 2|Death|0
860633|NCT00467779|1819908|FG002|Stage 2|Death|0
860634|NCT00467779|1819909|FG003|Stage 2|Death|0
860635|NCT00467779|1819910|FG004|Stage 2|Death|0
860636|NCT00467779|1819911|FG005|Stage 2|Death|0
860637|NCT00467779|1819912|FG006|Stage 2|Death|0
860638|NCT00467779|1819913|FG007|Stage 2|Death|0
860639|NCT00467779|1819914|FG008|Stage 2|Death|1
860640|NCT00467779|1819915|FG009|Stage 2|Death|0
860641|NCT00467779|1819916|FG010|Stage 2|Death|0
860642|NCT00467779|1819917|FG011|Stage 2|Death|0
860643|NCT00467779|1819918|FG012|Stage 2|Death|0
860644|NCT00467779|1819919|FG013|Stage 2|Death|0
860645|NCT00467779|1819920|FG014|Stage 2|Death|0
860646|NCT00467779|1819906|FG000|Stage 2|Disease Progression|0
860647|NCT00467779|1819907|FG001|Stage 2|Disease Progression|0
860648|NCT00467779|1819908|FG002|Stage 2|Disease Progression|0
860649|NCT00467779|1819909|FG003|Stage 2|Disease Progression|0
860650|NCT00467779|1819910|FG004|Stage 2|Disease Progression|0
860651|NCT00467779|1819911|FG005|Stage 2|Disease Progression|0
860652|NCT00467779|1819912|FG006|Stage 2|Disease Progression|0
860653|NCT00467779|1819913|FG007|Stage 2|Disease Progression|0
860654|NCT00467779|1819914|FG008|Stage 2|Disease Progression|16
860655|NCT00467779|1819915|FG009|Stage 2|Disease Progression|0
860656|NCT00467779|1819916|FG010|Stage 2|Disease Progression|0
860657|NCT00467779|1819917|FG011|Stage 2|Disease Progression|0
860658|NCT00467779|1819918|FG012|Stage 2|Disease Progression|0
860659|NCT00467779|1819919|FG013|Stage 2|Disease Progression|0
860660|NCT00467779|1819920|FG014|Stage 2|Disease Progression|0
860661|NCT00467779|1819906|FG000|Stage 2|Unspecified Reason|0
860662|NCT00467779|1819907|FG001|Stage 2|Unspecified Reason|0
860663|NCT00467779|1819908|FG002|Stage 2|Unspecified Reason|0
860664|NCT00467779|1819909|FG003|Stage 2|Unspecified Reason|0
860665|NCT00467779|1819910|FG004|Stage 2|Unspecified Reason|0
860666|NCT00467779|1819911|FG005|Stage 2|Unspecified Reason|0
860667|NCT00467779|1819912|FG006|Stage 2|Unspecified Reason|0
860668|NCT00467779|1819913|FG007|Stage 2|Unspecified Reason|0
860669|NCT00467779|1819914|FG008|Stage 2|Unspecified Reason|3
860670|NCT00467779|1819915|FG009|Stage 2|Unspecified Reason|0
860671|NCT00467779|1819916|FG010|Stage 2|Unspecified Reason|0
860672|NCT00467779|1819917|FG011|Stage 2|Unspecified Reason|0
860673|NCT00467779|1819918|FG012|Stage 2|Unspecified Reason|0
860674|NCT00467779|1819919|FG013|Stage 2|Unspecified Reason|0
860675|NCT00467779|1819920|FG014|Stage 2|Unspecified Reason|0
860676|NCT00467779|1819906|FG000|Stage 2A|Adverse Event|0
860677|NCT00467779|1819907|FG001|Stage 2A|Adverse Event|0
860678|NCT00467779|1819908|FG002|Stage 2A|Adverse Event|0
860679|NCT00467779|1819909|FG003|Stage 2A|Adverse Event|0
860680|NCT00467779|1819910|FG004|Stage 2A|Adverse Event|0
860681|NCT00467779|1819911|FG005|Stage 2A|Adverse Event|0
860682|NCT00467779|1819912|FG006|Stage 2A|Adverse Event|0
860683|NCT00467779|1819913|FG007|Stage 2A|Adverse Event|0
860684|NCT00467779|1819914|FG008|Stage 2A|Adverse Event|0
860685|NCT00467779|1819915|FG009|Stage 2A|Adverse Event|0
860686|NCT00467779|1819916|FG010|Stage 2A|Adverse Event|0
860687|NCT00467779|1819917|FG011|Stage 2A|Adverse Event|0
860688|NCT00467779|1819918|FG012|Stage 2A|Adverse Event|0
860689|NCT00467779|1819919|FG013|Stage 2A|Adverse Event|2
860690|NCT00467779|1819920|FG014|Stage 2A|Adverse Event|0
860691|NCT00467779|1819906|FG000|Stage 2A|Death|0
860692|NCT00467779|1819907|FG001|Stage 2A|Death|0
860693|NCT00467779|1819908|FG002|Stage 2A|Death|0
860694|NCT00467779|1819909|FG003|Stage 2A|Death|0
860695|NCT00467779|1819910|FG004|Stage 2A|Death|0
860696|NCT00467779|1819911|FG005|Stage 2A|Death|0
860697|NCT00467779|1819912|FG006|Stage 2A|Death|0
860698|NCT00467779|1819913|FG007|Stage 2A|Death|0
860699|NCT00467779|1819914|FG008|Stage 2A|Death|0
860700|NCT00467779|1819915|FG009|Stage 2A|Death|0
860701|NCT00467779|1819916|FG010|Stage 2A|Death|0
860702|NCT00467779|1819917|FG011|Stage 2A|Death|0
860703|NCT00467779|1819918|FG012|Stage 2A|Death|0
860704|NCT00467779|1819919|FG013|Stage 2A|Death|1
860705|NCT00467779|1819920|FG014|Stage 2A|Death|0
860706|NCT00467779|1819906|FG000|Stage 2A|Disease Progression|0
860707|NCT00467779|1819907|FG001|Stage 2A|Disease Progression|0
860708|NCT00467779|1819908|FG002|Stage 2A|Disease Progression|0
860709|NCT00467779|1819909|FG003|Stage 2A|Disease Progression|0
860710|NCT00467779|1819910|FG004|Stage 2A|Disease Progression|0
860711|NCT00467779|1819911|FG005|Stage 2A|Disease Progression|0
860712|NCT00467779|1819912|FG006|Stage 2A|Disease Progression|0
860713|NCT00467779|1819913|FG007|Stage 2A|Disease Progression|0
860714|NCT00467779|1819914|FG008|Stage 2A|Disease Progression|0
860715|NCT00467779|1819915|FG009|Stage 2A|Disease Progression|0
860716|NCT00467779|1819916|FG010|Stage 2A|Disease Progression|0
860717|NCT00467779|1819917|FG011|Stage 2A|Disease Progression|0
860718|NCT00467779|1819918|FG012|Stage 2A|Disease Progression|0
860719|NCT00467779|1819919|FG013|Stage 2A|Disease Progression|10
860720|NCT00467779|1819920|FG014|Stage 2A|Disease Progression|0
860721|NCT00467779|1819906|FG000|Stage 2A|Unspecified Reason|0
860722|NCT00467779|1819907|FG001|Stage 2A|Unspecified Reason|0
860723|NCT00467779|1819908|FG002|Stage 2A|Unspecified Reason|0
860724|NCT00467779|1819909|FG003|Stage 2A|Unspecified Reason|0
860725|NCT00467779|1819910|FG004|Stage 2A|Unspecified Reason|0
860726|NCT00467779|1819911|FG005|Stage 2A|Unspecified Reason|0
860727|NCT00467779|1819912|FG006|Stage 2A|Unspecified Reason|0
860728|NCT00467779|1819913|FG007|Stage 2A|Unspecified Reason|0
860729|NCT00467779|1819914|FG008|Stage 2A|Unspecified Reason|0
860730|NCT00467779|1819915|FG009|Stage 2A|Unspecified Reason|0
860731|NCT00467779|1819916|FG010|Stage 2A|Unspecified Reason|0
860732|NCT00467779|1819917|FG011|Stage 2A|Unspecified Reason|0
860733|NCT00467779|1819918|FG012|Stage 2A|Unspecified Reason|0
860734|NCT00467779|1819919|FG013|Stage 2A|Unspecified Reason|7
860735|NCT00467779|1819920|FG014|Stage 2A|Unspecified Reason|0
860736|NCT00467779|1819906|FG000|Stage 2A|Withdrawal by Subject|0
860737|NCT00467779|1819907|FG001|Stage 2A|Withdrawal by Subject|0
860738|NCT00467779|1819908|FG002|Stage 2A|Withdrawal by Subject|0
860739|NCT00467779|1819909|FG003|Stage 2A|Withdrawal by Subject|0
860740|NCT00467779|1819910|FG004|Stage 2A|Withdrawal by Subject|0
860741|NCT00467779|1819911|FG005|Stage 2A|Withdrawal by Subject|0
860742|NCT00467779|1819912|FG006|Stage 2A|Withdrawal by Subject|0
860743|NCT00467779|1819913|FG007|Stage 2A|Withdrawal by Subject|0
860744|NCT00467779|1819914|FG008|Stage 2A|Withdrawal by Subject|0
860745|NCT00467779|1819915|FG009|Stage 2A|Withdrawal by Subject|0
860746|NCT00467779|1819916|FG010|Stage 2A|Withdrawal by Subject|0
860747|NCT00467779|1819917|FG011|Stage 2A|Withdrawal by Subject|0
860748|NCT00467779|1819918|FG012|Stage 2A|Withdrawal by Subject|0
860749|NCT00467779|1819919|FG013|Stage 2A|Withdrawal by Subject|1
860750|NCT00467779|1819920|FG014|Stage 2A|Withdrawal by Subject|0
860751|NCT00467779|1819906|FG000|Stage 3|Adverse Event|0
860752|NCT00467779|1819907|FG001|Stage 3|Adverse Event|0
860753|NCT00467779|1819908|FG002|Stage 3|Adverse Event|0
860754|NCT00467779|1819909|FG003|Stage 3|Adverse Event|0
860755|NCT00467779|1819910|FG004|Stage 3|Adverse Event|0
860756|NCT00467779|1819911|FG005|Stage 3|Adverse Event|0
860757|NCT00467779|1819912|FG006|Stage 3|Adverse Event|0
860758|NCT00467779|1819913|FG007|Stage 3|Adverse Event|0
860759|NCT00467779|1819914|FG008|Stage 3|Adverse Event|0
860760|NCT00467779|1819915|FG009|Stage 3|Adverse Event|0
860761|NCT00467779|1819916|FG010|Stage 3|Adverse Event|0
860762|NCT00467779|1819917|FG011|Stage 3|Adverse Event|0
860763|NCT00467779|1819918|FG012|Stage 3|Adverse Event|0
860764|NCT00467779|1819919|FG013|Stage 3|Adverse Event|0
860765|NCT00467779|1819920|FG014|Stage 3|Adverse Event|2
860766|NCT00467779|1819906|FG000|Stage 3|Death|0
860767|NCT00467779|1819907|FG001|Stage 3|Death|0
860768|NCT00467779|1819908|FG002|Stage 3|Death|0
860769|NCT00467779|1819909|FG003|Stage 3|Death|0
860770|NCT00467779|1819910|FG004|Stage 3|Death|0
860771|NCT00467779|1819911|FG005|Stage 3|Death|0
860772|NCT00467779|1819912|FG006|Stage 3|Death|0
860773|NCT00467779|1819913|FG007|Stage 3|Death|0
860774|NCT00467779|1819914|FG008|Stage 3|Death|0
860775|NCT00467779|1819915|FG009|Stage 3|Death|0
860776|NCT00467779|1819916|FG010|Stage 3|Death|0
860777|NCT00467779|1819917|FG011|Stage 3|Death|0
860778|NCT00467779|1819918|FG012|Stage 3|Death|0
860779|NCT00467779|1819919|FG013|Stage 3|Death|0
860780|NCT00467779|1819920|FG014|Stage 3|Death|1
860781|NCT00467779|1819906|FG000|Stage 3|Disease Progression|0
860782|NCT00467779|1819907|FG001|Stage 3|Disease Progression|0
860783|NCT00467779|1819908|FG002|Stage 3|Disease Progression|0
860784|NCT00467779|1819909|FG003|Stage 3|Disease Progression|0
860785|NCT00467779|1819910|FG004|Stage 3|Disease Progression|0
860786|NCT00467779|1819911|FG005|Stage 3|Disease Progression|0
860787|NCT00467779|1819912|FG006|Stage 3|Disease Progression|0
860788|NCT00467779|1819913|FG007|Stage 3|Disease Progression|0
860789|NCT00467779|1819914|FG008|Stage 3|Disease Progression|0
860790|NCT00467779|1819915|FG009|Stage 3|Disease Progression|0
860791|NCT00467779|1819916|FG010|Stage 3|Disease Progression|0
860792|NCT00467779|1819917|FG011|Stage 3|Disease Progression|0
860793|NCT00467779|1819918|FG012|Stage 3|Disease Progression|0
860794|NCT00467779|1819919|FG013|Stage 3|Disease Progression|0
860795|NCT00467779|1819920|FG014|Stage 3|Disease Progression|9
860796|NCT00467779|1819906|FG000|Stage 3|Unspecified Reason|0
860797|NCT00467779|1819907|FG001|Stage 3|Unspecified Reason|0
860798|NCT00467779|1819908|FG002|Stage 3|Unspecified Reason|0
860799|NCT00467779|1819909|FG003|Stage 3|Unspecified Reason|0
860800|NCT00467779|1819910|FG004|Stage 3|Unspecified Reason|0
860801|NCT00467779|1819911|FG005|Stage 3|Unspecified Reason|0
860802|NCT00467779|1819912|FG006|Stage 3|Unspecified Reason|0
860803|NCT00467779|1819913|FG007|Stage 3|Unspecified Reason|0
860804|NCT00467779|1819914|FG008|Stage 3|Unspecified Reason|0
860805|NCT00467779|1819915|FG009|Stage 3|Unspecified Reason|0
860806|NCT00467779|1819916|FG010|Stage 3|Unspecified Reason|0
860807|NCT00467779|1819917|FG011|Stage 3|Unspecified Reason|0
860808|NCT00467779|1819918|FG012|Stage 3|Unspecified Reason|0
860809|NCT00467779|1819919|FG013|Stage 3|Unspecified Reason|0
860810|NCT00467779|1819920|FG014|Stage 3|Unspecified Reason|5
860811|NCT00467818|1819960|FG000|Overall Study|Adverse Event|1
860812|NCT00467818|1819961|FG001|Overall Study|Adverse Event|0
860813|NCT00467818|1819960|FG000|Overall Study|Lost to Follow-up|2
860814|NCT00467818|1819961|FG001|Overall Study|Lost to Follow-up|2
860815|NCT00467831|1819969|FG000|Overall Study|Death|2
860816|NCT00467831|1819969|FG000|Overall Study|Withdrawal by Subject|1
860817|NCT00467857|1819991|FG000|Overall Study|Adverse Event|1
860818|NCT00467857|1819992|FG001|Overall Study|Adverse Event|0
860819|NCT00467857|1819991|FG000|Overall Study|Withdrew consent|2
860820|NCT00467857|1819992|FG001|Overall Study|Withdrew consent|0
860821|NCT00467857|1819991|FG000|Overall Study|Death|0
860822|NCT00467857|1819992|FG001|Overall Study|Death|1
860823|NCT00467857|1819991|FG000|Overall Study|Discharged from court service|0
860824|NCT00467857|1819992|FG001|Overall Study|Discharged from court service|1
860825|NCT00467857|1819991|FG000|Overall Study|Emergency care required|0
860826|NCT00467857|1819992|FG001|Overall Study|Emergency care required|1
860827|NCT00467857|1819991|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0
860828|NCT00467857|1819992|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2
860829|NCT00467857|1819991|FG000|Overall Study|Discontinuation reason missing|0
860830|NCT00467857|1819992|FG001|Overall Study|Discontinuation reason missing|3
860831|NCT00467870|1820004|FG000|Overall Study|Adverse Event|13
860832|NCT00467870|1820005|FG001|Overall Study|Adverse Event|9
860833|NCT00467870|1820006|FG002|Overall Study|Adverse Event|1
860834|NCT00467870|1820007|FG003|Overall Study|Adverse Event|15
860835|NCT00467870|1820008|FG004|Overall Study|Adverse Event|15
860836|NCT00467870|1820009|FG005|Overall Study|Adverse Event|1
860837|NCT00467870|1820004|FG000|Overall Study|Protocol Violation|2
860838|NCT00467870|1820005|FG001|Overall Study|Protocol Violation|1
860839|NCT00467870|1820006|FG002|Overall Study|Protocol Violation|1
860840|NCT00467870|1820007|FG003|Overall Study|Protocol Violation|2
860841|NCT00467870|1820008|FG004|Overall Study|Protocol Violation|0
860842|NCT00467870|1820009|FG005|Overall Study|Protocol Violation|0
860843|NCT00467870|1820004|FG000|Overall Study|Withdrawal by Subject|14
860844|NCT00467870|1820005|FG001|Overall Study|Withdrawal by Subject|21
860845|NCT00467870|1820006|FG002|Overall Study|Withdrawal by Subject|0
860846|NCT00467870|1820007|FG003|Overall Study|Withdrawal by Subject|9
860847|NCT00467870|1820008|FG004|Overall Study|Withdrawal by Subject|10
860848|NCT00467870|1820009|FG005|Overall Study|Withdrawal by Subject|1
860849|NCT00467870|1820004|FG000|Overall Study|Lost to Follow-up|5
860850|NCT00467870|1820005|FG001|Overall Study|Lost to Follow-up|3
860851|NCT00467870|1820006|FG002|Overall Study|Lost to Follow-up|1
860852|NCT00467870|1820007|FG003|Overall Study|Lost to Follow-up|1
860853|NCT00467870|1820008|FG004|Overall Study|Lost to Follow-up|3
860854|NCT00467870|1820009|FG005|Overall Study|Lost to Follow-up|0
860855|NCT00467870|1820004|FG000|Overall Study|Subject Non-compliance|3
860856|NCT00467870|1820005|FG001|Overall Study|Subject Non-compliance|4
860857|NCT00467870|1820006|FG002|Overall Study|Subject Non-compliance|0
860858|NCT00467870|1820007|FG003|Overall Study|Subject Non-compliance|1
860859|NCT00467870|1820008|FG004|Overall Study|Subject Non-compliance|5
860860|NCT00467870|1820009|FG005|Overall Study|Subject Non-compliance|0
860861|NCT00467870|1820004|FG000|Overall Study|Other/Unknown|8
860862|NCT00467870|1820005|FG001|Overall Study|Other/Unknown|5
860863|NCT00467870|1820006|FG002|Overall Study|Other/Unknown|1
860864|NCT00467870|1820007|FG003|Overall Study|Other/Unknown|5
860865|NCT00467870|1820008|FG004|Overall Study|Other/Unknown|4
860866|NCT00467870|1820009|FG005|Overall Study|Other/Unknown|0
860867|NCT00467896|1820019|FG000|Overall Study|Consent Withdrawal|18
860868|NCT00467896|1820019|FG000|Overall Study|Adverse Event|7
860869|NCT00467896|1820019|FG000|Overall Study|Serious Adverse Event|13
860870|NCT00467896|1820019|FG000|Overall Study|Non-compliance|3
860871|NCT00467896|1820019|FG000|Overall Study|Changed therapy|2
860872|NCT00467896|1820019|FG000|Overall Study|Patient received transplant|2
860873|NCT00467896|1820019|FG000|Overall Study|Patient had atrial septostomy|1
860874|NCT00467896|1820019|FG000|Overall Study|Patient weaned off iloprost|1
860875|NCT00467896|1820019|FG000|Overall Study|Mainly used Prodose not I-neb® device|1
860876|NCT00467896|1820019|FG000|Overall Study|Started intravenous prostacyclin|1
860877|NCT00467896|1820019|FG000|Overall Study|Started inhaled Remodulin|1
860878|NCT00467896|1820019|FG000|Overall Study|Patient had no improvement|1
860879|NCT00467961|1820025|FG000|Overall Study|Technical Failures|5
860880|NCT00467961|1820025|FG000|Overall Study|Disease Progression|2
860881|NCT00468052|1820031|FG000|Overall Study|Protocol Violation|7
860882|NCT00468052|1820032|FG001|Overall Study|Protocol Violation|8
860883|NCT00468104|1820040|FG000|First Intervention|Protocol Violation|2
860884|NCT00468104|1820041|FG001|First Intervention|Protocol Violation|1
860885|NCT00468104|1820040|FG000|First Intervention|bleeding at chest tube site--first dose|1
860886|NCT00468104|1820041|FG001|First Intervention|bleeding at chest tube site--first dose|0
860887|NCT00468104|1820040|FG000|First Intervention|died within 3 weeks|1
860888|NCT00468104|1820041|FG001|First Intervention|died within 3 weeks|0
860889|NCT00468104|1820040|FG000|First Intervention|malposition/blocked chest tube tube|2
860890|NCT00468104|1820041|FG001|First Intervention|malposition/blocked chest tube tube|0
860891|NCT00468104|1820040|FG000|First Intervention|large lung mass with minimal effusion|1
860892|NCT00468104|1820041|FG001|First Intervention|large lung mass with minimal effusion|0
860893|NCT00468104|1820040|FG000|First Intervention|associated prolonged pneumothorax|1
860894|NCT00468104|1820041|FG001|First Intervention|associated prolonged pneumothorax|0
860895|NCT00468104|1820040|FG000|First Intervention|trapped lung|1
860896|NCT00468104|1820041|FG001|First Intervention|trapped lung|0
860897|NCT00468104|1820040|FG000|Second Intervention|Withdrawal by Subject|5
860898|NCT00468104|1820041|FG001|Second Intervention|Withdrawal by Subject|2
860899|NCT00468104|1820040|FG000|Second Intervention|discarded for malposition of chest tube|0
860900|NCT00468104|1820041|FG001|Second Intervention|discarded for malposition of chest tube|2
860901|NCT00468143|1820050|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3
860902|NCT00468143|1820051|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4
860903|NCT00468143|1820050|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3
860904|NCT00468143|1820051|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3
860905|NCT00468169|1820059|FG000|Overall Study|Withdrawal by Subject|1
860906|NCT00468169|1820060|FG001|Overall Study|Withdrawal by Subject|0
860907|NCT00468286|1820074|FG000|Overall Study|Adverse Event|1
860908|NCT00468286|1820075|FG001|Overall Study|Adverse Event|6
860909|NCT00468286|1820074|FG000|Overall Study|Protocol Violation|2
860910|NCT00468286|1820075|FG001|Overall Study|Protocol Violation|2
860911|NCT00468286|1820074|FG000|Overall Study|Withdrawal by Subject|4
860912|NCT00468286|1820075|FG001|Overall Study|Withdrawal by Subject|3
860913|NCT00468286|1820074|FG000|Overall Study|Physician Decision|0
860914|NCT00468286|1820075|FG001|Overall Study|Physician Decision|1
860915|NCT00468299|1820083|FG000|Overall Study|Withdrawal by Subject|0
860916|NCT00468299|1820084|FG001|Overall Study|Withdrawal by Subject|1
860917|NCT00468312|1820094|FG000|Overall Study|Adverse Event|2
860918|NCT00468312|1820095|FG001|Overall Study|Adverse Event|1
860919|NCT00468312|1820094|FG000|Overall Study|Lack of Efficacy|0
860920|NCT00468312|1820095|FG001|Overall Study|Lack of Efficacy|1
860921|NCT00468312|1820094|FG000|Overall Study|Withdrawal by Subject|0
860922|NCT00468312|1820095|FG001|Overall Study|Withdrawal by Subject|1
860923|NCT00468312|1820094|FG000|Overall Study|Protocol Violation|2
860924|NCT00468312|1820095|FG001|Overall Study|Protocol Violation|1
860925|NCT00468312|1820094|FG000|Overall Study|Did not meet protocol eligibility|0
860926|NCT00468312|1820095|FG001|Overall Study|Did not meet protocol eligibility|1
860927|NCT00468481|1820103|FG000|Overall Study|Adverse Event|13
860928|NCT00468481|1820104|FG001|Overall Study|Adverse Event|3
860929|NCT00468481|1820103|FG000|Overall Study|Lost to Follow-up|25
860930|NCT00468481|1820104|FG001|Overall Study|Lost to Follow-up|8
860931|NCT00468481|1820103|FG000|Overall Study|Pregnancy|2
860932|NCT00468481|1820104|FG001|Overall Study|Pregnancy|0
860933|NCT00468481|1820103|FG000|Overall Study|Protocol Violation|18
860934|NCT00468481|1820104|FG001|Overall Study|Protocol Violation|8
860935|NCT00468481|1820103|FG000|Overall Study|Withdrawal by Subject|12
860936|NCT00468481|1820104|FG001|Overall Study|Withdrawal by Subject|3
860937|NCT00468481|1820103|FG000|Overall Study|susp/diag malignant/premalignant disease|1
860938|NCT00468481|1820104|FG001|Overall Study|susp/diag malignant/premalignant disease|0
860939|NCT00468481|1820103|FG000|Overall Study|Prohibited Medication|1
860940|NCT00468481|1820104|FG001|Overall Study|Prohibited Medication|1
860941|NCT00468481|1820103|FG000|Overall Study|Egg Donor|1
860942|NCT00468481|1820104|FG001|Overall Study|Egg Donor|0
860943|NCT00468481|1820103|FG000|Overall Study|Moved out of area|4
860944|NCT00468481|1820104|FG001|Overall Study|Moved out of area|1
860945|NCT00468481|1820103|FG000|Overall Study|Non-Compliance|5
860946|NCT00468481|1820104|FG001|Overall Study|Non-Compliance|0
860947|NCT00468481|1820103|FG000|Overall Study|Other|6
860948|NCT00468481|1820104|FG001|Overall Study|Other|0
860949|NCT00468546|1820112|FG000|Week 24 Analysis|Lack of Efficacy|83
860950|NCT00468546|1820113|FG001|Week 24 Analysis|Lack of Efficacy|37
860951|NCT00468546|1820112|FG000|Week 24 Analysis|Refused treatment|5
860952|NCT00468546|1820113|FG001|Week 24 Analysis|Refused treatment|5
860953|NCT00468546|1820112|FG000|Week 24 Analysis|Adverse Event|1
860954|NCT00468546|1820113|FG001|Week 24 Analysis|Adverse Event|8
860955|NCT00468546|1820112|FG000|Week 24 Analysis|Failure to return|3
860956|NCT00468546|1820113|FG001|Week 24 Analysis|Failure to return|4
860957|NCT00468546|1820112|FG000|Week 24 Analysis|Rescue therapy|2
860958|NCT00468546|1820113|FG001|Week 24 Analysis|Rescue therapy|0
860959|NCT00468546|1820112|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0
860960|NCT00468546|1820113|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1
860961|NCT00468546|1820112|FG000|Week 24 Analysis|Due to clinical hold|1
860962|NCT00468546|1820113|FG001|Week 24 Analysis|Due to clinical hold|0
860963|NCT00468546|1820112|FG000|Week 24 Analysis|Went onto rescue therapy|1
860964|NCT00468546|1820113|FG001|Week 24 Analysis|Went onto rescue therapy|0
860965|NCT00468546|1820112|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1
860966|NCT00468546|1820113|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0
860967|NCT00468546|1820112|FG000|Week 24 to Week 104 Analysis|Adverse Event|2
860968|NCT00468546|1820113|FG001|Week 24 to Week 104 Analysis|Adverse Event|5
860969|NCT00468546|1820112|FG000|Week 24 to Week 104 Analysis|Death|1
860970|NCT00468546|1820113|FG001|Week 24 to Week 104 Analysis|Death|0
860971|NCT00468546|1820112|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3
860972|NCT00468546|1820113|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12
860973|NCT00468546|1820112|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0
860974|NCT00468546|1820113|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2
860975|NCT00468546|1820112|FG000|Week 24 to Week 104 Analysis|Refused treatment|4
860976|NCT00468546|1820113|FG001|Week 24 to Week 104 Analysis|Refused treatment|7
860977|NCT00468546|1820112|FG000|Week 24 to Week 104 Analysis|Failure to return|1
860978|NCT00468546|1820113|FG001|Week 24 to Week 104 Analysis|Failure to return|2
860979|NCT00468546|1820112|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
860980|NCT00468546|1820113|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
860981|NCT00468546|1820112|FG000|Week 24 to Week 104 Analysis|Other|17
860982|NCT00468546|1820113|FG001|Week 24 to Week 104 Analysis|Other|14
860983|NCT00468559|1820121|FG000|Open-label Treatment Phase|Adverse Event|5
860984|NCT00468559|1820122|FG001|Open-label Treatment Phase|Adverse Event|0
860985|NCT00468559|1820123|FG002|Open-label Treatment Phase|Adverse Event|0
860986|NCT00468559|1820121|FG000|Open-label Treatment Phase|Lack of Efficacy|9
860987|NCT00468559|1820122|FG001|Open-label Treatment Phase|Lack of Efficacy|0
860988|NCT00468559|1820123|FG002|Open-label Treatment Phase|Lack of Efficacy|0
860989|NCT00468559|1820121|FG000|Open-label Treatment Phase|Withdrawal by Subject|4
860990|NCT00468559|1820122|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
860991|NCT00468559|1820123|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
860992|NCT00468559|1820121|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
860993|NCT00468559|1820122|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
860994|NCT00468559|1820123|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
860995|NCT00468559|1820121|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
860996|NCT00468559|1820122|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
860997|NCT00468559|1820123|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
860998|NCT00468585|1820135|FG000|Overall Study|Patient not treated|1
860999|NCT00468585|1820136|FG001|Overall Study|Patient not treated|0
861000|NCT00468585|1820137|FG002|Overall Study|Patient not treated|1
861001|NCT00468585|1820138|FG003|Overall Study|Patient not treated|0
861002|NCT00468585|1820135|FG000|Overall Study|Patient found to be ineligible|0
861003|NCT00468585|1820136|FG001|Overall Study|Patient found to be ineligible|0
861004|NCT00468585|1820137|FG002|Overall Study|Patient found to be ineligible|1
861005|NCT00468585|1820138|FG003|Overall Study|Patient found to be ineligible|0
861006|NCT00468585|1820135|FG000|Overall Study|Adverse Event|0
861007|NCT00468585|1820136|FG001|Overall Study|Adverse Event|0
861008|NCT00468585|1820137|FG002|Overall Study|Adverse Event|1
861009|NCT00468585|1820138|FG003|Overall Study|Adverse Event|0
861010|NCT00468585|1820135|FG000|Overall Study|Withdrawal by Subject|0
861011|NCT00468585|1820136|FG001|Overall Study|Withdrawal by Subject|0
861012|NCT00468585|1820137|FG002|Overall Study|Withdrawal by Subject|2
861013|NCT00468585|1820138|FG003|Overall Study|Withdrawal by Subject|1
861014|NCT00468650|1820148|FG000|Overall Study|Lost to Follow-up|4
861015|NCT00468650|1820148|FG000|Overall Study|Withdrawal by Subject|2
861016|NCT00468650|1820148|FG000|Overall Study|Protocol Violation|1
861017|NCT00468676|1820155|FG000|Overall Study|Lost to Follow-up|14
861018|NCT00468676|1820156|FG001|Overall Study|Lost to Follow-up|11
861019|NCT00468676|1820155|FG000|Overall Study|Death|2
861020|NCT00468676|1820156|FG001|Overall Study|Death|1
861021|NCT00468728|1820166|FG000|Treatment|criteria for mITT population|4
861022|NCT00468728|1820167|FG001|Treatment|criteria for mITT population|11
861023|NCT00468728|1820166|FG000|Follow-up|mITT failure|34
861024|NCT00468728|1820167|FG001|Follow-up|mITT failure|31
861025|NCT00468819|1820178|FG000|Overall Study|Withdrawal by Subject|4
861026|NCT00468819|1820179|FG001|Overall Study|Withdrawal by Subject|0
861027|NCT00468819|1820180|FG002|Overall Study|Withdrawal by Subject|1
861028|NCT00468819|1820178|FG000|Overall Study|Lost to Follow-up|0
861029|NCT00468819|1820179|FG001|Overall Study|Lost to Follow-up|0
861030|NCT00468819|1820180|FG002|Overall Study|Lost to Follow-up|1
861031|NCT00468819|1820178|FG000|Overall Study|Drop-outs (Treatment never received)|2
861032|NCT00468819|1820179|FG001|Overall Study|Drop-outs (Treatment never received)|0
861033|NCT00468819|1820180|FG002|Overall Study|Drop-outs (Treatment never received)|0
861034|NCT00468845|1820193|FG000|Overall Study|Adverse Event|9
861035|NCT00468845|1820194|FG001|Overall Study|Adverse Event|14
861036|NCT00468845|1820195|FG002|Overall Study|Adverse Event|11
861037|NCT00468845|1820193|FG000|Overall Study|Lost to Follow-up|2
861038|NCT00468845|1820194|FG001|Overall Study|Lost to Follow-up|1
861039|NCT00468845|1820195|FG002|Overall Study|Lost to Follow-up|2
861040|NCT00468845|1820193|FG000|Overall Study|Other|4
861041|NCT00468845|1820194|FG001|Overall Study|Other|9
861042|NCT00468845|1820195|FG002|Overall Study|Other|5
861043|NCT00468845|1820193|FG000|Overall Study|No longer willing to participate|5
861044|NCT00468845|1820194|FG001|Overall Study|No longer willing to participate|6
861045|NCT00468845|1820195|FG002|Overall Study|No longer willing to participate|10
861046|NCT00468845|1820193|FG000|Overall Study|Randomized, not treated|1
861047|NCT00468845|1820194|FG001|Overall Study|Randomized, not treated|4
861048|NCT00468845|1820195|FG002|Overall Study|Randomized, not treated|2
861049|NCT00468858|1820206|FG000|Overall Study|Adverse Event|0
861050|NCT00468858|1820207|FG001|Overall Study|Adverse Event|1
861051|NCT00468858|1820208|FG002|Overall Study|Adverse Event|0
861052|NCT00468858|1820206|FG000|Overall Study|Withdrawal by Subject|7
861053|NCT00468858|1820207|FG001|Overall Study|Withdrawal by Subject|4
861054|NCT00468858|1820208|FG002|Overall Study|Withdrawal by Subject|5
861055|NCT00468858|1820206|FG000|Overall Study|Relocation|1
861056|NCT00468858|1820207|FG001|Overall Study|Relocation|3
861057|NCT00468858|1820208|FG002|Overall Study|Relocation|3
861058|NCT00468858|1820206|FG000|Overall Study|Lost to Follow-up|1
861059|NCT00468858|1820207|FG001|Overall Study|Lost to Follow-up|2
861060|NCT00468858|1820208|FG002|Overall Study|Lost to Follow-up|5
861061|NCT00468858|1820206|FG000|Overall Study|Other|0
861062|NCT00468858|1820207|FG001|Overall Study|Other|0
861063|NCT00468858|1820208|FG002|Overall Study|Other|1
861064|NCT00468910|1820272|FG000|Overall Study|Lost to Follow-up|2
861065|NCT00468910|1820273|FG001|Overall Study|Lost to Follow-up|1
861066|NCT00468910|1820272|FG000|Overall Study|Withdrawal by Subject|2
861067|NCT00468910|1820273|FG001|Overall Study|Withdrawal by Subject|1
861068|NCT00468910|1820272|FG000|Overall Study|Medical Contraindication|0
861069|NCT00468910|1820273|FG001|Overall Study|Medical Contraindication|1
861070|NCT00469014|1820284|FG000|Initial Phase Randomization|Disease Progression|0
861071|NCT00469014|1820285|FG001|Initial Phase Randomization|Disease Progression|1
861072|NCT00469014|1820286|FG002|Initial Phase Randomization|Disease Progression|1
861073|NCT00469014|1820287|FG003|Initial Phase Randomization|Disease Progression|0
861074|NCT00469014|1820284|FG000|Initial Phase Randomization|No Response|1
861075|NCT00469014|1820285|FG001|Initial Phase Randomization|No Response|0
861076|NCT00469014|1820286|FG002|Initial Phase Randomization|No Response|0
861077|NCT00469014|1820287|FG003|Initial Phase Randomization|No Response|1
861078|NCT00469014|1820284|FG000|Adaptive Randomization|Not Evaluable|1
861079|NCT00469014|1820285|FG001|Adaptive Randomization|Not Evaluable|0
861080|NCT00469014|1820286|FG002|Adaptive Randomization|Not Evaluable|0
861081|NCT00469014|1820287|FG003|Adaptive Randomization|Not Evaluable|1
861082|NCT00469014|1820284|FG000|Adaptive Randomization|No Response|0
861083|NCT00469014|1820285|FG001|Adaptive Randomization|No Response|1
861084|NCT00469014|1820286|FG002|Adaptive Randomization|No Response|0
861085|NCT00469014|1820287|FG003|Adaptive Randomization|No Response|0
861086|NCT00469014|1820284|FG000|Adaptive Randomization|Death|0
861087|NCT00469014|1820285|FG001|Adaptive Randomization|Death|0
861088|NCT00469014|1820286|FG002|Adaptive Randomization|Death|1
861089|NCT00469014|1820287|FG003|Adaptive Randomization|Death|0
861090|NCT00469079|1820300|FG000|Overall Study|Lack of Efficacy|3
861091|NCT00469079|1820301|FG001|Overall Study|Lack of Efficacy|8
861092|NCT00469079|1820302|FG002|Overall Study|Lack of Efficacy|5
861093|NCT00469079|1820300|FG000|Overall Study|Adverse Event|1
861094|NCT00469079|1820301|FG001|Overall Study|Adverse Event|3
861095|NCT00469079|1820302|FG002|Overall Study|Adverse Event|2
861096|NCT00469079|1820300|FG000|Overall Study|Lost to Follow-up|4
861097|NCT00469079|1820301|FG001|Overall Study|Lost to Follow-up|8
861098|NCT00469079|1820302|FG002|Overall Study|Lost to Follow-up|10
861099|NCT00469079|1820300|FG000|Overall Study|Withdrawal by Subject|1
861100|NCT00469079|1820301|FG001|Overall Study|Withdrawal by Subject|2
861101|NCT00469079|1820302|FG002|Overall Study|Withdrawal by Subject|2
861102|NCT00469079|1820300|FG000|Overall Study|Ineligible|0
861103|NCT00469079|1820301|FG001|Overall Study|Ineligible|1
861104|NCT00469079|1820302|FG002|Overall Study|Ineligible|0
861105|NCT00469092|1820318|FG000|Overall Study|Adverse Event|5
861106|NCT00469092|1820319|FG001|Overall Study|Adverse Event|4
861107|NCT00469092|1820318|FG000|Overall Study|Lack of Efficacy|1
861108|NCT00469092|1820319|FG001|Overall Study|Lack of Efficacy|0
861109|NCT00469092|1820318|FG000|Overall Study|Lost to Follow-up|1
861110|NCT00469092|1820319|FG001|Overall Study|Lost to Follow-up|2
861111|NCT00469092|1820318|FG000|Overall Study|Protocol Violation|3
861112|NCT00469092|1820319|FG001|Overall Study|Protocol Violation|3
861113|NCT00469092|1820318|FG000|Overall Study|Withdrawal by Subject|4
861114|NCT00469092|1820319|FG001|Overall Study|Withdrawal by Subject|4
861115|NCT00469092|1820318|FG000|Overall Study|Withdrawal Criteria|3
861116|NCT00469092|1820319|FG001|Overall Study|Withdrawal Criteria|4
861117|NCT00469092|1820318|FG000|Overall Study|Incorrectly Randomised|4
861118|NCT00469092|1820319|FG001|Overall Study|Incorrectly Randomised|3
861119|NCT00469092|1820318|FG000|Overall Study|Contraindication metformin/glimepiride|1
861120|NCT00469092|1820319|FG001|Overall Study|Contraindication metformin/glimepiride|0
861121|NCT00469092|1820318|FG000|Overall Study|Use of lipid lowering drug|1
861122|NCT00469092|1820319|FG001|Overall Study|Use of lipid lowering drug|0
861123|NCT00469092|1820318|FG000|Overall Study|Hypoglycaemic Episodes|1
861124|NCT00469092|1820319|FG001|Overall Study|Hypoglycaemic Episodes|1
861125|NCT00469092|1820318|FG000|Overall Study|Abnormal lab value|1
861126|NCT00469092|1820319|FG001|Overall Study|Abnormal lab value|0
861127|NCT00469092|1820318|FG000|Overall Study|Use of Corticosteroid|1
861128|NCT00469092|1820319|FG001|Overall Study|Use of Corticosteroid|0
861129|NCT00469144|1820327|FG000|Overall Study|Death|0
861130|NCT00469144|1820328|FG001|Overall Study|Death|1
861131|NCT00469144|1820327|FG000|Overall Study|No Response|5
861132|NCT00469144|1820328|FG001|Overall Study|No Response|5
861133|NCT00469144|1820327|FG000|Overall Study|Progressive Disease|1
861134|NCT00469144|1820328|FG001|Overall Study|Progressive Disease|0
861135|NCT00469209|1820341|FG000|Overall Study|Adverse Event|1
861136|NCT00469209|1820342|FG001|Overall Study|Adverse Event|0
861137|NCT00469209|1820343|FG002|Overall Study|Adverse Event|1
861138|NCT00469456|1820371|FG000|Overall Study|Adverse Event|4
861139|NCT00469456|1820372|FG001|Overall Study|Adverse Event|3
861140|NCT00469456|1820371|FG000|Overall Study|Protocol Violation|1
861141|NCT00469456|1820372|FG001|Overall Study|Protocol Violation|0
861142|NCT00469456|1820371|FG000|Overall Study|Withdrawal by Subject|4
861143|NCT00469456|1820372|FG001|Overall Study|Withdrawal by Subject|1
861144|NCT00469833|1820387|FG000|Overall Study|No IV access|2
861145|NCT00469859|1820399|FG000|Overall Study|Inevaluable|0
861146|NCT00469859|1820400|FG001|Overall Study|Inevaluable|2
861147|NCT00469898|1820406|FG000|Overall Study|Adverse Event|7
861148|NCT00469898|1820406|FG000|Overall Study|Withdrawal by Subject|4
861149|NCT00469898|1820406|FG000|Overall Study|Death|4
861150|NCT00469898|1820406|FG000|Overall Study|Disease progression|9
861151|NCT00469898|1820406|FG000|Overall Study|Decreased performance status|1
861152|NCT00470054|1820418|FG000|Overall Study|Ineligible|1
861153|NCT00470093|1820422|FG000|Overall Study|Adverse Event|2
861154|NCT00470158|1820452|FG000|Overall Study|Death|0
861155|NCT00470158|1820453|FG001|Overall Study|Death|0
861156|NCT00470158|1820454|FG002|Overall Study|Death|0
861157|NCT00470158|1820455|FG003|Overall Study|Death|0
861158|NCT00470158|1820456|FG004|Overall Study|Death|2
861159|NCT00470158|1820452|FG000|Overall Study|Lost to Follow-up|7
861160|NCT00470158|1820453|FG001|Overall Study|Lost to Follow-up|8
861161|NCT00470158|1820454|FG002|Overall Study|Lost to Follow-up|8
861162|NCT00470158|1820455|FG003|Overall Study|Lost to Follow-up|5
861163|NCT00470158|1820456|FG004|Overall Study|Lost to Follow-up|4
861164|NCT00470158|1820452|FG000|Overall Study|Protocol Violation|1
861165|NCT00470158|1820453|FG001|Overall Study|Protocol Violation|0
861166|NCT00470158|1820454|FG002|Overall Study|Protocol Violation|0
861167|NCT00470158|1820455|FG003|Overall Study|Protocol Violation|0
861168|NCT00470158|1820456|FG004|Overall Study|Protocol Violation|0
861169|NCT00470184|1820468|FG000|Overall Study|Not Treated(became ineligible)|4
861170|NCT00470184|1820468|FG000|Overall Study|Not treated (other)|1
861171|NCT00470184|1820468|FG000|Overall Study|disease Progression|4
861172|NCT00470184|1820468|FG000|Overall Study|Adverse Event|3
861173|NCT00470184|1820468|FG000|Overall Study|Withdrawal by Subject|4
861174|NCT00470184|1820468|FG000|Overall Study|other|5
861175|NCT00470184|1820468|FG000|Overall Study|recurrence|1
861176|NCT00470262|1820475|FG000|Overall Study|Withdrawal by Subject|2
861177|NCT00470262|1820476|FG001|Overall Study|Withdrawal by Subject|0
861178|NCT00470275|1820483|FG000|Overall Study|Death|1
861179|NCT00470275|1820483|FG000|Overall Study|Lack of Efficacy|7
861180|NCT00470275|1820483|FG000|Overall Study|Withdrawal by Subject|2
861181|NCT00470366|1820492|FG000|Overall Study|Adverse Event|3
861182|NCT00470366|1820492|FG000|Overall Study|Poor compliance|1
861183|NCT00470418|1820508|FG000|Overall Study|Withdrawal by Subject|1
861184|NCT00470418|1820509|FG001|Overall Study|Withdrawal by Subject|0
861185|NCT00470470|1820515|FG000|Overall Study|Adverse Event|2
861186|NCT00470470|1820515|FG000|Overall Study|Death|2
861187|NCT00470470|1820515|FG000|Overall Study|Not treated|1
861188|NCT00470535|1820519|FG000|Overall Study|Disease Progression|13
861189|NCT00470535|1820519|FG000|Overall Study|Withdrawal by Subject|1
861190|NCT00470535|1820519|FG000|Overall Study|Adverse Event|1
861191|NCT00470535|1820519|FG000|Overall Study|Death|1
861192|NCT00470535|1820519|FG000|Overall Study|Other|2
861193|NCT00470626|1820547|FG000|Overall Study|Lost to Follow-up|10
861194|NCT00470626|1820547|FG000|Overall Study|Withdrawal by Subject|7
861195|NCT00470834|1820557|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
861196|NCT00470834|1820558|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
861197|NCT00470834|1820557|FG000|Treatment Period (18 Months)|Adverse Event|7
861198|NCT00470834|1820558|FG001|Treatment Period (18 Months)|Adverse Event|6
861199|NCT00470834|1820557|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4
861200|NCT00470834|1820558|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5
861201|NCT00470834|1820557|FG000|Treatment Period (18 Months)|Physician Decision|4
861202|NCT00470834|1820558|FG001|Treatment Period (18 Months)|Physician Decision|4
861203|NCT00470834|1820557|FG000|Treatment Period (18 Months)|Protocol Violation|3
861204|NCT00470834|1820558|FG001|Treatment Period (18 Months)|Protocol Violation|1
861205|NCT00470834|1820557|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1
861206|NCT00470834|1820558|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1
861207|NCT00470834|1820557|FG000|Treatment Period (18 Months)|Lost to Follow-up|1
861208|NCT00470834|1820558|FG001|Treatment Period (18 Months)|Lost to Follow-up|0
861209|NCT00470834|1820557|FG000|Treatment Period (18 Months)|Non-compliance|1
861210|NCT00470834|1820558|FG001|Treatment Period (18 Months)|Non-compliance|0
861211|NCT00470834|1820557|FG000|Treatment Period (18 Months)|Lack of Efficacy|1
861212|NCT00470834|1820558|FG001|Treatment Period (18 Months)|Lack of Efficacy|0
861213|NCT00470834|1820557|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
861214|NCT00470834|1820558|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
861215|NCT00470834|1820557|FG000|Extension Period (24 Months)|Adverse Event|3
861216|NCT00470834|1820558|FG001|Extension Period (24 Months)|Adverse Event|4
861217|NCT00470834|1820557|FG000|Extension Period (24 Months)|Withdrawal by Subject|2
861218|NCT00470834|1820558|FG001|Extension Period (24 Months)|Withdrawal by Subject|5
861219|NCT00470834|1820557|FG000|Extension Period (24 Months)|Physician Decision|4
861220|NCT00470834|1820558|FG001|Extension Period (24 Months)|Physician Decision|3
861221|NCT00470834|1820557|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0
861222|NCT00470834|1820558|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1
861223|NCT00470834|1820557|FG000|Extension Period (24 Months)|Lost to Follow-up|0
861224|NCT00470834|1820558|FG001|Extension Period (24 Months)|Lost to Follow-up|1
861225|NCT00470834|1820557|FG000|Extension Period (24 Months)|Non-compliance|0
861226|NCT00470834|1820558|FG001|Extension Period (24 Months)|Non-compliance|1
861227|NCT00470834|1820557|FG000|Extension Period (24 Months)|Disease Progression|0
861228|NCT00470834|1820558|FG001|Extension Period (24 Months)|Disease Progression|1
861229|NCT00470847|1820564|FG000|Overall Study|Pt still receiving treatment|1
861230|NCT00471081|1820581|FG000|Active Phase|Protocol Violation|1
861231|NCT00471081|1820582|FG001|Active Phase|Protocol Violation|1
861232|NCT00471081|1820581|FG000|Active Phase|Withdrawal by Subject|0
861233|NCT00471081|1820582|FG001|Active Phase|Withdrawal by Subject|3
861234|NCT00471081|1820581|FG000|Active Phase|Lost to Follow-up|0
861235|NCT00471081|1820582|FG001|Active Phase|Lost to Follow-up|1
861236|NCT00471081|1820581|FG000|Active Phase|Lost health plan/insurance|1
861237|NCT00471081|1820582|FG001|Active Phase|Lost health plan/insurance|8
861238|NCT00471081|1820581|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1
861239|NCT00471081|1820582|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4
861240|NCT00471081|1820581|FG000|Extended Safety Follow-Up|Lost to Follow-up|1
861241|NCT00471081|1820582|FG001|Extended Safety Follow-Up|Lost to Follow-up|8
861242|NCT00471081|1820581|FG000|Extended Safety Follow-Up|Missing confirmed|0
861243|NCT00471081|1820582|FG001|Extended Safety Follow-Up|Missing confirmed|1
861244|NCT00471107|1820592|FG000|Overall Study|Technical problems/data loss|3
861245|NCT00471107|1820593|FG001|Overall Study|Technical problems/data loss|1
861246|NCT00471107|1820594|FG002|Overall Study|Technical problems/data loss|3
861247|NCT00471146|1820604|FG000|Overall Study|Adverse Event|32
861248|NCT00471146|1820605|FG001|Overall Study|Adverse Event|33
861249|NCT00471146|1820604|FG000|Overall Study|Withdrawal by Subject|14
861250|NCT00471146|1820605|FG001|Overall Study|Withdrawal by Subject|11
861251|NCT00471146|1820604|FG000|Overall Study|Death|11
861252|NCT00471146|1820605|FG001|Overall Study|Death|12
861253|NCT00471146|1820604|FG000|Overall Study|Lost to Follow-up|4
861254|NCT00471146|1820605|FG001|Overall Study|Lost to Follow-up|2
861255|NCT00471146|1820604|FG000|Overall Study|Protocol Violation|2
861256|NCT00471146|1820605|FG001|Overall Study|Protocol Violation|2
861257|NCT00471146|1820604|FG000|Overall Study|Objective progression or relapse|84
861258|NCT00471146|1820605|FG001|Overall Study|Objective progression or relapse|87
861259|NCT00471146|1820604|FG000|Overall Study|Global deterioration of health status|12
861260|NCT00471146|1820605|FG001|Overall Study|Global deterioration of health status|14
861261|NCT00471146|1820604|FG000|Overall Study|Randomized but not treated|9
861262|NCT00471146|1820605|FG001|Overall Study|Randomized but not treated|8
861263|NCT00471146|1820604|FG000|Overall Study|Other|4
861264|NCT00471146|1820605|FG001|Overall Study|Other|5
861265|NCT00471237|1820618|FG000|Overall Study|Adverse Event|6
861266|NCT00471237|1820619|FG001|Overall Study|Adverse Event|5
861267|NCT00471237|1820620|FG002|Overall Study|Adverse Event|4
861268|NCT00471237|1820621|FG003|Overall Study|Adverse Event|8
861269|NCT00471237|1820622|FG004|Overall Study|Adverse Event|7
861270|NCT00471237|1820623|FG005|Overall Study|Adverse Event|5
861271|NCT00471237|1820624|FG006|Overall Study|Adverse Event|0
861272|NCT00471237|1820618|FG000|Overall Study|Lost to Follow-up|1
861273|NCT00471237|1820619|FG001|Overall Study|Lost to Follow-up|1
861274|NCT00471237|1820620|FG002|Overall Study|Lost to Follow-up|0
861275|NCT00471237|1820621|FG003|Overall Study|Lost to Follow-up|2
861276|NCT00471237|1820622|FG004|Overall Study|Lost to Follow-up|3
861277|NCT00471237|1820623|FG005|Overall Study|Lost to Follow-up|0
861278|NCT00471237|1820624|FG006|Overall Study|Lost to Follow-up|0
861279|NCT00471237|1820618|FG000|Overall Study|Protocol Violation|3
861280|NCT00471237|1820619|FG001|Overall Study|Protocol Violation|6
861281|NCT00471237|1820620|FG002|Overall Study|Protocol Violation|3
861282|NCT00471237|1820621|FG003|Overall Study|Protocol Violation|2
861283|NCT00471237|1820622|FG004|Overall Study|Protocol Violation|2
861284|NCT00471237|1820623|FG005|Overall Study|Protocol Violation|4
861285|NCT00471237|1820624|FG006|Overall Study|Protocol Violation|1
861286|NCT00471237|1820618|FG000|Overall Study|Withdrawal by Subject|8
861287|NCT00471237|1820619|FG001|Overall Study|Withdrawal by Subject|6
861288|NCT00471237|1820620|FG002|Overall Study|Withdrawal by Subject|5
861289|NCT00471237|1820621|FG003|Overall Study|Withdrawal by Subject|8
861290|NCT00471237|1820622|FG004|Overall Study|Withdrawal by Subject|7
861291|NCT00471237|1820623|FG005|Overall Study|Withdrawal by Subject|4
861292|NCT00471237|1820624|FG006|Overall Study|Withdrawal by Subject|2
861293|NCT00471237|1820618|FG000|Overall Study|Sponsor terminated study|20
861294|NCT00471237|1820619|FG001|Overall Study|Sponsor terminated study|23
861295|NCT00471237|1820620|FG002|Overall Study|Sponsor terminated study|19
861296|NCT00471237|1820621|FG003|Overall Study|Sponsor terminated study|22
861297|NCT00471237|1820622|FG004|Overall Study|Sponsor terminated study|18
861298|NCT00471237|1820623|FG005|Overall Study|Sponsor terminated study|24
861299|NCT00471237|1820624|FG006|Overall Study|Sponsor terminated study|0
861300|NCT00471237|1820618|FG000|Overall Study|Non-compliance|0
861301|NCT00471237|1820619|FG001|Overall Study|Non-compliance|1
861302|NCT00471237|1820620|FG002|Overall Study|Non-compliance|0
861303|NCT00471237|1820621|FG003|Overall Study|Non-compliance|1
861304|NCT00471237|1820622|FG004|Overall Study|Non-compliance|0
861305|NCT00471237|1820623|FG005|Overall Study|Non-compliance|0
861306|NCT00471237|1820624|FG006|Overall Study|Non-compliance|0
861307|NCT00471237|1820618|FG000|Overall Study|Met serum creatinine withdrawal criteria|1
861308|NCT00471237|1820619|FG001|Overall Study|Met serum creatinine withdrawal criteria|0
861309|NCT00471237|1820620|FG002|Overall Study|Met serum creatinine withdrawal criteria|2
861310|NCT00471237|1820621|FG003|Overall Study|Met serum creatinine withdrawal criteria|2
861311|NCT00471237|1820622|FG004|Overall Study|Met serum creatinine withdrawal criteria|0
861312|NCT00471237|1820623|FG005|Overall Study|Met serum creatinine withdrawal criteria|0
861313|NCT00471237|1820624|FG006|Overall Study|Met serum creatinine withdrawal criteria|0
861314|NCT00471237|1820618|FG000|Overall Study|Early stopping due to non-efficacy|1
861315|NCT00471237|1820619|FG001|Overall Study|Early stopping due to non-efficacy|0
861316|NCT00471237|1820620|FG002|Overall Study|Early stopping due to non-efficacy|0
861317|NCT00471237|1820621|FG003|Overall Study|Early stopping due to non-efficacy|0
861318|NCT00471237|1820622|FG004|Overall Study|Early stopping due to non-efficacy|1
861319|NCT00471237|1820623|FG005|Overall Study|Early stopping due to non-efficacy|0
861320|NCT00471237|1820624|FG006|Overall Study|Early stopping due to non-efficacy|0
861321|NCT00471237|1820618|FG000|Overall Study|Participant planned to travel to abraod|1
861322|NCT00471237|1820619|FG001|Overall Study|Participant planned to travel to abraod|0
861323|NCT00471237|1820620|FG002|Overall Study|Participant planned to travel to abraod|0
861324|NCT00471237|1820621|FG003|Overall Study|Participant planned to travel to abraod|0
861325|NCT00471237|1820622|FG004|Overall Study|Participant planned to travel to abraod|0
861326|NCT00471237|1820623|FG005|Overall Study|Participant planned to travel to abraod|1
861327|NCT00471237|1820624|FG006|Overall Study|Participant planned to travel to abraod|0
861328|NCT00471237|1820618|FG000|Overall Study|High parathyroid hormone|0
861329|NCT00471237|1820619|FG001|Overall Study|High parathyroid hormone|0
861330|NCT00471237|1820620|FG002|Overall Study|High parathyroid hormone|1
861331|NCT00471237|1820621|FG003|Overall Study|High parathyroid hormone|0
861332|NCT00471237|1820622|FG004|Overall Study|High parathyroid hormone|0
861333|NCT00471237|1820623|FG005|Overall Study|High parathyroid hormone|0
861334|NCT00471237|1820624|FG006|Overall Study|High parathyroid hormone|0
861335|NCT00471237|1820618|FG000|Overall Study|Participant lost medication|0
861336|NCT00471237|1820619|FG001|Overall Study|Participant lost medication|0
861337|NCT00471237|1820620|FG002|Overall Study|Participant lost medication|0
861338|NCT00471237|1820621|FG003|Overall Study|Participant lost medication|0
861339|NCT00471237|1820622|FG004|Overall Study|Participant lost medication|1
861340|NCT00471237|1820623|FG005|Overall Study|Participant lost medication|0
861341|NCT00471237|1820624|FG006|Overall Study|Participant lost medication|0
861342|NCT00471237|1820618|FG000|Overall Study|Administration of prohibited medicine|0
861343|NCT00471237|1820619|FG001|Overall Study|Administration of prohibited medicine|0
861344|NCT00471237|1820620|FG002|Overall Study|Administration of prohibited medicine|0
861345|NCT00471237|1820621|FG003|Overall Study|Administration of prohibited medicine|0
861346|NCT00471237|1820622|FG004|Overall Study|Administration of prohibited medicine|1
861347|NCT00471237|1820623|FG005|Overall Study|Administration of prohibited medicine|0
861348|NCT00471237|1820624|FG006|Overall Study|Administration of prohibited medicine|0
861349|NCT00471237|1820618|FG000|Overall Study|Participant shifted residence|0
861350|NCT00471237|1820619|FG001|Overall Study|Participant shifted residence|0
861351|NCT00471237|1820620|FG002|Overall Study|Participant shifted residence|0
861352|NCT00471237|1820621|FG003|Overall Study|Participant shifted residence|0
861353|NCT00471237|1820622|FG004|Overall Study|Participant shifted residence|1
861354|NCT00471237|1820623|FG005|Overall Study|Participant shifted residence|0
861355|NCT00471237|1820624|FG006|Overall Study|Participant shifted residence|0
861356|NCT00471237|1820618|FG000|Overall Study|Participant's decision|0
861357|NCT00471237|1820619|FG001|Overall Study|Participant's decision|0
861358|NCT00471237|1820620|FG002|Overall Study|Participant's decision|0
861359|NCT00471237|1820621|FG003|Overall Study|Participant's decision|0
861360|NCT00471237|1820622|FG004|Overall Study|Participant's decision|0
861361|NCT00471237|1820623|FG005|Overall Study|Participant's decision|1
861362|NCT00471237|1820624|FG006|Overall Study|Participant's decision|0
861363|NCT00471276|1820644|FG000|Overall Study|Death|2
861364|NCT00471276|1820644|FG000|Overall Study|Adverse Event|16
861365|NCT00471276|1820644|FG000|Overall Study|Protocol Violation|1
861366|NCT00471276|1820644|FG000|Overall Study|Objective progression or relapse|54
861367|NCT00471276|1820644|FG000|Overall Study|Global deterioration of health status|1
861368|NCT00471276|1820644|FG000|Overall Study|Other|3
861369|NCT00471276|1820644|FG000|Overall Study|Refused treatment|6
861370|NCT00471315|1820648|FG000|Overall Study|Adverse Event|7
861371|NCT00471315|1820648|FG000|Overall Study|Withdrawal by Subject|1
861372|NCT00471328|1820654|FG000|Core Phase|Adverse Event|18
861373|NCT00471328|1820655|FG001|Core Phase|Adverse Event|6
861374|NCT00471328|1820654|FG000|Core Phase|Death|8
861375|NCT00471328|1820655|FG001|Core Phase|Death|4
861376|NCT00471328|1820654|FG000|Core Phase|Withdrawal by Subject|2
861377|NCT00471328|1820655|FG001|Core Phase|Withdrawal by Subject|2
861378|NCT00471328|1820654|FG000|Core Phase|Abnormal laboratory value|1
861379|NCT00471328|1820655|FG001|Core Phase|Abnormal laboratory value|0
861380|NCT00471328|1820654|FG000|Core Phase|Disease Progression|78
861381|NCT00471328|1820655|FG001|Core Phase|Disease Progression|53
861382|NCT00471328|1820654|FG000|Core Phase|Administrative Problem|0
861383|NCT00471328|1820655|FG001|Core Phase|Administrative Problem|1
861384|NCT00471328|1820654|FG000|Core Phase|Protocol Deviation|0
861385|NCT00471328|1820655|FG001|Core Phase|Protocol Deviation|1
861386|NCT00471328|1820654|FG000|Extension Phase|Adverse Event|3
861387|NCT00471328|1820655|FG001|Extension Phase|Adverse Event|12
861388|NCT00471328|1820654|FG000|Extension Phase|Withdrawal by Subject|0
861389|NCT00471328|1820655|FG001|Extension Phase|Withdrawal by Subject|2
861390|NCT00471328|1820654|FG000|Extension Phase|Death|1
861391|NCT00471328|1820655|FG001|Extension Phase|Death|7
861392|NCT00471328|1820654|FG000|Extension Phase|Protocol Deviation|3
861393|NCT00471328|1820655|FG001|Extension Phase|Protocol Deviation|1
861394|NCT00471328|1820654|FG000|Extension Phase|Treatment duration as per protocol|0
861395|NCT00471328|1820655|FG001|Extension Phase|Treatment duration as per protocol|1
861396|NCT00471328|1820654|FG000|Extension Phase|Disease Progression|32
861397|NCT00471328|1820655|FG001|Extension Phase|Disease Progression|44
861398|NCT00471328|1820654|FG000|Extension Phase|New cancer Therapy|1
861399|NCT00471328|1820655|FG001|Extension Phase|New cancer Therapy|0
861400|NCT00471328|1820654|FG000|Extension Phase|Administrative Problem|1
861401|NCT00471328|1820655|FG001|Extension Phase|Administrative Problem|0
861402|NCT00471354|1820663|FG000|Overall Study|Protocol Entry Criteria Not Met|1
861403|NCT00471354|1820663|FG000|Overall Study|Adverse Event|13
861404|NCT00471354|1820663|FG000|Overall Study|Protocol Violation|12
861405|NCT00471354|1820663|FG000|Overall Study|Withdrawal by Subject|1
861406|NCT00471354|1820663|FG000|Overall Study|Physician Decision|4
861407|NCT00471354|1820663|FG000|Overall Study|Sponsor Decision|1
861408|NCT00471354|1820663|FG000|Overall Study|Lost to Follow-up|3
861409|NCT00471354|1820663|FG000|Overall Study|Lack of Efficacy|5
861410|NCT00471354|1820663|FG000|Overall Study|Patient/Caregiver Decision|12
861411|NCT00471445|1820676|FG000|Overall Study|Withdrawal by Subject|1
861412|NCT00471445|1820677|FG001|Overall Study|Withdrawal by Subject|1
861413|NCT00471445|1820676|FG000|Overall Study|Ineligible|1
861414|NCT00471445|1820677|FG001|Overall Study|Ineligible|0
861415|NCT00471445|1820676|FG000|Overall Study|Protocol Violation|0
861416|NCT00471445|1820677|FG001|Overall Study|Protocol Violation|1
861417|NCT00471497|1820686|FG000|Core Treatment Phase|Abnormal Laboratory Values|3
861418|NCT00471497|1820687|FG001|Core Treatment Phase|Abnormal Laboratory Values|9
861419|NCT00471497|1820688|FG002|Core Treatment Phase|Abnormal Laboratory Values|9
861420|NCT00471497|1820686|FG000|Core Treatment Phase|Abnormal Test Procedures|1
861421|NCT00471497|1820687|FG001|Core Treatment Phase|Abnormal Test Procedures|0
861422|NCT00471497|1820688|FG002|Core Treatment Phase|Abnormal Test Procedures|1
861423|NCT00471497|1820686|FG000|Core Treatment Phase|Condition no longer requires study drug|0
861424|NCT00471497|1820687|FG001|Core Treatment Phase|Condition no longer requires study drug|1
861425|NCT00471497|1820688|FG002|Core Treatment Phase|Condition no longer requires study drug|0
861426|NCT00471497|1820686|FG000|Core Treatment Phase|Withdrawal by Subject|31
861427|NCT00471497|1820687|FG001|Core Treatment Phase|Withdrawal by Subject|29
861428|NCT00471497|1820688|FG002|Core Treatment Phase|Withdrawal by Subject|34
861429|NCT00471497|1820686|FG000|Core Treatment Phase|Lost to Follow-up|6
861430|NCT00471497|1820687|FG001|Core Treatment Phase|Lost to Follow-up|6
861431|NCT00471497|1820688|FG002|Core Treatment Phase|Lost to Follow-up|3
861432|NCT00471497|1820686|FG000|Core Treatment Phase|Death|3
861433|NCT00471497|1820687|FG001|Core Treatment Phase|Death|9
861434|NCT00471497|1820688|FG002|Core Treatment Phase|Death|3
861435|NCT00471497|1820686|FG000|Core Treatment Phase|Disease Progression|10
861436|NCT00471497|1820687|FG001|Core Treatment Phase|Disease Progression|2
861437|NCT00471497|1820688|FG002|Core Treatment Phase|Disease Progression|4
861438|NCT00471497|1820686|FG000|Core Treatment Phase|Protocol Violation|6
861439|NCT00471497|1820687|FG001|Core Treatment Phase|Protocol Violation|15
861440|NCT00471497|1820688|FG002|Core Treatment Phase|Protocol Violation|11
861441|NCT00471497|1820686|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19
861442|NCT00471497|1820687|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11
861443|NCT00471497|1820688|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13
861444|NCT00471497|1820686|FG000|Core Treatment Phase|Administrative problems|14
861445|NCT00471497|1820687|FG001|Core Treatment Phase|Administrative problems|14
861446|NCT00471497|1820688|FG002|Core Treatment Phase|Administrative problems|12
861447|NCT00471497|1820686|FG000|Core Treatment Phase|Adverse Event|43
861448|NCT00471497|1820687|FG001|Core Treatment Phase|Adverse Event|53
861449|NCT00471497|1820688|FG002|Core Treatment Phase|Adverse Event|89
861450|NCT00471497|1820686|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2
861451|NCT00471497|1820687|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
861452|NCT00471497|1820688|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
861453|NCT00471497|1820686|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46
861454|NCT00471497|1820687|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26
861455|NCT00471497|1820688|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3
861456|NCT00471497|1820686|FG000|Extension Phase|Adverse Event|9
861457|NCT00471497|1820687|FG001|Extension Phase|Adverse Event|5
861458|NCT00471497|1820688|FG002|Extension Phase|Adverse Event|1
861459|NCT00471497|1820686|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
861460|NCT00471497|1820687|FG001|Extension Phase|Unsatisfactory therapeutic effect|6
861461|NCT00471497|1820688|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
861462|NCT00471497|1820686|FG000|Extension Phase|Withdrawal by Subject|3
861463|NCT00471497|1820687|FG001|Extension Phase|Withdrawal by Subject|1
861464|NCT00471497|1820688|FG002|Extension Phase|Withdrawal by Subject|0
861465|NCT00471497|1820686|FG000|Extension Phase|Lost to Follow-up|2
861466|NCT00471497|1820687|FG001|Extension Phase|Lost to Follow-up|0
861467|NCT00471497|1820688|FG002|Extension Phase|Lost to Follow-up|0
861468|NCT00471497|1820686|FG000|Extension Phase|Death|1
861469|NCT00471497|1820687|FG001|Extension Phase|Death|0
861470|NCT00471497|1820688|FG002|Extension Phase|Death|0
861471|NCT00471497|1820686|FG000|Extension Phase|Disease progression|2
861472|NCT00471497|1820687|FG001|Extension Phase|Disease progression|0
861473|NCT00471497|1820688|FG002|Extension Phase|Disease progression|0
861474|NCT00471497|1820686|FG000|Extension Phase|Protocol Violation|2
861475|NCT00471497|1820687|FG001|Extension Phase|Protocol Violation|2
861476|NCT00471497|1820688|FG002|Extension Phase|Protocol Violation|0
861477|NCT00471536|1820699|FG000|Overall Study|Withdrawal by Subject|1
861478|NCT00471718|1820716|FG000|Overall Study|Adverse Event|3
861479|NCT00471718|1820716|FG000|Overall Study|other complicating disease|1
861480|NCT00471718|1820716|FG000|Overall Study|disease progression|22
861481|NCT00471718|1820716|FG000|Overall Study|Withdrawal by Subject|1
861482|NCT00471822|1820724|FG000|Overall Study|Protocol Violation|2
861483|NCT00471887|1820732|FG000|Overall Study|Adverse Event|9
861484|NCT00472030|1820738|FG000|Overall Study|Physician Decision|1
861485|NCT00472030|1820739|FG001|Overall Study|Physician Decision|0
861486|NCT00472199|1820766|FG000|Overall Study|Adverse Event|19
861487|NCT00472199|1820767|FG001|Overall Study|Adverse Event|23
861488|NCT00472199|1820766|FG000|Overall Study|Lack of Efficacy|4
861489|NCT00472199|1820767|FG001|Overall Study|Lack of Efficacy|25
861490|NCT00472199|1820766|FG000|Overall Study|Lost to Follow-up|2
861491|NCT00472199|1820767|FG001|Overall Study|Lost to Follow-up|4
861492|NCT00472199|1820766|FG000|Overall Study|Protocol Violation|3
861493|NCT00472199|1820767|FG001|Overall Study|Protocol Violation|2
861494|NCT00472199|1820766|FG000|Overall Study|Withdrawal by Subject|6
861495|NCT00472199|1820767|FG001|Overall Study|Withdrawal by Subject|5
861496|NCT00472199|1820766|FG000|Overall Study|personal reason|0
861497|NCT00472199|1820767|FG001|Overall Study|personal reason|1
861498|NCT00472199|1820766|FG000|Overall Study|patient was asymptomatic|1
861499|NCT00472199|1820767|FG001|Overall Study|patient was asymptomatic|0
861500|NCT00472290|1820773|FG000|Overall Study|Progression of Therapy-Related MDS|1
861501|NCT00472290|1820773|FG000|Overall Study|Protocol Specified Criteria|7
861502|NCT00472290|1820773|FG000|Overall Study|Administrative Decision|37
861503|NCT00472290|1820773|FG000|Overall Study|Death|3
861504|NCT00472290|1820773|FG000|Overall Study|Lost to Follow-up|1
861505|NCT00472290|1820773|FG000|Overall Study|Lack of Efficacy|1
861506|NCT00472290|1820773|FG000|Overall Study|Disease Progression|4
861507|NCT00472290|1820773|FG000|Overall Study|Withdrawal by Subject|5
861508|NCT00472290|1820773|FG000|Overall Study|Adverse Event|6
861509|NCT00472290|1820773|FG000|Overall Study|Requirement for alternative therapy|7
861510|NCT00472303|1820779|FG000|Titration Phase|Adverse Event|22
861511|NCT00472303|1820780|FG001|Titration Phase|Adverse Event|12
861512|NCT00472303|1820781|FG002|Titration Phase|Adverse Event|0
861513|NCT00472303|1820779|FG000|Titration Phase|Death|4
861514|NCT00472303|1820780|FG001|Titration Phase|Death|2
861515|NCT00472303|1820781|FG002|Titration Phase|Death|0
861516|NCT00472303|1820779|FG000|Titration Phase|Lack of Efficacy|10
861517|NCT00472303|1820780|FG001|Titration Phase|Lack of Efficacy|0
861518|NCT00472303|1820781|FG002|Titration Phase|Lack of Efficacy|0
861519|NCT00472303|1820779|FG000|Titration Phase|Withdrawal by Subject|16
861520|NCT00472303|1820780|FG001|Titration Phase|Withdrawal by Subject|13
861521|NCT00472303|1820781|FG002|Titration Phase|Withdrawal by Subject|0
861522|NCT00472303|1820779|FG000|Titration Phase|Trial Medication non-compliant|4
861523|NCT00472303|1820780|FG001|Titration Phase|Trial Medication non-compliant|1
861524|NCT00472303|1820781|FG002|Titration Phase|Trial Medication non-compliant|0
861525|NCT00472303|1820779|FG000|Titration Phase|Other|3
861526|NCT00472303|1820780|FG001|Titration Phase|Other|1
861527|NCT00472303|1820781|FG002|Titration Phase|Other|0
861528|NCT00472303|1820779|FG000|Discontinuations After Titration Phase|Adverse Event|6
861529|NCT00472303|1820780|FG001|Discontinuations After Titration Phase|Adverse Event|0
861530|NCT00472303|1820781|FG002|Discontinuations After Titration Phase|Adverse Event|0
861531|NCT00472303|1820779|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48
861532|NCT00472303|1820780|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17
861533|NCT00472303|1820781|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0
861534|NCT00472303|1820779|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2
861535|NCT00472303|1820780|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2
861536|NCT00472303|1820781|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0
861537|NCT00472303|1820779|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0
861538|NCT00472303|1820780|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1
861539|NCT00472303|1820781|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0
861540|NCT00472303|1820779|FG000|Discontinuations After Titration Phase|Other|5
861541|NCT00472303|1820780|FG001|Discontinuations After Titration Phase|Other|0
861542|NCT00472303|1820781|FG002|Discontinuations After Titration Phase|Other|0
861543|NCT00472303|1820779|FG000|Maintenance Phase|Adverse Event|5
861544|NCT00472303|1820780|FG001|Maintenance Phase|Adverse Event|6
861545|NCT00472303|1820781|FG002|Maintenance Phase|Adverse Event|6
861546|NCT00472303|1820779|FG000|Maintenance Phase|Death|3
861547|NCT00472303|1820780|FG001|Maintenance Phase|Death|0
861548|NCT00472303|1820781|FG002|Maintenance Phase|Death|2
861549|NCT00472303|1820779|FG000|Maintenance Phase|Lack of Efficacy|2
861550|NCT00472303|1820780|FG001|Maintenance Phase|Lack of Efficacy|2
861551|NCT00472303|1820781|FG002|Maintenance Phase|Lack of Efficacy|4
861552|NCT00472303|1820779|FG000|Maintenance Phase|Withdrawal by Subject|6
861553|NCT00472303|1820780|FG001|Maintenance Phase|Withdrawal by Subject|7
861554|NCT00472303|1820781|FG002|Maintenance Phase|Withdrawal by Subject|3
861555|NCT00472303|1820779|FG000|Maintenance Phase|Trial medication non-compliant|0
861556|NCT00472303|1820780|FG001|Maintenance Phase|Trial medication non-compliant|0
861557|NCT00472303|1820781|FG002|Maintenance Phase|Trial medication non-compliant|1
861558|NCT00472303|1820779|FG000|Maintenance Phase|Resolution of pain|0
861559|NCT00472303|1820780|FG001|Maintenance Phase|Resolution of pain|0
861560|NCT00472303|1820781|FG002|Maintenance Phase|Resolution of pain|1
861561|NCT00472303|1820779|FG000|Maintenance Phase|Other|1
861562|NCT00472303|1820780|FG001|Maintenance Phase|Other|1
861563|NCT00472303|1820781|FG002|Maintenance Phase|Other|0
861564|NCT00472420|1820809|FG000|Induction Treatment Period|Physician Decision|9
861565|NCT00472420|1820809|FG000|Induction Treatment Period|Adverse Event|3
861566|NCT00472420|1820809|FG000|Induction Treatment Period|Non-compliance|1
861567|NCT00472420|1820809|FG000|Induction Treatment Period|Death|3
861568|NCT00472420|1820809|FG000|Follow-up Period|Death|5
861569|NCT00472420|1820809|FG000|Follow-up Period|Physician Decision|9
861570|NCT00472420|1820809|FG000|Follow-up Period|Lost to Follow-up|2
861571|NCT00472420|1820809|FG000|Follow-up Period|Protocol Violation|1
861572|NCT00472446|1820817|FG000|Overall Study|Protocol Violation|0
861573|NCT00472446|1820818|FG001|Overall Study|Protocol Violation|0
861574|NCT00472446|1820819|FG002|Overall Study|Protocol Violation|0
861575|NCT00472446|1820820|FG003|Overall Study|Protocol Violation|1
861576|NCT00472446|1820817|FG000|Overall Study|Reintervention|0
861577|NCT00472446|1820818|FG001|Overall Study|Reintervention|0
861578|NCT00472446|1820819|FG002|Overall Study|Reintervention|1
861579|NCT00472446|1820820|FG003|Overall Study|Reintervention|1
861580|NCT00472446|1820817|FG000|Overall Study|Questionnaires not returned|5
861581|NCT00472446|1820818|FG001|Overall Study|Questionnaires not returned|6
861582|NCT00472446|1820819|FG002|Overall Study|Questionnaires not returned|6
861583|NCT00472446|1820820|FG003|Overall Study|Questionnaires not returned|4
861584|NCT00472641|1820839|FG000|Overall Study|Lack of Efficacy|3
861585|NCT00472641|1820839|FG000|Overall Study|Adverse Event|3
861586|NCT00472641|1820839|FG000|Overall Study|Lost to Follow-up|1
861587|NCT00473083|1820876|FG000|Overall Study|Adverse Event|1
861588|NCT00473083|1820877|FG001|Overall Study|Adverse Event|0
861589|NCT00473083|1820878|FG002|Overall Study|Adverse Event|0
861590|NCT00473265|1820889|FG000|Overall Study|Unrelated adverse event|5
861591|NCT00473265|1820889|FG000|Overall Study|Off treatment early|15
861592|NCT00473330|1820896|FG000|Core Study|Adverse Event|4
861593|NCT00473330|1820897|FG001|Core Study|Adverse Event|4
861594|NCT00473330|1820898|FG002|Core Study|Adverse Event|1
861595|NCT00473330|1820896|FG000|Core Study|Death|6
861596|NCT00473330|1820897|FG001|Core Study|Death|4
861597|NCT00473330|1820898|FG002|Core Study|Death|4
861598|NCT00473330|1820896|FG000|Core Study|Lost to Follow-up|5
861599|NCT00473330|1820897|FG001|Core Study|Lost to Follow-up|5
861600|NCT00473330|1820898|FG002|Core Study|Lost to Follow-up|10
861601|NCT00473330|1820896|FG000|Core Study|Physician Decision|2
861602|NCT00473330|1820897|FG001|Core Study|Physician Decision|1
861603|NCT00473330|1820898|FG002|Core Study|Physician Decision|3
861604|NCT00473330|1820896|FG000|Core Study|Subject Non-compliance|1
861605|NCT00473330|1820897|FG001|Core Study|Subject Non-compliance|2
861606|NCT00473330|1820898|FG002|Core Study|Subject Non-compliance|1
861607|NCT00473330|1820896|FG000|Core Study|Subject Required Other Therapy|0
861608|NCT00473330|1820897|FG001|Core Study|Subject Required Other Therapy|1
861609|NCT00473330|1820898|FG002|Core Study|Subject Required Other Therapy|3
861610|NCT00473330|1820896|FG000|Core Study|Subject's Decision|9
861611|NCT00473330|1820897|FG001|Core Study|Subject's Decision|8
861612|NCT00473330|1820898|FG002|Core Study|Subject's Decision|19
861613|NCT00473330|1820896|FG000|Open-label Extension Through Month 48|Adverse Event|0
861614|NCT00473330|1820897|FG001|Open-label Extension Through Month 48|Adverse Event|0
861615|NCT00473330|1820898|FG002|Open-label Extension Through Month 48|Adverse Event|2
861616|NCT00473330|1820896|FG000|Open-label Extension Through Month 48|Death|2
861617|NCT00473330|1820897|FG001|Open-label Extension Through Month 48|Death|0
861618|NCT00473330|1820898|FG002|Open-label Extension Through Month 48|Death|0
861619|NCT00473330|1820896|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
861620|NCT00473330|1820897|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0
861621|NCT00473330|1820898|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2
861622|NCT00473330|1820896|FG000|Open-label Extension Through Month 48|Physician's Decision|2
861623|NCT00473330|1820897|FG001|Open-label Extension Through Month 48|Physician's Decision|1
861624|NCT00473330|1820898|FG002|Open-label Extension Through Month 48|Physician's Decision|3
861625|NCT00473330|1820896|FG000|Open-label Extension Through Month 48|Subject's Decision|1
861626|NCT00473330|1820897|FG001|Open-label Extension Through Month 48|Subject's Decision|3
861627|NCT00473330|1820898|FG002|Open-label Extension Through Month 48|Subject's Decision|3
861628|NCT00473330|1820896|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18
861629|NCT00473330|1820897|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15
861630|NCT00473330|1820898|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16
861631|NCT00473330|1820896|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2
861632|NCT00473330|1820897|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1
861633|NCT00473330|1820898|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0
861634|NCT00473330|1820896|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0
861635|NCT00473330|1820897|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0
861636|NCT00473330|1820898|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1
861637|NCT00473330|1820896|FG000|Open-label Extension Through Month 60|Adverse Event|0
861638|NCT00473330|1820897|FG001|Open-label Extension Through Month 60|Adverse Event|0
861639|NCT00473330|1820898|FG002|Open-label Extension Through Month 60|Adverse Event|2
861640|NCT00473330|1820896|FG000|Open-label Extension Through Month 60|Death|2
861641|NCT00473330|1820897|FG001|Open-label Extension Through Month 60|Death|2
861642|NCT00473330|1820898|FG002|Open-label Extension Through Month 60|Death|1
861643|NCT00473330|1820896|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3
861644|NCT00473330|1820897|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0
861645|NCT00473330|1820898|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4
861646|NCT00473330|1820896|FG000|Open-label Extension Through Month 60|Physician's Decision|2
861647|NCT00473330|1820897|FG001|Open-label Extension Through Month 60|Physician's Decision|1
861648|NCT00473330|1820898|FG002|Open-label Extension Through Month 60|Physician's Decision|3
861649|NCT00473330|1820896|FG000|Open-label Extension Through Month 60|Subject's Decision|1
861650|NCT00473330|1820897|FG001|Open-label Extension Through Month 60|Subject's Decision|3
861651|NCT00473330|1820898|FG002|Open-label Extension Through Month 60|Subject's Decision|4
861652|NCT00473330|1820896|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77
861653|NCT00473330|1820897|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71
861654|NCT00473330|1820898|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62
861655|NCT00473330|1820896|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2
861656|NCT00473330|1820897|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1
861657|NCT00473330|1820898|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0
861658|NCT00473330|1820896|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1
861659|NCT00473330|1820897|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0
861660|NCT00473330|1820898|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1
861661|NCT00473382|1820929|FG000|Core Study|Adverse Event|3
861662|NCT00473382|1820930|FG001|Core Study|Adverse Event|1
861663|NCT00473382|1820931|FG002|Core Study|Adverse Event|1
861664|NCT00473382|1820929|FG000|Core Study|Death|3
861665|NCT00473382|1820930|FG001|Core Study|Death|5
861666|NCT00473382|1820931|FG002|Core Study|Death|10
861667|NCT00473382|1820929|FG000|Core Study|Lost to Follow-up|3
861668|NCT00473382|1820930|FG001|Core Study|Lost to Follow-up|3
861669|NCT00473382|1820931|FG002|Core Study|Lost to Follow-up|3
861670|NCT00473382|1820929|FG000|Core Study|Physician Decision|1
861671|NCT00473382|1820930|FG001|Core Study|Physician Decision|2
861672|NCT00473382|1820931|FG002|Core Study|Physician Decision|2
861673|NCT00473382|1820929|FG000|Core Study|Subject non-compliance|5
861674|NCT00473382|1820930|FG001|Core Study|Subject non-compliance|2
861675|NCT00473382|1820931|FG002|Core Study|Subject non-compliance|1
861676|NCT00473382|1820929|FG000|Core Study|Subject needed other treatment|1
861677|NCT00473382|1820930|FG001|Core Study|Subject needed other treatment|3
861678|NCT00473382|1820931|FG002|Core Study|Subject needed other treatment|2
861679|NCT00473382|1820929|FG000|Core Study|Subject's decision|12
861680|NCT00473382|1820930|FG001|Core Study|Subject's decision|11
861681|NCT00473382|1820931|FG002|Core Study|Subject's decision|10
861682|NCT00473382|1820929|FG000|Open-label Extension Through Month 48|Adverse Event|0
861683|NCT00473382|1820930|FG001|Open-label Extension Through Month 48|Adverse Event|0
861684|NCT00473382|1820931|FG002|Open-label Extension Through Month 48|Adverse Event|1
861685|NCT00473382|1820929|FG000|Open-label Extension Through Month 48|Death|1
861686|NCT00473382|1820930|FG001|Open-label Extension Through Month 48|Death|3
861687|NCT00473382|1820931|FG002|Open-label Extension Through Month 48|Death|3
861688|NCT00473382|1820929|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
861689|NCT00473382|1820930|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2
861690|NCT00473382|1820931|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1
861691|NCT00473382|1820929|FG000|Open-label Extension Through Month 48|Subject's Decision|5
861692|NCT00473382|1820930|FG001|Open-label Extension Through Month 48|Subject's Decision|1
861693|NCT00473382|1820931|FG002|Open-label Extension Through Month 48|Subject's Decision|6
861694|NCT00473382|1820929|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41
861695|NCT00473382|1820930|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34
861696|NCT00473382|1820931|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36
861697|NCT00473382|1820929|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2
861698|NCT00473382|1820930|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1
861699|NCT00473382|1820931|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0
861700|NCT00473382|1820929|FG000|Open-label Extension Through Month 60|Adverse Event|0
861701|NCT00473382|1820930|FG001|Open-label Extension Through Month 60|Adverse Event|0
861702|NCT00473382|1820931|FG002|Open-label Extension Through Month 60|Adverse Event|2
861703|NCT00473382|1820929|FG000|Open-label Extension Through Month 60|Death|1
861704|NCT00473382|1820930|FG001|Open-label Extension Through Month 60|Death|7
861705|NCT00473382|1820931|FG002|Open-label Extension Through Month 60|Death|4
861706|NCT00473382|1820929|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1
861707|NCT00473382|1820930|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3
861708|NCT00473382|1820931|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1
861709|NCT00473382|1820929|FG000|Open-label Extension Through Month 60|Subject's Decision|7
861710|NCT00473382|1820930|FG001|Open-label Extension Through Month 60|Subject's Decision|1
861711|NCT00473382|1820931|FG002|Open-label Extension Through Month 60|Subject's Decision|6
861712|NCT00473382|1820929|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75
861713|NCT00473382|1820930|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70
861714|NCT00473382|1820931|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69
861715|NCT00473382|1820929|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2
861716|NCT00473382|1820930|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1
861717|NCT00473382|1820931|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0
861718|NCT00473434|1820957|FG000|Overall Study|Physician Decision|3
861719|NCT00473434|1820957|FG000|Overall Study|Withdrawal by Subject|9
861720|NCT00473434|1820957|FG000|Overall Study|Compliance|3
861721|NCT00473434|1820957|FG000|Overall Study|Lack of Efficacy|3
861722|NCT00473434|1820957|FG000|Overall Study|Adverse Event|3
861723|NCT00473434|1820957|FG000|Overall Study|Patient was selling medication to others|1
861724|NCT00473434|1820957|FG000|Overall Study|Safety evaluation|1
861725|NCT00473434|1820957|FG000|Overall Study|Reason not specified|6
861726|NCT00473434|1820957|FG000|Overall Study|Ceased in favor of Paliperidone|1
861727|NCT00473434|1820957|FG000|Overall Study|Switching to trial medication|1
861728|NCT00473434|1820957|FG000|Overall Study|No longer required|1
861729|NCT00473512|1820979|FG000|Period 1 (Phase 1)|Adverse Event|0
861730|NCT00473512|1820980|FG001|Period 1 (Phase 1)|Adverse Event|0
861731|NCT00473512|1820981|FG002|Period 1 (Phase 1)|Adverse Event|0
861732|NCT00473512|1820982|FG003|Period 1 (Phase 1)|Adverse Event|5
861733|NCT00473512|1820983|FG004|Period 1 (Phase 1)|Adverse Event|0
861734|NCT00473512|1820979|FG000|Period 1 (Phase 1)|Death|0
861735|NCT00473512|1820980|FG001|Period 1 (Phase 1)|Death|0
861736|NCT00473512|1820981|FG002|Period 1 (Phase 1)|Death|0
861737|NCT00473512|1820982|FG003|Period 1 (Phase 1)|Death|1
861738|NCT00473512|1820983|FG004|Period 1 (Phase 1)|Death|0
861739|NCT00473512|1820979|FG000|Period 1 (Phase 1)|Disease Progression|1
861740|NCT00473512|1820980|FG001|Period 1 (Phase 1)|Disease Progression|1
861741|NCT00473512|1820981|FG002|Period 1 (Phase 1)|Disease Progression|0
861742|NCT00473512|1820982|FG003|Period 1 (Phase 1)|Disease Progression|10
861743|NCT00473512|1820983|FG004|Period 1 (Phase 1)|Disease Progression|1
861744|NCT00473512|1820979|FG000|Period 1 (Phase 1)|Other|0
861745|NCT00473512|1820980|FG001|Period 1 (Phase 1)|Other|0
861746|NCT00473512|1820981|FG002|Period 1 (Phase 1)|Other|0
861747|NCT00473512|1820982|FG003|Period 1 (Phase 1)|Other|1
861748|NCT00473512|1820983|FG004|Period 1 (Phase 1)|Other|0
861749|NCT00473512|1820979|FG000|Period 2 (Phase 2)|Adverse Event|0
861750|NCT00473512|1820980|FG001|Period 2 (Phase 2)|Adverse Event|0
861751|NCT00473512|1820981|FG002|Period 2 (Phase 2)|Adverse Event|0
861752|NCT00473512|1820982|FG003|Period 2 (Phase 2)|Adverse Event|1
861753|NCT00473512|1820983|FG004|Period 2 (Phase 2)|Adverse Event|0
861754|NCT00473512|1820979|FG000|Period 2 (Phase 2)|Death|0
861755|NCT00473512|1820980|FG001|Period 2 (Phase 2)|Death|0
861756|NCT00473512|1820981|FG002|Period 2 (Phase 2)|Death|0
861757|NCT00473512|1820982|FG003|Period 2 (Phase 2)|Death|1
861758|NCT00473512|1820983|FG004|Period 2 (Phase 2)|Death|1
861759|NCT00473512|1820979|FG000|Period 2 (Phase 2)|Disease Progression|0
861760|NCT00473512|1820980|FG001|Period 2 (Phase 2)|Disease Progression|2
861761|NCT00473512|1820981|FG002|Period 2 (Phase 2)|Disease Progression|2
861762|NCT00473512|1820982|FG003|Period 2 (Phase 2)|Disease Progression|17
861763|NCT00473512|1820983|FG004|Period 2 (Phase 2)|Disease Progression|1
861764|NCT00473512|1820979|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0
861765|NCT00473512|1820980|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0
861766|NCT00473512|1820981|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0
861767|NCT00473512|1820982|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1
861768|NCT00473512|1820983|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0
861769|NCT00473512|1820979|FG000|Period 2 (Phase 2)|Other|1
861770|NCT00473512|1820980|FG001|Period 2 (Phase 2)|Other|0
861771|NCT00473512|1820981|FG002|Period 2 (Phase 2)|Other|0
861772|NCT00473512|1820982|FG003|Period 2 (Phase 2)|Other|3
861773|NCT00473512|1820983|FG004|Period 2 (Phase 2)|Other|0
861774|NCT00473564|1821003|FG000|Overall Study|robot surgery aborted in OR|23
861775|NCT00473590|1821009|FG000|Overall Study|Adverse Event|3
861776|NCT00473590|1821010|FG001|Overall Study|Adverse Event|3
861777|NCT00473590|1821009|FG000|Overall Study|Death|4
861778|NCT00473590|1821010|FG001|Overall Study|Death|2
861779|NCT00473590|1821009|FG000|Overall Study|Progression not resulting in death|24
861780|NCT00473590|1821010|FG001|Overall Study|Progression not resulting in death|20
861781|NCT00473590|1821009|FG000|Overall Study|Non-protocol-specified therapy|7
861782|NCT00473590|1821010|FG001|Overall Study|Non-protocol-specified therapy|5
861783|NCT00473590|1821009|FG000|Overall Study|Physician Decision|2
861784|NCT00473590|1821010|FG001|Overall Study|Physician Decision|4
861785|NCT00473590|1821009|FG000|Overall Study|Withdrawal by Subject|5
861786|NCT00473590|1821010|FG001|Overall Study|Withdrawal by Subject|3
861787|NCT00473590|1821009|FG000|Overall Study|Other|0
861788|NCT00473590|1821010|FG001|Overall Study|Other|1
861789|NCT00473655|1821035|FG000|Overall Study|Lost to Follow-up|9
861790|NCT00473655|1821036|FG001|Overall Study|Lost to Follow-up|5
861791|NCT00473655|1821037|FG002|Overall Study|Lost to Follow-up|8
861792|NCT00473668|1821048|FG000|Overall Study|Withdrawal by Subject|0
861793|NCT00473668|1821049|FG001|Overall Study|Withdrawal by Subject|2
861794|NCT00473668|1821050|FG002|Overall Study|Withdrawal by Subject|0
861795|NCT00473668|1821048|FG000|Overall Study|Migrated/moved from study area|3
861796|NCT00473668|1821049|FG001|Overall Study|Migrated/moved from study area|2
861797|NCT00473668|1821050|FG002|Overall Study|Migrated/moved from study area|0
861798|NCT00473668|1821048|FG000|Overall Study|Lost to Follow-up|0
861799|NCT00473668|1821049|FG001|Overall Study|Lost to Follow-up|4
861800|NCT00473668|1821050|FG002|Overall Study|Lost to Follow-up|6
861801|NCT00473668|1821048|FG000|Overall Study|Other|2
861802|NCT00473668|1821049|FG001|Overall Study|Other|3
861803|NCT00473668|1821050|FG002|Overall Study|Other|4
861804|NCT00473694|1821062|FG000|Overall Study|Adverse Event|0
861805|NCT00473694|1821063|FG001|Overall Study|Adverse Event|1
861806|NCT00473694|1821064|FG002|Overall Study|Adverse Event|0
861807|NCT00473694|1821065|FG003|Overall Study|Adverse Event|0
861808|NCT00473694|1821062|FG000|Overall Study|Participants did not receive treatment|11
861809|NCT00473694|1821063|FG001|Overall Study|Participants did not receive treatment|3
861810|NCT00473694|1821064|FG002|Overall Study|Participants did not receive treatment|5
861811|NCT00473694|1821065|FG003|Overall Study|Participants did not receive treatment|6
861812|NCT00473694|1821062|FG000|Overall Study|Lost to Follow-up|0
861813|NCT00473694|1821063|FG001|Overall Study|Lost to Follow-up|0
861814|NCT00473694|1821064|FG002|Overall Study|Lost to Follow-up|0
861815|NCT00473694|1821065|FG003|Overall Study|Lost to Follow-up|1
861816|NCT00473746|1821083|FG000|Period 1 (Phase 1)|Adverse Event|1
861817|NCT00473746|1821084|FG001|Period 1 (Phase 1)|Adverse Event|0
861818|NCT00473746|1821085|FG002|Period 1 (Phase 1)|Adverse Event|0
861819|NCT00473746|1821086|FG003|Period 1 (Phase 1)|Adverse Event|0
861820|NCT00473746|1821087|FG004|Period 1 (Phase 1)|Adverse Event|0
861821|NCT00473746|1821083|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0
861822|NCT00473746|1821084|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1
861823|NCT00473746|1821085|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0
861824|NCT00473746|1821086|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0
861825|NCT00473746|1821087|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0
861826|NCT00473746|1821083|FG000|Period 1 (Phase 1)|Progressive Disease|5
861827|NCT00473746|1821084|FG001|Period 1 (Phase 1)|Progressive Disease|6
861828|NCT00473746|1821085|FG002|Period 1 (Phase 1)|Progressive Disease|6
861829|NCT00473746|1821086|FG003|Period 1 (Phase 1)|Progressive Disease|10
861830|NCT00473746|1821087|FG004|Period 1 (Phase 1)|Progressive Disease|0
861831|NCT00473746|1821083|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0
861832|NCT00473746|1821084|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1
861833|NCT00473746|1821085|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0
861834|NCT00473746|1821086|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0
861835|NCT00473746|1821087|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0
861836|NCT00473746|1821083|FG000|Period 1 (Phase 1)|Reason not specified|0
861837|NCT00473746|1821084|FG001|Period 1 (Phase 1)|Reason not specified|1
861838|NCT00473746|1821085|FG002|Period 1 (Phase 1)|Reason not specified|0
861839|NCT00473746|1821086|FG003|Period 1 (Phase 1)|Reason not specified|0
861840|NCT00473746|1821087|FG004|Period 1 (Phase 1)|Reason not specified|0
861841|NCT00473746|1821083|FG000|Period 2 (Phase 2)|Adverse Event|0
861842|NCT00473746|1821084|FG001|Period 2 (Phase 2)|Adverse Event|0
861843|NCT00473746|1821085|FG002|Period 2 (Phase 2)|Adverse Event|0
861844|NCT00473746|1821086|FG003|Period 2 (Phase 2)|Adverse Event|0
861845|NCT00473746|1821087|FG004|Period 2 (Phase 2)|Adverse Event|3
861846|NCT00473746|1821083|FG000|Period 2 (Phase 2)|Death|0
861847|NCT00473746|1821084|FG001|Period 2 (Phase 2)|Death|0
861848|NCT00473746|1821085|FG002|Period 2 (Phase 2)|Death|0
861849|NCT00473746|1821086|FG003|Period 2 (Phase 2)|Death|0
861850|NCT00473746|1821087|FG004|Period 2 (Phase 2)|Death|1
861851|NCT00473746|1821083|FG000|Period 2 (Phase 2)|Progressive Disease|0
861852|NCT00473746|1821084|FG001|Period 2 (Phase 2)|Progressive Disease|0
861853|NCT00473746|1821085|FG002|Period 2 (Phase 2)|Progressive Disease|0
861854|NCT00473746|1821086|FG003|Period 2 (Phase 2)|Progressive Disease|0
861855|NCT00473746|1821087|FG004|Period 2 (Phase 2)|Progressive Disease|20
861856|NCT00473746|1821083|FG000|Period 2 (Phase 2)|Reason not specified|0
861857|NCT00473746|1821084|FG001|Period 2 (Phase 2)|Reason not specified|0
861858|NCT00473746|1821085|FG002|Period 2 (Phase 2)|Reason not specified|0
861859|NCT00473746|1821086|FG003|Period 2 (Phase 2)|Reason not specified|0
861860|NCT00473746|1821087|FG004|Period 2 (Phase 2)|Reason not specified|3
861861|NCT00473824|1821103|FG000|Overall Study|Virologic Breakthrough|1
861862|NCT00473824|1821104|FG001|Overall Study|Virologic Breakthrough|0
861863|NCT00473824|1821103|FG000|Overall Study|Adverse Event|1
861864|NCT00473824|1821104|FG001|Overall Study|Adverse Event|0
861865|NCT00473824|1821103|FG000|Overall Study|Death|1
861866|NCT00473824|1821104|FG001|Overall Study|Death|0
861867|NCT00473824|1821103|FG000|Overall Study|Lost to Follow-up|1
861868|NCT00473824|1821104|FG001|Overall Study|Lost to Follow-up|0
861869|NCT00473824|1821103|FG000|Overall Study|Withdrawal by physician|1
861870|NCT00473824|1821104|FG001|Overall Study|Withdrawal by physician|0
861871|NCT00473876|1821121|FG000|Overall Study|Lost to Follow-up|3
861872|NCT00473876|1821122|FG001|Overall Study|Lost to Follow-up|1
861873|NCT00473889|1821132|FG000|Overall Study|Did not receive study medication|1
861874|NCT00473889|1821133|FG001|Overall Study|Did not receive study medication|4
861875|NCT00473889|1821132|FG000|Overall Study|Adverse Event|30
861876|NCT00473889|1821133|FG001|Overall Study|Adverse Event|17
861877|NCT00473889|1821132|FG000|Overall Study|Protocol Violation|4
861878|NCT00473889|1821133|FG001|Overall Study|Protocol Violation|2
861879|NCT00473889|1821132|FG000|Overall Study|Lack of Efficacy|28
861880|NCT00473889|1821133|FG001|Overall Study|Lack of Efficacy|29
861881|NCT00473889|1821132|FG000|Overall Study|Lost to Follow-up|2
861882|NCT00473889|1821133|FG001|Overall Study|Lost to Follow-up|1
861883|NCT00473889|1821132|FG000|Overall Study|Physician Decision|10
861884|NCT00473889|1821133|FG001|Overall Study|Physician Decision|5
861885|NCT00473889|1821132|FG000|Overall Study|Trial Terminated|3
861886|NCT00473889|1821133|FG001|Overall Study|Trial Terminated|6
861887|NCT00473889|1821132|FG000|Overall Study|Withdrawal by Subject|5
861888|NCT00473889|1821133|FG001|Overall Study|Withdrawal by Subject|0
861889|NCT00474045|1821141|FG000|Overall Study|Adverse Event|18
861890|NCT00474045|1821142|FG001|Overall Study|Adverse Event|8
861891|NCT00474045|1821141|FG000|Overall Study|Unclassified|1
861892|NCT00474045|1821142|FG001|Overall Study|Unclassified|3
861893|NCT00474045|1821141|FG000|Overall Study|Lack of Efficacy|0
861894|NCT00474045|1821142|FG001|Overall Study|Lack of Efficacy|9
861895|NCT00474045|1821141|FG000|Overall Study|Lost to Follow-up|1
861896|NCT00474045|1821142|FG001|Overall Study|Lost to Follow-up|1
861897|NCT00474045|1821141|FG000|Overall Study|Protocol Violation|10
861898|NCT00474045|1821142|FG001|Overall Study|Protocol Violation|12
861899|NCT00474045|1821141|FG000|Overall Study|Withdrawal by Subject|16
861900|NCT00474045|1821142|FG001|Overall Study|Withdrawal by Subject|18
861901|NCT00474045|1821141|FG000|Overall Study|Withdrawal criteria|60
861902|NCT00474045|1821142|FG001|Overall Study|Withdrawal criteria|50
861903|NCT00474058|1821150|FG000|Overall Study|Adverse Event|11
861904|NCT00474058|1821151|FG001|Overall Study|Adverse Event|6
861905|NCT00474058|1821150|FG000|Overall Study|Lack of Efficacy|0
861906|NCT00474058|1821151|FG001|Overall Study|Lack of Efficacy|4
861907|NCT00474058|1821150|FG000|Overall Study|Withdrawal by Subject|11
861908|NCT00474058|1821151|FG001|Overall Study|Withdrawal by Subject|7
861909|NCT00474058|1821150|FG000|Overall Study|Other|2
861910|NCT00474058|1821151|FG001|Overall Study|Other|0
861911|NCT00474175|1821169|FG000|Overall Study|Lack of Efficacy|0
861912|NCT00474175|1821170|FG001|Overall Study|Lack of Efficacy|0
861913|NCT00474175|1821171|FG002|Overall Study|Lack of Efficacy|1
861914|NCT00474175|1821169|FG000|Overall Study|Withdrawal by Subject|0
861915|NCT00474175|1821170|FG001|Overall Study|Withdrawal by Subject|1
861916|NCT00474175|1821171|FG002|Overall Study|Withdrawal by Subject|1
861917|NCT00474175|1821169|FG000|Overall Study|Ineligible|1
861918|NCT00474175|1821170|FG001|Overall Study|Ineligible|3
861919|NCT00474175|1821171|FG002|Overall Study|Ineligible|1
861920|NCT00474175|1821169|FG000|Overall Study|Protocol Violation|0
861921|NCT00474175|1821170|FG001|Overall Study|Protocol Violation|2
861922|NCT00474175|1821171|FG002|Overall Study|Protocol Violation|1
861923|NCT00474175|1821169|FG000|Overall Study|Administrative|0
861924|NCT00474175|1821170|FG001|Overall Study|Administrative|1
861925|NCT00474175|1821171|FG002|Overall Study|Administrative|0
861926|NCT00474240|1821190|FG000|Overall Study|Withdrawal by Subject|1
861927|NCT00474240|1821191|FG001|Overall Study|Withdrawal by Subject|1
861928|NCT00474240|1821192|FG002|Overall Study|Withdrawal by Subject|0
861929|NCT00474240|1821193|FG003|Overall Study|Withdrawal by Subject|2
861930|NCT00474240|1821194|FG004|Overall Study|Withdrawal by Subject|3
861931|NCT00474240|1821195|FG005|Overall Study|Withdrawal by Subject|1
861932|NCT00474240|1821190|FG000|Overall Study|Adverse Event|0
861933|NCT00474240|1821191|FG001|Overall Study|Adverse Event|0
861934|NCT00474240|1821192|FG002|Overall Study|Adverse Event|9
861935|NCT00474240|1821193|FG003|Overall Study|Adverse Event|14
861936|NCT00474240|1821194|FG004|Overall Study|Adverse Event|5
861937|NCT00474240|1821195|FG005|Overall Study|Adverse Event|16
861938|NCT00474240|1821190|FG000|Overall Study|Removed due to lab value|0
861939|NCT00474240|1821191|FG001|Overall Study|Removed due to lab value|0
861940|NCT00474240|1821192|FG002|Overall Study|Removed due to lab value|0
861941|NCT00474240|1821193|FG003|Overall Study|Removed due to lab value|0
861942|NCT00474240|1821194|FG004|Overall Study|Removed due to lab value|0
861943|NCT00474240|1821195|FG005|Overall Study|Removed due to lab value|1
861944|NCT00474253|1821211|FG000|Overall Study|Withdrew consent|2
861945|NCT00474253|1821212|FG001|Overall Study|Withdrew consent|0
861946|NCT00474253|1821211|FG000|Overall Study|Withdrew due to surgery-related issues|0
861947|NCT00474253|1821212|FG001|Overall Study|Withdrew due to surgery-related issues|3
861948|NCT00474253|1821211|FG000|Overall Study|Lost to Follow-up|1
861949|NCT00474253|1821212|FG001|Overall Study|Lost to Follow-up|0
861950|NCT00474253|1821211|FG000|Overall Study|Discharged prior to study completion|0
861951|NCT00474253|1821212|FG001|Overall Study|Discharged prior to study completion|1
861952|NCT00474266|1821222|FG000|Overall Study|Withdrawal by Subject|7
861953|NCT00474266|1821223|FG001|Overall Study|Withdrawal by Subject|20
861954|NCT00474266|1821224|FG002|Overall Study|Withdrawal by Subject|4
861955|NCT00474266|1821225|FG003|Overall Study|Withdrawal by Subject|7
861956|NCT00474383|1821238|FG000|Main Study|Adverse Event|11
861957|NCT00474383|1821239|FG001|Main Study|Adverse Event|0
861958|NCT00474383|1821238|FG000|Main Study|Symptomatic Deterioration|1
861959|NCT00474383|1821239|FG001|Main Study|Symptomatic Deterioration|0
861960|NCT00474383|1821238|FG000|Main Study|Progressive Disease|23
861961|NCT00474383|1821239|FG001|Main Study|Progressive Disease|0
861962|NCT00474383|1821238|FG000|Main Study|Other|1
861963|NCT00474383|1821239|FG001|Main Study|Other|0
861964|NCT00474383|1821238|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6
861965|NCT00474383|1821239|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0
861966|NCT00474383|1821238|FG000|Extension|Progressive Disease|0
861967|NCT00474383|1821239|FG001|Extension|Progressive Disease|5
861968|NCT00474487|1821247|FG000|Overall Study|Withdrawal by Subject|6
861969|NCT00474487|1821248|FG001|Overall Study|Withdrawal by Subject|0
861970|NCT00474487|1821249|FG002|Overall Study|Withdrawal by Subject|0
861971|NCT00474487|1821250|FG003|Overall Study|Withdrawal by Subject|0
861972|NCT00474487|1821247|FG000|Overall Study|Lost to Follow-up|20
861973|NCT00474487|1821248|FG001|Overall Study|Lost to Follow-up|1
861974|NCT00474487|1821249|FG002|Overall Study|Lost to Follow-up|7
861975|NCT00474487|1821250|FG003|Overall Study|Lost to Follow-up|0
861976|NCT00474487|1821247|FG000|Overall Study|Inappropriate enrollment|4
861977|NCT00474487|1821248|FG001|Overall Study|Inappropriate enrollment|0
861978|NCT00474487|1821249|FG002|Overall Study|Inappropriate enrollment|7
861979|NCT00474487|1821250|FG003|Overall Study|Inappropriate enrollment|0
861980|NCT00474487|1821247|FG000|Overall Study|Death|0
861981|NCT00474487|1821248|FG001|Overall Study|Death|1
861982|NCT00474487|1821249|FG002|Overall Study|Death|0
861983|NCT00474487|1821250|FG003|Overall Study|Death|0
861984|NCT00474526|1821277|FG000|Overall Study|ADMINISTRATIVE REASON|11
861985|NCT00474526|1821278|FG001|Overall Study|ADMINISTRATIVE REASON|9
861986|NCT00474526|1821279|FG002|Overall Study|ADMINISTRATIVE REASON|9
861987|NCT00474526|1821280|FG003|Overall Study|ADMINISTRATIVE REASON|20
861988|NCT00474526|1821281|FG004|Overall Study|ADMINISTRATIVE REASON|9
861989|NCT00474526|1821282|FG005|Overall Study|ADMINISTRATIVE REASON|1
861990|NCT00474526|1821283|FG006|Overall Study|ADMINISTRATIVE REASON|1
861991|NCT00474526|1821284|FG007|Overall Study|ADMINISTRATIVE REASON|0
861992|NCT00474526|1821285|FG008|Overall Study|ADMINISTRATIVE REASON|2
861993|NCT00474526|1821286|FG009|Overall Study|ADMINISTRATIVE REASON|1
861994|NCT00474526|1821287|FG010|Overall Study|ADMINISTRATIVE REASON|1
861995|NCT00474526|1821288|FG011|Overall Study|ADMINISTRATIVE REASON|1
861996|NCT00474526|1821289|FG012|Overall Study|ADMINISTRATIVE REASON|1
861997|NCT00474526|1821290|FG013|Overall Study|ADMINISTRATIVE REASON|1
861998|NCT00474526|1821291|FG014|Overall Study|ADMINISTRATIVE REASON|2
861999|NCT00474526|1821292|FG015|Overall Study|ADMINISTRATIVE REASON|0
862000|NCT00474526|1821293|FG016|Overall Study|ADMINISTRATIVE REASON|0
862001|NCT00474526|1821277|FG000|Overall Study|Adverse Event|2
862002|NCT00474526|1821278|FG001|Overall Study|Adverse Event|0
862003|NCT00474526|1821279|FG002|Overall Study|Adverse Event|2
862004|NCT00474526|1821280|FG003|Overall Study|Adverse Event|4
862005|NCT00474526|1821281|FG004|Overall Study|Adverse Event|2
862006|NCT00474526|1821282|FG005|Overall Study|Adverse Event|1
862007|NCT00474526|1821283|FG006|Overall Study|Adverse Event|1
862008|NCT00474526|1821284|FG007|Overall Study|Adverse Event|0
862009|NCT00474526|1821285|FG008|Overall Study|Adverse Event|0
862010|NCT00474526|1821286|FG009|Overall Study|Adverse Event|0
862011|NCT00474526|1821287|FG010|Overall Study|Adverse Event|0
862012|NCT00474526|1821288|FG011|Overall Study|Adverse Event|0
862013|NCT00474526|1821289|FG012|Overall Study|Adverse Event|0
862014|NCT00474526|1821290|FG013|Overall Study|Adverse Event|0
862015|NCT00474526|1821291|FG014|Overall Study|Adverse Event|1
862016|NCT00474526|1821292|FG015|Overall Study|Adverse Event|1
862017|NCT00474526|1821293|FG016|Overall Study|Adverse Event|0
862018|NCT00474526|1821277|FG000|Overall Study|Death|0
862019|NCT00474526|1821278|FG001|Overall Study|Death|0
862020|NCT00474526|1821279|FG002|Overall Study|Death|0
862021|NCT00474526|1821280|FG003|Overall Study|Death|0
862022|NCT00474526|1821281|FG004|Overall Study|Death|0
862023|NCT00474526|1821282|FG005|Overall Study|Death|0
862024|NCT00474526|1821283|FG006|Overall Study|Death|0
862025|NCT00474526|1821284|FG007|Overall Study|Death|0
862026|NCT00474526|1821285|FG008|Overall Study|Death|0
862027|NCT00474526|1821286|FG009|Overall Study|Death|0
862028|NCT00474526|1821287|FG010|Overall Study|Death|0
862029|NCT00474526|1821288|FG011|Overall Study|Death|0
862030|NCT00474526|1821289|FG012|Overall Study|Death|0
862031|NCT00474526|1821290|FG013|Overall Study|Death|3
862032|NCT00474526|1821291|FG014|Overall Study|Death|0
862033|NCT00474526|1821292|FG015|Overall Study|Death|0
862034|NCT00474526|1821293|FG016|Overall Study|Death|0
862035|NCT00474526|1821277|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0
862036|NCT00474526|1821278|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1
862037|NCT00474526|1821279|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0
862038|NCT00474526|1821280|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1
862039|NCT00474526|1821281|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2
862040|NCT00474526|1821282|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0
862041|NCT00474526|1821283|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0
862042|NCT00474526|1821284|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0
862043|NCT00474526|1821285|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0
862044|NCT00474526|1821286|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0
862045|NCT00474526|1821287|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0
862046|NCT00474526|1821288|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0
862047|NCT00474526|1821289|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0
862048|NCT00474526|1821290|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2
862049|NCT00474526|1821291|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2
862050|NCT00474526|1821292|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0
862051|NCT00474526|1821293|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0
862052|NCT00474526|1821277|FG000|Overall Study|Lost to Follow-up|8
862053|NCT00474526|1821278|FG001|Overall Study|Lost to Follow-up|6
862054|NCT00474526|1821279|FG002|Overall Study|Lost to Follow-up|13
862055|NCT00474526|1821280|FG003|Overall Study|Lost to Follow-up|29
862056|NCT00474526|1821281|FG004|Overall Study|Lost to Follow-up|11
862057|NCT00474526|1821282|FG005|Overall Study|Lost to Follow-up|5
862058|NCT00474526|1821283|FG006|Overall Study|Lost to Follow-up|8
862059|NCT00474526|1821284|FG007|Overall Study|Lost to Follow-up|1
862060|NCT00474526|1821285|FG008|Overall Study|Lost to Follow-up|0
862061|NCT00474526|1821286|FG009|Overall Study|Lost to Follow-up|6
862062|NCT00474526|1821287|FG010|Overall Study|Lost to Follow-up|2
862063|NCT00474526|1821288|FG011|Overall Study|Lost to Follow-up|4
862064|NCT00474526|1821289|FG012|Overall Study|Lost to Follow-up|6
862065|NCT00474526|1821290|FG013|Overall Study|Lost to Follow-up|74
862066|NCT00474526|1821291|FG014|Overall Study|Lost to Follow-up|29
862067|NCT00474526|1821292|FG015|Overall Study|Lost to Follow-up|4
862068|NCT00474526|1821293|FG016|Overall Study|Lost to Follow-up|5
862069|NCT00474526|1821277|FG000|Overall Study|Protocol Violation|2
862070|NCT00474526|1821278|FG001|Overall Study|Protocol Violation|6
862071|NCT00474526|1821279|FG002|Overall Study|Protocol Violation|4
862072|NCT00474526|1821280|FG003|Overall Study|Protocol Violation|12
862073|NCT00474526|1821281|FG004|Overall Study|Protocol Violation|3
862074|NCT00474526|1821282|FG005|Overall Study|Protocol Violation|1
862075|NCT00474526|1821283|FG006|Overall Study|Protocol Violation|3
862076|NCT00474526|1821284|FG007|Overall Study|Protocol Violation|0
862077|NCT00474526|1821285|FG008|Overall Study|Protocol Violation|0
862078|NCT00474526|1821286|FG009|Overall Study|Protocol Violation|4
862079|NCT00474526|1821287|FG010|Overall Study|Protocol Violation|2
862080|NCT00474526|1821288|FG011|Overall Study|Protocol Violation|2
862081|NCT00474526|1821289|FG012|Overall Study|Protocol Violation|4
862082|NCT00474526|1821290|FG013|Overall Study|Protocol Violation|19
862083|NCT00474526|1821291|FG014|Overall Study|Protocol Violation|9
862084|NCT00474526|1821292|FG015|Overall Study|Protocol Violation|6
862085|NCT00474526|1821293|FG016|Overall Study|Protocol Violation|2
862086|NCT00474526|1821277|FG000|Overall Study|UNABLE TO CLASSIFY|1
862087|NCT00474526|1821278|FG001|Overall Study|UNABLE TO CLASSIFY|0
862088|NCT00474526|1821279|FG002|Overall Study|UNABLE TO CLASSIFY|0
862089|NCT00474526|1821280|FG003|Overall Study|UNABLE TO CLASSIFY|1
862090|NCT00474526|1821281|FG004|Overall Study|UNABLE TO CLASSIFY|3
862091|NCT00474526|1821282|FG005|Overall Study|UNABLE TO CLASSIFY|2
862092|NCT00474526|1821283|FG006|Overall Study|UNABLE TO CLASSIFY|0
862093|NCT00474526|1821284|FG007|Overall Study|UNABLE TO CLASSIFY|1
862094|NCT00474526|1821285|FG008|Overall Study|UNABLE TO CLASSIFY|0
862095|NCT00474526|1821286|FG009|Overall Study|UNABLE TO CLASSIFY|3
862096|NCT00474526|1821287|FG010|Overall Study|UNABLE TO CLASSIFY|0
862097|NCT00474526|1821288|FG011|Overall Study|UNABLE TO CLASSIFY|0
862098|NCT00474526|1821289|FG012|Overall Study|UNABLE TO CLASSIFY|0
862099|NCT00474526|1821290|FG013|Overall Study|UNABLE TO CLASSIFY|20
862100|NCT00474526|1821291|FG014|Overall Study|UNABLE TO CLASSIFY|12
862101|NCT00474526|1821292|FG015|Overall Study|UNABLE TO CLASSIFY|6
862102|NCT00474526|1821293|FG016|Overall Study|UNABLE TO CLASSIFY|1
862103|NCT00474526|1821277|FG000|Overall Study|Withdrawal by Subject|9
862104|NCT00474526|1821278|FG001|Overall Study|Withdrawal by Subject|24
862105|NCT00474526|1821279|FG002|Overall Study|Withdrawal by Subject|21
862106|NCT00474526|1821280|FG003|Overall Study|Withdrawal by Subject|52
862107|NCT00474526|1821281|FG004|Overall Study|Withdrawal by Subject|38
862108|NCT00474526|1821282|FG005|Overall Study|Withdrawal by Subject|6
862109|NCT00474526|1821283|FG006|Overall Study|Withdrawal by Subject|12
862110|NCT00474526|1821284|FG007|Overall Study|Withdrawal by Subject|4
862111|NCT00474526|1821285|FG008|Overall Study|Withdrawal by Subject|4
862112|NCT00474526|1821286|FG009|Overall Study|Withdrawal by Subject|13
862113|NCT00474526|1821287|FG010|Overall Study|Withdrawal by Subject|5
862114|NCT00474526|1821288|FG011|Overall Study|Withdrawal by Subject|4
862115|NCT00474526|1821289|FG012|Overall Study|Withdrawal by Subject|4
862116|NCT00474526|1821290|FG013|Overall Study|Withdrawal by Subject|37
862117|NCT00474526|1821291|FG014|Overall Study|Withdrawal by Subject|22
862118|NCT00474526|1821292|FG015|Overall Study|Withdrawal by Subject|1
862119|NCT00474526|1821293|FG016|Overall Study|Withdrawal by Subject|1
862120|NCT00474539|1821381|FG000|Infant Series|Withdrawal by Subject|3
862121|NCT00474539|1821382|FG001|Infant Series|Withdrawal by Subject|4
862122|NCT00474539|1821381|FG000|Infant Series|Randomization error|5
862123|NCT00474539|1821382|FG001|Infant Series|Randomization error|0
862124|NCT00474539|1821381|FG000|Infant Series|Lost to Follow-up|2
862125|NCT00474539|1821382|FG001|Infant Series|Lost to Follow-up|1
862126|NCT00474539|1821381|FG000|Infant Series|Protocol Violation|0
862127|NCT00474539|1821382|FG001|Infant Series|Protocol Violation|1
862128|NCT00474539|1821381|FG000|After Infant Series|Lost to Follow-up|3
862129|NCT00474539|1821382|FG001|After Infant Series|Lost to Follow-up|0
862130|NCT00474539|1821381|FG000|After Infant Series|Withdrawal by Subject|1
862131|NCT00474539|1821382|FG001|After Infant Series|Withdrawal by Subject|0
862132|NCT00474539|1821381|FG000|Toddler Dose|Protocol Violation|1
862133|NCT00474539|1821382|FG001|Toddler Dose|Protocol Violation|0
862134|NCT00474630|1821428|FG000|Overall Study|Adverse Event|98
862135|NCT00474630|1821429|FG001|Overall Study|Adverse Event|26
862136|NCT00474630|1821428|FG000|Overall Study|Lost to Follow-up|22
862137|NCT00474630|1821429|FG001|Overall Study|Lost to Follow-up|15
862138|NCT00474630|1821428|FG000|Overall Study|Withdrawal by Subject|21
862139|NCT00474630|1821429|FG001|Overall Study|Withdrawal by Subject|15
862140|NCT00474630|1821428|FG000|Overall Study|Protocol Violation|3
862141|NCT00474630|1821429|FG001|Overall Study|Protocol Violation|4
862142|NCT00474630|1821428|FG000|Overall Study|Lack of Efficacy|5
862143|NCT00474630|1821429|FG001|Overall Study|Lack of Efficacy|6
862144|NCT00474630|1821428|FG000|Overall Study|Drug noncompliance, other|11
862145|NCT00474630|1821429|FG001|Overall Study|Drug noncompliance, other|4
862146|NCT00474708|1821438|FG000|Overall Study|Lack of Efficacy|11
862147|NCT00474708|1821439|FG001|Overall Study|Lack of Efficacy|5
862148|NCT00474708|1821438|FG000|Overall Study|Suicide ideation/behavior|0
862149|NCT00474708|1821439|FG001|Overall Study|Suicide ideation/behavior|1
862150|NCT00474708|1821438|FG000|Overall Study|Withdrawal by Subject|7
862151|NCT00474708|1821439|FG001|Overall Study|Withdrawal by Subject|0
862152|NCT00474708|1821438|FG000|Overall Study|Lack of compliance|12
862153|NCT00474708|1821439|FG001|Overall Study|Lack of compliance|4
862154|NCT00474708|1821438|FG000|Overall Study|Lost to Follow-up|18
862155|NCT00474708|1821439|FG001|Overall Study|Lost to Follow-up|9
862156|NCT00474708|1821438|FG000|Overall Study|Physician Decision|9
862157|NCT00474708|1821439|FG001|Overall Study|Physician Decision|6
862158|NCT00474760|1821452|FG000|Overall Study|Death|0
862159|NCT00474760|1821453|FG001|Overall Study|Death|0
862160|NCT00474760|1821454|FG002|Overall Study|Death|0
862161|NCT00474760|1821455|FG003|Overall Study|Death|0
862162|NCT00474760|1821456|FG004|Overall Study|Death|2
862163|NCT00474760|1821457|FG005|Overall Study|Death|0
862164|NCT00474760|1821458|FG006|Overall Study|Death|0
862165|NCT00474760|1821452|FG000|Overall Study|Adverse Event|0
862166|NCT00474760|1821453|FG001|Overall Study|Adverse Event|0
862167|NCT00474760|1821454|FG002|Overall Study|Adverse Event|0
862168|NCT00474760|1821455|FG003|Overall Study|Adverse Event|0
862169|NCT00474760|1821456|FG004|Overall Study|Adverse Event|1
862170|NCT00474760|1821457|FG005|Overall Study|Adverse Event|7
862171|NCT00474760|1821458|FG006|Overall Study|Adverse Event|0
862172|NCT00474760|1821452|FG000|Overall Study|Laboratory abnormality|0
862173|NCT00474760|1821453|FG001|Overall Study|Laboratory abnormality|0
862174|NCT00474760|1821454|FG002|Overall Study|Laboratory abnormality|0
862175|NCT00474760|1821455|FG003|Overall Study|Laboratory abnormality|0
862176|NCT00474760|1821456|FG004|Overall Study|Laboratory abnormality|0
862177|NCT00474760|1821457|FG005|Overall Study|Laboratory abnormality|1
862178|NCT00474760|1821458|FG006|Overall Study|Laboratory abnormality|0
862179|NCT00474760|1821452|FG000|Overall Study|Withdrawal by Subject|0
862180|NCT00474760|1821453|FG001|Overall Study|Withdrawal by Subject|0
862181|NCT00474760|1821454|FG002|Overall Study|Withdrawal by Subject|0
862182|NCT00474760|1821455|FG003|Overall Study|Withdrawal by Subject|1
862183|NCT00474760|1821456|FG004|Overall Study|Withdrawal by Subject|0
862184|NCT00474760|1821457|FG005|Overall Study|Withdrawal by Subject|1
862185|NCT00474760|1821458|FG006|Overall Study|Withdrawal by Subject|1
862186|NCT00474760|1821452|FG000|Overall Study|Other|0
862187|NCT00474760|1821453|FG001|Overall Study|Other|1
862188|NCT00474760|1821454|FG002|Overall Study|Other|0
862189|NCT00474760|1821455|FG003|Overall Study|Other|0
862190|NCT00474760|1821456|FG004|Overall Study|Other|1
862191|NCT00474760|1821457|FG005|Overall Study|Other|0
862192|NCT00474760|1821458|FG006|Overall Study|Other|0
862193|NCT00474760|1821452|FG000|Overall Study|Progressive disease|3
862194|NCT00474760|1821453|FG001|Overall Study|Progressive disease|2
862195|NCT00474760|1821454|FG002|Overall Study|Progressive disease|3
862196|NCT00474760|1821455|FG003|Overall Study|Progressive disease|2
862197|NCT00474760|1821456|FG004|Overall Study|Progressive disease|8
862198|NCT00474760|1821457|FG005|Overall Study|Progressive disease|20
862199|NCT00474760|1821458|FG006|Overall Study|Progressive disease|7
862200|NCT00474760|1821452|FG000|Overall Study|Terminated by sponsor|0
862201|NCT00474760|1821453|FG001|Overall Study|Terminated by sponsor|0
862202|NCT00474760|1821454|FG002|Overall Study|Terminated by sponsor|0
862203|NCT00474760|1821455|FG003|Overall Study|Terminated by sponsor|0
862204|NCT00474760|1821456|FG004|Overall Study|Terminated by sponsor|0
862205|NCT00474760|1821457|FG005|Overall Study|Terminated by sponsor|0
862206|NCT00474760|1821458|FG006|Overall Study|Terminated by sponsor|2
862207|NCT00474786|1821483|FG000|Overall Study|Not Meeting Study Criteria|0
862208|NCT00474786|1821484|FG001|Overall Study|Not Meeting Study Criteria|1
862209|NCT00474786|1821483|FG000|Overall Study|Investigator Request|2
862210|NCT00474786|1821484|FG001|Overall Study|Investigator Request|1
862211|NCT00474786|1821483|FG000|Overall Study|Death|189
862212|NCT00474786|1821484|FG001|Overall Study|Death|170
862213|NCT00474786|1821483|FG000|Overall Study|Discontinuation of Study by Sponsor|42
862214|NCT00474786|1821484|FG001|Overall Study|Discontinuation of Study by Sponsor|59
862215|NCT00474786|1821483|FG000|Overall Study|Lost to Follow-up|4
862216|NCT00474786|1821484|FG001|Overall Study|Lost to Follow-up|7
862217|NCT00474786|1821483|FG000|Overall Study|Protocol Violation|2
862218|NCT00474786|1821484|FG001|Overall Study|Protocol Violation|0
862219|NCT00474786|1821483|FG000|Overall Study|Withdrawal by Subject|15
862220|NCT00474786|1821484|FG001|Overall Study|Withdrawal by Subject|15
862221|NCT00474786|1821483|FG000|Overall Study|Other|5
862222|NCT00474786|1821484|FG001|Overall Study|Other|0
862223|NCT00474812|1821490|FG000|Overall Study|Withdrawal by Subject|5
862224|NCT00474812|1821490|FG000|Overall Study|No Initiation of treatment|2
862225|NCT00474903|1821507|FG000|Overall Study|Protocol Violation|1
862226|NCT00474903|1821508|FG001|Overall Study|Protocol Violation|5
862227|NCT00474903|1821509|FG002|Overall Study|Protocol Violation|2
862228|NCT00474929|1821522|FG000|Overall Study|Withdrawal by Subject|0
862229|NCT00474929|1821523|FG001|Overall Study|Withdrawal by Subject|1
862230|NCT00474929|1821524|FG002|Overall Study|Withdrawal by Subject|0
862231|NCT00474929|1821525|FG003|Overall Study|Withdrawal by Subject|0
862232|NCT00474929|1821526|FG004|Overall Study|Withdrawal by Subject|0
862233|NCT00474929|1821522|FG000|Overall Study|Unrelated medical condition|0
862234|NCT00474929|1821523|FG001|Overall Study|Unrelated medical condition|0
862235|NCT00474929|1821524|FG002|Overall Study|Unrelated medical condition|1
862236|NCT00474929|1821525|FG003|Overall Study|Unrelated medical condition|0
862237|NCT00474929|1821526|FG004|Overall Study|Unrelated medical condition|0
862238|NCT00474929|1821522|FG000|Overall Study|Physician Decision|0
862239|NCT00474929|1821523|FG001|Overall Study|Physician Decision|0
862240|NCT00474929|1821524|FG002|Overall Study|Physician Decision|1
862241|NCT00474929|1821525|FG003|Overall Study|Physician Decision|2
862242|NCT00474929|1821526|FG004|Overall Study|Physician Decision|0
862243|NCT00474955|1821539|FG000|Overall Study|Adverse Event|2
862244|NCT00474955|1821539|FG000|Overall Study|Drug unavailability|1
862245|NCT00474955|1821539|FG000|Overall Study|Personal reasons|5
862246|NCT00474968|1821545|FG000|Overall Study|Withdrawal by Subject|8
862247|NCT00474968|1821546|FG001|Overall Study|Withdrawal by Subject|7
862248|NCT00474968|1821545|FG000|Overall Study|Protocol Violation|9
862249|NCT00474968|1821546|FG001|Overall Study|Protocol Violation|8
862250|NCT00474968|1821545|FG000|Overall Study|Sample not collected|1
862251|NCT00474968|1821546|FG001|Overall Study|Sample not collected|1
862252|NCT00474994|1821552|FG000|Overall Study|Patient Not treated|1
862253|NCT00474994|1821552|FG000|Overall Study|Patient evaluable for toxicity only|3
862254|NCT00474994|1821552|FG000|Overall Study|Patient found to be ineligible|1
862255|NCT00475020|1821556|FG000|Overall Study|Physician Decision|3
862256|NCT00475020|1821556|FG000|Overall Study|Insurance Denial|1
862257|NCT00475020|1821556|FG000|Overall Study|Donor not able to donate the last minute|1
862258|NCT00475033|1821562|FG000|Infant Series|Failed to return|3
862259|NCT00475033|1821563|FG001|Infant Series|Failed to return|4
862260|NCT00475033|1821562|FG000|Infant Series|Parent or legal guardian request|1
862261|NCT00475033|1821563|FG001|Infant Series|Parent or legal guardian request|5
862262|NCT00475033|1821562|FG000|Infant Series|Protocol Violation|1
862263|NCT00475033|1821563|FG001|Infant Series|Protocol Violation|2
862264|NCT00475033|1821562|FG000|Infant Series|Lost to Follow-up|2
862265|NCT00475033|1821563|FG001|Infant Series|Lost to Follow-up|0
862266|NCT00475033|1821562|FG000|Infant Series|Adverse Event|0
862267|NCT00475033|1821563|FG001|Infant Series|Adverse Event|2
862268|NCT00475033|1821562|FG000|After the Infant Series|Adverse Event|0
862269|NCT00475033|1821563|FG001|After the Infant Series|Adverse Event|4
862270|NCT00475033|1821562|FG000|After the Infant Series|Parent or legal guardian request|2
862271|NCT00475033|1821563|FG001|After the Infant Series|Parent or legal guardian request|2
862272|NCT00475033|1821562|FG000|After the Infant Series|Failed to return|2
862273|NCT00475033|1821563|FG001|After the Infant Series|Failed to return|1
862274|NCT00475033|1821562|FG000|After the Infant Series|Protocol Violation|1
862275|NCT00475033|1821563|FG001|After the Infant Series|Protocol Violation|0
862276|NCT00475033|1821562|FG000|After the Infant Series|Lost to Follow-up|1
862277|NCT00475033|1821563|FG001|After the Infant Series|Lost to Follow-up|0
862278|NCT00475033|1821562|FG000|After the Infant Series|Other|0
862279|NCT00475033|1821563|FG001|After the Infant Series|Other|1
862280|NCT00475033|1821562|FG000|Toddler Dose|Parent or legal guardian request|2
862281|NCT00475033|1821563|FG001|Toddler Dose|Parent or legal guardian request|0
862282|NCT00475033|1821562|FG000|Toddler Dose|Failed to return|1
862283|NCT00475033|1821563|FG001|Toddler Dose|Failed to return|0
862284|NCT00475033|1821562|FG000|Toddler Dose|Lost to Follow-up|1
862285|NCT00475033|1821563|FG001|Toddler Dose|Lost to Follow-up|0
862286|NCT00475176|1821601|FG000|Overall Study|Adverse Event|2
862287|NCT00475176|1821601|FG000|Overall Study|Withdrawal by Subject|1
862288|NCT00475176|1821601|FG000|Overall Study|Protocol Violation|1
862289|NCT00475228|1821616|FG000|Overall Study|Lost to Follow-up|17
862290|NCT00475228|1821617|FG001|Overall Study|Lost to Follow-up|17
862291|NCT00475306|1821641|FG000|Overall Study|Protocol Violation|1
862292|NCT00475306|1821642|FG001|Overall Study|Protocol Violation|1
862293|NCT00475306|1821643|FG002|Overall Study|Protocol Violation|0
862294|NCT00475306|1821644|FG003|Overall Study|Protocol Violation|1
862295|NCT00475423|1821670|FG000|Overall Study|Protocol Violation|5
862296|NCT00475423|1821670|FG000|Overall Study|Adverse Event|4
862297|NCT00475423|1821670|FG000|Overall Study|Withdrawal by Subject|6
862298|NCT00475423|1821670|FG000|Overall Study|Lack of Efficacy|8
862299|NCT00475423|1821670|FG000|Overall Study|Death|1
862300|NCT00475423|1821670|FG000|Overall Study|Reason not specified|1
862301|NCT00475423|1821670|FG000|Overall Study|Lost to Follow-up|7
862302|NCT00475644|1821723|FG000|Overall Study|Protocol Violation|13
862303|NCT00475670|1821729|FG000|Overall Study|Death|0
862304|NCT00475670|1821730|FG001|Overall Study|Death|1
862305|NCT00475670|1821729|FG000|Overall Study|Lack of Efficacy|3
862306|NCT00475670|1821730|FG001|Overall Study|Lack of Efficacy|34
862307|NCT00475670|1821729|FG000|Overall Study|Refused treatment|0
862308|NCT00475670|1821730|FG001|Overall Study|Refused treatment|2
862309|NCT00475670|1821729|FG000|Overall Study|Failure to Return|0
862310|NCT00475670|1821730|FG001|Overall Study|Failure to Return|1
862311|NCT00475670|1821729|FG000|Overall Study|Other|0
862312|NCT00475670|1821730|FG001|Overall Study|Other|3
862313|NCT00475709|1821736|FG000|Overall Study|Did not meet eligibility criteria|8
862314|NCT00475709|1821736|FG000|Overall Study|Death|41
862315|NCT00475709|1821736|FG000|Overall Study|Device Explant|6
862316|NCT00475709|1821736|FG000|Overall Study|Lost to Follow-up|21
862317|NCT00475722|1821742|FG000|Overall Study|Withdrawal by Subject|12
862318|NCT00475722|1821743|FG001|Overall Study|Withdrawal by Subject|12
862319|NCT00475722|1821742|FG000|Overall Study|Protocol Violation|3
862320|NCT00475722|1821743|FG001|Overall Study|Protocol Violation|0
862321|NCT00475735|1821755|FG000|Treatment Period 1|Adverse Event|2
862322|NCT00475735|1821756|FG001|Treatment Period 1|Adverse Event|0
862323|NCT00475735|1821757|FG002|Treatment Period 1|Adverse Event|0
862324|NCT00475735|1821758|FG003|Treatment Period 1|Adverse Event|0
862325|NCT00475735|1821759|FG004|Treatment Period 1|Adverse Event|0
862326|NCT00475735|1821760|FG005|Treatment Period 1|Adverse Event|0
862327|NCT00475735|1821755|FG000|Treatment Period 1|Lack of Efficacy|1
862328|NCT00475735|1821756|FG001|Treatment Period 1|Lack of Efficacy|0
862329|NCT00475735|1821757|FG002|Treatment Period 1|Lack of Efficacy|0
862330|NCT00475735|1821758|FG003|Treatment Period 1|Lack of Efficacy|0
862331|NCT00475735|1821759|FG004|Treatment Period 1|Lack of Efficacy|0
862332|NCT00475735|1821760|FG005|Treatment Period 1|Lack of Efficacy|0
862333|NCT00475735|1821755|FG000|Treatment Period 1|Lost to Follow-up|0
862334|NCT00475735|1821756|FG001|Treatment Period 1|Lost to Follow-up|0
862335|NCT00475735|1821757|FG002|Treatment Period 1|Lost to Follow-up|0
862336|NCT00475735|1821758|FG003|Treatment Period 1|Lost to Follow-up|0
862337|NCT00475735|1821759|FG004|Treatment Period 1|Lost to Follow-up|0
862338|NCT00475735|1821760|FG005|Treatment Period 1|Lost to Follow-up|1
862339|NCT00475735|1821755|FG000|Treatment Period 1|Protocol Violation|0
862340|NCT00475735|1821756|FG001|Treatment Period 1|Protocol Violation|0
862341|NCT00475735|1821757|FG002|Treatment Period 1|Protocol Violation|0
862342|NCT00475735|1821758|FG003|Treatment Period 1|Protocol Violation|1
862343|NCT00475735|1821759|FG004|Treatment Period 1|Protocol Violation|0
862344|NCT00475735|1821760|FG005|Treatment Period 1|Protocol Violation|0
862345|NCT00475735|1821755|FG000|Treatment Period 1|Withdrawal by Subject|1
862346|NCT00475735|1821756|FG001|Treatment Period 1|Withdrawal by Subject|1
862347|NCT00475735|1821757|FG002|Treatment Period 1|Withdrawal by Subject|0
862348|NCT00475735|1821758|FG003|Treatment Period 1|Withdrawal by Subject|0
862349|NCT00475735|1821759|FG004|Treatment Period 1|Withdrawal by Subject|0
862350|NCT00475735|1821760|FG005|Treatment Period 1|Withdrawal by Subject|0
862351|NCT00475735|1821755|FG000|Treatment Period 1|DC due to AE but continuing|0
862352|NCT00475735|1821756|FG001|Treatment Period 1|DC due to AE but continuing|0
862353|NCT00475735|1821757|FG002|Treatment Period 1|DC due to AE but continuing|0
862354|NCT00475735|1821758|FG003|Treatment Period 1|DC due to AE but continuing|1
862355|NCT00475735|1821759|FG004|Treatment Period 1|DC due to AE but continuing|2
862356|NCT00475735|1821760|FG005|Treatment Period 1|DC due to AE but continuing|2
862357|NCT00475735|1821755|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0
862358|NCT00475735|1821756|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1
862359|NCT00475735|1821757|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0
862360|NCT00475735|1821758|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0
862361|NCT00475735|1821759|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0
862362|NCT00475735|1821760|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0
862363|NCT00475735|1821755|FG000|Treatment Washout|Lost to Follow-up|0
862364|NCT00475735|1821756|FG001|Treatment Washout|Lost to Follow-up|1
862365|NCT00475735|1821757|FG002|Treatment Washout|Lost to Follow-up|0
862366|NCT00475735|1821758|FG003|Treatment Washout|Lost to Follow-up|0
862367|NCT00475735|1821759|FG004|Treatment Washout|Lost to Follow-up|0
862368|NCT00475735|1821760|FG005|Treatment Washout|Lost to Follow-up|0
862369|NCT00475735|1821755|FG000|Treatment Washout|Protocol Violation|0
862370|NCT00475735|1821756|FG001|Treatment Washout|Protocol Violation|1
862371|NCT00475735|1821757|FG002|Treatment Washout|Protocol Violation|0
862372|NCT00475735|1821758|FG003|Treatment Washout|Protocol Violation|0
862373|NCT00475735|1821759|FG004|Treatment Washout|Protocol Violation|0
862374|NCT00475735|1821760|FG005|Treatment Washout|Protocol Violation|0
862375|NCT00475735|1821755|FG000|Treatment Period 2|Adverse Event|0
862376|NCT00475735|1821756|FG001|Treatment Period 2|Adverse Event|1
862377|NCT00475735|1821757|FG002|Treatment Period 2|Adverse Event|0
862378|NCT00475735|1821758|FG003|Treatment Period 2|Adverse Event|2
862379|NCT00475735|1821759|FG004|Treatment Period 2|Adverse Event|0
862380|NCT00475735|1821760|FG005|Treatment Period 2|Adverse Event|0
862381|NCT00475735|1821755|FG000|Treatment Period 2|Lack of Efficacy|0
862382|NCT00475735|1821756|FG001|Treatment Period 2|Lack of Efficacy|0
862383|NCT00475735|1821757|FG002|Treatment Period 2|Lack of Efficacy|0
862384|NCT00475735|1821758|FG003|Treatment Period 2|Lack of Efficacy|0
862385|NCT00475735|1821759|FG004|Treatment Period 2|Lack of Efficacy|0
862386|NCT00475735|1821760|FG005|Treatment Period 2|Lack of Efficacy|1
862387|NCT00475735|1821755|FG000|Treatment Period 2|Withdrawal by Subject|0
862388|NCT00475735|1821756|FG001|Treatment Period 2|Withdrawal by Subject|0
862389|NCT00475735|1821757|FG002|Treatment Period 2|Withdrawal by Subject|0
862390|NCT00475735|1821758|FG003|Treatment Period 2|Withdrawal by Subject|0
862391|NCT00475735|1821759|FG004|Treatment Period 2|Withdrawal by Subject|1
862392|NCT00475735|1821760|FG005|Treatment Period 2|Withdrawal by Subject|0
862393|NCT00475852|1821781|FG000|Overall Study|Death|444
862394|NCT00475852|1821782|FG001|Overall Study|Death|456
862395|NCT00475852|1821781|FG000|Overall Study|Withdrawal by Subject|19
862396|NCT00475852|1821782|FG001|Overall Study|Withdrawal by Subject|24
862397|NCT00475852|1821781|FG000|Overall Study|Lost to Follow-up|54
862398|NCT00475852|1821782|FG001|Overall Study|Lost to Follow-up|68
862399|NCT00475865|1821791|FG000|Overall Study|Adverse Event|0
862400|NCT00475865|1821792|FG001|Overall Study|Adverse Event|3
862401|NCT00475865|1821793|FG002|Overall Study|Adverse Event|4
862402|NCT00475865|1821791|FG000|Overall Study|Lack of Efficacy|1
862403|NCT00475865|1821792|FG001|Overall Study|Lack of Efficacy|0
862404|NCT00475865|1821793|FG002|Overall Study|Lack of Efficacy|0
862405|NCT00475865|1821791|FG000|Overall Study|Progressive disease|0
862406|NCT00475865|1821792|FG001|Overall Study|Progressive disease|1
862407|NCT00475865|1821793|FG002|Overall Study|Progressive disease|2
862408|NCT00475865|1821791|FG000|Overall Study|Participant did not wish to continue|1
862409|NCT00475865|1821792|FG001|Overall Study|Participant did not wish to continue|0
862410|NCT00475865|1821793|FG002|Overall Study|Participant did not wish to continue|0
862411|NCT00475865|1821791|FG000|Overall Study|Other than above|0
862412|NCT00475865|1821792|FG001|Overall Study|Other than above|1
862413|NCT00475865|1821793|FG002|Overall Study|Other than above|0
862414|NCT00475982|1821829|FG000|Overall Study|surgery rescheduled|7
862415|NCT00475982|1821830|FG001|Overall Study|surgery rescheduled|3
862416|NCT00476008|1821838|FG000|Overall Study|Adverse Event|4
862417|NCT00476008|1821839|FG001|Overall Study|Adverse Event|4
862418|NCT00476008|1821838|FG000|Overall Study|Placebo concerns|2
862419|NCT00476008|1821839|FG001|Overall Study|Placebo concerns|2
862420|NCT00476008|1821838|FG000|Overall Study|Physician Decision: Medication Noncompli|2
862421|NCT00476008|1821839|FG001|Overall Study|Physician Decision: Medication Noncompli|1
862422|NCT00476008|1821838|FG000|Overall Study|Withdrawal by Subject|0
862423|NCT00476008|1821839|FG001|Overall Study|Withdrawal by Subject|1
862424|NCT00476008|1821838|FG000|Overall Study|Death|1
862425|NCT00476008|1821839|FG001|Overall Study|Death|0
862426|NCT00476047|1821864|FG000|Overall Study|Lost to Follow-up|1
862427|NCT00476086|1821870|FG000|Overall Study|Alternative therapy|1
862428|NCT00476086|1821870|FG000|Overall Study|Progressive Disease|4
862429|NCT00476151|1821878|FG000|Overall Study|Adverse Event|0
862430|NCT00476151|1821879|FG001|Overall Study|Adverse Event|2
862431|NCT00476151|1821878|FG000|Overall Study|Protocol Violation|1
862432|NCT00476151|1821879|FG001|Overall Study|Protocol Violation|3
862433|NCT00476151|1821878|FG000|Overall Study|Withdrawal by Subject|2
862434|NCT00476151|1821879|FG001|Overall Study|Withdrawal by Subject|0
862435|NCT00476151|1821878|FG000|Overall Study|Physician Decision|0
862436|NCT00476151|1821879|FG001|Overall Study|Physician Decision|2
862437|NCT00476229|1821885|FG000|Overall Study|Progressive shortness of breath|1
862438|NCT00476476|1821902|FG000|Overall Study|Adverse Event|2
862439|NCT00476476|1821903|FG001|Overall Study|Adverse Event|7
862440|NCT00476476|1821902|FG000|Overall Study|Progressive Disease|0
862441|NCT00476476|1821903|FG001|Overall Study|Progressive Disease|17
862442|NCT00476593|1821912|FG000|Overall Study|Lost to Follow-up|10
862443|NCT00476593|1821913|FG001|Overall Study|Lost to Follow-up|2
862444|NCT00476593|1821914|FG002|Overall Study|Lost to Follow-up|8
862445|NCT00476593|1821915|FG003|Overall Study|Lost to Follow-up|22
862446|NCT00476957|1821935|FG000|Overall Study|Lost to Follow-up|176
862447|NCT00476957|1821936|FG001|Overall Study|Lost to Follow-up|193
862448|NCT00476996|1821945|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
862449|NCT00476996|1821946|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
862450|NCT00476996|1821947|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
862451|NCT00476996|1821948|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
862452|NCT00476996|1821945|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
862453|NCT00476996|1821946|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
862454|NCT00476996|1821947|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
862455|NCT00476996|1821948|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
862456|NCT00476996|1821945|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
862457|NCT00476996|1821946|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
862458|NCT00476996|1821947|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
862459|NCT00476996|1821948|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
862460|NCT00476996|1821945|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
862461|NCT00476996|1821946|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
862462|NCT00476996|1821947|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
862463|NCT00476996|1821948|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
862464|NCT00476996|1821945|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
862465|NCT00476996|1821946|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
862466|NCT00476996|1821947|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
862467|NCT00476996|1821948|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
862468|NCT00476996|1821945|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
862469|NCT00476996|1821946|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
862470|NCT00476996|1821947|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
862471|NCT00476996|1821948|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
862472|NCT00476996|1821945|FG000|Blinded Treatment Phase (up to Week 48)|Death|2
862473|NCT00476996|1821946|FG001|Blinded Treatment Phase (up to Week 48)|Death|1
862474|NCT00476996|1821947|FG002|Blinded Treatment Phase (up to Week 48)|Death|1
862475|NCT00476996|1821948|FG003|Blinded Treatment Phase (up to Week 48)|Death|0
862476|NCT00476996|1821945|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
862477|NCT00476996|1821946|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
862478|NCT00476996|1821947|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
862479|NCT00476996|1821948|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
862480|NCT00476996|1821945|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0
862481|NCT00476996|1821946|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0
862482|NCT00476996|1821947|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0
862483|NCT00476996|1821948|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50
862484|NCT00476996|1821945|FG000|OLE Phase (From Week 48)|Adverse Event|0
862485|NCT00476996|1821946|FG001|OLE Phase (From Week 48)|Adverse Event|0
862486|NCT00476996|1821947|FG002|OLE Phase (From Week 48)|Adverse Event|0
862487|NCT00476996|1821948|FG003|OLE Phase (From Week 48)|Adverse Event|8
862488|NCT00476996|1821945|FG000|OLE Phase (From Week 48)|Death|0
862489|NCT00476996|1821946|FG001|OLE Phase (From Week 48)|Death|0
862490|NCT00476996|1821947|FG002|OLE Phase (From Week 48)|Death|0
862491|NCT00476996|1821948|FG003|OLE Phase (From Week 48)|Death|7
862492|NCT00476996|1821945|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0
862493|NCT00476996|1821946|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0
862494|NCT00476996|1821947|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0
862495|NCT00476996|1821948|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13
862496|NCT00476996|1821945|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0
862497|NCT00476996|1821946|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0
862498|NCT00476996|1821947|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0
862499|NCT00476996|1821948|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4
862500|NCT00476996|1821945|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
862501|NCT00476996|1821946|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
862502|NCT00476996|1821947|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
862503|NCT00476996|1821948|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
862504|NCT00476996|1821945|FG000|OLE Phase (From Week 48)|Early termination of the study|0
862505|NCT00476996|1821946|FG001|OLE Phase (From Week 48)|Early termination of the study|0
862506|NCT00476996|1821947|FG002|OLE Phase (From Week 48)|Early termination of the study|0
862507|NCT00476996|1821948|FG003|OLE Phase (From Week 48)|Early termination of the study|578
862508|NCT00477152|1821961|FG000|Overall Study|Parent withdrew consent|2
862509|NCT00477152|1821961|FG000|Overall Study|Adverse Event|1
862510|NCT00477165|1821967|FG000|Overall Study|Adverse Event|7
862511|NCT00477165|1821968|FG001|Overall Study|Adverse Event|2
862512|NCT00477269|1821989|FG000|Core Study|Adverse Event|6
862513|NCT00477269|1821990|FG001|Core Study|Adverse Event|4
862514|NCT00477269|1821991|FG002|Core Study|Adverse Event|0
862515|NCT00477269|1821989|FG000|Core Study|Death|3
862516|NCT00477269|1821990|FG001|Core Study|Death|3
862517|NCT00477269|1821991|FG002|Core Study|Death|0
862518|NCT00477269|1821989|FG000|Core Study|Withdrawn Consent|0
862519|NCT00477269|1821990|FG001|Core Study|Withdrawn Consent|1
862520|NCT00477269|1821991|FG002|Core Study|Withdrawn Consent|0
862521|NCT00477269|1821989|FG000|Open Label Extension|Adverse Event|0
862522|NCT00477269|1821990|FG001|Open Label Extension|Adverse Event|0
862523|NCT00477269|1821991|FG002|Open Label Extension|Adverse Event|4
862524|NCT00477269|1821989|FG000|Open Label Extension|Abnormal laboratory values|0
862525|NCT00477269|1821990|FG001|Open Label Extension|Abnormal laboratory values|0
862526|NCT00477269|1821991|FG002|Open Label Extension|Abnormal laboratory values|1
862527|NCT00477269|1821989|FG000|Open Label Extension|unsatisfactory therapeutic effects|0
862528|NCT00477269|1821990|FG001|Open Label Extension|unsatisfactory therapeutic effects|0
862529|NCT00477269|1821991|FG002|Open Label Extension|unsatisfactory therapeutic effects|2
862530|NCT00477269|1821989|FG000|Open Label Extension|Adminiatrative problems|0
862531|NCT00477269|1821990|FG001|Open Label Extension|Adminiatrative problems|0
862532|NCT00477269|1821991|FG002|Open Label Extension|Adminiatrative problems|2
862533|NCT00477269|1821989|FG000|Open Label Extension|Death|0
862534|NCT00477269|1821990|FG001|Open Label Extension|Death|0
862535|NCT00477269|1821991|FG002|Open Label Extension|Death|4
862536|NCT00477295|1822001|FG000|Overall Study|Adverse Event|31
862537|NCT00477295|1822002|FG001|Overall Study|Adverse Event|35
862538|NCT00477295|1822001|FG000|Overall Study|Withdrawal by Subject|35
862539|NCT00477295|1822002|FG001|Overall Study|Withdrawal by Subject|24
862540|NCT00477295|1822001|FG000|Overall Study|Lack of Efficacy|23
862541|NCT00477295|1822002|FG001|Overall Study|Lack of Efficacy|23
862542|NCT00477295|1822001|FG000|Overall Study|Protocol Violation|3
862543|NCT00477295|1822002|FG001|Overall Study|Protocol Violation|8
862544|NCT00477295|1822001|FG000|Overall Study|Physician Decision|4
862545|NCT00477295|1822002|FG001|Overall Study|Physician Decision|5
862546|NCT00477295|1822001|FG000|Overall Study|Lost to Follow-up|21
862547|NCT00477295|1822002|FG001|Overall Study|Lost to Follow-up|11
862548|NCT00477295|1822001|FG000|Overall Study|Other|4
862549|NCT00477295|1822002|FG001|Overall Study|Other|3
862550|NCT00477334|1822012|FG000|Overall Study|Discontinued prior to taking study drug|106
862551|NCT00477334|1822013|FG001|Overall Study|Discontinued prior to taking study drug|53
862552|NCT00477334|1822012|FG000|Overall Study|Adverse Event|1
862553|NCT00477334|1822013|FG001|Overall Study|Adverse Event|2
862554|NCT00477334|1822012|FG000|Overall Study|Withdrawal by Subject|2
862555|NCT00477334|1822013|FG001|Overall Study|Withdrawal by Subject|1
862556|NCT00477334|1822012|FG000|Overall Study|Lost to Follow-up|15
862557|NCT00477334|1822013|FG001|Overall Study|Lost to Follow-up|4
862558|NCT00477334|1822012|FG000|Overall Study|Administrative Problems|39
862559|NCT00477334|1822013|FG001|Overall Study|Administrative Problems|15
862560|NCT00477334|1822012|FG000|Overall Study|Protocol Violation|7
862561|NCT00477334|1822013|FG001|Overall Study|Protocol Violation|1
862562|NCT00477386|1822025|FG000|Overall Study|Adverse Event|4
862563|NCT00477386|1822026|FG001|Overall Study|Adverse Event|8
862564|NCT00477386|1822025|FG000|Overall Study|Disease progression, relapse|3
862565|NCT00477386|1822026|FG001|Overall Study|Disease progression, relapse|4
862566|NCT00477386|1822025|FG000|Overall Study|Disease progression, refractory|1
862567|NCT00477386|1822026|FG001|Overall Study|Disease progression, refractory|3
862568|NCT00477386|1822025|FG000|Overall Study|Other|1
862569|NCT00477386|1822026|FG001|Overall Study|Other|2
862570|NCT00477386|1822025|FG000|Overall Study|Physician Decision|1
862571|NCT00477386|1822026|FG001|Overall Study|Physician Decision|0
862572|NCT00477386|1822025|FG000|Overall Study|Withdrawal by Subject|1
862573|NCT00477386|1822026|FG001|Overall Study|Withdrawal by Subject|0
862574|NCT00477464|1822047|FG000|Overall Study|Lost to Follow-up|1
862575|NCT00477464|1822047|FG000|Overall Study|Death|36
862576|NCT00477464|1822047|FG000|Overall Study|Completion of protocol-defined follow-up|14
862577|NCT00477490|1822058|FG000|Part I: 4 Week Efficacy|Adverse Event|1
862578|NCT00477490|1822059|FG001|Part I: 4 Week Efficacy|Adverse Event|4
862579|NCT00477490|1822060|FG002|Part I: 4 Week Efficacy|Adverse Event|0
862580|NCT00477490|1822061|FG003|Part I: 4 Week Efficacy|Adverse Event|5
862581|NCT00477490|1822062|FG004|Part I: 4 Week Efficacy|Adverse Event|6
862582|NCT00477490|1822063|FG005|Part I: 4 Week Efficacy|Adverse Event|0
862583|NCT00477490|1822064|FG006|Part I: 4 Week Efficacy|Adverse Event|0
862584|NCT00477490|1822065|FG007|Part I: 4 Week Efficacy|Adverse Event|0
862585|NCT00477490|1822066|FG008|Part I: 4 Week Efficacy|Adverse Event|0
862586|NCT00477490|1822058|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
862587|NCT00477490|1822059|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
862588|NCT00477490|1822060|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
862589|NCT00477490|1822061|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
862590|NCT00477490|1822062|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
862591|NCT00477490|1822063|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
862592|NCT00477490|1822064|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
862593|NCT00477490|1822065|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
862594|NCT00477490|1822066|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
862595|NCT00477490|1822058|FG000|Part I: 4 Week Efficacy|Protocol Violation|2
862596|NCT00477490|1822059|FG001|Part I: 4 Week Efficacy|Protocol Violation|0
862597|NCT00477490|1822060|FG002|Part I: 4 Week Efficacy|Protocol Violation|0
862598|NCT00477490|1822061|FG003|Part I: 4 Week Efficacy|Protocol Violation|0
862599|NCT00477490|1822062|FG004|Part I: 4 Week Efficacy|Protocol Violation|1
862600|NCT00477490|1822063|FG005|Part I: 4 Week Efficacy|Protocol Violation|0
862601|NCT00477490|1822064|FG006|Part I: 4 Week Efficacy|Protocol Violation|0
862602|NCT00477490|1822065|FG007|Part I: 4 Week Efficacy|Protocol Violation|0
862603|NCT00477490|1822066|FG008|Part I: 4 Week Efficacy|Protocol Violation|0
862604|NCT00477490|1822058|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6
862605|NCT00477490|1822059|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5
862606|NCT00477490|1822060|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6
862607|NCT00477490|1822061|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4
862608|NCT00477490|1822062|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9
862609|NCT00477490|1822063|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0
862610|NCT00477490|1822064|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0
862611|NCT00477490|1822065|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0
862612|NCT00477490|1822066|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0
862613|NCT00477490|1822058|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2
862614|NCT00477490|1822059|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4
862615|NCT00477490|1822060|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1
862616|NCT00477490|1822061|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5
862617|NCT00477490|1822062|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3
862618|NCT00477490|1822063|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0
862619|NCT00477490|1822064|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0
862620|NCT00477490|1822065|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0
862621|NCT00477490|1822066|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0
862622|NCT00477490|1822058|FG000|Part I: 4 Week Efficacy|Other, not specified|2
862623|NCT00477490|1822059|FG001|Part I: 4 Week Efficacy|Other, not specified|4
862624|NCT00477490|1822060|FG002|Part I: 4 Week Efficacy|Other, not specified|0
862625|NCT00477490|1822061|FG003|Part I: 4 Week Efficacy|Other, not specified|1
862626|NCT00477490|1822062|FG004|Part I: 4 Week Efficacy|Other, not specified|1
862627|NCT00477490|1822063|FG005|Part I: 4 Week Efficacy|Other, not specified|0
862628|NCT00477490|1822064|FG006|Part I: 4 Week Efficacy|Other, not specified|0
862629|NCT00477490|1822065|FG007|Part I: 4 Week Efficacy|Other, not specified|0
862630|NCT00477490|1822066|FG008|Part I: 4 Week Efficacy|Other, not specified|0
862631|NCT00477490|1822058|FG000|Part I: 4 Week Efficacy|Not Reported|1
862632|NCT00477490|1822059|FG001|Part I: 4 Week Efficacy|Not Reported|2
862633|NCT00477490|1822060|FG002|Part I: 4 Week Efficacy|Not Reported|3
862634|NCT00477490|1822061|FG003|Part I: 4 Week Efficacy|Not Reported|0
862635|NCT00477490|1822062|FG004|Part I: 4 Week Efficacy|Not Reported|1
862636|NCT00477490|1822063|FG005|Part I: 4 Week Efficacy|Not Reported|0
862637|NCT00477490|1822064|FG006|Part I: 4 Week Efficacy|Not Reported|0
862638|NCT00477490|1822065|FG007|Part I: 4 Week Efficacy|Not Reported|0
862639|NCT00477490|1822066|FG008|Part I: 4 Week Efficacy|Not Reported|0
862640|NCT00477490|1822058|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
862641|NCT00477490|1822059|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
862642|NCT00477490|1822060|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
862643|NCT00477490|1822061|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
862644|NCT00477490|1822062|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
862645|NCT00477490|1822063|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
862646|NCT00477490|1822064|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
862647|NCT00477490|1822065|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
862648|NCT00477490|1822066|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
862649|NCT00477490|1822058|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0
862650|NCT00477490|1822059|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2
862651|NCT00477490|1822060|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3
862652|NCT00477490|1822061|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1
862653|NCT00477490|1822062|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1
862654|NCT00477490|1822063|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1
862655|NCT00477490|1822064|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1
862656|NCT00477490|1822065|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1
862657|NCT00477490|1822066|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4
862658|NCT00477490|1822058|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
862659|NCT00477490|1822059|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
862660|NCT00477490|1822060|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
862661|NCT00477490|1822061|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
862662|NCT00477490|1822062|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
862663|NCT00477490|1822063|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
862664|NCT00477490|1822064|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
862665|NCT00477490|1822065|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
862666|NCT00477490|1822066|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
862667|NCT00477490|1822058|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
862668|NCT00477490|1822059|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
862669|NCT00477490|1822060|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
862670|NCT00477490|1822061|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
862671|NCT00477490|1822062|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
862672|NCT00477490|1822063|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
862673|NCT00477490|1822064|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
862674|NCT00477490|1822065|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
862675|NCT00477490|1822066|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
862676|NCT00477490|1822058|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0
862677|NCT00477490|1822059|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1
862678|NCT00477490|1822060|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0
862679|NCT00477490|1822061|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0
862680|NCT00477490|1822062|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0
862681|NCT00477490|1822063|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0
862682|NCT00477490|1822064|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0
862683|NCT00477490|1822065|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0
862684|NCT00477490|1822066|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0
862685|NCT00477490|1822058|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0
862686|NCT00477490|1822059|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4
862687|NCT00477490|1822060|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2
862688|NCT00477490|1822061|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4
862689|NCT00477490|1822062|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2
862690|NCT00477490|1822063|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1
862691|NCT00477490|1822064|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1
862692|NCT00477490|1822065|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0
862693|NCT00477490|1822066|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1
862694|NCT00477490|1822058|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0
862695|NCT00477490|1822059|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3
862696|NCT00477490|1822060|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1
862697|NCT00477490|1822061|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0
862698|NCT00477490|1822062|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1
862699|NCT00477490|1822063|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0
862700|NCT00477490|1822064|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0
862701|NCT00477490|1822065|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0
862702|NCT00477490|1822066|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0
862703|NCT00477594|1822096|FG000|Year 1 and Year 2|Adverse Event|4
862704|NCT00477594|1822097|FG001|Year 1 and Year 2|Adverse Event|2
862705|NCT00477594|1822096|FG000|Year 1 and Year 2|Physician Decision|2
862706|NCT00477594|1822097|FG001|Year 1 and Year 2|Physician Decision|1
862707|NCT00477594|1822096|FG000|Year 1 and Year 2|Withdrawal by Subject|2
862708|NCT00477594|1822097|FG001|Year 1 and Year 2|Withdrawal by Subject|1
862709|NCT00477594|1822096|FG000|Year 1 and Year 2|Other|1
862710|NCT00477594|1822097|FG001|Year 1 and Year 2|Other|0
862711|NCT00477594|1822096|FG000|Year 3|Adverse Event|1
862712|NCT00477594|1822097|FG001|Year 3|Adverse Event|0
862713|NCT00477594|1822096|FG000|Year 3|Withdrawal by Subject|1
862714|NCT00477594|1822097|FG001|Year 3|Withdrawal by Subject|0
862715|NCT00477594|1822096|FG000|Follow-up Period|Withdrawal by Subject|2
862716|NCT00477594|1822097|FG001|Follow-up Period|Withdrawal by Subject|1
862717|NCT00477594|1822096|FG000|Follow-up Period|Other|1
862718|NCT00477594|1822097|FG001|Follow-up Period|Other|0
862719|NCT00477607|1822105|FG000|Overall Study|Lost to Follow-up|7
862720|NCT00477607|1822106|FG001|Overall Study|Lost to Follow-up|7
862721|NCT00477633|1822112|FG000|Overall Study|Did not receive treatment|23
862722|NCT00477633|1822112|FG000|Overall Study|Adverse Event|143
862723|NCT00477633|1822112|FG000|Overall Study|Pregnancy|23
862724|NCT00477633|1822112|FG000|Overall Study|Lost to Follow-up|271
862725|NCT00477633|1822112|FG000|Overall Study|Withdrawal by Subject|149
862726|NCT00477633|1822112|FG000|Overall Study|Protocol Violation|25
862727|NCT00477633|1822112|FG000|Overall Study|Various (Moving, Enrollment closed)|75
862728|NCT00477672|1822123|FG000|Overall Study|Adverse Event|3
862729|NCT00477672|1822124|FG001|Overall Study|Adverse Event|5
862730|NCT00477672|1822125|FG002|Overall Study|Adverse Event|6
862731|NCT00477672|1822123|FG000|Overall Study|Death|0
862732|NCT00477672|1822124|FG001|Overall Study|Death|1
862733|NCT00477672|1822125|FG002|Overall Study|Death|0
862734|NCT00477672|1822123|FG000|Overall Study|Disease progression|0
862735|NCT00477672|1822124|FG001|Overall Study|Disease progression|1
862736|NCT00477672|1822125|FG002|Overall Study|Disease progression|0
862737|NCT00477672|1822123|FG000|Overall Study|Physician Decision|1
862738|NCT00477672|1822124|FG001|Overall Study|Physician Decision|0
862739|NCT00477672|1822125|FG002|Overall Study|Physician Decision|0
862740|NCT00477672|1822123|FG000|Overall Study|Protocol noncompliance|0
862741|NCT00477672|1822124|FG001|Overall Study|Protocol noncompliance|2
862742|NCT00477672|1822125|FG002|Overall Study|Protocol noncompliance|0
862743|NCT00477672|1822123|FG000|Overall Study|Consent withdrawn|2
862744|NCT00477672|1822124|FG001|Overall Study|Consent withdrawn|5
862745|NCT00477672|1822125|FG002|Overall Study|Consent withdrawn|10
862746|NCT00477672|1822123|FG000|Overall Study|Discretion of Sponsor|1
862747|NCT00477672|1822124|FG001|Overall Study|Discretion of Sponsor|2
862748|NCT00477672|1822125|FG002|Overall Study|Discretion of Sponsor|0
862749|NCT00477750|1822137|FG000|Overall Study|Currently Receiving Treatment|11
862750|NCT00477971|1822145|FG000|Overall Study|Disease progression|6
862751|NCT00477971|1822146|FG001|Overall Study|Disease progression|0
862752|NCT00477971|1822145|FG000|Overall Study|Withdrawal by Subject|3
862753|NCT00477971|1822146|FG001|Overall Study|Withdrawal by Subject|1
862754|NCT00477971|1822145|FG000|Overall Study|Adverse Event|3
862755|NCT00477971|1822146|FG001|Overall Study|Adverse Event|0
862756|NCT00477971|1822145|FG000|Overall Study|Death|2
862757|NCT00477971|1822146|FG001|Overall Study|Death|4
862758|NCT00477971|1822145|FG000|Overall Study|Alternative treatment|3
862759|NCT00477971|1822146|FG001|Overall Study|Alternative treatment|1
862760|NCT00478023|1822157|FG000|Overall Study|Adverse Event|11
862761|NCT00478023|1822158|FG001|Overall Study|Adverse Event|7
862762|NCT00478023|1822159|FG002|Overall Study|Adverse Event|8
862763|NCT00478023|1822160|FG003|Overall Study|Adverse Event|14
862764|NCT00478023|1822161|FG004|Overall Study|Adverse Event|6
862765|NCT00478023|1822157|FG000|Overall Study|Death|1
862766|NCT00478023|1822158|FG001|Overall Study|Death|0
862767|NCT00478023|1822159|FG002|Overall Study|Death|0
862768|NCT00478023|1822160|FG003|Overall Study|Death|0
862769|NCT00478023|1822161|FG004|Overall Study|Death|0
862770|NCT00478023|1822157|FG000|Overall Study|Lack of Efficacy|11
862771|NCT00478023|1822158|FG001|Overall Study|Lack of Efficacy|10
862772|NCT00478023|1822159|FG002|Overall Study|Lack of Efficacy|4
862773|NCT00478023|1822160|FG003|Overall Study|Lack of Efficacy|5
862774|NCT00478023|1822161|FG004|Overall Study|Lack of Efficacy|41
862775|NCT00478023|1822157|FG000|Overall Study|Lost to Follow-up|3
862776|NCT00478023|1822158|FG001|Overall Study|Lost to Follow-up|1
862777|NCT00478023|1822159|FG002|Overall Study|Lost to Follow-up|1
862778|NCT00478023|1822160|FG003|Overall Study|Lost to Follow-up|1
862779|NCT00478023|1822161|FG004|Overall Study|Lost to Follow-up|0
862780|NCT00478023|1822157|FG000|Overall Study|Withdrawal by Subject|2
862781|NCT00478023|1822158|FG001|Overall Study|Withdrawal by Subject|3
862782|NCT00478023|1822159|FG002|Overall Study|Withdrawal by Subject|2
862783|NCT00478023|1822160|FG003|Overall Study|Withdrawal by Subject|4
862784|NCT00478023|1822161|FG004|Overall Study|Withdrawal by Subject|5
862785|NCT00478023|1822157|FG000|Overall Study|Lack of pain, Technical difficulties|7
862786|NCT00478023|1822158|FG001|Overall Study|Lack of pain, Technical difficulties|3
862787|NCT00478023|1822159|FG002|Overall Study|Lack of pain, Technical difficulties|5
862788|NCT00478023|1822160|FG003|Overall Study|Lack of pain, Technical difficulties|6
862789|NCT00478023|1822161|FG004|Overall Study|Lack of pain, Technical difficulties|3
862790|NCT00478140|1822186|FG000|Overall Study|Clinical Disease Progression|1
862791|NCT00478205|1822206|FG000|Overall Study|Adverse Event|182
862792|NCT00478205|1822207|FG001|Overall Study|Adverse Event|39
862793|NCT00478205|1822206|FG000|Overall Study|Medication Non-compliance|9
862794|NCT00478205|1822207|FG001|Overall Study|Medication Non-compliance|4
862795|NCT00478205|1822206|FG000|Overall Study|Protocol Violation|15
862796|NCT00478205|1822207|FG001|Overall Study|Protocol Violation|5
862797|NCT00478205|1822206|FG000|Overall Study|Request of Investigator or Sponsor|4
862798|NCT00478205|1822207|FG001|Overall Study|Request of Investigator or Sponsor|5
862799|NCT00478205|1822206|FG000|Overall Study|Withdrawal by Subject|61
862800|NCT00478205|1822207|FG001|Overall Study|Withdrawal by Subject|22
862801|NCT00478205|1822206|FG000|Overall Study|Lack of Efficacy|1
862802|NCT00478205|1822207|FG001|Overall Study|Lack of Efficacy|0
862803|NCT00478205|1822206|FG000|Overall Study|Other|24
862804|NCT00478205|1822207|FG001|Overall Study|Other|12
862805|NCT00478231|1822222|FG000|Overall Study|Death|7
862806|NCT00478231|1822222|FG000|Overall Study|Lack of Efficacy|47
862807|NCT00478231|1822222|FG000|Overall Study|Lost to Follow-up|7
862808|NCT00478231|1822222|FG000|Overall Study|Withdrawal by Subject|6
862809|NCT00478231|1822222|FG000|Overall Study|Other|9
862810|NCT00478231|1822222|FG000|Overall Study|Adverse Event|5
862811|NCT00478231|1822222|FG000|Overall Study|Randomized, not treated|3
862812|NCT00478244|1822226|FG000|Overall Study|Did not receive transplant|1
862813|NCT00478257|1822232|FG000|Overall Study|Withdrawal by Subject|8
862814|NCT00478257|1822233|FG001|Overall Study|Withdrawal by Subject|3
862815|NCT00478426|1822252|FG000|Overall Study|Withdrawal by Subject|1
862816|NCT00478608|1822277|FG000|Overall Study|Adverse Event|1
862817|NCT00478608|1822277|FG000|Overall Study|Serious Adverse Event|14
862818|NCT00478608|1822277|FG000|Overall Study|Withdrawal by Subject|2
862819|NCT00478608|1822277|FG000|Overall Study|Protocol Violation|3
862820|NCT00478647|1822281|FG000|Overall Study|Adverse Event|1
862821|NCT00478647|1822281|FG000|Overall Study|Withdrawal by Subject|1
862822|NCT00478673|1822285|FG000|30-Days Post-Procedure|Death|2
862823|NCT00478673|1822285|FG000|30-Days Post-Procedure|Withdrawal by Subject|1
862824|NCT00478673|1822285|FG000|30-Days Post-Procedure|Missed Visit|7
862825|NCT00478673|1822285|FG000|12-Months Post-Procedure|Death|23
862826|NCT00478673|1822285|FG000|12-Months Post-Procedure|Lost to Follow-up|4
862827|NCT00478673|1822285|FG000|12-Months Post-Procedure|Withdrawal by Subject|6
862828|NCT00478673|1822285|FG000|12-Months Post-Procedure|Missed Visit|25
862829|NCT00478673|1822285|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6
862830|NCT00478777|1822289|FG000|Overall Study|Adverse Event|29
862831|NCT00478777|1822289|FG000|Overall Study|Lack of Efficacy|23
862832|NCT00478777|1822289|FG000|Overall Study|Withdrawal by Subject|4
862833|NCT00478777|1822289|FG000|Overall Study|Death|3
862834|NCT00478777|1822289|FG000|Overall Study|Protocol Violation|3
862835|NCT00478777|1822289|FG000|Overall Study|Lost to Follow-up|3
862836|NCT00478777|1822289|FG000|Overall Study|Physician Decision|1
862837|NCT00478777|1822289|FG000|Overall Study|Intolerance of therapy|1
862838|NCT00478777|1822289|FG000|Overall Study|Lack of compliance|1
862839|NCT00478777|1822289|FG000|Overall Study|Lymphocytes infusion|1
862840|NCT00478777|1822289|FG000|Overall Study|End of therapy|2
862841|NCT00478777|1822289|FG000|Overall Study|Not treated with lenalidomide|6
862842|NCT00478881|1822295|FG000|Overall Study|Adverse Event|31
862843|NCT00478881|1822296|FG001|Overall Study|Adverse Event|12
862844|NCT00478881|1822295|FG000|Overall Study|Lack of Efficacy|0
862845|NCT00478881|1822296|FG001|Overall Study|Lack of Efficacy|3
862846|NCT00478881|1822295|FG000|Overall Study|Lost to Follow-up|0
862847|NCT00478881|1822296|FG001|Overall Study|Lost to Follow-up|1
862848|NCT00478881|1822295|FG000|Overall Study|Protocol Violation|2
862849|NCT00478881|1822296|FG001|Overall Study|Protocol Violation|2
862850|NCT00478881|1822295|FG000|Overall Study|Withdrawal by Subject|6
862851|NCT00478881|1822296|FG001|Overall Study|Withdrawal by Subject|2
862852|NCT00478881|1822295|FG000|Overall Study|Non-Compliance with Study Medication|0
862853|NCT00478881|1822296|FG001|Overall Study|Non-Compliance with Study Medication|2
862854|NCT00478933|1822302|FG000|Overall Study|Protocol Violation|22
862855|NCT00478933|1822302|FG000|Overall Study|Informed consent not verified|3
862856|NCT00478933|1822302|FG000|Overall Study|Inadequate data available|53
862857|NCT00479232|1822359|FG000|Overall Study|Adverse Event|0
862858|NCT00479232|1822360|FG001|Overall Study|Adverse Event|0
862859|NCT00479232|1822361|FG002|Overall Study|Adverse Event|5
862860|NCT00479232|1822362|FG003|Overall Study|Adverse Event|0
862861|NCT00479232|1822363|FG004|Overall Study|Adverse Event|0
862862|NCT00479232|1822364|FG005|Overall Study|Adverse Event|10
862863|NCT00479232|1822359|FG000|Overall Study|Deviation from Protocol|0
862864|NCT00479232|1822360|FG001|Overall Study|Deviation from Protocol|0
862865|NCT00479232|1822361|FG002|Overall Study|Deviation from Protocol|1
862866|NCT00479232|1822362|FG003|Overall Study|Deviation from Protocol|0
862867|NCT00479232|1822363|FG004|Overall Study|Deviation from Protocol|0
862868|NCT00479232|1822364|FG005|Overall Study|Deviation from Protocol|0
862869|NCT00479232|1822359|FG000|Overall Study|Lack of Efficacy|0
862870|NCT00479232|1822360|FG001|Overall Study|Lack of Efficacy|0
862871|NCT00479232|1822361|FG002|Overall Study|Lack of Efficacy|2
862872|NCT00479232|1822362|FG003|Overall Study|Lack of Efficacy|0
862873|NCT00479232|1822363|FG004|Overall Study|Lack of Efficacy|0
862874|NCT00479232|1822364|FG005|Overall Study|Lack of Efficacy|4
862875|NCT00479232|1822359|FG000|Overall Study|Physician Decision|0
862876|NCT00479232|1822360|FG001|Overall Study|Physician Decision|0
862877|NCT00479232|1822361|FG002|Overall Study|Physician Decision|2
862878|NCT00479232|1822362|FG003|Overall Study|Physician Decision|0
862879|NCT00479232|1822363|FG004|Overall Study|Physician Decision|0
862880|NCT00479232|1822364|FG005|Overall Study|Physician Decision|1
862881|NCT00479232|1822359|FG000|Overall Study|Progressive Disease|3
862882|NCT00479232|1822360|FG001|Overall Study|Progressive Disease|1
862883|NCT00479232|1822361|FG002|Overall Study|Progressive Disease|12
862884|NCT00479232|1822362|FG003|Overall Study|Progressive Disease|3
862885|NCT00479232|1822363|FG004|Overall Study|Progressive Disease|3
862886|NCT00479232|1822364|FG005|Overall Study|Progressive Disease|12
862887|NCT00479232|1822359|FG000|Overall Study|Withdrew Consent|0
862888|NCT00479232|1822360|FG001|Overall Study|Withdrew Consent|2
862889|NCT00479232|1822361|FG002|Overall Study|Withdrew Consent|6
862890|NCT00479232|1822362|FG003|Overall Study|Withdrew Consent|0
862891|NCT00479232|1822363|FG004|Overall Study|Withdrew Consent|1
862892|NCT00479232|1822364|FG005|Overall Study|Withdrew Consent|3
862893|NCT00479336|1822386|FG000|Overall Study|Adverse Event|1
862894|NCT00479336|1822387|FG001|Overall Study|Adverse Event|1
862895|NCT00479336|1822388|FG002|Overall Study|Adverse Event|1
862896|NCT00479336|1822389|FG003|Overall Study|Adverse Event|3
862897|NCT00479336|1822386|FG000|Overall Study|Lack of Efficacy|1
862898|NCT00479336|1822387|FG001|Overall Study|Lack of Efficacy|0
862899|NCT00479336|1822388|FG002|Overall Study|Lack of Efficacy|0
862900|NCT00479336|1822389|FG003|Overall Study|Lack of Efficacy|0
862901|NCT00479336|1822386|FG000|Overall Study|Protocol Violation|0
862902|NCT00479336|1822387|FG001|Overall Study|Protocol Violation|1
862903|NCT00479336|1822388|FG002|Overall Study|Protocol Violation|0
862904|NCT00479336|1822389|FG003|Overall Study|Protocol Violation|0
862905|NCT00479336|1822386|FG000|Overall Study|Withdrawal by Subject|1
862906|NCT00479336|1822387|FG001|Overall Study|Withdrawal by Subject|2
862907|NCT00479336|1822388|FG002|Overall Study|Withdrawal by Subject|0
862908|NCT00479336|1822389|FG003|Overall Study|Withdrawal by Subject|0
862909|NCT00479336|1822386|FG000|Overall Study|Physician Decision|0
862910|NCT00479336|1822387|FG001|Overall Study|Physician Decision|1
862911|NCT00479336|1822388|FG002|Overall Study|Physician Decision|0
862912|NCT00479336|1822389|FG003|Overall Study|Physician Decision|2
862913|NCT00479336|1822386|FG000|Overall Study|Resolution of all hepatic edema findings|1
862914|NCT00479336|1822387|FG001|Overall Study|Resolution of all hepatic edema findings|1
862915|NCT00479336|1822388|FG002|Overall Study|Resolution of all hepatic edema findings|0
862916|NCT00479336|1822389|FG003|Overall Study|Resolution of all hepatic edema findings|0
862917|NCT00479388|1822401|FG000|Overall Study|Adverse Event|90
862918|NCT00479388|1822402|FG001|Overall Study|Adverse Event|45
862919|NCT00479388|1822401|FG000|Overall Study|Lost to Follow-up|0
862920|NCT00479388|1822402|FG001|Overall Study|Lost to Follow-up|2
862921|NCT00479388|1822401|FG000|Overall Study|Protocol Violation|10
862922|NCT00479388|1822402|FG001|Overall Study|Protocol Violation|9
862923|NCT00479388|1822401|FG000|Overall Study|Withdrawal by Subject|32
862924|NCT00479388|1822402|FG001|Overall Study|Withdrawal by Subject|17
862925|NCT00479401|1822411|FG000|Overall Study|Adverse Event|24
862926|NCT00479401|1822412|FG001|Overall Study|Adverse Event|20
862927|NCT00479401|1822413|FG002|Overall Study|Adverse Event|4
862928|NCT00479401|1822411|FG000|Overall Study|Lack of Efficacy|2
862929|NCT00479401|1822412|FG001|Overall Study|Lack of Efficacy|2
862930|NCT00479401|1822413|FG002|Overall Study|Lack of Efficacy|4
862931|NCT00479401|1822411|FG000|Overall Study|Protocol Violation|2
862932|NCT00479401|1822412|FG001|Overall Study|Protocol Violation|1
862933|NCT00479401|1822413|FG002|Overall Study|Protocol Violation|1
862934|NCT00479401|1822411|FG000|Overall Study|Lost to Follow-up|1
862935|NCT00479401|1822412|FG001|Overall Study|Lost to Follow-up|1
862936|NCT00479401|1822413|FG002|Overall Study|Lost to Follow-up|1
862937|NCT00479401|1822411|FG000|Overall Study|Withdrawal by Subject|16
862938|NCT00479401|1822412|FG001|Overall Study|Withdrawal by Subject|10
862939|NCT00479401|1822413|FG002|Overall Study|Withdrawal by Subject|2
862940|NCT00479401|1822411|FG000|Overall Study|Exclusion criteria, relocation|4
862941|NCT00479401|1822412|FG001|Overall Study|Exclusion criteria, relocation|3
862942|NCT00479401|1822413|FG002|Overall Study|Exclusion criteria, relocation|0
862943|NCT00479466|1822427|FG000|Overall Study|Adverse Event|5
862944|NCT00479466|1822428|FG001|Overall Study|Adverse Event|1
862945|NCT00479466|1822429|FG002|Overall Study|Adverse Event|0
862946|NCT00479466|1822430|FG003|Overall Study|Adverse Event|1
862947|NCT00479466|1822431|FG004|Overall Study|Adverse Event|2
862948|NCT00479466|1822432|FG005|Overall Study|Adverse Event|0
862949|NCT00479466|1822427|FG000|Overall Study|Hyperglycemia|0
862950|NCT00479466|1822428|FG001|Overall Study|Hyperglycemia|0
862951|NCT00479466|1822429|FG002|Overall Study|Hyperglycemia|0
862952|NCT00479466|1822430|FG003|Overall Study|Hyperglycemia|0
862953|NCT00479466|1822431|FG004|Overall Study|Hyperglycemia|0
862954|NCT00479466|1822432|FG005|Overall Study|Hyperglycemia|1
862955|NCT00479466|1822427|FG000|Overall Study|Lack of Efficacy|2
862956|NCT00479466|1822428|FG001|Overall Study|Lack of Efficacy|0
862957|NCT00479466|1822429|FG002|Overall Study|Lack of Efficacy|1
862958|NCT00479466|1822430|FG003|Overall Study|Lack of Efficacy|0
862959|NCT00479466|1822431|FG004|Overall Study|Lack of Efficacy|0
862960|NCT00479466|1822432|FG005|Overall Study|Lack of Efficacy|0
862961|NCT00479466|1822427|FG000|Overall Study|Lost to Follow-up|0
862962|NCT00479466|1822428|FG001|Overall Study|Lost to Follow-up|1
862963|NCT00479466|1822429|FG002|Overall Study|Lost to Follow-up|1
862964|NCT00479466|1822430|FG003|Overall Study|Lost to Follow-up|0
862965|NCT00479466|1822431|FG004|Overall Study|Lost to Follow-up|2
862966|NCT00479466|1822432|FG005|Overall Study|Lost to Follow-up|2
862967|NCT00479466|1822427|FG000|Overall Study|Physician Decision|2
862968|NCT00479466|1822428|FG001|Overall Study|Physician Decision|1
862969|NCT00479466|1822429|FG002|Overall Study|Physician Decision|1
862970|NCT00479466|1822430|FG003|Overall Study|Physician Decision|0
862971|NCT00479466|1822431|FG004|Overall Study|Physician Decision|0
862972|NCT00479466|1822432|FG005|Overall Study|Physician Decision|0
862973|NCT00479466|1822427|FG000|Overall Study|Pregnancy|0
862974|NCT00479466|1822428|FG001|Overall Study|Pregnancy|0
862975|NCT00479466|1822429|FG002|Overall Study|Pregnancy|0
862976|NCT00479466|1822430|FG003|Overall Study|Pregnancy|0
862977|NCT00479466|1822431|FG004|Overall Study|Pregnancy|1
862978|NCT00479466|1822432|FG005|Overall Study|Pregnancy|0
862979|NCT00479466|1822427|FG000|Overall Study|Protocol Violation|1
862980|NCT00479466|1822428|FG001|Overall Study|Protocol Violation|0
862981|NCT00479466|1822429|FG002|Overall Study|Protocol Violation|0
862982|NCT00479466|1822430|FG003|Overall Study|Protocol Violation|0
862983|NCT00479466|1822431|FG004|Overall Study|Protocol Violation|0
862984|NCT00479466|1822432|FG005|Overall Study|Protocol Violation|0
862985|NCT00479466|1822427|FG000|Overall Study|Withdrawal by Subject|3
862986|NCT00479466|1822428|FG001|Overall Study|Withdrawal by Subject|5
862987|NCT00479466|1822429|FG002|Overall Study|Withdrawal by Subject|0
862988|NCT00479466|1822430|FG003|Overall Study|Withdrawal by Subject|2
862989|NCT00479466|1822431|FG004|Overall Study|Withdrawal by Subject|3
862990|NCT00479466|1822432|FG005|Overall Study|Withdrawal by Subject|1
862991|NCT00479557|1822453|FG000|Overall Study|Death|0
862992|NCT00479557|1822454|FG001|Overall Study|Death|0
862993|NCT00479557|1822455|FG002|Overall Study|Death|0
862994|NCT00479557|1822456|FG003|Overall Study|Death|0
862995|NCT00479557|1822457|FG004|Overall Study|Death|0
862996|NCT00479557|1822458|FG005|Overall Study|Death|1
862997|NCT00479557|1822459|FG006|Overall Study|Death|0
862998|NCT00479557|1822453|FG000|Overall Study|Lack of Efficacy|1
862999|NCT00479557|1822454|FG001|Overall Study|Lack of Efficacy|0
863000|NCT00479557|1822455|FG002|Overall Study|Lack of Efficacy|0
863001|NCT00479557|1822456|FG003|Overall Study|Lack of Efficacy|0
863002|NCT00479557|1822457|FG004|Overall Study|Lack of Efficacy|0
863003|NCT00479557|1822458|FG005|Overall Study|Lack of Efficacy|0
863004|NCT00479557|1822459|FG006|Overall Study|Lack of Efficacy|0
863005|NCT00479557|1822453|FG000|Overall Study|Lost to Follow-up|0
863006|NCT00479557|1822454|FG001|Overall Study|Lost to Follow-up|2
863007|NCT00479557|1822455|FG002|Overall Study|Lost to Follow-up|0
863008|NCT00479557|1822456|FG003|Overall Study|Lost to Follow-up|2
863009|NCT00479557|1822457|FG004|Overall Study|Lost to Follow-up|0
863010|NCT00479557|1822458|FG005|Overall Study|Lost to Follow-up|0
863011|NCT00479557|1822459|FG006|Overall Study|Lost to Follow-up|0
863012|NCT00479557|1822453|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
863013|NCT00479557|1822454|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
863014|NCT00479557|1822455|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
863015|NCT00479557|1822456|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
863016|NCT00479557|1822457|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
863017|NCT00479557|1822458|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
863018|NCT00479557|1822459|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
863019|NCT00479557|1822453|FG000|Overall Study|AE not related to Study Drug|1
863020|NCT00479557|1822454|FG001|Overall Study|AE not related to Study Drug|3
863021|NCT00479557|1822455|FG002|Overall Study|AE not related to Study Drug|0
863022|NCT00479557|1822456|FG003|Overall Study|AE not related to Study Drug|0
863023|NCT00479557|1822457|FG004|Overall Study|AE not related to Study Drug|2
863024|NCT00479557|1822458|FG005|Overall Study|AE not related to Study Drug|2
863025|NCT00479557|1822459|FG006|Overall Study|AE not related to Study Drug|1
863026|NCT00479557|1822453|FG000|Overall Study|Caregiver Request|2
863027|NCT00479557|1822454|FG001|Overall Study|Caregiver Request|2
863028|NCT00479557|1822455|FG002|Overall Study|Caregiver Request|2
863029|NCT00479557|1822456|FG003|Overall Study|Caregiver Request|0
863030|NCT00479557|1822457|FG004|Overall Study|Caregiver Request|1
863031|NCT00479557|1822458|FG005|Overall Study|Caregiver Request|2
863032|NCT00479557|1822459|FG006|Overall Study|Caregiver Request|0
863033|NCT00479557|1822453|FG000|Overall Study|Investigator Request|0
863034|NCT00479557|1822454|FG001|Overall Study|Investigator Request|0
863035|NCT00479557|1822455|FG002|Overall Study|Investigator Request|1
863036|NCT00479557|1822456|FG003|Overall Study|Investigator Request|0
863037|NCT00479557|1822457|FG004|Overall Study|Investigator Request|0
863038|NCT00479557|1822458|FG005|Overall Study|Investigator Request|0
863039|NCT00479557|1822459|FG006|Overall Study|Investigator Request|0
863040|NCT00479557|1822453|FG000|Overall Study|Subject Request|3
863041|NCT00479557|1822454|FG001|Overall Study|Subject Request|0
863042|NCT00479557|1822455|FG002|Overall Study|Subject Request|1
863043|NCT00479557|1822456|FG003|Overall Study|Subject Request|1
863044|NCT00479557|1822457|FG004|Overall Study|Subject Request|1
863045|NCT00479557|1822458|FG005|Overall Study|Subject Request|4
863046|NCT00479557|1822459|FG006|Overall Study|Subject Request|1
863047|NCT00479557|1822453|FG000|Overall Study|Other|2
863048|NCT00479557|1822454|FG001|Overall Study|Other|3
863049|NCT00479557|1822455|FG002|Overall Study|Other|1
863050|NCT00479557|1822456|FG003|Overall Study|Other|0
863051|NCT00479557|1822457|FG004|Overall Study|Other|0
863052|NCT00479557|1822458|FG005|Overall Study|Other|3
863053|NCT00479557|1822459|FG006|Overall Study|Other|0
863054|NCT00479674|1822481|FG000|Overall Study|Adverse Event|18
863055|NCT00479674|1822481|FG000|Overall Study|Withdrawal by Subject|6
863056|NCT00479674|1822481|FG000|Overall Study|Physician Decision|14
863057|NCT00479674|1822481|FG000|Overall Study|none provided|3
863058|NCT00479687|1822487|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
863059|NCT00479687|1822488|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2
863060|NCT00479687|1822489|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
863061|NCT00479687|1822487|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0
863062|NCT00479687|1822488|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1
863063|NCT00479687|1822489|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0
863064|NCT00479687|1822487|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4
863065|NCT00479687|1822488|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5
863066|NCT00479687|1822489|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0
863067|NCT00479687|1822487|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2
863068|NCT00479687|1822488|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
863069|NCT00479687|1822489|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
863070|NCT00479687|1822487|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19
863071|NCT00479687|1822488|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11
863072|NCT00479687|1822489|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0
863073|NCT00479687|1822487|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
863074|NCT00479687|1822488|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
863075|NCT00479687|1822489|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4
863076|NCT00479687|1822487|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
863077|NCT00479687|1822488|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
863078|NCT00479687|1822489|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3
863079|NCT00479687|1822487|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
863080|NCT00479687|1822488|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
863081|NCT00479687|1822489|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1
863082|NCT00479687|1822487|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0
863083|NCT00479687|1822488|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0
863084|NCT00479687|1822489|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1
863085|NCT00479713|1822498|FG000|Overall Study|Adverse Event|8
863086|NCT00479713|1822499|FG001|Overall Study|Adverse Event|6
863087|NCT00479713|1822498|FG000|Overall Study|Death|1
863088|NCT00479713|1822499|FG001|Overall Study|Death|0
863089|NCT00479713|1822498|FG000|Overall Study|Lost to Follow-up|0
863090|NCT00479713|1822499|FG001|Overall Study|Lost to Follow-up|1
863091|NCT00479713|1822498|FG000|Overall Study|Protocol Violation|0
863092|NCT00479713|1822499|FG001|Overall Study|Protocol Violation|1
863093|NCT00479713|1822498|FG000|Overall Study|Withdrawal by Subject|4
863094|NCT00479713|1822499|FG001|Overall Study|Withdrawal by Subject|1
863095|NCT00479765|1822505|FG000|Overall Study|study terminated|4
863096|NCT00479856|1822509|FG000|Overall Study|Adverse Event|1
863097|NCT00479856|1822509|FG000|Overall Study|Withdrawal by Subject|1
863098|NCT00479856|1822509|FG000|Overall Study|Physician Decision|1
863099|NCT00479882|1822517|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
863100|NCT00479882|1822518|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
863101|NCT00479882|1822519|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
863102|NCT00479882|1822520|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
863103|NCT00479882|1822517|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
863104|NCT00479882|1822518|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
863105|NCT00479882|1822519|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
863106|NCT00479882|1822520|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
863107|NCT00479882|1822517|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
863108|NCT00479882|1822518|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
863109|NCT00479882|1822519|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
863110|NCT00479882|1822520|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
863111|NCT00479882|1822517|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4
863112|NCT00479882|1822518|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6
863113|NCT00479882|1822519|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9
863114|NCT00479882|1822520|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5
863115|NCT00479882|1822517|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
863116|NCT00479882|1822518|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
863117|NCT00479882|1822519|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
863118|NCT00479882|1822520|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
863119|NCT00479882|1822517|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
863120|NCT00479882|1822518|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
863121|NCT00479882|1822519|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
863122|NCT00479882|1822520|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
863123|NCT00479882|1822517|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
863124|NCT00479882|1822518|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
863125|NCT00479882|1822519|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
863126|NCT00479882|1822520|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
863127|NCT00479882|1822517|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
863128|NCT00479882|1822518|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
863129|NCT00479882|1822519|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
863130|NCT00479882|1822520|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
863131|NCT00479882|1822517|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
863132|NCT00479882|1822518|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
863133|NCT00479882|1822519|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
863134|NCT00479882|1822520|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
863135|NCT00479882|1822517|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
863136|NCT00479882|1822518|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
863137|NCT00479882|1822519|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
863138|NCT00479882|1822520|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
863139|NCT00479882|1822517|FG000|Crossover: Period III (Weeks 13-20)|Other|5
863140|NCT00479882|1822518|FG001|Crossover: Period III (Weeks 13-20)|Other|0
863141|NCT00479882|1822519|FG002|Crossover: Period III (Weeks 13-20)|Other|2
863142|NCT00479882|1822520|FG003|Crossover: Period III (Weeks 13-20)|Other|2
863143|NCT00479882|1822517|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1
863144|NCT00479882|1822518|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2
863145|NCT00479882|1822519|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1
863146|NCT00479882|1822520|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0
863147|NCT00479882|1822517|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
863148|NCT00479882|1822518|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
863149|NCT00479882|1822519|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
863150|NCT00479882|1822520|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
863151|NCT00479882|1822517|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
863152|NCT00479882|1822518|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
863153|NCT00479882|1822519|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
863154|NCT00479882|1822520|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
863155|NCT00480025|1822548|FG000|Overall Study|Protocol Violation|12
863156|NCT00480025|1822549|FG001|Overall Study|Protocol Violation|7
863157|NCT00480025|1822548|FG000|Overall Study|Patients remaining ongoing at Data Lock|101
863158|NCT00480025|1822549|FG001|Overall Study|Patients remaining ongoing at Data Lock|55
863159|NCT00480025|1822548|FG000|Overall Study|Disease Progression / Recurrence|449
863160|NCT00480025|1822549|FG001|Overall Study|Disease Progression / Recurrence|224
863161|NCT00480025|1822548|FG000|Overall Study|Adverse Event|44
863162|NCT00480025|1822549|FG001|Overall Study|Adverse Event|12
863163|NCT00480025|1822548|FG000|Overall Study|Other|70
863164|NCT00480025|1822549|FG001|Overall Study|Other|29
863165|NCT00480025|1822548|FG000|Overall Study|SAE including intercurrent illness|76
863166|NCT00480025|1822549|FG001|Overall Study|SAE including intercurrent illness|42
863167|NCT00480077|1822563|FG000|Overall Study|Death|19
863168|NCT00480077|1822564|FG001|Overall Study|Death|15
863169|NCT00480077|1822563|FG000|Overall Study|early exit|12
863170|NCT00480077|1822564|FG001|Overall Study|early exit|11
863171|NCT00480324|1822572|FG000|Overall Study|Adverse Event|1
863172|NCT00480324|1822573|FG001|Overall Study|Adverse Event|1
863173|NCT00480324|1822572|FG000|Overall Study|Protocol Violation|0
863174|NCT00480324|1822573|FG001|Overall Study|Protocol Violation|1
863175|NCT00480324|1822572|FG000|Overall Study|Withdrawal by Subject|14
863176|NCT00480324|1822573|FG001|Overall Study|Withdrawal by Subject|5
863177|NCT00480324|1822572|FG000|Overall Study|Lost to Follow-up|17
863178|NCT00480324|1822573|FG001|Overall Study|Lost to Follow-up|8
863179|NCT00480324|1822572|FG000|Overall Study|Subject's mother pregnant|0
863180|NCT00480324|1822573|FG001|Overall Study|Subject's mother pregnant|1
863181|NCT00480441|1822581|FG000|Screening|Not Eligible|37
863182|NCT00480441|1822582|FG001|Screening|Not Eligible|0
863183|NCT00480441|1822583|FG002|Screening|Not Eligible|0
863184|NCT00480441|1822581|FG000|Baseline Functional MRI|Functional MRI data not usable|4
863185|NCT00480441|1822582|FG001|Baseline Functional MRI|Functional MRI data not usable|0
863186|NCT00480441|1822583|FG002|Baseline Functional MRI|Functional MRI data not usable|0
863187|NCT00480441|1822581|FG000|Baseline Functional MRI|Lost to Follow-up|4
863188|NCT00480441|1822582|FG001|Baseline Functional MRI|Lost to Follow-up|0
863189|NCT00480441|1822583|FG002|Baseline Functional MRI|Lost to Follow-up|0
863190|NCT00480441|1822581|FG000|Baseline Functional MRI|physical contraindication|4
863191|NCT00480441|1822582|FG001|Baseline Functional MRI|physical contraindication|0
863192|NCT00480441|1822583|FG002|Baseline Functional MRI|physical contraindication|0
863193|NCT00480441|1822581|FG000|Randomization|Lost to Follow-up|0
863194|NCT00480441|1822582|FG001|Randomization|Lost to Follow-up|7
863195|NCT00480441|1822583|FG002|Randomization|Lost to Follow-up|2
863196|NCT00480493|1822592|FG000|Overall Study|moved|2
863197|NCT00480493|1822593|FG001|Overall Study|moved|7
863198|NCT00480532|1822605|FG000|Overall Study|Withdrawal by Subject|2
863199|NCT00480532|1822606|FG001|Overall Study|Withdrawal by Subject|4
863200|NCT00480532|1822607|FG002|Overall Study|Withdrawal by Subject|3
863201|NCT00480532|1822608|FG003|Overall Study|Withdrawal by Subject|1
863202|NCT00480532|1822605|FG000|Overall Study|Protocol Violation|0
863203|NCT00480532|1822606|FG001|Overall Study|Protocol Violation|0
863204|NCT00480532|1822607|FG002|Overall Study|Protocol Violation|1
863205|NCT00480532|1822608|FG003|Overall Study|Protocol Violation|0
863206|NCT00480636|1822618|FG000|Overall Study|Death|12
863207|NCT00480636|1822618|FG000|Overall Study|Lost to Follow-up|4
863208|NCT00480636|1822618|FG000|Overall Study|Other|2
863209|NCT00480636|1822618|FG000|Overall Study|Lost to follow-up; subsequently died|1
863210|NCT00480779|1822637|FG000|Overall Study|Other|2
863211|NCT00480779|1822638|FG001|Overall Study|Other|0
863212|NCT00480779|1822637|FG000|Overall Study|Job and Health-related|0
863213|NCT00480779|1822638|FG001|Overall Study|Job and Health-related|3
863214|NCT00480857|1822644|FG000|Overall Study|Lack of Efficacy|2
863215|NCT00481065|1822660|FG000|Overall Study|Adverse event or death|1
863216|NCT00481065|1822661|FG001|Overall Study|Adverse event or death|1
863217|NCT00481065|1822662|FG002|Overall Study|Adverse event or death|3
863218|NCT00481065|1822663|FG003|Overall Study|Adverse event or death|0
863219|NCT00481065|1822664|FG004|Overall Study|Adverse event or death|2
863220|NCT00481065|1822665|FG005|Overall Study|Adverse event or death|0
863221|NCT00481065|1822666|FG006|Overall Study|Adverse event or death|1
863222|NCT00481065|1822667|FG007|Overall Study|Adverse event or death|1
863223|NCT00481065|1822660|FG000|Overall Study|Withdrawal by Subject|11
863224|NCT00481065|1822661|FG001|Overall Study|Withdrawal by Subject|12
863225|NCT00481065|1822662|FG002|Overall Study|Withdrawal by Subject|7
863226|NCT00481065|1822663|FG003|Overall Study|Withdrawal by Subject|11
863227|NCT00481065|1822664|FG004|Overall Study|Withdrawal by Subject|13
863228|NCT00481065|1822665|FG005|Overall Study|Withdrawal by Subject|12
863229|NCT00481065|1822666|FG006|Overall Study|Withdrawal by Subject|9
863230|NCT00481065|1822667|FG007|Overall Study|Withdrawal by Subject|10
863231|NCT00481065|1822660|FG000|Overall Study|Lost to Follow-up|4
863232|NCT00481065|1822661|FG001|Overall Study|Lost to Follow-up|2
863233|NCT00481065|1822662|FG002|Overall Study|Lost to Follow-up|4
863234|NCT00481065|1822663|FG003|Overall Study|Lost to Follow-up|3
863235|NCT00481065|1822664|FG004|Overall Study|Lost to Follow-up|3
863236|NCT00481065|1822665|FG005|Overall Study|Lost to Follow-up|3
863237|NCT00481065|1822666|FG006|Overall Study|Lost to Follow-up|2
863238|NCT00481065|1822667|FG007|Overall Study|Lost to Follow-up|5
863239|NCT00481065|1822660|FG000|Overall Study|Inappropriate enrollment|4
863240|NCT00481065|1822661|FG001|Overall Study|Inappropriate enrollment|0
863241|NCT00481065|1822662|FG002|Overall Study|Inappropriate enrollment|2
863242|NCT00481065|1822663|FG003|Overall Study|Inappropriate enrollment|0
863243|NCT00481065|1822664|FG004|Overall Study|Inappropriate enrollment|2
863244|NCT00481065|1822665|FG005|Overall Study|Inappropriate enrollment|1
863245|NCT00481065|1822666|FG006|Overall Study|Inappropriate enrollment|0
863246|NCT00481065|1822667|FG007|Overall Study|Inappropriate enrollment|1
863247|NCT00481065|1822660|FG000|Overall Study|Administrative reason|0
863248|NCT00481065|1822661|FG001|Overall Study|Administrative reason|0
863249|NCT00481065|1822662|FG002|Overall Study|Administrative reason|0
863250|NCT00481065|1822663|FG003|Overall Study|Administrative reason|0
863251|NCT00481065|1822664|FG004|Overall Study|Administrative reason|0
863252|NCT00481065|1822665|FG005|Overall Study|Administrative reason|2
863253|NCT00481065|1822666|FG006|Overall Study|Administrative reason|1
863254|NCT00481065|1822667|FG007|Overall Study|Administrative reason|0
863255|NCT00481065|1822660|FG000|Overall Study|Protocol Violation|2
863256|NCT00481065|1822661|FG001|Overall Study|Protocol Violation|1
863257|NCT00481065|1822662|FG002|Overall Study|Protocol Violation|1
863258|NCT00481065|1822663|FG003|Overall Study|Protocol Violation|1
863259|NCT00481065|1822664|FG004|Overall Study|Protocol Violation|2
863260|NCT00481065|1822665|FG005|Overall Study|Protocol Violation|6
863261|NCT00481065|1822666|FG006|Overall Study|Protocol Violation|3
863262|NCT00481065|1822667|FG007|Overall Study|Protocol Violation|2
863263|NCT00481065|1822660|FG000|Overall Study|Unable to classify|0
863264|NCT00481065|1822661|FG001|Overall Study|Unable to classify|1
863265|NCT00481065|1822662|FG002|Overall Study|Unable to classify|2
863266|NCT00481065|1822663|FG003|Overall Study|Unable to classify|0
863267|NCT00481065|1822664|FG004|Overall Study|Unable to classify|1
863268|NCT00481065|1822665|FG005|Overall Study|Unable to classify|0
863269|NCT00481065|1822666|FG006|Overall Study|Unable to classify|0
863270|NCT00481065|1822667|FG007|Overall Study|Unable to classify|0
863271|NCT00481078|1822689|FG000|Overall Study|Progression of disease|11
863272|NCT00481078|1822690|FG001|Overall Study|Progression of disease|11
863273|NCT00481078|1822689|FG000|Overall Study|Adverse Event|15
863274|NCT00481078|1822690|FG001|Overall Study|Adverse Event|3
863275|NCT00481078|1822689|FG000|Overall Study|Death|5
863276|NCT00481078|1822690|FG001|Overall Study|Death|3
863277|NCT00481078|1822689|FG000|Overall Study|Intercurrent illness|1
863278|NCT00481078|1822690|FG001|Overall Study|Intercurrent illness|0
863279|NCT00481078|1822689|FG000|Overall Study|Withdrawal by Subject|7
863280|NCT00481078|1822690|FG001|Overall Study|Withdrawal by Subject|1
863281|NCT00481078|1822689|FG000|Overall Study|Information not available|1
863282|NCT00481078|1822690|FG001|Overall Study|Information not available|0
863283|NCT00481078|1822689|FG000|Overall Study|Received other treatment|2
863284|NCT00481078|1822690|FG001|Overall Study|Received other treatment|1
863285|NCT00481078|1822689|FG000|Overall Study|Brain metastasis|0
863286|NCT00481078|1822690|FG001|Overall Study|Brain metastasis|1
863287|NCT00481195|1822698|FG000|Overall Study|Adverse Event|16
863288|NCT00481195|1822699|FG001|Overall Study|Adverse Event|11
863289|NCT00481195|1822698|FG000|Overall Study|Lack of Efficacy|1
863290|NCT00481195|1822699|FG001|Overall Study|Lack of Efficacy|3
863291|NCT00481195|1822698|FG000|Overall Study|Lost to Follow-up|4
863292|NCT00481195|1822699|FG001|Overall Study|Lost to Follow-up|6
863293|NCT00481195|1822698|FG000|Overall Study|Physician Decision|3
863294|NCT00481195|1822699|FG001|Overall Study|Physician Decision|1
863295|NCT00481195|1822698|FG000|Overall Study|Protocol Violation|10
863296|NCT00481195|1822699|FG001|Overall Study|Protocol Violation|7
863297|NCT00481195|1822698|FG000|Overall Study|Withdrawal by Subject|3
863298|NCT00481195|1822699|FG001|Overall Study|Withdrawal by Subject|9
863299|NCT00481195|1822698|FG000|Overall Study|Miscellaneous|2
863300|NCT00481195|1822699|FG001|Overall Study|Miscellaneous|2
863301|NCT00481247|1822707|FG000|Overall Study|Death|0
863302|NCT00481247|1822708|FG001|Overall Study|Death|1
863303|NCT00481247|1822707|FG000|Overall Study|Disease progression|18
863304|NCT00481247|1822708|FG001|Overall Study|Disease progression|22
863305|NCT00481247|1822707|FG000|Overall Study|Intolerance|42
863306|NCT00481247|1822708|FG001|Overall Study|Intolerance|17
863307|NCT00481247|1822707|FG000|Overall Study|Treatment failure|10
863308|NCT00481247|1822708|FG001|Overall Study|Treatment failure|14
863309|NCT00481247|1822707|FG000|Overall Study|AE unrelated to study drug|13
863310|NCT00481247|1822708|FG001|Overall Study|AE unrelated to study drug|4
863311|NCT00481247|1822707|FG000|Overall Study|Withdrawal by Subject|8
863312|NCT00481247|1822708|FG001|Overall Study|Withdrawal by Subject|13
863313|NCT00481247|1822707|FG000|Overall Study|Pregnancy|2
863314|NCT00481247|1822708|FG001|Overall Study|Pregnancy|1
863315|NCT00481247|1822707|FG000|Overall Study|Lost to Follow-up|1
863316|NCT00481247|1822708|FG001|Overall Study|Lost to Follow-up|2
863317|NCT00481247|1822707|FG000|Overall Study|Poor compliance/noncompliance|1
863318|NCT00481247|1822708|FG001|Overall Study|Poor compliance/noncompliance|7
863319|NCT00481247|1822707|FG000|Overall Study|Administrative reason by sponsor|157
863320|NCT00481247|1822708|FG001|Overall Study|Administrative reason by sponsor|162
863321|NCT00481247|1822707|FG000|Overall Study|Varied|6
863322|NCT00481247|1822708|FG001|Overall Study|Varied|15
863323|NCT00481247|1822707|FG000|Overall Study|Did not receive treatment|1
863324|NCT00481247|1822708|FG001|Overall Study|Did not receive treatment|2
863325|NCT00481676|1822734|FG000|Overall Study|Adverse Event|0
863326|NCT00481676|1822735|FG001|Overall Study|Adverse Event|1
863327|NCT00481676|1822734|FG000|Overall Study|Unsatisfactory therapeutic effect|1
863328|NCT00481676|1822735|FG001|Overall Study|Unsatisfactory therapeutic effect|4
863329|NCT00481676|1822734|FG000|Overall Study|Administrative problem|1
863330|NCT00481676|1822735|FG001|Overall Study|Administrative problem|0
863331|NCT00481767|1822743|FG000|Overall Study|Withdrawal by Subject|16
863332|NCT00481767|1822744|FG001|Overall Study|Withdrawal by Subject|11
863333|NCT00481767|1822743|FG000|Overall Study|Lost to Follow-up|16
863334|NCT00481767|1822744|FG001|Overall Study|Lost to Follow-up|10
863335|NCT00481832|1822750|FG000|Enrollment|Physician Decision|8
863336|NCT00481832|1822750|FG000|Enrollment|Unable to collect enough stem cells|2
863337|NCT00481832|1822750|FG000|Inter-transplant Period|Adverse Event|4
863338|NCT00481832|1822750|FG000|Inter-transplant Period|Death|3
863339|NCT00481832|1822750|FG000|Inter-transplant Period|Physician Decision|4
863340|NCT00481832|1822750|FG000|Inter-transplant Period|Disease relapse|11
863341|NCT00481832|1822750|FG000|Inter-transplant Period|Lack of allogeneic donor|5
863342|NCT00481871|1822768|FG000|Overall Study|Progressive Disease - pt withdrew|0
863343|NCT00481871|1822769|FG001|Overall Study|Progressive Disease - pt withdrew|0
863344|NCT00481871|1822770|FG002|Overall Study|Progressive Disease - pt withdrew|1
863345|NCT00481871|1822771|FG003|Overall Study|Progressive Disease - pt withdrew|0
863346|NCT00481871|1822772|FG004|Overall Study|Progressive Disease - pt withdrew|0
863347|NCT00481988|1822782|FG000|Overall Study|Withdrawal by Subject|1
863348|NCT00481988|1822783|FG001|Overall Study|Withdrawal by Subject|1
863349|NCT00482001|1822791|FG000|Overall Study|Protocol Violation|1
863350|NCT00482001|1822792|FG001|Overall Study|Protocol Violation|1
863351|NCT00482014|1822804|FG000|Overall Study|Withdrawal by Subject|1
863352|NCT00482014|1822805|FG001|Overall Study|Withdrawal by Subject|2
863353|NCT00482014|1822806|FG002|Overall Study|Withdrawal by Subject|3
863354|NCT00482014|1822807|FG003|Overall Study|Withdrawal by Subject|4
863355|NCT00482014|1822804|FG000|Overall Study|Adverse Event|3
863356|NCT00482014|1822805|FG001|Overall Study|Adverse Event|0
863357|NCT00482014|1822806|FG002|Overall Study|Adverse Event|2
863358|NCT00482014|1822807|FG003|Overall Study|Adverse Event|8
863359|NCT00482014|1822804|FG000|Overall Study|Death|1
863360|NCT00482014|1822805|FG001|Overall Study|Death|2
863361|NCT00482014|1822806|FG002|Overall Study|Death|1
863362|NCT00482014|1822807|FG003|Overall Study|Death|4
863363|NCT00482014|1822804|FG000|Overall Study|Lack of Efficacy|1
863364|NCT00482014|1822805|FG001|Overall Study|Lack of Efficacy|0
863365|NCT00482014|1822806|FG002|Overall Study|Lack of Efficacy|4
863366|NCT00482014|1822807|FG003|Overall Study|Lack of Efficacy|6
863367|NCT00482014|1822804|FG000|Overall Study|Sponsor Decision|1
863368|NCT00482014|1822805|FG001|Overall Study|Sponsor Decision|2
863369|NCT00482014|1822806|FG002|Overall Study|Sponsor Decision|1
863370|NCT00482014|1822807|FG003|Overall Study|Sponsor Decision|1
863371|NCT00482053|1822819|FG000|Inter-treatment Period|Disease progression|1
863372|NCT00482170|1822825|FG000|Overall Study|Adverse Event|5
863373|NCT00482170|1822826|FG001|Overall Study|Adverse Event|14
863374|NCT00482170|1822825|FG000|Overall Study|Withdrawal by Subject|6
863375|NCT00482170|1822826|FG001|Overall Study|Withdrawal by Subject|1
863376|NCT00482170|1822825|FG000|Overall Study|Protocol Violation|2
863377|NCT00482170|1822826|FG001|Overall Study|Protocol Violation|3
863378|NCT00482170|1822825|FG000|Overall Study|Lost to Follow-up|2
863379|NCT00482170|1822826|FG001|Overall Study|Lost to Follow-up|0
863380|NCT00482170|1822825|FG000|Overall Study|Unspecified reason|0
863381|NCT00482170|1822826|FG001|Overall Study|Unspecified reason|2
863382|NCT00482274|1822832|FG000|Overall Study|Adverse Event|1
863383|NCT00482391|1822836|FG000|Overall Study|Withdrawal by Subject|1
863384|NCT00482391|1822836|FG000|Overall Study|Adverse Event|1
863385|NCT00482391|1822836|FG000|Overall Study|Death|1
863386|NCT00482612|1822854|FG000|In-treatment Period|No study medication administered|0
863387|NCT00482612|1822855|FG001|In-treatment Period|No study medication administered|0
863388|NCT00482612|1822856|FG002|In-treatment Period|No study medication administered|1
863389|NCT00482612|1822857|FG003|In-treatment Period|No study medication administered|0
863390|NCT00482612|1822854|FG000|Follow-up Period|Other|4
863391|NCT00482612|1822855|FG001|Follow-up Period|Other|2
863392|NCT00482612|1822856|FG002|Follow-up Period|Other|1
863393|NCT00482612|1822857|FG003|Follow-up Period|Other|2
863394|NCT00482612|1822854|FG000|Follow-up Period|Lack of compliance|0
863395|NCT00482612|1822855|FG001|Follow-up Period|Lack of compliance|0
863396|NCT00482612|1822856|FG002|Follow-up Period|Lack of compliance|1
863397|NCT00482612|1822857|FG003|Follow-up Period|Lack of compliance|0
863398|NCT00482612|1822854|FG000|Follow-up Period|Lost to Follow-up|0
863399|NCT00482612|1822855|FG001|Follow-up Period|Lost to Follow-up|4
863400|NCT00482612|1822856|FG002|Follow-up Period|Lost to Follow-up|2
863401|NCT00482612|1822857|FG003|Follow-up Period|Lost to Follow-up|1
863402|NCT00482612|1822854|FG000|Follow-up Period|Adverse Event|4
863403|NCT00482612|1822855|FG001|Follow-up Period|Adverse Event|7
863404|NCT00482612|1822856|FG002|Follow-up Period|Adverse Event|9
863405|NCT00482612|1822857|FG003|Follow-up Period|Adverse Event|0
863406|NCT00482612|1822854|FG000|Follow-up Period|Lack of Efficacy|2
863407|NCT00482612|1822855|FG001|Follow-up Period|Lack of Efficacy|0
863408|NCT00482612|1822856|FG002|Follow-up Period|Lack of Efficacy|1
863409|NCT00482612|1822857|FG003|Follow-up Period|Lack of Efficacy|0
863410|NCT00482612|1822854|FG000|Follow-up Period|Withdrawal by Subject|3
863411|NCT00482612|1822855|FG001|Follow-up Period|Withdrawal by Subject|5
863412|NCT00482612|1822856|FG002|Follow-up Period|Withdrawal by Subject|7
863413|NCT00482612|1822857|FG003|Follow-up Period|Withdrawal by Subject|2
863414|NCT00482612|1822854|FG000|Follow-up Period|Reasons not related to trial|1
863415|NCT00482612|1822855|FG001|Follow-up Period|Reasons not related to trial|0
863416|NCT00482612|1822856|FG002|Follow-up Period|Reasons not related to trial|1
863417|NCT00482612|1822857|FG003|Follow-up Period|Reasons not related to trial|3
863418|NCT00482703|1822886|FG000|Overall Study|Poor compliance|1
863419|NCT00482703|1822887|FG001|Overall Study|Poor compliance|0
863420|NCT00482729|1822902|FG000|Overall Study|Adverse Event|29
863421|NCT00482729|1822903|FG001|Overall Study|Adverse Event|33
863422|NCT00482729|1822902|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0
863423|NCT00482729|1822903|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2
863424|NCT00482729|1822902|FG000|Overall Study|Hyperglycemia Criteria|7
863425|NCT00482729|1822903|FG001|Overall Study|Hyperglycemia Criteria|5
863426|NCT00482729|1822902|FG000|Overall Study|Lack of Efficacy|4
863427|NCT00482729|1822903|FG001|Overall Study|Lack of Efficacy|16
863428|NCT00482729|1822902|FG000|Overall Study|Lost to Follow-up|86
863429|NCT00482729|1822903|FG001|Overall Study|Lost to Follow-up|66
863430|NCT00482729|1822902|FG000|Overall Study|Physician Decision|10
863431|NCT00482729|1822903|FG001|Overall Study|Physician Decision|7
863432|NCT00482729|1822902|FG000|Overall Study|Pregnancy|4
863433|NCT00482729|1822903|FG001|Overall Study|Pregnancy|2
863434|NCT00482729|1822902|FG000|Overall Study|Protocol Violation|10
863435|NCT00482729|1822903|FG001|Overall Study|Protocol Violation|18
863436|NCT00482729|1822902|FG000|Overall Study|Withdrawal by Subject|67
863437|NCT00482729|1822903|FG001|Overall Study|Withdrawal by Subject|69
863438|NCT00483002|1822918|FG000|Overall Study|Adverse Event|68
863439|NCT00483002|1822918|FG000|Overall Study|Lack of Efficacy|555
863440|NCT00483002|1822918|FG000|Overall Study|Lost to Follow-up|962
863441|NCT00483002|1822918|FG000|Overall Study|Other|2
863442|NCT00483002|1822918|FG000|Overall Study|Other|967
863443|NCT00483041|1822924|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
863444|NCT00483041|1822925|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
863445|NCT00483184|1822934|FG000|Overall Study|Withdrawal by Subject|2
863446|NCT00483184|1822935|FG001|Overall Study|Withdrawal by Subject|2
863447|NCT00483184|1822936|FG002|Overall Study|Withdrawal by Subject|0
863448|NCT00483184|1822934|FG000|Overall Study|Lost to Follow-up|1
863449|NCT00483184|1822935|FG001|Overall Study|Lost to Follow-up|0
863450|NCT00483184|1822936|FG002|Overall Study|Lost to Follow-up|0
863451|NCT00483184|1822934|FG000|Overall Study|Adverse Event|1
863452|NCT00483184|1822935|FG001|Overall Study|Adverse Event|2
863453|NCT00483184|1822936|FG002|Overall Study|Adverse Event|2
863454|NCT00483184|1822934|FG000|Overall Study|Protocol Violation|1
863455|NCT00483184|1822935|FG001|Overall Study|Protocol Violation|0
863456|NCT00483184|1822936|FG002|Overall Study|Protocol Violation|1
863457|NCT00483327|1822961|FG000|Overall Study|Adverse Event|1
863458|NCT00483327|1822961|FG000|Overall Study|Withdrawal by Subject|3
863459|NCT00483327|1822961|FG000|Overall Study|Lost to Follow-up|4
863460|NCT00483327|1822961|FG000|Overall Study|Patient Non Compliance|2
863461|NCT00483379|1822969|FG000|Treatment Period|Adverse Event|1
863462|NCT00483379|1822970|FG001|Treatment Period|Adverse Event|0
863463|NCT00483379|1822969|FG000|Treatment Period|Withdrawal by Subject|1
863464|NCT00483379|1822970|FG001|Treatment Period|Withdrawal by Subject|0
863465|NCT00483405|1822978|FG000|Overall Study|Adverse Event|8
863466|NCT00483405|1822978|FG000|Overall Study|Lack of Efficacy|14
863467|NCT00483405|1822978|FG000|Overall Study|Death|3
863468|NCT00483405|1822978|FG000|Overall Study|Withdrawal by Subject|2
863469|NCT00483405|1822978|FG000|Overall Study|Other complicating disease|1
863470|NCT00483548|1823000|FG000|Overall Study|Randomized; not treated with study drug|1
863471|NCT00483548|1823001|FG001|Overall Study|Randomized; not treated with study drug|3
863472|NCT00483548|1823000|FG000|Overall Study|Adverse Event|25
863473|NCT00483548|1823001|FG001|Overall Study|Adverse Event|14
863474|NCT00483548|1823000|FG000|Overall Study|Laboratory abnormality|1
863475|NCT00483548|1823001|FG001|Overall Study|Laboratory abnormality|2
863476|NCT00483548|1823000|FG000|Overall Study|Lack of Efficacy|4
863477|NCT00483548|1823001|FG001|Overall Study|Lack of Efficacy|8
863478|NCT00483548|1823000|FG000|Overall Study|Protocol Violation|11
863479|NCT00483548|1823001|FG001|Overall Study|Protocol Violation|7
863480|NCT00483548|1823000|FG000|Overall Study|Pregnancy|1
863481|NCT00483548|1823001|FG001|Overall Study|Pregnancy|0
863482|NCT00483548|1823000|FG000|Overall Study|Protocol required discontinuation|6
863483|NCT00483548|1823001|FG001|Overall Study|Protocol required discontinuation|6
863484|NCT00483548|1823000|FG000|Overall Study|Unable to comply with protocol schedule|1
863485|NCT00483548|1823001|FG001|Overall Study|Unable to comply with protocol schedule|0
863486|NCT00483548|1823000|FG000|Overall Study|Non-compliance with medication|2
863487|NCT00483548|1823001|FG001|Overall Study|Non-compliance with medication|0
863488|NCT00483548|1823000|FG000|Overall Study|Lost to Follow-up|3
863489|NCT00483548|1823001|FG001|Overall Study|Lost to Follow-up|4
863490|NCT00483548|1823000|FG000|Overall Study|Withdrawal by Subject|5
863491|NCT00483548|1823001|FG001|Overall Study|Withdrawal by Subject|2
863492|NCT00483574|1823013|FG000|Overall Study|Adverse Event|6
863493|NCT00483574|1823014|FG001|Overall Study|Adverse Event|0
863494|NCT00483574|1823013|FG000|Overall Study|Protocol Violation|28
863495|NCT00483574|1823014|FG001|Overall Study|Protocol Violation|9
863496|NCT00483574|1823013|FG000|Overall Study|Lost to Follow-up|16
863497|NCT00483574|1823014|FG001|Overall Study|Lost to Follow-up|4
863498|NCT00483574|1823013|FG000|Overall Study|Withdrawal by Subject|52
863499|NCT00483574|1823014|FG001|Overall Study|Withdrawal by Subject|0
863500|NCT00483652|1823024|FG000|Double-blind Treatment Period|Protocol Violation|2
863501|NCT00483652|1823025|FG001|Double-blind Treatment Period|Protocol Violation|1
863502|NCT00483652|1823024|FG000|Double-blind Treatment Period|Adverse Event|3
863503|NCT00483652|1823025|FG001|Double-blind Treatment Period|Adverse Event|4
863504|NCT00483652|1823024|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1
863505|NCT00483652|1823025|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0
863506|NCT00483652|1823024|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1
863507|NCT00483652|1823025|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0
863508|NCT00483704|1823034|FG000|Randomization|Withdrawal by Subject|19
863509|NCT00483704|1823035|FG001|Randomization|Withdrawal by Subject|28
863510|NCT00483704|1823036|FG002|Randomization|Withdrawal by Subject|18
863511|NCT00483704|1823034|FG000|Randomization|Protocol Violation|14
863512|NCT00483704|1823035|FG001|Randomization|Protocol Violation|25
863513|NCT00483704|1823036|FG002|Randomization|Protocol Violation|22
863514|NCT00483704|1823034|FG000|Randomization|Lost to Follow-up|14
863515|NCT00483704|1823035|FG001|Randomization|Lost to Follow-up|14
863516|NCT00483704|1823036|FG002|Randomization|Lost to Follow-up|19
863517|NCT00483704|1823034|FG000|Randomization|Pregnancy|1
863518|NCT00483704|1823035|FG001|Randomization|Pregnancy|0
863519|NCT00483704|1823036|FG002|Randomization|Pregnancy|0
863520|NCT00483704|1823034|FG000|Randomization|Physician Decision|2
863521|NCT00483704|1823035|FG001|Randomization|Physician Decision|4
863522|NCT00483704|1823036|FG002|Randomization|Physician Decision|0
863523|NCT00483704|1823034|FG000|Randomization|Progressive disease|0
863524|NCT00483704|1823035|FG001|Randomization|Progressive disease|0
863525|NCT00483704|1823036|FG002|Randomization|Progressive disease|1
863526|NCT00483704|1823034|FG000|Randomization|Lack of qualifying migraines|21
863527|NCT00483704|1823035|FG001|Randomization|Lack of qualifying migraines|25
863528|NCT00483704|1823036|FG002|Randomization|Lack of qualifying migraines|31
863529|NCT00483704|1823034|FG000|Treatment|Lack of qualifying migraines|101
863530|NCT00483704|1823035|FG001|Treatment|Lack of qualifying migraines|99
863531|NCT00483704|1823036|FG002|Treatment|Lack of qualifying migraines|116
863532|NCT00483704|1823034|FG000|Treatment|Adverse Event|3
863533|NCT00483704|1823035|FG001|Treatment|Adverse Event|5
863534|NCT00483704|1823036|FG002|Treatment|Adverse Event|4
863535|NCT00483704|1823034|FG000|Treatment|Withdrawal by Subject|16
863536|NCT00483704|1823035|FG001|Treatment|Withdrawal by Subject|12
863537|NCT00483704|1823036|FG002|Treatment|Withdrawal by Subject|21
863538|NCT00483704|1823034|FG000|Treatment|Protocol Violation|6
863539|NCT00483704|1823035|FG001|Treatment|Protocol Violation|3
863540|NCT00483704|1823036|FG002|Treatment|Protocol Violation|5
863541|NCT00483704|1823034|FG000|Treatment|Lost to Follow-up|2
863542|NCT00483704|1823035|FG001|Treatment|Lost to Follow-up|7
863543|NCT00483704|1823036|FG002|Treatment|Lost to Follow-up|5
863544|NCT00483704|1823034|FG000|Treatment|Lack of Efficacy|1
863545|NCT00483704|1823035|FG001|Treatment|Lack of Efficacy|1
863546|NCT00483704|1823036|FG002|Treatment|Lack of Efficacy|1
863547|NCT00483704|1823034|FG000|Treatment|Pregnancy|0
863548|NCT00483704|1823035|FG001|Treatment|Pregnancy|1
863549|NCT00483704|1823036|FG002|Treatment|Pregnancy|0
863550|NCT00483704|1823034|FG000|Treatment|Physician Decision|0
863551|NCT00483704|1823035|FG001|Treatment|Physician Decision|1
863552|NCT00483704|1823036|FG002|Treatment|Physician Decision|4
863553|NCT00483717|1823049|FG000|Overall Study|Protocol Violation|5
863554|NCT00483717|1823050|FG001|Overall Study|Protocol Violation|7
863555|NCT00483717|1823049|FG000|Overall Study|Time of dosing missing|1
863556|NCT00483717|1823050|FG001|Overall Study|Time of dosing missing|1
863557|NCT00483717|1823049|FG000|Overall Study|No treatment for migraine|16
863558|NCT00483717|1823050|FG001|Overall Study|No treatment for migraine|13
863559|NCT00483717|1823049|FG000|Overall Study|Lost to Follow-up|1
863560|NCT00483717|1823050|FG001|Overall Study|Lost to Follow-up|0
863561|NCT00483717|1823049|FG000|Overall Study|Withdrawal by Subject|1
863562|NCT00483717|1823050|FG001|Overall Study|Withdrawal by Subject|0
863563|NCT00483756|1823059|FG000|Overall Study|Death|2
863564|NCT00483756|1823060|FG001|Overall Study|Death|0
863565|NCT00483756|1823061|FG002|Overall Study|Death|1
863566|NCT00483756|1823059|FG000|Overall Study|Adverse Event|19
863567|NCT00483756|1823060|FG001|Overall Study|Adverse Event|38
863568|NCT00483756|1823061|FG002|Overall Study|Adverse Event|40
863569|NCT00483756|1823059|FG000|Overall Study|Lack of Efficacy|1
863570|NCT00483756|1823060|FG001|Overall Study|Lack of Efficacy|0
863571|NCT00483756|1823061|FG002|Overall Study|Lack of Efficacy|0
863572|NCT00483756|1823059|FG000|Overall Study|Lost to Follow-up|3
863573|NCT00483756|1823060|FG001|Overall Study|Lost to Follow-up|1
863574|NCT00483756|1823061|FG002|Overall Study|Lost to Follow-up|0
863575|NCT00483756|1823059|FG000|Overall Study|Withdrawal by Subject|5
863576|NCT00483756|1823060|FG001|Overall Study|Withdrawal by Subject|3
863577|NCT00483756|1823061|FG002|Overall Study|Withdrawal by Subject|4
863578|NCT00483756|1823059|FG000|Overall Study|Other|2
863579|NCT00483756|1823060|FG001|Overall Study|Other|4
863580|NCT00483756|1823061|FG002|Overall Study|Other|3
863581|NCT00483756|1823059|FG000|Overall Study|Randomized, Not Treated|1
863582|NCT00483756|1823060|FG001|Overall Study|Randomized, Not Treated|4
863583|NCT00483756|1823061|FG002|Overall Study|Randomized, Not Treated|4
863584|NCT00483938|1823076|FG000|Overall Study|Protocol Violation|0
863585|NCT00483938|1823077|FG001|Overall Study|Protocol Violation|0
863586|NCT00483938|1823078|FG002|Overall Study|Protocol Violation|0
863587|NCT00483938|1823079|FG003|Overall Study|Protocol Violation|0
863588|NCT00483938|1823080|FG004|Overall Study|Protocol Violation|0
863589|NCT00483938|1823081|FG005|Overall Study|Protocol Violation|0
863590|NCT00483938|1823082|FG006|Overall Study|Protocol Violation|3
863591|NCT00483938|1823076|FG000|Overall Study|Withdrawal by Subject|1
863592|NCT00483938|1823077|FG001|Overall Study|Withdrawal by Subject|6
863593|NCT00483938|1823078|FG002|Overall Study|Withdrawal by Subject|0
863594|NCT00483938|1823079|FG003|Overall Study|Withdrawal by Subject|0
863595|NCT00483938|1823080|FG004|Overall Study|Withdrawal by Subject|1
863596|NCT00483938|1823081|FG005|Overall Study|Withdrawal by Subject|3
863597|NCT00483938|1823082|FG006|Overall Study|Withdrawal by Subject|2
863598|NCT00483938|1823076|FG000|Overall Study|Lost to Follow-up|1
863599|NCT00483938|1823077|FG001|Overall Study|Lost to Follow-up|2
863600|NCT00483938|1823078|FG002|Overall Study|Lost to Follow-up|0
863601|NCT00483938|1823079|FG003|Overall Study|Lost to Follow-up|2
863602|NCT00483938|1823080|FG004|Overall Study|Lost to Follow-up|1
863603|NCT00483938|1823081|FG005|Overall Study|Lost to Follow-up|1
863604|NCT00483938|1823082|FG006|Overall Study|Lost to Follow-up|3
863605|NCT00483938|1823076|FG000|Overall Study|Death|0
863606|NCT00483938|1823077|FG001|Overall Study|Death|2
863607|NCT00483938|1823078|FG002|Overall Study|Death|0
863608|NCT00483938|1823079|FG003|Overall Study|Death|0
863609|NCT00483938|1823080|FG004|Overall Study|Death|0
863610|NCT00483938|1823081|FG005|Overall Study|Death|0
863611|NCT00483938|1823082|FG006|Overall Study|Death|0
863612|NCT00483938|1823076|FG000|Overall Study|Other|3
863613|NCT00483938|1823077|FG001|Overall Study|Other|9
863614|NCT00483938|1823078|FG002|Overall Study|Other|0
863615|NCT00483938|1823079|FG003|Overall Study|Other|4
863616|NCT00483938|1823080|FG004|Overall Study|Other|0
863617|NCT00483938|1823081|FG005|Overall Study|Other|4
863618|NCT00483938|1823082|FG006|Overall Study|Other|32
863619|NCT00484094|1823101|FG000|Overall Study|Discontinued|39
863620|NCT00484094|1823101|FG000|Overall Study|Other|3
863621|NCT00484159|1823108|FG000|Overall Study|Lost to Follow-up|1
863622|NCT00484159|1823109|FG001|Overall Study|Lost to Follow-up|1
863623|NCT00484159|1823110|FG002|Overall Study|Lost to Follow-up|0
863624|NCT00484185|1823118|FG000|Overall Study|Lost to Follow-up|44
863625|NCT00484185|1823118|FG000|Overall Study|Other|20
863626|NCT00484185|1823118|FG000|Overall Study|Randomized but not treated|5
863627|NCT00484185|1823118|FG000|Overall Study|Death|2
863628|NCT00484198|1823126|FG000|Overall Study|Participant Withdrew Consent|12
863629|NCT00484198|1823127|FG001|Overall Study|Participant Withdrew Consent|21
863630|NCT00484198|1823128|FG002|Overall Study|Participant Withdrew Consent|47
863631|NCT00484198|1823129|FG003|Overall Study|Participant Withdrew Consent|59
863632|NCT00484198|1823126|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16
863633|NCT00484198|1823127|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17
863634|NCT00484198|1823128|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29
863635|NCT00484198|1823129|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38
863636|NCT00484198|1823126|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3
863637|NCT00484198|1823127|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2
863638|NCT00484198|1823128|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6
863639|NCT00484198|1823129|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8
863640|NCT00484198|1823126|FG000|Overall Study|Adverse Event|3
863641|NCT00484198|1823127|FG001|Overall Study|Adverse Event|11
863642|NCT00484198|1823128|FG002|Overall Study|Adverse Event|32
863643|NCT00484198|1823129|FG003|Overall Study|Adverse Event|31
863644|NCT00484198|1823126|FG000|Overall Study|Protocol Violation|0
863645|NCT00484198|1823127|FG001|Overall Study|Protocol Violation|5
863646|NCT00484198|1823128|FG002|Overall Study|Protocol Violation|6
863647|NCT00484198|1823129|FG003|Overall Study|Protocol Violation|8
863648|NCT00484198|1823126|FG000|Overall Study|Other|7
863649|NCT00484198|1823127|FG001|Overall Study|Other|10
863650|NCT00484198|1823128|FG002|Overall Study|Other|31
863651|NCT00484198|1823129|FG003|Overall Study|Other|28
863652|NCT00484289|1823147|FG000|Long Term Phase|Adverse Event|1
863653|NCT00484289|1823148|FG001|Long Term Phase|Adverse Event|17
863654|NCT00484289|1823149|FG002|Long Term Phase|Adverse Event|5
863655|NCT00484289|1823147|FG000|Long Term Phase|Withdrawal by Subject|0
863656|NCT00484289|1823148|FG001|Long Term Phase|Withdrawal by Subject|7
863657|NCT00484289|1823149|FG002|Long Term Phase|Withdrawal by Subject|6
863658|NCT00484289|1823147|FG000|Long Term Phase|Inadequate response|2
863659|NCT00484289|1823148|FG001|Long Term Phase|Inadequate response|7
863660|NCT00484289|1823149|FG002|Long Term Phase|Inadequate response|4
863661|NCT00484289|1823147|FG000|Long Term Phase|Other Reason|0
863662|NCT00484289|1823148|FG001|Long Term Phase|Other Reason|5
863663|NCT00484289|1823149|FG002|Long Term Phase|Other Reason|1
863664|NCT00484289|1823147|FG000|Post Marketing Phase|Adverse Event|0
863665|NCT00484289|1823148|FG001|Post Marketing Phase|Adverse Event|1
863666|NCT00484289|1823149|FG002|Post Marketing Phase|Adverse Event|0
863667|NCT00484315|1823160|FG000|12-Month Clinical Follow-up|Death|6
863668|NCT00484315|1823161|FG001|12-Month Clinical Follow-up|Death|2
863669|NCT00484315|1823160|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4
863670|NCT00484315|1823161|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0
863671|NCT00484315|1823160|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
863672|NCT00484315|1823161|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1
863673|NCT00484315|1823160|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13
863674|NCT00484315|1823161|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4
863675|NCT00484315|1823160|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
863676|NCT00484315|1823161|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
863677|NCT00484315|1823160|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
863678|NCT00484315|1823161|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
863679|NCT00484315|1823160|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
863680|NCT00484315|1823161|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
863681|NCT00484419|1823188|FG000|Overall Study|Adverse Event|3
863682|NCT00484419|1823189|FG001|Overall Study|Adverse Event|0
863683|NCT00484419|1823190|FG002|Overall Study|Adverse Event|0
863684|NCT00484419|1823188|FG000|Overall Study|Lost to Follow-up|1
863685|NCT00484419|1823189|FG001|Overall Study|Lost to Follow-up|0
863686|NCT00484419|1823190|FG002|Overall Study|Lost to Follow-up|2
863687|NCT00484419|1823188|FG000|Overall Study|Withdrawal by Subject|3
863688|NCT00484419|1823189|FG001|Overall Study|Withdrawal by Subject|1
863689|NCT00484419|1823190|FG002|Overall Study|Withdrawal by Subject|1
863690|NCT00484419|1823188|FG000|Overall Study|subject met discontinuation criteria|2
863691|NCT00484419|1823189|FG001|Overall Study|subject met discontinuation criteria|2
863692|NCT00484419|1823190|FG002|Overall Study|subject met discontinuation criteria|4
863693|NCT00484419|1823188|FG000|Overall Study|required restricted medication|1
863694|NCT00484419|1823189|FG001|Overall Study|required restricted medication|0
863695|NCT00484419|1823190|FG002|Overall Study|required restricted medication|1
863696|NCT00484419|1823188|FG000|Overall Study|Physician Decision|1
863697|NCT00484419|1823189|FG001|Overall Study|Physician Decision|1
863698|NCT00484419|1823190|FG002|Overall Study|Physician Decision|1
863699|NCT00484419|1823188|FG000|Overall Study|subject unable to receive medication|1
863700|NCT00484419|1823189|FG001|Overall Study|subject unable to receive medication|0
863701|NCT00484419|1823190|FG002|Overall Study|subject unable to receive medication|0
863702|NCT00484419|1823188|FG000|Overall Study|subject relocated|0
863703|NCT00484419|1823189|FG001|Overall Study|subject relocated|1
863704|NCT00484419|1823190|FG002|Overall Study|subject relocated|0
863705|NCT00484419|1823188|FG000|Overall Study|sponsor decision, randomized in error|0
863706|NCT00484419|1823189|FG001|Overall Study|sponsor decision, randomized in error|0
863707|NCT00484419|1823190|FG002|Overall Study|sponsor decision, randomized in error|2
863708|NCT00484679|1823195|FG000|Overall Study|Withdrawal by Subject|3
863709|NCT00484939|1823208|FG000|Overall Study|Death|9
863710|NCT00484939|1823209|FG001|Overall Study|Death|13
863711|NCT00484939|1823208|FG000|Overall Study|Adverse Event|22
863712|NCT00484939|1823209|FG001|Overall Study|Adverse Event|12
863713|NCT00484939|1823208|FG000|Overall Study|Patient Withdrew Consent|19
863714|NCT00484939|1823209|FG001|Overall Study|Patient Withdrew Consent|10
863715|NCT00484939|1823208|FG000|Overall Study|Protocol Violation|3
863716|NCT00484939|1823209|FG001|Overall Study|Protocol Violation|3
863717|NCT00484939|1823208|FG000|Overall Study|Lost to Follow-up|0
863718|NCT00484939|1823209|FG001|Overall Study|Lost to Follow-up|3
863719|NCT00484939|1823208|FG000|Overall Study|Discretion of Investigator or Sponsor|7
863720|NCT00484939|1823209|FG001|Overall Study|Discretion of Investigator or Sponsor|3
863721|NCT00484939|1823208|FG000|Overall Study|Disease progression|67
863722|NCT00484939|1823209|FG001|Overall Study|Disease progression|88
863723|NCT00484939|1823208|FG000|Overall Study|Screen Failure|2
863724|NCT00484939|1823209|FG001|Overall Study|Screen Failure|2
863725|NCT00484939|1823208|FG000|Overall Study|Reason Not Specified|11
863726|NCT00484939|1823209|FG001|Overall Study|Reason Not Specified|6
863727|NCT00485069|1823217|FG000|Overall Study|Adverse Event|10
863728|NCT00485069|1823218|FG001|Overall Study|Adverse Event|4
863729|NCT00485069|1823217|FG000|Overall Study|Lack of Efficacy|2
863730|NCT00485069|1823218|FG001|Overall Study|Lack of Efficacy|1
863731|NCT00485069|1823217|FG000|Overall Study|Protocol Violation|0
863732|NCT00485069|1823218|FG001|Overall Study|Protocol Violation|1
863733|NCT00485069|1823217|FG000|Overall Study|Withdrawal by Subject|6
863734|NCT00485069|1823218|FG001|Overall Study|Withdrawal by Subject|6
863735|NCT00485134|1823239|FG000|Overall Study|Lost to Follow-up|1
863736|NCT00485134|1823240|FG001|Overall Study|Lost to Follow-up|0
863737|NCT00485134|1823241|FG002|Overall Study|Lost to Follow-up|0
863738|NCT00485134|1823242|FG003|Overall Study|Lost to Follow-up|0
863739|NCT00485134|1823243|FG004|Overall Study|Lost to Follow-up|0
863740|NCT00485134|1823244|FG005|Overall Study|Lost to Follow-up|0
863741|NCT00485134|1823245|FG006|Overall Study|Lost to Follow-up|0
863742|NCT00485134|1823246|FG007|Overall Study|Lost to Follow-up|0
863743|NCT00485134|1823239|FG000|Overall Study|Withdrawal by Subject|0
863744|NCT00485134|1823240|FG001|Overall Study|Withdrawal by Subject|1
863745|NCT00485134|1823241|FG002|Overall Study|Withdrawal by Subject|0
863746|NCT00485134|1823242|FG003|Overall Study|Withdrawal by Subject|0
863747|NCT00485134|1823243|FG004|Overall Study|Withdrawal by Subject|0
863748|NCT00485134|1823244|FG005|Overall Study|Withdrawal by Subject|0
863749|NCT00485134|1823245|FG006|Overall Study|Withdrawal by Subject|0
863750|NCT00485134|1823246|FG007|Overall Study|Withdrawal by Subject|0
863751|NCT00485134|1823239|FG000|Overall Study|Change in health status|0
863752|NCT00485134|1823240|FG001|Overall Study|Change in health status|1
863753|NCT00485134|1823241|FG002|Overall Study|Change in health status|2
863754|NCT00485134|1823242|FG003|Overall Study|Change in health status|1
863755|NCT00485134|1823243|FG004|Overall Study|Change in health status|0
863756|NCT00485134|1823244|FG005|Overall Study|Change in health status|1
863757|NCT00485134|1823245|FG006|Overall Study|Change in health status|0
863758|NCT00485134|1823246|FG007|Overall Study|Change in health status|0
863759|NCT00485134|1823239|FG000|Overall Study|Withdrew for adverse event|0
863760|NCT00485134|1823240|FG001|Overall Study|Withdrew for adverse event|0
863761|NCT00485134|1823241|FG002|Overall Study|Withdrew for adverse event|1
863762|NCT00485134|1823242|FG003|Overall Study|Withdrew for adverse event|0
863763|NCT00485134|1823243|FG004|Overall Study|Withdrew for adverse event|0
863764|NCT00485134|1823244|FG005|Overall Study|Withdrew for adverse event|0
863765|NCT00485134|1823245|FG006|Overall Study|Withdrew for adverse event|0
863766|NCT00485134|1823246|FG007|Overall Study|Withdrew for adverse event|0
863767|NCT00485134|1823239|FG000|Overall Study|Positive drug test|0
863768|NCT00485134|1823240|FG001|Overall Study|Positive drug test|0
863769|NCT00485134|1823241|FG002|Overall Study|Positive drug test|0
863770|NCT00485134|1823242|FG003|Overall Study|Positive drug test|0
863771|NCT00485134|1823243|FG004|Overall Study|Positive drug test|2
863772|NCT00485134|1823244|FG005|Overall Study|Positive drug test|1
863773|NCT00485134|1823245|FG006|Overall Study|Positive drug test|0
863774|NCT00485134|1823246|FG007|Overall Study|Positive drug test|0
863775|NCT00485134|1823239|FG000|Overall Study|Non-compliance|0
863776|NCT00485134|1823240|FG001|Overall Study|Non-compliance|0
863777|NCT00485134|1823241|FG002|Overall Study|Non-compliance|0
863778|NCT00485134|1823242|FG003|Overall Study|Non-compliance|0
863779|NCT00485134|1823243|FG004|Overall Study|Non-compliance|1
863780|NCT00485134|1823244|FG005|Overall Study|Non-compliance|2
863781|NCT00485134|1823245|FG006|Overall Study|Non-compliance|2
863782|NCT00485134|1823246|FG007|Overall Study|Non-compliance|0
863783|NCT00485134|1823239|FG000|Overall Study|Unable to comply with study schedule|0
863784|NCT00485134|1823240|FG001|Overall Study|Unable to comply with study schedule|0
863785|NCT00485134|1823241|FG002|Overall Study|Unable to comply with study schedule|0
863786|NCT00485134|1823242|FG003|Overall Study|Unable to comply with study schedule|0
863787|NCT00485134|1823243|FG004|Overall Study|Unable to comply with study schedule|0
863788|NCT00485134|1823244|FG005|Overall Study|Unable to comply with study schedule|0
863789|NCT00485134|1823245|FG006|Overall Study|Unable to comply with study schedule|0
863790|NCT00485134|1823246|FG007|Overall Study|Unable to comply with study schedule|1
863791|NCT00485134|1823239|FG000|Overall Study|Pregnancy|0
863792|NCT00485134|1823240|FG001|Overall Study|Pregnancy|0
863793|NCT00485134|1823241|FG002|Overall Study|Pregnancy|0
863794|NCT00485134|1823242|FG003|Overall Study|Pregnancy|0
863795|NCT00485134|1823243|FG004|Overall Study|Pregnancy|0
863796|NCT00485134|1823244|FG005|Overall Study|Pregnancy|0
863797|NCT00485134|1823245|FG006|Overall Study|Pregnancy|1
863798|NCT00485134|1823246|FG007|Overall Study|Pregnancy|0
863799|NCT00485173|1823260|FG000|Overall Study|Death|4
863800|NCT00485173|1823261|FG001|Overall Study|Death|3
863801|NCT00485173|1823260|FG000|Overall Study|Lost to Follow-up|32
863802|NCT00485173|1823261|FG001|Overall Study|Lost to Follow-up|61
863803|NCT00485264|1823273|FG000|Overall Study|Enrolled But Not Given Treatment|0
863804|NCT00485264|1823274|FG001|Overall Study|Enrolled But Not Given Treatment|0
863805|NCT00485264|1823275|FG002|Overall Study|Enrolled But Not Given Treatment|0
863806|NCT00485264|1823276|FG003|Overall Study|Enrolled But Not Given Treatment|0
863807|NCT00485264|1823277|FG004|Overall Study|Enrolled But Not Given Treatment|1
863808|NCT00485264|1823278|FG005|Overall Study|Enrolled But Not Given Treatment|0
863809|NCT00485264|1823273|FG000|Overall Study|Death|1
863810|NCT00485264|1823274|FG001|Overall Study|Death|0
863811|NCT00485264|1823275|FG002|Overall Study|Death|0
863812|NCT00485264|1823276|FG003|Overall Study|Death|0
863813|NCT00485264|1823277|FG004|Overall Study|Death|1
863814|NCT00485264|1823278|FG005|Overall Study|Death|0
863815|NCT00485264|1823273|FG000|Overall Study|Adverse Event|1
863816|NCT00485264|1823274|FG001|Overall Study|Adverse Event|0
863817|NCT00485264|1823275|FG002|Overall Study|Adverse Event|2
863818|NCT00485264|1823276|FG003|Overall Study|Adverse Event|3
863819|NCT00485264|1823277|FG004|Overall Study|Adverse Event|1
863820|NCT00485264|1823278|FG005|Overall Study|Adverse Event|3
863821|NCT00485264|1823273|FG000|Overall Study|Pregnancy|4
863822|NCT00485264|1823274|FG001|Overall Study|Pregnancy|0
863823|NCT00485264|1823275|FG002|Overall Study|Pregnancy|0
863824|NCT00485264|1823276|FG003|Overall Study|Pregnancy|0
863825|NCT00485264|1823277|FG004|Overall Study|Pregnancy|0
863826|NCT00485264|1823278|FG005|Overall Study|Pregnancy|0
863827|NCT00485264|1823273|FG000|Overall Study|Disallowed Medication|0
863828|NCT00485264|1823274|FG001|Overall Study|Disallowed Medication|0
863829|NCT00485264|1823275|FG002|Overall Study|Disallowed Medication|0
863830|NCT00485264|1823276|FG003|Overall Study|Disallowed Medication|0
863831|NCT00485264|1823277|FG004|Overall Study|Disallowed Medication|0
863832|NCT00485264|1823278|FG005|Overall Study|Disallowed Medication|1
863833|NCT00485264|1823273|FG000|Overall Study|Number/Volume/Timing of Study Meds|2
863834|NCT00485264|1823274|FG001|Overall Study|Number/Volume/Timing of Study Meds|1
863835|NCT00485264|1823275|FG002|Overall Study|Number/Volume/Timing of Study Meds|1
863836|NCT00485264|1823276|FG003|Overall Study|Number/Volume/Timing of Study Meds|0
863837|NCT00485264|1823277|FG004|Overall Study|Number/Volume/Timing of Study Meds|0
863838|NCT00485264|1823278|FG005|Overall Study|Number/Volume/Timing of Study Meds|0
863839|NCT00485264|1823273|FG000|Overall Study|Lack of Efficacy|0
863840|NCT00485264|1823274|FG001|Overall Study|Lack of Efficacy|1
863841|NCT00485264|1823275|FG002|Overall Study|Lack of Efficacy|0
863842|NCT00485264|1823276|FG003|Overall Study|Lack of Efficacy|0
863843|NCT00485264|1823277|FG004|Overall Study|Lack of Efficacy|0
863844|NCT00485264|1823278|FG005|Overall Study|Lack of Efficacy|0
863845|NCT00485264|1823273|FG000|Overall Study|Guardian Consent Withdrawn|1
863846|NCT00485264|1823274|FG001|Overall Study|Guardian Consent Withdrawn|0
863847|NCT00485264|1823275|FG002|Overall Study|Guardian Consent Withdrawn|0
863848|NCT00485264|1823276|FG003|Overall Study|Guardian Consent Withdrawn|0
863849|NCT00485264|1823277|FG004|Overall Study|Guardian Consent Withdrawn|1
863850|NCT00485264|1823278|FG005|Overall Study|Guardian Consent Withdrawn|0
863851|NCT00485264|1823273|FG000|Overall Study|Physician Decision|0
863852|NCT00485264|1823274|FG001|Overall Study|Physician Decision|2
863853|NCT00485264|1823275|FG002|Overall Study|Physician Decision|0
863854|NCT00485264|1823276|FG003|Overall Study|Physician Decision|0
863855|NCT00485264|1823277|FG004|Overall Study|Physician Decision|0
863856|NCT00485264|1823278|FG005|Overall Study|Physician Decision|0
863857|NCT00485264|1823273|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0
863858|NCT00485264|1823274|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0
863859|NCT00485264|1823275|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1
863860|NCT00485264|1823276|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0
863861|NCT00485264|1823277|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0
863862|NCT00485264|1823278|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0
863863|NCT00485264|1823273|FG000|Overall Study|Not Able to Attend Clinic|5
863864|NCT00485264|1823274|FG001|Overall Study|Not Able to Attend Clinic|0
863865|NCT00485264|1823275|FG002|Overall Study|Not Able to Attend Clinic|0
863866|NCT00485264|1823276|FG003|Overall Study|Not Able to Attend Clinic|1
863867|NCT00485264|1823277|FG004|Overall Study|Not Able to Attend Clinic|1
863868|NCT00485264|1823278|FG005|Overall Study|Not Able to Attend Clinic|2
863869|NCT00485264|1823273|FG000|Overall Study|Non-Compliant|17
863870|NCT00485264|1823274|FG001|Overall Study|Non-Compliant|2
863871|NCT00485264|1823275|FG002|Overall Study|Non-Compliant|1
863872|NCT00485264|1823276|FG003|Overall Study|Non-Compliant|0
863873|NCT00485264|1823277|FG004|Overall Study|Non-Compliant|1
863874|NCT00485264|1823278|FG005|Overall Study|Non-Compliant|0
863875|NCT00485264|1823273|FG000|Overall Study|Lost to Follow-up|2
863876|NCT00485264|1823274|FG001|Overall Study|Lost to Follow-up|1
863877|NCT00485264|1823275|FG002|Overall Study|Lost to Follow-up|1
863878|NCT00485264|1823276|FG003|Overall Study|Lost to Follow-up|0
863879|NCT00485264|1823277|FG004|Overall Study|Lost to Follow-up|0
863880|NCT00485264|1823278|FG005|Overall Study|Lost to Follow-up|1
863881|NCT00485264|1823273|FG000|Overall Study|Other Reason|3
863882|NCT00485264|1823274|FG001|Overall Study|Other Reason|0
863883|NCT00485264|1823275|FG002|Overall Study|Other Reason|0
863884|NCT00485264|1823276|FG003|Overall Study|Other Reason|0
863885|NCT00485264|1823277|FG004|Overall Study|Other Reason|0
863886|NCT00485264|1823278|FG005|Overall Study|Other Reason|0
863887|NCT00485303|1823297|FG000|Overall Study|Adverse Event|5
863888|NCT00485303|1823297|FG000|Overall Study|Progressive Disease|44
863889|NCT00485303|1823297|FG000|Overall Study|Other|3
863890|NCT00485303|1823297|FG000|Overall Study|Initiation of new anti-cancer treatment|2
863891|NCT00485303|1823297|FG000|Overall Study|Treatment ongoing at cutoff date|2
863892|NCT00485472|1823318|FG000|Overall Study|Adverse Event|8
863893|NCT00485472|1823319|FG001|Overall Study|Adverse Event|5
863894|NCT00485472|1823318|FG000|Overall Study|Lack of Efficacy|5
863895|NCT00485472|1823319|FG001|Overall Study|Lack of Efficacy|4
863896|NCT00485472|1823318|FG000|Overall Study|Withdrawal by Subject|1
863897|NCT00485472|1823319|FG001|Overall Study|Withdrawal by Subject|0
863898|NCT00485472|1823318|FG000|Overall Study|Protocol Violation|0
863899|NCT00485472|1823319|FG001|Overall Study|Protocol Violation|1
863900|NCT00485472|1823318|FG000|Overall Study|Other|2
863901|NCT00485472|1823319|FG001|Overall Study|Other|1
863902|NCT00485472|1823318|FG000|Overall Study|Lost to Follow-up|0
863903|NCT00485472|1823319|FG001|Overall Study|Lost to Follow-up|1
863904|NCT00485589|1823332|FG000|Overall Study|Death|2
863905|NCT00485589|1823333|FG001|Overall Study|Death|2
863906|NCT00485589|1823334|FG002|Overall Study|Death|0
863907|NCT00485589|1823332|FG000|Overall Study|Failure to return|6
863908|NCT00485589|1823333|FG001|Overall Study|Failure to return|5
863909|NCT00485589|1823334|FG002|Overall Study|Failure to return|1
863910|NCT00485589|1823332|FG000|Overall Study|Protocol Violation|1
863911|NCT00485589|1823333|FG001|Overall Study|Protocol Violation|0
863912|NCT00485589|1823334|FG002|Overall Study|Protocol Violation|0
863913|NCT00485589|1823332|FG000|Overall Study|Violation of selection criteria at entry|0
863914|NCT00485589|1823333|FG001|Overall Study|Violation of selection criteria at entry|3
863915|NCT00485589|1823334|FG002|Overall Study|Violation of selection criteria at entry|1
863916|NCT00485589|1823332|FG000|Overall Study|Administrative/Other|1
863917|NCT00485589|1823333|FG001|Overall Study|Administrative/Other|2
863918|NCT00485589|1823334|FG002|Overall Study|Administrative/Other|1
863919|NCT00485589|1823332|FG000|Overall Study|Insufficient therapeutic response|10
863920|NCT00485589|1823333|FG001|Overall Study|Insufficient therapeutic response|3
863921|NCT00485589|1823334|FG002|Overall Study|Insufficient therapeutic response|1
863922|NCT00485589|1823332|FG000|Overall Study|Refused treatment/did not cooperate|1
863923|NCT00485589|1823333|FG001|Overall Study|Refused treatment/did not cooperate|0
863924|NCT00485589|1823334|FG002|Overall Study|Refused treatment/did not cooperate|2
863925|NCT00485589|1823332|FG000|Overall Study|Withdrawal by Subject|3
863926|NCT00485589|1823333|FG001|Overall Study|Withdrawal by Subject|2
863927|NCT00485589|1823334|FG002|Overall Study|Withdrawal by Subject|2
863928|NCT00485589|1823332|FG000|Overall Study|Adverse Event|3
863929|NCT00485589|1823333|FG001|Overall Study|Adverse Event|3
863930|NCT00485589|1823334|FG002|Overall Study|Adverse Event|10
863931|NCT00485732|1823365|FG000|Overall Study|Protocol Violation|1
863932|NCT00485732|1823366|FG001|Overall Study|Protocol Violation|3
863933|NCT00485732|1823365|FG000|Overall Study|Withdrawal by Subject|5
863934|NCT00485732|1823366|FG001|Overall Study|Withdrawal by Subject|4
863935|NCT00485732|1823365|FG000|Overall Study|Lost to Follow-up|2
863936|NCT00485732|1823366|FG001|Overall Study|Lost to Follow-up|2
863937|NCT00485758|1823374|FG000|Overall Study|Adverse Event|102
863938|NCT00485758|1823375|FG001|Overall Study|Adverse Event|31
863939|NCT00485758|1823374|FG000|Overall Study|Death|0
863940|NCT00485758|1823375|FG001|Overall Study|Death|1
863941|NCT00485758|1823374|FG000|Overall Study|Lost to Follow-up|5
863942|NCT00485758|1823375|FG001|Overall Study|Lost to Follow-up|1
863943|NCT00485758|1823374|FG000|Overall Study|Physician Decision|3
863944|NCT00485758|1823375|FG001|Overall Study|Physician Decision|3
863945|NCT00485758|1823374|FG000|Overall Study|Protocol Violation|11
863946|NCT00485758|1823375|FG001|Overall Study|Protocol Violation|2
863947|NCT00485758|1823374|FG000|Overall Study|Withdrawal by Subject|32
863948|NCT00485758|1823375|FG001|Overall Study|Withdrawal by Subject|27
863949|NCT00485758|1823374|FG000|Overall Study|Study Terminated by Sponsor|3
863950|NCT00485758|1823375|FG001|Overall Study|Study Terminated by Sponsor|0
863951|NCT00486044|1823425|FG000|Overall Study|Withdrawal by Subject|2
863952|NCT00486044|1823426|FG001|Overall Study|Withdrawal by Subject|1
863953|NCT00486044|1823425|FG000|Overall Study|Adverse Event|0
863954|NCT00486044|1823426|FG001|Overall Study|Adverse Event|1
863955|NCT00486044|1823425|FG000|Overall Study|Lost to Follow-up|0
863956|NCT00486044|1823426|FG001|Overall Study|Lost to Follow-up|1
863957|NCT00486226|1823432|FG000|Overall Study|Death|3
863958|NCT00486226|1823432|FG000|Overall Study|Adverse Event|1
863959|NCT00486226|1823432|FG000|Overall Study|Withdrawal by Subject|1
863960|NCT00486226|1823432|FG000|Overall Study|Lost to Follow-up|8
863961|NCT00486252|1823439|FG000|Overall Study|Adverse Event|7
863962|NCT00486252|1823439|FG000|Overall Study|Lack of Efficacy|9
863963|NCT00486252|1823439|FG000|Overall Study|Lost to Follow-up|24
863964|NCT00486252|1823439|FG000|Overall Study|Other|18
863965|NCT00486265|1823445|FG000|Overall Study|Adverse Event|1
863966|NCT00486265|1823445|FG000|Overall Study|Lack of Efficacy|8
863967|NCT00486278|1823449|FG000|Overall Study|Adverse Event|5
863968|NCT00486278|1823449|FG000|Overall Study|Withdrawal by Subject|2
863969|NCT00486278|1823449|FG000|Overall Study|Physician Decision|2
863970|NCT00486291|1823465|FG000|Overall Study|Adverse Event|3
863971|NCT00486291|1823466|FG001|Overall Study|Adverse Event|4
863972|NCT00486291|1823465|FG000|Overall Study|Lost to Follow-up|3
863973|NCT00486291|1823466|FG001|Overall Study|Lost to Follow-up|7
863974|NCT00486291|1823465|FG000|Overall Study|protocol non-compliance|10
863975|NCT00486291|1823466|FG001|Overall Study|protocol non-compliance|15
863976|NCT00486291|1823465|FG000|Overall Study|requirement for restricted medication|0
863977|NCT00486291|1823466|FG001|Overall Study|requirement for restricted medication|3
863978|NCT00486330|1823472|FG000|Overall Study|Adverse Event|2
863979|NCT00486434|1823478|FG000|Overall Study|Withdrawal by Subject|34
863980|NCT00486434|1823479|FG001|Overall Study|Withdrawal by Subject|39
863981|NCT00486434|1823478|FG000|Overall Study|Adverse Event|118
863982|NCT00486434|1823479|FG001|Overall Study|Adverse Event|44
863983|NCT00486434|1823478|FG000|Overall Study|Protocol Violation|22
863984|NCT00486434|1823479|FG001|Overall Study|Protocol Violation|21
863985|NCT00486434|1823478|FG000|Overall Study|Lack of Efficacy|12
863986|NCT00486434|1823479|FG001|Overall Study|Lack of Efficacy|19
863987|NCT00486434|1823478|FG000|Overall Study|Lost to Follow-up|2
863988|NCT00486434|1823479|FG001|Overall Study|Lost to Follow-up|3
863989|NCT00486434|1823478|FG000|Overall Study|Death|1
863990|NCT00486434|1823479|FG001|Overall Study|Death|2
863991|NCT00486434|1823478|FG000|Overall Study|Personal reasons|5
863992|NCT00486434|1823479|FG001|Overall Study|Personal reasons|6
863993|NCT00486603|1823502|FG000|Overall Study|Withdrawal by Subject|1
863994|NCT00486603|1823503|FG001|Overall Study|Withdrawal by Subject|0
863995|NCT00486603|1823504|FG002|Overall Study|Withdrawal by Subject|0
863996|NCT00486603|1823505|FG003|Overall Study|Withdrawal by Subject|0
863997|NCT00486603|1823506|FG004|Overall Study|Withdrawal by Subject|0
863998|NCT00486603|1823502|FG000|Overall Study|Physician Decision|0
863999|NCT00486603|1823503|FG001|Overall Study|Physician Decision|1
864000|NCT00486603|1823504|FG002|Overall Study|Physician Decision|0
864001|NCT00486603|1823505|FG003|Overall Study|Physician Decision|0
864002|NCT00486603|1823506|FG004|Overall Study|Physician Decision|0
864003|NCT00486720|1823534|FG000|Overall Study|Adverse Event|1
864004|NCT00486720|1823535|FG001|Overall Study|Adverse Event|2
864005|NCT00486720|1823534|FG000|Overall Study|Lack of Efficacy|4
864006|NCT00486720|1823535|FG001|Overall Study|Lack of Efficacy|6
864007|NCT00486720|1823534|FG000|Overall Study|Physician Decision|1
864008|NCT00486720|1823535|FG001|Overall Study|Physician Decision|2
864009|NCT00486720|1823534|FG000|Overall Study|Protocol Violation|1
864010|NCT00486720|1823535|FG001|Overall Study|Protocol Violation|0
864011|NCT00486720|1823534|FG000|Overall Study|Withdrawal by Subject|3
864012|NCT00486720|1823535|FG001|Overall Study|Withdrawal by Subject|1
864013|NCT00486720|1823534|FG000|Overall Study|Progressive Disease|0
864014|NCT00486720|1823535|FG001|Overall Study|Progressive Disease|1
864015|NCT00486759|1823543|FG000|Treatment|Adverse event/intercurrent illness|86
864016|NCT00486759|1823544|FG001|Treatment|Adverse event/intercurrent illness|39
864017|NCT00486759|1823543|FG000|Treatment|Insufficient therapeutic response|37
864018|NCT00486759|1823544|FG001|Treatment|Insufficient therapeutic response|39
864019|NCT00486759|1823543|FG000|Treatment|Death|17
864020|NCT00486759|1823544|FG001|Treatment|Death|10
864021|NCT00486759|1823543|FG000|Treatment|Withdrew consent|15
864022|NCT00486759|1823544|FG001|Treatment|Withdrew consent|12
864023|NCT00486759|1823543|FG000|Treatment|Administrative/reason not specified|17
864024|NCT00486759|1823544|FG001|Treatment|Administrative/reason not specified|21
864025|NCT00486759|1823543|FG000|Treatment|Refused treatment|10
864026|NCT00486759|1823544|FG001|Treatment|Refused treatment|7
864027|NCT00486759|1823543|FG000|Treatment|Violation of selection criteria at entry|3
864028|NCT00486759|1823544|FG001|Treatment|Violation of selection criteria at entry|3
864029|NCT00486759|1823543|FG000|Treatment|Other protocol violation|1
864030|NCT00486759|1823544|FG001|Treatment|Other protocol violation|5
864031|NCT00486759|1823543|FG000|Treatment|Failure to return|1
864032|NCT00486759|1823544|FG001|Treatment|Failure to return|1
864033|NCT00486759|1823543|FG000|Safety Follow-up|Insufficient therapeutic response|40
864034|NCT00486759|1823544|FG001|Safety Follow-up|Insufficient therapeutic response|50
864035|NCT00486759|1823543|FG000|Safety Follow-up|Death|40
864036|NCT00486759|1823544|FG001|Safety Follow-up|Death|29
864037|NCT00486759|1823543|FG000|Safety Follow-up|Withdrew consent|32
864038|NCT00486759|1823544|FG001|Safety Follow-up|Withdrew consent|23
864039|NCT00486759|1823543|FG000|Safety Follow-up|Failure to return|9
864040|NCT00486759|1823544|FG001|Safety Follow-up|Failure to return|6
864041|NCT00486759|1823543|FG000|Safety Follow-up|Administrative/not specified|8
864042|NCT00486759|1823544|FG001|Safety Follow-up|Administrative/not specified|6
864043|NCT00486759|1823543|FG000|Safety Follow-up|Refused treatment/did not cooperate|6
864044|NCT00486759|1823544|FG001|Safety Follow-up|Refused treatment/did not cooperate|4
864045|NCT00486759|1823543|FG000|Safety Follow-up|Adverse event/intercurrent illness|4
864046|NCT00486759|1823544|FG001|Safety Follow-up|Adverse event/intercurrent illness|0
864047|NCT00486811|1823553|FG000|Overall Study|Adverse Event|28
864048|NCT00486811|1823554|FG001|Overall Study|Adverse Event|60
864049|NCT00486811|1823555|FG002|Overall Study|Adverse Event|135
864050|NCT00486811|1823553|FG000|Overall Study|Lack of Efficacy|34
864051|NCT00486811|1823554|FG001|Overall Study|Lack of Efficacy|14
864052|NCT00486811|1823555|FG002|Overall Study|Lack of Efficacy|7
864053|NCT00486811|1823553|FG000|Overall Study|Lost to Follow-up|4
864054|NCT00486811|1823554|FG001|Overall Study|Lost to Follow-up|6
864055|NCT00486811|1823555|FG002|Overall Study|Lost to Follow-up|4
864056|NCT00486811|1823553|FG000|Overall Study|Withdrawal by Subject|33
864057|NCT00486811|1823554|FG001|Overall Study|Withdrawal by Subject|44
864058|NCT00486811|1823555|FG002|Overall Study|Withdrawal by Subject|58
864059|NCT00486811|1823553|FG000|Overall Study|Study drug non-compliant|5
864060|NCT00486811|1823554|FG001|Overall Study|Study drug non-compliant|6
864061|NCT00486811|1823555|FG002|Overall Study|Study drug non-compliant|3
864062|NCT00486811|1823553|FG000|Overall Study|All other|18
864063|NCT00486811|1823554|FG001|Overall Study|All other|11
864064|NCT00486811|1823555|FG002|Overall Study|All other|7
864065|NCT00486837|1823574|FG000|Overall Study|Withdrawal by Subject|1
864066|NCT00486837|1823575|FG001|Overall Study|Withdrawal by Subject|0
864067|NCT00486837|1823574|FG000|Overall Study|Adverse Event|1
864068|NCT00486837|1823575|FG001|Overall Study|Adverse Event|1
864069|NCT00486837|1823574|FG000|Overall Study|Protocol Violation|4
864070|NCT00486837|1823575|FG001|Overall Study|Protocol Violation|2
864071|NCT00486837|1823574|FG000|Overall Study|No sputum, devise issues, exacerbation|3
864072|NCT00486837|1823575|FG001|Overall Study|No sputum, devise issues, exacerbation|4
864073|NCT00486902|1823595|FG000|Overall Study|Withdrawal by Subject|1
864074|NCT00486902|1823596|FG001|Overall Study|Withdrawal by Subject|2
864075|NCT00486902|1823595|FG000|Overall Study|decision for postpartum tubal ligation|3
864076|NCT00486902|1823596|FG001|Overall Study|decision for postpartum tubal ligation|1
864077|NCT00486902|1823595|FG000|Overall Study|spinal anesthetic protocal violation|1
864078|NCT00486902|1823596|FG001|Overall Study|spinal anesthetic protocal violation|1
864079|NCT00486902|1823595|FG000|Overall Study|Did not meet inclusion criteria|1
864080|NCT00486902|1823596|FG001|Overall Study|Did not meet inclusion criteria|0
864081|NCT00486902|1823595|FG000|Overall Study|No toradol due to hemmorhage or allergy|3
864082|NCT00486902|1823596|FG001|Overall Study|No toradol due to hemmorhage or allergy|1
864083|NCT00486954|1823606|FG000|Pilot Part|Adverse Event|4
864084|NCT00486954|1823607|FG001|Pilot Part|Adverse Event|0
864085|NCT00486954|1823608|FG002|Pilot Part|Adverse Event|5
864086|NCT00486954|1823609|FG003|Pilot Part|Adverse Event|0
864087|NCT00486954|1823610|FG004|Pilot Part|Adverse Event|0
864088|NCT00486954|1823606|FG000|Pilot Part|Disease Progression|2
864089|NCT00486954|1823607|FG001|Pilot Part|Disease Progression|0
864090|NCT00486954|1823608|FG002|Pilot Part|Disease Progression|1
864091|NCT00486954|1823609|FG003|Pilot Part|Disease Progression|0
864092|NCT00486954|1823610|FG004|Pilot Part|Disease Progression|0
864093|NCT00486954|1823606|FG000|Randomized Part|Lost to Follow-up|0
864094|NCT00486954|1823607|FG001|Randomized Part|Lost to Follow-up|0
864095|NCT00486954|1823608|FG002|Randomized Part|Lost to Follow-up|0
864096|NCT00486954|1823609|FG003|Randomized Part|Lost to Follow-up|0
864097|NCT00486954|1823610|FG004|Randomized Part|Lost to Follow-up|1
864098|NCT00486954|1823606|FG000|Randomized Part|Withdrawal by Subject|0
864099|NCT00486954|1823607|FG001|Randomized Part|Withdrawal by Subject|0
864100|NCT00486954|1823608|FG002|Randomized Part|Withdrawal by Subject|0
864101|NCT00486954|1823609|FG003|Randomized Part|Withdrawal by Subject|1
864102|NCT00486954|1823610|FG004|Randomized Part|Withdrawal by Subject|0
864103|NCT00486954|1823606|FG000|Randomized Part|Sponsor Terminated Study|0
864104|NCT00486954|1823607|FG001|Randomized Part|Sponsor Terminated Study|0
864105|NCT00486954|1823608|FG002|Randomized Part|Sponsor Terminated Study|0
864106|NCT00486954|1823609|FG003|Randomized Part|Sponsor Terminated Study|19
864107|NCT00486954|1823610|FG004|Randomized Part|Sponsor Terminated Study|13
864108|NCT00487084|1823623|FG000|Overall Study|Did not receive intervention|4
864109|NCT00487084|1823624|FG001|Overall Study|Did not receive intervention|3
864110|NCT00487084|1823625|FG002|Overall Study|Did not receive intervention|5
864111|NCT00487188|1823635|FG000|Induction Phase|Abnormality of Laboratory Test|0
864112|NCT00487188|1823636|FG001|Induction Phase|Abnormality of Laboratory Test|1
864113|NCT00487188|1823637|FG002|Induction Phase|Abnormality of Laboratory Test|0
864114|NCT00487188|1823635|FG000|Induction Phase|Adverse Event|5
864115|NCT00487188|1823636|FG001|Induction Phase|Adverse Event|0
864116|NCT00487188|1823637|FG002|Induction Phase|Adverse Event|0
864117|NCT00487188|1823635|FG000|Induction Phase|Lack of Efficacy|0
864118|NCT00487188|1823636|FG001|Induction Phase|Lack of Efficacy|1
864119|NCT00487188|1823637|FG002|Induction Phase|Lack of Efficacy|0
864120|NCT00487188|1823635|FG000|Induction Phase|Protocol Violation|1
864121|NCT00487188|1823636|FG001|Induction Phase|Protocol Violation|0
864122|NCT00487188|1823637|FG002|Induction Phase|Protocol Violation|0
864123|NCT00487188|1823635|FG000|Induction Phase|Refused Treatment|1
864124|NCT00487188|1823636|FG001|Induction Phase|Refused Treatment|2
864125|NCT00487188|1823637|FG002|Induction Phase|Refused Treatment|0
864126|NCT00487188|1823635|FG000|Induction Phase|Lost to Follow-up|2
864127|NCT00487188|1823636|FG001|Induction Phase|Lost to Follow-up|2
864128|NCT00487188|1823637|FG002|Induction Phase|Lost to Follow-up|0
864129|NCT00487188|1823635|FG000|Induction Phase|Administrative|0
864130|NCT00487188|1823636|FG001|Induction Phase|Administrative|1
864131|NCT00487188|1823637|FG002|Induction Phase|Administrative|0
864132|NCT00487188|1823635|FG000|Maintenance Phase|Adverse Event|1
864133|NCT00487188|1823636|FG001|Maintenance Phase|Adverse Event|0
864134|NCT00487188|1823637|FG002|Maintenance Phase|Adverse Event|0
864135|NCT00487188|1823635|FG000|Maintenance Phase|Death|1
864136|NCT00487188|1823636|FG001|Maintenance Phase|Death|0
864137|NCT00487188|1823637|FG002|Maintenance Phase|Death|0
864138|NCT00487188|1823635|FG000|Maintenance Phase|Lost to Follow-up|1
864139|NCT00487188|1823636|FG001|Maintenance Phase|Lost to Follow-up|0
864140|NCT00487188|1823637|FG002|Maintenance Phase|Lost to Follow-up|0
864141|NCT00487188|1823635|FG000|Maintenance Phase|Administrative|0
864142|NCT00487188|1823636|FG001|Maintenance Phase|Administrative|0
864143|NCT00487188|1823637|FG002|Maintenance Phase|Administrative|1
864144|NCT00487240|1823655|FG000|Overall Study|Withdrawal by Subject|12
864145|NCT00487240|1823656|FG001|Overall Study|Withdrawal by Subject|6
864146|NCT00487240|1823655|FG000|Overall Study|Lost to Follow-up|7
864147|NCT00487240|1823656|FG001|Overall Study|Lost to Follow-up|6
864148|NCT00487240|1823655|FG000|Overall Study|Adverse Event|0
864149|NCT00487240|1823656|FG001|Overall Study|Adverse Event|4
864150|NCT00487240|1823655|FG000|Overall Study|Protocol Violation|5
864151|NCT00487240|1823656|FG001|Overall Study|Protocol Violation|5
864152|NCT00487240|1823655|FG000|Overall Study|Entry Criteria Not Met|3
864153|NCT00487240|1823656|FG001|Overall Study|Entry Criteria Not Met|4
864154|NCT00487240|1823655|FG000|Overall Study|Sponsor Decision|2
864155|NCT00487240|1823656|FG001|Overall Study|Sponsor Decision|1
864156|NCT00487240|1823655|FG000|Overall Study|Physician Decision|2
864157|NCT00487240|1823656|FG001|Overall Study|Physician Decision|0
864158|NCT00487279|1823664|FG000|Overall Study|Death|1
864159|NCT00487279|1823665|FG001|Overall Study|Death|0
864160|NCT00487279|1823664|FG000|Overall Study|Withdrawal by Subject|0
864161|NCT00487279|1823665|FG001|Overall Study|Withdrawal by Subject|2
864162|NCT00487435|1823680|FG000|Overall Study|Adverse Event|146
864163|NCT00487435|1823680|FG000|Overall Study|Death|2
864164|NCT00487435|1823680|FG000|Overall Study|Lack of Efficacy|33
864165|NCT00487435|1823680|FG000|Overall Study|Lost to Follow-up|54
864166|NCT00487435|1823680|FG000|Overall Study|Pregnancy|2
864167|NCT00487435|1823680|FG000|Overall Study|Withdrawal by Subject|132
864168|NCT00487435|1823680|FG000|Overall Study|Resolution Of Pain|1
864169|NCT00487435|1823680|FG000|Overall Study|Study Medication Non-Compliant|32
864170|NCT00487435|1823680|FG000|Overall Study|Other|83
864171|NCT00487539|1823688|FG000|Overall Study|Adverse Event|3
864172|NCT00487539|1823689|FG001|Overall Study|Adverse Event|2
864173|NCT00487539|1823690|FG002|Overall Study|Adverse Event|1
864174|NCT00487539|1823691|FG003|Overall Study|Adverse Event|1
864175|NCT00487539|1823688|FG000|Overall Study|Unsatisfactory therapeutic effect|1
864176|NCT00487539|1823689|FG001|Overall Study|Unsatisfactory therapeutic effect|0
864177|NCT00487539|1823690|FG002|Overall Study|Unsatisfactory therapeutic effect|0
864178|NCT00487539|1823691|FG003|Overall Study|Unsatisfactory therapeutic effect|1
864179|NCT00487539|1823688|FG000|Overall Study|Other|3
864180|NCT00487539|1823689|FG001|Overall Study|Other|1
864181|NCT00487539|1823690|FG002|Overall Study|Other|2
864182|NCT00487539|1823691|FG003|Overall Study|Other|2
864183|NCT00487552|1823700|FG000|Overall Study|Unsuccessful magnet placements|3
864184|NCT00487552|1823700|FG000|Overall Study|Death due to progressive malignancy|2
864185|NCT00487552|1823700|FG000|Overall Study|Stent not placed|1
864186|NCT00487695|1823715|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1
864187|NCT00487695|1823716|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0
864188|NCT00487695|1823715|FG000|First Procedure|active wheezing (did not have procedure)|1
864189|NCT00487695|1823716|FG001|First Procedure|active wheezing (did not have procedure)|0
864190|NCT00487695|1823715|FG000|First Procedure|esophageal stricture found (excl crit)|1
864191|NCT00487695|1823716|FG001|First Procedure|esophageal stricture found (excl crit)|0
864192|NCT00487695|1823715|FG000|Second Procedure|active wheezing|0
864193|NCT00487695|1823716|FG001|Second Procedure|active wheezing|1
864194|NCT00487695|1823715|FG000|Second Procedure|Withdrawal by Subject|1
864195|NCT00487695|1823716|FG001|Second Procedure|Withdrawal by Subject|2
864196|NCT00487747|1823730|FG000|Overall Study|Adverse Event|1
864197|NCT00487747|1823730|FG000|Overall Study|Lost to Follow-up|9
864198|NCT00487747|1823730|FG000|Overall Study|Lack of Efficacy|1
864199|NCT00487825|1823736|FG000|Overall Study|Adverse Event|2
864200|NCT00487825|1823737|FG001|Overall Study|Adverse Event|2
864201|NCT00487825|1823736|FG000|Overall Study|Lack of Efficacy|1
864202|NCT00487825|1823737|FG001|Overall Study|Lack of Efficacy|1
864203|NCT00487825|1823736|FG000|Overall Study|Other|3
864204|NCT00487825|1823737|FG001|Overall Study|Other|2
864205|NCT00487942|1823747|FG000|Overall Study|Adverse Event|1
864206|NCT00487942|1823748|FG001|Overall Study|Adverse Event|1
864207|NCT00487942|1823749|FG002|Overall Study|Adverse Event|1
864208|NCT00487942|1823750|FG003|Overall Study|Adverse Event|1
864209|NCT00487942|1823747|FG000|Overall Study|Lost to Follow-up|1
864210|NCT00487942|1823748|FG001|Overall Study|Lost to Follow-up|0
864211|NCT00487942|1823749|FG002|Overall Study|Lost to Follow-up|0
864212|NCT00487942|1823750|FG003|Overall Study|Lost to Follow-up|1
864213|NCT00487942|1823747|FG000|Overall Study|Protocol Violation|1
864214|NCT00487942|1823748|FG001|Overall Study|Protocol Violation|1
864215|NCT00487942|1823749|FG002|Overall Study|Protocol Violation|0
864216|NCT00487942|1823750|FG003|Overall Study|Protocol Violation|0
864217|NCT00487942|1823747|FG000|Overall Study|Withdrawal by Subject|0
864218|NCT00487942|1823748|FG001|Overall Study|Withdrawal by Subject|1
864219|NCT00487942|1823749|FG002|Overall Study|Withdrawal by Subject|2
864220|NCT00487942|1823750|FG003|Overall Study|Withdrawal by Subject|0
864221|NCT00488033|1823762|FG000|Overall Study|Withdrawal by Subject|1
864222|NCT00488033|1823763|FG001|Overall Study|Withdrawal by Subject|0
864223|NCT00488293|1823786|FG000|Overall Study|Lost to Follow-up|28
864224|NCT00488293|1823787|FG001|Overall Study|Lost to Follow-up|25
864225|NCT00488293|1823786|FG000|Overall Study|Withdrawal by Subject|5
864226|NCT00488293|1823787|FG001|Overall Study|Withdrawal by Subject|3
864227|NCT00488293|1823786|FG000|Overall Study|Death|2
864228|NCT00488293|1823787|FG001|Overall Study|Death|1
864229|NCT00488293|1823786|FG000|Overall Study|Misrandomization/Other Unspecified|1
864230|NCT00488293|1823787|FG001|Overall Study|Misrandomization/Other Unspecified|1
864231|NCT00488319|1823796|FG000|Overall Study|Adverse Event|1
864232|NCT00488319|1823797|FG001|Overall Study|Adverse Event|2
864233|NCT00488319|1823798|FG002|Overall Study|Adverse Event|23
864234|NCT00488319|1823796|FG000|Overall Study|Lack of Efficacy|6
864235|NCT00488319|1823797|FG001|Overall Study|Lack of Efficacy|12
864236|NCT00488319|1823798|FG002|Overall Study|Lack of Efficacy|27
864237|NCT00488319|1823796|FG000|Overall Study|Lost to Follow-up|3
864238|NCT00488319|1823797|FG001|Overall Study|Lost to Follow-up|5
864239|NCT00488319|1823798|FG002|Overall Study|Lost to Follow-up|16
864240|NCT00488319|1823796|FG000|Overall Study|Withdrawal by Subject|5
864241|NCT00488319|1823797|FG001|Overall Study|Withdrawal by Subject|20
864242|NCT00488319|1823798|FG002|Overall Study|Withdrawal by Subject|44
864243|NCT00488319|1823796|FG000|Overall Study|Other reasons for withdrawal|0
864244|NCT00488319|1823797|FG001|Overall Study|Other reasons for withdrawal|4
864245|NCT00488319|1823798|FG002|Overall Study|Other reasons for withdrawal|12
864246|NCT00488345|1823810|FG000|Overall Study|Adverse Event|0
864247|NCT00488345|1823811|FG001|Overall Study|Adverse Event|1
864248|NCT00488345|1823812|FG002|Overall Study|Adverse Event|1
864249|NCT00488345|1823810|FG000|Overall Study|Unable to administer antibiotics at home|0
864250|NCT00488345|1823811|FG001|Overall Study|Unable to administer antibiotics at home|1
864251|NCT00488345|1823812|FG002|Overall Study|Unable to administer antibiotics at home|0
864252|NCT00488345|1823810|FG000|Overall Study|Institutional Review Board review|0
864253|NCT00488345|1823811|FG001|Overall Study|Institutional Review Board review|0
864254|NCT00488345|1823812|FG002|Overall Study|Institutional Review Board review|1
864255|NCT00488345|1823810|FG000|Overall Study|Surgical team recommendation|0
864256|NCT00488345|1823811|FG001|Overall Study|Surgical team recommendation|1
864257|NCT00488345|1823812|FG002|Overall Study|Surgical team recommendation|0
864258|NCT00488345|1823810|FG000|Overall Study|Parent/legal guardian request|0
864259|NCT00488345|1823811|FG001|Overall Study|Parent/legal guardian request|1
864260|NCT00488345|1823812|FG002|Overall Study|Parent/legal guardian request|1
864261|NCT00488475|1823821|FG000|Overall Study|Other|1754
864262|NCT00488514|1823829|FG000|Overall Study|Adverse Event|41
864263|NCT00488514|1823829|FG000|Overall Study|Lost to Follow-up|44
864264|NCT00488514|1823829|FG000|Overall Study|Protocol Violation|32
864265|NCT00488514|1823829|FG000|Overall Study|Withdrawal by Subject|106
864266|NCT00488514|1823829|FG000|Overall Study|Lack of Efficacy|28
864267|NCT00488514|1823829|FG000|Overall Study|Did not meet criteria for treatment|30
864268|NCT00488514|1823829|FG000|Overall Study|Postive drug screen|1
864269|NCT00488514|1823829|FG000|Overall Study|Withdrawn per medical monitor decision|2
864270|NCT00488514|1823829|FG000|Overall Study|Investigator decision|1
864271|NCT00488514|1823829|FG000|Overall Study|Participant had too few migraines|5
864272|NCT00488514|1823829|FG000|Overall Study|Increase in number of migraines|2
864273|NCT00488514|1823829|FG000|Overall Study|Increased use of concomitant medication|1
864274|NCT00488592|1823850|FG000|Overall Study|Withdrawal by Subject|1
864275|NCT00488592|1823850|FG000|Overall Study|Disease progression|1
864276|NCT00488592|1823850|FG000|Overall Study|Enrolled but not treated|1
864277|NCT00488618|1823856|FG000|Overall Study|Adverse Event|13
864278|NCT00488618|1823857|FG001|Overall Study|Adverse Event|17
864279|NCT00488618|1823856|FG000|Overall Study|Insufficient Therapeutic Response|18
864280|NCT00488618|1823857|FG001|Overall Study|Insufficient Therapeutic Response|11
864281|NCT00488618|1823856|FG000|Overall Study|Protocol Violation|0
864282|NCT00488618|1823857|FG001|Overall Study|Protocol Violation|2
864283|NCT00488618|1823856|FG000|Overall Study|Withdrawal of Consent|15
864284|NCT00488618|1823857|FG001|Overall Study|Withdrawal of Consent|13
864285|NCT00488618|1823856|FG000|Overall Study|Lost to Follow-up|1
864286|NCT00488618|1823857|FG001|Overall Study|Lost to Follow-up|0
864287|NCT00488631|1823869|FG000|Double Blind Period (Week 0-54)|Adverse Event|17
864288|NCT00488631|1823870|FG001|Double Blind Period (Week 0-54)|Adverse Event|12
864289|NCT00488631|1823871|FG002|Double Blind Period (Week 0-54)|Adverse Event|12
864290|NCT00488631|1823872|FG003|Double Blind Period (Week 0-54)|Adverse Event|12
864291|NCT00488631|1823873|FG004|Double Blind Period (Week 0-54)|Adverse Event|30
864292|NCT00488631|1823874|FG005|Double Blind Period (Week 0-54)|Adverse Event|50
864293|NCT00488631|1823875|FG006|Double Blind Period (Week 0-54)|Adverse Event|0
864294|NCT00488631|1823876|FG007|Double Blind Period (Week 0-54)|Adverse Event|0
864295|NCT00488631|1823877|FG008|Double Blind Period (Week 0-54)|Adverse Event|0
864296|NCT00488631|1823878|FG009|Double Blind Period (Week 0-54)|Adverse Event|0
864297|NCT00488631|1823869|FG000|Double Blind Period (Week 0-54)|Death|0
864298|NCT00488631|1823870|FG001|Double Blind Period (Week 0-54)|Death|0
864299|NCT00488631|1823871|FG002|Double Blind Period (Week 0-54)|Death|0
864300|NCT00488631|1823872|FG003|Double Blind Period (Week 0-54)|Death|0
864301|NCT00488631|1823873|FG004|Double Blind Period (Week 0-54)|Death|0
864302|NCT00488631|1823874|FG005|Double Blind Period (Week 0-54)|Death|1
864303|NCT00488631|1823875|FG006|Double Blind Period (Week 0-54)|Death|0
864304|NCT00488631|1823876|FG007|Double Blind Period (Week 0-54)|Death|0
864305|NCT00488631|1823877|FG008|Double Blind Period (Week 0-54)|Death|0
864306|NCT00488631|1823878|FG009|Double Blind Period (Week 0-54)|Death|0
864307|NCT00488631|1823869|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
864308|NCT00488631|1823870|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
864309|NCT00488631|1823871|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
864310|NCT00488631|1823872|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
864311|NCT00488631|1823873|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
864312|NCT00488631|1823874|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
864313|NCT00488631|1823875|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
864314|NCT00488631|1823876|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
864315|NCT00488631|1823877|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
864316|NCT00488631|1823878|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
864317|NCT00488631|1823869|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1
864318|NCT00488631|1823870|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2
864319|NCT00488631|1823871|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1
864320|NCT00488631|1823872|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0
864321|NCT00488631|1823873|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3
864322|NCT00488631|1823874|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7
864323|NCT00488631|1823875|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0
864324|NCT00488631|1823876|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0
864325|NCT00488631|1823877|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0
864326|NCT00488631|1823878|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0
864327|NCT00488631|1823869|FG000|Double Blind Period (Week 0-54)|Other|6
864328|NCT00488631|1823870|FG001|Double Blind Period (Week 0-54)|Other|12
864329|NCT00488631|1823871|FG002|Double Blind Period (Week 0-54)|Other|10
864330|NCT00488631|1823872|FG003|Double Blind Period (Week 0-54)|Other|11
864331|NCT00488631|1823873|FG004|Double Blind Period (Week 0-54)|Other|14
864332|NCT00488631|1823874|FG005|Double Blind Period (Week 0-54)|Other|34
864333|NCT00488631|1823875|FG006|Double Blind Period (Week 0-54)|Other|0
864334|NCT00488631|1823876|FG007|Double Blind Period (Week 0-54)|Other|0
864335|NCT00488631|1823877|FG008|Double Blind Period (Week 0-54)|Other|0
864336|NCT00488631|1823878|FG009|Double Blind Period (Week 0-54)|Other|0
864337|NCT00488631|1823869|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0
864338|NCT00488631|1823870|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0
864339|NCT00488631|1823871|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0
864340|NCT00488631|1823872|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0
864341|NCT00488631|1823873|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0
864342|NCT00488631|1823874|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0
864343|NCT00488631|1823875|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10
864344|NCT00488631|1823876|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8
864345|NCT00488631|1823877|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54
864346|NCT00488631|1823878|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0
864347|NCT00488631|1823869|FG000|Open Label Study Extension (Week 54-228)|Death|0
864348|NCT00488631|1823870|FG001|Open Label Study Extension (Week 54-228)|Death|0
864349|NCT00488631|1823871|FG002|Open Label Study Extension (Week 54-228)|Death|0
864350|NCT00488631|1823872|FG003|Open Label Study Extension (Week 54-228)|Death|0
864351|NCT00488631|1823873|FG004|Open Label Study Extension (Week 54-228)|Death|0
864352|NCT00488631|1823874|FG005|Open Label Study Extension (Week 54-228)|Death|0
864353|NCT00488631|1823875|FG006|Open Label Study Extension (Week 54-228)|Death|0
864354|NCT00488631|1823876|FG007|Open Label Study Extension (Week 54-228)|Death|0
864355|NCT00488631|1823877|FG008|Open Label Study Extension (Week 54-228)|Death|1
864356|NCT00488631|1823878|FG009|Open Label Study Extension (Week 54-228)|Death|0
864357|NCT00488631|1823869|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
864358|NCT00488631|1823870|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
864359|NCT00488631|1823871|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
864360|NCT00488631|1823872|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
864361|NCT00488631|1823873|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
864362|NCT00488631|1823874|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
864363|NCT00488631|1823875|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
864364|NCT00488631|1823876|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
864365|NCT00488631|1823877|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
864366|NCT00488631|1823878|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
864367|NCT00488631|1823869|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
864368|NCT00488631|1823870|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
864369|NCT00488631|1823871|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
864370|NCT00488631|1823872|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
864371|NCT00488631|1823873|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
864372|NCT00488631|1823874|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
864373|NCT00488631|1823875|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
864374|NCT00488631|1823876|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
864375|NCT00488631|1823877|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
864376|NCT00488631|1823878|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
864377|NCT00488631|1823869|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
864378|NCT00488631|1823870|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
864379|NCT00488631|1823871|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
864380|NCT00488631|1823872|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
864381|NCT00488631|1823873|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
864382|NCT00488631|1823874|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
864383|NCT00488631|1823875|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
864384|NCT00488631|1823876|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
864385|NCT00488631|1823877|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
864386|NCT00488631|1823878|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
864387|NCT00488644|1823901|FG000|Overall Study|Not Eligible|1
864388|NCT00488644|1823901|FG000|Overall Study|Not Evaluable|1
864389|NCT00488683|1823908|FG000|Overall Study|Withdrawal by Subject|1
864390|NCT00488683|1823909|FG001|Overall Study|Withdrawal by Subject|2
864391|NCT00488683|1823910|FG002|Overall Study|Withdrawal by Subject|2
864392|NCT00488683|1823908|FG000|Overall Study|Lost to Follow-up|5
864393|NCT00488683|1823909|FG001|Overall Study|Lost to Follow-up|3
864394|NCT00488683|1823910|FG002|Overall Study|Lost to Follow-up|0
864395|NCT00488683|1823908|FG000|Overall Study|Protocol Violation|5
864396|NCT00488683|1823909|FG001|Overall Study|Protocol Violation|1
864397|NCT00488683|1823910|FG002|Overall Study|Protocol Violation|0
864398|NCT00488683|1823908|FG000|Overall Study|Unable to Classify|1
864399|NCT00488683|1823909|FG001|Overall Study|Unable to Classify|0
864400|NCT00488683|1823910|FG002|Overall Study|Unable to Classify|0
864401|NCT00488774|1823926|FG000|Overall Study|Withdrawal of consent|2
864402|NCT00488774|1823927|FG001|Overall Study|Withdrawal of consent|2
864403|NCT00488774|1823928|FG002|Overall Study|Withdrawal of consent|2
864404|NCT00488774|1823929|FG003|Overall Study|Withdrawal of consent|0
864405|NCT00488774|1823926|FG000|Overall Study|Other|6
864406|NCT00488774|1823927|FG001|Overall Study|Other|3
864407|NCT00488774|1823928|FG002|Overall Study|Other|2
864408|NCT00488774|1823929|FG003|Overall Study|Other|2
864409|NCT00488774|1823926|FG000|Overall Study|Lost to Follow-up|0
864410|NCT00488774|1823927|FG001|Overall Study|Lost to Follow-up|0
864411|NCT00488774|1823928|FG002|Overall Study|Lost to Follow-up|1
864412|NCT00488774|1823929|FG003|Overall Study|Lost to Follow-up|1
864413|NCT00488826|1823943|FG000|Overall Study|Withdrawal by Subject|40
864414|NCT00488826|1823944|FG001|Overall Study|Withdrawal by Subject|35
864415|NCT00488826|1823945|FG002|Overall Study|Withdrawal by Subject|19
864416|NCT00488826|1823943|FG000|Overall Study|Protocol Violation|0
864417|NCT00488826|1823944|FG001|Overall Study|Protocol Violation|0
864418|NCT00488826|1823945|FG002|Overall Study|Protocol Violation|2
864419|NCT00488826|1823943|FG000|Overall Study|Adverse Event|9
864420|NCT00488826|1823944|FG001|Overall Study|Adverse Event|15
864421|NCT00488826|1823945|FG002|Overall Study|Adverse Event|4
864422|NCT00488826|1823943|FG000|Overall Study|Lost to Follow-up|5
864423|NCT00488826|1823944|FG001|Overall Study|Lost to Follow-up|1
864424|NCT00488826|1823945|FG002|Overall Study|Lost to Follow-up|0
864425|NCT00488826|1823943|FG000|Overall Study|Protocol Deviations|2
864426|NCT00488826|1823944|FG001|Overall Study|Protocol Deviations|1
864427|NCT00488826|1823945|FG002|Overall Study|Protocol Deviations|1
864428|NCT00488982|1823957|FG000|Course 1|Physician Decision|0
864429|NCT00488982|1823958|FG001|Course 1|Physician Decision|2
864430|NCT00488982|1823959|FG002|Course 1|Physician Decision|4
864431|NCT00488982|1823957|FG000|Course 1|Withdrawal by Subject|0
864432|NCT00488982|1823958|FG001|Course 1|Withdrawal by Subject|8
864433|NCT00488982|1823959|FG002|Course 1|Withdrawal by Subject|2
864434|NCT00488982|1823957|FG000|Course 1|nonprotocol therapy|0
864435|NCT00488982|1823958|FG001|Course 1|nonprotocol therapy|2
864436|NCT00488982|1823959|FG002|Course 1|nonprotocol therapy|2
864437|NCT00488982|1823957|FG000|Course 1|Adverse Event|0
864438|NCT00488982|1823958|FG001|Course 1|Adverse Event|0
864439|NCT00488982|1823959|FG002|Course 1|Adverse Event|6
864440|NCT00489216|1823977|FG000|Overall Study|Adverse Event|1
864441|NCT00489255|1823983|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9
864442|NCT00489255|1823984|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3
864443|NCT00489255|1823983|FG000|Period 1: Days 1 to 28|Adverse Event|21
864444|NCT00489255|1823984|FG001|Period 1: Days 1 to 28|Adverse Event|8
864445|NCT00489255|1823983|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5
864446|NCT00489255|1823984|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0
864447|NCT00489255|1823983|FG000|Period 1: Days 1 to 28|Physician Decision|1
864448|NCT00489255|1823984|FG001|Period 1: Days 1 to 28|Physician Decision|4
864449|NCT00489255|1823983|FG000|Period 1: Days 1 to 28|Noncompliance|2
864450|NCT00489255|1823984|FG001|Period 1: Days 1 to 28|Noncompliance|0
864451|NCT00489255|1823983|FG000|Period 2: Days 29 to 56|Adverse Event|3
864452|NCT00489255|1823984|FG001|Period 2: Days 29 to 56|Adverse Event|1
864453|NCT00489255|1823983|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0
864454|NCT00489255|1823984|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3
864455|NCT00489255|1823983|FG000|Period 3: Days 57 to 84|Adverse Event|3
864456|NCT00489255|1823984|FG001|Period 3: Days 57 to 84|Adverse Event|3
864457|NCT00489255|1823983|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1
864458|NCT00489255|1823984|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0
864459|NCT00489255|1823983|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0
864460|NCT00489255|1823984|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1
864461|NCT00489359|1824022|FG000|Overall Study|Death|0
864462|NCT00489359|1824023|FG001|Overall Study|Death|2
864463|NCT00489359|1824022|FG000|Overall Study|Progressive Disease|5
864464|NCT00489359|1824023|FG001|Overall Study|Progressive Disease|6
864465|NCT00489359|1824022|FG000|Overall Study|Lost to Follow-up|1
864466|NCT00489359|1824023|FG001|Overall Study|Lost to Follow-up|0
864467|NCT00489359|1824022|FG000|Overall Study|Withdrawal by Subject|1
864468|NCT00489359|1824023|FG001|Overall Study|Withdrawal by Subject|5
864469|NCT00489359|1824022|FG000|Overall Study|Adverse Event|0
864470|NCT00489359|1824023|FG001|Overall Study|Adverse Event|16
864471|NCT00489411|1824036|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
864472|NCT00489411|1824037|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
864473|NCT00489411|1824036|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
864474|NCT00489411|1824037|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
864475|NCT00489411|1824036|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
864476|NCT00489411|1824037|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
864477|NCT00489411|1824036|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
864478|NCT00489411|1824037|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
864479|NCT00489411|1824036|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
864480|NCT00489411|1824037|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
864481|NCT00489424|1824046|FG000|Overall Study|Adverse Event|3
864482|NCT00489424|1824047|FG001|Overall Study|Adverse Event|3
864483|NCT00489424|1824048|FG002|Overall Study|Adverse Event|4
864484|NCT00489424|1824046|FG000|Overall Study|Lack of Efficacy|1
864485|NCT00489424|1824047|FG001|Overall Study|Lack of Efficacy|0
864486|NCT00489424|1824048|FG002|Overall Study|Lack of Efficacy|0
864487|NCT00489424|1824046|FG000|Overall Study|Administrative problems|0
864488|NCT00489424|1824047|FG001|Overall Study|Administrative problems|2
864489|NCT00489424|1824048|FG002|Overall Study|Administrative problems|1
864490|NCT00489476|1824060|FG000|Overall Study|Lost to Follow-up|0
864491|NCT00489476|1824061|FG001|Overall Study|Lost to Follow-up|1
864492|NCT00489476|1824062|FG002|Overall Study|Lost to Follow-up|0
864493|NCT00489476|1824063|FG003|Overall Study|Lost to Follow-up|0
864494|NCT00489489|1824076|FG000|Overall Study|Not treated due to protocol violation|0
864495|NCT00489489|1824077|FG001|Overall Study|Not treated due to protocol violation|1
864496|NCT00489489|1824078|FG002|Overall Study|Not treated due to protocol violation|1
864497|NCT00489489|1824076|FG000|Overall Study|Adverse Event|1
864498|NCT00489489|1824077|FG001|Overall Study|Adverse Event|1
864499|NCT00489489|1824078|FG002|Overall Study|Adverse Event|1
864500|NCT00489489|1824076|FG000|Overall Study|Protocol Violation|1
864501|NCT00489489|1824077|FG001|Overall Study|Protocol Violation|0
864502|NCT00489489|1824078|FG002|Overall Study|Protocol Violation|1
864503|NCT00489489|1824076|FG000|Overall Study|Progressive disease|0
864504|NCT00489489|1824077|FG001|Overall Study|Progressive disease|1
864505|NCT00489489|1824078|FG002|Overall Study|Progressive disease|0
864506|NCT00489489|1824076|FG000|Overall Study|Participant did not wish to continue|1
864507|NCT00489489|1824077|FG001|Overall Study|Participant did not wish to continue|1
864508|NCT00489489|1824078|FG002|Overall Study|Participant did not wish to continue|0
864509|NCT00489489|1824076|FG000|Overall Study|Other than above|0
864510|NCT00489489|1824077|FG001|Overall Study|Other than above|1
864511|NCT00489489|1824078|FG002|Overall Study|Other than above|0
864512|NCT00489541|1824090|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2
864513|NCT00489541|1824091|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3
864514|NCT00489541|1824090|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
864515|NCT00489541|1824091|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0
864516|NCT00489541|1824090|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2
864517|NCT00489541|1824091|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0
864518|NCT00489541|1824090|FG000|12-Month Clinical Follow-up|Death|3
864519|NCT00489541|1824091|FG001|12-Month Clinical Follow-up|Death|2
864520|NCT00489541|1824090|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
864521|NCT00489541|1824091|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
864522|NCT00489541|1824090|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
864523|NCT00489541|1824091|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
864524|NCT00489554|1824097|FG000|Overall Study|Adverse Event|2
864525|NCT00489554|1824097|FG000|Overall Study|Withdrawal by Subject|1
864526|NCT00489554|1824097|FG000|Overall Study|Lost to Follow-up|1
864527|NCT00489736|1824103|FG000|Overall Study|Lack of Efficacy|53
864528|NCT00489736|1824104|FG001|Overall Study|Lack of Efficacy|14
864529|NCT00489736|1824103|FG000|Overall Study|Adverse Event|32
864530|NCT00489736|1824104|FG001|Overall Study|Adverse Event|45
864531|NCT00489736|1824103|FG000|Overall Study|Poor compliance|6
864532|NCT00489736|1824104|FG001|Overall Study|Poor compliance|2
864533|NCT00489736|1824103|FG000|Overall Study|Not coded/ Not pre-specified|5
864534|NCT00489736|1824104|FG001|Overall Study|Not coded/ Not pre-specified|8
864535|NCT00489827|1824112|FG000|Overall Study|Intraoperative exclusion criteria|1
864536|NCT00489827|1824113|FG001|Overall Study|Intraoperative exclusion criteria|1
864537|NCT00489827|1824112|FG000|Overall Study|Intraoperative exclusion criteria|1
864538|NCT00489827|1824113|FG001|Overall Study|Intraoperative exclusion criteria|1
864539|NCT00489853|1824119|FG000|Wash-out Period 1|Withdrawal by Subject|1
864540|NCT00489853|1824120|FG001|Wash-out Period 1|Withdrawal by Subject|0
864541|NCT00489853|1824121|FG002|Wash-out Period 1|Withdrawal by Subject|0
864542|NCT00489853|1824119|FG000|Wash-out Period 1|Adverse Event|0
864543|NCT00489853|1824120|FG001|Wash-out Period 1|Adverse Event|1
864544|NCT00489853|1824121|FG002|Wash-out Period 1|Adverse Event|1
864545|NCT00489853|1824119|FG000|Wash-out Period 1|Protocol Violation|0
864546|NCT00489853|1824120|FG001|Wash-out Period 1|Protocol Violation|1
864547|NCT00489853|1824121|FG002|Wash-out Period 1|Protocol Violation|1
864548|NCT00489853|1824119|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0
864549|NCT00489853|1824120|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1
864550|NCT00489853|1824121|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4
864551|NCT00489853|1824119|FG000|Wash-out Period 2|Adverse Event|1
864552|NCT00489853|1824120|FG001|Wash-out Period 2|Adverse Event|1
864553|NCT00489853|1824121|FG002|Wash-out Period 2|Adverse Event|0
864554|NCT00489853|1824119|FG000|Wash-out Period 2|Study specific discontinuation criteria|3
864555|NCT00489853|1824120|FG001|Wash-out Period 2|Study specific discontinuation criteria|2
864556|NCT00489853|1824121|FG002|Wash-out Period 2|Study specific discontinuation criteria|2
864557|NCT00489853|1824119|FG000|Treatment Period 3|Study specific discontinuation criteria|0
864558|NCT00489853|1824120|FG001|Treatment Period 3|Study specific discontinuation criteria|1
864559|NCT00489853|1824121|FG002|Treatment Period 3|Study specific discontinuation criteria|0
864560|NCT00489918|1824151|FG000|Overall Study|Withdrawal by Subject|2
864561|NCT00489918|1824152|FG001|Overall Study|Withdrawal by Subject|1
864562|NCT00489918|1824153|FG002|Overall Study|Withdrawal by Subject|1
864563|NCT00489918|1824154|FG003|Overall Study|Withdrawal by Subject|0
864564|NCT00489918|1824155|FG004|Overall Study|Withdrawal by Subject|1
864565|NCT00489918|1824151|FG000|Overall Study|Adverse Event|0
864566|NCT00489918|1824152|FG001|Overall Study|Adverse Event|1
864567|NCT00489918|1824153|FG002|Overall Study|Adverse Event|1
864568|NCT00489918|1824154|FG003|Overall Study|Adverse Event|0
864569|NCT00489918|1824155|FG004|Overall Study|Adverse Event|0
864570|NCT00489918|1824151|FG000|Overall Study|Lost to Follow-up|0
864571|NCT00489918|1824152|FG001|Overall Study|Lost to Follow-up|0
864572|NCT00489918|1824153|FG002|Overall Study|Lost to Follow-up|1
864573|NCT00489918|1824154|FG003|Overall Study|Lost to Follow-up|1
864574|NCT00489918|1824155|FG004|Overall Study|Lost to Follow-up|0
864575|NCT00489918|1824151|FG000|Overall Study|Physician Decision|0
864576|NCT00489918|1824152|FG001|Overall Study|Physician Decision|0
864577|NCT00489918|1824153|FG002|Overall Study|Physician Decision|1
864578|NCT00489918|1824154|FG003|Overall Study|Physician Decision|0
864579|NCT00489918|1824155|FG004|Overall Study|Physician Decision|0
864580|NCT00489970|1824170|FG000|Persistence Year 9|Lost to Follow-up|2
864581|NCT00489970|1824171|FG001|Persistence Year 9|Lost to Follow-up|2
864582|NCT00489970|1824172|FG002|Persistence Year 9|Lost to Follow-up|3
864583|NCT00489970|1824170|FG000|Persistence Year 9|Other|1
864584|NCT00489970|1824171|FG001|Persistence Year 9|Other|0
864585|NCT00489970|1824172|FG002|Persistence Year 9|Other|2
864586|NCT00490022|1824190|FG000|Overall Study|Adverse Event|0
864587|NCT00490022|1824191|FG001|Overall Study|Adverse Event|2
864588|NCT00490022|1824190|FG000|Overall Study|Withdrawal by Subject|1
864589|NCT00490022|1824191|FG001|Overall Study|Withdrawal by Subject|0
864590|NCT00490022|1824190|FG000|Overall Study|Subject failed to disclose concommitant|0
864591|NCT00490022|1824191|FG001|Overall Study|Subject failed to disclose concommitant|1
864592|NCT00490035|1824201|FG000|Overall Study|AE, non-serious non-fatal|3
864593|NCT00490035|1824202|FG001|Overall Study|AE, non-serious non-fatal|4
864594|NCT00490035|1824203|FG002|Overall Study|AE, non-serious non-fatal|4
864595|NCT00490035|1824204|FG003|Overall Study|AE, non-serious non-fatal|5
864596|NCT00490035|1824201|FG000|Overall Study|Lost to Follow-up|2
864597|NCT00490035|1824202|FG001|Overall Study|Lost to Follow-up|0
864598|NCT00490035|1824203|FG002|Overall Study|Lost to Follow-up|1
864599|NCT00490035|1824204|FG003|Overall Study|Lost to Follow-up|0
864600|NCT00490035|1824201|FG000|Overall Study|Withdrawal by Subject|2
864601|NCT00490035|1824202|FG001|Overall Study|Withdrawal by Subject|1
864602|NCT00490035|1824203|FG002|Overall Study|Withdrawal by Subject|1
864603|NCT00490035|1824204|FG003|Overall Study|Withdrawal by Subject|0
864604|NCT00490035|1824201|FG000|Overall Study|Other reason|0
864605|NCT00490035|1824202|FG001|Overall Study|Other reason|1
864606|NCT00490035|1824203|FG002|Overall Study|Other reason|3
864607|NCT00490035|1824204|FG003|Overall Study|Other reason|1
864608|NCT00490035|1824201|FG000|Overall Study|AE, serious fatal|1
864609|NCT00490035|1824202|FG001|Overall Study|AE, serious fatal|0
864610|NCT00490035|1824203|FG002|Overall Study|AE, serious fatal|0
864611|NCT00490035|1824204|FG003|Overall Study|AE, serious fatal|0
864612|NCT00490035|1824201|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0
864613|NCT00490035|1824202|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0
864614|NCT00490035|1824203|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1
864615|NCT00490035|1824204|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0
864616|NCT00490035|1824201|FG000|Overall Study|AE of unknown type|0
864617|NCT00490035|1824202|FG001|Overall Study|AE of unknown type|0
864618|NCT00490035|1824203|FG002|Overall Study|AE of unknown type|2
864619|NCT00490035|1824204|FG003|Overall Study|AE of unknown type|0
864620|NCT00490061|1824214|FG000|Overall Study|Physician Decision|1
864621|NCT00490139|1824227|FG000|Overall Study|Death|106
864622|NCT00490139|1824228|FG001|Overall Study|Death|119
864623|NCT00490139|1824229|FG002|Overall Study|Death|168
864624|NCT00490139|1824230|FG003|Overall Study|Death|135
864625|NCT00490139|1824227|FG000|Overall Study|Lost to Follow-up|56
864626|NCT00490139|1824228|FG001|Overall Study|Lost to Follow-up|46
864627|NCT00490139|1824229|FG002|Overall Study|Lost to Follow-up|58
864628|NCT00490139|1824230|FG003|Overall Study|Lost to Follow-up|56
864629|NCT00490139|1824227|FG000|Overall Study|Participant Withdrew Consent|146
864630|NCT00490139|1824228|FG001|Overall Study|Participant Withdrew Consent|110
864631|NCT00490139|1824229|FG002|Overall Study|Participant Withdrew Consent|208
864632|NCT00490139|1824230|FG003|Overall Study|Participant Withdrew Consent|116
864633|NCT00490282|1824260|FG000|Overall Study|Withdrawal by Subject|3
864634|NCT00490451|1824267|FG000|Overall Study|Adverse Event|3
864635|NCT00490451|1824268|FG001|Overall Study|Adverse Event|3
864636|NCT00490451|1824267|FG000|Overall Study|Death|3
864637|NCT00490451|1824268|FG001|Overall Study|Death|1
864638|NCT00490451|1824267|FG000|Overall Study|Withdrawal by Subject|2
864639|NCT00490451|1824268|FG001|Overall Study|Withdrawal by Subject|0
864640|NCT00490451|1824267|FG000|Overall Study|Investigator Decision|1
864641|NCT00490451|1824268|FG001|Overall Study|Investigator Decision|0
864642|NCT00490451|1824267|FG000|Overall Study|Protocol Violation|1
864643|NCT00490451|1824268|FG001|Overall Study|Protocol Violation|0
864644|NCT00490451|1824267|FG000|Overall Study|Progressive Disease|53
864645|NCT00490451|1824268|FG001|Overall Study|Progressive Disease|34
864646|NCT00490490|1824283|FG000|Completed Assessment for TTP|Withdrawal by Subject|1
864647|NCT00490490|1824283|FG000|Completed Assessment for TTP|Lost to Follow-up|2
864648|NCT00490529|1824287|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
864649|NCT00490529|1824287|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
864650|NCT00490529|1824287|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
864651|NCT00490529|1824287|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
864652|NCT00490529|1824287|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
864653|NCT00490529|1824287|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
864654|NCT00490542|1824293|FG000|Overall Study|Lost to Follow-up|3
864655|NCT00490542|1824294|FG001|Overall Study|Lost to Follow-up|0
864656|NCT00490542|1824293|FG000|Overall Study|Adverse Event|3
864657|NCT00490542|1824294|FG001|Overall Study|Adverse Event|3
864658|NCT00490542|1824293|FG000|Overall Study|Lack of Efficacy|1
864659|NCT00490542|1824294|FG001|Overall Study|Lack of Efficacy|1
864660|NCT00490555|1824304|FG000|Overall Study|noncompliant with drug administration|0
864661|NCT00490555|1824305|FG001|Overall Study|noncompliant with drug administration|0
864662|NCT00490555|1824306|FG002|Overall Study|noncompliant with drug administration|2
864663|NCT00490555|1824307|FG003|Overall Study|noncompliant with drug administration|0
864664|NCT00490568|1824317|FG000|Overall Study|Adverse Event|116
864665|NCT00490568|1824317|FG000|Overall Study|Lost to Follow-up|13
864666|NCT00490568|1824317|FG000|Overall Study|Protocol Violation|45
864667|NCT00490568|1824317|FG000|Overall Study|Withdrawal by Subject|135
864668|NCT00490568|1824317|FG000|Overall Study|Still in the study at termination|974
864669|NCT00490568|1824317|FG000|Overall Study|Other|1
864670|NCT00490568|1824317|FG000|Overall Study|Exclusion criteria met|1
864671|NCT00490568|1824317|FG000|Overall Study|Caregiver related|20
864672|NCT00490568|1824317|FG000|Overall Study|Abnormal ECG|25
864673|NCT00490568|1824317|FG000|Overall Study|Participant refused follow-up|9
864674|NCT00490568|1824317|FG000|Overall Study|Legal representative withdrew consent|1
864675|NCT00490568|1824317|FG000|Overall Study|Disease progression|4
864676|NCT00490568|1824317|FG000|Overall Study|Unmet inclusion-exclusion criteria|5
864677|NCT00490568|1824317|FG000|Overall Study|Investigator decision|3
864678|NCT00490568|1824317|FG000|Overall Study|Non-Compliance|7
864679|NCT00490568|1824317|FG000|Overall Study|Efficacy related|3
864680|NCT00490568|1824317|FG000|Overall Study|Participant died|1
864681|NCT00490568|1824317|FG000|Overall Study|Participant withdrawal due to surgery|1
864682|NCT00490646|1824324|FG000|Overall Study|Still on trastuzumab monotherapy|1
864683|NCT00490646|1824325|FG001|Overall Study|Still on trastuzumab monotherapy|1
864684|NCT00490646|1824324|FG000|Overall Study|Never Treated (had an adverse event)|1
864685|NCT00490646|1824325|FG001|Overall Study|Never Treated (had an adverse event)|0
864686|NCT00490646|1824324|FG000|Overall Study|Never Treated (withdrew consent)|0
864687|NCT00490646|1824325|FG001|Overall Study|Never Treated (withdrew consent)|1
864688|NCT00490698|1824331|FG000|Overall Study|Withdrawal by Subject|1
864689|NCT00490698|1824331|FG000|Overall Study|Disease Progression|7
864690|NCT00490698|1824331|FG000|Overall Study|Physician Decision|2
864691|NCT00490724|1824338|FG000|Period I|Physician Decision|0
864692|NCT00490724|1824339|FG001|Period I|Physician Decision|0
864693|NCT00490724|1824340|FG002|Period I|Physician Decision|1
864694|NCT00490724|1824338|FG000|Period II|Treatment Discontinuation|3
864695|NCT00490724|1824339|FG001|Period II|Treatment Discontinuation|1
864696|NCT00490724|1824340|FG002|Period II|Treatment Discontinuation|3
864697|NCT00490815|1824360|FG000|Overall Study|Adverse Event|2
864698|NCT00490815|1824361|FG001|Overall Study|Adverse Event|3
864699|NCT00490815|1824360|FG000|Overall Study|Withdrawal by Subject|4
864700|NCT00490815|1824361|FG001|Overall Study|Withdrawal by Subject|0
864701|NCT00490815|1824360|FG000|Overall Study|Lost to Follow-up|1
864702|NCT00490815|1824361|FG001|Overall Study|Lost to Follow-up|3
864703|NCT00490815|1824360|FG000|Overall Study|Death|1
864704|NCT00490815|1824361|FG001|Overall Study|Death|3
864705|NCT00490841|1824367|FG000|Overall Study|Death|5
864706|NCT00490841|1824367|FG000|Overall Study|Withdrawal by Subject|4
864707|NCT00490841|1824367|FG000|Overall Study|Lost to Follow-up|1
864708|NCT00490841|1824367|FG000|Overall Study|30 day f/u, only non-study stent used|3
864709|NCT00490919|1824374|FG000|Open-label Run-in Period|Adverse Event|239
864710|NCT00490919|1824375|FG001|Open-label Run-in Period|Adverse Event|0
864711|NCT00490919|1824376|FG002|Open-label Run-in Period|Adverse Event|0
864712|NCT00490919|1824374|FG000|Open-label Run-in Period|Withdrawal by Subject|37
864713|NCT00490919|1824375|FG001|Open-label Run-in Period|Withdrawal by Subject|0
864714|NCT00490919|1824376|FG002|Open-label Run-in Period|Withdrawal by Subject|0
864715|NCT00490919|1824374|FG000|Open-label Run-in Period|Lost to Follow-up|21
864716|NCT00490919|1824375|FG001|Open-label Run-in Period|Lost to Follow-up|0
864717|NCT00490919|1824376|FG002|Open-label Run-in Period|Lost to Follow-up|0
864718|NCT00490919|1824374|FG000|Open-label Run-in Period|Lack of Efficacy|143
864719|NCT00490919|1824375|FG001|Open-label Run-in Period|Lack of Efficacy|0
864720|NCT00490919|1824376|FG002|Open-label Run-in Period|Lack of Efficacy|0
864721|NCT00490919|1824374|FG000|Open-label Run-in Period|Administrative|40
864722|NCT00490919|1824375|FG001|Open-label Run-in Period|Administrative|0
864723|NCT00490919|1824376|FG002|Open-label Run-in Period|Administrative|0
864724|NCT00490919|1824374|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3
864725|NCT00490919|1824375|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0
864726|NCT00490919|1824376|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0
864727|NCT00490919|1824374|FG000|Double-blind Phase|Adverse Event|0
864728|NCT00490919|1824375|FG001|Double-blind Phase|Adverse Event|40
864729|NCT00490919|1824376|FG002|Double-blind Phase|Adverse Event|20
864730|NCT00490919|1824374|FG000|Double-blind Phase|Withdrawal by Subject|0
864731|NCT00490919|1824375|FG001|Double-blind Phase|Withdrawal by Subject|10
864732|NCT00490919|1824376|FG002|Double-blind Phase|Withdrawal by Subject|11
864733|NCT00490919|1824374|FG000|Double-blind Phase|Lost to Follow-up|0
864734|NCT00490919|1824375|FG001|Double-blind Phase|Lost to Follow-up|8
864735|NCT00490919|1824376|FG002|Double-blind Phase|Lost to Follow-up|11
864736|NCT00490919|1824374|FG000|Double-blind Phase|Lack of Efficacy|0
864737|NCT00490919|1824375|FG001|Double-blind Phase|Lack of Efficacy|22
864738|NCT00490919|1824376|FG002|Double-blind Phase|Lack of Efficacy|36
864739|NCT00490919|1824374|FG000|Double-blind Phase|Administrative|0
864740|NCT00490919|1824375|FG001|Double-blind Phase|Administrative|6
864741|NCT00490919|1824376|FG002|Double-blind Phase|Administrative|6
864742|NCT00490945|1824388|FG000|Overall Study|Adverse Event|0
864743|NCT00490945|1824389|FG001|Overall Study|Adverse Event|1
864744|NCT00490945|1824390|FG002|Overall Study|Adverse Event|0
864745|NCT00490945|1824391|FG003|Overall Study|Adverse Event|0
864746|NCT00490945|1824392|FG004|Overall Study|Adverse Event|0
864747|NCT00490971|1824412|FG000|Acute/Continuation|Adverse Event|62
864748|NCT00490971|1824413|FG001|Acute/Continuation|Adverse Event|13
864749|NCT00490971|1824414|FG002|Acute/Continuation|Adverse Event|0
864750|NCT00490971|1824415|FG003|Acute/Continuation|Adverse Event|0
864751|NCT00490971|1824416|FG004|Acute/Continuation|Adverse Event|0
864752|NCT00490971|1824412|FG000|Acute/Continuation|Death|2
864753|NCT00490971|1824413|FG001|Acute/Continuation|Death|0
864754|NCT00490971|1824414|FG002|Acute/Continuation|Death|0
864755|NCT00490971|1824415|FG003|Acute/Continuation|Death|0
864756|NCT00490971|1824416|FG004|Acute/Continuation|Death|0
864757|NCT00490971|1824412|FG000|Acute/Continuation|Lack of Efficacy|106
864758|NCT00490971|1824413|FG001|Acute/Continuation|Lack of Efficacy|12
864759|NCT00490971|1824414|FG002|Acute/Continuation|Lack of Efficacy|0
864760|NCT00490971|1824415|FG003|Acute/Continuation|Lack of Efficacy|0
864761|NCT00490971|1824416|FG004|Acute/Continuation|Lack of Efficacy|0
864762|NCT00490971|1824412|FG000|Acute/Continuation|Lost to Follow-up|23
864763|NCT00490971|1824413|FG001|Acute/Continuation|Lost to Follow-up|7
864764|NCT00490971|1824414|FG002|Acute/Continuation|Lost to Follow-up|0
864765|NCT00490971|1824415|FG003|Acute/Continuation|Lost to Follow-up|0
864766|NCT00490971|1824416|FG004|Acute/Continuation|Lost to Follow-up|0
864767|NCT00490971|1824412|FG000|Acute/Continuation|Protocol Violation|10
864768|NCT00490971|1824413|FG001|Acute/Continuation|Protocol Violation|2
864769|NCT00490971|1824414|FG002|Acute/Continuation|Protocol Violation|0
864770|NCT00490971|1824415|FG003|Acute/Continuation|Protocol Violation|0
864771|NCT00490971|1824416|FG004|Acute/Continuation|Protocol Violation|0
864772|NCT00490971|1824412|FG000|Acute/Continuation|Withdrawal by Subject|92
864773|NCT00490971|1824413|FG001|Acute/Continuation|Withdrawal by Subject|24
864774|NCT00490971|1824414|FG002|Acute/Continuation|Withdrawal by Subject|0
864775|NCT00490971|1824415|FG003|Acute/Continuation|Withdrawal by Subject|0
864776|NCT00490971|1824416|FG004|Acute/Continuation|Withdrawal by Subject|0
864777|NCT00490971|1824412|FG000|Acute/Continuation|Other|11
864778|NCT00490971|1824413|FG001|Acute/Continuation|Other|4
864779|NCT00490971|1824414|FG002|Acute/Continuation|Other|0
864780|NCT00490971|1824415|FG003|Acute/Continuation|Other|0
864781|NCT00490971|1824416|FG004|Acute/Continuation|Other|0
864782|NCT00490971|1824412|FG000|Maintenance|Adverse Event|0
864783|NCT00490971|1824413|FG001|Maintenance|Adverse Event|0
864784|NCT00490971|1824414|FG002|Maintenance|Adverse Event|4
864785|NCT00490971|1824415|FG003|Maintenance|Adverse Event|5
864786|NCT00490971|1824416|FG004|Maintenance|Adverse Event|7
864787|NCT00490971|1824412|FG000|Maintenance|Death|0
864788|NCT00490971|1824413|FG001|Maintenance|Death|0
864789|NCT00490971|1824414|FG002|Maintenance|Death|0
864790|NCT00490971|1824415|FG003|Maintenance|Death|2
864791|NCT00490971|1824416|FG004|Maintenance|Death|0
864792|NCT00490971|1824412|FG000|Maintenance|Lost to Follow-up|0
864793|NCT00490971|1824413|FG001|Maintenance|Lost to Follow-up|0
864794|NCT00490971|1824414|FG002|Maintenance|Lost to Follow-up|5
864795|NCT00490971|1824415|FG003|Maintenance|Lost to Follow-up|8
864796|NCT00490971|1824416|FG004|Maintenance|Lost to Follow-up|10
864797|NCT00490971|1824412|FG000|Maintenance|Pregnancy|0
864798|NCT00490971|1824413|FG001|Maintenance|Pregnancy|0
864799|NCT00490971|1824414|FG002|Maintenance|Pregnancy|1
864800|NCT00490971|1824415|FG003|Maintenance|Pregnancy|0
864801|NCT00490971|1824416|FG004|Maintenance|Pregnancy|0
864802|NCT00490971|1824412|FG000|Maintenance|Protocol Violation|0
864803|NCT00490971|1824413|FG001|Maintenance|Protocol Violation|0
864804|NCT00490971|1824414|FG002|Maintenance|Protocol Violation|4
864805|NCT00490971|1824415|FG003|Maintenance|Protocol Violation|1
864806|NCT00490971|1824416|FG004|Maintenance|Protocol Violation|1
864807|NCT00490971|1824412|FG000|Maintenance|Withdrawal by Subject|0
864808|NCT00490971|1824413|FG001|Maintenance|Withdrawal by Subject|0
864809|NCT00490971|1824414|FG002|Maintenance|Withdrawal by Subject|26
864810|NCT00490971|1824415|FG003|Maintenance|Withdrawal by Subject|28
864811|NCT00490971|1824416|FG004|Maintenance|Withdrawal by Subject|18
864812|NCT00490971|1824412|FG000|Maintenance|Other|0
864813|NCT00490971|1824413|FG001|Maintenance|Other|0
864814|NCT00490971|1824414|FG002|Maintenance|Other|11
864815|NCT00490971|1824415|FG003|Maintenance|Other|9
864816|NCT00490971|1824416|FG004|Maintenance|Other|3
864817|NCT00491075|1824428|FG000|Overall Study|Withdrawal by Subject|1
864818|NCT00491075|1824428|FG000|Overall Study|Physician Decision|1
864819|NCT00491179|1824434|FG000|Overall Study|Adverse Event|5
864820|NCT00491179|1824435|FG001|Overall Study|Adverse Event|1
864821|NCT00491179|1824434|FG000|Overall Study|Withdrawal by Subject|2
864822|NCT00491179|1824435|FG001|Overall Study|Withdrawal by Subject|1
864823|NCT00491322|1824452|FG000|Overall Study|Protocol Violation|1
864824|NCT00491322|1824453|FG001|Overall Study|Protocol Violation|0
864825|NCT00491322|1824452|FG000|Overall Study|Pregnancy|0
864826|NCT00491322|1824453|FG001|Overall Study|Pregnancy|1
864827|NCT00491504|1824481|FG000|Overall Study|Adverse Event|0
864828|NCT00491504|1824482|FG001|Overall Study|Adverse Event|1
864829|NCT00491504|1824483|FG002|Overall Study|Adverse Event|0
864830|NCT00491504|1824484|FG003|Overall Study|Adverse Event|0
864831|NCT00491504|1824481|FG000|Overall Study|Withdrawal by Subject|0
864832|NCT00491504|1824482|FG001|Overall Study|Withdrawal by Subject|0
864833|NCT00491504|1824483|FG002|Overall Study|Withdrawal by Subject|1
864834|NCT00491504|1824484|FG003|Overall Study|Withdrawal by Subject|2
864835|NCT00491504|1824481|FG000|Overall Study|Protocol Violation|0
864836|NCT00491504|1824482|FG001|Overall Study|Protocol Violation|0
864837|NCT00491504|1824483|FG002|Overall Study|Protocol Violation|3
864838|NCT00491504|1824484|FG003|Overall Study|Protocol Violation|2
864839|NCT00491530|1824495|FG000|Overall Study|Adverse Event|6
864840|NCT00491530|1824496|FG001|Overall Study|Adverse Event|1
864841|NCT00491530|1824497|FG002|Overall Study|Adverse Event|2
864842|NCT00491530|1824495|FG000|Overall Study|Withdrawal by Subject|3
864843|NCT00491530|1824496|FG001|Overall Study|Withdrawal by Subject|0
864844|NCT00491530|1824497|FG002|Overall Study|Withdrawal by Subject|0
864845|NCT00491530|1824495|FG000|Overall Study|Lost to Follow-up|3
864846|NCT00491530|1824496|FG001|Overall Study|Lost to Follow-up|2
864847|NCT00491530|1824497|FG002|Overall Study|Lost to Follow-up|2
864848|NCT00491530|1824495|FG000|Overall Study|Lack of Efficacy|0
864849|NCT00491530|1824496|FG001|Overall Study|Lack of Efficacy|1
864850|NCT00491530|1824497|FG002|Overall Study|Lack of Efficacy|0
864851|NCT00491530|1824495|FG000|Overall Study|Investigator Discretion|0
864852|NCT00491530|1824496|FG001|Overall Study|Investigator Discretion|1
864853|NCT00491530|1824497|FG002|Overall Study|Investigator Discretion|0
864854|NCT00491530|1824495|FG000|Overall Study|Patient Request|0
864855|NCT00491530|1824496|FG001|Overall Study|Patient Request|1
864856|NCT00491530|1824497|FG002|Overall Study|Patient Request|0
864857|NCT00491530|1824495|FG000|Overall Study|Use of Prohibited Medication|0
864858|NCT00491530|1824496|FG001|Overall Study|Use of Prohibited Medication|0
864859|NCT00491530|1824497|FG002|Overall Study|Use of Prohibited Medication|1
864860|NCT00491556|1824507|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
864861|NCT00491556|1824508|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
864862|NCT00491556|1824507|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
864863|NCT00491556|1824508|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
864864|NCT00491556|1824507|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
864865|NCT00491556|1824508|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
864866|NCT00491556|1824507|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
864867|NCT00491556|1824508|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
864868|NCT00491556|1824507|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
864869|NCT00491556|1824508|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
864870|NCT00491556|1824507|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
864871|NCT00491556|1824508|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
864872|NCT00491556|1824507|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
864873|NCT00491556|1824508|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
864874|NCT00491556|1824507|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
864875|NCT00491556|1824508|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
864876|NCT00491556|1824507|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3
864877|NCT00491556|1824508|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0
864878|NCT00491556|1824507|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
864879|NCT00491556|1824508|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
864880|NCT00491556|1824507|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
864881|NCT00491556|1824508|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
864882|NCT00491556|1824507|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
864883|NCT00491556|1824508|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
864884|NCT00491556|1824507|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
864885|NCT00491556|1824508|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
864886|NCT00491556|1824507|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
864887|NCT00491556|1824508|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
864888|NCT00491556|1824507|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
864889|NCT00491556|1824508|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
864890|NCT00491556|1824507|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
864891|NCT00491556|1824508|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
864892|NCT00491556|1824507|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
864893|NCT00491556|1824508|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
864894|NCT00491556|1824507|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
864895|NCT00491556|1824508|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
864896|NCT00491556|1824507|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
864897|NCT00491556|1824508|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
864898|NCT00491556|1824507|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
864899|NCT00491556|1824508|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
864900|NCT00491608|1824514|FG000|Overall Study|Death|2
864901|NCT00491608|1824514|FG000|Overall Study|Withdrawal by Subject|1
864902|NCT00491764|1824546|FG000|Overall Study|Adverse Event|1
864903|NCT00491764|1824547|FG001|Overall Study|Adverse Event|2
864904|NCT00491764|1824548|FG002|Overall Study|Adverse Event|4
864905|NCT00491764|1824549|FG003|Overall Study|Adverse Event|4
864906|NCT00491764|1824550|FG004|Overall Study|Adverse Event|0
864907|NCT00491764|1824551|FG005|Overall Study|Adverse Event|1
864908|NCT00491764|1824546|FG000|Overall Study|Lost to Follow-up|0
864909|NCT00491764|1824547|FG001|Overall Study|Lost to Follow-up|1
864910|NCT00491764|1824548|FG002|Overall Study|Lost to Follow-up|0
864911|NCT00491764|1824549|FG003|Overall Study|Lost to Follow-up|1
864912|NCT00491764|1824550|FG004|Overall Study|Lost to Follow-up|0
864913|NCT00491764|1824551|FG005|Overall Study|Lost to Follow-up|3
864914|NCT00491764|1824546|FG000|Overall Study|Withdrawal by Subject|2
864915|NCT00491764|1824547|FG001|Overall Study|Withdrawal by Subject|3
864916|NCT00491764|1824548|FG002|Overall Study|Withdrawal by Subject|1
864917|NCT00491764|1824549|FG003|Overall Study|Withdrawal by Subject|2
864918|NCT00491764|1824550|FG004|Overall Study|Withdrawal by Subject|2
864919|NCT00491764|1824551|FG005|Overall Study|Withdrawal by Subject|4
864920|NCT00491764|1824546|FG000|Overall Study|Non Compliance with the Protocol|1
864921|NCT00491764|1824547|FG001|Overall Study|Non Compliance with the Protocol|0
864922|NCT00491764|1824548|FG002|Overall Study|Non Compliance with the Protocol|0
864923|NCT00491764|1824549|FG003|Overall Study|Non Compliance with the Protocol|0
864924|NCT00491764|1824550|FG004|Overall Study|Non Compliance with the Protocol|0
864925|NCT00491764|1824551|FG005|Overall Study|Non Compliance with the Protocol|0
864926|NCT00491764|1824546|FG000|Overall Study|Did not Meet Protocol Eligibility|0
864927|NCT00491764|1824547|FG001|Overall Study|Did not Meet Protocol Eligibility|1
864928|NCT00491764|1824548|FG002|Overall Study|Did not Meet Protocol Eligibility|1
864929|NCT00491764|1824549|FG003|Overall Study|Did not Meet Protocol Eligibility|0
864930|NCT00491764|1824550|FG004|Overall Study|Did not Meet Protocol Eligibility|1
864931|NCT00491764|1824551|FG005|Overall Study|Did not Meet Protocol Eligibility|1
864932|NCT00491764|1824546|FG000|Overall Study|Administrative|1
864933|NCT00491764|1824547|FG001|Overall Study|Administrative|0
864934|NCT00491764|1824548|FG002|Overall Study|Administrative|2
864935|NCT00491764|1824549|FG003|Overall Study|Administrative|1
864936|NCT00491764|1824550|FG004|Overall Study|Administrative|0
864937|NCT00491764|1824551|FG005|Overall Study|Administrative|0
864938|NCT00491894|1824578|FG000|Overall Study|Adverse Event|14
864939|NCT00491894|1824578|FG000|Overall Study|Withdrawal by Subject|5
864940|NCT00491894|1824578|FG000|Overall Study|Death|3
864941|NCT00491894|1824578|FG000|Overall Study|Lost to Follow-up|3
864942|NCT00491894|1824578|FG000|Overall Study|Lack of Efficacy|2
864943|NCT00491894|1824578|FG000|Overall Study|Other-Failed to meet any criteria|2
864944|NCT00491894|1824578|FG000|Overall Study|Physician Decision|2
864945|NCT00491894|1824578|FG000|Overall Study|Protocol Violation|2
864946|NCT00491894|1824578|FG000|Overall Study|Other-Intake of prohibited medication|1
864947|NCT00492024|1824584|FG000|Treatment|Adverse Event|3
864948|NCT00492024|1824585|FG001|Treatment|Adverse Event|1
864949|NCT00492024|1824584|FG000|Treatment|Lack of Efficacy|21
864950|NCT00492024|1824585|FG001|Treatment|Lack of Efficacy|20
864951|NCT00492024|1824584|FG000|Treatment|Lost to Follow-up|3
864952|NCT00492024|1824585|FG001|Treatment|Lost to Follow-up|1
864953|NCT00492024|1824584|FG000|Treatment|Withdrawal by Subject|2
864954|NCT00492024|1824585|FG001|Treatment|Withdrawal by Subject|0
864955|NCT00492024|1824584|FG000|Follow up|Lack of Efficacy|0
864956|NCT00492024|1824585|FG001|Follow up|Lack of Efficacy|1
864957|NCT00492024|1824584|FG000|Follow up|Lost to Follow-up|1
864958|NCT00492024|1824585|FG001|Follow up|Lost to Follow-up|1
864959|NCT00492063|1824595|FG000|Overall Study|Death|0
864960|NCT00492063|1824596|FG001|Overall Study|Death|0
864961|NCT00492063|1824597|FG002|Overall Study|Death|1
864962|NCT00492063|1824598|FG003|Overall Study|Death|2
864963|NCT00492063|1824595|FG000|Overall Study|Withdrawal by Subject|4
864964|NCT00492063|1824596|FG001|Overall Study|Withdrawal by Subject|3
864965|NCT00492063|1824597|FG002|Overall Study|Withdrawal by Subject|5
864966|NCT00492063|1824598|FG003|Overall Study|Withdrawal by Subject|4
864967|NCT00492063|1824595|FG000|Overall Study|Lost to Follow-up|6
864968|NCT00492063|1824596|FG001|Overall Study|Lost to Follow-up|11
864969|NCT00492063|1824597|FG002|Overall Study|Lost to Follow-up|5
864970|NCT00492063|1824598|FG003|Overall Study|Lost to Follow-up|3
864971|NCT00492063|1824595|FG000|Overall Study|Protocol Violation|0
864972|NCT00492063|1824596|FG001|Overall Study|Protocol Violation|0
864973|NCT00492063|1824597|FG002|Overall Study|Protocol Violation|0
864974|NCT00492063|1824598|FG003|Overall Study|Protocol Violation|1
864975|NCT00492115|1824619|FG000|Overall Study|Withdrawal by Subject|3
864976|NCT00492115|1824620|FG001|Overall Study|Withdrawal by Subject|4
864977|NCT00492232|1824634|FG000|Placebo Run-in|Adverse Event|0
864978|NCT00492232|1824635|FG001|Placebo Run-in|Adverse Event|2
864979|NCT00492232|1824634|FG000|Placebo Run-in|Protocol Violation|0
864980|NCT00492232|1824635|FG001|Placebo Run-in|Protocol Violation|3
864981|NCT00492232|1824634|FG000|Placebo Run-in|Lost to Follow-up|0
864982|NCT00492232|1824635|FG001|Placebo Run-in|Lost to Follow-up|3
864983|NCT00492232|1824634|FG000|Placebo Run-in|Withdrawal by Subject|0
864984|NCT00492232|1824635|FG001|Placebo Run-in|Withdrawal by Subject|8
864985|NCT00492232|1824634|FG000|Placebo Run-in|Pregnancy|0
864986|NCT00492232|1824635|FG001|Placebo Run-in|Pregnancy|1
864987|NCT00492232|1824634|FG000|Placebo Run-in|Entrance criteria not met|0
864988|NCT00492232|1824635|FG001|Placebo Run-in|Entrance criteria not met|45
864989|NCT00492232|1824634|FG000|Placebo Run-in|Other|0
864990|NCT00492232|1824635|FG001|Placebo Run-in|Other|6
864991|NCT00492232|1824634|FG000|Placebo Run-in|Missing|0
864992|NCT00492232|1824635|FG001|Placebo Run-in|Missing|2
864993|NCT00492232|1824634|FG000|Double-Blind Treatment|Adverse Event|1
864994|NCT00492232|1824635|FG001|Double-Blind Treatment|Adverse Event|2
864995|NCT00492232|1824634|FG000|Double-Blind Treatment|Protocol Violation|3
864996|NCT00492232|1824635|FG001|Double-Blind Treatment|Protocol Violation|7
864997|NCT00492232|1824634|FG000|Double-Blind Treatment|Lost to Follow-up|2
864998|NCT00492232|1824635|FG001|Double-Blind Treatment|Lost to Follow-up|3
864999|NCT00492232|1824634|FG000|Double-Blind Treatment|Withdrawal by Subject|4
865000|NCT00492232|1824635|FG001|Double-Blind Treatment|Withdrawal by Subject|8
865001|NCT00492232|1824634|FG000|Double-Blind Treatment|Lack of Efficacy|1
865002|NCT00492232|1824635|FG001|Double-Blind Treatment|Lack of Efficacy|0
865003|NCT00492232|1824634|FG000|Double-Blind Treatment|Other|6
865004|NCT00492232|1824635|FG001|Double-Blind Treatment|Other|5
865005|NCT00492232|1824634|FG000|Double-Blind Treatment|Randomized not treated|1
865006|NCT00492232|1824635|FG001|Double-Blind Treatment|Randomized not treated|0
865007|NCT00492232|1824634|FG000|Open-Label Treatment|Withdrawal by Subject|1
865008|NCT00492232|1824635|FG001|Open-Label Treatment|Withdrawal by Subject|0
865009|NCT00492284|1824645|FG000|Overall Study|Adverse Event|0
865010|NCT00492284|1824646|FG001|Overall Study|Adverse Event|1
865011|NCT00492284|1824647|FG002|Overall Study|Adverse Event|1
865012|NCT00492284|1824648|FG003|Overall Study|Adverse Event|2
865013|NCT00492284|1824645|FG000|Overall Study|Lost to Follow-up|0
865014|NCT00492284|1824646|FG001|Overall Study|Lost to Follow-up|0
865015|NCT00492284|1824647|FG002|Overall Study|Lost to Follow-up|3
865016|NCT00492284|1824648|FG003|Overall Study|Lost to Follow-up|1
865017|NCT00492284|1824645|FG000|Overall Study|Death|0
865018|NCT00492284|1824646|FG001|Overall Study|Death|3
865019|NCT00492284|1824647|FG002|Overall Study|Death|2
865020|NCT00492284|1824648|FG003|Overall Study|Death|5
865021|NCT00492284|1824645|FG000|Overall Study|Withdrawal by Subject|1
865022|NCT00492284|1824646|FG001|Overall Study|Withdrawal by Subject|0
865023|NCT00492284|1824647|FG002|Overall Study|Withdrawal by Subject|0
865024|NCT00492284|1824648|FG003|Overall Study|Withdrawal by Subject|2
865025|NCT00492297|1824658|FG000|Treatment|Death|2
865026|NCT00492297|1824658|FG000|Treatment|Study terminated by sponsor|3
865027|NCT00492297|1824658|FG000|Active Follow-up 30(+4) Days Duration|Death|17
865028|NCT00492297|1824658|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
865029|NCT00492297|1824658|FG000|Survival Only Follow-up|Death|46
865030|NCT00492297|1824658|FG000|Survival Only Follow-up|Lack of Efficacy|1
865031|NCT00492297|1824658|FG000|Survival Only Follow-up|Study terminated by sponsor|12
865032|NCT00492531|1824692|FG000|Overall Study|Withdrawn(More than one reason selected)|22
865033|NCT00492531|1824693|FG001|Overall Study|Withdrawn(More than one reason selected)|23
865034|NCT00492557|1824705|FG000|Overall Study|Subject request|12
865035|NCT00492557|1824706|FG001|Overall Study|Subject request|11
865036|NCT00492557|1824705|FG000|Overall Study|Protocol Violation|7
865037|NCT00492557|1824706|FG001|Overall Study|Protocol Violation|8
865038|NCT00492557|1824705|FG000|Overall Study|Other|2
865039|NCT00492557|1824706|FG001|Overall Study|Other|2
865040|NCT00492557|1824705|FG000|Overall Study|Death|1
865041|NCT00492557|1824706|FG001|Overall Study|Death|1
865042|NCT00492557|1824705|FG000|Overall Study|Adverse Event|1
865043|NCT00492557|1824706|FG001|Overall Study|Adverse Event|0
865044|NCT00492557|1824705|FG000|Overall Study|Failed to return|1
865045|NCT00492557|1824706|FG001|Overall Study|Failed to return|0
865046|NCT00492557|1824705|FG000|Overall Study|Lost to Follow-up|0
865047|NCT00492557|1824706|FG001|Overall Study|Lost to Follow-up|1
865048|NCT00492648|1824734|FG000|Month 30 (109671 Study)|Protocol Violation|0
865049|NCT00492648|1824735|FG001|Month 30 (109671 Study)|Protocol Violation|1
865050|NCT00492726|1824743|FG000|Overall Study|Adverse Event|10
865051|NCT00492726|1824744|FG001|Overall Study|Adverse Event|6
865052|NCT00492726|1824743|FG000|Overall Study|Death|7
865053|NCT00492726|1824744|FG001|Overall Study|Death|2
865054|NCT00492726|1824743|FG000|Overall Study|Lack of Efficacy|0
865055|NCT00492726|1824744|FG001|Overall Study|Lack of Efficacy|2
865056|NCT00492726|1824743|FG000|Overall Study|Lost to Follow-up|27
865057|NCT00492726|1824744|FG001|Overall Study|Lost to Follow-up|19
865058|NCT00492726|1824743|FG000|Overall Study|Physician Decision|0
865059|NCT00492726|1824744|FG001|Overall Study|Physician Decision|1
865060|NCT00492726|1824743|FG000|Overall Study|Withdrawal by Subject|6
865061|NCT00492726|1824744|FG001|Overall Study|Withdrawal by Subject|3
865062|NCT00492726|1824743|FG000|Overall Study|Non compliant with study medication|0
865063|NCT00492726|1824744|FG001|Overall Study|Non compliant with study medication|3
865064|NCT00492752|1824752|FG000|Double Blind Treatment|Death|13
865065|NCT00492752|1824753|FG001|Double Blind Treatment|Death|0
865066|NCT00492752|1824754|FG002|Double Blind Treatment|Death|2
865067|NCT00492752|1824755|FG003|Double Blind Treatment|Death|0
865068|NCT00492752|1824752|FG000|Double Blind Treatment|Adverse Event|1
865069|NCT00492752|1824753|FG001|Double Blind Treatment|Adverse Event|0
865070|NCT00492752|1824754|FG002|Double Blind Treatment|Adverse Event|0
865071|NCT00492752|1824755|FG003|Double Blind Treatment|Adverse Event|0
865072|NCT00492752|1824752|FG000|Double Blind Treatment|Protocol Violation|0
865073|NCT00492752|1824753|FG001|Double Blind Treatment|Protocol Violation|0
865074|NCT00492752|1824754|FG002|Double Blind Treatment|Protocol Violation|1
865075|NCT00492752|1824755|FG003|Double Blind Treatment|Protocol Violation|0
865076|NCT00492752|1824752|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0
865077|NCT00492752|1824753|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2
865078|NCT00492752|1824754|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0
865079|NCT00492752|1824755|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2
865080|NCT00492752|1824752|FG000|Follow-up and/or Open Label Sorafenib|Death|75
865081|NCT00492752|1824753|FG001|Follow-up and/or Open Label Sorafenib|Death|5
865082|NCT00492752|1824754|FG002|Follow-up and/or Open Label Sorafenib|Death|45
865083|NCT00492752|1824755|FG003|Follow-up and/or Open Label Sorafenib|Death|1
865084|NCT00492752|1824752|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
865085|NCT00492752|1824753|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
865086|NCT00492752|1824754|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
865087|NCT00492752|1824755|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
865088|NCT00492752|1824752|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
865089|NCT00492752|1824753|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
865090|NCT00492752|1824754|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
865091|NCT00492752|1824755|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
865092|NCT00492752|1824752|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
865093|NCT00492752|1824753|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
865094|NCT00492752|1824754|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
865095|NCT00492752|1824755|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
865096|NCT00492752|1824752|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
865097|NCT00492752|1824753|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
865098|NCT00492752|1824754|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
865099|NCT00492752|1824755|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
865100|NCT00492752|1824752|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
865101|NCT00492752|1824753|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
865102|NCT00492752|1824754|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
865103|NCT00492752|1824755|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
865104|NCT00492752|1824752|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
865105|NCT00492752|1824753|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
865106|NCT00492752|1824754|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
865107|NCT00492752|1824755|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
865108|NCT00492856|1824762|FG000|Induction|Adverse Event|2
865109|NCT00492856|1824763|FG001|Induction|Adverse Event|0
865110|NCT00492856|1824764|FG002|Induction|Adverse Event|0
865111|NCT00492856|1824765|FG003|Induction|Adverse Event|0
865112|NCT00492856|1824762|FG000|Induction|Withdrawal by Subject|1
865113|NCT00492856|1824763|FG001|Induction|Withdrawal by Subject|0
865114|NCT00492856|1824764|FG002|Induction|Withdrawal by Subject|0
865115|NCT00492856|1824765|FG003|Induction|Withdrawal by Subject|0
865116|NCT00492856|1824762|FG000|Induction|Death|3
865117|NCT00492856|1824763|FG001|Induction|Death|0
865118|NCT00492856|1824764|FG002|Induction|Death|0
865119|NCT00492856|1824765|FG003|Induction|Death|0
865120|NCT00492856|1824762|FG000|Consolidation|Adverse Event|6
865121|NCT00492856|1824763|FG001|Consolidation|Adverse Event|0
865122|NCT00492856|1824764|FG002|Consolidation|Adverse Event|0
865123|NCT00492856|1824765|FG003|Consolidation|Adverse Event|0
865124|NCT00492856|1824762|FG000|Consolidation|Not protocol specified|2
865125|NCT00492856|1824763|FG001|Consolidation|Not protocol specified|0
865126|NCT00492856|1824764|FG002|Consolidation|Not protocol specified|0
865127|NCT00492856|1824765|FG003|Consolidation|Not protocol specified|0
865128|NCT00492856|1824762|FG000|Consolidation|Lost to Follow-up|1
865129|NCT00492856|1824763|FG001|Consolidation|Lost to Follow-up|0
865130|NCT00492856|1824764|FG002|Consolidation|Lost to Follow-up|0
865131|NCT00492856|1824765|FG003|Consolidation|Lost to Follow-up|0
865132|NCT00492856|1824762|FG000|Post-consolidation|Adverse Event|0
865133|NCT00492856|1824763|FG001|Post-consolidation|Adverse Event|4
865134|NCT00492856|1824764|FG002|Post-consolidation|Adverse Event|0
865135|NCT00492856|1824765|FG003|Post-consolidation|Adverse Event|1
865136|NCT00492856|1824762|FG000|Post-consolidation|Withdrawal by Subject|0
865137|NCT00492856|1824763|FG001|Post-consolidation|Withdrawal by Subject|4
865138|NCT00492856|1824764|FG002|Post-consolidation|Withdrawal by Subject|0
865139|NCT00492856|1824765|FG003|Post-consolidation|Withdrawal by Subject|0
865140|NCT00492856|1824762|FG000|Post-consolidation|Death|0
865141|NCT00492856|1824763|FG001|Post-consolidation|Death|1
865142|NCT00492856|1824764|FG002|Post-consolidation|Death|0
865143|NCT00492856|1824765|FG003|Post-consolidation|Death|0
865144|NCT00492856|1824762|FG000|Post-consolidation|Not protocol specified|0
865145|NCT00492856|1824763|FG001|Post-consolidation|Not protocol specified|1
865146|NCT00492856|1824764|FG002|Post-consolidation|Not protocol specified|0
865147|NCT00492856|1824765|FG003|Post-consolidation|Not protocol specified|0
865148|NCT00492856|1824762|FG000|Post-consolidation|Lost to Follow-up|0
865149|NCT00492856|1824763|FG001|Post-consolidation|Lost to Follow-up|2
865150|NCT00492856|1824764|FG002|Post-consolidation|Lost to Follow-up|0
865151|NCT00492856|1824765|FG003|Post-consolidation|Lost to Follow-up|0
865152|NCT00492856|1824762|FG000|Post-consolidation|Observation Arm|0
865153|NCT00492856|1824763|FG001|Post-consolidation|Observation Arm|0
865154|NCT00492856|1824764|FG002|Post-consolidation|Observation Arm|27
865155|NCT00492856|1824765|FG003|Post-consolidation|Observation Arm|0
865156|NCT00492921|1824777|FG000|Overall Study|Death|1
865157|NCT00492921|1824778|FG001|Overall Study|Death|0
865158|NCT00492921|1824779|FG002|Overall Study|Death|1
865159|NCT00493012|1824798|FG000|Overall Study|Lost to Follow-up|18
865160|NCT00493012|1824799|FG001|Overall Study|Lost to Follow-up|17
865161|NCT00493038|1824807|FG000|Treatment|Adverse Event|8
865162|NCT00493038|1824808|FG001|Treatment|Adverse Event|4
865163|NCT00493038|1824807|FG000|Treatment|Lost to Follow-up|5
865164|NCT00493038|1824808|FG001|Treatment|Lost to Follow-up|3
865165|NCT00493038|1824807|FG000|Treatment|Withdrawal by Subject|11
865166|NCT00493038|1824808|FG001|Treatment|Withdrawal by Subject|12
865167|NCT00493038|1824807|FG000|Treatment|Other|0
865168|NCT00493038|1824808|FG001|Treatment|Other|1
865169|NCT00493038|1824807|FG000|Follow-up|Lost to Follow-up|1
865170|NCT00493038|1824808|FG001|Follow-up|Lost to Follow-up|0
865171|NCT00493220|1824828|FG000|Third Intervention|Withdrawal by Subject|1
865172|NCT00493220|1824829|FG001|Third Intervention|Withdrawal by Subject|0
865173|NCT00493220|1824830|FG002|Third Intervention|Withdrawal by Subject|0
865174|NCT00493220|1824831|FG003|Third Intervention|Withdrawal by Subject|0
865175|NCT00493220|1824832|FG004|Third Intervention|Withdrawal by Subject|0
865176|NCT00493220|1824833|FG005|Third Intervention|Withdrawal by Subject|0
865177|NCT00493246|1824851|FG000|Overall Study|Withdrawal by Subject|0
865178|NCT00493246|1824852|FG001|Overall Study|Withdrawal by Subject|0
865179|NCT00493246|1824853|FG002|Overall Study|Withdrawal by Subject|0
865180|NCT00493246|1824854|FG003|Overall Study|Withdrawal by Subject|0
865181|NCT00493246|1824855|FG004|Overall Study|Withdrawal by Subject|1
865182|NCT00493246|1824856|FG005|Overall Study|Withdrawal by Subject|0
865183|NCT00493246|1824857|FG006|Overall Study|Withdrawal by Subject|0
865184|NCT00493246|1824858|FG007|Overall Study|Withdrawal by Subject|0
865185|NCT00493246|1824851|FG000|Overall Study|No access to draw blood|0
865186|NCT00493246|1824852|FG001|Overall Study|No access to draw blood|0
865187|NCT00493246|1824853|FG002|Overall Study|No access to draw blood|0
865188|NCT00493246|1824854|FG003|Overall Study|No access to draw blood|0
865189|NCT00493246|1824855|FG004|Overall Study|No access to draw blood|0
865190|NCT00493246|1824856|FG005|Overall Study|No access to draw blood|1
865191|NCT00493246|1824857|FG006|Overall Study|No access to draw blood|0
865192|NCT00493246|1824858|FG007|Overall Study|No access to draw blood|0
865193|NCT00493246|1824851|FG000|Overall Study|Lost to Follow-up|0
865194|NCT00493246|1824852|FG001|Overall Study|Lost to Follow-up|0
865195|NCT00493246|1824853|FG002|Overall Study|Lost to Follow-up|0
865196|NCT00493246|1824854|FG003|Overall Study|Lost to Follow-up|0
865197|NCT00493246|1824855|FG004|Overall Study|Lost to Follow-up|0
865198|NCT00493246|1824856|FG005|Overall Study|Lost to Follow-up|0
865199|NCT00493246|1824857|FG006|Overall Study|Lost to Follow-up|1
865200|NCT00493246|1824858|FG007|Overall Study|Lost to Follow-up|0
865201|NCT00493285|1824882|FG000|Overall Study|Lost to Follow-up|0
865202|NCT00493285|1824883|FG001|Overall Study|Lost to Follow-up|0
865203|NCT00493285|1824884|FG002|Overall Study|Lost to Follow-up|0
865204|NCT00493285|1824885|FG003|Overall Study|Lost to Follow-up|0
865205|NCT00493285|1824886|FG004|Overall Study|Lost to Follow-up|1
865206|NCT00493285|1824887|FG005|Overall Study|Lost to Follow-up|0
865207|NCT00493311|1824903|FG000|Overall Study|Need for rescue medication|2
865208|NCT00493311|1824904|FG001|Overall Study|Need for rescue medication|2
865209|NCT00493454|1824910|FG000|Overall Study|Withdrawal by Subject|1
865210|NCT00493467|1824914|FG000|Overall Study|Death|1
865211|NCT00493636|1824920|FG000|Overall Study|Withdrawal by Subject|1
865212|NCT00493636|1824921|FG001|Overall Study|Withdrawal by Subject|0
865213|NCT00493636|1824920|FG000|Overall Study|Disease progression/recurrence/relapse|0
865214|NCT00493636|1824921|FG001|Overall Study|Disease progression/recurrence/relapse|1
865215|NCT00493636|1824920|FG000|Overall Study|Mis-randomization|1
865216|NCT00493636|1824921|FG001|Overall Study|Mis-randomization|1
865217|NCT00493649|1824927|FG000|Overall Study|Adverse Event|44
865218|NCT00493649|1824927|FG000|Overall Study|Patient Request|21
865219|NCT00493649|1824927|FG000|Overall Study|Investigator Request|2
865220|NCT00493649|1824927|FG000|Overall Study|Disease Progression|1
865221|NCT00493649|1824927|FG000|Overall Study|Lost to Follow-up|1
865222|NCT00493649|1824927|FG000|Overall Study|Other|13
865223|NCT00493779|1824934|FG000|Overall Study|Logistical issue at site|1
865224|NCT00493974|1824948|FG000|Overall Study|Death|1
865225|NCT00493974|1824949|FG001|Overall Study|Death|2
865226|NCT00493974|1824948|FG000|Overall Study|Withdrawal by Subject|8
865227|NCT00493974|1824949|FG001|Overall Study|Withdrawal by Subject|6
865228|NCT00493974|1824948|FG000|Overall Study|Lost to Follow-up|4
865229|NCT00493974|1824949|FG001|Overall Study|Lost to Follow-up|6
865230|NCT00494013|1824957|FG000|Overall Study|Adverse Event|0
865231|NCT00494013|1824958|FG001|Overall Study|Adverse Event|1
865232|NCT00494013|1824957|FG000|Overall Study|Entry Criteria Not Met|1
865233|NCT00494013|1824958|FG001|Overall Study|Entry Criteria Not Met|4
865234|NCT00494013|1824957|FG000|Overall Study|Lost to Follow-up|5
865235|NCT00494013|1824958|FG001|Overall Study|Lost to Follow-up|6
865236|NCT00494013|1824957|FG000|Overall Study|Physician Decision|3
865237|NCT00494013|1824958|FG001|Overall Study|Physician Decision|5
865238|NCT00494013|1824957|FG000|Overall Study|Protocol Violation|8
865239|NCT00494013|1824958|FG001|Overall Study|Protocol Violation|5
865240|NCT00494013|1824957|FG000|Overall Study|Withdrawal by Subject|13
865241|NCT00494013|1824958|FG001|Overall Study|Withdrawal by Subject|14
865242|NCT00494013|1824957|FG000|Overall Study|Sponsor Decision|0
865243|NCT00494013|1824958|FG001|Overall Study|Sponsor Decision|1
865244|NCT00494026|1824964|FG000|Overall Study|Sponsor Decision|4
865245|NCT00494091|1824970|FG000|Overall Study|Death|5
865246|NCT00494091|1824971|FG001|Overall Study|Death|54
865247|NCT00494091|1824970|FG000|Overall Study|Lost to Follow-up|0
865248|NCT00494091|1824971|FG001|Overall Study|Lost to Follow-up|4
865249|NCT00494091|1824970|FG000|Overall Study|Other|1
865250|NCT00494091|1824971|FG001|Overall Study|Other|11
865251|NCT00494091|1824970|FG000|Overall Study|Withdrawal by Subject|0
865252|NCT00494091|1824971|FG001|Overall Study|Withdrawal by Subject|7
865253|NCT00494221|1824998|FG000|Overall Study|Death|15
865254|NCT00494221|1824999|FG001|Overall Study|Death|9
865255|NCT00494221|1825000|FG002|Overall Study|Death|14
865256|NCT00494221|1824998|FG000|Overall Study|Withdrawal by Subject|1
865257|NCT00494221|1824999|FG001|Overall Study|Withdrawal by Subject|2
865258|NCT00494221|1825000|FG002|Overall Study|Withdrawal by Subject|0
865259|NCT00494234|1825010|FG000|Overall Study|Lack of Efficacy|12
865260|NCT00494234|1825011|FG001|Overall Study|Lack of Efficacy|9
865261|NCT00494234|1825010|FG000|Overall Study|Withdrawal by Subject|1
865262|NCT00494234|1825011|FG001|Overall Study|Withdrawal by Subject|0
865263|NCT00494234|1825010|FG000|Overall Study|Death|2
865264|NCT00494234|1825011|FG001|Overall Study|Death|1
865265|NCT00494299|1825023|FG000|Overall Study|Adverse Event|93
865266|NCT00494299|1825024|FG001|Overall Study|Adverse Event|13
865267|NCT00494299|1825023|FG000|Overall Study|Lost to Follow-up|1
865268|NCT00494299|1825024|FG001|Overall Study|Lost to Follow-up|0
865269|NCT00494299|1825023|FG000|Overall Study|Physician Decision|0
865270|NCT00494299|1825024|FG001|Overall Study|Physician Decision|2
865271|NCT00494299|1825023|FG000|Overall Study|Protocol Violation|1
865272|NCT00494299|1825024|FG001|Overall Study|Protocol Violation|2
865273|NCT00494299|1825023|FG000|Overall Study|Withdrawal by Subject|8
865274|NCT00494299|1825024|FG001|Overall Study|Withdrawal by Subject|3
865275|NCT00494299|1825023|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109
865276|NCT00494299|1825024|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185
865277|NCT00494299|1825023|FG000|Overall Study|Participant Did Not Take Study Drug|0
865278|NCT00494299|1825024|FG001|Overall Study|Participant Did Not Take Study Drug|2
865279|NCT00494299|1825023|FG000|Overall Study|Site Closed by Sponsor|6
865280|NCT00494299|1825024|FG001|Overall Study|Site Closed by Sponsor|0
865281|NCT00494299|1825023|FG000|Overall Study|Protocol Driven Decision Point|11
865282|NCT00494299|1825024|FG001|Overall Study|Protocol Driven Decision Point|22
865283|NCT00494442|1825032|FG000|Overall Study|Death|1
865284|NCT00494442|1825033|FG001|Overall Study|Death|1
865285|NCT00494442|1825032|FG000|Overall Study|Lack of Efficacy|16
865286|NCT00494442|1825033|FG001|Overall Study|Lack of Efficacy|10
865287|NCT00494442|1825032|FG000|Overall Study|Adverse Event|0
865288|NCT00494442|1825033|FG001|Overall Study|Adverse Event|2
865289|NCT00494442|1825032|FG000|Overall Study|Physician Decision|0
865290|NCT00494442|1825033|FG001|Overall Study|Physician Decision|1
865291|NCT00494442|1825032|FG000|Overall Study|Non-compliance|0
865292|NCT00494442|1825033|FG001|Overall Study|Non-compliance|1
865293|NCT00494442|1825032|FG000|Overall Study|Intercurrent illness|0
865294|NCT00494442|1825033|FG001|Overall Study|Intercurrent illness|1
865295|NCT00494481|1825041|FG000|Overall Study|Condition under investigation worsened|11
865296|NCT00494481|1825042|FG001|Overall Study|Condition under investigation worsened|13
865297|NCT00494481|1825041|FG000|Overall Study|Adverse Event|15
865298|NCT00494481|1825042|FG001|Overall Study|Adverse Event|11
865299|NCT00494481|1825041|FG000|Overall Study|Other|1
865300|NCT00494481|1825042|FG001|Overall Study|Other|0
865301|NCT00494481|1825041|FG000|Overall Study|Never received IP|2
865302|NCT00494481|1825042|FG001|Overall Study|Never received IP|0
865303|NCT00494507|1825061|FG000|Double-Blind Phase|Adverse Event|2
865304|NCT00494507|1825062|FG001|Double-Blind Phase|Adverse Event|0
865305|NCT00494507|1825063|FG002|Double-Blind Phase|Adverse Event|1
865306|NCT00494507|1825064|FG003|Double-Blind Phase|Adverse Event|0
865307|NCT00494507|1825061|FG000|Double-Blind Phase|Withdrawal by Subject|1
865308|NCT00494507|1825062|FG001|Double-Blind Phase|Withdrawal by Subject|0
865309|NCT00494507|1825063|FG002|Double-Blind Phase|Withdrawal by Subject|0
865310|NCT00494507|1825064|FG003|Double-Blind Phase|Withdrawal by Subject|0
865311|NCT00494507|1825061|FG000|Double-Blind Phase|Subject Non-compliance|0
865312|NCT00494507|1825062|FG001|Double-Blind Phase|Subject Non-compliance|0
865313|NCT00494507|1825063|FG002|Double-Blind Phase|Subject Non-compliance|1
865314|NCT00494507|1825064|FG003|Double-Blind Phase|Subject Non-compliance|0
865315|NCT00494507|1825061|FG000|Double-Blind Phase|Negative DNA test|0
865316|NCT00494507|1825062|FG001|Double-Blind Phase|Negative DNA test|0
865317|NCT00494507|1825063|FG002|Double-Blind Phase|Negative DNA test|0
865318|NCT00494507|1825064|FG003|Double-Blind Phase|Negative DNA test|1
865319|NCT00494507|1825061|FG000|Open-Label Phase|Adverse Event|0
865320|NCT00494507|1825062|FG001|Open-Label Phase|Adverse Event|1
865321|NCT00494507|1825063|FG002|Open-Label Phase|Adverse Event|5
865322|NCT00494507|1825064|FG003|Open-Label Phase|Adverse Event|3
865323|NCT00494507|1825061|FG000|Open-Label Phase|Worsening Disease|0
865324|NCT00494507|1825062|FG001|Open-Label Phase|Worsening Disease|0
865325|NCT00494507|1825063|FG002|Open-Label Phase|Worsening Disease|0
865326|NCT00494507|1825064|FG003|Open-Label Phase|Worsening Disease|2
865327|NCT00494676|1825088|FG000|Allocation|Withdrawal by Subject|2
865328|NCT00494676|1825089|FG001|Allocation|Withdrawal by Subject|4
865329|NCT00494676|1825088|FG000|First Intervention|Withdrawal by Subject|1
865330|NCT00494676|1825089|FG001|First Intervention|Withdrawal by Subject|3
865331|NCT00494676|1825088|FG000|Second Intervention|Withdrawal by Subject|1
865332|NCT00494676|1825089|FG001|Second Intervention|Withdrawal by Subject|1
865333|NCT00494780|1825097|FG000|Overall Study|Adverse Event|1
865334|NCT00494780|1825098|FG001|Overall Study|Adverse Event|0
865335|NCT00494780|1825097|FG000|Overall Study|Withdrew before Dosed|0
865336|NCT00494780|1825098|FG001|Overall Study|Withdrew before Dosed|1
865337|NCT00494780|1825097|FG000|Overall Study|Progression of Study Disease|7
865338|NCT00494780|1825098|FG001|Overall Study|Progression of Study Disease|8
865339|NCT00494780|1825097|FG000|Overall Study|New Treatment|2
865340|NCT00494780|1825098|FG001|Overall Study|New Treatment|2
865341|NCT00494780|1825097|FG000|Overall Study|Non-compliance|1
865342|NCT00494780|1825098|FG001|Overall Study|Non-compliance|0
865343|NCT00494780|1825097|FG000|Overall Study|Residual Tumour Mass|0
865344|NCT00494780|1825098|FG001|Overall Study|Residual Tumour Mass|1
865345|NCT00494780|1825097|FG000|Overall Study|Insurance Issues|0
865346|NCT00494780|1825098|FG001|Overall Study|Insurance Issues|1
865347|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Adverse Event|73
865348|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Adverse Event|70
865349|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
865350|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
865351|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Death|8
865352|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Death|3
865353|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Physician Decision|4
865354|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Physician Decision|13
865355|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4
865356|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1
865357|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9
865358|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9
865359|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
865360|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
865361|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
865362|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
865363|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
865364|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
865365|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
865366|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
865367|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
865368|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
865369|NCT00494871|1825117|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
865370|NCT00494871|1825118|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
865371|NCT00494871|1825117|FG000|Follow-up (FU) Period|Adverse Event|1
865372|NCT00494871|1825118|FG001|Follow-up (FU) Period|Adverse Event|1
865373|NCT00494871|1825117|FG000|Follow-up (FU) Period|Death|13
865374|NCT00494871|1825118|FG001|Follow-up (FU) Period|Death|12
865375|NCT00494871|1825117|FG000|Follow-up (FU) Period|Lost to Follow-up|6
865376|NCT00494871|1825118|FG001|Follow-up (FU) Period|Lost to Follow-up|2
865377|NCT00494871|1825117|FG000|Follow-up (FU) Period|Physician Decision|0
865378|NCT00494871|1825118|FG001|Follow-up (FU) Period|Physician Decision|1
865379|NCT00494871|1825117|FG000|Follow-up (FU) Period|Protocol Violation|1
865380|NCT00494871|1825118|FG001|Follow-up (FU) Period|Protocol Violation|0
865381|NCT00494871|1825117|FG000|Follow-up (FU) Period|Withdrawal by Subject|5
865382|NCT00494871|1825118|FG001|Follow-up (FU) Period|Withdrawal by Subject|5
865383|NCT00494871|1825117|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3
865384|NCT00494871|1825118|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2
865385|NCT00495040|1825135|FG000|Overall Study|Withdrawal by Subject|3
865386|NCT00495131|1825148|FG000|Overall Study|Adverse Event|6
865387|NCT00495131|1825149|FG001|Overall Study|Adverse Event|2
865388|NCT00495131|1825148|FG000|Overall Study|Lack of Efficacy|0
865389|NCT00495131|1825149|FG001|Overall Study|Lack of Efficacy|2
865390|NCT00495131|1825148|FG000|Overall Study|Lost to Follow-up|0
865391|NCT00495131|1825149|FG001|Overall Study|Lost to Follow-up|2
865392|NCT00495131|1825148|FG000|Overall Study|Withdrawal by Subject|1
865393|NCT00495131|1825149|FG001|Overall Study|Withdrawal by Subject|0
865394|NCT00495170|1825166|FG000|Overall Study|Lost to Follow-up|9
865395|NCT00495170|1825166|FG000|Overall Study|Withdrawal by Subject|3
865396|NCT00495170|1825166|FG000|Overall Study|Inappropriate staging|8
865397|NCT00495391|1825175|FG000|Overall Study|Lack of Efficacy|34
865398|NCT00495391|1825176|FG001|Overall Study|Lack of Efficacy|18
865399|NCT00495391|1825175|FG000|Overall Study|Withdrawal by Subject|2
865400|NCT00495391|1825176|FG001|Overall Study|Withdrawal by Subject|3
865401|NCT00495469|1825189|FG000|Overall Study|Adverse Event|0
865402|NCT00495469|1825190|FG001|Overall Study|Adverse Event|1
865403|NCT00495469|1825191|FG002|Overall Study|Adverse Event|3
865404|NCT00495469|1825192|FG003|Overall Study|Adverse Event|0
865405|NCT00495469|1825193|FG004|Overall Study|Adverse Event|1
865406|NCT00495469|1825194|FG005|Overall Study|Adverse Event|1
865407|NCT00495469|1825195|FG006|Overall Study|Adverse Event|1
865408|NCT00495469|1825189|FG000|Overall Study|Lost to Follow-up|1
865409|NCT00495469|1825190|FG001|Overall Study|Lost to Follow-up|1
865410|NCT00495469|1825191|FG002|Overall Study|Lost to Follow-up|3
865411|NCT00495469|1825192|FG003|Overall Study|Lost to Follow-up|1
865412|NCT00495469|1825193|FG004|Overall Study|Lost to Follow-up|0
865413|NCT00495469|1825194|FG005|Overall Study|Lost to Follow-up|0
865414|NCT00495469|1825195|FG006|Overall Study|Lost to Follow-up|0
865415|NCT00495469|1825189|FG000|Overall Study|Protocol Violation|0
865416|NCT00495469|1825190|FG001|Overall Study|Protocol Violation|0
865417|NCT00495469|1825191|FG002|Overall Study|Protocol Violation|0
865418|NCT00495469|1825192|FG003|Overall Study|Protocol Violation|0
865419|NCT00495469|1825193|FG004|Overall Study|Protocol Violation|1
865420|NCT00495469|1825194|FG005|Overall Study|Protocol Violation|2
865421|NCT00495469|1825195|FG006|Overall Study|Protocol Violation|0
865422|NCT00495469|1825189|FG000|Overall Study|Withdrawal by Subject|5
865423|NCT00495469|1825190|FG001|Overall Study|Withdrawal by Subject|3
865424|NCT00495469|1825191|FG002|Overall Study|Withdrawal by Subject|1
865425|NCT00495469|1825192|FG003|Overall Study|Withdrawal by Subject|3
865426|NCT00495469|1825193|FG004|Overall Study|Withdrawal by Subject|3
865427|NCT00495469|1825194|FG005|Overall Study|Withdrawal by Subject|2
865428|NCT00495469|1825195|FG006|Overall Study|Withdrawal by Subject|3
865429|NCT00495469|1825189|FG000|Overall Study|Lack of Efficacy|0
865430|NCT00495469|1825190|FG001|Overall Study|Lack of Efficacy|0
865431|NCT00495469|1825191|FG002|Overall Study|Lack of Efficacy|0
865432|NCT00495469|1825192|FG003|Overall Study|Lack of Efficacy|0
865433|NCT00495469|1825193|FG004|Overall Study|Lack of Efficacy|0
865434|NCT00495469|1825194|FG005|Overall Study|Lack of Efficacy|0
865435|NCT00495469|1825195|FG006|Overall Study|Lack of Efficacy|1
865436|NCT00495469|1825189|FG000|Overall Study|Liver function test abnormality|0
865437|NCT00495469|1825190|FG001|Overall Study|Liver function test abnormality|1
865438|NCT00495469|1825191|FG002|Overall Study|Liver function test abnormality|0
865439|NCT00495469|1825192|FG003|Overall Study|Liver function test abnormality|0
865440|NCT00495469|1825193|FG004|Overall Study|Liver function test abnormality|0
865441|NCT00495469|1825194|FG005|Overall Study|Liver function test abnormality|0
865442|NCT00495469|1825195|FG006|Overall Study|Liver function test abnormality|0
865443|NCT00495469|1825189|FG000|Overall Study|ST depression at randomisation in ECG|0
865444|NCT00495469|1825190|FG001|Overall Study|ST depression at randomisation in ECG|1
865445|NCT00495469|1825191|FG002|Overall Study|ST depression at randomisation in ECG|0
865446|NCT00495469|1825192|FG003|Overall Study|ST depression at randomisation in ECG|0
865447|NCT00495469|1825193|FG004|Overall Study|ST depression at randomisation in ECG|0
865448|NCT00495469|1825194|FG005|Overall Study|ST depression at randomisation in ECG|0
865449|NCT00495469|1825195|FG006|Overall Study|ST depression at randomisation in ECG|0
865450|NCT00495495|1825218|FG000|Overall Study|Protocol Violation|99
865451|NCT00495521|1825225|FG000|Overall Study|Physician Decision|0
865452|NCT00495521|1825226|FG001|Overall Study|Physician Decision|1
865453|NCT00495586|1825234|FG000|Overall Study|Withdrawal by Subject|4
865454|NCT00495586|1825235|FG001|Overall Study|Withdrawal by Subject|4
865455|NCT00495612|1825245|FG000|Overall Study|Lost to Follow-up|1
865456|NCT00495612|1825246|FG001|Overall Study|Lost to Follow-up|0
865457|NCT00495612|1825245|FG000|Overall Study|Subject's Decision to Withdraw|3
865458|NCT00495612|1825246|FG001|Overall Study|Subject's Decision to Withdraw|0
865459|NCT00495625|1825252|FG000|Overall Study|Did not complete at least 1 42 day cycle|10
865460|NCT00495677|1825263|FG000|Stage 1 (25 Days)|Adverse Event|0
865461|NCT00495677|1825264|FG001|Stage 1 (25 Days)|Adverse Event|0
865462|NCT00495677|1825265|FG002|Stage 1 (25 Days)|Adverse Event|1
865463|NCT00495677|1825266|FG003|Stage 1 (25 Days)|Adverse Event|0
865464|NCT00495677|1825267|FG004|Stage 1 (25 Days)|Adverse Event|0
865465|NCT00495677|1825268|FG005|Stage 1 (25 Days)|Adverse Event|0
865466|NCT00495677|1825269|FG006|Stage 1 (25 Days)|Adverse Event|0
865467|NCT00495755|1825285|FG000|Overall Study|Adverse Event|3
865468|NCT00495794|1825292|FG000|Overall Study|Pharmacist did not activate patient|522
865469|NCT00495794|1825293|FG001|Overall Study|Pharmacist did not activate patient|0
865470|NCT00495820|1825301|FG000|Overall Study|Adverse Event|1
865471|NCT00495820|1825302|FG001|Overall Study|Adverse Event|1
865472|NCT00496015|1825313|FG000|Overall Study|Other|1
865473|NCT00496015|1825314|FG001|Overall Study|Other|0
865474|NCT00496015|1825315|FG002|Overall Study|Other|0
865475|NCT00496015|1825316|FG003|Overall Study|Other|1
865476|NCT00496015|1825317|FG004|Overall Study|Other|0
865477|NCT00496054|1825337|FG000|Overall Study|Adverse Event|1
865478|NCT00496054|1825337|FG000|Overall Study|Lost to Follow-up|7
865479|NCT00496080|1825341|FG000|Overall Study|Lost to Follow-up|9
865480|NCT00496080|1825341|FG000|Overall Study|Surgical re-intervention|7
865481|NCT00496080|1825341|FG000|Overall Study|Withdrawal by Subject|5
865482|NCT00496080|1825341|FG000|Overall Study|Physician Decision|6
865483|NCT00496197|1825346|FG000|Overall Study|Discontinued study due to death|43
865484|NCT00496197|1825346|FG000|Overall Study|Adverse Event|13
865485|NCT00496197|1825346|FG000|Overall Study|Does not meet entrance criteria|5
865486|NCT00496197|1825346|FG000|Overall Study|Insufficient clinical response|3
865487|NCT00496197|1825346|FG000|Overall Study|Insufficient bacteriological response|10
865488|NCT00496197|1825346|FG000|Overall Study|Lost to Follow-up|11
865489|NCT00496197|1825346|FG000|Overall Study|Withdrawal by Subject|11
865490|NCT00496197|1825346|FG000|Overall Study|Pathogen not isolated baseline specimen|4
865491|NCT00496197|1825346|FG000|Overall Study|Other|14
865492|NCT00496197|1825346|FG000|Overall Study|Protocol Violation|8
